CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

Abstract

CRISPR/CAS-related compositions and methods for treatment of Cystic Fibrosis (CF).

Description

REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 15/288,475, filed Oct. 7, 2016, which is a continuation of PCT International Patent Application No. PCT/US2015/023960, filed on Apr. 1, 2015, which claims the benefit of U.S. Provisional Application No. 61/977,488, filed Apr. 9, 2014, the contents of each of which are hereby incorporated by reference in their entirety herein, and to each of which priority is claimed.

SEQUENCE LISTING

The specification further incorporates by reference the Sequence Listing submitted herewith via EFS on Apr. 30, 2021. Pursuant to 37 C.F.R. § 1.52(e)(5), the Sequence Listing text file, identified as 084177_0247SEQ.txt, is 6,269,340 bytes and was created on Apr. 30, 2021. The Sequence Listing, electronically filed herewith, does not extend beyond the scope of the specification and thus does not contain new matter.

FIELD OF THE INVENTION

The invention relates to CRISPR/CAS-related methods and components for editing of a target nucleic acid sequence, and applications thereof in connection with Cystic Fibrosis (CF) or CF-like disease.

BACKGROUND

Cystic fibrosis (CF) is an autosomal recessive, hereditary disease caused by defects in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene encodes a cAMP-gated channel that is involved in chloride and bicarbonate transport. It regulates sodium transport through inhibition of the epithelial sodium channel, which is encoded by the SCNN1A gene. CFTR is expressed on the apical surface of epithelial cells in the airway, gastrointestinal tract, reproductive tract, sweat glands and submucosal glands.

CF affects one in 3,500 children born in the United States. It is the most common fatal autosomal recessive disease in individuals of European descent (Tobias 2011; Essential Medical Genetics, John Wiley & Sons, ed. p. 312). There are approximately 30,000 subjects in the United States with the disease (From The Cystic Fibrosis Foundation; cff.org, accessed on Mar. 19, 2015).

The most common mutation in the CFTR gene is a deletion of the three nucleotides encoding Phenylalanine (F) at position 508 of the CFTR protein (also sometime referred to herein as “F508del”). This mutation is the causative mutation in approximately two-thirds of CF cases. The remaining cases are caused by at least 1000 different mutations, many of which cause a less severe form of the disease.

Subjects having CF can present at birth or in early infancy with pancreatic insufficiency. Pancreatic dysfunction leads to malabsorption of fat and fat-soluble vitamins, which causes poor growth as well as gallstones and biliary disease. The lung manifestations of the disease can be more severe but may present slightly after pancreatic manifestations, in infancy or early childhood. Aberrant chloride and sodium transport due to decreased CFTR activity causes lowered apical surface fluid levels in the lungs, which leads to “sticky” mucous and lower airway obstruction. Subjects having CF or CF-like disease suffer from frequent infections due to inability to clear mucous. Local inflammatory mediators try to clear the infection but have difficulty. The triad of inflammation, infection and obstruction leads to progressive destruction of the lung parenchyma. Eventually, many subjects having CF or CF-like disease die in their late 30's due to respiratory failure.

Current treatments for CF or CF-like disease delay lung destruction and slow disease progression. Treatments for the pulmonary manifestations of CF or CF-like disease include: antibiotics (oral, inhaled and intravenous), CFTR modulators (including CFTR potentiators), DNase, chest physiotherapy to loosen secretions and anti-inflammatory therapeutics. Treatment of the gastrointestinal manifestations includes supplemental gut soluble vitamins, high calorie diet and oral pancreatic enzymes. Subjects who develop diabetes are treated with insulin injections or an insulin pump. At the end stage, patients may benefit from lung transplant. Lung transplant may be combined with liver and/or pancreatic transplant.

Current treatments do not reverse the damage to the lungs or cure CF or CF-like disease. The average life expectancy for subjects having CF or CF-like disease is 37 years of age (MacKenzie et al., 2014; Annals of Internal Medicine 161(4):233-41). 80% of patients with CF or CF-like disease die from end-stage lung disease.

In spite of current therapies, there is a need for a therapy that prevents or delays the progression of disease in CF or CF-like disease.

SUMMARY OF THE INVENTION

Methods and compositions discussed herein provide for the treatment and prevention of Cystic Fibrosis (CF) and CF-like disease. The approach described herein aims to restore CFTR channel function, restore chloride, bicarbonate and/or sodium balance, and/or decrease mucous viscosity within the lungs, airways, gastrointestinal tract and reproductive tract.

CFTR modulators (both approved and in development) improve the functioning of mutant CFTR. These therapeutics improve CFTR functioning but do not return functionality to wild type levels. The approach described herein is expected to restore CFTR function through complete correction of the gene.

Gene therapy approaches are in development that deliver the CFTR channel gene to the lungs of CF or CF-like disease patients. However, gene therapy may require constant readministration over the course of the lifetime of a subject due to high cell turnover in target epithelial cells. The approach described herein is expected to restore CFTR function and/or ameliorate SCNN1A disinhibition permanently through one, two or several doses.

The CFTR gene encodes a 180-kDA cAMP-gated chloride (Cl—) channel. The channel has six transmembrane spanning domains and is expressed by epithelial cells, lymphocytes and cardiac myocytes. The CFTR regulates the viscosity of mucous through its activity in the epithelial cells of the lungs, gastrointestinal tract and reproductive tract. Mutations in the CFTR result in decreased CFTR activity. Decreased CFTR activity can lead to aberrant ion transport, which gives rise to various disease symptoms in the lungs and other tissues, such as accumulation of sticky mucus, airway obstruction, infection and inflammation. Correction of CFTR mutations will ameliorate or cure lung, gastrointestinal and/or reproductive symptoms of CF or CF-like disease.

The SCNN1A gene encodes the alpha subunit of the epithelial sodium channel (ENaC). The channel, comprised of alpha, beta and gamma subunits, regulates sodium transport into epithelial cells, including the epithelium of the lungs, sweat glands and kidneys. Mutations in the SCNN1A gene, (e.g. Val114ILE) have been shown to cause CF-like disease, characterized by pulmonary disease, including bronchiectasis. Mutations in SCNN1A also cause pseudohypoaldosteronism, a severe disease of the kidney. Pseudohypoaldosteronism is due to defective sodium transport within kidney epithelial cells; it is not caused by defective sodium transport in other tissues. The methods described herein include the targeted knockout of SCNN1A in the lung, gastrointestinal tract and/or reproductive tract. The methods described herein will not target kidney epithelium and will avoid the negative consequences of SCNN1A mutations within the kidney epithelium. One mutation in the SCNN1A gene, a 1477T>G substitution (W493R) has been identified in subjects who also have a mutation in CFTR. This mutation is associated with a severe CF or CF-like disease phenotype, including severe bronchiectasis, chronic bronchitis and/or severe gastrointestinal symptoms. This mutation has been found to be associated with 4-fold overactivity of the ENaC channel (Azad et al., 2009; Human Mutation 30: 1093-1103). Overactivity of the SCNN1A-encoded ENaC channel can contribute to CF and CF-like disease. In all subjects, the CFTR is involved in inhibition of ENaC. CFTR mutations in subjects with CF or CF-like disease leads to ENaC disinhibition, leading to overactivity of the ENaC channel. ENaC overactivity can lead to further reduction in viscosity of mucous in CF or CF-like disease subjects, as more sodium is absorbed at the apical surface of epithelial cells, followed by increased fluid absorption from the mucous layer within the lung (Baker et al., 2012; Medicine & Science in Sports and Exercise 44(12): 2315-2321). Increased fluid absorption from the mucous layer reduces mucous viscosity. Inhibition of ENaC through SCNN1A knockout and/or knockdown in subjects with CF or CF-like disease can ameliorate the symptoms of CF or CF-like disease. Mutations in the CFTR gene (also known as ABC35, ATP-binding cassette sub-family C, member 7, CFTR/MRP, dJ760C5.1, MRP7 and TNR-CFTR) have been shown to cause CF and/or CF-like disease. Mutations in the CFTR gene leading to CF and/or CF-like disease can be described based on their target position in the CFTR protein. In an embodiment, the target position is F508, e.g., F508del (also sometimes referred to herein as “ΔF508”), in the CFTR protein, which corresponds to a deletion of three nucleotides c.1521_1523delCTT in the CFTR gene (e.g., c.1521_1523delCTT (p.Phe508delPhe)). In an embodiment, the target position is G551, e.g., G551D, in the CFTR protein, which corresponds to c.1652G>A in the CFTR gene. In an embodiment, the target position is G542, e.g., G542X, in the CFTR protein, which corresponds to c.1624G>T in the CFTR gene. In an embodiment, the target position is N1303, e.g., N1303K, in the CFTR protein, which corresponds to c.3909C>G in the CFTR gene. In an embodiment, the target position is R117, e.g., R117H, in the CFTR protein, which corresponds to c.350G>A in the CFTR gene. In an embodiment, the target position is W1282, e.g., W1282X, in the CFTR protein, which corresponds to c. c.3846G>A in the CFTR gene. In an embodiment, the target position is R553, e.g., R553X, in the CFTR protein, which corresponds to c.1657C>T in the CFTR gene. In an embodiment, the target position is c.3717+12191, also known as c.3849+10kb, which corresponds to 3717+12191C>T in the CFTR gene. In an embodiment, the target position is c.2657+5, also known as c.2789+5, which corresponds to 2657+5G>A in the CFTR gene. In an embodiment, the target position is c.3140-26, also known as c.3272-26, which corresponds to c.3140-26A>G in the CFTR gene.

Overactivity of the SCNN1A gene has been shown to contribute to bronchiectasis, bronchitis, and gastrointestinal symptoms in subjects with CF and in subjects with CF-like disease. In another aspect, methods and compositions discussed herein may be used to alter the SCNN1A gene (also known as sodium channel, non-voltage-gated 1 alpha subunit; amiloride-sensitive epithelial sodium channel alpha subunit; BESC2; ENaCa; SCNEA; SCNN1; ENaCalpha) to treat or prevent CF or CF-like disease, by targeting the SCNN1A gene, e.g., the non-coding or coding regions, e.g., a promoter region, or a transcribed sequence, e.g., intronic or exonic sequence. In an embodiment, the target position is V114, which corresponds to V114I in the SCNN1A gene. SCNN1A encodes an epithelial sodium channel, ENaC, that is negatively regulated by CFTR. In subjects with CFTR mutations, knocking out or knocking down the SCNN1A gene in certain cells will reduce or reverse the effect of defective CFTR. In subjects with no CFTR mutations but CF-like disease caused by SCNN1A mutations or other mechanisms, knocking out or knocking down the SCNN1A gene in certain cells will improve the viscosity of mucous and ameliorate disease.

Methods and compositions disclosed herein provide a number of approaches for treating or preventing CF and/or CF-like disease. As is discussed in more detail below, methods described herein provide for treating or preventing CF or CF-like disease by correcting a target position in the CFTR gene to provide corrected, or functional, e.g., wild type, CFTR. Other methods described herein allow for treating or preventing CF or CF-like disease by inducing or introducing a mutation that reduces the level of functional SCNN1A gene product.

In one aspect, methods and compositions discussed herein, provide for the correction of the underlying cause of CF or CF-like disease, e.g., the correction of a mutation at a target position in the CFTR gene, e.g., correction of a mutation in the CFTR gene that corresponds to amino acid position 508, e.g., an F508 deletion (F508del), in CFTR protein.

“CF target mutant position”, as used herein, refers to a target position in the CFTR gene, which, if mutated, can result in a mutant protein and give rise to CF or CF-like disease. In an embodiment, the target position comprises one, two, or three nucleotides. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at F508, e.g., F508del. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at G551, e.g., G551D. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at G542, e.g., G542X, in the CFTR protein, which corresponds to c.1624G>T in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at N1303, e.g., N1303K, in the CFTR protein, which corresponds to c.3909C>G in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at R117, e.g., R117H, in the CFTR protein, which corresponds to c.350G>A in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at W1282, e.g., W1282X, in the CFTR protein, which corresponds to c. c.3846G>A in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at R553, e.g., R553X, in the CFTR protein, which corresponds to c.1657C>T in the CFTR gene. In an embodiment, the CF target mutant position is c.3717+12191, also known as c.3849+10kb, which corresponds to 3717+12191C>T in the CFTR gene. In an embodiment, the CF target mutant position is c.2657+5, also known as c.2789+5, which corresponds to 2657+5G>A in the CFTR gene. In an embodiment, the CF target mutant position is c.3140-26, also known as c.3272-26, which corresponds to c.3140-26A>G in the CFTR gene. In an embodiment, the CF target mutant position is a position in the SCNN1A gene at which a change can give rise to a mutant protein having a mutation at V114, which corresponds to V114I in the SCNN1A gene.

While some of the disclosure herein is presented in the context of the mutation in the CFTR gene that gives rise to an F508 mutant protein (e.g., a F508del mutant protein), a G551 mutant protein (e.g., a G551D mutant protein), a G542 mutant protein (e.g., G542X mutant protein), a N1303 mutant protein (e.g., a N1303K mutant protein), a R117 mutant protein (e.g., an R117H mutant protein), a W1282 mutant protein (e.g., a W1282X mutant protein), an R553 mutant protein (e.g., an R553X mutant protein), a c.2789+5bp intronic mutant (e.g., a c.2789+5bp G>A mutant), or a c.3272-26bp intronic mutant (e.g., a c.3272-26bp A>G mutant), the methods and compositions herein are broadly applicable to any mutation, e.g., a point mutation or a deletion, in the CFTR gene that gives rise to CF or CF-like disease.

While not wishing to be bound by theory, it is believed that, in an embodiment, a mutation at a CF target mutant position is corrected by homology directed repair (HDR), as described herein.

In another aspect, methods and compositions discussed herein may be used to alter the SCNN1A gene (also known as sodium channel, non-voltage-gated 1 alpha subunit) to treat or prevent CF or CF-like disease, by targeting the SCNN1A gene, e.g., the non-coding or coding regions, e.g., a promoter region, or a transcribed sequence, e.g., intronic or exonic sequence. SCNN1A encodes an epithelial sodium channel that is negatively regulated by CFTR. By knocking out the SCNN1A gene in certain cells, the effect of defective CFTR can be reduced or reversed.

In another aspect, the methods and compositions discussed herein may be used to alter the SCNN1A gene to treat or prevent CF or CF-like disease by targeting the coding sequence of the SCNN1A gene. In one embodiment, the gene, e.g., the coding sequence of the SCNN1A gene, is targeted to knockout the gene, e.g., to eliminate expression of the gene, e.g., to knockout one or both alleles of the SCNN1A gene, e.g., by induction of an alteration comprising a deletion or mutation in the SCNN1A gene. In an embodiment, the method provides an alteration that comprises an insertion or deletion.

In an embodiment, coding region, e.g., an early coding region, of the SCNN1A gene, is targeted for alteration and knockout. In one embodiment, an early coding region of the SCNN1A gene is targeted to knockout the SCNN1A gene. In an embodiment, targeting affects both alleles of the SCNN1A gene. In an embodiment, targeting affects one allele of the SCNN1A gene. In an embodiment, a targeted knockout approach reduces or eliminates expression of functional SCNN1A gene product. In an embodiment, the method provides an alteration in the SCNN1A gene that comprises an insertion or deletion.

In another aspect, the methods and compositions discussed herein may be used to alter the SCNN1A gene to treat or prevent CF or CF-like disease by targeting non-coding sequence of the SCNN1A gene, e.g., promoter, an enhancer, an intron, 3′UTR, and/or polyadenylation signal. In an embodiment, the gene, e.g., the non-coding sequence of the SCNN1A gene, is targeted to knockout the gene, e.g., to eliminate expression of the gene, e.g., to knockout one or both alleles of the SCNN1A gene, e.g., by induction of an alteration comprising a deletion or mutation in the SCNN1A gene. In an embodiment, the method provides an alteration that comprises an insertion or deletion.

As described herein, in an embodiment, a targeted knockout approach is mediated by non-homologous end joining (NHEJ) using a CRISPR/Cas system comprising an enzymatically active Cas9 (eaCas9).

“CF target knockout position”, as used herein, refers to a position in the SCNN1A gene, which if altered by NHEJ-mediated alteration, results in alleviation of a symptom of CF or CF-like disease. In an embodiment, the alteration results in reduction or elimination of expression of functional SCNN1A gene product. In an embodiment, the position is in the SCNN1A coding region, e.g., an early coding region.

In an embodiment, the promoter region of the SCNN1A gene is targeted to knock down the expression of the SCNN1A gene. This type of alteration is also sometimes referred to as “knocking down” the SCNN1A gene. While not wishing to be bound by theory, in an embodiment, a targeted knockdown approach is mediated by a CRISPR/Cas system comprising a Cas9 molecule, e.g., an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain or chromatin modifying protein), as described herein. In an embodiment, the SCNN1A gene is targeted to alter (e.g., to block, reduce, or decrease) the transcription of the SCNN1A gene. In another embodiment, the SCNN1A gene is targeted to alter the chromatin structure (e.g., one or more histone and/or DNA modifications) of the SCNN1A gene. In an embodiment, a CF target knockdown position is targeted by genome editing using the CRISPR/Cas9 system. In an embodiment, one or more gRNA molecules comprising a targeting domain are configured to target an enzymatically inactive Cas9 (eiCas9) or an eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain), sufficiently close to a CF target knockdown position to reduce, decrease or repress expression of the SCNN1A gene.

“CF target knockdown position”, as used herein, refers to a position in the SCNN1A gene, which if targeted, e.g., by an eiCas9 molecule or an eiCas9 fusion described herein, results in reduction or elimination of expression of functional SCNN1A gene product. In an embodiment, the transcription of the SCNN1A gene is reduced or eliminated. In another embodiment, the chromatin structure of the SCNN1A gene is altered.

“CF target knockin position”, as used herein, refers to a sequence, which if modified by the insertion of CFTR sequence, results in an optimization of CFTR activity, e.g., by resulting in a CFTR sequence that encodes a protein having wild type activity. Exemplary CF target knockin position include: CFTR sequence within intron 2, into which, e.g., can be introduced CFTR sequence that codes for CFTR exons 3-27; and sequence within CFTR intron 10, into which sequence that codes for CFTR exons 11-27 can be introduced. In an embodiment, a CF target knockin position includes CFTR intronic sequence between a second and a third exon (e.g., intron 2), and CFTR sequence encoding the third exon through the final exon (exon 27), is introduced, resulting in a CFTR sequence that is free of one or more cryptic splice sites and that encodes a CFTR protein having wild type activity. In an embodiment, a CF target knockin position, is a position which is upstream of a mutation, or upstream of an intron having a mutation, and introduction of wild-type CFTR sequence results in a CFTR sequence that is free of the mutation. In an embodiment the CF target knockin position is in CFTR intronic sequence: between exon2 and exon 3; or between exon10 and exon 11. In an embodiment, the resulting CFTR sequence comprises subject sequence upstream from the CF target knockin position and newly introduced sequence downstream from the CF target knockin position, which taken together, encode a CFTR protein having wild type activity. In an embodiment, the point of insertion is 3′ to a splice donor site and 5′ from a splice acceptor site. In an embodiment, CFTR sequence encoding exons 3-27 is inserted under control of the promoter, e.g., at the transcription start site. In an embodiment, CFTR sequence introduced can exclude introns, e.g., a sequence encoding exons, but without introns, is inserted, e.g., CFTR CDNA sequence is introduced.

“CF target position”, as used herein, refers to a CF target mutant position, CF target knockout position, CF target knockdown position, and/or CF target knockin position, as described herein.

In one aspect, disclosed herein is a gRNA molecule, e.g., an isolated or non-naturally occurring gRNA molecule, comprising a targeting domain which is complementary with a target domain from the CFTR gene or SCNN1A gene.

In an embodiment, the targeting domain of the gRNA molecule is configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to a CF target position in the CFTR gene or SCNN1A gene to allow alteration, e.g., alteration associated with, respectively, HDR or NHEJ, of a CF target position in the CFTR gene or SCNN1A gene. In an embodiment, the targeting domain is configured such that a cleavage event, e.g., a double strand or single strand break, is positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of a CF target position. The break, e.g., a double strand or single strand break, can be positioned upstream or downstream of a CF target position in the CFTR gene or SCNN1A gene.

In an embodiment, a second gRNA molecule comprising a second targeting domain is configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to the CF target position in the CFTR gene or SCNN1A gene, to allow alteration, e.g., alteration associated with, respectively, HDR or NHEJ, of the CF target position in the CFTR gene or SCNN1A gene, either alone or in combination with the break positioned by said first gRNA molecule. In an embodiment, the targeting domains of the first and second gRNA molecules are configured such that a cleavage event, e.g., a double strand or single strand break, is positioned, independently for each of the gRNA molecules, within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position. In an embodiment, the breaks, e.g., double strand or single strand breaks, are positioned on both sides of a nucleotide of a CF target position in the CFTR gene or SCNN1A gene. In an embodiment, the breaks, e.g., double strand or single strand breaks, are positioned on one side, e.g., upstream or downstream, of a nucleotide of a CF target position in the CFTR gene or SCNN1A gene.

In an embodiment, a single strand break is accompanied by an additional single strand break, positioned by a second gRNA molecule, as discussed below. For example, the targeting domains are configured such that a cleavage event, e.g., the two single strand breaks, are positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of a CF target position. In an embodiment, the first and second gRNA molecules are configured such, that when guiding a Cas9 molecule, e.g., a Cas9 nickase, a single strand break will be accompanied by an additional single strand break, positioned by a second gRNA, sufficiently close to one another to result in alteration of a CF target position in the CFTR gene or SCNN1A gene. In an embodiment, the first and second gRNA molecules are configured such that a single strand break positioned by said second gRNA is within 10, 20, 30, 40, or 50 nucleotides of the break positioned by said first gRNA molecule, e.g., when the Cas9 molecule is a nickase. In an embodiment, the two gRNA molecules are configured to position cuts at the same position, or within a few nucleotides of one another, on different strands, e.g., essentially mimicking a double strand break.

In an embodiment, a double strand break can be accompanied by an additional double strand break, positioned by a second gRNA molecule, as is discussed below. For example, the targeting domain of a first gRNA molecule is configured such that a double strand break is positioned upstream of a CF target position in the CFTR gene or SCNN1A gene, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position; and the targeting domain of a second gRNA molecule is configured such that a double strand break is positioned downstream of a CF target position in the CFTR gene or SCNN1A gene, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position.

In an embodiment, a double strand break can be accompanied by two additional single strand breaks, positioned by a second gRNA molecule and a third gRNA molecule. For example, the targeting domain of a first gRNA molecule is configured such that a double strand break is positioned upstream of a CF target position in the CFTR gene or SCNN1A gene, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position; and the targeting domains of a second and third gRNA molecule are configured such that two single strand breaks are positioned downstream of a CF target position in the CFTR gene or SCNN1A gene, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position. In an embodiment, the targeting domain of the first, second and third gRNA molecules are configured such that a cleavage event, e.g., a double strand or single strand break, is positioned, independently for each of the gRNA molecules.

In an embodiment, a first and second single strand breaks can be accompanied by two additional single strand breaks positioned by a third gRNA molecule and a fourth gRNA molecule. For example, the targeting domain of a first and second gRNA molecule are configured such that two single strand breaks are positioned upstream of a CF target position in the CFTR gene or SCNN1A gene, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position; and the targeting domains of a third and fourth gRNA molecule are configured such that two single strand breaks are positioned downstream of a CF target position in the CFTR gene or SCNN1A gene, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 225, 250, or 300 nucleotides of the target position.

It is contemplated herein that, in an embodiment, when multiple gRNAs are used to generate (1) two single stranded breaks in close proximity, (2) two double stranded breaks, e.g., flanking a CF target position, e.g., a mutation (e.g., to remove a piece of DNA, e.g., to introduce a deletion mutation) or to create more than one indel in the gene, e.g., in a coding region, e.g., an early coding region, (3) one double stranded break and two paired nicks flanking a CF target position, e.g., a mutation (e.g., to remove a piece of DNA, e.g., to introduce a deletion mutation) or (4) four single stranded breaks, two on each side of a position, e.g., a mutation, that they are targeting the same CF target position. It is further contemplated herein that multiple gRNAs may be used to target more than one CF target position (e.g., mutation) in the same gene.

In an embodiment, the targeting domain of the first gRNA molecule and the targeting domain of the second gRNA molecules are complementary to opposite strands of the target nucleic acid molecule. In an embodiment, the gRNA molecule and the second gRNA molecule are configured such that the PAMs are oriented outward.

In an embodiment, the targeting domain of a gRNA molecule is configured to avoid unwanted target chromosome elements, such as repeat elements, e.g., Alu repeats, in the target domain. The gRNA molecule may be a first, second, third and/or fourth gRNA molecule, as described herein.

In an embodiment, the targeting domain of a gRNA molecule is configured to position a cleavage event sufficiently far from a preselected nucleotide, e.g., the nucleotide of a coding region, such that the nucleotide is not altered. In an embodiment, the targeting domain of a gRNA molecule is configured to position an intronic cleavage event sufficiently far from an intron/exon border, or naturally occurring splice signal, to avoid alteration of the exonic sequence or unwanted splicing events. The gRNA molecule may be a first, second, third and/or fourth gRNA molecule, as described herein.

In an embodiment, a CF target mutant position, e.g., a deletion in the CFTR gene, e.g., at F508, e.g., F508del, is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 1A-1E, 10A-10C, 11A-11E or 12A-12C. In some embodiments, the targeting domain is independently selected from those in Tables 1A-1E, 10A-10C, 11A-11E or 12A-12C. For example, in certain embodiments, the targeting domain is independently selected from:

(SEQ ID NO: 387)
GAGGGUAAAAUUAAGCACAG;
(SEQ ID NO: 388)
AGUUUCUUACCUCUUCUAGU;
(SEQ ID NO: 389)
AAUGGUGCCAGGCAUAAUCC;
(SEQ ID NO: 390)
GGUAAAAUUAAGCACAG;
(SEQ ID NO: 391)
AGCAUGCCAACUAGAAG;
or
(SEQ ID NO: 392)
GUAUCUAUAUUCAUCAU.

In an embodiment, when the CF target mutant position is F508, e.g., F508del, and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 1A-1E, 10A-10C, 11A-11E or 12A-12C.

In an embodiment, a CF target mutant position, e.g., a mutation in the CFTR gene, e.g., at G551, e.g., G551D, is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 2A-2E, 16A-16D, 17A-17E, or 18A-18C. In some embodiments, the targeting domain is independently selected from those in Tables 2A-2E, 16A-16D, 17A-17E, or 18A-18C. For example, in certain embodiments, the targeting domain is independently selected from:

(SEQ ID NO: 453)
GAGAAAGACAAUAUAGUUCU;
(SEQ ID NO: 454)
GGUGGAAUCACACUGAGUGG;
(SEQ ID NO: 455)
CCCACUAGCCAUAAAACCCC;
(SEQ ID NO: 456)
GGUGGAAUCACACUGAG;
(SEQ ID NO: 457)
GGAAUCACACUGAGUGG;
(SEQ ID NO: 458)
GGGGUUUUAUGGCUAGU;
or
(SEQ ID NO: 459)
ACUAGCCAUAAAACCCC.

In an embodiment, more than one gRNA is used to position breaks, e.g., two single stranded breaks or two double stranded breaks, or a combination of single strand and double strand breaks, e.g., to create one or more indels, in the target nucleic acid sequence. In an embodiment, the targeting domain of each guide RNA is independently selected from one of Tables 2A-2E, 16A-16D, 17A-17E, or 18A-18C.

In an embodiment, a mutation in the CFTR gene, e.g., at N1303, e.g., N1303K, is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 19A-19D, 20A-20E, or 21A-21B. In some embodiments, the targeting domain is independently selected from those in Tables 19A-19D, 20A-20E, or 21A-21B. For example, in certain embodiments, the targeting domain is selected from:

(SEQ ID NO: 2223)
GGAGUGAUCAAGAAAUA;
(SEQ ID NO: 2224)
GAGUACCCUAACAUACC;
(SEQ ID NO: 2225)
GUGUGUGCACAACUUUAAAA;
(SEQ ID NO: 2226)
GGAAAGUUGCAGAUGAGGUA;
(SEQ ID NO: 2227)
GAACUUGAUGGUAAGUACAU;
or
(SEQ ID NO: 2228)
GCUAUAUCAGCCAUUUGUGU.

In an embodiment, when the CF target mutant position is N1303, e.g., N1303K, and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 19A-19D, 20A-20E, or 21A-21B.

In an embodiment, a mutation in the CFTR gene, e.g., at W1282, e.g., W1282X, is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 28A-28D, 29A-29E, or 30A-30B. In some embodiments, the targeting domain is independently selected from those in Tables 28A-28D, 29A-29E, or 30A-30B. For example, in certain embodiments, the targeting domain is selected from:

(SEQ ID NO: 2993)
GAAUUAUGUUUAUGGCA;
(SEQ ID NO: 2994)
GGAGAAAUCCAGAUCGA;
(SEQ ID NO: 2995)
GGCCUCUUGGGAAGAAC;
(SEQ ID NO: 2996)
GUCCUUUUGCUCACCUG;
(SEQ ID NO: 2997)
GAUCGAUGGUGUGUCUU;
(SEQ ID NO: 2998)
GAAGGAGAAAUCCAGAUCGA;
(SEQ ID NO: 2999)
GUGGGCCUCUUGGGAAGAAC.

In an embodiment, when the CF target mutant position is W1282, e.g., W1282X, and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 28A-28D, 29A-29E, or 30A-30B.

In an embodiment, a mutation in the CFTR gene, e.g., at R553, e.g., R553X, is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 25A-25D, 26A-26E, or 27A-27D. In some embodiments, the targeting domain is independently selected from those in Tables 25A-25D, 26A-26E, or 27A-27D. For example, in certain embodiments, the targeting domain is selected from:

(SEQ ID NO: 466)
GCUUUAUAUUCUGUUUC;
(SEQ ID NO: 456)
GGUGGAAUCACACUGAG;
(SEQ ID NO: 457)
GGAAUCACACUGAGUGG;
(SEQ ID NO: 464)
GUUCAAAAUUUCAACUG;
(SEQ ID NO: 465)
GGUGAAUAACUAAUUAU;
(SEQ ID NO: 458)
GGGGUUUUAUGGCUAGU;
(SEQ ID NO: 462)
GAGCAAGAAUUUCUUUAGCA;
(SEQ ID NO: 460)
GACAAUAUAGUUCUUGGAGA;
(SEQ ID NO: 461)
GAAGGUGGAAUCACACUGAG;
(SEQ ID NO: 454)
GGUGGAAUCACACUGAGUGG;
or
(SEQ ID NO: 453)
GAGAAAGACAAUAUAGUUCU.

In an embodiment, when the CF target mutant position is R553, e.g., R553X, and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 25A-25D, 26A-26E, or 27A-27D.

In an embodiment, a mutation in the CFTR gene, e.g., at 3717+12191C>T, also known as 3849+10kbC>T is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 34A-34D, 35A-35D, or 36A-36D. In some embodiments, the targeting domain is independently selected from those in Tables 34A-34D, 35A-35D, or 36A-36D. For example, in certain embodiments, the targeting domain is selected from:

(SEQ ID NO: 3344)
GAGUAAGACACCCUGAA;
(SEQ ID NO: 3345)
GAUUUCUGGAGACCACA;
(SEQ ID NO: 3346)
GGUUUUAGCUAUUACUC;
(SEQ ID NO: 3347)
GUAGUUGAAUCAUUCAG;
(SEQ ID NO: 3348)
GAACUCAGUUUUUAGGU;
(SEQ ID NO: 3349)
GAAAGGAAAUGUUCUAUUCA;
(SEQ ID NO: 3350)
GUUUUUAGGUUGGGAAAGAC;
(SEQ ID NO: 3351)
GCACAUAAUAAUUAGUUUCC;
(SEQ ID NO: 3352)
GAGAACUCAGUUUUUAGGUU;
or
(SEQ ID NO: 3353)
GAAAACACUGACUUAGAUUU.

In an embodiment, when the CF target mutant position is 3717+12191C>T and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 34A-34D, 35A-35D, or 36A-36D.

In an embodiment, a mutation in the CFTR gene, e.g., at 2657+5G>A, also known as 2789+5G>A is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 4A-4D, 5A-5E, or 6A-6C. In some embodiments, the targeting domain is independently selected from those in Tables 4A-4D, 5A-5E, or 6A-6C. For example, in certain embodiments, the targeting domain is selected from:

(SEQ ID NO: 937)
GAAGCAGCCACCUGGAA;
(SEQ ID NO: 938)
GGAAUAUUCACUUUCCA;
(SEQ ID NO: 939)
GAAUUUAGAUGUGGGCA;
(SEQ ID NO: 940)
GUGUCUUGUUCCAUUCC;
(SEQ ID NO: 941)
GUGGGCAUGGGAGGAAU;
(SEQ ID NO: 942)
GUUGUGCUGUGGCUCCU;
(SEQ ID NO: 943)
GAUGUGAAUUUAGAUGU;
(SEQ ID NO: 944)
GACCCAGGAACACAAAGCAA;
(SEQ ID NO: 945)
GUGUCACCUCACCCAACUAA;
(SEQ ID NO: 946)
GUGUCUUGUUCCAUUCCAGG;
(SEQ ID NO: 947)
GAUGUGGGCAUGGGAGGAAU;
(SEQ ID NO: 948)
GUGAAUUUAGAUGUGGGCAU.

In an embodiment, when the CF target mutant position is 2657+5G>A and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 4A-4D, 5A-5E, or 6A-6C.

In an embodiment, a mutation in the CFTR gene, e.g., at 3140-26A>G, also known as 3272-26A>G, is targeted, e.g., for correction. In an embodiment, the targeting domain of a gRNA molecule comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 7A-7D, 8A-8E, or 9A-9B. In some embodiments, the targeting domain is independently selected from those in Tables 7A-7D, 8A-8E, or 9A-9B. For example, in certain embodiments, the targeting domain is selected from:

(SEQ ID NO: 1282)
GUAAGGCUGCCGUCCGA;
(SEQ ID NO: 1283)
GGAAAUAUUUCACAGGC;
(SEQ ID NO: 1284)
GUAAAUUCAGAGCUUUG;
(SEQ ID NO: 1285)
GGACACUUCGUGCCUUCGGA;
(SEQ ID NO: 1286)
GGAACCAGCGCAGUGUUGAC;
(SEQ ID NO: 1287)
GUAACAAGAUGAGUGAAAAU.

In an embodiment, when the CF target mutant position is 3140-26A>G and two gRNAs are used to position two breaks, e.g., two single stranded breaks, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 7A-7D, 8A-8E, or 9A-9B.

In another embodiment, a CF target knockout position, e.g., a position in the coding region, e.g., the early coding region, of the SCNN1A gene is targeted, e.g., for knockout. In an embodiment, the targeting domain comprises a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 3A-3D, 43A-43E, 44A-44G, or 45A-45E. In an embodiment, the targeting domain is independently selected from those in Tables 3A-3D, 43A-43E, 44A-44G, or 45A-45E. In another embodiment, the targeting domain is independently selected from:

(SEQ ID NO: 497)
GCCCAUACCAGGUCUCAUGG;
(SEQ ID NO: 498)
CCAUACCAGGUCUCAUGGAG;
(SEQ ID NO: 499)
GCCCUCCACAGUCCACUCCA;
(SEQ ID NO: 500)
CCCCUCCAUGAGACCUGGUA;
(SEQ ID NO: 501)
AUACCAGGUCUCAUGGA;
or
(SEQ ID NO: 502)
CUCCAUGAGACCUGGUA.

In an embodiment, when the CF target knockout position is the SCNN1A coding region, e.g., early coding region, and more than one gRNA is used to position breaks, e.g., two single stranded breaks or two double stranded breaks, or a combination of single strand and double strand breaks, e.g., to create one or more indels, in the target nucleic acid sequence, each guide RNA is independently selected from one of Tables 3A-3D, 43A-43E, 44A-44G, or 45A-45E.

In an embodiment, the targeting domain of the gRNA molecule is configured to target an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain), sufficiently close to a SCNN1A transcription start site (TSS) to reduce (e.g., block) transcription, e.g., transcription initiation or elongation, binding of one or more transcription enhancers or activators, and/or RNA polymerase. In an embodiment, the targeting domain is configured to target between 1000 bp upstream and 1000 bp downstream (e.g., between 500 bp upstream and 1000 bp downstream, between 1000 bp upstream and 500 bp downstream, between 500 bp upstream and 500 bp downstream, within 500 bp upstream, or within 500 bp downstream) of the TSS of the SCNN1A gene. One or more gRNAs may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

In an embodiment, when the SCNN1A promoter region is targeted, e.g., for knockdown, the targeting domain can comprise a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any one of Tables 46A-46E, 47A-47G, or 48A-48E. In an embodiment, the targeting domain is independently selected from those in Tables 46A-46E, 47A-47G, or 48A-48E.

In an embodiment, the targeting domain is independently selected from those in Table 46A. In an embodiment, the targeting domain is independently selected from those in Table 47A. In an embodiment, the targeting domain is independently selected from those in Table 48A.

In an embodiment, when the CF target knockdown position is the SCNN1A promoter region and more than one gRNA is used to position an eiCas9 molecule or an eiCas9-fusion protein (e.g., an eiCas9-transcription repressor domain fusion protein), in the target nucleic acid sequence, the targeting domain for each guide RNA is independently selected from one of Tables 46A-46E, 47A-47G, or 48A-48E.

In an embodiment, the gRNA, e.g., a gRNA comprising a targeting domain, which is complementary with the CFTR gene or SCNN1A gene, is a modular gRNA. In other embodiments, the gRNA is a unimolecular or chimeric gRNA.

In an embodiment, the targeting domain which is complementary with a target domain from the CF target position in the CFTR gene or SCNN1A gene is 16 nucleotides or more in length. In an embodiment, the targeting domain is 16 nucleotides in length. In an embodiment, the targeting domain is 17 nucleotides in length. In another embodiment, the targeting domain is 18 nucleotides in length. In still another embodiment, the targeting domain is 19 nucleotides in length. In still another embodiment, the targeting domain is 20 nucleotides in length. In still another embodiment, the targeting domain is 21 nucleotides in length. In still another embodiment, the targeting domain is 22 nucleotides in length. In still another embodiment, the targeting domain is 23 nucleotides in length. In still another embodiment, the targeting domain is 24 nucleotides in length. In still another embodiment, the targeting domain is 25 nucleotides in length. In still another embodiment, the targeting domain is 26 nucleotides in length.

In an embodiment, the targeting domain comprises 16 nucleotides.

In an embodiment, the targeting domain comprises 17 nucleotides.

In an embodiment, the targeting domain comprises 18 nucleotides.

In an embodiment, the targeting domain comprises 19 nucleotides.

In an embodiment, the targeting domain comprises 20 nucleotides.

In an embodiment, the targeting domain comprises 21 nucleotides.

In an embodiment, the targeting domain comprises 22 nucleotides.

In an embodiment, the targeting domain comprises 23 nucleotides.

In an embodiment, the targeting domain comprises 24 nucleotides.

In an embodiment, the targeting domain comprises 25 nucleotides.

In an embodiment, the targeting domain comprises 26 nucleotides.

A gRNA as described herein may comprise from 5′ to 3′: a targeting domain (comprising a “core domain”, and optionally a “secondary domain”); a first complementarity domain; a linking domain; a second complementarity domain; a proximal domain; and a tail domain. In some embodiments, the proximal domain and tail domain are taken together as a single domain.

In an embodiment, a gRNA comprises a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 20 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In another embodiment, a gRNA comprises a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 30 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In another embodiment, a gRNA comprises a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 35 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In another embodiment, a gRNA comprises a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 40 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

A cleavage event, e.g., a double strand or single strand break, is generated by a Cas9 molecule. The Cas9 molecule may be an enzymatically active Cas9 (eaCas9) molecule, e.g., an eaCas9 molecule that forms a double strand break in a target nucleic acid or an eaCas9 molecule forms a single strand break in a target nucleic acid (e.g., a nickase molecule).

In an embodiment, the eaCas9 molecule catalyzes a double strand break.

In some embodiments, the eaCas9 molecule comprises HNH-like domain cleavage activity but has no, or no significant, N-terminal RuvC-like domain cleavage activity. In this case, the eaCas9 molecule is an HNH-like domain nickase, e.g., the eaCas9 molecule comprises a mutation at D10, e.g., D10A. In other embodiments, the eaCas9 molecule comprises N-terminal RuvC-like domain cleavage activity but has no, or no significant, HNH-like domain cleavage activity. In an embodiment, the eaCas9 molecule is an N-terminal RuvC-like domain nickase, e.g., the eaCas9 molecule comprises a mutation at H840, e.g., H840A. In an embodiment, the eaCas9 molecule is an N-terminal RuvC-like domain nickase, e.g., the eaCas9 molecule comprises a mutation at N863, e.g., an N863A mutation.

In an embodiment, a single strand break is formed in the strand of the target nucleic acid to which the targeting domain of said gRNA is complementary. In another embodiment, a single strand break is formed in the strand of the target nucleic acid other than the strand to which the targeting domain of said gRNA is complementary.

In another aspect, disclosed herein is a nucleic acid, e.g., an isolated or non-naturally occurring nucleic acid, e.g., DNA, that comprises (a) a sequence that encodes a gRNA molecule comprising a targeting domain that is complementary with a target domain, e.g., with a CF target position, in the CFTR gene or SCNN1A gene as disclosed herein.

In an embodiment, the nucleic acid encodes a gRNA molecule, e.g., a first gRNA molecule, comprising a targeting domain configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to a CF target position in the CFTR gene or SCNN1A gene to allow alteration, e.g., alteration associated with, respectively, HDR or NHEJ, of a CF target position in the CFTR gene or SCNN1A gene.

In an embodiment, the nucleic acid encodes a gRNA molecule, e.g., a first gRNA molecule, comprising a targeting domain configured to target an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain), sufficiently close to a CF knockdown target position to reduce, decrease or repress expression of the SCNN1A gene.

In an embodiment, the nucleic acid encodes a gRNA molecule, e.g., the first gRNA molecule, comprising a targeting domain comprising a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence as described herein, e.g., from any one of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E. In an embodiment, the nucleic acid encodes a gRNA molecule comprising a targeting domain as described herein, e.g., that is selected from those in Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E.

In an embodiment, the nucleic acid encodes a modular gRNA, e.g., one or more nucleic acids encode a modular gRNA. In another embodiment, the nucleic acid encodes a chimeric gRNA. The nucleic acid may encode a gRNA, e.g., the first gRNA molecule, comprising a targeting domain comprising 16 nucleotides or more in length. In an embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 16 nucleotides in length. In another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 17 nucleotides in length. In yet another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 18 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 19 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 20 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 21 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 22 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 23 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 24 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 25 nucleotides in length. In still another embodiment, the nucleic acid encodes a gRNA, e.g., the first gRNA molecule, comprising a targeting domain that is 26 nucleotides in length.

In an embodiment, the targeting domain comprises 16 nucleotides.

In an embodiment, the targeting domain comprises 17 nucleotides.

In an embodiment, the targeting domain comprises 18 nucleotides.

In an embodiment, the targeting domain comprises 19 nucleotides.

In an embodiment, the targeting domain comprises 20 nucleotides.

In an embodiment, the targeting domain comprises 21 nucleotides.

In an embodiment, the targeting domain comprises 22 nucleotides.

In an embodiment, the targeting domain comprises 23 nucleotides.

In an embodiment, the targeting domain comprises 24 nucleotides.

In an embodiment, the targeting domain comprises 25 nucleotides.

In an embodiment, the targeting domain comprises 26 nucleotides.

In an embodiment, a nucleic acid encodes a gRNA comprising from 5′ to 3′: a targeting domain (comprising a “core domain”, and optionally a “secondary domain”); a first complementarity domain; a linking domain; a second complementarity domain; a proximal domain; and a tail domain. In some embodiments, the proximal domain and tail domain are taken together as a single domain.

In an embodiment, a nucleic acid encodes a gRNA e.g., the first gRNA molecule, comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 20 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid encodes a gRNA e.g., the first gRNA molecule, comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 30 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid encodes a gRNA e.g., the first gRNA molecule, comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 35 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid encodes a gRNA comprising e.g., the first gRNA molecule, a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 40 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid comprises (a) a sequence that encodes a gRNA molecule, e.g., the first gRNA molecule, comprising a targeting domain that is complementary with a target domain in the CFTR gene or SCNN1A gene as disclosed herein, and further comprising (b) a sequence that encodes a Cas9 molecule.

The Cas9 molecule may be a nickase molecule, an enzymatically activating Cas9 (eaCas9) molecule, e.g., an eaCas9 molecule that forms a double strand break in a target nucleic acid and/or an eaCas9 molecule forms a single strand break in a target nucleic acid. In an embodiment, a single strand break is formed in the strand of the target nucleic acid to which the targeting domain of said gRNA is complementary. In another embodiment, a single strand break is formed in the strand of the target nucleic acid other than the strand to which to which the targeting domain of said gRNA is complementary.

In an embodiment, the eaCas9 molecule catalyzes a double strand break.

In an embodiment, the eaCas9 molecule comprises HNH-like domain cleavage activity but has no, or no significant, N-terminal RuvC-like domain cleavage activity. In another embodiment, the said eaCas9 molecule is an HNH-like domain nickase, e.g., the eaCas9 molecule comprises a mutation at D10, e.g., D10A. In another embodiment, the eaCas9 molecule comprises N-terminal RuvC-like domain cleavage activity but has no, or no significant, HNH-like domain cleavage activity. In another embodiment, the eaCas9 molecule is an N-terminal RuvC-like domain nickase, e.g., the eaCas9 molecule comprises a mutation at H840, e.g., H840A. In another embodiment, the eaCas9 molecule is an N-terminal RuvC-like domain nickase, e.g., the eaCas9 molecule comprises a mutation at N863, e.g., an N863A mutation.

A nucleic acid disclosed herein may comprise (a) a sequence that encodes a gRNA molecule comprising a targeting domain that is complementary with a target domain in the CFTR and/or SCNN1A gene as disclosed herein; (b) a sequence that encodes a Cas9 molecule.

In an embodiment, the Cas9 molecule is an enzymatically active Cas9 (eaCas9) molecule. In an embodiment, the Cas9 molecule is an enzymatically inactive Cas9 (eiCas9) molecule or a modified eiCas9 molecule, e.g., the eiCas9 molecule is fused to Krüppel-associated box (KRAB) to generate an eiCas9-KRAB fusion protein molecule.

A nucleic acid disclosed herein may comprise (a) a sequence that encodes a gRNA molecule comprising a targeting domain that is complementary with a target domain in the CFTR gene or SCNN1A gene as disclosed herein; (b) a sequence that encodes a Cas9 molecule; and further may comprise (c)(i) a sequence that encodes a second gRNA molecule described herein having a targeting domain that is complementary to a second target domain of the CFTR gene or SCNN1A gene, and optionally, (c)(ii) a sequence that encodes a third gRNA molecule described herein having a targeting domain that is complementary to a third target domain of the CFTR gene or SCNN1A gene; and optionally, (c)(iii) a sequence that encodes a fourth gRNA molecule described herein having a targeting domain that is complementary to a fourth target domain of the CFTR gene or SCNN1A gene.

In an embodiment, a nucleic acid encodes a second gRNA molecule comprising a targeting domain configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to a CF target position in the CFTR gene or SCNN1A gene, to allow alteration, e.g., alteration associated with, respectively, HDR or NHEJ, of a CF target position in the CFTR gene or SCNN1A gene, either alone or in combination with the break positioned by said first gRNA molecule.

In an embodiment, a nucleic acid encodes a second gRNA molecule comprising a targeting domain configured to target an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain), sufficiently close to a CF knockdown target position to reduce, decrease or repress expression of the SCNN1A gene.

In an embodiment, a nucleic acid encodes a third gRNA molecule comprising a targeting domain configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to a CF target position in the CFTR gene or SCNN1A gene to allow alteration, e.g., alteration associated with, respectively, HDR or NHEJ, of a CF target position in the CFTR gene or SCNN1A gene, either alone or in combination with the break positioned by the first and/or second gRNA molecule.

In an embodiment, a nucleic acid encodes a third gRNA molecule comprising a targeting domain configured to target an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain), sufficiently close to a CF knockdown target position to reduce, decrease or repress expression of the SCNN1A gene.

In an embodiment, a nucleic acid encodes a fourth gRNA molecule comprising a targeting domain configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to a CF target position in the CFTR gene or SCNN1A gene to allow alteration, e.g., alteration associated with, respectively, HDR or NHEJ, of a CF target position in the CFTR gene or SCNN1A gene, either alone or in combination with the break positioned by the first gRNA molecule, the second gRNA molecule and/or the third gRNA molecule.

In an embodiment, the nucleic acid encodes a second gRNA molecule. The second gRNA is selected to target the same CF target position as the first gRNA molecule. Optionally, the nucleic acid may encode a third gRNA, and further optionally, the nucleic acid may encode a fourth gRNA molecule. The third gRNA molecule and the fourth gRNA molecule are selected to target the same CF target position as the first and second gRNA molecules.

In an embodiment, the nucleic acid encodes a second gRNA molecule comprising a targeting domain comprising a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from one of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E. In an embodiment, the nucleic acid encodes a second gRNA molecule comprising a targeting domain selected from those in Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E. In an embodiment, when a third or fourth gRNA molecule are present, the third and fourth gRNA molecules may independently comprise a targeting domain comprising a sequence that is the same as, or differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from one of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E. In a further embodiment, when a third or fourth gRNA molecule are present, the third and fourth gRNA molecules may independently comprise a targeting domain selected from those in Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E.

In an embodiment, the nucleic acid encodes a second gRNA which is a modular gRNA, e.g., wherein one or more nucleic acid molecules encode a modular gRNA. In another embodiment, the nucleic acid encoding a second gRNA is a chimeric gRNA. In another embodiment, when a nucleic acid encodes a third or fourth gRNA, the third and fourth gRNA may be a modular gRNA or a chimeric gRNA. When multiple gRNAs are used, any combination of modular or chimeric gRNAs may be used.

A nucleic acid may encode a second, a third, and/or a fourth gRNA, each independently, comprising a targeting domain comprising 16 nucleotides or more in length. In an embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 16 nucleotides in length. In an embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 17 nucleotides in length. In another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 18 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 19 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 20 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 21 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 22 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 23 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 24 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 25 nucleotides in length. In still another embodiment, the nucleic acid encodes a second gRNA comprising a targeting domain that is 26 nucleotides in length.

In an embodiment, the targeting domain comprises 16 nucleotides.

In an embodiment, the targeting domain comprises 17 nucleotides.

In an embodiment, the targeting domain comprises 18 nucleotides.

In an embodiment, the targeting domain comprises 19 nucleotides.

In an embodiment, the targeting domain comprises 20 nucleotides.

In an embodiment, the targeting domain comprises 21 nucleotides.

In an embodiment, the targeting domain comprises 22 nucleotides.

In an embodiment, the targeting domain comprises 23 nucleotides.

In an embodiment, the targeting domain comprises 24 nucleotides.

In an embodiment, the targeting domain comprises 25 nucleotides.

In an embodiment, the targeting domain comprises 26 nucleotides.

In an embodiment, a nucleic acid encodes a second, a third, and/or a fourth gRNA, each independently, comprising from 5′ to 3′: a targeting domain (comprising a “core domain”, and optionally a “secondary domain”); a first complementarity domain; a linking domain; a second complementarity domain; a proximal domain; and a tail domain. In some embodiments, the proximal domain and tail domain are taken together as a single domain.

In an embodiment, a nucleic acid encodes a second, a third, and/or a fourth gRNA comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 20 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid encodes a second, a third, and/or a fourth gRNA comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 30 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid encodes a second, a third, and/or a fourth gRNA comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 35 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, a nucleic acid encodes a second, a third, and/or a fourth gRNA comprising a linking domain of no more than 25 nucleotides in length; a proximal and tail domain, that taken together, are at least 40 nucleotides in length; and a targeting domain equal to or greater than 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, when the CFTR gene is corrected by HDR, the nucleic acid encodes (a) a sequence that encodes a gRNA molecule comprising a targeting domain that is complementary with a target domain in the CFTR gene as disclosed herein; (b) a sequence that encodes a Cas9 molecule; optionally, (c)(i) a sequence that encodes a second gRNA molecule described herein having a targeting domain that is complementary to a second target domain of the CFTR gene, and further optionally, (c)(ii) a sequence that encodes a third gRNA molecule described herein having a targeting domain that is complementary to a third target domain of the CFTR gene; and still further optionally, (c)(iii) a sequence that encodes a fourth gRNA molecule described herein having a targeting domain that is complementary to a fourth target domain of the CFTR gene; and further may comprise (d) a template nucleic acid, e.g., a template nucleic acid described herein.

In an embodiment, the template nucleic acid is a single stranded nucleic acid. In another embodiment, the template nucleic acid is a double stranded nucleic acid. In an embodiment, the template nucleic acid comprises a nucleotide sequence, e.g., of one or more nucleotides, that will be added to or will template a change in the target nucleic acid. In another embodiment, the template nucleic acid comprises a nucleotide sequence that may be used to modify the target position. In another embodiment, the template nucleic acid comprises a nucleotide sequence, e.g., of one or more nucleotides, that corresponds to wild type sequence of the target nucleic acid, e.g., of the target position.

The template nucleic acid may comprise a replacement sequence, e.g., a replacement sequence from the Table 49. In some embodiments, the template nucleic acid comprises a 5′ homology arm, e.g., a 5′ homology arm from Table 49. In other embodiments, the template nucleic acid comprises a 3′ homology arm, e.g., a 3′ homology arm from Table 49.

In an embodiment, a nucleic acid encodes (a) a sequence that encodes a gRNA molecule comprising a targeting domain that is complementary with a target domain in the CFTR gene or SCNN1A gene as disclosed herein, and (b) a sequence that encodes a Cas9 molecule, e.g., a Cas9 molecule described herein. In an embodiment, (a) and (b) are present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., the same adeno-associated virus (AAV) vector. In an embodiment, the nucleic acid molecule is an AAV vector. Exemplary AAV vectors that may be used in any of the described compositions and methods include an AAV2 vector, a modified AAV2 vector, an AAV3 vector, a modified AAV3 vector, an AAV6 vector, a modified AAV6 vector, an AAV8 vector and an AAV9 vector.

In another embodiment, (a) is present on a first nucleic acid molecule, e.g. a first vector, e.g., a first viral vector, e.g., a first AAV vector; and (b) is present on a second nucleic acid molecule, e.g., a second vector, e.g., a second vector, e.g., a second AAV vector. The first and second nucleic acid molecules may be AAV vectors.

In another embodiment, the nucleic acid may further comprise (c) a sequence that encodes a second, third and/or fourth gRNA molecule as described herein. In another embodiment, the nucleic acid comprises (a), (b) and (c)(i). Each of (a) and (c)(i) may be present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., the same adeno-associated virus (AAV) vector. In an embodiment, the nucleic acid molecule is an AAV vector.

In another embodiment, (a) and (c)(i) are on different vectors. For example, (a) may be present on a first nucleic acid molecule, e.g. a first vector, e.g., a first viral vector, e.g., a first AAV vector; and (c)(i) may be present on a second nucleic acid molecule, e.g., a second vector, e.g., a second vector, e.g., a second AAV vector. In an embodiment, the first and second nucleic acid molecules are AAV vectors.

In another embodiment, each of (a), (b), and (c)(i) are present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., an AAV vector. In an embodiment, the nucleic acid molecule is an AAV vector. In an alternate embodiment, one of (a), (b), and (c)(i) is encoded on a first nucleic acid molecule, e.g., a first vector, e.g., a first viral vector, e.g., a first AAV vector; and a second and third of (a), (b), and (c)(i) is encoded on a second nucleic acid molecule, e.g., a second vector, e.g., a second vector, e.g., a second AAV vector. The first and second nucleic acid molecule may be AAV vectors.

In an embodiment, (a) is present on a first nucleic acid molecule, e.g., a first vector, e.g., a first viral vector, a first AAV vector; and (b) and (c)(i) are present on a second nucleic acid molecule, e.g., a second vector, e.g., a second vector, e.g., a second AAV vector. The first and second nucleic acid molecule may be AAV vectors.

In another embodiment, (b) is present on a first nucleic acid molecule, e.g., a first vector, e.g., a first viral vector, e.g., a first AAV vector; and (a) and (c)(i) are present on a second nucleic acid molecule, e.g., a second vector, e.g., a second vector, e.g., a second AAV vector. The first and second nucleic acid molecule may be AAV vectors.

In another embodiment, (c)(i) is present on a first nucleic acid molecule, e.g., a first vector, e.g., a first viral vector, e.g., a first AAV vector; and (b) and (a) are present on a second nucleic acid molecule, e.g., a second vector, e.g., a second vector, e.g., a second AAV vector. The first and second nucleic acid molecule may be AAV vectors.

In another embodiment, each of (a), (b) and (c)(i) are present on different nucleic acid molecules, e.g., different vectors, e.g., different viral vectors, e.g., different AAV vector. For example, (a) may be on a first nucleic acid molecule, (b) on a second nucleic acid molecule, and (c)(i) on a third nucleic acid molecule. The first, second and third nucleic acid molecule may be AAV vectors.

In another embodiment, when a third and/or fourth gRNA molecule are present, each of (a), (b), (c)(i), (c)(ii) and (c)(iii) may be present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., an AAV vector. In an embodiment, the nucleic acid molecule is an AAV vector. In an alternate embodiment, each of (a), (b), (c)(i), (c)(ii) and (c)(iii) may be present on the different nucleic acid molecules, e.g., different vectors, e.g., the different viral vectors, e.g., different AAV vectors. In a further embodiment, each of (a), (b), (c)(i), (c)(ii) and (c)(iii) may be present on more than one nucleic acid molecule, but fewer than five nucleic acid molecules, e.g., AAV vectors.

In another embodiment, when (d) a template nucleic acid is present, each of (a), (b), and (d) may be present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., an AAV vector. In an embodiment, the nucleic acid molecule is an AAV vector. In an alternate embodiment, each of (a), (b), and (d) may be present on the different nucleic acid molecules, e.g., different vectors, e.g., the different viral vectors, e.g., different AAV vectors. In a further embodiment, each of (a), (b), and (d) may be present on more than one nucleic acid molecule, but fewer than three nucleic acid molecules, e.g., AAV vectors.

In another embodiment, when (d) a template nucleic acid is present, each of (a), (b), (c)(i) and (d) may be present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., an AAV vector. In an embodiment, the nucleic acid molecule is an AAV vector. In an alternate embodiment, each of (a), (b), (c)(i) and (d) may be present on the different nucleic acid molecules, e.g., different vectors, e.g., the different viral vectors, e.g., different AAV vectors. In a further embodiment, each of (a), (b), (c)(i) and (d) may be present on more than one nucleic acid molecule, but fewer than four nucleic acid molecules, e.g., AAV vectors.

In another embodiment, when (d) a template nucleic acid is present, each of (a), (b), (c)(i), (c)(ii) and (d) may be present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., an AAV vector. In an embodiment, the nucleic acid molecule is an AAV vector. In an alternate embodiment, each of (a), (b), (c)(i), (c)(ii) and (d) may be present on the different nucleic acid molecules, e.g., different vectors, e.g., the different viral vectors, e.g., different AAV vectors. In a further embodiment, each of (a), (b), (c)(i), (c)(ii) and (d) may be present on more than one nucleic acid molecule, but fewer than five nucleic acid molecules, e.g., AAV vectors.

In another embodiment, when (d) a template nucleic acid is present, each of (a), (b), (c)(i), (c)(ii), (c)(iii) and (d) may be present on the same nucleic acid molecule, e.g., the same vector, e.g., the same viral vector, e.g., an AAV vector. In an embodiment, the nucleic acid molecule is an AAV vector. In an alternate embodiment, each of (a), (b), (c)(i), (c)(ii), (c)(iii) and (d) may be present on the different nucleic acid molecules, e.g., different vectors, e.g., the different viral vectors, e.g., different AAV vectors. In a further embodiment, each of (a), (b), (c)(i), (c)(ii), (c)(iii) and (d) may be present on more than one nucleic acid molecule, but fewer than six nucleic acid molecules, e.g., AAV vectors.

The nucleic acids described herein may comprise a promoter operably linked to the sequence that encodes the gRNA molecule of (a), e.g., a promoter described herein. The nucleic acid may further comprise a second promoter operably linked to the sequence that encodes the second, third and/or fourth gRNA molecule of (c), e.g., a promoter described herein. The promoter and second promoter differ from one another. In some embodiments, the promoter and second promoter are the same.

The nucleic acids described herein may further comprise a promoter operably linked to the sequence that encodes the Cas9 molecule of (b), e.g., a promoter described herein.

In another aspect, disclosed herein is a composition comprising (a) a gRNA molecule comprising a targeting domain that is complementary with a target domain in the CFTR gene or SCNN1A gene, as described herein. The composition of (a) may further comprise (b) a Cas9 molecule, e.g., a Cas9 molecule as described herein. A composition of (a) and (b) may further comprise (c) a second, third and/or fourth gRNA molecule, e.g., a second, third and/or fourth gRNA molecule described herein. A composition of (a), (b) and (c) may further comprise (d) a template nucleic acid, e.g., a template nucleic acid described herein. In an embodiment, the composition is a pharmaceutical composition. The compositions described herein, e.g., pharmaceutical compositions described herein, can be used in the treatment or prevention of CF or CF-like disease in a subject, e.g., in accordance with a method disclosed herein.

In another aspect, disclosed herein is a method of altering a cell, e.g., altering the structure, e.g., altering the sequence, of a target nucleic acid of a cell, comprising contacting said cell with: (a) a gRNA that targets the CFTR gene or SCNN1A gene, e.g., a gRNA as described herein; (b) a Cas9 molecule, e.g., a Cas9 molecule as described herein; and optionally, (c) a second, third and/or fourth gRNA that targets CFTR gene or SCNN1A gene, e.g., a second, third and/or fourth gRNA as described herein; and optionally, (d) a template nucleic acid, e.g., a template nucleic acid as described herein.

In an embodiment, the method comprises contacting said cell with (a) and (b).

In an embodiment, the method comprises contacting said cell with (a), (b), and (c).

In an embodiment, the method comprises contacting said cell with (a), (b), (c) and (d).

The gRNA of (a) and optionally (c) may be selected from any of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E, or a gRNA that differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E.

In an embodiment, the method comprises contacting a cell from a subject suffering from or likely to develop CF or CF-like disease. The cell may be from a subject having a mutation at a CF target position in the CFTR gene or a subject which would benefit from having a mutation at a CF target position in the SCNN1A gene.

In an embodiment, the cell being contacted in the disclosed method is an epithelial cell, e.g., a pulmonary epithelial cell, e.g., a bronchial epithelial cell or an alveolar epithelial cell. The contacting may be performed ex vivo and the contacted cell may be returned to the subject's body after the contacting step. In other embodiments, the contacting step may be performed in vivo.

In an embodiment, the method of altering a cell as described herein comprises acquiring knowledge of the sequence at a CF target position in said cell, prior to the contacting step. Acquiring knowledge of the sequence at a CF target position in the cell may be by sequencing the CFTR gene or SCNN1A gene, or a portion of the CFTR gene or SCNN1A gene.

In an embodiment, the contacting step of the method comprises contacting the cell with a nucleic acid, e.g., a vector, e.g., an AAV vector, that expresses at least one of (a), (b), and (c). In an embodiment, the contacting step of the method comprises contacting the cell with a nucleic acid, e.g., a vector, e.g., an AAV vector, that expresses each of (a), (b), and (c). In another embodiment, the contacting step of the method comprises delivering to the cell a Cas9 molecule of (b) and a nucleic acid which encodes a gRNA of (a) and optionally, a second gRNA (c)(i) and further optionally, a third gRNA (c)(ii) and/or fourth gRNA (c)(iii)).

In an embodiment, the contacting step of the method comprises contacting the cell with a nucleic acid, e.g., a vector, e.g., an AAV vector, that expresses at least one of (a), (b), (c) and (d). In an embodiment, the contacting step of the method comprises contacting the cell with a nucleic acid, e.g., a vector, e.g., an AAV vector, that expresses each of (a), (b), and (c). In another embodiment, the contacting step of the method comprises delivering to the cell a Cas9 molecule of (b), a nucleic acid which encodes a gRNA of (a) and a template nucleic acid of (d), and optionally, a second gRNA (c)(i) and further optionally, a third gRNA (c)(ii) and/or fourth gRNA (c)(iii).

In an embodiment, contacting comprises contacting the cell with a nucleic acid, e.g., a vector, e.g., an AAV vector, e.g., an AAV2 vector, a modified AAV2 vector, an AAV3 vector, a modified AAV3 vector, an AAV6 vector, a modified AAV6 vector, an AAV8 vector or an AAV9 vector, as described herein.

In an embodiment, contacting comprises delivering to the cell a Cas9 molecule of (b), as a protein or an mRNA, and a nucleic acid which encodes a gRNA of (a) and optionally a second, third and/or fourth gRNA of (c).

In an embodiment, contacting comprises delivering to the cell a Cas9 molecule of (b), as a protein or an mRNA, said gRNA of (a), as an RNA, and optionally said second, third and/or fourth gRNA of (c), as an RNA.

In an embodiment, contacting comprises delivering to the cell a gRNA of (a) as an RNA, optionally the second, third and/or fourth gRNA of (c) as an RNA, and a nucleic acid that encodes the Cas9 molecule of (b).

In another aspect, disclosed herein is a method of treating or preventing a subject suffering from or likely to develop CF or CF-like disease, e.g., altering the structure, e.g., sequence, of a target nucleic acid of the subject, comprising contacting the subject (or a cell from the subject) with:

• • (a) a gRNA that targets the CFTR gene or SCNN1A gene, e.g., a gRNA disclosed herein;
  • (b) a Cas9 molecule, e.g., a Cas9 molecule disclosed herein; and
  • optionally, (c)(i) a second gRNA that targets the CFTR gene or SCNN1A gene, e.g., a second gRNA disclosed herein, and
  • further optionally, (c)(ii) a third gRNA, and still further optionally, (c)(iii) a fourth gRNA that target the CFTR gene or SCNN1A gene, e.g., a third and fourth gRNA disclosed herein.

The method of treating a subject may further comprise contacting the subject (or a cell from the subject) with (d) a template nucleic acid, e.g., a template nucleic acid disclosed herein. A template nucleic acid is used when the method of treating a subject uses HDR to alter the sequence of the target nucleic acid of the subject.

In some embodiments, contacting comprises contacting with (a) and (b).

In some embodiments, contacting comprises contacting with (a), (b), and (c)(i).

In some embodiments, contacting comprises contacting with (a), (b), (c)(i) and (c)(ii).

In some embodiments, contacting comprises contacting with (a), (b), (c)(i), (c)(ii) and (c)(iii).

In some embodiments, contacting comprises contacting with (a), (b), (c)(i) and (d).

In some embodiments, contacting comprises contacting with (a), (b), (c)(i), (c)(ii) and (d).

In some embodiments, contacting comprises contacting with (a), (b), (c)(i), (c)(ii), (c)(iii) and (d).

The gRNA of (a) or (c) (e.g., (c)(i), (c)(ii), or (c)(iii)) may be selected from any of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E, or a gRNA that differs by no more than 1, 2, 3, 4, or 5 nucleotides from, a targeting domain sequence from any of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E.

In an embodiment, the method comprises acquiring knowledge of the sequence (e.g., a mutation) of a CF target position in said subject.

In an embodiment, the method comprises acquiring knowledge of the sequence (e.g., a mutation) of a CF target position in said subject by sequencing the CFTR gene or SCNN1A gene or a portion of the CFTR gene or SCNN1A gene.

In an embodiment, the method comprises correcting a mutation at a CF target position in the CFTR gene.

In an embodiment, the method comprises correcting a mutation at a CF target position in the CFTR gene by HDR.

In an embodiment, the method comprises introducing a mutation at a CF target position in the SCNN1A gene.

In an embodiment, the method comprises introducing a mutation at a CF target position in the SCNN1A gene by NHEJ.

When the method comprises correcting the mutation at a CF target position by HDR, a Cas9 of (b), at least one guide RNA, e.g., a guide RNA of (a) and a template nucleic acid of (d) are included in the contacting step.

In an embodiment, a cell of the subject is contacted ex vivo with (a), (b), (d) and optionally (c). In an embodiment, said cell is returned to the subject's body.

In an embodiment, a cell of the subject is contacted is in vivo with (a), (b) (d) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii).

In an embodiment, the cell of the subject is contacted in vivo by inhalation delivery, e.g., via nebulizer, of (a), (b), (d) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii).

In an embodiment, the cell of the subject is contacted in vivo by intravenous delivery of (a), (b), (d) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii).

In an embodiment, the cell of the subject is contacted in vivo by intraparenchymal delivery of (a), (b), (d) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii), e.g., to lung tissue or bronchial tree.

In an embodiment, the contacting step comprises contacting the subject with a nucleic acid, e.g., a vector, e.g., an AAV vector, described herein, e.g., a nucleic acid that encodes at least one of (a), (b), (d) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii).

In an embodiment, the contacting step comprises delivering to said subject said Cas9 molecule of (b), as a protein or mRNA, and a nucleic acid which encodes (a), a nucleic acid of (d) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii).

In an embodiment, the contacting step comprises delivering to the subject the Cas9 molecule of (b), as a protein or mRNA, the gRNA of (a), as an RNA, a nucleic acid of (d) and optionally the second gRNA of (c)(i), further optionally said third gRNA of (c)(ii), and still further optionally said fourth gRNA of (c)(iii), as an RNA.

In an embodiment, the contacting step comprises delivering to the subject the gRNA of (a), as an RNA, optionally said second gRNA of (c)(i), further optionally said third gRNA of (c)(ii), and still further optionally said fourth gRNA of (c)(iii), as an RNA, a nucleic acid that encodes the Cas9 molecule of (b), and a nucleic acid of (d).

When the method comprises (1) introducing a mutation at a CF target position by NHEJ or (2) knocking down expression of the SCNN1A gene by targeting the promoter region, a Cas9 of (b) and at least one guide RNA, e.g., a guide RNA of (a) are included in the contacting step.

In an embodiment, a cell of the subject is contacted ex vivo with (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii). In an embodiment, said cell is returned to the subject's body.

In an embodiment, a population of cells from a subject is contacted ex vivo with (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d) to correct the F508del or G551D mutation in the CFTR gene and a second population of cells from the subject is contacted ex vivo with (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii), to introduce a mutation in the SCNN1A gene to knockout the SCNN1A gene. A mixture of the two cell populations may be returned to the subject's body to treat or prevent CF or CF-like disease.

In an embodiment, a cell of the subject is contacted is in vivo with (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d). In an embodiment, the cell of the subject is contacted in vivo by inhalation delivery, e.g., via nebulizer, of (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d). In an embodiment, the cell of the subject is contacted in vivo by intravenous delivery of (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d). In an embodiment, the cell of the subject is contacted in vivo by intraparenchymal delivery of (a), (b) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d), e.g., to lung tissue or bronchial tree.

In an embodiment, contacting comprises contacting the subject with a nucleic acid, e.g., a vector, e.g., an AAV vector, described herein, e.g., a nucleic acid that encodes at least one of (a), (b), and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d).

In an embodiment, contacting comprises delivering to said subject said Cas9 molecule of (b), as a protein or mRNA, and a nucleic acid which encodes (a) and optionally (c)(i), further optionally (c)(ii), and still further optionally (c)(iii) and/or (d).

In an embodiment, contacting comprises delivering to the subject the Cas9 molecule of (b), as a protein or mRNA, the gRNA of (a), as an RNA, and optionally the second gRNA of (c)(i), further optionally said third gRNA of (c)(ii), and still further optionally said fourth gRNA of (c)(iii), as an RNA, and further optionally the template nucleic acid of (d) as a DNA.

In an embodiment, contacting comprises delivering to the subject the gRNA of (a), as an RNA, optionally said second gRNA of (c)(i), further optionally said third gRNA of (c)(ii), and still further optionally said fourth gRNA of (c)(iii), as an RNA, and a nucleic acid that encodes the Cas9 molecule of (b), and optionally a nucleic acid that encodes the template nucleic acid of (d).

In another aspect, disclosed herein is a reaction mixture comprising a gRNA molecule, a nucleic acid, or a composition described herein, and a cell, e.g., a cell from a subject having, or likely to develop CF or CF-like disease, or a subject having a mutation at a CF target position in the CFTR gene, or a cell from a subject which would benefit from having a mutation at a CF target position in the SCNN1A gene.

In another aspect, disclosed herein is a kit comprising, (a) a gRNA molecule described herein, or nucleic acid that encodes the gRNA, and one or more of the following:

• • (b) a Cas9 molecule, e.g., a Cas9 molecule described herein, or a nucleic acid or mRNA that encodes the Cas9;
  • (c)(i) a second gRNA molecule, e.g., a second gRNA molecule described herein or a nucleic acid that encodes (c)(i);
  • (c)(ii) a third gRNA molecule, e.g., a second gRNA molecule described herein or a nucleic acid that encodes (c)(ii);
  • (c)(iii) a fourth gRNA molecule, e.g., a second gRNA molecule described herein or a nucleic acid that encodes (c)(iii); and
  • (d) a template nucleic acid, e.g, a template nucleic acid described herein.

In an embodiment, the kit comprises nucleic acid, e.g., an AAV vector, that encodes one or more of (a), (b), (c)(i), (c)(ii), (c)(iii) and (d).

In another aspect, disclosed herein is non-naturally occurring template nucleic acid described herein.

In yet another aspect, disclosed herein is a gRNA molecule, e.g., a gRNA molecule described herein, for use in treating or preventing CF or CF-like disease in a subject, e.g., in accordance with a method of treating or preventing CF or CF-like disease as described herein.

In an embodiment, the gRNA molecule in used in combination with a Cas9 molecule, e.g., a Cas9 molecule described herein. Additionally or alternatively, in an embodiment, the gRNA molecule is used in combination with a second, third and/or fourth gRNA molecule, e.g., a second, third and/or fourth gRNA molecule described herein.

In still another aspect, disclosed herein is use of a gRNA molecule, e.g., a gRNA molecule described herein, in the manufacture of a medicament for treating or preventing CF or CF-like disease in a subject, e.g., in accordance with a method of treating or preventing CF or CF-like disease as described herein.

In an embodiment, the medicament comprises a Cas9 molecule, e.g., a Cas9 molecule described herein. Additionally or alternatively, in an embodiment, the medicament comprises a second, third and/or fourth gRNA molecule, e.g., a second, third and/or fourth gRNA molecule described herein.

The gRNA molecules and methods, as disclosed herein, can be used in combination with a governing gRNA molecule. As used herein, a governing gRNA molecule refers to a gRNA molecule comprising a targeting domain which is complementary to a target domain on a nucleic acid that encodes a component of the CRISPR/Cas system introduced into a cell or subject. For example, the methods described herein can further include contacting a cell or subject with a governing gRNA molecule or a nucleic acid encoding a governing molecule. In an embodiment, the governing gRNA molecule targets a nucleic acid that encodes a Cas9 molecule or a nucleic acid that encodes a target gene gRNA molecule. In an embodiment, the governing gRNA comprises a targeting domain that is complementary to a target domain in a sequence that encodes a Cas9 component, e.g., a Cas9 molecule or target gene gRNA molecule. In an embodiment, the target domain is designed with, or has, minimal homology to other nucleic acid sequences in the cell, e.g., to minimize off-target cleavage. For example, the targeting domain on the governing gRNA can be selected to reduce or minimize off-target effects. In an embodiment, a target domain for a governing gRNA can be disposed in the control or coding region of a Cas9 molecule or disposed between a control region and a transcribed region. In an embodiment, a target domain for a governing gRNA can be disposed in the control or coding region of a target gene gRNA molecule or disposed between a control region and a transcribed region for a target gene gRNA. While not wishing to be bound by theory, in an embodiment, it is believed that altering, e.g., inactivating, a nucleic acid that encodes a Cas9 molecule or a nucleic acid that encodes a target gene gRNA molecule can be effected by cleavage of the targeted nucleic acid sequence or by binding of a Cas9 molecule/governing gRNA molecule complex to the targeted nucleic acid sequence.

The compositions, reaction mixtures and kits, as disclosed herein, can also include a governing gRNA molecule, e.g., a governing gRNA molecule disclosed herein.

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.

Headings, including numeric and alphabetical headings and subheadings, are for organization and presentation and are not intended to be limiting.

Other features and advantages of the invention will be apparent from the detailed description, drawings, and from the claims.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-1I are representations of several exemplary gRNAs.

FIG. 1A depicts a modular gRNA molecule derived in part (or modeled on a sequence in part) from Streptococcus pyogenes (S. pyogenes) as a duplexed structure (SEQ ID NOS: 42 and 43, respectively, in order of appearance);

FIG. 1B depicts a unimolecular (or chimeric) gRNA molecule derived in part from S. pyogenes as a duplexed structure (SEQ ID NO: 44);

FIG. 1C depicts a unimolecular gRNA molecule derived in part from S. pyogenes as a duplexed structure (SEQ ID NO: 45);

FIG. 1D depicts a unimolecular gRNA molecule derived in part from S. pyogenes as a duplexed structure (SEQ ID NO: 46);

FIG. 1E depicts a unimolecular gRNA molecule derived in part from S. pyogenes as a duplexed structure (SEQ ID NO: 47);

FIG. 1F depicts a modular gRNA molecule derived in part from Streptococcus thermophilus (S. thermophilus) as a duplexed structure (SEQ ID NOS: 48 and 49, respectively, in order of appearance);

FIG. 1G depicts an alignment of modular gRNA molecules of S. pyogenes and S. thermophilus (SEQ ID NOS: 50-53, respectively, in order of appearance).

FIGS. 1H-1I depicts additional exemplary structures of unimolecular gRNA molecules. FIG. 1H shows an exemplary structure of a unimolecular gRNA molecule derived in part from S. pyogenes as a duplexed structure (SEQ ID NO: 45). FIG. 1I shows an exemplary structure of a unimolecular gRNA molecule derived in part from S. aureus as a duplexed structure (SEQ ID NO: 40).

FIGS. 2A-2G depict an alignment of Cas9 sequences from Chylinski et al. (RNA Biol. 2013; 10(5): 726-737). The N-terminal RuvC-like domain is boxed and indicated with a “Y”. The other two RuvC-like domains are boxed and indicated with a “B”. The HNH-like domain is boxed and indicated by a “G”. Sm: S. mutans (SEQ ID NO: 1); Sp: S. pyogenes (SEQ ID NO: 2); St: S. thermophilus (SEQ ID NO: 3); Li: L. innocua (SEQ ID NO: 4). Motif: this is a motif based on the four sequences: residues conserved in all four sequences are indicated by single letter amino acid abbreviation; “*” indicates any amino acid found in the corresponding position of any of the four sequences; and “−” indicates any amino acid, e.g., any of the 20 naturally occurring amino acids, or absent.

FIGS. 3A-3B show an alignment of the N-terminal RuvC-like domain from the Cas9 molecules disclosed in Chylinski et al (SEQ ID NOS: 54-103, respectively, in order of appearance). The last line of FIG. 3B identifies 4 highly conserved residues.

FIGS. 4A-4B show an alignment of the N-terminal RuvC-like domain from the Cas9 molecules disclosed in Chylinski et al. with sequence outliers removed (SEQ ID NOS: 104-177, respectively, in order of appearance). The last line of FIG. 4B identifies 3 highly conserved residues.

FIGS. 5A-5C show an alignment of the HNH-like domain from the Cas9 molecules disclosed in Chylinski et al (SEQ ID NOS: 178-252, respectively, in order of appearance). The last line of FIG. 5C identifies conserved residues.

FIGS. 6A-6B show an alignment of the HNH-like domain from the Cas9 molecules disclosed in Chylinski et al. with sequence outliers removed (SEQ ID NOS: 253-302, respectively, in order of appearance). The last line of FIG. 6B identifies 3 highly conserved residues.

FIGS. 7A-7B depict an alignment of Cas9 sequences from S. pyogenes and Neisseria meningitidis (N. meningitidis). The N-terminal RuvC-like domain is boxed and indicated with a “Y”. The other two RuvC-like domains are boxed and indicated with a “B”. The HNH-like domain is boxed and indicated with a “G”. Sp: S. pyogenes; Nm: N. meningitidis. Motif: this is a motif based on the two sequences: residues conserved in both sequences are indicated by a single amino acid designation; “*” indicates any amino acid found in the corresponding position of any of the two sequences; “−” indicates any amino acid, e.g., any of the 20 naturally occurring amino acids, and “−” indicates any amino acid, e.g., any of the 20 naturally occurring amino acids, or absent.

FIG. 8 shows a nucleic acid sequence encoding Cas9 of N. meningitidis (SEQ ID NO: 303). Sequence indicated by an “R” is an SV40 NLS; sequence indicated as “G” is an HA tag; and sequence indicated by an “O” is a synthetic NLS sequence; the remaining (unmarked) sequence is the open reading frame (ORF).

FIGS. 9A and 9B are schematic representations of the domain organization of S. pyogenes Cas 9. FIG. 9A shows the organization of the Cas9 domains, including amino acid positions, in reference to the two lobes of Cas9 (recognition (REC) and nuclease (NUC) lobes). FIG. 9B shows the percent homology of each domain across 83 Cas9 orthologs.

DETAILED DESCRIPTION

Definitions

“CF target mutant position”, as used herein, refers to a target position in the CFTR gene, which, if mutated, can result in a mutant protein and give rise to CF or CF-like disease. In an embodiment, the target position comprises one, two, or three nucleotides. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at F508, e.g., F508del. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at G551, e.g., G551D. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at G542, e.g., G542X, in the CFTR protein, which corresponds to c.1624G>T in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at N1303, e.g., N1303K, in the CFTR protein, which corresponds to c.3909C>G in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at R117, e.g., R117H, in the CFTR protein, which corresponds to c.350G>A in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at W1282, e.g., W1282X, in the CFTR protein, which corresponds to c. c.3846G>A in the CFTR gene. In an embodiment, the CF target mutant position is a position in the CFTR gene at which a change can give rise to a mutant protein having a mutation at R553, e.g., R553X, in the CFTR protein, which corresponds to c.1657C>T in the CFTR gene. In an embodiment, the CF target mutant position is c.3717+12191, also known as c.3849+10kb, which corresponds to 3717+12191C>T in the CFTR gene. In an embodiment, the CF target mutant position is c.2657+5, also known as c.2789+5, which corresponds to 2657+5G>A in the CFTR gene. In an embodiment, the CF target mutant position is c.3140-26, also known as c.3272-26, which corresponds to c.3140-26A>G in the CFTR gene. In an embodiment, the CF target mutant position is a position in the SCNN1A gene at which a change can give rise to a mutant protein having a mutation at V114, which corresponds to V114I in the SCNN1A gene.

“CF target knockout position”, as used herein, refers to a position in the CFTR and/or SCNN1A gene, which if altered by NHEJ-mediated alteration, results in alleviation of a symptom of CF or CF-like disease. In an embodiment, the alteration restores expression of functional CFTR gene product. In an embodiment, the position is in the CFTR non-coding region, e.g., an intronic region (e.g., the alternation corrects a cryptic splice site). In an embodiment, the alteration results in reduction or elimination of expression of functional SCNN1A gene product. In an embodiment, the position is in the SCNN1A coding region, e.g., an early coding region.

“CF target knockdown position”, as used herein, refers to a position in the SCNN1A gene, which if targeted, e.g., by an eiCas9 molecule or an eiCas9 fusion described herein, results in reduction or elimination of expression of functional SCNN1A gene product. In an embodiment, the transcription of the SCNN1A gene is reduced or eliminated. In another embodiment, the chromatin structure of the SCNN1A gene is altered. In an embodiment, the position is in the SCNN1A early coding region sequence. In an embodiment, a position in early coding region of the SCNN1A gene is targeted by an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9-fusion protein, as described herein.

“CF target knockin position”, as used herein, refers to a sequence, which if modified by the insertion of CFTR sequence, results in an optimization of CFTR activity, e.g., by resulting in a CFTR sequence that encodes a protein having wild type activity. Exemplary CF target knockin position include: CFTR sequence within intron 2, into which, e.g., can be introduced CFTR sequence that codes for CFTR exons 3-27; and sequence within CFTR intron 10, into which sequence that codes for CFTR exons 11-27 can be introduced. In an embodiment, a CF target knockin position includes CFTR intronic sequence between a second and a third exon (e.g., intron 2), and CFTR sequence encoding the third exon through the final exon (exon 27), is introduced, resulting in a CFTR sequence that is free of one or more cryptic splice sites and that encodes a CFTR protein having wild type activity. In an embodiment, a CF target knockin position, is a position which is upstream of a mutation, or upstream of an intron having a mutation, and introduction of wild-type CFTR sequence results in a CFTR sequence that is free of the mutation. In an embodiment the CF target knockin position is in CFTR intronic sequence: between exon2 and exon 3; or between exon10 and exon 11. In an embodiment, the resulting CFTR sequence comprises subject sequence upstream from the CF target knockin position and newly introduced sequence downstream from the CF target knockin position, which taken together, encode a CFTR protein having wild type activity. In an embodiment, the point of insertion is 3′ to a splice donor site and 5′ from a splice acceptor site. In an embodiment, CFTR sequence encoding exons 3-27 is inserted under control of the promoter, e.g., at the transcription start site. In an embodiment, CFTR sequence introduced can exclude introns, e.g., a sequence encoding exons, but without introns, is inserted, e.g., CFTR CDNA sequence is introduced.

“CF target position”, as used herein, refers to a CF target mutant position, CF target knockout position, CF target knockdown position, and/or CF target knockin position, as described herein.

“Domain”, as used herein, is used to describe segments of a protein or nucleic acid. Unless otherwise indicated, a domain is not required to have any specific functional property.

Calculations of homology or sequence identity between two sequences (the terms are used interchangeably herein) are performed as follows. The sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in one or both of a first and a second amino acid or nucleic acid sequence for optimal alignment and non-homologous sequences can be disregarded for comparison purposes). The optimal alignment is determined as the best score using the GAP program in the GCG software package with a Blossum 62 scoring matrix with a gap penalty of 12, a gap extend penalty of 4, and a frame shift gap penalty of 5. The amino acid residues or nucleotides at corresponding amino acid positions or nucleotide positions are then compared. When a position in the first sequence is occupied by the same amino acid residue or nucleotide as the corresponding position in the second sequence, then the molecules are identical at that position. The percent identity between the two sequences is a function of the number of identical positions shared by the sequences.

“Governing gRNA molecule”, as used herein, refers to a gRNA molecule that comprises a targeting domain that is complementary to a target domain on a nucleic acid that comprises a sequence that encodes a component of the CRISPR/Cas system that is introduced into a cell or subject. A governing gRNA does not target an endogenous cell or subject sequence. In an embodiment, a governing gRNA molecule comprises a targeting domain that is complementary with a target sequence on: (a) a nucleic acid that encodes a Cas9 molecule; (b) a nucleic acid that encodes a gRNA which comprises a targeting domain that targets the CFTR or SCNN1A gene (a target gene gRNA); or on more than one nucleic acid that encodes a CRISPR/Cas component, e.g., both (a) and (b). In an embodiment, a nucleic acid molecule that encodes a CRISPR/Cas component, e.g., that encodes a Cas9 molecule or a target gene gRNA, comprises more than one target domain that is complementary with a governing gRNA targeting domain. While not wishing to be bound by theory, in an embodiment, it is believed that a governing gRNA molecule complexes with a Cas9 molecule and results in Cas9 mediated inactivation of the targeted nucleic acid, e.g., by cleavage or by binding to the nucleic acid, and results in cessation or reduction of the production of a CRISPR/Cas system component. In an embodiment, the Cas9 molecule forms two complexes: a complex comprising a Cas9 molecule with a target gene gRNA, which complex will alter the CFTR or SCNN1A gene; and a complex comprising a Cas9 molecule with a governing gRNA molecule, which complex will act to prevent further production of a CRISPR/Cas system component, e.g., a Cas9 molecule or a target gene gRNA molecule. In an embodiment, a governing gRNA molecule/Cas9 molecule complex binds to or promotes cleavage of a control region sequence, e.g., a promoter, operably linked to a sequence that encodes a Cas9 molecule, a sequence that encodes a transcribed region, an exon, or an intron, for the Cas9 molecule. In an embodiment, a governing gRNA molecule/Cas9 molecule complex binds to or promotes cleavage of a control region sequence, e.g., a promoter, operably linked to a gRNA molecule, or a sequence that encodes the gRNA molecule. In an embodiment, the governing gRNA, e.g., a Cas9-targeting governing gRNA molecule, or a target gene gRNA-targeting governing gRNA molecule, limits the effect of the Cas9 molecule/target gene gRNA molecule complex-mediated gene targeting. In an embodiment, a governing gRNA places temporal, level of expression, or other limits, on activity of the Cas9 molecule/target gene gRNA molecule complex. In an embodiment, a governing gRNA reduces off-target or other unwanted activity. In an embodiment, a governing gRNA molecule inhibits, e.g., entirely or substantially entirely inhibits, the production of a component of the Cas9 system and thereby limits, or governs, its activity.

“Modulator”, as used herein, refers to an entity, e.g., a drug, that can alter the activity (e.g., enzymatic activity, transcriptional activity, or translational activity), amount, distribution, or structure of a subject molecule or genetic sequence. In an embodiment, modulation comprises cleavage, e.g., breaking of a covalent or non-covalent bond, or the forming of a covalent or non-covalent bond, e.g., the attachment of a moiety, to the subject molecule. In an embodiment, a modulator alters the, three dimensional, secondary, tertiary, or quaternary structure, of a subject molecule. A modulator can increase, decrease, initiate, or eliminate a subject activity.

“Large molecule”, as used herein, refers to a molecule having a molecular weight of at least 2, 3, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 kD. Large molecules include proteins, polypeptides, nucleic acids, biologics, and carbohydrates.

“Polypeptide”, as used herein, refers to a polymer of amino acids having less than 100 amino acid residues. In an embodiment, it has less than 50, 20, or 10 amino acid residues.

“Reference molecule”, e.g., a reference Cas9 molecule or reference gRNA, as used herein, refers to a molecule to which a subject molecule, e.g., a subject Cas9 molecule of subject gRNA molecule, e.g., a modified or candidate Cas9 molecule is compared. For example, a Cas9 molecule can be characterized as having no more than 10% of the nuclease activity of a reference Cas9 molecule. Examples of reference Cas9 molecules include naturally occurring unmodified Cas9 molecules, e.g., a naturally occurring Cas9 molecule such as a Cas9 molecule of S. pyogenes, S. aureus or S. thermophilus. In an embodiment, the reference Cas9 molecule is the naturally occurring Cas9 molecule having the closest sequence identity or homology with the Cas9 molecule to which it is being compared. In an embodiment, the reference Cas9 molecule is a sequence, e.g., a naturally occurring or known sequence, which is the parental form on which a change, e.g., a mutation has been made.

“Replacement”, or “replaced”, as used herein with reference to a modification of a molecule does not require a process limitation but merely indicates that the replacement entity is present.

“Small molecule”, as used herein, refers to a compound having a molecular weight less than about 2 kD, e.g., less than about 2 kD, less than about 1.5 kD, less than about 1 kD, or less than about 0.75 kD.

“Subject”, as used herein, may mean either a human or non-human animal. The term includes, but is not limited to, mammals (e.g., humans, other primates, pigs, rodents (e.g., mice and rats or hamsters), rabbits, guinea pigs, cows, horses, cats, dogs, sheep, and goats). In an embodiment, the subject is a human. In other embodiments, the subject is poultry.

“Treat”, “treating” and “treatment”, as used herein, mean the treatment of a disease in a mammal, e.g., in a human, including (a) inhibiting the disease, i.e., arresting or preventing its development; (b) relieving the disease, i.e., causing regression of the disease state; and (c) curing the disease.

“X” as used herein in the context of an amino acid sequence, refers to any amino acid (e.g., any of the twenty natural amino acids) unless otherwise specified.

Cystic Fibrosis and CF-Like Disease

Cystic fibrosis (CF) is an autosomal recessive hereditary disease caused by defects in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene encodes a cAMP-gated channel that is involved in chloride and bicarbonate transport. It regulates sodium transport through inhibition of the epithelial sodium channel, which is encoded by the SCNN1A gene. CFTR is expressed on the apical surface of epithelial cells in the airway, gastrointestinal tract, reproductive tract, sweat glands and submucosal glands.

Subjects having CF or CF-like disease may present at birth or in early infancy with pancreatic insufficiency. Pancreatic dysfunction leads to malabsorption of fat and fat-soluble vitamins, which causes poor growth as well as gallstones and biliary disease. The lung manifestations of the disease can be more severe but may present slightly after pancreatic manifestations, in infancy or early childhood. Aberrant chloride and sodium transport due to decreased CFTR activity causes lowered apical surface fluid levels in the lungs, which leads to “sticky” mucous and lower airway obstruction. Subjects having CF or CF-like disease suffer from frequent infections due to inability to clear mucous. Local inflammatory mediators try to clear the infection but have difficulty. The triad of inflammation, infection and obstruction leads to progressive destruction of the lung parenchyma. Eventually, many subjects having CF or CF-like disease die in their late 30's due to respiratory failure.

Current treatments for CF or CF-like disease can increase the life expectancy of subjects with CF or CF-like disease. These treatments delay lung destruction and slow disease progression. These treatments do not reverse the damage to the lungs or cure CF or CF-like disease. Subjects having CF or CF-like disease eventually suffer from end-stage lung disease.

Treatments for the pulmonary manifestations of CF or CF-like disease include: antibiotics (oral, inhaled and intravenous), CFTR modulators (including CFTR potentiators), DNase, chest physiotherapy to loosen secretions and anti-inflammatory therapeutics. Treatment of the gastrointestinal manifestations includes supplemental gut soluble vitamins, high calorie diet and oral pancreatic enzymes. Subjects who develop diabetes are treated with insulin injections or an insulin pump. At the end stage, patients may benefit from lung transplant. Lung transplant may be combined with liver and/or pancreatic transplant. The average life expectancy for subjects having CF or CF-like disease is nearing 40 years of age.

Methods and compositions discussed herein provide for the treatment and prevention of Cystic Fibrosis (CF) and CF-like disease. The approach described herein aims to restore CFTR channel function, restore chloride, bicarbonate and/or sodium balance, and/or decrease mucous viscosity within the lungs, airways, gastrointestinal tract and reproductive tract.

CFTR modulators (both approved and in development) improve the functioning of mutant CFTR. These therapeutics improve CFTR functioning but do not return functionality to wild type levels. The approach described herein is expected to restore CFTR function through complete correction of the gene.

Gene therapy approaches are in development that deliver the CFTR channel gene to the lungs of CF patients. However, gene therapy may require constant readministration over the course of the lifetime of a subject due to high cell turnover in target epithelial cells. The approach described herein is expected to restore CFTR function and/or ameliorate SCNN1A disinhibition permanently through one, two or several doses.

The CFTR gene encodes a 180-kDA cAMP-gated chloride (Cl—) channel. The channel has six transmembrane spanning domains and is expressed by epithelial cells, lymphocytes and cardiac myocytes. The CFTR regulates the viscosity of mucous through its activity in the epithelial cells of the lungs, gastrointestinal tract and reproductive tract. Mutations in the CFTR result in decreased CFTR activity. Decreased CFTR activity can lead to aberrant ion transport, which gives rise to various disease symptoms in the lungs and other tissues, such as accumulation of sticky mucus, airway obstruction, infection and inflammation. Correction of CFTR mutations will ameliorate or cure lung, gastrointestinal and/or reproductive symptoms of CF.

The SCNN1A gene encodes the alpha subunit of the epithelial sodium channel (ENaC). The channel, comprised of alpha, beta and gamma subunits, regulates sodium transport into epithelial cells, including the epithelium of the lungs, sweat glands and kidneys. Mutations in the SCNN1A gene, (e.g. Val114ILE) have been shown to cause CF-like disease, characterized by pulmonary disease, including bronchiectasis. Mutations in SCNN1A also cause pseudohypoaldosteronism, a severe disease of the kidney. Pseudohypoaldosteronism is due to defective sodium transport within kidney epithelial cells; it is not caused by defective sodium transport in other tissues. The methods described herein include the targeted knockout of SCNN1A in the lung, gastrointestinal tract and/or reproductive tract. The methods described herein will not target kidney epithelium and will avoid the negative consequences of SCNN1A mutations within the kidney epithelium. One mutation in the SCNN1A gene, a 1477T>G substitution (W493R) has been identified in subjects who also have a mutation in CFTR. This mutation is associated with a severe CF phenotype, including severe bronchiectasis, chronic bronchitis and/or severe gastrointestinal symptoms. This mutation has been found to be associated with 4-fold overactivity of the ENaC channel (Azad et al., 2009; Human Mutation 30: 1093-1103). Overactivity of the SCNN1A-encoded ENaC channel can contribute to CF and CF-like disease. In all subjects, the CFTR is involved in inhibition of ENaC. CFTR mutations in subjects with CF or CF-like disease leads to ENaC disinhibition, leading to overactivity of the ENaC channel. ENaC overactivity can lead to further reduction in viscosity of mucous in CF or CF-like disease subjects, as more sodium is absorbed at the apical surface of epithelial cells, followed by increased fluid absorption from the mucous layer within the lung (Baker et al., 2012; Medicine & Science in Sports and Exercise 44(12): 2315-2321). Increased fluid absorption from the mucous layer reduces mucous viscosity. Inhibition of ENaC through SCNN1A knockout and/or knockdown in subjects with CF or CF-like disease can ameliorate the symptoms of CF or CF-like disease.

One common mutation in the CFTR gene is a deletion of the three nucleotides encoding Phenylalanine (F) at position 508 of the CFTR protein F508del (also sometime referred to herein as “F508del” or “delF508”). This mutation is the causative mutation in approximately two-thirds of CF cases. The remaining cases are caused by at least 1000 different mutations, many of which cause a less severe form of the disease.

Overactivity of the SCNN1A gene has been shown to contribute to bronchiectasis, bronchitis, and gastrointestinal symptoms in subjects with CF and in subjects with CF-like disease. In another aspect, methods and compositions discussed herein may be used to alter the SCNN1A gene (also known as sodium channel, non-voltage-gated 1 alpha subunit; amiloride-sensitive epithelial sodium channel alpha subunit; BESC2; ENaCa; SCNEA; SCNN1; ENaCalpha) to treat or prevent CF or CF-like disease, by targeting the SCNN1A gene, e.g., the non-coding or coding regions, e.g., a promoter region, or a transcribed sequence, e.g., intronic or exonic sequence. In an embodiment, the target position is V114, which corresponds to V114I in the SCNN1A gene. SCNN1A encodes an epithelial sodium channel, ENaC, that is negatively regulated by CFTR. In subjects with CFTR mutations, knocking out or knocking down the SCNN1A gene in certain cells will reduce or reverse the effect of defective CFTR. In subjects with no CFTR mutations but CF-like disease caused by SCNN1A mutations or other mechanisms, knocking out or knocking down the SCNN1A gene in certain cells will improve the viscosity of mucous and ameliorate disease.

Methods to Treat or Prevent Cystic Fibrosis and Cystic Fibrosis-Like Disease

Correction of the CFTR mutation (e.g., F508 deletion, e.g., G551D substitution, e.g., G542X nonsense mutation, e.g., N1303K substitution, e.g., R117H substitution, e.g., W1282X nonsense mutation, e.g., R553X nonsense mutation, e.g., 3849+10kbC>T substitution, e.g., 2789+5G>A substitution, e.g., 3273-26A>G substitution) or inactivation or knockdown of the SCNN1A gene, e.g., using the methods disclosed herein, can ameliorate the disease. In an embodiment, the method leads to normalized ion transport, less viscous mucous, and/or reduced mucous plugging and inflammation, e.g., early in the disease course. In an embodiment, the method results in fewer infections, decreased lung tissue destruction, and/or slowing in progression of disease. In an embodiment, the method improves mucous production and/or reduce frequency and/or length of infections, e.g., in later stages of the disease. In an embodiment, the method reduces or prevents further damage by ameliorating the triad of inflammation, infection and obstruction. In an embodiment, the method delays progression of the disease. In an embodiment, the method reduces or prevents further damage by ameliorating the triad of inflammation, infection and obstruction. In an embodiment, the method leads to normalized ion transport, and restoration of fertility. In an embodiment, the method leads to normalized ion transport, and improved gastrointestinal motility, absorption, and/or function.

Disclosed herein are the approaches to treat or prevent CF or CF-like disease, using the compositions and methods described herein.

While not wishing to be bound by theory, it is believed that, in an embodiment described herein, the CFTR channel is corrected and chloride and bicarbonate balance restored, e.g., within the lung, e.g., within the airway, e.g., within the gastrointestinal tract, e.g., within the reproductive tract, e.g., in the hepatobiliary epithelium, e.g. in the pancreas. CFTR modulators (both approved and in development) improve the functioning of mutant CFTR. These therapeutics improve CFTR functioning but do not return functionality to wild type levels.

In an embodiment, the approach described herein restores CFTR function through complete correction of the CFTR gene. In another embodiment, the approach described herein inactivates the SCNN1A gene, e.g., in the pulmonary epithelium, e.g., in the airway epithelium, e.g., in the gastrointestinal epithelium, e.g. in the reproductive epithelium, e.g., in the hepatobiliary epithelium, e.g. in the pancreatic ducts, in order to inhibit the abnormal sodium ion transport associated with reduced CFTR activity and/or in order to inhibit abnormal sodium ion transport associated with overactive ENaC activity. In an embodiment, these two approaches are combined to treat or prevent CF or CF-like disease. In an embodiment, the approaches described herein provide advantages over CFTR modulators.

It is contemplated that the compositions disclosed herein may be administered once or more than once (e.g., 2, 3, 4, 5, or more times) to correct a mutation in the CFTR gene or to inactivate or knock-down the SCNN1A gene. It is further contemplated that when the compositions disclosed herein are administered more than one time that the multiple administrations are intended to increase the number of cells (e.g., the number of cells in the subject) containing the corrected form of the CFTR gene and/or the inactivated/knocked-down form of the SCNN1A gene, thereby increasing the effectiveness of the treatment.

The methods of treatment described herein can be initiated for subjects at all stages of the disease. In an embodiment, the treatment is initiated after disease onset, e.g., as the subject presents with lung infections, wheezing and obstructed airways, and/or pancreatic insufficiency, decreased gastrointestinal function, malabsorption, and/or infertility. While not wishing to be bound by theory, in an embodiment, repair of the CFTR gene or inactivation/knock-down of the SCNN1A gene after disease onset but early in the disease course reduces or prevents progression of the disease. In an embodiment, the method comprises treating a subject with advanced disease. In an embodiment, the method reduces or prevents further progression of symptoms, with or without reversing pathology.

In an embodiment, the treatment is initiated prior to disease onset. In another embodiment, the treatment is initiated at an early stage of the disease, e.g., before the subject has noticed any decline in function or symptoms.

In an embodiment, treatment is initiated in utero.

In an embodiment, treatment is initiated after birth.

In an embodiment, treatment is initiated prior to the age of 1.

In an embodiment, treatment is initiated prior to the age of 2.

In an embodiment, treatment is initiated prior to the age of 5.

In an embodiment, treatment is initiated prior to the age of 10.

In an embodiment, the subject has tested positive for a mutation in the CFTR gene, e.g., a mutation described herein.

In an embodiment, the subject has tested positive for a mutation in the SCNN1A gene, e.g., a mutation described herein.

In an embodiment, the treatment is initiated at appearance of a symptom of CF or CF-like disease, e.g., any of the following symptoms: frequent lung infections, chronic cough, sputum production, or chronic wheeze. In an embodiment, the subject has a positive “sweat test” or elevated sweat Chloride indicating dysfunction of the CFTR channel and/or overactivity of the SCNN1A channel. In an embodiment, the subject has an elevated sweat Chloride, bronchiectasis and is found to have no mutation in the CFTR gene.

In an embodiment, the treatment is initiated if the subject is tested positive for a defect, e.g., a genetic defect, in the CFTR gene.

In an embodiment, the treatment is initiated if the subject is tested positive for a defect, e.g., a genetic defect, in the SCNN1A gene.

In an embodiment, the treatment is initiated if a family member of the subject has been diagnosed with CF or CF-like disease. In an embodiment, the subject has a symptom or sign of CF or CF-like disease. In an embodiment, the subject has a mutation in the CFTR gene, e.g., a mutation described herein.

In an embodiment, the treatment is initiated at the appearance of any of the following findings consistent with CF or CF-like disease, including but not limited to, obstructive lung disease on lung function tests; persistent colonization with B. cepacia, P. aeruginosa and S. aureus and other CF-related pathogens; chronic radiologic abnormalities on chest x-ray; or chronic sinusitis.

In an embodiment, the method comprises initiating treatment at the appearance of any of the following gastrointestinal findings consistent with CF or CF-like disease, including but not limited to: failure to thrive, steatorrhea, hypoproteinemia, vitamin deficiency due to fat-soluble vitamin malabsorption, meconium ileus, rectal prolapse, malabsorption, pancreatic insufficiency, pancreatitis, or chronic hepatobiliary disease. Evidence of chronic hepatobiliary disease can include, e.g., elevated transaminases and/or hyperbilirubinemia.

In an embodiment, a cell is treated ex vivo. In an embodiment, the cell is returned to the subject.

In an embodiment, it is contemplated herein that a population of cells from a subject may be contacted ex vivo to correct a mutation in the CFTR gene, e.g., F508del, e.g., G542X, e.g., G551D, e.g., N1303K, e.g., R117H, e.g., W1282X, e.g., R553X, e.g., 3849+10kbC>T, e.g., 2789+5G>A, e.g., 3273-26A>G, and a second population of cells from the subject is contacted ex vivo to introduce a mutation in the SCNN1A gene to knockout or knockdown SCNN1A. A mixture of the two cell populations may be returned to the subject's body to prevent or treat CF or CF-like disease.

In an embodiment, the cell is harvested from epidermis, pulmonary tree, hepatobiliary tree, gastrointestinal tract, reproductive tract, or other organ. In an embodiment, the cell is reprogrammed to an induced pluripotent stem (iPS) cell. In an embodiment, the iPS cell is differentiated into airway epithelium, pulmonary epithelium, submucosal glands, submucosal ducts, biliary epithelium, gastrointestinal epithelium, pancreatic duct cells, reproductive epithelium, epidydimal cells, and/or cells of the hepatobiliary tree, e.g., clara cells, e.g., ciliated cells, e.g., goblet cells, e.g., basal cells, e.g., acinus cells, e.g., bronchioalveolar stem cell e.g., lung epithelial cells, e.g., nasal epithelial cells, e.g., tracheal epithelial cells, e.g., bronchial epithelial cells, e.g., enteroendocrine cells, e.g., Brunner's gland cells, e.g., epididymal epithelium. In an embodiment, the CFTR gene in the cell is corrected with the method described herein. In an embodiment, the SCNN1A gene in the cell is corrected with the method described herein. In an embodiment, the CFTR gene and the SCNN1A gene in the cell is corrected with the method described herein. In an embodiment, the cell is re-introduced into an appropriate location in the subject, e.g., airway, pulmonary tree, bile duct system, gastrointestinal tract, pancreas, hepatobiliary tree, and/or reproductive tract.

In an embodiment, an autologous stem cell can be treated ex vivo, differentiated into airway epithelium, pulmonary epithelium, submucosal glands, submucosal ducts, biliary epithelium, gastrointestinal epithelium, pancreatic duct cells, reproductive epithelium, epidydimal cells, and/or cells of the hepatobiliary tree, e.g., clara cells, e.g., ciliated cells, e.g., goblet cells, e.g., basal cells, e.g., acinus cells, e.g., bronchioalveolar stem cell e.g., lung epithelial cells, e.g., nasal epithelial cells, e.g., tracheal epithelial cells, e.g., bronchial epithelial cells, e.g., enteroendocrine cells, e.g., Brunner's gland cells, e.g., epididymal epithelium, and transplanted into the subject.

In an embodiment, a heterologous stem cell can be treated ex vivo, differentiated into airway epithelium, pulmonary epithelium, submucosal glands, submucosal ducts, biliary epithelium, gastrointestinal epithelium, pancreatic duct cells, reproductive epithelium, epidydimal cells, and/or cells of the hepatobiliary tree, e.g., clara cells, e.g., ciliated cells, e.g., goblet cells, e.g., basal cells, e.g., acinus cells, e.g., bronchioalveolar stem cell e.g., lung epithelial cells, e.g., nasal epithelial cells, e.g., tracheal epithelial cells, e.g., bronchial epithelial cells, e.g., enteroendocrine cells, e.g., Brunner's gland cells, e.g., epididymal epithelium, and transplanted into the subject.

In an embodiment, the method described herein comprises delivery of gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid, by inhalation, e.g., via nebulizer. In an embodiment, the method described herein comprises delivery of gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid by intravenous administration. In an embodiment, the method described herein comprises delivery of gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid by intraparenchymal injection into lung tissue. In an embodiment, the method described herein comprises delivery of gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid, by intraparenchymal, intralveolar, intrabronchial, intratracheal injection into the trachea, bronchial tree and/or alveoli. In an embodiment, the method described herein comprises delivery of gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid, by intravenous, intraparenchymal or other directed injection or administration to any of the following locations: the portal circulation, liver parenchyma, pancreas, pancreatic duct, bile duct, jejunum, ileum, duodenum, stomach, upper intestine, lower intestine, gastrointestinal tract, epididymis, or reproductive tract.

In an embodiment, a gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid are delivered, e.g., to a subject, by AAV, e.g., via nebulizer, or via nasal spray or inhaled, with or without accelerants to aid in absorption. In an embodiment, a gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid are delivered, e.g., to a subject, by Sendai virus, adenovirus, lentivirus or other modified or unmodified viral delivery particle.

In an embodiment, a gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid are delivered, e.g., to a subject, via nebulizer or jet nebulizer, nasal spray, or inhalation. In an embodiment, a gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid, is formulated in an aerosolized cationic liposome, lipid nanoparticle, lipoplex, non-lipid polymer complex or dry powder, e.g., for delivery via nebulizer, with or without accelerants to aid in absorption.

In an embodiment, a gRNA or other components described herein, e.g., a Cas9 molecule and a template nucleic acid are delivered, e.g., to a subject, via liposome GL67A. GL67A is described, e.g., www.cfgenetherapy.org.uk/clinical/product.html; Eastman et al., Hum Gene Ther. 1997 Apr. 10; 8(6):765-73.

Disclosed herein are methods for altering the CF target position in the CFTR and/or SCNN1A genes.

Methods and compositions disclosed herein provide a number of approaches for treating or preventing CF and CF-like disease. In an embodiment, methods described herein provide for treating or preventing CF and CF-like disease by correcting a target position in the CFTR gene to provide corrected, or functional, e.g., wild type, CFTR. In an embodiment, methods described herein allow for treating or preventing CF and CF-like disease by inducing or introducing a mutation that reduces the level of functional SCNN1A gene product. In subjects with CF or CF-like disease, these methods can be used alone, e.g. CFTR correction, e.g., SCNN1A knockout or knockdown, or in combination, e.g., CFTR correction with SCNN1A knockout or knockdown.

Several approaches are detailed in the following, including target positions and mutations amenable to approach. In the description below, approaches 1, 2 and 3 (e.g., 3A and 3B) correspond to methods to alter CFTR. In the description below, approach 4 and 6 correspond to methods to alter SCNN1A. One or more of the approaches can be used alone or in combination. For example, approaches 1, 2, and 3 can be used alone or approach 1 can be combined with approach 4, or approach 2 can be combined with approach 4 or approach 3 (e.g., 3A or 3B) can be combined with approach 4.

Methods to Alter CFTR

In one aspect, methods and compositions discussed herein, provide for the correction of the underlying cause of CF or CF-like disease, e.g., the correction of a mutation at a target position in the CFTR gene.

As disclosed herein, the CFTR gene can be altered by gene editing, e.g., using CRISPR-Cas9 mediated methods as described herein. Methods and compositions discussed herein, provide for altering a CF target position in the CFTR gene. A CF target position can be altered by gene editing, e.g., using CRISPR-Cas9 mediated methods to alter the CFTR gene.

In an embodiment, while some of the disclosure herein is presented in the context of the mutation in the CFTR gene that gives rise to an F508 mutant protein (e.g., F508del mutant protein) or a G551 mutant protein (e.g., G551D mutant protein), or a G542 mutant protein (e.g., G542X mutant protein), or a mutant protein (e.g., mutant protein), or a N1303 mutant protein (e.g., N1303K mutant protein), or a R117 mutant protein (e.g., R117H mutant protein), or a W1282 mutant protein (e.g., W1282X mutant protein), or a R553 mutant protein (e.g., R553X mutant protein), or a c.3717+12191 mutant protein (e.g., c.3717+12191C>T mutant protein), or a c.2657+5 mutant protein (e.g., c.2657+5G>A mutant protein), or a c.3140-26 mutant protein (e.g., c.3140-26A>G mutant protein), the methods and compositions herein are broadly applicable to any mutation, e.g., a point mutation or a deletion, in the CFTR gene that gives rise to CF or CF-like disease.

The alteration of the CFTR gene can be mediated by any mechanism. Exemplary mechanisms that can be associated with the alteration of the CFTR gene include, but are not limited to, non-homologous end joining (e.g., classical or alternative), microhomology-mediated end joining (MMEJ), homology-directed repair (e.g., endogenous donor template mediated), SDSA (synthesis dependent strand annealing) or single strand annealing or single strand invasion, all with or without the addition of an endogenous-promoter driven cDNA encoding the CFTR gene.

Approach 1:

In an embodiment, one approach to treat or prevent CF or CF-like disease is to repair (i.e., correct) one or more mutations in the CFTR gene, e.g., by HDR. While not wishing to be bound by theory, it is believed that correction of the mutation(s) (e.g., mediated by HDR) restore the mutant CFTR gene to its wild type state. In an embodiment, single stranded oligonucleotides (ssODNs) are used as a donor template. In another embodiment, double stranded DNA donor is used as a donor template. Donor templates contain DNA sequence which, upon incorporation, result in the expression of a functional version of the CFTR protein. In an embodiment, one CFTR allele is repaired in the subject. In another embodiment, both CFTR alleles are repaired in the subject. In one aspect, methods and compositions discussed herein, provide for the correction of the underlying genetic cause of CF or CF-like disease, e.g., the correction of a mutation at a target position in the CFTR gene, e.g., correction of a mutation (e.g., delF508, G551DG542X, N1303K, R117H, W1282X, or R553X) in the CFTR gene.

Mutations in the CFTR gene amenable to the approach described herein include, but are not limited to any of the following mutations, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X.

In an embodiment, the homology-directed repair of genomic sequence including the mutation at the CF target position (e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X) gives rise to alteration of the CFTR gene. This approach leads to the cessation of production of mutant CFTR channel and results in the production of wild-type CFTR channel. This approach will prevent the development or progression of lung, gastrointestinal and/or reproductive disease in subjects with CFTR mutations.

In an embodiment, the method provides for the correction of a mutation at a target position in the CFTR gene, e.g., correction of a mutation, e.g., an F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X substitution in the CFTR gene. As described herein, in an embodiment, the method comprises the introduction of one or more breaks (e.g., single strand breaks or double strand breaks) sufficiently close to (e.g., either 5′ or 3′ to) the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X.

In an embodiment, the targeting domain of the gRNA molecule is configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to (e.g., either 5′ or 3′ to) the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X to allow correction, e.g., an alteration in the CFTR gene, e.g., an alternation associated with HDR. In an embodiment, the targeting domain is configured such that a cleavage event, e.g., a double strand or single strand break, is positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X. The break, e.g., a double strand or single strand break, can be positioned upstream or downstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X.

In an embodiment, a second, third and/or fourth gRNA molecule is configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to (e.g., either 5′ or 3′ to) the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X to allow correction, e.g., an alteration associated with HDR in the CFTR gene. In an embodiment, the targeting domain is configured such that a cleavage event, e.g., a double strand or single strand break, is positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X. The break, e.g., a double strand or single strand break, can be positioned upstream or downstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X.

In an embodiment, a single strand break is accompanied by an additional single strand break, positioned by a second, third and/or fourth gRNA molecule, as discussed below. For example, The targeting domains bind configured such that a cleavage event, e.g., the two single strand breaks, are positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X. In an embodiment, the first and second gRNA molecules are configured such, that when guiding a Cas9 nickase, a single strand break will be accompanied by an additional single strand break, positioned by a second gRNA, sufficiently close to one another to result in an alteration of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X. In an embodiment, the first and second gRNA molecules are configured such that a single strand break positioned by said second gRNA is within 10, 20, 30, 40, or 50 nucleotides of the break positioned by said first gRNA molecule, e.g., when the Cas9 is a nickase. In an embodiment, the two gRNA molecules are configured to position cuts at the same position, or within a few nucleotides of one another, on different strands, e.g., essentially mimicking a double strand break.

In an embodiment, a double strand break can be accompanied by an additional double strand break, positioned by a second, third and/or fourth gRNA molecule, as is discussed below. For example, the targeting domain of a first gRNA molecule is configured such that a double strand break is positioned upstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position; and the targeting domain of a second gRNA molecule is configured such that a double strand break is positioned downstream the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position.

In an embodiment, a double strand break can be accompanied by two additional single strand breaks, positioned by a second gRNA molecule and a third gRNA molecule. For example, the targeting domain of a first gRNA molecule is configured such that a double strand break is positioned upstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position; and the targeting domains of a second and third gRNA molecule are configured such that two single strand breaks are positioned downstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position. In an embodiment, the targeting domain of the first, second and third gRNA molecules are configured such that a cleavage event, e.g., a double strand or single strand break, is positioned, independently for each of the gRNA molecules.

In an embodiment, a first and second single strand breaks can be accompanied by two additional single strand breaks positioned by a third gRNA molecule and a fourth gRNA molecule. For example, the targeting domain of a first and second gRNA molecule are configured such that two single strand breaks are positioned upstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X; and the targeting domains of a third and fourth gRNA molecule are configured such that two single strand breaks are positioned downstream of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450 or 500 nucleotides of the target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, or R553X.

In an embodiment, a single strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nickase) is used to create a single strand break at or in close proximity to the CF target position, e.g., the gRNA is configured such that the single strand break is positioned either upstream (e.g., within 200 bp upstream) or downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, a double strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nuclease other than a Cas9 nickase) is used to create a double strand break at or in close proximity to the CF target position, e.g., the gRNA molecule is configured such that the double strand break is positioned either upstream (e.g., within 200 bp upstream) or downstream of (e.g., within 200 bp downstream) of a CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two single strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that both of the single strand breaks are positioned upstream (e.g., within 200 bp upstream) or downstream (e.g., within 200 bp downstream) of the CF target position. In another embodiment, two gRNA molecules (e.g., with two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that one single strand break is positioned upstream (e.g., within 200 bp upstream) and a second single strand break is positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two double strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nucleases that are not Cas9 nickases) are used to create two double strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that one double strand break is positioned upstream (e.g., within 200 bp upstream) and a second double strand break is positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, one double strand break and two single strand breaks are introduced (e.g., positioned by three gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, three gRNA molecules (e.g., with a Cas9 nuclease other than a Cas9 nickase and one or two Cas9 nickases) to create one double strand break and two single strand breaks to flank an CF target position, e.g., the gRNA molecules are configured such that the double strand break is positioned upstream or downstream of (e.g., within 200 bp upstream or downstream) of the CF target position, and the two single strand breaks are positioned at the opposite site, e.g., downstream or upstream (within 200 bp downstream or upstream), of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, four single strand breaks are introduced (e.g., positioned by four gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, four gRNA molecule (e.g., with one or more Cas9 nickases are used to create four single strand breaks to flank an CF target position in the CFTR gene, e.g., the gRNA molecules are configured such that a first and second single strand breaks are positioned upstream (e.g., within 200 bp upstream) of the CF target position, and a third and a fourth single stranded breaks are positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two or more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

Approach 2:

HDR-mediated knockin of cDNA to alter the CFTR gene. In an embodiment, a CF target knockin position is altered. Altering the CF target knockin position refers to homology-directed knockin of genomic sequence, including the delivery of cDNA template of contiguous exons (X+1) through exon 27 of CFTR gene, wherein exon X is any exon between exon 1 and exon 27. Targeted knockin of CFTR cDNA leads to the cessation of production of mutant or truncated CFTR protein and results in the production of functional CFTR protein. In an embodiment, a donor template is provided to mediate HDR-mediated knockin. In an embodiment, said donor template comprise homology arms, splice acceptor, contiguous coding sequence of exons (X+1) through exon 27 of CFTR gene and polyadenylation signal. While not wishing to be bound by theory, it is believed that correction of the mutation(s) (e.g., mediated by HDR) restore the mutant CFTR gene to its wild type state. In another embodiment, double stranded DNA donor is used as a donor template. Donor templates contain DNA sequence which, upon incorporation, would result in the expression of a functional version of the CFTR protein. In an embodiment, one CFTR allele is repaired in the subject. In another embodiment, both CFTR alleles are repaired in the subject. In one aspect, methods and compositions discussed herein, provide for the correction of the underlying genetic cause of CF or CF-like disease, e.g., the correction of a mutation at a CF target position in the CFTR gene, e.g., correction of a mutation. This approach leads to the cessation of production of mutant or truncated CFTR protein and results in the production of functional CFTR protein. This approach prevents the development or progression of lung, gastrointestinal and/or reproductive disease in a subject due to the cessation of production of mutant CFTR protein and restoration of functional CFTR protein production. This approach cures and/or prevents the progression of lung, gastrointestinal and/or reproductive disease in any subject with CF or CF-like disease deficiency who has a mutation in exon (X+1) through exon 27 of the CFTR gene, or in any subject who has a mutation in an intronic or exonic region of the CFTR gene that is after exon X.

In an embodiment, homology-directed repair of the CFTR gene in any subjects with CF mutations in exons 3 through 27 and introns 2 through 26 by targeting intronic region between exons 2 and 3 and with delivery of a homology-directed repair template including homology arms, splice acceptor, coding sequence of contiguous exons 3-27 of CFTR gene and polyadenylation signal.

In an embodiment, the CF target position is the intronic region between exons 2 and 3. Altering the CF target position refers to homology-directed repair of genomic sequence including the delivery of cDNA template of exons 3-27 of CFTR gene. This approach cures and/or prevents the progression of lung, gastrointestinal and/or reproductive disease in any subject with CF or CF-like disease deficiency who has a mutation in exons 3-27 of the CFTR gene, or in any subject who has a mutation in an intronic or exonic region of the CFTR gene that is on or after the second intron, including but not limited to the following mutations: e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, R553X, c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G.

In an embodiment, the CF target position is the intronic region between exons 10 and 11. Altering the CF target position refers to homology-directed repair of genomic sequence including the delivery of cDNA template of exons 11-27 of CFTR gene. This approach cures and/or prevents the progression of lung, gastrointestinal and/or reproductive disease in any subject with CF or CF-like disease deficiency who has a mutation in exons 11-27 of the CFTR gene, or in any subject who has a mutation in an intronic or exonic region of the CFTR gene that is on or after the second intron, including but not limited to the following mutations: e.g., F508del.

In an embodiment, the method provides for the correction of a mutation at a target position in the CFTR gene, e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, R553X, c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G. As described herein, in one embodiment, the method comprises the introduction of one or more breaks (e.g., single strand breaks or double strand breaks) sufficiently close to (e.g., either 5′ or 3′ to) the target position in the CFTR gene, e.g., intron 2 or intron 10.

In an embodiment, the targeting domain of the gRNA molecule is configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to (e.g., either 5′ or 3′ to) the target position e.g., intron 2 or intron 10 allow correction, e.g., an alteration in the CFTR gene, e.g., an alternation associated with HDR. In an embodiment, the targeting domain is configured such that a cleavage event, e.g., a double strand or single strand break, is positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position in the CFTR gene, e.g., intron 2 or intron 10. The break, e.g., a double strand or single strand break, can be positioned upstream or downstream of the target position in the CFTR gene, e.g., intron 2 or intron 10.

In an embodiment, a second, third and/or fourth gRNA molecule is configured to provide a cleavage event, e.g., a double strand break or a single strand break, sufficiently close to (e.g., either 5′ or 3′ to) the target position e.g., intron 2 or intron 10 to allow correction, e.g., an alteration associated with HDR in the CFTR gene. In an embodiment, the targeting domain is configured such that a cleavage event, e.g., a double strand or single strand break, is positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position in the CFTR gene, e.g., intron 2 or intron 10. The break, e.g., a double strand or single strand break, can be positioned upstream or downstream of the target position in the CFTR gene, e.g., intron 2 or intron 10.

In an embodiment, a single strand break is accompanied by an additional single strand break, positioned by a second, third and/or fourth gRNA molecule, as discussed below. For example, The targeting domains bind configured such that a cleavage event, e.g., the two single strand breaks, are positioned within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position in the CFTR gene, e.g., intron 2 or intron 10. In an embodiment, the first and second gRNA molecules are configured such, that when guiding a Cas9 nickase, a single strand break will be accompanied by an additional single strand break, positioned by a second gRNA, sufficiently close to one another to result in an alteration of the target position in the CFTR gene, e.g., intron 2 or intron 10. In an embodiment, the first and second gRNA molecules are configured such that a single strand break positioned by said second gRNA is within 10, 20, 30, 40, or 50 nucleotides of the break positioned by said first gRNA molecule, e.g., when the Cas9 is a nickase. In an embodiment, the two gRNA molecules are configured to position cuts at the same position, or within a few nucleotides of one another, on different strands, e.g., essentially mimicking a double strand break.

In an embodiment, a double strand break can be accompanied by an additional double strand break, positioned by a second, third and/or fourth gRNA molecule, as is discussed below. For example, the targeting domain of a first gRNA molecule is configured such that a double strand break is positioned upstream of the target position in the CFTR gene, e.g., intron 2 or intron 10, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position; and the targeting domain of a second gRNA molecule is configured such that a double strand break is positioned downstream the target position in the CFTR gene, e.g., intron 2 or intron 10, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position.

In an embodiment, a double strand break can be accompanied by two additional single strand breaks, positioned by a second gRNA molecule and a third gRNA molecule. For example, the targeting domain of a first gRNA molecule is configured such that a double strand break is positioned upstream of the target position in the CFTR gene, e.g., intron 2 or intron 10 e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position; and the targeting domains of a second and third gRNA molecule are configured such that two single strand breaks are positioned downstream of the target position in the CFTR gene, e.g., intron 2 or intron 10, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position. In an embodiment, the targeting domain of the first, second and third gRNA molecules are configured such that a cleavage event, e.g., a double strand or single strand break, is positioned, independently for each of the gRNA molecules.

In an embodiment, a first and second single strand breaks can be accompanied by two additional single strand breaks positioned by a third gRNA molecule and a fourth gRNA molecule. For example, the targeting domain of a first and second gRNA molecule are configured such that two single strand breaks are positioned upstream of the target position in the CFTR gene, e.g., intron 2 or intron 10, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position in the CFTR gene, e.g., intron 2 or intron 10; and the targeting domains of a third and fourth gRNA molecule are configured such that two single strand breaks are positioned downstream of the target position in the CFTR gene, e.g., intron 2 or intron 10, e.g., within 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200 nucleotides of the target position in the CFTR gene, e.g., intron 2 or intron 10.

In an embodiment, a single strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nickase) is used to create a single strand break at or in close proximity to the CF target position, e.g., the gRNA is configured such that the single strand break is positioned either upstream (e.g., within 200 bp upstream) or downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, a double strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nuclease other than a Cas9 nickase) is used to create a double strand break at or in close proximity to the CF target position, e.g., the gRNA molecule is configured such that the double strand break is positioned either upstream (e.g., within 200 bp upstream) or downstream of (e.g., within 200 bp downstream) of a CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two single strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that both of the single strand breaks are positioned upstream (e.g., within 200 bp upstream) or downstream (e.g., within 200 bp downstream) of the CF target position. In another embodiment, two gRNA molecules (e.g., with two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that one single strand break is positioned upstream (e.g., within 200 bp upstream) and a second single strand break is positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two double strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nucleases that are not Cas9 nickases) are used to create two double strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that one double strand break is positioned upstream (e.g., within 200 bp upstream) and a second double strand break is positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, one double strand break and two single strand breaks are introduced (e.g., positioned by three gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, three gRNA molecules (e.g., with a Cas9 nuclease other than a Cas9 nickase and one or two Cas9 nickases) to create one double strand break and two single strand breaks to flank an CF target position, e.g., the gRNA molecules are configured such that the double strand break is positioned upstream or downstream of (e.g., within 200 bp upstream or downstream) of the CF target position, and the two single strand breaks are positioned at the opposite site, e.g., downstream or upstream (within 200 bp downstream or upstream), of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, four single strand breaks are introduced (e.g., positioned by four gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, four gRNA molecule (e.g., with one or more Cas9 nickases are used to create four single strand breaks to flank an CF target position in the CFTR gene, e.g., the gRNA molecules are configured such that a first and second single strand breaks are positioned upstream (e.g., within 200 bp upstream) of the CF target position, and a third and a fourth single stranded breaks are positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two or more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

Approach 3A:

In an embodiment, Cas9-mediated removal and/or disruption of an intronic segment of DNA, within a CFTR intron, to restore post-transcriptional processing accuracy, e.g., without the use of homology-directed repair. CFTR mutations (e.g., c.3717+12191C>T, e.g., 2657+5G>A, e.g., c.3140-26A>G) can cause abbarent post-transcriptional processing, such as missplicing by the creation of novel splice sites which can lead to the early truncation of non-functional CFTR protein resulting in aberrant CFTR channel formation. In one aspect, methods and compositions discussed herein, provide for altering the CF target position in the CFTR gene. The CF target position (e.g. c.3717+12191, also known as c.3849+10kb, e.g., c.2657+5, also known as c.2789+5, e.g., c.3140-26A, also known as c.3272-26) can be altered, e.g., by non-homologous end-joining mediated removal and/or disruption of a splice site mutation. In the case of a subject with a 3717+12191C>T mutation, the CF target position is 500 bp upstream and/or downstream of c.3717+12191 within intron 22. In the case of a subject with a c.2657+5G>A mutation, the CF target position is 200 bp upstream within exon 16, and intron 16 and intron 15 and/or downstream of c.2657+5 within intron 16. In the case of a subject with a c.3140-26A>G mutation, the CF target position is 200 bp upstream and/or downstream of c.3140-26 within intron 19 and exon 20. The removal, disruption and/or repair of a splice site mutation will restore accurate splicing and cease production of aberrant truncation of CFTR protein. This approach will lead to the cessation of production of truncated non-functional CFTR channel and will lead to the production of wild-type CFTR channel. This approach will prevent the development or progression of lung, gastrointestinal and/or reproductive disease in subjects with CFTR mutations.

In an embodiment, methods and compositions discussed herein, provide for altering the CF target position in the CFTR gene. The alteration can be achieved by (1) break-induced introduction of an indel (also referred to herein as NHEJ-mediated introduction of an indel) in close proximity to or including a CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G), or (2) break-induced deletion (also referred to herein as NHEJ-mediated deletion) of genomic sequence including the mutation at a CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G). Both approaches give rise to the loss or destruction of the abbarent post-transcriptional processing.

In an embodiment, the method comprises introducing a break-induced indel in close proximity to or including the CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G). As described herein, in one embodiment, the method comprises the introduction of a double strand break sufficiently close to (e.g., either 5′ or 3′ to) the CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. A single gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, is configured to position a double strand break sufficiently close to the CF target position in the CFTR gene. The double strand break may be positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that NHEJ-mediated repair of the double strand break allows for the NHEJ-mediated introduction of an indel in close proximity to or including the CF target position.

In another embodiment, the method comprises the introduction of a pair of single strand breaks sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two single strand breaks sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that NHEJ mediated repair of the pair of single strand breaks allows for the NHEJ-mediated introduction of an indel in close proximity to or including the CF target position. In an embodiment, the pair of single strand breaks may be accompanied by an additional double strand break, positioned by a third gRNA molecule, as is discussed below. In another embodiment, the pair of single strand breaks may be accompanied by two additional single strand breaks positioned by a third gRNA molecule and a fourth gRNA molecule, as is discussed below.

In another embodiment, the method comprises the introduction of two sets of breaks (e.g., a pair of double strand breaks targeted by two gRNAs) sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G). such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two sets of breaks (e.g., a pair of double strand breaks) sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that NHEJ mediated repair of two sets of breaks (e.g., a pair of double strand breaks) allows for the NHEJ-mediated introduction of an indel in close proximity to or including the CF target position.

In another embodiment, the method comprises the introduction of two sets of breaks (e.g., one double strand break and a pair of single strand breaks targeted by three gRNAs) sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G). such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two sets of breaks (e.g., one double strand break and a pair of single strand breaks) sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that NHEJ mediated repair of two sets of breaks (e.g., one double strand break and a pair of single strand breaks) allows for the NHEJ-mediated introduction of an indel in close proximity to or including the CF target position.

In another embodiment, the method comprises the introduction of two sets of breaks (e.g., two pairs of single strand breaks targeted by four gRNAs) sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G). such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two sets of breaks (e.g., two pairs of single strand breaks s) sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, 200, 300, 400 or 500 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that NHEJ mediated repair of two sets of breaks (e.g., two pairs of single strand breaks) allows for the NHEJ-mediated introduction of an indel in close proximity to or including the CF target position.

In an embodiment, a single strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nickase) is used to create a single strand break at or in close proximity to the CF target position, e.g., the gRNA is configured such that the single strand break is positioned either upstream (e.g., within 500 bp, e.g., within 200 bp upstream) or downstream (e.g., within 500 bp, e.g., within 200 bp downstream) of the CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, a double strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nuclease other than a Cas9 nickase) is used to create a double strand break at or in close proximity to the CF target position, e.g., the gRNA molecule is configured such that the double strand break is positioned either upstream (e.g., within 500 bp, e.g., within 200 bp upstream) or downstream of (e.g., within 500 bp, e.g., within 200 bp downstream) of a CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two single strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that both of the single strand breaks are positioned upstream (e.g., within 500 bp, e.g., within 200 bp upstream) or downstream (e.g., within 500 bp, e.g., within 200 bp downstream) of the CF target position. In another embodiment, two gRNA molecules (e.g., with two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that one single strand break is positioned upstream (e.g., within 500 bp, e.g., within 200 bp upstream) and a second single strand break is positioned downstream (e.g., within 500 bp, e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two double strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nucleases that are not Cas9 nickases) are used to create two double strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that one double strand break is positioned upstream (e.g., within 500 bp, e.g., within 200 bp upstream) and a second double strand break is positioned downstream (e.g., within 500 bp, e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, one double strand break and two single strand breaks are introduced (e.g., positioned by three gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, three gRNA molecules (e.g., with a Cas9 nuclease other than a Cas9 nickase and one or two Cas9 nickases) to create one double strand break and two single strand breaks to flank an CF target position, e.g., the gRNA molecules are configured such that the double strand break is positioned upstream or downstream of (e.g., within 500 bp, e.g., within 200 bp upstream or downstream) of the CF target position, and the two single strand breaks are positioned at the opposite site, e.g., downstream or upstream (within 200 bp downstream or upstream), of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, four single strand breaks are introduced (e.g., positioned by four gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, four gRNA molecule (e.g., with one or more Cas9 nickases are used to create four single strand breaks to flank an CF target position in the CFTR gene, e.g., the gRNA molecules are configured such that a first and second single strand breaks are positioned upstream (e.g., within 500 bp, e.g., within 200 bp upstream) of the CF target position, and a third and a fourth single stranded breaks are positioned downstream (e.g., within 500 bp, e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two or more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

In an embodiment, a single strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nickase) is used to create a single strand break at or in close proximity to the CF target position, e.g., the gRNA is configured such that the single strand break is positioned either upstream (e.g., within 500 bp upstream) or downstream (e.g., within 500 bp downstream) of the CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, a double strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nuclease other than a Cas9 nickase) is used to create a double strand break at or in close proximity to the CF target position, e.g., the gRNA molecule is configured such that the double strand break is positioned either upstream (e.g., within 500 bp upstream) or downstream of (e.g., within 500 bp downstream) of a CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two single strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that both of the single strand breaks are positioned upstream (e.g., within 500 bp upstream) or downstream (e.g., within 500 bp downstream) of the CF target position. In another embodiment, two gRNA molecules (e.g., with two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that one single strand break is positioned upstream (e.g., within 500 bp upstream) and a second single strand break is positioned downstream (e.g., within 500 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two double strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nucleases that are not Cas9 nickases) are used to create two double strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that one double strand break is positioned upstream (e.g., within 500 bp upstream) and a second double strand break is positioned downstream (e.g., within 500 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, one double strand break and two single strand breaks are introduced (e.g., positioned by three gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, three gRNA molecules (e.g., with a Cas9 nuclease other than a Cas9 nickase and one or two Cas9 nickases) to create one double strand break and two single strand breaks to flank an CF target position, e.g., the gRNA molecules are configured such that the double strand break is positioned upstream or downstream of (e.g., within 500 bp upstream or downstream) of the CF target position, and the two single strand breaks are positioned at the opposite site, e.g., downstream or upstream (within 500 bp downstream or upstream), of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, four single strand breaks are introduced (e.g., positioned by four gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, four gRNA molecule (e.g., with one or more Cas9 nickases are used to create four single strand breaks to flank an CF target position in the CFTR gene, e.g., the gRNA molecules are configured such that a first and second single strand breaks are positioned upstream (e.g., within 500 bp upstream) of the CF target position, and a third and a fourth single stranded breaks are positioned downstream (e.g., within 500 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two or more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

Approach 3B:

In an embodiment, Cas9-mediated removal and/or disruption of an intronic segment of DNA, within a CFTR intron, to restore post-transcriptional processing accuracy, e.g., with the use of homology-directed repair. CFTR mutations e.g., c.2657+5 (also known as c.2789+5), or c.3140-26A (also known as c.3272-26) can cause abbarent post-transcriptional processing, such as missplicing by the creation of novel splice sites which can lead to production of non-functional CFTR protein resulting in aberrant CFTR channel formation. In one aspect, methods and compositions discussed herein, provide for altering the CF target position in the CFTR gene. The CF target position (e.g., c.2657+5, e.g., c.3140-26A) can be altered by non-homologous end-joining mediated removal of a splice site mutation. In the case of a subject with a c.2657+5G>A mutation, the CF target position is 200 bp upstream and/or downstream of c.2657+5 within within exon 16, and intron 16 and intron 15. In the case of a subject with a c.3140-26A>G mutation, the CF target position is 200 bp upstream and/or downstream of c.3140-26 within exon 20 and intron 19. In an embodiment, in a subject with a target mutation in close proximity to an exon (including, but not limited to the mutations, e.g., 2789+5G>A, e.g., 3272-26A>G), approach may include Cas-9 mediated removal and/or disruption of an intronic segment at or near the target site with homology-directed repair with delivery of Cas9 nuclease (or nickase, or dead-Cas9), CRISPR-gRNAs, and homology-directed repair donor templates. In an embodiment, the donor template will be comprised of a single-strand oligonucleotide donor of 50 NT to 200 NT (or more as the technology becomes available). In an embodiment, the donor template will be comprised of a double-strand DNA donor with homology arms of length 700 bps to 1200 bps. The repair of a splice site mutation will restore accurate splicing and cease aberrant truncation of CFTR transcript. This approach will lead to the cessation of production of truncated CFTR channel and will lead to the production of wild-type CFTR channel. This approach will prevent the development or progression of lung, gastrointestinal and/or reproductive disease in subjects with CFTR mutations.

In an embodiment, the method comprises the introduction of a double strand break sufficiently close to (e.g., either 5′ or 3′ to) the CF target position (e.g., c2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. A single gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, is configured to position a double strand break sufficiently close to the CF target position in the CFTR gene (e.g., 2657+5G>A, or c.3140-26A>G). The double strand break may be positioned within 200 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that HDR mediated repair of the break(s) restores the functional CFTR protein.

In another embodiment, the method comprises the introduction of a pair of single strand breaks sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two single strand breaks sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that HDR mediated repair of the break(s) restores the functional CFTR protein. In an embodiment, the pair of single strand breaks may be accompanied by an additional double strand break, positioned by a third gRNA molecule, as is discussed below. In another embodiment, the pair of single strand breaks may be accompanied by two additional single strand breaks positioned by a third gRNA molecule and a fourth gRNA molecule, as is discussed below.

In another embodiment, the method comprises the introduction of two sets of breaks (e.g., a pair of double strand breaks targeted by two gRNAs) sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two sets of breaks (e.g., a pair of double strand breaks) sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that HDR mediated repair of the break(s) restores the functional CFTR protein.

In another embodiment, the method comprises the introduction of two sets of breaks (e.g., one double strand break and a pair of single strand breaks targeted by three gRNAs) sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two sets of breaks (e.g., one double strand break and a pair of single strand breaks) sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that HDR mediated repair of the break(s) restores the functional CFTR protein.

In another embodiment, the method comprises the introduction of two sets of breaks (e.g., two pairs of single strand breaks targeted by four gRNAs) sufficiently close to (either 5′ or 3′ to, respectively) the mutation at the CF target position (e.g., c2657+5G>A, or c.3140-26A>G), such that the break-induced indel could be reasonably expected to span the mutation. Two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two sets of breaks (e.g., two pairs of single strand breaks s) sufficiently close to the CF target position in the CFTR gene. In an embodiment, the pair of single strand breaks is positioned within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) upstream of the CF target position, or within 500 nucleotides (e.g., within 1, 2, 3, 4, 5, 10, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 100, or 200 nucleotides) downstream of the CF target position. While not wishing to be bound by theory, in an embodiment, it is believed that HDR mediated repair of the break(s) restores the functional CFTR protein.

In an embodiment, a single strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nickase) is used to create a single strand break at or in close proximity to the CF target position, e.g., the gRNA is configured such that the single strand break is positioned either upstream (e.g., within 200 bp upstream) or downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, a double strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nuclease other than a Cas9 nickase) is used to create a double strand break at or in close proximity to the CF target position, e.g., the gRNA molecule is configured such that the double strand break is positioned either upstream (e.g., within 200 bp upstream) or downstream of (e.g., within 200 bp downstream) of a CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two single strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that both of the single strand breaks are positioned upstream (e.g., within 200 bp upstream) or downstream (e.g., within 200 bp downstream) of the CF target position. In another embodiment, two gRNA molecules (e.g., with two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that one single strand break is positioned upstream (e.g., within 200 bp upstream) and a second single strand break is positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two double strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nucleases that are not Cas9 nickases) are used to create two double strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that one double strand break is positioned upstream (e.g., within 200 bp upstream) and a second double strand break is positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, one double strand break and two single strand breaks are introduced (e.g., positioned by three gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, three gRNA molecules (e.g., with a Cas9 nuclease other than a Cas9 nickase and one or two Cas9 nickases) to create one double strand break and two single strand breaks to flank an CF target position, e.g., the gRNA molecules are configured such that the double strand break is positioned upstream or downstream of (e.g., within 200 bp upstream or downstream) of the CF target position, and the two single strand breaks are positioned at the opposite site, e.g., downstream or upstream (within 200 bp downstream or upstream), of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, four single strand breaks are introduced (e.g., positioned by four gRNA molecules) at or in close proximity to a CF target position in the CFTR gene. In an embodiment, four gRNA molecule (e.g., with one or more Cas9 nickases are used to create four single strand breaks to flank an CF target position in the CFTR gene, e.g., the gRNA molecules are configured such that a first and second single strand breaks are positioned upstream (e.g., within 200 bp upstream) of the CF target position, and a third and a fourth single stranded breaks are positioned downstream (e.g., within 200 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two or more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

When two or more gRNAs are used to position two or more cleavage events, e.g., double strand or single strand breaks, in a target nucleic acid, it is contemplated that the two or more cleavage events may be made by the same or different Cas9 proteins. For example, when two gRNAs are used to position two double strand breaks, a single Cas9 nuclease may be used to create both double strand breaks. When two or more gRNAs are used to position two or more single stranded breaks (single strand breaks), a single Cas9 nickase may be used to create the two or more single strand breaks. When two or more gRNAs are used to position at least one double strand break and at least one single strand break, two Cas9 proteins may be used, e.g., one Cas9 nuclease and one Cas9 nickase. It is contemplated that when two or more Cas9 proteins are used that the two or more Cas9 proteins may be delivered sequentially to control specificity of a double strand versus a single strand break at the desired position in the target nucleic acid.

In some embodiments, the targeting domain of the first gRNA molecule and the targeting domain of the second gRNA molecule hybridize to the target domain through complementary base pairing to opposite strands of the target nucleic acid molecule. In some embodiments, the gRNA molecule and the second gRNA molecule are configured such that the PAMs are oriented outward.

In an embodiment, the targeting domain of a gRNA molecule is configured to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat, or the endogenous CFTR splice sites, in the target domain. The gRNA molecule may be a first, second, third and/or fourth gRNA molecule.

In an embodiment, the targeting domain of a gRNA molecule is configured to position a cleavage event sufficiently far from a preselected nucleotide, e.g., the nucleotide of a coding region, such that the nucleotide is not altered. In an embodiment, the targeting domain of a gRNA molecule is configured to position an intronic cleavage event sufficiently far from an intron/exon border, or naturally occurring splice signal, to avoid alteration of the exonic sequence or unwanted splicing events. The gRNA molecule may be a first, second, third and/or fourth gRNA molecule, as described herein.

In an embodiment, the targeting domain of said gRNA molecule is configured to position a cleavage event sufficiently far from a preselected nucleotide, e.g., the nucleotide of a coding region, such that the nucleotide is not be altered. In an embodiment, the targeting domain of said gRNA molecule is configured to position an intronic cleavage event sufficiently far from an intron/exon border, or naturally occurring splice signal, to avoid alteration of the exonic sequence or unwanted splicing events.

Methods to Alter SCNN1A

As disclosed herein, the SCNN1A gene can be altered by gene editing, e.g., using CRISPR-Cas9 mediated methods as described herein. A CF or CF-like target position can be altered by gene editing, e.g., using CRISPR-Cas9 mediated methods to alter the SCNN1A gene. The alteration of the SCNN1A gene can be mediated by any mechanism. In an embodiment, CRISPR-Cas9 mediated methods to knockdown or knockout the SCNN1A gene may be applied to any subject with any CF mutation, including but not limited to, e.g., F508del, e.g., G551D, e.g., G542X, e.g., N1303K, e.g., R117H, e.g., W1282X, e.g., R553X, e.g., c.3717+12191, e.g., c.2657+5, e.g., c.3140-26A and/or any subject with any CF-like mutation, including but not limited to a SCNN1A mutation, e.g., V114I. Exemplary mechanisms that can be associated with the alteration of the SCNNA1 gene include, but are not limited to, non-homologous end joining (e.g., classical or alternative), microhomology-mediated end joining (MMEJ), SDSA (synthesis dependent strand annealing) or single strand annealing or single strand invasion, all with or without the alteration of the CFTR gene, including but not limited to the addition of an endogenous-promoter driven cDNA encoding the CFTR gene, or homology-directed repair mediated correction of mutations within the CFTR gene or CRISPR-cas9 mediated repair of splice mutations within the CFTR gene.

As disclosed herein, the SCNN1A gene can be targeted (e.g., altered) by gene editing, e.g., using CRISPR-Cas9 mediated methods as described herein.

Methods and compositions discussed herein, provide for targeting (e.g., altering) a CF target position in the SCNN1A gene. A CF target position can be targeted (e.g., altered) by gene editing, e.g., using CRISPR-Cas9 mediated methods to target (e.g. alter) the SCNN1A gene.

Disclosed herein are methods for targeting (e.g., altering) a SCNN1A target position in the SCNN1A gene. Targeting (e.g., altering) the CF target position is achieved, e.g., by:

• • (1) knocking out the SCNN1A gene by insertion or deletion (e.g., NHEJ-mediated insertion or deletion) of one or more nucleotides in close proximity to or within the early coding region of the SCNN1A gene, or
  • (2) knocking down the SCNN1A gene mediated by enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9-fusion protein by targeting non-coding region, e.g., a promoter region, of the gene.

All approaches give rise to targeting (e.g., alteration) of the SCNN1A gene.

In an embodiment, methods described herein introduce one or more breaks near the early coding region in at least one allele of the SCNN1A gene. In another embodiment, methods described herein introduce two or more breaks to flank at least a portion of the SCNN1A gene. The two or more breaks remove (e.g., delete) a genomic sequence including at least a portion of the SCNN1A gene. In another embodiment, methods described herein comprise knocking down the SCNN1A gene mediated by enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9-fusion protein by targeting the promoter region of SCNN1A target knockdown position. All methods described herein result in targeting (e.g., alteration) of the SCNN1A gene.

The targeting (e.g., alteration) of the SCNN1A gene can be mediated by any mechanism. Exemplary mechanisms that can be associated with the alteration of the SCNN1A gene include, but are not limited to, non-homologous end joining (e.g., classical or alternative), microhomology-mediated end joining (MMEJ), homology-directed repair (e.g., endogenous donor template mediated), SDSA (synthesis dependent strand annealing), single strand annealing or single strand invasion.

Approach 4: Knocking Out SCNN1A by Introducing an Indel or a Deletion in the SCNN1A Gene

In an embodiment, the method comprises introducing an insertion or deletion of one more nucleotides in close proximity to the SCNN1A target knockout position (e.g., the early coding region) of the SCNN1A gene. As described herein, in one embodiment, the method comprises the introduction of one or more breaks (e.g., single strand breaks or double strand breaks) sufficiently close to (e.g., either 5′ or 3′ to) the early coding region of the CF target knockout position, such that the break-induced indel could be reasonably expected to span the CF target knockout position (e.g., the early coding region in the SCNN1A gene). While not wishing to be bound by theory, it is believed that NHEJ-mediated repair of the break(s) allows for the NHEJ-mediated introduction of an indel in close proximity to within the early coding region of the CF target knockout position.

In an embodiment, the method comprises introducing a deletion of a genomic sequence comprising at least a portion of the SCNN1A gene. As described herein, in an embodiment, the method comprises the introduction of two double stand breaks—one 5′ and the other 3′ to (i.e., flanking) the CF target position. In an embodiment, two gRNAs, e.g., unimolecular (or chimeric) or modular gRNA molecules, are configured to position the two double strand breaks on opposite sides of the CF target knockout position in the SCNN1A gene.

In an embodiment, a single strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the SCNN1A gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nickase) is used to create a single strand break at or in close proximity to the CF target position, e.g., the gRNA is configured such that the single strand break is positioned either upstream (e.g., within 500 bp upstream, e.g., within 200 bp upstream) or downstream (e.g., within 500 bp downstream, e.g., within 200 bp downstream) of the CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, a double strand break is introduced (e.g., positioned by one gRNA molecule) at or in close proximity to a CF target position in the SCNN1A gene. In an embodiment, a single gRNA molecule (e.g., with a Cas9 nuclease other than a Cas9 nickase) is used to create a double strand break at or in close proximity to the CF target position, e.g., the gRNA molecule is configured such that the double strand break is positioned either upstream (e.g., within 500 bp upstream, upstream) or downstream of (e.g., within 500 bp downstream) of a CF target position. In an embodiment, the break is positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two single strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the SCNN1A gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the CF target position, e.g., the gRNAs molecules are configured such that both of the single strand breaks are positioned e.g., within 500 bp upstream, upstream) or downstream (e.g., within 500 bp downstream downstream) of the CF target position. In another embodiment, two gRNA molecules (e.g., with two Cas9 nickcases) are used to create two single strand breaks at or in close proximity to the SCNN1A target position, e.g., the gRNAs molecules are configured such that one single strand break is positioned upstream (e.g., within 500 bp upstream) and a second single strand break is positioned downstream (e.g., within 500 bp downstream) of the SCNN1A target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two double strand breaks are introduced (e.g., positioned by two gRNA molecules) at or in close proximity to a CF target position in the SCNN1A gene. In an embodiment, two gRNA molecules (e.g., with one or two Cas9 nucleases that are not Cas9 nickases) are used to create two double strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that one double strand break is positioned upstream (e.g., within 500 bp upstream) and a second double strand break is positioned downstream (e.g., within 500 bp downstream) of the SCNN1A target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, one double strand break and two single strand breaks are introduced (e.g., positioned by three gRNA molecules) at or in close proximity to a CF target position in the SCNN1A gene. In an embodiment, three gRNA molecules (e.g., with a Cas9 nuclease other than a Cas9 nickase and one or two Cas9 nickases) to create one double strand break and two single strand breaks to flank a CF target position, e.g., the gRNA molecules are configured such that the double strand break is positioned upstream or downstream of (e.g., within 500 bp upstream or downstream) of the SCNN1A target position, and the two single strand breaks are positioned at the opposite site, e.g., downstream or upstream (e.g., within 500 bp downstream or upstream), of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, four single strand breaks are introduced (e.g., positioned by four gRNA molecules) at or in close proximity to a CF target position in the SCNN1A gene. In an embodiment, four gRNA molecule (e.g., with one or more Cas9 nickases are used to create four single strand breaks to flank a CF target position in the SCNN1A gene, e.g., the gRNA molecules are configured such that a first and second single strand breaks are positioned upstream (e.g., within 500 bp upstream) of the CF target position, and a third and a fourth single stranded breaks are positioned downstream (e.g., within 500 bp downstream) of the CF target position. In an embodiment, the breaks are positioned to avoid unwanted target chromosome elements, such as repeat elements, e.g., an Alu repeat.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two ore more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

Approach 5: Knocking Down SCNN1A Mediated by an Enzymatically Inactive Cas9 (eiCas9) Molecule

A targeted knockdown approach reduces or eliminates expression of functional SCNN1A gene product. As described herein, in an embodiment, a targeted knockdown is mediated by targeting an enzymatically inactive Cas9 (eiCas9) molecule or an eiCas9 fused to a transcription repressor domain or chromatin modifying protein to alter transcription, e.g., to block, reduce, or decrease transcription, of the SCNN1A gene.

Methods and compositions discussed herein may be used to alter the expression of the SCNN1A gene to treat or prevent CF or CF-like disease by targeting a promoter region of the SCNN1A gene. In an embodiment, the promoter region is targeted to knock down expression of the SCNN1A gene. A targeted knockdown approach reduces or eliminates expression of functional SCNN1A gene product. As described herein, in an embodiment, a targeted knockdown is mediated by targeting an enzymatically inactive Cas9 (eiCas9) or an eiCas9 fused to a transcription repressor domain or chromatin modifying protein to alter transcription, e.g., to block, reduce, or decrease transcription, of the SCNN1A gene. In an embodiment, one or more eiCas9 molecules may be used to block binding of one or more endogenous transcription factors.

In another embodiment, an eiCas9 molecule can be fused to a chromatin modifying protein. Altering chromatin status can result in decreased expression of the target gene. One or more eiCas9 molecules fused to one or more chromatin modifying proteins may be used to alter chromatin status.

An eiCas9 mediated knock down of one of two SCNN1A allele/s by targeting the transcription start site of SCNN1A gene in exon I of all transcripts (including 500 bp upstream and downstream of transcription start site on all transcripts). This approach is performed in any subject with CF or CF-like disease, with or without a CFTR mutation and a WT or mutant SCNN1A. The CF or CF-like target position is at or near the transcription start site of the SCNN1A gene. Or, altering the CF or CF-like target position refers to delivering a dCas9 that sterically hinders transcription of either or both SCNN1A allele/s. This approach gives rise to the loss or destruction of transcription of the SCNN1A gene. This approach will lead to the reduction or cessation of production of ENaC. This approach will prevent the disinhibition of the ENaC channel in subjects with CF or CF-like disease. The viscosity of lung, gastrointestinal and reproductive tract mucous in subjects with CF or CF-like disease will not be further increased. This will lead to a reduction in viscosity of mucous within the lung, gastrointestinal and reproductive tract mucous in subjects with CF or CF-like disease. This approach will prevent the progression of CF and CF-like disease.

I. gRNA Molecules

A gRNA molecule, as that term is used herein, refers to a nucleic acid that promotes the specific targeting or homing of a gRNA molecule/Cas9 molecule complex to a target nucleic acid. gRNA molecules can be unimolecular (having a single RNA molecule), sometimes referred to herein as “chimeric” gRNAs, or modular (comprising more than one, and typically two, separate RNA molecules). A gRNA molecule comprises a number of domains. The gRNA molecule domains are described in more detail below.

Several exemplary gRNA structures, with domains indicated thereon, are provided in FIGS. 1A-1G. While not wishing to be bound by theory, in an embodiment, with regard to the three dimensional form, or intra- or inter-strand interactions of an active form of a gRNA, regions of high complementarity are sometimes shown as duplexes in FIGS. 1A-1G and other depictions provided herein.

In an embodiment, a unimolecular, or chimeric, gRNA comprises, preferably from 5′ to 3′:

• • a targeting domain (which is complementary to a target nucleic acid in the CFTR gene or SCNN1A gene, e.g., a targeting domain as described herein, e.g., a targeting domain from any of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, and 48A-48E;
  • a first complementarity domain;
  • a linking domain;
  • a second complementarity domain (which is complementary to the first complementarity domain);
  • a proximal domain; and
  • optionally, a tail domain.

In an embodiment, a modular gRNA comprises:

• • a first strand comprising, preferably from 5′ to 3′;
    • a targeting domain (which is complementary to a target nucleic acid in the CFTR gene or SCNN1A gene, e.g., a targeting domain as described herein, e.g., a targeting domain from any of Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E); and
    • a first complementarity domain; and
  • a second strand, comprising, preferably from 5′ to 3′:
    • optionally, a 5′ extension domain;
    • a second complementarity domain;
    • a proximal domain; and
    • optionally, a tail domain.

The domains are discussed briefly below.

The Targeting Domain

FIGS. 1A-1G provide examples of the placement of targeting domains.

The targeting domain comprises a nucleotide sequence that is complementary, e.g., at least 80, 85, 90, or 95% complementary, e.g., fully complementary, to the target sequence on the target nucleic acid. The targeting domain is part of an RNA molecule and will therefore comprise the base uracil (U), while any DNA encoding the gRNA molecule will comprise the base thymine (T). While not wishing to be bound by theory, in an embodiment, it is believed that the complementarity of the targeting domain with the target sequence contributes to specificity of the interaction of the gRNA molecule/Cas9 molecule complex with a target nucleic acid. It is understood that in a targeting domain and target sequence pair, the uracil bases in the targeting domain will pair with the adenine bases in the target sequence. In an embodiment, the target domain itself comprises in the 5′ to 3′ direction, an optional secondary domain, and a core domain. In an embodiment, the core domain is fully complementary with the target sequence. In an embodiment, the targeting domain is 5 to 50 nucleotides in length. The strand of the target nucleic acid with which the targeting domain is complementary is referred to herein as the complementary strand. Some or all of the nucleotides of the domain can have a modification, e.g., a modification found in Section VIII herein.

In an embodiment, the targeting domain is 16 nucleotides in length.

In an embodiment, the targeting domain is 17 nucleotides in length.

In an embodiment, the targeting domain is 18 nucleotides in length.

In an embodiment, the targeting domain is 19 nucleotides in length.

In an embodiment, the targeting domain is 20 nucleotides in length.

In an embodiment, the targeting domain is 21 nucleotides in length.

In an embodiment, the targeting domain is 22 nucleotides in length.

In an embodiment, the targeting domain is 23 nucleotides in length.

In an embodiment, the targeting domain is 24 nucleotides in length.

In an embodiment, the targeting domain is 25 nucleotides in length.

In an embodiment, the targeting domain is 26 nucleotides in length.

In an embodiment, the targeting domain comprises 16 nucleotides.

In an embodiment, the targeting domain comprises 17 nucleotides.

In an embodiment, the targeting domain comprises 18 nucleotides.

In an embodiment, the targeting domain comprises 19 nucleotides.

In an embodiment, the targeting domain comprises 20 nucleotides.

In an embodiment, the targeting domain comprises 21 nucleotides.

In an embodiment, the targeting domain comprises 22 nucleotides.

In an embodiment, the targeting domain comprises 23 nucleotides.

In an embodiment, the targeting domain comprises 24 nucleotides.

In an embodiment, the targeting domain comprises 25 nucleotides.

In an embodiment, the targeting domain comprises 26 nucleotides.

Targeting domains are discussed in more detail below.

The First Complementarity Domain

FIGS. 1A-1G provide examples of first complementarity domains.

The first complementarity domain is complementary with the second complementarity domain, and in an embodiment, has sufficient complementarity to the second complementarity domain to form a duplexed region under at least some physiological conditions. In an embodiment, the first complementarity domain is 5 to 30 nucleotides in length. In an embodiment, the first complementarity domain is 5 to 25 nucleotides in length. In an embodiment, the first complementary domain is 7 to 25 nucleotides in length. In an embodiment, the first complementary domain is 7 to 22 nucleotides in length. In an embodiment, the first complementary domain is 7 to 18 nucleotides in length. In an embodiment, the first complementary domain is 7 to 15 nucleotides in length. In an embodiment, the first complementary domain is 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 nucleotides in length.

In an embodiment, the first complementarity domain comprises 3 subdomains, which, in the 5′ to 3′ direction are: a 5′ subdomain, a central subdomain, and a 3′ subdomain. In an embodiment, the 5′ subdomain is 4 to 9, e.g., 4, 5, 6, 7, 8 or 9 nucleotides in length. In an embodiment, the central subdomain is 1, 2, or 3, e.g., 1, nucleotide in length. In an embodiment, the 3′ subdomain is 3 to 25, e.g., 4 to 22, 4 to 18, or 4 to 10, or 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 nucleotides in length.

The first complementarity domain can share homology with, or be derived from, a naturally occurring first complementarity domain. In an embodiment, it has at least 50% homology with a first complementarity domain disclosed herein, e.g., an S. pyogenes, S. aureus or S. thermophilus, first complementarity domain.

Some or all of the nucleotides of the domain can have a modification, e.g., a modification found in Section VIII herein.

First complementarity domains are discussed in more detail below.

The Linking Domain

FIGS. 1A-1G provide examples of linking domains.

A linking domain serves to link the first complementarity domain with the second complementarity domain of a unimolecular gRNA. The linking domain can link the first and second complementarity domains covalently or non-covalently. In an embodiment, the linkage is covalent. In an embodiment, the linking domain covalently couples the first and second complementarity domains, see, e.g., FIGS. 1B-1E. In an embodiment, the linking domain is, or comprises, a covalent bond interposed between the first complementarity domain and the second complementarity domain. Typically the linking domain comprises one or more, e.g., 2, 3, 4, 5, 6, 7, 8, 9, or 10 nucleotides.

In modular gRNA molecules the two molecules are associated by virtue of the hybridization of the complementarity domains see e.g., FIG. 1A.

A wide variety of linking domains are suitable for use in unimolecular gRNA molecules. Linking domains can consist of a covalent bond, or be as short as one or a few nucleotides, e.g., 1, 2, 3, 4, or 5 nucleotides in length. In an embodiment, a linking domain is 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, or 25 or more nucleotides in length. In an embodiment, a linking domain is 2 to 50, 2 to 40, 2 to 30, 2 to 20, 2 to 10, or 2 to 5 nucleotides in length. In an embodiment, a linking domain shares homology with, or is derived from, a naturally occurring sequence, e.g., the sequence of a tracrRNA that is 5′ to the second complementarity domain. In an embodiment, the linking domain has at least 50% homology with a linking domain disclosed herein.

Some or all of the nucleotides of the domain can have a modification, e.g., a modification found in Section VIII herein.

Linking domains are discussed in more detail below.

The 5′ Extension Domain

In an embodiment, a modular gRNA can comprise additional sequence, 5′ to the second complementarity domain, referred to herein as the 5′ extension domain, see, e.g., FIG. 1A. In an embodiment, the 5′ extension domain is, 2 to 10, 2 to 9, 2 to 8, 2 to 7, 2 to 6, 2 to 5, 2 to 4 nucleotides in length. In an embodiment, the 5′ extension domain is 2, 3, 4, 5, 6, 7, 8, 9, or 10 or more nucleotides in length.

The Second Complementarity Domain

FIGS. 1A-1G provide examples of second complementarity domains.

The second complementarity domain is complementary with the first complementarity domain, and in an embodiment, has sufficient complementarity to the second complementarity domain to form a duplexed region under at least some physiological conditions. In an embodiment, e.g., as shown in FIGS. 1A-1B, the second complementarity domain can include sequence that lacks complementarity with the first complementarity domain, e.g., sequence that loops out from the duplexed region.

In an embodiment, the second complementarity domain is 5 to 27 nucleotides in length. In an embodiment, it is longer than the first complementarity region. In an embodiment the second complementary domain is 7 to 27 nucleotides in length. In an embodiment, the second complementary domain is 7 to 25 nucleotides in length. In an embodiment, the second complementary domain is 7 to 20 nucleotides in length. In an embodiment, the second complementary domain is 7 to 17 nucleotides in length. In an embodiment, the complementary domain is 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 or 25 nucleotides in length.

In an embodiment, the second complementarity domain comprises 3 subdomains, which, in the 5′ to 3′ direction are: a 5′ subdomain, a central subdomain, and a 3′ subdomain. In an embodiment, the 5′ subdomain is 3 to 25, e.g., 4 to 22, 4 to 18, or 4 to 10, or 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 nucleotides in length. In an embodiment, the central subdomain is 1, 2, 3, 4 or 5, e.g., 3, nucleotides in length. In an embodiment, the 3′ subdomain is 4 to 9, e.g., 4, 5, 6, 7, 8 or 9 nucleotides in length.

In an embodiment, the 5′ subdomain and the 3′ subdomain of the first complementarity domain, are respectively, complementary, e.g., fully complementary, with the 3′ subdomain and the 5′ subdomain of the second complementarity domain.

The second complementarity domain can share homology with or be derived from a naturally occurring second complementarity domain. In an embodiment, it has at least 50% homology with a second complementarity domain disclosed herein, e.g., an S. pyogenes, S. aureus or S. thermophilus, first complementarity domain.

Some or all of the nucleotides of the domain can have a modification, e.g., a modification found in Section VIII herein.

A Proximal Domain

FIGS. 1A-1G provide examples of proximal domains.

In an embodiment, the proximal domain is 5 to 20 nucleotides in length. In an embodiment, the proximal domain can share homology with or be derived from a naturally occurring proximal domain. In an embodiment, it has at least 50% homology with a proximal domain disclosed herein, e.g., an S. pyogenes, S. aureus or S. thermophilus, proximal domain.

Some or all of the nucleotides of the domain can have a modification, e.g., a modification found in Section VIII herein.

A Tail Domain

FIGS. 1A-1G provide examples of tail domains.

As can be seen by inspection of the tail domains in FIGS. 1A-1E, a broad spectrum of tail domains are suitable for use in gRNA molecules. In an embodiment, the tail domain is 0 (absent), 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 nucleotides in length. In embodiment, the tail domain nucleotides are from or share homology with sequence from the 5′ end of a naturally occurring tail domain, see e.g., FIG. 1D or FIG. 1E. In an embodiment, the tail domain includes sequences that are complementary to each other and which, under at least some physiological conditions, form a duplexed region.

In an embodiment, the tail domain is absent or is 1 to 50 nucleotides in length. In an embodiment, the tail domain can share homology with or be derived from a naturally occurring proximal tail domain. In an embodiment, it has at least 50% homology with a tail domain disclosed herein, e.g., an S. pyogenes, S. aureus or S. thermophilus, tail domain.

In an embodiment, the tail domain includes nucleotides at the 3′ end that are related to the method of in vitro or in vivo transcription. When a T7 promoter is used for in vitro transcription of the gRNA, these nucleotides may be any nucleotides present before the 3′ end of the DNA template. When a U6 promoter is used for in vivo transcription, these nucleotides may be the sequence UUUUUU. When alternate pol-III promoters are used, these nucleotides may be various numbers or uracil bases or may include alternate bases.

The domains of gRNA molecules are described in more detail below.

The Targeting Domain

The “targeting domain” of the gRNA is complementary to the “target domain” on the target nucleic acid. The strand of the target nucleic acid comprising the nucleotide sequence complementary to the core domain of the gRNA is referred to herein as the “complementary strand” of the target nucleic acid. Guidance on the selection of targeting domains can be found, e.g., in Fu Y et al., Nat Biotechnol 2014 (doi: 10.1038/nbt.2808) and Sternberg S H et al., Nature 2014 (doi: 10.1038/nature13011).

In an embodiment, the targeting domain is 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, the targeting domain is 16 nucleotides in length.

In an embodiment, the targeting domain is 17 nucleotides in length.

In an embodiment, the targeting domain is 18 nucleotides in length.

In an embodiment, the targeting domain is 19 nucleotides in length.

In an embodiment, the targeting domain is 20 nucleotides in length.

In an embodiment, the targeting domain is 21 nucleotides in length.

In an embodiment, the targeting domain is 22 nucleotides in length.

In an embodiment, the targeting domain is 23 nucleotides in length.

In an embodiment, the targeting domain is 24 nucleotides in length.

In an embodiment, the targeting domain is 25 nucleotides in length.

In an embodiment, the targeting domain is 26 nucleotides in length.

In an embodiment, the targeting domain comprises 16 nucleotides.

In an embodiment, the targeting domain comprises 17 nucleotides.

In an embodiment, the targeting domain comprises 18 nucleotides.

In an embodiment, the targeting domain comprises 19 nucleotides.

In an embodiment, the targeting domain comprises 20 nucleotides.

In an embodiment, the targeting domain comprises 21 nucleotides.

In an embodiment, the targeting domain comprises 22 nucleotides.

In an embodiment, the targeting domain comprises 23 nucleotides.

In an embodiment, the targeting domain comprises 24 nucleotides.

In an embodiment, the targeting domain comprises 25 nucleotides.

In an embodiment, the targeting domain comprises 26 nucleotides.

In an embodiment, the targeting domain is 10+/−5, 20+/−5, 30+/−5, 40+/−5, 50+/−5, 60+/−5, 70+/−5, 80+/−5, 90+/−5, or 100+/−5 nucleotides, in length.

In an embodiment, the targeting domain is 20+/−5 nucleotides in length.

In an embodiment, the targeting domain is 20+/−10, 30+/−10, 40+/−10, 50+/−10, 60+/−10, 70+/−10, 80+/−10, 90+/−10, or 100+/−10 nucleotides, in length.

In an embodiment, the targeting domain is 30+/−10 nucleotides in length.

In an embodiment, the targeting domain is 10 to 100, 10 to 90, 10 to 80, 10 to 70, 10 to 60, 10 to 50, 10 to 40, 10 to 30, 10 to 20 or 10 to 15 nucleotides in length. In another embodiment, the targeting domain is 20 to 100, 20 to 90, 20 to 80, 20 to 70, 20 to 60, 20 to 50, 20 to 40, 20 to 30, or 20 to 25 nucleotides in length.

Typically the targeting domain has full complementarity with the target sequence. In an embodiment the targeting domain has or includes 1, 2, 3, 4, 5, 6, 7 or 8 nucleotides that are not complementary with the corresponding nucleotide of the targeting domain.

In an embodiment, the target domain includes 1, 2, 3, 4 or 5 nucleotides that are complementary with the corresponding nucleotide of the targeting domain within 5 nucleotides of its 5′ end. In an embodiment, the target domain includes 1, 2, 3, 4 or 5 nucleotides that are complementary with the corresponding nucleotide of the targeting domain within 5 nucleotides of its 3′ end.

In an embodiment, the target domain includes 1, 2, 3, or 4 nucleotides that are not complementary with the corresponding nucleotide of the targeting domain within 5 nucleotides of its 5′ end. In an embodiment, the target domain includes 1, 2, 3, or 4 nucleotides that are not complementary with the corresponding nucleotide of the targeting domain within 5 nucleotides of its 3′ end.

In an embodiment, the degree of complementarity, together with other properties of the gRNA, is sufficient to allow targeting of a Cas9 molecule to the target nucleic acid.

In an embodiment, the targeting domain comprises two consecutive nucleotides that are not complementary to the target domain (“non-complementary nucleotides”), e.g., two consecutive noncomplementary nucleotides that are within 5 nucleotides of the 5′ end of the targeting domain, within 5 nucleotides of the 3′ end of the targeting domain, or more than 5 nucleotides away from one or both ends of the targeting domain.

In an embodiment, no two consecutive nucleotides within 5 nucleotides of the 5′ end of the targeting domain, within 5 nucleotides of the 3′ end of the targeting domain, or within a region that is more than 5 nucleotides away from one or both ends of the targeting domain, are not complementary to the targeting domain.

In an embodiment, there are no noncomplementary nucleotides within 5 nucleotides of the 5′ end of the targeting domain, within 5 nucleotides of the 3′ end of the targeting domain, or within a region that is more than 5 nucleotides away from one or both ends of the targeting domain.

In an embodiment, the targeting domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the targeting domain comprises one or more modifications, e.g., modifications that it render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the targeting domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment, a nucleotide of the targeting domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII.

In an embodiment, the targeting domain includes 1, 2, 3, 4, 5, 6, 7 or 8 or more modifications. In an embodiment, the targeting domain includes 1, 2, 3, or 4 modifications within 5 nucleotides of its 5′ end. In an embodiment, the targeting domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 3′ end.

In an embodiment, the targeting domain comprises modifications at two consecutive nucleotides, e.g., two consecutive nucleotides that are within 5 nucleotides of the 5′ end of the targeting domain, within 5 nucleotides of the 3′ end of the targeting domain, or more than 5 nucleotides away from one or both ends of the targeting domain.

In an embodiment, no two consecutive nucleotides are modified within 5 nucleotides of the 5′ end of the targeting domain, within 5 nucleotides of the 3′ end of the targeting domain, or within a region that is more than 5 nucleotides away from one or both ends of the targeting domain. In an embodiment, no nucleotide is modified within 5 nucleotides of the 5′ end of the targeting domain, within 5 nucleotides of the 3′ end of the targeting domain, or within a region that is more than 5 nucleotides away from one or both ends of the targeting domain.

Modifications in the targeting domain can be selected so as to not interfere with targeting efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate targeting domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in a system in Section IV. The candidate targeting domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, all of the modified nucleotides are complementary to and capable of hybridizing to corresponding nucleotides present in the target domain. In another embodiment, 1, 2, 3, 4, 5, 6, 7 or 8 or more modified nucleotides are not complementary to or capable of hybridizing to corresponding nucleotides present in the target domain.

In an embodiment, the targeting domain comprises, preferably in the 5′→3′ direction: a secondary domain and a core domain. These domains are discussed in more detail below.

The Core Domain and Secondary Domain of the Targeting Domain

The “core domain” of the targeting domain is complementary to the “core domain target” on the target nucleic acid. In an embodiment, the core domain comprises about 8 to about 13 nucleotides from the 3′ end of the targeting domain (e.g., the most 3′ 8 to 13 nucleotides of the targeting domain).

In an embodiment, the core domain and targeting domain, are independently, 6+/−2, 7+/−2, 8+/−2, 9+/−2, 10+/−2, 11+/−2, 12+/−2, 13+/−2, 14+/−2, 15+/−2, or 16+−2, nucleotides in length.

In an embodiment, the core domain and targeting domain, are independently, 10+/−2 nucleotides in length.

In an embodiment, the core domain and targeting domain, are independently, 10+/−4 nucleotides in length.

In an embodiment, the core domain and targeting domain are independently 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18 nucleotides in length.

In an embodiment, the core domain and targeting domain are independently 3 to 20, 4 to 20, 5 to 20, 6 to 20, 7 to 20, 8 to 20, 9 to 20 10 to 20 or 15 to 20 nucleotides in length.

In an embodiment, the core domain and targeting domain are independently 3 to 15, e.g., 6 to 15, 7 to 14, 7 to 13, 6 to 12, 7 to 12, 7 to 11, 7 to 10, 8 to 14, 8 to 13, 8 to 12, 8 to 11, 8 to 10 or 8 to 9 nucleotides in length.

The core domain is complementary with the core domain target. Typically the core domain has exact complementarity with the core domain target. In some embodiments, the core domain can have 1, 2, 3, 4 or 5 nucleotides that are not complementary with the corresponding nucleotide of the core domain. In an embodiment, the degree of complementarity, together with other properties of the gRNA, is sufficient to allow targeting of a Cas9 molecule to the target nucleic acid.

The “secondary domain” of the targeting domain of the gRNA is complementary to the “secondary domain target” of the target nucleic acid.

In an embodiment, the secondary domain is positioned 5′ to the core domain.

In an embodiment, the secondary domain is absent or optional.

In an embodiment, if the targeting domain is 26 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 12 to 17 nucleotides in length.

In an embodiment, if the targeting domain is 25 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 12 to 17 nucleotides in length.

In an embodiment, if the targeting domain is 24 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 11 to 16 nucleotides in length.

In an embodiment, if the targeting domain is 23 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 10 to 15 nucleotides in length.

In an embodiment, if the targeting domain is 22 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 9 to 14 nucleotides in length.

In an embodiment, if the targeting domain is 21 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 8 to 13 nucleotides in length.

In an embodiment, if the targeting domain is 20 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 7 to 12 nucleotides in length.

In an embodiment, if the targeting domain is 19 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 6 to 11 nucleotides in length.

In an embodiment, if the targeting domain is 18 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 5 to 10 nucleotides in length.

In an embodiment, if the targeting domain is 17 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 4 to 9 nucleotides in length.

In an embodiment, if the targeting domain is 16 nucleotides in length and the core domain (counted from the 3′ end of the targeting domain) is 8 to 13 nucleotides in length, the secondary domain is 3 to 8 nucleotides in length.

In an embodiment, the secondary domain is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 nucleotides in length.

The secondary domain is complementary with the secondary domain target. Typically the secondary domain has exact complementarity with the secondary domain target. In an embodiment, the secondary domain can have 1, 2, 3, 4 or 5 nucleotides that are not complementary with the corresponding nucleotide of the secondary domain. In an embodiment, the degree of complementarity, together with other properties of the gRNA, is sufficient to allow targeting of a Cas9 molecule to the target nucleic acid.

In an embodiment, the core domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the core domain comprises one or more modifications, e.g., modifications that it render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the core domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment a nucleotide of the core domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII. Typically, a core domain will contain no more than 1, 2, or 3 modifications.

Modifications in the core domain can be selected so as to not interfere with targeting efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate core domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in the system described at Section IV. The candidate core domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, the secondary domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the secondary domain comprises one or more modifications, e.g., modifications that render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the secondary domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment a nucleotide of the secondary domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII. Typically, a secondary domain will contain no more than 1, 2, or 3 modifications.

Modifications in the secondary domain can be selected so as to not interfere with targeting efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate secondary domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in the system described at Section IV. The candidate secondary domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, (1) the degree of complementarity between the core domain and its target, and (2) the degree of complementarity between the secondary domain and its target, may differ. In an embodiment, (1) may be greater than (2). In an embodiment, (1) may be less than (2). In an embodiment, (1) and (2) are the same, e.g., each may be completely complementary with its target.

In an embodiment, (1) the number of modifications (e.g., modifications from Section VIII) of the nucleotides of the core domain and (2) the number of modifications (e.g., modifications from Section VIII) of the nucleotides of the secondary domain may differ. In an embodiment, (1) may be less than (2). In an embodiment, (1) may be greater than (2). In an embodiment, (1) and (2) may be the same, e.g., each may be free of modifications.

The First and Second Complementarity Domains

The first complementarity domain is complementary with the second complementarity domain.

Typically the first domain does not have exact complementarity with the second complementarity domain target. In some embodiments, the first complementarity domain can have 1, 2, 3, 4 or 5 nucleotides that are not complementary with the corresponding nucleotide of the second complementarity domain. In an embodiment, 1, 2, 3, 4, 5 or 6, e.g., 3 nucleotides, will not pair in the duplex, and, e.g., form a non-duplexed or looped-out region. In an embodiment, an unpaired, or loop-out, region, e.g., a loop-out of 3 nucleotides, is present on the second complementarity domain. In an embodiment, the unpaired region begins 1, 2, 3, 4, 5, or 6, e.g., 4, nucleotides from the 5′ end of the second complementarity domain.

In an embodiment, the degree of complementarity, together with other properties of the gRNA, is sufficient to allow targeting of a Cas9 molecule to the target nucleic acid.

In an embodiment, the first and second complementarity domains are:

• • independently, 6+/−2, 7+/−2, 8+/−2, 9+/−2, 10+/−2, 11+/−2, 12+/−2, 13+/−2, 14+/−2, 15+/−2, 16+/−2, 17+/−2, 18+/−2, 19+/−2, or 20+/−2, 21+/−2, 22+/−2, 23+/−2, or 24+/−2 nucleotides in length;
  • independently, 6, 7, 8, 9, 10, 11, 12, 13, 14, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26, nucleotides in length; or
  • independently, 5 to 24, 5 to 23, 5 to 22, 5 to 21, 5 to 20, 7 to 18, 9 to 16, or 10 to 14 nucleotides in length.

In an embodiment, the second complementarity domain is longer than the first complementarity domain, e.g., 2, 3, 4, 5, or 6, e.g., 6, nucleotides longer.

In an embodiment, the first and second complementary domains, independently, do not comprise modifications, e.g., modifications of the type provided in Section VIII.

In an embodiment, the first and second complementary domains, independently, comprise one or more modifications, e.g., modifications that the render the domain less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment a nucleotide of the domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII.

In an embodiment, the first and second complementary domains, independently, include 1, 2, 3, 4, 5, 6, 7 or 8 or more modifications. In an embodiment, the first and second complementary domains, independently, include 1, 2, 3, or 4 modifications within 5 nucleotides of its 5′ end. In an embodiment, the first and second complementary domains, independently, include as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 3′ end.

In an embodiment, the first and second complementary domains, independently, include modifications at two consecutive nucleotides, e.g., two consecutive nucleotides that are within 5 nucleotides of the 5′ end of the domain, within 5 nucleotides of the 3′ end of the domain, or more than 5 nucleotides away from one or both ends of the domain. In an embodiment, the first and second complementary domains, independently, include no two consecutive nucleotides that are modified, within 5 nucleotides of the 5′ end of the domain, within 5 nucleotides of the 3′ end of the domain, or within a region that is more than 5 nucleotides away from one or both ends of the domain. In an embodiment, the first and second complementary domains, independently, include no nucleotide that is modified within 5 nucleotides of the 5′ end of the domain, within 5 nucleotides of the 3′ end of the domain, or within a region that is more than 5 nucleotides away from one or both ends of the domain.

Modifications in a complementarity domain can be selected so as to not interfere with targeting efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate complementarity domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in the system described in Section IV. The candidate complementarity domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, the first complementarity domain has at least 60, 70, 80, 85%, 90% or 95% homology with, or differs by no more than 1, 2, 3, 4, 5, or 6 nucleotides from, a reference first complementarity domain, e.g., a naturally occurring, e.g., an S. pyogenes, S. aureus or S. thermophilus, first complementarity domain, or a first complementarity domain described herein, e.g., from FIGS. 1A-1G.

In an embodiment, the second complementarity domain has at least 60, 70, 80, 85%, 90%, or 95% homology with, or differs by no more than 1, 2, 3, 4, 5, or 6 nucleotides from, a reference second complementarity domain, e.g., a naturally occurring, e.g., an S. pyogenes, S. aureus or S. thermophilus, second complementarity domain, or a second complementarity domain described herein, e.g., from FIGS. 1A-1G.

The duplexed region formed by first and second complementarity domains is typically 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 or 22 base pairs in length (excluding any looped out or unpaired nucleotides).

In some embodiments, the first and second complementarity domains, when duplexed, comprise 11 paired nucleotides, for example, in the gRNA sequence (one paired strand underlined, one bolded):

(SEQ ID NO: 5)
NNNNNNNNNNNNNNNNNNNNGUUUUAGAGCUAGAAAUAGCAAGUUAAA
AUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGC.

In some embodiments, the first and second complementarity domains, when duplexed, comprise 15 paired nucleotides, for example in the gRNA sequence (one paired strand underlined, one bolded):

(SEQ ID NO: 27)
NNNNNNNNNNNNNNNNNNNNGUUUUAGAGCUAUGCUGAAAAGCAUAG
CAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACC
GAGUCGGUGC.

In some embodiments the first and second complementarity domains, when duplexed, comprise 16 paired nucleotides, for example in the gRNA sequence (one paired strand underlined, one bolded):

(SEQ ID NO: 28)
NNNNNNNNNNNNNNNNNNNNGUUUUAGAGCUAUGCUGGAAACAGCAU
AGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCA
CCGAGUCGGUGC.

In some embodiments the first and second complementarity domains, when duplexed, comprise 21 paired nucleotides, for example in the gRNA sequence (one paired strand underlined, one bolded):

(SEQ ID NO: 29)
NNNNNNNNNNNNNNNNNNNNGUUUUAGAGCUAUGCUGUUUUGGAAA
CAAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUU
GAAAAAGUGGCACCGAGUCGGUGC.

In some embodiments, nucleotides are exchanged to remove poly-U tracts, for example in the gRNA sequences (exchanged nucleotides underlined):

(SEQ ID NO: 30)
NNNNNNNNNNNNNNNNNNNNGUAUUAGAGCUAGAAAUAGCAAGUUAAUA
UAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGC;
(SEQ ID NO: 31)
NNNNNNNNNNNNNNNNNNNNGUUUAAGAGCUAGAAAUAGCAAGUUUAAA
UAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGC;
or
(SEQ ID NO: 32)
NNNNNNNNNNNNNNNNNNNNGUAUUAGAGCUAUGCUGUAUUGGAAACAA
UACAGCAUAGCAAGUUAAUAUAAGGCUAGUCCGUUAUCAACUUGAAAAA
GUGGCACCGAGUCGGUGC.

The 5′ Extension Domain

In an embodiment, a modular gRNA can comprise additional sequence, 5′ to the second complementarity domain. In an embodiment, the 5′ extension domain is 2 to 10, 2 to 9, 2 to 8, 2 to 7, 2 to 6, 2 to 5, or 2 to 4 nucleotides in length. In an embodiment, the 5′ extension domain is 2, 3, 4, 5, 6, 7, 8, 9, or 10 or more nucleotides in length.

In an embodiment, the 5′ extension domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the 5′ extension domain comprises one or more modifications, e.g., modifications that it render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the 5′ extension domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment, a nucleotide of the 5′ extension domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII.

In an embodiment, the 5′ extension domain can comprise as many as 1, 2, 3, 4, 5, 6, 7 or 8 modifications. In an embodiment, the 5′ extension domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 5′ end, e.g., in a modular gRNA molecule. In an embodiment, the 5′ extension domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 3′ end, e.g., in a modular gRNA molecule.

In an embodiment, the 5′ extension domain comprises modifications at two consecutive nucleotides, e.g., two consecutive nucleotides that are within 5 nucleotides of the 5′ end of the 5′ extension domain, within 5 nucleotides of the 3′ end of the 5′ extension domain, or more than 5 nucleotides away from one or both ends of the 5′ extension domain. In an embodiment, no two consecutive nucleotides are modified within 5 nucleotides of the 5′ end of the 5′ extension domain, within 5 nucleotides of the 3′ end of the 5′ extension domain, or within a region that is more than 5 nucleotides away from one or both ends of the 5′ extension domain. In an embodiment, no nucleotide is modified within 5 nucleotides of the 5′ end of the 5′ extension domain, within 5 nucleotides of the 3′ end of the 5′ extension domain, or within a region that is more than 5 nucleotides away from one or both ends of the 5′ extension domain.

Modifications in the 5′ extension domain can be selected so as to not interfere with gRNA molecule efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate 5′ extension domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in the system described at Section IV. The candidate 5′ extension domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, the 5′ extension domain has at least 60, 70, 80, 85, 90 or 95% homology with, or differs by no more than 1, 2, 3, 4, 5, or 6 nucleotides from, a reference 5′ extension domain, e.g., a naturally occurring, e.g., an S. pyogenes, or S. aureus S. thermophilus, 5′ extension domain, or a 5′ extension domain described herein, e.g., from FIGS. 1A-1G.

The Linking Domain

In a unimolecular gRNA molecule the linking domain is disposed between the first and second complementarity domains. In a modular gRNA molecule, the two molecules are associated with one another by the complementarity domains.

In an embodiment, the linking domain is 10+/−5, 20+/−5, 30+/−5, 40+/−5, 50+/−5, 60+/−5, 70+/−5, 80+/−5, 90+/−5, or 100+/−5 nucleotides, in length.

In an embodiment, the linking domain is 20+/−10, 30+/−10, 40+/−10, 50+/−10, 60+/−10, 70+/−10, 80+/−10, 90+/−10, or 100+/−10 nucleotides, in length.

In an embodiment, the linking domain is 10 to 100, 10 to 90, 10 to 80, 10 to 70, 10 to 60, 10 to 50, 10 to 40, 10 to 30, 10 to 20 or 10 to 15 nucleotides in length. In other embodiments, the linking domain is 20 to 100, 20 to 90, 20 to 80, 20 to 70, 20 to 60, 20 to 50, 20 to 40, 20 to 30, or 20 to 25 nucleotides in length.

In an embodiment, the linking domain is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 17, 18, 19, or 20 nucleotides in length.

In an embodiment, the linking domain is a covalent bond.

In an embodiment, the linking domain comprises a duplexed region, typically adjacent to or within 1, 2, or 3 nucleotides of the 3′ end of the first complementarity domain and/or the 5-end of the second complementarity domain. In an embodiment, the duplexed region can be 20+/−10 base pairs in length. In an embodiment, the duplexed region can be 10+/−5, 15+/−5, 20+/−5, or 30+/−5 base pairs in length. In an embodiment, the duplexed region can be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15 base pairs in length.

Typically the sequences forming the duplexed region have exact complementarity with one another, though in some embodiments as many as 1, 2, 3, 4, 5, 6, 7 or 8 nucleotides are not complementary with the corresponding nucleotides.

In an embodiment, the linking domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the linking domain comprises one or more modifications, e.g., modifications that it render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the linking domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment a nucleotide of the linking domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII. In some embodiments, the linking domain can comprise as many as 1, 2, 3, 4, 5, 6, 7 or 8 modifications.

Modifications in a linking domain can be selected so as to not interfere with targeting efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate linking domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated a system described in Section IV. A candidate linking domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, the linking domain has at least 60, 70, 80, 85, 90 or 95% homology with, or differs by no more than 1, 2, 3, 4, 5, or 6 nucleotides from, a reference linking domain, e.g., a linking domain described herein, e.g., from FIGS. 1A-1G.

The Proximal Domain

In an embodiment, the proximal domain is 6+/−2, 7+/−2, 8+/−2, 9+/−2, 10+/−2, 11+/−2, 12+/−2, 13+/−2, 14+/−2, 14+/−2, 16+/−2, 17+/−2, 18+/−2, 19+/−2, or 20+/−2 nucleotides in length.

In an embodiment, the proximal domain is 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, the proximal domain is 5 to 20, 7, to 18, 9 to 16, or 10 to 14 nucleotides in length.

In an embodiment, the proximal domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the proximal domain comprises one or more modifications, e.g., modifications that it render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the proximal domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment a nucleotide of the proximal domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII.

In an embodiment, the proximal domain can comprise as many as 1, 2, 3, 4, 5, 6, 7 or 8 modifications. In an embodiment, the proximal domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 5′ end, e.g., in a modular gRNA molecule. In an embodiment, the target domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 3′ end, e.g., in a modular gRNA molecule.

In an embodiment, the proximal domain comprises modifications at two consecutive nucleotides, e.g., two consecutive nucleotides that are within 5 nucleotides of the 5′ end of the proximal domain, within 5 nucleotides of the 3′ end of the proximal domain, or more than 5 nucleotides away from one or both ends of the proximal domain. In an embodiment, no two consecutive nucleotides are modified within 5 nucleotides of the 5′ end of the proximal domain, within 5 nucleotides of the 3′ end of the proximal domain, or within a region that is more than 5 nucleotides away from one or both ends of the proximal domain. In an embodiment, no nucleotide is modified within 5 nucleotides of the 5′ end of the proximal domain, within 5 nucleotides of the 3′ end of the proximal domain, or within a region that is more than 5 nucleotides away from one or both ends of the proximal domain.

Modifications in the proximal domain can be selected so as to not interfere with gRNA molecule efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate proximal domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in the system described at Section IV. The candidate proximal domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, the proximal domain has at least 60, 70, 80, 85 90 or 95% homology with, or differs by no more than 1, 2, 3, 4, 5, or 6 nucleotides from, a reference proximal domain, e.g., a naturally occurring, e.g., an S. pyogenes, S. aureus or S. thermophilus, proximal domain, or a proximal domain described herein, e.g., from FIGS. 1A-1G.

The Tail Domain

In an embodiment, the tail domain is 10+/−5, 20+/−5, 30+/−5, 40+/−5, 50+/−5, 60+/−5, 70+/−5, 80+/−5, 90+/−5, or 100+/−5 nucleotides, in length.

In an embodiment, the tail domain is 20+/−5 nucleotides in length.

In an embodiment, the tail domain is 20+/−10, 30+/−10, 40+/−10, 50+/−10, 60+/−10, 70+/−10, 80+/−10, 90+/−10, or 100+/−10 nucleotides, in length.

In an embodiment, the tail domain is 25+/−10 nucleotides in length.

In an embodiment, the tail domain is 10 to 100, 10 to 90, 10 to 80, 10 to 70, 10 to 60, 10 to 50, 10 to 40, 10 to 30, 10 to 20 or 10 to 15 nucleotides in length.

In other embodiments, the tail domain is 20 to 100, 20 to 90, 20 to 80, 20 to 70, 20 to 60, 20 to 50, 20 to 40, 20 to 30, or 20 to 25 nucleotides in length.

In an embodiment, the tail domain is 1 to 20, 1 to 15, 1 to 10, or 1 to 5 nucleotides in length.

In an embodiment, the tail domain nucleotides do not comprise modifications, e.g., modifications of the type provided in Section VIII. However, in an embodiment, the tail domain comprises one or more modifications, e.g., modifications that it render it less susceptible to degradation or more bio-compatible, e.g., less immunogenic. By way of example, the backbone of the tail domain can be modified with a phosphorothioate, or other modification(s) from Section VIII. In an embodiment a nucleotide of the tail domain can comprise a 2′ modification, e.g., a 2-acetylation, e.g., a 2′ methylation, or other modification(s) from Section VIII.

In some embodiments, the tail domain can have as many as 1, 2, 3, 4, 5, 6, 7 or 8 modifications. In an embodiment, the target domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 5′ end. In an embodiment, the target domain comprises as many as 1, 2, 3, or 4 modifications within 5 nucleotides of its 3′ end.

In an embodiment, the tail domain comprises a tail duplex domain, which can form a tail duplexed region. In an embodiment, the tail duplexed region can be 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 base pairs in length. In an embodiment, a further single stranded domain, exists 3′ to the tail duplexed domain. In an embodiment, this domain is 3, 4, 5, 6, 7, 8, 9, or 10 nucleotides in length. In an embodiment it is 4 to 6 nucleotides in length.

In an embodiment, the tail domain has at least 60, 70, 80, or 90% homology with, or differs by no more than 1, 2, 3, 4, 5, or 6 nucleotides from, a reference tail domain, e.g., a naturally occurring, e.g., an S. pyogenes, S. aureus or S. thermophilus, tail domain, or a tail domain described herein, e.g., from FIGS. 1A-1G.

In an embodiment, the proximal and tail domain, taken together, comprise the following sequences:

(SEQ ID NO: 33)
AAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCU,
or
(SEQ ID NO: 34)
AAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGGU
GC,
or
(SEQ ID NO: 35)
AAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCG
GAUC,
or
(SEQ ID NO: 36)
AAGGCUAGUCCGUUAUCAACUUGAAAAAGUG,
or
(SEQ ID NO: 37)
AAGGCUAGUCCGUUAUCA,
or
(SEQ ID NO: 38)
AAGGCUAGUCCG.

In an embodiment, the tail domain comprises the 3′ sequence UUUUUU, e.g., if a U6 promoter is used for transcription.

In an embodiment, the tail domain comprises the 3′ sequence UUUU, e.g., if an H1 promoter is used for transcription.

In an embodiment, tail domain comprises variable numbers of 3′ Us depending, e.g., on the termination signal of the pol-III promoter used.

In an embodiment, the tail domain comprises variable 3′ sequence derived from the DNA template if a T7 promoter is used.

In an embodiment, the tail domain comprises variable 3′ sequence derived from the DNA template, e.g., if in vitro transcription is used to generate the RNA molecule.

In an embodiment, the tail domain comprises variable 3′ sequence derived from the DNA template, e., if a pol-II promoter is used to drive transcription.

Modifications in the tail domain can be selected so as to not interfere with targeting efficacy, which can be evaluated by testing a candidate modification in the system described in Section IV. gRNAs having a candidate tail domain having a selected length, sequence, degree of complementarity, or degree of modification, can be evaluated in the system described in Section IV. The candidate tail domain can be placed, either alone, or with one or more other candidate changes in a gRNA molecule/Cas9 molecule system known to be functional with a selected target and evaluated.

In an embodiment, the tail domain comprises modifications at two consecutive nucleotides, e.g., two consecutive nucleotides that are within 5 nucleotides of the 5′ end of the tail domain, within 5 nucleotides of the 3′ end of the tail domain, or more than 5 nucleotides away from one or both ends of the tail domain. In an embodiment, no two consecutive nucleotides are modified within 5 nucleotides of the 5′ end of the tail domain, within 5 nucleotides of the 3′ end of the tail domain, or within a region that is more than 5 nucleotides away from one or both ends of the tail domain. In an embodiment, no nucleotide is modified within 5 nucleotides of the 5′ end of the tail domain, within 5 nucleotides of the 3′ end of the tail domain, or within a region that is more than 5 nucleotides away from one or both ends of the tail domain.

In an embodiment a gRNA has the following structure:

• • 5′ [targeting domain]-[first complementarity domain]-[linking domain]-[second complementarity domain]-[proximal domain]-[tail domain]-3′
  • wherein, the targeting domain comprises a core domain and optionally a secondary domain, and is 10 to 50 nucleotides in length;
  • the first complementarity domain is 5 to 25 nucleotides in length and, In an embodiment has at least 50, 60, 70, 80, 85, 90 or 95% homology with a reference first complementarity domain disclosed herein;
  • the linking domain is 1 to 5 nucleotides in length;
  • the second complementarity domain is 5 to 27 nucleotides in length and, in an embodiment has at least 50, 60, 70, 80, 85, 90 or 95% homology with a reference second complementarity domain disclosed herein;
  • the proximal domain is 5 to 20 nucleotides in length and, in an embodiment has at least 50, 60, 70, 80, 85, 90 or 95% homology with a reference proximal domain disclosed herein; and
  • the tail domain is absent or a nucleotide sequence is 1 to 50 nucleotides in length and, in an embodiment has at least 50, 60, 70, 80, 85, 90 or 95% homology with a reference tail domain disclosed herein.

Exemplary Chimeric gRNAs

In an embodiment, a unimolecular, or chimeric, gRNA comprises, preferably from 5′ to 3′:

• • a targeting domain (which is complementary to a target nucleic acid);
  • a first complementarity domain, e.g., comprising 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 nucleotides;
  • a linking domain;
  • a second complementarity domain (which is complementary to the first complementarity domain);
  • a proximal domain; and
  • a tail domain,
  • wherein,
  • (a) the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides;
  • (b) there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain; or
  • (c) there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the sequence from (a), (b), or (c), has at least 60, 75, 80, 85, 90, 95, or 99% homology with the corresponding sequence of a naturally occurring gRNA, or with a gRNA described herein.

In an embodiment, the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides (e.g., 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the unimolecular, or chimeric, gRNA molecule (comprising a targeting domain, a first complementary domain, a linking domain, a second complementary domain, a proximal domain and, optionally, a tail domain) comprises the following sequence in which the targeting domain is depicted as 20 Ns but could be any sequence and range in length from 16 to 26 nucleotides and in which the gRNA sequence is followed by 6 Us, which serve as a termination signal for the U6 promoter, but which could be either absent or fewer in number: NNNNNNNNNNNNNNNNNNNNGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGG CUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUUUU (SEQ ID NO: 45). In an embodiment, the unimolecular, or chimeric, gRNA molecule is a S. pyogenes gRNA molecule.

In some embodiments, the unimolecular, or chimeric, gRNA molecule (comprising a targeting domain, a first complementary domain, a linking domain, a second complementary domain, a proximal domain and, optionally, a tail domain) comprises the following sequence in which the targeting domain is depicted as 20 Ns but could be any sequence and range in length from 16 to 26 nucleotides and in which the gRNA sequence is followed by 6 Us, which serve as a termination signal for the U6 promoter, but which could be either absent or fewer in number: NNNNNNNNNNNNNNNNNNNNGUUUUAGUACUCUGGAAACAGAAUCUACUAAAAC AAGGCAAAAUGCCGUGUUUAUCUCGUCAACUUGUUGGCGAGAUUUUUU (SEQ ID NO: 40). In an embodiment, the unimolecular, or chimeric, gRNA molecule is a S. aureus gRNA molecule.

Exemplary Modular gRNAs

In an embodiment, a modular gRNA comprises:

• • a first strand comprising, preferably from 5′ to 3′;
    • a targeting domain, e.g., comprising 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or 26 nucleotides;
    • a first complementarity domain; and
    • a second strand, comprising, preferably from 5′ to 3′:
    • optionally a 5′ extension domain;
    • a second complementarity domain;
    • a proximal domain; and
    • a tail domain,
  • wherein:
  • (a) the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides;
  • (b) there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain; or
  • (c) there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the sequence from (a), (b), or (c), has at least 60, 75, 80, 85, 90, 95, or 99% homology with the corresponding sequence of a naturally occurring gRNA, or with a gRNA described herein.

In an embodiment, the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides (e.g., 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 16 nucleotides (e.g., 16 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 16 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 17 nucleotides (e.g., 17 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 17 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 18 nucleotides (e.g., 18 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 18 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 19 nucleotides (e.g., 19 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 19 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 20 nucleotides (e.g., 20 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 20 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 21 nucleotides (e.g., 21 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 21 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 22 nucleotides (e.g., 22 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 22 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 23 nucleotides (e.g., 23 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 23 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 24 nucleotides (e.g., 24 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 24 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 25 nucleotides (e.g., 25 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 25 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length; and the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length; and there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain.

In an embodiment, the targeting domain comprises, has, or consists of, 26 nucleotides (e.g., 26 consecutive nucleotides) having complementarity with the target domain, e.g., the targeting domain is 26 nucleotides in length; and there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain.

II. Methods for Designing gRNAs

Methods for designing gRNAs are described herein, including methods for selecting, designing and validating target domains. Exemplary targeting domains are also provided herein. Targeting Domains discussed herein can be incorporated into the gRNAs described herein.

Methods for selection and validation of target sequences as well as off-target analyses are described, e.g., in Mali et al., 2013 SCIENCE 339(6121): 823-826; Hsu et al. NAT BIOTECHNOL, 31(9): 827-32; Fu et al., 2014 NAT BIOTECHNOL, doi: 10.1038/nbt.2808. PubMed PMID: 24463574; Heigwer et al., 2014 NAT METHODS 11(2):122-3. doi: 10.1038/nmeth.2812. PubMed PMID: 24481216; Bae et al., 2014 BIOINFORMATICS PubMed PMID: 24463181; Xiao A et al., 2014 BIOINFORMATICS PubMed PMID: 24389662.

For example, a software tool can be used to optimize the choice of gRNA within a user's target sequence, e.g., to minimize total off-target activity across the genome. Off target activity may be other than cleavage. For each possible gRNA choice using S. pyogenes Cas9, the tool can identify all off-target sequences (preceding either NAG or NGG PAMs) across the genome that contain up to certain number (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10) of mismatched base-pairs. The cleavage efficiency at each off-target sequence can be predicted, e.g., using an experimentally-derived weighting scheme. Each possible gRNA is then ranked according to its total predicted off-target cleavage; the top-ranked gRNAs represent those that are likely to have the greatest on-target and the least off-target cleavage. Other functions, e.g., automated reagent design for CRISPR construction, primer design for the on-target Surveyor assay, and primer design for high-throughput detection and quantification of off-target cleavage via next-gen sequencing, can also be included in the tool. Candidate gRNA molecules can be evaluated by art-known methods or as described in Section IV herein.

The Targeting Domains discussed herein can be incorporated into the gRNAs described herein.

Strategies to Identify gRNAs for S. pyogenes, S. aureus, and N. meningitidis to Knock Out the SCNN1A Gene

As an example, three strategies were utilized to identify gRNAs for use with S. pyogenes, S. aureus and N. meningitidis Cas9 enzymes.

In the first strategy, guide RNAs (gRNAs) for use with the S. pyogenes Cas9 (Tables 3A-3C) were identified using the publically available web-based ZiFiT server (Fu et al., Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol. 2014 Jan. 26. doi: 10.1038/nbt.2808. PubMed PMID: 24463574, for the original references see Sander et al., 2007, NAR 35:W599-605; Sander et al., 2010, NAR 38: W462-8). In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available Repeat-Masker program. RepeatMmasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence. Following identification, gRNAs for use with a S. pyogenes Cas9 were ranked into 3 or 4 tiers, as described below.

The gRNAs in tier 1 were selected based on their distance to the target site and their orthogonality in the genome (based on the ZiFiT identification of close matches in the human genome containing an NGG PAM). As an example, for all targets, both 17-mer and 20-mer gRNAs were designed. gRNAs were also selected both for single-gRNA nuclease cutting and for the dual gRNA nickase strategy. Criteria for selecting gRNAs and the determination for which gRNAs can be used for which strategy is based on several considerations:

• • 1. For the dual nickase strategy, gRNA pairs should be oriented on the DNA such that PAMs are facing out and cutting with the D10A Cas9 nickase will result in 5′ overhangs.
  • 2. An assumption that cleaving with dual nickase pairs will result in deletion of the entire intervening sequence at a reasonable frequency. However, it will also often result in indel mutations at the site of only one of the gRNAs. Candidate pair members can be tested for how efficiently they remove the entire sequence versus just causing indel mutations at the site of one gRNA.

While it can be desirable to have gRNAs start with a 5′ G, this requirement was relaxed for some gRNAs in tier 1 in order to identify guides in the correct orientation, within a reasonable distance to the mutation and with a high level of orthogonality. In order to find a pair for the dual-nickase strategy it was necessary to either extend the distance from the mutation or remove the requirement for the 5′G. For selection of tier 2 gRNAs, the distance restriction was relaxed in some cases such that a longer sequence was scanned, but the 5′G was required for all gRNAs. Whether or not the distance requirement was relaxed depended on how many sites were found within the original search window. Tier 3 uses the same distance restriction as tier 2, but removes the requirement for a 5′G. Note that tiers are non-inclusive (each gRNA is listed only once).

As discussed above, gRNAs were identified for single-gRNA nuclease cleavage as well as for a dual-gRNA paired “nickase” strategy, as indicated.

gRNAs for use with the S. aureus (Tables 3D) Cas9s were identified manually by scanning genomic DNA sequence for the presence of PAM sequences. These gRNAs were not separated into tiers, but are provided in single lists for each species.

In a second strategy, Guide RNAs (gRNAs) for use with S. pyogenes, S. aureus and N. meningitidis Cas9s were identified using a DNA sequence searching algorithm. Guide RNA design was carried out using a custom guide RNA design software based on the public tool cas-offinder (reference:Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics. 2014 Feb. 17. Bae S, Park J, Kim J S. PMID:24463181). Said custom guide RNA design software scores guides after calculating their genomewide off-target propensity. Typically matches ranging from perfect matches to 7 mismatches are considered for guides ranging in length from 17 to 24. Once the off-target sites are computationally determined, an aggregate score is calculated for each guide and summarized in a tabular output using a web-interface. In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available RepeatMasker program. RepeatMasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence.

Following identification, gRNAs were ranked into tiers based on their distance to the target site, their orthogonality and presence of a 5′ G (based on identification of close matches in the human genome containing a relevant PAM (e.g., in the case of S. pyogenes, a NGG PAM, in the case of S. aureus, a NNGRRT or NNGRRV PAM, and in the case of N. meningitidis, a NNNNGATT or NNNNGCTT PAM). Orthogonality refers to the number of sequences in the human genome that contain a minimum number of mismatches to the target sequence. A “high level of orthogonality” or “good orthogonality” may, for example, refer to 20-mer gRNAs that have no identical sequences in the human genome besides the intended target, nor any sequences that contain one or two mismatches in the target sequence. Targeting domains with good orthogonality are selected to minimize off-target DNA cleavage.

As an example, for S. pyogenes and N. meningitidis targets, 17-mer, or 20-mer gRNAs were designed. As another example, for S. aureus targets, 18-mer, 19-mer, 20-mer, 21-mer, 22-mer, 23-mer and 24-mer gRNAs were designed. Targeting domains, disclosed herein, may comprise the 17-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 18 or more nucleotides may comprise the 17-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 18-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 19 or more nucleotides may comprise the 18-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 19-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 20 or more nucleotides may comprise the 19-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 20-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 21 or more nucleotides may comprise the 20-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 21-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 22 or more nucleotides may comprise the 21-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 22-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 23 or more nucleotides may comprise the 22-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 23-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 24 or more nucleotides may comprise the 23-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. Targeting domains, disclosed herein, may comprises the 24-mer described in Tables 43A-43E, 44A-44G or 45A-45E, e.g., the targeting domains of 25 or more nucleotides may comprise the 24-mer gRNAs described in Tables 43A-43E, 44A-44G or 45A-45E. gRNAs were identified for both single-gRNA nuclease cleavage and for a dual-gRNA paired “nickase” strategy. Criteria for selecting gRNAs and the determination for which gRNAs can be used for the dual-gRNA paired “nickase” strategy is based on two considerations:

• • 1. gRNA pairs should be oriented on the DNA such that PAMs are facing out and cutting with the D10A Cas9 nickase will result in 5′ overhangs.
  • 2. An assumption that cleaving with dual nickase pairs will result in deletion of the entire intervening sequence at a reasonable frequency. However, cleaving with dual nickase pairs can also result in indel mutations at the site of only one of the gRNAs. Candidate pair members can be tested for how efficiently they remove the entire sequence versus causing indel mutations at the site of one gRNA.
    The targeting domains discussed herein can be incorporated into the gRNAs described herein.

gRNAs were identified and ranked into 5 tiers for S. pyogenes (Tables 43A-43E), and N. meningitidis (Tables 45A-45E); and 7 tiers for S. aureus (Tables 44A-44G). For S. pyogenes, and N. meningitidis, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon), (2) a high level of orthogonality and (3) the presence of 5′G. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon) and (2) a high level of orthogonality. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon) and (2) the presence of 5′G. The targeting domain for tier 4 gRNA molecules were selected based on distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon). The targeting domain for tier 5 gRNA molecules were selected based on distance to the target site (e.g., start codon), e.g., within reminder of the coding sequence, e.g., downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon). For S. aureus, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon), (2) a high level of orthogonality, (3) the presence of 5′G and (4) PAM is NNGRRT. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon), (2) a high level of orthogonality, and (3) PAM is NNGRRT. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon) and (2) PAM is NNGRRT. The targeting domain for tier 4 gRNA molecules were selected based on (1) distance to a target site (e.g., start codon), e.g., within 500 bp (e.g., downstream) of the target site (e.g., start codon) and (2) PAM is NNGRRV. The targeting domain for tier 5 gRNA molecules were selected based on (1) distance to the target site (e.g., start codon), e.g., within reminder of the coding sequence, e.g., downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon), (2) the presence of 5′G and (3) PAM is NNGRRT. The targeting domain for tier 6 gRNA molecules were selected based on (1) distance to the target site (e.g., start codon), e.g., within reminder of the coding sequence, e.g., downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon) and (2) PAM is NNGRRT. The targeting domain for tier 7 gRNA molecules were selected based on (1) distance to the target site (e.g., start codon), e.g., within reminder of the coding sequence, e.g., downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon) and (2) PAM is NNGRRV. Note that tiers are non-inclusive (each gRNA is listed only once for the strategy). In certain instances, no gRNA was identified based on the criteria of the particular tier.

Strategies to Identify gRNAs for S. pyogenes, S. aureus, and N. meningitidis to Knock Down the SCNN1A Gene

As an example, three strategies were utilized to identify gRNAs for use with S. pyogenes, S. aureus and N. meningitidis Cas9 enzymes.

Guide RNAs (gRNAs) for use with S. pyogenes, S. aureus and N. meningitidis Cas9s were identified using a DNA sequence searching algorithm. Guide RNA design was carried out using a custom guide RNA design software based on the public tool cas-offinder (reference:Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics. 2014 Feb. 17. Bae S, Park J, Kim J S. PMID:24463181). Said custom guide RNA design software scores guides after calculating their genomewide off-target propensity. Typically matches ranging from perfect matches to 7 mismatches are considered for guides ranging in length from 17 to 24. Once the off-target sites are computationally determined, an aggregate score is calculated for each guide and summarized in a tabular output using a web-interface. In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available RepeatMasker program. RepeatMasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence.

Following identification, gRNAs were ranked into tiers based on their distance to the target site, their orthogonality and presence of a 5′ G (based on identification of close matches in the human genome containing a relevant PAM (e.g., in the case of S. pyogenes, a NGG PAM, in the case of S. aureus, a NNGRRT or NNGRRV PAM, and in the case of N. meningitidis, a NNNNGATT or NNNNGCTT PAM). Orthogonality refers to the number of sequences in the human genome that contain a minimum number of mismatches to the target sequence. A “high level of orthogonality” or “good orthogonality” may, for example, refer to 20-mer gRNAs that have no identical sequences in the human genome besides the intended target, nor any sequences that contain one or two mismatches in the target sequence. Targeting domains with good orthogonality are selected to minimize off-target DNA cleavage.

As an example, for S. pyogenes and N. meningitidis targets, 17-mer, or 20-mer gRNAs were designed. As another example, for S. aureus targets, 18-mer, 19-mer, 20-mer, 21-mer, 22-mer, 23-mer and 24-mer gRNAs were designed. Targeting domains, disclosed herein, may comprise the 17-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 18 or more nucleotides may comprise the 17-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 18-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 19 or more nucleotides may comprise the 18-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 19-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 20 or more nucleotides may comprise the 19-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 20-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 21 or more nucleotides may comprise the 20-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 21-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 22 or more nucleotides may comprise the 21-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 22-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 23 or more nucleotides may comprise the 22-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 23-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 24 or more nucleotides may comprise the 23-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E. Targeting domains, disclosed herein, may comprises the 24-mer described in Tables 46A-46E, 47A-47G or 48A-48E, e.g., the targeting domains of 25 or more nucleotides may comprise the 24-mer gRNAs described in Tables 46A-46E, 47A-47G or 48A-48E.

The targeting domains discussed herein can be incorporated into the gRNAs described herein.

gRNAs were identified and ranked into 5 tiers for S. pyogenes (Tables 46A-46E), and N. meningitidis (Tables 48A-48E); and 7 tiers for S. aureus (Tables 47A-47G). For S. pyogenes, and N. meningitidis, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), (2) a high level of orthogonality and (3) the presence of 5′G. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and (2) a high level of orthogonality. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and (2) the presence of 5′G. The targeting domain for tier 4 gRNA molecules were selected based on distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS). The targeting domain for tier 5 gRNA molecules were selected based on distance to the target site, e.g., within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS. For S. aureus, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), (2) a high level of orthogonality, (3) the presence of 5′G and (4) PAM is NNGRRT. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), (2) a high level of orthogonality, and (3) PAM is NNGRRT. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and (2) PAM is NNGRRT. The targeting domain for tier 4 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and (2) PAM is NNGRRV. The targeting domain for tier 5 gRNA molecules were selected based on (1) distance to the target site, e.g., within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS, (2) the presence of 5′G and (3) PAM is NNGRRT. The targeting domain for tier 6 gRNA molecules were selected based on (1) distance to the target site, e.g., within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS and (2) PAM is NNGRRT. The targeting domain for tier 7 gRNA molecules were selected based on (1) distance to the target site, e.g., within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS and (2) PAM is NNGRRV. Note that tiers are non-inclusive (each gRNA is listed only once for the strategy). In certain instances, no gRNA was identified based on the criteria of the particular tier.

Strategies to Identify gRNAs for S. pyogenes, S. aureus, and N. For Correcting a Mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G) in the CFTR Gene

As an example, three strategies were utilized to identify gRNAs for use with S. pyogenes, S. aureus and N. meningitidis Cas9 enzymes.

In the first strategy, guide RNAs (gRNAs) for use with the S. pyogenes Cas9 (Tables 1A-1C or 2A-2C) were identified using the publically available web-based ZiFiT server (Fu et al., Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol. 2014 Jan. 26. doi: 10.1038/nbt.2808. PubMed PMID: 24463574, for the original references see Sander et al., 2007, NAR 35:W599-605; Sander et al., 2010, NAR 38: W462-8). In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available Repeat-Masker program. RepeatMasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence. Following identification, gRNAs for use with a S. pyogenes Cas9 were ranked into 3 or 4 tiers, as described below.

The gRNAs in tier 1 were selected based on their distance to the target site and their orthogonality in the genome (based on the ZiFiT identification of close matches in the human genome containing an NGG PAM). As an example, for all targets, both 17-mer and 20-mer gRNAs were designed. gRNAs were also selected both for single-gRNA nuclease cutting and for the dual gRNA nickase strategy. Criteria for selecting gRNAs and the determination for which gRNAs can be used for which strategy is based on several considerations:

• • 3. For the dual nickase strategy, gRNA pairs should be oriented on the DNA such that PAMs are facing out and cutting with the D10A Cas9 nickase will result in 5′ overhangs.
  • 4. An assumption that cleaving with dual nickase pairs will result in deletion of the entire intervening sequence at a reasonable frequency. However, it will also often result in indel mutations at the site of only one of the gRNAs. Candidate pair members can be tested for how efficiently they remove the entire sequence versus just causing indel mutations at the site of one gRNA.

While it can be desirable to have gRNAs start with a 5′ G, this requirement was relaxed for some gRNAs in tier 1 in order to identify guides in the correct orientation, within a reasonable distance to the mutation and with a high level of orthogonality. In order to find a pair for the dual-nickase strategy it was necessary to either extend the distance from the mutation or remove the requirement for the 5′G. For selection of tier 2 gRNAs, the distance restriction was relaxed in some cases such that a longer sequence was scanned, but the 5′G was required for all gRNAs. Whether or not the distance requirement was relaxed depended on how many sites were found within the original search window. Tier 3 uses the same distance restriction as tier 2, but removes the requirement for a 5′G. Note that tiers are non-inclusive (each gRNA is listed only once).

As discussed above, gRNAs were identified for single-gRNA nuclease cleavage as well as for a dual-gRNA paired “nickase” strategy, as indicated.

gRNAs for use with the N. meningitidis (Tables 1E or 2E) and S. aureus (Tables 1D or 2D) Cas9s were identified manually by scanning genomic DNA sequence for the presence of PAM sequences. These gRNAs were not separated into tiers, but are provided in single lists for each species.

In a second strategy, Guide RNAs (gRNAs) for use with S. pyogenes, S. aureus and N. meningitidis Cas9s were identified using a DNA sequence searching algorithm. Guide RNA design was carried out using a custom guide RNA design software based on the public tool cas-offinder (reference:Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics. 2014 Feb. 17. Bae S, Park J, Kim J S. PMID:24463181). Said custom guide RNA design software scores guides after calculating their genomewide off-target propensity. Typically matches ranging from perfect matches to 7 mismatches are considered for guides ranging in length from 17 to 24. Once the off-target sites are computationally determined, an aggregate score is calculated for each guide and summarized in a tabular output using a web-interface. In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available RepeatMasker program. RepeatMasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence.

Following identification, gRNAs were ranked into tiers based on their distance to the target site, their orthogonality and presence of a 5′ G (based on identification of close matches in the human genome containing a relevant PAM (e.g., in the case of S. pyogenes, a NGG PAM, in the case of S. aureus, a NNGRRT or NNGRRV PAM, and in the case of N. meningitidis, a NNNNGATT or NNNNGCTT PAM). Orthogonality refers to the number of sequences in the human genome that contain a minimum number of mismatches to the target sequence. A “high level of orthogonality” or “good orthogonality” may, for example, refer to 20-mer gRNAs that have no identical sequences in the human genome besides the intended target, nor any sequences that contain one or two mismatches in the target sequence. Targeting domains with good orthogonality are selected to minimize off-target DNA cleavage.

As an example, for S. pyogenes and N. meningitidis targets, 17-mer, or 20-mer gRNAs were designed. As another example, for S. aureus targets, 18-mer, 19-mer, 20-mer, 21-mer, 22-mer, 23-mer and 24-mer gRNAs were designed. Targeting domains, disclosed herein, may comprise the 17-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 18 or more nucleotides may comprise the 17-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 18-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 19 or more nucleotides may comprise the 18-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 19-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 20 or more nucleotides may comprise the 19-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 20-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 21 or more nucleotides may comprise the 20-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 21-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 22 or more nucleotides may comprise the 21-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 22-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 23 or more nucleotides may comprise the 22-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 23-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 24 or more nucleotides may comprise the 23-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. Targeting domains, disclosed herein, may comprises the 24-mer described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B, e.g., the targeting domains of 25 or more nucleotides may comprise the 24-mer gRNAs described in Tables 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, or 30A-30B. gRNAs were identified for both single-gRNA nuclease cleavage and for a dual-gRNA paired “nickase” strategy. Criteria for selecting gRNAs and the determination for which gRNAs can be used for the dual-gRNA paired “nickase” strategy is based on two considerations:

• • 1. gRNA pairs should be oriented on the DNA such that PAMs are facing out and cutting with the D10A Cas9 nickase will result in 5′ overhangs.
  • 2. An assumption that cleaving with dual nickase pairs will result in deletion of the entire intervening sequence at a reasonable frequency. However, cleaving with dual nickase pairs can also result in indel mutations at the site of only one of the gRNAs. Candidate pair members can be tested for how efficiently they remove the entire sequence versus causing indel mutations at the site of one gRNA.
    The targeting domains discussed herein can be incorporated into the gRNAs described herein.

In an embodiment, gRNAs were identified and ranked into 4 tiers for S. pyogenes (Tables 4A-4D, 7A-7D, 10A-10C, 13A-13D, 16A-16D, 19A-19D, 12A-12D, 22A-22D, 25A-25D or 28A-28D), and N. meningitidis (Tables 6A-6C, 9A-9B, 12A-12C, 15A-15C, 18A-18C, 21A-21B, 24A-24D, 27A-27D, or 30A-30B); and 5 tiers for S. aureus (Tables 5A-5E, 8A-8E, 11A-11E, 14A-14E, 17A-17E, 20A-20E, 23A-23E, 26A-26E, or 29A-29E). For S. pyogenes, and N. meningitidis, the targeting domain or tier 1 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G), (2) a high level of orthogonality and (3) the presence of 5′G. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G) and (2) a high level of orthogonality. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G) and (2) the presence of 5′G. The targeting domain for tier 4 gRNA molecules were selected based on distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G). For S. aureus, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G), (2) a high level of orthogonality, (3) the presence of 5′G and (4) PAM is NNGRRT. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G), (2) a high level of orthogonality, and (3) PAM is NNGRRT. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G), (2) the presence of a 5′G and (2) PAM is NNGRRT. The targeting domain for tier 4 gRNA molecules were selected based on (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G) and (2) PAM is NNGRRT. The targeting domain for tier 5 gRNA molecules were selected based on (1) (1) distance to a target site, e.g., within 200 bp from a mutation (e.g., delF508, G551D, G542X, N1303K, R117H, W1282X, R553X, 2789+5G->A, or 3272-26A->G) and (2) PAM is NNGRRV. Note that tiers are non-inclusive (each gRNA is listed only once for the strategy). In certain instances, no gRNA was identified based on the criteria of the particular tier.

Strategies to Identify gRNAs for S. pyogenes, S. aureus, and N. meningitidis for Targeting an Intronic Mutation (e.g., 3849+10kbC->T or 3272-26A->G) Regions of the CFTR Gene (e.g., Mediated by NHEJ)

As an example, three strategies were utilized to identify gRNAs for use with S. pyogenes, S. aureus and N. meningitidis Cas9 enzymes.

Guide RNAs (gRNAs) for use with S. pyogenes, S. aureus and N. meningitidis Cas9s were identified using a DNA sequence searching algorithm. Guide RNA design was carried out using a custom guide RNA design software based on the public tool cas-offinder (reference:Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics. 2014 Feb. 17. Bae S, Park J, Kim J S. PMID:24463181). Said custom guide RNA design software scores guides after calculating their genomewide off-target propensity. Typically matches ranging from perfect matches to 7 mismatches are considered for guides ranging in length from 17 to 24. Once the off-target sites are computationally determined, an aggregate score is calculated for each guide and summarized in a tabular output using a web-interface. In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available RepeatMasker program. RepeatMasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence.

Following identification, gRNAs were ranked into tiers based on their distance to the target site, their orthogonality and presence of a 5′ G (based on identification of close matches in the human genome containing a relavant PAM (e.g., in the case of S. pyogenes, a NGG PAM, in the case of S. aureus, a NNGRRT or NNGRRV PAM, and in the case of N. meningitidis, a NNNNGATT or NNNNGCTT PAM). Orthogonality refers to the number of sequences in the human genome that contain a minimum number of mismatches to the target sequence. A “high level of orthogonality” or “good orthogonality” may, for example, refer to 20-mer gRNAs that have no identical sequences in the human genome besides the intended target, nor any sequences that contain one or two mismatches in the target sequence. Targeting domains with good orthogonality are selected to minimize off-target DNA cleavage.

As an example, for S. pyogenes and N. meningitidis targets, 17-mer, or 20-mer gRNAs were designed. As another example, for S. aureus targets, 18-mer, 19-mer, 20-mer, 21-mer, 22-mer, 23-mer and 24-mer gRNAs were designed. Targeting domains, disclosed herein, may comprise the 17-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 18 or more nucleotides may comprise the 17-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 18-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 19 or more nucleotides may comprise the 18-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 19-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 20 or more nucleotides may comprise the 19-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 20-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 21 or more nucleotides may comprise the 20-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 21-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 22 or more nucleotides may comprise the 21-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 22-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 23 or more nucleotides may comprise the 22-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 23-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 24 or more nucleotides may comprise the 23-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. Targeting domains, disclosed herein, may comprises the 24-mer described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, e.g., the targeting domains of 25 or more nucleotides may comprise the 24-mer gRNAs described in Tables 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D. gRNAs were identified for both single-gRNA nuclease cleavage and for a dual-gRNA paired “nickase” strategy. Criteria for selecting gRNAs and the determination for which gRNAs can be used for the dual-gRNA paired “nickase” strategy is based on two considerations:

• • 1. gRNA pairs should be oriented on the DNA such that PAMs are facing out and cutting with the D10A Cas9 nickase will result in 5′ overhangs.
  • 2. An assumption that cleaving with dual nickase pairs will result in deletion of the entire intervening sequence at a reasonable frequency. However, cleaving with dual nickase pairs can also result in indel mutations at the site of only one of the gRNAs. Candidate pair members can be tested for how efficiently they remove the entire sequence versus causing indel mutations at the site of one gRNA.
    The targeting domains discussed herein can be incorporated into the gRNAs described herein.

In an embodiment, gRNAs were identified and ranked into 4 tiers for S. pyogenes (Tables 31A-31D or 34A-34D), and N. meningitidis (Tables 33A-33B or 36A-36D); and 4 tiers for S. aureus (Tables 32A-32D or 35A-35D). For S. pyogenes, and N. meningitidis, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G), (2) a high level of orthogonality and (3) the presence of 5′G. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G) and (2) a high level of orthogonality. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G) and (2) the presence of 5′G. The targeting domain for tier 4 gRNA molecules were selected based on distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G). For S. aureus, the targeting domain for tier 1 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G), (2) a high level of orthogonality, (3) the presence of 5′G and (4) PAM is NNGRRT. The targeting domain for tier 2 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G), (2) a high level of orthogonality, and (3) PAM is NNGRRT. The targeting domain for tier 3 gRNA molecules were selected based on (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G) and (2) PAM is NNGRRT. The targeting domain for tier 4 gRNA molecules were selected based on (1) (1) distance to a target site, e.g., within 500 bp, e.g., within 200 bp from a mutation (e.g., 3849+10kbC->T or 3272-26A->G) and (2) PAM is NNGRRV. Note that tiers are non-inclusive (each gRNA is listed only once for the strategy). In certain instances, no gRNA was identified based on the criteria of the particular tier.

Strategies to Identify gRNAs for S. pyogenes, S. aureus, and N. for Targeting an Intronic Region (e.g., Intron 2 or Intron 10) of the CFTR Gene (e.g., Mediated by cDNA)

Guide RNAs (gRNAs) for use with S. pyogenes, S. aureus and N. meningitidis Cas9s were identified using a DNA sequence searching algorithm. Guide RNA design was carried out using a custom guide RNA design software based on the public tool cas-offinder (reference:Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics. 2014 Feb. 17. Bae S, Park J, Kim J S. PMID:24463181). Said custom guide RNA design software scores guides after calculating their genomewide off-target propensity. Typically matches ranging from perfect matches to 7 mismatches are considered for guides ranging in length from 17 to 24. Once the off-target sites are computationally determined, an aggregate score is calculated for each guide and summarized in a tabular output using a web-interface. In addition to identifying potential gRNA sites adjacent to PAM sequences, the software also identifies all PAM adjacent sequences that differ by 1, 2, 3 or more nucleotides from the selected gRNA sites. Genomic DNA sequence for each gene was obtained from the UCSC Genome browser and sequences were screened for repeat elements using the publically available RepeatMasker program. RepeatMasker searches input DNA sequences for repeated elements and regions of low complexity. The output is a detailed annotation of the repeats present in a given query sequence.

Following identification, gRNAs were ranked into tiers based on their distance to the target site, their orthogonality and presence of a 5′ G (based on identification of close matches in the human genome containing a relavant PAM (e.g., in the case of S. pyogenes, a NGG PAM, in the case of S. aureus, a NNGRRT or NNGRRV PAM, and in the case of N. meningitidis, a NNNNGATT or NNNNGCTT PAM). Orthogonality refers to the number of sequences in the human genome that contain a minimum number of mismatches to the target sequence. A “high level of orthogonality” or “good orthogonality” may, for example, refer to 20-mer gRNAs that have no identical sequences in the human genome besides the intended target, nor any sequences that contain one or two mismatches in the target sequence. Targeting domains with good orthogonality are selected to minimize off-target DNA cleavage.

As an example, for S. pyogenes and N. meningitidis targets, 17-mer, or 20-mer gRNAs were designed. As another example, for S. aureus targets, 18-mer, 19-mer, 20-mer, 21-mer, 22-mer, 23-mer and 24-mer gRNAs were designed. Targeting domains, disclosed herein, may comprise the 17-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 18 or more nucleotides may comprise the 17-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 18-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 19 or more nucleotides may comprise the 18-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 19-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 20 or more nucleotides may comprise the 19-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 20-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 21 or more nucleotides may comprise the 20-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 21-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 22 or more nucleotides may comprise the 21-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 22-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 23 or more nucleotides may comprise the 22-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 23-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 24 or more nucleotides may comprise the 23-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. Targeting domains, disclosed herein, may comprises the 24-mer described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D, e.g., the targeting domains of 25 or more nucleotides may comprise the 24-mer gRNAs described in Tables 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, or 42A-42D. gRNAs were identified for both single-gRNA nuclease cleavage and for a dual-gRNA paired “nickase” strategy. Criteria for selecting gRNAs and the determination for which gRNAs can be used for the dual-gRNA paired “nickase” strategy is based on two considerations:

• • 1. gRNA pairs should be oriented on the DNA such that PAMs are facing out and cutting with the D10A Cas9 nickase will result in 5′ overhangs.
  • 2. An assumption that cleaving with dual nickase pairs will result in deletion of the entire intervening sequence at a reasonable frequency. However, cleaving with dual nickase pairs can also result in indel mutations at the site of only one of the gRNAs. Candidate pair members can be tested for how efficiently they remove the entire sequence versus causing indel mutations at the site of one gRNA.
    The targeting domains discussed herein can be incorporated into the gRNAs described herein.

In an embodiment, gRNAs were identified and ranked into 4 tiers for S. pyogenes (Tables 37A-37D or 40A-40D), and N. meningitidis (Tables 39A-39D or 42A-42D); and 4 tiers for S. aureus (Tables 38A-38E or 41A-41E). For S. pyogenes, and N. meningitidis, the targeting domain for tier 1 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10, (2) a high level of orthogonality and (3) the presence of 5′G. The targeting domain for tier 2 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10 and (2) a high level of orthogonality. The targeting domain for tier 3 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10 and (2) the presence of 5′G. The targeting domain for tier 4 gRNA molecules were selected based on target position, e.g., intron 2 or intron 10. For S. aureus, the targeting domain for tier 1 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10, (2) a high level of orthogonality, (3) the presence of 5′G and (4) PAM is NNGRRT. The targeting domain for tier 2 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10, (2) a high level of orthogonality, and (3) PAM is NNGRRT. The targeting domain for tier 3 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10, (2) the presence of a 5′G and (2) PAM is NNGRRT. The targeting domain for tier 4 gRNA molecules were selected based on (1) target position, e.g., intron 2 or intron 10 and (2) PAM is NNGRRT. The targeting domain for tier 5 gRNA molecules were selected based on (1) (1) target position, e.g., intron 2 or intron 10 and (2) PAM is NNGRRV. Note that tiers are non-inclusive (each gRNA is listed only once for the strategy). In certain instances, no gRNA was identified based on the criteria of the particular tier.

In an embodiment, two or more (e.g., three or four) gRNA molecules are used with one Cas9 molecule. In another embodiment, when two or more (e.g., three or four) gRNAs are used with two or more Cas9 molecules, at least one Cas9 molecule is from a different species than the other Cas9 molecule(s). For example, when two gRNA molecules are used with two Cas9 molecules, one Cas9 molecule can be from one species and the other Cas9 molecule can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

Any of the targeting domains in the tables described herein can be used with a Cas9 nickase molecule to generate a single strand break.

Any of the targeting domains in the tables described herein can be used with a Cas9 nuclease molecule to generate a double strand break.

When two gRNAs designed for use to target two Cas9 molecules, one Cas9 can be one species, the second Cas9 can be from a different species. Both Cas9 species are used to generate a single or double-strand break, as desired.

It is contemplated herein that any upstream gRNA described herein may be paired with any downstream gRNA described herein. When an upstream gRNA designed for use with one species of Cas9 is paired with a downstream gRNA designed for use from a different species of Cas9, both Cas9 species are used to generate a single or double-strand break, as desired.

Exemplary Targeting Domains

Table 1A provides exemplary targeting domains for the F508del target position in the CFTR gene selected according to the first tier parameters. The targeting domains are selected based on close proximity to mutation and orthogonality in the human genome. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp. In an embodiment, two 17-mer RNAs are used to target two Cas9 nucleases or two Cas9 nickases, e.g., CFTR-18 and CFTR-16 are used.

TABLE A
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-1	−	GAGGGUAAAAUUAAGCACAG	20	387
CFTR-6	+	AGUUUCUUACCUCUUCUAGU	20	388
CFTR-10	+	AAUGGUGCCAGGCAUAAUCC	20	389
CFTR-12	−	GGUAAAAUUAAGCACAG	17	390
CFTR-16	−	AGCAUGCCAACUAGAAG	17	391
CFTR-18	+	GUAUCUAUAUUCAUCAU	17	392

Table 1B provides exemplary targeting domains for the F508del target position in the CFTR gene selected according to the second tier parameters. The targeting domains are selected based on the presence of a 5′ G and reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 1B
			Tar-
			get
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-19	+	GAUGAUAUUUUCUUUAA	17	393
CFTR-21	+	GGUGCCAGGCAUAAUCC	17	394
CFTR-24	-	GAUAAUGACCUAAUAAUGAU	20	395
CFTR-29	-	GGGAGAACUGGAGCCUUCAG	20	396
CFTR-30	-	GGAGAACUGGAGCCUUCAGA	20	397
CFTR-37	+	GUAGACUAACCGAUUGAAUA	20	398
CFTR-44	+	GUCAUUAUCAAAUCACGCUC	20	399
CFTR-50	-	GGUGAUUAUGGGAGAAC	17	400
CFTR-52	-	GAACUGGAGCCUUCAGA	17	401
CFTR-57	-	GGGUAAGCUACUGUGAA	17	402
CFTR-59	+	GACUAACCGAUUGAAUA	17	403
CFTR-60	+	GAGCCAAAUAUAUAAUU	17	404

Table 1C provides exemplary targeting domains for the F508del target position in the CFTR gene selected according to the third tier parameters. The targeting domains are selected based on reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 1C
			Target
gRNA	DNA		Site	Seq
Name	Strand	Targeting Domain	Length	ID
CFTR-2	-	CAUUCUGUUCUCAGUUUUCC	20	405
CFTR-3	-	CAGUUUUCCUGGAUUAUGCC	20	406
CFTR-4	-	AUUAAAGAAAAUAUCAUCUU	20	407
CFTR-5	-	CAAAGCAUGCCAACUAGAAG	20	408
CFTR-6	+	AGUUUCUUACCUCUUCUAGU	20	388
CFTR-7	+	UCUGUAUCUAUAUUCAUCAU	20	409
CFTR-8	+	AAAGAUGAUAUUUUCUUUAA	20	410
CFTR-9	+	AUAUUUUCUUUAAUGGUGCC	20	411
CFTR-10	+	AAUGGUGCCAGGCAUAAUCC	20	389
CFTR-11	+	UGCUUAAUUUUACCCUCUGA	20	412
CFTR-13	-	UCUGUUCUCAGUUUUCC	17	413
CFTR-14	-	UUUUCCUGGAUUAUGCC	17	414
CFTR-15	-	AAAGAAAAUAUCAUCUU	17	415
CFTR-16	-	AGCAUGCCAACUAGAAG	17	391
CFTR-17	+	UUCUUACCUCUUCUAGU	17	416
CFTR-20	+	UUUUCUUUAAUGGUGCC	17	417
CFTR-22	+	UUAAUUUUACCCUCUGA	17	418
CFTR-23	-	UGAUAAUGACCUAAUAAUGA	20	419
CFTR-25	-	UUUCCAGACUUCACUUCUAA	20	420
CFTR-26	-	UUCACUUCUAAUGGUGAUUA	20	421
CFTR-27	-	UCACUUCUAAUGGUGAUUAU	20	422
CFTR-28	-	AAUGGUGAUUAUGGGAGAAC	20	423
CFTR-31	-	CACUACCCAAAUUAUAUAUU	20	424
CFTR-32	-	UAUUUGGCUCCAUAUUCAAU	20	425
CFTR-33	-	AUAUAUUUAUGUUUCCUCUA	20	426
CFTR-34	-	UAUAUUUAUGUUUCCUCUAU	20	427
CFTR-35	-	UAUGGGUAAGCUACUGUGAA	20	428
CFTR-36	+	UCACAGUAGCUUACCCAUAG	20	429
CFTR-38	+	AUGGAGCCAAAUAUAUAAUU	20	430
CFTR-39	+	UGGAGCCAAAUAUAUAAUUU	20	431
CFTR-40	+	AUAUAAUUUGGGUAGUGUGA	20	432
CFTR-41	+	UAUAAUUUGGGUAGUGUGAA	20	433
CFTR-42	+	UCACCAUUAGAAGUGAAGUC	20	434
CFTR-43	+	AAAUAAAACCCAUCAUUAUU	20	435
CFTR-45	-	UAAUGACCUAAUAAUGA	17	436
CFTR-46	-	AAUGACCUAAUAAUGAU	17	437
CFTR-47	-	CCAGACUUCACUUCUAA	17	438
CFTR-48	-	ACUUCUAAUGGUGAUUA	17	439
CFTR-49	-	CUUCUAAUGGUGAUUAU	17	440
CFTR-51	-	AGAACUGGAGCCUUCAG	17	441
CFTR-53	-	UACCCAAAUUAUAUAUU	17	442
CFTR-54	-	UUGGCUCCAUAUUCAAU	17	443
CFTR-55	-	UAUUUAUGUUUCCUCUA	17	444
CFTR-56	-	AUUUAUGUUUCCUCUAU	17	445
CFTR-58	+	CAGUAGCUUACCCAUAG	17	446
CFTR-61	+	AGCCAAAUAUAUAAUUU	17	447
CFTR-62	+	UAAUUUGGGUAGUGUGA	17	448
CFTR-63	+	AAUUUGGGUAGUGUGAA	17	449
CFTR-64	+	CCAUUAGAAGUGAAGUC	17	450
CFTR-65	+	UAAAACCCAUCAUUAUU	17	451
CFTR-66	+	AUUAUCAAAUCACGCUC	17	452

Table 1D provides exemplary targeting domains for the F508del target position in the CFTR gene selected based on reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. aureus Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. aureus Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 1D
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-111	-	UAAUUGGAGGCAAGUGAAUC	20	655
CFTR-112	-	UUGAUAAUGACCUAAUAAUG	20	656
CFTR-113	-	CUUCACUUCUAAUGGUGAUU	20	657
CFTR-26	-	UUCACUUCUAAUGGUGAUUA	20	421
CFTR-27	-	UCACUUCUAAUGGUGAUUAU	20	422
CFTR-116	-	ACUUCUAAUGGUGAUUAUGG	20	658
CFTR-117	-	UAAUGGUGAUUAUGGGAGAA	20	659
CFTR-28	-	AAUGGUGAUUAUGGGAGAAC	20	423
CFTR-119	-	UAUGGGAGAACUGGAGCCUU	20	660
CFTR-120	-	UGGGAGAACUGGAGCCUUCA	20	661
CFTR-121	-	AGAGGGUAAAAUUAAGCACA	20	662
CFTR-1	-	GAGGGUAAAAUUAAGCACAG	20	387
CFTR-123	-	GGUAAAAUUAAGCACAGUGG	20	663
CFTR-124	-	UCAUUCUGUUCUCAGUUUUC	20	664
CFTR-125	-	GAUUAUGCCUGGCACCAUUA	20	665
CFTR-126	-	CAUCUUUGGUGUUUCCUAUG	20	666
CFTR-127	-	UCCUAUGAUGAAUAUAGAUA	20	667
CFTR-128	-	CGUCAUCAAAGCAUGCCAAC	20	668
CFTR-129	-	CAUCAAAGCAUGCCAACUAG	20	669
CFTR-130	-	GCAUGCCAACUAGAAGAGGU	20	670
CFTR-131	-	UAGAAGAGGUAAGAAACUAU	20	671
CFTR-132	-	AAAACUUUUUGAUUAUGCAU	20	672
CFTR-133	-	CAUAUAUUUAUGUUUCCUCU	20	673
CFTR-134	-	UCCUCUAUGGGUAAGCUACU	20	674
CFTR-135	-	CUAUGGGUAAGCUACUGUGA	20	675
CFTR-136	+	GGUCAUUAUCAAAUCACGCU	20	676
CFTR-42	+	UCACCAUUAGAAGUGAAGUC	20	434
CFTR-138	+	AUCACCAUUAGAAGUGAAGU	20	677
CFTR-139	+	UCCCAUAAUCACCAUUAGAA	20	678
CFTR-140	+	AGUUCUCCCAUAAUCACCAU	20	679
CFTR-141	+	ACUGUGCUUAAUUUUACCCU	20	680
CFTR-142	+	CCAGGAAAACUGAGAACAGA	20	681
CFTR-143	+	UAAUCCAGGAAAACUGAGAA	20	682
CFTR-144	+	AGGCAUAAUCCAGGAAAACU	20	683
CFTR-145	+	CCAGGCAUAAUCCAGGAAAA	20	684
CFTR-10	+	AAUGGUGCCAGGCAUAAUCC	20	389
CFTR-147	+	UAAUGGUGCCAGGCAUAAUC	20	685
CFTR-7	+	UCUGUAUCUAUAUUCAUCAU	20	409
CFTR-149	+	UUCUGUAUCUAUAUUCAUCA	20	686
CFTR-150	+	UAUAUAAUUUGGGUAGUGUG	20	687
CFTR-151	+	AAAUAUAUAAUUUGGGUAGU	20	688
CFTR-152	+	UAUGGAGCCAAAUAUAUAAU	20	689
CFTR-37	+	GUAGACUAACCGAUUGAAUA	20	398
CFTR-154	+	UGUAGACUAACCGAUUGAAU	20	690
CFTR-155	+	AAUAUAUGUAGACUAACCGA	20	691
CFTR-36	+	UCACAGUAGCUUACCCAUAG	20	429
CFTR-157	+	UUCACAGUAGCUUACCCAUA	20	692
CFTR-158	+	CAUUCACAGUAGCUUACCCA	20	693
CFTR-159	-	UUGGAGGCAAGUGAAUC	17	694
CFTR-160	-	AUAAUGACCUAAUAAUG	17	695
CFTR-161	-	CACUUCUAAUGGUGAUU	17	696
CFTR-48	-	ACUUCUAAUGGUGAUUA	17	439
CFTR-49	-	CUUCUAAUGGUGAUUAU	17	440
CFTR-164	-	UCUAAUGGUGAUUAUGG	17	697
CFTR-165	-	UGGUGAUUAUGGGAGAA	17	698
CFTR-50	-	GGUGAUUAUGGGAGAAC	17	400
CFTR-167	-	GGGAGAACUGGAGCCUU	17	699
CFTR-168	-	GAGAACUGGAGCCUUCA	17	700
CFTR-169	-	GGGUAAAAUUAAGCACA	17	701
CFTR-12	-	GGUAAAAUUAAGCACAG	17	390
CFTR-171	-	AAAAUUAAGCACAGUGG	17	702
CFTR-172	-	UUCUGUUCUCAGUUUUC	17	703
CFTR-173	-	UAUGCCUGGCACCAUUA	17	704
CFTR-174	-	CUUUGGUGUUUCCUAUG	17	705
CFTR-175	-	UAUGAUGAAUAUAGAUA	17	706
CFTR-176	-	CAUCAAAGCAUGCCAAC	17	707
CFTR-177	-	CAAAGCAUGCCAACUAG	17	708
CFTR-178	-	UGCCAACUAGAAGAGGU	17	709
CFTR-179	-	AAGAGGUAAGAAACUAU	17	710
CFTR-180	-	ACUUUUUGAUUAUGCAU	17	711
CFTR-181	-	AUAUUUAUGUUUCCUCU	17	712
CFTR-182	-	UCUAUGGGUAAGCUACU	17	713
CFTR-183	-	UGGGUAAGCUACUGUGA	17	714
CFTR-184	+	CAUUAUCAAAUCACGCU	17	715
CFTR-64	+	CCAUUAGAAGUGAAGUC	17	450
CFTR-186	+	ACCAUUAGAAGUGAAGU	17	716
CFTR-187	+	CAUAAUCACCAUUAGAA	17	717
CFTR-188	+	UCUCCCAUAAUCACCAU	17	718
CFTR-189	+	GUGCUUAAUUUUACCCU	17	719
CFTR-190	+	GGAAAACUGAGAACAGA	17	720
CFTR-191	+	UCCAGGAAAACUGAGAA	17	721
CFTR-192	+	CAUAAUCCAGGAAAACU	17	722
CFTR-193	+	GGCAUAAUCCAGGAAAA	17	723
CFTR-21	+	GGUGCCAGGCAUAAUCC	17	394
CFTR-195	+	UGGUGCCAGGCAUAAUC	17	724
CFTR-18	+	GUAUCUAUAUUCAUCAU	17	392
CFTR-197	+	UGUAUCUAUAUUCAUCA	17	725
CFTR-198	+	AUAAUUUGGGUAGUGUG	17	726
CFTR-199	+	UAUAUAAUUUGGGUAGU	17	727
CFTR-200	+	GGAGCCAAAUAUAUAAU	17	728
CFTR-59	+	GACUAACCGAUUGAAUA	17	403
CFTR-202	+	AGACUAACCGAUUGAAU	17	729
CFTR-203	+	AUAUGUAGACUAACCGA	17	730
CFTR-58	+	CAGUAGCUUACCCAUAG	17	446
CFTR-205	+	ACAGUAGCUUACCCAUA	17	731
CFTR-206	+	UCACAGUAGCUUACCCA	17	732

Table 1E provides exemplary targeting domains for the F508del target position in the CFTR gene selected based on reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using N. meningitidis Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE lE
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-207	-	UGGAGGCAAGUGAAUCCUGA	20	917
CFTR-25	-	UUUCCAGACUUCACUUCUAA	20	420
CFTR-209	-	UUCAUUCUGUUCUCAGUUUU	20	918
CFTR-210	-	UAAGAAACUAUGUGAAAACU	20	919
CFTR-211	+	AGGUCAUUAUCAAAUCACGC	20	920
CFTR-212	+	AACAUAAAUAUAUGUAGACU	20	921
CFTR-213	-	AGGCAAGUGAAUCCUGA	17	922
CFTR-47	-	CCAGACUUCACUUCUAA	17	438
CFTR-215	-	AUUCUGUUCUCAGUUUU	17	923
CFTR-216	-	GAAACUAUGUGAAAACU	17	924
CFTR-217	+	UCAUUAUCAAAUCACGC	17	925
CFTR-218	+	AUAAAUAUAUGUAGACU	17	926

Table 2A provides exemplary targeting domains for the G55D target position in the CFTR gene selected according to the first tier parameters. The targeting domains are selected based close proximity to mutation and orthogonality in the human genome. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 2A
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-71	-	GAGAAAGACAAUAUAGUUCU	20	453
CFTR-75	-	GGUGGAAUCACACUGAGUGG	20	454
CFTR-86	+	CCCACUAGCCAUAAAACCCC	20	455
CFTR-96	-	GGUGGAAUCACACUGAG	17	456
CFTR-97	-	GGAAUCACACUGAGUGG	17	457
CFTR-106	-	GGGGUUUUAUGGCUAGU	17	458
CFTR-108	+	ACUAGCCAUAAAACCCC	17	459

Table 2B provides exemplary targeting domains for the G551D target position in the CFTR gene selected according to the second tier parameters. The targeting domains are selected based on the presence of a 5′ G and reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 2B
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-72	-	GACAAUAUAGUUCUUGGAGA	20	460
CFTR-74	-	GAAGGUGGAAUCACACUGAG	20	461
CFTR-76	-	GAGCAAGAAUUUCUUUAGCA	20	462
CFTR-82	-	GAAAAAAUCCUGGGGUUUUA	20	463
CFTR-89	-	GUUCAAAAUUUCAACUG	17	464
CFTR-99	-	GGUGAAUAACUAAUUAU	17	465
CFTR-100	-	GCUUUAUAUUCUGUUUC	17	466
CFTR-102	-	GGAAUUGAAAAAAUCCU	17	467
CFTR-103	-	GAAUUGAAAAAAUCCUG	17	468
CFTR-109	+	GUCUUUCUCUGCAAACU	17	469

Table 2C provides exemplary targeting domains for the G551D target position in the CFTR gene selected according to the third tier parameters. The targeting domains are selected based on reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 2C
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-67	-	AAUGUUCAAAAUUUCAACUG	20	470
CFTR-68	-	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-69	-	ACUCUCUAAUUUUCUAUUUU	20	472
CFTR-70	-	AAUUUUCUAUUUUUGGUAAU	20	473
CFTR-73	-	AAUAUAGUUCUUGGAGAAGG	20	474
CFTR-77	-	CAAGGUGAAUAACUAAUUAU	20	475
CFTR-78	-	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-79	-	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-80	-	UCUGGAAUUGAAAAAAUCCU	20	478
CFTR-81	-	CUGGAAUUGAAAAAAUCCUG	20	479
CFTR-83	-	UCCUGGGGUUUUAUGGCUAG	20	480
CFTR-84	-	CCUGGGGUUUUAUGGCUAGU	20	481
CFTR-85	-	CAUUUAAGAACUAUAAAUAA	20	482
CFTR-87	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-88	+	AUGCUCAAUCUGAAUUUGAA	20	484
CFTR-90	-	UAUAUGAUUACAUUAGA	17	485
CFTR-91	-	CUCUAAUUUUCUAUUUU	17	486
CFTR-92	-	UUUCUAUUUUUGGUAAU	17	487
CFTR-93	-	AAAGACAAUAUAGUUCU	17	488
CFTR-94	-	AAUAUAGUUCUUGGAGA	17	489
CFTR-95	-	AUAGUUCUUGGAGAAGG	17	490
CFTR-98	-	CAAGAAUUUCUUUAGCA	17	491
CFTR-101	-	UGGAAUUGAAAAAAUCC	17	492
CFTR-104	-	AAAAUCCUGGGGUUUUA	17	493
CFTR-105	-	UGGGGUUUUAUGGCUAG	17	494
CFTR-107	-	UUAAGAACUAUAAAUAA	17	495
CFTR-110	+	CUCAAUCUGAAUUUGAA	17	496

Table 2D provides exemplary targeting domains for the G551D target position in the CFTR gene selected based on reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. aureus Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. aureus Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 2D
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-219	-	AGUGUGAUAUAUGAUUACAU	20	733
CFTR-220	-	GUGAUAUAUGAUUACAUUAG	20	734
CFTR-68	-	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-222	-	AUGUGCCUUUCAAAUUCAGA	20	735
CFTR-223	-	UAAUUUUCUAUUUUUGGUAA	20	736
CFTR-224	-	AUAGGACAUCUCCAAGUUUG	20	737
CFTR-225	-	AGGACAUCUCCAAGUUUGCA	20	738
CFTR-226	-	AGAGAAAGACAAUAUAGUUC	20	739
CFTR-71	-	GAGAAAGACAAUAUAGUUCU	20	453
CFTR-228	-	GAAAGACAAUAUAGUUCUUG	20	740
CFTR-229	-	CAAUAUAGUUCUUGGAGAAG	20	741
CFTR-73	-	AAUAUAGUUCUUGGAGAAGG	20	474
CFTR-231	-	UUGGAGAAGGUGGAAUCACA	20	742
CFTR-232	-	AGAAGGUGGAAUCACACUGA	20	743
CFTR-74	-	GAAGGUGGAAUCACACUGAG	20	461
CFTR-234	-	AUCACACUGAGUGGAGGUCA	20	744
CFTR-235	-	CUGAGUGGAGGUCAACGAGC	20	745
CFTR-236	-	GCAAGAAUUUCUUUAGCAAG	20	746
CFTR-237	-	UAUUGCUUUAUAUUCUGUUU	20	747
CFTR-78	-	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-239	-	UUUAUAUUCUGUUUCUGGAA	20	748
CFTR-240	-	UUUCUGGAAUUGAAAAAAUC	20	749
CFTR-79	-	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-242	-	AUCCUGGGGUUUUAUGGCUA	20	750
CFTR-243	-	GGUUUUAUGGCUAGUGGGUU	20	751
CFTR-244	-	GUGGGUUAAGAAUCACAUUU	20	752
CFTR-245	+	CUUUAACCACAGUUGAAAUU	20	753
CFTR-246	+	CACUAUUGCUUUAACCACAG	20	754
CFTR-247	+	UUAGUAUGCUCAAUCUGAAU	20	755
CFTR-248	+	UCACUUUUAGUAUGCUCAAU	20	756
CFTR-249	+	UUACCAAAAAUAGAAAAUUA	20	757
CFTR-250	+	UAUUACCAAAAAUAGAAAAU	20	758
CFTR-251	+	AGAUGUCCUAUUACCAAAAA	20	759
CFTR-87	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-253	+	UAUUGUCUUUCUCUGCAAAC	20	760
CFTR-254	+	AGUGUGAUUCCACCUUCUCC	20	761
CFTR-255	+	AUUAGUUAUUCACCUUGCUA	20	762
CFTR-256	+	AAUGUCUGUAAUUUUUUUAC	20	763
CFTR-257	+	AAACAGAAUAUAAAGCAAUA	20	764
CFTR-258	+	AGAAACAGAAUAUAAAGCAA	20	765
CFTR-259	+	GAUUUUUUCAAUUCCAGAAA	20	766
CFTR-260	+	CCCCAGGAUUUUUUCAAUUC	20	767
CFTR-261	-	GUGAUAUAUGAUUACAU	17	768
CFTR-262	-	AUAUAUGAUUACAUUAG	17	769
CFTR-90	-	UAUAUGAUUACAUUAGA	17	485
CFTR-264	-	UGCCUUUCAAAUUCAGA	17	770
CFTR-265	-	UUUUCUAUUUUUGGUAA	17	771
CFTR-266	-	GGACAUCUCCAAGUUUG	17	772
CFTR-267	-	ACAUCUCCAAGUUUGCA	17	773
CFTR-268	-	GAAAGACAAUAUAGUUC	17	774
CFTR-93	-	AAAGACAAUAUAGUUCU	17	488
CFTR-270	-	AGACAAUAUAGUUCUUG	17	775
CFTR-271	-	UAUAGUUCUUGGAGAAG	17	776
CFTR-95	-	AUAGUUCUUGGAGAAGG	17	490
CFTR-273	-	GAGAAGGUGGAAUCACA	17	777
CFTR-274	-	AGGUGGAAUCACACUGA	17	778
CFTR-96	-	GGUGGAAUCACACUGAG	17	456
CFTR-276	-	ACACUGAGUGGAGGUCA	17	779
CFTR-277	-	AGUGGAGGUCAACGAGC	17	780
CFTR-278	-	AGAAUUUCUUUAGCAAG	17	781
CFTR-279	-	UGCUUUAUAUUCUGUUU	17	782
CFTR-100	-	GCUUUAUAUUCUGUUUC	17	466
CFTR-281	-	AUAUUCUGUUUCUGGAA	17	783
CFTR-282	-	CUGGAAUUGAAAAAAUC	17	784
CFTR-101	-	UGGAAUUGAAAAAAUCC	17	492
CFTR-284	-	CUGGGGUUUUAUGGCUA	17	785
CFTR-285	-	UUUAUGGCUAGUGGGUU	17	786
CFTR-286	-	GGUUAAGAAUCACAUUU	17	787
CFTR-287	+	UAACCACAGUUGAAAUU	17	788
CFTR-288	+	UAUUGCUUUAACCACAG	17	789
CFTR-289	+	GUAUGCUCAAUCUGAAU	17	790
CFTR-290	+	CUUUUAGUAUGCUCAAU	17	791
CFTR-291	+	CCAAAAAUAGAAAAUUA	17	792
CFTR-292	+	UACCAAAAAUAGAAAAU	17	793
CFTR-293	+	UGUCCUAUUACCAAAAA	17	794
CFTR-109	+	GUCUUUCUCUGCAAACU	17	469
CFTR-295	+	UGUCUUUCUCUGCAAAC	17	795
CFTR-296	+	GUGAUUCCACCUUCUCC	17	796
CFTR-297	+	AGUUAUUCACCUUGCUA	17	797
CFTR-298	+	GUCUGUAAUUUUUUUAC	17	798
CFTR-299	+	CAGAAUAUAAAGCAAUA	17	799
CFTR-300	+	AACAGAAUAUAAAGCAA	17	800
CFTR-301	+	UUUUUCAAUUCCAGAAA	17	801
CFTR-302	+	CAGGAUUUUUUCAAUUC	17	802

Table 2E provides exemplary targeting domains for the G551D target position in the CFTR gene selected based on reasonable proximity to mutation. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using N. meningitidis Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 2E
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-303	-	GGUUAAAGCAAUAGUGUGAU	20	927
CFTR-304	-	AGGAAGAUGUGCCUUUCAAA	20	928
CFTR-305	+	UGCUCGUUGACCUCCACUCA	20	929
CFTR-306	+	AACCCACUAGCCAUAAAACC	20	930
CFTR-307	+	CCAUUAUUUAUAGUUCUUAA	20	931
CFTR-308	-	UAAAGCAAUAGUGUGAU	17	932
CFTR-309	-	AAGAUGUGCCUUUCAAA	17	933
CFTR-310	+	UCGUUGACCUCCACUCA	17	934
CFTR-311	+	CCACUAGCCAUAAAACC	17	935
CFTR-312	+	UUAUUUAUAGUUCUUAA	17	936

Table 3A provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the first tier parameters. The targeting domains are selected based close proximity to start codon and orthogonality in the human genome. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp. In an embodiment, two 20-mer RNAs are used to target two Cas9 nucleases or two Cas9 nickases, e.g., SCNN5A-78 and SCNN1A-9 are used.

TABLE 3A
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-2	-	GCCCAUACCAGGUCUCAUGG	20	497
SCNN1A-4	-	CCAUACCAGGUCUCAUGGAG	20	498
SCNN1A-9	-	GCCCUCCACAGUCCACUCCA	20	499
SCNN1A-78	+	CCCCUCCAUGAGACCUGGUA	20	500
SCNN1A-82	-	AUACCAGGUCUCAUGGA	17	501
SCNN1A-157	+	CUCCAUGAGACCUGGUA	17	502

Table 3B provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the second tier parameters. The targeting domains are selected based on the presence of a 5′ G and reasonable proximity to start codon. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp. In an embodiment, two 20-mer RNAs are used to target two Cas9 nucleases or two Cas9 nickases, e.g., SCNN2A-78 and SCNN1A-9 are used.

TABLE 3B
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-1	-	GCAGCCCAUACCAGGUCUCA	20	503
SCNN1A-7	-	GGGGAACAAGCUGGAGGAGC	20	504
SCNN1A-10	-	GUCCACUCCAGGGCUCAUGA	20	505
SCNN1A-14	-	GGGGAACAAGCGUGAGGAGC	20	506
SCNN1A-15	-	GGGAACAAGCGUGAGGAGCA	20	507
SCNN1A-16	-	GGAACAAGCGUGAGGAGCAG	20	508
SCNN1A-19	-	GGGGCUGGGCCCCGAACCUG	20	509
SCNN1A-21	-	GGCGCCCCAGCAGCCCACGG	20	510
SCNN1A-22	-	GCCCCAGCAGCCCACGGCGG	20	511
SCNN1A-24	-	GCAGCCCACGGCGGAGGAGG	20	512
SCNN1A-31	-	GUGCUGUGGCUCUGCACCUU	20	513
SCNN1A-32	-	GCACCUUUGGCAUGAUGUAC	20	514
SCNN1A-33	-	GGCAUGAUGUACUGGCAAUU	20	515
SCNN1A-36	+	GUAGGGAUUGAGGGUGCAGA	20	516
SCNN1A-37	+	GAGGGUGCAGAUGGUCACUG	20	517
SCNN1A-39	+	GGGUGCAGAUGGUCACUGCG	20	518
SCNN1A-42	+	GAGGUUGAUGUUGAGGCUGA	20	519
SCNN1A-44	+	GGUUGAUGUUGAGGCUGACG	20	520
SCNN1A-47	+	GAGCCACAGCACUGCCCAGA	20	521
SCNN1A-51	+	GGUUGUGCUGGGAGCACACC	20	522
SCNN1A-56	+	GCGGAUGGCGCCGUGGAUGG	20	523
SCNN1A-58	+	GAACUCGAAGAGCUCUCGGU	20	524
SCNN1A-62	+	GGAGCGGUGGAACUCGAUCA	20	525
SCNN1A-68	+	GUGGGCUGCUGGGGCGCCGC	20	526
SCNN1A-71	+	GCUGGGGCGCCGCAGGUUCG	20	527
SCNN1A-76	+	GCCCUGGAGUGGACUGUGGA	20	528
SCNN1A-80	-	GCCCAUACCAGGUCUCA	17	529
SCNN1A-85	-	GGAGGGGAACAAGCUGG	17	530
SCNN1A-86	-	GAACAAGCUGGAGGAGC	17	531
SCNN1A-92	-	GAAGGGGAACAAGCGUG	17	532
SCNN1A-93	-	GAACAAGCGUGAGGAGC	17	533
SCNN1A-96	-	GCGUGAGGAGCAGGGGC	17	534
SCNN1A-98	-	GCUGGGCCCCGAACCUG	17	535
SCNN1A-99	-	GGCGCCCCAGCAGCCCA	17	536
SCNN1A-100	-	GCCCCAGCAGCCCACGG	17	537
SCNN1A-102	-	GCAGCCCACGGCGGAGG	17	538
SCNN1A-103	-	GCCCACGGCGGAGGAGG	17	539
SCNN1A-106	-	GCACAACCGCAUGAAGA	17	540
SCNN1A-107	-	GCAUGAAGACGGCCUUC	17	541
SCNN1A-115	+	GGGAUUGAGGGUGCAGA	17	542
SCNN1A-116	+	GGUGCAGAUGGUCACUG	17	543
SCNN1A-117	+	GUGCAGAUGGUCACUGC	17	544
SCNN1A-121	+	GUUGAUGUUGAGGCUGA	17	545
SCNN1A-131	+	GCUGGGAGCACACCAGG	17	546
SCNN1A-132	+	GGAGCACACCAGGCGGA	17	547
SCNN1A-134	+	GCGGAUGGCGCCGUGGA	17	548
SCNN1A-135	+	GAUGGCGCCGUGGAUGG	17	549
SCNN1A-139	+	GCUCUCGGUAGGAGCGG	17	550
SCNN1A-141	+	GCGGUGGAACUCGAUCA	17	551
SCNN1A-142	+	GGCCUCCUCCUCCGCCG	17	552
SCNN1A-143	+	GCCUCCUCCUCCGCCGU	17	553
SCNN1A-147	+	GGCUGCUGGGGCGCCGC	17	554
SCNN1A-150	+	GGGGCGCCGCAGGUUCG	17	555

Table 3C provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the third tier parameters. The targeting domains are selected based on reasonable proximity to start codon. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. pyogenes Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. pyogenes Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp. In an embodiment, two 20-mer RNAs are used to target two Cas9 nucleases or two Cas9 nickases, e.g., SCNN1A-78 and SCNN1A-9 are used.

TABLE 3C
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-3	-	CCCAUACCAGGUCUCAUGGA	20	556
SCNN1A-5	-	UCUCAUGGAGGGGAACAAGC	20	557
SCNN1A-6	-	CAUGGAGGGGAACAAGCUGG	20	558
SCNN1A-8	-	AGCCCUCCACAGUCCACUCC	20	559
SCNN1A-11	-	UCCACUCCAGGGCUCAUGAA	20	560
SCNN1A-12	-	CCACUCCAGGGCUCAUGAAG	20	561
SCNN1A-13	-	CAUGAAGGGGAACAAGCGUG	20	562
SCNN1A-17	-	CAAGCGUGAGGAGCAGGGGC	20	563
SCNN1A-18	-	AAGCGUGAGGAGCAGGGGCU	20	564
SCNN1A-20	-	UGCGGCGCCCCAGCAGCCCA	20	565
SCNN1A-23	-	CCAGCAGCCCACGGCGGAGG	20	566
SCNN1A-25	-	UGCAACAACACCACCAUCCA	20	567
SCNN1A-26	-	CAUCCACGGCGCCAUCCGCC	20	568
SCNN1A-27	-	CCAGCACAACCGCAUGAAGA	20	569
SCNN1A-28	-	ACCGCAUGAAGACGGCCUUC	20	570
SCNN1A-29	-	CCGCAUGAAGACGGCCUUCU	20	571
SCNN1A-30	-	CGGCCUUCUGGGCAGUGCUG	20	572
SCNN1A-34	-	UGGCAAUUCGGCCUGCUUUU	20	573
SCNN1A-35	-	CCUCAACAUCAACCUCAACU	20	574
SCNN1A-38	+	AGGGUGCAGAUGGUCACUGC	20	575
SCNN1A-40	+	AGACGAGCUUGUCCGAGUUG	20	576
SCNN1A-41	+	CCGAGUUGAGGUUGAUGUUG	20	577
SCNN1A-43	+	AGGUUGAUGUUGAGGCUGAC	20	578
SCNN1A-45	+	UGAAGUACUCUCCGAAAAGC	20	579
SCNN1A-46	+	UUGCCAGUACAUCAUGCCAA	20	580
SCNN1A-48	+	CCCAGAAGGCCGUCUUCAUG	20	581
SCNN1A-49	+	CCGUCUUCAUGCGGUUGUGC	20	582
SCNN1A-50	+	CGUCUUCAUGCGGUUGUGCU	20	583
SCNN1A-52	+	UGUGCUGGGAGCACACCAGG	20	584
SCNN1A-53	+	CUGGGAGCACACCAGGCGGA	20	585
SCNN1A-54	+	ACACCAGGCGGAUGGCGCCG	20	586
SCNN1A-55	+	CAGGCGGAUGGCGCCGUGGA	20	587
SCNN1A-57	+	AGAAGAACUCGAAGAGCUCU	20	588
SCNN1A-59	+	CGAAGAGCUCUCGGUAGGAG	20	589
SCNN1A-60	+	AGAGCUCUCGGUAGGAGCGG	20	590
SCNN1A-61	+	AGGAGCGGUGGAACUCGAUC	20	591
SCNN1A-63	+	CAGGGCCUCCUCCUCCGCCG	20	592
SCNN1A-64	+	AGGGCCUCCUCCUCCGCCGU	20	593
SCNN1A-65	+	CCUCCUCCGCCGUGGGCUGC	20	594
SCNN1A-66	+	CUCCUCCGCCGUGGGCUGCU	20	595
SCNN1A-67	+	UCCUCCGCCGUGGGCUGCUG	20	596
SCNN1A-69	+	CUGCUGGGGCGCCGCAGGUU	20	597
SCNN1A-70	+	UGCUGGGGCGCCGCAGGUUC	20	598
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-73	+	CCCCUUCAUGAGCCCUGGAG	20	600
SCNN1A-74	+	AUGAGCCCUGGAGUGGACUG	20	601
SCNN1A-75	+	AGCCCUGGAGUGGACUGUGG	20	602
SCNN1A-77	+	UUGUUCCCCUCCAUGAGACC	20	603
SCNN1A-79	+	CCCUCCAUGAGACCUGGUAU	20	604
SCNN1A-81	-	CAUACCAGGUCUCAUGG	17	605
SCNN1A-83	-	UACCAGGUCUCAUGGAG	17	606
SCNN1A-84	-	CAUGGAGGGGAACAAGC	17	607
SCNN1A-87	-	CCUCCACAGUCCACUCC	17	608
SCNN1A-88	-	CUCCACAGUCCACUCCA	17	609
SCNN1A-89	-	CACUCCAGGGCUCAUGA	17	610
SCNN1A-90	-	ACUCCAGGGCUCAUGAA	17	611
SCNN1A-91	-	CUCCAGGGCUCAUGAAG	17	612
SCNN1A-94	-	AACAAGCGUGAGGAGCA	17	613
SCNN1A-95	-	ACAAGCGUGAGGAGCAG	17	614
SCNN1A-97	-	CGUGAGGAGCAGGGGCU	17	615
SCNN1A-101	-	CCAGCAGCCCACGGCGG	17	616
SCNN1A-104	-	AACAACACCACCAUCCA	17	617
SCNN1A-105	-	CCACGGCGCCAUCCGCC	17	618
SCNN1A-108	-	CAUGAAGACGGCCUUCU	17	619
SCNN1A-109	-	CCUUCUGGGCAGUGCUG	17	620
SCNN1A-110	-	CUGUGGCUCUGCACCUU	17	621
SCNN1A-111	-	CCUUUGGCAUGAUGUAC	17	622
SCNN1A-112	-	AUGAUGUACUGGCAAUU	17	623
SCNN1A-113	-	CAAUUCGGCCUGCUUUU	17	624
SCNN1A-114	-	CAACAUCAACCUCAACU	17	625
SCNN1A-118	+	UGCAGAUGGUCACUGCG	17	626
SCNN1A-119	+	CGAGCUUGUCCGAGUUG	17	627
SCNN1A-120	+	AGUUGAGGUUGAUGUUG	17	628
SCNN1A-122	+	UUGAUGUUGAGGCUGAC	17	629
SCNN1A-123	+	UGAUGUUGAGGCUGACG	17	630
SCNN1A-124	+	AGUACUCUCCGAAAAGC	17	631
SCNN1A-125	+	CCAGUACAUCAUGCCAA	17	632
SCNN1A-126	+	CCACAGCACUGCCCAGA	17	633
SCNN1A-127	+	AGAAGGCCGUCUUCAUG	17	634
SCNN1A-128	+	UCUUCAUGCGGUUGUGC	17	635
SCNN1A-129	+	CUUCAUGCGGUUGUGCU	17	636
SCNN1A-130	+	UGUGCUGGGAGCACACC	17	637
SCNN1A-133	+	CCAGGCGGAUGGCGCCG	17	638
SCNN1A-136	+	AGAACUCGAAGAGCUCU	17	639
SCNN1A-137	+	CUCGAAGAGCUCUCGGU	17	640
SCNN1A-138	+	AGAGCUCUCGGUAGGAG	17	641
SCNN1A-140	+	AGCGGUGGAACUCGAUC	17	642
SCNN1A-144	+	CCUCCGCCGUGGGCUGC	17	643
SCNN1A-145	+	CUCCGCCGUGGGCUGCU	17	644
SCNN1A-146	+	UCCGCCGUGGGCUGCUG	17	645
SCNN1A-148	+	CUGGGGCGCCGCAGGUU	17	646
SCNN1A-149	+	UGGGGCGCCGCAGGUUC	17	647
SCNN1A-151	+	UUCCCCUUCAUGAGCCC	17	648
SCNN1A-152	+	CUUCAUGAGCCCUGGAG	17	649
SCNN1A-153	+	AGCCCUGGAGUGGACUG	17	650
SCNN1A-154	+	CCUGGAGUGGACUGUGG	17	651
SCNN1A-155	+	CUGGAGUGGACUGUGGA	17	652
SCNN1A-156	+	UUCCCCUCCAUGAGACC	17	653
SCNN1A-158	+	UCCAUGAGACCUGGUAU	17	654

Table 3D provides exemplary targeting domains for knocking out the SCNN1A gene selected based on reasonable proximity to the start codon. It is contemplated herein that the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that gives double stranded cleavage. Any of the targeting domains in the table can be used with a S. aureus Cas9 single-stranded break nucleases (nickases). In an embodiment, dual targeting is used to create two nicks on opposite DNA strands by using S. aureus Cas9 nickases with two targeting domains that are complementary to opposite DNA strands, e.g., a gRNA comprising any minus strand targeting domain may be paired any gRNA comprising a plus strand targeting domain provided that the two gRNAs are oriented on the DNA such that PAMs face outward and the distance between the 5′ ends of the gRNAs is 0-50 bp.

TABLE 3D
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-159	-	UGCAGCCCAUACCAGGUCUC	20	803
SCNN1A-1	-	GCAGCCCAUACCAGGUCUCA	20	503
SCNN1A-161	-	AGCCCAUACCAGGUCUCAUG	20	804
SCNN1A-2	-	GCCCAUACCAGGUCUCAUGG	20	497
SCNN1A-3	-	CCCAUACCAGGUCUCAUGGA	20	556
SCNN1A-4	-	CCAUACCAGGUCUCAUGGAG	20	498
SCNN1A-165	-	GUCUCAUGGAGGGGAACAAG	20	805
SCNN1A-5	-	UCUCAUGGAGGGGAACAAGC	20	557
SCNN1A-167	-	UCAUGGAGGGGAACAAGCUG	20	806
SCNN1A-6	-	CAUGGAGGGGAACAAGCUGG	20	558
SCNN1A-169	-	AGGGGAACAAGCUGGAGGAG	20	807
SCNN1A-170	-	UAGCCCUCCACAGUCCACUC	20	808
SCNN1A-171	-	CACAGUCCACUCCAGGGCUC	20	809
SCNN1A-172	-	AGUCCACUCCAGGGCUCAUG	20	810
SCNN1A-10	-	GUCCACUCCAGGGCUCAUGA	20	505
SCNN1A-11	-	UCCACUCCAGGGCUCAUGAA	20	560
SCNN1A-12	-	CCACUCCAGGGCUCAUGAAG	20	561
SCNN1A-176	-	GCUCAUGAAGGGGAACAAGC	20	811
SCNN1A-177	-	UCAUGAAGGGGAACAAGCGU	20	812
SCNN1A-13	-	CAUGAAGGGGAACAAGCGUG	20	562
SCNN1A-179	-	AGGGGAACAAGCGUGAGGAG	20	813
SCNN1A-14	-	GGGGAACAAGCGUGAGGAGC	20	506
SCNN1A-181	-	ACAAGCGUGAGGAGCAGGGG	20	814
SCNN1A-182	-	UGAGGAGCAGGGGCUGGGCC	20	815
SCNN1A-183	-	CGGCGCCCCAGCAGCCCACG	20	816
SCNN1A-21	-	GGCGCCCCAGCAGCCCACGG	20	510
SCNN1A-185	-	CGCCCCAGCAGCCCACGGCG	20	817
SCNN1A-22	-	GCCCCAGCAGCCCACGGCGG	20	511
SCNN1A-187	-	CCCAGCAGCCCACGGCGGAG	20	818
SCNN1A-23	-	CCAGCAGCCCACGGCGGAGG	20	566
SCNN1A-189	-	GGCGGAGGAGGAGGCCCUGA	20	819
SCNN1A-190	-	AUCGAGUUCCACCGCUCCUA	20	820
SCNN1A-191	-	CGAGUUCCACCGCUCCUACC	20	821
SCNN1A-192	-	CCGCUCCUACCGAGAGCUCU	20	822
SCNN1A-193	-	UGUGCUCCCAGCACAACCGC	20	823
SCNN1A-194	-	AACCGCAUGAAGACGGCCUU	20	824
SCNN1A-195	-	CUGGCAAUUCGGCCUGCUUU	20	825
SCNN1A-34	-	UGGCAAUUCGGCCUGCUUUU	20	573
SCNN1A-197	-	GCAAUUCGGCCUGCUUUUCG	20	826
SCNN1A-198	-	GCCUCAACAUCAACCUCAAC	20	827
SCNN1A-199	+	UCCCCUCCAUGAGACCUGGU	20	828
SCNN1A-200	+	CCUCCAGCUUGUUCCCCUCC	20	829
SCNN1A-201	+	UGGAGUGGACUGUGGAGGGC	20	830
SCNN1A-202	+	GAGCCCUGGAGUGGACUGUG	20	831
SCNN1A-74	+	AUGAGCCCUGGAGUGGACUG	20	601
SCNN1A-204	+	CAUGAGCCCUGGAGUGGACU	20	832
SCNN1A-205	+	UCCCCUUCAUGAGCCCUGGA	20	833
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-207	+	CUUGUUCCCCUUCAUGAGCC	20	834
SCNN1A-208	+	CCUCACGCUUGUUCCCCUUC	20	835
SCNN1A-69	+	CUGCUGGGGCGCCGCAGGUU	20	597
SCNN1A-210	+	GCUGCUGGGGCGCCGCAGGU	20	836
SCNN1A-65	+	CCUCCUCCGCCGUGGGCUGC	20	594
SCNN1A-212	+	UCCUCCUCCGCCGUGGGCUG	20	837
SCNN1A-213	+	UCAGGGCCUCCUCCUCCGCC	20	838
SCNN1A-214	+	UAGGAGCGGUGGAACUCGAU	20	839
SCNN1A-60	+	AGAGCUCUCGGUAGGAGCGG	20	590
SCNN1A-216	+	AAGAGCUCUCGGUAGGAGCG	20	840
SCNN1A-58	+	GAACUCGAAGAGCUCUCGGU	20	524
SCNN1A-218	+	AGAACUCGAAGAGCUCUCGG	20	841
SCNN1A-219	+	UGUUGUUGCAGAAGAACUCG	20	842
SCNN1A-220	+	UGGUGUUGUUGCAGAAGAAC	20	843
SCNN1A-221	+	GGAUGGUGGUGUUGUUGCAG	20	844
SCNN1A-222	+	CGUGGAUGGUGGUGUUGUUG	20	845
SCNN1A-223	+	CACACCAGGCGGAUGGCGCC	20	846
SCNN1A-224	+	UUGUGCUGGGAGCACACCAG	20	847
SCNN1A-50	+	CGUCUUCAUGCGGUUGUGCU	20	583
SCNN1A-49	+	CCGUCUUCAUGCGGUUGUGC	20	582
SCNN1A-227	+	GCCGUCUUCAUGCGGUUGUG	20	848
SCNN1A-228	+	UGCAGAGCCACAGCACUGCC	20	849
SCNN1A-229	+	AGUACAUCAUGCCAAAGGUG	20	850
SCNN1A-230	+	AGUACUCUCCGAAAAGCAGG	20	851
SCNN1A-231	+	CGGGGUAGCUGAAGUACUCU	20	852
SCNN1A-232	+	UGUUGAGGCUGACGGGGUAG	20	853
SCNN1A-42	+	GAGGUUGAUGUUGAGGCUGA	20	519
SCNN1A-234	+	UGAGGUUGAUGUUGAGGCUG	20	854
SCNN1A-235	+	UGUCCGAGUUGAGGUUGAUG	20	855
SCNN1A-236	+	GGAAGACGAGCUUGUCCGAG	20	856
SCNN1A-237	+	UGCGGGGAAGACGAGCUUGU	20	857
SCNN1A-238	+	AGAUGGUCACUGCGGGGAAG	20	858
SCNN1A-39	+	GGGUGCAGAUGGUCACUGCG	20	518
SCNN1A-38	+	AGGGUGCAGAUGGUCACUGC	20	575
SCNN1A-37	+	GAGGGUGCAGAUGGUCACUG	20	517
SCNN1A-242	+	UGAGGGUGCAGAUGGUCACU	20	859
SCNN1A-243	-	AGCCCAUACCAGGUCUC	17	860
SCNN1A-80	-	GCCCAUACCAGGUCUCA	17	529
SCNN1A-245	-	CCAUACCAGGUCUCAUG	17	861
SCNN1A-81	-	CAUACCAGGUCUCAUGG	17	605
SCNN1A-82	-	AUACCAGGUCUCAUGGA	17	501
SCNN1A-83	-	UACCAGGUCUCAUGGAG	17	606
SCNN1A-249	-	UCAUGGAGGGGAACAAG	17	862
SCNN1A-84	-	CAUGGAGGGGAACAAGC	17	607
SCNN1A-251	-	UGGAGGGGAACAAGCUG	17	863
SCNN1A-85	-	GGAGGGGAACAAGCUGG	17	530
SCNN1A-253	-	GGAACAAGCUGGAGGAG	17	864
SCNN1A-254	-	CCCUCCACAGUCCACUC	17	865
SCNN1A-255	-	AGUCCACUCCAGGGCUC	17	866
SCNN1A-256	-	CCACUCCAGGGCUCAUG	17	867
SCNN1A-89	-	CACUCCAGGGCUCAUGA	17	610
SCNN1A-90	-	ACUCCAGGGCUCAUGAA	17	611
SCNN1A-91	-	CUCCAGGGCUCAUGAAG	17	612
SCNN1A-260	-	CAUGAAGGGGAACAAGC	17	868
SCNN1A-261	-	UGAAGGGGAACAAGCGU	17	869
SCNN1A-92	-	GAAGGGGAACAAGCGUG	17	532
SCNN1A-263	-	GGAACAAGCGUGAGGAG	17	870
SCNN1A-93	-	GAACAAGCGUGAGGAGC	17	533
SCNN1A-265	-	AGCGUGAGGAGCAGGGG	17	871
SCNN1A-266	-	GGAGCAGGGGCUGGGCC	17	872
SCNN1A-267	-	CGCCCCAGCAGCCCACG	17	873
SCNN1A-100	-	GCCCCAGCAGCCCACGG	17	537
SCNN1A-269	-	CCCAGCAGCCCACGGCG	17	874
SCNN1A-101	-	CCAGCAGCCCACGGCGG	17	616
SCNN1A-271	-	AGCAGCCCACGGCGGAG	17	875
SCNN1A-102	-	GCAGCCCACGGCGGAGG	17	538
SCNN1A-273	-	GGAGGAGGAGGCCCUGA	17	876
SCNN1A-274	-	GAGUUCCACCGCUCCUA	17	877
SCNN1A-275	-	GUUCCACCGCUCCUACC	17	878
SCNN1A-276	-	CUCCUACCGAGAGCUCU	17	879
SCNN1A-277	-	GCUCCCAGCACAACCGC	17	880
SCNN1A-278	-	CGCAUGAAGACGGCCUU	17	881
SCNN1A-279	-	GCAAUUCGGCCUGCUUU	17	882
SCNN1A-113	-	CAAUUCGGCCUGCUUUU	17	624
SCNN1A-281	-	AUUCGGCCUGCUUUUCG	17	883
SCNN1A-282	-	UCAACAUCAACCUCAAC	17	884
SCNN1A-283	+	CCUCCAUGAGACCUGGU	17	885
SCNN1A-284	+	CCAGCUUGUUCCCCUCC	17	886
SCNN1A-285	+	AGUGGACUGUGGAGGGC	17	887
SCNN1A-286	+	CCCUGGAGUGGACUGUG	17	888
SCNN1A-153	+	AGCCCUGGAGUGGACUG	17	650
SCNN1A-288	+	GAGCCCUGGAGUGGACU	17	889
SCNN1A-289	+	CCUUCAUGAGCCCUGGA	17	890
SCNN1A-151	+	UUCCCCUUCAUGAGCCC	17	648
SCNN1A-291	+	GUUCCCCUUCAUGAGCC	17	891
SCNN1A-292	+	CACGCUUGUUCCCCUUC	17	892
SCNN1A-148	+	CUGGGGCGCCGCAGGUU	17	646
SCNN1A-294	+	GCUGGGGCGCCGCAGGU	17	893
SCNN1A-144	+	CCUCCGCCGUGGGCUGC	17	643
SCNN1A-296	+	UCCUCCGCCGUGGGCUG	17	894
SCNN1A-297	+	GGGCCUCCUCCUCCGCC	17	895
SCNN1A-298	+	GAGCGGUGGAACUCGAU	17	896
SCNN1A-139	+	GCUCUCGGUAGGAGCGG	17	550
SCNN1A-300	+	AGCUCUCGGUAGGAGCG	17	897
SCNN1A-137	+	CUCGAAGAGCUCUCGGU	17	640
SCNN1A-302	+	ACUCGAAGAGCUCUCGG	17	898
SCNN1A-303	+	UGUUGCAGAAGAACUCG	17	899
SCNN1A-304	+	UGUUGUUGCAGAAGAAC	17	900
SCNN1A-305	+	UGGUGGUGUUGUUGCAG	17	901
SCNN1A-306	+	GGAUGGUGGUGUUGUUG	17	902
SCNN1A-307	+	ACCAGGCGGAUGGCGCC	17	903
SCNN1A-308	+	UGCUGGGAGCACACCAG	17	904
SCNN1A-129	+	CUUCAUGCGGUUGUGCU	17	636
SCNN1A-128	+	UCUUCAUGCGGUUGUGC	17	635
SCNN1A-311	+	GUCUUCAUGCGGUUGUG	17	905
SCNN1A-312	+	AGAGCCACAGCACUGCC	17	906
SCNN1A-313	+	ACAUCAUGCCAAAGGUG	17	907
SCNN1A-314	+	ACUCUCCGAAAAGCAGG	17	908
SCNN1A-315	+	GGUAGCUGAAGUACUCU	17	909
SCNN1A-316	+	UGAGGCUGACGGGGUAG	17	910
SCNN1A-121	+	GUUGAUGUUGAGGCUGA	17	545
SCNN1A-318	+	GGUUGAUGUUGAGGCUG	17	911
SCNN1A-319	+	CCGAGUUGAGGUUGAUG	17	912
SCNN1A-320	+	AGACGAGCUUGUCCGAG	17	913
SCNN1A-321	+	GGGGAAGACGAGCUUGU	17	914
SCNN1A-322	+	UGGUCACUGCGGGGAAG	17	915
SCNN1A-118	+	UGCAGAUGGUCACUGCG	17	626
SCNN1A-117	+	GUGCAGAUGGUCACUGC	17	544
SCNN1A-116	+	GGUGCAGAUGGUCACUG	17	543
SCNN1A-326	+	GGGUGCAGAUGGUCACU	17	916

Table 4A provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 4A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-2789-1	+	GAAGCAGCCACCUGGAA	17	937
CFTR-2789-2	+	GGAAUAUUCACUUUCCA	17	938
CFTR-2789-3	-	GAAUUUAGAUGUGGGCA	17	939
CFTR-2789-4	-	GUGUCUUGUUCCAUUCC	17	940
CFTR-2789-5	-	GUGGGCAUGGGAGGAAU	17	941
CFTR-2789-6	-	GUUGUGCUGUGGCUCCU	17	942
CFTR-2789-7	-	GAUGUGAAUUUAGAUGU	17	943
CFTR-2789-8	-	GACCCAGGAACACAAAGCAA	20	944
CFTR-2789-9	+	GUGUCACCUCACCCAACUAA	20	945
CFTR-2789-10	-	GUGUCUUGUUCCAUUCCAGG	20	946
CFTR-2789-11	-	GAUGUGGGCAUGGGAGGAAU	20	947
CFTR-2789-12	-	GUGAAUUUAGAUGUGGGCAU	20	948

Table 4B provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 4B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-2789-13	-	UUGGUACACACAUCAAA	17	949
CFTR-2789-14	+	UCACCUCACCCAACUAA	17	950
CFTR-2789-15	+	AUCUACACAAUAGGACA	17	951
CFTR-2789-16	+	UGUGUGUACCAAUAUCA	17	952
CFTR-2789-17	-	AUGGUAGUGGAAAGAUA	17	953
CFTR-2789-18	-	AUUUCUCCCAAGCAUUA	17	954
CFTR-2789-19	+	CCAAAGAAGCAGCCACC	17	955
CFTR-2789-20	+	CCUUUGCUUUGUGUUCC	17	956
CFTR-2789-21	-	CCCAAGCAUUAUGGUAG	17	957
CFTR-2789-22	-	UUAGAUGUGGGCAUGGG	17	958
CFTR-2789-23	-	CUUCUUUGGUUGUGCUG	17	959
CFTR-2789-24	-	UGACCAUUAGUUGGGUG	17	960
CFTR-2789-25	-	AAUUUAGAUGUGGGCAU	17	961
CFTR-2789-26	-	UGUGUGUACCUUGAUAU	17	962
CFTR-2789-27	+	UCCACUACCAUAAUGCU	17	963
CFTR-2789-28	-	AAAUGAUGACCAUUAGU	17	964
CFTR-2789-29	+	CCACUACCAUAAUGCUU	17	965
CFTR-2789-30	-	CCAGGUGGCUGCUUCUU	17	966
CFTR-2789-31	-	AUAUUGGUACACACAUCAAA	20	967
CFTR-2789-32	+	AAAGAAGCAGCCACCUGGAA	20	968
CFTR-2789-33	+	ACAAUCUACACAAUAGGACA	20	969
CFTR-2789-34	-	UGUGAAUUUAGAUGUGGGCA	20	970
CFTR-2789-35	+	UGAUGUGUGUACCAAUAUCA	20	971
CFTR-2789-36	-	AUUAUGGUAGUGGAAAGAUA	20	972
CFTR-2789-37	-	UUCAUUUCUCCCAAGCAUUA	20	973
CFTR-2789-38	+	CAACCAAAGAAGCAGCCACC	20	974
CFTR-2789-39	-	ACUGUGUCUUGUUCCAUUCC	20	975
CFTR-2789-40	+	CUUCCUUUGCUUUGUGUUCC	20	976
CFTR-2789-41	+	UACAAUACAUACAAACAUAG	20	977
CFTR-2789-42	-	UCUCCCAAGCAUUAUGGUAG	20	978
CFTR-2789-43	-	AAUUUAGAUGUGGGCAUGGG	20	979
CFTR-2789-44	-	CUGCUUCUUUGGUUGUGCUG	20	980
CFTR-2789-45	-	UGAUGACCAUUAGUUGGGUG	20	981
CFTR-2789-46	-	AAUUGUGUGUACCUUGAUAU	20	982
CFTR-2789-47	-	UUGGUUGUGCUGUGGCUCCU	20	983
CFTR-2789-48	+	CUUUCCACUACCAUAAUGCU	20	984
CFTR-2789-49	-	UUUAAAUGAUGACCAUUAGU	20	985
CFTR-2789-50	-	UGUGAUGUGAAUUUAGAUGU	20	986
CFTR-2789-51	+	UUUCCACUACCAUAAUGCUU	20	987
CFTR-2789-52	-	AUUCCAGGUGGCUGCUUCUU	20	988
CFTR-2789-53	-	UUAAAUGAUGACCAUUAGUU	20	989

Table 4C provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 4C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-2789-54	+	GGAGGAGCUAGGACUAC	17	990
CFTR-2789-55	+	GGAGAAAUGAAACAAAG	17	991
CFTR-2789-56	-	GUGUGAUGUGAAUUUAGAUG	20	992

Table 4D provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 4D
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-2789-57	-	CCAGGAACACAAAGCAA	17	993
CFTR-2789-58	-	AGUCCUAGCUCCUCCAC	17	994
CFTR-2789-59	+	AAUACAUACAAACAUAG	17	995
CFTR-2789-60	-	UCUUGUUCCAUUCCAGG	17	996
CFTR-2789-61	-	UGAUGUGAAUUUAGAUG	17	997
CFTR-2789-62	+	AACACAAUCUACACAAU	17	998
CFTR-2789-63	+	CUUUGCUUUGUGUUCCU	17	999
CFTR-2789-64	-	AAUGAUGACCAUUAGUU	17	1000
CFTR-2789-65	+	CAUGGAAUAUUCACUUUCCA	20	1001
CFTR-2789-66	-	UGUAGUCCUAGCUCCUCCAC	20	1002
CFTR-2789-67	+	UGUGGAGGAGCUAGGACUAC	20	1003
CFTR-2789-68	+	UUGGGAGAAAUGAAACAAAG	20	1004
CFTR-2789-69	+	UAAAACACAAUCUACACAAU	20	1005
CFTR-2789-70	+	UUCCUUUGCUUUGUGUUCCU	20	1006

Table 5A provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 5A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-2789-71	+	GAUUACAAUACAUACAAACAUA	22	1007
CFTR-2789-72	+	GGAUUACAAUACAUACAAACAUA	23	1008
CFTR-2789-73	-	GCUGUGGCUCCUUGGAAA	18	1009
CFTR-2789-74	-	GUGCUGUGGCUCCUUGGAAA	20	1010
CFTR-2789-75	-	GUUGUGCUGUGGCUCCUUGGAAA	23	1011
CFTR-2789-76	-	GGUUGUGCUGUGGCUCCUUGGAAA	24	1012
CFTR-2789-77	-	GUUUAAAUGAUGACCAUUAG	20	1013
CFTR-2789-78	-	GUACACACAUCAAAUGGUGUGAU	23	1014
CFTR-2789-79	-	GGUACACACAUCAAAUGGUGUGAU	24	1015

Table 5B provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 5B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-2789-80	+	UGGGAGAAAUGAAACAAA	18	1016
CFTR-2789-81	+	UUGGGAGAAAUGAAACAAA	19	1017
CFTR-2789-82	+	CUUGGGAGAAAUGAAACAAA	20	1018
CFTR-2789-83	+	ACAAUACAUACAAACAUA	18	1019
CFTR-2789-84	+	UACAAUACAUACAAACAUA	19	1020
CFTR-2789-85	+	UUACAAUACAUACAAACAUA	20	1021
CFTR-2789-86	+	AUUACAAUACAUACAAACAUA	21	1022
CFTR-2789-87	+	UGGAUUACAAUACAUACAAACAUA	24	1023
CFTR-2789-88	+	ACCAAAGAAGCAGCCACC	18	1024
CFTR-2789-89	+	AACCAAAGAAGCAGCCACC	19	1025
CFTR-2789-38	+	CAACCAAAGAAGCAGCCACC	20	974
CFTR-2789-90	+	UUCCUUUGCUUUGUGUUC	18	1026
CFTR-2789-91	+	CUUCCUUUGCUUUGUGUUC	19	1027
CFTR-2789-92	+	UCUUCCUUUGCUUUGUGUUC	20	1028
CFTR-2789-93	-	UGCUGUGGCUCCUUGGAAA	19	1029
CFTR-2789-94	-	UGUGCUGUGGCUCCUUGGAAA	21	1030
CFTR-2789-95	-	UUGUGCUGUGGCUCCUUGGAAA	22	1031
CFTR-2789-96	-	UUAAAUGAUGACCAUUAG	18	1032
CFTR-2789-97	-	UUUAAAUGAUGACCAUUAG	19	1033
CFTR-2789-98	-	UGUUUAAAUGAUGACCAUUAG	21	1034
CFTR-2789-99	-	UUGUUUAAAUGAUGACCAUUAG	22	1035
CFTR-2789-100	-	UUUGUUUAAAUGAUGACCAUUAG	23	1036
CFTR-2789-101	-	UUUUGUUUAAAUGAUGACCAUUAG	24	1037
CFTR-2789-102	-	UUUAGAUGUGGGCAUGGG	18	1038
CFTR-2789-103	-	AUUUAGAUGUGGGCAUGGG	19	1039
CFTR-2789-43	-	AAUUUAGAUGUGGGCAUGGG	20	979
CFTR-2789-104	-	CACAUCAAAUGGUGUGAU	18	1040
CFTR-2789-105	-	ACACAUCAAAUGGUGUGAU	19	1041
CFTR-2789-106	-	CACACAUCAAAUGGUGUGAU	20	1042
CFTR-2789-107	-	ACACACAUCAAAUGGUGUGAU	21	1043
CFTR-2789-108	-	UACACACAUCAAAUGGUGUGAU	22	1044

Table 5C provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), starts with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 5C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-2789-109	+	GCUUGGGAGAAAUGAAACAAA	21	1045
CFTR-2789-110	+	GUGGAGGAGCUAGGACUAC	19	1046
CFTR-2789-111	+	GCACAACCAAAGAAGCAGCCACC	23	1047
CFTR-2789-112	-	GAAUUUAGAUGUGGGCAUGGG	21	1048
CFTR-2789-113	-	GUGAAUUUAGAUGUGGGCAUGGG	23	1049

Table 5D provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 5D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-2789-114	+	UGCUUGGGAGAAAUGAAACAAA	22	1050
CFTR-2789-115	+	AUGCUUGGGAGAAAUGAAACAAA	23	1051
CFTR-2789-116	+	AAUGCUUGGGAGAAAUGAAACAAA	24	1052
CFTR-2789-117	+	AAUCUACACAAUAGGACA	18	1053
CFTR-2789-118	+	CAAUCUACACAAUAGGACA	19	1054
CFTR-2789-33	+	ACAAUCUACACAAUAGGACA	20	969
CFTR-2789-119	+	CACAAUCUACACAAUAGGACA	21	1055
CFTR-2789-120	+	ACACAAUCUACACAAUAGGACA	22	1056
CFTR-2789-121	+	AACACAAUCUACACAAUAGGACA	23	1057
CFTR-2789-122	+	AAACACAAUCUACACAAUAGGACA	24	1058
CFTR-2789-123	+	UGGAGGAGCUAGGACUAC	18	1059
CFTR-2789-67	+	UGUGGAGGAGCUAGGACUAC	20	1003
CFTR-2789-124	+	ACAACCAAAGAAGCAGCCACC	21	1060
CFTR-2789-125	+	CACAACCAAAGAAGCAGCCACC	22	1061
CFTR-2789-126	+	AGCACAACCAAAGAAGCAGCCACC	24	1062
CFTR-2789-127	+	AUCUUCCUUUGCUUUGUGUUC	21	1063
CFTR-2789-128	+	CAUCUUCCUUUGCUUUGUGUUC	22	1064
CFTR-2789-129	+	UCAUCUUCCUUUGCUUUGUGUUC	23	1065
CFTR-2789-130	+	UUCAUCUUCCUUUGCUUUGUGUUC	24	1066
CFTR-2789-131	-	UGAAUUUAGAUGUGGGCAUGGG	22	1067
CFTR-2789-132	-	UGUGAAUUUAGAUGUGGGCAUGGG	24	1068

Table 5E provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 5E
5th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-2789-133	+	AAAACACAAUCUACACAA	18	1069
CFTR-2789-134	+	UAAAACACAAUCUACACAA	19	1070
CFTR-2789-135	+	AUAAAACACAAUCUACACAA	20	1071
CFTR-2789-136	+	AAUAAAACACAAUCUACACAA	21	1072
CFTR-2789-137	+	AAAUAAAACACAAUCUACACAA	22	1073
CFTR-2789-138	+	GAAAUAAAACACAAUCUACACAA	23	1074
CFTR-2789-139	+	AGAAAUAAAACACAAUCUACACAA	24	1075
CFTR-2789-140	+	AUUACAAUAUUUAAUCAA	18	1076
CFTR-2789-141	+	GAUUACAAUAUUUAAUCAA	19	1077
CFTR-2789-142	+	GGAUUACAAUAUUUAAUCAA	20	1078
CFTR-2789-143	+	UGGAUUACAAUAUUUAAUCAA	21	1079
CFTR-2789-144	+	GUGGAUUACAAUAUUUAAUCAA	22	1080
CFTR-2789-145	+	AGUGGAUUACAAUAUUUAAUCAA	23	1081
CFTR-2789-146	+	UAGUGGAUUACAAUAUUUAAUCAA	24	1082
CFTR-2789-147	+	CCAUAAUGCUUGGGAGAA	18	1083
CFTR-2789-148	+	ACCAUAAUGCUUGGGAGAA	19	1084
CFTR-2789-149	+	UACCAUAAUGCUUGGGAGAA	20	1085
CFTR-2789-150	+	CUACCAUAAUGCUUGGGAGAA	21	1086
CFTR-2789-151	+	ACUACCAUAAUGCUUGGGAGAA	22	1087
CFTR-2789-152	+	CACUACCAUAAUGCUUGGGAGAA	23	1088
CFTR-2789-153	+	CCACUACCAUAAUGCUUGGGAGAA	24	1089
CFTR-2789-154	+	AGAAGCAGCCACCUGGAA	18	1090
CFTR-2789-155	+	AAGAAGCAGCCACCUGGAA	19	1091
CFTR-2789-32	+	AAAGAAGCAGCCACCUGGAA	20	968
CFTR-2789-156	+	CAAAGAAGCAGCCACCUGGAA	21	1092
CFTR-2789-157	+	CCAAAGAAGCAGCCACCUGGAA	22	1093
CFTR-2789-158	+	ACCAAAGAAGCAGCCACCUGGAA	23	1094
CFTR-2789-159	+	AACCAAAGAAGCAGCCACCUGGAA	24	1095
CFTR-2789-160	+	GGAGCCACAGCACAACCA	18	1096
CFTR-2789-161	+	AGGAGCCACAGCACAACCA	19	1097
CFTR-2789-162	+	AAGGAGCCACAGCACAACCA	20	1098
CFTR-2789-163	+	CAAGGAGCCACAGCACAACCA	21	1099
CFTR-2789-164	+	CCAAGGAGCCACAGCACAACCA	22	1100
CFTR-2789-165	+	UCCAAGGAGCCACAGCACAACCA	23	1101
CFTR-2789-166	+	UUCCAAGGAGCCACAGCACAACCA	24	1102
CFTR-2789-167	+	UGGAAUAUUCACUUUCCA	18	1103
CFTR-2789-168	+	AUGGAAUAUUCACUUUCCA	19	1104
CFTR-2789-65	+	CAUGGAAUAUUCACUUUCCA	20	1001
CFTR-2789-169	+	ACAUGGAAUAUUCACUUUCCA	21	1105
CFTR-2789-170	+	GACAUGGAAUAUUCACUUUCCA	22	1106
CFTR-2789-171	+	GGACAUGGAAUAUUCACUUUCCA	23	1107
CFTR-2789-172	+	AGGACAUGGAAUAUUCACUUUCCA	24	1108
CFTR-2789-173	+	AAGAAGCAGCCACCUGGA	18	1109
CFTR-2789-174	+	AAAGAAGCAGCCACCUGGA	19	1110
CFTR-2789-175	+	CAAAGAAGCAGCCACCUGGA	20	1111
CFTR-2789-176	+	CCAAAGAAGCAGCCACCUGGA	21	1112
CFTR-2789-177	+	ACCAAAGAAGCAGCCACCUGGA	22	1113
CFTR-2789-178	+	AACCAAAGAAGCAGCCACCUGGA	23	1114
CFTR-2789-179	+	CAACCAAAGAAGCAGCCACCUGGA	24	1115
CFTR-2789-180	+	GUGGAGGAGCUAGGACUA	18	1116
CFTR-2789-181	+	UGUGGAGGAGCUAGGACUA	19	1117
CFTR-2789-182	+	CUGUGGAGGAGCUAGGACUA	20	1118
CFTR-2789-183	+	AACCAAAGAAGCAGCCAC	18	1119
CFTR-2789-184	+	CAACCAAAGAAGCAGCCAC	19	1120
CFTR-2789-185	+	ACAACCAAAGAAGCAGCCAC	20	1121
CFTR-2789-186	+	CACAACCAAAGAAGCAGCCAC	21	1122
CFTR-2789-187	+	GCACAACCAAAGAAGCAGCCAC	22	1123
CFTR-2789-188	+	AGCACAACCAAAGAAGCAGCCAC	23	1124
CFTR-2789-189	+	CAGCACAACCAAAGAAGCAGCCAC	24	1125
CFTR-2789-190	+	CAAUCUACACAAUAGGAC	18	1126
CFTR-2789-191	+	ACAAUCUACACAAUAGGAC	19	1127
CFTR-2789-192	+	CACAAUCUACACAAUAGGAC	20	1128
CFTR-2789-193	+	ACACAAUCUACACAAUAGGAC	21	1129
CFTR-2789-194	+	AACACAAUCUACACAAUAGGAC	22	1130
CFTR-2789-195	+	AAACACAAUCUACACAAUAGGAC	23	1131
CFTR-2789-196	+	AAAACACAAUCUACACAAUAGGAC	24	1132
CFTR-2789-197	+	AUGGAAUAUUCACUUUCC	18	1133
CFTR-2789-198	+	CAUGGAAUAUUCACUUUCC	19	1134
CFTR-2789-199	+	ACAUGGAAUAUUCACUUUCC	20	1135
CFTR-2789-200	+	GACAUGGAAUAUUCACUUUCC	21	1136
CFTR-2789-201	+	GGACAUGGAAUAUUCACUUUCC	22	1137
CFTR-2789-202	+	AGGACAUGGAAUAUUCACUUUCC	23	1138
CFTR-2789-203	+	UAGGACAUGGAAUAUUCACUUUCC	24	1139
CFTR-2789-204	+	UUUCCACUACCAUAAUGC	18	1140
CFTR-2789-205	+	CUUUCCACUACCAUAAUGC	19	1141
CFTR-2789-206	+	UCUUUCCACUACCAUAAUGC	20	1142
CFTR-2789-207	+	AUCUUUCCACUACCAUAAUGC	21	1143
CFTR-2789-208	+	UAUCUUUCCACUACCAUAAUGC	22	1144
CFTR-2789-209	+	UUAUCUUUCCACUACCAUAAUGC	23	1145
CFTR-2789-210	+	CUUAUCUUUCCACUACCAUAAUGC	24	1146
CFTR-2789-211	+	CACUACCAUAAUGCUUGG	18	1147
CFTR-2789-212	+	CCACUACCAUAAUGCUUGG	19	1148
CFTR-2789-213	+	UCCACUACCAUAAUGCUUGG	20	1149
CFTR-2789-214	+	UUCCACUACCAUAAUGCUUGG	21	1150
CFTR-2789-215	+	UUUCCACUACCAUAAUGCUUGG	22	1151
CFTR-2789-216	+	CUUUCCACUACCAUAAUGCUUGG	23	1152
CFTR-2789-217	+	UCUUUCCACUACCAUAAUGCUUGG	24	1153
CFTR-2789-218	+	UUCCACUACCAUAAUGCU	18	1154
CFTR-2789-219	+	UUUCCACUACCAUAAUGCU	19	1155
CFTR-2789-48	+	CUUUCCACUACCAUAAUGCU	20	984
CFTR-2789-220	+	UCUUUCCACUACCAUAAUGCU	21	1156
CFTR-2789-221	+	AUCUUUCCACUACCAUAAUGCU	22	1157
CFTR-2789-222	+	UAUCUUUCCACUACCAUAAUGCU	23	1158
CFTR-2789-223	+	UUAUCUUUCCACUACCAUAAUGCU	24	1159
CFTR-2789-224	+	UCCACUACCAUAAUGCUU	18	1160
CFTR-2789-225	+	UUCCACUACCAUAAUGCUU	19	1161
CFTR-2789-51	+	UUUCCACUACCAUAAUGCUU	20	987
CFTR-2789-226	+	CUUUCCACUACCAUAAUGCUU	21	1162
CFTR-2789-227	+	UCUUUCCACUACCAUAAUGCUU	22	1163
CFTR-2789-228	+	AUCUUUCCACUACCAUAAUGCUU	23	1164
CFTR-2789-229	+	UAUCUUUCCACUACCAUAAUGCUU	24	1165
CFTR-2789-230	-	CCCAGGAACACAAAGCAA	18	1166
CFTR-2789-231	-	ACCCAGGAACACAAAGCAA	19	1167
CFTR-2789-8	-	GACCCAGGAACACAAAGCAA	20	944
CFTR-2789-232	-	GGACCCAGGAACACAAAGCAA	21	1168
CFTR-2789-233	-	UGGACCCAGGAACACAAAGCAA	22	1169
CFTR-2789-234	-	CUGGACCCAGGAACACAAAGCAA	23	1170
CFTR-2789-235	-	GCUGGACCCAGGAACACAAAGCAA	24	1171
CFTR-2789-236	-	ACCCAGGAACACAAAGCA	18	1172
CFTR-2789-237	-	GACCCAGGAACACAAAGCA	19	1173
CFTR-2789-238	-	GGACCCAGGAACACAAAGCA	20	1174
CFTR-2789-239	-	UGGACCCAGGAACACAAAGCA	21	1175
CFTR-2789-240	-	CUGGACCCAGGAACACAAAGCA	22	1176
CFTR-2789-241	-	GCUGGACCCAGGAACACAAAGCA	23	1177
CFTR-2789-242	-	UGCUGGACCCAGGAACACAAAGCA	24	1178
CFTR-2789-243	-	UGAAUUUAGAUGUGGGCA	18	1179
CFTR-2789-244	-	GUGAAUUUAGAUGUGGGCA	19	1180
CFTR-2789-34	-	UGUGAAUUUAGAUGUGGGCA	20	970
CFTR-2789-245	-	AUGUGAAUUUAGAUGUGGGCA	21	1181
CFTR-2789-246	-	GAUGUGAAUUUAGAUGUGGGCA	22	1182
CFTR-2789-247	-	UGAUGUGAAUUUAGAUGUGGGCA	23	1183
CFTR-2789-248	-	GUGAUGUGAAUUUAGAUGUGGGCA	24	1184
CFTR-2789-249	-	CUCCCAAGCAUUAUGGUA	18	1185
CFTR-2789-250	-	UCUCCCAAGCAUUAUGGUA	19	1186
CFTR-2789-251	-	UUCUCCCAAGCAUUAUGGUA	20	1187
CFTR-2789-252	-	UUUCUCCCAAGCAUUAUGGUA	21	1188
CFTR-2789-253	-	AUUUCUCCCAAGCAUUAUGGUA	22	1189
CFTR-2789-254	-	CAUUUCUCCCAAGCAUUAUGGUA	23	1190
CFTR-2789-255	-	UCAUUUCUCCCAAGCAUUAUGGUA	24	1191
CFTR-2789-256	-	UGGUUGUGCUGUGGCUCC	18	1192
CFTR-2789-257	-	UUGGUUGUGCUGUGGCUCC	19	1193
CFTR-2789-258	-	UUUGGUUGUGCUGUGGCUCC	20	1194
CFTR-2789-259	-	CUUUGGUUGUGCUGUGGCUCC	21	1195
CFTR-2789-260	-	UCUUUGGUUGUGCUGUGGCUCC	22	1196
CFTR-2789-261	-	UUCUUUGGUUGUGCUGUGGCUCC	23	1197
CFTR-2789-262	-	CUUCUUUGGUUGUGCUGUGGCUCC	24	1198
CFTR-2789-263	-	GUGAAUUUAGAUGUGGGC	18	1199
CFTR-2789-264	-	UGUGAAUUUAGAUGUGGGC	19	1200
CFTR-2789-265	-	AUGUGAAUUUAGAUGUGGGC	20	1201
CFTR-2789-266	-	GAUGUGAAUUUAGAUGUGGGC	21	1202
CFTR-2789-267	-	UGAUGUGAAUUUAGAUGUGGGC	22	1203
CFTR-2789-268	-	GUGAUGUGAAUUUAGAUGUGGGC	23	1204
CFTR-2789-269	-	UGUGAUGUGAAUUUAGAUGUGGGC	24	1205
CFTR-2789-270	-	AACACAAAGCAAAGGAAG	18	1206
CFTR-2789-271	-	GAACACAAAGCAAAGGAAG	19	1207
CFTR-2789-272	-	GGAACACAAAGCAAAGGAAG	20	1208
CFTR-2789-273	-	AGGAACACAAAGCAAAGGAAG	21	1209
CFTR-2789-274	-	CAGGAACACAAAGCAAAGGAAG	22	1210
CFTR-2789-275	-	CCAGGAACACAAAGCAAAGGAAG	23	1211
CFTR-2789-276	-	CCCAGGAACACAAAGCAAAGGAAG	24	1212
CFTR-2789-277	-	UGGGCAUGGGAGGAAUAG	18	1213
CFTR-2789-278	-	GUGGGCAUGGGAGGAAUAG	19	1214
CFTR-2789-279	-	UGUGGGCAUGGGAGGAAUAG	20	1215
CFTR-2789-280	-	AUGUGGGCAUGGGAGGAAUAG	21	1216
CFTR-2789-281	-	GAUGUGGGCAUGGGAGGAAUAG	22	1217
CFTR-2789-282	-	AGAUGUGGGCAUGGGAGGAAUAG	23	1218
CFTR-2789-283	-	UAGAUGUGGGCAUGGGAGGAAUAG	24	1219
CFTR-2789-284	-	UCCCAAGCAUUAUGGUAG	18	1220
CFTR-2789-285	-	CUCCCAAGCAUUAUGGUAG	19	1221
CFTR-2789-42	-	UCUCCCAAGCAUUAUGGUAG	20	978
CFTR-2789-286	-	UUCUCCCAAGCAUUAUGGUAG	21	1222
CFTR-2789-287	-	UUUCUCCCAAGCAUUAUGGUAG	22	1223
CFTR-2789-288	-	AUUUCUCCCAAGCAUUAUGGUAG	23	1224
CFTR-2789-289	-	CAUUUCUCCCAAGCAUUAUGGUAG	24	1225
CFTR-2789-290	-	AUUUAGAUGUGGGCAUGG	18	1226
CFTR-2789-291	-	AAUUUAGAUGUGGGCAUGG	19	1227
CFTR-2789-292	-	GAAUUUAGAUGUGGGCAUGG	20	1228
CFTR-2789-293	-	UGAAUUUAGAUGUGGGCAUGG	21	1229
CFTR-2789-294	-	GUGAAUUUAGAUGUGGGCAUGG	22	1230
CFTR-2789-295	-	UGUGAAUUUAGAUGUGGGCAUGG	23	1231
CFTR-2789-296	-	AUGUGAAUUUAGAUGUGGGCAGGU	24	1232
CFTR-2789-297	-	AUGAUGACCAUUAGUUGG	18	1233
CFTR-2789-298	-	AAUGAUGACCAUUAGUUGG	19	1234
CFTR-2789-299	-	AAAUGAUGACCAUUAGUUGG	20	1235
CFTR-2789-300	-	UAAAUGAUGACCAUUAGUUGG	21	1236
CFTR-2789-301	-	UUAAAUGAUGACCAUUAGUUGG	22	1237
CFTR-2789-302	-	UUUAAAUGAUGACCAUUAGUUGG	23	1238
CFTR-2789-303	-	GUUUAAAUGAUGACCAUUAGUUGG	24	1239
CFTR-2789-304	-	GAAUUUAGAUGUGGGCAU	18	1240
CFTR-2789-305	-	UGAAUUUAGAUGUGGGCAU	19	1241
CFTR-2789-12	-	GUGAAUUUAGAUGUGGGCAU	20	948
CFTR-2789-306	-	UGUGAAUUUAGAUGUGGGCAU	21	1242
CFTR-2789-307	-	AUGUGAAUUUAGAUGUGGGCAU	22	1243
CFTR-2789-308	-	GAUGUGAAUUUAGAUGUGGGCAU	23	1244
CFTR-2789-309	-	UGAUGUGAAUUUAGAUGUGGGCAU	24	1245
CFTR-2789-310	-	UGUGAUGUGAAUUUAGAU	18	1246
CFTR-2789-311	-	GUGUGAUGUGAAUUUAGAU	19	1247
CFTR-2789-312	-	GGUGUGAUGUGAAUUUAGAU	20	1248
CFTR-2789-313	-	UGGUGUGAUGUGAAUUUAGAU	21	1249
CFTR-2789-314	-	AUGGUGUGAUGUGAAUUUAGAU	22	1250
CFTR-2789-315	-	AAUGGUGUGAUGUGAAUUUAGAU	23	1251
CFTR-2789-316	-	AAAUGGUGUGAUGUGAAUUUAGAU	24	1252
CFTR-2789-317	-	GGUUGUGCUGUGGCUCCU	18	1253
CFTR-2789-318	-	UGGUUGUGCUGUGGCUCCU	19	1254
CFTR-2789-47	-	UUGGUUGUGCUGUGGCUCCU	20	983
CFTR-2789-319	-	UUUGGUUGUGCUGUGGCUCCU	21	1255
CFTR-2789-320	-	CUUUGGUUGUGCUGUGGCUCCU	22	1256
CFTR-2789-321	-	UCUUUGGUUGUGCUGUGGCUCCU	23	1257
CFTR-2789-322	-	UUCUUUGGUUGUGCUGUGGCUCCU	24	1258
CFTR-2789-323	-	AGGAAUAGGUGAAGAUGU	18	1259
CFTR-2789-324	-	GAGGAAUAGGUGAAGAUGU	19	1260
CFTR-2789-325	-	GGAGGAAUAGGUGAAGAUGU	20	1261
CFTR-2789-326	-	GGGAGGAAUAGGUGAAGAUGU	21	1262
CFTR-2789-327	-	UGGGAGGAAUAGGUGAAGAUGU	22	1263
CFTR-2789-328	-	AUGGGAGGAAUAGGUGAAGAUGU	23	1264
CFTR-2789-329	-	CAUGGGAGGAAUAGGUGAAGAUGU	24	1265

Table 6A provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 6A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-2789-	+	GGAAUGGAACAAGACAC	17	1266
330
CFTR-2789-	+	GCUUGGGAGAAAUGAAACAA	20	1267
331
CFTR-2789-	+	GUACACACAAUUUCAUCUUC	20	1268
332

Table 6B provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 6B
2nd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-2789-333	+	UGGGAGAAAUGAAACAA	17	1269
CFTR-2789-334	+	UUAUCUUUCCACUACCA	17	1270
CFTR-2789-335	+	CACACAAUUUCAUCUUC	17	1271
CFTR-2789-336	−	AGAUUGUGUUUUAUUUC	17	1272
CFTR-2789-337	−	UAUUCCAUGUCCUAUUG	17	1273
CFTR-2789-338	−	CUUGUUCCAUUCCAGGU	17	1274
CFTR-2789-339	+	ACCUUAUCUUUCCACUACCA	20	1275
CFTR-2789-340	+	CCUGGAAUGGAACAAGACAC	20	1276
CFTR-2789-341	−	UGUAGAUUGUGUUUUAUUUC	20	1277
CFTR-2789-342	+	AUUACAAUACAUACAAACAU	20	1278

Table 6C provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 6C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-2789-	−	GAAUAUUCCAUGUCCUAUUG	20	1279
343

Table 6D provides exemplary targeting domains for correcting a mutation (e.g., 2789+5G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 2789+5G). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 6D
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-2789-	+	ACAAUACAUACAAACAU	17	1280
344
CFTR-2789-	−	UGUCUUGUUCCAUUCCAGGU	20	1281
345

Table 7A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 7A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-1	+	GUAAGGCUGCCGUCCGA	17	1282
CFTR-3272-2	−	GGAAAUAUUUCACAGGC	17	1283
CFTR-3272-3	+	GUAAAUUCAGAGCUUUG	17	1284
CFTR-3272-4	−	GGACACUUCGUGCCUUCGGA	20	1285
CFTR-3272-5	+	GGAACCAGCGCAGUGUUGAC	20	1286
CFTR-3272-6	+	GUAACAAGAUGAGUGAAAAU	20	1287

Table 7B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 7B
2nd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-3272-7	−	CUUGUUACAAGCUUAAA	17	1288
CFTR-3272-8	−	CAUAUCUAUUCAAAGAA	17	1289
CFTR-3272-9	+	UACUUGGCUACCAGAGA	17	1290
CFTR-3272-10	−	CACUUCGUGCCUUCGGA	17	1291
CFTR-3272-11	−	CAAGCUUAAAAGGACUA	17	1292
CFTR-3272-12	−	AUUUACAUACUGCCAAC	17	1293
CFTR-3272-13	+	AAAGCUUUUUUUCACAC	17	1294
CFTR-3272-14	−	CUAUGGAAAUAUUUCAC	17	1295
CFTR-3272-15	+	ACCAGCGCAGUGUUGAC	17	1296
CFTR-3272-16	−	ACCUGUCAACACUGCGC	17	1297
CFTR-3272-17	−	CUAAUUUAGUCUUUUUC	17	1298
CFTR-3272-18	+	CAUAUCACAAAUGUCAU	17	1299
CFTR-3272-19	+	ACUUGGCUACCAGAGAU	17	1300
CFTR-3272-20	+	UACCCUCUUUUUUUACU	17	1301
CFTR-3272-21	+	CAGGUACAAGAACCAGU	17	1302
CFTR-3272-22	−	UGGACACUUCGUGCCUU	17	1303
CFTR-3272-23	−	CAUCUUGUUACAAGCUUAAA	20	1304
CFTR-3272-24	−	AAUCAUAUCUAUUCAAAGAA	20	1305
CFTR-3272-25	+	UUUUACUUGGCUACCAGAGA	20	1306
CFTR-3272-26	+	AAAGUAAGGCUGCCGUCCGA	20	1307
CFTR-3272-27	−	UUACAAGCUUAAAAGGACUA	20	1308
CFTR-3272-28	+	UGGAACAGAGUUUCAAAGUA	20	1309
CFTR-3272-29	−	UGAAUUUACAUACUGCCAAC	20	1310
CFTR-3272-30	+	UAAAAAGCUUUUUUUCACAC	20	1311
CFTR-3272-31	−	UUUCUAUGGAAAUAUUUCAC	20	1312
CFTR-3272-32	−	UGUACCUGUCAACACUGCGC	20	1313
CFTR-3272-33	−	UAUGGAAAUAUUUCACAGGC	20	1314
CFTR-3272-34	−	UGGUAGCCAAGUAAAAAAAG	20	1315
CFTR-3272-35	+	UAUGUAAAUUCAGAGCUUUG	20	1316
CFTR-3272-36	+	AAUCAUAUCACAAAUGUCAU	20	1317
CFTR-3272-37	+	UUUACUUGGCUACCAGAGAU	20	1318
CFTR-3272-38	+	AGUUACCCUCUUUUUUUACU	20	1319
CFTR-3272-39	+	UGACAGGUACAAGAACCAGU	20	1320
CFTR-3272-40	−	CUAUGGACACUUCGUGCCUU	20	1321

Table 7C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 7C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-	−	GGUAGCCAAGUAAAAAAAGA	20	1322
41
CFTR-3272-	−	GUUAUUUGCAGUGUUUUCUA	20	1323
42

Table 7D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 7D
4th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-3272-43	−	AGCCAAGUAAAAAAAGA	17	1324
CFTR-3272-44	−	AUUUGCAGUGUUUUCUA	17	1325
CFTR-3272-45	+	AACAGAGUUUCAAAGUA	17	1326
CFTR-3272-46	−	UAGCCAAGUAAAAAAAG	17	1327
CFTR-3272-47	+	ACAAGAUGAGUGAAAAU	17	1328
CFTR-3272-48	−	AUUCUAAUUUAGUCUUUUUC	20	1329

Table 8A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 8A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-49	+	GUCCUUUUAAGCUUGUAA	22	1330
		CAAG
CFTR-3272-50	+	GUACCUGAAAAAGACUAA	20	1331
		AU
CFTR-3272-51	−	GUCAACACUGCGCUGGUUC	24	1332
		CAAAU

Table 8B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 8B
2nd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-3272-52	+	UUUUAAGCUUGUAACAAG	18	1333
CFTR-3272-53	+	CUUUUAAGCUUGUAACAAG	19	1334
CFTR-3272-54	+	CCUUUUAAGCUUGUAACAAG	20	1335
CFTR-3272-55	+	UCCUUUUAAGCUUGUAACAAG	21	1336
CFTR-3272-56	+	AGUCCUUUUAAGCUUGUAACAAG	23	1337
CFTR-3272-57	+	UAGUCCUUUUAAGCUUGUAACAAG	24	1338
CFTR-3272-58	+	ACCUGAAAAAGACUAAAU	18	1339
CFTR-3272-59	+	UACCUGAAAAAGACUAAAU	19	1340
CFTR-3272-60	+	UGUACCUGAAAAAGACUAAAU	21	1341
CFTR-3272-61	+	UUGUACCUGAAAAAGACUAAAU	22	1342
CFTR-3272-62	+	CUUGUACCUGAAAAAGACUAAAU	23	1343
CFTR-3272-63	+	UCUUGUACCUGAAAAAGACUAAAU	24	1344
CFTR-3272-64	+	UCACACUGGUGCCAUUCU	18	1345
CFTR-3272-65	+	UUCACACUGGUGCCAUUCU	19	1346
CFTR-3272-66	+	UUUCACACUGGUGCCAUUCU	20	1347
CFTR-3272-67	+	UUUUCACACUGGUGCCAUUCU	21	1348
CFTR-3272-68	+	UUUUUCACACUGGUGCCAUUCU	22	1349
CFTR-3272-69	+	UUUUUUCACACUGGUGCCAUUCU	23	1350
CFTR-3272-70	+	UUUUUUUCACACUGGUGCCAUUCU	24	1351
CFTR-3272-71	−	ACAAAUCAUAUCUAUUCA	18	1352
CFTR-3272-72	−	AACAAAUCAUAUCUAUUCA	19	1353
CFTR-3272-73	−	UAACAAAUCAUAUCUAUUCA	20	1354
CFTR-3272-74	−	AUAACAAAUCAUAUCUAUUCA	21	1355
CFTR-3272-75	−	AAUAACAAAUCAUAUCUAUUCA	22	1356
CFTR-3272-76	−	AAAUAACAAAUCAUAUCUAUUCA	23	1357
CFTR-3272-77	−	AAAAUAACAAAUCAUAUCUAUUCA	24	1358
CFTR-3272-78	−	UGGAAAUAUUUCACAGGC	18	1359
CFTR-3272-79	−	AUGGAAAUAUUUCACAGGC	19	1360
CFTR-3272-33	−	UAUGGAAAUAUUUCACAGGC	20	1314
CFTR-3272-80	−	ACUGCGCUGGUUCCAAAU	18	1361
CFTR-3272-81	−	CACUGCGCUGGUUCCAAAU	19	1362
CFTR-3272-82	−	ACACUGCGCUGGUUCCAAAU	20	1363
CFTR-3272-83	−	AACACUGCGCUGGUUCCAAAU	21	1364
CFTR-3272-84	−	CAACACUGCGCUGGUUCCAAAU	22	1365
CFTR-3272-85	−	UCAACACUGCGCUGGUUCCAAAU	23	1366
CFTR-3272-86	−	ACUCUGUUCCACAAAGCU	18	1367
CFTR-3272-87	−	AACUCUGUUCCACAAAGCU	19	1368
CFTR-3272-88	−	AAACUCUGUUCCACAAAGCU	20	1369

Table 8C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 8C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-89	+	GUAAAUUCAGAGCUUUGUG	22	1370
		GAA
CFTR-3272-90	+	GAUAUGAUUUGUUAUUUUA	22	1371
		UUA
CFTR-3272-91	−	GGUAGCCAAGUAAAAAAA	18	1372
CFTR-3272-92	−	GAAACUCUGUUCCACAAAG	21	1373
		CU

Table 8D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 8D
4th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-3272-	+	AUUCAGAGCUUUGUGGAA	18	1374
93
CFTR-3272-	+	AAUUCAGAGCUUUGUGGAA	19	1375
94
CFTR-3272-	+	AAAUUCAGAGCUUUGUGGAA	20	1376
95
CFTR-3272-	+	UAAAUUCAGAGCUUUGUGGAA	21	1377
96
CFTR-3272-	+	UGUAAAUUCAGAGCUUUGUGGAA	23	1378
97
CFTR-3272-	+	AUGUAAAUUCAGAGCUUUGUGGAA	24	1379
98
CFTR-3272-	+	UGAUUUGUUAUUUUAUUA	18	1380
99
CFTR-3272-	+	AUGAUUUGUUAUUUUAUUA	19	1381
100
CFTR-3272-	+	UAUGAUUUGUUAUUUUAUUA	20	1382
101
CFTR-3272-	+	AUAUGAUUUGUUAUUUUAUUA	21	1383
102
CFTR-3272-	+	AGAUAUGAUUUGUUAUUUUAUUA	23	1384
103
CFTR-3272-	+	UAGAUAUGAUUUGUUAUUUUAUUA	24	1385
104
CFTR-3272-	−	UGGUAGCCAAGUAAAAAAA	19	1386
105
CFTR-3272-	−	CUGGUAGCCAAGUAAAAAAA	20	1387
106
CFTR-3272-	−	UCUGGUAGCCAAGUAAAAAAA	21	1388
107
CFTR-3272-	−	CUCUGGUAGCCAAGUAAAAAAA	22	1389
108
CFTR-3272-	−	UCUCUGGUAGCCAAGUAAAAAAA	23	1390
109
CFTR-3272-	−	AUCUCUGGUAGCCAAGUAAAAAAA	24	1391
110
CFTR-3272-	−	CUAUGGAAAUAUUUCACAGGC	21	1392
111
CFTR-3272-	−	UCUAUGGAAAUAUUUCACAGGC	22	1393
112
CFTR-3272-	−	UUCUAUGGAAAUAUUUCACAGGC	23	1394
113
CFTR-3272-	−	UUUCUAUGGAAAUAUUUCACAGGC	24	1395
114
CFTR-3272-	−	UGAAACUCUGUUCCACAAAGCU	22	1396
115
CFTR-3272-	−	UUGAAACUCUGUUCCACAAAGCU	23	1397
116
CFTR-3272-	−	UUUGAAACUCUGUUCCACAAAGCU	24	1398
117

Table 8E provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 8E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3272-118	+	UAACAAGAUGAGUGAAAA	18	1399
CFTR-3272-119	+	GUAACAAGAUGAGUGAAAA	19	1400
CFTR-3272-120	+	UGUAACAAGAUGAGUGAAAA	20	1401
CFTR-3272-121	+	UUGUAACAAGAUGAGUGAAAA	21	1402
CFTR-3272-122	+	CUUGUAACAAGAUGAGUGAAAA	22	1403
CFTR-3272-123	+	GCUUGUAACAAGAUGAGUGAAAA	23	1404
CFTR-3272-124	+	AGCUUGUAACAAGAUGAGUGAAAA	24	1405
CFTR-3272-125	+	GCCUGUGAAAUAUUUCCA	18	1406
CFTR-3272-126	+	UGCCUGUGAAAUAUUUCCA	19	1407
CFTR-3272-127	+	CUGCCUGUGAAAUAUUUCCA	20	1408
CFTR-3272-128	+	CCUGCCUGUGAAAUAUUUCCA	21	1409
CFTR-3272-129	+	UCCUGCCUGUGAAAUAUUUCCA	22	1410
CFTR-3272-130	+	CUCCUGCCUGUGAAAUAUUUCCA	23	1411
CFTR-3272-131	+	ACUCCUGCCUGUGAAAUAUUUCCA	24	1412
CFTR-3272-132	+	UUACUUGGCUACCAGAGA	18	1413
CFTR-3272-133	+	UUUACUUGGCUACCAGAGA	19	1414
CFTR-3272-25	+	UUUUACUUGGCUACCAGAGA	20	1306
CFTR-3272-134	+	UUUUUACUUGGCUACCAGAGA	21	1415
CFTR-3272-135	+	UUUUUUACUUGGCUACCAGAGA	22	1416
CFTR-3272-136	+	UUUUUUUACUUGGCUACCAGAGA	23	1417
CFTR-3272-137	+	CUUUUUUUACUUGGCUACCAGAGA	24	1418
CFTR-3272-138	+	AAGCUUGUAACAAGAUGA	18	1419
CFTR-3272-139	+	UAAGCUUGUAACAAGAUGA	19	1420
CFTR-3272-140	+	UUAAGCUUGUAACAAGAUGA	20	1421
CFTR-3272-141	+	UUUAAGCUUGUAACAAGAUGA	21	1422
CFTR-3272-142	+	UUUUAAGCUUGUAACAAGAUGA	22	1423
CFTR-3272-143	+	CUUUUAAGCUUGUAACAAGAUGA	23	1424
CFTR-3272-144	+	CCUUUUAAGCUUGUAACAAGAUGA	24	1425
CFTR-3272-145	+	CUUUUUUUACUUGGCUAC	18	1426
CFTR-3272-146	+	UCUUUUUUUACUUGGCUAC	19	1427
CFTR-3272-147	+	CUCUUUUUUUACUUGGCUAC	20	1428
CFTR-3272-148	+	CCUCUUUUUUUACUUGGCUAC	21	1429
CFTR-3272-149	+	CCCUCUUUUUUUACUUGGCUAC	22	1430
CFTR-3272-150	+	ACCCUCUUUUUUUACUUGGCUAC	23	1431
CFTR-3272-151	+	UACCCUCUUUUUUUACUUGGCUAC	24	1432
CFTR-3272-152	+	CGCAGUGUUGACAGGUAC	18	1433
CFTR-3272-153	+	GCGCAGUGUUGACAGGUAC	19	1434
CFTR-3272-154	+	AGCGCAGUGUUGACAGGUAC	20	1435
CFTR-3272-155	+	CAGCGCAGUGUUGACAGGUAC	21	1436
CFTR-3272-156	+	CCAGCGCAGUGUUGACAGGUAC	22	1437
CFTR-3272-157	+	ACCAGCGCAGUGUUGACAGGUAC	23	1438
CFTR-3272-158	+	AACCAGCGCAGUGUUGACAGGUAC	24	1439
CFTR-3272-159	+	UUUCAUAAUAUCUUGUAC	18	1440
CFTR-3272-160	+	AUUUCAUAAUAUCUUGUAC	19	1441
CFTR-3272-161	+	AAUUUCAUAAUAUCUUGUAC	20	1442
CFTR-3272-162	+	UAAUUUCAUAAUAUCUUGUAC	21	1443
CFTR-3272-163	+	GUAAUUUCAUAAUAUCUUGUAC	22	1444
CFTR-3272-164	+	UGUAAUUUCAUAAUAUCUUGUAC	23	1445
CFTR-3272-165	+	AUGUAAUUUCAUAAUAUCUUGUAC	24	1446
CFTR-3272-166	+	AGGCUGCCGUCCGAAGGC	18	1447
CFTR-3272-167	+	AAGGCUGCCGUCCGAAGGC	19	1448
CFTR-3272-168	+	UAAGGCUGCCGUCCGAAGGC	20	1449
CFTR-3272-169	+	GUAAGGCUGCCGUCCGAAGGC	21	1450
CFTR-3272-170	+	AGUAAGGCUGCCGUCCGAAGGC	22	1451
CFTR-3272-171	+	AAGUAAGGCUGCCGUCCGAAGGC	23	1452
CFTR-3272-172	+	AAAGUAAGGCUGCCGUCCGAAGGC	24	1453
CFTR-3272-173	+	UUUACUUGGCUACCAGAG	18	1454
CFTR-3272-174	+	UUUUACUUGGCUACCAGAG	19	1455
CFTR-3272-175	+	UUUUUACUUGGCUACCAGAG	20	1456
CFTR-3272-176	+	UUUUUUACUUGGCUACCAGAG	21	1457
CFTR-3272-177	+	UUUUUUUACUUGGCUACCAGAG	22	1458
CFTR-3272-178	+	CUUUUUUUACUUGGCUACCAGAG	23	1459
CFTR-3272-179	+	UCUUUUUUUACUUGGCUACCAGAG	24	1460
CFTR-3272-180	+	UGUAAAUUCAGAGCUUUG	18	1461
CFTR-3272-181	+	AUGUAAAUUCAGAGCUUUG	19	1462
CFTR-3272-35	+	UAUGUAAAUUCAGAGCUUUG	20	1316
CFTR-3272-182	+	GUAUGUAAAUUCAGAGCUUUG	21	1463
CFTR-3272-183	+	AGUAUGUAAAUUCAGAGCUUUG	22	1464
CFTR-3272-184	+	CAGUAUGUAAAUUCAGAGCUUUG	23	1465
CFTR-3272-185	+	GCAGUAUGUAAAUUCAGAGCUUUG	24	1466
CFTR-3272-186	+	UACUUGGCUACCAGAGAU	18	1467
CFTR-3272-187	+	UUACUUGGCUACCAGAGAU	19	1468
CFTR-3272-37	+	UUUACUUGGCUACCAGAGAU	20	1318
CFTR-3272-188	+	UUUUACUUGGCUACCAGAGAU	21	1469
CFTR-3272-189	+	UUUUUACUUGGCUACCAGAGAU	22	1470
CFTR-3272-190	+	UUUUUUACUUGGCUACCAGAGAU	23	1471
CFTR-3272-191	+	UUUUUUUACUUGGCUACCAGAGAU	24	1472
CFTR-3272-192	+	AAAAUUGGACUCCUGCCU	18	1473
CFTR-3272-193	+	GAAAAUUGGACUCCUGCCU	19	1474
CFTR-3272-194	+	UGAAAAUUGGACUCCUGCCU	20	1475
CFTR-3272-195	+	GUGAAAAUUGGACUCCUGCCU	21	1476
CFTR-3272-196	+	AGUGAAAAUUGGACUCCUGCCU	22	1477
CFTR-3272-197	+	GAGUGAAAAUUGGACUCCUGCCU	23	1478
CFTR-3272-198	+	UGAGUGAAAAUUGGACUCCUGCCU	24	1479
CFTR-3272-199	+	UCAAAGUAAGGCUGCCGU	18	1480
CFTR-3272-200	+	UUCAAAGUAAGGCUGCCGU	19	1481
CFTR-3272-201	+	UUUCAAAGUAAGGCUGCCGU	20	1482
CFTR-3272-202	+	GUUUCAAAGUAAGGCUGCCGU	21	1483
CFTR-3272-203	+	AGUUUCAAAGUAAGGCUGCCGU	22	1484
CFTR-3272-204	+	GAGUUUCAAAGUAAGGCUGCCGU	23	1485
CFTR-3272-205	+	AGAGUUUCAAAGUAAGGCUGCCGU	24	1486
CFTR-3272-206	+	GUUGGCAGUAUGUAAAUU	18	1487
CFTR-3272-207	+	AGUUGGCAGUAUGUAAAUU	19	1488
CFTR-3272-208	+	CAGUUGGCAGUAUGUAAAUU	20	1489
CFTR-3272-209	+	CCAGUUGGCAGUAUGUAAAUU	21	1490
CFTR-3272-210	+	ACCAGUUGGCAGUAUGUAAAUU	22	1491
CFTR-3272-211	+	AACCAGUUGGCAGUAUGUAAAUU	23	1492
CFTR-3272-212	+	GAACCAGUUGGCAGUAUGUAAAUU	24	1493
CFTR-3272-213	+	AUGUAAAUUCAGAGCUUU	18	1494
CFTR-3272-214	+	UAUGUAAAUUCAGAGCUUU	19	1495
CFTR-3272-215	+	GUAUGUAAAUUCAGAGCUUU	20	1496
CFTR-3272-216	+	AGUAUGUAAAUUCAGAGCUUU	21	1497
CFTR-3272-217	+	CAGUAUGUAAAUUCAGAGCUUU	22	1498
CFTR-3272-218	+	GCAGUAUGUAAAUUCAGAGCUUU	23	1499
CFTR-3272-219	+	GGCAGUAUGUAAAUUCAGAGCUUU	24	1500
CFTR-3272-220	−	CUGGUAGCCAAGUAAAAA	18	1501
CFTR-3272-221	−	UCUGGUAGCCAAGUAAAAA	19	1502
CFTR-3272-222	−	CUCUGGUAGCCAAGUAAAAA	20	1503
CFTR-3272-223	−	UCUCUGGUAGCCAAGUAAAAA	21	1504
CFTR-3272-224	−	AUCUCUGGUAGCCAAGUAAAAA	22	1505
CFTR-3272-225	−	CAUCUCUGGUAGCCAAGUAAAAA	23	1506
CFTR-3272-226	−	CCAUCUCUGGUAGCCAAGUAAAAA	24	1507
CFTR-3272-227	−	ACACUGCGCUGGUUCCAA	18	1508
CFTR-3272-228	−	AACACUGCGCUGGUUCCAA	19	1509
CFTR-3272-229	−	CAACACUGCGCUGGUUCCAA	20	1510
CFTR-3272-230	−	UCAACACUGCGCUGGUUCCAA	21	1511
CFTR-3272-231	−	GUCAACACUGCGCUGGUUCCAA	22	1512
CFTR-3272-232	−	UGUCAACACUGCGCUGGUUCCAA	23	1513
CFTR-3272-233	−	CUGUCAACACUGCGCUGGUUCCAA	24	1514
CFTR-3272-234	−	GCUGGUUCCAAAUGAGAA	18	1515
CFTR-3272-235	−	CGCUGGUUCCAAAUGAGAA	19	1516
CFTR-3272-236	−	GCGCUGGUUCCAAAUGAGAA	20	1517
CFTR-3272-237	−	UGCGCUGGUUCCAAAUGAGAA	21	1518
CFTR-3272-238	−	CUGCGCUGGUUCCAAAUGAGAA	22	1519
CFTR-3272-239	−	ACUGCGCUGGUUCCAAAUGAGAA	23	1520
CFTR-3272-240	−	CACUGCGCUGGUUCCAAAUGAGAA	24	1521
CFTR-3272-241	−	AUCUUGUUACAAGCUUAA	18	1522
CFTR-3272-242	−	CAUCUUGUUACAAGCUUAA	19	1523
CFTR-3272-243	−	UCAUCUUGUUACAAGCUUAA	20	1524
CFTR-3272-244	−	CUCAUCUUGUUACAAGCUUAA	21	1525
CFTR-3272-245	−	ACUCAUCUUGUUACAAGCUUAA	22	1526
CFTR-3272-246	−	CACUCAUCUUGUUACAAGCUUAA	23	1527
CFTR-3272-247	−	UCACUCAUCUUGUUACAAGCUUAA	24	1528
CFTR-3272-248	−	UAUUUGCAGUGUUUUCUA	18	1529
CFTR-3272-249	−	UUAUUUGCAGUGUUUUCUA	19	1530
CFTR-3272-42	−	GUUAUUUGCAGUGUUUUCUA	20	1323
CFTR-3272-250	−	UGUUAUUUGCAGUGUUUUCUA	21	1531
CFTR-3272-251	−	AUGUUAUUUGCAGUGUUUUCUA	22	1532
CFTR-3272-252	−	UAUGUUAUUUGCAGUGUUUUCUA	23	1533
CFTR-3272-253	−	UUAUGUUAUUUGCAGUGUUUUCUA	24	1534
CFTR-3272-254	−	AUGGAAAUAUUUCACAGG	18	1535
CFTR-3272-255	−	UAUGGAAAUAUUUCACAGG	19	1536
CFTR-3272-256	−	CUAUGGAAAUAUUUCACAGG	20	1537
CFTR-3272-257	−	UCUAUGGAAAUAUUUCACAGG	21	1538
CFTR-3272-258	−	UUCUAUGGAAAUAUUUCACAGG	22	1539
CFTR-3272-259	−	UUUCUAUGGAAAUAUUUCACAGG	23	1540
CFTR-3272-260	−	UUUUCUAUGGAAAUAUUUCACAGG	24	1541
CFTR-3272-261	−	UACAAGCUUAAAAGGACU	18	1542
CFTR-3272-262	−	UUACAAGCUUAAAAGGACU	19	1543
CFTR-3272-263	−	GUUACAAGCUUAAAAGGACU	20	1544
CFTR-3272-264	−	UGUUACAAGCUUAAAAGGACU	21	1545
CFTR-3272-265	−	UUGUUACAAGCUUAAAAGGACU	22	1546
CFTR-3272-266	−	CUUGUUACAAGCUUAAAAGGACU	23	1547
CFTR-3272-267	−	UCUUGUUACAAGCUUAAAAGGACU	24	1548
CFTR-3272-268	−	UCGGACGGCAGCCUUACU	18	1549
CFTR-3272-269	−	UUCGGACGGCAGCCUUACU	19	1550
CFTR-3272-270	−	CUUCGGACGGCAGCCUUACU	20	1551
CFTR-3272-271	−	CCUUCGGACGGCAGCCUUACU	21	1552
CFTR-3272-272	−	GCCUUCGGACGGCAGCCUUACU	22	1553
CFTR-3272-273	−	UGCCUUCGGACGGCAGCCUUACU	23	1554
CFTR-3272-274	−	GUGCCUUCGGACGGCAGCCUUACU	24	1555
CFTR-3272-275	−	UAUGGACACUUCGUGCCU	18	1556
CFTR-3272-276	−	CUAUGGACACUUCGUGCCU	19	1557
CFTR-3272-277	−	ACUAUGGACACUUCGUGCCU	20	1558
CFTR-3272-278	−	GACUAUGGACACUUCGUGCCU	21	1559
CFTR-3272-279	−	GGACUAUGGACACUUCGUGCCU	22	1560
CFTR-3272-280	−	AGGACUAUGGACACUUCGUGCCU	23	1561
CFTR-3272-281	−	AAGGACUAUGGACACUUCGUGCCU	24	1562
CFTR-3272-282	−	UUAUUUGCAGUGUUUUCU	18	1563
CFTR-3272-283	−	GUUAUUUGCAGUGUUUUCU	19	1564
CFTR-3272-284	−	UGUUAUUUGCAGUGUUUUCU	20	1565
CFTR-3272-285	−	AUGUUAUUUGCAGUGUUUUCU	21	1566
CFTR-3272-286	−	UAUGUUAUUUGCAGUGUUUUCU	22	1567
CFTR-3272-287	−	UUAUGUUAUUUGCAGUGUUUUCU	23	1568
CFTR-3272-288	−	UUUAUGUUAUUUGCAGUGUUUUCU	24	1569
CFTR-3272-289	−	UCAAAGAAUGGCACCAGU	18	1570
CFTR-3272-290	−	UUCAAAGAAUGGCACCAGU	19	1571
CFTR-3272-291	−	AUUCAAAGAAUGGCACCAGU	20	1572
CFTR-3272-292	−	UAUUCAAAGAAUGGCACCAGU	21	1573
CFTR-3272-293	−	CUAUUCAAAGAAUGGCACCAGU	22	1574
CFTR-3272-294	−	UCUAUUCAAAGAAUGGCACCAGU	23	1575
CFTR-3272-295	−	AUCUAUUCAAAGAAUGGCACCAGU	24	1576
CFTR-3272-296	−	UUUCAGGUACAAGAUAUU	18	1577
CFTR-3272-297	−	UUUUCAGGUACAAGAUAUU	19	1578
CFTR-3272-298	−	UUUUUCAGGUACAAGAUAUU	20	1579
CFTR-3272-299	−	CUUUUUCAGGUACAAGAUAUU	21	1580
CFTR-3272-300	−	UCUUUUUCAGGUACAAGAUAUU	22	1581
CFTR-3272-301	−	GUCUUUUUCAGGUACAAGAUAUU	23	1582
CFTR-3272-302	−	AGUCUUUUUCAGGUACAAGAUAUU	24	1583

Table 9A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 9A
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-	−	AUGGCACCAGUGUGAAA	17	1584
303
CFTR-3272-	+	UGCCAUUCUUUGAAUAG	17	1585
304
CFTR-3272-	+	UUGGCAGUAUGUAAAUU	17	1586
305
CFTR-3272-	+	AAGUGUCCAUAGUCCUU	17	1587
306
CFTR-3272-	−	AGAAUGGCACCAGUGUGAAA	20	1588
307
CFTR-3272-	+	UGGUGCCAUUCUUUGAAUAG	20	1589
308
CFTR-3272-	+	ACGAAGUGUCCAUAGUCCUU	20	1590
309

Table 9B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26A->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26A->G). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 9B
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-	+	ACAAAUGUCAUUGGUUA	17	1591
310
CFTR-3272-	−	AACCAAUGACAUUUGUG	17	1592
311
CFTR-3272-	−	UUUUCACUCAUCUUGUU	17	1593
312
CFTR-3272-	+	AUCACAAAUGUCAUUGGUUA	20	1594
313
CFTR-3272-	−	UUUAACCAAUGACAUUUGUG	20	1595
314
CFTR-3272-	+	CAGUUGGCAGUAUGUAAAUU	20	1489
208
CFTR-3272-	−	CAAUUUUCACUCAUCUUGUU	20	1596
315

Table 10A provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 10A
1st Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-1	−	GGGUAAGCUACUGUGAA	17	402
CFTR-DeltaF508-2	−	GAACUGGAGCCUUCAGA	17	401
CFTR-DeltaF508-3	+	GACUAACCGAUUGAAUA	17	403
CFTR-DeltaF508-4	−	GGUGAUUAUGGGAGAAC	17	400
CFTR-DeltaF508-5	+	GGUGCCAGGCAUAAUCC	17	394
CFTR-DeltaF508-6	−	GGUAAAAUUAAGCACAG	17	390
CFTR-DeltaF508-7	+	GUAUCUAUAUUCAUCAU	17	392
CFTR-DeltaF508-8	+	GAGCCAAAUAUAUAAUU	17	404
CFTR-DeltaF508-9	−	GGAGAACUGGAGCCUUCAGA	20	397
CFTR-DeltaF508-10	+	GUAGACUAACCGAUUGAAUA	20	398
CFTR-DeltaF508-11	+	GUCAUUAUCAAAUCACGCUC	20	399
CFTR-DeltaF508-12	−	GAGGGUAAAAUUAAGCACAG	20	387
CFTR-DeltaF508-13	−	GGGAGAACUGGAGCCUUCAG	20	396
CFTR-DeltaF508-14	−	GAUAAUGACCUAAUAAUGAU	20	395

Table 10B provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 10B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-15	+	AAUUUGGGUAGUGUGAA	17	449
CFTR-DeltaF508-16	−	CCAGACUUCACUUCUAA	17	438
CFTR-DeltaF508-17	−	UAAUGACCUAAUAAUGA	17	436
CFTR-DeltaF508-18	+	UUAAUUUUACCCUCUGA	17	418
CFTR-DeltaF508-19	+	UAAUUUGGGUAGUGUGA	17	448
CFTR-DeltaF508-20	−	UUUUCCUGGAUUAUGCC	17	414
CFTR-DeltaF508-21	+	UUUUCUUUAAUGGUGCC	17	417
CFTR-DeltaF508-22	−	UCUGUUCUCAGUUUUCC	17	413
CFTR-DeltaF508-23	+	AUUAUCAAAUCACGCUC	17	452
CFTR-DeltaF508-24	+	CCAUUAGAAGUGAAGUC	17	450
CFTR-DeltaF508-25	−	AGCAUGCCAACUAGAAG	17	391
CFTR-DeltaF508-26	−	AGAACUGGAGCCUUCAG	17	441
CFTR-DeltaF508-27	+	CAGUAGCUUACCCAUAG	17	446
CFTR-DeltaF508-28	−	UUGGCUCCAUAUUCAAU	17	443
CFTR-DeltaF508-29	−	CUUCUAAUGGUGAUUAU	17	440
CFTR-DeltaF508-30	+	UUCUUACCUCUUCUAGU	17	416
CFTR-DeltaF508-31	−	UACCCAAAUUAUAUAUU	17	442
CFTR-DeltaF508-32	−	UAUGGGUAAGCUACUGUGAA	20	428
CFTR-DeltaF508-33	+	UAUAAUUUGGGUAGUGUGAA	20	433
CFTR-DeltaF508-34	−	UUUCCAGACUUCACUUCUAA	20	420
CFTR-DeltaF508-35	+	ACCAAUGAUAUUUUCUUUAA	20	1597
CFTR-DeltaF508-36	−	UGAUAAUGACCUAAUAAUGA	20	419
CFTR-DeltaF508-37	+	UGCUUAAUUUUACCCUCUGA	20	412
CFTR-DeltaF508-38	+	AUAUAAUUUGGGUAGUGUGA	20	432
CFTR-DeltaF508-39	−	UUCACUUCUAAUGGUGAUUA	20	421
CFTR-DeltaF508-40	−	AAUGGUGAUUAUGGGAGAAC	20	423
CFTR-DeltaF508-41	−	CAGUUUUCCUGGAUUAUGCC	20	406
CFTR-DeltaF508-42	+	AUAUUUUCUUUAAUGGUGCC	20	411
CFTR-DeltaF508-43	+	AAUGGUGCCAGGCAUAAUCC	20	389
CFTR-DeltaF508-44	−	CAUUCUGUUCUCAGUUUUCC	20	405
CFTR-DeltaF508-45	+	UCACCAUUAGAAGUGAAGUC	20	434
CFTR-DeltaF508-46	−	CAAAGCAUGCCAACUAGAAG	20	408
CFTR-DeltaF508-47	+	UCACAGUAGCUUACCCAUAG	20	429
CFTR-DeltaF508-48	−	UAUUUGGCUCCAUAUUCAAU	20	425
CFTR-DeltaF508-49	+	UCUGUAUCUAUAUUCAUCAU	20	409
CFTR-DeltaF508-50	−	ACCAUUAAAGAAAAUAUCAU	20	1598
CFTR-DeltaF508-51	−	UCACUUCUAAUGGUGAUUAU	20	422
CFTR-DeltaF508-52	+	AGUUUCUUACCUCUUCUAGU	20	388
CFTR-DeltaF508-53	+	AUGGAGCCAAAUAUAUAAUU	20	430
CFTR-DeltaF508-54	−	CACUACCCAAAUUAUAUAUU	20	424

Table 10C provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 10C
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-55	+	AAUGAUAUUUUCUUUAA	17	1599
CFTR-DeltaF508-56	−	UAUUUAUGUUUCCUCUA	17	444
CFTR-DeltaF508-57	−	ACUUCUAAUGGUGAUUA	17	439
CFTR-DeltaF508-58	−	AUUAAAGAAAAUAUCAU	17	1600
CFTR-DeltaF508-59	−	AAUGACCUAAUAAUGAU	17	437
CFTR-DeltaF508-60	−	AUUUAUGUUUCCUCUAU	17	445
CFTR-DeltaF508-61	+	UAAAACCCAUCAUUAUU	17	451
CFTR-DeltaF508-62	+	AGCCAAAUAUAUAAUUU	17	447
CFTR-DeltaF508-63	−	AUAUAUUUAUGUUUCCUCUA	20	426
CFTR-DeltaF508-64	−	UAUAUUUAUGUUUCCUCUAU	20	427
CFTR-DeltaF508-65	+	AAAUAAAACCCAUCAUUAUU	20	435
CFTR-DeltaF508-66	+	UGGAGCCAAAUAUAUAAUUU	20	431

Table 11A provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 11A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-67	+	GAAUAUGGAGCCAAAUAUAUAAU	23	1601
CFTR-DeltaF508-68	+	GUCAUUAUCAAAUCACGCU	19	1602
CFTR-DeltaF508-69	+	GGUCAUUAUCAAAUCACGCU	20	676
CFTR-DeltaF508-70	−	GGAGAACUGGAGCCUUCA	18	1603
CFTR-DeltaF508-71	−	GGGAGAACUGGAGCCUUCA	19	1604
CFTR-DeltaF508-72	−	GUAAAAUUAAGCACAGUGG	19	1605
CFTR-DeltaF508-73	−	GGUAAAAUUAAGCACAGUGG	20	663
CFTR-DeltaF508-74	−	GGGUAAAAUUAAGCACAGUGG	21	1606
CFTR-DeltaF508-75	−	GAGGGUAAAAUUAAGCACAGUGG	23	1607
CFTR-DeltaF508-76	−	GAUAAUGACCUAAUAAUG	18	1608
CFTR-DeltaF508-77	−	GAUUUGAUAAUGACCUAAUAAUG	23	1609
CFTR-DeltaF508-78	−	GUUUCCUCUAUGGGUAAGCUACU	23	1610

Table 11B provides exemplary targeting domains for correcting a mutation (e.g., deltaF8) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 11B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-79	+	AUCCAGGAAAACUGAGAA	18	1611
CFTR-DeltaF508-80	+	AAUCCAGGAAAACUGAGAA	19	1612
CFTR-DeltaF508-81	+	UAAUCCAGGAAAACUGAGAA	20	682
CFTR-DeltaF508-82	+	UAUAUGUAGACUAACCGA	18	1613
CFTR-DeltaF508-83	+	AUAUAUGUAGACUAACCGA	19	1614
CFTR-DeltaF508-84	+	AAUAUAUGUAGACUAACCGA	20	691
CFTR-DeltaF508-85	+	AAAUAUAUGUAGACUAACCGA	21	1615
CFTR-DeltaF508-86	+	UAAAUAUAUGUAGACUAACCGA	22	1616
CFTR-DeltaF508-87	+	AUAAAUAUAUGUAGACUAACCGA	23	1617
CFTR-DeltaF508-88	+	CAUAAAUAUAUGUAGACUAACCGA	24	1618
CFTR-DeltaF508-89	+	UAUAAUUUGGGUAGUGUG	18	1619
CFTR-DeltaF508-90	+	AUAUAAUUUGGGUAGUGUG	19	1620
CFTR-DeltaF508-91	+	UAUAUAAUUUGGGUAGUGUG	20	687
CFTR-DeltaF508-92	+	AUAUAUAAUUUGGGUAGUGUG	21	1621
CFTR-DeltaF508-93	+	AAUAUAUAAUUUGGGUAGUGUG	22	1622
CFTR-DeltaF508-94	+	AAAUAUAUAAUUUGGGUAGUGUG	23	1623
CFTR-DeltaF508-95	+	CAAAUAUAUAAUUUGGGUAGUGUG	24	1624
CFTR-DeltaF508-96	+	UGGAGCCAAAUAUAUAAU	18	1625
CFTR-DeltaF508-97	+	AUGGAGCCAAAUAUAUAAU	19	1626
CFTR-DeltaF508-98	+	UAUGGAGCCAAAUAUAUAAU	20	689
CFTR-DeltaF508-99	+	AUAUGGAGCCAAAUAUAUAAU	21	1627
CFTR-DeltaF508-100	+	AAUAUGGAGCCAAAUAUAUAAU	22	1628
CFTR-DeltaF508-101	+	UGAAUAUGGAGCCAAAUAUAUAAU	24	1629
CFTR-DeltaF508-102	+	UCAUUAUCAAAUCACGCU	18	1630
CFTR-DeltaF508-103	+	AGGUCAUUAUCAAAUCACGCU	21	1631
CFTR-DeltaF508-104	+	UAGGUCAUUAUCAAAUCACGCU	22	1632
CFTR-DeltaF508-105	+	UUAGGUCAUUAUCAAAUCACGCU	23	1633
CFTR-DeltaF508-106	+	AUUAGGUCAUUAUCAAAUCACGCU	24	1634
CFTR-DeltaF508-107	−	UGGGAGAACUGGAGCCUUCA	20	661
CFTR-DeltaF508-108	−	AUGGGUAAGCUACUGUGA	18	1635
CFTR-DeltaF508-109	−	UAUGGGUAAGCUACUGUGA	19	1636
CFTR-DeltaF508-110	−	CUAUGGGUAAGCUACUGUGA	20	675
CFTR-DeltaF508-111	−	UCUAUGGGUAAGCUACUGUGA	21	1637
CFTR-DeltaF508-112	−	CUCUAUGGGUAAGCUACUGUGA	22	1638
CFTR-DeltaF508-113	−	CCUCUAUGGGUAAGCUACUGUGA	23	1639
CFTR-DeltaF508-114	−	UCCUCUAUGGGUAAGCUACUGUGA	24	1640
CFTR-DeltaF508-115	−	AUUCUGUUCUCAGUUUUC	18	1641
CFTR-DeltaF508-116	−	CAUUCUGUUCUCAGUUUUC	19	1642
CFTR-DeltaF508-117	−	UCAUUCUGUUCUCAGUUUUC	20	664
CFTR-DeltaF508-118	−	UUCAUUCUGUUCUCAGUUUUC	21	1643
CFTR-DeltaF508-119	−	UUUCAUUCUGUUCUCAGUUUUC	22	1644
CFTR-DeltaF508-120	−	AUUUCAUUCUGUUCUCAGUUUUC	23	1645
CFTR-DeltaF508-121	−	AAUUUCAUUCUGUUCUCAGUUUUC	24	1646
CFTR-DeltaF508-122	−	UAAAAUUAAGCACAGUGG	18	1647
CFTR-DeltaF508-123	−	AGGGUAAAAUUAAGCACAGUGG	22	1648
CFTR-DeltaF508-124	−	AGAGGGUAAAAUUAAGCACAGUGG	24	1649
CFTR-DeltaF508-125	−	UGAUAAUGACCUAAUAAUG	19	1650
CFTR-DeltaF508-126	−	UUGAUAAUGACCUAAUAAUG	20	656
CFTR-DeltaF508-127	−	UUUGAUAAUGACCUAAUAAUG	21	1651
CFTR-DeltaF508-128	−	AUUUGAUAAUGACCUAAUAAUG	22	1652
CFTR-DeltaF508-129	−	UGAUUUGAUAAUGACCUAAUAAUG	24	1653
CFTR-DeltaF508-130	−	UCAUUGGUGUUUCCUAUG	18	1654
CFTR-DeltaF508-131	−	AUCAUUGGUGUUUCCUAUG	19	1655
CFTR-DeltaF508-132	−	UAUCAUUGGUGUUUCCUAUG	20	1656
CFTR-DeltaF508-133	−	AUAUCAUUGGUGUUUCCUAUG	21	1657
CFTR-DeltaF508-134	−	AAUAUCAUUGGUGUUUCCUAUG	22	1658
CFTR-DeltaF508-135	−	AAAUAUCAUUGGUGUUUCCUAUG	23	1659
CFTR-DeltaF508-136	−	AAAAUAUCAUUGGUGUUUCCUAUG	24	1660
CFTR-DeltaF508-137	−	CUCUAUGGGUAAGCUACU	18	1661
CFTR-DeltaF508-138	−	CCUCUAUGGGUAAGCUACU	19	1662
CFTR-DeltaF508-139	−	UCCUCUAUGGGUAAGCUACU	20	674
CFTR-DeltaF508-140	−	UUCCUCUAUGGGUAAGCUACU	21	1663
CFTR-DeltaF508-141	−	UUUCCUCUAUGGGUAAGCUACU	22	1664
CFTR-DeltaF508-142	−	UGUUUCCUCUAUGGGUAAGCUACU	24	1665
CFTR-DeltaF508-143	−	UAUAUUUAUGUUUCCUCU	18	1666
CFTR-DeltaF508-144	−	AUAUAUUUAUGUUUCCUCU	19	1667
CFTR-DeltaF508-145	−	CAUAUAUUUAUGUUUCCUCU	20	673
CFTR-DeltaF508-146	−	ACAUAUAUUUAUGUUUCCUCU	21	1668
CFTR-DeltaF508-147	−	UACAUAUAUUUAUGUUUCCUCU	22	1669
CFTR-DeltaF508-148	−	CUACAUAUAUUUAUGUUUCCUCU	23	1670
CFTR-DeltaF508-149	−	UCUACAUAUAUUUAUGUUUCCUCU	24	1671

Table 11C provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 11C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-	+	GCAUAAUCCAGGAAAACU	23	1672
DeltaF508-		GAGAA
150
CFTR-	+	GGCAUAAUCCAGGAAAACU	24	1673
DeltaF508-		GAGAA
151

Table 11D provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 11D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-152	+	AUAAUCCAGGAAAACUGAGAA	21	1674
CFTR-DeltaF508-153	+	CAUAAUCCAGGAAAACUGAGAA	22	1675
CFTR-DeltaF508-154	−	AUGGGAGAACUGGAGCCUUCA	21	1676
CFTR-DeltaF508-155	−	UAUGGGAGAACUGGAGCCUUCA	22	1677
CFTR-DeltaF508-156	−	UUAUGGGAGAACUGGAGCCUUCA	23	1678
CFTR-DeltaF508-157	−	AUUAUGGGAGAACUGGAGCCUUCA	24	1679

Table 11E provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 11E
5th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-158	+	AGGCAUAAUCCAGGAAAA	18	1680
CFTR-DeltaF508-159	+	CAGGCAUAAUCCAGGAAAA	19	1681
CFTR-DeltaF508-160	+	CCAGGCAUAAUCCAGGAAAA	20	684
CFTR-DeltaF508-161	+	GCCAGGCAUAAUCCAGGAAAA	21	1682
CFTR-DeltaF508-162	+	UGCCAGGCAUAAUCCAGGAAAA	22	1683
CFTR-DeltaF508-163	+	GUGCCAGGCAUAAUCCAGGAAAA	23	1684
CFTR-DeltaF508-164	+	GGUGCCAGGCAUAAUCCAGGAAAA	24	1685
CFTR-DeltaF508-165	+	CCAUAAUCACCAUUAGAA	18	1686
CFTR-DeltaF508-166	+	CCCAUAAUCACCAUUAGAA	19	1687
CFTR-DeltaF508-167	+	UCCCAUAAUCACCAUUAGAA	20	678
CFTR-DeltaF508-168	+	CUCCCAUAAUCACCAUUAGAA	21	1688
CFTR-DeltaF508-169	+	UCUCCCAUAAUCACCAUUAGAA	22	1689
CFTR-DeltaF508-170	+	UUCUCCCAUAAUCACCAUUAGAA	23	1690
CFTR-DeltaF508-171	+	GUUCUCCCAUAAUCACCAUUAGAA	24	1691
CFTR-DeltaF508-172	+	UUCACAGUAGCUUACCCA	18	1692
CFTR-DeltaF508-173	+	AUUCACAGUAGCUUACCCA	19	1693
CFTR-DeltaF508-174	+	CAUUCACAGUAGCUUACCCA	20	693
CFTR-DeltaF508-175	+	CCAUUCACAGUAGCUUACCCA	21	1694
CFTR-DeltaF508-176	+	UCCAUUCACAGUAGCUUACCCA	22	1695
CFTR-DeltaF508-177	+	AUCCAUUCACAGUAGCUUACCCA	23	1696
CFTR-DeltaF508-178	+	GAUCCAUUCACAGUAGCUUACCCA	24	1697
CFTR-DeltaF508-179	+	CUGUAUCUAUAUUCAUCA	18	1698
CFTR-DeltaF508-180	+	UCUGUAUCUAUAUUCAUCA	19	1699
CFTR-DeltaF508-181	+	UUCUGUAUCUAUAUUCAUCA	20	686
CFTR-DeltaF508-182	+	CUUCUGUAUCUAUAUUCAUCA	21	1700
CFTR-DeltaF508-183	+	GCUUCUGUAUCUAUAUUCAUCA	22	1701
CFTR-DeltaF508-184	+	CGCUUCUGUAUCUAUAUUCAUCA	23	1702
CFTR-DeltaF508-185	+	ACGCUUCUGUAUCUAUAUUCAUCA	24	1703
CFTR-DeltaF508-186	+	AGGAAAACUGAGAACAGA	18	1704
CFTR-DeltaF508-187	+	CAGGAAAACUGAGAACAGA	19	1705
CFTR-DeltaF508-188	+	CCAGGAAAACUGAGAACAGA	20	681
CFTR-DeltaF508-189	+	UCCAGGAAAACUGAGAACAGA	21	1706
CFTR-DeltaF508-190	+	AUCCAGGAAAACUGAGAACAGA	22	1707
CFTR-DeltaF508-191	+	AAUCCAGGAAAACUGAGAACAGA	23	1708
CFTR-DeltaF508-192	+	UAAUCCAGGAAAACUGAGAACAGA	24	1709
CFTR-DeltaF508-193	+	AGACUAACCGAUUGAAUA	18	1710
CFTR-DeltaF508-194	+	UAGACUAACCGAUUGAAUA	19	1711
CFTR-DeltaF508-10	+	GUAGACUAACCGAUUGAAUA	20	398
CFTR-DeltaF508-195	+	UGUAGACUAACCGAUUGAAUA	21	1712
CFTR-DeltaF508-196	+	AUGUAGACUAACCGAUUGAAUA	22	1713
CFTR-DeltaF508-197	+	UAUGUAGACUAACCGAUUGAAUA	23	1714
CFTR-DeltaF508-198	+	AUAUGUAGACUAACCGAUUGAAUA	24	1715
CFTR-DeltaF508-199	+	CACAGUAGCUUACCCAUA	18	1716
CFTR-DeltaF508-200	+	UCACAGUAGCUUACCCAUA	19	1717
CFTR-DeltaF508-201	+	UUCACAGUAGCUUACCCAUA	20	692
CFTR-DeltaF508-202	+	AUUCACAGUAGCUUACCCAUA	21	1718
CFTR-DeltaF508-203	+	CAUUCACAGUAGCUUACCCAUA	22	1719
CFTR-DeltaF508-204	+	CCAUUCACAGUAGCUUACCCAUA	23	1720
CFTR-DeltaF508-205	+	UCCAUUCACAGUAGCUUACCCAUA	24	1721
CFTR-DeltaF508-206	+	UGGUGCCAGGCAUAAUCC	18	1722
CFTR-DeltaF508-207	+	AUGGUGCCAGGCAUAAUCC	19	1723
CFTR-DeltaF508-43	+	AAUGGUGCCAGGCAUAAUCC	20	389
CFTR-DeltaF508-208	+	UAAUGGUGCCAGGCAUAAUCC	21	1724
CFTR-DeltaF508-209	+	UUAAUGGUGCCAGGCAUAAUCC	22	1725
CFTR-DeltaF508-210	+	UUUAAUGGUGCCAGGCAUAAUCC	23	1726
CFTR-DeltaF508-211	+	CUUUAAUGGUGCCAGGCAUAAUCC	24	1727
CFTR-DeltaF508-212	+	AUGGUGCCAGGCAUAAUC	18	1728
CFTR-DeltaF508-213	+	AAUGGUGCCAGGCAUAAUC	19	1729
CFTR-DeltaF508-214	+	UAAUGGUGCCAGGCAUAAUC	20	685
CFTR-DeltaF508-215	+	UUAAUGGUGCCAGGCAUAAUC	21	1730
CFTR-DeltaF508-216	+	UUUAAUGGUGCCAGGCAUAAUC	22	1731
CFTR-DeltaF508-217	+	CUUUAAUGGUGCCAGGCAUAAUC	23	1732
CFTR-DeltaF508-218	+	UCUUUAAUGGUGCCAGGCAUAAUC	24	1733
CFTR-DeltaF508-219	+	ACCAUUAGAAGUGAAGUC	18	1734
CFTR-DeltaF508-220	+	CACCAUUAGAAGUGAAGUC	19	1735
CFTR-DeltaF508-45	+	UCACCAUUAGAAGUGAAGUC	20	434
CFTR-DeltaF508-221	+	AUCACCAUUAGAAGUGAAGUC	21	1736
CFTR-DeltaF508-222	+	AAUCACCAUUAGAAGUGAAGUC	22	1737
CFTR-DeltaF508-223	+	UAAUCACCAUUAGAAGUGAAGUC	23	1738
CFTR-DeltaF508-224	+	AUAAUCACCAUUAGAAGUGAAGUC	24	1739
CFTR-DeltaF508-225	+	ACAGUAGCUUACCCAUAG	18	1740
CFTR-DeltaF508-226	+	CACAGUAGCUUACCCAUAG	19	1741
CFTR-DeltaF508-47	+	UCACAGUAGCUUACCCAUAG	20	429
CFTR-DeltaF508-227	+	UUCACAGUAGCUUACCCAUAG	21	1742
CFTR-DeltaF508-228	+	AUUCACAGUAGCUUACCCAUAG	22	1743
CFTR-DeltaF508-229	+	CAUUCACAGUAGCUUACCCAUAG	23	1744
CFTR-DeltaF508-230	+	CCAUUCACAGUAGCUUACCCAUAG	24	1745
CFTR-DeltaF508-231	+	UAGACUAACCGAUUGAAU	18	1746
CFTR-DeltaF508-232	+	GUAGACUAACCGAUUGAAU	19	1747
CFTR-DeltaF508-233	+	UGUAGACUAACCGAUUGAAU	20	690
CFTR-DeltaF508-234	+	AUGUAGACUAACCGAUUGAAU	21	1748
CFTR-DeltaF508-235	+	UAUGUAGACUAACCGAUUGAAU	22	1749
CFTR-DeltaF508-236	+	AUAUGUAGACUAACCGAUUGAAU	23	1750
CFTR-DeltaF508-237	+	UAUAUGUAGACUAACCGAUUGAAU	24	1751
CFTR-DeltaF508-238	+	UUCUCCCAUAAUCACCAU	18	1752
CFTR-DeltaF508-239	+	GUUCUCCCAUAAUCACCAU	19	1753
CFTR-DeltaF508-240	+	AGUUCUCCCAUAAUCACCAU	20	679
CFTR-DeltaF508-241	+	CAGUUCUCCCAUAAUCACCAU	21	1754
CFTR-DeltaF508-242	+	CCAGUUCUCCCAUAAUCACCAU	22	1755
CFTR-DeltaF508-243	+	UCCAGUUCUCCCAUAAUCACCAU	23	1756
CFTR-DeltaF508-244	+	CUCCAGUUCUCCCAUAAUCACCAU	24	1757
CFTR-DeltaF508-245	+	UGUAUCUAUAUUCAUCAU	18	1758
CFTR-DeltaF508-246	+	CUGUAUCUAUAUUCAUCAU	19	1759
CFTR-DeltaF508-49	+	UCUGUAUCUAUAUUCAUCAU	20	409
CFTR-DeltaF508-247	+	UUCUGUAUCUAUAUUCAUCAU	21	1760
CFTR-DeltaF508-248	+	CUUCUGUAUCUAUAUUCAUCAU	22	1761
CFTR-DeltaF508-249	+	GCUUCUGUAUCUAUAUUCAUCAU	23	1762
CFTR-DeltaF508-250	+	CGCUUCUGUAUCUAUAUUCAUCAU	24	1763
CFTR-DeltaF508-251	+	GCAUAAUCCAGGAAAACU	18	1764
CFTR-DeltaF508-252	+	GGCAUAAUCCAGGAAAACU	19	1765
CFTR-DeltaF508-253	+	AGGCAUAAUCCAGGAAAACU	20	683
CFTR-DeltaF508-254	+	CAGGCAUAAUCCAGGAAAACU	21	1766
CFTR-DeltaF508-255	+	CCAGGCAUAAUCCAGGAAAACU	22	1767
CFTR-DeltaF508-256	+	GCCAGGCAUAAUCCAGGAAAACU	23	1768
CFTR-DeltaF508-257	+	UGCCAGGCAUAAUCCAGGAAAACU	24	1769
CFTR-DeltaF508-258	+	UGUGCUUAAUUUUACCCU	18	1770
CFTR-DeltaF508-259	+	CUGUGCUUAAUUUUACCCU	19	1771
CFTR-DeltaF508-260	+	ACUGUGCUUAAUUUUACCCU	20	680
CFTR-DeltaF508-261	+	CACUGUGCUUAAUUUUACCCU	21	1772
CFTR-DeltaF508-262	+	CCACUGUGCUUAAUUUUACCCU	22	1773
CFTR-DeltaF508-263	+	UCCACUGUGCUUAAUUUUACCCU	23	1774
CFTR-DeltaF508-264	+	UUCCACUGUGCUUAAUUUUACCCU	24	1775
CFTR-DeltaF508-265	+	CACCAUUAGAAGUGAAGU	18	1776
CFTR-DeltaF508-266	+	UCACCAUUAGAAGUGAAGU	19	1777
CFTR-DeltaF508-267	+	AUCACCAUUAGAAGUGAAGU	20	677
CFTR-DeltaF508-268	+	AAUCACCAUUAGAAGUGAAGU	21	1778
CFTR-DeltaF508-269	+	UAAUCACCAUUAGAAGUGAAGU	22	1779
CFTR-DeltaF508-270	+	AUAAUCACCAUUAGAAGUGAAGU	23	1780
CFTR-DeltaF508-271	+	CAUAAUCACCAUUAGAAGUGAAGU	24	1781
CFTR-DeltaF508-272	+	AUAUAUAAUUUGGGUAGU	18	1782
CFTR-DeltaF508-273	+	AAUAUAUAAUUUGGGUAGU	19	1783
CFTR-DeltaF508-274	+	AAAUAUAUAAUUUGGGUAGU	20	688
CFTR-DeltaF508-275	+	CAAAUAUAUAAUUUGGGUAGU	21	1784
CFTR-DeltaF508-276	+	CCAAAUAUAUAAUUUGGGUAGU	22	1785
CFTR-DeltaF508-277	+	GCCAAAUAUAUAAUUUGGGUAGU	23	1786
CFTR-DeltaF508-278	+	AGCCAAAUAUAUAAUUUGGGUAGU	24	1787
CFTR-DeltaF508-279	−	AUGGUGAUUAUGGGAGAA	18	1788
CFTR-DeltaF508-280	−	AAUGGUGAUUAUGGGAGAA	19	1789
CFTR-DeltaF508-281	−	UAAUGGUGAUUAUGGGAGAA	20	659
CFTR-DeltaF508-282	−	CUAAUGGUGAUUAUGGGAGAA	21	1790
CFTR-DeltaF508-283	−	UCUAAUGGUGAUUAUGGGAGAA	22	1791
CFTR-DeltaF508-284	−	UUCUAAUGGUGAUUAUGGGAGAA	23	1792
CFTR-DeltaF508-285	−	CUUCUAAUGGUGAUUAUGGGAGAA	24	1793
CFTR-DeltaF508-286	−	AGGGUAAAAUUAAGCACA	18	1794
CFTR-DeltaF508-287	−	GAGGGUAAAAUUAAGCACA	19	1795
CFTR-DeltaF508-288	−	AGAGGGUAAAAUUAAGCACA	20	662
CFTR-DeltaF508-289	−	CAGAGGGUAAAAUUAAGCACA	21	1796
CFTR-DeltaF508-290	−	UCAGAGGGUAAAAUUAAGCACA	22	1797
CFTR-DeltaF508-291	−	UUCAGAGGGUAAAAUUAAGCACA	23	1798
CFTR-DeltaF508-292	−	CUUCAGAGGGUAAAAUUAAGCACA	24	1799
CFTR-DeltaF508-293	−	CUAUGAUGAAUAUAGAUA	18	1800
CFTR-DeltaF508-294	−	CCUAUGAUGAAUAUAGAUA	19	1801
CFTR-DeltaF508-295	−	UCCUAUGAUGAAUAUAGAUA	20	667
CFTR-DeltaF508-296	−	UUCCUAUGAUGAAUAUAGAUA	21	1802
CFTR-DeltaF508-297	−	UUUCCUAUGAUGAAUAUAGAUA	22	1803
CFTR-DeltaF508-298	−	GUUUCCUAUGAUGAAUAUAGAUA	23	1804
CFTR-DeltaF508-299	−	UGUUUCCUAUGAUGAAUAUAGAUA	24	1805
CFTR-DeltaF508-300	−	UUAUGCCUGGCACCAUUA	18	1806
CFTR-DeltaF508-301	−	AUUAUGCCUGGCACCAUUA	19	1807
CFTR-DeltaF508-302	−	GAUUAUGCCUGGCACCAUUA	20	665
CFTR-DeltaF508-303	−	GGAUUAUGCCUGGCACCAUUA	21	1808
CFTR-DeltaF508-304	−	UGGAUUAUGCCUGGCACCAUUA	22	1809
CFTR-DeltaF508-305	−	CUGGAUUAUGCCUGGCACCAUUA	23	1810
CFTR-DeltaF508-306	−	CCUGGAUUAUGCCUGGCACCAUUA	24	1811
CFTR-DeltaF508-307	−	CACUUCUAAUGGUGAUUA	18	1812
CFTR-DeltaF508-308	−	UCACUUCUAAUGGUGAUUA	19	1813
CFTR-DeltaF508-39	−	UUCACUUCUAAUGGUGAUUA	20	421
CFTR-DeltaF508-309	−	CUUCACUUCUAAUGGUGAUUA	21	1814
CFTR-DeltaF508-310	−	ACUUCACUUCUAAUGGUGAUUA	22	1815
CFTR-DeltaF508-311	−	GACUUCACUUCUAAUGGUGAUUA	23	1816
CFTR-DeltaF508-312	−	AGACUUCACUUCUAAUGGUGAUUA	24	1817
CFTR-DeltaF508-313	−	UCAUCAAAGCAUGCCAAC	18	1818
CFTR-DeltaF508-314	−	GUCAUCAAAGCAUGCCAAC	19	1819
CFTR-DeltaF508-315	−	CGUCAUCAAAGCAUGCCAAC	20	668
CFTR-DeltaF508-316	−	GCGUCAUCAAAGCAUGCCAAC	21	1820
CFTR-DeltaF508-317	−	AGCGUCAUCAAAGCAUGCCAAC	22	1821
CFTR-DeltaF508-318	−	AAGCGUCAUCAAAGCAUGCCAAC	23	1822
CFTR-DeltaF508-319	−	GAAGCGUCAUCAAAGCAUGCCAAC	24	1823
CFTR-DeltaF508-320	−	UGGUGAUUAUGGGAGAAC	18	1824
CFTR-DeltaF508-321	−	AUGGUGAUUAUGGGAGAAC	19	1825
CFTR-DeltaF508-40	−	AAUGGUGAUUAUGGGAGAAC	20	423
CFTR-DeltaF508-322	−	UAAUGGUGAUUAUGGGAGAAC	21	1826
CFTR-DeltaF508-323	−	CUAAUGGUGAUUAUGGGAGAAC	22	1827
CFTR-DeltaF508-324	−	UCUAAUGGUGAUUAUGGGAGAAC	23	1828
CFTR-DeltaF508-325	−	UUCUAAUGGUGAUUAUGGGAGAAC	24	1829
CFTR-DeltaF508-326	−	AUUGGAGGCAAGUGAAUC	18	1830
CFTR-DeltaF508-327	−	AAUUGGAGGCAAGUGAAUC	19	1831
CFTR-DeltaF508-328	−	UAAUUGGAGGCAAGUGAAUC	20	655
CFTR-DeltaF508-329	−	GGGUAAAAUUAAGCACAG	18	1832
CFTR-DeltaF508-330	−	AGGGUAAAAUUAAGCACAG	19	1833
CFTR-DeltaF508-12	−	GAGGGUAAAAUUAAGCACAG	20	387
CFTR-DeltaF508-331	−	AGAGGGUAAAAUUAAGCACAG	21	1834
CFTR-DeltaF508-332	−	CAGAGGGUAAAAUUAAGCACAG	22	1835
CFTR-DeltaF508-333	−	UCAGAGGGUAAAAUUAAGCACAG	23	1836
CFTR-DeltaF508-334	−	UUCAGAGGGUAAAAUUAAGCACAG	24	1837
CFTR-DeltaF508-335	−	UCAAAGCAUGCCAACUAG	18	1838
CFTR-DeltaF508-336	−	AUCAAAGCAUGCCAACUAG	19	1839
CFTR-DeltaF508-337	−	CAUCAAAGCAUGCCAACUAG	20	669
CFTR-DeltaF508-338	−	UCAUCAAAGCAUGCCAACUAG	21	1840
CFTR-DeltaF508-339	−	GUCAUCAAAGCAUGCCAACUAG	22	1841
CFTR-DeltaF508-340	−	CGUCAUCAAAGCAUGCCAACUAG	23	1842
CFTR-DeltaF508-341	−	GCGUCAUCAAAGCAUGCCAACUAG	24	1843
CFTR-DeltaF508-342	−	UUCUAAUGGUGAUUAUGG	18	1844
CFTR-DeltaF508-343	−	CUUCUAAUGGUGAUUAUGG	19	1845
CFTR-DeltaF508-344	−	ACUUCUAAUGGUGAUUAUGG	20	658
CFTR-DeltaF508-345	−	CACUUCUAAUGGUGAUUAUGG	21	1846
CFTR-DeltaF508-346	−	UCACUUCUAAUGGUGAUUAUGG	22	1847
CFTR-DeltaF508-347	−	UUCACUUCUAAUGGUGAUUAUGG	23	1848
CFTR-DeltaF508-348	−	CUUCACUUCUAAUGGUGAUUAUGG	24	1849
CFTR-DeltaF508-349	−	AACUUUUUGAUUAUGCAU	18	1850
CFTR-DeltaF508-350	−	AAACUUUUUGAUUAUGCAU	19	1851
CFTR-DeltaF508-351	−	AAAACUUUUUGAUUAUGCAU	20	672
CFTR-DeltaF508-352	−	GAAAACUUUUUGAUUAUGCAU	21	1852
CFTR-DeltaF508-353	−	UGAAAACUUUUUGAUUAUGCAU	22	1853
CFTR-DeltaF508-354	−	GUGAAAACUUUUUGAUUAUGCAU	23	1854
CFTR-DeltaF508-355	−	UGUGAAAACUUUUUGAUUAUGCAU	24	1855
CFTR-DeltaF508-356	−	GAAGAGGUAAGAAACUAU	18	1856
CFTR-DeltaF508-357	−	AGAAGAGGUAAGAAACUAU	19	1857
CFTR-DeltaF508-358	−	UAGAAGAGGUAAGAAACUAU	20	671
CFTR-DeltaF508-359	−	CUAGAAGAGGUAAGAAACUAU	21	1858
CFTR-DeltaF508-360	−	ACUAGAAGAGGUAAGAAACUAU	22	1859
CFTR-DeltaF508-361	−	AACUAGAAGAGGUAAGAAACUAU	23	1860
CFTR-DeltaF508-362	−	CAACUAGAAGAGGUAAGAAACUAU	24	1861
CFTR-DeltaF508-363	−	ACUUCUAAUGGUGAUUAU	18	1862
CFTR-DeltaF508-364	−	CACUUCUAAUGGUGAUUAU	19	1863
CFTR-DeltaF508-51	−	UCACUUCUAAUGGUGAUUAU	20	422
CFTR-DeltaF508-365	−	UUCACUUCUAAUGGUGAUUAU	21	1864
CFTR-DeltaF508-366	−	CUUCACUUCUAAUGGUGAUUAU	22	1865
CFTR-DeltaF508-367	−	ACUUCACUUCUAAUGGUGAUUAU	23	1866
CFTR-DeltaF508-368	−	GACUUCACUUCUAAUGGUGAUUAU	24	1867
CFTR-DeltaF508-369	−	AUGCCAACUAGAAGAGGU	18	1868
CFTR-DeltaF508-370	−	CAUGCCAACUAGAAGAGGU	19	1869
CFTR-DeltaF508-371	−	GCAUGCCAACUAGAAGAGGU	20	670
CFTR-DeltaF508-372	−	AGCAUGCCAACUAGAAGAGGU	21	1870
CFTR-DeltaF508-373	−	AAGCAUGCCAACUAGAAGAGGU	22	1871
CFTR-DeltaF508-374	−	AAAGCAUGCCAACUAGAAGAGGU	23	1872
CFTR-DeltaF508-375	−	CAAAGCAUGCCAACUAGAAGAGGU	24	1873
CFTR-DeltaF508-376	−	UCACUUCUAAUGGUGAUU	18	1874
CFTR-DeltaF508-377	−	UUCACUUCUAAUGGUGAUU	19	1875
CFTR-DeltaF508-378	−	CUUCACUUCUAAUGGUGAUU	20	657
CFTR-DeltaF508-379	−	ACUUCACUUCUAAUGGUGAUU	21	1876
CFTR-DeltaF508-380	−	GACUUCACUUCUAAUGGUGAUU	22	1877
CFTR-DeltaF508-381	−	AGACUUCACUUCUAAUGGUGAUU	23	1878
CFTR-DeltaF508-382	−	CAGACUUCACUUCUAAUGGUGAUU	24	1879
CFTR-DeltaF508-383	−	UGGGAGAACUGGAGCCUU	18	1880
CFTR-DeltaF508-384	−	AUGGGAGAACUGGAGCCUU	19	1881
CFTR-DeltaF508-385	−	UAUGGGAGAACUGGAGCCUU	20	660
CFTR-DeltaF508-386	−	UUAUGGGAGAACUGGAGCCUU	21	1882
CFTR-DeltaF508-387	−	AUUAUGGGAGAACUGGAGCCUU	22	1883
CFTR-DeltaF508-388	−	GAUUAUGGGAGAACUGGAGCCUU	23	1884
CFTR-DeltaF508-389	−	UGAUUAUGGGAGAACUGGAGCCUU	24	1885

Table 12A provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 12A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-DeltaF508-	−	GAAACUAUGUGAAAACU	17	924
390

Table 12B provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 12B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-16	−	CCAGACUUCACUUCUAA	17	438
CFTR-DeltaF508-391	+	AGAAUGAAAUUCUUCCA	17	1886
CFTR-DeltaF508-392	−	AGGCAAGUGAAUCCUGA	17	922
CFTR-DeltaF508-393	+	UCAUUAUCAAAUCACGC	17	925
CFTR-DeltaF508-394	+	CUUACCUCUUCUAGUUG	17	1887
CFTR-DeltaF508-34	−	UUUCCAGACUUCACUUCUAA	20	420
CFTR-DeltaF508-395	−	UGGAGGCAAGUGAAUCCUGA	20	917
CFTR-DeltaF508-396	+	UUCUAGUUGGCAUGCUUUGA	20	1888
CFTR-DeltaF508-397	+	AGGUCAUUAUCAAAUCACGC	20	920
CFTR-DeltaF508-398	−	UAAGAAACUAUGUGAAAACU	20	919

Table 12C provides exemplary targeting domains for correcting a mutation (e.g., deltaF508) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., deltaF508). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 12C
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-DeltaF508-399	+	UAGUUGGCAUGCUUUGA	17	1889
CFTR-DeltaF508-400	+	AUAAAUAUAUGUAGACU	17	926
CFTR-DeltaF508-401	−	AUUCUGUUCUCAGUUUU	17	923
CFTR-DeltaF508-402	+	AACAGAAUGAAAUUCUUCCA	20	1890
CFTR-DeltaF508-403	+	UUUCUUACCUCUUCUAGUUG	20	1891
CFTR-DeltaF508-404	+	AACAUAAAUAUAUGUAGACU	20	921
CFTR-DeltaF508-405	−	UUCAUUCUGUUCUCAGUUUU	20	918

Table 13A provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 13A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-1	−	GCUUUAUAUUCUGUUUC	17	466
CFTR-G542X-2	−	GGUGGAAUCACACUGAG	17	456
CFTR-G542X-3	−	GGAAUCACACUGAGUGG	17	457
CFTR-G542X-4	−	GUUCAAAAUUUCAACUG	17	464
CFTR-G542X-5	−	GGUGAAUAACUAAUUAU	17	465
CFTR-G542X-6	−	GGGGUUUUAUGGCUAGU	17	458
CFTR-G542X-7	−	GAGCAAGAAUUUCUUUAGCA	20	462
CFTR-G542X-8	−	GAAGGUGGAAUCACACUGAG	20	461
CFTR-G542X-9	−	GGUGGAAUCACACUGAGUGG	20	454

Table 13B provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 13B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G542X-10	+	CUCAAUCUGAAUUUGAA	17	496
CFTR-G542X-11	−	CAAGAAUUUCUUUAGCA	17	491
CFTR-G542X-12	−	UAUAUGAUUACAUUAGA	17	485
CFTR-G542X-13	−	AAAAUCCUGGGGUUUUA	17	493
CFTR-G542X-14	+	ACUAGCCAUAAAACCCC	17	459
CFTR-G542X-15	−	UGGGGUUUUAUGGCUAG	17	494
CFTR-G542X-16	−	AUAGUUCUUUGAGAAGG	17	1892
CFTR-G542X-17	+	AUGCUCAAUCUGAAUUUGAA	20	484
CFTR-G542X-18	−	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-G542X-19	+	CCCACUAGCCAUAAAACCCC	20	455
CFTR-G542X-20	−	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-G542X-21	−	CUGGAAUUGAAAAAAUCCUG	20	479
CFTR-G542X-22	−	CAAGGUGAAUAACUAAUUAU	20	475
CFTR-G542X-23	−	CCUGGGGUUUUAUGGCUAGU	20	481

Table 13C provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 13C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G542X-24	−	GAAUUGAAAAAAUCCUG	17	468
CFTR-G542X-25	+	GUCUUUCUCUGCAAACU	17	469
CFTR-G542X-26	−	GGAAUUGAAAAAAUCCU	17	467
CFTR-G542X-27	−	GACAAUAUAGUUCUUUGAGA	20	1893
CFTR-G542X-28	−	GAAAAAAUCCUGGGGUUUUA	20	463

Table 13D provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 13D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G542X-29	−	AAUUGCAUUUGAAAUAA	17	1894
CFTR-G542X-30	−	AAUAUAGUUCUUUGAGA	17	1895
CFTR-G542X-31	−	UGGAAUUGAAAAAAUCC	17	492
CFTR-G542X-32	−	UUUCUAUUUUUGGUAAU	17	487
CFTR-G542X-33	−	CUCUAAUUUUCUAUUUU	17	486
CFTR-G542X-34	−	AUAAAUUGCAUUUGAAAUAA	20	1896
CFTR-G542X-35	−	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-G542X-36	−	UCCUGGGGUUUUAUGGCUAG	20	480
CFTR-G542X-37	−	AAUAUAGUUCUUUGAGAAGG	20	1897
CFTR-G542X-38	−	AAUGUUCAAAAUUUCAACUG	20	470
CFTR-G542X-39	−	AAUUUUCUAUUUUUGGUAAU	20	473
CFTR-G542X-40	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-G542X-41	−	UCUGGAAUUGAAAAAAUCCU	20	478
CFTR-G542X-42	−	ACUCUCUAAUUUUCUAUUUU	20	472

Table 14A provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 14A
1st Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-43	+	GAUUUUUUCAAUUCCAGAAA	20	766
CFTR-G542X-44	+	GGAUUUUUUCAAUUCCAGAAA	21	1898
CFTR-G542X-45	+	GUCACUUUUAGUAUGCUCAAU	21	1899
CFTR-G542X-46	+	GAGUCACUUUUAGUAUGCUCAAU	23	1900
CFTR-G542X-47	−	GAGUGGAGGUCAACGAGC	18	1901
CFTR-G542X-48	−	GCAAGAAUUUCUUUAGCAAG	20	746
CFTR-G542X-49	−	GAGCAAGAAUUUCUUUAGCAAG	22	1902
CFTR-G542X-50	−	GUUUUAUGGCUAGUGGGUU	19	1903
CFTR-G542X-51	−	GGUUUUAUGGCUAGUGGGUU	20	751
CFTR-G542X-52	−	GGGUUUUAUGGCUAGUGGGUU	21	1904
CFTR-G542X-53	−	GGGGUUUUAUGGCUAGUGGGUU	22	1905

Table 14B provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 14B
2nd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-54	+	UUUUUUCAAUUCCAGAAA	18	1906
CFTR-G542X-55	+	AUUUUUUCAAUUCCAGAAA	19	1907
CFTR-G542X-56	+	AGGAUUUUUUCAAUUCCAGAAA	22	1908
CFTR-G542X-57	+	CAGGAUUUUUUCAAUUCCAGAAA	23	1909
CFTR-G542X-58	+	CCAGGAUUUUUUCAAUUCCAGAAA	24	1910
CFTR-G542X-59	+	UGUCUGUAAUUUUUUUAC	18	1911
CFTR-G542X-60	+	AUGUCUGUAAUUUUUUUAC	19	1912
CFTR-G542X-61	+	AAUGUCUGUAAUUUUUUUAC	20	763
CFTR-G542X-62	+	CCACUAGCCAUAAAACCC	18	1913
CFTR-G542X-63	+	CCCACUAGCCAUAAAACCC	19	1914
CFTR-G542X-64	+	ACCCACUAGCCAUAAAACCC	20	1915
CFTR-G542X-65	+	AACCCACUAGCCAUAAAACCC	21	1916
CFTR-G542X-66	+	UAACCCACUAGCCAUAAAACCC	22	1917
CFTR-G542X-67	+	UUAACCCACUAGCCAUAAAACCC	23	1918
CFTR-G542X-68	+	CUUAACCCACUAGCCAUAAAACCC	24	1919
CFTR-G542X-69	+	ACUUUUAGUAUGCUCAAU	18	1920
CFTR-G542X-70	+	CACUUUUAGUAUGCUCAAU	19	1921
CFTR-G542X-71	+	UCACUUUUAGUAUGCUCAAU	20	756
CFTR-G542X-72	+	AGUCACUUUUAGUAUGCUCAAU	22	1922
CFTR-G542X-73	+	AGAGUCACUUUUAGUAUGCUCAAU	24	1923
CFTR-G542X-74	−	CCUGGGGUUUUAUGGCUA	18	1924
CFTR-G542X-75	−	UCCUGGGGUUUUAUGGCUA	19	1925
CFTR-G542X-76	−	AUCCUGGGGUUUUAUGGCUA	20	750
CFTR-G542X-77	−	AAUCCUGGGGUUUUAUGGCUA	21	1926
CFTR-G542X-78	−	AAAUCCUGGGGUUUUAUGGCUA	22	1927
CFTR-G542X-79	−	AAAAUCCUGGGGUUUUAUGGCUA	23	1928
CFTR-G542X-80	−	AAAAAUCCUGGGGUUUUAUGGCUA	24	1929
CFTR-G542X-81	−	UGAGUGGAGGUCAACGAGC	19	1930
CFTR-G542X-82	−	CUGAGUGGAGGUCAACGAGC	20	745
CFTR-G542X-83	−	UGCUUUAUAUUCUGUUUC	18	1931
CFTR-G542X-84	−	UUGCUUUAUAUUCUGUUUC	19	1932
CFTR-G542X-35	−	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-G542X-85	−	UAUUGCUUUAUAUUCUGUUUC	21	1933
CFTR-G542X-86	−	CUAUUGCUUUAUAUUCUGUUUC	22	1934
CFTR-G542X-87	−	UCUAUUGCUUUAUAUUCUGUUUC	23	1935
CFTR-G542X-88	−	CUCUAUUGCUUUAUAUUCUGUUUC	24	1936
CFTR-G542X-89	−	AAGAAUUUCUUUAGCAAG	18	1937
CFTR-G542X-90	−	CAAGAAUUUCUUUAGCAAG	19	1938
CFTR-G542X-91	−	AGCAAGAAUUUCUUUAGCAAG	21	1939
CFTR-G542X-92	−	CGAGCAAGAAUUUCUUUAGCAAG	23	1940
CFTR-G542X-93	−	ACGAGCAAGAAUUUCUUUAGCAAG	24	1941
CFTR-G542X-94	−	UUUUAUGGCUAGUGGGUU	18	1942
CFTR-G542X-95	−	UGGGGUUUUAUGGCUAGUGGGUU	23	1943
CFTR-G542X-96	−	CUGGGGUUUUAUGGCUAGUGGGUU	24	1944

Table 14C provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 14C
3rd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-97	+	GAAAUGUCUGUAAUUUUUUUAC	22	1945
CFTR-G542X-98	+	GAGAAAUGUCUGUAAUUUUUUUAC	24	1946
CFTR-G542X-99	−	GUUCUUUGAGAAGGUGGAAUCACA	24	1947
CFTR-G542X-100	−	GUUUCUGGAAUUGAAAAAAUCC	22	1948
CFTR-G542X-101	−	GACAAUAUAGUUCUUUGAGAAGG	23	1949

Table 14D provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 14D
4th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-102	+	ACCAAAAAUAGAAAAUUA	18	1950
CFTR-G542X-103	+	UACCAAAAAUAGAAAAUUA	19	1951
CFTR-G542X-104	+	UUACCAAAAAUAGAAAAUUA	20	757
CFTR-G542X-105	+	AUUACCAAAAAUAGAAAAUUA	21	1952
CFTR-G542X-106	+	UAUUACCAAAAAUAGAAAAUUA	22	1953
CFTR-G542X-107	+	CUAUUACCAAAAAUAGAAAAUUA	23	1954
CFTR-G542X-108	+	CCUAUUACCAAAAAUAGAAAAUUA	24	1955
CFTR-G542X-109	+	AAAUGUCUGUAAUUUUUUUAC	21	1956
CFTR-G542X-110	+	AGAAAUGUCUGUAAUUUUUUUAC	23	1957
CFTR-G542X-111	−	UGAGAAGGUGGAAUCACA	18	1958
CFTR-G542X-112	−	UUGAGAAGGUGGAAUCACA	19	1959
CFTR-G542X-113	−	UUUGAGAAGGUGGAAUCACA	20	1960
CFTR-G542X-114	−	CUUUGAGAAGGUGGAAUCACA	21	1961
CFTR-G542X-115	−	UCUUUGAGAAGGUGGAAUCACA	22	1962
CFTR-G542X-116	−	UUCUUUGAGAAGGUGGAAUCACA	23	1963
CFTR-G542X-117	−	CUGGAAUUGAAAAAAUCC	18	1964
CFTR-G542X-118	−	UCUGGAAUUGAAAAAAUCC	19	1965
CFTR-G542X-20	−	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-G542X-119	−	UUUCUGGAAUUGAAAAAAUCC	21	1966
CFTR-G542X-120	−	UGUUUCUGGAAUUGAAAAAAUCC	23	1967
CFTR-G542X-121	−	CUGUUUCUGGAAUUGAAAAAAUCC	24	1968
CFTR-G542X-122	−	ACUGAGUGGAGGUCAACGAGC	21	1969
CFTR-G542X-123	−	CACUGAGUGGAGGUCAACGAGC	22	1970
CFTR-G542X-124	−	ACACUGAGUGGAGGUCAACGAGC	23	1971
CFTR-G542X-125	−	CACACUGAGUGGAGGUCAACGAGC	24	1972
CFTR-G542X-126	−	UAUAGUUCUUUGAGAAGG	18	1973
CFTR-G542X-127	−	AUAUAGUUCUUUGAGAAGG	19	1974
CFTR-G542X-37	−	AAUAUAGUUCUUUGAGAAGG	20	1897
CFTR-G542X-128	−	CAAUAUAGUUCUUUGAGAAGG	21	1975
CFTR-G542X-129	−	ACAAUAUAGUUCUUUGAGAAGG	22	1976
CFTR-G542X-130	−	AGACAAUAUAGUUCUUUGAGAAGG	24	1977

Table 14E provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 14E
5th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-131	+	AUGUCCUAUUACCAAAAA	18	1978
CFTR-G542X-132	+	GAUGUCCUAUUACCAAAAA	19	1979
CFTR-G542X-133	+	AGAUGUCCUAUUACCAAAAA	20	759
CFTR-G542X-134	+	GAGAUGUCCUAUUACCAAAAA	21	1980
CFTR-G542X-135	+	GGAGAUGUCCUAUUACCAAAAA	22	1981
CFTR-G542X-136	+	UGGAGAUGUCCUAUUACCAAAAA	23	1982
CFTR-G542X-137	+	UUGGAGAUGUCCUAUUACCAAAAA	24	1983
CFTR-G542X-138	+	AAACAGAAUAUAAAGCAA	18	1984
CFTR-G542X-139	+	GAAACAGAAUAUAAAGCAA	19	1985
CFTR-G542X-140	+	AGAAACAGAAUAUAAAGCAA	20	765
CFTR-G542X-141	+	CAGAAACAGAAUAUAAAGCAA	21	1986
CFTR-G542X-142	+	CCAGAAACAGAAUAUAAAGCAA	22	1987
CFTR-G542X-143	+	UCCAGAAACAGAAUAUAAAGCAA	23	1988
CFTR-G542X-144	+	UUCCAGAAACAGAAUAUAAAGCAA	24	1989
CFTR-G542X-145	+	UGUGAUUCCACCUUCUCA	18	1990
CFTR-G542X-146	+	GUGUGAUUCCACCUUCUCA	19	1991
CFTR-G542X-147	+	AGUGUGAUUCCACCUUCUCA	20	1992
CFTR-G542X-148	+	CAGUGUGAUUCCACCUUCUCA	21	1993
CFTR-G542X-149	+	UCAGUGUGAUUCCACCUUCUCA	22	1994
CFTR-G542X-150	+	CUCAGUGUGAUUCCACCUUCUCA	23	1995
CFTR-G542X-151	+	ACUCAGUGUGAUUCCACCUUCUCA	24	1996
CFTR-G542X-152	+	ACAGAAUAUAAAGCAAUA	18	1997
CFTR-G542X-153	+	AACAGAAUAUAAAGCAAUA	19	1998
CFTR-G542X-154	+	AAACAGAAUAUAAAGCAAUA	20	764
CFTR-G542X-155	+	GAAACAGAAUAUAAAGCAAUA	21	1999
CFTR-G542X-156	+	AGAAACAGAAUAUAAAGCAAUA	22	2000
CFTR-G542X-157	+	CAGAAACAGAAUAUAAAGCAAUA	23	2001
CFTR-G542X-158	+	CCAGAAACAGAAUAUAAAGCAAUA	24	2002
CFTR-G542X-159	+	UAGUUAUUCACCUUGCUA	18	2003
CFTR-G542X-160	+	UUAGUUAUUCACCUUGCUA	19	2004
CFTR-G542X-161	+	AUUAGUUAUUCACCUUGCUA	20	762
CFTR-G542X-162	+	AAUUAGUUAUUCACCUUGCUA	21	2005
CFTR-G542X-163	+	UAAUUAGUUAUUCACCUUGCUA	22	2006
CFTR-G542X-164	+	AUAAUUAGUUAUUCACCUUGCUA	23	2007
CFTR-G542X-165	+	AAUAAUUAGUUAUUCACCUUGCUA	24	2008
CFTR-G542X-166	+	UUGUCUUUCUCUGCAAAC	18	2009
CFTR-G542X-167	+	AUUGUCUUUCUCUGCAAAC	19	2010
CFTR-G542X-168	+	UAUUGUCUUUCUCUGCAAAC	20	760
CFTR-G542X-169	+	AUAUUGUCUUUCUCUGCAAAC	21	2011
CFTR-G542X-170	+	UAUAUUGUCUUUCUCUGCAAAC	22	2012
CFTR-G542X-171	+	CUAUAUUGUCUUUCUCUGCAAAC	23	2013
CFTR-G542X-172	+	ACUAUAUUGUCUUUCUCUGCAAAC	24	2014
CFTR-G542X-173	+	CCAGGAUUUUUUCAAUUC	18	2015
CFTR-G542X-174	+	CCCAGGAUUUUUUCAAUUC	19	2016
CFTR-G542X-175	+	CCCCAGGAUUUUUUCAAUUC	20	767
CFTR-G542X-176	+	ACCCCAGGAUUUUUUCAAUUC	21	2017
CFTR-G542X-177	+	AACCCCAGGAUUUUUUCAAUUC	22	2018
CFTR-G542X-178	+	AAACCCCAGGAUUUUUUCAAUUC	23	2019
CFTR-G542X-179	+	AAAACCCCAGGAUUUUUUCAAUUC	24	2020
CFTR-G542X-180	+	CUAUUGCUUUAACCACAG	18	2021
CFTR-G542X-181	+	ACUAUUGCUUUAACCACAG	19	2022
CFTR-G542X-182	+	CACUAUUGCUUUAACCACAG	20	754
CFTR-G542X-183	+	ACACUAUUGCUUUAACCACAG	21	2023
CFTR-G542X-184	+	CACACUAUUGCUUUAACCACAG	22	2024
CFTR-G542X-185	+	UCACACUAUUGCUUUAACCACAG	23	2025
CFTR-G542X-186	+	AUCACACUAUUGCUUUAACCACAG	24	2026
CFTR-G542X-187	+	UUACCAAAAAUAGAAAAU	18	2027
CFTR-G542X-188	+	AUUACCAAAAAUAGAAAAU	19	2028
CFTR-G542X-189	+	UAUUACCAAAAAUAGAAAAU	20	758
CFTR-G542X-190	+	CUAUUACCAAAAAUAGAAAAU	21	2029
CFTR-G542X-191	+	CCUAUUACCAAAAAUAGAAAAU	22	2030
CFTR-G542X-192	+	UCCUAUUACCAAAAAUAGAAAAU	23	2031
CFTR-G542X-193	+	GUCCUAUUACCAAAAAUAGAAAAU	24	2032
CFTR-G542X-194	+	AGUAUGCUCAAUCUGAAU	18	2033
CFTR-G542X-195	+	UAGUAUGCUCAAUCUGAAU	19	2034
CFTR-G542X-196	+	UUAGUAUGCUCAAUCUGAAU	20	755
CFTR-G542X-197	+	UUUAGUAUGCUCAAUCUGAAU	21	2035
CFTR-G542X-198	+	UUUUAGUAUGCUCAAUCUGAAU	22	2036
CFTR-G542X-199	+	CUUUUAGUAUGCUCAAUCUGAAU	23	2037
CFTR-G542X-200	+	ACUUUUAGUAUGCUCAAUCUGAAU	24	2038
CFTR-G542X-201	+	UGUCUUUCUCUGCAAACU	18	2039
CFTR-G542X-202	+	UUGUCUUUCUCUGCAAACU	19	2040
CFTR-G542X-40	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-G542X-203	+	UAUUGUCUUUCUCUGCAAACU	21	2041
CFTR-G542X-204	+	AUAUUGUCUUUCUCUGCAAACU	22	2042
CFTR-G542X-205	+	UAUAUUGUCUUUCUCUGCAAACU	23	2043
CFTR-G542X-206	+	CUAUAUUGUCUUUCUCUGCAAACU	24	2044
CFTR-G542X-207	+	UUAACCACAGUUGAAAUU	18	2045
CFTR-G542X-208	+	UUUAACCACAGUUGAAAUU	19	2046
CFTR-G542X-209	+	CUUUAACCACAGUUGAAAUU	20	753
CFTR-G542X-210	+	GCUUUAACCACAGUUGAAAUU	21	2047
CFTR-G542X-211	+	UGCUUUAACCACAGUUGAAAUU	22	2048
CFTR-G542X-212	+	UUGCUUUAACCACAGUUGAAAUU	23	2049
CFTR-G542X-213	+	AUUGCUUUAACCACAGUUGAAAUU	24	2050
CFTR-G542X-214	−	UAUAUUCUGUUUCUGGAA	18	2051
CFTR-G542X-215	−	UUAUAUUCUGUUUCUGGAA	19	2052
CFTR-G542X-216	−	UUUAUAUUCUGUUUCUGGAA	20	748
CFTR-G542X-217	−	CUUUAUAUUCUGUUUCUGGAA	21	2053
CFTR-G542X-218	−	GCUUUAUAUUCUGUUUCUGGAA	22	2054
CFTR-G542X-219	−	UGCUUUAUAUUCUGUUUCUGGAA	23	2055
CFTR-G542X-220	−	UUGCUUUAUAUUCUGUUUCUGGAA	24	2056
CFTR-G542X-221	−	AAAUUGCAUUUGAAAUAA	18	2057
CFTR-G542X-222	−	UAAAUUGCAUUUGAAAUAA	19	2058
CFTR-G542X-34	−	AUAAAUUGCAUUUGAAAUAA	20	1896
CFTR-G542X-223	−	AUUUUCUAUUUUUGGUAA	18	2059
CFTR-G542X-224	−	AAUUUUCUAUUUUUGGUAA	19	2060
CFTR-G542X-225	−	UAAUUUUCUAUUUUUGGUAA	20	736
CFTR-G542X-226	−	CUAAUUUUCUAUUUUUGGUAA	21	2061
CFTR-G542X-227	−	UCUAAUUUUCUAUUUUUGGUAA	22	2062
CFTR-G542X-228	−	CUCUAAUUUUCUAUUUUUGGUAA	23	2063
CFTR-G542X-229	−	UCUCUAAUUUUCUAUUUUUGGUAA	24	2064
CFTR-G542X-230	−	GACAUCUCCAAGUUUGCA	18	2065
CFTR-G542X-231	−	GGACAUCUCCAAGUUUGCA	19	2066
CFTR-G542X-232	−	AGGACAUCUCCAAGUUUGCA	20	738
CFTR-G542X-233	−	UAGGACAUCUCCAAGUUUGCA	21	2067
CFTR-G542X-234	−	AUAGGACAUCUCCAAGUUUGCA	22	2068
CFTR-G542X-235	−	AAUAGGACAUCUCCAAGUUUGCA	23	2069
CFTR-G542X-236	−	UAAUAGGACAUCUCCAAGUUUGCA	24	2070
CFTR-G542X-237	−	CACACUGAGUGGAGGUCA	18	2071
CFTR-G542X-238	−	UCACACUGAGUGGAGGUCA	19	2072
CFTR-G542X-239	−	AUCACACUGAGUGGAGGUCA	20	744
CFTR-G542X-240	−	AAUCACACUGAGUGGAGGUCA	21	2073
CFTR-G542X-241	−	GAAUCACACUGAGUGGAGGUCA	22	2074
CFTR-G542X-242	−	GGAAUCACACUGAGUGGAGGUCA	23	2075
CFTR-G542X-243	−	UGGAAUCACACUGAGUGGAGGUCA	24	2076
CFTR-G542X-244	−	GUGCCUUUCAAAUUCAGA	18	2077
CFTR-G542X-245	−	UGUGCCUUUCAAAUUCAGA	19	2078
CFTR-G542X-246	−	AUGUGCCUUUCAAAUUCAGA	20	735
CFTR-G542X-247	−	GAUGUGCCUUUCAAAUUCAGA	21	2079
CFTR-G542X-248	−	AGAUGUGCCUUUCAAAUUCAGA	22	2080
CFTR-G542X-249	−	AAGAUGUGCCUUUCAAAUUCAGA	23	2081
CFTR-G542X-250	−	GAAGAUGUGCCUUUCAAAUUCAGA	24	2082
CFTR-G542X-251	−	AUAUAUGAUUACAUUAGA	18	2083
CFTR-G542X-252	−	GAUAUAUGAUUACAUUAGA	19	2084
CFTR-G542X-18	−	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-G542X-253	−	GUGAUAUAUGAUUACAUUAGA	21	2085
CFTR-G542X-254	−	UGUGAUAUAUGAUUACAUUAGA	22	2086
CFTR-G542X-255	−	GUGUGAUAUAUGAUUACAUUAGA	23	2087
CFTR-G542X-256	−	AGUGUGAUAUAUGAUUACAUUAGA	24	2088
CFTR-G542X-257	−	AAGGUGGAAUCACACUGA	18	2089
CFTR-G542X-258	−	GAAGGUGGAAUCACACUGA	19	2090
CFTR-G542X-259	−	AGAAGGUGGAAUCACACUGA	20	743
CFTR-G542X-260	−	GAGAAGGUGGAAUCACACUGA	21	2091
CFTR-G542X-261	−	UGAGAAGGUGGAAUCACACUGA	22	2092
CFTR-G542X-262	−	UUGAGAAGGUGGAAUCACACUGA	23	2093
CFTR-G542X-263	−	UUUGAGAAGGUGGAAUCACACUGA	24	2094
CFTR-G542X-264	−	UAAAUUGCAUUUGAAAUA	18	2095
CFTR-G542X-265	−	AUAAAUUGCAUUUGAAAUA	19	2096
CFTR-G542X-266	−	AAUAAAUUGCAUUUGAAAUA	20	2097
CFTR-G542X-267	−	UCUGGAAUUGAAAAAAUC	18	2098
CFTR-G542X-268	−	UUCUGGAAUUGAAAAAAUC	19	2099
CFTR-G542X-269	−	UUUCUGGAAUUGAAAAAAUC	20	749
CFTR-G542X-270	−	GUUUCUGGAAUUGAAAAAAUC	21	2100
CFTR-G542X-271	−	UGUUUCUGGAAUUGAAAAAAUC	22	2101
CFTR-G542X-272	−	CUGUUUCUGGAAUUGAAAAAAUC	23	2102
CFTR-G542X-273	−	UCUGUUUCUGGAAUUGAAAAAAUC	24	2103
CFTR-G542X-274	−	AUAUAGUUCUUUGAGAAG	18	2104
CFTR-G542X-275	−	AAUAUAGUUCUUUGAGAAG	19	2105
CFTR-G542X-276	−	CAAUAUAGUUCUUUGAGAAG	20	2106
CFTR-G542X-277	−	ACAAUAUAGUUCUUUGAGAAG	21	2107
CFTR-G542X-278	−	GACAAUAUAGUUCUUUGAGAAG	22	2108
CFTR-G542X-279	−	AGACAAUAUAGUUCUUUGAGAAG	23	2109
CFTR-G542X-280	−	AAGACAAUAUAGUUCUUUGAGAAG	24	2110
CFTR-G542X-281	−	AGGUGGAAUCACACUGAG	18	2111
CFTR-G542X-282	−	AAGGUGGAAUCACACUGAG	19	2112
CFTR-G542X-8	−	GAAGGUGGAAUCACACUGAG	20	461
CFTR-G542X-283	−	AGAAGGUGGAAUCACACUGAG	21	2113
CFTR-G542X-284	−	GAGAAGGUGGAAUCACACUGAG	22	2114
CFTR-G542X-285	−	UGAGAAGGUGGAAUCACACUGAG	23	2115
CFTR-G542X-286	−	UUGAGAAGGUGGAAUCACACUGAG	24	2116
CFTR-G542X-287	−	GAUAUAUGAUUACAUUAG	18	2117
CFTR-G542X-288	−	UGAUAUAUGAUUACAUUAG	19	2118
CFTR-G542X-289	−	GUGAUAUAUGAUUACAUUAG	20	734
CFTR-G542X-290	−	UGUGAUAUAUGAUUACAUUAG	21	2119
CFTR-G542X-291	−	GUGUGAUAUAUGAUUACAUUAG	22	2120
CFTR-G542X-292	−	AGUGUGAUAUAUGAUUACAUUAG	23	2121
CFTR-G542X-293	−	UAGUGUGAUAUAUGAUUACAUUAG	24	2122
CFTR-G542X-294	−	AGGACAUCUCCAAGUUUG	18	2123
CFTR-G542X-295	−	UAGGACAUCUCCAAGUUUG	19	2124
CFTR-G542X-296	−	AUAGGACAUCUCCAAGUUUG	20	737
CFTR-G542X-297	−	AAUAGGACAUCUCCAAGUUUG	21	2125
CFTR-G542X-298	−	UAAUAGGACAUCUCCAAGUUUG	22	2126
CFTR-G542X-299	−	GUAAUAGGACAUCUCCAAGUUUG	23	2127
CFTR-G542X-300	−	GGUAAUAGGACAUCUCCAAGUUUG	24	2128
CFTR-G542X-301	−	UGUGAUAUAUGAUUACAU	18	2129
CFTR-G542X-302	−	GUGUGAUAUAUGAUUACAU	19	2130
CFTR-G542X-303	−	AGUGUGAUAUAUGAUUACAU	20	733
CFTR-G542X-304	−	UAGUGUGAUAUAUGAUUACAU	21	2131
CFTR-G542X-305	−	AUAGUGUGAUAUAUGAUUACAU	22	2132
CFTR-G542X-306	−	AAUAGUGUGAUAUAUGAUUACAU	23	2133
CFTR-G542X-307	−	CAAUAGUGUGAUAUAUGAUUACAU	24	2134
CFTR-G542X-308	−	GAAAGACAAUAUAGUUCU	18	2135
CFTR-G542X-309	−	AGAAAGACAAUAUAGUUCU	19	2136
CFTR-G542X-310	−	GAGAAAGACAAUAUAGUUCU	20	453
CFTR-G542X-311	−	AGAGAAAGACAAUAUAGUUCU	21	2137
CFTR-G542X-312	−	CAGAGAAAGACAAUAUAGUUCU	22	2138
CFTR-G542X-313	−	GCAGAGAAAGACAAUAUAGUUCU	23	2139
CFTR-G542X-314	−	UGCAGAGAAAGACAAUAUAGUUCU	24	2140
CFTR-G542X-315	−	AAGACAAUAUAGUUCUUU	18	2141
CFTR-G542X-316	−	AAAGACAAUAUAGUUCUUU	19	2142
CFTR-G542X-317	−	GAAAGACAAUAUAGUUCUUU	20	2143
CFTR-G542X-318	−	AGAAAGACAAUAUAGUUCUUU	21	2144
CFTR-G542X-319	−	GAGAAAGACAAUAUAGUUCUUU	22	2145
CFTR-G542X-320	−	AGAGAAAGACAAUAUAGUUCUUU	23	2146
CFTR-G542X-321	−	CAGAGAAAGACAAUAUAGUUCUUU	24	2147
CFTR-G542X-322	−	UUGCUUUAUAUUCUGUUU	18	2148
CFTR-G542X-323	−	AUUGCUUUAUAUUCUGUUU	19	2149
CFTR-G542X-324	−	UAUUGCUUUAUAUUCUGUUU	20	747
CFTR-G542X-325	−	CUAUUGCUUUAUAUUCUGUUU	21	2150
CFTR-G542X-326	−	UCUAUUGCUUUAUAUUCUGUUU	22	2151
CFTR-G542X-327	−	CUCUAUUGCUUUAUAUUCUGUUU	23	2152
CFTR-G542X-328	−	UCUCUAUUGCUUUAUAUUCUGUUU	24	2153

Table 15A provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 15A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G542X-329	+	GUAAUCAUAUAUCACAC	17	2154
CFTR-G542X-330	−	GGUUAAAGCAAUAGUGUGAU	20	927

Table 15B provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 15B
2nd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-331	+	UCGUUGACCUCCACUCA	17	934
CFTR-G542X-332	+	CCACUAGCCAUAAAACC	17	935
CFTR-G542X-333	+	UGAAUGACAUUUACAGC	17	2155
CFTR-G542X-334	−	UAAAGCAAUAGUGUGAU	17	932
CFTR-G542X-335	−	AGGAAGAUGUGCCUUUCAAA	20	928
CFTR-G542X-336	+	UGCUCGUUGACCUCCACUCA	20	929
CFTR-G542X-337	+	AAUGUAAUCAUAUAUCACAC	20	2156
CFTR-G542X-338	+	AACCCACUAGCCAUAAAACC	20	930
CFTR-G542X-339	+	ACAUGAAUGACAUUUACAGC	20	2157

Table 15C provides exemplary targeting domains for correcting a mutation (e.g., G542X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G542X). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 15C
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G542X-340	−	AAGAUGUGCCUUUCAAA	17	933
CFTR-G542X-341	−	AAUUACAGACAUUUCUC	17	2158
CFTR-G542X-342	−	AAAAAUUACAGACAUUUCUC	20	2159

Table 16A provides exemplary targeting domains for correcting a mutation (e.g., G55D) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 16A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G551D-1	−	GCUUUAUAUUCUGUUUC	17	466
CFTR-G551D-2	−	GGUGGAAUCACACUGAG	17	456
CFTR-G551D-3	−	GUUCAAAAUUUCAACUG	17	464
CFTR-G551D-4	−	GGUGAAUAACUAAUUAU	17	465
CFTR-G551D-5	−	GGGGUUUUAUGGCUAGU	17	458
CFTR-G551D-6	−	GAGCAAGAAUUUCUUUAGCA	20	462
CFTR-G551D-7	−	GACAAUAUAGUUCUUGGAGA	20	460
CFTR-G551D-8	−	GAAGGUGGAAUCACACUGAG	20	461
CFTR-G551D-9	−	GAGAAAGACAAUAUAGUUCU	20	453

Table 16B provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G55D) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 16B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G551D-10	+	CUCAAUCUGAAUUUGAA	17	496
CFTR-G551D-11	−	CAAGAAUUUCUUUAGCA	17	491
CFTR-G551D-12	−	AAUAUAGUUCUUGGAGA	17	489
CFTR-G551D-13	−	UAUAUGAUUACAUUAGA	17	485
CFTR-G551D-14	−	AAAAUCCUGGGGUUUUA	17	493
CFTR-G551D-15	+	ACUAGCCAUAAAACCCC	17	459
CFTR-G551D-16	−	UGGGGUUUUAUGGCUAG	17	494
CFTR-G551D-17	−	AUAGUUCUUGGAGAAGG	17	490
CFTR-G551D-18	−	AAAGACAAUAUAGUUCU	17	488
CFTR-G551D-19	+	AUGCUCAAUCUGAAUUUGAA	20	484
CFTR-G551D-20	−	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-G551D-21	+	CCCACUAGCCAUAAAACCCC	20	455
CFTR-G551D-22	−	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-G551D-23	−	AAUAUAGUUCUUGGAGAAGG	20	474
CFTR-G551D-24	−	CUGGAAUUGAAAAAAUCCUG	20	479
CFTR-G551D-25	−	CAAGGUGAAUAACUAAUUAU	20	475
CFTR-G551D-26	−	CCUGGGGUUUUAUGGCUAGU	20	481

Table 16C provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 16C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G551D-27	−	GAAUUGAAAAAAUCCUG	17	468
CFTR-G551D-28	+	GUCUUUCUCUGCAAACU	17	469
CFTR-G551D-29	−	GGAAUUGAAAAAAUCCU	17	467
CFTR-G551D-30	−	GAAAAAAUCCUGGGGUUUUA	20	463

Table 16D provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 16D
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G551D-31	−	UUAAGAACUAUAAAUAA	17	495
CFTR-G551D-32	−	UGGAAUUGAAAAAAUCC	17	492
CFTR-G551D-33	−	UUUCUAUUUUUGGUAAU	17	487
CFTR-G551D-34	−	CUCUAAUUUUCUAUUUU	17	486
CFTR-G551D-35	−	CAUUUAAGAACUAUAAAUAA	20	482
CFTR-G551D-36	−	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-G551D-37	−	UCCUGGGGUUUUAUGGCUAG	20	480
CFTR-G551D-38	−	AAUGUUCAAAAUUUCAACUG	20	470
CFTR-G551D-39	−	AAUUUUCUAUUUUUGGUAAU	20	473
CFTR-G551D-40	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-G551D-41	−	UCUGGAAUUGAAAAAAUCCU	20	478
CFTR-G551D-42	−	ACUCUCUAAUUUUCUAUUUU	20	472

Table 17A provides exemplary targeting domains for correcting a mutation (e.g., G55D) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 17A
1st Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G551D-43	+	GAUUUUUUCAAUUCCAGAAA	20	766
CFTR-G551D-44	+	GGAUUUUUUCAAUUCCAGAAA	21	1898
CFTR-G551D-45	+	GUCACUUUUAGUAUGCUCAAU	21	1899
CFTR-G551D-46	+	GAGUCACUUUUAGUAUGCUCAAU	23	1900
CFTR-G551D-47	−	GGAGAAGGUGGAAUCACA	18	2160
CFTR-G551D-48	−	GUUCUUGGAGAAGGUGGAAUCACA	24	2161
CFTR-G551D-49	−	GCAAGAAUUUCUUUAGCAAG	20	746
CFTR-G551D-50	−	GAGCAAGAAUUUCUUUAGCAAG	22	1902
CFTR-G551D-51	−	GACAAUAUAGUUCUUGGAGAAGG	23	2162
CFTR-G551D-52	−	GUUUUAUGGCUAGUGGGUU	19	1903
CFTR-G551D-53	−	GGUUUUAUGGCUAGUGGGUU	20	751
CFTR-G551D-54	−	GGGUUUUAUGGCUAGUGGGUU	21	1904
CFTR-G551D-55	−	GGGGUUUUAUGGCUAGUGGGUU	22	1905

Table 17B provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G55AD), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 17B
2nd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G551D-56	+	UUUUUUCAAUUCCAGAAA	18	1906
CFTR-G551D-57	+	AUUUUUUCAAUUCCAGAAA	19	1907
CFTR-G551D-58	+	AGGAUUUUUUCAAUUCCAGAAA	22	1908
CFTR-G551D-59	+	CAGGAUUUUUUCAAUUCCAGAAA	23	1909
CFTR-G551D-60	+	CCAGGAUUUUUUCAAUUCCAGAAA	24	1910
CFTR-G551D-61	+	UGUCUGUAAUUUUUUUAC	18	1911
CFTR-G551D-62	+	AUGUCUGUAAUUUUUUUAC	19	1912
CFTR-G551D-63	+	AAUGUCUGUAAUUUUUUUAC	20	763
CFTR-G551D-64	+	CCACUAGCCAUAAAACCC	18	1913
CFTR-G551D-65	+	CCCACUAGCCAUAAAACCC	19	1914
CFTR-G551D-66	+	ACCCACUAGCCAUAAAACCC	20	1915
CFTR-G551D-67	+	AACCCACUAGCCAUAAAACCC	21	1916
CFTR-G551D-68	+	UAACCCACUAGCCAUAAAACCC	22	1917
CFTR-G551D-69	+	UUAACCCACUAGCCAUAAAACCC	23	1918
CFTR-G551D-70	+	CUUAACCCACUAGCCAUAAAACCC	24	1919
CFTR-G551D-71	+	ACUUUUAGUAUGCUCAAU	18	1920
CFTR-G551D-72	+	CACUUUUAGUAUGCUCAAU	19	1921
CFTR-G551D-73	+	UCACUUUUAGUAUGCUCAAU	20	756
CFTR-G551D-74	+	AGUCACUUUUAGUAUGCUCAAU	22	1922
CFTR-G551D-75	+	AGAGUCACUUUUAGUAUGCUCAAU	24	1923
CFTR-G551D-76	−	UGGAGAAGGUGGAAUCACA	19	2163
CFTR-G551D-77	−	UUGGAGAAGGUGGAAUCACA	20	742
CFTR-G551D-78	−	CUUGGAGAAGGUGGAAUCACA	21	2164
CFTR-G551D-79	−	UCUUGGAGAAGGUGGAAUCACA	22	2165
CFTR-G551D-80	−	UUCUUGGAGAAGGUGGAAUCACA	23	2166
CFTR-G551D-81	−	CCUGGGGUUUUAUGGCUA	18	1924
CFTR-G551D-82	−	UCCUGGGGUUUUAUGGCUA	19	1925
CFTR-G551D-83	−	AUCCUGGGGUUUUAUGGCUA	20	750
CFTR-G551D-84	−	AAUCCUGGGGUUUUAUGGCUA	21	1926
CFTR-G551D-85	−	AAAUCCUGGGGUUUUAUGGCUA	22	1927
CFTR-G551D-86	−	AAAAUCCUGGGGUUUUAUGGCUA	23	1928
CFTR-G551D-87	−	AAAAAUCCUGGGGUUUUAUGGCUA	24	1929
CFTR-G551D-88	−	UGCUUUAUAUUCUGUUUC	18	1931
CFTR-G551D-89	−	UUGCUUUAUAUUCUGUUUC	19	1932
CFTR-G551D-36	−	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-G551D-90	−	UAUUGCUUUAUAUUCUGUUUC	21	1933
CFTR-G551D-91	−	CUAUUGCUUUAUAUUCUGUUUC	22	1934
CFTR-G551D-92	−	UCUAUUGCUUUAUAUUCUGUUUC	23	1935
CFTR-G551D-93	−	CUCUAUUGCUUUAUAUUCUGUUUC	24	1936
CFTR-G551D-94	−	AAGAAUUUCUUUAGCAAG	18	1937
CFTR-G551D-95	−	CAAGAAUUUCUUUAGCAAG	19	1938
CFTR-G551D-96	−	AGCAAGAAUUUCUUUAGCAAG	21	1939
CFTR-G551D-97	−	CGAGCAAGAAUUUCUUUAGCAAG	23	1940
CFTR-G551D-98	−	ACGAGCAAGAAUUUCUUUAGCAAG	24	1941
CFTR-G551D-99	−	UAUAGUUCUUGGAGAAGG	18	2167
CFTR-G551D-100	−	AUAUAGUUCUUGGAGAAGG	19	2168
CFTR-G551D-23	−	AAUAUAGUUCUUGGAGAAGG	20	474
CFTR-G551D-101	−	CAAUAUAGUUCUUGGAGAAGG	21	2169
CFTR-G551D-102	−	ACAAUAUAGUUCUUGGAGAAGG	22	2170
CFTR-G551D-103	−	AGACAAUAUAGUUCUUGGAGAAGG	24	2171
CFTR-G551D-104	−	UUUUAUGGCUAGUGGGUU	18	1942
CFTR-G551D-105	−	UGGGGUUUUAUGGCUAGUGGGUU	23	1943
CFTR-G551D-106	−	CUGGGGUUUUAUGGCUAGUGGGUU	24	1944

Table 17C provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 17C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G551D-107	+	GAAAUGUCUGUAAUUUUUUUAC	22	1945
CFTR-G551D-108	+	GAGAAAUGUCUGUAAUUUUUUUAC	24	1946
CFTR-G551D-109	−	GUUUCUGGAAUUGAAAAAAUCC	22	1948
CFTR-G551D-110	−	GAGUGGAGAUCAACGAGC	18	2172

Table 17D provides exemplary targeting domains for correcting a mutation (e.g., G55D) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G555D), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 17D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G551D-111	+	ACCAAAAAUAGAAAAUUA	18	1950
CFTR-G551D-112	+	UACCAAAAAUAGAAAAUUA	19	1951
CFTR-G551D-113	+	UUACCAAAAAUAGAAAAUUA	20	757
CFTR-G551D-114	+	AUUACCAAAAAUAGAAAAUUA	21	1952
CFTR-G551D-115	+	UAUUACCAAAAAUAGAAAAUUA	22	1953
CFTR-G551D-116	+	CUAUUACCAAAAAUAGAAAAUUA	23	1954
CFTR-G551D-117	+	CCUAUUACCAAAAAUAGAAAAUUA	24	1955
CFTR-G551D-118	+	AAAUGUCUGUAAUUUUUUUAC	21	1956
CFTR-G551D-119	+	AGAAAUGUCUGUAAUUUUUUUAC	23	1957
CFTR-G551D-120	−	CUGGAAUUGAAAAAAUCC	18	1964
CFTR-G551D-121	−	UCUGGAAUUGAAAAAAUCC	19	1965
CFTR-G551D-22	−	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-G551D-122	−	UUUCUGGAAUUGAAAAAAUCC	21	1966
CFTR-G551D-123	−	UGUUUCUGGAAUUGAAAAAAUCC	23	1967
CFTR-G551D-124	−	CUGUUUCUGGAAUUGAAAAAAUCC	24	1968
CFTR-G551D-125	−	UGAGUGGAGAUCAACGAGC	19	2173
CFTR-G551D-126	−	CUGAGUGGAGAUCAACGAGC	20	2174
CFTR-G551D-127	−	ACUGAGUGGAGAUCAACGAGC	21	2175
CFTR-G551D-128	−	CACUGAGUGGAGAUCAACGAGC	22	2176
CFTR-G551D-129	−	ACACUGAGUGGAGAUCAACGAGC	23	2177
CFTR-G551D-130	−	CACACUGAGUGGAGAUCAACGAGC	24	2178

Table 17E provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 17E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G551D-131	+	AUGUCCUAUUACCAAAAA	18	1978
CFTR-G551D-132	+	GAUGUCCUAUUACCAAAAA	19	1979
CFTR-G551D-133	+	AGAUGUCCUAUUACCAAAAA	20	759
CFTR-G551D-134	+	GAGAUGUCCUAUUACCAAAAA	21	1980
CFTR-G551D-135	+	GGAGAUGUCCUAUUACCAAAAA	22	1981
CFTR-G551D-136	+	UGGAGAUGUCCUAUUACCAAAAA	23	1982
CFTR-G551D-137	+	UUGGAGAUGUCCUAUUACCAAAAA	24	1983
CFTR-G551D-138	+	AAACAGAAUAUAAAGCAA	18	1984
CFTR-G551D-139	+	GAAACAGAAUAUAAAGCAA	19	1985
CFTR-G551D-140	+	AGAAACAGAAUAUAAAGCAA	20	765
CFTR-G551D-141	+	CAGAAACAGAAUAUAAAGCAA	21	1986
CFTR-G551D-142	+	CCAGAAACAGAAUAUAAAGCAA	22	1987
CFTR-G551D-143	+	UCCAGAAACAGAAUAUAAAGCAA	23	1988
CFTR-G551D-144	+	UUCCAGAAACAGAAUAUAAAGCAA	24	1989
CFTR-G551D-145	+	ACAGAAUAUAAAGCAAUA	18	1997
CFTR-G551D-146	+	AACAGAAUAUAAAGCAAUA	19	1998
CFTR-G551D-147	+	AAACAGAAUAUAAAGCAAUA	20	764
CFTR-G551D-148	+	GAAACAGAAUAUAAAGCAAUA	21	1999
CFTR-G551D-149	+	AGAAACAGAAUAUAAAGCAAUA	22	2000
CFTR-G551D-150	+	CAGAAACAGAAUAUAAAGCAAUA	23	2001
CFTR-G551D-151	+	CCAGAAACAGAAUAUAAAGCAAUA	24	2002
CFTR-G551D-152	+	UAGUUAUUCACCUUGCUA	18	2003
CFTR-G551D-153	+	UUAGUUAUUCACCUUGCUA	19	2004
CFTR-G551D-154	+	AUUAGUUAUUCACCUUGCUA	20	762
CFTR-G551D-155	+	AAUUAGUUAUUCACCUUGCUA	21	2005
CFTR-G551D-156	+	UAAUUAGUUAUUCACCUUGCUA	22	2006
CFTR-G551D-157	+	AUAAUUAGUUAUUCACCUUGCUA	23	2007
CFTR-G551D-158	+	AAUAAUUAGUUAUUCACCUUGCUA	24	2008
CFTR-G551D-159	+	UUGUCUUUCUCUGCAAAC	18	2009
CFTR-G551D-160	+	AUUGUCUUUCUCUGCAAAC	19	2010
CFTR-G551D-161	+	UAUUGUCUUUCUCUGCAAAC	20	760
CFTR-G551D-162	+	AUAUUGUCUUUCUCUGCAAAC	21	2011
CFTR-G551D-163	+	UAUAUUGUCUUUCUCUGCAAAC	22	2012
CFTR-G551D-164	+	CUAUAUUGUCUUUCUCUGCAAAC	23	2013
CFTR-G551D-165	+	ACUAUAUUGUCUUUCUCUGCAAAC	24	2014
CFTR-G551D-166	+	UGUGAUUCCACCUUCUCC	18	2179
CFTR-G551D-167	+	GUGUGAUUCCACCUUCUCC	19	2180
CFTR-G551D-168	+	AGUGUGAUUCCACCUUCUCC	20	761
CFTR-G551D-169	+	CAGUGUGAUUCCACCUUCUCC	21	2181
CFTR-G551D-170	+	UCAGUGUGAUUCCACCUUCUCC	22	2182
CFTR-G551D-171	+	CUCAGUGUGAUUCCACCUUCUCC	23	2183
CFTR-G551D-172	+	ACUCAGUGUGAUUCCACCUUCUCC	24	2184
CFTR-G551D-173	+	CCAGGAUUUUUUCAAUUC	18	2015
CFTR-G551D-174	+	CCCAGGAUUUUUUCAAUUC	19	2016
CFTR-G551D-175	+	CCCCAGGAUUUUUUCAAUUC	20	767
CFTR-G551D-176	+	ACCCCAGGAUUUUUUCAAUUC	21	2017
CFTR-G551D-177	+	AACCCCAGGAUUUUUUCAAUUC	22	2018
CFTR-G551D-178	+	AAACCCCAGGAUUUUUUCAAUUC	23	2019
CFTR-G551D-179	+	AAAACCCCAGGAUUUUUUCAAUUC	24	2020
CFTR-G551D-180	+	CUAUUGCUUUAACCACAG	18	2021
CFTR-G551D-181	+	ACUAUUGCUUUAACCACAG	19	2022
CFTR-G551D-182	+	CACUAUUGCUUUAACCACAG	20	754
CFTR-G551D-183	+	ACACUAUUGCUUUAACCACAG	21	2023
CFTR-G551D-184	+	CACACUAUUGCUUUAACCACAG	22	2024
CFTR-G551D-185	+	UCACACUAUUGCUUUAACCACAG	23	2025
CFTR-G551D-186	+	AUCACACUAUUGCUUUAACCACAG	24	2026
CFTR-G551D-187	+	UUACCAAAAAUAGAAAAU	18	2027
CFTR-G551D-188	+	AUUACCAAAAAUAGAAAAU	19	2028
CFTR-G551D-189	+	UAUUACCAAAAAUAGAAAAU	20	758
CFTR-G551D-190	+	CUAUUACCAAAAAUAGAAAAU	21	2029
CFTR-G551D-191	+	CCUAUUACCAAAAAUAGAAAAU	22	2030
CFTR-G551D-192	+	UCCUAUUACCAAAAAUAGAAAAU	23	2031
CFTR-G551D-193	+	GUCCUAUUACCAAAAAUAGAAAAU	24	2032
CFTR-G551D-194	+	AGUAUGCUCAAUCUGAAU	18	2033
CFTR-G551D-195	+	UAGUAUGCUCAAUCUGAAU	19	2034
CFTR-G551D-196	+	UUAGUAUGCUCAAUCUGAAU	20	755
CFTR-G551D-197	+	UUUAGUAUGCUCAAUCUGAAU	21	2035
CFTR-G551D-198	+	UUUUAGUAUGCUCAAUCUGAAU	22	2036
CFTR-G551D-199	+	CUUUUAGUAUGCUCAAUCUGAAU	23	2037
CFTR-G551D-200	+	ACUUUUAGUAUGCUCAAUCUGAAU	24	2038
CFTR-G551D-201	+	UGUCUUUCUCUGCAAACU	18	2039
CFTR-G551D-202	+	UUGUCUUUCUCUGCAAACU	19	2040
CFTR-G551D-40	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-G551D-203	+	UAUUGUCUUUCUCUGCAAACU	21	2041
CFTR-G551D-204	+	AUAUUGUCUUUCUCUGCAAACU	22	2042
CFTR-G551D-205	+	UAUAUUGUCUUUCUCUGCAAACU	23	2043
CFTR-G551D-206	+	CUAUAUUGUCUUUCUCUGCAAACU	24	2044
CFTR-G551D-207	+	UUAACCACAGUUGAAAUU	18	2045
CFTR-G551D-208	+	UUUAACCACAGUUGAAAUU	19	2046
CFTR-G551D-209	+	CUUUAACCACAGUUGAAAUU	20	753
CFTR-G551D-210	+	GCUUUAACCACAGUUGAAAUU	21	2047
CFTR-G551D-211	+	UGCUUUAACCACAGUUGAAAUU	22	2048
CFTR-G551D-212	+	UUGCUUUAACCACAGUUGAAAUU	23	2049
CFTR-G551D-213	+	AUUGCUUUAACCACAGUUGAAAUU	24	2050
CFTR-G551D-214	−	UAUAUUCUGUUUCUGGAA	18	2051
CFTR-G551D-215	−	UUAUAUUCUGUUUCUGGAA	19	2052
CFTR-G551D-216	−	UUUAUAUUCUGUUUCUGGAA	20	748
CFTR-G551D-217	−	CUUUAUAUUCUGUUUCUGGAA	21	2053
CFTR-G551D-218	−	GCUUUAUAUUCUGUUUCUGGAA	22	2054
CFTR-G551D-219	−	UGCUUUAUAUUCUGUUUCUGGAA	23	2055
CFTR-G551D-220	−	UUGCUUUAUAUUCUGUUUCUGGAA	24	2056
CFTR-G551D-221	−	AUUUUCUAUUUUUGGUAA	18	2059
CFTR-G551D-222	−	AAUUUUCUAUUUUUGGUAA	19	2060
CFTR-G551D-223	−	UAAUUUUCUAUUUUUGGUAA	20	736
CFTR-G551D-224	−	CUAAUUUUCUAUUUUUGGUAA	21	2061
CFTR-G551D-225	−	UCUAAUUUUCUAUUUUUGGUAA	22	2062
CFTR-G551D-226	−	CUCUAAUUUUCUAUUUUUGGUAA	23	2063
CFTR-G551D-227	−	UCUCUAAUUUUCUAUUUUUGGUAA	24	2064
CFTR-G551D-228	−	GACAUCUCCAAGUUUGCA	18	2065
CFTR-G551D-229	−	GGACAUCUCCAAGUUUGCA	19	2066
CFTR-G551D-230	−	AGGACAUCUCCAAGUUUGCA	20	738
CFTR-G551D-231	−	UAGGACAUCUCCAAGUUUGCA	21	2067
CFTR-G551D-232	−	AUAGGACAUCUCCAAGUUUGCA	22	2068
CFTR-G551D-233	−	AAUAGGACAUCUCCAAGUUUGCA	23	2069
CFTR-G551D-234	−	UAAUAGGACAUCUCCAAGUUUGCA	24	2070
CFTR-G551D-235	−	CACACUGAGUGGAGAUCA	18	2185
CFTR-G551D-236	−	UCACACUGAGUGGAGAUCA	19	2186
CFTR-G551D-237	−	AUCACACUGAGUGGAGAUCA	20	2187
CFTR-G551D-238	−	AAUCACACUGAGUGGAGAUCA	21	2188
CFTR-G551D-239	−	GAAUCACACUGAGUGGAGAUCA	22	2189
CFTR-G551D-240	−	GGAAUCACACUGAGUGGAGAUCA	23	2190
CFTR-G551D-241	−	UGGAAUCACACUGAGUGGAGAUCA	24	2191
CFTR-G551D-242	−	GUGCCUUUCAAAUUCAGA	18	2077
CFTR-G551D-243	−	UGUGCCUUUCAAAUUCAGA	19	2078
CFTR-G551D-244	−	AUGUGCCUUUCAAAUUCAGA	20	735
CFTR-G551D-245	−	GAUGUGCCUUUCAAAUUCAGA	21	2079
CFTR-G551D-246	−	AGAUGUGCCUUUCAAAUUCAGA	22	2080
CFTR-G551D-247	−	AAGAUGUGCCUUUCAAAUUCAGA	23	2081
CFTR-G551D-248	−	GAAGAUGUGCCUUUCAAAUUCAGA	24	2082
CFTR-G551D-249	−	AUAUAUGAUUACAUUAGA	18	2083
CFTR-G551D-250	−	GAUAUAUGAUUACAUUAGA	19	2084
CFTR-G551D-20	−	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-G551D-251	−	GUGAUAUAUGAUUACAUUAGA	21	2085
CFTR-G551D-252	−	UGUGAUAUAUGAUUACAUUAGA	22	2086
CFTR-G551D-253	−	GUGUGAUAUAUGAUUACAUUAGA	23	2087
CFTR-G551D-254	−	AGUGUGAUAUAUGAUUACAUUAGA	24	2088
CFTR-G551D-255	−	AAGGUGGAAUCACACUGA	18	2089
CFTR-G551D-256	−	GAAGGUGGAAUCACACUGA	19	2090
CFTR-G551D-257	−	AGAAGGUGGAAUCACACUGA	20	743
CFTR-G551D-258	−	GAGAAGGUGGAAUCACACUGA	21	2091
CFTR-G551D-259	−	GGAGAAGGUGGAAUCACACUGA	22	2192
CFTR-G551D-260	−	UGGAGAAGGUGGAAUCACACUGA	23	2193
CFTR-G551D-261	−	UUGGAGAAGGUGGAAUCACACUGA	24	2194
CFTR-G551D-262	−	UCUGGAAUUGAAAAAAUC	18	2098
CFTR-G551D-263	−	UUCUGGAAUUGAAAAAAUC	19	2099
CFTR-G551D-264	−	UUUCUGGAAUUGAAAAAAUC	20	749
CFTR-G551D-265	−	GUUUCUGGAAUUGAAAAAAUC	21	2100
CFTR-G551D-266	−	UGUUUCUGGAAUUGAAAAAAUC	22	2101
CFTR-G551D-267	−	CUGUUUCUGGAAUUGAAAAAAUC	23	2102
CFTR-G551D-268	−	UCUGUUUCUGGAAUUGAAAAAAUC	24	2103
CFTR-G551D-269	−	AGAAAGACAAUAUAGUUC	18	2195
CFTR-G551D-270	−	GAGAAAGACAAUAUAGUUC	19	2196
CFTR-G551D-271	−	AGAGAAAGACAAUAUAGUUC	20	739
CFTR-G551D-272	−	CAGAGAAAGACAAUAUAGUUC	21	2197
CFTR-G551D-273	−	GCAGAGAAAGACAAUAUAGUUC	22	2198
CFTR-G551D-274	−	UGCAGAGAAAGACAAUAUAGUUC	23	2199
CFTR-G551D-275	−	UUGCAGAGAAAGACAAUAUAGUUC	24	2200
CFTR-G551D-276	−	AUAUAGUUCUUGGAGAAG	18	2201
CFTR-G551D-277	−	AAUAUAGUUCUUGGAGAAG	19	2202
CFTR-G551D-278	−	CAAUAUAGUUCUUGGAGAAG	20	741
CFTR-G551D-279	−	ACAAUAUAGUUCUUGGAGAAG	21	2203
CFTR-G551D-280	−	GACAAUAUAGUUCUUGGAGAAG	22	2204
CFTR-G551D-281	−	AGACAAUAUAGUUCUUGGAGAAG	23	2205
CFTR-G551D-282	−	AAGACAAUAUAGUUCUUGGAGAAG	24	2206
CFTR-G551D-283	−	AGGUGGAAUCACACUGAG	18	2111
CFTR-G551D-284	−	AAGGUGGAAUCACACUGAG	19	2112
CFTR-G551D-8	−	GAAGGUGGAAUCACACUGAG	20	461
CFTR-G551D-285	−	AGAAGGUGGAAUCACACUGAG	21	2113
CFTR-G551D-286	−	GAGAAGGUGGAAUCACACUGAG	22	2114
CFTR-G551D-287	−	GGAGAAGGUGGAAUCACACUGAG	23	2207
CFTR-G551D-288	−	UGGAGAAGGUGGAAUCACACUGAG	24	2208
CFTR-G551D-289	−	GAUAUAUGAUUACAUUAG	18	2117
CFTR-G551D-290	−	UGAUAUAUGAUUACAUUAG	19	2118
CFTR-G551D-291	−	GUGAUAUAUGAUUACAUUAG	20	734
CFTR-G551D-292	−	UGUGAUAUAUGAUUACAUUAG	21	2119
CFTR-G551D-293	−	GUGUGAUAUAUGAUUACAUUAG	22	2120
CFTR-G551D-294	−	AGUGUGAUAUAUGAUUACAUUAG	23	2121
CFTR-G551D-295	−	UAGUGUGAUAUAUGAUUACAUUAG	24	2122
CFTR-G551D-296	−	AAGACAAUAUAGUUCUUG	18	2209
CFTR-G551D-297	−	AAAGACAAUAUAGUUCUUG	19	2210
CFTR-G551D-298	−	GAAAGACAAUAUAGUUCUUG	20	740
CFTR-G551D-299	−	AGAAAGACAAUAUAGUUCUUG	21	2211
CFTR-G551D-300	−	GAGAAAGACAAUAUAGUUCUUG	22	2212
CFTR-G551D-301	−	AGAGAAAGACAAUAUAGUUCUUG	23	2213
CFTR-G551D-302	−	CAGAGAAAGACAAUAUAGUUCUUG	24	2214
CFTR-G551D-303	−	AGGACAUCUCCAAGUUUG	18	2123
CFTR-G551D-304	−	UAGGACAUCUCCAAGUUUG	19	2124
CFTR-G551D-305	−	AUAGGACAUCUCCAAGUUUG	20	737
CFTR-G551D-306	−	AAUAGGACAUCUCCAAGUUUG	21	2125
CFTR-G551D-307	−	UAAUAGGACAUCUCCAAGUUUG	22	2126
CFTR-G551D-308	−	GUAAUAGGACAUCUCCAAGUUUG	23	2127
CFTR-G551D-309	−	GGUAAUAGGACAUCUCCAAGUUUG	24	2128
CFTR-G551D-310	−	UGUGAUAUAUGAUUACAU	18	2129
CFTR-G551D-311	−	GUGUGAUAUAUGAUUACAU	19	2130
CFTR-G551D-312	−	AGUGUGAUAUAUGAUUACAU	20	733
CFTR-G551D-313	−	UAGUGUGAUAUAUGAUUACAU	21	2131
CFTR-G551D-314	−	AUAGUGUGAUAUAUGAUUACAU	22	2132
CFTR-G551D-315	−	AAUAGUGUGAUAUAUGAUUACAU	23	2133
CFTR-G551D-316	−	CAAUAGUGUGAUAUAUGAUUACAU	24	2134
CFTR-G551D-317	−	GAAAGACAAUAUAGUUCU	18	2135
CFTR-G551D-318	−	AGAAAGACAAUAUAGUUCU	19	2136
CFTR-G551D-9	−	GAGAAAGACAAUAUAGUUCU	20	453
CFTR-G551D-319	−	AGAGAAAGACAAUAUAGUUCU	21	2137
CFTR-G551D-320	−	CAGAGAAAGACAAUAUAGUUCU	22	2138
CFTR-G551D-321	−	GCAGAGAAAGACAAUAUAGUUCU	23	2139
CFTR-G551D-322	−	UGCAGAGAAAGACAAUAUAGUUCU	24	2140
CFTR-G551D-323	−	GGGUUAAGAAUCACAUUU	18	2215
CFTR-G551D-324	−	UGGGUUAAGAAUCACAUUU	19	2216
CFTR-G551D-325	−	GUGGGUUAAGAAUCACAUUU	20	752
CFTR-G551D-326	−	AGUGGGUUAAGAAUCACAUUU	21	2217
CFTR-G551D-327	−	UAGUGGGUUAAGAAUCACAUUU	22	2218
CFTR-G551D-328	−	CUAGUGGGUUAAGAAUCACAUUU	23	2219
CFTR-G551D-329	−	GCUAGUGGGUUAAGAAUCACAUUU	24	2220
CFTR-G551D-330	−	UUGCUUUAUAUUCUGUUU	18	2148
CFTR-G551D-331	−	AUUGCUUUAUAUUCUGUUU	19	2149
CFTR-G551D-332	−	UAUUGCUUUAUAUUCUGUUU	20	747
CFTR-G551D-333	−	CUAUUGCUUUAUAUUCUGUUU	21	2150
CFTR-G551D-334	−	UCUAUUGCUUUAUAUUCUGUUU	22	2151
CFTR-G551D-335	−	CUCUAUUGCUUUAUAUUCUGUUU	23	2152
CFTR-G551D-336	−	UCUCUAUUGCUUUAUAUUCUGUUU	24	2153

Table 18A provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 18A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-G551D-337	+	GUAAUCAUAUAUCACAC	17	2154
CFTR-G551D-338	−	GGUUAAAGCAAUAGUGU	20	927
		GAU

Table 18B provides exemplary targeting domains for correcting a mutation (e.g., G551D) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G551D) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 18B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G551D-339	+	CCACUAGCCAUAAAACC	17	935
CFTR-G551D-340	+	UGAAUGACAUUUACAGC	17	2155
CFTR-G551D-341	−	UAAAGCAAUAGUGUGAU	17	932
CFTR-G551D-342	−	AGGAAGAUGUGCCUUUCAAA	20	928
CFTR-G551D-343	+	AAUGUAAUCAUAUAUCACAC	20	2156
CFTR-G551D-344	+	AACCCACUAGCCAUAAAACC	20	930
CFTR-G551D-345	+	ACAUGAAUGACAUUUACAGC	20	2157

Table 18C provides exemplary targeting domains for correcting a mutation (e.g., G55D) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., G55D). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 18C
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-G551D-346	−	AAGAUGUGCCUUUCAAA	17	933
CFTR-G551D-347	+	UUAUUUAUAGUUCUUAA	17	936
CFTR-G551D-348	+	UCGUUGAUCUCCACUCA	17	2221
CFTR-G551D-349	−	AAUUACAGACAUUUCUC	17	2158
CFTR-G551D-350	+	CCAUUAUUUAUAGUUCUUAA	20	931
CFTR-G551D-351	+	UGCUCGUUGAUCUCCACUCA	20	2222
CFTR-G551D-352	−	AAAAAUUACAGACAUUUCUC	20	2159

Table 19A provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 19A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-1	−	GGAGUGAUCAAGAAAUA	17	2223
CFTR-N1303K-2	−	GAGUACCCUAACAUACC	17	2224
CFTR-N1303K-3	−	GUGUGUGCACAACUUUAA	20	2225
		AA
CFTR-N1303K-4	−	GGAAAGUUGCAGAUGAGG	20	2226
		UA
CFTR-N1303K-5	−	GAACUUGAUGGUAAGUAC	20	2227
		AU
CFTR-N1303K-6	+	GCUAUAUCAGCCAUUUGU	20	2228
		GU

Table 19B provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 19B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-7	−	UGUGCACAACUUUAAAA	17	2229
CFTR-N1303K-8	−	ACUUGAUGGUAAGUACA	17	2230
CFTR-N1303K-9	−	AAUUUGAGAGAACUUGA	17	2231
CFTR-N1303K-10	+	UCACUCCACUGUUCAUA	17	2232
CFTR-N1303K-11	−	AAGUUGCAGAUGAGGUA	17	2233
CFTR-N1303K-12	−	UGGAUCCCUAUGAACAG	17	2234
CFTR-N1303K-13	−	AUGGAAAGUUGCAGAUG	17	2235
CFTR-N1303K-14	−	CUUGAUGGUAAGUACAU	17	2236
CFTR-N1303K-15	+	AUCACUCCACUGUUCAU	17	2237
CFTR-N1303K-16	+	AUAUCAGCCAUUUGUGU	17	2238
CFTR-N1303K-17	−	AGAACUUGAUGGUAAGUACA	20	2239
CFTR-N1303K-18	−	AGUGGAGUGAUCAAGAAAUA	20	2240
CFTR-N1303K-19	+	UGAUCACUCCACUGUUCAUA	20	2241
CFTR-N1303K-20	−	AAUAUGGAAAGUUGCAGAUG	20	2242
CFTR-N1303K-21	+	UUGAUCACUCCACUGUUCAU	20	2243

Table 19C provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 19C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-N1303K-22	−	GUAACUCAUACCAACACA	20	2244
		AA

Table 19D provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 19D
4th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-23	−	ACUCAUACCAACACAAA	17	2245
CFTR-N1303K-24	−	CUGAAAUGAUUUUGAAA	17	2246
CFTR-N1303K-25	−	ACUGAAAUGAUUUUGAA	17	2247
CFTR-N1303K-26	−	AUUUUACAAUACAAUAA	17	2248
CFTR-N1303K-27	−	UAUUUUACAAUACAAUA	17	2249
CFTR-N1303K-28	+	UUGCUCCAGGUAUGUUA	17	2250
CFTR-N1303K-29	−	AAAGUAUUUAUUUUUUC	17	2251
CFTR-N1303K-30	−	UGAAAUGAUUUUGAAAG	17	2252
CFTR-N1303K-31	−	AACAUUUAGAAAAAAGU	17	2253
CFTR-N1303K-32	−	UAACUGAAAUGAUUUUGAAA	20	2254
CFTR-N1303K-33	−	CUAACUGAAAUGAUUUUGAA	20	2255
CFTR-N1303K-34	−	AAUAUUUUACAAUACAAUAA	20	2256
CFTR-N1303K-35	−	UAAAAUUUGAGAGAACUUGA	20	2257
CFTR-N1303K-36	−	AAAUAUUUUACAAUACAAUA	20	2258
CFTR-N1303K-37	−	AUGGAGUACCCUAACAUACC	20	2259
CFTR-N1303K-38	−	UAGAAAGUAUUUAUUUUUUC	20	2260
CFTR-N1303K-39	−	AACUGAAAUGAUUUUGAAAG	20	2261
CFTR-N1303K-40	−	AGUUGGAUCCCUAUGAACAG	20	2262
CFTR-N1303K-41	−	UGGAACAUUUAGAAAAAAGU	20	2263

Table 20A provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 20A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-42	+	GAUCACUCCACUGUUCAU	18	2264
CFTR-N1303K-43	−	GUGUGCACAACUUUAAAA	18	2265
CFTR-N1303K-3	−	GUGUGUGCACAACUUUAAAA	20	2225
CFTR-N1303K-44	−	GCUAACUGAAAUGAUUUUGAA	21	2266
CFTR-N1303K-45	−	GCUGCUAACUGAAAUGAUUUUGAA	24	2267
CFTR-N1303K-46	−	GAACUUGAUGGUAAGUAC	18	2268
CFTR-N1303K-47	−	GAGAACUUGAUGGUAAGUAC	20	2269
CFTR-N1303K-48	−	GAGAGAACUUGAUGGUAAGUAC	22	2270

Table 20B provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 20B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-49	+	UGAUCACUCCACUGUUCAU	19	2271
CFTR-N1303K-21	+	UUGAUCACUCCACUGUUCAU	20	2243
CFTR-N1303K-50	+	CUUGAUCACUCCACUGUUCAU	21	2272
CFTR-N1303K-51	+	UCUUGAUCACUCCACUGUUCAU	22	2273
CFTR-N1303K-52	+	UUCUUGAUCACUCCACUGUUCAU	23	2274
CFTR-N1303K-53	+	UUUCUUGAUCACUCCACUGUUCAU	24	2275
CFTR-N1303K-54	−	UGUGUGCACAACUUUAAAA	19	2276
CFTR-N1303K-55	−	UGCUAACUGAAAUGAUUUUGAA	22	2277
CFTR-N1303K-56	−	CUGCUAACUGAAAUGAUUUUGAA	23	2278
CFTR-N1303K-57	−	AGAACUUGAUGGUAAGUAC	19	2279
CFTR-N1303K-58	−	AGAGAACUUGAUGGUAAGUAC	21	2280
CFTR-N1303K-59	−	UGAGAGAACUUGAUGGUAAGUAC	23	2281
CFTR-N1303K-60	−	UUGAGAGAACUUGAUGGUAAGUAC	24	2282

Table 20C provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 20C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-N1303K-61	+	GCUAUAUCAGCCAUUUG	24	2283
		UGUUGGU
CFTR-N1303K-62	−	GUAUGUGUGUGCACAACU	24	2284
		UUAAAA
CFTR-N1303K-63	−	GGAACAUUUAGAAAAAAG	18	2285
CFTR-N1303K-64	−	GUUGGAUCCCUAUGAAC	19	2286
		AG

Table 20D provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 20D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-65	+	ACAUGCACACAAAGUGUG	18	2287
CFTR-N1303K-66	+	UACAUGCACACAAAGUGUG	19	2288
CFTR-N1303K-67	+	AUACAUGCACACAAAGUGUG	20	2289
CFTR-N1303K-68	+	CAUACAUGCACACAAAGUGUG	21	2290
CFTR-N1303K-69	+	ACAUACAUGCACACAAAGUGUG	22	2291
CFTR-N1303K-70	+	CACAUACAUGCACACAAAGUGUG	23	2292
CFTR-N1303K-71	+	ACACAUACAUGCACACAAAGUGUG	24	2293
CFTR-N1303K-72	+	AGAAAAGAAGAAGAAAGU	18	2294
CFTR-N1303K-73	+	AAGAAAAGAAGAAGAAAGU	19	2295
CFTR-N1303K-74	+	AAAGAAAAGAAGAAGAAAGU	20	2296
CFTR-N1303K-75	+	AAAAGAAAAGAAGAAGAAAGU	21	2297
CFTR-N1303K-76	+	AAAAAGAAAAGAAGAAGAAAGU	22	2298
CFTR-N1303K-77	+	AAAAAAGAAAAGAAGAAGAAAGU	23	2299
CFTR-N1303K-78	+	CAAAAAAGAAAAGAAGAAGAAAGU	24	2300
CFTR-N1303K-79	+	UCAGCCAUUUGUGUUGGU	18	2301
CFTR-N1303K-80	+	AUCAGCCAUUUGUGUUGGU	19	2302
CFTR-N1303K-81	+	UAUCAGCCAUUUGUGUUGGU	20	2303
CFTR-N1303K-82	+	AUAUCAGCCAUUUGUGUUGGU	21	2304
CFTR-N1303K-83	+	UAUAUCAGCCAUUUGUGUUGGU	22	2305
CFTR-N1303K-84	+	CUAUAUCAGCCAUUUGUGUUGGU	23	2306
CFTR-N1303K-85	−	UGUGUGUGCACAACUUUAAAA	21	2307
CFTR-N1303K-86	−	AUGUGUGUGCACAACUUUAAAA	22	2308
CFTR-N1303K-87	−	UAUGUGUGUGCACAACUUUAAAA	23	2309
CFTR-N1303K-88	−	AACUGAAAUGAUUUUGAA	18	2310
CFTR-N1303K-89	−	UAACUGAAAUGAUUUUGAA	19	2311
CFTR-N1303K-33	−	CUAACUGAAAUGAUUUUGAA	20	2255
CFTR-N1303K-90	−	UGGAACAUUUAGAAAAAAG	19	2312
CFTR-N1303K-91	−	CUGGAACAUUUAGAAAAAAG	20	2313
CFTR-N1303K-92	−	UCUGGAACAUUUAGAAAAAAG	21	2314
CFTR-N1303K-93	−	UUCUGGAACAUUUAGAAAAAAG	22	2315
CFTR-N1303K-94	−	UUUCUGGAACAUUUAGAAAAAAG	23	2316
CFTR-N1303K-95	−	UUUUCUGGAACAUUUAGAAAAAAG	24	2317
CFTR-N1303K-96	−	UUGGAUCCCUAUGAACAG	18	2318
CFTR-N1303K-40	−	AGUUGGAUCCCUAUGAACAG	20	2262
CFTR-N1303K-97	−	AAGUUGGAUCCCUAUGAACAG	21	2319
CFTR-N1303K-98	−	AAAGUUGGAUCCCUAUGAACAG	22	2320
CFTR-N1303K-99	−	AAAAGUUGGAUCCCUAUGAACAG	23	2321
CFTR-N1303K-100	−	AAAAAGUUGGAUCCCUAUGAACAG	24	2322

Table 20E provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 20E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-N1303K-101	+	AUACUUUCUAUAGCAAAA	18	2323
CFTR-N1303K-102	+	AAUACUUUCUAUAGCAAAA	19	2324
CFTR-N1303K-103	+	AAAUACUUUCUAUAGCAAAA	20	2325
CFTR-N1303K-104	+	UAAAUACUUUCUAUAGCAAAA	21	2326
CFTR-N1303K-105	+	AUAAAUACUUUCUAUAGCAAAA	22	2327
CFTR-N1303K-106	+	AAUAAAUACUUUCUAUAGCAAAA	23	2328
CFTR-N1303K-107	+	AAAUAAAUACUUUCUAUAGCAAAA	24	2329
CFTR-N1303K-108	+	UUCUAUAGCAAAAAAGAA	18	2330
CFTR-N1303K-109	+	UUUCUAUAGCAAAAAAGAA	19	2331
CFTR-N1303K-110	+	CUUUCUAUAGCAAAAAAGAA	20	2332
CFTR-N1303K-111	+	ACUUUCUAUAGCAAAAAAGAA	21	2333
CFTR-N1303K-112	+	UACUUUCUAUAGCAAAAAAGAA	22	2334
CFTR-N1303K-113	+	AUACUUUCUAUAGCAAAAAAGAA	23	2335
CFTR-N1303K-114	+	AAUACUUUCUAUAGCAAAAAAGAA	24	2336
CFTR-N1303K-115	+	UGAUCACUCCACUGUUCA	18	2337
CFTR-N1303K-116	+	UUGAUCACUCCACUGUUCA	19	2338
CFTR-N1303K-117	+	CUUGAUCACUCCACUGUUCA	20	2339
CFTR-N1303K-118	+	UCUUGAUCACUCCACUGUUCA	21	2340
CFTR-N1303K-119	+	UUCUUGAUCACUCCACUGUUCA	22	2341
CFTR-N1303K-120	+	UUUCUUGAUCACUCCACUGUUCA	23	2342
CFTR-N1303K-121	+	AUUUCUUGAUCACUCCACUGUUCA	24	2343
CFTR-N1303K-122	+	ACUUUUUUCUAAAUGUUC	18	2344
CFTR-N1303K-123	+	AACUUUUUUCUAAAUGUUC	19	2345
CFTR-N1303K-124	+	CAACUUUUUUCUAAAUGUUC	20	2346
CFTR-N1303K-125	+	CCAACUUUUUUCUAAAUGUUC	21	2347
CFTR-N1303K-126	+	UCCAACUUUUUUCUAAAUGUUC	22	2348
CFTR-N1303K-127	+	AUCCAACUUUUUUCUAAAUGUUC	23	2349
CFTR-N1303K-128	+	GAUCCAACUUUUUUCUAAAUGUUC	24	2350
CFTR-N1303K-129	+	UAUAGCAAAAAAGAAAAG	18	2351
CFTR-N1303K-130	+	CUAUAGCAAAAAAGAAAAG	19	2352
CFTR-N1303K-131	+	UCUAUAGCAAAAAAGAAAAG	20	2353
CFTR-N1303K-132	+	UUCUAUAGCAAAAAAGAAAAG	21	2354
CFTR-N1303K-133	+	UUUCUAUAGCAAAAAAGAAAAG	22	2355
CFTR-N1303K-134	+	CUUUCUAUAGCAAAAAAGAAAAG	23	2356
CFTR-N1303K-135	+	ACUUUCUAUAGCAAAAAAGAAAAG	24	2357
CFTR-N1303K-136	+	AUUGUAAAAUAUUUCAAG	18	2358
CFTR-N1303K-137	+	UAUUGUAAAAUAUUUCAAG	19	2359
CFTR-N1303K-138	+	GUAUUGUAAAAUAUUUCAAG	20	2360
CFTR-N1303K-139	+	UGUAUUGUAAAAUAUUUCAAG	21	2361
CFTR-N1303K-140	+	UUGUAUUGUAAAAUAUUUCAAG	22	2362
CFTR-N1303K-141	+	AUUGUAUUGUAAAAUAUUUCAAG	23	2363
CFTR-N1303K-142	+	UAUUGUAUUGUAAAAUAUUUCAAG	24	2364
CFTR-N1303K-143	+	AGCAAAAAAGAAAAGAAG	18	2365
CFTR-N1303K-144	+	UAGCAAAAAAGAAAAGAAG	19	2366
CFTR-N1303K-145	+	AUAGCAAAAAAGAAAAGAAG	20	2367
CFTR-N1303K-146	+	UAUAGCAAAAAAGAAAAGAAG	21	2368
CFTR-N1303K-147	+	CUAUAGCAAAAAAGAAAAGAAG	22	2369
CFTR-N1303K-148	+	UCUAUAGCAAAAAAGAAAAGAAG	23	2370
CFTR-N1303K-149	+	UUCUAUAGCAAAAAAGAAAAGAAG	24	2371
CFTR-N1303K-150	+	GAAAAAUUAUUUUAAAAU	18	2372
CFTR-N1303K-151	+	AGAAAAAUUAUUUUAAAAU	19	2373
CFTR-N1303K-152	+	UAGAAAAAUUAUUUUAAAAU	20	2374
CFTR-N1303K-153	+	GUAGAAAAAUUAUUUUAAAAU	21	2375
CFTR-N1303K-154	+	AGUAGAAAAAUUAUUUUAAAAU	22	2376
CFTR-N1303K-155	+	AAGUAGAAAAAUUAUUUUAAAAU	23	2377
CFTR-N1303K-156	+	CAAGUAGAAAAAUUAUUUUAAAAU	24	2378
CFTR-N1303K-157	−	UGUGUGCACAACUUUAAA	18	2379
CFTR-N1303K-158	−	GUGUGUGCACAACUUUAAA	19	2380
CFTR-N1303K-159	−	UGUGUGUGCACAACUUUAAA	20	2381
CFTR-N1303K-160	−	AUGUGUGUGCACAACUUUAAA	21	2382
CFTR-N1303K-161	−	UAUGUGUGUGCACAACUUUAAA	22	2383
CFTR-N1303K-162	−	GUAUGUGUGUGCACAACUUUAAA	23	2384
CFTR-N1303K-163	−	UGUAUGUGUGUGCACAACUUUAAA	24	2385
CFTR-N1303K-164	−	UAUUUUACAAUACAAUAA	18	2386
CFTR-N1303K-165	−	AUAUUUUACAAUACAAUAA	19	2387
CFTR-N1303K-34	−	AAUAUUUUACAAUACAAUAA	20	2256
CFTR-N1303K-166	−	AAAUAUUUUACAAUACAAUAA	21	2388
CFTR-N1303K-167	−	GAAAUAUUUUACAAUACAAUAA	22	2389
CFTR-N1303K-168	−	UGAAAUAUUUUACAAUACAAUAA	23	2390
CFTR-N1303K-169	−	UUGAAAUAUUUUACAAUACAAUAA	24	2391
CFTR-N1303K-170	−	AUGAGGUAAGGCUGCUAA	18	2392
CFTR-N1303K-171	−	GAUGAGGUAAGGCUGCUAA	19	2393
CFTR-N1303K-172	−	AGAUGAGGUAAGGCUGCUAA	20	2394
CFTR-N1303K-173	−	CAGAUGAGGUAAGGCUGCUAA	21	2395
CFTR-N1303K-174	−	GCAGAUGAGGUAAGGCUGCUAA	22	2396
CFTR-N1303K-175	−	UGCAGAUGAGGUAAGGCUGCUAA	23	2397
CFTR-N1303K-176	−	UUGCAGAUGAGGUAAGGCUGCUAA	24	2398
CFTR-N1303K-177	−	GUUGGAUCCCUAUGAACA	18	2399
CFTR-N1303K-178	−	AGUUGGAUCCCUAUGAACA	19	2400
CFTR-N1303K-179	−	AAGUUGGAUCCCUAUGAACA	20	2401
CFTR-N1303K-180	−	AAAGUUGGAUCCCUAUGAACA	21	2402
CFTR-N1303K-181	−	AAAAGUUGGAUCCCUAUGAACA	22	2403
CFTR-N1303K-182	−	AAAAAGUUGGAUCCCUAUGAACA	23	2404
CFTR-N1303K-183	−	AAAAAAGUUGGAUCCCUAUGAACA	24	2405
CFTR-N1303K-184	−	UAAAAUAUUAAAAUUUGA	18	2406
CFTR-N1303K-185	−	AUAAAAUAUUAAAAUUUGA	19	2407
CFTR-N1303K-186	−	GAUAAAAUAUUAAAAUUUGA	20	2408
CFTR-N1303K-187	−	UGAUAAAAUAUUAAAAUUUGA	21	2409
CFTR-N1303K-188	−	AUGAUAAAAUAUUAAAAUUUGA	22	2410
CFTR-N1303K-189	−	CAUGAUAAAAUAUUAAAAUUUGA	23	2411
CFTR-N1303K-190	−	ACAUGAUAAAAUAUUAAAAUUUGA	24	2412
CFTR-N1303K-191	−	UAACUGAAAUGAUUUUGA	18	2413
CFTR-N1303K-192	−	CUAACUGAAAUGAUUUUGA	19	2414
CFTR-N1303K-193	−	GCUAACUGAAAUGAUUUUGA	20	2415
CFTR-N1303K-194	−	UGCUAACUGAAAUGAUUUUGA	21	2416
CFTR-N1303K-195	−	CUGCUAACUGAAAUGAUUUUGA	22	2417
CFTR-N1303K-196	−	GCUGCUAACUGAAAUGAUUUUGA	23	2418
CFTR-N1303K-197	−	GGCUGCUAACUGAAAUGAUUUUGA	24	2419
CFTR-N1303K-198	−	UGGAGUGAUCAAGAAAUA	18	2420
CFTR-N1303K-199	−	GUGGAGUGAUCAAGAAAUA	19	2421
CFTR-N1303K-18	−	AGUGGAGUGAUCAAGAAAUA	20	2240
CFTR-N1303K-200	−	CAGUGGAGUGAUCAAGAAAUA	21	2422
CFTR-N1303K-201	−	ACAGUGGAGUGAUCAAGAAAUA	22	2423
CFTR-N1303K-202	−	AACAGUGGAGUGAUCAAGAAAUA	23	2424
CFTR-N1303K-203	−	GAACAGUGGAGUGAUCAAGAAAUA	24	2425
CFTR-N1303K-204	−	AUAUUUUACAAUACAAUA	18	2426
CFTR-N1303K-205	−	AAUAUUUUACAAUACAAUA	19	2427
CFTR-N1303K-36	−	AAAUAUUUUACAAUACAAUA	20	2258
CFTR-N1303K-206	−	GAAAUAUUUUACAAUACAAUA	21	2428
CFTR-N1303K-207	−	UGAAAUAUUUUACAAUACAAUA	22	2429
CFTR-N1303K-208	−	UUGAAAUAUUUUACAAUACAAUA	23	2430
CFTR-N1303K-209	−	CUUGAAAUAUUUUACAAUACAAUA	24	2431
CFTR-N1303K-210	−	UUCUUUUCUUUUUUGCUA	18	2432
CFTR-N1303K-211	−	CUUCUUUUCUUUUUUGCUA	19	2433
CFTR-N1303K-212	−	UCUUCUUUUCUUUUUUGCUA	20	2434
CFTR-N1303K-213	−	UUCUUCUUUUCUUUUUUGCUA	21	2435
CFTR-N1303K-214	−	CUUCUUCUUUUCUUUUUUGCUA	22	2436
CFTR-N1303K-215	−	UCUUCUUCUUUUCUUUUUUGCUA	23	2437
CFTR-N1303K-216	−	UUCUUCUUCUUUUCUUUUUUGCUA	24	2438
CFTR-N1303K-217	−	UGGAGUACCCUAACAUAC	18	2439
CFTR-N1303K-218	−	AUGGAGUACCCUAACAUAC	19	2440
CFTR-N1303K-219	−	AAUGGAGUACCCUAACAUAC	20	2441
CFTR-N1303K-220	−	AAAUGGAGUACCCUAACAUAC	21	2442
CFTR-N1303K-221	−	AAAAUGGAGUACCCUAACAUAC	22	2443
CFTR-N1303K-222	−	UAAAAUGGAGUACCCUAACAUAC	23	2444
CFTR-N1303K-223	−	UUAAAAUGGAGUACCCUAACAUAC	24	2445
CFTR-N1303K-224	−	UUAAAAUAAUUUUUCUAC	18	2446
CFTR-N1303K-225	−	UUUAAAAUAAUUUUUCUAC	19	2447
CFTR-N1303K-226	−	UUUUAAAAUAAUUUUUCUAC	20	2448
CFTR-N1303K-227	−	AUUUUAAAAUAAUUUUUCUAC	21	2449
CFTR-N1303K-228	−	UAUUUUAAAAUAAUUUUUCUAC	22	2450
CFTR-N1303K-229	−	UUAUUUUAAAAUAAUUUUUCUAC	23	2451
CFTR-N1303K-230	−	CUUAUUUUAAAAUAAUUUUUCUAC	24	2452
CFTR-N1303K-231	−	GGAGUACCCUAACAUACC	18	2453
CFTR-N1303K-232	−	UGGAGUACCCUAACAUACC	19	2454
CFTR-N1303K-37	−	AUGGAGUACCCUAACAUACC	20	2259
CFTR-N1303K-233	−	AAUGGAGUACCCUAACAUACC	21	2455
CFTR-N1303K-234	−	AAAUGGAGUACCCUAACAUACC	22	2456
CFTR-N1303K-235	−	AAAAUGGAGUACCCUAACAUACC	23	2457
CFTR-N1303K-236	−	UAAAAUGGAGUACCCUAACAUACC	24	2458
CFTR-N1303K-237	−	AUGAACAGUGGAGUGAUC	18	2459
CFTR-N1303K-238	−	UAUGAACAGUGGAGUGAUC	19	2460
CFTR-N1303K-239	−	CUAUGAACAGUGGAGUGAUC	20	2461
CFTR-N1303K-240	−	CCUAUGAACAGUGGAGUGAUC	21	2462
CFTR-N1303K-241	−	CCCUAUGAACAGUGGAGUGAUC	22	2463
CFTR-N1303K-242	−	UCCCUAUGAACAGUGGAGUGAUC	23	2464
CFTR-N1303K-243	−	AUCCCUAUGAACAGUGGAGUGAUC	24	2465
CFTR-N1303K-244	−	GAAAGUAUUUAUUUUUUC	18	2466
CFTR-N1303K-245	−	AGAAAGUAUUUAUUUUUUC	19	2467
CFTR-N1303K-38	−	UAGAAAGUAUUUAUUUUUUC	20	2260
CFTR-N1303K-246	−	AUAGAAAGUAUUUAUUUUUUC	21	2468
CFTR-N1303K-247	−	UAUAGAAAGUAUUUAUUUUUUC	22	2469
CFTR-N1303K-248	−	CUAUAGAAAGUAUUUAUUUUUUC	23	2470
CFTR-N1303K-249	−	GCUAUAGAAAGUAUUUAUUUUUUC	24	2471
CFTR-N1303K-250	−	AAAUAUGGAAAGUUGCAG	18	2472
CFTR-N1303K-251	−	GAAAUAUGGAAAGUUGCAG	19	2473
CFTR-N1303K-252	−	AGAAAUAUGGAAAGUUGCAG	20	2474
CFTR-N1303K-253	−	AAGAAAUAUGGAAAGUUGCAG	21	2475
CFTR-N1303K-254	−	CAAGAAAUAUGGAAAGUUGCAG	22	2476
CFTR-N1303K-255	−	UCAAGAAAUAUGGAAAGUUGCAG	23	2477
CFTR-N1303K-256	−	AUCAAGAAAUAUGGAAAGUUGCAG	24	2478
CFTR-N1303K-257	−	AUGAUAAAAUAUUAAAAU	18	2479
CFTR-N1303K-258	−	CAUGAUAAAAUAUUAAAAU	19	2480
CFTR-N1303K-259	−	ACAUGAUAAAAUAUUAAAAU	20	2481
CFTR-N1303K-260	−	GUGGAGUGAUCAAGAAAU	18	2482
CFTR-N1303K-261	−	AGUGGAGUGAUCAAGAAAU	19	2483
CFTR-N1303K-262	−	CAGUGGAGUGAUCAAGAAAU	20	2484
CFTR-N1303K-263	−	ACAGUGGAGUGAUCAAGAAAU	21	2485
CFTR-N1303K-264	−	AACAGUGGAGUGAUCAAGAAAU	22	2486
CFTR-N1303K-265	−	GAACAGUGGAGUGAUCAAGAAAU	23	2487
CFTR-N1303K-266	−	UGAACAGUGGAGUGAUCAAGAAAU	24	2488
CFTR-N1303K-267	−	AAUAUUUUACAAUACAAU	18	2489
CFTR-N1303K-268	−	AAAUAUUUUACAAUACAAU	19	2490
CFTR-N1303K-269	−	GAAAUAUUUUACAAUACAAU	20	2491
CFTR-N1303K-270	−	UGAAAUAUUUUACAAUACAAU	21	2492
CFTR-N1303K-271	−	UUGAAAUAUUUUACAAUACAAU	22	2493
CFTR-N1303K-272	−	CUUGAAAUAUUUUACAAUACAAU	23	2494
CFTR-N1303K-273	−	ACUUGAAAUAUUUUACAAUACAAU	24	2495
CFTR-N1303K-274	−	GAAAAAAGUUGGAUCCCU	18	2496
CFTR-N1303K-275	−	AGAAAAAAGUUGGAUCCCU	19	2497
CFTR-N1303K-276	−	UAGAAAAAAGUUGGAUCCCU	20	2498
CFTR-N1303K-277	−	UUAGAAAAAAGUUGGAUCCCU	21	2499
CFTR-N1303K-278	−	UUUAGAAAAAAGUUGGAUCCCU	22	2500
CFTR-N1303K-279	−	AUUUAGAAAAAAGUUGGAUCCCU	23	2501
CFTR-N1303K-280	−	CAUUUAGAAAAAAGUUGGAUCCCU	24	2502
CFTR-N1303K-281	−	UAUUUUUUCUGGAACAUU	18	2503
CFTR-N1303K-282	−	UUAUUUUUUCUGGAACAUU	19	2504
CFTR-N1303K-283	−	UUUAUUUUUUCUGGAACAUU	20	2505
CFTR-N1303K-284	−	AUUUAUUUUUUCUGGAACAUU	21	2506
CFTR-N1303K-285	−	UAUUUAUUUUUUCUGGAACAUU	22	2507
CFTR-N1303K-286	−	GUAUUUAUUUUUUCUGGAACAUU	23	2508
CFTR-N1303K-287	−	AGUAUUUAUUUUUUCUGGAACAUU	24	2509
CFTR-N1303K-288	−	CUGCUAACUGAAAUGAUU	18	2510
CFTR-N1303K-289	−	GCUGCUAACUGAAAUGAUU	19	2511
CFTR-N1303K-290	−	GGCUGCUAACUGAAAUGAUU	20	2512
CFTR-N1303K-291	−	AGGCUGCUAACUGAAAUGAUU	21	2513
CFTR-N1303K-292	−	AAGGCUGCUAACUGAAAUGAUU	22	2514
CFTR-N1303K-293	−	UAAGGCUGCUAACUGAAAUGAUU	23	2515
CFTR-N1303K-294	−	GUAAGGCUGCUAACUGAAAUGAUU	24	2516
CFTR-N1303K-295	−	GAUAAAAUAUUAAAAUUU	18	2517
CFTR-N1303K-296	−	UGAUAAAAUAUUAAAAUUU	19	2518
CFTR-N1303K-297	−	AUGAUAAAAUAUUAAAAUUU	20	2519
CFTR-N1303K-298	−	AGAAAGUAUUUAUUUUUU	18	2520
CFTR-N1303K-299	−	UAGAAAGUAUUUAUUUUUU	19	2521
CFTR-N1303K-300	−	AUAGAAAGUAUUUAUUUUUU	20	2522
CFTR-N1303K-301	−	UAUAGAAAGUAUUUAUUUUUU	21	2523
CFTR-N1303K-302	−	CUAUAGAAAGUAUUUAUUUUUU	22	2524
CFTR-N1303K-303	−	GCUAUAGAAAGUAUUUAUUUUUU	23	2525
CFTR-N1303K-304	−	UGCUAUAGAAAGUAUUUAUUUUUU	24	2526

Table 21A provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 21A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-N1303K-305	−	GGUAAGGCUGCUAACUG	17	2527

Table 21B provides exemplary targeting domains for correcting a mutation (e.g., N1303K) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., N1303K) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 21B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-N1303K-306	−	UGAGGUAAGGCUGCUAACUG	20	2528

Table 22A provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 22A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-1	+	GUGAUGAAGGCCAAAAA	17	2529
CFTR-R117H-2	+	GGUGACUUCCUACAAAA	17	2530
CFTR-R117H-3	+	GCCAUGGGGCCUGUGCA	17	2531
CFTR-R117H-4	+	GCAUUCCAAUGUGAUGA	17	2532
CFTR-R117H-5	−	GUAAUACUUCCUUGCAC	17	2533
CFTR-R117H-6	+	GUGACUUCCUACAAAAG	17	2534
CFTR-R117H-7	−	GCCUUCUCUUUAUUGUG	17	2535
CFTR-R117H-8	−	GCGAUUUAUCUAGGCAU	17	2536
CFTR-R117H-9	−	GUACAGCCUCUCUUACU	17	2537
CFTR-R117H-10	+	GAAGGCCAAAAAUGGCU	17	2538
CFTR-R117H-11	+	GAGAGGCUGUACUGCUU	17	2539
CFTR-R117H-12	+	GAUACAGAAUAUAUGUGCCA	20	2540
CFTR-R117H-13	−	GUCUUGUGUUGAAAUUCUCA	20	2541
CFTR-R117H-14	+	GUGUCCUCACAAUAAAGAGA	20	2542
CFTR-R117H-15	−	GCAGUACAGCCUCUCUUACU	20	2543
CFTR-R117H-16	+	GAUGAAGGCCAAAAAUGGCU	20	2544
CFTR-R117H-17	+	GGCCAAAAAUGGCUGGGUGU	20	2545

Table 22B provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 22B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-18	+	UGGUGACUUCCUACAAA	17	2546
CFTR-R117H-19	−	CUAUGACCCGGAUAACA	17	2547
CFTR-R117H-20	−	UUGUGUUGAAAUUCUCA	17	2548
CFTR-R117H-21	−	UAGUUUGAUUUAUAAGA	17	2549
CFTR-R117H-22	+	UCCUCACAAUAAAGAGA	17	2550
CFTR-R117H-23	−	AGUACAGCCUCUCUUAC	17	2551
CFTR-R117H-24	−	CAUAGCUUCCUAUGACC	17	2552
CFTR-R117H-25	+	UGAAGGCCAAAAAUGGC	17	2553
CFTR-R117H-26	+	UGUUCCUCCUUGUUAUC	17	2554
CFTR-R117H-27	−	CUUGUGUUGAAAUUCUC	17	2555
CFTR-R117H-28	+	AUUCUUCCCAGUAAGAG	17	2556
CFTR-R117H-29	+	AGACUUUUCAUCUUUAG	17	2557
CFTR-R117H-30	−	UGACCCGGAUAACAAGG	17	2558
CFTR-R117H-31	−	UUUGGCCUUCAUCACAU	17	2559
CFTR-R117H-32	+	CAGAAUAUAUGUGCCAU	17	2560
CFTR-R117H-33	+	CUUGUUAUCCGGGUCAU	17	2561
CFTR-R117H-34	−	UCUAUCGCGAUUUAUCU	17	2562
CFTR-R117H-35	+	CAAAAAUGGCUGGGUGU	17	2563
CFTR-R117H-36	−	CUACACCCAGCCAUUUU	17	2564
CFTR-R117H-37	+	AAUGUGAUGAAGGCCAAAAA	20	2565
CFTR-R117H-38	+	UUUGGUGACUUCCUACAAAA	20	2566
CFTR-R117H-39	+	CUUUGGUGACUUCCUACAAA	20	2567
CFTR-R117H-40	−	UUCCUAUGACCCGGAUAACA	20	2568
CFTR-R117H-41	−	ACUUCCUUGCACAGGCCCCA	20	2569
CFTR-R117H-42	+	UGUGCCAUGGGGCCUGUGCA	20	2570
CFTR-R117H-43	+	UCUGCAUUCCAAUGUGAUGA	20	2571
CFTR-R117H-44	−	AAGGUAAUACUUCCUUGCAC	20	2572
CFTR-R117H-45	−	AGCAGUACAGCCUCUCUUAC	20	2573
CFTR-R117H-46	−	AAUCAUAGCUUCCUAUGACC	20	2574
CFTR-R117H-47	+	UGAUGAAGGCCAAAAAUGGC	20	2575
CFTR-R117H-48	−	AGUCUUGUGUUGAAAUUCUC	20	2576
CFTR-R117H-49	+	UUGGUGACUUCCUACAAAAG	20	2577
CFTR-R117H-50	+	AUGAUUCUUCCCAGUAAGAG	20	2578
CFTR-R117H-51	+	CUUAAAAUGAGUUUAUAUAG	20	2579
CFTR-R117H-52	+	ACAAGACUUUUCAUCUUUAG	20	2580
CFTR-R117H-53	−	CUAUGACCCGGAUAACAAGG	20	2581
CFTR-R117H-54	+	UACAGAAUAUAUGUGCCAUG	20	2582
CFTR-R117H-55	−	UAUGCCUUCUCUUUAUUGUG	20	2583
CFTR-R117H-56	−	AUUUUUGGCCUUCAUCACAU	20	2584
CFTR-R117H-57	+	AUACAGAAUAUAUGUGCCAU	20	2585
CFTR-R117H-58	−	AUCGCGAUUUAUCUAGGCAU	20	2586
CFTR-R117H-59	+	CUCCUUGUUAUCCGGGUCAU	20	2587
CFTR-R117H-60	+	UAAGAGAGGCUGUACUGCUU	20	2588
CFTR-R117H-61	−	CUCCUACACCCAGCCAUUUU	20	2589

Table 22C provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 22C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-62	+	GUUCCUCCUUGUUAUCC	17	2590
CFTR-R117H-63	−	GUUUAGUUUGAUUUAUAAGA	20	2591
CFTR-R117H-64	+	GAGUGUUCCUCCUUGUUAUC	20	2592

Table 22D provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 22D
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-65	−	UCCUUGCACAGGCCCCA	17	2593
CFTR-R117H-66	+	ACAGAAUAUAUGUGCCA	17	2594
CFTR-R117H-67	+	AAAUGAGUUUAUAUAGA	17	2595
CFTR-R117H-68	+	AAAAUGAGUUUAUAUAG	17	2596
CFTR-R117H-69	+	AGAAUAUAUGUGCCAUG	17	2597
CFTR-R117H-70	−	UGUUUUUCCCCUUUUGU	17	2598
CFTR-R117H-71	+	UUAAAAUGAGUUUAUAUAGA	20	2599
CFTR-R117H-72	+	AGUGUUCCUCCUUGUUAUCC	20	2600
CFTR-R117H-73	−	CACUCUAUCGCGAUUUAUCU	20	2601
CFTR-R117H-74	−	CUCUGUUUUUCCCCUUUUGU	20	2602

Table 23A provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 23A
1st Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-75	+	GCCUAUGCCUAGAUAAAUCGCGA	23	2603
CFTR-R117H-76	+	GAUGAAGGCCAAAAAUGG	18	2604
CFTR-R117H-77	+	GUGAUGAAGGCCAAAAAUGG	20	2605
CFTR-R117H-78	−	GAAUCAUAGCUUCCUAUGAC	20	2606
CFTR-R117H-79	−	GAAGAAUCAUAGCUUCCUAUGAC	23	2607
CFTR-R117H-80	−	GGAAGAAUCAUAGCUUCCUAUGAC	24	2608
CFTR-R117H-81	−	GUACAGCCUCUCUUACUGGG	20	2609
CFTR-R117H-82	−	GCAGUACAGCCUCUCUUACUGGG	23	2610
CFTR-R117H-83	−	GCCAUUUUUGGCCUUCAUCACAU	23	2611
CFTR-R117H-84	−	GUCUUGUGUUGAAAUUCU	18	2612
CFTR-R117H-85	−	GAAAAGUCUUGUGUUGAAAUUCU	23	2613

Table 23B provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 23B
2nd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-86	+	CUUUAGAGGAGACUUAAA	18	2614
CFTR-R117H-87	+	UCUUUAGAGGAGACUUAAA	19	2615
CFTR-R117H-88	+	AUCUUUAGAGGAGACUUAAA	20	2616
CFTR-R117H-89	+	CAUCUUUAGAGGAGACUUAAA	21	2617
CFTR-R117H-90	+	UCAUCUUUAGAGGAGACUUAAA	22	2618
CFTR-R117H-91	+	UUCAUCUUUAGAGGAGACUUAAA	23	2619
CFTR-R117H-92	+	UUUCAUCUUUAGAGGAGACUUAAA	24	2620
CFTR-R117H-93	+	UGCCUAGAUAAAUCGCGA	18	2621
CFTR-R117H-94	+	AUGCCUAGAUAAAUCGCGA	19	2622
CFTR-R117H-95	+	UAUGCCUAGAUAAAUCGCGA	20	2623
CFTR-R117H-96	+	CUAUGCCUAGAUAAAUCGCGA	21	2624
CFTR-R117H-97	+	CCUAUGCCUAGAUAAAUCGCGA	22	2625
CFTR-R117H-98	+	AGCCUAUGCCUAGAUAAAUCGCGA	24	2626
CFTR-R117H-99	+	AUUAAAACAUGUACGAUA	18	2627
CFTR-R117H-100	+	CAUUAAAACAUGUACGAUA	19	2628
CFTR-R117H-101	+	ACAUUAAAACAUGUACGAUA	20	2629
CFTR-R117H-102	+	UUAAAAUGAGUUUAUAUA	18	2630
CFTR-R117H-103	+	CUUAAAAUGAGUUUAUAUA	19	2631
CFTR-R117H-104	+	ACUUAAAAUGAGUUUAUAUA	20	2632
CFTR-R117H-105	+	UGAUGAAGGCCAAAAAUGG	19	2633
CFTR-R117H-106	+	UGUGAUGAAGGCCAAAAAUGG	21	2634
CFTR-R117H-107	+	AUGUGAUGAAGGCCAAAAAUGG	22	2635
CFTR-R117H-108	+	AAUGUGAUGAAGGCCAAAAAUGG	23	2636
CFTR-R117H-109	+	CAAUGUGAUGAAGGCCAAAAAUGG	24	2637
CFTR-R117H-110	+	UUUCUCAUAAAAUACCCU	18	2638
CFTR-R117H-111	+	AUUUCUCAUAAAAUACCCU	19	2639
CFTR-R117H-112	+	UAUUUCUCAUAAAAUACCCU	20	2640
CFTR-R117H-113	−	AUCAUAGCUUCCUAUGAC	18	2641
CFTR-R117H-114	−	AAUCAUAGCUUCCUAUGAC	19	2642
CFTR-R117H-115	−	AGAAUCAUAGCUUCCUAUGAC	21	2643
CFTR-R117H-116	−	AAGAAUCAUAGCUUCCUAUGAC	22	2644
CFTR-R117H-117	−	ACAGCCUCUCUUACUGGG	18	2645
CFTR-R117H-118	−	UACAGCCUCUCUUACUGGG	19	2646
CFTR-R117H-119	−	AGUACAGCCUCUCUUACUGGG	21	2647
CFTR-R117H-120	−	CAGUACAGCCUCUCUUACUGGG	22	2648
CFTR-R117H-121	−	AGCAGUACAGCCUCUCUUACUGGG	24	2649
CFTR-R117H-122	−	UUUUGGCCUUCAUCACAU	18	2650
CFTR-R117H-123	−	UUUUUGGCCUUCAUCACAU	19	2651
CFTR-R117H-56	−	AUUUUUGGCCUUCAUCACAU	20	2584
CFTR-R117H-124	−	CAUUUUUGGCCUUCAUCACAU	21	2652
CFTR-R117H-125	−	CCAUUUUUGGCCUUCAUCACAU	22	2653
CFTR-R117H-126	−	AGCCAUUUUUGGCCUUCAUCACAU	24	2654
CFTR-R117H-127	−	AGUCUUGUGUUGAAAUUCU	19	2655
CFTR-R117H-128	−	AAGUCUUGUGUUGAAAUUCU	20	2656
CFTR-R117H-129	−	AAAGUCUUGUGUUGAAAUUCU	21	2657
CFTR-R117H-130	−	AAAAGUCUUGUGUUGAAAUUCU	22	2658
CFTR-R117H-131	−	UGAAAAGUCUUGUGUUGAAAUUCU	24	2659

Table 23C provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 23C
3rd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-132	+	GACUUAAAAUGAGUUUAUAUA	21	2660
CFTR-R117H-133	+	GAGACUUAAAAUGAGUUUAUAUA	23	2661
CFTR-R117H-134	+	GGAGACUUAAAAUGAGUUUAUAUA	24	2662
CFTR-R117H-135	+	GAGUGUUCCUCCUUGUUAU	19	2663
CFTR-R117H-136	+	GAUAGAGUGUUCCUCCUUGUUAU	23	2664

Table 23D provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 23D
4th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-137	+	AGACUUAAAAUGAGUUUAUAUA	22	2665
CFTR-R117H-138	+	AGUGUUCCUCCUUGUUAU	18	2666
CFTR-R117H-139	+	AGAGUGUUCCUCCUUGUUAU	20	2667
CFTR-R117H-140	+	UAGAGUGUUCCUCCUUGUUAU	21	2668
CFTR-R117H-141	+	AUAGAGUGUUCCUCCUUGUUAU	22	2669
CFTR-R117H-142	+	CGAUAGAGUGUUCCUCCUUGUUAU	24	2670
CFTR-R117H-143	+	UUAUUUCUCAUAAAAUACCCU	21	2671
CFTR-R117H-144	+	UUUAUUUCUCAUAAAAUACCCU	22	2672
CFTR-R117H-145	+	AUUUAUUUCUCAUAAAAUACCCU	23	2673
CFTR-R117H-146	+	CAUUUAUUUCUCAUAAAAUACCCU	24	2674
CFTR-R117H-147	−	UCACAUUGGAAUGCAGAU	18	2675
CFTR-R117H-148	−	AUCACAUUGGAAUGCAGAU	19	2676
CFTR-R117H-149	−	CAUCACAUUGGAAUGCAGAU	20	2677
CFTR-R117H-150	−	UCAUCACAUUGGAAUGCAGAU	21	2678
CFTR-R117H-151	−	UUCAUCACAUUGGAAUGCAGAU	22	2679
CFTR-R117H-152	−	CUUCAUCACAUUGGAAUGCAGAU	23	2680
CFTR-R117H-153	−	CCUUCAUCACAUUGGAAUGCAGAU	24	2681

Table 23E provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 23E
5th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-154	+	CCUACAAAAGGGGAAAAA	18	2682
CFTR-R117H-155	+	UCCUACAAAAGGGGAAAAA	19	2683
CFTR-R117H-156	+	UUCCUACAAAAGGGGAAAAA	20	2684
CFTR-R117H-157	+	CUUCCUACAAAAGGGGAAAAA	21	2685
CFTR-R117H-158	+	ACUUCCUACAAAAGGGGAAAAA	22	2686
CFTR-R117H-159	+	GACUUCCUACAAAAGGGGAAAAA	23	2687
CFTR-R117H-160	+	UGACUUCCUACAAAAGGGGAAAAA	24	2688
CFTR-R117H-161	+	UGGUGACUUCCUACAAAA	18	2689
CFTR-R117H-162	+	UUGGUGACUUCCUACAAAA	19	2690
CFTR-R117H-38	+	UUUGGUGACUUCCUACAAAA	20	2566
CFTR-R117H-163	+	CUUUGGUGACUUCCUACAAAA	21	2691
CFTR-R117H-164	+	GCUUUGGUGACUUCCUACAAAA	22	2692
CFTR-R117H-165	+	UGCUUUGGUGACUUCCUACAAAA	23	2693
CFTR-R117H-166	+	CUGCUUUGGUGACUUCCUACAAAA	24	2694
CFTR-R117H-167	+	UUGGUGACUUCCUACAAA	18	2695
CFTR-R117H-168	+	UUUGGUGACUUCCUACAAA	19	2696
CFTR-R117H-39	+	CUUUGGUGACUUCCUACAAA	20	2567
CFTR-R117H-169	+	GCUUUGGUGACUUCCUACAAA	21	2697
CFTR-R117H-170	+	UGCUUUGGUGACUUCCUACAAA	22	2698
CFTR-R117H-171	+	CUGCUUUGGUGACUUCCUACAAA	23	2699
CFTR-R117H-172	+	ACUGCUUUGGUGACUUCCUACAAA	24	2700
CFTR-R117H-173	+	CAGUGUCCUCACAAUAAA	18	2701
CFTR-R117H-174	+	GCAGUGUCCUCACAAUAAA	19	2702
CFTR-R117H-175	+	AGCAGUGUCCUCACAAUAAA	20	2703
CFTR-R117H-176	+	GAGCAGUGUCCUCACAAUAAA	21	2704
CFTR-R117H-177	+	GGAGCAGUGUCCUCACAAUAAA	22	2705
CFTR-R117H-178	+	AGGAGCAGUGUCCUCACAAUAAA	23	2706
CFTR-R117H-179	+	UAGGAGCAGUGUCCUCACAAUAAA	24	2707
CFTR-R117H-180	+	UUUGGUGACUUCCUACAA	18	2708
CFTR-R117H-181	+	CUUUGGUGACUUCCUACAA	19	2709
CFTR-R117H-182	+	GCUUUGGUGACUUCCUACAA	20	2710
CFTR-R117H-183	+	UGCUUUGGUGACUUCCUACAA	21	2711
CFTR-R117H-184	+	CUGCUUUGGUGACUUCCUACAA	22	2712
CFTR-R117H-185	+	ACUGCUUUGGUGACUUCCUACAA	23	2713
CFTR-R117H-186	+	UACUGCUUUGGUGACUUCCUACAA	24	2714
CFTR-R117H-187	+	UAUGAUUCUUCCCAGUAA	18	2715
CFTR-R117H-188	+	CUAUGAUUCUUCCCAGUAA	19	2716
CFTR-R117H-189	+	GCUAUGAUUCUUCCCAGUAA	20	2717
CFTR-R117H-190	+	AGCUAUGAUUCUUCCCAGUAA	21	2718
CFTR-R117H-191	+	AAGCUAUGAUUCUUCCCAGUAA	22	2719
CFTR-R117H-192	+	GAAGCUAUGAUUCUUCCCAGUAA	23	2720
CFTR-R117H-193	+	GGAAGCUAUGAUUCUUCCCAGUAA	24	2721
CFTR-R117H-194	+	UACAAAAGGGGAAAAACA	18	2722
CFTR-R117H-195	+	CUACAAAAGGGGAAAAACA	19	2723
CFTR-R117H-196	+	CCUACAAAAGGGGAAAAACA	20	2724
CFTR-R117H-197	+	UCCUACAAAAGGGGAAAAACA	21	2725
CFTR-R117H-198	+	UUCCUACAAAAGGGGAAAAACA	22	2726
CFTR-R117H-199	+	CUUCCUACAAAAGGGGAAAAACA	23	2727
CFTR-R117H-200	+	ACUUCCUACAAAAGGGGAAAAACA	24	2728
CFTR-R117H-201	+	UACAGAAUAUAUGUGCCA	18	2729
CFTR-R117H-202	+	AUACAGAAUAUAUGUGCCA	19	2730
CFTR-R117H-12	+	GAUACAGAAUAUAUGUGCCA	20	2540
CFTR-R117H-203	+	CGAUACAGAAUAUAUGUGCCA	21	2731
CFTR-R117H-204	+	ACGAUACAGAAUAUAUGUGCCA	22	2732
CFTR-R117H-205	+	UACGAUACAGAAUAUAUGUGCCA	23	2733
CFTR-R117H-206	+	GUACGAUACAGAAUAUAUGUGCCA	24	2734
CFTR-R117H-207	+	UGCCAUGGGGCCUGUGCA	18	2735
CFTR-R117H-208	+	GUGCCAUGGGGCCUGUGCA	19	2736
CFTR-R117H-42	+	UGUGCCAUGGGGCCUGUGCA	20	2570
CFTR-R117H-209	+	AUGUGCCAUGGGGCCUGUGCA	21	2737
CFTR-R117H-210	+	UAUGUGCCAUGGGGCCUGUGCA	22	2738
CFTR-R117H-211	+	AUAUGUGCCAUGGGGCCUGUGCA	23	2739
CFTR-R117H-212	+	UAUAUGUGCCAUGGGGCCUGUGCA	24	2740
CFTR-R117H-213	+	UCCUUGUUAUCCGGGUCA	18	2741
CFTR-R117H-214	+	CUCCUUGUUAUCCGGGUCA	19	2742
CFTR-R117H-215	+	CCUCCUUGUUAUCCGGGUCA	20	2743
CFTR-R117H-216	+	UCCUCCUUGUUAUCCGGGUCA	21	2744
CFTR-R117H-217	+	UUCCUCCUUGUUAUCCGGGUCA	22	2745
CFTR-R117H-218	+	GUUCCUCCUUGUUAUCCGGGUCA	23	2746
CFTR-R117H-219	+	UGUUCCUCCUUGUUAUCCGGGUCA	24	2747
CFTR-R117H-220	+	AGCAGUGUCCUCACAAUA	18	2748
CFTR-R117H-221	+	GAGCAGUGUCCUCACAAUA	19	2749
CFTR-R117H-222	+	GGAGCAGUGUCCUCACAAUA	20	2750
CFTR-R117H-223	+	AGGAGCAGUGUCCUCACAAUA	21	2751
CFTR-R117H-224	+	UAGGAGCAGUGUCCUCACAAUA	22	2752
CFTR-R117H-225	+	GUAGGAGCAGUGUCCUCACAAUA	23	2753
CFTR-R117H-226	+	UGUAGGAGCAGUGUCCUCACAAUA	24	2754
CFTR-R117H-227	+	ACUUAAAAUGAGUUUAUA	18	2755
CFTR-R117H-228	+	GACUUAAAAUGAGUUUAUA	19	2756
CFTR-R117H-229	+	AGACUUAAAAUGAGUUUAUA	20	2757
CFTR-R117H-230	+	GAGACUUAAAAUGAGUUUAUA	21	2758
CFTR-R117H-231	+	GGAGACUUAAAAUGAGUUUAUA	22	2759
CFTR-R117H-232	+	AGGAGACUUAAAAUGAGUUUAUA	23	2760
CFTR-R117H-233	+	GAGGAGACUUAAAAUGAGUUUAUA	24	2761
CFTR-R117H-234	+	CAAGACUUUUCAUCUUUA	18	2762
CFTR-R117H-235	+	ACAAGACUUUUCAUCUUUA	19	2763
CFTR-R117H-236	+	CACAAGACUUUUCAUCUUUA	20	2764
CFTR-R117H-237	+	ACACAAGACUUUUCAUCUUUA	21	2765
CFTR-R117H-238	+	AACACAAGACUUUUCAUCUUUA	22	2766
CFTR-R117H-239	+	CAACACAAGACUUUUCAUCUUUA	23	2767
CFTR-R117H-240	+	UCAACACAAGACUUUUCAUCUUUA	24	2768
CFTR-R117H-241	+	UAUUUCUCAUAAAAUACC	18	2769
CFTR-R117H-242	+	UUAUUUCUCAUAAAAUACC	19	2770
CFTR-R117H-243	+	UUUAUUUCUCAUAAAAUACC	20	2771
CFTR-R117H-244	+	AUUUAUUUCUCAUAAAAUACC	21	2772
CFTR-R117H-245	+	CAU UUAUUUCUCAUAAAAUACC	22	2773
CFTR-R117H-246	+	UCAUUUAUUUCUCAUAAAAUACC	23	2774
CFTR-R117H-247	+	UUCAUUUAUUUCUCAUAAAAUACC	24	2775
CFTR-R117H-248	+	AUACAGAAUAUAUGUGCC	18	2776
CFTR-R117H-249	+	GAUACAGAAUAUAUGUGCC	19	2777
CFTR-R117H-250	+	CGAUACAGAAUAUAUGUGCC	20	2778
CFTR-R117H-251	+	ACGAUACAGAAUAUAUGUGCC	21	2779
CFTR-R117H-252	+	UACGAUACAGAAUAUAUGUGCC	22	2780
CFTR-R117H-253	+	GUACGAUACAGAAUAUAUGUGCC	23	2781
CFTR-R117H-254	+	UGUACGAUACAGAAUAUAUGUGCC	24	2782
CFTR-R117H-255	+	GUGCCAUGGGGCCUGUGC	18	2783
CFTR-R117H-256	+	UGUGCCAUGGGGCCUGUGC	19	2784
CFTR-R117H-257	+	AUGUGCCAUGGGGCCUGUGC	20	2785
CFTR-R117H-258	+	UAUGUGCCAUGGGGCCUGUGC	21	2786
CFTR-R117H-259	+	AUAUGUGCCAUGGGGCCUGUGC	22	2787
CFTR-R117H-260	+	UAUAUGUGCCAUGGGGCCUGUGC	23	2788
CFTR-R117H-261	+	AUAUAUGUGCCAUGGGGCCUGUGC	24	2789
CFTR-R117H-262	+	GGUGACUUCCUACAAAAG	18	2790
CFTR-R117H-263	+	UGGUGACUUCCUACAAAAG	19	2791
CFTR-R117H-49	+	UUGGUGACUUCCUACAAAAG	20	2577
CFTR-R117H-264	+	UUUGGUGACUUCCUACAAAAG	21	2792
CFTR-R117H-265	+	CUUUGGUGACUUCCUACAAAAG	22	2793
CFTR-R117H-266	+	GCUUUGGUGACUUCCUACAAAAG	23	2794
CFTR-R117H-267	+	UGCUUUGGUGACUUCCUACAAAAG	24	2795
CFTR-R117H-268	+	AAGACUUUUCAUCUUUAG	18	2796
CFTR-R117H-269	+	CAAGACUUUUCAUCUUUAG	19	2797
CFTR-R117H-52	+	ACAAGACUUUUCAUCUUUAG	20	2580
CFTR-R117H-270	+	CACAAGACUUUUCAUCUUUAG	21	2798
CFTR-R117H-271	+	ACACAAGACUUUUCAUCUUUAG	22	2799
CFTR-R117H-272	+	AACACAAGACUUUUCAUCUUUAG	23	2800
CFTR-R117H-273	+	CAACACAAGACUUUUCAUCUUUAG	24	2801
CFTR-R117H-274	+	GCCAAAAAUGGCUGGGUG	18	2802
CFTR-R117H-275	+	GGCCAAAAAUGGCUGGGUG	19	2803
CFTR-R117H-276	+	AGGCCAAAAAUGGCUGGGUG	20	2804
CFTR-R117H-277	+	AAGGCCAAAAAUGGCUGGGUG	21	2805
CFTR-R117H-278	+	GAAGGCCAAAAAUGGCUGGGUG	22	2806
CFTR-R117H-279	+	UGAAGGCCAAAAAUGGCUGGGUG	23	2807
CFTR-R117H-280	+	AUGAAGGCCAAAAAUGGCUGGGUG	24	2808
CFTR-R117H-281	+	CAUCUGCAUUCCAAUGUG	18	2809
CFTR-R117H-282	+	UCAUCUGCAUUCCAAUGUG	19	2810
CFTR-R117H-283	+	CUCAUCUGCAUUCCAAUGUG	20	2811
CFTR-R117H-284	+	UCUCAUCUGCAUUCCAAUGUG	21	2812
CFTR-R117H-285	+	UUCUCAUCUGCAUUCCAAUGUG	22	2813
CFTR-R117H-286	+	AUUCUCAUCUGCAUUCCAAUGUG	23	2814
CFTR-R117H-287	+	UAUUCUCAUCUGCAUUCCAAUGUG	24	2815
CFTR-R117H-288	+	CCUUGUUAUCCGGGUCAU	18	2816
CFTR-R117H-289	+	UCCUUGUUAUCCGGGUCAU	19	2817
CFTR-R117H-59	+	CUCCUUGUUAUCCGGGUCAU	20	2587
CFTR-R117H-290	+	CCUCCUUGUUAUCCGGGUCAU	21	2818
CFTR-R117H-291	+	UCCUCCUUGUUAUCCGGGUCAU	22	2819
CFTR-R117H-292	+	UUCCUCCUUGUUAUCCGGGUCAU	23	2820
CFTR-R117H-293	+	GUUCCUCCUUGUUAUCCGGGUCAU	24	2821
CFTR-R117H-294	+	GCUAUGAUUCUUCCCAGU	18	2822
CFTR-R117H-295	+	AGCUAUGAUUCUUCCCAGU	19	2823
CFTR-R117H-296	+	AAGCUAUGAUUCUUCCCAGU	20	2824
CFTR-R117H-297	+	GAAGCUAUGAUUCUUCCCAGU	21	2825
CFTR-R117H-298	+	GGAAGCUAUGAUUCUUCCCAGU	22	2826
CFTR-R117H-299	+	AGGAAGCUAUGAUUCUUCCCAGU	23	2827
CFTR-R117H-300	+	UAGGAAGCUAUGAUUCUUCCCAGU	24	2828
CFTR-R117H-301	+	CCAAAAAUGGCUGGGUGU	18	2829
CFTR-R117H-302	+	GCCAAAAAUGGCUGGGUGU	19	2830
CFTR-R117H-17	+	GGCCAAAAAUGGCUGGGUGU	20	2545
CFTR-R117H-303	+	AGGCCAAAAAUGGCUGGGUGU	21	2831
CFTR-R117H-304	+	AAGGCCAAAAAUGGCUGGGUGU	22	2832
CFTR-R117H-305	+	GAAGGCCAAAAAUGGCUGGGUGU	23	2833
CFTR-R117H-306	+	UGAAGGCCAAAAAUGGCUGGGUGU	24	2834
CFTR-R117H-307	+	CACAAGACUUUUCAUCUU	18	2835
CFTR-R117H-308	+	ACACAAGACUUUUCAUCUU	19	2836
CFTR-R117H-309	+	AACACAAGACUUUUCAUCUU	20	2837
CFTR-R117H-310	+	CAACACAAGACUUUUCAUCUU	21	2838
CFTR-R117H-311	+	UCAACACAAGACUUUUCAUCUU	22	2839
CFTR-R117H-312	+	UUCAACACAAGACUUUUCAUCUU	23	2840
CFTR-R117H-313	+	UUUCAACACAAGACUUUUCAUCUU	24	2841
CFTR-R117H-314	−	GUAUUUUAUGAGAAAUAA	18	2842
CFTR-R117H-315	−	GGUAUUUUAUGAGAAAUAA	19	2843
CFTR-R117H-316	−	GGGUAUUUUAUGAGAAAUAA	20	2844
CFTR-R117H-317	−	AGGGUAUUUUAUGAGAAAUAA	21	2845
CFTR-R117H-318	−	CAGGGUAUUUUAUGAGAAAUAA	22	2846
CFTR-R117H-319	−	UCAGGGUAUUUUAUGAGAAAUAA	23	2847
CFTR-R117H-320	−	CUCAGGGUAUUUUAUGAGAAAUAA	24	2848
CFTR-R117H-321	−	CCUAUGACCCGGAUAACA	18	2849
CFTR-R117H-322	−	UCCUAUGACCCGGAUAACA	19	2850
CFTR-R117H-40	−	UUCCUAUGACCCGGAUAACA	20	2568
CFTR-R117H-323	−	CUUCCUAUGACCCGGAUAACA	21	2851
CFTR-R117H-324	−	GCUUCCUAUGACCCGGAUAACA	22	2852
CFTR-R117H-325	−	AGCUUCCUAUGACCCGGAUAACA	23	2853
CFTR-R117H-326	−	UAGCUUCCUAUGACCCGGAUAACA	24	2854
CFTR-R117H-327	−	UUUUUGGCCUUCAUCACA	18	2855
CFTR-R117H-328	−	AUUUUUGGCCUUCAUCACA	19	2856
CFTR-R117H-329	−	CAUUUUUGGCCUUCAUCACA	20	2857
CFTR-R117H-330	−	CCAUUUUUGGCCUUCAUCACA	21	2858
CFTR-R117H-331	−	GCCAUUUUUGGCCUUCAUCACA	22	2859
CFTR-R117H-332	−	AGCCAUUUUUGGCCUUCAUCACA	23	2860
CFTR-R117H-333	−	CAGCCAUUUUUGGCCUUCAUCACA	24	2861
CFTR-R117H-334	−	GCAGUACAGCCUCUCUUA	18	2862
CFTR-R117H-335	−	AGCAGUACAGCCUCUCUUA	19	2863
CFTR-R117H-336	−	AAGCAGUACAGCCUCUCUUA	20	2864
CFTR-R117H-337	−	AAAGCAGUACAGCCUCUCUUA	21	2865
CFTR-R117H-338	−	CAAAGCAGUACAGCCUCUCUUA	22	2866
CFTR-R117H-339	−	CCAAAGCAGUACAGCCUCUCUUA	23	2867
CFTR-R117H-340	−	ACCAAAGCAGUACAGCCUCUCUUA	24	2868
CFTR-R117H-341	−	UCCUAUGACCCGGAUAAC	18	2869
CFTR-R117H-342	−	UUCCUAUGACCCGGAUAAC	19	2870
CFTR-R117H-343	−	CUUCCUAUGACCCGGAUAAC	20	2871
CFTR-R117H-344	−	GCUUCCUAUGACCCGGAUAAC	21	2872
CFTR-R117H-345	−	AGCUUCCUAUGACCCGGAUAAC	22	2873
CFTR-R117H-346	−	UAGCUUCCUAUGACCCGGAUAAC	23	2874
CFTR-R117H-347	−	AUAGCUUCCUAUGACCCGGAUAAC	24	2875
CFTR-R117H-348	−	CAGUACAGCCUCUCUUAC	18	2876
CFTR-R117H-349	−	GCAGUACAGCCUCUCUUAC	19	2877
CFTR-R117H-45	−	AGCAGUACAGCCUCUCUUAC	20	2573
CFTR-R117H-350	−	AAGCAGUACAGCCUCUCUUAC	21	2878
CFTR-R117H-351	−	AAAGCAGUACAGCCUCUCUUAC	22	2879
CFTR-R117H-352	−	CAAAGCAGUACAGCCUCUCUUAC	23	2880
CFTR-R117H-353	−	CCAAAGCAGUACAGCCUCUCUUAC	24	2881
CFTR-R117H-354	−	UUUAAGUCUCCUCUAAAG	18	2882
CFTR-R117H-355	−	UUUUAAGUCUCCUCUAAAG	19	2883
CFTR-R117H-356	−	AUUUUAAGUCUCCUCUAAAG	20	2884
CFTR-R117H-357	−	CAUUUUAAGUCUCCUCUAAAG	21	2885
CFTR-R117H-358	−	UCAUUUUAAGUCUCCUCUAAAG	22	2886
CFTR-R117H-359	−	CUCAUUUUAAGUCUCCUCUAAAG	23	2887
CFTR-R117H-360	−	ACUCAUUUUAAGUCUCCUCUAAAG	24	2888
CFTR-R117H-361	−	UAUGACCCGGAUAACAAG	18	2889
CFTR-R117H-362	−	CUAUGACCCGGAUAACAAG	19	2890
CFTR-R117H-363	−	CCUAUGACCCGGAUAACAAG	20	2891
CFTR-R117H-364	−	UCCUAUGACCCGGAUAACAAG	21	2892
CFTR-R117H-365	−	UUCCUAUGACCCGGAUAACAAG	22	2893
CFTR-R117H-366	−	CUUCCUAUGACCCGGAUAACAAG	23	2894
CFTR-R117H-367	−	GCUUCCUAUGACCCGGAUAACAAG	24	2895
CFTR-R117H-368	−	CAUCACAUUGGAAUGCAG	18	2896
CFTR-R117H-369	−	UCAUCACAUUGGAAUGCAG	19	2897
CFTR-R117H-370	−	UUCAUCACAUUGGAAUGCAG	20	2898
CFTR-R117H-371	−	CUUCAUCACAUUGGAAUGCAG	21	2899
CFTR-R117H-372	−	CCUUCAUCACAUUGGAAUGCAG	22	2900
CFTR-R117H-373	−	GCCUUCAUCACAUUGGAAUGCAG	23	2901
CFTR-R117H-374	−	GGCCUUCAUCACAUUGGAAUGCAG	24	2902
CFTR-R117H-375	−	AUGACCCGGAUAACAAGG	18	2903
CFTR-R117H-376	−	UAUGACCCGGAUAACAAGG	19	2904
CFTR-R117H-53	−	CUAUGACCCGGAUAACAAGG	20	2581
CFTR-R117H-377	−	CCUAUGACCCGGAUAACAAGG	21	2905
CFTR-R117H-378	−	UCCUAUGACCCGGAUAACAAGG	22	2906
CFTR-R117H-379	−	UUCCUAUGACCCGGAUAACAAGG	23	2907
CFTR-R117H-380	−	CUUCCUAUGACCCGGAUAACAAGG	24	2908
CFTR-R117H-381	−	AAGAUGAAAAGUCUUGUG	18	2909
CFTR-R117H-382	−	AAAGAUGAAAAGUCUUGUG	19	2910
CFTR-R117H-383	−	UAAAGAUGAAAAGUCUUGUG	20	2911
CFTR-R117H-384	−	CUAAAGAUGAAAAGUCUUGUG	21	2912
CFTR-R117H-385	−	UCUAAAGAUGAAAAGUCUUGUG	22	2913
CFTR-R117H-386	−	CUCUAAAGAUGAAAAGUCUUGUG	23	2914
CFTR-R117H-387	−	CCUCUAAAGAUGAAAAGUCUUGUG	24	2915
CFTR-R117H-388	−	UCUGUUUUUCCCCUUUUG	18	2916
CFTR-R117H-389	−	CUCUGUUUUUCCCCUUUUG	19	2917
CFTR-R117H-390	−	UCUCUGUUUUUCCCCUUUUG	20	2918
CFTR-R117H-391	−	UUCUCUGUUUUUCCCCUUUUG	21	2919
CFTR-R117H-392	−	UUUCUCUGUUUUUCCCCUUUUG	22	2920
CFTR-R117H-393	−	AUUUCUCUGUUUUUCCCCUUUUG	23	2921
CFTR-R117H-394	−	AAUUUCUCUGUUUUUCCCCUUUUG	24	2922
CFTR-R117H-395	−	AUGUUUAGUUUGAUUUAU	18	2923
CFTR-R117H-396	−	UAUGUUUAGUUUGAUUUAU	19	2924
CFTR-R117H-397	−	CUAUGUUUAGUUUGAUUUAU	20	2925
CFTR-R117H-398	−	GCUAUGUUUAGUUUGAUUUAU	21	2926
CFTR-R117H-399	−	AGCUAUGUUUAGUUUGAUUUAU	22	2927
CFTR-R117H-400	−	UAGCUAUGUUUAGUUUGAUUUAU	23	2928
CFTR-R117H-401	−	AUAGCUAUGUUUAGUUUGAUUUAU	24	2929
CFTR-R117H-402	−	AUUCUCAGGGUAUUUUAU	18	2930
CFTR-R117H-403	−	AAUUCUCAGGGUAUUUUAU	19	2931
CFTR-R117H-404	−	AAAUUCUCAGGGUAUUUUAU	20	2932
CFTR-R117H-405	−	GAAAUUCUCAGGGUAUUUUAU	21	2933
CFTR-R117H-406	−	UGAAAUUCUCAGGGUAUUUUAU	22	2934
CFTR-R117H-407	−	UUGAAAUUCUCAGGGUAUUUUAU	23	2935
CFTR-R117H-408	−	GUUGAAAUUCUCAGGGUAUUUUAU	24	2936
CFTR-R117H-409	−	AGUACAGCCUCUCUUACU	18	2937
CFTR-R117H-410	−	CAGUACAGCCUCUCUUACU	19	2938
CFTR-R117H-15	−	GCAGUACAGCCUCUCUUACU	20	2543
CFTR-R117H-411	−	AGCAGUACAGCCUCUCUUACU	21	2939
CFTR-R117H-412	−	AAGCAGUACAGCCUCUCUUACU	22	2940
CFTR-R117H-413	−	AAAGCAGUACAGCCUCUCUUACU	23	2941
CFTR-R117H-414	−	CAAAGCAGUACAGCCUCUCUUACU	24	2942
CFTR-R117H-415	−	AUGCCUUCUCUUUAUUGU	18	2943
CFTR-R117H-416	−	UAUGCCUUCUCUUUAUUGU	19	2944
CFTR-R117H-417	−	UUAUGCCUUCUCUUUAUUGU	20	2945
CFTR-R117H-418	−	CUUAUGCCUUCUCUUUAUUGU	21	2946
CFTR-R117H-419	−	GCUUAUGCCUUCUCUUUAUUGU	22	2947
CFTR-R117H-420	−	GGCUUAUGCCUUCUCUUUAUUGU	23	2948
CFTR-R117H-421	−	AGGCUUAUGCCUUCUCUUUAUUGU	24	2949
CFTR-R117H-422	−	CUGUUUUUCCCCUUUUGU	18	2950
CFTR-R117H-423	−	UCUGUUUUUCCCCUUUUGU	19	2951
CFTR-R117H-74	−	CUCUGUUUUUCCCCUUUUGU	20	2602
CFTR-R117H-424	−	UCUCUGUUUUUCCCCUUUUGU	21	2952
CFTR-R117H-425	−	UUCUCUGUUUUUCCCCUUUUGU	22	2953
CFTR-R117H-426	−	UUUCUCUGUUUUUCCCCUUUUGU	23	2954
CFTR-R117H-427	−	AUUUCUCUGUUUUUCCCCUUUUGU	24	2955
CFTR-R117H-428	−	UUAUGCCUUCUCUUUAUU	18	2956
CFTR-R117H-429	−	CUUAUGCCUUCUCUUUAUU	19	2957
CFTR-R117H-430	−	GCUUAUGCCUUCUCUUUAUU	20	2958
CFTR-R117H-431	−	GGCUUAUGCCUUCUCUUUAUU	21	2959
CFTR-R117H-432	−	AGGCUUAUGCCUUCUCUUUAUU	22	2960
CFTR-R117H-433	−	UAGGCUUAUGCCUUCUCUUUAUU	23	2961
CFTR-R117H-434	−	AUAGGCUUAUGCCUUCUCUUUAUU	24	2962
CFTR-R117H-435	−	AAAUUCUCAGGGUAUUUU	18	2963
CFTR-R117H-436	−	GAAAUUCUCAGGGUAUUUU	19	2964
CFTR-R117H-437	−	UGAAAUUCUCAGGGUAUUUU	20	2965
CFTR-R117H-438	−	UUGAAAUUCUCAGGGUAUUUU	21	2966
CFTR-R117H-439	−	GUUGAAAUUCUCAGGGUAUUUU	22	2967
CFTR-R117H-440	−	UGUUGAAAUUCUCAGGGUAUUUU	23	2968
CFTR-R117H-441	−	GUGUUGAAAUUCUCAGGGUAUUUU	24	2969

Table 24A provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 24A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-442	+	GUUAUCCGGGUCAUAGGAAG	20	2970

Table 24B provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 24B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-443	−	UCGCGAUUUAUCUAGGC	17	2971
CFTR-R117H-444	+	AUCCGGGUCAUAGGAAG	17	2972
CFTR-R117H-445	−	CUCUUACUGGGAAGAAU	17	2973
CFTR-R117H-446	−	CUAUCGCGAUUUAUCUAGGC	20	2974
CFTR-R117H-447	+	CUUCCCAGUAAGAGAGGCUG	20	2975
CFTR-R117H-448	−	CCUCUCUUACUGGGAAGAAU	20	2976

Table 24C provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 24C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-R117H-449	−	GAGAAUAGCUAUGUUUA	17	2977
CFTR-R117H-450	−	GAUGAGAAUAGCUAUGUUUA	20	2978

Table 24D provides exemplary targeting domains for correcting a mutation (e.g., R117H) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R117H). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 24D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R117H-451	-	CAAGGAGGAACACUCUA	17	2979
CFTR-R117H-452	+	CCCAGUAAGAGAGGCUG	17	2980
CFTR-R117H-453	−	UAACAAGGAGGAACACUCUA	20	2981

Table 25A provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 25A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-1	-	GCUUUAUAUUCUGUUUC	17	466
CFTR-R553X-2	-	GGUGGAAUCACACUGAG	17	456
CFTR-R553X-3	-	GGAAUCACACUGAGUGG	17	457
CFTR-R553X-4	-	GUUCAAAAUUUCAACUG	17	464
CFTR-R553X-5	-	GGUGAAUAACUAAUUAU	17	465
CFTR-R553X-6	-	GGGGUUUUAUGGCUAGU	17	458
CFTR-R553X-7	-	GAGCAAGAAUUUCUUUAGCA	20	462
CFTR-R553X-8	-	GACAAUAUAGUUCUUGGAGA	20	460
CFTR-R553X-9	-	GAAGGUGGAAUCACACUGAG	20	461
CFTR-R553X-10	-	GGUGGAAUCACACUGAGUGG	20	454
CFTR-R553X-11	-	GAGAAAGACAAUAUAGUUCU	20	453

Table 25B provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 25B
2nd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-12	+	CUCAAUCUGAAUUUGAA	17	496
CFTR-R553X-13	-	CAAGAAUUUCUUUAGCA	17	491
CFTR-R553X-14	-	AAUAUAGUUCUUGGAGA	17	489
CFTR-R553X-15	-	UAUAUGAUUACAUUAGA	17	485
CFTR-R553X-16	-	AAAAUCCUGGGGUUUUA	17	493
CFTR-R553X-17	+	ACUAGCCAUAAAACCCC	17	459
CFTR-R553X-18	-	UGGGGUUUUAUGGCUAG	17	494
CFTR-R553X-19	-	AUAGUUCUUGGAGAAGG	17	490
CFTR-R553X-20	-	AAAGACAAUAUAGUUCU	17	488
CFTR-R553X-21	+	AUGCUCAAUCUGAAUUUGAA	20	484
CFTR-R553X-22	-	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-R553X-23	+	CCCACUAGCCAUAAAACCCC	20	455
CFTR-R553X-24	-	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-R553X-25	-	AAUAUAGUUCUUGGAGAAGG	20	474
CFTR-R553X-26	-	CUGGAAUUGAAAAAAUCCUG	20	479
CFTR-R553X-27	-	CAAGGUGAAUAACUAAUUAU	20	475
CFTR-R553X-28	-	CCUGGGGUUUUAUGGCUAGU	20	481

Table 25C provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 25C
3rd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-29	-	GAAUUGAAAAAAUCCUG	17	468
CFTR-R553X-30	+	GUCUUUCUCUGCAAACU	17	469
CFTR-R553X-31	-	GGAAUUGAAAAAAUCCU	17	467
CFTR-R553X-32	-	GAAAAAAUCCUGGGGUUUUA	20	463

Table 25D provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 25D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-33	-	UUAAGAACUAUAAAUAA	17	495
CFTR-R553X-34	-	UGGAAUUGAAAAAAUCC	17	492
CFTR-R553X-35	-	UUUCUAUUUUUGGUAAU	17	487
CFTR-R553X-36	-	CUCUAAUUUUCUAUUUU	17	486
CFTR-R553X-37	-	CAUUUAAGAACUAUAAAUAA	20	482
CFTR-R553X-38	-	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-R553X-39	-	UCCUGGGGUUUUAUGGCUAG	20	480
CFTR-R553X-40	-	AAUUUUCUAUUUUUGGUAAU	20	473
CFTR-R553X-41	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-R553X-42	-	UCUGGAAUUGAAAAAAUCCU	20	478
CFTR-R553X-43	-	ACUCUCUAAUUUUCUAUUUU	20	472

Table 26A provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 26A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-44	+	GAUUUUUUCAAUUCCAGAAA	20	766
CFTR-R553X-45	+	GGAUUUUUUCAAUUCCAGAAA	21	1898
CFTR-R553X-46	+	GUCACUUUUAGUAUGCUCAAU	21	1899
CFTR-R553X-47	+	GAGUCACUUUUAGUAUGCUCAAU	23	1900
CFTR-R553X-48	-	GGAGAAGGUGGAAUCACA	18	2160
CFTR-R553X-49	-	GUUCUUGGAGAAGGUGGAAUCACA	24	2161
CFTR-R553X-50	-	GCAAGAAUUUCUUUAGCAAG	20	746
CFTR-R553X-51	-	GACAAUAUAGUUCUUGGAGAAGG	23	2162
CFTR-R553X-52	-	GUUUUAUGGCUAGUGGGUU	19	1903
CFTR-R553X-53	-	GGUUUUAUGGCUAGUGGGUU	20	751
CFTR-R553X-54	-	GGGUUUUAUGGCUAGUGGGUU	21	1904
CFTR-R553X-55	-	GGGGUUUUAUGGCUAGUGGGUU	22	1905

Table 26B provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 26B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-56	+	UUUUUUCAAUUCCAGAAA	18	1906
CFTR-R553X-57	+	AUUUUUUCAAUUCCAGAAA	19	1907
CFTR-R553X-58	+	AGGAUUUUUUCAAUUCCAGAAA	22	1908
CFTR-R553X-59	+	CAGGAUUUUUUCAAUUCCAGAAA	23	1909
CFTR-R553X-60	+	CCAGGAUUUUUUCAAUUCCAGAAA	24	1910
CFTR-R553X-61	+	UGUCUGUAAUUUUUUUAC	18	1911
CFTR-R553X-62	+	AUGUCUGUAAUUUUUUUAC	19	1912
CFTR-R553X-63	+	AAUGUCUGUAAUUUUUUUAC	20	763
CFTR-R553X-64	+	CCACUAGCCAUAAAACCC	18	1913
CFTR-R553X-65	+	CCCACUAGCCAUAAAACCC	19	1914
CFTR-R553X-66	+	ACCCACUAGCCAUAAAACCC	20	1915
CFTR-R553X-67	+	AACCCACUAGCCAUAAAACCC	21	1916
CFTR-R553X-68	+	UAACCCACUAGCCAUAAAACCC	22	1917
CFTR-R553X-69	+	UUAACCCACUAGCCAUAAAACCC	23	1918
CFTR-R553X-70	+	CUUAACCCACUAGCCAUAAAACCC	24	1919
CFTR-R553X-71	+	ACUUUUAGUAUGCUCAAU	18	1920
CFTR-R553X-72	+	CACUUUUAGUAUGCUCAAU	19	1921
CFTR-R553X-73	+	UCACUUUUAGUAUGCUCAAU	20	756
CFTR-R553X-74	+	AGUCACUUUUAGUAUGCUCAAU	22	1922
CFTR-R553X-75	+	AGAGUCACUUUUAGUAUGCUCAAU	24	1923
CFTR-R553X-76	-	UGGAGAAGGUGGAAUCACA	19	2163
CFTR-R553X-77	-	UUGGAGAAGGUGGAAUCACA	20	742
CFTR-R553X-78	-	CUUGGAGAAGGUGGAAUCACA	21	2164
CFTR-R553X-79	-	UCUUGGAGAAGGUGGAAUCACA	22	2165
CFTR-R553X-80	-	UUCUUGGAGAAGGUGGAAUCACA	23	2166
CFTR-R553X-81	-	CCUGGGGUUUUAUGGCUA	18	1924
CFTR-R553X-82	-	UCCUGGGGUUUUAUGGCUA	19	1925
CFTR-R553X-83	-	AUCCUGGGGUUUUAUGGCUA	20	750
CFTR-R553X-84	-	AAUCCUGGGGUUUUAUGGCUA	21	1926
CFTR-R553X-85	-	AAAUCCUGGGGUUUUAUGGCUA	22	1927
CFTR-R553X-86	-	AAAAUCCUGGGGUUUUAUGGCUA	23	1928
CFTR-R553X-87	-	AAAAAUCCUGGGGUUUUAUGGCUA	24	1929
CFTR-R553X-88	-	UGCUUUAUAUUCUGUUUC	18	1931
CFTR-R553X-89	-	UUGCUUUAUAUUCUGUUUC	19	1932
CFTR-R553X-38	-	AUUGCUUUAUAUUCUGUUUC	20	476
CFTR-R553X-90	-	UAUUGCUUUAUAUUCUGUUUC	21	1933
CFTR-R553X-91	-	CUAUUGCUUUAUAUUCUGUUUC	22	1934
CFTR-R553X-92	-	UCUAUUGCUUUAUAUUCUGUUUC	23	1935
CFTR-R553X-93	-	CUCUAUUGCUUUAUAUUCUGUUUC	24	1936
CFTR-R553X-94	-	AAGAAUUUCUUUAGCAAG	18	1937
CFTR-R553X-95	-	CAAGAAUUUCUUUAGCAAG	19	1938
CFTR-R553X-96	-	UAUAGUUCUUGGAGAAGG	18	2167
CFTR-R553X-97	-	AUAUAGUUCUUGGAGAAGG	19	2168
CFTR-R553X-25	-	AAUAUAGUUCUUGGAGAAGG	20	474
CFTR-R553X-98	-	CAAUAUAGUUCUUGGAGAAGG	21	2169
CFTR-R553X-99	-	ACAAUAUAGUUCUUGGAGAAGG	22	2170
CFTR-R553X-100	-	AGACAAUAUAGUUCUUGGAGAAGG	24	2171
CFTR-R553X-101	-	UUUUAUGGCUAGUGGGUU	18	1942
CFTR-R553X-102	-	UGGGGUUUUAUGGCUAGUGGGUU	23	1943
CFTR-R553X-103	-	CUGGGGUUUUAUGGCUAGUGGGUU	24	1944

Table 26C provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 26C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-104	+	GAAAUGUCUGUAAUUUUUUUAC	22	1945
CFTR-R553X-105	+	GAGAAAUGUCUGUAAUUUUUUUAC	24	1946
CFTR-R553X-106	-	GUUUCUGGAAUUGAAAAAAUCC	22	1948
CFTR-R553X-107	-	GAGUGGAGGUCAAUGAGC	18	2982
CFTR-R553X-108	-	GAGCAAGAAUUUCUUUAGCAAG	22	1902

Table 26D provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 26D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-109	+	ACCAAAAAUAGAAAAUUA	18	1950
CFTR-R553X-110	+	UACCAAAAAUAGAAAAUUA	19	1951
CFTR-R553X-111	+	UUACCAAAAAUAGAAAAUUA	20	757
CFTR-R553X-112	+	AUUACCAAAAAUAGAAAAUUA	21	1952
CFTR-R553X-113	+	UAUUACCAAAAAUAGAAAAUUA	22	1953
CFTR-R553X-114	+	CUAUUACCAAAAAUAGAAAAUUA	23	1954
CFTR-R553X-115	+	CCUAUUACCAAAAAUAGAAAAUUA	24	1955
CFTR-R553X-116	+	AAAUGUCUGUAAUUUUUUUAC	21	1956
CFTR-R553X-117	+	AGAAAUGUCUGUAAUUUUUUUAC	23	1957
CFTR-R553X-118	-	CUGGAAUUGAAAAAAUCC	18	1964
CFTR-R553X-119	-	UCUGGAAUUGAAAAAAUCC	19	1965
CFTR-R553X-24	-	UUCUGGAAUUGAAAAAAUCC	20	477
CFTR-R553X-120	-	UUUCUGGAAUUGAAAAAAUCC	21	1966
CFTR-R553X-121	-	UGUUUCUGGAAUUGAAAAAAUCC	23	1967
CFTR-R553X-122	-	CUGUUUCUGGAAUUGAAAAAAUCC	24	1968
CFTR-R553X-123	-	UGAGUGGAGGUCAAUGAGC	19	2983
CFTR-R553X-124	-	CUGAGUGGAGGUCAAUGAGC	20	2984
CFTR-R553X-125	-	ACUGAGUGGAGGUCAAUGAGC	21	2985
CFTR-R553X-126	-	CACUGAGUGGAGGUCAAUGAGC	22	2986
CFTR-R553X-127	-	ACACUGAGUGGAGGUCAAUGAGC	23	2987
CFTR-R553X-128	-	CACACUGAGUGGAGGUCAAUGAGC	24	2988
CFTR-R553X-129	-	AGCAAGAAUUUCUUUAGCAAG	21	1939
CFTR-R553X-130	-	UGAGCAAGAAUUUCUUUAGCAAG	23	2989
CFTR-R553X-131	-	AUGAGCAAGAAUUUCUUUAGCAAG	24	2990

Table 26E provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 26E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-132	+	AUGUCCUAUUACCAAAAA	18	1978
CFTR-R553X-133	+	GAUGUCCUAUUACCAAAAA	19	1979
CFTR-R553X-134	+	AGAUGUCCUAUUACCAAAAA	20	759
CFTR-R553X-135	+	GAGAUGUCCUAUUACCAAAAA	21	1980
CFTR-R553X-136	+	GGAGAUGUCCUAUUACCAAAAA	22	1981
CFTR-R553X-137	+	UGGAGAUGUCCUAUUACCAAAAA	23	1982
CFTR-R553X-138	+	UUGGAGAUGUCCUAUUACCAAAAA	24	1983
CFTR-R553X-139	+	AAACAGAAUAUAAAGCAA	18	1984
CFTR-R553X-140	+	GAAACAGAAUAUAAAGCAA	19	1985
CFTR-R553X-141	+	AGAAACAGAAUAUAAAGCAA	20	765
CFTR-R553X-142	+	CAGAAACAGAAUAUAAAGCAA	21	1986
CFTR-R553X-143	+	CCAGAAACAGAAUAUAAAGCAA	22	1987
CFTR-R553X-144	+	UCCAGAAACAGAAUAUAAAGCAA	23	1988
CFTR-R553X-145	+	UUCCAGAAACAGAAUAUAAAGCAA	24	1989
CFTR-R553X-146	+	ACAGAAUAUAAAGCAAUA	18	1997
CFTR-R553X-147	+	AACAGAAUAUAAAGCAAUA	19	1998
CFTR-R553X-148	+	AAACAGAAUAUAAAGCAAUA	20	764
CFTR-R553X-149	+	GAAACAGAAUAUAAAGCAAUA	21	1999
CFTR-R553X-150	+	AGAAACAGAAUAUAAAGCAAUA	22	2000
CFTR-R553X-151	+	CAGAAACAGAAUAUAAAGCAAUA	23	2001
CFTR-R553X-152	+	CCAGAAACAGAAUAUAAAGCAAUA	24	2002
CFTR-R553X-153	+	UAGUUAUUCACCUUGCUA	18	2003
CFTR-R553X-154	+	UUAGUUAUUCACCUUGCUA	19	2004
CFTR-R553X-155	+	AUUAGUUAUUCACCUUGCUA	20	762
CFTR-R553X-156	+	AAUUAGUUAUUCACCUUGCUA	21	2005
CFTR-R553X-157	+	UAAUUAGUUAUUCACCUUGCUA	22	2006
CFTR-R553X-158	+	AUAAUUAGUUAUUCACCUUGCUA	23	2007
CFTR-R553X-159	+	AAUAAUUAGUUAUUCACCUUGCUA	24	2008
CFTR-R553X-160	+	UUGUCUUUCUCUGCAAAC	18	2009
CFTR-R553X-161	+	AUUGUCUUUCUCUGCAAAC	19	2010
CFTR-R553X-162	+	UAUUGUCUUUCUCUGCAAAC	20	760
CFTR-R553X-163	+	AUAUUGUCUUUCUCUGCAAAC	21	2011
CFTR-R553X-164	+	UAUAUUGUCUUUCUCUGCAAAC	22	2012
CFTR-R553X-165	+	CUAUAUUGUCUUUCUCUGCAAAC	23	2013
CFTR-R553X-166	+	ACUAUAUUGUCUUUCUCUGCAAAC	24	2014
CFTR-R553X-167	+	UGUGAUUCCACCUUCUCC	18	2179
CFTR-R553X-168	+	GUGUGAUUCCACCUUCUCC	19	2180
CFTR-R553X-169	+	AGUGUGAUUCCACCUUCUCC	20	761
CFTR-R553X-170	+	CAGUGUGAUUCCACCUUCUCC	21	2181
CFTR-R553X-171	+	UCAGUGUGAUUCCACCUUCUCC	22	2182
CFTR-R553X-172	+	CUCAGUGUGAUUCCACCUUCUCC	23	2183
CFTR-R553X-173	+	ACUCAGUGUGAUUCCACCUUCUCC	24	2184
CFTR-R553X-174	+	CCAGGAUUUUUUCAAUUC	18	2015
CFTR-R553X-175	+	CCCAGGAUUUUUUCAAUUC	19	2016
CFTR-R553X-176	+	CCCCAGGAUUUUUUCAAUUC	20	767
CFTR-R553X-177	+	ACCCCAGGAUUUUUUCAAUUC	21	2017
CFTR-R553X-178	+	AACCCCAGGAUUUUUUCAAUUC	22	2018
CFTR-R553X-179	+	AAACCCCAGGAUUUUUUCAAUUC	23	2019
CFTR-R553X-180	+	AAAACCCCAGGAUUUUUUCAAUUC	24	2020
CFTR-R553X-181	+	CUAUUGCUUUAACCACAG	18	2021
CFTR-R553X-182	+	ACUAUUGCUUUAACCACAG	19	2022
CFTR-R553X-183	+	CACUAUUGCUUUAACCACAG	20	754
CFTR-R553X-184	+	ACACUAUUGCUUUAACCACAG	21	2023
CFTR-R553X-185	+	CACACUAUUGCUUUAACCACAG	22	2024
CFTR-R553X-186	+	UCACACUAUUGCUUUAACCACAG	23	2025
CFTR-R553X-187	+	AUCACACUAUUGCUUUAACCACAG	24	2026
CFTR-R553X-188	+	UUACCAAAAAUAGAAAAU	18	2027
CFTR-R553X-189	+	AUUACCAAAAAUAGAAAAU	19	2028
CFTR-R553X-190	+	UAUUACCAAAAAUAGAAAAU	20	758
CFTR-R553X-191	+	CUAUUACCAAAAAUAGAAAAU	21	2029
CFTR-R553X-192	+	CCUAUUACCAAAAAUAGAAAAU	22	2030
CFTR-R553X-193	+	UCCUAUUACCAAAAAUAGAAAAU	23	2031
CFTR-R553X-194	+	GUCCUAUUACCAAAAAUAGAAAAU	24	2032
CFTR-R553X-195	+	AGUAUGCUCAAUCUGAAU	18	2033
CFTR-R553X-196	+	UAGUAUGCUCAAUCUGAAU	19	2034
CFTR-R553X-197	+	UUAGUAUGCUCAAUCUGAAU	20	755
CFTR-R553X-198	+	UUUAGUAUGCUCAAUCUGAAU	21	2035
CFTR-R553X-199	+	UUUUAGUAUGCUCAAUCUGAAU	22	2036
CFTR-R553X-200	+	CUUUUAGUAUGCUCAAUCUGAAU	23	2037
CFTR-R553X-201	+	ACUUUUAGUAUGCUCAAUCUGAAU	24	2038
CFTR-R553X-202	+	UGUCUUUCUCUGCAAACU	18	2039
CFTR-R553X-203	+	UUGUCUUUCUCUGCAAACU	19	2040
CFTR-R553X-41	+	AUUGUCUUUCUCUGCAAACU	20	483
CFTR-R553X-204	+	UAUUGUCUUUCUCUGCAAACU	21	2041
CFTR-R553X-205	+	AUAUUGUCUUUCUCUGCAAACU	22	2042
CFTR-R553X-206	+	UAUAUUGUCUUUCUCUGCAAACU	23	2043
CFTR-R553X-207	+	CUAUAUUGUCUUUCUCUGCAAACU	24	2044
CFTR-R553X-208	+	UUAACCACAGUUGAAAUU	18	2045
CFTR-R553X-209	+	UUUAACCACAGUUGAAAUU	19	2046
CFTR-R553X-210	+	CUUUAACCACAGUUGAAAUU	20	753
CFTR-R553X-211	+	GCUUUAACCACAGUUGAAAUU	21	2047
CFTR-R553X-212	+	UGCUUUAACCACAGUUGAAAUU	22	2048
CFTR-R553X-213	+	UUGCUUUAACCACAGUUGAAAUU	23	2049
CFTR-R553X-214	+	AUUGCUUUAACCACAGUUGAAAUU	24	2050
CFTR-R553X-215	-	UAUAUUCUGUUUCUGGAA	18	2051
CFTR-R553X-216	-	UUAUAUUCUGUUUCUGGAA	19	2052
CFTR-R553X-217	-	UUUAUAUUCUGUUUCUGGAA	20	748
CFTR-R553X-218	-	CUUUAUAUUCUGUUUCUGGAA	21	2053
CFTR-R553X-219	-	GCUUUAUAUUCUGUUUCUGGAA	22	2054
CFTR-R553X-220	-	UGCUUUAUAUUCUGUUUCUGGAA	23	2055
CFTR-R553X-221	-	UUGCUUUAUAUUCUGUUUCUGGAA	24	2056
CFTR-R553X-222	-	AUUUUCUAUUUUUGGUAA	18	2059
CFTR-R553X-223	-	AAUUUUCUAUUUUUGGUAA	19	2060
CFTR-R553X-224	-	UAAUUUUCUAUUUUUGGUAA	20	736
CFTR-R553X-225	-	CUAAUUUUCUAUUUUUGGUAA	21	2061
CFTR-R553X-226	-	UCUAAUUUUCUAUUUUUGGUAA	22	2062
CFTR-R553X-227	-	CUCUAAUUUUCUAUUUUUGGUAA	23	2063
CFTR-R553X-228	-	UCUCUAAUUUUCUAUUUUUGGUAA	24	2064
CFTR-R553X-229	-	GACAUCUCCAAGUUUGCA	18	2065
CFTR-R553X-230	-	GGACAUCUCCAAGUUUGCA	19	2066
CFTR-R553X-231	-	AGGACAUCUCCAAGUUUGCA	20	738
CFTR-R553X-232	-	UAGGACAUCUCCAAGUUUGCA	21	2067
CFTR-R553X-233	-	AUAGGACAUCUCCAAGUUUGCA	22	2068
CFTR-R553X-234	-	AAUAGGACAUCUCCAAGUUUGCA	23	2069
CFTR-R553X-235	-	UAAUAGGACAUCUCCAAGUUUGCA	24	2070
CFTR-R553X-236	-	CACACUGAGUGGAGGUCA	18	2071
CFTR-R553X-237	-	UCACACUGAGUGGAGGUCA	19	2072
CFTR-R553X-238	-	AUCACACUGAGUGGAGGUCA	20	744
CFTR-R553X-239	-	AAUCACACUGAGUGGAGGUCA	21	2073
CFTR-R553X-240	-	GAAUCACACUGAGUGGAGGUCA	22	2074
CFTR-R553X-241	-	GGAAUCACACUGAGUGGAGGUCA	23	2075
CFTR-R553X-242	-	UGGAAUCACACUGAGUGGAGGUCA	24	2076
CFTR-R553X-243	-	GUGCCUUUCAAAUUCAGA	18	2077
CFTR-R553X-244	-	UGUGCCUUUCAAAUUCAGA	19	2078
CFTR-R553X-245	-	AUGUGCCUUUCAAAUUCAGA	20	735
CFTR-R553X-246	-	GAUGUGCCUUUCAAAUUCAGA	21	2079
CFTR-R553X-247	-	AGAUGUGCCUUUCAAAUUCAGA	22	2080
CFTR-R553X-248	-	AAGAUGUGCCUUUCAAAUUCAGA	23	2081
CFTR-R553X-249	-	GAAGAUGUGCCUUUCAAAUUCAGA	24	2082
CFTR-R553X-250	-	AUAUAUGAUUACAUUAGA	18	2083
CFTR-R553X-251	-	GAUAUAUGAUUACAUUAGA	19	2084
CFTR-R553X-22	-	UGAUAUAUGAUUACAUUAGA	20	471
CFTR-R553X-252	-	GUGAUAUAUGAUUACAUUAGA	21	2085
CFTR-R553X-253	-	UGUGAUAUAUGAUUACAUUAGA	22	2086
CFTR-R553X-254	-	GUGUGAUAUAUGAUUACAUUAGA	23	2087
CFTR-R553X-255	-	AGUGUGAUAUAUGAUUACAUUAGA	24	2088
CFTR-R553X-256	-	AAGGUGGAAUCACACUGA	18	2089
CFTR-R553X-257	-	GAAGGUGGAAUCACACUGA	19	2090
CFTR-R553X-258	-	AGAAGGUGGAAUCACACUGA	20	743
CFTR-R553X-259	-	GAGAAGGUGGAAUCACACUGA	21	2091
CFTR-R553X-260	-	GGAGAAGGUGGAAUCACACUGA	22	2192
CFTR-R553X-261	-	UGGAGAAGGUGGAAUCACACUGA	23	2193
CFTR-R553X-262	-	UUGGAGAAGGUGGAAUCACACUGA	24	2194
CFTR-R553X-263	-	UCUGGAAUUGAAAAAAUC	18	2098
CFTR-R553X-264	-	UUCUGGAAUUGAAAAAAUC	19	2099
CFTR-R553X-265	-	UUUCUGGAAUUGAAAAAAUC	20	749
CFTR-R553X-266	-	GUUUCUGGAAUUGAAAAAAUC	21	2100
CFTR-R553X-267	-	UGUUUCUGGAAUUGAAAAAAUC	22	2101
CFTR-R553X-268	-	CUGUUUCUGGAAUUGAAAAAAUC	23	2102
CFTR-R553X-269	-	UCUGUUUCUGGAAUUGAAAAAAUC	24	2103
CFTR-R553X-270	-	AGAAAGACAAUAUAGUUC	18	2195
CFTR-R553X-271	-	GAGAAAGACAAUAUAGUUC	19	2196
CFTR-R553X-272	-	AGAGAAAGACAAUAUAGUUC	20	739
CFTR-R553X-273	-	CAGAGAAAGACAAUAUAGUUC	21	2197
CFTR-R553X-274	-	GCAGAGAAAGACAAUAUAGUUC	22	2198
CFTR-R553X-275	-	UGCAGAGAAAGACAAUAUAGUUC	23	2199
CFTR-R553X-276	-	UUGCAGAGAAAGACAAUAUAGUUC	24	2200
CFTR-R553X-277	-	AUAUAGUUCUUGGAGAAG	18	2201
CFTR-R553X-278	-	AAUAUAGUUCUUGGAGAAG	19	2202
CFTR-R553X-279	-	CAAUAUAGUUCUUGGAGAAG	20	741
CFTR-R553X-280	-	ACAAUAUAGUUCUUGGAGAAG	21	2203
CFTR-R553X-281	-	GACAAUAUAGUUCUUGGAGAAG	22	2204
CFTR-R553X-282	-	AGACAAUAUAGUUCUUGGAGAAG	23	2205
CFTR-R553X-283	-	AAGACAAUAUAGUUCUUGGAGAAG	24	2206
CFTR-R553X-284	-	AGGUGGAAUCACACUGAG	18	2111
CFTR-R553X-285	-	AAGGUGGAAUCACACUGAG	19	2112
CFTR-R553X-9	-	GAAGGUGGAAUCACACUGAG	20	461
CFTR-R553X-286	-	AGAAGGUGGAAUCACACUGAG	21	2113
CFTR-R553X-287	-	GAGAAGGUGGAAUCACACUGAG	22	2114
CFTR-R553X-288	-	GGAGAAGGUGGAAUCACACUGAG	23	2207
CFTR-R553X-289	-	UGGAGAAGGUGGAAUCACACUGAG	24	2208
CFTR-R553X-290	-	GAUAUAUGAUUACAUUAG	18	2117
CFTR-R553X-291	-	UGAUAUAUGAUUACAUUAG	19	2118
CFTR-R553X-292	-	GUGAUAUAUGAUUACAUUAG	20	734
CFTR-R553X-293	-	UGUGAUAUAUGAUUACAUUAG	21	2119
CFTR-R553X-294	-	GUGUGAUAUAUGAUUACAUUAG	22	2120
CFTR-R553X-295	-	AGUGUGAUAUAUGAUUACAUUAG	23	2121
CFTR-R553X-296	-	UAGUGUGAUAUAUGAUUACAUUAG	24	2122
CFTR-R553X-297	-	AAGACAAUAUAGUUCUUG	18	2209
CFTR-R553X-298	-	AAAGACAAUAUAGUUCUUG	19	2210
CFTR-R553X-299	-	GAAAGACAAUAUAGUUCUUG	20	740
CFTR-R553X-300	-	AGAAAGACAAUAUAGUUCUUG	21	2211
CFTR-R553X-301	-	GAGAAAGACAAUAUAGUUCUUG	22	2212
CFTR-R553X-302	-	AGAGAAAGACAAUAUAGUUCUUG	23	2213
CFTR-R553X-303	-	CAGAGAAAGACAAUAUAGUUCUUG	24	2214
CFTR-R553X-304	-	AGGACAUCUCCAAGUUUG	18	2123
CFTR-R553X-305	-	UAGGACAUCUCCAAGUUUG	19	2124
CFTR-R553X-306	-	AUAGGACAUCUCCAAGUUUG	20	737
CFTR-R553X-307	-	AAUAGGACAUCUCCAAGUUUG	21	2125
CFTR-R553X-308	-	UAAUAGGACAUCUCCAAGUUUG	22	2126
CFTR-R553X-309	-	GUAAUAGGACAUCUCCAAGUUUG	23	2127
CFTR-R553X-310	-	GGUAAUAGGACAUCUCCAAGUUUG	24	2128
CFTR-R553X-311	-	UGUGAUAUAUGAUUACAU	18	2129
CFTR-R553X-312	-	GUGUGAUAUAUGAUUACAU	19	2130
CFTR-R553X-313	-	AGUGUGAUAUAUGAUUACAU	20	733
CFTR-R553X-314	-	UAGUGUGAUAUAUGAUUACAU	21	2131
CFTR-R553X-315	-	AUAGUGUGAUAUAUGAUUACAU	22	2132
CFTR-R553X-316	-	AAUAGUGUGAUAUAUGAUUACAU	23	2133
CFTR-R553X-317	-	CAAUAGUGUGAUAUAUGAUUACAU	24	2134
CFTR-R553X-318	-	GAAAGACAAUAUAGUUCU	18	2135
CFTR-R553X-319	-	AGAAAGACAAUAUAGUUCU	19	2136
CFTR-R553X-11	-	GAGAAAGACAAUAUAGUUCU	20	453
CFTR-R553X-320	-	AGAGAAAGACAAUAUAGUUCU	21	2137
CFTR-R553X-321	-	CAGAGAAAGACAAUAUAGUUCU	22	2138
CFTR-R553X-322	-	GCAGAGAAAGACAAUAUAGUUCU	23	2139
CFTR-R553X-323	-	UGCAGAGAAAGACAAUAUAGUUCU	24	2140
CFTR-R553X-324	-	GGGUUAAGAAUCACAUUU	18	2215
CFTR-R553X-325	-	UGGGUUAAGAAUCACAUUU	19	2216
CFTR-R553X-326	-	GUGGGUUAAGAAUCACAUUU	20	752
CFTR-R553X-327	-	AGUGGGUUAAGAAUCACAUUU	21	2217
CFTR-R553X-328	-	UAGUGGGUUAAGAAUCACAUUU	22	2218
CFTR-R553X-329	-	CUAGUGGGUUAAGAAUCACAUUU	23	2219
CFTR-R553X-330	-	GCUAGUGGGUUAAGAAUCACAUUU	24	2220
CFTR-R553X-331	-	UUGCUUUAUAUUCUGUUU	18	2148
CFTR-R553X-332	-	AUUGCUUUAUAUUCUGUUU	19	2149
CFTR-R553X-333	-	UAUUGCUUUAUAUUCUGUUU	20	747
CFTR-R553X-334	-	CUAUUGCUUUAUAUUCUGUUU	21	2150
CFTR-R553X-335	-	UCUAUUGCUUUAUAUUCUGUUU	22	2151
CFTR-R553X-336	-	CUCUAUUGCUUUAUAUUCUGUUU	23	2152
CFTR-R553X-337	-	UCUCUAUUGCUUUAUAUUCUGUUU	24	2153

Table 27A provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 27A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-338	+	GUAAUCAUAUAUCACAC	17	2154
CFTR-R553X-339	-	GGUUAAAGCAAUAGUGUGAU	20	927

Table 27B provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 27B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-340	+	CCACUAGCCAUAAAACC	17	935
CFTR-R553X-341	+	UGAAUGACAUUUACAGC	17	2155
CFTR-R553X-342	-	UAAAGCAAUAGUGUGAU	17	932
CFTR-R553X-343	-	AGGAAGAUGUGCCUUUCAAA	20	928
CFTR-R553X-344	+	AAUGUAAUCAUAUAUCACAC	20	2156
CFTR-R553X-345	+	AACCCACUAGCCAUAAAACC	20	930
CFTR-R553X-346	+	ACAUGAAUGACAUUUACAGC	20	2157

Table 27C provides exemplary targeting domains for correcting a mutation (e.g., R553X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., R553X). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 27C
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-R553X-347	-	AAGAUGUGCCUUUCAAA	17	933
CFTR-R553X-348	+	UUAUUUAUAGUUCUUAA	17	936
CFTR-R553X-349	+	UCAUUGACCUCCACUCA	17	2991
CFTR-R553X-350	-	AAUUACAGACAUUUCUC	17	2158
CFTR-R553X-351	+	CCAUUAUUUAUAGUUCUUAA	20	931
CFTR-R553X-352	+	UGCUCAUUGACCUCCACUCA	20	2992
CFTR-R553X-353	-	AAAAAUUACAGACAUUUCUC	20	2159

Table 28A provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table lean be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 28A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-W1282X-1	-	GAAUUAUGUUUAUGGCA	17	2993
CFTR-W1282X-2	-	GGAGAAAUCCAGAUCGA	17	2994
CFTR-W1282X-3	-	GGCCUCUUGGGAAGAAC	17	2995
CFTR-W1282X-4	+	GUCCUUUUGCUCACCUG	17	2996
CFTR-W1282X-5	-	GAUCGAUGGUGUGUCUU	17	2997
CFTR-W1282X-6	-	GAAGGAGAAAUCCAGAUCGA	20	2998
CFTR-W1282X-7	-	GUGGGCCUCUUGGGAAGAAC	20	2999

Table 28B provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 28B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-W1282X-8	-	UACCACAGGUGAGCAAA	17	3000
CFTR-W1282X-9	+	CUGUGGUAUCACUCCAA	17	3001
CFTR-W1282X-10	-	AGACUACUGAACACUGA	17	3002
CFTR-W1282X-11	+	CUAUAAGGUAAAAGUGA	17	3003
CFTR-W1282X-12	-	UAACUUUGCAACAGUGA	17	3004
CFTR-W1282X-13	+	CAAGAGGCCCACCUAUA	17	3005
CFTR-W1282X-14	-	CUUUGGAGUGAUACCAC	17	3006
CFTR-W1282X-15	+	CUAUGAGAAAACUGCAC	17	3007
CFTR-W1282X-16	+	AAGACACACCAUCGAUC	17	3008
CFTR-W1282X-17	-	UUGGGAAGAACUGGAUC	17	3009
CFTR-W1282X-18	+	AUCCAGUUCUUCCCAAG	17	3010
CFTR-W1282X-19	-	CACUUUUACCUUAUAGG	17	3011
CFTR-W1282X-20	-	CAGUGCAGUUUUCUCAU	17	3012
CFTR-W1282X-21	+	UAUAAGGUAAAAGUGAU	17	3013
CFTR-W1282X-22	+	UCACUUCUGUGACAUAU	17	3014
CFTR-W1282X-23	-	CAUCACUUUUACCUUAU	17	3015
CFTR-W1282X-24	-	CUUAUAGGUGGGCCUCU	17	3016
CFTR-W1282X-25	-	AGAUCGAUGGUGUGUCU	17	3017
CFTR-W1282X-26	-	ACUUUUACCUUAUAGGU	17	3018
CFTR-W1282X-27	-	UUAUAGGUGGGCCUCUU	17	3019
CFTR-W1282X-28	-	AAAGGACUUAGCCAGAAAAA	20	3020
CFTR-W1282X-29	+	CACCUGUGGUAUCACUCCAA	20	3021
CFTR-W1282X-30	-	ACUGAAUUAUGUUUAUGGCA	20	3022
CFTR-W1282X-31	-	UCUUGGGAAGAACUGGAUCA	20	3023
CFTR-W1282X-32	-	UUGAGACUACUGAACACUGA	20	3024
CFTR-W1282X-33	+	CACCUAUAAGGUAAAAGUGA	20	3025
CFTR-W1282X-34	+	UCCCAAGAGGCCCACCUAUA	20	3026
CFTR-W1282X-35	-	ACAAUACUGAAUUAUGUUUA	20	3027
CFTR-W1282X-36	-	AGCCUUUGGAGUGAUACCAC	20	3028
CFTR-W1282X-37	+	UGCCUAUGAGAAAACUGCAC	20	3029
CFTR-W1282X-38	+	CCCAAGACACACCAUCGAUC	20	3030
CFTR-W1282X-39	-	CUCUUGGGAAGAACUGGAUC	20	3031
CFTR-W1282X-40	+	UAAUUUAGUUGCCUUUUUUC	20	3032
CFTR-W1282X-41	+	CUGAUCCAGUUCUUCCCAAG	20	3033
CFTR-W1282X-42	-	CAUCACUUUUACCUUAUAGG	20	3034
CFTR-W1282X-43	+	UAAGUCCUUUUGCUCACCUG	20	3035
CFTR-W1282X-44	-	CUCCAGUGCAGUUUUCUCAU	20	3036
CFTR-W1282X-45	+	ACCUAUAAGGUAAAAGUGAU	20	3037
CFTR-W1282X-46	-	UCCCAUCACUUUUACCUUAU	20	3038
CFTR-W1282X-47	-	UACCUUAUAGGUGGGCCUCU	20	3039
CFTR-W1282X-48	-	UCCAGAUCGAUGGUGUGUCU	20	3040
CFTR-W1282X-49	-	AUCACUUUUACCUUAUAGGU	20	3041
CFTR-W1282X-50	-	CCAGAUCGAUGGUGUGUCUU	20	3042

Table 28C provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 28C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-51	−	GGACUUAGCCAGAAAAA	17	3043
CFTR-W1282X-52	+	GGAUCACUUCUGUGACAUAU	20	3044

Table 28D provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 28D
4th Tier
			Tar-
			get
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-53	−	UGGGAAGAACUGGAUCA	17	3045
CFTR-W1282X-54	−	AUACUGAAUUAUGUUUA	17	3046
CFTR-W1282X-55	+	UUUAGUUGCCUUUUUUC	17	3047
CFTR-W1282X-56	−	CAGUGAAGGAAAGCCUU	17	3048
CFTR-W1282X-57	−	UGAUACCACAGGUGAGCAAA	20	3049
CFTR-W1282X-58	−	CAAUAACUUUGCAACAGUGA	20	3050
CFTR-W1282X-59	−	CAACAGUGAAGGAAAGCCUU	20	3051
CFTR-W1282X-60	−	ACCUUAUAGGUGGGCCUCUU	20	3052

Table 29A provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 29A
1st Tier
	DNA		Target	Seq
gRNA Name	Strand	Targeting Domain	Site Length	ID
CFTR-W1282X-61	+	GCCCACCUAUAAGGUAAAAGUGA	23	3053
CFTR-W1282X-62	+	GGCCCACCUAUAAGGUAAAAGUGA	24	3054
CFTR-W1282X-63	+	GCAUAACAAAUAUAUUUUG	19	3055
CFTR-W1282X-64	+	GAAUCCCAAGACACACCAUCGAU	23	3056
CFTR-W1282X-65	−	GUGGGCCUCUUGGGAAGAA	19	3057
CFTR-W1282X-66	−	GGUGGGCCUCUUGGGAAGAA	20	3058
CFTR-W1282X-67	−	GGAAGAACUGGAUCAGGG	18	3059
CFTR-W1282X-68	−	GGGAAGAACUGGAUCAGGG	19	3060
CFTR-W1282X-69	−	GAAAUCCAGAUCGAUGGUGUGUCU	24	3061

Table 29B provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 29B
2nd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-70	+	CCUAUAAGGUAAAAGUGA	18	3062
CFTR-W1282X-71	+	ACCUAUAAGGUAAAAGUGA	19	3063
CFTR-W1282X-33	+	CACCUAUAAGGUAAAAGUGA	20	3025
CFTR-W1282X-72	+	CCACCUAUAAGGUAAAAGUGA	21	3064
CFTR-W1282X-73	+	CCCACCUAUAAGGUAAAAGUGA	22	3065
CFTR-W1282X-74	+	UUGCAGAGUAAUAUGAAUUUC	21	3066
CFTR-W1282X-75	+	UUUGCAGAGUAAUAUGAAUUUC	22	3067
CFTR-W1282X-76	+	UUUUGCAGAGUAAUAUGAAUUUC	23	3068
CFTR-W1282X-77	+	AUUUUGCAGAGUAAUAUGAAUUUC	24	3069
CFTR-W1282X-78	+	CAUAACAAAUAUAUUUUG	18	3070
CFTR-W1282X-79	+	UGCAUAACAAAUAUAUUUUG	20	3071
CFTR-W1282X-80	+	UAUAUUUUGCAGAGUAAU	18	3072
CFTR-W1282X-81	+	AUAUAUUUUGCAGAGUAAU	19	3073
CFTR-W1282X-82	+	AAUAUAUUUUGCAGAGUAAU	20	3074
CFTR-W1282X-83	+	CCAAGACACACCAUCGAU	18	3075
CFTR-W1282X-84	+	CCCAAGACACACCAUCGAU	19	3076
CFTR-W1282X-85	+	UCCCAAGACACACCAUCGAU	20	3077
CFTR-W1282X-86	+	AUCCCAAGACACACCAUCGAU	21	3078
CFTR-W1282X-87	+	AAUCCCAAGACACACCAUCGAU	22	3079
CFTR-W1282X-88	+	UGAAUCCCAAGACACACCAUCGAU	24	3080
CFTR-W1282X-89	−	UGGGCCUCUUGGGAAGAA	18	3081
CFTR-W1282X-90	−	AGGUGGGCCUCUUGGGAAGAA	21	3082
CFTR-W1282X-91	−	UAGGUGGGCCUCUUGGGAAGAA	22	3083
CFTR-W1282X-92	−	AUAGGUGGGCCUCUUGGGAAGAA	23	3084
CFTR-W1282X-93	−	UAUAGGUGGGCCUCUUGGGAAGAA	24	3085
CFTR-W1282X-94	−	UGGGAAGAACUGGAUCAGGG	20	3086
CFTR-W1282X-95	−	UUGGGAAGAACUGGAUCAGGG	21	3087
CFTR-W1282X-96	−	CUUGGGAAGAACUGGAUCAGGG	22	3088
CFTR-W1282X-97	−	UCUUGGGAAGAACUGGAUCAGGG	23	3089
CFTR-W1282X-98	−	CUCUUGGGAAGAACUGGAUCAGGG	24	3090
CFTR-W1282X-99	−	CAGAUCGAUGGUGUGUCU	18	3091
CFTR-W1282X-100	−	CCAGAUCGAUGGUGUGUCU	19	3092
CFTR-W1282X-48	−	UCCAGAUCGAUGGUGUGUCU	20	3040
CFTR-W1282X-101	−	AUCCAGAUCGAUGGUGUGUCU	21	3093
CFTR-W1282X-102	−	AAUCCAGAUCGAUGGUGUGUCU	22	3094
CFTR-W1282X-103	−	AAAUCCAGAUCGAUGGUGUGUCU	23	3095

Table 29C provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 29C
3rd Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-104	+	GCAGAGUAAUAUGAAUUUC	19	3096
CFTR-W1282X-105	+	GCAAUGCAUAACAAAUAUAUUUUG	24	3097
CFTR-W1282X-106	-	GCAACAGUGAAGGAAAGCCUU	21	3098

Table 29D provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 29D
4th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-107	+	UUCACUGUUGCAAAGUUA	18	3099
CFTR-W1282X-108	+	CUUCACUGUUGCAAAGUUA	19	3100
CFTR-W1282X-109	+	CCUUCACUGUUGCAAAGUUA	20	3101
CFTR-W1282X-110	+	UCCUUCACUGUUGCAAAGUUA	21	3102
CFTR-W1282X-111	+	UUCCUUCACUGUUGCAAAGUUA	22	3103
CFTR-W1282X-112	+	UUUCCUUCACUGUUGCAAAGUUA	23	3104
CFTR-W1282X-113	+	CUUUCCUUCACUGUUGCAAAGUUA	24	3105
CFTR-W1282X-114	+	CAGAGUAAUAUGAAUUUC	18	3106
CFTR-W1282X-115	+	UGCAGAGUAAUAUGAAUUUC	20	3107
CFTR-W1282X-116	+	AUGCAUAACAAAUAUAUUUUG	21	3108
CFTR-W1282X-117	+	AAUGCAUAACAAAUAUAUUUUG	22	3109
CFTR-W1282X-118	+	CAAUGCAUAACAAAUAUAUUUUG	23	3110
CFTR-W1282X-119	+	AAAUAUAUUUUGCAGAGUAAU	21	3111
CFTR-W1282X-120	+	CAAAUAUAUUUUGCAGAGUAAU	22	3112
CFTR-W1282X-121	+	ACAAAUAUAUUUUGCAGAGUAAU	23	3113
CFTR-W1282X-122	+	AACAAAUAUAUUUUGCAGAGUAAU	24	3114
CFTR-W1282X-123	-	ACAGUGAAGGAAAGCCUU	18	3115
CFTR-W1282X-124	-	AACAGUGAAGGAAAGCCUU	19	3116
CFTR-W1282X-59	-	CAACAGUGAAGGAAAGCCUU	20	3051
CFTR-W1282X-125	-	UGCAACAGUGAAGGAAAGCCUU	22	3117
CFTR-W1282X-126	-	UUGCAACAGUGAAGGAAAGCCUU	23	3118
CFTR-W1282X-127	-	UUUGCAACAGUGAAGGAAAGCCUU	24	3119

Table 29E provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table lean be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 29E
5th Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-128	+	GCCUAUGAGAAAACUGCA	18	3120
CFTR-W1282X-129	+	UGCCUAUGAGAAAACUGCA	19	3121
CFTR-W1282X-130	+	CUGCCUAUGAGAAAACUGCA	20	3122
CFTR-W1282X-131	+	UCUGCCUAUGAGAAAACUGCA	21	3123
CFTR-W1282X-132	+	UUCUGCCUAUGAGAAAACUGCA	22	3124
CFTR-W1282X-133	+	UUUCUGCCUAUGAGAAAACUGCA	23	3125
CFTR-W1282X-134	+	UUUUCUGCCUAUGAGAAAACUGCA	24	3126
CFTR-W1282X-135	+	CCUAUGAGAAAACUGCAC	18	3127
CFTR-W1282X-136	+	GCCUAUGAGAAAACUGCAC	19	3128
CFTR-W1282X-37	+	UGCCUAUGAGAAAACUGCAC	20	3029
CFTR-W1282X-137	+	CUGCCUAUGAGAAAACUGCAC	21	3129
CFTR-W1282X-138	+	UCUGCCUAUGAGAAAACUGCAC	22	3130
CFTR-W1282X-139	+	UUCUGCCUAUGAGAAAACUGCAC	23	3131
CFTR-W1282X-140	+	UUUCUGCCUAUGAGAAAACUGCAC	24	3132
CFTR-W1282X-141	+	CCUGAUCCAGUUCUUCCC	18	3133
CFTR-W1282X-142	+	CCCUGAUCCAGUUCUUCCC	19	3134
CFTR-W1282X-143	+	UCCCUGAUCCAGUUCUUCCC	20	3135
CFTR-W1282X-144	+	UUCCCUGAUCCAGUUCUUCCC	21	3136
CFTR-W1282X-145	+	CUUCCCUGAUCCAGUUCUUCCC	22	3137
CFTR-W1282X-146	+	UCUUCCCUGAUCCAGUUCUUCCC	23	3138
CFTR-W1282X-147	+	CUCUUCCCUGAUCCAGUUCUUCCC	24	3139
CFTR-W1282X-148	+	UAUGAGAAAACUGCACUG	18	3140
CFTR-W1282X-149	+	CUAUGAGAAAACUGCACUG	19	3141
CFTR-W1282X-150	+	CCUAUGAGAAAACUGCACUG	20	3142
CFTR-W1282X-151	+	GCCUAUGAGAAAACUGCACUG	21	3143
CFTR-W1282X-152	+	UGCCUAUGAGAAAACUGCACUG	22	3144
CFTR-W1282X-153	+	CUGCCUAUGAGAAAACUGCACUG	23	3145
CFTR-W1282X-154	+	UCUGCCUAUGAGAAAACUGCACUG	24	3146
CFTR-W1282X-155	+	ACCUAUAAGGUAAAAGUG	18	3147
CFTR-W1282X-156	+	CACCUAUAAGGUAAAAGUG	19	3148
CFTR-W1282X-157	+	CCACCUAUAAGGUAAAAGUG	20	3149
CFTR-W1282X-158	+	CCCACCUAUAAGGUAAAAGUG	21	3150
CFTR-W1282X-159	+	GCCCACCUAUAAGGUAAAAGUG	22	3151
CFTR-W1282X-160	+	GGCCCACCUAUAAGGUAAAAGUG	23	3152
CFTR-W1282X-161	+	AGGCCCACCUAUAAGGUAAAAGUG	24	3153
CFTR-W1282X-162	+	GACAUCUUUUCUGCCUAU	18	3154
CFTR-W1282X-163	+	AGACAUCUUUUCUGCCUAU	19	3155
CFTR-W1282X-164	+	GAGACAUCUUUUCUGCCUAU	20	3156
CFTR-W1282X-165	+	AGAGACAUCUUUUCUGCCUAU	21	3157
CFTR-W1282X-166	+	UAGAGACAUCUUUUCUGCCUAU	22	3158
CFTR-W1282X-167	+	UUAGAGACAUCUUUUCUGCCUAU	23	3159
CFTR-W1282X-168	+	UUUAGAGACAUCUUUUCUGCCUAU	24	3160
CFTR-W1282X-169	+	GAGACAUCUUUUCUGCCU	18	3161
CFTR-W1282X-170	+	AGAGACAUCUUUUCUGCCU	19	3162
CFTR-W1282X-171	+	UAGAGACAUCUUUUCUGCCU	20	3163
CFTR-W1282X-172	+	UUAGAGACAUCUUUUCUGCCU	21	3164
CFTR-W1282X-173	+	UUUAGAGACAUCUUUUCUGCCU	22	3165
CFTR-W1282X-174	+	UUUUAGAGACAUCUUUUCUGCCU	23	3166
CFTR-W1282X-175	+	CUUUUAGAGACAUCUUUUCUGCCU	24	3167
CFTR-W1282X-176	-	GAUACCACAGGUGAGCAA	18	3168
CFTR-W1282X-177	-	UGAUACCACAGGUGAGCAA	19	3169
CFTR-W1282X-178	-	GUGAUACCACAGGUGAGCAA	20	3170
CFTR-W1282X-179	-	AGUGAUACCACAGGUGAGCAA	21	3171
CFTR-W1282X-180	-	GAGUGAUACCACAGGUGAGCAA	22	3172
CFTR-W1282X-181	-	GGAGUGAUACCACAGGUGAGCAA	23	3173
CFTR-W1282X-182	-	UGGAGUGAUACCACAGGUGAGCAA	24	3174
CFTR-W1282X-183	-	UUCAAUAACUUUGCAACA	18	3175
CFTR-W1282X-184	-	AUUCAAUAACUUUGCAACA	19	3176
CFTR-W1282X-185	-	GAUUCAAUAACUUUGCAACA	20	3177
CFTR-W1282X-186	-	GGAUUCAAUAACUUUGCAACA	21	3178
CFTR-W1282X-187	-	GGGAUUCAAUAACUUUGCAACA	22	3179
CFTR-W1282X-188	-	UGGGAUUCAAUAACUUUGCAACA	23	3180
CFTR-W1282X-189	-	UUGGGAUUCAAUAACUUUGCAACA	24	3181
CFTR-W1282X-190	-	UUUUGAGACUACUGAACA	18	3182
CFTR-W1282X-191	-	UUUUUGAGACUACUGAACA	19	3183
CFTR-W1282X-192	-	UUUUUUGAGACUACUGAACA	20	3184
CFTR-W1282X-193	-	CUUUUUUGAGACUACUGAACA	21	3185
CFTR-W1282X-194	-	GCUUUUUUGAGACUACUGAACA	22	3186
CFTR-W1282X-195	-	AGCUUUUUUGAGACUACUGAACA	23	3187
CFTR-W1282X-196	-	CAGCUUUUUUGAGACUACUGAACA	24	3188
CFTR-W1282X-197	-	UUGGGAAGAACUGGAUCA	18	3189
CFTR-W1282X-198	-	CUUGGGAAGAACUGGAUCA	19	3190
CFTR-W1282X-31	-	UCUUGGGAAGAACUGGAUCA	20	3023
CFTR-W1282X-199	-	CUCUUGGGAAGAACUGGAUCA	21	3191
CFTR-W1282X-200	-	CCUCUUGGGAAGAACUGGAUCA	22	3192
CFTR-W1282X-201	-	GCCUCUUGGGAAGAACUGGAUCA	23	3193
CFTR-W1282X-202	-	GGCCUCUUGGGAAGAACUGGAUCA	24	3194
CFTR-W1282X-203	-	CAUGGUACCUAUAUGUCA	18	3195
CFTR-W1282X-204	-	GCAUGGUACCUAUAUGUCA	19	3196
CFTR-W1282X-205	-	GGCAUGGUACCUAUAUGUCA	20	3197
CFTR-W1282X-206	-	UGGCAUGGUACCUAUAUGUCA	21	3198
CFTR-W1282X-207	-	AUGGCAUGGUACCUAUAUGUCA	22	3199
CFTR-W1282X-208	-	UAUGGCAUGGUACCUAUAUGUCA	23	3200
CFTR-W1282X-209	-	UUAUGGCAUGGUACCUAUAUGUCA	24	3201
CFTR-W1282X-210	-	GAGACUACUGAACACUGA	18	3202
CFTR-W1282X-211	-	UGAGACUACUGAACACUGA	19	3203
CFTR-W1282X-32	-	UUGAGACUACUGAACACUGA	20	3024
CFTR-W1282X-212	-	UUUGAGACUACUGAACACUGA	21	3204
CFTR-W1282X-213	-	UUUUGAGACUACUGAACACUGA	22	3205
CFTR-W1282X-214	-	UUUUUGAGACUACUGAACACUGA	23	3206
CFTR-W1282X-215	-	UUUUUUGAGACUACUGAACACUGA	24	3207
CFTR-W1282X-216	-	AUAACUUUGCAACAGUGA	18	3208
CFTR-W1282X-217	-	AAUAACUUUGCAACAGUGA	19	3209
CFTR-W1282X-58	-	CAAUAACUUUGCAACAGUGA	20	3050
CFTR-W1282X-218	-	UCAAUAACUUUGCAACAGUGA	21	3210
CFTR-W1282X-219	-	UUCAAUAACUUUGCAACAGUGA	22	3211
CFTR-W1282X-220	-	AUUCAAUAACUUUGCAACAGUGA	23	3212
CFTR-W1282X-221	-	GAUUCAAUAACUUUGCAACAGUGA	24	3213
CFTR-W1282X-222	-	UCAGCUUUUUUGAGACUA	18	3214
CFTR-W1282X-223	-	AUCAGCUUUUUUGAGACUA	19	3215
CFTR-W1282X-224	-	UAUCAGCUUUUUUGAGACUA	20	3216
CFTR-W1282X-225	-	UUAUCAGCUUUUUUGAGACUA	21	3217
CFTR-W1282X-226	-	GUUAUCAGCUUUUUUGAGACUA	22	3218
CFTR-W1282X-227	-	UGUUAUCAGCUUUUUUGAGACUA	23	3219
CFTR-W1282X-228	-	UUGUUAUCAGCUUUUUUGAGACUA	24	3220
CFTR-W1282X-229	-	UGAGCAAAAGGACUUAGC	18	3221
CFTR-W1282X-230	-	GUGAGCAAAAGGACUUAGC	19	3222
CFTR-W1282X-231	-	GGUGAGCAAAAGGACUUAGC	20	3223
CFTR-W1282X-232	-	AGGUGAGCAAAAGGACUUAGC	21	3224
CFTR-W1282X-233	-	CAGGUGAGCAAAAGGACUUAGC	22	3225
CFTR-W1282X-234	-	ACAGGUGAGCAAAAGGACUUAGC	23	3226
CFTR-W1282X-235	-	CACAGGUGAGCAAAAGGACUUAGC	24	3227
CFTR-W1282X-236	-	CUUGGGAAGAACUGGAUC	18	3228
CFTR-W1282X-237	-	UCUUGGGAAGAACUGGAUC	19	3229
CFTR-W1282X-39	-	CUCUUGGGAAGAACUGGAUC	20	3031
CFTR-W1282X-238	-	CCUCUUGGGAAGAACUGGAUC	21	3230
CFTR-W1282X-239	-	GCCUCUUGGGAAGAACUGGAUC	22	3231
CFTR-W1282X-240	-	GGCCUCUUGGGAAGAACUGGAUC	23	3232
CFTR-W1282X-241	-	GGGCCUCUUGGGAAGAACUGGAUC	24	3233
CFTR-W1282X-242	-	UAUUUGAUACUUGUACUC	18	3234
CFTR-W1282X-243	-	CUAUUUGAUACUUGUACUC	19	3235
CFTR-W1282X-244	-	GCUAUUUGAUACUUGUACUC	20	3236
CFTR-W1282X-245	-	UGCUAUUUGAUACUUGUACUC	21	3237
CFTR-W1282X-246	-	CUGCUAUUUGAUACUUGUACUC	22	3238
CFTR-W1282X-247	-	ACUGCUAUUUGAUACUUGUACUC	23	3239
CFTR-W1282X-248	-	UACUGCUAUUUGAUACUUGUACUC	24	3240
CFTR-W1282X-249	-	ACCUUAUAGGUGGGCCUC	18	3241
CFTR-W1282X-250	-	UACCUUAUAGGUGGGCCUC	19	3242
CFTR-W1282X-251	-	UUACCUUAUAGGUGGGCCUC	20	3243
CFTR-W1282X-252	-	UUUACCUUAUAGGUGGGCCUC	21	3244
CFTR-W1282X-253	-	UUUUACCUUAUAGGUGGGCCUC	22	3245
CFTR-W1282X-254	-	CUUUUACCUUAUAGGUGGGCCUC	23	3246
CFTR-W1282X-255	-	ACUUUUACCUUAUAGGUGGGCCUC	24	3247
CFTR-W1282X-256	-	CCAGAUCGAUGGUGUGUC	18	3248
CFTR-W1282X-257	-	UCCAGAUCGAUGGUGUGUC	19	3249
CFTR-W1282X-258	-	AUCCAGAUCGAUGGUGUGUC	20	3250
CFTR-W1282X-259	-	AAUCCAGAUCGAUGGUGUGUC	21	3251
CFTR-W1282X-260	-	AAAUCCAGAUCGAUGGUGUGUC	22	3252
CFTR-W1282X-261	-	GAAAUCCAGAUCGAUGGUGUGUC	23	3253
CFTR-W1282X-262	-	AGAAAUCCAGAUCGAUGGUGUGUC	24	3254
CFTR-W1282X-263	-	GACUACUGAACACUGAAG	18	3255
CFTR-W1282X-264	-	AGACUACUGAACACUGAAG	19	3256
CFTR-W1282X-265	-	GAGACUACUGAACACUGAAG	20	3257
CFTR-W1282X-266	-	UGAGACUACUGAACACUGAAG	21	3258
CFTR-W1282X-267	-	UUGAGACUACUGAACACUGAAG	22	3259
CFTR-W1282X-268	-	UUUGAGACUACUGAACACUGAAG	23	3260
CFTR-W1282X-269	-	UUUUGAGACUACUGAACACUGAAG	24	3261
CFTR-W1282X-270	-	UUUGGAGUGAUACCACAG	18	3262
CFTR-W1282X-271	-	CUUUGGAGUGAUACCACAG	19	3263
CFTR-W1282X-272	-	CCUUUGGAGUGAUACCACAG	20	3264
CFTR-W1282X-273	-	GCCUUUGGAGUGAUACCACAG	21	3265
CFTR-W1282X-274	-	AGCCUUUGGAGUGAUACCACAG	22	3266
CFTR-W1282X-275	-	AAGCCUUUGGAGUGAUACCACAG	23	3267
CFTR-W1282X-276	-	AAAGCCUUUGGAGUGAUACCACAG	24	3268
CFTR-W1282X-277	-	AUCACUUUUACCUUAUAG	18	3269
CFTR-W1282X-278	-	CAUCACUUUUACCUUAUAG	19	3270
CFTR-W1282X-279	-	CCAUCACUUUUACCUUAUAG	20	3271
CFTR-W1282X-280	-	CCCAUCACUUUUACCUUAUAG	21	3272
CFTR-W1282X-281	-	UCCCAUCACUUUUACCUUAUAG	22	3273
CFTR-W1282X-282	-	AUCCCAUCACUUUUACCUUAUAG	23	3274
CFTR-W1282X-283	-	GAUCCCAUCACUUUUACCUUAUAG	24	3275
CFTR-W1282X-284	-	GUGCAGUUUUCUCAUAGG	18	3276
CFTR-W1282X-285	-	AGUGCAGUUUUCUCAUAGG	19	3277
CFTR-W1282X-286	-	CAGUGCAGUUUUCUCAUAGG	20	3278
CFTR-W1282X-287	-	CCAGUGCAGUUUUCUCAUAGG	21	3279
CFTR-W1282X-288	-	UCCAGUGCAGUUUUCUCAUAGG	22	3280
CFTR-W1282X-289	-	CUCCAGUGCAGUUUUCUCAUAGG	23	3281
CFTR-W1282X-290	-	UCUCCAGUGCAGUUUUCUCAUAGG	24	3282
CFTR-W1282X-291	-	AUAGGUGGGCCUCUUGGG	18	3283
CFTR-W1282X-292	-	UAUAGGUGGGCCUCUUGGG	19	3284
CFTR-W1282X-293	-	UUAUAGGUGGGCCUCUUGGG	20	3285
CFTR-W1282X-294	-	CUUAUAGGUGGGCCUCUUGGG	21	3286
CFTR-W1282X-295	-	CCUUAUAGGUGGGCCUCUUGGG	22	3287
CFTR-W1282X-296	-	ACCUUAUAGGUGGGCCUCUUGGG	23	3288
CFTR-W1282X-297	-	UACCUUAUAGGUGGGCCUCUUGGG	24	3289
CFTR-W1282X-298	-	UGAGACUACUGAACACUG	18	3290
CFTR-W1282X-299	-	UUGAGACUACUGAACACUG	19	3291
CFTR-W1282X-300	-	UUUGAGACUACUGAACACUG	20	3292
CFTR-W1282X-301	-	UUUUGAGACUACUGAACACUG	21	3293
CFTR-W1282X-302	-	UUUUUGAGACUACUGAACACUG	22	3294
CFTR-W1282X-303	-	UUUUUUGAGACUACUGAACACUG	23	3295
CFTR-W1282X-304	-	CUUUUUUGAGACUACUGAACACUG	24	3296
CFTR-W1282X-305	-	AAUAACUUUGCAACAGUG	18	3297
CFTR-W1282X-306	-	CAAUAACUUUGCAACAGUG	19	3298
CFTR-W1282X-307	-	UCAAUAACUUUGCAACAGUG	20	3299
CFTR-W1282X-308	-	UUCAAUAACUUUGCAACAGUG	21	3300
CFTR-W1282X-309	-	AUUCAAUAACUUUGCAACAGUG	22	3301
CFTR-W1282X-310	-	GAUUCAAUAACUUUGCAACAGUG	23	3302
CFTR-W1282X-311	-	GGAUUCAAUAACUUUGCAACAGUG	24	3303
CFTR-W1282X-312	-	UCUUGGGAAGAACUGGAU	18	3304
CFTR-W1282X-313	-	CUCUUGGGAAGAACUGGAU	19	3305
CFTR-W1282X-314	-	CCUCUUGGGAAGAACUGGAU	20	3306
CFTR-W1282X-315	-	GCCUCUUGGGAAGAACUGGAU	21	3307
CFTR-W1282X-316	-	GGCCUCUUGGGAAGAACUGGAU	22	3308
CFTR-W1282X-317	-	GGGCCUCUUGGGAAGAACUGGAU	23	3309
CFTR-W1282X-318	-	UGGGCCUCUUGGGAAGAACUGGAU	24	3310
CFTR-W1282X-319	-	AACAGUGAAGGAAAGCCU	18	3311
CFTR-W1282X-320	-	CAACAGUGAAGGAAAGCCU	19	3312
CFTR-W1282X-321	-	GCAACAGUGAAGGAAAGCCU	20	3313
CFTR-W1282X-322	-	UGCAACAGUGAAGGAAAGCCU	21	3314
CFTR-W1282X-323	-	UUGCAACAGUGAAGGAAAGCCU	22	3315
CFTR-W1282X-324	-	UUUGCAACAGUGAAGGAAAGCCU	23	3316
CFTR-W1282X-325	-	CUUUGCAACAGUGAAGGAAAGCCU	24	3317
CFTR-W1282X-326	-	CCUUAUAGGUGGGCCUCU	18	3318
CFTR-W1282X-327	-	ACCUUAUAGGUGGGCCUCU	19	3319
CFTR-W1282X-47	-	UACCUUAUAGGUGGGCCUCU	20	3039
CFTR-W1282X-328	-	UUACCUUAUAGGUGGGCCUCU	21	3320
CFTR-W1282X-329	-	UUUACCUUAUAGGUGGGCCUCU	22	3321
CFTR-W1282X-330	-	UUUUACCUUAUAGGUGGGCCUCU	23	3322
CFTR-W1282X-331	-	CUUUUACCUUAUAGGUGGGCCUCU	24	3323
CFTR-W1282X-332	-	CUUAUAGGUGGGCCUCUU	18	3324
CFTR-W1282X-333	-	CCUUAUAGGUGGGCCUCUU	19	3325
CFTR-W1282X-60	-	ACCUUAUAGGUGGGCCUCUU	20	3052
CFTR-W1282X-334	-	UACCUUAUAGGUGGGCCUCUU	21	3326
CFTR-W1282X-335	-	UUACCUUAUAGGUGGGCCUCUU	22	3327
CFTR-W1282X-336	-	UUUACCUUAUAGGUGGGCCUCUU	23	3328
CFTR-W1282X-337	-	UUUUACCUUAUAGGUGGGCCUCUU	24	3329
CFTR-W1282X-338	-	ACUUUGUUAUCAGCUUUU	18	3330
CFTR-W1282X-339	-	UACUUUGUUAUCAGCUUUU	19	3331
CFTR-W1282X-340	-	GUACUUUGUUAUCAGCUUUU	20	3332
CFTR-W1282X-341	-	AGUACUUUGUUAUCAGCUUUU	21	3333
CFTR-W1282X-342	-	GAGUACUUUGUUAUCAGCUUUU	22	3334
CFTR-W1282X-343	-	AGAGUACUUUGUUAUCAGCUUUU	23	3335
CFTR-W1282X-344	-	AAGAGUACUUUGUUAUCAGCUUUU	24	3336

Table 30A provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 30A
1st Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-W1282X-345	-	GGGAAGAGUACUUUGUU	17	3337

Table 30B provides exemplary targeting domains for correcting a mutation (e.g., W1282X) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., W1282X) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table 1 can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 30B
2nd Tier
			Target Site	Seq
gRNA Name	DNA Strand	Targeting Domain	Length	ID
CFTR-W1282X-346	+	CCAAGACACACCAUCGA	17	3338
CFTR-W1282X-347	+	ACCUGUGGUAUCACUCC	17	3339
CFTR-W1282X-348	-	CAGAUCGAUGGUGUGUC	17	3340
CFTR-W1282X-349	+	AUCCCAAGACACACCAUCGA	20	3341
CFTR-W1282X-350	+	CUCACCUGUGGUAUCACUCC	20	3342
CFTR-W1282X-258	-	AUCCAGAUCGAUGGUGUGUC	20	3250
CFTR-W1282X-351	-	UCAGGGAAGAGUACUUUGUU	20	3343

Table 31A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 31A
1st Tier
			Tar-
	DNA		get	Seq
			Site
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-1	+	GUAAGGCUGCCGUCCGA	17	1282
CFTR-3272-2	-	GGAAAUAUUUCACAGGC	17	1283
CFTR-3272-3	+	GUAAAUUCAGAGCUUUG	17	1284
CFTR-3272-4	-	GGACACUUCGUGCCUUCGGA	20	1285
CFTR-3272-5	+	GGAACCAGCGCAGUGUUGAC	20	1286
CFTR-3272-6	+	GUAACAAGAUGAGUGAAAAU	20	1287

Table 31B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 31B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-7	-	CUUGUUACAAGCUUAAA	17	1288
CFTR-3272-8	-	CAUAUCUAUUCAAAGAA	17	1289
CFTR-3272-9	+	UACUUGGCUACCAGAGA	17	1290
CFTR-3272-10	-	CACUUCGUGCCUUCGGA	17	1291
CFTR-3272-11	-	CAAGCUUAAAAGGACUA	17	1292
CFTR-3272-12	-	AUUUACAUACUGCCAAC	17	1293
CFTR-3272-13	+	AAAGCUUUUUUUCACAC	17	1294
CFTR-3272-14	-	CUAUGGAAAUAUUUCAC	17	1295
CFTR-3272-15	+	ACCAGCGCAGUGUUGAC	17	1296
CFTR-3272-16	-	ACCUGUCAACACUGCGC	17	1297
CFTR-3272-17	-	CUAAUUUAGUCUUUUUC	17	1298
CFTR-3272-18	+	CAUAUCACAAAUGUCAU	17	1299
CFTR-3272-19	+	ACUUGGCUACCAGAGAU	17	1300
CFTR-3272-20	+	UACCCUCUUUUUUUACU	17	1301
CFTR-3272-21	+	CAGGUACAAGAACCAGU	17	1302
CFTR-3272-22	-	UGGACACUUCGUGCCUU	17	1303
CFTR-3272-23	-	CAUCUUGUUACAAGCUUAAA	20	1304
CFTR-3272-24	-	AAUCAUAUCUAUUCAAAGAA	20	1305
CFTR-3272-25	+	UUUUACUUGGCUACCAGAGA	20	1306
CFTR-3272-26	+	AAAGUAAGGCUGCCGUCCGA	20	1307
CFTR-3272-27	-	UUACAAGCUUAAAAGGACUA	20	1308
CFTR-3272-28	+	UGGAACAGAGUUUCAAAGUA	20	1309
CFTR-3272-29	-	UGAAUUUACAUACUGCCAAC	20	1310
CFTR-3272-30	+	UAAAAAGCUUUUUUUCACAC	20	1311
CFTR-3272-31	-	UUUCUAUGGAAAUAUUUCAC	20	1312
CFTR-3272-32	-	UGUACCUGUCAACACUGCGC	20	1313
CFTR-3272-33	-	UAUGGAAAUAUUUCACAGGC	20	1314
CFTR-3272-34	-	UGGUAGCCAAGUAAAAAAAG	20	1315
CFTR-3272-35	+	UAUGUAAAUUCAGAGCUUUG	20	1316
CFTR-3272-36	+	AAUCAUAUCACAAAUGUCAU	20	1317
CFTR-3272-37	+	UUUACUUGGCUACCAGAGAU	20	1318
CFTR-3272-38	+	AGUUACCCUCUUUUUUUACU	20	1319
CFTR-3272-39	+	UGACAGGUACAAGAACCAGU	20	1320
CFTR-3272-40	-	CUAUGGACACUUCGUGCCUU	20	1321

Table 31C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 31C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-	-	GGUAGCCAAGUAAAAAAAGA	20	1322
41
CFTR-3272-	-	GUUAUUUGCAGUGUUUUCUA	20	1323
42

Table 31D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 31D
4th Tier
			Target Site	Seq
gRNA Name	DNA Strand	Targeting Domain	Length	ID
CFTR-3272-43	-	AGCCAAGUAAAAAAAGA	17	1324
CFTR-3272-44	-	AUUUGCAGUGUUUUCUA	17	1325
CFTR-3272-45	+	AACAGAGUUUCAAAGUA	17	1326
CFTR-3272-46	-	UAGCCAAGUAAAAAAAG	17	1327
CFTR-3272-47	+	ACAAGAUGAGUGAAAAU	17	1328
CFTR-3272-48	-	AUUCUAAUUUAGUCUUUUUC	20	1329

Table 32A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 32A
1st Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-49	+	GUCCUUUUAAGCUUGUAACAAG	22	1330
CFTR-3272-50	+	GUACCUGAAAAAGACUAAAU	20	1331
CFTR-3272-51	-	GUCAACACUGCGCUGGUUCCAAAU	24	1332

Table 32B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 32B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3272-52	+	UUUUAAGCUUGUAACAAG	18	1333
CFTR-3272-53	+	CUUUUAAGCUUGUAACAAG	19	1334
CFTR-3272-54	+	CCUUUUAAGCUUGUAACAAG	20	1335
CFTR-3272-55	+	UCCUUUUAAGCUUGUAACAAG	21	1336
CFTR-3272-56	+	AGUCCUUUUAAGCUUGUAACAAG	23	1337
CFTR-3272-57	+	UAGUCCUUUUAAGCUUGUAACAAG	24	1338
CFTR-3272-58	+	ACCUGAAAAAGACUAAAU	18	1339
CFTR-3272-59	+	UACCUGAAAAAGACUAAAU	19	1340
CFTR-3272-60	+	UGUACCUGAAAAAGACUAAAU	21	1341
CFTR-3272-61	+	UUGUACCUGAAAAAGACUAAAU	22	1342
CFTR-3272-62	+	CUUGUACCUGAAAAAGACUAAAU	23	1343
CFTR-3272-63	+	UCUUGUACCUGAAAAAGACUAAAU	24	1344
CFTR-3272-64	+	UCACACUGGUGCCAUUCU	18	1345
CFTR-3272-65	+	UUCACACUGGUGCCAUUCU	19	1346
CFTR-3272-66	+	UUUCACACUGGUGCCAUUCU	20	1347
CFTR-3272-67	+	UUUUCACACUGGUGCCAUUCU	21	1348
CFTR-3272-68	+	UUUUUCACACUGGUGCCAUUCU	22	1349
CFTR-3272-69	+	UUUUUUCACACUGGUGCCAUUCU	23	1350
CFTR-3272-70	+	UUUUUUUCACACUGGUGCCAUUCU	24	1351
CFTR-3272-71	-	ACAAAUCAUAUCUAUUCA	18	1352
CFTR-3272-72	-	AACAAAUCAUAUCUAUUCA	19	1353
CFTR-3272-73	-	UAACAAAUCAUAUCUAUUCA	20	1354
CFTR-3272-74	-	AUAACAAAUCAUAUCUAUUCA	21	1355
CFTR-3272-75	-	AAUAACAAAUCAUAUCUAUUCA	22	1356
CFTR-3272-76	-	AAAUAACAAAUCAUAUCUAUUCA	23	1357
CFTR-3272-77	-	AAAAUAACAAAUCAUAUCUAUUCA	24	1358
CFTR-3272-78	-	UGGAAAUAUUUCACAGGC	18	1359
CFTR-3272-79	-	AUGGAAAUAUUUCACAGGC	19	1360
CFTR-3272-33	-	UAUGGAAAUAUUUCACAGGC	20	1314
CFTR-3272-80	-	ACUGCGCUGGUUCCAAAU	18	1361
CFTR-3272-81	-	CACUGCGCUGGUUCCAAAU	19	1362
CFTR-3272-82	-	ACACUGCGCUGGUUCCAAAU	20	1363
CFTR-3272-83	-	AACACUGCGCUGGUUCCAAAU	21	1364
CFTR-3272-84	-	CAACACUGCGCUGGUUCCAAAU	22	1365
CFTR-3272-85	-	UCAACACUGCGCUGGUUCCAAAU	23	1366
CFTR-3272-86	-	ACUCUGUUCCACAAAGCU	18	1367
CFTR-3272-87	-	AACUCUGUUCCACAAAGCU	19	1368
CFTR-3272-88	-	AAACUCUGUUCCACAAAGCU	20	1369

Table 32C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 32C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3272-89	+	AUUCAGAGCUUUGUGGAA	18	1374
CFTR-3272-90	+	AAUUCAGAGCUUUGUGGAA	19	1375
CFTR-3272-91	+	AAAUUCAGAGCUUUGUGGAA	20	1376
CFTR-3272-92	+	UAAAUUCAGAGCUUUGUGGAA	21	1377
CFTR-3272-93	+	GUAAAUUCAGAGCUUUGUGGAA	22	1370
CFTR-3272-94	+	UGUAAAUUCAGAGCUUUGUGGAA	23	1378
CFTR-3272-95	+	AUGUAAAUUCAGAGCUUUGUGGAA	24	1379
CFTR-3272-96	+	UGAUUUGUUAUUUUAUUA	18	1380
CFTR-3272-97	+	AUGAUUUGUUAUUUUAUUA	19	1381
CFTR-3272-98	+	UAUGAUUUGUUAUUUUAUUA	20	1382
CFTR-3272-99	+	AUAUGAUUUGUUAUUUUAUUA	21	1383
CFTR-3272-100	+	GAUAUGAUUUGUUAUUUUAUUA	22	1371
CFTR-3272-101	+	AGAUAUGAUUUGUUAUUUUAUUA	23	1384
CFTR-3272-102	+	UAGAUAUGAUUUGUUAUUUUAUUA	24	1385
CFTR-3272-103	−	GGUAGCCAAGUAAAAAAA	18	1372
CFTR-3272-104	−	UGGUAGCCAAGUAAAAAAA	19	1386
CFTR-3272-105	−	CUGGUAGCCAAGUAAAAAAA	20	1387
CFTR-3272-106	−	UCUGGUAGCCAAGUAAAAAAA	21	1388
CFTR-3272-107	−	CUCUGGUAGCCAAGUAAAAAAA	22	1389
CFTR-3272-108	−	UCUCUGGUAGCCAAGUAAAAAAA	23	1390
CFTR-3272-109	−	AUCUCUGGUAGCCAAGUAAAAAAA	24	1391
CFTR-3272-110	−	CUAUGGAAAUAUUUCACAGGC	21	1392
CFTR-3272-111	−	UCUAUGGAAAUAUUUCACAGGC	22	1393
CFTR-3272-112	−	UUCUAUGGAAAUAUUUCACAGGC	23	1394
CFTR-3272-113	−	UUUCUAUGGAAAUAUUUCACAGGC	24	1395
CFTR-3272-114	−	GAAACUCUGUUCCACAAAGCU	21	1373
CFTR-3272-115	−	UGAAACUCUGUUCCACAAAGCU	22	1396
CFTR-3272-116	−	UUGAAACUCUGUUCCACAAAGCU	23	1397
CFTR-3272-117	−	UUUGAAACUCUGUUCCACAAAGCU	24	1398

Table 32D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 32D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3272-118	+	UAACAAGAUGAGUGAAAA	18	1399
CFTR-3272-119	+	GUAACAAGAUGAGUGAAAA	19	1400
CFTR-3272-120	+	UGUAACAAGAUGAGUGAAAA	20	1401
CFTR-3272-121	+	UUGUAACAAGAUGAGUGAAAA	21	1402
CFTR-3272-122	+	CUUGUAACAAGAUGAGUGAAAA	22	1403
CFTR-3272-123	+	GCUUGUAACAAGAUGAGUGAAAA	23	1404
CFTR-3272-124	+	AGCUUGUAACAAGAUGAGUGAAAA	24	1405
CFTR-3272-125	+	GCCUGUGAAAUAUUUCCA	18	1406
CFTR-3272-126	+	UGCCUGUGAAAUAUUUCCA	19	1407
CFTR-3272-127	+	CUGCCUGUGAAAUAUUUCCA	20	1408
CFTR-3272-128	+	CCUGCCUGUGAAAUAUUUCCA	21	1409
CFTR-3272-129	+	UCCUGCCUGUGAAAUAUUUCCA	22	1410
CFTR-3272-130	+	CUCCUGCCUGUGAAAUAUUUCCA	23	1411
CFTR-3272-131	+	ACUCCUGCCUGUGAAAUAUUUCCA	24	1412
CFTR-3272-132	+	UUACUUGGCUACCAGAGA	18	1413
CFTR-3272-133	+	UUUACUUGGCUACCAGAGA	19	1414
CFTR-3272-25	+	UUUUACUUGGCUACCAGAGA	20	1306
CFTR-3272-134	+	UUUUUACUUGGCUACCAGAGA	21	1415
CFTR-3272-135	+	UUUUUUACUUGGCUACCAGAGA	22	1416
CFTR-3272-136	+	UUUUUUUACUUGGCUACCAGAGA	23	1417
CFTR-3272-137	+	CUUUUUUUACUUGGCUACCAGAGA	24	1418
CFTR-3272-138	+	AAGCUUGUAACAAGAUGA	18	1419
CFTR-3272-139	+	UAAGCUUGUAACAAGAUGA	19	1420
CFTR-3272-140	+	UUAAGCUUGUAACAAGAUGA	20	1421
CFTR-3272-141	+	UUUAAGCUUGUAACAAGAUGA	21	1422
CFTR-3272-142	+	UUUUAAGCUUGUAACAAGAUGA	22	1423
CFTR-3272-143	+	CUUUUAAGCUUGUAACAAGAUGA	23	1424
CFTR-3272-144	+	CCUUUUAAGCUUGUAACAAGAUGA	24	1425
CFTR-3272-145	+	CUUUUUUUACUUGGCUAC	18	1426
CFTR-3272-146	+	UCUUUUUUUACUUGGCUAC	19	1427
CFTR-3272-147	+	CUCUUUUUUUACUUGGCUAC	20	1428
CFTR-3272-148	+	CCUCUUUUUUUACUUGGCUAC	21	1429
CFTR-3272-149	+	CCCUCUUUUUUUACUUGGCUAC	22	1430
CFTR-3272-150	+	ACCCUCUUUUUUUACUUGGCUAC	23	1431
CFTR-3272-151	+	UACCCUCUUUUUUUACUUGGCUAC	24	1432
CFTR-3272-152	+	CGCAGUGUUGACAGGUAC	18	1433
CFTR-3272-153	+	GCGCAGUGUUGACAGGUAC	19	1434
CFTR-3272-154	+	AGCGCAGUGUUGACAGGUAC	20	1435
CFTR-3272-155	+	CAGCGCAGUGUUGACAGGUAC	21	1436
CFTR-3272-156	+	CCAGCGCAGUGUUGACAGGUAC	22	1437
CFTR-3272-157	+	ACCAGCGCAGUGUUGACAGGUAC	23	1438
CFTR-3272-158	+	AACCAGCGCAGUGUUGACAGGUAC	24	1439
CFTR-3272-159	+	UUUCAUAAUAUCUUGUAC	18	1440
CFTR-3272-160	+	AUUUCAUAAUAUCUUGUAC	19	1441
CFTR-3272-161	+	AAUUUCAUAAUAUCUUGUAC	20	1442
CFTR-3272-162	+	UAAUUUCAUAAUAUCUUGUAC	21	1443
CFTR-3272-163	+	GUAAUUUCAUAAUAUCUUGUAC	22	1444
CFTR-3272-164	+	UGUAAUUUCAUAAUAUCUUGUAC	23	1445
CFTR-3272-165	+	AUGUAAUUUCAUAAUAUCUUGUAC	24	1446
CFTR-3272-166	+	AGGCUGCCGUCCGAAGGC	18	1447
CFTR-3272-167	+	AAGGCUGCCGUCCGAAGGC	19	1448
CFTR-3272-168	+	UAAGGCUGCCGUCCGAAGGC	20	1449
CFTR-3272-169	+	GUAAGGCUGCCGUCCGAAGGC	21	1450
CFTR-3272-170	+	AGUAAGGCUGCCGUCCGAAGGC	22	1451
CFTR-3272-171	+	AAGUAAGGCUGCCGUCCGAAGGC	23	1452
CFTR-3272-172	+	AAAGUAAGGCUGCCGUCCGAAGGC	24	1453
CFTR-3272-173	+	UUUACUUGGCUACCAGAG	18	1454
CFTR-3272-174	+	UUUUACUUGGCUACCAGAG	19	1455
CFTR-3272-175	+	UUUUUACUUGGCUACCAGAG	20	1456
CFTR-3272-176	+	UUUUUUACUUGGCUACCAGAG	21	1457
CFTR-3272-177	+	UUUUUUUACUUGGCUACCAGAG	22	1458
CFTR-3272-178	+	CUUUUUUUACUUGGCUACCAGAG	23	1459
CFTR-3272-179	+	UCUUUUUUUACUUGGCUACCAGAG	24	1460
CFTR-3272-180	+	UGUAAAUUCAGAGCUUUG	18	1461
CFTR-3272-181	+	AUGUAAAUUCAGAGCUUUG	19	1462
CFTR-3272-35	+	UAUGUAAAUUCAGAGCUUUG	20	1316
CFTR-3272-182	+	GUAUGUAAAUUCAGAGCUUUG	21	1463
CFTR-3272-183	+	AGUAUGUAAAUUCAGAGCUUUG	22	1464
CFTR-3272-184	+	CAGUAUGUAAAUUCAGAGCUUUG	23	1465
CFTR-3272-185	+	GCAGUAUGUAAAUUCAGAGCUUUG	24	1466
CFTR-3272-186	+	UACUUGGCUACCAGAGAU	18	1467
CFTR-3272-187	+	UUACUUGGCUACCAGAGAU	19	1468
CFTR-3272-37	+	UUUACUUGGCUACCAGAGAU	20	1318
CFTR-3272-188	+	UUUUACUUGGCUACCAGAGAU	21	1469
CFTR-3272-189	+	UUUUUACUUGGCUACCAGAGAU	22	1470
CFTR-3272-190	+	UUUUUUACUUGGCUACCAGAGAU	23	1471
CFTR-3272-191	+	UUUUUUUACUUGGCUACCAGAGAU	24	1472
CFTR-3272-192	+	AAAAUUGGACUCCUGCCU	18	1473
CFTR-3272-193	+	GAAAAUUGGACUCCUGCCU	19	1474
CFTR-3272-194	+	UGAAAAUUGGACUCCUGCCU	20	1475
CFTR-3272-195	+	GUGAAAAUUGGACUCCUGCCU	21	1476
CFTR-3272-196	+	AGUGAAAAUUGGACUCCUGCCU	22	1477
CFTR-3272-197	+	GAGUGAAAAUUGGACUCCUGCCU	23	1478
CFTR-3272-198	+	UGAGUGAAAAUUGGACUCCUGCCU	24	1479
CFTR-3272-199	+	UCAAAGUAAGGCUGCCGU	18	1480
CFTR-3272-200	+	UUCAAAGUAAGGCUGCCGU	19	1481
CFTR-3272-201	+	UUUCAAAGUAAGGCUGCCGU	20	1482
CFTR-3272-202	+	GUUUCAAAGUAAGGCUGCCGU	21	1483
CFTR-3272-203	+	AGUUUCAAAGUAAGGCUGCCGU	22	1484
CFTR-3272-204	+	GAGUUUCAAAGUAAGGCUGCCGU	23	1485
CFTR-3272-205	+	AGAGUUUCAAAGUAAGGCUGCCGU	24	1486
CFTR-3272-206	+	GUUGGCAGUAUGUAAAUU	18	1487
CFTR-3272-207	+	AGUUGGCAGUAUGUAAAUU	19	1488
CFTR-3272-208	+	CAGUUGGCAGUAUGUAAAUU	20	1489
CFTR-3272-209	+	CCAGUUGGCAGUAUGUAAAUU	21	1490
CFTR-3272-210	+	ACCAGUUGGCAGUAUGUAAAUU	22	1491
CFTR-3272-211	+	AACCAGUUGGCAGUAUGUAAAUU	23	1492
CFTR-3272-212	+	GAACCAGUUGGCAGUAUGUAAAUU	24	1493
CFTR-3272-213	+	AUGUAAAUUCAGAGCUUU	18	1494
CFTR-3272-214	+	UAUGUAAAUUCAGAGCUUU	19	1495
CFTR-3272-215	+	GUAUGUAAAUUCAGAGCUUU	20	1496
CFTR-3272-216	+	AGUAUGUAAAUUCAGAGCUUU	21	1497
CFTR-3272-217	+	CAGUAUGUAAAUUCAGAGCUUU	22	1498
CFTR-3272-218	+	GCAGUAUGUAAAUUCAGAGCUUU	23	1499
CFTR-3272-219	+	GGCAGUAUGUAAAUUCAGAGCUUU	24	1500
CFTR-3272-220	−	CUGGUAGCCAAGUAAAAA	18	1501
CFTR-3272-221	−	UCUGGUAGCCAAGUAAAAA	19	1502
CFTR-3272-222	−	CUCUGGUAGCCAAGUAAAAA	20	1503
CFTR-3272-223	−	UCUCUGGUAGCCAAGUAAAAA	21	1504
CFTR-3272-224	−	AUCUCUGGUAGCCAAGUAAAAA	22	1505
CFTR-3272-225	−	CAUCUCUGGUAGCCAAGUAAAAA	23	1506
CFTR-3272-226	−	CCAUCUCUGGUAGCCAAGUAAAAA	24	1507
CFTR-3272-227	−	ACACUGCGCUGGUUCCAA	18	1508
CFTR-3272-228	−	AACACUGCGCUGGUUCCAA	19	1509
CFTR-3272-229	−	CAACACUGCGCUGGUUCCAA	20	1510
CFTR-3272-230	−	UCAACACUGCGCUGGUUCCAA	21	1511
CFTR-3272-231	−	GUCAACACUGCGCUGGUUCCAA	22	1512
CFTR-3272-232	−	UGUCAACACUGCGCUGGUUCCAA	23	1513
CFTR-3272-233	−	CUGUCAACACUGCGCUGGUUCCAA	24	1514
CFTR-3272-234	−	GCUGGUUCCAAAUGAGAA	18	1515
CFTR-3272-235	−	CGCUGGUUCCAAAUGAGAA	19	1516
CFTR-3272-236	−	GCGCUGGUUCCAAAUGAGAA	20	1517
CFTR-3272-237	−	UGCGCUGGUUCCAAAUGAGAA	21	1518
CFTR-3272-238	−	CUGCGCUGGUUCCAAAUGAGAA	22	1519
CFTR-3272-239	−	ACUGCGCUGGUUCCAAAUGAGAA	23	1520
CFTR-3272-240	−	CACUGCGCUGGUUCCAAAUGAGAA	24	1521
CFTR-3272-241	−	AUCUUGUUACAAGCUUAA	18	1522
CFTR-3272-242	−	CAUCUUGUUACAAGCUUAA	19	1523
CFTR-3272-243	−	UCAUCUUGUUACAAGCUUAA	20	1524
CFTR-3272-244	−	CUCAUCUUGUUACAAGCUUAA	21	1525
CFTR-3272-245	−	ACUCAUCUUGUUACAAGCUUAA	22	1526
CFTR-3272-246	−	CACUCAUCUUGUUACAAGCUUAA	23	1527
CFTR-3272-247	−	UCACUCAUCUUGUUACAAGCUUAA	24	1528
CFTR-3272-248	−	UAUUUGCAGUGUUUUCUA	18	1529
CFTR-3272-249	−	UUAUUUGCAGUGUUUUCUA	19	1530
CFTR-3272-42	−	GUUAUUUGCAGUGUUUUCUA	20	1323
CFTR-3272-250	−	UGUUAUUUGCAGUGUUUUCUA	21	1531
CFTR-3272-251	−	AUGUUAUUUGCAGUGUUUUCUA	22	1532
CFTR-3272-252	−	UAUGUUAUUUGCAGUGUUUUCUA	23	1533
CFTR-3272-253	−	UUAUGUUAUUUGCAGUGUUUUCUA	24	1534
CFTR-3272-254	−	AUGGAAAUAUUUCACAGG	18	1535
CFTR-3272-255	−	UAUGGAAAUAUUUCACAGG	19	1536
CFTR-3272-256	−	CUAUGGAAAUAUUUCACAGG	20	1537
CFTR-3272-257	−	UCUAUGGAAAUAUUUCACAGG	21	1538
CFTR-3272-258	−	UUCUAUGGAAAUAUUUCACAGG	22	1539
CFTR-3272-259	−	UUUCUAUGGAAAUAUUUCACAGG	23	1540
CFTR-3272-260	−	UUUUCUAUGGAAAUAUUUCACAGG	24	1541
CFTR-3272-261	−	UACAAGCUUAAAAGGACU	18	1542
CFTR-3272-262	−	UUACAAGCUUAAAAGGACU	19	1543
CFTR-3272-263	−	GUUACAAGCUUAAAAGGACU	20	1544
CFTR-3272-264	−	UGUUACAAGCUUAAAAGGACU	21	1545
CFTR-3272-265	−	UUGUUACAAGCUUAAAAGGACU	22	1546
CFTR-3272-266	−	CUUGUUACAAGCUUAAAAGGACU	23	1547
CFTR-3272-267	−	UCUUGUUACAAGCUUAAAAGGACU	24	1548
CFTR-3272-268	−	UCGGACGGCAGCCUUACU	18	1549
CFTR-3272-269	−	UUCGGACGGCAGCCUUACU	19	1550
CFTR-3272-270	−	CUUCGGACGGCAGCCUUACU	20	1551
CFTR-3272-271	−	CCUUCGGACGGCAGCCUUACU	21	1552
CFTR-3272-272	−	GCCUUCGGACGGCAGCCUUACU	22	1553
CFTR-3272-273	−	UGCCUUCGGACGGCAGCCUUACU	23	1554
CFTR-3272-274	−	GUGCCUUCGGACGGCAGCCUUACU	24	1555
CFTR-3272-275	−	UAUGGACACUUCGUGCCU	18	1556
CFTR-3272-276	−	CUAUGGACACUUCGUGCCU	19	1557
CFTR-3272-277	−	ACUAUGGACACUUCGUGCCU	20	1558
CFTR-3272-278	−	GACUAUGGACACUUCGUGCCU	21	1559
CFTR-3272-279	−	GGACUAUGGACACUUCGUGCCU	22	1560
CFTR-3272-280	−	AGGACUAUGGACACUUCGUGCCU	23	1561
CFTR-3272-281	−	AAGGACUAUGGACACUUCGUGCCU	24	1562
CFTR-3272-282	−	UUAUUUGCAGUGUUUUCU	18	1563
CFTR-3272-283	−	GUUAUUUGCAGUGUUUUCU	19	1564
CFTR-3272-284	−	UGUUAUUUGCAGUGUUUUCU	20	1565
CFTR-3272-285	−	AUGUUAUUUGCAGUGUUUUCU	21	1566
CFTR-3272-286	−	UAUGUUAUUUGCAGUGUUUUCU	22	1567
CFTR-3272-287	−	UUAUGUUAUUUGCAGUGUUUUCU	23	1568
CFTR-3272-288	−	UUUAUGUUAUUUGCAGUGUUUUCU	24	1569
CFTR-3272-289	−	UCAAAGAAUGGCACCAGU	18	1570
CFTR-3272-290	−	UUCAAAGAAUGGCACCAGU	19	1571
CFTR-3272-291	−	AUUCAAAGAAUGGCACCAGU	20	1572
CFTR-3272-292	−	UAUUCAAAGAAUGGCACCAGU	21	1573
CFTR-3272-293	−	CUAUUCAAAGAAUGGCACCAGU	22	1574
CFTR-3272-294	−	UCUAUUCAAAGAAUGGCACCAGU	23	1575
CFTR-3272-295	−	AUCUAUUCAAAGAAUGGCACCAGU	24	1576
CFTR-3272-296	−	UUUCAGGUACAAGAUAUU	18	1577
CFTR-3272-297	−	UUUUCAGGUACAAGAUAUU	19	1578
CFTR-3272-298	−	UUUUUCAGGUACAAGAUAUU	20	1579
CFTR-3272-299	−	CUUUUUCAGGUACAAGAUAUU	21	1580
CFTR-3272-300	−	UCUUUUUCAGGUACAAGAUAUU	22	1581
CFTR-3272-301	−	GUCUUUUUCAGGUACAAGAUAUU	23	1582
CFTR-3272-302	−	AGUCUUUUUCAGGUACAAGAUAUU	24	1583

Table 33A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 33A
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3272-303	−	AUGGCACCAGUGUGAAA	17	1584
CFTR-3272-304	+	UGCCAUUCUUUGAAUAG	17	1585
CFTR-3272-305	+	UUGGCAGUAUGUAAAUU	17	1586
CFTR-3272-306	+	AAGUGUCCAUAGUCCUU	17	1587
CFTR-3272-307	−	AGAAUGGCACCAGUGUGAAA	20	1588
CFTR-3272-308	+	UGGUGCCAUUCUUUGAAUAG	20	1589
CFTR-3272-309	+	ACGAAGUGUCCAUAGUCCUU	20	1590

Table 33B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 200 bp from a mutation (e.g., 3272-26->G). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 33B
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3272-310	+	ACAAAUGUCAUUGGUUA	17	1591
CFTR-3272-311	−	AACCAAUGACAUUUGUG	17	1592
CFTR-3272-312	−	UUUUCACUCAUCUUGUU	17	1593
CFTR-3272-313	+	AUCACAAAUGUCAUUGGUUA	20	1594
CFTR-3272-314	−	UUUAACCAAUGACAUUUGUG	20	1595
CFTR-3272-208	+	CAGUUGGCAGUAUGUAAAUU	20	1489
CFTR-3272-315	−	CAAUUUUCACUCAUCUUGUU	20	1596

Table 34A provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 34A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-1	−	GAGUAAGACACCCUGAA	17	3344
CFTR-3849-2	−	GAUUUCUGGAGACCACA	17	3345
CFTR-3849-3	+	GGUUUUAGCUAUUACUC	17	3346
CFTR-3849-4	−	GUAGUUGAAUCAUUCAG	17	3347
CFTR-3849-5	+	GAACUCAGUUUUUAGGU	17	3348
CFTR-3849-6	−	GAAAGGAAAUGUUCUAUUCA	20	3349
CFTR-3849-7	+	GUUUUUAGGUUGGGAAAGAC	20	3350
CFTR-3849-8	+	GCACAUAAUAAUUAGUUUCC	20	3351
CFTR-3849-9	+	GAGAACUCAGUUUUUAGGUU	20	3352
CFTR-3849-10	−	GAAAACACUGACUUAGAUUU	20	3353

Table 34B provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+17kbC->T) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 34B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-11	+	UCUGACACAUUUUUCAA	17	3354
CFTR-3849-12	+	CUUUGGUUUAGCUUUAA	17	3355
CFTR-3849-13	+	UGAAAUUUAGAUCCACA	17	3356
CFTR-3849-14	−	UUGAUCCAACAUUCUCA	17	3357
CFTR-3849-15	−	AGGAAAUGUUCUAUUCA	17	3358
CFTR-3849-16	+	UUUAAUACUGCAACAGA	17	3359
CFTR-3849-17	+	CAGUGAUCUGUUGAAUA	17	3360
CFTR-3849-18	−	AGCAGUUCAAUGAUAUA	17	3361
CFTR-3849-19	−	ACACUGACUUAGAUUUA	17	3362
CFTR-3849-20	+	CUUCUUGUUUAUAUAAC	17	3363
CFTR-3849-21	+	CAAAGGCAAGGAAUCAC	17	3364
CFTR-3849-22	+	UUUAGGUUGGGAAAGAC	17	3365
CFTR-3849-23	−	UGUAUAUAUCACAGUAC	17	3366
CFTR-3849-24	−	CAGAUCACUGAGAAGCC	17	3367
CFTR-3849-25	+	CAUAAUAAUUAGUUUCC	17	3368
CFTR-3849-26	+	CCGGGAUUUGUUUUUCC	17	3369
CFTR-3849-27	+	UUAUAUCAUUGAACUGC	17	3370
CFTR-3849-28	−	CUUAAAAGCUUAUUUGC	17	3371
CFTR-3849-29	−	AUUCUUCAUGAUAAAUC	17	3372
CFTR-3849-30	−	CUUGAUCCAACAUUCUC	17	3373
CFTR-3849-31	+	AUAGAACAUUUCCUUUC	17	3374
CFTR-3849-32	+	ACAUAAUAAUUAGUUUC	17	3375
CFTR-3849-33	+	AAUAUCUAUUUAAUCAG	17	3376
CFTR-3849-34	−	CAACAUUCUCAGGGAGG	17	3377
CFTR-3849-35	−	AUCCAACAUUCUCAGGG	17	3378
CFTR-3849-36	+	AUACAAUAUACCAUAUG	17	3379
CFTR-3849-37	−	CAAUUAUAAUCACCUUG	17	3380
CFTR-3849-38	−	UCUAUCUUGAUAAACAU	17	3381
CFTR-3849-39	−	UAGUUGAAUCAUUCAGU	17	3382
CFTR-3849-40	+	CUCCUCCCUGAGAAUGU	17	3383
CFTR-3849-41	−	AAACAAGAAGACUUUGU	17	3384
CFTR-3849-42	+	AACUCAGUUUUUAGGUU	17	3385
CFTR-3849-43	−	AACAAGAAGACUUUGUU	17	3386
CFTR-3849-44	−	AACACUGACUUAGAUUU	17	3387
CFTR-3849-45	−	UUUAAGGUCUAUACUUU	17	3388
CFTR-3849-46	−	CAUCUGUUGCAGUAUUAAAA	20	3389
CFTR-3849-47	+	UAUUUUCAAGAGACUACAAA	20	3390
CFTR-3849-48	+	AUAUCUGACACAUUUUUCAA	20	3391
CFTR-3849-49	+	AAUCUUUGGUUUAGCUUUAA	20	3392
CFTR-3849-50	−	CUUGAUUUCUGGAGACCACA	20	3393
CFTR-3849-51	+	UGACACAUUUUUCAAAGGCA	20	3394
CFTR-3849-52	−	AUCUUGAUCCAACAUUCUCA	20	3395
CFTR-3849-53	+	CAUUUUAAUACUGCAACAGA	20	3396
CFTR-3849-54	+	UCUCAGUGAUCUGUUGAAUA	20	3397
CFTR-3849-55	−	CUUAAUCAAAAUUCCUCAUA	20	3398
CFTR-3849-56	−	ACCAGCAGUUCAAUGAUAUA	20	3399
CFTR-3849-57	−	AAAACACUGACUUAGAUUUA	20	3400
CFTR-3849-58	−	AGAUAUUUGAUAGUACUUUA	20	3401
CFTR-3849-59	+	UUUCAAAGGCAAGGAAUCAC	20	3402
CFTR-3849-60	−	UAUUGUAUAUAUCACAGUAC	20	3403
CFTR-3849-61	−	CAACAGAUCACUGAGAAGCC	20	3404
CFTR-3849-62	−	AAGCCUGGAAAAACAAAUCC	20	3405
CFTR-3849-63	+	UUUCCGGGAUUUGUUUUUCC	20	3406
CFTR-3849-64	+	UCCUUAUAUCAUUGAACUGC	20	3407
CFTR-3849-65	−	UGUCUUAAAAGCUUAUUUGC	20	3408
CFTR-3849-66	+	AAAGGUUUUAGCUAUUACUC	20	3409
CFTR-3849-67	−	UAUCUUGAUCCAACAUUCUC	20	3410
CFTR-3849-68	−	UGACUUGUCAUCUUGAUUUC	20	3411
CFTR-3849-69	+	UGAAUAGAACAUUUCCUUUC	20	3412
CFTR-3849-70	+	UUGGGAAAGACUGGAUGAAG	20	3413
CFTR-3849-71	+	UCAAAUAUCUAUUUAAUCAG	20	3414
CFTR-3849-72	−	AAAGUAGUUGAAUCAUUCAG	20	3415
CFTR-3849-73	−	AUCCAACAUUCUCAGGGAGG	20	3416
CFTR-3849-74	−	UUGAUCCAACAUUCUCAGGG	20	3417
CFTR-3849-75	−	AUUCAAUUAUAAUCACCUUG	20	3418
CFTR-3849-76	−	AUGUCUUAAAAGCUUAUUUG	20	3419
CFTR-3849-77	−	UUUUCUAUCUUGAUAAACAU	20	3420
CFTR-3849-78	+	AGAGAACUCAGUUUUUAGGU	20	3421
CFTR-3849-79	+	CACCUCCUCCCUGAGAAUGU	20	3422
CFTR-3849-80	−	UAUAAACAAGAAGACUUUGU	20	3423
CFTR-3849-81	+	AAGUUAAACAGUGUUGAAUU	20	3424
CFTR-3849-82	−	AUAAACAAGAAGACUUUGUU	20	3425
CFTR-3849-83	+	AACAAAGCAAACAAGUAUUU	20	3426
CFTR-3849-84	−	UACUUUAAGGUCUAUACUUU	20	3427

Table 34C provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 34C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-85	+	GGAAAGACUGGAUGAAG	17	3428
CFTR-3849-86	+	GGCAAUUUGUAAAUCUU	17	3429
CFTR-3849-87	−	GUAUUUUUUUCUGAAGAAAA	20	3430
CFTR-3849-88	−	GGUGAGUAAGACACCCUGAA	20	3431
CFTR-3849-89	+	GAAUAGAACAUUUCCUUUCA	20	3432
CFTR-3849-90	+	GGCACAUAAUAAUUAGUUUC	20	3433

Table 34D provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+35kbC->T). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 34D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-91	−	UUUUUUUCUGAAGAAAA	17	3434
CFTR-3849-92	+	UUUAUCAAGAUAGAAAA	17	3435
CFTR-3849-93	−	CUGUUGCAGUAUUAAAA	17	3436
CFTR-3849-94	+	UUUCAAGAGACUACAAA	17	3437
CFTR-3849-95	−	AUUUUUUUCUGAAGAAA	17	3438
CFTR-3849-96	+	CACAUUUUUCAAAGGCA	17	3439
CFTR-3849-97	−	AAUUUAUAAGAAUAUCA	17	3440
CFTR-3849-98	+	UAGAACAUUUCCUUUCA	17	3441
CFTR-3849-99	−	AAUCAAAAUUCCUCAUA	17	3442
CFTR-3849-100	−	UAUUUGAUAGUACUUUA	17	3443
CFTR-3849-101	−	CCUGGAAAAACAAAUCC	17	3444
CFTR-3849-102	−	CUUGUCAUCUUGAUUUC	17	3445
CFTR-3849-103	−	UUUUUUCUGAAGAAAAG	17	3446
CFTR-3849-104	+	UAUUUUUCAUUACCUUG	17	3447
CFTR-3849-105	−	UCUUAAAAGCUUAUUUG	17	3448
CFTR-3849-106	+	UUAUCAAGAUAGAAAAU	17	3449
CFTR-3849-107	+	UUAAACAGUGUUGAAUU	17	3450
CFTR-3849-108	+	AAAGCAAACAAGUAUUU	17	3451
CFTR-3849-109	+	UAGAGAACUCAGUUUUU	17	3452
CFTR-3849-110	+	AUGUUUAUCAAGAUAGAAAA	20	3453
CFTR-3849-111	−	AGUAUUUUUUUCUGAAGAAA	20	3454
CFTR-3849-112	+	AACUGAAAUUUAGAUCCACA	20	3455
CFTR-3849-113	−	AAUAAUUUAUAAGAAUAUCA	20	3456
CFTR-3849-114	+	AGUCUUCUUGUUUAUAUAAC	20	3457
CFTR-3849-115	−	UAUUUUUUUCUGAAGAAAAG	20	3458
CFTR-3849-116	+	UAUAUACAAUAUACCAUAUG	20	3459
CFTR-3849-117	+	AAUUAUUUUUCAUUACCUUG	20	3460
CFTR-3849-118	+	UGUUUAUCAAGAUAGAAAAU	20	3461
CFTR-3849-119	−	AAGUAGUUGAAUCAUUCAGU	20	3462
CFTR-3849-120	+	AGAGGCAAUUUGUAAAUCUU	20	3463
CFTR-3849-121	+	UUUUAGAGAACUCAGUUUUU	20	3464

Table 35A provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 35A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-122	+	GUUUAUCAAGAUAGAAAA	18	3465
CFTR-3849-123	+	GAUCCACAAGGUGAUUAUAA	20	3466
CFTR-3849-124	+	GAAUAUGCUGCUUAUACCCA	20	3467
CFTR-3849-125	+	GACACAUUUUUCAAAGGCA	19	3468
CFTR-3849-126	+	GUUUUUAGGUUGGGAAAGA	19	3469
CFTR-3849-127	+	GCUGUAAUUGCAUUGUACC	19	3470
CFTR-3849-128	+	GCUAGCUGUAAUUGCAUUGUACC	23	3471
CFTR-3849-129	+	GUGAUCUGUUGAAUAAGGC	19	3472
CFTR-3849-130	+	GCACAUAAUAAUUAGUUUC	19	3473
CFTR-3849-90	+	GGCACAUAAUAAUUAGUUUC	20	3433
CFTR-3849-131	+	GCACCUCCUCCCUGAGAAUG	20	3474
CFTR-3849-132	+	GAUUAAGUCCAGAUUUAUCAUG	22	3475
CFTR-3849-133	+	GAUAUAUACAAUAUACCAUAUG	22	3476
CFTR-3849-134	+	GUGAUAUAUACAAUAUACCAUAUG	24	3477
CFTR-3849-135	+	GUUGAAAGUUAAACAGUG	18	3478
CFTR-3849-136	+	GUGUUUGUGCUGAUAUGAU	19	3479
CFTR-3849-137	+	GGUGUUUGUGCUGAUAUGAU	20	3480
CFTR-3849-138	−	GUCUUUCCCAACCUAAAAA	19	3481
CFTR-3849-139	−	GUUCAAUGAUAUAAGGAAAC	20	3482
CFTR-3849-140	−	GCAGUUCAAUGAUAUAAGGAAAC	23	3483
CFTR-3849-141	−	GUAAUGAAAAAUAAUUAC	18	3484
CFTR-3849-142	−	GGUAAUGAAAAAUAAUUAC	19	3485
CFTR-3849-143	−	GAAAUAAUUUAUAAGAAUAUC	21	3486
CFTR-3849-144	−	GAUAAACAUUGGUGUAAAGUAG	22	3487
CFTR-3849-145	−	GUUAUAUAAACAAGAAGACUUUG	23	3488
CFTR-3849-146	−	GAAAACACUGACUUAGAUU	19	3489
CFTR-3849-147	−	GUACUUUAAGGUCUAUACUU	20	3490
CFTR-3849-148	−	GAUAGUACUUUAAGGUCUAUACUU	24	3491
CFTR-3849-149	−	GAUUCAAUUAUAAUCACCUU	20	3492

Table 35B provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 35B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-150	+	UGUUUAUCAAGAUAGAAAA	19	3493
CFTR-3849-110	+	AUGUUUAUCAAGAUAGAAAA	20	3453
CFTR-3849-151	+	UCCACAAGGUGAUUAUAA	18	3494
CFTR-3849-152	+	AUCCACAAGGUGAUUAUAA	19	3495
CFTR-3849-153	+	AUAUGCUGCUUAUACCCA	18	3496
CFTR-3849-154	+	AAUAUGCUGCUUAUACCCA	19	3497
CFTR-3849-155	+	ACACAUUUUUCAAAGGCA	18	3498
CFTR-3849-51	+	UGACACAUUUUUCAAAGGCA	20	3394
CFTR-3849-156	+	CUGACACAUUUUUCAAAGGCA	21	3499
CFTR-3849-157	+	UCUGACACAUUUUUCAAAGGCA	22	3500
CFTR-3849-158	+	AUCUGACACAUUUUUCAAAGGCA	23	3501
CFTR-3849-159	+	UAUCUGACACAUUUUUCAAAGGCA	24	3502
CFTR-3849-160	+	UUUUUAGGUUGGGAAAGA	18	3503
CFTR-3849-161	+	AGUUUUUAGGUUGGGAAAGA	20	3504
CFTR-3849-162	+	CAGUUUUUAGGUUGGGAAAGA	21	3505
CFTR-3849-163	+	UCAGUUUUUAGGUUGGGAAAGA	22	3506
CFTR-3849-164	+	CUCAGUUUUUAGGUUGGGAAAGA	23	3507
CFTR-3849-165	+	ACUCAGUUUUUAGGUUGGGAAAGA	24	3508
CFTR-3849-166	+	CUGUAAUUGCAUUGUACC	18	3509
CFTR-3849-167	+	AGCUGUAAUUGCAUUGUACC	20	3510
CFTR-3849-168	+	UAGCUGUAAUUGCAUUGUACC	21	3511
CFTR-3849-169	+	CUAGCUGUAAUUGCAUUGUACC	22	3512
CFTR-3849-170	+	UGCUAGCUGUAAUUGCAUUGUACC	24	3513
CFTR-3849-171	+	UGAUCUGUUGAAUAAGGC	18	3514
CFTR-3849-172	+	AGUGAUCUGUUGAAUAAGGC	20	3515
CFTR-3849-173	+	CAGUGAUCUGUUGAAUAAGGC	21	3516
CFTR-3849-174	+	UCAGUGAUCUGUUGAAUAAGGC	22	3517
CFTR-3849-175	+	CUCAGUGAUCUGUUGAAUAAGGC	23	3518
CFTR-3849-176	+	UCUCAGUGAUCUGUUGAAUAAGGC	24	3519
CFTR-3849-177	+	CACAUAAUAAUUAGUUUC	18	3520
CFTR-3849-178	+	UGGCACAUAAUAAUUAGUUUC	21	3521
CFTR-3849-179	+	CUGGCACAUAAUAAUUAGUUUC	22	3522
CFTR-3849-180	+	ACUGGCACAUAAUAAUUAGUUUC	23	3523
CFTR-3849-181	+	AACUGGCACAUAAUAAUUAGUUUC	24	3524
CFTR-3849-182	+	ACCUCCUCCCUGAGAAUG	18	3525
CFTR-3849-183	+	CACCUCCUCCCUGAGAAUG	19	3526
CFTR-3849-184	+	UGCACCUCCUCCCUGAGAAUG	21	3527
CFTR-3849-185	+	AUGCACCUCCUCCCUGAGAAUG	22	3528
CFTR-3849-186	+	AAUGCACCUCCUCCCUGAGAAUG	23	3529
CFTR-3849-187	+	CAAUGCACCUCCUCCCUGAGAAUG	24	3530
CFTR-3849-188	+	AAGUCCAGAUUUAUCAUG	18	3531
CFTR-3849-189	+	UAAGUCCAGAUUUAUCAUG	19	3532
CFTR-3849-190	+	UUAAGUCCAGAUUUAUCAUG	20	3533
CFTR-3849-191	+	AUUAAGUCCAGAUUUAUCAUG	21	3534
CFTR-3849-192	+	UGAUUAAGUCCAGAUUUAUCAUG	23	3535
CFTR-3849-193	+	UUGAUUAAGUCCAGAUUUAUCAUG	24	3536
CFTR-3849-194	+	UAUACAAUAUACCAUAUG	18	3537
CFTR-3849-195	+	AUAUACAAUAUACCAUAUG	19	3538
CFTR-3849-116	+	UAUAUACAAUAUACCAUAUG	20	3459
CFTR-3849-196	+	AUAUAUACAAUAUACCAUAUG	21	3539
CFTR-3849-197	+	UGAUAUAUACAAUAUACCAUAUG	23	3540
CFTR-3849-198	+	AGGCUUCUCAGUGAUCUG	18	3541
CFTR-3849-199	+	CAGGCUUCUCAGUGAUCUG	19	3542
CFTR-3849-200	+	CCAGGCUUCUCAGUGAUCUG	20	3543
CFTR-3849-201	+	UCCAGGCUUCUCAGUGAUCUG	21	3544
CFTR-3849-202	+	UUCCAGGCUUCUCAGUGAUCUG	22	3545
CFTR-3849-203	+	UUUCCAGGCUUCUCAGUGAUCUG	23	3546
CFTR-3849-204	+	UUUUCCAGGCUUCUCAGUGAUCUG	24	3547
CFTR-3849-205	+	UGUUGAAAGUUAAACAGUG	19	3548
CFTR-3849-206	+	AUGUUGAAAGUUAAACAGUG	20	3549
CFTR-3849-207	+	UAUGUUGAAAGUUAAACAGUG	21	3550
CFTR-3849-208	+	AUAUGUUGAAAGUUAAACAGUG	22	3551
CFTR-3849-209	+	AAUAUGUUGAAAGUUAAACAGUG	23	3552
CFTR-3849-210	+	UAAUAUGUUGAAAGUUAAACAGUG	24	3553
CFTR-3849-211	+	UGUUUGUGCUGAUAUGAU	18	3554
CFTR-3849-212	+	AGGUGUUUGUGCUGAUAUGAU	21	3555
CFTR-3849-213	+	UAGGUGUUUGUGCUGAUAUGAU	22	3556
CFTR-3849-214	+	UUAGGUGUUUGUGCUGAUAUGAU	23	3557
CFTR-3849-215	+	UUUAGGUGUUUGUGCUGAUAUGAU	24	3558
CFTR-3849-216	+	UCAAUGCACCUCCUCCCU	18	3559
CFTR-3849-217	+	UUCAAUGCACCUCCUCCCU	19	3560
CFTR-3849-218	+	CUUCAAUGCACCUCCUCCCU	20	3561
CFTR-3849-219	+	ACUUCAAUGCACCUCCUCCCU	21	3562
CFTR-3849-220	+	AACUUCAAUGCACCUCCUCCCU	22	3563
CFTR-3849-221	+	UAACUUCAAUGCACCUCCUCCCU	23	3564
CFTR-3849-222	+	AUAACUUCAAUGCACCUCCUCCCU	24	3565
CFTR-3849-223	+	UUAAUGAAACAUAGUAUU	18	3566
CFTR-3849-224	+	AUUAAUGAAACAUAGUAUU	19	3567
CFTR-3849-225	+	UAUUAAUGAAACAUAGUAUU	20	3568
CFTR-3849-226	+	UUAUUAAUGAAACAUAGUAUU	21	3569
CFTR-3849-227	+	AUUAUUAAUGAAACAUAGUAUU	22	3570
CFTR-3849-228	+	AAUUAUUAAUGAAACAUAGUAUU	23	3571
CFTR-3849-229	+	UAAUUAUUAAUGAAACAUAGUAUU	24	3572
CFTR-3849-230	+	CAUGAAUAGAACAUUUCCUUU	21	3573
CFTR-3849-231	+	CCAUGAAUAGAACAUUUCCUUU	22	3574
CFTR-3849-232	+	ACCAUGAAUAGAACAUUUCCUUU	23	3575
CFTR-3849-233	+	UACCAUGAAUAGAACAUUUCCUUU	24	3576
CFTR-3849-234	−	UCUUUCCCAACCUAAAAA	18	3577
CFTR-3849-235	−	AGUCUUUCCCAACCUAAAAA	20	3578
CFTR-3849-236	−	CAGUCUUUCCCAACCUAAAAA	21	3579
CFTR-3849-237	−	CCAGUCUUUCCCAACCUAAAAA	22	3580
CFTR-3849-238	−	UCCAGUCUUUCCCAACCUAAAAA	23	3581
CFTR-3849-239	−	AUCCAGUCUUUCCCAACCUAAAAA	24	3582
CFTR-3849-240	−	AAGUAGUUGAAUCAUUCA	18	3583
CFTR-3849-241	−	AAAGUAGUUGAAUCAUUCA	19	3584
CFTR-3849-242	−	UAAAGUAGUUGAAUCAUUCA	20	3585
CFTR-3849-243	−	AUUGUAUAUAUCACAGUA	18	3586
CFTR-3849-244	−	UAUUGUAUAUAUCACAGUA	19	3587
CFTR-3849-245	−	AUAUUGUAUAUAUCACAGUA	20	3588
CFTR-3849-246	−	UCAAUGAUAUAAGGAAAC	18	3589
CFTR-3849-247	−	UUCAAUGAUAUAAGGAAAC	19	3590
CFTR-3849-248	−	AGUUCAAUGAUAUAAGGAAAC	21	3591
CFTR-3849-249	−	CAGUUCAAUGAUAUAAGGAAAC	22	3592
CFTR-3849-250	−	AGCAGUUCAAUGAUAUAAGGAAAC	24	3593
CFTR-3849-251	−	AGGUAAUGAAAAAUAAUUAC	20	3594
CFTR-3849-252	−	AGAAAUAAUUUAUAAGAAUAUC	22	3595
CFTR-3849-253	−	CAGAAAUAAUUUAUAAGAAUAUC	23	3596
CFTR-3849-254	−	UCAGAAAUAAUUUAUAAGAAUAUC	24	3597
CFTR-3849-255	−	AACAUUGGUGUAAAGUAG	18	3598
CFTR-3849-256	−	AAACAUUGGUGUAAAGUAG	19	3599
CFTR-3849-257	−	UAAACAUUGGUGUAAAGUAG	20	3600
CFTR-3849-258	−	AUAAACAUUGGUGUAAAGUAG	21	3601
CFTR-3849-259	−	UGAUAAACAUUGGUGUAAAGUAG	23	3602
CFTR-3849-260	−	UUGAUAAACAUUGGUGUAAAGUAG	24	3603
CFTR-3849-261	−	UGUUGCAGUAUUAAAAUG	18	3604
CFTR-3849-262	−	CUGUUGCAGUAUUAAAAUG	19	3605
CFTR-3849-263	−	UCUGUUGCAGUAUUAAAAUG	20	3606
CFTR-3849-264	−	AUCUGUUGCAGUAUUAAAAUG	21	3607
CFTR-3849-265	−	CAUCUGUUGCAGUAUUAAAAUG	22	3608
CFTR-3849-266	−	CCAUCUGUUGCAGUAUUAAAAUG	23	3609
CFTR-3849-267	−	UCCAUCUGUUGCAGUAUUAAAAUG	24	3610
CFTR-3849-268	−	AUAAACAAGAAGACUUUG	18	3611
CFTR-3849-269	−	UAUAAACAAGAAGACUUUG	19	3612
CFTR-3849-270	−	AUAUAAACAAGAAGACUUUG	20	3613
CFTR-3849-271	−	UAUAUAAACAAGAAGACUUUG	21	3614
CFTR-3849-272	−	UUAUAUAAACAAGAAGACUUUG	22	3615
CFTR-3849-273	−	AGUUAUAUAAACAAGAAGACUUUG	24	3616
CFTR-3849-274	−	AAAACACUGACUUAGAUU	18	3617
CFTR-3849-275	−	AGAAAACACUGACUUAGAUU	20	3618
CFTR-3849-276	−	UAGAAAACACUGACUUAGAUU	21	3619
CFTR-3849-277	−	UUAGAAAACACUGACUUAGAUU	22	3620
CFTR-3849-278	−	AUUAGAAAACACUGACUUAGAUU	23	3621
CFTR-3849-279	−	UAUUAGAAAACACUGACUUAGAUU	24	3622
CFTR-3849-280	−	ACUUUAAGGUCUAUACUU	18	3623
CFTR-3849-281	−	UACUUUAAGGUCUAUACUU	19	3624
CFTR-3849-282	−	AGUACUUUAAGGUCUAUACUU	21	3625
CFTR-3849-283	−	UAGUACUUUAAGGUCUAUACUU	22	3626
CFTR-3849-284	−	AUAGUACUUUAAGGUCUAUACUU	23	3627
CFTR-3849-285	−	UUCAAUUAUAAUCACCUU	18	3628
CFTR-3849-286	−	AUUCAAUUAUAAUCACCUU	19	3629
CFTR-3849-287	−	AGAUUCAAUUAUAAUCACCUU	21	3630
CFTR-3849-288	−	AAGAUUCAAUUAUAAUCACCUU	22	3631
CFTR-3849-289	−	AAAGAUUCAAUUAUAAUCACCUU	23	3632
CFTR-3849-290	−	AAAAGAUUCAAUUAUAAUCACCUU	24	3633

Table 35C provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 35C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-291	+	AAUGUUUAUCAAGAUAGAAAA	21	3634
CFTR-3849-292	+	CAAUGUUUAUCAAGAUAGAAAA	22	3635
CFTR-3849-293	+	CCAAUGUUUAUCAAGAUAGAAAA	23	3636
CFTR-3849-294	+	ACCAAUGUUUAUCAAGAUAGAAAA	24	3637
CFTR-3849-295	+	AGAUCCACAAGGUGAUUAUAA	21	3638
CFTR-3849-296	+	UAGAUCCACAAGGUGAUUAUAA	22	3639
CFTR-3849-297	+	UUAGAUCCACAAGGUGAUUAUAA	23	3640
CFTR-3849-298	+	UUUAGAUCCACAAGGUGAUUAUAA	24	3641
CFTR-3849-299	+	AGAAUAUGCUGCUUAUACCCA	21	3642
CFTR-3849-300	+	GAGAAUAUGCUGCUUAUACCCA	22	3643
CFTR-3849-301	+	UGAGAAUAUGCUGCUUAUACCCA	23	3644
CFTR-3849-302	+	UUGAGAAUAUGCUGCUUAUACCCA	24	3645
CFTR-3849-303	+	GAAUAGAACAUUUCCUUU	18	3646
CFTR-3849-304	+	UGAAUAGAACAUUUCCUUU	19	3647
CFTR-3849-305	+	AUGAAUAGAACAUUUCCUUU	20	3648
CFTR-3849-306	−	GUAAAGUAGUUGAAUCAUUCA	21	3649
CFTR-3849-307	−	UGUAAAGUAGUUGAAUCAUUCA	22	3650
CFTR-3849-308	−	GUGUAAAGUAGUUGAAUCAUUCA	23	3651
CFTR-3849-309	−	GGUGUAAAGUAGUUGAAUCAUUCA	24	3652
CFTR-3849-310	−	UAUAUUGUAUAUAUCACAGUA	21	3653
CFTR-3849-311	−	GUAUAUUGUAUAUAUCACAGUA	22	3654
CFTR-3849-312	−	GGUAUAUUGUAUAUAUCACAGUA	23	3655
CFTR-3849-313	−	UGGUAUAUUGUAUAUAUCACAGUA	24	3656
CFTR-3849-314	−	AAGGUAAUGAAAAAUAAUUAC	21	3657
CFTR-3849-315	−	CAAGGUAAUGAAAAAUAAUUAC	22	3658
CFTR-3849-316	−	ACAAGGUAAUGAAAAAUAAUUAC	23	3659
CFTR-3849-317	−	CACAAGGUAAUGAAAAAUAAUUAC	24	3660
CFTR-3849-318	−	AUAAUUUAUAAGAAUAUC	18	3661
CFTR-3849-319	−	AAUAAUUUAUAAGAAUAUC	19	3662
CFTR-3849-320	−	AAAUAAUUUAUAAGAAUAUC	20	3663
CFTR-3849-321	−	AUUUCAGAAAUAAUUUAU	18	3664
CFTR-3849-322	−	AAUUUCAGAAAUAAUUUAU	19	3665
CFTR-3849-323	−	AAAUUUCAGAAAUAAUUUAU	20	3666
CFTR-3849-324	−	GAAAUUUCAGAAAUAAUUUAU	21	3667
CFTR-3849-325	−	AGAAAUUUCAGAAAUAAUUUAU	22	3668
CFTR-3849-326	−	CAGAAAUUUCAGAAAUAAUUUAU	23	3669
CFTR-3849-327	−	ACAGAAAUUUCAGAAAUAAUUUAU	24	3670

Table 35D provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+21kbC->T), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 35D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-328	+	UUUUCAAGAGACUACAAA	18	3671
CFTR-3849-329	+	AUUUUCAAGAGACUACAAA	19	3672
CFTR-3849-47	+	UAUUUUCAAGAGACUACAAA	20	3390
CFTR-3849-330	+	GUAUUUUCAAGAGACUACAAA	21	3673
CFTR-3849-331	+	UGUAUUUUCAAGAGACUACAAA	22	3674
CFTR-3849-332	+	CUGUAUUUUCAAGAGACUACAAA	23	3675
CFTR-3849-333	+	UCUGUAUUUUCAAGAGACUACAAA	24	3676
CFTR-3849-334	+	UGUUUAUCAAGAUAGAAA	18	3677
CFTR-3849-335	+	AUGUUUAUCAAGAUAGAAA	19	3678
CFTR-3849-336	+	AAUGUUUAUCAAGAUAGAAA	20	3679
CFTR-3849-337	+	CAAUGUUUAUCAAGAUAGAAA	21	3680
CFTR-3849-338	+	CCAAUGUUUAUCAAGAUAGAAA	22	3681
CFTR-3849-339	+	ACCAAUGUUUAUCAAGAUAGAAA	23	3682
CFTR-3849-340	+	CACCAAUGUUUAUCAAGAUAGAAA	24	3683
CFTR-3849-341	+	AUUUUCAAGAGACUACAA	18	3684
CFTR-3849-342	+	UAUUUUCAAGAGACUACAA	19	3685
CFTR-3849-343	+	GUAUUUUCAAGAGACUACAA	20	3686
CFTR-3849-344	+	UGUAUUUUCAAGAGACUACAA	21	3687
CFTR-3849-345	+	CUGUAUUUUCAAGAGACUACAA	22	3688
CFTR-3849-346	+	UCUGUAUUUUCAAGAGACUACAA	23	3689
CFTR-3849-347	+	UUCUGUAUUUUCAAGAGACUACAA	24	3690
CFTR-3849-348	+	AUCAAGAUGACAAGUCAA	18	3691
CFTR-3849-349	+	AAUCAAGAUGACAAGUCAA	19	3692
CFTR-3849-350	+	AAAUCAAGAUGACAAGUCAA	20	3693
CFTR-3849-351	+	GAAAUCAAGAUGACAAGUCAA	21	3694
CFTR-3849-352	+	AGAAAUCAAGAUGACAAGUCAA	22	3695
CFTR-3849-353	+	CAGAAAUCAAGAUGACAAGUCAA	23	3696
CFTR-3849-354	+	CCAGAAAUCAAGAUGACAAGUCAA	24	3697
CFTR-3849-355	+	AUUGCAUUGUACCAUGAA	18	3698
CFTR-3849-356	+	AAUUGCAUUGUACCAUGAA	19	3699
CFTR-3849-357	+	UAAUUGCAUUGUACCAUGAA	20	3700
CFTR-3849-358	+	GUAAUUGCAUUGUACCAUGAA	21	3701
CFTR-3849-359	+	UGUAAUUGCAUUGUACCAUGAA	22	3702
CFTR-3849-360	+	CUGUAAUUGCAUUGUACCAUGAA	23	3703
CFTR-3849-361	+	GCUGUAAUUGCAUUGUACCAUGAA	24	3704
CFTR-3849-362	+	CAAAUAUCUAUUUAAUCA	18	3705
CFTR-3849-363	+	UCAAAUAUCUAUUUAAUCA	19	3706
CFTR-3849-364	+	AUCAAAUAUCUAUUUAAUCA	20	3707
CFTR-3849-365	+	UAUCAAAUAUCUAUUUAAUCA	21	3708
CFTR-3849-366	+	CUAUCAAAUAUCUAUUUAAUCA	22	3709
CFTR-3849-367	+	ACUAUCAAAUAUCUAUUUAAUCA	23	3710
CFTR-3849-368	+	UACUAUCAAAUAUCUAUUUAAUCA	24	3711
CFTR-3849-369	+	UCUGGUUUCCUUAUAUCA	18	3712
CFTR-3849-370	+	CUCUGGUUUCCUUAUAUCA	19	3713
CFTR-3849-371	+	ACUCUGGUUUCCUUAUAUCA	20	3714
CFTR-3849-372	+	UACUCUGGUUUCCUUAUAUCA	21	3715
CFTR-3849-373	+	UUACUCUGGUUUCCUUAUAUCA	22	3716
CFTR-3849-374	+	AUUACUCUGGUUUCCUUAUAUCA	23	3717
CFTR-3849-375	+	UAUUACUCUGGUUUCCUUAUAUCA	24	3718
CFTR-3849-376	+	CACCAAUGUUUAUCAAGA	18	3719
CFTR-3849-377	+	ACACCAAUGUUUAUCAAGA	19	3720
CFTR-3849-378	+	UACACCAAUGUUUAUCAAGA	20	3721
CFTR-3849-379	+	UUACACCAAUGUUUAUCAAGA	21	3722
CFTR-3849-380	+	UUUACACCAAUGUUUAUCAAGA	22	3723
CFTR-3849-381	+	CUUUACACCAAUGUUUAUCAAGA	23	3724
CFTR-3849-382	+	ACUUUACACCAAUGUUUAUCAAGA	24	3725
CFTR-3849-383	+	UUUUAAUACUGCAACAGA	18	3726
CFTR-3849-384	+	AUUUUAAUACUGCAACAGA	19	3727
CFTR-3849-53	+	CAUUUUAAUACUGCAACAGA	20	3396
CFTR-3849-385	+	CCAUUUUAAUACUGCAACAGA	21	3728
CFTR-3849-386	+	ACCAUUUUAAUACUGCAACAGA	22	3729
CFTR-3849-387	+	CACCAUUUUAAUACUGCAACAGA	23	3730
CFTR-3849-388	+	UCACCAUUUUAAUACUGCAACAGA	24	3731
CFTR-3849-389	+	UAUUAAUGAAACAUAGUA	18	3732
CFTR-3849-390	+	UUAUUAAUGAAACAUAGUA	19	3733
CFTR-3849-391	+	AUUAUUAAUGAAACAUAGUA	20	3734
CFTR-3849-392	+	AAUUAUUAAUGAAACAUAGUA	21	3735
CFTR-3849-393	+	UAAUUAUUAAUGAAACAUAGUA	22	3736
CFTR-3849-394	+	UUAAUUAUUAAUGAAACAUAGUA	23	3737
CFTR-3849-395	+	AUUAAUUAUUAAUGAAACAUAGUA	24	3738
CFTR-3849-396	+	UAUCUCUAUUAAUUAUUA	18	3739
CFTR-3849-397	+	AUAUCUCUAUUAAUUAUUA	19	3740
CFTR-3849-398	+	UAUAUCUCUAUUAAUUAUUA	20	3741
CFTR-3849-399	+	AUAUAUCUCUAUUAAUUAUUA	21	3742
CFTR-3849-400	+	CAUAUAUCUCUAUUAAUUAUUA	22	3743
CFTR-3849-401	+	UCAUAUAUCUCUAUUAAUUAUUA	23	3744
CFTR-3849-402	+	UUCAUAUAUCUCUAUUAAUUAUUA	24	3745
CFTR-3849-403	+	AAAAUACUAAAAUUUUUA	18	3746
CFTR-3849-404	+	AAAAAUACUAAAAUUUUUA	19	3747
CFTR-3849-405	+	AAAAAAUACUAAAAUUUUUA	20	3748
CFTR-3849-406	+	AAAAAAAUACUAAAAUUUUUA	21	3749
CFTR-3849-407	+	GAAAAAAAUACUAAAAUUUUUA	22	3750
CFTR-3849-408	+	AGAAAAAAAUACUAAAAUUUUUA	23	3751
CFTR-3849-409	+	CAGAAAAAAAUACUAAAAUUUUUA	24	3752
CFTR-3849-410	+	CUUCAAUGCACCUCCUCC	18	3753
CFTR-3849-411	+	ACUUCAAUGCACCUCCUCC	19	3754
CFTR-3849-412	+	AACUUCAAUGCACCUCCUCC	20	3755
CFTR-3849-413	+	UAACUUCAAUGCACCUCCUCC	21	3756
CFTR-3849-414	+	AUAACUUCAAUGCACCUCCUCC	22	3757
CFTR-3849-415	+	AAUAACUUCAAUGCACCUCCUCC	23	3758
CFTR-3849-416	+	UAAUAACUUCAAUGCACCUCCUCC	24	3759
CFTR-3849-417	+	GACACAUUUUUCAAAGGC	18	3760
CFTR-3849-418	+	UGACACAUUUUUCAAAGGC	19	3761
CFTR-3849-419	+	CUGACACAUUUUUCAAAGGC	20	3762
CFTR-3849-420	+	UCUGACACAUUUUUCAAAGGC	21	3763
CFTR-3849-421	+	AUCUGACACAUUUUUCAAAGGC	22	3764
CFTR-3849-422	+	UAUCUGACACAUUUUUCAAAGGC	23	3765
CFTR-3849-423	+	AUAUCUGACACAUUUUUCAAAGGC	24	3766
CFTR-3849-424	+	AUUAAGUCCAGAUUUAUC	18	3767
CFTR-3849-425	+	GAUUAAGUCCAGAUUUAUC	19	3768
CFTR-3849-426	+	UGAUUAAGUCCAGAUUUAUC	20	3769
CFTR-3849-427	+	UUGAUUAAGUCCAGAUUUAUC	21	3770
CFTR-3849-428	+	UUUGAUUAAGUCCAGAUUUAUC	22	3771
CFTR-3849-429	+	UUUUGAUUAAGUCCAGAUUUAUC	23	3772
CFTR-3849-430	+	AUUUUGAUUAAGUCCAGAUUUAUC	24	3773
CFTR-3849-431	+	UCAUUACCUUGUGGUCUC	18	3774
CFTR-3849-432	+	UUCAUUACCUUGUGGUCUC	19	3775
CFTR-3849-433	+	UUUCAUUACCUUGUGGUCUC	20	3776
CFTR-3849-434	+	UUUUCAUUACCUUGUGGUCUC	21	3777
CFTR-3849-435	+	UUUUUCAUUACCUUGUGGUCUC	22	3778
CFTR-3849-436	+	AUUUUUCAUUACCUUGUGGUCUC	23	3779
CFTR-3849-437	+	UAUUUUUCAUUACCUUGUGGUCUC	24	3780
CFTR-3849-438	+	UGAAAUUUCUGUAUUUUC	18	3781
CFTR-3849-439	+	CUGAAAUUUCUGUAUUUUC	19	3782
CFTR-3849-440	+	UCUGAAAUUUCUGUAUUUUC	20	3783
CFTR-3849-441	+	UUCUGAAAUUUCUGUAUUUUC	21	3784
CFTR-3849-442	+	UUUCUGAAAUUUCUGUAUUUUC	22	3785
CFTR-3849-443	+	AUUUCUGAAAUUUCUGUAUUUUC	23	3786
CFTR-3849-444	+	UAUUUCUGAAAUUUCUGUAUUUUC	24	3787
CFTR-3849-445	+	AUUUUAAUACUGCAACAG	18	3788
CFTR-3849-446	+	CAUUUUAAUACUGCAACAG	19	3789
CFTR-3849-447	+	CCAUUUUAAUACUGCAACAG	20	3790
CFTR-3849-448	+	ACCAUUUUAAUACUGCAACAG	21	3791
CFTR-3849-449	+	CACCAUUUUAAUACUGCAACAG	22	3792
CFTR-3849-450	+	UCACCAUUUUAAUACUGCAACAG	23	3793
CFTR-3849-451	+	CUCACCAUUUUAAUACUGCAACAG	24	3794
CFTR-3849-452	+	GAGAACUCAGUUUUUAGG	18	3795
CFTR-3849-453	+	AGAGAACUCAGUUUUUAGG	19	3796
CFTR-3849-454	+	UAGAGAACUCAGUUUUUAGG	20	3797
CFTR-3849-455	+	UUAGAGAACUCAGUUUUUAGG	21	3798
CFTR-3849-456	+	UUUAGAGAACUCAGUUUUUAGG	22	3799
CFTR-3849-457	+	UUUUAGAGAACUCAGUUUUUAGG	23	3800
CFTR-3849-458	+	UUUUUAGAGAACUCAGUUUUUAGG	24	3801
CFTR-3849-459	+	UAGGUUGGGAAAGACUGG	18	3802
CFTR-3849-460	+	UUAGGUUGGGAAAGACUGG	19	3803
CFTR-3849-461	+	UUUAGGUUGGGAAAGACUGG	20	3804
CFTR-3849-462	+	UUUUAGGUUGGGAAAGACUGG	21	3805
CFTR-3849-463	+	UUUUUAGGUUGGGAAAGACUGG	22	3806
CFTR-3849-464	+	GUUUUUAGGUUGGGAAAGACUGG	23	3807
CFTR-3849-465	+	AGUUUUUAGGUUGGGAAAGACUGG	24	3808
CFTR-3849-466	+	UUCAAGAGACUACAAAUG	18	3809
CFTR-3849-467	+	UUUCAAGAGACUACAAAUG	19	3810
CFTR-3849-468	+	UUUUCAAGAGACUACAAAUG	20	3811
CFTR-3849-469	+	AUUUUCAAGAGACUACAAAUG	21	3812
CFTR-3849-470	+	UAUUUUCAAGAGACUACAAAUG	22	3813
CFTR-3849-471	+	GUAUUUUCAAGAGACUACAAAUG	23	3814
CFTR-3849-472	+	UGUAUUUUCAAGAGACUACAAAUG	24	3815
CFTR-3849-473	+	GUUGGGAAAGACUGGAUG	18	3816
CFTR-3849-474	+	GGUUGGGAAAGACUGGAUG	19	3817
CFTR-3849-475	+	AGGUUGGGAAAGACUGGAUG	20	3818
CFTR-3849-476	+	UAGGUUGGGAAAGACUGGAUG	21	3819
CFTR-3849-477	+	UUAGGUUGGGAAAGACUGGAUG	22	3820
CFTR-3849-478	+	UUUAGGUUGGGAAAGACUGGAUG	23	3821
CFTR-3849-479	+	UUUUAGGUUGGGAAAGACUGGAUG	24	3822
CFTR-3849-480	+	AUAAAUCAAAAUAAUAUG	18	3823
CFTR-3849-481	+	GAUAAAUCAAAAUAAUAUG	19	3824
CFTR-3849-482	+	AGAUAAAUCAAAAUAAUAUG	20	3825
CFTR-3849-483	+	AAGAUAAAUCAAAAUAAUAUG	21	3826
CFTR-3849-484	+	CAAGAUAAAUCAAAAUAAUAUG	22	3827
CFTR-3849-485	+	UCAAGAUAAAUCAAAAUAAUAUG	23	3828
CFTR-3849-486	+	AUCAAGAUAAAUCAAAAUAAUAUG	24	3829
CFTR-3849-487	+	AUCAAAUAUCUAUUUAAU	18	3830
CFTR-3849-488	+	UAUCAAAUAUCUAUUUAAU	19	3831
CFTR-3849-489	+	CUAUCAAAUAUCUAUUUAAU	20	3832
CFTR-3849-490	+	ACUAUCAAAUAUCUAUUUAAU	21	3833
CFTR-3849-491	+	UACUAUCAAAUAUCUAUUUAAU	22	3834
CFTR-3849-492	+	GUACUAUCAAAUAUCUAUUUAAU	23	3835
CFTR-3849-493	+	AGUACUAUCAAAUAUCUAUUUAAU	24	3836
CFTR-3849-494	+	AUAUAUACAAUAUACCAU	18	3837
CFTR-3849-495	+	GAUAUAUACAAUAUACCAU	19	3838
CFTR-3849-496	+	UGAUAUAUACAAUAUACCAU	20	3839
CFTR-3849-497	+	GUGAUAUAUACAAUAUACCAU	21	3840
CFTR-3849-498	+	UGUGAUAUAUACAAUAUACCAU	22	3841
CFTR-3849-499	+	CUGUGAUAUAUACAAUAUACCAU	23	3842
CFTR-3849-500	+	ACUGUGAUAUAUACAAUAUACCAU	24	3843
CFTR-3849-501	+	AUAUACAAUAUACCAUAU	18	3844
CFTR-3849-502	+	UAUAUACAAUAUACCAUAU	19	3845
CFTR-3849-503	+	AUAUAUACAAUAUACCAUAU	20	3846
CFTR-3849-504	+	GAUAUAUACAAUAUACCAUAU	21	3847
CFTR-3849-505	+	UGAUAUAUACAAUAUACCAUAU	22	3848
CFTR-3849-506	+	GUGAUAUAUACAAUAUACCAUAU	23	3849
CFTR-3849-507	+	UGUGAUAUAUACAAUAUACCAUAU	24	3850
CFTR-3849-508	+	AGAACUCAGUUUUUAGGU	18	3851
CFTR-3849-509	+	GAGAACUCAGUUUUUAGGU	19	3852
CFTR-3849-78	+	AGAGAACUCAGUUUUUAGGU	20	3421
CFTR-3849-510	+	UAGAGAACUCAGUUUUUAGGU	21	3853
CFTR-3849-511	+	UUAGAGAACUCAGUUUUUAGGU	22	3854
CFTR-3849-512	+	UUUAGAGAACUCAGUUUUUAGGU	23	3855
CFTR-3849-513	+	UUUUAGAGAACUCAGUUUUUAGGU	24	3856
CFTR-3849-514	+	GAACUCAGUUUUUAGGUU	18	3857
CFTR-3849-515	+	AGAACUCAGUUUUUAGGUU	19	3858
CFTR-3849-9	+	GAGAACUCAGUUUUUAGGUU	20	3352
CFTR-3849-516	+	AGAGAACUCAGUUUUUAGGUU	21	3859
CFTR-3849-517	+	UAGAGAACUCAGUUUUUAGGUU	22	3860
CFTR-3849-518	+	UUAGAGAACUCAGUUUUUAGGUU	23	3861
CFTR-3849-519	+	UUUAGAGAACUCAGUUUUUAGGUU	24	3862
CFTR-3849-520	+	UAUUCUUAUAAAUUAUUU	18	3863
CFTR-3849-521	+	AUAUUCUUAUAAAUUAUUU	19	3864
CFTR-3849-522	+	GAUAUUCUUAUAAAUUAUUU	20	3865
CFTR-3849-523	+	UGAUAUUCUUAUAAAUUAUUU	21	3866
CFTR-3849-524	+	UUGAUAUUCUUAUAAAUUAUUU	22	3867
CFTR-3849-525	+	CUUGAUAUUCUUAUAAAUUAUUU	23	3868
CFTR-3849-526	+	CCUUGAUAUUCUUAUAAAUUAUUU	24	3869
CFTR-3849-527	+	GCACAUAAUAAUUAGUUU	18	3870
CFTR-3849-528	+	GGCACAUAAUAAUUAGUUU	19	3871
CFTR-3849-529	+	UGGCACAUAAUAAUUAGUUU	20	3872
CFTR-3849-530	+	CUGGCACAUAAUAAUUAGUUU	21	3873
CFTR-3849-531	+	ACUGGCACAUAAUAAUUAGUUU	22	3874
CFTR-3849-532	+	AACUGGCACAUAAUAAUUAGUUU	23	3875
CFTR-3849-533	+	UAACUGGCACAUAAUAAUUAGUUU	24	3876
CFTR-3849-534	+	AAAAAAUACUAAAAUUUU	18	3877
CFTR-3849-535	+	AAAAAAAUACUAAAAUUUU	19	3878
CFTR-3849-536	+	GAAAAAAAUACUAAAAUUUU	20	3879
CFTR-3849-537	+	AGAAAAAAAUACUAAAAUUUU	21	3880
CFTR-3849-538	+	CAGAAAAAAAUACUAAAAUUUU	22	3881
CFTR-3849-539	+	UCAGAAAAAAAUACUAAAAUUUU	23	3882
CFTR-3849-540	+	UUCAGAAAAAAAUACUAAAAUUUU	24	3883
CFTR-3849-541	−	AUUUUUUUCUGAAGAAAA	18	3884
CFTR-3849-542	−	UAUUUUUUUCUGAAGAAAA	19	3885
CFTR-3849-87	−	GUAUUUUUUUCUGAAGAAAA	20	3430
CFTR-3849-543	−	AGUAUUUUUUUCUGAAGAAAA	21	3886
CFTR-3849-544	−	UAGUAUUUUUUUCUGAAGAAAA	22	3887
CFTR-3849-545	−	UUAGUAUUUUUUUCUGAAGAAAA	23	3888
CFTR-3849-546	−	UUUAGUAUUUUUUUCUGAAGAAAA	24	3889
CFTR-3849-547	−	UAUUUUUUUCUGAAGAAA	18	3890
CFTR-3849-548	−	GUAUUUUUUUCUGAAGAAA	19	3891
CFTR-3849-111	−	AGUAUUUUUUUCUGAAGAAA	20	3454
CFTR-3849-549	−	UAGUAUUUUUUUCUGAAGAAA	21	3892
CFTR-3849-550	−	UUAGUAUUUUUUUCUGAAGAAA	22	3893
CFTR-3849-551	−	UUUAGUAUUUUUUUCUGAAGAAA	23	3849
CFTR-3849-552	−	UUUUAGUAUUUUUUUCUGAAGAAA	24	3895
CFTR-3849-553	−	GUAUUUUUUUCUGAAGAA	18	3896
CFTR-3849-554	−	AGUAUUUUUUUCUGAAGAA	19	3897
CFTR-3849-555	−	UAGUAUUUUUUUCUGAAGAA	20	3898
CFTR-3849-556	−	UUAGUAUUUUUUUCUGAAGAA	21	3899
CFTR-3849-557	−	UUUAGUAUUUUUUUCUGAAGAA	22	3900
CFTR-3849-558	−	UUUUAGUAUUUUUUUCUGAAGAA	23	3901
CFTR-3849-559	−	AUUUUAGUAUUUUUUUCUGAAGAA	24	3902
CFTR-3849-560	−	UGAGUAAGACACCCUGAA	18	3903
CFTR-3849-561	−	GUGAGUAAGACACCCUGAA	19	3904
CFTR-3849-88	−	GGUGAGUAAGACACCCUGAA	20	3431
CFTR-3849-562	−	UGGUGAGUAAGACACCCUGAA	21	3905
CFTR-3849-563	−	AUGGUGAGUAAGACACCCUGAA	22	3906
CFTR-3849-564	−	AAUGGUGAGUAAGACACCCUGAA	23	3907
CFTR-3849-565	−	AAAUGGUGAGUAAGACACCCUGAA	24	3908
CFTR-3849-566	−	UGUUUCAUUAAUAAUUAA	18	3909
CFTR-3849-567	−	AUGUUUCAUUAAUAAUUAA	19	3910
CFTR-3849-568	−	UAUGUUUCAUUAAUAAUUAA	20	3911
CFTR-3849-569	−	CUAUGUUUCAUUAAUAAUUAA	21	3912
CFTR-3849-570	−	ACUAUGUUUCAUUAAUAAUUAA	22	3913
CFTR-3849-571	−	UACUAUGUUUCAUUAAUAAUUAA	23	3914
CFTR-3849-572	−	AUACUAUGUUUCAUUAAUAAUUAA	24	3915
CFTR-3849-573	−	UCUCAGGGAGGAGGUGCA	18	3916
CFTR-3849-574	−	UUCUCAGGGAGGAGGUGCA	19	3917
CFTR-3849-575	−	AUUCUCAGGGAGGAGGUGCA	20	3918
CFTR-3849-576	−	CAUUCUCAGGGAGGAGGUGCA	21	3919
CFTR-3849-577	−	ACAUUCUCAGGGAGGAGGUGCA	22	3920
CFTR-3849-578	−	AACAUUCUCAGGGAGGAGGUGCA	23	3921
CFTR-3849-579	−	CAACAUUCUCAGGGAGGAGGUGCA	24	3922
CFTR-3849-580	−	GCCUUAUUCAACAGAUCA	18	3923
CFTR-3849-581	−	AGCCUUAUUCAACAGAUCA	19	3924
CFTR-3849-582	−	UAGCCUUAUUCAACAGAUCA	20	3925
CFTR-3849-583	−	CUAGCCUUAUUCAACAGAUCA	21	3926
CFTR-3849-584	−	UCUAGCCUUAUUCAACAGAUCA	22	3927
CFTR-3849-585	−	CUCUAGCCUUAUUCAACAGAUCA	23	3928
CFTR-3849-586	−	ACUCUAGCCUUAUUCAACAGAUCA	24	3929
CFTR-3849-587	−	CUUGAUCCAACAUUCUCA	18	3930
CFTR-3849-588	−	UCUUGAUCCAACAUUCUCA	19	3931
CFTR-3849-52	−	AUCUUGAUCCAACAUUCUCA	20	3395
CFTR-3849-589	−	UAUCUUGAUCCAACAUUCUCA	21	3932
CFTR-3849-590	−	UUAUCUUGAUCCAACAUUCUCA	22	3933
CFTR-3849-591	−	UUUAUCUUGAUCCAACAUUCUCA	23	3934
CFTR-3849-592	−	AUUUAUCUUGAUCCAACAUUCUCA	24	3935
CFTR-3849-593	−	GUGAGUAAGACACCCUGA	18	3936
CFTR-3849-594	−	GGUGAGUAAGACACCCUGA	19	3937
CFTR-3849-595	−	UGGUGAGUAAGACACCCUGA	20	3938
CFTR-3849-596	−	AUGGUGAGUAAGACACCCUGA	21	3939
CFTR-3849-597	−	AAUGGUGAGUAAGACACCCUGA	22	3940
CFTR-3849-598	−	AAAUGGUGAGUAAGACACCCUGA	23	3941
CFTR-3849-599	−	AAAAUGGUGAGUAAGACACCCUGA	24	3942
CFTR-3849-600	−	UGUAGUCUCUUGAAAAUA	18	3943
CFTR-3849-601	−	UUGUAGUCUCUUGAAAAUA	19	3944
CFTR-3849-602	−	UUUGUAGUCUCUUGAAAAUA	20	3945
CFTR-3849-603	−	AUUUGUAGUCUCUUGAAAAUA	21	3946
CFTR-3849-604	−	CAUUUGUAGUCUCUUGAAAAUA	22	3947
CFTR-3849-605	−	CCAUUUGUAGUCUCUUGAAAAUA	23	3948
CFTR-3849-606	−	UCCAUUUGUAGUCUCUUGAAAAUA	24	3949
CFTR-3849-607	−	CAGCAGUUCAAUGAUAUA	18	3950
CFTR-3849-608	−	CCAGCAGUUCAAUGAUAUA	19	3951
CFTR-3849-56	−	ACCAGCAGUUCAAUGAUAUA	20	3399
CFTR-3849-609	−	UACCAGCAGUUCAAUGAUAUA	21	3952
CFTR-3849-610	−	UUACCAGCAGUUCAAUGAUAUA	22	3953
CFTR-3849-611	−	AUUACCAGCAGUUCAAUGAUAUA	23	3954
CFTR-3849-612	−	CAUUACCAGCAGUUCAAUGAUAUA	24	3955
CFTR-3849-613	−	UCUGGAGACCACAAGGUA	18	3956
CFTR-3849-614	−	UUCUGGAGACCACAAGGUA	19	3957
CFTR-3849-615	−	UUUCUGGAGACCACAAGGUA	20	3958
CFTR-3849-616	−	AUUUCUGGAGACCACAAGGUA	21	3959
CFTR-3849-617	−	GAUUUCUGGAGACCACAAGGUA	22	3960
CFTR-3849-618	−	UGAUUUCUGGAGACCACAAGGUA	23	3961
CFTR-3849-619	−	UUGAUUUCUGGAGACCACAAGGUA	24	3962
CFTR-3849-620	−	UGUGCCAGUUAUAUAAAC	18	3963
CFTR-3849-621	−	AUGUGCCAGUUAUAUAAAC	19	3964
CFTR-3849-622	−	UAUGUGCCAGUUAUAUAAAC	20	3965
CFTR-3849-623	−	UUAUGUGCCAGUUAUAUAAAC	21	3966
CFTR-3849-624	−	AUUAUGUGCCAGUUAUAUAAAC	22	3967
CFTR-3849-625	−	UAUUAUGUGCCAGUUAUAUAAAC	23	3968
CFTR-3849-626	−	UUAUUAUGUGCCAGUUAUAUAAAC	24	3969
CFTR-3849-627	−	AAUGGUGAGUAAGACACC	18	3970
CFTR-3849-628	−	AAAUGGUGAGUAAGACACC	19	3971
CFTR-3849-629	−	AAAAUGGUGAGUAAGACACC	20	3972
CFTR-3849-630	−	UAAAAUGGUGAGUAAGACACC	21	3973
CFTR-3849-631	−	UUAAAAUGGUGAGUAAGACACC	22	3974
CFTR-3849-632	−	AUUAAAAUGGUGAGUAAGACACC	23	3975
CFTR-3849-633	−	UAUUAAAAUGGUGAGUAAGACACC	24	3976
CFTR-3849-634	−	ACAGAUCACUGAGAAGCC	18	3977
CFTR-3849-635	−	AACAGAUCACUGAGAAGCC	19	3978
CFTR-3849-61	−	CAACAGAUCACUGAGAAGCC	20	3404
CFTR-3849-636	−	UCAACAGAUCACUGAGAAGCC	21	3979
CFTR-3849-637	−	UUCAACAGAUCACUGAGAAGCC	22	3980
CFTR-3849-638	−	AU UCAACAGAUCACUGAGAAGCC	23	3981
CFTR-3849-639	−	UAUUCAACAGAUCACUGAGAAGCC	24	3982
CFTR-3849-640	−	GCCUGGAAAAACAAAUCC	18	3983
CFTR-3849-641	−	AGCCUGGAAAAACAAAUCC	19	3984
CFTR-3849-62	−	AAGCCUGGAAAAACAAAUCC	20	3405
CFTR-3849-642	−	GAAGCCUGGAAAAACAAAUCC	21	3985
CFTR-3849-643	−	AGAAGCCUGGAAAAACAAAUCC	22	3986
CFTR-3849-644	−	GAGAAGCCUGGAAAAACAAAUCC	23	3987
CFTR-3849-645	−	UGAGAAGCCUGGAAAAACAAAUCC	24	3988
CFTR-3849-646	−	AACAGAUCACUGAGAAGC	18	3989
CFTR-3849-647	−	CAACAGAUCACUGAGAAGC	19	3990
CFTR-3849-648	−	UCAACAGAUCACUGAGAAGC	20	3991
CFTR-3849-649	−	UUCAACAGAUCACUGAGAAGC	21	3992
CFTR-3849-650	−	AUUCAACAGAUCACUGAGAAGC	22	3993
CFTR-3849-651	−	UAUUCAACAGAUCACUGAGAAGC	23	3994
CFTR-3849-652	−	UUAUUCAACAGAUCACUGAGAAGC	24	3995
CFTR-3849-653	−	UCUUAAAAGCUUAUUUGC	18	3996
CFTR-3849-654	−	GUCUUAAAAGCUUAUUUGC	19	3997
CFTR-3849-65	−	UGUCUUAAAAGCUUAUUUGC	20	3408
CFTR-3849-655	−	AUGUCUUAAAAGCUUAUUUGC	21	3998
CFTR-3849-656	−	UAUGUCUUAAAAGCUUAUUUGC	22	3999
CFTR-3849-657	−	GUAUGUCUUAAAAGCUUAUUUGC	23	4000
CFTR-3849-658	−	GGUAUGUCUUAAAAGCUUAUUUGC	24	4001
CFTR-3849-659	−	AGCCUGGAAAAACAAAUC	18	4002
CFTR-3849-660	−	AAGCCUGGAAAAACAAAUC	19	4003
CFTR-3849-661	−	GAAGCCUGGAAAAACAAAUC	20	4004
CFTR-3849-662	−	AGAAGCCUGGAAAAACAAAUC	21	4005
CFTR-3849-663	−	GAGAAGCCUGGAAAAACAAAUC	22	4006
CFTR-3849-664	−	UGAGAAGCCUGGAAAAACAAAUC	23	4007
CFTR-3849-665	−	CUGAGAAGCCUGGAAAAACAAAUC	24	4008
CFTR-3849-666	−	UUCUCCAUUUGUAGUCUC	18	4009
CFTR-3849-667	−	UUUCUCCAUUUGUAGUCUC	19	4010
CFTR-3849-668	−	CUUUCUCCAUUUGUAGUCUC	20	4011
CFTR-3849-669	−	GCUUUCUCCAUUUGUAGUCUC	21	4012
CFTR-3849-670	−	UGCUUUCUCCAUUUGUAGUCUC	22	4013
CFTR-3849-671	−	CUGCUUUCUCCAUUUGUAGUCUC	23	4014
CFTR-3849-672	−	ACUGCUUUCUCCAUUUGUAGUCUC	24	4015
CFTR-3849-673	−	UCUUGAUCCAACAUUCUC	18	4016
CFTR-3849-674	−	AUCUUGAUCCAACAUUCUC	19	4017
CFTR-3849-67	−	UAUCUUGAUCCAACAUUCUC	20	3410
CFTR-3849-675	−	UUAUCUUGAUCCAACAUUCUC	21	4018
CFTR-3849-676	−	UUUAUCUUGAUCCAACAUUCUC	22	4019
CFTR-3849-677	−	AUUUAUCUUGAUCCAACAUUCUC	23	4020
CFTR-3849-678	−	GAUUUAUCUUGAUCCAACAUUCUC	24	4021
CFTR-3849-679	−	ACUUGUCAUCUUGAUUUC	18	4022
CFTR-3849-680	−	GACUUGUCAUCUUGAUUUC	19	4023
CFTR-3849-68	−	UGACUUGUCAUCUUGAUUUC	20	3411
CFTR-3849-681	−	UUGACUUGUCAUCUUGAUUUC	21	4024
CFTR-3849-682	−	GUUGACUUGUCAUCUUGAUUUC	22	4025
CFTR-3849-683	−	AGUUGACUUGUCAUCUUGAUUUC	23	4026
CFTR-3849-684	−	CAGUUGACUUGUCAUCUUGAUUUC	24	4027
CFTR-3849-685	−	UUUUUUUCUGAAGAAAAG	18	4028
CFTR-3849-686	−	AUUUUUUUCUGAAGAAAAG	19	4029
CFTR-3849-115	−	UAUUUUUUUCUGAAGAAAAG	20	3458
CFTR-3849-687	−	GUAUUUUUUUCUGAAGAAAAG	21	4030
CFTR-3849-688	−	AGUAUUUUUUUCUGAAGAAAAG	22	4031
CFTR-3849-689	−	UAGUAUUUUUUUCUGAAGAAAAG	23	4032
CFTR-3849-690	−	UUAGUAUUUUUUUCUGAAGAAAAG	24	4033
CFTR-3849-691	−	UGAUCCAACAUUCUCAGG	18	4034
CFTR-3849-692	−	UUGAUCCAACAUUCUCAGG	19	4035
CFTR-3849-693	−	CUUGAUCCAACAUUCUCAGG	20	4036
CFTR-3849-694	−	UCUUGAUCCAACAUUCUCAGG	21	4037
CFTR-3849-695	−	AUCUUGAUCCAACAUUCUCAGG	22	4038
CFTR-3849-696	−	UAUCUUGAUCCAACAUUCUCAGG	23	4039
CFTR-3849-697	−	UUAUCUUGAUCCAACAUUCUCAGG	24	4040
CFTR-3849-698	−	GAUCCAACAUUCUCAGGG	18	4041
CFTR-3849-699	−	UGAUCCAACAUUCUCAGGG	19	4042
CFTR-3849-74	−	UUGAUCCAACAUUCUCAGGG	20	3417
CFTR-3849-700	−	CUUGAUCCAACAUUCUCAGGG	21	4043
CFTR-3849-701	−	UCUUGAUCCAACAUUCUCAGGG	22	4044
CFTR-3849-702	−	AUCUUGAUCCAACAUUCUCAGGG	23	4045
CFTR-3849-703	−	UAUCUUGAUCCAACAUUCUCAGGG	24	4046
CFTR-3849-704	−	UAAGGUCUAUACUUUUGG	18	4047
CFTR-3849-705	−	UUAAGGUCUAUACUUUUGG	19	4048
CFTR-3849-706	−	UUUAAGGUCUAUACUUUUGG	20	4049
CFTR-3849-707	−	CUUUAAGGUCUAUACUUUUGG	21	4050
CFTR-3849-708	−	ACUUUAAGGUCUAUACUUUUGG	22	4051
CFTR-3849-709	−	UACUUUAAGGUCUAUACUUUUGG	23	4052
CFTR-3849-710	−	GUACUUUAAGGUCUAUACUUUUGG	24	4053
CFTR-3849-711	−	UUUUAGUAUUUUUUUCUG	18	4054
CFTR-3849-712	−	AUUUUAGUAUUUUUUUCUG	19	4055
CFTR-3849-713	−	AAUUUUAGUAUUUUUUUCUG	20	4056
CFTR-3849-714	−	AAAUUUUAGUAUUUUUUUCUG	21	4057
CFTR-3849-715	−	AAAAUUUUAGUAUUUUUUUCUG	22	4058
CFTR-3849-716	−	AAAAAUUUUAGUAUUUUUUUCUG	23	4059
CFTR-3849-717	−	UAAAAAUUUUAGUAUUUUUUUCUG	24	4060
CFTR-3849-718	−	GUCUUAAAAGCUUAUUUG	18	4061
CFTR-3849-719	−	UGUCUUAAAAGCUUAUUUG	19	4062
CFTR-3849-76	−	AUGUCUUAAAAGCUUAUUUG	20	3419
CFTR-3849-720	−	UAUGUCUUAAAAGCUUAUUUG	21	4063
CFTR-3849-721	−	GUAUGUCUUAAAAGCUUAUUUG	22	4064
CFTR-3849-722	−	GGUAUGUCUUAAAAGCUUAUUUG	23	4065
CFTR-3849-723	−	GGGUAUGUCUUAAAAGCUUAUUUG	24	4066
CFTR-3849-724	−	AAUAAUUAAUAGAGAUAU	18	4067
CFTR-3849-725	−	UAAUAAUUAAUAGAGAUAU	19	4068
CFTR-3849-726	−	UUAAUAAUUAAUAGAGAUAU	20	4069
CFTR-3849-727	−	AUUAAUAAUUAAUAGAGAUAU	21	4070
CFTR-3849-728	−	CAUUAAUAAUUAAUAGAGAUAU	22	4071
CFTR-3849-729	−	UCAUUAAUAAUUAAUAGAGAUAU	23	4072
CFTR-3849-730	−	UUCAUUAAUAAUUAAUAGAGAUAU	24	4073
CFTR-3849-731	−	CCAGCAGUUCAAUGAUAU	18	4074
CFTR-3849-732	−	ACCAGCAGUUCAAUGAUAU	19	4075
CFTR-3849-733	−	UACCAGCAGUUCAAUGAUAU	20	4076
CFTR-3849-734	−	UUACCAGCAGUUCAAUGAUAU	21	4077
CFTR-3849-735	−	AUUACCAGCAGUUCAAUGAUAU	22	4078
CFTR-3849-736	−	CAUUACCAGCAGUUCAAUGAUAU	23	4079
CFTR-3849-737	−	GCAUUACCAGCAGUUCAAUGAUAU	24	4080
CFTR-3849-738	−	GAGGUGCAUUGAAGUUAU	18	4081
CFTR-3849-739	−	GGAGGUGCAUUGAAGUUAU	19	4082
CFTR-3849-740	−	AGGAGGUGCAUUGAAGUUAU	20	4083
CFTR-3849-741	−	GAGGAGGUGCAUUGAAGUUAU	21	4084
CFTR-3849-742	−	GGAGGAGGUGCAUUGAAGUUAU	22	4085
CFTR-3849-743	−	GGGAGGAGGUGCAUUGAAGUUAU	23	4086
CFTR-3849-744	−	AGGGAGGAGGUGCAUUGAAGUUAU	24	4087
CFTR-3849-745	−	CUUAUUCAACAGAUCACU	18	4088
CFTR-3849-746	−	CCUUAUUCAACAGAUCACU	19	4089
CFTR-3849-747	−	GCCUUAUUCAACAGAUCACU	20	4090
CFTR-3849-748	−	AGCCUUAUUCAACAGAUCACU	21	4091
CFTR-3849-749	−	UAGCCUUAUUCAACAGAUCACU	22	4092
CFTR-3849-750	−	CUAGCCUUAUUCAACAGAUCACU	23	4093
CFTR-3849-751	−	UCUAGCCUUAUUCAACAGAUCACU	24	4094
CFTR-3849-752	−	ACCAGUGAUUCCUUGCCU	18	4095
CFTR-3849-753	−	AACCAGUGAUUCCUUGCCU	19	4096
CFTR-3849-754	−	AAACCAGUGAUUCCUUGCCU	20	4097
CFTR-3849-755	−	CAAACCAGUGAUUCCUUGCCU	21	4098
CFTR-3849-756	−	ACAAACCAGUGAUUCCUUGCCU	22	4099
CFTR-3849-757	−	UACAAACCAGUGAUUCCUUGCCU	23	4100
CFTR-3849-758	−	GUACAAACCAGUGAUUCCUUGCCU	24	4101
CFTR-3849-759	−	AUCUUGAUCCAACAUUCU	18	4102
CFTR-3849-760	−	UAUCUUGAUCCAACAUUCU	19	4103
CFTR-3849-761	−	UUAUCUUGAUCCAACAUUCU	20	4104
CFTR-3849-762	−	UUUAUCUUGAUCCAACAUUCU	21	4105
CFTR-3849-763	−	AUUUAUCUUGAUCCAACAUUCU	22	4106
CFTR-3849-764	−	GAUUUAUCUUGAUCCAACAUUCU	23	4107
CFTR-3849-765	−	UGAUUUAUCUUGAUCCAACAUUCU	24	4108
CFTR-3849-766	−	UUGAAAAUACAGAAAUUU	18	4109
CFTR-3849-767	−	CUUGAAAAUACAGAAAUUU	19	4110
CFTR-3849-768	−	UCUUGAAAAUACAGAAAUUU	20	4111
CFTR-3849-769	−	CUCUUGAAAAUACAGAAAUUU	21	4112
CFTR-3849-770	−	UCUCUUGAAAAUACAGAAAUUU	22	4113
CFTR-3849-771	−	GUCUCUUGAAAAUACAGAAAUUU	23	4114
CFTR-3849-772	−	AGUCUCUUGAAAAUACAGAAAUUU	24	4115
CFTR-3849-773	−	GACUUGUCAUCUUGAUUU	18	4116
CFTR-3849-774	−	UGACUUGUCAUCUUGAUUU	19	4117
CFTR-3849-775	−	UUGACUUGUCAUCUUGAUUU	20	4118
CFTR-3849-776	−	GUUGACUUGUCAUCUUGAUUU	21	4119
CFTR-3849-777	−	AGUUGACUUGUCAUCUUGAUUU	22	4120
CFTR-3849-778	−	CAGUUGACUUGUCAUCUUGAUUU	23	4121
CFTR-3849-779	−	UCAGUUGACUUGUCAUCUUGAUUU	24	4122
CFTR-3849-780	−	UGUCUUAAAAGCUUAUUU	18	4123
CFTR-3849-781	−	AUGUCUUAAAAGCUUAUUU	19	4124
CFTR-3849-782	−	UAUGUCUUAAAAGCUUAUUU	20	4125
CFTR-3849-783	−	GUAUGUCUUAAAAGCUUAUUU	21	4126
CFTR-3849-784	−	GGUAUGUCUUAAAAGCUUAUUU	22	4127
CFTR-3849-785	−	GGGUAUGUCUUAAAAGCUUAUUU	23	4128
CFTR-3849-786	−	AGGGUAUGUCUUAAAAGCUUAUUU	24	4129
CFTR-3849-787	−	AAAUUUUAGUAUUUUUUU	18	4130
CFTR-3849-788	−	AAAAUUUUAGUAUUUUUUU	19	4131
CFTR-3849-789	−	AAAAAUUUUAGUAUUUUUUU	20	4132
CFTR-3849-790	−	UAAAAAUUUUAGUAUUUUUUU	21	4133
CFTR-3849-791	−	CUAAAAAUUUUAGUAUUUUUUU	22	4134
CFTR-3849-792	−	UCUAAAAAUUUUAGUAUUUUUUU	23	4135
CFTR-3849-793	−	CUCUAAAAAUUUUAGUAUUUUUUU	24	4136

Table 36A provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 36A
1st Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
CFTR-3849-794	+	GAGGAAUUUUGAUUAAG	17	4137
CFTR-3849-795	−	GAGAUAUAUGAACACAU	17	4138
CFTR-3849-796	−	GAUUUAGGGUAUGUCUU	17	4139
CFTR-3849-797	+	GGCUAGAGUACUUCCCGCAA	20	4140
CFTR-3849-798	+	GAAACAUAGUAUUGAGAAUA	20	4141
CFTR-3849-799	−	GUUUAACUUUCAACAUAUUA	20	4142
CFTR-3849-800	+	GGCAAUUUGUAAAUCUUUGG	20	4143
CFTR-3849-801	+	GUAUUUAGGUGUUUGUGCUG	20	4144
CFTR-3849-802	−	GCACAAACACCUAAAUACUU	20	4145

Table 36B provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 36B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-803	+	UAGAGUACUUCCCGCAA	17	4146
CFTR-3849-804	+	AUAUACCAUAUGAGGAA	17	4147
CFTR-3849-13	+	UGAAAUUUAGAUCCACA	17	3356
CFTR-3849-805	−	UUUCAGUUGACUUGUCA	17	4148
CFTR-3849-806	+	ACAUAGUAUUGAGAAUA	17	4149
CFTR-3849-807	−	UAACUUUCAACAUAUUA	17	4150
CFTR-3849-808	−	CUUUGUUGGGUACAAAC	17	4151
CFTR-3849-809	−	AACCUUUAAAGCUAAAC	17	4152
CFTR-3849-810	−	CACAGUACUGGAUAGUC	17	4153
CFTR-3849-811	+	AAUUUGUAAAUCUUUGG	17	4154
CFTR-3849-812	+	UUUAGGUGUUUGUGCUG	17	4155
CFTR-3849-813	−	UACUUUUGGAUGAACUU	17	4156
CFTR-3849-814	+	CACAUAAUAAUUAGUUU	17	4157
CFTR-3849-815	+	ACAAUAUACCAUAUGAGGAA	20	4158
CFTR-3849-112	+	AACUGAAAUUUAGAUCCACA	20	3455
CFTR-3849-816	−	AAAUUUCAGUUGACUUGUCA	20	4159
CFTR-3849-817	−	AGACUUUGUUGGGUACAAAC	20	4160
CFTR-3849-818	−	UAAAACCUUUAAAGCUAAAC	20	4161
CFTR-3849-819	−	UAUCACAGUACUGGAUAGUC	20	4162
CFTR-3849-820	+	UAUGAGGAAUUUUGAUUAAG	20	4163
CFTR-3849-821	−	AUAGAGAUAUAUGAACACAU	20	4164
CFTR-3849-822	+	AUAUGCUGCUUAUACCCACU	20	4165
CFTR-3849-823	−	CUAUACUUUUGGAUGAACUU	20	4166
CFTR-3849-824	−	UUAGAUUUAGGGUAUGUCUU	20	4167
CFTR-3849-529	+	UGGCACAUAAUAAUUAGUUU	20	3872

Table 36C provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 36C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-3849-	−	GAAAUAAUUUAUAAGAAUAU	20	4168
825

Table 36D provides exemplary targeting domains for correcting a mutation (e.g., 3849+10kbC->T) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within 500 bp from a mutation (e.g., 3849+10kbC->T). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 36D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-3849-826	−	UUAUUAGAAAACACUGA	17	4169
CFTR-3849-827	−	AUAAUUUAUAAGAAUAU	17	4170
CFTR-3849-828	+	UGCUGCUUAUACCCACU	17	4171
CFTR-3849-829	−	CAAACACCUAAAUACUU	17	4172
CFTR-3849-830	+	UUCCGGGAUUUGUUUUU	17	4173
CFTR-3849-831	−	AAGUUAUUAGAAAACACUGA	20	4174
CFTR-3849-832	+	AGUUUCCGGGAUUUGUUUUU	20	4175

Table 37A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within intron 2, have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 37A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-1	+	GUACAAAGUACCAAAAA	17	15101
CFTR-Intron2-2	−	GCCUGAUGCCAGAUAAA	17	15102
CFTR-Intron2-3	+	GGUAAACAAUUAGACAA	17	15103
CFTR-Intron2-4	+	GACUAUGAGUGGCCCAA	17	15104
CFTR-Intron2-5	−	GCCUUGCUCUCUAGGAA	17	15105
CFTR-Intron2-6	+	GCUCUAAAUCACUCUAA	17	15106
CFTR-Intron2-7	−	GGGAAGUCUUAAGGUAA	17	15107
CFTR-Intron2-8	+	GUUACCAUAAGUAAACA	17	15108
CFTR-Intron2-9	+	GCAAAGAGUUCUAACCA	17	15109
CFTR-Intron2-10	−	GGAACUCAAUGGGACCA	17	15110
CFTR-Intron2-11	−	GCUCAAUUUUGUGACCA	17	15111
CFTR-Intron2-12	+	GCCAGGGUCACUUCCCA	17	15112
CFTR-Intron2-13	+	GUAGAGGAUUCAAUCCA	17	15113
CFTR-Intron2-14	+	GACCUCAGCUGGAAUCA	17	15114
CFTR-Intron2-15	+	GUAGUUACCUGAGGAGA	17	15115
CFTR-Intron2-16	−	GGAGAAGCAUGUGGGGA	17	15116
CFTR-Intron2-17	+	GUCCCAUUGAGUUCCUA	17	15117
CFTR-Intron2-18	−	GCAAAUGCCAUGAGGUA	17	15118
CFTR-Intron2-19	+	GAGGUCUCUAGUGACCC	17	15119
CFTR-Intron2-20	+	GCAAUACAGACCUCAGC	17	15120
CFTR-Intron2-21	−	GAAACCUGUAGCAUUGC	17	15121
CFTR-Intron2-22	+	GAUUCAUGUUCUCUAUC	17	15122
CFTR-Intron2-23	−	GAAUUUGCAGAAUUAUC	17	15123
CFTR-Intron2-24	−	GACCUUGCCUUCUCCUC	17	15124
CFTR-Intron2-25	−	GUUCCAAGAUUGUAGUC	17	15125
CFTR-Intron2-26	+	GGUUCAAUGUGAAAAAG	17	15126
CFTR-Intron2-27	+	GUAAUAGGCCGGGGCAG	17	15127
CFTR-Intron2-28	+	GCUUUACGUUUCAUCAG	17	15128
CFTR-Intron2-29	+	GAGAGAUUCUUUAUGGG	17	15129
CFTR-Intron2-30	−	GAUCUGGGCCUGGUAUG	17	15130
CFTR-Intron2-31	−	GGCCUUAGGAACUCAAU	17	15131
CFTR-Intron2-32	−	GGUAACUUGACAGUAAU	17	15132
CFTR-Intron2-33	+	GAUCCUAACCUUUUGAU	17	15133
CFTR-Intron2-34	+	GUGAAACUUGAACAACU	17	15134
CFTR-Intron2-35	−	GAACUAUGUGAAGACCU	17	15135
CFTR-Intron2-36	+	GGUGGCAUUUGAGUCCU	17	15136
CFTR-Intron2-37	−	GUAUUGCCUUGCUCUCU	17	15137
CFTR-Intron2-38	−	GAAUGAUUAAUCAGAGU	17	15138
CFTR-Intron2-39	+	GGUGAUGUGGUUCUAGU	17	15139
CFTR-Intron2-40	−	GGUGGAGAACUGGCCUU	17	15140
CFTR-Intron2-41	−	GAGUGACAUACCAUUUU	17	15141
CFTR-Intron2-42	+	GCCUUCAAAAUGCCAAAAAA	20	15142
CFTR-Intron2-43	+	GAGGUACAAAGUACCAAAAA	20	15143
CFTR-Intron2-44	+	GUGUACAUAAACCAACAAAA	20	15144
CFTR-Intron2-45	−	GGUAAUUAGGCUUUAUAGAA	20	15145
CFTR-Intron2-46	+	GCAAUGUAGUUUUAGGAACA	20	15146
CFTR-Intron2-47	+	GGAGCAAAGAGUUCUAACCA	20	15147
CFTR-Intron2-48	+	GAAGCCAGGGUCACUUCCCA	20	15148
CFTR-Intron2-49	+	GGAUUUUUCACAUUUAGCCA	20	15149
CFTR-Intron2-50	−	GAUUCACACUUCUAAGAUCA	20	15150
CFTR-Intron2-51	−	GCCCUCAAGUGGUUGCCAGA	20	15151
CFTR-Intron2-52	+	GGGGUAGUUACCUGAGGAGA	20	15152
CFTR-Intron2-53	−	GGUGGAGAAGCAUGUGGGGA	20	15153
CFTR-Intron2-54	−	GAGUAACCAAAUGUUAUGGA	20	15154
CFTR-Intron2-55	−	GGGAAUGAUUAAUCAGAGUA	20	15155
CFTR-Intron2-56	−	GUACUCCCUGGGAAGUCUUA	20	15156
CFTR-Intron2-57	+	GGAAACUGAGAGAUUCUUUA	20	15157
CFTR-Intron2-58	−	GAGUCUCGUGCCAACAGCAC	20	15158
CFTR-Intron2-59	+	GUAAAUUGGGUUUCUGUCAC	20	15159
CFTR-Intron2-60	+	GAAAGUGAAGUAGAGAGACC	20	15160
CFTR-Intron2-61	−	GCACCCUUGGGAAGUGACCC	20	15161
CFTR-Intron2-62	−	GCUAACAUUCUCUGCUCUCC	20	15162
CFTR-Intron2-63	+	GUUAAUGUUCUUCAACCAUC	20	15163
CFTR-Intron2-64	−	GACCAGCUUUCUACAUAAAG	20	15164
CFTR-Intron2-65	+	GUGUUGUUAUAUUUCAUAAG	20	15165
CFTR-Intron2-66	+	GGAGUAAUAGGCCGGGGCAG	20	15166
CFTR-Intron2-67	+	GUCACUUCCCAAGGGUGCAG	20	15167
CFTR-Intron2-68	−	GAUAAAAGGGUGAGUGAAGG	20	15168
CFTR-Intron2-69	−	GAACUAUGUGAAGACCUAGG	20	15169
CFTR-Intron2-70	−	GUUUACCUAGUUCUUCCUUG	20	15170
CFTR-Intron2-71	+	GGUCGGGGAAUUUCUUUAAU	20	15171
CFTR-Intron2-72	+	GUCACAAAAUUGAGCCAGAU	20	15172
CFTR-Intron2-73	+	GAAACUGAGAGAUUCUUUAU	20	15173
CFTR-Intron2-74	−	GAGUCAUAGUGCUUACCCCU	20	15174
CFTR-Intron2-75	−	GCUCUCAUUAGCAAGCUUCU	20	15175
CFTR-Intron2-76	+	GUAGGUGAUGUGGUUCUAGU	20	15176
CFTR-Intron2-77	−	GAAGAGUGACAUACCAUUUU	20	15177

Table 37B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 2 and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 37B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-78	−	CCUGAUGCCAGAUAAAA	17	15178
CFTR-Intron2-79	+	AUUUAGCCAAGGACAAA	17	15179
CFTR-Intron2-80	+	CAUUUAGCCAAGGACAA	17	15180
CFTR-Intron2-81	+	CCAGGGUCACUUCCCAA	17	15181
CFTR-Intron2-82	+	UGUCAAUAUACCUGCAA	17	15182
CFTR-Intron2-83	+	CUCACCUUCUCCAUCAA	17	15183
CFTR-Intron2-84	−	CACACUUCUAAGAUCAA	17	15184
CFTR-Intron2-85	−	UGGCCUUAGGAACUCAA	17	15185
CFTR-Intron2-86	+	CCAGGCCCAGAUCAGAA	17	15186
CFTR-Intron2-87	−	AAUUAGGCUUUAUAGAA	17	15187
CFTR-Intron2-88	+	ACGGAAGUAAUGUAGAA	17	15188
CFTR-Intron2-89	+	UAACCUUUUGAUUGGAA	17	15189
CFTR-Intron2-90	+	UGACUACAAUCUUGGAA	17	15190
CFTR-Intron2-91	+	CACGAUUUACUUCAUAA	17	15191
CFTR-Intron2-92	−	UGGUAACUUGACAGUAA	17	15192
CFTR-Intron2-93	+	UCGGGGAAUUUCUUUAA	17	15193
CFTR-Intron2-94	+	AUGUAGUUUUAGGAACA	17	15194
CFTR-Intron2-95	+	AAAUUUCAUGAACCACA	17	15195
CFTR-Intron2-96	+	UGAAAAAGUGGUCCACA	17	15196
CFTR-Intron2-97	+	UGAGGGCCAUGGUCACA	17	15197
CFTR-Intron2-98	−	UAACUGCCUUGUGACCA	17	15198
CFTR-Intron2-99	+	AGACUAUGAGUGGCCCA	17	15199
CFTR-Intron2-100	−	UAAAACUACAUUGCCCA	17	15200
CFTR-Intron2-101	+	UACCUUAAGACUUCCCA	17	15201
CFTR-Intron2-102	+	UUUUUCACAUUUAGCCA	17	15202
CFTR-Intron2-103	+	CAACCACUUGAGGGCCA	17	15203
CFTR-Intron2-104	+	CUGGCAAUCUCUAAGCA	17	15204
CFTR-Intron2-105	+	ACCAUUCCUAGAGAGCA	17	15205
CFTR-Intron2-106	+	UACCUGAGGAGAAGGCA	17	15206
CFTR-Intron2-107	−	UCACACUUCUAAGAUCA	17	15207
CFTR-Intron2-108	+	AAAGUAUCCCUACCUCA	17	15208
CFTR-Intron2-109	+	UCACAAAAUCCAUCUCA	17	15209
CFTR-Intron2-110	−	UUAAGGACCACGAAAGA	17	15210
CFTR-Intron2-111	−	CUCAAGUGGUUGCCAGA	17	15211
CFTR-Intron2-112	+	ACCAGGCCCAGAUCAGA	17	15212
CFTR-Intron2-113	−	UAAUUAGGCUUUAUAGA	17	15213
CFTR-Intron2-114	−	UAACCAAAUGUUAUGGA	17	15214
CFTR-Intron2-115	−	UGCCAGUUAAUGAAUGA	17	15215
CFTR-Intron2-116	+	AUCUGGCAACCACUUGA	17	15216
CFTR-Intron2-117	−	UCAUUAGCAAGCUUCUA	17	15217
CFTR-Intron2-118	−	UCUCAGCUCCUGAAGUA	17	15218
CFTR-Intron2-119	−	AAUGAUUAAUCAGAGUA	17	15219
CFTR-Intron2-120	−	AGAGCCAUGUUUACUUA	17	15220
CFTR-Intron2-121	−	CUCCCUGGGAAGUCUUA	17	15221
CFTR-Intron2-122	−	UGAGUAACCAAAUGUUA	17	15222
CFTR-Intron2-123	−	CUUUGCUCCUAUCUUUA	17	15223
CFTR-Intron2-124	+	AACUGAGAGAUUCUUUA	17	15224
CFTR-Intron2-125	+	UUAAAUAGUCUGAAAAC	17	15225
CFTR-Intron2-126	−	AGACCUAGGUGGAGAAC	17	15226
CFTR-Intron2-127	+	UCUACCUGGCAUGUAAC	17	15227
CFTR-Intron2-128	+	CUCCAUCAUUCAUUAAC	17	15228
CFTR-Intron2-129	−	UCUCGUGCCAACAGCAC	17	15229
CFTR-Intron2-130	−	CUUAAGGUAAUGGCUAC	17	15230
CFTR-Intron2-131	+	CUCUCCAGCAAUGCUAC	17	15231
CFTR-Intron2-132	+	AACGUAUGGGUUUGUAC	17	15232
CFTR-Intron2-133	+	AGCAAAGAGUUCUAACC	17	15233
CFTR-Intron2-134	+	AUAAGGCAAAUGCCACC	17	15234
CFTR-Intron2-135	−	AGGACUCAAAUGCCACC	17	15235
CFTR-Intron2-136	+	AGUGAAGUAGAGAGACC	17	15236
CFTR-Intron2-137	+	UAGUAGGACCACAUACC	17	15237
CFTR-Intron2-138	+	AGAGGAGAUAUUCUACC	17	15238
CFTR-Intron2-139	−	CCCUUGGGAAGUGACCC	17	15239
CFTR-Intron2-140	−	CUAAAACUACAUUGCCC	17	15240
CFTR-Intron2-141	−	AAUACAAAUGUACUCCC	17	15241
CFTR-Intron2-142	−	UACAUAAAGUGGGUCCC	17	15242
CFTR-Intron2-143	+	UUACCUUAAGACUUCCC	17	15243
CFTR-Intron2-144	+	UUAUGAAAUGUGAAGCC	17	15244
CFTR-Intron2-145	+	UAAAGGAGUAAUAGGCC	17	15245
CFTR-Intron2-146	−	CAUGCUUAGAGAUUGCC	17	15246
CFTR-Intron2-147	+	ACUUAGAUAUUCAAAGC	17	15247
CFTR-Intron2-148	+	CACUUUAUGUAGAAAGC	17	15248
CFTR-Intron2-149	+	UGUUCAAUAAUAGAAGC	17	15249
CFTR-Intron2-150	−	UAAUAAAUACAAUCAGC	17	15250
CFTR-Intron2-151	+	CUAAAGGAGUAAUAGGC	17	15251
CFTR-Intron2-152	−	AUUAAUCAGAGUAGGGC	17	15252
CFTR-Intron2-153	−	UGGCAUUUGCCUUAUGC	17	15253
CFTR-Intron2-154	−	UAAACAUAAUCCAUUGC	17	15254
CFTR-Intron2-155	+	AAUGUUCUUCAACCAUC	17	15255
CFTR-Intron2-156	+	CCCUUUUAUCUGGCAUC	17	15256
CFTR-Intron2-157	−	AAGAACAUUAACCUAUC	17	15257
CFTR-Intron2-158	+	UCACUCACCCUUUUAUC	17	15258
CFTR-Intron2-159	+	UAUGACUCAAGAGUCUC	17	15259
CFTR-Intron2-160	+	UAUGUAGAAAGCUGGUC	17	15260
CFTR-Intron2-161	+	AGGUCUUCACAUAGUUC	17	15261
CFTR-Intron2-162	−	CAGCUUUCUACAUAAAG	17	15262
CFTR-Intron2-163	+	ACUAUGAGUGGCCCAAG	17	15263
CFTR-Intron2-164	−	UGACCAUGGCCCUCAAG	17	15264
CFTR-Intron2-165	+	UUGUUAUAUUUCAUAAG	17	15265
CFTR-Intron2-166	+	ACUUCCCAAGGGUGCAG	17	15266
CFTR-Intron2-167	+	AUGCUUUCCACUCAGAG	17	15267
CFTR-Intron2-168	+	UCAUUCUAGACUAUGAG	17	15268
CFTR-Intron2-169	−	UCAAAGAAUUAAGCUAG	17	15269
CFTR-Intron2-170	−	CAUUAGCAAGCUUCUAG	17	15270
CFTR-Intron2-171	+	ACACUGCAGUUAUGUAG	17	15271
CFTR-Intron2-172	+	AAAGGAGUAAUAGGCCG	17	15272
CFTR-Intron2-173	+	AGGAGAAGGCAAGGUCG	17	15273
CFTR-Intron2-174	+	AAGGGCUCCUUCUUUCG	17	15274
CFTR-Intron2-175	−	CUAUGUGAAGACCUAGG	17	15275
CFTR-Intron2-176	+	AGAGAUUCUUUAUGGGG	17	15276
CFTR-Intron2-177	−	UGGAGAAGCAUGUGGGG	17	15277
CFTR-Intron2-178	−	CAAAUGUUAUGGAUGGG	17	15278
CFTR-Intron2-179	+	UAGUUUUAGGAACAUGG	17	15279
CFTR-Intron2-180	+	UGAGAGAUUCUUUAUGG	17	15280
CFTR-Intron2-181	−	ACUCAAAUGCCACCUGG	17	15281
CFTR-Intron2-182	+	UAAAUUGAAUCAACAUG	17	15282
CFTR-Intron2-183	−	UGUGUGCAAAUGCCAUG	17	15283
CFTR-Intron2-184	−	AAAGGUGGAGAAGCAUG	17	15284
CFTR-Intron2-185	+	AAUGGGGUAGUUACCUG	17	15285
CFTR-Intron2-186	−	AGCCAUGAUUCCAGCUG	17	15286
CFTR-Intron2-187	−	UCUACAUUACUUCCGUG	17	15287
CFTR-Intron2-188	+	AUCUUGGAACGGAUGUG	17	15288
CFTR-Intron2-189	+	CAUCUGGCAACCACUUG	17	15289
CFTR-Intron2-190	+	CCUAUUCUAGGCACUUG	17	15290
CFTR-Intron2-191	−	UACCUAGUUCUUCCUUG	17	15291
CFTR-Intron2-192	−	UUGGUGCUAACAAUUUG	17	15292
CFTR-Intron2-193	+	UACUUAAGCUAGUAAAU	17	15293
CFTR-Intron2-194	−	CCCCAAGUGCCUAGAAU	17	15294
CFTR-Intron2-195	+	CACUCUAAAGGAGUAAU	17	15295
CFTR-Intron2-196	+	CGGGGAAUUUCUUUAAU	17	15296
CFTR-Intron2-197	+	UCGUGGUCCUUAAAGAU	17	15297
CFTR-Intron2-198	+	ACAAAAUUGAGCCAGAU	17	15298
CFTR-Intron2-199	−	UGGGGAGGGAAAUAGAU	17	15299
CFTR-Intron2-200	−	AACCAAAUGUUAUGGAU	17	15300
CFTR-Intron2-201	+	AAAAUAAUAGAACGUAU	17	15301
CFTR-Intron2-202	−	AAAAGGAACGAAUUUAU	17	15302
CFTR-Intron2-203	+	ACUGAGAGAUUCUUUAU	17	15303
CFTR-Intron2-204	+	AACCACAAGGAAGAACU	17	15304
CFTR-Intron2-205	−	AUAGUCUAGAAUGAACU	17	15305
CFTR-Intron2-206	+	AGGCCAGUUCUCCACCU	17	15306
CFTR-Intron2-207	−	UUGUACCUCUGCACCCU	17	15307
CFTR-Intron2-208	+	AGGUCUCUAGUGACCCU	17	15308
CFTR-Intron2-209	−	UCAUAGUGCUUACCCCU	17	15309
CFTR-Intron2-210	−	AUACAAAUGUACUCCCU	17	15310
CFTR-Intron2-211	−	UGUACACACCCCUUCCU	17	15311
CFTR-Intron2-212	+	CUUAGAUAUUCAAAGCU	17	15312
CFTR-Intron2-213	−	UUAAUCAGAGUAGGGCU	17	15313
CFTR-Intron2-214	+	UAUCCUGACUACAAUCU	17	15314
CFTR-Intron2-215	+	UCUCUAAGCAUGGAUCU	17	15315
CFTR-Intron2-216	−	ACCACAUCACCUACUCU	17	15316
CFTR-Intron2-217	+	AUGACUCAAGAGUCUCU	17	15317
CFTR-Intron2-218	−	CUCAUUAGCAAGCUUCU	17	15318
CFTR-Intron2-219	+	UUGUUAGCACCAAGAGU	17	15319
CFTR-Intron2-220	−	CAAAGAAUUAAGCUAGU	17	15320
CFTR-Intron2-221	−	AAGGUGGAGAAGCAUGU	17	15321
CFTR-Intron2-222	+	CAUCAGGCCUGUGCUGU	17	15322
CFTR-Intron2-223	−	CAUUGAACCCAUUUUGU	17	15323
CFTR-Intron2-224	+	ACUUAAGCUAGUAAAUU	17	15324
CFTR-Intron2-225	+	CUCCCAUCCAUAACAUU	17	15325
CFTR-Intron2-226	−	UGUACCUCUGCACCCUU	17	15326
CFTR-Intron2-227	−	CAUAGUGCUUACCCCUU	17	15327
CFTR-Intron2-228	−	UUUCCAAUCAAAAGGUU	17	15328
CFTR-Intron2-229	−	AGGCCUGAUGCCAGAUAAAA	20	15329
CFTR-Intron2-230	+	CUUCUCCAUCAAAGGAGAAA	20	15330
CFTR-Intron2-231	−	AUCCAUGAUGGAAUGUGAAA	20	15331
CFTR-Intron2-232	−	CAGGCCUGAUGCCAGAUAAA	20	15332
CFTR-Intron2-233	+	AGCCUUUUUUCUCUUCACAA	20	15333
CFTR-Intron2-234	+	CUAGGUAAACAAUUAGACAA	20	15334
CFTR-Intron2-235	+	UCACAUUUAGCCAAGGACAA	20	15335
CFTR-Intron2-236	+	CUAGACUAUGAGUGGCCCAA	20	15336
CFTR-Intron2-237	+	AAGCCAGGGUCACUUCCCAA	20	15337
CFTR-Intron2-238	+	ACUUGUCAAUAUACCUGCAA	20	15338
CFTR-Intron2-239	+	AGACUCACCUUCUCCAUCAA	20	15339
CFTR-Intron2-240	−	AUUCACACUUCUAAGAUCAA	20	15340
CFTR-Intron2-241	−	AACUGGCCUUAGGAACUCAA	20	15341
CFTR-Intron2-242	+	AUACCAGGCCCAGAUCAGAA	20	15342
CFTR-Intron2-243	−	UAGCUCUGUGUGUGAGAGAA	20	15343
CFTR-Intron2-244	+	CACACGGAAGUAAUGUAGAA	20	15344
CFTR-Intron2-245	−	AUUGCCUUGCUCUCUAGGAA	20	15345
CFTR-Intron2-246	+	UCCUAACCUUUUGAUUGGAA	20	15346
CFTR-Intron2-247	+	UCCUGACUACAAUCUUGGAA	20	15347
CFTR-Intron2-248	−	CAGAUAAAAGGGUGAGUGAA	20	15348
CFTR-Intron2-249	+	AUACACGAUUUACUUCAUAA	20	15349
CFTR-Intron2-250	+	AUGGCUCUAAAUCACUCUAA	20	15350
CFTR-Intron2-251	−	UUAUGGUAACUUGACAGUAA	20	15351
CFTR-Intron2-252	−	CCUGGGAAGUCUUAAGGUAA	20	15352
CFTR-Intron2-253	+	CUACUAAAAUCAUGUAUUAA	20	15353
CFTR-Intron2-254	+	AGGUCGGGGAAUUUCUUUAA	20	15354
CFTR-Intron2-255	+	CAAGUUACCAUAAGUAAACA	20	15355
CFTR-Intron2-256	+	AUGUGAAAAAGUGGUCCACA	20	15356
CFTR-Intron2-257	+	ACUUGAGGGCCAUGGUCACA	20	15357
CFTR-Intron2-258	−	UUAGGAACUCAAUGGGACCA	20	15358
CFTR-Intron2-259	−	UCAUAACUGCCUUGUGACCA	20	15359
CFTR-Intron2-260	−	CUGGCUCAAUUUUGUGACCA	20	15360
CFTR-Intron2-261	+	UCUAGACUAUGAGUGGCCCA	20	15361
CFTR-Intron2-262	−	UCCUAAAACUACAUUGCCCA	20	15362
CFTR-Intron2-263	+	CAUUACCUUAAGACUUCCCA	20	15363
CFTR-Intron2-264	+	AGUUAUGAAAUGUGAAGCCA	20	15364
CFTR-Intron2-265	+	UGGCAACCACUUGAGGGCCA	20	15365
CFTR-Intron2-266	+	UAUGUAGAGGAUUCAAUCCA	20	15366
CFTR-Intron2-267	+	AGCCUGGCAAUCUCUAAGCA	20	15367
CFTR-Intron2-268	+	ACUACCAUUCCUAGAGAGCA	20	15368
CFTR-Intron2-269	+	AGUUACCUGAGGAGAAGGCA	20	15369
CFTR-Intron2-270	+	ACAGACCUCAGCUGGAAUCA	20	15370
CFTR-Intron2-271	+	AGCCAUUUCACAUUCCAUCA	20	15371
CFTR-Intron2-272	+	AACAAAGUAUCCCUACCUCA	20	15372
CFTR-Intron2-273	+	UUUUCACAAAAUCCAUCUCA	20	15373
CFTR-Intron2-274	−	UCUUUAAGGACCACGAAAGA	20	15374
CFTR-Intron2-275	+	CAUACCAGGCCCAGAUCAGA	20	15375
CFTR-Intron2-276	+	CAAAGGAGAAAUGGAUCAGA	20	15376
CFTR-Intron2-277	−	UCUUAUUAGAGACCAUGAGA	20	15377
CFTR-Intron2-278	−	CAUGUGGGGAGGGAAAUAGA	20	15378
CFTR-Intron2-279	−	AGGUAAUUAGGCUUUAUAGA	20	15379
CFTR-Intron2-280	+	UCAGAUGGGAAAGCCAAGGA	20	15380
CFTR-Intron2-281	−	CUUUGCCAGUUAAUGAAUGA	20	15381
CFTR-Intron2-282	−	AAGUUUUAAUUGGAUGCUGA	20	15382
CFTR-Intron2-283	−	CCAGAUAAAAGGGUGAGUGA	20	15383
CFTR-Intron2-284	+	ACCAUCUGGCAACCACUUGA	20	15384
CFTR-Intron2-285	−	CUGAUCCAUUUCUCCUUUGA	20	15385
CFTR-Intron2-286	−	UCCUUUUUUUGGCAUUUUGA	20	15386
CFTR-Intron2-287	+	UCAGAGUAAGAAGCUAAAUA	20	15387
CFTR-Intron2-288	−	AUCCCCAAGUGCCUAGAAUA	20	15388
CFTR-Intron2-289	+	UUGGUCCCAUUGAGUUCCUA	20	15389
CFTR-Intron2-290	−	CUCUCAUUAGCAAGCUUCUA	20	15390
CFTR-Intron2-291	−	ACAUCUCAGCUCCUGAAGUA	20	15391
CFTR-Intron2-292	−	UGUGCAAAUGCCAUGAGGUA	20	15392
CFTR-Intron2-293	−	UUUAGAGCCAUGUUUACUUA	20	15393
CFTR-Intron2-294	−	CUCUGAGUAACCAAAUGUUA	20	15394
CFTR-Intron2-295	−	ACUCUUUGCUCCUAUCUUUA	20	15395
CFTR-Intron2-296	+	ACAUUAAAUAGUCUGAAAAC	20	15396
CFTR-Intron2-297	+	AUGGGGGAUACAGUGAAAAC	20	15397
CFTR-Intron2-298	−	UGAAGACCUAGGUGGAGAAC	20	15398
CFTR-Intron2-299	+	UAUUCUACCUGGCAUGUAAC	20	15399
CFTR-Intron2-300	+	UGGCUCCAUCAUUCAUUAAC	20	15400
CFTR-Intron2-301	−	CUGGUUUUAUUUUCUCAGAC	20	15401
CFTR-Intron2-302	−	AGUCUUAAGGUAAUGGCUAC	20	15402
CFTR-Intron2-303	+	UAUCUCUCCAGCAAUGCUAC	20	15403
CFTR-Intron2-304	+	UAGAACGUAUGGGUUUGUAC	20	15404
CFTR-Intron2-305	+	AGGAGCAAAGAGUUCUAACC	20	15405
CFTR-Intron2-306	+	AGCAUAAGGCAAAUGCCACC	20	15406
CFTR-Intron2-307	−	CCAAGGACUCAAAUGCCACC	20	15407
CFTR-Intron2-308	+	UUCUAGUAGGACCACAUACC	20	15408
CFTR-Intron2-309	+	CUGAGAGGAGAUAUUCUACC	20	15409
CFTR-Intron2-310	+	UAAGAGGUCUCUAGUGACCC	20	15410
CFTR-Intron2-311	−	UUCCUAAAACUACAUUGCCC	20	15411
CFTR-Intron2-312	−	UUGAAUACAAAUGUACUCCC	20	15412
CFTR-Intron2-313	−	UUCUACAUAAAGUGGGUCCC	20	15413
CFTR-Intron2-314	+	CCAUUACCUUAAGACUUCCC	20	15414
CFTR-Intron2-315	+	CAGUUAUGAAAUGUGAAGCC	20	15415
CFTR-Intron2-316	−	CUUCCCUUCUGAUCUGGGCC	20	15416
CFTR-Intron2-317	−	AUCCAUGCUUAGAGAUUGCC	20	15417
CFTR-Intron2-318	+	AAAACUUAGAUAUUCAAAGC	20	15418
CFTR-Intron2-319	+	ACCCACUUUAUGUAGAAAGC	20	15419
CFTR-Intron2-320	+	AAGUGUUCAAUAAUAGAAGC	20	15420
CFTR-Intron2-321	−	ACUUAAUAAAUACAAUCAGC	20	15421
CFTR-Intron2-322	+	AAGGCAAUACAGACCUCAGC	20	15422
CFTR-Intron2-323	−	AUGAUUAAUCAGAGUAGGGC	20	15423
CFTR-Intron2-324	−	AUAUAAACAUAAUCCAUUGC	20	15424
CFTR-Intron2-325	−	AUAGAAACCUGUAGCAUUGC	20	15425
CFTR-Intron2-326	−	AAACUUCUUCCCUUCUGAUC	20	15426
CFTR-Intron2-327	−	UUGAAGAACAUUAACCUAUC	20	15427
CFTR-Intron2-328	+	UCAGAUUCAUGUUCUCUAUC	20	15428
CFTR-Intron2-329	−	UCUGAAUUUGCAGAAUUAUC	20	15429
CFTR-Intron2-330	−	CCCGACCUUGCCUUCUCCUC	20	15430
CFTR-Intron2-331	+	CACUAUGACUCAAGAGUCUC	20	15431
CFTR-Intron2-332	−	UCCGUUCCAAGAUUGUAGUC	20	15432
CFTR-Intron2-333	+	CCUGAGGAGAAGGCAAGGUC	20	15433
CFTR-Intron2-334	+	CUUUAUGUAGAAAGCUGGUC	20	15434
CFTR-Intron2-335	+	CCUAGGUCUUCACAUAGUUC	20	15435
CFTR-Intron2-336	+	AUGGGUUCAAUGUGAAAAAG	20	15436
CFTR-Intron2-337	+	UAGACUAUGAGUGGCCCAAG	20	15437
CFTR-Intron2-338	−	UUGUGACCAUGGCCCUCAAG	20	15438
CFTR-Intron2-339	−	CUUUCAUUAACAGAAAUCAG	20	15439
CFTR-Intron2-340	+	AAGGCUUUACGUUUCAUCAG	20	15440
CFTR-Intron2-341	+	AUGAUGCUUUCCACUCAGAG	20	15441
CFTR-Intron2-342	+	AGUUCAUUCUAGACUAUGAG	20	15442
CFTR-Intron2-343	+	UUCCACUCAGAGUGGCUGAG	20	15443
CFTR-Intron2-344	−	CUCCUCUCAGCCACUCUGAG	20	15444
CFTR-Intron2-345	−	UAUUCAAAGAAUUAAGCUAG	20	15445
CFTR-Intron2-346	−	UCUCAUUAGCAAGCUUCUAG	20	15446
CFTR-Intron2-347	+	UGCACACUGCAGUUAUGUAG	20	15447
CFTR-Intron2-348	+	UCUAAAGGAGUAAUAGGCCG	20	15448
CFTR-Intron2-349	+	CUGAGGAGAAGGCAAGGUCG	20	15449
CFTR-Intron2-350	+	AUAAGGCAAAUGCCACCAGG	20	15450
CFTR-Intron2-351	+	CUGAGAGAUUCUUUAUGGGG	20	15451
CFTR-Intron2-352	−	AACCAAAUGUUAUGGAUGGG	20	15452
CFTR-Intron2-353	+	ACUGAGAGAUUCUUUAUGGG	20	15453
CFTR-Intron2-354	+	UUUAAAUUGAAUCAACAUGG	20	15454
CFTR-Intron2-355	+	AUGUAGUUUUAGGAACAUGG	20	15455
CFTR-Intron2-356	+	AACUGAGAGAUUCUUUAUGG	20	15456
CFTR-Intron2-357	−	AGGACUCAAAUGCCACCUGG	20	15457
CFTR-Intron2-358	+	UUUUAAAUUGAAUCAACAUG	20	15458
CFTR-Intron2-359	+	AGCACCAAGAGUAGGUGAUG	20	15459
CFTR-Intron2-360	−	UCUGAUCUGGGCCUGGUAUG	20	15460
CFTR-Intron2-361	+	AAACUGAGAGAUUCUUUAUG	20	15461
CFTR-Intron2-362	+	UAGAAUGGGGUAGUUACCUG	20	15462
CFTR-Intron2-363	−	UGGAGCCAUGAUUCCAGCUG	20	15463
CFTR-Intron2-364	−	UAAGUUUUAAUUGGAUGCUG	20	15464
CFTR-Intron2-365	−	CUUUCUACAUUACUUCCGUG	20	15465
CFTR-Intron2-366	+	ACAAUCUUGGAACGGAUGUG	20	15466
CFTR-Intron2-367	+	AACCAUCUGGCAACCACUUG	20	15467
CFTR-Intron2-368	−	CUCUUGGUGCUAACAAUUUG	20	15468
CFTR-Intron2-369	+	UGUACAUAAACCAACAAAAU	20	15469
CFTR-Intron2-370	+	AUUUACUUAAGCUAGUAAAU	20	15470
CFTR-Intron2-371	−	ACUGGCCUUAGGAACUCAAU	20	15471
CFTR-Intron2-372	−	CAAGUUCAAAAUAAUAUAAU	20	15472
CFTR-Intron2-373	−	UAUGGUAACUUGACAGUAAU	20	15473
CFTR-Intron2-374	+	AAUCACUCUAAAGGAGUAAU	20	15474
CFTR-Intron2-375	+	CUUUCGUGGUCCUUAAAGAU	20	15475
CFTR-Intron2-376	+	AAAGGAGAAAUGGAUCAGAU	20	15476
CFTR-Intron2-377	−	AUGUGGGGAGGGAAAUAGAU	20	15477
CFTR-Intron2-378	−	AGUAACCAAAUGUUAUGGAU	20	15478
CFTR-Intron2-379	+	AAGGAUCCUAACCUUUUGAU	20	15479
CFTR-Intron2-380	+	ACAAAAAUAAUAGAACGUAU	20	15480
CFTR-Intron2-381	−	AAUAAAAGGAACGAAUUUAU	20	15481
CFTR-Intron2-382	+	UGGGUGAAACUUGAACAACU	20	15482
CFTR-Intron2-383	+	AUGAACCACAAGGAAGAACU	20	15483
CFTR-Intron2-384	−	CUCAUAGUCUAGAAUGAACU	20	15484
CFTR-Intron2-385	−	AGCUUCUAUUAUUGAACACU	20	15485
CFTR-Intron2-386	+	CUAAGGCCAGUUCUCCACCU	20	15486
CFTR-Intron2-387	−	CCUGAACUAUGUGAAGACCU	20	15487
CFTR-Intron2-388	+	AAGAGGUCUCUAGUGACCCU	20	15488
CFTR-Intron2-389	−	UGAAUACAAAUGUACUCCCU	20	15489
CFTR-Intron2-390	+	CCAGGUGGCAUUUGAGUCCU	20	15490
CFTR-Intron2-391	−	AAGAAGGAGCCCUUUGUCCU	20	15491
CFTR-Intron2-392	−	UUAUGUACACACCCCUUCCU	20	15492
CFTR-Intron2-393	+	AAACUUAGAUAUUCAAAGCU	20	15493
CFTR-Intron2-394	−	UGAUUAAUCAGAGUAGGGCU	20	15494
CFTR-Intron2-395	+	UCAUAUCCUGACUACAAUCU	20	15495
CFTR-Intron2-396	+	CAAUCUCUAAGCAUGGAUCU	20	15496
CFTR-Intron2-397	−	AACUUCUUCCCUUCUGAUCU	20	15497
CFTR-Intron2-398	−	AGAACCACAUCACCUACUCU	20	15498
CFTR-Intron2-399	−	UCUGUAUUGCCUUGCUCUCU	20	15499
CFTR-Intron2-400	+	ACUAUGACUCAAGAGUCUCU	20	15500
CFTR-Intron2-401	−	ACCAGCUUUCUACAUAAAGU	20	15501
CFTR-Intron2-402	+	AAAUUGUUAGCACCAAGAGU	20	15502
CFTR-Intron2-403	−	AGGGAAUGAUUAAUCAGAGU	20	15503
CFTR-Intron2-404	−	AUUCAAAGAAUUAAGCUAGU	20	15504
CFTR-Intron2-405	+	ACCUGAGGAGAAGGCAAGGU	20	15505
CFTR-Intron2-406	−	AGAAAGGUGGAGAAGCAUGU	20	15506
CFTR-Intron2-407	+	UGGCAUCAGGCCUGUGCUGU	20	15507
CFTR-Intron2-408	−	UCACAUUGAACCCAUUUUGU	20	15508
CFTR-Intron2-409	−	AUAGAUGGGAAAAGGUAAUU	20	15509
CFTR-Intron2-410	+	AACCUCCCAUCCAUAACAUU	20	15510
CFTR-Intron2-411	+	UCAACUCAAUGUUUUUACUU	20	15511
CFTR-Intron2-412	−	CUUUGUACCUCUGCACCCUU	20	15512
CFTR-Intron2-413	−	AGUCAUAGUGCUUACCCCUU	20	15513
CFTR-Intron2-414	−	CUAGGUGGAGAACUGGCCUU	20	15514
CFTR-Intron2-415	−	UCCUUUCCAAUCAAAAGGUU	20	15515
CFTR-Intron2-416	+	ACCCUGGGCAAUGUAGUUUU	20	15516

Table 37C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within intron 2 and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 37C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-417	−	GGGAAAUAGAUGGGAAA	17	15517
CFTR-Intron2-418	+	GACCAGCCUGGCCAACA	17	15518
CFTR-Intron2-419	−	GCUAAUUUUUGUAGAGA	17	15519
CFTR-Intron2-420	−	GUGGGGAGGGAAAUAGA	17	15520
CFTR-Intron2-421	+	GAUGGGAAAGCCAAGGA	17	15521
CFTR-Intron2-422	−	GUUGAAUGAAUCCAUGA	17	15522
CFTR-Intron2-423	−	GAUAAAAGGGUGAGUGA	17	15523
CFTR-Intron2-424	+	GAGUAAGAAGCUAAAUA	17	15524
CFTR-Intron2-425	−	GAAUAGGGCCUGGCAUA	17	15525
CFTR-Intron2-426	+	GGGGAUACAGUGAAAAC	17	15526
CFTR-Intron2-427	−	GUUUUAUUUUCUCAGAC	17	15527
CFTR-Intron2-428	+	GAGAAUCACUUGAACCC	17	15528
CFTR-Intron2-429	+	GAGAUUCGCUUGAACCC	17	15529
CFTR-Intron2-430	−	GUCUCGCUGUGUCACCC	17	15530
CFTR-Intron2-431	−	GGCGUGAGCCACUGCCC	17	15531
CFTR-Intron2-432	−	GUCUUGCUCUGUUGCCC	17	15532
CFTR-Intron2-433	+	GGAGUUCAAGACCAGCC	17	15533
CFTR-Intron2-434	−	GCAUGCACCACCAGGCC	17	15534
CFTR-Intron2-435	−	GUGCCUAGAAUAGGGCC	17	15535
CFTR-Intron2-436	−	GUUUUGCUAUGCUGGCC	17	15536
CFTR-Intron2-437	−	GUUUCGCCAUGUUGGCC	17	15537
CFTR-Intron2-438	−	GCACUCGCCACAAUGCC	17	15538
CFTR-Intron2-439	+	GAGGAGAAGGCAAGGUC	17	15539
CFTR-Intron2-440	+	GCAGAUCACUUGAGGUC	17	15540
CFTR-Intron2-441	+	GGUGGAAACCAUACUUC	17	15541
CFTR-Intron2-442	+	GAAAAGAAGUAACAGGG	17	15542
CFTR-Intron2-443	−	GUUUUAAUUGGAUGCUG	17	15543
CFTR-Intron2-444	+	GGCGGGCAGAUCACUUG	17	15544
CFTR-Intron2-445	+	GGUGGGCAGAUCACUUG	17	15545
CFTR-Intron2-446	+	GAAAGAAAAAAUAGAAU	17	15546
CFTR-Intron2-447	−	GUUCAAAAUAAUAUAAU	17	15547
CFTR-Intron2-448	+	GGAGAAAUGGAUCAGAU	17	15548
CFTR-Intron2-449	+	GCCCUAUUCUAGGCACU	17	15549
CFTR-Intron2-450	−	GUGGAGUUUCGCCAUGU	17	15550
CFTR-Intron2-451	−	GAUGGGAAAAGGUAAUU	17	15551
CFTR-Intron2-452	−	GUUUUUUAUUUUUUAUU	17	15552
CFTR-Intron2-453	−	GUGUAAUGGUGCAAUUU	17	15553
CFTR-Intron2-454	−	GGAGGGAAAUAGAUGGGAAA	20	15554
CFTR-Intron2-455	+	GAAAAAUUUCAUGAACCACA	20	15555
CFTR-Intron2-456	+	GAGAAAAUAAAACCAGCAUA	20	15556
CFTR-Intron2-457	−	GACUACAGGCAUGCACCACC	20	15557
CFTR-Intron2-458	−	GGGGUUUUGCUAUGCUGGCC	20	15558
CFTR-Intron2-459	−	GGAGUUUCGCCAUGUUGGCC	20	15559
CFTR-Intron2-460	−	GCCUCAGCCUCUCGAGUAGC	20	15560
CFTR-Intron2-461	+	GCUACUCGAGAGGCUGAGGC	20	15561
CFTR-Intron2-462	−	GAGACGGGGUUUUGCUAUGC	20	15562
CFTR-Intron2-463	+	GCCUGUAGUCCCAGCUACUC	20	15563
CFTR-Intron2-464	+	GACUUUGUUUUUAAAAGUAG	20	15564
CFTR-Intron2-465	−	GGCUAAUUUUUGUAGAGACG	20	15565
CFTR-Intron2-466	+	GAGAUUCGCUUGAACCCAGG	20	15566
CFTR-Intron2-467	−	GAGAAAGGUGGAGAAGCAUG	20	15567
CFTR-Intron2-468	−	GAAAGGUGGAGAAGCAUGUG	20	15568
CFTR-Intron2-469	+	GGCCCUAUUCUAGGCACUUG	20	15569
CFTR-Intron2-470	+	GCACCAUUACACUCCAGCCU	20	15570
CFTR-Intron2-471	+	GCAUUUUGGGAGGCCAAGGU	20	15571
CFTR-Intron2-472	−	GUGUGCAAAUGCCAUGAGGU	20	15572
CFTR-Intron2-473	−	GAUGUGGAGUUUCGCCAUGU	20	15573
CFTR-Intron2-474	−	GCCUUGGCCUCCCAAAGUGU	20	15574
CFTR-Intron2-475	−	GGAGUGUAAUGGUGCAAUUU	20	15575
CFTR-Intron2-476	+	GCCACUAAUCCCAACACUUU	20	15576

Table 37D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within intron 2. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 37D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-477	+	UUCAAAAUGCCAAAAAA	17	15577
CFTR-Intron2-478	−	CUUUGUGAAGAGAAAAA	17	15578
CFTR-Intron2-479	+	UACAUAAACCAACAAAA	17	15579
CFTR-Intron2-480	−	UUUCCUUUCCAAUCAAA	17	15580
CFTR-Intron2-481	+	UGUCACUGGCAAUCAAA	17	15581
CFTR-Intron2-482	+	CUCCAUCAAAGGAGAAA	17	15582
CFTR-Intron2-483	−	CAUGAUGGAAUGUGAAA	17	15583
CFTR-Intron2-484	−	UAGCUUAAGUAAAUAAA	17	15584
CFTR-Intron2-485	+	CUUUUUUCUCUUCACAA	17	15585
CFTR-Intron2-486	−	CUCUGUGUGUGAGAGAA	17	15586
CFTR-Intron2-487	+	UGAAAGAAAAAAUAGAA	17	15587
CFTR-Intron2-488	+	AUGGGAAAGCCAAGGAA	17	15588
CFTR-Intron2-489	−	AUAAAAGGGUGAGUGAA	17	15589
CFTR-Intron2-490	+	ACAAACAAAAAACAUAA	17	15590
CFTR-Intron2-491	+	UUUGUAUUCAAAUAUAA	17	15591
CFTR-Intron2-492	−	AGUUCAAAAUAAUAUAA	17	15592
CFTR-Intron2-493	−	CCCAGGCUGGAGUGUAA	17	15593
CFTR-Intron2-494	+	CUAAAAUCAUGUAUUAA	17	15594
CFTR-Intron2-495	+	UUUAAAUUGAAUCAACA	17	15595
CFTR-Intron2-496	+	UAAGAAAAGAAGUAACA	17	15596
CFTR-Intron2-497	+	AUCAGAUGGGAAAGCCA	17	15597
CFTR-Intron2-498	+	UAUGAAAUGUGAAGCCA	17	15598
CFTR-Intron2-499	+	AACACUUUGGGAGGCCA	17	15599
CFTR-Intron2-500	+	AGCAUUUUGGGAGGCCA	17	15600
CFTR-Intron2-501	+	CAUUUCACAUUCCAUCA	17	15601
CFTR-Intron2-502	+	AGGAGAAAUGGAUCAGA	17	15602
CFTR-Intron2-503	−	UUCUCCUUUGAUGGAGA	17	15603
CFTR-Intron2-504	−	UAUUAGAGACCAUGAGA	17	15604
CFTR-Intron2-505	−	UUUUAAUUGGAUGCUGA	17	15605
CFTR-Intron2-506	−	AUCCAUUUCUCCUUUGA	17	15606
CFTR-Intron2-507	−	UUUUUUUGGCAUUUUGA	17	15607
CFTR-Intron2-508	−	CCCAAGUGCCUAGAAUA	17	15608
CFTR-Intron2-509	+	AAAAUAAAACCAGCAUA	17	15609
CFTR-Intron2-510	+	AAAAAUAAUAGAACGUA	17	15610
CFTR-Intron2-511	−	UGAUACAUUUGUAUUUA	17	15611
CFTR-Intron2-512	+	AUAAGAAAAGAAGUAAC	17	15612
CFTR-Intron2-513	+	AAUUGGGUUUCUGUCAC	17	15613
CFTR-Intron2-514	−	CUAAUUUUUGUAGAGAC	17	15614
CFTR-Intron2-515	−	UGAGUAGCUGGGACUAC	17	15615
CFTR-Intron2-516	−	CGAGUAGCUGGGUUUAC	17	15616
CFTR-Intron2-517	−	UACAGGCAUGCACCACC	17	15617
CFTR-Intron2-518	+	AGAUUUGAAGACAAGCC	17	15618
CFTR-Intron2-519	+	ACCACUACACUCCAGCC	17	15619
CFTR-Intron2-520	+	ACCAUUACACUCCAGCC	17	15620
CFTR-Intron2-521	+	AAAUACAAAAAUUAGCC	17	15621
CFTR-Intron2-522	+	CUCUACAAAAAUUAGCC	17	15622
CFTR-Intron2-523	+	CAAAAAUUAGCCAGGCC	17	15623
CFTR-Intron2-524	−	CCCUUCUGAUCUGGGCC	17	15624
CFTR-Intron2-525	−	AGUACCUGUUACAUGCC	17	15625
CFTR-Intron2-526	+	AGUAUAUACCAUAUGCC	17	15626
CFTR-Intron2-527	−	CUGCAAACUCUGCCUCC	17	15627
CFTR-Intron2-528	−	AACAUUCUCUGCUCUCC	17	15628
CFTR-Intron2-529	−	CUGCAAACUUCGUCUCC	17	15629
CFTR-Intron2-530	−	UCAGCCUCUCGAGUAGC	17	15630
CFTR-Intron2-531	−	UCAGUCUCCUGAGUAGC	17	15631
CFTR-Intron2-532	+	CUUUGGGAGGCCAAGGC	17	15632
CFTR-Intron2-533	−	CGCUGUGUCACCCAGGC	17	15633
CFTR-Intron2-534	−	UGCUCUGUUGCCCAGGC	17	15634
CFTR-Intron2-535	−	UGCUAUGCUGGCCAGGC	17	15635
CFTR-Intron2-536	−	CGCCAUGUUGGCCAGGC	17	15636
CFTR-Intron2-537	+	ACUCGAGAGGCUGAGGC	17	15637
CFTR-Intron2-538	−	UUGGCCUCCCAAAAUGC	17	15638
CFTR-Intron2-539	−	ACGGGGUUUUGCUAUGC	17	15639
CFTR-Intron2-540	−	CUUCUUCCCUUCUGAUC	17	15640
CFTR-Intron2-541	+	UGUAGUCCCAGCUACUC	17	15641
CFTR-Intron2-542	+	CCAAAUGUGUAUUUUUC	17	15642
CFTR-Intron2-543	+	UGGGAAAGCCAAGGAAG	17	15643
CFTR-Intron2-544	−	UAAAAGGGUGAGUGAAG	17	15644
CFTR-Intron2-545	−	UCAUUAACAGAAAUCAG	17	15645
CFTR-Intron2-546	+	AAACCCAGCUACUCGAG	17	15646
CFTR-Intron2-547	+	CACUCAGAGUGGCUGAG	17	15647
CFTR-Intron2-548	−	CUCUCAGCCACUCUGAG	17	15648
CFTR-Intron2-549	+	UUCAAAGCUGGGCAUAG	17	15649
CFTR-Intron2-550	+	UUUGUUUUUAAAAGUAG	17	15650
CFTR-Intron2-551	−	CCCAGGCUGGAGUGUAG	17	15651
CFTR-Intron2-552	−	CAAAGUGUUGGGAUUAG	17	15652
CFTR-Intron2-553	−	UAAUUUUUGUAGAGACG	17	15653
CFTR-Intron2-554	−	UGUGUGUGAGAGAAAGG	17	15654
CFTR-Intron2-555	+	ACUUUGGGAGGCCAAGG	17	15655
CFTR-Intron2-556	+	AUUUUGGGAGGCCAAGG	17	15656
CFTR-Intron2-557	−	AAAAGGGUGAGUGAAGG	17	15657
CFTR-Intron2-558	+	AGGCAAAUGCCACCAGG	17	15658
CFTR-Intron2-559	+	AUUCGCUUGAACCCAGG	17	15659
CFTR-Intron2-560	+	AAUCCCAACACUUUGGG	17	15660
CFTR-Intron2-561	+	AAUCCCAGCAUUUUGGG	17	15661
CFTR-Intron2-562	+	AAAUUGAAUCAACAUGG	17	15662
CFTR-Intron2-563	+	AAAUUAGCCAGGCCUGG	17	15663
CFTR-Intron2-564	+	AAAGAAAAAAUAGAAUG	17	15664
CFTR-Intron2-565	−	UUGUAUUUUAGUAGAUG	17	15665
CFTR-Intron2-566	+	ACCAAGAGUAGGUGAUG	17	15666
CFTR-Intron2-567	+	CUGAGAGAUUCUUUAUG	17	15667
CFTR-Intron2-568	−	UACAGAAAAGCAAACUG	17	15668
CFTR-Intron2-569	+	AGCUACUCGAGAGGCUG	17	15669
CFTR-Intron2-570	−	AGGUGGAGAAGCAUGUG	17	15670
CFTR-Intron2-571	+	AAAUUAGCCAGGCAUUG	17	15671
CFTR-Intron2-572	+	ACAUAAACCAACAAAAU	17	15672
CFTR-Intron2-573	−	UUCUUUUCUUAUAAAAU	17	15673
CFTR-Intron2-574	+	UUGAAUUGAAGUAAAAU	17	15674
CFTR-Intron2-575	−	AAUAUCUAAGUUUUAAU	17	15675
CFTR-Intron2-576	+	UUAAAUUGAAUCAACAU	17	15676
CFTR-Intron2-577	+	UUUCUUUUAAAUACUAU	17	15677
CFTR-Intron2-578	−	CAAAAUGCUGGGAUUAU	17	15678
CFTR-Intron2-579	−	UGUUUUUUAUUUUUUAU	17	15679
CFTR-Intron2-580	−	UUCUAUUAUUGAACACU	17	15680
CFTR-Intron2-581	−	AAGUGAUCUGCCCACCU	17	15681
CFTR-Intron2-582	+	CCACUACACUCCAGCCU	17	15682
CFTR-Intron2-583	+	CCAUUACACUCCAGCCU	17	15683
CFTR-Intron2-584	−	AAGUGAUCUGCCCGCCU	17	15684
CFTR-Intron2-585	−	UGCAAACUCUGCCUCCU	17	15685
CFTR-Intron2-586	−	UGCAAACUUCGUCUCCU	17	15686
CFTR-Intron2-587	−	AAGGAGCCCUUUGUCCU	17	15687
CFTR-Intron2-588	−	CAGCCUCUCGAGUAGCU	17	15688
CFTR-Intron2-589	−	CAGUCUCCUGAGUAGCU	17	15689
CFTR-Intron2-590	−	UGGCCUCCCAAAAUGCU	17	15690
CFTR-Intron2-591	−	UUCUUCCCUUCUGAUCU	17	15691
CFTR-Intron2-592	+	AUGCCAGGCCCUAUUCU	17	15692
CFTR-Intron2-593	−	AGCUUUCUACAUAAAGU	17	15693
CFTR-Intron2-594	+	UUUUGGGAGGCCAAGGU	17	15694
CFTR-Intron2-595	+	UGAGGAGAAGGCAAGGU	17	15695
CFTR-Intron2-596	−	UGCAAAUGCCAUGAGGU	17	15696
CFTR-Intron2-597	−	UUGGCCUCCCAAAGUGU	17	15697
CFTR-Intron2-598	−	CCUGAAAAAUACACAUU	17	15698
CFTR-Intron2-599	+	CACUAAUCCCAACACUU	17	15699
CFTR-Intron2-600	+	CCCUAUUCUAGGCACUU	17	15700
CFTR-Intron2-601	+	ACUCAAUGUUUUUACUU	17	15701
CFTR-Intron2-602	−	UGGCCUCCCAAAGUGUU	17	15702
CFTR-Intron2-603	+	CUAUAAUCCCAGCAUUU	17	15703
CFTR-Intron2-604	−	AAUUUAUUGAAAUAUUU	17	15704
CFTR-Intron2-605	+	ACUAAUCCCAACACUUU	17	15705
CFTR-Intron2-606	+	UAUAAUCCCAGCAUUUU	17	15706
CFTR-Intron2-607	+	CUGGGCAAUGUAGUUUU	17	15707
CFTR-Intron2-608	−	AAUUCAUUUCCUUUUUU	17	15708
CFTR-Intron2-609	−	UUCCUUUGUGAAGAGAAAAA	20	15709
CFTR-Intron2-610	+	CACAUUUAGCCAAGGACAAA	20	15710
CFTR-Intron2-611	−	CAGUUUCCUUUCCAAUCAAA	20	15711
CFTR-Intron2-612	+	UUCUGUCACUGGCAAUCAAA	20	15712
CFTR-Intron2-613	−	UACUAGCUUAAGUAAAUAAA	20	15713
CFTR-Intron2-614	+	CUAUGAAAGAAAAAAUAGAA	20	15714
CFTR-Intron2-615	+	CAGAUGGGAAAGCCAAGGAA	20	15715
CFTR-Intron2-616	+	CAAACAAACAAAAAACAUAA	20	15716
CFTR-Intron2-617	+	ACAUUUGUAUUCAAAUAUAA	20	15717
CFTR-Intron2-618	−	ACAAGUUCAAAAUAAUAUAA	20	15718
CFTR-Intron2-619	−	UUGCCCAGGCUGGAGUGUAA	20	15719
CFTR-Intron2-620	+	CAAGACCAGCCUGGCCAACA	20	15720
CFTR-Intron2-621	+	UUUUUUAAAUUGAAUCAACA	20	15721
CFTR-Intron2-622	+	UUAUAAGAAAAGAAGUAACA	20	15722
CFTR-Intron2-623	+	UGGAUCAGAUGGGAAAGCCA	20	15723
CFTR-Intron2-624	+	CCCAACACUUUGGGAGGCCA	20	15724
CFTR-Intron2-625	+	CCCAGCAUUUUGGGAGGCCA	20	15725
CFTR-Intron2-626	−	CUGGCUAAUUUUUGUAGAGA	20	15726
CFTR-Intron2-627	−	CAUUUCUCCUUUGAUGGAGA	20	15727
CFTR-Intron2-628	−	UUUGUUGAAUGAAUCCAUGA	20	15728
CFTR-Intron2-629	−	CUAGAAUAGGGCCUGGCAUA	20	15729
CFTR-Intron2-630	+	AACAAAAAUAAUAGAACGUA	20	15730
CFTR-Intron2-631	−	AUGUGAUACAUUUGUAUUUA	20	15731
CFTR-Intron2-632	+	UUUAUAAGAAAAGAAGUAAC	20	15732
CFTR-Intron2-633	−	UGGCUAAUUUUUGUAGAGAC	20	15733
CFTR-Intron2-634	−	UCCUGAGUAGCUGGGACUAC	20	15734
CFTR-Intron2-635	−	UCUCGAGUAGCUGGGUUUAC	20	15735
CFTR-Intron2-636	+	CAGGAGAAUCACUUGAACCC	20	15736
CFTR-Intron2-637	+	ACUGAGAUUCGCUUGAACCC	20	15737
CFTR-Intron2-638	−	AGAGUCUCGCUGUGUCACCC	20	15738
CFTR-Intron2-639	−	AGUGGCGUGAGCCACUGCCC	20	15739
CFTR-Intron2-640	−	AGAGUCUUGCUCUGUUGCCC	20	15740
CFTR-Intron2-641	+	CUGAGAUUUGAAGACAAGCC	20	15741
CFTR-Intron2-642	+	UCAGGAGUUCAAGACCAGCC	20	15742
CFTR-Intron2-643	+	CACACCACUACACUCCAGCC	20	15743
CFTR-Intron2-644	+	UGCACCAUUACACUCCAGCC	20	15744
CFTR-Intron2-645	+	CUAAAAUACAAAAAUUAGCC	20	15745
CFTR-Intron2-646	+	CGUCUCUACAAAAAUUAGCC	20	15746
CFTR-Intron2-647	−	CAGGCAUGCACCACCAGGCC	20	15747
CFTR-Intron2-648	+	CUACAAAAAUUAGCCAGGCC	20	15748
CFTR-Intron2-649	+	CUCUAAAGGAGUAAUAGGCC	20	15749
CFTR-Intron2-650	−	CAAGUGCCUAGAAUAGGGCC	20	15750
CFTR-Intron2-651	−	CAGGCACUCGCCACAAUGCC	20	15751
CFTR-Intron2-652	−	UUGAGUACCUGUUACAUGCC	20	15752
CFTR-Intron2-653	+	UUGAGUAUAUACCAUAUGCC	20	15753
CFTR-Intron2-654	−	UCACUGCAAACUCUGCCUCC	20	15754
CFTR-Intron2-655	−	UCACUGCAAACUUCGUCUCC	20	15755
CFTR-Intron2-656	−	AUCUCAGUCUCCUGAGUAGC	20	15756
CFTR-Intron2-657	+	ACACUUUGGGAGGCCAAGGC	20	15757
CFTR-Intron2-658	−	UCUCGCUGUGUCACCCAGGC	20	15758
CFTR-Intron2-659	−	UCUUGCUCUGUUGCCCAGGC	20	15759
CFTR-Intron2-660	−	UUUUGCUAUGCUGGCCAGGC	20	15760
CFTR-Intron2-661	−	UUUCGCCAUGUUGGCCAGGC	20	15761
CFTR-Intron2-662	+	ACUCUAAAGGAGUAAUAGGC	20	15762
CFTR-Intron2-663	−	ACCUUGGCCUCCCAAAAUGC	20	15763
CFTR-Intron2-664	−	UGGUGGCAUUUGCCUUAUGC	20	15764
CFTR-Intron2-665	+	UCACCCUUUUAUCUGGCAUC	20	15765
CFTR-Intron2-666	+	CCUUCACUCACCCUUUUAUC	20	15766
CFTR-Intron2-667	+	CGGGCAGAUCACUUGAGGUC	20	15767
CFTR-Intron2-668	+	UGGGCAGAUCACUUGAGGUC	20	15768
CFTR-Intron2-669	+	CAUGGUGGAAACCAUACUUC	20	15769
CFTR-Intron2-670	+	AAACCAAAUGUGUAUUUUUC	20	15770
CFTR-Intron2-671	+	AGAUGGGAAAGCCAAGGAAG	20	15771
CFTR-Intron2-672	−	AGAUAAAAGGGUGAGUGAAG	20	15772
CFTR-Intron2-673	+	UGUAAACCCAGCUACUCGAG	20	15773
CFTR-Intron2-674	+	AUAUUCAAAGCUGGGCAUAG	20	15774
CFTR-Intron2-675	−	UCACCCAGGCUGGAGUGUAG	20	15775
CFTR-Intron2-676	−	UCCCAAAGUGUUGGGAUUAG	20	15776
CFTR-Intron2-677	+	ACAAAGGGCUCCUUCUUUCG	20	15777
CFTR-Intron2-678	−	CUCUGUGUGUGAGAGAAAGG	20	15778
CFTR-Intron2-679	+	AACACUUUGGGAGGCCAAGG	20	15779
CFTR-Intron2-680	+	AGCAUUUUGGGAGGCCAAGG	20	15780
CFTR-Intron2-681	+	UAAGAAAAGAAGUAACAGGG	20	15781
CFTR-Intron2-682	−	AGGUGGAGAAGCAUGUGGGG	20	15782
CFTR-Intron2-683	+	ACUAAUCCCAACACUUUGGG	20	15783
CFTR-Intron2-684	+	UAUAAUCCCAGCAUUUUGGG	20	15784
CFTR-Intron2-685	+	CAAAAAUUAGCCAGGCCUGG	20	15785
CFTR-Intron2-686	+	AUGAAAGAAAAAAUAGAAUG	20	15786
CFTR-Intron2-687	−	UGGUGUGUGCAAAUGCCAUG	20	15787
CFTR-Intron2-688	−	UUUUUGUAUUUUAGUAGAUG	20	15788
CFTR-Intron2-689	−	UUUUACAGAAAAGCAAACUG	20	15789
CFTR-Intron2-690	+	CCCAGCUACUCGAGAGGCUG	20	15790
CFTR-Intron2-691	+	CAAAAAUUAGCCAGGCAUUG	20	15791
CFTR-Intron2-692	+	CAAGGCGGGCAGAUCACUUG	20	15792
CFTR-Intron2-693	+	CAAGGUGGGCAGAUCACUUG	20	15793
CFTR-Intron2-694	−	UACUUCUUUUCUUAUAAAAU	20	15794
CFTR-Intron2-695	+	UUGUUGAAUUGAAGUAAAAU	20	15795
CFTR-Intron2-696	+	UAUGAAAGAAAAAAUAGAAU	20	15796
CFTR-Intron2-697	−	UAUCCCCAAGUGCCUAGAAU	20	15797
CFTR-Intron2-698	−	UUGAAUAUCUAAGUUUUAAU	20	15798
CFTR-Intron2-699	+	UUUUUAAAUUGAAUCAACAU	20	15799
CFTR-Intron2-700	+	UGUUUUCUUUUAAAUACUAU	20	15800
CFTR-Intron2-701	−	UCCCAAAAUGCUGGGAUUAU	20	15801
CFTR-Intron2-702	−	UUUUGUUUUUUAUUUUUUAU	20	15802
CFTR-Intron2-703	+	CAGGCCCUAUUCUAGGCACU	20	15803
CFTR-Intron2-704	−	CUCAAGUGAUCUGCCCACCU	20	15804
CFTR-Intron2-705	−	ACUUUGUACCUCUGCACCCU	20	15805
CFTR-Intron2-706	+	ACACCACUACACUCCAGCCU	20	15806
CFTR-Intron2-707	−	CUCAAGUGAUCUGCCCGCCU	20	15807
CFTR-Intron2-708	−	CACUGCAAACUCUGCCUCCU	20	15808
CFTR-Intron2-709	−	CACUGCAAACUUCGUCUCCU	20	15809
CFTR-Intron2-710	−	CCUCAGCCUCUCGAGUAGCU	20	15810
CFTR-Intron2-711	−	UCUCAGUCUCCUGAGUAGCU	20	15811
CFTR-Intron2-712	−	CCUUGGCCUCCCAAAAUGCU	20	15812
CFTR-Intron2-713	+	CAUAUGCCAGGCCCUAUUCU	20	15813
CFTR-Intron2-714	+	UUUACUUAAGCUAGUAAAUU	20	15814
CFTR-Intron2-715	−	UUUCCUGAAAAAUACACAUU	20	15815
CFTR-Intron2-716	−	UUUGUUUUUUAUUUUUUAUU	20	15816
CFTR-Intron2-717	+	CGCCACUAAUCCCAACACUU	20	15817
CFTR-Intron2-718	+	AGGCCCUAUUCUAGGCACUU	20	15818
CFTR-Intron2-719	−	CCUUGGCCUCCCAAAGUGUU	20	15819
CFTR-Intron2-720	+	CACCUAUAAUCCCAGCAUUU	20	15820
CFTR-Intron2-721	−	UGAAAUUUAUUGAAAUAUUU	20	15821
CFTR-Intron2-722	+	ACCUAUAAUCCCAGCAUUUU	20	15822
CFTR-Intron2-723	−	UUAAAUUCAUUUCCUUUUUU	20	15823

Table 38A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within intron 2, have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 38A
1st Tier
	DNA		Target Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
CFTR-Intron2-724	+	GUUAGCUAUGAAAGAAAAAA	20	15824
CFTR-Intron2-725	+	GUGUACAUAAACCAACAAA	19	15825
CFTR-Intron2-726	+	GUGUGUACAUAAACCAACAAA	21	15826
CFTR-Intron2-727	+	GGUGUGUACAUAAACCAACAAA	22	15827
CFTR-Intron2-728	+	GGGUGUGUACAUAAACCAACAAA	23	15828
CFTR-Intron2-729	+	GGGGUGUGUACAUAAACCAACAAA	24	15829
CFTR-Intron2-730	+	GCCUUUUUUCUCUUCACAA	19	15830
CFTR-Intron2-731	+	GAAAGCCUUUUUUCUCUUCACAA	23	15831
CFTR-Intron2-732	+	GGCUCUAAAUCACUCUAA	18	15832
CFTR-Intron2-733	+	GCAUUUGAGUCCUUGGUCCCA	21	15833
CFTR-Intron2-734	+	GGCAUUUGAGUCCUUGGUCCCA	22	15834
CFTR-Intron2-735	+	GUGGCAUUUGAGUCCUUGGUCCCA	24	15835
CFTR-Intron2-736	+	GCCAUUACCUUAAGACUUCCCA	22	15836
CFTR-Intron2-737	+	GUAGAGAGACCAGGAGAGCA	20	15837
CFTR-Intron2-738	+	GUCCUUAAAGAUAGGAGCA	19	15838
CFTR-Intron2-739	+	GGUCCUUAAAGAUAGGAGCA	20	15839
CFTR-Intron2-740	+	GUGGUCCUUAAAGAUAGGAGCA	22	15840
CFTR-Intron2-741	+	GAACUUGUCAAUAUACCUGCA	21	15841
CFTR-Intron2-742	+	GCACACUGCAGUUAUGUA	18	15842
CFTR-Intron2-743	+	GUUUGCACACUGCAGUUAUGUA	22	15843
CFTR-Intron2-744	+	GGUUUGCACACUGCAGUUAUGUA	23	15844
CFTR-Intron2-745	+	GGUCGGGGAAUUUCUUUA	18	15845
CFTR-Intron2-746	+	GCAAGGUCGGGGAAUUUCUUUA	22	15846
CFTR-Intron2-747	+	GGCAAGGUCGGGGAAUUUCUUUA	23	15847
CFTR-Intron2-748	+	GCCACAAAUUGUUAGCACC	19	15848
CFTR-Intron2-749	+	GUGCCACAAAUUGUUAGCACC	21	15849
CFTR-Intron2-750	+	GGUGCCACAAAUUGUUAGCACC	22	15850
CFTR-Intron2-751	+	GAAGCCAGGGUCACUUCCC	19	15851
CFTR-Intron2-752	+	GUGAAGCCAGGGUCACUUCCC	21	15852
CFTR-Intron2-753	+	GCAGUUAUGAAAUGUGAAGC	20	15853
CFTR-Intron2-754	+	GGCAGUUAUGAAAUGUGAAGC	21	15854
CFTR-Intron2-755	+	GCCUGGCAAUCUCUAAGC	18	15855
CFTR-Intron2-756	+	GACAAGCCUGGCAAUCUCUAAGC	23	15856
CFTR-Intron2-757	+	GGCAAUACAGACCUCAGC	18	15857
CFTR-Intron2-758	+	GCAAGGCAAUACAGACCUCAGC	22	15858
CFTR-Intron2-759	+	GAGCAAGGCAAUACAGACCUCAGC	24	15859
CFTR-Intron2-760	+	GCCAUUUCACAUUCCAUC	18	15860
CFTR-Intron2-761	+	GCUAGCCAUUUCACAUUCCAUC	22	15861
CFTR-Intron2-762	+	GGGUAAGCACUAUGACUC	18	15862
CFTR-Intron2-763	+	GGGGUAAGCACUAUGACUC	19	15863
CFTR-Intron2-764	+	GCACUAUGACUCAAGAGUCUC	21	15864
CFTR-Intron2-765	+	GAGGAGAAGGCAAGGUCG	18	15865
CFTR-Intron2-766	+	GUUUGUACUGGCAUAGCAUUG	21	15866
CFTR-Intron2-767	+	GGUUUGUACUGGCAUAGCAUUG	22	15867
CFTR-Intron2-768	+	GGGUUUGUACUGGCAUAGCAUUG	23	15868
CFTR-Intron2-769	+	GCAAAUGCCACCAGGUGGCAU	21	15869
CFTR-Intron2-770	+	GGCAAAUGCCACCAGGUGGCAU	22	15870
CFTR-Intron2-771	+	GAUAAUGAUGCUUUCCACU	19	15871
CFTR-Intron2-772	+	GCCUAGUUCAUUCUAGACU	19	15872
CFTR-Intron2-773	+	GCUACUCCCACUAGCUUAAUUCU	23	15873
CFTR-Intron2-774	+	GCCCUUGAUCUUAGAAGU	18	15874
CFTR-Intron2-775	+	GGCCCUUGAUCUUAGAAGU	19	15875
CFTR-Intron2-776	+	GCUGGCCCUUGAUCUUAGAAGU	22	15876
CFTR-Intron2-777	−	GACCAGCUUUCUACAUAAA	19	15877
CFTR-Intron2-778	−	GGACCAGCUUUCUACAUAAA	20	15878
CFTR-Intron2-779	−	GACCGGACCAGCUUUCUACAUAAA	24	15879
CFTR-Intron2-780	−	GCACAGGCCUGAUGCCAGAUAA	22	15880
CFTR-Intron2-781	−	GCUUUGAAUAUCUAAGUUUUAA	22	15881
CFTR-Intron2-782	−	GAAAAAUACACAUUUGGUUUCA	22	15882
CFTR-Intron2-783	−	GCUUAAGUAAAUAAAAGGA	19	15883
CFTR-Intron2-784	−	GCUCAAUUUUGUGACCAUGGA	21	15884
CFTR-Intron2-785	−	GGCUCAAUUUUGUGACCAUGGA	22	15885
CFTR-Intron2-786	−	GUUUUAAUUGGAUGCUGA	18	15886
CFTR-Intron2-787	−	GAAUGGUAGUCCCCCCCAUA	20	15887
CFTR-Intron2-788	−	GGAAUGGUAGUCCCCCCCAUA	21	15888
CFTR-Intron2-789	−	GACAAGUUCAAAAUAAUAUA	20	15889
CFTR-Intron2-790	−	GCUCUCAUUAGCAAGCUUCUA	21	15890
CFTR-Intron2-791	−	GGCUCUCAUUAGCAAGCUUCUA	22	15891
CFTR-Intron2-792	−	GGGCUCUCAUUAGCAAGCUUCUA	23	15892
CFTR-Intron2-793	−	GUUCAAAAUAAUAUAAUGGGUA	22	15893
CFTR-Intron2-794	−	GAUAAUAUACUUUGCCAGUUA	21	15894
CFTR-Intron2-795	−	GAGAUAAUAUACUUUGCCAGUUA	23	15895
CFTR-Intron2-796	−	GUAUUUAUGGCCAGAUAGAGAAC	23	15896
CFTR-Intron2-797	−	GAUGUAUCCCCAAGUGCC	18	15897
CFTR-Intron2-798	−	GUUCCUAAAACUACAUUGCC	20	15898
CFTR-Intron2-799	−	GAAAAAUCCCAGAGACUC	18	15899
CFTR-Intron2-800	−	GUGAAAAAUCCCAGAGACUC	20	15900
CFTR-Intron2-801	−	GCCAGAUAAAAGGGUGAGUGAAG	23	15901
CFTR-Intron2-802	−	GUCUUAUUAGAGACCAUGAG	20	15902
CFTR-Intron2-803	−	GCCUGAUGCCAGAUAAAAGG	20	15903
CFTR-Intron2-804	−	GUACCUGUUACAUGCCAGG	19	15904
CFTR-Intron2-805	−	GAGUACCUGUUACAUGCCAGG	21	15905
CFTR-Intron2-806	−	GAAUGAUUAAUCAGAGUAGGG	21	15906
CFTR-Intron2-807	−	GGAAUGAUUAAUCAGAGUAGGG	22	15907
CFTR-Intron2-808	−	GGGAAUGAUUAAUCAGAGUAGGG	23	15908
CFTR-Intron2-809	−	GAACAUGAAUCUGAAUUUG	19	15909
CFTR-Intron2-810	−	GCCAGAUAGAGAACAUGAAU	20	15910
CFTR-Intron2-811	−	GAUGCUGAGGGAAUGAUUAAU	21	15911
CFTR-Intron2-812	−	GGAUGCUGAGGGAAUGAUUAAU	22	15912
CFTR-Intron2-813	−	GCUUUCAAAACCUUUAUAU	19	15913
CFTR-Intron2-814	−	GAAUAUCUCCUCUCAGCCACU	21	15914
CFTR-Intron2-815	−	GUAGAAUAUCUCCUCUCAGCCACU	24	15915
CFTR-Intron2-816	−	GCUCCAUAUUUAGCUUCUUACU	22	15916
CFTR-Intron2-817	−	GUCUGUAUUGCCUUGCUCUCU	21	15917
CFTR-Intron2-818	−	GGUCUGUAUUGCCUUGCUCUCU	22	15918
CFTR-Intron2-819	−	GAGGUCUGUAUUGCCUUGCUCUCU	24	15919
CFTR-Intron2-820	−	GUUUCCUUUCCAAUCAAAAGGU	22	15920
CFTR-Intron2-821	−	GCCCCGGCCUAUUACUCCUU	20	15921
CFTR-Intron2-822	−	GUCAGGAUAUGAACUUUUU	19	15922
CFTR-Intron2-823	−	GUAGUCAGGAUAUGAACUUUUU	22	15923

Table 38B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 2, have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 38B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-824	+	UAGCUAUGAAAGAAAAAA	18	15924
CFTR-Intron2-825	+	UUAGCUAUGAAAGAAAAAA	19	15925
CFTR-Intron2-826	+	UGUACAUAAACCAACAAA	18	15926
CFTR-Intron2-827	+	UGUGUACAUAAACCAACAAA	20	15927
CFTR-Intron2-828	+	UUAUUUACUUAAGCUAGUAAA	21	15928
CFTR-Intron2-829	+	UUUAUUUACUUAAGCUAGUAAA	22	15929
CFTR-Intron2-830	+	UUUUAUUUACUUAAGCUAGUAAA	23	15930
CFTR-Intron2-831	+	CUUUUAUUUACUUAAGCUAGUAAA	24	15931
CFTR-Intron2-832	+	CCUUUUUUCUCUUCACAA	18	15932
CFTR-Intron2-233	+	AGCCUUUUUUCUCUUCACAA	20	15333
CFTR-Intron2-833	+	AAGCCUUUUUUCUCUUCACAA	21	15933
CFTR-Intron2-834	+	AAAGCCUUUUUUCUCUUCACAA	22	15934
CFTR-Intron2-835	+	UGAAAGCCUUUUUUCUCUUCACAA	24	15935
CFTR-Intron2-836	+	ACCUUCUCCAUCAAAGGAGAA	21	15936
CFTR-Intron2-837	+	CACCUUCUCCAUCAAAGGAGAA	22	15937
CFTR-Intron2-838	+	UCACCUUCUCCAUCAAAGGAGAA	23	15938
CFTR-Intron2-839	+	CUCACCUUCUCCAUCAAAGGAGAA	24	15939
CFTR-Intron2-840	+	UGGCUCUAAAUCACUCUAA	19	15940
CFTR-Intron2-250	+	AUGGCUCUAAAUCACUCUAA	20	15350
CFTR-Intron2-841	+	CAUGGCUCUAAAUCACUCUAA	21	15941
CFTR-Intron2-842	+	ACAUGGCUCUAAAUCACUCUAA	22	15942
CFTR-Intron2-843	+	AACAUGGCUCUAAAUCACUCUAA	23	15943
CFTR-Intron2-844	+	AAACAUGGCUCUAAAUCACUCUAA	24	15944
CFTR-Intron2-845	+	UAGACUAUGAGUGGCCCA	18	15945
CFTR-Intron2-846	+	CUAGACUAUGAGUGGCCCA	19	15946
CFTR-Intron2-261	+	UCUAGACUAUGAGUGGCCCA	20	15361
CFTR-Intron2-847	+	UUCUAGACUAUGAGUGGCCCA	21	15947
CFTR-Intron2-848	+	AUUCUAGACUAUGAGUGGCCCA	22	15948
CFTR-Intron2-849	+	CAUUCUAGACUAUGAGUGGCCCA	23	15949
CFTR-Intron2-850	+	UCAUUCUAGACUAUGAGUGGCCCA	24	15950
CFTR-Intron2-851	+	UUUGAGUCCUUGGUCCCA	18	15951
CFTR-Intron2-852	+	AUUUGAGUCCUUGGUCCCA	19	15952
CFTR-Intron2-853	+	CAUUUGAGUCCUUGGUCCCA	20	15953
CFTR-Intron2-854	+	UGGCAUUUGAGUCCUUGGUCCCA	23	15954
CFTR-Intron2-855	+	UUACCUUAAGACUUCCCA	18	15955
CFTR-Intron2-856	+	AUUACCUUAAGACUUCCCA	19	15956
CFTR-Intron2-263	+	CAUUACCUUAAGACUUCCCA	20	15363
CFTR-Intron2-857	+	CCAUUACCUUAAGACUUCCCA	21	15957
CFTR-Intron2-858	+	AGCCAUUACCUUAAGACUUCCCA	23	15958
CFTR-Intron2-859	+	UAGCCAUUACCUUAAGACUUCCCA	24	15959
CFTR-Intron2-860	+	AGAGAGACCAGGAGAGCA	18	15960
CFTR-Intron2-861	+	UAGAGAGACCAGGAGAGCA	19	15961
CFTR-Intron2-862	+	UCCUUAAAGAUAGGAGCA	18	15962
CFTR-Intron2-863	+	UGGUCCUUAAAGAUAGGAGCA	21	15963
CFTR-Intron2-864	+	CGUGGUCCUUAAAGAUAGGAGCA	23	15964
CFTR-Intron2-865	+	UCGUGGUCCUUAAAGAUAGGAGCA	24	15965
CFTR-Intron2-866	+	CUUGUCAAUAUACCUGCA	18	15966
CFTR-Intron2-867	+	ACUUGUCAAUAUACCUGCA	19	15967
CFTR-Intron2-868	+	AACUUGUCAAUAUACCUGCA	20	15968
CFTR-Intron2-869	+	UGAACUUGUCAAUAUACCUGCA	22	15969
CFTR-Intron2-870	+	UUGAACUUGUCAAUAUACCUGCA	23	15970
CFTR-Intron2-871	+	UUUGAACUUGUCAAUAUACCUGCA	24	15971
CFTR-Intron2-872	+	AGAUGGGAAAGCCAAGGA	18	15972
CFTR-Intron2-873	+	CAGAUGGGAAAGCCAAGGA	19	15973
CFTR-Intron2-280	+	UCAGAUGGGAAAGCCAAGGA	20	15380
CFTR-Intron2-874	+	CCUGACUACAAUCUUGGA	18	15974
CFTR-Intron2-875	+	UCCUGACUACAAUCUUGGA	19	15975
CFTR-Intron2-876	+	AUCCUGACUACAAUCUUGGA	20	15976
CFTR-Intron2-877	+	UAUCCUGACUACAAUCUUGGA	21	15977
CFTR-Intron2-878	+	AUAUCCUGACUACAAUCUUGGA	22	15978
CFTR-Intron2-879	+	CAUAUCCUGACUACAAUCUUGGA	23	15979
CFTR-Intron2-880	+	UCAUAUCCUGACUACAAUCUUGGA	24	15980
CFTR-Intron2-881	+	UGCACACUGCAGUUAUGUA	19	15981
CFTR-Intron2-882	+	UUGCACACUGCAGUUAUGUA	20	15982
CFTR-Intron2-883	+	UUUGCACACUGCAGUUAUGUA	21	15983
CFTR-Intron2-884	+	UGGUUUGCACACUGCAGUUAUGUA	24	15984
CFTR-Intron2-885	+	AGGUCGGGGAAUUUCUUUA	19	15985
CFTR-Intron2-886	+	AAGGUCGGGGAAUUUCUUUA	20	15986
CFTR-Intron2-887	+	CAAGGUCGGGGAAUUUCUUUA	21	15987
CFTR-Intron2-888	+	AGGCAAGGUCGGGGAAUUUCUUUA	24	15988
CFTR-Intron2-889	+	CCACAAAUUGUUAGCACC	18	15989
CFTR-Intron2-890	+	UGCCACAAAUUGUUAGCACC	20	15990
CFTR-Intron2-891	+	UGGUGCCACAAAUUGUUAGCACC	23	15991
CFTR-Intron2-892	+	UUGGUGCCACAAAUUGUUAGCACC	24	15992
CFTR-Intron2-893	+	AAGCCAGGGUCACUUCCC	18	15993
CFTR-Intron2-894	+	UGAAGCCAGGGUCACUUCCC	20	15994
CFTR-Intron2-895	+	UGUGAAGCCAGGGUCACUUCCC	22	15995
CFTR-Intron2-896	+	AUGUGAAGCCAGGGUCACUUCCC	23	15996
CFTR-Intron2-897	+	AAUGUGAAGCCAGGGUCACUUCCC	24	15997
CFTR-Intron2-898	+	AGUUAUGAAAUGUGAAGC	18	15998
CFTR-Intron2-899	+	CAGUUAUGAAAUGUGAAGC	19	15999
CFTR-Intron2-900	+	AGGCAGUUAUGAAAUGUGAAGC	22	16000
CFTR-Intron2-901	+	AAGGCAGUUAUGAAAUGUGAAGC	23	16001
CFTR-Intron2-902	+	CAAGGCAGUUAUGAAAUGUGAAGC	24	16002
CFTR-Intron2-903	+	AGCCUGGCAAUCUCUAAGC	19	16003
CFTR-Intron2-904	+	AAGCCUGGCAAUCUCUAAGC	20	16004
CFTR-Intron2-905	+	CAAGCCUGGCAAUCUCUAAGC	21	16005
CFTR-Intron2-906	+	ACAAGCCUGGCAAUCUCUAAGC	22	16006
CFTR-Intron2-907	+	AGACAAGCCUGGCAAUCUCUAAGC	24	16007
CFTR-Intron2-908	+	AGGCAAUACAGACCUCAGC	19	16008
CFTR-Intron2-322	+	AAGGCAAUACAGACCUCAGC	20	15422
CFTR-Intron2-909	+	CAAGGCAAUACAGACCUCAGC	21	16009
CFTR-Intron2-910	+	AGCAAGGCAAUACAGACCUCAGC	23	16010
CFTR-Intron2-911	+	AGCCAUUUCACAUUCCAUC	19	16011
CFTR-Intron2-912	+	UAGCCAUUUCACAUUCCAUC	20	16012
CFTR-Intron2-913	+	CUAGCCAUUUCACAUUCCAUC	21	16013
CFTR-Intron2-914	+	UGCUAGCCAUUUCACAUUCCAUC	23	16014
CFTR-Intron2-915	+	AUGCUAGCCAUUUCACAUUCCAUC	24	16015
CFTR-Intron2-916	+	AGGGGUAAGCACUAUGACUC	20	16016
CFTR-Intron2-917	+	AAGGGGUAAGCACUAUGACUC	21	16017
CFTR-Intron2-918	+	CAAGGGGUAAGCACUAUGACUC	22	16018
CFTR-Intron2-919	+	CCAAGGGGUAAGCACUAUGACUC	23	16019
CFTR-Intron2-920	+	CCCAAGGGGUAAGCACUAUGACUC	24	16020
CFTR-Intron2-921	+	CUAUGACUCAAGAGUCUC	18	16021
CFTR-Intron2-922	+	ACUAUGACUCAAGAGUCUC	19	16022
CFTR-Intron2-331	+	CACUAUGACUCAAGAGUCUC	20	15431
CFTR-Intron2-923	+	AGCACUAUGACUCAAGAGUCUC	22	16023
CFTR-Intron2-924	+	AAGCACUAUGACUCAAGAGUCUC	23	16024
CFTR-Intron2-925	+	UAAGCACUAUGACUCAAGAGUCUC	24	16025
CFTR-Intron2-926	+	UGAGGAGAAGGCAAGGUCG	19	16026
CFTR-Intron2-349	+	CUGAGGAGAAGGCAAGGUCG	20	15449
CFTR-Intron2-927	+	UUAAAUUGAAUCAACAUG	18	16027
CFTR-Intron2-928	+	UUUAAAUUGAAUCAACAUG	19	16028
CFTR-Intron2-358	+	UUUUAAAUUGAAUCAACAUG	20	15458
CFTR-Intron2-929	+	UGUACUGGCAUAGCAUUG	18	16029
CFTR-Intron2-930	+	UUGUACUGGCAUAGCAUUG	19	16030
CFTR-Intron2-931	+	UUUGUACUGGCAUAGCAUUG	20	16031
CFTR-Intron2-932	+	UGGGUUUGUACUGGCAUAGCAUUG	24	16032
CFTR-Intron2-933	+	AGGCAAAUGCCACCAGGUGGCAU	23	16033
CFTR-Intron2-934	+	AAGGCAAAUGCCACCAGGUGGCAU	24	16034
CFTR-Intron2-935	+	AUAAUGAUGCUUUCCACU	18	16035
CFTR-Intron2-936	+	AGAUAAUGAUGCUUUCCACU	20	16036
CFTR-Intron2-937	+	CCUAGUUCAUUCUAGACU	18	16037
CFTR-Intron2-938	+	AGCCUAGUUCAUUCUAGACU	20	16038
CFTR-Intron2-939	+	CAGCCUAGUUCAUUCUAGACU	21	16039
CFTR-Intron2-940	+	UCAGCCUAGUUCAUUCUAGACU	22	16040
CFTR-Intron2-941	+	CUCAGCCUAGUUCAUUCUAGACU	23	16041
CFTR-Intron2-942	+	ACUCAGCCUAGUUCAUUCUAGACU	24	16042
CFTR-Intron2-943	+	CCAUAACAUUUGGUUACU	18	16043
CFTR-Intron2-944	+	UCCAUAACAUUUGGUUACU	19	16044
CFTR-Intron2-945	+	AUCCAUAACAUUUGGUUACU	20	16045
CFTR-Intron2-946	+	CAUCCAUAACAUUUGGUUACU	21	16046
CFTR-Intron2-947	+	CCAUCCAUAACAUUUGGUUACU	22	16047
CFTR-Intron2-948	+	CCCAUCCAUAACAUUUGGUUACU	23	16048
CFTR-Intron2-949	+	UCCCAUCCAUAACAUUUGGUUACU	24	16049
CFTR-Intron2-950	+	UCCCACUAGCUUAAUUCU	18	16050
CFTR-Intron2-951	+	CUCCCACUAGCUUAAUUCU	19	16051
CFTR-Intron2-952	+	ACUCCCACUAGCUUAAUUCU	20	16052
CFTR-Intron2-953	+	UACUCCCACUAGCUUAAUUCU	21	16053
CFTR-Intron2-954	+	CUACUCCCACUAGCUUAAUUCU	22	16054
CFTR-Intron2-955	+	UGCUACUCCCACUAGCUUAAUUCU	24	16055
CFTR-Intron2-956	+	UGGCCCUUGAUCUUAGAAGU	20	16056
CFTR-Intron2-957	+	CUGGCCCUUGAUCUUAGAAGU	21	16057
CFTR-Intron2-958	+	AGCUGGCCCUUGAUCUUAGAAGU	23	16058
CFTR-Intron2-959	+	AAGCUGGCCCUUGAUCUUAGAAGU	24	16059
CFTR-Intron2-960	−	ACCAGCUUUCUACAUAAA	18	16060
CFTR-Intron2-961	−	CGGACCAGCUUUCUACAUAAA	21	16061
CFTR-Intron2-962	−	CCGGACCAGCUUUCUACAUAAA	22	16062
CFTR-Intron2-963	−	ACCGGACCAGCUUUCUACAUAAA	23	16063
CFTR-Intron2-964	−	AGGCCUGAUGCCAGAUAA	18	16064
CFTR-Intron2-965	−	CAGGCCUGAUGCCAGAUAA	19	16065
CFTR-Intron2-966	−	ACAGGCCUGAUGCCAGAUAA	20	16066
CFTR-Intron2-967	−	CACAGGCCUGAUGCCAGAUAA	21	16067
CFTR-Intron2-968	−	AGCACAGGCCUGAUGCCAGAUAA	23	16068
CFTR-Intron2-969	−	CAGCACAGGCCUGAUGCCAGAUAA	24	16069
CFTR-Intron2-970	−	CUUUGAAUAUCUAAGUUUUAA	21	16070
CFTR-Intron2-971	−	AGCUUUGAAUAUCUAAGUUUUAA	23	16071
CFTR-Intron2-972	−	CAGCUUUGAAUAUCUAAGUUUUAA	24	16072
CFTR-Intron2-973	−	UGCACCAAAGUAAAAACA	18	16073
CFTR-Intron2-974	−	UUGCACCAAAGUAAAAACA	19	16074
CFTR-Intron2-975	−	AUUGCACCAAAGUAAAAACA	20	16075
CFTR-Intron2-976	−	UAUUGCACCAAAGUAAAAACA	21	16076
CFTR-Intron2-977	−	UUAUUGCACCAAAGUAAAAACA	22	16077
CFTR-Intron2-978	−	AUUAUUGCACCAAAGUAAAAACA	23	16078
CFTR-Intron2-979	−	AAUUAUUGCACCAAAGUAAAAACA	24	16079
CFTR-Intron2-980	−	AAAAAUACACAUUUGGUUUCA	21	16080
CFTR-Intron2-981	−	UGAAAAAUACACAUUUGGUUUCA	23	16081
CFTR-Intron2-982	−	CUGAAAAAUACACAUUUGGUUUCA	24	16082
CFTR-Intron2-983	−	CUUAAGUAAAUAAAAGGA	18	16083
CFTR-Intron2-984	−	AGCUUAAGUAAAUAAAAGGA	20	16084
CFTR-Intron2-985	−	CAAUUUUGUGACCAUGGA	18	16085
CFTR-Intron2-986	−	UCAAUUUUGUGACCAUGGA	19	16086
CFTR-Intron2-987	−	CUCAAUUUUGUGACCAUGGA	20	16087
CFTR-Intron2-988	−	UGGCUCAAUUUUGUGACCAUGGA	23	16088
CFTR-Intron2-989	−	CUGGCUCAAUUUUGUGACCAUGGA	24	16089
CFTR-Intron2-990	−	AGUUUUAAUUGGAUGCUGA	19	16090
CFTR-Intron2-282	−	AAGUUUUAAUUGGAUGCUGA	20	15382
CFTR-Intron2-991	−	UAAGUUUUAAUUGGAUGCUGA	21	16091
CFTR-Intron2-992	−	CUAAGUUUUAAUUGGAUGCUGA	22	16092
CFTR-Intron2-993	−	UCUAAGUUUUAAUUGGAUGCUGA	23	16093
CFTR-Intron2-994	−	AUCUAAGUUUUAAUUGGAUGCUGA	24	16094
CFTR-Intron2-995	−	AUGGUAGUCCCCCCCAUA	18	16095
CFTR-Intron2-996	−	AAUGGUAGUCCCCCCCAUA	19	16096
CFTR-Intron2-997	−	AGGAAUGGUAGUCCCCCCCAUA	22	16097
CFTR-Intron2-998	−	UAGGAAUGGUAGUCCCCCCCAUA	23	16098
CFTR-Intron2-999	−	CUAGGAAUGGUAGUCCCCCCCAUA	24	16099
CFTR-Intron2-1000	−	CAAGUUCAAAAUAAUAUA	18	16100
CFTR-Intron2-1001	−	ACAAGUUCAAAAUAAUAUA	19	16101
CFTR-Intron2-1002	−	UGACAAGUUCAAAAUAAUAUA	21	16102
CFTR-Intron2-1003	−	UUGACAAGUUCAAAAUAAUAUA	22	16103
CFTR-Intron2-1004	−	AUUGACAAGUUCAAAAUAAUAUA	23	16104
CFTR-Intron2-1005	−	UAUUGACAAGUUCAAAAUAAUAUA	24	16105
CFTR-Intron2-1006	−	CUCAUUAGCAAGCUUCUA	18	16106
CFTR-Intron2-1007	−	UCUCAUUAGCAAGCUUCUA	19	16107
CFTR-Intron2-290	−	CUCUCAUUAGCAAGCUUCUA	20	15390
CFTR-Intron2-1008	−	AGGGCUCUCAUUAGCAAGCUUCUA	24	16108
CFTR-Intron2-1009	−	AAAAUAAUAUAAUGGGUA	18	16109
CFTR-Intron2-1010	−	CAAAAUAAUAUAAUGGGUA	19	16110
CFTR-Intron2-1011	−	UCAAAAUAAUAUAAUGGGUA	20	16111
CFTR-Intron2-1012	−	UUCAAAAUAAUAUAAUGGGUA	21	16112
CFTR-Intron2-1013	−	AGUUCAAAAUAAUAUAAUGGGUA	23	16113
CFTR-Intron2-1014	−	AAGUUCAAAAUAAUAUAAUGGGUA	24	16114
CFTR-Intron2-1015	−	AAUAUACUUUGCCAGUUA	18	16115
CFTR-Intron2-1016	−	UAAUAUACUUUGCCAGUUA	19	16116
CFTR-Intron2-1017	−	AUAAUAUACUUUGCCAGUUA	20	16117
CFTR-Intron2-1018	−	AGAUAAUAUACUUUGCCAGUUA	22	16118
CFTR-Intron2-1019	−	AGAGAUAAUAUACUUUGCCAGUUA	24	16119
CFTR-Intron2-1020	−	UAUGGCCAGAUAGAGAAC	18	16120
CFTR-Intron2-1021	−	UUAUGGCCAGAUAGAGAAC	19	16121
CFTR-Intron2-1022	−	UUUAUGGCCAGAUAGAGAAC	20	16122
CFTR-Intron2-1023	−	AUUUAUGGCCAGAUAGAGAAC	21	16123
CFTR-Intron2-1024	−	UAUUUAUGGCCAGAUAGAGAAC	22	16124
CFTR-Intron2-1025	−	UGUAUUUAUGGCCAGAUAGAGAAC	24	16125
CFTR-Intron2-1026	−	UGGCUCAAUUUUGUGACC	18	16126
CFTR-Intron2-1027	−	CUGGCUCAAUUUUGUGACC	19	16127
CFTR-Intron2-1028	−	UCUGGCUCAAUUUUGUGACC	20	16128
CFTR-Intron2-1029	−	AUCUGGCUCAAUUUUGUGACC	21	16129
CFTR-Intron2-1030	−	UAUCUGGCUCAAUUUUGUGACC	22	16130
CFTR-Intron2-1031	−	CUAUCUGGCUCAAUUUUGUGACC	23	16131
CFTR-Intron2-1032	−	CCUAUCUGGCUCAAUUUUGUGACC	24	16132
CFTR-Intron2-1033	−	UGAUGUAUCCCCAAGUGCC	19	16133
CFTR-Intron2-1034	−	AUGAUGUAUCCCCAAGUGCC	20	16134
CFTR-Intron2-1035	−	UCCUAAAACUACAUUGCC	18	16135
CFTR-Intron2-1036	−	UUCCUAAAACUACAUUGCC	19	16136
CFTR-Intron2-1037	−	UGUUCCUAAAACUACAUUGCC	21	16137
CFTR-Intron2-1038	−	AUGUUCCUAAAACUACAUUGCC	22	16138
CFTR-Intron2-1039	−	CAUGUUCCUAAAACUACAUUGCC	23	16139
CFTR-Intron2-1040	−	CCAUGUUCCUAAAACUACAUUGCC	24	16140
CFTR-Intron2-1041	−	UGAAAAAUCCCAGAGACUC	19	16141
CFTR-Intron2-1042	−	UGUGAAAAAUCCCAGAGACUC	21	16142
CFTR-Intron2-1043	−	AUGUGAAAAAUCCCAGAGACUC	22	16143
CFTR-Intron2-1044	−	AAUGUGAAAAAUCCCAGAGACUC	23	16144
CFTR-Intron2-1045	−	AAAUGUGAAAAAUCCCAGAGACUC	24	16145
CFTR-Intron2-1046	−	CUUGGGCCACUCAUAGUC	18	16146
CFTR-Intron2-1047	−	CCUUGGGCCACUCAUAGUC	19	16147
CFTR-Intron2-1048	−	CCCUUGGGCCACUCAUAGUC	20	16148
CFTR-Intron2-1049	−	CCCCUUGGGCCACUCAUAGUC	21	16149
CFTR-Intron2-1050	−	ACCCCUUGGGCCACUCAUAGUC	22	16150
CFTR-Intron2-1051	−	UACCCCUUGGGCCACUCAUAGUC	23	16151
CFTR-Intron2-1052	−	UUACCCCUUGGGCCACUCAUAGUC	24	16152
CFTR-Intron2-1053	−	AUUUCUCCUUUGAUGGAGAAG	21	16153
CFTR-Intron2-1054	−	CAUUUCUCCUUUGAUGGAGAAG	22	16154
CFTR-Intron2-1055	−	CCAUUUCUCCUUUGAUGGAGAAG	23	16155
CFTR-Intron2-1056	−	UCCAUUUCUCCUUUGAUGGAGAAG	24	16156
CFTR-Intron2-1057	−	CAGAUAAAAGGGUGAGUGAAG	21	16157
CFTR-Intron2-1058	−	CCAGAUAAAAGGGUGAGUGAAG	22	16158
CFTR-Intron2-1059	−	UGCCAGAUAAAAGGGUGAGUGAAG	24	16159
CFTR-Intron2-1060	−	CUUAUUAGAGACCAUGAG	18	16160
CFTR-Intron2-1061	−	UCUUAUUAGAGACCAUGAG	19	16161
CFTR-Intron2-1062	−	UGUCUUAUUAGAGACCAUGAG	21	16162
CFTR-Intron2-1063	−	UUGUCUUAUUAGAGACCAUGAG	22	16163
CFTR-Intron2-1064	−	UUUGUCUUAUUAGAGACCAUGAG	23	16164
CFTR-Intron2-1065	−	AUUUGUCUUAUUAGAGACCAUGAG	24	16165
CFTR-Intron2-1066	−	CUGAUGCCAGAUAAAAGG	18	16166
CFTR-Intron2-1067	−	CCUGAUGCCAGAUAAAAGG	19	16167
CFTR-Intron2-1068	−	UACCUGUUACAUGCCAGG	18	16168
CFTR-Intron2-1069	−	AGUACCUGUUACAUGCCAGG	20	16169
CFTR-Intron2-1070	−	UGAGUACCUGUUACAUGCCAGG	22	16170
CFTR-Intron2-1071	−	UUGAGUACCUGUUACAUGCCAGG	23	16171
CFTR-Intron2-1072	−	UUUGAGUACCUGUUACAUGCCAGG	24	16172
CFTR-Intron2-1073	−	AGUCUAGAAUGAACUAGG	18	16173
CFTR-Intron2-1074	−	UAGUCUAGAAUGAACUAGG	19	16174
CFTR-Intron2-1075	−	AUAGUCUAGAAUGAACUAGG	20	16175
CFTR-Intron2-1076	−	CAUAGUCUAGAAUGAACUAGG	21	16176
CFTR-Intron2-1077	−	UCAUAGUCUAGAAUGAACUAGG	22	16177
CFTR-Intron2-1078	−	CUCAUAGUCUAGAAUGAACUAGG	23	16178
CFTR-Intron2-1079	−	ACUCAUAGUCUAGAAUGAACUAGG	24	16179
CFTR-Intron2-1080	−	UGAUUAAUCAGAGUAGGG	18	16180
CFTR-Intron2-1081	−	AUGAUUAAUCAGAGUAGGG	19	16181
CFTR-Intron2-1082	−	AAUGAUUAAUCAGAGUAGGG	20	16182
CFTR-Intron2-1083	−	AGGGAAUGAUUAAUCAGAGUAGGG	24	16183
CFTR-Intron2-1084	−	UUUAUUGAAAUAUUUUGG	18	16184
CFTR-Intron2-1085	−	AUUUAUUGAAAUAUUUUGG	19	16185
CFTR-Intron2-1086	−	AAUUUAUUGAAAUAUUUUGG	20	16186
CFTR-Intron2-1087	−	AACAUGAAUCUGAAUUUG	18	16187
CFTR-Intron2-1088	−	AGAACAUGAAUCUGAAUUUG	20	16188
CFTR-Intron2-1089	−	CAGAUAGAGAACAUGAAU	18	16189
CFTR-Intron2-1090	−	CCAGAUAGAGAACAUGAAU	19	16190
CFTR-Intron2-1091	−	UGGUAACUUGACAGUAAU	18	16191
CFTR-Intron2-1092	−	AUGGUAACUUGACAGUAAU	19	16192
CFTR-Intron2-373	−	UAUGGUAACUUGACAGUAAU	20	15473
CFTR-Intron2-1093	−	UUAUGGUAACUUGACAGUAAU	21	16193
CFTR-Intron2-1094	−	CUUAUGGUAACUUGACAGUAAU	22	16194
CFTR-Intron2-1095	−	ACUUAUGGUAACUUGACAGUAAU	23	16195
CFTR-Intron2-1096	−	UACUUAUGGUAACUUGACAGUAAU	24	16196
CFTR-Intron2-1097	−	UGGAUGCUGAGGGAAUGAUUAAU	23	16197
CFTR-Intron2-1098	−	UUGGAUGCUGAGGGAAUGAUUAAU	24	16198
CFTR-Intron2-1099	−	CUUUCAAAACCUUUAUAU	18	16199
CFTR-Intron2-1100	−	UGCUUUCAAAACCUUUAUAU	20	16200
CFTR-Intron2-1101	−	UAUCUCCUCUCAGCCACU	18	16201
CFTR-Intron2-1102	−	AUAUCUCCUCUCAGCCACU	19	16202
CFTR-Intron2-1103	−	AAUAUCUCCUCUCAGCCACU	20	16203
CFTR-Intron2-1104	−	AGAAUAUCUCCUCUCAGCCACU	22	16204
CFTR-Intron2-1105	−	UAGAAUAUCUCCUCUCAGCCACU	23	16205
CFTR-Intron2-1106	−	CAUAUUUAGCUUCUUACU	18	16206
CFTR-Intron2-1107	−	CCAUAUUUAGCUUCUUACU	19	16207
CFTR-Intron2-1108	−	UCCAUAUUUAGCUUCUUACU	20	16208
CFTR-Intron2-1109	−	CUCCAUAUUUAGCUUCUUACU	21	16209
CFTR-Intron2-1110	−	UGCUCCAUAUUUAGCUUCUUACU	23	16210
CFTR-Intron2-1111	−	CUGCUCCAUAUUUAGCUUCUUACU	24	16211
CFTR-Intron2-1112	−	UGUAUUGCCUUGCUCUCU	18	16212
CFTR-Intron2-1113	−	CUGUAUUGCCUUGCUCUCU	19	16213
CFTR-Intron2-399	−	UCUGUAUUGCCUUGCUCUCU	20	15499
CFTR-Intron2-1114	−	AGGUCUGUAUUGCCUUGCUCUCU	23	16214
CFTR-Intron2-1115	−	UCAAAGAAUUAAGCUAGU	18	16215
CFTR-Intron2-1116	−	UUCAAAGAAUUAAGCUAGU	19	16216
CFTR-Intron2-404	−	AUUCAAAGAAUUAAGCUAGU	20	15504
CFTR-Intron2-1117	−	UAUUCAAAGAAUUAAGCUAGU	21	16217
CFTR-Intron2-1118	−	UUAUUCAAAGAAUUAAGCUAGU	22	16218
CFTR-Intron2-1119	−	UUUAUUCAAAGAAUUAAGCUAGU	23	16219
CFTR-Intron2-1120	−	UUUUAUUCAAAGAAUUAAGCUAGU	24	16220
CFTR-Intron2-1121	−	CCGUUCCAAGAUUGUAGU	18	16221
CFTR-Intron2-1122	−	UCCGUUCCAAGAUUGUAGU	19	16222
CFTR-Intron2-1123	−	AUCCGUUCCAAGAUUGUAGU	20	16223
CFTR-Intron2-1124	−	CAUCCGUUCCAAGAUUGUAGU	21	16224
CFTR-Intron2-1125	−	ACAUCCGUUCCAAGAUUGUAGU	22	16225
CFTR-Intron2-1126	−	CACAUCCGUUCCAAGAUUGUAGU	23	16226
CFTR-Intron2-1127	−	ACACAUCCGUUCCAAGAUUGUAGU	24	16227
CFTR-Intron2-1128	−	CCUUUCCAAUCAAAAGGU	18	16228
CFTR-Intron2-1129	−	UCCUUUCCAAUCAAAAGGU	19	16229
CFTR-Intron2-1130	−	UUCCUUUCCAAUCAAAAGGU	20	16230
CFTR-Intron2-1131	−	UUUCCUUUCCAAUCAAAAGGU	21	16231
CFTR-Intron2-1132	−	AGUUUCCUUUCCAAUCAAAAGGU	23	16232
CFTR-Intron2-1133	−	CAGUUUCCUUUCCAAUCAAAAGGU	24	16233
CFTR-Intron2-1134	−	CCCGGCCUAUUACUCCUU	18	16234
CFTR-Intron2-1135	−	CCCCGGCCUAUUACUCCUU	19	16235
CFTR-Intron2-1136	−	UGCCCCGGCCUAUUACUCCUU	21	16236
CFTR-Intron2-1137	−	CUGCCCCGGCCUAUUACUCCUU	22	16237
CFTR-Intron2-1138	−	ACUGCCCCGGCCUAUUACUCCUU	23	16238
CFTR-Intron2-1139	−	CACUGCCCCGGCCUAUUACUCCUU	24	16239
CFTR-Intron2-1140	−	UCUGAGUAACCAAAUGUU	18	16240
CFTR-Intron2-1141	−	CUCUGAGUAACCAAAUGUU	19	16241
CFTR-Intron2-1142	−	ACUCUGAGUAACCAAAUGUU	20	16242
CFTR-Intron2-1143	−	UACUCUGAGUAACCAAAUGUU	21	16243
CFTR-Intron2-1144	−	UUACUCUGAGUAACCAAAUGUU	22	16244
CFTR-Intron2-1145	−	CUUACUCUGAGUAACCAAAUGUU	23	16245
CFTR-Intron2-1146	−	UCUUACUCUGAGUAACCAAAUGUU	24	16246
CFTR-Intron2-1147	−	UCAGGAUAUGAACUUUUU	18	16247
CFTR-Intron2-1148	−	AGUCAGGAUAUGAACUUUUU	20	16248
CFTR-Intron2-1149	−	UAGUCAGGAUAUGAACUUUUU	21	16249
CFTR-Intron2-1150	−	UGUAGUCAGGAUAUGAACUUUUU	23	16250
CFTR-Intron2-1151	−	UUGUAGUCAGGAUAUGAACUUUUU	24	16251

Table 38C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 2, start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 38C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-1152	+	GAAUGUUAGCUAUGAAAGAAAAAA	24	16252
CFTR-Intron2-1153	+	GUAAAAUAGGUAUAUUUUUUAAA	23	16253
CFTR-Intron2-1154	+	GUUUCUGUCACUGGCAAUCAA	21	16254
CFTR-Intron2-1155	+	GGUUUCUGUCACUGGCAAUCAA	22	16255
CFTR-Intron2-1156	+	GGGUUUCUGUCACUGGCAAUCAA	23	16256
CFTR-Intron2-1157	+	GCUAUGAAAGAAAAAAUAGAA	21	16257
CFTR-Intron2-1158	+	GAAGUAGAGAGACCAGGAGAGCA	23	16258
CFTR-Intron2-1159	+	GAUCAGAUGGGAAAGCCAAGGA	22	16259
CFTR-Intron2-1160	+	GGAUCAGAUGGGAAAGCCAAGGA	23	16260
CFTR-Intron2-1161	+	GAUUCAUUCAACAAAUAUUUA	21	16261
CFTR-Intron2-1162	+	GGAUUCAUUCAACAAAUAUUUA	22	16262
CFTR-Intron2-1163	+	GAUCACACCACUACACUCCAGC	22	16263
CFTR-Intron2-1164	+	GAGAUCACACCACUACACUCCAGC	24	16264
CFTR-Intron2-1165	+	GGCAGAUCACUUGAGGUC	18	16265
CFTR-Intron2-1166	+	GGGCAGAUCACUUGAGGUC	19	16266
CFTR-Intron2-1167	+	GCGGGCAGAUCACUUGAGGUC	21	16267
CFTR-Intron2-1168	+	GGCGGGCAGAUCACUUGAGGUC	22	16268
CFTR-Intron2-1169	+	GUGGGCAGAUCACUUGAGGUC	21	16269
CFTR-Intron2-1170	+	GGUGGGCAGAUCACUUGAGGUC	22	16270
CFTR-Intron2-1171	+	GCUACUCGAGAGGCUGAGGCAG	22	16271
CFTR-Intron2-1172	+	GAUUCGCUUGAACCCAGGAGG	21	16272
CFTR-Intron2-1173	+	GAGAUUCGCUUGAACCCAGGAGG	23	16273
CFTR-Intron2-1174	+	GAGAUAAUGAUGCUUUCCACU	21	16274
CFTR-Intron2-1175	+	GCCCUAUUCUAGGCACUU	18	16275
CFTR-Intron2-1176	+	GGCCCUAUUCUAGGCACUU	19	16276
CFTR-Intron2-1177	+	GCCAGGCCCUAUUCUAGGCACUU	23	16277
CFTR-Intron2-1178	−	GCAAACUCUGCCUCCUGGGUUCAA	24	16278
CFTR-Intron2-1179	−	GGCUAAUUUUUGUAGAGA	18	16279
CFTR-Intron2-1180	−	GCCUGGCUAAUUUUUGUAGAGA	22	16280
CFTR-Intron2-1181	−	GGCCUGGCUAAUUUUUGUAGAGA	23	16281
CFTR-Intron2-1182	−	GUUGCUGUUGUUUUUGAGA	19	16282
CFTR-Intron2-1183	−	GUUGUUGCUGUUGUUUUUGAGA	22	16283
CFTR-Intron2-1184	−	GUGUUGUUUGUUUUUGAGA	19	16284
CFTR-Intron2-1185	−	GUUUGUGUUGUUUGUUUUUGAGA	23	16285
CFTR-Intron2-1186	−	GUUUUGUUUUUUAUUUUUUA	20	16286
CFTR-Intron2-1187	−	GUUUAUGAUGUAUCCCCAAGUGCC	24	16287
CFTR-Intron2-1188	−	GUCUCGCUGUGUCACCCAGGC	21	16288
CFTR-Intron2-1189	−	GAGUCUCGCUGUGUCACCCAGGC	23	16289
CFTR-Intron2-1190	−	GUCUUGCUCUGUUGCCCAGGC	21	16290
CFTR-Intron2-1191	−	GAGUCUUGCUCUGUUGCCCAGGC	23	16291
CFTR-Intron2-1192	−	GCCCACCUUGGCCUCCCAAAAUGC	24	16292
CFTR-Intron2-1193	−	GAUUCUCCUGCCUCAGCCUC	20	16293
CFTR-Intron2-1194	−	GUGAUUCUCCUGCCUCAGCCUC	22	16294
CFTR-Intron2-1195	−	GCUCACUGCAAACUCUGCCUC	21	16295
CFTR-Intron2-1196	−	GUUCAAGCGAAUCUCAGUCUC	21	16296
CFTR-Intron2-1197	−	GGUUCAAGCGAAUCUCAGUCUC	22	16297
CFTR-Intron2-1198	−	GGGUUCAAGCGAAUCUCAGUCUC	23	16298
CFTR-Intron2-1199	−	GCUCACUGCAAACUUCGUCUC	21	16299
CFTR-Intron2-1200	−	GGCUCACUGCAAACUUCGUCUC	22	16300
CFTR-Intron2-1201	−	GAUAAAAGGGUGAGUGAAG	19	16301
CFTR-Intron2-1202	−	GCCUCAGCCUCUCGAGUAG	19	16302
CFTR-Intron2-1203	−	GGCCUGAUGCCAGAUAAAAGG	21	16303
CFTR-Intron2-1204	−	GAAAUUUAUUGAAAUAUUUUGG	22	16304
CFTR-Intron2-1205	−	GAGAACAUGAAUCUGAAUUUG	21	16305
CFTR-Intron2-1206	−	GUAUAUACUCAAUAAAUAUUUG	22	16306
CFTR-Intron2-1207	−	GGUAUAUACUCAAUAAAUAUUUG	23	16307
CFTR-Intron2-1208	−	GGCCAGAUAGAGAACAUGAAU	21	16308
CFTR-Intron2-1209	−	GCUGAGGGAAUGAUUAAU	18	16309
CFTR-Intron2-1210	−	GAGCCACUAUGCCCAGCU	18	16310
CFTR-Intron2-1211	−	GUGAGCCACUAUGCCCAGCU	20	16311
CFTR-Intron2-1212	−	GUGUGAGCCACUAUGCCCAGCU	22	16312
CFTR-Intron2-1213	−	GGUGUGAGCCACUAUGCCCAGCU	23	16313
CFTR-Intron2-1214	−	GUGCAAAUGCCAUGAGGU	18	16314
CFTR-Intron2-472	−	GUGUGCAAAUGCCAUGAGGU	20	15572
CFTR-Intron2-1215	−	GUGUGUGCAAAUGCCAUGAGGU	22	16315
CFTR-Intron2-1216	−	GGUGUGUGCAAAUGCCAUGAGGU	23	16316
CFTR-Intron2-474	−	GCCUUGGCCUCCCAAAGUGU	20	15574
CFTR-Intron2-1217	−	GCCCGCCUUGGCCUCCCAAAGUGU	24	16317

Table 38D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within intron 2, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 38D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-1218	+	UGUUAGCUAUGAAAGAAAAAA	21	16318
CFTR-Intron2-1219	+	AUGUUAGCUAUGAAAGAAAAAA	22	16319
CFTR-Intron2-1220	+	AAUGUUAGCUAUGAAAGAAAAAA	23	16320
CFTR-Intron2-1221	+	UUUACUUAAGCUAGUAAA	18	16321
CFTR-Intron2-1222	+	AUUUACUUAAGCUAGUAAA	19	16322
CFTR-Intron2-1223	+	UAUUUACUUAAGCUAGUAAA	20	16323
CFTR-Intron2-1224	+	AUAGGUAUAUUUUUUAAA	18	16324
CFTR-Intron2-1225	+	AAUAGGUAUAUUUUUUAAA	19	16325
CFTR-Intron2-1226	+	AAAUAGGUAUAUUUUUUAAA	20	16326
CFTR-Intron2-1227	+	AAAAUAGGUAUAUUUUUUAAA	21	16327
CFTR-Intron2-1228	+	UAAAAUAGGUAUAUUUUUUAAA	22	16328
CFTR-Intron2-1229	+	AGUAAAAUAGGUAUAUUUUUUAAA	24	16329
CFTR-Intron2-1230	+	UCUGUCACUGGCAAUCAA	18	16330
CFTR-Intron2-1231	+	UUCUGUCACUGGCAAUCAA	19	16331
CFTR-Intron2-1232	+	UUUCUGUCACUGGCAAUCAA	20	16332
CFTR-Intron2-1233	+	UGGGUUUCUGUCACUGGCAAUCAA	24	16333
CFTR-Intron2-1234	+	UUCUCCAUCAAAGGAGAA	18	16334
CFTR-Intron2-1235	+	CUUCUCCAUCAAAGGAGAA	19	16335
CFTR-Intron2-1236	+	CCUUCUCCAUCAAAGGAGAA	20	16336
CFTR-Intron2-1237	+	AUGAAAGAAAAAAUAGAA	18	16337
CFTR-Intron2-1238	+	UAUGAAAGAAAAAAUAGAA	19	16338
CFTR-Intron2-614	+	CUAUGAAAGAAAAAAUAGAA	20	15714
CFTR-Intron2-1239	+	AGCUAUGAAAGAAAAAAUAGAA	22	16339
CFTR-Intron2-1240	+	UAGCUAUGAAAGAAAAAAUAGAA	23	16340
CFTR-Intron2-1241	+	UUAGCUAUGAAAGAAAAAAUAGAA	24	16341
CFTR-Intron2-1242	+	AAAUGCCAAAAAAAGGAA	18	16342
CFTR-Intron2-1243	+	AAAAUGCCAAAAAAAGGAA	19	16343
CFTR-Intron2-1244	+	CAAAAUGCCAAAAAAAGGAA	20	16344
CFTR-Intron2-1245	+	UCAAAAUGCCAAAAAAAGGAA	21	16345
CFTR-Intron2-1246	+	UUCAAAAUGCCAAAAAAAGGAA	22	16346
CFTR-Intron2-1247	+	CUUCAAAAUGCCAAAAAAAGGAA	23	16347
CFTR-Intron2-1248	+	CCUUCAAAAUGCCAAAAAAAGGAA	24	16348
CFTR-Intron2-1249	+	AACAAACAAAAAACAUAA	18	16349
CFTR-Intron2-1250	+	AAACAAACAAAAAACAUAA	19	16350
CFTR-Intron2-616	+	CAAACAAACAAAAAACAUAA	20	15716
CFTR-Intron2-1251	+	ACAAACAAACAAAAAACAUAA	21	16351
CFTR-Intron2-1252	+	CACAAACAAACAAAAAACAUAA	22	16352
CFTR-Intron2-1253	+	ACACAAACAAACAAAAAACAUAA	23	16353
CFTR-Intron2-1254	+	AACACAAACAAACAAAAAACAUAA	24	16354
CFTR-Intron2-1255	+	UUAUAAGAAAAGAAGUAA	18	16355
CFTR-Intron2-1256	+	UUUAUAAGAAAAGAAGUAA	19	16356
CFTR-Intron2-1257	+	UUUUAUAAGAAAAGAAGUAA	20	16357
CFTR-Intron2-1258	+	AUUUUAUAAGAAAAGAAGUAA	21	16358
CFTR-Intron2-1259	+	AAUUUUAUAAGAAAAGAAGUAA	22	16359
CFTR-Intron2-1260	+	CAAUUUUAUAAGAAAAGAAGUAA	23	16360
CFTR-Intron2-1261	+	CCAAUUUUAUAAGAAAAGAAGUAA	24	16361
CFTR-Intron2-1262	+	AGUAGAGAGACCAGGAGAGCA	21	16362
CFTR-Intron2-1263	+	AAGUAGAGAGACCAGGAGAGCA	22	16363
CFTR-Intron2-1264	+	UGAAGUAGAGAGACCAGGAGAGCA	24	16364
CFTR-Intron2-1265	+	AUCAGAUGGGAAAGCCAAGGA	21	16365
CFTR-Intron2-1266	+	UGGAUCAGAUGGGAAAGCCAAGGA	24	16366
CFTR-Intron2-1267	+	UCAUUCAACAAAUAUUUA	18	16367
CFTR-Intron2-1268	+	UUCAUUCAACAAAUAUUUA	19	16368
CFTR-Intron2-1269	+	AUUCAUUCAACAAAUAUUUA	20	16369
CFTR-Intron2-1270	+	UGGAUUCAUUCAACAAAUAUUUA	23	16370
CFTR-Intron2-1271	+	AUGGAUUCAUUCAACAAAUAUUUA	24	16371
CFTR-Intron2-1272	+	ACACCACUACACUCCAGC	18	16372
CFTR-Intron2-1273	+	CACACCACUACACUCCAGC	19	16373
CFTR-Intron2-1274	+	UCACACCACUACACUCCAGC	20	16374
CFTR-Intron2-1275	+	AUCACACCACUACACUCCAGC	21	16375
CFTR-Intron2-1276	+	AGAUCACACCACUACACUCCAGC	23	16376
CFTR-Intron2-667	+	CGGGCAGAUCACUUGAGGUC	20	15767
CFTR-Intron2-1277	+	AGGCGGGCAGAUCACUUGAGGUC	23	16377
CFTR-Intron2-1278	+	AAGGCGGGCAGAUCACUUGAGGUC	24	16378
CFTR-Intron2-668	+	UGGGCAGAUCACUUGAGGUC	20	15768
CFTR-Intron2-1279	+	AGGUGGGCAGAUCACUUGAGGUC	23	16379
CFTR-Intron2-1280	+	AAGGUGGGCAGAUCACUUGAGGUC	24	16380
CFTR-Intron2-1281	+	CUCGAGAGGCUGAGGCAG	18	16381
CFTR-Intron2-1282	+	ACUCGAGAGGCUGAGGCAG	19	16382
CFTR-Intron2-1283	+	UACUCGAGAGGCUGAGGCAG	20	16383
CFTR-Intron2-1284	+	CUACUCGAGAGGCUGAGGCAG	21	16384
CFTR-Intron2-1285	+	AGCUACUCGAGAGGCUGAGGCAG	23	16385
CFTR-Intron2-1286	+	CAGCUACUCGAGAGGCUGAGGCAG	24	16386
CFTR-Intron2-1287	+	CCUGAGGAGAAGGCAAGGUCG	21	16387
CFTR-Intron2-1288	+	ACCUGAGGAGAAGGCAAGGUCG	22	16388
CFTR-Intron2-1289	+	UACCUGAGGAGAAGGCAAGGUCG	23	16389
CFTR-Intron2-1290	+	UUACCUGAGGAGAAGGCAAGGUCG	24	16390
CFTR-Intron2-1291	+	UCGCUUGAACCCAGGAGG	18	16391
CFTR-Intron2-1292	+	UUCGCUUGAACCCAGGAGG	19	16392
CFTR-Intron2-1293	+	AUUCGCUUGAACCCAGGAGG	20	16393
CFTR-Intron2-1294	+	AGAUUCGCUUGAACCCAGGAGG	22	16394
CFTR-Intron2-1295	+	UGAGAUUCGCUUGAACCCAGGAGG	24	16395
CFTR-Intron2-1296	+	UUUUUAAAUUGAAUCAACAUG	21	16396
CFTR-Intron2-1297	+	UUUUUUAAAUUGAAUCAACAUG	22	16397
CFTR-Intron2-1298	+	AUUUUUUAAAUUGAAUCAACAUG	23	16398
CFTR-Intron2-1299	+	UAUUUUUUAAAUUGAAUCAACAUG	24	16399
CFTR-Intron2-1300	+	AAUUAGCCAGGCAUUGUG	18	16400
CFTR-Intron2-1301	+	AAAUUAGCCAGGCAUUGUG	19	16401
CFTR-Intron2-1302	+	AAAAUUAGCCAGGCAUUGUG	20	16402
CFTR-Intron2-1303	+	AAAAAUUAGCCAGGCAUUGUG	21	16403
CFTR-Intron2-1304	+	CAAAAAUUAGCCAGGCAUUGUG	22	16404
CFTR-Intron2-1305	+	ACAAAAAUUAGCCAGGCAUUGUG	23	16405
CFTR-Intron2-1306	+	UACAAAAAUUAGCCAGGCAUUGUG	24	16406
CFTR-Intron2-1307	+	AAUGCCACCAGGUGGCAU	18	16407
CFTR-Intron2-1308	+	AAAUGCCACCAGGUGGCAU	19	16408
CFTR-Intron2-1309	+	CAAAUGCCACCAGGUGGCAU	20	16409
CFTR-Intron2-1310	+	AGAGAUAAUGAUGCUUUCCACU	22	16410
CFTR-Intron2-1311	+	UAGAGAUAAUGAUGCUUUCCACU	23	16411
CFTR-Intron2-1312	+	AUAGAGAUAAUGAUGCUUUCCACU	24	16412
CFTR-Intron2-1313	+	UAUAUUUUCUAUUAUAGU	18	16413
CFTR-Intron2-1314	+	AUAUAUUUUCUAUUAUAGU	19	16414
CFTR-Intron2-1315	+	UAUAUAUUUUCUAUUAUAGU	20	16415
CFTR-Intron2-1316	+	UUAUAUAUUUUCUAUUAUAGU	21	16416
CFTR-Intron2-1317	+	AUUAUAUAUUUUCUAUUAUAGU	22	16417
CFTR-Intron2-1318	+	AAUUAUAUAUUUUCUAUUAUAGU	23	16418
CFTR-Intron2-1319	+	AAAUUAUAUAUUUUCUAUUAUAGU	24	16419
CFTR-Intron2-1320	+	ACAAAAAUAAUAGAACGU	18	16420
CFTR-Intron2-1321	+	AACAAAAAUAAUAGAACGU	19	16421
CFTR-Intron2-1322	+	AAACAAAAAUAAUAGAACGU	20	16422
CFTR-Intron2-1323	+	AAAACAAAAAUAAUAGAACGU	21	16423
CFTR-Intron2-1324	+	CAAAACAAAAAUAAUAGAACGU	22	16424
CFTR-Intron2-1325	+	ACAAAACAAAAAUAAUAGAACGU	23	16425
CFTR-Intron2-1326	+	AACAAAACAAAAAUAAUAGAACGU	24	16426
CFTR-Intron2-718	+	AGGCCCUAUUCUAGGCACUU	20	15818
CFTR-Intron2-1327	+	CAGGCCCUAUUCUAGGCACUU	21	16427
CFTR-Intron2-1328	+	CCAGGCCCUAUUCUAGGCACUU	22	16428
CFTR-Intron2-1329	+	UGCCAGGCCCUAUUCUAGGCACUU	24	16429
CFTR-Intron2-1330	−	UCUGCCUCCUGGGUUCAA	18	16430
CFTR-Intron2-1331	−	CUCUGCCUCCUGGGUUCAA	19	16431
CFTR-Intron2-1332	−	ACUCUGCCUCCUGGGUUCAA	20	16432
CFTR-Intron2-1333	−	AACUCUGCCUCCUGGGUUCAA	21	16433
CFTR-Intron2-1334	−	AAACUCUGCCUCCUGGGUUCAA	22	16434
CFTR-Intron2-1335	−	CAAACUCUGCCUCCUGGGUUCAA	23	16435
CFTR-Intron2-1336	−	UGAAUAUCUAAGUUUUAA	18	16436
CFTR-Intron2-1337	−	UUGAAUAUCUAAGUUUUAA	19	16437
CFTR-Intron2-1338	−	UUUGAAUAUCUAAGUUUUAA	20	16438
CFTR-Intron2-1339	−	UUUUAUUGAUUUUAUUCA	18	16439
CFTR-Intron2-1340	−	UUUUUAUUGAUUUUAUUCA	19	16440
CFTR-Intron2-1341	−	AUUUUUAUUGAUUUUAUUCA	20	16441
CFTR-Intron2-1342	−	UAUUUUUAUUGAUUUUAUUCA	21	16442
CFTR-Intron2-1343	−	UUAUUUUUAUUGAUUUUAUUCA	22	16443
CFTR-Intron2-1344	−	UUUAUUUUUAUUGAUUUUAUUCA	23	16444
CFTR-Intron2-1345	−	CUUUAUUUUUAUUGAUUUUAUUCA	24	16445
CFTR-Intron2-1346	−	AAUACACAUUUGGUUUCA	18	16446
CFTR-Intron2-1347	−	AAAUACACAUUUGGUUUCA	19	16447
CFTR-Intron2-1348	−	AAAAUACACAUUUGGUUUCA	20	16448
CFTR-Intron2-1349	−	UGGCUAAUUUUUGUAGAGA	19	16449
CFTR-Intron2-626	−	CUGGCUAAUUUUUGUAGAGA	20	15726
CFTR-Intron2-1350	−	CCUGGCUAAUUUUUGUAGAGA	21	16450
CFTR-Intron2-1351	−	AGGCCUGGCUAAUUUUUGUAGAGA	24	16451
CFTR-Intron2-1352	−	UUGCUGUUGUUUUUGAGA	18	16452
CFTR-Intron2-1353	−	UGUUGCUGUUGUUUUUGAGA	20	16453
CFTR-Intron2-1354	−	UUGUUGCUGUUGUUUUUGAGA	21	16454
CFTR-Intron2-1355	−	UGUUGUUGCUGUUGUUUUUGAGA	23	16455
CFTR-Intron2-1356	−	UUGUUGUUGCUGUUGUUUUUGAGA	24	16456
CFTR-Intron2-1357	−	UGUUGUUUGUUUUUGAGA	18	16457
CFTR-Intron2-1358	−	UGUGUUGUUUGUUUUUGAGA	20	16458
CFTR-Intron2-1359	−	UUGUGUUGUUUGUUUUUGAGA	21	16459
CFTR-Intron2-1360	−	UUUGUGUUGUUUGUUUUUGAGA	22	16460
CFTR-Intron2-1361	−	UGUUUGUGUUGUUUGUUUUUGAGA	24	16461
CFTR-Intron2-1362	−	UAGCUUAAGUAAAUAAAAGGA	21	16462
CFTR-Intron2-1363	−	CUAGCUUAAGUAAAUAAAAGGA	22	16463
CFTR-Intron2-1364	−	ACUAGCUUAAGUAAAUAAAAGGA	23	16464
CFTR-Intron2-1365	−	UACUAGCUUAAGUAAAUAAAAGGA	24	16465
CFTR-Intron2-1366	−	UGUUGAAUGAAUCCAUGA	18	16466
CFTR-Intron2-1367	−	UUGUUGAAUGAAUCCAUGA	19	16467
CFTR-Intron2-628	−	UUUGUUGAAUGAAUCCAUGA	20	15728
CFTR-Intron2-1368	−	AUUUGUUGAAUGAAUCCAUGA	21	16468
CFTR-Intron2-1369	−	UAUUUGUUGAAUGAAUCCAUGA	22	16469
CFTR-Intron2-1370	−	AUAUUUGUUGAAUGAAUCCAUGA	23	16470
CFTR-Intron2-1371	−	AAUAUUUGUUGAAUGAAUCCAUGA	24	16471
CFTR-Intron2-1372	−	UCAAUAAAUAUUUGUUGA	18	16472
CFTR-Intron2-1373	−	CUCAAUAAAUAUUUGUUGA	19	16473
CFTR-Intron2-1374	−	ACUCAAUAAAUAUUUGUUGA	20	16474
CFTR-Intron2-1375	−	UACUCAAUAAAUAUUUGUUGA	21	16475
CFTR-Intron2-1376	−	AUACUCAAUAAAUAUUUGUUGA	22	16476
CFTR-Intron2-1377	−	UAUACUCAAUAAAUAUUUGUUGA	23	16477
CFTR-Intron2-1378	−	AUAUACUCAAUAAAUAUUUGUUGA	24	16478
CFTR-Intron2-1379	−	UUUGUUUUUUAUUUUUUA	18	16479
CFTR-Intron2-1380	−	UUUUGUUUUUUAUUUUUUA	19	16480
CFTR-Intron2-1381	−	UGUUUUGUUUUUUAUUUUUUA	21	16481
CFTR-Intron2-1382	−	UUGUUUUGUUUUUUAUUUUUUA	22	16482
CFTR-Intron2-1383	−	UUUGUUUUGUUUUUUAUUUUUUA	23	16483
CFTR-Intron2-1384	−	CUUUGUUUUGUUUUUUAUUUUUUA	24	16484
CFTR-Intron2-1385	−	UAUGAUGUAUCCCCAAGUGCC	21	16485
CFTR-Intron2-1386	−	UUAUGAUGUAUCCCCAAGUGCC	22	16486
CFTR-Intron2-1387	−	UUUAUGAUGUAUCCCCAAGUGCC	23	16487
CFTR-Intron2-1388	−	UCGCUGUGUCACCCAGGC	18	16488
CFTR-Intron2-1389	−	CUCGCUGUGUCACCCAGGC	19	16489
CFTR-Intron2-658	−	UCUCGCUGUGUCACCCAGGC	20	15758
CFTR-Intron2-1390	−	AGUCUCGCUGUGUCACCCAGGC	22	16490
CFTR-Intron2-1391	−	AGAGUCUCGCUGUGUCACCCAGGC	24	16491
CFTR-Intron2-1392	−	UUGCUCUGUUGCCCAGGC	18	16492
CFTR-Intron2-1393	−	CUUGCUCUGUUGCCCAGGC	19	16493
CFTR-Intron2-659	−	UCUUGCUCUGUUGCCCAGGC	20	15759
CFTR-Intron2-1394	−	AGUCUUGCUCUGUUGCCCAGGC	22	16494
CFTR-Intron2-1395	−	AGAGUCUUGCUCUGUUGCCCAGGC	24	16495
CFTR-Intron2-1396	−	CUUGGCCUCCCAAAAUGC	18	16496
CFTR-Intron2-1397	−	CCUUGGCCUCCCAAAAUGC	19	16497
CFTR-Intron2-663	−	ACCUUGGCCUCCCAAAAUGC	20	15763
CFTR-Intron2-1398	−	CACCUUGGCCUCCCAAAAUGC	21	16498
CFTR-Intron2-1399	−	CCACCUUGGCCUCCCAAAAUGC	22	16499
CFTR-Intron2-1400	−	CCCACCUUGGCCUCCCAAAAUGC	23	16500
CFTR-Intron2-1401	−	UUCUCCUGCCUCAGCCUC	18	16501
CFTR-Intron2-1402	−	AUUCUCCUGCCUCAGCCUC	19	16502
CFTR-Intron2-1403	−	UGAUUCUCCUGCCUCAGCCUC	21	16503
CFTR-Intron2-1404	−	AGUGAUUCUCCUGCCUCAGCCUC	23	16504
CFTR-Intron2-1405	−	AAGUGAUUCUCCUGCCUCAGCCUC	24	16505
CFTR-Intron2-1406	−	CACUGCAAACUCUGCCUC	18	16506
CFTR-Intron2-1407	−	UCACUGCAAACUCUGCCUC	19	16507
CFTR-Intron2-1408	−	CUCACUGCAAACUCUGCCUC	20	16508
CFTR-Intron2-1409	−	AGCUCACUGCAAACUCUGCCUC	22	16509
CFTR-Intron2-1410	−	CAGCUCACUGCAAACUCUGCCUC	23	16510
CFTR-Intron2-1411	−	UCAGCUCACUGCAAACUCUGCCUC	24	16511
CFTR-Intron2-1412	−	CAAGCGAAUCUCAGUCUC	18	16512
CFTR-Intron2-1413	−	UCAAGCGAAUCUCAGUCUC	19	16513
CFTR-Intron2-1414	−	UUCAAGCGAAUCUCAGUCUC	20	16514
CFTR-Intron2-1415	−	UGGGUUCAAGCGAAUCUCAGUCUC	24	16515
CFTR-Intron2-1416	−	CACUGCAAACUUCGUCUC	18	16516
CFTR-Intron2-1417	−	UCACUGCAAACUUCGUCUC	19	16517
CFTR-Intron2-1418	−	CUCACUGCAAACUUCGUCUC	20	16518
CFTR-Intron2-1419	−	UGGCUCACUGCAAACUUCGUCUC	23	16519
CFTR-Intron2-1420	−	UUGGCUCACUGCAAACUUCGUCUC	24	16520
CFTR-Intron2-1421	−	UCUCCUUUGAUGGAGAAG	18	16521
CFTR-Intron2-1422	−	UUCUCCUUUGAUGGAGAAG	19	16522
CFTR-Intron2-1423	−	UUUCUCCUUUGAUGGAGAAG	20	16523
CFTR-Intron2-1424	−	AUAAAAGGGUGAGUGAAG	18	16524
CFTR-Intron2-672	−	AGAUAAAAGGGUGAGUGAAG	20	15772
CFTR-Intron2-1425	−	CCUCAGCCUCUCGAGUAG	18	16525
CFTR-Intron2-1426	−	UGCCUCAGCCUCUCGAGUAG	20	16526
CFTR-Intron2-1427	−	CUGCCUCAGCCUCUCGAGUAG	21	16527
CFTR-Intron2-1428	−	CCUGCCUCAGCCUCUCGAGUAG	22	16528
CFTR-Intron2-1429	−	UCCUGCCUCAGCCUCUCGAGUAG	23	16529
CFTR-Intron2-1430	−	CUCCUGCCUCAGCCUCUCGAGUAG	24	16530
CFTR-Intron2-1431	−	AGGCCUGAUGCCAGAUAAAAGG	22	16531
CFTR-Intron2-1432	−	CAGGCCUGAUGCCAGAUAAAAGG	23	16532
CFTR-Intron2-1433	−	ACAGGCCUGAUGCCAGAUAAAAGG	24	16533
CFTR-Intron2-1434	−	AAAUUUAUUGAAAUAUUUUGG	21	16534
CFTR-Intron2-1435	−	UGAAAUUUAUUGAAAUAUUUUGG	23	16535
CFTR-Intron2-1436	−	UUGAAAUUUAUUGAAAUAUUUUGG	24	16536
CFTR-Intron2-1437	−	UUUGUAUUUUAGUAGAUG	18	16537
CFTR-Intron2-1438	−	UUUUGUAUUUUAGUAGAUG	19	16538
CFTR-Intron2-688	−	UUUUUGUAUUUUAGUAGAUG	20	15788
CFTR-Intron2-1439	−	AUUUUUGUAUUUUAGUAGAUG	21	16539
CFTR-Intron2-1440	−	AAUUUUUGUAUUUUAGUAGAUG	22	16540
CFTR-Intron2-1441	−	UAAUUUUUGUAUUUUAGUAGAUG	23	16541
CFTR-Intron2-1442	−	CUAAUUUUUGUAUUUUAGUAGAUG	24	16542
CFTR-Intron2-1443	−	AGAGAACAUGAAUCUGAAUUUG	22	16543
CFTR-Intron2-1444	−	UAGAGAACAUGAAUCUGAAUUUG	23	16544
CFTR-Intron2-1445	−	AUAGAGAACAUGAAUCUGAAUUUG	24	16545
CFTR-Intron2-1446	−	AUACUCAAUAAAUAUUUG	18	16546
CFTR-Intron2-1447	−	UAUACUCAAUAAAUAUUUG	19	16547
CFTR-Intron2-1448	−	AUAUACUCAAUAAAUAUUUG	20	16548
CFTR-Intron2-1449	−	UAUAUACUCAAUAAAUAUUUG	21	16549
CFTR-Intron2-1450	−	UGGUAUAUACUCAAUAAAUAUUUG	24	16550
CFTR-Intron2-1451	−	UGGCCAGAUAGAGAACAUGAAU	22	16551
CFTR-Intron2-1452	−	AUGGCCAGAUAGAGAACAUGAAU	23	16552
CFTR-Intron2-1453	−	UAUGGCCAGAUAGAGAACAUGAAU	24	16553
CFTR-Intron2-1454	−	UGCUGAGGGAAUGAUUAAU	19	16554
CFTR-Intron2-1455	−	AUGCUGAGGGAAUGAUUAAU	20	16555
CFTR-Intron2-1456	−	UUGCUUUCAAAACCUUUAUAU	21	16556
CFTR-Intron2-1457	−	UUUGCUUUCAAAACCUUUAUAU	22	16557
CFTR-Intron2-1458	−	AUUUGCUUUCAAAACCUUUAUAU	23	16558
CFTR-Intron2-1459	−	UAUUUGCUUUCAAAACCUUUAUAU	24	16559
CFTR-Intron2-1460	−	UGAGCCACUAUGCCCAGCU	19	16560
CFTR-Intron2-1461	−	UGUGAGCCACUAUGCCCAGCU	21	16561
CFTR-Intron2-1462	−	AGGUGUGAGCCACUAUGCCCAGCU	24	16562
CFTR-Intron2-1463	−	UGUGCAAAUGCCAUGAGGU	19	16563
CFTR-Intron2-1464	−	UGUGUGCAAAUGCCAUGAGGU	21	16564
CFTR-Intron2-1465	−	UGGUGUGUGCAAAUGCCAUGAGGU	24	16565
CFTR-Intron2-1466	−	CUUGGCCUCCCAAAGUGU	18	16566
CFTR-Intron2-1467	−	CCUUGGCCUCCCAAAGUGU	19	16567
CFTR-Intron2-1468	−	CGCCUUGGCCUCCCAAAGUGU	21	16568
CFTR-Intron2-1469	−	CCGCCUUGGCCUCCCAAAGUGU	22	16569
CFTR-Intron2-1470	−	CCCGCCUUGGCCUCCCAAAGUGU	23	16570
CFTR-Intron2-1471	−	UGUAAAAAUUGUAUAUUU	18	16571
CFTR-Intron2-1472	−	AUGUAAAAAUUGUAUAUUU	19	16572
CFTR-Intron2-1473	−	AAUGUAAAAAUUGUAUAUUU	20	16573
CFTR-Intron2-1474	−	AAAUGUAAAAAUUGUAUAUUU	21	16574
CFTR-Intron2-1475	−	CAAAUGUAAAAAUUGUAUAUUU	22	16575
CFTR-Intron2-1476	−	ACAAAUGUAAAAAUUGUAUAUUU	23	16576
CFTR-Intron2-1477	−	AACAAAUGUAAAAAUUGUAUAUUU	24	16577

Table 38E provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within intron 2, and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 38E
5th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-1478	+	CUUCAAAAUGCCAAAAAA	18	16578
CFTR-Intron2-1479	+	CCUUCAAAAUGCCAAAAAA	19	16579
CFTR-Intron2-42	+	GCCUUCAAAAUGCCAAAAAA	20	15142
CFTR-Intron2-1480	+	UGCCUUCAAAAUGCCAAAAAA	21	16580
CFTR-Intron2-1481	+	UUGCCUUCAAAAUGCCAAAAAA	22	16581
CFTR-Intron2-1482	+	UUUGCCUUCAAAAUGCCAAAAAA	23	16582
CFTR-Intron2-1483	+	CUUUGCCUUCAAAAUGCCAAAAAA	24	16583
CFTR-Intron2-1484	+	CCUUCAAAAUGCCAAAAA	18	16584
CFTR-Intron2-1485	+	GCCUUCAAAAUGCCAAAAA	19	16585
CFTR-Intron2-1486	+	UGCCUUCAAAAUGCCAAAAA	20	16586
CFTR-Intron2-1487	+	UUGCCUUCAAAAUGCCAAAAA	21	16587
CFTR-Intron2-1488	+	UUUGCCUUCAAAAUGCCAAAAA	22	16588
CFTR-Intron2-1489	+	CUUUGCCUUCAAAAUGCCAAAAA	23	16589
CFTR-Intron2-1490	+	ACUUUGCCUUCAAAAUGCCAAAAA	24	16590
CFTR-Intron2-1491	+	CAAUCCAUGGUCACAAAA	18	16591
CFTR-Intron2-1492	+	UCAAUCCAUGGUCACAAAA	19	16592
CFTR-Intron2-1493	+	UUCAAUCCAUGGUCACAAAA	20	16593
CFTR-Intron2-1494	+	AUUCAAUCCAUGGUCACAAAA	21	16594
CFTR-Intron2-1495	+	GAUUCAAUCCAUGGUCACAAAA	22	16595
CFTR-Intron2-1496	+	GGAUUCAAUCCAUGGUCACAAAA	23	16596
CFTR-Intron2-1497	+	AGGAUUCAAUCCAUGGUCACAAAA	24	16597
CFTR-Intron2-1498	+	UGGGGGAUACAGUGAAAA	18	16598
CFTR-Intron2-1499	+	AUGGGGGAUACAGUGAAAA	19	16599
CFTR-Intron2-1500	+	CAUGGGGGAUACAGUGAAAA	20	16600
CFTR-Intron2-1501	+	ACAUGGGGGAUACAGUGAAAA	21	16601
CFTR-Intron2-1502	+	AACAUGGGGGAUACAGUGAAAA	22	16602
CFTR-Intron2-1503	+	CAACAUGGGGGAUACAGUGAAAA	23	16603
CFTR-Intron2-1504	+	UCAACAUGGGGGAUACAGUGAAAA	24	16604
CFTR-Intron2-1505	+	AUUAAAGGUCUUUGAAAA	18	16605
CFTR-Intron2-1506	+	UAUUAAAGGUCUUUGAAAA	19	16606
CFTR-Intron2-1507	+	GUAUUAAAGGUCUUUGAAAA	20	16607
CFTR-Intron2-1508	+	UGUAUUAAAGGUCUUUGAAAA	21	16608
CFTR-Intron2-1509	+	AUGUAUUAAAGGUCUUUGAAAA	22	16609
CFTR-Intron2-1510	+	CAUGUAUUAAAGGUCUUUGAAAA	23	16610
CFTR-Intron2-1511	+	UCAUGUAUUAAAGGUCUUUGAAAA	24	16611
CFTR-Intron2-1512	+	GUUUGCUUUUCUGUAAAA	18	16612
CFTR-Intron2-1513	+	AGUUUGCUUUUCUGUAAAA	19	16613
CFTR-Intron2-1514	+	CAGUUUGCUUUUCUGUAAAA	20	16614
CFTR-Intron2-1515	+	UCAGUUUGCUUUUCUGUAAAA	21	16615
CFTR-Intron2-1516	+	CUCAGUUUGCUUUUCUGUAAAA	22	16616
CFTR-Intron2-1517	+	CCUCAGUUUGCUUUUCUGUAAAA	23	16617
CFTR-Intron2-1518	+	GCCUCAGUUUGCUUUUCUGUAAAA	24	16618
CFTR-Intron2-1519	+	UUUUGAUUGGAAAGGAAA	18	16619
CFTR-Intron2-1520	+	CUUUUGAUUGGAAAGGAAA	19	16620
CFTR-Intron2-1521	+	CCUUUUGAUUGGAAAGGAAA	20	16621
CFTR-Intron2-1522	+	ACCUUUUGAUUGGAAAGGAAA	21	16622
CFTR-Intron2-1523	+	AACCUUUUGAUUGGAAAGGAAA	22	16623
CFTR-Intron2-1524	+	UAACCUUUUGAUUGGAAAGGAAA	23	16624
CFTR-Intron2-1525	+	CUAACCUUUUGAUUGGAAAGGAAA	24	16625
CFTR-Intron2-1526	+	GCUGAGAUGUAAAUGAAA	18	16626
CFTR-Intron2-1527	+	AGCUGAGAUGUAAAUGAAA	19	16627
CFTR-Intron2-1528	+	GAGCUGAGAUGUAAAUGAAA	20	16628
CFTR-Intron2-1529	+	GGAGCUGAGAUGUAAAUGAAA	21	16629
CFTR-Intron2-1530	+	AGGAGCUGAGAUGUAAAUGAAA	22	16630
CFTR-Intron2-1531	+	CAGGAGCUGAGAUGUAAAUGAAA	23	16631
CFTR-Intron2-1532	+	UCAGGAGCUGAGAUGUAAAUGAAA	24	16632
CFTR-Intron2-1533	+	GGGAUACAUCAUAAACAA	18	16633
CFTR-Intron2-1534	+	GGGGAUACAUCAUAAACAA	19	16634
CFTR-Intron2-1535	+	UGGGGAUACAUCAUAAACAA	20	16635
CFTR-Intron2-1536	+	UUGGGGAUACAUCAUAAACAA	21	16636
CFTR-Intron2-1537	+	CUUGGGGAUACAUCAUAAACAA	22	16637
CFTR-Intron2-1538	+	ACUUGGGGAUACAUCAUAAACAA	23	16638
CFTR-Intron2-1539	+	CACUUGGGGAUACAUCAUAAACAA	24	16639
CFTR-Intron2-1540	+	ACACUCCAGCCUGGGCAA	18	16640
CFTR-Intron2-1541	+	UACACUCCAGCCUGGGCAA	19	16641
CFTR-Intron2-1542	+	UUACACUCCAGCCUGGGCAA	20	16642
CFTR-Intron2-1543	+	AUUACACUCCAGCCUGGGCAA	21	16643
CFTR-Intron2-1544	+	CAUUACACUCCAGCCUGGGCAA	22	16644
CFTR-Intron2-1545	+	CCAUUACACUCCAGCCUGGGCAA	23	16645
CFTR-Intron2-1546	+	ACCAUUACACUCCAGCCUGGGCAA	24	16646
CFTR-Intron2-1547	+	ACUCACCUUCUCCAUCAA	18	16647
CFTR-Intron2-1548	+	GACUCACCUUCUCCAUCAA	19	16648
CFTR-Intron2-239	+	AGACUCACCUUCUCCAUCAA	20	15339
CFTR-Intron2-1549	+	CAGACUCACCUUCUCCAUCAA	21	16649
CFTR-Intron2-1550	+	GCAGACUCACCUUCUCCAUCAA	22	16650
CFTR-Intron2-1551	+	AGCAGACUCACCUUCUCCAUCAA	23	16651
CFTR-Intron2-1552	+	GAGCAGACUCACCUUCUCCAUCAA	24	16652
CFTR-Intron2-1553	+	AUACCAAUUUUAUAAGAA	18	16653
CFTR-Intron2-1554	+	AAUACCAAUUUUAUAAGAA	19	16654
CFTR-Intron2-1555	+	AAAUACCAAUUUUAUAAGAA	20	16655
CFTR-Intron2-1556	+	CAAAUACCAAUUUUAUAAGAA	21	16656
CFTR-Intron2-1557	+	UCAAAUACCAAUUUUAUAAGAA	22	16657
CFTR-Intron2-1558	+	UUCAAAUACCAAUUUUAUAAGAA	23	16658
CFTR-Intron2-1559	+	UUUCAAAUACCAAUUUUAUAAGAA	24	16659
CFTR-Intron2-1560	+	ACCAGGCCCAGAUCAGAA	18	16660
CFTR-Intron2-1561	+	UACCAGGCCCAGAUCAGAA	19	16661
CFTR-Intron2-242	+	AUACCAGGCCCAGAUCAGAA	20	15342
CFTR-Intron2-1562	+	CAUACCAGGCCCAGAUCAGAA	21	16662
CFTR-Intron2-1563	+	ACAUACCAGGCCCAGAUCAGAA	22	16663
CFTR-Intron2-1564	+	CACAUACCAGGCCCAGAUCAGAA	23	16664
CFTR-Intron2-1565	+	CCACAUACCAGGCCCAGAUCAGAA	24	16665
CFTR-Intron2-1566	+	CUAACCUUUUGAUUGGAA	18	16666
CFTR-Intron2-1567	+	CCUAACCUUUUGAUUGGAA	19	16667
CFTR-Intron2-246	+	UCCUAACCUUUUGAUUGGAA	20	15346
CFTR-Intron2-1568	+	AUCCUAACCUUUUGAUUGGAA	21	16668
CFTR-Intron2-1569	+	GAUCCUAACCUUUUGAUUGGAA	22	16669
CFTR-Intron2-1570	+	GGAUCCUAACCUUUUGAUUGGAA	23	16670
CFTR-Intron2-1571	+	AGGAUCCUAACCUUUUGAUUGGAA	24	16671
CFTR-Intron2-1572	+	UGGCAUAGCAUUGUUGAA	18	16672
CFTR-Intron2-1573	+	CUGGCAUAGCAUUGUUGAA	19	16673
CFTR-Intron2-1574	+	ACUGGCAUAGCAUUGUUGAA	20	16674
CFTR-Intron2-1575	+	UACUGGCAUAGCAUUGUUGAA	21	16675
CFTR-Intron2-1576	+	GUACUGGCAUAGCAUUGUUGAA	22	16676
CFTR-Intron2-1577	+	UGUACUGGCAUAGCAUUGUUGAA	23	16677
CFTR-Intron2-1578	+	UUGUACUGGCAUAGCAUUGUUGAA	24	16678
CFTR-Intron2-1579	+	AAAACAAAACAAAAAUAA	18	16679
CFTR-Intron2-1580	+	CAAAACAAAACAAAAAUAA	19	16680
CFTR-Intron2-1581	+	ACAAAACAAAACAAAAAUAA	20	16681
CFTR-Intron2-1582	+	AACAAAACAAAACAAAAAUAA	21	16682
CFTR-Intron2-1583	+	AAACAAAACAAAACAAAAAUAA	22	16683
CFTR-Intron2-1584	+	AAAACAAAACAAAACAAAAAUAA	23	16684
CFTR-Intron2-1585	+	AAAAACAAAACAAAACAAAAAUAA	24	16685
CFTR-Intron2-1586	+	ACACCAAGUGUUCAAUAA	18	16686
CFTR-Intron2-1587	+	CACACCAAGUGUUCAAUAA	19	16687
CFTR-Intron2-1588	+	ACACACCAAGUGUUCAAUAA	20	16688
CFTR-Intron2-1589	+	CACACACCAAGUGUUCAAUAA	21	16689
CFTR-Intron2-1590	+	GCACACACCAAGUGUUCAAUAA	22	16690
CFTR-Intron2-1591	+	UGCACACACCAAGUGUUCAAUAA	23	16691
CFTR-Intron2-1592	+	UUGCACACACCAAGUGUUCAAUAA	24	16692
CFTR-Intron2-1593	+	UCAGGAGCUGAGAUGUAA	18	16693
CFTR-Intron2-1594	+	UUCAGGAGCUGAGAUGUAA	19	16694
CFTR-Intron2-1595	+	CUUCAGGAGCUGAGAUGUAA	20	16695
CFTR-Intron2-1596	+	ACUUCAGGAGCUGAGAUGUAA	21	16696
CFTR-Intron2-1597	+	UACUUCAGGAGCUGAGAUGUAA	22	16697
CFTR-Intron2-1598	+	AUACUUCAGGAGCUGAGAUGUAA	23	16698
CFTR-Intron2-1599	+	CAUACUUCAGGAGCUGAGAUGUAA	24	16699
CFTR-Intron2-1600	+	GGAAAUGAAUUUAAUUAA	18	16700
CFTR-Intron2-1601	+	AGGAAAUGAAUUUAAUUAA	19	16701
CFTR-Intron2-1602	+	AAGGAAAUGAAUUUAAUUAA	20	16702
CFTR-Intron2-1603	+	AAAGGAAAUGAAUUUAAUUAA	21	16703
CFTR-Intron2-1604	+	AAAAGGAAAUGAAUUUAAUUAA	22	16704
CFTR-Intron2-1605	+	AAAAAGGAAAUGAAUUUAAUUAA	23	16705
CFTR-Intron2-1606	+	AAAAAAGGAAAUGAAUUUAAUUAA	24	16706
CFTR-Intron2-1607	+	UUUUAAAUUGAAUCAACA	18	16707
CFTR-Intron2-1608	+	UUUUUAAAUUGAAUCAACA	19	16708
CFTR-Intron2-621	+	UUUUUUAAAUUGAAUCAACA	20	15721
CFTR-Intron2-1609	+	AUUUUUUAAAUUGAAUCAACA	21	16709
CFTR-Intron2-1610	+	UAUUUUUUAAAUUGAAUCAACA	22	16710
CFTR-Intron2-1611	+	AUAUUUUUUAAAUUGAAUCAACA	23	16711
CFTR-Intron2-1612	+	UAUAUUUUUUAAAUUGAAUCAACA	24	16712
CFTR-Intron2-1613	+	CCACCUUUCUCUCACACA	18	16713
CFTR-Intron2-1614	+	UCCACCUUUCUCUCACACA	19	16714
CFTR-Intron2-1615	+	CUCCACCUUUCUCUCACACA	20	16715
CFTR-Intron2-1616	+	UCUCCACCUUUCUCUCACACA	21	16716
CFTR-Intron2-1617	+	UUCUCCACCUUUCUCUCACACA	22	16717
CFTR-Intron2-1618	+	CUUCUCCACCUUUCUCUCACACA	23	16718
CFTR-Intron2-1619	+	GCUUCUCCACCUUUCUCUCACACA	24	16719
CFTR-Intron2-1620	+	UCCAGCCUGGGUGACACA	18	16720
CFTR-Intron2-1621	+	CUCCAGCCUGGGUGACACA	19	16721
CFTR-Intron2-1622	+	ACUCCAGCCUGGGUGACACA	20	16722
CFTR-Intron2-1623	+	CACUCCAGCCUGGGUGACACA	21	16723
CFTR-Intron2-1624	+	ACACUCCAGCCUGGGUGACACA	22	16724
CFTR-Intron2-1625	+	UACACUCCAGCCUGGGUGACACA	23	16725
CFTR-Intron2-1626	+	CUACACUCCAGCCUGGGUGACACA	24	16726
CFTR-Intron2-1627	+	AAAAUUUCAUGAACCACA	18	16727
CFTR-Intron2-1628	+	AAAAAUUUCAUGAACCACA	19	16728
CFTR-Intron2-455	+	GAAAAAUUUCAUGAACCACA	20	15555
CFTR-Intron2-1629	+	UGAAAAAUUUCAUGAACCACA	21	16729
CFTR-Intron2-1630	+	AUGAAAAAUUUCAUGAACCACA	22	16730
CFTR-Intron2-1631	+	GAUGAAAAAUUUCAUGAACCACA	23	16731
CFTR-Intron2-1632	+	AGAUGAAAAAUUUCAUGAACCACA	24	16732
CFTR-Intron2-1633	+	GUGAAAAAGUGGUCCACA	18	16733
CFTR-Intron2-1634	+	UGUGAAAAAGUGGUCCACA	19	16734
CFTR-Intron2-256	+	AUGUGAAAAAGUGGUCCACA	20	15356
CFTR-Intron2-1635	+	AAUGUGAAAAAGUGGUCCACA	21	16735
CFTR-Intron2-1636	+	CAAUGUGAAAAAGUGGUCCACA	22	16736
CFTR-Intron2-1637	+	UCAAUGUGAAAAAGUGGUCCACA	23	16737
CFTR-Intron2-1638	+	UUCAAUGUGAAAAAGUGGUCCACA	24	16738
CFTR-Intron2-1639	+	GCCUUUUUUCUCUUCACA	18	16739
CFTR-Intron2-1640	+	AGCCUUUUUUCUCUUCACA	19	16740
CFTR-Intron2-1641	+	AAGCCUUUUUUCUCUUCACA	20	16741
CFTR-Intron2-1642	+	AAAGCCUUUUUUCUCUUCACA	21	16742
CFTR-Intron2-1643	+	GAAAGCCUUUUUUCUCUUCACA	22	16743
CFTR-Intron2-1644	+	UGAAAGCCUUUUUUCUCUUCACA	23	16744
CFTR-Intron2-1645	+	AUGAAAGCCUUUUUUCUCUUCACA	24	16745
CFTR-Intron2-1646	+	CACAUUUAGCCAAGGACA	18	16746
CFTR-Intron2-1647	+	UCACAUUUAGCCAAGGACA	19	16747
CFTR-Intron2-1648	+	UUCACAUUUAGCCAAGGACA	20	16748
CFTR-Intron2-1649	+	UUUCACAUUUAGCCAAGGACA	21	16749
CFTR-Intron2-1650	+	UUUUCACAUUUAGCCAAGGACA	22	16750
CFTR-Intron2-1651	+	UUUUUCACAUUUAGCCAAGGACA	23	16751
CFTR-Intron2-1652	+	AUUUUUCACAUUUAGCCAAGGACA	24	16752
CFTR-Intron2-1653	+	AUCAACAUGGGGGAUACA	18	16753
CFTR-Intron2-1654	+	AAUCAACAUGGGGGAUACA	19	16754
CFTR-Intron2-1655	+	GAAUCAACAUGGGGGAUACA	20	16755
CFTR-Intron2-1656	+	UGAAUCAACAUGGGGGAUACA	21	16756
CFTR-Intron2-1657	+	UUGAAUCAACAUGGGGGAUACA	22	16757
CFTR-Intron2-1658	+	AUUGAAUCAACAUGGGGGAUACA	23	16758
CFTR-Intron2-1659	+	AAUUGAAUCAACAUGGGGGAUACA	24	16759
CFTR-Intron2-1660	+	GAUCAGAUGGGAAAGCCA	18	16760
CFTR-Intron2-1661	+	GGAUCAGAUGGGAAAGCCA	19	16761
CFTR-Intron2-623	+	UGGAUCAGAUGGGAAAGCCA	20	15723
CFTR-Intron2-1662	+	AUGGAUCAGAUGGGAAAGCCA	21	16762
CFTR-Intron2-1663	+	AAUGGAUCAGAUGGGAAAGCCA	22	16763
CFTR-Intron2-1664	+	AAAUGGAUCAGAUGGGAAAGCCA	23	16764
CFTR-Intron2-1665	+	GAAAUGGAUCAGAUGGGAAAGCCA	24	16765
CFTR-Intron2-1666	+	CAGGAGACGAAGUUUGCA	18	16766
CFTR-Intron2-1667	+	CCAGGAGACGAAGUUUGCA	19	16767
CFTR-Intron2-1668	+	CCCAGGAGACGAAGUUUGCA	20	16768
CFTR-Intron2-1669	+	ACCCAGGAGACGAAGUUUGCA	21	16769
CFTR-Intron2-1670	+	AACCCAGGAGACGAAGUUUGCA	22	16770
CFTR-Intron2-1671	+	GAACCCAGGAGACGAAGUUUGCA	23	16771
CFTR-Intron2-1672	+	UGAACCCAGGAGACGAAGUUUGCA	24	16772
CFTR-Intron2-1673	+	CAGGAGGCAGAGUUUGCA	18	16773
CFTR-Intron2-1674	+	CCAGGAGGCAGAGUUUGCA	19	16774
CFTR-Intron2-1675	+	CCCAGGAGGCAGAGUUUGCA	20	16775
CFTR-Intron2-1676	+	ACCCAGGAGGCAGAGUUUGCA	21	16776
CFTR-Intron2-1677	+	AACCCAGGAGGCAGAGUUUGCA	22	16777
CFTR-Intron2-1678	+	GAACCCAGGAGGCAGAGUUUGCA	23	16778
CFTR-Intron2-1679	+	UGAACCCAGGAGGCAGAGUUUGCA	24	16779
CFTR-Intron2-1680	+	GACUCACCUUCUCCAUCA	18	16780
CFTR-Intron2-1681	+	AGACUCACCUUCUCCAUCA	19	16781
CFTR-Intron2-1682	+	CAGACUCACCUUCUCCAUCA	20	16782
CFTR-Intron2-1683	+	GCAGACUCACCUUCUCCAUCA	21	16783
CFTR-Intron2-1684	+	AGCAGACUCACCUUCUCCAUCA	22	16784
CFTR-Intron2-1685	+	GAGCAGACUCACCUUCUCCAUCA	23	16785
CFTR-Intron2-1686	+	GGAGCAGACUCACCUUCUCCAUCA	24	16786
CFTR-Intron2-1687	+	UUUCGUGGUCCUUAAAGA	18	16787
CFTR-Intron2-1688	+	CUUUCGUGGUCCUUAAAGA	19	16788
CFTR-Intron2-1689	+	UCUUUCGUGGUCCUUAAAGA	20	16789
CFTR-Intron2-1690	+	UUCUUUCGUGGUCCUUAAAGA	21	16790
CFTR-Intron2-1691	+	CUUCUUUCGUGGUCCUUAAAGA	22	16791
CFTR-Intron2-1692	+	CCUUCUUUCGUGGUCCUUAAAGA	23	16792
CFTR-Intron2-1693	+	UCCUUCUUUCGUGGUCCUUAAAGA	24	16793
CFTR-Intron2-1694	+	UACCAGGCCCAGAUCAGA	18	16794
CFTR-Intron2-1695	+	AUACCAGGCCCAGAUCAGA	19	16795
CFTR-Intron2-275	+	CAUACCAGGCCCAGAUCAGA	20	15375
CFTR-Intron2-1696	+	ACAUACCAGGCCCAGAUCAGA	21	16796
CFTR-Intron2-1697	+	CACAUACCAGGCCCAGAUCAGA	22	16797
CFTR-Intron2-1698	+	CCACAUACCAGGCCCAGAUCAGA	23	16798
CFTR-Intron2-1699	+	ACCACAUACCAGGCCCAGAUCAGA	24	16799
CFTR-Intron2-1700	+	AAGGAGAAAUGGAUCAGA	18	16800
CFTR-Intron2-1701	+	AAAGGAGAAAUGGAUCAGA	19	16801
CFTR-Intron2-276	+	CAAAGGAGAAAUGGAUCAGA	20	15376
CFTR-Intron2-1702	+	UCAAAGGAGAAAUGGAUCAGA	21	16802
CFTR-Intron2-1703	+	AUCAAAGGAGAAAUGGAUCAGA	22	16803
CFTR-Intron2-1704	+	CAUCAAAGGAGAAAUGGAUCAGA	23	16804
CFTR-Intron2-1705	+	CCAUCAAAGGAGAAAUGGAUCAGA	24	16805
CFTR-Intron2-1706	+	CAUCAUAAACAAAAGAGA	18	16806
CFTR-Intron2-1707	+	ACAUCAUAAACAAAAGAGA	19	16807
CFTR-Intron2-1708	+	UACAUCAUAAACAAAAGAGA	20	16808
CFTR-Intron2-1709	+	AUACAUCAUAAACAAAAGAGA	21	16809
CFTR-Intron2-1710	+	GAUACAUCAUAAACAAAAGAGA	22	16810
CFTR-Intron2-1711	+	GGAUACAUCAUAAACAAAAGAGA	23	16811
CFTR-Intron2-1712	+	GGGAUACAUCAUAAACAAAAGAGA	24	16812
CFTR-Intron2-1713	+	UCCCAGCUACUCAGGAGA	18	16813
CFTR-Intron2-1714	+	GUCCCAGCUACUCAGGAGA	19	16814
CFTR-Intron2-1715	+	AGUCCCAGCUACUCAGGAGA	20	16815
CFTR-Intron2-1716	+	UAGUCCCAGCUACUCAGGAGA	21	16816
CFTR-Intron2-1717	+	GUAGUCCCAGCUACUCAGGAGA	22	16817
CFTR-Intron2-1718	+	UGUAGUCCCAGCUACUCAGGAGA	23	16818
CFTR-Intron2-1719	+	CUGUAGUCCCAGCUACUCAGGAGA	24	16819
CFTR-Intron2-1720	+	UAUGAAAGAAAAAAUAGA	18	16820
CFTR-Intron2-1721	+	CUAUGAAAGAAAAAAUAGA	19	16821
CFTR-Intron2-1722	+	GCUAUGAAAGAAAAAAUAGA	20	16822
CFTR-Intron2-1723	+	AGCUAUGAAAGAAAAAAUAGA	21	16823
CFTR-Intron2-1724	+	UAGCUAUGAAAGAAAAAAUAGA	22	16824
CFTR-Intron2-1725	+	UUAGCUAUGAAAGAAAAAAUAGA	23	16825
CFTR-Intron2-1726	+	GUUAGCUAUGAAAGAAAAAAUAGA	24	16826
CFTR-Intron2-1727	+	GAUACAGUGAAAACUGGA	18	16827
CFTR-Intron2-1728	+	GGAUACAGUGAAAACUGGA	19	16828
CFTR-Intron2-1729	+	GGGAUACAGUGAAAACUGGA	20	16829
CFTR-Intron2-1730	+	GGGGAUACAGUGAAAACUGGA	21	16830
CFTR-Intron2-1731	+	GGGGGAUACAGUGAAAACUGGA	22	16831
CFTR-Intron2-1732	+	UGGGGGAUACAGUGAAAACUGGA	23	16832
CFTR-Intron2-1733	+	AUGGGGGAUACAGUGAAAACUGGA	24	16833
CFTR-Intron2-1734	+	CCUAACCUUUUGAUUGGA	18	16834
CFTR-Intron2-1735	+	UCCUAACCUUUUGAUUGGA	19	16835
CFTR-Intron2-1736	+	AUCCUAACCUUUUGAUUGGA	20	16836
CFTR-Intron2-1737	+	GAUCCUAACCUUUUGAUUGGA	21	16837
CFTR-Intron2-1738	+	GGAUCCUAACCUUUUGAUUGGA	22	16838
CFTR-Intron2-1739	+	AGGAUCCUAACCUUUUGAUUGGA	23	16839
CFTR-Intron2-1740	+	AAGGAUCCUAACCUUUUGAUUGGA	24	16840
CFTR-Intron2-1741	+	AGAGAAUGUUAGCUAUGA	18	16841
CFTR-Intron2-1742	+	CAGAGAAUGUUAGCUAUGA	19	16842
CFTR-Intron2-1743	+	GCAGAGAAUGUUAGCUAUGA	20	16843
CFTR-Intron2-1744	+	AGCAGAGAAUGUUAGCUAUGA	21	16844
CFTR-Intron2-1745	+	GAGCAGAGAAUGUUAGCUAUGA	22	16845
CFTR-Intron2-1746	+	AGAGCAGAGAAUGUUAGCUAUGA	23	16846
CFTR-Intron2-1747	+	GAGAGCAGAGAAUGUUAGCUAUGA	24	16847
CFTR-Intron2-1748	+	UCCACUCAGAGUGGCUGA	18	16848
CFTR-Intron2-1749	+	UUCCACUCAGAGUGGCUGA	19	16849
CFTR-Intron2-1750	+	UUUCCACUCAGAGUGGCUGA	20	16850
CFTR-Intron2-1751	+	CUUUCCACUCAGAGUGGCUGA	21	16851
CFTR-Intron2-1752	+	GCUUUCCACUCAGAGUGGCUGA	22	16852
CFTR-Intron2-1753	+	UGCUUUCCACUCAGAGUGGCUGA	23	16853
CFTR-Intron2-1754	+	AUGCUUUCCACUCAGAGUGGCUGA	24	16854
CFTR-Intron2-1755	+	AGGAUCCUAACCUUUUGA	18	16855
CFTR-Intron2-1756	+	AAGGAUCCUAACCUUUUGA	19	16856
CFTR-Intron2-1757	+	AAAGGAUCCUAACCUUUUGA	20	16857
CFTR-Intron2-1758	+	AAAAGGAUCCUAACCUUUUGA	21	16858
CFTR-Intron2-1759	+	CAAAAGGAUCCUAACCUUUUGA	22	16859
CFTR-Intron2-1760	+	UCAAAAGGAUCCUAACCUUUUGA	23	16860
CFTR-Intron2-1761	+	AUCAAAAGGAUCCUAACCUUUUGA	24	16861
CFTR-Intron2-1762	+	AGAGUAAGAAGCUAAAUA	18	16862
CFTR-Intron2-1763	+	CAGAGUAAGAAGCUAAAUA	19	16863
CFTR-Intron2-287	+	UCAGAGUAAGAAGCUAAAUA	20	15387
CFTR-Intron2-1764	+	CUCAGAGUAAGAAGCUAAAUA	21	16864
CFTR-Intron2-1765	+	ACUCAGAGUAAGAAGCUAAAUA	22	16865
CFTR-Intron2-1766	+	UACUCAGAGUAAGAAGCUAAAUA	23	16866
CFTR-Intron2-1767	+	UUACUCAGAGUAAGAAGCUAAAUA	24	16867
CFTR-Intron2-1768	+	AAACAAACAAAAAACAUA	18	16868
CFTR-Intron2-1769	+	CAAACAAACAAAAAACAUA	19	16869
CFTR-Intron2-1770	+	ACAAACAAACAAAAAACAUA	20	16870
CFTR-Intron2-1771	+	CACAAACAAACAAAAAACAUA	21	16871
CFTR-Intron2-1772	+	ACACAAACAAACAAAAAACAUA	22	16872
CFTR-Intron2-1773	+	AACACAAACAAACAAAAAACAUA	23	16873
CFTR-Intron2-1774	+	CAACACAAACAAACAAAAAACAUA	24	16874
CFTR-Intron2-1775	+	GUUUUCUUUUAAAUACUA	18	16875
CFTR-Intron2-1776	+	UGUUUUCUUUUAAAUACUA	19	16876
CFTR-Intron2-1777	+	CUGUUUUCUUUUAAAUACUA	20	16877
CFTR-Intron2-1778	+	UCUGUUUUCUUUUAAAUACUA	21	16878
CFTR-Intron2-1779	+	UUCUGUUUUCUUUUAAAUACUA	22	16879
CFTR-Intron2-1780	+	UUUCUGUUUUCUUUUAAAUACUA	23	16880
CFTR-Intron2-1781	+	CUUUCUGUUUUCUUUUAAAUACUA	24	16881
CFTR-Intron2-1782	+	GGGGGACUACCAUUCCUA	18	16882
CFTR-Intron2-1783	+	GGGGGGACUACCAUUCCUA	19	16883
CFTR-Intron2-1784	+	GGGGGGGACUACCAUUCCUA	20	16884
CFTR-Intron2-1785	+	UGGGGGGGACUACCAUUCCUA	21	16885
CFTR-Intron2-1786	+	AUGGGGGGGACUACCAUUCCUA	22	16886
CFTR-Intron2-1787	+	UAUGGGGGGGACUACCAUUCCUA	23	16887
CFTR-Intron2-1788	+	UUAUGGGGGGGACUACCAUUCCUA	24	16888
CFTR-Intron2-1789	+	UCCCCUAGAAGCUUGCUA	18	16889
CFTR-Intron2-1790	+	AUCCCCUAGAAGCUUGCUA	19	16890
CFTR-Intron2-1791	+	CAUCCCCUAGAAGCUUGCUA	20	16891
CFTR-Intron2-1792	+	GCAUCCCCUAGAAGCUUGCUA	21	16892
CFTR-Intron2-1793	+	GGCAUCCCCUAGAAGCUUGCUA	22	16893
CFTR-Intron2-1794	+	UGGCAUCCCCUAGAAGCUUGCUA	23	16894
CFTR-Intron2-1795	+	UUGGCAUCCCCUAGAAGCUUGCUA	24	16895
CFTR-Intron2-1796	+	UGGCUCUAAAUCACUCUA	18	16896
CFTR-Intron2-1797	+	AUGGCUCUAAAUCACUCUA	19	16897
CFTR-Intron2-1798	+	CAUGGCUCUAAAUCACUCUA	20	16898
CFTR-Intron2-1799	+	ACAUGGCUCUAAAUCACUCUA	21	16899
CFTR-Intron2-1800	+	AACAUGGCUCUAAAUCACUCUA	22	16900
CFTR-Intron2-1801	+	AAACAUGGCUCUAAAUCACUCUA	23	16901
CFTR-Intron2-1802	+	UAAACAUGGCUCUAAAUCACUCUA	24	16902
CFTR-Intron2-1803	+	GUAAAUGAAAGUGAAGUA	18	16903
CFTR-Intron2-1804	+	UGUAAAUGAAAGUGAAGUA	19	16904
CFTR-Intron2-1805	+	AUGUAAAUGAAAGUGAAGUA	20	16905
CFTR-Intron2-1806	+	GAUGUAAAUGAAAGUGAAGUA	21	16906
CFTR-Intron2-1807	+	AGAUGUAAAUGAAAGUGAAGUA	22	16907
CFTR-Intron2-1808	+	GAGAUGUAAAUGAAAGUGAAGUA	23	16908
CFTR-Intron2-1809	+	UGAGAUGUAAAUGAAAGUGAAGUA	24	16909
CFTR-Intron2-1810	+	CUUAAUUUUCAAACUGUA	18	16910
CFTR-Intron2-1811	+	UCUUAAUUUUCAAACUGUA	19	16911
CFTR-Intron2-1812	+	AUCUUAAUUUUCAAACUGUA	20	16912
CFTR-Intron2-1813	+	CAUCUUAAUUUUCAAACUGUA	21	16913
CFTR-Intron2-1814	+	UCAUCUUAAUUUUCAAACUGUA	22	16914
CFTR-Intron2-1815	+	AUCAUCUUAAUUUUCAAACUGUA	23	16915
CFTR-Intron2-1816	+	UAUCAUCUUAAUUUUCAAACUGUA	24	16916
CFTR-Intron2-1817	+	UGCCACUGAUUUCUGUUA	18	16917
CFTR-Intron2-1818	+	UUGCCACUGAUUUCUGUUA	19	16918
CFTR-Intron2-1819	+	AUUGCCACUGAUUUCUGUUA	20	16919
CFTR-Intron2-1820	+	UAUUGCCACUGAUUUCUGUUA	21	16920
CFTR-Intron2-1821	+	UUAUUGCCACUGAUUUCUGUUA	22	16921
CFTR-Intron2-1822	+	GUUAUUGCCACUGAUUUCUGUUA	23	16922
CFTR-Intron2-1823	+	AGUUAUUGCCACUGAUUUCUGUUA	24	16923
CFTR-Intron2-1824	+	AAACUGAGAGAUUCUUUA	18	16924
CFTR-Intron2-1825	+	GAAACUGAGAGAUUCUUUA	19	16925
CFTR-Intron2-57	+	GGAAACUGAGAGAUUCUUUA	20	15157
CFTR-Intron2-1826	+	AGGAAACUGAGAGAUUCUUUA	21	16926
CFTR-Intron2-1827	+	AAGGAAACUGAGAGAUUCUUUA	22	16927
CFTR-Intron2-1828	+	AAAGGAAACUGAGAGAUUCUUUA	23	16928
CFTR-Intron2-1829	+	GAAAGGAAACUGAGAGAUUCUUUA	24	16929
CFTR-Intron2-1830	+	GGGGGAUACAGUGAAAAC	18	16930
CFTR-Intron2-1831	+	UGGGGGAUACAGUGAAAAC	19	16931
CFTR-Intron2-297	+	AUGGGGGAUACAGUGAAAAC	20	15397
CFTR-Intron2-1832	+	CAUGGGGGAUACAGUGAAAAC	21	16932
CFTR-Intron2-1833	+	ACAUGGGGGAUACAGUGAAAAC	22	16933
CFTR-Intron2-1834	+	AACAUGGGGGAUACAGUGAAAAC	23	16934
CFTR-Intron2-1835	+	CAACAUGGGGGAUACAGUGAAAAC	24	16935
CFTR-Intron2-1836	+	UUCUUUAAUGGGUGAAAC	18	16936
CFTR-Intron2-1837	+	UUUCUUUAAUGGGUGAAAC	19	16937
CFTR-Intron2-1838	+	AUUUCUUUAAUGGGUGAAAC	20	16938
CFTR-Intron2-1839	+	AAUUUCUUUAAUGGGUGAAAC	21	16939
CFTR-Intron2-1840	+	GAAUUUCUUUAAUGGGUGAAAC	22	16940
CFTR-Intron2-1841	+	GGAAUUUCUUUAAUGGGUGAAAC	23	16941
CFTR-Intron2-1842	+	GGGAAUUUCUUUAAUGGGUGAAAC	24	16942
CFTR-Intron2-1843	+	UUUUUAAAUUGAAUCAAC	18	16943
CFTR-Intron2-1844	+	UUUUUUAAAUUGAAUCAAC	19	16944
CFTR-Intron2-1845	+	AUUUUUUAAAUUGAAUCAAC	20	16945
CFTR-Intron2-1846	+	UAUUUUUUAAAUUGAAUCAAC	21	16946
CFTR-Intron2-1847	+	AUAUUUUUUAAAUUGAAUCAAC	22	16947
CFTR-Intron2-1848	+	UAUAUUUUUUAAAUUGAAUCAAC	23	16948
CFTR-Intron2-1849	+	GUAUAUUUUUUAAAUUGAAUCAAC	24	16949
CFTR-Intron2-1850	+	GGAGCAAAGAGUUCUAAC	18	16950
CFTR-Intron2-1851	+	AGGAGCAAAGAGUUCUAAC	19	16951
CFTR-Intron2-1852	+	UAGGAGCAAAGAGUUCUAAC	20	16952
CFTR-Intron2-1853	+	AUAGGAGCAAAGAGUUCUAAC	21	16953
CFTR-Intron2-1854	+	GAUAGGAGCAAAGAGUUCUAAC	22	16954
CFTR-Intron2-1855	+	AGAUAGGAGCAAAGAGUUCUAAC	23	16955
CFTR-Intron2-1856	+	AAGAUAGGAGCAAAGAGUUCUAAC	24	16956
CFTR-Intron2-1857	+	CAACCAUCUGGCAACCAC	18	16957
CFTR-Intron2-1858	+	UCAACCAUCUGGCAACCAC	19	16958
CFTR-Intron2-1859	+	UUCAACCAUCUGGCAACCAC	20	16959
CFTR-Intron2-1860	+	CUUCAACCAUCUGGCAACCAC	21	16960
CFTR-Intron2-1861	+	UCUUCAACCAUCUGGCAACCAC	22	16961
CFTR-Intron2-1862	+	UUCUUCAACCAUCUGGCAACCAC	23	16962
CFTR-Intron2-1863	+	GUUCUUCAACCAUCUGGCAACCAC	24	16963
CFTR-Intron2-1864	+	AAAAAUUUCAUGAACCAC	18	16964
CFTR-Intron2-1865	+	GAAAAAUUUCAUGAACCAC	19	16965
CFTR-Intron2-1866	+	UGAAAAAUUUCAUGAACCAC	20	16966
CFTR-Intron2-1867	+	AUGAAAAAUUUCAUGAACCAC	21	16967
CFTR-Intron2-1868	+	GAUGAAAAAUUUCAUGAACCAC	22	16968
CFTR-Intron2-1869	+	AGAUGAAAAAUUUCAUGAACCAC	23	16969
CFTR-Intron2-1870	+	GAGAUGAAAAAUUUCAUGAACCAC	24	16970
CFTR-Intron2-1871	+	UGUGAAAAAGUGGUCCAC	18	16971
CFTR-Intron2-1872	+	AUGUGAAAAAGUGGUCCAC	19	16972
CFTR-Intron2-1873	+	AAUGUGAAAAAGUGGUCCAC	20	16973
CFTR-Intron2-1874	+	CAAUGUGAAAAAGUGGUCCAC	21	16974
CFTR-Intron2-1875	+	UCAAUGUGAAAAAGUGGUCCAC	22	16975
CFTR-Intron2-1876	+	UUCAAUGUGAAAAAGUGGUCCAC	23	16976
CFTR-Intron2-1877	+	GUUCAAUGUGAAAAAGUGGUCCAC	24	16977
CFTR-Intron2-1878	+	AGGCCCUAUUCUAGGCAC	18	16978
CFTR-Intron2-1879	+	CAGGCCCUAUUCUAGGCAC	19	16979
CFTR-Intron2-1880	+	CCAGGCCCUAUUCUAGGCAC	20	16980
CFTR-Intron2-1881	+	GCCAGGCCCUAUUCUAGGCAC	21	16981
CFTR-Intron2-1882	+	UGCCAGGCCCUAUUCUAGGCAC	22	16982
CFTR-Intron2-1883	+	AUGCCAGGCCCUAUUCUAGGCAC	23	16983
CFTR-Intron2-1884	+	UAUGCCAGGCCCUAUUCUAGGCAC	24	16984
CFTR-Intron2-1885	+	CUGAGGCAGGAGAAUCAC	18	16985
CFTR-Intron2-1886	+	GCUGAGGCAGGAGAAUCAC	19	16986
CFTR-Intron2-1887	+	GGCUGAGGCAGGAGAAUCAC	20	16987
CFTR-Intron2-1888	+	AGGCUGAGGCAGGAGAAUCAC	21	16988
CFTR-Intron2-1889	+	GAGGCUGAGGCAGGAGAAUCAC	22	16989
CFTR-Intron2-1890	+	AGAGGCUGAGGCAGGAGAAUCAC	23	16990
CFTR-Intron2-1891	+	GAGAGGCUGAGGCAGGAGAAUCAC	24	16991
CFTR-Intron2-1892	+	CCAAGGCGGGCAGAUCAC	18	16992
CFTR-Intron2-1893	+	GCCAAGGCGGGCAGAUCAC	19	16993
CFTR-Intron2-1894	+	GGCCAAGGCGGGCAGAUCAC	20	16994
CFTR-Intron2-1895	+	AGGCCAAGGCGGGCAGAUCAC	21	16995
CFTR-Intron2-1896	+	GAGGCCAAGGCGGGCAGAUCAC	22	16996
CFTR-Intron2-1897	+	GGAGGCCAAGGCGGGCAGAUCAC	23	16997
CFTR-Intron2-1898	+	GGGAGGCCAAGGCGGGCAGAUCAC	24	16998
CFTR-Intron2-1899	+	CCAAGGUGGGCAGAUCAC	18	16999
CFTR-Intron2-1900	+	GCCAAGGUGGGCAGAUCAC	19	17000
CFTR-Intron2-1901	+	GGCCAAGGUGGGCAGAUCAC	20	17001
CFTR-Intron2-1902	+	AGGCCAAGGUGGGCAGAUCAC	21	17002
CFTR-Intron2-1903	+	GAGGCCAAGGUGGGCAGAUCAC	22	17003
CFTR-Intron2-1904	+	GGAGGCCAAGGUGGGCAGAUCAC	23	17004
CFTR-Intron2-1905	+	GGGAGGCCAAGGUGGGCAGAUCAC	24	17005
CFTR-Intron2-1906	+	AAAGUGAAGUAGAGAGAC	18	17006
CFTR-Intron2-1907	+	GAAAGUGAAGUAGAGAGAC	19	17007
CFTR-Intron2-1908	+	UGAAAGUGAAGUAGAGAGAC	20	17008
CFTR-Intron2-1909	+	AUGAAAGUGAAGUAGAGAGAC	21	17009
CFTR-Intron2-1910	+	AAUGAAAGUGAAGUAGAGAGAC	22	17010
CFTR-Intron2-1911	+	AAAUGAAAGUGAAGUAGAGAGAC	23	17011
CFTR-Intron2-1912	+	UAAAUGAAAGUGAAGUAGAGAGAC	24	17012
CFTR-Intron2-1913	+	GCCUGUAAACCCAGCUAC	18	17013
CFTR-Intron2-1914	+	UGCCUGUAAACCCAGCUAC	19	17014
CFTR-Intron2-1915	+	GUGCCUGUAAACCCAGCUAC	20	17015
CFTR-Intron2-1916	+	AGUGCCUGUAAACCCAGCUAC	21	17016
CFTR-Intron2-1917	+	GAGUGCCUGUAAACCCAGCUAC	22	17017
CFTR-Intron2-1918	+	CGAGUGCCUGUAAACCCAGCUAC	23	17018
CFTR-Intron2-1919	+	GCGAGUGCCUGUAAACCCAGCUAC	24	17019
CFTR-Intron2-1920	+	AUAGAAUGGGGUAGUUAC	18	17020
CFTR-Intron2-1921	+	AAUAGAAUGGGGUAGUUAC	19	17021
CFTR-Intron2-1922	+	AAAUAGAAUGGGGUAGUUAC	20	17022
CFTR-Intron2-1923	+	AAAAUAGAAUGGGGUAGUUAC	21	17023
CFTR-Intron2-1924	+	AAAAAUAGAAUGGGGUAGUUAC	22	17024
CFTR-Intron2-1925	+	AAAAAAUAGAAUGGGGUAGUUAC	23	17025
CFTR-Intron2-1926	+	GAAAAAAUAGAAUGGGGUAGUUAC	24	17026
CFTR-Intron2-1927	+	AGGAGAAUCACUUGAACC	18	17027
CFTR-Intron2-1928	+	CAGGAGAAUCACUUGAACC	19	17028
CFTR-Intron2-1929	+	GCAGGAGAAUCACUUGAACC	20	17029
CFTR-Intron2-1930	+	GGCAGGAGAAUCACUUGAACC	21	17030
CFTR-Intron2-1931	+	AGGCAGGAGAAUCACUUGAACC	22	17031
CFTR-Intron2-1932	+	GAGGCAGGAGAAUCACUUGAACC	23	17032
CFTR-Intron2-1933	+	UGAGGCAGGAGAAUCACUUGAACC	24	17033
CFTR-Intron2-1934	+	CUGAGAUUCGCUUGAACC	18	17034
CFTR-Intron2-1935	+	ACUGAGAUUCGCUUGAACC	19	17035
CFTR-Intron2-1936	+	GACUGAGAUUCGCUUGAACC	20	17036
CFTR-Intron2-1937	+	AGACUGAGAUUCGCUUGAACC	21	17037
CFTR-Intron2-1938	+	GAGACUGAGAUUCGCUUGAACC	22	17038
CFTR-Intron2-1939	+	GGAGACUGAGAUUCGCUUGAACC	23	17039
CFTR-Intron2-1940	+	AGGAGACUGAGAUUCGCUUGAACC	24	17040
CFTR-Intron2-1941	+	GAGCAAAGAGUUCUAACC	18	17041
CFTR-Intron2-1942	+	GGAGCAAAGAGUUCUAACC	19	17042
CFTR-Intron2-305	+	AGGAGCAAAGAGUUCUAACC	20	15405
CFTR-Intron2-1943	+	UAGGAGCAAAGAGUUCUAACC	21	17043
CFTR-Intron2-1944	+	AUAGGAGCAAAGAGUUCUAACC	22	17044
CFTR-Intron2-1945	+	GAUAGGAGCAAAGAGUUCUAACC	23	17045
CFTR-Intron2-1946	+	AGAUAGGAGCAAAGAGUUCUAACC	24	17046
CFTR-Intron2-1947	+	AAGUGAAGUAGAGAGACC	18	17047
CFTR-Intron2-1948	+	AAAGUGAAGUAGAGAGACC	19	17048
CFTR-Intron2-60	+	GAAAGUGAAGUAGAGAGACC	20	15160
CFTR-Intron2-1949	+	UGAAAGUGAAGUAGAGAGACC	21	17049
CFTR-Intron2-1950	+	AUGAAAGUGAAGUAGAGAGACC	22	17050
CFTR-Intron2-1951	+	AAUGAAAGUGAAGUAGAGAGACC	23	17051
CFTR-Intron2-1952	+	AAAUGAAAGUGAAGUAGAGAGACC	24	17052
CFTR-Intron2-1953	+	AAGAGGUCUCUAGUGACC	18	17053
CFTR-Intron2-1954	+	UAAGAGGUCUCUAGUGACC	19	17054
CFTR-Intron2-1955	+	AUAAGAGGUCUCUAGUGACC	20	17055
CFTR-Intron2-1956	+	CAUAAGAGGUCUCUAGUGACC	21	17056
CFTR-Intron2-1957	+	UCAUAAGAGGUCUCUAGUGACC	22	17057
CFTR-Intron2-1958	+	UUCAUAAGAGGUCUCUAGUGACC	23	17058
CFTR-Intron2-1959	+	UUUCAUAAGAGGUCUCUAGUGACC	24	17059
CFTR-Intron2-1960	+	GGAGAAUCACUUGAACCC	18	17060
CFTR-Intron2-1961	+	AGGAGAAUCACUUGAACCC	19	17061
CFTR-Intron2-636	+	CAGGAGAAUCACUUGAACCC	20	15736
CFTR-Intron2-1962	+	GCAGGAGAAUCACUUGAACCC	21	17062
CFTR-Intron2-1963	+	GGCAGGAGAAUCACUUGAACCC	22	17063
CFTR-Intron2-1964	+	AGGCAGGAGAAUCACUUGAACCC	23	17064
CFTR-Intron2-1965	+	GAGGCAGGAGAAUCACUUGAACCC	24	17065
CFTR-Intron2-1966	+	UGAGAUUCGCUUGAACCC	18	17066
CFTR-Intron2-1967	+	CUGAGAUUCGCUUGAACCC	19	17067
CFTR-Intron2-637	+	ACUGAGAUUCGCUUGAACCC	20	15737
CFTR-Intron2-1968	+	GACUGAGAUUCGCUUGAACCC	21	17068
CFTR-Intron2-1969	+	AGACUGAGAUUCGCUUGAACCC	22	17069
CFTR-Intron2-1970	+	GAGACUGAGAUUCGCUUGAACCC	23	17070
CFTR-Intron2-1971	+	GGAGACUGAGAUUCGCUUGAACCC	24	17071
CFTR-Intron2-1972	+	AUGGAUCUUGGCAUCCCC	18	17072
CFTR-Intron2-1973	+	CAUGGAUCUUGGCAUCCCC	19	17073
CFTR-Intron2-1974	+	GCAUGGAUCUUGGCAUCCCC	20	17074
CFTR-Intron2-1975	+	AGCAUGGAUCUUGGCAUCCCC	21	17075
CFTR-Intron2-1976	+	AAGCAUGGAUCUUGGCAUCCCC	22	17076
CFTR-Intron2-1977	+	UAAGCAUGGAUCUUGGCAUCCCC	23	17077
CFTR-Intron2-1978	+	CUAAGCAUGGAUCUUGGCAUCCCC	24	17078
CFTR-Intron2-1979	+	CUAGACUAUGAGUGGCCC	18	17079
CFTR-Intron2-1980	+	UCUAGACUAUGAGUGGCCC	19	17080
CFTR-Intron2-1981	+	UUCUAGACUAUGAGUGGCCC	20	17081
CFTR-Intron2-1982	+	AUUCUAGACUAUGAGUGGCCC	21	17082
CFTR-Intron2-1983	+	CAUUCUAGACUAUGAGUGGCCC	22	17083
CFTR-Intron2-1984	+	UCAUUCUAGACUAUGAGUGGCCC	23	17084
CFTR-Intron2-1985	+	UUCAUUCUAGACUAUGAGUGGCCC	24	17085
CFTR-Intron2-1986	+	AUUACCUUAAGACUUCCC	18	17086
CFTR-Intron2-1987	+	CAUUACCUUAAGACUUCCC	19	17087
CFTR-Intron2-314	+	CCAUUACCUUAAGACUUCCC	20	15414
CFTR-Intron2-1988	+	GCCAUUACCUUAAGACUUCCC	21	17088
CFTR-Intron2-1989	+	AGCCAUUACCUUAAGACUUCCC	22	17089
CFTR-Intron2-1990	+	UAGCCAUUACCUUAAGACUUCCC	23	17090
CFTR-Intron2-1991	+	GUAGCCAUUACCUUAAGACUUCCC	24	17091
CFTR-Intron2-1992	+	GGAUCAGAUGGGAAAGCC	18	17092
CFTR-Intron2-1993	+	UGGAUCAGAUGGGAAAGCC	19	17093
CFTR-Intron2-1994	+	AUGGAUCAGAUGGGAAAGCC	20	17094
CFTR-Intron2-1995	+	AAUGGAUCAGAUGGGAAAGCC	21	17095
CFTR-Intron2-1996	+	AAAUGGAUCAGAUGGGAAAGCC	22	17096
CFTR-Intron2-1997	+	GAAAUGGAUCAGAUGGGAAAGCC	23	17097
CFTR-Intron2-1998	+	AGAAAUGGAUCAGAUGGGAAAGCC	24	17098
CFTR-Intron2-1999	+	GAUUUUUCACAUUUAGCC	18	17099
CFTR-Intron2-2000	+	GGAUUUUUCACAUUUAGCC	19	17100
CFTR-Intron2-2001	+	GGGAUUUUUCACAUUUAGCC	20	17101
CFTR-Intron2-2002	+	UGGGAUUUUUCACAUUUAGCC	21	17102
CFTR-Intron2-2003	+	CUGGGAUUUUUCACAUUUAGCC	22	17103
CFTR-Intron2-2004	+	UCUGGGAUUUUUCACAUUUAGCC	23	17104
CFTR-Intron2-2005	+	CUCUGGGAUUUUUCACAUUUAGCC	24	17105
CFTR-Intron2-2006	+	GGGGGGGACUACCAUUCC	18	17106
CFTR-Intron2-2007	+	UGGGGGGGACUACCAUUCC	19	17107
CFTR-Intron2-2008	+	AUGGGGGGGACUACCAUUCC	20	17108
CFTR-Intron2-2009	+	UAUGGGGGGGACUACCAUUCC	21	17109
CFTR-Intron2-2010	+	UUAUGGGGGGGACUACCAUUCC	22	17110
CFTR-Intron2-2011	+	UUUAUGGGGGGGACUACCAUUCC	23	17111
CFTR-Intron2-2012	+	CUUUAUGGGGGGGACUACCAUUCC	24	17112
CFTR-Intron2-2013	+	CAUUACCUUAAGACUUCC	18	17113
CFTR-Intron2-2014	+	CCAUUACCUUAAGACUUCC	19	17114
CFTR-Intron2-2015	+	GCCAUUACCUUAAGACUUCC	20	17115
CFTR-Intron2-2016	+	AGCCAUUACCUUAAGACUUCC	21	17116
CFTR-Intron2-2017	+	UAGCCAUUACCUUAAGACUUCC	22	17117
CFTR-Intron2-2018	+	GUAGCCAUUACCUUAAGACUUCC	23	17118
CFTR-Intron2-2019	+	AGUAGCCAUUACCUUAAGACUUCC	24	17119
CFTR-Intron2-2020	+	GCACCAUUACACUCCAGC	18	17120
CFTR-Intron2-2021	+	UGCACCAUUACACUCCAGC	19	17121
CFTR-Intron2-2022	+	UUGCACCAUUACACUCCAGC	20	17122
CFTR-Intron2-2023	+	AUUGCACCAUUACACUCCAGC	21	17123
CFTR-Intron2-2024	+	AAUUGCACCAUUACACUCCAGC	22	17124
CFTR-Intron2-2025	+	AAAUUGCACCAUUACACUCCAGC	23	17125
CFTR-Intron2-2026	+	AAAAUUGCACCAUUACACUCCAGC	24	17126
CFTR-Intron2-2027	+	CAGGAGACUGAGAUUCGC	18	17127
CFTR-Intron2-2028	+	UCAGGAGACUGAGAUUCGC	19	17128
CFTR-Intron2-2029	+	CUCAGGAGACUGAGAUUCGC	20	17129
CFTR-Intron2-2030	+	ACUCAGGAGACUGAGAUUCGC	21	17130
CFTR-Intron2-2031	+	UACUCAGGAGACUGAGAUUCGC	22	17131
CFTR-Intron2-2032	+	CUACUCAGGAGACUGAGAUUCGC	23	17132
CFTR-Intron2-2033	+	GCUACUCAGGAGACUGAGAUUCGC	24	17133
CFTR-Intron2-2034	+	UACUCGAGAGGCUGAGGC	18	17134
CFTR-Intron2-2035	+	CUACUCGAGAGGCUGAGGC	19	17135
CFTR-Intron2-461	+	GCUACUCGAGAGGCUGAGGC	20	15561
CFTR-Intron2-2036	+	AGCUACUCGAGAGGCUGAGGC	21	17136
CFTR-Intron2-2037	+	CAGCUACUCGAGAGGCUGAGGC	22	17137
CFTR-Intron2-2038	+	CCAGCUACUCGAGAGGCUGAGGC	23	17138
CFTR-Intron2-2039	+	CCCAGCUACUCGAGAGGCUGAGGC	24	17139
CFTR-Intron2-2040	+	UCUAAAGGAGUAAUAGGC	18	17140
CFTR-Intron2-2041	+	CUCUAAAGGAGUAAUAGGC	19	17141
CFTR-Intron2-662	+	ACUCUAAAGGAGUAAUAGGC	20	15762
CFTR-Intron2-2042	+	CACUCUAAAGGAGUAAUAGGC	21	17142
CFTR-Intron2-2043	+	UCACUCUAAAGGAGUAAUAGGC	22	17143
CFTR-Intron2-2044	+	AUCACUCUAAAGGAGUAAUAGGC	23	17144
CFTR-Intron2-2045	+	AAUCACUCUAAAGGAGUAAUAGGC	24	17145
CFTR-Intron2-2046	+	CAGGCCUGUGCUGUUGGC	18	17146
CFTR-Intron2-2047	+	UCAGGCCUGUGCUGUUGGC	19	17147
CFTR-Intron2-2048	+	AUCAGGCCUGUGCUGUUGGC	20	17148
CFTR-Intron2-2049	+	CAUCAGGCCUGUGCUGUUGGC	21	17149
CFTR-Intron2-2050	+	GCAUCAGGCCUGUGCUGUUGGC	22	17150
CFTR-Intron2-2051	+	GGCAUCAGGCCUGUGCUGUUGGC	23	17151
CFTR-Intron2-2052	+	UGGCAUCAGGCCUGUGCUGUUGGC	24	17152
CFTR-Intron2-2053	+	CAUAUCCUGACUACAAUC	18	17153
CFTR-Intron2-2054	+	UCAUAUCCUGACUACAAUC	19	17154
CFTR-Intron2-2055	+	UUCAUAUCCUGACUACAAUC	20	17155
CFTR-Intron2-2056	+	GUUCAUAUCCUGACUACAAUC	21	17156
CFTR-Intron2-2057	+	AGUUCAUAUCCUGACUACAAUC	22	17157
CFTR-Intron2-2058	+	AAGUUCAUAUCCUGACUACAAUC	23	17158
CFTR-Intron2-2059	+	AAAGUUCAUAUCCUGACUACAAUC	24	17159
CFTR-Intron2-2060	+	CUGUAAACCCAGCUACUC	18	17160
CFTR-Intron2-2061	+	CCUGUAAACCCAGCUACUC	19	17161
CFTR-Intron2-2062	+	GCCUGUAAACCCAGCUACUC	20	17162
CFTR-Intron2-2063	+	UGCCUGUAAACCCAGCUACUC	21	17163
CFTR-Intron2-2064	+	GUGCCUGUAAACCCAGCUACUC	22	17164
CFTR-Intron2-2065	+	AGUGCCUGUAAACCCAGCUACUC	23	17165
CFTR-Intron2-2066	+	GAGUGCCUGUAAACCCAGCUACUC	24	17166
CFTR-Intron2-2067	+	CUGUAGUCCCAGCUACUC	18	17167
CFTR-Intron2-2068	+	CCUGUAGUCCCAGCUACUC	19	17168
CFTR-Intron2-463	+	GCCUGUAGUCCCAGCUACUC	20	15563
CFTR-Intron2-2069	+	UGCCUGUAGUCCCAGCUACUC	21	17169
CFTR-Intron2-2070	+	AUGCCUGUAGUCCCAGCUACUC	22	17170
CFTR-Intron2-2071	+	CAUGCCUGUAGUCCCAGCUACUC	23	17171
CFTR-Intron2-2072	+	GCAUGCCUGUAGUCCCAGCUACUC	24	17172
CFTR-Intron2-2073	+	UGAGGAGAAGGCAAGGUC	18	17173
CFTR-Intron2-2074	+	CUGAGGAGAAGGCAAGGUC	19	17174
CFTR-Intron2-333	+	CCUGAGGAGAAGGCAAGGUC	20	15433
CFTR-Intron2-2075	+	ACCUGAGGAGAAGGCAAGGUC	21	17175
CFTR-Intron2-2076	+	UACCUGAGGAGAAGGCAAGGUC	22	17176
CFTR-Intron2-2077	+	UUACCUGAGGAGAAGGCAAGGUC	23	17177
CFTR-Intron2-2078	+	GUUACCUGAGGAGAAGGCAAGGUC	24	17178
CFTR-Intron2-2079	+	UGGUGGAAACCAUACUUC	18	17179
CFTR-Intron2-2080	+	AUGGUGGAAACCAUACUUC	19	17180
CFTR-Intron2-669	+	CAUGGUGGAAACCAUACUUC	20	15769
CFTR-Intron2-2081	+	ACAUGGUGGAAACCAUACUUC	21	17181
CFTR-Intron2-2082	+	AACAUGGUGGAAACCAUACUUC	22	17182
CFTR-Intron2-2083	+	GAACAUGGUGGAAACCAUACUUC	23	17183
CFTR-Intron2-2084	+	GGAACAUGGUGGAAACCAUACUUC	24	17184
CFTR-Intron2-2085	+	UCACAUAGUUCAGGCUUC	18	17185
CFTR-Intron2-2086	+	UUCACAUAGUUCAGGCUUC	19	17186
CFTR-Intron2-2087	+	CUUCACAUAGUUCAGGCUUC	20	17187
CFTR-Intron2-2088	+	UCUUCACAUAGUUCAGGCUUC	21	17188
CFTR-Intron2-2089	+	GUCUUCACAUAGUUCAGGCUUC	22	17189
CFTR-Intron2-2090	+	GGUCUUCACAUAGUUCAGGCUUC	23	17190
CFTR-Intron2-2091	+	AGGUCUUCACAUAGUUCAGGCUUC	24	17191
CFTR-Intron2-2092	+	ACAGAGAUGAAAAAUUUC	18	17192
CFTR-Intron2-2093	+	UACAGAGAUGAAAAAUUUC	19	17193
CFTR-Intron2-2094	+	GUACAGAGAUGAAAAAUUUC	20	17194
CFTR-Intron2-2095	+	UGUACAGAGAUGAAAAAUUUC	21	17195
CFTR-Intron2-2096	+	CUGUACAGAGAUGAAAAAUUUC	22	17196
CFTR-Intron2-2097	+	ACUGUACAGAGAUGAAAAAUUUC	23	17197
CFTR-Intron2-2098	+	AACUGUACAGAGAUGAAAAAUUUC	24	17198
CFTR-Intron2-2099	+	ACCAAAUGUGUAUUUUUC	18	17199
CFTR-Intron2-2100	+	AACCAAAUGUGUAUUUUUC	19	17200
CFTR-Intron2-670	+	AAACCAAAUGUGUAUUUUUC	20	15770
CFTR-Intron2-2101	+	GAAACCAAAUGUGUAUUUUUC	21	17201
CFTR-Intron2-2102	+	UGAAACCAAAUGUGUAUUUUUC	22	17202
CFTR-Intron2-2103	+	CUGAAACCAAAUGUGUAUUUUUC	23	17203
CFTR-Intron2-2104	+	UCUGAAACCAAAUGUGUAUUUUUC	24	17204
CFTR-Intron2-2105	+	UCACCUUCUCCAUCAAAG	18	17205
CFTR-Intron2-2106	+	CUCACCUUCUCCAUCAAAG	19	17206
CFTR-Intron2-2107	+	ACUCACCUUCUCCAUCAAAG	20	17207
CFTR-Intron2-2108	+	GACUCACCUUCUCCAUCAAAG	21	17208
CFTR-Intron2-2109	+	AGACUCACCUUCUCCAUCAAAG	22	17209
CFTR-Intron2-2110	+	CAGACUCACCUUCUCCAUCAAAG	23	17210
CFTR-Intron2-2111	+	GCAGACUCACCUUCUCCAUCAAAG	24	17211
CFTR-Intron2-2112	+	AAACUUAGAUAUUCAAAG	18	17212
CFTR-Intron2-2113	+	AAAACUUAGAUAUUCAAAG	19	17213
CFTR-Intron2-2114	+	UAAAACUUAGAUAUUCAAAG	20	17214
CFTR-Intron2-2115	+	UUAAAACUUAGAUAUUCAAAG	21	17215
CFTR-Intron2-2116	+	AUUAAAACUUAGAUAUUCAAAG	22	17216
CFTR-Intron2-2117	+	AAUUAAAACUUAGAUAUUCAAAG	23	17217
CFTR-Intron2-2118	+	CAAUUAAAACUUAGAUAUUCAAAG	24	17218
CFTR-Intron2-2119	+	ACACUUUGGGAGGCCAAG	18	17219
CFTR-Intron2-2120	+	AACACUUUGGGAGGCCAAG	19	17220
CFTR-Intron2-2121	+	CAACACUUUGGGAGGCCAAG	20	17221
CFTR-Intron2-2122	+	CCAACACUUUGGGAGGCCAAG	21	17222
CFTR-Intron2-2123	+	CCCAACACUUUGGGAGGCCAAG	22	17223
CFTR-Intron2-2124	+	UCCCAACACUUUGGGAGGCCAAG	23	17224
CFTR-Intron2-2125	+	AUCCCAACACUUUGGGAGGCCAAG	24	17225
CFTR-Intron2-2126	+	GCAUUUUGGGAGGCCAAG	18	17226
CFTR-Intron2-2127	+	AGCAUUUUGGGAGGCCAAG	19	17227
CFTR-Intron2-2128	+	CAGCAUUUUGGGAGGCCAAG	20	17228
CFTR-Intron2-2129	+	CCAGCAUUUUGGGAGGCCAAG	21	17229
CFTR-Intron2-2130	+	CCCAGCAUUUUGGGAGGCCAAG	22	17230
CFTR-Intron2-2131	+	UCCCAGCAUUUUGGGAGGCCAAG	23	17231
CFTR-Intron2-2132	+	AUCCCAGCAUUUUGGGAGGCCAAG	24	17232
CFTR-Intron2-2133	+	AUGUAAAUGAAAGUGAAG	18	17233
CFTR-Intron2-2134	+	GAUGUAAAUGAAAGUGAAG	19	17234
CFTR-Intron2-2135	+	AGAUGUAAAUGAAAGUGAAG	20	17235
CFTR-Intron2-2136	+	GAGAUGUAAAUGAAAGUGAAG	21	17236
CFTR-Intron2-2137	+	UGAGAUGUAAAUGAAAGUGAAG	22	17237
CFTR-Intron2-2138	+	CUGAGAUGUAAAUGAAAGUGAAG	23	17238
CFTR-Intron2-2139	+	GCUGAGAUGUAAAUGAAAGUGAAG	24	17239
CFTR-Intron2-2140	+	UAAAGGAGUAAUACACAG	18	17240
CFTR-Intron2-2141	+	AUAAAGGAGUAAUACACAG	19	17241
CFTR-Intron2-2142	+	CAUAAAGGAGUAAUACACAG	20	17242
CFTR-Intron2-2143	+	ACAUAAAGGAGUAAUACACAG	21	17243
CFTR-Intron2-2144	+	AACAUAAAGGAGUAAUACACAG	22	17244
CFTR-Intron2-2145	+	AAACAUAAAGGAGUAAUACACAG	23	17245
CFTR-Intron2-2146	+	AAAACAUAAAGGAGUAAUACACAG	24	17246
CFTR-Intron2-2147	+	GUGAAGUAGAGAGACCAG	18	17247
CFTR-Intron2-2148	+	AGUGAAGUAGAGAGACCAG	19	17248
CFTR-Intron2-2149	+	AAGUGAAGUAGAGAGACCAG	20	17249
CFTR-Intron2-2150	+	AAAGUGAAGUAGAGAGACCAG	21	17250
CFTR-Intron2-2151	+	GAAAGUGAAGUAGAGAGACCAG	22	17251
CFTR-Intron2-2152	+	UGAAAGUGAAGUAGAGAGACCAG	23	17252
CFTR-Intron2-2153	+	AUGAAAGUGAAGUAGAGAGACCAG	24	17253
CFTR-Intron2-2154	+	AUACCAGGCCCAGAUCAG	18	17254
CFTR-Intron2-2155	+	CAUACCAGGCCCAGAUCAG	19	17255
CFTR-Intron2-2156	+	ACAUACCAGGCCCAGAUCAG	20	17256
CFTR-Intron2-2157	+	CACAUACCAGGCCCAGAUCAG	21	17257
CFTR-Intron2-2158	+	CCACAUACCAGGCCCAGAUCAG	22	17258
CFTR-Intron2-2159	+	ACCACAUACCAGGCCCAGAUCAG	23	17259
CFTR-Intron2-2160	+	GACCACAUACCAGGCCCAGAUCAG	24	17260
CFTR-Intron2-2161	+	AAAGGAGAAAUGGAUCAG	18	17261
CFTR-Intron2-2162	+	CAAAGGAGAAAUGGAUCAG	19	17262
CFTR-Intron2-2163	+	UCAAAGGAGAAAUGGAUCAG	20	17263
CFTR-Intron2-2164	+	AUCAAAGGAGAAAUGGAUCAG	21	17264
CFTR-Intron2-2165	+	CAUCAAAGGAGAAAUGGAUCAG	22	17265
CFTR-Intron2-2166	+	CCAUCAAAGGAGAAAUGGAUCAG	23	17266
CFTR-Intron2-2167	+	UCCAUCAAAGGAGAAAUGGAUCAG	24	17267
CFTR-Intron2-2168	+	AGGCAAUACAGACCUCAG	18	17268
CFTR-Intron2-2169	+	AAGGCAAUACAGACCUCAG	19	17269
CFTR-Intron2-2170	+	CAAGGCAAUACAGACCUCAG	20	17270
CFTR-Intron2-2171	+	GCAAGGCAAUACAGACCUCAG	21	17271
CFTR-Intron2-2172	+	AGCAAGGCAAUACAGACCUCAG	22	17272
CFTR-Intron2-2173	+	GAGCAAGGCAAUACAGACCUCAG	23	17273
CFTR-Intron2-2174	+	AGAGCAAGGCAAUACAGACCUCAG	24	17274
CFTR-Intron2-2175	+	UUUUCAAACUGUACAGAG	18	17275
CFTR-Intron2-2176	+	AUUUUCAAACUGUACAGAG	19	17276
CFTR-Intron2-2177	+	AAUUUUCAAACUGUACAGAG	20	17277
CFTR-Intron2-2178	+	UAAUUUUCAAACUGUACAGAG	21	17278
CFTR-Intron2-2179	+	UUAAUUUUCAAACUGUACAGAG	22	17279
CFTR-Intron2-2180	+	CUUAAUUUUCAAACUGUACAGAG	23	17280
CFTR-Intron2-2181	+	UCUUAAUUUUCAAACUGUACAGAG	24	17281
CFTR-Intron2-2182	+	GUAGAGAGACCAGGAGAG	18	17282
CFTR-Intron2-2183	+	AGUAGAGAGACCAGGAGAG	19	17283
CFTR-Intron2-2184	+	AAGUAGAGAGACCAGGAGAG	20	17284
CFTR-Intron2-2185	+	GAAGUAGAGAGACCAGGAGAG	21	17285
CFTR-Intron2-2186	+	UGAAGUAGAGAGACCAGGAGAG	22	17286
CFTR-Intron2-2187	+	GUGAAGUAGAGAGACCAGGAGAG	23	17287
CFTR-Intron2-2188	+	AGUGAAGUAGAGAGACCAGGAGAG	24	17288
CFTR-Intron2-2189	+	AUCACUUGAACCCAGGAG	18	17289
CFTR-Intron2-2190	+	AAUCACUUGAACCCAGGAG	19	17290
CFTR-Intron2-2191	+	GAAUCACUUGAACCCAGGAG	20	17291
CFTR-Intron2-2192	+	AGAAUCACUUGAACCCAGGAG	21	17292
CFTR-Intron2-2193	+	GAGAAUCACUUGAACCCAGGAG	22	17293
CFTR-Intron2-2194	+	GGAGAAUCACUUGAACCCAGGAG	23	17294
CFTR-Intron2-2195	+	AGGAGAAUCACUUGAACCCAGGAG	24	17295
CFTR-Intron2-2196	+	GAAACCAUACUUCAGGAG	18	17296
CFTR-Intron2-2197	+	GGAAACCAUACUUCAGGAG	19	17297
CFTR-Intron2-2198	+	UGGAAACCAUACUUCAGGAG	20	17298
CFTR-Intron2-2199	+	GUGGAAACCAUACUUCAGGAG	21	17299
CFTR-Intron2-2200	+	GGUGGAAACCAUACUUCAGGAG	22	17300
CFTR-Intron2-2201	+	UGGUGGAAACCAUACUUCAGGAG	23	17301
CFTR-Intron2-2202	+	AUGGUGGAAACCAUACUUCAGGAG	24	17302
CFTR-Intron2-2203	+	AUGGGGUAGUUACCUGAG	18	17303
CFTR-Intron2-2204	+	AAUGGGGUAGUUACCUGAG	19	17304
CFTR-Intron2-2205	+	GAAUGGGGUAGUUACCUGAG	20	17305
CFTR-Intron2-2206	+	AGAAUGGGGUAGUUACCUGAG	21	17306
CFTR-Intron2-2207	+	UAGAAUGGGGUAGUUACCUGAG	22	17307
CFTR-Intron2-2208	+	AUAGAAUGGGGUAGUUACCUGAG	23	17308
CFTR-Intron2-2209	+	AAUAGAAUGGGGUAGUUACCUGAG	24	17309
CFTR-Intron2-2210	+	CCACUCAGAGUGGCUGAG	18	17310
CFTR-Intron2-2211	+	UCCACUCAGAGUGGCUGAG	19	17311
CFTR-Intron2-343	+	UUCCACUCAGAGUGGCUGAG	20	15443
CFTR-Intron2-2212	+	UUUCCACUCAGAGUGGCUGAG	21	17312
CFTR-Intron2-2213	+	CUUUCCACUCAGAGUGGCUGAG	22	17313
CFTR-Intron2-2214	+	GCUUUCCACUCAGAGUGGCUGAG	23	17314
CFTR-Intron2-2215	+	UGCUUUCCACUCAGAGUGGCUGAG	24	17315
CFTR-Intron2-2216	+	GGCAGAGUUUGCAGUGAG	18	17316
CFTR-Intron2-2217	+	AGGCAGAGUUUGCAGUGAG	19	17317
CFTR-Intron2-2218	+	GAGGCAGAGUUUGCAGUGAG	20	17318
CFTR-Intron2-2219	+	GGAGGCAGAGUUUGCAGUGAG	21	17319
CFTR-Intron2-2220	+	AGGAGGCAGAGUUUGCAGUGAG	22	17320
CFTR-Intron2-2221	+	CAGGAGGCAGAGUUUGCAGUGAG	23	17321
CFTR-Intron2-2222	+	CCAGGAGGCAGAGUUUGCAGUGAG	24	17322
CFTR-Intron2-2223	+	UAGGUGAUGUGGUUCUAG	18	17323
CFTR-Intron2-2224	+	GUAGGUGAUGUGGUUCUAG	19	17324
CFTR-Intron2-2225	+	AGUAGGUGAUGUGGUUCUAG	20	17325
CFTR-Intron2-2226	+	GAGUAGGUGAUGUGGUUCUAG	21	17326
CFTR-Intron2-2227	+	AGAGUAGGUGAUGUGGUUCUAG	22	17327
CFTR-Intron2-2228	+	AAGAGUAGGUGAUGUGGUUCUAG	23	17328
CFTR-Intron2-2229	+	CAAGAGUAGGUGAUGUGGUUCUAG	24	17329
CFTR-Intron2-2230	+	AUUUCAUGAACCACAAGG	18	17330
CFTR-Intron2-2231	+	AAUUUCAUGAACCACAAGG	19	17331
CFTR-Intron2-2232	+	AAAUUUCAUGAACCACAAGG	20	17332
CFTR-Intron2-2233	+	AAAAUUUCAUGAACCACAAGG	21	17333
CFTR-Intron2-2234	+	AAAAAUUUCAUGAACCACAAGG	22	17334
CFTR-Intron2-2235	+	GAAAAAUUUCAUGAACCACAAGG	23	17335
CFTR-Intron2-2236	+	UGAAAAAUUUCAUGAACCACAAGG	24	17336
CFTR-Intron2-2237	+	CAGAUGGGAAAGCCAAGG	18	17337
CFTR-Intron2-2238	+	UCAGAUGGGAAAGCCAAGG	19	17338
CFTR-Intron2-2239	+	AUCAGAUGGGAAAGCCAAGG	20	17339
CFTR-Intron2-2240	+	GAUCAGAUGGGAAAGCCAAGG	21	17340
CFTR-Intron2-2241	+	GGAUCAGAUGGGAAAGCCAAGG	22	17341
CFTR-Intron2-2242	+	UGGAUCAGAUGGGAAAGCCAAGG	23	17342
CFTR-Intron2-2243	+	AUGGAUCAGAUGGGAAAGCCAAGG	24	17343
CFTR-Intron2-2244	+	CCUGAGGAGAAGGCAAGG	18	17344
CFTR-Intron2-2245	+	ACCUGAGGAGAAGGCAAGG	19	17345
CFTR-Intron2-2246	+	UACCUGAGGAGAAGGCAAGG	20	17346
CFTR-Intron2-2247	+	UUACCUGAGGAGAAGGCAAGG	21	17347
CFTR-Intron2-2248	+	GUUACCUGAGGAGAAGGCAAGG	22	17348
CFTR-Intron2-2249	+	AGUUACCUGAGGAGAAGGCAAGG	23	17349
CFTR-Intron2-2250	+	UAGUUACCUGAGGAGAAGGCAAGG	24	17350
CFTR-Intron2-2251	+	AAGAAAAGAAGUAACAGG	18	17351
CFTR-Intron2-2252	+	UAAGAAAAGAAGUAACAGG	19	17352
CFTR-Intron2-2253	+	AUAAGAAAAGAAGUAACAGG	20	17353
CFTR-Intron2-2254	+	UAUAAGAAAAGAAGUAACAGG	21	17354
CFTR-Intron2-2255	+	UUAUAAGAAAAGAAGUAACAGG	22	17355
CFTR-Intron2-2256	+	UUUAUAAGAAAAGAAGUAACAGG	23	17356
CFTR-Intron2-2257	+	UUUUAUAAGAAAAGAAGUAACAGG	24	17357
CFTR-Intron2-2258	+	ACCCAGCUACUCGAGAGG	18	17358
CFTR-Intron2-2259	+	AACCCAGCUACUCGAGAGG	19	17359
CFTR-Intron2-2260	+	AAACCCAGCUACUCGAGAGG	20	17360
CFTR-Intron2-2261	+	UAAACCCAGCUACUCGAGAGG	21	17361
CFTR-Intron2-2262	+	GUAAACCCAGCUACUCGAGAGG	22	17362
CFTR-Intron2-2263	+	UGUAAACCCAGCUACUCGAGAGG	23	17363
CFTR-Intron2-2264	+	CUGUAAACCCAGCUACUCGAGAGG	24	17364
CFTR-Intron2-2265	+	CUACUCGAGAGGCUGAGG	18	17365
CFTR-Intron2-2266	+	GCUACUCGAGAGGCUGAGG	19	17366
CFTR-Intron2-2267	+	AGCUACUCGAGAGGCUGAGG	20	17367
CFTR-Intron2-2268	+	CAGCUACUCGAGAGGCUGAGG	21	17368
CFTR-Intron2-2269	+	CCAGCUACUCGAGAGGCUGAGG	22	17369
CFTR-Intron2-2270	+	CCCAGCUACUCGAGAGGCUGAGG	23	17370
CFTR-Intron2-2271	+	ACCCAGCUACUCGAGAGGCUGAGG	24	17371
CFTR-Intron2-2272	+	CUCUAAAGGAGUAAUAGG	18	17372
CFTR-Intron2-2273	+	ACUCUAAAGGAGUAAUAGG	19	17373
CFTR-Intron2-2274	+	CACUCUAAAGGAGUAAUAGG	20	17374
CFTR-Intron2-2275	+	UCACUCUAAAGGAGUAAUAGG	21	17375
CFTR-Intron2-2276	+	AUCACUCUAAAGGAGUAAUAGG	22	17376
CFTR-Intron2-2277	+	AAUCACUCUAAAGGAGUAAUAGG	23	17377
CFTR-Intron2-2278	+	AAAUCACUCUAAAGGAGUAAUAGG	24	17378
CFTR-Intron2-2279	+	AGGCCCAGAUCAGAAGGG	18	17379
CFTR-Intron2-2280	+	CAGGCCCAGAUCAGAAGGG	19	17380
CFTR-Intron2-2281	+	CCAGGCCCAGAUCAGAAGGG	20	17381
CFTR-Intron2-2282	+	ACCAGGCCCAGAUCAGAAGGG	21	17382
CFTR-Intron2-2283	+	UACCAGGCCCAGAUCAGAAGGG	22	17383
CFTR-Intron2-2284	+	AUACCAGGCCCAGAUCAGAAGGG	23	17384
CFTR-Intron2-2285	+	CAUACCAGGCCCAGAUCAGAAGGG	24	17385
CFTR-Intron2-2286	+	AGAAAAGAAGUAACAGGG	18	17386
CFTR-Intron2-2287	+	AAGAAAAGAAGUAACAGGG	19	17387
CFTR-Intron2-681	+	UAAGAAAAGAAGUAACAGGG	20	15781
CFTR-Intron2-2288	+	AUAAGAAAAGAAGUAACAGGG	21	17388
CFTR-Intron2-2289	+	UAUAAGAAAAGAAGUAACAGGG	22	17389
CFTR-Intron2-2290	+	UUAUAAGAAAAGAAGUAACAGGG	23	17390
CFTR-Intron2-2291	+	UUUAUAAGAAAAGAAGUAACAGGG	24	17391
CFTR-Intron2-2292	+	UGAGAGAUUCUUUAUGGG	18	17392
CFTR-Intron2-2293	+	CUGAGAGAUUCUUUAUGGG	19	17393
CFTR-Intron2-353	+	ACUGAGAGAUUCUUUAUGGG	20	15453
CFTR-Intron2-2294	+	AACUGAGAGAUUCUUUAUGGG	21	17394
CFTR-Intron2-2295	+	AAACUGAGAGAUUCUUUAUGGG	22	17395
CFTR-Intron2-2296	+	GAAACUGAGAGAUUCUUUAUGGG	23	17396
CFTR-Intron2-2297	+	GGAAACUGAGAGAUUCUUUAUGGG	24	17397
CFTR-Intron2-2298	+	GGGGAAUUUCUUUAAUGG	18	17398
CFTR-Intron2-2299	+	CGGGGAAUUUCUUUAAUGG	19	17399
CFTR-Intron2-2300	+	UCGGGGAAUUUCUUUAAUGG	20	17400
CFTR-Intron2-2301	+	GUCGGGGAAUUUCUUUAAUGG	21	17401
CFTR-Intron2-2302	+	GGUCGGGGAAUUUCUUUAAUGG	22	17402
CFTR-Intron2-2303	+	AGGUCGGGGAAUUUCUUUAAUGG	23	17403
CFTR-Intron2-2304	+	AAGGUCGGGGAAUUUCUUUAAUGG	24	17404
CFTR-Intron2-2305	+	GUAGUUUUAGGAACAUGG	18	17405
CFTR-Intron2-2306	+	UGUAGUUUUAGGAACAUGG	19	17406
CFTR-Intron2-355	+	AUGUAGUUUUAGGAACAUGG	20	15455
CFTR-Intron2-2307	+	AAUGUAGUUUUAGGAACAUGG	21	17407
CFTR-Intron2-2308	+	CAAUGUAGUUUUAGGAACAUGG	22	17408
CFTR-Intron2-2309	+	GCAAUGUAGUUUUAGGAACAUGG	23	17409
CFTR-Intron2-2310	+	GGCAAUGUAGUUUUAGGAACAUGG	24	17410
CFTR-Intron2-2311	+	CUGAGAGAUUCUUUAUGG	18	17411
CFTR-Intron2-2312	+	ACUGAGAGAUUCUUUAUGG	19	17412
CFTR-Intron2-356	+	AACUGAGAGAUUCUUUAUGG	20	15456
CFTR-Intron2-2313	+	AAACUGAGAGAUUCUUUAUGG	21	17413
CFTR-Intron2-2314	+	GAAACUGAGAGAUUCUUUAUGG	22	17414
CFTR-Intron2-2315	+	GGAAACUGAGAGAUUCUUUAUGG	23	17415
CFTR-Intron2-2316	+	AGGAAACUGAGAGAUUCUUUAUGG	24	17416
CFTR-Intron2-2317	+	AAAUAGUCUGAAAACUGG	18	17417
CFTR-Intron2-2318	+	UAAAUAGUCUGAAAACUGG	19	17418
CFTR-Intron2-2319	+	UUAAAUAGUCUGAAAACUGG	20	17419
CFTR-Intron2-2320	+	AUUAAAUAGUCUGAAAACUGG	21	17420
CFTR-Intron2-2321	+	CAUUAAAUAGUCUGAAAACUGG	22	17421
CFTR-Intron2-2322	+	ACAUUAAAUAGUCUGAAAACUGG	23	17422
CFTR-Intron2-2323	+	GACAUUAAAUAGUCUGAAAACUGG	24	17423
CFTR-Intron2-2324	+	GCUUUCCACUCAGAGUGG	18	17424
CFTR-Intron2-2325	+	UGCUUUCCACUCAGAGUGG	19	17425
CFTR-Intron2-2326	+	AUGCUUUCCACUCAGAGUGG	20	17426
CFTR-Intron2-2327	+	GAUGCUUUCCACUCAGAGUGG	21	17427
CFTR-Intron2-2328	+	UGAUGCUUUCCACUCAGAGUGG	22	17428
CFTR-Intron2-2329	+	AUGAUGCUUUCCACUCAGAGUGG	23	17429
CFTR-Intron2-2330	+	AAUGAUGCUUUCCACUCAGAGUGG	24	17430
CFTR-Intron2-2331	+	GUCCACACGGAAGUAAUG	18	17431
CFTR-Intron2-2332	+	GGUCCACACGGAAGUAAUG	19	17432
CFTR-Intron2-2333	+	UGGUCCACACGGAAGUAAUG	20	17433
CFTR-Intron2-2334	+	GUGGUCCACACGGAAGUAAUG	21	17434
CFTR-Intron2-2335	+	AGUGGUCCACACGGAAGUAAUG	22	17435
CFTR-Intron2-2336	+	AAGUGGUCCACACGGAAGUAAUG	23	17436
CFTR-Intron2-2337	+	AAAGUGGUCCACACGGAAGUAAUG	24	17437
CFTR-Intron2-2338	+	ACCAGCCUGGCCAACAUG	18	17438
CFTR-Intron2-2339	+	GACCAGCCUGGCCAACAUG	19	17439
CFTR-Intron2-2340	+	AGACCAGCCUGGCCAACAUG	20	17440
CFTR-Intron2-2341	+	AAGACCAGCCUGGCCAACAUG	21	17441
CFTR-Intron2-2342	+	CAAGACCAGCCUGGCCAACAUG	22	17442
CFTR-Intron2-2343	+	UCAAGACCAGCCUGGCCAACAUG	23	17443
CFTR-Intron2-2344	+	UUCAAGACCAGCCUGGCCAACAUG	24	17444
CFTR-Intron2-2345	+	UGUAGUUUUAGGAACAUG	18	17445
CFTR-Intron2-2346	+	AUGUAGUUUUAGGAACAUG	19	17446
CFTR-Intron2-2347	+	AAUGUAGUUUUAGGAACAUG	20	17447
CFTR-Intron2-2348	+	CAAUGUAGUUUUAGGAACAUG	21	17448
CFTR-Intron2-2349	+	GCAAUGUAGUUUUAGGAACAUG	22	17449
CFTR-Intron2-2350	+	GGCAAUGUAGUUUUAGGAACAUG	23	17450
CFTR-Intron2-2351	+	GGGCAAUGUAGUUUUAGGAACAUG	24	17451
CFTR-Intron2-2352	+	UUGCACACUGCAGUUAUG	18	17452
CFTR-Intron2-2353	+	UUUGCACACUGCAGUUAUG	19	17453
CFTR-Intron2-2354	+	GUUUGCACACUGCAGUUAUG	20	17454
CFTR-Intron2-2355	+	GGUUUGCACACUGCAGUUAUG	21	17455
CFTR-Intron2-2356	+	UGGUUUGCACACUGCAGUUAUG	22	17456
CFTR-Intron2-2357	+	GUGGUUUGCACACUGCAGUUAUG	23	17457
CFTR-Intron2-2358	+	UGUGGUUUGCACACUGCAGUUAUG	24	17458
CFTR-Intron2-2359	+	CCAGGGACCCACUUUAUG	18	17459
CFTR-Intron2-2360	+	ACCAGGGACCCACUUUAUG	19	17460
CFTR-Intron2-2361	+	AACCAGGGACCCACUUUAUG	20	17461
CFTR-Intron2-2362	+	UAACCAGGGACCCACUUUAUG	21	17462
CFTR-Intron2-2363	+	CUAACCAGGGACCCACUUUAUG	22	17463
CFTR-Intron2-2364	+	UCUAACCAGGGACCCACUUUAUG	23	17464
CFTR-Intron2-2365	+	UUCUAACCAGGGACCCACUUUAUG	24	17465
CFTR-Intron2-2366	+	ACUGAGAGAUUCUUUAUG	18	17466
CFTR-Intron2-2367	+	AACUGAGAGAUUCUUUAUG	19	17467
CFTR-Intron2-361	+	AAACUGAGAGAUUCUUUAUG	20	15461
CFTR-Intron2-2368	+	GAAACUGAGAGAUUCUUUAUG	21	17468
CFTR-Intron2-2369	+	GGAAACUGAGAGAUUCUUUAUG	22	17469
CFTR-Intron2-2370	+	AGGAAACUGAGAGAUUCUUUAUG	23	17470
CFTR-Intron2-2371	+	AAGGAAACUGAGAGAUUCUUUAUG	24	17471
CFTR-Intron2-2372	+	GAAUGGGGUAGUUACCUG	18	17472
CFTR-Intron2-2373	+	AGAAUGGGGUAGUUACCUG	19	17473
CFTR-Intron2-362	+	UAGAAUGGGGUAGUUACCUG	20	15462
CFTR-Intron2-2374	+	AUAGAAUGGGGUAGUUACCUG	21	17474
CFTR-Intron2-2375	+	AAUAGAAUGGGGUAGUUACCUG	22	17475
CFTR-Intron2-2376	+	AAAUAGAAUGGGGUAGUUACCUG	23	17476
CFTR-Intron2-2377	+	AAAAUAGAAUGGGGUAGUUACCUG	24	17477
CFTR-Intron2-2378	+	GGUCACUUCCCAAGGGUG	18	17478
CFTR-Intron2-2379	+	GGGUCACUUCCCAAGGGUG	19	17479
CFTR-Intron2-2380	+	AGGGUCACUUCCCAAGGGUG	20	17480
CFTR-Intron2-2381	+	CAGGGUCACUUCCCAAGGGUG	21	17481
CFTR-Intron2-2382	+	CCAGGGUCACUUCCCAAGGGUG	22	17482
CFTR-Intron2-2383	+	GCCAGGGUCACUUCCCAAGGGUG	23	17483
CFTR-Intron2-2384	+	AGCCAGGGUCACUUCCCAAGGGUG	24	17484
CFTR-Intron2-2385	+	UAAAGGUCUUUGAAAAAU	18	17485
CFTR-Intron2-2386	+	UUAAAGGUCUUUGAAAAAU	19	17486
CFTR-Intron2-2387	+	AUUAAAGGUCUUUGAAAAAU	20	17487
CFTR-Intron2-2388	+	UAUUAAAGGUCUUUGAAAAAU	21	17488
CFTR-Intron2-2389	+	GUAUUAAAGGUCUUUGAAAAAU	22	17489
CFTR-Intron2-2390	+	UGUAUUAAAGGUCUUUGAAAAAU	23	17490
CFTR-Intron2-2391	+	AUGUAUUAAAGGUCUUUGAAAAAU	24	17491
CFTR-Intron2-2392	+	ACAAGGCAGUUAUGAAAU	18	17492
CFTR-Intron2-2393	+	CACAAGGCAGUUAUGAAAU	19	17493
CFTR-Intron2-2394	+	UCACAAGGCAGUUAUGAAAU	20	17494
CFTR-Intron2-2395	+	GUCACAAGGCAGUUAUGAAAU	21	17495
CFTR-Intron2-2396	+	GGUCACAAGGCAGUUAUGAAAU	22	17496
CFTR-Intron2-2397	+	UGGUCACAAGGCAGUUAUGAAAU	23	17497
CFTR-Intron2-2398	+	AUGGUCACAAGGCAGUUAUGAAAU	24	17498
CFTR-Intron2-2399	+	CAGAGUAAGAAGCUAAAU	18	17499
CFTR-Intron2-2400	+	UCAGAGUAAGAAGCUAAAU	19	17500
CFTR-Intron2-2401	+	CUCAGAGUAAGAAGCUAAAU	20	17501
CFTR-Intron2-2402	+	ACUCAGAGUAAGAAGCUAAAU	21	17502
CFTR-Intron2-2403	+	UACUCAGAGUAAGAAGCUAAAU	22	17503
CFTR-Intron2-2404	+	UUACUCAGAGUAAGAAGCUAAAU	23	17504
CFTR-Intron2-2405	+	GUUACUCAGAGUAAGAAGCUAAAU	24	17505
CFTR-Intron2-2406	+	CAACAAAAUGGGUUCAAU	18	17506
CFTR-Intron2-2407	+	CCAACAAAAUGGGUUCAAU	19	17507
CFTR-Intron2-2408	+	ACCAACAAAAUGGGUUCAAU	20	17508
CFTR-Intron2-2409	+	AACCAACAAAAUGGGUUCAAU	21	17509
CFTR-Intron2-2410	+	AAACCAACAAAAUGGGUUCAAU	22	17510
CFTR-Intron2-2411	+	UAAACCAACAAAAUGGGUUCAAU	23	17511
CFTR-Intron2-2412	+	AUAAACCAACAAAAUGGGUUCAAU	24	17512
CFTR-Intron2-2413	+	CCCUAGAAGCUUGCUAAU	18	17513
CFTR-Intron2-2414	+	CCCCUAGAAGCUUGCUAAU	19	17514
CFTR-Intron2-2415	+	UCCCCUAGAAGCUUGCUAAU	20	17515
CFTR-Intron2-2416	+	AUCCCCUAGAAGCUUGCUAAU	21	17516
CFTR-Intron2-2417	+	CAUCCCCUAGAAGCUUGCUAAU	22	17517
CFTR-Intron2-2418	+	GCAUCCCCUAGAAGCUUGCUAAU	23	17518
CFTR-Intron2-2419	+	GGCAUCCCCUAGAAGCUUGCUAAU	24	17519
CFTR-Intron2-2420	+	UUUAAAUUGAAUCAACAU	18	17520
CFTR-Intron2-2421	+	UUUUAAAUUGAAUCAACAU	19	17521
CFTR-Intron2-699	+	UUUUUAAAUUGAAUCAACAU	20	15799
CFTR-Intron2-2422	+	UUUUUUAAAUUGAAUCAACAU	21	17522
CFTR-Intron2-2423	+	AUUUUUUAAAUUGAAUCAACAU	22	17523
CFTR-Intron2-2424	+	UAUUUUUUAAAUUGAAUCAACAU	23	17524
CFTR-Intron2-2425	+	AUAUUUUUUAAAUUGAAUCAACAU	24	17525
CFTR-Intron2-2426	+	GGUGUUGUUAUAUUUCAU	18	17526
CFTR-Intron2-2427	+	AGGUGUUGUUAUAUUUCAU	19	17527
CFTR-Intron2-2428	+	AAGGUGUUGUUAUAUUUCAU	20	17528
CFTR-Intron2-2429	+	AAAGGUGUUGUUAUAUUUCAU	21	17529
CFTR-Intron2-2430	+	GAAAGGUGUUGUUAUAUUUCAU	22	17530
CFTR-Intron2-2431	+	AGAAAGGUGUUGUUAUAUUUCAU	23	17531
CFTR-Intron2-2432	+	UAGAAAGGUGUUGUUAUAUUUCAU	24	17532
CFTR-Intron2-2433	+	UUCGUGGUCCUUAAAGAU	18	17533
CFTR-Intron2-2434	+	UUUCGUGGUCCUUAAAGAU	19	17534
CFTR-Intron2-375	+	CUUUCGUGGUCCUUAAAGAU	20	15475
CFTR-Intron2-2435	+	UCUUUCGUGGUCCUUAAAGAU	21	17535
CFTR-Intron2-2436	+	UUCUUUCGUGGUCCUUAAAGAU	22	17536
CFTR-Intron2-2437	+	CUUCUUUCGUGGUCCUUAAAGAU	23	17537
CFTR-Intron2-2438	+	CCUUCUUUCGUGGUCCUUAAAGAU	24	17538
CFTR-Intron2-2439	+	CACAUACCAGGCCCAGAU	18	17539
CFTR-Intron2-2440	+	CCACAUACCAGGCCCAGAU	19	17540
CFTR-Intron2-2441	+	ACCACAUACCAGGCCCAGAU	20	17541
CFTR-Intron2-2442	+	GACCACAUACCAGGCCCAGAU	21	17542
CFTR-Intron2-2443	+	GGACCACAUACCAGGCCCAGAU	22	17543
CFTR-Intron2-2444	+	AGGACCACAUACCAGGCCCAGAU	23	17544
CFTR-Intron2-2445	+	UAGGACCACAUACCAGGCCCAGAU	24	17545
CFTR-Intron2-2446	+	AGGAGAAAUGGAUCAGAU	18	17546
CFTR-Intron2-2447	+	AAGGAGAAAUGGAUCAGAU	19	17547
CFTR-Intron2-376	+	AAAGGAGAAAUGGAUCAGAU	20	15476
CFTR-Intron2-2448	+	CAAAGGAGAAAUGGAUCAGAU	21	17548
CFTR-Intron2-2449	+	UCAAAGGAGAAAUGGAUCAGAU	22	17549
CFTR-Intron2-2450	+	AUCAAAGGAGAAAUGGAUCAGAU	23	17550
CFTR-Intron2-2451	+	CAUCAAAGGAGAAAUGGAUCAGAU	24	17551
CFTR-Intron2-2452	+	GUAAUACACAGCUGAGAU	18	17552
CFTR-Intron2-2453	+	AGUAAUACACAGCUGAGAU	19	17553
CFTR-Intron2-2454	+	GAGUAAUACACAGCUGAGAU	20	17554
CFTR-Intron2-2455	+	GGAGUAAUACACAGCUGAGAU	21	17555
CFTR-Intron2-2456	+	AGGAGUAAUACACAGCUGAGAU	22	17556
CFTR-Intron2-2457	+	AAGGAGUAAUACACAGCUGAGAU	23	17557
CFTR-Intron2-2458	+	AAAGGAGUAAUACACAGCUGAGAU	24	17558
CFTR-Intron2-2459	+	GGAUCCUAACCUUUUGAU	18	17559
CFTR-Intron2-2460	+	AGGAUCCUAACCUUUUGAU	19	17560
CFTR-Intron2-379	+	AAGGAUCCUAACCUUUUGAU	20	15479
CFTR-Intron2-2461	+	AAAGGAUCCUAACCUUUUGAU	21	17561
CFTR-Intron2-2462	+	AAAAGGAUCCUAACCUUUUGAU	22	17562
CFTR-Intron2-2463	+	CAAAAGGAUCCUAACCUUUUGAU	23	17563
CFTR-Intron2-2464	+	UCAAAAGGAUCCUAACCUUUUGAU	24	17564
CFTR-Intron2-2465	+	UUUUCUUUUAAAUACUAU	18	17565
CFTR-Intron2-2466	+	GUUUUCUUUUAAAUACUAU	19	17566
CFTR-Intron2-700	+	UGUUUUCUUUUAAAUACUAU	20	15800
CFTR-Intron2-2467	+	CUGUUUUCUUUUAAAUACUAU	21	17567
CFTR-Intron2-2468	+	UCUGUUUUCUUUUAAAUACUAU	22	17568
CFTR-Intron2-2469	+	UUCUGUUUUCUUUUAAAUACUAU	23	17569
CFTR-Intron2-2470	+	UUUCUGUUUUCUUUUAAAUACUAU	24	17570
CFTR-Intron2-2471	+	AACUGAGAGAUUCUUUAU	18	17571
CFTR-Intron2-2472	+	AAACUGAGAGAUUCUUUAU	19	17572
CFTR-Intron2-73	+	GAAACUGAGAGAUUCUUUAU	20	15173
CFTR-Intron2-2473	+	GGAAACUGAGAGAUUCUUUAU	21	17573
CFTR-Intron2-2474	+	AGGAAACUGAGAGAUUCUUUAU	22	17574
CFTR-Intron2-2475	+	AAGGAAACUGAGAGAUUCUUUAU	23	17575
CFTR-Intron2-2476	+	AAAGGAAACUGAGAGAUUCUUUAU	24	17576
CFTR-Intron2-2477	+	UUCAAAUACCAAUUUUAU	18	17577
CFTR-Intron2-2478	+	UUUCAAAUACCAAUUUUAU	19	17578
CFTR-Intron2-2479	+	AUUUCAAAUACCAAUUUUAU	20	17579
CFTR-Intron2-2480	+	AAUUUCAAAUACCAAUUUUAU	21	17580
CFTR-Intron2-2481	+	AAAUUUCAAAUACCAAUUUUAU	22	17581
CFTR-Intron2-2482	+	UAAAUUUCAAAUACCAAUUUUAU	23	17582
CFTR-Intron2-2483	+	AUAAAUUUCAAAUACCAAUUUUAU	24	17583
CFTR-Intron2-2484	+	UUGAUUGGAAAGGAAACU	18	17584
CFTR-Intron2-2485	+	UUUGAUUGGAAAGGAAACU	19	17585
CFTR-Intron2-2486	+	UUUUGAUUGGAAAGGAAACU	20	17586
CFTR-Intron2-2487	+	CUUUUGAUUGGAAAGGAAACU	21	17587
CFTR-Intron2-2488	+	CCUUUUGAUUGGAAAGGAAACU	22	17588
CFTR-Intron2-2489	+	ACCUUUUGAUUGGAAAGGAAACU	23	17589
CFTR-Intron2-2490	+	AACCUUUUGAUUGGAAAGGAAACU	24	17590
CFTR-Intron2-2491	+	GCCACUAAUCCCAACACU	18	17591
CFTR-Intron2-2492	+	CGCCACUAAUCCCAACACU	19	17592
CFTR-Intron2-2493	+	ACGCCACUAAUCCCAACACU	20	17593
CFTR-Intron2-2494	+	CACGCCACUAAUCCCAACACU	21	17594
CFTR-Intron2-2495	+	UCACGCCACUAAUCCCAACACU	22	17595
CFTR-Intron2-2496	+	CUCACGCCACUAAUCCCAACACU	23	17596
CFTR-Intron2-2497	+	GCUCACGCCACUAAUCCCAACACU	24	17597
CFTR-Intron2-2498	+	GGCCCUAUUCUAGGCACU	18	17598
CFTR-Intron2-2499	+	AGGCCCUAUUCUAGGCACU	19	17599
CFTR-Intron2-703	+	CAGGCCCUAUUCUAGGCACU	20	15803
CFTR-Intron2-2500	+	CCAGGCCCUAUUCUAGGCACU	21	17600
CFTR-Intron2-2501	+	GCCAGGCCCUAUUCUAGGCACU	22	17601
CFTR-Intron2-2502	+	UGCCAGGCCCUAUUCUAGGCACU	23	17602
CFTR-Intron2-2503	+	AUGCCAGGCCCUAUUCUAGGCACU	24	17603
CFTR-Intron2-2504	+	CCUGUAGUCCCAGCUACU	18	17604
CFTR-Intron2-2505	+	GCCUGUAGUCCCAGCUACU	19	17605
CFTR-Intron2-2506	+	UGCCUGUAGUCCCAGCUACU	20	17606
CFTR-Intron2-2507	+	AUGCCUGUAGUCCCAGCUACU	21	17607
CFTR-Intron2-2508	+	CAUGCCUGUAGUCCCAGCUACU	22	17608
CFTR-Intron2-2509	+	GCAUGCCUGUAGUCCCAGCUACU	23	17609
CFTR-Intron2-2510	+	UGCAUGCCUGUAGUCCCAGCUACU	24	17610
CFTR-Intron2-2511	+	AGAAUGGGGUAGUUACCU	18	17611
CFTR-Intron2-2512	+	UAGAAUGGGGUAGUUACCU	19	17612
CFTR-Intron2-2513	+	AUAGAAUGGGGUAGUUACCU	20	17613
CFTR-Intron2-2514	+	AAUAGAAUGGGGUAGUUACCU	21	17614
CFTR-Intron2-2515	+	AAAUAGAAUGGGGUAGUUACCU	22	17615
CFTR-Intron2-2516	+	AAAAUAGAAUGGGGUAGUUACCU	23	17616
CFTR-Intron2-2517	+	AAAAAUAGAAUGGGGUAGUUACCU	24	17617
CFTR-Intron2-2518	+	GAGCAGAGAAUGUUAGCU	18	17618
CFTR-Intron2-2519	+	AGAGCAGAGAAUGUUAGCU	19	17619
CFTR-Intron2-2520	+	GAGAGCAGAGAAUGUUAGCU	20	17620
CFTR-Intron2-2521	+	GGAGAGCAGAGAAUGUUAGCU	21	17621
CFTR-Intron2-2522	+	AGGAGAGCAGAGAAUGUUAGCU	22	17622
CFTR-Intron2-2523	+	CAGGAGAGCAGAGAAUGUUAGCU	23	17623
CFTR-Intron2-2524	+	CCAGGAGAGCAGAGAAUGUUAGCU	24	17624
CFTR-Intron2-2525	+	UUUCCACUCAGAGUGGCU	18	17625
CFTR-Intron2-2526	+	CUUUCCACUCAGAGUGGCU	19	17626
CFTR-Intron2-2527	+	GCUUUCCACUCAGAGUGGCU	20	17627
CFTR-Intron2-2528	+	UGCUUUCCACUCAGAGUGGCU	21	17628
CFTR-Intron2-2529	+	AUGCUUUCCACUCAGAGUGGCU	22	17629
CFTR-Intron2-2530	+	GAUGCUUUCCACUCAGAGUGGCU	23	17630
CFTR-Intron2-2531	+	UGAUGCUUUCCACUCAGAGUGGCU	24	17631
CFTR-Intron2-2532	+	AUAUCCUGACUACAAUCU	18	17632
CFTR-Intron2-2533	+	CAUAUCCUGACUACAAUCU	19	17633
CFTR-Intron2-395	+	UCAUAUCCUGACUACAAUCU	20	15495
CFTR-Intron2-2534	+	UUCAUAUCCUGACUACAAUCU	21	17634
CFTR-Intron2-2535	+	GUUCAUAUCCUGACUACAAUCU	22	17635
CFTR-Intron2-2536	+	AGUUCAUAUCCUGACUACAAUCU	23	17636
CFTR-Intron2-2537	+	AAGUUCAUAUCCUGACUACAAUCU	24	17637
CFTR-Intron2-2538	+	GAAGCUGGCCCUUGAUCU	18	17638
CFTR-Intron2-2539	+	AGAAGCUGGCCCUUGAUCU	19	17639
CFTR-Intron2-2540	+	UAGAAGCUGGCCCUUGAUCU	20	17640
CFTR-Intron2-2541	+	AUAGAAGCUGGCCCUUGAUCU	21	17641
CFTR-Intron2-2542	+	AAUAGAAGCUGGCCCUUGAUCU	22	17642
CFTR-Intron2-2543	+	UAAUAGAAGCUGGCCCUUGAUCU	23	17643
CFTR-Intron2-2544	+	AUAAUAGAAGCUGGCCCUUGAUCU	24	17644
CFTR-Intron2-2545	+	GCAAAGUAUAUUAUCUCU	18	17645
CFTR-Intron2-2546	+	GGCAAAGUAUAUUAUCUCU	19	17646
CFTR-Intron2-2547	+	UGGCAAAGUAUAUUAUCUCU	20	17647
CFTR-Intron2-2548	+	CUGGCAAAGUAUAUUAUCUCU	21	17648
CFTR-Intron2-2549	+	ACUGGCAAAGUAUAUUAUCUCU	22	17649
CFTR-Intron2-2550	+	AACUGGCAAAGUAUAUUAUCUCU	23	17650
CFTR-Intron2-2551	+	UAACUGGCAAAGUAUAUUAUCUCU	24	17651
CFTR-Intron2-2552	+	ACUAUGACUCAAGAGUCU	18	17652
CFTR-Intron2-2553	+	CACUAUGACUCAAGAGUCU	19	17653
CFTR-Intron2-2554	+	GCACUAUGACUCAAGAGUCU	20	17654
CFTR-Intron2-2555	+	AGCACUAUGACUCAAGAGUCU	21	17655
CFTR-Intron2-2556	+	AAGCACUAUGACUCAAGAGUCU	22	17656
CFTR-Intron2-2557	+	UAAGCACUAUGACUCAAGAGUCU	23	17657
CFTR-Intron2-2558	+	GUAAGCACUAUGACUCAAGAGUCU	24	17658
CFTR-Intron2-2559	+	AUCAUGUAUUAAAGGUCU	18	17659
CFTR-Intron2-2560	+	AAUCAUGUAUUAAAGGUCU	19	17660
CFTR-Intron2-2561	+	AAAUCAUGUAUUAAAGGUCU	20	17661
CFTR-Intron2-2562	+	AAAAUCAUGUAUUAAAGGUCU	21	17662
CFTR-Intron2-2563	+	UAAAAUCAUGUAUUAAAGGUCU	22	17663
CFTR-Intron2-2564	+	CUAAAAUCAUGUAUUAAAGGUCU	23	17664
CFTR-Intron2-2565	+	ACUAAAAUCAUGUAUUAAAGGUCU	24	17665
CFTR-Intron2-2566	+	AGAAAGCUGGUCCGGUCU	18	17666
CFTR-Intron2-2567	+	UAGAAAGCUGGUCCGGUCU	19	17667
CFTR-Intron2-2568	+	GUAGAAAGCUGGUCCGGUCU	20	17668
CFTR-Intron2-2569	+	UGUAGAAAGCUGGUCCGGUCU	21	17669
CFTR-Intron2-2570	+	AUGUAGAAAGCUGGUCCGGUCU	22	17670
CFTR-Intron2-2571	+	UAUGUAGAAAGCUGGUCCGGUCU	23	17671
CFTR-Intron2-2572	+	UUAUGUAGAAAGCUGGUCCGGUCU	24	17672
CFTR-Intron2-2573	+	UCUAAUAAGACAAAUUCU	18	17673
CFTR-Intron2-2574	+	CUCUAAUAAGACAAAUUCU	19	17674
CFTR-Intron2-2575	+	UCUCUAAUAAGACAAAUUCU	20	17675
CFTR-Intron2-2576	+	GUCUCUAAUAAGACAAAUUCU	21	17676
CFTR-Intron2-2577	+	GGUCUCUAAUAAGACAAAUUCU	22	17677
CFTR-Intron2-2578	+	UGGUCUCUAAUAAGACAAAUUCU	23	17678
CFTR-Intron2-2579	+	AUGGUCUCUAAUAAGACAAAUUCU	24	17679
CFTR-Intron2-2580	+	CAUUUGGUUACUCAGAGU	18	17680
CFTR-Intron2-2581	+	ACAUUUGGUUACUCAGAGU	19	17681
CFTR-Intron2-2582	+	AACAUUUGGUUACUCAGAGU	20	17682
CFTR-Intron2-2583	+	UAACAUUUGGUUACUCAGAGU	21	17683
CFTR-Intron2-2584	+	AUAACAUUUGGUUACUCAGAGU	22	17684
CFTR-Intron2-2585	+	CAUAACAUUUGGUUACUCAGAGU	23	17685
CFTR-Intron2-2586	+	CCAUAACAUUUGGUUACUCAGAGU	24	17686
CFTR-Intron2-2587	+	GAAUAGACAUUAAAUAGU	18	17687
CFTR-Intron2-2588	+	AGAAUAGACAUUAAAUAGU	19	17688
CFTR-Intron2-2589	+	AAGAAUAGACAUUAAAUAGU	20	17689
CFTR-Intron2-2590	+	UAAGAAUAGACAUUAAAUAGU	21	17690
CFTR-Intron2-2591	+	GUAAGAAUAGACAUUAAAUAGU	22	17691
CFTR-Intron2-2592	+	AGUAAGAAUAGACAUUAAAUAGU	23	17692
CFTR-Intron2-2593	+	UAGUAAGAAUAGACAUUAAAUAGU	24	17693
CFTR-Intron2-2594	+	CUGAGGAGAAGGCAAGGU	18	17694
CFTR-Intron2-2595	+	CCUGAGGAGAAGGCAAGGU	19	17695
CFTR-Intron2-405	+	ACCUGAGGAGAAGGCAAGGU	20	15505
CFTR-Intron2-2596	+	UACCUGAGGAGAAGGCAAGGU	21	17696
CFTR-Intron2-2597	+	UUACCUGAGGAGAAGGCAAGGU	22	17697
CFTR-Intron2-2598	+	GUUACCUGAGGAGAAGGCAAGGU	23	17698
CFTR-Intron2-2599	+	AGUUACCUGAGGAGAAGGCAAGGU	24	17699
CFTR-Intron2-2600	+	GGGCAGAUCACUUGAGGU	18	17700
CFTR-Intron2-2601	+	CGGGCAGAUCACUUGAGGU	19	17701
CFTR-Intron2-2602	+	GCGGGCAGAUCACUUGAGGU	20	17702
CFTR-Intron2-2603	+	GGCGGGCAGAUCACUUGAGGU	21	17703
CFTR-Intron2-2604	+	AGGCGGGCAGAUCACUUGAGGU	22	17704
CFTR-Intron2-2605	+	AAGGCGGGCAGAUCACUUGAGGU	23	17705
CFTR-Intron2-2606	+	CAAGGCGGGCAGAUCACUUGAGGU	24	17706
CFTR-Intron2-2607	+	UGGGCAGAUCACUUGAGGU	19	17707
CFTR-Intron2-2608	+	GUGGGCAGAUCACUUGAGGU	20	17708
CFTR-Intron2-2609	+	GGUGGGCAGAUCACUUGAGGU	21	17709
CFTR-Intron2-2610	+	AGGUGGGCAGAUCACUUGAGGU	22	17710
CFTR-Intron2-2611	+	AAGGUGGGCAGAUCACUUGAGGU	23	17711
CFTR-Intron2-2612	+	CAAGGUGGGCAGAUCACUUGAGGU	24	17712
CFTR-Intron2-2613	+	GUAGAAAGCUGGUCCGGU	18	17713
CFTR-Intron2-2614	+	UGUAGAAAGCUGGUCCGGU	19	17714
CFTR-Intron2-2615	+	AUGUAGAAAGCUGGUCCGGU	20	17715
CFTR-Intron2-2616	+	UAUGUAGAAAGCUGGUCCGGU	21	17716
CFTR-Intron2-2617	+	UUAUGUAGAAAGCUGGUCCGGU	22	17717
CFTR-Intron2-2618	+	UUUAUGUAGAAAGCUGGUCCGGU	23	17718
CFTR-Intron2-2619	+	CUUUAUGUAGAAAGCUGGUCCGGU	24	17719
CFTR-Intron2-2620	+	ACCUAUAAUCCCAGCAUU	18	17720
CFTR-Intron2-2621	+	CACCUAUAAUCCCAGCAUU	19	17721
CFTR-Intron2-2622	+	ACACCUAUAAUCCCAGCAUU	20	17722
CFTR-Intron2-2623	+	CACACCUAUAAUCCCAGCAUU	21	17723
CFTR-Intron2-2624	+	UCACACCUAUAAUCCCAGCAUU	22	17724
CFTR-Intron2-2625	+	CUCACACCUAUAAUCCCAGCAUU	23	17725
CFTR-Intron2-2626	+	GCUCACACCUAUAAUCCCAGCAUU	24	17726
CFTR-Intron2-2627	+	AAUACCCAUUAUAUUAUU	18	17727
CFTR-Intron2-2628	+	CAAUACCCAUUAUAUUAUU	19	17728
CFTR-Intron2-2629	+	UCAAUACCCAUUAUAUUAUU	20	17729
CFTR-Intron2-2630	+	UUCAAUACCCAUUAUAUUAUU	21	17730
CFTR-Intron2-2631	+	AUUCAAUACCCAUUAUAUUAUU	22	17731
CFTR-Intron2-2632	+	UAUUCAAUACCCAUUAUAUUAUU	23	17732
CFTR-Intron2-2633	+	AUAUUCAAUACCCAUUAUAUUAUU	24	17733
CFTR-Intron2-2634	+	CCACUAAUCCCAACACUU	18	17734
CFTR-Intron2-2635	+	GCCACUAAUCCCAACACUU	19	17735
CFTR-Intron2-717	+	CGCCACUAAUCCCAACACUU	20	15817
CFTR-Intron2-2636	+	ACGCCACUAAUCCCAACACUU	21	17736
CFTR-Intron2-2637	+	CACGCCACUAAUCCCAACACUU	22	17737
CFTR-Intron2-2638	+	UCACGCCACUAAUCCCAACACUU	23	17738
CFTR-Intron2-2639	+	CUCACGCCACUAAUCCCAACACUU	24	17739
CFTR-Intron2-2640	+	ACCAUCUGGCAACCACUU	18	17740
CFTR-Intron2-2641	+	AACCAUCUGGCAACCACUU	19	17741
CFTR-Intron2-2642	+	CAACCAUCUGGCAACCACUU	20	17742
CFTR-Intron2-2643	+	UCAACCAUCUGGCAACCACUU	21	17743
CFTR-Intron2-2644	+	UUCAACCAUCUGGCAACCACUU	22	17744
CFTR-Intron2-2645	+	CUUCAACCAUCUGGCAACCACUU	23	17745
CFTR-Intron2-2646	+	UCUUCAACCAUCUGGCAACCACUU	24	17746
CFTR-Intron2-2647	+	AUGGUGGAAACCAUACUU	18	17747
CFTR-Intron2-2648	+	CAUGGUGGAAACCAUACUU	19	17748
CFTR-Intron2-2649	+	ACAUGGUGGAAACCAUACUU	20	17749
CFTR-Intron2-2650	+	AACAUGGUGGAAACCAUACUU	21	17750
CFTR-Intron2-2651	+	GAACAUGGUGGAAACCAUACUU	22	17751
CFTR-Intron2-2652	+	GGAACAUGGUGGAAACCAUACUU	23	17752
CFTR-Intron2-2653	+	AGGAACAUGGUGGAAACCAUACUU	24	17753
CFTR-Intron2-2654	+	CAUGGUCACAAGGCAGUU	18	17754
CFTR-Intron2-2655	+	CCAUGGUCACAAGGCAGUU	19	17755
CFTR-Intron2-2656	+	GCCAUGGUCACAAGGCAGUU	20	17756
CFTR-Intron2-2657	+	GGCCAUGGUCACAAGGCAGUU	21	17757
CFTR-Intron2-2658	+	GGGCCAUGGUCACAAGGCAGUU	22	17758
CFTR-Intron2-2659	+	AGGGCCAUGGUCACAAGGCAGUU	23	17759
CFTR-Intron2-2660	+	GAGGGCCAUGGUCACAAGGCAGUU	24	17760
CFTR-Intron2-2661	+	UAUUCAAAUAUAAAGGUU	18	17761
CFTR-Intron2-2662	+	GUAUUCAAAUAUAAAGGUU	19	17762
CFTR-Intron2-2663	+	UGUAUUCAAAUAUAAAGGUU	20	17763
CFTR-Intron2-2664	+	UUGUAUUCAAAUAUAAAGGUU	21	17764
CFTR-Intron2-2665	+	UUUGUAUUCAAAUAUAAAGGUU	22	17765
CFTR-Intron2-2666	+	AUUUGUAUUCAAAUAUAAAGGUU	23	17766
CFTR-Intron2-2667	+	CAUUUGUAUUCAAAUAUAAAGGUU	24	17767
CFTR-Intron2-2668	+	CCUAUAAUCCCAGCAUUU	18	17768
CFTR-Intron2-2669	+	ACCUAUAAUCCCAGCAUUU	19	17769
CFTR-Intron2-720	+	CACCUAUAAUCCCAGCAUUU	20	15820
CFTR-Intron2-2670	+	ACACCUAUAAUCCCAGCAUUU	21	17770
CFTR-Intron2-2671	+	CACACCUAUAAUCCCAGCAUUU	22	17771
CFTR-Intron2-2672	+	UCACACCUAUAAUCCCAGCAUUU	23	17772
CFTR-Intron2-2673	+	CUCACACCUAUAAUCCCAGCAUUU	24	17773
CFTR-Intron2-2674	+	CACUAAUCCCAACACUUU	18	17774
CFTR-Intron2-2675	+	CCACUAAUCCCAACACUUU	19	17775
CFTR-Intron2-476	+	GCCACUAAUCCCAACACUUU	20	15576
CFTR-Intron2-2676	+	CGCCACUAAUCCCAACACUUU	21	17776
CFTR-Intron2-2677	+	ACGCCACUAAUCCCAACACUUU	22	17777
CFTR-Intron2-2678	+	CACGCCACUAAUCCCAACACUUU	23	17778
CFTR-Intron2-2679	+	UCACGCCACUAAUCCCAACACUUU	24	17779
CFTR-Intron2-2680	+	GAAACUGAGAGAUUCUUU	18	17780
CFTR-Intron2-2681	+	GGAAACUGAGAGAUUCUUU	19	17781
CFTR-Intron2-2682	+	AGGAAACUGAGAGAUUCUUU	20	17782
CFTR-Intron2-2683	+	AAGGAAACUGAGAGAUUCUUU	21	17783
CFTR-Intron2-2684	+	AAAGGAAACUGAGAGAUUCUUU	22	17784
CFTR-Intron2-2685	+	GAAAGGAAACUGAGAGAUUCUUU	23	17785
CFTR-Intron2-2686	+	GGAAAGGAAACUGAGAGAUUCUUU	24	17786
CFTR-Intron2-2687	+	CCCUGGGCAAUGUAGUUU	18	17787
CFTR-Intron2-2688	+	ACCCUGGGCAAUGUAGUUU	19	17788
CFTR-Intron2-2689	+	GACCCUGGGCAAUGUAGUUU	20	17789
CFTR-Intron2-2690	+	UGACCCUGGGCAAUGUAGUUU	21	17790
CFTR-Intron2-2691	+	GUGACCCUGGGCAAUGUAGUUU	22	17791
CFTR-Intron2-2692	+	AGUGACCCUGGGCAAUGUAGUUU	23	17792
CFTR-Intron2-2693	+	UAGUGACCCUGGGCAAUGUAGUUU	24	17793
CFTR-Intron2-2694	+	CUAUAAUCCCAGCAUUUU	18	17794
CFTR-Intron2-2695	+	CCUAUAAUCCCAGCAUUUU	19	17795
CFTR-Intron2-722	+	ACCUAUAAUCCCAGCAUUUU	20	15822
CFTR-Intron2-2696	+	CACCUAUAAUCCCAGCAUUUU	21	17796
CFTR-Intron2-2697	+	ACACCUAUAAUCCCAGCAUUUU	22	17797
CFTR-Intron2-2698	+	CACACCUAUAAUCCCAGCAUUUU	23	17798
CFTR-Intron2-2699	+	UCACACCUAUAAUCCCAGCAUUUU	24	17799
CFTR-Intron2-2700	+	CCUGGGCAAUGUAGUUUU	18	17800
CFTR-Intron2-2701	+	CCCUGGGCAAUGUAGUUUU	19	17801
CFTR-Intron2-416	+	ACCCUGGGCAAUGUAGUUUU	20	15516
CFTR-Intron2-2702	+	GACCCUGGGCAAUGUAGUUUU	21	17802
CFTR-Intron2-2703	+	UGACCCUGGGCAAUGUAGUUUU	22	17803
CFTR-Intron2-2704	+	GUGACCCUGGGCAAUGUAGUUUU	23	17804
CFTR-Intron2-2705	+	AGUGACCCUGGGCAAUGUAGUUUU	24	17805
CFTR-Intron2-2706	+	AACCAAAUGUGUAUUUUU	18	17806
CFTR-Intron2-2707	+	AAACCAAAUGUGUAUUUUU	19	17807
CFTR-Intron2-2708	+	GAAACCAAAUGUGUAUUUUU	20	17808
CFTR-Intron2-2709	+	UGAAACCAAAUGUGUAUUUUU	21	17809
CFTR-Intron2-2710	+	CUGAAACCAAAUGUGUAUUUUU	22	17810
CFTR-Intron2-2711	+	UCUGAAACCAAAUGUGUAUUUUU	23	17811
CFTR-Intron2-2712	+	CUCUGAAACCAAAUGUGUAUUUUU	24	17812
CFTR-Intron2-2713	−	AUAGUAUUUAAAAGAAAA	18	17813
CFTR-Intron2-2714	−	UAUAGUAUUUAAAAGAAAA	19	17814
CFTR-Intron2-2715	−	CUAUAGUAUUUAAAAGAAAA	20	17815
CFTR-Intron2-2716	−	CCUAUAGUAUUUAAAAGAAAA	21	17816
CFTR-Intron2-2717	−	UCCUAUAGUAUUUAAAAGAAAA	22	17817
CFTR-Intron2-2718	−	UUCCUAUAGUAUUUAAAAGAAAA	23	17818
CFTR-Intron2-2719	−	GUUCCUAUAGUAUUUAAAAGAAAA	24	17819
CFTR-Intron2-2720	−	AUUUUACAGAAAAGCAAA	18	17820
CFTR-Intron2-2721	−	UAUUUUACAGAAAAGCAAA	19	17821
CFTR-Intron2-2722	−	CUAUUUUACAGAAAAGCAAA	20	17822
CFTR-Intron2-2723	−	UCUAUUUUACAGAAAAGCAAA	21	17823
CFTR-Intron2-2724	−	CUCUAUUUUACAGAAAAGCAAA	22	17824
CFTR-Intron2-2725	−	UCUCUAUUUUACAGAAAAGCAAA	23	17825
CFTR-Intron2-2726	−	AUCUCUAUUUUACAGAAAAGCAAA	24	17826
CFTR-Intron2-2727	−	UGAUUUUAGUAGUUGAAA	18	17827
CFTR-Intron2-2728	−	AUGAUUUUAGUAGUUGAAA	19	17828
CFTR-Intron2-2729	−	CAUGAUUUUAGUAGUUGAAA	20	17829
CFTR-Intron2-2730	−	ACAUGAUUUUAGUAGUUGAAA	21	17830
CFTR-Intron2-2731	−	UACAUGAUUUUAGUAGUUGAAA	22	17831
CFTR-Intron2-2732	−	AUACAUGAUUUUAGUAGUUGAAA	23	17832
CFTR-Intron2-2733	−	AAUACAUGAUUUUAGUAGUUGAAA	24	17833
CFTR-Intron2-2734	−	CUAGCUUAAGUAAAUAAA	18	17834
CFTR-Intron2-2735	−	ACUAGCUUAAGUAAAUAAA	19	17835
CFTR-Intron2-613	−	UACUAGCUUAAGUAAAUAAA	20	15713
CFTR-Intron2-2736	−	UUACUAGCUUAAGUAAAUAAA	21	17836
CFTR-Intron2-2737	−	UUUACUAGCUUAAGUAAAUAAA	22	17837
CFTR-Intron2-2738	−	AUUUACUAGCUUAAGUAAAUAAA	23	17838
CFTR-Intron2-2739	−	AAUUUACUAGCUUAAGUAAAUAAA	24	17839
CFTR-Intron2-2740	−	CUGGCCUUAGGAACUCAA	18	17840
CFTR-Intron2-2741	−	ACUGGCCUUAGGAACUCAA	19	17841
CFTR-Intron2-241	−	AACUGGCCUUAGGAACUCAA	20	15341
CFTR-Intron2-2742	−	GAACUGGCCUUAGGAACUCAA	21	17842
CFTR-Intron2-2743	−	AGAACUGGCCUUAGGAACUCAA	22	17843
CFTR-Intron2-2744	−	GAGAACUGGCCUUAGGAACUCAA	23	17844
CFTR-Intron2-2745	−	GGAGAACUGGCCUUAGGAACUCAA	24	17845
CFTR-Intron2-2746	−	AUCCCCAAGUGCCUAGAA	18	17846
CFTR-Intron2-2747	−	UAUCCCCAAGUGCCUAGAA	19	17847
CFTR-Intron2-2748	−	GUAUCCCCAAGUGCCUAGAA	20	17848
CFTR-Intron2-2749	−	UGUAUCCCCAAGUGCCUAGAA	21	17849
CFTR-Intron2-2750	−	AUGUAUCCCCAAGUGCCUAGAA	22	17850
CFTR-Intron2-2751	−	GAUGUAUCCCCAAGUGCCUAGAA	23	17851
CFTR-Intron2-2752	−	UGAUGUAUCCCCAAGUGCCUAGAA	24	17852
CFTR-Intron2-2753	−	GAUAAAAGGGUGAGUGAA	18	17853
CFTR-Intron2-2754	−	AGAUAAAAGGGUGAGUGAA	19	17854
CFTR-Intron2-248	−	CAGAUAAAAGGGUGAGUGAA	20	15348
CFTR-Intron2-2755	−	CCAGAUAAAAGGGUGAGUGAA	21	17855
CFTR-Intron2-2756	−	GCCAGAUAAAAGGGUGAGUGAA	22	17856
CFTR-Intron2-2757	−	UGCCAGAUAAAAGGGUGAGUGAA	23	17857
CFTR-Intron2-2758	−	AUGCCAGAUAAAAGGGUGAGUGAA	24	17858
CFTR-Intron2-2759	−	AUUUUAUUCCUUUGUGAA	18	17859
CFTR-Intron2-2760	−	UAUUUUAUUCCUUUGUGAA	19	17860
CFTR-Intron2-2761	−	AUAUUUUAUUCCUUUGUGAA	20	17861
CFTR-Intron2-2762	−	GAUAUUUUAUUCCUUUGUGAA	21	17862
CFTR-Intron2-2763	−	AGAUAUUUUAUUCCUUUGUGAA	22	17863
CFTR-Intron2-2764	−	GAGAUAUUUUAUUCCUUUGUGAA	23	17864
CFTR-Intron2-2765	−	AGAGAUAUUUUAUUCCUUUGUGAA	24	17865
CFTR-Intron2-2766	−	ACUAGCUUAAGUAAAUAA	18	17866
CFTR-Intron2-2767	−	UACUAGCUUAAGUAAAUAA	19	17867
CFTR-Intron2-2768	−	UUACUAGCUUAAGUAAAUAA	20	17868
CFTR-Intron2-2769	−	UUUACUAGCUUAAGUAAAUAA	21	17869
CFTR-Intron2-2770	−	AUUUACUAGCUUAAGUAAAUAA	22	17870
CFTR-Intron2-2771	−	AAUUUACUAGCUUAAGUAAAUAA	23	17871
CFTR-Intron2-2772	−	CAAUUUACUAGCUUAAGUAAAUAA	24	17872
CFTR-Intron2-2773	−	UGUCUAUUCUUACUAUAA	18	17873
CFTR-Intron2-2774	−	AUGUCUAUUCUUACUAUAA	19	17874
CFTR-Intron2-2775	−	AAUGUCUAUUCUUACUAUAA	20	17875
CFTR-Intron2-2776	−	UAAUGUCUAUUCUUACUAUAA	21	17876
CFTR-Intron2-2777	−	UUAAUGUCUAUUCUUACUAUAA	22	17877
CFTR-Intron2-2778	−	UUUAAUGUCUAUUCUUACUAUAA	23	17878
CFTR-Intron2-2779	−	AUUUAAUGUCUAUUCUUACUAUAA	24	17879
CFTR-Intron2-2780	−	AUGGUAACUUGACAGUAA	18	17880
CFTR-Intron2-2781	−	UAUGGUAACUUGACAGUAA	19	17881
CFTR-Intron2-251	−	UUAUGGUAACUUGACAGUAA	20	15351
CFTR-Intron2-2782	−	CUUAUGGUAACUUGACAGUAA	21	17882
CFTR-Intron2-2783	−	ACUUAUGGUAACUUGACAGUAA	22	17883
CFTR-Intron2-2784	−	UACUUAUGGUAACUUGACAGUAA	23	17884
CFTR-Intron2-2785	−	UUACUUAUGGUAACUUGACAGUAA	24	17885
CFTR-Intron2-2786	−	AAAAAAGGCUUUCAUUAA	18	17886
CFTR-Intron2-2787	−	GAAAAAAGGCUUUCAUUAA	19	17887
CFTR-Intron2-2788	−	AGAAAAAAGGCUUUCAUUAA	20	17888
CFTR-Intron2-2789	−	GAGAAAAAAGGCUUUCAUUAA	21	17889
CFTR-Intron2-2790	−	AGAGAAAAAAGGCUUUCAUUAA	22	17890
CFTR-Intron2-2791	−	AAGAGAAAAAAGGCUUUCAUUAA	23	17891
CFTR-Intron2-2792	−	GAAGAGAAAAAAGGCUUUCAUUAA	24	17892
CFTR-Intron2-2793	−	AGAGUAGGGCUGGGUUAA	18	17893
CFTR-Intron2-2794	−	CAGAGUAGGGCUGGGUUAA	19	17894
CFTR-Intron2-2795	−	UCAGAGUAGGGCUGGGUUAA	20	17895
CFTR-Intron2-2796	−	AUCAGAGUAGGGCUGGGUUAA	21	17896
CFTR-Intron2-2797	−	AAUCAGAGUAGGGCUGGGUUAA	22	17897
CFTR-Intron2-2798	−	UAAUCAGAGUAGGGCUGGGUUAA	23	17898
CFTR-Intron2-2799	−	UUAAUCAGAGUAGGGCUGGGUUAA	24	17899
CFTR-Intron2-2800	−	UGUUCCUAUAGUAUUUAA	18	17900
CFTR-Intron2-2801	−	GUGUUCCUAUAGUAUUUAA	19	17901
CFTR-Intron2-2802	−	GGUGUUCCUAUAGUAUUUAA	20	17902
CFTR-Intron2-2803	−	UGGUGUUCCUAUAGUAUUUAA	21	17903
CFTR-Intron2-2804	−	CUGGUGUUCCUAUAGUAUUUAA	22	17904
CFTR-Intron2-2805	−	GCUGGUGUUCCUAUAGUAUUUAA	23	17905
CFTR-Intron2-2806	−	AGCUGGUGUUCCUAUAGUAUUUAA	24	17906
CFTR-Intron2-2807	−	GUGGACCACUUUUUCACA	18	17907
CFTR-Intron2-2808	−	UGUGGACCACUUUUUCACA	19	17908
CFTR-Intron2-2809	−	GUGUGGACCACUUUUUCACA	20	17909
CFTR-Intron2-2810	−	CGUGUGGACCACUUUUUCACA	21	17910
CFTR-Intron2-2811	−	CCGUGUGGACCACUUUUUCACA	22	17911
CFTR-Intron2-2812	−	UCCGUGUGGACCACUUUUUCACA	23	17912
CFTR-Intron2-2813	−	UUCCGUGUGGACCACUUUUUCACA	24	17913
CFTR-Intron2-2814	−	GAAAUGGCUAGCAUUACA	18	17914
CFTR-Intron2-2815	−	UGAAAUGGCUAGCAUUACA	19	17915
CFTR-Intron2-2816	−	GUGAAAUGGCUAGCAUUACA	20	17916
CFTR-Intron2-2817	−	UGUGAAAUGGCUAGCAUUACA	21	17917
CFTR-Intron2-2818	−	AUGUGAAAUGGCUAGCAUUACA	22	17918
CFTR-Intron2-2819	−	AAUGUGAAAUGGCUAGCAUUACA	23	17919
CFTR-Intron2-2820	−	GAAUGUGAAAUGGCUAGCAUUACA	24	17920
CFTR-Intron2-2821	−	ACUGGCCUUAGGAACUCA	18	17921
CFTR-Intron2-2822	−	AACUGGCCUUAGGAACUCA	19	17922
CFTR-Intron2-2823	−	GAACUGGCCUUAGGAACUCA	20	17923
CFTR-Intron2-2824	−	AGAACUGGCCUUAGGAACUCA	21	17924
CFTR-Intron2-2825	−	GAGAACUGGCCUUAGGAACUCA	22	17925
CFTR-Intron2-2826	−	GGAGAACUGGCCUUAGGAACUCA	23	17926
CFTR-Intron2-2827	−	UGGAGAACUGGCCUUAGGAACUCA	24	17927
CFTR-Intron2-2828	−	AAAGCAAACUGAGGCUCA	18	17928
CFTR-Intron2-2829	−	AAAAGCAAACUGAGGCUCA	19	17929
CFTR-Intron2-2830	−	GAAAAGCAAACUGAGGCUCA	20	17930
CFTR-Intron2-2831	−	AGAAAAGCAAACUGAGGCUCA	21	17931
CFTR-Intron2-2832	−	CAGAAAAGCAAACUGAGGCUCA	22	17932
CFTR-Intron2-2833	−	ACAGAAAAGCAAACUGAGGCUCA	23	17933
CFTR-Intron2-2834	−	UACAGAAAAGCAAACUGAGGCUCA	24	17934
CFTR-Intron2-2835	−	UUUAAGGACCACGAAAGA	18	17935
CFTR-Intron2-2836	−	CUUUAAGGACCACGAAAGA	19	17936
CFTR-Intron2-274	−	UCUUUAAGGACCACGAAAGA	20	15374
CFTR-Intron2-2837	−	AUCUUUAAGGACCACGAAAGA	21	17937
CFTR-Intron2-2838	−	UAUCUUUAAGGACCACGAAAGA	22	17938
CFTR-Intron2-2839	−	CUAUCUUUAAGGACCACGAAAGA	23	17939
CFTR-Intron2-2840	−	CCUAUCUUUAAGGACCACGAAAGA	24	17940
CFTR-Intron2-2841	−	UUUGUAUUUAUGGCCAGA	18	17941
CFTR-Intron2-2842	−	AUUUGUAUUUAUGGCCAGA	19	17942
CFTR-Intron2-2843	−	CAUUUGUAUUUAUGGCCAGA	20	17943
CFTR-Intron2-2844	−	ACAUUUGUAUUUAUGGCCAGA	21	17944
CFTR-Intron2-2845	−	UACAUUUGUAUUUAUGGCCAGA	22	17945
CFTR-Intron2-2846	−	AUACAUUUGUAUUUAUGGCCAGA	23	17946
CFTR-Intron2-2847	−	GAUACAUUUGUAUUUAUGGCCAGA	24	17947
CFTR-Intron2-2848	−	UGGUUUUAUUUUCUCAGA	18	17948
CFTR-Intron2-2849	−	CUGGUUUUAUUUUCUCAGA	19	17949
CFTR-Intron2-2850	−	GCUGGUUUUAUUUUCUCAGA	20	17950
CFTR-Intron2-2851	−	UGCUGGUUUUAUUUUCUCAGA	21	17951
CFTR-Intron2-2852	−	AUGCUGGUUUUAUUUUCUCAGA	22	17952
CFTR-Intron2-2853	−	UAUGCUGGUUUUAUUUUCUCAGA	23	17953
CFTR-Intron2-2854	−	UUAUGCUGGUUUUAUUUUCUCAGA	24	17954
CFTR-Intron2-2855	−	UGUGGGGAGGGAAAUAGA	18	17955
CFTR-Intron2-2856	−	AUGUGGGGAGGGAAAUAGA	19	17956
CFTR-Intron2-278	−	CAUGUGGGGAGGGAAAUAGA	20	15378
CFTR-Intron2-2857	−	GCAUGUGGGGAGGGAAAUAGA	21	17957
CFTR-Intron2-2858	−	AGCAUGUGGGGAGGGAAAUAGA	22	17958
CFTR-Intron2-2859	−	AAGCAUGUGGGGAGGGAAAUAGA	23	17959
CFTR-Intron2-2860	−	GAAGCAUGUGGGGAGGGAAAUAGA	24	17960
CFTR-Intron2-2861	−	GGCCACUCAUAGUCUAGA	18	17961
CFTR-Intron2-2862	−	GGGCCACUCAUAGUCUAGA	19	17962
CFTR-Intron2-2863	−	UGGGCCACUCAUAGUCUAGA	20	17963
CFTR-Intron2-2864	−	UUGGGCCACUCAUAGUCUAGA	21	17964
CFTR-Intron2-2865	−	CUUGGGCCACUCAUAGUCUAGA	22	17965
CFTR-Intron2-2866	−	CCUUGGGCCACUCAUAGUCUAGA	23	17966
CFTR-Intron2-2867	−	CCCUUGGGCCACUCAUAGUCUAGA	24	17967
CFTR-Intron2-2868	−	UAUCUUUAAGGACCACGA	18	17968
CFTR-Intron2-2869	−	CUAUCUUUAAGGACCACGA	19	17969
CFTR-Intron2-2870	−	CCUAUCUUUAAGGACCACGA	20	17970
CFTR-Intron2-2871	−	UCCUAUCUUUAAGGACCACGA	21	17971
CFTR-Intron2-2872	−	CUCCUAUCUUUAAGGACCACGA	22	17972
CFTR-Intron2-2873	−	GCUCCUAUCUUUAAGGACCACGA	23	17973
CFTR-Intron2-2874	−	UGCUCCUAUCUUUAAGGACCACGA	24	17974
CFTR-Intron2-2875	−	UGGAGAAGCAUGUGGGGA	18	17975
CFTR-Intron2-2876	−	GUGGAGAAGCAUGUGGGGA	19	17976
CFTR-Intron2-53	−	GGUGGAGAAGCAUGUGGGGA	20	15153
CFTR-Intron2-2877	−	AGGUGGAGAAGCAUGUGGGGA	21	17977
CFTR-Intron2-2878	−	AAGGUGGAGAAGCAUGUGGGGA	22	17978
CFTR-Intron2-2879	−	AAAGGUGGAGAAGCAUGUGGGGA	23	17979
CFTR-Intron2-2880	−	GAAAGGUGGAGAAGCAUGUGGGGA	24	17980
CFTR-Intron2-2881	−	GUAACCAAAUGUUAUGGA	18	17981
CFTR-Intron2-2882	−	AGUAACCAAAUGUUAUGGA	19	17982
CFTR-Intron2-54	−	GAGUAACCAAAUGUUAUGGA	20	15154
CFTR-Intron2-2883	−	UGAGUAACCAAAUGUUAUGGA	21	17983
CFTR-Intron2-2884	−	CUGAGUAACCAAAUGUUAUGGA	22	17984
CFTR-Intron2-2885	−	UCUGAGUAACCAAAUGUUAUGGA	23	17985
CFTR-Intron2-2886	−	CUCUGAGUAACCAAAUGUUAUGGA	24	17986
CFTR-Intron2-2887	−	UUGCCAGUUAAUGAAUGA	18	17987
CFTR-Intron2-2888	−	UUUGCCAGUUAAUGAAUGA	19	17988
CFTR-Intron2-281	−	CUUUGCCAGUUAAUGAAUGA	20	15381
CFTR-Intron2-2889	−	ACUUUGCCAGUUAAUGAAUGA	21	17989
CFTR-Intron2-2890	−	UACUUUGCCAGUUAAUGAAUGA	22	17990
CFTR-Intron2-2891	−	AUACUUUGCCAGUUAAUGAAUGA	23	17991
CFTR-Intron2-2892	−	UAUACUUUGCCAGUUAAUGAAUGA	24	17992
CFTR-Intron2-2893	−	UCCUCUCAGCCACUCUGA	18	17993
CFTR-Intron2-2894	−	CUCCUCUCAGCCACUCUGA	19	17994
CFTR-Intron2-2895	−	UCUCCUCUCAGCCACUCUGA	20	17995
CFTR-Intron2-2896	−	AUCUCCUCUCAGCCACUCUGA	21	17996
CFTR-Intron2-2897	−	UAUCUCCUCUCAGCCACUCUGA	22	17997
CFTR-Intron2-2898	−	AUAUCUCCUCUCAGCCACUCUGA	23	17998
CFTR-Intron2-2899	−	AAUAUCUCCUCUCAGCCACUCUGA	24	17999
CFTR-Intron2-2900	−	CCUUUUGAUUGCCAGUGA	18	18000
CFTR-Intron2-2901	−	UCCUUUUGAUUGCCAGUGA	19	18001
CFTR-Intron2-2902	−	AUCCUUUUGAUUGCCAGUGA	20	18002
CFTR-Intron2-2903	−	GAUCCUUUUGAUUGCCAGUGA	21	18003
CFTR-Intron2-2904	−	GGAUCCUUUUGAUUGCCAGUGA	22	18004
CFTR-Intron2-2905	−	AGGAUCCUUUUGAUUGCCAGUGA	23	18005
CFTR-Intron2-2906	−	UAGGAUCCUUUUGAUUGCCAGUGA	24	18006
CFTR-Intron2-2907	−	AGAUAAAAGGGUGAGUGA	18	18007
CFTR-Intron2-2908	−	CAGAUAAAAGGGUGAGUGA	19	18008
CFTR-Intron2-283	−	CCAGAUAAAAGGGUGAGUGA	20	15383
CFTR-Intron2-2909	−	GCCAGAUAAAAGGGUGAGUGA	21	18009
CFTR-Intron2-2910	−	UGCCAGAUAAAAGGGUGAGUGA	22	18010
CFTR-Intron2-2911	−	AUGCCAGAUAAAAGGGUGAGUGA	23	18011
CFTR-Intron2-2912	−	GAUGCCAGAUAAAAGGGUGAGUGA	24	18012
CFTR-Intron2-2913	−	UGCCAGAUAAAAGGGUGA	18	18013
CFTR-Intron2-2914	−	AUGCCAGAUAAAAGGGUGA	19	18014
CFTR-Intron2-2915	−	GAUGCCAGAUAAAAGGGUGA	20	18015
CFTR-Intron2-2916	−	UGAUGCCAGAUAAAAGGGUGA	21	18016
CFTR-Intron2-2917	−	CUGAUGCCAGAUAAAAGGGUGA	22	18017
CFTR-Intron2-2918	−	CCUGAUGCCAGAUAAAAGGGUGA	23	18018
CFTR-Intron2-2919	−	GCCUGAUGCCAGAUAAAAGGGUGA	24	18019
CFTR-Intron2-2920	−	GGUUAGCUCUGUGUGUGA	18	18020
CFTR-Intron2-2921	−	AGGUUAGCUCUGUGUGUGA	19	18021
CFTR-Intron2-2922	−	GAGGUUAGCUCUGUGUGUGA	20	18022
CFTR-Intron2-2923	−	GGAGGUUAGCUCUGUGUGUGA	21	18023
CFTR-Intron2-2924	−	GGGAGGUUAGCUCUGUGUGUGA	22	18024
CFTR-Intron2-2925	−	UGGGAGGUUAGCUCUGUGUGUGA	23	18025
CFTR-Intron2-2926	−	AUGGGAGGUUAGCUCUGUGUGUGA	24	18026
CFTR-Intron2-2927	−	GAUCCAUUUCUCCUUUGA	18	18027
CFTR-Intron2-2928	−	UGAUCCAUUUCUCCUUUGA	19	18028
CFTR-Intron2-285	−	CUGAUCCAUUUCUCCUUUGA	20	15385
CFTR-Intron2-2929	−	UCUGAUCCAUUUCUCCUUUGA	21	18029
CFTR-Intron2-2930	−	AUCUGAUCCAUUUCUCCUUUGA	22	18030
CFTR-Intron2-2931	−	CAUCUGAUCCAUUUCUCCUUUGA	23	18031
CFTR-Intron2-2932	−	CCAUCUGAUCCAUUUCUCCUUUGA	24	18032
CFTR-Intron2-2933	−	UGUAUUUAUGGCCAGAUA	18	18033
CFTR-Intron2-2934	−	UUGUAUUUAUGGCCAGAUA	19	18034
CFTR-Intron2-2935	−	UUUGUAUUUAUGGCCAGAUA	20	18035
CFTR-Intron2-2936	−	AUUUGUAUUUAUGGCCAGAUA	21	18036
CFTR-Intron2-2937	−	CAUUUGUAUUUAUGGCCAGAUA	22	18037
CFTR-Intron2-2938	−	ACAUUUGUAUUUAUGGCCAGAUA	23	18038
CFTR-Intron2-2939	−	UACAUUUGUAUUUAUGGCCAGAUA	24	18039
CFTR-Intron2-2940	−	AUUCAAAGAAUUAAGCUA	18	18040
CFTR-Intron2-2941	−	UAUUCAAAGAAUUAAGCUA	19	18041
CFTR-Intron2-2942	−	UUAUUCAAAGAAUUAAGCUA	20	18042
CFTR-Intron2-2943	−	UUUAUUCAAAGAAUUAAGCUA	21	18043
CFTR-Intron2-2944	−	UUUUAUUCAAAGAAUUAAGCUA	22	18044
CFTR-Intron2-2945	−	AUUUUAUUCAAAGAAUUAAGCUA	23	18045
CFTR-Intron2-2946	−	GAUUUUAUUCAAAGAAUUAAGCUA	24	18046
CFTR-Intron2-2947	−	UAUGGUAACUUGACAGUA	18	18047
CFTR-Intron2-2948	−	UUAUGGUAACUUGACAGUA	19	18048
CFTR-Intron2-2949	−	CUUAUGGUAACUUGACAGUA	20	18049
CFTR-Intron2-2950	−	ACUUAUGGUAACUUGACAGUA	21	18050
CFTR-Intron2-2951	−	UACUUAUGGUAACUUGACAGUA	22	18051
CFTR-Intron2-2952	−	UUACUUAUGGUAACUUGACAGUA	23	18052
CFTR-Intron2-2953	−	UUUACUUAUGGUAACUUGACAGUA	24	18053
CFTR-Intron2-2954	−	UUCAAGUUUCACCCAUUA	18	18054
CFTR-Intron2-2955	−	GUUCAAGUUUCACCCAUUA	19	18055
CFTR-Intron2-2956	−	UGUUCAAGUUUCACCCAUUA	20	18056
CFTR-Intron2-2957	−	UUGUUCAAGUUUCACCCAUUA	21	18057
CFTR-Intron2-2958	−	GUUGUUCAAGUUUCACCCAUUA	22	18058
CFTR-Intron2-2959	−	AGUUGUUCAAGUUUCACCCAUUA	23	18059
CFTR-Intron2-2960	−	AAGUUGUUCAAGUUUCACCCAUUA	24	18060
CFTR-Intron2-2961	−	AAGGGCCAGCUUCUAUUA	18	18061
CFTR-Intron2-2962	−	CAAGGGCCAGCUUCUAUUA	19	18062
CFTR-Intron2-2963	−	UCAAGGGCCAGCUUCUAUUA	20	18063
CFTR-Intron2-2964	−	AUCAAGGGCCAGCUUCUAUUA	21	18064
CFTR-Intron2-2965	−	GAUCAAGGGCCAGCUUCUAUUA	22	18065
CFTR-Intron2-2966	−	AGAUCAAGGGCCAGCUUCUAUUA	23	18066
CFTR-Intron2-2967	−	AAGAUCAAGGGCCAGCUUCUAUUA	24	18067
CFTR-Intron2-2968	−	AUUGGUAUUUGAAAUUUA	18	18068
CFTR-Intron2-2969	−	AAUUGGUAUUUGAAAUUUA	19	18069
CFTR-Intron2-2970	−	AAAUUGGUAUUUGAAAUUUA	20	18070
CFTR-Intron2-2971	−	AAAAUUGGUAUUUGAAAUUUA	21	18071
CFTR-Intron2-2972	−	UAAAAUUGGUAUUUGAAAUUUA	22	18072
CFTR-Intron2-2973	−	AUAAAAUUGGUAUUUGAAAUUUA	23	18073
CFTR-Intron2-2974	−	UAUAAAAUUGGUAUUUGAAAUUUA	24	18074
CFTR-Intron2-2975	−	AAAGGUAAUUAGGCUUUA	18	18075
CFTR-Intron2-2976	−	AAAAGGUAAUUAGGCUUUA	19	18076
CFTR-Intron2-2977	−	GAAAAGGUAAUUAGGCUUUA	20	18077
CFTR-Intron2-2978	−	GGAAAAGGUAAUUAGGCUUUA	21	18078
CFTR-Intron2-2979	−	GGGAAAAGGUAAUUAGGCUUUA	22	18079
CFTR-Intron2-2980	−	UGGGAAAAGGUAAUUAGGCUUUA	23	18080
CFTR-Intron2-2981	−	AUGGGAAAAGGUAAUUAGGCUUUA	24	18081
CFTR-Intron2-2982	−	AUCAUUAUCUCUAUUUUA	18	18082
CFTR-Intron2-2983	−	CAUCAUUAUCUCUAUUUUA	19	18083
CFTR-Intron2-2984	−	GCAUCAUUAUCUCUAUUUUA	20	18084
CFTR-Intron2-2985	−	AGCAUCAUUAUCUCUAUUUUA	21	18085
CFTR-Intron2-2986	−	AAGCAUCAUUAUCUCUAUUUUA	22	18086
CFTR-Intron2-2987	−	AAAGCAUCAUUAUCUCUAUUUUA	23	18087
CFTR-Intron2-2988	−	GAAAGCAUCAUUAUCUCUAUUUUA	24	18088
CFTR-Intron2-2989	−	UACAUUGCCCAGGGUCAC	18	18089
CFTR-Intron2-2990	−	CUACAUUGCCCAGGGUCAC	19	18090
CFTR-Intron2-2991	−	ACUACAUUGCCCAGGGUCAC	20	18091
CFTR-Intron2-2992	−	AACUACAUUGCCCAGGGUCAC	21	18092
CFTR-Intron2-2993	−	AAACUACAUUGCCCAGGGUCAC	22	18093
CFTR-Intron2-2994	−	AAAACUACAUUGCCCAGGGUCAC	23	18094
CFTR-Intron2-2995	−	UAAAACUACAUUGCCCAGGGUCAC	24	18095
CFTR-Intron2-2996	−	CCUGGUAUGUGGUCCUAC	18	18096
CFTR-Intron2-2997	−	GCCUGGUAUGUGGUCCUAC	19	18097
CFTR-Intron2-2998	−	GGCCUGGUAUGUGGUCCUAC	20	18098
CFTR-Intron2-2999	−	GGGCCUGGUAUGUGGUCCUAC	21	18099
CFTR-Intron2-3000	−	UGGGCCUGGUAUGUGGUCCUAC	22	18100
CFTR-Intron2-3001	−	CUGGGCCUGGUAUGUGGUCCUAC	23	18101
CFTR-Intron2-3002	−	UCUGGGCCUGGUAUGUGGUCCUAC	24	18102
CFTR-Intron2-3003	−	UUUGUCUUAUUAGAGACC	18	18103
CFTR-Intron2-3004	−	AUUUGUCUUAUUAGAGACC	19	18104
CFTR-Intron2-3005	−	AAUUUGUCUUAUUAGAGACC	20	18105
CFTR-Intron2-3006	−	GAAUUUGUCUUAUUAGAGACC	21	18106
CFTR-Intron2-3007	−	AGAAUUUGUCUUAUUAGAGACC	22	18107
CFTR-Intron2-3008	−	GAGAAUUUGUCUUAUUAGAGACC	23	18108
CFTR-Intron2-3009	−	AGAGAAUUUGUCUUAUUAGAGACC	24	18109
CFTR-Intron2-3010	−	CUCCUAUCUUUAAGGACC	18	18110
CFTR-Intron2-3011	−	GCUCCUAUCUUUAAGGACC	19	18111
CFTR-Intron2-3012	−	UGCUCCUAUCUUUAAGGACC	20	18112
CFTR-Intron2-3013	−	UUGCUCCUAUCUUUAAGGACC	21	18113
CFTR-Intron2-3014	−	UUUGCUCCUAUCUUUAAGGACC	22	18114
CFTR-Intron2-3015	−	CUUUGCUCCUAUCUUUAAGGACC	23	18115
CFTR-Intron2-3016	−	UCUUUGCUCCUAUCUUUAAGGACC	24	18116
CFTR-Intron2-3017	−	UAGGAACUCAAUGGGACC	18	18117
CFTR-Intron2-3018	−	UUAGGAACUCAAUGGGACC	19	18118
CFTR-Intron2-3019	−	CUUAGGAACUCAAUGGGACC	20	18119
CFTR-Intron2-3020	−	CCUUAGGAACUCAAUGGGACC	21	18120
CFTR-Intron2-3021	−	GCCUUAGGAACUCAAUGGGACC	22	18121
CFTR-Intron2-3022	−	GGCCUUAGGAACUCAAUGGGACC	23	18122
CFTR-Intron2-3023	−	UGGCCUUAGGAACUCAAUGGGACC	24	18123
CFTR-Intron2-3024	−	CUUUGUACCUCUGCACCC	18	18124
CFTR-Intron2-3025	−	ACUUUGUACCUCUGCACCC	19	18125
CFTR-Intron2-3026	−	UACUUUGUACCUCUGCACCC	20	18126
CFTR-Intron2-3027	−	GUACUUUGUACCUCUGCACCC	21	18127
CFTR-Intron2-3028	−	GGUACUUUGUACCUCUGCACCC	22	18128
CFTR-Intron2-3029	−	UGGUACUUUGUACCUCUGCACCC	23	18129
CFTR-Intron2-3030	−	UUGGUACUUUGUACCUCUGCACCC	24	18130
CFTR-Intron2-3031	−	AGUCAUAGUGCUUACCCC	18	18131
CFTR-Intron2-3032	−	GAGUCAUAGUGCUUACCCC	19	18132
CFTR-Intron2-3033	−	UGAGUCAUAGUGCUUACCCC	20	18133
CFTR-Intron2-3034	−	UUGAGUCAUAGUGCUUACCCC	21	18134
CFTR-Intron2-3035	−	CUUGAGUCAUAGUGCUUACCCC	22	18135
CFTR-Intron2-3036	−	UCUUGAGUCAUAGUGCUUACCCC	23	18136
CFTR-Intron2-3037	−	CUCUUGAGUCAUAGUGCUUACCCC	24	18137
CFTR-Intron2-3038	−	GAAUACAAAUGUACUCCC	18	18138
CFTR-Intron2-3039	−	UGAAUACAAAUGUACUCCC	19	18139
CFTR-Intron2-312	−	UUGAAUACAAAUGUACUCCC	20	15412
CFTR-Intron2-3040	−	UUUGAAUACAAAUGUACUCCC	21	18140
CFTR-Intron2-3041	−	AUUUGAAUACAAAUGUACUCCC	22	18141
CFTR-Intron2-3042	−	UAUUUGAAUACAAAUGUACUCCC	23	18142
CFTR-Intron2-3043	−	AUAUUUGAAUACAAAUGUACUCCC	24	18143
CFTR-Intron2-3044	−	UUGGUGUGUGCAAAUGCC	18	18144
CFTR-Intron2-3045	−	CUUGGUGUGUGCAAAUGCC	19	18145
CFTR-Intron2-3046	−	ACUUGGUGUGUGCAAAUGCC	20	18146
CFTR-Intron2-3047	−	CACUUGGUGUGUGCAAAUGCC	21	18147
CFTR-Intron2-3048	−	ACACUUGGUGUGUGCAAAUGCC	22	18148
CFTR-Intron2-3049	−	AACACUUGGUGUGUGCAAAUGCC	23	18149
CFTR-Intron2-3050	−	GAACACUUGGUGUGUGCAAAUGCC	24	18150
CFTR-Intron2-3051	−	GCUAAAUGUGAAAAAUCC	18	18151
CFTR-Intron2-3052	−	GGCUAAAUGUGAAAAAUCC	19	18152
CFTR-Intron2-3053	−	UGGCUAAAUGUGAAAAAUCC	20	18153
CFTR-Intron2-3054	−	UUGGCUAAAUGUGAAAAAUCC	21	18154
CFTR-Intron2-3055	−	CUUGGCUAAAUGUGAAAAAUCC	22	18155
CFTR-Intron2-3056	−	CCUUGGCUAAAUGUGAAAAAUCC	23	18156
CFTR-Intron2-3057	−	UCCUUGGCUAAAUGUGAAAAAUCC	24	18157
CFTR-Intron2-3058	−	UGAAUACAAAUGUACUCC	18	18158
CFTR-Intron2-3059	−	UUGAAUACAAAUGUACUCC	19	18159
CFTR-Intron2-3060	−	UUUGAAUACAAAUGUACUCC	20	18160
CFTR-Intron2-3061	−	AUUUGAAUACAAAUGUACUCC	21	18161
CFTR-Intron2-3062	−	UAUUUGAAUACAAAUGUACUCC	22	18162
CFTR-Intron2-3063	−	AUAUUUGAAUACAAAUGUACUCC	23	18163
CFTR-Intron2-3064	−	UAUAUUUGAAUACAAAUGUACUCC	24	18164
CFTR-Intron2-3065	−	UUUAUUGGCUCAUGAAGC	18	18165
CFTR-Intron2-3066	−	AUUUAUUGGCUCAUGAAGC	19	18166
CFTR-Intron2-3067	−	AAUUUAUUGGCUCAUGAAGC	20	18167
CFTR-Intron2-3068	−	GAAUUUAUUGGCUCAUGAAGC	21	18168
CFTR-Intron2-3069	−	CGAAUUUAUUGGCUCAUGAAGC	22	18169
CFTR-Intron2-3070	−	ACGAAUUUAUUGGCUCAUGAAGC	23	18170
CFTR-Intron2-3071	−	AACGAAUUUAUUGGCUCAUGAAGC	24	18171
CFTR-Intron2-3072	−	CUCAGUCUCCUGAGUAGC	18	18172
CFTR-Intron2-3073	−	UCUCAGUCUCCUGAGUAGC	19	18173
CFTR-Intron2-656	−	AUCUCAGUCUCCUGAGUAGC	20	15756
CFTR-Intron2-3074	−	AAUCUCAGUCUCCUGAGUAGC	21	18174
CFTR-Intron2-3075	−	GAAUCUCAGUCUCCUGAGUAGC	22	18175
CFTR-Intron2-3076	−	CGAAUCUCAGUCUCCUGAGUAGC	23	18176
CFTR-Intron2-3077	−	GCGAAUCUCAGUCUCCUGAGUAGC	24	18177
CFTR-Intron2-3078	−	AGUGUUGGGAUUAGUGGC	18	18178
CFTR-Intron2-3079	−	AAGUGUUGGGAUUAGUGGC	19	18179
CFTR-Intron2-3080	−	AAAGUGUUGGGAUUAGUGGC	20	18180
CFTR-Intron2-3081	−	CAAAGUGUUGGGAUUAGUGGC	21	18181
CFTR-Intron2-3082	−	CCAAAGUGUUGGGAUUAGUGGC	22	18182
CFTR-Intron2-3083	−	CCCAAAGUGUUGGGAUUAGUGGC	23	18183
CFTR-Intron2-3084	−	UCCCAAAGUGUUGGGAUUAGUGGC	24	18184
CFTR-Intron2-3085	−	AGAAACCUGUAGCAUUGC	18	18185
CFTR-Intron2-3086	−	UAGAAACCUGUAGCAUUGC	19	18186
CFTR-Intron2-325	−	AUAGAAACCUGUAGCAUUGC	20	15425
CFTR-Intron2-3087	−	CAUAGAAACCUGUAGCAUUGC	21	18187
CFTR-Intron2-3088	−	ACAUAGAAACCUGUAGCAUUGC	22	18188
CFTR-Intron2-3089	−	UACAUAGAAACCUGUAGCAUUGC	23	18189
CFTR-Intron2-3090	−	UUACAUAGAAACCUGUAGCAUUGC	24	18190
CFTR-Intron2-3091	−	AUUCACACUUCUAAGAUC	18	18191
CFTR-Intron2-3092	−	GAUUCACACUUCUAAGAUC	19	18192
CFTR-Intron2-3093	−	AGAUUCACACUUCUAAGAUC	20	18193
CFTR-Intron2-3094	−	CAGAUUCACACUUCUAAGAUC	21	18194
CFTR-Intron2-3095	−	GCAGAUUCACACUUCUAAGAUC	22	18195
CFTR-Intron2-3096	−	AGCAGAUUCACACUUCUAAGAUC	23	18196
CFTR-Intron2-3097	−	UAGCAGAUUCACACUUCUAAGAUC	24	18197
CFTR-Intron2-3098	−	UCAUUUACAUCUCAGCUC	18	18198
CFTR-Intron2-3099	−	UUCAUUUACAUCUCAGCUC	19	18199
CFTR-Intron2-3100	−	UUUCAUUUACAUCUCAGCUC	20	18200
CFTR-Intron2-3101	−	CUUUCAUUUACAUCUCAGCUC	21	18201
CFTR-Intron2-3102	−	ACUUUCAUUUACAUCUCAGCUC	22	18202
CFTR-Intron2-3103	−	CACUUUCAUUUACAUCUCAGCUC	23	18203
CFTR-Intron2-3104	−	UCACUUUCAUUUACAUCUCAGCUC	24	18204
CFTR-Intron2-3105	−	GAACGAAUUUAUUGGCUC	18	18205
CFTR-Intron2-3106	−	GGAACGAAUUUAUUGGCUC	19	18206
CFTR-Intron2-3107	−	AGGAACGAAUUUAUUGGCUC	20	18207
CFTR-Intron2-3108	−	AAGGAACGAAUUUAUUGGCUC	21	18208
CFTR-Intron2-3109	−	AAAGGAACGAAUUUAUUGGCUC	22	18209
CFTR-Intron2-3110	−	AAAAGGAACGAAUUUAUUGGCUC	23	18210
CFTR-Intron2-3111	−	UAAAAGGAACGAAUUUAUUGGCUC	24	18211
CFTR-Intron2-3112	−	CUGUAUUGCCUUGCUCUC	18	18212
CFTR-Intron2-3113	−	UCUGUAUUGCCUUGCUCUC	19	18213
CFTR-Intron2-3114	−	GUCUGUAUUGCCUUGCUCUC	20	18214
CFTR-Intron2-3115	−	GGUCUGUAUUGCCUUGCUCUC	21	18215
CFTR-Intron2-3116	−	AGGUCUGUAUUGCCUUGCUCUC	22	18216
CFTR-Intron2-3117	−	GAGGUCUGUAUUGCCUUGCUCUC	23	18217
CFTR-Intron2-3118	−	UGAGGUCUGUAUUGCCUUGCUCUC	24	18218
CFTR-Intron2-3119	−	AUGCUGGCCAGGCUGGUC	18	18219
CFTR-Intron2-3120	−	UAUGCUGGCCAGGCUGGUC	19	18220
CFTR-Intron2-3121	−	CUAUGCUGGCCAGGCUGGUC	20	18221
CFTR-Intron2-3122	−	GCUAUGCUGGCCAGGCUGGUC	21	18222
CFTR-Intron2-3123	−	UGCUAUGCUGGCCAGGCUGGUC	22	18223
CFTR-Intron2-3124	−	UUGCUAUGCUGGCCAGGCUGGUC	23	18224
CFTR-Intron2-3125	−	UUUGCUAUGCUGGCCAGGCUGGUC	24	18225
CFTR-Intron2-3126	−	AUGUUGGCCAGGCUGGUC	18	18226
CFTR-Intron2-3127	−	CAUGUUGGCCAGGCUGGUC	19	18227
CFTR-Intron2-3128	−	CCAUGUUGGCCAGGCUGGUC	20	18228
CFTR-Intron2-3129	−	GCCAUGUUGGCCAGGCUGGUC	21	18229
CFTR-Intron2-3130	−	CGCCAUGUUGGCCAGGCUGGUC	22	18230
CFTR-Intron2-3131	−	UCGCCAUGUUGGCCAGGCUGGUC	23	18231
CFTR-Intron2-3132	−	UUCGCCAUGUUGGCCAGGCUGGUC	24	18232
CFTR-Intron2-3133	−	CUCUCAUUAGCAAGCUUC	18	18233
CFTR-Intron2-3134	−	GCUCUCAUUAGCAAGCUUC	19	18234
CFTR-Intron2-3135	−	GGCUCUCAUUAGCAAGCUUC	20	18235
CFTR-Intron2-3136	−	GGGCUCUCAUUAGCAAGCUUC	21	18236
CFTR-Intron2-3137	−	AGGGCUCUCAUUAGCAAGCUUC	22	18237
CFTR-Intron2-3138	−	AAGGGCUCUCAUUAGCAAGCUUC	23	18238
CFTR-Intron2-3139	−	GAAGGGCUCUCAUUAGCAAGCUUC	24	18239
CFTR-Intron2-3140	−	AGUUCUUCCUUGUGGUUC	18	18240
CFTR-Intron2-3141	−	UAGUUCUUCCUUGUGGUUC	19	18241
CFTR-Intron2-3142	−	CUAGUUCUUCCUUGUGGUUC	20	18242
CFTR-Intron2-3143	−	CCUAGUUCUUCCUUGUGGUUC	21	18243
CFTR-Intron2-3144	−	ACCUAGUUCUUCCUUGUGGUUC	22	18244
CFTR-Intron2-3145	−	UACCUAGUUCUUCCUUGUGGUUC	23	18245
CFTR-Intron2-3146	−	UUACCUAGUUCUUCCUUGUGGUUC	24	18246
CFTR-Intron2-3147	−	UCUGUGUGUGAGAGAAAG	18	18247
CFTR-Intron2-3148	−	CUCUGUGUGUGAGAGAAAG	19	18248
CFTR-Intron2-3149	−	GCUCUGUGUGUGAGAGAAAG	20	18249
CFTR-Intron2-3150	−	AGCUCUGUGUGUGAGAGAAAG	21	18250
CFTR-Intron2-3151	−	UAGCUCUGUGUGUGAGAGAAAG	22	18251
CFTR-Intron2-3152	−	UUAGCUCUGUGUGUGAGAGAAAG	23	18252
CFTR-Intron2-3153	−	GUUAGCUCUGUGUGUGAGAGAAAG	24	18253
CFTR-Intron2-3154	−	CUUUAAGGACCACGAAAG	18	18254
CFTR-Intron2-3155	−	UCUUUAAGGACCACGAAAG	19	18255
CFTR-Intron2-3156	−	AUCUUUAAGGACCACGAAAG	20	18256
CFTR-Intron2-3157	−	UAUCUUUAAGGACCACGAAAG	21	18257
CFTR-Intron2-3158	−	CUAUCUUUAAGGACCACGAAAG	22	18258
CFTR-Intron2-3159	−	CCUAUCUUUAAGGACCACGAAAG	23	18259
CFTR-Intron2-3160	−	UCCUAUCUUUAAGGACCACGAAAG	24	18260
CFTR-Intron2-3161	−	AUGGAGCCAUGAUUCCAG	18	18261
CFTR-Intron2-3162	−	GAUGGAGCCAUGAUUCCAG	19	18262
CFTR-Intron2-3163	−	UGAUGGAGCCAUGAUUCCAG	20	18263
CFTR-Intron2-3164	−	AUGAUGGAGCCAUGAUUCCAG	21	18264
CFTR-Intron2-3165	−	AAUGAUGGAGCCAUGAUUCCAG	22	18265
CFTR-Intron2-3166	−	GAAUGAUGGAGCCAUGAUUCCAG	23	18266
CFTR-Intron2-3167	−	UGAAUGAUGGAGCCAUGAUUCCAG	24	18267
CFTR-Intron2-3168	−	GGGAAUGAUUAAUCAGAG	18	18268
CFTR-Intron2-3169	−	AGGGAAUGAUUAAUCAGAG	19	18269
CFTR-Intron2-3170	−	GAGGGAAUGAUUAAUCAGAG	20	18270
CFTR-Intron2-3171	−	UGAGGGAAUGAUUAAUCAGAG	21	18271
CFTR-Intron2-3172	−	CUGAGGGAAUGAUUAAUCAGAG	22	18272
CFTR-Intron2-3173	−	GCUGAGGGAAUGAUUAAUCAGAG	23	18273
CFTR-Intron2-3174	−	UGCUGAGGGAAUGAUUAAUCAGAG	24	18274
CFTR-Intron2-3175	−	UGGCUAAUUUUUGUAGAG	18	18275
CFTR-Intron2-3176	−	CUGGCUAAUUUUUGUAGAG	19	18276
CFTR-Intron2-3177	−	CCUGGCUAAUUUUUGUAGAG	20	18277
CFTR-Intron2-3178	−	GCCUGGCUAAUUUUUGUAGAG	21	18278
CFTR-Intron2-3179	−	GGCCUGGCUAAUUUUUGUAGAG	22	18279
CFTR-Intron2-3180	−	AGGCCUGGCUAAUUUUUGUAGAG	23	18280
CFTR-Intron2-3181	−	CAGGCCUGGCUAAUUUUUGUAGAG	24	18281
CFTR-Intron2-3182	−	CCUCUCAGCCACUCUGAG	18	18282
CFTR-Intron2-3183	−	UCCUCUCAGCCACUCUGAG	19	18283
CFTR-Intron2-344	−	CUCCUCUCAGCCACUCUGAG	20	15444
CFTR-Intron2-3184	−	UCUCCUCUCAGCCACUCUGAG	21	18284
CFTR-Intron2-3185	−	AUCUCCUCUCAGCCACUCUGAG	22	18285
CFTR-Intron2-3186	−	UAUCUCCUCUCAGCCACUCUGAG	23	18286
CFTR-Intron2-3187	−	AUAUCUCCUCUCAGCCACUCUGAG	24	18287
CFTR-Intron2-3188	−	AUGUGGGGAGGGAAAUAG	18	18288
CFTR-Intron2-3189	−	CAUGUGGGGAGGGAAAUAG	19	18289
CFTR-Intron2-3190	−	GCAUGUGGGGAGGGAAAUAG	20	18290
CFTR-Intron2-3191	−	AGCAUGUGGGGAGGGAAAUAG	21	18291
CFTR-Intron2-3192	−	AAGCAUGUGGGGAGGGAAAUAG	22	18292
CFTR-Intron2-3193	−	GAAGCAUGUGGGGAGGGAAAUAG	23	18293
CFTR-Intron2-3194	−	AGAAGCAUGUGGGGAGGGAAAUAG	24	18294
CFTR-Intron2-3195	−	GGUAAUUAGGCUUUAUAG	18	18295
CFTR-Intron2-3196	−	AGGUAAUUAGGCUUUAUAG	19	18296
CFTR-Intron2-3197	−	AAGGUAAUUAGGCUUUAUAG	20	18297
CFTR-Intron2-3198	−	AAAGGUAAUUAGGCUUUAUAG	21	18298
CFTR-Intron2-3199	−	AAAAGGUAAUUAGGCUUUAUAG	22	18299
CFTR-Intron2-3200	−	GAAAAGGUAAUUAGGCUUUAUAG	23	18300
CFTR-Intron2-3201	−	GGAAAAGGUAAUUAGGCUUUAUAG	24	18301
CFTR-Intron2-3202	−	AACUAUGUGAAGACCUAG	18	18302
CFTR-Intron2-3203	−	GAACUAUGUGAAGACCUAG	19	18303
CFTR-Intron2-3204	−	UGAACUAUGUGAAGACCUAG	20	18304
CFTR-Intron2-3205	−	CUGAACUAUGUGAAGACCUAG	21	18305
CFTR-Intron2-3206	−	CCUGAACUAUGUGAAGACCUAG	22	18306
CFTR-Intron2-3207	−	GCCUGAACUAUGUGAAGACCUAG	23	18307
CFTR-Intron2-3208	−	AGCCUGAACUAUGUGAAGACCUAG	24	18308
CFTR-Intron2-3209	−	UUCAAAGAAUUAAGCUAG	18	18309
CFTR-Intron2-3210	−	AUUCAAAGAAUUAAGCUAG	19	18310
CFTR-Intron2-345	−	UAUUCAAAGAAUUAAGCUAG	20	15445
CFTR-Intron2-3211	−	UUAUUCAAAGAAUUAAGCUAG	21	18311
CFTR-Intron2-3212	−	UUUAUUCAAAGAAUUAAGCUAG	22	18312
CFTR-Intron2-3213	−	UUUUAUUCAAAGAAUUAAGCUAG	23	18313
CFTR-Intron2-3214	−	AUUUUAUUCAAAGAAUUAAGCUAG	24	18314
CFTR-Intron2-3215	−	UCUCAGUCUCCUGAGUAG	18	18315
CFTR-Intron2-3216	−	AUCUCAGUCUCCUGAGUAG	19	18316
CFTR-Intron2-3217	−	AAUCUCAGUCUCCUGAGUAG	20	18317
CFTR-Intron2-3218	−	GAAUCUCAGUCUCCUGAGUAG	21	18318
CFTR-Intron2-3219	−	CGAAUCUCAGUCUCCUGAGUAG	22	18319
CFTR-Intron2-3220	−	GCGAAUCUCAGUCUCCUGAGUAG	23	18320
CFTR-Intron2-3221	−	AGCGAAUCUCAGUCUCCUGAGUAG	24	18321
CFTR-Intron2-3222	−	AAUACAUGAUUUUAGUAG	18	18322
CFTR-Intron2-3223	−	UAAUACAUGAUUUUAGUAG	19	18323
CFTR-Intron2-3224	−	UUAAUACAUGAUUUUAGUAG	20	18324
CFTR-Intron2-3225	−	UUUAAUACAUGAUUUUAGUAG	21	18325
CFTR-Intron2-3226	−	CUUUAAUACAUGAUUUUAGUAG	22	18326
CFTR-Intron2-3227	−	CCUUUAAUACAUGAUUUUAGUAG	23	18327
CFTR-Intron2-3228	−	ACCUUUAAUACAUGAUUUUAGUAG	24	18328
CFTR-Intron2-3229	−	CUGUGUGUGAGAGAAAGG	18	18329
CFTR-Intron2-3230	−	UCUGUGUGUGAGAGAAAGG	19	18330
CFTR-Intron2-678	−	CUCUGUGUGUGAGAGAAAGG	20	15778
CFTR-Intron2-3231	−	GCUCUGUGUGUGAGAGAAAGG	21	18331
CFTR-Intron2-3232	−	AGCUCUGUGUGUGAGAGAAAGG	22	18332
CFTR-Intron2-3233	−	UAGCUCUGUGUGUGAGAGAAAGG	23	18333
CFTR-Intron2-3234	−	UUAGCUCUGUGUGUGAGAGAAAGG	24	18334
CFTR-Intron2-3235	−	CUCGCUGUGUCACCCAGG	18	18335
CFTR-Intron2-3236	−	UCUCGCUGUGUCACCCAGG	19	18336
CFTR-Intron2-3237	−	GUCUCGCUGUGUCACCCAGG	20	18337
CFTR-Intron2-3238	−	AGUCUCGCUGUGUCACCCAGG	21	18338
CFTR-Intron2-3239	−	GAGUCUCGCUGUGUCACCCAGG	22	18339
CFTR-Intron2-3240	−	AGAGUCUCGCUGUGUCACCCAGG	23	18340
CFTR-Intron2-3241	−	CAGAGUCUCGCUGUGUCACCCAGG	24	18341
CFTR-Intron2-3242	−	CUUGCUCUGUUGCCCAGG	18	18342
CFTR-Intron2-3243	−	UCUUGCUCUGUUGCCCAGG	19	18343
CFTR-Intron2-3244	−	GUCUUGCUCUGUUGCCCAGG	20	18344
CFTR-Intron2-3245	−	AGUCUUGCUCUGUUGCCCAGG	21	18345
CFTR-Intron2-3246	−	GAGUCUUGCUCUGUUGCCCAGG	22	18346
CFTR-Intron2-3247	−	AGAGUCUUGCUCUGUUGCCCAGG	23	18347
CFTR-Intron2-3248	−	CAGAGUCUUGCUCUGUUGCCCAGG	24	18348
CFTR-Intron2-3249	−	UGUGCAAAUGCCAUGAGG	18	18349
CFTR-Intron2-3250	−	GUGUGCAAAUGCCAUGAGG	19	18350
CFTR-Intron2-3251	−	UGUGUGCAAAUGCCAUGAGG	20	18351
CFTR-Intron2-3252	−	GUGUGUGCAAAUGCCAUGAGG	21	18352
CFTR-Intron2-3253	−	GGUGUGUGCAAAUGCCAUGAGG	22	18353
CFTR-Intron2-3254	−	UGGUGUGUGCAAAUGCCAUGAGG	23	18354
CFTR-Intron2-3255	−	UUGGUGUGUGCAAAUGCCAUGAGG	24	18355
CFTR-Intron2-3256	−	ACUAUGUGAAGACCUAGG	18	18356
CFTR-Intron2-3257	−	AACUAUGUGAAGACCUAGG	19	18357
CFTR-Intron2-69	−	GAACUAUGUGAAGACCUAGG	20	15169
CFTR-Intron2-3258	−	UGAACUAUGUGAAGACCUAGG	21	18358
CFTR-Intron2-3259	−	CUGAACUAUGUGAAGACCUAGG	22	18359
CFTR-Intron2-3260	−	CCUGAACUAUGUGAAGACCUAGG	23	18360
CFTR-Intron2-3261	−	GCCUGAACUAUGUGAAGACCUAGG	24	18361
CFTR-Intron2-3262	−	GUGGAGAAGCAUGUGGGG	18	18362
CFTR-Intron2-3263	−	GGUGGAGAAGCAUGUGGGG	19	18363
CFTR-Intron2-682	−	AGGUGGAGAAGCAUGUGGGG	20	15782
CFTR-Intron2-3264	−	AAGGUGGAGAAGCAUGUGGGG	21	18364
CFTR-Intron2-3265	−	AAAGGUGGAGAAGCAUGUGGGG	22	18365
CFTR-Intron2-3266	−	GAAAGGUGGAGAAGCAUGUGGGG	23	18366
CFTR-Intron2-3267	−	AGAAAGGUGGAGAAGCAUGUGGGG	24	18367
CFTR-Intron2-3268	−	GGUGGAGAAGCAUGUGGG	18	18368
CFTR-Intron2-3269	−	AGGUGGAGAAGCAUGUGGG	19	18369
CFTR-Intron2-3270	−	AAGGUGGAGAAGCAUGUGGG	20	18370
CFTR-Intron2-3271	−	AAAGGUGGAGAAGCAUGUGGG	21	18371
CFTR-Intron2-3272	−	GAAAGGUGGAGAAGCAUGUGGG	22	18372
CFTR-Intron2-3273	−	AGAAAGGUGGAGAAGCAUGUGGG	23	18373
CFTR-Intron2-3274	−	GAGAAAGGUGGAGAAGCAUGUGGG	24	18374
CFTR-Intron2-3275	−	CAAGUGGUUGCCAGAUGG	18	18375
CFTR-Intron2-3276	−	UCAAGUGGUUGCCAGAUGG	19	18376
CFTR-Intron2-3277	−	CUCAAGUGGUUGCCAGAUGG	20	18377
CFTR-Intron2-3278	−	CCUCAAGUGGUUGCCAGAUGG	21	18378
CFTR-Intron2-3279	−	CCCUCAAGUGGUUGCCAGAUGG	22	18379
CFTR-Intron2-3280	−	GCCCUCAAGUGGUUGCCAGAUGG	23	18380
CFTR-Intron2-3281	−	GGCCCUCAAGUGGUUGCCAGAUGG	24	18381
CFTR-Intron2-3282	−	AGUAACCAAAUGUUAUGG	18	18382
CFTR-Intron2-3283	−	GAGUAACCAAAUGUUAUGG	19	18383
CFTR-Intron2-3284	−	UGAGUAACCAAAUGUUAUGG	20	18384
CFTR-Intron2-3285	−	CUGAGUAACCAAAUGUUAUGG	21	18385
CFTR-Intron2-3286	−	UCUGAGUAACCAAAUGUUAUGG	22	18386
CFTR-Intron2-3287	−	CUCUGAGUAACCAAAUGUUAUGG	23	18387
CFTR-Intron2-3288	−	ACUCUGAGUAACCAAAUGUUAUGG	24	18388
CFTR-Intron2-3289	−	CCUUGGCCUCCCAAAAUG	18	18389
CFTR-Intron2-3290	−	ACCUUGGCCUCCCAAAAUG	19	18390
CFTR-Intron2-3291	−	CACCUUGGCCUCCCAAAAUG	20	18391
CFTR-Intron2-3292	−	CCACCUUGGCCUCCCAAAAUG	21	18392
CFTR-Intron2-3293	−	CCCACCUUGGCCUCCCAAAAUG	22	18393
CFTR-Intron2-3294	−	GCCCACCUUGGCCUCCCAAAAUG	23	18394
CFTR-Intron2-3295	−	UGCCCACCUUGGCCUCCCAAAAUG	24	18395
CFTR-Intron2-3296	−	UUUGCCAGUUAAUGAAUG	18	18396
CFTR-Intron2-3297	−	CUUUGCCAGUUAAUGAAUG	19	18397
CFTR-Intron2-3298	−	ACUUUGCCAGUUAAUGAAUG	20	18398
CFTR-Intron2-3299	−	UACUUUGCCAGUUAAUGAAUG	21	18399
CFTR-Intron2-3300	−	AUACUUUGCCAGUUAAUGAAUG	22	18400
CFTR-Intron2-3301	−	UAUACUUUGCCAGUUAAUGAAUG	23	18401
CFTR-Intron2-3302	−	AUAUACUUUGCCAGUUAAUGAAUG	24	18402
CFTR-Intron2-3303	−	UUGUUGAAUGAAUCCAUG	18	18403
CFTR-Intron2-3304	−	UUUGUUGAAUGAAUCCAUG	19	18404
CFTR-Intron2-3305	−	AUUUGUUGAAUGAAUCCAUG	20	18405
CFTR-Intron2-3306	−	UAUUUGUUGAAUGAAUCCAUG	21	18406
CFTR-Intron2-3307	−	AUAUUUGUUGAAUGAAUCCAUG	22	18407
CFTR-Intron2-3308	−	AAUAUUUGUUGAAUGAAUCCAUG	23	18408
CFTR-Intron2-3309	−	AAAUAUUUGUUGAAUGAAUCCAUG	24	18409
CFTR-Intron2-3310	−	GAAAGGUGGAGAAGCAUG	18	18410
CFTR-Intron2-3311	−	AGAAAGGUGGAGAAGCAUG	19	18411
CFTR-Intron2-467	−	GAGAAAGGUGGAGAAGCAUG	20	15567
CFTR-Intron2-3312	−	AGAGAAAGGUGGAGAAGCAUG	21	18412
CFTR-Intron2-3313	−	GAGAGAAAGGUGGAGAAGCAUG	22	18413
CFTR-Intron2-3314	−	UGAGAGAAAGGUGGAGAAGCAUG	23	18414
CFTR-Intron2-3315	−	GUGAGAGAAAGGUGGAGAAGCAUG	24	18415
CFTR-Intron2-3316	−	CUAAGUUUUAAUUGGAUG	18	18416
CFTR-Intron2-3317	−	UCUAAGUUUUAAUUGGAUG	19	18417
CFTR-Intron2-3318	−	AUCUAAGUUUUAAUUGGAUG	20	18418
CFTR-Intron2-3319	−	UAUCUAAGUUUUAAUUGGAUG	21	18419
CFTR-Intron2-3320	−	AUAUCUAAGUUUUAAUUGGAUG	22	18420
CFTR-Intron2-3321	−	AAUAUCUAAGUUUUAAUUGGAUG	23	18421
CFTR-Intron2-3322	−	GAAUAUCUAAGUUUUAAUUGGAUG	24	18422
CFTR-Intron2-3323	−	UCCAUUUCUCCUUUGAUG	18	18423
CFTR-Intron2-3324	−	AUCCAUUUCUCCUUUGAUG	19	18424
CFTR-Intron2-3325	−	GAUCCAUUUCUCCUUUGAUG	20	18425
CFTR-Intron2-3326	−	UGAUCCAUUUCUCCUUUGAUG	21	18426
CFTR-Intron2-3327	−	CUGAUCCAUUUCUCCUUUGAUG	22	18427
CFTR-Intron2-3328	−	UCUGAUCCAUUUCUCCUUUGAUG	23	18428
CFTR-Intron2-3329	−	AUCUGAUCCAUUUCUCCUUUGAUG	24	18429
CFTR-Intron2-3330	−	UAAUGGGAAUAACCACUG	18	18430
CFTR-Intron2-3331	−	GUAAUGGGAAUAACCACUG	19	18431
CFTR-Intron2-3332	−	AGUAAUGGGAAUAACCACUG	20	18432
CFTR-Intron2-3333	−	CAGUAAUGGGAAUAACCACUG	21	18433
CFTR-Intron2-3334	−	ACAGUAAUGGGAAUAACCACUG	22	18434
CFTR-Intron2-3335	−	GACAGUAAUGGGAAUAACCACUG	23	18435
CFTR-Intron2-3336	−	UGACAGUAAUGGGAAUAACCACUG	24	18436
CFTR-Intron2-3337	−	AGUUUUAAUUGGAUGCUG	18	18437
CFTR-Intron2-3338	−	AAGUUUUAAUUGGAUGCUG	19	18438
CFTR-Intron2-364	−	UAAGUUUUAAUUGGAUGCUG	20	15464
CFTR-Intron2-3339	−	CUAAGUUUUAAUUGGAUGCUG	21	18439
CFTR-Intron2-3340	−	UCUAAGUUUUAAUUGGAUGCUG	22	18440
CFTR-Intron2-3341	−	AUCUAAGUUUUAAUUGGAUGCUG	23	18441
CFTR-Intron2-3342	−	UAUCUAAGUUUUAAUUGGAUGCUG	24	18442
CFTR-Intron2-3343	−	AAACCUGUAGCAUUGCUG	18	18443
CFTR-Intron2-3344	−	GAAACCUGUAGCAUUGCUG	19	18444
CFTR-Intron2-3345	−	AGAAACCUGUAGCAUUGCUG	20	18445
CFTR-Intron2-3346	−	UAGAAACCUGUAGCAUUGCUG	21	18446
CFTR-Intron2-3347	−	AUAGAAACCUGUAGCAUUGCUG	22	18447
CFTR-Intron2-3348	−	CAUAGAAACCUGUAGCAUUGCUG	23	18448
CFTR-Intron2-3349	−	ACAUAGAAACCUGUAGCAUUGCUG	24	18449
CFTR-Intron2-3350	−	CCUUGGCCUCCCAAAGUG	18	18450
CFTR-Intron2-3351	−	GCCUUGGCCUCCCAAAGUG	19	18451
CFTR-Intron2-3352	−	CGCCUUGGCCUCCCAAAGUG	20	18452
CFTR-Intron2-3353	−	CCGCCUUGGCCUCCCAAAGUG	21	18453
CFTR-Intron2-3354	−	CCCGCCUUGGCCUCCCAAAGUG	22	18454
CFTR-Intron2-3355	−	GCCCGCCUUGGCCUCCCAAAGUG	23	18455
CFTR-Intron2-3356	−	UGCCCGCCUUGGCCUCCCAAAGUG	24	18456
CFTR-Intron2-3357	−	CAGAUAAAAGGGUGAGUG	18	18457
CFTR-Intron2-3358	−	CCAGAUAAAAGGGUGAGUG	19	18458
CFTR-Intron2-3359	−	GCCAGAUAAAAGGGUGAGUG	20	18459
CFTR-Intron2-3360	−	UGCCAGAUAAAAGGGUGAGUG	21	18460
CFTR-Intron2-3361	−	AUGCCAGAUAAAAGGGUGAGUG	22	18461
CFTR-Intron2-3362	−	GAUGCCAGAUAAAAGGGUGAGUG	23	18462
CFTR-Intron2-3363	−	UGAUGCCAGAUAAAAGGGUGAGUG	24	18463
CFTR-Intron2-3364	−	GUGUGUGAGAGAAAGGUG	18	18464
CFTR-Intron2-3365	−	UGUGUGUGAGAGAAAGGUG	19	18465
CFTR-Intron2-3366	−	CUGUGUGUGAGAGAAAGGUG	20	18466
CFTR-Intron2-3367	−	UCUGUGUGUGAGAGAAAGGUG	21	18467
CFTR-Intron2-3368	−	CUCUGUGUGUGAGAGAAAGGUG	22	18468
CFTR-Intron2-3369	−	GCUCUGUGUGUGAGAGAAAGGUG	23	18469
CFTR-Intron2-3370	−	AGCUCUGUGUGUGAGAGAAAGGUG	24	18470
CFTR-Intron2-3371	−	UAUGUGAAGACCUAGGUG	18	18471
CFTR-Intron2-3372	−	CUAUGUGAAGACCUAGGUG	19	18472
CFTR-Intron2-3373	−	ACUAUGUGAAGACCUAGGUG	20	18473
CFTR-Intron2-3374	−	AACUAUGUGAAGACCUAGGUG	21	18474
CFTR-Intron2-3375	−	GAACUAUGUGAAGACCUAGGUG	22	18475
CFTR-Intron2-3376	−	UGAACUAUGUGAAGACCUAGGUG	23	18476
CFTR-Intron2-3377	−	CUGAACUAUGUGAAGACCUAGGUG	24	18477
CFTR-Intron2-3378	−	AAGGUGGAGAAGCAUGUG	18	18478
CFTR-Intron2-3379	−	AAAGGUGGAGAAGCAUGUG	19	18479
CFTR-Intron2-468	−	GAAAGGUGGAGAAGCAUGUG	20	15568
CFTR-Intron2-3380	−	AGAAAGGUGGAGAAGCAUGUG	21	18480
CFTR-Intron2-3381	−	GAGAAAGGUGGAGAAGCAUGUG	22	18481
CFTR-Intron2-3382	−	AGAGAAAGGUGGAGAAGCAUGUG	23	18482
CFTR-Intron2-3383	−	GAGAGAAAGGUGGAGAAGCAUGUG	24	18483
CFTR-Intron2-3384	−	AUAUUUUAUUCCUUUGUG	18	18484
CFTR-Intron2-3385	−	GAUAUUUUAUUCCUUUGUG	19	18485
CFTR-Intron2-3386	−	AGAUAUUUUAUUCCUUUGUG	20	18486
CFTR-Intron2-3387	−	GAGAUAUUUUAUUCCUUUGUG	21	18487
CFTR-Intron2-3388	−	AGAGAUAUUUUAUUCCUUUGUG	22	18488
CFTR-Intron2-3389	−	UAGAGAUAUUUUAUUCCUUUGUG	23	18489
CFTR-Intron2-3390	−	UUAGAGAUAUUUUAUUCCUUUGUG	24	18490
CFTR-Intron2-3391	−	UAGAAACCUGUAGCAUUG	18	18491
CFTR-Intron2-3392	−	AUAGAAACCUGUAGCAUUG	19	18492
CFTR-Intron2-3393	−	CAUAGAAACCUGUAGCAUUG	20	18493
CFTR-Intron2-3394	−	ACAUAGAAACCUGUAGCAUUG	21	18494
CFTR-Intron2-3395	−	UACAUAGAAACCUGUAGCAUUG	22	18495
CFTR-Intron2-3396	−	UUACAUAGAAACCUGUAGCAUUG	23	18496
CFTR-Intron2-3397	−	AUUACAUAGAAACCUGUAGCAUUG	24	18497
CFTR-Intron2-3398	−	GUGGUUGCCAGAUGGUUG	18	18498
CFTR-Intron2-3399	−	AGUGGUUGCCAGAUGGUUG	19	18499
CFTR-Intron2-3400	−	AAGUGGUUGCCAGAUGGUUG	20	18500
CFTR-Intron2-3401	−	CAAGUGGUUGCCAGAUGGUUG	21	18501
CFTR-Intron2-3402	−	UCAAGUGGUUGCCAGAUGGUUG	22	18502
CFTR-Intron2-3403	−	CUCAAGUGGUUGCCAGAUGGUUG	23	18503
CFTR-Intron2-3404	−	CCUCAAGUGGUUGCCAGAUGGUUG	24	18504
CFTR-Intron2-3405	−	UGAUCCAUUUCUCCUUUG	18	18505
CFTR-Intron2-3406	−	CUGAUCCAUUUCUCCUUUG	19	18506
CFTR-Intron2-3407	−	UCUGAUCCAUUUCUCCUUUG	20	18507
CFTR-Intron2-3408	−	AUCUGAUCCAUUUCUCCUUUG	21	18508
CFTR-Intron2-3409	−	CAUCUGAUCCAUUUCUCCUUUG	22	18509
CFTR-Intron2-3410	−	CCAUCUGAUCCAUUUCUCCUUUG	23	18510
CFTR-Intron2-3411	−	CCCAUCUGAUCCAUUUCUCCUUUG	24	18511
CFTR-Intron2-3412	−	AGGCCUGGCUAAUUUUUG	18	18512
CFTR-Intron2-3413	−	CAGGCCUGGCUAAUUUUUG	19	18513
CFTR-Intron2-3414	−	CCAGGCCUGGCUAAUUUUUG	20	18514
CFTR-Intron2-3415	−	ACCAGGCCUGGCUAAUUUUUG	21	18515
CFTR-Intron2-3416	−	CACCAGGCCUGGCUAAUUUUUG	22	18516
CFTR-Intron2-3417	−	CCACCAGGCCUGGCUAAUUUUUG	23	18517
CFTR-Intron2-3418	−	ACCACCAGGCCUGGCUAAUUUUUG	24	18518
CFTR-Intron2-3419	−	CUUUGUCCUUGGCUAAAU	18	18519
CFTR-Intron2-3420	−	CCUUUGUCCUUGGCUAAAU	19	18520
CFTR-Intron2-3421	−	CCCUUUGUCCUUGGCUAAAU	20	18521
CFTR-Intron2-3422	−	GCCCUUUGUCCUUGGCUAAAU	21	18522
CFTR-Intron2-3423	−	AGCCCUUUGUCCUUGGCUAAAU	22	18523
CFTR-Intron2-3424	−	GAGCCCUUUGUCCUUGGCUAAAU	23	18524
CFTR-Intron2-3425	−	GGAGCCCUUUGUCCUUGGCUAAAU	24	18525
CFTR-Intron2-3426	−	AUGAAUCCAUGAUGGAAU	18	18526
CFTR-Intron2-3427	−	AAUGAAUCCAUGAUGGAAU	19	18527
CFTR-Intron2-3428	−	GAAUGAAUCCAUGAUGGAAU	20	18528
CFTR-Intron2-3429	−	UGAAUGAAUCCAUGAUGGAAU	21	18529
CFTR-Intron2-3430	−	UUGAAUGAAUCCAUGAUGGAAU	22	18530
CFTR-Intron2-3431	−	GUUGAAUGAAUCCAUGAUGGAAU	23	18531
CFTR-Intron2-3432	−	UGUUGAAUGAAUCCAUGAUGGAAU	24	18532
CFTR-Intron2-3433	−	AGAAAGGUGGAGAAGCAU	18	18533
CFTR-Intron2-3434	−	GAGAAAGGUGGAGAAGCAU	19	18534
CFTR-Intron2-3435	−	AGAGAAAGGUGGAGAAGCAU	20	18535
CFTR-Intron2-3436	−	GAGAGAAAGGUGGAGAAGCAU	21	18536
CFTR-Intron2-3437	−	UGAGAGAAAGGUGGAGAAGCAU	22	18537
CFTR-Intron2-3438	−	GUGAGAGAAAGGUGGAGAAGCAU	23	18538
CFTR-Intron2-3439	−	UGUGAGAGAAAGGUGGAGAAGCAU	24	18539
CFTR-Intron2-3440	−	GUGGGGAGGGAAAUAGAU	18	18540
CFTR-Intron2-3441	−	UGUGGGGAGGGAAAUAGAU	19	18541
CFTR-Intron2-377	−	AUGUGGGGAGGGAAAUAGAU	20	15477
CFTR-Intron2-3442	−	CAUGUGGGGAGGGAAAUAGAU	21	18542
CFTR-Intron2-3443	−	GCAUGUGGGGAGGGAAAUAGAU	22	18543
CFTR-Intron2-3444	−	AGCAUGUGGGGAGGGAAAUAGAU	23	18544
CFTR-Intron2-3445	−	AAGCAUGUGGGGAGGGAAAUAGAU	24	18545
CFTR-Intron2-3446	−	UUUUGUAUUUUAGUAGAU	18	18546
CFTR-Intron2-3447	−	UUUUUGUAUUUUAGUAGAU	19	18547
CFTR-Intron2-3448	−	AUUUUUGUAUUUUAGUAGAU	20	18548
CFTR-Intron2-3449	−	AAUUUUUGUAUUUUAGUAGAU	21	18549
CFTR-Intron2-3450	−	UAAUUUUUGUAUUUUAGUAGAU	22	18550
CFTR-Intron2-3451	−	CUAAUUUUUGUAUUUUAGUAGAU	23	18551
CFTR-Intron2-3452	−	GCUAAUUUUUGUAUUUUAGUAGAU	24	18552
CFTR-Intron2-3453	−	CAAGAUUGUAGUCAGGAU	18	18553
CFTR-Intron2-3454	−	CCAAGAUUGUAGUCAGGAU	19	18554
CFTR-Intron2-3455	−	UCCAAGAUUGUAGUCAGGAU	20	18555
CFTR-Intron2-3456	−	UUCCAAGAUUGUAGUCAGGAU	21	18556
CFTR-Intron2-3457	−	GUUCCAAGAUUGUAGUCAGGAU	22	18557
CFTR-Intron2-3458	−	CGUUCCAAGAUUGUAGUCAGGAU	23	18558
CFTR-Intron2-3459	−	CCGUUCCAAGAUUGUAGUCAGGAU	24	18559
CFTR-Intron2-3460	−	UAACCAAAUGUUAUGGAU	18	18560
CFTR-Intron2-3461	−	GUAACCAAAUGUUAUGGAU	19	18561
CFTR-Intron2-378	−	AGUAACCAAAUGUUAUGGAU	20	15478
CFTR-Intron2-3462	−	GAGUAACCAAAUGUUAUGGAU	21	18562
CFTR-Intron2-3463	−	UGAGUAACCAAAUGUUAUGGAU	22	18563
CFTR-Intron2-3464	−	CUGAGUAACCAAAUGUUAUGGAU	23	18564
CFTR-Intron2-3465	−	UCUGAGUAACCAAAUGUUAUGGAU	24	18565
CFTR-Intron2-3466	−	AACUUCUUCCCUUCUGAU	18	18566
CFTR-Intron2-3467	−	AAACUUCUUCCCUUCUGAU	19	18567
CFTR-Intron2-3468	−	AAAACUUCUUCCCUUCUGAU	20	18568
CFTR-Intron2-3469	−	UAAAACUUCUUCCCUUCUGAU	21	18569
CFTR-Intron2-3470	−	AUAAAACUUCUUCCCUUCUGAU	22	18570
CFTR-Intron2-3471	−	AAUAAAACUUCUUCCCUUCUGAU	23	18571
CFTR-Intron2-3472	−	GAAUAAAACUUCUUCCCUUCUGAU	24	18572
CFTR-Intron2-3473	−	UCAUGAAGCCUGAACUAU	18	18573
CFTR-Intron2-3474	−	CUCAUGAAGCCUGAACUAU	19	18574
CFTR-Intron2-3475	−	GCUCAUGAAGCCUGAACUAU	20	18575
CFTR-Intron2-3476	−	GGCUCAUGAAGCCUGAACUAU	21	18576
CFTR-Intron2-3477	−	UGGCUCAUGAAGCCUGAACUAU	22	18577
CFTR-Intron2-3478	−	UUGGCUCAUGAAGCCUGAACUAU	23	18578
CFTR-Intron2-3479	−	AUUGGCUCAUGAAGCCUGAACUAU	24	18579
CFTR-Intron2-3480	−	UUCUUAUAAAAUUGGUAU	18	18580
CFTR-Intron2-3481	−	UUUCUUAUAAAAUUGGUAU	19	18581
CFTR-Intron2-3482	−	UUUUCUUAUAAAAUUGGUAU	20	18582
CFTR-Intron2-3483	−	CUUUUCUUAUAAAAUUGGUAU	21	18583
CFTR-Intron2-3484	−	UCUUUUCUUAUAAAAUUGGUAU	22	18584
CFTR-Intron2-3485	−	UUCUUUUCUUAUAAAAUUGGUAU	23	18585
CFTR-Intron2-3486	−	CUUCUUUUCUUAUAAAAUUGGUAU	24	18586
CFTR-Intron2-3487	−	UCAGAGAAUUUGUCUUAU	18	18587
CFTR-Intron2-3488	−	UUCAGAGAAUUUGUCUUAU	19	18588
CFTR-Intron2-3489	−	UUUCAGAGAAUUUGUCUUAU	20	18589
CFTR-Intron2-3490	−	GUUUCAGAGAAUUUGUCUUAU	21	18590
CFTR-Intron2-3491	−	GGUUUCAGAGAAUUUGUCUUAU	22	18591
CFTR-Intron2-3492	−	UGGUUUCAGAGAAUUUGUCUUAU	23	18592
CFTR-Intron2-3493	−	UUGGUUUCAGAGAAUUUGUCUUAU	24	18593
CFTR-Intron2-3494	−	UUUGUACCUCUGCACCCU	18	18594
CFTR-Intron2-3495	−	CUUUGUACCUCUGCACCCU	19	18595
CFTR-Intron2-705	−	ACUUUGUACCUCUGCACCCU	20	15805
CFTR-Intron2-3496	−	UACUUUGUACCUCUGCACCCU	21	18596
CFTR-Intron2-3497	−	GUACUUUGUACCUCUGCACCCU	22	18597
CFTR-Intron2-3498	−	GGUACUUUGUACCUCUGCACCCU	23	18598
CFTR-Intron2-3499	−	UGGUACUUUGUACCUCUGCACCCU	24	18599
CFTR-Intron2-3500	−	AAUACAAAUGUACUCCCU	18	18600
CFTR-Intron2-3501	−	GAAUACAAAUGUACUCCCU	19	18601
CFTR-Intron2-389	−	UGAAUACAAAUGUACUCCCU	20	15489
CFTR-Intron2-3502	−	UUGAAUACAAAUGUACUCCCU	21	18602
CFTR-Intron2-3503	−	UUUGAAUACAAAUGUACUCCCU	22	18603
CFTR-Intron2-3504	−	AUUUGAAUACAAAUGUACUCCCU	23	18604
CFTR-Intron2-3505	−	UAUUUGAAUACAAAUGUACUCCCU	24	18605
CFTR-Intron2-3506	−	UAGGUGGAGAACUGGCCU	18	18606
CFTR-Intron2-3507	−	CUAGGUGGAGAACUGGCCU	19	18607
CFTR-Intron2-3508	−	CCUAGGUGGAGAACUGGCCU	20	18608
CFTR-Intron2-3509	−	ACCUAGGUGGAGAACUGGCCU	21	18609
CFTR-Intron2-3510	−	GACCUAGGUGGAGAACUGGCCU	22	18610
CFTR-Intron2-3511	−	AGACCUAGGUGGAGAACUGGCCU	23	18611
CFTR-Intron2-3512	−	AAGACCUAGGUGGAGAACUGGCCU	24	18612
CFTR-Intron2-3513	−	GAAAAGCAAACUGAGGCU	18	18613
CFTR-Intron2-3514	−	AGAAAAGCAAACUGAGGCU	19	18614
CFTR-Intron2-3515	−	CAGAAAAGCAAACUGAGGCU	20	18615
CFTR-Intron2-3516	−	ACAGAAAAGCAAACUGAGGCU	21	18616
CFTR-Intron2-3517	−	UACAGAAAAGCAAACUGAGGCU	22	18617
CFTR-Intron2-3518	−	UUACAGAAAAGCAAACUGAGGCU	23	18618
CFTR-Intron2-3519	−	UUUACAGAAAAGCAAACUGAGGCU	24	18619
CFTR-Intron2-3520	−	GAUGCCAAGAUCCAUGCU	18	18620
CFTR-Intron2-3521	−	GGAUGCCAAGAUCCAUGCU	19	18621
CFTR-Intron2-3522	−	GGGAUGCCAAGAUCCAUGCU	20	18622
CFTR-Intron2-3523	−	GGGGAUGCCAAGAUCCAUGCU	21	18623
CFTR-Intron2-3524	−	AGGGGAUGCCAAGAUCCAUGCU	22	18624
CFTR-Intron2-3525	−	UAGGGGAUGCCAAGAUCCAUGCU	23	18625
CFTR-Intron2-3526	−	CUAGGGGAUGCCAAGAUCCAUGCU	24	18626
CFTR-Intron2-3527	−	AAGUUUUAAUUGGAUGCU	18	18627
CFTR-Intron2-3528	−	UAAGUUUUAAUUGGAUGCU	19	18628
CFTR-Intron2-3529	−	CUAAGUUUUAAUUGGAUGCU	20	18629
CFTR-Intron2-3530	−	UCUAAGUUUUAAUUGGAUGCU	21	18630
CFTR-Intron2-3531	−	AUCUAAGUUUUAAUUGGAUGCU	22	18631
CFTR-Intron2-3532	−	UAUCUAAGUUUUAAUUGGAUGCU	23	18632
CFTR-Intron2-3533	−	AUAUCUAAGUUUUAAUUGGAUGCU	24	18633
CFTR-Intron2-3534	−	UCUCAUUAGCAAGCUUCU	18	18634
CFTR-Intron2-3535	−	CUCUCAUUAGCAAGCUUCU	19	18635
CFTR-Intron2-75	−	GCUCUCAUUAGCAAGCUUCU	20	15175
CFTR-Intron2-3536	−	GGCUCUCAUUAGCAAGCUUCU	21	18636
CFTR-Intron2-3537	−	GGGCUCUCAUUAGCAAGCUUCU	22	18637
CFTR-Intron2-3538	−	AGGGCUCUCAUUAGCAAGCUUCU	23	18638
CFTR-Intron2-3539	−	AAGGGCUCUCAUUAGCAAGCUUCU	24	18639
CFTR-Intron2-3540	−	UUUUCAUCUCUGUACAGU	18	18640
CFTR-Intron2-3541	−	UUUUUCAUCUCUGUACAGU	19	18641
CFTR-Intron2-3542	−	AUUUUUCAUCUCUGUACAGU	20	18642
CFTR-Intron2-3543	−	AAUUUUUCAUCUCUGUACAGU	21	18643
CFTR-Intron2-3544	−	AAAUUUUUCAUCUCUGUACAGU	22	18644
CFTR-Intron2-3545	−	GAAAUUUUUCAUCUCUGUACAGU	23	18645
CFTR-Intron2-3546	−	UGAAAUUUUUCAUCUCUGUACAGU	24	18646
CFTR-Intron2-3547	−	UUUCUACAUUACUUCCGU	18	18647
CFTR-Intron2-3548	−	CUUUCUACAUUACUUCCGU	19	18648
CFTR-Intron2-3549	−	CCUUUCUACAUUACUUCCGU	20	18649
CFTR-Intron2-3550	−	ACCUUUCUACAUUACUUCCGU	21	18650
CFTR-Intron2-3551	−	CACCUUUCUACAUUACUUCCGU	22	18651
CFTR-Intron2-3552	−	ACACCUUUCUACAUUACUUCCGU	23	18652
CFTR-Intron2-3553	−	AACACCUUUCUACAUUACUUCCGU	24	18653
CFTR-Intron2-3554	−	AAUGCUGGGAUUAUAGGU	18	18654
CFTR-Intron2-3555	−	AAAUGCUGGGAUUAUAGGU	19	18655
CFTR-Intron2-3556	−	AAAAUGCUGGGAUUAUAGGU	20	18656
CFTR-Intron2-3557	−	CAAAAUGCUGGGAUUAUAGGU	21	18657
CFTR-Intron2-3558	−	CCAAAAUGCUGGGAUUAUAGGU	22	18658
CFTR-Intron2-3559	−	CCCAAAAUGCUGGGAUUAUAGGU	23	18659
CFTR-Intron2-3560	−	UCCCAAAAUGCUGGGAUUAUAGGU	24	18660
CFTR-Intron2-3561	−	AUAAAGUGGGUCCCUGGU	18	18661
CFTR-Intron2-3562	−	CAUAAAGUGGGUCCCUGGU	19	18662
CFTR-Intron2-3563	−	ACAUAAAGUGGGUCCCUGGU	20	18663
CFTR-Intron2-3564	−	UACAUAAAGUGGGUCCCUGGU	21	18664
CFTR-Intron2-3565	−	CUACAUAAAGUGGGUCCCUGGU	22	18665
CFTR-Intron2-3566	−	UCUACAUAAAGUGGGUCCCUGGU	23	18666
CFTR-Intron2-3567	−	UUCUACAUAAAGUGGGUCCCUGGU	24	18667
CFTR-Intron2-3568	−	AAAGGUGGAGAAGCAUGU	18	18668
CFTR-Intron2-3569	−	GAAAGGUGGAGAAGCAUGU	19	18669
CFTR-Intron2-406	−	AGAAAGGUGGAGAAGCAUGU	20	15506
CFTR-Intron2-3570	−	GAGAAAGGUGGAGAAGCAUGU	21	18670
CFTR-Intron2-3571	−	AGAGAAAGGUGGAGAAGCAUGU	22	18671
CFTR-Intron2-3572	−	GAGAGAAAGGUGGAGAAGCAUGU	23	18672
CFTR-Intron2-3573	−	UGAGAGAAAGGUGGAGAAGCAUGU	24	18673
CFTR-Intron2-3574	−	GGGAGGUUAGCUCUGUGU	18	18674
CFTR-Intron2-3575	−	UGGGAGGUUAGCUCUGUGU	19	18675
CFTR-Intron2-3576	−	AUGGGAGGUUAGCUCUGUGU	20	18676
CFTR-Intron2-3577	−	GAUGGGAGGUUAGCUCUGUGU	21	18677
CFTR-Intron2-3578	−	GGAUGGGAGGUUAGCUCUGUGU	22	18678
CFTR-Intron2-3579	−	UGGAUGGGAGGUUAGCUCUGUGU	23	18679
CFTR-Intron2-3580	−	AUGGAUGGGAGGUUAGCUCUGUGU	24	18680
CFTR-Intron2-3581	−	GAGGUUAGCUCUGUGUGU	18	18681
CFTR-Intron2-3582	−	GGAGGUUAGCUCUGUGUGU	19	18682
CFTR-Intron2-3583	−	GGGAGGUUAGCUCUGUGUGU	20	18683
CFTR-Intron2-3584	−	UGGGAGGUUAGCUCUGUGUGU	21	18684
CFTR-Intron2-3585	−	AUGGGAGGUUAGCUCUGUGUGU	22	18685
CFTR-Intron2-3586	−	GAUGGGAGGUUAGCUCUGUGUGU	23	18686
CFTR-Intron2-3587	−	GGAUGGGAGGUUAGCUCUGUGUGU	24	18687
CFTR-Intron2-3588	−	AACUAAAGUAACACCAUU	18	18688
CFTR-Intron2-3589	−	AAACUAAAGUAACACCAUU	19	18689
CFTR-Intron2-3590	−	AAAACUAAAGUAACACCAUU	20	18690
CFTR-Intron2-3591	−	GAAAACUAAAGUAACACCAUU	21	18691
CFTR-Intron2-3592	−	UGAAAACUAAAGUAACACCAUU	22	18692
CFTR-Intron2-3593	−	GUGAAAACUAAAGUAACACCAUU	23	18693
CFTR-Intron2-3594	−	UGUGAAAACUAAAGUAACACCAUU	24	18694
CFTR-Intron2-3595	−	UUUCCUUUUUUUGGCAUU	18	18695
CFTR-Intron2-3596	−	AUUUCCUUUUUUUGGCAUU	19	18696
CFTR-Intron2-3597	−	CAUUUCCUUUUUUUGGCAUU	20	18697
CFTR-Intron2-3598	−	UCAUUUCCUUUUUUUGGCAUU	21	18698
CFTR-Intron2-3599	−	UUCAUUUCCUUUUUUUGGCAUU	22	18699
CFTR-Intron2-3600	−	AUUCAUUUCCUUUUUUUGGCAUU	23	18700
CFTR-Intron2-3601	−	AAUUCAUUUCCUUUUUUUGGCAUU	24	18701
CFTR-Intron2-3602	−	UACUCCUUUAGAGUGAUU	18	18702
CFTR-Intron2-3603	−	UUACUCCUUUAGAGUGAUU	19	18703
CFTR-Intron2-3604	−	AUUACUCCUUUAGAGUGAUU	20	18704
CFTR-Intron2-3605	−	UAUUACUCCUUUAGAGUGAUU	21	18705
CFTR-Intron2-3606	−	CUAUUACUCCUUUAGAGUGAUU	22	18706
CFTR-Intron2-3607	−	CCUAUUACUCCUUUAGAGUGAUU	23	18707
CFTR-Intron2-3608	−	GCCUAUUACUCCUUUAGAGUGAUU	24	18708
CFTR-Intron2-3609	−	GAAAUUUAUUGAAAUAUU	18	18709
CFTR-Intron2-3610	−	UGAAAUUUAUUGAAAUAUU	19	18710
CFTR-Intron2-3611	−	UUGAAAUUUAUUGAAAUAUU	20	18711
CFTR-Intron2-3612	−	UUUGAAAUUUAUUGAAAUAUU	21	18712
CFTR-Intron2-3613	−	AUUUGAAAUUUAUUGAAAUAUU	22	18713
CFTR-Intron2-3614	−	UAUUUGAAAUUUAUUGAAAUAUU	23	18714
CFTR-Intron2-3615	−	GUAUUUGAAAUUUAUUGAAAUAUU	24	18715
CFTR-Intron2-3616	−	AAUUAAGAUGAUAAUAUU	18	18716
CFTR-Intron2-3617	−	AAAUUAAGAUGAUAAUAUU	19	18717
CFTR-Intron2-3618	−	AAAAUUAAGAUGAUAAUAUU	20	18718
CFTR-Intron2-3619	−	GAAAAUUAAGAUGAUAAUAUU	21	18719
CFTR-Intron2-3620	−	UGAAAAUUAAGAUGAUAAUAUU	22	18720
CFTR-Intron2-3621	−	UUGAAAAUUAAGAUGAUAAUAUU	23	18721
CFTR-Intron2-3622	−	UUUGAAAAUUAAGAUGAUAAUAUU	24	18722
CFTR-Intron2-3623	−	UUGUACCUCUGCACCCUU	18	18723
CFTR-Intron2-3624	−	UUUGUACCUCUGCACCCUU	19	18724
CFTR-Intron2-412	−	CUUUGUACCUCUGCACCCUU	20	15512
CFTR-Intron2-3625	−	ACUUUGUACCUCUGCACCCUU	21	18725
CFTR-Intron2-3626	−	UACUUUGUACCUCUGCACCCUU	22	18726
CFTR-Intron2-3627	−	GUACUUUGUACCUCUGCACCCUU	23	18727
CFTR-Intron2-3628	−	GGUACUUUGUACCUCUGCACCCUU	24	18728
CFTR-Intron2-3629	−	AGGUGGAGAACUGGCCUU	18	18729
CFTR-Intron2-3630	−	UAGGUGGAGAACUGGCCUU	19	18730
CFTR-Intron2-414	−	CUAGGUGGAGAACUGGCCUU	20	15514
CFTR-Intron2-3631	−	CCUAGGUGGAGAACUGGCCUU	21	18731
CFTR-Intron2-3632	−	ACCUAGGUGGAGAACUGGCCUU	22	18732
CFTR-Intron2-3633	−	GACCUAGGUGGAGAACUGGCCUU	23	18733
CFTR-Intron2-3634	−	AGACCUAGGUGGAGAACUGGCCUU	24	18734
CFTR-Intron2-3635	−	GGUCACUAGAGACCUCUU	18	18735
CFTR-Intron2-3636	−	GGGUCACUAGAGACCUCUU	19	18736
CFTR-Intron2-3637	−	AGGGUCACUAGAGACCUCUU	20	18737
CFTR-Intron2-3638	−	CAGGGUCACUAGAGACCUCUU	21	18738
CFTR-Intron2-3639	−	CCAGGGUCACUAGAGACCUCUU	22	18739
CFTR-Intron2-3640	−	CCCAGGGUCACUAGAGACCUCUU	23	18740
CFTR-Intron2-3641	−	GCCCAGGGUCACUAGAGACCUCUU	24	18741
CFTR-Intron2-3642	−	AAAUUUAUUGAAAUAUUU	18	18742
CFTR-Intron2-3643	−	GAAAUUUAUUGAAAUAUUU	19	18743
CFTR-Intron2-721	−	UGAAAUUUAUUGAAAUAUUU	20	15821
CFTR-Intron2-3644	−	UUGAAAUUUAUUGAAAUAUUU	21	18744
CFTR-Intron2-3645	−	UUUGAAAUUUAUUGAAAUAUUU	22	18745
CFTR-Intron2-3646	−	AUUUGAAAUUUAUUGAAAUAUUU	23	18746
CFTR-Intron2-3647	−	UAUUUGAAAUUUAUUGAAAUAUUU	24	18747
CFTR-Intron2-3648	−	GAGAUAUUUUAUUCCUUU	18	18748
CFTR-Intron2-3649	−	AGAGAUAUUUUAUUCCUUU	19	18749
CFTR-Intron2-3650	−	UAGAGAUAUUUUAUUCCUUU	20	18750
CFTR-Intron2-3651	−	UUAGAGAUAUUUUAUUCCUUU	21	18751
CFTR-Intron2-3652	−	UUUAGAGAUAUUUUAUUCCUUU	22	18752
CFTR-Intron2-3653	−	AUUUAGAGAUAUUUUAUUCCUUU	23	18753
CFTR-Intron2-3654	−	UAUUUAGAGAUAUUUUAUUCCUUU	24	18754
CFTR-Intron2-3655	−	CUCUUUGCUCCUAUCUUU	18	18755
CFTR-Intron2-3656	−	ACUCUUUGCUCCUAUCUUU	19	18756
CFTR-Intron2-3657	−	AACUCUUUGCUCCUAUCUUU	20	18757
CFTR-Intron2-3658	−	GAACUCUUUGCUCCUAUCUUU	21	18758
CFTR-Intron2-3659	−	AGAACUCUUUGCUCCUAUCUUU	22	18759
CFTR-Intron2-3660	−	UAGAACUCUUUGCUCCUAUCUUU	23	18760
CFTR-Intron2-3661	−	UUAGAACUCUUUGCUCCUAUCUUU	24	18761
CFTR-Intron2-3662	−	AAAAUACACAUUUGGUUU	18	18762
CFTR-Intron2-3663	−	AAAAAUACACAUUUGGUUU	19	18763
CFTR-Intron2-3664	−	GAAAAAUACACAUUUGGUUU	20	18764
CFTR-Intron2-3665	−	UGAAAAAUACACAUUUGGUUU	21	18765
CFTR-Intron2-3666	−	CUGAAAAAUACACAUUUGGUUU	22	18766
CFTR-Intron2-3667	−	CCUGAAAAAUACACAUUUGGUUU	23	18767
CFTR-Intron2-3668	−	UCCUGAAAAAUACACAUUUGGUUU	24	18768
CFTR-Intron2-3669	−	UUGUUGUUGCUGUUGUUU	18	18769
CFTR-Intron2-3670	−	GUUGUUGUUGCUGUUGUUU	19	18770
CFTR-Intron2-3671	−	UGUUGUUGUUGCUGUUGUUU	20	18771
CFTR-Intron2-3672	−	UUGUUGUUGUUGCUGUUGUUU	21	18772
CFTR-Intron2-3673	−	GUUGUUGUUGUUGCUGUUGUUU	22	18773
CFTR-Intron2-3674	−	UGUUGUUGUUGUUGCUGUUGUUU	23	18774
CFTR-Intron2-3675	−	UUGUUGUUGUUGUUGCUGUUGUUU	24	18775
CFTR-Intron2-3676	−	UGUUUGUGUUGUUUGUUU	18	18776
CFTR-Intron2-3677	−	UUGUUUGUGUUGUUUGUUU	19	18777
CFTR-Intron2-3678	−	UUUGUUUGUGUUGUUUGUUU	20	18778
CFTR-Intron2-3679	−	GUUUGUUUGUGUUGUUUGUUU	21	18779
CFTR-Intron2-3680	−	UGUUUGUUUGUGUUGUUUGUUU	22	18780
CFTR-Intron2-3681	−	UUGUUUGUUUGUGUUGUUUGUUU	23	18781
CFTR-Intron2-3682	−	UUUGUUUGUUUGUGUUGUUUGUUU	24	18782
CFTR-Intron2-3683	−	GACCAUGAGAUGGAUUUU	18	18783
CFTR-Intron2-3684	−	AGACCAUGAGAUGGAUUUU	19	18784
CFTR-Intron2-3685	−	GAGACCAUGAGAUGGAUUUU	20	18785
CFTR-Intron2-3686	−	AGAGACCAUGAGAUGGAUUUU	21	18786
CFTR-Intron2-3687	−	UAGAGACCAUGAGAUGGAUUUU	22	18787
CFTR-Intron2-3688	−	UUAGAGACCAUGAGAUGGAUUUU	23	18788
CFTR-Intron2-3689	−	AUUAGAGACCAUGAGAUGGAUUUU	24	18789

Table 39A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within intron 2, have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 39A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-3690	−	GGUGAGUCUGCUCCAUA	17	18790
CFTR-Intron2-3691	−	GGCCUAUUACUCCUUUA	17	18791
CFTR-Intron2-3692	+	GUGAAUCUGCUACUCCC	17	18792
CFTR-Intron2-3693	+	GUUUUGAAAGCAAAUAU	17	18793
CFTR-Intron2-3694	+	GGAUCUUGGCAUCCCCU	17	18794
CFTR-Intron2-3695	+	GCACACUGCAGUUAUGU	17	18795
CFTR-Intron2-3696	−	GAAGGUGAGUCUGCUCCAUA	20	18796
CFTR-Intron2-3697	+	GAACUUGUCAAUAUACCUGC	20	18797
CFTR-Intron2-3698	−	GUUUAUGUACACACCCCUUC	20	18798
CFTR-Intron2-3699	−	GUUUUAAUUGGAUGCUGAGG	20	18799
CFTR-Intron2-3700	−	GUUUUAUUUUCUCAGACCGG	20	18800
CFTR-Intron2-3522	−	GGGAUGCCAAGAUCCAUGCU	20	18622
CFTR-Intron2-2554	+	GCACUAUGACUCAAGAGUCU	20	17654
CFTR-Intron2-3701	−	GUGCAAACCACACAUCCGUU	20	18801

Table 39B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 2 and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 39B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-3702	−	UAGAUGGGAAAAGGUAA	17	18802
CFTR-Intron2-3703	−	CUUAUUAGAGACCAUGA	17	18803
CFTR-Intron2-3704	+	CAAUUAACCCAGCCCUA	17	18804
CFTR-Intron2-3705	−	CUGAAUUUGCAGAAUUA	17	18805
CFTR-Intron2-3706	+	UAGGUAAACAAUUAGAC	17	18806
CFTR-Intron2-3707	−	CACCCUUGGGAAGUGAC	17	18807
CFTR-Intron2-3708	−	UGGCUCAAUUUUGUGAC	17	18808
CFTR-Intron2-3709	+	UCAAAAGGAUCCUAACC	17	18809
CFTR-Intron2-3710	+	AAUACUAUAGGAACACC	17	18810
CFTR-Intron2-3711	+	CAUCUAUUUCCCUCCCC	17	18811
CFTR-Intron2-3712	−	UCAAAAGGUUAGGAUCC	17	18812
CFTR-Intron2-3713	+	CUUGUCAAUAUACCUGC	17	18813
CFTR-Intron2-3714	+	AUUUAUUAAGUUAUUGC	17	18814
CFTR-Intron2-3715	−	UAUGUACACACCCCUUC	17	18815
CFTR-Intron2-3716	+	AAAGGAGUAAUACACAG	17	18816
CFTR-Intron2-3717	−	CACUUCUAAGAUCAAGG	17	18817
CFTR-Intron2-3718	−	UUAAUUGGAUGCUGAGG	17	18818
CFTR-Intron2-3719	−	UUAUUUUCUCAGACCGG	17	18819
CFTR-Intron2-3720	−	UCCAUGCUUAGAGAUUG	17	18820
CFTR-Intron2-3721	−	UUUCAAAGACCUUUAAU	17	18821
CFTR-Intron2-3722	−	CUAGGGGAUGCCAAGAU	17	18822
CFTR-Intron2-3723	−	UGAAGUAAAUCGUGUAU	17	18823
CFTR-Intron2-3724	+	UGAUUGGAAAGGAAACU	17	18824
CFTR-Intron2-3725	−	AUGCCAAGAUCCAUGCU	17	18825
CFTR-Intron2-3726	−	AUUAAGCUAGUGGGAGU	17	18826
CFTR-Intron2-3727	+	CUAGGUCUUCACAUAGU	17	18827
CFTR-Intron2-3728	−	CAAACCACACAUCCGUU	17	18828
CFTR-Intron2-3729	−	AAAUAGAUGGGAAAAGGUAA	20	18829
CFTR-Intron2-3730	−	AGUUUUCACUGUAUCCCCCA	20	18830
CFTR-Intron2-3731	−	UCCCAGAGACUCUUGAGUCA	20	18831
CFTR-Intron2-3732	−	UGUCUUAUUAGAGACCAUGA	20	18832
CFTR-Intron2-3733	+	UUUCAAUUAACCCAGCCCUA	20	18833
CFTR-Intron2-3734	−	AAUCUGAAUUUGCAGAAUUA	20	18834
CFTR-Intron2-3735	−	CCCGGCCUAUUACUCCUUUA	20	18835
CFTR-Intron2-3736	+	AACUAGGUAAACAAUUAGAC	20	18836
CFTR-Intron2-3737	−	CUGCACCCUUGGGAAGUGAC	20	18837
CFTR-Intron2-3738	−	AUCUGGCUCAAUUUUGUGAC	20	18838
CFTR-Intron2-3739	+	CAAUCAAAAGGAUCCUAACC	20	18839
CFTR-Intron2-3740	+	UUAAAUACUAUAGGAACACC	20	18840
CFTR-Intron2-3741	+	AGUGUGAAUCUGCUACUCCC	20	18841
CFTR-Intron2-3742	−	CAAUCAAAAGGUUAGGAUCC	20	18842
CFTR-Intron2-2142	+	CAUAAAGGAGUAAUACACAG	20	17242
CFTR-Intron2-3743	−	UCACACUUCUAAGAUCAAGG	20	18843
CFTR-Intron2-3744	+	CUAGCCAUUUCACAUUCCAU	20	18844
CFTR-Intron2-3745	−	CUUCUAGGGGAUGCCAAGAU	20	18845
CFTR-Intron2-2486	+	UUUUGAUUGGAAAGGAAACU	20	17586
CFTR-Intron2-3746	+	CAUGGAUCUUGGCAUCCCCU	20	18846
CFTR-Intron2-3747	−	AGAAUUAAGCUAGUGGGAGU	20	18847
CFTR-Intron2-3748	+	CACCUAGGUCUUCACAUAGU	20	18848
CFTR-Intron2-3749	+	UUUGCACACUGCAGUUAUGU	20	18849
CFTR-Intron2-3750	−	CAGUGACAGAAACCCAAUUU	20	18850

Table 39C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within intron 2 and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 39C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-3751	−	GUUAAUGAAUGAUGGAG	17	18851
CFTR-Intron2-3752	+	GCCAUUUCACAUUCCAU	17	18852

Table 39D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within intron 2. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 39D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron2-3753	+	CCAGAUAAUUCUGCAAA	17	18853
CFTR-Intron2-3754	−	UCCUUUGUGAAGAGAAA	17	18854
CFTR-Intron2-3755	+	CUGUAAAAUAGAGAUAA	17	18855
CFTR-Intron2-3756	−	UUUCACUGUAUCCCCCA	17	18856
CFTR-Intron2-3757	+	UAUCUCUCUGAGCCUCA	17	18857
CFTR-Intron2-3758	−	CAGAGACUCUUGAGUCA	17	18858
CFTR-Intron2-3759	+	CCCAGCUACUCAGGAGA	17	18859
CFTR-Intron2-3760	−	UAGAAGGGCUCUCAUUA	17	18860
CFTR-Intron2-3761	−	CUUCGUCUCCUGGGUUC	17	18861
CFTR-Intron2-3762	+	CUACUCAGGAGACUGAG	17	18862
CFTR-Intron2-3763	−	CUUGGCCUCCCAAAAUG	17	18863
CFTR-Intron2-3764	−	AGGUGUGAGCCACUAUG	17	18864
CFTR-Intron2-3765	−	CUUGGCCUCCCAAAGUG	17	18865
CFTR-Intron2-3766	+	CUAUGACUCAAGAGUCU	17	18866
CFTR-Intron2-3767	−	UGACAGAAACCCAAUUU	17	18867
CFTR-Intron2-3768	−	AAGAAAACAGAAAGUUU	17	18868
CFTR-Intron2-3769	−	AUAUUAAACUUUAUUUU	17	18869
CFTR-Intron2-3770	+	AAGCCAGAUAAUUCUGCAAA	20	18870
CFTR-Intron2-3771	−	UAUUCCUUUGUGAAGAGAAA	20	18871
CFTR-Intron2-3772	+	UUUCUGUAAAAUAGAGAUAA	20	18872
CFTR-Intron2-3773	+	UAUUAUCUCUCUGAGCCUCA	20	18873
CFTR-Intron2-1715	+	AGUCCCAGCUACUCAGGAGA	20	16815
CFTR-Intron2-3774	−	UUAUAGAAGGGCUCUCAUUA	20	18874
CFTR-Intron2-3775	+	UCCCAUCUAUUUCCCUCCCC	20	18875
CFTR-Intron2-3776	+	UGUAUUUAUUAAGUUAUUGC	20	18876
CFTR-Intron2-3777	−	AAACUUCGUCUCCUGGGUUC	20	18877
CFTR-Intron2-3778	−	CCAGUUAAUGAAUGAUGGAG	20	18878
CFTR-Intron2-3779	+	CAGCUACUCAGGAGACUGAG	20	18879
CFTR-Intron2-3291	−	CACCUUGGCCUCCCAAAAUG	20	18391
CFTR-Intron2-3780	−	UAUAGGUGUGAGCCACUAUG	20	18880
CFTR-Intron2-3352	−	CGCCUUGGCCUCCCAAAGUG	20	18452
CFTR-Intron2-3781	−	AGAUCCAUGCUUAGAGAUUG	20	18881
CFTR-Intron2-3782	−	AUUUUUCAAAGACCUUUAAU	20	18882
CFTR-Intron2-3783	+	AAGGUUUUGAAAGCAAAUAU	20	18883
CFTR-Intron2-3784	−	UUAUGAAGUAAAUCGUGUAU	20	18884
CFTR-Intron2-3785	−	UAAAAGAAAACAGAAAGUUU	20	18885
CFTR-Intron2-3786	−	AAGAUAUUAAACUUUAUUUU	20	18886

Table 40A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within intron 10, have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 40A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-1	−	GCUUUCUAGUAUUAGAA	17	18887
CFTR-Intron10-2	−	GGCCUUUAAACAUUGAA	17	18888
CFTR-Intron10-3	−	GUAGUAUUAAACCAUAA	17	18889
CFTR-Intron10-4	−	GUUUACUAGAAAGAUAA	17	18890
CFTR-Intron10-5	−	GACCUAAGAUAUCCUAA	17	18891
CFTR-Intron10-6	−	GUAUUAGAAUGGGCUAA	17	18892
CFTR-Intron10-7	−	GCUGGAUAAGAUUCUAA	17	18893
CFTR-Intron10-8	+	GAUCAAUAAUAGAGACA	17	18894
CFTR-Intron10-9	+	GUGUUUAAAUAUUCCCA	17	18895
CFTR-Intron10-10	−	GUGCCACUAGUGAUGCA	17	18896
CFTR-Intron10-11	−	GUACAAGUCUAGUUUCA	17	18897
CFTR-Intron10-12	−	GGCUGGUAGUGUGAAGA	17	18898
CFTR-Intron10-13	+	GUGAUGCAGACAACAGA	17	18899
CFTR-Intron10-14	+	GACUAAAACUGAGUAGA	17	18900
CFTR-Intron10-15	+	GGUACAAAUUUCAGGGA	17	18901
CFTR-Intron10-16	+	GUCUCUCUAAGGUGUGA	17	18902
CFTR-Intron10-17	+	GUUCUUAGGGUGGGAUA	17	18903
CFTR-Intron10-18	−	GUGUAGGGGUUAGCCUA	17	18904
CFTR-Intron10-19	+	GCCUAUCACCUAGGCUA	17	18905
CFTR-Intron10-20	+	GUGUGAGGGUCUCUCUA	17	18906
CFTR-Intron10-21	−	GACUGAAAGCUGGCUUA	17	18907
CFTR-Intron10-22	+	GUAUGUAGGAAAACAAC	17	18908
CFTR-Intron10-23	+	GUAUUAAGUAUAGCCAC	17	18909
CFTR-Intron10-24	−	GUGAGAUUAGAGGCCAC	17	18910
CFTR-Intron10-25	−	GAUGAGCAGAUAAUUAC	17	18911
CFTR-Intron10-26	+	GUAUCUCCAAAUAUGCC	17	18912
CFTR-Intron10-27	−	GAAUGAAUGUGGUAUCC	17	18913
CFTR-Intron10-28	+	GACAUCAGUUGGGUUCC	17	18914
CFTR-Intron10-29	+	GUUGGAUGAGGGAAUGC	17	18915
CFTR-Intron10-30	+	GCUAUUUAAACAGAAUC	17	18916
CFTR-Intron10-31	−	GACUGACUAUACCUGUC	17	18917
CFTR-Intron10-32	−	GUCUAUUGUGCCAGUUC	17	18918
CFTR-Intron10-33	+	GAAUUGGUACAAAUUUC	17	18919
CFTR-Intron10-34	−	GAUGAUUCCAAGCUUUC	17	18920
CFTR-Intron10-35	+	GAUAUCUUAGGUCAAAG	17	18921
CFTR-Intron10-36	−	GUCUAGUUUCAAGGAAG	17	18922
CFTR-Intron10-37	+	GCUAAAGUAUUACCCAG	17	18923
CFTR-Intron10-38	−	GGCAUUCUAAGUAUUAG	17	18924
CFTR-Intron10-39	−	GUCAGAGAAGUAAUCGG	17	18925
CFTR-Intron10-40	−	GAAGUAAUCGGCGGUGG	17	18926
CFTR-Intron10-41	+	GCUACCUUGGUUGGAUG	17	18927
CFTR-Intron10-42	−	GAUUGUCAUUUUAGCUG	17	18928
CFTR-Intron10-43	+	GAAAUGGGGUAUAAGUG	17	18929
CFTR-Intron10-44	−	GAUGGUAUUGCAGGGUG	17	18930
CFTR-Intron10-45	−	GAGCCAAAAAUUGGGUG	17	18931
CFTR-Intron10-46	−	GGCAUCUCACCAGUGUG	17	18932
CFTR-Intron10-47	+	GGUCUCUCUAAGGUGUG	17	18933
CFTR-Intron10-48	−	GGUAAGCUCAAGCAUUG	17	18934
CFTR-Intron10-49	−	GUAUUUACCAUAUAUUG	17	18935
CFTR-Intron10-50	−	GGUUUCCACUCAACAAU	17	18936
CFTR-Intron10-51	−	GCUGGUAGUGUGAAGAU	17	18937
CFTR-Intron10-52	−	GUGCAAAGCUUUCAGAU	17	18938
CFTR-Intron10-53	−	GAAGGGUGUUAUCAACU	17	18939
CFTR-Intron10-54	−	GAAUUGAAUAUGAGACU	17	18940
CFTR-Intron10-55	−	GGAAGGCAGUGGUCCCU	17	18941
CFTR-Intron10-56	−	GUGAAAAUAUCACUUCU	17	18942
CFTR-Intron10-57	−	GGAGCCAAAAAUUGGGU	17	18943
CFTR-Intron10-58	+	GGAUUGGCUACCUUGGU	17	18944
CFTR-Intron10-59	−	GUCACUGUAUUGUCUGU	17	18945
CFTR-Intron10-60	−	GCAUCUCACCAGUGUGU	17	18946
CFTR-Intron10-61	+	GAAGUAGAAGAACUAUU	17	18947
CFTR-Intron10-62	+	GUUUGUCUUAGAUUAUU	17	18948
CFTR-Intron10-63	−	GAUUAGCUUAUAUACUU	17	18949
CFTR-Intron10-64	−	GAAGGCAGUGGUCCCUU	17	18950
CFTR-Intron10-65	+	GAGUGCAUAAAGGUUGAAAA	20	18951
CFTR-Intron10-66	−	GCUAUUCUGUAGGGAGACAA	20	18952
CFTR-Intron10-67	−	GAUACUAAAUAAGUUAGCAA	20	18953
CFTR-Intron10-68	−	GAGGGUUGAUAAGAAGAGAA	20	18954
CFTR-Intron10-69	−	GCCGUUUACUAGAAAGAUAA	20	18955
CFTR-Intron10-70	−	GGGUGUAGGGGUUAGCCUAA	20	18956
CFTR-Intron10-71	−	GGGGCUGGAUAAGAUUCUAA	20	18957
CFTR-Intron10-72	+	GGUAUAAGUGUGGAGUGUAA	20	18958
CFTR-Intron10-73	−	GGAAGAUCCAAUAGGAUUAA	20	18959
CFTR-Intron10-74	−	GGCUGGCAUAGAGUAAGACA	20	18960
CFTR-Intron10-75	−	GGCUAUUCUGUAGGGAGACA	20	18961
CFTR-Intron10-76	+	GAAGUGUUUAAAUAUUCCCA	20	18962
CFTR-Intron10-77	+	GUGCUAUUUAAACAGAAUCA	20	18963
CFTR-Intron10-78	+	GGAUUGCUUGAUGUUAUUCA	20	18964
CFTR-Intron10-79	−	GAUGUACAAGUCUAGUUUCA	20	18965
CFTR-Intron10-80	−	GGGGGCUGGUAGUGUGAAGA	20	18966
CFTR-Intron10-81	+	GCUGUGAUGCAGACAACAGA	20	18967
CFTR-Intron10-82	−	GCAAGUGCAAAGCUUUCAGA	20	18968
CFTR-Intron10-83	−	GGCAUAGAGUAAGACAGGGA	20	18969
CFTR-Intron10-84	+	GUUGUUCUUAGGGUGGGAUA	20	18970
CFTR-Intron10-85	−	GGGGUGUAGGGGUUAGCCUA	20	18971
CFTR-Intron10-86	−	GUCUGGUUUGAAGAACAGUA	20	18972
CFTR-Intron10-87	+	GCCAGGUUAAGUUGUUCUUA	20	18973
CFTR-Intron10-88	−	GAGUUUUAAACAGAAGUAAC	20	18974
CFTR-Intron10-89	+	GACUGAAACUCCCCACACAC	20	18975
CFTR-Intron10-90	+	GCUAAGAGACUCCUGAAUCC	20	18976
CFTR-Intron10-91	+	GUUUUAGUAGAAACCUAAUC	20	18977
CFTR-Intron10-92	−	GGAUUAGGGAAUGCAGACUC	20	18978
CFTR-Intron10-93	−	GGAGUCUAUUGUGCCAGUUC	20	18979
CFTR-Intron10-94	+	GCUUGACAUCAGUUGGGUUC	20	18980
CFTR-Intron10-95	−	GAUAAGAUUCUAAAGGAAAG	20	18981
CFTR-Intron10-96	+	GGGUCAAUUGUAUUAGCAAG	20	18982
CFTR-Intron10-97	+	GGCUUAACCCAUCUAUUAAG	20	18983
CFTR-Intron10-98	+	GCAUAUUGGACCAGACACAG	20	18984
CFTR-Intron10-99	−	GCAUAUGAGAAAAGUCACAG	20	18985
CFTR-Intron10-100	+	GCCUAGAUGAUUAUUAAUAG	20	18986
CFTR-Intron10-101	−	GUAAUCGGCGGUGGAGGUAG	20	18987
CFTR-Intron10-102	+	GAUCAAUAAUAGAGACAAGG	20	18988
CFTR-Intron10-103	−	GUCUAGUUUCAAGGAAGAGG	20	18989
CFTR-Intron10-104	−	GUUUACUAACUCAAUCUAGG	20	18990
CFTR-Intron10-105	−	GUCAGAGAAGUAAUCGGCGG	20	18991
CFTR-Intron10-106	−	GGGCUGGUAGUGUGAAGAUG	20	18992
CFTR-Intron10-107	+	GUUACAUAAAAAGAGAGGUG	20	18993
CFTR-Intron10-108	+	GAGGGUCUCUCUAAGGUGUG	20	18994
CFTR-Intron10-109	−	GCUUUGAAGGAAGAUCCAAU	20	18995
CFTR-Intron10-110	−	GAGCUUUCUAGUAUUAGAAU	20	18996
CFTR-Intron10-111	−	GGGGCUGGUAGUGUGAAGAU	20	18997
CFTR-Intron10-112	−	GUCUUUUCCUCUUAAUAGAU	20	18998
CFTR-Intron10-113	−	GCAGAAGGGUGUUAUCAACU	20	18999
CFTR-Intron10-114	−	GAAGAAUUGAAUAUGAGACU	20	19000
CFTR-Intron10-115	+	GUUACAACAGUCUUUAUACU	20	19001
CFTR-Intron10-116	+	GUUACCUGGAUUGGCUACCU	20	19002
CFTR-Intron10-117	+	GUUACUCAGUCCAGAAAGCU	20	19003
CFTR-Intron10-118	−	GGAGUUUACUAACUCAAUCU	20	19004
CFTR-Intron10-119	−	GAUUAGGGAAUGCAGACUCU	20	19005
CFTR-Intron10-120	+	GGAAAGUUGUCCAAGAUAGU	20	19006
CFTR-Intron10-121	−	GUAUUAGAGGUUAAGGAGGU	20	19007
CFTR-Intron10-122	−	GGAAGCAGUGCUGCUGCUGU	20	19008
CFTR-Intron10-123	−	GAAGUCACUGUAUUGUCUGU	20	19009
CFTR-Intron10-124	−	GUUACCCAAUAAAAAAAAUU	20	19010
CFTR-Intron10-125	−	GCUUUCAGGAGCCAAAAAUU	20	19011
CFTR-Intron10-126	−	GGCUGCCUUUUAGUAGUAUU	20	19012
CFTR-Intron10-127	−	GAGGAAGGCAGUGGUCCCUU	20	19013
CFTR-Intron10-128	−	GUUUUGGAUGGAGCUUGGUU	20	19014
CFTR-Intron10-129	−	GGGUUUGAUUAGAUAAAUUU	20	19015
CFTR-Intron10-130	−	GUUGUUAUCUCUGAAAUUUU	20	19016
CFTR-Intron10-131	+	GGGCUCCCCCACCCAAUUUU	20	19017

Table 40B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 10 and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 40B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-132	+	AGCUAUGCCCUUAAAAA	17	19018
CFTR-Intron10-133	−	AUCAUCUAGGCUGCAAA	17	19019
CFTR-Intron10-134	−	ACCUUCAUGUUGAUAAA	17	19020
CFTR-Intron10-135	+	UUCCUAAUACUACUAAA	17	19021
CFTR-Intron10-136	−	UAUUAGAAUGGGCUAAA	17	19022
CFTR-Intron10-137	+	UCACGUGGUGUUUUAAA	17	19023
CFTR-Intron10-138	+	UACCAUUAUCUACACAA	17	19024
CFTR-Intron10-139	−	AUUCUGUAGGGAGACAA	17	19025
CFTR-Intron10-140	−	ACUAAAUAAGUUAGCAA	17	19026
CFTR-Intron10-141	+	AGCCAGCUUUCAGUCAA	17	19027
CFTR-Intron10-142	−	UGUUGAUAAAGGGUCAA	17	19028
CFTR-Intron10-143	−	ACUGAUGUCAAGCAGAA	17	19029
CFTR-Intron10-144	−	UUUAGUAGUAUUAGGAA	17	19030
CFTR-Intron10-145	−	UAAGAAAGACUCCUGAA	17	19031
CFTR-Intron10-146	+	AAGCAAAGAGUGCAUAA	17	19032
CFTR-Intron10-147	−	ACCCAUUGUGUAGAUAA	17	19033
CFTR-Intron10-148	−	AACCUUCAUGUUGAUAA	17	19034
CFTR-Intron10-149	−	UUGGUGUAGUUCUAUAA	17	19035
CFTR-Intron10-150	−	UGUAGGGGUUAGCCUAA	17	19036
CFTR-Intron10-151	+	AUAAGUGUGGAGUGUAA	17	19037
CFTR-Intron10-152	−	AGAUCCAAUAGGAUUAA	17	19038
CFTR-Intron10-153	+	UCAACUUUAUCUGUUAA	17	19039
CFTR-Intron10-154	+	UACCUUUCAAUGUUUAA	17	19040
CFTR-Intron10-155	−	UAGCAAUGGUCUAAACA	17	19041
CFTR-Intron10-156	+	ACAAUCAAAUGGGAACA	17	19042
CFTR-Intron10-157	+	ACCUAUAAGGAAUAACA	17	19043
CFTR-Intron10-158	−	UGGCAUAGAGUAAGACA	17	19044
CFTR-Intron10-159	−	UAUUCUGUAGGGAGACA	17	19045
CFTR-Intron10-160	+	UUACAAUUCUUAUUACA	17	19046
CFTR-Intron10-161	−	AUUCCCUCAUCCAACCA	17	19047
CFTR-Intron10-162	+	UAAAGACUUCACCCUCA	17	19048
CFTR-Intron10-163	+	AAGCCAGCUUUCAGUCA	17	19049
CFTR-Intron10-164	+	AUCUAAAAGCUAAUUCA	17	19050
CFTR-Intron10-165	+	UUGCUUGAUGUUAUUCA	17	19051
CFTR-Intron10-166	−	UCUAGUUUCAAGGAAGA	17	19052
CFTR-Intron10-167	−	AACUGAUGUCAAGCAGA	17	19053
CFTR-Intron10-168	−	AGUGCAAAGCUUUCAGA	17	19054
CFTR-Intron10-169	+	ACCCUUUAUCAACAUGA	17	19055
CFTR-Intron10-170	+	CUACCUUGGUUGGAUGA	17	19056
CFTR-Intron10-171	−	AUGAAAAGCAGCUAUGA	17	19057
CFTR-Intron10-172	−	UUAAAGAAUGACUGUGA	17	19058
CFTR-Intron10-173	−	CGGUGUCUUCUGAAAUA	17	19059
CFTR-Intron10-174	+	CUAGAUGAUUAUUAAUA	17	19060
CFTR-Intron10-175	−	ACUAAUUGUAGUACAUA	17	19061
CFTR-Intron10-176	+	AAAUUACAGAACCUAUA	17	19062
CFTR-Intron10-177	−	UGAUCAUUGCCUCACUA	17	19063
CFTR-Intron10-178	−	AGUGCUCGUAAAGACUA	17	19064
CFTR-Intron10-179	−	UGACCUAAGAUAUCCUA	17	19065
CFTR-Intron10-180	−	AAUCGGCGGUGGAGGUA	17	19066
CFTR-Intron10-181	+	ACUCUAUUUAGAGUGUA	17	19067
CFTR-Intron10-182	+	AGGUUAAGUUGUUCUUA	17	19068
CFTR-Intron10-183	+	UAUCAACAUGAAGGUUA	17	19069
CFTR-Intron10-184	−	CUAAGUAUUAGAGGUUA	17	19070
CFTR-Intron10-185	+	CUAUUAUUCAACAUUUA	17	19071
CFTR-Intron10-186	+	UCUUUACGAGCACUUUA	17	19072
CFTR-Intron10-187	+	CAAGCCUGUAUUGUUUA	17	19073
CFTR-Intron10-188	+	CUUACCGUAAUAGCAAC	17	19074
CFTR-Intron10-189	+	UCAUCACUUGCCUGAAC	17	19075
CFTR-Intron10-190	+	AACCUAUAAGGAAUAAC	17	19076
CFTR-Intron10-191	−	CUUAUUCUUGUAAUAAC	17	19077
CFTR-Intron10-192	−	UUUCUGGACUGAGUAAC	17	19078
CFTR-Intron10-193	+	UGAAACUCCCCACACAC	17	19079
CFTR-Intron10-194	+	CGUAUUUCAGAAGACAC	17	19080
CFTR-Intron10-195	−	CAUUUCAACUUAUACAC	17	19081
CFTR-Intron10-196	−	UUCUGUUUAAAUAGCAC	17	19082
CFTR-Intron10-197	−	AUAGAAUUUUGCAUCAC	17	19083
CFTR-Intron10-198	−	CUGGCAUAGAGUAAGAC	17	19084
CFTR-Intron10-199	+	UGUUCUUCAAACCAGAC	17	19085
CFTR-Intron10-200	−	AGUGCCUAGCACUUGAC	17	19086
CFTR-Intron10-201	+	UACAACAGUCUUUAUAC	17	19087
CFTR-Intron10-202	−	CAAAUUCCAAGACUUAC	17	19088
CFTR-Intron10-203	−	CUAAGAACAACUUAACC	17	19089
CFTR-Intron10-204	+	CUACUUCCACUACUACC	17	19090
CFTR-Intron10-205	−	CUAACACCUACCCUACC	17	19091
CFTR-Intron10-206	+	UUACUGUGAAUGGUGCC	17	19092
CFTR-Intron10-207	−	ACCAAGGUAGCCAAUCC	17	19093
CFTR-Intron10-208	+	AAGAGACUCCUGAAUCC	17	19094
CFTR-Intron10-209	+	UAUAGCUCUGAUAAUCC	17	19095
CFTR-Intron10-210	−	AAGACAGCUGGCUAUCC	17	19096
CFTR-Intron10-211	+	AUUAGCAAGUGGACUCC	17	19097
CFTR-Intron10-212	−	UUCUUUUGAUAUACUCC	17	19098
CFTR-Intron10-213	−	UGCCCUUGACUGAAAGC	17	19099
CFTR-Intron10-214	−	UAAAUUUGGUGUCAGGC	17	19100
CFTR-Intron10-215	−	UAGUGUGAAGAUGGGGC	17	19101
CFTR-Intron10-216	+	UCAUGUUAGACAUAUGC	17	19102
CFTR-Intron10-217	+	CAAGACUUCACACCUGC	17	19103
CFTR-Intron10-218	−	AGCAGACCCAAAUCUGC	17	19104
CFTR-Intron10-219	+	AUUUAUCUCGAAAUUGC	17	19105
CFTR-Intron10-220	+	UUAGUAGAAACCUAAUC	17	19106
CFTR-Intron10-221	−	UUAGGGAAUGCAGACUC	17	19107
CFTR-Intron10-222	−	AGCUGUGCAUUUUCCUC	17	19108
CFTR-Intron10-223	−	ACUAAGGCUUAUUUCUC	17	19109
CFTR-Intron10-224	−	UAACUUUUCUUAUUGUC	17	19110
CFTR-Intron10-225	−	ACCAAAACUUUAUUGUC	17	19111
CFTR-Intron10-226	−	CUGGCUAUCCAGGAUUC	17	19112
CFTR-Intron10-227	+	UGACAUCAGUUGGGUUC	17	19113
CFTR-Intron10-228	+	UCAAUUGUAUUAGCAAG	17	19114
CFTR-Intron10-229	−	AGUAGGCUUCCUAUAAG	17	19115
CFTR-Intron10-230	+	UUAACCCAUCUAUUAAG	17	19116
CFTR-Intron10-231	+	UAUUGGACCAGACACAG	17	19117
CFTR-Intron10-232	−	CUAGUUUCAAGGAAGAG	17	19118
CFTR-Intron10-233	+	UACCAAAUUGUAUUGAG	17	19119
CFTR-Intron10-234	+	ACACCAAAUUUAUUGAG	17	19120
CFTR-Intron10-235	+	AAAGUUGUCCAAGAUAG	17	19121
CFTR-Intron10-236	+	UUUCCGUGCAUCACUAG	17	19122
CFTR-Intron10-237	−	CUUGAUCCAGGUAGUAG	17	19123
CFTR-Intron10-238	−	AUCGGCGGUGGAGGUAG	17	19124
CFTR-Intron10-239	−	AAGAGAAAGGGGUGUAG	17	19125
CFTR-Intron10-240	−	UCUCUGGGUGAGAUUAG	17	19126
CFTR-Intron10-241	+	AUCAACAUGAAGGUUAG	17	19127
CFTR-Intron10-242	−	UGUGAGAAAAAGUUUAG	17	19128
CFTR-Intron10-243	−	AAAUCAGUGCUUUUUCG	17	19129
CFTR-Intron10-244	+	CAAUAAUAGAGACAAGG	17	19130
CFTR-Intron10-245	−	AGUAUUAGAGGUUAAGG	17	19131
CFTR-Intron10-246	−	UUCAACUUAUACACAGG	17	19132
CFTR-Intron10-247	−	AUUAGAGGUUAAGGAGG	17	19133
CFTR-Intron10-248	−	UACUAACUCAAUCUAGG	17	19134
CFTR-Intron10-249	−	UCGGCGGUGGAGGUAGG	17	19135
CFTR-Intron10-250	−	AGAGAAGUAAUCGGCGG	17	19136
CFTR-Intron10-251	−	CAUAGAGUAAGACAGGG	17	19137
CFTR-Intron10-252	+	UUAAGUUGUUCUUAGGG	17	19138
CFTR-Intron10-253	−	AGGAGCCAAAAAUUGGG	17	19139
CFTR-Intron10-254	−	AGCCAAAAAUUGGGUGG	17	19140
CFTR-Intron10-255	−	CUGGUAGUGUGAAGAUG	17	19141
CFTR-Intron10-256	−	UAUCAAUAUCUAAGAUG	17	19142
CFTR-Intron10-257	+	AUCUGUUAGUAAUGCUG	17	19143
CFTR-Intron10-258	−	UUAAGGGCAUAGCUCUG	17	19144
CFTR-Intron10-259	+	AACUCAGUACCAUAGUG	17	19145
CFTR-Intron10-260	+	CUGUUAGUAAUGCUGUG	17	19146
CFTR-Intron10-261	−	CAUCUCACCAGUGUGUG	17	19147
CFTR-Intron10-262	−	CUCUCUUUUAACUAUUG	17	19148
CFTR-Intron10-263	+	UGAGUGGAAAUUUUUUG	17	19149
CFTR-Intron10-264	−	UUUCAGGAGCCAAAAAU	17	19150
CFTR-Intron10-265	+	ACCAUUAUCUACACAAU	17	19151
CFTR-Intron10-266	−	AUGGGCUAAAGGGCAAU	17	19152
CFTR-Intron10-267	−	CUUUCUAGUAUUAGAAU	17	19153
CFTR-Intron10-268	+	AUGGCAUGAGUACGAAU	17	19154
CFTR-Intron10-269	+	CCUAGAUGAUUAUUAAU	17	19155
CFTR-Intron10-270	−	UUUUCCUCUUAAUAGAU	17	19156
CFTR-Intron10-271	+	AAAAAAGUUACCUGGAU	17	19157
CFTR-Intron10-272	+	UUAUCCAUUAAUCCUAU	17	19158
CFTR-Intron10-273	+	AAUGCUUGACCACUUAU	17	19159
CFTR-Intron10-274	−	UCCCUGUUAUUCCUUAU	17	19160
CFTR-Intron10-275	+	ACAACAGUCUUUAUACU	17	19161
CFTR-Intron10-276	+	UUGCUUCACCUGCUACU	17	19162
CFTR-Intron10-277	+	AUCUUAUAGAGAUUACU	17	19163
CFTR-Intron10-278	+	UUUUGAGCCUAUCACCU	17	19164
CFTR-Intron10-279	+	ACCUGGAUUGGCUACCU	17	19165
CFTR-Intron10-280	+	CACUUGUUGACAGUCCU	17	19166
CFTR-Intron10-281	+	ACUCAGUCCAGAAAGCU	17	19167
CFTR-Intron10-282	+	ACUCAUAAGGGACCGCU	17	19168
CFTR-Intron10-283	−	AAAUUUGGUGUCAGGCU	17	19169
CFTR-Intron10-284	+	AGCCUAUCACCUAGGCU	17	19170
CFTR-Intron10-285	+	UAUACCUGUCAAGUGCU	17	19171
CFTR-Intron10-286	−	CCUAUUAAUAAUCAUCU	17	19172
CFTR-Intron10-287	−	UAGGGAAUGCAGACUCU	17	19173
CFTR-Intron10-288	+	UAGAGAGAAACAUCUCU	17	19174
CFTR-Intron10-289	−	CUAAGGCUUAUUUCUCU	17	19175
CFTR-Intron10-290	+	UAAUUGCCAGUAAGUCU	17	19176
CFTR-Intron10-291	+	AUUUUCUCGGUAUUUCU	17	19177
CFTR-Intron10-292	−	AUUUUUGACUAUACAGU	17	19178
CFTR-Intron10-293	+	UUCUGCUUGACAUCAGU	17	19179
CFTR-Intron10-294	+	ACCAAAUUGUAUUGAGU	17	19180
CFTR-Intron10-295	+	AAGUUGUCCAAGAUAGU	17	19181
CFTR-Intron10-296	−	CAAAUAGAGAUGUUAGU	17	19182
CFTR-Intron10-297	+	UGUGAAUGGUGCCAGGU	17	19183
CFTR-Intron10-298	−	UAAUCGGCGGUGGAGGU	17	19184
CFTR-Intron10-299	−	UGAUGGUAUUGCAGGGU	17	19185
CFTR-Intron10-300	+	AUGGUGCCAGGUAGGGU	17	19186
CFTR-Intron10-301	+	UAAGUUGUUCUUAGGGU	17	19187
CFTR-Intron10-302	−	UUGACUAUACAGUGGGU	17	19188
CFTR-Intron10-303	+	AAAGCUGUUUCGUAUGU	17	19189
CFTR-Intron10-304	+	UCUGUUAGUAAUGCUGU	17	19190
CFTR-Intron10-305	−	AGCAGUGCUGCUGCUGU	17	19191
CFTR-Intron10-306	−	UUUUUAGGCUAUUCUGU	17	19192
CFTR-Intron10-307	−	UUCAGGAGCCAAAAAUU	17	19193
CFTR-Intron10-308	−	ACCCACUCAAUACAAUU	17	19194
CFTR-Intron10-309	−	AUGCUAAUAAUACAAUU	17	19195
CFTR-Intron10-310	−	AAUAUCACCAACUCAUU	17	19196
CFTR-Intron10-311	+	AUCUCUGCAAACAUAUU	17	19197
CFTR-Intron10-312	−	ACUUAACCUGGCAUAUU	17	19198
CFTR-Intron10-313	+	CAACUAACAUCUCUAUU	17	19199
CFTR-Intron10-314	−	UGCCUUUUAGUAGUAUU	17	19200
CFTR-Intron10-315	+	CAAUGGUUGUCUGUAUU	17	19201
CFTR-Intron10-316	+	AUACUUAGAAUGCCCUU	17	19202
CFTR-Intron10-317	−	UUGCAGGGUGGGGCCUU	17	19203
CFTR-Intron10-318	−	AUGUGCAAAAAUAGCUU	17	19204
CFTR-Intron10-319	+	CAGGUUAAGUUGUUCUU	17	19205
CFTR-Intron10-320	−	UUAGUUAGCAUAAAGUU	17	19206
CFTR-Intron10-321	+	UCUGCUUGACAUCAGUU	17	19207
CFTR-Intron10-322	+	UUAUCAACAUGAAGGUU	17	19208
CFTR-Intron10-323	−	AGUGCUUUUUCGAGGUU	17	19209
CFTR-Intron10-324	−	UUGGAUGGAGCUUGGUU	17	19210
CFTR-Intron10-325	+	UUCAUGGAAAGCUUGUU	17	19211
CFTR-Intron10-326	−	UUGUGUACUUGUGAUUU	17	19212
CFTR-Intron10-327	−	UAUGCACUCUUUGCUUU	17	19213
CFTR-Intron10-328	+	UCCUGACAAUAAAGUUU	17	19214
CFTR-Intron10-329	−	UGGAUGGAGCUUGGUUU	17	19215
CFTR-Intron10-330	−	AGAGCUAUAUUGUGUUU	17	19216
CFTR-Intron10-331	+	CUCCCCCACCCAAUUUU	17	19217
CFTR-Intron10-332	+	CAGAGCUAUGCCCUUAAAAA	20	19218
CFTR-Intron10-333	−	UGCUUCAGAAGUCUAUAAAA	20	19219
CFTR-Intron10-334	−	AUAAUCAUCUAGGCUGCAAA	20	19220
CFTR-Intron10-335	+	CAGCUAAAAUGACAAUCAAA	20	19221
CFTR-Intron10-336	−	CGUGUUAUUCAGCCAAUAAA	20	19222
CFTR-Intron10-337	−	CUAACCUUCAUGUUGAUAAA	20	19223
CFTR-Intron10-338	+	CCAUUCCUAAUACUACUAAA	20	19224
CFTR-Intron10-339	−	UAGUAUUAGAAUGGGCUAAA	20	19225
CFTR-Intron10-340	+	CCCAUUAUCUUUCUAGUAAA	20	19226
CFTR-Intron10-341	−	UUAAUGGAUAAGUUGAACAA	20	19227
CFTR-Intron10-342	+	UUUUACCAUUAUCUACACAA	20	19228
CFTR-Intron10-343	−	CUAGGUUUAAUUUUGUACAA	20	19229
CFTR-Intron10-344	+	AAGUGUUUAAAUAUUCCCAA	20	19230
CFTR-Intron10-345	+	UCAAAAGAAUAAGGCAUCAA	20	19231
CFTR-Intron10-346	+	AUAAGCCAGCUUUCAGUCAA	20	19232
CFTR-Intron10-347	−	CCAACUGAUGUCAAGCAGAA	20	19233
CFTR-Intron10-348	−	AGAGCUUUCUAGUAUUAGAA	20	19234
CFTR-Intron10-349	+	CUAAAACUGAGUAGAAGGAA	20	19235
CFTR-Intron10-350	−	CCUUUUAGUAGUAUUAGGAA	20	19236
CFTR-Intron10-351	−	AAUUAAGAAAGACUCCUGAA	20	19237
CFTR-Intron10-352	−	AGUGGCCUUUAAACAUUGAA	20	19238
CFTR-Intron10-353	−	AAUGUAGUAUUAAACCAUAA	20	19239
CFTR-Intron10-354	+	CUAAAGCAAAGAGUGCAUAA	20	19240
CFTR-Intron10-355	−	AUAACCCAUUGUGUAGAUAA	20	19241
CFTR-Intron10-356	−	CCUAACCUUCAUGUUGAUAA	20	19242
CFTR-Intron10-357	−	AUUUUGGUGUAGUUCUAUAA	20	19243
CFTR-Intron10-358	−	UUUGACCUAAGAUAUCCUAA	20	19244
CFTR-Intron10-359	−	CUAGUAUUAGAAUGGGCUAA	20	19245
CFTR-Intron10-360	+	UUGGGUAACAAUAAUAUUAA	20	19246
CFTR-Intron10-361	+	AAUUCAACUUUAUCUGUUAA	20	19247
CFTR-Intron10-362	−	AGUUAGCAAUGGUCUAAACA	20	19248
CFTR-Intron10-363	+	AUGACAAUCAAAUGGGAACA	20	19249
CFTR-Intron10-364	+	AGAACCUAUAAGGAAUAACA	20	19250
CFTR-Intron10-365	−	AGUUUUAAACAGAAGUAACA	20	19251
CFTR-Intron10-366	−	UGCAUUCCCUCAUCCAACCA	20	19252
CFTR-Intron10-367	+	UACUAAAGACUUCACCCUCA	20	19253
CFTR-Intron10-368	+	CAUAAGCCAGCUUUCAGUCA	20	19254
CFTR-Intron10-369	+	UAAAUCUAAAAGCUAAUUCA	20	19255
CFTR-Intron10-370	+	ACGAAUUGGUACAAAUUUCA	20	19256
CFTR-Intron10-371	−	AUAAGAUUCUAAAGGAAAGA	20	19257
CFTR-Intron10-372	−	AAGUCUAGUUUCAAGGAAGA	20	19258
CFTR-Intron10-373	−	CCCAACUGAUGUCAAGCAGA	20	19259
CFTR-Intron10-374	+	ACUGACUAAAACUGAGUAGA	20	19260
CFTR-Intron10-375	+	UGGCUACCUUGGUUGGAUGA	20	19261
CFTR-Intron10-376	−	CCAGUUCAGGCAAGUGAUGA	20	19262
CFTR-Intron10-377	−	CUUAUGAAAAGCAGCUAUGA	20	19263
CFTR-Intron10-378	−	UUGUUAAAGAAUGACUGUGA	20	19264
CFTR-Intron10-379	+	AGGGUCUCUCUAAGGUGUGA	20	19265
CFTR-Intron10-380	−	AACCGGUGUCUUCUGAAAUA	20	19266
CFTR-Intron10-381	+	AGGAGUAUAUCAAAAGAAUA	20	19267
CFTR-Intron10-382	+	AGUCCUCUGUGCUUUGAAUA	20	19268
CFTR-Intron10-383	−	CCCAUAAAUGUUGAAUAAUA	20	19269
CFTR-Intron10-384	+	AGCCUAGAUGAUUAUUAAUA	20	19270
CFTR-Intron10-385	−	UAUUGAUCAUUGCCUCACUA	20	19271
CFTR-Intron10-386	−	UAAAGUGCUCGUAAAGACUA	20	19272
CFTR-Intron10-387	−	CUUUGACCUAAGAUAUCCUA	20	19273
CFTR-Intron10-388	+	UGAGCCUAUCACCUAGGCUA	20	19274
CFTR-Intron10-389	−	AGUAAUCGGCGGUGGAGGUA	20	19275
CFTR-Intron10-390	−	UGUUUUUAGGCUAUUCUGUA	20	19276
CFTR-Intron10-391	+	AGCACUCUAUUUAGAGUGUA	20	19277
CFTR-Intron10-392	−	UAAGAAGAGAAAGGGGUGUA	20	19278
CFTR-Intron10-393	+	CAAUUAGUUUUAUGCCAUUA	20	19279
CFTR-Intron10-394	−	UUGCAGGAGGUGAGGGAUUA	20	19280
CFTR-Intron10-395	−	CUUGACUGAAAGCUGGCUUA	20	19281
CFTR-Intron10-396	+	CUUUAUCAACAUGAAGGUUA	20	19282
CFTR-Intron10-397	−	AUUCUAAGUAUUAGAGGUUA	20	19283
CFTR-Intron10-398	+	CCCCUAUUAUUCAACAUUUA	20	19284
CFTR-Intron10-399	+	UAGUCUUUACGAGCACUUUA	20	19285
CFTR-Intron10-400	−	AGAAAGAUAAUGGGAGAAAC	20	19286
CFTR-Intron10-401	+	UACGAUAUAAGAAAUGAAAC	20	19287
CFTR-Intron10-402	+	UUCGUAUGUAGGAAAACAAC	20	19288
CFTR-Intron10-403	+	CAGAACCUAUAAGGAAUAAC	20	19289
CFTR-Intron10-404	−	UAGCUUAUUCUUGUAAUAAC	20	19290
CFTR-Intron10-405	−	AUGAAACUGUUAUAAUUAAC	20	19291
CFTR-Intron10-406	+	CUCCGUAUUUCAGAAGACAC	20	19292
CFTR-Intron10-407	−	UAUCAUUUCAACUUAUACAC	20	19293
CFTR-Intron10-408	+	UUAGUAUUAAGUAUAGCCAC	20	19294
CFTR-Intron10-409	−	UGGGUGAGAUUAGAGGCCAC	20	19295
CFTR-Intron10-410	−	UGAUUCUGUUUAAAUAGCAC	20	19296
CFTR-Intron10-411	−	AGUAUAGAAUUUUGCAUCAC	20	19297
CFTR-Intron10-412	−	AGGCUGGCAUAGAGUAAGAC	20	19298
CFTR-Intron10-413	+	UACUGUUCUUCAAACCAGAC	20	19299
CFTR-Intron10-414	+	UGUUACAACAGUCUUUAUAC	20	19300
CFTR-Intron10-415	−	AUUGAUGAGCAGAUAAUUAC	20	19301
CFTR-Intron10-416	−	UUACAAAUUCCAAGACUUAC	20	19302
CFTR-Intron10-417	+	UACAAAUAUUGACUAUUUAC	20	19303
CFTR-Intron10-418	−	ACCCUAAGAACAACUUAACC	20	19304
CFTR-Intron10-419	+	AUACUACUUCCACUACUACC	20	19305
CFTR-Intron10-420	−	ACACUAACACCUACCCUACC	20	19306
CFTR-Intron10-421	+	AGAUACUAAAAAAAGUUACC	20	19307
CFTR-Intron10-422	+	UCUUUACUGUGAAUGGUGCC	20	19308
CFTR-Intron10-423	−	CCAACCAAGGUAGCCAAUCC	20	19309
CFTR-Intron10-424	+	CAAUAUAGCUCUGAUAAUCC	20	19310
CFTR-Intron10-425	−	AGUGAAUGAAUGUGGUAUCC	20	19311
CFTR-Intron10-426	+	UGUAUUAGCAAGUGGACUCC	20	19312
CFTR-Intron10-427	+	CUUGACAUCAGUUGGGUUCC	20	19313
CFTR-Intron10-428	−	AGUAAGGAGGUCACUGAGGC	20	19314
CFTR-Intron10-429	−	AGUUUCAAGGAAGAGGGGGC	20	19315
CFTR-Intron10-430	−	UGGUAGUGUGAAGAUGGGGC	20	19316
CFTR-Intron10-431	+	UUGGUUGGAUGAGGGAAUGC	20	19317
CFTR-Intron10-432	+	UUUUCAUGUUAGACAUAUGC	20	19318
CFTR-Intron10-433	+	AGUGCUAUUUAAACAGAAUC	20	19319
CFTR-Intron10-434	−	AAAAGCUGUGCAUUUUCCUC	20	19320
CFTR-Intron10-435	−	AAGACUAAGGCUUAUUUCUC	20	19321
CFTR-Intron10-436	−	UGGGACUGACUAUACCUGUC	20	19322
CFTR-Intron10-437	+	AAUAGAGACAAGGUGGUGUC	20	19323
CFTR-Intron10-438	−	CACUCAAUAAAUUUGGUGUC	20	19324
CFTR-Intron10-439	−	UUCUAACUUUUCUUAUUGUC	20	19325
CFTR-Intron10-440	−	AGGACCAAAACUUUAUUGUC	20	19326
CFTR-Intron10-441	−	CAGCUGGCUAUCCAGGAUUC	20	19327
CFTR-Intron10-442	+	UAUUAAGAGGAAAAGACUUC	20	19328
CFTR-Intron10-443	+	UACGAAUUGGUACAAAUUUC	20	19329
CFTR-Intron10-444	−	CUUACUGGCAAUUAAAUUUC	20	19330
CFTR-Intron10-445	+	UUGAUAAAUAAUUGCCUUUC	20	19331
CFTR-Intron10-446	+	CCUAAAAACAUUAGCCAAAG	20	19332
CFTR-Intron10-447	+	UAGGAUAUCUUAGGUCAAAG	20	19333
CFTR-Intron10-448	+	UAGGGUGGGAUAUGGAGAAG	20	19334
CFTR-Intron10-449	−	CAAGUCUAGUUUCAAGGAAG	20	19335
CFTR-Intron10-450	−	UUUCCAUAUUCAAAGCACAG	20	19336
CFTR-Intron10-451	+	ACAGCUAAAGUAUUACCCAG	20	19337
CFTR-Intron10-452	−	AGUCUAUAUUUGUUUUCCAG	20	19338
CFTR-Intron10-453	+	UGCUAUUUAAACAGAAUCAG	20	19339
CFTR-Intron10-454	+	AUAUUGUUACAUAAAAAGAG	20	19340
CFTR-Intron10-455	−	AGUCUAGUUUCAAGGAAGAG	20	19341
CFTR-Intron10-456	+	AAUUACCAAAUUGUAUUGAG	20	19342
CFTR-Intron10-457	+	CUGACACCAAAUUUAUUGAG	20	19343
CFTR-Intron10-458	−	CCAUAAAUGUUGAAUAAUAG	20	19344
CFTR-Intron10-459	+	UGGAAAGUUGUCCAAGAUAG	20	19345
CFTR-Intron10-460	+	ACUUUUCCGUGCAUCACUAG	20	19346
CFTR-Intron10-461	−	UGGCUUGAUCCAGGUAGUAG	20	19347
CFTR-Intron10-462	−	AUUUCUCUGGGUGAGAUUAG	20	19348
CFTR-Intron10-463	−	AAGGGCAUUCUAAGUAUUAG	20	19349
CFTR-Intron10-464	−	AGCUAUGAAGGCAGAGUUAG	20	19350
CFTR-Intron10-465	+	UUUAUCAACAUGAAGGUUAG	20	19351
CFTR-Intron10-466	−	AUAAAAUCAGUGCUUUUUCG	20	19352
CFTR-Intron10-467	−	CUAAGUAUUAGAGGUUAAGG	20	19353
CFTR-Intron10-468	−	CAUUUCAACUUAUACACAGG	20	19354
CFTR-Intron10-469	+	UUGUUACAUAAAAAGAGAGG	20	19355
CFTR-Intron10-470	−	AGUAUUAGAGGUUAAGGAGG	20	19356
CFTR-Intron10-471	−	UAAUCGGCGGUGGAGGUAGG	20	19357
CFTR-Intron10-472	−	ACUGUCAGAGAAGUAAUCGG	20	19358
CFTR-Intron10-473	−	AUUCUGUAGGGAGACAAGGG	20	19359
CFTR-Intron10-474	−	UGGCAUAGAGUAAGACAGGG	20	19360
CFTR-Intron10-475	+	AGGUUAAGUUGUUCUUAGGG	20	19361
CFTR-Intron10-476	−	UUCAGGAGCCAAAAAUUGGG	20	19362
CFTR-Intron10-477	−	AGAGAAGUAAUCGGCGGUGG	20	19363
CFTR-Intron10-478	−	AGGAGCCAAAAAUUGGGUGG	20	19364
CFTR-Intron10-479	−	ACAAAGCUAGUGAAUGAAUG	20	19365
CFTR-Intron10-480	−	AUUUAUCAAUAUCUAAGAUG	20	19366
CFTR-Intron10-481	+	UUGGCUACCUUGGUUGGAUG	20	19367
CFTR-Intron10-482	+	CCUAUUAUUCAACAUUUAUG	20	19368
CFTR-Intron10-483	+	CACGAAUAUAUUCUUUUAUG	20	19369
CFTR-Intron10-484	−	UUUGAUUGUCAUUUUAGCUG	20	19370
CFTR-Intron10-485	+	AUCAUCUGUUAGUAAUGCUG	20	19371
CFTR-Intron10-486	−	UUUUUAAGGGCAUAGCUCUG	20	19372
CFTR-Intron10-487	+	AAGGAAAUGGGGUAUAAGUG	20	19373
CFTR-Intron10-488	+	UAAAACUCAGUACCAUAGUG	20	19374
CFTR-Intron10-489	−	CAGGAGCCAAAAAUUGGGUG	20	19375
CFTR-Intron10-490	+	CAUCUGUUAGUAAUGCUGUG	20	19376
CFTR-Intron10-491	−	UAUGGCAUCUCACCAGUGUG	20	19377
CFTR-Intron10-492	−	UGGCAUCUCACCAGUGUGUG	20	19378
CFTR-Intron10-493	−	UACGGUAAGCUCAAGCAUUG	20	19379
CFTR-Intron10-494	−	UUGGUAUUUACCAUAUAUUG	20	19380
CFTR-Intron10-495	−	UUGCUCUCUUUUAACUAUUG	20	19381
CFTR-Intron10-496	+	UAUUGAGUGGAAAUUUUUUG	20	19382
CFTR-Intron10-497	−	UGCUUUCAGGAGCCAAAAAU	20	19383
CFTR-Intron10-498	+	AGCUAAAAUGACAAUCAAAU	20	19384
CFTR-Intron10-499	−	AGAAUGGGCUAAAGGGCAAU	20	19385
CFTR-Intron10-500	+	UGUAUGGCAUGAGUACGAAU	20	19386
CFTR-Intron10-501	−	CCGUUUACUAGAAAGAUAAU	20	19387
CFTR-Intron10-502	−	AAUACUGUCAGAGAAGUAAU	20	19388
CFTR-Intron10-503	+	CAGCCUAGAUGAUUAUUAAU	20	19389
CFTR-Intron10-504	−	CAAGUGCAAAGCUUUCAGAU	20	19390
CFTR-Intron10-505	+	CUAAAAAAAGUUACCUGGAU	20	19391
CFTR-Intron10-506	+	UCUUUGUGUUAACAAAAUAU	20	19392
CFTR-Intron10-507	+	AACUUAUCCAUUAAUCCUAU	20	19393
CFTR-Intron10-508	+	ACAAAUGCUUGACCACUUAU	20	19394
CFTR-Intron10-509	+	CCCUAUUAUUCAACAUUUAU	20	19395
CFTR-Intron10-510	+	UUCUUUAACAAACCUUUUAU	20	19396
CFTR-Intron10-511	−	AGCUUAUUCUUGUAAUAACU	20	19397
CFTR-Intron10-512	+	CACUUGCUUCACCUGCUACU	20	19398
CFTR-Intron10-513	+	AAAAUCUUAUAGAGAUUACU	20	19399
CFTR-Intron10-514	+	UUUUUUUGAGCCUAUCACCU	20	19400
CFTR-Intron10-515	−	AGAGGAAGGCAGUGGUCCCU	20	19401
CFTR-Intron10-516	+	AGGCACUUGUUGACAGUCCU	20	19402
CFTR-Intron10-517	−	AACAGGUUUUGGAUGGAGCU	20	19403
CFTR-Intron10-518	+	AAAACUCAUAAGGGACCGCU	20	19404
CFTR-Intron10-519	−	AAUAAAUUUGGUGUCAGGCU	20	19405
CFTR-Intron10-520	+	UUGAGCCUAUCACCUAGGCU	20	19406
CFTR-Intron10-521	−	UUCAAAUUAUUUCUACUGCU	20	19407
CFTR-Intron10-522	+	UAAUAUACCUGUCAAGUGCU	20	19408
CFTR-Intron10-523	−	UCCCCUAUUAAUAAUCAUCU	20	19409
CFTR-Intron10-524	−	UCUUGCUUUUCCCACUAUCU	20	19410
CFTR-Intron10-525	−	AGACUAAGGCUUAUUUCUCU	20	19411
CFTR-Intron10-526	+	AUUUAAUUGCCAGUAAGUCU	20	19412
CFTR-Intron10-527	+	AAUAAUUUGAACAACAUUCU	20	19413
CFTR-Intron10-528	−	UAUGUGAAAAUAUCACUUCU	20	19414
CFTR-Intron10-529	+	CCCUUCUGCUUGACAUCAGU	20	19415
CFTR-Intron10-530	+	AGUCAGUUUUAUUUUUCAGU	20	19416
CFTR-Intron10-531	+	UGUACAUUUUCCUAAUGAGU	20	19417
CFTR-Intron10-532	+	AUUACCAAAUUGUAUUGAGU	20	19418
CFTR-Intron10-533	−	AGUAGUGGAAGUAGUAUAGU	20	19419
CFTR-Intron10-534	+	UACUGUGAAUGGUGCCAGGU	20	19420
CFTR-Intron10-535	+	UGUUACAUAAAAAGAGAGGU	20	19421
CFTR-Intron10-536	−	AAGUAAUCGGCGGUGGAGGU	20	19422
CFTR-Intron10-537	−	UCAGGAGCCAAAAAUUGGGU	20	19423
CFTR-Intron10-538	+	CCUGGAUUGGCUACCUUGGU	20	19424
CFTR-Intron10-539	+	UUAAAAGCUGUUUCGUAUGU	20	19425
CFTR-Intron10-540	+	UCAUCUGUUAGUAAUGCUGU	20	19426
CFTR-Intron10-541	−	AUGUUUUUAGGCUAUUCUGU	20	19427
CFTR-Intron10-542	−	AUGGCAUCUCACCAGUGUGU	20	19428
CFTR-Intron10-543	−	CUUACCCACUCAAUACAAUU	20	19429
CFTR-Intron10-544	−	AAAAAUAUCACCAACUCAUU	20	19430
CFTR-Intron10-545	+	AAGAUCUCUGCAAACAUAUU	20	19431
CFTR-Intron10-546	−	ACAACUUAACCUGGCAUAUU	20	19432
CFTR-Intron10-547	+	AUCCAACUAACAUCUCUAUU	20	19433
CFTR-Intron10-548	+	CAUCAAUGGUUGUCUGUAUU	20	19434
CFTR-Intron10-549	−	CAGAAGUAACAGGGCCACUU	20	19435
CFTR-Intron10-550	−	AUAGAUUAGCUUAUAUACUU	20	19436
CFTR-Intron10-551	+	CUAAUACUUAGAAUGCCCUU	20	19437
CFTR-Intron10-552	−	UAGAUGUGCAAAAAUAGCUU	20	19438
CFTR-Intron10-553	+	UGCCAGGUUAAGUUGUUCUU	20	19439
CFTR-Intron10-554	+	CCUUCUGCUUGACAUCAGUU	20	19440
CFTR-Intron10-555	+	CCUUUAUCAACAUGAAGGUU	20	19441
CFTR-Intron10-556	−	AUCAGUGCUUUUUCGAGGUU	20	19442
CFTR-Intron10-557	+	UAAUUCAUGGAAAGCUUGUU	20	19443
CFTR-Intron10-558	−	CAUUUGUGUACUUGUGAUUU	20	19444
CFTR-Intron10-559	+	AGAUCUCUGCAAACAUAUUU	20	19445
CFTR-Intron10-560	−	CUUUAUGCACUCUUUGCUUU	20	19446
CFTR-Intron10-561	+	UUCUCCUGACAAUAAAGUUU	20	19447
CFTR-Intron10-562	−	AUAAUGGGAGAAACAGGUUU	20	19448
CFTR-Intron10-563	−	UUUUGGAUGGAGCUUGGUUU	20	19449
CFTR-Intron10-564	−	AUCAGAGCUAUAUUGUGUUU	20	19450
CFTR-Intron10-565	−	CCACUUUGGCUAAUGUUUUU	20	19451

Table 40C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within intron 10 and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 40C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-566	+	GACCAUCCCGGCUAAAA	17	19452
CFTR-Intron10-567	−	GUUGAUAAGAAGAGAAA	17	19453
CFTR-Intron10-568	−	GAUGUUUAUUUAUGAAA	17	19454
CFTR-Intron10-569	−	GUUAUUCAGCCAAUAAA	17	19455
CFTR-Intron10-570	−	GGUUUAAUUUUGUACAA	17	19456
CFTR-Intron10-571	+	GACUAAUCACCUCCCAA	17	19457
CFTR-Intron10-572	+	GUUCUCACAUGGCAGAA	17	19458
CFTR-Intron10-573	−	GGUUGAUAAGAAGAGAA	17	19459
CFTR-Intron10-574	+	GAGGGAAUGCAGGAGAA	17	19460
CFTR-Intron10-575	+	GGGAGGCUGAAGCGGAA	17	19461
CFTR-Intron10-576	+	GGAUUUCAACAUAUGAA	17	19462
CFTR-Intron10-577	+	GGUAACAAUAAUAUUAA	17	19463
CFTR-Intron10-578	−	GACCAGCGUGGGCAACA	17	19464
CFTR-Intron10-579	+	GUACAGUGGUGCAAUCA	17	19465
CFTR-Intron10-580	−	GAAGGAAGGAAGUAAGA	17	19466
CFTR-Intron10-581	−	GAAAGCAAUAGUAGAGA	17	19467
CFTR-Intron10-582	−	GUAGGAGGAAGGAAGGA	17	19468
CFTR-Intron10-583	−	GGAAGUAGGAGGAAGGA	17	19469
CFTR-Intron10-584	−	GAAAAAGAAAGAGAGGA	17	19470
CFTR-Intron10-585	−	GAAAGGAAGUAGGAGGA	17	19471
CFTR-Intron10-586	+	GUCCCAGCUACUUGGGA	17	19472
CFTR-Intron10-587	−	GUAUUCUAUCAUAUGGA	17	19473
CFTR-Intron10-588	−	GAGAAACAGGUUUUGGA	17	19474
CFTR-Intron10-589	−	GUUCAGGCAAGUGAUGA	17	19475
CFTR-Intron10-590	+	GGGUGAGGGUCUCUCUA	17	19476
CFTR-Intron10-591	+	GUGAAUGGUGCCAGGUA	17	19477
CFTR-Intron10-592	−	GAAGAGAAAGGGGUGUA	17	19478
CFTR-Intron10-593	+	GAAAAAAAAUUCAAAAC	17	19479
CFTR-Intron10-594	+	GAUAUAAGAAAUGAAAC	17	19480
CFTR-Intron10-595	−	GUAUUUUUAGUAGAGAC	17	19481
CFTR-Intron10-596	+	GGAGAAUGGCGUGAACC	17	19482
CFTR-Intron10-597	+	GAGAAUGGCGUGAACCC	17	19483
CFTR-Intron10-598	+	GUCUCACUCUGUCACCC	17	19484
CFTR-Intron10-599	−	GUCUUACUCUGUCACCC	17	19485
CFTR-Intron10-600	+	GAGAAUUGCUUGAGCCC	17	19486
CFTR-Intron10-601	−	GUCUCGCUCUGUCGCCC	17	19487
CFTR-Intron10-602	+	GCCACUGCACUCCAGCC	17	19488
CFTR-Intron10-603	+	GGAGAAUUGCUUGAGCC	17	19489
CFTR-Intron10-604	−	GCCACUGCACUCUAGCC	17	19490
CFTR-Intron10-605	+	GUUUCACUGUGUUAGCC	17	19491
CFTR-Intron10-606	−	GUUUCACCGUUUUAGCC	17	19492
CFTR-Intron10-607	−	GCGCCCGCCACUACGCC	17	19493
CFTR-Intron10-608	−	GCGUGAGCCACCGCGCC	17	19494
CFTR-Intron10-609	−	GUUUCACCAUGUUGGCC	17	19495
CFTR-Intron10-610	−	GGAGAUCAAGACCAUCC	17	19496
CFTR-Intron10-611	+	GGAGAUCGAGACCAUCC	17	19497
CFTR-Intron10-612	−	GUGAAUUGCUUGAGUCC	17	19498
CFTR-Intron10-613	−	GGUUUCACCGUUUUAGC	17	19499
CFTR-Intron10-614	−	GGCUGGAGUGCAGUGGC	17	19500
CFTR-Intron10-615	+	GCACCCGCCAUCACGUC	17	19501
CFTR-Intron10-616	+	GGGCGGAUCACGAGGUC	17	19502
CFTR-Intron10-617	−	GCAUGAGCCACUGUGUC	17	19503
CFTR-Intron10-618	+	GGUGGGAUAUGGAGAAG	17	19504
CFTR-Intron10-619	+	GUAAUAGCAACAGGAAG	17	19505
CFTR-Intron10-620	−	GAUUUUUGACUAUACAG	17	19506
CFTR-Intron10-621	−	GAGUUAGAGGAAGGCAG	17	19507
CFTR-Intron10-622	+	GUUUGUGUUUUUUGUAG	17	19508
CFTR-Intron10-623	+	GAGGCGGGCGGAUCACG	17	19509
CFTR-Intron10-624	−	GAGUCAAAAAUUAUACG	17	19510
CFTR-Intron10-625	−	GGAGUUUGAGACCAGCG	17	19511
CFTR-Intron10-626	−	GAACAAAGACUUGCAGG	17	19512
CFTR-Intron10-627	+	GGCGUGAACCCGGGAGG	17	19513
CFTR-Intron10-628	−	GGAAGAAAGGAAGUAGG	17	19514
CFTR-Intron10-629	−	GUGAUGGUAUUGCAGGG	17	19515
CFTR-Intron10-630	−	GAAGAAAGAAGGAAAUG	17	19516
CFTR-Intron10-631	−	GAGGUGAUUAGUCCAUG	17	19517
CFTR-Intron10-632	+	GAGGCAGGCAGAUCAUG	17	19518
CFTR-Intron10-633	+	GAAUAUAUUCUUUUAUG	17	19519
CFTR-Intron10-634	+	GUAGCAAAUGAUAAAAU	17	19520
CFTR-Intron10-635	−	GUUUACUAACUCAAUCU	17	19521
CFTR-Intron10-636	+	GUGCAGUGGCGCGAUCU	17	19522
CFTR-Intron10-637	−	GCACAGUGGUGCGAUCU	17	19523
CFTR-Intron10-638	−	GUGCAGUGGCGGGAUCU	17	19524
CFTR-Intron10-639	−	GCUGUGCAUUUUCCUCU	17	19525
CFTR-Intron10-640	−	GAGUUUGAGACCAGCGU	17	19526
CFTR-Intron10-641	+	GUGUUUUUUGUAGAGGU	17	19527
CFTR-Intron10-642	−	GUACUACUGUAAUAAUU	17	19528
CFTR-Intron10-643	−	GCAGGAGGUGAGGGAUU	17	19529
CFTR-Intron10-644	−	GUUAUCUCUGAAAUUUU	17	19530
CFTR-Intron10-645	+	GAAUGCAGGAGAAUGGAAAA	20	19531
CFTR-Intron10-646	+	GUGUUCUCACAUGGCAGAAA	20	19532
CFTR-Intron10-647	+	GCAUCACGUGGUGUUUUAAA	20	19533
CFTR-Intron10-648	+	GGGAGGCUGAGGCAGGAGAA	20	19534
CFTR-Intron10-649	+	GAUGAGGGAAUGCAGGAGAA	20	19535
CFTR-Intron10-650	−	GGGAGACAAGGGAGGAAGCA	20	19536
CFTR-Intron10-651	+	GGCUGGGAAGUCCAAGAUCA	20	19537
CFTR-Intron10-652	−	GAAGUAGGAGGAAGGAAGGA	20	19538
CFTR-Intron10-653	−	GAAGAAAGGAAGUAGGAGGA	20	19539
CFTR-Intron10-654	+	GUAGUCCCAGCUACUUGGGA	20	19540
CFTR-Intron10-655	−	GGGAGGUGAUUAGUCCAUGA	20	19541
CFTR-Intron10-656	−	GACUGUUUAUGUUAUCUGUA	20	19542
CFTR-Intron10-657	−	GCCACUUCCUGUUGCUAUUA	20	19543
CFTR-Intron10-658	−	GUGUGUAUAUGUGUGUAUUA	20	19544
CFTR-Intron10-659	+	GUUCAAGCCUGUAUUGUUUA	20	19545
CFTR-Intron10-660	+	GAGCUUACCGUAAUAGCAAC	20	19546
CFTR-Intron10-661	+	GCAGGAGAAUGGCGUGAACC	20	19547
CFTR-Intron10-662	−	GCAUAUAUAUAUUUUUAACC	20	19548
CFTR-Intron10-663	−	GACAGAGUCUUACUGUCACC	20	19549
CFTR-Intron10-664	−	GGAGUCUCGCUCUGUCGCCC	20	19550
CFTR-Intron10-665	+	GCAGGAGAAUUGCUUGAGCC	20	19551
CFTR-Intron10-666	+	GGAGUUUCACUGUGUUAGCC	20	19552
CFTR-Intron10-667	−	GGGGUUUCACCGUUUUAGCC	20	19553
CFTR-Intron10-668	−	GGGGUUUCACCAUGUUGGCC	20	19554
CFTR-Intron10-669	+	GAUGUAUCUCCAAAUAUGCC	20	19555
CFTR-Intron10-670	−	GGAUGCCCUUGACUGAAAGC	20	19556
CFTR-Intron10-671	−	GAACACAGCAGGAAGACAGC	20	19557
CFTR-Intron10-672	−	GCCUCACCCUCCCAAGUAGC	20	19558
CFTR-Intron10-673	−	GCCUCAGCCUCCCAAGUAGC	20	19559
CFTR-Intron10-674	−	GGAAGAGUCUUCCAAGUAGC	20	19560
CFTR-Intron10-675	+	GCCUCAGCCUCCCGAGUAGC	20	19561
CFTR-Intron10-676	+	GUUUGCCAUGUUGCCCACGC	20	19562
CFTR-Intron10-677	−	GAGUCUUACUGUCACCAGGC	20	19563
CFTR-Intron10-678	−	GCACUUUUGGAGGCAGAGGC	20	19564
CFTR-Intron10-679	+	GCACUUUGGGAGGCCGAGGC	20	19565
CFTR-Intron10-680	−	GCUACUCGGGAGGCUGAGGC	20	19566
CFTR-Intron10-681	+	GCUACUUGGGAGGCUGAGGC	20	19567
CFTR-Intron10-682	+	GCUACUUGGGAGGGUGAGGC	20	19568
CFTR-Intron10-683	+	GAUUUCAACAUAUGAAUGGC	20	19569
CFTR-Intron10-684	+	GUGCAAGACUUCACACCUGC	20	19570
CFTR-Intron10-685	−	GCUUCAGCCUCCCAAAGUGC	20	19571
CFTR-Intron10-686	−	GCCUCGGCCUCCCAAAGUGC	20	19572
CFTR-Intron10-687	−	GCCCGUAGUCCCAGCUACUC	20	19573
CFTR-Intron10-688	+	GGCGGGCGGAUCACGAGGUC	20	19574
CFTR-Intron10-689	+	GAAUUUAUUUCUCACAGUUC	20	19575
CFTR-Intron10-690	+	GUGUGUGUGUGUCCUUGUUC	20	19576
CFTR-Intron10-691	−	GGGUUGAUAAGAAGAGAAAG	20	19577
CFTR-Intron10-692	−	GAUCACCUGAGCCUGAGAAG	20	19578
CFTR-Intron10-693	−	GAAAGAAGGAAGGAAGUAAG	20	19579
CFTR-Intron10-694	−	GUCACCAGGCUGGAGCACAG	20	19580
CFTR-Intron10-695	−	GUGGAUUUUUGACUAUACAG	20	19581
CFTR-Intron10-696	−	GCAGAGUUAGAGGAAGGCAG	20	19582
CFTR-Intron10-697	+	GCCGAGGCGGGCGGAUCACG	20	19583
CFTR-Intron10-698	−	GUGGAGUCAAAAAUUAUACG	20	19584
CFTR-Intron10-699	+	GAAAUGAAACAGGCCGGGCG	20	19585
CFTR-Intron10-700	−	GAGAAUGGCGUGAACCCAGG	20	19586
CFTR-Intron10-701	+	GUUUGUGUUUUUUGUAGAGG	20	19587
CFTR-Intron10-702	+	GAGAAUGGCGUGAACCCGGG	20	19588
CFTR-Intron10-703	+	GAGAAUUGCUUGAGCCCGGG	20	19589
CFTR-Intron10-704	−	GUUCAGGCAAGUGAUGAUGG	20	19590
CFTR-Intron10-705	+	GCCGAGGCAGGCAGAUCAUG	20	19591
CFTR-Intron10-706	−	GAACAGUAAGGAGGUCACUG	20	19592
CFTR-Intron10-707	−	GGUGAUGGUAUUGCAGGGUG	20	19593
CFTR-Intron10-708	−	GGCUCAAAAAAAAAAAAAAU	20	19594
CFTR-Intron10-709	−	GCACCACUGUACCCUAGCCU	20	19595
CFTR-Intron10-710	−	GCGCCACUGCACUCUAGCCU	20	19596
CFTR-Intron10-711	−	GGAGCACAGUGGUGCGAUCU	20	19597
CFTR-Intron10-712	−	GGAGUGCAGUGGCGGGAUCU	20	19598
CFTR-Intron10-713	−	GCUACUUGGGAGGCUGAGGU	20	19599
CFTR-Intron10-714	+	GGUUAAGUUGUUCUUAGGGU	20	19600
CFTR-Intron10-715	−	GAGACGGGGUUUCACCAUGU	20	19601
CFTR-Intron10-716	−	GCCUCGGCCUCCCAAAGUGU	20	19602
CFTR-Intron10-717	−	GCAAUGCUAAUAAUACAAUU	20	19603
CFTR-Intron10-718	+	GAUCAAGGUGCCAGCAGAUU	20	19604
CFTR-Intron10-719	+	GUUUCCAAAUUUUUUUUAUU	20	19605
CFTR-Intron10-720	+	GCCUGUAGUCCCAGCUACUU	20	19606
CFTR-Intron10-721	−	GUAUUGCAGGGUGGGGCCUU	20	19607
CFTR-Intron10-722	+	GCCUGUAAUCCCAACACUUU	20	19608
CFTR-Intron10-723	+	GCCUAUAAACCCAGCACUUU	20	19609
CFTR-Intron10-724	+	GCCUGUAAUCCCAGCACUUU	20	19610
CFTR-Intron10-725	−	GAACACUUUAUAGUUUUUUU	20	19611

Table 40D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within intron 10. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. pyogenes Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 40D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-726	+	AACAAAGAAACAAAAAA	17	19612
CFTR-Intron10-727	+	UAUGAUUUUAUGAAAAA	17	19613
CFTR-Intron10-728	+	UGCAGGAGAAUGGAAAA	17	19614
CFTR-Intron10-729	+	UGCAUAAAGGUUGAAAA	17	19615
CFTR-Intron10-730	−	UUCAGAAGUCUAUAAAA	17	19616
CFTR-Intron10-731	−	AAAGAAAAAACAGCAAA	17	19617
CFTR-Intron10-732	+	AGUAAAAAAAAAUCAAA	17	19618
CFTR-Intron10-733	+	CUAAAAUGACAAUCAAA	17	19619
CFTR-Intron10-734	+	AAAAGCUGAAAGUCAAA	17	19620
CFTR-Intron10-735	+	AUUCAAUGAAAAAGAAA	17	19621
CFTR-Intron10-736	+	UUCUCACAUGGCAGAAA	17	19622
CFTR-Intron10-737	−	UAAACACUUCUGAGAAA	17	19623
CFTR-Intron10-738	+	UAAACAAACAAAGGAAA	17	19624
CFTR-Intron10-739	+	AUUAUCUUUCUAGUAAA	17	19625
CFTR-Intron10-740	+	ACCAAAUAAACAAACAA	17	19626
CFTR-Intron10-741	−	AUGGAUAAGUUGAACAA	17	19627
CFTR-Intron10-742	−	AUUAGGAAAAUGUACAA	17	19628
CFTR-Intron10-743	+	UGUUUAAAUAUUCCCAA	17	19629
CFTR-Intron10-744	+	AAAGAAUAAGGCAUCAA	17	19630
CFTR-Intron10-745	+	AAAUAUAUUCAAAAGAA	17	19631
CFTR-Intron10-746	+	UGAGAGACAGUAAAGAA	17	19632
CFTR-Intron10-747	−	AAGGAAAUGAGGAAGAA	17	19633
CFTR-Intron10-748	+	AGGCUGAGGCAGGAGAA	17	19634
CFTR-Intron10-749	+	AAACUGAGUAGAAGGAA	17	19635
CFTR-Intron10-750	+	UUUCUCUUUACUGUGAA	17	19636
CFTR-Intron10-751	+	AAGAAAAGUAUCAAUAA	17	19637
CFTR-Intron10-752	+	CAGUGACUUCAUAAUAA	17	19638
CFTR-Intron10-753	+	AUAGAGAAAACUCAUAA	17	19639
CFTR-Intron10-754	+	ACAAAAAUUAAAACUAA	17	19640
CFTR-Intron10-755	+	UCUAGAAAACAAUGUAA	17	19641
CFTR-Intron10-756	−	AGAUAAAGUUGAAUUAA	17	19642
CFTR-Intron10-757	+	AAGCCUGUAUUGUUUAA	17	19643
CFTR-Intron10-758	−	AUUUUGACCAUUUUUAA	17	19644
CFTR-Intron10-759	+	UACCAUCCUGGCCAACA	17	19645
CFTR-Intron10-760	−	UUAUAGCAGCCUGAACA	17	19646
CFTR-Intron10-761	−	UUUAAACAGAAGUAACA	17	19647
CFTR-Intron10-762	+	AGAGAGAACUGCUCACA	17	19648
CFTR-Intron10-763	+	CCUGCUGUGUUCUCACA	17	19649
CFTR-Intron10-764	−	UGAAAUCCUAAUUCCCA	17	19650
CFTR-Intron10-765	−	UUUAUUUUUAUAUUCCA	17	19651
CFTR-Intron10-766	−	AGACAAGGGAGGAAGCA	17	19652
CFTR-Intron10-767	+	UCAACAUAUGAAUGGCA	17	19653
CFTR-Intron10-768	−	UACAGGCUUGAACUGCA	17	19654
CFTR-Intron10-769	−	AAGGUGAUGGUAUUGCA	17	19655
CFTR-Intron10-770	+	CUAUUUAAACAGAAUCA	17	19656
CFTR-Intron10-771	+	UGGGAAGUCCAAGAUCA	17	19657
CFTR-Intron10-772	+	UUCACUAAAAUAAUUCA	17	19658
CFTR-Intron10-773	+	UAUAUUUUAUGCAUUCA	17	19659
CFTR-Intron10-774	−	AUAAGCCACACAGUUCA	17	19660
CFTR-Intron10-775	+	UUGAGCCCAGGAGUUCA	17	19661
CFTR-Intron10-776	+	AAUUGGUACAAAUUUCA	17	19662
CFTR-Intron10-777	−	AGAGGAAGGAAGAAAGA	17	19663
CFTR-Intron10-778	−	AGAUUCUAAAGGAAAGA	17	19664
CFTR-Intron10-779	−	AAGGAAGGAAGGAAAGA	17	19665
CFTR-Intron10-780	+	UGUAUUUUUAGUAGAGA	17	19666
CFTR-Intron10-781	−	UUUUUUUUUUUUUGAGA	17	19667
CFTR-Intron10-782	−	CUUUUCCUCUUAAUAGA	17	19668
CFTR-Intron10-783	+	AUAUUCAAAAGAAAGGA	17	19669
CFTR-Intron10-784	−	AAGGAAGGAAAGAAGGA	17	19670
CFTR-Intron10-785	+	CACUGUGUUAGCCAGGA	17	19671
CFTR-Intron10-786	−	CACCAUGUUGGCCAGGA	17	19672
CFTR-Intron10-787	−	AAGGCAGAGUUAGAGGA	17	19673
CFTR-Intron10-788	−	AAAAUUAUACUAUAGGA	17	19674
CFTR-Intron10-789	−	AUAGAGUAAGACAGGGA	17	19675
CFTR-Intron10-790	−	CACCGUUUUAGCCGGGA	17	19676
CFTR-Intron10-791	−	UGGACUGAGUAACUGGA	17	19677
CFTR-Intron10-792	−	AUAUAUGUGUGUCUGGA	17	19678
CFTR-Intron10-793	−	AGGUGAUUAGUCCAUGA	17	19679
CFTR-Intron10-794	+	UGGCAUAGCUGCACUGA	17	19680
CFTR-Intron10-795	−	AAAUUAGCCAGACGUGA	17	19681
CFTR-Intron10-796	−	CCUAAUUCCCAAGGUGA	17	19682
CFTR-Intron10-797	−	AGACUUGCAGGAGGUGA	17	19683
CFTR-Intron10-798	+	AUGGCAGAAAGGGGUGA	17	19684
CFTR-Intron10-799	−	UUCAGGACAUGCUUUGA	17	19685
CFTR-Intron10-800	+	UUCAAUUCUUCAAAAUA	17	19686
CFTR-Intron10-801	+	AGUAUAUCAAAAGAAUA	17	19687
CFTR-Intron10-802	+	CCUCUGUGCUUUGAAUA	17	19688
CFTR-Intron10-803	−	AUAAAUGUUGAAUAAUA	17	19689
CFTR-Intron10-804	−	CAUAGUAUUCUAUCAUA	17	19690
CFTR-Intron10-805	+	CAUAGAGAAAACUCAUA	17	19691
CFTR-Intron10-806	+	CUGCAGACCUCAAUAUA	17	19692
CFTR-Intron10-807	−	AAGUUUCUCAUCUUAUA	17	19693
CFTR-Intron10-808	+	CCGAGUAGCUGGGACUA	17	19694
CFTR-Intron10-809	−	UGGUUUGAAGAACAGUA	17	19695
CFTR-Intron10-810	−	UGUUUAUGUUAUCUGUA	17	19696
CFTR-Intron10-811	−	UUUUAGGCUAUUCUGUA	17	19697
CFTR-Intron10-812	+	ACUAGUGGCACUUUGUA	17	19698
CFTR-Intron10-813	+	UUAGUUUUAUGCCAUUA	17	19699
CFTR-Intron10-814	−	CAGGAGGUGAGGGAUUA	17	19700
CFTR-Intron10-815	−	ACUUCCUGUUGCUAUUA	17	19701
CFTR-Intron10-816	−	UGUAUAUGUGUGUAUUA	17	19702
CFTR-Intron10-817	+	AUGUUAUUCAAGGUUUA	17	19703
CFTR-Intron10-818	−	CAUUUUGACCAUUUUUA	17	19704
CFTR-Intron10-819	−	AAGAUAAUGGGAGAAAC	17	19705
CFTR-Intron10-820	+	UGUGGCUUAUAAACAAC	17	19706
CFTR-Intron10-821	−	UUUUAAACAGAAGUAAC	17	19707
CFTR-Intron10-822	−	AAACUGUUAUAAUUAAC	17	19708
CFTR-Intron10-823	−	UGACCCUUAAACAAUAC	17	19709
CFTR-Intron10-824	+	CAAGUAGCUGGGACUAC	17	19710
CFTR-Intron10-825	+	CGAGUAGCUGGGACUAC	17	19711
CFTR-Intron10-826	−	CAAAGUGCUGGGAUUAC	17	19712
CFTR-Intron10-827	−	CAAAGUGUUGGGAUUAC	17	19713
CFTR-Intron10-828	+	UGCAAUAUGCAAUUUAC	17	19714
CFTR-Intron10-829	+	AAAUAUUGACUAUUUAC	17	19715
CFTR-Intron10-830	−	UAUAUAUAUUUUUAACC	17	19716
CFTR-Intron10-831	−	AGAGUCUUACUGUCACC	17	19717
CFTR-Intron10-832	+	UACUAAAAAAAGUUACC	17	19718
CFTR-Intron10-833	+	AAAGGUCAAUUGAGCCC	17	19719
CFTR-Intron10-834	−	UGCAAGCUCCGCCUCCC	17	19720
CFTR-Intron10-835	−	UGCAACCUCUGCCUCCC	17	19721
CFTR-Intron10-836	+	ACCACUGUGCUCCAGCC	17	19722
CFTR-Intron10-837	+	ACCACUGAAGUUCAGCC	17	19723
CFTR-Intron10-838	+	AAUACAAAAAAUUAGCC	17	19724
CFTR-Intron10-839	+	AAGAAAUGAAACAGGCC	17	19725
CFTR-Intron10-840	+	AGAGAUCAAUACCAUCC	17	19726
CFTR-Intron10-841	−	UGAUGGUGGCUUGAUCC	17	19727
CFTR-Intron10-842	+	CGCUGGUCUCAAACUCC	17	19728
CFTR-Intron10-843	−	CUGUAACCUUGAACUCC	17	19729
CFTR-Intron10-844	−	CUGCAAGCUCCGCCUCC	17	19730
CFTR-Intron10-845	−	CUGCAACCUCUGCCUCC	17	19731
CFTR-Intron10-846	+	CUGCAAGUUCUGCCUCC	17	19732
CFTR-Intron10-847	−	CCAUGUGAGAACACAGC	17	19733
CFTR-Intron10-848	−	CACAGCAGGAAGACAGC	17	19734
CFTR-Intron10-849	−	AGUGCAGCUAUGCCAGC	17	19735
CFTR-Intron10-850	−	UUUUAAAACAAAAUAGC	17	19736
CFTR-Intron10-851	−	AAACAAAAGAAAAUAGC	17	19737
CFTR-Intron10-852	−	UCACCCUCCCAAGUAGC	17	19738
CFTR-Intron10-853	+	UCAGCCUCCCAAGUAGC	17	19739
CFTR-Intron10-854	−	AGAGUCUUCCAAGUAGC	17	19740
CFTR-Intron10-855	+	UCAGCCUCCCGAGUAGC	17	19741
CFTR-Intron10-856	+	AAAUACAAAAAAUUAGC	17	19742
CFTR-Intron10-857	+	UGCCAUGUUGCCCACGC	17	19743
CFTR-Intron10-858	+	UAAGAAAUGAAACAGGC	17	19744
CFTR-Intron10-859	−	UCUUACUGUCACCAGGC	17	19745
CFTR-Intron10-860	−	CGCUCUGUCGCCCAGGC	17	19746
CFTR-Intron10-861	−	CUUUUGGAGGCAGAGGC	17	19747
CFTR-Intron10-862	+	CUUUGGGAGGCCGAGGC	17	19748
CFTR-Intron10-863	+	CUCACAGUUCUGGAGGC	17	19749
CFTR-Intron10-864	−	AAGGAGGUCACUGAGGC	17	19750
CFTR-Intron10-865	−	ACUCGGGAGGCUGAGGC	17	19751
CFTR-Intron10-866	+	ACUUGGGAGGCUGAGGC	17	19752
CFTR-Intron10-867	+	ACUUGGGAGGGUGAGGC	17	19753
CFTR-Intron10-868	−	UUCAAGGAAGAGGGGGC	17	19754
CFTR-Intron10-869	+	UUCAACAUAUGAAUGGC	17	19755
CFTR-Intron10-870	−	UAGCCAGACGUGAUGGC	17	19756
CFTR-Intron10-871	+	UAGCCGGGCGUAGUGGC	17	19757
CFTR-Intron10-872	−	UCAGCCUCCCAAAGUGC	17	19758
CFTR-Intron10-873	−	UCGGCCUCCCAAAGUGC	17	19759
CFTR-Intron10-874	−	CAAGGUGAUGGUAUUGC	17	19760
CFTR-Intron10-875	−	UUUGAACAAAGACUUGC	17	19761
CFTR-Intron10-876	−	CGUAGUCCCAGCUACUC	17	19762
CFTR-Intron10-877	+	CUCCACUUCUCAGGCUC	17	19763
CFTR-Intron10-878	+	AUAGAGAGAAACAUCUC	17	19764
CFTR-Intron10-879	+	UGCAGCCUCCACUUCUC	17	19765
CFTR-Intron10-880	+	AGAGACAAGGUGGUGUC	17	19766
CFTR-Intron10-881	−	UCAAUAAAUUUGGUGUC	17	19767
CFTR-Intron10-882	−	AUGUAUAUAUGUGUGUC	17	19768
CFTR-Intron10-883	+	UCUUUCUAAUUUCAUUC	17	19769
CFTR-Intron10-884	−	AGGAAGUGAUCAGAUUC	17	19770
CFTR-Intron10-885	+	UAAGAGGAAAAGACUUC	17	19771
CFTR-Intron10-886	+	UUUAUUUCUCACAGUUC	17	19772
CFTR-Intron10-887	+	UGUGUGUGUCCUUGUUC	17	19773
CFTR-Intron10-888	−	ACUGGCAAUUAAAUUUC	17	19774
CFTR-Intron10-889	−	UCUUUUGAAUAUAUUUC	17	19775
CFTR-Intron10-890	+	AUAAAUAAUUGCCUUUC	17	19776
CFTR-Intron10-891	−	AUUAUAACACUGCUUUC	17	19777
CFTR-Intron10-892	+	AAAAUUUGUUUUCUUUC	17	19778
CFTR-Intron10-893	+	AAAAACAUUAGCCAAAG	17	19779
CFTR-Intron10-894	+	UCUCACAUGGCAGAAAG	17	19780
CFTR-Intron10-895	−	UUGAUAAGAAGAGAAAG	17	19781
CFTR-Intron10-896	−	AAGAUUCUAAAGGAAAG	17	19782
CFTR-Intron10-897	−	UGAAUUUUUUUUCCAAG	17	19783
CFTR-Intron10-898	−	CACCUGAGCCUGAGAAG	17	19784
CFTR-Intron10-899	+	ACUUUGGGAGGCUGAAG	17	19785
CFTR-Intron10-900	+	AAAAAUUCACAAAUAAG	17	19786
CFTR-Intron10-901	−	AAAUUAGAAAGAAUAAG	17	19787
CFTR-Intron10-902	−	AAAAAUAAAAAUAUAAG	17	19788
CFTR-Intron10-903	−	AGAAGGAAGGAAGUAAG	17	19789
CFTR-Intron10-904	−	CCAUAUUCAAAGCACAG	17	19790
CFTR-Intron10-905	−	ACCAGGCUGGAGCACAG	17	19791
CFTR-Intron10-906	+	UUAAUGGCUGUGCACAG	17	19792
CFTR-Intron10-907	−	UAUGAGAAAAGUCACAG	17	19793
CFTR-Intron10-908	+	CCUAGGCUAGGGUACAG	17	19794
CFTR-Intron10-909	+	UGUUUAAAACUCUCCAG	17	19795
CFTR-Intron10-910	−	CUAUAUUUGUUUUCCAG	17	19796
CFTR-Intron10-911	+	AGGAAAGGAGGUAGCAG	17	19797
CFTR-Intron10-912	+	UUGAGCCCGGGAGGCAG	17	19798
CFTR-Intron10-913	−	AGCACUUUUGGAGGCAG	17	19799
CFTR-Intron10-914	+	CAACAUAUGAAUGGCAG	17	19800
CFTR-Intron10-915	+	CCCAGGCUAGAGUGCAG	17	19801
CFTR-Intron10-916	−	CCCAGGCUGGAGUGCAG	17	19802
CFTR-Intron10-917	−	UGUCAGGCUGGGUGCAG	17	19803
CFTR-Intron10-918	+	UAUUUAAACAGAAUCAG	17	19804
CFTR-Intron10-919	−	AAUGUUAAUUUAUUCAG	17	19805
CFTR-Intron10-920	−	CCCAGGCUGAACUUCAG	17	19806
CFTR-Intron10-921	+	UUGUUACAUAAAAAGAG	17	19807
CFTR-Intron10-922	−	AACAGAAAAAGAAAGAG	17	19808
CFTR-Intron10-923	−	AAAUUAUACUAUAGGAG	17	19809
CFTR-Intron10-924	+	AAUAGCCUAUUGUUGAG	17	19810
CFTR-Intron10-925	−	UAAAUGUUGAAUAAUAG	17	19811
CFTR-Intron10-926	+	UAGAUGAUUAUUAAUAG	17	19812
CFTR-Intron10-927	−	UAAAAAGUGAUCUCUAG	17	19813
CFTR-Intron10-928	+	AAAUUAGCCGGGCGUAG	17	19814
CFTR-Intron10-929	−	UAUGAAGGCAGAGUUAG	17	19815
CFTR-Intron10-930	+	AGAUGAUUAGCAUCACG	17	19816
CFTR-Intron10-931	−	UAUUUUUAGUAGAGACG	17	19817
CFTR-Intron10-932	+	AACACUUUGGGAGGCCG	17	19818
CFTR-Intron10-933	+	AGCACUUUGGGAGGCCG	17	19819
CFTR-Intron10-934	+	AUGAAACAGGCCGGGCG	17	19820
CFTR-Intron10-935	+	AAAAAAAAAUCAAAAGG	17	19821
CFTR-Intron10-936	+	CUGAGUAGAAGGAAAGG	17	19822
CFTR-Intron10-937	−	UUUGAAGAACAGUAAGG	17	19823
CFTR-Intron10-938	−	AAUGGCGUGAACCCAGG	17	19824
CFTR-Intron10-939	−	UAGUUUCAAGGAAGAGG	17	19825
CFTR-Intron10-940	+	UUACAUAAAAAGAGAGG	17	19826
CFTR-Intron10-941	+	UGUGUUUUUUGUAGAGG	17	19827
CFTR-Intron10-942	+	ACUUUGGGAGGCCGAGG	17	19828
CFTR-Intron10-943	−	UACUUGGGAGGCUGAGG	17	19829
CFTR-Intron10-944	−	AAAAAUUAUACUAUAGG	17	19830
CFTR-Intron10-945	+	AAACAGGCCGGGCGCGG	17	19831
CFTR-Intron10-946	−	CUGUAGGGAGACAAGGG	17	19832
CFTR-Intron10-947	+	AAUGGCGUGAACCCGGG	17	19833
CFTR-Intron10-948	+	AAUUGCUUGAGCCCGGG	17	19834
CFTR-Intron10-949	+	UGGGAGGCCGAGGCGGG	17	19835
CFTR-Intron10-950	−	AGUCCCAGCUACUCGGG	17	19836
CFTR-Intron10-951	−	UGGGAGGCUGAGGUGGG	17	19837
CFTR-Intron10-952	+	AGUCCCAGCUACUUGGG	17	19838
CFTR-Intron10-953	+	AAUCCCAACACUUUGGG	17	15660
CFTR-Intron10-954	+	AAACCCAGCACUUUGGG	17	19839
CFTR-Intron10-955	+	AAUCCCAGCACUUUGGG	17	19840
CFTR-Intron10-956	−	AGGGUGGGGCCUUUGGG	17	19841
CFTR-Intron10-957	−	CAGGCAAGUGAUGAUGG	17	19842
CFTR-Intron10-958	−	UUAGCCAGACGUGAUGG	17	19843
CFTR-Intron10-959	+	AUUUCUCACAGUUCUGG	17	19844
CFTR-Intron10-960	−	CUGAGCCUGAGAAGUGG	17	19845
CFTR-Intron10-961	−	AGGCUGGAGUGCAGUGG	17	19846
CFTR-Intron10-962	+	UUAGCCGGGCGUAGUGG	17	19847
CFTR-Intron10-963	−	AAAAUAGCUGGGUGUGG	17	19848
CFTR-Intron10-964	+	UCAAAAAAUAUUUGUGG	17	19849
CFTR-Intron10-965	−	AAUCCUAGCACUUUUGG	17	19850
CFTR-Intron10-966	−	AAUUUUAUAUAGAAAUG	17	19851
CFTR-Intron10-967	+	AACAAACAAAGGAAAUG	17	19852
CFTR-Intron10-968	−	AAGCUAGUGAAUGAAUG	17	19853
CFTR-Intron10-969	+	AUUAUUCAACAUUUAUG	17	19854
CFTR-Intron10-970	−	CAGUAAGGAGGUCACUG	17	19855
CFTR-Intron10-971	−	AGCUACUCGGGAGGCUG	17	19856
CFTR-Intron10-972	+	AGCUACUUGGGAGGCUG	17	19857
CFTR-Intron10-973	+	CAAAAAUUAGCUGAGUG	17	19858
CFTR-Intron10-974	+	ACAUAAAAAGAGAGGUG	17	19859
CFTR-Intron10-975	+	UGUUUUUUGUAGAGGUG	17	19860
CFTR-Intron10-976	−	AAGACUUGCAGGAGGUG	17	19861
CFTR-Intron10-977	+	AGCUACUUGGGAGGGUG	17	19862
CFTR-Intron10-978	+	CAUGGCAGAAAGGGGUG	17	19863
CFTR-Intron10-979	−	AAGAAAAUAGCUGGGUG	17	19864
CFTR-Intron10-980	+	AAAUACCAUGAACUGUG	17	19865
CFTR-Intron10-981	−	UUUAUAAAAAAUAAUUG	17	19866
CFTR-Intron10-982	+	UAUUCAAAAAAUAUUUG	17	19867
CFTR-Intron10-983	−	ACAUUGGAAAAUUUUUG	17	19868
CFTR-Intron10-984	−	UAGUAGUUAAGUUUUUG	17	19869
CFTR-Intron10-985	−	UCAAAAAAAAAAAAAAU	17	19870
CFTR-Intron10-986	+	UAAAAUGACAAUCAAAU	17	19871
CFTR-Intron10-987	+	CUAUUUGGAUGUCAAAU	17	19872
CFTR-Intron10-988	+	AAACAAACAAAGGAAAU	17	19873
CFTR-Intron10-989	−	UUGAAGGAAGAUCCAAU	17	19874
CFTR-Intron10-990	−	CAUAAAUGUUGAAUAAU	17	19875
CFTR-Intron10-991	−	UUUACUAGAAAGAUAAU	17	19876
CFTR-Intron10-992	−	ACUGUCAGAGAAGUAAU	17	19877
CFTR-Intron10-993	−	UUUUUCAGUUAAUACAU	17	19878
CFTR-Intron10-994	+	UACAAUUCUUAUUACAU	17	19879
CFTR-Intron10-995	−	ACAGGCUUGAACUGCAU	17	19880
CFTR-Intron10-996	−	ACCCUAGCCUAGGUGAU	17	19881
CFTR-Intron10-997	+	UUGUGUUAACAAAAUAU	17	19882
CFTR-Intron10-998	+	AAUAUAUAUAUGCAUAU	17	19883
CFTR-Intron10-999	−	UUAAAAAAUUAUACUAU	17	19884
CFTR-Intron10-1000	−	AAAGUUUCUCAUCUUAU	17	19885
CFTR-Intron10-1001	+	UAUUAUUCAACAUUUAU	17	19886
CFTR-Intron10-1002	−	CAAAGUGCUGGGUUUAU	17	19887
CFTR-Intron10-1003	+	UCAGACUUUUAUUUUAU	17	19888
CFTR-Intron10-1004	+	UUUAACAAACCUUUUAU	17	19889
CFTR-Intron10-1005	+	UUCCAAAUUUUUUUUAU	17	19890
CFTR-Intron10-1006	−	UUAUUCUUGUAAUAACU	17	19891
CFTR-Intron10-1007	−	CCGUAGUCCCAGCUACU	17	19892
CFTR-Intron10-1008	+	CUGUAGUCCCAGCUACU	17	19893
CFTR-Intron10-1009	+	CUGCAAUACCAUCACCU	17	19894
CFTR-Intron10-1010	+	CCACUGCACUCCAGCCU	17	19895
CFTR-Intron10-1011	+	CCACUGAAGUUCAGCCU	17	19896
CFTR-Intron10-1012	−	CCACUGUACCCUAGCCU	17	19897
CFTR-Intron10-1013	−	CCACUGCACUCUAGCCU	17	19898
CFTR-Intron10-1014	−	UCGUGAUCCGCCCGCCU	17	19899
CFTR-Intron10-1015	−	UCAUGAUCUGCCUGCCU	17	19900
CFTR-Intron10-1016	−	UGUAACCUUGAACUCCU	17	19901
CFTR-Intron10-1017	+	UGCAAGUUCUGCCUCCU	17	19902
CFTR-Intron10-1018	−	AGGUUUUGGAUGGAGCU	17	19903
CFTR-Intron10-1019	−	AACAAAAGAAAAUAGCU	17	19904
CFTR-Intron10-1020	−	CACCCUCCCAAGUAGCU	17	19905
CFTR-Intron10-1021	+	CAGCCUCCCAAGUAGCU	17	19906
CFTR-Intron10-1022	+	CAGCCUCCCGAGUAGCU	17	19907
CFTR-Intron10-1023	+	UCACAGUUCUGGAGGCU	17	19908
CFTR-Intron10-1024	−	AAAUUAUUUCUACUGCU	17	19909
CFTR-Intron10-1025	+	CUGCCUCCAAAAGUGCU	17	19910
CFTR-Intron10-1026	−	CAGCCUCCCAAAGUGCU	17	19911
CFTR-Intron10-1027	−	CGGCCUCCCAAAGUGCU	17	19912
CFTR-Intron10-1028	−	AAAAAAGUUGAGUUGCU	17	19913
CFTR-Intron10-1029	−	UGCUGGCACCUUGAUCU	17	19914
CFTR-Intron10-1030	−	UGCUUUUCCCACUAUCU	17	19915
CFTR-Intron10-1031	+	AAUUUGAACAACAUUCU	17	19916
CFTR-Intron10-1032	+	UUUUUCAUUAUGAUUCU	17	19917
CFTR-Intron10-1033	+	CUUUUUCUUAAUUUUCU	17	19918
CFTR-Intron10-1034	−	UGAGGAAGAAAGGAAGU	17	19919
CFTR-Intron10-1035	−	UCUGCAAUUGUAUCAGU	17	19920
CFTR-Intron10-1036	+	CAGUUUUAUUUUUCAGU	17	19921
CFTR-Intron10-1037	+	ACAUUUUCCUAAUGAGU	17	19922
CFTR-Intron10-1038	−	AGUGGAAGUAGUAUAGU	17	19923
CFTR-Intron10-1039	+	UACAUAAAAAGAGAGGU	17	19924
CFTR-Intron10-1040	−	UUAGAGGUUAAGGAGGU	17	19925
CFTR-Intron10-1041	−	ACUUGGGAGGCUGAGGU	17	19926
CFTR-Intron10-1042	−	ACGGGGUUUCACCAUGU	17	19927
CFTR-Intron10-1043	−	UCGGCCUCCCAAAGUGU	17	19928
CFTR-Intron10-1044	−	AGAAGAGAAAGGGGUGU	17	19929
CFTR-Intron10-1045	−	ACCCAAUAAAAAAAAUU	17	19930
CFTR-Intron10-1046	−	UUUCCACUCAAUAAAUU	17	19931
CFTR-Intron10-1047	+	CCAUCACCUUGGGAAUU	17	19932
CFTR-Intron10-1048	−	CACUAUUGAUUGACAUU	17	19933
CFTR-Intron10-1049	+	CAAGGUGCCAGCAGAUU	17	19934
CFTR-Intron10-1050	−	UAUUCUUUUUAGAGAUU	17	19935
CFTR-Intron10-1051	−	UACUUUUCUUCCUGAUU	17	19936
CFTR-Intron10-1052	−	UUUUCAUUGAAUGUAUU	17	19937
CFTR-Intron10-1053	−	UCCUUUGUUUGUUUAUU	17	19938
CFTR-Intron10-1054	+	CAGACUUUUAUUUUAUU	17	19939
CFTR-Intron10-1055	+	UCCAAAUUUUUUUUAUU	17	19940
CFTR-Intron10-1056	+	CUGUAAUCCCAACACUU	17	19941
CFTR-Intron10-1057	−	AAGUAACAGGGCCACUU	17	19942
CFTR-Intron10-1058	+	CUAUAAACCCAGCACUU	17	19943
CFTR-Intron10-1059	+	CUGUAAUCCCAGCACUU	17	19944
CFTR-Intron10-1060	−	AAUUGAAUAUGAGACUU	17	19945
CFTR-Intron10-1061	+	UGUAGUCCCAGCUACUU	17	19946
CFTR-Intron10-1062	+	UGCAAUACCAUCACCUU	17	19947
CFTR-Intron10-1063	+	AUGUUAAAUUUUCCCUU	17	19948
CFTR-Intron10-1064	+	UUCCCUUAGGAUAUCUU	17	19949
CFTR-Intron10-1065	−	AAGCAAGGAGAUGAGUU	17	19950
CFTR-Intron10-1066	−	CGGCCUCCCAAAGUGUU	17	19951
CFTR-Intron10-1067	−	UGUUAUCUCUGAAAUUU	17	19952
CFTR-Intron10-1068	−	UUUGAUUAGAUAAAUUU	17	19953
CFTR-Intron10-1069	−	UCAAUAUUUUGGAAUUU	17	19954
CFTR-Intron10-1070	−	ACUAUUGAUUGACAUUU	17	19955
CFTR-Intron10-1071	+	AAGGUGCCAGCAGAUUU	17	19956
CFTR-Intron10-1072	−	UAGUUUUAUCAAUAUUU	17	19957
CFTR-Intron10-1073	+	UCUCUGCAAACAUAUUU	17	19958
CFTR-Intron10-1074	−	CAUUAUUCAUGAUAUUU	17	19959
CFTR-Intron10-1075	−	UUUCAUUGAAUGUAUUU	17	19960
CFTR-Intron10-1076	+	UGUAAUCCCAACACUUU	17	19961
CFTR-Intron10-1077	+	UAUAAACCCAGCACUUU	17	19962
CFTR-Intron10-1078	+	UGUAAUCCCAGCACUUU	17	19963
CFTR-Intron10-1079	−	UGUAAUCCUAGCACUUU	17	19964
CFTR-Intron10-1080	−	UGCAGGGUGGGGCCUUU	17	19965
CFTR-Intron10-1081	−	UUUAACUGAAUAUCUUU	17	19966
CFTR-Intron10-1082	−	AUGGGAGAAACAGGUUU	17	19967
CFTR-Intron10-1083	−	AUACAUUGGAAAAUUUU	17	19968
CFTR-Intron10-1084	−	CAAUAUUUUGGAAUUUU	17	19969
CFTR-Intron10-1085	−	UACAUUGGAAAAUUUUU	17	19970
CFTR-Intron10-1086	−	CUUUGGCUAAUGUUUUU	17	19971
CFTR-Intron10-1087	−	CACUUUAUAGUUUUUUU	17	19972
CFTR-Intron10-1088	+	ACAAACAAAGAAACAAAAAA	20	19973
CFTR-Intron10-1089	+	ACAUAUGAUUUUAUGAAAAA	20	19974
CFTR-Intron10-1090	+	CGAGACCAUCCCGGCUAAAA	20	19975
CFTR-Intron10-1091	−	UAGAAAGAAAAAACAGCAAA	20	19976
CFTR-Intron10-1092	+	AUUAGUAAAAAAAAAUCAAA	20	19977
CFTR-Intron10-1093	+	AAGAAAAGCUGAAAGUCAAA	20	19978
CFTR-Intron10-1094	+	UACAUUCAAUGAAAAAGAAA	20	19979
CFTR-Intron10-1095	−	AGGGUUGAUAAGAAGAGAAA	20	19980
CFTR-Intron10-1096	−	AUUUAAACACUUCUGAGAAA	20	19981
CFTR-Intron10-1097	+	AAAUAAACAAACAAAGGAAA	20	19982
CFTR-Intron10-1098	−	AAGGAUGUUUAUUUAUGAAA	20	19983
CFTR-Intron10-1099	+	AAAACCAAAUAAACAAACAA	20	19984
CFTR-Intron10-1100	−	CUCAUUAGGAAAAUGUACAA	20	19985
CFTR-Intron10-1101	+	AUGGACUAAUCACCUCCCAA	20	19986
CFTR-Intron10-1102	−	UCAUGUUGAUAAAGGGUCAA	20	19987
CFTR-Intron10-1103	+	CUGAAAUAUAUUCAAAAGAA	20	19988
CFTR-Intron10-1104	+	AGAUGAGAGACAGUAAAGAA	20	19989
CFTR-Intron10-1105	−	AAGAAGGAAAUGAGGAAGAA	20	19990
CFTR-Intron10-1106	+	UGUGUUCUCACAUGGCAGAA	20	19991
CFTR-Intron10-1107	+	UUUGGGAGGCUGAAGCGGAA	20	19992
CFTR-Intron10-1108	+	UUAGGAUUUCAACAUAUGAA	20	19993
CFTR-Intron10-1109	+	ACAUUUCUCUUUACUGUGAA	20	19994
CFTR-Intron10-1110	+	AGGAAGAAAAGUAUCAAUAA	20	19995
CFTR-Intron10-1111	+	AUACAGUGACUUCAUAAUAA	20	19996
CFTR-Intron10-1112	+	AACAUAGAGAAAACUCAUAA	20	19997
CFTR-Intron10-1113	+	UGAACAAAAAUUAAAACUAA	20	19998
CFTR-Intron10-1114	+	UUUUCUAGAAAACAAUGUAA	20	19999
CFTR-Intron10-1115	−	AACAGAUAAAGUUGAAUUAA	20	20000
CFTR-Intron10-1116	+	UGUUACCUUUCAAUGUUUAA	20	20001
CFTR-Intron10-1117	+	UUCAAGCCUGUAUUGUUUAA	20	20002
CFTR-Intron10-1118	−	AUCAUUUUGACCAUUUUUAA	20	20003
CFTR-Intron10-1119	+	CAAUACCAUCCUGGCCAACA	20	20004
CFTR-Intron10-1120	−	UGAGACCAGCGUGGGCAACA	20	20005
CFTR-Intron10-1121	−	UUGUUAUAGCAGCCUGAACA	20	20006
CFTR-Intron10-1122	+	UGGAGAGAGAACUGCUCACA	20	20007
CFTR-Intron10-1123	+	CUUCCUGCUGUGUUCUCACA	20	20008
CFTR-Intron10-1124	+	AAUGAUCAAUAAUAGAGACA	20	20009
CFTR-Intron10-1125	+	AUUUUACAAUUCUUAUUACA	20	20010
CFTR-Intron10-1126	−	UGUUGAAAUCCUAAUUCCCA	20	20011
CFTR-Intron10-1127	−	UUCUUUAUUUUUAUAUUCCA	20	20012
CFTR-Intron10-1128	+	AUUUCAACAUAUGAAUGGCA	20	20013
CFTR-Intron10-1129	−	AAAGUGCCACUAGUGAUGCA	20	20014
CFTR-Intron10-1130	−	CAAUACAGGCUUGAACUGCA	20	20015
CFTR-Intron10-1131	−	CCCAAGGUGAUGGUAUUGCA	20	20016
CFTR-Intron10-1132	+	AGGGUACAGUGGUGCAAUCA	20	20017
CFTR-Intron10-1133	+	UGCUUCACUAAAAUAAUUCA	20	20018
CFTR-Intron10-1134	+	ACAUAUAUUUUAUGCAUUCA	20	20019
CFTR-Intron10-1135	−	UUUAUAAGCCACACAGUUCA	20	20020
CFTR-Intron10-1136	+	CAAUUGAGCCCAGGAGUUCA	20	20021
CFTR-Intron10-1137	−	AAGAGAGGAAGGAAGAAAGA	20	20022
CFTR-Intron10-1138	−	AGGAAGGAAGGAAGGAAAGA	20	20023
CFTR-Intron10-1139	−	AAAGAAGGAAGGAAGUAAGA	20	20024
CFTR-Intron10-1140	−	AAUGAAAGCAAUAGUAGAGA	20	20025
CFTR-Intron10-1141	+	UUUUGUAUUUUUAGUAGAGA	20	20026
CFTR-Intron10-1142	−	UUUUUUUUUUUUUUUUGAGA	20	20027
CFTR-Intron10-1143	−	AGUCUUUUCCUCUUAAUAGA	20	20028
CFTR-Intron10-1144	+	AAUAUAUUCAAAAGAAAGGA	20	20029
CFTR-Intron10-1145	−	AGGAAGGAAGGAAAGAAGGA	20	20030
CFTR-Intron10-1146	−	AAAGGAAGUAGGAGGAAGGA	20	20031
CFTR-Intron10-1147	+	UUUCACUGUGUUAGCCAGGA	20	20032
CFTR-Intron10-1148	−	UUUCACCAUGUUGGCCAGGA	20	20033
CFTR-Intron10-1149	−	ACAGAAAAAGAAAGAGAGGA	20	20034
CFTR-Intron10-1150	−	AUGAAGGCAGAGUUAGAGGA	20	20035
CFTR-Intron10-1151	−	UAAAAAAUUAUACUAUAGGA	20	20036
CFTR-Intron10-1152	+	AUUGGUACAAAUUUCAGGGA	20	20037
CFTR-Intron10-1153	−	UUUCACCGUUUUAGCCGGGA	20	20038
CFTR-Intron10-1154	−	AUAGUAUUCUAUCAUAUGGA	20	20039
CFTR-Intron10-1155	−	UUCUGGACUGAGUAACUGGA	20	20040
CFTR-Intron10-1156	−	UGUAUAUAUGUGUGUCUGGA	20	20041
CFTR-Intron10-1157	−	UGGGAGAAACAGGUUUUGGA	20	20042
CFTR-Intron10-1158	+	UUGACCCUUUAUCAACAUGA	20	20043
CFTR-Intron10-1159	+	UGCUGGCAUAGCUGCACUGA	20	20044
CFTR-Intron10-1160	−	AAAAAAUUAGCCAGACGUGA	20	20045
CFTR-Intron10-1161	−	AAUCCUAAUUCCCAAGGUGA	20	20046
CFTR-Intron10-1162	−	CAAAGACUUGCAGGAGGUGA	20	20047
CFTR-Intron10-1163	+	CACAUGGCAGAAAGGGGUGA	20	20048
CFTR-Intron10-1164	−	AGAUUCAGGACAUGCUUUGA	20	20049
CFTR-Intron10-1165	+	AUAUUCAAUUCUUCAAAAUA	20	20050
CFTR-Intron10-1166	−	AAAACUAAUUGUAGUACAUA	20	20051
CFTR-Intron10-1167	−	AUGCAUAGUAUUCUAUCAUA	20	20052
CFTR-Intron10-1168	+	AAACAUAGAGAAAACUCAUA	20	20053
CFTR-Intron10-1169	+	UAGCUGCAGACCUCAAUAUA	20	20054
CFTR-Intron10-1170	+	CAAAAAUUACAGAACCUAUA	20	20055
CFTR-Intron10-1171	−	AAAAAGUUUCUCAUCUUAUA	20	20056
CFTR-Intron10-1172	+	CUCCCGAGUAGCUGGGACUA	20	20057
CFTR-Intron10-1173	+	AAGGGGUGAGGGUCUCUCUA	20	20058
CFTR-Intron10-1174	+	AAGGUGUGAGGGUCUCUCUA	20	20059
CFTR-Intron10-1175	+	ACUGUGAAUGGUGCCAGGUA	20	20060
CFTR-Intron10-1176	+	AUCACUAGUGGCACUUUGUA	20	20061
CFTR-Intron10-1177	+	UUGAUGUUAUUCAAGGUUUA	20	20062
CFTR-Intron10-1178	−	UAUCAUUUUGACCAUUUUUA	20	20063
CFTR-Intron10-1179	+	UUGGAAAAAAAAUUCAAAAC	20	20064
CFTR-Intron10-1180	+	CUGUGUGGCUUAUAAACAAC	20	20065
CFTR-Intron10-1181	+	CCAUCAUCACUUGCCUGAAC	20	20066
CFTR-Intron10-1182	−	AGCUUUCUGGACUGAGUAAC	20	20067
CFTR-Intron10-1183	−	UUUGUAUUUUUAGUAGAGAC	20	20068
CFTR-Intron10-1184	−	ACAAGUGCCUAGCACUUGAC	20	20069
CFTR-Intron10-1185	−	AAUUGACCCUUAAACAAUAC	20	20070
CFTR-Intron10-1186	+	UCCCAAGUAGCUGGGACUAC	20	20071
CFTR-Intron10-1187	+	UCCCGAGUAGCUGGGACUAC	20	20072
CFTR-Intron10-1188	−	UCCCAAAGUGCUGGGAUUAC	20	20073
CFTR-Intron10-1189	−	UCCCAAAGUGUUGGGAUUAC	20	20074
CFTR-Intron10-1190	+	UACUGCAAUAUGCAAUUUAC	20	20075
CFTR-Intron10-1191	+	CAGGAGAAUGGCGUGAACCC	20	20076
CFTR-Intron10-1192	+	AGAGUCUCACUCUGUCACCC	20	20077
CFTR-Intron10-1193	−	UAGGUCUUACUCUGUCACCC	20	20078
CFTR-Intron10-1194	+	CGGAAAGGUCAAUUGAGCCC	20	20079
CFTR-Intron10-1195	+	CAGGAGAAUUGCUUGAGCCC	20	20080
CFTR-Intron10-1196	−	CACUGCAAGCUCCGCCUCCC	20	20081
CFTR-Intron10-1197	−	CACUGCAACCUCUGCCUCCC	20	20082
CFTR-Intron10-1198	+	CCCGCCACUGCACUCCAGCC	20	20083
CFTR-Intron10-1199	+	CGCACCACUGUGCUCCAGCC	20	20084
CFTR-Intron10-1200	+	CACACCACUGAAGUUCAGCC	20	20085
CFTR-Intron10-1201	−	CGCGCCACUGCACUCUAGCC	20	20086
CFTR-Intron10-1202	+	AAAAAUACAAAAAAUUAGCC	20	20087
CFTR-Intron10-1203	−	CAGGCGCCCGCCACUACGCC	20	20088
CFTR-Intron10-1204	−	CAGGCGUGAGCCACCGCGCC	20	20089
CFTR-Intron10-1205	+	UAUAAGAAAUGAAACAGGCC	20	20090
CFTR-Intron10-1206	−	UUAGGAGAUCAAGACCAUCC	20	20091
CFTR-Intron10-1207	+	UCAGGAGAUCGAGACCAUCC	20	20092
CFTR-Intron10-1208	+	UCAAGAGAUCAAUACCAUCC	20	20093
CFTR-Intron10-1209	−	UGAUGAUGGUGGCUUGAUCC	20	20094
CFTR-Intron10-1210	−	AGGAAGACAGCUGGCUAUCC	20	20095
CFTR-Intron10-1211	+	CCACGCUGGUCUCAAACUCC	20	20096
CFTR-Intron10-1212	−	UCACUGUAACCUUGAACUCC	20	20097
CFTR-Intron10-1213	−	UUAUUCUUUUGAUAUACUCC	20	20098
CFTR-Intron10-1214	−	UCACUGCAAGCUCCGCCUCC	20	20099
CFTR-Intron10-1215	−	UCACUGCAACCUCUGCCUCC	20	20100
CFTR-Intron10-1216	+	UCACUGCAAGUUCUGCCUCC	20	20101
CFTR-Intron10-1217	−	CAGGUGAAUUGCUUGAGUCC	20	20102
CFTR-Intron10-1218	−	CUGCCAUGUGAGAACACAGC	20	20103
CFTR-Intron10-1219	−	AUCAGUGCAGCUAUGCCAGC	20	20104
CFTR-Intron10-1220	−	AGCUUUUAAAACAAAAUAGC	20	20105
CFTR-Intron10-1221	−	CACAAACAAAAGAAAAUAGC	20	20106
CFTR-Intron10-1222	+	ACCUCAGCCUCCCAAGUAGC	20	20107
CFTR-Intron10-1223	+	UAAAAAUACAAAAAAUUAGC	20	20108
CFTR-Intron10-1224	−	CGGGGUUUCACCGUUUUAGC	20	20109
CFTR-Intron10-1225	+	AUAUAAGAAAUGAAACAGGC	20	20110
CFTR-Intron10-1226	−	UCUCGCUCUGUCGCCCAGGC	20	20111
CFTR-Intron10-1227	−	CAAUAAAUUUGGUGUCAGGC	20	20112
CFTR-Intron10-1228	+	ACACUUUGGGAGGCCGAGGC	20	20113
CFTR-Intron10-1229	+	UUUCUCACAGUUCUGGAGGC	20	20114
CFTR-Intron10-1230	−	AAUUAGCCAGACGUGAUGGC	20	20115
CFTR-Intron10-1231	−	CCAGGCUGGAGUGCAGUGGC	20	20116
CFTR-Intron10-1232	+	AAUUAGCCGGGCGUAGUGGC	20	20117
CFTR-Intron10-1233	−	CUUAGCAGACCCAAAUCUGC	20	20118
CFTR-Intron10-1234	+	UUCAUUUAUCUCGAAAUUGC	20	20119
CFTR-Intron10-1235	−	UCCCAAGGUGAUGGUAUUGC	20	20120
CFTR-Intron10-1236	−	ACAUUUGAACAAAGACUUGC	20	20121
CFTR-Intron10-1237	+	AGCCUCCACUUCUCAGGCUC	20	20122
CFTR-Intron10-1238	+	UAUAUAGAGAGAAACAUCUC	20	20123
CFTR-Intron10-1239	+	CACUGCAGCCUCCACUUCUC	20	20124
CFTR-Intron10-1240	+	CGGGCACCCGCCAUCACGUC	20	20125
CFTR-Intron10-1241	−	UAGGCAUGAGCCACUGUGUC	20	20126
CFTR-Intron10-1242	−	UGUAUGUAUAUAUGUGUGUC	20	20127
CFTR-Intron10-1243	+	UAUUCUUUCUAAUUUCAUUC	20	20128
CFTR-Intron10-1244	−	AGUAGGAAGUGAUCAGAUUC	20	20129
CFTR-Intron10-1245	−	CUUUCUUUUGAAUAUAUUUC	20	20130
CFTR-Intron10-1246	−	AAAGAUGAUUCCAAGCUUUC	20	20131
CFTR-Intron10-1247	−	UUCAUUAUAACACUGCUUUC	20	20132
CFTR-Intron10-1248	+	AAGAAAAUUUGUUUUCUUUC	20	20133
CFTR-Intron10-1249	+	UGUUCUCACAUGGCAGAAAG	20	20134
CFTR-Intron10-1250	−	UUUUGAAUUUUUUUUCCAAG	20	20135
CFTR-Intron10-1251	+	ACCGUAAUAGCAACAGGAAG	20	20136
CFTR-Intron10-1252	+	AGCACUUUGGGAGGCUGAAG	20	20137
CFTR-Intron10-1253	+	AAAAAAAAUUCACAAAUAAG	20	20138
CFTR-Intron10-1254	−	AUGAAAUUAGAAAGAAUAAG	20	20139
CFTR-Intron10-1255	−	AUCAAAAAUAAAAAUAUAAG	20	20140
CFTR-Intron10-1256	−	AUCAGUAGGCUUCCUAUAAG	20	20141
CFTR-Intron10-1257	+	AUAUUAAUGGCUGUGCACAG	20	20142
CFTR-Intron10-1258	+	UCACCUAGGCUAGGGUACAG	20	20143
CFTR-Intron10-1259	+	UUCUGUUUAAAACUCUCCAG	20	20144
CFTR-Intron10-1260	+	AGAAGGAAAGGAGGUAGCAG	20	20145
CFTR-Intron10-1261	+	UGCUUGAGCCCGGGAGGCAG	20	20146
CFTR-Intron10-1262	−	CCUAGCACUUUUGGAGGCAG	20	20147
CFTR-Intron10-1263	+	UUUCAACAUAUGAAUGGCAG	20	20148
CFTR-Intron10-1264	+	UCACCCAGGCUAGAGUGCAG	20	20149
CFTR-Intron10-1265	−	UCGCCCAGGCUGGAGUGCAG	20	20150
CFTR-Intron10-1266	−	UGGUGUCAGGCUGGGUGCAG	20	20151
CFTR-Intron10-1267	−	AGGAAUGUUAAUUUAUUCAG	20	20152
CFTR-Intron10-1268	−	UCACCCAGGCUGAACUUCAG	20	20153
CFTR-Intron10-1269	−	ACAAACAGAAAAAGAAAGAG	20	20154
CFTR-Intron10-1270	−	AAAAAAUUAUACUAUAGGAG	20	20155
CFTR-Intron10-1271	+	ACUAAUAGCCUAUUGUUGAG	20	20156
CFTR-Intron10-1272	−	CAGUAAAAAGUGAUCUCUAG	20	20157
CFTR-Intron10-1273	+	AAAAAAUUAGCCGGGCGUAG	20	20158
CFTR-Intron10-1274	−	AAGAAGAGAAAGGGGUGUAG	20	20159
CFTR-Intron10-1275	+	UUUGUUUGUGUUUUUUGUAG	20	20160
CFTR-Intron10-1276	−	AAAUGUGAGAAAAAGUUUAG	20	20161
CFTR-Intron10-1277	+	CGGAGAUGAUUAGCAUCACG	20	20162
CFTR-Intron10-1278	−	UUGUAUUUUUAGUAGAGACG	20	20163
CFTR-Intron10-1279	+	CCCAACACUUUGGGAGGCCG	20	20164
CFTR-Intron10-1280	+	CCCAGCACUUUGGGAGGCCG	20	20165
CFTR-Intron10-1281	−	CCAGGAGUUUGAGACCAGCG	20	20166
CFTR-Intron10-1282	+	AGUAAAAAAAAAUCAAAAGG	20	20167
CFTR-Intron10-1283	+	AAACUGAGUAGAAGGAAAGG	20	20168
CFTR-Intron10-1284	−	UGGUUUGAAGAACAGUAAGG	20	20169
CFTR-Intron10-1285	−	UUUGAACAAAGACUUGCAGG	20	20170
CFTR-Intron10-1286	+	AGCACUUUGGGAGGCCGAGG	20	20171
CFTR-Intron10-1287	+	AAUGGCGUGAACCCGGGAGG	20	20172
CFTR-Intron10-1288	−	AGCUACUUGGGAGGCUGAGG	20	20173
CFTR-Intron10-1289	−	UUAAAAAAUUAUACUAUAGG	20	20174
CFTR-Intron10-1290	−	UGAGGAAGAAAGGAAGUAGG	20	20175
CFTR-Intron10-1291	+	AUGAAACAGGCCGGGCGCGG	20	20176
CFTR-Intron10-1292	−	AAGGUGAUGGUAUUGCAGGG	20	20177
CFTR-Intron10-1293	+	CUUUGGGAGGCCGAGGCGGG	20	20178
CFTR-Intron10-1294	−	CGUAGUCCCAGCUACUCGGG	20	20179
CFTR-Intron10-1295	−	ACUUGGGAGGCUGAGGUGGG	20	20180
CFTR-Intron10-1296	+	UGUAGUCCCAGCUACUUGGG	20	20181
CFTR-Intron10-1297	+	UGUAAUCCCAACACUUUGGG	20	20182
CFTR-Intron10-1298	+	UAUAAACCCAGCACUUUGGG	20	20183
CFTR-Intron10-1299	+	UGUAAUCCCAGCACUUUGGG	20	20184
CFTR-Intron10-1300	−	UGCAGGGUGGGGCCUUUGGG	20	20185
CFTR-Intron10-1301	−	AAAUUAGCCAGACGUGAUGG	20	20186
CFTR-Intron10-1302	+	UUUAUUUCUCACAGUUCUGG	20	20187
CFTR-Intron10-1303	−	CACCUGAGCCUGAGAAGUGG	20	20188
CFTR-Intron10-1304	−	CCCAGGCUGGAGUGCAGUGG	20	20189
CFTR-Intron10-1305	+	AAAUUAGCCGGGCGUAGUGG	20	20190
CFTR-Intron10-1306	−	AAGAAAAUAGCUGGGUGUGG	20	20191
CFTR-Intron10-1307	+	UAUUCAAAAAAUAUUUGUGG	20	20192
CFTR-Intron10-1308	−	UGUAAUCCUAGCACUUUUGG	20	20193
CFTR-Intron10-1309	−	AGGAAUUUUAUAUAGAAAUG	20	20194
CFTR-Intron10-1310	+	AUAAACAAACAAAGGAAAUG	20	20195
CFTR-Intron10-1311	−	AAGGAAGAAAGAAGGAAAUG	20	20196
CFTR-Intron10-1312	−	UGGGAGGUGAUUAGUCCAUG	20	20197
CFTR-Intron10-1313	−	CCCAGCUACUCGGGAGGCUG	20	20198
CFTR-Intron10-1314	+	CCCAGCUACUUGGGAGGCUG	20	20199
CFTR-Intron10-1315	+	AUACAAAAAUUAGCUGAGUG	20	20200
CFTR-Intron10-1316	+	UUGUGUUUUUUGUAGAGGUG	20	20201
CFTR-Intron10-1317	−	ACAAAGACUUGCAGGAGGUG	20	20202
CFTR-Intron10-1318	+	CCCAGCUACUUGGGAGGGUG	20	20203
CFTR-Intron10-1319	+	UCACAUGGCAGAAAGGGGUG	20	20204
CFTR-Intron10-1320	−	CAAAAGAAAAUAGCUGGGUG	20	20205
CFTR-Intron10-1321	+	ACAAAAUACCAUGAACUGUG	20	20206
CFTR-Intron10-1322	−	AUUUUUAUAAAAAAUAAUUG	20	20207
CFTR-Intron10-1323	+	AUCUAUUCAAAAAAUAUUUG	20	20208
CFTR-Intron10-1324	−	AAUACAUUGGAAAAUUUUUG	20	20209
CFTR-Intron10-1325	−	UAUUAGUAGUUAAGUUUUUG	20	20210
CFTR-Intron10-1326	+	AUAGUAGCAAAUGAUAAAAU	20	20211
CFTR-Intron10-1327	+	UCUCUAUUUGGAUGUCAAAU	20	20212
CFTR-Intron10-1328	+	AAUAAACAAACAAAGGAAAU	20	20213
CFTR-Intron10-1329	−	UAAGGUUUCCACUCAACAAU	20	20214
CFTR-Intron10-1330	+	UUUACCAUUAUCUACACAAU	20	20215
CFTR-Intron10-1331	−	CCCCAUAAAUGUUGAAUAAU	20	20216
CFTR-Intron10-1332	−	UUUUUUUUCAGUUAAUACAU	20	20217
CFTR-Intron10-1333	+	UUUUACAAUUCUUAUUACAU	20	20218
CFTR-Intron10-1334	−	AAUACAGGCUUGAACUGCAU	20	20219
CFTR-Intron10-1335	−	UGUACCCUAGCCUAGGUGAU	20	20220
CFTR-Intron10-1336	+	AAAAAUAUAUAUAUGCAUAU	20	20221
CFTR-Intron10-1337	−	CUAUUAAAAAAUUAUACUAU	20	20222
CFTR-Intron10-1338	−	UUCUCCCUGUUAUUCCUUAU	20	20223
CFTR-Intron10-1339	−	UAAAAAGUUUCUCAUCUUAU	20	20224
CFTR-Intron10-1340	−	UCCCAAAGUGCUGGGUUUAU	20	20225
CFTR-Intron10-1341	+	UUCUCAGACUUUUAUUUUAU	20	20226
CFTR-Intron10-1342	+	AGUUUCCAAAUUUUUUUUAU	20	20227
CFTR-Intron10-1343	−	UGCCCGUAGUCCCAGCUACU	20	20228
CFTR-Intron10-1344	+	CGCCUGUAGUCCCAGCUACU	20	20229
CFTR-Intron10-1345	+	UGCCUGUAGUCCCAGCUACU	20	17606
CFTR-Intron10-1346	+	ACCCUGCAAUACCAUCACCU	20	20230
CFTR-Intron10-1347	+	CCGCCACUGCACUCCAGCCU	20	20231
CFTR-Intron10-1348	+	ACACCACUGAAGUUCAGCCU	20	20232
CFTR-Intron10-1349	−	ACCUCGUGAUCCGCCCGCCU	20	20233
CFTR-Intron10-1350	−	ACCUCAUGAUCUGCCUGCCU	20	20234
CFTR-Intron10-1351	−	CACUGUAACCUUGAACUCCU	20	20235
CFTR-Intron10-1352	+	CACUGCAAGUUCUGCCUCCU	20	20236
CFTR-Intron10-1353	−	ACAAACAAAAGAAAAUAGCU	20	20237
CFTR-Intron10-1354	−	CCUCACCCUCCCAAGUAGCU	20	20238
CFTR-Intron10-1355	+	CCUCAGCCUCCCAAGUAGCU	20	20239
CFTR-Intron10-1356	+	CCUCAGCCUCCCGAGUAGCU	20	20240
CFTR-Intron10-1357	+	UUCUCACAGUUCUGGAGGCU	20	20241
CFTR-Intron10-1358	+	CCUCUGCCUCCAAAAGUGCU	20	20242
CFTR-Intron10-1359	−	CUUCAGCCUCCCAAAGUGCU	20	20243
CFTR-Intron10-1360	−	CCUCGGCCUCCCAAAGUGCU	20	20244
CFTR-Intron10-1361	−	AAGAAAAAAGUUGAGUUGCU	20	20245
CFTR-Intron10-1362	+	AGAGUGCAGUGGCGCGAUCU	20	20246
CFTR-Intron10-1363	−	AUCUGCUGGCACCUUGAUCU	20	20247
CFTR-Intron10-1364	−	AAAGCUGUGCAUUUUCCUCU	20	20248
CFTR-Intron10-1365	+	AUAUAGAGAGAAACAUCUCU	20	20249
CFTR-Intron10-1366	+	AUAUUUUUCAUUAUGAUUCU	20	20250
CFTR-Intron10-1367	+	UUAAUUUUCUCGGUAUUUCU	20	20251
CFTR-Intron10-1368	+	UUACUUUUUCUUAAUUUUCU	20	20252
CFTR-Intron10-1369	−	AAAUGAGGAAGAAAGGAAGU	20	20253
CFTR-Intron10-1370	−	UGGAUUUUUGACUAUACAGU	20	20254
CFTR-Intron10-1371	−	ACAUCUGCAAUUGUAUCAGU	20	20255
CFTR-Intron10-1372	−	AUCCAAAUAGAGAUGUUAGU	20	20256
CFTR-Intron10-1373	−	CAGGAGUUUGAGACCAGCGU	20	20257
CFTR-Intron10-1374	+	UUUGUGUUUUUUGUAGAGGU	20	20258
CFTR-Intron10-1375	−	AGGUGAUGGUAUUGCAGGGU	20	20259
CFTR-Intron10-1376	+	UGAAUGGUGCCAGGUAGGGU	20	20260
CFTR-Intron10-1377	−	UUUUUGACUAUACAGUGGGU	20	20261
CFTR-Intron10-1378	−	AUAAGAAGAGAAAGGGGUGU	20	20262
CFTR-Intron10-1379	−	AAAUUUCCACUCAAUAAAUU	20	20263
CFTR-Intron10-1380	+	AUACCAUCACCUUGGGAAUU	20	20264
CFTR-Intron10-1381	−	AUGGUACUACUGUAAUAAUU	20	20265
CFTR-Intron10-1382	−	AAUCACUAUUGAUUGACAUU	20	20266
CFTR-Intron10-1383	−	UUUUAUUCUUUUUAGAGAUU	20	20267
CFTR-Intron10-1384	−	CUUGCAGGAGGUGAGGGAUU	20	20268
CFTR-Intron10-1385	−	UGAUACUUUUCUUCCUGAUU	20	20269
CFTR-Intron10-1386	+	AUAGAAGUAGAAGAACUAUU	20	20270
CFTR-Intron10-1387	−	UCUUUUUCAUUGAAUGUAUU	20	20271
CFTR-Intron10-1388	+	UCUGUUUGUCUUAGAUUAUU	20	20272
CFTR-Intron10-1389	−	AUUUCCUUUGUUUGUUUAUU	20	20273
CFTR-Intron10-1390	+	UCUCAGACUUUUAUUUUAUU	20	20274
CFTR-Intron10-1391	+	UGCCUGUAAUCCCAACACUU	20	20275
CFTR-Intron10-1392	+	UGCCUAUAAACCCAGCACUU	20	20276
CFTR-Intron10-1393	+	CGCCUGUAAUCCCAGCACUU	20	20277
CFTR-Intron10-1394	−	AAGAAUUGAAUAUGAGACUU	20	20278
CFTR-Intron10-1395	+	CCCUGCAAUACCAUCACCUU	20	20279
CFTR-Intron10-1396	+	AAAAUGUUAAAUUUUCCCUU	20	20280
CFTR-Intron10-1397	+	AUUUUCCCUUAGGAUAUCUU	20	20281
CFTR-Intron10-1398	−	CUUUUAGUUAGCAUAAAGUU	20	20282
CFTR-Intron10-1399	−	AGGAAGCAAGGAGAUGAGUU	20	20283
CFTR-Intron10-1400	−	CCUCGGCCUCCCAAAGUGUU	20	20284
CFTR-Intron10-1401	−	AGUUGUUAUCUCUGAAAUUU	20	20285
CFTR-Intron10-1402	−	UUAUCAAUAUUUUGGAAUUU	20	20286
CFTR-Intron10-1403	−	AUCACUAUUGAUUGACAUUU	20	20287
CFTR-Intron10-1404	+	AUCAAGGUGCCAGCAGAUUU	20	20288
CFTR-Intron10-1405	−	AAAUAGUUUUAUCAAUAUUU	20	20289
CFTR-Intron10-1406	−	CAUCAUUAUUCAUGAUAUUU	20	20290
CFTR-Intron10-1407	−	CUUUUUCAUUGAAUGUAUUU	20	20291
CFTR-Intron10-1408	−	ACUUGUAAUCCUAGCACUUU	20	20292
CFTR-Intron10-1409	−	UAUUGCAGGGUGGGGCCUUU	20	20293
CFTR-Intron10-1410	−	AAAUUUAACUGAAUAUCUUU	20	20294
CFTR-Intron10-1411	−	UUAAUACAUUGGAAAAUUUU	20	20295
CFTR-Intron10-1412	−	UAUCAAUAUUUUGGAAUUUU	20	20296
CFTR-Intron10-1413	−	UAAUACAUUGGAAAAUUUUU	20	20297

Table 41A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within intron 10, have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 41A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-1414	+	GAUAAUACUACUGACUAAAA	20	20298
CFTR-Intron10-1415	+	GUAACUCCAGUGCUAUUUAAA	21	20299
CFTR-Intron10-1416	+	GGUAACUCCAGUGCUAUUUAAA	22	20300
CFTR-Intron10-1417	+	GACUCCAGGAGUAUAUCAA	19	20301
CFTR-Intron10-1418	+	GGACUCCAGGAGUAUAUCAA	20	20302
CFTR-Intron10-1419	+	GUGGACUCCAGGAGUAUAUCAA	22	20303
CFTR-Intron10-1420	+	GAUGAGAGACAGUAAAGAA	19	20304
CFTR-Intron10-1421	+	GCUAUUUUUGCACAUCUAUCA	21	20305
CFTR-Intron10-1422	+	GCUACCUUGGUUGGAUGA	18	20306
CFTR-Intron10-1423	+	GGCUACCUUGGUUGGAUGA	19	20307
CFTR-Intron10-1424	+	GAUUGGCUACCUUGGUUGGAUGA	23	20308
CFTR-Intron10-1425	+	GGAUUGGCUACCUUGGUUGGAUGA	24	20309
CFTR-Intron10-1426	+	GAAUAUCCAUCCAUAUGA	18	20310
CFTR-Intron10-1427	+	GUUACAACAGUCUUUAUA	18	20311
CFTR-Intron10-1428	+	GUUCAACUUAUCCAUUAAUCCUA	23	20312
CFTR-Intron10-1429	+	GAUACAAAUUACCAAAUUGUA	21	20313
CFTR-Intron10-1430	+	GCACCCAGCCUGACACCAAAUUUA	24	20314
CFTR-Intron10-1431	+	GUACAAAUAUUGACUAUUUA	20	20315
CFTR-Intron10-1432	+	GCAAGUACAAAUAUUGACUAUUUA	24	20316
CFTR-Intron10-1433	+	GAGCUCAUAUUAGUGAAC	18	20317
CFTR-Intron10-1434	+	GAUACUAAAAAAAGUUAC	18	20318
CFTR-Intron10-1435	+	GUAUUAGCAAGUGGACUCC	19	20319
CFTR-Intron10-1436	+	GCACUCUAUUUAGAGUGUAUGGC	23	20320
CFTR-Intron10-1437	+	GAAAAGGCUCUUUAUAAUGC	20	20321
CFTR-Intron10-1438	+	GCUAAGAGACUCCUGAAUC	19	20322
CFTR-Intron10-1439	+	GUCUGCUAAGAGACUCCUGAAUC	23	20323
CFTR-Intron10-1440	+	GGUCUGCUAAGAGACUCCUGAAUC	24	20324
CFTR-Intron10-1441	+	GUAGAAGACCUAAAUAUC	18	20325
CFTR-Intron10-1442	+	GAUGUAGAAGACCUAAAUAUC	21	20326
CFTR-Intron10-1443	+	GAAGAUGUAGAAGACCUAAAUAUC	24	20327
CFTR-Intron10-1444	+	GGGUCUGCUAAGAGACUC	18	20328
CFTR-Intron10-1445	+	GAUUUGGGUCUGCUAAGAGACUC	23	20329
CFTR-Intron10-1446	+	GAUAUUUUUCAUUAUGAUUC	20	20330
CFTR-Intron10-94	+	GCUUGACAUCAGUUGGGUUC	20	18980
CFTR-Intron10-1447	+	GAUAAAUAAUUGCCUUUC	18	20331
CFTR-Intron10-1448	+	GAUAUUGAUAAAUAAUUGCCUUUC	24	20332
CFTR-Intron10-1449	+	GUUGGAUGAGGGAAUGCAG	19	20333
CFTR-Intron10-1450	+	GGUUGGAUGAGGGAAUGCAG	20	20334
CFTR-Intron10-1451	+	GAAUUGAUCUUGAAGACAUACG	22	20335
CFTR-Intron10-1452	+	GCCUAGAUGAUUAUUAAUAGGG	22	20336
CFTR-Intron10-1453	+	GUUAAGUUGUUCUUAGGG	18	20337
CFTR-Intron10-1454	+	GGUUAAGUUGUUCUUAGGG	19	20338
CFTR-Intron10-1455	+	GCCAGGUUAAGUUGUUCUUAGGG	23	20339
CFTR-Intron10-1456	+	GUUACCUGGAUUGGCUACCUUGG	23	20340
CFTR-Intron10-1457	+	GGAAAUGGGGUAUAAGUG	18	20341
CFTR-Intron10-107	+	GUUACAUAAAAAGAGAGGUG	20	18993
CFTR-Intron10-1458	+	GCUAAUAGCUUAUUCUAUACAU	22	20342
CFTR-Intron10-1459	+	GAGCUAAUAGCUUAUUCUAUACAU	24	20343
CFTR-Intron10-1460	+	GAAUAAUGAUGUACAUUUAAUAU	23	20344
CFTR-Intron10-1461	+	GUAAUGGAAACACUAUAUAU	20	20345
CFTR-Intron10-1462	+	GUACAUCCAACUAACAUCUCUAU	23	20346
CFTR-Intron10-1463	+	GGAAAAUGUUAAAUUUUCCCU	21	20347
CFTR-Intron10-1464	+	GCACUUGUUGACAGUCCU	18	20348
CFTR-Intron10-1465	+	GGCACUUGUUGACAGUCCU	19	20349
CFTR-Intron10-1466	+	GCUAGGCACUUGUUGACAGUCCU	23	20350
CFTR-Intron10-117	+	GUUACUCAGUCCAGAAAGCU	20	19003
CFTR-Intron10-1467	+	GUGCAAGUCCUCUGUGCU	18	20351
CFTR-Intron10-1468	+	GCCAGGUUAAGUUGUUCU	18	20352
CFTR-Intron10-1469	+	GAGGGUCUCUCUAAGGUGU	19	20353
CFTR-Intron10-1470	+	GUGAGGGUCUCUCUAAGGUGU	21	20354
CFTR-Intron10-1471	+	GGUGAGGGUCUCUCUAAGGUGU	22	20355
CFTR-Intron10-1472	+	GGGUGAGGGUCUCUCUAAGGUGU	23	20356
CFTR-Intron10-1473	+	GGGGUGAGGGUCUCUCUAAGGUGU	24	20357
CFTR-Intron10-1474	+	GGAAAUCAGCACUCUAUU	18	20358
CFTR-Intron10-1475	+	GGGAAAUCAGCACUCUAUU	19	20359
CFTR-Intron10-1476	+	GGGGAAAUCAGCACUCUAUU	20	20360
CFTR-Intron10-1477	+	GUGGGGAAAUCAGCACUCUAUU	22	20361
CFTR-Intron10-1478	+	GUAACUCUUUAUUCACUU	18	20362
CFTR-Intron10-1479	−	GCUUUCAGGAGCCAAAAA	18	20363
CFTR-Intron10-1480	−	GAUAAGAUUCUAAAGGAAA	19	20364
CFTR-Intron10-1481	−	GGAUAAGAUUCUAAAGGAAA	20	20365
CFTR-Intron10-1482	−	GCUGGAUAAGAUUCUAAAGGAAA	23	20366
CFTR-Intron10-1483	−	GGCUGGAUAAGAUUCUAAAGGAAA	24	20367
CFTR-Intron10-1484	−	GUACUCAUGCCAUACACUCUAAA	23	20368
CFTR-Intron10-1485	−	GCUUUGAAGGAAGAUCCAA	19	20369
CFTR-Intron10-1486	−	GGAGAACCAUAUUUUGAAGAA	21	20370
CFTR-Intron10-1487	−	GAGGAGAACCAUAUUUUGAAGAA	23	20371
CFTR-Intron10-1488	−	GGGUUGAUAAGAAGAGAA	18	20372
CFTR-Intron10-68	−	GAGGGUUGAUAAGAAGAGAA	20	18954
CFTR-Intron10-1489	−	GAAAGAGGGUUGAUAAGAAGAGAA	24	20373
CFTR-Intron10-1490	−	GUACUUGCUCUCUGACCACAUAA	23	20374
CFTR-Intron10-1491	−	GUAUAUGAUAUACUCUUAA	19	20375
CFTR-Intron10-1492	−	GAUGUAUAUGAUAUACUCUUAA	22	20376
CFTR-Intron10-1493	−	GGAUGUAUAUGAUAUACUCUUAA	23	20377
CFTR-Intron10-1494	−	GUAUAGAAUUUUGCAUCA	18	20378
CFTR-Intron10-1495	−	GGUAGUAAUUGUGUUUCA	18	20379
CFTR-Intron10-1496	−	GAAAAGGUAGUAAUUGUGUUUCA	23	20380
CFTR-Intron10-1497	−	GAUCUAGCUAAAAUAUAAGA	20	20381
CFTR-Intron10-1498	−	GAUUCCAAGCUUUCUGGA	18	20382
CFTR-Intron10-1499	−	GAUAUACUCUUAAGUGAAUA	20	20383
CFTR-Intron10-1500	−	GAUGGAUAUUCUAUGAUAUA	20	20384
CFTR-Intron10-1501	−	GGAUGGAUAUUCUAUGAUAUA	21	20385
CFTR-Intron10-1502	−	GUUUUUGCUUGCUUUUUAUA	20	20386
CFTR-Intron10-1503	−	GUCUGAGAAGACAAAGCUA	19	20387
CFTR-Intron10-1504	−	GUAAUCGGCGGUGGAGGUA	19	20388
CFTR-Intron10-1505	−	GAAGUAAUCGGCGGUGGAGGUA	22	20389
CFTR-Intron10-1506	−	GAGAAGUAAUCGGCGGUGGAGGUA	24	20390
CFTR-Intron10-1507	−	GAUCAUUGCCUCACUAUGGUA	21	20391
CFTR-Intron10-1508	−	GUAAUAACUGGGACUCAUAUGUA	23	20392
CFTR-Intron10-1509	−	GAAGAUCCAAUAGGAUUA	18	20393
CFTR-Intron10-1510	−	GGAAGAUCCAAUAGGAUUA	19	20394
CFTR-Intron10-1511	−	GAAGGAAGAUCCAAUAGGAUUA	22	20395
CFTR-Intron10-1512	−	GCAGGAGGUGAGGGAUUA	18	20396
CFTR-Intron10-1513	−	GUUAGCAAUGGUCUAAAC	18	20397
CFTR-Intron10-1514	−	GAUUCUGUUUAAAUAGCAC	19	20398
CFTR-Intron10-1515	−	GAGAAGGUCAAACUUGAC	18	20399
CFTR-Intron10-1516	−	GUAGAGAAGGUCAAACUUGAC	21	20400
CFTR-Intron10-1517	−	GCCUUAUUCUUUUGAUAUACUCC	23	20401
CFTR-Intron10-1518	−	GUCUUGCGCUUAUGAAACUUCC	22	20402
CFTR-Intron10-1519	−	GCUUUUAAAACAAAAUAGC	19	20403
CFTR-Intron10-1520	−	GGAAGACAGCUGGCUAUC	18	20404
CFTR-Intron10-1521	−	GCAGGAAGACAGCUGGCUAUC	21	20405
CFTR-Intron10-1522	−	GCUGGCUAUCCAGGAUUC	18	20406
CFTR-Intron10-1523	−	GACAGCUGGCUAUCCAGGAUUC	22	20407
CFTR-Intron10-1524	−	GUUCUGUAAUUUUUGCUUC	19	20408
CFTR-Intron10-1525	−	GGUUCUGUAAUUUUUGCUUC	20	20409
CFTR-Intron10-1526	−	GACUUUGUAGUGAUCUUC	18	20410
CFTR-Intron10-1527	−	GAAGACUUUGUAGUGAUCUUC	21	20411
CFTR-Intron10-1528	−	GAGAAGACUUUGUAGUGAUCUUC	23	20412
CFTR-Intron10-1529	−	GGAGAAGACUUUGUAGUGAUCUUC	24	20413
CFTR-Intron10-1530	−	GCUUUUCAAAAUACUUUC	18	20414
CFTR-Intron10-1531	−	GAAGCUUUUCAAAAUACUUUC	21	20415
CFTR-Intron10-1532	−	GUAACAGUACAAGAAAAAAG	20	20416
CFTR-Intron10-99	−	GCAUAUGAGAAAAGUCACAG	20	18985
CFTR-Intron10-1533	−	GGCAUAUGAGAAAAGUCACAG	21	20417
CFTR-Intron10-1534	−	GAACCCAACUGAUGUCAAGCAG	22	20418
CFTR-Intron10-1535	−	GGAACCCAACUGAUGUCAAGCAG	23	20419
CFTR-Intron10-1536	−	GUAUUAGAGGUUAAGGAG	18	20420
CFTR-Intron10-1537	−	GUCUUUUCCUCUUAAUAG	18	20421
CFTR-Intron10-1538	−	GAAGUCUUUUCCUCUUAAUAG	21	20422
CFTR-Intron10-1539	−	GAAAAGCAGCUAUGAAGG	18	20423
CFTR-Intron10-1540	−	GCUUAUGAAAAGCAGCUAUGAAGG	24	20424
CFTR-Intron10-1541	−	GGCAUAGAGUAAGACAGG	18	20425
CFTR-Intron10-1542	−	GCUGGCAUAGAGUAAGACAGG	21	20426
CFTR-Intron10-1543	−	GGCUGGCAUAGAGUAAGACAGG	22	20427
CFTR-Intron10-1544	−	GAGGCUGGCAUAGAGUAAGACAGG	24	20428
CFTR-Intron10-1545	−	GGUAGUGUGAAGAUGGGG	18	20429
CFTR-Intron10-1546	−	GCUGGUAGUGUGAAGAUGGGG	21	20430
CFTR-Intron10-1547	−	GGCUGGUAGUGUGAAGAUGGGG	22	20431
CFTR-Intron10-1548	−	GGGCUGGUAGUGUGAAGAUGGGG	23	20432
CFTR-Intron10-1549	−	GGGGCUGGUAGUGUGAAGAUGGGG	24	20433
CFTR-Intron10-1550	−	GGGAAUGCAGACUCUGGG	18	20434
CFTR-Intron10-1551	−	GAUUAGGGAAUGCAGACUCUGGG	23	20435
CFTR-Intron10-1552	−	GGAUUAGGGAAUGCAGACUCUGGG	24	20436
CFTR-Intron10-1553	−	GGGGGAGCCCCAUAAAUG	18	20437
CFTR-Intron10-1554	−	GUGGGGGAGCCCCAUAAAUG	20	20438
CFTR-Intron10-1555	−	GUGAGAUUAGAGGCCACUG	19	20439
CFTR-Intron10-1556	−	GGUGAGAUUAGAGGCCACUG	20	20440
CFTR-Intron10-1557	−	GCACAUAUGUUCAGACUG	18	20441
CFTR-Intron10-1558	−	GACUUGCACAUAUGUUCAGACUG	23	20442
CFTR-Intron10-1559	−	GGACUUGCACAUAUGUUCAGACUG	24	20443
CFTR-Intron10-1560	−	GCAUCUCACCAGUGUGUG	18	20444
CFTR-Intron10-1561	−	GGCAUCUCACCAGUGUGUG	19	20445
CFTR-Intron10-1562	−	GAGGAGAACCAUAUUUUG	18	20446
CFTR-Intron10-1563	−	GAUGAGGAGAACCAUAUUUUG	21	20447
CFTR-Intron10-1564	−	GCCCCAUAAAUGUUGAAUAAU	21	20448
CFTR-Intron10-1565	−	GAGCCCCAUAAAUGUUGAAUAAU	23	20449
CFTR-Intron10-1566	−	GGAGCCCCAUAAAUGUUGAAUAAU	24	20450
CFTR-Intron10-1567	−	GAUUUUUUCCCAUGUAAU	18	20451
CFTR-Intron10-1568	−	GAAUCACUAUUGAUUGACAU	20	20452
CFTR-Intron10-1569	−	GUAGUUUCUAUUAAUAGAU	19	20453
CFTR-Intron10-1570	−	GUGUAGUUUCUAUUAAUAGAU	21	20454
CFTR-Intron10-1571	−	GAAAGAGCUUUCUAGUAU	18	20455
CFTR-Intron10-1572	−	GAGAAAGAGCUUUCUAGUAU	20	20456
CFTR-Intron10-1573	−	GUUCAAAUUAUUUCUACUGCU	21	20457
CFTR-Intron10-1574	−	GUUGUUCAAAUUAUUUCUACUGCU	24	20458
CFTR-Intron10-1575	−	GUAAAGACUAAGGCUUAUUUCU	22	20459
CFTR-Intron10-1576	−	GAUAAGAAGAGAAAGGGGUGU	21	20460
CFTR-Intron10-1577	−	GUUGAUAAGAAGAGAAAGGGGUGU	24	20461
CFTR-Intron10-1578	−	GUUGUUAUCUCUGAAAUU	18	20462
CFTR-Intron10-1579	−	GCUAUUACGGUAAGCUCAAGCAUU	24	20463
CFTR-Intron10-1580	−	GCUGCCUUUUAGUAGUAUU	19	20464
CFTR-Intron10-126	−	GGCUGCCUUUUAGUAGUAUU	20	19012
CFTR-Intron10-1581	−	GAGGCUGCCUUUUAGUAGUAUU	22	20465
CFTR-Intron10-1582	−	GGAGGCUGCCUUUUAGUAGUAUU	23	20466
CFTR-Intron10-1583	−	GAAUAGAUUAGCUUAUAUACUU	22	20467
CFTR-Intron10-1584	−	GUUAGAGGAAGGCAGUGGUCCCUU	24	20468
CFTR-Intron10-1585	−	GAUGUGCAAAAAUAGCUU	18	20469
CFTR-Intron10-1586	−	GAUAGAUGUGCAAAAAUAGCUU	22	20470
CFTR-Intron10-1587	−	GUUACAUGACCUUCCUUUCUU	21	20471
CFTR-Intron10-1588	−	GAUAAUGGGAGAAACAGGUU	20	20472
CFTR-Intron10-1589	−	GCACUGGAGUUACCUGUU	18	20473
CFTR-Intron10-1590	−	GCAAAUAGUUUUAUCAAUAUUU	22	20474
CFTR-Intron10-1591	−	GUUUUGGAUGGAGCUUGGUUU	21	20475
CFTR-Intron10-1592	−	GGUUUUGGAUGGAGCUUGGUUU	22	20476
CFTR-Intron10-1593	−	GUCCUCCACAAAUAUUUU	18	20477

Table 41B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 10, have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 41B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-1594	+	CAUAUGAUUUUAUGAAAA	18	20478
CFTR-Intron10-1595	+	ACAUAUGAUUUUAUGAAAA	19	20479
CFTR-Intron10-1596	+	UACAUAUGAUUUUAUGAAAA	20	20480
CFTR-Intron10-1597	+	UAAUACUACUGACUAAAA	18	20481
CFTR-Intron10-1598	+	AUAAUACUACUGACUAAAA	19	20482
CFTR-Intron10-1599	+	ACUCCAGUGCUAUUUAAA	18	20483
CFTR-Intron10-1600	+	AACUCCAGUGCUAUUUAAA	19	20484
CFTR-Intron10-1601	+	UAACUCCAGUGCUAUUUAAA	20	20485
CFTR-Intron10-1602	+	AGGUAACUCCAGUGCUAUUUAAA	23	20486
CFTR-Intron10-1603	+	CAGGUAACUCCAGUGCUAUUUAAA	24	20487
CFTR-Intron10-1604	+	ACUCCAGGAGUAUAUCAA	18	20488
CFTR-Intron10-1605	+	UGGACUCCAGGAGUAUAUCAA	21	20489
CFTR-Intron10-1606	+	AGUGGACUCCAGGAGUAUAUCAA	23	20490
CFTR-Intron10-1607	+	AAGUGGACUCCAGGAGUAUAUCAA	24	20491
CFTR-Intron10-1608	+	AUGAGAGACAGUAAAGAA	18	20492
CFTR-Intron10-1104	+	AGAUGAGAGACAGUAAAGAA	20	19989
CFTR-Intron10-1609	+	AGGGUGGGAUAUGGAGAA	18	20493
CFTR-Intron10-1610	+	UAGGGUGGGAUAUGGAGAA	19	20494
CFTR-Intron10-1611	+	UUAGGGUGGGAUAUGGAGAA	20	20495
CFTR-Intron10-1612	+	UUUACCAUUAUCUACACA	18	20496
CFTR-Intron10-1613	+	UUUUACCAUUAUCUACACA	19	20497
CFTR-Intron10-1614	+	UUUUUACCAUUAUCUACACA	20	20498
CFTR-Intron10-1615	+	UAGUGAACUAGAGUCACA	18	20499
CFTR-Intron10-1616	+	UUAGUGAACUAGAGUCACA	19	20500
CFTR-Intron10-1617	+	AUUAGUGAACUAGAGUCACA	20	20501
CFTR-Intron10-1618	+	UAUUAGUGAACUAGAGUCACA	21	20502
CFTR-Intron10-1619	+	AUAUUAGUGAACUAGAGUCACA	22	20503
CFTR-Intron10-1620	+	CAUAUUAGUGAACUAGAGUCACA	23	20504
CFTR-Intron10-1621	+	UCAUAUUAGUGAACUAGAGUCACA	24	20505
CFTR-Intron10-1622	+	UGGAGAAGAGGAUGACCA	18	20506
CFTR-Intron10-1623	+	AUGGAGAAGAGGAUGACCA	19	20507
CFTR-Intron10-1624	+	UAUGGAGAAGAGGAUGACCA	20	20508
CFTR-Intron10-1625	+	AGAGACACACCUAAAGCA	18	20509
CFTR-Intron10-1626	+	AAGAGACACACCUAAAGCA	19	20510
CFTR-Intron10-1627	+	AAAGAGACACACCUAAAGCA	20	20511
CFTR-Intron10-1628	+	UAGUGAUUCAUUAUAUCA	18	20512
CFTR-Intron10-1629	+	AUAGUGAUUCAUUAUAUCA	19	20513
CFTR-Intron10-1630	+	AAUAGUGAUUCAUUAUAUCA	20	20514
CFTR-Intron10-1631	+	AUUUUUGCACAUCUAUCA	18	20515
CFTR-Intron10-1632	+	UAUUUUUGCACAUCUAUCA	19	20516
CFTR-Intron10-1633	+	CUAUUUUUGCACAUCUAUCA	20	20517
CFTR-Intron10-1634	+	AGCUAUUUUUGCACAUCUAUCA	22	20518
CFTR-Intron10-1635	+	AAGCUAUUUUUGCACAUCUAUCA	23	20519
CFTR-Intron10-1636	+	AAAGCUAUUUUUGCACAUCUAUCA	24	20520
CFTR-Intron10-1637	+	AAAAGGCAGCCUCCUAGA	18	20521
CFTR-Intron10-1638	+	UAAAAGGCAGCCUCCUAGA	19	20522
CFTR-Intron10-1639	+	CUAAAAGGCAGCCUCCUAGA	20	20523
CFTR-Intron10-375	+	UGGCUACCUUGGUUGGAUGA	20	19261
CFTR-Intron10-1640	+	UUGGCUACCUUGGUUGGAUGA	21	20524
CFTR-Intron10-1641	+	AUUGGCUACCUUGGUUGGAUGA	22	20525
CFTR-Intron10-1642	+	AGAAUAUCCAUCCAUAUGA	19	20526
CFTR-Intron10-1643	+	UAGAAUAUCCAUCCAUAUGA	20	20527
CFTR-Intron10-1644	+	AUAGAAUAUCCAUCCAUAUGA	21	20528
CFTR-Intron10-1645	+	CAUAGAAUAUCCAUCCAUAUGA	22	20529
CFTR-Intron10-1646	+	UCAUAGAAUAUCCAUCCAUAUGA	23	20530
CFTR-Intron10-1647	+	AUCAUAGAAUAUCCAUCCAUAUGA	24	20531
CFTR-Intron10-1648	+	AUUACCAAAUUGUAUUGA	18	20532
CFTR-Intron10-1649	+	AAUUACCAAAUUGUAUUGA	19	20533
CFTR-Intron10-1650	+	AAAUUACCAAAUUGUAUUGA	20	20534
CFTR-Intron10-1651	+	AAAAUUACAGAACCUAUA	18	20535
CFTR-Intron10-1652	+	AAAAAUUACAGAACCUAUA	19	20536
CFTR-Intron10-1170	+	CAAAAAUUACAGAACCUAUA	20	20055
CFTR-Intron10-1653	+	UGUUACAACAGUCUUUAUA	19	20537
CFTR-Intron10-1654	+	UUGUUACAACAGUCUUUAUA	20	20538
CFTR-Intron10-1655	+	UCCUCCCUUGUCUCCCUA	18	20539
CFTR-Intron10-1656	+	UUCCUCCCUUGUCUCCCUA	19	20540
CFTR-Intron10-1657	+	CUUCCUCCCUUGUCUCCCUA	20	20541
CFTR-Intron10-1658	+	ACUUAUCCAUUAAUCCUA	18	20542
CFTR-Intron10-1659	+	AACUUAUCCAUUAAUCCUA	19	20543
CFTR-Intron10-1660	+	CAACUUAUCCAUUAAUCCUA	20	20544
CFTR-Intron10-1661	+	UCAACUUAUCCAUUAAUCCUA	21	20545
CFTR-Intron10-1662	+	UUCAACUUAUCCAUUAAUCCUA	22	20546
CFTR-Intron10-1663	+	UGUUCAACUUAUCCAUUAAUCCUA	24	20547
CFTR-Intron10-1664	+	ACAAAUUACCAAAUUGUA	18	20548
CFTR-Intron10-1665	+	UACAAAUUACCAAAUUGUA	19	20549
CFTR-Intron10-1666	+	AUACAAAUUACCAAAUUGUA	20	20550
CFTR-Intron10-1667	+	UGAUACAAAUUACCAAAUUGUA	22	20551
CFTR-Intron10-1668	+	CUGAUACAAAUUACCAAAUUGUA	23	20552
CFTR-Intron10-1669	+	UCUGAUACAAAUUACCAAAUUGUA	24	20553
CFTR-Intron10-1670	+	AGCCUGACACCAAAUUUA	18	20554
CFTR-Intron10-1671	+	CAGCCUGACACCAAAUUUA	19	20555
CFTR-Intron10-1672	+	CCAGCCUGACACCAAAUUUA	20	20556
CFTR-Intron10-1673	+	CCCAGCCUGACACCAAAUUUA	21	20557
CFTR-Intron10-1674	+	ACCCAGCCUGACACCAAAUUUA	22	20558
CFTR-Intron10-1675	+	CACCCAGCCUGACACCAAAUUUA	23	20559
CFTR-Intron10-1676	+	ACAAAUAUUGACUAUUUA	18	20560
CFTR-Intron10-1677	+	UACAAAUAUUGACUAUUUA	19	20561
CFTR-Intron10-1678	+	AGUACAAAUAUUGACUAUUUA	21	20562
CFTR-Intron10-1679	+	AAGUACAAAUAUUGACUAUUUA	22	20563
CFTR-Intron10-1680	+	CAAGUACAAAUAUUGACUAUUUA	23	20564
CFTR-Intron10-1681	+	AGAGCUCAUAUUAGUGAAC	19	20565
CFTR-Intron10-1682	+	CAGAGCUCAUAUUAGUGAAC	20	20566
CFTR-Intron10-1683	+	UCAGAGCUCAUAUUAGUGAAC	21	20567
CFTR-Intron10-1684	+	AUCAGAGCUCAUAUUAGUGAAC	22	20568
CFTR-Intron10-1685	+	UAUCAGAGCUCAUAUUAGUGAAC	23	20569
CFTR-Intron10-1686	+	UUAUCAGAGCUCAUAUUAGUGAAC	24	20570
CFTR-Intron10-1687	+	UCUAUUAAUAGAAACUAC	18	20571
CFTR-Intron10-1688	+	AUCUAUUAAUAGAAACUAC	19	20572
CFTR-Intron10-1689	+	AAUCUAUUAAUAGAAACUAC	20	20573
CFTR-Intron10-1690	+	UAAUCUAUUAAUAGAAACUAC	21	20574
CFTR-Intron10-1691	+	CUAAUCUAUUAAUAGAAACUAC	22	20575
CFTR-Intron10-1692	+	UCUAAUCUAUUAAUAGAAACUAC	23	20576
CFTR-Intron10-1693	+	CUCUAAUCUAUUAAUAGAAACUAC	24	20577
CFTR-Intron10-1694	+	UACUACUUCCACUACUAC	18	20578
CFTR-Intron10-1695	+	AUACUACUUCCACUACUAC	19	20579
CFTR-Intron10-1696	+	UAUACUACUUCCACUACUAC	20	20580
CFTR-Intron10-1697	+	CUAUACUACUUCCACUACUAC	21	20581
CFTR-Intron10-1698	+	ACUAUACUACUUCCACUACUAC	22	20582
CFTR-Intron10-1699	+	UACUAUACUACUUCCACUACUAC	23	20583
CFTR-Intron10-1700	+	CUACUAUACUACUUCCACUACUAC	24	20584
CFTR-Intron10-1701	+	AUGAGUCCCAGUUAUUAC	18	20585
CFTR-Intron10-1702	+	UAUGAGUCCCAGUUAUUAC	19	20586
CFTR-Intron10-1703	+	AUAUGAGUCCCAGUUAUUAC	20	20587
CFTR-Intron10-1704	+	CAUAUGAGUCCCAGUUAUUAC	21	20588
CFTR-Intron10-1705	+	ACAUAUGAGUCCCAGUUAUUAC	22	20589
CFTR-Intron10-1706	+	UACAUAUGAGUCCCAGUUAUUAC	23	20590
CFTR-Intron10-1707	+	AUACAUAUGAGUCCCAGUUAUUAC	24	20591
CFTR-Intron10-1708	+	AGAUACUAAAAAAAGUUAC	19	20592
CFTR-Intron10-1709	+	AAGAUACUAAAAAAAGUUAC	20	20593
CFTR-Intron10-1710	+	UAUUAGCAAGUGGACUCC	18	20594
CFTR-Intron10-426	+	UGUAUUAGCAAGUGGACUCC	20	19312
CFTR-Intron10-1711	+	UUGUAUUAGCAAGUGGACUCC	21	20595
CFTR-Intron10-1712	+	AUUGUAUUAGCAAGUGGACUCC	22	20596
CFTR-Intron10-1713	+	AAUUGUAUUAGCAAGUGGACUCC	23	20597
CFTR-Intron10-1714	+	CAAUUGUAUUAGCAAGUGGACUCC	24	20598
CFTR-Intron10-1715	+	UGAGCCUAUCACCUAGGC	18	20599
CFTR-Intron10-1716	+	UUGAGCCUAUCACCUAGGC	19	20600
CFTR-Intron10-1717	+	UUUGAGCCUAUCACCUAGGC	20	20601
CFTR-Intron10-1718	+	CUAUUUAGAGUGUAUGGC	18	20602
CFTR-Intron10-1719	+	UCUAUUUAGAGUGUAUGGC	19	20603
CFTR-Intron10-1720	+	CUCUAUUUAGAGUGUAUGGC	20	20604
CFTR-Intron10-1721	+	ACUCUAUUUAGAGUGUAUGGC	21	20605
CFTR-Intron10-1722	+	CACUCUAUUUAGAGUGUAUGGC	22	20606
CFTR-Intron10-1723	+	AGCACUCUAUUUAGAGUGUAUGGC	24	20607
CFTR-Intron10-1724	+	AAAGGCUCUUUAUAAUGC	18	20608
CFTR-Intron10-1725	+	AAAAGGCUCUUUAUAAUGC	19	20609
CFTR-Intron10-1726	+	AGAAAAGGCUCUUUAUAAUGC	21	20610
CFTR-Intron10-1727	+	AAGAAAAGGCUCUUUAUAAUGC	22	20611
CFTR-Intron10-1728	+	AAAGAAAAGGCUCUUUAUAAUGC	23	20612
CFTR-Intron10-1729	+	AAAAGAAAAGGCUCUUUAUAAUGC	24	20613
CFTR-Intron10-1730	+	CUAAGAGACUCCUGAAUC	18	20614
CFTR-Intron10-1731	+	UGCUAAGAGACUCCUGAAUC	20	20615
CFTR-Intron10-1732	+	CUGCUAAGAGACUCCUGAAUC	21	20616
CFTR-Intron10-1733	+	UCUGCUAAGAGACUCCUGAAUC	22	20617
CFTR-Intron10-1734	+	UGUAGAAGACCUAAAUAUC	19	20618
CFTR-Intron10-1735	+	AUGUAGAAGACCUAAAUAUC	20	20619
CFTR-Intron10-1736	+	AGAUGUAGAAGACCUAAAUAUC	22	20620
CFTR-Intron10-1737	+	AAGAUGUAGAAGACCUAAAUAUC	23	20621
CFTR-Intron10-1738	+	UGGGUCUGCUAAGAGACUC	19	20622
CFTR-Intron10-1739	+	UUGGGUCUGCUAAGAGACUC	20	20623
CFTR-Intron10-1740	+	UUUGGGUCUGCUAAGAGACUC	21	20624
CFTR-Intron10-1741	+	AUUUGGGUCUGCUAAGAGACUC	22	20625
CFTR-Intron10-1742	+	AGAUUUGGGUCUGCUAAGAGACUC	24	20626
CFTR-Intron10-1743	+	UACUAUUGCUUUCAUUAAGUC	21	20627
CFTR-Intron10-1744	+	CUACUAUUGCUUUCAUUAAGUC	22	20628
CFTR-Intron10-1745	+	UCUACUAUUGCUUUCAUUAAGUC	23	20629
CFTR-Intron10-1746	+	CUCUACUAUUGCUUUCAUUAAGUC	24	20630
CFTR-Intron10-1747	+	UAGAGACAAGGUGGUGUC	18	20631
CFTR-Intron10-1748	+	AUAGAGACAAGGUGGUGUC	19	20632
CFTR-Intron10-437	+	AAUAGAGACAAGGUGGUGUC	20	19323
CFTR-Intron10-1749	+	UAAUAGAGACAAGGUGGUGUC	21	20633
CFTR-Intron10-1750	+	AUAAUAGAGACAAGGUGGUGUC	22	20634
CFTR-Intron10-1751	+	AAUAAUAGAGACAAGGUGGUGUC	23	20635
CFTR-Intron10-1752	+	CAAUAAUAGAGACAAGGUGGUGUC	24	20636
CFTR-Intron10-1753	+	UAUUUUUCAUUAUGAUUC	18	20637
CFTR-Intron10-1754	+	AUAUUUUUCAUUAUGAUUC	19	20638
CFTR-Intron10-1755	+	UUGACAUCAGUUGGGUUC	18	20639
CFTR-Intron10-1756	+	CUUGACAUCAGUUGGGUUC	19	20640
CFTR-Intron10-1757	+	UGCUUGACAUCAGUUGGGUUC	21	20641
CFTR-Intron10-1758	+	CUGCUUGACAUCAGUUGGGUUC	22	20642
CFTR-Intron10-1759	+	UCUGCUUGACAUCAGUUGGGUUC	23	20643
CFTR-Intron10-1760	+	UUCUGCUUGACAUCAGUUGGGUUC	24	20644
CFTR-Intron10-1761	+	UGAUAAAUAAUUGCCUUUC	19	20645
CFTR-Intron10-445	+	UUGAUAAAUAAUUGCCUUUC	20	19331
CFTR-Intron10-1762	+	AUUGAUAAAUAAUUGCCUUUC	21	20646
CFTR-Intron10-1763	+	UAUUGAUAAAUAAUUGCCUUUC	22	20647
CFTR-Intron10-1764	+	AUAUUGAUAAAUAAUUGCCUUUC	23	20648
CFTR-Intron10-1765	+	UUGGAUGAGGGAAUGCAG	18	20649
CFTR-Intron10-1766	+	UGGUUGGAUGAGGGAAUGCAG	21	20650
CFTR-Intron10-1767	+	UUGGUUGGAUGAGGGAAUGCAG	22	20651
CFTR-Intron10-1768	+	CUUGGUUGGAUGAGGGAAUGCAG	23	20652
CFTR-Intron10-1769	+	CCUUGGUUGGAUGAGGGAAUGCAG	24	20653
CFTR-Intron10-1770	+	CCUUCUGCUUGACAUCAG	18	20654
CFTR-Intron10-1771	+	CCCUUCUGCUUGACAUCAG	19	20655
CFTR-Intron10-1772	+	ACCCUUCUGCUUGACAUCAG	20	20656
CFTR-Intron10-1773	+	CACCCUUCUGCUUGACAUCAG	21	20657
CFTR-Intron10-1774	+	ACACCCUUCUGCUUGACAUCAG	22	20658
CFTR-Intron10-1775	+	AACACCCUUCUGCUUGACAUCAG	23	20659
CFTR-Intron10-1776	+	UAACACCCUUCUGCUUGACAUCAG	24	20660
CFTR-Intron10-1777	+	AAUUGAUCUUGAAGACAUACG	21	20661
CFTR-Intron10-1778	+	AGAAUUGAUCUUGAAGACAUACG	23	20662
CFTR-Intron10-1779	+	UAGAAUUGAUCUUGAAGACAUACG	24	20663
CFTR-Intron10-1780	+	ACUGUGAAUGGUGCCAGG	18	20664
CFTR-Intron10-1781	+	UACUGUGAAUGGUGCCAGG	19	20665
CFTR-Intron10-1782	+	UUACUGUGAAUGGUGCCAGG	20	20666
CFTR-Intron10-1783	+	UUUACUGUGAAUGGUGCCAGG	21	20667
CFTR-Intron10-1784	+	CUUUACUGUGAAUGGUGCCAGG	22	20668
CFTR-Intron10-1785	+	UCUUUACUGUGAAUGGUGCCAGG	23	20669
CFTR-Intron10-1786	+	CUCUUUACUGUGAAUGGUGCCAGG	24	20670
CFTR-Intron10-1787	+	AGAUGAUUAUUAAUAGGG	18	20671
CFTR-Intron10-1788	+	UAGAUGAUUAUUAAUAGGG	19	20672
CFTR-Intron10-1789	+	CUAGAUGAUUAUUAAUAGGG	20	20673
CFTR-Intron10-1790	+	CCUAGAUGAUUAUUAAUAGGG	21	20674
CFTR-Intron10-1791	+	AGCCUAGAUGAUUAUUAAUAGGG	23	20675
CFTR-Intron10-1792	+	CAGCCUAGAUGAUUAUUAAUAGGG	24	20676
CFTR-Intron10-475	+	AGGUUAAGUUGUUCUUAGGG	20	19361
CFTR-Intron10-1793	+	CAGGUUAAGUUGUUCUUAGGG	21	20677
CFTR-Intron10-1794	+	CCAGGUUAAGUUGUUCUUAGGG	22	20678
CFTR-Intron10-1795	+	UGCCAGGUUAAGUUGUUCUUAGGG	24	20679
CFTR-Intron10-1796	+	UAACAAACCUUUUAUUGG	18	20680
CFTR-Intron10-1797	+	UUAACAAACCUUUUAUUGG	19	20681
CFTR-Intron10-1798	+	UUUAACAAACCUUUUAUUGG	20	20682
CFTR-Intron10-1799	+	CUGGAUUGGCUACCUUGG	18	20683
CFTR-Intron10-1800	+	CCUGGAUUGGCUACCUUGG	19	20684
CFTR-Intron10-1801	+	ACCUGGAUUGGCUACCUUGG	20	20685
CFTR-Intron10-1802	+	UACCUGGAUUGGCUACCUUGG	21	20686
CFTR-Intron10-1803	+	UUACCUGGAUUGGCUACCUUGG	22	20687
CFTR-Intron10-1804	+	AGUUACCUGGAUUGGCUACCUUGG	24	20688
CFTR-Intron10-1805	+	AGGAAAUGGGGUAUAAGUG	19	20689
CFTR-Intron10-487	+	AAGGAAAUGGGGUAUAAGUG	20	19373
CFTR-Intron10-1806	+	UACAUAAAAAGAGAGGUG	18	20690
CFTR-Intron10-1807	+	UUACAUAAAAAGAGAGGUG	19	20691
CFTR-Intron10-1808	+	UGUUACAUAAAAAGAGAGGUG	21	20692
CFTR-Intron10-1809	+	UUGUUACAUAAAAAGAGAGGUG	22	20693
CFTR-Intron10-1810	+	AUUGUUACAUAAAAAGAGAGGUG	23	20694
CFTR-Intron10-1811	+	UAUUGUUACAUAAAAAGAGAGGUG	24	20695
CFTR-Intron10-1812	+	ACAGUUUCAUCUUACUUG	18	20696
CFTR-Intron10-1813	+	AACAGUUUCAUCUUACUUG	19	20697
CFTR-Intron10-1814	+	UAACAGUUUCAUCUUACUUG	20	20698
CFTR-Intron10-1815	+	AUAACAGUUUCAUCUUACUUG	21	20699
CFTR-Intron10-1816	+	UAUAACAGUUUCAUCUUACUUG	22	20700
CFTR-Intron10-1817	+	UUAUAACAGUUUCAUCUUACUUG	23	20701
CFTR-Intron10-1818	+	AUUAUAACAGUUUCAUCUUACUUG	24	20702
CFTR-Intron10-1819	+	UAUUACAUGGGAAAAAAU	18	20703
CFTR-Intron10-1820	+	UUAUUACAUGGGAAAAAAU	19	20704
CFTR-Intron10-1821	+	CUUAUUACAUGGGAAAAAAU	20	20705
CFTR-Intron10-1822	+	UCUUAUUACAUGGGAAAAAAU	21	20706
CFTR-Intron10-1823	+	UUCUUAUUACAUGGGAAAAAAU	22	20707
CFTR-Intron10-1824	+	AUUCUUAUUACAUGGGAAAAAAU	23	20708
CFTR-Intron10-1825	+	AAUUCUUAUUACAUGGGAAAAAAU	24	20709
CFTR-Intron10-1826	+	AUAGCUUAUUCUAUACAU	18	20710
CFTR-Intron10-1827	+	AAUAGCUUAUUCUAUACAU	19	20711
CFTR-Intron10-1828	+	UAAUAGCUUAUUCUAUACAU	20	20712
CFTR-Intron10-1829	+	CUAAUAGCUUAUUCUAUACAU	21	20713
CFTR-Intron10-1830	+	AGCUAAUAGCUUAUUCUAUACAU	23	20714
CFTR-Intron10-1831	+	AUGAUGUACAUUUAAUAU	18	20715
CFTR-Intron10-1832	+	AAUGAUGUACAUUUAAUAU	19	20716
CFTR-Intron10-1833	+	UAAUGAUGUACAUUUAAUAU	20	20717
CFTR-Intron10-1834	+	AUAAUGAUGUACAUUUAAUAU	21	20718
CFTR-Intron10-1835	+	AAUAAUGAUGUACAUUUAAUAU	22	20719
CFTR-Intron10-1836	+	UGAAUAAUGAUGUACAUUUAAUAU	24	20720
CFTR-Intron10-1837	+	AGAUCUCUGCAAACAUAU	18	20721
CFTR-Intron10-1838	+	AAGAUCUCUGCAAACAUAU	19	20722
CFTR-Intron10-1839	+	UAAGAUCUCUGCAAACAUAU	20	20723
CFTR-Intron10-1840	+	AUAAGAUCUCUGCAAACAUAU	21	20724
CFTR-Intron10-1841	+	CAUAAGAUCUCUGCAAACAUAU	22	20725
CFTR-Intron10-1842	+	ACAUAAGAUCUCUGCAAACAUAU	23	20726
CFTR-Intron10-1843	+	UACAUAAGAUCUCUGCAAACAUAU	24	20727
CFTR-Intron10-1844	+	AAUGGAAACACUAUAUAU	18	20728
CFTR-Intron10-1845	+	UAAUGGAAACACUAUAUAU	19	20729
CFTR-Intron10-1846	+	UGUAAUGGAAACACUAUAUAU	21	20730
CFTR-Intron10-1847	+	AUGUAAUGGAAACACUAUAUAU	22	20731
CFTR-Intron10-1848	+	AAUGUAAUGGAAACACUAUAUAU	23	20732
CFTR-Intron10-1849	+	CAAUGUAAUGGAAACACUAUAUAU	24	20733
CFTR-Intron10-1850	+	UCCAACUAACAUCUCUAU	18	20734
CFTR-Intron10-1851	+	AUCCAACUAACAUCUCUAU	19	20735
CFTR-Intron10-1852	+	CAUCCAACUAACAUCUCUAU	20	20736
CFTR-Intron10-1853	+	ACAUCCAACUAACAUCUCUAU	21	20737
CFTR-Intron10-1854	+	UACAUCCAACUAACAUCUCUAU	22	20738
CFTR-Intron10-1855	+	UGUACAUCCAACUAACAUCUCUAU	24	20739
CFTR-Intron10-1856	+	UCCUUAACCUCUAAUACU	18	20740
CFTR-Intron10-1857	+	CUCCUUAACCUCUAAUACU	19	20741
CFTR-Intron10-1858	+	CCUCCUUAACCUCUAAUACU	20	20742
CFTR-Intron10-1859	+	ACCUCCUUAACCUCUAAUACU	21	20743
CFTR-Intron10-1860	+	CACCUCCUUAACCUCUAAUACU	22	20744
CFTR-Intron10-1861	+	CCACCUCCUUAACCUCUAAUACU	23	20745
CFTR-Intron10-1862	+	CCCACCUCCUUAACCUCUAAUACU	24	20746
CFTR-Intron10-1863	+	UGGAAAAUGUUAAAUUUUCCCU	22	20747
CFTR-Intron10-1864	+	CUGGAAAAUGUUAAAUUUUCCCU	23	20748
CFTR-Intron10-1865	+	UCUGGAAAAUGUUAAAUUUUCCCU	24	20749
CFTR-Intron10-516	+	AGGCACUUGUUGACAGUCCU	20	19402
CFTR-Intron10-1866	+	UAGGCACUUGUUGACAGUCCU	21	20750
CFTR-Intron10-1867	+	CUAGGCACUUGUUGACAGUCCU	22	20751
CFTR-Intron10-1868	+	UGCUAGGCACUUGUUGACAGUCCU	24	20752
CFTR-Intron10-1869	+	UACUCAGUCCAGAAAGCU	18	20753
CFTR-Intron10-1870	+	UUACUCAGUCCAGAAAGCU	19	20754
CFTR-Intron10-1871	+	UGUGCAAGUCCUCUGUGCU	19	20755
CFTR-Intron10-1872	+	AUGUGCAAGUCCUCUGUGCU	20	20756
CFTR-Intron10-1873	+	UAUGUGCAAGUCCUCUGUGCU	21	20757
CFTR-Intron10-1874	+	AUAUGUGCAAGUCCUCUGUGCU	22	20758
CFTR-Intron10-1875	+	CAUAUGUGCAAGUCCUCUGUGCU	23	20759
CFTR-Intron10-1876	+	ACAUAUGUGCAAGUCCUCUGUGCU	24	20760
CFTR-Intron10-1877	+	UUAAUUGCCAGUAAGUCU	18	20761
CFTR-Intron10-1878	+	UUUAAUUGCCAGUAAGUCU	19	20762
CFTR-Intron10-526	+	AUUUAAUUGCCAGUAAGUCU	20	19412
CFTR-Intron10-1879	+	UGCCAGGUUAAGUUGUUCU	19	20763
CFTR-Intron10-1880	+	AUGCCAGGUUAAGUUGUUCU	20	20764
CFTR-Intron10-1881	+	AGAGUGUAUGGCAUGAGU	18	20765
CFTR-Intron10-1882	+	UAGAGUGUAUGGCAUGAGU	19	20766
CFTR-Intron10-1883	+	UUAGAGUGUAUGGCAUGAGU	20	20767
CFTR-Intron10-1884	+	UUUAGAGUGUAUGGCAUGAGU	21	20768
CFTR-Intron10-1885	+	AUUUAGAGUGUAUGGCAUGAGU	22	20769
CFTR-Intron10-1886	+	UAUUUAGAGUGUAUGGCAUGAGU	23	20770
CFTR-Intron10-1887	+	CUAUUUAGAGUGUAUGGCAUGAGU	24	20771
CFTR-Intron10-1888	+	AGGGUCUCUCUAAGGUGU	18	20772
CFTR-Intron10-1889	+	UGAGGGUCUCUCUAAGGUGU	20	20773
CFTR-Intron10-1890	+	UGGGGAAAUCAGCACUCUAUU	21	20774
CFTR-Intron10-1891	+	UGUGGGGAAAUCAGCACUCUAUU	23	20775
CFTR-Intron10-1892	+	CUGUGGGGAAAUCAGCACUCUAUU	24	20776
CFTR-Intron10-1893	+	UGUAACUCUUUAUUCACUU	19	20777
CFTR-Intron10-1894	+	UUGUAACUCUUUAUUCACUU	20	20778
CFTR-Intron10-1895	+	UUUGUAACUCUUUAUUCACUU	21	20779
CFTR-Intron10-1896	+	UUUUGUAACUCUUUAUUCACUU	22	20780
CFTR-Intron10-1897	+	AUUUUGUAACUCUUUAUUCACUU	23	20781
CFTR-Intron10-1898	+	CAUUUUGUAACUCUUUAUUCACUU	24	20782
CFTR-Intron10-1899	+	UAUCAACCCUCUUUCCUU	18	20783
CFTR-Intron10-1900	+	UUAUCAACCCUCUUUCCUU	19	20784
CFTR-Intron10-1901	+	CUUAUCAACCCUCUUUCCUU	20	20785
CFTR-Intron10-1902	+	UCUUAUCAACCCUCUUUCCUU	21	20786
CFTR-Intron10-1903	+	UUCUUAUCAACCCUCUUUCCUU	22	20787
CFTR-Intron10-1904	+	CUUCUUAUCAACCCUCUUUCCUU	23	20788
CFTR-Intron10-1905	+	UCUUCUUAUCAACCCUCUUUCCUU	24	20789
CFTR-Intron10-1906	+	UUUAUCAACAUGAAGGUU	18	20790
CFTR-Intron10-1907	+	CUUUAUCAACAUGAAGGUU	19	20791
CFTR-Intron10-555	+	CCUUUAUCAACAUGAAGGUU	20	19441
CFTR-Intron10-1908	−	UGCUUUCAGGAGCCAAAAA	19	20792
CFTR-Intron10-1909	−	CUGCUUUCAGGAGCCAAAAA	20	20793
CFTR-Intron10-1910	−	ACUGCUUUCAGGAGCCAAAAA	21	20794
CFTR-Intron10-1911	−	CACUGCUUUCAGGAGCCAAAAA	22	20795
CFTR-Intron10-1912	−	ACACUGCUUUCAGGAGCCAAAAA	23	20796
CFTR-Intron10-1913	−	AACACUGCUUUCAGGAGCCAAAAA	24	20797
CFTR-Intron10-1914	−	UUAAACACUUCUGAGAAA	18	20798
CFTR-Intron10-1915	−	UUUAAACACUUCUGAGAAA	19	20799
CFTR-Intron10-1096	−	AUUUAAACACUUCUGAGAAA	20	19981
CFTR-Intron10-1916	−	AUAAGAUUCUAAAGGAAA	18	20800
CFTR-Intron10-1917	−	UGGAUAAGAUUCUAAAGGAAA	21	20801
CFTR-Intron10-1918	−	CUGGAUAAGAUUCUAAAGGAAA	22	20802
CFTR-Intron10-1919	−	CAUGCCAUACACUCUAAA	18	20803
CFTR-Intron10-1920	−	UCAUGCCAUACACUCUAAA	19	20804
CFTR-Intron10-1921	−	CUCAUGCCAUACACUCUAAA	20	20805
CFTR-Intron10-1922	−	ACUCAUGCCAUACACUCUAAA	21	20806
CFTR-Intron10-1923	−	UACUCAUGCCAUACACUCUAAA	22	20807
CFTR-Intron10-1924	−	CGUACUCAUGCCAUACACUCUAAA	24	20808
CFTR-Intron10-1925	−	AGGUUUAAUUUUGUACAA	18	20809
CFTR-Intron10-1926	−	UAGGUUUAAUUUUGUACAA	19	20810
CFTR-Intron10-343	−	CUAGGUUUAAUUUUGUACAA	20	19229
CFTR-Intron10-1927	−	UCUAGGUUUAAUUUUGUACAA	21	20811
CFTR-Intron10-1928	−	UUCUAGGUUUAAUUUUGUACAA	22	20812
CFTR-Intron10-1929	−	CUUCUAGGUUUAAUUUUGUACAA	23	20813
CFTR-Intron10-1930	−	ACUUCUAGGUUUAAUUUUGUACAA	24	20814
CFTR-Intron10-1931	−	CUUUGAAGGAAGAUCCAA	18	20815
CFTR-Intron10-1932	−	UGCUUUGAAGGAAGAUCCAA	20	20816
CFTR-Intron10-1933	−	UAAUCAUCUAGGCUGCAA	18	20817
CFTR-Intron10-1934	−	AUAAUCAUCUAGGCUGCAA	19	20818
CFTR-Intron10-1935	−	AAUAAUCAUCUAGGCUGCAA	20	20819
CFTR-Intron10-1936	−	UAAUAAUCAUCUAGGCUGCAA	21	20820
CFTR-Intron10-1937	−	UUAAUAAUCAUCUAGGCUGCAA	22	20821
CFTR-Intron10-1938	−	AUUAAUAAUCAUCUAGGCUGCAA	23	20822
CFTR-Intron10-1939	−	UAUUAAUAAUCAUCUAGGCUGCAA	24	20823
CFTR-Intron10-1940	−	AGGAGAACCAUAUUUUGAAGAA	22	20824
CFTR-Intron10-1941	−	UGAGGAGAACCAUAUUUUGAAGAA	24	20825
CFTR-Intron10-1942	−	AGGGUUGAUAAGAAGAGAA	19	20826
CFTR-Intron10-1943	−	AGAGGGUUGAUAAGAAGAGAA	21	20827
CFTR-Intron10-1944	−	AAGAGGGUUGAUAAGAAGAGAA	22	20828
CFTR-Intron10-1945	−	AAAGAGGGUUGAUAAGAAGAGAA	23	20829
CFTR-Intron10-1946	−	UGCUCUCUGACCACAUAA	18	20830
CFTR-Intron10-1947	−	UUGCUCUCUGACCACAUAA	19	20831
CFTR-Intron10-1948	−	CUUGCUCUCUGACCACAUAA	20	20832
CFTR-Intron10-1949	−	ACUUGCUCUCUGACCACAUAA	21	20833
CFTR-Intron10-1950	−	UACUUGCUCUCUGACCACAUAA	22	20834
CFTR-Intron10-1951	−	UGUACUUGCUCUCUGACCACAUAA	24	20835
CFTR-Intron10-1952	−	UAUAUGAUAUACUCUUAA	18	20836
CFTR-Intron10-1953	−	UGUAUAUGAUAUACUCUUAA	20	20837
CFTR-Intron10-1954	−	AUGUAUAUGAUAUACUCUUAA	21	20838
CFTR-Intron10-1955	−	CGGAUGUAUAUGAUAUACUCUUAA	24	20839
CFTR-Intron10-1956	−	AACUCAUUAGGAAAAUGUACA	21	20840
CFTR-Intron10-1957	−	CAACUCAUUAGGAAAAUGUACA	22	20841
CFTR-Intron10-1958	−	CCAACUCAUUAGGAAAAUGUACA	23	20842
CFTR-Intron10-1959	−	ACCAACUCAUUAGGAAAAUGUACA	24	20843
CFTR-Intron10-1960	−	AUGAAGUUAAAAACAUCA	18	20844
CFTR-Intron10-1961	−	UAUGAAGUUAAAAACAUCA	19	20845
CFTR-Intron10-1962	−	AUAUGAAGUUAAAAACAUCA	20	20846
CFTR-Intron10-1963	−	AGUAUAGAAUUUUGCAUCA	19	20847
CFTR-Intron10-1964	−	UAGUAUAGAAUUUUGCAUCA	20	20848
CFTR-Intron10-1965	−	AGGUAGUAAUUGUGUUUCA	19	20849
CFTR-Intron10-1966	−	AAGGUAGUAAUUGUGUUUCA	20	20850
CFTR-Intron10-1967	−	AAAGGUAGUAAUUGUGUUUCA	21	20851
CFTR-Intron10-1968	−	AAAAGGUAGUAAUUGUGUUUCA	22	20852
CFTR-Intron10-1969	−	UGAAAAGGUAGUAAUUGUGUUUCA	24	20853
CFTR-Intron10-1970	−	AGAGCCUUUUCUUUUUCA	18	20854
CFTR-Intron10-1971	−	AAGAGCCUUUUCUUUUUCA	19	20855
CFTR-Intron10-1972	−	AAAGAGCCUUUUCUUUUUCA	20	20856
CFTR-Intron10-1973	−	UCUAGCUAAAAUAUAAGA	18	20857
CFTR-Intron10-1974	−	AUCUAGCUAAAAUAUAAGA	19	20858
CFTR-Intron10-1975	−	CUUGACCAGAAUGAAAUUAGA	21	20859
CFTR-Intron10-1976	−	ACUUGACCAGAAUGAAAUUAGA	22	20860
CFTR-Intron10-1977	−	AACUUGACCAGAAUGAAAUUAGA	23	20861
CFTR-Intron10-1978	−	AAACUUGACCAGAAUGAAAUUAGA	24	20862
CFTR-Intron10-1979	−	AGGAAAAUGUACAAAGGA	18	20863
CFTR-Intron10-1980	−	UAGGAAAAUGUACAAAGGA	19	20864
CFTR-Intron10-1981	−	UUAGGAAAAUGUACAAAGGA	20	20865
CFTR-Intron10-1982	−	UGAUUCCAAGCUUUCUGGA	19	20866
CFTR-Intron10-1983	−	AUGAUUCCAAGCUUUCUGGA	20	20867
CFTR-Intron10-1984	−	UAUACUCUUAAGUGAAUA	18	20868
CFTR-Intron10-1985	−	AUAUACUCUUAAGUGAAUA	19	20869
CFTR-Intron10-1986	−	UGAUAUACUCUUAAGUGAAUA	21	20870
CFTR-Intron10-1987	−	AUGAUAUACUCUUAAGUGAAUA	22	20871
CFTR-Intron10-1988	−	UAUGAUAUACUCUUAAGUGAAUA	23	20872
CFTR-Intron10-1989	−	AUAUGAUAUACUCUUAAGUGAAUA	24	20873
CFTR-Intron10-1990	−	CUAACCUUCAUGUUGAUA	18	20874
CFTR-Intron10-1991	−	CCUAACCUUCAUGUUGAUA	19	20875
CFTR-Intron10-1992	−	CCCUAACCUUCAUGUUGAUA	20	20876
CFTR-Intron10-1993	−	UGGAUAUUCUAUGAUAUA	18	20877
CFTR-Intron10-1994	−	AUGGAUAUUCUAUGAUAUA	19	20878
CFTR-Intron10-1995	−	UGGAUGGAUAUUCUAUGAUAUA	22	20879
CFTR-Intron10-1996	−	AUGGAUGGAUAUUCUAUGAUAUA	23	20880
CFTR-Intron10-1997	−	UAUGGAUGGAUAUUCUAUGAUAUA	24	20881
CFTR-Intron10-1998	−	AUACUUUCUAGAAUUAUA	18	20882
CFTR-Intron10-1999	−	AAUACUUUCUAGAAUUAUA	19	20883
CFTR-Intron10-2000	−	AAAUACUUUCUAGAAUUAUA	20	20884
CFTR-Intron10-2001	−	UUUUGCUUGCUUUUUAUA	18	20885
CFTR-Intron10-2002	−	UUUUUGCUUGCUUUUUAUA	19	20886
CFTR-Intron10-2003	−	UCUGAGAAGACAAAGCUA	18	20887
CFTR-Intron10-2004	−	AGUCUGAGAAGACAAAGCUA	20	20888
CFTR-Intron10-2005	−	AAGUCUGAGAAGACAAAGCUA	21	20889
CFTR-Intron10-2006	−	AAAGUCUGAGAAGACAAAGCUA	22	20890
CFTR-Intron10-2007	−	AAAAGUCUGAGAAGACAAAGCUA	23	20891
CFTR-Intron10-2008	−	UAAAAGUCUGAGAAGACAAAGCUA	24	20892
CFTR-Intron10-2009	−	AGUGAAGCAAUAUUAGUA	18	20893
CFTR-Intron10-2010	−	UAGUGAAGCAAUAUUAGUA	19	20894
CFTR-Intron10-2011	−	UUAGUGAAGCAAUAUUAGUA	20	20895
CFTR-Intron10-2012	−	UUUAGUGAAGCAAUAUUAGUA	21	20896
CFTR-Intron10-2013	−	UUUUAGUGAAGCAAUAUUAGUA	22	20897
CFTR-Intron10-2014	−	AUUUUAGUGAAGCAAUAUUAGUA	23	20898
CFTR-Intron10-2015	−	UAUUUUAGUGAAGCAAUAUUAGUA	24	20899
CFTR-Intron10-2016	−	UAAUCGGCGGUGGAGGUA	18	20900
CFTR-Intron10-389	−	AGUAAUCGGCGGUGGAGGUA	20	19275
CFTR-Intron10-2017	−	AAGUAAUCGGCGGUGGAGGUA	21	20901
CFTR-Intron10-2018	−	AGAAGUAAUCGGCGGUGGAGGUA	23	20902
CFTR-Intron10-2019	−	CAUUGCCUCACUAUGGUA	18	20903
CFTR-Intron10-2020	−	UCAUUGCCUCACUAUGGUA	19	20904
CFTR-Intron10-2021	−	AUCAUUGCCUCACUAUGGUA	20	20905
CFTR-Intron10-2022	−	UGAUCAUUGCCUCACUAUGGUA	22	20906
CFTR-Intron10-2023	−	UUGAUCAUUGCCUCACUAUGGUA	23	20907
CFTR-Intron10-2024	−	AUUGAUCAUUGCCUCACUAUGGUA	24	20908
CFTR-Intron10-2025	−	AACUGGGACUCAUAUGUA	18	20909
CFTR-Intron10-2026	−	UAACUGGGACUCAUAUGUA	19	20910
CFTR-Intron10-2027	−	AUAACUGGGACUCAUAUGUA	20	20911
CFTR-Intron10-2028	−	AAUAACUGGGACUCAUAUGUA	21	20912
CFTR-Intron10-2029	−	UAAUAACUGGGACUCAUAUGUA	22	20913
CFTR-Intron10-2030	−	UGUAAUAACUGGGACUCAUAUGUA	24	20914
CFTR-Intron10-2031	−	AGGAAGAUCCAAUAGGAUUA	20	20915
CFTR-Intron10-2032	−	AAGGAAGAUCCAAUAGGAUUA	21	20916
CFTR-Intron10-2033	−	UGAAGGAAGAUCCAAUAGGAUUA	23	20917
CFTR-Intron10-2034	−	UUGAAGGAAGAUCCAAUAGGAUUA	24	20918
CFTR-Intron10-2035	−	UGCAGGAGGUGAGGGAUUA	19	20919
CFTR-Intron10-394	−	UUGCAGGAGGUGAGGGAUUA	20	19280
CFTR-Intron10-2036	−	CAGCCAAUAAAAGGUUUGUUA	21	20920
CFTR-Intron10-2037	−	UCAGCCAAUAAAAGGUUUGUUA	22	20921
CFTR-Intron10-2038	−	UUCAGCCAAUAAAAGGUUUGUUA	23	20922
CFTR-Intron10-2039	−	AUUCAGCCAAUAAAAGGUUUGUUA	24	20923
CFTR-Intron10-2040	−	AGUUAGCAAUGGUCUAAAC	19	20924
CFTR-Intron10-2041	−	AAGUUAGCAAUGGUCUAAAC	20	20925
CFTR-Intron10-2042	−	AUUCUGUUUAAAUAGCAC	18	20926
CFTR-Intron10-410	−	UGAUUCUGUUUAAAUAGCAC	20	19296
CFTR-Intron10-2043	−	CUGAUUCUGUUUAAAUAGCAC	21	20927
CFTR-Intron10-2044	−	CCUGAUUCUGUUUAAAUAGCAC	22	20928
CFTR-Intron10-2045	−	CCCUGAUUCUGUUUAAAUAGCAC	23	20929
CFTR-Intron10-2046	−	CCCCUGAUUCUGUUUAAAUAGCAC	24	20930
CFTR-Intron10-2047	−	AGAGAAGGUCAAACUUGAC	19	20931
CFTR-Intron10-2048	−	UAGAGAAGGUCAAACUUGAC	20	20932
CFTR-Intron10-2049	−	AGUAGAGAAGGUCAAACUUGAC	22	20933
CFTR-Intron10-2050	−	UAGUAGAGAAGGUCAAACUUGAC	23	20934
CFTR-Intron10-2051	−	AUAGUAGAGAAGGUCAAACUUGAC	24	20935
CFTR-Intron10-2052	−	CUCUAUAUAAAGUGAUCC	18	20936
CFTR-Intron10-2053	−	UCUCUAUAUAAAGUGAUCC	19	20937
CFTR-Intron10-2054	−	CUCUCUAUAUAAAGUGAUCC	20	20938
CFTR-Intron10-2055	−	UCUCUCUAUAUAAAGUGAUCC	21	20939
CFTR-Intron10-2056	−	UUCUCUCUAUAUAAAGUGAUCC	22	20940
CFTR-Intron10-2057	−	UUUCUCUCUAUAUAAAGUGAUCC	23	20941
CFTR-Intron10-2058	−	AUUUCUCUCUAUAUAAAGUGAUCC	24	20942
CFTR-Intron10-2059	−	AUUCUUUUGAUAUACUCC	18	20943
CFTR-Intron10-2060	−	UAUUCUUUUGAUAUACUCC	19	20944
CFTR-Intron10-1213	−	UUAUUCUUUUGAUAUACUCC	20	20098
CFTR-Intron10-2061	−	CUUAUUCUUUUGAUAUACUCC	21	20945
CFTR-Intron10-2062	−	CCUUAUUCUUUUGAUAUACUCC	22	20946
CFTR-Intron10-2063	−	UGCCUUAUUCUUUUGAUAUACUCC	24	20947
CFTR-Intron10-2064	−	UGCGCUUAUGAAACUUCC	18	20948
CFTR-Intron10-2065	−	UUGCGCUUAUGAAACUUCC	19	20949
CFTR-Intron10-2066	−	CUUGCGCUUAUGAAACUUCC	20	20950
CFTR-Intron10-2067	−	UCUUGCGCUUAUGAAACUUCC	21	20951
CFTR-Intron10-2068	−	UGUCUUGCGCUUAUGAAACUUCC	23	20952
CFTR-Intron10-2069	−	AUGUCUUGCGCUUAUGAAACUUCC	24	20953
CFTR-Intron10-2070	−	AAACCAAACAAGCUUUCC	18	20954
CFTR-Intron10-2071	−	AAAACCAAACAAGCUUUCC	19	20955
CFTR-Intron10-2072	−	UAAAACCAAACAAGCUUUCC	20	20956
CFTR-Intron10-2073	−	CUUUUAAAACAAAAUAGC	18	20957
CFTR-Intron10-1220	−	AGCUUUUAAAACAAAAUAGC	20	20105
CFTR-Intron10-2074	−	AGGAAGACAGCUGGCUAUC	19	20958
CFTR-Intron10-2075	−	CAGGAAGACAGCUGGCUAUC	20	20959
CFTR-Intron10-2076	−	AGCAGGAAGACAGCUGGCUAUC	22	20960
CFTR-Intron10-2077	−	CAGCAGGAAGACAGCUGGCUAUC	23	20961
CFTR-Intron10-2078	−	ACAGCAGGAAGACAGCUGGCUAUC	24	20962
CFTR-Intron10-2079	−	AGCUGGCUAUCCAGGAUUC	19	20963
CFTR-Intron10-441	−	CAGCUGGCUAUCCAGGAUUC	20	19327
CFTR-Intron10-2080	−	ACAGCUGGCUAUCCAGGAUUC	21	20964
CFTR-Intron10-2081	−	AGACAGCUGGCUAUCCAGGAUUC	23	20965
CFTR-Intron10-2082	−	AAGACAGCUGGCUAUCCAGGAUUC	24	20966
CFTR-Intron10-2083	−	UUCUGUAAUUUUUGCUUC	18	20967
CFTR-Intron10-2084	−	AGACUUUGUAGUGAUCUUC	19	20968
CFTR-Intron10-2085	−	AAGACUUUGUAGUGAUCUUC	20	20969
CFTR-Intron10-2086	−	AGAAGACUUUGUAGUGAUCUUC	22	20970
CFTR-Intron10-2087	−	AGCUUUUCAAAAUACUUUC	19	20971
CFTR-Intron10-2088	−	AAGCUUUUCAAAAUACUUUC	20	20972
CFTR-Intron10-2089	−	UGAAGCUUUUCAAAAUACUUUC	22	20973
CFTR-Intron10-2090	−	UUGAAGCUUUUCAAAAUACUUUC	23	20974
CFTR-Intron10-2091	−	CUUGAAGCUUUUCAAAAUACUUUC	24	20975
CFTR-Intron10-2092	−	AACAGUACAAGAAAAAAG	18	20976
CFTR-Intron10-2093	−	UAACAGUACAAGAAAAAAG	19	20977
CFTR-Intron10-2094	−	UGCCAUUAACAGAUAAAG	18	20978
CFTR-Intron10-2095	−	UUGCCAUUAACAGAUAAAG	19	20979
CFTR-Intron10-2096	−	UUUGCCAUUAACAGAUAAAG	20	20980
CFTR-Intron10-2097	−	AUAUGAGAAAAGUCACAG	18	20981
CFTR-Intron10-2098	−	CAUAUGAGAAAAGUCACAG	19	20982
CFTR-Intron10-2099	−	UGGCAUAUGAGAAAAGUCACAG	22	20983
CFTR-Intron10-2100	−	AUGGCAUAUGAGAAAAGUCACAG	23	20984
CFTR-Intron10-2101	−	AAUGGCAUAUGAGAAAAGUCACAG	24	20985
CFTR-Intron10-2102	−	CCAACUGAUGUCAAGCAG	18	20986
CFTR-Intron10-2103	−	CCCAACUGAUGUCAAGCAG	19	20987
CFTR-Intron10-2104	−	ACCCAACUGAUGUCAAGCAG	20	20988
CFTR-Intron10-2105	−	AACCCAACUGAUGUCAAGCAG	21	20989
CFTR-Intron10-2106	−	CGGAACCCAACUGAUGUCAAGCAG	24	20990
CFTR-Intron10-2107	−	AGUAUUAGAGGUUAAGGAG	19	20991
CFTR-Intron10-2108	−	AAGUAUUAGAGGUUAAGGAG	20	20992
CFTR-Intron10-2109	−	UAAGUAUUAGAGGUUAAGGAG	21	20993
CFTR-Intron10-2110	−	CUAAGUAUUAGAGGUUAAGGAG	22	20994
CFTR-Intron10-2111	−	UCUAAGUAUUAGAGGUUAAGGAG	23	20995
CFTR-Intron10-2112	−	UUCUAAGUAUUAGAGGUUAAGGAG	24	20996
CFTR-Intron10-2113	−	AGUCUUUUCCUCUUAAUAG	19	20997
CFTR-Intron10-2114	−	AAGUCUUUUCCUCUUAAUAG	20	20998
CFTR-Intron10-2115	−	UGAAGUCUUUUCCUCUUAAUAG	22	20999
CFTR-Intron10-2116	−	CUGAAGUCUUUUCCUCUUAAUAG	23	21000
CFTR-Intron10-2117	−	CCUGAAGUCUUUUCCUCUUAAUAG	24	21001
CFTR-Intron10-2118	−	UGAAAAGCAGCUAUGAAGG	19	21002
CFTR-Intron10-2119	−	AUGAAAAGCAGCUAUGAAGG	20	21003
CFTR-Intron10-2120	−	UAUGAAAAGCAGCUAUGAAGG	21	21004
CFTR-Intron10-2121	−	UUAUGAAAAGCAGCUAUGAAGG	22	21005
CFTR-Intron10-2122	−	CUUAUGAAAAGCAGCUAUGAAGG	23	21006
CFTR-Intron10-2123	−	UUUCAACUUAUACACAGG	18	21007
CFTR-Intron10-2124	−	AUUUCAACUUAUACACAGG	19	21008
CFTR-Intron10-468	−	CAUUUCAACUUAUACACAGG	20	19354
CFTR-Intron10-2125	−	UCAUUUCAACUUAUACACAGG	21	21009
CFTR-Intron10-2126	−	AUCAUUUCAACUUAUACACAGG	22	21010
CFTR-Intron10-2127	−	UAUCAUUUCAACUUAUACACAGG	23	21011
CFTR-Intron10-2128	−	AUAUCAUUUCAACUUAUACACAGG	24	21012
CFTR-Intron10-2129	−	UGGCAUAGAGUAAGACAGG	19	21013
CFTR-Intron10-2130	−	CUGGCAUAGAGUAAGACAGG	20	21014
CFTR-Intron10-2131	−	AGGCUGGCAUAGAGUAAGACAGG	23	21015
CFTR-Intron10-2132	−	AAUAAAUUUGGUGUCAGG	18	21016
CFTR-Intron10-2133	−	CAAUAAAUUUGGUGUCAGG	19	21017
CFTR-Intron10-2134	−	UCAAUAAAUUUGGUGUCAGG	20	21018
CFTR-Intron10-2135	−	CUCAAUAAAUUUGGUGUCAGG	21	21019
CFTR-Intron10-2136	−	ACUCAAUAAAUUUGGUGUCAGG	22	21020
CFTR-Intron10-2137	−	CACUCAAUAAAUUUGGUGUCAGG	23	21021
CFTR-Intron10-2138	−	CCACUCAAUAAAUUUGGUGUCAGG	24	21022
CFTR-Intron10-2139	−	UGGUAGUGUGAAGAUGGGG	19	21023
CFTR-Intron10-2140	−	CUGGUAGUGUGAAGAUGGGG	20	21024
CFTR-Intron10-2141	−	AGGGAAUGCAGACUCUGGG	19	21025
CFTR-Intron10-2142	−	UAGGGAAUGCAGACUCUGGG	20	21026
CFTR-Intron10-2143	−	UUAGGGAAUGCAGACUCUGGG	21	21027
CFTR-Intron10-2144	−	AUUAGGGAAUGCAGACUCUGGG	22	21028
CFTR-Intron10-2145	−	UGGGGGAGCCCCAUAAAUG	19	21029
CFTR-Intron10-2146	−	UUUUUAUGUAACAAUAUG	18	21030
CFTR-Intron10-2147	−	CUUUUUAUGUAACAAUAUG	19	21031
CFTR-Intron10-2148	−	UCUUUUUAUGUAACAAUAUG	20	21032
CFTR-Intron10-2149	−	CUCUUUUUAUGUAACAAUAUG	21	21033
CFTR-Intron10-2150	−	UCUCUUUUUAUGUAACAAUAUG	22	21034
CFTR-Intron10-2151	−	CUCUCUUUUUAUGUAACAAUAUG	23	21035
CFTR-Intron10-2152	−	CCUCUCUUUUUAUGUAACAAUAUG	24	21036
CFTR-Intron10-2153	−	UGAGAUUAGAGGCCACUG	18	21037
CFTR-Intron10-2154	−	UGCACAUAUGUUCAGACUG	19	21038
CFTR-Intron10-2155	−	UUGCACAUAUGUUCAGACUG	20	21039
CFTR-Intron10-2156	−	CUUGCACAUAUGUUCAGACUG	21	21040
CFTR-Intron10-2157	−	ACUUGCACAUAUGUUCAGACUG	22	21041
CFTR-Intron10-2158	−	UGUUAAAGAAUGACUGUG	18	21042
CFTR-Intron10-2159	−	UUGUUAAAGAAUGACUGUG	19	21043
CFTR-Intron10-2160	−	UUUGUUAAAGAAUGACUGUG	20	21044
CFTR-Intron10-492	−	UGGCAUCUCACCAGUGUGUG	20	19378
CFTR-Intron10-2161	−	AUGGCAUCUCACCAGUGUGUG	21	21045
CFTR-Intron10-2162	−	UAUGGCAUCUCACCAGUGUGUG	22	21046
CFTR-Intron10-2163	−	UUAUGGCAUCUCACCAGUGUGUG	23	21047
CFTR-Intron10-2164	−	CUUAUGGCAUCUCACCAGUGUGUG	24	21048
CFTR-Intron10-2165	−	UGAGGAGAACCAUAUUUUG	19	21049
CFTR-Intron10-2166	−	AUGAGGAGAACCAUAUUUUG	20	21050
CFTR-Intron10-2167	−	AGAUGAGGAGAACCAUAUUUUG	22	21051
CFTR-Intron10-2168	−	AAGAUGAGGAGAACCAUAUUUUG	23	21052
CFTR-Intron10-2169	−	UAAGAUGAGGAGAACCAUAUUUUG	24	21053
CFTR-Intron10-2170	−	CCAUAAAUGUUGAAUAAU	18	21054
CFTR-Intron10-2171	−	CCCAUAAAUGUUGAAUAAU	19	21055
CFTR-Intron10-1331	−	CCCCAUAAAUGUUGAAUAAU	20	20216
CFTR-Intron10-2172	−	AGCCCCAUAAAUGUUGAAUAAU	22	21056
CFTR-Intron10-2173	−	AGAUUUUUUCCCAUGUAAU	19	21057
CFTR-Intron10-2174	−	CAGAUUUUUUCCCAUGUAAU	20	21058
CFTR-Intron10-2175	−	AUCACUAUUGAUUGACAU	18	21059
CFTR-Intron10-2176	−	AAUCACUAUUGAUUGACAU	19	21060
CFTR-Intron10-2177	−	UGAAUCACUAUUGAUUGACAU	21	21061
CFTR-Intron10-2178	−	AUGAAUCACUAUUGAUUGACAU	22	21062
CFTR-Intron10-2179	−	AAUGAAUCACUAUUGAUUGACAU	23	21063
CFTR-Intron10-2180	−	UAAUGAAUCACUAUUGAUUGACAU	24	21064
CFTR-Intron10-2181	−	UAGUUUCUAUUAAUAGAU	18	21065
CFTR-Intron10-2182	−	UGUAGUUUCUAUUAAUAGAU	20	21066
CFTR-Intron10-2183	−	CGUGUAGUUUCUAUUAAUAGAU	22	21067
CFTR-Intron10-2184	−	UCGUGUAGUUUCUAUUAAUAGAU	23	21068
CFTR-Intron10-2185	−	UUCGUGUAGUUUCUAUUAAUAGAU	24	21069
CFTR-Intron10-2186	−	AGAAAGAGCUUUCUAGUAU	19	21070
CFTR-Intron10-2187	−	AAAGCUGUGCAUUUUCCU	18	21071
CFTR-Intron10-2188	−	AAAAGCUGUGCAUUUUCCU	19	21072
CFTR-Intron10-2189	−	AAAAAGCUGUGCAUUUUCCU	20	21073
CFTR-Intron10-2190	−	UGUUCAAAUUAUUUCUACUGCU	22	21074
CFTR-Intron10-2191	−	UUGUUCAAAUUAUUUCUACUGCU	23	21075
CFTR-Intron10-2192	−	UGUAGGCUAUAUGUAUCU	18	21076
CFTR-Intron10-2193	−	CUGUAGGCUAUAUGUAUCU	19	21077
CFTR-Intron10-2194	−	UCUGUAGGCUAUAUGUAUCU	20	21078
CFTR-Intron10-2195	−	AGACUAAGGCUUAUUUCU	18	21079
CFTR-Intron10-2196	−	AAGACUAAGGCUUAUUUCU	19	21080
CFTR-Intron10-2197	−	AAAGACUAAGGCUUAUUUCU	20	21081
CFTR-Intron10-2198	−	UAAAGACUAAGGCUUAUUUCU	21	21082
CFTR-Intron10-2199	−	CGUAAAGACUAAGGCUUAUUUCU	23	21083
CFTR-Intron10-2200	−	UCGUAAAGACUAAGGCUUAUUUCU	24	21084
CFTR-Intron10-2201	−	AAGAAGAGAAAGGGGUGU	18	21085
CFTR-Intron10-2202	−	UAAGAAGAGAAAGGGGUGU	19	21086
CFTR-Intron10-1378	−	AUAAGAAGAGAAAGGGGUGU	20	20262
CFTR-Intron10-2203	−	UGAUAAGAAGAGAAAGGGGUGU	22	21087
CFTR-Intron10-2204	−	UUGAUAAGAAGAGAAAGGGGUGU	23	21088
CFTR-Intron10-2205	−	AGUUGUUAUCUCUGAAAUU	19	21089
CFTR-Intron10-2206	−	AAGUUGUUAUCUCUGAAAUU	20	21090
CFTR-Intron10-2207	−	CAAGUUGUUAUCUCUGAAAUU	21	21091
CFTR-Intron10-2208	−	UCAAGUUGUUAUCUCUGAAAUU	22	21092
CFTR-Intron10-2209	−	AUCAAGUUGUUAUCUCUGAAAUU	23	21093
CFTR-Intron10-2210	−	UAUCAAGUUGUUAUCUCUGAAAUU	24	21094
CFTR-Intron10-2211	−	ACGGUAAGCUCAAGCAUU	18	21095
CFTR-Intron10-2212	−	UACGGUAAGCUCAAGCAUU	19	21096
CFTR-Intron10-2213	−	UUACGGUAAGCUCAAGCAUU	20	21097
CFTR-Intron10-2214	−	AUUACGGUAAGCUCAAGCAUU	21	21098
CFTR-Intron10-2215	−	UAUUACGGUAAGCUCAAGCAUU	22	21099
CFTR-Intron10-2216	−	CUAUUACGGUAAGCUCAAGCAUU	23	21100
CFTR-Intron10-2217	−	CUGCCUUUUAGUAGUAUU	18	21101
CFTR-Intron10-2218	−	AGGCUGCCUUUUAGUAGUAUU	21	21102
CFTR-Intron10-2219	−	AGGAGGCUGCCUUUUAGUAGUAUU	24	21103
CFTR-Intron10-2220	−	AGAUUAGCUUAUAUACUU	18	21104
CFTR-Intron10-2221	−	UAGAUUAGCUUAUAUACUU	19	21105
CFTR-Intron10-550	−	AUAGAUUAGCUUAUAUACUU	20	19436
CFTR-Intron10-2222	−	AAUAGAUUAGCUUAUAUACUU	21	21106
CFTR-Intron10-2223	−	UGAAUAGAUUAGCUUAUAUACUU	23	21107
CFTR-Intron10-2224	−	UUGAAUAGAUUAGCUUAUAUACUU	24	21108
CFTR-Intron10-2225	−	UUUUCCAAGCGGUCCCUU	18	21109
CFTR-Intron10-2226	−	UUUUUCCAAGCGGUCCCUU	19	21110
CFTR-Intron10-2227	−	UUUUUUCCAAGCGGUCCCUU	20	21111
CFTR-Intron10-2228	−	UUUUUUUCCAAGCGGUCCCUU	21	21112
CFTR-Intron10-2229	−	UUUUUUUUCCAAGCGGUCCCUU	22	21113
CFTR-Intron10-2230	−	AUUUUUUUUCCAAGCGGUCCCUU	23	21114
CFTR-Intron10-2231	−	AAUUUUUUUUCCAAGCGGUCCCUU	24	21115
CFTR-Intron10-2232	−	AGAGGAAGGCAGUGGUCCCUU	21	21116
CFTR-Intron10-2233	−	UAGAGGAAGGCAGUGGUCCCUU	22	21117
CFTR-Intron10-2234	−	UUAGAGGAAGGCAGUGGUCCCUU	23	21118
CFTR-Intron10-2235	−	AGAUGUGCAAAAAUAGCUU	19	21119
CFTR-Intron10-552	−	UAGAUGUGCAAAAAUAGCUU	20	19438
CFTR-Intron10-2236	−	AUAGAUGUGCAAAAAUAGCUU	21	21120
CFTR-Intron10-2237	−	UGAUAGAUGUGCAAAAAUAGCUU	23	21121
CFTR-Intron10-2238	−	AUGAUAGAUGUGCAAAAAUAGCUU	24	21122
CFTR-Intron10-2239	−	ACAUGACCUUCCUUUCUU	18	21123
CFTR-Intron10-2240	−	UACAUGACCUUCCUUUCUU	19	21124
CFTR-Intron10-2241	−	UUACAUGACCUUCCUUUCUU	20	21125
CFTR-Intron10-2242	−	UGUUACAUGACCUUCCUUUCUU	22	21126
CFTR-Intron10-2243	−	CUGUUACAUGACCUUCCUUUCUU	23	21127
CFTR-Intron10-2244	−	UCUGUUACAUGACCUUCCUUUCUU	24	21128
CFTR-Intron10-2245	−	UAAUGGGAGAAACAGGUU	18	21129
CFTR-Intron10-2246	−	AUAAUGGGAGAAACAGGUU	19	21130
CFTR-Intron10-2247	−	AGCACUGGAGUUACCUGUU	19	21131
CFTR-Intron10-2248	−	UAGCACUGGAGUUACCUGUU	20	21132
CFTR-Intron10-2249	−	AUAGCACUGGAGUUACCUGUU	21	21133
CFTR-Intron10-2250	−	AAUAGCACUGGAGUUACCUGUU	22	21134
CFTR-Intron10-2251	−	AAAUAGCACUGGAGUUACCUGUU	23	21135
CFTR-Intron10-2252	−	UAAAUAGCACUGGAGUUACCUGUU	24	21136
CFTR-Intron10-2253	−	CAAAUAGUUUUAUCAAUAUUU	21	21137
CFTR-Intron10-2254	−	UGCAAAUAGUUUUAUCAAUAUUU	23	21138
CFTR-Intron10-2255	−	CUGCAAAUAGUUUUAUCAAUAUUU	24	21139
CFTR-Intron10-2256	−	UUGGAUGGAGCUUGGUUU	18	21140
CFTR-Intron10-2257	−	UUUGGAUGGAGCUUGGUUU	19	21141
CFTR-Intron10-563	−	UUUUGGAUGGAGCUUGGUUU	20	19449
CFTR-Intron10-2258	−	AGGUUUUGGAUGGAGCUUGGUUU	23	21142
CFTR-Intron10-2259	−	CAGGUUUUGGAUGGAGCUUGGUUU	24	21143
CFTR-Intron10-2260	−	UGUCCUCCACAAAUAUUUU	19	21144
CFTR-Intron10-2261	−	AUGUCCUCCACAAAUAUUUU	20	21145

Table 41C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 10, start with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 41C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-2262	+	GUAAGACCUAAUCUCUAAA	19	21146
CFTR-Intron10-2263	+	GAGUAAGACCUAAUCUCUAAA	21	21147
CFTR-Intron10-2264	+	GACAGAUGAGAGACAGUAAAGAA	23	21148
CFTR-Intron10-2265	+	GGACAGAUGAGAGACAGUAAAGAA	24	21149
CFTR-Intron10-2266	+	GUGUUCUCACAUGGCAGAA	19	21150
CFTR-Intron10-2267	+	GCUGUGUUCUCACAUGGCAGAA	22	21151
CFTR-Intron10-2268	+	GUUCUUAGGGUGGGAUAUGGAGAA	24	21152
CFTR-Intron10-2269	+	GAAGAAAAGUAUCAAUAA	18	21153
CFTR-Intron10-2270	+	GGAAGAAAAGUAUCAAUAA	19	21154
CFTR-Intron10-2271	+	GUUUUUACCAUUAUCUACACA	21	21155
CFTR-Intron10-2272	+	GAUAUGGAGAAGAGGAUGACCA	22	21156
CFTR-Intron10-2273	+	GGAUAUGGAGAAGAGGAUGACCA	23	21157
CFTR-Intron10-2274	+	GGGAUAUGGAGAAGAGGAUGACCA	24	21158
CFTR-Intron10-2275	+	GAAGUUCAGCCUGGGUGA	18	21159
CFTR-Intron10-2276	+	GCAAAAAUUACAGAACCUAUA	21	21160
CFTR-Intron10-2277	+	GAAGCAAAAAUUACAGAACCUAUA	24	21161
CFTR-Intron10-2278	+	GCUUCCUCCCUUGUCUCCCUA	21	21162
CFTR-Intron10-2279	+	GUCUUCUCAGACUUUUAUUUUA	22	21163
CFTR-Intron10-2280	+	GUUUCCAAAUUUUUUUUA	18	21164
CFTR-Intron10-2281	+	GACAAGUUUCCAAAUUUUUUUUA	23	21165
CFTR-Intron10-2282	+	GUGUGGCUUAUAAACAAC	18	21166
CFTR-Intron10-2283	+	GAACUGUGUGGCUUAUAAACAAC	23	21167
CFTR-Intron10-2284	+	GAAGAUACUAAAAAAAGUUAC	21	21168
CFTR-Intron10-2285	+	GGAAGAUACUAAAAAAAGUUAC	22	21169
CFTR-Intron10-2286	+	GGGAAGAUACUAAAAAAAGUUAC	23	21170
CFTR-Intron10-2287	+	GAAAGGUCAAUUGAGCCC	18	21171
CFTR-Intron10-2288	+	GGAAAGGUCAAUUGAGCCC	19	21172
CFTR-Intron10-2289	+	GCGGAAAGGUCAAUUGAGCCC	21	21173
CFTR-Intron10-2290	+	GAAGCGGAAAGGUCAAUUGAGCCC	24	21174
CFTR-Intron10-2291	+	GCUACUUGGAAGACUCUUCC	20	21175
CFTR-Intron10-2292	+	GAUCACACCACUGAAGUUCAGC	22	21176
CFTR-Intron10-2293	+	GAGUUUCACUGUGUUAGC	18	21177
CFTR-Intron10-2294	+	GGAGUUUCACUGUGUUAGC	19	21178
CFTR-Intron10-2295	+	GACGGAGUUUCACUGUGUUAGC	22	21179
CFTR-Intron10-2296	+	GAGACGGAGUUUCACUGUGUUAGC	24	21180
CFTR-Intron10-2297	+	GUCUCACUCUGUCACCCAGGC	21	21181
CFTR-Intron10-2298	+	GAGUCUCACUCUGUCACCCAGGC	23	21182
CFTR-Intron10-2299	+	GCCUCUGCCUCCAAAAGUGC	20	21183
CFTR-Intron10-2300	+	GCCAUUCUCCUGCCUCAGCCUC	22	21184
CFTR-Intron10-2301	+	GCUCACUGCAAGUUCUGCCUC	21	21185
CFTR-Intron10-2302	+	GGCUCACUGCAAGUUCUGCCUC	22	21186
CFTR-Intron10-2303	+	GAUCUUCCUUCAAAGCAUGUC	21	21187
CFTR-Intron10-2304	+	GGAUCUUCCUUCAAAGCAUGUC	22	21188
CFTR-Intron10-2305	+	GUGAUAUUUUUCAUUAUGAUUC	22	21189
CFTR-Intron10-2306	+	GGUGAUAUUUUUCAUUAUGAUUC	23	21190
CFTR-Intron10-2307	+	GCUACUUGGGAGGCUGAGGCAG	22	21191
CFTR-Intron10-2308	+	GCUACUUGGGAGGGUGAGGCAG	22	21192
CFTR-Intron10-701	+	GUUUGUGUUUUUUGUAGAGG	20	19587
CFTR-Intron10-2309	+	GCACUUUGGGAGGCCGAGGCGG	22	21193
CFTR-Intron10-2310	+	GAACAAAAAUUAAAACUAAUGG	22	21194
CFTR-Intron10-2311	+	GUGAACAAAAAUUAAAACUAAUGG	24	21195
CFTR-Intron10-2312	+	GUAGUCCCAGCUACUUGG	18	21196
CFTR-Intron10-2313	+	GCCUGUAGUCCCAGCUACUUGG	22	21197
CFTR-Intron10-2314	+	GUGCCUGUAGUCCCAGCUACUUGG	24	21198
CFTR-Intron10-2315	+	GCAAUACCAUCACCUUGGGAAU	22	21199
CFTR-Intron10-2316	+	GAAUUAGGAUUUCAACAU	18	21200
CFTR-Intron10-2317	+	GGAAUUAGGAUUUCAACAU	19	21201
CFTR-Intron10-2318	+	GGGAAUUAGGAUUUCAACAU	20	21202
CFTR-Intron10-2319	+	GAUCAAGGUGCCAGCAGAU	19	21203
CFTR-Intron10-2320	+	GUGAUAGUUGCACAACUAU	19	21204
CFTR-Intron10-2321	+	GGUGAUAGUUGCACAACUAU	20	21205
CFTR-Intron10-2322	+	GAGGUGAUAGUUGCACAACUAU	22	21206
CFTR-Intron10-2323	+	GGAGGUGAUAGUUGCACAACUAU	23	21207
CFTR-Intron10-2324	+	GUUUAUUUACAUUUCUCUUUACU	23	21208
CFTR-Intron10-2325	+	GAAAAUGUUAAAUUUUCCCU	20	21209
CFTR-Intron10-2326	+	GAAAUUUAAUUGCCAGUAAGUCU	23	21210
CFTR-Intron10-2327	+	GUUCUCACAUGGCAGAAAGGGGU	23	21211
CFTR-Intron10-2328	+	GCAUCACUAGUGGCACUUUGU	21	21212
CFTR-Intron10-2329	+	GUGCAUCACUAGUGGCACUUUGU	23	21213
CFTR-Intron10-2330	+	GACCCUUUAUCAACAUGAAGGUU	23	21214
CFTR-Intron10-2331	+	GAAAUAUAGAUUUAAUCUUAUUU	23	21215
CFTR-Intron10-2332	+	GGAAAUAUAGAUUUAAUCUUAUUU	24	21216
CFTR-Intron10-2333	+	GUAUUUCUAGGCUAGACAGUUU	22	21217
CFTR-Intron10-2334	+	GGUAUUUCUAGGCUAGACAGUUU	23	21218
CFTR-Intron10-2335	+	GUUCAAGCCUGUAUUGUUU	19	21219
CFTR-Intron10-2336	+	GCAGUUCAAGCCUGUAUUGUUU	22	21220
CFTR-Intron10-2337	−	GAAUAUUUAAACACUUCUGAGAAA	24	21221
CFTR-Intron10-2338	−	GACAUGCUUUGAAGGAAGAUCCAA	24	21222
CFTR-Intron10-2339	−	GAACCAUAUUUUGAAGAA	18	21223
CFTR-Intron10-2340	−	GAGAACCAUAUUUUGAAGAA	20	21224
CFTR-Intron10-2341	−	GUAUAUUAUAGAAAUUUAA	19	21225
CFTR-Intron10-2342	−	GGUAUAUUAUAGAAAUUUAA	20	21226
CFTR-Intron10-2343	−	GACAGGUAUAUUAUAGAAAUUUAA	24	21227
CFTR-Intron10-2344	−	GUGGAUUUUUGACUAUACA	19	21228
CFTR-Intron10-2345	−	GAGGUCACUGAGGCUGGCA	19	21229
CFTR-Intron10-2346	−	GGAGGUCACUGAGGCUGGCA	20	21230
CFTR-Intron10-2347	−	GUAAGGAGGUCACUGAGGCUGGCA	24	21231
CFTR-Intron10-2348	−	GAUAUGAAGUUAAAAACAUCA	21	21232
CFTR-Intron10-2349	−	GAGAUAUGAAGUUAAAAACAUCA	23	21233
CFTR-Intron10-2350	−	GGAGAUAUGAAGUUAAAAACAUCA	24	21234
CFTR-Intron10-2351	−	GACCAGAAUGAAAUUAGA	18	21235
CFTR-Intron10-2352	−	GAUGAUUCCAAGCUUUCUGGA	21	21236
CFTR-Intron10-2353	−	GAAAUAAAUUUAAAGACAUGA	21	21237
CFTR-Intron10-2354	−	GGAAAUAAAUUUAAAGACAUGA	22	21238
CFTR-Intron10-2355	−	GAGGAAAUAAAUUUAAAGACAUGA	24	21239
CFTR-Intron10-2356	−	GAGAAGACAAAGCUAGUGA	19	21240
CFTR-Intron10-2357	−	GUCUGAGAAGACAAAGCUAGUGA	23	21241
CFTR-Intron10-2358	−	GCACUCUAGCCUGGGUGA	18	21242
CFTR-Intron10-2359	−	GCCACUGCACUCUAGCCUGGGUGA	24	21243
CFTR-Intron10-2360	−	GCACCCCUAACCUUCAUGUUGAUA	24	21244
CFTR-Intron10-2361	−	GACUUGCAGGAGGUGAGGGAUUA	23	21245
CFTR-Intron10-2362	−	GCCAAUAAAAGGUUUGUUA	19	21246
CFTR-Intron10-2363	−	GCAUAUAUAUAUUUUUAAC	19	21247
CFTR-Intron10-2364	−	GUGGAGUCAAAAAUUAUAC	19	21248
CFTR-Intron10-2365	−	GUUUAGUGCAAUGCCAUAAACC	22	21249
CFTR-Intron10-2366	−	GAAAAAGUAAGAUAUGCC	18	21250
CFTR-Intron10-2367	−	GGUGAAUUGCUUGAGUCC	18	21251
CFTR-Intron10-2368	−	GCAGGUGAAUUGCUUGAGUCC	21	21252
CFTR-Intron10-2369	−	GGCAGGUGAAUUGCUUGAGUCC	22	21253
CFTR-Intron10-2370	−	GAGGCAGGUGAAUUGCUUGAGUCC	24	21254
CFTR-Intron10-2371	−	GAAAACAAAUUUUCUUUGUUUUCC	24	21255
CFTR-Intron10-2372	−	GCGCCACUGCACUCUAGC	18	21256
CFTR-Intron10-2373	−	GAUCGCGCCACUGCACUCUAGC	22	21257
CFTR-Intron10-2374	−	GAGAUCGCGCCACUGCACUCUAGC	24	21258
CFTR-Intron10-2375	−	GGGUUUCACCGUUUUAGC	18	21259
CFTR-Intron10-2376	−	GGGGUUUCACCGUUUUAGC	19	21260
CFTR-Intron10-2377	−	GACGGGGUUUCACCGUUUUAGC	22	21261
CFTR-Intron10-2378	−	GAGACGGGGUUUCACCGUUUUAGC	24	21262
CFTR-Intron10-2379	−	GUCUCGCUCUGUCGCCCAGGC	21	21263
CFTR-Intron10-2380	−	GAGUCUCGCUCUGUCGCCCAGGC	23	21264
CFTR-Intron10-2381	−	GGAGUCUCGCUCUGUCGCCCAGGC	24	21265
CFTR-Intron10-2382	−	GGGUUUCACCAUGUUGGC	18	21266
CFTR-Intron10-2383	−	GGGGUUUCACCAUGUUGGC	19	21267
CFTR-Intron10-2384	−	GACGGGGUUUCACCAUGUUGGC	22	21268
CFTR-Intron10-2385	−	GAGACGGGGUUUCACCAUGUUGGC	24	21269
CFTR-Intron10-686	−	GCCUCGGCCUCCCAAAGUGC	20	19572
CFTR-Intron10-2386	−	GCCCGCCUCGGCCUCCCAAAGUGC	24	21270
CFTR-Intron10-2387	−	GCAGAGGCAGGUGAAUUGC	19	21271
CFTR-Intron10-2388	−	GGCAGAGGCAGGUGAAUUGC	20	21272
CFTR-Intron10-2389	−	GAGGCAGAGGCAGGUGAAUUGC	22	21273
CFTR-Intron10-2390	−	GGAGGCAGAGGCAGGUGAAUUGC	23	21274
CFTR-Intron10-2391	−	GCUCACUGCAAGCUCCGCCUC	21	21275
CFTR-Intron10-2392	−	GGCUCACUGCAAGCUCCGCCUC	22	21276
CFTR-Intron10-2393	−	GUUGUAACAGUACAAGAAAAAAG	23	21277
CFTR-Intron10-2394	−	GCUUUGCCAUUAACAGAUAAAG	22	21278
CFTR-Intron10-2395	−	GCACUUUUGGAGGCAGAGGCAG	22	21279
CFTR-Intron10-2396	−	GCUACUCGGGAGGCUGAGGCAG	22	21280
CFTR-Intron10-2397	−	GACAAGGGAGGAAGCAAGGAG	21	21281
CFTR-Intron10-2398	−	GAGACAAGGGAGGAAGCAAGGAG	23	21282
CFTR-Intron10-2399	−	GGAGACAAGGGAGGAAGCAAGGAG	24	21283
CFTR-Intron10-2400	−	GACAUCCAAAUAGAGAUGUUAG	22	21284
CFTR-Intron10-2401	−	GCAUAGAGUAAGACAGGGAGGG	22	21285
CFTR-Intron10-2402	−	GGCAUAGAGUAAGACAGGGAGGG	23	21286
CFTR-Intron10-2403	−	GCAUAGUAUUCUAUCAUAUGG	21	21287
CFTR-Intron10-2404	−	GAUGCAUAGUAUUCUAUCAUAUGG	24	21288
CFTR-Intron10-2405	−	GCUUUCUGGACUGAGUAACUGG	22	21289
CFTR-Intron10-2406	−	GUAUAUAUGUGUGUCUGG	18	21290
CFTR-Intron10-2407	−	GUAUGUAUAUAUGUGUGUCUGG	22	21291
CFTR-Intron10-2408	−	GCCCAGGCUGGAGUGCAGUGG	21	21292
CFTR-Intron10-2409	−	GUCGCCCAGGCUGGAGUGCAGUGG	24	21293
CFTR-Intron10-2410	−	GCUACUUGGGAGGCUGAGGUGG	22	21294
CFTR-Intron10-2411	−	GGUGGGGGAGCCCCAUAAAUG	21	21295
CFTR-Intron10-2412	−	GGGUGGGGGAGCCCCAUAAAUG	22	21296
CFTR-Intron10-2413	−	GGGUGAGAUUAGAGGCCACUG	21	21297
CFTR-Intron10-2414	−	GCUUCAGCCUCCCAAAGUG	19	21298
CFTR-Intron10-2415	−	GAACAAAGACUUGCAGGAGGUG	22	21299
CFTR-Intron10-2416	−	GUUUGUUAAAGAAUGACUGUG	21	21300
CFTR-Intron10-2417	−	GGUUUGUUAAAGAAUGACUGUG	22	21301
CFTR-Intron10-2418	−	GCUAUUAGUAGUUAAGUUUUUG	22	21302
CFTR-Intron10-2419	−	GGCUAUUAGUAGUUAAGUUUUUG	23	21303
CFTR-Intron10-2420	−	GGGAGGUGAUUAGUCCAU	18	21304
CFTR-Intron10-2421	−	GCCUUUGGGAGGUGAUUAGUCCAU	24	21305
CFTR-Intron10-2422	−	GAUGCAUAGUAUUCUAUCAU	20	21306
CFTR-Intron10-2423	−	GAUGAGAAAGAGCUUUCUAGUAU	23	21307
CFTR-Intron10-2424	−	GUCUGUAGGCUAUAUGUAUCU	21	21308
CFTR-Intron10-716	−	GCCUCGGCCUCCCAAAGUGU	20	19602
CFTR-Intron10-2425	−	GCCUGCCUCGGCCUCCCAAAGUGU	24	21309
CFTR-Intron10-2426	−	GGAAGGCAGUGGUCCCUU	18	21310
CFTR-Intron10-127	−	GAGGAAGGCAGUGGUCCCUU	20	19013
CFTR-Intron10-2427	−	GAAGCAAGGAGAUGAGUU	18	21311
CFTR-Intron10-2428	−	GGAAGCAAGGAGAUGAGUU	19	21312
CFTR-Intron10-2429	−	GAGGAAGCAAGGAGAUGAGUU	21	21313
CFTR-Intron10-2430	−	GGAGGAAGCAAGGAGAUGAGUU	22	21314
CFTR-Intron10-2431	−	GGGAGGAAGCAAGGAGAUGAGUU	23	21315
CFTR-Intron10-2432	−	GAAAGAUAAUGGGAGAAACAGGUU	24	21316
CFTR-Intron10-2433	−	GCAUGGGUCCACUUAUUU	18	21317
CFTR-Intron10-2434	−	GAACUGCAUGGGUCCACUUAUUU	23	21318
CFTR-Intron10-2435	−	GCUUUUUUGUUGUUUUUCUAGUUU	24	21319
CFTR-Intron10-2436	−	GUUAAUACAUUGGAAAAUUUU	21	21320
CFTR-Intron10-2437	−	GUAUGUCCUCCACAAAUAUUUU	22	21321

Table 41D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within intron 10, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 41D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-2438	+	CAAAAAAGCGAAGAAAAA	18	21322
CFTR-Intron10-2439	+	ACAAAAAAGCGAAGAAAAA	19	21323
CFTR-Intron10-2440	+	AACAAAAAAGCGAAGAAAAA	20	21324
CFTR-Intron10-2441	+	CAACAAAAAAGCGAAGAAAAA	21	21325
CFTR-Intron10-2442	+	ACAACAAAAAAGCGAAGAAAAA	22	21326
CFTR-Intron10-2443	+	AACAACAAAAAAGCGAAGAAAAA	23	21327
CFTR-Intron10-2444	+	AAACAACAAAAAAGCGAAGAAAAA	24	21328
CFTR-Intron10-2445	+	AUACAUAUGAUUUUAUGAAAA	21	21329
CFTR-Intron10-2446	+	CAUACAUAUGAUUUUAUGAAAA	22	21330
CFTR-Intron10-2447	+	ACAUACAUAUGAUUUUAUGAAAA	23	21331
CFTR-Intron10-2448	+	UACAUACAUAUGAUUUUAUGAAAA	24	21332
CFTR-Intron10-2449	+	AGAUAAUACUACUGACUAAAA	21	21333
CFTR-Intron10-2450	+	AAGAUAAUACUACUGACUAAAA	22	21334
CFTR-Intron10-2451	+	AAAGAUAAUACUACUGACUAAAA	23	21335
CFTR-Intron10-2452	+	AAAAGAUAAUACUACUGACUAAAA	24	21336
CFTR-Intron10-2453	+	AUAAACAAACAAAGGAAA	18	21337
CFTR-Intron10-2454	+	AAUAAACAAACAAAGGAAA	19	21338
CFTR-Intron10-1097	+	AAAUAAACAAACAAAGGAAA	20	19982
CFTR-Intron10-2455	+	CAAAUAAACAAACAAAGGAAA	21	21339
CFTR-Intron10-2456	+	CCAAAUAAACAAACAAAGGAAA	22	21340
CFTR-Intron10-2457	+	ACCAAAUAAACAAACAAAGGAAA	23	21341
CFTR-Intron10-2458	+	AACCAAAUAAACAAACAAAGGAAA	24	21342
CFTR-Intron10-2459	+	UAAGACCUAAUCUCUAAA	18	21343
CFTR-Intron10-2460	+	AGUAAGACCUAAUCUCUAAA	20	21344
CFTR-Intron10-2461	+	AGAGUAAGACCUAAUCUCUAAA	22	21345
CFTR-Intron10-2462	+	CAGAGUAAGACCUAAUCUCUAAA	23	21346
CFTR-Intron10-2463	+	ACAGAGUAAGACCUAAUCUCUAAA	24	21347
CFTR-Intron10-2464	+	CAGAUGAGAGACAGUAAAGAA	21	21348
CFTR-Intron10-2465	+	ACAGAUGAGAGACAGUAAAGAA	22	21349
CFTR-Intron10-2466	+	UGUUCUCACAUGGCAGAA	18	21350
CFTR-Intron10-1106	+	UGUGUUCUCACAUGGCAGAA	20	19991
CFTR-Intron10-2467	+	CUGUGUUCUCACAUGGCAGAA	21	21351
CFTR-Intron10-2468	+	UGCUGUGUUCUCACAUGGCAGAA	23	21352
CFTR-Intron10-2469	+	CUGCUGUGUUCUCACAUGGCAGAA	24	21353
CFTR-Intron10-2470	+	CUUAGGGUGGGAUAUGGAGAA	21	21354
CFTR-Intron10-2471	+	UCUUAGGGUGGGAUAUGGAGAA	22	21355
CFTR-Intron10-2472	+	UUCUUAGGGUGGGAUAUGGAGAA	23	21356
CFTR-Intron10-1110	+	AGGAAGAAAAGUAUCAAUAA	20	19995
CFTR-Intron10-2473	+	CAGGAAGAAAAGUAUCAAUAA	21	21357
CFTR-Intron10-2474	+	UCAGGAAGAAAAGUAUCAAUAA	22	21358
CFTR-Intron10-2475	+	AUCAGGAAGAAAAGUAUCAAUAA	23	21359
CFTR-Intron10-2476	+	AAUCAGGAAGAAAAGUAUCAAUAA	24	21360
CFTR-Intron10-2477	+	AGUUUUUACCAUUAUCUACACA	22	21361
CFTR-Intron10-2478	+	AAGUUUUUACCAUUAUCUACACA	23	21362
CFTR-Intron10-2479	+	CAAGUUUUUACCAUUAUCUACACA	24	21363
CFTR-Intron10-2480	+	AUAUGGAGAAGAGGAUGACCA	21	21364
CFTR-Intron10-2481	+	AAAAGAGACACACCUAAAGCA	21	21365
CFTR-Intron10-2482	+	UAAAAGAGACACACCUAAAGCA	22	21366
CFTR-Intron10-2483	+	CUAAAAGAGACACACCUAAAGCA	23	21367
CFTR-Intron10-2484	+	ACUAAAAGAGACACACCUAAAGCA	24	21368
CFTR-Intron10-2485	+	CAAUAGUGAUUCAUUAUAUCA	21	21369
CFTR-Intron10-2486	+	UCAAUAGUGAUUCAUUAUAUCA	22	21370
CFTR-Intron10-2487	+	AUCAAUAGUGAUUCAUUAUAUCA	23	21371
CFTR-Intron10-2488	+	AAUCAAUAGUGAUUCAUUAUAUCA	24	21372
CFTR-Intron10-2489	+	UUGUAUUUUUAGUAGAGA	18	21373
CFTR-Intron10-2490	+	UUUGUAUUUUUAGUAGAGA	19	21374
CFTR-Intron10-1141	+	UUUUGUAUUUUUAGUAGAGA	20	20026
CFTR-Intron10-2491	+	UUUUUGUAUUUUUAGUAGAGA	21	21375
CFTR-Intron10-2492	+	UUUUUUGUAUUUUUAGUAGAGA	22	21376
CFTR-Intron10-2493	+	AUUUUUUGUAUUUUUAGUAGAGA	23	21377
CFTR-Intron10-2494	+	AAUUUUUUGUAUUUUUAGUAGAGA	24	21378
CFTR-Intron10-2495	+	UAUUUAUUUAUUUAGAGA	18	21379
CFTR-Intron10-2496	+	UUAUUUAUUUAUUUAGAGA	19	21380
CFTR-Intron10-2497	+	UUUAUUUAUUUAUUUAGAGA	20	21381
CFTR-Intron10-2498	+	AUUUAUUUAUUUAUUUAGAGA	21	21382
CFTR-Intron10-2499	+	UAUUUAUUUAUUUAUUUAGAGA	22	21383
CFTR-Intron10-2500	+	UUAUUUAUUUAUUUAUUUAGAGA	23	21384
CFTR-Intron10-2501	+	UUUAUUUAUUUAUUUAUUUAGAGA	24	21385
CFTR-Intron10-2502	+	ACUAAAAGGCAGCCUCCUAGA	21	21386
CFTR-Intron10-2503	+	UACUAAAAGGCAGCCUCCUAGA	22	21387
CFTR-Intron10-2504	+	CUACUAAAAGGCAGCCUCCUAGA	23	21388
CFTR-Intron10-2505	+	ACUACUAAAAGGCAGCCUCCUAGA	24	21389
CFTR-Intron10-2506	+	UGAAGUUCAGCCUGGGUGA	19	21390
CFTR-Intron10-2507	+	CUGAAGUUCAGCCUGGGUGA	20	21391
CFTR-Intron10-2508	+	ACUGAAGUUCAGCCUGGGUGA	21	21392
CFTR-Intron10-2509	+	CACUGAAGUUCAGCCUGGGUGA	22	21393
CFTR-Intron10-2510	+	CCACUGAAGUUCAGCCUGGGUGA	23	21394
CFTR-Intron10-2511	+	ACCACUGAAGUUCAGCCUGGGUGA	24	21395
CFTR-Intron10-2512	+	CAAAUUACCAAAUUGUAUUGA	21	21396
CFTR-Intron10-2513	+	ACAAAUUACCAAAUUGUAUUGA	22	21397
CFTR-Intron10-2514	+	UACAAAUUACCAAAUUGUAUUGA	23	21398
CFTR-Intron10-2515	+	AUACAAAUUACCAAAUUGUAUUGA	24	21399
CFTR-Intron10-2516	+	AGCAAAAAUUACAGAACCUAUA	22	21400
CFTR-Intron10-2517	+	AAGCAAAAAUUACAGAACCUAUA	23	21401
CFTR-Intron10-2518	+	UUUGUUACAACAGUCUUUAUA	21	21402
CFTR-Intron10-2519	+	UUUUGUUACAACAGUCUUUAUA	22	21403
CFTR-Intron10-2520	+	CUUUUGUUACAACAGUCUUUAUA	23	21404
CFTR-Intron10-2521	+	UCUUUUGUUACAACAGUCUUUAUA	24	21405
CFTR-Intron10-2522	+	UGCUUCCUCCCUUGUCUCCCUA	22	21406
CFTR-Intron10-2523	+	UUGCUUCCUCCCUUGUCUCCCUA	23	21407
CFTR-Intron10-2524	+	CUUGCUUCCUCCCUUGUCUCCCUA	24	21408
CFTR-Intron10-2525	+	CCUUUGUACAUUUUCCUA	18	21409
CFTR-Intron10-2526	+	UCCUUUGUACAUUUUCCUA	19	21410
CFTR-Intron10-2527	+	AUCCUUUGUACAUUUUCCUA	20	21411
CFTR-Intron10-2528	+	AAUCCUUUGUACAUUUUCCUA	21	21412
CFTR-Intron10-2529	+	CAAUCCUUUGUACAUUUUCCUA	22	21413
CFTR-Intron10-2530	+	UCAAUCCUUUGUACAUUUUCCUA	23	21414
CFTR-Intron10-2531	+	UUCAAUCCUUUGUACAUUUUCCUA	24	21415
CFTR-Intron10-2532	+	AGAUAAAAUUAUAAAUUA	18	21416
CFTR-Intron10-2533	+	AAGAUAAAAUUAUAAAUUA	19	21417
CFTR-Intron10-2534	+	AAAGAUAAAAUUAUAAAUUA	20	21418
CFTR-Intron10-2535	+	UAAAGAUAAAAUUAUAAAUUA	21	21419
CFTR-Intron10-2536	+	AUAAAGAUAAAAUUAUAAAUUA	22	21420
CFTR-Intron10-2537	+	AAUAAAGAUAAAAUUAUAAAUUA	23	21421
CFTR-Intron10-2538	+	UAAUAAAGAUAAAAUUAUAAAUUA	24	21422
CFTR-Intron10-2539	+	UCUCAGACUUUUAUUUUA	18	21423
CFTR-Intron10-2540	+	UUCUCAGACUUUUAUUUUA	19	21424
CFTR-Intron10-2541	+	CUUCUCAGACUUUUAUUUUA	20	21425
CFTR-Intron10-2542	+	UCUUCUCAGACUUUUAUUUUA	21	21426
CFTR-Intron10-2543	+	UGUCUUCUCAGACUUUUAUUUUA	23	21427
CFTR-Intron10-2544	+	UUGUCUUCUCAGACUUUUAUUUUA	24	21428
CFTR-Intron10-2545	+	AGUUUCCAAAUUUUUUUUA	19	21429
CFTR-Intron10-2546	+	AAGUUUCCAAAUUUUUUUUA	20	21430
CFTR-Intron10-2547	+	CAAGUUUCCAAAUUUUUUUUA	21	21431
CFTR-Intron10-2548	+	ACAAGUUUCCAAAUUUUUUUUA	22	21432
CFTR-Intron10-2549	+	AGACAAGUUUCCAAAUUUUUUUUA	24	21433
CFTR-Intron10-2550	+	UGUGUGGCUUAUAAACAAC	19	21434
CFTR-Intron10-1180	+	CUGUGUGGCUUAUAAACAAC	20	20065
CFTR-Intron10-2551	+	ACUGUGUGGCUUAUAAACAAC	21	21435
CFTR-Intron10-2552	+	AACUGUGUGGCUUAUAAACAAC	22	21436
CFTR-Intron10-2553	+	UGAACUGUGUGGCUUAUAAACAAC	24	21437
CFTR-Intron10-2554	+	UGGGAAGAUACUAAAAAAAGUUAC	24	21438
CFTR-Intron10-1194	+	CGGAAAGGUCAAUUGAGCCC	20	20079
CFTR-Intron10-2555	+	AGCGGAAAGGUCAAUUGAGCCC	22	21439
CFTR-Intron10-2556	+	AAGCGGAAAGGUCAAUUGAGCCC	23	21440
CFTR-Intron10-2557	+	UACUUGGAAGACUCUUCC	18	21441
CFTR-Intron10-2558	+	CUACUUGGAAGACUCUUCC	19	21442
CFTR-Intron10-2559	+	UGCUACUUGGAAGACUCUUCC	21	21443
CFTR-Intron10-2560	+	CUGCUACUUGGAAGACUCUUCC	22	21444
CFTR-Intron10-2561	+	CCUGCUACUUGGAAGACUCUUCC	23	21445
CFTR-Intron10-2562	+	ACCUGCUACUUGGAAGACUCUUCC	24	21446
CFTR-Intron10-2563	+	ACACCACUGAAGUUCAGC	18	21447
CFTR-Intron10-2564	+	CACACCACUGAAGUUCAGC	19	21448
CFTR-Intron10-2565	+	UCACACCACUGAAGUUCAGC	20	21449
CFTR-Intron10-2566	+	AUCACACCACUGAAGUUCAGC	21	21450
CFTR-Intron10-2567	+	UGAUCACACCACUGAAGUUCAGC	23	21451
CFTR-Intron10-2568	+	AUGAUCACACCACUGAAGUUCAGC	24	21452
CFTR-Intron10-2569	+	CGGAGUUUCACUGUGUUAGC	20	21453
CFTR-Intron10-2570	+	ACGGAGUUUCACUGUGUUAGC	21	21454
CFTR-Intron10-2571	+	AGACGGAGUUUCACUGUGUUAGC	23	21455
CFTR-Intron10-2572	+	UCACUCUGUCACCCAGGC	18	21456
CFTR-Intron10-2573	+	CUCACUCUGUCACCCAGGC	19	21457
CFTR-Intron10-2574	+	UCUCACUCUGUCACCCAGGC	20	21458
CFTR-Intron10-2575	+	AGUCUCACUCUGUCACCCAGGC	22	21459
CFTR-Intron10-2576	+	AGAGUCUCACUCUGUCACCCAGGC	24	21460
CFTR-Intron10-2577	+	UUUUGAGCCUAUCACCUAGGC	21	21461
CFTR-Intron10-2578	+	UUUUUGAGCCUAUCACCUAGGC	22	21462
CFTR-Intron10-2579	+	UUUUUUGAGCCUAUCACCUAGGC	23	21463
CFTR-Intron10-2580	+	UUUUUUUGAGCCUAUCACCUAGGC	24	21464
CFTR-Intron10-2581	+	CUCUGCCUCCAAAAGUGC	18	21465
CFTR-Intron10-2582	+	CCUCUGCCUCCAAAAGUGC	19	21466
CFTR-Intron10-2583	+	UGCCUCUGCCUCCAAAAGUGC	21	21467
CFTR-Intron10-2584	+	CUGCCUCUGCCUCCAAAAGUGC	22	21468
CFTR-Intron10-2585	+	CCUGCCUCUGCCUCCAAAAGUGC	23	21469
CFTR-Intron10-2586	+	ACCUGCCUCUGCCUCCAAAAGUGC	24	21470
CFTR-Intron10-2587	+	UUCUCCUGCCUCAGCCUC	18	16501
CFTR-Intron10-2588	+	AUUCUCCUGCCUCAGCCUC	19	16502
CFTR-Intron10-2589	+	CAUUCUCCUGCCUCAGCCUC	20	21471
CFTR-Intron10-2590	+	CCAUUCUCCUGCCUCAGCCUC	21	21472
CFTR-Intron10-2591	+	CGCCAUUCUCCUGCCUCAGCCUC	23	21473
CFTR-Intron10-2592	+	ACGCCAUUCUCCUGCCUCAGCCUC	24	21474
CFTR-Intron10-2593	+	CACUGCAAGUUCUGCCUC	18	21475
CFTR-Intron10-2594	+	UCACUGCAAGUUCUGCCUC	19	21476
CFTR-Intron10-2595	+	CUCACUGCAAGUUCUGCCUC	20	21477
CFTR-Intron10-2596	+	CGGCUCACUGCAAGUUCUGCCUC	23	21478
CFTR-Intron10-2597	+	UCGGCUCACUGCAAGUUCUGCCUC	24	21479
CFTR-Intron10-2598	+	UAUUGCUUUCAUUAAGUC	18	21480
CFTR-Intron10-2599	+	CUAUUGCUUUCAUUAAGUC	19	21481
CFTR-Intron10-2600	+	ACUAUUGCUUUCAUUAAGUC	20	21482
CFTR-Intron10-2601	+	CUUCCUUCAAAGCAUGUC	18	21483
CFTR-Intron10-2602	+	UCUUCCUUCAAAGCAUGUC	19	21484
CFTR-Intron10-2603	+	AUCUUCCUUCAAAGCAUGUC	20	21485
CFTR-Intron10-2604	+	UGGAUCUUCCUUCAAAGCAUGUC	23	21486
CFTR-Intron10-2605	+	UUGGAUCUUCCUUCAAAGCAUGUC	24	21487
CFTR-Intron10-2606	+	UGAUAUUUUUCAUUAUGAUUC	21	21488
CFTR-Intron10-2607	+	UGGUGAUAUUUUUCAUUAUGAUUC	24	21489
CFTR-Intron10-2608	+	CUUGGGAGGCUGAGGCAG	18	21490
CFTR-Intron10-2609	+	ACUUGGGAGGCUGAGGCAG	19	21491
CFTR-Intron10-2610	+	UACUUGGGAGGCUGAGGCAG	20	21492
CFTR-Intron10-2611	+	CUACUUGGGAGGCUGAGGCAG	21	21493
CFTR-Intron10-2612	+	AGCUACUUGGGAGGCUGAGGCAG	23	21494
CFTR-Intron10-2613	+	CAGCUACUUGGGAGGCUGAGGCAG	24	21495
CFTR-Intron10-2614	+	CUUGGGAGGGUGAGGCAG	18	21496
CFTR-Intron10-2615	+	ACUUGGGAGGGUGAGGCAG	19	21497
CFTR-Intron10-2616	+	UACUUGGGAGGGUGAGGCAG	20	21498
CFTR-Intron10-2617	+	CUACUUGGGAGGGUGAGGCAG	21	21499
CFTR-Intron10-2618	+	AGCUACUUGGGAGGGUGAGGCAG	23	21500
CFTR-Intron10-2619	+	CAGCUACUUGGGAGGGUGAGGCAG	24	21501
CFTR-Intron10-2620	+	UAAAAAUACAAAAAUUAG	18	21502
CFTR-Intron10-2621	+	CUAAAAAUACAAAAAUUAG	19	21503
CFTR-Intron10-2622	+	ACUAAAAAUACAAAAAUUAG	20	21504
CFTR-Intron10-2623	+	UACUAAAAAUACAAAAAUUAG	21	21505
CFTR-Intron10-2624	+	CUACUAAAAAUACAAAAAUUAG	22	21506
CFTR-Intron10-2625	+	UCUACUAAAAAUACAAAAAUUAG	23	21507
CFTR-Intron10-2626	+	CUCUACUAAAAAUACAAAAAUUAG	24	21508
CFTR-Intron10-2627	+	UGAUCUUGAAGACAUACG	18	21509
CFTR-Intron10-2628	+	UUGAUCUUGAAGACAUACG	19	21510
CFTR-Intron10-2629	+	AUUGAUCUUGAAGACAUACG	20	21511
CFTR-Intron10-2630	+	UUGUGUUUUUUGUAGAGG	18	21512
CFTR-Intron10-2631	+	UUUGUGUUUUUUGUAGAGG	19	21513
CFTR-Intron10-2632	+	UGUUUGUGUUUUUUGUAGAGG	21	21514
CFTR-Intron10-2633	+	UUGUUUGUGUUUUUUGUAGAGG	22	21515
CFTR-Intron10-2634	+	UUUGUUUGUGUUUUUUGUAGAGG	23	21516
CFTR-Intron10-2635	+	UUUUGUUUGUGUUUUUUGUAGAGG	24	21517
CFTR-Intron10-2636	+	UUUGGGAGGCCGAGGCGG	18	21518
CFTR-Intron10-2637	+	CUUUGGGAGGCCGAGGCGG	19	21519
CFTR-Intron10-2638	+	ACUUUGGGAGGCCGAGGCGG	20	21520
CFTR-Intron10-2639	+	CACUUUGGGAGGCCGAGGCGG	21	21521
CFTR-Intron10-2640	+	AGCACUUUGGGAGGCCGAGGCGG	23	21522
CFTR-Intron10-2641	+	CAGCACUUUGGGAGGCCGAGGCGG	24	21523
CFTR-Intron10-2642	+	AAAAAUUAAAACUAAUGG	18	21524
CFTR-Intron10-2643	+	CAAAAAUUAAAACUAAUGG	19	21525
CFTR-Intron10-2644	+	ACAAAAAUUAAAACUAAUGG	20	21526
CFTR-Intron10-2645	+	AACAAAAAUUAAAACUAAUGG	21	21527
CFTR-Intron10-2646	+	UGAACAAAAAUUAAAACUAAUGG	23	21528
CFTR-Intron10-2647	+	CUUUAACAAACCUUUUAUUGG	21	21529
CFTR-Intron10-2648	+	UCUUUAACAAACCUUUUAUUGG	22	21530
CFTR-Intron10-2649	+	UUCUUUAACAAACCUUUUAUUGG	23	21531
CFTR-Intron10-2650	+	AUUCUUUAACAAACCUUUUAUUGG	24	21532
CFTR-Intron10-2651	+	UGUAGUCCCAGCUACUUGG	19	21533
CFTR-Intron10-2652	+	CUGUAGUCCCAGCUACUUGG	20	21534
CFTR-Intron10-2653	+	CCUGUAGUCCCAGCUACUUGG	21	21535
CFTR-Intron10-2654	+	UGCCUGUAGUCCCAGCUACUUGG	23	21536
CFTR-Intron10-2655	+	AAAGGAAAUGGGGUAUAAGUG	21	21537
CFTR-Intron10-2656	+	CAAAGGAAAUGGGGUAUAAGUG	22	21538
CFTR-Intron10-2657	+	ACAAAGGAAAUGGGGUAUAAGUG	23	21539
CFTR-Intron10-2658	+	AACAAAGGAAAUGGGGUAUAAGUG	24	21540
CFTR-Intron10-2659	+	ACUACUAAUAGCCUAUUG	18	21541
CFTR-Intron10-2660	+	AACUACUAAUAGCCUAUUG	19	21542
CFTR-Intron10-2661	+	UAACUACUAAUAGCCUAUUG	20	21543
CFTR-Intron10-2662	+	UUAACUACUAAUAGCCUAUUG	21	21544
CFTR-Intron10-2663	+	CUUAACUACUAAUAGCCUAUUG	22	21545
CFTR-Intron10-2664	+	ACUUAACUACUAAUAGCCUAUUG	23	21546
CFTR-Intron10-2665	+	AACUUAACUACUAAUAGCCUAUUG	24	21547
CFTR-Intron10-2666	+	UAAAACUAAUGGCAGAAU	18	21548
CFTR-Intron10-2667	+	UUAAAACUAAUGGCAGAAU	19	21549
CFTR-Intron10-2668	+	AUUAAAACUAAUGGCAGAAU	20	21550
CFTR-Intron10-2669	+	AAUUAAAACUAAUGGCAGAAU	21	21551
CFTR-Intron10-2670	+	AAAUUAAAACUAAUGGCAGAAU	22	21552
CFTR-Intron10-2671	+	AAAAUUAAAACUAAUGGCAGAAU	23	21553
CFTR-Intron10-2672	+	AAAAAUUAAAACUAAUGGCAGAAU	24	21554
CFTR-Intron10-2673	+	UACCAUCACCUUGGGAAU	18	21555
CFTR-Intron10-2674	+	AUACCAUCACCUUGGGAAU	19	21556
CFTR-Intron10-2675	+	AAUACCAUCACCUUGGGAAU	20	21557
CFTR-Intron10-2676	+	CAAUACCAUCACCUUGGGAAU	21	21558
CFTR-Intron10-2677	+	UGCAAUACCAUCACCUUGGGAAU	23	21559
CFTR-Intron10-2678	+	CUGCAAUACCAUCACCUUGGGAAU	24	21560
CFTR-Intron10-2679	+	UGGGAAUUAGGAUUUCAACAU	21	21561
CFTR-Intron10-2680	+	UUGGGAAUUAGGAUUUCAACAU	22	21562
CFTR-Intron10-2681	+	CUUGGGAAUUAGGAUUUCAACAU	23	21563
CFTR-Intron10-2682	+	CCUUGGGAAUUAGGAUUUCAACAU	24	21564
CFTR-Intron10-2683	+	AUCAAGGUGCCAGCAGAU	18	21565
CFTR-Intron10-2684	+	AGAUCAAGGUGCCAGCAGAU	20	21566
CFTR-Intron10-2685	+	AAGAUCAAGGUGCCAGCAGAU	21	21567
CFTR-Intron10-2686	+	CAAGAUCAAGGUGCCAGCAGAU	22	21568
CFTR-Intron10-2687	+	CCAAGAUCAAGGUGCCAGCAGAU	23	21569
CFTR-Intron10-2688	+	UCCAAGAUCAAGGUGCCAGCAGAU	24	21570
CFTR-Intron10-2689	+	UGAUAGUUGCACAACUAU	18	21571
CFTR-Intron10-2690	+	AGGUGAUAGUUGCACAACUAU	21	21572
CFTR-Intron10-2691	+	AGGAGGUGAUAGUUGCACAACUAU	24	21573
CFTR-Intron10-2692	+	UUUACAUUUCUCUUUACU	18	21574
CFTR-Intron10-2693	+	AUUUACAUUUCUCUUUACU	19	21575
CFTR-Intron10-2694	+	UAUUUACAUUUCUCUUUACU	20	21576
CFTR-Intron10-2695	+	UUAUUUACAUUUCUCUUUACU	21	21577
CFTR-Intron10-2696	+	UUUAUUUACAUUUCUCUUUACU	22	21578
CFTR-Intron10-2697	+	UGUUUAUUUACAUUUCUCUUUACU	24	21579
CFTR-Intron10-2698	+	AAAUGUUAAAUUUUCCCU	18	21580
CFTR-Intron10-2699	+	AAAAUGUUAAAUUUUCCCU	19	21581
CFTR-Intron10-2700	+	AGUUACUCAGUCCAGAAAGCU	21	21582
CFTR-Intron10-2701	+	CAGUUACUCAGUCCAGAAAGCU	22	21583
CFTR-Intron10-2702	+	CCAGUUACUCAGUCCAGAAAGCU	23	21584
CFTR-Intron10-2703	+	UCCAGUUACUCAGUCCAGAAAGCU	24	21585
CFTR-Intron10-2704	+	AAUUUAAUUGCCAGUAAGUCU	21	21586
CFTR-Intron10-2705	+	AAAUUUAAUUGCCAGUAAGUCU	22	21587
CFTR-Intron10-2706	+	UGAAAUUUAAUUGCCAGUAAGUCU	24	21588
CFTR-Intron10-2707	+	UAUGCCAGGUUAAGUUGUUCU	21	21589
CFTR-Intron10-2708	+	AUAUGCCAGGUUAAGUUGUUCU	22	21590
CFTR-Intron10-2709	+	AAUAUGCCAGGUUAAGUUGUUCU	23	21591
CFTR-Intron10-2710	+	AAAUAUGCCAGGUUAAGUUGUUCU	24	21592
CFTR-Intron10-2711	+	CACAUGGCAGAAAGGGGU	18	21593
CFTR-Intron10-2712	+	UCACAUGGCAGAAAGGGGU	19	21594
CFTR-Intron10-2713	+	CUCACAUGGCAGAAAGGGGU	20	21595
CFTR-Intron10-2714	+	UCUCACAUGGCAGAAAGGGGU	21	21596
CFTR-Intron10-2715	+	UUCUCACAUGGCAGAAAGGGGU	22	21597
CFTR-Intron10-2716	+	UGUUCUCACAUGGCAGAAAGGGGU	24	21598
CFTR-Intron10-2717	+	UCACUAGUGGCACUUUGU	18	21599
CFTR-Intron10-2718	+	AUCACUAGUGGCACUUUGU	19	21600
CFTR-Intron10-2719	+	CAUCACUAGUGGCACUUUGU	20	21601
CFTR-Intron10-2720	+	UGCAUCACUAGUGGCACUUUGU	22	21602
CFTR-Intron10-2721	+	CGUGCAUCACUAGUGGCACUUUGU	24	21603
CFTR-Intron10-2722	+	CUGCAAUACCAUCACCUU	18	21604
CFTR-Intron10-2723	+	CCUGCAAUACCAUCACCUU	19	21605
CFTR-Intron10-1395	+	CCCUGCAAUACCAUCACCUU	20	20279
CFTR-Intron10-2724	+	ACCCUGCAAUACCAUCACCUU	21	21606
CFTR-Intron10-2725	+	CACCCUGCAAUACCAUCACCUU	22	21607
CFTR-Intron10-2726	+	CCACCCUGCAAUACCAUCACCUU	23	21608
CFTR-Intron10-2727	+	CCCACCCUGCAAUACCAUCACCUU	24	21609
CFTR-Intron10-2728	+	AUAAAAGAAAUGCAAGUU	18	21610
CFTR-Intron10-2729	+	AAUAAAAGAAAUGCAAGUU	19	21611
CFTR-Intron10-2730	+	UAAUAAAAGAAAUGCAAGUU	20	21612
CFTR-Intron10-2731	+	AUAAUAAAAGAAAUGCAAGUU	21	21613
CFTR-Intron10-2732	+	UAUAAUAAAAGAAAUGCAAGUU	22	21614
CFTR-Intron10-2733	+	UUAUAAUAAAAGAAAUGCAAGUU	23	21615
CFTR-Intron10-2734	+	CUUAUAAUAAAAGAAAUGCAAGUU	24	21616
CFTR-Intron10-2735	+	CCCUUUAUCAACAUGAAGGUU	21	21617
CFTR-Intron10-2736	+	ACCCUUUAUCAACAUGAAGGUU	22	21618
CFTR-Intron10-2737	+	UGACCCUUUAUCAACAUGAAGGUU	24	21619
CFTR-Intron10-2738	+	AUAGAUUUAAUCUUAUUU	18	21620
CFTR-Intron10-2739	+	UAUAGAUUUAAUCUUAUUU	19	21621
CFTR-Intron10-2740	+	AUAUAGAUUUAAUCUUAUUU	20	21622
CFTR-Intron10-2741	+	AAUAUAGAUUUAAUCUUAUUU	21	21623
CFTR-Intron10-2742	+	AAAUAUAGAUUUAAUCUUAUUU	22	21624
CFTR-Intron10-2743	+	UUCUAGGCUAGACAGUUU	18	21625
CFTR-Intron10-2744	+	UUUCUAGGCUAGACAGUUU	19	21626
CFTR-Intron10-2745	+	AUUUCUAGGCUAGACAGUUU	20	21627
CFTR-Intron10-2746	+	UAUUUCUAGGCUAGACAGUUU	21	21628
CFTR-Intron10-2747	+	CGGUAUUUCUAGGCUAGACAGUUU	24	21629
CFTR-Intron10-2748	+	UUCAAGCCUGUAUUGUUU	18	21630
CFTR-Intron10-2749	+	AGUUCAAGCCUGUAUUGUUU	20	21631
CFTR-Intron10-2750	+	CAGUUCAAGCCUGUAUUGUUU	21	21632
CFTR-Intron10-2751	+	UGCAGUUCAAGCCUGUAUUGUUU	23	21633
CFTR-Intron10-2752	+	AUGCAGUUCAAGCCUGUAUUGUUU	24	21634
CFTR-Intron10-2753	−	UAUUUAAACACUUCUGAGAAA	21	21635
CFTR-Intron10-2754	−	AUAUUUAAACACUUCUGAGAAA	22	21636
CFTR-Intron10-2755	−	AAUAUUUAAACACUUCUGAGAAA	23	21637
CFTR-Intron10-2756	−	AUGCUUUGAAGGAAGAUCCAA	21	21638
CFTR-Intron10-2757	−	CAUGCUUUGAAGGAAGAUCCAA	22	21639
CFTR-Intron10-2758	−	ACAUGCUUUGAAGGAAGAUCCAA	23	21640
CFTR-Intron10-2759	−	AGAACCAUAUUUUGAAGAA	19	21641
CFTR-Intron10-2760	−	UAUAUUAUAGAAAUUUAA	18	21642
CFTR-Intron10-2761	−	AGGUAUAUUAUAGAAAUUUAA	21	21643
CFTR-Intron10-2762	−	CAGGUAUAUUAUAGAAAUUUAA	22	21644
CFTR-Intron10-2763	−	ACAGGUAUAUUAUAGAAAUUUAA	23	21645
CFTR-Intron10-2764	−	UGGAUUUUUGACUAUACA	18	21646
CFTR-Intron10-2765	−	CGUGGAUUUUUGACUAUACA	20	21647
CFTR-Intron10-2766	−	ACGUGGAUUUUUGACUAUACA	21	21648
CFTR-Intron10-2767	−	UACGUGGAUUUUUGACUAUACA	22	21649
CFTR-Intron10-2768	−	AUACGUGGAUUUUUGACUAUACA	23	21650
CFTR-Intron10-2769	−	UAUACGUGGAUUUUUGACUAUACA	24	21651
CFTR-Intron10-2770	−	UCAUUAGGAAAAUGUACA	18	21652
CFTR-Intron10-2771	−	CUCAUUAGGAAAAUGUACA	19	21653
CFTR-Intron10-2772	−	ACUCAUUAGGAAAAUGUACA	20	21654
CFTR-Intron10-2773	−	AGGUCACUGAGGCUGGCA	18	21655
CFTR-Intron10-2774	−	AGGAGGUCACUGAGGCUGGCA	21	21656
CFTR-Intron10-2775	−	AAGGAGGUCACUGAGGCUGGCA	22	21657
CFTR-Intron10-2776	−	UAAGGAGGUCACUGAGGCUGGCA	23	21658
CFTR-Intron10-2777	−	AGAUAUGAAGUUAAAAACAUCA	22	21659
CFTR-Intron10-2778	−	UUAGUAUAGAAUUUUGCAUCA	21	21660
CFTR-Intron10-2779	−	AUUAGUAUAGAAUUUUGCAUCA	22	21661
CFTR-Intron10-2780	−	UAUUAGUAUAGAAUUUUGCAUCA	23	21662
CFTR-Intron10-2781	−	AUAUUAGUAUAGAAUUUUGCAUCA	24	21663
CFTR-Intron10-2782	−	UAAAGAGCCUUUUCUUUUUCA	21	21664
CFTR-Intron10-2783	−	AUAAAGAGCCUUUUCUUUUUCA	22	21665
CFTR-Intron10-2784	−	UAUAAAGAGCCUUUUCUUUUUCA	23	21666
CFTR-Intron10-2785	−	UUAUAAAGAGCCUUUUCUUUUUCA	24	21667
CFTR-Intron10-2786	−	AGAUCUAGCUAAAAUAUAAGA	21	21668
CFTR-Intron10-2787	−	AAGAUCUAGCUAAAAUAUAAGA	22	21669
CFTR-Intron10-2788	−	AAAGAUCUAGCUAAAAUAUAAGA	23	21670
CFTR-Intron10-2789	−	AAAAGAUCUAGCUAAAAUAUAAGA	24	21671
CFTR-Intron10-2790	−	AUUUUUGUAUUUUUAGUAGAGA	22	21672
CFTR-Intron10-2791	−	AAUUUUUGUAUUUUUAGUAGAGA	23	21673
CFTR-Intron10-2792	−	UAAUUUUUGUAUUUUUAGUAGAGA	24	21674
CFTR-Intron10-2793	−	UUACUAUUAUUUUUGAGA	18	21675
CFTR-Intron10-2794	−	AUUACUAUUAUUUUUGAGA	19	21676
CFTR-Intron10-2795	−	UAUUACUAUUAUUUUUGAGA	20	21677
CFTR-Intron10-2796	−	AUAUUACUAUUAUUUUUGAGA	21	21678
CFTR-Intron10-2797	−	AAUAUUACUAUUAUUUUUGAGA	22	21679
CFTR-Intron10-2798	−	UAAUAUUACUAUUAUUUUUGAGA	23	21680
CFTR-Intron10-2799	−	UUAAUAUUACUAUUAUUUUUGAGA	24	21681
CFTR-Intron10-2800	−	UUUUUUUUUUUUUUGAGA	18	21682
CFTR-Intron10-2801	−	UUUUUUUUUUUUUUUGAGA	19	21683
CFTR-Intron10-1142	−	UUUUUUUUUUUUUUUUGAGA	20	20027
CFTR-Intron10-2802	−	UUUUUUUUUUUUUUUUUGAGA	21	21684
CFTR-Intron10-2803	−	UUUUUUUUUUUUUUUUUUGAGA	22	21685
CFTR-Intron10-2804	−	UUUUUUUUUUUUUUUUUUUGAGA	23	21686
CFTR-Intron10-2805	−	UUUUUUUUUUUUUUUUUUUUGAGA	24	21687
CFTR-Intron10-2806	−	UGACCAGAAUGAAAUUAGA	19	21688
CFTR-Intron10-2807	−	UUGACCAGAAUGAAAUUAGA	20	21689
CFTR-Intron10-2808	−	AUUAGGAAAAUGUACAAAGGA	21	21690
CFTR-Intron10-2809	−	CAUUAGGAAAAUGUACAAAGGA	22	21691
CFTR-Intron10-2810	−	UCAUUAGGAAAAUGUACAAAGGA	23	21692
CFTR-Intron10-2811	−	CUCAUUAGGAAAAUGUACAAAGGA	24	21693
CFTR-Intron10-2812	−	AGAUGAUUCCAAGCUUUCUGGA	22	21694
CFTR-Intron10-2813	−	AAGAUGAUUCCAAGCUUUCUGGA	23	21695
CFTR-Intron10-2814	−	AAAGAUGAUUCCAAGCUUUCUGGA	24	21696
CFTR-Intron10-2815	−	AUAAAUUUAAAGACAUGA	18	21697
CFTR-Intron10-2816	−	AAUAAAUUUAAAGACAUGA	19	21698
CFTR-Intron10-2817	−	AAAUAAAUUUAAAGACAUGA	20	21699
CFTR-Intron10-2818	−	AGGAAAUAAAUUUAAAGACAUGA	23	21700
CFTR-Intron10-2819	−	AGAAGACAAAGCUAGUGA	18	21701
CFTR-Intron10-2820	−	UGAGAAGACAAAGCUAGUGA	20	21702
CFTR-Intron10-2821	−	CUGAGAAGACAAAGCUAGUGA	21	21703
CFTR-Intron10-2822	−	UCUGAGAAGACAAAGCUAGUGA	22	21704
CFTR-Intron10-2823	−	AGUCUGAGAAGACAAAGCUAGUGA	24	21705
CFTR-Intron10-2824	−	UGCACUCUAGCCUGGGUGA	19	21706
CFTR-Intron10-2825	−	CUGCACUCUAGCCUGGGUGA	20	21707
CFTR-Intron10-2826	−	ACUGCACUCUAGCCUGGGUGA	21	21708
CFTR-Intron10-2827	−	CACUGCACUCUAGCCUGGGUGA	22	21709
CFTR-Intron10-2828	−	CCACUGCACUCUAGCCUGGGUGA	23	21710
CFTR-Intron10-2829	−	CCCCUAACCUUCAUGUUGAUA	21	21711
CFTR-Intron10-2830	−	ACCCCUAACCUUCAUGUUGAUA	22	21712
CFTR-Intron10-2831	−	CACCCCUAACCUUCAUGUUGAUA	23	21713
CFTR-Intron10-2832	−	AAAAUACUUUCUAGAAUUAUA	21	21714
CFTR-Intron10-2833	−	CAAAAUACUUUCUAGAAUUAUA	22	21715
CFTR-Intron10-2834	−	UCAAAAUACUUUCUAGAAUUAUA	23	21716
CFTR-Intron10-2835	−	UUCAAAAUACUUUCUAGAAUUAUA	24	21717
CFTR-Intron10-2836	−	CGUUUUUGCUUGCUUUUUAUA	21	21718
CFTR-Intron10-2837	−	ACGUUUUUGCUUGCUUUUUAUA	22	21719
CFTR-Intron10-2838	−	CACGUUUUUGCUUGCUUUUUAUA	23	21720
CFTR-Intron10-2839	−	UCACGUUUUUGCUUGCUUUUUAUA	24	21721
CFTR-Intron10-2840	−	CUUGCAGGAGGUGAGGGAUUA	21	21722
CFTR-Intron10-2841	−	ACUUGCAGGAGGUGAGGGAUUA	22	21723
CFTR-Intron10-2842	−	AGACUUGCAGGAGGUGAGGGAUUA	24	21724
CFTR-Intron10-2843	−	CCAAUAAAAGGUUUGUUA	18	21725
CFTR-Intron10-2844	−	AGCCAAUAAAAGGUUUGUUA	20	21726
CFTR-Intron10-2845	−	UAAGUUAGCAAUGGUCUAAAC	21	21727
CFTR-Intron10-2846	−	AUAAGUUAGCAAUGGUCUAAAC	22	21728
CFTR-Intron10-2847	−	AAUAAGUUAGCAAUGGUCUAAAC	23	21729
CFTR-Intron10-2848	−	AAAUAAGUUAGCAAUGGUCUAAAC	24	21730
CFTR-Intron10-2849	−	UAAACUUUGUUUUUCAAC	18	21731
CFTR-Intron10-2850	−	UUAAACUUUGUUUUUCAAC	19	21732
CFTR-Intron10-2851	−	UUUAAACUUUGUUUUUCAAC	20	21733
CFTR-Intron10-2852	−	AUUUAAACUUUGUUUUUCAAC	21	21734
CFTR-Intron10-2853	−	UAUUUAAACUUUGUUUUUCAAC	22	21735
CFTR-Intron10-2854	−	AUAUUUAAACUUUGUUUUUCAAC	23	21736
CFTR-Intron10-2855	−	CAUAUUUAAACUUUGUUUUUCAAC	24	21737
CFTR-Intron10-2856	−	CAUAUAUAUAUUUUUAAC	18	21738
CFTR-Intron10-2857	−	UGCAUAUAUAUAUUUUUAAC	20	21739
CFTR-Intron10-2858	−	AUGCAUAUAUAUAUUUUUAAC	21	21740
CFTR-Intron10-2859	−	UAUGCAUAUAUAUAUUUUUAAC	22	21741
CFTR-Intron10-2860	−	AUAUGCAUAUAUAUAUUUUUAAC	23	21742
CFTR-Intron10-2861	−	AAUAUGCAUAUAUAUAUUUUUAAC	24	21743
CFTR-Intron10-2862	−	UGGAGUCAAAAAUUAUAC	18	21744
CFTR-Intron10-2863	−	UGUGGAGUCAAAAAUUAUAC	20	21745
CFTR-Intron10-2864	−	UUGUGGAGUCAAAAAUUAUAC	21	21746
CFTR-Intron10-2865	−	UUUGUGGAGUCAAAAAUUAUAC	22	21747
CFTR-Intron10-2866	−	UUUUGUGGAGUCAAAAAUUAUAC	23	21748
CFTR-Intron10-2867	−	UUUUUGUGGAGUCAAAAAUUAUAC	24	21749
CFTR-Intron10-2868	−	AGUGCAAUGCCAUAAACC	18	21750
CFTR-Intron10-2869	−	UAGUGCAAUGCCAUAAACC	19	21751
CFTR-Intron10-2870	−	UUAGUGCAAUGCCAUAAACC	20	21752
CFTR-Intron10-2871	−	UUUAGUGCAAUGCCAUAAACC	21	21753
CFTR-Intron10-2872	−	UGUUUAGUGCAAUGCCAUAAACC	23	21754
CFTR-Intron10-2873	−	AUGUUUAGUGCAAUGCCAUAAACC	24	21755
CFTR-Intron10-2874	−	AGAAAAAGUAAGAUAUGCC	19	21756
CFTR-Intron10-2875	−	AAGAAAAAGUAAGAUAUGCC	20	21757
CFTR-Intron10-2876	−	UAAGAAAAAGUAAGAUAUGCC	21	21758
CFTR-Intron10-2877	−	UUAAGAAAAAGUAAGAUAUGCC	22	21759
CFTR-Intron10-2878	−	AUUAAGAAAAAGUAAGAUAUGCC	23	21760
CFTR-Intron10-2879	−	AAUUAAGAAAAAGUAAGAUAUGCC	24	21761
CFTR-Intron10-2880	−	AGGUGAAUUGCUUGAGUCC	19	21762
CFTR-Intron10-1217	−	CAGGUGAAUUGCUUGAGUCC	20	20102
CFTR-Intron10-2881	−	AGGCAGGUGAAUUGCUUGAGUCC	23	21763
CFTR-Intron10-2882	−	CUAAAACCAAACAAGCUUUCC	21	21764
CFTR-Intron10-2883	−	ACUAAAACCAAACAAGCUUUCC	22	21765
CFTR-Intron10-2884	−	UACUAAAACCAAACAAGCUUUCC	23	21766
CFTR-Intron10-2885	−	CUACUAAAACCAAACAAGCUUUCC	24	21767
CFTR-Intron10-2886	−	AAAUUUUCUUUGUUUUCC	18	21768
CFTR-Intron10-2887	−	CAAAUUUUCUUUGUUUUCC	19	21769
CFTR-Intron10-2888	−	ACAAAUUUUCUUUGUUUUCC	20	21770
CFTR-Intron10-2889	−	AACAAAUUUUCUUUGUUUUCC	21	21771
CFTR-Intron10-2890	−	AAACAAAUUUUCUUUGUUUUCC	22	21772
CFTR-Intron10-2891	−	AAAACAAAUUUUCUUUGUUUUCC	23	21773
CFTR-Intron10-2892	−	CAGCUUUUAAAACAAAAUAGC	21	21774
CFTR-Intron10-2893	−	ACAGCUUUUAAAACAAAAUAGC	22	21775
CFTR-Intron10-2894	−	AACAGCUUUUAAAACAAAAUAGC	23	21776
CFTR-Intron10-2895	−	AAACAGCUUUUAAAACAAAAUAGC	24	21777
CFTR-Intron10-2896	−	CGCGCCACUGCACUCUAGC	19	21778
CFTR-Intron10-2897	−	UCGCGCCACUGCACUCUAGC	20	21779
CFTR-Intron10-2898	−	AUCGCGCCACUGCACUCUAGC	21	21780
CFTR-Intron10-2899	−	AGAUCGCGCCACUGCACUCUAGC	23	21781
CFTR-Intron10-1224	−	CGGGGUUUCACCGUUUUAGC	20	20109
CFTR-Intron10-2900	−	ACGGGGUUUCACCGUUUUAGC	21	21782
CFTR-Intron10-2901	−	AGACGGGGUUUCACCGUUUUAGC	23	21783
CFTR-Intron10-2902	−	UCGCUCUGUCGCCCAGGC	18	21784
CFTR-Intron10-2903	−	CUCGCUCUGUCGCCCAGGC	19	21785
CFTR-Intron10-1226	−	UCUCGCUCUGUCGCCCAGGC	20	20111
CFTR-Intron10-2904	−	AGUCUCGCUCUGUCGCCCAGGC	22	21786
CFTR-Intron10-2905	−	CGGGGUUUCACCAUGUUGGC	20	21787
CFTR-Intron10-2906	−	ACGGGGUUUCACCAUGUUGGC	21	21788
CFTR-Intron10-2907	−	AGACGGGGUUUCACCAUGUUGGC	23	21789
CFTR-Intron10-2908	−	AAUACAGGCUUGAACUGC	18	21790
CFTR-Intron10-2909	−	CAAUACAGGCUUGAACUGC	19	21791
CFTR-Intron10-2910	−	ACAAUACAGGCUUGAACUGC	20	21792
CFTR-Intron10-2911	−	AACAAUACAGGCUUGAACUGC	21	21793
CFTR-Intron10-2912	−	AAACAAUACAGGCUUGAACUGC	22	21794
CFTR-Intron10-2913	−	UAAACAAUACAGGCUUGAACUGC	23	21795
CFTR-Intron10-2914	−	UUAAACAAUACAGGCUUGAACUGC	24	21796
CFTR-Intron10-2915	−	CUCGGCCUCCCAAAGUGC	18	21797
CFTR-Intron10-2916	−	CCUCGGCCUCCCAAAGUGC	19	21798
CFTR-Intron10-2917	−	CGCCUCGGCCUCCCAAAGUGC	21	21799
CFTR-Intron10-2918	−	CCGCCUCGGCCUCCCAAAGUGC	22	21800
CFTR-Intron10-2919	−	CCCGCCUCGGCCUCCCAAAGUGC	23	21801
CFTR-Intron10-2920	−	CAGAGGCAGGUGAAUUGC	18	21802
CFTR-Intron10-2921	−	AGGCAGAGGCAGGUGAAUUGC	21	21803
CFTR-Intron10-2922	−	UGGAGGCAGAGGCAGGUGAAUUGC	24	21804
CFTR-Intron10-2923	−	CACUGCAAGCUCCGCCUC	18	21805
CFTR-Intron10-2924	−	UCACUGCAAGCUCCGCCUC	19	21806
CFTR-Intron10-2925	−	CUCACUGCAAGCUCCGCCUC	20	21807
CFTR-Intron10-2926	−	CGGCUCACUGCAAGCUCCGCCUC	23	21808
CFTR-Intron10-2927	−	UCGGCUCACUGCAAGCUCCGCCUC	24	21809
CFTR-Intron10-2928	−	AGGUUCUGUAAUUUUUGCUUC	21	21810
CFTR-Intron10-2929	−	UAGGUUCUGUAAUUUUUGCUUC	22	21811
CFTR-Intron10-2930	−	AUAGGUUCUGUAAUUUUUGCUUC	23	21812
CFTR-Intron10-2931	−	UAUAGGUUCUGUAAUUUUUGCUUC	24	21813
CFTR-Intron10-2932	−	UGUAACAGUACAAGAAAAAAG	21	21814
CFTR-Intron10-2933	−	UUGUAACAGUACAAGAAAAAAG	22	21815
CFTR-Intron10-2934	−	AGUUGUAACAGUACAAGAAAAAAG	24	21816
CFTR-Intron10-2935	−	CUUUGCCAUUAACAGAUAAAG	21	21817
CFTR-Intron10-2936	−	UGCUUUGCCAUUAACAGAUAAAG	23	21818
CFTR-Intron10-2937	−	UUGCUUUGCCAUUAACAGAUAAAG	24	21819
CFTR-Intron10-2938	−	UUUUGGAGGCAGAGGCAG	18	21820
CFTR-Intron10-2939	−	CUUUUGGAGGCAGAGGCAG	19	21821
CFTR-Intron10-2940	−	ACUUUUGGAGGCAGAGGCAG	20	21822
CFTR-Intron10-2941	−	CACUUUUGGAGGCAGAGGCAG	21	21823
CFTR-Intron10-2942	−	AGCACUUUUGGAGGCAGAGGCAG	23	21824
CFTR-Intron10-2943	−	UAGCACUUUUGGAGGCAGAGGCAG	24	21825
CFTR-Intron10-2944	−	CUCGGGAGGCUGAGGCAG	18	21826
CFTR-Intron10-2945	−	ACUCGGGAGGCUGAGGCAG	19	21827
CFTR-Intron10-2946	−	UACUCGGGAGGCUGAGGCAG	20	21828
CFTR-Intron10-2947	−	CUACUCGGGAGGCUGAGGCAG	21	21829
CFTR-Intron10-2948	−	AGCUACUCGGGAGGCUGAGGCAG	23	21830
CFTR-Intron10-2949	−	CAGCUACUCGGGAGGCUGAGGCAG	24	21831
CFTR-Intron10-2950	−	AAGGGAGGAAGCAAGGAG	18	21832
CFTR-Intron10-2951	−	CAAGGGAGGAAGCAAGGAG	19	21833
CFTR-Intron10-2952	−	ACAAGGGAGGAAGCAAGGAG	20	21834
CFTR-Intron10-2953	−	AGACAAGGGAGGAAGCAAGGAG	22	21835
CFTR-Intron10-2954	−	ACAAACAAAAGAAAAUAG	18	21836
CFTR-Intron10-2955	−	CACAAACAAAAGAAAAUAG	19	21837
CFTR-Intron10-2956	−	ACACAAACAAAAGAAAAUAG	20	21838
CFTR-Intron10-2957	−	AACACAAACAAAAGAAAAUAG	21	21839
CFTR-Intron10-2958	−	AAACACAAACAAAAGAAAAUAG	22	21840
CFTR-Intron10-2959	−	AAAACACAAACAAAAGAAAAUAG	23	21841
CFTR-Intron10-2960	−	AAAAACACAAACAAAAGAAAAUAG	24	21842
CFTR-Intron10-2961	−	UCCAAAUAGAGAUGUUAG	18	21843
CFTR-Intron10-2962	−	AUCCAAAUAGAGAUGUUAG	19	21844
CFTR-Intron10-2963	−	CAUCCAAAUAGAGAUGUUAG	20	21845
CFTR-Intron10-2964	−	ACAUCCAAAUAGAGAUGUUAG	21	21846
CFTR-Intron10-2965	−	UGACAUCCAAAUAGAGAUGUUAG	23	21847
CFTR-Intron10-2966	−	UUGACAUCCAAAUAGAGAUGUUAG	24	21848
CFTR-Intron10-2967	−	AGAGUAAGACAGGGAGGG	18	21849
CFTR-Intron10-2968	−	UAGAGUAAGACAGGGAGGG	19	21850
CFTR-Intron10-2969	−	AUAGAGUAAGACAGGGAGGG	20	21851
CFTR-Intron10-2970	−	CAUAGAGUAAGACAGGGAGGG	21	21852
CFTR-Intron10-2971	−	UGGCAUAGAGUAAGACAGGGAGGG	24	21853
CFTR-Intron10-2972	−	UAGUAUUCUAUCAUAUGG	18	21854
CFTR-Intron10-2973	−	AUAGUAUUCUAUCAUAUGG	19	21855
CFTR-Intron10-2974	−	CAUAGUAUUCUAUCAUAUGG	20	21856
CFTR-Intron10-2975	−	UGCAUAGUAUUCUAUCAUAUGG	22	21857
CFTR-Intron10-2976	−	AUGCAUAGUAUUCUAUCAUAUGG	23	21858
CFTR-Intron10-2977	−	UCUGGACUGAGUAACUGG	18	21859
CFTR-Intron10-2978	−	UUCUGGACUGAGUAACUGG	19	21860
CFTR-Intron10-2979	−	UUUCUGGACUGAGUAACUGG	20	21861
CFTR-Intron10-2980	−	CUUUCUGGACUGAGUAACUGG	21	21862
CFTR-Intron10-2981	−	AGCUUUCUGGACUGAGUAACUGG	23	21863
CFTR-Intron10-2982	−	AAGCUUUCUGGACUGAGUAACUGG	24	21864
CFTR-Intron10-2983	−	UGUAUAUAUGUGUGUCUGG	19	21865
CFTR-Intron10-2984	−	AUGUAUAUAUGUGUGUCUGG	20	21866
CFTR-Intron10-2985	−	UAUGUAUAUAUGUGUGUCUGG	21	21867
CFTR-Intron10-2986	−	UGUAUGUAUAUAUGUGUGUCUGG	23	21868
CFTR-Intron10-2987	−	AUGUAUGUAUAUAUGUGUGUCUGG	24	21869
CFTR-Intron10-2988	−	CAGGCUGGAGUGCAGUGG	18	21870
CFTR-Intron10-2989	−	CCAGGCUGGAGUGCAGUGG	19	21871
CFTR-Intron10-1304	−	CCCAGGCUGGAGUGCAGUGG	20	20189
CFTR-Intron10-2990	−	CGCCCAGGCUGGAGUGCAGUGG	22	21872
CFTR-Intron10-2991	−	UCGCCCAGGCUGGAGUGCAGUGG	23	21873
CFTR-Intron10-2992	−	CUUGGGAGGCUGAGGUGG	18	21874
CFTR-Intron10-2993	−	ACUUGGGAGGCUGAGGUGG	19	21875
CFTR-Intron10-2994	−	UACUUGGGAGGCUGAGGUGG	20	21876
CFTR-Intron10-2995	−	CUACUUGGGAGGCUGAGGUGG	21	21877
CFTR-Intron10-2996	−	AGCUACUUGGGAGGCUGAGGUGG	23	21878
CFTR-Intron10-2997	−	CAGCUACUUGGGAGGCUGAGGUGG	24	21879
CFTR-Intron10-2998	−	UGGGUGGGGGAGCCCCAUAAAUG	23	21880
CFTR-Intron10-2999	−	UUGGGUGGGGGAGCCCCAUAAAUG	24	21881
CFTR-Intron10-3000	−	AAUUAGCCAGACGUGAUG	18	21882
CFTR-Intron10-3001	−	AAAUUAGCCAGACGUGAUG	19	21883
CFTR-Intron10-3002	−	AAAAUUAGCCAGACGUGAUG	20	21884
CFTR-Intron10-3003	−	AAAAAUUAGCCAGACGUGAUG	21	21885
CFTR-Intron10-3004	−	AAAAAAUUAGCCAGACGUGAUG	22	21886
CFTR-Intron10-3005	−	CAAAAAAUUAGCCAGACGUGAUG	23	21887
CFTR-Intron10-3006	−	ACAAAAAAUUAGCCAGACGUGAUG	24	21888
CFTR-Intron10-3007	−	UGGGUGAGAUUAGAGGCCACUG	22	21889
CFTR-Intron10-3008	−	CUGGGUGAGAUUAGAGGCCACUG	23	21890
CFTR-Intron10-3009	−	UCUGGGUGAGAUUAGAGGCCACUG	24	21891
CFTR-Intron10-3010	−	CUUCAGCCUCCCAAAGUG	18	21892
CFTR-Intron10-3011	−	CGCUUCAGCCUCCCAAAGUG	20	21893
CFTR-Intron10-3012	−	CCGCUUCAGCCUCCCAAAGUG	21	21894
CFTR-Intron10-3013	−	UCCGCUUCAGCCUCCCAAAGUG	22	21895
CFTR-Intron10-3014	−	UUCCGCUUCAGCCUCCCAAAGUG	23	21896
CFTR-Intron10-3015	−	UUUCCGCUUCAGCCUCCCAAAGUG	24	21897
CFTR-Intron10-3016	−	AAAGACUUGCAGGAGGUG	18	21898
CFTR-Intron10-3017	−	CAAAGACUUGCAGGAGGUG	19	21899
CFTR-Intron10-1317	−	ACAAAGACUUGCAGGAGGUG	20	20202
CFTR-Intron10-3018	−	AACAAAGACUUGCAGGAGGUG	21	21900
CFTR-Intron10-3019	−	UGAACAAAGACUUGCAGGAGGUG	23	21901
CFTR-Intron10-3020	−	UUGAACAAAGACUUGCAGGAGGUG	24	21902
CFTR-Intron10-3021	−	AGGUUUGUUAAAGAAUGACUGUG	23	21903
CFTR-Intron10-3022	−	AAGGUUUGUUAAAGAAUGACUGUG	24	21904
CFTR-Intron10-3023	−	CCCAAGGUGAUGGUAUUG	18	21905
CFTR-Intron10-3024	−	UCCCAAGGUGAUGGUAUUG	19	21906
CFTR-Intron10-3025	−	UUCCCAAGGUGAUGGUAUUG	20	21907
CFTR-Intron10-3026	−	AUUCCCAAGGUGAUGGUAUUG	21	21908
CFTR-Intron10-3027	−	AAUUCCCAAGGUGAUGGUAUUG	22	21909
CFTR-Intron10-3028	−	UAAUUCCCAAGGUGAUGGUAUUG	23	21910
CFTR-Intron10-3029	−	CUAAUUCCCAAGGUGAUGGUAUUG	24	21911
CFTR-Intron10-3030	−	UUAGUAGUUAAGUUUUUG	18	21912
CFTR-Intron10-3031	−	AUUAGUAGUUAAGUUUUUG	19	21913
CFTR-Intron10-1325	−	UAUUAGUAGUUAAGUUUUUG	20	20210
CFTR-Intron10-3032	−	CUAUUAGUAGUUAAGUUUUUG	21	21914
CFTR-Intron10-3033	−	AGGCUAUUAGUAGUUAAGUUUUUG	24	21915
CFTR-Intron10-3034	−	UCAGAUUUUUUCCCAUGUAAU	21	21916
CFTR-Intron10-3035	−	UUCAGAUUUUUUCCCAUGUAAU	22	21917
CFTR-Intron10-3036	−	AUUCAGAUUUUUUCCCAUGUAAU	23	21918
CFTR-Intron10-3037	−	AAUUCAGAUUUUUUCCCAUGUAAU	24	21919
CFTR-Intron10-3038	−	UGGGAGGUGAUUAGUCCAU	19	21920
CFTR-Intron10-3039	−	UUGGGAGGUGAUUAGUCCAU	20	21921
CFTR-Intron10-3040	−	UUUGGGAGGUGAUUAGUCCAU	21	21922
CFTR-Intron10-3041	−	CUUUGGGAGGUGAUUAGUCCAU	22	21923
CFTR-Intron10-3042	−	CCUUUGGGAGGUGAUUAGUCCAU	23	21924
CFTR-Intron10-3043	−	UGCAUAGUAUUCUAUCAU	18	21925
CFTR-Intron10-3044	−	AUGCAUAGUAUUCUAUCAU	19	21926
CFTR-Intron10-3045	−	AGAUGCAUAGUAUUCUAUCAU	21	21927
CFTR-Intron10-3046	−	UAGAUGCAUAGUAUUCUAUCAU	22	21928
CFTR-Intron10-3047	−	AUAGAUGCAUAGUAUUCUAUCAU	23	21929
CFTR-Intron10-3048	−	AAUAGAUGCAUAGUAUUCUAUCAU	24	21930
CFTR-Intron10-3049	−	UGAGAAAGAGCUUUCUAGUAU	21	21931
CFTR-Intron10-3050	−	AUGAGAAAGAGCUUUCUAGUAU	22	21932
CFTR-Intron10-3051	−	AGAUGAGAAAGAGCUUUCUAGUAU	24	21933
CFTR-Intron10-3052	−	UAAAAAGCUGUGCAUUUUCCU	21	21934
CFTR-Intron10-3053	−	UUAAAAAGCUGUGCAUUUUCCU	22	21935
CFTR-Intron10-3054	−	UUUAAAAAGCUGUGCAUUUUCCU	23	21936
CFTR-Intron10-3055	−	UUUUAAAAAGCUGUGCAUUUUCCU	24	21937
CFTR-Intron10-3056	−	CAAAUUAUUUCUACUGCU	18	21938
CFTR-Intron10-3057	−	UCAAAUUAUUUCUACUGCU	19	21939
CFTR-Intron10-521	−	UUCAAAUUAUUUCUACUGCU	20	19407
CFTR-Intron10-3058	−	UGUCUGUAGGCUAUAUGUAUCU	22	21940
CFTR-Intron10-3059	−	UUGUCUGUAGGCUAUAUGUAUCU	23	21941
CFTR-Intron10-3060	−	AUUGUCUGUAGGCUAUAUGUAUCU	24	21942
CFTR-Intron10-3061	−	CUCGGCCUCCCAAAGUGU	18	21943
CFTR-Intron10-3062	−	CCUCGGCCUCCCAAAGUGU	19	21944
CFTR-Intron10-3063	−	UGCCUCGGCCUCCCAAAGUGU	21	21945
CFTR-Intron10-3064	−	CUGCCUCGGCCUCCCAAAGUGU	22	21946
CFTR-Intron10-3065	−	CCUGCCUCGGCCUCCCAAAGUGU	23	21947
CFTR-Intron10-3066	−	AGGAAGGCAGUGGUCCCUU	19	21948
CFTR-Intron10-1399	−	AGGAAGCAAGGAGAUGAGUU	20	20283
CFTR-Intron10-3067	−	AGGGAGGAAGCAAGGAGAUGAGUU	24	21949
CFTR-Intron10-3068	−	AGAUAAUGGGAGAAACAGGUU	21	21950
CFTR-Intron10-3069	−	AAGAUAAUGGGAGAAACAGGUU	22	21951
CFTR-Intron10-3070	−	AAAGAUAAUGGGAGAAACAGGUU	23	21952
CFTR-Intron10-3071	−	AUAGUUUUAUCAAUAUUU	18	21953
CFTR-Intron10-3072	−	AAUAGUUUUAUCAAUAUUU	19	21954
CFTR-Intron10-1405	−	AAAUAGUUUUAUCAAUAUUU	20	20289
CFTR-Intron10-3073	−	UGCAUGGGUCCACUUAUUU	19	21955
CFTR-Intron10-3074	−	CUGCAUGGGUCCACUUAUUU	20	21956
CFTR-Intron10-3075	−	ACUGCAUGGGUCCACUUAUUU	21	21957
CFTR-Intron10-3076	−	AACUGCAUGGGUCCACUUAUUU	22	21958
CFTR-Intron10-3077	−	UGAACUGCAUGGGUCCACUUAUUU	24	21959
CFTR-Intron10-3078	−	UUGUUGUUUUUCUAGUUU	18	21960
CFTR-Intron10-3079	−	UUUGUUGUUUUUCUAGUUU	19	21961
CFTR-Intron10-3080	−	UUUUGUUGUUUUUCUAGUUU	20	21962
CFTR-Intron10-3081	−	UUUUUGUUGUUUUUCUAGUUU	21	21963
CFTR-Intron10-3082	−	UUUUUUGUUGUUUUUCUAGUUU	22	21964
CFTR-Intron10-3083	−	CUUUUUUGUUGUUUUUCUAGUUU	23	21965
CFTR-Intron10-3084	−	AAUACAUUGGAAAAUUUU	18	21966
CFTR-Intron10-3085	−	UAAUACAUUGGAAAAUUUU	19	21967
CFTR-Intron10-1411	−	UUAAUACAUUGGAAAAUUUU	20	20295
CFTR-Intron10-3086	−	AGUUAAUACAUUGGAAAAUUUU	22	21968
CFTR-Intron10-3087	−	CAGUUAAUACAUUGGAAAAUUUU	23	21969
CFTR-Intron10-3088	−	UCAGUUAAUACAUUGGAAAAUUUU	24	21970
CFTR-Intron10-3089	−	UAUGUCCUCCACAAAUAUUUU	21	21971
CFTR-Intron10-3090	−	AGUAUGUCCUCCACAAAUAUUUU	23	21972
CFTR-Intron10-3091	−	AAGUAUGUCCUCCACAAAUAUUUU	24	21973

Table 41E provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fifth tier parameters. The targeting domains bind within intron 10, and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 41E
5th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-3092	+	AAAAAAAAAAAAAAAAAA	18	21974
CFTR-Intron10-3093	+	AAAAAAAAAAAAAAAAAAA	19	21975
CFTR-Intron10-3094	+	AAAAAAAAAAAAAAAAAAAA	20	21976
CFTR-Intron10-3095	+	AAAAAAAAAAAAAAAAAAAAA	21	21977
CFTR-Intron10-3096	+	AAAAAAAAAAAAAAAAAAAAAA	22	21978
CFTR-Intron10-3097	+	AAAAAAAAAAAAAAAAAAAAAAA	23	21979
CFTR-Intron10-3098	+	CAAAAAAAAAAAAAAAAAAAAAAA	24	21980
CFTR-Intron10-3099	+	UAGAAAAACAACAAAAAA	18	21981
CFTR-Intron10-3100	+	CUAGAAAAACAACAAAAAA	19	21982
CFTR-Intron10-3101	+	ACUAGAAAAACAACAAAAAA	20	21983
CFTR-Intron10-3102	+	AACUAGAAAAACAACAAAAAA	21	21984
CFTR-Intron10-3103	+	AAACUAGAAAAACAACAAAAAA	22	21985
CFTR-Intron10-3104	+	AAAACUAGAAAAACAACAAAAAA	23	21986
CFTR-Intron10-3105	+	AAAAACUAGAAAAACAACAAAAAA	24	21987
CFTR-Intron10-3106	+	CAAACAAAGAAACAAAAA	18	21988
CFTR-Intron10-3107	+	ACAAACAAAGAAACAAAAA	19	21989
CFTR-Intron10-3108	+	UACAAACAAAGAAACAAAAA	20	21990
CFTR-Intron10-3109	+	AUACAAACAAAGAAACAAAAA	21	21991
CFTR-Intron10-3110	+	AAUACAAACAAAGAAACAAAAA	22	21992
CFTR-Intron10-3111	+	AAAUACAAACAAAGAAACAAAAA	23	21993
CFTR-Intron10-3112	+	UAAAUACAAACAAAGAAACAAAAA	24	21994
CFTR-Intron10-3113	+	CAUAUUGUUACAUAAAAA	18	21995
CFTR-Intron10-3114	+	GCAUAUUGUUACAUAAAAA	19	21996
CFTR-Intron10-3115	+	UGCAUAUUGUUACAUAAAAA	20	21997
CFTR-Intron10-3116	+	CUGCAUAUUGUUACAUAAAAA	21	21998
CFTR-Intron10-3117	+	UCUGCAUAUUGUUACAUAAAAA	22	21999
CFTR-Intron10-3118	+	CUCUGCAUAUUGUUACAUAAAAA	23	22000
CFTR-Intron10-3119	+	ACUCUGCAUAUUGUUACAUAAAAA	24	22001
CFTR-Intron10-3120	+	GUGCAUAAAGGUUGAAAA	18	22002
CFTR-Intron10-3121	+	AGUGCAUAAAGGUUGAAAA	19	22003
CFTR-Intron10-65	+	GAGUGCAUAAAGGUUGAAAA	20	18951
CFTR-Intron10-3122	+	AGAGUGCAUAAAGGUUGAAAA	21	22004
CFTR-Intron10-3123	+	AAGAGUGCAUAAAGGUUGAAAA	22	22005
CFTR-Intron10-3124	+	AAAGAGUGCAUAAAGGUUGAAAA	23	22006
CFTR-Intron10-3125	+	CAAAGAGUGCAUAAAGGUUGAAAA	24	22007
CFTR-Intron10-3126	+	UUUCCUCAAUAGUUAAAA	18	22008
CFTR-Intron10-3127	+	AUUUCCUCAAUAGUUAAAA	19	22009
CFTR-Intron10-3128	+	UAUUUCCUCAAUAGUUAAAA	20	22010
CFTR-Intron10-3129	+	UUAUUUCCUCAAUAGUUAAAA	21	22011
CFTR-Intron10-3130	+	UUUAUUUCCUCAAUAGUUAAAA	22	22012
CFTR-Intron10-3131	+	AUUUAUUUCCUCAAUAGUUAAAA	23	22013
CFTR-Intron10-3132	+	AAUUUAUUUCCUCAAUAGUUAAAA	24	22014
CFTR-Intron10-3133	+	UAGUAAAAAAAAAUCAAA	18	22015
CFTR-Intron10-3134	+	UUAGUAAAAAAAAAUCAAA	19	22016
CFTR-Intron10-1092	+	AUUAGUAAAAAAAAAUCAAA	20	19977
CFTR-Intron10-3135	+	AAUUAGUAAAAAAAAAUCAAA	21	22017
CFTR-Intron10-3136	+	AAAUUAGUAAAAAAAAAUCAAA	22	22018
CFTR-Intron10-3137	+	AAAAUUAGUAAAAAAAAAUCAAA	23	22019
CFTR-Intron10-3138	+	CAAAAUUAGUAAAAAAAAAUCAAA	24	22020
CFTR-Intron10-3139	+	GCUAAAAUGACAAUCAAA	18	22021
CFTR-Intron10-3140	+	AGCUAAAAUGACAAUCAAA	19	22022
CFTR-Intron10-335	+	CAGCUAAAAUGACAAUCAAA	20	19221
CFTR-Intron10-3141	+	ACAGCUAAAAUGACAAUCAAA	21	22023
CFTR-Intron10-3142	+	CACAGCUAAAAUGACAAUCAAA	22	22024
CFTR-Intron10-3143	+	CCACAGCUAAAAUGACAAUCAAA	23	22025
CFTR-Intron10-3144	+	ACCACAGCUAAAAUGACAAUCAAA	24	22026
CFTR-Intron10-3145	+	AGGAUAUCUUAGGUCAAA	18	22027
CFTR-Intron10-3146	+	UAGGAUAUCUUAGGUCAAA	19	22028
CFTR-Intron10-3147	+	UUAGGAUAUCUUAGGUCAAA	20	22029
CFTR-Intron10-3148	+	CUUAGGAUAUCUUAGGUCAAA	21	22030
CFTR-Intron10-3149	+	CCUUAGGAUAUCUUAGGUCAAA	22	22031
CFTR-Intron10-3150	+	CCCUUAGGAUAUCUUAGGUCAAA	23	22032
CFTR-Intron10-3151	+	UCCCUUAGGAUAUCUUAGGUCAAA	24	22033
CFTR-Intron10-3152	+	AAUGCAGGAGAAUGGAAA	18	22034
CFTR-Intron10-3153	+	GAAUGCAGGAGAAUGGAAA	19	22035
CFTR-Intron10-3154	+	GGAAUGCAGGAGAAUGGAAA	20	22036
CFTR-Intron10-3155	+	GGGAAUGCAGGAGAAUGGAAA	21	22037
CFTR-Intron10-3156	+	AGGGAAUGCAGGAGAAUGGAAA	22	22038
CFTR-Intron10-3157	+	GAGGGAAUGCAGGAGAAUGGAAA	23	22039
CFTR-Intron10-3158	+	UGAGGGAAUGCAGGAGAAUGGAAA	24	22040
CFTR-Intron10-3159	+	CAAAUACAUUCAAUGAAA	18	22041
CFTR-Intron10-3160	+	CCAAAUACAUUCAAUGAAA	19	22042
CFTR-Intron10-3161	+	CCCAAAUACAUUCAAUGAAA	20	22043
CFTR-Intron10-3162	+	GCCCAAAUACAUUCAAUGAAA	21	22044
CFTR-Intron10-3163	+	GGCCCAAAUACAUUCAAUGAAA	22	22045
CFTR-Intron10-3164	+	AGGCCCAAAUACAUUCAAUGAAA	23	22046
CFTR-Intron10-3165	+	CAGGCCCAAAUACAUUCAAUGAAA	24	22047
CFTR-Intron10-3166	+	AGUGCAUAAAGGUUGAAA	18	22048
CFTR-Intron10-3167	+	GAGUGCAUAAAGGUUGAAA	19	22049
CFTR-Intron10-3168	+	AGAGUGCAUAAAGGUUGAAA	20	22050
CFTR-Intron10-3169	+	AAGAGUGCAUAAAGGUUGAAA	21	22051
CFTR-Intron10-3170	+	AAAGAGUGCAUAAAGGUUGAAA	22	22052
CFTR-Intron10-3171	+	CAAAGAGUGCAUAAAGGUUGAAA	23	22053
CFTR-Intron10-3172	+	GCAAAGAGUGCAUAAAGGUUGAAA	24	22054
CFTR-Intron10-3173	+	UGCAUAUUGUUACAUAAA	18	22055
CFTR-Intron10-3174	+	CUGCAUAUUGUUACAUAAA	19	22056
CFTR-Intron10-3175	+	UCUGCAUAUUGUUACAUAAA	20	22057
CFTR-Intron10-3176	+	CUCUGCAUAUUGUUACAUAAA	21	22058
CFTR-Intron10-3177	+	ACUCUGCAUAUUGUUACAUAAA	22	22059
CFTR-Intron10-3178	+	AACUCUGCAUAUUGUUACAUAAA	23	22060
CFTR-Intron10-3179	+	AAACUCUGCAUAUUGUUACAUAAA	24	22061
CFTR-Intron10-3180	+	UCGUAUGUAGGAAAACAA	18	22062
CFTR-Intron10-3181	+	UUCGUAUGUAGGAAAACAA	19	22063
CFTR-Intron10-3182	+	UUUCGUAUGUAGGAAAACAA	20	22064
CFTR-Intron10-3183	+	GUUUCGUAUGUAGGAAAACAA	21	22065
CFTR-Intron10-3184	+	UGUUUCGUAUGUAGGAAAACAA	22	22066
CFTR-Intron10-3185	+	CUGUUUCGUAUGUAGGAAAACAA	23	22067
CFTR-Intron10-3186	+	GCUGUUUCGUAUGUAGGAAAACAA	24	22068
CFTR-Intron10-3187	+	AACCAAAUAAACAAACAA	18	22069
CFTR-Intron10-3188	+	AAACCAAAUAAACAAACAA	19	22070
CFTR-Intron10-1099	+	AAAACCAAAUAAACAAACAA	20	19984
CFTR-Intron10-3189	+	AAAAACCAAAUAAACAAACAA	21	22071
CFTR-Intron10-3190	+	UAAAAACCAAAUAAACAAACAA	22	22072
CFTR-Intron10-3191	+	GUAAAAACCAAAUAAACAAACAA	23	22073
CFTR-Intron10-3192	+	AGUAAAAACCAAAUAAACAAACAA	24	22074
CFTR-Intron10-3193	+	UGUGUGGCUUAUAAACAA	18	22075
CFTR-Intron10-3194	+	CUGUGUGGCUUAUAAACAA	19	22076
CFTR-Intron10-3195	+	ACUGUGUGGCUUAUAAACAA	20	22077
CFTR-Intron10-3196	+	AACUGUGUGGCUUAUAAACAA	21	22078
CFTR-Intron10-3197	+	GAACUGUGUGGCUUAUAAACAA	22	22079
CFTR-Intron10-3198	+	UGAACUGUGUGGCUUAUAAACAA	23	22080
CFTR-Intron10-3199	+	AUGAACUGUGUGGCUUAUAAACAA	24	22081
CFTR-Intron10-3200	+	CAGCUGUGAUGCAGACAA	18	22082
CFTR-Intron10-3201	+	UCAGCUGUGAUGCAGACAA	19	22083
CFTR-Intron10-3202	+	UUCAGCUGUGAUGCAGACAA	20	22084
CFTR-Intron10-3203	+	CUUCAGCUGUGAUGCAGACAA	21	22085
CFTR-Intron10-3204	+	GCUUCAGCUGUGAUGCAGACAA	22	22086
CFTR-Intron10-3205	+	UGCUUCAGCUGUGAUGCAGACAA	23	22087
CFTR-Intron10-3206	+	CUGCUUCAGCUGUGAUGCAGACAA	24	22088
CFTR-Intron10-3207	+	UAAUGAGUUACAAUACAA	18	22089
CFTR-Intron10-3208	+	UUAAUGAGUUACAAUACAA	19	22090
CFTR-Intron10-3209	+	AUUAAUGAGUUACAAUACAA	20	22091
CFTR-Intron10-3210	+	AAUUAAUGAGUUACAAUACAA	21	22092
CFTR-Intron10-3211	+	AAAUUAAUGAGUUACAAUACAA	22	22093
CFTR-Intron10-3212	+	UAAAUUAAUGAGUUACAAUACAA	23	22094
CFTR-Intron10-3213	+	AUAAAUUAAUGAGUUACAAUACAA	24	22095
CFTR-Intron10-3214	+	AGCUUACCGUAAUAGCAA	18	22096
CFTR-Intron10-3215	+	GAGCUUACCGUAAUAGCAA	19	22097
CFTR-Intron10-3216	+	UGAGCUUACCGUAAUAGCAA	20	22098
CFTR-Intron10-3217	+	UUGAGCUUACCGUAAUAGCAA	21	22099
CFTR-Intron10-3218	+	CUUGAGCUUACCGUAAUAGCAA	22	22100
CFTR-Intron10-3219	+	GCUUGAGCUUACCGUAAUAGCAA	23	22101
CFTR-Intron10-3220	+	UGCUUGAGCUUACCGUAAUAGCAA	24	22102
CFTR-Intron10-3221	+	GGUCAAUUGUAUUAGCAA	18	22103
CFTR-Intron10-3222	+	GGGUCAAUUGUAUUAGCAA	19	22104
CFTR-Intron10-3223	+	AGGGUCAAUUGUAUUAGCAA	20	22105
CFTR-Intron10-3224	+	AAGGGUCAAUUGUAUUAGCAA	21	22106
CFTR-Intron10-3225	+	UAAGGGUCAAUUGUAUUAGCAA	22	22107
CFTR-Intron10-3226	+	UUAAGGGUCAAUUGUAUUAGCAA	23	22108
CFTR-Intron10-3227	+	UUUAAGGGUCAAUUGUAUUAGCAA	24	22109
CFTR-Intron10-3228	+	UUAGUAAAAAAAAAUCAA	18	22110
CFTR-Intron10-3229	+	AUUAGUAAAAAAAAAUCAA	19	22111
CFTR-Intron10-3230	+	AAUUAGUAAAAAAAAAUCAA	20	22112
CFTR-Intron10-3231	+	AAAUUAGUAAAAAAAAAUCAA	21	22113
CFTR-Intron10-3232	+	AAAAUUAGUAAAAAAAAAUCAA	22	22114
CFTR-Intron10-3233	+	CAAAAUUAGUAAAAAAAAAUCAA	23	22115
CFTR-Intron10-3234	+	ACAAAAUUAGUAAAAAAAAAUCAA	24	22116
CFTR-Intron10-3235	+	AGCUAAAAUGACAAUCAA	18	22117
CFTR-Intron10-3236	+	CAGCUAAAAUGACAAUCAA	19	22118
CFTR-Intron10-3237	+	ACAGCUAAAAUGACAAUCAA	20	22119
CFTR-Intron10-3238	+	CACAGCUAAAAUGACAAUCAA	21	22120
CFTR-Intron10-3239	+	CCACAGCUAAAAUGACAAUCAA	22	22121
CFTR-Intron10-3240	+	ACCACAGCUAAAAUGACAAUCAA	23	22122
CFTR-Intron10-3241	+	UACCACAGCUAAAAUGACAAUCAA	24	22123
CFTR-Intron10-3242	+	CUGAAGCGGAAAGGUCAA	18	22124
CFTR-Intron10-3243	+	GCUGAAGCGGAAAGGUCAA	19	22125
CFTR-Intron10-3244	+	GGCUGAAGCGGAAAGGUCAA	20	22126
CFTR-Intron10-3245	+	AGGCUGAAGCGGAAAGGUCAA	21	22127
CFTR-Intron10-3246	+	GAGGCUGAAGCGGAAAGGUCAA	22	22128
CFTR-Intron10-3247	+	GGAGGCUGAAGCGGAAAGGUCAA	23	22129
CFTR-Intron10-3248	+	GGGAGGCUGAAGCGGAAAGGUCAA	24	22130
CFTR-Intron10-3249	+	CACCUGAAAUAUAUUCAA	18	22131
CFTR-Intron10-3250	+	UCACCUGAAAUAUAUUCAA	19	22132
CFTR-Intron10-3251	+	AUCACCUGAAAUAUAUUCAA	20	22133
CFTR-Intron10-3252	+	UAUCACCUGAAAUAUAUUCAA	21	22134
CFTR-Intron10-3253	+	AUAUCACCUGAAAUAUAUUCAA	22	22135
CFTR-Intron10-3254	+	AAUAUCACCUGAAAUAUAUUCAA	23	22136
CFTR-Intron10-3255	+	UAAUAUCACCUGAAAUAUAUUCAA	24	22137
CFTR-Intron10-3256	+	AAAAAAAAAAAAAAAGAA	18	22138
CFTR-Intron10-3257	+	AAAAAAAAAAAAAAAAGAA	19	22139
CFTR-Intron10-3258	+	AAAAAAAAAAAAAAAAAGAA	20	22140
CFTR-Intron10-3259	+	AAAAAAAAAAAAAAAAAAGAA	21	22141
CFTR-Intron10-3260	+	AAAAAAAAAAAAAAAAAAAGAA	22	22142
CFTR-Intron10-3261	+	AAAAAAAAAAAAAAAAAAAAGAA	23	22143
CFTR-Intron10-3262	+	AAAAAAAAAAAAAAAAAAAAAGAA	24	22144
CFTR-Intron10-3263	+	GAAAUAUAUUCAAAAGAA	18	22145
CFTR-Intron10-3264	+	UGAAAUAUAUUCAAAAGAA	19	22146
CFTR-Intron10-1103	+	CUGAAAUAUAUUCAAAAGAA	20	19988
CFTR-Intron10-3265	+	CCUGAAAUAUAUUCAAAAGAA	21	22147
CFTR-Intron10-3266	+	ACCUGAAAUAUAUUCAAAAGAA	22	22148
CFTR-Intron10-3267	+	CACCUGAAAUAUAUUCAAAAGAA	23	22149
CFTR-Intron10-3268	+	UCACCUGAAAUAUAUUCAAAAGAA	24	22150
CFTR-Intron10-3269	+	AAAAAUACGAUAUAAGAA	18	22151
CFTR-Intron10-3270	+	CAAAAAUACGAUAUAAGAA	19	22152
CFTR-Intron10-3271	+	GCAAAAAUACGAUAUAAGAA	20	22153
CFTR-Intron10-3272	+	UGCAAAAAUACGAUAUAAGAA	21	22154
CFTR-Intron10-3273	+	UUGCAAAAAUACGAUAUAAGAA	22	22155
CFTR-Intron10-3274	+	GUUGCAAAAAUACGAUAUAAGAA	23	22156
CFTR-Intron10-3275	+	AGUUGCAAAAAUACGAUAUAAGAA	24	22157
CFTR-Intron10-3276	+	UGAGGGAAUGCAGGAGAA	18	22158
CFTR-Intron10-3277	+	AUGAGGGAAUGCAGGAGAA	19	22159
CFTR-Intron10-649	+	GAUGAGGGAAUGCAGGAGAA	20	19535
CFTR-Intron10-3278	+	GGAUGAGGGAAUGCAGGAGAA	21	22160
CFTR-Intron10-3279	+	UGGAUGAGGGAAUGCAGGAGAA	22	22161
CFTR-Intron10-3280	+	UUGGAUGAGGGAAUGCAGGAGAA	23	22162
CFTR-Intron10-3281	+	GUUGGAUGAGGGAAUGCAGGAGAA	24	22163
CFTR-Intron10-3282	+	AAUAAACAAACAAAGGAA	18	22164
CFTR-Intron10-3283	+	AAAUAAACAAACAAAGGAA	19	22165
CFTR-Intron10-3284	+	CAAAUAAACAAACAAAGGAA	20	22166
CFTR-Intron10-3285	+	CCAAAUAAACAAACAAAGGAA	21	22167
CFTR-Intron10-3286	+	ACCAAAUAAACAAACAAAGGAA	22	22168
CFTR-Intron10-3287	+	AACCAAAUAAACAAACAAAGGAA	23	22169
CFTR-Intron10-3288	+	AAACCAAAUAAACAAACAAAGGAA	24	22170
CFTR-Intron10-3289	+	AAAACUGAGUAGAAGGAA	18	22171
CFTR-Intron10-3290	+	UAAAACUGAGUAGAAGGAA	19	22172
CFTR-Intron10-349	+	CUAAAACUGAGUAGAAGGAA	20	19235
CFTR-Intron10-3291	+	ACUAAAACUGAGUAGAAGGAA	21	22173
CFTR-Intron10-3292	+	GACUAAAACUGAGUAGAAGGAA	22	22174
CFTR-Intron10-3293	+	UGACUAAAACUGAGUAGAAGGAA	23	22175
CFTR-Intron10-3294	+	CUGACUAAAACUGAGUAGAAGGAA	24	22176
CFTR-Intron10-3295	+	UAAACAGAAUCAGGGGAA	18	22177
CFTR-Intron10-3296	+	UUAAACAGAAUCAGGGGAA	19	22178
CFTR-Intron10-3297	+	UUUAAACAGAAUCAGGGGAA	20	22179
CFTR-Intron10-3298	+	AUUUAAACAGAAUCAGGGGAA	21	22180
CFTR-Intron10-3299	+	UAUUUAAACAGAAUCAGGGGAA	22	22181
CFTR-Intron10-3300	+	CUAUUUAAACAGAAUCAGGGGAA	23	22182
CFTR-Intron10-3301	+	GCUAUUUAAACAGAAUCAGGGGAA	24	22183
CFTR-Intron10-3302	+	GCACUUUGGGAGGCUGAA	18	22184
CFTR-Intron10-3303	+	AGCACUUUGGGAGGCUGAA	19	22185
CFTR-Intron10-3304	+	CAGCACUUUGGGAGGCUGAA	20	22186
CFTR-Intron10-3305	+	CCAGCACUUUGGGAGGCUGAA	21	22187
CFTR-Intron10-3306	+	CCCAGCACUUUGGGAGGCUGAA	22	22188
CFTR-Intron10-3307	+	ACCCAGCACUUUGGGAGGCUGAA	23	22189
CFTR-Intron10-3308	+	AACCCAGCACUUUGGGAGGCUGAA	24	22190
CFTR-Intron10-3309	+	GUACAUUUAAUAUCUGAA	18	22191
CFTR-Intron10-3310	+	UGUACAUUUAAUAUCUGAA	19	22192
CFTR-Intron10-3311	+	AUGUACAUUUAAUAUCUGAA	20	22193
CFTR-Intron10-3312	+	GAUGUACAUUUAAUAUCUGAA	21	22194
CFTR-Intron10-3313	+	UGAUGUACAUUUAAUAUCUGAA	22	22195
CFTR-Intron10-3314	+	AUGAUGUACAUUUAAUAUCUGAA	23	22196
CFTR-Intron10-3315	+	AAUGAUGUACAUUUAAUAUCUGAA	24	22197
CFTR-Intron10-3316	+	AAAAAAAUUCACAAAUAA	18	22198
CFTR-Intron10-3317	+	AAAAAAAAUUCACAAAUAA	19	22199
CFTR-Intron10-3318	+	GAAAAAAAAUUCACAAAUAA	20	22200
CFTR-Intron10-3319	+	UGAAAAAAAAUUCACAAAUAA	21	22201
CFTR-Intron10-3320	+	CUGAAAAAAAAUUCACAAAUAA	22	22202
CFTR-Intron10-3321	+	ACUGAAAAAAAAUUCACAAAUAA	23	22203
CFTR-Intron10-3322	+	AACUGAAAAAAAAUUCACAAAUAA	24	22204
CFTR-Intron10-3323	+	UGAGGCAAUGAUCAAUAA	18	22205
CFTR-Intron10-3324	+	GUGAGGCAAUGAUCAAUAA	19	22206
CFTR-Intron10-3325	+	AGUGAGGCAAUGAUCAAUAA	20	22207
CFTR-Intron10-3326	+	UAGUGAGGCAAUGAUCAAUAA	21	22208
CFTR-Intron10-3327	+	AUAGUGAGGCAAUGAUCAAUAA	22	22209
CFTR-Intron10-3328	+	CAUAGUGAGGCAAUGAUCAAUAA	23	22210
CFTR-Intron10-3329	+	CCAUAGUGAGGCAAUGAUCAAUAA	24	22211
CFTR-Intron10-3330	+	AGAACCUAUAAGGAAUAA	18	22212
CFTR-Intron10-3331	+	CAGAACCUAUAAGGAAUAA	19	22213
CFTR-Intron10-3332	+	ACAGAACCUAUAAGGAAUAA	20	22214
CFTR-Intron10-3333	+	UACAGAACCUAUAAGGAAUAA	21	22215
CFTR-Intron10-3334	+	UUACAGAACCUAUAAGGAAUAA	22	22216
CFTR-Intron10-3335	+	AUUACAGAACCUAUAAGGAAUAA	23	22217
CFTR-Intron10-3336	+	AAUUACAGAACCUAUAAGGAAUAA	24	22218
CFTR-Intron10-3337	+	ACAGUGACUUCAUAAUAA	18	22219
CFTR-Intron10-3338	+	UACAGUGACUUCAUAAUAA	19	22220
CFTR-Intron10-1111	+	AUACAGUGACUUCAUAAUAA	20	19996
CFTR-Intron10-3339	+	AAUACAGUGACUUCAUAAUAA	21	22221
CFTR-Intron10-3340	+	CAAUACAGUGACUUCAUAAUAA	22	22222
CFTR-Intron10-3341	+	ACAAUACAGUGACUUCAUAAUAA	23	22223
CFTR-Intron10-3342	+	GACAAUACAGUGACUUCAUAAUAA	24	22224
CFTR-Intron10-3343	+	UUACACUACUUAUAAUAA	18	22225
CFTR-Intron10-3344	+	UUUACACUACUUAUAAUAA	19	22226
CFTR-Intron10-3345	+	UUUUACACUACUUAUAAUAA	20	22227
CFTR-Intron10-3346	+	AUUUUACACUACUUAUAAUAA	21	22228
CFTR-Intron10-3347	+	UAUUUUACACUACUUAUAAUAA	22	22229
CFTR-Intron10-3348	+	AUAUUUUACACUACUUAUAAUAA	23	22230
CFTR-Intron10-3349	+	GAUAUUUUACACUACUUAUAAUAA	24	22231
CFTR-Intron10-3350	+	CAAGUAGAAAAAAGAUAA	18	22232
CFTR-Intron10-3351	+	GCAAGUAGAAAAAAGAUAA	19	22233
CFTR-Intron10-3352	+	AGCAAGUAGAAAAAAGAUAA	20	22234
CFTR-Intron10-3353	+	AAGCAAGUAGAAAAAAGAUAA	21	22235
CFTR-Intron10-3354	+	AAAGCAAGUAGAAAAAAGAUAA	22	22236
CFTR-Intron10-3355	+	CAAAGCAAGUAGAAAAAAGAUAA	23	22237
CFTR-Intron10-3356	+	GCAAAGCAAGUAGAAAAAAGAUAA	24	22238
CFTR-Intron10-3357	+	AUAAUAUACAAGAUAUAA	18	22239
CFTR-Intron10-3358	+	AAUAAUAUACAAGAUAUAA	19	22240
CFTR-Intron10-3359	+	UAAUAAUAUACAAGAUAUAA	20	22241
CFTR-Intron10-3360	+	GUAAUAAUAUACAAGAUAUAA	21	22242
CFTR-Intron10-3361	+	AGUAAUAAUAUACAAGAUAUAA	22	22243
CFTR-Intron10-3362	+	UAGUAAUAAUAUACAAGAUAUAA	23	22244
CFTR-Intron10-3363	+	CUAGUAAUAAUAUACAAGAUAUAA	24	22245
CFTR-Intron10-3364	+	UAACUUUAUGCUAACUAA	18	22246
CFTR-Intron10-3365	+	CUAACUUUAUGCUAACUAA	19	22247
CFTR-Intron10-3366	+	CCUAACUUUAUGCUAACUAA	20	22248
CFTR-Intron10-3367	+	ACCUAACUUUAUGCUAACUAA	21	22249
CFTR-Intron10-3368	+	AACCUAACUUUAUGCUAACUAA	22	22250
CFTR-Intron10-3369	+	AAACCUAACUUUAUGCUAACUAA	23	22251
CFTR-Intron10-3370	+	CAAACCUAACUUUAUGCUAACUAA	24	22252
CFTR-Intron10-3371	+	AGUAAAGUAACAAAGUAA	18	22253
CFTR-Intron10-3372	+	CAGUAAAGUAACAAAGUAA	19	22254
CFTR-Intron10-3373	+	UCAGUAAAGUAACAAAGUAA	20	22255
CFTR-Intron10-3374	+	AUCAGUAAAGUAACAAAGUAA	21	22256
CFTR-Intron10-3375	+	UAUCAGUAAAGUAACAAAGUAA	22	22257
CFTR-Intron10-3376	+	UUAUCAGUAAAGUAACAAAGUAA	23	22258
CFTR-Intron10-3377	+	UUUAUCAGUAAAGUAACAAAGUAA	24	22259
CFTR-Intron10-3378	+	AGCUAAUAAAUAAAGUAA	18	22260
CFTR-Intron10-3379	+	AAGCUAAUAAAUAAAGUAA	19	22261
CFTR-Intron10-3380	+	AAAGCUAAUAAAUAAAGUAA	20	22262
CFTR-Intron10-3381	+	UAAAGCUAAUAAAUAAAGUAA	21	22263
CFTR-Intron10-3382	+	UUAAAGCUAAUAAAUAAAGUAA	22	22264
CFTR-Intron10-3383	+	UUUAAAGCUAAUAAAUAAAGUAA	23	22265
CFTR-Intron10-3384	+	AUUUAAAGCUAAUAAAUAAAGUAA	24	22266
CFTR-Intron10-3385	+	UUCUAGAAAACAAUGUAA	18	22267
CFTR-Intron10-3386	+	UUUCUAGAAAACAAUGUAA	19	22268
CFTR-Intron10-1114	+	UUUUCUAGAAAACAAUGUAA	20	19999
CFTR-Intron10-3387	+	AUUUUCUAGAAAACAAUGUAA	21	22269
CFTR-Intron10-3388	+	GAUUUUCUAGAAAACAAUGUAA	22	22270
CFTR-Intron10-3389	+	AGAUUUUCUAGAAAACAAUGUAA	23	22271
CFTR-Intron10-3390	+	CAGAUUUUCUAGAAAACAAUGUAA	24	22272
CFTR-Intron10-3391	+	UAUAAGUGUGGAGUGUAA	18	22273
CFTR-Intron10-3392	+	GUAUAAGUGUGGAGUGUAA	19	22274
CFTR-Intron10-72	+	GGUAUAAGUGUGGAGUGUAA	20	18958
CFTR-Intron10-3393	+	GGGUAUAAGUGUGGAGUGUAA	21	22275
CFTR-Intron10-3394	+	GGGGUAUAAGUGUGGAGUGUAA	22	22276
CFTR-Intron10-3395	+	UGGGGUAUAAGUGUGGAGUGUAA	23	22277
CFTR-Intron10-3396	+	AUGGGGUAUAAGUGUGGAGUGUAA	24	22278
CFTR-Intron10-3397	+	UGAACUCUAAUCUAUUAA	18	22279
CFTR-Intron10-3398	+	UUGAACUCUAAUCUAUUAA	19	22280
CFTR-Intron10-3399	+	AUUGAACUCUAAUCUAUUAA	20	22281
CFTR-Intron10-3400	+	AAUUGAACUCUAAUCUAUUAA	21	22282
CFTR-Intron10-3401	+	GAAUUGAACUCUAAUCUAUUAA	22	22283
CFTR-Intron10-3402	+	UGAAUUGAACUCUAAUCUAUUAA	23	22284
CFTR-Intron10-3403	+	CUGAAUUGAACUCUAAUCUAUUAA	24	22285
CFTR-Intron10-3404	+	GCUUAACCCAUCUAUUAA	18	22286
CFTR-Intron10-3405	+	GGCUUAACCCAUCUAUUAA	19	22287
CFTR-Intron10-3406	+	UGGCUUAACCCAUCUAUUAA	20	22288
CFTR-Intron10-3407	+	UUGGCUUAACCCAUCUAUUAA	21	22289
CFTR-Intron10-3408	+	GUUGGCUUAACCCAUCUAUUAA	22	22290
CFTR-Intron10-3409	+	AGUUGGCUUAACCCAUCUAUUAA	23	22291
CFTR-Intron10-3410	+	CAGUUGGCUUAACCCAUCUAUUAA	24	22292
CFTR-Intron10-3411	+	AAUUUUCCAAUGUAUUAA	18	22293
CFTR-Intron10-3412	+	AAAUUUUCCAAUGUAUUAA	19	22294
CFTR-Intron10-3413	+	AAAAUUUUCCAAUGUAUUAA	20	22295
CFTR-Intron10-3414	+	AAAAAUUUUCCAAUGUAUUAA	21	22296
CFTR-Intron10-3415	+	CAAAAAUUUUCCAAUGUAUUAA	22	22297
CFTR-Intron10-3416	+	CCAAAAAUUUUCCAAUGUAUUAA	23	22298
CFTR-Intron10-3417	+	CCCAAAAAUUUUCCAAUGUAUUAA	24	22299
CFTR-Intron10-3418	+	AGCCUAGAUGAUUAUUAA	18	22300
CFTR-Intron10-3419	+	CAGCCUAGAUGAUUAUUAA	19	22301
CFTR-Intron10-3420	+	GCAGCCUAGAUGAUUAUUAA	20	22302
CFTR-Intron10-3421	+	UGCAGCCUAGAUGAUUAUUAA	21	22303
CFTR-Intron10-3422	+	UUGCAGCCUAGAUGAUUAUUAA	22	22304
CFTR-Intron10-3423	+	UUUGCAGCCUAGAUGAUUAUUAA	23	22305
CFTR-Intron10-3424	+	UUUUGCAGCCUAGAUGAUUAUUAA	24	22306
CFTR-Intron10-3425	+	UAUUUCCUCAAUAGUUAA	18	22307
CFTR-Intron10-3426	+	UUAUUUCCUCAAUAGUUAA	19	22308
CFTR-Intron10-3427	+	UUUAUUUCCUCAAUAGUUAA	20	22309
CFTR-Intron10-3428	+	AUUUAUUUCCUCAAUAGUUAA	21	22310
CFTR-Intron10-3429	+	AAUUUAUUUCCUCAAUAGUUAA	22	22311
CFTR-Intron10-3430	+	AAAUUUAUUUCCUCAAUAGUUAA	23	22312
CFTR-Intron10-3431	+	UAAAUUUAUUUCCUCAAUAGUUAA	24	22313
CFTR-Intron10-3432	+	CAACAUUCUUGGAAAACA	18	22314
CFTR-Intron10-3433	+	ACAACAUUCUUGGAAAACA	19	22315
CFTR-Intron10-3434	+	AACAACAUUCUUGGAAAACA	20	22316
CFTR-Intron10-3435	+	GAACAACAUUCUUGGAAAACA	21	22317
CFTR-Intron10-3436	+	UGAACAACAUUCUUGGAAAACA	22	22318
CFTR-Intron10-3437	+	UUGAACAACAUUCUUGGAAAACA	23	22319
CFTR-Intron10-3438	+	UUUGAACAACAUUCUUGGAAAACA	24	22320
CFTR-Intron10-3439	+	AAUGAAACAAAUAAAACA	18	22321
CFTR-Intron10-3440	+	AAAUGAAACAAAUAAAACA	19	22322
CFTR-Intron10-3441	+	GAAAUGAAACAAAUAAAACA	20	22323
CFTR-Intron10-3442	+	AGAAAUGAAACAAAUAAAACA	21	22324
CFTR-Intron10-3443	+	AAGAAAUGAAACAAAUAAAACA	22	22325
CFTR-Intron10-3444	+	AAAGAAAUGAAACAAAUAAAACA	23	22326
CFTR-Intron10-3445	+	AAAAGAAAUGAAACAAAUAAAACA	24	22327
CFTR-Intron10-3446	+	AAACCAAAUAAACAAACA	18	22328
CFTR-Intron10-3447	+	AAAACCAAAUAAACAAACA	19	22329
CFTR-Intron10-3448	+	AAAAACCAAAUAAACAAACA	20	22330
CFTR-Intron10-3449	+	UAAAAACCAAAUAAACAAACA	21	22331
CFTR-Intron10-3450	+	GUAAAAACCAAAUAAACAAACA	22	22332
CFTR-Intron10-3451	+	AGUAAAAACCAAAUAAACAAACA	23	22333
CFTR-Intron10-3452	+	AAGUAAAAACCAAAUAAACAAACA	24	22334
CFTR-Intron10-3453	+	AAACUGUAAAUACAAACA	18	22335
CFTR-Intron10-3454	+	AAAACUGUAAAUACAAACA	19	22336
CFTR-Intron10-3455	+	UAAAACUGUAAAUACAAACA	20	22337
CFTR-Intron10-3456	+	UUAAAACUGUAAAUACAAACA	21	22338
CFTR-Intron10-3457	+	CUUAAAACUGUAAAUACAAACA	22	22339
CFTR-Intron10-3458	+	ACUUAAAACUGUAAAUACAAACA	23	22340
CFTR-Intron10-3459	+	AACUUAAAACUGUAAAUACAAACA	24	22341
CFTR-Intron10-3460	+	GACAAUCAAAUGGGAACA	18	22342
CFTR-Intron10-3461	+	UGACAAUCAAAUGGGAACA	19	22343
CFTR-Intron10-363	+	AUGACAAUCAAAUGGGAACA	20	19249
CFTR-Intron10-3462	+	AAUGACAAUCAAAUGGGAACA	21	22344
CFTR-Intron10-3463	+	AAAUGACAAUCAAAUGGGAACA	22	22345
CFTR-Intron10-3464	+	AAAAUGACAAUCAAAUGGGAACA	23	22346
CFTR-Intron10-3465	+	UAAAAUGACAAUCAAAUGGGAACA	24	22347
CFTR-Intron10-3466	+	AACCUAUAAGGAAUAACA	18	22348
CFTR-Intron10-3467	+	GAACCUAUAAGGAAUAACA	19	22349
CFTR-Intron10-364	+	AGAACCUAUAAGGAAUAACA	20	19250
CFTR-Intron10-3468	+	CAGAACCUAUAAGGAAUAACA	21	22350
CFTR-Intron10-3469	+	ACAGAACCUAUAAGGAAUAACA	22	22351
CFTR-Intron10-3470	+	UACAGAACCUAUAAGGAAUAACA	23	22352
CFTR-Intron10-3471	+	UUACAGAACCUAUAAGGAAUAACA	24	22353
CFTR-Intron10-3472	+	GAGAGAGAACUGCUCACA	18	22354
CFTR-Intron10-3473	+	GGAGAGAGAACUGCUCACA	19	22355
CFTR-Intron10-1122	+	UGGAGAGAGAACUGCUCACA	20	20007
CFTR-Intron10-3474	+	CUGGAGAGAGAACUGCUCACA	21	22356
CFTR-Intron10-3475	+	ACUGGAGAGAGAACUGCUCACA	22	22357
CFTR-Intron10-3476	+	UACUGGAGAGAGAACUGCUCACA	23	22358
CFTR-Intron10-3477	+	UUACUGGAGAGAGAACUGCUCACA	24	22359
CFTR-Intron10-3478	+	UUUACAAUUCUUAUUACA	18	22360
CFTR-Intron10-3479	+	UUUUACAAUUCUUAUUACA	19	22361
CFTR-Intron10-1125	+	AUUUUACAAUUCUUAUUACA	20	20010
CFTR-Intron10-3480	+	AAUUUUACAAUUCUUAUUACA	21	22362
CFTR-Intron10-3481	+	AAAUUUUACAAUUCUUAUUACA	22	22363
CFTR-Intron10-3482	+	UAAAUUUUACAAUUCUUAUUACA	23	22364
CFTR-Intron10-3483	+	GUAAAUUUUACAAUUCUUAUUACA	24	22365
CFTR-Intron10-3484	+	CAGGAGUUCAAGGUUACA	18	22366
CFTR-Intron10-3485	+	CCAGGAGUUCAAGGUUACA	19	22367
CFTR-Intron10-3486	+	CCCAGGAGUUCAAGGUUACA	20	22368
CFTR-Intron10-3487	+	GCCCAGGAGUUCAAGGUUACA	21	22369
CFTR-Intron10-3488	+	AGCCCAGGAGUUCAAGGUUACA	22	22370
CFTR-Intron10-3489	+	GAGCCCAGGAGUUCAAGGUUACA	23	22371
CFTR-Intron10-3490	+	UGAGCCCAGGAGUUCAAGGUUACA	24	22372
CFTR-Intron10-3491	+	UGAGCUAUGAUCACACCA	18	22373
CFTR-Intron10-3492	+	GUGAGCUAUGAUCACACCA	19	22374
CFTR-Intron10-3493	+	AGUGAGCUAUGAUCACACCA	20	22375
CFTR-Intron10-3494	+	CAGUGAGCUAUGAUCACACCA	21	22376
CFTR-Intron10-3495	+	ACAGUGAGCUAUGAUCACACCA	22	22377
CFTR-Intron10-3496	+	UACAGUGAGCUAUGAUCACACCA	23	22378
CFTR-Intron10-3497	+	UUACAGUGAGCUAUGAUCACACCA	24	22379
CFTR-Intron10-3498	+	GGCCUCUAAUCUCACCCA	18	22380
CFTR-Intron10-3499	+	UGGCCUCUAAUCUCACCCA	19	22381
CFTR-Intron10-3500	+	GUGGCCUCUAAUCUCACCCA	20	22382
CFTR-Intron10-3501	+	AGUGGCCUCUAAUCUCACCCA	21	22383
CFTR-Intron10-3502	+	CAGUGGCCUCUAAUCUCACCCA	22	22384
CFTR-Intron10-3503	+	CCAGUGGCCUCUAAUCUCACCCA	23	22385
CFTR-Intron10-3504	+	UCCAGUGGCCUCUAAUCUCACCCA	24	22386
CFTR-Intron10-3505	+	CAGCUAAAGUAUUACCCA	18	22387
CFTR-Intron10-3506	+	ACAGCUAAAGUAUUACCCA	19	22388
CFTR-Intron10-3507	+	UACAGCUAAAGUAUUACCCA	20	22389
CFTR-Intron10-3508	+	AUACAGCUAAAGUAUUACCCA	21	22390
CFTR-Intron10-3509	+	UAUACAGCUAAAGUAUUACCCA	22	22391
CFTR-Intron10-3510	+	AUAUACAGCUAAAGUAUUACCCA	23	22392
CFTR-Intron10-3511	+	AAUAUACAGCUAAAGUAUUACCCA	24	22393
CFTR-Intron10-3512	+	AGUGUUUAAAUAUUCCCA	18	22394
CFTR-Intron10-3513	+	AAGUGUUUAAAUAUUCCCA	19	22395
CFTR-Intron10-76	+	GAAGUGUUUAAAUAUUCCCA	20	18962
CFTR-Intron10-3514	+	AGAAGUGUUUAAAUAUUCCCA	21	22396
CFTR-Intron10-3515	+	CAGAAGUGUUUAAAUAUUCCCA	22	22397
CFTR-Intron10-3516	+	UCAGAAGUGUUUAAAUAUUCCCA	23	22398
CFTR-Intron10-3517	+	CUCAGAAGUGUUUAAAUAUUCCCA	24	22399
CFTR-Intron10-3518	+	UAGUAUUAAGUAUAGCCA	18	22400
CFTR-Intron10-3519	+	UUAGUAUUAAGUAUAGCCA	19	22401
CFTR-Intron10-3520	+	AUUAGUAUUAAGUAUAGCCA	20	22402
CFTR-Intron10-3521	+	UAUUAGUAUUAAGUAUAGCCA	21	22403
CFTR-Intron10-3522	+	UUAUUAGUAUUAAGUAUAGCCA	22	22404
CFTR-Intron10-3523	+	GUUAUUAGUAUUAAGUAUAGCCA	23	22405
CFTR-Intron10-3524	+	AGUUAUUAGUAUUAAGUAUAGCCA	24	22406
CFTR-Intron10-3525	+	UGAGUAUACUUUAUGCCA	18	22407
CFTR-Intron10-3526	+	GUGAGUAUACUUUAUGCCA	19	22408
CFTR-Intron10-3527	+	UGUGAGUAUACUUUAUGCCA	20	22409
CFTR-Intron10-3528	+	AUGUGAGUAUACUUUAUGCCA	21	22410
CFTR-Intron10-3529	+	UAUGUGAGUAUACUUUAUGCCA	22	22411
CFTR-Intron10-3530	+	CUAUGUGAGUAUACUUUAUGCCA	23	22412
CFTR-Intron10-3531	+	ACUAUGUGAGUAUACUUUAUGCCA	24	22413
CFTR-Intron10-3532	+	GAAGGAAAGGAGGUAGCA	18	22414
CFTR-Intron10-3533	+	AGAAGGAAAGGAGGUAGCA	19	22415
CFTR-Intron10-3534	+	UAGAAGGAAAGGAGGUAGCA	20	22416
CFTR-Intron10-3535	+	GUAGAAGGAAAGGAGGUAGCA	21	22417
CFTR-Intron10-3536	+	AGUAGAAGGAAAGGAGGUAGCA	22	22418
CFTR-Intron10-3537	+	GAGUAGAAGGAAAGGAGGUAGCA	23	22419
CFTR-Intron10-3538	+	UGAGUAGAAGGAAAGGAGGUAGCA	24	22420
CFTR-Intron10-3539	+	UUCAACAUAUGAAUGGCA	18	22421
CFTR-Intron10-3540	+	UUUCAACAUAUGAAUGGCA	19	22422
CFTR-Intron10-1128	+	AUUUCAACAUAUGAAUGGCA	20	20013
CFTR-Intron10-3541	+	GAUUUCAACAUAUGAAUGGCA	21	22423
CFTR-Intron10-3542	+	GGAUUUCAACAUAUGAAUGGCA	22	22424
CFTR-Intron10-3543	+	AGGAUUUCAACAUAUGAAUGGCA	23	22425
CFTR-Intron10-3544	+	UAGGAUUUCAACAUAUGAAUGGCA	24	22426
CFTR-Intron10-3545	+	CGGGAGGCGGAGCUUGCA	18	22427
CFTR-Intron10-3546	+	CCGGGAGGCGGAGCUUGCA	19	22428
CFTR-Intron10-3547	+	CCCGGGAGGCGGAGCUUGCA	20	22429
CFTR-Intron10-3548	+	ACCCGGGAGGCGGAGCUUGCA	21	22430
CFTR-Intron10-3549	+	AACCCGGGAGGCGGAGCUUGCA	22	22431
CFTR-Intron10-3550	+	GAACCCGGGAGGCGGAGCUUGCA	23	22432
CFTR-Intron10-3551	+	UGAACCCGGGAGGCGGAGCUUGCA	24	22433
CFTR-Intron10-3552	+	CGGGAGGCAGAGGUUGCA	18	22434
CFTR-Intron10-3553	+	CCGGGAGGCAGAGGUUGCA	19	22435
CFTR-Intron10-3554	+	CCCGGGAGGCAGAGGUUGCA	20	22436
CFTR-Intron10-3555	+	GCCCGGGAGGCAGAGGUUGCA	21	22437
CFTR-Intron10-3556	+	AGCCCGGGAGGCAGAGGUUGCA	22	22438
CFTR-Intron10-3557	+	GAGCCCGGGAGGCAGAGGUUGCA	23	22439
CFTR-Intron10-3558	+	UGAGCCCGGGAGGCAGAGGUUGCA	24	22440
CFTR-Intron10-3559	+	GCUAUUUAAACAGAAUCA	18	22441
CFTR-Intron10-3560	+	UGCUAUUUAAACAGAAUCA	19	22442
CFTR-Intron10-77	+	GUGCUAUUUAAACAGAAUCA	20	18963
CFTR-Intron10-3561	+	AGUGCUAUUUAAACAGAAUCA	21	22443
CFTR-Intron10-3562	+	CAGUGCUAUUUAAACAGAAUCA	22	22444
CFTR-Intron10-3563	+	CCAGUGCUAUUUAAACAGAAUCA	23	22445
CFTR-Intron10-3564	+	UCCAGUGCUAUUUAAACAGAAUCA	24	22446
CFTR-Intron10-3565	+	AGUACAAAAGGACUAUCA	18	22447
CFTR-Intron10-3566	+	UAGUACAAAAGGACUAUCA	19	22448
CFTR-Intron10-3567	+	AUAGUACAAAAGGACUAUCA	20	22449
CFTR-Intron10-3568	+	GAUAGUACAAAAGGACUAUCA	21	22450
CFTR-Intron10-3569	+	UGAUAGUACAAAAGGACUAUCA	22	22451
CFTR-Intron10-3570	+	AUGAUAGUACAAAAGGACUAUCA	23	22452
CFTR-Intron10-3571	+	GAUGAUAGUACAAAAGGACUAUCA	24	22453
CFTR-Intron10-3572	+	UUAGGAUAUCUUAGGUCA	18	22454
CFTR-Intron10-3573	+	CUUAGGAUAUCUUAGGUCA	19	22455
CFTR-Intron10-3574	+	CCUUAGGAUAUCUUAGGUCA	20	22456
CFTR-Intron10-3575	+	CCCUUAGGAUAUCUUAGGUCA	21	22457
CFTR-Intron10-3576	+	UCCCUUAGGAUAUCUUAGGUCA	22	22458
CFTR-Intron10-3577	+	UUCCCUUAGGAUAUCUUAGGUCA	23	22459
CFTR-Intron10-3578	+	UUUCCCUUAGGAUAUCUUAGGUCA	24	22460
CFTR-Intron10-3579	+	UAUUCUUUUAUGUGGUCA	18	22461
CFTR-Intron10-3580	+	AUAUUCUUUUAUGUGGUCA	19	22462
CFTR-Intron10-3581	+	UAUAUUCUUUUAUGUGGUCA	20	22463
CFTR-Intron10-3582	+	AUAUAUUCUUUUAUGUGGUCA	21	22464
CFTR-Intron10-3583	+	AAUAUAUUCUUUUAUGUGGUCA	22	22465
CFTR-Intron10-3584	+	GAAUAUAUUCUUUUAUGUGGUCA	23	22466
CFTR-Intron10-3585	+	CGAAUAUAUUCUUUUAUGUGGUCA	24	22467
CFTR-Intron10-3586	+	CUUCACUAAAAUAAUUCA	18	22468
CFTR-Intron10-3587	+	GCUUCACUAAAAUAAUUCA	19	22469
CFTR-Intron10-1133	+	UGCUUCACUAAAAUAAUUCA	20	20018
CFTR-Intron10-3588	+	UUGCUUCACUAAAAUAAUUCA	21	22470
CFTR-Intron10-3589	+	AUUGCUUCACUAAAAUAAUUCA	22	22471
CFTR-Intron10-3590	+	UAUUGCUUCACUAAAAUAAUUCA	23	22472
CFTR-Intron10-3591	+	AUAUUGCUUCACUAAAAUAAUUCA	24	22473
CFTR-Intron10-3592	+	AAUCUAAAAGCUAAUUCA	18	22474
CFTR-Intron10-3593	+	AAAUCUAAAAGCUAAUUCA	19	22475
CFTR-Intron10-369	+	UAAAUCUAAAAGCUAAUUCA	20	19255
CFTR-Intron10-3594	+	GUAAAUCUAAAAGCUAAUUCA	21	22476
CFTR-Intron10-3595	+	AGUAAAUCUAAAAGCUAAUUCA	22	22477
CFTR-Intron10-3596	+	AAGUAAAUCUAAAAGCUAAUUCA	23	22478
CFTR-Intron10-3597	+	UAAGUAAAUCUAAAAGCUAAUUCA	24	22479
CFTR-Intron10-3598	+	CAGGCCCAAAUACAUUCA	18	22480
CFTR-Intron10-3599	+	GCAGGCCCAAAUACAUUCA	19	22481
CFTR-Intron10-3600	+	UGCAGGCCCAAAUACAUUCA	20	22482
CFTR-Intron10-3601	+	AUGCAGGCCCAAAUACAUUCA	21	22483
CFTR-Intron10-3602	+	UAUGCAGGCCCAAAUACAUUCA	22	22484
CFTR-Intron10-3603	+	AUAUGCAGGCCCAAAUACAUUCA	23	22485
CFTR-Intron10-3604	+	CAUAUGCAGGCCCAAAUACAUUCA	24	22486
CFTR-Intron10-3605	+	GAAUUGGUACAAAUUUCA	18	22487
CFTR-Intron10-3606	+	CGAAUUGGUACAAAUUUCA	19	22488
CFTR-Intron10-370	+	ACGAAUUGGUACAAAUUUCA	20	19256
CFTR-Intron10-3607	+	UACGAAUUGGUACAAAUUUCA	21	22489
CFTR-Intron10-3608	+	GUACGAAUUGGUACAAAUUUCA	22	22490
CFTR-Intron10-3609	+	AGUACGAAUUGGUACAAAUUUCA	23	22491
CFTR-Intron10-3610	+	GAGUACGAAUUGGUACAAAUUUCA	24	22492
CFTR-Intron10-3611	+	UGAAAUAUAUUCAAAAGA	18	22493
CFTR-Intron10-3612	+	CUGAAAUAUAUUCAAAAGA	19	22494
CFTR-Intron10-3613	+	CCUGAAAUAUAUUCAAAAGA	20	22495
CFTR-Intron10-3614	+	ACCUGAAAUAUAUUCAAAAGA	21	22496
CFTR-Intron10-3615	+	CACCUGAAAUAUAUUCAAAAGA	22	22497
CFTR-Intron10-3616	+	UCACCUGAAAUAUAUUCAAAAGA	23	22498
CFTR-Intron10-3617	+	AUCACCUGAAAUAUAUUCAAAAGA	24	22499
CFTR-Intron10-3618	+	GAUGAGAGACAGUAAAGA	18	22500
CFTR-Intron10-3619	+	AGAUGAGAGACAGUAAAGA	19	22501
CFTR-Intron10-3620	+	CAGAUGAGAGACAGUAAAGA	20	22502
CFTR-Intron10-3621	+	ACAGAUGAGAGACAGUAAAGA	21	22503
CFTR-Intron10-3622	+	GACAGAUGAGAGACAGUAAAGA	22	22504
CFTR-Intron10-3623	+	GGACAGAUGAGAGACAGUAAAGA	23	22505
CFTR-Intron10-3624	+	UGGACAGAUGAGAGACAGUAAAGA	24	22506
CFTR-Intron10-3625	+	AAUAAUAACAUUUUAAGA	18	22507
CFTR-Intron10-3626	+	AAAUAAUAACAUUUUAAGA	19	22508
CFTR-Intron10-3627	+	AAAAUAAUAACAUUUUAAGA	20	22509
CFTR-Intron10-3628	+	AAAAAUAAUAACAUUUUAAGA	21	22510
CFTR-Intron10-3629	+	GAAAAAUAAUAACAUUUUAAGA	22	22511
CFTR-Intron10-3630	+	AGAAAAAUAAUAACAUUUUAAGA	23	22512
CFTR-Intron10-3631	+	AAGAAAAAUAAUAACAUUUUAAGA	24	22513
CFTR-Intron10-3632	+	UCCAGCCUGGGCGACAGA	18	22514
CFTR-Intron10-3633	+	CUCCAGCCUGGGCGACAGA	19	22515
CFTR-Intron10-3634	+	ACUCCAGCCUGGGCGACAGA	20	22516
CFTR-Intron10-3635	+	CACUCCAGCCUGGGCGACAGA	21	22517
CFTR-Intron10-3636	+	GCACUCCAGCCUGGGCGACAGA	22	22518
CFTR-Intron10-3637	+	UGCACUCCAGCCUGGGCGACAGA	23	22519
CFTR-Intron10-3638	+	CUGCACUCCAGCCUGGGCGACAGA	24	22520
CFTR-Intron10-3639	+	GUGUUCUCACAUGGCAGA	18	22521
CFTR-Intron10-3640	+	UGUGUUCUCACAUGGCAGA	19	22522
CFTR-Intron10-3641	+	CUGUGUUCUCACAUGGCAGA	20	22523
CFTR-Intron10-3642	+	GCUGUGUUCUCACAUGGCAGA	21	22524
CFTR-Intron10-3643	+	UGCUGUGUUCUCACAUGGCAGA	22	22525
CFTR-Intron10-3644	+	CUGCUGUGUUCUCACAUGGCAGA	23	22526
CFTR-Intron10-3645	+	CCUGCUGUGUUCUCACAUGGCAGA	24	22527
CFTR-Intron10-3646	+	UGAAUGGCAGGGGAGAGA	18	22528
CFTR-Intron10-3647	+	AUGAAUGGCAGGGGAGAGA	19	22529
CFTR-Intron10-3648	+	UAUGAAUGGCAGGGGAGAGA	20	22530
CFTR-Intron10-3649	+	AUAUGAAUGGCAGGGGAGAGA	21	22531
CFTR-Intron10-3650	+	CAUAUGAAUGGCAGGGGAGAGA	22	22532
CFTR-Intron10-3651	+	ACAUAUGAAUGGCAGGGGAGAGA	23	22533
CFTR-Intron10-3652	+	AACAUAUGAAUGGCAGGGGAGAGA	24	22534
CFTR-Intron10-3653	+	AUGAGGGAAUGCAGGAGA	18	22535
CFTR-Intron10-3654	+	GAUGAGGGAAUGCAGGAGA	19	22536
CFTR-Intron10-3655	+	GGAUGAGGGAAUGCAGGAGA	20	22537
CFTR-Intron10-3656	+	UGGAUGAGGGAAUGCAGGAGA	21	22538
CFTR-Intron10-3657	+	UUGGAUGAGGGAAUGCAGGAGA	22	22539
CFTR-Intron10-3658	+	GUUGGAUGAGGGAAUGCAGGAGA	23	22540
CFTR-Intron10-3659	+	GGUUGGAUGAGGGAAUGCAGGAGA	24	22541
CFTR-Intron10-3660	+	GAUCACGAGGUCAGGAGA	18	22542
CFTR-Intron10-3661	+	GGAUCACGAGGUCAGGAGA	19	22543
CFTR-Intron10-3662	+	CGGAUCACGAGGUCAGGAGA	20	22544
CFTR-Intron10-3663	+	GCGGAUCACGAGGUCAGGAGA	21	22545
CFTR-Intron10-3664	+	GGCGGAUCACGAGGUCAGGAGA	22	22546
CFTR-Intron10-3665	+	GGGCGGAUCACGAGGUCAGGAGA	23	22547
CFTR-Intron10-3666	+	CGGGCGGAUCACGAGGUCAGGAGA	24	22548
CFTR-Intron10-3667	+	UAGGAAAACAACUGGAGA	18	22549
CFTR-Intron10-3668	+	GUAGGAAAACAACUGGAGA	19	22550
CFTR-Intron10-3669	+	UGUAGGAAAACAACUGGAGA	20	22551
CFTR-Intron10-3670	+	AUGUAGGAAAACAACUGGAGA	21	22552
CFTR-Intron10-3671	+	UAUGUAGGAAAACAACUGGAGA	22	22553
CFTR-Intron10-3672	+	GUAUGUAGGAAAACAACUGGAGA	23	22554
CFTR-Intron10-3673	+	CGUAUGUAGGAAAACAACUGGAGA	24	22555
CFTR-Intron10-3674	+	UAUGCAAUUUACUGGAGA	18	22556
CFTR-Intron10-3675	+	AUAUGCAAUUUACUGGAGA	19	22557
CFTR-Intron10-3676	+	AAUAUGCAAUUUACUGGAGA	20	22558
CFTR-Intron10-3677	+	CAAUAUGCAAUUUACUGGAGA	21	22559
CFTR-Intron10-3678	+	GCAAUAUGCAAUUUACUGGAGA	22	22560
CFTR-Intron10-3679	+	UGCAAUAUGCAAUUUACUGGAGA	23	22561
CFTR-Intron10-3680	+	CUGCAAUAUGCAAUUUACUGGAGA	24	22562
CFTR-Intron10-3681	+	GAACUAGAGUCACAUAGA	18	22563
CFTR-Intron10-3682	+	UGAACUAGAGUCACAUAGA	19	22564
CFTR-Intron10-3683	+	GUGAACUAGAGUCACAUAGA	20	22565
CFTR-Intron10-3684	+	AGUGAACUAGAGUCACAUAGA	21	22566
CFTR-Intron10-3685	+	UAGUGAACUAGAGUCACAUAGA	22	22567
CFTR-Intron10-3686	+	UUAGUGAACUAGAGUCACAUAGA	23	22568
CFTR-Intron10-3687	+	AUUAGUGAACUAGAGUCACAUAGA	24	22569
CFTR-Intron10-3688	+	AUUGAUUAUAUAUAUAGA	18	22570
CFTR-Intron10-3689	+	UAUUGAUUAUAUAUAUAGA	19	22571
CFTR-Intron10-3690	+	AUAUUGAUUAUAUAUAUAGA	20	22572
CFTR-Intron10-3691	+	UAUAUUGAUUAUAUAUAUAGA	21	22573
CFTR-Intron10-3692	+	GUAUAUUGAUUAUAUAUAUAGA	22	22574
CFTR-Intron10-3693	+	UGUAUAUUGAUUAUAUAUAUAGA	23	22575
CFTR-Intron10-3694	+	AUGUAUAUUGAUUAUAUAUAUAGA	24	22576
CFTR-Intron10-3695	+	AGGAUCACUUUAUAUAGA	18	22577
CFTR-Intron10-3696	+	UAGGAUCACUUUAUAUAGA	19	22578
CFTR-Intron10-3697	+	CUAGGAUCACUUUAUAUAGA	20	22579
CFTR-Intron10-3698	+	UCUAGGAUCACUUUAUAUAGA	21	22580
CFTR-Intron10-3699	+	UUCUAGGAUCACUUUAUAUAGA	22	22581
CFTR-Intron10-3700	+	AUUCUAGGAUCACUUUAUAUAGA	23	22582
CFTR-Intron10-3701	+	GAUUCUAGGAUCACUUUAUAUAGA	24	22583
CFTR-Intron10-3702	+	UGACUAAAACUGAGUAGA	18	22584
CFTR-Intron10-3703	+	CUGACUAAAACUGAGUAGA	19	22585
CFTR-Intron10-374	+	ACUGACUAAAACUGAGUAGA	20	19260
CFTR-Intron10-3704	+	UACUGACUAAAACUGAGUAGA	21	22586
CFTR-Intron10-3705	+	CUACUGACUAAAACUGAGUAGA	22	22587
CFTR-Intron10-3706	+	ACUACUGACUAAAACUGAGUAGA	23	22588
CFTR-Intron10-3707	+	UACUACUGACUAAAACUGAGUAGA	24	22589
CFTR-Intron10-3708	+	GCACUCCAGCCUGGGCGA	18	22590
CFTR-Intron10-3709	+	UGCACUCCAGCCUGGGCGA	19	22591
CFTR-Intron10-3710	+	CUGCACUCCAGCCUGGGCGA	20	22592
CFTR-Intron10-3711	+	ACUGCACUCCAGCCUGGGCGA	21	22593
CFTR-Intron10-3712	+	CACUGCACUCCAGCCUGGGCGA	22	22594
CFTR-Intron10-3713	+	CCACUGCACUCCAGCCUGGGCGA	23	22595
CFTR-Intron10-3714	+	GCCACUGCACUCCAGCCUGGGCGA	24	22596
CFTR-Intron10-3715	+	UGACUUCAUAAUAAAGGA	18	22597
CFTR-Intron10-3716	+	GUGACUUCAUAAUAAAGGA	19	22598
CFTR-Intron10-3717	+	AGUGACUUCAUAAUAAAGGA	20	22599
CFTR-Intron10-3718	+	CAGUGACUUCAUAAUAAAGGA	21	22600
CFTR-Intron10-3719	+	ACAGUGACUUCAUAAUAAAGGA	22	22601
CFTR-Intron10-3720	+	UACAGUGACUUCAUAAUAAAGGA	23	22602
CFTR-Intron10-3721	+	AUACAGUGACUUCAUAAUAAAGGA	24	22603
CFTR-Intron10-3722	+	AUGCAGACAACAGAAGGA	18	22604
CFTR-Intron10-3723	+	GAUGCAGACAACAGAAGGA	19	22605
CFTR-Intron10-3724	+	UGAUGCAGACAACAGAAGGA	20	22606
CFTR-Intron10-3725	+	GUGAUGCAGACAACAGAAGGA	21	22607
CFTR-Intron10-3726	+	UGUGAUGCAGACAACAGAAGGA	22	22608
CFTR-Intron10-3727	+	CUGUGAUGCAGACAACAGAAGGA	23	22609
CFTR-Intron10-3728	+	GCUGUGAUGCAGACAACAGAAGGA	24	22610
CFTR-Intron10-3729	+	UAAAACUGAGUAGAAGGA	18	22611
CFTR-Intron10-3730	+	CUAAAACUGAGUAGAAGGA	19	22612
CFTR-Intron10-3731	+	ACUAAAACUGAGUAGAAGGA	20	22613
CFTR-Intron10-3732	+	GACUAAAACUGAGUAGAAGGA	21	22614
CFTR-Intron10-3733	+	UGACUAAAACUGAGUAGAAGGA	22	22615
CFTR-Intron10-3734	+	CUGACUAAAACUGAGUAGAAGGA	23	22616
CFTR-Intron10-3735	+	ACUGACUAAAACUGAGUAGAAGGA	24	22617
CFTR-Intron10-3736	+	UGUAGGAAAACAACUGGA	18	22618
CFTR-Intron10-3737	+	AUGUAGGAAAACAACUGGA	19	22619
CFTR-Intron10-3738	+	UAUGUAGGAAAACAACUGGA	20	22620
CFTR-Intron10-3739	+	GUAUGUAGGAAAACAACUGGA	21	22621
CFTR-Intron10-3740	+	CGUAUGUAGGAAAACAACUGGA	22	22622
CFTR-Intron10-3741	+	UCGUAUGUAGGAAAACAACUGGA	23	22623
CFTR-Intron10-3742	+	UUCGUAUGUAGGAAAACAACUGGA	24	22624
CFTR-Intron10-3743	+	AAUAUGCAAUUUACUGGA	18	22625
CFTR-Intron10-3744	+	CAAUAUGCAAUUUACUGGA	19	22626
CFTR-Intron10-3745	+	GCAAUAUGCAAUUUACUGGA	20	22627
CFTR-Intron10-3746	+	UGCAAUAUGCAAUUUACUGGA	21	22628
CFTR-Intron10-3747	+	CUGCAAUAUGCAAUUUACUGGA	22	22629
CFTR-Intron10-3748	+	ACUGCAAUAUGCAAUUUACUGGA	23	22630
CFTR-Intron10-3749	+	UACUGCAAUAUGCAAUUUACUGGA	24	22631
CFTR-Intron10-3750	+	UUUCAUCUUACUUGAUGA	18	22632
CFTR-Intron10-3751	+	GUUUCAUCUUACUUGAUGA	19	22633
CFTR-Intron10-3752	+	AGUUUCAUCUUACUUGAUGA	20	22634
CFTR-Intron10-3753	+	CAGUUUCAUCUUACUUGAUGA	21	22635
CFTR-Intron10-3754	+	ACAGUUUCAUCUUACUUGAUGA	22	22636
CFTR-Intron10-3755	+	AACAGUUUCAUCUUACUUGAUGA	23	22637
CFTR-Intron10-3756	+	UAACAGUUUCAUCUUACUUGAUGA	24	22638
CFTR-Intron10-3757	+	UGACACCAAAUUUAUUGA	18	22639
CFTR-Intron10-3758	+	CUGACACCAAAUUUAUUGA	19	22640
CFTR-Intron10-3759	+	CCUGACACCAAAUUUAUUGA	20	22641
CFTR-Intron10-3760	+	GCCUGACACCAAAUUUAUUGA	21	22642
CFTR-Intron10-3761	+	AGCCUGACACCAAAUUUAUUGA	22	22643
CFTR-Intron10-3762	+	CAGCCUGACACCAAAUUUAUUGA	23	22644
CFTR-Intron10-3763	+	CCAGCCUGACACCAAAUUUAUUGA	24	22645
CFTR-Intron10-3764	+	CUAAUAGCCUAUUGUUGA	18	22646
CFTR-Intron10-3765	+	ACUAAUAGCCUAUUGUUGA	19	22647
CFTR-Intron10-3766	+	UACUAAUAGCCUAUUGUUGA	20	22648
CFTR-Intron10-3767	+	CUACUAAUAGCCUAUUGUUGA	21	22649
CFTR-Intron10-3768	+	ACUACUAAUAGCCUAUUGUUGA	22	22650
CFTR-Intron10-3769	+	AACUACUAAUAGCCUAUUGUUGA	23	22651
CFTR-Intron10-3770	+	UAACUACUAAUAGCCUAUUGUUGA	24	22652
CFTR-Intron10-3771	+	CCUUGGAAUAUAAAAAUA	18	22653
CFTR-Intron10-3772	+	UCCUUGGAAUAUAAAAAUA	19	22654
CFTR-Intron10-3773	+	GUCCUUGGAAUAUAAAAAUA	20	22655
CFTR-Intron10-3774	+	AGUCCUUGGAAUAUAAAAAUA	21	22656
CFTR-Intron10-3775	+	CAGUCCUUGGAAUAUAAAAAUA	22	22657
CFTR-Intron10-3776	+	ACAGUCCUUGGAAUAUAAAAAUA	23	22658
CFTR-Intron10-3777	+	GACAGUCCUUGGAAUAUAAAAAUA	24	22659
CFTR-Intron10-3778	+	CUUUGUGUUAACAAAAUA	18	22660
CFTR-Intron10-3779	+	UCUUUGUGUUAACAAAAUA	19	22661
CFTR-Intron10-3780	+	UUCUUUGUGUUAACAAAAUA	20	22662
CFTR-Intron10-3781	+	GUUCUUUGUGUUAACAAAAUA	21	22663
CFTR-Intron10-3782	+	UGUUCUUUGUGUUAACAAAAUA	22	22664
CFTR-Intron10-3783	+	UUGUUCUUUGUGUUAACAAAAUA	23	22665
CFTR-Intron10-3784	+	GUUGUUCUUUGUGUUAACAAAAUA	24	22666
CFTR-Intron10-3785	+	GGAAGAAAAGUAUCAAUA	18	22667
CFTR-Intron10-3786	+	AGGAAGAAAAGUAUCAAUA	19	22668
CFTR-Intron10-3787	+	CAGGAAGAAAAGUAUCAAUA	20	22669
CFTR-Intron10-3788	+	UCAGGAAGAAAAGUAUCAAUA	21	22670
CFTR-Intron10-3789	+	AUCAGGAAGAAAAGUAUCAAUA	22	22671
CFTR-Intron10-3790	+	AAUCAGGAAGAAAAGUAUCAAUA	23	22672
CFTR-Intron10-3791	+	UAAUCAGGAAGAAAAGUAUCAAUA	24	22673
CFTR-Intron10-3792	+	UCCUCUGUGCUUUGAAUA	18	22674
CFTR-Intron10-3793	+	GUCCUCUGUGCUUUGAAUA	19	22675
CFTR-Intron10-382	+	AGUCCUCUGUGCUUUGAAUA	20	19268
CFTR-Intron10-3794	+	AAGUCCUCUGUGCUUUGAAUA	21	22676
CFTR-Intron10-3795	+	CAAGUCCUCUGUGCUUUGAAUA	22	22677
CFTR-Intron10-3796	+	GCAAGUCCUCUGUGCUUUGAAUA	23	22678
CFTR-Intron10-3797	+	UGCAAGUCCUCUGUGCUUUGAAUA	24	22679
CFTR-Intron10-3798	+	UACAGUGACUUCAUAAUA	18	22680
CFTR-Intron10-3799	+	AUACAGUGACUUCAUAAUA	19	22681
CFTR-Intron10-3800	+	AAUACAGUGACUUCAUAAUA	20	22682
CFTR-Intron10-3801	+	CAAUACAGUGACUUCAUAAUA	21	22683
CFTR-Intron10-3802	+	ACAAUACAGUGACUUCAUAAUA	22	22684
CFTR-Intron10-3803	+	GACAAUACAGUGACUUCAUAAUA	23	22685
CFTR-Intron10-3804	+	AGACAAUACAGUGACUUCAUAAUA	24	22686
CFTR-Intron10-3805	+	CCUAGAUGAUUAUUAAUA	18	22687
CFTR-Intron10-3806	+	GCCUAGAUGAUUAUUAAUA	19	22688
CFTR-Intron10-384	+	AGCCUAGAUGAUUAUUAAUA	20	19270
CFTR-Intron10-3807	+	CAGCCUAGAUGAUUAUUAAUA	21	22689
CFTR-Intron10-3808	+	GCAGCCUAGAUGAUUAUUAAUA	22	22690
CFTR-Intron10-3809	+	UGCAGCCUAGAUGAUUAUUAAUA	23	22691
CFTR-Intron10-3810	+	UUGCAGCCUAGAUGAUUAUUAAUA	24	22692
CFTR-Intron10-3811	+	UAGUAUAAUUUUUUAAUA	18	22693
CFTR-Intron10-3812	+	AUAGUAUAAUUUUUUAAUA	19	22694
CFTR-Intron10-3813	+	UAUAGUAUAAUUUUUUAAUA	20	22695
CFTR-Intron10-3814	+	CUAUAGUAUAAUUUUUUAAUA	21	22696
CFTR-Intron10-3815	+	CCUAUAGUAUAAUUUUUUAAUA	22	22697
CFTR-Intron10-3816	+	UCCUAUAGUAUAAUUUUUUAAUA	23	22698
CFTR-Intron10-3817	+	CUCCUAUAGUAUAAUUUUUUAAUA	24	22699
CFTR-Intron10-3818	+	UGAAACAAAUAAAACAUA	18	22700
CFTR-Intron10-3819	+	AUGAAACAAAUAAAACAUA	19	22701
CFTR-Intron10-3820	+	AAUGAAACAAAUAAAACAUA	20	22702
CFTR-Intron10-3821	+	AAAUGAAACAAAUAAAACAUA	21	22703
CFTR-Intron10-3822	+	GAAAUGAAACAAAUAAAACAUA	22	22704
CFTR-Intron10-3823	+	AGAAAUGAAACAAAUAAAACAUA	23	22705
CFTR-Intron10-3824	+	AAGAAAUGAAACAAAUAAAACAUA	24	22706
CFTR-Intron10-3825	+	CUAAAACUCAGUACCAUA	18	22707
CFTR-Intron10-3826	+	GCUAAAACUCAGUACCAUA	19	22708
CFTR-Intron10-3827	+	AGCUAAAACUCAGUACCAUA	20	22709
CFTR-Intron10-3828	+	AAGCUAAAACUCAGUACCAUA	21	22710
CFTR-Intron10-3829	+	UAAGCUAAAACUCAGUACCAUA	22	22711
CFTR-Intron10-3830	+	AUAAGCUAAAACUCAGUACCAUA	23	22712
CFTR-Intron10-3831	+	AAUAAGCUAAAACUCAGUACCAUA	24	22713
CFTR-Intron10-3832	+	AAAAUAUAUAUAUGCAUA	18	22714
CFTR-Intron10-3833	+	AAAAAUAUAUAUAUGCAUA	19	22715
CFTR-Intron10-3834	+	UAAAAAUAUAUAUAUGCAUA	20	22716
CFTR-Intron10-3835	+	UUAAAAAUAUAUAUAUGCAUA	21	22717
CFTR-Intron10-3836	+	GUUAAAAAUAUAUAUAUGCAUA	22	22718
CFTR-Intron10-3837	+	GGUUAAAAAUAUAUAUAUGCAUA	23	22719
CFTR-Intron10-3838	+	AGGUUAAAAAUAUAUAUAUGCAUA	24	22720
CFTR-Intron10-3839	+	ACAUAGAGAAAACUCAUA	18	22721
CFTR-Intron10-3840	+	AACAUAGAGAAAACUCAUA	19	22722
CFTR-Intron10-1168	+	AAACAUAGAGAAAACUCAUA	20	20053
CFTR-Intron10-3841	+	AAAACAUAGAGAAAACUCAUA	21	22723
CFTR-Intron10-3842	+	UAAAACAUAGAGAAAACUCAUA	22	22724
CFTR-Intron10-3843	+	AUAAAACAUAGAGAAAACUCAUA	23	22725
CFTR-Intron10-3844	+	AAUAAAACAUAGAGAAAACUCAUA	24	22726
CFTR-Intron10-3845	+	GGAAAGUUGUCCAAGAUA	18	22727
CFTR-Intron10-3846	+	UGGAAAGUUGUCCAAGAUA	19	22728
CFTR-Intron10-3847	+	AUGGAAAGUUGUCCAAGAUA	20	22729
CFTR-Intron10-3848	+	UAUGGAAAGUUGUCCAAGAUA	21	22730
CFTR-Intron10-3849	+	AUAUGGAAAGUUGUCCAAGAUA	22	22731
CFTR-Intron10-3850	+	AAUAUGGAAAGUUGUCCAAGAUA	23	22732
CFTR-Intron10-3851	+	GAAUAUGGAAAGUUGUCCAAGAUA	24	22733
CFTR-Intron10-3852	+	UGUUCUUAGGGUGGGAUA	18	22734
CFTR-Intron10-3853	+	UUGUUCUUAGGGUGGGAUA	19	22735
CFTR-Intron10-84	+	GUUGUUCUUAGGGUGGGAUA	20	18970
CFTR-Intron10-3854	+	AGUUGUUCUUAGGGUGGGAUA	21	22736
CFTR-Intron10-3855	+	AAGUUGUUCUUAGGGUGGGAUA	22	22737
CFTR-Intron10-3856	+	UAAGUUGUUCUUAGGGUGGGAUA	23	22738
CFTR-Intron10-3857	+	UUAAGUUGUUCUUAGGGUGGGAUA	24	22739
CFTR-Intron10-3858	+	AUAUUGAUUAUAUAUAUA	18	22740
CFTR-Intron10-3859	+	UAUAUUGAUUAUAUAUAUA	19	22741
CFTR-Intron10-3860	+	GUAUAUUGAUUAUAUAUAUA	20	22742
CFTR-Intron10-3861	+	UGUAUAUUGAUUAUAUAUAUA	21	22743
CFTR-Intron10-3862	+	AUGUAUAUUGAUUAUAUAUAUA	22	22744
CFTR-Intron10-3863	+	AAUGUAUAUUGAUUAUAUAUAUA	23	22745
CFTR-Intron10-3864	+	AAAUGUAUAUUGAUUAUAUAUAUA	24	22746
CFTR-Intron10-3865	+	GUAUAUUGAUUAUAUAUA	18	22747
CFTR-Intron10-3866	+	UGUAUAUUGAUUAUAUAUA	19	22748
CFTR-Intron10-3867	+	AUGUAUAUUGAUUAUAUAUA	20	22749
CFTR-Intron10-3868	+	AAUGUAUAUUGAUUAUAUAUA	21	22750
CFTR-Intron10-3869	+	AAAUGUAUAUUGAUUAUAUAUA	22	22751
CFTR-Intron10-3870	+	AAAAUGUAUAUUGAUUAUAUAUA	23	22752
CFTR-Intron10-3871	+	AAAAAUGUAUAUUGAUUAUAUAUA	24	22753
CFTR-Intron10-3872	+	CUAGGAUCACUUUAUAUA	18	22754
CFTR-Intron10-3873	+	UCUAGGAUCACUUUAUAUA	19	22755
CFTR-Intron10-3874	+	UUCUAGGAUCACUUUAUAUA	20	22756
CFTR-Intron10-3875	+	AUUCUAGGAUCACUUUAUAUA	21	22757
CFTR-Intron10-3876	+	GAUUCUAGGAUCACUUUAUAUA	22	22758
CFTR-Intron10-3877	+	UGAUUCUAGGAUCACUUUAUAUA	23	22759
CFTR-Intron10-3878	+	AUGAUUCUAGGAUCACUUUAUAUA	24	22760
CFTR-Intron10-3879	+	CCUGAAAGCAGUGUUAUA	18	22761
CFTR-Intron10-3880	+	UCCUGAAAGCAGUGUUAUA	19	22762
CFTR-Intron10-3881	+	CUCCUGAAAGCAGUGUUAUA	20	22763
CFTR-Intron10-3882	+	GCUCCUGAAAGCAGUGUUAUA	21	22764
CFTR-Intron10-3883	+	GGCUCCUGAAAGCAGUGUUAUA	22	22765
CFTR-Intron10-3884	+	UGGCUCCUGAAAGCAGUGUUAUA	23	22766
CFTR-Intron10-3885	+	UUGGCUCCUGAAAGCAGUGUUAUA	24	22767
CFTR-Intron10-3886	+	UUCUAGGAUCACUUUAUA	18	22768
CFTR-Intron10-3887	+	AUUCUAGGAUCACUUUAUA	19	22769
CFTR-Intron10-3888	+	GAUUCUAGGAUCACUUUAUA	20	22770
CFTR-Intron10-3889	+	UGAUUCUAGGAUCACUUUAUA	21	22771
CFTR-Intron10-3890	+	AUGAUUCUAGGAUCACUUUAUA	22	22772
CFTR-Intron10-3891	+	UAUGAUUCUAGGAUCACUUUAUA	23	22773
CFTR-Intron10-3892	+	UUAUGAUUCUAGGAUCACUUUAUA	24	22774
CFTR-Intron10-3893	+	GACAGAUGAGAGACAGUA	18	22775
CFTR-Intron10-3894	+	GGACAGAUGAGAGACAGUA	19	22776
CFTR-Intron10-3895	+	UGGACAGAUGAGAGACAGUA	20	22777
CFTR-Intron10-3896	+	AUGGACAGAUGAGAGACAGUA	21	22778
CFTR-Intron10-3897	+	AAUGGACAGAUGAGAGACAGUA	22	22779
CFTR-Intron10-3898	+	AAAUGGACAGAUGAGAGACAGUA	23	22780
CFTR-Intron10-3899	+	AAAAUGGACAGAUGAGAGACAGUA	24	22781
CFTR-Intron10-3900	+	UUUCUAGAAAACAAUGUA	18	22782
CFTR-Intron10-3901	+	UUUUCUAGAAAACAAUGUA	19	22783
CFTR-Intron10-3902	+	AUUUUCUAGAAAACAAUGUA	20	22784
CFTR-Intron10-3903	+	GAUUUUCUAGAAAACAAUGUA	21	22785
CFTR-Intron10-3904	+	AGAUUUUCUAGAAAACAAUGUA	22	22786
CFTR-Intron10-3905	+	CAGAUUUUCUAGAAAACAAUGUA	23	22787
CFTR-Intron10-3906	+	ACAGAUUUUCUAGAAAACAAUGUA	24	22788
CFTR-Intron10-3907	+	GUAUAAGUGUGGAGUGUA	18	22789
CFTR-Intron10-3908	+	GGUAUAAGUGUGGAGUGUA	19	22790
CFTR-Intron10-3909	+	GGGUAUAAGUGUGGAGUGUA	20	22791
CFTR-Intron10-3910	+	GGGGUAUAAGUGUGGAGUGUA	21	22792
CFTR-Intron10-3911	+	UGGGGUAUAAGUGUGGAGUGUA	22	22793
CFTR-Intron10-3912	+	AUGGGGUAUAAGUGUGGAGUGUA	23	22794
CFTR-Intron10-3913	+	AAUGGGGUAUAAGUGUGGAGUGUA	24	22795
CFTR-Intron10-3914	+	UUCUUGAAGCAAAAAUUA	18	22796
CFTR-Intron10-3915	+	AUUCUUGAAGCAAAAAUUA	19	22797
CFTR-Intron10-3916	+	UAUUCUUGAAGCAAAAAUUA	20	22798
CFTR-Intron10-3917	+	AUAUUCUUGAAGCAAAAAUUA	21	22799
CFTR-Intron10-3918	+	AAUAUUCUUGAAGCAAAAAUUA	22	22800
CFTR-Intron10-3919	+	CAAUAUUCUUGAAGCAAAAAUUA	23	22801
CFTR-Intron10-3920	+	GCAAUAUUCUUGAAGCAAAAAUUA	24	22802
CFTR-Intron10-3921	+	CUGAAUAACACGCCAUUA	18	22803
CFTR-Intron10-3922	+	GCUGAAUAACACGCCAUUA	19	22804
CFTR-Intron10-3923	+	GGCUGAAUAACACGCCAUUA	20	22805
CFTR-Intron10-3924	+	UGGCUGAAUAACACGCCAUUA	21	22806
CFTR-Intron10-3925	+	UUGGCUGAAUAACACGCCAUUA	22	22807
CFTR-Intron10-3926	+	AUUGGCUGAAUAACACGCCAUUA	23	22808
CFTR-Intron10-3927	+	UAUUGGCUGAAUAACACGCCAUUA	24	22809
CFTR-Intron10-3928	+	UUAUCAGAGCUCAUAUUA	18	22810
CFTR-Intron10-3929	+	UUUAUCAGAGCUCAUAUUA	19	22811
CFTR-Intron10-3930	+	UUUUAUCAGAGCUCAUAUUA	20	22812
CFTR-Intron10-3931	+	AUUUUAUCAGAGCUCAUAUUA	21	22813
CFTR-Intron10-3932	+	GAUUUUAUCAGAGCUCAUAUUA	22	22814
CFTR-Intron10-3933	+	UGAUUUUAUCAGAGCUCAUAUUA	23	22815
CFTR-Intron10-3934	+	CUGAUUUUAUCAGAGCUCAUAUUA	24	22816
CFTR-Intron10-3935	+	CAAAUGCUUGACCACUUA	18	22817
CFTR-Intron10-3936	+	ACAAAUGCUUGACCACUUA	19	22818
CFTR-Intron10-3937	+	CACAAAUGCUUGACCACUUA	20	22819
CFTR-Intron10-3938	+	ACACAAAUGCUUGACCACUUA	21	22820
CFTR-Intron10-3939	+	UACACAAAUGCUUGACCACUUA	22	22821
CFTR-Intron10-3940	+	GUACACAAAUGCUUGACCACUUA	23	22822
CFTR-Intron10-3941	+	AGUACACAAAUGCUUGACCACUUA	24	22823
CFTR-Intron10-3942	+	AUUAAUAACAAAAUCUUA	18	22824
CFTR-Intron10-3943	+	UAUUAAUAACAAAAUCUUA	19	22825
CFTR-Intron10-3944	+	AUAUUAAUAACAAAAUCUUA	20	22826
CFTR-Intron10-3945	+	AAUAUUAAUAACAAAAUCUUA	21	22827
CFTR-Intron10-3946	+	UAAUAUUAAUAACAAAAUCUUA	22	22828
CFTR-Intron10-3947	+	GUAAUAUUAAUAACAAAAUCUUA	23	22829
CFTR-Intron10-3948	+	AGUAAUAUUAAUAACAAAAUCUUA	24	22830
CFTR-Intron10-3949	+	ACAUAUUUGGGUAAGUUA	18	22831
CFTR-Intron10-3950	+	AACAUAUUUGGGUAAGUUA	19	22832
CFTR-Intron10-3951	+	AAACAUAUUUGGGUAAGUUA	20	22833
CFTR-Intron10-3952	+	CAAACAUAUUUGGGUAAGUUA	21	22834
CFTR-Intron10-3953	+	GCAAACAUAUUUGGGUAAGUUA	22	22835
CFTR-Intron10-3954	+	UGCAAACAUAUUUGGGUAAGUUA	23	22836
CFTR-Intron10-3955	+	CUGCAAACAUAUUUGGGUAAGUUA	24	22837
CFTR-Intron10-3956	+	ACUGCAAUAUGCAAUUUA	18	22838
CFTR-Intron10-3957	+	UACUGCAAUAUGCAAUUUA	19	22839
CFTR-Intron10-3958	+	UUACUGCAAUAUGCAAUUUA	20	22840
CFTR-Intron10-3959	+	UUUACUGCAAUAUGCAAUUUA	21	22841
CFTR-Intron10-3960	+	UUUUACUGCAAUAUGCAAUUUA	22	22842
CFTR-Intron10-3961	+	UUUUUACUGCAAUAUGCAAUUUA	23	22843
CFTR-Intron10-3962	+	CUUUUUACUGCAAUAUGCAAUUUA	24	22844
CFTR-Intron10-3963	+	CCUAUUAUUCAACAUUUA	18	22845
CFTR-Intron10-3964	+	CCCUAUUAUUCAACAUUUA	19	22846
CFTR-Intron10-398	+	CCCCUAUUAUUCAACAUUUA	20	19284
CFTR-Intron10-3965	+	ACCCCUAUUAUUCAACAUUUA	21	22847
CFTR-Intron10-3966	+	AACCCCUAUUAUUCAACAUUUA	22	22848
CFTR-Intron10-3967	+	AAACCCCUAUUAUUCAACAUUUA	23	22849
CFTR-Intron10-3968	+	CAAACCCCUAUUAUUCAACAUUUA	24	22850
CFTR-Intron10-3969	+	UAAAAAGCAAGCAAAAAC	18	22851
CFTR-Intron10-3970	+	AUAAAAAGCAAGCAAAAAC	19	22852
CFTR-Intron10-3971	+	UAUAAAAAGCAAGCAAAAAC	20	22853
CFTR-Intron10-3972	+	GUAUAAAAAGCAAGCAAAAAC	21	22854
CFTR-Intron10-3973	+	UGUAUAAAAAGCAAGCAAAAAC	22	22855
CFTR-Intron10-3974	+	CUGUAUAAAAAGCAAGCAAAAAC	23	22856
CFTR-Intron10-3975	+	UCUGUAUAAAAAGCAAGCAAAAAC	24	22857
CFTR-Intron10-3976	+	AACAUCUAACUCAAAAAC	18	22858
CFTR-Intron10-3977	+	AAACAUCUAACUCAAAAAC	19	22859
CFTR-Intron10-3978	+	CAAACAUCUAACUCAAAAAC	20	22860
CFTR-Intron10-3979	+	UCAAACAUCUAACUCAAAAAC	21	22861
CFTR-Intron10-3980	+	GUCAAACAUCUAACUCAAAAAC	22	22862
CFTR-Intron10-3981	+	CGUCAAACAUCUAACUCAAAAAC	23	22863
CFTR-Intron10-3982	+	GCGUCAAACAUCUAACUCAAAAAC	24	22864
CFTR-Intron10-3983	+	CGUAUGUAGGAAAACAAC	18	22865
CFTR-Intron10-3984	+	UCGUAUGUAGGAAAACAAC	19	22866
CFTR-Intron10-402	+	UUCGUAUGUAGGAAAACAAC	20	19288
CFTR-Intron10-3985	+	UUUCGUAUGUAGGAAAACAAC	21	22867
CFTR-Intron10-3986	+	GUUUCGUAUGUAGGAAAACAAC	22	22868
CFTR-Intron10-3987	+	UGUUUCGUAUGUAGGAAAACAAC	23	22869
CFTR-Intron10-3988	+	CUGUUUCGUAUGUAGGAAAACAAC	24	22870
CFTR-Intron10-3989	+	GCUUACCGUAAUAGCAAC	18	22871
CFTR-Intron10-3990	+	AGCUUACCGUAAUAGCAAC	19	22872
CFTR-Intron10-660	+	GAGCUUACCGUAAUAGCAAC	20	19546
CFTR-Intron10-3991	+	UGAGCUUACCGUAAUAGCAAC	21	22873
CFTR-Intron10-3992	+	UUGAGCUUACCGUAAUAGCAAC	22	22874
CFTR-Intron10-3993	+	CUUGAGCUUACCGUAAUAGCAAC	23	22875
CFTR-Intron10-3994	+	GCUUGAGCUUACCGUAAUAGCAAC	24	22876
CFTR-Intron10-3995	+	CAUUGACCCUUUAUCAAC	18	22877
CFTR-Intron10-3996	+	CCAUUGACCCUUUAUCAAC	19	22878
CFTR-Intron10-3997	+	ACCAUUGACCCUUUAUCAAC	20	22879
CFTR-Intron10-3998	+	UACCAUUGACCCUUUAUCAAC	21	22880
CFTR-Intron10-3999	+	AUACCAUUGACCCUUUAUCAAC	22	22881
CFTR-Intron10-4000	+	UAUACCAUUGACCCUUUAUCAAC	23	22882
CFTR-Intron10-4001	+	AUAUACCAUUGACCCUUUAUCAAC	24	22883
CFTR-Intron10-4002	+	UGACAAUCAAAUGGGAAC	18	22884
CFTR-Intron10-4003	+	AUGACAAUCAAAUGGGAAC	19	22885
CFTR-Intron10-4004	+	AAUGACAAUCAAAUGGGAAC	20	22886
CFTR-Intron10-4005	+	AAAUGACAAUCAAAUGGGAAC	21	22887
CFTR-Intron10-4006	+	AAAAUGACAAUCAAAUGGGAAC	22	22888
CFTR-Intron10-4007	+	UAAAAUGACAAUCAAAUGGGAAC	23	22889
CFTR-Intron10-4008	+	CUAAAAUGACAAUCAAAUGGGAAC	24	22890
CFTR-Intron10-4009	+	CAGGAGAAUGGCGUGAAC	18	22891
CFTR-Intron10-4010	+	GCAGGAGAAUGGCGUGAAC	19	22892
CFTR-Intron10-4011	+	GGCAGGAGAAUGGCGUGAAC	20	22893
CFTR-Intron10-4012	+	AGGCAGGAGAAUGGCGUGAAC	21	22894
CFTR-Intron10-4013	+	GAGGCAGGAGAAUGGCGUGAAC	22	22895
CFTR-Intron10-4014	+	UGAGGCAGGAGAAUGGCGUGAAC	23	22896
CFTR-Intron10-4015	+	CUGAGGCAGGAGAAUGGCGUGAAC	24	22897
CFTR-Intron10-4016	+	GAACCUAUAAGGAAUAAC	18	22898
CFTR-Intron10-4017	+	AGAACCUAUAAGGAAUAAC	19	22899
CFTR-Intron10-403	+	CAGAACCUAUAAGGAAUAAC	20	19289
CFTR-Intron10-4018	+	ACAGAACCUAUAAGGAAUAAC	21	22900
CFTR-Intron10-4019	+	UACAGAACCUAUAAGGAAUAAC	22	22901
CFTR-Intron10-4020	+	UUACAGAACCUAUAAGGAAUAAC	23	22902
CFTR-Intron10-4021	+	AUUACAGAACCUAUAAGGAAUAAC	24	22903
CFTR-Intron10-4022	+	AAAAUAUGCGAGAACCAC	18	22904
CFTR-Intron10-4023	+	AAAAAUAUGCGAGAACCAC	19	22905
CFTR-Intron10-4024	+	GAAAAAUAUGCGAGAACCAC	20	22906
CFTR-Intron10-4025	+	UGAAAAAUAUGCGAGAACCAC	21	22907
CFTR-Intron10-4026	+	AUGAAAAAUAUGCGAGAACCAC	22	22908
CFTR-Intron10-4027	+	GAUGAAAAAUAUGCGAGAACCAC	23	22909
CFTR-Intron10-4028	+	UGAUGAAAAAUAUGCGAGAACCAC	24	22910
CFTR-Intron10-4029	+	AGUAUUAAGUAUAGCCAC	18	22911
CFTR-Intron10-4030	+	UAGUAUUAAGUAUAGCCAC	19	22912
CFTR-Intron10-408	+	UUAGUAUUAAGUAUAGCCAC	20	19294
CFTR-Intron10-4031	+	AUUAGUAUUAAGUAUAGCCAC	21	22913
CFTR-Intron10-4032	+	UAUUAGUAUUAAGUAUAGCCAC	22	22914
CFTR-Intron10-4033	+	UUAUUAGUAUUAAGUAUAGCCAC	23	22915
CFTR-Intron10-4034	+	GUUAUUAGUAUUAAGUAUAGCCAC	24	22916
CFTR-Intron10-4035	+	UUUAAUAAAUAAUAUCAC	18	22917
CFTR-Intron10-4036	+	UUUUAAUAAAUAAUAUCAC	19	22918
CFTR-Intron10-4037	+	AUUUUAAUAAAUAAUAUCAC	20	22919
CFTR-Intron10-4038	+	AAUUUUAAUAAAUAAUAUCAC	21	22920
CFTR-Intron10-4039	+	AAAUUUUAAUAAAUAAUAUCAC	22	22921
CFTR-Intron10-4040	+	UAAAUUUUAAUAAAUAAUAUCAC	23	22922
CFTR-Intron10-4041	+	UUAAAUUUUAAUAAAUAAUAUCAC	24	22923
CFTR-Intron10-4042	+	GGAGAGAGAACUGCUCAC	18	22924
CFTR-Intron10-4043	+	UGGAGAGAGAACUGCUCAC	19	22925
CFTR-Intron10-4044	+	CUGGAGAGAGAACUGCUCAC	20	22926
CFTR-Intron10-4045	+	ACUGGAGAGAGAACUGCUCAC	21	22927
CFTR-Intron10-4046	+	UACUGGAGAGAGAACUGCUCAC	22	22928
CFTR-Intron10-4047	+	UUACUGGAGAGAGAACUGCUCAC	23	22929
CFTR-Intron10-4048	+	UUUACUGGAGAGAGAACUGCUCAC	24	22930
CFTR-Intron10-4049	+	AAGACAUUUAAUGUAGAC	18	22931
CFTR-Intron10-4050	+	CAAGACAUUUAAUGUAGAC	19	22932
CFTR-Intron10-4051	+	GCAAGACAUUUAAUGUAGAC	20	22933
CFTR-Intron10-4052	+	CGCAAGACAUUUAAUGUAGAC	21	22934
CFTR-Intron10-4053	+	GCGCAAGACAUUUAAUGUAGAC	22	22935
CFTR-Intron10-4054	+	AGCGCAAGACAUUUAAUGUAGAC	23	22936
CFTR-Intron10-4055	+	AAGCGCAAGACAUUUAAUGUAGAC	24	22937
CFTR-Intron10-4056	+	UUUAGCCCAUUCUAAUAC	18	22938
CFTR-Intron10-4057	+	CUUUAGCCCAUUCUAAUAC	19	22939
CFTR-Intron10-4058	+	CCUUUAGCCCAUUCUAAUAC	20	22940
CFTR-Intron10-4059	+	CCCUUUAGCCCAUUCUAAUAC	21	22941
CFTR-Intron10-4060	+	GCCCUUUAGCCCAUUCUAAUAC	22	22942
CFTR-Intron10-4061	+	UGCCCUUUAGCCCAUUCUAAUAC	23	22943
CFTR-Intron10-4062	+	UUGCCCUUUAGCCCAUUCUAAUAC	24	22944
CFTR-Intron10-4063	+	UAUUUGUGGAGGACAUAC	18	22945
CFTR-Intron10-4064	+	AUAUUUGUGGAGGACAUAC	19	22946
CFTR-Intron10-4065	+	AAUAUUUGUGGAGGACAUAC	20	22947
CFTR-Intron10-4066	+	AAAUAUUUGUGGAGGACAUAC	21	22948
CFTR-Intron10-4067	+	AAAAUAUUUGUGGAGGACAUAC	22	22949
CFTR-Intron10-4068	+	AAAAAUAUUUGUGGAGGACAUAC	23	22950
CFTR-Intron10-4069	+	AAAAAAUAUUUGUGGAGGACAUAC	24	22951
CFTR-Intron10-4070	+	GCCUGUAGUCCCAGCUAC	18	22952
CFTR-Intron10-4071	+	CGCCUGUAGUCCCAGCUAC	19	22953
CFTR-Intron10-4072	+	GCGCCUGUAGUCCCAGCUAC	20	22954
CFTR-Intron10-4073	+	GGCGCCUGUAGUCCCAGCUAC	21	22955
CFTR-Intron10-4074	+	GGGCGCCUGUAGUCCCAGCUAC	22	22956
CFTR-Intron10-4075	+	CGGGCGCCUGUAGUCCCAGCUAC	23	22957
CFTR-Intron10-4076	+	GCGGGCGCCUGUAGUCCCAGCUAC	24	22958
CFTR-Intron10-4077	+	UGCCUGUAGUCCCAGCUAC	19	22959
CFTR-Intron10-4078	+	GUGCCUGUAGUCCCAGCUAC	20	22960
CFTR-Intron10-4079	+	CGUGCCUGUAGUCCCAGCUAC	21	22961
CFTR-Intron10-4080	+	GCGUGCCUGUAGUCCCAGCUAC	22	22962
CFTR-Intron10-4081	+	UGCGUGCCUGUAGUCCCAGCUAC	23	22963
CFTR-Intron10-4082	+	GUGCGUGCCUGUAGUCCCAGCUAC	24	22964
CFTR-Intron10-4083	+	ACUUGCUUCACCUGCUAC	18	22965
CFTR-Intron10-4084	+	CACUUGCUUCACCUGCUAC	19	22966
CFTR-Intron10-4085	+	GCACUUGCUUCACCUGCUAC	20	22967
CFTR-Intron10-4086	+	UGCACUUGCUUCACCUGCUAC	21	22968
CFTR-Intron10-4087	+	UUGCACUUGCUUCACCUGCUAC	22	22969
CFTR-Intron10-4088	+	UUUGCACUUGCUUCACCUGCUAC	23	22970
CFTR-Intron10-4089	+	CUUUGCACUUGCUUCACCUGCUAC	24	22971
CFTR-Intron10-4090	+	AAAUCUUAUAGAGAUUAC	18	22972
CFTR-Intron10-4091	+	AAAAUCUUAUAGAGAUUAC	19	22973
CFTR-Intron10-4092	+	CAAAAUCUUAUAGAGAUUAC	20	22974
CFTR-Intron10-4093	+	ACAAAAUCUUAUAGAGAUUAC	21	22975
CFTR-Intron10-4094	+	AACAAAAUCUUAUAGAGAUUAC	22	22976
CFTR-Intron10-4095	+	UAACAAAAUCUUAUAGAGAUUAC	23	22977
CFTR-Intron10-4096	+	AUAACAAAAUCUUAUAGAGAUUAC	24	22978
CFTR-Intron10-4097	+	UUUUACAAUUCUUAUUAC	18	22979
CFTR-Intron10-4098	+	AUUUUACAAUUCUUAUUAC	19	22980
CFTR-Intron10-4099	+	AAUUUUACAAUUCUUAUUAC	20	22981
CFTR-Intron10-4100	+	AAAUUUUACAAUUCUUAUUAC	21	22982
CFTR-Intron10-4101	+	UAAAUUUUACAAUUCUUAUUAC	22	22983
CFTR-Intron10-4102	+	GUAAAUUUUACAAUUCUUAUUAC	23	22984
CFTR-Intron10-4103	+	AGUAAAUUUUACAAUUCUUAUUAC	24	22985
CFTR-Intron10-4104	+	CUGCAAUAUGCAAUUUAC	18	22986
CFTR-Intron10-4105	+	ACUGCAAUAUGCAAUUUAC	19	22987
CFTR-Intron10-1190	+	UACUGCAAUAUGCAAUUUAC	20	20075
CFTR-Intron10-4106	+	UUACUGCAAUAUGCAAUUUAC	21	22988
CFTR-Intron10-4107	+	UUUACUGCAAUAUGCAAUUUAC	22	22989
CFTR-Intron10-4108	+	UUUUACUGCAAUAUGCAAUUUAC	23	22990
CFTR-Intron10-4109	+	UUUUUACUGCAAUAUGCAAUUUAC	24	22991
CFTR-Intron10-4110	+	UUUGUACAAAAUUAAACC	18	22992
CFTR-Intron10-4111	+	CUUUGUACAAAAUUAAACC	19	22993
CFTR-Intron10-4112	+	CCUUUGUACAAAAUUAAACC	20	22994
CFTR-Intron10-4113	+	UCCUUUGUACAAAAUUAAACC	21	22995
CFTR-Intron10-4114	+	UUCCUUUGUACAAAAUUAAACC	22	22996
CFTR-Intron10-4115	+	AUUCCUUUGUACAAAAUUAAACC	23	22997
CFTR-Intron10-4116	+	AAUUCCUUUGUACAAAAUUAAACC	24	22998
CFTR-Intron10-4117	+	AGGAGAAUGGCGUGAACC	18	22999
CFTR-Intron10-4118	+	CAGGAGAAUGGCGUGAACC	19	23000
CFTR-Intron10-661	+	GCAGGAGAAUGGCGUGAACC	20	19547
CFTR-Intron10-4119	+	GGCAGGAGAAUGGCGUGAACC	21	23001
CFTR-Intron10-4120	+	AGGCAGGAGAAUGGCGUGAACC	22	23002
CFTR-Intron10-4121	+	GAGGCAGGAGAAUGGCGUGAACC	23	23003
CFTR-Intron10-4122	+	UGAGGCAGGAGAAUGGCGUGAACC	24	23004
CFTR-Intron10-4123	+	GGUCUUGAUCUCCUAACC	18	23005
CFTR-Intron10-4124	+	UGGUCUUGAUCUCCUAACC	19	23006
CFTR-Intron10-4125	+	AUGGUCUUGAUCUCCUAACC	20	23007
CFTR-Intron10-4126	+	GAUGGUCUUGAUCUCCUAACC	21	23008
CFTR-Intron10-4127	+	GGAUGGUCUUGAUCUCCUAACC	22	23009
CFTR-Intron10-4128	+	AGGAUGGUCUUGAUCUCCUAACC	23	23010
CFTR-Intron10-4129	+	CAGGAUGGUCUUGAUCUCCUAACC	24	23011
CFTR-Intron10-4130	+	CCCUGCAAUACCAUCACC	18	23012
CFTR-Intron10-4131	+	ACCCUGCAAUACCAUCACC	19	23013
CFTR-Intron10-4132	+	CACCCUGCAAUACCAUCACC	20	23014
CFTR-Intron10-4133	+	CCACCCUGCAAUACCAUCACC	21	23015
CFTR-Intron10-4134	+	CCCACCCUGCAAUACCAUCACC	22	23016
CFTR-Intron10-4135	+	CCCCACCCUGCAAUACCAUCACC	23	23017
CFTR-Intron10-4136	+	GCCCCACCCUGCAAUACCAUCACC	24	23018
CFTR-Intron10-4137	+	GUGGCCUCUAAUCUCACC	18	23019
CFTR-Intron10-4138	+	AGUGGCCUCUAAUCUCACC	19	23020
CFTR-Intron10-4139	+	CAGUGGCCUCUAAUCUCACC	20	23021
CFTR-Intron10-4140	+	CCAGUGGCCUCUAAUCUCACC	21	23022
CFTR-Intron10-4141	+	UCCAGUGGCCUCUAAUCUCACC	22	23023
CFTR-Intron10-4142	+	CUCCAGUGGCCUCUAAUCUCACC	23	23024
CFTR-Intron10-4143	+	UCUCCAGUGGCCUCUAAUCUCACC	24	23025
CFTR-Intron10-4144	+	CUGCUAUAACAAAAUACC	18	23026
CFTR-Intron10-4145	+	GCUGCUAUAACAAAAUACC	19	23027
CFTR-Intron10-4146	+	GGCUGCUAUAACAAAAUACC	20	23028
CFTR-Intron10-4147	+	AGGCUGCUAUAACAAAAUACC	21	23029
CFTR-Intron10-4148	+	CAGGCUGCUAUAACAAAAUACC	22	23030
CFTR-Intron10-4149	+	UCAGGCUGCUAUAACAAAAUACC	23	23031
CFTR-Intron10-4150	+	UUCAGGCUGCUAUAACAAAAUACC	24	23032
CFTR-Intron10-4151	+	UACAGCUAAAGUAUUACC	18	23033
CFTR-Intron10-4152	+	AUACAGCUAAAGUAUUACC	19	23034
CFTR-Intron10-4153	+	UAUACAGCUAAAGUAUUACC	20	23035
CFTR-Intron10-4154	+	AUAUACAGCUAAAGUAUUACC	21	23036
CFTR-Intron10-4155	+	AAUAUACAGCUAAAGUAUUACC	22	23037
CFTR-Intron10-4156	+	UAAUAUACAGCUAAAGUAUUACC	23	23038
CFTR-Intron10-4157	+	AUAAUAUACAGCUAAAGUAUUACC	24	23039
CFTR-Intron10-4158	+	GGAGAAUGGCGUGAACCC	18	23040
CFTR-Intron10-4159	+	AGGAGAAUGGCGUGAACCC	19	23041
CFTR-Intron10-1191	+	CAGGAGAAUGGCGUGAACCC	20	20076
CFTR-Intron10-4160	+	GCAGGAGAAUGGCGUGAACCC	21	23042
CFTR-Intron10-4161	+	GGCAGGAGAAUGGCGUGAACCC	22	23043
CFTR-Intron10-4162	+	AGGCAGGAGAAUGGCGUGAACCC	23	23044
CFTR-Intron10-4163	+	GAGGCAGGAGAAUGGCGUGAACCC	24	23045
CFTR-Intron10-4164	+	GGAGAAUUGCUUGAGCCC	18	23046
CFTR-Intron10-4165	+	AGGAGAAUUGCUUGAGCCC	19	23047
CFTR-Intron10-1195	+	CAGGAGAAUUGCUUGAGCCC	20	20080
CFTR-Intron10-4166	+	GCAGGAGAAUUGCUUGAGCCC	21	23048
CFTR-Intron10-4167	+	GGCAGGAGAAUUGCUUGAGCCC	22	23049
CFTR-Intron10-4168	+	AGGCAGGAGAAUUGCUUGAGCCC	23	23050
CFTR-Intron10-4169	+	GAGGCAGGAGAAUUGCUUGAGCCC	24	23051
CFTR-Intron10-4170	+	AAGUGUUUAAAUAUUCCC	18	23052
CFTR-Intron10-4171	+	GAAGUGUUUAAAUAUUCCC	19	23053
CFTR-Intron10-4172	+	AGAAGUGUUUAAAUAUUCCC	20	23054
CFTR-Intron10-4173	+	CAGAAGUGUUUAAAUAUUCCC	21	23055
CFTR-Intron10-4174	+	UCAGAAGUGUUUAAAUAUUCCC	22	23056
CFTR-Intron10-4175	+	CUCAGAAGUGUUUAAAUAUUCCC	23	23057
CFTR-Intron10-4176	+	UCUCAGAAGUGUUUAAAUAUUCCC	24	23058
CFTR-Intron10-4177	+	GGAAAGGUCAAUUGAGCC	18	23059
CFTR-Intron10-4178	+	CGGAAAGGUCAAUUGAGCC	19	23060
CFTR-Intron10-4179	+	GCGGAAAGGUCAAUUGAGCC	20	23061
CFTR-Intron10-4180	+	AGCGGAAAGGUCAAUUGAGCC	21	23062
CFTR-Intron10-4181	+	AAGCGGAAAGGUCAAUUGAGCC	22	23063
CFTR-Intron10-4182	+	GAAGCGGAAAGGUCAAUUGAGCC	23	23064
CFTR-Intron10-4183	+	UGAAGCGGAAAGGUCAAUUGAGCC	24	23065
CFTR-Intron10-4184	+	AGGAGAAUUGCUUGAGCC	18	23066
CFTR-Intron10-4185	+	CAGGAGAAUUGCUUGAGCC	19	23067
CFTR-Intron10-665	+	GCAGGAGAAUUGCUUGAGCC	20	19551
CFTR-Intron10-4186	+	GGCAGGAGAAUUGCUUGAGCC	21	23068
CFTR-Intron10-4187	+	AGGCAGGAGAAUUGCUUGAGCC	22	23069
CFTR-Intron10-4188	+	GAGGCAGGAGAAUUGCUUGAGCC	23	23070
CFTR-Intron10-4189	+	UGAGGCAGGAGAAUUGCUUGAGCC	24	23071
CFTR-Intron10-4190	+	GGCACUUGUUGACAGUCC	18	23072
CFTR-Intron10-4191	+	AGGCACUUGUUGACAGUCC	19	23073
CFTR-Intron10-4192	+	UAGGCACUUGUUGACAGUCC	20	23074
CFTR-Intron10-4193	+	CUAGGCACUUGUUGACAGUCC	21	23075
CFTR-Intron10-4194	+	GCUAGGCACUUGUUGACAGUCC	22	23076
CFTR-Intron10-4195	+	UGCUAGGCACUUGUUGACAGUCC	23	23077
CFTR-Intron10-4196	+	GUGCUAGGCACUUGUUGACAGUCC	24	23078
CFTR-Intron10-4197	+	CUACCAGCCCCCUCUUCC	18	23079
CFTR-Intron10-4198	+	ACUACCAGCCCCCUCUUCC	19	23080
CFTR-Intron10-4199	+	CACUACCAGCCCCCUCUUCC	20	23081
CFTR-Intron10-4200	+	ACACUACCAGCCCCCUCUUCC	21	23082
CFTR-Intron10-4201	+	CACACUACCAGCCCCCUCUUCC	22	23083
CFTR-Intron10-4202	+	UCACACUACCAGCCCCCUCUUCC	23	23084
CFTR-Intron10-4203	+	UUCACACUACCAGCCCCCUCUUCC	24	23085
CFTR-Intron10-4204	+	CAAGAUAGUGGGAAAAGC	18	23086
CFTR-Intron10-4205	+	CCAAGAUAGUGGGAAAAGC	19	23087
CFTR-Intron10-4206	+	UCCAAGAUAGUGGGAAAAGC	20	23088
CFTR-Intron10-4207	+	GUCCAAGAUAGUGGGAAAAGC	21	23089
CFTR-Intron10-4208	+	UGUCCAAGAUAGUGGGAAAAGC	22	23090
CFTR-Intron10-4209	+	UUGUCCAAGAUAGUGGGAAAAGC	23	23091
CFTR-Intron10-4210	+	GUUGUCCAAGAUAGUGGGAAAAGC	24	23092
CFTR-Intron10-4211	+	UUACUCAGUCCAGAAAGC	18	23093
CFTR-Intron10-4212	+	GUUACUCAGUCCAGAAAGC	19	23094
CFTR-Intron10-4213	+	AGUUACUCAGUCCAGAAAGC	20	23095
CFTR-Intron10-4214	+	CAGUUACUCAGUCCAGAAAGC	21	23096
CFTR-Intron10-4215	+	CCAGUUACUCAGUCCAGAAAGC	22	23097
CFTR-Intron10-4216	+	UCCAGUUACUCAGUCCAGAAAGC	23	23098
CFTR-Intron10-4217	+	UUCCAGUUACUCAGUCCAGAAAGC	24	23099
CFTR-Intron10-4218	+	CCGCCACUGCACUCCAGC	18	23100
CFTR-Intron10-4219	+	CCCGCCACUGCACUCCAGC	19	23101
CFTR-Intron10-4220	+	UCCCGCCACUGCACUCCAGC	20	23102
CFTR-Intron10-4221	+	AUCCCGCCACUGCACUCCAGC	21	23103
CFTR-Intron10-4222	+	GAUCCCGCCACUGCACUCCAGC	22	23104
CFTR-Intron10-4223	+	AGAUCCCGCCACUGCACUCCAGC	23	23105
CFTR-Intron10-4224	+	GAGAUCCCGCCACUGCACUCCAGC	24	23106
CFTR-Intron10-4225	+	CAGGAGAAUUGCUUGAGC	18	23107
CFTR-Intron10-4226	+	GCAGGAGAAUUGCUUGAGC	19	23108
CFTR-Intron10-4227	+	GGCAGGAGAAUUGCUUGAGC	20	23109
CFTR-Intron10-4228	+	AGGCAGGAGAAUUGCUUGAGC	21	23110
CFTR-Intron10-4229	+	GAGGCAGGAGAAUUGCUUGAGC	22	23111
CFTR-Intron10-4230	+	UGAGGCAGGAGAAUUGCUUGAGC	23	23112
CFTR-Intron10-4231	+	GUGAGGCAGGAGAAUUGCUUGAGC	24	23113
CFTR-Intron10-1222	+	ACCUCAGCCUCCCAAGUAGC	20	20107
CFTR-Intron10-4232	+	CACCUCAGCCUCCCAAGUAGC	21	23114
CFTR-Intron10-4233	+	CCACCUCAGCCUCCCAAGUAGC	22	23115
CFTR-Intron10-4234	+	CCCACCUCAGCCUCCCAAGUAGC	23	23116
CFTR-Intron10-4235	+	UCCCACCUCAGCCUCCCAAGUAGC	24	23117
CFTR-Intron10-4236	+	CUCAGCCUCCCGAGUAGC	18	23118
CFTR-Intron10-4237	+	CCUCAGCCUCCCGAGUAGC	19	23119
CFTR-Intron10-675	+	GCCUCAGCCUCCCGAGUAGC	20	19561
CFTR-Intron10-4238	+	UGCCUCAGCCUCCCGAGUAGC	21	23120
CFTR-Intron10-4239	+	CUGCCUCAGCCUCCCGAGUAGC	22	23121
CFTR-Intron10-4240	+	CCUGCCUCAGCCUCCCGAGUAGC	23	23122
CFTR-Intron10-4241	+	UCCUGCCUCAGCCUCCCGAGUAGC	24	23123
CFTR-Intron10-4242	+	AAACUCAUAAGGGACCGC	18	23124
CFTR-Intron10-4243	+	AAAACUCAUAAGGGACCGC	19	23125
CFTR-Intron10-4244	+	GAAAACUCAUAAGGGACCGC	20	23126
CFTR-Intron10-4245	+	AGAAAACUCAUAAGGGACCGC	21	23127
CFTR-Intron10-4246	+	GAGAAAACUCAUAAGGGACCGC	22	23128
CFTR-Intron10-4247	+	AGAGAAAACUCAUAAGGGACCGC	23	23129
CFTR-Intron10-4248	+	UAGAGAAAACUCAUAAGGGACCGC	24	23130
CFTR-Intron10-4249	+	UCUCACAGUUCUGGAGGC	18	23131
CFTR-Intron10-4250	+	UUCUCACAGUUCUGGAGGC	19	23132
CFTR-Intron10-1229	+	UUUCUCACAGUUCUGGAGGC	20	20114
CFTR-Intron10-4251	+	AUUUCUCACAGUUCUGGAGGC	21	23133
CFTR-Intron10-4252	+	UAUUUCUCACAGUUCUGGAGGC	22	23134
CFTR-Intron10-4253	+	UUAUUUCUCACAGUUCUGGAGGC	23	23135
CFTR-Intron10-4254	+	UUUAUUUCUCACAGUUCUGGAGGC	24	23136
CFTR-Intron10-4255	+	UACUUGGGAGGCUGAGGC	18	23137
CFTR-Intron10-4256	+	CUACUUGGGAGGCUGAGGC	19	23138
CFTR-Intron10-681	+	GCUACUUGGGAGGCUGAGGC	20	19567
CFTR-Intron10-4257	+	AGCUACUUGGGAGGCUGAGGC	21	23139
CFTR-Intron10-4258	+	CAGCUACUUGGGAGGCUGAGGC	22	23140
CFTR-Intron10-4259	+	CCAGCUACUUGGGAGGCUGAGGC	23	23141
CFTR-Intron10-4260	+	CCCAGCUACUUGGGAGGCUGAGGC	24	23142
CFTR-Intron10-4261	+	UACUUGGGAGGGUGAGGC	18	23143
CFTR-Intron10-4262	+	CUACUUGGGAGGGUGAGGC	19	23144
CFTR-Intron10-682	+	GCUACUUGGGAGGGUGAGGC	20	19568
CFTR-Intron10-4263	+	AGCUACUUGGGAGGGUGAGGC	21	23145
CFTR-Intron10-4264	+	CAGCUACUUGGGAGGGUGAGGC	22	23146
CFTR-Intron10-4265	+	CCAGCUACUUGGGAGGGUGAGGC	23	23147
CFTR-Intron10-4266	+	CCCAGCUACUUGGGAGGGUGAGGC	24	23148
CFTR-Intron10-4267	+	CUGAGGCAGGAGAAUGGC	18	23149
CFTR-Intron10-4268	+	GCUGAGGCAGGAGAAUGGC	19	23150
CFTR-Intron10-4269	+	GGCUGAGGCAGGAGAAUGGC	20	23151
CFTR-Intron10-4270	+	AGGCUGAGGCAGGAGAAUGGC	21	23152
CFTR-Intron10-4271	+	GAGGCUGAGGCAGGAGAAUGGC	22	23153
CFTR-Intron10-4272	+	GGAGGCUGAGGCAGGAGAAUGGC	23	23154
CFTR-Intron10-4273	+	GGGAGGCUGAGGCAGGAGAAUGGC	24	23155
CFTR-Intron10-4274	+	UUUCAACAUAUGAAUGGC	18	23156
CFTR-Intron10-4275	+	AUUUCAACAUAUGAAUGGC	19	23157
CFTR-Intron10-683	+	GAUUUCAACAUAUGAAUGGC	20	19569
CFTR-Intron10-4276	+	GGAUUUCAACAUAUGAAUGGC	21	23158
CFTR-Intron10-4277	+	AGGAUUUCAACAUAUGAAUGGC	22	23159
CFTR-Intron10-4278	+	UAGGAUUUCAACAUAUGAAUGGC	23	23160
CFTR-Intron10-4279	+	UUAGGAUUUCAACAUAUGAAUGGC	24	23161
CFTR-Intron10-4280	+	AAUGGCUAUCCACAAUGC	18	23162
CFTR-Intron10-4281	+	AAAUGGCUAUCCACAAUGC	19	23163
CFTR-Intron10-4282	+	UAAAUGGCUAUCCACAAUGC	20	23164
CFTR-Intron10-4283	+	UUAAAUGGCUAUCCACAAUGC	21	23165
CFTR-Intron10-4284	+	UUUAAAUGGCUAUCCACAAUGC	22	23166
CFTR-Intron10-4285	+	UUUUAAAUGGCUAUCCACAAUGC	23	23167
CFTR-Intron10-4286	+	GUUUUAAAUGGCUAUCCACAAUGC	24	23168
CFTR-Intron10-4287	+	GGUUGGAUGAGGGAAUGC	18	23169
CFTR-Intron10-4288	+	UGGUUGGAUGAGGGAAUGC	19	23170
CFTR-Intron10-431	+	UUGGUUGGAUGAGGGAAUGC	20	19317
CFTR-Intron10-4289	+	CUUGGUUGGAUGAGGGAAUGC	21	23171
CFTR-Intron10-4290	+	CCUUGGUUGGAUGAGGGAAUGC	22	23172
CFTR-Intron10-4291	+	ACCUUGGUUGGAUGAGGGAAUGC	23	23173
CFTR-Intron10-4292	+	UACCUUGGUUGGAUGAGGGAAUGC	24	23174
CFTR-Intron10-4293	+	ACAUGAUGAAAAAUAUGC	18	23175
CFTR-Intron10-4294	+	AACAUGAUGAAAAAUAUGC	19	23176
CFTR-Intron10-4295	+	AAACAUGAUGAAAAAUAUGC	20	23177
CFTR-Intron10-4296	+	UAAACAUGAUGAAAAAUAUGC	21	23178
CFTR-Intron10-4297	+	CUAAACAUGAUGAAAAAUAUGC	22	23179
CFTR-Intron10-4298	+	ACUAAACAUGAUGAAAAAUAUGC	23	23180
CFTR-Intron10-4299	+	CACUAAACAUGAUGAAAAAUAUGC	24	23181
CFTR-Intron10-4300	+	CAAUUUUAAUAAAACUGC	18	23182
CFTR-Intron10-4301	+	UCAAUUUUAAUAAAACUGC	19	23183
CFTR-Intron10-4302	+	AUCAAUUUUAAUAAAACUGC	20	23184
CFTR-Intron10-4303	+	CAUCAAUUUUAAUAAAACUGC	21	23185
CFTR-Intron10-4304	+	UCAUCAAUUUUAAUAAAACUGC	22	23186
CFTR-Intron10-4305	+	CUCAUCAAUUUUAAUAAAACUGC	23	23187
CFTR-Intron10-4306	+	GCUCAUCAAUUUUAAUAAAACUGC	24	23188
CFTR-Intron10-4307	+	GUGAGGCAGGAGAAUUGC	18	23189
CFTR-Intron10-4308	+	GGUGAGGCAGGAGAAUUGC	19	23190
CFTR-Intron10-4309	+	GGGUGAGGCAGGAGAAUUGC	20	23191
CFTR-Intron10-4310	+	AGGGUGAGGCAGGAGAAUUGC	21	23192
CFTR-Intron10-4311	+	GAGGGUGAGGCAGGAGAAUUGC	22	23193
CFTR-Intron10-4312	+	GGAGGGUGAGGCAGGAGAAUUGC	23	23194
CFTR-Intron10-4313	+	GGGAGGGUGAGGCAGGAGAAUUGC	24	23195
CFTR-Intron10-4314	+	GCCACCAUCAUCACUUGC	18	23196
CFTR-Intron10-4315	+	AGCCACCAUCAUCACUUGC	19	23197
CFTR-Intron10-4316	+	AAGCCACCAUCAUCACUUGC	20	23198
CFTR-Intron10-4317	+	CAAGCCACCAUCAUCACUUGC	21	23199
CFTR-Intron10-4318	+	UCAAGCCACCAUCAUCACUUGC	22	23200
CFTR-Intron10-4319	+	AUCAAGCCACCAUCAUCACUUGC	23	23201
CFTR-Intron10-4320	+	GAUCAAGCCACCAUCAUCACUUGC	24	23202
CFTR-Intron10-4321	+	ACAAAGUAACAGAAAAUC	18	23203
CFTR-Intron10-4322	+	AACAAAGUAACAGAAAAUC	19	23204
CFTR-Intron10-4323	+	UAACAAAGUAACAGAAAAUC	20	23205
CFTR-Intron10-4324	+	GUAACAAAGUAACAGAAAAUC	21	23206
CFTR-Intron10-4325	+	AGUAACAAAGUAACAGAAAAUC	22	23207
CFTR-Intron10-4326	+	AAGUAACAAAGUAACAGAAAAUC	23	23208
CFTR-Intron10-4327	+	AAAGUAACAAAGUAACAGAAAAUC	24	23209
CFTR-Intron10-4328	+	UGCUAUUUAAACAGAAUC	18	23210
CFTR-Intron10-4329	+	GUGCUAUUUAAACAGAAUC	19	23211
CFTR-Intron10-433	+	AGUGCUAUUUAAACAGAAUC	20	19319
CFTR-Intron10-4330	+	CAGUGCUAUUUAAACAGAAUC	21	23212
CFTR-Intron10-4331	+	CCAGUGCUAUUUAAACAGAAUC	22	23213
CFTR-Intron10-4332	+	UCCAGUGCUAUUUAAACAGAAUC	23	23214
CFTR-Intron10-4333	+	CUCCAGUGCUAUUUAAACAGAAUC	24	23215
CFTR-Intron10-4334	+	UUUAGUAGAAACCUAAUC	18	23216
CFTR-Intron10-4335	+	UUUUAGUAGAAACCUAAUC	19	23217
CFTR-Intron10-91	+	GUUUUAGUAGAAACCUAAUC	20	18977
CFTR-Intron10-4336	+	GGUUUUAGUAGAAACCUAAUC	21	23218
CFTR-Intron10-4337	+	UGGUUUUAGUAGAAACCUAAUC	22	23219
CFTR-Intron10-4338	+	UUGGUUUUAGUAGAAACCUAAUC	23	23220
CFTR-Intron10-4339	+	UUUGGUUUUAGUAGAAACCUAAUC	24	23221
CFTR-Intron10-4340	+	GGCCGAGGCAGGCAGAUC	18	23222
CFTR-Intron10-4341	+	AGGCCGAGGCAGGCAGAUC	19	23223
CFTR-Intron10-4342	+	GAGGCCGAGGCAGGCAGAUC	20	23224
CFTR-Intron10-4343	+	GGAGGCCGAGGCAGGCAGAUC	21	23225
CFTR-Intron10-4344	+	GGGAGGCCGAGGCAGGCAGAUC	22	23226
CFTR-Intron10-4345	+	UGGGAGGCCGAGGCAGGCAGAUC	23	23227
CFTR-Intron10-4346	+	UUGGGAGGCCGAGGCAGGCAGAUC	24	23228
CFTR-Intron10-4347	+	GGCCGAGGCGGGCGGAUC	18	23229
CFTR-Intron10-4348	+	AGGCCGAGGCGGGCGGAUC	19	23230
CFTR-Intron10-4349	+	GAGGCCGAGGCGGGCGGAUC	20	23231
CFTR-Intron10-4350	+	GGAGGCCGAGGCGGGCGGAUC	21	23232
CFTR-Intron10-4351	+	GGGAGGCCGAGGCGGGCGGAUC	22	23233
CFTR-Intron10-4352	+	UGGGAGGCCGAGGCGGGCGGAUC	23	23234
CFTR-Intron10-4353	+	UUGGGAGGCCGAGGCGGGCGGAUC	24	23235
CFTR-Intron10-4354	+	UCUAUCAUAGAAUUGAUC	18	23236
CFTR-Intron10-4355	+	AUCUAUCAUAGAAUUGAUC	19	23237
CFTR-Intron10-4356	+	CAUCUAUCAUAGAAUUGAUC	20	23238
CFTR-Intron10-4357	+	ACAUCUAUCAUAGAAUUGAUC	21	23239
CFTR-Intron10-4358	+	CACAUCUAUCAUAGAAUUGAUC	22	23240
CFTR-Intron10-4359	+	GCACAUCUAUCAUAGAAUUGAUC	23	23241
CFTR-Intron10-4360	+	UGCACAUCUAUCAUAGAAUUGAUC	24	23242
CFTR-Intron10-4361	+	AUACUGGGUUCAUUUAUC	18	23243
CFTR-Intron10-4362	+	UAUACUGGGUUCAUUUAUC	19	23244
CFTR-Intron10-4363	+	UUAUACUGGGUUCAUUUAUC	20	23245
CFTR-Intron10-4364	+	UUUAUACUGGGUUCAUUUAUC	21	23246
CFTR-Intron10-4365	+	CUUUAUACUGGGUUCAUUUAUC	22	23247
CFTR-Intron10-4366	+	UCUUUAUACUGGGUUCAUUUAUC	23	23248
CFTR-Intron10-4367	+	GUCUUUAUACUGGGUUCAUUUAUC	24	23249
CFTR-Intron10-4368	+	CACGCUGGUCUCAAACUC	18	23250
CFTR-Intron10-4369	+	CCACGCUGGUCUCAAACUC	19	23251
CFTR-Intron10-4370	+	CCCACGCUGGUCUCAAACUC	20	23252
CFTR-Intron10-4371	+	GCCCACGCUGGUCUCAAACUC	21	23253
CFTR-Intron10-4372	+	UGCCCACGCUGGUCUCAAACUC	22	23254
CFTR-Intron10-4373	+	UUGCCCACGCUGGUCUCAAACUC	23	23255
CFTR-Intron10-4374	+	GUUGCCCACGCUGGUCUCAAACUC	24	23256
CFTR-Intron10-4375	+	GUAUUAGCAAGUGGACUC	18	23257
CFTR-Intron10-4376	+	UGUAUUAGCAAGUGGACUC	19	23258
CFTR-Intron10-4377	+	UUGUAUUAGCAAGUGGACUC	20	23259
CFTR-Intron10-4378	+	AUUGUAUUAGCAAGUGGACUC	21	23260
CFTR-Intron10-4379	+	AAUUGUAUUAGCAAGUGGACUC	22	23261
CFTR-Intron10-4380	+	CAAUUGUAUUAGCAAGUGGACUC	23	23262
CFTR-Intron10-4381	+	UCAAUUGUAUUAGCAAGUGGACUC	24	23263
CFTR-Intron10-4382	+	ACUAAAGACUUCACCCUC	18	23264
CFTR-Intron10-4383	+	UACUAAAGACUUCACCCUC	19	23265
CFTR-Intron10-4384	+	UUACUAAAGACUUCACCCUC	20	23266
CFTR-Intron10-4385	+	UUUACUAAAGACUUCACCCUC	21	23267
CFTR-Intron10-4386	+	AUUUACUAAAGACUUCACCCUC	22	23268
CFTR-Intron10-4387	+	CAUUUACUAAAGACUUCACCCUC	23	23269
CFTR-Intron10-4388	+	UCAUUUACUAAAGACUUCACCCUC	24	23270
CFTR-Intron10-4389	+	CCACCCAAUUUUUGGCUC	18	23271
CFTR-Intron10-4390	+	CCCACCCAAUUUUUGGCUC	19	23272
CFTR-Intron10-4391	+	CCCCACCCAAUUUUUGGCUC	20	23273
CFTR-Intron10-4392	+	CCCCCACCCAAUUUUUGGCUC	21	23274
CFTR-Intron10-4393	+	UCCCCCACCCAAUUUUUGGCUC	22	23275
CFTR-Intron10-4394	+	CUCCCCCACCCAAUUUUUGGCUC	23	23276
CFTR-Intron10-4395	+	GCUCCCCCACCCAAUUUUUGGCUC	24	23277
CFTR-Intron10-4396	+	UAUAGAGAGAAACAUCUC	18	23278
CFTR-Intron10-4397	+	AUAUAGAGAGAAACAUCUC	19	23279
CFTR-Intron10-1238	+	UAUAUAGAGAGAAACAUCUC	20	20123
CFTR-Intron10-4398	+	AUAUAUAGAGAGAAACAUCUC	21	23280
CFTR-Intron10-4399	+	UAUAUAUAGAGAGAAACAUCUC	22	23281
CFTR-Intron10-4400	+	AUAUAUAUAGAGAGAAACAUCUC	23	23282
CFTR-Intron10-4401	+	UAUAUAUAUAGAGAGAAACAUCUC	24	23283
CFTR-Intron10-4402	+	UUUAAUUGCCAGUAAGUC	18	23284
CFTR-Intron10-4403	+	AUUUAAUUGCCAGUAAGUC	19	23285
CFTR-Intron10-4404	+	AAUUUAAUUGCCAGUAAGUC	20	23286
CFTR-Intron10-4405	+	AAAUUUAAUUGCCAGUAAGUC	21	23287
CFTR-Intron10-4406	+	GAAAUUUAAUUGCCAGUAAGUC	22	23288
CFTR-Intron10-4407	+	UGAAAUUUAAUUGCCAGUAAGUC	23	23289
CFTR-Intron10-4408	+	CUGAAAUUUAAUUGCCAGUAAGUC	24	23290
CFTR-Intron10-4409	+	CCUUCCAGUUACUCAGUC	18	23291
CFTR-Intron10-4410	+	UCCUUCCAGUUACUCAGUC	19	23292
CFTR-Intron10-4411	+	AUCCUUCCAGUUACUCAGUC	20	23293
CFTR-Intron10-4412	+	UAUCCUUCCAGUUACUCAGUC	21	23294
CFTR-Intron10-4413	+	UUAUCCUUCCAGUUACUCAGUC	22	23295
CFTR-Intron10-4414	+	UUUAUCCUUCCAGUUACUCAGUC	23	23296
CFTR-Intron10-4415	+	AUUUAUCCUUCCAGUUACUCAGUC	24	23297
CFTR-Intron10-4416	+	AUAAGCCAGCUUUCAGUC	18	23298
CFTR-Intron10-4417	+	CAUAAGCCAGCUUUCAGUC	19	23299
CFTR-Intron10-4418	+	CCAUAAGCCAGCUUUCAGUC	20	23300
CFTR-Intron10-4419	+	GCCAUAAGCCAGCUUUCAGUC	21	23301
CFTR-Intron10-4420	+	UGCCAUAAGCCAGCUUUCAGUC	22	23302
CFTR-Intron10-4421	+	AUGCCAUAAGCCAGCUUUCAGUC	23	23303
CFTR-Intron10-4422	+	GAUGCCAUAAGCCAGCUUUCAGUC	24	23304
CFTR-Intron10-4423	+	CGGGCGGAUCACGAGGUC	18	23305
CFTR-Intron10-4424	+	GCGGGCGGAUCACGAGGUC	19	23306
CFTR-Intron10-688	+	GGCGGGCGGAUCACGAGGUC	20	19574
CFTR-Intron10-4425	+	AGGCGGGCGGAUCACGAGGUC	21	23307
CFTR-Intron10-4426	+	GAGGCGGGCGGAUCACGAGGUC	22	23308
CFTR-Intron10-4427	+	CGAGGCGGGCGGAUCACGAGGUC	23	23309
CFTR-Intron10-4428	+	CCGAGGCGGGCGGAUCACGAGGUC	24	23310
CFTR-Intron10-4429	+	CAGGCAGAUCAUGAGGUC	18	23311
CFTR-Intron10-4430	+	GCAGGCAGAUCAUGAGGUC	19	23312
CFTR-Intron10-4431	+	GGCAGGCAGAUCAUGAGGUC	20	23313
CFTR-Intron10-4432	+	AGGCAGGCAGAUCAUGAGGUC	21	23314
CFTR-Intron10-4433	+	GAGGCAGGCAGAUCAUGAGGUC	22	23315
CFTR-Intron10-4434	+	CGAGGCAGGCAGAUCAUGAGGUC	23	23316
CFTR-Intron10-4435	+	CCGAGGCAGGCAGAUCAUGAGGUC	24	23317
CFTR-Intron10-4436	+	GCUUCACUAAAAUAAUUC	18	23318
CFTR-Intron10-4437	+	UGCUUCACUAAAAUAAUUC	19	23319
CFTR-Intron10-4438	+	UUGCUUCACUAAAAUAAUUC	20	23320
CFTR-Intron10-4439	+	AUUGCUUCACUAAAAUAAUUC	21	23321
CFTR-Intron10-4440	+	UAUUGCUUCACUAAAAUAAUUC	22	23322
CFTR-Intron10-4441	+	AUAUUGCUUCACUAAAAUAAUUC	23	23323
CFTR-Intron10-4442	+	AAUAUUGCUUCACUAAAAUAAUUC	24	23324
CFTR-Intron10-4443	+	GAUUAUUCGGUAUAAUUC	18	23325
CFTR-Intron10-4444	+	AGAUUAUUCGGUAUAAUUC	19	23326
CFTR-Intron10-4445	+	UAGAUUAUUCGGUAUAAUUC	20	23327
CFTR-Intron10-4446	+	UUAGAUUAUUCGGUAUAAUUC	21	23328
CFTR-Intron10-4447	+	CUUAGAUUAUUCGGUAUAAUUC	22	23329
CFTR-Intron10-4448	+	UCUUAGAUUAUUCGGUAUAAUUC	23	23330
CFTR-Intron10-4449	+	GUCUUAGAUUAUUCGGUAUAAUUC	24	23331
CFTR-Intron10-4450	+	AAAUCUAAAAGCUAAUUC	18	23332
CFTR-Intron10-4451	+	UAAAUCUAAAAGCUAAUUC	19	23333
CFTR-Intron10-4452	+	GUAAAUCUAAAAGCUAAUUC	20	23334
CFTR-Intron10-4453	+	AGUAAAUCUAAAAGCUAAUUC	21	23335
CFTR-Intron10-4454	+	AAGUAAAUCUAAAAGCUAAUUC	22	23336
CFTR-Intron10-4455	+	UAAGUAAAUCUAAAAGCUAAUUC	23	23337
CFTR-Intron10-4456	+	AUAAGUAAAUCUAAAAGCUAAUUC	24	23338
CFTR-Intron10-4457	+	AUAAUUUGAACAACAUUC	18	23339
CFTR-Intron10-4458	+	AAUAAUUUGAACAACAUUC	19	23340
CFTR-Intron10-4459	+	AAAUAAUUUGAACAACAUUC	20	23341
CFTR-Intron10-4460	+	GAAAUAAUUUGAACAACAUUC	21	23342
CFTR-Intron10-4461	+	AGAAAUAAUUUGAACAACAUUC	22	23343
CFTR-Intron10-4462	+	UAGAAAUAAUUUGAACAACAUUC	23	23344
CFTR-Intron10-4463	+	GUAGAAAUAAUUUGAACAACAUUC	24	23345
CFTR-Intron10-4464	+	AUUUAAAAAGCAAUAUUC	18	23346
CFTR-Intron10-4465	+	AAUUUAAAAAGCAAUAUUC	19	23347
CFTR-Intron10-4466	+	AAAUUUAAAAAGCAAUAUUC	20	23348
CFTR-Intron10-4467	+	UAAAUUUAAAAAGCAAUAUUC	21	23349
CFTR-Intron10-4468	+	UUAAAUUUAAAAAGCAAUAUUC	22	23350
CFTR-Intron10-4469	+	AUUAAAUUUAAAAAGCAAUAUUC	23	23351
CFTR-Intron10-4470	+	UAUUAAAUUUAAAAAGCAAUAUUC	24	23352
CFTR-Intron10-4471	+	ACACAAUGGGUUAUAUUC	18	23353
CFTR-Intron10-4472	+	UACACAAUGGGUUAUAUUC	19	23354
CFTR-Intron10-4473	+	CUACACAAUGGGUUAUAUUC	20	23355
CFTR-Intron10-4474	+	UCUACACAAUGGGUUAUAUUC	21	23356
CFTR-Intron10-4475	+	AUCUACACAAUGGGUUAUAUUC	22	23357
CFTR-Intron10-4476	+	UAUCUACACAAUGGGUUAUAUUC	23	23358
CFTR-Intron10-4477	+	UUAUCUACACAAUGGGUUAUAUUC	24	23359
CFTR-Intron10-4478	+	AGUAUUUUGAAAAGCUUC	18	23360
CFTR-Intron10-4479	+	AAGUAUUUUGAAAAGCUUC	19	23361
CFTR-Intron10-4480	+	AAAGUAUUUUGAAAAGCUUC	20	23362
CFTR-Intron10-4481	+	GAAAGUAUUUUGAAAAGCUUC	21	23363
CFTR-Intron10-4482	+	AGAAAGUAUUUUGAAAAGCUUC	22	23364
CFTR-Intron10-4483	+	UAGAAAGUAUUUUGAAAAGCUUC	23	23365
CFTR-Intron10-4484	+	CUAGAAAGUAUUUUGAAAAGCUUC	24	23366
CFTR-Intron10-4485	+	AUUUAUUUCUCACAGUUC	18	23367
CFTR-Intron10-4486	+	AAUUUAUUUCUCACAGUUC	19	23368
CFTR-Intron10-689	+	GAAUUUAUUUCUCACAGUUC	20	19575
CFTR-Intron10-4487	+	GGAAUUUAUUUCUCACAGUUC	21	23369
CFTR-Intron10-4488	+	AGGAAUUUAUUUCUCACAGUUC	22	23370
CFTR-Intron10-4489	+	CAGGAAUUUAUUUCUCACAGUUC	23	23371
CFTR-Intron10-4490	+	ACAGGAAUUUAUUUCUCACAGUUC	24	23372
CFTR-Intron10-4491	+	CGAAUUGGUACAAAUUUC	18	23373
CFTR-Intron10-4492	+	ACGAAUUGGUACAAAUUUC	19	23374
CFTR-Intron10-443	+	UACGAAUUGGUACAAAUUUC	20	19329
CFTR-Intron10-4493	+	GUACGAAUUGGUACAAAUUUC	21	23375
CFTR-Intron10-4494	+	AGUACGAAUUGGUACAAAUUUC	22	23376
CFTR-Intron10-4495	+	GAGUACGAAUUGGUACAAAUUUC	23	23377
CFTR-Intron10-4496	+	UGAGUACGAAUUGGUACAAAUUUC	24	23378
CFTR-Intron10-4497	+	GAAAAUUUGUUUUCUUUC	18	23379
CFTR-Intron10-4498	+	AGAAAAUUUGUUUUCUUUC	19	23380
CFTR-Intron10-1248	+	AAGAAAAUUUGUUUUCUUUC	20	20133
CFTR-Intron10-4499	+	AAAGAAAAUUUGUUUUCUUUC	21	23381
CFTR-Intron10-4500	+	CAAAGAAAAUUUGUUUUCUUUC	22	23382
CFTR-Intron10-4501	+	ACAAAGAAAAUUUGUUUUCUUUC	23	23383
CFTR-Intron10-4502	+	AACAAAGAAAAUUUGUUUUCUUUC	24	23384
CFTR-Intron10-4503	+	UCAAAGCUACAGAUUUUC	18	23385
CFTR-Intron10-4504	+	AUCAAAGCUACAGAUUUUC	19	23386
CFTR-Intron10-4505	+	AAUCAAAGCUACAGAUUUUC	20	23387
CFTR-Intron10-4506	+	AAAUCAAAGCUACAGAUUUUC	21	23388
CFTR-Intron10-4507	+	UAAAUCAAAGCUACAGAUUUUC	22	23389
CFTR-Intron10-4508	+	AUAAAUCAAAGCUACAGAUUUUC	23	23390
CFTR-Intron10-4509	+	UAUAAAUCAAAGCUACAGAUUUUC	24	23391
CFTR-Intron10-4510	+	UUGCUUUAUUAAGAAAAG	18	23392
CFTR-Intron10-4511	+	AUUGCUUUAUUAAGAAAAG	19	23393
CFTR-Intron10-4512	+	GAUUGCUUUAUUAAGAAAAG	20	23394
CFTR-Intron10-4513	+	UGAUUGCUUUAUUAAGAAAAG	21	23395
CFTR-Intron10-4514	+	CUGAUUGCUUUAUUAAGAAAAG	22	23396
CFTR-Intron10-4515	+	GCUGAUUGCUUUAUUAAGAAAAG	23	23397
CFTR-Intron10-4516	+	UGCUGAUUGCUUUAUUAAGAAAAG	24	23398
CFTR-Intron10-4517	+	GGAUAUCUUAGGUCAAAG	18	23399
CFTR-Intron10-4518	+	AGGAUAUCUUAGGUCAAAG	19	23400
CFTR-Intron10-447	+	UAGGAUAUCUUAGGUCAAAG	20	19333
CFTR-Intron10-4519	+	UUAGGAUAUCUUAGGUCAAAG	21	23401
CFTR-Intron10-4520	+	CUUAGGAUAUCUUAGGUCAAAG	22	23402
CFTR-Intron10-4521	+	CCUUAGGAUAUCUUAGGUCAAAG	23	23403
CFTR-Intron10-4522	+	CCCUUAGGAUAUCUUAGGUCAAAG	24	23404
CFTR-Intron10-4523	+	UGUUAAUGGCAAAGCAAG	18	23405
CFTR-Intron10-4524	+	CUGUUAAUGGCAAAGCAAG	19	23406
CFTR-Intron10-4525	+	UCUGUUAAUGGCAAAGCAAG	20	23407
CFTR-Intron10-4526	+	AUCUGUUAAUGGCAAAGCAAG	21	23408
CFTR-Intron10-4527	+	UAUCUGUUAAUGGCAAAGCAAG	22	23409
CFTR-Intron10-4528	+	UUAUCUGUUAAUGGCAAAGCAAG	23	23410
CFTR-Intron10-4529	+	UUUAUCUGUUAAUGGCAAAGCAAG	24	23411
CFTR-Intron10-4530	+	UUGGGUAAGUUAUAGAAG	18	23412
CFTR-Intron10-4531	+	UUUGGGUAAGUUAUAGAAG	19	23413
CFTR-Intron10-4532	+	AUUUGGGUAAGUUAUAGAAG	20	23414
CFTR-Intron10-4533	+	UAUUUGGGUAAGUUAUAGAAG	21	23415
CFTR-Intron10-4534	+	AUAUUUGGGUAAGUUAUAGAAG	22	23416
CFTR-Intron10-4535	+	CAUAUUUGGGUAAGUUAUAGAAG	23	23417
CFTR-Intron10-4536	+	ACAUAUUUGGGUAAGUUAUAGAAG	24	23418
CFTR-Intron10-4537	+	CACUUUGGGAGGCUGAAG	18	23419
CFTR-Intron10-4538	+	GCACUUUGGGAGGCUGAAG	19	23420
CFTR-Intron10-1252	+	AGCACUUUGGGAGGCUGAAG	20	20137
CFTR-Intron10-4539	+	CAGCACUUUGGGAGGCUGAAG	21	23421
CFTR-Intron10-4540	+	CCAGCACUUUGGGAGGCUGAAG	22	23422
CFTR-Intron10-4541	+	CCCAGCACUUUGGGAGGCUGAAG	23	23423
CFTR-Intron10-4542	+	ACCCAGCACUUUGGGAGGCUGAAG	24	23424
CFTR-Intron10-4543	+	UACUAUUUUCCCUAUAAG	18	23425
CFTR-Intron10-4544	+	AUACUAUUUUCCCUAUAAG	19	23426
CFTR-Intron10-4545	+	CAUACUAUUUUCCCUAUAAG	20	23427
CFTR-Intron10-4546	+	ACAUACUAUUUUCCCUAUAAG	21	23428
CFTR-Intron10-4547	+	GACAUACUAUUUUCCCUAUAAG	22	23429
CFTR-Intron10-4548	+	UGACAUACUAUUUUCCCUAUAAG	23	23430
CFTR-Intron10-4549	+	UUGACAUACUAUUUUCCCUAUAAG	24	23431
CFTR-Intron10-4550	+	AUUCCUCCUGUGUAUAAG	18	23432
CFTR-Intron10-4551	+	AAUUCCUCCUGUGUAUAAG	19	23433
CFTR-Intron10-4552	+	AAAUUCCUCCUGUGUAUAAG	20	23434
CFTR-Intron10-4553	+	GAAAUUCCUCCUGUGUAUAAG	21	23435
CFTR-Intron10-4554	+	AGAAAUUCCUCCUGUGUAUAAG	22	23436
CFTR-Intron10-4555	+	GAGAAAUUCCUCCUGUGUAUAAG	23	23437
CFTR-Intron10-4556	+	AGAGAAAUUCCUCCUGUGUAUAAG	24	23438
CFTR-Intron10-4557	+	CUUAACCCAUCUAUUAAG	18	23439
CFTR-Intron10-4558	+	GCUUAACCCAUCUAUUAAG	19	23440
CFTR-Intron10-97	+	GGCUUAACCCAUCUAUUAAG	20	18983
CFTR-Intron10-4559	+	UGGCUUAACCCAUCUAUUAAG	21	23441
CFTR-Intron10-4560	+	UUGGCUUAACCCAUCUAUUAAG	22	23442
CFTR-Intron10-4561	+	GUUGGCUUAACCCAUCUAUUAAG	23	23443
CFTR-Intron10-4562	+	AGUUGGCUUAACCCAUCUAUUAAG	24	23444
CFTR-Intron10-4563	+	CUGUGAUGCAGACAACAG	18	23445
CFTR-Intron10-4564	+	GCUGUGAUGCAGACAACAG	19	23446
CFTR-Intron10-4565	+	AGCUGUGAUGCAGACAACAG	20	23447
CFTR-Intron10-4566	+	CAGCUGUGAUGCAGACAACAG	21	23448
CFTR-Intron10-4567	+	UCAGCUGUGAUGCAGACAACAG	22	23449
CFTR-Intron10-4568	+	UUCAGCUGUGAUGCAGACAACAG	23	23450
CFTR-Intron10-4569	+	CUUCAGCUGUGAUGCAGACAACAG	24	23451
CFTR-Intron10-4570	+	AGAAUGGAAAAUGGACAG	18	23452
CFTR-Intron10-4571	+	GAGAAUGGAAAAUGGACAG	19	23453
CFTR-Intron10-4572	+	GGAGAAUGGAAAAUGGACAG	20	23454
CFTR-Intron10-4573	+	AGGAGAAUGGAAAAUGGACAG	21	23455
CFTR-Intron10-4574	+	CAGGAGAAUGGAAAAUGGACAG	22	23456
CFTR-Intron10-4575	+	GCAGGAGAAUGGAAAAUGGACAG	23	23457
CFTR-Intron10-4576	+	UGCAGGAGAAUGGAAAAUGGACAG	24	23458
CFTR-Intron10-4577	+	AGCUAAAGUAUUACCCAG	18	23459
CFTR-Intron10-4578	+	CAGCUAAAGUAUUACCCAG	19	23460
CFTR-Intron10-451	+	ACAGCUAAAGUAUUACCCAG	20	19337
CFTR-Intron10-4579	+	UACAGCUAAAGUAUUACCCAG	21	23461
CFTR-Intron10-4580	+	AUACAGCUAAAGUAUUACCCAG	22	23462
CFTR-Intron10-4581	+	UAUACAGCUAAAGUAUUACCCAG	23	23463
CFTR-Intron10-4582	+	AUAUACAGCUAAAGUAUUACCCAG	24	23464
CFTR-Intron10-4583	+	GAUAAAAAUUCCAAGCAG	18	23465
CFTR-Intron10-4584	+	UGAUAAAAAUUCCAAGCAG	19	23466
CFTR-Intron10-4585	+	AUGAUAAAAAUUCCAAGCAG	20	23467
CFTR-Intron10-4586	+	AAUGAUAAAAAUUCCAAGCAG	21	23468
CFTR-Intron10-4587	+	AAAUGAUAAAAAUUCCAAGCAG	22	23469
CFTR-Intron10-4588	+	AAAAUGAUAAAAAUUCCAAGCAG	23	23470
CFTR-Intron10-4589	+	AAAAAUGAUAAAAAUUCCAAGCAG	24	23471
CFTR-Intron10-4590	+	AAGGAAAGGAGGUAGCAG	18	23472
CFTR-Intron10-4591	+	GAAGGAAAGGAGGUAGCAG	19	23473
CFTR-Intron10-1260	+	AGAAGGAAAGGAGGUAGCAG	20	20145
CFTR-Intron10-4592	+	UAGAAGGAAAGGAGGUAGCAG	21	23474
CFTR-Intron10-4593	+	GUAGAAGGAAAGGAGGUAGCAG	22	23475
CFTR-Intron10-4594	+	AGUAGAAGGAAAGGAGGUAGCAG	23	23476
CFTR-Intron10-4595	+	GAGUAGAAGGAAAGGAGGUAGCAG	24	23477
CFTR-Intron10-4596	+	UCAACAUAUGAAUGGCAG	18	23478
CFTR-Intron10-4597	+	UUCAACAUAUGAAUGGCAG	19	23479
CFTR-Intron10-1263	+	UUUCAACAUAUGAAUGGCAG	20	20148
CFTR-Intron10-4598	+	AUUUCAACAUAUGAAUGGCAG	21	23480
CFTR-Intron10-4599	+	GAUUUCAACAUAUGAAUGGCAG	22	23481
CFTR-Intron10-4600	+	GGAUUUCAACAUAUGAAUGGCAG	23	23482
CFTR-Intron10-4601	+	AGGAUUUCAACAUAUGAAUGGCAG	24	23483
CFTR-Intron10-4602	+	CUAUUUAAACAGAAUCAG	18	23484
CFTR-Intron10-4603	+	GCUAUUUAAACAGAAUCAG	19	23485
CFTR-Intron10-453	+	UGCUAUUUAAACAGAAUCAG	20	19339
CFTR-Intron10-4604	+	GUGCUAUUUAAACAGAAUCAG	21	23486
CFTR-Intron10-4605	+	AGUGCUAUUUAAACAGAAUCAG	22	23487
CFTR-Intron10-4606	+	CAGUGCUAUUUAAACAGAAUCAG	23	23488
CFTR-Intron10-4607	+	CCAGUGCUAUUUAAACAGAAUCAG	24	23489
CFTR-Intron10-4608	+	CAUAAUAAGACAGCUCAG	18	23490
CFTR-Intron10-4609	+	ACAUAAUAAGACAGCUCAG	19	23491
CFTR-Intron10-4610	+	AACAUAAUAAGACAGCUCAG	20	23492
CFTR-Intron10-4611	+	AAACAUAAUAAGACAGCUCAG	21	23493
CFTR-Intron10-4612	+	AAAACAUAAUAAGACAGCUCAG	22	23494
CFTR-Intron10-4613	+	CAAAACAUAAUAAGACAGCUCAG	23	23495
CFTR-Intron10-4614	+	ACAAAACAUAAUAAGACAGCUCAG	24	23496
CFTR-Intron10-4615	+	AAGAGGAAAAGACUUCAG	18	23497
CFTR-Intron10-4616	+	UAAGAGGAAAAGACUUCAG	19	23498
CFTR-Intron10-4617	+	UUAAGAGGAAAAGACUUCAG	20	23499
CFTR-Intron10-4618	+	AUUAAGAGGAAAAGACUUCAG	21	23500
CFTR-Intron10-4619	+	UAUUAAGAGGAAAAGACUUCAG	22	23501
CFTR-Intron10-4620	+	CUAUUAAGAGGAAAAGACUUCAG	23	23502
CFTR-Intron10-4621	+	UCUAUUAAGAGGAAAAGACUUCAG	24	23503
CFTR-Intron10-4622	+	UGUUACAUAAAAAGAGAG	18	23504
CFTR-Intron10-4623	+	UUGUUACAUAAAAAGAGAG	19	23505
CFTR-Intron10-4624	+	AUUGUUACAUAAAAAGAGAG	20	23506
CFTR-Intron10-4625	+	UAUUGUUACAUAAAAAGAGAG	21	23507
CFTR-Intron10-4626	+	AUAUUGUUACAUAAAAAGAGAG	22	23508
CFTR-Intron10-4627	+	CAUAUUGUUACAUAAAAAGAGAG	23	23509
CFTR-Intron10-4628	+	GCAUAUUGUUACAUAAAAAGAGAG	24	23510
CFTR-Intron10-4629	+	UUUGUAUUUUUAGUAGAG	18	23511
CFTR-Intron10-4630	+	UUUUGUAUUUUUAGUAGAG	19	23512
CFTR-Intron10-4631	+	UUUUUGUAUUUUUAGUAGAG	20	23513
CFTR-Intron10-4632	+	UUUUUUGUAUUUUUAGUAGAG	21	23514
CFTR-Intron10-4633	+	AUUUUUUGUAUUUUUAGUAGAG	22	23515
CFTR-Intron10-4634	+	AAUUUUUUGUAUUUUUAGUAGAG	23	23516
CFTR-Intron10-4635	+	UAAUUUUUUGUAUUUUUAGUAGAG	24	23517
CFTR-Intron10-4636	+	UUUGUGUUUUUUGUAGAG	18	23518
CFTR-Intron10-4637	+	GUUUGUGUUUUUUGUAGAG	19	23519
CFTR-Intron10-4638	+	UGUUUGUGUUUUUUGUAGAG	20	23520
CFTR-Intron10-4639	+	UUGUUUGUGUUUUUUGUAGAG	21	23521
CFTR-Intron10-4640	+	UUUGUUUGUGUUUUUUGUAGAG	22	23522
CFTR-Intron10-4641	+	UUUUGUUUGUGUUUUUUGUAGAG	23	23523
CFTR-Intron10-4642	+	CUUUUGUUUGUGUUUUUUGUAGAG	24	23524
CFTR-Intron10-4643	+	GCACUUUGGGAGGCCGAG	18	23525
CFTR-Intron10-4644	+	AGCACUUUGGGAGGCCGAG	19	23526
CFTR-Intron10-4645	+	CAGCACUUUGGGAGGCCGAG	20	23527
CFTR-Intron10-4646	+	CCAGCACUUUGGGAGGCCGAG	21	23528
CFTR-Intron10-4647	+	CCCAGCACUUUGGGAGGCCGAG	22	23529
CFTR-Intron10-4648	+	UCCCAGCACUUUGGGAGGCCGAG	23	23530
CFTR-Intron10-4649	+	AUCCCAGCACUUUGGGAGGCCGAG	24	23531
CFTR-Intron10-4650	+	CUAAUGGCAGAAUUCGAG	18	23532
CFTR-Intron10-4651	+	ACUAAUGGCAGAAUUCGAG	19	23533
CFTR-Intron10-4652	+	AACUAAUGGCAGAAUUCGAG	20	23534
CFTR-Intron10-4653	+	AAACUAAUGGCAGAAUUCGAG	21	23535
CFTR-Intron10-4654	+	AAAACUAAUGGCAGAAUUCGAG	22	23536
CFTR-Intron10-4655	+	UAAAACUAAUGGCAGAAUUCGAG	23	23537
CFTR-Intron10-4656	+	UUAAAACUAAUGGCAGAAUUCGAG	24	23538
CFTR-Intron10-4657	+	AUGGCGUGAACCCGGGAG	18	23539
CFTR-Intron10-4658	+	AAUGGCGUGAACCCGGGAG	19	23540
CFTR-Intron10-4659	+	GAAUGGCGUGAACCCGGGAG	20	23541
CFTR-Intron10-4660	+	AGAAUGGCGUGAACCCGGGAG	21	23542
CFTR-Intron10-4661	+	GAGAAUGGCGUGAACCCGGGAG	22	23543
CFTR-Intron10-4662	+	GGAGAAUGGCGUGAACCCGGGAG	23	23544
CFTR-Intron10-4663	+	AGGAGAAUGGCGUGAACCCGGGAG	24	23545
CFTR-Intron10-4664	+	UUAGGGUGGGAUAUGGAG	18	23546
CFTR-Intron10-4665	+	CUUAGGGUGGGAUAUGGAG	19	23547
CFTR-Intron10-4666	+	UCUUAGGGUGGGAUAUGGAG	20	23548
CFTR-Intron10-4667	+	UUCUUAGGGUGGGAUAUGGAG	21	23549
CFTR-Intron10-4668	+	GUUCUUAGGGUGGGAUAUGGAG	22	23550
CFTR-Intron10-4669	+	UGUUCUUAGGGUGGGAUAUGGAG	23	23551
CFTR-Intron10-4670	+	UUGUUCUUAGGGUGGGAUAUGGAG	24	23552
CFTR-Intron10-4671	+	CUACUGACUAAAACUGAG	18	23553
CFTR-Intron10-4672	+	ACUACUGACUAAAACUGAG	19	23554
CFTR-Intron10-4673	+	UACUACUGACUAAAACUGAG	20	23555
CFTR-Intron10-4674	+	AUACUACUGACUAAAACUGAG	21	23556
CFTR-Intron10-4675	+	AAUACUACUGACUAAAACUGAG	22	23557
CFTR-Intron10-4676	+	UAAUACUACUGACUAAAACUGAG	23	23558
CFTR-Intron10-4677	+	AUAAUACUACUGACUAAAACUGAG	24	23559
CFTR-Intron10-4678	+	GGCGGAGCUUGCAGUGAG	18	23560
CFTR-Intron10-4679	+	AGGCGGAGCUUGCAGUGAG	19	23561
CFTR-Intron10-4680	+	GAGGCGGAGCUUGCAGUGAG	20	23562
CFTR-Intron10-4681	+	GGAGGCGGAGCUUGCAGUGAG	21	23563
CFTR-Intron10-4682	+	GGGAGGCGGAGCUUGCAGUGAG	22	23564
CFTR-Intron10-4683	+	CGGGAGGCGGAGCUUGCAGUGAG	23	23565
CFTR-Intron10-4684	+	CCGGGAGGCGGAGCUUGCAGUGAG	24	23566
CFTR-Intron10-4685	+	GGCAGAGGUUGCAGUGAG	18	23567
CFTR-Intron10-4686	+	AGGCAGAGGUUGCAGUGAG	19	23568
CFTR-Intron10-4687	+	GAGGCAGAGGUUGCAGUGAG	20	23569
CFTR-Intron10-4688	+	GGAGGCAGAGGUUGCAGUGAG	21	23570
CFTR-Intron10-4689	+	GGGAGGCAGAGGUUGCAGUGAG	22	23571
CFTR-Intron10-4690	+	CGGGAGGCAGAGGUUGCAGUGAG	23	23572
CFTR-Intron10-4691	+	CCGGGAGGCAGAGGUUGCAGUGAG	24	23573
CFTR-Intron10-4692	+	GACACCAAAUUUAUUGAG	18	23574
CFTR-Intron10-4693	+	UGACACCAAAUUUAUUGAG	19	23575
CFTR-Intron10-457	+	CUGACACCAAAUUUAUUGAG	20	19343
CFTR-Intron10-4694	+	CCUGACACCAAAUUUAUUGAG	21	23576
CFTR-Intron10-4695	+	GCCUGACACCAAAUUUAUUGAG	22	23577
CFTR-Intron10-4696	+	AGCCUGACACCAAAUUUAUUGAG	23	23578
CFTR-Intron10-4697	+	CAGCCUGACACCAAAUUUAUUGAG	24	23579
CFTR-Intron10-4698	+	UAAUAGCCUAUUGUUGAG	18	23580
CFTR-Intron10-4699	+	CUAAUAGCCUAUUGUUGAG	19	23581
CFTR-Intron10-1271	+	ACUAAUAGCCUAUUGUUGAG	20	20156
CFTR-Intron10-4700	+	UACUAAUAGCCUAUUGUUGAG	21	23582
CFTR-Intron10-4701	+	CUACUAAUAGCCUAUUGUUGAG	22	23583
CFTR-Intron10-4702	+	ACUACUAAUAGCCUAUUGUUGAG	23	23584
CFTR-Intron10-4703	+	AACUACUAAUAGCCUAUUGUUGAG	24	23585
CFTR-Intron10-4704	+	CUAGAUGAUUAUUAAUAG	18	23586
CFTR-Intron10-4705	+	CCUAGAUGAUUAUUAAUAG	19	23587
CFTR-Intron10-100	+	GCCUAGAUGAUUAUUAAUAG	20	18986
CFTR-Intron10-4706	+	AGCCUAGAUGAUUAUUAAUAG	21	23588
CFTR-Intron10-4707	+	CAGCCUAGAUGAUUAUUAAUAG	22	23589
CFTR-Intron10-4708	+	GCAGCCUAGAUGAUUAUUAAUAG	23	23590
CFTR-Intron10-4709	+	UGCAGCCUAGAUGAUUAUUAAUAG	24	23591
CFTR-Intron10-4710	+	GAAAGUUGUCCAAGAUAG	18	23592
CFTR-Intron10-4711	+	GGAAAGUUGUCCAAGAUAG	19	23593
CFTR-Intron10-459	+	UGGAAAGUUGUCCAAGAUAG	20	19345
CFTR-Intron10-4712	+	AUGGAAAGUUGUCCAAGAUAG	21	23594
CFTR-Intron10-4713	+	UAUGGAAAGUUGUCCAAGAUAG	22	23595
CFTR-Intron10-4714	+	AUAUGGAAAGUUGUCCAAGAUAG	23	23596
CFTR-Intron10-4715	+	AAUAUGGAAAGUUGUCCAAGAUAG	24	23597
CFTR-Intron10-4716	+	CCUCAGCCUCCCAAGUAG	18	23598
CFTR-Intron10-4717	+	ACCUCAGCCUCCCAAGUAG	19	23599
CFTR-Intron10-4718	+	CACCUCAGCCUCCCAAGUAG	20	23600
CFTR-Intron10-4719	+	CCACCUCAGCCUCCCAAGUAG	21	23601
CFTR-Intron10-4720	+	CCCACCUCAGCCUCCCAAGUAG	22	23602
CFTR-Intron10-4721	+	UCCCACCUCAGCCUCCCAAGUAG	23	23603
CFTR-Intron10-4722	+	CUCCCACCUCAGCCUCCCAAGUAG	24	23604
CFTR-Intron10-4723	+	GGUAAGUUAUAGAAGUAG	18	23605
CFTR-Intron10-4724	+	GGGUAAGUUAUAGAAGUAG	19	23606
CFTR-Intron10-4725	+	UGGGUAAGUUAUAGAAGUAG	20	23607
CFTR-Intron10-4726	+	UUGGGUAAGUUAUAGAAGUAG	21	23608
CFTR-Intron10-4727	+	UUUGGGUAAGUUAUAGAAGUAG	22	23609
CFTR-Intron10-4728	+	AUUUGGGUAAGUUAUAGAAGUAG	23	23610
CFTR-Intron10-4729	+	UAUUUGGGUAAGUUAUAGAAGUAG	24	23611
CFTR-Intron10-4730	+	CCUCAGCCUCCCGAGUAG	18	23612
CFTR-Intron10-4731	+	GCCUCAGCCUCCCGAGUAG	19	23613
CFTR-Intron10-4732	+	UGCCUCAGCCUCCCGAGUAG	20	23614
CFTR-Intron10-4733	+	CUGCCUCAGCCUCCCGAGUAG	21	23615
CFTR-Intron10-4734	+	CCUGCCUCAGCCUCCCGAGUAG	22	23616
CFTR-Intron10-4735	+	UCCUGCCUCAGCCUCCCGAGUAG	23	23617
CFTR-Intron10-4736	+	CUCCUGCCUCAGCCUCCCGAGUAG	24	23618
CFTR-Intron10-4737	+	CUGACUAAAACUGAGUAG	18	23619
CFTR-Intron10-4738	+	ACUGACUAAAACUGAGUAG	19	23620
CFTR-Intron10-4739	+	UACUGACUAAAACUGAGUAG	20	23621
CFTR-Intron10-4740	+	CUACUGACUAAAACUGAGUAG	21	23622
CFTR-Intron10-4741	+	ACUACUGACUAAAACUGAGUAG	22	23623
CFTR-Intron10-4742	+	UACUACUGACUAAAACUGAGUAG	23	23624
CFTR-Intron10-4743	+	AUACUACUGACUAAAACUGAGUAG	24	23625
CFTR-Intron10-4744	+	UAGAAGGAAAGGAGGUAG	18	23626
CFTR-Intron10-4745	+	GUAGAAGGAAAGGAGGUAG	19	23627
CFTR-Intron10-4746	+	AGUAGAAGGAAAGGAGGUAG	20	23628
CFTR-Intron10-4747	+	GAGUAGAAGGAAAGGAGGUAG	21	23629
CFTR-Intron10-4748	+	UGAGUAGAAGGAAAGGAGGUAG	22	23630
CFTR-Intron10-4749	+	CUGAGUAGAAGGAAAGGAGGUAG	23	23631
CFTR-Intron10-4750	+	ACUGAGUAGAAGGAAAGGAGGUAG	24	23632
CFTR-Intron10-4751	+	AGGGAGAAAUGUAUGUAG	18	23633
CFTR-Intron10-4752	+	CAGGGAGAAAUGUAUGUAG	19	23634
CFTR-Intron10-4753	+	ACAGGGAGAAAUGUAUGUAG	20	23635
CFTR-Intron10-4754	+	AACAGGGAGAAAUGUAUGUAG	21	23636
CFTR-Intron10-4755	+	UAACAGGGAGAAAUGUAUGUAG	22	23637
CFTR-Intron10-4756	+	AUAACAGGGAGAAAUGUAUGUAG	23	23638
CFTR-Intron10-4757	+	AAUAACAGGGAGAAAUGUAUGUAG	24	23639
CFTR-Intron10-4758	+	AAAAAUACAAAAAAUUAG	18	23640
CFTR-Intron10-4759	+	UAAAAAUACAAAAAAUUAG	19	23641
CFTR-Intron10-4760	+	CUAAAAAUACAAAAAAUUAG	20	23642
CFTR-Intron10-4761	+	ACUAAAAAUACAAAAAAUUAG	21	23643
CFTR-Intron10-4762	+	UACUAAAAAUACAAAAAAUUAG	22	23644
CFTR-Intron10-4763	+	CUACUAAAAAUACAAAAAAUUAG	23	23645
CFTR-Intron10-4764	+	UCUACUAAAAAUACAAAAAAUUAG	24	23646
CFTR-Intron10-4765	+	AAGCUUGUUUGGUUUUAG	18	23647
CFTR-Intron10-4766	+	AAAGCUUGUUUGGUUUUAG	19	23648
CFTR-Intron10-4767	+	GAAAGCUUGUUUGGUUUUAG	20	23649
CFTR-Intron10-4768	+	GGAAAGCUUGUUUGGUUUUAG	21	23650
CFTR-Intron10-4769	+	UGGAAAGCUUGUUUGGUUUUAG	22	23651
CFTR-Intron10-4770	+	AUGGAAAGCUUGUUUGGUUUUAG	23	23652
CFTR-Intron10-4771	+	CAUGGAAAGCUUGUUUGGUUUUAG	24	23653
CFTR-Intron10-4772	+	AAUUUUUUGUAUUUUUAG	18	23654
CFTR-Intron10-4773	+	UAAUUUUUUGUAUUUUUAG	19	23655
CFTR-Intron10-4774	+	CUAAUUUUUUGUAUUUUUAG	20	23656
CFTR-Intron10-4775	+	GCUAAUUUUUUGUAUUUUUAG	21	23657
CFTR-Intron10-4776	+	GGCUAAUUUUUUGUAUUUUUAG	22	23658
CFTR-Intron10-4777	+	UGGCUAAUUUUUUGUAUUUUUAG	23	23659
CFTR-Intron10-4778	+	CUGGCUAAUUUUUUGUAUUUUUAG	24	23660
CFTR-Intron10-4779	+	ACCAUCCCGGCUAAAACG	18	23661
CFTR-Intron10-4780	+	GACCAUCCCGGCUAAAACG	19	23662
CFTR-Intron10-4781	+	AGACCAUCCCGGCUAAAACG	20	23663
CFTR-Intron10-4782	+	GAGACCAUCCCGGCUAAAACG	21	23664
CFTR-Intron10-4783	+	CGAGACCAUCCCGGCUAAAACG	22	23665
CFTR-Intron10-4784	+	UCGAGACCAUCCCGGCUAAAACG	23	23666
CFTR-Intron10-4785	+	AUCGAGACCAUCCCGGCUAAAACG	24	23667
CFTR-Intron10-4786	+	AAAAACAACAAAAAAGCG	18	23668
CFTR-Intron10-4787	+	GAAAAACAACAAAAAAGCG	19	23669
CFTR-Intron10-4788	+	AGAAAAACAACAAAAAAGCG	20	23670
CFTR-Intron10-4789	+	UAGAAAAACAACAAAAAAGCG	21	23671
CFTR-Intron10-4790	+	CUAGAAAAACAACAAAAAAGCG	22	23672
CFTR-Intron10-4791	+	ACUAGAAAAACAACAAAAAAGCG	23	23673
CFTR-Intron10-4792	+	AACUAGAAAAACAACAAAAAAGCG	24	23674
CFTR-Intron10-4793	+	GCAAAGAGUGCAUAAAGG	18	23675
CFTR-Intron10-4794	+	AGCAAAGAGUGCAUAAAGG	19	23676
CFTR-Intron10-4795	+	AAGCAAAGAGUGCAUAAAGG	20	23677
CFTR-Intron10-4796	+	AAAGCAAAGAGUGCAUAAAGG	21	23678
CFTR-Intron10-4797	+	UAAAGCAAAGAGUGCAUAAAGG	22	23679
CFTR-Intron10-4798	+	CUAAAGCAAAGAGUGCAUAAAGG	23	23680
CFTR-Intron10-4799	+	CCUAAAGCAAAGAGUGCAUAAAGG	24	23681
CFTR-Intron10-4800	+	UAUAAGAAAUGAAACAGG	18	23682
CFTR-Intron10-4801	+	AUAUAAGAAAUGAAACAGG	19	23683
CFTR-Intron10-4802	+	GAUAUAAGAAAUGAAACAGG	20	23684
CFTR-Intron10-4803	+	CGAUAUAAGAAAUGAAACAGG	21	23685
CFTR-Intron10-4804	+	ACGAUAUAAGAAAUGAAACAGG	22	23686
CFTR-Intron10-4805	+	UACGAUAUAAGAAAUGAAACAGG	23	23687
CFTR-Intron10-4806	+	AUACGAUAUAAGAAAUGAAACAGG	24	23688
CFTR-Intron10-4807	+	CCUAUAAGGAAUAACAGG	18	23689
CFTR-Intron10-4808	+	ACCUAUAAGGAAUAACAGG	19	23690
CFTR-Intron10-4809	+	AACCUAUAAGGAAUAACAGG	20	23691
CFTR-Intron10-4810	+	GAACCUAUAAGGAAUAACAGG	21	23692
CFTR-Intron10-4811	+	AGAACCUAUAAGGAAUAACAGG	22	23693
CFTR-Intron10-4812	+	CAGAACCUAUAAGGAAUAACAGG	23	23694
CFTR-Intron10-4813	+	ACAGAACCUAUAAGGAAUAACAGG	24	23695
CFTR-Intron10-4814	+	AGUAGAAACCUAAUCAGG	18	23696
CFTR-Intron10-4815	+	UAGUAGAAACCUAAUCAGG	19	23697
CFTR-Intron10-4816	+	UUAGUAGAAACCUAAUCAGG	20	23698
CFTR-Intron10-4817	+	UUUAGUAGAAACCUAAUCAGG	21	23699
CFTR-Intron10-4818	+	UUUUAGUAGAAACCUAAUCAGG	22	23700
CFTR-Intron10-4819	+	GUUUUAGUAGAAACCUAAUCAGG	23	23701
CFTR-Intron10-4820	+	GGUUUUAGUAGAAACCUAAUCAGG	24	23702
CFTR-Intron10-4821	+	GAAAGGAGGUAGCAGAGG	18	23703
CFTR-Intron10-4822	+	GGAAAGGAGGUAGCAGAGG	19	23704
CFTR-Intron10-4823	+	AGGAAAGGAGGUAGCAGAGG	20	23705
CFTR-Intron10-4824	+	AAGGAAAGGAGGUAGCAGAGG	21	23706
CFTR-Intron10-4825	+	GAAGGAAAGGAGGUAGCAGAGG	22	23707
CFTR-Intron10-4826	+	AGAAGGAAAGGAGGUAGCAGAGG	23	23708
CFTR-Intron10-4827	+	UAGAAGGAAAGGAGGUAGCAGAGG	24	23709
CFTR-Intron10-4828	+	GUUACAUAAAAAGAGAGG	18	23710
CFTR-Intron10-4829	+	UGUUACAUAAAAAGAGAGG	19	23711
CFTR-Intron10-469	+	UUGUUACAUAAAAAGAGAGG	20	19355
CFTR-Intron10-4830	+	AUUGUUACAUAAAAAGAGAGG	21	23712
CFTR-Intron10-4831	+	UAUUGUUACAUAAAAAGAGAGG	22	23713
CFTR-Intron10-4832	+	AUAUUGUUACAUAAAAAGAGAGG	23	23714
CFTR-Intron10-4833	+	CAUAUUGUUACAUAAAAAGAGAGG	24	23715
CFTR-Intron10-4834	+	UGGCGUGAACCCGGGAGG	18	23716
CFTR-Intron10-4835	+	AUGGCGUGAACCCGGGAGG	19	23717
CFTR-Intron10-1287	+	AAUGGCGUGAACCCGGGAGG	20	20172
CFTR-Intron10-4836	+	GAAUGGCGUGAACCCGGGAGG	21	23718
CFTR-Intron10-4837	+	AGAAUGGCGUGAACCCGGGAGG	22	23719
CFTR-Intron10-4838	+	GAGAAUGGCGUGAACCCGGGAGG	23	23720
CFTR-Intron10-4839	+	GGAGAAUGGCGUGAACCCGGGAGG	24	23721
CFTR-Intron10-4840	+	UUGCUUGAGCCCGGGAGG	18	23722
CFTR-Intron10-4841	+	AUUGCUUGAGCCCGGGAGG	19	23723
CFTR-Intron10-4842	+	AAUUGCUUGAGCCCGGGAGG	20	23724
CFTR-Intron10-4843	+	GAAUUGCUUGAGCCCGGGAGG	21	23725
CFTR-Intron10-4844	+	AGAAUUGCUUGAGCCCGGGAGG	22	23726
CFTR-Intron10-4845	+	GAGAAUUGCUUGAGCCCGGGAGG	23	23727
CFTR-Intron10-4846	+	GGAGAAUUGCUUGAGCCCGGGAGG	24	23728
CFTR-Intron10-4847	+	UCCCAGCUACUUGGGAGG	18	23729
CFTR-Intron10-4848	+	GUCCCAGCUACUUGGGAGG	19	23730
CFTR-Intron10-4849	+	AGUCCCAGCUACUUGGGAGG	20	23731
CFTR-Intron10-4850	+	UAGUCCCAGCUACUUGGGAGG	21	23732
CFTR-Intron10-4851	+	GUAGUCCCAGCUACUUGGGAGG	22	23733
CFTR-Intron10-4852	+	UGUAGUCCCAGCUACUUGGGAGG	23	23734
CFTR-Intron10-4853	+	CUGUAGUCCCAGCUACUUGGGAGG	24	23735
CFTR-Intron10-4854	+	UCCCAACACUUUGGGAGG	18	23736
CFTR-Intron10-4855	+	AUCCCAACACUUUGGGAGG	19	23737
CFTR-Intron10-4856	+	AAUCCCAACACUUUGGGAGG	20	23738
CFTR-Intron10-4857	+	UAAUCCCAACACUUUGGGAGG	21	23739
CFTR-Intron10-4858	+	GUAAUCCCAACACUUUGGGAGG	22	23740
CFTR-Intron10-4859	+	UGUAAUCCCAACACUUUGGGAGG	23	23741
CFTR-Intron10-4860	+	CUGUAAUCCCAACACUUUGGGAGG	24	23742
CFTR-Intron10-4861	+	ACCCAGCACUUUGGGAGG	18	23743
CFTR-Intron10-4862	+	AACCCAGCACUUUGGGAGG	19	23744
CFTR-Intron10-4863	+	AAACCCAGCACUUUGGGAGG	20	23745
CFTR-Intron10-4864	+	UAAACCCAGCACUUUGGGAGG	21	23746
CFTR-Intron10-4865	+	AUAAACCCAGCACUUUGGGAGG	22	23747
CFTR-Intron10-4866	+	UAUAAACCCAGCACUUUGGGAGG	23	23748
CFTR-Intron10-4867	+	CUAUAAACCCAGCACUUUGGGAGG	24	23749
CFTR-Intron10-4868	+	UCCCAGCACUUUGGGAGG	18	23750
CFTR-Intron10-4869	+	AUCCCAGCACUUUGGGAGG	19	23751
CFTR-Intron10-4870	+	AAUCCCAGCACUUUGGGAGG	20	23752
CFTR-Intron10-4871	+	UAAUCCCAGCACUUUGGGAGG	21	23753
CFTR-Intron10-4872	+	GUAAUCCCAGCACUUUGGGAGG	22	23754
CFTR-Intron10-4873	+	UGUAAUCCCAGCACUUUGGGAGG	23	23755
CFTR-Intron10-4874	+	CUGUAAUCCCAGCACUUUGGGAGG	24	23756
CFTR-Intron10-4875	+	UUCUCACAGUUCUGGAGG	18	23757
CFTR-Intron10-4876	+	UUUCUCACAGUUCUGGAGG	19	23758
CFTR-Intron10-4877	+	AUUUCUCACAGUUCUGGAGG	20	23759
CFTR-Intron10-4878	+	UAUUUCUCACAGUUCUGGAGG	21	23760
CFTR-Intron10-4879	+	UUAUUUCUCACAGUUCUGGAGG	22	23761
CFTR-Intron10-4880	+	UUUAUUUCUCACAGUUCUGGAGG	23	23762
CFTR-Intron10-4881	+	AUUUAUUUCUCACAGUUCUGGAGG	24	23763
CFTR-Intron10-4882	+	CAGCUACUUGGGAGGCUGAGG	21	23764
CFTR-Intron10-4883	+	CCAGCUACUUGGGAGGCUGAGG	22	23765
CFTR-Intron10-4884	+	CCCAGCUACUUGGGAGGCUGAGG	23	23766
CFTR-Intron10-4885	+	UCCCAGCUACUUGGGAGGCUGAGG	24	23767
CFTR-Intron10-4886	+	CUACUUGGGAGGGUGAGG	18	23768
CFTR-Intron10-4887	+	GCUACUUGGGAGGGUGAGG	19	23769
CFTR-Intron10-4888	+	AGCUACUUGGGAGGGUGAGG	20	23770
CFTR-Intron10-4889	+	CAGCUACUUGGGAGGGUGAGG	21	23771
CFTR-Intron10-4890	+	CCAGCUACUUGGGAGGGUGAGG	22	23772
CFTR-Intron10-4891	+	CCCAGCUACUUGGGAGGGUGAGG	23	23773
CFTR-Intron10-4892	+	UCCCAGCUACUUGGGAGGGUGAGG	24	23774
CFTR-Intron10-4893	+	GGUUAAGUUGUUCUUAGG	18	23775
CFTR-Intron10-4894	+	AGGUUAAGUUGUUCUUAGG	19	23776
CFTR-Intron10-4895	+	CAGGUUAAGUUGUUCUUAGG	20	23777
CFTR-Intron10-4896	+	CCAGGUUAAGUUGUUCUUAGG	21	23778
CFTR-Intron10-4897	+	GCCAGGUUAAGUUGUUCUUAGG	22	23779
CFTR-Intron10-4898	+	UGCCAGGUUAAGUUGUUCUUAGG	23	23780
CFTR-Intron10-4899	+	AUGCCAGGUUAAGUUGUUCUUAGG	24	23781
CFTR-Intron10-4900	+	CUCACAUGGCAGAAAGGG	18	23782
CFTR-Intron10-4901	+	UCUCACAUGGCAGAAAGGG	19	23783
CFTR-Intron10-4902	+	UUCUCACAUGGCAGAAAGGG	20	23784
CFTR-Intron10-4903	+	GUUCUCACAUGGCAGAAAGGG	21	23785
CFTR-Intron10-4904	+	UGUUCUCACAUGGCAGAAAGGG	22	23786
CFTR-Intron10-4905	+	GUGUUCUCACAUGGCAGAAAGGG	23	23787
CFTR-Intron10-4906	+	UGUGUUCUCACAUGGCAGAAAGGG	24	23788
CFTR-Intron10-4907	+	AACAUAUGAAUGGCAGGG	18	23789
CFTR-Intron10-4908	+	CAACAUAUGAAUGGCAGGG	19	23790
CFTR-Intron10-4909	+	UCAACAUAUGAAUGGCAGGG	20	23791
CFTR-Intron10-4910	+	UUCAACAUAUGAAUGGCAGGG	21	23792
CFTR-Intron10-4911	+	UUUCAACAUAUGAAUGGCAGGG	22	23793
CFTR-Intron10-4912	+	AUUUCAACAUAUGAAUGGCAGGG	23	23794
CFTR-Intron10-4913	+	GAUUUCAACAUAUGAAUGGCAGGG	24	23795
CFTR-Intron10-4914	+	UUGGUACAAAUUUCAGGG	18	23796
CFTR-Intron10-4915	+	AUUGGUACAAAUUUCAGGG	19	23797
CFTR-Intron10-4916	+	AAUUGGUACAAAUUUCAGGG	20	23798
CFTR-Intron10-4917	+	GAAUUGGUACAAAUUUCAGGG	21	23799
CFTR-Intron10-4918	+	CGAAUUGGUACAAAUUUCAGGG	22	23800
CFTR-Intron10-4919	+	ACGAAUUGGUACAAAUUUCAGGG	23	23801
CFTR-Intron10-4920	+	UACGAAUUGGUACAAAUUUCAGGG	24	23802
CFTR-Intron10-4921	+	AUUUCAACAUAUGAAUGG	18	23803
CFTR-Intron10-4922	+	GAUUUCAACAUAUGAAUGG	19	23804
CFTR-Intron10-4923	+	GGAUUUCAACAUAUGAAUGG	20	23805
CFTR-Intron10-4924	+	AGGAUUUCAACAUAUGAAUGG	21	23806
CFTR-Intron10-4925	+	UAGGAUUUCAACAUAUGAAUGG	22	23807
CFTR-Intron10-4926	+	UUAGGAUUUCAACAUAUGAAUGG	23	23808
CFTR-Intron10-4927	+	AUUAGGAUUUCAACAUAUGAAUGG	24	23809
CFTR-Intron10-4928	+	UGCUGUGUUCUCACAUGG	18	23810
CFTR-Intron10-4929	+	CUGCUGUGUUCUCACAUGG	19	23811
CFTR-Intron10-4930	+	CCUGCUGUGUUCUCACAUGG	20	23812
CFTR-Intron10-4931	+	UCCUGCUGUGUUCUCACAUGG	21	23813
CFTR-Intron10-4932	+	UUCCUGCUGUGUUCUCACAUGG	22	23814
CFTR-Intron10-4933	+	CUUCCUGCUGUGUUCUCACAUGG	23	23815
CFTR-Intron10-4934	+	UCUUCCUGCUGUGUUCUCACAUGG	24	23816
CFTR-Intron10-4935	+	AUUGGCUACCUUGGUUGG	18	23817
CFTR-Intron10-4936	+	GAUUGGCUACCUUGGUUGG	19	23818
CFTR-Intron10-4937	+	GGAUUGGCUACCUUGGUUGG	20	23819
CFTR-Intron10-4938	+	UGGAUUGGCUACCUUGGUUGG	21	23820
CFTR-Intron10-4939	+	CUGGAUUGGCUACCUUGGUUGG	22	23821
CFTR-Intron10-4940	+	CCUGGAUUGGCUACCUUGGUUGG	23	23822
CFTR-Intron10-4941	+	ACCUGGAUUGGCUACCUUGGUUGG	24	23823
CFTR-Intron10-4942	+	UGGUUGGAUGAGGGAAUG	18	23824
CFTR-Intron10-4943	+	UUGGUUGGAUGAGGGAAUG	19	23825
CFTR-Intron10-4944	+	CUUGGUUGGAUGAGGGAAUG	20	23826
CFTR-Intron10-4945	+	CCUUGGUUGGAUGAGGGAAUG	21	23827
CFTR-Intron10-4946	+	ACCUUGGUUGGAUGAGGGAAUG	22	23828
CFTR-Intron10-4947	+	UACCUUGGUUGGAUGAGGGAAUG	23	23829
CFTR-Intron10-4948	+	CUACCUUGGUUGGAUGAGGGAAUG	24	23830
CFTR-Intron10-4949	+	GAAAGCAGUGUUAUAAUG	18	23831
CFTR-Intron10-4950	+	UGAAAGCAGUGUUAUAAUG	19	23832
CFTR-Intron10-4951	+	CUGAAAGCAGUGUUAUAAUG	20	23833
CFTR-Intron10-4952	+	CCUGAAAGCAGUGUUAUAAUG	21	23834
CFTR-Intron10-4953	+	UCCUGAAAGCAGUGUUAUAAUG	22	23835
CFTR-Intron10-4954	+	CUCCUGAAAGCAGUGUUAUAAUG	23	23836
CFTR-Intron10-4955	+	GCUCCUGAAAGCAGUGUUAUAAUG	24	23837
CFTR-Intron10-4956	+	GGCAUUGCACUAAACAUG	18	23838
CFTR-Intron10-4957	+	UGGCAUUGCACUAAACAUG	19	23839
CFTR-Intron10-4958	+	AUGGCAUUGCACUAAACAUG	20	23840
CFTR-Intron10-4959	+	UAUGGCAUUGCACUAAACAUG	21	23841
CFTR-Intron10-4960	+	UUAUGGCAUUGCACUAAACAUG	22	23842
CFTR-Intron10-4961	+	UUUAUGGCAUUGCACUAAACAUG	23	23843
CFTR-Intron10-4962	+	GUUUAUGGCAUUGCACUAAACAUG	24	23844
CFTR-Intron10-4963	+	ACCAUCCUGGCCAACAUG	18	23845
CFTR-Intron10-4964	+	UACCAUCCUGGCCAACAUG	19	23846
CFTR-Intron10-4965	+	AUACCAUCCUGGCCAACAUG	20	23847
CFTR-Intron10-4966	+	AAUACCAUCCUGGCCAACAUG	21	23848
CFTR-Intron10-4967	+	CAAUACCAUCCUGGCCAACAUG	22	23849
CFTR-Intron10-4968	+	UCAAUACCAUCCUGGCCAACAUG	23	23850
CFTR-Intron10-4969	+	AUCAAUACCAUCCUGGCCAACAUG	24	23851
CFTR-Intron10-4970	+	AAAAGAUAAGUGAAGAUG	18	23852
CFTR-Intron10-4971	+	AAAAAGAUAAGUGAAGAUG	19	23853
CFTR-Intron10-4972	+	AAAAAAGAUAAGUGAAGAUG	20	23854
CFTR-Intron10-4973	+	GAAAAAAGAUAAGUGAAGAUG	21	23855
CFTR-Intron10-4974	+	AGAAAAAAGAUAAGUGAAGAUG	22	23856
CFTR-Intron10-4975	+	UAGAAAAAAGAUAAGUGAAGAUG	23	23857
CFTR-Intron10-4976	+	GUAGAAAAAAGAUAAGUGAAGAUG	24	23858
CFTR-Intron10-4977	+	GGCUACCUUGGUUGGAUG	18	23859
CFTR-Intron10-4978	+	UGGCUACCUUGGUUGGAUG	19	23860
CFTR-Intron10-481	+	UUGGCUACCUUGGUUGGAUG	20	19367
CFTR-Intron10-4979	+	AUUGGCUACCUUGGUUGGAUG	21	23861
CFTR-Intron10-4980	+	GAUUGGCUACCUUGGUUGGAUG	22	23862
CFTR-Intron10-4981	+	GGAUUGGCUACCUUGGUUGGAUG	23	23863
CFTR-Intron10-4982	+	UGGAUUGGCUACCUUGGUUGGAUG	24	23864
CFTR-Intron10-4983	+	UUCUUAGGGUGGGAUAUG	18	23865
CFTR-Intron10-4984	+	GUUCUUAGGGUGGGAUAUG	19	23866
CFTR-Intron10-4985	+	UGUUCUUAGGGUGGGAUAUG	20	23867
CFTR-Intron10-4986	+	UUGUUCUUAGGGUGGGAUAUG	21	23868
CFTR-Intron10-4987	+	GUUGUUCUUAGGGUGGGAUAUG	22	23869
CFTR-Intron10-4988	+	AGUUGUUCUUAGGGUGGGAUAUG	23	23870
CFTR-Intron10-4989	+	AAGUUGUUCUUAGGGUGGGAUAUG	24	23871
CFTR-Intron10-4990	+	UAAAAGCUGUUUCGUAUG	18	23872
CFTR-Intron10-4991	+	UUAAAAGCUGUUUCGUAUG	19	23873
CFTR-Intron10-4992	+	UUUAAAAGCUGUUUCGUAUG	20	23874
CFTR-Intron10-4993	+	UUUUAAAAGCUGUUUCGUAUG	21	23875
CFTR-Intron10-4994	+	GUUUUAAAAGCUGUUUCGUAUG	22	23876
CFTR-Intron10-4995	+	UGUUUUAAAAGCUGUUUCGUAUG	23	23877
CFTR-Intron10-4996	+	UUGUUUUAAAAGCUGUUUCGUAUG	24	23878
CFTR-Intron10-4997	+	UAUGUAGGAAAACAACUG	18	23879
CFTR-Intron10-4998	+	GUAUGUAGGAAAACAACUG	19	23880
CFTR-Intron10-4999	+	CGUAUGUAGGAAAACAACUG	20	23881
CFTR-Intron10-5000	+	UCGUAUGUAGGAAAACAACUG	21	23882
CFTR-Intron10-5001	+	UUCGUAUGUAGGAAAACAACUG	22	23883
CFTR-Intron10-5002	+	UUUCGUAUGUAGGAAAACAACUG	23	23884
CFTR-Intron10-5003	+	GUUUCGUAUGUAGGAAAACAACUG	24	23885
CFTR-Intron10-5004	+	GAAACUCCCCACACACUG	18	23886
CFTR-Intron10-5005	+	UGAAACUCCCCACACACUG	19	23887
CFTR-Intron10-5006	+	CUGAAACUCCCCACACACUG	20	23888
CFTR-Intron10-5007	+	ACUGAAACUCCCCACACACUG	21	23889
CFTR-Intron10-5008	+	GACUGAAACUCCCCACACACUG	22	23890
CFTR-Intron10-5009	+	GGACUGAAACUCCCCACACACUG	23	23891
CFTR-Intron10-5010	+	AGGACUGAAACUCCCCACACACUG	24	23892
CFTR-Intron10-5011	+	GCAAUAUGCAAUUUACUG	18	23893
CFTR-Intron10-5012	+	UGCAAUAUGCAAUUUACUG	19	23894
CFTR-Intron10-5013	+	CUGCAAUAUGCAAUUUACUG	20	23895
CFTR-Intron10-5014	+	ACUGCAAUAUGCAAUUUACUG	21	23896
CFTR-Intron10-5015	+	UACUGCAAUAUGCAAUUUACUG	22	23897
CFTR-Intron10-5016	+	UUACUGCAAUAUGCAAUUUACUG	23	23898
CFTR-Intron10-5017	+	UUUACUGCAAUAUGCAAUUUACUG	24	23899
CFTR-Intron10-5018	+	CAUCUGUUAGUAAUGCUG	18	23900
CFTR-Intron10-5019	+	UCAUCUGUUAGUAAUGCUG	19	23901
CFTR-Intron10-485	+	AUCAUCUGUUAGUAAUGCUG	20	19371
CFTR-Intron10-5020	+	UAUCAUCUGUUAGUAAUGCUG	21	23902
CFTR-Intron10-5021	+	AUAUCAUCUGUUAGUAAUGCUG	22	23903
CFTR-Intron10-5022	+	AAUAUCAUCUGUUAGUAAUGCUG	23	23904
CFTR-Intron10-5023	+	UAAUAUCAUCUGUUAGUAAUGCUG	24	23905
CFTR-Intron10-5024	+	AAUUAGCCGGGCGUAGUG	18	23906
CFTR-Intron10-5025	+	AAAUUAGCCGGGCGUAGUG	19	23907
CFTR-Intron10-5026	+	AAAAUUAGCCGGGCGUAGUG	20	23908
CFTR-Intron10-5027	+	AAAAAUUAGCCGGGCGUAGUG	21	23909
CFTR-Intron10-5028	+	AAAAAAUUAGCCGGGCGUAGUG	22	23910
CFTR-Intron10-5029	+	CAAAAAAUUAGCCGGGCGUAGUG	23	23911
CFTR-Intron10-5030	+	ACAAAAAAUUAGCCGGGCGUAGUG	24	23912
CFTR-Intron10-5031	+	UCUGUUAGUAAUGCUGUG	18	23913
CFTR-Intron10-5032	+	AUCUGUUAGUAAUGCUGUG	19	23914
CFTR-Intron10-490	+	CAUCUGUUAGUAAUGCUGUG	20	19376
CFTR-Intron10-5033	+	UCAUCUGUUAGUAAUGCUGUG	21	23915
CFTR-Intron10-5034	+	AUCAUCUGUUAGUAAUGCUGUG	22	23916
CFTR-Intron10-5035	+	UAUCAUCUGUUAGUAAUGCUGUG	23	23917
CFTR-Intron10-5036	+	AUAUCAUCUGUUAGUAAUGCUGUG	24	23918
CFTR-Intron10-5037	+	AUUCAAAAAAUAUUUGUG	18	23919
CFTR-Intron10-5038	+	UAUUCAAAAAAUAUUUGUG	19	23920
CFTR-Intron10-5039	+	CUAUUCAAAAAAUAUUUGUG	20	23921
CFTR-Intron10-5040	+	UCUAUUCAAAAAAUAUUUGUG	21	23922
CFTR-Intron10-5041	+	AUCUAUUCAAAAAAUAUUUGUG	22	23923
CFTR-Intron10-5042	+	AAUCUAUUCAAAAAAUAUUUGUG	23	23924
CFTR-Intron10-5043	+	UAAUCUAUUCAAAAAAUAUUUGUG	24	23925
CFTR-Intron10-5044	+	CUAUUCAAAAAAUAUUUG	18	23926
CFTR-Intron10-5045	+	UCUAUUCAAAAAAUAUUUG	19	23927
CFTR-Intron10-1323	+	AUCUAUUCAAAAAAUAUUUG	20	20208
CFTR-Intron10-5046	+	AAUCUAUUCAAAAAAUAUUUG	21	23928
CFTR-Intron10-5047	+	UAAUCUAUUCAAAAAAUAUUUG	22	23929
CFTR-Intron10-5048	+	CUAAUCUAUUCAAAAAAUAUUUG	23	23930
CFTR-Intron10-5049	+	GCUAAUCUAUUCAAAAAAUAUUUG	24	23931
CFTR-Intron10-5050	+	CUUAUAUUUUUAUUUUUG	18	23932
CFTR-Intron10-5051	+	ACUUAUAUUUUUAUUUUUG	19	23933
CFTR-Intron10-5052	+	CACUUAUAUUUUUAUUUUUG	20	23934
CFTR-Intron10-5053	+	CCACUUAUAUUUUUAUUUUUG	21	23935
CFTR-Intron10-5054	+	GCCACUUAUAUUUUUAUUUUUG	22	23936
CFTR-Intron10-5055	+	GGCCACUUAUAUUUUUAUUUUUG	23	23937
CFTR-Intron10-5056	+	AGGCCACUUAUAUUUUUAUUUUUG	24	23938
CFTR-Intron10-5057	+	UUUUGUUUGUGUUUUUUG	18	23939
CFTR-Intron10-5058	+	CUUUUGUUUGUGUUUUUUG	19	23940
CFTR-Intron10-5059	+	UCUUUUGUUUGUGUUUUUUG	20	23941
CFTR-Intron10-5060	+	UUCUUUUGUUUGUGUUUUUUG	21	23942
CFTR-Intron10-5061	+	UUUCUUUUGUUUGUGUUUUUUG	22	23943
CFTR-Intron10-5062	+	UUUUCUUUUGUUUGUGUUUUUUG	23	23944
CFTR-Intron10-5063	+	AUUUUCUUUUGUUUGUGUUUUUUG	24	23945
CFTR-Intron10-5064	+	CUAAAAUGACAAUCAAAU	18	23946
CFTR-Intron10-5065	+	GCUAAAAUGACAAUCAAAU	19	23947
CFTR-Intron10-498	+	AGCUAAAAUGACAAUCAAAU	20	19384
CFTR-Intron10-5066	+	CAGCUAAAAUGACAAUCAAAU	21	23948
CFTR-Intron10-5067	+	ACAGCUAAAAUGACAAUCAAAU	22	23949
CFTR-Intron10-5068	+	CACAGCUAAAAUGACAAUCAAAU	23	23950
CFTR-Intron10-5069	+	CCACAGCUAAAAUGACAAUCAAAU	24	23951
CFTR-Intron10-5070	+	AACAAUACAAAGAUAAAU	18	23952
CFTR-Intron10-5071	+	UAACAAUACAAAGAUAAAU	19	23953
CFTR-Intron10-5072	+	UUAACAAUACAAAGAUAAAU	20	23954
CFTR-Intron10-5073	+	UUUAACAAUACAAAGAUAAAU	21	23955
CFTR-Intron10-5074	+	AUUUAACAAUACAAAGAUAAAU	22	23956
CFTR-Intron10-5075	+	GAUUUAACAAUACAAAGAUAAAU	23	23957
CFTR-Intron10-5076	+	AGAUUUAACAAUACAAAGAUAAAU	24	23958
CFTR-Intron10-5077	+	GUUAUAUGUCCUGACAAU	18	23959
CFTR-Intron10-5078	+	UGUUAUAUGUCCUGACAAU	19	23960
CFTR-Intron10-5079	+	AUGUUAUAUGUCCUGACAAU	20	23961
CFTR-Intron10-5080	+	UAUGUUAUAUGUCCUGACAAU	21	23962
CFTR-Intron10-5081	+	AUAUGUUAUAUGUCCUGACAAU	22	23963
CFTR-Intron10-5082	+	AAUAUGUUAUAUGUCCUGACAAU	23	23964
CFTR-Intron10-5083	+	AAAUAUGUUAUAUGUCCUGACAAU	24	23965
CFTR-Intron10-5084	+	GUGCUAUUUAAACAGAAU	18	23966
CFTR-Intron10-5085	+	AGUGCUAUUUAAACAGAAU	19	23967
CFTR-Intron10-5086	+	CAGUGCUAUUUAAACAGAAU	20	23968
CFTR-Intron10-5087	+	CCAGUGCUAUUUAAACAGAAU	21	23969
CFTR-Intron10-5088	+	UCCAGUGCUAUUUAAACAGAAU	22	23970
CFTR-Intron10-5089	+	CUCCAGUGCUAUUUAAACAGAAU	23	23971
CFTR-Intron10-5090	+	ACUCCAGUGCUAUUUAAACAGAAU	24	23972
CFTR-Intron10-5091	+	GUCCUCUGUGCUUUGAAU	18	23973
CFTR-Intron10-5092	+	AGUCCUCUGUGCUUUGAAU	19	23974
CFTR-Intron10-5093	+	AAGUCCUCUGUGCUUUGAAU	20	23975
CFTR-Intron10-5094	+	CAAGUCCUCUGUGCUUUGAAU	21	23976
CFTR-Intron10-5095	+	GCAAGUCCUCUGUGCUUUGAAU	22	23977
CFTR-Intron10-5096	+	UGCAAGUCCUCUGUGCUUUGAAU	23	23978
CFTR-Intron10-5097	+	GUGCAAGUCCUCUGUGCUUUGAAU	24	23979
CFTR-Intron10-5098	+	CCAAGCAGUAGAAAUAAU	18	23980
CFTR-Intron10-5099	+	UCCAAGCAGUAGAAAUAAU	19	23981
CFTR-Intron10-5100	+	UUCCAAGCAGUAGAAAUAAU	20	23982
CFTR-Intron10-5101	+	AUUCCAAGCAGUAGAAAUAAU	21	23983
CFTR-Intron10-5102	+	AAUUCCAAGCAGUAGAAAUAAU	22	23984
CFTR-Intron10-5103	+	AAAUUCCAAGCAGUAGAAAUAAU	23	23985
CFTR-Intron10-5104	+	AAAAUUCCAAGCAGUAGAAAUAAU	24	23986
CFTR-Intron10-5105	+	UUUUAGUAGAAACCUAAU	18	23987
CFTR-Intron10-5106	+	GUUUUAGUAGAAACCUAAU	19	23988
CFTR-Intron10-5107	+	GGUUUUAGUAGAAACCUAAU	20	23989
CFTR-Intron10-5108	+	UGGUUUUAGUAGAAACCUAAU	21	23990
CFTR-Intron10-5109	+	UUGGUUUUAGUAGAAACCUAAU	22	23991
CFTR-Intron10-5110	+	UUUGGUUUUAGUAGAAACCUAAU	23	23992
CFTR-Intron10-5111	+	GUUUGGUUUUAGUAGAAACCUAAU	24	23993
CFTR-Intron10-5112	+	GCCUAGAUGAUUAUUAAU	18	23994
CFTR-Intron10-5113	+	AGCCUAGAUGAUUAUUAAU	19	23995
CFTR-Intron10-503	+	CAGCCUAGAUGAUUAUUAAU	20	19389
CFTR-Intron10-5114	+	GCAGCCUAGAUGAUUAUUAAU	21	23996
CFTR-Intron10-5115	+	UGCAGCCUAGAUGAUUAUUAAU	22	23997
CFTR-Intron10-5116	+	UUGCAGCCUAGAUGAUUAUUAAU	23	23998
CFTR-Intron10-5117	+	UUUGCAGCCUAGAUGAUUAUUAAU	24	23999
CFTR-Intron10-5118	+	UUACAAUUCUUAUUACAU	18	24000
CFTR-Intron10-5119	+	UUUACAAUUCUUAUUACAU	19	24001
CFTR-Intron10-1333	+	UUUUACAAUUCUUAUUACAU	20	20218
CFTR-Intron10-5120	+	AUUUUACAAUUCUUAUUACAU	21	24002
CFTR-Intron10-5121	+	AAUUUUACAAUUCUUAUUACAU	22	24003
CFTR-Intron10-5122	+	AAAUUUUACAAUUCUUAUUACAU	23	24004
CFTR-Intron10-5123	+	UAAAUUUUACAAUUCUUAUUACAU	24	24005
CFTR-Intron10-5124	+	AGGUAUAGUCAGUCCCAU	18	24006
CFTR-Intron10-5125	+	CAGGUAUAGUCAGUCCCAU	19	24007
CFTR-Intron10-5126	+	ACAGGUAUAGUCAGUCCCAU	20	24008
CFTR-Intron10-5127	+	GACAGGUAUAGUCAGUCCCAU	21	24009
CFTR-Intron10-5128	+	AGACAGGUAUAGUCAGUCCCAU	22	24010
CFTR-Intron10-5129	+	CAGACAGGUAUAGUCAGUCCCAU	23	24011
CFTR-Intron10-5130	+	CCAGACAGGUAUAGUCAGUCCCAU	24	24012
CFTR-Intron10-5131	+	AACAUAGAGAAAACUCAU	18	24013
CFTR-Intron10-5132	+	AAACAUAGAGAAAACUCAU	19	24014
CFTR-Intron10-5133	+	AAAACAUAGAGAAAACUCAU	20	24015
CFTR-Intron10-5134	+	UAAAACAUAGAGAAAACUCAU	21	24016
CFTR-Intron10-5135	+	AUAAAACAUAGAGAAAACUCAU	22	24017
CFTR-Intron10-5136	+	AAUAAAACAUAGAGAAAACUCAU	23	24018
CFTR-Intron10-5137	+	AAAUAAAACAUAGAGAAAACUCAU	24	24019
CFTR-Intron10-5138	+	CUAUUUUCCCUAUAAGAU	18	24020
CFTR-Intron10-5139	+	ACUAUUUUCCCUAUAAGAU	19	24021
CFTR-Intron10-5140	+	UACUAUUUUCCCUAUAAGAU	20	24022
CFTR-Intron10-5141	+	AUACUAUUUUCCCUAUAAGAU	21	24023
CFTR-Intron10-5142	+	CAUACUAUUUUCCCUAUAAGAU	22	24024
CFTR-Intron10-5143	+	ACAUACUAUUUUCCCUAUAAGAU	23	24025
CFTR-Intron10-5144	+	GACAUACUAUUUUCCCUAUAAGAU	24	24026
CFTR-Intron10-5145	+	AAUGGAAAAUGGACAGAU	18	24027
CFTR-Intron10-5146	+	GAAUGGAAAAUGGACAGAU	19	24028
CFTR-Intron10-5147	+	AGAAUGGAAAAUGGACAGAU	20	24029
CFTR-Intron10-5148	+	GAGAAUGGAAAAUGGACAGAU	21	24030
CFTR-Intron10-5149	+	GGAGAAUGGAAAAUGGACAGAU	22	24031
CFTR-Intron10-5150	+	AGGAGAAUGGAAAAUGGACAGAU	23	24032
CFTR-Intron10-5151	+	CAGGAGAAUGGAAAAUGGACAGAU	24	24033
CFTR-Intron10-5152	+	UUGUUCUUAGGGUGGGAU	18	24034
CFTR-Intron10-5153	+	GUUGUUCUUAGGGUGGGAU	19	24035
CFTR-Intron10-5154	+	AGUUGUUCUUAGGGUGGGAU	20	24036
CFTR-Intron10-5155	+	AAGUUGUUCUUAGGGUGGGAU	21	24037
CFTR-Intron10-5156	+	UAAGUUGUUCUUAGGGUGGGAU	22	24038
CFTR-Intron10-5157	+	UUAAGUUGUUCUUAGGGUGGGAU	23	24039
CFTR-Intron10-5158	+	GUUAAGUUGUUCUUAGGGUGGGAU	24	24040
CFTR-Intron10-5159	+	UGGCUACCUUGGUUGGAU	18	24041
CFTR-Intron10-5160	+	UUGGCUACCUUGGUUGGAU	19	24042
CFTR-Intron10-5161	+	AUUGGCUACCUUGGUUGGAU	20	24043
CFTR-Intron10-5162	+	GAUUGGCUACCUUGGUUGGAU	21	24044
CFTR-Intron10-5163	+	GGAUUGGCUACCUUGGUUGGAU	22	24045
CFTR-Intron10-5164	+	UGGAUUGGCUACCUUGGUUGGAU	23	24046
CFTR-Intron10-5165	+	CUGGAUUGGCUACCUUGGUUGGAU	24	24047
CFTR-Intron10-5166	+	AAACAUGAUGAAAAAUAU	18	24048
CFTR-Intron10-5167	+	UAAACAUGAUGAAAAAUAU	19	24049
CFTR-Intron10-5168	+	CUAAACAUGAUGAAAAAUAU	20	24050
CFTR-Intron10-5169	+	ACUAAACAUGAUGAAAAAUAU	21	24051
CFTR-Intron10-5170	+	CACUAAACAUGAUGAAAAAUAU	22	24052
CFTR-Intron10-5171	+	GCACUAAACAUGAUGAAAAAUAU	23	24053
CFTR-Intron10-5172	+	UGCACUAAACAUGAUGAAAAAUAU	24	24054
CFTR-Intron10-5173	+	UUUGUGUUAACAAAAUAU	18	24055
CFTR-Intron10-5174	+	CUUUGUGUUAACAAAAUAU	19	24056
CFTR-Intron10-506	+	UCUUUGUGUUAACAAAAUAU	20	19392
CFTR-Intron10-5175	+	UUCUUUGUGUUAACAAAAUAU	21	24057
CFTR-Intron10-5176	+	GUUCUUUGUGUUAACAAAAUAU	22	24058
CFTR-Intron10-5177	+	UGUUCUUUGUGUUAACAAAAUAU	23	24059
CFTR-Intron10-5178	+	UUGUUCUUUGUGUUAACAAAAUAU	24	24060
CFTR-Intron10-5179	+	GUUGCAAAAAUACGAUAU	18	24061
CFTR-Intron10-5180	+	AGUUGCAAAAAUACGAUAU	19	24062
CFTR-Intron10-5181	+	GAGUUGCAAAAAUACGAUAU	20	24063
CFTR-Intron10-5182	+	GGAGUUGCAAAAAUACGAUAU	21	24064
CFTR-Intron10-5183	+	AGGAGUUGCAAAAAUACGAUAU	22	24065
CFTR-Intron10-5184	+	AAGGAGUUGCAAAAAUACGAUAU	23	24066
CFTR-Intron10-5185	+	AAAGGAGUUGCAAAAAUACGAUAU	24	24067
CFTR-Intron10-5186	+	AAAAAUUACAGAACCUAU	18	24068
CFTR-Intron10-5187	+	CAAAAAUUACAGAACCUAU	19	24069
CFTR-Intron10-5188	+	GCAAAAAUUACAGAACCUAU	20	24070
CFTR-Intron10-5189	+	AGCAAAAAUUACAGAACCUAU	21	24071
CFTR-Intron10-5190	+	AAGCAAAAAUUACAGAACCUAU	22	24072
CFTR-Intron10-5191	+	GAAGCAAAAAUUACAGAACCUAU	23	24073
CFTR-Intron10-5192	+	UGAAGCAAAAAUUACAGAACCUAU	24	24074
CFTR-Intron10-5193	+	AAAUGCUUGACCACUUAU	18	24075
CFTR-Intron10-5194	+	CAAAUGCUUGACCACUUAU	19	24076
CFTR-Intron10-508	+	ACAAAUGCUUGACCACUUAU	20	19394
CFTR-Intron10-5195	+	CACAAAUGCUUGACCACUUAU	21	24077
CFTR-Intron10-5196	+	ACACAAAUGCUUGACCACUUAU	22	24078
CFTR-Intron10-5197	+	UACACAAAUGCUUGACCACUUAU	23	24079
CFTR-Intron10-5198	+	GUACACAAAUGCUUGACCACUUAU	24	24080
CFTR-Intron10-5199	+	AAAAAGCACUGAUUUUAU	18	24081
CFTR-Intron10-5200	+	GAAAAAGCACUGAUUUUAU	19	24082
CFTR-Intron10-5201	+	CGAAAAAGCACUGAUUUUAU	20	24083
CFTR-Intron10-5202	+	UCGAAAAAGCACUGAUUUUAU	21	24084
CFTR-Intron10-5203	+	CUCGAAAAAGCACUGAUUUUAU	22	24085
CFTR-Intron10-5204	+	CCUCGAAAAAGCACUGAUUUUAU	23	24086
CFTR-Intron10-5205	+	ACCUCGAAAAAGCACUGAUUUUAU	24	24087
CFTR-Intron10-5206	+	ACAAAGAUUUAUAUAACU	18	24088
CFTR-Intron10-5207	+	AACAAAGAUUUAUAUAACU	19	24089
CFTR-Intron10-5208	+	GAACAAAGAUUUAUAUAACU	20	24090
CFTR-Intron10-5209	+	UGAACAAAGAUUUAUAUAACU	21	24091
CFTR-Intron10-5210	+	GUGAACAAAGAUUUAUAUAACU	22	24092
CFTR-Intron10-5211	+	AGUGAACAAAGAUUUAUAUAACU	23	24093
CFTR-Intron10-5212	+	CAGUGAACAAAGAUUUAUAUAACU	24	24094
CFTR-Intron10-5213	+	GCCUGUAAUCCCAACACU	18	24095
CFTR-Intron10-5214	+	UGCCUGUAAUCCCAACACU	19	24096
CFTR-Intron10-5215	+	AUGCCUGUAAUCCCAACACU	20	24097
CFTR-Intron10-5216	+	CAUGCCUGUAAUCCCAACACU	21	24098
CFTR-Intron10-5217	+	UCAUGCCUGUAAUCCCAACACU	22	24099
CFTR-Intron10-5218	+	CUCAUGCCUGUAAUCCCAACACU	23	24100
CFTR-Intron10-5219	+	GCUCAUGCCUGUAAUCCCAACACU	24	24101
CFTR-Intron10-5220	+	GCCUAUAAACCCAGCACU	18	24102
CFTR-Intron10-5221	+	UGCCUAUAAACCCAGCACU	19	24103
CFTR-Intron10-5222	+	AUGCCUAUAAACCCAGCACU	20	24104
CFTR-Intron10-5223	+	CAUGCCUAUAAACCCAGCACU	21	24105
CFTR-Intron10-5224	+	UCAUGCCUAUAAACCCAGCACU	22	24106
CFTR-Intron10-5225	+	CUCAUGCCUAUAAACCCAGCACU	23	24107
CFTR-Intron10-5226	+	GCUCAUGCCUAUAAACCCAGCACU	24	24108
CFTR-Intron10-5227	+	GCCUGUAAUCCCAGCACU	18	24109
CFTR-Intron10-5228	+	CGCCUGUAAUCCCAGCACU	19	24110
CFTR-Intron10-5229	+	ACGCCUGUAAUCCCAGCACU	20	24111
CFTR-Intron10-5230	+	CACGCCUGUAAUCCCAGCACU	21	24112
CFTR-Intron10-5231	+	UCACGCCUGUAAUCCCAGCACU	22	24113
CFTR-Intron10-5232	+	CUCACGCCUGUAAUCCCAGCACU	23	24114
CFTR-Intron10-5233	+	GCUCACGCCUGUAAUCCCAGCACU	24	24115
CFTR-Intron10-5234	+	UCCCGAGUAGCUGGGACU	18	24116
CFTR-Intron10-5235	+	CUCCCGAGUAGCUGGGACU	19	24117
CFTR-Intron10-5236	+	CCUCCCGAGUAGCUGGGACU	20	24118
CFTR-Intron10-5237	+	GCCUCCCGAGUAGCUGGGACU	21	24119
CFTR-Intron10-5238	+	AGCCUCCCGAGUAGCUGGGACU	22	24120
CFTR-Intron10-5239	+	CAGCCUCCCGAGUAGCUGGGACU	23	24121
CFTR-Intron10-5240	+	UCAGCCUCCCGAGUAGCUGGGACU	24	24122
CFTR-Intron10-5241	+	CCUGUAGUCCCAGCUACU	18	17604
CFTR-Intron10-5242	+	GCCUGUAGUCCCAGCUACU	19	17605
CFTR-Intron10-1344	+	CGCCUGUAGUCCCAGCUACU	20	20229
CFTR-Intron10-5243	+	GCGCCUGUAGUCCCAGCUACU	21	24123
CFTR-Intron10-5244	+	GGCGCCUGUAGUCCCAGCUACU	22	24124
CFTR-Intron10-5245	+	GGGCGCCUGUAGUCCCAGCUACU	23	24125
CFTR-Intron10-5246	+	CGGGCGCCUGUAGUCCCAGCUACU	24	24126
CFTR-Intron10-1345	+	UGCCUGUAGUCCCAGCUACU	20	17606
CFTR-Intron10-5247	+	CGUGCCUGUAGUCCCAGCUACU	22	24127
CFTR-Intron10-5248	+	GCGUGCCUGUAGUCCCAGCUACU	23	24128
CFTR-Intron10-5249	+	UGCGUGCCUGUAGUCCCAGCUACU	24	24129
CFTR-Intron10-5250	+	CUUGCUUCACCUGCUACU	18	24130
CFTR-Intron10-5251	+	ACUUGCUUCACCUGCUACU	19	24131
CFTR-Intron10-512	+	CACUUGCUUCACCUGCUACU	20	19398
CFTR-Intron10-5252	+	GCACUUGCUUCACCUGCUACU	21	24132
CFTR-Intron10-5253	+	UGCACUUGCUUCACCUGCUACU	22	24133
CFTR-Intron10-5254	+	UUGCACUUGCUUCACCUGCUACU	23	24134
CFTR-Intron10-5255	+	UUUGCACUUGCUUCACCUGCUACU	24	24135
CFTR-Intron10-5256	+	AAUCUUAUAGAGAUUACU	18	24136
CFTR-Intron10-5257	+	AAAUCUUAUAGAGAUUACU	19	24137
CFTR-Intron10-513	+	AAAAUCUUAUAGAGAUUACU	20	19399
CFTR-Intron10-5258	+	CAAAAUCUUAUAGAGAUUACU	21	24138
CFTR-Intron10-5259	+	ACAAAAUCUUAUAGAGAUUACU	22	24139
CFTR-Intron10-5260	+	AACAAAAUCUUAUAGAGAUUACU	23	24140
CFTR-Intron10-5261	+	UAACAAAAUCUUAUAGAGAUUACU	24	24141
CFTR-Intron10-5262	+	CCUGCAAUACCAUCACCU	18	24142
CFTR-Intron10-5263	+	CCCUGCAAUACCAUCACCU	19	24143
CFTR-Intron10-1346	+	ACCCUGCAAUACCAUCACCU	20	20230
CFTR-Intron10-5264	+	CACCCUGCAAUACCAUCACCU	21	24144
CFTR-Intron10-5265	+	CCACCCUGCAAUACCAUCACCU	22	24145
CFTR-Intron10-5266	+	CCCACCCUGCAAUACCAUCACCU	23	24146
CFTR-Intron10-5267	+	CCCCACCCUGCAAUACCAUCACCU	24	24147
CFTR-Intron10-5268	+	AACUCAUAAGGGACCGCU	18	24148
CFTR-Intron10-5269	+	AAACUCAUAAGGGACCGCU	19	24149
CFTR-Intron10-518	+	AAAACUCAUAAGGGACCGCU	20	19404
CFTR-Intron10-5270	+	GAAAACUCAUAAGGGACCGCU	21	24150
CFTR-Intron10-5271	+	AGAAAACUCAUAAGGGACCGCU	22	24151
CFTR-Intron10-5272	+	GAGAAAACUCAUAAGGGACCGCU	23	24152
CFTR-Intron10-5273	+	AGAGAAAACUCAUAAGGGACCGCU	24	24153
CFTR-Intron10-5274	+	CUCACAGUUCUGGAGGCU	18	24154
CFTR-Intron10-5275	+	UCUCACAGUUCUGGAGGCU	19	24155
CFTR-Intron10-1357	+	UUCUCACAGUUCUGGAGGCU	20	20241
CFTR-Intron10-5276	+	UUUCUCACAGUUCUGGAGGCU	21	24156
CFTR-Intron10-5277	+	AUUUCUCACAGUUCUGGAGGCU	22	24157
CFTR-Intron10-5278	+	UAUUUCUCACAGUUCUGGAGGCU	23	24158
CFTR-Intron10-5279	+	UUAUUUCUCACAGUUCUGGAGGCU	24	24159
CFTR-Intron10-5280	+	UCAUCUGUUAGUAAUGCU	18	24160
CFTR-Intron10-5281	+	AUCAUCUGUUAGUAAUGCU	19	24161
CFTR-Intron10-5282	+	UAUCAUCUGUUAGUAAUGCU	20	24162
CFTR-Intron10-5283	+	AUAUCAUCUGUUAGUAAUGCU	21	24163
CFTR-Intron10-5284	+	AAUAUCAUCUGUUAGUAAUGCU	22	24164
CFTR-Intron10-5285	+	UAAUAUCAUCUGUUAGUAAUGCU	23	24165
CFTR-Intron10-5286	+	AUAAUAUCAUCUGUUAGUAAUGCU	24	24166
CFTR-Intron10-5287	+	AGCAGAUUUGGGUCUGCU	18	24167
CFTR-Intron10-5288	+	CAGCAGAUUUGGGUCUGCU	19	24168
CFTR-Intron10-5289	+	CCAGCAGAUUUGGGUCUGCU	20	24169
CFTR-Intron10-5290	+	GCCAGCAGAUUUGGGUCUGCU	21	24170
CFTR-Intron10-5291	+	UGCCAGCAGAUUUGGGUCUGCU	22	24171
CFTR-Intron10-5292	+	GUGCCAGCAGAUUUGGGUCUGCU	23	24172
CFTR-Intron10-5293	+	GGUGCCAGCAGAUUUGGGUCUGCU	24	24173
CFTR-Intron10-5294	+	AUAUAGAGAGAAACAUCU	18	24174
CFTR-Intron10-5295	+	UAUAUAGAGAGAAACAUCU	19	24175
CFTR-Intron10-5296	+	AUAUAUAGAGAGAAACAUCU	20	24176
CFTR-Intron10-5297	+	UAUAUAUAGAGAGAAACAUCU	21	24177
CFTR-Intron10-5298	+	AUAUAUAUAGAGAGAAACAUCU	22	24178
CFTR-Intron10-5299	+	UAUAUAUAUAGAGAGAAACAUCU	23	24179
CFTR-Intron10-5300	+	UUAUAUAUAUAGAGAGAAACAUCU	24	24180
CFTR-Intron10-5301	+	AUAGAGAGAAACAUCUCU	18	24181
CFTR-Intron10-5302	+	UAUAGAGAGAAACAUCUCU	19	24182
CFTR-Intron10-1365	+	AUAUAGAGAGAAACAUCUCU	20	20249
CFTR-Intron10-5303	+	UAUAUAGAGAGAAACAUCUCU	21	24183
CFTR-Intron10-5304	+	AUAUAUAGAGAGAAACAUCUCU	22	24184
CFTR-Intron10-5305	+	UAUAUAUAGAGAGAAACAUCUCU	23	24185
CFTR-Intron10-5306	+	AUAUAUAUAGAGAGAAACAUCUCU	24	24186
CFTR-Intron10-5307	+	AUUAAUUUUAAAAAUUCU	18	24187
CFTR-Intron10-5308	+	AAUUAAUUUUAAAAAUUCU	19	24188
CFTR-Intron10-5309	+	GAAUUAAUUUUAAAAAUUCU	20	24189
CFTR-Intron10-5310	+	AGAAUUAAUUUUAAAAAUUCU	21	24190
CFTR-Intron10-5311	+	CAGAAUUAAUUUUAAAAAUUCU	22	24191
CFTR-Intron10-5312	+	GCAGAAUUAAUUUUAAAAAUUCU	23	24192
CFTR-Intron10-5313	+	CGCAGAAUUAAUUUUAAAAAUUCU	24	24193
CFTR-Intron10-5314	+	UAAUUUGAACAACAUUCU	18	24194
CFTR-Intron10-5315	+	AUAAUUUGAACAACAUUCU	19	24195
CFTR-Intron10-527	+	AAUAAUUUGAACAACAUUCU	20	19413
CFTR-Intron10-5316	+	AAAUAAUUUGAACAACAUUCU	21	24196
CFTR-Intron10-5317	+	GAAAUAAUUUGAACAACAUUCU	22	24197
CFTR-Intron10-5318	+	AGAAAUAAUUUGAACAACAUUCU	23	24198
CFTR-Intron10-5319	+	UAGAAAUAAUUUGAACAACAUUCU	24	24199
CFTR-Intron10-5320	+	UUAGUAAACUCCGUUUCU	18	24200
CFTR-Intron10-5321	+	GUUAGUAAACUCCGUUUCU	19	24201
CFTR-Intron10-5322	+	AGUUAGUAAACUCCGUUUCU	20	24202
CFTR-Intron10-5323	+	GAGUUAGUAAACUCCGUUUCU	21	24203
CFTR-Intron10-5324	+	UGAGUUAGUAAACUCCGUUUCU	22	24204
CFTR-Intron10-5325	+	UUGAGUUAGUAAACUCCGUUUCU	23	24205
CFTR-Intron10-5326	+	AUUGAGUUAGUAAACUCCGUUUCU	24	24206
CFTR-Intron10-5327	+	CCUGACAAUAAGAAAAGU	18	24207
CFTR-Intron10-5328	+	UCCUGACAAUAAGAAAAGU	19	24208
CFTR-Intron10-5329	+	GUCCUGACAAUAAGAAAAGU	20	24209
CFTR-Intron10-5330	+	UGUCCUGACAAUAAGAAAAGU	21	24210
CFTR-Intron10-5331	+	AUGUCCUGACAAUAAGAAAAGU	22	24211
CFTR-Intron10-5332	+	UAUGUCCUGACAAUAAGAAAAGU	23	24212
CFTR-Intron10-5333	+	AUAUGUCCUGACAAUAAGAAAAGU	24	24213
CFTR-Intron10-5334	+	AGUGCUAGGAUUACAAGU	18	24214
CFTR-Intron10-5335	+	AAGUGCUAGGAUUACAAGU	19	24215
CFTR-Intron10-5336	+	AAAGUGCUAGGAUUACAAGU	20	24216
CFTR-Intron10-5337	+	AAAAGUGCUAGGAUUACAAGU	21	24217
CFTR-Intron10-5338	+	CAAAAGUGCUAGGAUUACAAGU	22	24218
CFTR-Intron10-5339	+	CCAAAAGUGCUAGGAUUACAAGU	23	24219
CFTR-Intron10-5340	+	UCCAAAAGUGCUAGGAUUACAAGU	24	24220
CFTR-Intron10-5341	+	AGGAAAUGGGGUAUAAGU	18	24221
CFTR-Intron10-5342	+	AAGGAAAUGGGGUAUAAGU	19	24222
CFTR-Intron10-5343	+	AAAGGAAAUGGGGUAUAAGU	20	24223
CFTR-Intron10-5344	+	CAAAGGAAAUGGGGUAUAAGU	21	24224
CFTR-Intron10-5345	+	ACAAAGGAAAUGGGGUAUAAGU	22	24225
CFTR-Intron10-5346	+	AACAAAGGAAAUGGGGUAUAAGU	23	24226
CFTR-Intron10-5347	+	AAACAAAGGAAAUGGGGUAUAAGU	24	24227
CFTR-Intron10-5348	+	ACAGAAAUAUUCAGCAGU	18	24228
CFTR-Intron10-5349	+	GACAGAAAUAUUCAGCAGU	19	24229
CFTR-Intron10-5350	+	AGACAGAAAUAUUCAGCAGU	20	24230
CFTR-Intron10-5351	+	GAGACAGAAAUAUUCAGCAGU	21	24231
CFTR-Intron10-5352	+	AGAGACAGAAAUAUUCAGCAGU	22	24232
CFTR-Intron10-5353	+	GAGAGACAGAAAUAUUCAGCAGU	23	24233
CFTR-Intron10-5354	+	GGAGAGACAGAAAUAUUCAGCAGU	24	24234
CFTR-Intron10-5355	+	AAAGUUGUCCAAGAUAGU	18	24235
CFTR-Intron10-5356	+	GAAAGUUGUCCAAGAUAGU	19	24236
CFTR-Intron10-120	+	GGAAAGUUGUCCAAGAUAGU	20	19006
CFTR-Intron10-5357	+	UGGAAAGUUGUCCAAGAUAGU	21	24237
CFTR-Intron10-5358	+	AUGGAAAGUUGUCCAAGAUAGU	22	24238
CFTR-Intron10-5359	+	UAUGGAAAGUUGUCCAAGAUAGU	23	24239
CFTR-Intron10-5360	+	AUAUGGAAAGUUGUCCAAGAUAGU	24	24240
CFTR-Intron10-5361	+	CUUUAUCAACAUGAAGGU	18	24241
CFTR-Intron10-5362	+	CCUUUAUCAACAUGAAGGU	19	24242
CFTR-Intron10-5363	+	CCCUUUAUCAACAUGAAGGU	20	24243
CFTR-Intron10-5364	+	ACCCUUUAUCAACAUGAAGGU	21	24244
CFTR-Intron10-5365	+	GACCCUUUAUCAACAUGAAGGU	22	24245
CFTR-Intron10-5366	+	UGACCCUUUAUCAACAUGAAGGU	23	24246
CFTR-Intron10-5367	+	UUGACCCUUUAUCAACAUGAAGGU	24	24247
CFTR-Intron10-5368	+	UGAGGGUCUCUCUAAGGU	18	24248
CFTR-Intron10-5369	+	GUGAGGGUCUCUCUAAGGU	19	24249
CFTR-Intron10-5370	+	GGUGAGGGUCUCUCUAAGGU	20	24250
CFTR-Intron10-5371	+	GGGUGAGGGUCUCUCUAAGGU	21	24251
CFTR-Intron10-5372	+	GGGGUGAGGGUCUCUCUAAGGU	22	24252
CFTR-Intron10-5373	+	AGGGGUGAGGGUCUCUCUAAGGU	23	24253
CFTR-Intron10-5374	+	AAGGGGUGAGGGUCUCUCUAAGGU	24	24254
CFTR-Intron10-5375	+	UUACAUAAAAAGAGAGGU	18	24255
CFTR-Intron10-5376	+	GUUACAUAAAAAGAGAGGU	19	24256
CFTR-Intron10-535	+	UGUUACAUAAAAAGAGAGGU	20	19421
CFTR-Intron10-5377	+	UUGUUACAUAAAAAGAGAGGU	21	24257
CFTR-Intron10-5378	+	AUUGUUACAUAAAAAGAGAGGU	22	24258
CFTR-Intron10-5379	+	UAUUGUUACAUAAAAAGAGAGGU	23	24259
CFTR-Intron10-5380	+	AUAUUGUUACAUAAAAAGAGAGGU	24	24260
CFTR-Intron10-5381	+	GCGGGCGGAUCACGAGGU	18	24261
CFTR-Intron10-5382	+	GGCGGGCGGAUCACGAGGU	19	24262
CFTR-Intron10-5383	+	AGGCGGGCGGAUCACGAGGU	20	24263
CFTR-Intron10-5384	+	GAGGCGGGCGGAUCACGAGGU	21	24264
CFTR-Intron10-5385	+	CGAGGCGGGCGGAUCACGAGGU	22	24265
CFTR-Intron10-5386	+	CCGAGGCGGGCGGAUCACGAGGU	23	24266
CFTR-Intron10-5387	+	GCCGAGGCGGGCGGAUCACGAGGU	24	24267
CFTR-Intron10-5388	+	UAUAUUCUUUUAUGUGGU	18	24268
CFTR-Intron10-5389	+	AUAUAUUCUUUUAUGUGGU	19	24269
CFTR-Intron10-5390	+	AAUAUAUUCUUUUAUGUGGU	20	24270
CFTR-Intron10-5391	+	GAAUAUAUUCUUUUAUGUGGU	21	24271
CFTR-Intron10-5392	+	CGAAUAUAUUCUUUUAUGUGGU	22	24272
CFTR-Intron10-5393	+	ACGAAUAUAUUCUUUUAUGUGGU	23	24273
CFTR-Intron10-5394	+	CACGAAUAUAUUCUUUUAUGUGGU	24	24274
CFTR-Intron10-5395	+	AAAAGCUGUUUCGUAUGU	18	24275
CFTR-Intron10-5396	+	UAAAAGCUGUUUCGUAUGU	19	24276
CFTR-Intron10-539	+	UUAAAAGCUGUUUCGUAUGU	20	19425
CFTR-Intron10-5397	+	UUUAAAAGCUGUUUCGUAUGU	21	24277
CFTR-Intron10-5398	+	UUUUAAAAGCUGUUUCGUAUGU	22	24278
CFTR-Intron10-5399	+	GUUUUAAAAGCUGUUUCGUAUGU	23	24279
CFTR-Intron10-5400	+	UGUUUUAAAAGCUGUUUCGUAUGU	24	24280
CFTR-Intron10-5401	+	AUCUGUUAGUAAUGCUGU	18	24281
CFTR-Intron10-5402	+	CAUCUGUUAGUAAUGCUGU	19	24282
CFTR-Intron10-540	+	UCAUCUGUUAGUAAUGCUGU	20	19426
CFTR-Intron10-5403	+	AUCAUCUGUUAGUAAUGCUGU	21	24283
CFTR-Intron10-5404	+	UAUCAUCUGUUAGUAAUGCUGU	22	24284
CFTR-Intron10-5405	+	AUAUCAUCUGUUAGUAAUGCUGU	23	24285
CFTR-Intron10-5406	+	AAUAUCAUCUGUUAGUAAUGCUGU	24	24286
CFTR-Intron10-5407	+	AUAGAGACAAGGUGGUGU	18	24287
CFTR-Intron10-5408	+	AAUAGAGACAAGGUGGUGU	19	24288
CFTR-Intron10-5409	+	UAAUAGAGACAAGGUGGUGU	20	24289
CFTR-Intron10-5410	+	AUAAUAGAGACAAGGUGGUGU	21	24290
CFTR-Intron10-5411	+	AAUAAUAGAGACAAGGUGGUGU	22	24291
CFTR-Intron10-5412	+	CAAUAAUAGAGACAAGGUGGUGU	23	24292
CFTR-Intron10-5413	+	UCAAUAAUAGAGACAAGGUGGUGU	24	24293
CFTR-Intron10-5414	+	GAAAGAAAAUGUUUUUGU	18	24294
CFTR-Intron10-5415	+	AGAAAGAAAAUGUUUUUGU	19	24295
CFTR-Intron10-5416	+	AAGAAAGAAAAUGUUUUUGU	20	24296
CFTR-Intron10-5417	+	UAAGAAAGAAAAUGUUUUUGU	21	24297
CFTR-Intron10-5418	+	UUAAGAAAGAAAAUGUUUUUGU	22	24298
CFTR-Intron10-5419	+	UUUAAGAAAGAAAAUGUUUUUGU	23	24299
CFTR-Intron10-5420	+	UUUUAAGAAAGAAAAUGUUUUUGU	24	24300
CFTR-Intron10-5421	+	UGGCUUAACCCAUCUAUU	18	24301
CFTR-Intron10-5422	+	UUGGCUUAACCCAUCUAUU	19	24302
CFTR-Intron10-5423	+	GUUGGCUUAACCCAUCUAUU	20	24303
CFTR-Intron10-5424	+	AGUUGGCUUAACCCAUCUAUU	21	24304
CFTR-Intron10-5425	+	CAGUUGGCUUAACCCAUCUAUU	22	24305
CFTR-Intron10-5426	+	UCAGUUGGCUUAACCCAUCUAUU	23	24306
CFTR-Intron10-5427	+	UUCAGUUGGCUUAACCCAUCUAUU	24	24307
CFTR-Intron10-5428	+	AUAAUUCUAGAAAGUAUU	18	24308
CFTR-Intron10-5429	+	UAUAAUUCUAGAAAGUAUU	19	24309
CFTR-Intron10-5430	+	GUAUAAUUCUAGAAAGUAUU	20	24310
CFTR-Intron10-5431	+	GGUAUAAUUCUAGAAAGUAUU	21	24311
CFTR-Intron10-5432	+	CGGUAUAAUUCUAGAAAGUAUU	22	24312
CFTR-Intron10-5433	+	UCGGUAUAAUUCUAGAAAGUAUU	23	24313
CFTR-Intron10-5434	+	UUCGGUAUAAUUCUAGAAAGUAUU	24	24314
CFTR-Intron10-5435	+	UUUAUUUAUUUAUUUAUU	18	24315
CFTR-Intron10-5436	+	AUUUAUUUAUUUAUUUAUU	19	24316
CFTR-Intron10-5437	+	UAUUUAUUUAUUUAUUUAUU	20	24317
CFTR-Intron10-5438	+	UUAUUUAUUUAUUUAUUUAUU	21	24318
CFTR-Intron10-5439	+	UUUAUUUAUUUAUUUAUUUAUU	22	24319
CFTR-Intron10-5440	+	AUUUAUUUAUUUAUUUAUUUAUU	23	24320
CFTR-Intron10-5441	+	UAUUUAUUUAUUUAUUUAUUUAUU	24	24321
CFTR-Intron10-5442	+	UUUGCUGAUUGCUUUAUU	18	24322
CFTR-Intron10-5443	+	AUUUGCUGAUUGCUUUAUU	19	24323
CFTR-Intron10-5444	+	AAUUUGCUGAUUGCUUUAUU	20	24324
CFTR-Intron10-5445	+	AAAUUUGCUGAUUGCUUUAUU	21	24325
CFTR-Intron10-5446	+	GAAAUUUGCUGAUUGCUUUAUU	22	24326
CFTR-Intron10-5447	+	GGAAAUUUGCUGAUUGCUUUAUU	23	24327
CFTR-Intron10-5448	+	AGGAAAUUUGCUGAUUGCUUUAUU	24	24328
CFTR-Intron10-5449	+	CCUGUAAUCCCAACACUU	18	24329
CFTR-Intron10-5450	+	GCCUGUAAUCCCAACACUU	19	24330
CFTR-Intron10-1391	+	UGCCUGUAAUCCCAACACUU	20	20275
CFTR-Intron10-5451	+	AUGCCUGUAAUCCCAACACUU	21	24331
CFTR-Intron10-5452	+	CAUGCCUGUAAUCCCAACACUU	22	24332
CFTR-Intron10-5453	+	UCAUGCCUGUAAUCCCAACACUU	23	24333
CFTR-Intron10-5454	+	CUCAUGCCUGUAAUCCCAACACUU	24	24334
CFTR-Intron10-5455	+	CCUAUAAACCCAGCACUU	18	24335
CFTR-Intron10-5456	+	GCCUAUAAACCCAGCACUU	19	24336
CFTR-Intron10-1392	+	UGCCUAUAAACCCAGCACUU	20	20276
CFTR-Intron10-5457	+	AUGCCUAUAAACCCAGCACUU	21	24337
CFTR-Intron10-5458	+	CAUGCCUAUAAACCCAGCACUU	22	24338
CFTR-Intron10-5459	+	UCAUGCCUAUAAACCCAGCACUU	23	24339
CFTR-Intron10-5460	+	CUCAUGCCUAUAAACCCAGCACUU	24	24340
CFTR-Intron10-5461	+	CCUGUAAUCCCAGCACUU	18	24341
CFTR-Intron10-5462	+	GCCUGUAAUCCCAGCACUU	19	24342
CFTR-Intron10-1393	+	CGCCUGUAAUCCCAGCACUU	20	20277
CFTR-Intron10-5463	+	ACGCCUGUAAUCCCAGCACUU	21	24343
CFTR-Intron10-5464	+	CACGCCUGUAAUCCCAGCACUU	22	24344
CFTR-Intron10-5465	+	UCACGCCUGUAAUCCCAGCACUU	23	24345
CFTR-Intron10-5466	+	CUCACGCCUGUAAUCCCAGCACUU	24	24346
CFTR-Intron10-5467	+	GAACCAUUUUAUAGACUU	18	24347
CFTR-Intron10-5468	+	GGAACCAUUUUAUAGACUU	19	24348
CFTR-Intron10-5469	+	AGGAACCAUUUUAUAGACUU	20	24349
CFTR-Intron10-5470	+	AAGGAACCAUUUUAUAGACUU	21	24350
CFTR-Intron10-5471	+	CAAGGAACCAUUUUAUAGACUU	22	24351
CFTR-Intron10-5472	+	ACAAGGAACCAUUUUAUAGACUU	23	24352
CFTR-Intron10-5473	+	AACAAGGAACCAUUUUAUAGACUU	24	24353
CFTR-Intron10-5474	+	CUGUAGUCCCAGCUACUU	18	24354
CFTR-Intron10-5475	+	CCUGUAGUCCCAGCUACUU	19	24355
CFTR-Intron10-720	+	GCCUGUAGUCCCAGCUACUU	20	19606
CFTR-Intron10-5476	+	CGCCUGUAGUCCCAGCUACUU	21	24356
CFTR-Intron10-5477	+	GCGCCUGUAGUCCCAGCUACUU	22	24357
CFTR-Intron10-5478	+	GGCGCCUGUAGUCCCAGCUACUU	23	24358
CFTR-Intron10-5479	+	GGGCGCCUGUAGUCCCAGCUACUU	24	24359
CFTR-Intron10-5480	+	UGCCUGUAGUCCCAGCUACUU	21	24360
CFTR-Intron10-5481	+	GUGCCUGUAGUCCCAGCUACUU	22	24361
CFTR-Intron10-5482	+	CGUGCCUGUAGUCCCAGCUACUU	23	24362
CFTR-Intron10-5483	+	GCGUGCCUGUAGUCCCAGCUACUU	24	24363
CFTR-Intron10-5484	+	AAUUUAUUUCUCACAGUU	18	24364
CFTR-Intron10-5485	+	GAAUUUAUUUCUCACAGUU	19	24365
CFTR-Intron10-5486	+	GGAAUUUAUUUCUCACAGUU	20	24366
CFTR-Intron10-5487	+	AGGAAUUUAUUUCUCACAGUU	21	24367
CFTR-Intron10-5488	+	CAGGAAUUUAUUUCUCACAGUU	22	24368
CFTR-Intron10-5489	+	ACAGGAAUUUAUUUCUCACAGUU	23	24369
CFTR-Intron10-5490	+	AACAGGAAUUUAUUUCUCACAGUU	24	24370
CFTR-Intron10-5491	+	CUUGACAUCAGUUGGGUU	18	24371
CFTR-Intron10-5492	+	GCUUGACAUCAGUUGGGUU	19	24372
CFTR-Intron10-5493	+	UGCUUGACAUCAGUUGGGUU	20	24373
CFTR-Intron10-5494	+	CUGCUUGACAUCAGUUGGGUU	21	24374
CFTR-Intron10-5495	+	UCUGCUUGACAUCAGUUGGGUU	22	24375
CFTR-Intron10-5496	+	UUCUGCUUGACAUCAGUUGGGUU	23	24376
CFTR-Intron10-5497	+	CUUCUGCUUGACAUCAGUUGGGUU	24	24377
CFTR-Intron10-5498	+	AAAAUAUACCCAAAAUUU	18	24378
CFTR-Intron10-5499	+	UAAAAUAUACCCAAAAUUU	19	24379
CFTR-Intron10-5500	+	AUAAAAUAUACCCAAAAUUU	20	24380
CFTR-Intron10-5501	+	UAUAAAAUAUACCCAAAAUUU	21	24381
CFTR-Intron10-5502	+	AUAUAAAAUAUACCCAAAAUUU	22	24382
CFTR-Intron10-5503	+	AAUAUAAAAUAUACCCAAAAUUU	23	24383
CFTR-Intron10-5504	+	AAAUAUAAAAUAUACCCAAAAUUU	24	24384
CFTR-Intron10-5505	+	ACGAAUUGGUACAAAUUU	18	24385
CFTR-Intron10-5506	+	UACGAAUUGGUACAAAUUU	19	24386
CFTR-Intron10-5507	+	GUACGAAUUGGUACAAAUUU	20	24387
CFTR-Intron10-5508	+	AGUACGAAUUGGUACAAAUUU	21	24388
CFTR-Intron10-5509	+	GAGUACGAAUUGGUACAAAUUU	22	24389
CFTR-Intron10-5510	+	UGAGUACGAAUUGGUACAAAUUU	23	24390
CFTR-Intron10-5511	+	AUGAGUACGAAUUGGUACAAAUUU	24	24391
CFTR-Intron10-5512	+	CCCUAUUAUUCAACAUUU	18	24392
CFTR-Intron10-5513	+	CCCCUAUUAUUCAACAUUU	19	24393
CFTR-Intron10-5514	+	ACCCCUAUUAUUCAACAUUU	20	24394
CFTR-Intron10-5515	+	AACCCCUAUUAUUCAACAUUU	21	24395
CFTR-Intron10-5516	+	AAACCCCUAUUAUUCAACAUUU	22	24396
CFTR-Intron10-5517	+	CAAACCCCUAUUAUUCAACAUUU	23	24397
CFTR-Intron10-5518	+	UCAAACCCCUAUUAUUCAACAUUU	24	24398
CFTR-Intron10-5519	+	UCUAUUCAAAAAAUAUUU	18	24399
CFTR-Intron10-5520	+	AUCUAUUCAAAAAAUAUUU	19	24400
CFTR-Intron10-5521	+	AAUCUAUUCAAAAAAUAUUU	20	24401
CFTR-Intron10-5522	+	UAAUCUAUUCAAAAAAUAUUU	21	24402
CFTR-Intron10-5523	+	CUAAUCUAUUCAAAAAAUAUUU	22	24403
CFTR-Intron10-5524	+	GCUAAUCUAUUCAAAAAAUAUUU	23	24404
CFTR-Intron10-5525	+	AGCUAAUCUAUUCAAAAAAUAUUU	24	24405
CFTR-Intron10-5526	+	CGAGUUAUCUCCGUAUUU	18	24406
CFTR-Intron10-5527	+	ACGAGUUAUCUCCGUAUUU	19	24407
CFTR-Intron10-5528	+	CACGAGUUAUCUCCGUAUUU	20	24408
CFTR-Intron10-5529	+	UCACGAGUUAUCUCCGUAUUU	21	24409
CFTR-Intron10-5530	+	GUCACGAGUUAUCUCCGUAUUU	22	24410
CFTR-Intron10-5531	+	AGUCACGAGUUAUCUCCGUAUUU	23	24411
CFTR-Intron10-5532	+	AAGUCACGAGUUAUCUCCGUAUUU	24	24412
CFTR-Intron10-5533	+	CUGUAAUCCCAACACUUU	18	24413
CFTR-Intron10-5534	+	CCUGUAAUCCCAACACUUU	19	24414
CFTR-Intron10-722	+	GCCUGUAAUCCCAACACUUU	20	19608
CFTR-Intron10-5535	+	UGCCUGUAAUCCCAACACUUU	21	24415
CFTR-Intron10-5536	+	AUGCCUGUAAUCCCAACACUUU	22	24416
CFTR-Intron10-5537	+	CAUGCCUGUAAUCCCAACACUUU	23	24417
CFTR-Intron10-5538	+	UCAUGCCUGUAAUCCCAACACUUU	24	24418
CFTR-Intron10-5539	+	CUAUAAACCCAGCACUUU	18	24419
CFTR-Intron10-5540	+	CCUAUAAACCCAGCACUUU	19	24420
CFTR-Intron10-723	+	GCCUAUAAACCCAGCACUUU	20	19609
CFTR-Intron10-5541	+	UGCCUAUAAACCCAGCACUUU	21	24421
CFTR-Intron10-5542	+	AUGCCUAUAAACCCAGCACUUU	22	24422
CFTR-Intron10-5543	+	CAUGCCUAUAAACCCAGCACUUU	23	24423
CFTR-Intron10-5544	+	UCAUGCCUAUAAACCCAGCACUUU	24	24424
CFTR-Intron10-5545	+	CUGUAAUCCCAGCACUUU	18	24425
CFTR-Intron10-5546	+	CCUGUAAUCCCAGCACUUU	19	24426
CFTR-Intron10-724	+	GCCUGUAAUCCCAGCACUUU	20	19610
CFTR-Intron10-5547	+	CGCCUGUAAUCCCAGCACUUU	21	24427
CFTR-Intron10-5548	+	ACGCCUGUAAUCCCAGCACUUU	22	24428
CFTR-Intron10-5549	+	CACGCCUGUAAUCCCAGCACUUU	23	24429
CFTR-Intron10-5550	+	UCACGCCUGUAAUCCCAGCACUUU	24	24430
CFTR-Intron10-5551	+	UGAUAAAUAAUUGCCUUU	18	24431
CFTR-Intron10-5552	+	UUGAUAAAUAAUUGCCUUU	19	24432
CFTR-Intron10-5553	+	AUUGAUAAAUAAUUGCCUUU	20	24433
CFTR-Intron10-5554	+	UAUUGAUAAAUAAUUGCCUUU	21	24434
CFTR-Intron10-5555	+	AUAUUGAUAAAUAAUUGCCUUU	22	24435
CFTR-Intron10-5556	+	GAUAUUGAUAAAUAAUUGCCUUU	23	24436
CFTR-Intron10-5557	+	AGAUAUUGAUAAAUAAUUGCCUUU	24	24437
CFTR-Intron10-5558	+	AAAUAAGCCUUAGUCUUU	18	24438
CFTR-Intron10-5559	+	GAAAUAAGCCUUAGUCUUU	19	24439
CFTR-Intron10-5560	+	AGAAAUAAGCCUUAGUCUUU	20	24440
CFTR-Intron10-5561	+	GAGAAAUAAGCCUUAGUCUUU	21	24441
CFTR-Intron10-5562	+	AGAGAAAUAAGCCUUAGUCUUU	22	24442
CFTR-Intron10-5563	+	CAGAGAAAUAAGCCUUAGUCUUU	23	24443
CFTR-Intron10-5564	+	CCAGAGAAAUAAGCCUUAGUCUUU	24	24444
CFTR-Intron10-5565	+	AGAAAAUUUGUUUUCUUU	18	24445
CFTR-Intron10-5566	+	AAGAAAAUUUGUUUUCUUU	19	24446
CFTR-Intron10-5567	+	AAAGAAAAUUUGUUUUCUUU	20	24447
CFTR-Intron10-5568	+	CAAAGAAAAUUUGUUUUCUUU	21	24448
CFTR-Intron10-5569	+	ACAAAGAAAAUUUGUUUUCUUU	22	24449
CFTR-Intron10-5570	+	AACAAAGAAAAUUUGUUUUCUUU	23	24450
CFTR-Intron10-5571	+	AAACAAAGAAAAUUUGUUUUCUUU	24	24451
CFTR-Intron10-5572	+	GAAAAAUAAUAACAUUUU	18	24452
CFTR-Intron10-5573	+	AGAAAAAUAAUAACAUUUU	19	24453
CFTR-Intron10-5574	+	AAGAAAAAUAAUAACAUUUU	20	24454
CFTR-Intron10-5575	+	AAAGAAAAAUAAUAACAUUUU	21	24455
CFTR-Intron10-5576	+	AAAAGAAAAAUAAUAACAUUUU	22	24456
CFTR-Intron10-5577	+	UAAAAGAAAAAUAAUAACAUUUU	23	24457
CFTR-Intron10-5578	+	AUAAAAGAAAAAUAAUAACAUUUU	24	24458
CFTR-Intron10-5579	+	AUACAUACAUAUGAUUUU	18	24459
CFTR-Intron10-5580	+	UAUACAUACAUAUGAUUUU	19	24460
CFTR-Intron10-5581	+	AUAUACAUACAUAUGAUUUU	20	24461
CFTR-Intron10-5582	+	UAUAUACAUACAUAUGAUUUU	21	24462
CFTR-Intron10-5583	+	AUAUAUACAUACAUAUGAUUUU	22	24463
CFTR-Intron10-5584	+	CAUAUAUACAUACAUAUGAUUUU	23	24464
CFTR-Intron10-5585	+	ACAUAUAUACAUACAUAUGAUUUU	24	24465
CFTR-Intron10-5586	+	CACCAAUUUUUUUUUUUU	18	24466
CFTR-Intron10-5587	+	ACACCAAUUUUUUUUUUUU	19	24467
CFTR-Intron10-5588	+	AACACCAAUUUUUUUUUUUU	20	24468
CFTR-Intron10-5589	+	AAACACCAAUUUUUUUUUUUU	21	24469
CFTR-Intron10-5590	+	CAAACACCAAUUUUUUUUUUUU	22	24470
CFTR-Intron10-5591	+	GCAAACACCAAUUUUUUUUUUUU	23	24471
CFTR-Intron10-5592	+	UGCAAACACCAAUUUUUUUUUUUU	24	24472
CFTR-Intron10-5593	−	UAAAAAUGUUAAUGAAAA	18	24473
CFTR-Intron10-5594	−	GUAAAAAUGUUAAUGAAAA	19	24474
CFTR-Intron10-5595	−	GGUAAAAAUGUUAAUGAAAA	20	24475
CFTR-Intron10-5596	−	AGGUAAAAAUGUUAAUGAAAA	21	24476
CFTR-Intron10-5597	−	UAGGUAAAAAUGUUAAUGAAAA	22	24477
CFTR-Intron10-5598	−	GUAGGUAAAAAUGUUAAUGAAAA	23	24478
CFTR-Intron10-5599	−	UGUAGGUAAAAAUGUUAAUGAAAA	24	24479
CFTR-Intron10-5600	−	AUUUAUUAAAAUUUAAAA	18	24480
CFTR-Intron10-5601	−	UAUUUAUUAAAAUUUAAAA	19	24481
CFTR-Intron10-5602	−	UUAUUUAUUAAAAUUUAAAA	20	24482
CFTR-Intron10-5603	−	AUUAUUUAUUAAAAUUUAAAA	21	24483
CFTR-Intron10-5604	−	UAUUAUUUAUUAAAAUUUAAAA	22	24484
CFTR-Intron10-5605	−	AUAUUAUUUAUUAAAAUUUAAAA	23	24485
CFTR-Intron10-5606	−	GAUAUUAUUUAUUAAAAUUUAAAA	24	24486
CFTR-Intron10-5607	−	CGAAUAAUCUAAGACAAA	18	24487
CFTR-Intron10-5608	−	CCGAAUAAUCUAAGACAAA	19	24488
CFTR-Intron10-5609	−	ACCGAAUAAUCUAAGACAAA	20	24489
CFTR-Intron10-5610	−	UACCGAAUAAUCUAAGACAAA	21	24490
CFTR-Intron10-5611	−	AUACCGAAUAAUCUAAGACAAA	22	24491
CFTR-Intron10-5612	−	UAUACCGAAUAAUCUAAGACAAA	23	24492
CFTR-Intron10-5613	−	UUAUACCGAAUAAUCUAAGACAAA	24	24493
CFTR-Intron10-5614	−	GCCUAUUUGACAUCCAAA	18	24494
CFTR-Intron10-5615	−	UGCCUAUUUGACAUCCAAA	19	24495
CFTR-Intron10-5616	−	AUGCCUAUUUGACAUCCAAA	20	24496
CFTR-Intron10-5617	−	AAUGCCUAUUUGACAUCCAAA	21	24497
CFTR-Intron10-5618	−	AAAUGCCUAUUUGACAUCCAAA	22	24498
CFTR-Intron10-5619	−	GAAAUGCCUAUUUGACAUCCAAA	23	24499
CFTR-Intron10-5620	−	UGAAAUGCCUAUUUGACAUCCAAA	24	24500
CFTR-Intron10-5621	−	GACAAACAGAAAAAGAAA	18	24501
CFTR-Intron10-5622	−	AGACAAACAGAAAAAGAAA	19	24502
CFTR-Intron10-5623	−	AAGACAAACAGAAAAAGAAA	20	24503
CFTR-Intron10-5624	−	UAAGACAAACAGAAAAAGAAA	21	24504
CFTR-Intron10-5625	−	CUAAGACAAACAGAAAAAGAAA	22	24505
CFTR-Intron10-5626	−	UCUAAGACAAACAGAAAAAGAAA	23	24506
CFTR-Intron10-5627	−	AUCUAAGACAAACAGAAAAAGAAA	24	24507
CFTR-Intron10-5628	−	AUCUAAGACAAACAGAAA	18	24508
CFTR-Intron10-5629	−	AAUCUAAGACAAACAGAAA	19	24509
CFTR-Intron10-5630	−	UAAUCUAAGACAAACAGAAA	20	24510
CFTR-Intron10-5631	−	AUAAUCUAAGACAAACAGAAA	21	24511
CFTR-Intron10-5632	−	AAUAAUCUAAGACAAACAGAAA	22	24512
CFTR-Intron10-5633	−	GAAUAAUCUAAGACAAACAGAAA	23	24513
CFTR-Intron10-5634	−	CGAAUAAUCUAAGACAAACAGAAA	24	24514
CFTR-Intron10-5635	−	GGCACCAUUCACAGUAAA	18	24515
CFTR-Intron10-5636	−	UGGCACCAUUCACAGUAAA	19	24516
CFTR-Intron10-5637	−	CUGGCACCAUUCACAGUAAA	20	24517
CFTR-Intron10-5638	−	CCUGGCACCAUUCACAGUAAA	21	24518
CFTR-Intron10-5639	−	ACCUGGCACCAUUCACAGUAAA	22	24519
CFTR-Intron10-5640	−	UACCUGGCACCAUUCACAGUAAA	23	24520
CFTR-Intron10-5641	−	CUACCUGGCACCAUUCACAGUAAA	24	24521
CFTR-Intron10-5642	−	CCACUGGAGAGUUUUAAA	18	24522
CFTR-Intron10-5643	−	GCCACUGGAGAGUUUUAAA	19	24523
CFTR-Intron10-5644	−	GGCCACUGGAGAGUUUUAAA	20	24524
CFTR-Intron10-5645	−	AGGCCACUGGAGAGUUUUAAA	21	24525
CFTR-Intron10-5646	−	GAGGCCACUGGAGAGUUUUAAA	22	24526
CFTR-Intron10-5647	−	AGAGGCCACUGGAGAGUUUUAAA	23	24527
CFTR-Intron10-5648	−	UAGAGGCCACUGGAGAGUUUUAAA	24	24528
CFTR-Intron10-5649	−	UACAAAAAACACAAACAA	18	24529
CFTR-Intron10-5650	−	CUACAAAAAACACAAACAA	19	24530
CFTR-Intron10-5651	−	UCUACAAAAAACACAAACAA	20	24531
CFTR-Intron10-5652	−	CUCUACAAAAAACACAAACAA	21	24532
CFTR-Intron10-5653	−	CCUCUACAAAAAACACAAACAA	22	24533
CFTR-Intron10-5654	−	ACCUCUACAAAAAACACAAACAA	23	24534
CFTR-Intron10-5655	−	CACCUCUACAAAAAACACAAACAA	24	24535
CFTR-Intron10-5656	−	UAAAGACUGUUGUAACAA	18	24536
CFTR-Intron10-5657	−	AUAAAGACUGUUGUAACAA	19	24537
CFTR-Intron10-5658	−	UAUAAAGACUGUUGUAACAA	20	24538
CFTR-Intron10-5659	−	GUAUAAAGACUGUUGUAACAA	21	24539
CFTR-Intron10-5660	−	AGUAUAAAGACUGUUGUAACAA	22	24540
CFTR-Intron10-5661	−	CAGUAUAAAGACUGUUGUAACAA	23	24541
CFTR-Intron10-5662	−	CCAGUAUAAAGACUGUUGUAACAA	24	24542
CFTR-Intron10-5663	−	UAUUCUGUAGGGAGACAA	18	24543
CFTR-Intron10-5664	−	CUAUUCUGUAGGGAGACAA	19	24544
CFTR-Intron10-66	−	GCUAUUCUGUAGGGAGACAA	20	18952
CFTR-Intron10-5665	−	GGCUAUUCUGUAGGGAGACAA	21	24545
CFTR-Intron10-5666	−	AGGCUAUUCUGUAGGGAGACAA	22	24546
CFTR-Intron10-5667	−	UAGGCUAUUCUGUAGGGAGACAA	23	24547
CFTR-Intron10-5668	−	UUAGGCUAUUCUGUAGGGAGACAA	24	24548
CFTR-Intron10-5669	−	AUAGAUGGGUUAAGCCAA	18	24549
CFTR-Intron10-5670	−	AAUAGAUGGGUUAAGCCAA	19	24550
CFTR-Intron10-5671	−	UAAUAGAUGGGUUAAGCCAA	20	24551
CFTR-Intron10-5672	−	UUAAUAGAUGGGUUAAGCCAA	21	24552
CFTR-Intron10-5673	−	CUUAAUAGAUGGGUUAAGCCAA	22	24553
CFTR-Intron10-5674	−	UCUUAAUAGAUGGGUUAAGCCAA	23	24554
CFTR-Intron10-5675	−	CUCUUAAUAGAUGGGUUAAGCCAA	24	24555
CFTR-Intron10-5676	−	AGAAAGAAAAAACAGCAA	18	24556
CFTR-Intron10-5677	−	UAGAAAGAAAAAACAGCAA	19	24557
CFTR-Intron10-5678	−	UUAGAAAGAAAAAACAGCAA	20	24558
CFTR-Intron10-5679	−	AUUAGAAAGAAAAAACAGCAA	21	24559
CFTR-Intron10-5680	−	GAUUAGAAAGAAAAAACAGCAA	22	24560
CFTR-Intron10-5681	−	AGAUUAGAAAGAAAAAACAGCAA	23	24561
CFTR-Intron10-5682	−	UAGAUUAGAAAGAAAAAACAGCAA	24	24562
CFTR-Intron10-5683	−	ACUGUUGUAACAAAAGAA	18	24563
CFTR-Intron10-5684	−	GACUGUUGUAACAAAAGAA	19	24564
CFTR-Intron10-5685	−	AGACUGUUGUAACAAAAGAA	20	24565
CFTR-Intron10-5686	−	AAGACUGUUGUAACAAAAGAA	21	24566
CFTR-Intron10-5687	−	AAAGACUGUUGUAACAAAAGAA	22	24567
CFTR-Intron10-5688	−	UAAAGACUGUUGUAACAAAAGAA	23	24568
CFTR-Intron10-5689	−	AUAAAGACUGUUGUAACAAAAGAA	24	24569
CFTR-Intron10-5690	−	GAAGGAAAUGAGGAAGAA	18	24570
CFTR-Intron10-5691	−	AGAAGGAAAUGAGGAAGAA	19	24571
CFTR-Intron10-1105	−	AAGAAGGAAAUGAGGAAGAA	20	19990
CFTR-Intron10-5692	−	AAAGAAGGAAAUGAGGAAGAA	21	24572
CFTR-Intron10-5693	−	GAAAGAAGGAAAUGAGGAAGAA	22	24573
CFTR-Intron10-5694	−	AGAAAGAAGGAAAUGAGGAAGAA	23	24574
CFTR-Intron10-5695	−	AAGAAAGAAGGAAAUGAGGAAGAA	24	24575
CFTR-Intron10-5696	−	AAAGAGGGUUGAUAAGAA	18	24576
CFTR-Intron10-5697	−	GAAAGAGGGUUGAUAAGAA	19	24577
CFTR-Intron10-5698	−	GGAAAGAGGGUUGAUAAGAA	20	24578
CFTR-Intron10-5699	−	AGGAAAGAGGGUUGAUAAGAA	21	24579
CFTR-Intron10-5700	−	AAGGAAAGAGGGUUGAUAAGAA	22	24580
CFTR-Intron10-5701	−	AAAGGAAAGAGGGUUGAUAAGAA	23	24581
CFTR-Intron10-5702	−	UAAAGGAAAGAGGGUUGAUAAGAA	24	24582
CFTR-Intron10-5703	−	AUCACCUGAGCCUGAGAA	18	24583
CFTR-Intron10-5704	−	GAUCACCUGAGCCUGAGAA	19	24584
CFTR-Intron10-5705	−	GGAUCACCUGAGCCUGAGAA	20	24585
CFTR-Intron10-5706	−	AGGAUCACCUGAGCCUGAGAA	21	24586
CFTR-Intron10-5707	−	GAGGAUCACCUGAGCCUGAGAA	22	24587
CFTR-Intron10-5708	−	GGAGGAUCACCUGAGCCUGAGAA	23	24588
CFTR-Intron10-5709	−	GGGAGGAUCACCUGAGCCUGAGAA	24	24589
CFTR-Intron10-5710	−	UUUAAACACUUCUGAGAA	18	24590
CFTR-Intron10-5711	−	AUUUAAACACUUCUGAGAA	19	24591
CFTR-Intron10-5712	−	UAUUUAAACACUUCUGAGAA	20	24592
CFTR-Intron10-5713	−	AUAUUUAAACACUUCUGAGAA	21	24593
CFTR-Intron10-5714	−	AAUAUUUAAACACUUCUGAGAA	22	24594
CFTR-Intron10-5715	−	GAAUAUUUAAACACUUCUGAGAA	23	24595
CFTR-Intron10-5716	−	GGAAUAUUUAAACACUUCUGAGAA	24	24596
CFTR-Intron10-5717	−	AAGGAAUUUUAUAUAGAA	18	24597
CFTR-Intron10-5718	−	AAAGGAAUUUUAUAUAGAA	19	24598
CFTR-Intron10-5719	−	CAAAGGAAUUUUAUAUAGAA	20	24599
CFTR-Intron10-5720	−	ACAAAGGAAUUUUAUAUAGAA	21	24600
CFTR-Intron10-5721	−	UACAAAGGAAUUUUAUAUAGAA	22	24601
CFTR-Intron10-5722	−	GUACAAAGGAAUUUUAUAUAGAA	23	24602
CFTR-Intron10-5723	−	UGUACAAAGGAAUUUUAUAUAGAA	24	24603
CFTR-Intron10-5724	−	AAGUCUAGUUUCAAGGAA	18	24604
CFTR-Intron10-5725	−	CAAGUCUAGUUUCAAGGAA	19	24605
CFTR-Intron10-5726	−	ACAAGUCUAGUUUCAAGGAA	20	24606
CFTR-Intron10-5727	−	UACAAGUCUAGUUUCAAGGAA	21	24607
CFTR-Intron10-5728	−	GUACAAGUCUAGUUUCAAGGAA	22	24608
CFTR-Intron10-5729	−	UGUACAAGUCUAGUUUCAAGGAA	23	24609
CFTR-Intron10-5730	−	AUGUACAAGUCUAGUUUCAAGGAA	24	24610
CFTR-Intron10-5731	−	GAAGGAAGAAAGAAGGAA	18	24611
CFTR-Intron10-5732	−	GGAAGGAAGAAAGAAGGAA	19	24612
CFTR-Intron10-5733	−	AGGAAGGAAGAAAGAAGGAA	20	24613
CFTR-Intron10-5734	−	GAGGAAGGAAGAAAGAAGGAA	21	24614
CFTR-Intron10-5735	−	AGAGGAAGGAAGAAAGAAGGAA	22	24615
CFTR-Intron10-5736	−	GAGAGGAAGGAAGAAAGAAGGAA	23	24616
CFTR-Intron10-5737	−	AGAGAGGAAGGAAGAAAGAAGGAA	24	24617
CFTR-Intron10-5738	−	UUUUAGUAGUAUUAGGAA	18	24618
CFTR-Intron10-5739	−	CUUUUAGUAGUAUUAGGAA	19	24619
CFTR-Intron10-350	−	CCUUUUAGUAGUAUUAGGAA	20	19236
CFTR-Intron10-5740	−	GCCUUUUAGUAGUAUUAGGAA	21	24620
CFTR-Intron10-5741	−	UGCCUUUUAGUAGUAUUAGGAA	22	24621
CFTR-Intron10-5742	−	CUGCCUUUUAGUAGUAUUAGGAA	23	24622
CFTR-Intron10-5743	−	GCUGCCUUUUAGUAGUAUUAGGAA	24	24623
CFTR-Intron10-5744	−	UGAAAUUAGAAAGAAUAA	18	24624
CFTR-Intron10-5745	−	AUGAAAUUAGAAAGAAUAA	19	24625
CFTR-Intron10-5746	−	AAUGAAAUUAGAAAGAAUAA	20	24626
CFTR-Intron10-5747	−	GAAUGAAAUUAGAAAGAAUAA	21	24627
CFTR-Intron10-5748	−	AGAAUGAAAUUAGAAAGAAUAA	22	24628
CFTR-Intron10-5749	−	CAGAAUGAAAUUAGAAAGAAUAA	23	24629
CFTR-Intron10-5750	−	CCAGAAUGAAAUUAGAAAGAAUAA	24	24630
CFTR-Intron10-5751	−	AAAUAUAAGAUUGAAUAA	18	24631
CFTR-Intron10-5752	−	AAAAUAUAAGAUUGAAUAA	19	24632
CFTR-Intron10-5753	−	UAAAAUAUAAGAUUGAAUAA	20	24633
CFTR-Intron10-5754	−	CUAAAAUAUAAGAUUGAAUAA	21	24634
CFTR-Intron10-5755	−	GCUAAAAUAUAAGAUUGAAUAA	22	24635
CFTR-Intron10-5756	−	AGCUAAAAUAUAAGAUUGAAUAA	23	24636
CFTR-Intron10-5757	−	UAGCUAAAAUAUAAGAUUGAAUAA	24	24637
CFTR-Intron10-5758	−	CCCAUAAAUGUUGAAUAA	18	24638
CFTR-Intron10-5759	−	CCCCAUAAAUGUUGAAUAA	19	24639
CFTR-Intron10-5760	−	GCCCCAUAAAUGUUGAAUAA	20	24640
CFTR-Intron10-5761	−	AGCCCCAUAAAUGUUGAAUAA	21	24641
CFTR-Intron10-5762	−	GAGCCCCAUAAAUGUUGAAUAA	22	24642
CFTR-Intron10-5763	−	GGAGCCCCAUAAAUGUUGAAUAA	23	24643
CFTR-Intron10-5764	−	GGGAGCCCCAUAAAUGUUGAAUAA	24	24644
CFTR-Intron10-5765	−	AGCUUAUUCUUGUAAUAA	18	24645
CFTR-Intron10-5766	−	UAGCUUAUUCUUGUAAUAA	19	24646
CFTR-Intron10-5767	−	UUAGCUUAUUCUUGUAAUAA	20	24647
CFTR-Intron10-5768	−	UUUAGCUUAUUCUUGUAAUAA	21	24648
CFTR-Intron10-5769	−	UUUUAGCUUAUUCUUGUAAUAA	22	24649
CFTR-Intron10-5770	−	GUUUUAGCUUAUUCUUGUAAUAA	23	24650
CFTR-Intron10-5771	−	AGUUUUAGCUUAUUCUUGUAAUAA	24	24651
CFTR-Intron10-5772	−	CGUUUACUAGAAAGAUAA	18	24652
CFTR-Intron10-5773	−	CCGUUUACUAGAAAGAUAA	19	24653
CFTR-Intron10-69	−	GCCGUUUACUAGAAAGAUAA	20	18955
CFTR-Intron10-5774	−	UGCCGUUUACUAGAAAGAUAA	21	24654
CFTR-Intron10-5775	−	GUGCCGUUUACUAGAAAGAUAA	22	24655
CFTR-Intron10-5776	−	UGUGCCGUUUACUAGAAAGAUAA	23	24656
CFTR-Intron10-5777	−	AUGUGCCGUUUACUAGAAAGAUAA	24	24657
CFTR-Intron10-5778	−	CCUGCAAUUUCGAGAUAA	18	24658
CFTR-Intron10-5779	−	GCCUGCAAUUUCGAGAUAA	19	24659
CFTR-Intron10-5780	−	UGCCUGCAAUUUCGAGAUAA	20	24660
CFTR-Intron10-5781	−	UUGCCUGCAAUUUCGAGAUAA	21	24661
CFTR-Intron10-5782	−	GUUGCCUGCAAUUUCGAGAUAA	22	24662
CFTR-Intron10-5783	−	AGUUGCCUGCAAUUUCGAGAUAA	23	24663
CFTR-Intron10-5784	−	CAGUUGCCUGCAAUUUCGAGAUAA	24	24664
CFTR-Intron10-5785	−	AGAUUAGUGUCUUUAUAA	18	24665
CFTR-Intron10-5786	−	GAGAUUAGUGUCUUUAUAA	19	24666
CFTR-Intron10-5787	−	UGAGAUUAGUGUCUUUAUAA	20	24667
CFTR-Intron10-5788	−	AUGAGAUUAGUGUCUUUAUAA	21	24668
CFTR-Intron10-5789	−	AAUGAGAUUAGUGUCUUUAUAA	22	24669
CFTR-Intron10-5790	−	AAAUGAGAUUAGUGUCUUUAUAA	23	24670
CFTR-Intron10-5791	−	UAAAUGAGAUUAGUGUCUUUAUAA	24	24671
CFTR-Intron10-5792	−	UGACCUAAGAUAUCCUAA	18	24672
CFTR-Intron10-5793	−	UUGACCUAAGAUAUCCUAA	19	24673
CFTR-Intron10-358	−	UUUGACCUAAGAUAUCCUAA	20	19244
CFTR-Intron10-5794	−	CUUUGACCUAAGAUAUCCUAA	21	24674
CFTR-Intron10-5795	−	UCUUUGACCUAAGAUAUCCUAA	22	24675
CFTR-Intron10-5796	−	CUCUUUGACCUAAGAUAUCCUAA	23	24676
CFTR-Intron10-5797	−	CCUCUUUGACCUAAGAUAUCCUAA	24	24677
CFTR-Intron10-5798	−	GGCUGGAUAAGAUUCUAA	18	24678
CFTR-Intron10-5799	−	GGGCUGGAUAAGAUUCUAA	19	24679
CFTR-Intron10-71	−	GGGGCUGGAUAAGAUUCUAA	20	18957
CFTR-Intron10-5800	−	UGGGGCUGGAUAAGAUUCUAA	21	24680
CFTR-Intron10-5801	−	AUGGGGCUGGAUAAGAUUCUAA	22	24681
CFTR-Intron10-5802	−	GAUGGGGCUGGAUAAGAUUCUAA	23	24682
CFTR-Intron10-5803	−	AGAUGGGGCUGGAUAAGAUUCUAA	24	24683
CFTR-Intron10-5804	−	AGUUUUAAACAGAAGUAA	18	24684
CFTR-Intron10-5805	−	GAGUUUUAAACAGAAGUAA	19	24685
CFTR-Intron10-5806	−	AGAGUUUUAAACAGAAGUAA	20	24686
CFTR-Intron10-5807	−	GAGAGUUUUAAACAGAAGUAA	21	24687
CFTR-Intron10-5808	−	GGAGAGUUUUAAACAGAAGUAA	22	24688
CFTR-Intron10-5809	−	UGGAGAGUUUUAAACAGAAGUAA	23	24689
CFTR-Intron10-5810	−	CUGGAGAGUUUUAAACAGAAGUAA	24	24690
CFTR-Intron10-5811	−	AAAGAAGGAAGGAAGUAA	18	24691
CFTR-Intron10-5812	−	GAAAGAAGGAAGGAAGUAA	19	24692
CFTR-Intron10-5813	−	GGAAAGAAGGAAGGAAGUAA	20	24693
CFTR-Intron10-5814	−	AGGAAAGAAGGAAGGAAGUAA	21	24694
CFTR-Intron10-5815	−	AAGGAAAGAAGGAAGGAAGUAA	22	24695
CFTR-Intron10-5816	−	GAAGGAAAGAAGGAAGGAAGUAA	23	24696
CFTR-Intron10-5817	−	GGAAGGAAAGAAGGAAGGAAGUAA	24	24697
CFTR-Intron10-5818	−	GCUUUCUGGACUGAGUAA	18	24698
CFTR-Intron10-5819	−	AGCUUUCUGGACUGAGUAA	19	24699
CFTR-Intron10-5820	−	AAGCUUUCUGGACUGAGUAA	20	24700
CFTR-Intron10-5821	−	CAAGCUUUCUGGACUGAGUAA	21	24701
CFTR-Intron10-5822	−	CCAAGCUUUCUGGACUGAGUAA	22	24702
CFTR-Intron10-5823	−	UCCAAGCUUUCUGGACUGAGUAA	23	24703
CFTR-Intron10-5824	−	UUCCAAGCUUUCUGGACUGAGUAA	24	24704
CFTR-Intron10-5825	−	GGGUGAAGUCUUUAGUAA	18	24705
CFTR-Intron10-5826	−	AGGGUGAAGUCUUUAGUAA	19	24706
CFTR-Intron10-5827	−	GAGGGUGAAGUCUUUAGUAA	20	24707
CFTR-Intron10-5828	−	UGAGGGUGAAGUCUUUAGUAA	21	24708
CFTR-Intron10-5829	−	AUGAGGGUGAAGUCUUUAGUAA	22	24709
CFTR-Intron10-5830	−	CAUGAGGGUGAAGUCUUUAGUAA	23	24710
CFTR-Intron10-5831	−	CCAUGAGGGUGAAGUCUUUAGUAA	24	24711
CFTR-Intron10-5832	−	AUAAGUGGCCUUUAAACA	18	24712
CFTR-Intron10-5833	−	UAUAAGUGGCCUUUAAACA	19	24713
CFTR-Intron10-5834	−	AUAUAAGUGGCCUUUAAACA	20	24714
CFTR-Intron10-5835	−	AAUAUAAGUGGCCUUUAAACA	21	24715
CFTR-Intron10-5836	−	AAAUAUAAGUGGCCUUUAAACA	22	24716
CFTR-Intron10-5837	−	AAAAUAUAAGUGGCCUUUAAACA	23	24717
CFTR-Intron10-5838	−	AAAAAUAUAAGUGGCCUUUAAACA	24	24718
CFTR-Intron10-5839	−	ACCAUCCUGGCUAACACA	18	24719
CFTR-Intron10-5840	−	GACCAUCCUGGCUAACACA	19	24720
CFTR-Intron10-5841	−	AGACCAUCCUGGCUAACACA	20	24721
CFTR-Intron10-5842	−	AAGACCAUCCUGGCUAACACA	21	24722
CFTR-Intron10-5843	−	CAAGACCAUCCUGGCUAACACA	22	24723
CFTR-Intron10-5844	−	UCAAGACCAUCCUGGCUAACACA	23	24724
CFTR-Intron10-5845	−	AUCAAGACCAUCCUGGCUAACACA	24	24725
CFTR-Intron10-5846	−	CAAUAUUUUGUUAACACA	18	24726
CFTR-Intron10-5847	−	CCAAUAUUUUGUUAACACA	19	24727
CFTR-Intron10-5848	−	UCCAAUAUUUUGUUAACACA	20	24728
CFTR-Intron10-5849	−	UUCCAAUAUUUUGUUAACACA	21	24729
CFTR-Intron10-5850	−	UUUCCAAUAUUUUGUUAACACA	22	24730
CFTR-Intron10-5851	−	GUUUCCAAUAUUUUGUUAACACA	23	24731
CFTR-Intron10-5852	−	UGUUUCCAAUAUUUUGUUAACACA	24	24732
CFTR-Intron10-5853	−	UUCCAUAUUCAAAGCACA	18	24733
CFTR-Intron10-5854	−	UUUCCAUAUUCAAAGCACA	19	24734
CFTR-Intron10-5855	−	CUUUCCAUAUUCAAAGCACA	20	24735
CFTR-Intron10-5856	−	ACUUUCCAUAUUCAAAGCACA	21	24736
CFTR-Intron10-5857	−	AACUUUCCAUAUUCAAAGCACA	22	24737
CFTR-Intron10-5858	−	CAACUUUCCAUAUUCAAAGCACA	23	24738
CFTR-Intron10-5859	−	ACAACUUUCCAUAUUCAAAGCACA	24	24739
CFTR-Intron10-5860	−	CAUAUGAGAAAAGUCACA	18	24740
CFTR-Intron10-5861	−	GCAUAUGAGAAAAGUCACA	19	24741
CFTR-Intron10-5862	−	GGCAUAUGAGAAAAGUCACA	20	24742
CFTR-Intron10-5863	−	UGGCAUAUGAGAAAAGUCACA	21	24743
CFTR-Intron10-5864	−	AUGGCAUAUGAGAAAAGUCACA	22	24744
CFTR-Intron10-5865	−	AAUGGCAUAUGAGAAAAGUCACA	23	24745
CFTR-Intron10-5866	−	CAAUGGCAUAUGAGAAAAGUCACA	24	24746
CFTR-Intron10-5867	−	CUGGCAUAGAGUAAGACA	18	24747
CFTR-Intron10-5868	−	GCUGGCAUAGAGUAAGACA	19	24748
CFTR-Intron10-74	−	GGCUGGCAUAGAGUAAGACA	20	18960
CFTR-Intron10-5869	−	AGGCUGGCAUAGAGUAAGACA	21	24749
CFTR-Intron10-5870	−	GAGGCUGGCAUAGAGUAAGACA	22	24750
CFTR-Intron10-5871	−	UGAGGCUGGCAUAGAGUAAGACA	23	24751
CFTR-Intron10-5872	−	CUGAGGCUGGCAUAGAGUAAGACA	24	24752
CFTR-Intron10-5873	−	CUAUUCUGUAGGGAGACA	18	24753
CFTR-Intron10-5874	−	GCUAUUCUGUAGGGAGACA	19	24754
CFTR-Intron10-75	−	GGCUAUUCUGUAGGGAGACA	20	18961
CFTR-Intron10-5875	−	AGGCUAUUCUGUAGGGAGACA	21	24755
CFTR-Intron10-5876	−	UAGGCUAUUCUGUAGGGAGACA	22	24756
CFTR-Intron10-5877	−	UUAGGCUAUUCUGUAGGGAGACA	23	24757
CFTR-Intron10-5878	−	UUUAGGCUAUUCUGUAGGGAGACA	24	24758
CFTR-Intron10-5879	−	UUUUUUUCAGUUAAUACA	18	24759
CFTR-Intron10-5880	−	UUUUUUUUCAGUUAAUACA	19	24760
CFTR-Intron10-5881	−	AUUUUUUUUCAGUUAAUACA	20	24761
CFTR-Intron10-5882	−	AAUUUUUUUUCAGUUAAUACA	21	24762
CFTR-Intron10-5883	−	GAAUUUUUUUUCAGUUAAUACA	22	24763
CFTR-Intron10-5884	−	UGAAUUUUUUUUCAGUUAAUACA	23	24764
CFTR-Intron10-5885	−	GUGAAUUUUUUUUCAGUUAAUACA	24	24765
CFTR-Intron10-5886	−	AUCAUUUCAACUUAUACA	18	24766
CFTR-Intron10-5887	−	UAUCAUUUCAACUUAUACA	19	24767
CFTR-Intron10-5888	−	AUAUCAUUUCAACUUAUACA	20	24768
CFTR-Intron10-5889	−	AAUAUCAUUUCAACUUAUACA	21	24769
CFTR-Intron10-5890	−	AAAUAUCAUUUCAACUUAUACA	22	24770
CFTR-Intron10-5891	−	AAAAUAUCAUUUCAACUUAUACA	23	24771
CFTR-Intron10-5892	−	UAAAAUAUCAUUUCAACUUAUACA	24	24772
CFTR-Intron10-5893	−	UAGGUUUAAUUUUGUACA	18	24773
CFTR-Intron10-5894	−	CUAGGUUUAAUUUUGUACA	19	24774
CFTR-Intron10-5895	−	UCUAGGUUUAAUUUUGUACA	20	24775
CFTR-Intron10-5896	−	UUCUAGGUUUAAUUUUGUACA	21	24776
CFTR-Intron10-5897	−	CUUCUAGGUUUAAUUUUGUACA	22	24777
CFTR-Intron10-5898	−	ACUUCUAGGUUUAAUUUUGUACA	23	24778
CFTR-Intron10-5899	−	CACUUCUAGGUUUAAUUUUGUACA	24	24779
CFTR-Intron10-5900	−	GGGUGAGAUUAGAGGCCA	18	24780
CFTR-Intron10-5901	−	UGGGUGAGAUUAGAGGCCA	19	24781
CFTR-Intron10-5902	−	CUGGGUGAGAUUAGAGGCCA	20	24782
CFTR-Intron10-5903	−	UCUGGGUGAGAUUAGAGGCCA	21	24783
CFTR-Intron10-5904	−	CUCUGGGUGAGAUUAGAGGCCA	22	24784
CFTR-Intron10-5905	−	UCUCUGGGUGAGAUUAGAGGCCA	23	24785
CFTR-Intron10-5906	−	UUCUCUGGGUGAGAUUAGAGGCCA	24	24786
CFTR-Intron10-5907	−	CUUUCCAUAUUCAAAGCA	18	24787
CFTR-Intron10-5908	−	ACUUUCCAUAUUCAAAGCA	19	24788
CFTR-Intron10-5909	−	AACUUUCCAUAUUCAAAGCA	20	24789
CFTR-Intron10-5910	−	CAACUUUCCAUAUUCAAAGCA	21	24790
CFTR-Intron10-5911	−	ACAACUUUCCAUAUUCAAAGCA	22	24791
CFTR-Intron10-5912	−	GACAACUUUCCAUAUUCAAAGCA	23	24792
CFTR-Intron10-5913	−	GGACAACUUUCCAUAUUCAAAGCA	24	24793
CFTR-Intron10-5914	−	GAGACAAGGGAGGAAGCA	18	24794
CFTR-Intron10-5915	−	GGAGACAAGGGAGGAAGCA	19	24795
CFTR-Intron10-650	−	GGGAGACAAGGGAGGAAGCA	20	19536
CFTR-Intron10-5916	−	AGGGAGACAAGGGAGGAAGCA	21	24796
CFTR-Intron10-5917	−	UAGGGAGACAAGGGAGGAAGCA	22	24797
CFTR-Intron10-5918	−	GUAGGGAGACAAGGGAGGAAGCA	23	24798
CFTR-Intron10-5919	−	UGUAGGGAGACAAGGGAGGAAGCA	24	24799
CFTR-Intron10-5920	−	GAUUCUGUUUAAAUAGCA	18	24800
CFTR-Intron10-5921	−	UGAUUCUGUUUAAAUAGCA	19	24801
CFTR-Intron10-5922	−	CUGAUUCUGUUUAAAUAGCA	20	24802
CFTR-Intron10-5923	−	CCUGAUUCUGUUUAAAUAGCA	21	24803
CFTR-Intron10-5924	−	CCCUGAUUCUGUUUAAAUAGCA	22	24804
CFTR-Intron10-5925	−	CCCCUGAUUCUGUUUAAAUAGCA	23	24805
CFTR-Intron10-5926	−	UCCCCUGAUUCUGUUUAAAUAGCA	24	24806
CFTR-Intron10-5927	−	AGUGCCACUAGUGAUGCA	18	24807
CFTR-Intron10-5928	−	AAGUGCCACUAGUGAUGCA	19	24808
CFTR-Intron10-1129	−	AAAGUGCCACUAGUGAUGCA	20	20014
CFTR-Intron10-5929	−	CAAAGUGCCACUAGUGAUGCA	21	24809
CFTR-Intron10-5930	−	ACAAAGUGCCACUAGUGAUGCA	22	24810
CFTR-Intron10-5931	−	UACAAAGUGCCACUAGUGAUGCA	23	24811
CFTR-Intron10-5932	−	AUACAAAGUGCCACUAGUGAUGCA	24	24812
CFTR-Intron10-5933	−	UGAGAAGUGGAGGCUGCA	18	24813
CFTR-Intron10-5934	−	CUGAGAAGUGGAGGCUGCA	19	24814
CFTR-Intron10-5935	−	CCUGAGAAGUGGAGGCUGCA	20	24815
CFTR-Intron10-5936	−	GCCUGAGAAGUGGAGGCUGCA	21	24816
CFTR-Intron10-5937	−	AGCCUGAGAAGUGGAGGCUGCA	22	24817
CFTR-Intron10-5938	−	GAGCCUGAGAAGUGGAGGCUGCA	23	24818
CFTR-Intron10-5939	−	UGAGCCUGAGAAGUGGAGGCUGCA	24	24819
CFTR-Intron10-5940	−	CAGGAGGCAGAACUUGCA	18	24820
CFTR-Intron10-5941	−	CCAGGAGGCAGAACUUGCA	19	24821
CFTR-Intron10-5942	−	CCCAGGAGGCAGAACUUGCA	20	24822
CFTR-Intron10-5943	−	ACCCAGGAGGCAGAACUUGCA	21	24823
CFTR-Intron10-5944	−	AACCCAGGAGGCAGAACUUGCA	22	24824
CFTR-Intron10-5945	−	GAACCCAGGAGGCAGAACUUGCA	23	24825
CFTR-Intron10-5946	−	UGAACCCAGGAGGCAGAACUUGCA	24	24826
CFTR-Intron10-5947	−	GGCAUAUGAGAAAAGUCA	18	24827
CFTR-Intron10-5948	−	UGGCAUAUGAGAAAAGUCA	19	24828
CFTR-Intron10-5949	−	AUGGCAUAUGAGAAAAGUCA	20	24829
CFTR-Intron10-5950	−	AAUGGCAUAUGAGAAAAGUCA	21	24830
CFTR-Intron10-5951	−	CAAUGGCAUAUGAGAAAAGUCA	22	24831
CFTR-Intron10-5952	−	ACAAUGGCAUAUGAGAAAAGUCA	23	24832
CFTR-Intron10-5953	−	AACAAUGGCAUAUGAGAAAAGUCA	24	24833
CFTR-Intron10-5954	−	AGAACAGUAAGGAGGUCA	18	24834
CFTR-Intron10-5955	−	AAGAACAGUAAGGAGGUCA	19	24835
CFTR-Intron10-5956	−	GAAGAACAGUAAGGAGGUCA	20	24836
CFTR-Intron10-5957	−	UGAAGAACAGUAAGGAGGUCA	21	24837
CFTR-Intron10-5958	−	UUGAAGAACAGUAAGGAGGUCA	22	24838
CFTR-Intron10-5959	−	UUUGAAGAACAGUAAGGAGGUCA	23	24839
CFTR-Intron10-5960	−	GUUUGAAGAACAGUAAGGAGGUCA	24	24840
CFTR-Intron10-5961	−	GAGGGUAGAAUACUGUCA	18	24841
CFTR-Intron10-5962	−	GGAGGGUAGAAUACUGUCA	19	24842
CFTR-Intron10-5963	−	GGGAGGGUAGAAUACUGUCA	20	24843
CFTR-Intron10-5964	−	AGGGAGGGUAGAAUACUGUCA	21	24844
CFTR-Intron10-5965	−	CAGGGAGGGUAGAAUACUGUCA	22	24845
CFTR-Intron10-5966	−	ACAGGGAGGGUAGAAUACUGUCA	23	24846
CFTR-Intron10-5967	−	GACAGGGAGGGUAGAAUACUGUCA	24	24847
CFTR-Intron10-5968	−	UGUACAAGUCUAGUUUCA	18	24848
CFTR-Intron10-5969	−	AUGUACAAGUCUAGUUUCA	19	24849
CFTR-Intron10-79	−	GAUGUACAAGUCUAGUUUCA	20	18965
CFTR-Intron10-5970	−	GGAUGUACAAGUCUAGUUUCA	21	24850
CFTR-Intron10-5971	−	UGGAUGUACAAGUCUAGUUUCA	22	24851
CFTR-Intron10-5972	−	UUGGAUGUACAAGUCUAGUUUCA	23	24852
CFTR-Intron10-5973	−	GUUGGAUGUACAAGUCUAGUUUCA	24	24853
CFTR-Intron10-5974	−	AAGACAAACAGAAAAAGA	18	24854
CFTR-Intron10-5975	−	UAAGACAAACAGAAAAAGA	19	24855
CFTR-Intron10-5976	−	CUAAGACAAACAGAAAAAGA	20	24856
CFTR-Intron10-5977	−	UCUAAGACAAACAGAAAAAGA	21	24857
CFTR-Intron10-5978	−	AUCUAAGACAAACAGAAAAAGA	22	24858
CFTR-Intron10-5979	−	AAUCUAAGACAAACAGAAAAAGA	23	24859
CFTR-Intron10-5980	−	UAAUCUAAGACAAACAGAAAAAGA	24	24860
CFTR-Intron10-5981	−	CAAACAGAAAAAGAAAGA	18	24861
CFTR-Intron10-5982	−	ACAAACAGAAAAAGAAAGA	19	24862
CFTR-Intron10-5983	−	GACAAACAGAAAAAGAAAGA	20	24863
CFTR-Intron10-5984	−	AGACAAACAGAAAAAGAAAGA	21	24864
CFTR-Intron10-5985	−	AAGACAAACAGAAAAAGAAAGA	22	24865
CFTR-Intron10-5986	−	UAAGACAAACAGAAAAAGAAAGA	23	24866
CFTR-Intron10-5987	−	CUAAGACAAACAGAAAAAGAAAGA	24	24867
CFTR-Intron10-5988	−	GAGAGGAAGGAAGAAAGA	18	24868
CFTR-Intron10-5989	−	AGAGAGGAAGGAAGAAAGA	19	24869
CFTR-Intron10-1137	−	AAGAGAGGAAGGAAGAAAGA	20	20022
CFTR-Intron10-5990	−	AAAGAGAGGAAGGAAGAAAGA	21	24870
CFTR-Intron10-5991	−	GAAAGAGAGGAAGGAAGAAAGA	22	24871
CFTR-Intron10-5992	−	AGAAAGAGAGGAAGGAAGAAAGA	23	24872
CFTR-Intron10-5993	−	AAGAAAGAGAGGAAGGAAGAAAGA	24	24873
CFTR-Intron10-5994	−	GAAGGAAGGAAGGAAAGA	18	24874
CFTR-Intron10-5995	−	GGAAGGAAGGAAGGAAAGA	19	24875
CFTR-Intron10-1138	−	AGGAAGGAAGGAAGGAAAGA	20	20023
CFTR-Intron10-5996	−	GAGGAAGGAAGGAAGGAAAGA	21	24876
CFTR-Intron10-5997	−	GGAGGAAGGAAGGAAGGAAAGA	22	24877
CFTR-Intron10-5998	−	AGGAGGAAGGAAGGAAGGAAAGA	23	24878
CFTR-Intron10-5999	−	UAGGAGGAAGGAAGGAAGGAAAGA	24	24879
CFTR-Intron10-6000	−	GUCUAGUUUCAAGGAAGA	18	24880
CFTR-Intron10-6001	−	AGUCUAGUUUCAAGGAAGA	19	24881
CFTR-Intron10-372	−	AAGUCUAGUUUCAAGGAAGA	20	19258
CFTR-Intron10-6002	−	CAAGUCUAGUUUCAAGGAAGA	21	24882
CFTR-Intron10-6003	−	ACAAGUCUAGUUUCAAGGAAGA	22	24883
CFTR-Intron10-6004	−	UACAAGUCUAGUUUCAAGGAAGA	23	24884
CFTR-Intron10-6005	−	GUACAAGUCUAGUUUCAAGGAAGA	24	24885
CFTR-Intron10-6006	−	GAAAGAGAGGAAGGAAGA	18	24886
CFTR-Intron10-6007	−	AGAAAGAGAGGAAGGAAGA	19	24887
CFTR-Intron10-6008	−	AAGAAAGAGAGGAAGGAAGA	20	24888
CFTR-Intron10-6009	−	AAAGAAAGAGAGGAAGGAAGA	21	24889
CFTR-Intron10-6010	−	AAAAGAAAGAGAGGAAGGAAGA	22	24890
CFTR-Intron10-6011	−	AAAAAGAAAGAGAGGAAGGAAGA	23	24891
CFTR-Intron10-6012	−	GAAAAAGAAAGAGAGGAAGGAAGA	24	24892
CFTR-Intron10-6013	−	AGAAGGAAAUGAGGAAGA	18	24893
CFTR-Intron10-6014	−	AAGAAGGAAAUGAGGAAGA	19	24894
CFTR-Intron10-6015	−	AAAGAAGGAAAUGAGGAAGA	20	24895
CFTR-Intron10-6016	−	GAAAGAAGGAAAUGAGGAAGA	21	24896
CFTR-Intron10-6017	−	AGAAAGAAGGAAAUGAGGAAGA	22	24897
CFTR-Intron10-6018	−	AAGAAAGAAGGAAAUGAGGAAGA	23	24898
CFTR-Intron10-6019	−	GAAGAAAGAAGGAAAUGAGGAAGA	24	24899
CFTR-Intron10-6020	−	GGGCUGGUAGUGUGAAGA	18	24900
CFTR-Intron10-6021	−	GGGGCUGGUAGUGUGAAGA	19	24901
CFTR-Intron10-80	−	GGGGGCUGGUAGUGUGAAGA	20	18966
CFTR-Intron10-6022	−	AGGGGGCUGGUAGUGUGAAGA	21	24902
CFTR-Intron10-6023	−	GAGGGGGCUGGUAGUGUGAAGA	22	24903
CFTR-Intron10-6024	−	AGAGGGGGCUGGUAGUGUGAAGA	23	24904
CFTR-Intron10-6025	−	AAGAGGGGGCUGGUAGUGUGAAGA	24	24905
CFTR-Intron10-6026	−	AGAAGGAAGGAAGUAAGA	18	24906
CFTR-Intron10-6027	−	AAGAAGGAAGGAAGUAAGA	19	24907
CFTR-Intron10-1139	−	AAAGAAGGAAGGAAGUAAGA	20	20024
CFTR-Intron10-6028	−	GAAAGAAGGAAGGAAGUAAGA	21	24908
CFTR-Intron10-6029	−	GGAAAGAAGGAAGGAAGUAAGA	22	24909
CFTR-Intron10-6030	−	AGGAAAGAAGGAAGGAAGUAAGA	23	24910
CFTR-Intron10-6031	−	AAGGAAAGAAGGAAGGAAGUAAGA	24	24911
CFTR-Intron10-6032	−	GGCUGGCAUAGAGUAAGA	18	24912
CFTR-Intron10-6033	−	AGGCUGGCAUAGAGUAAGA	19	24913
CFTR-Intron10-6034	−	GAGGCUGGCAUAGAGUAAGA	20	24914
CFTR-Intron10-6035	−	UGAGGCUGGCAUAGAGUAAGA	21	24915
CFTR-Intron10-6036	−	CUGAGGCUGGCAUAGAGUAAGA	22	24916
CFTR-Intron10-6037	−	ACUGAGGCUGGCAUAGAGUAAGA	23	24917
CFTR-Intron10-6038	−	CACUGAGGCUGGCAUAGAGUAAGA	24	24918
CFTR-Intron10-6039	−	UCUAGCCUGGGUGACAGA	18	24919
CFTR-Intron10-6040	−	CUCUAGCCUGGGUGACAGA	19	24920
CFTR-Intron10-6041	−	ACUCUAGCCUGGGUGACAGA	20	24921
CFTR-Intron10-6042	−	CACUCUAGCCUGGGUGACAGA	21	24922
CFTR-Intron10-6043	−	GCACUCUAGCCUGGGUGACAGA	22	24923
CFTR-Intron10-6044	−	UGCACUCUAGCCUGGGUGACAGA	23	24924
CFTR-Intron10-6045	−	CUGCACUCUAGCCUGGGUGACAGA	24	24925
CFTR-Intron10-6046	−	AGGUCAAACUUGACCAGA	18	24926
CFTR-Intron10-6047	−	AAGGUCAAACUUGACCAGA	19	24927
CFTR-Intron10-6048	−	GAAGGUCAAACUUGACCAGA	20	24928
CFTR-Intron10-6049	−	AGAAGGUCAAACUUGACCAGA	21	24929
CFTR-Intron10-6050	−	GAGAAGGUCAAACUUGACCAGA	22	24930
CFTR-Intron10-6051	−	AGAGAAGGUCAAACUUGACCAGA	23	24931
CFTR-Intron10-6052	−	UAGAGAAGGUCAAACUUGACCAGA	24	24932
CFTR-Intron10-6053	−	AAUUUAACAUUUUCCAGA	18	24933
CFTR-Intron10-6054	−	AAAUUUAACAUUUUCCAGA	19	24934
CFTR-Intron10-6055	−	AAAAUUUAACAUUUUCCAGA	20	24935
CFTR-Intron10-6056	−	GAAAAUUUAACAUUUUCCAGA	21	24936
CFTR-Intron10-6057	−	GGAAAAUUUAACAUUUUCCAGA	22	24937
CFTR-Intron10-6058	−	GGGAAAAUUUAACAUUUUCCAGA	23	24938
CFTR-Intron10-6059	−	AGGGAAAAUUUAACAUUUUCCAGA	24	24939
CFTR-Intron10-6060	−	AAGUGCAAAGCUUUCAGA	18	24940
CFTR-Intron10-6061	−	CAAGUGCAAAGCUUUCAGA	19	24941
CFTR-Intron10-82	−	GCAAGUGCAAAGCUUUCAGA	20	18968
CFTR-Intron10-6062	−	AGCAAGUGCAAAGCUUUCAGA	21	24942
CFTR-Intron10-6063	−	AAGCAAGUGCAAAGCUUUCAGA	22	24943
CFTR-Intron10-6064	−	GAAGCAAGUGCAAAGCUUUCAGA	23	24944
CFTR-Intron10-6065	−	UGAAGCAAGUGCAAAGCUUUCAGA	24	24945
CFTR-Intron10-6066	−	AGGGUUGAUAAGAAGAGA	18	24946
CFTR-Intron10-6067	−	GAGGGUUGAUAAGAAGAGA	19	24947
CFTR-Intron10-6068	−	AGAGGGUUGAUAAGAAGAGA	20	24948
CFTR-Intron10-6069	−	AAGAGGGUUGAUAAGAAGAGA	21	24949
CFTR-Intron10-6070	−	AAAGAGGGUUGAUAAGAAGAGA	22	24950
CFTR-Intron10-6071	−	GAAAGAGGGUUGAUAAGAAGAGA	23	24951
CFTR-Intron10-6072	−	GGAAAGAGGGUUGAUAAGAAGAGA	24	24952
CFTR-Intron10-6073	−	AUCAAAUUAGAGAUGAGA	18	24953
CFTR-Intron10-6074	−	AAUCAAAUUAGAGAUGAGA	19	24954
CFTR-Intron10-6075	−	GAAUCAAAUUAGAGAUGAGA	20	24955
CFTR-Intron10-6076	−	AGAAUCAAAUUAGAGAUGAGA	21	24956
CFTR-Intron10-6077	−	AAGAAUCAAAUUAGAGAUGAGA	22	24957
CFTR-Intron10-6078	−	AAAGAAUCAAAUUAGAGAUGAGA	23	24958
CFTR-Intron10-6079	−	GAAAGAAUCAAAUUAGAGAUGAGA	24	24959
CFTR-Intron10-6080	−	AAAAAAUAGUAGAUUAGA	18	24960
CFTR-Intron10-6081	−	GAAAAAAUAGUAGAUUAGA	19	24961
CFTR-Intron10-6082	−	UGAAAAAAUAGUAGAUUAGA	20	24962
CFTR-Intron10-6083	−	CUGAAAAAAUAGUAGAUUAGA	21	24963
CFTR-Intron10-6084	−	UCUGAAAAAAUAGUAGAUUAGA	22	24964
CFTR-Intron10-6085	−	AUCUGAAAAAAUAGUAGAUUAGA	23	24965
CFTR-Intron10-6086	−	CAUCUGAAAAAAUAGUAGAUUAGA	24	24966
CFTR-Intron10-6087	−	GAGCUUUCUAGUAUUAGA	18	24967
CFTR-Intron10-6088	−	AGAGCUUUCUAGUAUUAGA	19	24968
CFTR-Intron10-6089	−	AAGAGCUUUCUAGUAUUAGA	20	24969
CFTR-Intron10-6090	−	AAAGAGCUUUCUAGUAUUAGA	21	24970
CFTR-Intron10-6091	−	GAAAGAGCUUUCUAGUAUUAGA	22	24971
CFTR-Intron10-6092	−	AGAAAGAGCUUUCUAGUAUUAGA	23	24972
CFTR-Intron10-6093	−	GAGAAAGAGCUUUCUAGUAUUAGA	24	24973
CFTR-Intron10-6094	−	GGAUAAGAUUCUAAAGGA	18	24974
CFTR-Intron10-6095	−	UGGAUAAGAUUCUAAAGGA	19	24975
CFTR-Intron10-6096	−	CUGGAUAAGAUUCUAAAGGA	20	24976
CFTR-Intron10-6097	−	GCUGGAUAAGAUUCUAAAGGA	21	24977
CFTR-Intron10-6098	−	GGCUGGAUAAGAUUCUAAAGGA	22	24978
CFTR-Intron10-6099	−	GGGCUGGAUAAGAUUCUAAAGGA	23	24979
CFTR-Intron10-6100	−	GGGGCUGGAUAAGAUUCUAAAGGA	24	24980
CFTR-Intron10-6101	−	GAAGGAAGGAAAGAAGGA	18	24981
CFTR-Intron10-6102	−	GGAAGGAAGGAAAGAAGGA	19	24982
CFTR-Intron10-1145	−	AGGAAGGAAGGAAAGAAGGA	20	20030
CFTR-Intron10-6103	−	AAGGAAGGAAGGAAAGAAGGA	21	24983
CFTR-Intron10-6104	−	GAAGGAAGGAAGGAAAGAAGGA	22	24984
CFTR-Intron10-6105	−	GGAAGGAAGGAAGGAAAGAAGGA	23	24985
CFTR-Intron10-6106	−	AGGAAGGAAGGAAGGAAAGAAGGA	24	24986
CFTR-Intron10-6107	−	GGAGGAAGGAAGGAAGGA	18	24987
CFTR-Intron10-6108	−	AGGAGGAAGGAAGGAAGGA	19	24988
CFTR-Intron10-6109	−	UAGGAGGAAGGAAGGAAGGA	20	24989
CFTR-Intron10-6110	−	GUAGGAGGAAGGAAGGAAGGA	21	24990
CFTR-Intron10-6111	−	AGUAGGAGGAAGGAAGGAAGGA	22	24991
CFTR-Intron10-6112	−	AAGUAGGAGGAAGGAAGGAAGGA	23	24992
CFTR-Intron10-6113	−	GAAGUAGGAGGAAGGAAGGAAGGA	24	24993
CFTR-Intron10-6114	−	AGUAGGAGGAAGGAAGGA	18	24994
CFTR-Intron10-6115	−	AAGUAGGAGGAAGGAAGGA	19	24995
CFTR-Intron10-652	−	GAAGUAGGAGGAAGGAAGGA	20	19538
CFTR-Intron10-6116	−	GGAAGUAGGAGGAAGGAAGGA	21	24996
CFTR-Intron10-6117	−	AGGAAGUAGGAGGAAGGAAGGA	22	24997
CFTR-Intron10-6118	−	AAGGAAGUAGGAGGAAGGAAGGA	23	24998
CFTR-Intron10-6119	−	AAAGGAAGUAGGAGGAAGGAAGGA	24	24999
CFTR-Intron10-6120	−	AGGAAGUAGGAGGAAGGA	18	25000
CFTR-Intron10-6121	−	AAGGAAGUAGGAGGAAGGA	19	25001
CFTR-Intron10-1146	−	AAAGGAAGUAGGAGGAAGGA	20	20031
CFTR-Intron10-6122	−	GAAAGGAAGUAGGAGGAAGGA	21	25002
CFTR-Intron10-6123	−	AGAAAGGAAGUAGGAGGAAGGA	22	25003
CFTR-Intron10-6124	−	AAGAAAGGAAGUAGGAGGAAGGA	23	25004
CFTR-Intron10-6125	−	GAAGAAAGGAAGUAGGAGGAAGGA	24	25005
CFTR-Intron10-6126	−	UUAGAAAGAAUAAGAGGA	18	25006
CFTR-Intron10-6127	−	AUUAGAAAGAAUAAGAGGA	19	25007
CFTR-Intron10-6128	−	AAUUAGAAAGAAUAAGAGGA	20	25008
CFTR-Intron10-6129	−	AAAUUAGAAAGAAUAAGAGGA	21	25009
CFTR-Intron10-6130	−	GAAAUUAGAAAGAAUAAGAGGA	22	25010
CFTR-Intron10-6131	−	UGAAAUUAGAAAGAAUAAGAGGA	23	25011
CFTR-Intron10-6132	−	AUGAAAUUAGAAAGAAUAAGAGGA	24	25012
CFTR-Intron10-6133	−	AGAAAAAGAAAGAGAGGA	18	25013
CFTR-Intron10-6134	−	CAGAAAAAGAAAGAGAGGA	19	25014
CFTR-Intron10-1149	−	ACAGAAAAAGAAAGAGAGGA	20	20034
CFTR-Intron10-6135	−	AACAGAAAAAGAAAGAGAGGA	21	25015
CFTR-Intron10-6136	−	AAACAGAAAAAGAAAGAGAGGA	22	25016
CFTR-Intron10-6137	−	CAAACAGAAAAAGAAAGAGAGGA	23	25017
CFTR-Intron10-6138	−	ACAAACAGAAAAAGAAAGAGAGGA	24	25018
CFTR-Intron10-6139	−	AGAAAGGAAGUAGGAGGA	18	25019
CFTR-Intron10-6140	−	AAGAAAGGAAGUAGGAGGA	19	25020
CFTR-Intron10-653	−	GAAGAAAGGAAGUAGGAGGA	20	19539
CFTR-Intron10-6141	−	GGAAGAAAGGAAGUAGGAGGA	21	25021
CFTR-Intron10-6142	−	AGGAAGAAAGGAAGUAGGAGGA	22	25022
CFTR-Intron10-6143	−	GAGGAAGAAAGGAAGUAGGAGGA	23	25023
CFTR-Intron10-6144	−	UGAGGAAGAAAGGAAGUAGGAGGA	24	25024
CFTR-Intron10-6145	−	CUUUUAGUAGUAUUAGGA	18	25025
CFTR-Intron10-6146	−	CCUUUUAGUAGUAUUAGGA	19	25026
CFTR-Intron10-6147	−	GCCUUUUAGUAGUAUUAGGA	20	25027
CFTR-Intron10-6148	−	UGCCUUUUAGUAGUAUUAGGA	21	25028
CFTR-Intron10-6149	−	CUGCCUUUUAGUAGUAUUAGGA	22	25029
CFTR-Intron10-6150	−	GCUGCCUUUUAGUAGUAUUAGGA	23	25030
CFTR-Intron10-6151	−	GGCUGCCUUUUAGUAGUAUUAGGA	24	25031
CFTR-Intron10-6152	−	GGAGAAACAGGUUUUGGA	18	25032
CFTR-Intron10-6153	−	GGGAGAAACAGGUUUUGGA	19	25033
CFTR-Intron10-1157	−	UGGGAGAAACAGGUUUUGGA	20	20042
CFTR-Intron10-6154	−	AUGGGAGAAACAGGUUUUGGA	21	25034
CFTR-Intron10-6155	−	AAUGGGAGAAACAGGUUUUGGA	22	25035
CFTR-Intron10-6156	−	UAAUGGGAGAAACAGGUUUUGGA	23	25036
CFTR-Intron10-6157	−	AUAAUGGGAGAAACAGGUUUUGGA	24	25037
CFTR-Intron10-6158	−	AUCACUGGAUGCCCUUGA	18	25038
CFTR-Intron10-6159	−	CAUCACUGGAUGCCCUUGA	19	25039
CFTR-Intron10-6160	−	GCAUCACUGGAUGCCCUUGA	20	25040
CFTR-Intron10-6161	−	UGCAUCACUGGAUGCCCUUGA	21	25041
CFTR-Intron10-6162	−	UUGCAUCACUGGAUGCCCUUGA	22	25042
CFTR-Intron10-6163	−	UUUGCAUCACUGGAUGCCCUUGA	23	25043
CFTR-Intron10-6164	−	UUUUGCAUCACUGGAUGCCCUUGA	24	25044
CFTR-Intron10-6165	−	AUUCAGGACAUGCUUUGA	18	25045
CFTR-Intron10-6166	−	GAUUCAGGACAUGCUUUGA	19	25046
CFTR-Intron10-1164	−	AGAUUCAGGACAUGCUUUGA	20	20049
CFTR-Intron10-6167	−	CAGAUUCAGGACAUGCUUUGA	21	25047
CFTR-Intron10-6168	−	UCAGAUUCAGGACAUGCUUUGA	22	25048
CFTR-Intron10-6169	−	AUCAGAUUCAGGACAUGCUUUGA	23	25049
CFTR-Intron10-6170	−	GAUCAGAUUCAGGACAUGCUUUGA	24	25050
CFTR-Intron10-6171	−	CUGUCUAGCCUAGAAAUA	18	25051
CFTR-Intron10-6172	−	ACUGUCUAGCCUAGAAAUA	19	25052
CFTR-Intron10-6173	−	AACUGUCUAGCCUAGAAAUA	20	25053
CFTR-Intron10-6174	−	AAACUGUCUAGCCUAGAAAUA	21	25054
CFTR-Intron10-6175	−	CAAACUGUCUAGCCUAGAAAUA	22	25055
CFTR-Intron10-6176	−	ACAAACUGUCUAGCCUAGAAAUA	23	25056
CFTR-Intron10-6177	−	CACAAACUGUCUAGCCUAGAAAUA	24	25057
CFTR-Intron10-6178	−	CCGGUGUCUUCUGAAAUA	18	25058
CFTR-Intron10-6179	−	ACCGGUGUCUUCUGAAAUA	19	25059
CFTR-Intron10-380	−	AACCGGUGUCUUCUGAAAUA	20	19266
CFTR-Intron10-6180	−	UAACCGGUGUCUUCUGAAAUA	21	25060
CFTR-Intron10-6181	−	UUAACCGGUGUCUUCUGAAAUA	22	25061
CFTR-Intron10-6182	−	AUUAACCGGUGUCUUCUGAAAUA	23	25062
CFTR-Intron10-6183	−	AAUUAACCGGUGUCUUCUGAAAUA	24	25063
CFTR-Intron10-6184	−	AGUGAUCCUAGAAUCAUA	18	25064
CFTR-Intron10-6185	−	AAGUGAUCCUAGAAUCAUA	19	25065
CFTR-Intron10-6186	−	AAAGUGAUCCUAGAAUCAUA	20	25066
CFTR-Intron10-6187	−	UAAAGUGAUCCUAGAAUCAUA	21	25067
CFTR-Intron10-6188	−	AUAAAGUGAUCCUAGAAUCAUA	22	25068
CFTR-Intron10-6189	−	UAUAAAGUGAUCCUAGAAUCAUA	23	25069
CFTR-Intron10-6190	−	AUAUAAAGUGAUCCUAGAAUCAUA	24	25070
CFTR-Intron10-6191	−	CCGUUUACUAGAAAGAUA	18	25071
CFTR-Intron10-6192	−	GCCGUUUACUAGAAAGAUA	19	25072
CFTR-Intron10-6193	−	UGCCGUUUACUAGAAAGAUA	20	25073
CFTR-Intron10-6194	−	GUGCCGUUUACUAGAAAGAUA	21	25074
CFTR-Intron10-6195	−	UGUGCCGUUUACUAGAAAGAUA	22	25075
CFTR-Intron10-6196	−	AUGUGCCGUUUACUAGAAAGAUA	23	25076
CFTR-Intron10-6197	−	AAUGUGCCGUUUACUAGAAAGAUA	24	25077
CFTR-Intron10-6198	−	CUUGGUAUUUACCAUAUA	18	25078
CFTR-Intron10-6199	−	GCUUGGUAUUUACCAUAUA	19	25079
CFTR-Intron10-6200	−	UGCUUGGUAUUUACCAUAUA	20	25080
CFTR-Intron10-6201	−	UUGCUUGGUAUUUACCAUAUA	21	25081
CFTR-Intron10-6202	−	GUUGCUUGGUAUUUACCAUAUA	22	25082
CFTR-Intron10-6203	−	AGUUGCUUGGUAUUUACCAUAUA	23	25083
CFTR-Intron10-6204	−	GAGUUGCUUGGUAUUUACCAUAUA	24	25084
CFTR-Intron10-6205	−	UUACACUCUAGCAUUAUA	18	25085
CFTR-Intron10-6206	−	AUUACACUCUAGCAUUAUA	19	25086
CFTR-Intron10-6207	−	AAUUACACUCUAGCAUUAUA	20	25087
CFTR-Intron10-6208	−	UAAUUACACUCUAGCAUUAUA	21	25088
CFTR-Intron10-6209	−	AUAAUUACACUCUAGCAUUAUA	22	25089
CFTR-Intron10-6210	−	UAUAAUUACACUCUAGCAUUAUA	23	25090
CFTR-Intron10-6211	−	UUAUAAUUACACUCUAGCAUUAUA	24	25091
CFTR-Intron10-6212	−	AAAGUUUCUCAUCUUAUA	18	25092
CFTR-Intron10-6213	−	AAAAGUUUCUCAUCUUAUA	19	25093
CFTR-Intron10-1171	−	AAAAAGUUUCUCAUCUUAUA	20	20056
CFTR-Intron10-6214	−	UAAAAAGUUUCUCAUCUUAUA	21	25094
CFTR-Intron10-6215	−	UUAAAAAGUUUCUCAUCUUAUA	22	25095
CFTR-Intron10-6216	−	UUUAAAAAGUUUCUCAUCUUAUA	23	25096
CFTR-Intron10-6217	−	AUUUAAAAAGUUUCUCAUCUUAUA	24	25097
CFTR-Intron10-6218	−	GUACAAAGGAAUUUUAUA	18	25098
CFTR-Intron10-6219	−	UGUACAAAGGAAUUUUAUA	19	25099
CFTR-Intron10-6220	−	UUGUACAAAGGAAUUUUAUA	20	25100
CFTR-Intron10-6221	−	UUUGUACAAAGGAAUUUUAUA	21	25101
CFTR-Intron10-6222	−	UUUUGUACAAAGGAAUUUUAUA	22	25102
CFTR-Intron10-6223	−	AUUUUGUACAAAGGAAUUUUAUA	23	25103
CFTR-Intron10-6224	−	AAUUUUGUACAAAGGAAUUUUAUA	24	25104
CFTR-Intron10-6225	−	CUUGCUCUCUUUUAACUA	18	25105
CFTR-Intron10-6226	−	ACUUGCUCUCUUUUAACUA	19	25106
CFTR-Intron10-6227	−	AACUUGCUCUCUUUUAACUA	20	25107
CFTR-Intron10-6228	−	AAACUUGCUCUCUUUUAACUA	21	25108
CFTR-Intron10-6229	−	AAAACUUGCUCUCUUUUAACUA	22	25109
CFTR-Intron10-6230	−	AAAAACUUGCUCUCUUUUAACUA	23	25110
CFTR-Intron10-6231	−	UAAAAACUUGCUCUCUUUUAACUA	24	25111
CFTR-Intron10-6232	−	UAUUAAAAAAUUAUACUA	18	25112
CFTR-Intron10-6233	−	CUAUUAAAAAAUUAUACUA	19	25113
CFTR-Intron10-6234	−	ACUAUUAAAAAAUUAUACUA	20	25114
CFTR-Intron10-6235	−	CACUAUUAAAAAAUUAUACUA	21	25115
CFTR-Intron10-6236	−	UCACUAUUAAAAAAUUAUACUA	22	25116
CFTR-Intron10-6237	−	UUCACUAUUAAAAAAUUAUACUA	23	25117
CFTR-Intron10-6238	−	GUUCACUAUUAAAAAAUUAUACUA	24	25118
CFTR-Intron10-6239	−	UUGACCUAAGAUAUCCUA	18	25119
CFTR-Intron10-6240	−	UUUGACCUAAGAUAUCCUA	19	25120
CFTR-Intron10-387	−	CUUUGACCUAAGAUAUCCUA	20	19273
CFTR-Intron10-6241	−	UCUUUGACCUAAGAUAUCCUA	21	25121
CFTR-Intron10-6242	−	CUCUUUGACCUAAGAUAUCCUA	22	25122
CFTR-Intron10-6243	−	CCUCUUUGACCUAAGAUAUCCUA	23	25123
CFTR-Intron10-6244	−	UCCUCUUUGACCUAAGAUAUCCUA	24	25124
CFTR-Intron10-6245	−	UAGUAUUAGAAUGGGCUA	18	25125
CFTR-Intron10-6246	−	CUAGUAUUAGAAUGGGCUA	19	25126
CFTR-Intron10-6247	−	UCUAGUAUUAGAAUGGGCUA	20	25127
CFTR-Intron10-6248	−	UUCUAGUAUUAGAAUGGGCUA	21	25128
CFTR-Intron10-6249	−	UUUCUAGUAUUAGAAUGGGCUA	22	25129
CFTR-Intron10-6250	−	CUUUCUAGUAUUAGAAUGGGCUA	23	25130
CFTR-Intron10-6251	−	GCUUUCUAGUAUUAGAAUGGGCUA	24	25131
CFTR-Intron10-6252	−	GGGCUGGAUAAGAUUCUA	18	25132
CFTR-Intron10-6253	−	GGGGCUGGAUAAGAUUCUA	19	25133
CFTR-Intron10-6254	−	UGGGGCUGGAUAAGAUUCUA	20	25134
CFTR-Intron10-6255	−	AUGGGGCUGGAUAAGAUUCUA	21	25135
CFTR-Intron10-6256	−	GAUGGGGCUGGAUAAGAUUCUA	22	25136
CFTR-Intron10-6257	−	AGAUGGGGCUGGAUAAGAUUCUA	23	25137
CFTR-Intron10-6258	−	AAGAUGGGGCUGGAUAAGAUUCUA	24	25138
CFTR-Intron10-6259	−	CUGGUUUGAAGAACAGUA	18	25139
CFTR-Intron10-6260	−	UCUGGUUUGAAGAACAGUA	19	25140
CFTR-Intron10-86	−	GUCUGGUUUGAAGAACAGUA	20	18972
CFTR-Intron10-6261	−	UGUCUGGUUUGAAGAACAGUA	21	25141
CFTR-Intron10-6262	−	CUGUCUGGUUUGAAGAACAGUA	22	25142
CFTR-Intron10-6263	−	CCUGUCUGGUUUGAAGAACAGUA	23	25143
CFTR-Intron10-6264	−	ACCUGUCUGGUUUGAAGAACAGUA	24	25144
CFTR-Intron10-6265	−	CUGGCACCAUUCACAGUA	18	25145
CFTR-Intron10-6266	−	CCUGGCACCAUUCACAGUA	19	25146
CFTR-Intron10-6267	−	ACCUGGCACCAUUCACAGUA	20	25147
CFTR-Intron10-6268	−	UACCUGGCACCAUUCACAGUA	21	25148
CFTR-Intron10-6269	−	CUACCUGGCACCAUUCACAGUA	22	25149
CFTR-Intron10-6270	−	CCUACCUGGCACCAUUCACAGUA	23	25150
CFTR-Intron10-6271	−	CCCUACCUGGCACCAUUCACAGUA	24	25151
CFTR-Intron10-6272	−	UUAAUGAAAGCAAUAGUA	18	25152
CFTR-Intron10-6273	−	CUUAAUGAAAGCAAUAGUA	19	25153
CFTR-Intron10-6274	−	ACUUAAUGAAAGCAAUAGUA	20	25154
CFTR-Intron10-6275	−	GACUUAAUGAAAGCAAUAGUA	21	25155
CFTR-Intron10-6276	−	UGACUUAAUGAAAGCAAUAGUA	22	25156
CFTR-Intron10-6277	−	GUGACUUAAUGAAAGCAAUAGUA	23	25157
CFTR-Intron10-6278	−	CGUGACUUAAUGAAAGCAAUAGUA	24	25158
CFTR-Intron10-6279	−	GGCUUGAUCCAGGUAGUA	18	25159
CFTR-Intron10-6280	−	UGGCUUGAUCCAGGUAGUA	19	25160
CFTR-Intron10-6281	−	GUGGCUUGAUCCAGGUAGUA	20	25161
CFTR-Intron10-6282	−	GGUGGCUUGAUCCAGGUAGUA	21	25162
CFTR-Intron10-6283	−	UGGUGGCUUGAUCCAGGUAGUA	22	25163
CFTR-Intron10-6284	−	AUGGUGGCUUGAUCCAGGUAGUA	23	25164
CFTR-Intron10-6285	−	GAUGGUGGCUUGAUCCAGGUAGUA	24	25165
CFTR-Intron10-6286	−	UUUUUAGGCUAUUCUGUA	18	25166
CFTR-Intron10-6287	−	GUUUUUAGGCUAUUCUGUA	19	25167
CFTR-Intron10-390	−	UGUUUUUAGGCUAUUCUGUA	20	19276
CFTR-Intron10-6288	−	AUGUUUUUAGGCUAUUCUGUA	21	25168
CFTR-Intron10-6289	−	AAUGUUUUUAGGCUAUUCUGUA	22	25169
CFTR-Intron10-6290	−	UAAUGUUUUUAGGCUAUUCUGUA	23	25170
CFTR-Intron10-6291	−	CUAAUGUUUUUAGGCUAUUCUGUA	24	25171
CFTR-Intron10-6292	−	CACUUGACAGGUAUAUUA	18	25172
CFTR-Intron10-6293	−	GCACUUGACAGGUAUAUUA	19	25173
CFTR-Intron10-6294	−	AGCACUUGACAGGUAUAUUA	20	25174
CFTR-Intron10-6295	−	UAGCACUUGACAGGUAUAUUA	21	25175
CFTR-Intron10-6296	−	CUAGCACUUGACAGGUAUAUUA	22	25176
CFTR-Intron10-6297	−	CCUAGCACUUGACAGGUAUAUUA	23	25177
CFTR-Intron10-6298	−	GCCUAGCACUUGACAGGUAUAUUA	24	25178
CFTR-Intron10-6299	−	GAGAUAACUCGUGACUUA	18	25179
CFTR-Intron10-6300	−	GGAGAUAACUCGUGACUUA	19	25180
CFTR-Intron10-6301	−	CGGAGAUAACUCGUGACUUA	20	25181
CFTR-Intron10-6302	−	ACGGAGAUAACUCGUGACUUA	21	25182
CFTR-Intron10-6303	−	UACGGAGAUAACUCGUGACUUA	22	25183
CFTR-Intron10-6304	−	AUACGGAGAUAACUCGUGACUUA	23	25184
CFTR-Intron10-6305	−	AAUACGGAGAUAACUCGUGACUUA	24	25185
CFTR-Intron10-6306	−	UUUAUAAAAGAAACCUUA	18	25186
CFTR-Intron10-6307	−	CUUUAUAAAAGAAACCUUA	19	25187
CFTR-Intron10-6308	−	UCUUUAUAAAAGAAACCUUA	20	25188
CFTR-Intron10-6309	−	GUCUUUAUAAAAGAAACCUUA	21	25189
CFTR-Intron10-6310	−	UGUCUUUAUAAAAGAAACCUUA	22	25190
CFTR-Intron10-6311	−	GUGUCUUUAUAAAAGAAACCUUA	23	25191
CFTR-Intron10-6312	−	AGUGUCUUUAUAAAAGAAACCUUA	24	25192
CFTR-Intron10-6313	−	AGAGACCCUCACACCUUA	18	25193
CFTR-Intron10-6314	−	GAGAGACCCUCACACCUUA	19	25194
CFTR-Intron10-6315	−	AGAGAGACCCUCACACCUUA	20	25195
CFTR-Intron10-6316	−	UAGAGAGACCCUCACACCUUA	21	25196
CFTR-Intron10-6317	−	UUAGAGAGACCCUCACACCUUA	22	25197
CFTR-Intron10-6318	−	CUUAGAGAGACCCUCACACCUUA	23	25198
CFTR-Intron10-6319	−	CCUUAGAGAGACCCUCACACCUUA	24	25199
CFTR-Intron10-6320	−	AAAAAGUUUCUCAUCUUA	18	25200
CFTR-Intron10-6321	−	UAAAAAGUUUCUCAUCUUA	19	25201
CFTR-Intron10-6322	−	UUAAAAAGUUUCUCAUCUUA	20	25202
CFTR-Intron10-6323	−	UUUAAAAAGUUUCUCAUCUUA	21	25203
CFTR-Intron10-6324	−	AUUUAAAAAGUUUCUCAUCUUA	22	25204
CFTR-Intron10-6325	−	AAUUUAAAAAGUUUCUCAUCUUA	23	25205
CFTR-Intron10-6326	−	UAAUUUAAAAAGUUUCUCAUCUUA	24	25206
CFTR-Intron10-6327	−	GCUAUGAAGGCAGAGUUA	18	25207
CFTR-Intron10-6328	−	AGCUAUGAAGGCAGAGUUA	19	25208
CFTR-Intron10-6329	−	CAGCUAUGAAGGCAGAGUUA	20	25209
CFTR-Intron10-6330	−	GCAGCUAUGAAGGCAGAGUUA	21	25210
CFTR-Intron10-6331	−	AGCAGCUAUGAAGGCAGAGUUA	22	25211
CFTR-Intron10-6332	−	AAGCAGCUAUGAAGGCAGAGUUA	23	25212
CFTR-Intron10-6333	−	AAAGCAGCUAUGAAGGCAGAGUUA	24	25213
CFTR-Intron10-6334	−	UCUAAGUAUUAGAGGUUA	18	25214
CFTR-Intron10-6335	−	UUCUAAGUAUUAGAGGUUA	19	25215
CFTR-Intron10-397	−	AUUCUAAGUAUUAGAGGUUA	20	19283
CFTR-Intron10-6336	−	CAUUCUAAGUAUUAGAGGUUA	21	25216
CFTR-Intron10-6337	−	GCAUUCUAAGUAUUAGAGGUUA	22	25217
CFTR-Intron10-6338	−	GGCAUUCUAAGUAUUAGAGGUUA	23	25218
CFTR-Intron10-6339	−	GGGCAUUCUAAGUAUUAGAGGUUA	24	25219
CFTR-Intron10-6340	−	CUGUAGGUAAAAAUGUUA	18	25220
CFTR-Intron10-6341	−	GCUGUAGGUAAAAAUGUUA	19	25221
CFTR-Intron10-6342	−	UGCUGUAGGUAAAAAUGUUA	20	25222
CFTR-Intron10-6343	−	CUGCUGUAGGUAAAAAUGUUA	21	25223
CFTR-Intron10-6344	−	GCUGCUGUAGGUAAAAAUGUUA	22	25224
CFTR-Intron10-6345	−	UGCUGCUGUAGGUAAAAAUGUUA	23	25225
CFTR-Intron10-6346	−	CUGCUGCUGUAGGUAAAAAUGUUA	24	25226
CFTR-Intron10-6347	−	UAAGAAUUGUAAAAUUUA	18	25227
CFTR-Intron10-6348	−	AUAAGAAUUGUAAAAUUUA	19	25228
CFTR-Intron10-6349	−	AAUAAGAAUUGUAAAAUUUA	20	25229
CFTR-Intron10-6350	−	UAAUAAGAAUUGUAAAAUUUA	21	25230
CFTR-Intron10-6351	−	GUAAUAAGAAUUGUAAAAUUUA	22	25231
CFTR-Intron10-6352	−	UGUAAUAAGAAUUGUAAAAUUUA	23	25232
CFTR-Intron10-6353	−	AUGUAAUAAGAAUUGUAAAAUUUA	24	25233
CFTR-Intron10-6354	−	CUUCCUUGAAUUAUUUUA	18	25234
CFTR-Intron10-6355	−	ACUUCCUUGAAUUAUUUUA	19	25235
CFTR-Intron10-6356	−	AACUUCCUUGAAUUAUUUUA	20	25236
CFTR-Intron10-6357	−	AAACUUCCUUGAAUUAUUUUA	21	25237
CFTR-Intron10-6358	−	GAAACUUCCUUGAAUUAUUUUA	22	25238
CFTR-Intron10-6359	−	UGAAACUUCCUUGAAUUAUUUUA	23	25239
CFTR-Intron10-6360	−	AUGAAACUUCCUUGAAUUAUUUUA	24	25240
CFTR-Intron10-6361	−	UGUUAUAGCAGCCUGAAC	18	25241
CFTR-Intron10-6362	−	UUGUUAUAGCAGCCUGAAC	19	25242
CFTR-Intron10-6363	−	UUUGUUAUAGCAGCCUGAAC	20	25243
CFTR-Intron10-6364	−	UUUUGUUAUAGCAGCCUGAAC	21	25244
CFTR-Intron10-6365	−	AUUUUGUUAUAGCAGCCUGAAC	22	25245
CFTR-Intron10-6366	−	UAUUUUGUUAUAGCAGCCUGAAC	23	25246
CFTR-Intron10-6367	−	GUAUUUUGUUAUAGCAGCCUGAAC	24	25247
CFTR-Intron10-6368	−	GCUUAUUCUUGUAAUAAC	18	25248
CFTR-Intron10-6369	−	AGCUUAUUCUUGUAAUAAC	19	25249
CFTR-Intron10-404	−	UAGCUUAUUCUUGUAAUAAC	20	19290
CFTR-Intron10-6370	−	UUAGCUUAUUCUUGUAAUAAC	21	25250
CFTR-Intron10-6371	−	UUUAGCUUAUUCUUGUAAUAAC	22	25251
CFTR-Intron10-6372	−	UUUUAGCUUAUUCUUGUAAUAAC	23	25252
CFTR-Intron10-6373	−	GUUUUAGCUUAUUCUUGUAAUAAC	24	25253
CFTR-Intron10-6374	−	GGCCUGCAUAUGUCUAAC	18	25254
CFTR-Intron10-6375	−	GGGCCUGCAUAUGUCUAAC	19	25255
CFTR-Intron10-6376	−	UGGGCCUGCAUAUGUCUAAC	20	25256
CFTR-Intron10-6377	−	UUGGGCCUGCAUAUGUCUAAC	21	25257
CFTR-Intron10-6378	−	UUUGGGCCUGCAUAUGUCUAAC	22	25258
CFTR-Intron10-6379	−	AUUUGGGCCUGCAUAUGUCUAAC	23	25259
CFTR-Intron10-6380	−	UAUUUGGGCCUGCAUAUGUCUAAC	24	25260
CFTR-Intron10-6381	−	CUUUCUGGACUGAGUAAC	18	25261
CFTR-Intron10-6382	−	GCUUUCUGGACUGAGUAAC	19	25262
CFTR-Intron10-1182	−	AGCUUUCUGGACUGAGUAAC	20	20067
CFTR-Intron10-6383	−	AAGCUUUCUGGACUGAGUAAC	21	25263
CFTR-Intron10-6384	−	CAAGCUUUCUGGACUGAGUAAC	22	25264
CFTR-Intron10-6385	−	CCAAGCUUUCUGGACUGAGUAAC	23	25265
CFTR-Intron10-6386	−	UCCAAGCUUUCUGGACUGAGUAAC	24	25266
CFTR-Intron10-6387	−	UCAUUUCAACUUAUACAC	18	25267
CFTR-Intron10-6388	−	AUCAUUUCAACUUAUACAC	19	25268
CFTR-Intron10-407	−	UAUCAUUUCAACUUAUACAC	20	19293
CFTR-Intron10-6389	−	AUAUCAUUUCAACUUAUACAC	21	25269
CFTR-Intron10-6390	−	AAUAUCAUUUCAACUUAUACAC	22	25270
CFTR-Intron10-6391	−	AAAUAUCAUUUCAACUUAUACAC	23	25271
CFTR-Intron10-6392	−	AAAAUAUCAUUUCAACUUAUACAC	24	25272
CFTR-Intron10-6393	−	GGUGAGAUUAGAGGCCAC	18	25273
CFTR-Intron10-6394	−	GGGUGAGAUUAGAGGCCAC	19	25274
CFTR-Intron10-409	−	UGGGUGAGAUUAGAGGCCAC	20	19295
CFTR-Intron10-6395	−	CUGGGUGAGAUUAGAGGCCAC	21	25275
CFTR-Intron10-6396	−	UCUGGGUGAGAUUAGAGGCCAC	22	25276
CFTR-Intron10-6397	−	CUCUGGGUGAGAUUAGAGGCCAC	23	25277
CFTR-Intron10-6398	−	UCUCUGGGUGAGAUUAGAGGCCAC	24	25278
CFTR-Intron10-6399	−	CUGAGGUGGGAGGAUCAC	18	25279
CFTR-Intron10-6400	−	GCUGAGGUGGGAGGAUCAC	19	25280
CFTR-Intron10-6401	−	GGCUGAGGUGGGAGGAUCAC	20	25281
CFTR-Intron10-6402	−	AGGCUGAGGUGGGAGGAUCAC	21	25282
CFTR-Intron10-6403	−	GAGGCUGAGGUGGGAGGAUCAC	22	25283
CFTR-Intron10-6404	−	GGAGGCUGAGGUGGGAGGAUCAC	23	25284
CFTR-Intron10-6405	−	GGGAGGCUGAGGUGGGAGGAUCAC	24	25285
CFTR-Intron10-6406	−	GUUUGUCUUUAAUUUCAC	18	25286
CFTR-Intron10-6407	−	GGUUUGUCUUUAAUUUCAC	19	25287
CFTR-Intron10-6408	−	AGGUUUGUCUUUAAUUUCAC	20	25288
CFTR-Intron10-6409	−	UAGGUUUGUCUUUAAUUUCAC	21	25289
CFTR-Intron10-6410	−	UUAGGUUUGUCUUUAAUUUCAC	22	25290
CFTR-Intron10-6411	−	GUUAGGUUUGUCUUUAAUUUCAC	23	25291
CFTR-Intron10-6412	−	AGUUAGGUUUGUCUUUAAUUUCAC	24	25292
CFTR-Intron10-6413	−	GGAAAUAAAUUUAAAGAC	18	25293
CFTR-Intron10-6414	−	AGGAAAUAAAUUUAAAGAC	19	25294
CFTR-Intron10-6415	−	GAGGAAAUAAAUUUAAAGAC	20	25295
CFTR-Intron10-6416	−	UGAGGAAAUAAAUUUAAAGAC	21	25296
CFTR-Intron10-6417	−	UUGAGGAAAUAAAUUUAAAGAC	22	25297
CFTR-Intron10-6418	−	AUUGAGGAAAUAAAUUUAAAGAC	23	25298
CFTR-Intron10-6419	−	UAUUGAGGAAAUAAAUUUAAAGAC	24	25299
CFTR-Intron10-6420	−	GCUGGCAUAGAGUAAGAC	18	25300
CFTR-Intron10-6421	−	GGCUGGCAUAGAGUAAGAC	19	25301
CFTR-Intron10-412	−	AGGCUGGCAUAGAGUAAGAC	20	19298
CFTR-Intron10-6422	−	GAGGCUGGCAUAGAGUAAGAC	21	25302
CFTR-Intron10-6423	−	UGAGGCUGGCAUAGAGUAAGAC	22	25303
CFTR-Intron10-6424	−	CUGAGGCUGGCAUAGAGUAAGAC	23	25304
CFTR-Intron10-6425	−	ACUGAGGCUGGCAUAGAGUAAGAC	24	25305
CFTR-Intron10-6426	−	GCUAUUCUGUAGGGAGAC	18	25306
CFTR-Intron10-6427	−	GGCUAUUCUGUAGGGAGAC	19	25307
CFTR-Intron10-6428	−	AGGCUAUUCUGUAGGGAGAC	20	25308
CFTR-Intron10-6429	−	UAGGCUAUUCUGUAGGGAGAC	21	25309
CFTR-Intron10-6430	−	UUAGGCUAUUCUGUAGGGAGAC	22	25310
CFTR-Intron10-6431	−	UUUAGGCUAUUCUGUAGGGAGAC	23	25311
CFTR-Intron10-6432	−	UUUUAGGCUAUUCUGUAGGGAGAC	24	25312
CFTR-Intron10-6433	−	AAGAAUUGAAUAUGAGAC	18	25313
CFTR-Intron10-6434	−	GAAGAAUUGAAUAUGAGAC	19	25314
CFTR-Intron10-6435	−	UGAAGAAUUGAAUAUGAGAC	20	25315
CFTR-Intron10-6436	−	UUGAAGAAUUGAAUAUGAGAC	21	25316
CFTR-Intron10-6437	−	UUUGAAGAAUUGAAUAUGAGAC	22	25317
CFTR-Intron10-6438	−	UUUUGAAGAAUUGAAUAUGAGAC	23	25318
CFTR-Intron10-6439	−	AUUUUGAAGAAUUGAAUAUGAGAC	24	25319
CFTR-Intron10-6440	−	GCCCGUAGUCCCAGCUAC	18	25320
CFTR-Intron10-6441	−	UGCCCGUAGUCCCAGCUAC	19	25321
CFTR-Intron10-6442	−	GUGCCCGUAGUCCCAGCUAC	20	25322
CFTR-Intron10-6443	−	GGUGCCCGUAGUCCCAGCUAC	21	25323
CFTR-Intron10-6444	−	GGGUGCCCGUAGUCCCAGCUAC	22	25324
CFTR-Intron10-6445	−	CGGGUGCCCGUAGUCCCAGCUAC	23	25325
CFTR-Intron10-6446	−	GCGGGUGCCCGUAGUCCCAGCUAC	24	25326
CFTR-Intron10-6447	−	UGUGCCUGUAGUCCCAGCUAC	21	25327
CFTR-Intron10-6448	−	GUGUGCCUGUAGUCCCAGCUAC	22	25328
CFTR-Intron10-6449	−	UGUGUGCCUGUAGUCCCAGCUAC	23	25329
CFTR-Intron10-6450	−	GUGUGUGCCUGUAGUCCCAGCUAC	24	25330
CFTR-Intron10-6451	−	GAAAAGUUGUAACAGUAC	18	25331
CFTR-Intron10-6452	−	GGAAAAGUUGUAACAGUAC	19	25332
CFTR-Intron10-6453	−	CGGAAAAGUUGUAACAGUAC	20	25333
CFTR-Intron10-6454	−	ACGGAAAAGUUGUAACAGUAC	21	25334
CFTR-Intron10-6455	−	CACGGAAAAGUUGUAACAGUAC	22	25335
CFTR-Intron10-6456	−	GCACGGAAAAGUUGUAACAGUAC	23	25336
CFTR-Intron10-6457	−	UGCACGGAAAAGUUGUAACAGUAC	24	25337
CFTR-Intron10-6458	−	GAUAAAUGUGCCGUUUAC	18	25338
CFTR-Intron10-6459	−	GGAUAAAUGUGCCGUUUAC	19	25339
CFTR-Intron10-6460	−	AGGAUAAAUGUGCCGUUUAC	20	25340
CFTR-Intron10-6461	−	AAGGAUAAAUGUGCCGUUUAC	21	25341
CFTR-Intron10-6462	−	GAAGGAUAAAUGUGCCGUUUAC	22	25342
CFTR-Intron10-6463	−	GGAAGGAUAAAUGUGCCGUUUAC	23	25343
CFTR-Intron10-6464	−	UGGAAGGAUAAAUGUGCCGUUUAC	24	25344
CFTR-Intron10-6465	−	UCAUAGCUCACUGUAACC	18	25345
CFTR-Intron10-6466	−	AUCAUAGCUCACUGUAACC	19	25346
CFTR-Intron10-6467	−	GAUCAUAGCUCACUGUAACC	20	25347
CFTR-Intron10-6468	−	UGAUCAUAGCUCACUGUAACC	21	25348
CFTR-Intron10-6469	−	GUGAUCAUAGCUCACUGUAACC	22	25349
CFTR-Intron10-6470	−	UGUGAUCAUAGCUCACUGUAACC	23	25350
CFTR-Intron10-6471	−	GUGUGAUCAUAGCUCACUGUAACC	24	25351
CFTR-Intron10-6472	−	GUCUAGCCUAGAAAUACC	18	25352
CFTR-Intron10-6473	−	UGUCUAGCCUAGAAAUACC	19	25353
CFTR-Intron10-6474	−	CUGUCUAGCCUAGAAAUACC	20	25354
CFTR-Intron10-6475	−	ACUGUCUAGCCUAGAAAUACC	21	25355
CFTR-Intron10-6476	−	AACUGUCUAGCCUAGAAAUACC	22	25356
CFTR-Intron10-6477	−	AAACUGUCUAGCCUAGAAAUACC	23	25357
CFTR-Intron10-6478	−	CAAACUGUCUAGCCUAGAAAUACC	24	25358
CFTR-Intron10-6479	−	GAGGAAGGCAGUGGUCCC	18	25359
CFTR-Intron10-6480	−	AGAGGAAGGCAGUGGUCCC	19	25360
CFTR-Intron10-6481	−	UAGAGGAAGGCAGUGGUCCC	20	25361
CFTR-Intron10-6482	−	UUAGAGGAAGGCAGUGGUCCC	21	25362
CFTR-Intron10-6483	−	GUUAGAGGAAGGCAGUGGUCCC	22	25363
CFTR-Intron10-6484	−	AGUUAGAGGAAGGCAGUGGUCCC	23	25364
CFTR-Intron10-6485	−	GAGUUAGAGGAAGGCAGUGGUCCC	24	25365
CFTR-Intron10-6486	−	CUCACAAACUGUCUAGCC	18	25366
CFTR-Intron10-6487	−	ACUCACAAACUGUCUAGCC	19	25367
CFTR-Intron10-6488	−	AACUCACAAACUGUCUAGCC	20	25368
CFTR-Intron10-6489	−	AAACUCACAAACUGUCUAGCC	21	25369
CFTR-Intron10-6490	−	AAAACUCACAAACUGUCUAGCC	22	25370
CFTR-Intron10-6491	−	AAAAACUCACAAACUGUCUAGCC	23	25371
CFTR-Intron10-6492	−	AAAAAACUCACAAACUGUCUAGCC	24	25372
CFTR-Intron10-6493	−	UGAAUGAAUGUGGUAUCC	18	25373
CFTR-Intron10-6494	−	GUGAAUGAAUGUGGUAUCC	19	25374
CFTR-Intron10-425	−	AGUGAAUGAAUGUGGUAUCC	20	19311
CFTR-Intron10-6495	−	UAGUGAAUGAAUGUGGUAUCC	21	25375
CFTR-Intron10-6496	−	CUAGUGAAUGAAUGUGGUAUCC	22	25376
CFTR-Intron10-6497	−	GCUAGUGAAUGAAUGUGGUAUCC	23	25377
CFTR-Intron10-6498	−	AGCUAGUGAAUGAAUGUGGUAUCC	24	25378
CFTR-Intron10-6499	−	UUGGGAGGUGAUUAGUCC	18	25379
CFTR-Intron10-6500	−	UUUGGGAGGUGAUUAGUCC	19	25380
CFTR-Intron10-6501	−	CUUUGGGAGGUGAUUAGUCC	20	25381
CFTR-Intron10-6502	−	CCUUUGGGAGGUGAUUAGUCC	21	25382
CFTR-Intron10-6503	−	GCCUUUGGGAGGUGAUUAGUCC	22	25383
CFTR-Intron10-6504	−	GGCCUUUGGGAGGUGAUUAGUCC	23	25384
CFTR-Intron10-6505	−	GGGCCUUUGGGAGGUGAUUAGUCC	24	25385
CFTR-Intron10-6506	−	UCUUUAUUUUUAUAUUCC	18	25386
CFTR-Intron10-6507	−	UUCUUUAUUUUUAUAUUCC	19	25387
CFTR-Intron10-6508	−	CUUCUUUAUUUUUAUAUUCC	20	25388
CFTR-Intron10-6509	−	UCUUCUUUAUUUUUAUAUUCC	21	25389
CFTR-Intron10-6510	−	GUCUUCUUUAUUUUUAUAUUCC	22	25390
CFTR-Intron10-6511	−	UGUCUUCUUUAUUUUUAUAUUCC	23	25391
CFTR-Intron10-6512	−	AUGUCUUCUUUAUUUUUAUAUUCC	24	25392
CFTR-Intron10-6513	−	GUUGUCAAAUGUCCUUCC	18	25393
CFTR-Intron10-6514	−	UGUUGUCAAAUGUCCUUCC	19	25394
CFTR-Intron10-6515	−	AUGUUGUCAAAUGUCCUUCC	20	25395
CFTR-Intron10-6516	−	GAUGUUGUCAAAUGUCCUUCC	21	25396
CFTR-Intron10-6517	−	AGAUGUUGUCAAAUGUCCUUCC	22	25397
CFTR-Intron10-6518	−	UAGAUGUUGUCAAAUGUCCUUCC	23	25398
CFTR-Intron10-6519	−	GUAGAUGUUGUCAAAUGUCCUUCC	24	25399
CFTR-Intron10-6520	−	CUUUUUUUAGUAUCUUCC	18	25400
CFTR-Intron10-6521	−	ACUUUUUUUAGUAUCUUCC	19	25401
CFTR-Intron10-6522	−	AACUUUUUUUAGUAUCUUCC	20	25402
CFTR-Intron10-6523	−	UAACUUUUUUUAGUAUCUUCC	21	25403
CFTR-Intron10-6524	−	GUAACUUUUUUUAGUAUCUUCC	22	25404
CFTR-Intron10-6525	−	GGUAACUUUUUUUAGUAUCUUCC	23	25405
CFTR-Intron10-6526	−	AGGUAACUUUUUUUAGUAUCUUCC	24	25406
CFTR-Intron10-6527	−	GGAGACAAGGGAGGAAGC	18	25407
CFTR-Intron10-6528	−	GGGAGACAAGGGAGGAAGC	19	25408
CFTR-Intron10-6529	−	AGGGAGACAAGGGAGGAAGC	20	25409
CFTR-Intron10-6530	−	UAGGGAGACAAGGGAGGAAGC	21	25410
CFTR-Intron10-6531	−	GUAGGGAGACAAGGGAGGAAGC	22	25411
CFTR-Intron10-6532	−	UGUAGGGAGACAAGGGAGGAAGC	23	25412
CFTR-Intron10-6533	−	CUGUAGGGAGACAAGGGAGGAAGC	24	25413
CFTR-Intron10-6534	−	GCCAUGUGAGAACACAGC	18	25414
CFTR-Intron10-6535	−	UGCCAUGUGAGAACACAGC	19	25415
CFTR-Intron10-1218	−	CUGCCAUGUGAGAACACAGC	20	20103
CFTR-Intron10-6536	−	UCUGCCAUGUGAGAACACAGC	21	25416
CFTR-Intron10-6537	−	UUCUGCCAUGUGAGAACACAGC	22	25417
CFTR-Intron10-6538	−	UUUCUGCCAUGUGAGAACACAGC	23	25418
CFTR-Intron10-6539	−	CUUUCUGCCAUGUGAGAACACAGC	24	25419
CFTR-Intron10-6540	−	CAGGAGUUUGAGACCAGC	18	25420
CFTR-Intron10-6541	−	CCAGGAGUUUGAGACCAGC	19	25421
CFTR-Intron10-6542	−	UCCAGGAGUUUGAGACCAGC	20	25422
CFTR-Intron10-6543	−	GUCCAGGAGUUUGAGACCAGC	21	25423
CFTR-Intron10-6544	−	AGUCCAGGAGUUUGAGACCAGC	22	25424
CFTR-Intron10-6545	−	GAGUCCAGGAGUUUGAGACCAGC	23	25425
CFTR-Intron10-6546	−	UGAGUCCAGGAGUUUGAGACCAGC	24	25426
CFTR-Intron10-6547	−	GUAUUUUGUUAUAGCAGC	18	25427
CFTR-Intron10-6548	−	GGUAUUUUGUUAUAGCAGC	19	25428
CFTR-Intron10-6549	−	UGGUAUUUUGUUAUAGCAGC	20	25429
CFTR-Intron10-6550	−	AUGGUAUUUUGUUAUAGCAGC	21	25430
CFTR-Intron10-6551	−	CAUGGUAUUUUGUUAUAGCAGC	22	25431
CFTR-Intron10-6552	−	UCAUGGUAUUUUGUUAUAGCAGC	23	25432
CFTR-Intron10-6553	−	UUCAUGGUAUUUUGUUAUAGCAGC	24	25433
CFTR-Intron10-6554	−	UGGGAGGAUCACCUGAGC	18	25434
CFTR-Intron10-6555	−	GUGGGAGGAUCACCUGAGC	19	25435
CFTR-Intron10-6556	−	GGUGGGAGGAUCACCUGAGC	20	25436
CFTR-Intron10-6557	−	AGGUGGGAGGAUCACCUGAGC	21	25437
CFTR-Intron10-6558	−	GAGGUGGGAGGAUCACCUGAGC	22	25438
CFTR-Intron10-6559	−	UGAGGUGGGAGGAUCACCUGAGC	23	25439
CFTR-Intron10-6560	−	CUGAGGUGGGAGGAUCACCUGAGC	24	25440
CFTR-Intron10-6561	−	CUCACCCUCCCAAGUAGC	18	25441
CFTR-Intron10-6562	−	CCUCACCCUCCCAAGUAGC	19	25442
CFTR-Intron10-672	−	GCCUCACCCUCCCAAGUAGC	20	19558
CFTR-Intron10-6563	−	UGCCUCACCCUCCCAAGUAGC	21	25443
CFTR-Intron10-6564	−	CUGCCUCACCCUCCCAAGUAGC	22	25444
CFTR-Intron10-6565	−	CCUGCCUCACCCUCCCAAGUAGC	23	25445
CFTR-Intron10-6566	−	UCCUGCCUCACCCUCCCAAGUAGC	24	25446
CFTR-Intron10-6567	−	CUCAGCCUCCCAAGUAGC	18	25447
CFTR-Intron10-6568	−	CCUCAGCCUCCCAAGUAGC	19	25448
CFTR-Intron10-673	−	GCCUCAGCCUCCCAAGUAGC	20	19559
CFTR-Intron10-6569	−	UGCCUCAGCCUCCCAAGUAGC	21	25449
CFTR-Intron10-6570	−	CUGCCUCAGCCUCCCAAGUAGC	22	25450
CFTR-Intron10-6571	−	CCUGCCUCAGCCUCCCAAGUAGC	23	25451
CFTR-Intron10-6572	−	UCCUGCCUCAGCCUCCCAAGUAGC	24	25452
CFTR-Intron10-6573	−	CCCUUAAACAAUACAGGC	18	25453
CFTR-Intron10-6574	−	ACCCUUAAACAAUACAGGC	19	25454
CFTR-Intron10-6575	−	GACCCUUAAACAAUACAGGC	20	25455
CFTR-Intron10-6576	−	UGACCCUUAAACAAUACAGGC	21	25456
CFTR-Intron10-6577	−	UUGACCCUUAAACAAUACAGGC	22	25457
CFTR-Intron10-6578	−	AUUGACCCUUAAACAAUACAGGC	23	25458
CFTR-Intron10-6579	−	AAUUGACCCUUAAACAAUACAGGC	24	25459
CFTR-Intron10-6580	−	AGUGCUGGGAUUACAGGC	18	25460
CFTR-Intron10-6581	−	AAGUGCUGGGAUUACAGGC	19	25461
CFTR-Intron10-6582	−	AAAGUGCUGGGAUUACAGGC	20	25462
CFTR-Intron10-6583	−	CAAAGUGCUGGGAUUACAGGC	21	25463
CFTR-Intron10-6584	−	CCAAAGUGCUGGGAUUACAGGC	22	25464
CFTR-Intron10-6585	−	CCCAAAGUGCUGGGAUUACAGGC	23	25465
CFTR-Intron10-6586	−	UCCCAAAGUGCUGGGAUUACAGGC	24	25466
CFTR-Intron10-6587	−	AGUGUUGGGAUUACAGGC	18	25467
CFTR-Intron10-6588	−	AAGUGUUGGGAUUACAGGC	19	25468
CFTR-Intron10-6589	−	AAAGUGUUGGGAUUACAGGC	20	25469
CFTR-Intron10-6590	−	CAAAGUGUUGGGAUUACAGGC	21	25470
CFTR-Intron10-6591	−	CCAAAGUGUUGGGAUUACAGGC	22	25471
CFTR-Intron10-6592	−	CCCAAAGUGUUGGGAUUACAGGC	23	25472
CFTR-Intron10-6593	−	UCCCAAAGUGUUGGGAUUACAGGC	24	25473
CFTR-Intron10-6594	−	GUCUUACUGUCACCAGGC	18	25474
CFTR-Intron10-6595	−	AGUCUUACUGUCACCAGGC	19	25475
CFTR-Intron10-677	−	GAGUCUUACUGUCACCAGGC	20	19563
CFTR-Intron10-6596	−	AGAGUCUUACUGUCACCAGGC	21	25476
CFTR-Intron10-6597	−	CAGAGUCUUACUGUCACCAGGC	22	25477
CFTR-Intron10-6598	−	ACAGAGUCUUACUGUCACCAGGC	23	25478
CFTR-Intron10-6599	−	GACAGAGUCUUACUGUCACCAGGC	24	25479
CFTR-Intron10-6600	−	UACUCGGGAGGCUGAGGC	18	25480
CFTR-Intron10-6601	−	CUACUCGGGAGGCUGAGGC	19	25481
CFTR-Intron10-680	−	GCUACUCGGGAGGCUGAGGC	20	19566
CFTR-Intron10-6602	−	AGCUACUCGGGAGGCUGAGGC	21	25482
CFTR-Intron10-6603	−	CAGCUACUCGGGAGGCUGAGGC	22	25483
CFTR-Intron10-6604	−	CCAGCUACUCGGGAGGCUGAGGC	23	25484
CFTR-Intron10-6605	−	CCCAGCUACUCGGGAGGCUGAGGC	24	25485
CFTR-Intron10-6606	−	AGUGCUGGGUUUAUAGGC	18	25486
CFTR-Intron10-6607	−	AAGUGCUGGGUUUAUAGGC	19	25487
CFTR-Intron10-6608	−	AAAGUGCUGGGUUUAUAGGC	20	25488
CFTR-Intron10-6609	−	CAAAGUGCUGGGUUUAUAGGC	21	25489
CFTR-Intron10-6610	−	CCAAAGUGCUGGGUUUAUAGGC	22	25490
CFTR-Intron10-6611	−	CCCAAAGUGCUGGGUUUAUAGGC	23	25491
CFTR-Intron10-6612	−	UCCCAAAGUGCUGGGUUUAUAGGC	24	25492
CFTR-Intron10-6613	−	AAGUGCCACUAGUGAUGC	18	25493
CFTR-Intron10-6614	−	AAAGUGCCACUAGUGAUGC	19	25494
CFTR-Intron10-6615	−	CAAAGUGCCACUAGUGAUGC	20	25495
CFTR-Intron10-6616	−	ACAAAGUGCCACUAGUGAUGC	21	25496
CFTR-Intron10-6617	−	UACAAAGUGCCACUAGUGAUGC	22	25497
CFTR-Intron10-6618	−	AUACAAAGUGCCACUAGUGAUGC	23	25498
CFTR-Intron10-6619	−	CAUACAAAGUGCCACUAGUGAUGC	24	25499
CFTR-Intron10-6620	−	UCAAAUUAUUUCUACUGC	18	25500
CFTR-Intron10-6621	−	UUCAAAUUAUUUCUACUGC	19	25501
CFTR-Intron10-6622	−	GUUCAAAUUAUUUCUACUGC	20	25502
CFTR-Intron10-6623	−	UGUUCAAAUUAUUUCUACUGC	21	25503
CFTR-Intron10-6624	−	UUGUUCAAAUUAUUUCUACUGC	22	25504
CFTR-Intron10-6625	−	GUUGUUCAAAUUAUUUCUACUGC	23	25505
CFTR-Intron10-6626	−	UGUUGUUCAAAUUAUUUCUACUGC	24	25506
CFTR-Intron10-6627	−	AUUUGAACAAAGACUUGC	18	25507
CFTR-Intron10-6628	−	CAUUUGAACAAAGACUUGC	19	25508
CFTR-Intron10-1236	−	ACAUUUGAACAAAGACUUGC	20	20121
CFTR-Intron10-6629	−	AACAUUUGAACAAAGACUUGC	21	25509
CFTR-Intron10-6630	−	UAACAUUUGAACAAAGACUUGC	22	25510
CFTR-Intron10-6631	−	GUAACAUUUGAACAAAGACUUGC	23	25511
CFTR-Intron10-6632	−	GGUAACAUUUGAACAAAGACUUGC	24	25512
CFTR-Intron10-6633	−	GAGUUUACUAACUCAAUC	18	25513
CFTR-Intron10-6634	−	GGAGUUUACUAACUCAAUC	19	25514
CFTR-Intron10-6635	−	CGGAGUUUACUAACUCAAUC	20	25515
CFTR-Intron10-6636	−	ACGGAGUUUACUAACUCAAUC	21	25516
CFTR-Intron10-6637	−	AACGGAGUUUACUAACUCAAUC	22	25517
CFTR-Intron10-6638	−	AAACGGAGUUUACUAACUCAAUC	23	25518
CFTR-Intron10-6639	−	GAAACGGAGUUUACUAACUCAAUC	24	25519
CFTR-Intron10-6640	−	UCUGCUGGCACCUUGAUC	18	25520
CFTR-Intron10-6641	−	AUCUGCUGGCACCUUGAUC	19	25521
CFTR-Intron10-6642	−	AAUCUGCUGGCACCUUGAUC	20	25522
CFTR-Intron10-6643	−	AAAUCUGCUGGCACCUUGAUC	21	25523
CFTR-Intron10-6644	−	CAAAUCUGCUGGCACCUUGAUC	22	25524
CFTR-Intron10-6645	−	CCAAAUCUGCUGGCACCUUGAUC	23	25525
CFTR-Intron10-6646	−	CCCAAAUCUGCUGGCACCUUGAUC	24	25526
CFTR-Intron10-6647	−	CUUGCUUUUCCCACUAUC	18	25527
CFTR-Intron10-6648	−	UCUUGCUUUUCCCACUAUC	19	25528
CFTR-Intron10-6649	−	UUCUUGCUUUUCCCACUAUC	20	25529
CFTR-Intron10-6650	−	CUUCUUGCUUUUCCCACUAUC	21	25530
CFTR-Intron10-6651	−	GCUUCUUGCUUUUCCCACUAUC	22	25531
CFTR-Intron10-6652	−	UGCUUCUUGCUUUUCCCACUAUC	23	25532
CFTR-Intron10-6653	−	UUGCUUCUUGCUUUUCCCACUAUC	24	25533
CFTR-Intron10-6654	−	GUGAAUGAAUGUGGUAUC	18	25534
CFTR-Intron10-6655	−	AGUGAAUGAAUGUGGUAUC	19	25535
CFTR-Intron10-6656	−	UAGUGAAUGAAUGUGGUAUC	20	25536
CFTR-Intron10-6657	−	CUAGUGAAUGAAUGUGGUAUC	21	25537
CFTR-Intron10-6658	−	GCUAGUGAAUGAAUGUGGUAUC	22	25538
CFTR-Intron10-6659	−	AGCUAGUGAAUGAAUGUGGUAUC	23	25539
CFTR-Intron10-6660	−	AAGCUAGUGAAUGAAUGUGGUAUC	24	25540
CFTR-Intron10-6661	−	CACUGUAACCUUGAACUC	18	25541
CFTR-Intron10-6662	−	UCACUGUAACCUUGAACUC	19	25542
CFTR-Intron10-6663	−	CUCACUGUAACCUUGAACUC	20	25543
CFTR-Intron10-6664	−	GCUCACUGUAACCUUGAACUC	21	25544
CFTR-Intron10-6665	−	AGCUCACUGUAACCUUGAACUC	22	25545
CFTR-Intron10-6666	−	UAGCUCACUGUAACCUUGAACUC	23	25546
CFTR-Intron10-6667	−	AUAGCUCACUGUAACCUUGAACUC	24	25547
CFTR-Intron10-6668	−	AGAAAUUAAGAAAGACUC	18	25548
CFTR-Intron10-6669	−	UAGAAAUUAAGAAAGACUC	19	25549
CFTR-Intron10-6670	−	AUAGAAAUUAAGAAAGACUC	20	25550
CFTR-Intron10-6671	−	AAUAGAAAUUAAGAAAGACUC	21	25551
CFTR-Intron10-6672	−	AAAUAGAAAUUAAGAAAGACUC	22	25552
CFTR-Intron10-6673	−	AAAAUAGAAAUUAAGAAAGACUC	23	25553
CFTR-Intron10-6674	−	GAAAAUAGAAAUUAAGAAAGACUC	24	25554
CFTR-Intron10-6675	−	AUUAGGGAAUGCAGACUC	18	25555
CFTR-Intron10-6676	−	GAUUAGGGAAUGCAGACUC	19	25556
CFTR-Intron10-92	−	GGAUUAGGGAAUGCAGACUC	20	18978
CFTR-Intron10-6677	−	GGGAUUAGGGAAUGCAGACUC	21	25557
CFTR-Intron10-6678	−	AGGGAUUAGGGAAUGCAGACUC	22	25558
CFTR-Intron10-6679	−	GAGGGAUUAGGGAAUGCAGACUC	23	25559
CFTR-Intron10-6680	−	UGAGGGAUUAGGGAAUGCAGACUC	24	25560
CFTR-Intron10-6681	−	UAUUCUUUUGAUAUACUC	18	25561
CFTR-Intron10-6682	−	UUAUUCUUUUGAUAUACUC	19	25562
CFTR-Intron10-6683	−	CUUAUUCUUUUGAUAUACUC	20	25563
CFTR-Intron10-6684	−	CCUUAUUCUUUUGAUAUACUC	21	25564
CFTR-Intron10-6685	−	GCCUUAUUCUUUUGAUAUACUC	22	25565
CFTR-Intron10-6686	−	UGCCUUAUUCUUUUGAUAUACUC	23	25566
CFTR-Intron10-6687	−	AUGCCUUAUUCUUUUGAUAUACUC	24	25567
CFTR-Intron10-6688	−	CCGUAGUCCCAGCUACUC	18	25568
CFTR-Intron10-6689	−	CCCGUAGUCCCAGCUACUC	19	25569
CFTR-Intron10-687	−	GCCCGUAGUCCCAGCUACUC	20	19573
CFTR-Intron10-6690	−	UGCCCGUAGUCCCAGCUACUC	21	25570
CFTR-Intron10-6691	−	GUGCCCGUAGUCCCAGCUACUC	22	25571
CFTR-Intron10-6692	−	GGUGCCCGUAGUCCCAGCUACUC	23	25572
CFTR-Intron10-6693	−	GGGUGCCCGUAGUCCCAGCUACUC	24	25573
CFTR-Intron10-6694	−	CUUGGACUUCCCAGCCUC	18	25574
CFTR-Intron10-6695	−	UCUUGGACUUCCCAGCCUC	19	25575
CFTR-Intron10-6696	−	AUCUUGGACUUCCCAGCCUC	20	25576
CFTR-Intron10-6697	−	GAUCUUGGACUUCCCAGCCUC	21	25577
CFTR-Intron10-6698	−	UGAUCUUGGACUUCCCAGCCUC	22	25578
CFTR-Intron10-6699	−	UUGAUCUUGGACUUCCCAGCCUC	23	25579
CFTR-Intron10-6700	−	CUUGAUCUUGGACUUCCCAGCCUC	24	25580
CFTR-Intron10-6701	−	CACUGCAACCUCUGCCUC	18	25581
CFTR-Intron10-6702	−	UCACUGCAACCUCUGCCUC	19	25582
CFTR-Intron10-6703	−	CUCACUGCAACCUCUGCCUC	20	25583
CFTR-Intron10-6704	−	GCUCACUGCAACCUCUGCCUC	21	25584
CFTR-Intron10-6705	−	GGCUCACUGCAACCUCUGCCUC	22	25585
CFTR-Intron10-6706	−	CGGCUCACUGCAACCUCUGCCUC	23	25586
CFTR-Intron10-6707	−	UCGGCUCACUGCAACCUCUGCCUC	24	25587
CFTR-Intron10-6708	−	AAAAAGUUUAGUGGUCUC	18	25588
CFTR-Intron10-6709	−	GAAAAAGUUUAGUGGUCUC	19	25589
CFTR-Intron10-6710	−	AGAAAAAGUUUAGUGGUCUC	20	25590
CFTR-Intron10-6711	−	GAGAAAAAGUUUAGUGGUCUC	21	25591
CFTR-Intron10-6712	−	UGAGAAAAAGUUUAGUGGUCUC	22	25592
CFTR-Intron10-6713	−	GUGAGAAAAAGUUUAGUGGUCUC	23	25593
CFTR-Intron10-6714	−	UGUGAGAAAAAGUUUAGUGGUCUC	24	25594
CFTR-Intron10-6715	−	AGGUGAAUUGCUUGAGUC	18	25595
CFTR-Intron10-6716	−	CAGGUGAAUUGCUUGAGUC	19	25596
CFTR-Intron10-6717	−	GCAGGUGAAUUGCUUGAGUC	20	25597
CFTR-Intron10-6718	−	GGCAGGUGAAUUGCUUGAGUC	21	25598
CFTR-Intron10-6719	−	AGGCAGGUGAAUUGCUUGAGUC	22	25599
CFTR-Intron10-6720	−	GAGGCAGGUGAAUUGCUUGAGUC	23	25600
CFTR-Intron10-6721	−	AGAGGCAGGUGAAUUGCUUGAGUC	24	25601
CFTR-Intron10-6722	−	UAUGUAUAUAUGUGUGUC	18	25602
CFTR-Intron10-6723	−	GUAUGUAUAUAUGUGUGUC	19	25603
CFTR-Intron10-1242	−	UGUAUGUAUAUAUGUGUGUC	20	20127
CFTR-Intron10-6724	−	AUGUAUGUAUAUAUGUGUGUC	21	25604
CFTR-Intron10-6725	−	UAUGUAUGUAUAUAUGUGUGUC	22	25605
CFTR-Intron10-6726	−	AUAUGUAUGUAUAUAUGUGUGUC	23	25606
CFTR-Intron10-6727	−	CAUAUGUAUGUAUAUAUGUGUGUC	24	25607
CFTR-Intron10-6728	−	GACCAAAACUUUAUUGUC	18	25608
CFTR-Intron10-6729	−	GGACCAAAACUUUAUUGUC	19	25609
CFTR-Intron10-440	−	AGGACCAAAACUUUAUUGUC	20	19326
CFTR-Intron10-6730	−	AAGGACCAAAACUUUAUUGUC	21	25610
CFTR-Intron10-6731	−	AAAGGACCAAAACUUUAUUGUC	22	25611
CFTR-Intron10-6732	−	AAAAGGACCAAAACUUUAUUGUC	23	25612
CFTR-Intron10-6733	−	CAAAAGGACCAAAACUUUAUUGUC	24	25613
CFTR-Intron10-6734	−	CAUUAUAACACUGCUUUC	18	25614
CFTR-Intron10-6735	−	UCAUUAUAACACUGCUUUC	19	25615
CFTR-Intron10-1247	−	UUCAUUAUAACACUGCUUUC	20	20132
CFTR-Intron10-6736	−	CUUCAUUAUAACACUGCUUUC	21	25616
CFTR-Intron10-6737	−	UCUUCAUUAUAACACUGCUUUC	22	25617
CFTR-Intron10-6738	−	CUCUUCAUUAUAACACUGCUUUC	23	25618
CFTR-Intron10-6739	−	GCUCUUCAUUAUAACACUGCUUUC	24	25619
CFTR-Intron10-6740	−	AUGUACAAGUCUAGUUUC	18	25620
CFTR-Intron10-6741	−	GAUGUACAAGUCUAGUUUC	19	25621
CFTR-Intron10-6742	−	GGAUGUACAAGUCUAGUUUC	20	25622
CFTR-Intron10-6743	−	UGGAUGUACAAGUCUAGUUUC	21	25623
CFTR-Intron10-6744	−	UUGGAUGUACAAGUCUAGUUUC	22	25624
CFTR-Intron10-6745	−	GUUGGAUGUACAAGUCUAGUUUC	23	25625
CFTR-Intron10-6746	−	AGUUGGAUGUACAAGUCUAGUUUC	24	25626
CFTR-Intron10-6747	−	GGAAAAUUUAACAUUUUC	18	25627
CFTR-Intron10-6748	−	GGGAAAAUUUAACAUUUUC	19	25628
CFTR-Intron10-6749	−	AGGGAAAAUUUAACAUUUUC	20	25629
CFTR-Intron10-6750	−	AAGGGAAAAUUUAACAUUUUC	21	25630
CFTR-Intron10-6751	−	UAAGGGAAAAUUUAACAUUUUC	22	25631
CFTR-Intron10-6752	−	CUAAGGGAAAAUUUAACAUUUUC	23	25632
CFTR-Intron10-6753	−	CCUAAGGGAAAAUUUAACAUUUUC	24	25633
CFTR-Intron10-6754	−	UUCCAUUACAUUGUUUUC	18	25634
CFTR-Intron10-6755	−	UUUCCAUUACAUUGUUUUC	19	25635
CFTR-Intron10-6756	−	GUUUCCAUUACAUUGUUUUC	20	25636
CFTR-Intron10-6757	−	UGUUUCCAUUACAUUGUUUUC	21	25637
CFTR-Intron10-6758	−	GUGUUUCCAUUACAUUGUUUUC	22	25638
CFTR-Intron10-6759	−	AGUGUUUCCAUUACAUUGUUUUC	23	25639
CFTR-Intron10-6760	−	UAGUGUUUCCAUUACAUUGUUUUC	24	25640
CFTR-Intron10-6761	−	AUUAAAAUAUAUAAAAAG	18	25641
CFTR-Intron10-6762	−	AAUUAAAAUAUAUAAAAAG	19	25642
CFTR-Intron10-6763	−	AAAUUAAAAUAUAUAAAAAG	20	25643
CFTR-Intron10-6764	−	AAAAUUAAAAUAUAUAAAAAG	21	25644
CFTR-Intron10-6765	−	GAAAAUUAAAAUAUAUAAAAAG	22	25645
CFTR-Intron10-6766	−	UGAAAAUUAAAAUAUAUAAAAAG	23	25646
CFTR-Intron10-6767	−	AUGAAAAUUAAAAUAUAUAAAAAG	24	25647
CFTR-Intron10-6768	−	AGAGAGGAAGGAAGAAAG	18	25648
CFTR-Intron10-6769	−	AAGAGAGGAAGGAAGAAAG	19	25649
CFTR-Intron10-6770	−	AAAGAGAGGAAGGAAGAAAG	20	25650
CFTR-Intron10-6771	−	GAAAGAGAGGAAGGAAGAAAG	21	25651
CFTR-Intron10-6772	−	AGAAAGAGAGGAAGGAAGAAAG	22	25652
CFTR-Intron10-6773	−	AAGAAAGAGAGGAAGGAAGAAAG	23	25653
CFTR-Intron10-6774	−	AAAGAAAGAGAGGAAGGAAGAAAG	24	25654
CFTR-Intron10-6775	−	GGAAGGAAGGAAGGAAAG	18	25655
CFTR-Intron10-6776	−	AGGAAGGAAGGAAGGAAAG	19	25656
CFTR-Intron10-6777	−	GAGGAAGGAAGGAAGGAAAG	20	25657
CFTR-Intron10-6778	−	GGAGGAAGGAAGGAAGGAAAG	21	25658
CFTR-Intron10-6779	−	AGGAGGAAGGAAGGAAGGAAAG	22	25659
CFTR-Intron10-6780	−	UAGGAGGAAGGAAGGAAGGAAAG	23	25660
CFTR-Intron10-6781	−	GUAGGAGGAAGGAAGGAAGGAAAG	24	25661
CFTR-Intron10-6782	−	AACCCAACUGAUGUCAAG	18	25662
CFTR-Intron10-6783	−	GAACCCAACUGAUGUCAAG	19	25663
CFTR-Intron10-6784	−	GGAACCCAACUGAUGUCAAG	20	25664
CFTR-Intron10-6785	−	CGGAACCCAACUGAUGUCAAG	21	25665
CFTR-Intron10-6786	−	CCGGAACCCAACUGAUGUCAAG	22	25666
CFTR-Intron10-6787	−	CCCGGAACCCAACUGAUGUCAAG	23	25667
CFTR-Intron10-6788	−	UCCCGGAACCCAACUGAUGUCAAG	24	25668
CFTR-Intron10-6789	−	UCACCUGAGCCUGAGAAG	18	25669
CFTR-Intron10-6790	−	AUCACCUGAGCCUGAGAAG	19	25670
CFTR-Intron10-692	−	GAUCACCUGAGCCUGAGAAG	20	19578
CFTR-Intron10-6791	−	GGAUCACCUGAGCCUGAGAAG	21	25671
CFTR-Intron10-6792	−	AGGAUCACCUGAGCCUGAGAAG	22	25672
CFTR-Intron10-6793	−	GAGGAUCACCUGAGCCUGAGAAG	23	25673
CFTR-Intron10-6794	−	GGAGGAUCACCUGAGCCUGAGAAG	24	25674
CFTR-Intron10-6795	−	AAUGAGGAAGAAAGGAAG	18	25675
CFTR-Intron10-6796	−	AAAUGAGGAAGAAAGGAAG	19	25676
CFTR-Intron10-6797	−	GAAAUGAGGAAGAAAGGAAG	20	25677
CFTR-Intron10-6798	−	GGAAAUGAGGAAGAAAGGAAG	21	25678
CFTR-Intron10-6799	−	AGGAAAUGAGGAAGAAAGGAAG	22	25679
CFTR-Intron10-6800	−	AAGGAAAUGAGGAAGAAAGGAAG	23	25680
CFTR-Intron10-6801	−	GAAGGAAAUGAGGAAGAAAGGAAG	24	25681
CFTR-Intron10-6802	−	AGUCUAGUUUCAAGGAAG	18	25682
CFTR-Intron10-6803	−	AAGUCUAGUUUCAAGGAAG	19	25683
CFTR-Intron10-449	−	CAAGUCUAGUUUCAAGGAAG	20	19335
CFTR-Intron10-6804	−	ACAAGUCUAGUUUCAAGGAAG	21	25684
CFTR-Intron10-6805	−	UACAAGUCUAGUUUCAAGGAAG	22	25685
CFTR-Intron10-6806	−	GUACAAGUCUAGUUUCAAGGAAG	23	25686
CFTR-Intron10-6807	−	UGUACAAGUCUAGUUUCAAGGAAG	24	25687
CFTR-Intron10-6808	−	GGGGCUGGUAGUGUGAAG	18	25688
CFTR-Intron10-6809	−	GGGGGCUGGUAGUGUGAAG	19	25689
CFTR-Intron10-6810	−	AGGGGGCUGGUAGUGUGAAG	20	25690
CFTR-Intron10-6811	−	GAGGGGGCUGGUAGUGUGAAG	21	25691
CFTR-Intron10-6812	−	AGAGGGGGCUGGUAGUGUGAAG	22	25692
CFTR-Intron10-6813	−	AAGAGGGGGCUGGUAGUGUGAAG	23	25693
CFTR-Intron10-6814	−	GAAGAGGGGGCUGGUAGUGUGAAG	24	25694
CFTR-Intron10-6815	−	GAAAUUAGAAAGAAUAAG	18	25695
CFTR-Intron10-6816	−	UGAAAUUAGAAAGAAUAAG	19	25696
CFTR-Intron10-1254	−	AUGAAAUUAGAAAGAAUAAG	20	20139
CFTR-Intron10-6817	−	AAUGAAAUUAGAAAGAAUAAG	21	25697
CFTR-Intron10-6818	−	GAAUGAAAUUAGAAAGAAUAAG	22	25698
CFTR-Intron10-6819	−	AGAAUGAAAUUAGAAAGAAUAAG	23	25699
CFTR-Intron10-6820	−	CAGAAUGAAAUUAGAAAGAAUAAG	24	25700
CFTR-Intron10-6821	−	AUAGGAUUAAUGGAUAAG	18	25701
CFTR-Intron10-6822	−	AAUAGGAUUAAUGGAUAAG	19	25702
CFTR-Intron10-6823	−	CAAUAGGAUUAAUGGAUAAG	20	25703
CFTR-Intron10-6824	−	CCAAUAGGAUUAAUGGAUAAG	21	25704
CFTR-Intron10-6825	−	UCCAAUAGGAUUAAUGGAUAAG	22	25705
CFTR-Intron10-6826	−	AUCCAAUAGGAUUAAUGGAUAAG	23	25706
CFTR-Intron10-6827	−	GAUCCAAUAGGAUUAAUGGAUAAG	24	25707
CFTR-Intron10-6828	−	GGAAAGAGGGUUGAUAAG	18	25708
CFTR-Intron10-6829	−	AGGAAAGAGGGUUGAUAAG	19	25709
CFTR-Intron10-6830	−	AAGGAAAGAGGGUUGAUAAG	20	25710
CFTR-Intron10-6831	−	AAAGGAAAGAGGGUUGAUAAG	21	25711
CFTR-Intron10-6832	−	UAAAGGAAAGAGGGUUGAUAAG	22	25712
CFTR-Intron10-6833	−	CUAAAGGAAAGAGGGUUGAUAAG	23	25713
CFTR-Intron10-6834	−	UCUAAAGGAAAGAGGGUUGAUAAG	24	25714
CFTR-Intron10-6835	−	UAUUUAUCAAUAUCUAAG	18	25715
CFTR-Intron10-6836	−	UUAUUUAUCAAUAUCUAAG	19	25716
CFTR-Intron10-6837	−	AUUAUUUAUCAAUAUCUAAG	20	25717
CFTR-Intron10-6838	−	AAUUAUUUAUCAAUAUCUAAG	21	25718
CFTR-Intron10-6839	−	CAAUUAUUUAUCAAUAUCUAAG	22	25719
CFTR-Intron10-6840	−	GCAAUUAUUUAUCAAUAUCUAAG	23	25720
CFTR-Intron10-6841	−	GGCAAUUAUUUAUCAAUAUCUAAG	24	25721
CFTR-Intron10-6842	−	GCUCAUUCAUCAAGUAAG	18	25722
CFTR-Intron10-6843	−	UGCUCAUUCAUCAAGUAAG	19	25723
CFTR-Intron10-6844	−	AUGCUCAUUCAUCAAGUAAG	20	25724
CFTR-Intron10-6845	−	AAUGCUCAUUCAUCAAGUAAG	21	25725
CFTR-Intron10-6846	−	AAAUGCUCAUUCAUCAAGUAAG	22	25726
CFTR-Intron10-6847	−	CAAAUGCUCAUUCAUCAAGUAAG	23	25727
CFTR-Intron10-6848	−	UCAAAUGCUCAUUCAUCAAGUAAG	24	25728
CFTR-Intron10-6849	−	AAGAAGGAAGGAAGUAAG	18	25729
CFTR-Intron10-6850	−	AAAGAAGGAAGGAAGUAAG	19	25730
CFTR-Intron10-693	−	GAAAGAAGGAAGGAAGUAAG	20	19579
CFTR-Intron10-6851	−	GGAAAGAAGGAAGGAAGUAAG	21	25731
CFTR-Intron10-6852	−	AGGAAAGAAGGAAGGAAGUAAG	22	25732
CFTR-Intron10-6853	−	AAGGAAAGAAGGAAGGAAGUAAG	23	25733
CFTR-Intron10-6854	−	GAAGGAAAGAAGGAAGGAAGUAAG	24	25734
CFTR-Intron10-6855	−	UGCCAUGUGAGAACACAG	18	25735
CFTR-Intron10-6856	−	CUGCCAUGUGAGAACACAG	19	25736
CFTR-Intron10-6857	−	UCUGCCAUGUGAGAACACAG	20	25737
CFTR-Intron10-6858	−	UUCUGCCAUGUGAGAACACAG	21	25738
CFTR-Intron10-6859	−	UUUCUGCCAUGUGAGAACACAG	22	25739
CFTR-Intron10-6860	−	CUUUCUGCCAUGUGAGAACACAG	23	25740
CFTR-Intron10-6861	−	CCUUUCUGCCAUGUGAGAACACAG	24	25741
CFTR-Intron10-6862	−	AUUUCAACUUAUACACAG	18	25742
CFTR-Intron10-6863	−	CAUUUCAACUUAUACACAG	19	25743
CFTR-Intron10-6864	−	UCAUUUCAACUUAUACACAG	20	25744
CFTR-Intron10-6865	−	AUCAUUUCAACUUAUACACAG	21	25745
CFTR-Intron10-6866	−	UAUCAUUUCAACUUAUACACAG	22	25746
CFTR-Intron10-6867	−	AUAUCAUUUCAACUUAUACACAG	23	25747
CFTR-Intron10-6868	−	AAUAUCAUUUCAACUUAUACACAG	24	25748
CFTR-Intron10-6869	−	CUGUUGUCUGCAUCACAG	18	25749
CFTR-Intron10-6870	−	UCUGUUGUCUGCAUCACAG	19	25750
CFTR-Intron10-6871	−	UUCUGUUGUCUGCAUCACAG	20	25751
CFTR-Intron10-6872	−	CUUCUGUUGUCUGCAUCACAG	21	25752
CFTR-Intron10-6873	−	CCUUCUGUUGUCUGCAUCACAG	22	25753
CFTR-Intron10-6874	−	UCCUUCUGUUGUCUGCAUCACAG	23	25754
CFTR-Intron10-6875	−	GUCCUUCUGUUGUCUGCAUCACAG	24	25755
CFTR-Intron10-6876	−	GAGUCUUCCAAGUAGCAG	18	25756
CFTR-Intron10-6877	−	AGAGUCUUCCAAGUAGCAG	19	25757
CFTR-Intron10-6878	−	AAGAGUCUUCCAAGUAGCAG	20	25758
CFTR-Intron10-6879	−	GAAGAGUCUUCCAAGUAGCAG	21	25759
CFTR-Intron10-6880	−	GGAAGAGUCUUCCAAGUAGCAG	22	25760
CFTR-Intron10-6881	−	GGGAAGAGUCUUCCAAGUAGCAG	23	25761
CFTR-Intron10-6882	−	UGGGAAGAGUCUUCCAAGUAGCAG	24	25762
CFTR-Intron10-6883	−	CCAAAACUUUAUUGUCAG	18	25763
CFTR-Intron10-6884	−	ACCAAAACUUUAUUGUCAG	19	25764
CFTR-Intron10-6885	−	GACCAAAACUUUAUUGUCAG	20	25765
CFTR-Intron10-6886	−	GGACCAAAACUUUAUUGUCAG	21	25766
CFTR-Intron10-6887	−	AGGACCAAAACUUUAUUGUCAG	22	25767
CFTR-Intron10-6888	−	AAGGACCAAAACUUUAUUGUCAG	23	25768
CFTR-Intron10-6889	−	AAAGGACCAAAACUUUAUUGUCAG	24	25769
CFTR-Intron10-6890	−	CAAGUGCAAAGCUUUCAG	18	25770
CFTR-Intron10-6891	−	GCAAGUGCAAAGCUUUCAG	19	25771
CFTR-Intron10-6892	−	AGCAAGUGCAAAGCUUUCAG	20	25772
CFTR-Intron10-6893	−	AAGCAAGUGCAAAGCUUUCAG	21	25773
CFTR-Intron10-6894	−	GAAGCAAGUGCAAAGCUUUCAG	22	25774
CFTR-Intron10-6895	−	UGAAGCAAGUGCAAAGCUUUCAG	23	25775
CFTR-Intron10-6896	−	GUGAAGCAAGUGCAAAGCUUUCAG	24	25776
CFTR-Intron10-6897	−	AAACAGAAAAAGAAAGAG	18	25777
CFTR-Intron10-6898	−	CAAACAGAAAAAGAAAGAG	19	25778
CFTR-Intron10-1269	−	ACAAACAGAAAAAGAAAGAG	20	20154
CFTR-Intron10-6899	−	GACAAACAGAAAAAGAAAGAG	21	25779
CFTR-Intron10-6900	−	AGACAAACAGAAAAAGAAAGAG	22	25780
CFTR-Intron10-6901	−	AAGACAAACAGAAAAAGAAAGAG	23	25781
CFTR-Intron10-6902	−	UAAGACAAACAGAAAAAGAAAGAG	24	25782
CFTR-Intron10-6903	−	AUUUUUGUAUUUUUAGUAGAG	21	25783
CFTR-Intron10-6904	−	AAUUUUUGUAUUUUUAGUAGAG	22	25784
CFTR-Intron10-6905	−	UAAUUUUUGUAUUUUUAGUAGAG	23	25785
CFTR-Intron10-6906	−	CUAAUUUUUGUAUUUUUAGUAGAG	24	25786
CFTR-Intron10-6907	−	GAAAGAAUCAAAUUAGAG	18	25787
CFTR-Intron10-6908	−	UGAAAGAAUCAAAUUAGAG	19	25788
CFTR-Intron10-6909	−	AUGAAAGAAUCAAAUUAGAG	20	25789
CFTR-Intron10-6910	−	CAUGAAAGAAUCAAAUUAGAG	21	25790
CFTR-Intron10-6911	−	ACAUGAAAGAAUCAAAUUAGAG	22	25791
CFTR-Intron10-6912	−	GACAUGAAAGAAUCAAAUUAGAG	23	25792
CFTR-Intron10-6913	−	AGACAUGAAAGAAUCAAAUUAGAG	24	25793
CFTR-Intron10-6914	−	AACAAAGACUUGCAGGAG	18	25794
CFTR-Intron10-6915	−	GAACAAAGACUUGCAGGAG	19	25795
CFTR-Intron10-6916	−	UGAACAAAGACUUGCAGGAG	20	25796
CFTR-Intron10-6917	−	UUGAACAAAGACUUGCAGGAG	21	25797
CFTR-Intron10-6918	−	UUUGAACAAAGACUUGCAGGAG	22	25798
CFTR-Intron10-6919	−	AUUUGAACAAAGACUUGCAGGAG	23	25799
CFTR-Intron10-6920	−	CAUUUGAACAAAGACUUGCAGGAG	24	25800
CFTR-Intron10-6921	−	AUCAAUAUCUAAGAUGAG	18	25801
CFTR-Intron10-6922	−	UAUCAAUAUCUAAGAUGAG	19	25802
CFTR-Intron10-6923	−	UUAUCAAUAUCUAAGAUGAG	20	25803
CFTR-Intron10-6924	−	UUUAUCAAUAUCUAAGAUGAG	21	25804
CFTR-Intron10-6925	−	AUUUAUCAAUAUCUAAGAUGAG	22	25805
CFTR-Intron10-6926	−	UAUUUAUCAAUAUCUAAGAUGAG	23	25806
CFTR-Intron10-6927	−	UUAUUUAUCAAUAUCUAAGAUGAG	24	25807
CFTR-Intron10-6928	−	GCUACUUGGGAGGCUGAG	18	25808
CFTR-Intron10-6929	−	AGCUACUUGGGAGGCUGAG	19	25809
CFTR-Intron10-6930	−	CAGCUACUUGGGAGGCUGAG	20	25810
CFTR-Intron10-6931	−	CCAGCUACUUGGGAGGCUGAG	21	25811
CFTR-Intron10-6932	−	CCCAGCUACUUGGGAGGCUGAG	22	25812
CFTR-Intron10-6933	−	UCCCAGCUACUUGGGAGGCUGAG	23	25813
CFTR-Intron10-6934	−	GUCCCAGCUACUUGGGAGGCUGAG	24	25814
CFTR-Intron10-6935	−	GGCAGAACUUGCAGUGAG	18	25815
CFTR-Intron10-6936	−	AGGCAGAACUUGCAGUGAG	19	25816
CFTR-Intron10-6937	−	GAGGCAGAACUUGCAGUGAG	20	25817
CFTR-Intron10-6938	−	GGAGGCAGAACUUGCAGUGAG	21	25818
CFTR-Intron10-6939	−	AGGAGGCAGAACUUGCAGUGAG	22	25819
CFTR-Intron10-6940	−	CAGGAGGCAGAACUUGCAGUGAG	23	25820
CFTR-Intron10-6941	−	CCAGGAGGCAGAACUUGCAGUGAG	24	25821
CFTR-Intron10-6942	−	UUUUUUUUUUUUUUUGAG	18	25822
CFTR-Intron10-6943	−	UUUUUUUUUUUUUUUUGAG	19	25823
CFTR-Intron10-6944	−	UUUUUUUUUUUUUUUUUGAG	20	25824
CFTR-Intron10-6945	−	UUUUUUUUUUUUUUUUUUGAG	21	25825
CFTR-Intron10-6946	−	UUUUUUUUUUUUUUUUUUUGAG	22	25826
CFTR-Intron10-6947	−	UUUUUUUUUUUUUUUUUUUUGAG	23	25827
CFTR-Intron10-6948	−	UUUUUUUUUUUUUUUUUUUUUGAG	24	25828
CFTR-Intron10-6949	−	GCUUUUAAAACAAAAUAG	18	25829
CFTR-Intron10-6950	−	AGCUUUUAAAACAAAAUAG	19	25830
CFTR-Intron10-6951	−	CAGCUUUUAAAACAAAAUAG	20	25831
CFTR-Intron10-6952	−	ACAGCUUUUAAAACAAAAUAG	21	25832
CFTR-Intron10-6953	−	AACAGCUUUUAAAACAAAAUAG	22	25833
CFTR-Intron10-6954	−	AAACAGCUUUUAAAACAAAAUAG	23	25834
CFTR-Intron10-6955	−	GAAACAGCUUUUAAAACAAAAUAG	24	25835
CFTR-Intron10-6956	−	ACUUAAUGAAAGCAAUAG	18	25836
CFTR-Intron10-6957	−	GACUUAAUGAAAGCAAUAG	19	25837
CFTR-Intron10-6958	−	UGACUUAAUGAAAGCAAUAG	20	25838
CFTR-Intron10-6959	−	GUGACUUAAUGAAAGCAAUAG	21	25839
CFTR-Intron10-6960	−	CGUGACUUAAUGAAAGCAAUAG	22	25840
CFTR-Intron10-6961	−	UCGUGACUUAAUGAAAGCAAUAG	23	25841
CFTR-Intron10-6962	−	CUCGUGACUUAAUGAAAGCAAUAG	24	25842
CFTR-Intron10-6963	−	UAAAAAAUUAUACUAUAG	18	25843
CFTR-Intron10-6964	−	UUAAAAAAUUAUACUAUAG	19	25844
CFTR-Intron10-6965	−	AUUAAAAAAUUAUACUAUAG	20	25845
CFTR-Intron10-6966	−	UAUUAAAAAAUUAUACUAUAG	21	25846
CFTR-Intron10-6967	−	CUAUUAAAAAAUUAUACUAUAG	22	25847
CFTR-Intron10-6968	−	ACUAUUAAAAAAUUAUACUAUAG	23	25848
CFTR-Intron10-6969	−	CACUAUUAAAAAAUUAUACUAUAG	24	25849
CFTR-Intron10-6970	−	GUAGUGGAAGUAGUAUAG	18	25850
CFTR-Intron10-6971	−	AGUAGUGGAAGUAGUAUAG	19	25851
CFTR-Intron10-6972	−	UAGUAGUGGAAGUAGUAUAG	20	25852
CFTR-Intron10-6973	−	GUAGUAGUGGAAGUAGUAUAG	21	25853
CFTR-Intron10-6974	−	GGUAGUAGUGGAAGUAGUAUAG	22	25854
CFTR-Intron10-6975	−	AGGUAGUAGUGGAAGUAGUAUAG	23	25855
CFTR-Intron10-6976	−	CAGGUAGUAGUGGAAGUAGUAUAG	24	25856
CFTR-Intron10-6977	−	CCUCACCCUCCCAAGUAG	18	25857
CFTR-Intron10-6978	−	GCCUCACCCUCCCAAGUAG	19	25858
CFTR-Intron10-6979	−	UGCCUCACCCUCCCAAGUAG	20	25859
CFTR-Intron10-6980	−	CUGCCUCACCCUCCCAAGUAG	21	25860
CFTR-Intron10-6981	−	CCUGCCUCACCCUCCCAAGUAG	22	25861
CFTR-Intron10-6982	−	UCCUGCCUCACCCUCCCAAGUAG	23	25862
CFTR-Intron10-6983	−	CUCCUGCCUCACCCUCCCAAGUAG	24	25863
CFTR-Intron10-6984	−	GCCUCAGCCUCCCAAGUAG	19	25864
CFTR-Intron10-6985	−	UGCCUCAGCCUCCCAAGUAG	20	25865
CFTR-Intron10-6986	−	CUGCCUCAGCCUCCCAAGUAG	21	25866
CFTR-Intron10-6987	−	CCUGCCUCAGCCUCCCAAGUAG	22	25867
CFTR-Intron10-6988	−	UCCUGCCUCAGCCUCCCAAGUAG	23	25868
CFTR-Intron10-6989	−	CUCCUGCCUCAGCCUCCCAAGUAG	24	25869
CFTR-Intron10-6990	−	GAGGAAGAAAGGAAGUAG	18	25870
CFTR-Intron10-6991	−	UGAGGAAGAAAGGAAGUAG	19	25871
CFTR-Intron10-6992	−	AUGAGGAAGAAAGGAAGUAG	20	25872
CFTR-Intron10-6993	−	AAUGAGGAAGAAAGGAAGUAG	21	25873
CFTR-Intron10-6994	−	AAAUGAGGAAGAAAGGAAGUAG	22	25874
CFTR-Intron10-6995	−	GAAAUGAGGAAGAAAGGAAGUAG	23	25875
CFTR-Intron10-6996	−	GGAAAUGAGGAAGAAAGGAAGUAG	24	25876
CFTR-Intron10-6997	−	GCUUGAUCCAGGUAGUAG	18	25877
CFTR-Intron10-6998	−	GGCUUGAUCCAGGUAGUAG	19	25878
CFTR-Intron10-461	−	UGGCUUGAUCCAGGUAGUAG	20	19347
CFTR-Intron10-6999	−	GUGGCUUGAUCCAGGUAGUAG	21	25879
CFTR-Intron10-7000	−	GGUGGCUUGAUCCAGGUAGUAG	22	25880
CFTR-Intron10-7001	−	UGGUGGCUUGAUCCAGGUAGUAG	23	25881
CFTR-Intron10-7002	−	AUGGUGGCUUGAUCCAGGUAGUAG	24	25882
CFTR-Intron10-7003	−	CUAUGAAGGCAGAGUUAG	18	25883
CFTR-Intron10-7004	−	GCUAUGAAGGCAGAGUUAG	19	25884
CFTR-Intron10-464	−	AGCUAUGAAGGCAGAGUUAG	20	19350
CFTR-Intron10-7005	−	CAGCUAUGAAGGCAGAGUUAG	21	25885
CFTR-Intron10-7006	−	GCAGCUAUGAAGGCAGAGUUAG	22	25886
CFTR-Intron10-7007	−	AGCAGCUAUGAAGGCAGAGUUAG	23	25887
CFTR-Intron10-7008	−	AAGCAGCUAUGAAGGCAGAGUUAG	24	25888
CFTR-Intron10-7009	−	GGGGUUUCACCGUUUUAG	18	25889
CFTR-Intron10-7010	−	CGGGGUUUCACCGUUUUAG	19	25890
CFTR-Intron10-7011	−	ACGGGGUUUCACCGUUUUAG	20	25891
CFTR-Intron10-7012	−	GACGGGGUUUCACCGUUUUAG	21	25892
CFTR-Intron10-7013	−	AGACGGGGUUUCACCGUUUUAG	22	25893
CFTR-Intron10-7014	−	GAGACGGGGUUUCACCGUUUUAG	23	25894
CFTR-Intron10-7015	−	AGAGACGGGGUUUCACCGUUUUAG	24	25895
CFTR-Intron10-7016	−	UAAUUUUUGUAUUUUUAG	18	25896
CFTR-Intron10-7017	−	CUAAUUUUUGUAUUUUUAG	19	25897
CFTR-Intron10-7018	−	GCUAAUUUUUGUAUUUUUAG	20	25898
CFTR-Intron10-7019	−	AGCUAAUUUUUGUAUUUUUAG	21	25899
CFTR-Intron10-7020	−	CAGCUAAUUUUUGUAUUUUUAG	22	25900
CFTR-Intron10-7021	−	UCAGCUAAUUUUUGUAUUUUUAG	23	25901
CFTR-Intron10-7022	−	CUCAGCUAAUUUUUGUAUUUUUAG	24	25902
CFTR-Intron10-7023	−	CGGCUAAUUUUUUGUAUUUUUAG	23	25903
CFTR-Intron10-7024	−	CCGGCUAAUUUUUUGUAUUUUUAG	24	25904
CFTR-Intron10-7025	−	UCAGAGAAGUAAUCGGCG	18	25905
CFTR-Intron10-7026	−	GUCAGAGAAGUAAUCGGCG	19	25906
CFTR-Intron10-7027	−	UGUCAGAGAAGUAAUCGGCG	20	25907
CFTR-Intron10-7028	−	CUGUCAGAGAAGUAAUCGGCG	21	25908
CFTR-Intron10-7029	−	ACUGUCAGAGAAGUAAUCGGCG	22	25909
CFTR-Intron10-7030	−	UACUGUCAGAGAAGUAAUCGGCG	23	25910
CFTR-Intron10-7031	−	AUACUGUCAGAGAAGUAAUCGGCG	24	25911
CFTR-Intron10-7032	−	UUCUGUAGGGAGACAAGG	18	25912
CFTR-Intron10-7033	−	AUUCUGUAGGGAGACAAGG	19	25913
CFTR-Intron10-7034	−	UAUUCUGUAGGGAGACAAGG	20	25914
CFTR-Intron10-7035	−	CUAUUCUGUAGGGAGACAAGG	21	25915
CFTR-Intron10-7036	−	GCUAUUCUGUAGGGAGACAAGG	22	25916
CFTR-Intron10-7037	−	GGCUAUUCUGUAGGGAGACAAGG	23	25917
CFTR-Intron10-7038	−	AGGCUAUUCUGUAGGGAGACAAGG	24	25918
CFTR-Intron10-7039	−	ACAAGUCUAGUUUCAAGG	18	25919
CFTR-Intron10-7040	−	UACAAGUCUAGUUUCAAGG	19	25920
CFTR-Intron10-7041	−	GUACAAGUCUAGUUUCAAGG	20	25921
CFTR-Intron10-7042	−	UGUACAAGUCUAGUUUCAAGG	21	25922
CFTR-Intron10-7043	−	AUGUACAAGUCUAGUUUCAAGG	22	25923
CFTR-Intron10-7044	−	GAUGUACAAGUCUAGUUUCAAGG	23	25924
CFTR-Intron10-7045	−	GGAUGUACAAGUCUAGUUUCAAGG	24	25925
CFTR-Intron10-7046	−	GGAAGGAAGGAAAGAAGG	18	25926
CFTR-Intron10-7047	−	AGGAAGGAAGGAAAGAAGG	19	25927
CFTR-Intron10-7048	−	AAGGAAGGAAGGAAAGAAGG	20	25928
CFTR-Intron10-7049	−	GAAGGAAGGAAGGAAAGAAGG	21	25929
CFTR-Intron10-7050	−	GGAAGGAAGGAAGGAAAGAAGG	22	25930
CFTR-Intron10-7051	−	AGGAAGGAAGGAAGGAAAGAAGG	23	25931
CFTR-Intron10-7052	−	GAGGAAGGAAGGAAGGAAAGAAGG	24	25932
CFTR-Intron10-7053	−	AAGUAGGAGGAAGGAAGG	18	25933
CFTR-Intron10-7054	−	GAAGUAGGAGGAAGGAAGG	19	25934
CFTR-Intron10-7055	−	GGAAGUAGGAGGAAGGAAGG	20	25935
CFTR-Intron10-7056	−	AGGAAGUAGGAGGAAGGAAGG	21	25936
CFTR-Intron10-7057	−	AAGGAAGUAGGAGGAAGGAAGG	22	25937
CFTR-Intron10-7058	−	AAAGGAAGUAGGAGGAAGGAAGG	23	25938
CFTR-Intron10-7059	−	GAAAGGAAGUAGGAGGAAGGAAGG	24	25939
CFTR-Intron10-7060	−	AAAAGAAAGAGAGGAAGG	18	25940
CFTR-Intron10-7061	−	AAAAAGAAAGAGAGGAAGG	19	25941
CFTR-Intron10-7062	−	GAAAAAGAAAGAGAGGAAGG	20	25942
CFTR-Intron10-7063	−	AGAAAAAGAAAGAGAGGAAGG	21	25943
CFTR-Intron10-7064	−	CAGAAAAAGAAAGAGAGGAAGG	22	25944
CFTR-Intron10-7065	−	ACAGAAAAAGAAAGAGAGGAAGG	23	25945
CFTR-Intron10-7066	−	AACAGAAAAAGAAAGAGAGGAAGG	24	25946
CFTR-Intron10-7067	−	AAGGAAGUAGGAGGAAGG	18	25947
CFTR-Intron10-7068	−	AAAGGAAGUAGGAGGAAGG	19	25948
CFTR-Intron10-7069	−	GAAAGGAAGUAGGAGGAAGG	20	25949
CFTR-Intron10-7070	−	AGAAAGGAAGUAGGAGGAAGG	21	25950
CFTR-Intron10-7071	−	AAGAAAGGAAGUAGGAGGAAGG	22	25951
CFTR-Intron10-7072	−	GAAGAAAGGAAGUAGGAGGAAGG	23	25952
CFTR-Intron10-7073	−	GGAAGAAAGGAAGUAGGAGGAAGG	24	25953
CFTR-Intron10-7074	−	AGUCUUACUGUCACCAGG	18	25954
CFTR-Intron10-7075	−	GAGUCUUACUGUCACCAGG	19	25955
CFTR-Intron10-7076	−	AGAGUCUUACUGUCACCAGG	20	25956
CFTR-Intron10-7077	−	CAGAGUCUUACUGUCACCAGG	21	25957
CFTR-Intron10-7078	−	ACAGAGUCUUACUGUCACCAGG	22	25958
CFTR-Intron10-7079	−	GACAGAGUCUUACUGUCACCAGG	23	25959
CFTR-Intron10-7080	−	AGACAGAGUCUUACUGUCACCAGG	24	25960
CFTR-Intron10-7081	−	CUUACUCUGUCACCCAGG	18	25961
CFTR-Intron10-7082	−	UCUUACUCUGUCACCCAGG	19	25962
CFTR-Intron10-7083	−	GUCUUACUCUGUCACCCAGG	20	25963
CFTR-Intron10-7084	−	GGUCUUACUCUGUCACCCAGG	21	25964
CFTR-Intron10-7085	−	AGGUCUUACUCUGUCACCCAGG	22	25965
CFTR-Intron10-7086	−	UAGGUCUUACUCUGUCACCCAGG	23	25966
CFTR-Intron10-7087	−	UUAGGUCUUACUCUGUCACCCAGG	24	25967
CFTR-Intron10-7088	−	CUCGCUCUGUCGCCCAGG	18	25968
CFTR-Intron10-7089	−	UCUCGCUCUGUCGCCCAGG	19	25969
CFTR-Intron10-7090	−	GUCUCGCUCUGUCGCCCAGG	20	25970
CFTR-Intron10-7091	−	AGUCUCGCUCUGUCGCCCAGG	21	25971
CFTR-Intron10-7092	−	GAGUCUCGCUCUGUCGCCCAGG	22	25972
CFTR-Intron10-7093	−	GGAGUCUCGCUCUGUCGCCCAGG	23	25973
CFTR-Intron10-7094	−	CGGAGUCUCGCUCUGUCGCCCAGG	24	25974
CFTR-Intron10-7095	−	AGGUGAUGGUAUUGCAGG	18	25975
CFTR-Intron10-7096	−	AAGGUGAUGGUAUUGCAGG	19	25976
CFTR-Intron10-7097	−	CAAGGUGAUGGUAUUGCAGG	20	25977
CFTR-Intron10-7098	−	CCAAGGUGAUGGUAUUGCAGG	21	25978
CFTR-Intron10-7099	−	CCCAAGGUGAUGGUAUUGCAGG	22	25979
CFTR-Intron10-7100	−	UCCCAAGGUGAUGGUAUUGCAGG	23	25980
CFTR-Intron10-7101	−	UUCCCAAGGUGAUGGUAUUGCAGG	24	25981
CFTR-Intron10-7102	−	CAGAAAAAGAAAGAGAGG	18	25982
CFTR-Intron10-7103	−	ACAGAAAAAGAAAGAGAGG	19	25983
CFTR-Intron10-7104	−	AACAGAAAAAGAAAGAGAGG	20	25984
CFTR-Intron10-7105	−	AAACAGAAAAAGAAAGAGAGG	21	25985
CFTR-Intron10-7106	−	CAAACAGAAAAAGAAAGAGAGG	22	25986
CFTR-Intron10-7107	−	ACAAACAGAAAAAGAAAGAGAGG	23	25987
CFTR-Intron10-7108	−	GACAAACAGAAAAAGAAAGAGAGG	24	25988
CFTR-Intron10-7109	−	UGGCGUGAACCCAGGAGG	18	25989
CFTR-Intron10-7110	−	AUGGCGUGAACCCAGGAGG	19	25990
CFTR-Intron10-7111	−	AAUGGCGUGAACCCAGGAGG	20	25991
CFTR-Intron10-7112	−	GAAUGGCGUGAACCCAGGAGG	21	25992
CFTR-Intron10-7113	−	AGAAUGGCGUGAACCCAGGAGG	22	25993
CFTR-Intron10-7114	−	GAGAAUGGCGUGAACCCAGGAGG	23	25994
CFTR-Intron10-7115	−	GGAGAAUGGCGUGAACCCAGGAGG	24	25995
CFTR-Intron10-7116	−	AAGAAAGGAAGUAGGAGG	18	25996
CFTR-Intron10-7117	−	GAAGAAAGGAAGUAGGAGG	19	25997
CFTR-Intron10-7118	−	GGAAGAAAGGAAGUAGGAGG	20	25998
CFTR-Intron10-7119	−	AGGAAGAAAGGAAGUAGGAGG	21	25999
CFTR-Intron10-7120	−	GAGGAAGAAAGGAAGUAGGAGG	22	26000
CFTR-Intron10-7121	−	UGAGGAAGAAAGGAAGUAGGAGG	23	26001
CFTR-Intron10-7122	−	AUGAGGAAGAAAGGAAGUAGGAGG	24	26002
CFTR-Intron10-7123	−	UCCCAGCUACUCGGGAGG	18	26003
CFTR-Intron10-7124	−	GUCCCAGCUACUCGGGAGG	19	26004
CFTR-Intron10-7125	−	AGUCCCAGCUACUCGGGAGG	20	26005
CFTR-Intron10-7126	−	UAGUCCCAGCUACUCGGGAGG	21	26006
CFTR-Intron10-7127	−	GUAGUCCCAGCUACUCGGGAGG	22	26007
CFTR-Intron10-7128	−	CGUAGUCCCAGCUACUCGGGAGG	23	26008
CFTR-Intron10-7129	−	CCGUAGUCCCAGCUACUCGGGAGG	24	26009
CFTR-Intron10-7130	−	AGUAAUCGGCGGUGGAGG	18	26010
CFTR-Intron10-7131	−	AAGUAAUCGGCGGUGGAGG	19	26011
CFTR-Intron10-7132	−	GAAGUAAUCGGCGGUGGAGG	20	26012
CFTR-Intron10-7133	−	AGAAGUAAUCGGCGGUGGAGG	21	26013
CFTR-Intron10-7134	−	GAGAAGUAAUCGGCGGUGGAGG	22	26014
CFTR-Intron10-7135	−	AGAGAAGUAAUCGGCGGUGGAGG	23	26015
CFTR-Intron10-7136	−	CAGAGAAGUAAUCGGCGGUGGAGG	24	26016
CFTR-Intron10-7137	−	UCCUAGCACUUUUGGAGG	18	26017
CFTR-Intron10-7138	−	AUCCUAGCACUUUUGGAGG	19	26018
CFTR-Intron10-7139	−	AAUCCUAGCACUUUUGGAGG	20	26019
CFTR-Intron10-7140	−	UAAUCCUAGCACUUUUGGAGG	21	26020
CFTR-Intron10-7141	−	GUAAUCCUAGCACUUUUGGAGG	22	26021
CFTR-Intron10-7142	−	UGUAAUCCUAGCACUUUUGGAGG	23	26022
CFTR-Intron10-7143	−	UUGUAAUCCUAGCACUUUUGGAGG	24	26023
CFTR-Intron10-7144	−	AGAAAGAAGGAAAUGAGG	18	26024
CFTR-Intron10-7145	−	AAGAAAGAAGGAAAUGAGG	19	26025
CFTR-Intron10-7146	−	GAAGAAAGAAGGAAAUGAGG	20	26026
CFTR-Intron10-7147	−	GGAAGAAAGAAGGAAAUGAGG	21	26027
CFTR-Intron10-7148	−	AGGAAGAAAGAAGGAAAUGAGG	22	26028
CFTR-Intron10-7149	−	AAGGAAGAAAGAAGGAAAUGAGG	23	26029
CFTR-Intron10-7150	−	GAAGGAAGAAAGAAGGAAAUGAGG	24	26030
CFTR-Intron10-7151	−	GGUGAUUAGUCCAUGAGG	18	26031
CFTR-Intron10-7152	−	AGGUGAUUAGUCCAUGAGG	19	26032
CFTR-Intron10-7153	−	GAGGUGAUUAGUCCAUGAGG	20	26033
CFTR-Intron10-7154	−	GGAGGUGAUUAGUCCAUGAGG	21	26034
CFTR-Intron10-7155	−	GGGAGGUGAUUAGUCCAUGAGG	22	26035
CFTR-Intron10-7156	−	UGGGAGGUGAUUAGUCCAUGAGG	23	26036
CFTR-Intron10-7157	−	UUGGGAGGUGAUUAGUCCAUGAGG	24	26037
CFTR-Intron10-7158	−	CUACUCGGGAGGCUGAGG	18	26038
CFTR-Intron10-7159	−	GCUACUCGGGAGGCUGAGG	19	26039
CFTR-Intron10-7160	−	AGCUACUCGGGAGGCUGAGG	20	26040
CFTR-Intron10-7161	−	CAGCUACUCGGGAGGCUGAGG	21	26041
CFTR-Intron10-7162	−	CCAGCUACUCGGGAGGCUGAGG	22	26042
CFTR-Intron10-7163	−	CCCAGCUACUCGGGAGGCUGAGG	23	26043
CFTR-Intron10-7164	−	UCCCAGCUACUCGGGAGGCUGAGG	24	26044
CFTR-Intron10-7165	−	CUACUUGGGAGGCUGAGG	18	26045
CFTR-Intron10-7166	−	GCUACUUGGGAGGCUGAGG	19	26046
CFTR-Intron10-1288	−	AGCUACUUGGGAGGCUGAGG	20	20173
CFTR-Intron10-7167	−	AAAAAAUUAUACUAUAGG	18	26047
CFTR-Intron10-7168	−	UAAAAAAUUAUACUAUAGG	19	26048
CFTR-Intron10-1289	−	UUAAAAAAUUAUACUAUAGG	20	20174
CFTR-Intron10-7169	−	AUUAAAAAAUUAUACUAUAGG	21	26049
CFTR-Intron10-7170	−	UAUUAAAAAAUUAUACUAUAGG	22	26050
CFTR-Intron10-7171	−	CUAUUAAAAAAUUAUACUAUAGG	23	26051
CFTR-Intron10-7172	−	ACUAUUAAAAAAUUAUACUAUAGG	24	26052
CFTR-Intron10-7173	−	AGGAAGAAAGGAAGUAGG	18	26053
CFTR-Intron10-7174	−	GAGGAAGAAAGGAAGUAGG	19	26054
CFTR-Intron10-1290	−	UGAGGAAGAAAGGAAGUAGG	20	20175
CFTR-Intron10-7175	−	AUGAGGAAGAAAGGAAGUAGG	21	26055
CFTR-Intron10-7176	−	AAUGAGGAAGAAAGGAAGUAGG	22	26056
CFTR-Intron10-7177	−	AAAUGAGGAAGAAAGGAAGUAGG	23	26057
CFTR-Intron10-7178	−	GAAAUGAGGAAGAAAGGAAGUAGG	24	26058
CFTR-Intron10-7179	−	CAGAGAAGUAAUCGGCGG	18	26059
CFTR-Intron10-7180	−	UCAGAGAAGUAAUCGGCGG	19	26060
CFTR-Intron10-105	−	GUCAGAGAAGUAAUCGGCGG	20	18991
CFTR-Intron10-7181	−	UGUCAGAGAAGUAAUCGGCGG	21	26061
CFTR-Intron10-7182	−	CUGUCAGAGAAGUAAUCGGCGG	22	26062
CFTR-Intron10-7183	−	ACUGUCAGAGAAGUAAUCGGCGG	23	26063
CFTR-Intron10-7184	−	UACUGUCAGAGAAGUAAUCGGCGG	24	26064
CFTR-Intron10-7185	−	UCUGUAGGGAGACAAGGG	18	26065
CFTR-Intron10-7186	−	UUCUGUAGGGAGACAAGGG	19	26066
CFTR-Intron10-473	−	AUUCUGUAGGGAGACAAGGG	20	19359
CFTR-Intron10-7187	−	UAUUCUGUAGGGAGACAAGGG	21	26067
CFTR-Intron10-7188	−	CUAUUCUGUAGGGAGACAAGGG	22	26068
CFTR-Intron10-7189	−	GCUAUUCUGUAGGGAGACAAGGG	23	26069
CFTR-Intron10-7190	−	GGCUAUUCUGUAGGGAGACAAGGG	24	26070
CFTR-Intron10-7191	−	GGUGAUGGUAUUGCAGGG	18	26071
CFTR-Intron10-7192	−	AGGUGAUGGUAUUGCAGGG	19	26072
CFTR-Intron10-1292	−	AAGGUGAUGGUAUUGCAGGG	20	20177
CFTR-Intron10-7193	−	CAAGGUGAUGGUAUUGCAGGG	21	26073
CFTR-Intron10-7194	−	CCAAGGUGAUGGUAUUGCAGGG	22	26074
CFTR-Intron10-7195	−	CCCAAGGUGAUGGUAUUGCAGGG	23	26075
CFTR-Intron10-7196	−	UCCCAAGGUGAUGGUAUUGCAGGG	24	26076
CFTR-Intron10-7197	−	CAGGAGCCAAAAAUUGGG	18	26077
CFTR-Intron10-7198	−	UCAGGAGCCAAAAAUUGGG	19	26078
CFTR-Intron10-476	−	UUCAGGAGCCAAAAAUUGGG	20	19362
CFTR-Intron10-7199	−	UUUCAGGAGCCAAAAAUUGGG	21	26079
CFTR-Intron10-7200	−	CUUUCAGGAGCCAAAAAUUGGG	22	26080
CFTR-Intron10-7201	−	GCUUUCAGGAGCCAAAAAUUGGG	23	26081
CFTR-Intron10-7202	−	UGCUUUCAGGAGCCAAAAAUUGGG	24	26082
CFTR-Intron10-7203	−	UUACUAGAAAGAUAAUGG	18	26083
CFTR-Intron10-7204	−	UUUACUAGAAAGAUAAUGG	19	26084
CFTR-Intron10-7205	−	GUUUACUAGAAAGAUAAUGG	20	26085
CFTR-Intron10-7206	−	CGUUUACUAGAAAGAUAAUGG	21	26086
CFTR-Intron10-7207	−	CCGUUUACUAGAAAGAUAAUGG	22	26087
CFTR-Intron10-7208	−	GCCGUUUACUAGAAAGAUAAUGG	23	26088
CFTR-Intron10-7209	−	UGCCGUUUACUAGAAAGAUAAUGG	24	26089
CFTR-Intron10-7210	−	UAAGGCUUAUUUCUCUGG	18	26090
CFTR-Intron10-7211	−	CUAAGGCUUAUUUCUCUGG	19	26091
CFTR-Intron10-7212	−	ACUAAGGCUUAUUUCUCUGG	20	26092
CFTR-Intron10-7213	−	GACUAAGGCUUAUUUCUCUGG	21	26093
CFTR-Intron10-7214	−	AGACUAAGGCUUAUUUCUCUGG	22	26094
CFTR-Intron10-7215	−	AAGACUAAGGCUUAUUUCUCUGG	23	26095
CFTR-Intron10-7216	−	AAAGACUAAGGCUUAUUUCUCUGG	24	26096
CFTR-Intron10-7217	−	UAGAGGUUAAGGAGGUGG	18	26097
CFTR-Intron10-7218	−	UUAGAGGUUAAGGAGGUGG	19	26098
CFTR-Intron10-7219	−	AUUAGAGGUUAAGGAGGUGG	20	26099
CFTR-Intron10-7220	−	UAUUAGAGGUUAAGGAGGUGG	21	26100
CFTR-Intron10-7221	−	GUAUUAGAGGUUAAGGAGGUGG	22	26101
CFTR-Intron10-7222	−	AGUAUUAGAGGUUAAGGAGGUGG	23	26102
CFTR-Intron10-7223	−	AAGUAUUAGAGGUUAAGGAGGUGG	24	26103
CFTR-Intron10-7224	−	GAGCCAAAAAUUGGGUGG	18	26104
CFTR-Intron10-7225	−	GGAGCCAAAAAUUGGGUGG	19	26105
CFTR-Intron10-478	−	AGGAGCCAAAAAUUGGGUGG	20	19364
CFTR-Intron10-7226	−	CAGGAGCCAAAAAUUGGGUGG	21	26106
CFTR-Intron10-7227	−	UCAGGAGCCAAAAAUUGGGUGG	22	26107
CFTR-Intron10-7228	−	UUCAGGAGCCAAAAAUUGGGUGG	23	26108
CFTR-Intron10-7229	−	UUUCAGGAGCCAAAAAUUGGGUGG	24	26109
CFTR-Intron10-7230	−	UCAGGAGCCAAAAAUUGG	18	26110
CFTR-Intron10-7231	−	UUCAGGAGCCAAAAAUUGG	19	26111
CFTR-Intron10-7232	−	UUUCAGGAGCCAAAAAUUGG	20	26112
CFTR-Intron10-7233	−	CUUUCAGGAGCCAAAAAUUGG	21	26113
CFTR-Intron10-7234	−	GCUUUCAGGAGCCAAAAAUUGG	22	26114
CFTR-Intron10-7235	−	UGCUUUCAGGAGCCAAAAAUUGG	23	26115
CFTR-Intron10-7236	−	CUGCUUUCAGGAGCCAAAAAUUGG	24	26116
CFTR-Intron10-7237	−	GGGAGAAACAGGUUUUGG	18	26117
CFTR-Intron10-7238	−	UGGGAGAAACAGGUUUUGG	19	26118
CFTR-Intron10-7239	−	AUGGGAGAAACAGGUUUUGG	20	26119
CFTR-Intron10-7240	−	AAUGGGAGAAACAGGUUUUGG	21	26120
CFTR-Intron10-7241	−	UAAUGGGAGAAACAGGUUUUGG	22	26121
CFTR-Intron10-7242	−	AUAAUGGGAGAAACAGGUUUUGG	23	26122
CFTR-Intron10-7243	−	GAUAAUGGGAGAAACAGGUUUUGG	24	26123
CFTR-Intron10-7244	−	GGAAGAAAGAAGGAAAUG	18	26124
CFTR-Intron10-7245	−	AGGAAGAAAGAAGGAAAUG	19	26125
CFTR-Intron10-1311	−	AAGGAAGAAAGAAGGAAAUG	20	20196
CFTR-Intron10-7246	−	GAAGGAAGAAAGAAGGAAAUG	21	26126
CFTR-Intron10-7247	−	GGAAGGAAGAAAGAAGGAAAUG	22	26127
CFTR-Intron10-7248	−	AGGAAGGAAGAAAGAAGGAAAUG	23	26128
CFTR-Intron10-7249	−	GAGGAAGGAAGAAAGAAGGAAAUG	24	26129
CFTR-Intron10-7250	−	UUAUCAAUAUCUAAGAUG	18	26130
CFTR-Intron10-7251	−	UUUAUCAAUAUCUAAGAUG	19	26131
CFTR-Intron10-480	−	AUUUAUCAAUAUCUAAGAUG	20	19366
CFTR-Intron10-7252	−	UAUUUAUCAAUAUCUAAGAUG	21	26132
CFTR-Intron10-7253	−	UUAUUUAUCAAUAUCUAAGAUG	22	26133
CFTR-Intron10-7254	−	AUUAUUUAUCAAUAUCUAAGAUG	23	26134
CFTR-Intron10-7255	−	AAUUAUUUAUCAAUAUCUAAGAUG	24	26135
CFTR-Intron10-7256	−	UCCCCUGCCAUUCAUAUG	18	26136
CFTR-Intron10-7257	−	CUCCCCUGCCAUUCAUAUG	19	26137
CFTR-Intron10-7258	−	UCUCCCCUGCCAUUCAUAUG	20	26138
CFTR-Intron10-7259	−	CUCUCCCCUGCCAUUCAUAUG	21	26139
CFTR-Intron10-7260	−	UCUCUCCCCUGCCAUUCAUAUG	22	26140
CFTR-Intron10-7261	−	GUCUCUCCCCUGCCAUUCAUAUG	23	26141
CFTR-Intron10-7262	−	UGUCUCUCCCCUGCCAUUCAUAUG	24	26142
CFTR-Intron10-7263	−	UGUUUUUAGGCUAUUCUG	18	26143
CFTR-Intron10-7264	−	AUGUUUUUAGGCUAUUCUG	19	26144
CFTR-Intron10-7265	−	AAUGUUUUUAGGCUAUUCUG	20	26145
CFTR-Intron10-7266	−	UAAUGUUUUUAGGCUAUUCUG	21	26146
CFTR-Intron10-7267	−	CUAAUGUUUUUAGGCUAUUCUG	22	26147
CFTR-Intron10-7268	−	GCUAAUGUUUUUAGGCUAUUCUG	23	26148
CFTR-Intron10-7269	−	GGCUAAUGUUUUUAGGCUAUUCUG	24	26149
CFTR-Intron10-7270	−	CCUCGGCCUCCCAAAGUG	18	26150
CFTR-Intron10-7271	−	GCCUCGGCCUCCCAAAGUG	19	26151
CFTR-Intron10-7272	−	CGCCUCGGCCUCCCAAAGUG	20	26152
CFTR-Intron10-7273	−	CCGCCUCGGCCUCCCAAAGUG	21	26153
CFTR-Intron10-7274	−	CCCGCCUCGGCCUCCCAAAGUG	22	26154
CFTR-Intron10-7275	−	GCCCGCCUCGGCCUCCCAAAGUG	23	26155
CFTR-Intron10-7276	−	CGCCCGCCUCGGCCUCCCAAAGUG	24	26156
CFTR-Intron10-7277	−	UGCCUCGGCCUCCCAAAGUG	20	26157
CFTR-Intron10-7278	−	CUGCCUCGGCCUCCCAAAGUG	21	26158
CFTR-Intron10-7279	−	CCUGCCUCGGCCUCCCAAAGUG	22	26159
CFTR-Intron10-7280	−	GCCUGCCUCGGCCUCCCAAAGUG	23	26160
CFTR-Intron10-7281	−	UGCCUGCCUCGGCCUCCCAAAGUG	24	26161
CFTR-Intron10-7282	−	CCAGGCUGGAGUGCAGUG	18	26162
CFTR-Intron10-7283	−	CCCAGGCUGGAGUGCAGUG	19	26163
CFTR-Intron10-7284	−	GCCCAGGCUGGAGUGCAGUG	20	26164
CFTR-Intron10-7285	−	CGCCCAGGCUGGAGUGCAGUG	21	26165
CFTR-Intron10-7286	−	UCGCCCAGGCUGGAGUGCAGUG	22	26166
CFTR-Intron10-7287	−	GUCGCCCAGGCUGGAGUGCAGUG	23	26167
CFTR-Intron10-7288	−	UGUCGCCCAGGCUGGAGUGCAGUG	24	26168
CFTR-Intron10-7289	−	UAAGAAGAGAAAGGGGUG	18	26169
CFTR-Intron10-7290	−	AUAAGAAGAGAAAGGGGUG	19	26170
CFTR-Intron10-7291	−	GAUAAGAAGAGAAAGGGGUG	20	26171
CFTR-Intron10-7292	−	UGAUAAGAAGAGAAAGGGGUG	21	26172
CFTR-Intron10-7293	−	UUGAUAAGAAGAGAAAGGGGUG	22	26173
CFTR-Intron10-7294	−	GUUGAUAAGAAGAGAAAGGGGUG	23	26174
CFTR-Intron10-7295	−	GGUUGAUAAGAAGAGAAAGGGGUG	24	26175
CFTR-Intron10-7296	−	AGGUUAAGGAGGUGGGUG	18	26176
CFTR-Intron10-7297	−	GAGGUUAAGGAGGUGGGUG	19	26177
CFTR-Intron10-7298	−	AGAGGUUAAGGAGGUGGGUG	20	26178
CFTR-Intron10-7299	−	UAGAGGUUAAGGAGGUGGGUG	21	26179
CFTR-Intron10-7300	−	UUAGAGGUUAAGGAGGUGGGUG	22	26180
CFTR-Intron10-7301	−	AUUAGAGGUUAAGGAGGUGGGUG	23	26181
CFTR-Intron10-7302	−	UAUUAGAGGUUAAGGAGGUGGGUG	24	26182
CFTR-Intron10-7303	−	GGAGCCAAAAAUUGGGUG	18	26183
CFTR-Intron10-7304	−	AGGAGCCAAAAAUUGGGUG	19	26184
CFTR-Intron10-489	−	CAGGAGCCAAAAAUUGGGUG	20	19375
CFTR-Intron10-7305	−	UCAGGAGCCAAAAAUUGGGUG	21	26185
CFTR-Intron10-7306	−	UUCAGGAGCCAAAAAUUGGGUG	22	26186
CFTR-Intron10-7307	−	UUUCAGGAGCCAAAAAUUGGGUG	23	26187
CFTR-Intron10-7308	−	CUUUCAGGAGCCAAAAAUUGGGUG	24	26188
CFTR-Intron10-7309	−	UGGCAUCUCACCAGUGUG	18	26189
CFTR-Intron10-7310	−	AUGGCAUCUCACCAGUGUG	19	26190
CFTR-Intron10-491	−	UAUGGCAUCUCACCAGUGUG	20	19377
CFTR-Intron10-7311	−	UUAUGGCAUCUCACCAGUGUG	21	26191
CFTR-Intron10-7312	−	CUUAUGGCAUCUCACCAGUGUG	22	26192
CFTR-Intron10-7313	−	GCUUAUGGCAUCUCACCAGUGUG	23	26193
CFTR-Intron10-7314	−	GGCUUAUGGCAUCUCACCAGUGUG	24	26194
CFTR-Intron10-7315	−	UUAUAAAAAAUAAUUGUG	18	26195
CFTR-Intron10-7316	−	UUUAUAAAAAAUAAUUGUG	19	26196
CFTR-Intron10-7317	−	UUUUAUAAAAAAUAAUUGUG	20	26197
CFTR-Intron10-7318	−	UUUUUAUAAAAAAUAAUUGUG	21	26198
CFTR-Intron10-7319	−	AUUUUUAUAAAAAAUAAUUGUG	22	26199
CFTR-Intron10-7320	−	GAUUUUUAUAAAAAAUAAUUGUG	23	26200
CFTR-Intron10-7321	−	AGAUUUUUAUAAAAAAUAAUUGUG	24	26201
CFTR-Intron10-7322	−	GCAGUUUUAUUAAAAUUG	18	26202
CFTR-Intron10-7323	−	GGCAGUUUUAUUAAAAUUG	19	26203
CFTR-Intron10-7324	−	AGGCAGUUUUAUUAAAAUUG	20	26204
CFTR-Intron10-7325	−	CAGGCAGUUUUAUUAAAAUUG	21	26205
CFTR-Intron10-7326	−	UCAGGCAGUUUUAUUAAAAUUG	22	26206
CFTR-Intron10-7327	−	UUCAGGCAGUUUUAUUAAAAUUG	23	26207
CFTR-Intron10-7328	−	UUUCAGGCAGUUUUAUUAAAAUUG	24	26208
CFTR-Intron10-7329	−	GCUCUCUUUUAACUAUUG	18	26209
CFTR-Intron10-7330	−	UGCUCUCUUUUAACUAUUG	19	26210
CFTR-Intron10-495	−	UUGCUCUCUUUUAACUAUUG	20	19381
CFTR-Intron10-7331	−	CUUGCUCUCUUUUAACUAUUG	21	26211
CFTR-Intron10-7332	−	ACUUGCUCUCUUUUAACUAUUG	22	26212
CFTR-Intron10-7333	−	AACUUGCUCUCUUUUAACUAUUG	23	26213
CFTR-Intron10-7334	−	AAACUUGCUCUCUUUUAACUAUUG	24	26214
CFTR-Intron10-7335	−	CAUUUGAACAAAGACUUG	18	26215
CFTR-Intron10-7336	−	ACAUUUGAACAAAGACUUG	19	26216
CFTR-Intron10-7337	−	AACAUUUGAACAAAGACUUG	20	26217
CFTR-Intron10-7338	−	UAACAUUUGAACAAAGACUUG	21	26218
CFTR-Intron10-7339	−	GUAACAUUUGAACAAAGACUUG	22	26219
CFTR-Intron10-7340	−	GGUAACAUUUGAACAAAGACUUG	23	26220
CFTR-Intron10-7341	−	AGGUAACAUUUGAACAAAGACUUG	24	26221
CFTR-Intron10-7342	−	UUUAGCUGUGGUACUUUG	18	26222
CFTR-Intron10-7343	−	UUUUAGCUGUGGUACUUUG	19	26223
CFTR-Intron10-7344	−	AUUUUAGCUGUGGUACUUUG	20	26224
CFTR-Intron10-7345	−	CAUUUUAGCUGUGGUACUUUG	21	26225
CFTR-Intron10-7346	−	UCAUUUUAGCUGUGGUACUUUG	22	26226
CFTR-Intron10-7347	−	GUCAUUUUAGCUGUGGUACUUUG	23	26227
CFTR-Intron10-7348	−	UGUCAUUUUAGCUGUGGUACUUUG	24	26228
CFTR-Intron10-7349	−	GAUUCAGGACAUGCUUUG	18	26229
CFTR-Intron10-7350	−	AGAUUCAGGACAUGCUUUG	19	26230
CFTR-Intron10-7351	−	CAGAUUCAGGACAUGCUUUG	20	26231
CFTR-Intron10-7352	−	UCAGAUUCAGGACAUGCUUUG	21	26232
CFTR-Intron10-7353	−	AUCAGAUUCAGGACAUGCUUUG	22	26233
CFTR-Intron10-7354	−	GAUCAGAUUCAGGACAUGCUUUG	23	26234
CFTR-Intron10-7355	−	UGAUCAGAUUCAGGACAUGCUUUG	24	26235
CFTR-Intron10-7356	−	CUAUACCUGUCUGGUUUG	18	26236
CFTR-Intron10-7357	−	ACUAUACCUGUCUGGUUUG	19	26237
CFTR-Intron10-7358	−	GACUAUACCUGUCUGGUUUG	20	26238
CFTR-Intron10-7359	−	UGACUAUACCUGUCUGGUUUG	21	26239
CFTR-Intron10-7360	−	CUGACUAUACCUGUCUGGUUUG	22	26240
CFTR-Intron10-7361	−	ACUGACUAUACCUGUCUGGUUUG	23	26241
CFTR-Intron10-7362	−	GACUGACUAUACCUGUCUGGUUUG	24	26242
CFTR-Intron10-7363	−	CUUACCCAAAUAUGUUUG	18	26243
CFTR-Intron10-7364	−	ACUUACCCAAAUAUGUUUG	19	26244
CFTR-Intron10-7365	−	AACUUACCCAAAUAUGUUUG	20	26245
CFTR-Intron10-7366	−	UAACUUACCCAAAUAUGUUUG	21	26246
CFTR-Intron10-7367	−	AUAACUUACCCAAAUAUGUUUG	22	26247
CFTR-Intron10-7368	−	UAUAACUUACCCAAAUAUGUUUG	23	26248
CFTR-Intron10-7369	−	CUAUAACUUACCCAAAUAUGUUUG	24	26249
CFTR-Intron10-7370	−	UUACCCAAUAAAAAAAAU	18	26250
CFTR-Intron10-7371	−	GUUACCCAAUAAAAAAAAU	19	26251
CFTR-Intron10-7372	−	UGUUACCCAAUAAAAAAAAU	20	26252
CFTR-Intron10-7373	−	UUGUUACCCAAUAAAAAAAAU	21	26253
CFTR-Intron10-7374	−	AUUGUUACCCAAUAAAAAAAAU	22	26254
CFTR-Intron10-7375	−	UAUUGUUACCCAAUAAAAAAAAU	23	26255
CFTR-Intron10-7376	−	UUAUUGUUACCCAAUAAAAAAAAU	24	26256
CFTR-Intron10-7377	−	UUUUGCAAAAUACAAAAU	18	26257
CFTR-Intron10-7378	−	UUUUUGCAAAAUACAAAAU	19	26258
CFTR-Intron10-7379	−	CUUUUUGCAAAAUACAAAAU	20	26259
CFTR-Intron10-7380	−	ACUUUUUGCAAAAUACAAAAU	21	26260
CFTR-Intron10-7381	−	CACUUUUUGCAAAAUACAAAAU	22	26261
CFTR-Intron10-7382	−	GCACUUUUUGCAAAAUACAAAAU	23	26262
CFTR-Intron10-7383	−	UGCACUUUUUGCAAAAUACAAAAU	24	26263
CFTR-Intron10-7384	−	AACAAAAGAAAAGAAAAU	18	26264
CFTR-Intron10-7385	−	UAACAAAAGAAAAGAAAAU	19	26265
CFTR-Intron10-7386	−	GUAACAAAAGAAAAGAAAAU	20	26266
CFTR-Intron10-7387	−	UGUAACAAAAGAAAAGAAAAU	21	26267
CFTR-Intron10-7388	−	UUGUAACAAAAGAAAAGAAAAU	22	26268
CFTR-Intron10-7389	−	GUUGUAACAAAAGAAAAGAAAAU	23	26269
CFTR-Intron10-7390	−	UGUUGUAACAAAAGAAAAGAAAAU	24	26270
CFTR-Intron10-7391	−	GACAUGAAAGAAUCAAAU	18	26271
CFTR-Intron10-7392	−	AGACAUGAAAGAAUCAAAU	19	26272
CFTR-Intron10-7393	−	AAGACAUGAAAGAAUCAAAU	20	26273
CFTR-Intron10-7394	−	AAAGACAUGAAAGAAUCAAAU	21	26274
CFTR-Intron10-7395	−	UAAAGACAUGAAAGAAUCAAAU	22	26275
CFTR-Intron10-7396	−	UUAAAGACAUGAAAGAAUCAAAU	23	26276
CFTR-Intron10-7397	−	UUUAAAGACAUGAAAGAAUCAAAU	24	26277
CFTR-Intron10-7398	−	GUGGUACUUUGUAGAAAU	18	26278
CFTR-Intron10-7399	−	UGUGGUACUUUGUAGAAAU	19	26279
CFTR-Intron10-7400	−	CUGUGGUACUUUGUAGAAAU	20	26280
CFTR-Intron10-7401	−	GCUGUGGUACUUUGUAGAAAU	21	26281
CFTR-Intron10-7402	−	AGCUGUGGUACUUUGUAGAAAU	22	26282
CFTR-Intron10-7403	−	UAGCUGUGGUACUUUGUAGAAAU	23	26283
CFTR-Intron10-7404	−	UUAGCUGUGGUACUUUGUAGAAAU	24	26284
CFTR-Intron10-7405	−	AGGAAGAAAGAAGGAAAU	18	26285
CFTR-Intron10-7406	−	AAGGAAGAAAGAAGGAAAU	19	26286
CFTR-Intron10-7407	−	GAAGGAAGAAAGAAGGAAAU	20	26287
CFTR-Intron10-7408	−	GGAAGGAAGAAAGAAGGAAAU	21	26288
CFTR-Intron10-7409	−	AGGAAGGAAGAAAGAAGGAAAU	22	26289
CFTR-Intron10-7410	−	GAGGAAGGAAGAAAGAAGGAAAU	23	26290
CFTR-Intron10-7411	−	AGAGGAAGGAAGAAAGAAGGAAAU	24	26291
CFTR-Intron10-7412	−	ACUUGACCAGAAUGAAAU	18	26292
CFTR-Intron10-7413	−	AACUUGACCAGAAUGAAAU	19	26293
CFTR-Intron10-7414	−	AAACUUGACCAGAAUGAAAU	20	26294
CFTR-Intron10-7415	−	CAAACUUGACCAGAAUGAAAU	21	26295
CFTR-Intron10-7416	−	UCAAACUUGACCAGAAUGAAAU	22	26296
CFTR-Intron10-7417	−	GUCAAACUUGACCAGAAUGAAAU	23	26297
CFTR-Intron10-7418	−	GGUCAAACUUGACCAGAAUGAAAU	24	26298
CFTR-Intron10-7419	−	ACCGGUGUCUUCUGAAAU	18	26299
CFTR-Intron10-7420	−	AACCGGUGUCUUCUGAAAU	19	26300
CFTR-Intron10-7421	−	UAACCGGUGUCUUCUGAAAU	20	26301
CFTR-Intron10-7422	−	UUAACCGGUGUCUUCUGAAAU	21	26302
CFTR-Intron10-7423	−	AUUAACCGGUGUCUUCUGAAAU	22	26303
CFTR-Intron10-7424	−	AAUUAACCGGUGUCUUCUGAAAU	23	26304
CFTR-Intron10-7425	−	UAAUUAACCGGUGUCUUCUGAAAU	24	26305
CFTR-Intron10-7426	−	UUGGGGUUUUUUGACAAU	18	26306
CFTR-Intron10-7427	−	UUUGGGGUUUUUUGACAAU	19	26307
CFTR-Intron10-7428	−	UUUUGGGGUUUUUUGACAAU	20	26308
CFTR-Intron10-7429	−	UUUUUGGGGUUUUUUGACAAU	21	26309
CFTR-Intron10-7430	−	AUUUUUGGGGUUUUUUGACAAU	22	26310
CFTR-Intron10-7431	−	AAUUUUUGGGGUUUUUUGACAAU	23	26311
CFTR-Intron10-7432	−	AAAUUUUUGGGGUUUUUUGACAAU	24	26312
CFTR-Intron10-7433	−	AAUGAAAUUAGAAAGAAU	18	26313
CFTR-Intron10-7434	−	GAAUGAAAUUAGAAAGAAU	19	26314
CFTR-Intron10-7435	−	AGAAUGAAAUUAGAAAGAAU	20	26315
CFTR-Intron10-7436	−	CAGAAUGAAAUUAGAAAGAAU	21	26316
CFTR-Intron10-7437	−	CCAGAAUGAAAUUAGAAAGAAU	22	26317
CFTR-Intron10-7438	−	ACCAGAAUGAAAUUAGAAAGAAU	23	26318
CFTR-Intron10-7439	−	GACCAGAAUGAAAUUAGAAAGAAU	24	26319
CFTR-Intron10-7440	−	UAUUUUGAAGAAUUGAAU	18	26320
CFTR-Intron10-7441	−	AUAUUUUGAAGAAUUGAAU	19	26321
CFTR-Intron10-7442	−	CAUAUUUUGAAGAAUUGAAU	20	26322
CFTR-Intron10-7443	−	CCAUAUUUUGAAGAAUUGAAU	21	26323
CFTR-Intron10-7444	−	ACCAUAUUUUGAAGAAUUGAAU	22	26324
CFTR-Intron10-7445	−	AACCAUAUUUUGAAGAAUUGAAU	23	26325
CFTR-Intron10-7446	−	GAACCAUAUUUUGAAGAAUUGAAU	24	26326
CFTR-Intron10-7447	−	UGGUACUACUGUAAUAAU	18	26327
CFTR-Intron10-7448	−	AUGGUACUACUGUAAUAAU	19	26328
CFTR-Intron10-7449	−	UAUGGUACUACUGUAAUAAU	20	26329
CFTR-Intron10-7450	−	AUAUGGUACUACUGUAAUAAU	21	26330
CFTR-Intron10-7451	−	CAUAUGGUACUACUGUAAUAAU	22	26331
CFTR-Intron10-7452	−	ACAUAUGGUACUACUGUAAUAAU	23	26332
CFTR-Intron10-7453	−	UACAUAUGGUACUACUGUAAUAAU	24	26333
CFTR-Intron10-7454	−	GUUUACUAGAAAGAUAAU	18	26334
CFTR-Intron10-7455	−	CGUUUACUAGAAAGAUAAU	19	26335
CFTR-Intron10-501	−	CCGUUUACUAGAAAGAUAAU	20	19387
CFTR-Intron10-7456	−	GCCGUUUACUAGAAAGAUAAU	21	26336
CFTR-Intron10-7457	−	UGCCGUUUACUAGAAAGAUAAU	22	26337
CFTR-Intron10-7458	−	GUGCCGUUUACUAGAAAGAUAAU	23	26338
CFTR-Intron10-7459	−	UGUGCCGUUUACUAGAAAGAUAAU	24	26339
CFTR-Intron10-7460	−	UGACUCUAGUUCACUAAU	18	26340
CFTR-Intron10-7461	−	GUGACUCUAGUUCACUAAU	19	26341
CFTR-Intron10-7462	−	UGUGACUCUAGUUCACUAAU	20	26342
CFTR-Intron10-7463	−	AUGUGACUCUAGUUCACUAAU	21	26343
CFTR-Intron10-7464	−	UAUGUGACUCUAGUUCACUAAU	22	26344
CFTR-Intron10-7465	−	CUAUGUGACUCUAGUUCACUAAU	23	26345
CFTR-Intron10-7466	−	UCUAUGUGACUCUAGUUCACUAAU	24	26346
CFTR-Intron10-7467	−	AACAUUGAAAGGUAACAU	18	26347
CFTR-Intron10-7468	−	AAACAUUGAAAGGUAACAU	19	26348
CFTR-Intron10-7469	−	UAAACAUUGAAAGGUAACAU	20	26349
CFTR-Intron10-7470	−	UUAAACAUUGAAAGGUAACAU	21	26350
CFTR-Intron10-7471	−	UUUAAACAUUGAAAGGUAACAU	22	26351
CFTR-Intron10-7472	−	CUUUAAACAUUGAAAGGUAACAU	23	26352
CFTR-Intron10-7473	−	CCUUUAAACAUUGAAAGGUAACAU	24	26353
CFTR-Intron10-7474	−	UUUUUUCAGUUAAUACAU	18	26354
CFTR-Intron10-7475	−	UUUUUUUCAGUUAAUACAU	19	26355
CFTR-Intron10-1332	−	UUUUUUUUCAGUUAAUACAU	20	20217
CFTR-Intron10-7476	−	AUUUUUUUUCAGUUAAUACAU	21	26356
CFTR-Intron10-7477	−	AAUUUUUUUUCAGUUAAUACAU	22	26357
CFTR-Intron10-7478	−	GAAUUUUUUUUCAGUUAAUACAU	23	26358
CFTR-Intron10-7479	−	UGAAUUUUUUUUCAGUUAAUACAU	24	26359
CFTR-Intron10-7480	−	GCAUAUUUGGAGAUACAU	18	26360
CFTR-Intron10-7481	−	GGCAUAUUUGGAGAUACAU	19	26361
CFTR-Intron10-7482	−	UGGCAUAUUUGGAGAUACAU	20	26362
CFTR-Intron10-7483	−	CUGGCAUAUUUGGAGAUACAU	21	26363
CFTR-Intron10-7484	−	CCUGGCAUAUUUGGAGAUACAU	22	26364
CFTR-Intron10-7485	−	ACCUGGCAUAUUUGGAGAUACAU	23	26365
CFTR-Intron10-7486	−	AACCUGGCAUAUUUGGAGAUACAU	24	26366
CFTR-Intron10-7487	−	CCAGUUGUUUUCCUACAU	18	26367
CFTR-Intron10-7488	−	UCCAGUUGUUUUCCUACAU	19	26368
CFTR-Intron10-7489	−	CUCCAGUUGUUUUCCUACAU	20	26369
CFTR-Intron10-7490	−	UCUCCAGUUGUUUUCCUACAU	21	26370
CFTR-Intron10-7491	−	CUCUCCAGUUGUUUUCCUACAU	22	26371
CFTR-Intron10-7492	−	UCUCUCCAGUUGUUUUCCUACAU	23	26372
CFTR-Intron10-7493	−	CUCUCUCCAGUUGUUUUCCUACAU	24	26373
CFTR-Intron10-7494	−	CUCACCCCUUUCUGCCAU	18	26374
CFTR-Intron10-7495	−	CCUCACCCCUUUCUGCCAU	19	26375
CFTR-Intron10-7496	−	CCCUCACCCCUUUCUGCCAU	20	26376
CFTR-Intron10-7497	−	ACCCUCACCCCUUUCUGCCAU	21	26377
CFTR-Intron10-7498	−	GACCCUCACCCCUUUCUGCCAU	22	26378
CFTR-Intron10-7499	−	AGACCCUCACCCCUUUCUGCCAU	23	26379
CFTR-Intron10-7500	−	GAGACCCUCACCCCUUUCUGCCAU	24	26380
CFTR-Intron10-7501	−	UAAGUUGAACAAUGGCAU	18	26381
CFTR-Intron10-7502	−	AUAAGUUGAACAAUGGCAU	19	26382
CFTR-Intron10-7503	−	GAUAAGUUGAACAAUGGCAU	20	26383
CFTR-Intron10-7504	−	GGAUAAGUUGAACAAUGGCAU	21	26384
CFTR-Intron10-7505	−	UGGAUAAGUUGAACAAUGGCAU	22	26385
CFTR-Intron10-7506	−	AUGGAUAAGUUGAACAAUGGCAU	23	26386
CFTR-Intron10-7507	−	AAUGGAUAAGUUGAACAAUGGCAU	24	26387
CFTR-Intron10-7508	−	AAAAUAUCACCAACUCAU	18	26388
CFTR-Intron10-7509	−	AAAAAUAUCACCAACUCAU	19	26389
CFTR-Intron10-7510	−	GAAAAAUAUCACCAACUCAU	20	26390
CFTR-Intron10-7511	−	UGAAAAAUAUCACCAACUCAU	21	26391
CFTR-Intron10-7512	−	AUGAAAAAUAUCACCAACUCAU	22	26392
CFTR-Intron10-7513	−	AAUGAAAAAUAUCACCAACUCAU	23	26393
CFTR-Intron10-7514	−	UAAUGAAAAAUAUCACCAACUCAU	24	26394
CFTR-Intron10-7515	−	UUUGUAAAUUUGUUUCAU	18	26395
CFTR-Intron10-7516	−	UUUUGUAAAUUUGUUUCAU	19	26396
CFTR-Intron10-7517	−	AUUUUGUAAAUUUGUUUCAU	20	26397
CFTR-Intron10-7518	−	AAUUUUGUAAAUUUGUUUCAU	21	26398
CFTR-Intron10-7519	−	UAAUUUUGUAAAUUUGUUUCAU	22	26399
CFTR-Intron10-7520	−	CUAAUUUUGUAAAUUUGUUUCAU	23	26400
CFTR-Intron10-7521	−	ACUAAUUUUGUAAAUUUGUUUCAU	24	26401
CFTR-Intron10-7522	−	UUUAUCAAUAUCUAAGAU	18	26402
CFTR-Intron10-7523	−	AUUUAUCAAUAUCUAAGAU	19	26403
CFTR-Intron10-7524	−	UAUUUAUCAAUAUCUAAGAU	20	26404
CFTR-Intron10-7525	−	UUAUUUAUCAAUAUCUAAGAU	21	26405
CFTR-Intron10-7526	−	AUUAUUUAUCAAUAUCUAAGAU	22	26406
CFTR-Intron10-7527	−	AAUUAUUUAUCAAUAUCUAAGAU	23	26407
CFTR-Intron10-7528	−	CAAUUAUUUAUCAAUAUCUAAGAU	24	26408
CFTR-Intron10-7529	−	AAGAAUCAAAUUAGAGAU	18	26409
CFTR-Intron10-7530	−	AAAGAAUCAAAUUAGAGAU	19	26410
CFTR-Intron10-7531	−	GAAAGAAUCAAAUUAGAGAU	20	26411
CFTR-Intron10-7532	−	UGAAAGAAUCAAAUUAGAGAU	21	26412
CFTR-Intron10-7533	−	AUGAAAGAAUCAAAUUAGAGAU	22	26413
CFTR-Intron10-7534	−	CAUGAAAGAAUCAAAUUAGAGAU	23	26414
CFTR-Intron10-7535	−	ACAUGAAAGAAUCAAAUUAGAGAU	24	26415
CFTR-Intron10-7536	−	UUUGGAAUUUUGGGAGAU	18	26416
CFTR-Intron10-7537	−	UUUUGGAAUUUUGGGAGAU	19	26417
CFTR-Intron10-7538	−	AUUUUGGAAUUUUGGGAGAU	20	26418
CFTR-Intron10-7539	−	UAUUUUGGAAUUUUGGGAGAU	21	26419
CFTR-Intron10-7540	−	AUAUUUUGGAAUUUUGGGAGAU	22	26420
CFTR-Intron10-7541	−	AAUAUUUUGGAAUUUUGGGAGAU	23	26421
CFTR-Intron10-7542	−	CAAUAUUUUGGAAUUUUGGGAGAU	24	26422
CFTR-Intron10-7543	−	UAUUUCUCUGGGUGAGAU	18	26423
CFTR-Intron10-7544	−	UUAUUUCUCUGGGUGAGAU	19	26424
CFTR-Intron10-7545	−	CUUAUUUCUCUGGGUGAGAU	20	26425
CFTR-Intron10-7546	−	GCUUAUUUCUCUGGGUGAGAU	21	26426
CFTR-Intron10-7547	−	GGCUUAUUUCUCUGGGUGAGAU	22	26427
CFTR-Intron10-7548	−	AGGCUUAUUUCUCUGGGUGAGAU	23	26428
CFTR-Intron10-7549	−	AAGGCUUAUUUCUCUGGGUGAGAU	24	26429
CFTR-Intron10-7550	−	UCUGAAAAAAUAGUAGAU	18	26430
CFTR-Intron10-7551	−	AUCUGAAAAAAUAGUAGAU	19	26431
CFTR-Intron10-7552	−	CAUCUGAAAAAAUAGUAGAU	20	26432
CFTR-Intron10-7553	−	ACAUCUGAAAAAAUAGUAGAU	21	26433
CFTR-Intron10-7554	−	UACAUCUGAAAAAAUAGUAGAU	22	26434
CFTR-Intron10-7555	−	AUACAUCUGAAAAAAUAGUAGAU	23	26435
CFTR-Intron10-7556	−	GAUACAUCUGAAAAAAUAGUAGAU	24	26436
CFTR-Intron10-7557	−	UUGCAGGAGGUGAGGGAU	18	26437
CFTR-Intron10-7558	−	CUUGCAGGAGGUGAGGGAU	19	26438
CFTR-Intron10-7559	−	ACUUGCAGGAGGUGAGGGAU	20	26439
CFTR-Intron10-7560	−	GACUUGCAGGAGGUGAGGGAU	21	26440
CFTR-Intron10-7561	−	AGACUUGCAGGAGGUGAGGGAU	22	26441
CFTR-Intron10-7562	−	AAGACUUGCAGGAGGUGAGGGAU	23	26442
CFTR-Intron10-7563	−	AAAGACUUGCAGGAGGUGAGGGAU	24	26443
CFTR-Intron10-7564	−	AAAGGAAAGAGGGUUGAU	18	26444
CFTR-Intron10-7565	−	UAAAGGAAAGAGGGUUGAU	19	26445
CFTR-Intron10-7566	−	CUAAAGGAAAGAGGGUUGAU	20	26446
CFTR-Intron10-7567	−	UCUAAAGGAAAGAGGGUUGAU	21	26447
CFTR-Intron10-7568	−	UUCUAAAGGAAAGAGGGUUGAU	22	26448
CFTR-Intron10-7569	−	AUUCUAAAGGAAAGAGGGUUGAU	23	26449
CFTR-Intron10-7570	−	GAUUCUAAAGGAAAGAGGGUUGAU	24	26450
CFTR-Intron10-7571	−	AGUUGAACAAUGGCAUAU	18	26451
CFTR-Intron10-7572	−	AAGUUGAACAAUGGCAUAU	19	26452
CFTR-Intron10-7573	−	UAAGUUGAACAAUGGCAUAU	20	26453
CFTR-Intron10-7574	−	AUAAGUUGAACAAUGGCAUAU	21	26454
CFTR-Intron10-7575	−	GAUAAGUUGAACAAUGGCAUAU	22	26455
CFTR-Intron10-7576	−	GGAUAAGUUGAACAAUGGCAUAU	23	26456
CFTR-Intron10-7577	−	UGGAUAAGUUGAACAAUGGCAUAU	24	26457
CFTR-Intron10-7578	−	CAACUUAACCUGGCAUAU	18	26458
CFTR-Intron10-7579	−	ACAACUUAACCUGGCAUAU	19	26459
CFTR-Intron10-7580	−	AACAACUUAACCUGGCAUAU	20	26460
CFTR-Intron10-7581	−	GAACAACUUAACCUGGCAUAU	21	26461
CFTR-Intron10-7582	−	AGAACAACUUAACCUGGCAUAU	22	26462
CFTR-Intron10-7583	−	AAGAACAACUUAACCUGGCAUAU	23	26463
CFTR-Intron10-7584	−	UAAGAACAACUUAACCUGGCAUAU	24	26464
CFTR-Intron10-7585	−	AUUAAAAAAUUAUACUAU	18	26465
CFTR-Intron10-7586	−	UAUUAAAAAAUUAUACUAU	19	26466
CFTR-Intron10-1337	−	CUAUUAAAAAAUUAUACUAU	20	20222
CFTR-Intron10-7587	−	ACUAUUAAAAAAUUAUACUAU	21	26467
CFTR-Intron10-7588	−	CACUAUUAAAAAAUUAUACUAU	22	26468
CFTR-Intron10-7589	−	UCACUAUUAAAAAAUUAUACUAU	23	26469
CFTR-Intron10-7590	−	UUCACUAUUAAAAAAUUAUACUAU	24	26470
CFTR-Intron10-7591	−	UUUAUAAAGCUGUACUAU	18	26471
CFTR-Intron10-7592	−	GUUUAUAAAGCUGUACUAU	19	26472
CFTR-Intron10-7593	−	GGUUUAUAAAGCUGUACUAU	20	26473
CFTR-Intron10-7594	−	AGGUUUAUAAAGCUGUACUAU	21	26474
CFTR-Intron10-7595	−	UAGGUUUAUAAAGCUGUACUAU	22	26475
CFTR-Intron10-7596	−	UUAGGUUUAUAAAGCUGUACUAU	23	26476
CFTR-Intron10-7597	−	UUUAGGUUUAUAAAGCUGUACUAU	24	26477
CFTR-Intron10-7598	−	UAAGGGCAUUCUAAGUAU	18	26478
CFTR-Intron10-7599	−	CUAAGGGCAUUCUAAGUAU	19	26479
CFTR-Intron10-7600	−	CCUAAGGGCAUUCUAAGUAU	20	26480
CFTR-Intron10-7601	−	GCCUAAGGGCAUUCUAAGUAU	21	26481
CFTR-Intron10-7602	−	AGCCUAAGGGCAUUCUAAGUAU	22	26482
CFTR-Intron10-7603	−	UAGCCUAAGGGCAUUCUAAGUAU	23	26483
CFTR-Intron10-7604	−	UUAGCCUAAGGGCAUUCUAAGUAU	24	26484
CFTR-Intron10-7605	−	GCUGCCUUUUAGUAGUAU	18	26485
CFTR-Intron10-7606	−	GGCUGCCUUUUAGUAGUAU	19	26486
CFTR-Intron10-7607	−	AGGCUGCCUUUUAGUAGUAU	20	26487
CFTR-Intron10-7608	−	GAGGCUGCCUUUUAGUAGUAU	21	26488
CFTR-Intron10-7609	−	GGAGGCUGCCUUUUAGUAGUAU	22	26489
CFTR-Intron10-7610	−	AGGAGGCUGCCUUUUAGUAGUAU	23	26490
CFTR-Intron10-7611	−	UAGGAGGCUGCCUUUUAGUAGUAU	24	26491
CFTR-Intron10-7612	−	CUUUUUCAUUGAAUGUAU	18	26492
CFTR-Intron10-7613	−	UCUUUUUCAUUGAAUGUAU	19	26493
CFTR-Intron10-7614	−	UUCUUUUUCAUUGAAUGUAU	20	26494
CFTR-Intron10-7615	−	UUUCUUUUUCAUUGAAUGUAU	21	26495
CFTR-Intron10-7616	−	UUUUCUUUUUCAUUGAAUGUAU	22	26496
CFTR-Intron10-7617	−	CUUUUCUUUUUCAUUGAAUGUAU	23	26497
CFTR-Intron10-7618	−	CCUUUUCUUUUUCAUUGAAUGUAU	24	26498
CFTR-Intron10-7619	−	CAAUUUGGUAAUUUGUAU	18	26499
CFTR-Intron10-7620	−	ACAAUUUGGUAAUUUGUAU	19	26500
CFTR-Intron10-7621	−	UACAAUUUGGUAAUUUGUAU	20	26501
CFTR-Intron10-7622	−	AUACAAUUUGGUAAUUUGUAU	21	26502
CFTR-Intron10-7623	−	AAUACAAUUUGGUAAUUUGUAU	22	26503
CFTR-Intron10-7624	−	CAAUACAAUUUGGUAAUUUGUAU	23	26504
CFTR-Intron10-7625	−	UCAAUACAAUUUGGUAAUUUGUAU	24	26505
CFTR-Intron10-7626	−	AUUUUUAACCUGGAUUAU	18	26506
CFTR-Intron10-7627	−	UAUUUUUAACCUGGAUUAU	19	26507
CFTR-Intron10-7628	−	AUAUUUUUAACCUGGAUUAU	20	26508
CFTR-Intron10-7629	−	UAUAUUUUUAACCUGGAUUAU	21	26509
CFTR-Intron10-7630	−	AUAUAUUUUUAACCUGGAUUAU	22	26510
CFTR-Intron10-7631	−	UAUAUAUUUUUAACCUGGAUUAU	23	26511
CFTR-Intron10-7632	−	AUAUAUAUUUUUAACCUGGAUUAU	24	26512
CFTR-Intron10-7633	−	AAAAGUUUCUCAUCUUAU	18	26513
CFTR-Intron10-7634	−	AAAAAGUUUCUCAUCUUAU	19	26514
CFTR-Intron10-1339	−	UAAAAAGUUUCUCAUCUUAU	20	20224
CFTR-Intron10-7635	−	UUAAAAAGUUUCUCAUCUUAU	21	26515
CFTR-Intron10-7636	−	UUUAAAAAGUUUCUCAUCUUAU	22	26516
CFTR-Intron10-7637	−	AUUUAAAAAGUUUCUCAUCUUAU	23	26517
CFTR-Intron10-7638	−	AAUUUAAAAAGUUUCUCAUCUUAU	24	26518
CFTR-Intron10-7639	−	UUCCCAGCCUCCAGAACU	18	26519
CFTR-Intron10-7640	−	CUUCCCAGCCUCCAGAACU	19	26520
CFTR-Intron10-7641	−	ACUUCCCAGCCUCCAGAACU	20	26521
CFTR-Intron10-7642	−	GACUUCCCAGCCUCCAGAACU	21	26522
CFTR-Intron10-7643	−	GGACUUCCCAGCCUCCAGAACU	22	26523
CFTR-Intron10-7644	−	UGGACUUCCCAGCCUCCAGAACU	23	26524
CFTR-Intron10-7645	−	UUGGACUUCCCAGCCUCCAGAACU	24	26525
CFTR-Intron10-7646	−	GAUUAGGGAAUGCAGACU	18	26526
CFTR-Intron10-7647	−	GGAUUAGGGAAUGCAGACU	19	26527
CFTR-Intron10-7648	−	GGGAUUAGGGAAUGCAGACU	20	26528
CFTR-Intron10-7649	−	AGGGAUUAGGGAAUGCAGACU	21	26529
CFTR-Intron10-7650	−	GAGGGAUUAGGGAAUGCAGACU	22	26530
CFTR-Intron10-7651	−	UGAGGGAUUAGGGAAUGCAGACU	23	26531
CFTR-Intron10-7652	−	GUGAGGGAUUAGGGAAUGCAGACU	24	26532
CFTR-Intron10-7653	−	AGAAUUGAAUAUGAGACU	18	26533
CFTR-Intron10-7654	−	AAGAAUUGAAUAUGAGACU	19	26534
CFTR-Intron10-114	−	GAAGAAUUGAAUAUGAGACU	20	19000
CFTR-Intron10-7655	−	UGAAGAAUUGAAUAUGAGACU	21	26535
CFTR-Intron10-7656	−	UUGAAGAAUUGAAUAUGAGACU	22	26536
CFTR-Intron10-7657	−	UUUGAAGAAUUGAAUAUGAGACU	23	26537
CFTR-Intron10-7658	−	UUUUGAAGAAUUGAAUAUGAGACU	24	26538
CFTR-Intron10-7659	−	UAGAUUAGCUUAUAUACU	18	26539
CFTR-Intron10-7660	−	AUAGAUUAGCUUAUAUACU	19	26540
CFTR-Intron10-7661	−	AAUAGAUUAGCUUAUAUACU	20	26541
CFTR-Intron10-7662	−	GAAUAGAUUAGCUUAUAUACU	21	26542
CFTR-Intron10-7663	−	UGAAUAGAUUAGCUUAUAUACU	22	26543
CFTR-Intron10-7664	−	UUGAAUAGAUUAGCUUAUAUACU	23	26544
CFTR-Intron10-7665	−	UUUGAAUAGAUUAGCUUAUAUACU	24	26545
CFTR-Intron10-7666	−	CCCGUAGUCCCAGCUACU	18	26546
CFTR-Intron10-7667	−	GCCCGUAGUCCCAGCUACU	19	26547
CFTR-Intron10-1343	−	UGCCCGUAGUCCCAGCUACU	20	20228
CFTR-Intron10-7668	−	GUGCCCGUAGUCCCAGCUACU	21	26548
CFTR-Intron10-7669	−	GGUGCCCGUAGUCCCAGCUACU	22	26549
CFTR-Intron10-7670	−	GGGUGCCCGUAGUCCCAGCUACU	23	26550
CFTR-Intron10-7671	−	CGGGUGCCCGUAGUCCCAGCUACU	24	26551
CFTR-Intron10-7672	−	GUGCCUGUAGUCCCAGCUACU	21	26552
CFTR-Intron10-7673	−	UGUGCCUGUAGUCCCAGCUACU	22	26553
CFTR-Intron10-7674	−	GUGUGCCUGUAGUCCCAGCUACU	23	26554
CFTR-Intron10-7675	−	UGUGUGCCUGUAGUCCCAGCUACU	24	26555
CFTR-Intron10-7676	−	UCUUUAUAAAAGAAACCU	18	26556
CFTR-Intron10-7677	−	GUCUUUAUAAAAGAAACCU	19	26557
CFTR-Intron10-7678	−	UGUCUUUAUAAAAGAAACCU	20	26558
CFTR-Intron10-7679	−	GUGUCUUUAUAAAAGAAACCU	21	26559
CFTR-Intron10-7680	−	AGUGUCUUUAUAAAAGAAACCU	22	26560
CFTR-Intron10-7681	−	UAGUGUCUUUAUAAAAGAAACCU	23	26561
CFTR-Intron10-7682	−	UUAGUGUCUUUAUAAAAGAAACCU	24	26562
CFTR-Intron10-7683	−	AGAGAGACCCUCACACCU	18	26563
CFTR-Intron10-7684	−	UAGAGAGACCCUCACACCU	19	26564
CFTR-Intron10-7685	−	UUAGAGAGACCCUCACACCU	20	26565
CFTR-Intron10-7686	−	CUUAGAGAGACCCUCACACCU	21	26566
CFTR-Intron10-7687	−	CCUUAGAGAGACCCUCACACCU	22	26567
CFTR-Intron10-7688	−	ACCUUAGAGAGACCCUCACACCU	23	26568
CFTR-Intron10-7689	−	AACCUUAGAGAGACCCUCACACCU	24	26569
CFTR-Intron10-7690	−	UUCUCCAUAUCCCACCCU	18	26570
CFTR-Intron10-7691	−	CUUCUCCAUAUCCCACCCU	19	26571
CFTR-Intron10-7692	−	UCUUCUCCAUAUCCCACCCU	20	26572
CFTR-Intron10-7693	−	CUCUUCUCCAUAUCCCACCCU	21	26573
CFTR-Intron10-7694	−	CCUCUUCUCCAUAUCCCACCCU	22	26574
CFTR-Intron10-7695	−	UCCUCUUCUCCAUAUCCCACCCU	23	26575
CFTR-Intron10-7696	−	AUCCUCUUCUCCAUAUCCCACCCU	24	26576
CFTR-Intron10-7697	−	AGGAAGGCAGUGGUCCCU	18	26577
CFTR-Intron10-7698	−	GAGGAAGGCAGUGGUCCCU	19	26578
CFTR-Intron10-515	−	AGAGGAAGGCAGUGGUCCCU	20	19401
CFTR-Intron10-7699	−	UAGAGGAAGGCAGUGGUCCCU	21	26579
CFTR-Intron10-7700	−	UUAGAGGAAGGCAGUGGUCCCU	22	26580
CFTR-Intron10-7701	−	GUUAGAGGAAGGCAGUGGUCCCU	23	26581
CFTR-Intron10-7702	−	AGUUAGAGGAAGGCAGUGGUCCCU	24	26582
CFTR-Intron10-7703	−	GGAGGAUCACCUGAGCCU	18	26583
CFTR-Intron10-7704	−	GGGAGGAUCACCUGAGCCU	19	26584
CFTR-Intron10-7705	−	UGGGAGGAUCACCUGAGCCU	20	26585
CFTR-Intron10-7706	−	GUGGGAGGAUCACCUGAGCCU	21	26586
CFTR-Intron10-7707	−	GGUGGGAGGAUCACCUGAGCCU	22	26587
CFTR-Intron10-7708	−	AGGUGGGAGGAUCACCUGAGCCU	23	26588
CFTR-Intron10-7709	−	GAGGUGGGAGGAUCACCUGAGCCU	24	26589
CFTR-Intron10-7710	−	GGGUGUAGGGGUUAGCCU	18	26590
CFTR-Intron10-7711	−	GGGGUGUAGGGGUUAGCCU	19	26591
CFTR-Intron10-7712	−	AGGGGUGUAGGGGUUAGCCU	20	26592
CFTR-Intron10-7713	−	AAGGGGUGUAGGGGUUAGCCU	21	26593
CFTR-Intron10-7714	−	AAAGGGGUGUAGGGGUUAGCCU	22	26594
CFTR-Intron10-7715	−	GAAAGGGGUGUAGGGGUUAGCCU	23	26595
CFTR-Intron10-7716	−	AGAAAGGGGUGUAGGGGUUAGCCU	24	26596
CFTR-Intron10-7717	−	UAUUGCAGGGUGGGGCCU	18	26597
CFTR-Intron10-7718	−	GUAUUGCAGGGUGGGGCCU	19	26598
CFTR-Intron10-7719	−	GGUAUUGCAGGGUGGGGCCU	20	26599
CFTR-Intron10-7720	−	UGGUAUUGCAGGGUGGGGCCU	21	26600
CFTR-Intron10-7721	−	AUGGUAUUGCAGGGUGGGGCCU	22	26601
CFTR-Intron10-7722	−	GAUGGUAUUGCAGGGUGGGGCCU	23	26602
CFTR-Intron10-7723	−	UGAUGGUAUUGCAGGGUGGGGCCU	24	26603
CFTR-Intron10-7724	−	UUUGACCUAAGAUAUCCU	18	26604
CFTR-Intron10-7725	−	CUUUGACCUAAGAUAUCCU	19	26605
CFTR-Intron10-7726	−	UCUUUGACCUAAGAUAUCCU	20	26606
CFTR-Intron10-7727	−	CUCUUUGACCUAAGAUAUCCU	21	26607
CFTR-Intron10-7728	−	CCUCUUUGACCUAAGAUAUCCU	22	26608
CFTR-Intron10-7729	−	UCCUCUUUGACCUAAGAUAUCCU	23	26609
CFTR-Intron10-7730	−	UUCCUCUUUGACCUAAGAUAUCCU	24	26610
CFTR-Intron10-7731	−	AGCUUAUGAAAAGCAGCU	18	26611
CFTR-Intron10-7732	−	UAGCUUAUGAAAAGCAGCU	19	26612
CFTR-Intron10-7733	−	AUAGCUUAUGAAAAGCAGCU	20	26613
CFTR-Intron10-7734	−	UAUAGCUUAUGAAAAGCAGCU	21	26614
CFTR-Intron10-7735	−	UUAUAGCUUAUGAAAAGCAGCU	22	26615
CFTR-Intron10-7736	−	GUUAUAGCUUAUGAAAAGCAGCU	23	26616
CFTR-Intron10-7737	−	AGUUAUAGCUUAUGAAAAGCAGCU	24	26617
CFTR-Intron10-7738	−	AGAUGUGCAAAAAUAGCU	18	26618
CFTR-Intron10-7739	−	UAGAUGUGCAAAAAUAGCU	19	26619
CFTR-Intron10-7740	−	AUAGAUGUGCAAAAAUAGCU	20	26620
CFTR-Intron10-7741	−	GAUAGAUGUGCAAAAAUAGCU	21	26621
CFTR-Intron10-7742	−	UGAUAGAUGUGCAAAAAUAGCU	22	26622
CFTR-Intron10-7743	−	AUGAUAGAUGUGCAAAAAUAGCU	23	26623
CFTR-Intron10-7744	−	UAUGAUAGAUGUGCAAAAAUAGCU	24	26624
CFTR-Intron10-7745	−	UCAGAUUCAGGACAUGCU	18	26625
CFTR-Intron10-7746	−	AUCAGAUUCAGGACAUGCU	19	26626
CFTR-Intron10-7747	−	GAUCAGAUUCAGGACAUGCU	20	26627
CFTR-Intron10-7748	−	UGAUCAGAUUCAGGACAUGCU	21	26628
CFTR-Intron10-7749	−	GUGAUCAGAUUCAGGACAUGCU	22	26629
CFTR-Intron10-7750	−	AGUGAUCAGAUUCAGGACAUGCU	23	26630
CFTR-Intron10-7751	−	AAGUGAUCAGAUUCAGGACAUGCU	24	26631
CFTR-Intron10-7752	−	AGUUUACUAACUCAAUCU	18	26632
CFTR-Intron10-7753	−	GAGUUUACUAACUCAAUCU	19	26633
CFTR-Intron10-118	−	GGAGUUUACUAACUCAAUCU	20	19004
CFTR-Intron10-7754	−	CGGAGUUUACUAACUCAAUCU	21	26634
CFTR-Intron10-7755	−	ACGGAGUUUACUAACUCAAUCU	22	26635
CFTR-Intron10-7756	−	AACGGAGUUUACUAACUCAAUCU	23	26636
CFTR-Intron10-7757	−	AAACGGAGUUUACUAACUCAAUCU	24	26637
CFTR-Intron10-7758	−	UUUAUCAAGUUGUUAUCU	18	26638
CFTR-Intron10-7759	−	AUUUAUCAAGUUGUUAUCU	19	26639
CFTR-Intron10-7760	−	AAUUUAUCAAGUUGUUAUCU	20	26640
CFTR-Intron10-7761	−	AAAUUUAUCAAGUUGUUAUCU	21	26641
CFTR-Intron10-7762	−	UAAAUUUAUCAAGUUGUUAUCU	22	26642
CFTR-Intron10-7763	−	AUAAAUUUAUCAAGUUGUUAUCU	23	26643
CFTR-Intron10-7764	−	GAUAAAUUUAUCAAGUUGUUAUCU	24	26644
CFTR-Intron10-7765	−	UUAGGGAAUGCAGACUCU	18	26645
CFTR-Intron10-7766	−	AUUAGGGAAUGCAGACUCU	19	26646
CFTR-Intron10-119	−	GAUUAGGGAAUGCAGACUCU	20	19005
CFTR-Intron10-7767	−	GGAUUAGGGAAUGCAGACUCU	21	26647
CFTR-Intron10-7768	−	GGGAUUAGGGAAUGCAGACUCU	22	26648
CFTR-Intron10-7769	−	AGGGAUUAGGGAAUGCAGACUCU	23	26649
CFTR-Intron10-7770	−	GAGGGAUUAGGGAAUGCAGACUCU	24	26650
CFTR-Intron10-7771	−	CCAAUAAAAUAAAAGUCU	18	26651
CFTR-Intron10-7772	−	CCCAAUAAAAUAAAAGUCU	19	26652
CFTR-Intron10-7773	−	ACCCAAUAAAAUAAAAGUCU	20	26653
CFTR-Intron10-7774	−	AACCCAAUAAAAUAAAAGUCU	21	26654
CFTR-Intron10-7775	−	AAACCCAAUAAAAUAAAAGUCU	22	26655
CFTR-Intron10-7776	−	AAAACCCAAUAAAAUAAAAGUCU	23	26656
CFTR-Intron10-7777	−	GAAAACCCAAUAAAAUAAAAGUCU	24	26657
CFTR-Intron10-7778	−	GAAUAUUUAAACACUUCU	18	26658
CFTR-Intron10-7779	−	GGAAUAUUUAAACACUUCU	19	26659
CFTR-Intron10-7780	−	GGGAAUAUUUAAACACUUCU	20	26660
CFTR-Intron10-7781	−	UGGGAAUAUUUAAACACUUCU	21	26661
CFTR-Intron10-7782	−	UUGGGAAUAUUUAAACACUUCU	22	26662
CFTR-Intron10-7783	−	CUUGGGAAUAUUUAAACACUUCU	23	26663
CFTR-Intron10-7784	−	CCUUGGGAAUAUUUAAACACUUCU	24	26664
CFTR-Intron10-7785	−	ACCCAAUAAAAUAAAAGU	18	26665
CFTR-Intron10-7786	−	AACCCAAUAAAAUAAAAGU	19	26666
CFTR-Intron10-7787	−	AAACCCAAUAAAAUAAAAGU	20	26667
CFTR-Intron10-7788	−	AAAACCCAAUAAAAUAAAAGU	21	26668
CFTR-Intron10-7789	−	GAAAACCCAAUAAAAUAAAAGU	22	26669
CFTR-Intron10-7790	−	AGAAAACCCAAUAAAAUAAAAGU	23	26670
CFTR-Intron10-7791	−	AAGAAAACCCAAUAAAAUAAAAGU	24	26671
CFTR-Intron10-7792	−	AUGAGGAAGAAAGGAAGU	18	26672
CFTR-Intron10-7793	−	AAUGAGGAAGAAAGGAAGU	19	26673
CFTR-Intron10-1369	−	AAAUGAGGAAGAAAGGAAGU	20	20253
CFTR-Intron10-7794	−	GAAAUGAGGAAGAAAGGAAGU	21	26674
CFTR-Intron10-7795	−	GGAAAUGAGGAAGAAAGGAAGU	22	26675
CFTR-Intron10-7796	−	AGGAAAUGAGGAAGAAAGGAAGU	23	26676
CFTR-Intron10-7797	−	AAGGAAAUGAGGAAGAAAGGAAGU	24	26677
CFTR-Intron10-7798	−	GGAAAGAAGGAAGGAAGU	18	26678
CFTR-Intron10-7799	−	AGGAAAGAAGGAAGGAAGU	19	26679
CFTR-Intron10-7800	−	AAGGAAAGAAGGAAGGAAGU	20	26680
CFTR-Intron10-7801	−	GAAGGAAAGAAGGAAGGAAGU	21	26681
CFTR-Intron10-7802	−	GGAAGGAAAGAAGGAAGGAAGU	22	26682
CFTR-Intron10-7803	−	AGGAAGGAAAGAAGGAAGGAAGU	23	26683
CFTR-Intron10-7804	−	AAGGAAGGAAAGAAGGAAGGAAGU	24	26684
CFTR-Intron10-7805	−	GGUUUGGGAAUAUUAAGU	18	26685
CFTR-Intron10-7806	−	UGGUUUGGGAAUAUUAAGU	19	26686
CFTR-Intron10-7807	−	UUGGUUUGGGAAUAUUAAGU	20	26687
CFTR-Intron10-7808	−	CUUGGUUUGGGAAUAUUAAGU	21	26688
CFTR-Intron10-7809	−	GCUUGGUUUGGGAAUAUUAAGU	22	26689
CFTR-Intron10-7810	−	AGCUUGGUUUGGGAAUAUUAAGU	23	26690
CFTR-Intron10-7811	−	GAGCUUGGUUUGGGAAUAUUAAGU	24	26691
CFTR-Intron10-7812	−	UCUGGUUUGAAGAACAGU	18	26692
CFTR-Intron10-7813	−	GUCUGGUUUGAAGAACAGU	19	26693
CFTR-Intron10-7814	−	UGUCUGGUUUGAAGAACAGU	20	26694
CFTR-Intron10-7815	−	CUGUCUGGUUUGAAGAACAGU	21	26695
CFTR-Intron10-7816	−	CCUGUCUGGUUUGAAGAACAGU	22	26696
CFTR-Intron10-7817	−	ACCUGUCUGGUUUGAAGAACAGU	23	26697
CFTR-Intron10-7818	−	UACCUGUCUGGUUUGAAGAACAGU	24	26698
CFTR-Intron10-7819	−	CAGCUAUGAAGGCAGAGU	18	26699
CFTR-Intron10-7820	−	GCAGCUAUGAAGGCAGAGU	19	26700
CFTR-Intron10-7821	−	AGCAGCUAUGAAGGCAGAGU	20	26701
CFTR-Intron10-7822	−	AAGCAGCUAUGAAGGCAGAGU	21	26702
CFTR-Intron10-7823	−	AAAGCAGCUAUGAAGGCAGAGU	22	26703
CFTR-Intron10-7824	−	AAAAGCAGCUAUGAAGGCAGAGU	23	26704
CFTR-Intron10-7825	−	GAAAAGCAGCUAUGAAGGCAGAGU	24	26705
CFTR-Intron10-7826	−	UUGCUUGAGUCCAGGAGU	18	26706
CFTR-Intron10-7827	−	AUUGCUUGAGUCCAGGAGU	19	26707
CFTR-Intron10-7828	−	AAUUGCUUGAGUCCAGGAGU	20	26708
CFTR-Intron10-7829	−	GAAUUGCUUGAGUCCAGGAGU	21	26709
CFTR-Intron10-7830	−	UGAAUUGCUUGAGUCCAGGAGU	22	26710
CFTR-Intron10-7831	−	GUGAAUUGCUUGAGUCCAGGAGU	23	26711
CFTR-Intron10-7832	−	GGUGAAUUGCUUGAGUCCAGGAGU	24	26712
CFTR-Intron10-7833	−	GGAAGCAAGGAGAUGAGU	18	26713
CFTR-Intron10-7834	−	AGGAAGCAAGGAGAUGAGU	19	26714
CFTR-Intron10-7835	−	GAGGAAGCAAGGAGAUGAGU	20	26715
CFTR-Intron10-7836	−	GGAGGAAGCAAGGAGAUGAGU	21	26716
CFTR-Intron10-7837	−	GGGAGGAAGCAAGGAGAUGAGU	22	26717
CFTR-Intron10-7838	−	AGGGAGGAAGCAAGGAGAUGAGU	23	26718
CFTR-Intron10-7839	−	AAGGGAGGAAGCAAGGAGAUGAGU	24	26719
CFTR-Intron10-7840	−	UAGUGGAAGUAGUAUAGU	18	26720
CFTR-Intron10-7841	−	GUAGUGGAAGUAGUAUAGU	19	26721
CFTR-Intron10-533	−	AGUAGUGGAAGUAGUAUAGU	20	19419
CFTR-Intron10-7842	−	UAGUAGUGGAAGUAGUAUAGU	21	26722
CFTR-Intron10-7843	−	GUAGUAGUGGAAGUAGUAUAGU	22	26723
CFTR-Intron10-7844	−	GGUAGUAGUGGAAGUAGUAUAGU	23	26724
CFTR-Intron10-7845	−	AGGUAGUAGUGGAAGUAGUAUAGU	24	26725
CFTR-Intron10-7846	−	GAAGAGGGGGCUGGUAGU	18	26726
CFTR-Intron10-7847	−	GGAAGAGGGGGCUGGUAGU	19	26727
CFTR-Intron10-7848	−	AGGAAGAGGGGGCUGGUAGU	20	26728
CFTR-Intron10-7849	−	AAGGAAGAGGGGGCUGGUAGU	21	26729
CFTR-Intron10-7850	−	CAAGGAAGAGGGGGCUGGUAGU	22	26730
CFTR-Intron10-7851	−	UCAAGGAAGAGGGGGCUGGUAGU	23	26731
CFTR-Intron10-7852	−	UUCAAGGAAGAGGGGGCUGGUAGU	24	26732
CFTR-Intron10-7853	−	GAUGCUAAUCAUCUCCGU	18	26733
CFTR-Intron10-7854	−	UGAUGCUAAUCAUCUCCGU	19	26734
CFTR-Intron10-7855	−	GUGAUGCUAAUCAUCUCCGU	20	26735
CFTR-Intron10-7856	−	CGUGAUGCUAAUCAUCUCCGU	21	26736
CFTR-Intron10-7857	−	ACGUGAUGCUAAUCAUCUCCGU	22	26737
CFTR-Intron10-7858	−	CACGUGAUGCUAAUCAUCUCCGU	23	26738
CFTR-Intron10-7859	−	CCACGUGAUGCUAAUCAUCUCCGU	24	26739
CFTR-Intron10-7860	−	GCAGCUAUGCCAGCAGGU	18	26740
CFTR-Intron10-7861	−	UGCAGCUAUGCCAGCAGGU	19	26741
CFTR-Intron10-7862	−	GUGCAGCUAUGCCAGCAGGU	20	26742
CFTR-Intron10-7863	−	AGUGCAGCUAUGCCAGCAGGU	21	26743
CFTR-Intron10-7864	−	CAGUGCAGCUAUGCCAGCAGGU	22	26744
CFTR-Intron10-7865	−	UCAGUGCAGCUAUGCCAGCAGGU	23	26745
CFTR-Intron10-7866	−	AUCAGUGCAGCUAUGCCAGCAGGU	24	26746
CFTR-Intron10-7867	−	UCAGUGCUUUUUCGAGGU	18	26747
CFTR-Intron10-7868	−	AUCAGUGCUUUUUCGAGGU	19	26748
CFTR-Intron10-7869	−	AAUCAGUGCUUUUUCGAGGU	20	26749
CFTR-Intron10-7870	−	AAAUCAGUGCUUUUUCGAGGU	21	26750
CFTR-Intron10-7871	−	AAAAUCAGUGCUUUUUCGAGGU	22	26751
CFTR-Intron10-7872	−	UAAAAUCAGUGCUUUUUCGAGGU	23	26752
CFTR-Intron10-7873	−	AUAAAAUCAGUGCUUUUUCGAGGU	24	26753
CFTR-Intron10-7874	−	CAAAGACUUGCAGGAGGU	18	26754
CFTR-Intron10-7875	−	ACAAAGACUUGCAGGAGGU	19	26755
CFTR-Intron10-7876	−	AACAAAGACUUGCAGGAGGU	20	26756
CFTR-Intron10-7877	−	GAACAAAGACUUGCAGGAGGU	21	26757
CFTR-Intron10-7878	−	UGAACAAAGACUUGCAGGAGGU	22	26758
CFTR-Intron10-7879	−	UUGAACAAAGACUUGCAGGAGGU	23	26759
CFTR-Intron10-7880	−	UUUGAACAAAGACUUGCAGGAGGU	24	26760
CFTR-Intron10-7881	−	GUAAUCGGCGGUGGAGGU	18	26761
CFTR-Intron10-7882	−	AGUAAUCGGCGGUGGAGGU	19	26762
CFTR-Intron10-536	−	AAGUAAUCGGCGGUGGAGGU	20	19422
CFTR-Intron10-7883	−	GAAGUAAUCGGCGGUGGAGGU	21	26763
CFTR-Intron10-7884	−	AGAAGUAAUCGGCGGUGGAGGU	22	26764
CFTR-Intron10-7885	−	GAGAAGUAAUCGGCGGUGGAGGU	23	26765
CFTR-Intron10-7886	−	AGAGAAGUAAUCGGCGGUGGAGGU	24	26766
CFTR-Intron10-7887	−	UACUUGGGAGGCUGAGGU	18	26767
CFTR-Intron10-7888	−	CUACUUGGGAGGCUGAGGU	19	26768
CFTR-Intron10-713	−	GCUACUUGGGAGGCUGAGGU	20	19599
CFTR-Intron10-7889	−	AGCUACUUGGGAGGCUGAGGU	21	26769
CFTR-Intron10-7890	−	CAGCUACUUGGGAGGCUGAGGU	22	26770
CFTR-Intron10-7891	−	CCAGCUACUUGGGAGGCUGAGGU	23	26771
CFTR-Intron10-7892	−	CCCAGCUACUUGGGAGGCUGAGGU	24	26772
CFTR-Intron10-7893	−	AGGAGCCAAAAAUUGGGU	18	26773
CFTR-Intron10-7894	−	CAGGAGCCAAAAAUUGGGU	19	26774
CFTR-Intron10-537	−	UCAGGAGCCAAAAAUUGGGU	20	19423
CFTR-Intron10-7895	−	UUCAGGAGCCAAAAAUUGGGU	21	26775
CFTR-Intron10-7896	−	UUUCAGGAGCCAAAAAUUGGGU	22	26776
CFTR-Intron10-7897	−	CUUUCAGGAGCCAAAAAUUGGGU	23	26777
CFTR-Intron10-7898	−	GCUUUCAGGAGCCAAAAAUUGGGU	24	26778
CFTR-Intron10-7899	−	UGACUAUACCUGUCUGGU	18	26779
CFTR-Intron10-7900	−	CUGACUAUACCUGUCUGGU	19	26780
CFTR-Intron10-7901	−	ACUGACUAUACCUGUCUGGU	20	26781
CFTR-Intron10-7902	−	GACUGACUAUACCUGUCUGGU	21	26782
CFTR-Intron10-7903	−	GGACUGACUAUACCUGUCUGGU	22	26783
CFTR-Intron10-7904	−	GGGACUGACUAUACCUGUCUGGU	23	26784
CFTR-Intron10-7905	−	UGGGACUGACUAUACCUGUCUGGU	24	26785
CFTR-Intron10-7906	−	UUUUGGAUGGAGCUUGGU	18	26786
CFTR-Intron10-7907	−	GUUUUGGAUGGAGCUUGGU	19	26787
CFTR-Intron10-7908	−	GGUUUUGGAUGGAGCUUGGU	20	26788
CFTR-Intron10-7909	−	AGGUUUUGGAUGGAGCUUGGU	21	26789
CFTR-Intron10-7910	−	CAGGUUUUGGAUGGAGCUUGGU	22	26790
CFTR-Intron10-7911	−	ACAGGUUUUGGAUGGAGCUUGGU	23	26791
CFTR-Intron10-7912	−	AACAGGUUUUGGAUGGAGCUUGGU	24	26792
CFTR-Intron10-7913	−	GGUACUUUGUAGAAAUGU	18	26793
CFTR-Intron10-7914	−	UGGUACUUUGUAGAAAUGU	19	26794
CFTR-Intron10-7915	−	GUGGUACUUUGUAGAAAUGU	20	26795
CFTR-Intron10-7916	−	UGUGGUACUUUGUAGAAAUGU	21	26796
CFTR-Intron10-7917	−	CUGUGGUACUUUGUAGAAAUGU	22	26797
CFTR-Intron10-7918	−	GCUGUGGUACUUUGUAGAAAUGU	23	26798
CFTR-Intron10-7919	−	AGCUGUGGUACUUUGUAGAAAUGU	24	26799
CFTR-Intron10-7920	−	CACCCCUUUCUGCCAUGU	18	26800
CFTR-Intron10-7921	−	UCACCCCUUUCUGCCAUGU	19	26801
CFTR-Intron10-7922	−	CUCACCCCUUUCUGCCAUGU	20	26802
CFTR-Intron10-7923	−	CCUCACCCCUUUCUGCCAUGU	21	26803
CFTR-Intron10-7924	−	CCCUCACCCCUUUCUGCCAUGU	22	26804
CFTR-Intron10-7925	−	ACCCUCACCCCUUUCUGCCAUGU	23	26805
CFTR-Intron10-7926	−	GACCCUCACCCCUUUCUGCCAUGU	24	26806
CFTR-Intron10-7927	−	CCCAGCCUCCAGAACUGU	18	26807
CFTR-Intron10-7928	−	UCCCAGCCUCCAGAACUGU	19	26808
CFTR-Intron10-7929	−	UUCCCAGCCUCCAGAACUGU	20	26809
CFTR-Intron10-7930	−	CUUCCCAGCCUCCAGAACUGU	21	26810
CFTR-Intron10-7931	−	ACUUCCCAGCCUCCAGAACUGU	22	26811
CFTR-Intron10-7932	−	GACUUCCCAGCCUCCAGAACUGU	23	26812
CFTR-Intron10-7933	−	GGACUUCCCAGCCUCCAGAACUGU	24	26813
CFTR-Intron10-7934	−	GGGAGGGUAGAAUACUGU	18	26814
CFTR-Intron10-7935	−	AGGGAGGGUAGAAUACUGU	19	26815
CFTR-Intron10-7936	−	CAGGGAGGGUAGAAUACUGU	20	26816
CFTR-Intron10-7937	−	ACAGGGAGGGUAGAAUACUGU	21	26817
CFTR-Intron10-7938	−	GACAGGGAGGGUAGAAUACUGU	22	26818
CFTR-Intron10-7939	−	AGACAGGGAGGGUAGAAUACUGU	23	26819
CFTR-Intron10-7940	−	AAGACAGGGAGGGUAGAAUACUGU	24	26820
CFTR-Intron10-7941	−	GUUUUUAGGCUAUUCUGU	18	26821
CFTR-Intron10-7942	−	UGUUUUUAGGCUAUUCUGU	19	26822
CFTR-Intron10-541	−	AUGUUUUUAGGCUAUUCUGU	20	19427
CFTR-Intron10-7943	−	AAUGUUUUUAGGCUAUUCUGU	21	26823
CFTR-Intron10-7944	−	UAAUGUUUUUAGGCUAUUCUGU	22	26824
CFTR-Intron10-7945	−	CUAAUGUUUUUAGGCUAUUCUGU	23	26825
CFTR-Intron10-7946	−	GCUAAUGUUUUUAGGCUAUUCUGU	24	26826
CFTR-Intron10-7947	−	AUGGCAUCUCACCAGUGU	18	26827
CFTR-Intron10-7948	−	UAUGGCAUCUCACCAGUGU	19	26828
CFTR-Intron10-7949	−	UUAUGGCAUCUCACCAGUGU	20	26829
CFTR-Intron10-7950	−	CUUAUGGCAUCUCACCAGUGU	21	26830
CFTR-Intron10-7951	−	GCUUAUGGCAUCUCACCAGUGU	22	26831
CFTR-Intron10-7952	−	GGCUUAUGGCAUCUCACCAGUGU	23	26832
CFTR-Intron10-7953	−	UGGCUUAUGGCAUCUCACCAGUGU	24	26833
CFTR-Intron10-7954	−	GGCAUCUCACCAGUGUGU	18	26834
CFTR-Intron10-7955	−	UGGCAUCUCACCAGUGUGU	19	26835
CFTR-Intron10-542	−	AUGGCAUCUCACCAGUGUGU	20	19428
CFTR-Intron10-7956	−	UAUGGCAUCUCACCAGUGUGU	21	26836
CFTR-Intron10-7957	−	UUAUGGCAUCUCACCAGUGUGU	22	26837
CFTR-Intron10-7958	−	CUUAUGGCAUCUCACCAGUGUGU	23	26838
CFTR-Intron10-7959	−	GCUUAUGGCAUCUCACCAGUGUGU	24	26839
CFTR-Intron10-7960	−	GUAUGUAUAUAUGUGUGU	18	26840
CFTR-Intron10-7961	−	UGUAUGUAUAUAUGUGUGU	19	26841
CFTR-Intron10-7962	−	AUGUAUGUAUAUAUGUGUGU	20	26842
CFTR-Intron10-7963	−	UAUGUAUGUAUAUAUGUGUGU	21	26843
CFTR-Intron10-7964	−	AUAUGUAUGUAUAUAUGUGUGU	22	26844
CFTR-Intron10-7965	−	CAUAUGUAUGUAUAUAUGUGUGU	23	26845
CFTR-Intron10-7966	−	UCAUAUGUAUGUAUAUAUGUGUGU	24	26846
CFTR-Intron10-7967	−	UCUAACUUUUCUUAUUGU	18	26847
CFTR-Intron10-7968	−	UUCUAACUUUUCUUAUUGU	19	26848
CFTR-Intron10-7969	−	CUUCUAACUUUUCUUAUUGU	20	26849
CFTR-Intron10-7970	−	ACUUCUAACUUUUCUUAUUGU	21	26850
CFTR-Intron10-7971	−	UACUUCUAACUUUUCUUAUUGU	22	26851
CFTR-Intron10-7972	−	UUACUUCUAACUUUUCUUAUUGU	23	26852
CFTR-Intron10-7973	−	UUUACUUCUAACUUUUCUUAUUGU	24	26853
CFTR-Intron10-7974	−	GGACCAAAACUUUAUUGU	18	26854
CFTR-Intron10-7975	−	AGGACCAAAACUUUAUUGU	19	26855
CFTR-Intron10-7976	−	AAGGACCAAAACUUUAUUGU	20	26856
CFTR-Intron10-7977	−	AAAGGACCAAAACUUUAUUGU	21	26857
CFTR-Intron10-7978	−	AAAAGGACCAAAACUUUAUUGU	22	26858
CFTR-Intron10-7979	−	CAAAAGGACCAAAACUUUAUUGU	23	26859
CFTR-Intron10-7980	−	GCAAAAGGACCAAAACUUUAUUGU	24	26860
CFTR-Intron10-7981	−	UACCCAAUAAAAAAAAUU	18	26861
CFTR-Intron10-7982	−	UUACCCAAUAAAAAAAAUU	19	26862
CFTR-Intron10-124	−	GUUACCCAAUAAAAAAAAUU	20	19010
CFTR-Intron10-7983	−	UGUUACCCAAUAAAAAAAAUU	21	26863
CFTR-Intron10-7984	−	UUGUUACCCAAUAAAAAAAAUU	22	26864
CFTR-Intron10-7985	−	AUUGUUACCCAAUAAAAAAAAUU	23	26865
CFTR-Intron10-7986	−	UAUUGUUACCCAAUAAAAAAAAUU	24	26866
CFTR-Intron10-7987	−	AGAAAUACCGAGAAAAUU	18	26867
CFTR-Intron10-7988	−	UAGAAAUACCGAGAAAAUU	19	26868
CFTR-Intron10-7989	−	CUAGAAAUACCGAGAAAAUU	20	26869
CFTR-Intron10-7990	−	CCUAGAAAUACCGAGAAAAUU	21	26870
CFTR-Intron10-7991	−	GCCUAGAAAUACCGAGAAAAUU	22	26871
CFTR-Intron10-7992	−	AGCCUAGAAAUACCGAGAAAAUU	23	26872
CFTR-Intron10-7993	−	UAGCCUAGAAAUACCGAGAAAAUU	24	26873
CFTR-Intron10-7994	−	UUAAUGAAAAUAGAAAUU	18	26874
CFTR-Intron10-7995	−	GUUAAUGAAAAUAGAAAUU	19	26875
CFTR-Intron10-7996	−	UGUUAAUGAAAAUAGAAAUU	20	26876
CFTR-Intron10-7997	−	AUGUUAAUGAAAAUAGAAAUU	21	26877
CFTR-Intron10-7998	−	AAUGUUAAUGAAAAUAGAAAUU	22	26878
CFTR-Intron10-7999	−	AAAUGUUAAUGAAAAUAGAAAUU	23	26879
CFTR-Intron10-8000	−	AAAAUGUUAAUGAAAAUAGAAAUU	24	26880
CFTR-Intron10-8001	−	CUACAGUUGCCUGCAAUU	18	26881
CFTR-Intron10-8002	−	GCUACAGUUGCCUGCAAUU	19	26882
CFTR-Intron10-8003	−	AGCUACAGUUGCCUGCAAUU	20	26883
CFTR-Intron10-8004	−	CAGCUACAGUUGCCUGCAAUU	21	26884
CFTR-Intron10-8005	−	GCAGCUACAGUUGCCUGCAAUU	22	26885
CFTR-Intron10-8006	−	UGCAGCUACAGUUGCCUGCAAUU	23	26886
CFTR-Intron10-8007	−	CUGCAGCUACAGUUGCCUGCAAUU	24	26887
CFTR-Intron10-8008	−	UAUCAAUAUUUUGGAAUU	18	26888
CFTR-Intron10-8009	−	UUAUCAAUAUUUUGGAAUU	19	26889
CFTR-Intron10-8010	−	UUUAUCAAUAUUUUGGAAUU	20	26890
CFTR-Intron10-8011	−	UUUUAUCAAUAUUUUGGAAUU	21	26891
CFTR-Intron10-8012	−	GUUUUAUCAAUAUUUUGGAAUU	22	26892
CFTR-Intron10-8013	−	AGUUUUAUCAAUAUUUUGGAAUU	23	26893
CFTR-Intron10-8014	−	UAGUUUUAUCAAUAUUUUGGAAUU	24	26894
CFTR-Intron10-8015	−	GGUACUACUGUAAUAAUU	18	26895
CFTR-Intron10-8016	−	UGGUACUACUGUAAUAAUU	19	26896
CFTR-Intron10-1381	−	AUGGUACUACUGUAAUAAUU	20	20265
CFTR-Intron10-8017	−	UAUGGUACUACUGUAAUAAUU	21	26897
CFTR-Intron10-8018	−	AUAUGGUACUACUGUAAUAAUU	22	26898
CFTR-Intron10-8019	−	CAUAUGGUACUACUGUAAUAAUU	23	26899
CFTR-Intron10-8020	−	ACAUAUGGUACUACUGUAAUAAUU	24	26900
CFTR-Intron10-8021	−	AAAUAUCACCAACUCAUU	18	26901
CFTR-Intron10-8022	−	AAAAUAUCACCAACUCAUU	19	26902
CFTR-Intron10-544	−	AAAAAUAUCACCAACUCAUU	20	19430
CFTR-Intron10-8023	−	GAAAAAUAUCACCAACUCAUU	21	26903
CFTR-Intron10-8024	−	UGAAAAAUAUCACCAACUCAUU	22	26904
CFTR-Intron10-8025	−	AUGAAAAAUAUCACCAACUCAUU	23	26905
CFTR-Intron10-8026	−	AAUGAAAAAUAUCACCAACUCAUU	24	26906
CFTR-Intron10-8027	−	GUAGGAAGUGAUCAGAUU	18	26907
CFTR-Intron10-8028	−	AGUAGGAAGUGAUCAGAUU	19	26908
CFTR-Intron10-8029	−	UAGUAGGAAGUGAUCAGAUU	20	26909
CFTR-Intron10-8030	−	AUAGUAGGAAGUGAUCAGAUU	21	26910
CFTR-Intron10-8031	−	UAUAGUAGGAAGUGAUCAGAUU	22	26911
CFTR-Intron10-8032	−	GUAUAGUAGGAAGUGAUCAGAUU	23	26912
CFTR-Intron10-8033	−	AGUAUAGUAGGAAGUGAUCAGAUU	24	26913
CFTR-Intron10-8034	−	AGCUGGCUAUCCAGGAUU	18	26914
CFTR-Intron10-8035	−	CAGCUGGCUAUCCAGGAUU	19	26915
CFTR-Intron10-8036	−	ACAGCUGGCUAUCCAGGAUU	20	26916
CFTR-Intron10-8037	−	GACAGCUGGCUAUCCAGGAUU	21	26917
CFTR-Intron10-8038	−	AGACAGCUGGCUAUCCAGGAUU	22	26918
CFTR-Intron10-8039	−	AAGACAGCUGGCUAUCCAGGAUU	23	26919
CFTR-Intron10-8040	−	GAAGACAGCUGGCUAUCCAGGAUU	24	26920
CFTR-Intron10-8041	−	UGCAGGAGGUGAGGGAUU	18	26921
CFTR-Intron10-8042	−	UUGCAGGAGGUGAGGGAUU	19	26922
CFTR-Intron10-1384	−	CUUGCAGGAGGUGAGGGAUU	20	20268
CFTR-Intron10-8043	−	ACUUGCAGGAGGUGAGGGAUU	21	26923
CFTR-Intron10-8044	−	GACUUGCAGGAGGUGAGGGAUU	22	26924
CFTR-Intron10-8045	−	AGACUUGCAGGAGGUGAGGGAUU	23	26925
CFTR-Intron10-8046	−	AAGACUUGCAGGAGGUGAGGGAUU	24	26926
CFTR-Intron10-8047	−	AAUAGUUUUAUCAAUAUU	18	26927
CFTR-Intron10-8048	−	AAAUAGUUUUAUCAAUAUU	19	26928
CFTR-Intron10-8049	−	CAAAUAGUUUUAUCAAUAUU	20	26929
CFTR-Intron10-8050	−	GCAAAUAGUUUUAUCAAUAUU	21	26930
CFTR-Intron10-8051	−	UGCAAAUAGUUUUAUCAAUAUU	22	26931
CFTR-Intron10-8052	−	CUGCAAAUAGUUUUAUCAAUAUU	23	26932
CFTR-Intron10-8053	−	UCUGCAAAUAGUUUUAUCAAUAUU	24	26933
CFTR-Intron10-8054	−	GAUGAGGAGAACCAUAUU	18	26934
CFTR-Intron10-8055	−	AGAUGAGGAGAACCAUAUU	19	26935
CFTR-Intron10-8056	−	AAGAUGAGGAGAACCAUAUU	20	26936
CFTR-Intron10-8057	−	UAAGAUGAGGAGAACCAUAUU	21	26937
CFTR-Intron10-8058	−	CUAAGAUGAGGAGAACCAUAUU	22	26938
CFTR-Intron10-8059	−	UCUAAGAUGAGGAGAACCAUAUU	23	26939
CFTR-Intron10-8060	−	AUCUAAGAUGAGGAGAACCAUAUU	24	26940
CFTR-Intron10-8061	−	AACUUAACCUGGCAUAUU	18	26941
CFTR-Intron10-8062	−	CAACUUAACCUGGCAUAUU	19	26942
CFTR-Intron10-546	−	ACAACUUAACCUGGCAUAUU	20	19432
CFTR-Intron10-8063	−	AACAACUUAACCUGGCAUAUU	21	26943
CFTR-Intron10-8064	−	GAACAACUUAACCUGGCAUAUU	22	26944
CFTR-Intron10-8065	−	AGAACAACUUAACCUGGCAUAUU	23	26945
CFTR-Intron10-8066	−	AAGAACAACUUAACCUGGCAUAUU	24	26946
CFTR-Intron10-8067	−	UGCUCUCUUUUAACUAUU	18	26947
CFTR-Intron10-8068	−	UUGCUCUCUUUUAACUAUU	19	26948
CFTR-Intron10-8069	−	CUUGCUCUCUUUUAACUAUU	20	26949
CFTR-Intron10-8070	−	ACUUGCUCUCUUUUAACUAUU	21	26950
CFTR-Intron10-8071	−	AACUUGCUCUCUUUUAACUAUU	22	26951
CFTR-Intron10-8072	−	AAACUUGCUCUCUUUUAACUAUU	23	26952
CFTR-Intron10-8073	−	AAAACUUGCUCUCUUUUAACUAUU	24	26953
CFTR-Intron10-8074	−	GUUUUUCUUUCCUUUAUU	18	26954
CFTR-Intron10-8075	−	UGUUUUUCUUUCCUUUAUU	19	26955
CFTR-Intron10-8076	−	AUGUUUUUCUUUCCUUUAUU	20	26956
CFTR-Intron10-8077	−	UAUGUUUUUCUUUCCUUUAUU	21	26957
CFTR-Intron10-8078	−	UUAUGUUUUUCUUUCCUUUAUU	22	26958
CFTR-Intron10-8079	−	UUUAUGUUUUUCUUUCCUUUAUU	23	26959
CFTR-Intron10-8080	−	UUUUAUGUUUUUCUUUCCUUUAUU	24	26960
CFTR-Intron10-8081	−	GGGAAUAUUUAAACACUU	18	26961
CFTR-Intron10-8082	−	UGGGAAUAUUUAAACACUU	19	26962
CFTR-Intron10-8083	−	UUGGGAAUAUUUAAACACUU	20	26963
CFTR-Intron10-8084	−	CUUGGGAAUAUUUAAACACUU	21	26964
CFTR-Intron10-8085	−	CCUUGGGAAUAUUUAAACACUU	22	26965
CFTR-Intron10-8086	−	CCCUUGGGAAUAUUUAAACACUU	23	26966
CFTR-Intron10-8087	−	UCCCUUGGGAAUAUUUAAACACUU	24	26967
CFTR-Intron10-8088	−	CUUGUAAUCCUAGCACUU	18	26968
CFTR-Intron10-8089	−	ACUUGUAAUCCUAGCACUU	19	26969
CFTR-Intron10-8090	−	CACUUGUAAUCCUAGCACUU	20	26970
CFTR-Intron10-8091	−	ACACUUGUAAUCCUAGCACUU	21	26971
CFTR-Intron10-8092	−	CACACUUGUAAUCCUAGCACUU	22	26972
CFTR-Intron10-8093	−	UCACACUUGUAAUCCUAGCACUU	23	26973
CFTR-Intron10-8094	−	CUCACACUUGUAAUCCUAGCACUU	24	26974
CFTR-Intron10-8095	−	GAAUUGAAUAUGAGACUU	18	26975
CFTR-Intron10-8096	−	AGAAUUGAAUAUGAGACUU	19	26976
CFTR-Intron10-1394	−	AAGAAUUGAAUAUGAGACUU	20	20278
CFTR-Intron10-8097	−	GAAGAAUUGAAUAUGAGACUU	21	26977
CFTR-Intron10-8098	−	UGAAGAAUUGAAUAUGAGACUU	22	26978
CFTR-Intron10-8099	−	UUGAAGAAUUGAAUAUGAGACUU	23	26979
CFTR-Intron10-8100	−	UUUGAAGAAUUGAAUAUGAGACUU	24	26980
CFTR-Intron10-8101	−	UGUGCCUGUAGUCCCAGCUACUU	23	26981
CFTR-Intron10-8102	−	GUGUGCCUGUAGUCCCAGCUACUU	24	26982
CFTR-Intron10-8103	−	AUUGCAGGGUGGGGCCUU	18	26983
CFTR-Intron10-8104	−	UAUUGCAGGGUGGGGCCUU	19	26984
CFTR-Intron10-721	−	GUAUUGCAGGGUGGGGCCUU	20	19607
CFTR-Intron10-8105	−	GGUAUUGCAGGGUGGGGCCUU	21	26985
CFTR-Intron10-8106	−	UGGUAUUGCAGGGUGGGGCCUU	22	26986
CFTR-Intron10-8107	−	AUGGUAUUGCAGGGUGGGGCCUU	23	26987
CFTR-Intron10-8108	−	GAUGGUAUUGCAGGGUGGGGCCUU	24	26988
CFTR-Intron10-8109	−	ACAGUGCAGUUAUAGCUU	18	26989
CFTR-Intron10-8110	−	GACAGUGCAGUUAUAGCUU	19	26990
CFTR-Intron10-8111	−	UGACAGUGCAGUUAUAGCUU	20	26991
CFTR-Intron10-8112	−	CUGACAGUGCAGUUAUAGCUU	21	26992
CFTR-Intron10-8113	−	GCUGACAGUGCAGUUAUAGCUU	22	26993
CFTR-Intron10-8114	−	GGCUGACAGUGCAGUUAUAGCUU	23	26994
CFTR-Intron10-8115	−	UGGCUGACAGUGCAGUUAUAGCUU	24	26995
CFTR-Intron10-8116	−	AUUAAAUGUCUUGCGCUU	18	26996
CFTR-Intron10-8117	−	CAUUAAAUGUCUUGCGCUU	19	26997
CFTR-Intron10-8118	−	ACAUUAAAUGUCUUGCGCUU	20	26998
CFTR-Intron10-8119	−	UACAUUAAAUGUCUUGCGCUU	21	26999
CFTR-Intron10-8120	−	CUACAUUAAAUGUCUUGCGCUU	22	27000
CFTR-Intron10-8121	−	UCUACAUUAAAUGUCUUGCGCUU	23	27001
CFTR-Intron10-8122	−	GUCUACAUUAAAUGUCUUGCGCUU	24	27002
CFTR-Intron10-8123	−	GGCAAUAGGUAUUUGCUU	18	27003
CFTR-Intron10-8124	−	GGGCAAUAGGUAUUUGCUU	19	27004
CFTR-Intron10-8125	−	AGGGCAAUAGGUAUUUGCUU	20	27005
CFTR-Intron10-8126	−	AAGGGCAAUAGGUAUUUGCUU	21	27006
CFTR-Intron10-8127	−	AAAGGGCAAUAGGUAUUUGCUU	22	27007
CFTR-Intron10-8128	−	UAAAGGGCAAUAGGUAUUUGCUU	23	27008
CFTR-Intron10-8129	−	CUAAAGGGCAAUAGGUAUUUGCUU	24	27009
CFTR-Intron10-8130	−	AAUUUAACUGAAUAUCUU	18	27010
CFTR-Intron10-8131	−	AAAUUUAACUGAAUAUCUU	19	27011
CFTR-Intron10-8132	−	GAAAUUUAACUGAAUAUCUU	20	27012
CFTR-Intron10-8133	−	AGAAAUUUAACUGAAUAUCUU	21	27013
CFTR-Intron10-8134	−	UAGAAAUUUAACUGAAUAUCUU	22	27014
CFTR-Intron10-8135	−	AUAGAAAUUUAACUGAAUAUCUU	23	27015
CFTR-Intron10-8136	−	UAUAGAAAUUUAACUGAAUAUCUU	24	27016
CFTR-Intron10-8137	−	AUAAUUAACCGGUGUCUU	18	27017
CFTR-Intron10-8138	−	UAUAAUUAACCGGUGUCUU	19	27018
CFTR-Intron10-8139	−	UUAUAAUUAACCGGUGUCUU	20	27019
CFTR-Intron10-8140	−	GUUAUAAUUAACCGGUGUCUU	21	27020
CFTR-Intron10-8141	−	UGUUAUAAUUAACCGGUGUCUU	22	27021
CFTR-Intron10-8142	−	CUGUUAUAAUUAACCGGUGUCUU	23	27022
CFTR-Intron10-8143	−	ACUGUUAUAAUUAACCGGUGUCUU	24	27023
CFTR-Intron10-8144	−	UUCUAAGUAUUAGAGGUU	18	27024
CFTR-Intron10-8145	−	AUUCUAAGUAUUAGAGGUU	19	27025
CFTR-Intron10-8146	−	CAUUCUAAGUAUUAGAGGUU	20	27026
CFTR-Intron10-8147	−	GCAUUCUAAGUAUUAGAGGUU	21	27027
CFTR-Intron10-8148	−	GGCAUUCUAAGUAUUAGAGGUU	22	27028
CFTR-Intron10-8149	−	GGGCAUUCUAAGUAUUAGAGGUU	23	27029
CFTR-Intron10-8150	−	AGGGCAUUCUAAGUAUUAGAGGUU	24	27030
CFTR-Intron10-8151	−	CAGUGCUUUUUCGAGGUU	18	27031
CFTR-Intron10-8152	−	UCAGUGCUUUUUCGAGGUU	19	27032
CFTR-Intron10-556	−	AUCAGUGCUUUUUCGAGGUU	20	19442
CFTR-Intron10-8153	−	AAUCAGUGCUUUUUCGAGGUU	21	27033
CFTR-Intron10-8154	−	AAAUCAGUGCUUUUUCGAGGUU	22	27034
CFTR-Intron10-8155	−	AAAAUCAGUGCUUUUUCGAGGUU	23	27035
CFTR-Intron10-8156	−	UAAAAUCAGUGCUUUUUCGAGGUU	24	27036
CFTR-Intron10-8157	−	UUUGGAUGGAGCUUGGUU	18	27037
CFTR-Intron10-8158	−	UUUUGGAUGGAGCUUGGUU	19	27038
CFTR-Intron10-128	−	GUUUUGGAUGGAGCUUGGUU	20	19014
CFTR-Intron10-8159	−	GGUUUUGGAUGGAGCUUGGUU	21	27039
CFTR-Intron10-8160	−	AGGUUUUGGAUGGAGCUUGGUU	22	27040
CFTR-Intron10-8161	−	CAGGUUUUGGAUGGAGCUUGGUU	23	27041
CFTR-Intron10-8162	−	ACAGGUUUUGGAUGGAGCUUGGUU	24	27042
CFTR-Intron10-8163	−	UAAUACAUUGGAAAAUUU	18	27043
CFTR-Intron10-8164	−	UUAAUACAUUGGAAAAUUU	19	27044
CFTR-Intron10-8165	−	GUUAAUACAUUGGAAAAUUU	20	27045
CFTR-Intron10-8166	−	AGUUAAUACAUUGGAAAAUUU	21	27046
CFTR-Intron10-8167	−	CAGUUAAUACAUUGGAAAAUUU	22	27047
CFTR-Intron10-8168	−	UCAGUUAAUACAUUGGAAAAUUU	23	27048
CFTR-Intron10-8169	−	UUCAGUUAAUACAUUGGAAAAUUU	24	27049
CFTR-Intron10-8170	−	AUCAAUAUUUUGGAAUUU	18	27050
CFTR-Intron10-8171	−	UAUCAAUAUUUUGGAAUUU	19	27051
CFTR-Intron10-1402	−	UUAUCAAUAUUUUGGAAUUU	20	20286
CFTR-Intron10-8172	−	UUUAUCAAUAUUUUGGAAUUU	21	27052
CFTR-Intron10-8173	−	UUUUAUCAAUAUUUUGGAAUUU	22	27053
CFTR-Intron10-8174	−	GUUUUAUCAAUAUUUUGGAAUUU	23	27054
CFTR-Intron10-8175	−	AGUUUUAUCAAUAUUUUGGAAUUU	24	27055
CFTR-Intron10-8176	−	UUAAUAUUACUAUUAUUU	18	27056
CFTR-Intron10-8177	−	AUUAAUAUUACUAUUAUUU	19	27057
CFTR-Intron10-8178	−	UAUUAAUAUUACUAUUAUUU	20	27058
CFTR-Intron10-8179	−	UUAUUAAUAUUACUAUUAUUU	21	27059
CFTR-Intron10-8180	−	GUUAUUAAUAUUACUAUUAUUU	22	27060
CFTR-Intron10-8181	−	UGUUAUUAAUAUUACUAUUAUUU	23	27061
CFTR-Intron10-8182	−	UUGUUAUUAAUAUUACUAUUAUUU	24	27062
CFTR-Intron10-8183	−	AAACAAGGAUGUUUAUUU	18	27063
CFTR-Intron10-8184	−	UAAACAAGGAUGUUUAUUU	19	27064
CFTR-Intron10-8185	−	CUAAACAAGGAUGUUUAUUU	20	27065
CFTR-Intron10-8186	−	UCUAAACAAGGAUGUUUAUUU	21	27066
CFTR-Intron10-8187	−	GUCUAAACAAGGAUGUUUAUUU	22	27067
CFTR-Intron10-8188	−	GGUCUAAACAAGGAUGUUUAUUU	23	27068
CFTR-Intron10-8189	−	UGGUCUAAACAAGGAUGUUUAUUU	24	27069
CFTR-Intron10-8190	−	UUGUAAUCCUAGCACUUU	18	27070
CFTR-Intron10-8191	−	CUUGUAAUCCUAGCACUUU	19	27071
CFTR-Intron10-1408	−	ACUUGUAAUCCUAGCACUUU	20	20292
CFTR-Intron10-8192	−	CACUUGUAAUCCUAGCACUUU	21	27072
CFTR-Intron10-8193	−	ACACUUGUAAUCCUAGCACUUU	22	27073
CFTR-Intron10-8194	−	CACACUUGUAAUCCUAGCACUUU	23	27074
CFTR-Intron10-8195	−	UCACACUUGUAAUCCUAGCACUUU	24	27075
CFTR-Intron10-8196	−	UUGCAGGGUGGGGCCUUU	18	27076
CFTR-Intron10-8197	−	AUUGCAGGGUGGGGCCUUU	19	27077
CFTR-Intron10-1409	−	UAUUGCAGGGUGGGGCCUUU	20	20293
CFTR-Intron10-8198	−	GUAUUGCAGGGUGGGGCCUUU	21	27078
CFTR-Intron10-8199	−	GGUAUUGCAGGGUGGGGCCUUU	22	27079
CFTR-Intron10-8200	−	UGGUAUUGCAGGGUGGGGCCUUU	23	27080
CFTR-Intron10-8201	−	AUGGUAUUGCAGGGUGGGGCCUUU	24	27081
CFTR-Intron10-8202	−	AAGAUGAUUCCAAGCUUU	18	27082
CFTR-Intron10-8203	−	AAAGAUGAUUCCAAGCUUU	19	27083
CFTR-Intron10-8204	−	CAAAGAUGAUUCCAAGCUUU	20	27084
CFTR-Intron10-8205	−	UCAAAGAUGAUUCCAAGCUUU	21	27085
CFTR-Intron10-8206	−	GUCAAAGAUGAUUCCAAGCUUU	22	27086
CFTR-Intron10-8207	−	AGUCAAAGAUGAUUCCAAGCUUU	23	27087
CFTR-Intron10-8208	−	GAGUCAAAGAUGAUUCCAAGCUUU	24	27088
CFTR-Intron10-8209	−	UCAUUAUAACACUGCUUU	18	27089
CFTR-Intron10-8210	−	UUCAUUAUAACACUGCUUU	19	27090
CFTR-Intron10-8211	−	CUUCAUUAUAACACUGCUUU	20	27091
CFTR-Intron10-8212	−	UCUUCAUUAUAACACUGCUUU	21	27092
CFTR-Intron10-8213	−	CUCUUCAUUAUAACACUGCUUU	22	27093
CFTR-Intron10-8214	−	GCUCUUCAUUAUAACACUGCUUU	23	27094
CFTR-Intron10-8215	−	AGCUCUUCAUUAUAACACUGCUUU	24	27095
CFTR-Intron10-8216	−	AUUUAACUGAAUAUCUUU	18	27096
CFTR-Intron10-8217	−	AAUUUAACUGAAUAUCUUU	19	27097
CFTR-Intron10-1410	−	AAAUUUAACUGAAUAUCUUU	20	20294
CFTR-Intron10-8218	−	GAAAUUUAACUGAAUAUCUUU	21	27098
CFTR-Intron10-8219	−	AGAAAUUUAACUGAAUAUCUUU	22	27099
CFTR-Intron10-8220	−	UAGAAAUUUAACUGAAUAUCUUU	23	27100
CFTR-Intron10-8221	−	AUAGAAAUUUAACUGAAUAUCUUU	24	27101
CFTR-Intron10-8222	−	UCAAUAUUUUGGAAUUUU	18	27102
CFTR-Intron10-8223	−	AUCAAUAUUUUGGAAUUUU	19	27103
CFTR-Intron10-1412	−	UAUCAAUAUUUUGGAAUUUU	20	20296
CFTR-Intron10-8224	−	UUAUCAAUAUUUUGGAAUUUU	21	27104
CFTR-Intron10-8225	−	UUUAUCAAUAUUUUGGAAUUUU	22	27105
CFTR-Intron10-8226	−	UUUUAUCAAUAUUUUGGAAUUUU	23	27106
CFTR-Intron10-8227	−	GUUUUAUCAAUAUUUUGGAAUUUU	24	27107
CFTR-Intron10-8228	−	GAUAAAAUCAGUGCUUUU	18	27108
CFTR-Intron10-8229	−	UGAUAAAAUCAGUGCUUUU	19	27109
CFTR-Intron10-8230	−	CUGAUAAAAUCAGUGCUUUU	20	27110
CFTR-Intron10-8231	−	UCUGAUAAAAUCAGUGCUUUU	21	27111
CFTR-Intron10-8232	−	CUCUGAUAAAAUCAGUGCUUUU	22	27112
CFTR-Intron10-8233	−	GCUCUGAUAAAAUCAGUGCUUUU	23	27113
CFTR-Intron10-8234	−	AGCUCUGAUAAAAUCAGUGCUUUU	24	27114
CFTR-Intron10-8235	−	UUAAAAUUUUAUUCUUUU	18	27115
CFTR-Intron10-8236	−	UUUAAAAUUUUAUUCUUUU	19	27116
CFTR-Intron10-8237	−	UUUUAAAAUUUUAUUCUUUU	20	27117
CFTR-Intron10-8238	−	UUUUUAAAAUUUUAUUCUUUU	21	27118
CFTR-Intron10-8239	−	AUUUUUAAAAUUUUAUUCUUUU	22	27119
CFTR-Intron10-8240	−	AAUUUUUAAAAUUUUAUUCUUUU	23	27120
CFTR-Intron10-8241	−	UAAUUUUUAAAAUUUUAUUCUUUU	24	27121
CFTR-Intron10-8242	−	AUCAUUUUGACCAUUUUU	18	27122
CFTR-Intron10-8243	−	UAUCAUUUUGACCAUUUUU	19	27123
CFTR-Intron10-8244	−	UUAUCAUUUUGACCAUUUUU	20	27124
CFTR-Intron10-8245	−	UUUAUCAUUUUGACCAUUUUU	21	27125
CFTR-Intron10-8246	−	AUUUAUCAUUUUGACCAUUUUU	22	27126
CFTR-Intron10-8247	−	AAUUUAUCAUUUUGACCAUUUUU	23	27127
CFTR-Intron10-8248	−	AAAUUUAUCAUUUUGACCAUUUUU	24	27128
CFTR-Intron10-8249	−	AUUAGUAGUUAAGUUUUU	18	27129
CFTR-Intron10-8250	−	UAUUAGUAGUUAAGUUUUU	19	27130
CFTR-Intron10-8251	−	CUAUUAGUAGUUAAGUUUUU	20	27131
CFTR-Intron10-8252	−	GCUAUUAGUAGUUAAGUUUUU	21	27132
CFTR-Intron10-8253	−	GGCUAUUAGUAGUUAAGUUUUU	22	27133
CFTR-Intron10-8254	−	AGGCUAUUAGUAGUUAAGUUUUU	23	27134
CFTR-Intron10-8255	−	UAGGCUAUUAGUAGUUAAGUUUUU	24	27135
CFTR-Intron10-8256	−	AACACUUUAUAGUUUUUU	18	27136
CFTR-Intron10-8257	−	GAACACUUUAUAGUUUUUU	19	27137
CFTR-Intron10-8258	−	GGAACACUUUAUAGUUUUUU	20	27138
CFTR-Intron10-8259	−	UGGAACACUUUAUAGUUUUUU	21	27139
CFTR-Intron10-8260	−	AUGGAACACUUUAUAGUUUUUU	22	27140
CFTR-Intron10-8261	−	AAUGGAACACUUUAUAGUUUUUU	23	27141
CFTR-Intron10-8262	−	GAAUGGAACACUUUAUAGUUUUUU	24	27142
CFTR-Intron10-8263	−	UUUUUUUUUUUUUUUUUU	18	27143
CFTR-Intron10-8264	−	UUUUUUUUUUUUUUUUUUU	19	27144
CFTR-Intron10-8265	−	UUUUUUUUUUUUUUUUUUUU	20	27145
CFTR-Intron10-8266	−	UUUUUUUUUUUUUUUUUUUUU	21	27146
CFTR-Intron10-8267	−	UUUUUUUUUUUUUUUUUUUUUU	22	27147
CFTR-Intron10-8268	−	UUUUUUUUUUUUUUUUUUUUUUU	23	27148
CFTR-Intron10-8269	−	CUUUUUUUUUUUUUUUUUUUUUUU	24	27149

Table 42A provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the first tier parameters. The targeting domains bind within intron 10, have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 42A
1st Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-8270	−	GGUGAAGUCUUUAGUAA	17	27150
CFTR-Intron10-8271	+	GUUGGUGAUAUUUUUCA	17	27151
CFTR-Intron10-8272	−	GUCAAGCAUUUGUGUAC	17	27152
CFTR-Intron10-8273	−	GAUACAUCUGAAAAAAU	17	27153
CFTR-Intron10-8274	+	GGAGUGUAAAGGAAAUU	17	27154
CFTR-Intron10-5827	−	GAGGGUGAAGUCUUUAGUAA	20	24707
CFTR-Intron10-8275	+	GGGGAAUAAUAAAAAAUGUA	20	27155
CFTR-Intron10-8276	+	GGUUUACCCCCUACCUCCAC	20	27156
CFTR-Intron10-8277	−	GUGGUCAAGCAUUUGUGUAC	20	27157
CFTR-Intron10-8278	+	GGUAGCAGAGGAAGAAAAAG	20	27158
CFTR-Intron10-8279	−	GCCAUACACUCUAAAUAGAG	20	27159
CFTR-Intron10-8280	−	GUUUUCUAGAAAAUCUGUAG	20	27160
CFTR-Intron10-8281	−	GGAGAUACAUCUGAAAAAAU	20	27161
CFTR-Intron10-8282	−	GCAGGAAGACAGCUGGCUAU	20	27162

Table 42B provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the second tier parameters. The targeting domains bind within intron 10 and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 42B
2nd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-8283	+	UAGAGAUUACUUGGAAA	17	27163
CFTR-Intron10-8284	−	AGUCACAGAGGAGUCAA	17	27164
CFTR-Intron10-8285	+	AAAGGACUAUCAGUGAA	17	27165
CFTR-Intron10-8286	−	ACUGAAUAUCUUUAGGA	17	27166
CFTR-Intron10-8287	+	UUACCCCCUACCUCCAC	17	27167
CFTR-Intron10-8288	−	UCAUUAGGAAAAUGUAC	17	27168
CFTR-Intron10-8289	−	AAUGGUUCCUUGUUCCC	17	27169
CFTR-Intron10-8290	−	AAACUUGUCUUCUUUUC	17	27170
CFTR-Intron10-8291	+	UCCUAACCUCGAAAAAG	17	27171
CFTR-Intron10-8292	−	AUACACUCUAAAUAGAG	17	27172
CFTR-Intron10-8293	−	UUCUAGAAAAUCUGUAG	17	27173
CFTR-Intron10-8294	−	AAGGCUUAUUUCUCUGG	17	27174
CFTR-Intron10-8295	+	CAAAUUGUAUUGAGUGG	17	27175
CFTR-Intron10-8296	−	UAUAUAUAUGACACUAU	17	27176
CFTR-Intron10-8297	+	CUACUAAAAGGCAGCCU	17	27177
CFTR-Intron10-8298	+	UGAUCCUUUUGCAGCCU	17	27178
CFTR-Intron10-8299	−	CUUUCCAUGAAUUAGCU	17	27179
CFTR-Intron10-8300	−	AUUUCCAAGUAAUCUCU	17	27180
CFTR-Intron10-8301	−	UUCGUGUAGUUUCUAUU	17	27181
CFTR-Intron10-8302	−	AAAAGUCACAGAGGAGUCAA	20	27182
CFTR-Intron10-8303	+	ACAAAAGGACUAUCAGUGAA	20	27183
CFTR-Intron10-8304	+	UGAGUUGGUGAUAUUUUUCA	20	27184
CFTR-Intron10-8305	−	UUAACUGAAUAUCUUUAGGA	20	27185
CFTR-Intron10-8306	+	AAUAAAGUAAUAGAAGCAUA	20	27186
CFTR-Intron10-8307	+	AAAGCUCUUUCUCAUCUCUA	20	27187
CFTR-Intron10-3944	+	AUAUUAAUAACAAAAUCUUA	20	22826
CFTR-Intron10-8308	−	UCUAUGAUAUAAUGAAUCAC	20	27188
CFTR-Intron10-8309	−	UAAAAUGGUUCCUUGUUCCC	20	27189
CFTR-Intron10-8310	−	UGGAAACUUGUCUUCUUUUC	20	27190
CFTR-Intron10-8311	−	UAGUGUGAAGAUGGGGCUGG	20	27191
CFTR-Intron10-7212	−	ACUAAGGCUUAUUUCUCUGG	20	26092
CFTR-Intron10-8312	+	UACCAAAUUGUAUUGAGUGG	20	27192
CFTR-Intron10-8313	+	AUACUACUAAAAGGCAGCCU	20	27193
CFTR-Intron10-8314	−	UAUAUUUCCAAGUAAUCUCU	20	27194
CFTR-Intron10-8315	+	UGUGGAGUGUAAAGGAAAUU	20	27195
CFTR-Intron10-8316	−	AUAUUCGUGUAGUUUCUAUU	20	27196

Table 42C provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the third tier parameters. The targeting domains bind within intron 10 and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 42C
3rd Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-8317	+	GCUCUUUCUCAUCUCUA	17	27197
CFTR-Intron10-8318	+	GAAUAAUAAAAAAUGUA	17	27198
CFTR-Intron10-8319	+	GAUACUAAAAAAAGUUA	17	27199
CFTR-Intron10-8320	−	GUGCAACUAUCACCUCC	17	27200
CFTR-Intron10-8321	−	GUGGAGGCUGCAGUGAG	17	27201
CFTR-Intron10-8322	+	GAGAACUGCUCACACGG	17	27202
CFTR-Intron10-8323	−	GGAAGACAGCUGGCUAU	17	27203
CFTR-Intron10-8324	+	GAAGAUACUAAAAAAAGUUA	20	27204
CFTR-Intron10-8325	−	GUUGUGCAACUAUCACCUCC	20	27205
CFTR-Intron10-8326	−	GAAGUGGAGGCUGCAGUGAG	20	27206
CFTR-Intron10-8327	+	GCAUCACUAGUGGCACUUUG	20	27207
CFTR-Intron10-8328	+	GAUAAAUUUUAACUUUUUAU	20	27208

Table 42D provides exemplary targeting domains for correcting a mutation (e.g., 3272-26->G) in the CFTR gene selected according to the fourth tier parameters. The targeting domains bind within intron 10. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the Table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 42D
4th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
CFTR-Intron10-8329	−	CUUUGGAAUUUGUUAAA	17	27209
CFTR-Intron10-8330	+	ACCCAAAUGUCAAUCAA	17	27210
CFTR-Intron10-8331	+	UACCAUCACCUUGGGAA	17	27211
CFTR-Intron10-8332	−	UGUAUUUAUAUUCAUAA	17	27212
CFTR-Intron10-8333	−	AUAUAGAAAUGAGGUAA	17	27213
CFTR-Intron10-8334	−	CAUAUAUAUAUUUUUAA	17	27214
CFTR-Intron10-8335	−	CUUUGAAGGAAGAUCCA	17	27215
CFTR-Intron10-8336	+	AAAGUAAUAGAAGCAUA	17	27216
CFTR-Intron10-8337	−	UGGAGUCAAAAAUUAUA	17	27217
CFTR-Intron10-8338	+	UUAAUAACAAAAUCUUA	17	27218
CFTR-Intron10-8339	−	AUGAUAUAAUGAAUCAC	17	27219
CFTR-Intron10-8340	+	CACACAUAUAUACAUAC	17	27220
CFTR-Intron10-8341	+	UCCAAGAUCAAGGUGCC	17	27221
CFTR-Intron10-8342	+	CAAAUAUAAAUCAAAGC	17	27222
CFTR-Intron10-8343	+	AGCAGAGGAAGAAAAAG	17	27223
CFTR-Intron10-8344	−	AAUGUUGAAUAAUAGGG	17	27224
CFTR-Intron10-956	−	AGGGUGGGGCCUUUGGG	17	19841
CFTR-Intron10-8345	−	UGUGAAGAUGGGGCUGG	17	27225
CFTR-Intron10-8346	+	CUCUGCCUCCAAAAGUG	17	27226
CFTR-Intron10-8347	−	CUCGGCCUCCCAAAGUG	17	27227
CFTR-Intron10-8348	−	UAGUAUAGUAGGAAGUG	17	27228
CFTR-Intron10-8349	+	UCACUAGUGGCACUUUG	17	27229
CFTR-Intron10-8350	−	UCCACAAAUAUUUUUUG	17	27230
CFTR-Intron10-8351	−	AAAGAUCUAGCUAAAAU	17	27231
CFTR-Intron10-8352	+	AAAUUUUAACUUUUUAU	17	27232
CFTR-Intron10-8353	−	UUUAUUGAUACUUUUCU	17	27233
CFTR-Intron10-8354	−	AAAGACUUGCAGGAGGU	17	27234
CFTR-Intron10-8355	+	UUUCUUUUUCUGUUUGU	17	27235
CFTR-Intron10-8356	−	UGGGUAUAUUUUAUAUU	17	27236
CFTR-Intron10-8357	−	CAGUAGUAUUAUCUUUU	17	27237
CFTR-Intron10-8358	−	UAAAAUUUUAUUCUUUU	17	27238
CFTR-Intron10-8359	+	UUAUAGAGAUUACUUGGAAA	20	27239
CFTR-Intron10-8360	−	AUACUUUGGAAUUUGUUAAA	20	27240
CFTR-Intron10-8361	+	ACAACCCAAAUGUCAAUCAA	20	27241
CFTR-Intron10-8362	+	CAAUACCAUCACCUUGGGAA	20	27242
CFTR-Intron10-8363	−	UUUUGUAUUUAUAUUCAUAA	20	27243
CFTR-Intron10-8364	−	UUUAUAUAGAAAUGAGGUAA	20	27244
CFTR-Intron10-8365	−	AUGCAUAUAUAUAUUUUUAA	20	27245
CFTR-Intron10-8366	−	AUGCUUUGAAGGAAGAUCCA	20	27246
CFTR-Intron10-8367	−	UUGUGGAGUCAAAAAUUAUA	20	27247
CFTR-Intron10-8368	+	AGACACACAUAUAUACAUAC	20	27248
CFTR-Intron10-8369	−	AACUCAUUAGGAAAAUGUAC	20	27249
CFTR-Intron10-8370	+	AAGUCCAAGAUCAAGGUGCC	20	27250
CFTR-Intron10-8371	+	AAACAAAUAUAAAUCAAAGC	20	27251
CFTR-Intron10-8372	+	AUCUCCUAACCUCGAAAAAG	20	27252
CFTR-Intron10-8373	+	AGAGAGAACUGCUCACACGG	20	27253
CFTR-Intron10-8374	−	AUAAAUGUUGAAUAAUAGGG	20	27254
CFTR-Intron10-1300	−	UGCAGGGUGGGGCCUUUGGG	20	20185
CFTR-Intron10-8375	+	UGCCUCUGCCUCCAAAAGUG	20	27255
CFTR-Intron10-7272	−	CGCCUCGGCCUCCCAAAGUG	20	26152
CFTR-Intron10-7277	−	UGCCUCGGCCUCCCAAAGUG	20	26157
CFTR-Intron10-8376	−	AAGUAGUAUAGUAGGAAGUG	20	27256
CFTR-Intron10-8377	−	UCCUCCACAAAUAUUUUUUG	20	27257
CFTR-Intron10-8378	−	ACAAAAGAUCUAGCUAAAAU	20	27258
CFTR-Intron10-8379	−	ACAUAUAUAUAUGACACUAU	20	27259
CFTR-Intron10-8380	+	ACAUGAUCCUUUUGCAGCCU	20	27260
CFTR-Intron10-8381	−	AAGCUUUCCAUGAAUUAGCU	20	27261
CFTR-Intron10-8382	−	UCCUUUAUUGAUACUUUUCU	20	27262
CFTR-Intron10-7876	−	AACAAAGACUUGCAGGAGGU	20	26756
CFTR-Intron10-8383	+	CUCUUUCUUUUUCUGUUUGU	20	27263
CFTR-Intron10-8384	−	UUUUGGGUAUAUUUUAUAUU	20	27264
CFTR-Intron10-8385	−	AGUCAGUAGUAUUAUCUUUU	20	27265
CFTR-Intron10-8237	−	UUUUAAAAUUUUAUUCUUUU	20	27117

Table 43A provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the first tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogeness Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 43A
1st Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-327	+	GAUACCUCCCCUUGGAA	17	4176
SCNN1A-328	−	GGGCGCAGGGUGGGACA	17	4177
SCNN1A-99	−	GGCGCCCCAGCAGCCCA	17	536
SCNN1A-329	−	GCCUCACUCGGGUUCCA	17	4178
SCNN1A-330	−	GGGAGAAUGUGGGCGCA	17	4179
SCNN1A-141	+	GCGGUGGAACUCGAUCA	17	551
SCNN1A-80	−	GCCCAUACCAGGUCUCA	17	529
SCNN1A-106	−	GCACAACCGCAUGAAGA	17	540
SCNN1A-132	+	GGAGCACACCAGGCGGA	17	547
SCNN1A-121	+	GUUGAUGUUGAGGCUGA	17	545
SCNN1A-331	+	GGACUAACCGACCUGUA	17	4180
SCNN1A-332	−	GCACCCUCAAUCCCUAC	17	4181
SCNN1A-93	−	GAACAAGCGUGAGGAGC	17	533
SCNN1A-147	+	GGCUGCUGGGGCGCCGC	17	554
SCNN1A-117	+	GUGCAGAUGGUCACUGC	17	544
SCNN1A-333	−	GAUGGGAGAGGGCACUC	17	4182
SCNN1A-107	−	GCAUGAAGACGGCCUUC	17	541
SCNN1A-334	−	GACAUGGGCAUGGCCAG	17	4183
SCNN1A-142	+	GGCCUCCUCCUCCGCCG	17	552
SCNN1A-150	+	GGGGCGCCGCAGGUUCG	17	555
SCNN1A-131	+	GCUGGGAGCACACCAGG	17	546
SCNN1A-103	−	GCCCACGGCGGAGGAGG	17	539
SCNN1A-102	−	GCAGCCCACGGCGGAGG	17	538
SCNN1A-139	+	GCUCUCGGUAGGAGCGG	17	550
SCNN1A-116	+	GGUGCAGAUGGUCACUG	17	543
SCNN1A-98	−	GCUGGGCCCCGAACCUG	17	535
SCNN1A-335	−	GGCGCAGGGUGGGACAU	17	4184
SCNN1A-336	+	GGUCAAGGCUGAGCUCU	17	4185
SCNN1A-143	+	GCCUCCUCCUCCGCCGU	17	553
SCNN1A-337	−	GAAUGUGGGCGCAGGGU	17	4186
SCNN1A-338	+	GGGACUAACCGACCUGU	17	4187
SCNN1A-339	+	GAGCCCCGGAGUGGAUU	17	4188
SCNN1A-340	−	GUGGGACAUGGGCAUGGCCA	20	4189
SCNN1A-341	−	GCAGCCUCACUCGGGUUCCA	20	4190
SCNN1A-342	−	GAGCAGUAUCAAGGUAAGCA	20	4191
SCNN1A-15	−	GGGAACAAGCGUGAGGAGCA	20	507
SCNN1A-62	+	GGAGCGGUGGAACUCGAUCA	20	525
SCNN1A-343	−	GUGAUGGGAGAGGGCACUCA	20	4192
SCNN1A-1	−	GCAGCCCAUACCAGGUCUCA	20	503
SCNN1A-36	+	GUAGGGAUUGAGGGUGCAGA	20	516
SCNN1A-76	+	GCCCUGGAGUGGACUGUGGA	20	528
SCNN1A-10	−	GUCCACUCCAGGGCUCAUGA	20	505
SCNN1A-42	+	GAGGUUGAUGUUGAGGCUGA	20	519
SCNN1A-344	+	GUAUGGGCUGCAGAGGUCUA	20	4193
SCNN1A-345	+	GAGGGACUAACCGACCUGUA	20	4194
SCNN1A-32	−	GCACCUUUGGCAUGAUGUAC	20	514
SCNN1A-51	+	GGUUGUGCUGGGAGCACACC	20	522
SCNN1A-346	+	GUGCCCUCUCCCAUCACCCC	20	4195
SCNN1A-347	−	GGUGGGACAUGGGCAUGGCC	20	4196
SCNN1A-348	−	GGCAGCCUCACUCGGGUUCC	20	4197
SCNN1A-176	−	GCUCAUGAAGGGGAACAAGC	20	811
SCNN1A-68	+	GUGGGCUGCUGGGGCGCCGC	20	526
SCNN1A-349	−	GAGUGGGAGAAUGUGGGCGC	20	4198
SCNN1A-350	−	GGUGAUGGGAGAGGGCACUC	20	4199
SCNN1A-351	−	GGCCAGGGGCAGCCUCACUC	20	4200
SCNN1A-352	+	GAUUGGGGAGAGCAAGGGUC	20	4201
SCNN1A-16	−	GGAACAAGCGUGAGGAGCAG	20	508
SCNN1A-44	+	GGUUGAUGUUGAGGCUGACG	20	520
SCNN1A-353	−	GCUCUCCCCAAUCCACUCCG	20	4202
SCNN1A-39	+	GGGUGCAGAUGGUCACUGCG	20	518
SCNN1A-71	+	GCUGGGGCGCCGCAGGUUCG	20	527
SCNN1A-21	−	GGCGCCCCAGCAGCCCACGG	20	510
SCNN1A-22	−	GCCCCAGCAGCCCACGGCGG	20	511
SCNN1A-354	−	GGGAGAAUGUGGGCGCAGGG	20	4203
SCNN1A-2	−	GCCCAUACCAGGUCUCAUGG	20	497
SCNN1A-37	+	GAGGGUGCAGAUGGUCACUG	20	517
SCNN1A-19	−	GGGGCUGGGCCCCGAACCUG	20	509
SCNN1A-355	−	GUGGGCGCAGGGUGGGACAU	20	4204
SCNN1A-356	+	GGUAUGGGCUGCAGAGGUCU	20	4205
SCNN1A-58	+	GAACUCGAAGAGCUCUCGGU	20	524
SCNN1A-357	−	GGAGAAUGUGGGCGCAGGGU	20	4206
SCNN1A-33	−	GGCAUGAUGUACUGGCAAUU	20	515
SCNN1A-31	−	GUGCUGUGGCUCUGCACCUU	20	513

Table 43B provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the second tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogeness Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 43B
2nd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-125	+	CCAGUACAUCAUGCCAA	17	632
SCNN1A-358	−	CCAGCUGUCCCUUCCAA	17	4207
SCNN1A-359	−	AGUAUCAAGGUAAGCAA	17	4208
SCNN1A-90	−	ACUCCAGGGCUCAUGAA	17	611
SCNN1A-360	−	ACUCCGGGGCUCAUGAA	17	4209
SCNN1A-104	−	AACAACACCACCAUCCA	17	617
SCNN1A-88	−	CUCCACAGUCCACUCCA	17	609
SCNN1A-361	−	CAGUAUCAAGGUAAGCA	17	4210
SCNN1A-94	−	AACAAGCGUGAGGAGCA	17	613
SCNN1A-362	−	UAUCAUGAGCAGUAUCA	17	4211
SCNN1A-363	−	AUGGGAGAGGGCACUCA	17	4212
SCNN1A-126	+	CCACAGCACUGCCCAGA	17	633
SCNN1A-82	−	AUACCAGGUCUCAUGGA	17	501
SCNN1A-364	+	UGAUACCUCCCCUUGGA	17	4213
SCNN1A-89	−	CACUCCAGGGCUCAUGA	17	610
SCNN1A-365	−	CACUCCGGGGCUCAUGA	17	4214
SCNN1A-366	−	UCGGGUUCCAGGGGUGA	17	4215
SCNN1A-367	+	CGACCUGUAGGGAUUGA	17	4216
SCNN1A-157	+	CUCCAUGAGACCUGGUA	17	502
SCNN1A-122	+	UUGAUGUUGAGGCUGAC	17	629
SCNN1A-111	−	CCUUUGGCAUGAUGUAC	17	622
SCNN1A-130	+	UGUGCUGGGAGCACACC	17	637
SCNN1A-156	+	UUCCCCUCCAUGAGACC	17	653
SCNN1A-368	−	CCUCUGCAGCCCAUACC	17	4217
SCNN1A-369	+	CCGAGUGAGGCUGCCCC	17	4218
SCNN1A-370	−	UCUCCCCAAUCCACUCC	17	4219
SCNN1A-87	−	CCUCCACAGUCCACUCC	17	608
SCNN1A-371	−	AGCCUCACUCGGGUUCC	17	4220
SCNN1A-124	+	AGUACUCUCCGAAAAGC	17	631
SCNN1A-260	−	CAUGAAGGGGAACAAGC	17	868
SCNN1A-84	−	CAUGGAGGGGAACAAGC	17	607
SCNN1A-372	+	CCCUUGGAAGGGACAGC	17	4221
SCNN1A-373	−	UGGGAGAAUGUGGGCGC	17	4222
SCNN1A-144	+	CCUCCGCCGUGGGCUGC	17	643
SCNN1A-128	+	UCUUCAUGCGGUUGUGC	17	635
SCNN1A-140	+	AGCGGUGGAACUCGAUC	17	642
SCNN1A-374	−	CUCUCCCCAAUCCACUC	17	4223
SCNN1A-375	−	CAGGGGCAGCCUCACUC	17	4224
SCNN1A-376	+	UGGGGAGAGCAAGGGUC	17	4225
SCNN1A-149	+	UGGGGCGCCGCAGGUUC	17	647
SCNN1A-377	−	CAGCUGUCCCUUCCAAG	17	4226
SCNN1A-91	−	CUCCAGGGCUCAUGAAG	17	612
SCNN1A-378	−	CUCCGGGGCUCAUGAAG	17	4227
SCNN1A-379	−	CCUCACUCGGGUUCCAG	17	4228
SCNN1A-95	−	ACAAGCGUGAGGAGCAG	17	614
SCNN1A-380	+	CCUGGUAUGGGCUGCAG	17	4229
SCNN1A-138	+	AGAGCUCUCGGUAGGAG	17	641
SCNN1A-381	+	CUUCAUGAGCCCCGGAG	17	4230
SCNN1A-152	+	CUUCAUGAGCCCUGGAG	17	649
SCNN1A-123	+	UGAUGUUGAGGCUGACG	17	630
SCNN1A-382	−	CUCCCCAAUCCACUCCG	17	4231
SCNN1A-118	+	UGCAGAUGGUCACUGCG	17	626
SCNN1A-101	−	CCAGCAGCCCACGGCGG	17	616
SCNN1A-383	−	AGAAUGUGGGCGCAGGG	17	4232
SCNN1A-384	−	CUGUCCCUUCCAAGGGG	17	4233
SCNN1A-81	−	CAUACCAGGUCUCAUGG	17	605
SCNN1A-127	+	AGAAGGCCGUCUUCAUG	17	634
SCNN1A-146	+	UCCGCCGUGGGCUGCUG	17	645
SCNN1A-385	+	CCCCUGGAACCCGAGUG	17	4234
SCNN1A-386	+	CCGACCUGUAGGGAUUG	17	4235
SCNN1A-387	+	AGCCCCGGAGUGGAUUG	17	4236
SCNN1A-119	+	CGAGCUUGUCCGAGUUG	17	627
SCNN1A-120	+	AGUUGAGGUUGAUGUUG	17	628
SCNN1A-388	+	UGAGCCCCGGAGUGGAU	17	4237
SCNN1A-389	−	CGGGUUCCAGGGGUGAU	17	4238
SCNN1A-158	+	UCCAUGAGACCUGGUAU	17	654
SCNN1A-114	−	CAACAUCAACCUCAACU	17	625
SCNN1A-97	−	CGUGAGGAGCAGGGGCU	17	615
SCNN1A-145	+	CUCCGCCGUGGGCUGCU	17	644
SCNN1A-129	+	CUUCAUGCGGUUGUGCU	17	636
SCNN1A-136	+	AGAACUCGAAGAGCUCU	17	639
SCNN1A-390	+	AUGGGCUGCAGAGGUCU	17	4239
SCNN1A-108	−	CAUGAAGACGGCCUUCU	17	619
SCNN1A-391	−	CCUCAAUCCCUACAGGU	17	4240
SCNN1A-137	+	CUCGAAGAGCUCUCGGU	17	640
SCNN1A-112	−	AUGAUGUACUGGCAAUU	17	623
SCNN1A-110	−	CUGUGGCUCUGCACCUU	17	621
SCNN1A-148	+	CUGGGGCGCCGCAGGUU	17	646
SCNN1A-392	−	AGCAAGGGAACCUGGUU	17	4241
SCNN1A-113	−	CAAUUCGGCCUGCUUUU	17	624
SCNN1A-46	+	UUGCCAGUACAUCAUGCCAA	20	580
SCNN1A-393	−	AGCAGUAUCAAGGUAAGCAA	20	4242
SCNN1A-394	+	CAUGAUACCUCCCCUUGGAA	20	4243
SCNN1A-395	−	UGUGGGCGCAGGGUGGGACA	20	4244
SCNN1A-20	−	UGCGGCGCCCCAGCAGCCCA	20	565
SCNN1A-25	−	UGCAACAACACCACCAUCCA	20	567
SCNN1A-396	−	AGUGGGAGAAUGUGGGCGCA	20	4245
SCNN1A-397	−	AGGUAUCAUGAGCAGUAUCA	20	4246
SCNN1A-398	+	AUUGGGGAGAGCAAGGGUCA	20	4247
SCNN1A-27	−	CCAGCACAACCGCAUGAAGA	20	569
SCNN1A-53	+	CUGGGAGCACACCAGGCGGA	20	585
SCNN1A-3	−	CCCAUACCAGGUCUCAUGGA	20	556
SCNN1A-399	+	UCAUGAUACCUCCCCUUGGA	20	4248
SCNN1A-400	−	AUCCACUCCGGGGCUCAUGA	20	4249
SCNN1A-401	−	CACUCGGGUUCCAGGGGUGA	20	4250
SCNN1A-402	+	AACCGACCUGUAGGGAUUGA	20	4251
SCNN1A-78	+	CCCCUCCAUGAGACCUGGUA	20	500
SCNN1A-43	+	AGGUUGAUGUUGAGGCUGAC	20	578
SCNN1A-403	−	UCUGCACCCUCAAUCCCUAC	20	4252
SCNN1A-404	−	UCAAGGUAAGCAAGGGAACC	20	4253
SCNN1A-405	−	AGACCUCUGCAGCCCAUACC	20	4254
SCNN1A-406	+	AACCCGAGUGAGGCUGCCCC	20	4255
SCNN1A-407	−	UAGUCCCUCUGCCCCUUCCC	20	4256
SCNN1A-408	−	UGCUCUCCCCAAUCCACUCC	20	4257
SCNN1A-8	−	AGCCCUCCACAGUCCACUCC	20	559
SCNN1A-45	+	UGAAGUACUCUCCGAAAAGC	20	579
SCNN1A-5	−	UCUCAUGGAGGGGAACAAGC	20	557
SCNN1A-409	+	CUCCCCUUGGAAGGGACAGC	20	4258
SCNN1A-17	−	CAAGCGUGAGGAGCAGGGGC	20	563
SCNN1A-38	+	AGGGUGCAGAUGGUCACUGC	20	575
SCNN1A-65	+	CCUCCUCCGCCGUGGGCUGC	20	594
SCNN1A-49	+	CCGUCUUCAUGCGGUUGUGC	20	582
SCNN1A-61	+	AGGAGCGGUGGAACUCGAUC	20	591
SCNN1A-410	−	UUGCUCUCCCCAAUCCACUC	20	4259
SCNN1A-411	+	UCAGGGUCAAGGCUGAGCUC	20	4260
SCNN1A-28	−	ACCGCAUGAAGACGGCCUUC	20	570
SCNN1A-70	+	UGCUGGGGCGCCGCAGGUUC	20	598
SCNN1A-412	−	AUCCAGCUGUCCCUUCCAAG	20	4261
SCNN1A-413	−	UGGGACAUGGGCAUGGCCAG	20	4262
SCNN1A-414	−	CAGCCUCACUCGGGUUCCAG	20	4263
SCNN1A-415	+	AGACCUGGUAUGGGCUGCAG	20	4264
SCNN1A-59	+	CGAAGAGCUCUCGGUAGGAG	20	589
SCNN1A-4	−	CCAUACCAGGUCUCAUGGAG	20	498
SCNN1A-63	+	CAGGGCCUCCUCCUCCGCCG	20	592
SCNN1A-52	+	UGUGCUGGGAGCACACCAGG	20	584
SCNN1A-23	−	CCAGCAGCCCACGGCGGAGG	20	566
SCNN1A-60	+	AGAGCUCUCGGUAGGAGCGG	20	590
SCNN1A-416	−	CAGCUGUCCCUUCCAAGGGG	20	4265
SCNN1A-75	+	AGCCCUGGAGUGGACUGUGG	20	602
SCNN1A-48	+	CCCAGAAGGCCGUCUUCAUG	20	581
SCNN1A-74	+	AUGAGCCCUGGAGUGGACUG	20	601
SCNN1A-67	+	UCCUCCGCCGUGGGCUGCUG	20	596
SCNN1A-417	+	UCACCCCUGGAACCCGAGUG	20	4266
SCNN1A-13	−	CAUGAAGGGGAACAAGCGUG	20	562
SCNN1A-418	+	UAACCGACCUGUAGGGAUUG	20	4267
SCNN1A-419	+	AUGAGCCCCGGAGUGGAUUG	20	4268
SCNN1A-40	+	AGACGAGCUUGUCCGAGUUG	20	576
SCNN1A-41	+	CCGAGUUGAGGUUGAUGUUG	20	577
SCNN1A-420	+	UCAUGAGCCCCGGAGUGGAU	20	4269
SCNN1A-421	−	ACUCGGGUUCCAGGGGUGAU	20	4270
SCNN1A-79	+	CCCUCCAUGAGACCUGGUAU	20	604
SCNN1A-35	−	CCUCAACAUCAACCUCAACU	20	574
SCNN1A-18	−	AAGCGUGAGGAGCAGGGGCU	20	564
SCNN1A-66	+	CUCCUCCGCCGUGGGCUGCU	20	595
SCNN1A-50	+	CGUCUUCAUGCGGUUGUGCU	20	583
SCNN1A-57	+	AGAAGAACUCGAAGAGCUCU	20	588
SCNN1A-422	+	CAGGGUCAAGGCUGAGCUCU	20	4271
SCNN1A-29	−	CCGCAUGAAGACGGCCUUCU	20	571
SCNN1A-64	+	AGGGCCUCCUCCUCCGCCGU	20	593
SCNN1A-423	−	CACCCUCAAUCCCUACAGGU	20	4272
SCNN1A-424	+	AGAGGGACUAACCGACCUGU	20	4273
SCNN1A-425	+	CAUGAGCCCCGGAGUGGAUU	20	4274
SCNN1A-69	+	CUGCUGGGGCGCCGCAGGUU	20	597
SCNN1A-34	−	UGGCAAUUCGGCCUGCUUUU	20	573

Table 43C provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the third tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogeness Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 43C
3rd Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-426	−	GGACAUGGGCAUGGCCA	17	4275
SCNN1A-427	+	GUGGAUUGGGGAGAGCA	17	4276
SCNN1A-428	+	GGGGAGAGCAAGGGUCA	17	4277
SCNN1A-115	+	GGGAUUGAGGGUGCAGA	17	542
SCNN1A-134	+	GCGGAUGGCGCCGUGGA	17	548
SCNN1A-429	−	GGGACAUGGGCAUGGCC	17	4278
SCNN1A-86	−	GAACAAGCUGGAGGAGC	17	531
SCNN1A-96	−	GCGUGAGGAGCAGGGGC	17	534
SCNN1A-430	+	GGGUCAAGGCUGAGCUC	17	4279
SCNN1A-100	−	GCCCCAGCAGCCCACGG	17	537
SCNN1A-135	+	GAUGGCGCCGUGGAUGG	17	549
SCNN1A-431	−	GAAGGGGAACAAGCUGG	17	4280
SCNN1A-85	−	GGAGGGGAACAAGCUGG	17	530
SCNN1A-92	−	GAAGGGGAACAAGCGUG	17	532
SCNN1A-432	+	GAGUGGAUUGGGGAGAGCAA	20	4281
SCNN1A-9	−	GCCCUCCACAGUCCACUCCA	20	499
SCNN1A-433	+	GGAGUGGAUUGGGGAGAGCA	20	4282
SCNN1A-434	+	GAGAGCAAGGGUCAGGGUCA	20	4283
SCNN1A-47	+	GAGCCACAGCACUGCCCAGA	20	521
SCNN1A-435	−	GUUCCAGGGGUGAUGGGAGA	20	4284
SCNN1A-7	−	GGGGAACAAGCUGGAGGAGC	20	504
SCNN1A-14	−	GGGGAACAAGCGUGAGGAGC	20	506
SCNN1A-436	−	GGUUCCAGGGGUGAUGGGAG	20	4285
SCNN1A-24	−	GCAGCCCACGGCGGAGGAGG	20	512
SCNN1A-56	+	GCGGAUGGCGCCGUGGAUGG	20	523
SCNN1A-437	−	GUAAGCAAGGGAACCUGGUU	20	4286

Table 43D provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fourth tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogeness Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 43D
4th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-438	+	UGGAUUGGGGAGAGCAA	17	4287
SCNN1A-439	−	UCCAGCUGUCCCUUCCA	17	4288
SCNN1A-440	−	AGGGUGGGACAUGGGCA	17	4289
SCNN1A-441	+	AGCAAGGGUCAGGGUCA	17	4290
SCNN1A-442	+	ACCAGGGAAGGGGCAGA	17	4291
SCNN1A-443	−	CCAGGGGUGAUGGGAGA	17	4292
SCNN1A-155	+	CUGGAGUGGACUGUGGA	17	652
SCNN1A-444	+	UGGGCUGCAGAGGUCUA	17	4293
SCNN1A-445	−	AGGUAAGCAAGGGAACC	17	4294
SCNN1A-446	+	CCCUCUCCCAUCACCCC	17	4295
SCNN1A-151	+	UUCCCCUUCAUGAGCCC	17	648
SCNN1A-447	−	UCCCUCUGCCCCUUCCC	17	4296
SCNN1A-105	−	CCACGGCGCCAUCCGCC	17	618
SCNN1A-448	−	UCCAGGGGUGAUGGGAG	17	4297
SCNN1A-83	−	UACCAGGUCUCAUGGAG	17	606
SCNN1A-133	+	CCAGGCGGAUGGCGCCG	17	638
SCNN1A-154	+	CCUGGAGUGGACUGUGG	17	651
SCNN1A-153	+	AGCCCUGGAGUGGACUG	17	650
SCNN1A-109	−	CCUUCUGGGCAGUGCUG	17	620
SCNN1A-449	−	CCAGGGGCAGCCUCACU	17	4298
SCNN1A-450	+	CUCAUGAUACCUCCCCU	17	4299
SCNN1A-11	−	UCCACUCCAGGGCUCAUGAA	20	560
SCNN1A-451	−	UCCACUCCGGGGCUCAUGAA	20	4300
SCNN1A-452	−	CGCAGGGUGGGACAUGGGCA	20	4301
SCNN1A-55	+	CAGGCGGAUGGCGCCGUGGA	20	587
SCNN1A-77	+	UUGUUCCCCUCCAUGAGACC	20	603
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-26	−	CAUCCACGGCGCCAUCCGCC	20	568
SCNN1A-12	−	CCACUCCAGGGCUCAUGAAG	20	561
SCNN1A-453	−	CCACUCCGGGGCUCAUGAAG	20	4302
SCNN1A-454	+	CCCCUUCAUGAGCCCCGGAG	20	4303
SCNN1A-73	+	CCCCUUCAUGAGCCCUGGAG	20	600
SCNN1A-54	+	ACACCAGGCGGAUGGCGCCG	20	586
SCNN1A-455	−	CAUGAAGGGGAACAAGCUGG	20	4304
SCNN1A-6	−	CAUGGAGGGGAACAAGCUGG	20	558
SCNN1A-30	−	CGGCCUUCUGGGCAGUGCUG	20	572
SCNN1A-456	−	UGGCCAGGGGCAGCCUCACU	20	4305
SCNN1A-457	+	CUGCUCAUGAUACCUCCCCU	20	4306

Table 43E provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fifth tier parameters. The targeting domains fall in the coding sequence of the gene, downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon of the gene). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogeness Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 43E
5th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-458	−	GCCCCACACCUAAGAAA	17	4307
SCNN1A-459	−	AUGCCUGGAAUCAACAA	17	4308
SCNN1A-460	+	ACCCUCAGGCGCUGCAA	17	4309
SCNN1A-461	+	CCAUUCCUAGGAAAGAA	17	4310
SCNN1A-462	−	GGCGACUGCACCAAGAA	17	4311
SCNN1A-463	+	ACGCUGGGGAUGGAGAA	17	4312
SCNN1A-464	−	CCAUUCUUUCCUAGGAA	17	4313
SCNN1A-465	+	AACCUGUACCCGGGGAA	17	4314
SCNN1A-466	−	AGGUAGAGUGUGGGGAA	17	4315
SCNN1A-467	+	UGAAUACACACCUGGAA	17	4316
SCNN1A-468	+	AUUUCCGGGUACCUGAA	17	4317
SCNN1A-469	+	GCUGUGUGUACUUUGAA	17	4318
SCNN1A-470	+	GCCACCAUCAUCCAUAA	17	4319
SCNN1A-471	+	UGUACUUUGAAGGGUAA	17	4320
SCNN1A-472	−	GACUGGGGCCCGGGUAA	17	4321
SCNN1A-473	−	AUCUCUCUGUACCCACA	17	4322
SCNN1A-474	+	GGACAAGGACAGAGACA	17	4323
SCNN1A-475	+	AGGGCCUGGCUGGGACA	17	4324
SCNN1A-476	−	AGAGGUUUCUCACACCA	17	4325
SCNN1A-477	+	UCUUGUGGCUGGGACCA	17	4326
SCNN1A-478	+	AGAUGGGCGGGGGCCCA	17	4327
SCNN1A-479	+	AGGAGGGGAGGAUGCCA	17	4328
SCNN1A-480	−	CCUGGGGUGAGACUCCA	17	4329
SCNN1A-481	+	CAGCGUGUCCUCCUCCA	17	4330
SCNN1A-482	−	GCUCCCUGCUUGCUCCA	17	4331
SCNN1A-483	−	GCCCCCGCCCAUCUCCA	17	4332
SCNN1A-484	+	GCCCCCAAGUCUGUCCA	17	4333
SCNN1A-485	+	GCGCCAUGGAGCAAGCA	17	4334
SCNN1A-486	+	AGUCACUGUGGACAGCA	17	4335
SCNN1A-487	+	AGGCUGGAGAGGGAGCA	17	4336
SCNN1A-488	−	UCAGCAUGAGGAAGGCA	17	4337
SCNN1A-489	+	GUUGUUGAUUCCAGGCA	17	4338
SCNN1A-490	+	CCAGGGUGGCAUAGGCA	17	4339
SCNN1A-491	−	UCCAGGCCGAGGGGGCA	17	4340
SCNN1A-492	+	GGGGACACUAACCUGCA	17	4341
SCNN1A-493	+	GACCCUCAGGCGCUGCA	17	4342
SCNN1A-494	−	CUCCAGGGGGCUCUGCA	17	4343
SCNN1A-495	−	GCCCGGGUAAUGGUGCA	17	4344
SCNN1A-496	+	CUCUGCGCGCAGCAUCA	17	4345
SCNN1A-497	−	ACCAGACAUACUCAUCA	17	4346
SCNN1A-498	+	GAAUGGGGGUGUCAUCA	17	4347
SCNN1A-499	−	CCAGGAGAGCAUGAUCA	17	4348
SCNN1A-500	−	GUCCCGCCCCCGCCUCA	17	4349
SCNN1A-501	+	CCUCUCCUUCCCUCUCA	17	4350
SCNN1A-502	+	AGGGGGAGGGGCUGUCA	17	4351
SCNN1A-503	−	UGAGUCUCCCUCUGUCA	17	4352
SCNN1A-504	−	AGUCAACAUCUUCUUCA	17	4353
SCNN1A-505	+	AAGGGGCGAGGGGAAGA	17	4354
SCNN1A-506	−	ACCUCUCCUCUCACAGA	17	4355
SCNN1A-507	+	CGACCUACCGUGACAGA	17	4356
SCNN1A-508	+	CUUAGGUGUGGGGCAGA	17	4357
SCNN1A-509	+	CAGAGACUAGAGUCAGA	17	4358
SCNN1A-510	+	GGAGGGUGGAGAGGAGA	17	4359
SCNN1A-511	+	GCAGAGCCCCCUGGAGA	17	4360
SCNN1A-512	+	GCUGUCAAGGCUGGAGA	17	4361
SCNN1A-513	−	GUUGUCUGUGGUGGAGA	17	4362
SCNN1A-514	−	CUGGGGGGGCCCUGAGA	17	4363
SCNN1A-515	−	CUGCUGGUUACUCACGA	17	4364
SCNN1A-516	+	GAGAGGUACAUUGACGA	17	4365
SCNN1A-517	+	ACCUGGGAUGUCACCGA	17	4366
SCNN1A-518	−	GAGGCCCGCAGCGCCGA	17	4367
SCNN1A-519	−	ACUGGUCUCCAGGCCGA	17	4368
SCNN1A-520	−	UCCUCAUGCUGCUCCGA	17	4369
SCNN1A-521	+	UCCCCCGCAGGUCGCGA	17	4370
SCNN1A-522	+	GGUACCUGAAGGGGCGA	17	4371
SCNN1A-523	+	CCACGCUACGGGCUCGA	17	4372
SCNN1A-524	+	GGCAGAAGUGGGAAGGA	17	4373
SCNN1A-525	+	GCCCAGGUUGGACAGGA	17	4374
SCNN1A-526	+	ACACCUGGAAGGGAGGA	17	4375
SCNN1A-527	−	CUCCAUCAGCAUGAGGA	17	4376
SCNN1A-528	−	AGAGUGUGGGGAAGGGA	17	4377
SCNN1A-529	+	GUGUCCUCCUCCAGGGA	17	4378
SCNN1A-530	−	GGGGGCCCUGAGAGGGA	17	4379
SCNN1A-531	+	CAACCUGUACCCGGGGA	17	4380
SCNN1A-532	+	UGGCAUAGGCAGGGGGA	17	4381
SCNN1A-533	+	GCUGGUCACGCUGGGGA	17	4382
SCNN1A-534	−	CAGGUAGAGUGUGGGGA	17	4383
SCNN1A-535	+	UGGGGGCAGAAGUGGGA	17	4384
SCNN1A-536	−	CCCCCAGGUGGACUGGA	17	4385
SCNN1A-537	+	GUGAAUACACACCUGGA	17	4386
SCNN1A-538	−	UGACUGGGAGGCCUGGA	17	4387
SCNN1A-539	−	GGUAGGUCGUGCCUGGA	17	4388
SCNN1A-540	−	CCUGCCUUUAUGGAUGA	17	4389
SCNN1A-541	+	AAUUUCCGGGUACCUGA	17	4390
SCNN1A-542	−	CCCCUUGCAGCGCCUGA	17	4391
SCNN1A-543	+	UGCCUUCCUCAUGCUGA	17	4392
SCNN1A-544	−	AGGGGUGGAUGCGGUGA	17	4393
SCNN1A-545	+	GGCCACGAGAGUGGUGA	17	4394
SCNN1A-546	+	UGACCUCUUGUUGUUGA	17	4395
SCNN1A-547	+	UGCUGUGUGUACUUUGA	17	4396
SCNN1A-548	−	CUCUCUCUUUCCUGAUA	17	4397
SCNN1A-549	+	CAUCAGGGACAGACCUA	17	4398
SCNN1A-550	+	AGCUGGAGGCCACGCUA	17	4399
SCNN1A-551	+	UCAGGAAAGAGAGAGUA	17	4400
SCNN1A-552	−	UUCCACCACCCGAUGUA	17	4401
SCNN1A-553	−	AGACUUGGGGGCGAUUA	17	4402
SCNN1A-554	−	GGAUGAACCUGCCUUUA	17	4403
SCNN1A-555	+	GGGUAAAGGUUCUCAAC	17	4404
SCNN1A-556	+	AGGACAGGUGGAGGAAC	17	4405
SCNN1A-557	+	CCGAGGAGCCGAACCAC	17	4406
SCNN1A-558	−	CAUCUCUCUGUACCCAC	17	4407
SCNN1A-559	+	CGAACCACAGGCUCCAC	17	4408
SCNN1A-560	−	CCCGGGUAAUGGUGCAC	17	4409
SCNN1A-561	+	AUUUGUUCUGGUUGCAC	17	4410
SCNN1A-562	−	UCCCGCCCCCGCCUCAC	17	4411
SCNN1A-563	+	UCUCUGGCAGCCUCGAC	17	4412
SCNN1A-564	+	CACGCUACGGGCUCGAC	17	4413
SCNN1A-565	−	AGGUGGACUGGAAGGAC	17	4414
SCNN1A-566	+	GGGCCCCCCCAGAGGAC	17	4415
SCNN1A-567	−	ACAACCCCCAGGUGGAC	17	4416
SCNN1A-568	+	GGCUGCCCAGGUUGGAC	17	4417
SCNN1A-569	−	AAGGCAAGGAUGCUGAC	17	4418
SCNN1A-570	−	CUGCUGUCCACAGUGAC	17	4419
SCNN1A-571	−	GGUUCCGAAGCCGAUAC	17	4420
SCNN1A-572	+	GCUGGAGGCCACGCUAC	17	4421
SCNN1A-573	−	UCCCCUUCCCCGGGUAC	17	4422
SCNN1A-574	+	AGGAGCUGUAUUUGUAC	17	4423
SCNN1A-575	−	CACCCUCCUGUCCAACC	17	4424
SCNN1A-576	−	CCAGGUCUCCUGCAACC	17	4425
SCNN1A-577	+	CUGAGGAGAAGUCAACC	17	4426
SCNN1A-578	−	CGCCUGCCGCUUCAACC	17	4427
SCNN1A-579	+	AGGAGUGAAUACACACC	17	4428
SCNN1A-580	−	CUUCUCCUCAGACCACC	17	4429
SCNN1A-581	+	AGUCCUUCCAGUCCACC	17	4430
SCNN1A-582	+	CCUGGUUGCAGGAGACC	17	4431
SCNN1A-583	+	CUUCCCCACACUCUACC	17	4432
SCNN1A-584	−	UCGCCCCUUCAGGUACC	17	4433
SCNN1A-585	+	GCCCGUGCACCAUUACC	17	4434
SCNN1A-586	−	GGGUUCAUAGGAAACCC	17	4435
SCNN1A-587	−	CCCUGCCUAUGCCACCC	17	4436
SCNN1A-588	−	GGAGGUAGCCUCCACCC	17	4437
SCNN1A-589	+	CCCGUGCACCAUUACCC	17	4438
SCNN1A-590	+	CCCUGGAGUCUCACCCC	17	4439
SCNN1A-591	−	GCGGGACAACAACCCCC	17	4440
SCNN1A-592	+	GCCCCUGCAGAGCCCCC	17	4441
SCNN1A-593	−	UUAGUGUCCCCUUCCCC	17	4442
SCNN1A-594	+	ACUUGGUGAAACAGCCC	17	4443
SCNN1A-595	+	GAGAUGGGCGGGGGCCC	17	4444
SCNN1A-596	−	CACAGUGACUGGGGCCC	17	4445
SCNN1A-597	−	AGAGGUCAGUCCUGCCC	17	4446
SCNN1A-598	+	GGCUCCACUGGCUGCCC	17	4447
SCNN1A-599	−	GCCCUCGGUGACAUCCC	17	4448
SCNN1A-600	−	AGAGACUCUGCCAUCCC	17	4449
SCNN1A-601	+	GCAGGGUGGGGGCUCCC	17	4450
SCNN1A-602	−	GUUAGUGUCCCCUUCCC	17	4451
SCNN1A-603	−	CUGUCCUUGUCCCAGCC	17	4452
SCNN1A-604	+	AUGGAGGUCUCCACGCC	17	4453
SCNN1A-605	+	CAGGACUGACUCACGCC	17	4454
SCNN1A-606	−	AUGCUGACUGGGAGGCC	17	4455
SCNN1A-607	−	GGCUUUAACUUGCGGCC	17	4456
SCNN1A-608	+	CCCCUGCCCCCUCGGCC	17	4457
SCNN1A-609	+	GGAGAGGGAGCAGGGCC	17	4458
SCNN1A-610	−	CCACAGUGACUGGGGCC	17	4459
SCNN1A-611	−	UGGAUGUCUUCCAUGCC	17	4460
SCNN1A-612	+	AAGGAGGGGAGGAUGCC	17	4461
SCNN1A-613	−	CGUGAGUCAGUCCUGCC	17	4462
SCNN1A-614	−	UCACGGUAGGUCGUGCC	17	4463
SCNN1A-615	+	CAUCACAGGCUCCAUCC	17	4464
SCNN1A-616	−	UCCUGGGGUGAGACUCC	17	4465
SCNN1A-617	+	CCAGCGUGUCCUCCUCC	17	4466
SCNN1A-618	−	CUGCUACUAUAAGCUCC	17	4467
SCNN1A-619	−	GGCCCCCGCCCAUCUCC	17	4468
SCNN1A-620	+	CCUUGAUCAUGCUCUCC	17	4469
SCNN1A-621	−	AGCCGAUACUGGUCUCC	17	4470
SCNN1A-622	+	CGCCCCCAAGUCUGUCC	17	4471
SCNN1A-623	+	UCACCGUUGUUGAUUCC	17	4472
SCNN1A-624	−	CCACCCUCCUCCCUUCC	17	4473
SCNN1A-625	−	UAUUCACUCCUGCUUCC	17	4474
SCNN1A-626	−	ACAGAAAGCACAGUUCC	17	4475
SCNN1A-627	+	GCUCCUCUUUAAUUUCC	17	4476
SCNN1A-628	+	GGCGCCAUGGAGCAAGC	17	4477
SCNN1A-629	+	GUUGUUGUCCCGCAAGC	17	4478
SCNN1A-630	+	CAUGCUCUCCUGGAAGC	17	4479
SCNN1A-631	−	UUCAAAGUACACACAGC	17	4480
SCNN1A-632	+	CAGUCACUGUGGACAGC	17	4481
SCNN1A-633	+	CUGCGGGCCUCACCAGC	17	4482
SCNN1A-634	+	GGAACAUGAUGACCAGC	17	4483
SCNN1A-635	−	GAAGAUCGGCUUCCAGC	17	4484
SCNN1A-636	+	AGUAACCAGCAGAGAGC	17	4485
SCNN1A-637	−	GGAAAUUAAAGAGGAGC	17	4486
SCNN1A-638	−	AGAGGAGCUGGAGGAGC	17	4487
SCNN1A-639	+	AAGGCUGGAGAGGGAGC	17	4488
SCNN1A-640	+	GCGACGGCUGCGGGAGC	17	4489
SCNN1A-641	+	AGCAGAGAGCUGGUAGC	17	4490
SCNN1A-642	−	CCUGGAGGAGGACACGC	17	4491
SCNN1A-643	+	CUGGUAGCUGGUCACGC	17	4492
SCNN1A-644	+	GCGGCAGAGUCCCCCGC	17	4493
SCNN1A-645	+	CCAUCAUCCAUAAAGGC	17	4494
SCNN1A-646	+	GGAGGGGCUGUCAAGGC	17	4495
SCNN1A-647	+	AGAGCAAGGAGCCAGGC	17	4496
SCNN1A-648	+	GACGGGCCCCGUGAGGC	17	4497
SCNN1A-649	+	CCCAGGGUGGCAUAGGC	17	4498
SCNN1A-650	+	GACCUGGUUGAAGCGGC	17	4499
SCNN1A-651	+	GUGGCUGGGACCAGGGC	17	4500
SCNN1A-652	−	GGUAAUGGUGCACGGGC	17	4501
SCNN1A-653	−	CUCCAGGCCGAGGGGGC	17	4502
SCNN1A-654	+	CCCCGUGAGGCGGGGGC	17	4503
SCNN1A-655	+	GCCCCCUGGAGAUGGGC	17	4504
SCNN1A-656	+	AGGGAGCAGGGCCUGGC	17	4505
SCNN1A-657	−	UUCACCACUCUCGUGGC	17	4506
SCNN1A-658	−	AGUGCCGGAAGCCAUGC	17	4507
SCNN1A-659	−	CAGCCGUCGCGACCUGC	17	4508
SCNN1A-660	−	GCUCGUCUUUGACCUGC	17	4509
SCNN1A-661	+	GGGCCCCUCGGCGCUGC	17	4510
SCNN1A-662	+	CAGGUCGCGACGGCUGC	17	4511
SCNN1A-663	−	UCUCCAGGGGGCUCUGC	17	4512
SCNN1A-664	−	AGCUACCAGCUCUCUGC	17	4513
SCNN1A-665	−	GCUGUUUCACCAAGUGC	17	4514
SCNN1A-666	−	CGUGGCCUCCAGCUUGC	17	4515
SCNN1A-667	+	GACUCACGCCUGGUUGC	17	4516
SCNN1A-668	+	AGCAGUUUCCAUACAUC	17	4517
SCNN1A-669	+	GCUCUGCGCGCAGCAUC	17	4518
SCNN1A-670	+	UCUGUCGCGAUAGCAUC	17	4519
SCNN1A-671	−	UACCAGACAUACUCAUC	17	4520
SCNN1A-672	+	GAGAGUAAUUCCUUAUC	17	4521
SCNN1A-673	−	AGAACAACUCCAACCUC	17	4522
SCNN1A-674	+	GCGGGGGCGGGACCCUC	17	4523
SCNN1A-675	−	UUCCUCCACCUGUCCUC	17	4524
SCNN1A-676	−	AGGGGGCAGGGGUGCUC	17	4525
SCNN1A-677	+	ACCUCUCCUUCCCUCUC	17	4526
SCNN1A-678	+	AGGGAUGGCAGAGUCUC	17	4527
SCNN1A-679	+	GCGAGGGGAAGAGGGUC	17	4528
SCNN1A-680	+	CCCCUGAUGAGUAUGUC	17	4529
SCNN1A-681	−	CUUCCCCUCGCCCCUUC	17	4530
SCNN1A-682	+	CUAACCUGCAUGGCUUC	17	4531
SCNN1A-683	+	CACAGUACUCCACGUUC	17	4532
SCNN1A-684	+	AGCAGUCCGAUUUGUUC	17	4533
SCNN1A-685	+	AGCUCCUCUUUAAUUUC	17	4534
SCNN1A-686	−	GUACCCGGAAAUUAAAG	17	4535
SCNN1A-687	−	ACACCGUCAACAACAAG	17	4536
SCNN1A-688	+	CCCUCAGGCGCUGCAAG	17	4537
SCNN1A-689	+	UGGGGUGGGGGCAGAAG	17	4538
SCNN1A-690	+	GAAGGGGCGAGGGGAAG	17	4539
SCNN1A-691	+	ACCUGUACCCGGGGAAG	17	4540
SCNN1A-692	+	UGUUGAUGUAGUGGAAG	17	4541
SCNN1A-693	+	UUUCCGGGUACCUGAAG	17	4542
SCNN1A-694	+	AGGAGACCUGGUUGAAG	17	4543
SCNN1A-695	+	ACGACCUACCGUGACAG	17	4544
SCNN1A-696	+	UCUCAGGGCCCCCCCAG	17	4545
SCNN1A-697	−	CCAACCUGGGCAGCCAG	17	4546
SCNN1A-698	+	GCAUGGAAGACAUCCAG	17	4547
SCNN1A-699	−	CCCCCGCCCAUCUCCAG	17	4548
SCNN1A-700	+	GUCACUGUGGACAGCAG	17	4549
SCNN1A-701	+	CAGGGUGGCAUAGGCAG	17	4550
SCNN1A-702	−	CCAGGCCGAGGGGGCAG	17	4551
SCNN1A-703	+	UCUUAGGUGUGGGGCAG	17	4552
SCNN1A-704	−	UCCAGGGGGCUCUGCAG	17	4553
SCNN1A-705	−	CCAGACAUACUCAUCAG	17	4554
SCNN1A-706	+	ACAGAGACUAGAGUCAG	17	4555
SCNN1A-707	+	AGAGACUAGAGUCAGAG	17	4556
SCNN1A-708	+	GGAGCCGGCCACGAGAG	17	4557
SCNN1A-709	−	AGGCCCGCAGCGCCGAG	17	4558
SCNN1A-710	−	CUGGUCUCCAGGCCGAG	17	4559
SCNN1A-711	+	GUACCUGAAGGGGCGAG	17	4560
SCNN1A-712	−	CCCUGAGAGGGAAGGAG	17	4561
SCNN1A-713	+	GCAGAAGUGGGAAGGAG	17	4562
SCNN1A-714	+	AGGAGGGUGGAGAGGAG	17	4563
SCNN1A-715	+	ACCAUCUGUGAGAGGAG	17	4564
SCNN1A-716	−	UGGAUGCGGUGAGGGAG	17	4565
SCNN1A-717	+	GGCAUAGGCAGGGGGAG	17	4566
SCNN1A-718	−	ACACCUAAGAAAUGGAG	17	4567
SCNN1A-719	+	GGCUGUCAAGGCUGGAG	17	4568
SCNN1A-720	+	AAGGGAGGAGGGUGGAG	17	4569
SCNN1A-721	−	UCUGGGGGGGCCCUGAG	17	4570
SCNN1A-722	+	GGGUGACCAUCUGUGAG	17	4571
SCNN1A-723	+	AUCAGGGACAGACCUAG	17	4572
SCNN1A-724	+	ACAGGAUGUUGAUGUAG	17	4573
SCNN1A-725	−	UCCGCGGCCCCAGAACG	17	4574
SCNN1A-726	−	CCCGCCCCCGCCUCACG	17	4575
SCNN1A-727	+	CACCACAGACAACACCG	17	4576
SCNN1A-728	+	UACCUGGGAUGUCACCG	17	4577
SCNN1A-729	−	UGAGGCCCGCAGCGCCG	17	4578
SCNN1A-730	−	UACUGGUCUCCAGGCCG	17	4579
SCNN1A-731	+	UCCACGUUCUGGGGCCG	17	4580
SCNN1A-732	−	CCUACAUCUUCUAUCCG	17	4581
SCNN1A-733	−	GGCCCAACCUGAUUCCG	17	4582
SCNN1A-734	−	CCGUCGAGCCCGUAGCG	17	4583
SCNN1A-735	+	ACGGGCCCCGUGAGGCG	17	4584
SCNN1A-736	+	GGGUACCUGAAGGGGCG	17	4585
SCNN1A-737	+	CCCCCUGGAGAUGGGCG	17	4586
SCNN1A-738	−	UAACUUGCGGCCUGGCG	17	4587
SCNN1A-739	−	AGCCGUCGCGACCUGCG	17	4588
SCNN1A-740	−	CUCCUUCACCACUCUCG	17	4589
SCNN1A-741	−	ACAUCAACAUCCUGUCG	17	4590
SCNN1A-742	+	GGGCAGAAGUGGGAAGG	17	4591
SCNN1A-743	+	CCCCCCCAGAGGACAGG	17	4592
SCNN1A-744	+	UGCCCAGGUUGGACAGG	17	4593
SCNN1A-745	−	GGACAACAACCCCCAGG	17	4594
SCNN1A-746	+	UGGUGAAACAGCCCAGG	17	4595
SCNN1A-747	−	CCCCGCCCAUCUCCAGG	17	4596
SCNN1A-748	+	AGGGUGGCAUAGGCAGG	17	4597
SCNN1A-749	−	GGGCAGGGGUGCUCAGG	17	4598
SCNN1A-750	−	UGGUCUCCAGGCCGAGG	17	4599
SCNN1A-751	+	CACACCUGGAAGGGAGG	17	4600
SCNN1A-752	−	UCUGCCAUCCCUGGAGG	17	4601
SCNN1A-753	+	CGACGGGCCCCGUGAGG	17	4602
SCNN1A-754	+	CGGGCCCCGUGAGGCGG	17	4603
SCNN1A-755	+	CCCCUGGAGAUGGGCGG	17	4604
SCNN1A-756	−	GCCGUCGCGACCUGCGG	17	4605
SCNN1A-757	+	AUACACACCUGGAAGGG	17	4606
SCNN1A-758	+	UGGGCGGGGGCCCAGGG	17	4607
SCNN1A-759	+	AGGGGAGGAUGCCAGGG	17	4608
SCNN1A-760	+	AGGUGUGGGGCAGAGGG	17	4609
SCNN1A-761	+	CCUGGAAGGGAGGAGGG	17	4610
SCNN1A-762	+	AGUUUCCAUACAUCGGG	17	4611
SCNN1A-763	−	GACAUACUCAUCAGGGG	17	4612
SCNN1A-764	+	GAAGUGGGAAGGAGGGG	17	4613
SCNN1A-765	+	GUGGCAUAGGCAGGGGG	17	4614
SCNN1A-766	+	GCCCCGUGAGGCGGGGG	17	4615
SCNN1A-767	+	AGGACAGAGACAUGGGG	17	4616
SCNN1A-768	−	CCACCUGUCCUCUGGGG	17	4617
SCNN1A-769	+	AGCCCCCUGGAGAUGGG	17	4618
SCNN1A-770	−	UGUGGGGAAGGGAUGGG	17	4619
SCNN1A-771	−	CAAGGAUGCUGACUGGG	17	4620
SCNN1A-772	−	UCCACCUGUCCUCUGGG	17	4621
SCNN1A-773	+	UUCCUAGGAAAGAAUGG	17	4622
SCNN1A-774	−	GCCUUUAUGGAUGAUGG	17	4623
SCNN1A-775	+	CUUCCUCAUGCUGAUGG	17	4624
SCNN1A-776	+	CCUUCCAGUCCACCUGG	17	4625
SCNN1A-777	−	GACUCUGCCAUCCCUGG	17	4626
SCNN1A-778	+	GUUGUCCCGCAAGCUGG	17	4627
SCNN1A-779	−	AAUUAAAGAGGAGCUGG	17	4628
SCNN1A-780	−	CUCCACCUGUCCUCUGG	17	4629
SCNN1A-781	+	CCCCAGAGGACAGGUGG	17	4630
SCNN1A-782	+	GGAGGAUGCCAGGGUGG	17	4631
SCNN1A-783	+	UUCCAUACAUCGGGUGG	17	4632
SCNN1A-784	+	ACAGAGACAUGGGGUGG	17	4633
SCNN1A-785	−	GGGGAAGGGAUGGGUGG	17	4634
SCNN1A-786	−	CUCGGUGUUGUCUGUGG	17	4635
SCNN1A-787	−	ACCCUGGACAGACUUGG	17	4636
SCNN1A-788	+	AUUCCUAGGAAAGAAUG	17	4637
SCNN1A-789	+	ACAAGGACAGAGACAUG	17	4638
SCNN1A-790	+	ACCUUCGGAGCAGCAUG	17	4639
SCNN1A-791	−	AGACCUCCAUCAGCAUG	17	4640
SCNN1A-792	−	CUCAUCAGGGGUGGAUG	17	4641
SCNN1A-793	+	GCGUCUGCUCUGUGAUG	17	4642
SCNN1A-794	−	UGAUCUCUUGGUGUAUG	17	4643
SCNN1A-795	+	CCGGGCCCCAGUCACUG	17	4644
SCNN1A-796	−	GCUGUCCACAGUGACUG	17	4645
SCNN1A-797	+	UCCUUCCAGUCCACCUG	17	4646
SCNN1A-798	−	GCAGCCGUCGCGACCUG	17	4647
SCNN1A-799	+	AUAGUAGCAGUACCCUG	17	4648
SCNN1A-800	−	GCAGCCAGUGGAGCCUG	17	4649
SCNN1A-801	−	ACCCCUUGCAGCGCCUG	17	4650
SCNN1A-802	−	AGAAAGCACAGUUCCUG	17	4651
SCNN1A-803	+	GGUAGCUGGUCACGCUG	17	4652
SCNN1A-804	+	CGGGCCCCUCGGCGCUG	17	4653
SCNN1A-805	+	GCAGGUCGCGACGGCUG	17	4654
SCNN1A-806	−	CCUCCACCUGUCCUCUG	17	4655
SCNN1A-807	+	ACAGCCCAGGUGGUCUG	17	4656
SCNN1A-808	−	CUCCUCGGUGUUGUCUG	17	4657
SCNN1A-809	+	CAGUACUCCACGUUCUG	17	4658
SCNN1A-810	−	ACAUCCCAGGUAGAGUG	17	4659
SCNN1A-811	−	AGCAUGAUCAAGGAGUG	17	4660
SCNN1A-812	+	GCUCGACGGGCCCCGUG	17	4661
SCNN1A-813	−	AGUACACACAGCAGGUG	17	4662
SCNN1A-814	+	ACUCCAUUUCUUAGGUG	17	4663
SCNN1A-815	−	CAGGGGUGGAUGCGGUG	17	4664
SCNN1A-816	+	AGGCGCUGCAAGGGGUG	17	4665
SCNN1A-817	+	GACAGAGACAUGGGGUG	17	4666
SCNN1A-818	−	UGGGGAAGGGAUGGGUG	17	4667
SCNN1A-819	−	UCGGCUUCCAGCUGGUG	17	4668
SCNN1A-820	−	AUCCCAGGUAGAGUGUG	17	4669
SCNN1A-821	+	UCCAUUUCUUAGGUGUG	17	4670
SCNN1A-822	−	AUGGUGGCUUUAACUUG	17	4671
SCNN1A-823	−	AACCCUGGACAGACUUG	17	4672
SCNN1A-824	−	GCGUGGCCUCCAGCUUG	17	4673
SCNN1A-825	−	GUGCAACCAGAACAAAU	17	4674
SCNN1A-826	+	CAUUCCUAGGAAAGAAU	17	4675
SCNN1A-827	+	AGAGGGAGACUCAGAAU	17	4676
SCNN1A-828	−	CAUUCUUUCCUAGGAAU	17	4677
SCNN1A-829	+	GACAAGGACAGAGACAU	17	4678
SCNN1A-830	+	UAGCAGUUUCCAUACAU	17	4679
SCNN1A-831	+	GGGGCCCAGGGUGGCAU	17	4680
SCNN1A-832	−	GGUGUAUGUGGGUUCAU	17	4681
SCNN1A-833	−	UGGAAGGACUGGAAGAU	17	4682
SCNN1A-834	+	CAGAGCCCCCUGGAGAU	17	4683
SCNN1A-835	+	AGAGGUACAUUGACGAU	17	4684
SCNN1A-836	−	GAGUGUGGGGAAGGGAU	17	4685
SCNN1A-837	+	GGCCUGGAGACCAGUAU	17	4686
SCNN1A-838	+	GCAUGGCUUCCGGCACU	17	4687
SCNN1A-839	−	GAAACCCUGGACAGACU	17	4688
SCNN1A-840	−	AGGCAAGGAUGCUGACU	17	4689
SCNN1A-841	−	UGCUGUCCACAGUGACU	17	4690
SCNN1A-842	−	ACCCUCCUGUCCAACCU	17	4691
SCNN1A-843	−	UUCUCCUCAGACCACCU	17	4692
SCNN1A-844	+	GUCCUUCCAGUCCACCU	17	4693
SCNN1A-845	+	GCAUCAGGGACAGACCU	17	4694
SCNN1A-846	+	UUCCCCACACUCUACCU	17	4695
SCNN1A-847	−	CCUGCCUAUGCCACCCU	17	4696
SCNN1A-848	−	GCUCUCUCUGCACCCCU	17	4697
SCNN1A-849	+	GAGCACCCCUGCCCCCU	17	4698
SCNN1A-850	−	UUACUCACGAUGGCCCU	17	4699
SCNN1A-851	−	CCUGUGGUUCGGCUCCU	17	4700
SCNN1A-852	+	CUGGAAGACCCAUUCCU	17	4701
SCNN1A-853	−	CAGAAAGCACAGUUCCU	17	4702
SCNN1A-854	−	CACCCCCAUUCUUUCCU	17	4703
SCNN1A-855	−	CUGGAGGAGGACACGCU	17	4704
SCNN1A-856	+	UGGUAGCUGGUCACGCU	17	4705
SCNN1A-857	+	GGGAGCAGGGCCUGGCU	17	4706
SCNN1A-858	−	UCCUCCACCUGUCCUCU	17	4707
SCNN1A-859	+	AACAUCACUGCCAUUCU	17	4708
SCNN1A-860	+	ACAGUACUCCACGUUCU	17	4709
SCNN1A-861	+	GGGGUGGGGGCAGAAGU	17	4710
SCNN1A-862	+	UGCAGAGAGAGCAGAGU	17	4711
SCNN1A-863	+	AUCAGGAAAGAGAGAGU	17	4712
SCNN1A-864	+	CCACUGGCUGCCCAGGU	17	4713
SCNN1A-865	+	CUGCCACGGAAUCAGGU	17	4714
SCNN1A-866	+	GGAAGACAUCCAGAGGU	17	4715
SCNN1A-867	−	UCUCCCUCUGUCACGGU	17	4716
SCNN1A-868	+	GGUGUGGGGCAGAGGGU	17	4717
SCNN1A-869	+	GGACAGAGACAUGGGGU	17	4718
SCNN1A-870	−	GUGGGGAAGGGAUGGGU	17	4719
SCNN1A-871	+	CCGCGGAUAGAAGAUGU	17	4720
SCNN1A-872	−	GAUCUCUUGGUGUAUGU	17	4721
SCNN1A-873	+	UAGUAGCAGUACCCUGU	17	4722
SCNN1A-874	+	AGAAAGGUGCUCAGUGU	17	4723
SCNN1A-875	−	CAUCCCAGGUAGAGUGU	17	4724
SCNN1A-876	+	CUCCAUUUCUUAGGUGU	17	4725
SCNN1A-877	−	AAACCCUGGACAGACUU	17	4726
SCNN1A-878	+	GAAGAAGAUGUUGACUU	17	4727
SCNN1A-879	+	AUCGGCUUCGGAACCUU	17	4728
SCNN1A-880	+	GAGACCAGUAUCGGCUU	17	4729
SCNN1A-881	+	UGGCCACUCCAUUUCUU	17	4730
SCNN1A-882	+	UGCCACGGAAUCAGGUU	17	4731
SCNN1A-883	−	CAGUGGAGCCUGUGGUU	17	4732
SCNN1A-884	−	UCUGCCCCACACCUAAGAAA	20	4733
SCNN1A-885	−	UCCAUGCCUGGAAUCAACAA	20	4734
SCNN1A-886	+	GGGACCCUCAGGCGCUGCAA	20	4735
SCNN1A-887	+	GACCCAUUCCUAGGAAAGAA	20	4736
SCNN1A-888	−	UAUGGCGACUGCACCAAGAA	20	4737
SCNN1A-889	+	GUCACGCUGGGGAUGGAGAA	20	4738
SCNN1A-890	−	CCCCCAUUCUUUCCUAGGAA	20	4739
SCNN1A-891	−	CCCAGGUAGAGUGUGGGGAA	20	4740
SCNN1A-892	+	GAGUGAAUACACACCUGGAA	20	4741
SCNN1A-893	+	UUAAUUUCCGGGUACCUGAA	20	4742
SCNN1A-894	+	CCUGCUGUGUGUACUUUGAA	20	4743
SCNN1A-895	+	AAAGCCACCAUCAUCCAUAA	20	4744
SCNN1A-896	+	GUGUGUACUUUGAAGGGUAA	20	4745
SCNN1A-897	−	AGUGACUGGGGCCCGGGUAA	20	4746
SCNN1A-898	−	GGCAUCUCUCUGUACCCACA	20	4747
SCNN1A-899	+	CUGGGACAAGGACAGAGACA	20	4748
SCNN1A-900	+	AGCAGGGCCUGGCUGGGACA	20	4749
SCNN1A-901	−	AGGAGAGGUUUCUCACACCA	20	4750
SCNN1A-902	+	UGGAGAUGGGCGGGGGCCCA	20	4751
SCNN1A-903	+	GGAAGGAGGGGAGGAUGCCA	20	4752
SCNN1A-904	−	GUUCCUGGGGUGAGACUCCA	20	4753
SCNN1A-905	+	GCCCAGCGUGUCCUCCUCCA	20	4754
SCNN1A-906	−	GAAGCUCCCUGCUUGCUCCA	20	4755
SCNN1A-907	−	UGGGCCCCCGCCCAUCUCCA	20	4756
SCNN1A-908	+	AUCGCCCCCAAGUCUGUCCA	20	4757
SCNN1A-909	+	AGGGCGCCAUGGAGCAAGCA	20	4758
SCNN1A-910	+	CCCAGUCACUGUGGACAGCA	20	4759
SCNN1A-911	+	UCAAGGCUGGAGAGGGAGCA	20	4760
SCNN1A-912	−	CCAUCAGCAUGAGGAAGGCA	20	4761
SCNN1A-913	+	ACCGUUGUUGAUUCCAGGCA	20	4762
SCNN1A-914	+	GGCCCAGGGUGGCAUAGGCA	20	4763
SCNN1A-915	−	GUCUCCAGGCCGAGGGGGCA	20	4764
SCNN1A-916	+	GAAGGGGACACUAACCUGCA	20	4765
SCNN1A-917	+	CGGGACCCUCAGGCGCUGCA	20	4766
SCNN1A-918	−	CAUCUCCAGGGGGCUCUGCA	20	4767
SCNN1A-919	−	GGGGCCCGGGUAAUGGUGCA	20	4768
SCNN1A-920	+	CUGCUCUGCGCGCAGCAUCA	20	4769
SCNN1A-921	−	UCUACCAGACAUACUCAUCA	20	4770
SCNN1A-922	+	AAAGAAUGGGGGUGUCAUCA	20	4771
SCNN1A-923	−	CUUCCAGGAGAGCAUGAUCA	20	4772
SCNN1A-924	−	AGGGUCCCGCCCCCGCCUCA	20	4773
SCNN1A-925	+	AAACCUCUCCUUCCCUCUCA	20	4774
SCNN1A-926	+	GGCAGGGGGAGGGGCUGUCA	20	4775
SCNN1A-927	−	UUCUGAGUCUCCCUCUGUCA	20	4776
SCNN1A-928	−	CAAAGUCAACAUCUUCUUCA	20	4777
SCNN1A-929	+	CUGAAGGGGCGAGGGGAAGA	20	4778
SCNN1A-930	−	UGUACCUCUCCUCUCACAGA	20	4779
SCNN1A-931	+	GCACGACCUACCGUGACAGA	20	4780
SCNN1A-932	+	UUUCUUAGGUGUGGGGCAGA	20	4781
SCNN1A-933	+	ACACAGAGACUAGAGUCAGA	20	4782
SCNN1A-934	+	GGAGGAGGGUGGAGAGGAGA	20	4783
SCNN1A-935	+	CCUGCAGAGCCCCCUGGAGA	20	4784
SCNN1A-936	+	GGGGCUGUCAAGGCUGGAGA	20	4785
SCNN1A-937	−	GGUGUUGUCUGUGGUGGAGA	20	4786
SCNN1A-938	−	CCUCUGGGGGGGCCCUGAGA	20	4787
SCNN1A-939	−	UCUCUGCUGGUUACUCACGA	20	4788
SCNN1A-940	+	GAGGAGAGGUACAUUGACGA	20	4789
SCNN1A-941	+	UCUACCUGGGAUGUCACCGA	20	4790
SCNN1A-942	−	GGUGAGGCCCGCAGCGCCGA	20	4791
SCNN1A-943	−	GAUACUGGUCUCCAGGCCGA	20	4792
SCNN1A-944	−	UGUUCCUCAUGCUGCUCCGA	20	4793
SCNN1A-945	+	GAGUCCCCCGCAGGUCGCGA	20	4794
SCNN1A-946	+	CCGGGUACCUGAAGGGGCGA	20	4795
SCNN1A-947	+	AGGCCACGCUACGGGCUCGA	20	4796
SCNN1A-948	+	GGGGGCAGAAGUGGGAAGGA	20	4797
SCNN1A-949	+	GCUGCCCAGGUUGGACAGGA	20	4798
SCNN1A-950	+	UACACACCUGGAAGGGAGGA	20	4799
SCNN1A-951	−	GACCUCCAUCAGCAUGAGGA	20	4800
SCNN1A-952	−	GGUAGAGUGUGGGGAAGGGA	20	4801
SCNN1A-953	+	AGCGUGUCCUCCUCCAGGGA	20	4802
SCNN1A-954	−	UGGGGGGGCCCUGAGAGGGA	20	4803
SCNN1A-955	+	GGGUGGCAUAGGCAGGGGGA	20	4804
SCNN1A-956	+	GUAGCUGGUCACGCUGGGGA	20	4805
SCNN1A-957	−	UCCCAGGUAGAGUGUGGGGA	20	4806
SCNN1A-958	+	GGGUGGGGGCAGAAGUGGGA	20	4807
SCNN1A-959	−	CAACCCCCAGGUGGACUGGA	20	4808
SCNN1A-960	+	GGAGUGAAUACACACCUGGA	20	4809
SCNN1A-961	−	UGCUGACUGGGAGGCCUGGA	20	4810
SCNN1A-962	−	CACGGUAGGUCGUGCCUGGA	20	4811
SCNN1A-963	−	GAACCUGCCUUUAUGGAUGA	20	4812
SCNN1A-964	+	UUUAAUUUCCGGGUACCUGA	20	4813
SCNN1A-965	−	GCACCCCUUGCAGCGCCUGA	20	4814
SCNN1A-966	+	CCUUGCCUUCCUCAUGCUGA	20	4815
SCNN1A-967	−	AUCAGGGGUGGAUGCGGUGA	20	4816
SCNN1A-968	+	GCCGGCCACGAGAGUGGUGA	20	4817
SCNN1A-969	+	GACUGACCUCUUGUUGUUGA	20	4818
SCNN1A-970	+	ACCUGCUGUGUGUACUUUGA	20	4819
SCNN1A-971	−	CUACUCUCUCUUUCCUGAUA	20	4820
SCNN1A-972	+	CAGCAUCAGGGACAGACCUA	20	4821
SCNN1A-973	+	GCAAGCUGGAGGCCACGCUA	20	4822
SCNN1A-974	+	UUAUCAGGAAAGAGAGAGUA	20	4823
SCNN1A-975	−	CACUUCCACCACCCGAUGUA	20	4824
SCNN1A-976	−	GACAGACUUGGGGGCGAUUA	20	4825
SCNN1A-977	−	GCAGGAUGAACCUGCCUUUA	20	4826
SCNN1A-978	+	GAAGGGUAAAGGUUCUCAAC	20	4827
SCNN1A-979	+	CAGAGGACAGGUGGAGGAAC	20	4828
SCNN1A-980	+	ACACCGAGGAGCCGAACCAC	20	4829
SCNN1A-981	−	AGGCAUCUCUCUGUACCCAC	20	4830
SCNN1A-982	+	AGCCGAACCACAGGCUCCAC	20	4831
SCNN1A-983	−	GGGCCCGGGUAAUGGUGCAC	20	4832
SCNN1A-984	+	CCGAUUUGUUCUGGUUGCAC	20	4833
SCNN1A-985	−	GGGUCCCGCCCCCGCCUCAC	20	4834
SCNN1A-986	+	GAGUCUCUGGCAGCCUCGAC	20	4835
SCNN1A-987	+	GGCCACGCUACGGGCUCGAC	20	4836
SCNN1A-988	−	CCCAGGUGGACUGGAAGGAC	20	4837
SCNN1A-989	+	UCAGGGCCCCCCCAGAGGAC	20	4838
SCNN1A-990	−	ACAACAACCCCCAGGUGGAC	20	4839
SCNN1A-991	+	ACUGGCUGCCCAGGUUGGAC	20	4840
SCNN1A-992	−	AGGAAGGCAAGGAUGCUGAC	20	4841
SCNN1A-993	−	CCCCUGCUGUCCACAGUGAC	20	4842
SCNN1A-994	−	GAAGGUUCCGAAGCCGAUAC	20	4843
SCNN1A-995	+	CAAGCUGGAGGCCACGCUAC	20	4844
SCNN1A-996	−	GUGUCCCCUUCCCCGGGUAC	20	4845
SCNN1A-997	+	UGAAGGAGCUGUAUUUGUAC	20	4846
SCNN1A-998	−	GGUCACCCUCCUGUCCAACC	20	4847
SCNN1A-999	−	CAACCAGGUCUCCUGCAACC	20	4848
SCNN1A-1000	+	GGUCUGAGGAGAAGUCAACC	20	4849
SCNN1A-1001	−	CUUCGCCUGCCGCUUCAACC	20	4850
SCNN1A-1002	+	AGCAGGAGUGAAUACACACC	20	4851
SCNN1A-1003	−	UGACUUCUCCUCAGACCACC	20	4852
SCNN1A-1004	+	UCCAGUCCUUCCAGUCCACC	20	4853
SCNN1A-1005	+	ACGCCUGGUUGCAGGAGACC	20	4854
SCNN1A-1006	+	UCCCUUCCCCACACUCUACC	20	4855
SCNN1A-1007	−	CCCUCGCCCCUUCAGGUACC	20	4856
SCNN1A-1008	+	CCUGCCCGUGCACCAUUACC	20	4857
SCNN1A-1009	−	UGUGGGUUCAUAGGAAACCC	20	4858
SCNN1A-1010	−	UCCCCCUGCCUAUGCCACCC	20	4859
SCNN1A-1011	−	UCAGGAGGUAGCCUCCACCC	20	4860
SCNN1A-1012	+	CUGCCCGUGCACCAUUACCC	20	4861
SCNN1A-1013	+	GCUCCCUGGAGUCUCACCCC	20	4862
SCNN1A-1014	−	CUUGCGGGACAACAACCCCC	20	4863
SCNN1A-1015	+	CUGGCCCCUGCAGAGCCCCC	20	4864
SCNN1A-1016	−	AGGUUAGUGUCCCCUUCCCC	20	4865
SCNN1A-1017	+	GGCACUUGGUGAAACAGCCC	20	4866
SCNN1A-1018	+	CUGGAGAUGGGCGGGGGCCC	20	4867
SCNN1A-1019	−	GUCCACAGUGACUGGGGCCC	20	4868
SCNN1A-1020	−	ACAAGAGGUCAGUCCUGCCC	20	4869
SCNN1A-1021	+	ACAGGCUCCACUGGCUGCCC	20	4870
SCNN1A-1022	−	AUGGCCCUCGGUGACAUCCC	20	4871
SCNN1A-1023	−	GCCAGAGACUCUGCCAUCCC	20	4872
SCNN1A-1024	−	CAGGUUAGUGUCCCCUUCCC	20	4873
SCNN1A-1025	−	UCUCUGUCCUUGUCCCAGCC	20	4874
SCNN1A-1026	+	CUGAUGGAGGUCUCCACGCC	20	4875
SCNN1A-1027	+	AGGCAGGACUGACUCACGCC	20	4876
SCNN1A-1028	−	AGGAUGCUGACUGGGAGGCC	20	4877
SCNN1A-1029	−	GGUGGCUUUAACUUGCGGCC	20	4878
SCNN1A-1030	+	GCACCCCUGCCCCCUCGGCC	20	4879
SCNN1A-1031	+	GCUGGAGAGGGAGCAGGGCC	20	4880
SCNN1A-1032	−	UGUCCACAGUGACUGGGGCC	20	4881
SCNN1A-1033	−	CUCUGGAUGUCUUCCAUGCC	20	4882
SCNN1A-1034	+	GGGAAGGAGGGGAGGAUGCC	20	4883
SCNN1A-1035	−	AGGCGUGAGUCAGUCCUGCC	20	4884
SCNN1A-1036	−	CUGUCACGGUAGGUCGUGCC	20	4885
SCNN1A-1037	−	AGUUCCUGGGGUGAGACUCC	20	4886
SCNN1A-1038	+	UGCCCAGCGUGUCCUCCUCC	20	4887
SCNN1A-1039	−	GUACUGCUACUAUAAGCUCC	20	4888
SCNN1A-1040	−	CUGGGCCCCCGCCCAUCUCC	20	4889
SCNN1A-1041	+	ACUCCUUGAUCAUGCUCUCC	20	4890
SCNN1A-1042	−	CGAAGCCGAUACUGGUCUCC	20	4891
SCNN1A-1043	+	AAUCGCCCCCAAGUCUGUCC	20	4892
SCNN1A-1044	+	UUCUCACCGUUGUUGAUUCC	20	4893
SCNN1A-1045	−	UCUCCACCCUCCUCCCUUCC	20	4894
SCNN1A-1046	−	GUGUAUUCACUCCUGCUUCC	20	4895
SCNN1A-1047	−	ACUACAGAAAGCACAGUUCC	20	4896
SCNN1A-1048	+	CCAGCUCCUCUUUAAUUUCC	20	4897
SCNN1A-1049	+	GAGGGCGCCAUGGAGCAAGC	20	4898
SCNN1A-1050	+	GGGGUUGUUGUCCCGCAAGC	20	4899
SCNN1A-1051	+	GAUCAUGCUCUCCUGGAAGC	20	4900
SCNN1A-1052	−	CCCUUCAAAGUACACACAGC	20	4901
SCNN1A-1053	+	CCCCAGUCACUGUGGACAGC	20	4902
SCNN1A-1054	+	GCGCUGCGGGCCUCACCAGC	20	4903
SCNN1A-1055	+	UGAGGAACAUGAUGACCAGC	20	4904
SCNN1A-1056	−	CUGGAAGAUCGGCUUCCAGC	20	4905
SCNN1A-1057	+	GUGAGUAACCAGCAGAGAGC	20	4906
SCNN1A-1058	−	CCCGGAAAUUAAAGAGGAGC	20	4907
SCNN1A-1059	−	UAAAGAGGAGCUGGAGGAGC	20	4908
SCNN1A-1060	+	GUCAAGGCUGGAGAGGGAGC	20	4909
SCNN1A-1061	+	GUCGCGACGGCUGCGGGAGC	20	4910
SCNN1A-1062	+	ACCAGCAGAGAGCUGGUAGC	20	4911
SCNN1A-1063	−	AUCCCUGGAGGAGGACACGC	20	4912
SCNN1A-1064	+	GAGCUGGUAGCUGGUCACGC	20	4913
SCNN1A-1065	+	GGUGCGGCAGAGUCCCCCGC	20	4914
SCNN1A-1066	+	CCACCAUCAUCCAUAAAGGC	20	4915
SCNN1A-1067	+	GGGGGAGGGGCUGUCAAGGC	20	4916
SCNN1A-1068	+	CUCGACGGGCCCCGUGAGGC	20	4917
SCNN1A-1069	+	GGGCCCAGGGUGGCAUAGGC	20	4918
SCNN1A-1070	+	GGAGACCUGGUUGAAGCGGC	20	4919
SCNN1A-1071	+	CUUGUGGCUGGGACCAGGGC	20	4920
SCNN1A-1072	−	CCGGGUAAUGGUGCACGGGC	20	4921
SCNN1A-1073	−	GGUCUCCAGGCCGAGGGGGC	20	4922
SCNN1A-1074	+	GGGCCCCGUGAGGCGGGGGC	20	4923
SCNN1A-1075	+	AGAGCCCCCUGGAGAUGGGC	20	4924
SCNN1A-1076	+	GAGAGGGAGCAGGGCCUGGC	20	4925
SCNN1A-1077	−	UCCUUCACCACUCUCGUGGC	20	4926
SCNN1A-1078	−	CCAAGUGCCGGAAGCCAUGC	20	4927
SCNN1A-1079	−	CCGCAGCCGUCGCGACCUGC	20	4928
SCNN1A-1080	−	UGAGCUCGUCUUUGACCUGC	20	4929
SCNN1A-1081	+	GGCGGGCCCCUCGGCGCUGC	20	4930
SCNN1A-1082	+	CCGCAGGUCGCGACGGCUGC	20	4931
SCNN1A-1083	−	CCAUCUCCAGGGGGCUCUGC	20	4932
SCNN1A-1084	−	ACCAGCUACCAGCUCUCUGC	20	4933
SCNN1A-1085	−	UGGGCUGUUUCACCAAGUGC	20	4934
SCNN1A-1086	−	UAGCGUGGCCUCCAGCUUGC	20	4935
SCNN1A-1087	+	ACUGACUCACGCCUGGUUGC	20	4936
SCNN1A-1088	+	UAUAGCAGUUUCCAUACAUC	20	4937
SCNN1A-1089	+	UCUGCUCUGCGCGCAGCAUC	20	4938
SCNN1A-1090	+	UGUUCUGUCGCGAUAGCAUC	20	4939
SCNN1A-1091	−	UUCUACCAGACAUACUCAUC	20	4940
SCNN1A-1092	+	AGUGAGAGUAAUUCCUUAUC	20	4941
SCNN1A-1093	−	ACAAGAACAACUCCAACCUC	20	4942
SCNN1A-1094	+	GAGGCGGGGGCGGGACCCUC	20	4943
SCNN1A-1095	−	CAGUUCCUCCACCUGUCCUC	20	4944
SCNN1A-1096	−	CCGAGGGGGCAGGGGUGCUC	20	4945
SCNN1A-1097	+	GAAACCUCUCCUUCCCUCUC	20	4946
SCNN1A-1098	+	UCCAGGGAUGGCAGAGUCUC	20	4947
SCNN1A-1099	+	GGGGCGAGGGGAAGAGGGUC	20	4948
SCNN1A-1100	+	CCACCCCUGAUGAGUAUGUC	20	4949
SCNN1A-1101	−	CCUCUUCCCCUCGCCCCUUC	20	4950
SCNN1A-1102	+	ACACUAACCUGCAUGGCUUC	20	4951
SCNN1A-1103	+	AGUCACAGUACUCCACGUUC	20	4952
SCNN1A-1104	+	AGAAGCAGUCCGAUUUGUUC	20	4953
SCNN1A-1105	+	UCCAGCUCCUCUUUAAUUUC	20	4954
SCNN1A-1106	−	CAGGUACCCGGAAAUUAAAG	20	4955
SCNN1A-1107	−	AUUACACCGUCAACAACAAG	20	4956
SCNN1A-1108	+	GGACCCUCAGGCGCUGCAAG	20	4957
SCNN1A-1109	+	ACAUGGGGUGGGGGCAGAAG	20	4958
SCNN1A-1110	+	CCUGAAGGGGCGAGGGGAAG	20	4959
SCNN1A-1111	+	GGAUGUUGAUGUAGUGGAAG	20	4960
SCNN1A-1112	+	UAAUUUCCGGGUACCUGAAG	20	4961
SCNN1A-1113	+	UGCAGGAGACCUGGUUGAAG	20	4962
SCNN1A-1114	+	GGCACGACCUACCGUGACAG	20	4963
SCNN1A-1115	+	CCCUCUCAGGGCCCCCCCAG	20	4964
SCNN1A-1116	−	UGUCCAACCUGGGCAGCCAG	20	4965
SCNN1A-1117	+	CAGGCAUGGAAGACAUCCAG	20	4966
SCNN1A-1118	−	GGGCCCCCGCCCAUCUCCAG	20	4967
SCNN1A-1119	+	CCAGUCACUGUGGACAGCAG	20	4968
SCNN1A-1120	+	GCCCAGGGUGGCAUAGGCAG	20	4969
SCNN1A-1121	−	UCUCCAGGCCGAGGGGGCAG	20	4970
SCNN1A-1122	+	AUUUCUUAGGUGUGGGGCAG	20	4971
SCNN1A-1123	−	AUCUCCAGGGGGCUCUGCAG	20	4972
SCNN1A-1124	−	CUACCAGACAUACUCAUCAG	20	4973
SCNN1A-1125	+	GACACAGAGACUAGAGUCAG	20	4974
SCNN1A-1126	+	CACAGAGACUAGAGUCAGAG	20	4975
SCNN1A-1127	+	GCGGGAGCCGGCCACGAGAG	20	4976
SCNN1A-1128	−	GUGAGGCCCGCAGCGCCGAG	20	4977
SCNN1A-1129	−	AUACUGGUCUCCAGGCCGAG	20	4978
SCNN1A-1130	+	CGGGUACCUGAAGGGGCGAG	20	4979
SCNN1A-1131	−	GGGCCCUGAGAGGGAAGGAG	20	4980
SCNN1A-1132	+	GGGGCAGAAGUGGGAAGGAG	20	4981
SCNN1A-1133	+	GGGAGGAGGGUGGAGAGGAG	20	4982
SCNN1A-1134	+	GUGACCAUCUGUGAGAGGAG	20	4983
SCNN1A-1135	−	GGGUGGAUGCGGUGAGGGAG	20	4984
SCNN1A-1136	+	GGUGGCAUAGGCAGGGGGAG	20	4985
SCNN1A-1137	−	CCCACACCUAAGAAAUGGAG	20	4986
SCNN1A-1138	+	AGGGGCUGUCAAGGCUGGAG	20	4987
SCNN1A-1139	+	UGGAAGGGAGGAGGGUGGAG	20	4988
SCNN1A-1140	−	UCCUCUGGGGGGGCCCUGAG	20	4989
SCNN1A-1141	+	GGAGGGUGACCAUCUGUGAG	20	4990
SCNN1A-1142	+	AGCAUCAGGGACAGACCUAG	20	4991
SCNN1A-1143	+	UCGACAGGAUGUUGAUGUAG	20	4992
SCNN1A-1144	−	CUAUCCGCGGCCCCAGAACG	20	4993
SCNN1A-1145	−	GGUCCCGCCCCCGCCUCACG	20	4994
SCNN1A-1146	+	CUCCACCACAGACAACACCG	20	4995
SCNN1A-1147	+	CUCUACCUGGGAUGUCACCG	20	4996
SCNN1A-1148	−	UGGUGAGGCCCGCAGCGCCG	20	4997
SCNN1A-1149	−	CGAUACUGGUCUCCAGGCCG	20	4998
SCNN1A-1150	+	UACUCCACGUUCUGGGGCCG	20	4999
SCNN1A-1151	−	GUGCCUACAUCUUCUAUCCG	20	5000
SCNN1A-1152	−	UGAGGCCCAACCUGAUUCCG	20	5001
SCNN1A-1153	−	GGCCCGUCGAGCCCGUAGCG	20	5002
SCNN1A-1154	+	UCGACGGGCCCCGUGAGGCG	20	5003
SCNN1A-1155	+	UCCGGGUACCUGAAGGGGCG	20	5004
SCNN1A-1156	+	GAGCCCCCUGGAGAUGGGCG	20	5005
SCNN1A-1157	−	CUUUAACUUGCGGCCUGGCG	20	5006
SCNN1A-1158	−	CGCAGCCGUCGCGACCUGCG	20	5007
SCNN1A-1159	−	CAGCUCCUUCACCACUCUCG	20	5008
SCNN1A-1160	−	ACUACAUCAACAUCCUGUCG	20	5009
SCNN1A-1161	+	UGGGGGCAGAAGUGGGAAGG	20	5010
SCNN1A-1162	+	GGGCCCCCCCAGAGGACAGG	20	5011
SCNN1A-1163	+	GGCUGCCCAGGUUGGACAGG	20	5012
SCNN1A-1164	−	GCGGGACAACAACCCCCAGG	20	5013
SCNN1A-1165	+	ACUUGGUGAAACAGCCCAGG	20	5014
SCNN1A-1166	−	GGCCCCCGCCCAUCUCCAGG	20	5015
SCNN1A-1167	+	CCCAGGGUGGCAUAGGCAGG	20	5016
SCNN1A-1168	−	AGGGGGCAGGGGUGCUCAGG	20	5017
SCNN1A-1169	−	UACUGGUCUCCAGGCCGAGG	20	5018
SCNN1A-1170	+	AUACACACCUGGAAGGGAGG	20	5019
SCNN1A-1171	−	GACUCUGCCAUCCCUGGAGG	20	5020
SCNN1A-1172	+	GCUCGACGGGCCCCGUGAGG	20	5021
SCNN1A-1173	+	CGACGGGCCCCGUGAGGCGG	20	5022
SCNN1A-1174	+	AGCCCCCUGGAGAUGGGCGG	20	5023
SCNN1A-1175	−	GCAGCCGUCGCGACCUGCGG	20	5024
SCNN1A-1176	+	UGAAUACACACCUGGAAGGG	20	5025
SCNN1A-1177	+	AGAUGGGCGGGGGCCCAGGG	20	5026
SCNN1A-1178	+	AGGAGGGGAGGAUGCCAGGG	20	5027
SCNN1A-1179	+	CUUAGGUGUGGGGCAGAGGG	20	5028
SCNN1A-1180	+	ACACCUGGAAGGGAGGAGGG	20	5029
SCNN1A-1181	+	AGCAGUUUCCAUACAUCGGG	20	5030
SCNN1A-1182	−	CCAGACAUACUCAUCAGGGG	20	5031
SCNN1A-1183	+	GCAGAAGUGGGAAGGAGGGG	20	5032
SCNN1A-1184	+	AGGGUGGCAUAGGCAGGGGG	20	5033
SCNN1A-1185	+	CGGGCCCCGUGAGGCGGGGG	20	5034
SCNN1A-1186	+	ACAAGGACAGAGACAUGGGG	20	5035
SCNN1A-1187	−	CCUCCACCUGUCCUCUGGGG	20	5036
SCNN1A-1188	+	CAGAGCCCCCUGGAGAUGGG	20	5037
SCNN1A-1189	−	GAGUGUGGGGAAGGGAUGGG	20	5038
SCNN1A-1190	−	AGGCAAGGAUGCUGACUGGG	20	5039
SCNN1A-1191	−	UCCUCCACCUGUCCUCUGGG	20	5040
SCNN1A-1192	+	CCAUUCCUAGGAAAGAAUGG	20	5041
SCNN1A-1193	−	CCUGCCUUUAUGGAUGAUGG	20	5042
SCNN1A-1194	+	UGCCUUCCUCAUGCUGAUGG	20	5043
SCNN1A-1195	+	AGUCCUUCCAGUCCACCUGG	20	5044
SCNN1A-1196	−	AGAGACUCUGCCAUCCCUGG	20	5045
SCNN1A-1197	+	GUUGUUGUCCCGCAAGCUGG	20	5046
SCNN1A-1198	−	GGAAAUUAAAGAGGAGCUGG	20	5047
SCNN1A-1199	−	UUCCUCCACCUGUCCUCUGG	20	5048
SCNN1A-1200	+	CCCCCCCAGAGGACAGGUGG	20	5049
SCNN1A-1201	+	AGGGGAGGAUGCCAGGGUGG	20	5050
SCNN1A-1202	+	AGUUUCCAUACAUCGGGUGG	20	5051
SCNN1A-1203	+	AGGACAGAGACAUGGGGUGG	20	5052
SCNN1A-1204	−	UGUGGGGAAGGGAUGGGUGG	20	5053
SCNN1A-1205	−	CUCCUCGGUGUUGUCUGUGG	20	5054
SCNN1A-1206	−	GAAACCCUGGACAGACUUGG	20	5055
SCNN1A-1207	+	CCCAUUCCUAGGAAAGAAUG	20	5056
SCNN1A-1208	+	GGGACAAGGACAGAGACAUG	20	5057
SCNN1A-1209	+	GGAACCUUCGGAGCAGCAUG	20	5058
SCNN1A-1210	−	UGGAGACCUCCAUCAGCAUG	20	5059
SCNN1A-1211	−	AUACUCAUCAGGGGUGGAUG	20	5060
SCNN1A-1212	+	AGAGCGUCUGCUCUGUGAUG	20	5061
SCNN1A-1213	+	UACCCGGGCCCCAGUCACUG	20	5062
SCNN1A-1214	−	CCUGCUGUCCACAGUGACUG	20	5063
SCNN1A-1215	+	CAGUCCUUCCAGUCCACCUG	20	5064
SCNN1A-1216	−	CCCGCAGCCGUCGCGACCUG	20	5065
SCNN1A-1217	+	CUUAUAGUAGCAGUACCCUG	20	5066
SCNN1A-1218	−	UGGGCAGCCAGUGGAGCCUG	20	5067
SCNN1A-1219	−	CGCACCCCUUGCAGCGCCUG	20	5068
SCNN1A-1220	−	UACAGAAAGCACAGUUCCUG	20	5069
SCNN1A-1221	+	GCUGGUAGCUGGUCACGCUG	20	5070
SCNN1A-1222	+	GGGCGGGCCCCUCGGCGCUG	20	5071
SCNN1A-1223	+	CCCGCAGGUCGCGACGGCUG	20	5072
SCNN1A-1224	−	GUUCCUCCACCUGUCCUCUG	20	5073
SCNN1A-1225	+	GAAACAGCCCAGGUGGUCUG	20	5074
SCNN1A-1226	−	CGGCUCCUCGGUGUUGUCUG	20	5075
SCNN1A-1227	+	UCACAGUACUCCACGUUCUG	20	5076
SCNN1A-1228	−	GUGACAUCCCAGGUAGAGUG	20	5077
SCNN1A-1229	−	GAGAGCAUGAUCAAGGAGUG	20	5078
SCNN1A-1230	+	CGGGCUCGACGGGCCCCGUG	20	5079
SCNN1A-1231	−	CAAAGUACACACAGCAGGUG	20	5080
SCNN1A-1232	+	GCCACUCCAUUUCUUAGGUG	20	5081
SCNN1A-1233	−	CAUCAGGGGUGGAUGCGGUG	20	5082
SCNN1A-1234	+	CUCAGGCGCUGCAAGGGGUG	20	5083
SCNN1A-1235	+	AAGGACAGAGACAUGGGGUG	20	5084
SCNN1A-1236	−	GUGUGGGGAAGGGAUGGGUG	20	5085
SCNN1A-1237	−	AGAUCGGCUUCCAGCUGGUG	20	5086
SCNN1A-1238	−	GACAUCCCAGGUAGAGUGUG	20	5087
SCNN1A-1239	+	CACUCCAUUUCUUAGGUGUG	20	5088
SCNN1A-1240	−	AUGAUGGUGGCUUUAACUUG	20	5089
SCNN1A-1241	−	GGAAACCCUGGACAGACUUG	20	5090
SCNN1A-1242	−	GUAGCGUGGCCUCCAGCUUG	20	5091
SCNN1A-1243	−	CCAGUGCAACCAGAACAAAU	20	5092
SCNN1A-1244	+	ACCCAUUCCUAGGAAAGAAU	20	5093
SCNN1A-1245	+	GACAGAGGGAGACUCAGAAU	20	5094
SCNN1A-1246	−	CCCCAUUCUUUCCUAGGAAU	20	5095
SCNN1A-1247	+	UGGGACAAGGACAGAGACAU	20	5096
SCNN1A-1248	+	GUAUAGCAGUUUCCAUACAU	20	5097
SCNN1A-1249	+	GCGGGGGCCCAGGGUGGCAU	20	5098
SCNN1A-1250	−	CUUGGUGUAUGUGGGUUCAU	20	5099
SCNN1A-1251	−	GACUGGAAGGACUGGAAGAU	20	5100
SCNN1A-1252	+	CUGCAGAGCCCCCUGGAGAU	20	5101
SCNN1A-1253	+	AGGAGAGGUACAUUGACGAU	20	5102
SCNN1A-1254	−	GUAGAGUGUGGGGAAGGGAU	20	5103
SCNN1A-1255	+	CUCGGCCUGGAGACCAGUAU	20	5104
SCNN1A-1256	+	CCUGCAUGGCUUCCGGCACU	20	5105
SCNN1A-1257	−	UAGGAAACCCUGGACAGACU	20	5106
SCNN1A-1258	−	GGAAGGCAAGGAUGCUGACU	20	5107
SCNN1A-1259	−	CCCUGCUGUCCACAGUGACU	20	5108
SCNN1A-1260	−	GUCACCCUCCUGUCCAACCU	20	5109
SCNN1A-1261	−	GACUUCUCCUCAGACCACCU	20	5110
SCNN1A-1262	+	CCAGUCCUUCCAGUCCACCU	20	5111
SCNN1A-1263	+	GCAGCAUCAGGGACAGACCU	20	5112
SCNN1A-1264	+	CCCUUCCCCACACUCUACCU	20	5113
SCNN1A-1265	−	CCCCCUGCCUAUGCCACCCU	20	5114
SCNN1A-1266	−	UCUGCUCUCUCUGCACCCCU	20	5115
SCNN1A-1267	+	CCUGAGCACCCCUGCCCCCU	20	5116
SCNN1A-1268	−	UGGUUACUCACGAUGGCCCU	20	5117
SCNN1A-1269	−	GAGCCUGUGGUUCGGCUCCU	20	5118
SCNN1A-1270	+	CAUCUGGAAGACCCAUUCCU	20	5119
SCNN1A-1271	−	CUACAGAAAGCACAGUUCCU	20	5120
SCNN1A-1272	−	UGACACCCCCAUUCUUUCCU	20	5121
SCNN1A-1273	−	UCCCUGGAGGAGGACACGCU	20	5122
SCNN1A-1274	+	AGCUGGUAGCUGGUCACGCU	20	5123
SCNN1A-1275	+	AGAGGGAGCAGGGCCUGGCU	20	5124
SCNN1A-1276	−	AGUUCCUCCACCUGUCCUCU	20	5125
SCNN1A-1277	+	AGGAACAUCACUGCCAUUCU	20	5126
SCNN1A-1278	+	GUCACAGUACUCCACGUUCU	20	5127
SCNN1A-1279	+	CAUGGGGUGGGGGCAGAAGU	20	5128
SCNN1A-1280	+	GGGUGCAGAGAGAGCAGAGU	20	5129
SCNN1A-1281	+	CUUAUCAGGAAAGAGAGAGU	20	5130
SCNN1A-1282	+	GCUCCACUGGCUGCCCAGGU	20	5131
SCNN1A-1283	+	UGGCUGCCACGGAAUCAGGU	20	5132
SCNN1A-1284	+	CAUGGAAGACAUCCAGAGGU	20	5133
SCNN1A-1285	−	GAGUCUCCCUCUGUCACGGU	20	5134
SCNN1A-1286	+	UUAGGUGUGGGGCAGAGGGU	20	5135
SCNN1A-1287	+	CAAGGACAGAGACAUGGGGU	20	5136
SCNN1A-1288	−	AGUGUGGGGAAGGGAUGGGU	20	5137
SCNN1A-1289	+	GGGCCGCGGAUAGAAGAUGU	20	5138
SCNN1A-1290	−	UCUGAUCUCUUGGUGUAUGU	20	5139
SCNN1A-1291	+	UUAUAGUAGCAGUACCCUGU	20	5140
SCNN1A-1292	+	UGGAGAAAGGUGCUCAGUGU	20	5141
SCNN1A-1293	−	UGACAUCCCAGGUAGAGUGU	20	5142
SCNN1A-1294	+	CCACUCCAUUUCUUAGGUGU	20	5143
SCNN1A-1295	−	AGGAAACCCUGGACAGACUU	20	5144
SCNN1A-1296	+	CUUGAAGAAGAUGUUGACUU	20	5145
SCNN1A-1297	+	AGUAUCGGCUUCGGAACCUU	20	5146
SCNN1A-1298	+	CUGGAGACCAGUAUCGGCUU	20	5147
SCNN1A-1299	+	CUUUGGCCACUCCAUUUCUU	20	5148
SCNN1A-1300	+	GGCUGCCACGGAAUCAGGUU	20	5149
SCNN1A-1301	−	AGCCAGUGGAGCCUGUGGUU	20	5150

Table 44A provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the first tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44A
1st Tier
			Target
gRNA Name	DNA Strand	Targeting Domain	Site Length	Seq ID
SCNN1A-1302	+	GGUUGAUGUUGAGGCUGA	18	5151
SCNN1A-42	+	GAGGUUGAUGUUGAGGCUGA	20	519
SCNN1A-1303	+	GUUGAGGUUGAUGUUGAGGCUGA	23	5152
SCNN1A-1304	+	GCCCUCUCCCAUCACCCCUGGAAC	24	5153
SCNN1A-1305	+	GUCAAGGCUGAGCUCUGGGCC	21	5154
SCNN1A-1306	+	GGUCAAGGCUGAGCUCUGGGCC	22	5155
SCNN1A-1307	+	GGGUCAAGGCUGAGCUCUGGGCC	23	5156
SCNN1A-1308	+	GAGUGGAUUGGGGAGAGC	18	5157
SCNN1A-1309	+	GGAGUGGAUUGGGGAGAGC	19	5158
SCNN1A-1310	+	GCCCCGGAGUGGAUUGGGGAGAGC	24	5159
SCNN1A-1311	+	GCCCUGGAGUGGACUGUGGAGGGC	24	5160
SCNN1A-1312	+	GUAUGGGCUGCAGAGGUC	18	5161
SCNN1A-1313	+	GGUAUGGGCUGCAGAGGUC	19	5162
SCNN1A-1314	+	GACCUGGUAUGGGCUGCAGAGGUC	24	5163
SCNN1A-1315	+	GAUACCUCCCCUUGGAAGGGACAG	24	5164
SCNN1A-1316	+	GUGCUGGGAGCACACCAG	18	5165
SCNN1A-1317	+	GUUGUGCUGGGAGCACACCAG	21	5166
SCNN1A-1318	+	GGUUGUGCUGGGAGCACACCAG	22	5167
SCNN1A-1319	+	GCGGUUGUGCUGGGAGCACACCAG	24	5168
SCNN1A-1320	+	GUACUCUCCGAAAAGCAGG	19	5169
SCNN1A-1321	+	GAAGUACUCUCCGAAAAGCAGG	22	5170
SCNN1A-1322	+	GAUUGGGGAGAGCAAGGGU	19	5171
SCNN1A-1323	+	GGAUUGGGGAGAGCAAGGGU	20	5172
SCNN1A-1324	+	GUGGAUUGGGGAGAGCAAGGGU	22	5173
SCNN1A-1325	+	GAGUGGAUUGGGGAGAGCAAGGGU	24	5174
SCNN1A-1326	+	GAGGGACUAACCGACCUGU	19	5175
SCNN1A-1327	+	GCAGAGGGACUAACCGACCUGU	22	5176
SCNN1A-1328	+	GGCAGAGGGACUAACCGACCUGU	23	5177
SCNN1A-1329	+	GGGCAGAGGGACUAACCGACCUGU	24	5178
SCNN1A-1330	+	GCGGGGAAGACGAGCUUGU	19	5179
SCNN1A-1331	+	GACUAACCGACCUGUAGGGAUU	22	5180
SCNN1A-1332	+	GGACUAACCGACCUGUAGGGAUU	23	5181
SCNN1A-1333	+	GGGACUAACCGACCUGUAGGGAUU	24	5182
SCNN1A-1334	−	GCGGAGGAGGAGGCCCUGA	19	5183
SCNN1A-189	−	GGCGGAGGAGGAGGCCCUGA	20	819
SCNN1A-1335	−	GGCCAGGGGCAGCCUCAC	18	5184
SCNN1A-1336	−	GCAGCCUCACUCGGGUUCC	19	5185
SCNN1A-348	−	GGCAGCCUCACUCGGGUUCC	20	4197
SCNN1A-197	−	GCAAUUCGGCCUGCUUUUCG	20	826
SCNN1A-1337	−	GGCAAUUCGGCCUGCUUUUCG	21	5186
SCNN1A-1338	−	GCUCCUACCGAGAGCUCU	18	5187
SCNN1A-437	−	GUAAGCAAGGGAACCUGGUU	20	4286
SCNN1A-1339	−	GGUAAGCAAGGGAACCUGGUU	21	5188

Table 44B provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the second tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44B
2nd Tier
			Target
gRNA Name	DNA Strand	Targeting Domain	Site Length	Seq ID
SCNN1A-1340	+	AGGUUGAUGUUGAGGCUGA	19	5189
SCNN1A-1341	+	UGAGGUUGAUGUUGAGGCUGA	21	5190
SCNN1A-1342	+	UUGAGGUUGAUGUUGAGGCUGA	22	5191
SCNN1A-1343	+	AGUUGAGGUUGAUGUUGAGGCUGA	24	5192
SCNN1A-1344	+	UCCCAUCACCCCUGGAAC	18	5193
SCNN1A-1345	+	CUCCCAUCACCCCUGGAAC	19	5194
SCNN1A-1346	+	UCUCCCAUCACCCCUGGAAC	20	5195
SCNN1A-1347	+	CUCUCCCAUCACCCCUGGAAC	21	5196
SCNN1A-1348	+	CCUCUCCCAUCACCCCUGGAAC	22	5197
SCNN1A-1349	+	CCCUCUCCCAUCACCCCUGGAAC	23	5198
SCNN1A-1350	+	AAGGCUGAGCUCUGGGCC	18	5199
SCNN1A-1351	+	CAAGGCUGAGCUCUGGGCC	19	5200
SCNN1A-1352	+	UCAAGGCUGAGCUCUGGGCC	20	5201
SCNN1A-1353	+	AGGGUCAAGGCUGAGCUCUGGGCC	24	5202
SCNN1A-1354	+	CGGAGUGGAUUGGGGAGAGC	20	5203
SCNN1A-1355	+	CCGGAGUGGAUUGGGGAGAGC	21	5204
SCNN1A-1356	+	CCCGGAGUGGAUUGGGGAGAGC	22	5205
SCNN1A-1357	+	CCCCGGAGUGGAUUGGGGAGAGC	23	5206
SCNN1A-1358	+	CUGGAGUGGACUGUGGAGGGC	21	5207
SCNN1A-1359	+	CCUGGAGUGGACUGUGGAGGGC	22	5208
SCNN1A-1360	+	CCCUGGAGUGGACUGUGGAGGGC	23	5209
SCNN1A-1361	+	UGGUAUGGGCUGCAGAGGUC	20	5210
SCNN1A-1362	+	CUGGUAUGGGCUGCAGAGGUC	21	5211
SCNN1A-1363	+	CCUGGUAUGGGCUGCAGAGGUC	22	5212
SCNN1A-1364	+	ACCUGGUAUGGGCUGCAGAGGUC	23	5213
SCNN1A-1365	+	UCCCCUUGGAAGGGACAG	18	5214
SCNN1A-1366	+	CUCCCCUUGGAAGGGACAG	19	5215
SCNN1A-1367	+	CCUCCCCUUGGAAGGGACAG	20	5216
SCNN1A-1368	+	ACCUCCCCUUGGAAGGGACAG	21	5217
SCNN1A-1369	+	UACCUCCCCUUGGAAGGGACAG	22	5218
SCNN1A-1370	+	AUACCUCCCCUUGGAAGGGACAG	23	5219
SCNN1A-1371	+	UGUGCUGGGAGCACACCAG	19	5220
SCNN1A-224	+	UUGUGCUGGGAGCACACCAG	20	847
SCNN1A-1372	+	CGGUUGUGCUGGGAGCACACCAG	23	5221
SCNN1A-1373	+	UACUCUCCGAAAAGCAGG	18	5222
SCNN1A-230	+	AGUACUCUCCGAAAAGCAGG	20	851
SCNN1A-1374	+	AAGUACUCUCCGAAAAGCAGG	21	5223
SCNN1A-1375	+	UGAAGUACUCUCCGAAAAGCAGG	23	5224
SCNN1A-1376	+	CUGAAGUACUCUCCGAAAAGCAGG	24	5225
SCNN1A-1377	+	AUUGGGGAGAGCAAGGGU	18	5226
SCNN1A-1378	+	UGGAUUGGGGAGAGCAAGGGU	21	5227
SCNN1A-1379	+	AGUGGAUUGGGGAGAGCAAGGGU	23	5228
SCNN1A-1380	+	AGGGACUAACCGACCUGU	18	5229
SCNN1A-424	+	AGAGGGACUAACCGACCUGU	20	4273
SCNN1A-1381	+	CAGAGGGACUAACCGACCUGU	21	5230
SCNN1A-1382	+	CGGGGAAGACGAGCUUGU	18	5231
SCNN1A-237	+	UGCGGGGAAGACGAGCUUGU	20	857
SCNN1A-1383	+	CUGCGGGGAAGACGAGCUUGU	21	5232
SCNN1A-1384	+	ACUGCGGGGAAGACGAGCUUGU	22	5233
SCNN1A-1385	+	CACUGCGGGGAAGACGAGCUUGU	23	5234
SCNN1A-1386	+	UCACUGCGGGGAAGACGAGCUUGU	24	5235
SCNN1A-1387	+	AACCGACCUGUAGGGAUU	18	5236
SCNN1A-1388	+	UAACCGACCUGUAGGGAUU	19	5237
SCNN1A-1389	+	CUAACCGACCUGUAGGGAUU	20	5238
SCNN1A-1390	+	ACUAACCGACCUGUAGGGAUU	21	5239
SCNN1A-1391	−	CGGAGGAGGAGGCCCUGA	18	5240
SCNN1A-1392	−	UGGCCAGGGGCAGCCUCAC	19	5241
SCNN1A-1393	−	AUGGCCAGGGGCAGCCUCAC	20	5242
SCNN1A-1394	−	CAGCCUCACUCGGGUUCC	18	5243
SCNN1A-1395	−	AAUUCGGCCUGCUUUUCG	18	5244
SCNN1A-1396	−	CAAUUCGGCCUGCUUUUCG	19	5245
SCNN1A-1397	−	UGGCAAUUCGGCCUGCUUUUCG	22	5246
SCNN1A-1398	−	CUGGCAAUUCGGCCUGCUUUUCG	23	5247
SCNN1A-1399	−	ACUGGCAAUUCGGCCUGCUUUUCG	24	5248
SCNN1A-1400	−	CGCUCCUACCGAGAGCUCU	19	5249
SCNN1A-192	−	CCGCUCCUACCGAGAGCUCU	20	822
SCNN1A-1401	−	ACCGCUCCUACCGAGAGCUCU	21	5250
SCNN1A-1402	−	CACCGCUCCUACCGAGAGCUCU	22	5251
SCNN1A-1403	−	CCACCGCUCCUACCGAGAGCUCU	23	5252
SCNN1A-1404	−	UCCACCGCUCCUACCGAGAGCUCU	24	5253
SCNN1A-1405	−	AAGCAAGGGAACCUGGUU	18	5254
SCNN1A-1406	−	UAAGCAAGGGAACCUGGUU	19	5255
SCNN1A-1407	−	AGGUAAGCAAGGGAACCUGGUU	22	5256
SCNN1A-1408	−	AAGGUAAGCAAGGGAACCUGGUU	23	5257
SCNN1A-1409	−	CAAGGUAAGCAAGGGAACCUGGUU	24	5258

Table 44C provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the third tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44C
3rd Tier
			Target
gRNA Name	DNA Strand	Targeting Domain	Site Length	Seq ID
SCNN1A-1410	+	CCCUUCAUGAGCCCCGGA	18	5259
SCNN1A-1411	+	CCCCUUCAUGAGCCCCGGA	19	5260
SCNN1A-1412	+	UCCCCUUCAUGAGCCCCGGA	20	5261
SCNN1A-1413	+	UUCCCCUUCAUGAGCCCCGGA	21	5262
SCNN1A-1414	+	GUUCCCCUUCAUGAGCCCCGGA	22	5263
SCNN1A-1415	+	UGUUCCCCUUCAUGAGCCCCGGA	23	5264
SCNN1A-1416	+	UUGUUCCCCUUCAUGAGCCCCGGA	24	5265
SCNN1A-1417	+	GUUCCCCUUCAUGAGCCC	18	5266
SCNN1A-1418	+	UGUUCCCCUUCAUGAGCCC	19	5267
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-1419	+	CUUGUUCCCCUUCAUGAGCCC	21	5268
SCNN1A-1420	+	GCUUGUUCCCCUUCAUGAGCCC	22	5269
SCNN1A-1421	+	AGCUUGUUCCCCUUCAUGAGCCC	23	5270
SCNN1A-1422	+	CAGCUUGUUCCCCUUCAUGAGCCC	24	5271
SCNN1A-1423	+	CGCUUGUUCCCCUUCAUGAGCCC	23	5272
SCNN1A-1424	+	ACGCUUGUUCCCCUUCAUGAGCCC	24	5273
SCNN1A-1425	+	CACCAGGCGGAUGGCGCC	18	5274
SCNN1A-1426	+	ACACCAGGCGGAUGGCGCC	19	5275
SCNN1A-223	+	CACACCAGGCGGAUGGCGCC	20	846
SCNN1A-1427	+	GCACACCAGGCGGAUGGCGCC	21	5276
SCNN1A-1428	+	AGCACACCAGGCGGAUGGCGCC	22	5277
SCNN1A-1429	+	GAGCACACCAGGCGGAUGGCGCC	23	5278
SCNN1A-1430	+	GGAGCACACCAGGCGGAUGGCGCC	24	5279
SCNN1A-1431	+	GAGUGGACUGUGGAGGGC	18	5280
SCNN1A-1432	+	GGAGUGGACUGUGGAGGGC	19	5281
SCNN1A-201	+	UGGAGUGGACUGUGGAGGGC	20	830
SCNN1A-1433	−	CGGCGGAGGAGGAGGCCCUGA	21	5282
SCNN1A-1434	−	ACGGCGGAGGAGGAGGCCCUGA	22	5283
SCNN1A-1435	−	CACGGCGGAGGAGGAGGCCCUGA	23	5284
SCNN1A-1436	−	CCACGGCGGAGGAGGAGGCCCUGA	24	5285
SCNN1A-1437	−	CAUGGCCAGGGGCAGCCUCAC	21	5286
SCNN1A-1438	−	GCAUGGCCAGGGGCAGCCUCAC	22	5287
SCNN1A-1439	−	GGCAUGGCCAGGGGCAGCCUCAC	23	5288
SCNN1A-1440	−	GGGCAUGGCCAGGGGCAGCCUCAC	24	5289
SCNN1A-1441	−	GGGCAGCCUCACUCGGGUUCC	21	5290
SCNN1A-1442	−	GGGGCAGCCUCACUCGGGUUCC	22	5291
SCNN1A-1443	−	AGGGGCAGCCUCACUCGGGUUCC	23	5292
SCNN1A-1444	−	CAGGGGCAGCCUCACUCGGGUUCC	24	5293

Table 44D provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fourth tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon), have a high level of orthogonality and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44D
4th Tier
			Target
gRNA Name	DNA Strand	Targeting Domain	Site Length	Seq ID
SCNN1A-1445	+	AUCACCCCUGGAACCCGA	18	5294
SCNN1A-1446	+	CAUCACCCCUGGAACCCGA	19	5295
SCNN1A-1447	+	CCAUCACCCCUGGAACCCGA	20	5296
SCNN1A-1448	+	CCCAUCACCCCUGGAACCCGA	21	5297
SCNN1A-1449	+	UCCCAUCACCCCUGGAACCCGA	22	5298
SCNN1A-1450	+	CUCCCAUCACCCCUGGAACCCGA	23	5299
SCNN1A-1451	+	UCUCCCAUCACCCCUGGAACCCGA	24	5300
SCNN1A-1452	+	CUAACCGACCUGUAGGGA	18	5301
SCNN1A-1453	+	ACUAACCGACCUGUAGGGA	19	5302
SCNN1A-1454	+	GACUAACCGACCUGUAGGGA	20	5303
SCNN1A-1455	+	GGACUAACCGACCUGUAGGGA	21	5304
SCNN1A-1456	+	GGGACUAACCGACCUGUAGGGA	22	5305
SCNN1A-1457	+	AGGGACUAACCGACCUGUAGGGA	23	5306
SCNN1A-1458	+	GAGGGACUAACCGACCUGUAGGGA	24	5307
SCNN1A-1459	+	CCCUUCAUGAGCCCUGGA	18	5308
SCNN1A-1460	+	CCCCUUCAUGAGCCCUGGA	19	5309
SCNN1A-205	+	UCCCCUUCAUGAGCCCUGGA	20	833
SCNN1A-1461	+	UUCCCCUUCAUGAGCCCUGGA	21	5310
SCNN1A-1462	+	GUUCCCCUUCAUGAGCCCUGGA	22	5311
SCNN1A-1463	+	UGUUCCCCUUCAUGAGCCCUGGA	23	5312
SCNN1A-1464	+	UUGUUCCCCUUCAUGAGCCCUGGA	24	5313
SCNN1A-1465	+	CAUGAGCCCCGGAGUGGA	18	5314
SCNN1A-1466	+	UCAUGAGCCCCGGAGUGGA	19	5315
SCNN1A-1467	+	UUCAUGAGCCCCGGAGUGGA	20	5316
SCNN1A-1468	+	CUUCAUGAGCCCCGGAGUGGA	21	5317
SCNN1A-1469	+	CCUUCAUGAGCCCCGGAGUGGA	22	5318
SCNN1A-1470	+	CCCUUCAUGAGCCCCGGAGUGGA	23	5319
SCNN1A-1471	+	CCCCUUCAUGAGCCCCGGAGUGGA	24	5320
SCNN1A-1472	+	AUGAUACCUCCCCUUGGA	18	5321
SCNN1A-1473	+	CAUGAUACCUCCCCUUGGA	19	5322
SCNN1A-399	+	UCAUGAUACCUCCCCUUGGA	20	4248
SCNN1A-1474	+	CUCAUGAUACCUCCCCUUGGA	21	5323
SCNN1A-1475	+	GCUCAUGAUACCUCCCCUUGGA	22	5324
SCNN1A-1476	+	UGCUCAUGAUACCUCCCCUUGGA	23	5325
SCNN1A-1477	+	CUGCUCAUGAUACCUCCCCUUGGA	24	5326
SCNN1A-1478	+	GUGUUGUUGCAGAAGAAC	18	5327
SCNN1A-1479	+	GGUGUUGUUGCAGAAGAAC	19	5328
SCNN1A-220	+	UGGUGUUGUUGCAGAAGAAC	20	843
SCNN1A-1480	+	GUGGUGUUGUUGCAGAAGAAC	21	5329
SCNN1A-1481	+	GGUGGUGUUGUUGCAGAAGAAC	22	5330
SCNN1A-1482	+	UGGUGGUGUUGUUGCAGAAGAAC	23	5331
SCNN1A-1483	+	AUGGUGGUGUUGUUGCAGAAGAAC	24	5332
SCNN1A-1484	+	UGCCCUCUCCCAUCACCC	18	5333
SCNN1A-1485	+	GUGCCCUCUCCCAUCACCC	19	5334
SCNN1A-1486	+	AGUGCCCUCUCCCAUCACCC	20	5335
SCNN1A-1487	+	GAGUGCCCUCUCCCAUCACCC	21	5336
SCNN1A-1488	+	UGAGUGCCCUCUCCCAUCACCC	22	5337
SCNN1A-1489	+	CUGAGUGCCCUCUCCCAUCACCC	23	5338
SCNN1A-1490	+	CCUGAGUGCCCUCUCCCAUCACCC	24	5339
SCNN1A-1491	+	GCCCUCUCCCAUCACCCC	18	5340
SCNN1A-1492	+	UGCCCUCUCCCAUCACCCC	19	5341
SCNN1A-346	+	GUGCCCUCUCCCAUCACCCC	20	4195
SCNN1A-1493	+	AGUGCCCUCUCCCAUCACCCC	21	5342
SCNN1A-1494	+	GAGUGCCCUCUCCCAUCACCCC	22	5343
SCNN1A-1495	+	UGAGUGCCCUCUCCCAUCACCCC	23	5344
SCNN1A-1496	+	CUGAGUGCCCUCUCCCAUCACCCC	24	5345
SCNN1A-1497	+	UGCUCAUGAUACCUCCCC	18	5346
SCNN1A-1498	+	CUGCUCAUGAUACCUCCCC	19	5347
SCNN1A-1499	+	ACUGCUCAUGAUACCUCCCC	20	5348
SCNN1A-1500	+	UACUGCUCAUGAUACCUCCCC	21	5349
SCNN1A-1501	+	AUACUGCUCAUGAUACCUCCCC	22	5350
SCNN1A-1502	+	GAUACUGCUCAUGAUACCUCCCC	23	5351
SCNN1A-1503	+	UGAUACUGCUCAUGAUACCUCCCC	24	5352
SCNN1A-1504	+	UGUUCCCCUUCAUGAGCC	18	5353
SCNN1A-1505	+	UUGUUCCCCUUCAUGAGCC	19	5354
SCNN1A-207	+	CUUGUUCCCCUUCAUGAGCC	20	834
SCNN1A-1506	+	GCUUGUUCCCCUUCAUGAGCC	21	5355
SCNN1A-1507	+	AGCUUGUUCCCCUUCAUGAGCC	22	5356
SCNN1A-1508	+	CAGCUUGUUCCCCUUCAUGAGCC	23	5357
SCNN1A-1509	+	CCAGCUUGUUCCCCUUCAUGAGCC	24	5358
SCNN1A-1510	+	CGCUUGUUCCCCUUCAUGAGCC	22	5359
SCNN1A-1511	+	ACGCUUGUUCCCCUUCAUGAGCC	23	5360
SCNN1A-1512	+	CACGCUUGUUCCCCUUCAUGAGCC	24	5361
SCNN1A-1513	+	AGGGCCUCCUCCUCCGCC	18	5362
SCNN1A-1514	+	CAGGGCCUCCUCCUCCGCC	19	5363
SCNN1A-213	+	UCAGGGCCUCCUCCUCCGCC	20	838
SCNN1A-1515	+	AUCAGGGCCUCCUCCUCCGCC	21	5364
SCNN1A-1516	+	GAUCAGGGCCUCCUCCUCCGCC	22	5365
SCNN1A-1517	+	CGAUCAGGGCCUCCUCCUCCGCC	23	5366
SCNN1A-1518	+	UCGAUCAGGGCCUCCUCCUCCGCC	24	5367
SCNN1A-1519	+	CAGAGCCACAGCACUGCC	18	5368
SCNN1A-1520	+	GCAGAGCCACAGCACUGCC	19	5369
SCNN1A-228	+	UGCAGAGCCACAGCACUGCC	20	849
SCNN1A-1521	+	GUGCAGAGCCACAGCACUGCC	21	5370
SCNN1A-1522	+	GGUGCAGAGCCACAGCACUGCC	22	5371
SCNN1A-1523	+	AGGUGCAGAGCCACAGCACUGCC	23	5372
SCNN1A-1524	+	AAGGUGCAGAGCCACAGCACUGCC	24	5373
SCNN1A-1525	+	UCCAGCUUGUUCCCCUCC	18	5374
SCNN1A-1526	+	CUCCAGCUUGUUCCCCUCC	19	5375
SCNN1A-200	+	CCUCCAGCUUGUUCCCCUCC	20	829
SCNN1A-1527	+	UCCUCCAGCUUGUUCCCCUCC	21	5376
SCNN1A-1528	+	CUCCUCCAGCUUGUUCCCCUCC	22	5377
SCNN1A-1529	+	GCUCCUCCAGCUUGUUCCCCUCC	23	5378
SCNN1A-1530	+	UGCUCCUCCAGCUUGUUCCCCUCC	24	5379
SCNN1A-1531	+	GGUGCAGAUGGUCACUGC	18	5380
SCNN1A-1532	+	GGGUGCAGAUGGUCACUGC	19	5381
SCNN1A-38	+	AGGGUGCAGAUGGUCACUGC	20	575
SCNN1A-1533	+	GAGGGUGCAGAUGGUCACUGC	21	5382
SCNN1A-1534	+	UGAGGGUGCAGAUGGUCACUGC	22	5383
SCNN1A-1535	+	UUGAGGGUGCAGAUGGUCACUGC	23	5384
SCNN1A-1536	+	AUUGAGGGUGCAGAUGGUCACUGC	24	5385
SCNN1A-1537	+	UCCUCCGCCGUGGGCUGC	18	5386
SCNN1A-1538	+	CUCCUCCGCCGUGGGCUGC	19	5387
SCNN1A-65	+	CCUCCUCCGCCGUGGGCUGC	20	594
SCNN1A-1539	+	UCCUCCUCCGCCGUGGGCUGC	21	5388
SCNN1A-1540	+	CUCCUCCUCCGCCGUGGGCUGC	22	5389
SCNN1A-1541	+	CCUCCUCCUCCGCCGUGGGCUGC	23	5390
SCNN1A-1542	+	GCCUCCUCCUCCGCCGUGGGCUGC	24	5391
SCNN1A-1543	+	GUCUUCAUGCGGUUGUGC	18	5392
SCNN1A-1544	+	CGUCUUCAUGCGGUUGUGC	19	5393
SCNN1A-49	+	CCGUCUUCAUGCGGUUGUGC	20	582
SCNN1A-1545	+	GCCGUCUUCAUGCGGUUGUGC	21	5394
SCNN1A-1546	+	GGCCGUCUUCAUGCGGUUGUGC	22	5395
SCNN1A-1547	+	AGGCCGUCUUCAUGCGGUUGUGC	23	5396
SCNN1A-1548	+	AAGGCCGUCUUCAUGCGGUUGUGC	24	5397
SCNN1A-1549	+	UCCAGCUUGUUCCCCUUC	18	5398
SCNN1A-1550	+	CUCCAGCUUGUUCCCCUUC	19	5399
SCNN1A-1551	+	CCUCCAGCUUGUUCCCCUUC	20	5400
SCNN1A-1552	+	UCCUCCAGCUUGUUCCCCUUC	21	5401
SCNN1A-1553	+	CUCCUCCAGCUUGUUCCCCUUC	22	5402
SCNN1A-1554	+	GCUCCUCCAGCUUGUUCCCCUUC	23	5403
SCNN1A-1555	+	UGCUCCUCCAGCUUGUUCCCCUUC	24	5404
SCNN1A-1556	+	UCACGCUUGUUCCCCUUC	18	5405
SCNN1A-1557	+	CUCACGCUUGUUCCCCUUC	19	5406
SCNN1A-208	+	CCUCACGCUUGUUCCCCUUC	20	835
SCNN1A-1558	+	UCCUCACGCUUGUUCCCCUUC	21	5407
SCNN1A-1559	+	CUCCUCACGCUUGUUCCCCUUC	22	5408
SCNN1A-1560	+	GCUCCUCACGCUUGUUCCCCUUC	23	5409
SCNN1A-1561	+	UGCUCCUCACGCUUGUUCCCCUUC	24	5410
SCNN1A-1562	+	AUGGUCACUGCGGGGAAG	18	5411
SCNN1A-1563	+	GAUGGUCACUGCGGGGAAG	19	5412
SCNN1A-238	+	AGAUGGUCACUGCGGGGAAG	20	858
SCNN1A-1564	+	CAGAUGGUCACUGCGGGGAAG	21	5413
SCNN1A-1565	+	GCAGAUGGUCACUGCGGGGAAG	22	5414
SCNN1A-1566	+	UGCAGAUGGUCACUGCGGGGAAG	23	5415
SCNN1A-1567	+	GUGCAGAUGGUCACUGCGGGGAAG	24	5416
SCNN1A-1568	+	AUGGUGGUGUUGUUGCAG	18	5417
SCNN1A-1569	+	GAUGGUGGUGUUGUUGCAG	19	5418
SCNN1A-221	+	GGAUGGUGGUGUUGUUGCAG	20	844
SCNN1A-1570	+	UGGAUGGUGGUGUUGUUGCAG	21	5419
SCNN1A-1571	+	GUGGAUGGUGGUGUUGUUGCAG	22	5420
SCNN1A-1572	+	CGUGGAUGGUGGUGUUGUUGCAG	23	5421
SCNN1A-1573	+	CCGUGGAUGGUGGUGUUGUUGCAG	24	5422
SCNN1A-1574	+	AAGACGAGCUUGUCCGAG	18	5423
SCNN1A-1575	+	GAAGACGAGCUUGUCCGAG	19	5424
SCNN1A-236	+	GGAAGACGAGCUUGUCCGAG	20	856
SCNN1A-1576	+	GGGAAGACGAGCUUGUCCGAG	21	5425
SCNN1A-1577	+	GGGGAAGACGAGCUUGUCCGAG	22	5426
SCNN1A-1578	+	CGGGGAAGACGAGCUUGUCCGAG	23	5427
SCNN1A-1579	+	GCGGGGAAGACGAGCUUGUCCGAG	24	5428
SCNN1A-1580	+	UUGAGGCUGACGGGGUAG	18	5429
SCNN1A-1581	+	GUUGAGGCUGACGGGGUAG	19	5430
SCNN1A-232	+	UGUUGAGGCUGACGGGGUAG	20	853
SCNN1A-1582	+	AUGUUGAGGCUGACGGGGUAG	21	5431
SCNN1A-1583	+	GAUGUUGAGGCUGACGGGGUAG	22	5432
SCNN1A-1584	+	UGAUGUUGAGGCUGACGGGGUAG	23	5433
SCNN1A-1585	+	UUGAUGUUGAGGCUGACGGGGUAG	24	5434
SCNN1A-1586	+	GAGCUCUCGGUAGGAGCG	18	5435
SCNN1A-1587	+	AGAGCUCUCGGUAGGAGCG	19	5436
SCNN1A-216	+	AAGAGCUCUCGGUAGGAGCG	20	840
SCNN1A-1588	+	GAAGAGCUCUCGGUAGGAGCG	21	5437
SCNN1A-1589	+	CGAAGAGCUCUCGGUAGGAGCG	22	5438
SCNN1A-1590	+	UCGAAGAGCUCUCGGUAGGAGCG	23	5439
SCNN1A-1591	+	CUCGAAGAGCUCUCGGUAGGAGCG	24	5440
SCNN1A-1592	+	GUGCAGAUGGUCACUGCG	18	5441
SCNN1A-1593	+	GGUGCAGAUGGUCACUGCG	19	5442
SCNN1A-39	+	GGGUGCAGAUGGUCACUGCG	20	518
SCNN1A-1594	+	AGGGUGCAGAUGGUCACUGCG	21	5443
SCNN1A-1595	+	GAGGGUGCAGAUGGUCACUGCG	22	5444
SCNN1A-1596	+	UGAGGGUGCAGAUGGUCACUGCG	23	5445
SCNN1A-1597	+	UUGAGGGUGCAGAUGGUCACUGCG	24	5446
SCNN1A-1598	+	UUGUUGCAGAAGAACUCG	18	5447
SCNN1A-1599	+	GUUGUUGCAGAAGAACUCG	19	5448
SCNN1A-219	+	UGUUGUUGCAGAAGAACUCG	20	842
SCNN1A-1600	+	GUGUUGUUGCAGAAGAACUCG	21	5449
SCNN1A-1601	+	GGUGUUGUUGCAGAAGAACUCG	22	5450
SCNN1A-1602	+	UGGUGUUGUUGCAGAAGAACUCG	23	5451
SCNN1A-1603	+	GUGGUGUUGUUGCAGAAGAACUCG	24	5452
SCNN1A-1604	+	CAAGGGUCAGGGUCAAGG	18	5453
SCNN1A-1605	+	GCAAGGGUCAGGGUCAAGG	19	5454
SCNN1A-1606	+	AGCAAGGGUCAGGGUCAAGG	20	5455
SCNN1A-1607	+	GAGCAAGGGUCAGGGUCAAGG	21	5456
SCNN1A-1608	+	AGAGCAAGGGUCAGGGUCAAGG	22	5457
SCNN1A-1609	+	GAGAGCAAGGGUCAGGGUCAAGG	23	5458
SCNN1A-1610	+	GGAGAGCAAGGGUCAGGGUCAAGG	24	5459
SCNN1A-1611	+	AGCUCUCGGUAGGAGCGG	18	5460
SCNN1A-1612	+	GAGCUCUCGGUAGGAGCGG	19	5461
SCNN1A-60	+	AGAGCUCUCGGUAGGAGCGG	20	590
SCNN1A-1613	+	AAGAGCUCUCGGUAGGAGCGG	21	5462
SCNN1A-1614	+	GAAGAGCUCUCGGUAGGAGCGG	22	5463
SCNN1A-1615	+	CGAAGAGCUCUCGGUAGGAGCGG	23	5464
SCNN1A-1616	+	UCGAAGAGCUCUCGGUAGGAGCGG	24	5465
SCNN1A-1617	+	AACUCGAAGAGCUCUCGG	18	5466
SCNN1A-1618	+	GAACUCGAAGAGCUCUCGG	19	5467
SCNN1A-218	+	AGAACUCGAAGAGCUCUCGG	20	841
SCNN1A-1619	+	AAGAACUCGAAGAGCUCUCGG	21	5468
SCNN1A-1620	+	GAAGAACUCGAAGAGCUCUCGG	22	5469
SCNN1A-1621	+	AGAAGAACUCGAAGAGCUCUCGG	23	5470
SCNN1A-1622	+	CAGAAGAACUCGAAGAGCUCUCGG	24	5471
SCNN1A-1623	+	GCCCCGGAGUGGAUUGGG	18	5472
SCNN1A-1624	+	AGCCCCGGAGUGGAUUGGG	19	5473
SCNN1A-1625	+	GAGCCCCGGAGUGGAUUGGG	20	5474
SCNN1A-1626	+	UGAGCCCCGGAGUGGAUUGGG	21	5475
SCNN1A-1627	+	AUGAGCCCCGGAGUGGAUUGGG	22	5476
SCNN1A-1628	+	CAUGAGCCCCGGAGUGGAUUGGG	23	5477
SCNN1A-1629	+	UCAUGAGCCCCGGAGUGGAUUGGG	24	5478
SCNN1A-1630	+	CAUGAUACCUCCCCUUGG	18	5479
SCNN1A-1631	+	UCAUGAUACCUCCCCUUGG	19	5480
SCNN1A-1632	+	CUCAUGAUACCUCCCCUUGG	20	5481
SCNN1A-1633	+	GCUCAUGAUACCUCCCCUUGG	21	5482
SCNN1A-1634	+	UGCUCAUGAUACCUCCCCUUGG	22	5483
SCNN1A-1635	+	CUGCUCAUGAUACCUCCCCUUGG	23	5484
SCNN1A-1636	+	ACUGCUCAUGAUACCUCCCCUUGG	24	5485
SCNN1A-1637	+	UCCGAGUUGAGGUUGAUG	18	5486
SCNN1A-1638	+	GUCCGAGUUGAGGUUGAUG	19	5487
SCNN1A-235	+	UGUCCGAGUUGAGGUUGAUG	20	855
SCNN1A-1639	+	UUGUCCGAGUUGAGGUUGAUG	21	5488
SCNN1A-1640	+	CUUGUCCGAGUUGAGGUUGAUG	22	5489
SCNN1A-1641	+	GCUUGUCCGAGUUGAGGUUGAUG	23	5490
SCNN1A-1642	+	AGCUUGUCCGAGUUGAGGUUGAUG	24	5491
SCNN1A-1643	+	GGGUGCAGAUGGUCACUG	18	5492
SCNN1A-1644	+	AGGGUGCAGAUGGUCACUG	19	5493
SCNN1A-37	+	GAGGGUGCAGAUGGUCACUG	20	517
SCNN1A-1645	+	UGAGGGUGCAGAUGGUCACUG	21	5494
SCNN1A-1646	+	UUGAGGGUGCAGAUGGUCACUG	22	5495
SCNN1A-1647	+	AUUGAGGGUGCAGAUGGUCACUG	23	5496
SCNN1A-1648	+	GAUUGAGGGUGCAGAUGGUCACUG	24	5497
SCNN1A-1649	+	GAGCCCUGGAGUGGACUG	18	5498
SCNN1A-1650	+	UGAGCCCUGGAGUGGACUG	19	5499
SCNN1A-74	+	AUGAGCCCUGGAGUGGACUG	20	601
SCNN1A-1651	+	CAUGAGCCCUGGAGUGGACUG	21	5500
SCNN1A-1652	+	UCAUGAGCCCUGGAGUGGACUG	22	5501
SCNN1A-1653	+	UUCAUGAGCCCUGGAGUGGACUG	23	5502
SCNN1A-1654	+	CUUCAUGAGCCCUGGAGUGGACUG	24	5503
SCNN1A-1655	+	GAGGGACUAACCGACCUG	18	5504
SCNN1A-1656	+	AGAGGGACUAACCGACCUG	19	5505
SCNN1A-1657	+	CAGAGGGACUAACCGACCUG	20	5506
SCNN1A-1658	+	GCAGAGGGACUAACCGACCUG	21	5507
SCNN1A-1659	+	GGCAGAGGGACUAACCGACCUG	22	5508
SCNN1A-1660	+	GGGCAGAGGGACUAACCGACCUG	23	5509
SCNN1A-1661	+	GGGGCAGAGGGACUAACCGACCUG	24	5510
SCNN1A-1662	+	AGGUUGAUGUUGAGGCUG	18	5511
SCNN1A-1663	+	GAGGUUGAUGUUGAGGCUG	19	5512
SCNN1A-234	+	UGAGGUUGAUGUUGAGGCUG	20	854
SCNN1A-1664	+	UUGAGGUUGAUGUUGAGGCUG	21	5513
SCNN1A-1665	+	GUUGAGGUUGAUGUUGAGGCUG	22	5514
SCNN1A-1666	+	AGUUGAGGUUGAUGUUGAGGCUG	23	5515
SCNN1A-1667	+	GAGUUGAGGUUGAUGUUGAGGCUG	24	5516
SCNN1A-1668	+	GAGACCUGGUAUGGGCUG	18	5517
SCNN1A-1669	+	UGAGACCUGGUAUGGGCUG	19	5518
SCNN1A-1670	+	AUGAGACCUGGUAUGGGCUG	20	5519
SCNN1A-1671	+	CAUGAGACCUGGUAUGGGCUG	21	5520
SCNN1A-1672	+	CCAUGAGACCUGGUAUGGGCUG	22	5521
SCNN1A-1673	+	UCCAUGAGACCUGGUAUGGGCUG	23	5522
SCNN1A-1674	+	CUCCAUGAGACCUGGUAUGGGCUG	24	5523
SCNN1A-1675	+	CUCCUCCGCCGUGGGCUG	18	5524
SCNN1A-1676	+	CCUCCUCCGCCGUGGGCUG	19	5525
SCNN1A-212	+	UCCUCCUCCGCCGUGGGCUG	20	837
SCNN1A-1677	+	CUCCUCCUCCGCCGUGGGCUG	21	5526
SCNN1A-1678	+	CCUCCUCCUCCGCCGUGGGCUG	22	5527
SCNN1A-1679	+	GCCUCCUCCUCCGCCGUGGGCUG	23	5528
SCNN1A-1680	+	GGCCUCCUCCUCCGCCGUGGGCUG	24	5529
SCNN1A-1681	+	UACAUCAUGCCAAAGGUG	18	5530
SCNN1A-1682	+	GUACAUCAUGCCAAAGGUG	19	5531
SCNN1A-229	+	AGUACAUCAUGCCAAAGGUG	20	850
SCNN1A-1683	+	CAGUACAUCAUGCCAAAGGUG	21	5532
SCNN1A-1684	+	CCAGUACAUCAUGCCAAAGGUG	22	5533
SCNN1A-1685	+	GCCAGUACAUCAUGCCAAAGGUG	23	5534
SCNN1A-1686	+	UGCCAGUACAUCAUGCCAAAGGUG	24	5535
SCNN1A-1687	+	GCCCUGGAGUGGACUGUG	18	5536
SCNN1A-1688	+	AGCCCUGGAGUGGACUGUG	19	5537
SCNN1A-202	+	GAGCCCUGGAGUGGACUGUG	20	831
SCNN1A-1689	+	UGAGCCCUGGAGUGGACUGUG	21	5538
SCNN1A-1690	+	AUGAGCCCUGGAGUGGACUGUG	22	5539
SCNN1A-1691	+	CAUGAGCCCUGGAGUGGACUGUG	23	5540
SCNN1A-1692	+	UCAUGAGCCCUGGAGUGGACUGUG	24	5541
SCNN1A-1693	+	CGUCUUCAUGCGGUUGUG	18	5542
SCNN1A-1694	+	CCGUCUUCAUGCGGUUGUG	19	5543
SCNN1A-227	+	GCCGUCUUCAUGCGGUUGUG	20	848
SCNN1A-1695	+	GGCCGUCUUCAUGCGGUUGUG	21	5544
SCNN1A-1696	+	AGGCCGUCUUCAUGCGGUUGUG	22	5545
SCNN1A-1697	+	AAGGCCGUCUUCAUGCGGUUGUG	23	5546
SCNN1A-1698	+	GAAGGCCGUCUUCAUGCGGUUGUG	24	5547
SCNN1A-1699	+	GAGCCCCGGAGUGGAUUG	18	5548
SCNN1A-1700	+	UGAGCCCCGGAGUGGAUUG	19	5549
SCNN1A-419	+	AUGAGCCCCGGAGUGGAUUG	20	4268
SCNN1A-1701	+	CAUGAGCCCCGGAGUGGAUUG	21	5550
SCNN1A-1702	+	UCAUGAGCCCCGGAGUGGAUUG	22	5551
SCNN1A-1703	+	UUCAUGAGCCCCGGAGUGGAUUG	23	5552
SCNN1A-1704	+	CUUCAUGAGCCCCGGAGUGGAUUG	24	5553
SCNN1A-1705	+	UGGAUGGUGGUGUUGUUG	18	5554
SCNN1A-1706	+	GUGGAUGGUGGUGUUGUUG	19	5555
SCNN1A-222	+	CGUGGAUGGUGGUGUUGUUG	20	845
SCNN1A-1707	+	CCGUGGAUGGUGGUGUUGUUG	21	5556
SCNN1A-1708	+	GCCGUGGAUGGUGGUGUUGUUG	22	5557
SCNN1A-1709	+	CGCCGUGGAUGGUGGUGUUGUUG	23	5558
SCNN1A-1710	+	GCGCCGUGGAUGGUGGUGUUGUUG	24	5559
SCNN1A-1711	+	GGAGCGGUGGAACUCGAU	18	5560
SCNN1A-1712	+	AGGAGCGGUGGAACUCGAU	19	5561
SCNN1A-214	+	UAGGAGCGGUGGAACUCGAU	20	839
SCNN1A-1713	+	GUAGGAGCGGUGGAACUCGAU	21	5562
SCNN1A-1714	+	GGUAGGAGCGGUGGAACUCGAU	22	5563
SCNN1A-1715	+	CGGUAGGAGCGGUGGAACUCGAU	23	5564
SCNN1A-1716	+	UCGGUAGGAGCGGUGGAACUCGAU	24	5565
SCNN1A-1717	+	AUGAGCCCCGGAGUGGAU	18	5566
SCNN1A-1718	+	CAUGAGCCCCGGAGUGGAU	19	5567
SCNN1A-420	+	UCAUGAGCCCCGGAGUGGAU	20	4269
SCNN1A-1719	+	UUCAUGAGCCCCGGAGUGGAU	21	5568
SCNN1A-1720	+	CUUCAUGAGCCCCGGAGUGGAU	22	5569
SCNN1A-1721	+	CCUUCAUGAGCCCCGGAGUGGAU	23	5570
SCNN1A-1722	+	CCCUUCAUGAGCCCCGGAGUGGAU	24	5571
SCNN1A-1723	+	AGGGUGCAGAUGGUCACU	18	5572
SCNN1A-1724	+	GAGGGUGCAGAUGGUCACU	19	5573
SCNN1A-242	+	UGAGGGUGCAGAUGGUCACU	20	859
SCNN1A-1725	+	UUGAGGGUGCAGAUGGUCACU	21	5574
SCNN1A-1726	+	AUUGAGGGUGCAGAUGGUCACU	22	5575
SCNN1A-1727	+	GAUUGAGGGUGCAGAUGGUCACU	23	5576
SCNN1A-1728	+	GGAUUGAGGGUGCAGAUGGUCACU	24	5577
SCNN1A-1729	+	UGAGCCCUGGAGUGGACU	18	5578
SCNN1A-1730	+	AUGAGCCCUGGAGUGGACU	19	5579
SCNN1A-204	+	CAUGAGCCCUGGAGUGGACU	20	832
SCNN1A-1731	+	UCAUGAGCCCUGGAGUGGACU	21	5580
SCNN1A-1732	+	UUCAUGAGCCCUGGAGUGGACU	22	5581
SCNN1A-1733	+	CUUCAUGAGCCCUGGAGUGGACU	23	5582
SCNN1A-1734	+	CCUUCAUGAGCCCUGGAGUGGACU	24	5583
SCNN1A-1735	+	GCUCAUGAUACCUCCCCU	18	5584
SCNN1A-1736	+	UGCUCAUGAUACCUCCCCU	19	5585
SCNN1A-457	+	CUGCUCAUGAUACCUCCCCU	20	4306
SCNN1A-1737	+	ACUGCUCAUGAUACCUCCCCU	21	5586
SCNN1A-1738	+	UACUGCUCAUGAUACCUCCCCU	22	5587
SCNN1A-1739	+	AUACUGCUCAUGAUACCUCCCCU	23	5588
SCNN1A-1740	+	GAUACUGCUCAUGAUACCUCCCCU	24	5589
SCNN1A-1741	+	CAGGGUCAAGGCUGAGCU	18	5590
SCNN1A-1742	+	UCAGGGUCAAGGCUGAGCU	19	5591
SCNN1A-1743	+	GUCAGGGUCAAGGCUGAGCU	20	5592
SCNN1A-1744	+	GGUCAGGGUCAAGGCUGAGCU	21	5593
SCNN1A-1745	+	GGGUCAGGGUCAAGGCUGAGCU	22	5594
SCNN1A-1746	+	AGGGUCAGGGUCAAGGCUGAGCU	23	5595
SCNN1A-1747	+	AAGGGUCAGGGUCAAGGCUGAGCU	24	5596
SCNN1A-1748	+	UCUUCAUGCGGUUGUGCU	18	5597
SCNN1A-1749	+	GUCUUCAUGCGGUUGUGCU	19	5598
SCNN1A-50	+	CGUCUUCAUGCGGUUGUGCU	20	583
SCNN1A-1750	+	CCGUCUUCAUGCGGUUGUGCU	21	5599
SCNN1A-1751	+	GCCGUCUUCAUGCGGUUGUGCU	22	5600
SCNN1A-1752	+	GGCCGUCUUCAUGCGGUUGUGCU	23	5601
SCNN1A-1753	+	AGGCCGUCUUCAUGCGGUUGUGCU	24	5602
SCNN1A-1754	+	GGGUAGCUGAAGUACUCU	18	5603
SCNN1A-1755	+	GGGGUAGCUGAAGUACUCU	19	5604
SCNN1A-231	+	CGGGGUAGCUGAAGUACUCU	20	852
SCNN1A-1756	+	ACGGGGUAGCUGAAGUACUCU	21	5605
SCNN1A-1757	+	GACGGGGUAGCUGAAGUACUCU	22	5606
SCNN1A-1758	+	UGACGGGGUAGCUGAAGUACUCU	23	5607
SCNN1A-1759	+	CUGACGGGGUAGCUGAAGUACUCU	24	5608
SCNN1A-1760	+	UGCUGGGGCGCCGCAGGU	18	5609
SCNN1A-1761	+	CUGCUGGGGCGCCGCAGGU	19	5610
SCNN1A-210	+	GCUGCUGGGGCGCCGCAGGU	20	836
SCNN1A-1762	+	GGCUGCUGGGGCGCCGCAGGU	21	5611
SCNN1A-1763	+	GGGCUGCUGGGGCGCCGCAGGU	22	5612
SCNN1A-1764	+	UGGGCUGCUGGGGCGCCGCAGGU	23	5613
SCNN1A-1765	+	GUGGGCUGCUGGGGCGCCGCAGGU	24	5614
SCNN1A-1766	+	ACUCGAAGAGCUCUCGGU	18	5615
SCNN1A-1767	+	AACUCGAAGAGCUCUCGGU	19	5616
SCNN1A-58	+	GAACUCGAAGAGCUCUCGGU	20	524
SCNN1A-1768	+	AGAACUCGAAGAGCUCUCGGU	21	5617
SCNN1A-1769	+	AAGAACUCGAAGAGCUCUCGGU	22	5618
SCNN1A-1770	+	GAAGAACUCGAAGAGCUCUCGGU	23	5619
SCNN1A-1771	+	AGAAGAACUCGAAGAGCUCUCGGU	24	5620
SCNN1A-1772	+	CCCUCCAUGAGACCUGGU	18	5621
SCNN1A-1773	+	CCCCUCCAUGAGACCUGGU	19	5622
SCNN1A-199	+	UCCCCUCCAUGAGACCUGGU	20	828
SCNN1A-1774	+	UUCCCCUCCAUGAGACCUGGU	21	5623
SCNN1A-1775	+	GUUCCCCUCCAUGAGACCUGGU	22	5624
SCNN1A-1776	+	UGUUCCCCUCCAUGAGACCUGGU	23	5625
SCNN1A-1777	+	UUGUUCCCCUCCAUGAGACCUGGU	24	5626
SCNN1A-1778	+	UGAGCCCCGGAGUGGAUU	18	5627
SCNN1A-1779	+	AUGAGCCCCGGAGUGGAUU	19	5628
SCNN1A-425	+	CAUGAGCCCCGGAGUGGAUU	20	4274
SCNN1A-1780	+	UCAUGAGCCCCGGAGUGGAUU	21	5629
SCNN1A-1781	+	UUCAUGAGCCCCGGAGUGGAUU	22	5630
SCNN1A-1782	+	CUUCAUGAGCCCCGGAGUGGAUU	23	5631
SCNN1A-1783	+	CCUUCAUGAGCCCCGGAGUGGAUU	24	5632
SCNN1A-1784	+	GCUGGGGCGCCGCAGGUU	18	5633
SCNN1A-1785	+	UGCUGGGGCGCCGCAGGUU	19	5634
SCNN1A-69	+	CUGCUGGGGCGCCGCAGGUU	20	597
SCNN1A-1786	+	GCUGCUGGGGCGCCGCAGGUU	21	5635
SCNN1A-1787	+	GGCUGCUGGGGCGCCGCAGGUU	22	5636
SCNN1A-1788	+	GGGCUGCUGGGGCGCCGCAGGUU	23	5637
SCNN1A-1789	+	UGGGCUGCUGGGGCGCCGCAGGUU	24	5638
SCNN1A-1790	−	CAGUAUCAAGGUAAGCAA	18	5639
SCNN1A-1791	−	GCAGUAUCAAGGUAAGCAA	19	5640
SCNN1A-393	−	AGCAGUAUCAAGGUAAGCAA	20	4242
SCNN1A-1792	−	GAGCAGUAUCAAGGUAAGCAA	21	5641
SCNN1A-1793	−	UGAGCAGUAUCAAGGUAAGCAA	22	5642
SCNN1A-1794	−	AUGAGCAGUAUCAAGGUAAGCAA	23	5643
SCNN1A-1795	−	CAUGAGCAGUAUCAAGGUAAGCAA	24	5644
SCNN1A-1796	−	CACUCCAGGGCUCAUGAA	18	5645
SCNN1A-1797	−	CCACUCCAGGGCUCAUGAA	19	5646
SCNN1A-11	−	UCCACUCCAGGGCUCAUGAA	20	560
SCNN1A-1798	−	GUCCACUCCAGGGCUCAUGAA	21	5647
SCNN1A-1799	−	AGUCCACUCCAGGGCUCAUGAA	22	5648
SCNN1A-1800	−	CAGUCCACUCCAGGGCUCAUGAA	23	5649
SCNN1A-1801	−	ACAGUCCACUCCAGGGCUCAUGAA	24	5650
SCNN1A-1802	−	CACUCCGGGGCUCAUGAA	18	5651
SCNN1A-1803	−	CCACUCCGGGGCUCAUGAA	19	5652
SCNN1A-451	−	UCCACUCCGGGGCUCAUGAA	20	4300
SCNN1A-1804	−	AUCCACUCCGGGGCUCAUGAA	21	5653
SCNN1A-1805	−	AAUCCACUCCGGGGCUCAUGAA	22	5654
SCNN1A-1806	−	CAAUCCACUCCGGGGCUCAUGAA	23	5655
SCNN1A-1807	−	CCAAUCCACUCCGGGGCUCAUGAA	24	5656
SCNN1A-1808	−	GCAGUAUCAAGGUAAGCA	18	5657
SCNN1A-1809	−	AGCAGUAUCAAGGUAAGCA	19	5658
SCNN1A-342	−	GAGCAGUAUCAAGGUAAGCA	20	4191
SCNN1A-1810	−	UGAGCAGUAUCAAGGUAAGCA	21	5659
SCNN1A-1811	−	AUGAGCAGUAUCAAGGUAAGCA	22	5660
SCNN1A-1812	−	CAUGAGCAGUAUCAAGGUAAGCA	23	5661
SCNN1A-1813	−	UCAUGAGCAGUAUCAAGGUAAGCA	24	5662
SCNN1A-1814	−	AGCCCAUACCAGGUCUCA	18	5663
SCNN1A-1815	−	CAGCCCAUACCAGGUCUCA	19	5664
SCNN1A-1	−	GCAGCCCAUACCAGGUCUCA	20	503
SCNN1A-1816	−	UGCAGCCCAUACCAGGUCUCA	21	5665
SCNN1A-1817	−	CUGCAGCCCAUACCAGGUCUCA	22	5666
SCNN1A-1818	−	UCUGCAGCCCAUACCAGGUCUCA	23	5667
SCNN1A-1819	−	CUCUGCAGCCCAUACCAGGUCUCA	24	5668
SCNN1A-1820	−	GUUCCAGGGGUGAUGGGA	18	5669
SCNN1A-1821	−	GGUUCCAGGGGUGAUGGGA	19	5670
SCNN1A-1822	−	GGGUUCCAGGGGUGAUGGGA	20	5671
SCNN1A-1823	−	CGGGUUCCAGGGGUGAUGGGA	21	5672
SCNN1A-1824	−	UCGGGUUCCAGGGGUGAUGGGA	22	5673
SCNN1A-1825	−	CUCGGGUUCCAGGGGUGAUGGGA	23	5674
SCNN1A-1826	−	ACUCGGGUUCCAGGGGUGAUGGGA	24	5675
SCNN1A-1827	−	CAUACCAGGUCUCAUGGA	18	5676
SCNN1A-1828	−	CCAUACCAGGUCUCAUGGA	19	5677
SCNN1A-3	−	CCCAUACCAGGUCUCAUGGA	20	556
SCNN1A-1829	−	GCCCAUACCAGGUCUCAUGGA	21	5678
SCNN1A-1830	−	AGCCCAUACCAGGUCUCAUGGA	22	5679
SCNN1A-1831	−	CAGCCCAUACCAGGUCUCAUGGA	23	5680
SCNN1A-1832	−	GCAGCCCAUACCAGGUCUCAUGGA	24	5681
SCNN1A-1833	−	CCACUCCAGGGCUCAUGA	18	5682
SCNN1A-1834	−	UCCACUCCAGGGCUCAUGA	19	5683
SCNN1A-10	−	GUCCACUCCAGGGCUCAUGA	20	505
SCNN1A-1835	−	AGUCCACUCCAGGGCUCAUGA	21	5684
SCNN1A-1836	−	CAGUCCACUCCAGGGCUCAUGA	22	5685
SCNN1A-1837	−	ACAGUCCACUCCAGGGCUCAUGA	23	5686
SCNN1A-1838	−	CACAGUCCACUCCAGGGCUCAUGA	24	5687
SCNN1A-1839	−	CCACUCCGGGGCUCAUGA	18	5688
SCNN1A-1840	−	UCCACUCCGGGGCUCAUGA	19	5689
SCNN1A-400	−	AUCCACUCCGGGGCUCAUGA	20	4249
SCNN1A-1841	−	AAUCCACUCCGGGGCUCAUGA	21	5690
SCNN1A-1842	−	CAAUCCACUCCGGGGCUCAUGA	22	5691
SCNN1A-1843	−	CCAAUCCACUCCGGGGCUCAUGA	23	5692
SCNN1A-1844	−	CCCAAUCCACUCCGGGGCUCAUGA	24	5693
SCNN1A-1845	−	CUCGGGUUCCAGGGGUGA	18	5694
SCNN1A-1846	−	ACUCGGGUUCCAGGGGUGA	19	5695
SCNN1A-401	−	CACUCGGGUUCCAGGGGUGA	20	4250
SCNN1A-1847	−	UCACUCGGGUUCCAGGGGUGA	21	5696
SCNN1A-1848	−	CUCACUCGGGUUCCAGGGGUGA	22	5697
SCNN1A-1849	−	CCUCACUCGGGUUCCAGGGGUGA	23	5698
SCNN1A-1850	−	GCCUCACUCGGGUUCCAGGGGUGA	24	5699
SCNN1A-1851	−	CGAGUUCCACCGCUCCUA	18	5700
SCNN1A-1852	−	UCGAGUUCCACCGCUCCUA	19	5701
SCNN1A-190	−	AUCGAGUUCCACCGCUCCUA	20	820
SCNN1A-1853	−	GAUCGAGUUCCACCGCUCCUA	21	5702
SCNN1A-1854	−	UGAUCGAGUUCCACCGCUCCUA	22	5703
SCNN1A-1855	−	CUGAUCGAGUUCCACCGCUCCUA	23	5704
SCNN1A-1856	−	CCUGAUCGAGUUCCACCGCUCCUA	24	5705
SCNN1A-1857	−	CUCAACAUCAACCUCAAC	18	5706
SCNN1A-1858	−	CCUCAACAUCAACCUCAAC	19	5707
SCNN1A-198	−	GCCUCAACAUCAACCUCAAC	20	827
SCNN1A-1859	−	AGCCUCAACAUCAACCUCAAC	21	5708
SCNN1A-1860	−	CAGCCUCAACAUCAACCUCAAC	22	5709
SCNN1A-1861	−	UCAGCCUCAACAUCAACCUCAAC	23	5710
SCNN1A-1862	−	GUCAGCCUCAACAUCAACCUCAAC	24	5711
SCNN1A-1863	−	GUGGGCGCAGGGUGGGAC	18	5712
SCNN1A-1864	−	UGUGGGCGCAGGGUGGGAC	19	5713
SCNN1A-1865	−	AUGUGGGCGCAGGGUGGGAC	20	5714
SCNN1A-1866	−	AAUGUGGGCGCAGGGUGGGAC	21	5715
SCNN1A-1867	−	GAAUGUGGGCGCAGGGUGGGAC	22	5716
SCNN1A-1868	−	AGAAUGUGGGCGCAGGGUGGGAC	23	5717
SCNN1A-1869	−	GAGAAUGUGGGCGCAGGGUGGGAC	24	5718
SCNN1A-1870	−	AGUUCCACCGCUCCUACC	18	5719
SCNN1A-1871	−	GAGUUCCACCGCUCCUACC	19	5720
SCNN1A-191	−	CGAGUUCCACCGCUCCUACC	20	821
SCNN1A-1872	−	UCGAGUUCCACCGCUCCUACC	21	5721
SCNN1A-1873	−	AUCGAGUUCCACCGCUCCUACC	22	5722
SCNN1A-1874	−	GAUCGAGUUCCACCGCUCCUACC	23	5723
SCNN1A-1875	−	UGAUCGAGUUCCACCGCUCCUACC	24	5724
SCNN1A-1876	−	GAGAGGGCACUCAGGGCC	18	5725
SCNN1A-1877	−	GGAGAGGGCACUCAGGGCC	19	5726
SCNN1A-1878	−	GGGAGAGGGCACUCAGGGCC	20	5727
SCNN1A-1879	−	UGGGAGAGGGCACUCAGGGCC	21	5728
SCNN1A-1880	−	AUGGGAGAGGGCACUCAGGGCC	22	5729
SCNN1A-1881	−	GAUGGGAGAGGGCACUCAGGGCC	23	5730
SCNN1A-1882	−	UGAUGGGAGAGGGCACUCAGGGCC	24	5731
SCNN1A-1883	−	AGGAGCAGGGGCUGGGCC	18	5732
SCNN1A-1884	−	GAGGAGCAGGGGCUGGGCC	19	5733
SCNN1A-182	−	UGAGGAGCAGGGGCUGGGCC	20	815
SCNN1A-1885	−	GUGAGGAGCAGGGGCUGGGCC	21	5734
SCNN1A-1886	−	CGUGAGGAGCAGGGGCUGGGCC	22	5735
SCNN1A-1887	−	GCGUGAGGAGCAGGGGCUGGGCC	23	5736
SCNN1A-1888	−	AGCGUGAGGAGCAGGGGCUGGGCC	24	5737
SCNN1A-1889	−	UGGGACAUGGGCAUGGCC	18	5738
SCNN1A-1890	−	GUGGGACAUGGGCAUGGCC	19	5739
SCNN1A-347	−	GGUGGGACAUGGGCAUGGCC	20	4196
SCNN1A-1891	−	GGGUGGGACAUGGGCAUGGCC	21	5740
SCNN1A-1892	−	AGGGUGGGACAUGGGCAUGGCC	22	5741
SCNN1A-1893	−	CAGGGUGGGACAUGGGCAUGGCC	23	5742
SCNN1A-1894	−	GCAGGGUGGGACAUGGGCAUGGCC	24	5743
SCNN1A-1895	−	UCAUGAAGGGGAACAAGC	18	5744
SCNN1A-1896	−	CUCAUGAAGGGGAACAAGC	19	5745
SCNN1A-176	−	GCUCAUGAAGGGGAACAAGC	20	811
SCNN1A-1897	−	GGCUCAUGAAGGGGAACAAGC	21	5746
SCNN1A-1898	−	GGGCUCAUGAAGGGGAACAAGC	22	5747
SCNN1A-1899	−	AGGGCUCAUGAAGGGGAACAAGC	23	5748
SCNN1A-1900	−	CAGGGCUCAUGAAGGGGAACAAGC	24	5749
SCNN1A-1901	−	GGGGCUCAUGAAGGGGAACAAGC	23	5750
SCNN1A-1902	−	CGGGGCUCAUGAAGGGGAACAAGC	24	5751
SCNN1A-1903	−	UCAUGGAGGGGAACAAGC	18	5752
SCNN1A-1904	−	CUCAUGGAGGGGAACAAGC	19	5753
SCNN1A-5	−	UCUCAUGGAGGGGAACAAGC	20	557
SCNN1A-1905	−	GUCUCAUGGAGGGGAACAAGC	21	5754
SCNN1A-1906	−	GGUCUCAUGGAGGGGAACAAGC	22	5755
SCNN1A-1907	−	AGGUCUCAUGGAGGGGAACAAGC	23	5756
SCNN1A-1908	−	CAGGUCUCAUGGAGGGGAACAAGC	24	5757
SCNN1A-1909	−	AGCAGUAUCAAGGUAAGC	18	5758
SCNN1A-1910	−	GAGCAGUAUCAAGGUAAGC	19	5759
SCNN1A-1911	−	UGAGCAGUAUCAAGGUAAGC	20	5760
SCNN1A-1912	−	AUGAGCAGUAUCAAGGUAAGC	21	5761
SCNN1A-1913	−	CAUGAGCAGUAUCAAGGUAAGC	22	5762
SCNN1A-1914	−	UCAUGAGCAGUAUCAAGGUAAGC	23	5763
SCNN1A-1915	−	AUCAUGAGCAGUAUCAAGGUAAGC	24	5764
SCNN1A-1916	−	GGAACAAGCGUGAGGAGC	18	5765
SCNN1A-1917	−	GGGAACAAGCGUGAGGAGC	19	5766
SCNN1A-14	−	GGGGAACAAGCGUGAGGAGC	20	506
SCNN1A-1918	−	AGGGGAACAAGCGUGAGGAGC	21	5767
SCNN1A-1919	−	AAGGGGAACAAGCGUGAGGAGC	22	5768
SCNN1A-1920	−	GAAGGGGAACAAGCGUGAGGAGC	23	5769
SCNN1A-1921	−	UGAAGGGGAACAAGCGUGAGGAGC	24	5770
SCNN1A-1922	−	UGCUCCCAGCACAACCGC	18	5771
SCNN1A-1923	−	GUGCUCCCAGCACAACCGC	19	5772
SCNN1A-193	−	UGUGCUCCCAGCACAACCGC	20	823
SCNN1A-1924	−	GUGUGCUCCCAGCACAACCGC	21	5773
SCNN1A-1925	−	GGUGUGCUCCCAGCACAACCGC	22	5774
SCNN1A-1926	−	UGGUGUGCUCCCAGCACAACCGC	23	5775
SCNN1A-1927	−	CUGGUGUGCUCCCAGCACAACCGC	24	5776
SCNN1A-1928	−	GUGGGACAUGGGCAUGGC	18	5777
SCNN1A-1929	−	GGUGGGACAUGGGCAUGGC	19	5778
SCNN1A-1930	−	GGGUGGGACAUGGGCAUGGC	20	5779
SCNN1A-1931	−	AGGGUGGGACAUGGGCAUGGC	21	5780
SCNN1A-1932	−	CAGGGUGGGACAUGGGCAUGGC	22	5781
SCNN1A-1933	−	GCAGGGUGGGACAUGGGCAUGGC	23	5782
SCNN1A-1934	−	CGCAGGGUGGGACAUGGGCAUGGC	24	5783
SCNN1A-1935	−	CUUCCAAGGGGAGGUAUC	18	5784
SCNN1A-1936	−	CCUUCCAAGGGGAGGUAUC	19	5785
SCNN1A-1937	−	CCCUUCCAAGGGGAGGUAUC	20	5786
SCNN1A-1938	−	UCCCUUCCAAGGGGAGGUAUC	21	5787
SCNN1A-1939	−	GUCCCUUCCAAGGGGAGGUAUC	22	5788
SCNN1A-1940	−	UGUCCCUUCCAAGGGGAGGUAUC	23	5789
SCNN1A-1941	−	CUGUCCCUUCCAAGGGGAGGUAUC	24	5790
SCNN1A-1942	−	GCUCUCCCCAAUCCACUC	18	5791
SCNN1A-1943	−	UGCUCUCCCCAAUCCACUC	19	5792
SCNN1A-410	−	UUGCUCUCCCCAAUCCACUC	20	4259
SCNN1A-1944	−	CUUGCUCUCCCCAAUCCACUC	21	5793
SCNN1A-1945	−	CCUUGCUCUCCCCAAUCCACUC	22	5794
SCNN1A-1946	−	CCCUUGCUCUCCCCAAUCCACUC	23	5795
SCNN1A-1947	−	ACCCUUGCUCUCCCCAAUCCACUC	24	5796
SCNN1A-1948	−	GCCCUCCACAGUCCACUC	18	5797
SCNN1A-1949	−	AGCCCUCCACAGUCCACUC	19	5798
SCNN1A-170	−	UAGCCCUCCACAGUCCACUC	20	808
SCNN1A-1950	−	CUAGCCCUCCACAGUCCACUC	21	5799
SCNN1A-1951	−	UCUAGCCCUCCACAGUCCACUC	22	5800
SCNN1A-1952	−	CUCUAGCCCUCCACAGUCCACUC	23	5801
SCNN1A-1953	−	ACUCUAGCCCUCCACAGUCCACUC	24	5802
SCNN1A-1954	−	CAGUCCACUCCAGGGCUC	18	5803
SCNN1A-1955	−	ACAGUCCACUCCAGGGCUC	19	5804
SCNN1A-171	−	CACAGUCCACUCCAGGGCUC	20	809
SCNN1A-1956	−	CCACAGUCCACUCCAGGGCUC	21	5805
SCNN1A-1957	−	UCCACAGUCCACUCCAGGGCUC	22	5806
SCNN1A-1958	−	CUCCACAGUCCACUCCAGGGCUC	23	5807
SCNN1A-1959	−	CCUCCACAGUCCACUCCAGGGCUC	24	5808
SCNN1A-1960	−	CAAUCCACUCCGGGGCUC	18	5809
SCNN1A-1961	−	CCAAUCCACUCCGGGGCUC	19	5810
SCNN1A-1962	−	CCCAAUCCACUCCGGGGCUC	20	5811
SCNN1A-1963	−	CCCCAAUCCACUCCGGGGCUC	21	5812
SCNN1A-1964	−	UCCCCAAUCCACUCCGGGGCUC	22	5813
SCNN1A-1965	−	CUCCCCAAUCCACUCCGGGGCUC	23	5814
SCNN1A-1966	−	UCUCCCCAAUCCACUCCGGGGCUC	24	5815
SCNN1A-1967	−	CAGCCCAUACCAGGUCUC	18	5816
SCNN1A-1968	−	GCAGCCCAUACCAGGUCUC	19	5817
SCNN1A-159	−	UGCAGCCCAUACCAGGUCUC	20	803
SCNN1A-1969	−	CUGCAGCCCAUACCAGGUCUC	21	5818
SCNN1A-1970	−	UCUGCAGCCCAUACCAGGUCUC	22	5819
SCNN1A-1971	−	CUCUGCAGCCCAUACCAGGUCUC	23	5820
SCNN1A-1972	−	CCUCUGCAGCCCAUACCAGGUCUC	24	5821
SCNN1A-1973	−	GCAGCCUCACUCGGGUUC	18	5822
SCNN1A-1974	−	GGCAGCCUCACUCGGGUUC	19	5823
SCNN1A-1975	−	GGGCAGCCUCACUCGGGUUC	20	5824
SCNN1A-1976	−	GGGGCAGCCUCACUCGGGUUC	21	5825
SCNN1A-1977	−	AGGGGCAGCCUCACUCGGGUUC	22	5826
SCNN1A-1978	−	CAGGGGCAGCCUCACUCGGGUUC	23	5827
SCNN1A-1979	−	CCAGGGGCAGCCUCACUCGGGUUC	24	5828
SCNN1A-1980	−	CUCAUGAAGGGGAACAAG	18	5829
SCNN1A-1981	−	GCUCAUGAAGGGGAACAAG	19	5830
SCNN1A-1982	−	GGCUCAUGAAGGGGAACAAG	20	5831
SCNN1A-1983	−	GGGCUCAUGAAGGGGAACAAG	21	5832
SCNN1A-1984	−	GGGGCUCAUGAAGGGGAACAAG	22	5833
SCNN1A-1985	−	CGGGGCUCAUGAAGGGGAACAAG	23	5834
SCNN1A-1986	−	CCGGGGCUCAUGAAGGGGAACAAG	24	5835
SCNN1A-1987	−	CUCAUGGAGGGGAACAAG	18	5836
SCNN1A-1988	−	UCUCAUGGAGGGGAACAAG	19	5837
SCNN1A-165	−	GUCUCAUGGAGGGGAACAAG	20	805
SCNN1A-1989	−	GGUCUCAUGGAGGGGAACAAG	21	5838
SCNN1A-1990	−	AGGUCUCAUGGAGGGGAACAAG	22	5839
SCNN1A-1991	−	CAGGUCUCAUGGAGGGGAACAAG	23	5840
SCNN1A-1992	−	CCAGGUCUCAUGGAGGGGAACAAG	24	5841
SCNN1A-1993	−	CCAGCUGUCCCUUCCAAG	18	5842
SCNN1A-1994	−	UCCAGCUGUCCCUUCCAAG	19	5843
SCNN1A-412	−	AUCCAGCUGUCCCUUCCAAG	20	4261
SCNN1A-1995	−	ACUCCAGGGCUCAUGAAG	18	5844
SCNN1A-1996	−	CACUCCAGGGCUCAUGAAG	19	5845
SCNN1A-12	−	CCACUCCAGGGCUCAUGAAG	20	561
SCNN1A-1997	−	UCCACUCCAGGGCUCAUGAAG	21	5846
SCNN1A-1998	−	GUCCACUCCAGGGCUCAUGAAG	22	5847
SCNN1A-1999	−	AGUCCACUCCAGGGCUCAUGAAG	23	5848
SCNN1A-2000	−	CAGUCCACUCCAGGGCUCAUGAAG	24	5849
SCNN1A-2001	−	ACUCCGGGGCUCAUGAAG	18	5850
SCNN1A-2002	−	CACUCCGGGGCUCAUGAAG	19	5851
SCNN1A-453	−	CCACUCCGGGGCUCAUGAAG	20	4302
SCNN1A-2003	−	UCCACUCCGGGGCUCAUGAAG	21	5852
SCNN1A-2004	−	AUCCACUCCGGGGCUCAUGAAG	22	5853
SCNN1A-2005	−	AAUCCACUCCGGGGCUCAUGAAG	23	5854
SCNN1A-2006	−	CAAUCCACUCCGGGGCUCAUGAAG	24	5855
SCNN1A-2007	−	GGGAACAAGCUGGAGGAG	18	5856
SCNN1A-2008	−	GGGGAACAAGCUGGAGGAG	19	5857
SCNN1A-169	−	AGGGGAACAAGCUGGAGGAG	20	807
SCNN1A-2009	−	AAGGGGAACAAGCUGGAGGAG	21	5858
SCNN1A-2010	−	GAAGGGGAACAAGCUGGAGGAG	22	5859
SCNN1A-2011	−	UGAAGGGGAACAAGCUGGAGGAG	23	5860
SCNN1A-2012	−	AUGAAGGGGAACAAGCUGGAGGAG	24	5861
SCNN1A-2013	−	GAGGGGAACAAGCUGGAGGAG	21	5862
SCNN1A-2014	−	GGAGGGGAACAAGCUGGAGGAG	22	5863
SCNN1A-2015	−	UGGAGGGGAACAAGCUGGAGGAG	23	5864
SCNN1A-2016	−	AUGGAGGGGAACAAGCUGGAGGAG	24	5865
SCNN1A-2017	−	GGGAACAAGCGUGAGGAG	18	5866
SCNN1A-2018	−	GGGGAACAAGCGUGAGGAG	19	5867
SCNN1A-179	−	AGGGGAACAAGCGUGAGGAG	20	813
SCNN1A-2019	−	AAGGGGAACAAGCGUGAGGAG	21	5868
SCNN1A-2020	−	GAAGGGGAACAAGCGUGAGGAG	22	5869
SCNN1A-2021	−	UGAAGGGGAACAAGCGUGAGGAG	23	5870
SCNN1A-2022	−	AUGAAGGGGAACAAGCGUGAGGAG	24	5871
SCNN1A-2023	−	CAGCAGCCCACGGCGGAG	18	5872
SCNN1A-2024	−	CCAGCAGCCCACGGCGGAG	19	5873
SCNN1A-187	−	CCCAGCAGCCCACGGCGGAG	20	818
SCNN1A-2025	−	CCCCAGCAGCCCACGGCGGAG	21	5874
SCNN1A-2026	−	GCCCCAGCAGCCCACGGCGGAG	22	5875
SCNN1A-2027	−	CGCCCCAGCAGCCCACGGCGGAG	23	5876
SCNN1A-2028	−	GCGCCCCAGCAGCCCACGGCGGAG	24	5877
SCNN1A-2029	−	AUACCAGGUCUCAUGGAG	18	5878
SCNN1A-2030	−	CAUACCAGGUCUCAUGGAG	19	5879
SCNN1A-4	−	CCAUACCAGGUCUCAUGGAG	20	498
SCNN1A-2031	−	CCCAUACCAGGUCUCAUGGAG	21	5880
SCNN1A-2032	−	GCCCAUACCAGGUCUCAUGGAG	22	5881
SCNN1A-2033	−	AGCCCAUACCAGGUCUCAUGGAG	23	5882
SCNN1A-2034	−	CAGCCCAUACCAGGUCUCAUGGAG	24	5883
SCNN1A-2035	−	GCGCCCCAGCAGCCCACG	18	5884
SCNN1A-2036	−	GGCGCCCCAGCAGCCCACG	19	5885
SCNN1A-183	−	CGGCGCCCCAGCAGCCCACG	20	816
SCNN1A-2037	−	GCGGCGCCCCAGCAGCCCACG	21	5886
SCNN1A-2038	−	UGCGGCGCCCCAGCAGCCCACG	22	5887
SCNN1A-2039	−	CUGCGGCGCCCCAGCAGCCCACG	23	5888
SCNN1A-2040	−	CCUGCGGCGCCCCAGCAGCCCACG	24	5889
SCNN1A-2041	−	CCCCAGCAGCCCACGGCG	18	5890
SCNN1A-2042	−	GCCCCAGCAGCCCACGGCG	19	5891
SCNN1A-185	−	CGCCCCAGCAGCCCACGGCG	20	817
SCNN1A-2043	−	GCGCCCCAGCAGCCCACGGCG	21	5892
SCNN1A-2044	−	GGCGCCCCAGCAGCCCACGGCG	22	5893
SCNN1A-2045	−	CGGCGCCCCAGCAGCCCACGGCG	23	5894
SCNN1A-2046	−	GCGGCGCCCCAGCAGCCCACGGCG	24	5895
SCNN1A-2047	−	GGAGAAUGUGGGCGCAGG	18	5896
SCNN1A-2048	−	GGGAGAAUGUGGGCGCAGG	19	5897
SCNN1A-2049	−	UGGGAGAAUGUGGGCGCAGG	20	5898
SCNN1A-2050	−	AGCAGCCCACGGCGGAGG	18	5899
SCNN1A-2051	−	CAGCAGCCCACGGCGGAGG	19	5900
SCNN1A-23		CCAGCAGCCCACGGCGGAGG	20	566
SCNN1A-2052	−	CCCAGCAGCCCACGGCGGAGG	21	5901
SCNN1A-2053	−	CCCCAGCAGCCCACGGCGGAGG	22	5902
SCNN1A-2054	−	GCCCCAGCAGCCCACGGCGGAGG	23	5903
SCNN1A-2055	−	CGCCCCAGCAGCCCACGGCGGAGG	24	5904
SCNN1A-2056	−	CGCCCCAGCAGCCCACGG	18	5905
SCNN1A-2057	−	GCGCCCCAGCAGCCCACGG	19	5906
SCNN1A-21		GGCGCCCCAGCAGCCCACGG	20	510
SCNN1A-2058	−	CGGCGCCCCAGCAGCCCACGG	21	5907
SCNN1A-2059	−	GCGGCGCCCCAGCAGCCCACGG	22	5908
SCNN1A-2060	−	UGCGGCGCCCCAGCAGCCCACGG	23	5909
SCNN1A-2061	−	CUGCGGCGCCCCAGCAGCCCACGG	24	5910
SCNN1A-2062	−	CCCAGCAGCCCACGGCGG	18	5911
SCNN1A-2063	−	CCCCAGCAGCCCACGGCGG	19	5912
SCNN1A-22	−	GCCCCAGCAGCCCACGGCGG	20	511
SCNN1A-2064	−	CGCCCCAGCAGCCCACGGCGG	21	5913
SCNN1A-2065	−	GCGCCCCAGCAGCCCACGGCGG	22	5914
SCNN1A-2066	−	GGCGCCCCAGCAGCCCACGGCGG	23	5915
SCNN1A-2067	−	CGGCGCCCCAGCAGCCCACGGCGG	24	5916
SCNN1A-2068	−	GAGAAUGUGGGCGCAGGG	18	5917
SCNN1A-2069	−	GGAGAAUGUGGGCGCAGGG	19	5918
SCNN1A-354	−	GGGAGAAUGUGGGCGCAGGG	20	4203
SCNN1A-2070	−	UGGGAGAAUGUGGGCGCAGGG	21	5919
SCNN1A-2071	−	GUGGGAGAAUGUGGGCGCAGGG	22	5920
SCNN1A-2072	−	AGUGGGAGAAUGUGGGCGCAGGG	23	5921
SCNN1A-2073	−	GAGUGGGAGAAUGUGGGCGCAGGG	24	5922
SCNN1A-2074	−	AAGCGUGAGGAGCAGGGG	18	5923
SCNN1A-2075	−	CAAGCGUGAGGAGCAGGGG	19	5924
SCNN1A-181		ACAAGCGUGAGGAGCAGGGG	20	814
SCNN1A-2076	−	AACAAGCGUGAGGAGCAGGGG	21	5925
SCNN1A-2077	−	GAACAAGCGUGAGGAGCAGGGG	22	5926
SCNN1A-2078	−	GGAACAAGCGUGAGGAGCAGGGG	23	5927
SCNN1A-2079	−	GGGAACAAGCGUGAGGAGCAGGGG	24	5928
SCNN1A-2080	−	CCAUACCAGGUCUCAUGG	18	5929
SCNN1A-2081	−	CCCAUACCAGGUCUCAUGG	19	5930
SCNN1A-2	−	GCCCAUACCAGGUCUCAUGG	20	497
SCNN1A-2082	−	AGCCCAUACCAGGUCUCAUGG	21	5931
SCNN1A-2083	−	CAGCCCAUACCAGGUCUCAUGG	22	5932
SCNN1A-2084	−	GCAGCCCAUACCAGGUCUCAUGG	23	5933
SCNN1A-2085	−	UGCAGCCCAUACCAGGUCUCAUGG	24	5934
SCNN1A-2086	−	GGGUUCCAGGGGUGAUGG	18	5935
SCNN1A-2087	−	CGGGUUCCAGGGGUGAUGG	19	5936
SCNN1A-2088	−	UCGGGUUCCAGGGGUGAUGG	20	5937
SCNN1A-2089	−	CUCGGGUUCCAGGGGUGAUGG	21	5938
SCNN1A-2090	−	ACUCGGGUUCCAGGGGUGAUGG	22	5939
SCNN1A-2091	−	CACUCGGGUUCCAGGGGUGAUGG	23	5940
SCNN1A-2092	−	UCACUCGGGUUCCAGGGGUGAUGG	24	5941
SCNN1A-2093	−	UGAAGGGGAACAAGCUGG	18	5942
SCNN1A-2094	−	AUGAAGGGGAACAAGCUGG	19	5943
SCNN1A-455	−	CAUGAAGGGGAACAAGCUGG	20	4304
SCNN1A-2095	−	UCAUGAAGGGGAACAAGCUGG	21	5944
SCNN1A-2096	−	CUCAUGAAGGGGAACAAGCUGG	22	5945
SCNN1A-2097	−	GCUCAUGAAGGGGAACAAGCUGG	23	5946
SCNN1A-2098	−	GGCUCAUGAAGGGGAACAAGCUGG	24	5947
SCNN1A-2099	−	UGGAGGGGAACAAGCUGG	18	5948
SCNN1A-2100	−	AUGGAGGGGAACAAGCUGG	19	5949
SCNN1A-6	−	CAUGGAGGGGAACAAGCUGG	20	558
SCNN1A-2101	−	UCAUGGAGGGGAACAAGCUGG	21	5950
SCNN1A-2102	−	CUCAUGGAGGGGAACAAGCUGG	22	5951
SCNN1A-2103	−	UCUCAUGGAGGGGAACAAGCUGG	23	5952
SCNN1A-2104	−	GUCUCAUGGAGGGGAACAAGCUGG	24	5953
SCNN1A-2105	−	UCCACUCCAGGGCUCAUG	18	5954
SCNN1A-2106	−	GUCCACUCCAGGGCUCAUG	19	5955
SCNN1A-172	−	AGUCCACUCCAGGGCUCAUG	20	810
SCNN1A-2107	−	CAGUCCACUCCAGGGCUCAUG	21	5956
SCNN1A-2108	−	ACAGUCCACUCCAGGGCUCAUG	22	5957
SCNN1A-2109	−	CACAGUCCACUCCAGGGCUCAUG	23	5958
SCNN1A-2110	−	CCACAGUCCACUCCAGGGCUCAUG	24	5959
SCNN1A-2111	−	UCCACUCCGGGGCUCAUG	18	5960
SCNN1A-2112	−	AUCCACUCCGGGGCUCAUG	19	5961
SCNN1A-2113	−	AAUCCACUCCGGGGCUCAUG	20	5962
SCNN1A-2114	−	CAAUCCACUCCGGGGCUCAUG	21	5963
SCNN1A-2115	−	CCAAUCCACUCCGGGGCUCAUG	22	5964
SCNN1A-2116	−	CCCAAUCCACUCCGGGGCUCAUG	23	5965
SCNN1A-2117	−	CCCCAAUCCACUCCGGGGCUCAUG	24	5966
SCNN1A-2118	−	CCCAUACCAGGUCUCAUG	18	5967
SCNN1A-2119	−	GCCCAUACCAGGUCUCAUG	19	5968
SCNN1A-161	−	AGCCCAUACCAGGUCUCAUG	20	804
SCNN1A-2120	−	CAGCCCAUACCAGGUCUCAUG	21	5969
SCNN1A-2121	−	GCAGCCCAUACCAGGUCUCAUG	22	5970
SCNN1A-2122	−	UGCAGCCCAUACCAGGUCUCAUG	23	5971
SCNN1A-2123	−	CUGCAGCCCAUACCAGGUCUCAUG	24	5972
SCNN1A-2124	−	AUGAAGGGGAACAAGCUG	18	5973
SCNN1A-2125	−	CAUGAAGGGGAACAAGCUG	19	5974
SCNN1A-2126	−	UCAUGAAGGGGAACAAGCUG	20	5975
SCNN1A-2127	−	CUCAUGAAGGGGAACAAGCUG	21	5976
SCNN1A-2128	−	GCUCAUGAAGGGGAACAAGCUG	22	5977
SCNN1A-2129	−	GGCUCAUGAAGGGGAACAAGCUG	23	5978
SCNN1A-2130	−	GGGCUCAUGAAGGGGAACAAGCUG	24	5979
SCNN1A-2131	−	AUGGAGGGGAACAAGCUG	18	5980
SCNN1A-2132	−	CAUGGAGGGGAACAAGCUG	19	5981
SCNN1A-167	−	UCAUGGAGGGGAACAAGCUG	20	806
SCNN1A-2133	−	CUCAUGGAGGGGAACAAGCUG	21	5982
SCNN1A-2134	−	UCUCAUGGAGGGGAACAAGCUG	22	5983
SCNN1A-2135	−	GUCUCAUGGAGGGGAACAAGCUG	23	5984
SCNN1A-2136	−	GGUCUCAUGGAGGGGAACAAGCUG	24	5985
SCNN1A-2137	−	UGAAGGGGAACAAGCGUG	18	5986
SCNN1A-2138	−	AUGAAGGGGAACAAGCGUG	19	5987
SCNN1A-13	−	CAUGAAGGGGAACAAGCGUG	20	562
SCNN1A-2139	−	UCAUGAAGGGGAACAAGCGUG	21	5988
SCNN1A-2140	−	CUCAUGAAGGGGAACAAGCGUG	22	5989
SCNN1A-2141	−	GCUCAUGAAGGGGAACAAGCGUG	23	5990
SCNN1A-2142	−	GGCUCAUGAAGGGGAACAAGCGUG	24	5991
SCNN1A-2143	−	ACUCGGGUUCCAGGGGUG	18	5992
SCNN1A-2144	−	CACUCGGGUUCCAGGGGUG	19	5993
SCNN1A-2145	−	UCACUCGGGUUCCAGGGGUG	20	5994
SCNN1A-2146	−	CUCACUCGGGUUCCAGGGGUG	21	5995
SCNN1A-2147	−	CCUCACUCGGGUUCCAGGGGUG	22	5996
SCNN1A-2148	−	GCCUCACUCGGGUUCCAGGGGUG	23	5997
SCNN1A-2149	−	AGCCUCACUCGGGUUCCAGGGGUG	24	5998
SCNN1A-2150	−	UCGGGUUCCAGGGGUGAU	18	5999
SCNN1A-2151	−	CUCGGGUUCCAGGGGUGAU	19	6000
SCNN1A-421	−	ACUCGGGUUCCAGGGGUGAU	20	4270
SCNN1A-2152	−	CACUCGGGUUCCAGGGGUGAU	21	6001
SCNN1A-2153	−	UCACUCGGGUUCCAGGGGUGAU	22	6002
SCNN1A-2154	−	CUCACUCGGGUUCCAGGGGUGAU	23	6003
SCNN1A-2155	−	CCUCACUCGGGUUCCAGGGGUGAU	24	6004
SCNN1A-2156	−	UGCUCUCCCCAAUCCACU	18	6005
SCNN1A-2157	−	UUGCUCUCCCCAAUCCACU	19	6006
SCNN1A-2158	−	CUUGCUCUCCCCAAUCCACU	20	6007
SCNN1A-2159	−	CCUUGCUCUCCCCAAUCCACU	21	6008
SCNN1A-2160	−	CCCUUGCUCUCCCCAAUCCACU	22	6009
SCNN1A-2161	−	ACCCUUGCUCUCCCCAAUCCACU	23	6010
SCNN1A-2162	−	GACCCUUGCUCUCCCCAAUCCACU	24	6011
SCNN1A-2163	−	GUGAUGGGAGAGGGCACU	18	6012
SCNN1A-2164	−	GGUGAUGGGAGAGGGCACU	19	6013
SCNN1A-2165	−	GGGUGAUGGGAGAGGGCACU	20	6014
SCNN1A-2166	−	GGGGUGAUGGGAGAGGGCACU	21	6015
SCNN1A-2167	−	AGGGGUGAUGGGAGAGGGCACU	22	6016
SCNN1A-2168	−	CAGGGGUGAUGGGAGAGGGCACU	23	6017
SCNN1A-2169	−	CCAGGGGUGAUGGGAGAGGGCACU	24	6018
SCNN1A-2170	−	AUGAAGGGGAACAAGCGU	18	6019
SCNN1A-2171	−	CAUGAAGGGGAACAAGCGU	19	6020
SCNN1A-177	−	UCAUGAAGGGGAACAAGCGU	20	812
SCNN1A-2172	−	CUCAUGAAGGGGAACAAGCGU	21	6021
SCNN1A-2173	−	GCUCAUGAAGGGGAACAAGCGU	22	6022
SCNN1A-2174	−	GGCUCAUGAAGGGGAACAAGCGU	23	6023
SCNN1A-2175	−	GGGCUCAUGAAGGGGAACAAGCGU	24	6024
SCNN1A-2176	−	UAAGCAAGGGAACCUGGU	18	6025
SCNN1A-2177	−	GUAAGCAAGGGAACCUGGU	19	6026
SCNN1A-2178	−	GGUAAGCAAGGGAACCUGGU	20	6027
SCNN1A-2179	−	AGGUAAGCAAGGGAACCUGGU	21	6028
SCNN1A-2180	−	AAGGUAAGCAAGGGAACCUGGU	22	6029
SCNN1A-2181	−	CAAGGUAAGCAAGGGAACCUGGU	23	6030
SCNN1A-2182	−	UCAAGGUAAGCAAGGGAACCUGGU	24	6031
SCNN1A-2183	−	CCGCAUGAAGACGGCCUU	18	6032
SCNN1A-2184	−	ACCGCAUGAAGACGGCCUU	19	6033
SCNN1A-194	−	AACCGCAUGAAGACGGCCUU	20	824
SCNN1A-2185	−	CAACCGCAUGAAGACGGCCUU	21	6034
SCNN1A-2186	−	ACAACCGCAUGAAGACGGCCUU	22	6035
SCNN1A-2187	−	CACAACCGCAUGAAGACGGCCUU	23	6036
SCNN1A-2188	−	GCACAACCGCAUGAAGACGGCCUU	24	6037
SCNN1A-2189	−	GGCAAUUCGGCCUGCUUU	18	6038
SCNN1A-2190	−	UGGCAAUUCGGCCUGCUUU	19	6039
SCNN1A-195	−	CUGGCAAUUCGGCCUGCUUU	20	825
SCNN1A-2191	−	ACUGGCAAUUCGGCCUGCUUU	21	6040
SCNN1A-2192	−	UACUGGCAAUUCGGCCUGCUUU	22	6041
SCNN1A-2193	−	GUACUGGCAAUUCGGCCUGCUUU	23	6042
SCNN1A-2194	−	UGUACUGGCAAUUCGGCCUGCUUU	24	6043
SCNN1A-2195	−	GCAAUUCGGCCUGCUUUU	18	6044
SCNN1A-2196	−	GGCAAUUCGGCCUGCUUUU	19	6045
SCNN1A-34	−	UGGCAAUUCGGCCUGCUUUU	20	573
SCNN1A-2197	−	CUGGCAAUUCGGCCUGCUUUU	21	6046
SCNN1A-2198	−	ACUGGCAAUUCGGCCUGCUUUU	22	6047
SCNN1A-2199	−	UACUGGCAAUUCGGCCUGCUUUU	23	6048
SCNN1A-2200	−	GUACUGGCAAUUCGGCCUGCUUUU	24	6049

Table 44E provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fifth tier parameters. The targeting domains fall in the coding sequence of the gene, downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon of the gene), starts with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-2201	+	GUACCUGAAGGGGCGAGGGGAA	22	6050
SCNN1A-2202	+	GGUACCUGAAGGGGCGAGGGGAA	23	6051
SCNN1A-2203	+	GGGUACCUGAAGGGGCGAGGGGAA	24	6052
SCNN1A-2204	+	GGGACAAGGACAGAGACA	18	6053
SCNN1A-2205	+	GCUGGGACAAGGACAGAGACA	21	6054
SCNN1A-2206	+	GGCUGGGACAAGGACAGAGACA	22	6055
SCNN1A-2207	+	GUAUAGCAGUUUCCAUACA	19	6056
SCNN1A-2208	+	GAAAGUAUAGCAGUUUCCAUACA	23	6057
SCNN1A-2209	+	GGACCCUCAGGCGCUGCA	18	6058
SCNN1A-2210	+	GGGACCCUCAGGCGCUGCA	19	6059
SCNN1A-2211	+	GCGGGACCCUCAGGCGCUGCA	21	6060
SCNN1A-2212	+	GGCGGGACCCUCAGGCGCUGCA	22	6061
SCNN1A-2213	+	GGGCGGGACCCUCAGGCGCUGCA	23	6062
SCNN1A-2214	+	GGGGCGGGACCCUCAGGCGCUGCA	24	6063
SCNN1A-2215	+	GUAAUUCCUUAUCAGGAAAGA	21	6064
SCNN1A-2216	+	GAGUAAUUCCUUAUCAGGAAAGA	23	6065
SCNN1A-2217	+	GAGUCUCUGGCAGCCUCGA	19	6066
SCNN1A-2218	+	GCAGAGUCUCUGGCAGCCUCGA	22	6067
SCNN1A-2219	+	GGCAGAGUCUCUGGCAGCCUCGA	23	6068
SCNN1A-2220	+	GCUCUCCUGGAAGCAGGA	18	6069
SCNN1A-2221	+	GAUCAUGCUCUCCUGGAAGCAGGA	24	6070
SCNN1A-2222	+	GAAGACCCAUUCCUAGGA	18	6071
SCNN1A-2223	+	GGAAGACCCAUUCCUAGGA	19	6072
SCNN1A-2224	+	GCUGCGGGAGCCGGCCAC	18	6073
SCNN1A-2225	+	GGCUGCGGGAGCCGGCCAC	19	6074
SCNN1A-2226	+	GACGGCUGCGGGAGCCGGCCAC	22	6075
SCNN1A-2227	+	GCGACGGCUGCGGGAGCCGGCCAC	24	6076
SCNN1A-2228	+	GUUGCACUGGACACAGAGAC	20	6077
SCNN1A-2229	+	GGUUGCACUGGACACAGAGAC	21	6078
SCNN1A-2230	+	GCCCCCUGGAGAUGGGCGGGGGCC	24	6079
SCNN1A-2231	+	GUACUCCACGUUCUGGGGCC	20	6080
SCNN1A-2232	+	GCCCAGCGUGUCCUCCUCC	19	6081
SCNN1A-2233	+	GUUGCCCAGCGUGUCCUCCUCC	22	6082
SCNN1A-1051	+	GAUCAUGCUCUCCUGGAAGC	20	4900
SCNN1A-2234	+	GGAAGGAGGGGAGGAUGC	18	6083
SCNN1A-2235	+	GGGAAGGAGGGGAGGAUGC	19	6084
SCNN1A-2236	+	GUGGGAAGGAGGGGAGGAUGC	21	6085
SCNN1A-2237	+	GAAGUGGGAAGGAGGGGAGGAUGC	24	6086
SCNN1A-2238	+	GAUGUCACCGAGGGCCAUC	19	6087
SCNN1A-2239	+	GGAUGUCACCGAGGGCCAUC	20	6088
SCNN1A-2240	+	GGGAUGUCACCGAGGGCCAUC	21	6089
SCNN1A-2241	+	GCCAUAAUCGCCCCCAAGUCUGUC	24	6090
SCNN1A-2242	+	GCUGCCCAGGUUGGACAG	18	6091
SCNN1A-2243	+	GGCUGCCCAGGUUGGACAG	19	6092
SCNN1A-2244	+	GCCCCAGUCACUGUGGACAGCAG	23	6093
SCNN1A-2245	+	GGCCCCAGUCACUGUGGACAGCAG	24	6094
SCNN1A-2246	+	GACCUAGGGGUGCAGAGAGAG	21	6095
SCNN1A-2247	+	GAAUACACACCUGGAAGGGAG	21	6096
SCNN1A-2248	+	GUGAAUACACACCUGGAAGGGAG	23	6097
SCNN1A-2249	+	GCGCUGCAAGGGGUGCGG	18	6098
SCNN1A-2250	+	GGCGCUGCAAGGGGUGCGG	19	6099
SCNN1A-2251	+	GCAGAAGUGGGAAGGAGGG	19	6100
SCNN1A-2252	+	GGCAGAAGUGGGAAGGAGGG	20	6101
SCNN1A-2253	+	GGGCAGAAGUGGGAAGGAGGG	21	6102
SCNN1A-2254	+	GGGGCAGAAGUGGGAAGGAGGG	22	6103
SCNN1A-2255	+	GGGGGCAGAAGUGGGAAGGAGGG	23	6104
SCNN1A-2256	+	GUCCUCCUCCAGGGAUGG	18	6105
SCNN1A-2257	+	GUGUCCUCCUCCAGGGAUGG	20	6106
SCNN1A-2258	+	GCGUGUCCUCCUCCAGGGAUGG	22	6107
SCNN1A-2259	+	GCCUCACCUGCUGUGUGUACUUUG	24	6108
SCNN1A-2260	+	GACCCAUUCCUAGGAAAGAAU	21	6109
SCNN1A-2261	+	GAAGACCCAUUCCUAGGAAAGAAU	24	6110
SCNN1A-2262	+	GACCUACCGUGACAGAGGGAGACU	24	6111
SCNN1A-1263	+	GCAGCAUCAGGGACAGACCU	20	5112
SCNN1A-2263	+	GCGCAGCAUCAGGGACAGACCU	22	6112
SCNN1A-2264	+	GCGCGCAGCAUCAGGGACAGACCU	24	6113
SCNN1A-2265	+	GCUUAUAGUAGCAGUACCCU	20	6114
SCNN1A-2266	+	GAGCUUAUAGUAGCAGUACCCU	22	6115
SCNN1A-2267	+	GGAGCUUAUAGUAGCAGUACCCU	23	6116
SCNN1A-2268	+	GCUGGUAGCUGGUCACGCU	19	6117
SCNN1A-2269	+	GAGCUGGUAGCUGGUCACGCU	21	6118
SCNN1A-2270	+	GAGAGCUGGUAGCUGGUCACGCU	23	6119
SCNN1A-2271	+	GCAUGGAAGACAUCCAGAGGU	21	6120
SCNN1A-2272	+	GGCAUGGAAGACAUCCAGAGGU	22	6121
SCNN1A-2273	+	GCUCCUCCAGCUCCUCUUUAAUUU	24	6122
SCNN1A-2274	−	GGCAUCUCUCUGUACCCA	18	6123
SCNN1A-2275	−	GAACAGGCAUCUCUCUGUACCCA	23	6124
SCNN1A-2276	−	GCUUCCAGGAGAGCAUGAUCA	21	6125
SCNN1A-2277	−	GACACCCCCAUUCUUUCCUAGGA	23	6126
SCNN1A-2278	−	GACAUCCCAGGUAGAGUGUGGGGA	24	6127
SCNN1A-2279	−	GACCCUACUCUCUCUUUCCUGAUA	24	6128
SCNN1A-2280	−	GAUUAUGGCGACUGCACC	18	6129
SCNN1A-2281	−	GCGAUUAUGGCGACUGCACC	20	6130
SCNN1A-2282	−	GGCGAUUAUGGCGACUGCACC	21	6131
SCNN1A-2283	−	GGGCGAUUAUGGCGACUGCACC	22	6132
SCNN1A-2284	−	GGGGCGAUUAUGGCGACUGCACC	23	6133
SCNN1A-2285	−	GGGGGCGAUUAUGGCGACUGCACC	24	6134
SCNN1A-2286	−	GCAGGUUAGUGUCCCCUUCC	20	6135
SCNN1A-2287	−	GACUACAGAAAGCACAGUUCC	21	6136
SCNN1A-2288	−	GUGACUACAGAAAGCACAGUUCC	23	6137
SCNN1A-2289	−	GACCUCCAUCAGCAUGAGGAAGGC	24	6138
SCNN1A-2290	−	GGUCUCCUGCAACCAGGC	18	6139
SCNN1A-2291	−	GUCUCCAGGCCGAGGGGGC	19	6140
SCNN1A-1073	−	GGUCUCCAGGCCGAGGGGGC	20	4922
SCNN1A-2292	−	GUCCACAGUGACUGGGGC	18	6141
SCNN1A-2293	−	GCUGUCCACAGUGACUGGGGC	21	6142
SCNN1A-2294	−	GCUUCUACCAGACAUACUCAUC	22	6143
SCNN1A-2295	−	GUCCCUGAUGCUGCGCGCAGAG	22	6144
SCNN1A-2296	−	GCCCUCGGUGACAUCCCAGG	20	6145
SCNN1A-2297	−	GGCCCUCGGUGACAUCCCAGG	21	6146
SCNN1A-2298	−	GAUGGCCCUCGGUGACAUCCCAGG	24	6147
SCNN1A-2299	−	GUAGAGUGUGGGGAAGGG	18	6148
SCNN1A-2300	−	GGUAGAGUGUGGGGAAGGG	19	6149
SCNN1A-2301	−	GCCCGGGUAAUGGUGCACGGG	21	6150
SCNN1A-2302	−	GGCCCGGGUAAUGGUGCACGGG	22	6151
SCNN1A-2303	−	GGGCCCGGGUAAUGGUGCACGGG	23	6152
SCNN1A-2304	−	GGGGCCCGGGUAAUGGUGCACGGG	24	6153
SCNN1A-2305	−	GUGGGGAAGGGAUGGGUG	18	6154
SCNN1A-1236	−	GUGUGGGGAAGGGAUGGGUG	20	5085
SCNN1A-2306	−	GAGUGUGGGGAAGGGAUGGGUG	22	6155
SCNN1A-2307	−	GACAAGAACAACUCCAACCU	20	6156
SCNN1A-2308	−	GCACCCCUUGCAGCGCCU	18	6157
SCNN1A-2309	−	GCCGCACCCCUUGCAGCGCCU	21	6158
SCNN1A-2310	−	GACACCCCCAUUCUUUCCU	19	6159
SCNN1A-2311	−	GAUGACACCCCCAUUCUUUCCU	22	6160
SCNN1A-2312	−	GCUGAACUACAAAACCAAUU	20	6161
SCNN1A-2313	−	GAGCUGAACUACAAAACCAAUU	22	6162
SCNN1A-2314	−	GGAGCUGAACUACAAAACCAAUU	23	6163
SCNN1A-2315	−	GCAGGAUGAACCUGCCUUU	19	6164
SCNN1A-2316	−	GGCAGGAUGAACCUGCCUUU	20	6165
SCNN1A-2317	−	GGGCAGGAUGAACCUGCCUUU	21	6166

Table 44F provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the six tier parameters. The targeting domains fall in the coding sequence of the gene, downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon of the gene) and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44F
6th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-2318	+	CUGAAGGGGCGAGGGGAA	18	6167
SCNN1A-2319	+	CCUGAAGGGGCGAGGGGAA	19	6168
SCNN1A-2320	+	ACCUGAAGGGGCGAGGGGAA	20	6169
SCNN1A-2321	+	UACCUGAAGGGGCGAGGGGAA	21	6170
SCNN1A-2322	+	UGGGACAAGGACAGAGACA	19	6171
SCNN1A-899	+	CUGGGACAAGGACAGAGACA	20	4748
SCNN1A-2323	+	UGGCUGGGACAAGGACAGAGACA	23	6172
SCNN1A-2324	+	CUGGCUGGGACAAGGACAGAGACA	24	6173
SCNN1A-2325	+	UAUAGCAGUUUCCAUACA	18	6174
SCNN1A-2326	+	AGUAUAGCAGUUUCCAUACA	20	6175
SCNN1A-2327	+	AAGUAUAGCAGUUUCCAUACA	21	6176
SCNN1A-2328	+	AAAGUAUAGCAGUUUCCAUACA	22	6177
SCNN1A-2329	+	UGAAAGUAUAGCAGUUUCCAUACA	24	6178
SCNN1A-2330	+	UUUCUUAGGUGUGGGGCA	18	6179
SCNN1A-2331	+	AUUUCUUAGGUGUGGGGCA	19	6180
SCNN1A-2332	+	CAUUUCUUAGGUGUGGGGCA	20	6181
SCNN1A-2333	+	CCAUUUCUUAGGUGUGGGGCA	21	6182
SCNN1A-2334	+	UCCAUUUCUUAGGUGUGGGGCA	22	6183
SCNN1A-2335	+	CUCCAUUUCUUAGGUGUGGGGCA	23	6184
SCNN1A-2336	+	ACUCCAUUUCUUAGGUGUGGGGCA	24	6185
SCNN1A-917	+	CGGGACCCUCAGGCGCUGCA	20	4766
SCNN1A-2337	+	AUUCCUUAUCAGGAAAGA	18	6186
SCNN1A-2338	+	AAUUCCUUAUCAGGAAAGA	19	6187
SCNN1A-2339	+	UAAUUCCUUAUCAGGAAAGA	20	6188
SCNN1A-2340	+	AGUAAUUCCUUAUCAGGAAAGA	22	6189
SCNN1A-2341	+	AGAGUAAUUCCUUAUCAGGAAAGA	24	6190
SCNN1A-2342	+	AGUCUCUGGCAGCCUCGA	18	6191
SCNN1A-2343	+	AGAGUCUCUGGCAGCCUCGA	20	6192
SCNN1A-2344	+	CAGAGUCUCUGGCAGCCUCGA	21	6193
SCNN1A-2345	+	UGGCAGAGUCUCUGGCAGCCUCGA	24	6194
SCNN1A-2346	+	UGCUCUCCUGGAAGCAGGA	19	6195
SCNN1A-2347	+	AUGCUCUCCUGGAAGCAGGA	20	6196
SCNN1A-2348	+	CAUGCUCUCCUGGAAGCAGGA	21	6197
SCNN1A-2349	+	UCAUGCUCUCCUGGAAGCAGGA	22	6198
SCNN1A-2350	+	AUCAUGCUCUCCUGGAAGCAGGA	23	6199
SCNN1A-2351	+	UGGAAGACCCAUUCCUAGGA	20	6200
SCNN1A-2352	+	CUGGAAGACCCAUUCCUAGGA	21	6201
SCNN1A-2353	+	UCUGGAAGACCCAUUCCUAGGA	22	6202
SCNN1A-2354	+	AUCUGGAAGACCCAUUCCUAGGA	23	6203
SCNN1A-2355	+	CAUCUGGAAGACCCAUUCCUAGGA	24	6204
SCNN1A-2356	+	CGGCUGCGGGAGCCGGCCAC	20	6205
SCNN1A-2357	+	ACGGCUGCGGGAGCCGGCCAC	21	6206
SCNN1A-2358	+	CGACGGCUGCGGGAGCCGGCCAC	23	6207
SCNN1A-2359	+	UGCACUGGACACAGAGAC	18	6208
SCNN1A-2360	+	UUGCACUGGACACAGAGAC	19	6209
SCNN1A-2361	+	UGGUUGCACUGGACACAGAGAC	22	6210
SCNN1A-2362	+	CUGGUUGCACUGGACACAGAGAC	23	6211
SCNN1A-2363	+	UCUGGUUGCACUGGACACAGAGAC	24	6212
SCNN1A-2364	+	CCUUCCCCACACUCUACC	18	6213
SCNN1A-2365	+	CCCUUCCCCACACUCUACC	19	6214
SCNN1A-1006	+	UCCCUUCCCCACACUCUACC	20	4855
SCNN1A-2366	+	AUCCCUUCCCCACACUCUACC	21	6215
SCNN1A-2367	+	CAUCCCUUCCCCACACUCUACC	22	6216
SCNN1A-2368	+	CCAUCCCUUCCCCACACUCUACC	23	6217
SCNN1A-2369	+	CCCAUCCCUUCCCCACACUCUACC	24	6218
SCNN1A-2370	+	UGGAGAUGGGCGGGGGCC	18	6219
SCNN1A-2371	+	CUGGAGAUGGGCGGGGGCC	19	6220
SCNN1A-2372	+	CCUGGAGAUGGGCGGGGGCC	20	6221
SCNN1A-2373	+	CCCUGGAGAUGGGCGGGGGCC	21	6222
SCNN1A-2374	+	CCCCUGGAGAUGGGCGGGGGCC	22	6223
SCNN1A-2375	+	CCCCCUGGAGAUGGGCGGGGGCC	23	6224
SCNN1A-2376	+	ACUCCACGUUCUGGGGCC	18	6225
SCNN1A-2377	+	UACUCCACGUUCUGGGGCC	19	6226
SCNN1A-2378	+	AGUACUCCACGUUCUGGGGCC	21	6227
SCNN1A-2379	+	CAGUACUCCACGUUCUGGGGCC	22	6228
SCNN1A-2380	+	ACAGUACUCCACGUUCUGGGGCC	23	6229
SCNN1A-2381	+	CACAGUACUCCACGUUCUGGGGCC	24	6230
SCNN1A-2382	+	CCCAGCGUGUCCUCCUCC	18	6231
SCNN1A-1038	+	UGCCCAGCGUGUCCUCCUCC	20	4887
SCNN1A-2383	+	UUGCCCAGCGUGUCCUCCUCC	21	6232
SCNN1A-2384	+	AGUUGCCCAGCGUGUCCUCCUCC	23	6233
SCNN1A-2385	+	AAGUUGCCCAGCGUGUCCUCCUCC	24	6234
SCNN1A-2386	+	UCAUGCUCUCCUGGAAGC	18	6235
SCNN1A-2387	+	AUCAUGCUCUCCUGGAAGC	19	6236
SCNN1A-2388	+	UGAUCAUGCUCUCCUGGAAGC	21	6237
SCNN1A-2389	+	UUGAUCAUGCUCUCCUGGAAGC	22	6238
SCNN1A-2390	+	CUUGAUCAUGCUCUCCUGGAAGC	23	6239
SCNN1A-2391	+	CCUUGAUCAUGCUCUCCUGGAAGC	24	6240
SCNN1A-2392	+	UGGGAAGGAGGGGAGGAUGC	20	6241
SCNN1A-2393	+	AGUGGGAAGGAGGGGAGGAUGC	22	6242
SCNN1A-2394	+	AAGUGGGAAGGAGGGGAGGAUGC	23	6243
SCNN1A-2395	+	AUGUCACCGAGGGCCAUC	18	6244
SCNN1A-2396	+	UGGGAUGUCACCGAGGGCCAUC	22	6245
SCNN1A-2397	+	CUGGGAUGUCACCGAGGGCCAUC	23	6246
SCNN1A-2398	+	CCUGGGAUGUCACCGAGGGCCAUC	24	6247
SCNN1A-2399	+	AUCGCCCCCAAGUCUGUC	18	6248
SCNN1A-2400	+	AAUCGCCCCCAAGUCUGUC	19	6249
SCNN1A-2401	+	UAAUCGCCCCCAAGUCUGUC	20	6250
SCNN1A-2402	+	AUAAUCGCCCCCAAGUCUGUC	21	6251
SCNN1A-2403	+	CAUAAUCGCCCCCAAGUCUGUC	22	6252
SCNN1A-2404	+	CCAUAAUCGCCCCCAAGUCUGUC	23	6253
SCNN1A-2405	+	UGGCUGCCCAGGUUGGACAG	20	6254
SCNN1A-2406	+	CUGGCUGCCCAGGUUGGACAG	21	6255
SCNN1A-2407	+	ACUGGCUGCCCAGGUUGGACAG	22	6256
SCNN1A-2408	+	CACUGGCUGCCCAGGUUGGACAG	23	6257
SCNN1A-2409	+	CCACUGGCUGCCCAGGUUGGACAG	24	6258
SCNN1A-2410	+	AGUCACUGUGGACAGCAG	18	6259
SCNN1A-2411	+	CAGUCACUGUGGACAGCAG	19	6260
SCNN1A-1119	+	CCAGUCACUGUGGACAGCAG	20	4968
SCNN1A-2412	+	CCCAGUCACUGUGGACAGCAG	21	6261
SCNN1A-2413	+	CCCCAGUCACUGUGGACAGCAG	22	6262
SCNN1A-2414	+	UUAUCAGGAAAGAGAGAG	18	6263
SCNN1A-2415	+	CUUAUCAGGAAAGAGAGAG	19	6264
SCNN1A-2416	+	CCUUAUCAGGAAAGAGAGAG	20	6265
SCNN1A-2417	+	UCCUUAUCAGGAAAGAGAGAG	21	6266
SCNN1A-2418	+	UUCCUUAUCAGGAAAGAGAGAG	22	6267
SCNN1A-2419	+	AUUCCUUAUCAGGAAAGAGAGAG	23	6268
SCNN1A-2420	+	AAUUCCUUAUCAGGAAAGAGAGAG	24	6269
SCNN1A-2421	+	CUAGGGGUGCAGAGAGAG	18	6270
SCNN1A-2422	+	CCUAGGGGUGCAGAGAGAG	19	6271
SCNN1A-2423	+	ACCUAGGGGUGCAGAGAGAG	20	6272
SCNN1A-2424	+	AGACCUAGGGGUGCAGAGAGAG	22	6273
SCNN1A-2425	+	CAGACCUAGGGGUGCAGAGAGAG	23	6274
SCNN1A-2426	+	ACAGACCUAGGGGUGCAGAGAGAG	24	6275
SCNN1A-2427	+	UACACACCUGGAAGGGAG	18	6276
SCNN1A-2428	+	AUACACACCUGGAAGGGAG	19	6277
SCNN1A-2429	+	AAUACACACCUGGAAGGGAG	20	6278
SCNN1A-2430	+	UGAAUACACACCUGGAAGGGAG	22	6279
SCNN1A-2431	+	AGUGAAUACACACCUGGAAGGGAG	24	6280
SCNN1A-2432	+	AGGCGCUGCAAGGGGUGCGG	20	6281
SCNN1A-2433	+	CAGGCGCUGCAAGGGGUGCGG	21	6282
SCNN1A-2434	+	UCAGGCGCUGCAAGGGGUGCGG	22	6283
SCNN1A-2435	+	CUCAGGCGCUGCAAGGGGUGCGG	23	6284
SCNN1A-2436	+	CCUCAGGCGCUGCAAGGGGUGCGG	24	6285
SCNN1A-2437	+	CAGAAGUGGGAAGGAGGG	18	6286
SCNN1A-2438	+	UGGGGGCAGAAGUGGGAAGGAGGG	24	6287
SCNN1A-2439	+	UGUCCUCCUCCAGGGAUGG	19	6288
SCNN1A-2440	+	CGUGUCCUCCUCCAGGGAUGG	21	6289
SCNN1A-2441	+	AGCGUGUCCUCCUCCAGGGAUGG	23	6290
SCNN1A-2442	+	CAGCGUGUCCUCCUCCAGGGAUGG	24	6291
SCNN1A-2443	+	UCACCGCAUCCACCCCUG	18	6292
SCNN1A-2444	+	CUCACCGCAUCCACCCCUG	19	6293
SCNN1A-2445	+	CCUCACCGCAUCCACCCCUG	20	6294
SCNN1A-2446	+	CCCUCACCGCAUCCACCCCUG	21	6295
SCNN1A-2447	+	UCCCUCACCGCAUCCACCCCUG	22	6296
SCNN1A-2448	+	CUCCCUCACCGCAUCCACCCCUG	23	6297
SCNN1A-2449	+	ACUCCCUCACCGCAUCCACCCCUG	24	6298
SCNN1A-2450	+	CCUGCUGUGUGUACUUUG	18	6299
SCNN1A-2451	+	ACCUGCUGUGUGUACUUUG	19	6300
SCNN1A-2452	+	CACCUGCUGUGUGUACUUUG	20	6301
SCNN1A-2453	+	UCACCUGCUGUGUGUACUUUG	21	6302
SCNN1A-2454	+	CUCACCUGCUGUGUGUACUUUG	22	6303
SCNN1A-2455	+	CCUCACCUGCUGUGUGUACUUUG	23	6304
SCNN1A-2456	+	CCAUUCCUAGGAAAGAAU	18	6305
SCNN1A-2457	+	CCCAUUCCUAGGAAAGAAU	19	6306
SCNN1A-1244	+	ACCCAUUCCUAGGAAAGAAU	20	5093
SCNN1A-2458	+	AGACCCAUUCCUAGGAAAGAAU	22	6307
SCNN1A-2459	+	AAGACCCAUUCCUAGGAAAGAAU	23	6308
SCNN1A-2460	+	CCGUGACAGAGGGAGACU	18	6309
SCNN1A-2461	+	ACCGUGACAGAGGGAGACU	19	6310
SCNN1A-2462	+	UACCGUGACAGAGGGAGACU	20	6311
SCNN1A-2463	+	CUACCGUGACAGAGGGAGACU	21	6312
SCNN1A-2464	+	CCUACCGUGACAGAGGGAGACU	22	6313
SCNN1A-2465	+	ACCUACCGUGACAGAGGGAGACU	23	6314
SCNN1A-2466	+	AGUCCUUCCAGUCCACCU	18	6315
SCNN1A-2467	+	CAGUCCUUCCAGUCCACCU	19	6316
SCNN1A-1262	+	CCAGUCCUUCCAGUCCACCU	20	5111
SCNN1A-2468	+	UCCAGUCCUUCCAGUCCACCU	21	6317
SCNN1A-2469	+	UUCCAGUCCUUCCAGUCCACCU	22	6318
SCNN1A-2470	+	CUUCCAGUCCUUCCAGUCCACCU	23	6319
SCNN1A-2471	+	UCUUCCAGUCCUUCCAGUCCACCU	24	6320
SCNN1A-2472	+	AGCAUCAGGGACAGACCU	18	6321
SCNN1A-2473	+	CAGCAUCAGGGACAGACCU	19	6322
SCNN1A-2474	+	CGCAGCAUCAGGGACAGACCU	21	6323
SCNN1A-2475	+	CGCGCAGCAUCAGGGACAGACCU	23	6324
SCNN1A-2476	+	UUAUAGUAGCAGUACCCU	18	6325
SCNN1A-2477	+	CUUAUAGUAGCAGUACCCU	19	6326
SCNN1A-2478	+	AGCUUAUAGUAGCAGUACCCU	21	6327
SCNN1A-2479	+	UGGAGCUUAUAGUAGCAGUACCCU	24	6328
SCNN1A-2480	+	CUGGUAGCUGGUCACGCU	18	6329
SCNN1A-1274	+	AGCUGGUAGCUGGUCACGCU	20	5123
SCNN1A-2481	+	AGAGCUGGUAGCUGGUCACGCU	22	6330
SCNN1A-2482	+	AGAGAGCUGGUAGCUGGUCACGCU	24	6331
SCNN1A-2483	+	ACAUCGGGUGGUGGAAGU	18	6332
SCNN1A-2484	+	UACAUCGGGUGGUGGAAGU	19	6333
SCNN1A-2485	+	AUACAUCGGGUGGUGGAAGU	20	6334
SCNN1A-2486	+	CAUACAUCGGGUGGUGGAAGU	21	6335
SCNN1A-2487	+	CCAUACAUCGGGUGGUGGAAGU	22	6336
SCNN1A-2488	+	UCCAUACAUCGGGUGGUGGAAGU	23	6337
SCNN1A-2489	+	UUCCAUACAUCGGGUGGUGGAAGU	24	6338
SCNN1A-2490	+	UGGAAGACAUCCAGAGGU	18	6339
SCNN1A-2491	+	AUGGAAGACAUCCAGAGGU	19	6340
SCNN1A-1284	+	CAUGGAAGACAUCCAGAGGU	20	5133
SCNN1A-2492	+	AGGCAUGGAAGACAUCCAGAGGU	23	6341
SCNN1A-2493	+	CAGGCAUGGAAGACAUCCAGAGGU	24	6342
SCNN1A-2494	+	CCAGCUCCUCUUUAAUUU	18	6343
SCNN1A-2495	+	UCCAGCUCCUCUUUAAUUU	19	6344
SCNN1A-2496	+	CUCCAGCUCCUCUUUAAUUU	20	6345
SCNN1A-2497	+	CCUCCAGCUCCUCUUUAAUUU	21	6346
SCNN1A-2498	+	UCCUCCAGCUCCUCUUUAAUUU	22	6347
SCNN1A-2499	+	CUCCUCCAGCUCCUCUUUAAUUU	23	6348
SCNN1A-2500	−	UGCCCCACACCUAAGAAA	18	6349
SCNN1A-2501	−	CUGCCCCACACCUAAGAAA	19	6350
SCNN1A-884	−	UCUGCCCCACACCUAAGAAA	20	4733
SCNN1A-2502	−	CUCUGCCCCACACCUAAGAAA	21	6351
SCNN1A-2503	−	CCUCUGCCCCACACCUAAGAAA	22	6352
SCNN1A-2504	−	CCCUCUGCCCCACACCUAAGAAA	23	6353
SCNN1A-2505	−	ACCCUCUGCCCCACACCUAAGAAA	24	6354
SCNN1A-2506	−	AGGCAUCUCUCUGUACCCA	19	6355
SCNN1A-2507	−	CAGGCAUCUCUCUGUACCCA	20	6356
SCNN1A-2508	−	ACAGGCAUCUCUCUGUACCCA	21	6357
SCNN1A-2509	−	AACAGGCAUCUCUCUGUACCCA	22	6358
SCNN1A-2510	−	AGAACAGGCAUCUCUCUGUACCCA	24	6359
SCNN1A-2511	−	UCCAGGAGAGCAUGAUCA	18	6360
SCNN1A-2512	−	UUCCAGGAGAGCAUGAUCA	19	6361
SCNN1A-923	−	CUUCCAGGAGAGCAUGAUCA	20	4772
SCNN1A-2513	−	UGCUUCCAGGAGAGCAUGAUCA	22	6362
SCNN1A-2514	−	CUGCUUCCAGGAGAGCAUGAUCA	23	6363
SCNN1A-2515	−	CCUGCUUCCAGGAGAGCAUGAUCA	24	6364
SCNN1A-2516	−	CCCCAUUCUUUCCUAGGA	18	6365
SCNN1A-2517	−	CCCCCAUUCUUUCCUAGGA	19	6366
SCNN1A-2518	−	ACCCCCAUUCUUUCCUAGGA	20	6367
SCNN1A-2519	−	CACCCCCAUUCUUUCCUAGGA	21	6368
SCNN1A-2520	−	ACACCCCCAUUCUUUCCUAGGA	22	6369
SCNN1A-2521	−	UGACACCCCCAUUCUUUCCUAGGA	24	6370
SCNN1A-2522	−	CCAGGUAGAGUGUGGGGA	18	6371
SCNN1A-2523	−	CCCAGGUAGAGUGUGGGGA	19	6372
SCNN1A-957	−	UCCCAGGUAGAGUGUGGGGA	20	4806
SCNN1A-2524	−	AUCCCAGGUAGAGUGUGGGGA	21	6373
SCNN1A-2525	−	CAUCCCAGGUAGAGUGUGGGGA	22	6374
SCNN1A-2526	−	ACAUCCCAGGUAGAGUGUGGGGA	23	6375
SCNN1A-2527	−	CAGGGGUGGAUGCGGUGA	18	6376
SCNN1A-2528	−	UCAGGGGUGGAUGCGGUGA	19	6377
SCNN1A-967	−	AUCAGGGGUGGAUGCGGUGA	20	4816
SCNN1A-2529	−	CAUCAGGGGUGGAUGCGGUGA	21	6378
SCNN1A-2530	−	UCAUCAGGGGUGGAUGCGGUGA	22	6379
SCNN1A-2531	−	CUCAUCAGGGGUGGAUGCGGUGA	23	6380
SCNN1A-2532	−	ACUCAUCAGGGGUGGAUGCGGUGA	24	6381
SCNN1A-2533	−	ACUCUCUCUUUCCUGAUA	18	6382
SCNN1A-2534	−	UACUCUCUCUUUCCUGAUA	19	6383
SCNN1A-971	−	CUACUCUCUCUUUCCUGAUA	20	4820
SCNN1A-2535	−	CCUACUCUCUCUUUCCUGAUA	21	6384
SCNN1A-2536	−	CCCUACUCUCUCUUUCCUGAUA	22	6385
SCNN1A-2537	−	ACCCUACUCUCUCUUUCCUGAUA	23	6386
SCNN1A-2538	−	CGAUUAUGGCGACUGCACC	19	6387
SCNN1A-2539	−	CUGGAUGUCUUCCAUGCC	18	6388
SCNN1A-2540	−	UCUGGAUGUCUUCCAUGCC	19	6389
SCNN1A-1033	−	CUCUGGAUGUCUUCCAUGCC	20	4882
SCNN1A-2541	−	CCUCUGGAUGUCUUCCAUGCC	21	6390
SCNN1A-2542	−	ACCUCUGGAUGUCUUCCAUGCC	22	6391
SCNN1A-2543	−	AACCUCUGGAUGUCUUCCAUGCC	23	6392
SCNN1A-2544	−	CAACCUCUGGAUGUCUUCCAUGCC	24	6393
SCNN1A-2545	−	AGGUUAGUGUCCCCUUCC	18	6394
SCNN1A-2546	−	CAGGUUAGUGUCCCCUUCC	19	6395
SCNN1A-2547	−	UGCAGGUUAGUGUCCCCUUCC	21	6396
SCNN1A-2548	−	AUGCAGGUUAGUGUCCCCUUCC	22	6397
SCNN1A-2549	−	CAUGCAGGUUAGUGUCCCCUUCC	23	6398
SCNN1A-2550	−	CCAUGCAGGUUAGUGUCCCCUUCC	24	6399
SCNN1A-2551	−	UACAGAAAGCACAGUUCC	18	6400
SCNN1A-2552	−	CUACAGAAAGCACAGUUCC	19	6401
SCNN1A-1047	−	ACUACAGAAAGCACAGUUCC	20	4896
SCNN1A-2553	−	UGACUACAGAAAGCACAGUUCC	22	6402
SCNN1A-2554	−	UGUGACUACAGAAAGCACAGUUCC	24	6403
SCNN1A-2555	−	CAUCAGCAUGAGGAAGGC	18	6404
SCNN1A-2556	−	CCAUCAGCAUGAGGAAGGC	19	6405
SCNN1A-2557	−	UCCAUCAGCAUGAGGAAGGC	20	6406
SCNN1A-2558	−	CUCCAUCAGCAUGAGGAAGGC	21	6407
SCNN1A-2559	−	CCUCCAUCAGCAUGAGGAAGGC	22	6408
SCNN1A-2560	−	ACCUCCAUCAGCAUGAGGAAGGC	23	6409
SCNN1A-2561	−	AGGUCUCCUGCAACCAGGC	19	6410
SCNN1A-2562	−	CAGGUCUCCUGCAACCAGGC	20	6411
SCNN1A-2563	−	CCAGGUCUCCUGCAACCAGGC	21	6412
SCNN1A-2564	−	ACCAGGUCUCCUGCAACCAGGC	22	6413
SCNN1A-2565	−	AACCAGGUCUCCUGCAACCAGGC	23	6414
SCNN1A-2566	−	CAACCAGGUCUCCUGCAACCAGGC	24	6415
SCNN1A-2567	−	UCUCCAGGCCGAGGGGGC	18	6416
SCNN1A-2568	−	UGGUCUCCAGGCCGAGGGGGC	21	6417
SCNN1A-2569	−	CUGGUCUCCAGGCCGAGGGGGC	22	6418
SCNN1A-2570	−	ACUGGUCUCCAGGCCGAGGGGGC	23	6419
SCNN1A-2571	−	UACUGGUCUCCAGGCCGAGGGGGC	24	6420
SCNN1A-2572	−	UGUCCACAGUGACUGGGGC	19	6421
SCNN1A-2573	−	CUGUCCACAGUGACUGGGGC	20	6422
SCNN1A-2574	−	UGCUGUCCACAGUGACUGGGGC	22	6423
SCNN1A-2575	−	CUGCUGUCCACAGUGACUGGGGC	23	6424
SCNN1A-2576	−	CCUGCUGUCCACAGUGACUGGGGC	24	6425
SCNN1A-2577	−	UGUCACGGUAGGUCGUGC	18	6426
SCNN1A-2578	−	CUGUCACGGUAGGUCGUGC	19	6427
SCNN1A-2579	−	UCUGUCACGGUAGGUCGUGC	20	6428
SCNN1A-2580	−	CUCUGUCACGGUAGGUCGUGC	21	6429
SCNN1A-2581	−	CCUCUGUCACGGUAGGUCGUGC	22	6430
SCNN1A-2582	−	CCCUCUGUCACGGUAGGUCGUGC	23	6431
SCNN1A-2583	−	UCCCUCUGUCACGGUAGGUCGUGC	24	6432
SCNN1A-2584	−	CUACCAGACAUACUCAUC	18	6433
SCNN1A-2585	−	UCUACCAGACAUACUCAUC	19	6434
SCNN1A-1091	−	UUCUACCAGACAUACUCAUC	20	4940
SCNN1A-2586	−	CUUCUACCAGACAUACUCAUC	21	6435
SCNN1A-2587	−	UGCUUCUACCAGACAUACUCAUC	23	6436
SCNN1A-2588	−	CUGCUUCUACCAGACAUACUCAUC	24	6437
SCNN1A-2589	−	CUGAUGCUGCGCGCAGAG	18	6438
SCNN1A-2590	−	CCUGAUGCUGCGCGCAGAG	19	6439
SCNN1A-2591	−	CCCUGAUGCUGCGCGCAGAG	20	6440
SCNN1A-2592	−	UCCCUGAUGCUGCGCGCAGAG	21	6441
SCNN1A-2593	−	UGUCCCUGAUGCUGCGCGCAGAG	23	6442
SCNN1A-2594	−	CUGUCCCUGAUGCUGCGCGCAGAG	24	6443
SCNN1A-2595	−	AUCCGCGGCCCCAGAACG	18	6444
SCNN1A-2596	−	UAUCCGCGGCCCCAGAACG	19	6445
SCNN1A-1144	−	CUAUCCGCGGCCCCAGAACG	20	4993
SCNN1A-2597	−	UCUAUCCGCGGCCCCAGAACG	21	6446
SCNN1A-2598	−	UUCUAUCCGCGGCCCCAGAACG	22	6447
SCNN1A-2599	−	CUUCUAUCCGCGGCCCCAGAACG	23	6448
SCNN1A-2600	−	UCUUCUAUCCGCGGCCCCAGAACG	24	6449
SCNN1A-2601	−	CCUCGGUGACAUCCCAGG	18	6450
SCNN1A-2602	−	CCCUCGGUGACAUCCCAGG	19	6451
SCNN1A-2603	−	UGGCCCUCGGUGACAUCCCAGG	22	6452
SCNN1A-2604	−	AUGGCCCUCGGUGACAUCCCAGG	23	6453
SCNN1A-2605	−	AGGUAGAGUGUGGGGAAGGG	20	6454
SCNN1A-2606	−	CAGGUAGAGUGUGGGGAAGGG	21	6455
SCNN1A-2607	−	CCAGGUAGAGUGUGGGGAAGGG	22	6456
SCNN1A-2608	−	CCCAGGUAGAGUGUGGGGAAGGG	23	6457
SCNN1A-2609	−	UCCCAGGUAGAGUGUGGGGAAGGG	24	6458
SCNN1A-2610	−	CAGACAUACUCAUCAGGG	18	6459
SCNN1A-2611	−	CCAGACAUACUCAUCAGGG	19	6460
SCNN1A-2612	−	ACCAGACAUACUCAUCAGGG	20	6461
SCNN1A-2613	−	UACCAGACAUACUCAUCAGGG	21	6462
SCNN1A-2614	−	CUACCAGACAUACUCAUCAGGG	22	6463
SCNN1A-2615	−	UCUACCAGACAUACUCAUCAGGG	23	6464
SCNN1A-2616	−	UUCUACCAGACAUACUCAUCAGGG	24	6465
SCNN1A-2617	−	CGGGUAAUGGUGCACGGG	18	6466
SCNN1A-2618	−	CCGGGUAAUGGUGCACGGG	19	6467
SCNN1A-2619	−	CCCGGGUAAUGGUGCACGGG	20	6468
SCNN1A-2620	−	UGUGGGGAAGGGAUGGGUG	19	6469
SCNN1A-2621	−	AGUGUGGGGAAGGGAUGGGUG	21	6470
SCNN1A-2622	−	AGAGUGUGGGGAAGGGAUGGGUG	23	6471
SCNN1A-2623	−	UAGAGUGUGGGGAAGGGAUGGGUG	24	6472
SCNN1A-2624	−	CAAGAACAACUCCAACCU	18	6473
SCNN1A-2625	−	ACAAGAACAACUCCAACCU	19	6474
SCNN1A-2626	−	UGACAAGAACAACUCCAACCU	21	6475
SCNN1A-2627	−	AUGACAAGAACAACUCCAACCU	22	6476
SCNN1A-2628	−	AAUGACAAGAACAACUCCAACCU	23	6477
SCNN1A-2629	−	CAAUGACAAGAACAACUCCAACCU	24	6478
SCNN1A-2630	−	CGCACCCCUUGCAGCGCCU	19	6479
SCNN1A-2631	−	CCGCACCCCUUGCAGCGCCU	20	6480
SCNN1A-2632	−	UGCCGCACCCCUUGCAGCGCCU	22	6481
SCNN1A-2633	−	CUGCCGCACCCCUUGCAGCGCCU	23	6482
SCNN1A-2634	−	UCUGCCGCACCCCUUGCAGCGCCU	24	6483
SCNN1A-2635	−	ACACCCCCAUUCUUUCCU	18	6484
SCNN1A-1272	−	UGACACCCCCAUUCUUUCCU	20	5121
SCNN1A-2636	−	AUGACACCCCCAUUCUUUCCU	21	6485
SCNN1A-2637	−	UGAUGACACCCCCAUUCUUUCCU	23	6486
SCNN1A-2638	−	UUGAUGACACCCCCAUUCUUUCCU	24	6487
SCNN1A-2639	−	UGAACUACAAAACCAAUU	18	6488
SCNN1A-2640	−	CUGAACUACAAAACCAAUU	19	6489
SCNN1A-2641	−	AGCUGAACUACAAAACCAAUU	21	6490
SCNN1A-2642	−	AGGAGCUGAACUACAAAACCAAUU	24	6491
SCNN1A-2643	−	CAGGAUGAACCUGCCUUU	18	6492
SCNN1A-2644	−	CGGGCAGGAUGAACCUGCCUUU	22	6493
SCNN1A-2645	−	ACGGGCAGGAUGAACCUGCCUUU	23	6494
SCNN1A-2646	−	CACGGGCAGGAUGAACCUGCCUUU	24	6495

Table 44G provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the seven tier parameters. The targeting domains fall in the coding sequence of the gene, downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon of the gene) and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 44G
7th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-2647	+	UAAUUCCUUAUCAGGAAA	18	6496
SCNN1A-2648	+	GUAAUUCCUUAUCAGGAAA	19	6497
SCNN1A-2649	+	AGUAAUUCCUUAUCAGGAAA	20	6498
SCNN1A-2650	+	GAGUAAUUCCUUAUCAGGAAA	21	6499
SCNN1A-2651	+	AGAGUAAUUCCUUAUCAGGAAA	22	6500
SCNN1A-2652	+	GAGAGUAAUUCCUUAUCAGGAAA	23	6501
SCNN1A-2653	+	UGAGAGUAAUUCCUUAUCAGGAAA	24	6502
SCNN1A-2654	+	AAGGGUAAAGGUUCUCAA	18	6503
SCNN1A-2655	+	GAAGGGUAAAGGUUCUCAA	19	6504
SCNN1A-2656	+	UGAAGGGUAAAGGUUCUCAA	20	6505
SCNN1A-2657	+	UUGAAGGGUAAAGGUUCUCAA	21	6506
SCNN1A-2658	+	UUUGAAGGGUAAAGGUUCUCAA	22	6507
SCNN1A-2659	+	CUUUGAAGGGUAAAGGUUCUCAA	23	6508
SCNN1A-2660	+	ACUUUGAAGGGUAAAGGUUCUCAA	24	6509
SCNN1A-2661	+	CCCAUUCCUAGGAAAGAA	18	6510
SCNN1A-2662	+	ACCCAUUCCUAGGAAAGAA	19	6511
SCNN1A-887	+	GACCCAUUCCUAGGAAAGAA	20	4736
SCNN1A-2663	+	AGACCCAUUCCUAGGAAAGAA	21	6512
SCNN1A-2664	+	AAGACCCAUUCCUAGGAAAGAA	22	6513
SCNN1A-2665	+	GAAGACCCAUUCCUAGGAAAGAA	23	6514
SCNN1A-2666	+	GGAAGACCCAUUCCUAGGAAAGAA	24	6515
SCNN1A-2667	+	CAUGGGGUGGGGGCAGAA	18	6516
SCNN1A-2668	+	ACAUGGGGUGGGGGCAGAA	19	6517
SCNN1A-2669	+	GACAUGGGGUGGGGGCAGAA	20	6518
SCNN1A-2670	+	AGACAUGGGGUGGGGGCAGAA	21	6519
SCNN1A-2671	+	GAGACAUGGGGUGGGGGCAGAA	22	6520
SCNN1A-2672	+	AGAGACAUGGGGUGGGGGCAGAA	23	6521
SCNN1A-2673	+	CAGAGACAUGGGGUGGGGGCAGAA	24	6522
SCNN1A-2674	+	GUGAAUACACACCUGGAA	18	6523
SCNN1A-2675	+	AGUGAAUACACACCUGGAA	19	6524
SCNN1A-892	+	GAGUGAAUACACACCUGGAA	20	4741
SCNN1A-2676	+	GGAGUGAAUACACACCUGGAA	21	6525
SCNN1A-2677	+	AGGAGUGAAUACACACCUGGAA	22	6526
SCNN1A-2678	+	CAGGAGUGAAUACACACCUGGAA	23	6527
SCNN1A-2679	+	GCAGGAGUGAAUACACACCUGGAA	24	6528
SCNN1A-2680	+	AUACAUCGGGUGGUGGAA	18	6529
SCNN1A-2681	+	CAUACAUCGGGUGGUGGAA	19	6530
SCNN1A-2682	+	CCAUACAUCGGGUGGUGGAA	20	6531
SCNN1A-2683	+	UCCAUACAUCGGGUGGUGGAA	21	6532
SCNN1A-2684	+	UUCCAUACAUCGGGUGGUGGAA	22	6533
SCNN1A-2685	+	UUUCCAUACAUCGGGUGGUGGAA	23	6534
SCNN1A-2686	+	GUUUCCAUACAUCGGGUGGUGGAA	24	6535
SCNN1A-2687	+	UCUCCACCACAGACAACA	18	6536
SCNN1A-2688	+	AUCUCCACCACAGACAACA	19	6537
SCNN1A-2689	+	CAUCUCCACCACAGACAACA	20	6538
SCNN1A-2690	+	CCAUCUCCACCACAGACAACA	21	6539
SCNN1A-2691	+	GCCAUCUCCACCACAGACAACA	22	6540
SCNN1A-2692	+	AGCCAUCUCCACCACAGACAACA	23	6541
SCNN1A-2693	+	CAGCCAUCUCCACCACAGACAACA	24	6542
SCNN1A-2694	+	UUCUGGUUGCACUGGACA	18	6543
SCNN1A-2695	+	GUUCUGGUUGCACUGGACA	19	6544
SCNN1A-2696	+	UGUUCUGGUUGCACUGGACA	20	6545
SCNN1A-2697	+	UUGUUCUGGUUGCACUGGACA	21	6546
SCNN1A-2698	+	UUUGUUCUGGUUGCACUGGACA	22	6547
SCNN1A-2699	+	AUUUGUUCUGGUUGCACUGGACA	23	6548
SCNN1A-2700	+	GAUUUGUUCUGGUUGCACUGGACA	24	6549
SCNN1A-2701	+	GCACGACCUACCGUGACA	18	6550
SCNN1A-2702	+	GGCACGACCUACCGUGACA	19	6551
SCNN1A-2703	+	AGGCACGACCUACCGUGACA	20	6552
SCNN1A-2704	+	CAGGCACGACCUACCGUGACA	21	6553
SCNN1A-2705	+	CCAGGCACGACCUACCGUGACA	22	6554
SCNN1A-2706	+	UCCAGGCACGACCUACCGUGACA	23	6555
SCNN1A-2707	+	AUCCAGGCACGACCUACCGUGACA	24	6556
SCNN1A-2708	+	CAGUACCCUGUGGGUACA	18	6557
SCNN1A-2709	+	GCAGUACCCUGUGGGUACA	19	6558
SCNN1A-2710	+	AGCAGUACCCUGUGGGUACA	20	6559
SCNN1A-2711	+	UAGCAGUACCCUGUGGGUACA	21	6560
SCNN1A-2712	+	GUAGCAGUACCCUGUGGGUACA	22	6561
SCNN1A-2713	+	AGUAGCAGUACCCUGUGGGUACA	23	6562
SCNN1A-2714	+	UAGUAGCAGUACCCUGUGGGUACA	24	6563
SCNN1A-2715	+	CCUCUCAGGGCCCCCCCA	18	6564
SCNN1A-2716	+	CCCUCUCAGGGCCCCCCCA	19	6565
SCNN1A-2717	+	UCCCUCUCAGGGCCCCCCCA	20	6566
SCNN1A-2718	+	UUCCCUCUCAGGGCCCCCCCA	21	6567
SCNN1A-2719	+	CUUCCCUCUCAGGGCCCCCCCA	22	6568
SCNN1A-2720	+	CCUUCCCUCUCAGGGCCCCCCCA	23	6569
SCNN1A-2721	+	UCCUUCCCUCUCAGGGCCCCCCCA	24	6570
SCNN1A-2722	+	GGCGCCAUGGAGCAAGCA	18	6571
SCNN1A-2723	+	GGGCGCCAUGGAGCAAGCA	19	6572
SCNN1A-909	+	AGGGCGCCAUGGAGCAAGCA	20	4758
SCNN1A-2724	+	GAGGGCGCCAUGGAGCAAGCA	21	6573
SCNN1A-2725	+	AGAGGGCGCCAUGGAGCAAGCA	22	6574
SCNN1A-2726	+	CAGAGGGCGCCAUGGAGCAAGCA	23	6575
SCNN1A-2727	+	GCAGAGGGCGCCAUGGAGCAAGCA	24	6576
SCNN1A-2728	+	CAGUCACUGUGGACAGCA	18	6577
SCNN1A-2729	+	CCAGUCACUGUGGACAGCA	19	6578
SCNN1A-910	+	CCCAGUCACUGUGGACAGCA	20	4759
SCNN1A-2730	+	CCCCAGUCACUGUGGACAGCA	21	6579
SCNN1A-2731	+	GCCCCAGUCACUGUGGACAGCA	22	6580
SCNN1A-2732	+	GGCCCCAGUCACUGUGGACAGCA	23	6581
SCNN1A-2733	+	GGGCCCCAGUCACUGUGGACAGCA	24	6582
SCNN1A-2734	+	CAUCGUGAGUAACCAGCA	18	6583
SCNN1A-2735	+	CCAUCGUGAGUAACCAGCA	19	6584
SCNN1A-2736	+	GCCAUCGUGAGUAACCAGCA	20	6585
SCNN1A-2737	+	GGCCAUCGUGAGUAACCAGCA	21	6586
SCNN1A-2738	+	GGGCCAUCGUGAGUAACCAGCA	22	6587
SCNN1A-2739	+	AGGGCCAUCGUGAGUAACCAGCA	23	6588
SCNN1A-2740	+	GAGGGCCAUCGUGAGUAACCAGCA	24	6589
SCNN1A-2741	+	CGUUGUUGAUUCCAGGCA	18	6590
SCNN1A-2742	+	CCGUUGUUGAUUCCAGGCA	19	6591
SCNN1A-913	+	ACCGUUGUUGAUUCCAGGCA	20	4762
SCNN1A-2743	+	CACCGUUGUUGAUUCCAGGCA	21	6592
SCNN1A-2744	+	UCACCGUUGUUGAUUCCAGGCA	22	6593
SCNN1A-2745	+	CUCACCGUUGUUGAUUCCAGGCA	23	6594
SCNN1A-2746	+	UCUCACCGUUGUUGAUUCCAGGCA	24	6595
SCNN1A-2747	+	CCCAGGGUGGCAUAGGCA	18	6596
SCNN1A-2748	+	GCCCAGGGUGGCAUAGGCA	19	6597
SCNN1A-914	+	GGCCCAGGGUGGCAUAGGCA	20	4763
SCNN1A-2749	+	GGGCCCAGGGUGGCAUAGGCA	21	6598
SCNN1A-2750	+	GGGGCCCAGGGUGGCAUAGGCA	22	6599
SCNN1A-2751	+	GGGGGCCCAGGGUGGCAUAGGCA	23	6600
SCNN1A-2752	+	CGGGGGCCCAGGGUGGCAUAGGCA	24	6601
SCNN1A-2753	+	GACAGACCUAGGGGUGCA	18	6602
SCNN1A-2754	+	GGACAGACCUAGGGGUGCA	19	6603
SCNN1A-2755	+	GGGACAGACCUAGGGGUGCA	20	6604
SCNN1A-2756	+	AGGGACAGACCUAGGGGUGCA	21	6605
SCNN1A-2757	+	CAGGGACAGACCUAGGGGUGCA	22	6606
SCNN1A-2758	+	UCAGGGACAGACCUAGGGGUGCA	23	6607
SCNN1A-2759	+	AUCAGGGACAGACCUAGGGGUGCA	24	6608
SCNN1A-2760	+	CGAUUUGUUCUGGUUGCA	18	6609
SCNN1A-2761	+	CCGAUUUGUUCUGGUUGCA	19	6610
SCNN1A-2762	+	UCCGAUUUGUUCUGGUUGCA	20	6611
SCNN1A-2763	+	GUCCGAUUUGUUCUGGUUGCA	21	6612
SCNN1A-2764	+	AGUCCGAUUUGUUCUGGUUGCA	22	6613
SCNN1A-2765	+	CAGUCCGAUUUGUUCUGGUUGCA	23	6614
SCNN1A-2766	+	GCAGUCCGAUUUGUUCUGGUUGCA	24	6615
SCNN1A-2767	+	ACACAGAGACUAGAGUCA	18	6616
SCNN1A-2768	+	GACACAGAGACUAGAGUCA	19	6617
SCNN1A-2769	+	GGACACAGAGACUAGAGUCA	20	6618
SCNN1A-2770	+	UGGACACAGAGACUAGAGUCA	21	6619
SCNN1A-2771	+	CUGGACACAGAGACUAGAGUCA	22	6620
SCNN1A-2772	+	ACUGGACACAGAGACUAGAGUCA	23	6621
SCNN1A-2773	+	CACUGGACACAGAGACUAGAGUCA	24	6622
SCNN1A-2774	+	CUGUAUUUGUACAGGUCA	18	6623
SCNN1A-2775	+	GCUGUAUUUGUACAGGUCA	19	6624
SCNN1A-2776	+	AGCUGUAUUUGUACAGGUCA	20	6625
SCNN1A-2777	+	GAGCUGUAUUUGUACAGGUCA	21	6626
SCNN1A-2778	+	GGAGCUGUAUUUGUACAGGUCA	22	6627
SCNN1A-2779	+	AGGAGCUGUAUUUGUACAGGUCA	23	6628
SCNN1A-2780	+	AAGGAGCUGUAUUUGUACAGGUCA	24	6629
SCNN1A-2781	+	ACUCUACCUGGGAUGUCA	18	6630
SCNN1A-2782	+	CACUCUACCUGGGAUGUCA	19	6631
SCNN1A-2783	+	ACACUCUACCUGGGAUGUCA	20	6632
SCNN1A-2784	+	CACACUCUACCUGGGAUGUCA	21	6633
SCNN1A-2785	+	CCACACUCUACCUGGGAUGUCA	22	6634
SCNN1A-2786	+	CCCACACUCUACCUGGGAUGUCA	23	6635
SCNN1A-2787	+	CCCCACACUCUACCUGGGAUGUCA	24	6636
SCNN1A-2788	+	UUGGAGUUGUUCUUGUCA	18	6637
SCNN1A-2789	+	GUUGGAGUUGUUCUUGUCA	19	6638
SCNN1A-2790	+	GGUUGGAGUUGUUCUUGUCA	20	6639
SCNN1A-2791	+	AGGUUGGAGUUGUUCUUGUCA	21	6640
SCNN1A-2792	+	GAGGUUGGAGUUGUUCUUGUCA	22	6641
SCNN1A-2793	+	AGAGGUUGGAGUUGUUCUUGUCA	23	6642
SCNN1A-2794	+	CAGAGGUUGGAGUUGUUCUUGUCA	24	6643
SCNN1A-2795	+	ACCCAUUCCUAGGAAAGA	18	6644
SCNN1A-2796	+	GACCCAUUCCUAGGAAAGA	19	6645
SCNN1A-2797	+	AGACCCAUUCCUAGGAAAGA	20	6646
SCNN1A-2798	+	AAGACCCAUUCCUAGGAAAGA	21	6647
SCNN1A-2799	+	GAAGACCCAUUCCUAGGAAAGA	22	6648
SCNN1A-2800	+	GGAAGACCCAUUCCUAGGAAAGA	23	6649
SCNN1A-2801	+	UGGAAGACCCAUUCCUAGGAAAGA	24	6650
SCNN1A-2802	+	ACGACCUACCGUGACAGA	18	6651
SCNN1A-2803	+	CACGACCUACCGUGACAGA	19	6652
SCNN1A-931	+	GCACGACCUACCGUGACAGA	20	4780
SCNN1A-2804	+	GGCACGACCUACCGUGACAGA	21	6653
SCNN1A-2805	+	AGGCACGACCUACCGUGACAGA	22	6654
SCNN1A-2806	+	CAGGCACGACCUACCGUGACAGA	23	6655
SCNN1A-2807	+	CCAGGCACGACCUACCGUGACAGA	24	6656
SCNN1A-2808	+	CAGACCUAGGGGUGCAGA	18	6657
SCNN1A-2809	+	ACAGACCUAGGGGUGCAGA	19	6658
SCNN1A-2810	+	GACAGACCUAGGGGUGCAGA	20	6659
SCNN1A-2811	+	GGACAGACCUAGGGGUGCAGA	21	6660
SCNN1A-2812	+	GGGACAGACCUAGGGGUGCAGA	22	6661
SCNN1A-2813	+	AGGGACAGACCUAGGGGUGCAGA	23	6662
SCNN1A-2814	+	CAGGGACAGACCUAGGGGUGCAGA	24	6663
SCNN1A-2815	+	ACAGAGACUAGAGUCAGA	18	6664
SCNN1A-2816	+	CACAGAGACUAGAGUCAGA	19	6665
SCNN1A-933	+	ACACAGAGACUAGAGUCAGA	20	4782
SCNN1A-2817	+	GACACAGAGACUAGAGUCAGA	21	6666
SCNN1A-2818	+	GGACACAGAGACUAGAGUCAGA	22	6667
SCNN1A-2819	+	UGGACACAGAGACUAGAGUCAGA	23	6668
SCNN1A-2820	+	CUGGACACAGAGACUAGAGUCAGA	24	6669
SCNN1A-2821	+	GGCUGUCAAGGCUGGAGA	18	6670
SCNN1A-2822	+	GGGCUGUCAAGGCUGGAGA	19	6671
SCNN1A-936	+	GGGGCUGUCAAGGCUGGAGA	20	4785
SCNN1A-2823	+	AGGGGCUGUCAAGGCUGGAGA	21	6672
SCNN1A-2824	+	GAGGGGCUGUCAAGGCUGGAGA	22	6673
SCNN1A-2825	+	GGAGGGGCUGUCAAGGCUGGAGA	23	6674
SCNN1A-2826	+	GGGAGGGGCUGUCAAGGCUGGAGA	24	6675
SCNN1A-2827	+	GGGUACCUGAAGGGGCGA	18	6676
SCNN1A-2828	+	CGGGUACCUGAAGGGGCGA	19	6677
SCNN1A-946	+	CCGGGUACCUGAAGGGGCGA	20	4795
SCNN1A-2829	+	UCCGGGUACCUGAAGGGGCGA	21	6678
SCNN1A-2830	+	UUCCGGGUACCUGAAGGGGCGA	22	6679
SCNN1A-2831	+	UUUCCGGGUACCUGAAGGGGCGA	23	6680
SCNN1A-2832	+	AUUUCCGGGUACCUGAAGGGGCGA	24	6681
SCNN1A-2833	+	GCCUGGCUGGGACAAGGA	18	6682
SCNN1A-2834	+	GGCCUGGCUGGGACAAGGA	19	6683
SCNN1A-2835	+	GGGCCUGGCUGGGACAAGGA	20	6684
SCNN1A-2836	+	AGGGCCUGGCUGGGACAAGGA	21	6685
SCNN1A-2837	+	CAGGGCCUGGCUGGGACAAGGA	22	6686
SCNN1A-2838	+	GCAGGGCCUGGCUGGGACAAGGA	23	6687
SCNN1A-2839	+	AGCAGGGCCUGGCUGGGACAAGGA	24	6688
SCNN1A-2840	+	GGGCAGAAGUGGGAAGGA	18	6689
SCNN1A-2841	+	GGGGCAGAAGUGGGAAGGA	19	6690
SCNN1A-948	+	GGGGGCAGAAGUGGGAAGGA	20	4797
SCNN1A-2842	+	UGGGGGCAGAAGUGGGAAGGA	21	6691
SCNN1A-2843	+	GUGGGGGCAGAAGUGGGAAGGA	22	6692
SCNN1A-2844	+	GGUGGGGGCAGAAGUGGGAAGGA	23	6693
SCNN1A-2845	+	GGGUGGGGGCAGAAGUGGGAAGGA	24	6694
SCNN1A-2846	+	AGUAAUUCCUUAUCAGGA	18	6695
SCNN1A-2847	+	GAGUAAUUCCUUAUCAGGA	19	6696
SCNN1A-2848	+	AGAGUAAUUCCUUAUCAGGA	20	6697
SCNN1A-2849	+	GAGAGUAAUUCCUUAUCAGGA	21	6698
SCNN1A-2850	+	UGAGAGUAAUUCCUUAUCAGGA	22	6699
SCNN1A-2851	+	GUGAGAGUAAUUCCUUAUCAGGA	23	6700
SCNN1A-2852	+	AGUGAGAGUAAUUCCUUAUCAGGA	24	6701
SCNN1A-2853	+	GGAGGAGGGUGGAGAGGA	18	6702
SCNN1A-2854	+	GGGAGGAGGGUGGAGAGGA	19	6703
SCNN1A-2855	+	AGGGAGGAGGGUGGAGAGGA	20	6704
SCNN1A-2856	+	AAGGGAGGAGGGUGGAGAGGA	21	6705
SCNN1A-2857	+	GAAGGGAGGAGGGUGGAGAGGA	22	6706
SCNN1A-2858	+	GGAAGGGAGGAGGGUGGAGAGGA	23	6707
SCNN1A-2859	+	UGGAAGGGAGGAGGGUGGAGAGGA	24	6708
SCNN1A-2860	+	ACGUUCUGGGGCCGCGGA	18	6709
SCNN1A-2861	+	CACGUUCUGGGGCCGCGGA	19	6710
SCNN1A-2862	+	CCACGUUCUGGGGCCGCGGA	20	6711
SCNN1A-2863	+	UCCACGUUCUGGGGCCGCGGA	21	6712
SCNN1A-2864	+	CUCCACGUUCUGGGGCCGCGGA	22	6713
SCNN1A-2865	+	ACUCCACGUUCUGGGGCCGCGGA	23	6714
SCNN1A-2866	+	UACUCCACGUUCUGGGGCCGCGGA	24	6715
SCNN1A-2867	+	ACUGUGGACAGCAGGGGA	18	6716
SCNN1A-2868	+	CACUGUGGACAGCAGGGGA	19	6717
SCNN1A-2869	+	UCACUGUGGACAGCAGGGGA	20	6718
SCNN1A-2870	+	GUCACUGUGGACAGCAGGGGA	21	6719
SCNN1A-2871	+	AGUCACUGUGGACAGCAGGGGA	22	6720
SCNN1A-2872	+	CAGUCACUGUGGACAGCAGGGGA	23	6721
SCNN1A-2873	+	CCAGUCACUGUGGACAGCAGGGGA	24	6722
SCNN1A-2874	+	AGCUGGUCACGCUGGGGA	18	6723
SCNN1A-2875	+	UAGCUGGUCACGCUGGGGA	19	6724
SCNN1A-956	+	GUAGCUGGUCACGCUGGGGA	20	4805
SCNN1A-2876	+	GGUAGCUGGUCACGCUGGGGA	21	6725
SCNN1A-2877	+	UGGUAGCUGGUCACGCUGGGGA	22	6726
SCNN1A-2878	+	CUGGUAGCUGGUCACGCUGGGGA	23	6727
SCNN1A-2879	+	GCUGGUAGCUGGUCACGCUGGGGA	24	6728
SCNN1A-2880	+	GUGGGGGCAGAAGUGGGA	18	6729
SCNN1A-2881	+	GGUGGGGGCAGAAGUGGGA	19	6730
SCNN1A-958	+	GGGUGGGGGCAGAAGUGGGA	20	4807
SCNN1A-2882	+	GGGGUGGGGGCAGAAGUGGGA	21	6731
SCNN1A-2883	+	UGGGGUGGGGGCAGAAGUGGGA	22	6732
SCNN1A-2884	+	AUGGGGUGGGGGCAGAAGUGGGA	23	6733
SCNN1A-2885	+	CAUGGGGUGGGGGCAGAAGUGGGA	24	6734
SCNN1A-2886	+	AGUGAAUACACACCUGGA	18	6735
SCNN1A-2887	+	GAGUGAAUACACACCUGGA	19	6736
SCNN1A-960	+	GGAGUGAAUACACACCUGGA	20	4809
SCNN1A-2888	+	AGGAGUGAAUACACACCUGGA	21	6737
SCNN1A-2889	+	CAGGAGUGAAUACACACCUGGA	22	6738
SCNN1A-2890	+	GCAGGAGUGAAUACACACCUGGA	23	6739
SCNN1A-2891	+	AGCAGGAGUGAAUACACACCUGGA	24	6740
SCNN1A-2892	+	GGGGCUGUCAAGGCUGGA	18	6741
SCNN1A-2893	+	AGGGGCUGUCAAGGCUGGA	19	6742
SCNN1A-2894	+	GAGGGGCUGUCAAGGCUGGA	20	6743
SCNN1A-2895	+	GGAGGGGCUGUCAAGGCUGGA	21	6744
SCNN1A-2896	+	GGGAGGGGCUGUCAAGGCUGGA	22	6745
SCNN1A-2897	+	GGGGAGGGGCUGUCAAGGCUGGA	23	6746
SCNN1A-2898	+	GGGGGAGGGGCUGUCAAGGCUGGA	24	6747
SCNN1A-2899	+	GGAAGGGAGGAGGGUGGA	18	6748
SCNN1A-2900	+	UGGAAGGGAGGAGGGUGGA	19	6749
SCNN1A-2901	+	CUGGAAGGGAGGAGGGUGGA	20	6750
SCNN1A-2902	+	CCUGGAAGGGAGGAGGGUGGA	21	6751
SCNN1A-2903	+	ACCUGGAAGGGAGGAGGGUGGA	22	6752
SCNN1A-2904	+	CACCUGGAAGGGAGGAGGGUGGA	23	6753
SCNN1A-2905	+	ACACCUGGAAGGGAGGAGGGUGGA	24	6754
SCNN1A-2906	+	CUGGCUGCCCAGGUUGGA	18	6755
SCNN1A-2907	+	ACUGGCUGCCCAGGUUGGA	19	6756
SCNN1A-2908	+	CACUGGCUGCCCAGGUUGGA	20	6757
SCNN1A-2909	+	CCACUGGCUGCCCAGGUUGGA	21	6758
SCNN1A-2910	+	UCCACUGGCUGCCCAGGUUGGA	22	6759
SCNN1A-2911	+	CUCCACUGGCUGCCCAGGUUGGA	23	6760
SCNN1A-2912	+	GCUCCACUGGCUGCCCAGGUUGGA	24	6761
SCNN1A-2913	+	UAAUUUCCGGGUACCUGA	18	6762
SCNN1A-2914	+	UUAAUUUCCGGGUACCUGA	19	6763
SCNN1A-964	+	UUUAAUUUCCGGGUACCUGA	20	4813
SCNN1A-2915	+	CUUUAAUUUCCGGGUACCUGA	21	6764
SCNN1A-2916	+	UCUUUAAUUUCCGGGUACCUGA	22	6765
SCNN1A-2917	+	CUCUUUAAUUUCCGGGUACCUGA	23	6766
SCNN1A-2918	+	CCUCUUUAAUUUCCGGGUACCUGA	24	6767
SCNN1A-2919	+	UUGCCUUCCUCAUGCUGA	18	6768
SCNN1A-2920	+	CUUGCCUUCCUCAUGCUGA	19	6769
SCNN1A-966	+	CCUUGCCUUCCUCAUGCUGA	20	4815
SCNN1A-2921	+	UCCUUGCCUUCCUCAUGCUGA	21	6770
SCNN1A-2922	+	AUCCUUGCCUUCCUCAUGCUGA	22	6771
SCNN1A-2923	+	CAUCCUUGCCUUCCUCAUGCUGA	23	6772
SCNN1A-2924	+	GCAUCCUUGCCUUCCUCAUGCUGA	24	6773
SCNN1A-2925	+	AGGCACGACCUACCGUGA	18	6774
SCNN1A-2926	+	CAGGCACGACCUACCGUGA	19	6775
SCNN1A-2927	+	CCAGGCACGACCUACCGUGA	20	6776
SCNN1A-2928	+	UCCAGGCACGACCUACCGUGA	21	6777
SCNN1A-2929	+	AUCCAGGCACGACCUACCGUGA	22	6778
SCNN1A-2930	+	CAUCCAGGCACGACCUACCGUGA	23	6779
SCNN1A-2931	+	CCAUCCAGGCACGACCUACCGUGA	24	6780
SCNN1A-2932	+	CGGCCACGAGAGUGGUGA	18	6781
SCNN1A-2933	+	CCGGCCACGAGAGUGGUGA	19	6782
SCNN1A-968	+	GCCGGCCACGAGAGUGGUGA	20	4817
SCNN1A-2934	+	AGCCGGCCACGAGAGUGGUGA	21	6783
SCNN1A-2935	+	GAGCCGGCCACGAGAGUGGUGA	22	6784
SCNN1A-2936	+	GGAGCCGGCCACGAGAGUGGUGA	23	6785
SCNN1A-2937	+	GGGAGCCGGCCACGAGAGUGGUGA	24	6786
SCNN1A-2938	+	GAGGGUGACCAUCUGUGA	18	6787
SCNN1A-2939	+	GGAGGGUGACCAUCUGUGA	19	6788
SCNN1A-2940	+	AGGAGGGUGACCAUCUGUGA	20	6789
SCNN1A-2941	+	CAGGAGGGUGACCAUCUGUGA	21	6790
SCNN1A-2942	+	ACAGGAGGGUGACCAUCUGUGA	22	6791
SCNN1A-2943	+	GACAGGAGGGUGACCAUCUGUGA	23	6792
SCNN1A-2944	+	GGACAGGAGGGUGACCAUCUGUGA	24	6793
SCNN1A-2945	+	AGCAGUACCCUGUGGGUA	18	6794
SCNN1A-2946	+	UAGCAGUACCCUGUGGGUA	19	6795
SCNN1A-2947	+	GUAGCAGUACCCUGUGGGUA	20	6796
SCNN1A-2948	+	AGUAGCAGUACCCUGUGGGUA	21	6797
SCNN1A-2949	+	UAGUAGCAGUACCCUGUGGGUA	22	6798
SCNN1A-2950	+	AUAGUAGCAGUACCCUGUGGGUA	23	6799
SCNN1A-2951	+	UAUAGUAGCAGUACCCUGUGGGUA	24	6800
SCNN1A-2952	+	CGACAGGAUGUUGAUGUA	18	6801
SCNN1A-2953	+	UCGACAGGAUGUUGAUGUA	19	6802
SCNN1A-2954	+	CUCGACAGGAUGUUGAUGUA	20	6803
SCNN1A-2955	+	CCUCGACAGGAUGUUGAUGUA	21	6804
SCNN1A-2956	+	GCCUCGACAGGAUGUUGAUGUA	22	6805
SCNN1A-2957	+	AGCCUCGACAGGAUGUUGAUGUA	23	6806
SCNN1A-2958	+	CAGCCUCGACAGGAUGUUGAUGUA	24	6807
SCNN1A-2959	+	AGGGUAAAGGUUCUCAAC	18	6808
SCNN1A-2960	+	AAGGGUAAAGGUUCUCAAC	19	6809
SCNN1A-978	+	GAAGGGUAAAGGUUCUCAAC	20	4827
SCNN1A-2961	+	UGAAGGGUAAAGGUUCUCAAC	21	6810
SCNN1A-2962	+	UUGAAGGGUAAAGGUUCUCAAC	22	6811
SCNN1A-2963	+	UUUGAAGGGUAAAGGUUCUCAAC	23	6812
SCNN1A-2964	+	CUUUGAAGGGUAAAGGUUCUCAAC	24	6813
SCNN1A-2965	+	GUCUGAGGAGAAGUCAAC	18	6814
SCNN1A-2966	+	GGUCUGAGGAGAAGUCAAC	19	6815
SCNN1A-2967	+	UGGUCUGAGGAGAAGUCAAC	20	6816
SCNN1A-2968	+	GUGGUCUGAGGAGAAGUCAAC	21	6817
SCNN1A-2969	+	GGUGGUCUGAGGAGAAGUCAAC	22	6818
SCNN1A-2970	+	AGGUGGUCUGAGGAGAAGUCAAC	23	6819
SCNN1A-2971	+	CAGGUGGUCUGAGGAGAAGUCAAC	24	6820
SCNN1A-2972	+	GCAGGAGUGAAUACACAC	18	6821
SCNN1A-2973	+	AGCAGGAGUGAAUACACAC	19	6822
SCNN1A-2974	+	AAGCAGGAGUGAAUACACAC	20	6823
SCNN1A-2975	+	GAAGCAGGAGUGAAUACACAC	21	6824
SCNN1A-2976	+	GGAAGCAGGAGUGAAUACACAC	22	6825
SCNN1A-2977	+	UGGAAGCAGGAGUGAAUACACAC	23	6826
SCNN1A-2978	+	CUGGAAGCAGGAGUGAAUACACAC	24	6827
SCNN1A-2979	+	CCAGUCCUUCCAGUCCAC	18	6828
SCNN1A-2980	+	UCCAGUCCUUCCAGUCCAC	19	6829
SCNN1A-2981	+	UUCCAGUCCUUCCAGUCCAC	20	6830
SCNN1A-2982	+	CUUCCAGUCCUUCCAGUCCAC	21	6831
SCNN1A-2983	+	UCUUCCAGUCCUUCCAGUCCAC	22	6832
SCNN1A-2984	+	AUCUUCCAGUCCUUCCAGUCCAC	23	6833
SCNN1A-2985	+	GAUCUUCCAGUCCUUCCAGUCCAC	24	6834
SCNN1A-2986	+	UGGGACAAGGACAGAGAC	18	6835
SCNN1A-2987	+	CUGGGACAAGGACAGAGAC	19	6836
SCNN1A-2988	+	GCUGGGACAAGGACAGAGAC	20	6837
SCNN1A-2989	+	GGCUGGGACAAGGACAGAGAC	21	6838
SCNN1A-2990	+	UGGCUGGGACAAGGACAGAGAC	22	6839
SCNN1A-2991	+	CUGGCUGGGACAAGGACAGAGAC	23	6840
SCNN1A-2992	+	CCUGGCUGGGACAAGGACAGAGAC	24	6841
SCNN1A-2993	+	GCAGGGCCUGGCUGGGAC	18	6842
SCNN1A-2994	+	AGCAGGGCCUGGCUGGGAC	19	6843
SCNN1A-2995	+	GAGCAGGGCCUGGCUGGGAC	20	6844
SCNN1A-2996	+	GGAGCAGGGCCUGGCUGGGAC	21	6845
SCNN1A-2997	+	GGGAGCAGGGCCUGGCUGGGAC	22	6846
SCNN1A-2998	+	AGGGAGCAGGGCCUGGCUGGGAC	23	6847
SCNN1A-2999	+	GAGGGAGCAGGGCCUGGCUGGGAC	24	6848
SCNN1A-3000	+	UGGCUGCCCAGGUUGGAC	18	6849
SCNN1A-3001	+	CUGGCUGCCCAGGUUGGAC	19	6850
SCNN1A-991	+	ACUGGCUGCCCAGGUUGGAC	20	4840
SCNN1A-3002	+	CACUGGCUGCCCAGGUUGGAC	21	6851
SCNN1A-3003	+	CCACUGGCUGCCCAGGUUGGAC	22	6852
SCNN1A-3004	+	UCCACUGGCUGCCCAGGUUGGAC	23	6853
SCNN1A-3005	+	CUCCACUGGCUGCCCAGGUUGGAC	24	6854
SCNN1A-3006	+	CCCUUCCCCACACUCUAC	18	6855
SCNN1A-3007	+	UCCCUUCCCCACACUCUAC	19	6856
SCNN1A-3008	+	AUCCCUUCCCCACACUCUAC	20	6857
SCNN1A-3009	+	CAUCCCUUCCCCACACUCUAC	21	6858
SCNN1A-3010	+	CCAUCCCUUCCCCACACUCUAC	22	6859
SCNN1A-3011	+	CCCAUCCCUUCCCCACACUCUAC	23	6860
SCNN1A-3012	+	ACCCAUCCCUUCCCCACACUCUAC	24	6861
SCNN1A-3013	+	UCUUUAAUUUCCGGGUAC	18	6862
SCNN1A-3014	+	CUCUUUAAUUUCCGGGUAC	19	6863
SCNN1A-3015	+	CCUCUUUAAUUUCCGGGUAC	20	6864
SCNN1A-3016	+	UCCUCUUUAAUUUCCGGGUAC	21	6865
SCNN1A-3017	+	CUCCUCUUUAAUUUCCGGGUAC	22	6866
SCNN1A-3018	+	GCUCCUCUUUAAUUUCCGGGUAC	23	6867
SCNN1A-3019	+	AGCUCCUCUUUAAUUUCCGGGUAC	24	6868
SCNN1A-3020	+	CUGCCCGUGCACCAUUAC	18	6869
SCNN1A-3021	+	CCUGCCCGUGCACCAUUAC	19	6870
SCNN1A-3022	+	UCCUGCCCGUGCACCAUUAC	20	6871
SCNN1A-3023	+	AUCCUGCCCGUGCACCAUUAC	21	6872
SCNN1A-3024	+	CAUCCUGCCCGUGCACCAUUAC	22	6873
SCNN1A-3025	+	UCAUCCUGCCCGUGCACCAUUAC	23	6874
SCNN1A-3026	+	UUCAUCCUGCCCGUGCACCAUUAC	24	6875
SCNN1A-3027	+	UCUGAGGAGAAGUCAACC	18	6876
SCNN1A-3028	+	GUCUGAGGAGAAGUCAACC	19	6877
SCNN1A-1000	+	GGUCUGAGGAGAAGUCAACC	20	4849
SCNN1A-3029	+	UGGUCUGAGGAGAAGUCAACC	21	6878
SCNN1A-3030	+	GUGGUCUGAGGAGAAGUCAACC	22	6879
SCNN1A-3031	+	GGUGGUCUGAGGAGAAGUCAACC	23	6880
SCNN1A-3032	+	AGGUGGUCUGAGGAGAAGUCAACC	24	6881
SCNN1A-3033	+	UCCACCACAGACAACACC	18	6882
SCNN1A-3034	+	CUCCACCACAGACAACACC	19	6883
SCNN1A-3035	+	UCUCCACCACAGACAACACC	20	6884
SCNN1A-3036	+	AUCUCCACCACAGACAACACC	21	6885
SCNN1A-3037	+	CAUCUCCACCACAGACAACACC	22	6886
SCNN1A-3038	+	CCAUCUCCACCACAGACAACACC	23	6887
SCNN1A-3039	+	GCCAUCUCCACCACAGACAACACC	24	6888
SCNN1A-3040	+	CAGGAGUGAAUACACACC	18	6889
SCNN1A-3041	+	GCAGGAGUGAAUACACACC	19	6890
SCNN1A-1002	+	AGCAGGAGUGAAUACACACC	20	4851
SCNN1A-3042	+	AAGCAGGAGUGAAUACACACC	21	6891
SCNN1A-3043	+	GAAGCAGGAGUGAAUACACACC	22	6892
SCNN1A-3044	+	GGAAGCAGGAGUGAAUACACACC	23	6893
SCNN1A-3045	+	UGGAAGCAGGAGUGAAUACACACC	24	6894
SCNN1A-3046	+	UAUGAACCCACAUACACC	18	6895
SCNN1A-3047	+	CUAUGAACCCACAUACACC	19	6896
SCNN1A-3048	+	CCUAUGAACCCACAUACACC	20	6897
SCNN1A-3049	+	UCCUAUGAACCCACAUACACC	21	6898
SCNN1A-3050	+	UUCCUAUGAACCCACAUACACC	22	6899
SCNN1A-3051	+	UUUCCUAUGAACCCACAUACACC	23	6900
SCNN1A-3052	+	GUUUCCUAUGAACCCACAUACACC	24	6901
SCNN1A-3053	+	CAGUCCUUCCAGUCCACC	18	6902
SCNN1A-3054	+	CCAGUCCUUCCAGUCCACC	19	6903
SCNN1A-1004	+	UCCAGUCCUUCCAGUCCACC	20	4853
SCNN1A-3055	+	UUCCAGUCCUUCCAGUCCACC	21	6904
SCNN1A-3056	+	CUUCCAGUCCUUCCAGUCCACC	22	6905
SCNN1A-3057	+	UCUUCCAGUCCUUCCAGUCCACC	23	6906
SCNN1A-3058	+	AUCUUCCAGUCCUUCCAGUCCACC	24	6907
SCNN1A-3059	+	UCUACCUGGGAUGUCACC	18	6908
SCNN1A-3060	+	CUCUACCUGGGAUGUCACC	19	6909
SCNN1A-3061	+	ACUCUACCUGGGAUGUCACC	20	6910
SCNN1A-3062	+	CACUCUACCUGGGAUGUCACC	21	6911
SCNN1A-3063	+	ACACUCUACCUGGGAUGUCACC	22	6912
SCNN1A-3064	+	CACACUCUACCUGGGAUGUCACC	23	6913
SCNN1A-3065	+	CCACACUCUACCUGGGAUGUCACC	24	6914
SCNN1A-3066	+	CAGCAUCAGGGACAGACC	18	6915
SCNN1A-3067	+	GCAGCAUCAGGGACAGACC	19	6916
SCNN1A-3068	+	CGCAGCAUCAGGGACAGACC	20	6917
SCNN1A-3069	+	GCGCAGCAUCAGGGACAGACC	21	6918
SCNN1A-3070	+	CGCGCAGCAUCAGGGACAGACC	22	6919
SCNN1A-3071	+	GCGCGCAGCAUCAGGGACAGACC	23	6920
SCNN1A-3072	+	UGCGCGCAGCAUCAGGGACAGACC	24	6921
SCNN1A-3073	+	CUCCCUGGAGUCUCACCC	18	6922
SCNN1A-3074	+	GCUCCCUGGAGUCUCACCC	19	6923
SCNN1A-3075	+	GGCUCCCUGGAGUCUCACCC	20	6924
SCNN1A-3076	+	GGGCUCCCUGGAGUCUCACCC	21	6925
SCNN1A-3077	+	GGGGCUCCCUGGAGUCUCACCC	22	6926
SCNN1A-3078	+	GGGGGCUCCCUGGAGUCUCACCC	23	6927
SCNN1A-3079	+	UGGGGGCUCCCUGGAGUCUCACCC	24	6928
SCNN1A-3080	+	UCCCUGGAGUCUCACCCC	18	6929
SCNN1A-3081	+	CUCCCUGGAGUCUCACCCC	19	6930
SCNN1A-1013	+	GCUCCCUGGAGUCUCACCCC	20	4862
SCNN1A-3082	+	GGCUCCCUGGAGUCUCACCCC	21	6931
SCNN1A-3083	+	GGGCUCCCUGGAGUCUCACCCC	22	6932
SCNN1A-3084	+	GGGGCUCCCUGGAGUCUCACCCC	23	6933
SCNN1A-3085	+	GGGGGCUCCCUGGAGUCUCACCCC	24	6934
SCNN1A-3086	+	UCCCUCUCAGGGCCCCCC	18	6935
SCNN1A-3087	+	UUCCCUCUCAGGGCCCCCC	19	6936
SCNN1A-3088	+	CUUCCCUCUCAGGGCCCCCC	20	6937
SCNN1A-3089	+	CCUUCCCUCUCAGGGCCCCCC	21	6938
SCNN1A-3090	+	UCCUUCCCUCUCAGGGCCCCCC	22	6939
SCNN1A-3091	+	CUCCUUCCCUCUCAGGGCCCCCC	23	6940
SCNN1A-3092	+	UCUCCUUCCCUCUCAGGGCCCCCC	24	6941
SCNN1A-3093	+	GGCCCCUGCAGAGCCCCC	18	6942
SCNN1A-3094	+	UGGCCCCUGCAGAGCCCCC	19	6943
SCNN1A-1015	+	CUGGCCCCUGCAGAGCCCCC	20	4864
SCNN1A-3095	+	ACUGGCCCCUGCAGAGCCCCC	21	6944
SCNN1A-3096	+	AACUGGCCCCUGCAGAGCCCCC	22	6945
SCNN1A-3097	+	GAACUGGCCCCUGCAGAGCCCCC	23	6946
SCNN1A-3098	+	GGAACUGGCCCCUGCAGAGCCCCC	24	6947
SCNN1A-3099	+	UGGCCCCUGCAGAGCCCC	18	6948
SCNN1A-3100	+	CUGGCCCCUGCAGAGCCCC	19	6949
SCNN1A-3101	+	ACUGGCCCCUGCAGAGCCCC	20	6950
SCNN1A-3102	+	AACUGGCCCCUGCAGAGCCCC	21	6951
SCNN1A-3103	+	GAACUGGCCCCUGCAGAGCCCC	22	6952
SCNN1A-3104	+	GGAACUGGCCCCUGCAGAGCCCC	23	6953
SCNN1A-3105	+	AGGAACUGGCCCCUGCAGAGCCCC	24	6954
SCNN1A-3106	+	ACGGGCUCGACGGGCCCC	18	6955
SCNN1A-3107	+	UACGGGCUCGACGGGCCCC	19	6956
SCNN1A-3108	+	CUACGGGCUCGACGGGCCCC	20	6957
SCNN1A-3109	+	GCUACGGGCUCGACGGGCCCC	21	6958
SCNN1A-3110	+	CGCUACGGGCUCGACGGGCCCC	22	6959
SCNN1A-3111	+	ACGCUACGGGCUCGACGGGCCCC	23	6960
SCNN1A-3112	+	CACGCUACGGGCUCGACGGGCCCC	24	6961
SCNN1A-3113	+	CGGCUGCGGGAGCCGGCC	18	6962
SCNN1A-3114	+	ACGGCUGCGGGAGCCGGCC	19	6963
SCNN1A-3115	+	GACGGCUGCGGGAGCCGGCC	20	6964
SCNN1A-3116	+	CGACGGCUGCGGGAGCCGGCC	21	6965
SCNN1A-3117	+	GCGACGGCUGCGGGAGCCGGCC	22	6966
SCNN1A-3118	+	CGCGACGGCUGCGGGAGCCGGCC	23	6967
SCNN1A-3119	+	UCGCGACGGCUGCGGGAGCCGGCC	24	6968
SCNN1A-3120	+	ACCCCUGCCCCCUCGGCC	18	6969
SCNN1A-3121	+	CACCCCUGCCCCCUCGGCC	19	6970
SCNN1A-1030	+	GCACCCCUGCCCCCUCGGCC	20	4879
SCNN1A-3122	+	AGCACCCCUGCCCCCUCGGCC	21	6971
SCNN1A-3123	+	GAGCACCCCUGCCCCCUCGGCC	22	6972
SCNN1A-3124	+	UGAGCACCCCUGCCCCCUCGGCC	23	6973
SCNN1A-3125	+	CUGAGCACCCCUGCCCCCUCGGCC	24	6974
SCNN1A-3126	+	GUUUUGUAGUUCAGCUCC	18	6975
SCNN1A-3127	+	GGUUUUGUAGUUCAGCUCC	19	6976
SCNN1A-3128	+	UGGUUUUGUAGUUCAGCUCC	20	6977
SCNN1A-3129	+	UUGGUUUUGUAGUUCAGCUCC	21	6978
SCNN1A-3130	+	AUUGGUUUUGUAGUUCAGCUCC	22	6979
SCNN1A-3131	+	AAUUGGUUUUGUAGUUCAGCUCC	23	6980
SCNN1A-3132	+	GAAUUGGUUUUGUAGUUCAGCUCC	24	6981
SCNN1A-3133	+	UCCUUGAUCAUGCUCUCC	18	6982
SCNN1A-3134	+	CUCCUUGAUCAUGCUCUCC	19	6983
SCNN1A-1041	+	ACUCCUUGAUCAUGCUCUCC	20	4890
SCNN1A-3135	+	CACUCCUUGAUCAUGCUCUCC	21	6984
SCNN1A-3136	+	ACACUCCUUGAUCAUGCUCUCC	22	6985
SCNN1A-3137	+	CACACUCCUUGAUCAUGCUCUCC	23	6986
SCNN1A-3138	+	CCACACUCCUUGAUCAUGCUCUCC	24	6987
SCNN1A-3139	+	AUCUGGAAGACCCAUUCC	18	6988
SCNN1A-3140	+	CAUCUGGAAGACCCAUUCC	19	6989
SCNN1A-3141	+	GCAUCUGGAAGACCCAUUCC	20	6990
SCNN1A-3142	+	AGCAUCUGGAAGACCCAUUCC	21	6991
SCNN1A-3143	+	UAGCAUCUGGAAGACCCAUUCC	22	6992
SCNN1A-3144	+	AUAGCAUCUGGAAGACCCAUUCC	23	6993
SCNN1A-3145	+	GAUAGCAUCUGGAAGACCCAUUCC	24	6994
SCNN1A-3146	+	GGGCGCCAUGGAGCAAGC	18	6995
SCNN1A-3147	+	AGGGCGCCAUGGAGCAAGC	19	6996
SCNN1A-1049	+	GAGGGCGCCAUGGAGCAAGC	20	4898
SCNN1A-3148	+	AGAGGGCGCCAUGGAGCAAGC	21	6997
SCNN1A-3149	+	CAGAGGGCGCCAUGGAGCAAGC	22	6998
SCNN1A-3150	+	GCAGAGGGCGCCAUGGAGCAAGC	23	6999
SCNN1A-3151	+	AGCAGAGGGCGCCAUGGAGCAAGC	24	7000
SCNN1A-3152	+	GGUUGUUGUCCCGCAAGC	18	7001
SCNN1A-3153	+	GGGUUGUUGUCCCGCAAGC	19	7002
SCNN1A-1050	+	GGGGUUGUUGUCCCGCAAGC	20	4899
SCNN1A-3154	+	GGGGGUUGUUGUCCCGCAAGC	21	7003
SCNN1A-3155	+	UGGGGGUUGUUGUCCCGCAAGC	22	7004
SCNN1A-3156	+	CUGGGGGUUGUUGUCCCGCAAGC	23	7005
SCNN1A-3157	+	CCUGGGGGUUGUUGUCCCGCAAGC	24	7006
SCNN1A-3158	+	CCAGUCACUGUGGACAGC	18	7007
SCNN1A-3159	+	CCCAGUCACUGUGGACAGC	19	7008
SCNN1A-1053	+	CCCCAGUCACUGUGGACAGC	20	4902
SCNN1A-3160	+	GCCCCAGUCACUGUGGACAGC	21	7009
SCNN1A-3161	+	GGCCCCAGUCACUGUGGACAGC	22	7010
SCNN1A-3162	+	GGGCCCCAGUCACUGUGGACAGC	23	7011
SCNN1A-3163	+	CGGGCCCCAGUCACUGUGGACAGC	24	7012
SCNN1A-3164	+	GCUGCGGGCCUCACCAGC	18	7013
SCNN1A-3165	+	CGCUGCGGGCCUCACCAGC	19	7014
SCNN1A-1054	+	GCGCUGCGGGCCUCACCAGC	20	4903
SCNN1A-3166	+	GGCGCUGCGGGCCUCACCAGC	21	7015
SCNN1A-3167	+	CGGCGCUGCGGGCCUCACCAGC	22	7016
SCNN1A-3168	+	UCGGCGCUGCGGGCCUCACCAGC	23	7017
SCNN1A-3169	+	CUCGGCGCUGCGGGCCUCACCAGC	24	7018
SCNN1A-3170	+	CGGAACCUUCGGAGCAGC	18	7019
SCNN1A-3171	+	UCGGAACCUUCGGAGCAGC	19	7020
SCNN1A-3172	+	UUCGGAACCUUCGGAGCAGC	20	7021
SCNN1A-3173	+	CUUCGGAACCUUCGGAGCAGC	21	7022
SCNN1A-3174	+	GCUUCGGAACCUUCGGAGCAGC	22	7023
SCNN1A-3175	+	GGCUUCGGAACCUUCGGAGCAGC	23	7024
SCNN1A-3176	+	CGGCUUCGGAACCUUCGGAGCAGC	24	7025
SCNN1A-3177	+	GCUGGUAGCUGGUCACGC	18	7026
SCNN1A-3178	+	AGCUGGUAGCUGGUCACGC	19	7027
SCNN1A-1064	+	GAGCUGGUAGCUGGUCACGC	20	4913
SCNN1A-3179	+	AGAGCUGGUAGCUGGUCACGC	21	7028
SCNN1A-3180	+	GAGAGCUGGUAGCUGGUCACGC	22	7029
SCNN1A-3181	+	AGAGAGCUGGUAGCUGGUCACGC	23	7030
SCNN1A-3182	+	CAGAGAGCUGGUAGCUGGUCACGC	24	7031
SCNN1A-3183	+	GGGAGGGGCUGUCAAGGC	18	7032
SCNN1A-3184	+	GGGGAGGGGCUGUCAAGGC	19	7033
SCNN1A-1067	+	GGGGGAGGGGCUGUCAAGGC	20	4916
SCNN1A-3185	+	AGGGGGAGGGGCUGUCAAGGC	21	7034
SCNN1A-3186	+	CAGGGGGAGGGGCUGUCAAGGC	22	7035
SCNN1A-3187	+	GCAGGGGGAGGGGCUGUCAAGGC	23	7036
SCNN1A-3188	+	GGCAGGGGGAGGGGCUGUCAAGGC	24	7037
SCNN1A-3189	+	CCGUUGUUGAUUCCAGGC	18	7038
SCNN1A-3190	+	ACCGUUGUUGAUUCCAGGC	19	7039
SCNN1A-3191	+	CACCGUUGUUGAUUCCAGGC	20	7040
SCNN1A-3192	+	UCACCGUUGUUGAUUCCAGGC	21	7041
SCNN1A-3193	+	CUCACCGUUGUUGAUUCCAGGC	22	7042
SCNN1A-3194	+	UCUCACCGUUGUUGAUUCCAGGC	23	7043
SCNN1A-3195	+	UUCUCACCGUUGUUGAUUCCAGGC	24	7044
SCNN1A-3196	+	CGACGGGCCCCGUGAGGC	18	7045
SCNN1A-3197	+	UCGACGGGCCCCGUGAGGC	19	7046
SCNN1A-1068	+	CUCGACGGGCCCCGUGAGGC	20	4917
SCNN1A-3198	+	GCUCGACGGGCCCCGUGAGGC	21	7047
SCNN1A-3199	+	GGCUCGACGGGCCCCGUGAGGC	22	7048
SCNN1A-3200	+	GGGCUCGACGGGCCCCGUGAGGC	23	7049
SCNN1A-3201	+	CGGGCUCGACGGGCCCCGUGAGGC	24	7050
SCNN1A-3202	+	GCCCAGGGUGGCAUAGGC	18	7051
SCNN1A-3203	+	GGCCCAGGGUGGCAUAGGC	19	7052
SCNN1A-1069	+	GGGCCCAGGGUGGCAUAGGC	20	4918
SCNN1A-3204	+	GGGGCCCAGGGUGGCAUAGGC	21	7053
SCNN1A-3205	+	GGGGGCCCAGGGUGGCAUAGGC	22	7054
SCNN1A-3206	+	CGGGGGCCCAGGGUGGCAUAGGC	23	7055
SCNN1A-3207	+	GCGGGGGCCCAGGGUGGCAUAGGC	24	7056
SCNN1A-3208	+	CACCCCUGCCCCCUCGGC	18	7057
SCNN1A-3209	+	GCACCCCUGCCCCCUCGGC	19	7058
SCNN1A-3210	+	AGCACCCCUGCCCCCUCGGC	20	7059
SCNN1A-3211	+	GAGCACCCCUGCCCCCUCGGC	21	7060
SCNN1A-3212	+	UGAGCACCCCUGCCCCCUCGGC	22	7061
SCNN1A-3213	+	CUGAGCACCCCUGCCCCCUCGGC	23	7062
SCNN1A-3214	+	CCUGAGCACCCCUGCCCCCUCGGC	24	7063
SCNN1A-3215	+	CCGGGUACCUGAAGGGGC	18	7064
SCNN1A-3216	+	UCCGGGUACCUGAAGGGGC	19	7065
SCNN1A-3217	+	UUCCGGGUACCUGAAGGGGC	20	7066
SCNN1A-3218	+	UUUCCGGGUACCUGAAGGGGC	21	7067
SCNN1A-3219	+	AUUUCCGGGUACCUGAAGGGGC	22	7068
SCNN1A-3220	+	AAUUUCCGGGUACCUGAAGGGGC	23	7069
SCNN1A-3221	+	UAAUUUCCGGGUACCUGAAGGGGC	24	7070
SCNN1A-3222	+	AGCCCCCUGGAGAUGGGC	18	7071
SCNN1A-3223	+	GAGCCCCCUGGAGAUGGGC	19	7072
SCNN1A-1075	+	AGAGCCCCCUGGAGAUGGGC	20	4924
SCNN1A-3224	+	CAGAGCCCCCUGGAGAUGGGC	21	7073
SCNN1A-3225	+	GCAGAGCCCCCUGGAGAUGGGC	22	7074
SCNN1A-3226	+	UGCAGAGCCCCCUGGAGAUGGGC	23	7075
SCNN1A-3227	+	CUGCAGAGCCCCCUGGAGAUGGGC	24	7076
SCNN1A-3228	+	GAGGGAGCAGGGCCUGGC	18	7077
SCNN1A-3229	+	AGAGGGAGCAGGGCCUGGC	19	7078
SCNN1A-1076	+	GAGAGGGAGCAGGGCCUGGC	20	4925
SCNN1A-3230	+	GGAGAGGGAGCAGGGCCUGGC	21	7079
SCNN1A-3231	+	UGGAGAGGGAGCAGGGCCUGGC	22	7080
SCNN1A-3232	+	CUGGAGAGGGAGCAGGGCCUGGC	23	7081
SCNN1A-3233	+	GCUGGAGAGGGAGCAGGGCCUGGC	24	7082
SCNN1A-3234	+	GGGACCCUCAGGCGCUGC	18	7083
SCNN1A-3235	+	CGGGACCCUCAGGCGCUGC	19	7084
SCNN1A-3236	+	GCGGGACCCUCAGGCGCUGC	20	7085
SCNN1A-3237	+	GGCGGGACCCUCAGGCGCUGC	21	7086
SCNN1A-3238	+	GGGCGGGACCCUCAGGCGCUGC	22	7087
SCNN1A-3239	+	GGGGCGGGACCCUCAGGCGCUGC	23	7088
SCNN1A-3240	+	GGGGGCGGGACCCUCAGGCGCUGC	24	7089
SCNN1A-3241	+	GCAGGUCGCGACGGCUGC	18	7090
SCNN1A-3242	+	CGCAGGUCGCGACGGCUGC	19	7091
SCNN1A-1082	+	CCGCAGGUCGCGACGGCUGC	20	4931
SCNN1A-3243	+	CCCGCAGGUCGCGACGGCUGC	21	7092
SCNN1A-3244	+	CCCCGCAGGUCGCGACGGCUGC	22	7093
SCNN1A-3245	+	CCCCCGCAGGUCGCGACGGCUGC	23	7094
SCNN1A-3246	+	UCCCCCGCAGGUCGCGACGGCUGC	24	7095
SCNN1A-3247	+	UGACUCACGCCUGGUUGC	18	7096
SCNN1A-3248	+	CUGACUCACGCCUGGUUGC	19	7097
SCNN1A-1087	+	ACUGACUCACGCCUGGUUGC	20	4936
SCNN1A-3249	+	GACUGACUCACGCCUGGUUGC	21	7098
SCNN1A-3250	+	GGACUGACUCACGCCUGGUUGC	22	7099
SCNN1A-3251	+	AGGACUGACUCACGCCUGGUUGC	23	7100
SCNN1A-3252	+	CAGGACUGACUCACGCCUGGUUGC	24	7101
SCNN1A-3253	+	CCAGGCAUGGAAGACAUC	18	7102
SCNN1A-3254	+	UCCAGGCAUGGAAGACAUC	19	7103
SCNN1A-3255	+	UUCCAGGCAUGGAAGACAUC	20	7104
SCNN1A-3256	+	AUUCCAGGCAUGGAAGACAUC	21	7105
SCNN1A-3257	+	GAUUCCAGGCAUGGAAGACAUC	22	7106
SCNN1A-3258	+	UGAUUCCAGGCAUGGAAGACAUC	23	7107
SCNN1A-3259	+	UUGAUUCCAGGCAUGGAAGACAUC	24	7108
SCNN1A-3260	+	UGCUCUGCGCGCAGCAUC	18	7109
SCNN1A-3261	+	CUGCUCUGCGCGCAGCAUC	19	7110
SCNN1A-1089	+	UCUGCUCUGCGCGCAGCAUC	20	4938
SCNN1A-3262	+	UUCUGCUCUGCGCGCAGCAUC	21	7111
SCNN1A-3263	+	AUUCUGCUCUGCGCGCAGCAUC	22	7112
SCNN1A-3264	+	CAUUCUGCUCUGCGCGCAGCAUC	23	7113
SCNN1A-3265	+	UCAUUCUGCUCUGCGCGCAGCAUC	24	7114
SCNN1A-3266	+	UUCUGUCGCGAUAGCAUC	18	7115
SCNN1A-3267	+	GUUCUGUCGCGAUAGCAUC	19	7116
SCNN1A-1090	+	UGUUCUGUCGCGAUAGCAUC	20	4939
SCNN1A-3268	+	UUGUUCUGUCGCGAUAGCAUC	21	7117
SCNN1A-3269	+	AUUGUUCUGUCGCGAUAGCAUC	22	7118
SCNN1A-3270	+	AAUUGUUCUGUCGCGAUAGCAUC	23	7119
SCNN1A-3271	+	UAAUUGUUCUGUCGCGAUAGCAUC	24	7120
SCNN1A-3272	+	UGAGAGUAAUUCCUUAUC	18	7121
SCNN1A-3273	+	GUGAGAGUAAUUCCUUAUC	19	7122
SCNN1A-1092	+	AGUGAGAGUAAUUCCUUAUC	20	4941
SCNN1A-3274	+	AAGUGAGAGUAAUUCCUUAUC	21	7123
SCNN1A-3275	+	GAAGUGAGAGUAAUUCCUUAUC	22	7124
SCNN1A-3276	+	GGAAGUGAGAGUAAUUCCUUAUC	23	7125
SCNN1A-3277	+	UGGAAGUGAGAGUAAUUCCUUAUC	24	7126
SCNN1A-3278	+	CAGGGUGGAGGCUACCUC	18	7127
SCNN1A-3279	+	CCAGGGUGGAGGCUACCUC	19	7128
SCNN1A-3280	+	GCCAGGGUGGAGGCUACCUC	20	7129
SCNN1A-3281	+	UGCCAGGGUGGAGGCUACCUC	21	7130
SCNN1A-3282	+	AUGCCAGGGUGGAGGCUACCUC	22	7131
SCNN1A-3283	+	GAUGCCAGGGUGGAGGCUACCUC	23	7132
SCNN1A-3284	+	GGAUGCCAGGGUGGAGGCUACCUC	24	7133
SCNN1A-3285	+	GCCCAGCGUGUCCUCCUC	18	7134
SCNN1A-3286	+	UGCCCAGCGUGUCCUCCUC	19	7135
SCNN1A-3287	+	UUGCCCAGCGUGUCCUCCUC	20	7136
SCNN1A-3288	+	GUUGCCCAGCGUGUCCUCCUC	21	7137
SCNN1A-3289	+	AGUUGCCCAGCGUGUCCUCCUC	22	7138
SCNN1A-3290	+	AAGUUGCCCAGCGUGUCCUCCUC	23	7139
SCNN1A-3291	+	GAAGUUGCCCAGCGUGUCCUCCUC	24	7140
SCNN1A-3292	+	CUCCUUGAUCAUGCUCUC	18	7141
SCNN1A-3293	+	ACUCCUUGAUCAUGCUCUC	19	7142
SCNN1A-3294	+	CACUCCUUGAUCAUGCUCUC	20	7143
SCNN1A-3295	+	ACACUCCUUGAUCAUGCUCUC	21	7144
SCNN1A-3296	+	CACACUCCUUGAUCAUGCUCUC	22	7145
SCNN1A-3297	+	CCACACUCCUUGAUCAUGCUCUC	23	7146
SCNN1A-3298	+	GCCACACUCCUUGAUCAUGCUCUC	24	7147
SCNN1A-3299	+	UCACAGUACUCCACGUUC	18	7148
SCNN1A-3300	+	GUCACAGUACUCCACGUUC	19	7149
SCNN1A-1103	+	AGUCACAGUACUCCACGUUC	20	4952
SCNN1A-3301	+	UAGUCACAGUACUCCACGUUC	21	7150
SCNN1A-3302	+	GUAGUCACAGUACUCCACGUUC	22	7151
SCNN1A-3303	+	UGUAGUCACAGUACUCCACGUUC	23	7152
SCNN1A-3304	+	CUGUAGUCACAGUACUCCACGUUC	24	7153
SCNN1A-3305	+	AUGACCAGCAGGUCAAAG	18	7154
SCNN1A-3306	+	GAUGACCAGCAGGUCAAAG	19	7155
SCNN1A-3307	+	UGAUGACCAGCAGGUCAAAG	20	7156
SCNN1A-3308	+	AUGAUGACCAGCAGGUCAAAG	21	7157
SCNN1A-3309	+	CAUGAUGACCAGCAGGUCAAAG	22	7158
SCNN1A-3310	+	ACAUGAUGACCAGCAGGUCAAAG	23	7159
SCNN1A-3311	+	AACAUGAUGACCAGCAGGUCAAAG	24	7160
SCNN1A-3312	+	AGGGCGCCAUGGAGCAAG	18	7161
SCNN1A-3313	+	GAGGGCGCCAUGGAGCAAG	19	7162
SCNN1A-3314	+	AGAGGGCGCCAUGGAGCAAG	20	7163
SCNN1A-3315	+	CAGAGGGCGCCAUGGAGCAAG	21	7164
SCNN1A-3316	+	GCAGAGGGCGCCAUGGAGCAAG	22	7165
SCNN1A-3317	+	AGCAGAGGGCGCCAUGGAGCAAG	23	7166
SCNN1A-3318	+	AAGCAGAGGGCGCCAUGGAGCAAG	24	7167
SCNN1A-3319	+	GGGUUGUUGUCCCGCAAG	18	7168
SCNN1A-3320	+	GGGGUUGUUGUCCCGCAAG	19	7169
SCNN1A-3321	+	GGGGGUUGUUGUCCCGCAAG	20	7170
SCNN1A-3322	+	UGGGGGUUGUUGUCCCGCAAG	21	7171
SCNN1A-3323	+	CUGGGGGUUGUUGUCCCGCAAG	22	7172
SCNN1A-3324	+	CCUGGGGGUUGUUGUCCCGCAAG	23	7173
SCNN1A-3325	+	ACCUGGGGGUUGUUGUCCCGCAAG	24	7174
SCNN1A-3326	+	AUGGGGUGGGGGCAGAAG	18	7175
SCNN1A-3327	+	CAUGGGGUGGGGGCAGAAG	19	7176
SCNN1A-1109	+	ACAUGGGGUGGGGGCAGAAG	20	4958
SCNN1A-3328	+	GACAUGGGGUGGGGGCAGAAG	21	7177
SCNN1A-3329	+	AGACAUGGGGUGGGGGCAGAAG	22	7178
SCNN1A-3330	+	GAGACAUGGGGUGGGGGCAGAAG	23	7179
SCNN1A-3331	+	AGAGACAUGGGGUGGGGGCAGAAG	24	7180
SCNN1A-3332	+	UUGAAGCGGCAGGCGAAG	18	7181
SCNN1A-3333	+	GUUGAAGCGGCAGGCGAAG	19	7182
SCNN1A-3334	+	GGUUGAAGCGGCAGGCGAAG	20	7183
SCNN1A-3335	+	UGGUUGAAGCGGCAGGCGAAG	21	7184
SCNN1A-3336	+	CUGGUUGAAGCGGCAGGCGAAG	22	7185
SCNN1A-3337	+	CCUGGUUGAAGCGGCAGGCGAAG	23	7186
SCNN1A-3338	+	ACCUGGUUGAAGCGGCAGGCGAAG	24	7187
SCNN1A-3339	+	GGGGGCAGAAGUGGGAAG	18	7188
SCNN1A-3340	+	UGGGGGCAGAAGUGGGAAG	19	7189
SCNN1A-3341	+	GUGGGGGCAGAAGUGGGAAG	20	7190
SCNN1A-3342	+	GGUGGGGGCAGAAGUGGGAAG	21	7191
SCNN1A-3343	+	GGGUGGGGGCAGAAGUGGGAAG	22	7192
SCNN1A-3344	+	GGGGUGGGGGCAGAAGUGGGAAG	23	7193
SCNN1A-3345	+	UGGGGUGGGGGCAGAAGUGGGAAG	24	7194
SCNN1A-3346	+	AUCAUGCUCUCCUGGAAG	18	7195
SCNN1A-3347	+	GAUCAUGCUCUCCUGGAAG	19	7196
SCNN1A-3348	+	UGAUCAUGCUCUCCUGGAAG	20	7197
SCNN1A-3349	+	UUGAUCAUGCUCUCCUGGAAG	21	7198
SCNN1A-3350	+	CUUGAUCAUGCUCUCCUGGAAG	22	7199
SCNN1A-3351	+	CCUUGAUCAUGCUCUCCUGGAAG	23	7200
SCNN1A-3352	+	UCCUUGAUCAUGCUCUCCUGGAAG	24	7201
SCNN1A-3353	+	GGCCCCCCCAGAGGACAG	18	7202
SCNN1A-3354	+	GGGCCCCCCCAGAGGACAG	19	7203
SCNN1A-3355	+	AGGGCCCCCCCAGAGGACAG	20	7204
SCNN1A-3356	+	CAGGGCCCCCCCAGAGGACAG	21	7205
SCNN1A-3357	+	UCAGGGCCCCCCCAGAGGACAG	22	7206
SCNN1A-3358	+	CUCAGGGCCCCCCCAGAGGACAG	23	7207
SCNN1A-3359	+	UCUCAGGGCCCCCCCAGAGGACAG	24	7208
SCNN1A-3360	+	CCCAGUCACUGUGGACAG	18	7209
SCNN1A-3361	+	CCCCAGUCACUGUGGACAG	19	7210
SCNN1A-3362	+	GCCCCAGUCACUGUGGACAG	20	7211
SCNN1A-3363	+	GGCCCCAGUCACUGUGGACAG	21	7212
SCNN1A-3364	+	GGGCCCCAGUCACUGUGGACAG	22	7213
SCNN1A-3365	+	CGGGCCCCAGUCACUGUGGACAG	23	7214
SCNN1A-3366	+	CCGGGCCCCAGUCACUGUGGACAG	24	7215
SCNN1A-3367	+	CACGACCUACCGUGACAG	18	7216
SCNN1A-3368	+	GCACGACCUACCGUGACAG	19	7217
SCNN1A-1114	+	GGCACGACCUACCGUGACAG	20	4963
SCNN1A-3369	+	AGGCACGACCUACCGUGACAG	21	7218
SCNN1A-3370	+	CAGGCACGACCUACCGUGACAG	22	7219
SCNN1A-3371	+	CCAGGCACGACCUACCGUGACAG	23	7220
SCNN1A-3372	+	UCCAGGCACGACCUACCGUGACAG	24	7221
SCNN1A-3373	+	GCCAUCGUGAGUAACCAG	18	7222
SCNN1A-3374	+	GGCCAUCGUGAGUAACCAG	19	7223
SCNN1A-3375	+	GGGCCAUCGUGAGUAACCAG	20	7224
SCNN1A-3376	+	AGGGCCAUCGUGAGUAACCAG	21	7225
SCNN1A-3377	+	GAGGGCCAUCGUGAGUAACCAG	22	7226
SCNN1A-3378	+	CGAGGGCCAUCGUGAGUAACCAG	23	7227
SCNN1A-3379	+	CCGAGGGCCAUCGUGAGUAACCAG	24	7228
SCNN1A-3380	+	CGCUGCGGGCCUCACCAG	18	7229
SCNN1A-3381	+	GCGCUGCGGGCCUCACCAG	19	7230
SCNN1A-3382	+	GGCGCUGCGGGCCUCACCAG	20	7231
SCNN1A-3383	+	CGGCGCUGCGGGCCUCACCAG	21	7232
SCNN1A-3384	+	UCGGCGCUGCGGGCCUCACCAG	22	7233
SCNN1A-3385	+	CUCGGCGCUGCGGGCCUCACCAG	23	7234
SCNN1A-3386	+	CCUCGGCGCUGCGGGCCUCACCAG	24	7235
SCNN1A-3387	+	CCAGGGUGGCAUAGGCAG	18	7236
SCNN1A-3388	+	CCCAGGGUGGCAUAGGCAG	19	7237
SCNN1A-1120	+	GCCCAGGGUGGCAUAGGCAG	20	4969
SCNN1A-3389	+	GGCCCAGGGUGGCAUAGGCAG	21	7238
SCNN1A-3390	+	GGGCCCAGGGUGGCAUAGGCAG	22	7239
SCNN1A-3391	+	GGGGCCCAGGGUGGCAUAGGCAG	23	7240
SCNN1A-3392	+	GGGGGCCCAGGGUGGCAUAGGCAG	24	7241
SCNN1A-3393	+	ACCUGGUUGAAGCGGCAG	18	7242
SCNN1A-3394	+	GACCUGGUUGAAGCGGCAG	19	7243
SCNN1A-3395	+	AGACCUGGUUGAAGCGGCAG	20	7244
SCNN1A-3396	+	GAGACCUGGUUGAAGCGGCAG	21	7245
SCNN1A-3397	+	GGAGACCUGGUUGAAGCGGCAG	22	7246
SCNN1A-3398	+	AGGAGACCUGGUUGAAGCGGCAG	23	7247
SCNN1A-3399	+	CAGGAGACCUGGUUGAAGCGGCAG	24	7248
SCNN1A-3400	+	CACAGAGACUAGAGUCAG	18	7249
SCNN1A-3401	+	ACACAGAGACUAGAGUCAG	19	7250
SCNN1A-1125	+	GACACAGAGACUAGAGUCAG	20	4974
SCNN1A-3402	+	GGACACAGAGACUAGAGUCAG	21	7251
SCNN1A-3403	+	UGGACACAGAGACUAGAGUCAG	22	7252
SCNN1A-3404	+	CUGGACACAGAGACUAGAGUCAG	23	7253
SCNN1A-3405	+	ACUGGACACAGAGACUAGAGUCAG	24	7254
SCNN1A-3406	+	AGGGAGGAGGGUGGAGAG	18	7255
SCNN1A-3407	+	AAGGGAGGAGGGUGGAGAG	19	7256
SCNN1A-3408	+	GAAGGGAGGAGGGUGGAGAG	20	7257
SCNN1A-3409	+	GGAAGGGAGGAGGGUGGAGAG	21	7258
SCNN1A-3410	+	UGGAAGGGAGGAGGGUGGAGAG	22	7259
SCNN1A-3411	+	CUGGAAGGGAGGAGGGUGGAGAG	23	7260
SCNN1A-3412	+	CCUGGAAGGGAGGAGGGUGGAGAG	24	7261
SCNN1A-3413	+	GGUGACCAUCUGUGAGAG	18	7262
SCNN1A-3414	+	GGGUGACCAUCUGUGAGAG	19	7263
SCNN1A-3415	+	AGGGUGACCAUCUGUGAGAG	20	7264
SCNN1A-3416	+	GAGGGUGACCAUCUGUGAGAG	21	7265
SCNN1A-3417	+	GGAGGGUGACCAUCUGUGAGAG	22	7266
SCNN1A-3418	+	AGGAGGGUGACCAUCUGUGAGAG	23	7267
SCNN1A-3419	+	CAGGAGGGUGACCAUCUGUGAGAG	24	7268
SCNN1A-3420	+	GGUACCUGAAGGGGCGAG	18	7269
SCNN1A-3421	+	GGGUACCUGAAGGGGCGAG	19	7270
SCNN1A-1130	+	CGGGUACCUGAAGGGGCGAG	20	4979
SCNN1A-3422	+	CCGGGUACCUGAAGGGGCGAG	21	7271
SCNN1A-3423	+	UCCGGGUACCUGAAGGGGCGAG	22	7272
SCNN1A-3424	+	UUCCGGGUACCUGAAGGGGCGAG	23	7273
SCNN1A-3425	+	UUUCCGGGUACCUGAAGGGGCGAG	24	7274
SCNN1A-3426	+	GGCAGAAGUGGGAAGGAG	18	7275
SCNN1A-3427	+	GGGCAGAAGUGGGAAGGAG	19	7276
SCNN1A-1132	+	GGGGCAGAAGUGGGAAGGAG	20	4981
SCNN1A-3428	+	GGGGGCAGAAGUGGGAAGGAG	21	7277
SCNN1A-3429	+	UGGGGGCAGAAGUGGGAAGGAG	22	7278
SCNN1A-3430	+	GUGGGGGCAGAAGUGGGAAGGAG	23	7279
SCNN1A-3431	+	GGUGGGGGCAGAAGUGGGAAGGAG	24	7280
SCNN1A-3432	+	ACAGACAACACCGAGGAG	18	7281
SCNN1A-3433	+	CACAGACAACACCGAGGAG	19	7282
SCNN1A-3434	+	CCACAGACAACACCGAGGAG	20	7283
SCNN1A-3435	+	ACCACAGACAACACCGAGGAG	21	7284
SCNN1A-3436	+	CACCACAGACAACACCGAGGAG	22	7285
SCNN1A-3437	+	CCACCACAGACAACACCGAGGAG	23	7286
SCNN1A-3438	+	UCCACCACAGACAACACCGAGGAG	24	7287
SCNN1A-3439	+	UCAAGGCUGGAGAGGGAG	18	7288
SCNN1A-3440	+	GUCAAGGCUGGAGAGGGAG	19	7289
SCNN1A-3441	+	UGUCAAGGCUGGAGAGGGAG	20	7290
SCNN1A-3442	+	CUGUCAAGGCUGGAGAGGGAG	21	7291
SCNN1A-3443	+	GCUGUCAAGGCUGGAGAGGGAG	22	7292
SCNN1A-3444	+	GGCUGUCAAGGCUGGAGAGGGAG	23	7293
SCNN1A-3445	+	GGGCUGUCAAGGCUGGAGAGGGAG	24	7294
SCNN1A-3446	+	CUGCAGAGCCCCCUGGAG	18	7295
SCNN1A-3447	+	CCUGCAGAGCCCCCUGGAG	19	7296
SCNN1A-3448	+	CCCUGCAGAGCCCCCUGGAG	20	7297
SCNN1A-3449	+	CCCCUGCAGAGCCCCCUGGAG	21	7298
SCNN1A-3450	+	GCCCCUGCAGAGCCCCCUGGAG	22	7299
SCNN1A-3451	+	GGCCCCUGCAGAGCCCCCUGGAG	23	7300
SCNN1A-3452	+	UGGCCCCUGCAGAGCCCCCUGGAG	24	7301
SCNN1A-3453	+	GGGCUGUCAAGGCUGGAG	18	7302
SCNN1A-3454	+	GGGGCUGUCAAGGCUGGAG	19	7303
SCNN1A-1138	+	AGGGGCUGUCAAGGCUGGAG	20	4987
SCNN1A-3455	+	GAGGGGCUGUCAAGGCUGGAG	21	7304
SCNN1A-3456	+	GGAGGGGCUGUCAAGGCUGGAG	22	7305
SCNN1A-3457	+	GGGAGGGGCUGUCAAGGCUGGAG	23	7306
SCNN1A-3458	+	GGGGAGGGGCUGUCAAGGCUGGAG	24	7307
SCNN1A-3459	+	GAAGGGAGGAGGGUGGAG	18	7308
SCNN1A-3460	+	GGAAGGGAGGAGGGUGGAG	19	7309
SCNN1A-1139	+	UGGAAGGGAGGAGGGUGGAG	20	4988
SCNN1A-3461	+	CUGGAAGGGAGGAGGGUGGAG	21	7310
SCNN1A-3462	+	CCUGGAAGGGAGGAGGGUGGAG	22	7311
SCNN1A-3463	+	ACCUGGAAGGGAGGAGGGUGGAG	23	7312
SCNN1A-3464	+	CACCUGGAAGGGAGGAGGGUGGAG	24	7313
SCNN1A-3465	+	CAGCCCAGGUGGUCUGAG	18	7314
SCNN1A-3466	+	ACAGCCCAGGUGGUCUGAG	19	7315
SCNN1A-3467	+	AACAGCCCAGGUGGUCUGAG	20	7316
SCNN1A-3468	+	AAACAGCCCAGGUGGUCUGAG	21	7317
SCNN1A-3469	+	GAAACAGCCCAGGUGGUCUGAG	22	7318
SCNN1A-3470	+	UGAAACAGCCCAGGUGGUCUGAG	23	7319
SCNN1A-3471	+	GUGAAACAGCCCAGGUGGUCUGAG	24	7320
SCNN1A-3472	+	CUCGACGGGCCCCGUGAG	18	7321
SCNN1A-3473	+	GCUCGACGGGCCCCGUGAG	19	7322
SCNN1A-3474	+	GGCUCGACGGGCCCCGUGAG	20	7323
SCNN1A-3475	+	GGGCUCGACGGGCCCCGUGAG	21	7324
SCNN1A-3476	+	CGGGCUCGACGGGCCCCGUGAG	22	7325
SCNN1A-3477	+	ACGGGCUCGACGGGCCCCGUGAG	23	7326
SCNN1A-3478	+	UACGGGCUCGACGGGCCCCGUGAG	24	7327
SCNN1A-3479	+	AGGGUGACCAUCUGUGAG	18	7328
SCNN1A-3480	+	GAGGGUGACCAUCUGUGAG	19	7329
SCNN1A-1141	+	GGAGGGUGACCAUCUGUGAG	20	4990
SCNN1A-3481	+	AGGAGGGUGACCAUCUGUGAG	21	7330
SCNN1A-3482	+	CAGGAGGGUGACCAUCUGUGAG	22	7331
SCNN1A-3483	+	ACAGGAGGGUGACCAUCUGUGAG	23	7332
SCNN1A-3484	+	GACAGGAGGGUGACCAUCUGUGAG	24	7333
SCNN1A-3485	+	GACAGGAUGUUGAUGUAG	18	7334
SCNN1A-3486	+	CGACAGGAUGUUGAUGUAG	19	7335
SCNN1A-1143	+	UCGACAGGAUGUUGAUGUAG	20	4992
SCNN1A-3487	+	CUCGACAGGAUGUUGAUGUAG	21	7336
SCNN1A-3488	+	CCUCGACAGGAUGUUGAUGUAG	22	7337
SCNN1A-3489	+	GCCUCGACAGGAUGUUGAUGUAG	23	7338
SCNN1A-3490	+	AGCCUCGACAGGAUGUUGAUGUAG	24	7339
SCNN1A-3491	+	AGCUGGUAGCUGGUCACG	18	7340
SCNN1A-3492	+	GAGCUGGUAGCUGGUCACG	19	7341
SCNN1A-3493	+	AGAGCUGGUAGCUGGUCACG	20	7342
SCNN1A-3494	+	GAGAGCUGGUAGCUGGUCACG	21	7343
SCNN1A-3495	+	AGAGAGCUGGUAGCUGGUCACG	22	7344
SCNN1A-3496	+	CAGAGAGCUGGUAGCUGGUCACG	23	7345
SCNN1A-3497	+	GCAGAGAGCUGGUAGCUGGUCACG	24	7346
SCNN1A-3498	+	AGGAGAGGUACAUUGACG	18	7347
SCNN1A-3499	+	GAGGAGAGGUACAUUGACG	19	7348
SCNN1A-3500	+	AGAGGAGAGGUACAUUGACG	20	7349
SCNN1A-3501	+	GAGAGGAGAGGUACAUUGACG	21	7350
SCNN1A-3502	+	UGAGAGGAGAGGUACAUUGACG	22	7351
SCNN1A-3503	+	GUGAGAGGAGAGGUACAUUGACG	23	7352
SCNN1A-3504	+	UGUGAGAGGAGAGGUACAUUGACG	24	7353
SCNN1A-3505	+	CCACCACAGACAACACCG	18	7354
SCNN1A-3506	+	UCCACCACAGACAACACCG	19	7355
SCNN1A-1146	+	CUCCACCACAGACAACACCG	20	4995
SCNN1A-3507	+	UCUCCACCACAGACAACACCG	21	7356
SCNN1A-3508	+	AUCUCCACCACAGACAACACCG	22	7357
SCNN1A-3509	+	CAUCUCCACCACAGACAACACCG	23	7358
SCNN1A-3510	+	CCAUCUCCACCACAGACAACACCG	24	7359
SCNN1A-3511	+	CGGGUACCUGAAGGGGCG	18	7360
SCNN1A-3512	+	CCGGGUACCUGAAGGGGCG	19	7361
SCNN1A-1155	+	UCCGGGUACCUGAAGGGGCG	20	5004
SCNN1A-3513	+	UUCCGGGUACCUGAAGGGGCG	21	7362
SCNN1A-3514	+	UUUCCGGGUACCUGAAGGGGCG	22	7363
SCNN1A-3515	+	AUUUCCGGGUACCUGAAGGGGCG	23	7364
SCNN1A-3516	+	AAUUUCCGGGUACCUGAAGGGGCG	24	7365
SCNN1A-3517	+	GGCCACGCUACGGGCUCG	18	7366
SCNN1A-3518	+	AGGCCACGCUACGGGCUCG	19	7367
SCNN1A-3519	+	GAGGCCACGCUACGGGCUCG	20	7368
SCNN1A-3520	+	GGAGGCCACGCUACGGGCUCG	21	7369
SCNN1A-3521	+	UGGAGGCCACGCUACGGGCUCG	22	7370
SCNN1A-3522	+	CUGGAGGCCACGCUACGGGCUCG	23	7371
SCNN1A-3523	+	GCUGGAGGCCACGCUACGGGCUCG	24	7372
SCNN1A-3524	+	GGGGAGGGGCUGUCAAGG	18	7373
SCNN1A-3525	+	GGGGGAGGGGCUGUCAAGG	19	7374
SCNN1A-3526	+	AGGGGGAGGGGCUGUCAAGG	20	7375
SCNN1A-3527	+	CAGGGGGAGGGGCUGUCAAGG	21	7376
SCNN1A-3528	+	GCAGGGGGAGGGGCUGUCAAGG	22	7377
SCNN1A-3529	+	GGCAGGGGGAGGGGCUGUCAAGG	23	7378
SCNN1A-3530	+	AGGCAGGGGGAGGGGCUGUCAAGG	24	7379
SCNN1A-3531	+	GGGGCAGAAGUGGGAAGG	18	7380
SCNN1A-3532	+	GGGGGCAGAAGUGGGAAGG	19	7381
SCNN1A-1161	+	UGGGGGCAGAAGUGGGAAGG	20	5010
SCNN1A-3533	+	GUGGGGGCAGAAGUGGGAAGG	21	7382
SCNN1A-3534	+	GGUGGGGGCAGAAGUGGGAAGG	22	7383
SCNN1A-3535	+	GGGUGGGGGCAGAAGUGGGAAGG	23	7384
SCNN1A-3536	+	GGGGUGGGGGCAGAAGUGGGAAGG	24	7385
SCNN1A-3537	+	GAAUACACACCUGGAAGG	18	7386
SCNN1A-3538	+	UGAAUACACACCUGGAAGG	19	7387
SCNN1A-3539	+	GUGAAUACACACCUGGAAGG	20	7388
SCNN1A-3540	+	AGUGAAUACACACCUGGAAGG	21	7389
SCNN1A-3541	+	GAGUGAAUACACACCUGGAAGG	22	7390
SCNN1A-3542	+	GGAGUGAAUACACACCUGGAAGG	23	7391
SCNN1A-3543	+	AGGAGUGAAUACACACCUGGAAGG	24	7392
SCNN1A-3544	+	GCCCCCCCAGAGGACAGG	18	7393
SCNN1A-3545	+	GGCCCCCCCAGAGGACAGG	19	7394
SCNN1A-1162	+	GGGCCCCCCCAGAGGACAGG	20	5011
SCNN1A-3546	+	AGGGCCCCCCCAGAGGACAGG	21	7395
SCNN1A-3547	+	CAGGGCCCCCCCAGAGGACAGG	22	7396
SCNN1A-3548	+	UCAGGGCCCCCCCAGAGGACAGG	23	7397
SCNN1A-3549	+	CUCAGGGCCCCCCCAGAGGACAGG	24	7398
SCNN1A-3550	+	CUCCACUGGCUGCCCAGG	18	7399
SCNN1A-3551	+	GCUCCACUGGCUGCCCAGG	19	7400
SCNN1A-3552	+	GGCUCCACUGGCUGCCCAGG	20	7401
SCNN1A-3553	+	AGGCUCCACUGGCUGCCCAGG	21	7402
SCNN1A-3554	+	CAGGCUCCACUGGCUGCCCAGG	22	7403
SCNN1A-3555	+	ACAGGCUCCACUGGCUGCCCAGG	23	7404
SCNN1A-3556	+	CACAGGCUCCACUGGCUGCCCAGG	24	7405
SCNN1A-3557	+	GGAGGGGAGGAUGCCAGG	18	7406
SCNN1A-3558	+	AGGAGGGGAGGAUGCCAGG	19	7407
SCNN1A-3559	+	AAGGAGGGGAGGAUGCCAGG	20	7408
SCNN1A-3560	+	GAAGGAGGGGAGGAUGCCAGG	21	7409
SCNN1A-3561	+	GGAAGGAGGGGAGGAUGCCAGG	22	7410
SCNN1A-3562	+	GGGAAGGAGGGGAGGAUGCCAGG	23	7411
SCNN1A-3563	+	UGGGAAGGAGGGGAGGAUGCCAGG	24	7412
SCNN1A-3564	+	CAGGGUGGCAUAGGCAGG	18	7413
SCNN1A-3565	+	CCAGGGUGGCAUAGGCAGG	19	7414
SCNN1A-1167	+	CCCAGGGUGGCAUAGGCAGG	20	5016
SCNN1A-3566	+	GCCCAGGGUGGCAUAGGCAGG	21	7415
SCNN1A-3567	+	GGCCCAGGGUGGCAUAGGCAGG	22	7416
SCNN1A-3568	+	GGGCCCAGGGUGGCAUAGGCAGG	23	7417
SCNN1A-3569	+	GGGGCCCAGGGUGGCAUAGGCAGG	24	7418
SCNN1A-3570	+	AUGGAAGACAUCCAGAGG	18	7419
SCNN1A-3571	+	CAUGGAAGACAUCCAGAGG	19	7420
SCNN1A-3572	+	GCAUGGAAGACAUCCAGAGG	20	7421
SCNN1A-3573	+	GGCAUGGAAGACAUCCAGAGG	21	7422
SCNN1A-3574	+	AGGCAUGGAAGACAUCCAGAGG	22	7423
SCNN1A-3575	+	CAGGCAUGGAAGACAUCCAGAGG	23	7424
SCNN1A-3576	+	CCAGGCAUGGAAGACAUCCAGAGG	24	7425
SCNN1A-3577	+	UUAGGUGUGGGGCAGAGG	18	7426
SCNN1A-3578	+	CUUAGGUGUGGGGCAGAGG	19	7427
SCNN1A-3579	+	UCUUAGGUGUGGGGCAGAGG	20	7428
SCNN1A-3580	+	UUCUUAGGUGUGGGGCAGAGG	21	7429
SCNN1A-3581	+	UUUCUUAGGUGUGGGGCAGAGG	22	7430
SCNN1A-3582	+	AUUUCUUAGGUGUGGGGCAGAGG	23	7431
SCNN1A-3583	+	CAUUUCUUAGGUGUGGGGCAGAGG	24	7432
SCNN1A-3584	+	CACCUGGAAGGGAGGAGG	18	7433
SCNN1A-3585	+	ACACCUGGAAGGGAGGAGG	19	7434
SCNN1A-3586	+	CACACCUGGAAGGGAGGAGG	20	7435
SCNN1A-3587	+	ACACACCUGGAAGGGAGGAGG	21	7436
SCNN1A-3588	+	UACACACCUGGAAGGGAGGAGG	22	7437
SCNN1A-3589	+	AUACACACCUGGAAGGGAGGAGG	23	7438
SCNN1A-3590	+	AAUACACACCUGGAAGGGAGGAGG	24	7439
SCNN1A-3591	+	UCGACGGGCCCCGUGAGG	18	7440
SCNN1A-3592	+	CUCGACGGGCCCCGUGAGG	19	7441
SCNN1A-1172	+	GCUCGACGGGCCCCGUGAGG	20	5021
SCNN1A-3593	+	GGCUCGACGGGCCCCGUGAGG	21	7442
SCNN1A-3594	+	GGGCUCGACGGGCCCCGUGAGG	22	7443
SCNN1A-3595	+	CGGGCUCGACGGGCCCCGUGAGG	23	7444
SCNN1A-3596	+	ACGGGCUCGACGGGCCCCGUGAGG	24	7445
SCNN1A-3597	+	GGCCCAGGGUGGCAUAGG	18	7446
SCNN1A-3598	+	GGGCCCAGGGUGGCAUAGG	19	7447
SCNN1A-3599	+	GGGGCCCAGGGUGGCAUAGG	20	7448
SCNN1A-3600	+	GGGGGCCCAGGGUGGCAUAGG	21	7449
SCNN1A-3601	+	CGGGGGCCCAGGGUGGCAUAGG	22	7450
SCNN1A-3602	+	GCGGGGGCCCAGGGUGGCAUAGG	23	7451
SCNN1A-3603	+	GGCGGGGGCCCAGGGUGGCAUAGG	24	7452
SCNN1A-3604	+	AAUACACACCUGGAAGGG	18	7453
SCNN1A-3605	+	GAAUACACACCUGGAAGGG	19	7454
SCNN1A-1176	+	UGAAUACACACCUGGAAGGG	20	5025
SCNN1A-3606	+	GUGAAUACACACCUGGAAGGG	21	7455
SCNN1A-3607	+	AGUGAAUACACACCUGGAAGGG	22	7456
SCNN1A-3608	+	GAGUGAAUACACACCUGGAAGGG	23	7457
SCNN1A-3609	+	GGAGUGAAUACACACCUGGAAGGG	24	7458
SCNN1A-3610	+	UUCCGGGUACCUGAAGGG	18	7459
SCNN1A-3611	+	UUUCCGGGUACCUGAAGGG	19	7460
SCNN1A-3612	+	AUUUCCGGGUACCUGAAGGG	20	7461
SCNN1A-3613	+	AAUUUCCGGGUACCUGAAGGG	21	7462
SCNN1A-3614	+	UAAUUUCCGGGUACCUGAAGGG	22	7463
SCNN1A-3615	+	UUAAUUUCCGGGUACCUGAAGGG	23	7464
SCNN1A-3616	+	UUUAAUUUCCGGGUACCUGAAGGG	24	7465
SCNN1A-3617	+	UUGUGGCUGGGACCAGGG	18	7466
SCNN1A-3618	+	CUUGUGGCUGGGACCAGGG	19	7467
SCNN1A-3619	+	UCUUGUGGCUGGGACCAGGG	20	7468
SCNN1A-3620	+	GAGGGGAGGAUGCCAGGG	18	7469
SCNN1A-3621	+	GGAGGGGAGGAUGCCAGGG	19	7470
SCNN1A-1178	+	AGGAGGGGAGGAUGCCAGGG	20	5027
SCNN1A-3622	+	AAGGAGGGGAGGAUGCCAGGG	21	7471
SCNN1A-3623	+	GAAGGAGGGGAGGAUGCCAGGG	22	7472
SCNN1A-3624	+	GGAAGGAGGGGAGGAUGCCAGGG	23	7473
SCNN1A-3625	+	GGGAAGGAGGGGAGGAUGCCAGGG	24	7474
SCNN1A-3626	+	UAGGUGUGGGGCAGAGGG	18	7475
SCNN1A-3627	+	UUAGGUGUGGGGCAGAGGG	19	7476
SCNN1A-1179	+	CUUAGGUGUGGGGCAGAGGG	20	5028
SCNN1A-3628	+	UCUUAGGUGUGGGGCAGAGGG	21	7477
SCNN1A-3629	+	UUCUUAGGUGUGGGGCAGAGGG	22	7478
SCNN1A-3630	+	UUUCUUAGGUGUGGGGCAGAGGG	23	7479
SCNN1A-3631	+	AUUUCUUAGGUGUGGGGCAGAGGG	24	7480
SCNN1A-3632	+	ACCUGGAAGGGAGGAGGG	18	7481
SCNN1A-3633	+	CACCUGGAAGGGAGGAGGG	19	7482
SCNN1A-1180	+	ACACCUGGAAGGGAGGAGGG	20	5029
SCNN1A-3634	+	CACACCUGGAAGGGAGGAGGG	21	7483
SCNN1A-3635	+	ACACACCUGGAAGGGAGGAGGG	22	7484
SCNN1A-3636	+	UACACACCUGGAAGGGAGGAGGG	23	7485
SCNN1A-3637	+	AUACACACCUGGAAGGGAGGAGGG	24	7486
SCNN1A-3638	+	GGGUGGCAUAGGCAGGGG	18	7487
SCNN1A-3639	+	AGGGUGGCAUAGGCAGGGG	19	7488
SCNN1A-3640	+	CAGGGUGGCAUAGGCAGGGG	20	7489
SCNN1A-3641	+	CCAGGGUGGCAUAGGCAGGGG	21	7490
SCNN1A-3642	+	CCCAGGGUGGCAUAGGCAGGGG	22	7491
SCNN1A-3643	+	GCCCAGGGUGGCAUAGGCAGGGG	23	7492
SCNN1A-3644	+	GGCCCAGGGUGGCAUAGGCAGGGG	24	7493
SCNN1A-3645	+	ACCUGAAGGGGCGAGGGG	18	7494
SCNN1A-3646	+	UACCUGAAGGGGCGAGGGG	19	7495
SCNN1A-3647	+	GUACCUGAAGGGGCGAGGGG	20	7496
SCNN1A-3648	+	GGUACCUGAAGGGGCGAGGGG	21	7497
SCNN1A-3649	+	GGGUACCUGAAGGGGCGAGGGG	22	7498
SCNN1A-3650	+	CGGGUACCUGAAGGGGCGAGGGG	23	7499
SCNN1A-3651	+	CCGGGUACCUGAAGGGGCGAGGGG	24	7500
SCNN1A-3652	+	GGGCCCCGUGAGGCGGGG	18	7501
SCNN1A-3653	+	CGGGCCCCGUGAGGCGGGG	19	7502
SCNN1A-3654	+	ACGGGCCCCGUGAGGCGGGG	20	7503
SCNN1A-3655	+	GACGGGCCCCGUGAGGCGGGG	21	7504
SCNN1A-3656	+	CGACGGGCCCCGUGAGGCGGGG	22	7505
SCNN1A-3657	+	UCGACGGGCCCCGUGAGGCGGGG	23	7506
SCNN1A-3658	+	CUCGACGGGCCCCGUGAGGCGGGG	24	7507
SCNN1A-3659	+	GGUGGCAUAGGCAGGGGG	18	7508
SCNN1A-3660	+	GGGUGGCAUAGGCAGGGGG	19	7509
SCNN1A-1184	+	AGGGUGGCAUAGGCAGGGGG	20	5033
SCNN1A-3661	+	CAGGGUGGCAUAGGCAGGGGG	21	7510
SCNN1A-3662	+	CCAGGGUGGCAUAGGCAGGGGG	22	7511
SCNN1A-3663	+	CCCAGGGUGGCAUAGGCAGGGGG	23	7512
SCNN1A-3664	+	GCCCAGGGUGGCAUAGGCAGGGGG	24	7513
SCNN1A-3665	+	GGCCCCGUGAGGCGGGGG	18	7514
SCNN1A-3666	+	GGGCCCCGUGAGGCGGGGG	19	7515
SCNN1A-1185	+	CGGGCCCCGUGAGGCGGGGG	20	5034
SCNN1A-3667	+	ACGGGCCCCGUGAGGCGGGGG	21	7516
SCNN1A-3668	+	GACGGGCCCCGUGAGGCGGGGG	22	7517
SCNN1A-3669	+	CGACGGGCCCCGUGAGGCGGGGG	23	7518
SCNN1A-3670	+	UCGACGGGCCCCGUGAGGCGGGGG	24	7519
SCNN1A-3671	+	AGAGACAUGGGGUGGGGG	18	7520
SCNN1A-3672	+	CAGAGACAUGGGGUGGGGG	19	7521
SCNN1A-3673	+	ACAGAGACAUGGGGUGGGGG	20	7522
SCNN1A-3674	+	GACAGAGACAUGGGGUGGGGG	21	7523
SCNN1A-3675	+	GGACAGAGACAUGGGGUGGGGG	22	7524
SCNN1A-3676	+	AGGACAGAGACAUGGGGUGGGGG	23	7525
SCNN1A-3677	+	AAGGACAGAGACAUGGGGUGGGGG	24	7526
SCNN1A-3678	+	AAGGACAGAGACAUGGGG	18	7527
SCNN1A-3679	+	CAAGGACAGAGACAUGGGG	19	7528
SCNN1A-1186	+	ACAAGGACAGAGACAUGGGG	20	5035
SCNN1A-3680	+	GACAAGGACAGAGACAUGGGG	21	7529
SCNN1A-3681	+	GGACAAGGACAGAGACAUGGGG	22	7530
SCNN1A-3682	+	GGGACAAGGACAGAGACAUGGGG	23	7531
SCNN1A-3683	+	UGGGACAAGGACAGAGACAUGGGG	24	7532
SCNN1A-3684	+	UAGCUGGUCACGCUGGGG	18	7533
SCNN1A-3685	+	GUAGCUGGUCACGCUGGGG	19	7534
SCNN1A-3686	+	GGUAGCUGGUCACGCUGGGG	20	7535
SCNN1A-3687	+	UGGUAGCUGGUCACGCUGGGG	21	7536
SCNN1A-3688	+	CUGGUAGCUGGUCACGCUGGGG	22	7537
SCNN1A-3689	+	GCUGGUAGCUGGUCACGCUGGGG	23	7538
SCNN1A-3690	+	AGCUGGUAGCUGGUCACGCUGGGG	24	7539
SCNN1A-3691	+	CAUUUCUUAGGUGUGGGG	18	7540
SCNN1A-3692	+	CCAUUUCUUAGGUGUGGGG	19	7541
SCNN1A-3693	+	UCCAUUUCUUAGGUGUGGGG	20	7542
SCNN1A-3694	+	CUCCAUUUCUUAGGUGUGGGG	21	7543
SCNN1A-3695	+	ACUCCAUUUCUUAGGUGUGGGG	22	7544
SCNN1A-3696	+	CACUCCAUUUCUUAGGUGUGGGG	23	7545
SCNN1A-3697	+	CCACUCCAUUUCUUAGGUGUGGGG	24	7546
SCNN1A-3698	+	CAAGGACAGAGACAUGGG	18	7547
SCNN1A-3699	+	ACAAGGACAGAGACAUGGG	19	7548
SCNN1A-3700	+	GACAAGGACAGAGACAUGGG	20	7549
SCNN1A-3701	+	GGACAAGGACAGAGACAUGGG	21	7550
SCNN1A-3702	+	GGGACAAGGACAGAGACAUGGG	22	7551
SCNN1A-3703	+	UGGGACAAGGACAGAGACAUGGG	23	7552
SCNN1A-3704	+	CUGGGACAAGGACAGAGACAUGGG	24	7553
SCNN1A-3705	+	GAGCCCCCUGGAGAUGGG	18	7554
SCNN1A-3706	+	AGAGCCCCCUGGAGAUGGG	19	7555
SCNN1A-1188	+	CAGAGCCCCCUGGAGAUGGG	20	5037
SCNN1A-3707	+	GCAGAGCCCCCUGGAGAUGGG	21	7556
SCNN1A-3708	+	UGCAGAGCCCCCUGGAGAUGGG	22	7557
SCNN1A-3709	+	CUGCAGAGCCCCCUGGAGAUGGG	23	7558
SCNN1A-3710	+	CCUGCAGAGCCCCCUGGAGAUGGG	24	7559
SCNN1A-3711	+	GGUGGGGGCAGAAGUGGG	18	7560
SCNN1A-3712	+	GGGUGGGGGCAGAAGUGGG	19	7561
SCNN1A-3713	+	GGGGUGGGGGCAGAAGUGGG	20	7562
SCNN1A-3714	+	UGGGGUGGGGGCAGAAGUGGG	21	7563
SCNN1A-3715	+	AUGGGGUGGGGGCAGAAGUGGG	22	7564
SCNN1A-3716	+	CAUGGGGUGGGGGCAGAAGUGGG	23	7565
SCNN1A-3717	+	ACAUGGGGUGGGGGCAGAAGUGGG	24	7566
SCNN1A-3718	+	UGUGGGGCAGAGGGUGGG	18	7567
SCNN1A-3719	+	GUGUGGGGCAGAGGGUGGG	19	7568
SCNN1A-3720	+	GGUGUGGGGCAGAGGGUGGG	20	7569
SCNN1A-3721	+	AGGUGUGGGGCAGAGGGUGGG	21	7570
SCNN1A-3722	+	UAGGUGUGGGGCAGAGGGUGGG	22	7571
SCNN1A-3723	+	UUAGGUGUGGGGCAGAGGGUGGG	23	7572
SCNN1A-3724	+	CUUAGGUGUGGGGCAGAGGGUGGG	24	7573
SCNN1A-3725	+	AGAGCCCCCUGGAGAUGG	18	7574
SCNN1A-3726	+	CAGAGCCCCCUGGAGAUGG	19	7575
SCNN1A-3727	+	GCAGAGCCCCCUGGAGAUGG	20	7576
SCNN1A-3728	+	UGCAGAGCCCCCUGGAGAUGG	21	7577
SCNN1A-3729	+	CUGCAGAGCCCCCUGGAGAUGG	22	7578
SCNN1A-3730	+	CCUGCAGAGCCCCCUGGAGAUGG	23	7579
SCNN1A-3731	+	CCCUGCAGAGCCCCCUGGAGAUGG	24	7580
SCNN1A-3732	+	GAGUGAAUACACACCUGG	18	7581
SCNN1A-3733	+	GGAGUGAAUACACACCUGG	19	7582
SCNN1A-3734	+	AGGAGUGAAUACACACCUGG	20	7583
SCNN1A-3735	+	CAGGAGUGAAUACACACCUGG	21	7584
SCNN1A-3736	+	GCAGGAGUGAAUACACACCUGG	22	7585
SCNN1A-3737	+	AGCAGGAGUGAAUACACACCUGG	23	7586
SCNN1A-3738	+	AAGCAGGAGUGAAUACACACCUGG	24	7587
SCNN1A-3739	+	UGGUUGCAGGAGACCUGG	18	7588
SCNN1A-3740	+	CUGGUUGCAGGAGACCUGG	19	7589
SCNN1A-3741	+	CCUGGUUGCAGGAGACCUGG	20	7590
SCNN1A-3742	+	GCCUGGUUGCAGGAGACCUGG	21	7591
SCNN1A-3743	+	CGCCUGGUUGCAGGAGACCUGG	22	7592
SCNN1A-3744	+	ACGCCUGGUUGCAGGAGACCUGG	23	7593
SCNN1A-3745	+	CACGCCUGGUUGCAGGAGACCUGG	24	7594
SCNN1A-3746	+	AGAGGGAGCAGGGCCUGG	18	7595
SCNN1A-3747	+	GAGAGGGAGCAGGGCCUGG	19	7596
SCNN1A-3748	+	GGAGAGGGAGCAGGGCCUGG	20	7597
SCNN1A-3749	+	UGGAGAGGGAGCAGGGCCUGG	21	7598
SCNN1A-3750	+	CUGGAGAGGGAGCAGGGCCUGG	22	7599
SCNN1A-3751	+	GCUGGAGAGGGAGCAGGGCCUGG	23	7600
SCNN1A-3752	+	GGCUGGAGAGGGAGCAGGGCCUGG	24	7601
SCNN1A-3753	+	CCUGAUGAGUAUGUCUGG	18	7602
SCNN1A-3754	+	CCCUGAUGAGUAUGUCUGG	19	7603
SCNN1A-3755	+	CCCCUGAUGAGUAUGUCUGG	20	7604
SCNN1A-3756	+	ACCCCUGAUGAGUAUGUCUGG	21	7605
SCNN1A-3757	+	CACCCCUGAUGAGUAUGUCUGG	22	7606
SCNN1A-3758	+	CCACCCCUGAUGAGUAUGUCUGG	23	7607
SCNN1A-3759	+	UCCACCCCUGAUGAGUAUGUCUGG	24	7608
SCNN1A-3760	+	CCCCCAGAGGACAGGUGG	18	7609
SCNN1A-3761	+	CCCCCCAGAGGACAGGUGG	19	7610
SCNN1A-1200	+	CCCCCCCAGAGGACAGGUGG	20	5049
SCNN1A-3762	+	GCCCCCCCAGAGGACAGGUGG	21	7611
SCNN1A-3763	+	GGCCCCCCCAGAGGACAGGUGG	22	7612
SCNN1A-3764	+	GGGCCCCCCCAGAGGACAGGUGG	23	7613
SCNN1A-3765	+	AGGGCCCCCCCAGAGGACAGGUGG	24	7614
SCNN1A-3766	+	UUUCCAUACAUCGGGUGG	18	7615
SCNN1A-3767	+	GUUUCCAUACAUCGGGUGG	19	7616
SCNN1A-1202	+	AGUUUCCAUACAUCGGGUGG	20	5051
SCNN1A-3768	+	CAGUUUCCAUACAUCGGGUGG	21	7617
SCNN1A-3769	+	GCAGUUUCCAUACAUCGGGUGG	22	7618
SCNN1A-3770	+	AGCAGUUUCCAUACAUCGGGUGG	23	7619
SCNN1A-3771	+	UAGCAGUUUCCAUACAUCGGGUGG	24	7620
SCNN1A-3772	+	AACCUUCGGAGCAGCAUG	18	7621
SCNN1A-3773	+	GAACCUUCGGAGCAGCAUG	19	7622
SCNN1A-1209	+	GGAACCUUCGGAGCAGCAUG	20	5058
SCNN1A-3774	+	CGGAACCUUCGGAGCAGCAUG	21	7623
SCNN1A-3775	+	UCGGAACCUUCGGAGCAGCAUG	22	7624
SCNN1A-3776	+	UUCGGAACCUUCGGAGCAGCAUG	23	7625
SCNN1A-3777	+	CUUCGGAACCUUCGGAGCAGCAUG	24	7626
SCNN1A-3778	+	CUGGUCACGCUGGGGAUG	18	7627
SCNN1A-3779	+	GCUGGUCACGCUGGGGAUG	19	7628
SCNN1A-3780	+	AGCUGGUCACGCUGGGGAUG	20	7629
SCNN1A-3781	+	UAGCUGGUCACGCUGGGGAUG	21	7630
SCNN1A-3782	+	GUAGCUGGUCACGCUGGGGAUG	22	7631
SCNN1A-3783	+	GGUAGCUGGUCACGCUGGGGAUG	23	7632
SCNN1A-3784	+	UGGUAGCUGGUCACGCUGGGGAUG	24	7633
SCNN1A-3785	+	UUAAUUUCCGGGUACCUG	18	7634
SCNN1A-3786	+	UUUAAUUUCCGGGUACCUG	19	7635
SCNN1A-3787	+	CUUUAAUUUCCGGGUACCUG	20	7636
SCNN1A-3788	+	UCUUUAAUUUCCGGGUACCUG	21	7637
SCNN1A-3789	+	CUCUUUAAUUUCCGGGUACCUG	22	7638
SCNN1A-3790	+	CCUCUUUAAUUUCCGGGUACCUG	23	7639
SCNN1A-3791	+	UCCUCUUUAAUUUCCGGGUACCUG	24	7640
SCNN1A-3792	+	UGGAGGAACUGGCCCCUG	18	7641
SCNN1A-3793	+	GUGGAGGAACUGGCCCCUG	19	7642
SCNN1A-3794	+	GGUGGAGGAACUGGCCCCUG	20	7643
SCNN1A-3795	+	AGGUGGAGGAACUGGCCCCUG	21	7644
SCNN1A-3796	+	CAGGUGGAGGAACUGGCCCCUG	22	7645
SCNN1A-3797	+	ACAGGUGGAGGAACUGGCCCCUG	23	7646
SCNN1A-3798	+	GACAGGUGGAGGAACUGGCCCCUG	24	7647
SCNN1A-3799	+	GAGGGGCUGUCAAGGCUG	18	7648
SCNN1A-3800	+	GGAGGGGCUGUCAAGGCUG	19	7649
SCNN1A-3801	+	GGGAGGGGCUGUCAAGGCUG	20	7650
SCNN1A-3802	+	GGGGAGGGGCUGUCAAGGCUG	21	7651
SCNN1A-3803	+	GGGGGAGGGGCUGUCAAGGCUG	22	7652
SCNN1A-3804	+	AGGGGGAGGGGCUGUCAAGGCUG	23	7653
SCNN1A-3805	+	CAGGGGGAGGGGCUGUCAAGGCUG	24	7654
SCNN1A-3806	+	CGCAGGUCGCGACGGCUG	18	7655
SCNN1A-3807	+	CCGCAGGUCGCGACGGCUG	19	7656
SCNN1A-1223	+	CCCGCAGGUCGCGACGGCUG	20	5072
SCNN1A-3808	+	CCCCGCAGGUCGCGACGGCUG	21	7657
SCNN1A-3809	+	CCCCCGCAGGUCGCGACGGCUG	22	7658
SCNN1A-3810	+	UCCCCCGCAGGUCGCGACGGCUG	23	7659
SCNN1A-3811	+	GUCCCCCGCAGGUCGCGACGGCUG	24	7660
SCNN1A-3812	+	CUUGCCUUCCUCAUGCUG	18	7661
SCNN1A-3813	+	CCUUGCCUUCCUCAUGCUG	19	7662
SCNN1A-3814	+	UCCUUGCCUUCCUCAUGCUG	20	7663
SCNN1A-3815	+	AUCCUUGCCUUCCUCAUGCUG	21	7664
SCNN1A-3816	+	CAUCCUUGCCUUCCUCAUGCUG	22	7665
SCNN1A-3817	+	GCAUCCUUGCCUUCCUCAUGCUG	23	7666
SCNN1A-3818	+	AGCAUCCUUGCCUUCCUCAUGCUG	24	7667
SCNN1A-3819	+	AACAGCCCAGGUGGUCUG	18	7668
SCNN1A-3820	+	AAACAGCCCAGGUGGUCUG	19	7669
SCNN1A-1225	+	GAAACAGCCCAGGUGGUCUG	20	5074
SCNN1A-3821	+	UGAAACAGCCCAGGUGGUCUG	21	7670
SCNN1A-3822	+	GUGAAACAGCCCAGGUGGUCUG	22	7671
SCNN1A-3823	+	GGUGAAACAGCCCAGGUGGUCUG	23	7672
SCNN1A-3824	+	UGGUGAAACAGCCCAGGUGGUCUG	24	7673
SCNN1A-3825	+	GAGCCGGCCACGAGAGUG	18	7674
SCNN1A-3826	+	GGAGCCGGCCACGAGAGUG	19	7675
SCNN1A-3827	+	GGGAGCCGGCCACGAGAGUG	20	7676
SCNN1A-3828	+	CGGGAGCCGGCCACGAGAGUG	21	7677
SCNN1A-3829	+	GCGGGAGCCGGCCACGAGAGUG	22	7678
SCNN1A-3830	+	UGCGGGAGCCGGCCACGAGAGUG	23	7679
SCNN1A-3831	+	CUGCGGGAGCCGGCCACGAGAGUG	24	7680
SCNN1A-3832	+	CCCCCCAGAGGACAGGUG	18	7681
SCNN1A-3833	+	CCCCCCCAGAGGACAGGUG	19	7682
SCNN1A-3834	+	GCCCCCCCAGAGGACAGGUG	20	7683
SCNN1A-3835	+	GGCCCCCCCAGAGGACAGGUG	21	7684
SCNN1A-3836	+	GGGCCCCCCCAGAGGACAGGUG	22	7685
SCNN1A-3837	+	AGGGCCCCCCCAGAGGACAGGUG	23	7686
SCNN1A-3838	+	CAGGGCCCCCCCAGAGGACAGGUG	24	7687
SCNN1A-3839	+	CACUCCAUUUCUUAGGUG	18	7688
SCNN1A-3840	+	CCACUCCAUUUCUUAGGUG	19	7689
SCNN1A-1232	+	GCCACUCCAUUUCUUAGGUG	20	5081
SCNN1A-3841	+	GGCCACUCCAUUUCUUAGGUG	21	7690
SCNN1A-3842	+	UGGCCACUCCAUUUCUUAGGUG	22	7691
SCNN1A-3843	+	UUGGCCACUCCAUUUCUUAGGUG	23	7692
SCNN1A-3844	+	UUUGGCCACUCCAUUUCUUAGGUG	24	7693
SCNN1A-3845	+	CUGGAAGGGAGGAGGGUG	18	7694
SCNN1A-3846	+	CCUGGAAGGGAGGAGGGUG	19	7695
SCNN1A-3847	+	ACCUGGAAGGGAGGAGGGUG	20	7696
SCNN1A-3848	+	CACCUGGAAGGGAGGAGGGUG	21	7697
SCNN1A-3849	+	ACACCUGGAAGGGAGGAGGGUG	22	7698
SCNN1A-3850	+	CACACCUGGAAGGGAGGAGGGUG	23	7699
SCNN1A-3851	+	ACACACCUGGAAGGGAGGAGGGUG	24	7700
SCNN1A-3852	+	GUUUCCAUACAUCGGGUG	18	7701
SCNN1A-3853	+	AGUUUCCAUACAUCGGGUG	19	7702
SCNN1A-3854	+	CAGUUUCCAUACAUCGGGUG	20	7703
SCNN1A-3855	+	GCAGUUUCCAUACAUCGGGUG	21	7704
SCNN1A-3856	+	AGCAGUUUCCAUACAUCGGGUG	22	7705
SCNN1A-3857	+	UAGCAGUUUCCAUACAUCGGGUG	23	7706
SCNN1A-3858	+	AUAGCAGUUUCCAUACAUCGGGUG	24	7707
SCNN1A-3859	+	GGGACAGACCUAGGGGUG	18	7708
SCNN1A-3860	+	AGGGACAGACCUAGGGGUG	19	7709
SCNN1A-3861	+	CAGGGACAGACCUAGGGGUG	20	7710
SCNN1A-3862	+	UCAGGGACAGACCUAGGGGUG	21	7711
SCNN1A-3863	+	AUCAGGGACAGACCUAGGGGUG	22	7712
SCNN1A-3864	+	CAUCAGGGACAGACCUAGGGGUG	23	7713
SCNN1A-3865	+	GCAUCAGGGACAGACCUAGGGGUG	24	7714
SCNN1A-3866	+	CCGGCCACGAGAGUGGUG	18	7715
SCNN1A-3867	+	GCCGGCCACGAGAGUGGUG	19	7716
SCNN1A-3868	+	AGCCGGCCACGAGAGUGGUG	20	7717
SCNN1A-3869	+	GAGCCGGCCACGAGAGUGGUG	21	7718
SCNN1A-3870	+	GGAGCCGGCCACGAGAGUGGUG	22	7719
SCNN1A-3871	+	GGGAGCCGGCCACGAGAGUGGUG	23	7720
SCNN1A-3872	+	CGGGAGCCGGCCACGAGAGUGGUG	24	7721
SCNN1A-3873	+	CAUGGCUUCCGGCACUUG	18	7722
SCNN1A-3874	+	GCAUGGCUUCCGGCACUUG	19	7723
SCNN1A-3875	+	UGCAUGGCUUCCGGCACUUG	20	7724
SCNN1A-3876	+	CUGCAUGGCUUCCGGCACUUG	21	7725
SCNN1A-3877	+	CCUGCAUGGCUUCCGGCACUUG	22	7726
SCNN1A-3878	+	ACCUGCAUGGCUUCCGGCACUUG	23	7727
SCNN1A-3879	+	AACCUGCAUGGCUUCCGGCACUUG	24	7728
SCNN1A-3880	+	UUGUAGUUCAGCUCCUUG	18	7729
SCNN1A-3881	+	UUUGUAGUUCAGCUCCUUG	19	7730
SCNN1A-3882	+	UUUUGUAGUUCAGCUCCUUG	20	7731
SCNN1A-3883	+	GUUUUGUAGUUCAGCUCCUUG	21	7732
SCNN1A-3884	+	GGUUUUGUAGUUCAGCUCCUUG	22	7733
SCNN1A-3885	+	UGGUUUUGUAGUUCAGCUCCUUG	23	7734
SCNN1A-3886	+	UUGGUUUUGUAGUUCAGCUCCUUG	24	7735
SCNN1A-3887	+	CUGACUCACGCCUGGUUG	18	7736
SCNN1A-3888	+	ACUGACUCACGCCUGGUUG	19	7737
SCNN1A-3889	+	GACUGACUCACGCCUGGUUG	20	7738
SCNN1A-3890	+	GGACUGACUCACGCCUGGUUG	21	7739
SCNN1A-3891	+	AGGACUGACUCACGCCUGGUUG	22	7740
SCNN1A-3892	+	CAGGACUGACUCACGCCUGGUUG	23	7741
SCNN1A-3893	+	GCAGGACUGACUCACGCCUGGUUG	24	7742
SCNN1A-3894	+	GAACCUUCGGAGCAGCAU	18	7743
SCNN1A-3895	+	GGAACCUUCGGAGCAGCAU	19	7744
SCNN1A-3896	+	CGGAACCUUCGGAGCAGCAU	20	7745
SCNN1A-3897	+	UCGGAACCUUCGGAGCAGCAU	21	7746
SCNN1A-3898	+	UUCGGAACCUUCGGAGCAGCAU	22	7747
SCNN1A-3899	+	CUUCGGAACCUUCGGAGCAGCAU	23	7748
SCNN1A-3900	+	GCUUCGGAACCUUCGGAGCAGCAU	24	7749
SCNN1A-3901	+	CUGCUCUGCGCGCAGCAU	18	7750
SCNN1A-3902	+	UCUGCUCUGCGCGCAGCAU	19	7751
SCNN1A-3903	+	UUCUGCUCUGCGCGCAGCAU	20	7752
SCNN1A-3904	+	AUUCUGCUCUGCGCGCAGCAU	21	7753
SCNN1A-3905	+	CAUUCUGCUCUGCGCGCAGCAU	22	7754
SCNN1A-3906	+	UCAUUCUGCUCUGCGCGCAGCAU	23	7755
SCNN1A-3907	+	GUCAUUCUGCUCUGCGCGCAGCAU	24	7756
SCNN1A-3908	+	GUUCUGUCGCGAUAGCAU	18	7757
SCNN1A-3909	+	UGUUCUGUCGCGAUAGCAU	19	7758
SCNN1A-3910	+	UUGUUCUGUCGCGAUAGCAU	20	7759
SCNN1A-3911	+	AUUGUUCUGUCGCGAUAGCAU	21	7760
SCNN1A-3912	+	AAUUGUUCUGUCGCGAUAGCAU	22	7761
SCNN1A-3913	+	UAAUUGUUCUGUCGCGAUAGCAU	23	7762
SCNN1A-3914	+	GUAAUUGUUCUGUCGCGAUAGCAU	24	7763
SCNN1A-3915	+	GUGAGAGUAAUUCCUUAU	18	7764
SCNN1A-3916	+	AGUGAGAGUAAUUCCUUAU	19	7765
SCNN1A-3917	+	AAGUGAGAGUAAUUCCUUAU	20	7766
SCNN1A-3918	+	GAAGUGAGAGUAAUUCCUUAU	21	7767
SCNN1A-3919	+	GGAAGUGAGAGUAAUUCCUUAU	22	7768
SCNN1A-3920	+	UGGAAGUGAGAGUAAUUCCUUAU	23	7769
SCNN1A-3921	+	GUGGAAGUGAGAGUAAUUCCUUAU	24	7770
SCNN1A-3922	+	ACCCGGGCCCCAGUCACU	18	7771
SCNN1A-3923	+	UACCCGGGCCCCAGUCACU	19	7772
SCNN1A-3924	+	UUACCCGGGCCCCAGUCACU	20	7773
SCNN1A-3925	+	AUUACCCGGGCCCCAGUCACU	21	7774
SCNN1A-3926	+	CAUUACCCGGGCCCCAGUCACU	22	7775
SCNN1A-3927	+	CCAUUACCCGGGCCCCAGUCACU	23	7776
SCNN1A-3928	+	ACCAUUACCCGGGCCCCAGUCACU	24	7777
SCNN1A-3929	+	UCACCUGCUGUGUGUACU	18	7778
SCNN1A-3930	+	CUCACCUGCUGUGUGUACU	19	7779
SCNN1A-3931	+	CCUCACCUGCUGUGUGUACU	20	7780
SCNN1A-3932	+	GCCUCACCUGCUGUGUGUACU	21	7781
SCNN1A-3933	+	GGCCUCACCUGCUGUGUGUACU	22	7782
SCNN1A-3934	+	GGGCCUCACCUGCUGUGUGUACU	23	7783
SCNN1A-3935	+	UGGGCCUCACCUGCUGUGUGUACU	24	7784
SCNN1A-3936	+	GUAUCGGCUUCGGAACCU	18	7785
SCNN1A-3937	+	AGUAUCGGCUUCGGAACCU	19	7786
SCNN1A-3938	+	CAGUAUCGGCUUCGGAACCU	20	7787
SCNN1A-3939	+	CCAGUAUCGGCUUCGGAACCU	21	7788
SCNN1A-3940	+	ACCAGUAUCGGCUUCGGAACCU	22	7789
SCNN1A-3941	+	GACCAGUAUCGGCUUCGGAACCU	23	7790
SCNN1A-3942	+	AGACCAGUAUCGGCUUCGGAACCU	24	7791
SCNN1A-3943	+	UCUGGAAGACCCAUUCCU	18	7792
SCNN1A-3944	+	AUCUGGAAGACCCAUUCCU	19	7793
SCNN1A-1270	+	CAUCUGGAAGACCCAUUCCU	20	5119
SCNN1A-3945	+	GCAUCUGGAAGACCCAUUCCU	21	7794
SCNN1A-3946	+	AGCAUCUGGAAGACCCAUUCCU	22	7795
SCNN1A-3947	+	UAGCAUCUGGAAGACCCAUUCCU	23	7796
SCNN1A-3948	+	AUAGCAUCUGGAAGACCCAUUCCU	24	7797
SCNN1A-3949	+	GUCUGUCCAGGGUUUCCU	18	7798
SCNN1A-3950	+	AGUCUGUCCAGGGUUUCCU	19	7799
SCNN1A-3951	+	AAGUCUGUCCAGGGUUUCCU	20	7800
SCNN1A-3952	+	CAAGUCUGUCCAGGGUUUCCU	21	7801
SCNN1A-3953	+	CCAAGUCUGUCCAGGGUUUCCU	22	7802
SCNN1A-3954	+	CCCAAGUCUGUCCAGGGUUUCCU	23	7803
SCNN1A-3955	+	CCCCAAGUCUGUCCAGGGUUUCCU	24	7804
SCNN1A-3956	+	CAAGCUGGAGGCCACGCU	18	7805
SCNN1A-3957	+	GCAAGCUGGAGGCCACGCU	19	7806
SCNN1A-3958	+	CGCAAGCUGGAGGCCACGCU	20	7807
SCNN1A-3959	+	CCGCAAGCUGGAGGCCACGCU	21	7808
SCNN1A-3960	+	CCCGCAAGCUGGAGGCCACGCU	22	7809
SCNN1A-3961	+	UCCCGCAAGCUGGAGGCCACGCU	23	7810
SCNN1A-3962	+	GUCCCGCAAGCUGGAGGCCACGCU	24	7811
SCNN1A-3963	+	CCGCAGGUCGCGACGGCU	18	7812
SCNN1A-3964	+	CCCGCAGGUCGCGACGGCU	19	7813
SCNN1A-3965	+	CCCCGCAGGUCGCGACGGCU	20	7814
SCNN1A-3966	+	CCCCCGCAGGUCGCGACGGCU	21	7815
SCNN1A-3967	+	UCCCCCGCAGGUCGCGACGGCU	22	7816
SCNN1A-3968	+	GUCCCCCGCAGGUCGCGACGGCU	23	7817
SCNN1A-3969	+	AGUCCCCCGCAGGUCGCGACGGCU	24	7818
SCNN1A-3970	+	UGGAGACCAGUAUCGGCU	18	7819
SCNN1A-3971	+	CUGGAGACCAGUAUCGGCU	19	7820
SCNN1A-3972	+	CCUGGAGACCAGUAUCGGCU	20	7821
SCNN1A-3973	+	GCCUGGAGACCAGUAUCGGCU	21	7822
SCNN1A-3974	+	GGCCUGGAGACCAGUAUCGGCU	22	7823
SCNN1A-3975	+	CGGCCUGGAGACCAGUAUCGGCU	23	7824
SCNN1A-3976	+	UCGGCCUGGAGACCAGUAUCGGCU	24	7825
SCNN1A-3977	+	ACAGGAGGGUGACCAUCU	18	7826
SCNN1A-3978	+	GACAGGAGGGUGACCAUCU	19	7827
SCNN1A-3979	+	GGACAGGAGGGUGACCAUCU	20	7828
SCNN1A-3980	+	UGGACAGGAGGGUGACCAUCU	21	7829
SCNN1A-3981	+	UUGGACAGGAGGGUGACCAUCU	22	7830
SCNN1A-3982	+	GUUGGACAGGAGGGUGACCAUCU	23	7831
SCNN1A-3983	+	GGUUGGACAGGAGGGUGACCAUCU	24	7832
SCNN1A-3984	+	AAACCUCUCCUUCCCUCU	18	7833
SCNN1A-3985	+	GAAACCUCUCCUUCCCUCU	19	7834
SCNN1A-3986	+	AGAAACCUCUCCUUCCCUCU	20	7835
SCNN1A-3987	+	GAGAAACCUCUCCUUCCCUCU	21	7836
SCNN1A-3988	+	UGAGAAACCUCUCCUUCCCUCU	22	7837
SCNN1A-3989	+	GUGAGAAACCUCUCCUUCCCUCU	23	7838
SCNN1A-3990	+	UGUGAGAAACCUCUCCUUCCCUCU	24	7839
SCNN1A-3991	+	AAACAGCCCAGGUGGUCU	18	7840
SCNN1A-3992	+	GAAACAGCCCAGGUGGUCU	19	7841
SCNN1A-3993	+	UGAAACAGCCCAGGUGGUCU	20	7842
SCNN1A-3994	+	GUGAAACAGCCCAGGUGGUCU	21	7843
SCNN1A-3995	+	GGUGAAACAGCCCAGGUGGUCU	22	7844
SCNN1A-3996	+	UGGUGAAACAGCCCAGGUGGUCU	23	7845
SCNN1A-3997	+	UUGGUGAAACAGCCCAGGUGGUCU	24	7846
SCNN1A-3998	+	UGGGGUGGGGGCAGAAGU	18	7847
SCNN1A-3999	+	AUGGGGUGGGGGCAGAAGU	19	7848
SCNN1A-1279	+	CAUGGGGUGGGGGCAGAAGU	20	5128
SCNN1A-4000	+	ACAUGGGGUGGGGGCAGAAGU	21	7849
SCNN1A-4001	+	GACAUGGGGUGGGGGCAGAAGU	22	7850
SCNN1A-4002	+	AGACAUGGGGUGGGGGCAGAAGU	23	7851
SCNN1A-4003	+	GAGACAUGGGGUGGGGGCAGAAGU	24	7852
SCNN1A-4004	+	GGACACAGAGACUAGAGU	18	7853
SCNN1A-4005	+	UGGACACAGAGACUAGAGU	19	7854
SCNN1A-4006	+	CUGGACACAGAGACUAGAGU	20	7855
SCNN1A-4007	+	ACUGGACACAGAGACUAGAGU	21	7856
SCNN1A-4008	+	CACUGGACACAGAGACUAGAGU	22	7857
SCNN1A-4009	+	GCACUGGACACAGAGACUAGAGU	23	7858
SCNN1A-4010	+	UGCACUGGACACAGAGACUAGAGU	24	7859
SCNN1A-4011	+	CCACUCCAUUUCUUAGGU	18	7860
SCNN1A-4012	+	GCCACUCCAUUUCUUAGGU	19	7861
SCNN1A-4013	+	GGCCACUCCAUUUCUUAGGU	20	7862
SCNN1A-4014	+	UGGCCACUCCAUUUCUUAGGU	21	7863
SCNN1A-4015	+	UUGGCCACUCCAUUUCUUAGGU	22	7864
SCNN1A-4016	+	UUUGGCCACUCCAUUUCUUAGGU	23	7865
SCNN1A-4017	+	CUUUGGCCACUCCAUUUCUUAGGU	24	7866
SCNN1A-4018	+	AGGUGUGGGGCAGAGGGU	18	7867
SCNN1A-4019	+	UAGGUGUGGGGCAGAGGGU	19	7868
SCNN1A-1286	+	UUAGGUGUGGGGCAGAGGGU	20	5135
SCNN1A-4020	+	CUUAGGUGUGGGGCAGAGGGU	21	7869
SCNN1A-4021	+	UCUUAGGUGUGGGGCAGAGGGU	22	7870
SCNN1A-4022	+	UUCUUAGGUGUGGGGCAGAGGGU	23	7871
SCNN1A-4023	+	UUUCUUAGGUGUGGGGCAGAGGGU	24	7872
SCNN1A-4024	+	GGAAAGAGAGAGUAGGGU	18	7873
SCNN1A-4025	+	AGGAAAGAGAGAGUAGGGU	19	7874
SCNN1A-4026	+	CAGGAAAGAGAGAGUAGGGU	20	7875
SCNN1A-4027	+	UCAGGAAAGAGAGAGUAGGGU	21	7876
SCNN1A-4028	+	AUCAGGAAAGAGAGAGUAGGGU	22	7877
SCNN1A-4029	+	UAUCAGGAAAGAGAGAGUAGGGU	23	7878
SCNN1A-4030	+	UUAUCAGGAAAGAGAGAGUAGGGU	24	7879
SCNN1A-4031	+	AGGACAGAGACAUGGGGU	18	7880
SCNN1A-4032	+	AAGGACAGAGACAUGGGGU	19	7881
SCNN1A-1287	+	CAAGGACAGAGACAUGGGGU	20	5136
SCNN1A-4033	+	ACAAGGACAGAGACAUGGGGU	21	7882
SCNN1A-4034	+	GACAAGGACAGAGACAUGGGGU	22	7883
SCNN1A-4035	+	GGACAAGGACAGAGACAUGGGGU	23	7884
SCNN1A-4036	+	GGGACAAGGACAGAGACAUGGGGU	24	7885
SCNN1A-4037	+	UGAAACAGCCCAGGUGGU	18	7886
SCNN1A-4038	+	GUGAAACAGCCCAGGUGGU	19	7887
SCNN1A-4039	+	GGUGAAACAGCCCAGGUGGU	20	7888
SCNN1A-4040	+	UGGUGAAACAGCCCAGGUGGU	21	7889
SCNN1A-4041	+	UUGGUGAAACAGCCCAGGUGGU	22	7890
SCNN1A-4042	+	CUUGGUGAAACAGCCCAGGUGGU	23	7891
SCNN1A-4043	+	ACUUGGUGAAACAGCCCAGGUGGU	24	7892
SCNN1A-4044	+	AGGAGGGUGACCAUCUGU	18	7893
SCNN1A-4045	+	CAGGAGGGUGACCAUCUGU	19	7894
SCNN1A-4046	+	ACAGGAGGGUGACCAUCUGU	20	7895
SCNN1A-4047	+	GACAGGAGGGUGACCAUCUGU	21	7896
SCNN1A-4048	+	GGACAGGAGGGUGACCAUCUGU	22	7897
SCNN1A-4049	+	UGGACAGGAGGGUGACCAUCUGU	23	7898
SCNN1A-4050	+	UUGGACAGGAGGGUGACCAUCUGU	24	7899
SCNN1A-4051	+	UAUCGGCUUCGGAACCUU	18	7900
SCNN1A-4052	+	GUAUCGGCUUCGGAACCUU	19	7901
SCNN1A-1297	+	AGUAUCGGCUUCGGAACCUU	20	5146
SCNN1A-4053	+	CAGUAUCGGCUUCGGAACCUU	21	7902
SCNN1A-4054	+	CCAGUAUCGGCUUCGGAACCUU	22	7903
SCNN1A-4055	+	ACCAGUAUCGGCUUCGGAACCUU	23	7904
SCNN1A-4056	+	GACCAGUAUCGGCUUCGGAACCUU	24	7905
SCNN1A-4057	+	GGAGACCAGUAUCGGCUU	18	7906
SCNN1A-4058	+	UGGAGACCAGUAUCGGCUU	19	7907
SCNN1A-1298	+	CUGGAGACCAGUAUCGGCUU	20	5147
SCNN1A-4059	+	CCUGGAGACCAGUAUCGGCUU	21	7908
SCNN1A-4060	+	GCCUGGAGACCAGUAUCGGCUU	22	7909
SCNN1A-4061	+	GGCCUGGAGACCAGUAUCGGCUU	23	7910
SCNN1A-4062	+	CGGCCUGGAGACCAGUAUCGGCUU	24	7911
SCNN1A-4063	+	GUCACAGUACUCCACGUU	18	7912
SCNN1A-4064	+	AGUCACAGUACUCCACGUU	19	7913
SCNN1A-4065	+	UAGUCACAGUACUCCACGUU	20	7914
SCNN1A-4066	+	GUAGUCACAGUACUCCACGUU	21	7915
SCNN1A-4067	+	UGUAGUCACAGUACUCCACGUU	22	7916
SCNN1A-4068	+	CUGUAGUCACAGUACUCCACGUU	23	7917
SCNN1A-4069	+	UCUGUAGUCACAGUACUCCACGUU	24	7918
SCNN1A-4070	−	CAGUGCAACCAGAACAAA	18	7919
SCNN1A-4071	−	CCAGUGCAACCAGAACAAA	19	7920
SCNN1A-4072	−	UCCAGUGCAACCAGAACAAA	20	7921
SCNN1A-4073	−	GUCCAGUGCAACCAGAACAAA	21	7922
SCNN1A-4074	−	UGUCCAGUGCAACCAGAACAAA	22	7923
SCNN1A-4075	−	GUGUCCAGUGCAACCAGAACAAA	23	7924
SCNN1A-4076	−	UGUGUCCAGUGCAACCAGAACAAA	24	7925
SCNN1A-4077	−	AGGUACCCGGAAAUUAAA	18	7926
SCNN1A-4078	−	CAGGUACCCGGAAAUUAAA	19	7927
SCNN1A-4079	−	UCAGGUACCCGGAAAUUAAA	20	7928
SCNN1A-4080	−	UUCAGGUACCCGGAAAUUAAA	21	7929
SCNN1A-4081	−	CUUCAGGUACCCGGAAAUUAAA	22	7930
SCNN1A-4082	−	CCUUCAGGUACCCGGAAAUUAAA	23	7931
SCNN1A-4083	−	CCCUUCAGGUACCCGGAAAUUAAA	24	7932
SCNN1A-4084	−	CUGCCCCACACCUAAGAA	18	7933
SCNN1A-4085	−	UCUGCCCCACACCUAAGAA	19	7934
SCNN1A-4086	−	CUCUGCCCCACACCUAAGAA	20	7935
SCNN1A-4087	−	CCUCUGCCCCACACCUAAGAA	21	7936
SCNN1A-4088	−	CCCUCUGCCCCACACCUAAGAA	22	7937
SCNN1A-4089	−	ACCCUCUGCCCCACACCUAAGAA	23	7938
SCNN1A-4090	−	CACCCUCUGCCCCACACCUAAGAA	24	7939
SCNN1A-4091	−	GUCCAACCUGGGCAGCCA	18	7940
SCNN1A-4092	−	UGUCCAACCUGGGCAGCCA	19	7941
SCNN1A-4093	−	CUGUCCAACCUGGGCAGCCA	20	7942
SCNN1A-4094	−	CCUGUCCAACCUGGGCAGCCA	21	7943
SCNN1A-4095	−	UCCUGUCCAACCUGGGCAGCCA	22	7944
SCNN1A-4096	−	CUCCUGUCCAACCUGGGCAGCCA	23	7945
SCNN1A-4097	−	CCUCCUGUCCAACCUGGGCAGCCA	24	7946
SCNN1A-4098	−	UCCUGGGGUGAGACUCCA	18	7947
SCNN1A-4099	−	UUCCUGGGGUGAGACUCCA	19	7948
SCNN1A-904	−	GUUCCUGGGGUGAGACUCCA	20	4753
SCNN1A-4100	−	AGUUCCUGGGGUGAGACUCCA	21	7949
SCNN1A-4101	−	CAGUUCCUGGGGUGAGACUCCA	22	7950
SCNN1A-4102	−	ACAGUUCCUGGGGUGAGACUCCA	23	7951
SCNN1A-4103	−	CACAGUUCCUGGGGUGAGACUCCA	24	7952
SCNN1A-4104	−	GGCCCCCGCCCAUCUCCA	18	7953
SCNN1A-4105	−	GGGCCCCCGCCCAUCUCCA	19	7954
SCNN1A-907	−	UGGGCCCCCGCCCAUCUCCA	20	4756
SCNN1A-4106	−	CUGGGCCCCCGCCCAUCUCCA	21	7955
SCNN1A-4107	−	CCUGGGCCCCCGCCCAUCUCCA	22	7956
SCNN1A-4108	−	CCCUGGGCCCCCGCCCAUCUCCA	23	7957
SCNN1A-4109	−	ACCCUGGGCCCCCGCCCAUCUCCA	24	7958
SCNN1A-4110	−	AGGAGCUGGACCGCAUCA	18	7959
SCNN1A-4111	−	GAGGAGCUGGACCGCAUCA	19	7960
SCNN1A-4112	−	GGAGGAGCUGGACCGCAUCA	20	7961
SCNN1A-4113	−	UGGAGGAGCUGGACCGCAUCA	21	7962
SCNN1A-4114	−	CUGGAGGAGCUGGACCGCAUCA	22	7963
SCNN1A-4115	−	GCUGGAGGAGCUGGACCGCAUCA	23	7964
SCNN1A-4116	−	AGCUGGAGGAGCUGGACCGCAUCA	24	7965
SCNN1A-4117	−	GGUCCCGCCCCCGCCUCA	18	7966
SCNN1A-4118	−	GGGUCCCGCCCCCGCCUCA	19	7967
SCNN1A-924	−	AGGGUCCCGCCCCCGCCUCA	20	4773
SCNN1A-4119	−	GAGGGUCCCGCCCCCGCCUCA	21	7968
SCNN1A-4120	−	UGAGGGUCCCGCCCCCGCCUCA	22	7969
SCNN1A-4121	−	CUGAGGGUCCCGCCCCCGCCUCA	23	7970
SCNN1A-4122	−	CCUGAGGGUCCCGCCCCCGCCUCA	24	7971
SCNN1A-4123	−	AAGUCAACAUCUUCUUCA	18	7972
SCNN1A-4124	−	AAAGUCAACAUCUUCUUCA	19	7973
SCNN1A-928	−	CAAAGUCAACAUCUUCUUCA	20	4777
SCNN1A-4125	−	CCAAAGUCAACAUCUUCUUCA	21	7974
SCNN1A-4126	−	GCCAAAGUCAACAUCUUCUUCA	22	7975
SCNN1A-4127	−	GGCCAAAGUCAACAUCUUCUUCA	23	7976
SCNN1A-4128	−	UGGCCAAAGUCAACAUCUUCUUCA	24	7977
SCNN1A-4129	−	UUGGUGUAUGUGGGUUCA	18	7978
SCNN1A-4130	−	CUUGGUGUAUGUGGGUUCA	19	7979
SCNN1A-4131	−	UCUUGGUGUAUGUGGGUUCA	20	7980
SCNN1A-4132	−	CUCUUGGUGUAUGUGGGUUCA	21	7981
SCNN1A-4133	−	UCUCUUGGUGUAUGUGGGUUCA	22	7982
SCNN1A-4134	−	AUCUCUUGGUGUAUGUGGGUUCA	23	7983
SCNN1A-4135	−	GAUCUCUUGGUGUAUGUGGGUUCA	24	7984
SCNN1A-4136	−	UCUGGGGGGGCCCUGAGA	18	7985
SCNN1A-4137	−	CUCUGGGGGGGCCCUGAGA	19	7986
SCNN1A-938	−	CCUCUGGGGGGGCCCUGAGA	20	4787
SCNN1A-4138	−	UCCUCUGGGGGGGCCCUGAGA	21	7987
SCNN1A-4139	−	GUCCUCUGGGGGGGCCCUGAGA	22	7988
SCNN1A-4140	−	UGUCCUCUGGGGGGGCCCUGAGA	23	7989
SCNN1A-4141	−	CUGUCCUCUGGGGGGGCCCUGAGA	24	7990
SCNN1A-4142	−	UACUGGUCUCCAGGCCGA	18	7991
SCNN1A-4143	−	AUACUGGUCUCCAGGCCGA	19	7992
SCNN1A-943	−	GAUACUGGUCUCCAGGCCGA	20	4792
SCNN1A-4144	−	CGAUACUGGUCUCCAGGCCGA	21	7993
SCNN1A-4145	−	CCGAUACUGGUCUCCAGGCCGA	22	7994
SCNN1A-4146	−	GCCGAUACUGGUCUCCAGGCCGA	23	7995
SCNN1A-4147	−	AGCCGAUACUGGUCUCCAGGCCGA	24	7996
SCNN1A-4148	−	UUCCAGAUGCUAUCGCGA	18	7997
SCNN1A-4149	−	CUUCCAGAUGCUAUCGCGA	19	7998
SCNN1A-4150	−	UCUUCCAGAUGCUAUCGCGA	20	7999
SCNN1A-4151	−	GUCUUCCAGAUGCUAUCGCGA	21	8000
SCNN1A-4152	−	GGUCUUCCAGAUGCUAUCGCGA	22	8001
SCNN1A-4153	−	GGGUCUUCCAGAUGCUAUCGCGA	23	8002
SCNN1A-4154	−	UGGGUCUUCCAGAUGCUAUCGCGA	24	8003
SCNN1A-4155	−	CCAGGUGGACUGGAAGGA	18	8004
SCNN1A-4156	−	CCCAGGUGGACUGGAAGGA	19	8005
SCNN1A-4157	−	CCCCAGGUGGACUGGAAGGA	20	8006
SCNN1A-4158	−	CCCCCAGGUGGACUGGAAGGA	21	8007
SCNN1A-4159	−	ACCCCCAGGUGGACUGGAAGGA	22	8008
SCNN1A-4160	−	AACCCCCAGGUGGACUGGAAGGA	23	8009
SCNN1A-4161	−	CAACCCCCAGGUGGACUGGAAGGA	24	8010
SCNN1A-4162	−	GGGGGGCCCUGAGAGGGA	18	8011
SCNN1A-4163	−	GGGGGGGCCCUGAGAGGGA	19	8012
SCNN1A-954	−	UGGGGGGGCCCUGAGAGGGA	20	4803
SCNN1A-4164	−	CUGGGGGGGCCCUGAGAGGGA	21	8013
SCNN1A-4165	−	UCUGGGGGGGCCCUGAGAGGGA	22	8014
SCNN1A-4166	−	CUCUGGGGGGGCCCUGAGAGGGA	23	8015
SCNN1A-4167	−	CCUCUGGGGGGGCCCUGAGAGGGA	24	8016
SCNN1A-4168	−	CGGUAGGUCGUGCCUGGA	18	8017
SCNN1A-4169	−	ACGGUAGGUCGUGCCUGGA	19	8018
SCNN1A-962	−	CACGGUAGGUCGUGCCUGGA	20	4811
SCNN1A-4170	−	UCACGGUAGGUCGUGCCUGGA	21	8019
SCNN1A-4171	−	GUCACGGUAGGUCGUGCCUGGA	22	8020
SCNN1A-4172	−	UGUCACGGUAGGUCGUGCCUGGA	23	8021
SCNN1A-4173	−	CUGUCACGGUAGGUCGUGCCUGGA	24	8022
SCNN1A-4174	−	CAACAACCCCCAGGUGGA	18	8023
SCNN1A-4175	−	ACAACAACCCCCAGGUGGA	19	8024
SCNN1A-4176	−	GACAACAACCCCCAGGUGGA	20	8025
SCNN1A-4177	−	GGACAACAACCCCCAGGUGGA	21	8026
SCNN1A-4178	−	GGGACAACAACCCCCAGGUGGA	22	8027
SCNN1A-4179	−	CGGGACAACAACCCCCAGGUGGA	23	8028
SCNN1A-4180	−	GCGGGACAACAACCCCCAGGUGGA	24	8029
SCNN1A-4181	−	CCUCUGGGGGGGCCCUGA	18	8030
SCNN1A-4182	−	UCCUCUGGGGGGGCCCUGA	19	8031
SCNN1A-4183	−	GUCCUCUGGGGGGGCCCUGA	20	8032
SCNN1A-4184	−	UGUCCUCUGGGGGGGCCCUGA	21	8033
SCNN1A-4185	−	CUGUCCUCUGGGGGGGCCCUGA	22	8034
SCNN1A-4186	−	CCUGUCCUCUGGGGGGGCCCUGA	23	8035
SCNN1A-4187	−	ACCUGUCCUCUGGGGGGGCCCUGA	24	8036
SCNN1A-4188	−	GGAAGGCAAGGAUGCUGA	18	8037
SCNN1A-4189	−	AGGAAGGCAAGGAUGCUGA	19	8038
SCNN1A-4190	−	GAGGAAGGCAAGGAUGCUGA	20	8039
SCNN1A-4191	−	UGAGGAAGGCAAGGAUGCUGA	21	8040
SCNN1A-4192	−	AUGAGGAAGGCAAGGAUGCUGA	22	8041
SCNN1A-4193	−	CAUGAGGAAGGCAAGGAUGCUGA	23	8042
SCNN1A-4194	−	GCAUGAGGAAGGCAAGGAUGCUGA	24	8043
SCNN1A-4195	−	CCCUGCUGUCCACAGUGA	18	8044
SCNN1A-4196	−	CCCCUGCUGUCCACAGUGA	19	8045
SCNN1A-4197	−	UCCCCUGCUGUCCACAGUGA	20	8046
SCNN1A-4198	−	UUCCCCUGCUGUCCACAGUGA	21	8047
SCNN1A-4199	−	AUUCCCCUGCUGUCCACAGUGA	22	8048
SCNN1A-4200	−	CAUUCCCCUGCUGUCCACAGUGA	23	8049
SCNN1A-4201	−	UCAUUCCCCUGCUGUCCACAGUGA	24	8050
SCNN1A-4202	−	CGUGGAGUACUGUGACUA	18	8051
SCNN1A-4203	−	ACGUGGAGUACUGUGACUA	19	8052
SCNN1A-4204	−	AACGUGGAGUACUGUGACUA	20	8053
SCNN1A-4205	−	GAACGUGGAGUACUGUGACUA	21	8054
SCNN1A-4206	−	AGAACGUGGAGUACUGUGACUA	22	8055
SCNN1A-4207	−	CAGAACGUGGAGUACUGUGACUA	23	8056
SCNN1A-4208	−	CCAGAACGUGGAGUACUGUGACUA	24	8057
SCNN1A-4209	−	CUUCCACCACCCGAUGUA	18	8058
SCNN1A-4210	−	ACUUCCACCACCCGAUGUA	19	8059
SCNN1A-975	−	CACUUCCACCACCCGAUGUA	20	4824
SCNN1A-4211	−	UCACUUCCACCACCCGAUGUA	21	8060
SCNN1A-4212	−	CUCACUUCCACCACCCGAUGUA	22	8061
SCNN1A-4213	−	UCUCACUUCCACCACCCGAUGUA	23	8062
SCNN1A-4214	−	CUCUCACUUCCACCACCCGAUGUA	24	8063
SCNN1A-4215	−	UCAGGUACCCGGAAAUUA	18	8064
SCNN1A-4216	−	UUCAGGUACCCGGAAAUUA	19	8065
SCNN1A-4217	−	CUUCAGGUACCCGGAAAUUA	20	8066
SCNN1A-4218	−	CCUUCAGGUACCCGGAAAUUA	21	8067
SCNN1A-4219	−	CCCUUCAGGUACCCGGAAAUUA	22	8068
SCNN1A-4220	−	CCCCUUCAGGUACCCGGAAAUUA	23	8069
SCNN1A-4221	−	GCCCCUUCAGGUACCCGGAAAUUA	24	8070
SCNN1A-4222	−	AAUUACACCGUCAACAAC	18	8071
SCNN1A-4223	−	CAAUUACACCGUCAACAAC	19	8072
SCNN1A-4224	−	ACAAUUACACCGUCAACAAC	20	8073
SCNN1A-4225	−	AACAAUUACACCGUCAACAAC	21	8074
SCNN1A-4226	−	GAACAAUUACACCGUCAACAAC	22	8075
SCNN1A-4227	−	AGAACAAUUACACCGUCAACAAC	23	8076
SCNN1A-4228	−	CAGAACAAUUACACCGUCAACAAC	24	8077
SCNN1A-4229	−	GUCACCCUCCUGUCCAAC	18	8078
SCNN1A-4230	−	GGUCACCCUCCUGUCCAAC	19	8079
SCNN1A-4231	−	UGGUCACCCUCCUGUCCAAC	20	8080
SCNN1A-4232	−	AUGGUCACCCUCCUGUCCAAC	21	8081
SCNN1A-4233	−	GAUGGUCACCCUCCUGUCCAAC	22	8082
SCNN1A-4234	−	AGAUGGUCACCCUCCUGUCCAAC	23	8083
SCNN1A-4235	−	CAGAUGGUCACCCUCCUGUCCAAC	24	8084
SCNN1A-4236	−	CUCUGUGUCCAGUGCAAC	18	8085
SCNN1A-4237	−	UCUCUGUGUCCAGUGCAAC	19	8086
SCNN1A-4238	−	GUCUCUGUGUCCAGUGCAAC	20	8087
SCNN1A-4239	−	AGUCUCUGUGUCCAGUGCAAC	21	8088
SCNN1A-4240	−	UAGUCUCUGUGUCCAGUGCAAC	22	8089
SCNN1A-4241	−	CUAGUCUCUGUGUCCAGUGCAAC	23	8090
SCNN1A-4242	−	UCUAGUCUCUGUGUCCAGUGCAAC	24	8091
SCNN1A-4243	−	UAUCCGCGGCCCCAGAAC	18	8092
SCNN1A-4244	−	CUAUCCGCGGCCCCAGAAC	19	8093
SCNN1A-4245	−	UCUAUCCGCGGCCCCAGAAC	20	8094
SCNN1A-4246	−	UUCUAUCCGCGGCCCCAGAAC	21	8095
SCNN1A-4247	−	CUUCUAUCCGCGGCCCCAGAAC	22	8096
SCNN1A-4248	−	UCUUCUAUCCGCGGCCCCAGAAC	23	8097
SCNN1A-4249	−	AUCUUCUAUCCGCGGCCCCAGAAC	24	8098
SCNN1A-4250	−	GACUUCUCCUCAGACCAC	18	8099
SCNN1A-4251	−	UGACUUCUCCUCAGACCAC	19	8100
SCNN1A-4252	−	UUGACUUCUCCUCAGACCAC	20	8101
SCNN1A-4253	−	GUUGACUUCUCCUCAGACCAC	21	8102
SCNN1A-4254	−	GGUUGACUUCUCCUCAGACCAC	22	8103
SCNN1A-4255	−	AGGUUGACUUCUCCUCAGACCAC	23	8104
SCNN1A-4256	−	CAGGUUGACUUCUCCUCAGACCAC	24	8105
SCNN1A-4257	−	AGGAAACCCUGGACAGAC	18	8106
SCNN1A-4258	−	UAGGAAACCCUGGACAGAC	19	8107
SCNN1A-4259	−	AUAGGAAACCCUGGACAGAC	20	8108
SCNN1A-4260	−	CAUAGGAAACCCUGGACAGAC	21	8109
SCNN1A-4261	−	UCAUAGGAAACCCUGGACAGAC	22	8110
SCNN1A-4262	−	UUCAUAGGAAACCCUGGACAGAC	23	8111
SCNN1A-4263	−	GUUCAUAGGAAACCCUGGACAGAC	24	8112
SCNN1A-4264	−	CAGGUGGACUGGAAGGAC	18	8113
SCNN1A-4265	−	CCAGGUGGACUGGAAGGAC	19	8114
SCNN1A-988	−	CCCAGGUGGACUGGAAGGAC	20	4837
SCNN1A-4266	−	CCCCAGGUGGACUGGAAGGAC	21	8115
SCNN1A-4267	−	CCCCCAGGUGGACUGGAAGGAC	22	8116
SCNN1A-4268	−	ACCCCCAGGUGGACUGGAAGGAC	23	8117
SCNN1A-4269	−	AACCCCCAGGUGGACUGGAAGGAC	24	8118
SCNN1A-4270	−	AACAACCCCCAGGUGGAC	18	8119
SCNN1A-4271	−	CAACAACCCCCAGGUGGAC	19	8120
SCNN1A-990	−	ACAACAACCCCCAGGUGGAC	20	4839
SCNN1A-4272	−	GACAACAACCCCCAGGUGGAC	21	8121
SCNN1A-4273	−	GGACAACAACCCCCAGGUGGAC	22	8122
SCNN1A-4274	−	GGGACAACAACCCCCAGGUGGAC	23	8123
SCNN1A-4275	−	CGGGACAACAACCCCCAGGUGGAC	24	8124
SCNN1A-4276	−	UGCUAUACUUUCAAUGAC	18	8125
SCNN1A-4277	−	CUGCUAUACUUUCAAUGAC	19	8126
SCNN1A-4278	−	ACUGCUAUACUUUCAAUGAC	20	8127
SCNN1A-4279	−	AACUGCUAUACUUUCAAUGAC	21	8128
SCNN1A-4280	−	AAACUGCUAUACUUUCAAUGAC	22	8129
SCNN1A-4281	−	GAAACUGCUAUACUUUCAAUGAC	23	8130
SCNN1A-4282	−	GGAAACUGCUAUACUUUCAAUGAC	24	8131
SCNN1A-4283	−	GAAGGCAAGGAUGCUGAC	18	8132
SCNN1A-4284	−	GGAAGGCAAGGAUGCUGAC	19	8133
SCNN1A-992	−	AGGAAGGCAAGGAUGCUGAC	20	4841
SCNN1A-4285	−	GAGGAAGGCAAGGAUGCUGAC	21	8134
SCNN1A-4286	−	UGAGGAAGGCAAGGAUGCUGAC	22	8135
SCNN1A-4287	−	AUGAGGAAGGCAAGGAUGCUGAC	23	8136
SCNN1A-4288	−	CAUGAGGAAGGCAAGGAUGCUGAC	24	8137
SCNN1A-4289	−	CCUGCUGUCCACAGUGAC	18	8138
SCNN1A-4290	−	CCCUGCUGUCCACAGUGAC	19	8139
SCNN1A-993	−	CCCCUGCUGUCCACAGUGAC	20	4842
SCNN1A-4291	−	UCCCCUGCUGUCCACAGUGAC	21	8140
SCNN1A-4292	−	UUCCCCUGCUGUCCACAGUGAC	22	8141
SCNN1A-4293	−	AUUCCCCUGCUGUCCACAGUGAC	23	8142
SCNN1A-4294	−	CAUUCCCCUGCUGUCCACAGUGAC	24	8143
SCNN1A-4295	−	CCUCGCCCCUUCAGGUAC	18	8144
SCNN1A-4296	−	CCCUCGCCCCUUCAGGUAC	19	8145
SCNN1A-4297	−	CCCCUCGCCCCUUCAGGUAC	20	8146
SCNN1A-4298	−	UCCCCUCGCCCCUUCAGGUAC	21	8147
SCNN1A-4299	−	UUCCCCUCGCCCCUUCAGGUAC	22	8148
SCNN1A-4300	−	CUUCCCCUCGCCCCUUCAGGUAC	23	8149
SCNN1A-4301	−	UCUUCCCCUCGCCCCUUCAGGUAC	24	8150
SCNN1A-4302	−	GUGGGUUCAUAGGAAACC	18	8151
SCNN1A-4303	−	UGUGGGUUCAUAGGAAACC	19	8152
SCNN1A-4304	−	AUGUGGGUUCAUAGGAAACC	20	8153
SCNN1A-4305	−	UAUGUGGGUUCAUAGGAAACC	21	8154
SCNN1A-4306	−	GUAUGUGGGUUCAUAGGAAACC	22	8155
SCNN1A-4307	−	UGUAUGUGGGUUCAUAGGAAACC	23	8156
SCNN1A-4308	−	GUGUAUGUGGGUUCAUAGGAAACC	24	8157
SCNN1A-4309	−	CCCCCUGCCUAUGCCACC	18	8158
SCNN1A-4310	−	UCCCCCUGCCUAUGCCACC	19	8159
SCNN1A-4311	−	CUCCCCCUGCCUAUGCCACC	20	8160
SCNN1A-4312	−	CCUCCCCCUGCCUAUGCCACC	21	8161
SCNN1A-4313	−	CCCUCCCCCUGCCUAUGCCACC	22	8162
SCNN1A-4314	−	CCCCUCCCCCUGCCUAUGCCACC	23	8163
SCNN1A-4315	−	GCCCCUCCCCCUGCCUAUGCCACC	24	8164
SCNN1A-4316	−	CUCGCCCCUUCAGGUACC	18	8165
SCNN1A-4317	−	CCUCGCCCCUUCAGGUACC	19	8166
SCNN1A-1007	−	CCCUCGCCCCUUCAGGUACC	20	4856
SCNN1A-4318	−	CCCCUCGCCCCUUCAGGUACC	21	8167
SCNN1A-4319	−	UCCCCUCGCCCCUUCAGGUACC	22	8168
SCNN1A-4320	−	UUCCCCUCGCCCCUUCAGGUACC	23	8169
SCNN1A-4321	−	CUUCCCCUCGCCCCUUCAGGUACC	24	8170
SCNN1A-4322	−	AUCUUCUAUCCGCGGCCC	18	8171
SCNN1A-4323	−	CAUCUUCUAUCCGCGGCCC	19	8172
SCNN1A-4324	−	ACAUCUUCUAUCCGCGGCCC	20	8173
SCNN1A-4325	−	UACAUCUUCUAUCCGCGGCCC	21	8174
SCNN1A-4326	−	CUACAUCUUCUAUCCGCGGCCC	22	8175
SCNN1A-4327	−	CCUACAUCUUCUAUCCGCGGCCC	23	8176
SCNN1A-4328	−	GCCUACAUCUUCUAUCCGCGGCCC	24	8177
SCNN1A-4329	−	CAGAGACUCUGCCAUCCC	18	8178
SCNN1A-4330	−	CCAGAGACUCUGCCAUCCC	19	8179
SCNN1A-1023	−	GCCAGAGACUCUGCCAUCCC	20	4872
SCNN1A-4331	−	UGCCAGAGACUCUGCCAUCCC	21	8180
SCNN1A-4332	−	CUGCCAGAGACUCUGCCAUCCC	22	8181
SCNN1A-4333	−	GCUGCCAGAGACUCUGCCAUCCC	23	8182
SCNN1A-4334	−	GGCUGCCAGAGACUCUGCCAUCCC	24	8183
SCNN1A-4335	−	GGUGAGGCCCGCAGCGCC	18	8184
SCNN1A-4336	−	UGGUGAGGCCCGCAGCGCC	19	8185
SCNN1A-4337	−	CUGGUGAGGCCCGCAGCGCC	20	8186
SCNN1A-4338	−	GCUGGUGAGGCCCGCAGCGCC	21	8187
SCNN1A-4339	−	AGCUGGUGAGGCCCGCAGCGCC	22	8188
SCNN1A-4340	−	CAGCUGGUGAGGCCCGCAGCGCC	23	8189
SCNN1A-4341	−	CCAGCUGGUGAGGCCCGCAGCGCC	24	8190
SCNN1A-4342	−	GAUACUGGUCUCCAGGCC	18	8191
SCNN1A-4343	−	CGAUACUGGUCUCCAGGCC	19	8192
SCNN1A-4344	−	CCGAUACUGGUCUCCAGGCC	20	8193
SCNN1A-4345	−	GCCGAUACUGGUCUCCAGGCC	21	8194
SCNN1A-4346	−	AGCCGAUACUGGUCUCCAGGCC	22	8195
SCNN1A-4347	−	AAGCCGAUACUGGUCUCCAGGCC	23	8196
SCNN1A-4348	−	GAAGCCGAUACUGGUCUCCAGGCC	24	8197
SCNN1A-4349	−	GAUGCUGACUGGGAGGCC	18	8198
SCNN1A-4350	−	GGAUGCUGACUGGGAGGCC	19	8199
SCNN1A-1028	−	AGGAUGCUGACUGGGAGGCC	20	4877
SCNN1A-4351	−	AAGGAUGCUGACUGGGAGGCC	21	8200
SCNN1A-4352	−	CAAGGAUGCUGACUGGGAGGCC	22	8201
SCNN1A-4353	−	GCAAGGAUGCUGACUGGGAGGCC	23	8202
SCNN1A-4354	−	GGCAAGGAUGCUGACUGGGAGGCC	24	8203
SCNN1A-4355	−	CUGUCCUCUGGGGGGGCC	18	8204
SCNN1A-4356	−	CCUGUCCUCUGGGGGGGCC	19	8205
SCNN1A-4357	−	ACCUGUCCUCUGGGGGGGCC	20	8206
SCNN1A-4358	−	CACCUGUCCUCUGGGGGGGCC	21	8207
SCNN1A-4359	−	CCACCUGUCCUCUGGGGGGGCC	22	8208
SCNN1A-4360	−	UCCACCUGUCCUCUGGGGGGGCC	23	8209
SCNN1A-4361	−	CUCCACCUGUCCUCUGGGGGGGCC	24	8210
SCNN1A-4362	−	CCAGAGACUCUGCCAUCC	18	8211
SCNN1A-4363	−	GCCAGAGACUCUGCCAUCC	19	8212
SCNN1A-4364	−	UGCCAGAGACUCUGCCAUCC	20	8213
SCNN1A-4365	−	CUGCCAGAGACUCUGCCAUCC	21	8214
SCNN1A-4366	−	GCUGCCAGAGACUCUGCCAUCC	22	8215
SCNN1A-4367	−	GGCUGCCAGAGACUCUGCCAUCC	23	8216
SCNN1A-4368	−	AGGCUGCCAGAGACUCUGCCAUCC	24	8217
SCNN1A-4369	−	UUCCUGGGGUGAGACUCC	18	8218
SCNN1A-4370	−	GUUCCUGGGGUGAGACUCC	19	8219
SCNN1A-1037	−	AGUUCCUGGGGUGAGACUCC	20	4886
SCNN1A-4371	−	CAGUUCCUGGGGUGAGACUCC	21	8220
SCNN1A-4372	−	ACAGUUCCUGGGGUGAGACUCC	22	8221
SCNN1A-4373	−	CACAGUUCCUGGGGUGAGACUCC	23	8222
SCNN1A-4374	−	GCACAGUUCCUGGGGUGAGACUCC	24	8223
SCNN1A-4375	−	GGGCCCCCGCCCAUCUCC	18	8224
SCNN1A-4376	−	UGGGCCCCCGCCCAUCUCC	19	8225
SCNN1A-1040	−	CUGGGCCCCCGCCCAUCUCC	20	4889
SCNN1A-4377	−	CCUGGGCCCCCGCCCAUCUCC	21	8226
SCNN1A-4378	−	CCCUGGGCCCCCGCCCAUCUCC	22	8227
SCNN1A-4379	−	ACCCUGGGCCCCCGCCCAUCUCC	23	8228
SCNN1A-4380	−	CACCCUGGGCCCCCGCCCAUCUCC	24	8229
SCNN1A-4381	−	GUAUUCACUCCUGCUUCC	18	8230
SCNN1A-4382	−	UGUAUUCACUCCUGCUUCC	19	8231
SCNN1A-1046	−	GUGUAUUCACUCCUGCUUCC	20	4895
SCNN1A-4383	−	UGUGUAUUCACUCCUGCUUCC	21	8232
SCNN1A-4384	−	GUGUGUAUUCACUCCUGCUUCC	22	8233
SCNN1A-4385	−	GGUGUGUAUUCACUCCUGCUUCC	23	8234
SCNN1A-4386	−	AGGUGUGUAUUCACUCCUGCUUCC	24	8235
SCNN1A-4387	−	GACACCCCCAUUCUUUCC	18	8236
SCNN1A-4388	−	UGACACCCCCAUUCUUUCC	19	8237
SCNN1A-4389	−	AUGACACCCCCAUUCUUUCC	20	8238
SCNN1A-4390	−	GAUGACACCCCCAUUCUUUCC	21	8239
SCNN1A-4391	−	UGAUGACACCCCCAUUCUUUCC	22	8240
SCNN1A-4392	−	UUGAUGACACCCCCAUUCUUUCC	23	8241
SCNN1A-4393	−	CUUGAUGACACCCCCAUUCUUUCC	24	8242
SCNN1A-4394	−	GUGGAGACCUCCAUCAGC	18	8243
SCNN1A-4395	−	CGUGGAGACCUCCAUCAGC	19	8244
SCNN1A-4396	−	GCGUGGAGACCUCCAUCAGC	20	8245
SCNN1A-4397	−	GGCGUGGAGACCUCCAUCAGC	21	8246
SCNN1A-4398	−	UGGCGUGGAGACCUCCAUCAGC	22	8247
SCNN1A-4399	−	CUGGCGUGGAGACCUCCAUCAGC	23	8248
SCNN1A-4400	−	CCUGGCGUGGAGACCUCCAUCAGC	24	8249
SCNN1A-4401	−	CGGAAAUUAAAGAGGAGC	18	8250
SCNN1A-4402	−	CCGGAAAUUAAAGAGGAGC	19	8251
SCNN1A-1058	−	CCCGGAAAUUAAAGAGGAGC	20	4907
SCNN1A-4403	−	ACCCGGAAAUUAAAGAGGAGC	21	8252
SCNN1A-4404	−	UACCCGGAAAUUAAAGAGGAGC	22	8253
SCNN1A-4405	−	GUACCCGGAAAUUAAAGAGGAGC	23	8254
SCNN1A-4406	−	GGUACCCGGAAAUUAAAGAGGAGC	24	8255
SCNN1A-4407	−	CCGCACCCCUUGCAGCGC	18	8256
SCNN1A-4408	−	GCCGCACCCCUUGCAGCGC	19	8257
SCNN1A-4409	−	UGCCGCACCCCUUGCAGCGC	20	8258
SCNN1A-4410	−	CUGCCGCACCCCUUGCAGCGC	21	8259
SCNN1A-4411	−	UCUGCCGCACCCCUUGCAGCGC	22	8260
SCNN1A-4412	−	CUCUGCCGCACCCCUUGCAGCGC	23	8261
SCNN1A-4413	−	ACUCUGCCGCACCCCUUGCAGCGC	24	8262
SCNN1A-4414	−	GGAUGCUGACUGGGAGGC	18	8263
SCNN1A-4415	−	AGGAUGCUGACUGGGAGGC	19	8264
SCNN1A-4416	−	AAGGAUGCUGACUGGGAGGC	20	8265
SCNN1A-4417	−	CAAGGAUGCUGACUGGGAGGC	21	8266
SCNN1A-4418	−	GCAAGGAUGCUGACUGGGAGGC	22	8267
SCNN1A-4419	−	GGCAAGGAUGCUGACUGGGAGGC	23	8268
SCNN1A-4420	−	AGGCAAGGAUGCUGACUGGGAGGC	24	8269
SCNN1A-4421	−	UUUAACUUGCGGCCUGGC	18	8270
SCNN1A-4422	−	CUUUAACUUGCGGCCUGGC	19	8271
SCNN1A-4423	−	GCUUUAACUUGCGGCCUGGC	20	8272
SCNN1A-4424	−	GGCUUUAACUUGCGGCCUGGC	21	8273
SCNN1A-4425	−	UGGCUUUAACUUGCGGCCUGGC	22	8274
SCNN1A-4426	−	GUGGCUUUAACUUGCGGCCUGGC	23	8275
SCNN1A-4427	−	GGUGGCUUUAACUUGCGGCCUGGC	24	8276
SCNN1A-4428	−	UCUGGAUGUCUUCCAUGC	18	8277
SCNN1A-4429	−	CUCUGGAUGUCUUCCAUGC	19	8278
SCNN1A-4430	−	CCUCUGGAUGUCUUCCAUGC	20	8279
SCNN1A-4431	−	ACCUCUGGAUGUCUUCCAUGC	21	8280
SCNN1A-4432	−	AACCUCUGGAUGUCUUCCAUGC	22	8281
SCNN1A-4433	−	CAACCUCUGGAUGUCUUCCAUGC	23	8282
SCNN1A-4434	−	CCAACCUCUGGAUGUCUUCCAUGC	24	8283
SCNN1A-4435	−	GCAGCCGUCGCGACCUGC	18	8284
SCNN1A-4436	−	CGCAGCCGUCGCGACCUGC	19	8285
SCNN1A-1079	−	CCGCAGCCGUCGCGACCUGC	20	4928
SCNN1A-4437	−	CCCGCAGCCGUCGCGACCUGC	21	8286
SCNN1A-4438	−	UCCCGCAGCCGUCGCGACCUGC	22	8287
SCNN1A-4439	−	CUCCCGCAGCCGUCGCGACCUGC	23	8288
SCNN1A-4440	−	GCUCCCGCAGCCGUCGCGACCUGC	24	8289
SCNN1A-4441	−	ACAUCCUGUCGAGGCUGC	18	8290
SCNN1A-4442	−	AACAUCCUGUCGAGGCUGC	19	8291
SCNN1A-4443	−	CAACAUCCUGUCGAGGCUGC	20	8292
SCNN1A-4444	−	UCAACAUCCUGUCGAGGCUGC	21	8293
SCNN1A-4445	−	AUCAACAUCCUGUCGAGGCUGC	22	8294
SCNN1A-4446	−	CAUCAACAUCCUGUCGAGGCUGC	23	8295
SCNN1A-4447	−	ACAUCAACAUCCUGUCGAGGCUGC	24	8296
SCNN1A-4448	−	AUCUCCAGGGGGCUCUGC	18	8297
SCNN1A-4449	−	CAUCUCCAGGGGGCUCUGC	19	8298
SCNN1A-1083	−	CCAUCUCCAGGGGGCUCUGC	20	4932
SCNN1A-4450	−	CCCAUCUCCAGGGGGCUCUGC	21	8299
SCNN1A-4451	−	GCCCAUCUCCAGGGGGCUCUGC	22	8300
SCNN1A-4452	−	CGCCCAUCUCCAGGGGGCUCUGC	23	8301
SCNN1A-4453	−	CCGCCCAUCUCCAGGGGGCUCUGC	24	8302
SCNN1A-4454	−	GGCUGUUUCACCAAGUGC	18	8303
SCNN1A-4455	−	GGGCUGUUUCACCAAGUGC	19	8304
SCNN1A-1085	−	UGGGCUGUUUCACCAAGUGC	20	4934
SCNN1A-4456	−	CUGGGCUGUUUCACCAAGUGC	21	8305
SCNN1A-4457	−	CCUGGGCUGUUUCACCAAGUGC	22	8306
SCNN1A-4458	−	ACCUGGGCUGUUUCACCAAGUGC	23	8307
SCNN1A-4459	−	CACCUGGGCUGUUUCACCAAGUGC	24	8308
SCNN1A-4460	−	GGGCCCGGGUAAUGGUGC	18	8309
SCNN1A-4461	−	GGGGCCCGGGUAAUGGUGC	19	8310
SCNN1A-4462	−	UGGGGCCCGGGUAAUGGUGC	20	8311
SCNN1A-4463	−	CUGGGGCCCGGGUAAUGGUGC	21	8312
SCNN1A-4464	−	ACUGGGGCCCGGGUAAUGGUGC	22	8313
SCNN1A-4465	−	GACUGGGGCCCGGGUAAUGGUGC	23	8314
SCNN1A-4466	−	UGACUGGGGCCCGGGUAAUGGUGC	24	8315
SCNN1A-4467	−	UUCCAGGAGAGCAUGAUC	18	8316
SCNN1A-4468	−	CUUCCAGGAGAGCAUGAUC	19	8317
SCNN1A-4469	−	GCUUCCAGGAGAGCAUGAUC	20	8318
SCNN1A-4470	−	UGCUUCCAGGAGAGCAUGAUC	21	8319
SCNN1A-4471	−	CUGCUUCCAGGAGAGCAUGAUC	22	8320
SCNN1A-4472	−	CCUGCUUCCAGGAGAGCAUGAUC	23	8321
SCNN1A-4473	−	UCCUGCUUCCAGGAGAGCAUGAUC	24	8322
SCNN1A-4474	−	GUUCCUGGGGUGAGACUC	18	8323
SCNN1A-4475	−	AGUUCCUGGGGUGAGACUC	19	8324
SCNN1A-4476	−	CAGUUCCUGGGGUGAGACUC	20	8325
SCNN1A-4477	−	ACAGUUCCUGGGGUGAGACUC	21	8326
SCNN1A-4478	−	CACAGUUCCUGGGGUGAGACUC	22	8327
SCNN1A-4479	−	GCACAGUUCCUGGGGUGAGACUC	23	8328
SCNN1A-4480	−	AGCACAGUUCCUGGGGUGAGACUC	24	8329
SCNN1A-4481	−	GGGUCCCGCCCCCGCCUC	18	8330
SCNN1A-4482	−	AGGGUCCCGCCCCCGCCUC	19	8331
SCNN1A-4483	−	GAGGGUCCCGCCCCCGCCUC	20	8332
SCNN1A-4484	−	UGAGGGUCCCGCCCCCGCCUC	21	8333
SCNN1A-4485	−	CUGAGGGUCCCGCCCCCGCCUC	22	8334
SCNN1A-4486	−	CCUGAGGGUCCCGCCCCCGCCUC	23	8335
SCNN1A-4487	−	GCCUGAGGGUCCCGCCCCCGCCUC	24	8336
SCNN1A-4488	−	GUUCCUCCACCUGUCCUC	18	8337
SCNN1A-4489	−	AGUUCCUCCACCUGUCCUC	19	8338
SCNN1A-1095	−	CAGUUCCUCCACCUGUCCUC	20	4944
SCNN1A-4490	−	CCAGUUCCUCCACCUGUCCUC	21	8339
SCNN1A-4491	−	GCCAGUUCCUCCACCUGUCCUC	22	8340
SCNN1A-4492	−	GGCCAGUUCCUCCACCUGUCCUC	23	8341
SCNN1A-4493	−	GGGCCAGUUCCUCCACCUGUCCUC	24	8342
SCNN1A-4494	−	GAGGGGGCAGGGGUGCUC	18	8343
SCNN1A-4495	−	CGAGGGGGCAGGGGUGCUC	19	8344
SCNN1A-1096	−	CCGAGGGGGCAGGGGUGCUC	20	4945
SCNN1A-4496	−	GCCGAGGGGGCAGGGGUGCUC	21	8345
SCNN1A-4497	−	GGCCGAGGGGGCAGGGGUGCUC	22	8346
SCNN1A-4498	−	AGGCCGAGGGGGCAGGGGUGCUC	23	8347
SCNN1A-4499	−	CAGGCCGAGGGGGCAGGGGUGCUC	24	8348
SCNN1A-4500	−	UGGGCCCCCGCCCAUCUC	18	8349
SCNN1A-4501	−	CUGGGCCCCCGCCCAUCUC	19	8350
SCNN1A-4502	−	CCUGGGCCCCCGCCCAUCUC	20	8351
SCNN1A-4503	−	CCCUGGGCCCCCGCCCAUCUC	21	8352
SCNN1A-4504	−	ACCCUGGGCCCCCGCCCAUCUC	22	8353
SCNN1A-4505	−	CACCCUGGGCCCCCGCCCAUCUC	23	8354
SCNN1A-4506	−	CCACCCUGGGCCCCCGCCCAUCUC	24	8355
SCNN1A-4507	−	UGUAUUCACUCCUGCUUC	18	8356
SCNN1A-4508	−	GUGUAUUCACUCCUGCUUC	19	8357
SCNN1A-4509	−	UGUGUAUUCACUCCUGCUUC	20	8358
SCNN1A-4510	−	GUGUGUAUUCACUCCUGCUUC	21	8359
SCNN1A-4511	−	GGUGUGUAUUCACUCCUGCUUC	22	8360
SCNN1A-4512	−	AGGUGUGUAUUCACUCCUGCUUC	23	8361
SCNN1A-4513	−	CAGGUGUGUAUUCACUCCUGCUUC	24	8362
SCNN1A-4514	−	AAAGUCAACAUCUUCUUC	18	8363
SCNN1A-4515	−	CAAAGUCAACAUCUUCUUC	19	8364
SCNN1A-4516	−	CCAAAGUCAACAUCUUCUUC	20	8365
SCNN1A-4517	−	GCCAAAGUCAACAUCUUCUUC	21	8366
SCNN1A-4518	−	GGCCAAAGUCAACAUCUUCUUC	22	8367
SCNN1A-4519	−	UGGCCAAAGUCAACAUCUUCUUC	23	8368
SCNN1A-4520	−	GUGGCCAAAGUCAACAUCUUCUUC	24	8369
SCNN1A-4521	−	CUACAGAAAGCACAGUUC	18	8370
SCNN1A-4522	−	ACUACAGAAAGCACAGUUC	19	8371
SCNN1A-4523	−	GACUACAGAAAGCACAGUUC	20	8372
SCNN1A-4524	−	UGACUACAGAAAGCACAGUUC	21	8373
SCNN1A-4525	−	GUGACUACAGAAAGCACAGUUC	22	8374
SCNN1A-4526	−	UGUGACUACAGAAAGCACAGUUC	23	8375
SCNN1A-4527	−	CUGUGACUACAGAAAGCACAGUUC	24	8376
SCNN1A-4528	−	GGUACCCGGAAAUUAAAG	18	8377
SCNN1A-4529	−	AGGUACCCGGAAAUUAAAG	19	8378
SCNN1A-1106	−	CAGGUACCCGGAAAUUAAAG	20	4955
SCNN1A-4530	−	UCAGGUACCCGGAAAUUAAAG	21	8379
SCNN1A-4531	−	UUCAGGUACCCGGAAAUUAAAG	22	8380
SCNN1A-4532	−	CUUCAGGUACCCGGAAAUUAAAG	23	8381
SCNN1A-4533	−	CCUUCAGGUACCCGGAAAUUAAAG	24	8382
SCNN1A-4534	−	GGGGCCCUGAGAGGGAAG	18	8383
SCNN1A-4535	−	GGGGGCCCUGAGAGGGAAG	19	8384
SCNN1A-4536	−	GGGGGGCCCUGAGAGGGAAG	20	8385
SCNN1A-4537	−	GGGGGGGCCCUGAGAGGGAAG	21	8386
SCNN1A-4538	−	UGGGGGGGCCCUGAGAGGGAAG	22	8387
SCNN1A-4539	−	CUGGGGGGGCCCUGAGAGGGAAG	23	8388
SCNN1A-4540	−	UCUGGGGGGGCCCUGAGAGGGAAG	24	8389
SCNN1A-4541	−	CGGGACAACAACCCCCAG	18	8390
SCNN1A-4542	−	GCGGGACAACAACCCCCAG	19	8391
SCNN1A-4543	−	UGCGGGACAACAACCCCCAG	20	8392
SCNN1A-4544	−	UUGCGGGACAACAACCCCCAG	21	8393
SCNN1A-4545	−	CUUGCGGGACAACAACCCCCAG	22	8394
SCNN1A-4546	−	GCUUGCGGGACAACAACCCCCAG	23	8395
SCNN1A-4547	−	AGCUUGCGGGACAACAACCCCCAG	24	8396
SCNN1A-4548	−	UCCAACCUGGGCAGCCAG	18	8397
SCNN1A-4549	−	GUCCAACCUGGGCAGCCAG	19	8398
SCNN1A-1116	−	UGUCCAACCUGGGCAGCCAG	20	4965
SCNN1A-4550	−	CUGUCCAACCUGGGCAGCCAG	21	8399
SCNN1A-4551	−	CCUGUCCAACCUGGGCAGCCAG	22	8400
SCNN1A-4552	−	UCCUGUCCAACCUGGGCAGCCAG	23	8401
SCNN1A-4553	−	CUCCUGUCCAACCUGGGCAGCCAG	24	8402
SCNN1A-4554	−	AUUCACUCCUGCUUCCAG	18	8403
SCNN1A-4555	−	UAUUCACUCCUGCUUCCAG	19	8404
SCNN1A-4556	−	GUAUUCACUCCUGCUUCCAG	20	8405
SCNN1A-4557	−	UGUAUUCACUCCUGCUUCCAG	21	8406
SCNN1A-4558	−	GUGUAUUCACUCCUGCUUCCAG	22	8407
SCNN1A-4559	−	UGUGUAUUCACUCCUGCUUCCAG	23	8408
SCNN1A-4560	−	GUGUGUAUUCACUCCUGCUUCCAG	24	8409
SCNN1A-4561	−	UCAAAGUACACACAGCAG	18	8410
SCNN1A-4562	−	UUCAAAGUACACACAGCAG	19	8411
SCNN1A-4563	−	CUUCAAAGUACACACAGCAG	20	8412
SCNN1A-4564	−	CCUUCAAAGUACACACAGCAG	21	8413
SCNN1A-4565	−	CCCUUCAAAGUACACACAGCAG	22	8414
SCNN1A-4566	−	ACCCUUCAAAGUACACACAGCAG	23	8415
SCNN1A-4567	−	UACCCUUCAAAGUACACACAGCAG	24	8416
SCNN1A-4568	−	AACAUCUUCUUCAAGGAG	18	8417
SCNN1A-4569	−	CAACAUCUUCUUCAAGGAG	19	8418
SCNN1A-4570	−	UCAACAUCUUCUUCAAGGAG	20	8419
SCNN1A-4571	−	GUCAACAUCUUCUUCAAGGAG	21	8420
SCNN1A-4572	−	AGUCAACAUCUUCUUCAAGGAG	22	8421
SCNN1A-4573	−	AAGUCAACAUCUUCUUCAAGGAG	23	8422
SCNN1A-4574	−	AAAGUCAACAUCUUCUUCAAGGAG	24	8423
SCNN1A-4575	−	CCGGAAAUUAAAGAGGAG	18	8424
SCNN1A-4576	−	CCCGGAAAUUAAAGAGGAG	19	8425
SCNN1A-4577	−	ACCCGGAAAUUAAAGAGGAG	20	8426
SCNN1A-4578	−	UACCCGGAAAUUAAAGAGGAG	21	8427
SCNN1A-4579	−	GUACCCGGAAAUUAAAGAGGAG	22	8428
SCNN1A-4580	−	GGUACCCGGAAAUUAAAGAGGAG	23	8429
SCNN1A-4581	−	AGGUACCCGGAAAUUAAAGAGGAG	24	8430
SCNN1A-4582	−	AAAGAGGAGCUGGAGGAG	18	8431
SCNN1A-4583	−	UAAAGAGGAGCUGGAGGAG	19	8432
SCNN1A-4584	−	UUAAAGAGGAGCUGGAGGAG	20	8433
SCNN1A-4585	−	AUUAAAGAGGAGCUGGAGGAG	21	8434
SCNN1A-4586	−	AAUUAAAGAGGAGCUGGAGGAG	22	8435
SCNN1A-4587	−	AAAUUAAAGAGGAGCUGGAGGAG	23	8436
SCNN1A-4588	−	GAAAUUAAAGAGGAGCUGGAGGAG	24	8437
SCNN1A-4589	−	ACUCUGCCAUCCCUGGAG	18	8438
SCNN1A-4590	−	GACUCUGCCAUCCCUGGAG	19	8439
SCNN1A-4591	−	AGACUCUGCCAUCCCUGGAG	20	8440
SCNN1A-4592	−	GAGACUCUGCCAUCCCUGGAG	21	8441
SCNN1A-4593	−	AGAGACUCUGCCAUCCCUGGAG	22	8442
SCNN1A-4594	−	CAGAGACUCUGCCAUCCCUGGAG	23	8443
SCNN1A-4595	−	CCAGAGACUCUGCCAUCCCUGGAG	24	8444
SCNN1A-4596	−	CUCUGGGGGGGCCCUGAG	18	8445
SCNN1A-4597	−	CCUCUGGGGGGGCCCUGAG	19	8446
SCNN1A-1140	−	UCCUCUGGGGGGGCCCUGAG	20	4989
SCNN1A-4598	−	GUCCUCUGGGGGGGCCCUGAG	21	8447
SCNN1A-4599	−	UGUCCUCUGGGGGGGCCCUGAG	22	8448
SCNN1A-4600	−	CUGUCCUCUGGGGGGGCCCUGAG	23	8449
SCNN1A-4601	−	CCUGUCCUCUGGGGGGGCCCUGAG	24	8450
SCNN1A-4602	−	UGCCUGGAAUCAACAACG	18	8451
SCNN1A-4603	−	AUGCCUGGAAUCAACAACG	19	8452
SCNN1A-4604	−	CAUGCCUGGAAUCAACAACG	20	8453
SCNN1A-4605	−	CCAUGCCUGGAAUCAACAACG	21	8454
SCNN1A-4606	−	UCCAUGCCUGGAAUCAACAACG	22	8455
SCNN1A-4607	−	UUCCAUGCCUGGAAUCAACAACG	23	8456
SCNN1A-4608	−	CUUCCAUGCCUGGAAUCAACAACG	24	8457
SCNN1A-4609	−	UCCCUGGAGGAGGACACG	18	8458
SCNN1A-4610	−	AUCCCUGGAGGAGGACACG	19	8459
SCNN1A-4611	−	CAUCCCUGGAGGAGGACACG	20	8460
SCNN1A-4612	−	CCAUCCCUGGAGGAGGACACG	21	8461
SCNN1A-4613	−	GCCAUCCCUGGAGGAGGACACG	22	8462
SCNN1A-4614	−	UGCCAUCCCUGGAGGAGGACACG	23	8463
SCNN1A-4615	−	CUGCCAUCCCUGGAGGAGGACACG	24	8464
SCNN1A-4616	−	CCCGCCUCACGGGGCCCG	18	8465
SCNN1A-4617	−	CCCCGCCUCACGGGGCCCG	19	8466
SCNN1A-4618	−	CCCCCGCCUCACGGGGCCCG	20	8467
SCNN1A-4619	−	GCCCCCGCCUCACGGGGCCCG	21	8468
SCNN1A-4620	−	CGCCCCCGCCUCACGGGGCCCG	22	8469
SCNN1A-4621	−	CCGCCCCCGCCUCACGGGGCCCG	23	8470
SCNN1A-4622	−	CCCGCCCCCGCCUCACGGGGCCCG	24	8471
SCNN1A-4623	−	GUGAGGCCCGCAGCGCCG	18	8472
SCNN1A-4624	−	GGUGAGGCCCGCAGCGCCG	19	8473
SCNN1A-1148	−	UGGUGAGGCCCGCAGCGCCG	20	4997
SCNN1A-4625	−	CUGGUGAGGCCCGCAGCGCCG	21	8474
SCNN1A-4626	−	GCUGGUGAGGCCCGCAGCGCCG	22	8475
SCNN1A-4627	−	AGCUGGUGAGGCCCGCAGCGCCG	23	8476
SCNN1A-4628	−	CAGCUGGUGAGGCCCGCAGCGCCG	24	8477
SCNN1A-4629	−	AUACUGGUCUCCAGGCCG	18	8478
SCNN1A-4630	−	GAUACUGGUCUCCAGGCCG	19	8479
SCNN1A-1149	−	CGAUACUGGUCUCCAGGCCG	20	4998
SCNN1A-4631	−	CCGAUACUGGUCUCCAGGCCG	21	8480
SCNN1A-4632	−	GCCGAUACUGGUCUCCAGGCCG	22	8481
SCNN1A-4633	−	AGCCGAUACUGGUCUCCAGGCCG	23	8482
SCNN1A-4634	−	AAGCCGAUACUGGUCUCCAGGCCG	24	8483
SCNN1A-4635	−	CUGGUGAGGCCCGCAGCG	18	8484
SCNN1A-4636	−	GCUGGUGAGGCCCGCAGCG	19	8485
SCNN1A-4637	−	AGCUGGUGAGGCCCGCAGCG	20	8486
SCNN1A-4638	−	CAGCUGGUGAGGCCCGCAGCG	21	8487
SCNN1A-4639	−	CCAGCUGGUGAGGCCCGCAGCG	22	8488
SCNN1A-4640	−	UCCAGCUGGUGAGGCCCGCAGCG	23	8489
SCNN1A-4641	−	UUCCAGCUGGUGAGGCCCGCAGCG	24	8490
SCNN1A-4642	−	UGUCCCUGAUGCUGCGCG	18	8491
SCNN1A-4643	−	CUGUCCCUGAUGCUGCGCG	19	8492
SCNN1A-4644	−	UCUGUCCCUGAUGCUGCGCG	20	8493
SCNN1A-4645	−	GUCUGUCCCUGAUGCUGCGCG	21	8494
SCNN1A-4646	−	GGUCUGUCCCUGAUGCUGCGCG	22	8495
SCNN1A-4647	−	AGGUCUGUCCCUGAUGCUGCGCG	23	8496
SCNN1A-4648	−	UAGGUCUGUCCCUGAUGCUGCGCG	24	8497
SCNN1A-4649	−	UUAACUUGCGGCCUGGCG	18	8498
SCNN1A-4650	−	UUUAACUUGCGGCCUGGCG	19	8499
SCNN1A-1157	−	CUUUAACUUGCGGCCUGGCG	20	5006
SCNN1A-4651	−	GCUUUAACUUGCGGCCUGGCG	21	8500
SCNN1A-4652	−	GGCUUUAACUUGCGGCCUGGCG	22	8501
SCNN1A-4653	−	UGGCUUUAACUUGCGGCCUGGCG	23	8502
SCNN1A-4654	−	GUGGCUUUAACUUGCGGCCUGGCG	24	8503
SCNN1A-4655	−	UCAUCAGGGGUGGAUGCG	18	8504
SCNN1A-4656	−	CUCAUCAGGGGUGGAUGCG	19	8505
SCNN1A-4657	−	ACUCAUCAGGGGUGGAUGCG	20	8506
SCNN1A-4658	−	UACUCAUCAGGGGUGGAUGCG	21	8507
SCNN1A-4659	−	AUACUCAUCAGGGGUGGAUGCG	22	8508
SCNN1A-4660	−	CAUACUCAUCAGGGGUGGAUGCG	23	8509
SCNN1A-4661	−	ACAUACUCAUCAGGGGUGGAUGCG	24	8510
SCNN1A-4662	−	CAGCCGUCGCGACCUGCG	18	8511
SCNN1A-4663	−	GCAGCCGUCGCGACCUGCG	19	8512
SCNN1A-1158	−	CGCAGCCGUCGCGACCUGCG	20	5007
SCNN1A-4664	−	CCGCAGCCGUCGCGACCUGCG	21	8513
SCNN1A-4665	−	CCCGCAGCCGUCGCGACCUGCG	22	8514
SCNN1A-4666	−	UCCCGCAGCCGUCGCGACCUGCG	23	8515
SCNN1A-4667	−	CUCCCGCAGCCGUCGCGACCUGCG	24	8516
SCNN1A-4668	−	CCGAUACUGGUCUCCAGG	18	8517
SCNN1A-4669	−	GCCGAUACUGGUCUCCAGG	19	8518
SCNN1A-4670	−	AGCCGAUACUGGUCUCCAGG	20	8519
SCNN1A-4671	−	AAGCCGAUACUGGUCUCCAGG	21	8520
SCNN1A-4672	−	GAAGCCGAUACUGGUCUCCAGG	22	8521
SCNN1A-4673	−	CGAAGCCGAUACUGGUCUCCAGG	23	8522
SCNN1A-4674	−	CCGAAGCCGAUACUGGUCUCCAGG	24	8523
SCNN1A-4675	−	UAAUGGUGCACGGGCAGG	18	8524
SCNN1A-4676	−	GUAAUGGUGCACGGGCAGG	19	8525
SCNN1A-4677	−	GGUAAUGGUGCACGGGCAGG	20	8526
SCNN1A-4678	−	GGGUAAUGGUGCACGGGCAGG	21	8527
SCNN1A-4679	−	CGGGUAAUGGUGCACGGGCAGG	22	8528
SCNN1A-4680	−	CCGGGUAAUGGUGCACGGGCAGG	23	8529
SCNN1A-4681	−	CCCGGGUAAUGGUGCACGGGCAGG	24	8530
SCNN1A-4682	−	GGGGGGGCCCUGAGAGGG	18	8531
SCNN1A-4683	−	UGGGGGGGCCCUGAGAGGG	19	8532
SCNN1A-4684	−	CUGGGGGGGCCCUGAGAGGG	20	8533
SCNN1A-4685	−	UCUGGGGGGGCCCUGAGAGGG	21	8534
SCNN1A-4686	−	CUCUGGGGGGGCCCUGAGAGGG	22	8535
SCNN1A-4687	−	CCUCUGGGGGGGCCCUGAGAGGG	23	8536
SCNN1A-4688	−	UCCUCUGGGGGGGCCCUGAGAGGG	24	8537
SCNN1A-4689	−	GUCUCCAGGCCGAGGGGG	18	8538
SCNN1A-4690	−	GGUCUCCAGGCCGAGGGGG	19	8539
SCNN1A-4691	−	UGGUCUCCAGGCCGAGGGGG	20	8540
SCNN1A-4692	−	CUGGUCUCCAGGCCGAGGGGG	21	8541
SCNN1A-4693	−	ACUGGUCUCCAGGCCGAGGGGG	22	8542
SCNN1A-4694	−	UACUGGUCUCCAGGCCGAGGGGG	23	8543
SCNN1A-4695	−	AUACUGGUCUCCAGGCCGAGGGGG	24	8544
SCNN1A-4696	−	CCCAGGUAGAGUGUGGGG	18	8545
SCNN1A-4697	−	UCCCAGGUAGAGUGUGGGG	19	8546
SCNN1A-4698	−	AUCCCAGGUAGAGUGUGGGG	20	8547
SCNN1A-4699	−	CAUCCCAGGUAGAGUGUGGGG	21	8548
SCNN1A-4700	−	ACAUCCCAGGUAGAGUGUGGGG	22	8549
SCNN1A-4701	−	GACAUCCCAGGUAGAGUGUGGGG	23	8550
SCNN1A-4702	−	UGACAUCCCAGGUAGAGUGUGGGG	24	8551
SCNN1A-4703	−	GUGUGGGGAAGGGAUGGG	18	8552
SCNN1A-4704	−	AGUGUGGGGAAGGGAUGGG	19	8553
SCNN1A-1189	−	GAGUGUGGGGAAGGGAUGGG	20	5038
SCNN1A-4705	−	AGAGUGUGGGGAAGGGAUGGG	21	8554
SCNN1A-4706	−	UAGAGUGUGGGGAAGGGAUGGG	22	8555
SCNN1A-4707	−	GUAGAGUGUGGGGAAGGGAUGGG	23	8556
SCNN1A-4708	−	GGUAGAGUGUGGGGAAGGGAUGGG	24	8557
SCNN1A-4709	−	GAAAGCACAGUUCCUGGG	18	8558
SCNN1A-4710	−	AGAAAGCACAGUUCCUGGG	19	8559
SCNN1A-4711	−	CAGAAAGCACAGUUCCUGGG	20	8560
SCNN1A-4712	−	ACAGAAAGCACAGUUCCUGGG	21	8561
SCNN1A-4713	−	UACAGAAAGCACAGUUCCUGGG	22	8562
SCNN1A-4714	−	CUACAGAAAGCACAGUUCCUGGG	23	8563
SCNN1A-4715	−	ACUACAGAAAGCACAGUUCCUGGG	24	8564
SCNN1A-4716	−	UGUCUGUGGUGGAGAUGG	18	8565
SCNN1A-4717	−	UUGUCUGUGGUGGAGAUGG	19	8566
SCNN1A-4718	−	GUUGUCUGUGGUGGAGAUGG	20	8567
SCNN1A-4719	−	UGUUGUCUGUGGUGGAGAUGG	21	8568
SCNN1A-4720	−	GUGUUGUCUGUGGUGGAGAUGG	22	8569
SCNN1A-4721	−	GGUGUUGUCUGUGGUGGAGAUGG	23	8570
SCNN1A-4722	−	CGGUGUUGUCUGUGGUGGAGAUGG	24	8571
SCNN1A-4723	−	AGUGUGGGGAAGGGAUGG	18	8572
SCNN1A-4724	−	GAGUGUGGGGAAGGGAUGG	19	8573
SCNN1A-4725	−	AGAGUGUGGGGAAGGGAUGG	20	8574
SCNN1A-4726	−	UAGAGUGUGGGGAAGGGAUGG	21	8575
SCNN1A-4727	−	GUAGAGUGUGGGGAAGGGAUGG	22	8576
SCNN1A-4728	−	GGUAGAGUGUGGGGAAGGGAUGG	23	8577
SCNN1A-4729	−	AGGUAGAGUGUGGGGAAGGGAUGG	24	8578
SCNN1A-4730	−	AACCCCCAGGUGGACUGG	18	8579
SCNN1A-4731	−	CAACCCCCAGGUGGACUGG	19	8580
SCNN1A-4732	−	ACAACCCCCAGGUGGACUGG	20	8581
SCNN1A-4733	−	AACAACCCCCAGGUGGACUGG	21	8582
SCNN1A-4734	−	CAACAACCCCCAGGUGGACUGG	22	8583
SCNN1A-4735	−	ACAACAACCCCCAGGUGGACUGG	23	8584
SCNN1A-4736	−	GACAACAACCCCCAGGUGGACUGG	24	8585
SCNN1A-4737	−	AGACUCUGCCAUCCCUGG	18	8586
SCNN1A-4738	−	GAGACUCUGCCAUCCCUGG	19	8587
SCNN1A-1196	−	AGAGACUCUGCCAUCCCUGG	20	5045
SCNN1A-4739	−	CAGAGACUCUGCCAUCCCUGG	21	8588
SCNN1A-4740	−	CCAGAGACUCUGCCAUCCCUGG	22	8589
SCNN1A-4741	−	GCCAGAGACUCUGCCAUCCCUGG	23	8590
SCNN1A-4742	−	UGCCAGAGACUCUGCCAUCCCUGG	24	8591
SCNN1A-4743	−	ACGGUAGGUCGUGCCUGG	18	8592
SCNN1A-4744	−	CACGGUAGGUCGUGCCUGG	19	8593
SCNN1A-4745	−	UCACGGUAGGUCGUGCCUGG	20	8594
SCNN1A-4746	−	GUCACGGUAGGUCGUGCCUGG	21	8595
SCNN1A-4747	−	UGUCACGGUAGGUCGUGCCUGG	22	8596
SCNN1A-4748	−	CUGUCACGGUAGGUCGUGCCUGG	23	8597
SCNN1A-4749	−	UCUGUCACGGUAGGUCGUGCCUGG	24	8598
SCNN1A-4750	−	AAAUUAAAGAGGAGCUGG	18	8599
SCNN1A-4751	−	GAAAUUAAAGAGGAGCUGG	19	8600
SCNN1A-1198	−	GGAAAUUAAAGAGGAGCUGG	20	5047
SCNN1A-4752	−	CGGAAAUUAAAGAGGAGCUGG	21	8601
SCNN1A-4753	−	CCGGAAAUUAAAGAGGAGCUGG	22	8602
SCNN1A-4754	−	CCCGGAAAUUAAAGAGGAGCUGG	23	8603
SCNN1A-4755	−	ACCCGGAAAUUAAAGAGGAGCUGG	24	8604
SCNN1A-4756	−	CCUCCACCUGUCCUCUGG	18	8605
SCNN1A-4757	−	UCCUCCACCUGUCCUCUGG	19	8606
SCNN1A-1199	−	UUCCUCCACCUGUCCUCUGG	20	5048
SCNN1A-4758	−	GUUCCUCCACCUGUCCUCUGG	21	8607
SCNN1A-4759	−	AGUUCCUCCACCUGUCCUCUGG	22	8608
SCNN1A-4760	−	CAGUUCCUCCACCUGUCCUCUGG	23	8609
SCNN1A-4761	−	CCAGUUCCUCCACCUGUCCUCUGG	24	8610
SCNN1A-4762	−	CCUCGGUGUUGUCUGUGG	18	8611
SCNN1A-4763	−	UCCUCGGUGUUGUCUGUGG	19	8612
SCNN1A-1205	−	CUCCUCGGUGUUGUCUGUGG	20	5054
SCNN1A-4764	−	GCUCCUCGGUGUUGUCUGUGG	21	8613
SCNN1A-4765	−	GGCUCCUCGGUGUUGUCUGUGG	22	8614
SCNN1A-4766	−	CGGCUCCUCGGUGUUGUCUGUGG	23	8615
SCNN1A-4767	−	UCGGCUCCUCGGUGUUGUCUGUGG	24	8616
SCNN1A-4768	−	GAGACCUCCAUCAGCAUG	18	8617
SCNN1A-4769	−	GGAGACCUCCAUCAGCAUG	19	8618
SCNN1A-1210	−	UGGAGACCUCCAUCAGCAUG	20	5059
SCNN1A-4770	−	GUGGAGACCUCCAUCAGCAUG	21	8619
SCNN1A-4771	−	CGUGGAGACCUCCAUCAGCAUG	22	8620
SCNN1A-4772	−	GCGUGGAGACCUCCAUCAGCAUG	23	8621
SCNN1A-4773	−	GGCGUGGAGACCUCCAUCAGCAUG	24	8622
SCNN1A-4774	−	CGCAGCCGUCGCGACCUG	18	8623
SCNN1A-4775	−	CCGCAGCCGUCGCGACCUG	19	8624
SCNN1A-1216	−	CCCGCAGCCGUCGCGACCUG	20	5065
SCNN1A-4776	−	UCCCGCAGCCGUCGCGACCUG	21	8625
SCNN1A-4777	−	CUCCCGCAGCCGUCGCGACCUG	22	8626
SCNN1A-4778	−	GCUCCCGCAGCCGUCGCGACCUG	23	8627
SCNN1A-4779	−	GGCUCCCGCAGCCGUCGCGACCUG	24	8628
SCNN1A-4780	−	GAGACUCUGCCAUCCCUG	18	8629
SCNN1A-4781	−	AGAGACUCUGCCAUCCCUG	19	8630
SCNN1A-4782	−	CAGAGACUCUGCCAUCCCUG	20	8631
SCNN1A-4783	−	CCAGAGACUCUGCCAUCCCUG	21	8632
SCNN1A-4784	−	GCCAGAGACUCUGCCAUCCCUG	22	8633
SCNN1A-4785	−	UGCCAGAGACUCUGCCAUCCCUG	23	8634
SCNN1A-4786	−	CUGCCAGAGACUCUGCCAUCCCUG	24	8635
SCNN1A-4787	−	CACUACAUCAACAUCCUG	18	8636
SCNN1A-4788	−	CCACUACAUCAACAUCCUG	19	8637
SCNN1A-4789	−	UCCACUACAUCAACAUCCUG	20	8638
SCNN1A-4790	−	UUCCACUACAUCAACAUCCUG	21	8639
SCNN1A-4791	−	CUUCCACUACAUCAACAUCCUG	22	8640
SCNN1A-4792	−	GCUUCCACUACAUCAACAUCCUG	23	8641
SCNN1A-4793	−	CGCUUCCACUACAUCAACAUCCUG	24	8642
SCNN1A-4794	−	AUGGCAGUGAUGUUCCUG	18	8643
SCNN1A-4795	−	AAUGGCAGUGAUGUUCCUG	19	8644
SCNN1A-4796	−	GAAUGGCAGUGAUGUUCCUG	20	8645
SCNN1A-4797	−	AGAAUGGCAGUGAUGUUCCUG	21	8646
SCNN1A-4798	−	AAGAAUGGCAGUGAUGUUCCUG	22	8647
SCNN1A-4799	−	CAAGAAUGGCAGUGAUGUUCCUG	23	8648
SCNN1A-4800	−	CCAAGAAUGGCAGUGAUGUUCCUG	24	8649
SCNN1A-4801	−	AAGAUCGGCUUCCAGCUG	18	8650
SCNN1A-4802	−	GAAGAUCGGCUUCCAGCUG	19	8651
SCNN1A-4803	−	GGAAGAUCGGCUUCCAGCUG	20	8652
SCNN1A-4804	−	UGGAAGAUCGGCUUCCAGCUG	21	8653
SCNN1A-4805	−	CUGGAAGAUCGGCUUCCAGCUG	22	8654
SCNN1A-4806	−	ACUGGAAGAUCGGCUUCCAGCUG	23	8655
SCNN1A-4807	−	GACUGGAAGAUCGGCUUCCAGCUG	24	8656
SCNN1A-4808	−	GAAAUUAAAGAGGAGCUG	18	8657
SCNN1A-4809	−	GGAAAUUAAAGAGGAGCUG	19	8658
SCNN1A-4810	−	CGGAAAUUAAAGAGGAGCUG	20	8659
SCNN1A-4811	−	CCGGAAAUUAAAGAGGAGCUG	21	8660
SCNN1A-4812	−	CCCGGAAAUUAAAGAGGAGCUG	22	8661
SCNN1A-4813	−	ACCCGGAAAUUAAAGAGGAGCUG	23	8662
SCNN1A-4814	−	UACCCGGAAAUUAAAGAGGAGCUG	24	8663
SCNN1A-4815	−	UCCUCCACCUGUCCUCUG	18	8664
SCNN1A-4816	−	UUCCUCCACCUGUCCUCUG	19	8665
SCNN1A-1224	−	GUUCCUCCACCUGUCCUCUG	20	5073
SCNN1A-4817	−	AGUUCCUCCACCUGUCCUCUG	21	8666
SCNN1A-4818	−	CAGUUCCUCCACCUGUCCUCUG	22	8667
SCNN1A-4819	−	CCAGUUCCUCCACCUGUCCUCUG	23	8668
SCNN1A-4820	−	GCCAGUUCCUCCACCUGUCCUCUG	24	8669
SCNN1A-4821	−	CAUCUCCAGGGGGCUCUG	18	8670
SCNN1A-4822	−	CCAUCUCCAGGGGGCUCUG	19	8671
SCNN1A-4823	−	CCCAUCUCCAGGGGGCUCUG	20	8672
SCNN1A-4824	−	GCCCAUCUCCAGGGGGCUCUG	21	8673
SCNN1A-4825	−	CGCCCAUCUCCAGGGGGCUCUG	22	8674
SCNN1A-4826	−	CCGCCCAUCUCCAGGGGGCUCUG	23	8675
SCNN1A-4827	−	CCCGCCCAUCUCCAGGGGGCUCUG	24	8676
SCNN1A-4828	−	GGGCUGUUUCACCAAGUG	18	8677
SCNN1A-4829	−	UGGGCUGUUUCACCAAGUG	19	8678
SCNN1A-4830	−	CUGGGCUGUUUCACCAAGUG	20	8679
SCNN1A-4831	−	CCUGGGCUGUUUCACCAAGUG	21	8680
SCNN1A-4832	−	ACCUGGGCUGUUUCACCAAGUG	22	8681
SCNN1A-4833	−	CACCUGGGCUGUUUCACCAAGUG	23	8682
SCNN1A-4834	−	CCACCUGGGCUGUUUCACCAAGUG	24	8683
SCNN1A-4835	−	GACAUCCCAGGUAGAGUG	18	8684
SCNN1A-4836	−	UGACAUCCCAGGUAGAGUG	19	8685
SCNN1A-1228	−	GUGACAUCCCAGGUAGAGUG	20	5077
SCNN1A-4837	−	GGUGACAUCCCAGGUAGAGUG	21	8686
SCNN1A-4838	−	CGGUGACAUCCCAGGUAGAGUG	22	8687
SCNN1A-4839	−	UCGGUGACAUCCCAGGUAGAGUG	23	8688
SCNN1A-4840	−	CUCGGUGACAUCCCAGGUAGAGUG	24	8689
SCNN1A-4841	−	UCAGGGGUGGAUGCGGUG	18	8690
SCNN1A-4842	−	AUCAGGGGUGGAUGCGGUG	19	8691
SCNN1A-1233	−	CAUCAGGGGUGGAUGCGGUG	20	5082
SCNN1A-4843	−	UCAUCAGGGGUGGAUGCGGUG	21	8692
SCNN1A-4844	−	CUCAUCAGGGGUGGAUGCGGUG	22	8693
SCNN1A-4845	−	ACUCAUCAGGGGUGGAUGCGGUG	23	8694
SCNN1A-4846	−	UACUCAUCAGGGGUGGAUGCGGUG	24	8695
SCNN1A-4847	−	UCCUCGGUGUUGUCUGUG	18	8696
SCNN1A-4848	−	CUCCUCGGUGUUGUCUGUG	19	8697
SCNN1A-4849	−	GCUCCUCGGUGUUGUCUGUG	20	8698
SCNN1A-4850	−	GGCUCCUCGGUGUUGUCUGUG	21	8699
SCNN1A-4851	−	CGGCUCCUCGGUGUUGUCUGUG	22	8700
SCNN1A-4852	−	UCGGCUCCUCGGUGUUGUCUGUG	23	8701
SCNN1A-4853	−	UUCGGCUCCUCGGUGUUGUCUGUG	24	8702
SCNN1A-4854	−	CAUCCCAGGUAGAGUGUG	18	8703
SCNN1A-4855	−	ACAUCCCAGGUAGAGUGUG	19	8704
SCNN1A-1238	−	GACAUCCCAGGUAGAGUGUG	20	5087
SCNN1A-4856	−	UGACAUCCCAGGUAGAGUGUG	21	8705
SCNN1A-4857	−	GUGACAUCCCAGGUAGAGUGUG	22	8706
SCNN1A-4858	−	GGUGACAUCCCAGGUAGAGUGUG	23	8707
SCNN1A-4859	−	CGGUGACAUCCCAGGUAGAGUGUG	24	8708
SCNN1A-4860	−	AGCGUGGCCUCCAGCUUG	18	8709
SCNN1A-4861	−	UAGCGUGGCCUCCAGCUUG	19	8710
SCNN1A-1242	−	GUAGCGUGGCCUCCAGCUUG	20	5091
SCNN1A-4862	−	CGUAGCGUGGCCUCCAGCUUG	21	8711
SCNN1A-4863	−	CCGUAGCGUGGCCUCCAGCUUG	22	8712
SCNN1A-4864	−	CCCGUAGCGUGGCCUCCAGCUUG	23	8713
SCNN1A-4865	−	GCCCGUAGCGUGGCCUCCAGCUUG	24	8714
SCNN1A-4866	−	GGAGACCUCCAUCAGCAU	18	8715
SCNN1A-4867	−	UGGAGACCUCCAUCAGCAU	19	8716
SCNN1A-4868	−	GUGGAGACCUCCAUCAGCAU	20	8717
SCNN1A-4869	−	CGUGGAGACCUCCAUCAGCAU	21	8718
SCNN1A-4870	−	GCGUGGAGACCUCCAUCAGCAU	22	8719
SCNN1A-4871	−	GGCGUGGAGACCUCCAUCAGCAU	23	8720
SCNN1A-4872	−	UGGCGUGGAGACCUCCAUCAGCAU	24	8721
SCNN1A-4873	−	UCUACCAGACAUACUCAU	18	8722
SCNN1A-4874	−	UUCUACCAGACAUACUCAU	19	8723
SCNN1A-4875	−	CUUCUACCAGACAUACUCAU	20	8724
SCNN1A-4876	−	GCUUCUACCAGACAUACUCAU	21	8725
SCNN1A-4877	−	UGCUUCUACCAGACAUACUCAU	22	8726
SCNN1A-4878	−	CUGCUUCUACCAGACAUACUCAU	23	8727
SCNN1A-4879	−	ACUGCUUCUACCAGACAUACUCAU	24	8728
SCNN1A-4880	−	UGGUGUAUGUGGGUUCAU	18	8729
SCNN1A-4881	−	UUGGUGUAUGUGGGUUCAU	19	8730
SCNN1A-1250	−	CUUGGUGUAUGUGGGUUCAU	20	5099
SCNN1A-4882	−	UCUUGGUGUAUGUGGGUUCAU	21	8731
SCNN1A-4883	−	CUCUUGGUGUAUGUGGGUUCAU	22	8732
SCNN1A-4884	−	UCUCUUGGUGUAUGUGGGUUCAU	23	8733
SCNN1A-4885	−	AUCUCUUGGUGUAUGUGGGUUCAU	24	8734
SCNN1A-4886	−	UACUCUCUCUUUCCUGAU	18	8735
SCNN1A-4887	−	CUACUCUCUCUUUCCUGAU	19	8736
SCNN1A-4888	−	CCUACUCUCUCUUUCCUGAU	20	8737
SCNN1A-4889	−	CCCUACUCUCUCUUUCCUGAU	21	8738
SCNN1A-4890	−	ACCCUACUCUCUCUUUCCUGAU	22	8739
SCNN1A-4891	−	GACCCUACUCUCUCUUUCCUGAU	23	8740
SCNN1A-4892	−	UGACCCUACUCUCUCUUUCCUGAU	24	8741
SCNN1A-4893	−	GGAAACCCUGGACAGACU	18	8742
SCNN1A-4894	−	AGGAAACCCUGGACAGACU	19	8743
SCNN1A-1257	−	UAGGAAACCCUGGACAGACU	20	5106
SCNN1A-4895	−	AUAGGAAACCCUGGACAGACU	21	8744
SCNN1A-4896	−	CAUAGGAAACCCUGGACAGACU	22	8745
SCNN1A-4897	−	UCAUAGGAAACCCUGGACAGACU	23	8746
SCNN1A-4898	−	UUCAUAGGAAACCCUGGACAGACU	24	8747
SCNN1A-4899	−	AAGGCAAGGAUGCUGACU	18	8748
SCNN1A-4900	−	GAAGGCAAGGAUGCUGACU	19	8749
SCNN1A-1258	−	GGAAGGCAAGGAUGCUGACU	20	5107
SCNN1A-4901	−	AGGAAGGCAAGGAUGCUGACU	21	8750
SCNN1A-4902	−	GAGGAAGGCAAGGAUGCUGACU	22	8751
SCNN1A-4903	−	UGAGGAAGGCAAGGAUGCUGACU	23	8752
SCNN1A-4904	−	AUGAGGAAGGCAAGGAUGCUGACU	24	8753
SCNN1A-4905	−	ACCCUCUGCCCCACACCU	18	8754
SCNN1A-4906	−	CACCCUCUGCCCCACACCU	19	8755
SCNN1A-4907	−	CCACCCUCUGCCCCACACCU	20	8756
SCNN1A-4908	−	CCCACCCUCUGCCCCACACCU	21	8757
SCNN1A-4909	−	UCCCACCCUCUGCCCCACACCU	22	8758
SCNN1A-4910	−	UUCCCACCCUCUGCCCCACACCU	23	8759
SCNN1A-4911	−	CUUCCCACCCUCUGCCCCACACCU	24	8760
SCNN1A-4912	−	CCGCAGCCGUCGCGACCU	18	8761
SCNN1A-4913	−	CCCGCAGCCGUCGCGACCU	19	8762
SCNN1A-4914	−	UCCCGCAGCCGUCGCGACCU	20	8763
SCNN1A-4915	−	CUCCCGCAGCCGUCGCGACCU	21	8764
SCNN1A-4916	−	GCUCCCGCAGCCGUCGCGACCU	22	8765
SCNN1A-4917	−	GGCUCCCGCAGCCGUCGCGACCU	23	8766
SCNN1A-4918	−	CGGCUCCCGCAGCCGUCGCGACCU	24	8767
SCNN1A-4919	−	GUCCUCUGGGGGGGCCCU	18	8768
SCNN1A-4920	−	UGUCCUCUGGGGGGGCCCU	19	8769
SCNN1A-4921	−	CUGUCCUCUGGGGGGGCCCU	20	8770
SCNN1A-4922	−	CCUGUCCUCUGGGGGGGCCCU	21	8771
SCNN1A-4923	−	ACCUGUCCUCUGGGGGGGCCCU	22	8772
SCNN1A-4924	−	CACCUGUCCUCUGGGGGGGCCCU	23	8773
SCNN1A-4925	−	CCACCUGUCCUCUGGGGGGGCCCU	24	8774
SCNN1A-4926	−	AGUUCCUCCACCUGUCCU	18	8775
SCNN1A-4927	−	CAGUUCCUCCACCUGUCCU	19	8776
SCNN1A-4928	−	CCAGUUCCUCCACCUGUCCU	20	8777
SCNN1A-4929	−	GCCAGUUCCUCCACCUGUCCU	21	8778
SCNN1A-4930	−	GGCCAGUUCCUCCACCUGUCCU	22	8779
SCNN1A-4931	−	GGGCCAGUUCCUCCACCUGUCCU	23	8780
SCNN1A-4932	−	GGGGCCAGUUCCUCCACCUGUCCU	24	8781
SCNN1A-4933	−	CAUGUUCCUCAUGCUGCU	18	8782
SCNN1A-4934	−	UCAUGUUCCUCAUGCUGCU	19	8783
SCNN1A-4935	−	AUCAUGUUCCUCAUGCUGCU	20	8784
SCNN1A-4936	−	CAUCAUGUUCCUCAUGCUGCU	21	8785
SCNN1A-4937	−	UCAUCAUGUUCCUCAUGCUGCU	22	8786
SCNN1A-4938	−	GUCAUCAUGUUCCUCAUGCUGCU	23	8787
SCNN1A-4939	−	GGUCAUCAUGUUCCUCAUGCUGCU	24	8788
SCNN1A-4940	−	CGAGGGGGCAGGGGUGCU	18	8789
SCNN1A-4941	−	CCGAGGGGGCAGGGGUGCU	19	8790
SCNN1A-4942	−	GCCGAGGGGGCAGGGGUGCU	20	8791
SCNN1A-4943	−	GGCCGAGGGGGCAGGGGUGCU	21	8792
SCNN1A-4944	−	AGGCCGAGGGGGCAGGGGUGCU	22	8793
SCNN1A-4945	−	CAGGCCGAGGGGGCAGGGGUGCU	23	8794
SCNN1A-4946	−	CCAGGCCGAGGGGGCAGGGGUGCU	24	8795
SCNN1A-4947	−	UUCCUCCACCUGUCCUCU	18	8796
SCNN1A-4948	−	GUUCCUCCACCUGUCCUCU	19	8797
SCNN1A-1276	−	AGUUCCUCCACCUGUCCUCU	20	5125
SCNN1A-4949	−	CAGUUCCUCCACCUGUCCUCU	21	8798
SCNN1A-4950	−	CCAGUUCCUCCACCUGUCCUCU	22	8799
SCNN1A-4951	−	GCCAGUUCCUCCACCUGUCCUCU	23	8800
SCNN1A-4952	−	GGCCAGUUCCUCCACCUGUCCUCU	24	8801
SCNN1A-4953	−	UGACAUCCCAGGUAGAGU	18	8802
SCNN1A-4954	−	GUGACAUCCCAGGUAGAGU	19	8803
SCNN1A-4955	−	GGUGACAUCCCAGGUAGAGU	20	8804
SCNN1A-4956	−	CGGUGACAUCCCAGGUAGAGU	21	8805
SCNN1A-4957	−	UCGGUGACAUCCCAGGUAGAGU	22	8806
SCNN1A-4958	−	CUCGGUGACAUCCCAGGUAGAGU	23	8807
SCNN1A-4959	−	CCUCGGUGACAUCCCAGGUAGAGU	24	8808
SCNN1A-4960	−	CCUGGAAUCAACAACGGU	18	8809
SCNN1A-4961	−	GCCUGGAAUCAACAACGGU	19	8810
SCNN1A-4962	−	UGCCUGGAAUCAACAACGGU	20	8811
SCNN1A-4963	−	AUGCCUGGAAUCAACAACGGU	21	8812
SCNN1A-4964	−	CAUGCCUGGAAUCAACAACGGU	22	8813
SCNN1A-4965	−	CCAUGCCUGGAAUCAACAACGGU	23	8814
SCNN1A-4966	−	UCCAUGCCUGGAAUCAACAACGGU	24	8815
SCNN1A-4967	−	AUCAGGGGUGGAUGCGGU	18	8816
SCNN1A-4968	−	CAUCAGGGGUGGAUGCGGU	19	8817
SCNN1A-4969	−	UCAUCAGGGGUGGAUGCGGU	20	8818
SCNN1A-4970	−	CUCAUCAGGGGUGGAUGCGGU	21	8819
SCNN1A-4971	−	ACUCAUCAGGGGUGGAUGCGGU	22	8820
SCNN1A-4972	−	UACUCAUCAGGGGUGGAUGCGGU	23	8821
SCNN1A-4973	−	AUACUCAUCAGGGGUGGAUGCGGU	24	8822
SCNN1A-4974	−	UGUGGGGAAGGGAUGGGU	18	8823
SCNN1A-4975	−	GUGUGGGGAAGGGAUGGGU	19	8824
SCNN1A-1288	−	AGUGUGGGGAAGGGAUGGGU	20	5137
SCNN1A-4976	−	GAGUGUGGGGAAGGGAUGGGU	21	8825
SCNN1A-4977	−	AGAGUGUGGGGAAGGGAUGGGU	22	8826
SCNN1A-4978	−	UAGAGUGUGGGGAAGGGAUGGGU	23	8827
SCNN1A-4979	−	GUAGAGUGUGGGGAAGGGAUGGGU	24	8828
SCNN1A-4980	−	ACUUCCACCACCCGAUGU	18	8829
SCNN1A-4981	−	CACUUCCACCACCCGAUGU	19	8830
SCNN1A-4982	−	UCACUUCCACCACCCGAUGU	20	8831
SCNN1A-4983	−	CUCACUUCCACCACCCGAUGU	21	8832
SCNN1A-4984	−	UCUCACUUCCACCACCCGAUGU	22	8833
SCNN1A-4985	−	CUCUCACUUCCACCACCCGAUGU	23	8834
SCNN1A-4986	−	ACUCUCACUUCCACCACCCGAUGU	24	8835
SCNN1A-4987	−	ACAUCCCAGGUAGAGUGU	18	8836
SCNN1A-4988	−	GACAUCCCAGGUAGAGUGU	19	8837
SCNN1A-1293	−	UGACAUCCCAGGUAGAGUGU	20	5142
SCNN1A-4989	−	GUGACAUCCCAGGUAGAGUGU	21	8838
SCNN1A-4990	−	GGUGACAUCCCAGGUAGAGUGU	22	8839
SCNN1A-4991	−	CGGUGACAUCCCAGGUAGAGUGU	23	8840
SCNN1A-4992	−	UCGGUGACAUCCCAGGUAGAGUGU	24	8841
SCNN1A-4993	−	GAAACCCUGGACAGACUU	18	8842
SCNN1A-4994	−	GGAAACCCUGGACAGACUU	19	8843
SCNN1A-1295	−	AGGAAACCCUGGACAGACUU	20	5144
SCNN1A-4995	−	UAGGAAACCCUGGACAGACUU	21	8844
SCNN1A-4996	−	AUAGGAAACCCUGGACAGACUU	22	8845
SCNN1A-4997	−	CAUAGGAAACCCUGGACAGACUU	23	8846
SCNN1A-4998	−	UCAUAGGAAACCCUGGACAGACUU	24	8847
SCNN1A-4999	−	UAGCGUGGCCUCCAGCUU	18	8848
SCNN1A-5000	−	GUAGCGUGGCCUCCAGCUU	19	8849
SCNN1A-5001	−	CGUAGCGUGGCCUCCAGCUU	20	8850
SCNN1A-5002	−	CCGUAGCGUGGCCUCCAGCUU	21	8851
SCNN1A-5003	−	CCCGUAGCGUGGCCUCCAGCUU	22	8852
SCNN1A-5004	−	GCCCGUAGCGUGGCCUCCAGCUU	23	8853
SCNN1A-5005	−	AGCCCGUAGCGUGGCCUCCAGCUU	24	8854
SCNN1A-5006	−	CAUGCUGCUCCGAAGGUU	18	8855
SCNN1A-5007	−	UCAUGCUGCUCCGAAGGUU	19	8856
SCNN1A-5008	−	CUCAUGCUGCUCCGAAGGUU	20	8857
SCNN1A-5009	−	CCUCAUGCUGCUCCGAAGGUU	21	8858
SCNN1A-5010	−	UCCUCAUGCUGCUCCGAAGGUU	22	8859
SCNN1A-5011	−	UUCCUCAUGCUGCUCCGAAGGUU	23	8860
SCNN1A-5012	−	GUUCCUCAUGCUGCUCCGAAGGUU	24	8861
SCNN1A-5013	−	GGCAGUGAUGUUCCUGUU	18	8862
SCNN1A-5014	−	UGGCAGUGAUGUUCCUGUU	19	8863
SCNN1A-5015	−	AUGGCAGUGAUGUUCCUGUU	20	8864
SCNN1A-5016	−	AAUGGCAGUGAUGUUCCUGUU	21	8865
SCNN1A-5017	−	GAAUGGCAGUGAUGUUCCUGUU	22	8866
SCNN1A-5018	−	AGAAUGGCAGUGAUGUUCCUGUU	23	8867
SCNN1A-5019	−	AAGAAUGGCAGUGAUGUUCCUGUU	24	8868

Table 45A provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the first tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 45A
1st Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5020	+	GGCUAGAGUCCUGCUCC	17	8869
SCNN1A-5021	+	GUCUAGGGUCCUGCUCC	17	8870
SCNN1A-5022	+	GAUUCCAAACCAGGUUC	17	8871
SCNN1A-5023	−	GAUGUACUGGCAAUUCG	17	8872

Table 45B provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the second tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 45B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-322	+	UGGUCACUGCGGGGAAG	17	915
SCNN1A-5024	+	CCCUUCAUGAGCCCCGG	17	8873
SCNN1A-5025	+	AGGGACUAACCGACCUG	17	8874
SCNN1A-238	+	AGAUGGUCACUGCGGGGAAG	20	858
SCNN1A-5026	−	CAUGAUGUACUGGCAAUUCG	20	8875
SCNN1A-5027	+	UUCCCCUUCAUGAGCCCCGG	20	8876
SCNN1A-1657	+	CAGAGGGACUAACCGACCUG	20	5506

Table 45C provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the third tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 45C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5028	+	GGCCCAGCCCCUGCUCC	17	8877
SCNN1A-5029	+	GAGGGCUAGAGUCCUGCUCC	20	8878
SCNN1A-5030	+	GAGGUCUAGGGUCCUGCUCC	20	8879

Table 45D provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fourth tier parameters. The targeting domains bind within the first 500 bp of the coding sequence (e.g., with 500 bp downstream from the start codon). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 45D
4th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5031	+	CGGGGCCCAGCCCCUGCUCC	20	8880
SCNN1A-5032	+	CAGGAUUCCAAACCAGGUUC	20	8881

Table 45E provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fifth tier parameters. The targeting domains fall in the coding sequence of the gene, downstream of the first 500 bp of coding sequence (e.g., anywhere from +500 (relative to the start codon) to the stop codon of the gene). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. meningitidis Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 45E
5th Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5033	+	GAGUCUCACCCCAGGAA	17	8882
SCNN1A-5034	−	ACAGCAGGUGAGGCCCA	17	8883
SCNN1A-485	+	GCGCCAUGGAGCAAGCA	17	4334
SCNN1A-5035	+	UAUGUCUGGUAGAAGCA	17	8884
SCNN1A-5036		UCCAGGUGUGUAUUCAC	17	8885
SCNN1A-577	+	CUGAGGAGAAGUCAACC	17	4426
SCNN1A-5037	−	GCUUGCUCCAUGGCGCC	17	8886
SCNN1A-5038	−	GCAACUUCAUCUUCGCC	17	8887
SCNN1A-5039	−	GAGCCCGUAGCGUGGCC	17	8888
SCNN1A-5040	−	ACUGGAAGGACUGGAAG	17	8889
SCNN1A-5041	−	GCAACCAGAACAAAUCG	17	8890
SCNN1A-5042	−	AUGCGGUGAGGGAGUGG	17	8891
SCNN1A-787	−	ACCCUGGACAGACUUGG	17	4636
SCNN1A-5043	+	AAGGGGACACUAACCUG	17	8892
SCNN1A-5044	−	CUGCCUUUAUGGAUGAU	17	8893
SCNN1A-5045	−	AACAACGGUGAGAAGCU	17	8894
SCNN1A-5046	+	UCGGCCUGGAGACCAGU	17	8895
SCNN1A-5047	+	AGGGAGCUUCUCACCGU	17	8896
SCNN1A-5048	+	CUGGAGUCUCACCCCAGGAA	20	8897
SCNN1A-5049	−	CACACAGCAGGUGAGGCCCA	20	8898
SCNN1A-909	+	AGGGCGCCAUGGAGCAAGCA	20	4758
SCNN1A-5050	+	GAGUAUGUCUGGUAGAAGCA	20	8899
SCNN1A-5051	−	CCUUCCAGGUGUGUAUUCAC	20	8900
SCNN1A-1000	+	GGUCUGAGGAGAAGUCAACC	20	4849
SCNN1A-5052	−	CCUGCUUGCUCCAUGGCGCC	20	8901
SCNN1A-5053	−	UGGGCAACUUCAUCUUCGCC	20	8902
SCNN1A-5054	−	GUCGAGCCCGUAGCGUGGCC	20	8903
SCNN1A-5055	−	UGGACUGGAAGGACUGGAAG	20	8904
SCNN1A-5056	−	AGUGCAACCAGAACAAAUCG	20	8905
SCNN1A-5057	−	UGGAUGCGGUGAGGGAGUGG	20	8906
SCNN1A-1206	−	GAAACCCUGGACAGACUUGG	20	5055
SCNN1A-5058	+	GGGAAGGGGACACUAACCUG	20	8907
SCNN1A-5059	−	AACCUGCCUUUAUGGAUGAU	20	8908
SCNN1A-5060	−	AUCAACAACGGUGAGAAGCU	20	8909
SCNN1A-5061	+	CCCUCGGCCUGGAGACCAGU	20	8910
SCNN1A-5062	+	AGCAGGGAGCUUCUCACCGU	20	8911

Table 46A provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the first tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN8A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 46A
1st Tier
			Tar-
			get
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5063	+	GAGAAUCAGACCCAAAA	17	8912
SCNN1A-5064	−	GAGCUGGCAAAUAGAAA	17	8913
SCNN1A-5065	+	GAAGGAGCCAGCACCAA	17	8914
SCNN1A-5066	+	GGGCAACACAAGGAGAA	17	8915
SCNN1A-5067	+	GCUGGGCUUCCCUAGAA	17	8916
SCNN1A-5068	−	GCCAGAUUCAACUGGAA	17	8917
SCNN1A-327	+	GAUACCUCCCCUUGGAA	17	4176
SCNN1A-5069	+	GCUAGGAGGGCAACACA	17	8918
SCNN1A-328	−	GGGCGCAGGGUGGGACA	17	4177
SCNN1A-5070	+	GAAACUGACCCUUCCCA	17	8919
SCNN1A-5071	−	GAGAGCAGACGAAUCCA	17	8920
SCNN1A-329	−	GCCUCACUCGGGUUCCA	17	4178
SCNN1A-5072	+	GUGCCAAGUGGUGAGCA	17	8921
SCNN1A-330	−	GGGAGAAUGUGGGCGCA	17	4179
SCNN1A-5073	+	GGUCCUUACAUUGGGCA	17	8922
SCNN1A-5074	−	GAAAGGUGGCCCUAUCA	17	8923
SCNN1A-5075	+	GCAGUACUCCAGGCUCA	17	8924
SCNN1A-80	−	GCCCAUACCAGGUCUCA	17	529
SCNN1A-5076	−	GACACAGCUCGAGGUCA	17	8925
SCNN1A-5077	+	GAGUACUGGACCUGAGA	17	8926
SCNN1A-5078	−	GAGGGCCUAGAGUGAGA	17	8927
SCNN1A-5079	+	GGAAGGAGGGCUCCCGA	17	8928
SCNN1A-5080	+	GGGAGUUUUCCGAAGGA	17	8929
SCNN1A-5081	+	GUUUUCCGAAGGAAGGA	17	8930
SCNN1A-5082	+	GAACCGGGAGGACAGGA	17	8931
SCNN1A-5083	+	GGAGUCUGUCUCCAGGA	17	8932
SCNN1A-5084	+	GGAUGUGAAAGCCGGGA	17	8933
SCNN1A-5085	−	GUCUGCUGGCUUGUGGA	17	8934
SCNN1A-5086	−	GUCUGGACAAGGUUGGA	17	8935
SCNN1A-5087	−	GCUCUGUGUGGGAGUGA	17	8936
SCNN1A-5088	+	GAGGAGAAAUUCGUUGA	17	8937
SCNN1A-5089	−	GAGGAGAGGCCGUUCUA	17	8938
SCNN1A-5090	−	GGAGACUGGAGUUUCUA	17	8939
SCNN1A-5091	−	GGACCAUGCCCAAUGUA	17	8940
SCNN1A-5092	−	GGAAUCCUGGUUGACAC	17	8941
SCNN1A-5093	+	GGCUGCCGCUUCCUCAC	17	8942
SCNN1A-5094	+	GGGCUUUAGACGCAGAC	17	8943
SCNN1A-5095	+	GAAAGCCGGUGUCAACC	17	8944
SCNN1A-5096	+	GAGCAUUGAUACACACC	17	8945
SCNN1A-5097	+	GAUUCUGUCUCUGCCCC	17	8946
SCNN1A-5098	−	GGGCGGGCUCCCCAGCC	17	8947
SCNN1A-5099	−	GCUGAGCCUCUAGCUCC	17	8948
SCNN1A-5100	−	GGGCGAUUACACAUUCC	17	8949
SCNN1A-5101	+	GUCCCAAGUGUGCUUCC	17	8950
SCNN1A-5102	−	GGUGGCGAGGAAUCAGC	17	8951
SCNN1A-5103	+	GCCAAAAGUGCCGGAGC	17	8952
SCNN1A-5104	+	GAGGAUGUGGCCAGCGC	17	8953
SCNN1A-5105	+	GAAGCUGGGGGCUAGGC	17	8954
SCNN1A-5106	+	GAAGGCGGACUCUGGGC	17	8955
SCNN1A-5107	+	GGAGCCCGCCCGCUGGC	17	8956
SCNN1A-5108	+	GCCUAGGGGCUCACUGC	17	8957
SCNN1A-5109	+	GGAGCCAGCAGACCUGC	17	8958
SCNN1A-5110	−	GCUGGGCCUUUGUCUGC	17	8959
SCNN1A-5111	+	GUUGGGGCCAAAAGUGC	17	8960
SCNN1A-5112	+	GCAGGCACUGAAGGUGC	17	8961
SCNN1A-5113	+	GUCUGCUCUCUGGGUGC	17	8962
SCNN1A-5114	−	GCUGAGCACCUUAUUGC	17	8963
SCNN1A-5115	−	GGGGCAGAGACAGAAUC	17	8964
SCNN1A-5116	+	GUGGGAGCAGCGCACUC	17	8965
SCNN1A-333	−	GAUGGGAGAGGGCACUC	17	4182
SCNN1A-5117	−	GGCCCUCGCGCUGCCUC	17	8966
SCNN1A-5118	+	GGCAGUACUCCAGGCUC	17	8967
SCNN1A-5119	−	GGUGUGUAUCAAUGCUC	17	8968
SCNN1A-5120	−	GAGUUUCUAGGGGUCUC	17	8969
SCNN1A-5121	−	GGACACAGCUCGAGGUC	17	8970
SCNN1A-5122	−	GCUAGUGGUUGGAUUUC	17	8971
SCNN1A-5123	+	GCUAGAGGCUCAGCAAG	17	8972
SCNN1A-5124	+	GGAAUGUGGGCAACCAG	17	8973
SCNN1A-334	−	GACAUGGGCAUGGCCAG	17	4183
SCNN1A-5125	+	GGGCUAGGGGAGCCUAG	17	8974
SCNN1A-5126	+	GUGCUUCCAGGAGCUAG	17	8975
SCNN1A-5127	−	GAGACUGGAGUUUCUAG	17	8976
SCNN1A-5128	+	GGGCACUGAGUGAGUAG	17	8977
SCNN1A-5129	−	GUCCACAGUGUCCUGCG	17	8978
SCNN1A-5130	−	GGACAAAACUCGAAAGG	17	8979
SCNN1A-5131	+	GACGCAGACAGGCAAGG	17	8980
SCNN1A-5132	+	GGAACCGGGAGGACAGG	17	8981
SCNN1A-5133	+	GGAGCAGCGCACUCAGG	17	8982
SCNN1A-5134	−	GUAGAUAGCCCCAGAGG	17	8983
SCNN1A-5135	−	GGGCCUAGAGUGAGAGG	17	8984
SCNN1A-5136	+	GCAUUGAUACACACCGG	17	8985
SCNN1A-5137	+	GCACUGAAGGUGCAGGG	17	8986
SCNN1A-5138	+	GACCCAAAAAGGGCUGG	17	8987
SCNN1A-5139	−	GGUCUGGACAAGGUUGG	17	8988
SCNN1A-5140	−	GGGGUCUCUGGGAUAUG	17	8989
SCNN1A-5141	+	GGCCACGCAGGACACUG	17	8990
SCNN1A-5142	+	GUGCAGCGGCCUGGCUG	17	8991
SCNN1A-5143	+	GGGUCCAACCUGGUCUG	17	8992
SCNN1A-5144	+	GAUAAAUCAGUUUUCUG	17	8993
SCNN1A-5145	+	GUGAGUAGAGGCAGGUG	17	8994
SCNN1A-5146	−	GCUGCACCUGUCAGGUG	17	8995
SCNN1A-5147	−	GGUCUCUGGGAUAUGUG	17	8996
SCNN1A-335	−	GGCGCAGGGUGGGACAU	17	4184
SCNN1A-5148	+	GAGCCAGGUCCUUACAU	17	8997
SCNN1A-5149	+	GCGAAGGACAGAGAGAU	17	8998
SCNN1A-5150	+	GGGCUAGGCGGGGCCCU	17	8999
SCNN1A-5151	−	GAAAACUGAUUUAUCCU	17	9000
SCNN1A-5152	+	GUGCUGGGUUAUCUCCU	17	9001
SCNN1A-5153	−	GUAUCAAUGCUCAGGCU	17	9002
SCNN1A-5154	+	GGUGCAGCGGCCUGGCU	17	9003
SCNN1A-336	+	GGUCAAGGCUGAGCUCU	17	4185
SCNN1A-5155	+	GGAUUCGUCUGCUCUCU	17	9004
SCNN1A-5156	−	GAGAUGACACCUUCUCU	17	9005
SCNN1A-5157	−	GGGAGACUGGAGUUUCU	17	9006
SCNN1A-5158	−	GGGAUAUGUGGGGCAGU	17	9007
SCNN1A-5159	+	GAGCAGCGCACUCAGGU	17	9008
SCNN1A-337	−	GAAUGUGGGCGCAGGGU	17	4186
SCNN1A-5160	−	GGGUCUCUGGGAUAUGU	17	9009
SCNN1A-5161	+	GUUCUUUUUUACACUGU	17	9010
SCNN1A-5162	−	GGGUGAGGCUGACCUGU	17	9011
SCNN1A-5163	−	GUUGCCCUCCUAGCUGU	17	9012
SCNN1A-5164	−	GGGUCAGUUUCUUCAUU	17	9013
SCNN1A-339	+	GAGCCCCGGAGUGGAUU	17	4188
SCNN1A-5165	−	GGGAGCCCUCCUUCCUU	17	9014
SCNN1A-5166	+	GCAGACCUGCGGGAGUU	17	9015
SCNN1A-5167	+	GCAAGUGGGCAGCCCUCCAA	20	9016
SCNN1A-5168	+	GUCUCCAGGAAGGAGAGCAA	20	9017
SCNN1A-5169	+	GCAAAUAGUUUUCAUAUCAA	20	9018
SCNN1A-5170	+	GGAGGGCAACACAAGGAGAA	20	9019
SCNN1A-5171	+	GGAGCUGGGCUUCCCUAGAA	20	9020
SCNN1A-5172	−	GUGCUAGGACAAAACUCGAA	20	9021
SCNN1A-5173	−	GCUGCCAGAUUCAACUGGAA	20	9022
SCNN1A-5174	+	GGAUGUGGCCAGCGCUGGAA	20	9023
SCNN1A-5175	−	GCCCCUCCCGGGUCUGGACA	20	9024
SCNN1A-5176	+	GAAGAAACUGACCCUUCCCA	20	9025
SCNN1A-5177	+	GAGAUAAGACAUAAGAGCCA	20	9026
SCNN1A-5178	+	GCCCGCCCGCUGGCCGGCCA	20	9027
SCNN1A-340	−	GUGGGACAUGGGCAUGGCCA	20	4189
SCNN1A-341	−	GCAGCCUCACUCGGGUUCCA	20	4190
SCNN1A-342	−	GAGCAGUAUCAAGGUAAGCA	20	4191
SCNN1A-5179	+	GGAGUGCCAAGUGGUGAGCA	20	9028
SCNN1A-5180	−	GCUGGCAAAUAGAAAAGGCA	20	9029
SCNN1A-5181	+	GCUUUAGACGCAGACAGGCA	20	9030
SCNN1A-5182	−	GCCUAGAGUGAGAGGGGGCA	20	9031
SCNN1A-5183	+	GAGAAGGCGGACUCUGGGCA	20	9032
SCNN1A-5184	−	GUGCUGAGCACCUUAUUGCA	20	9033
SCNN1A-5185	+	GGCAAAUAGUUUUCAUAUCA	20	9034
SCNN1A-343	−	GUGAUGGGAGAGGGCACUCA	20	4192
SCNN1A-5186	+	GGAAGGCUGCCGCUUCCUCA	20	9035
SCNN1A-1	−	GCAGCCCAUACCAGGUCUCA	20	503
SCNN1A-5187	+	GCCAGCGCUGGAAAGGAAGA	20	9036
SCNN1A-5188	−	GCUGAGGGCCUAGAGUGAGA	20	9037
SCNN1A-5189	+	GGCAACCAGAGGCAGCGCGA	20	9038
SCNN1A-5190	+	GCCGGGAGUUUUCCGAAGGA	20	9039
SCNN1A-5191	+	GGAGUUUUCCGAAGGAAGGA	20	9040
SCNN1A-5192	+	GCCCGCUGGCCGGCCAGGGA	20	9041
SCNN1A-5193	+	GGCCCUGCACGCGGCAGGGA	20	9042
SCNN1A-76	+	GCCCUGGAGUGGACUGUGGA	20	528
SCNN1A-5194	−	GACCUGUGGGUGCCCUUGGA	20	9043
SCNN1A-5195	+	GAGGAGGAGAAAUUCGUUGA	20	9044
SCNN1A-5196	+	GCAUGGUCCUCCCUGCAAUA	20	9045
SCNN1A-5197	+	GCCUGCAAUACAAUAAGAUA	20	9046
SCNN1A-5198	+	GACAUAAGAGCCAAGGGCUA	20	9047
SCNN1A-344	+	GUAUGGGCUGCAGAGGUCUA	20	4193
SCNN1A-5199	−	GCAGAGGAGAGGCCGUUCUA	20	9048
SCNN1A-5200	−	GGAGGACCAUGCCCAAUGUA	20	9049
SCNN1A-5201	+	GAAAUCCAACCACUAGCUUA	20	9050
SCNN1A-5202	−	GUUUGGCUGCCAGAUUCAAC	20	9051
SCNN1A-5203	+	GCUCCCGAGGGCAGGUGAAC	20	9052
SCNN1A-5204	+	GCCUGAGCAUUGAUACACAC	20	9053
SCNN1A-5205	+	GAAGGCUGCCGCUUCCUCAC	20	9054
SCNN1A-5206	+	GAGUGCAGGAAUGUGGUCAC	20	9055
SCNN1A-5207	−	GGACCUGGCUCAAGGGAGAC	20	9056
SCNN1A-5208	+	GGCAUGGCACACGCCUAGAC	20	9057
SCNN1A-5209	+	GGGUGGGGAACCGGGAGGAC	20	9058
SCNN1A-5210	+	GGUUGCGGCUGGACUGGGAC	20	9059
SCNN1A-5211	+	GGCAGGUGAACUGGGAGUAC	20	9060
SCNN1A-5212	+	GUCAACCAGGAUUCCAAACC	20	9061
SCNN1A-5213	−	GUCCCAGUCCAGCCGCAACC	20	9062
SCNN1A-5214	+	GAGGGCCUGGGUGGGGAACC	20	9063
SCNN1A-5215	+	GAUCGGGGCUCAGGUGCACC	20	9064
SCNN1A-5216	−	GCCUAGCCCCCAGCUUCACC	20	9065
SCNN1A-5217	+	GGACACUGUGGACACAGACC	20	9066
SCNN1A-5218	−	GUCCUCCCGGUUCCCCACCC	20	9067
SCNN1A-346	+	GUGCCCUCUCCCAUCACCCC	20	4195
SCNN1A-5219	+	GCACACGCCUAGACAGGCCC	20	9068
SCNN1A-5220	−	GCUUCACCUGGGCCCCUCCC	20	9069
SCNN1A-5221	+	GCUGAGGAGGAGUCAGAGCC	20	9070
SCNN1A-347	−	GGUGGGACAUGGGCAUGGCC	20	4196
SCNN1A-5222	−	GCGAUUACACAUUCCUGGCC	20	9071
SCNN1A-5223	+	GUGAGAAGAAUUGCAAUGCC	20	9072
SCNN1A-5224	−	GGGAACCUGGUUUGGAAUCC	20	9073
SCNN1A-5225	+	GGGAUGCGUCUGCCUCCUCC	20	9074
SCNN1A-5226	+	GGAGUCCCAAGUGUGCUUCC	20	9075
SCNN1A-348	−	GGCAGCCUCACUCGGGUUCC	20	4197
SCNN1A-5227	+	GUGCACCUGGAUGUGAAAGC	20	9076
SCNN1A-176	−	GCUCAUGAAGGGGAACAAGC	20	811
SCNN1A-5228	−	GCAACCUGGGAGUGGGAAGC	20	9077
SCNN1A-5229	−	GGGGGUGGCGAGGAAUCAGC	20	9078
SCNN1A-5230	−	GCUGCUCCCACUUAGUGAGC	20	9079
SCNN1A-349	−	GAGUGGGAGAAUGUGGGCGC	20	4198
SCNN1A-5231	−	GUGUGUAUCAAUGCUCAGGC	20	9080
SCNN1A-5232	+	GAAUCAGACCCAAAAAGGGC	20	9081
SCNN1A-5233	+	GAAGGAGGGCUCCCGAGGGC	20	9082
SCNN1A-5234	+	GACAGGUGCAGCGGCCUGGC	20	9083
SCNN1A-5235	+	GGAGCCUAGGGGCUCACUGC	20	9084
SCNN1A-5236	+	GGAGUUGGGGCCAAAAGUGC	20	9085
SCNN1A-5237	−	GGUGCUGAGCACCUUAUUGC	20	9086
SCNN1A-5238	+	GGUUCCUUUCCAGUUGAAUC	20	9087
SCNN1A-350	−	GGUGAUGGGAGAGGGCACUC	20	4199
SCNN1A-351	−	GGCCAGGGGCAGCCUCACUC	20	4200
SCNN1A-5239	+	GGGCUCACUGCAGGAGACUC	20	9088
SCNN1A-5240	+	GGACCUGAGAAGGCGGACUC	20	9089
SCNN1A-5241	−	GUUCUAGGGAAGCCCAGCUC	20	9090
SCNN1A-5242	−	GCCCUCCUAGCUGUGGGCUC	20	9091
SCNN1A-352	+	GAUUGGGGAGAGCAAGGGUC	20	4201
SCNN1A-5243	−	GCCAGGCCGCUGCACCUGUC	20	9092
SCNN1A-5244	−	GCGAGGAAUCAGCAGGAAAG	20	9093
SCNN1A-5245	+	GGAGCUAGAGGCUCAGCAAG	20	9094
SCNN1A-5246	−	GUGAGAGGGGGCAAGGCAAG	20	9095
SCNN1A-5247	+	GGCCAGCGCUGGAAAGGAAG	20	9096
SCNN1A-5248	+	GCAGGAAUGUGGGCAACCAG	20	9097
SCNN1A-5249	−	GCAAGAGACUGCCGCAAGAG	20	9098
SCNN1A-5250	−	GAAACAGAAGGCAGAUAGAG	20	9099
SCNN1A-5251	−	GUCCAGCCGCAACCUGGGAG	20	9100
SCNN1A-5252	−	GGGUCUGGACAAGGUUGGAG	20	9101
SCNN1A-5253	−	GCCAUGCUGCCUUAAGCUAG	20	9102
SCNN1A-5254	+	GAGGGGCACUGAGUGAGUAG	20	9103
SCNN1A-353	−	GCUCUCCCCAAUCCACUCCG	20	4202
SCNN1A-5255	+	GGGCAACCAGAGGCAGCGCG	20	9104
SCNN1A-5256	+	GUGAAGCUGGGGGCUAGGCG	20	9105
SCNN1A-5257	+	GACAGACUCAUGGGGGAUCG	20	9106
SCNN1A-5258	+	GAGUACUGGACCUGAGAAGG	20	9107
SCNN1A-5259	+	GGGAGUUUUCCGAAGGAAGG	20	9108
SCNN1A-5260	+	GUGGGAGCAGCGCACUCAGG	20	9109
SCNN1A-5261	−	GUAGAUAGCCCCAGAGGAGG	20	9110
SCNN1A-5262	−	GGUCUGGACAAGGUUGGAGG	20	9111
SCNN1A-354	−	GGGAGAAUGUGGGCGCAGGG	20	4203
SCNN1A-5263	−	GGCAAAUAGAAAAGGCAGGG	20	9112
SCNN1A-5264	+	GGCCUGGGUGGGGAACCGGG	20	9113
SCNN1A-5265	+	GCAUUGAUACACACCGGGGG	20	9114
SCNN1A-2	−	GCCCAUACCAGGUCUCAUGG	20	497
SCNN1A-5266	−	GCUGGCUCCAGGAAAGGUGG	20	9115
SCNN1A-5267	+	GUCACAGAGUUGCAGGAAUG	20	9116
SCNN1A-5268	+	GAGGGCCACGCAGGACACUG	20	9117
SCNN1A-5269	−	GCACUCUGGGCUGCCUCCUG	20	9118
SCNN1A-5270	−	GCCGCUGCACCUGUCAGGUG	20	9119
SCNN1A-5271	−	GGCCUUUGUCUGCUGGCUUG	20	9120
SCNN1A-355	−	GUGGGCGCAGGGUGGGACAU	20	4204
SCNN1A-5272	+	GAGACAGACUCAUGGGGGAU	20	9121
SCNN1A-5273	−	GUCUCCUGCAGUGAGCCCCU	20	9122
SCNN1A-5274	−	GGCUGACCUGUGGGUGCCCU	20	9123
SCNN1A-5275	+	GCCAAGGGCUAGGGGAGCCU	20	9124
SCNN1A-5276	+	GCCUUGCCCCCUCUCACUCU	20	9125
SCNN1A-5277	+	GACCUGAGAAGGCGGACUCU	20	9126
SCNN1A-356	+	GGUAUGGGCUGCAGAGGUCU	20	4205
SCNN1A-5278	+	GCCAGCAGACCUGCGGGAGU	20	9127
SCNN1A-5279	−	GAGGAAGCCACAGACCAGGU	20	9128
SCNN1A-357	−	GGAGAAUGUGGGCGCAGGGU	20	4206
SCNN1A-5280	+	GCGCUGGAAAGGAAGAGGGU	20	9129
SCNN1A-5281	−	GUGCAGGGCCUGGGUUGUGU	20	9130
SCNN1A-5282	−	GAAGGGUCAGUUUCUUCAUU	20	9131
SCNN1A-5283	−	GAGUCUCCUCCAGCCCUUUU	20	9132

Table 46B provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the second tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 46B
2nd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5284	+	AAGGAGCCAGCACCAAA	17	9133
SCNN1A-5285	+	AAACUUAAUGCAGCAAA	17	9134
SCNN1A-5286	−	CUGUCUCAGGAAGUAAA	17	9135
SCNN1A-5287	+	UAAGACAUAAGAGCCAA	17	9136
SCNN1A-5288	+	AGUGGGCAGCCCUCCAA	17	9137
SCNN1A-358	−	CCAGCUGUCCCUUCCAA	17	4207
SCNN1A-359	−	AGUAUCAAGGUAAGCAA	17	4208
SCNN1A-5289	+	UGGCUGUUUGAUCUCAA	17	9138
SCNN1A-5290	−	CUAGGACAAAACUCGAA	17	9139
SCNN1A-5291	−	UCUGCUGGCUCCAGGAA	17	9140
SCNN1A-5292	−	UGAUUUAUCCUUGGGAA	17	9141
SCNN1A-5293	+	UGUGGCCAGCGCUGGAA	17	9142
SCNN1A-360	−	ACUCCGGGGCUCAUGAA	17	4209
SCNN1A-5294	+	AUUAGCAUCUCAAUUAA	17	9143
SCNN1A-5295	−	CCUCCCGGGUCUGGACA	17	9144
SCNN1A-5296	−	UUGAGAUCAAACAGCCA	17	9145
SCNN1A-5297	+	AUAAGACAUAAGAGCCA	17	9146
SCNN1A-5298	−	ACCUUUUCACAGAGCCA	17	9147
SCNN1A-5299	+	CGCCCGCUGGCCGGCCA	17	9148
SCNN1A-88	−	CUCCACAGUCCACUCCA	17	609
SCNN1A-5300	+	AAGUGGGCAGCCCUCCA	17	9149
SCNN1A-5301	+	CUGAAUCUUGACAAGCA	17	9150
SCNN1A-361	−	CAGUAUCAAGGUAAGCA	17	4210
SCNN1A-5302	−	ACUCUGUGACCACAGCA	17	9151
SCNN1A-5303	+	ACUAGCUUAAGGCAGCA	17	9152
SCNN1A-5304	+	UCAAUUAAAGGUGAGCA	17	9153
SCNN1A-5305	−	UGAGAGGGGGCAAGGCA	17	9154
SCNN1A-5306	+	UUAGACGCAGACAGGCA	17	9155
SCNN1A-5307	+	AGGCCCUGCACGCGGCA	17	9156
SCNN1A-5308	−	CUUCCCUGCCGCGUGCA	17	9157
SCNN1A-5309	+	CAGGCACUGAAGGUGCA	17	9158
SCNN1A-5310	−	CUGAGCACCUUAUUGCA	17	9159
SCNN1A-362	−	UAUCAUGAGCAGUAUCA	17	4211
SCNN1A-363	−	AUGGGAGAGGGCACUCA	17	4212
SCNN1A-5311	+	UUCCUGAGACAGACUCA	17	9160
SCNN1A-5312	+	AGGCUGCCGCUUCCUCA	17	9161
SCNN1A-5313	−	UGUAAGGACCUGGCUCA	17	9162
SCNN1A-5314	+	AGCGCUGGAAAGGAAGA	17	9163
SCNN1A-5315	+	AGGGCAACACAAGGAGA	17	9164
SCNN1A-5316	+	UGGUGGGGGCAAAUAGA	17	9165
SCNN1A-5317	+	AGCCGGGAGUUUUCCGA	17	9166
SCNN1A-5318	+	AACCAGAGGCAGCGCGA	17	9167
SCNN1A-5319	+	UGAGCCCACAGCUAGGA	17	9168
SCNN1A-5320	+	CGCUGGCCGGCCAGGGA	17	9169
SCNN1A-5321	+	CCUGCACGCGGCAGGGA	17	9170
SCNN1A-5322	+	CUUGUCCAGACCCGGGA	17	9171
SCNN1A-5323	+	UGAGCAGGGCGGGGGGA	17	9172
SCNN1A-5324	−	UGACACCUUCUCUGGGA	17	9173
SCNN1A-82	−	AUACCAGGUCUCAUGGA	17	501
SCNN1A-364	+	UGAUACCUCCCCUUGGA	17	4213
SCNN1A-5325	−	CUGUGGGUGCCCUUGGA	17	9174
SCNN1A-365	−	CACUCCGGGGCUCAUGA	17	4214
SCNN1A-5326	−	CUGCACCUGUCAGGUGA	17	9175
SCNN1A-366	−	UCGGGUUCCAGGGGUGA	17	4215
SCNN1A-5327	+	UGGUCCUCCCUGCAAUA	17	9176
SCNN1A-5328	+	CGAAGGACAGAGAGAUA	17	9177
SCNN1A-5329	+	AGGGCUAGGGGAGCCUA	17	9178
SCNN1A-5330	−	AAGAACAGAAUGUCCUA	17	9179
SCNN1A-5331	+	AUAAGAGCCAAGGGCUA	17	9180
SCNN1A-157	+	CUCCAUGAGACCUGGUA	17	502
SCNN1A-5332	+	AUCCAACCACUAGCUUA	17	9181
SCNN1A-5333	−	UGGCUGCCAGAUUCAAC	17	9182
SCNN1A-5334	+	CCCGAGGGCAGGUGAAC	17	9183
SCNN1A-5335	+	UGAGCAUUGAUACACAC	17	9184
SCNN1A-5336	+	CCUCCAAGGGCACCCAC	17	9185
SCNN1A-5337	+	UUCCUCACGGGCCCCAC	17	9186
SCNN1A-5338	−	AGAGCAGACGAAUCCAC	17	9187
SCNN1A-5339	+	UGCAGGAAUGUGGUCAC	17	9188
SCNN1A-5340	−	CCUGGCUCAAGGGAGAC	17	9189
SCNN1A-5341	+	AUGGCACACGCCUAGAC	17	9190
SCNN1A-5342	+	CCAGGGAUGGAAGCGAC	17	9191
SCNN1A-5343	+	UGGGGAACCGGGAGGAC	17	9192
SCNN1A-5344	+	UGCGGCUGGACUGGGAC	17	9193
SCNN1A-5345	+	CCAGGUUGCGGCUGGAC	17	9194
SCNN1A-5346	+	CCUCCCCCUCACCUGAC	17	9195
SCNN1A-5347	+	AGGUGAACUGGGAGUAC	17	9196
SCNN1A-5348	+	AGGCUCAGGGUCCAACC	17	9197
SCNN1A-5349	−	CCAGUCCAGCCGCAACC	17	9198
SCNN1A-5350	+	CCAACCUUGUCCAGACC	17	9199
SCNN1A-156	+	UUCCCCUCCAUGAGACC	17	653
SCNN1A-5351	−	UGCCCAAUGUAAGGACC	17	9200
SCNN1A-368	−	CCUCUGCAGCCCAUACC	17	4217
SCNN1A-5352	−	CUCCCGGUUCCCCACCC	17	9201
SCNN1A-5353	+	UAAGGUGCUCAGCACCC	17	9202
SCNN1A-5354	+	CAACCUUGUCCAGACCC	17	9203
SCNN1A-369	+	CCGAGUGAGGCUGCCCC	17	4218
SCNN1A-5355	−	AGGCCUAUCUCCUCCCC	17	9204
SCNN1A-5356	+	ACACAGACCCGGAGCCC	17	9205
SCNN1A-5357	+	AGACCCGGGAGGGGCCC	17	9206
SCNN1A-5358	−	CCUGUCGCUUCCAUCCC	17	9207
SCNN1A-5359	−	AGGUUGGACCCUGAGCC	17	9208
SCNN1A-5360	+	CCAGUCUCCCUUGAGCC	17	9209
SCNN1A-5361	+	CCGCCCGCUGGCCGGCC	17	9210
SCNN1A-5362	+	UGACAGGUGCAGCGGCC	17	9211
SCNN1A-5363	−	CUGCCGCGUGCAGGGCC	17	9212
SCNN1A-5364	+	AGAAGAAUUGCAAUGCC	17	9213
SCNN1A-5365	+	UUACACUGUUGGCUGCC	17	9214
SCNN1A-5366	−	UCCCGGCUUUCACAUCC	17	9215
SCNN1A-5367	−	AGCUGAGACACAGAUCC	17	9216
SCNN1A-5368	−	UUCCUUCGGAAAACUCC	17	9217
SCNN1A-370	−	UCUCCCCAAUCCACUCC	17	4219
SCNN1A-87	−	CCUCCACAGUCCACUCC	17	608
SCNN1A-5369	+	AGAAAAGGCAGUACUCC	17	9218
SCNN1A-5370	−	UUCACCUGGGCCCCUCC	17	9219
SCNN1A-5371	+	AUGCGUCUGCCUCCUCC	17	9220
SCNN1A-5372	+	UUUGGUCUUCUUCCUCC	17	9221
SCNN1A-5373	+	AAAGGGAGUCUGUCUCC	17	9222
SCNN1A-371	−	AGCCUCACUCGGGUUCC	17	4220
SCNN1A-5374	+	CUUCUUAAAGUGAAAGC	17	9223
SCNN1A-5375	+	CACCUGGAUGUGAAAGC	17	9224
SCNN1A-260	−	CAUGAAGGGGAACAAGC	17	868
SCNN1A-84	−	CAUGGAGGGGAACAAGC	17	607
SCNN1A-5376	+	AGGGGCCCAGGUGAAGC	17	9225
SCNN1A-5377	−	AACUCUGUGACCACAGC	17	9226
SCNN1A-372	+	CCCUUGGAAGGGACAGC	17	4221
SCNN1A-5378	−	AUCCCUGGCCGGCCAGC	17	9227
SCNN1A-5379	+	CUCAAUUAAAGGUGAGC	17	9228
SCNN1A-5380	+	CAAGCAAGGAGUUUAGC	17	9229
SCNN1A-5381	+	CAGCGCGAGGGCCACGC	17	9230
SCNN1A-5382	+	CUGGGGAGCCCGCCCGC	17	9231
SCNN1A-5383	−	UUGGCCCCAACUCCCGC	17	9232
SCNN1A-5384	−	CUCUUCCUUUCCAGCGC	17	9233
SCNN1A-373	−	UGGGAGAAUGUGGGCGC	17	4222
SCNN1A-5385	−	UGGCAAAUAGAAAAGGC	17	9234
SCNN1A-5386	−	UGUAUCAAUGCUCAGGC	17	9235
SCNN1A-5387	+	ACUGAGUGAGUAGAGGC	17	9236
SCNN1A-5388	+	CAGGCCCUGCACGCGGC	17	9237
SCNN1A-5389	+	CACUCCCAGGUUGCGGC	17	9238
SCNN1A-5390	+	UCAGACCCAAAAAGGGC	17	9239
SCNN1A-5391	+	UUAAAGGUGAGCAGGGC	17	9240
SCNN1A-5392	−	CUGGCCGGCCAGCGGGC	17	9241
SCNN1A-5393	−	UCGCUUCCAUCCCUGGC	17	9242
SCNN1A-5394	+	AGGUGCAGCGGCCUGGC	17	9243
SCNN1A-5395	+	AGAGAAGAGGUCUCUGC	17	9244
SCNN1A-5396	−	AACUCCCGCAGGUCUGC	17	9245
SCNN1A-5397	−	CCUUCCCUGCCGCGUGC	17	9246
SCNN1A-5398	−	CAGACUCCCUUUGGUGC	17	9247
SCNN1A-5399	−	UUAUCUUAUUGUAUUGC	17	9248
SCNN1A-5400	+	UGUGGUCACAGAGUUGC	17	9249
SCNN1A-5401	+	UCCUUUCCAGUUGAAUC	17	9250
SCNN1A-5402	+	CAGACUCAUGGGGGAUC	17	9251
SCNN1A-5403	−	CGAAAGGUGGCCCUAUC	17	9252
SCNN1A-374	−	CUCUCCCCAAUCCACUC	17	4223
SCNN1A-375	−	CAGGGGCAGCCUCACUC	17	4224
SCNN1A-5404	+	CUCACUGCAGGAGACUC	17	9253
SCNN1A-5405	+	CCUGAGAAGGCGGACUC	17	9254
SCNN1A-5406	+	AGGUCAGCCUCACCCUC	17	9255
SCNN1A-5407	−	CCAGUUCACCUGCCCUC	17	9256
SCNN1A-5408	−	CUAGGGAAGCCCAGCUC	17	9257
SCNN1A-5409	+	AUGGGGGAUCGGGGCUC	17	9258
SCNN1A-5410	−	CUCCUAGCUGUGGGCUC	17	9259
SCNN1A-5411	+	UGGAUUCGUCUGCUCUC	17	9260
SCNN1A-5412	−	CCCCAUGAGUCUGUCUC	17	9261
SCNN1A-5413	−	AGAGAUGACACCUUCUC	17	9262
SCNN1A-5414	−	CCAGAGUCCGCCUUCUC	17	9263
SCNN1A-376	+	UGGGGAGAGCAAGGGUC	17	4225
SCNN1A-5415	+	AAUUGCAAUGCCUGGUC	17	9264
SCNN1A-5416	−	AGGCCGCUGCACCUGUC	17	9265
SCNN1A-5417	+	AGGAGUGGAGUGCCAAG	17	9266
SCNN1A-377	−	CAGCUGUCCCUUCCAAG	17	4226
SCNN1A-5418	+	CAGCGCUGGAAAGGAAG	17	9267
SCNN1A-5419	+	ACCCGGAGCCCAGGAAG	17	9268
SCNN1A-5420	−	UGGGGCCCGUGAGGAAG	17	9269
SCNN1A-378	−	CUCCGGGGCUCAUGAAG	17	4227
SCNN1A-5421	+	CCUCCCCGCUCACUAAG	17	9270
SCNN1A-5422	−	UAAGUAGAUAGCCCCAG	17	9271
SCNN1A-5423	−	CAUCCCUGGCCGGCCAG	17	9272
SCNN1A-5424	−	CUCGAGGUCAGGGCCAG	17	9273
SCNN1A-379	−	CCUCACUCGGGUUCCAG	17	4228
SCNN1A-5425	−	CCCUAUCAGGGAAGCAG	17	9274
SCNN1A-5426	−	CUCUGUGACCACAGCAG	17	9275
SCNN1A-5427	−	UGGGAUAUGUGGGGCAG	17	9276
SCNN1A-5428	+	AGGCGGACUCUGGGCAG	17	9277
SCNN1A-380	+	CCUGGUAUGGGCUGCAG	17	4229
SCNN1A-5429	+	UCACCUGACAGGUGCAG	17	9278
SCNN1A-5430	−	AGAGACUGCCGCAAGAG	17	9279
SCNN1A-5431	−	AGGGCCUAGAGUGAGAG	17	9280
SCNN1A-381	+	CUUCAUGAGCCCCGGAG	17	4230
SCNN1A-5432	+	UUGUCCAGACCCGGGAG	17	9281
SCNN1A-5433	−	CAAGGCAAGGGGGGGAG	17	9282
SCNN1A-5434	−	CAGCCGCAACCUGGGAG	17	9283
SCNN1A-5435	−	UCUGGACAAGGUUGGAG	17	9284
SCNN1A-5436	−	UGAGGGCCUAGAGUGAG	17	9285
SCNN1A-5437	−	UGCUCCCACUUAGUGAG	17	9286
SCNN1A-5438	−	AUGCUGCCUUAAGCUAG	17	9287
SCNN1A-5439	+	UAAGAGCCAAGGGCUAG	17	9288
SCNN1A-5440	+	AACCCAGGCCCUGCACG	17	9289
SCNN1A-5441	+	AGCAUUGAUACACACCG	17	9290
SCNN1A-5442	+	CUCCCACACAGAGCCCG	17	9291
SCNN1A-5443	+	AGGAAGGAGGGCUCCCG	17	9292
SCNN1A-382	−	CUCCCCAAUCCACUCCG	17	4231
SCNN1A-5444	−	CUCCCACUUAGUGAGCG	17	9293
SCNN1A-5445	+	CAACCAGAGGCAGCGCG	17	9294
SCNN1A-5446	+	UAAAGGUGAGCAGGGCG	17	9295
SCNN1A-5447	+	AGACUCAUGGGGGAUCG	17	9296
SCNN1A-5448	−	AAUCAGGACACAGCUCG	17	9297
SCNN1A-5449	+	AGUUUUCCGAAGGAAGG	17	9298
SCNN1A-5450	+	CUCACGGGCCCCACAGG	17	9299
SCNN1A-5451	+	AAAGGUGAGCAGGGCGG	17	9300
SCNN1A-5452	+	AUUAAAGGUGAGCAGGG	17	9301
SCNN1A-383	−	AGAAUGUGGGCGCAGGG	17	4232
SCNN1A-5453	−	AGCACCUUAUUGCAGGG	17	9302
SCNN1A-5454	+	CUGGGUGGGGAACCGGG	17	9303
SCNN1A-5455	+	CCUUGUCCAGACCCGGG	17	9304
SCNN1A-5456	−	CCUGGCCGGCCAGCGGG	17	9305
SCNN1A-5457	+	AAGGUGAGCAGGGCGGG	17	9306
SCNN1A-384	−	CUGUCCCUUCCAAGGGG	17	4233
SCNN1A-5458	−	CCACUUAGUGAGCGGGG	17	9307
SCNN1A-5459	+	UUGAUACACACCGGGGG	17	9308
SCNN1A-5460	+	CCUAGACAGGCCCUGGG	17	9309
SCNN1A-5461	+	CUGAGACAGACUCAUGG	17	9310
SCNN1A-81	−	CAUACCAGGUCUCAUGG	17	605
SCNN1A-5462	−	UGAGACACAGAUCCUGG	17	9311
SCNN1A-5463	−	UGUCUGCUGGCUUGUGG	17	9312
SCNN1A-5464	−	CCUGUGGGUGCCCUUGG	17	9313
SCNN1A-5465	+	ACAGAGUUGCAGGAAUG	17	9314
SCNN1A-5466	+	CCUGAGACAGACUCAUG	17	9315
SCNN1A-5467	−	UGUUGCCCUCCUAGCUG	17	9316
SCNN1A-5468	+	UGUAAUCGCCCCUGCUG	17	9317
SCNN1A-385	+	CCCCUGGAACCCGAGUG	17	4234
SCNN1A-5469	−	CUCCUGUGGGGCCCGUG	17	9318
SCNN1A-5470	−	AAUCCACGGGCUCUGUG	17	9319
SCNN1A-387	+	AGCCCCGGAGUGGAUUG	17	4236
SCNN1A-5471	+	UGUGGCUUCCUCUCUUG	17	9320
SCNN1A-5472	+	CAGACCUGCGGGAGUUG	17	9321
SCNN1A-5473	+	UCCUGAGACAGACUCAU	17	9322
SCNN1A-5474	+	ACACCGGGGGAGGAGAU	17	9323
SCNN1A-5475	+	ACAGACUCAUGGGGGAU	17	9324
SCNN1A-388	+	UGAGCCCCGGAGUGGAU	17	4237
SCNN1A-5476	+	UCCUCUGCUUCCCUGAU	17	9325
SCNN1A-389	−	CGGGUUCCAGGGGUGAU	17	4238
SCNN1A-5477	+	AGGAGAAAUUCGUUGAU	17	9326
SCNN1A-158	+	UCCAUGAGACCUGGUAU	17	654
SCNN1A-5478	+	CCGAGGGCAGGUGAACU	17	9327
SCNN1A-5479	−	UCUCCUUGCUCACCACU	17	9328
SCNN1A-5480	+	CAGGUUGCGGCUGGACU	17	9329
SCNN1A-5481	−	CAGUCCAGCCGCAACCU	17	9330
SCNN1A-5482	−	AGCCCCCAGCUUCACCU	17	9331
SCNN1A-5483	−	UAGGCUCCCCUAGCCCU	17	9332
SCNN1A-5484	+	ACGCCUAGACAGGCCCU	17	9333
SCNN1A-5485	−	UGACCUGUGGGUGCCCU	17	9334
SCNN1A-5486	+	AAGGGCUAGGGGAGCCU	17	9335
SCNN1A-5487	−	UGCCGCGUGCAGGGCCU	17	9336
SCNN1A-5488	+	AUCCUGAGCCCACAGCU	17	9337
SCNN1A-5489	+	CCAAAAGUGCCGGAGCU	17	9338
SCNN1A-5490	+	CAUAAGAGCCAAGGGCU	17	9339
SCNN1A-5491	−	CCACAUUCCUGCACUCU	17	9340
SCNN1A-5492	+	UUGCCCCCUCUCACUCU	17	9341
SCNN1A-5493	+	CUGAGAAGGCGGACUCU	17	9342
SCNN1A-5494	−	AGUUUCUAGGGGUCUCU	17	9343
SCNN1A-390	+	AUGGGCUGCAGAGGUCU	17	4239
SCNN1A-5495	+	AGGGCUCCAGGAGGUCU	17	9344
SCNN1A-5496	−	AGAGGAGAGGCCGUUCU	17	9345
SCNN1A-5497	+	CUAGAGGCUCAGCAAGU	17	9346
SCNN1A-5498	+	CUCCCCGCUCACUAAGU	17	9347
SCNN1A-5499	+	AGCAGACCUGCGGGAGU	17	9348
SCNN1A-5500	−	AGCCGCAACCUGGGAGU	17	9349
SCNN1A-5501	−	CCGGGUCUGGACAAGGU	17	9350
SCNN1A-5502	+	AGUGAGUAGAGGCAGGU	17	9351
SCNN1A-5503	−	UGCCUUAAGCUAGUGGU	17	9352
SCNN1A-5504	+	CAGAGUUGCAGGAAUGU	17	9353
SCNN1A-5505	−	UCUGGGCUGCCUCCUGU	17	9354
SCNN1A-5506	−	AUCCACGGGCUCUGUGU	17	9355
SCNN1A-5507	+	AGCCAGGUCCUUACAUU	17	9356
SCNN1A-5508	−	CUCCUGGAAGCACACUU	17	9357
SCNN1A-5509	−	UGGAGACAGACUCCCUU	17	9358
SCNN1A-5510	−	UUUUGCUGCAUUAAGUU	17	9359
SCNN1A-392	−	AGCAAGGGAACCUGGUU	17	4241
SCNN1A-5511	−	CCCAGCUCCGGCACUUU	17	9360
SCNN1A-5512	−	UCUCCUCCAGCCCUUUU	17	9361
SCNN1A-5513	−	CUCCUCCAGCCCUUUUU	17	9362
SCNN1A-5514	+	UCAGAGAAUCAGACCCAAAA	20	9363
SCNN1A-5515	+	UAGAAGGAGCCAGCACCAAA	20	9364
SCNN1A-5516	−	CAUGAGCUGGCAAAUAGAAA	20	9365
SCNN1A-5517	+	AUCUCCUUGGCUCUGUGAAA	20	9366
SCNN1A-5518	+	AUAGAAGGAGCCAGCACCAA	20	9367
SCNN1A-5519	−	UCCUGGAGGAAGAAGACCAA	20	9368
SCNN1A-5520	+	AGAUAAGACAUAAGAGCCAA	20	9369
SCNN1A-5521	−	AAUCCAGCUGUCCCUUCCAA	20	9370
SCNN1A-393	−	AGCAGUAUCAAGGUAAGCAA	20	4242
SCNN1A-5522	−	AAUGUAAGGACCUGGCUCAA	20	9371
SCNN1A-5523	+	CCCUGGCUGUUUGAUCUCAA	20	9372
SCNN1A-5524	−	AGGUCUGCUGGCUCCAGGAA	20	9373
SCNN1A-5525	−	AACUGAUUUAUCCUUGGGAA	20	9374
SCNN1A-394	+	CAUGAUACCUCCCCUUGGAA	20	4243
SCNN1A-5526	+	CUCAUUAGCAUCUCAAUUAA	20	9375
SCNN1A-5527	+	ACAGCUAGGAGGGCAACACA	20	9376
SCNN1A-395	−	UGUGGGCGCAGGGUGGGACA	20	4244
SCNN1A-5528	−	CCUUUGAGAUCAAACAGCCA	20	9377
SCNN1A-5529	−	CCAGAGAGCAGACGAAUCCA	20	9378
SCNN1A-5530	+	AGCAAGUGGGCAGCCCUCCA	20	9379
SCNN1A-5531	−	AAAUCCAGCUGUCCCUUCCA	20	9380
SCNN1A-5532	+	CUGCUGAAUCUUGACAAGCA	20	9381
SCNN1A-5533	+	UGUCUCCAGGAAGGAGAGCA	20	9382
SCNN1A-5534	+	AUCUCAAUUAAAGGUGAGCA	20	9383
SCNN1A-396	−	AGUGGGAGAAUGUGGGCGCA	20	4245
SCNN1A-5535	+	CCGGAGCCCAGGAAGAGGCA	20	9384
SCNN1A-5536	+	CCCAGGCCCUGCACGCGGCA	20	9385
SCNN1A-5537	+	CCAGGUCCUUACAUUGGGCA	20	9386
SCNN1A-5538	−	AGCCUUCCCUGCCGCGUGCA	20	9387
SCNN1A-5539	+	AAGCAGGCACUGAAGGUGCA	20	9388
SCNN1A-5540	−	CUCGAAAGGUGGCCCUAUCA	20	9389
SCNN1A-397	−	AGGUAUCAUGAGCAGUAUCA	20	4246
SCNN1A-5541	+	AAGGCAGUACUCCAGGCUCA	20	9390
SCNN1A-5542	−	CAAUGUAAGGACCUGGCUCA	20	9391
SCNN1A-398	+	AUUGGGGAGAGCAAGGGUCA	20	4247
SCNN1A-5543	+	UGGGAGUACUGGACCUGAGA	20	9392
SCNN1A-5544	+	CAGAGCCGGGAGUUUUCCGA	20	9393
SCNN1A-5545	+	ACAAUAGAGAGGGACAGCGA	20	9394
SCNN1A-5546	+	AAGGGAGUCUGUCUCCAGGA	20	9395
SCNN1A-5547	+	UCCUGAGCCCACAGCUAGGA	20	9396
SCNN1A-5548	+	AACCUUGUCCAGACCCGGGA	20	9397
SCNN1A-5549	+	CCUGGAUGUGAAAGCCGGGA	20	9398
SCNN1A-5550	−	AGAUGACACCUUCUCUGGGA	20	9399
SCNN1A-5551	−	AAACUGAUUUAUCCUUGGGA	20	9400
SCNN1A-3	−	CCCAUACCAGGUCUCAUGGA	20	556
SCNN1A-5552	−	UUUGUCUGCUGGCUUGUGGA	20	9401
SCNN1A-399	+	UCAUGAUACCUCCCCUUGGA	20	4248
SCNN1A-5553	−	CGGGUCUGGACAAGGUUGGA	20	9402
SCNN1A-400	−	AUCCACUCCGGGGCUCAUGA	20	4249
SCNN1A-5554	−	CUCUUCUCUGCAGGGCCUGA	20	9403
SCNN1A-5555	−	CGGGCUCUGUGUGGGAGUGA	20	9404
SCNN1A-5556	−	CCGCUGCACCUGUCAGGUGA	20	9405
SCNN1A-401	−	CACUCGGGUUCCAGGGGUGA	20	4250
SCNN1A-5557	+	UCUCCUCUGCUUCCCUGAUA	20	9406
SCNN1A-5558	−	AAGGGAGACUGGAGUUUCUA	20	9407
SCNN1A-78	+	CCCCUCCAUGAGACCUGGUA	20	500
SCNN1A-5559	−	UUUGGAAUCCUGGUUGACAC	20	9408
SCNN1A-5560	+	AGCCCUCCAAGGGCACCCAC	20	9409
SCNN1A-5561	+	CGCUUCCUCACGGGCCCCAC	20	9410
SCNN1A-5562	−	CAGAGAGCAGACGAAUCCAC	20	9411
SCNN1A-5563	+	CAGGGGCUUUAGACGCAGAC	20	9412
SCNN1A-5564	+	CGGCCAGGGAUGGAAGCGAC	20	9413
SCNN1A-5565	+	CUCCCAGGUUGCGGCUGGAC	20	9414
SCNN1A-5566	+	UCCAGGCUCAGGGUCCAACC	20	9415
SCNN1A-5567	+	AGUGAAAGCCGGUGUCAACC	20	9416
SCNN1A-404	−	UCAAGGUAAGCAAGGGAACC	20	4253
SCNN1A-5568	+	CCUGAGCAUUGAUACACACC	20	9417
SCNN1A-5569	+	CCUCCAACCUUGUCCAGACC	20	9418
SCNN1A-5570	−	CCAUGCCCAAUGUAAGGACC	20	9419
SCNN1A-5571	−	AGCAGGAAAGAGGAGGGACC	20	9420
SCNN1A-405	−	AGACCUCUGCAGCCCAUACC	20	4254
SCNN1A-5572	+	CUCCAACCUUGUCCAGACCC	20	9421
SCNN1A-406	+	AACCCGAGUGAGGCUGCCCC	20	4255
SCNN1A-5573	+	CCUGAUUCUGUCUCUGCCCC	20	9422
SCNN1A-5574	−	UGCAGGCCUAUCUCCUCCCC	20	9423
SCNN1A-5575	+	UGGACACAGACCCGGAGCCC	20	9424
SCNN1A-5576	−	AUUCCUGUCGCUUCCAUCCC	20	9425
SCNN1A-5577	−	AACGAAUUUCUCCUCCUCCC	20	9426
SCNN1A-5578	−	ACCUUUGAGAUCAAACAGCC	20	9427
SCNN1A-5579	−	AGCGGGCGGGCUCCCCAGCC	20	9428
SCNN1A-5580	+	ACAAGGAGAAGGGGCCAGCC	20	9429
SCNN1A-5581	−	ACCAGGUUGGACCCUGAGCC	20	9430
SCNN1A-5582	+	ACUCCAGUCUCCCUUGAGCC	20	9431
SCNN1A-5583	+	ACACUGUUGGCUGCCAGGCC	20	9432
SCNN1A-5584	+	ACCUGACAGGUGCAGCGGCC	20	9433
SCNN1A-5585	−	UCCCUGCCGCGUGCAGGGCC	20	9434
SCNN1A-5586	+	UUUUUACACUGUUGGCUGCC	20	9435
SCNN1A-5587	−	CCUUCCCGGCUUUCACAUCC	20	9436
SCNN1A-5588	−	AGGAGCUGAGACACAGAUCC	20	9437
SCNN1A-5589	−	UCCUUCCUUCGGAAAACUCC	20	9438
SCNN1A-408	−	UGCUCUCCCCAAUCCACUCC	20	4257
SCNN1A-8	−	AGCCCUCCACAGUCCACUCC	20	559
SCNN1A-5590	+	AAGAGAAAAGGCAGUACUCC	20	9439
SCNN1A-5591	−	UGGAGGCAGCCCAGACCUCC	20	9440
SCNN1A-5592	−	AGCUUCACCUGGGCCCCUCC	20	9441
SCNN1A-5593	−	UUUCUGCCCUCCUGUCCUCC	20	9442
SCNN1A-5594	−	CUUGCUGAGCCUCUAGCUCC	20	9443
SCNN1A-5595	−	CCCGCAGGUCUGCUGGCUCC	20	9444
SCNN1A-5596	+	ACCAAAGGGAGUCUGUCUCC	20	9445
SCNN1A-5597	−	CAGGGGCGAUUACACAUUCC	20	9446
SCNN1A-5598	−	UCCCCCCUUGCUCUCCUUCC	20	9447
SCNN1A-5	−	UCUCAUGGAGGGGAACAAGC	20	557
SCNN1A-5599	−	UGCAACUCUGUGACCACAGC	20	9448
SCNN1A-409	+	CUCCCCUUGGAAGGGACAGC	20	4258
SCNN1A-5600	−	UCCAUCCCUGGCCGGCCAGC	20	9449
SCNN1A-5601	+	CAUCUCAAUUAAAGGUGAGC	20	9450
SCNN1A-5602	+	UGACAAGCAAGGAGUUUAGC	20	9451
SCNN1A-5603	+	AGGCAGCGCGAGGGCCACGC	20	9452
SCNN1A-5604	+	UGGCUGGGGAGCCCGCCCGC	20	9453
SCNN1A-5605	−	CUUUUGGCCCCAACUCCCGC	20	9454
SCNN1A-5606	−	ACCCUCUUCCUUUCCAGCGC	20	9455
SCNN1A-5607	−	UCGAGGUCAGGGCCAGAGGC	20	9456
SCNN1A-5608	+	ACGCAGACAGGCAAGGAGGC	20	9457
SCNN1A-5609	+	ACCCAGGCCCUGCACGCGGC	20	9458
SCNN1A-5610	+	UCCCACUCCCAGGUUGCGGC	20	9459
SCNN1A-5611	+	CAAUUAAAGGUGAGCAGGGC	20	9460
SCNN1A-5612	−	UCCCUGGCCGGCCAGCGGGC	20	9461
SCNN1A-5613	+	UGAGAAGGCGGACUCUGGGC	20	9462
SCNN1A-5614	−	CUGUCGCUUCCAUCCCUGGC	20	9463
SCNN1A-5615	+	CCUGGAGCCAGCAGACCUGC	20	9464
SCNN1A-5616	+	AAGAGAGAAGAGGUCUCUGC	20	9465
SCNN1A-5617	−	CCCAACUCCCGCAGGUCUGC	20	9466
SCNN1A-5618	−	CAGGCUGGGCCUUUGUCUGC	20	9467
SCNN1A-5619	−	CAGCCUUCCCUGCCGCGUGC	20	9468
SCNN1A-5620	+	AAAGCAGGCACUGAAGGUGC	20	9469
SCNN1A-5621	+	UUCGUCUGCUCUCUGGGUGC	20	9470
SCNN1A-5622	−	ACCUUAUCUUAUUGUAUUGC	20	9471
SCNN1A-5623	+	UGCUGUGGUCACAGAGUUGC	20	9472
SCNN1A-5624	−	CCUGGGGCAGAGACAGAAUC	20	9473
SCNN1A-5625	+	AGACAGACUCAUGGGGGAUC	20	9474
SCNN1A-5626	−	ACUCGAAAGGUGGCCCUAUC	20	9475
SCNN1A-410	−	UUGCUCUCCCCAAUCCACUC	20	4259
SCNN1A-5627	+	UAAGUGGGAGCAGCGCACUC	20	9476
SCNN1A-5628	+	AAAAGGGCUGGAGGAGACUC	20	9477
SCNN1A-5629	+	CACAGGUCAGCCUCACCCUC	20	9478
SCNN1A-5630	−	CGUGGCCCUCGCGCUGCCUC	20	9479
SCNN1A-411	+	UCAGGGUCAAGGCUGAGCUC	20	4260
SCNN1A-5631	+	AAAGGCAGUACUCCAGGCUC	20	9480
SCNN1A-5632	+	CUCAUGGGGGAUCGGGGCUC	20	9481
SCNN1A-5633	−	CCCGGUGUGUAUCAAUGCUC	20	9482
SCNN1A-5634	+	CCGUGGAUUCGUCUGCUCUC	20	9483
SCNN1A-5635	−	CUGGAGUUUCUAGGGGUCUC	20	9484
SCNN1A-5636	−	AUCCCCCAUGAGUCUGUCUC	20	9485
SCNN1A-5637	−	AGCAGAGAUGACACCUUCUC	20	9486
SCNN1A-5638	−	UGCCCAGAGUCCGCCUUCUC	20	9487
SCNN1A-5639	−	UCAGGACACAGCUCGAGGUC	20	9488
SCNN1A-5640	+	AAGAAUUGCAAUGCCUGGUC	20	9489
SCNN1A-5641	−	UAAGCUAGUGGUUGGAUUUC	20	9490
SCNN1A-5642	+	AUAAGGAGUGGAGUGCCAAG	20	9491
SCNN1A-412	−	AUCCAGCUGUCCCUUCCAAG	20	4261
SCNN1A-5643	+	CAGACCCGGAGCCCAGGAAG	20	9492
SCNN1A-5644	−	CUGUGGGGCCCGUGAGGAAG	20	9493
SCNN1A-5645	+	UCUCCUCCCCGCUCACUAAG	20	9494
SCNN1A-5646	−	CGCUAAGUAGAUAGCCCCAG	20	9495
SCNN1A-5647	−	UUCCAUCCCUGGCCGGCCAG	20	9496
SCNN1A-5648	−	CAGCUCGAGGUCAGGGCCAG	20	9497
SCNN1A-413	−	UGGGACAUGGGCAUGGCCAG	20	4262
SCNN1A-414	−	CAGCCUCACUCGGGUUCCAG	20	4263
SCNN1A-5649	−	UGGCCCUAUCAGGGAAGCAG	20	9498
SCNN1A-5650	−	CAACUCUGUGACCACAGCAG	20	9499
SCNN1A-5651	−	CUCUGGGAUAUGUGGGGCAG	20	9500
SCNN1A-5652	+	AGAAGGCGGACUCUGGGCAG	20	9501
SCNN1A-415	+	AGACCUGGUAUGGGCUGCAG	20	4264
SCNN1A-5653	−	CUGAGGGCCUAGAGUGAGAG	20	9502
SCNN1A-5654	+	UGCAGCAAAAGGAUAAGGAG	20	9503
SCNN1A-5655	+	ACCUUGUCCAGACCCGGGAG	20	9504
SCNN1A-4	−	CCAUACCAGGUCUCAUGGAG	20	498
SCNN1A-5656	+	AAGGGGCCAGCCAGGCUGAG	20	9505
SCNN1A-5657	−	AGCUGAGGGCCUAGAGUGAG	20	9506
SCNN1A-5658	−	CGCUGCUCCCACUUAGUGAG	20	9507
SCNN1A-5659	−	CGCUGCACCUGUCAGGUGAG	20	9508
SCNN1A-5660	+	CAAGGGCUAGGGGAGCCUAG	20	9509
SCNN1A-5661	+	AGUGUGCUUCCAGGAGCUAG	20	9510
SCNN1A-5662	+	ACAUAAGAGCCAAGGGCUAG	20	9511
SCNN1A-5663	−	AGGGAGACUGGAGUUUCUAG	20	9512
SCNN1A-5664	+	CACAACCCAGGCCCUGCACG	20	9513
SCNN1A-5665	+	CUGAGCAUUGAUACACACCG	20	9514
SCNN1A-5666	+	UCACUCCCACACAGAGCCCG	20	9515
SCNN1A-5667	+	CGAAGGAAGGAGGGCUCCCG	20	9516
SCNN1A-5668	−	CUGCUCCCACUUAGUGAGCG	20	9517
SCNN1A-5669	+	AAUUAAAGGUGAGCAGGGCG	20	9518
SCNN1A-5670	−	CAAGGUUGGAGGGGGUGGCG	20	9519
SCNN1A-5671	−	UGUGUCCACAGUGUCCUGCG	20	9520
SCNN1A-5672	−	CAGAAUCAGGACACAGCUCG	20	9521
SCNN1A-5673	−	CUAGGACAAAACUCGAAAGG	20	9522
SCNN1A-5674	+	UUAGACGCAGACAGGCAAGG	20	9523
SCNN1A-5675	+	UUCCUCACGGGCCCCACAGG	20	9524
SCNN1A-5676	+	UGGGGAACCGGGAGGACAGG	20	9525
SCNN1A-5677	+	ACUGAGUGAGUAGAGGCAGG	20	9526
SCNN1A-5678	−	UAAGUAGAUAGCCCCAGAGG	20	9527
SCNN1A-5679	−	UGAGGGCCUAGAGUGAGAGG	20	9528
SCNN1A-5680	+	AUCCUGAGCCCACAGCUAGG	20	9529
SCNN1A-5681	+	AGGUGAAGCUGGGGGCUAGG	20	9530
SCNN1A-5682	+	UGAGCAUUGAUACACACCGG	20	9531
SCNN1A-5683	+	AUUAAAGGUGAGCAGGGCGG	20	9532
SCNN1A-5684	+	CAGGCACUGAAGGUGCAGGG	20	9533
SCNN1A-5685	−	CUGAGCACCUUAUUGCAGGG	20	9534
SCNN1A-5686	+	CAACCUUGUCCAGACCCGGG	20	9535
SCNN1A-5687	−	AUCCCUGGCCGGCCAGCGGG	20	9536
SCNN1A-5688	+	UUAAAGGUGAGCAGGGCGGG	20	9537
SCNN1A-416	−	CAGCUGUCCCUUCCAAGGGG	20	4265
SCNN1A-5689	−	CUCCCACUUAGUGAGCGGGG	20	9538
SCNN1A-5690	−	CUGGACAAGGUUGGAGGGGG	20	9539
SCNN1A-5691	+	ACGCCUAGACAGGCCCUGGG	20	9540
SCNN1A-5692	+	UUCCUGAGACAGACUCAUGG	20	9541
SCNN1A-5693	−	AGCUGAGACACAGAUCCUGG	20	9542
SCNN1A-5694	+	UCAGACCCAAAAAGGGCUGG	20	9543
SCNN1A-75	+	AGCCCUGGAGUGGACUGUGG	20	602
SCNN1A-5695	−	CUUUGUCUGCUGGCUUGUGG	20	9544
SCNN1A-5696	−	UGACCUGUGGGUGCCCUUGG	20	9545
SCNN1A-5697	−	CCGGGUCUGGACAAGGUUGG	20	9546
SCNN1A-5698	+	CUUCCUGAGACAGACUCAUG	20	9547
SCNN1A-5699	+	CUGAAGGUGCAGGGAGGAUG	20	9548
SCNN1A-5700	−	CUAGGGGUCUCUGGGAUAUG	20	9549
SCNN1A-5701	+	UCCUGGAGCCAGCAGACCUG	20	9550
SCNN1A-5702	−	CUGAGGGUGAGGCUGACCUG	20	9551
SCNN1A-5703	−	UCUCUUCUCUGCAGGGCCUG	20	9552
SCNN1A-5704	−	UUGUGUUGCCCUCCUAGCUG	20	9553
SCNN1A-5705	+	CAGGUGCAGCGGCCUGGCUG	20	9554
SCNN1A-5706	+	AUGUGUAAUCGCCCCUGCUG	20	9555
SCNN1A-5707	+	AGAAUUCUCCUCCUCCUCUG	20	9556
SCNN1A-5708	+	UCAGGGUCCAACCUGGUCUG	20	9557
SCNN1A-5709	+	AAGGAUAAAUCAGUUUUCUG	20	9558
SCNN1A-5710	−	CUGGGAUAUGUGGGGCAGUG	20	9559
SCNN1A-417	+	UCACCCCUGGAACCCGAGUG	20	4266
SCNN1A-5711	−	ACGGGCUCUGUGUGGGAGUG	20	9560
SCNN1A-5712	−	UGCCUCCUGUGGGGCCCGUG	20	9561
SCNN1A-5713	+	UGAGUGAGUAGAGGCAGGUG	20	9562
SCNN1A-5714	−	CUCUGCAGGGCCUGAGGGUG	20	9563
SCNN1A-5715	−	AGGGGUCUCUGGGAUAUGUG	20	9564
SCNN1A-5716	−	ACUCUGGGCUGCCUCCUGUG	20	9565
SCNN1A-5717	−	ACGAAUCCACGGGCUCUGUG	20	9566
SCNN1A-5718	−	CGUGCAGGGCCUGGGUUGUG	20	9567
SCNN1A-419	+	AUGAGCCCCGGAGUGGAUUG	20	4268
SCNN1A-5719	+	CAGCAGACCUGCGGGAGUUG	20	9568
SCNN1A-5720	+	CUGAGGUUAGAAAACAAAAU	20	9569
SCNN1A-5721	+	CUUGAGCCAGGUCCUUACAU	20	9570
SCNN1A-5722	+	ACAGCGAAGGACAGAGAGAU	20	9571
SCNN1A-5723	+	UACACACCGGGGGAGGAGAU	20	9572
SCNN1A-420	+	UCAUGAGCCCCGGAGUGGAU	20	4269
SCNN1A-5724	+	CUCUCCUCUGCUUCCCUGAU	20	9573
SCNN1A-421	−	ACUCGGGUUCCAGGGGUGAU	20	4270
SCNN1A-5725	+	AGGAGGAGAAAUUCGUUGAU	20	9574
SCNN1A-79	+	CCCUCCAUGAGACCUGGUAU	20	604
SCNN1A-5726	+	CUCCCGAGGGCAGGUGAACU	20	9575
SCNN1A-5727	−	CUAGCUCCUGGAAGCACACU	20	9576
SCNN1A-5728	−	CUCUCUCCUUGCUCACCACU	20	9577
SCNN1A-5729	+	AAAAAGGGCUGGAGGAGACU	20	9578
SCNN1A-5730	+	UCCCAGGUUGCGGCUGGACU	20	9579
SCNN1A-5731	−	UCCCAGUCCAGCCGCAACCU	20	9580
SCNN1A-5732	−	CCUAGCCCCCAGCUUCACCU	20	9581
SCNN1A-5733	−	CCCUAGGCUCCCCUAGCCCU	20	9582
SCNN1A-5734	+	CACACGCCUAGACAGGCCCU	20	9583
SCNN1A-5735	+	UGGGGGCUAGGCGGGGCCCU	20	9584
SCNN1A-5736	−	ACUCCCAGUUCACCUGCCCU	20	9585
SCNN1A-5737	−	CCCUGCCGCGUGCAGGGCCU	20	9586
SCNN1A-5738	+	UGGGUGCUGGGUUAUCUCCU	20	9587
SCNN1A-5739	−	UCCUGGAGCCCUGCAGUCCU	20	9588
SCNN1A-5740	+	AGGAUCCUGAGCCCACAGCU	20	9589
SCNN1A-5741	−	UGUGUAUCAAUGCUCAGGCU	20	9590
SCNN1A-5742	+	CGCAGACAGGCAAGGAGGCU	20	9591
SCNN1A-5743	+	AGACAUAAGAGCCAAGGGCU	20	9592
SCNN1A-5744	+	ACAGGUGCAGCGGCCUGGCU	20	9593
SCNN1A-5745	+	UCGUCUGCUCUCUGGGUGCU	20	9594
SCNN1A-5746	−	UGACCACAUUCCUGCACUCU	20	9595
SCNN1A-422	+	CAGGGUCAAGGCUGAGCUCU	20	4271
SCNN1A-5747	+	CGUGGAUUCGUCUGCUCUCU	20	9596
SCNN1A-5748	−	UGGAGUUUCUAGGGGUCUCU	20	9597
SCNN1A-5749	+	UGCAGGGCUCCAGGAGGUCU	20	9598
SCNN1A-5750	−	AGCAGAGGAGAGGCCGUUCU	20	9599
SCNN1A-5751	−	CAAGGGAGACUGGAGUUUCU	20	9600
SCNN1A-5752	+	CUCCUCCCCGCUCACUAAGU	20	9601
SCNN1A-5753	−	UCUGGGAUAUGUGGGGCAGU	20	9602
SCNN1A-5754	−	UCCAGCCGCAACCUGGGAGU	20	9603
SCNN1A-5755	−	CUCCCGGGUCUGGACAAGGU	20	9604
SCNN1A-5756	+	CUGAGUGAGUAGAGGCAGGU	20	9605
SCNN1A-5757	+	UGGGAGCAGCGCACUCAGGU	20	9606
SCNN1A-5758	−	UGCUGCCUUAAGCUAGUGGU	20	9607
SCNN1A-5759	−	AGGGAGGAGUGGGAGAAUGU	20	9608
SCNN1A-5760	+	UCACAGAGUUGCAGGAAUGU	20	9609
SCNN1A-5761	−	UAGGGGUCUCUGGGAUAUGU	20	9610
SCNN1A-5762	+	UCUGUUCUUUUUUACACUGU	20	9611
SCNN1A-5763	−	UGAGGGUGAGGCUGACCUGU	20	9612
SCNN1A-5764	−	CACUCUGGGCUGCCUCCUGU	20	9613
SCNN1A-5765	−	UGUGUUGCCCUCCUAGCUGU	20	9614
SCNN1A-5766	−	CGAAUCCACGGGCUCUGUGU	20	9615
SCNN1A-5767	+	UUGAGCCAGGUCCUUACAUU	20	9616
SCNN1A-425	+	CAUGAGCCCCGGAGUGGAUU	20	4274
SCNN1A-5768	−	UAGCUCCUGGAAGCACACUU	20	9617
SCNN1A-5769	−	UCCUGGAGACAGACUCCCUU	20	9618
SCNN1A-5770	−	CUCGGGAGCCCUCCUUCCUU	20	9619
SCNN1A-5771	−	UCCUUUUGCUGCAUUAAGUU	20	9620
SCNN1A-5772	+	CCAGCAGACCUGCGGGAGUU	20	9621
SCNN1A-5773	−	UUAAGUUUGGAAAGAGAUUU	20	9622
SCNN1A-5774	−	AAGCCCAGCUCCGGCACUUU	20	9623
SCNN1A-5775	−	AGUCUCCUCCAGCCCUUUUU	20	9624

Table 46C provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the third tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN9A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene

TABLE 46C
3rd Tier
			Target
	DNA		Site	Seq
gRNA Name	Strand	Targeting Domain	Length	ID
SCNN1A-5776	−	GGGGGCAGAGACAGAAA	17	9625
SCNN1A-5777	−	GAGAGGGGGCAAGGCAA	17	9626
SCNN1A-5778	−	GUAAGGACCUGGCUCAA	17	9627
SCNN1A-5779	−	GAAGAAGACCAAAGGAA	17	9628
SCNN1A-426	−	GGACAUGGGCAUGGCCA	17	4275
SCNN1A-427	+	GUGGAUUGGGGAGAGCA	17	4276
SCNN1A-5780	−	GGCAAAUAGAAAAGGCA	17	9629
SCNN1A-5781	+	GAGCCCAGGAAGAGGCA	17	9630
SCNN1A-428	+	GGGGAGAGCAAGGGUCA	17	4277
SCNN1A-5782	+	GGAAGCCUUCCCAGAGA	17	9631
SCNN1A-5783	+	GAGGGAGACAAUAGAGA	17	9632
SCNN1A-5784	+	GGCCAGCCAGGCUGAGA	17	9633
SCNN1A-5785	−	GGAAGAAGACCAAAGGA	17	9634
SCNN1A-5786	+	GAGGCUGGGGGACAGGA	17	9635
SCNN1A-5787	+	GAGAUAGGGAUGGAGGA	17	9636
SCNN1A-5788	−	GAAAGGUGGAGGAGGGA	17	9637
SCNN1A-5789	+	GGACAGAGAGAUAGGGA	17	9638
SCNN1A-5790	+	GGGAAAGCAGGCACUGA	17	9639
SCNN1A-5791	+	GACAGGAUGGCAGGUGA	17	9640
SCNN1A-5792	+	GGGCCUGGGUGGGGAAC	17	9641
SCNN1A-5793	+	GGCCUGGGUGGGGAACC	17	9642
SCNN1A-5794	−	GAAUUUCUCCUCCUCCC	17	9643
SCNN1A-5795	+	GAGGAGGAGUCAGAGCC	17	9644
SCNN1A-5796	+	GCCAGGCUGAGAGGGCC	17	9645
SCNN1A-429	−	GGGACAUGGGCAUGGCC	17	4278
SCNN1A-5797	−	GCCUCUUCCUGGGCUCC	17	9646
SCNN1A-5798	−	GCAGGUCUGCUGGCUCC	17	9647
SCNN1A-5799	+	GAAGAGGCAGGGAAAGC	17	9648
SCNN1A-5800	−	GCCAGAAAGAGGAGAGC	17	9649
SCNN1A-86	−	GAACAAGCUGGAGGAGC	17	531
SCNN1A-5801	−	GGAUUUCAGGCAUGAGC	17	9650
SCNN1A-5802	−	GCUCCCACUUAGUGAGC	17	9651
SCNN1A-5803	+	GGAGCCCAGGAAGAGGC	17	9652
SCNN1A-5804	−	GGGAGAGGAAGAGAGGC	17	9653
SCNN1A-5805	−	GAGAGGGAGUGAGAGGC	17	9654
SCNN1A-5806	−	GAUUAGAGAGAGGAGGC	17	9655
SCNN1A-5807	−	GGCUUGUGGAGGGAGGC	17	9656
SCNN1A-5808	+	GGAGGGCUCCCGAGGGC	17	9657
SCNN1A-5809	−	GGCCCUCUCAGCCUGGC	17	9658
SCNN1A-5810	+	GAGGCAGCCCAGAGUGC	17	9659
SCNN1A-5811	+	GAAUUCUCCUCCUCCUC	17	9660
SCNN1A-430	+	GGGUCAAGGCUGAGCUC	17	4279
SCNN1A-5812	−	GGAGGCAGGCCAGAAAG	17	9661
SCNN1A-5813	+	GACAGGAGGGCAGAAAG	17	9662
SCNN1A-5814	+	GGCAACACAAGGAGAAG	17	9663
SCNN1A-5815	−	GGGGGGGAGAGGAAGAG	17	9664
SCNN1A-5816	+	GGUGAGCAAGGAGAGAG	17	9665
SCNN1A-5817	−	GAGGCAGGAUUAGAGAG	17	9666
SCNN1A-5818	−	GAGGAGGGAGGGAGGAG	17	9667
SCNN1A-5819	+	GAGCAGGGCGGGGGGAG	17	9668
SCNN1A-5820	+	GGGCCAGCCAGGCUGAG	17	9669
SCNN1A-5821	−	GAUAGAGAGGGAGUGAG	17	9670
SCNN1A-5822	−	GGUUGGAGGGGGUGGCG	17	9671
SCNN1A-5823	−	GCUGGCUCCAGGAAAGG	17	9672
SCNN1A-5824	−	GAGGGGGCAAGGCAAGG	17	9673
SCNN1A-5825	+	GACUGCAGGGCUCCAGG	17	9674
SCNN1A-5826	+	GAGUGAGUAGAGGCAGG	17	9675
SCNN1A-5827	+	GAGCAAGGAGAGAGAGG	17	9676
SCNN1A-5828	−	GCAGGAUUAGAGAGAGG	17	9677
SCNN1A-5829	−	GAGGAGGGACCAGGAGG	17	9678
SCNN1A-5830	−	GAUAGCCCCAGAGGAGG	17	9679
SCNN1A-5831	+	GGGGGGAGGGGCUGAGG	17	9680
SCNN1A-5832	−	GCACCUGUCAGGUGAGG	17	9681
SCNN1A-5833	−	GGCAGAGACAGAAAGGG	17	9682
SCNN1A-5834	+	GCUGGAAAGGAAGAGGG	17	9683
SCNN1A-5835	−	GGAAAGGUGGAGGAGGG	17	9684
SCNN1A-5836	−	GGGGGCAAGGCAAGGGG	17	9685
SCNN1A-5837	−	GACAAGGUUGGAGGGGG	17	9686
SCNN1A-5838	+	GUGAGCAGGGCGGGGGG	17	9687
SCNN1A-5839	+	GGCUGAGAGGGCCUGGG	17	9688
SCNN1A-5840	+	GAGUAGAGGCAGGUGGG	17	9689
SCNN1A-5841	−	GGCCUGGGUUGUGUGGG	17	9690
SCNN1A-431	−	GAAGGGGAACAAGCUGG	17	4280
SCNN1A-85	−	GGAGGGGAACAAGCUGG	17	530
SCNN1A-5842	+	GGCCCAGGUGAAGCUGG	17	9691
SCNN1A-5843	−	GGCUCCAGGAAAGGUGG	17	9692
SCNN1A-5844	+	GUGGGGGGCAGUGGUGG	17	9693
SCNN1A-5845	−	GGAGGAGUGGGAGAAUG	17	9694
SCNN1A-5846	−	GGAGCCCUGCAGUCCUG	17	9695
SCNN1A-5847	+	GGGCCCAGGUGAAGCUG	17	9696
SCNN1A-5848	−	GCCAGAGGCUGGAGCUG	17	9697
SCNN1A-5849	+	GACAGGCAAGGAGGCUG	17	9698
SCNN1A-5850	+	GGCGGGGGGAGGGGCUG	17	9699
SCNN1A-5851	−	GGAUAUGUGGGGCAGUG	17	9700
SCNN1A-5852	−	GGCUCUGUGUGGGAGUG	17	9701
SCNN1A-5853	+	GGACAGGAUGGCAGGUG	17	9702
SCNN1A-5854	+	GGUGGGGGGCAGUGGUG	17	9703
SCNN1A-5855	−	GCAGGGCCUGGGUUGUG	17	9704
SCNN1A-5856	−	GCUCCUGGAAGCACACU	17	9705
SCNN1A-5857	+	GGGGCCCAGGUGAAGCU	17	9706
SCNN1A-5858	−	GAAGCCACAGACCAGGU	17	9707
SCNN1A-5859	+	GCUGAGAGGGCCUGGGU	17	9708
SCNN1A-5860	−	GAGGAGUGGGAGAAUGU	17	9709
SCNN1A-5861	−	GAGGGGGAGGAGAGGUU	17	9710
SCNN1A-5862	+	GCCUUCUGUUUCUCUUU	17	9711
SCNN1A-5863	−	GAAGGGGGCAGAGACAGAAA	20	9712
SCNN1A-432	+	GAGUGGAUUGGGGAGAGCAA	20	4281
SCNN1A-5864	−	GGAAGGGGGCAGAGACAGAA	20	9713
SCNN1A-5865	−	GAGGAAGAAGACCAAAGGAA	20	9714
SCNN1A-5866	−	GAGACCUUUUCACAGAGCCA	20	9715
SCNN1A-9	−	GCCCUCCACAGUCCACUCCA	20	499
SCNN1A-5867	−	GCAACUCUGUGACCACAGCA	20	9716
SCNN1A-433	+	GGAGUGGAUUGGGGAGAGCA	20	4282
SCNN1A-5868	−	GAGUGAGAGGGGGCAAGGCA	20	9717
SCNN1A-5869	+	GGAAAGGAAGAGGGUGGGCA	20	9718
SCNN1A-5870	+	GUCUCUGCCCCAGGACUGCA	20	9719
SCNN1A-434	+	GAGAGCAAGGGUCAGGGUCA	20	4283
SCNN1A-5871	−	GAGACCCAAAGAGAAACAGA	20	9720
SCNN1A-435	−	GUUCCAGGGGUGAUGGGAGA	20	4284
SCNN1A-5872	+	GAAGGAAGGAGGGCUCCCGA	20	9721
SCNN1A-5873	−	GGAGGAAGAAGACCAAAGGA	20	9722
SCNN1A-5874	+	GGGGAACCGGGAGGACAGGA	20	9723
SCNN1A-5875	−	GGAAUCAGCAGGAAAGAGGA	20	9724
SCNN1A-5876	+	GUGAGCAAGGAGAGAGAGGA	20	9725
SCNN1A-5877	−	GCUCCAGGAAAGGUGGAGGA	20	9726
SCNN1A-5878	+	GAAGGACAGAGAGAUAGGGA	20	9727
SCNN1A-5879	+	GCAGGGAAAGCAGGCACUGA	20	9728
SCNN1A-5880	−	GGGCCAGAGGCUGGAGCUGA	20	9729
SCNN1A-5881	+	GGGGACAGGAUGGCAGGUGA	20	9730
SCNN1A-5882	+	GAGAGCCACCCACACAACCC	20	9731
SCNN1A-5883	+	GCCUCCAGCUUCCCACUCCC	20	9732
SCNN1A-5884	−	GGGAGUGAGGGAGGCCUUCC	20	9733
SCNN1A-5885	+	GGGAGGGGCCCAGGUGAAGC	20	9734
SCNN1A-5886	+	GGCUGAGGAGGAGUCAGAGC	20	9735
SCNN1A-7	−	GGGGAACAAGCUGGAGGAGC	20	504
SCNN1A-5887	+	GGGGCCAAAAGUGCCGGAGC	20	9736
SCNN1A-5888	−	GUUGGAUUUCAGGCAUGAGC	20	9737
SCNN1A-5889	−	GGGGGGAGAGGAAGAGAGGC	20	9738
SCNN1A-5890	+	GGCACUGAGUGAGUAGAGGC	20	9739
SCNN1A-5891	−	GCUGGCUUGUGGAGGGAGGC	20	9740
SCNN1A-5892	+	GGUGAAGCUGGGGGCUAGGC	20	9741
SCNN1A-5893	−	GUGACCACAUUCCUGCACUC	20	9742
SCNN1A-5894	+	GAGGACAGGAGGGCAGAAAG	20	9743
SCNN1A-5895	+	GAGGGCAACACAAGGAGAAG	20	9744
SCNN1A-5896	+	GAAAGAGGGAGACAAUAGAG	20	9745
SCNN1A-5897	−	GUGGAGGAGGGAGGGAGGAG	20	9746
SCNN1A-5898	+	GAGAGAUAGGGAUGGAGGAG	20	9747
SCNN1A-5899	+	GGUGAGCAGGGCGGGGGGAG	20	9748
SCNN1A-5900	−	GGGCAAGGCAAGGGGGGGAG	20	9749
SCNN1A-436	−	GGUUCCAGGGGUGAUGGGAG	20	4285
SCNN1A-5901	−	GCAGAUAGAGAGGGAGUGAG	20	9750
SCNN1A-5902	+	GGGACAGGAUGGCAGGUGAG	20	9751
SCNN1A-5903	−	GGAAGAAGACCAAAGGAAGG	20	9752
SCNN1A-5904	+	GGUGAGCAAGGAGAGAGAGG	20	9753
SCNN1A-5905	−	GAGGCAGGAUUAGAGAGAGG	20	9754
SCNN1A-5906	−	GGCUCCAGGAAAGGUGGAGG	20	9755
SCNN1A-5907	+	GGCGGGGGGAGGGGCUGAGG	20	9756
SCNN1A-5908	−	GCUGCACCUGUCAGGUGAGG	20	9757
SCNN1A-5909	−	GGGGGCAGAGACAGAAAGGG	20	9758
SCNN1A-5910	−	GAGAGGGGGCAAGGCAAGGG	20	9759
SCNN1A-5911	−	GAAAGGUGGAGGAGGGAGGG	20	9760
SCNN1A-5912	−	GUCUGCUGGCUUGUGGAGGG	20	9761
SCNN1A-5913	−	GCUCUGUGUGGGAGUGAGGG	20	9762
SCNN1A-5914	−	GCACCUGUCAGGUGAGGGGG	20	9763
SCNN1A-5915	+	GGACAGAGAGAUAGGGAUGG	20	9764
SCNN1A-5916	+	GAGUGAGUAGAGGCAGGUGG	20	9765
SCNN1A-5917	−	GAGGGAGGAGUGGGAGAAUG	20	9766
SCNN1A-5918	+	GAGGGGCCCAGGUGAAGCUG	20	9767
SCNN1A-5919	+	GCAGACAGGCAAGGAGGCUG	20	9768
SCNN1A-5920	+	GGGGGACAGGAUGGCAGGUG	20	9769
SCNN1A-5921	+	GCAGGUGGGGGGCAGUGGUG	20	9770
SCNN1A-5922	+	GUCUGUGGCUUCCUCUCUUG	20	9771
SCNN1A-5923	+	GGAGGGGCCCAGGUGAAGCU	20	9772
SCNN1A-5924	+	GGGCCAAAAGUGCCGGAGCU	20	9773
SCNN1A-5925	−	GAGACAGAAAGGGAGGUGCU	20	9774
SCNN1A-5926	−	GCAGAGAUGACACCUUCUCU	20	9775
SCNN1A-5927	+	GAGCUAGAGGCUCAGCAAGU	20	9776
SCNN1A-5928	+	GGCAGGUGGGGGGCAGUGGU	20	9777
SCNN1A-5929	−	GGUGAGGGGGAGGAGAGGUU	20	9778
SCNN1A-437	−	GUAAGCAAGGGAACCUGGUU	20	4286

Table 46D provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the fourth tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene

TABLE 46D
4th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-5930	+	AGAAUCAGACCCAAAAA	17	9779
SCNN1A-5931	+	AAAGAUUGUCUUUAAAA	17	9780
SCNN1A-5932	+	CAGGCAAAGAAGAGAAA	17	9781
SCNN1A-5933	+	UCCUUGGCUCUGUGAAA	17	9782
SCNN1A-5934	+	CACAAGCCAGCAGACAA	17	9783
SCNN1A-5935	−	UGGAGGAAGAAGACCAA	17	9784
SCNN1A-5936	+	UCCAGGAAGGAGAGCAA	17	9785
SCNN1A-438	+	UGGAUUGGGGAGAGCAA	17	4287
SCNN1A-5937	+	AAUAGUUUUCAUAUCAA	17	9786
SCNN1A-5938	−	AGGGGGCAGAGACAGAA	17	9787
SCNN1A-5939	−	AAUUUCUCCUCCUCCCA	17	9788
SCNN1A-439	−	UCCAGCUGUCCCUUCCA	17	4288
SCNN1A-5940	+	CUCCAGGAAGGAGAGCA	17	9789
SCNN1A-5941	−	UAGAGUGAGAGGGGGCA	17	9790
SCNN1A-440	−	AGGGUGGGACAUGGGCA	17	4289
SCNN1A-5942	+	AAGGCGGACUCUGGGCA	17	9791
SCNN1A-5943	+	AAGGAAGAGGGUGGGCA	17	9792
SCNN1A-5944	+	UCUGCCCCAGGACUGCA	17	9793
SCNN1A-5945	−	CUUCUCUCUUCUCUGCA	17	9794
SCNN1A-5946	+	AAAUAGUUUUCAUAUCA	17	9795
SCNN1A-441	+	AGCAAGGGUCAGGGUCA	17	4290
SCNN1A-5947	+	ACAGGAGGGCAGAAAGA	17	9796
SCNN1A-5948	−	ACCCAAAGAGAAACAGA	17	9797
SCNN1A-5949	−	CAGAAGGCAGAUAGAGA	17	9798
SCNN1A-443	−	CCAGGGGUGAUGGGAGA	17	4292
SCNN1A-5950	+	AGAUCUGAACAAGUAGA	17	9799
SCNN1A-5951	+	AUAGAGAGGGACAGCGA	17	9800
SCNN1A-5952	−	AUCAGCAGGAAAGAGGA	17	9801
SCNN1A-5953	+	AGCAAGGAGAGAGAGGA	17	9802
SCNN1A-5954	−	CCAGGAAAGGUGGAGGA	17	9803
SCNN1A-5955	−	CUGAUUUAUCCUUGGGA	17	9804
SCNN1A-155	+	CUGGAGUGGACUGUGGA	17	652
SCNN1A-5956	−	UUCUCUGCAGGGCCUGA	17	9805
SCNN1A-5957	−	CCAGAGGCUGGAGCUGA	17	9806
SCNN1A-5958	+	UGCAAUACAAUAAGAUA	17	9807
SCNN1A-5959	+	AAUGCAGCAAAAGGAUA	17	9808
SCNN1A-5960	+	CCUCUGCUUCCCUGAUA	17	9809
SCNN1A-444	+	UGGGCUGCAGAGGUCUA	17	4293
SCNN1A-5961	+	CAAGGAGGCUGGGGGAC	17	9810
SCNN1A-5962	+	AACCAGGAUUCCAAACC	17	9811
SCNN1A-445	−	AGGUAAGCAAGGGAACC	17	4294
SCNN1A-5963	+	CGGGGCUCAGGUGCACC	17	9812
SCNN1A-5964	−	UAGCCCCCAGCUUCACC	17	9813
SCNN1A-5965	+	CACUGUGGACACAGACC	17	9814
SCNN1A-5966	−	AGAGGAAGCCACAGACC	17	9815
SCNN1A-5967	−	AGGAAAGAGGAGGGACC	17	9816
SCNN1A-5968	+	AGCCACCCACACAACCC	17	9817
SCNN1A-446	+	CCCUCUCCCAUCACCCC	17	4295
SCNN1A-151	+	UUCCCCUUCAUGAGCCC	17	648
SCNN1A-5969	+	CACGCCUAGACAGGCCC	17	9818
SCNN1A-5970	+	UCCAGCUUCCCACUCCC	17	9819
SCNN1A-5971	−	UCACCUGGGCCCCUCCC	17	9820
SCNN1A-5972	+	ACCUGGAUGUGAAAGCC	17	9821
SCNN1A-5973	−	UUUGAGAUCAAACAGCC	17	9822
SCNN1A-5974	+	AGGAGAAGGGGCCAGCC	17	9823
SCNN1A-5975	−	CCCAGGCCCUCUCAGCC	17	9824
SCNN1A-5976	+	CUGUUGGCUGCCAGGCC	17	9825
SCNN1A-5977	−	AUUACACAUUCCUGGCC	17	9826
SCNN1A-5978	−	AACCUGGUUUGGAAUCC	17	9827
SCNN1A-5979	−	AGGCAGCCCAGACCUCC	17	9828
SCNN1A-5980	−	CUGCCCUCCUGUCCUCC	17	9829
SCNN1A-5981	+	CAGGACUGCAGGGCUCC	17	9830
SCNN1A-5982	−	CUGGAGCCCUGCAGUCC	17	9831
SCNN1A-5983	−	AGUGAGGGAGGCCUUCC	17	9832
SCNN1A-5984	−	CCCCUUGCUCUCCUUCC	17	9833
SCNN1A-5985	−	CUUUCCCUGCCUCUUCC	17	9834
SCNN1A-5986	+	CCCUCCUCCACCUUUCC	17	9835
SCNN1A-5987	−	ACCUGGGAGUGGGAAGC	17	9836
SCNN1A-5988	+	UGAGGAGGAGUCAGAGC	17	9837
SCNN1A-5989	−	AGGUCAGGGCCAGAGGC	17	9838
SCNN1A-5990	+	CAGACAGGCAAGGAGGC	17	9839
SCNN1A-5991	+	CUGGGGGACAGGAUGGC	17	9840
SCNN1A-5992	+	CUCUGCCCCAGGACUGC	17	9841
SCNN1A-5993	−	UCUUCUCUCUUCUCUGC	17	9842
SCNN1A-5994	−	ACCACAUUCCUGCACUC	17	9843
SCNN1A-5995	+	AGGGCUGGAGGAGACUC	17	9844
SCNN1A-5996	+	CCCUCAGCUCCAGCCUC	17	9845
SCNN1A-5997	−	UGCCUCUUCCUGGGCUC	17	9846
SCNN1A-5998	+	CAGGGCUCCAGGAGGUC	17	9847
SCNN1A-5999	−	UGGGCCCCUCCCGGGUC	17	9848
SCNN1A-6000	+	UCCUGCUCUCCUCUUUC	17	9849
SCNN1A-6001	−	AGGAAUCAGCAGGAAAG	17	9850
SCNN1A-6002	+	CCAGGAAGGAGAGCAAG	17	9851
SCNN1A-6003	−	AGAGGGGGCAAGGCAAG	17	9852
SCNN1A-6004	+	UGCAGAGAAGAGAGAAG	17	9853
SCNN1A-6005	−	AAGAAGACCAAAGGAAG	17	9854
SCNN1A-6006	+	AGGCAGGUGGGGGGCAG	17	9855
SCNN1A-6007	+	AGAGGGAGACAAUAGAG	17	9856
SCNN1A-6008	−	ACAGAAGGCAGAUAGAG	17	9857
SCNN1A-6009	+	AGCAAAAGGAUAAGGAG	17	9858
SCNN1A-6010	−	UCAGGGAAGCAGAGGAG	17	9859
SCNN1A-6011	−	CAGGUGAGGGGGAGGAG	17	9860
SCNN1A-6012	+	AGAUAGGGAUGGAGGAG	17	9861
SCNN1A-448	−	UCCAGGGGUGAUGGGAG	17	4297
SCNN1A-83	−	UACCAGGUCUCAUGGAG	17	606
SCNN1A-6013	+	ACAGGAUGGCAGGUGAG	17	9862
SCNN1A-6014	−	UGCACCUGUCAGGUGAG	17	9863
SCNN1A-6015	+	AAGCUGGGGGCUAGGCG	17	9864
SCNN1A-6016	+	CAGGAAGGAGAGCAAGG	17	9865
SCNN1A-6017	+	UACUGGACCUGAGAAGG	17	9866
SCNN1A-6018	−	AGAAGACCAAAGGAAGG	17	9867
SCNN1A-6019	−	AAAGAGGAGGGACCAGG	17	9868
SCNN1A-6020	−	AAUCAGCAGGAAAGAGG	17	9869
SCNN1A-6021	+	AGACAGGCCCUGGGAGG	17	9870
SCNN1A-6022	+	AGAGAUAGGGAUGGAGG	17	9871
SCNN1A-6023	−	UCCAGGAAAGGUGGAGG	17	9872
SCNN1A-6024	−	CUGGACAAGGUUGGAGG	17	9873
SCNN1A-6025	+	CUGAGCCCACAGCUAGG	17	9874
SCNN1A-6026	+	UGAAGCUGGGGGCUAGG	17	9875
SCNN1A-6027	+	AGGAAGGAGAGCAAGGG	17	9876
SCNN1A-6028	−	AGGGGGCAAGGCAAGGG	17	9877
SCNN1A-6029	−	AAAUAGAAAAGGCAGGG	17	9878
SCNN1A-6030	−	AGGUGGAGGAGGGAGGG	17	9879
SCNN1A-6031	−	UGCUGGCUUGUGGAGGG	17	9880
SCNN1A-6032	−	CUGUGUGGGAGUGAGGG	17	9881
SCNN1A-6033	−	CCUGUCAGGUGAGGGGG	17	9882
SCNN1A-6034	+	CAGAGAGAUAGGGAUGG	17	9883
SCNN1A-6035	−	UGGGAGUGGGAAGCUGG	17	9884
SCNN1A-6036	+	ACAGGCAAGGAGGCUGG	17	9885
SCNN1A-6037	+	CAGGUGGGGGGCAGUGG	17	9886
SCNN1A-6038	+	UGAGUAGAGGCAGGUGG	17	9887
SCNN1A-154	+	CCUGGAGUGGACUGUGG	17	651
SCNN1A-6039	+	CCCAGAGUGCAGGAAUG	17	9888
SCNN1A-6040	+	AAGGUGCAGGGAGGAUG	17	9889
SCNN1A-153	+	AGCCCUGGAGUGGACUG	17	650
SCNN1A-6041	+	UGGAGCCAGCAGACCUG	17	9890
SCNN1A-6042	−	AGGGUGAGGCUGACCUG	17	9891
SCNN1A-6043	−	CUUCUCUGCAGGGCCUG	17	9892
SCNN1A-6044	−	CUCUGGGCUGCCUCCUG	17	9893
SCNN1A-6045	+	AUUCUCCUCCUCCUCUG	17	9894
SCNN1A-6046	−	UGCAGGGCCUGAGGGUG	17	9895
SCNN1A-6047	+	CUGAGAGGGCCUGGGUG	17	9896
SCNN1A-6048	−	CUGGGCUGCCUCCUGUG	17	9897
SCNN1A-6049	−	CUUUGUCUGCUGGCUUG	17	9898
SCNN1A-6050	+	UUCCCACUCCCAGGUUG	17	9899
SCNN1A-6051	+	AGGUUAGAAAACAAAAU	17	9900
SCNN1A-449	−	CCAGGGGCAGCCUCACU	17	4298
SCNN1A-6052	+	AAGGGCUGGAGGAGACU	17	9901
SCNN1A-6053	−	UCCUGCAGUGAGCCCCU	17	9902
SCNN1A-450	+	CUCAUGAUACCUCCCCU	17	4299
SCNN1A-6054	−	CCCAGUUCACCUGCCCU	17	9903
SCNN1A-6055	+	CCAGGCUGAGAGGGCCU	17	9904
SCNN1A-6056	−	UGGAGCCCUGCAGUCCU	17	9905
SCNN1A-6057	−	AAAGAACAGAAUGUCCU	17	9906
SCNN1A-6058	−	UUUCCCUGCCUCUUCCU	17	9907
SCNN1A-6059	+	AGACAGGCAAGGAGGCU	17	9908
SCNN1A-6060	+	AGGUGAAGCUGGGGGCU	17	9909
SCNN1A-6061	−	ACAGAAAGGGAGGUGCU	17	9910
SCNN1A-6062	+	UCUGCUCUCUGGGUGCU	17	9911
SCNN1A-6063	+	AAUUCUCCUCCUCCUCU	17	9912
SCNN1A-6064	−	CCUCCCAGGGCCUGUCU	17	9913
SCNN1A-6065	−	AGGAGGGAGGGAGGAGU	17	9914
SCNN1A-6066	+	CUGGAAAGGAAGAGGGU	17	9915
SCNN1A-6067	+	AGGUGGGGGGCAGUGGU	17	9916
SCNN1A-6068	−	CAGGGCCUGGGUUGUGU	17	9917
SCNN1A-6069	−	AAAACUGAUUUAUCCUU	17	9918
SCNN1A-6070	+	UCUCUGCCCCCUUCCUU	17	9919
SCNN1A-6071	+	UGCCUUCUGUUUCUCUU	17	9920
SCNN1A-6072	−	AGUUUGGAAAGAGAUUU	17	9921
SCNN1A-6073	+	CAGAGAAUCAGACCCAAAAA	20	9922
SCNN1A-6074	+	UUAAAAGAUUGUCUUUAAAA	20	9923
SCNN1A-6075	+	UCCAAACUUAAUGCAGCAAA	20	9924
SCNN1A-6076	+	UAGCAGGCAAAGAAGAGAAA	20	9925
SCNN1A-6077	−	AGUCUGUCUCAGGAAGUAAA	20	9926
SCNN1A-6078	+	CUCCACAAGCCAGCAGACAA	20	9927
SCNN1A-6079	−	AGUGAGAGGGGGCAAGGCAA	20	9928
SCNN1A-451	−	UCCACUCCGGGGCUCAUGAA	20	4300
SCNN1A-6080	−	ACGAAUUUCUCCUCCUCCCA	20	9929
SCNN1A-6081	+	ACCACUAGCUUAAGGCAGCA	20	9930
SCNN1A-452	−	CGCAGGGUGGGACAUGGGCA	20	4301
SCNN1A-6082	−	CCUCUUCUCUCUUCUCUGCA	20	9931
SCNN1A-6083	+	UACUUCCUGAGACAGACUCA	20	9932
SCNN1A-6084	−	CAGGACACAGCUCGAGGUCA	20	9933
SCNN1A-6085	+	AGGACAGGAGGGCAGAAAGA	20	9934
SCNN1A-6086	+	UCAGGAAGCCUUCCCAGAGA	20	9935
SCNN1A-6087	+	AAAGAGGGAGACAAUAGAGA	20	9936
SCNN1A-6088	−	AAACAGAAGGCAGAUAGAGA	20	9937
SCNN1A-6089	+	AGGAGGGCAACACAAGGAGA	20	9938
SCNN1A-6090	+	AGGGGCCAGCCAGGCUGAGA	20	9939
SCNN1A-6091	+	CAGUGGUGGGGGCAAAUAGA	20	9940
SCNN1A-6092	+	CAAAGAUCUGAACAAGUAGA	20	9941
SCNN1A-6093	+	AAGGAGGCUGGGGGACAGGA	20	9942
SCNN1A-6094	+	AGAGAGAUAGGGAUGGAGGA	20	9943
SCNN1A-6095	−	CAGGAAAGGUGGAGGAGGGA	20	9944
SCNN1A-6096	+	AGGUGAGCAGGGCGGGGGGA	20	9945
SCNN1A-6097	+	CAGCGAAGGACAGAGAGAUA	20	9946
SCNN1A-6098	+	CUUAAUGCAGCAAAAGGAUA	20	9947
SCNN1A-6099	+	CCAAGGGCUAGGGGAGCCUA	20	9948
SCNN1A-6100	−	AAAAAGAACAGAAUGUCCUA	20	9949
SCNN1A-6101	+	AGAGGGCCUGGGUGGGGAAC	20	9950
SCNN1A-6102	+	AGGCAAGGAGGCUGGGGGAC	20	9951
SCNN1A-6103	+	UCUCCUCCCCCUCACCUGAC	20	9952
SCNN1A-6104	−	AAGAGAGGAAGCCACAGACC	20	9953
SCNN1A-77	+	UUGUUCCCCUCCAUGAGACC	20	603
SCNN1A-6105	+	CAAUAAGGUGCUCAGCACCC	20	9954
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-6106	+	UCCAGACCCGGGAGGGGCCC	20	9955
SCNN1A-6107	+	UGCACCUGGAUGUGAAAGCC	20	9956
SCNN1A-6108	−	CCACCCAGGCCCUCUCAGCC	20	9957
SCNN1A-6109	+	AGCCCGCCCGCUGGCCGGCC	20	9958
SCNN1A-6110	+	CCAGCCAGGCUGAGAGGGCC	20	9959
SCNN1A-6111	+	UCCUUUGGUCUUCUUCCUCC	20	9960
SCNN1A-6112	+	CCCCAGGACUGCAGGGCUCC	20	9961
SCNN1A-6113	−	CCUGCCUCUUCCUGGGCUCC	20	9962
SCNN1A-6114	−	CUCCUGGAGCCCUGCAGUCC	20	9963
SCNN1A-6115	−	CUGCUUUCCCUGCCUCUUCC	20	9964
SCNN1A-6116	+	CCUCCCUCCUCCACCUUUCC	20	9965
SCNN1A-6117	+	CAGGAAGAGGCAGGGAAAGC	20	9966
SCNN1A-6118	+	CGACUUCUUAAAGUGAAAGC	20	9967
SCNN1A-6119	−	CAGGCCAGAAAGAGGAGAGC	20	9968
SCNN1A-6120	+	AGGGAGGAUGUGGCCAGCGC	20	9969
SCNN1A-6121	−	AGCUGGCAAAUAGAAAAGGC	20	9970
SCNN1A-6122	+	CCCGGAGCCCAGGAAGAGGC	20	9971
SCNN1A-6123	−	AUAGAGAGGGAGUGAGAGGC	20	9972
SCNN1A-6124	−	CAGGAUUAGAGAGAGGAGGC	20	9973
SCNN1A-6125	+	AGGCUGGGGGACAGGAUGGC	20	9974
SCNN1A-6126	−	CCAGGCCCUCUCAGCCUGGC	20	9975
SCNN1A-6127	+	UGGGGAGCCCGCCCGCUGGC	20	9976
SCNN1A-6128	+	UGUCUCUGCCCCAGGACUGC	20	9977
SCNN1A-6129	−	ACCUCUUCUCUCUUCUCUGC	20	9978
SCNN1A-6130	+	CAGGAGGCAGCCCAGAGUGC	20	9979
SCNN1A-6131	−	AGACAGACUCCCUUUGGUGC	20	9980
SCNN1A-6132	−	CUCCCAGUUCACCUGCCCUC	20	9981
SCNN1A-6133	+	AGGCCCUCAGCUCCAGCCUC	20	9982
SCNN1A-6134	+	UCAGAAUUCUCCUCCUCCUC	20	9983
SCNN1A-6135	−	CCCUGCCUCUUCCUGGGCUC	20	9984
SCNN1A-6136	+	CUGCAGGGCUCCAGGAGGUC	20	9985
SCNN1A-6137	−	ACCUGGGCCCCUCCCGGGUC	20	9986
SCNN1A-6138	+	CUCUCCUGCUCUCCUCUUUC	20	9987
SCNN1A-6139	−	AGAGGAGGCAGGCCAGAAAG	20	9988
SCNN1A-6140	+	UCUCCAGGAAGGAGAGCAAG	20	9989
SCNN1A-6141	+	CCCUGCAGAGAAGAGAGAAG	20	9990
SCNN1A-6142	−	AGGAAGAAGACCAAAGGAAG	20	9991
SCNN1A-453	−	CCACUCCGGGGCUCAUGAAG	20	4302
SCNN1A-6143	+	UAGAGGCAGGUGGGGGGCAG	20	9992
SCNN1A-6144	+	CCCUCACCUGACAGGUGCAG	20	9993
SCNN1A-6145	−	CAAGGGGGGGAGAGGAAGAG	20	9994
SCNN1A-6146	+	AGUGGUGAGCAAGGAGAGAG	20	9995
SCNN1A-6147	−	AGAGAGGCAGGAUUAGAGAG	20	9996
SCNN1A-6148	−	CUAUCAGGGAAGCAGAGGAG	20	9997
SCNN1A-6149	−	UGUCAGGUGAGGGGGAGGAG	20	9998
SCNN1A-454	+	CCCCUUCAUGAGCCCCGGAG	20	4303
SCNN1A-6150	−	UCUGCUGGCUCCAGGAAAGG	20	9999
SCNN1A-6151	+	CUCCAGGAAGGAGAGCAAGG	20	10000
SCNN1A-6152	−	UGAGAGGGGGCAAGGCAAGG	20	10001
SCNN1A-6153	−	AGGAAAGAGGAGGGACCAGG	20	10002
SCNN1A-6154	+	CAGGACUGCAGGGCUCCAGG	20	10003
SCNN1A-6155	−	AGGAAUCAGCAGGAAAGAGG	20	10004
SCNN1A-6156	−	AAAGAGGAGGGACCAGGAGG	20	10005
SCNN1A-6157	+	CCUAGACAGGCCCUGGGAGG	20	10006
SCNN1A-6158	+	CAGAGAGAUAGGGAUGGAGG	20	10007
SCNN1A-6159	+	UCCAGGAAGGAGAGCAAGGG	20	10008
SCNN1A-6160	+	UCAAUUAAAGGUGAGCAGGG	20	10009
SCNN1A-6161	+	AGCGCUGGAAAGGAAGAGGG	20	10010
SCNN1A-6162	−	CCAGGAAAGGUGGAGGAGGG	20	10011
SCNN1A-6163	−	AGAGGGGGCAAGGCAAGGGG	20	10012
SCNN1A-6164	+	AAGGUGAGCAGGGCGGGGGG	20	10013
SCNN1A-6165	+	CCAGGCUGAGAGGGCCUGGG	20	10014
SCNN1A-6166	+	AGUGAGUAGAGGCAGGUGGG	20	10015
SCNN1A-6167	−	CAGGGCCUGGGUUGUGUGGG	20	10016
SCNN1A-455	−	CAUGAAGGGGAACAAGCUGG	20	4304
SCNN1A-6	−	CAUGGAGGGGAACAAGCUGG	20	558
SCNN1A-6168	−	ACCUGGGAGUGGGAAGCUGG	20	10017
SCNN1A-6169	+	AGGGGCCCAGGUGAAGCUGG	20	10018
SCNN1A-6170	+	CAGACAGGCAAGGAGGCUGG	20	10019
SCNN1A-6171	+	AGGCAGGUGGGGGGCAGUGG	20	10020
SCNN1A-6172	+	CAGGUGGGGGGCAGUGGUGG	20	10021
SCNN1A-6173	+	CAGCCCAGAGUGCAGGAAUG	20	10022
SCNN1A-6174	−	CCUGGAGCCCUGCAGUCCUG	20	10023
SCNN1A-6175	−	AGGGCCAGAGGCUGGAGCUG	20	10024
SCNN1A-6176	+	CAGGGCGGGGGGAGGGGCUG	20	10025
SCNN1A-6177	+	AGGCUGAGAGGGCCUGGGUG	20	10026
SCNN1A-6178	+	AGCUUCCCACUCCCAGGUUG	20	10027
SCNN1A-6179	+	ACUUCCUGAGACAGACUCAU	20	10028
SCNN1A-456	−	UGGCCAGGGGCAGCCUCACU	20	4305
SCNN1A-457	+	CUGCUCAUGAUACCUCCCCU	20	4306
SCNN1A-6180	+	CAGCCAGGCUGAGAGGGCCU	20	10029
SCNN1A-6181	−	UCAGAAAACUGAUUUAUCCU	20	10030
SCNN1A-6182	−	AAAAAAGAACAGAAUGUCCU	20	10031
SCNN1A-6183	−	UGCUUUCCCUGCCUCUUCCU	20	10032
SCNN1A-6184	+	CCCAGGUGAAGCUGGGGGCU	20	10033
SCNN1A-6185	+	CAGAAUUCUCCUCCUCCUCU	20	10034
SCNN1A-6186	−	CCUCCUCCCAGGGCCUGUCU	20	10035
SCNN1A-6187	−	UGGAGGAGGGAGGGAGGAGU	20	10036
SCNN1A-6188	+	CAGGCUGAGAGGGCCUGGGU	20	10037
SCNN1A-6189	−	CAGAAAACUGAUUUAUCCUU	20	10038
SCNN1A-6190	+	CUGUCUCUGCCCCCUUCCUU	20	10039
SCNN1A-6191	+	AUCUGCCUUCUGUUUCUCUU	20	10040
SCNN1A-6192	+	UCUGCCUUCUGUUUCUCUUU	20	10041

Table 46E provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the fifth tier parameters. The targeting domains bind within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. pyogenes eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 46E
5th Tier
			Target Site
gRNA Name	DNA Strand	Targeting Domain	Length	Seq ID
SCNN1A-6193	−	GAAAAUAAAAGCAAAAA	17	10042
SCNN1A-6194	−	AAAGAUCAUCUUUAAAA	17	10043
SCNN1A-6195	+	UCCUUUCCCUCCCCAAA	17	10044
SCNN1A-6196	+	GUCUGGGCUGAGCCAAA	17	10045
SCNN1A-6197	+	UUCCUUUCCCUCCCCAA	17	10046
SCNN1A-6198	+	GGUCUGGGCUGAGCCAA	17	10047
SCNN1A-125	+	CCAGUACAUCAUGCCAA	17	632
SCNN1A-6199	−	UUGGGGAGGGAAAGGAA	17	10048
SCNN1A-6200	+	GCGCAGGCACCAGGGAA	17	10049
SCNN1A-6201	−	CCCCUUUGGGGAGGGAA	17	10050
SCNN1A-6202	−	GGUGCCUGCGCCUGGAA	17	10051
SCNN1A-90	−	ACUCCAGGGCUCAUGAA	17	611
SCNN1A-6203	−	UACAUGUAAGUUUAUAA	17	10052
SCNN1A-6204	−	GAAAGGAAGGGGACUAA	17	10053
SCNN1A-6205	+	GAGCUCUACCUGGGACA	17	10054
SCNN1A-6206	+	UCCAGGCGCAGGCACCA	17	10055
SCNN1A-99	−	GGCGCCCCAGCAGCCCA	17	536
SCNN1A-104	−	AACAACACCACCAUCCA	17	617
SCNN1A-88	−	CUCCACAGUCCACUCCA	17	609
SCNN1A-6207	−	CCUGGAAGGGUGGUCCA	17	10056
SCNN1A-94	−	AACAAGCGUGAGGAGCA	17	613
SCNN1A-6208	−	GAAACAUACCUAUAGCA	17	10057
SCNN1A-6209	−	CCCGGCAGGACGUGGCA	17	10058
SCNN1A-141	+	GCGGUGGAACUCGAUCA	17	551
SCNN1A-106	−	GCACAACCGCAUGAAGA	17	540
SCNN1A-126	+	CCACAGCACUGCCCAGA	17	633
SCNN1A-442	+	ACCAGGGAAGGGGCAGA	17	4291
SCNN1A-115	+	GGGAUUGAGGGUGCAGA	17	542
SCNN1A-6210	−	UUUGGGGAGGGAAAGGA	17	10059
SCNN1A-132	+	GGAGCACACCAGGCGGA	17	547
SCNN1A-6211	+	GGCGCAGGCACCAGGGA	17	10060
SCNN1A-6212	−	UGGCUCCCCUUUGGGGA	17	10061
SCNN1A-6213	−	UGGUGCCUGCGCCUGGA	17	10062
SCNN1A-134	+	GCGGAUGGCGCCGUGGA	17	548
SCNN1A-155	+	CUGGAGUGGACUGUGGA	17	652
SCNN1A-89	−	CACUCCAGGGCUCAUGA	17	610
SCNN1A-6214	−	CAGAGCCUCAGACCUGA	17	10063
SCNN1A-121	+	GUUGAUGUUGAGGCUGA	17	545
SCNN1A-367	+	CGACCUGUAGGGAUUGA	17	4216
SCNN1A-6215	−	GGAAAGGAAGGGGACUA	17	10064
SCNN1A-6216	+	CCACGUCCUGCCGGGUA	17	10065
SCNN1A-331	+	GGACUAACCGACCUGUA	17	4180
SCNN1A-6217	−	GACAGAUAUACAAAUUA	17	10066
SCNN1A-6218	+	CUGGAGCGGGCUAGAAC	17	10067
SCNN1A-6219	−	GGUGCUGAGGUGCUCAC	17	10068
SCNN1A-6220	+	UUAUUUAUCUUAGAGAC	17	10069
SCNN1A-6221	+	UGAGCUCUACCUGGGAC	17	10070
SCNN1A-122	+	UUGAUGUUGAGGCUGAC	17	629
SCNN1A-332	−	GCACCCUCAAUCCCUAC	17	4181
SCNN1A-111	−	CCUUUGGCAUGAUGUAC	17	622
SCNN1A-130	+	UGUGCUGGGAGCACACC	17	637
SCNN1A-6222	+	UUCCAGGCGCAGGCACC	17	10071
SCNN1A-6223	−	UUGGCUCAGCCCAGACC	17	10072
SCNN1A-6224	+	AAUAGAAAUCUGAGACC	17	10073
SCNN1A-6225	+	CUGCAGCAUUCUAGACC	17	10074
SCNN1A-6226	−	AUUGCCACUCCCAUACC	17	10075
SCNN1A-6227	+	CAGCAGUGAGCUCUACC	17	10076
SCNN1A-6228	+	UGAGCACCUCAGCACCC	17	10077
SCNN1A-151	+	UUCCCCUUCAUGAGCCC	17	648
SCNN1A-6229	−	ACUGACACCCCUGUCCC	17	10078
SCNN1A-447	−	UCCCUCUGCCCCUUCCC	17	4296
SCNN1A-105	−	CCACGGCGCCAUCCGCC	17	618
SCNN1A-6230	−	UCCCUGGUGCCUGCGCC	17	10079
SCNN1A-5364	+	AGAAGAAUUGCAAUGCC	17	9213
SCNN1A-6231	+	CCCUGCCACGUCCUGCC	17	10080
SCNN1A-87	−	CCUCCACAGUCCACUCC	17	608
SCNN1A-6232	−	CUGUUCUAGCCCGCUCC	17	10081
SCNN1A-6233	−	ACUUCUGACCAAAGUCC	17	10082
SCNN1A-6234	−	GCCUGGAAGGGUGGUCC	17	10083
SCNN1A-6235	+	CCCUGGACCACCCUUCC	17	10084
SCNN1A-124	+	AGUACUCUCCGAAAAGC	17	631
SCNN1A-93	−	GAACAAGCGUGAGGAGC	17	533
SCNN1A-6236	+	CAUUCUAGACCUGGAGC	17	10085
SCNN1A-147	+	GGCUGCUGGGGCGCCGC	17	554
SCNN1A-6237	+	ACCACCCUUCCAGGCGC	17	10086
SCNN1A-6238	+	UGCACUAUCCUCUAGGC	17	10087
SCNN1A-6239	−	CCACUCCCAUACCCGGC	17	10088
SCNN1A-96	−	GCGUGAGGAGCAGGGGC	17	534
SCNN1A-6240	−	UGAGGUGCUCACUGGGC	17	10089
SCNN1A-6241	−	ACCCGGCAGGACGUGGC	17	10090
SCNN1A-6242	−	CAGGUAGAGCUCACUGC	17	10091
SCNN1A-117	+	GUGCAGAUGGUCACUGC	17	544
SCNN1A-6243	+	ACCCUGCCACGUCCUGC	17	10092
SCNN1A-144	+	CCUCCGCCGUGGGCUGC	17	643
SCNN1A-128	+	UCUUCAUGCGGUUGUGC	17	635
SCNN1A-140	+	AGCGGUGGAACUCGAUC	17	642
SCNN1A-6244	+	UGUCAGUUCCCACCCUC	17	10093
SCNN1A-5415	+	AAUUGCAAUGCCUGGUC	17	9264
SCNN1A-107	−	GCAUGAAGACGGCCUUC	17	541
SCNN1A-149	+	UGGGGCGCCGCAGGUUC	17	647
SCNN1A-6245	+	CCUUUCCCUCCCCAAAG	17	10094
SCNN1A-6246	−	UGGGGAGGGAAAGGAAG	17	10095
SCNN1A-6247	+	CGCAGGCACCAGGGAAG	17	10096
SCNN1A-91	−	CUCCAGGGCUCAUGAAG	17	612
SCNN1A-6248	+	AGCUCUACCUGGGACAG	17	10097
SCNN1A-95	−	ACAAGCGUGAGGAGCAG	17	614
SCNN1A-6249	+	CACCAGGGAAGGGGCAG	17	10098
SCNN1A-138	+	AGAGCUCUCGGUAGGAG	17	641
SCNN1A-6250	+	CCUGCCGGGUAUGGGAG	17	10099
SCNN1A-6251	+	GCAUUCUAGACCUGGAG	17	10100
SCNN1A-152	+	CUUCAUGAGCCCUGGAG	17	649
SCNN1A-6252	−	GCUGUACUCCAGCCUAG	17	10101
SCNN1A-6253	−	CCAUACCCGGCAGGACG	17	10102
SCNN1A-123	+	UGAUGUUGAGGCUGACG	17	630
SCNN1A-142	+	GGCCUCCUCCUCCGCCG	17	552
SCNN1A-133	+	CCAGGCGGAUGGCGCCG	17	638
SCNN1A-118	+	UGCAGAUGGUCACUGCG	17	626
SCNN1A-150	+	GGGGCGCCGCAGGUUCG	17	555
SCNN1A-131	+	GCUGGGAGCACACCAGG	17	546
SCNN1A-103	−	GCCCACGGCGGAGGAGG	17	539
SCNN1A-102	−	GCAGCCCACGGCGGAGG	17	538
SCNN1A-100	−	GCCCCAGCAGCCCACGG	17	537
SCNN1A-139	+	GCUCUCGGUAGGAGCGG	17	550
SCNN1A-101	−	CCAGCAGCCCACGGCGG	17	616
SCNN1A-6254	+	UGGGCUGAGCCAAAGGG	17	10103
SCNN1A-6255	−	GCCUGCGCCUGGAAGGG	17	10104
SCNN1A-6256	−	AGCCUCAGACCUGAGGG	17	10105
SCNN1A-6257	−	GUGGCUCCCCUUUGGGG	17	10106
SCNN1A-135	+	GAUGGCGCCGUGGAUGG	17	549
SCNN1A-6258	−	AGAUAUACAAAUUAUGG	17	10107
SCNN1A-154	+	CCUGGAGUGGACUGUGG	17	651
SCNN1A-127	+	AGAAGGCCGUCUUCAUG	17	634
SCNN1A-116	+	GGUGCAGAUGGUCACUG	17	543
SCNN1A-153	+	AGCCCUGGAGUGGACUG	17	650
SCNN1A-98	−	GCUGGGCCCCGAACCUG	17	535
SCNN1A-6259	−	GCAGAGCCUCAGACCUG	17	10108
SCNN1A-146	+	UCCGCCGUGGGCUGCUG	17	645
SCNN1A-109	−	CCUUCUGGGCAGUGCUG	17	620
SCNN1A-6260	−	GGUGGUCCAGGGUGCUG	17	10109
SCNN1A-6261	+	UCCCACCCUCAGGUCUG	17	10110
SCNN1A-92	−	GAAGGGGAACAAGCGUG	17	532
SCNN1A-6262	+	ACAGGCUUGGUGUUGUG	17	10111
SCNN1A-386	+	CCGACCUGUAGGGAUUG	17	4235
SCNN1A-119	+	CGAGCUUGUCCGAGUUG	17	627
SCNN1A-120	+	AGUUGAGGUUGAUGUUG	17	628
SCNN1A-6263	−	AUGGUGGCUCCCCUUUG	17	10112
SCNN1A-6264	+	GACAGAGACCAUGCUAU	17	10113
SCNN1A-6265	+	CACGUCCUGCCGGGUAU	17	10114
SCNN1A-114	−	CAACAUCAACCUCAACU	17	625
SCNN1A-6266	−	UAGAAUGCUGCAGCACU	17	10115
SCNN1A-6267	−	GUGCUGAGGUGCUCACU	17	10116
SCNN1A-6268	+	AGCAGUGAGCUCUACCU	17	10117
SCNN1A-6269	+	GCGGGCUAGAACAGGCU	17	10118
SCNN1A-97	−	CGUGAGGAGCAGGGGCU	17	615
SCNN1A-145	+	CUCCGCCGUGGGCUGCU	17	644
SCNN1A-129	+	CUUCAUGCGGUUGUGCU	17	636
SCNN1A-6270	+	AUCAUGCACUAUCCUCU	17	10119
SCNN1A-136	+	AGAACUCGAAGAGCUCU	17	639
SCNN1A-6271	+	AUUGCAAUGCCUGGUCU	17	10120
SCNN1A-108	−	CAUGAAGACGGCCUUCU	17	619
SCNN1A-143	+	GCCUCCUCCUCCGCCGU	17	553
SCNN1A-391	−	CCUCAAUCCCUACAGGU	17	4240
SCNN1A-137	+	CUCGAAGAGCUCUCGGU	17	640
SCNN1A-6272	−	GCCUCAGACCUGAGGGU	17	10121
SCNN1A-338	+	GGGACUAACCGACCUGU	17	4187
SCNN1A-112	−	AUGAUGUACUGGCAAUU	17	623
SCNN1A-6273	+	AUCUGAGACCUGGACUU	17	10122
SCNN1A-110	−	CUGUGGCUCUGCACCUU	17	621
SCNN1A-6274	−	GCAGGGUCACCACCCUU	17	10123
SCNN1A-6275	−	UUAUGGUGGCUCCCCUU	17	10124
SCNN1A-148	+	CUGGGGCGCCGCAGGUU	17	646
SCNN1A-6276	−	UAUGGUGGCUCCCCUUU	17	10125
SCNN1A-113	−	CAAUUCGGCCUGCUUUU	17	624
SCNN1A-6277	−	UAAGAAAAUAAAAGCAAAAA	20	10126
SCNN1A-6278	−	UUAAAAGAUCAUCUUUAAAA	20	10127
SCNN1A-6279	+	CCUUCCUUUCCCUCCCCAAA	20	10128
SCNN1A-6280	+	CUGGUCUGGGCUGAGCCAAA	20	10129
SCNN1A-6281	+	CCCUUCCUUUCCCUCCCCAA	20	10130
SCNN1A-6282	+	CCUGGUCUGGGCUGAGCCAA	20	10131
SCNN1A-46	+	UUGCCAGUACAUCAUGCCAA	20	580
SCNN1A-6283	−	CCUUUGGGGAGGGAAAGGAA	20	10132
SCNN1A-6284	+	CAGGCGCAGGCACCAGGGAA	20	10133
SCNN1A-6285	−	GCUCCCCUUUGGGGAGGGAA	20	10134
SCNN1A-6286	−	CCUGGUGCCUGCGCCUGGAA	20	10135
SCNN1A-11	−	UCCACUCCAGGGCUCAUGAA	20	560
SCNN1A-6287	−	AAAUACAUGUAAGUUUAUAA	20	10136
SCNN1A-6288	−	AGGGAAAGGAAGGGGACUAA	20	10137
SCNN1A-6289	+	AGUGAGCUCUACCUGGGACA	20	10138
SCNN1A-6290	+	CCUUCCAGGCGCAGGCACCA	20	10139
SCNN1A-20	−	UGCGGCGCCCCAGCAGCCCA	20	565
SCNN1A-25	−	UGCAACAACACCACCAUCCA	20	567
SCNN1A-9	−	GCCCUCCACAGUCCACUCCA	20	499
SCNN1A-6291	−	GCGCCUGGAAGGGUGGUCCA	20	10140
SCNN1A-15	−	GGGAACAAGCGUGAGGAGCA	20	507
SCNN1A-6292	−	GUAGAAACAUACCUAUAGCA	20	10141
SCNN1A-6293	−	AUACCCGGCAGGACGUGGCA	20	10142
SCNN1A-62	+	GGAGCGGUGGAACUCGAUCA	20	525
SCNN1A-27	−	CCAGCACAACCGCAUGAAGA	20	569
SCNN1A-47	+	GAGCCACAGCACUGCCCAGA	20	521
SCNN1A-6294	+	GGCACCAGGGAAGGGGCAGA	20	10143
SCNN1A-36	+	GUAGGGAUUGAGGGUGCAGA	20	516
SCNN1A-6295	−	CCCUUUGGGGAGGGAAAGGA	20	10144
SCNN1A-53	+	CUGGGAGCACACCAGGCGGA	20	585
SCNN1A-6296	+	CCAGGCGCAGGCACCAGGGA	20	10145
SCNN1A-6297	−	UGGUGGCUCCCCUUUGGGGA	20	10146
SCNN1A-6298	−	CCCUGGUGCCUGCGCCUGGA	20	10147
SCNN1A-55	+	CAGGCGGAUGGCGCCGUGGA	20	587
SCNN1A-76	+	GCCCUGGAGUGGACUGUGGA	20	528
SCNN1A-10	−	GUCCACUCCAGGGCUCAUGA	20	505
SCNN1A-6299	−	AGGCAGAGCCUCAGACCUGA	20	10148
SCNN1A-42	+	GAGGUUGAUGUUGAGGCUGA	20	519
SCNN1A-402	+	AACCGACCUGUAGGGAUUGA	20	4251
SCNN1A-6300	−	GAGGGAAAGGAAGGGGACUA	20	10149
SCNN1A-6301	+	CUGCCACGUCCUGCCGGGUA	20	10150
SCNN1A-345	+	GAGGGACUAACCGACCUGUA	20	4194
SCNN1A-6302	−	AUAGACAGAUAUACAAAUUA	20	10151
SCNN1A-6303	+	GACCUGGAGCGGGCUAGAAC	20	10152
SCNN1A-6304	−	CAGGGUGCUGAGGUGCUCAC	20	10153
SCNN1A-6305	+	UUCUUAUUUAUCUUAGAGAC	20	10154
SCNN1A-6306	+	CAGUGAGCUCUACCUGGGAC	20	10155
SCNN1A-43	+	AGGUUGAUGUUGAGGCUGAC	20	578
SCNN1A-403	−	UCUGCACCCUCAAUCCCUAC	20	4252
SCNN1A-32	−	GCACCUUUGGCAUGAUGUAC	20	514
SCNN1A-51	+	GGUUGUGCUGGGAGCACACC	20	522
SCNN1A-6307	+	CCCUUCCAGGCGCAGGCACC	20	10156
SCNN1A-6308	−	CCUUUGGCUCAGCCCAGACC	20	10157
SCNN1A-6309	+	GAAAAUAGAAAUCUGAGACC	20	10158
SCNN1A-6310	+	GUGCUGCAGCAUUCUAGACC	20	10159
SCNN1A-6311	−	CGCAUUGCCACUCCCAUACC	20	10160
SCNN1A-6312	+	UGCCAGCAGUGAGCUCUACC	20	10161
SCNN1A-6313	+	CAGUGAGCACCUCAGCACCC	20	10162
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-6314	−	GGAACUGACACCCCUGUCCC	20	10163
SCNN1A-407	−	UAGUCCCUCUGCCCCUUCCC	20	4256
SCNN1A-26	−	CAUCCACGGCGCCAUCCGCC	20	568
SCNN1A-6315	−	CCUUCCCUGGUGCCUGCGCC	20	10164
SCNN1A-5223	+	GUGAGAAGAAUUGCAAUGCC	20	9072
SCNN1A-6316	+	UGACCCUGCCACGUCCUGCC	20	10165
SCNN1A-8	−	AGCCCUCCACAGUCCACUCC	20	559
SCNN1A-6317	−	AGCCUGUUCUAGCCCGCUCC	20	10166
SCNN1A-6318	−	UGGACUUCUGACCAAAGUCC	20	10167
SCNN1A-6319	−	UGCGCCUGGAAGGGUGGUCC	20	10168
SCNN1A-6320	+	GCACCCUGGACCACCCUUCC	20	10169
SCNN1A-45	+	UGAAGUACUCUCCGAAAAGC	20	579
SCNN1A-14	−	GGGGAACAAGCGUGAGGAGC	20	506
SCNN1A-6321	+	CAGCAUUCUAGACCUGGAGC	20	10170
SCNN1A-68	+	GUGGGCUGCUGGGGCGCCGC	20	526
SCNN1A-6322	+	UGGACCACCCUUCCAGGCGC	20	10171
SCNN1A-6323	+	UCAUGCACUAUCCUCUAGGC	20	10172
SCNN1A-6324	−	UUGCCACUCCCAUACCCGGC	20	10173
SCNN1A-17	−	CAAGCGUGAGGAGCAGGGGC	20	563
SCNN1A-6325	−	UGCUGAGGUGCUCACUGGGC	20	10174
SCNN1A-6326	−	CAUACCCGGCAGGACGUGGC	20	10175
SCNN1A-6327	−	UCCCAGGUAGAGCUCACUGC	20	10176
SCNN1A-38	+	AGGGUGCAGAUGGUCACUGC	20	575
SCNN1A-6328	+	GUGACCCUGCCACGUCCUGC	20	10177
SCNN1A-65	+	CCUCCUCCGCCGUGGGCUGC	20	594
SCNN1A-49	+	CCGUCUUCAUGCGGUUGUGC	20	582
SCNN1A-61	+	AGGAGCGGUGGAACUCGAUC	20	591
SCNN1A-6329	+	GGGUGUCAGUUCCCACCCUC	20	10178
SCNN1A-5640	+	AAGAAUUGCAAUGCCUGGUC	20	9489
SCNN1A-28	−	ACCGCAUGAAGACGGCCUUC	20	570
SCNN1A-70	+	UGCUGGGGCGCCGCAGGUUC	20	598
SCNN1A-6330	+	CUUCCUUUCCCUCCCCAAAG	20	10179
SCNN1A-6331	−	CUUUGGGGAGGGAAAGGAAG	20	10180
SCNN1A-6332	+	AGGCGCAGGCACCAGGGAAG	20	10181
SCNN1A-12	−	CCACUCCAGGGCUCAUGAAG	20	561
SCNN1A-6333	+	GUGAGCUCUACCUGGGACAG	20	10182
SCNN1A-16	−	GGAACAAGCGUGAGGAGCAG	20	508
SCNN1A-6334	+	AGGCACCAGGGAAGGGGCAG	20	10183
SCNN1A-59	+	CGAAGAGCUCUCGGUAGGAG	20	589
SCNN1A-6335	+	CGUCCUGCCGGGUAUGGGAG	20	10184
SCNN1A-6336	+	GCAGCAUUCUAGACCUGGAG	20	10185
SCNN1A-73	+	CCCCUUCAUGAGCCCUGGAG	20	600
SCNN1A-6337	−	GCUGCUGUACUCCAGCCUAG	20	10186
SCNN1A-6338	−	CUCCCAUACCCGGCAGGACG	20	10187
SCNN1A-44	+	GGUUGAUGUUGAGGCUGACG	20	520
SCNN1A-63	+	CAGGGCCUCCUCCUCCGCCG	20	592
SCNN1A-54	+	ACACCAGGCGGAUGGCGCCG	20	586
SCNN1A-39	+	GGGUGCAGAUGGUCACUGCG	20	518
SCNN1A-71	+	GCUGGGGCGCCGCAGGUUCG	20	527
SCNN1A-52	+	UGUGCUGGGAGCACACCAGG	20	584
SCNN1A-24	−	GCAGCCCACGGCGGAGGAGG	20	512
SCNN1A-23	−	CCAGCAGCCCACGGCGGAGG	20	566
SCNN1A-21	−	GGCGCCCCAGCAGCCCACGG	20	510
SCNN1A-60	+	AGAGCUCUCGGUAGGAGCGG	20	590
SCNN1A-22	−	GCCCCAGCAGCCCACGGCGG	20	511
SCNN1A-6339	+	GUCUGGGCUGAGCCAAAGGG	20	10188
SCNN1A-6340	−	GGUGCCUGCGCCUGGAAGGG	20	10189
SCNN1A-6341	−	CAGAGCCUCAGACCUGAGGG	20	10190
SCNN1A-6342	−	AUGGUGGCUCCCCUUUGGGG	20	10191
SCNN1A-56	+	GCGGAUGGCGCCGUGGAUGG	20	523
SCNN1A-6343	−	GACAGAUAUACAAAUUAUGG	20	10192
SCNN1A-75	+	AGCCCUGGAGUGGACUGUGG	20	602
SCNN1A-48	+	CCCAGAAGGCCGUCUUCAUG	20	581
SCNN1A-37	+	GAGGGUGCAGAUGGUCACUG	20	517
SCNN1A-74	+	AUGAGCCCUGGAGUGGACUG	20	601
SCNN1A-19	−	GGGGCUGGGCCCCGAACCUG	20	509
SCNN1A-6344	−	CAGGCAGAGCCUCAGACCUG	20	10193
SCNN1A-67	+	UCCUCCGCCGUGGGCUGCUG	20	596
SCNN1A-30	−	CGGCCUUCUGGGCAGUGCUG	20	572
SCNN1A-6345	−	AAGGGUGGUCCAGGGUGCUG	20	10194
SCNN1A-6346	+	AGUUCCCACCCUCAGGUCUG	20	10195
SCNN1A-13	−	CAUGAAGGGGAACAAGCGUG	20	562
SCNN1A-6347	+	AGAACAGGCUUGGUGUUGUG	20	10196
SCNN1A-418	+	UAACCGACCUGUAGGGAUUG	20	4267
SCNN1A-40	+	AGACGAGCUUGUCCGAGUUG	20	576
SCNN1A-41	+	CCGAGUUGAGGUUGAUGUUG	20	577
SCNN1A-6348	−	AUUAUGGUGGCUCCCCUUUG	20	10197
SCNN1A-6349	+	UAUGACAGAGACCAUGCUAU	20	10198
SCNN1A-6350	+	UGCCACGUCCUGCCGGGUAU	20	10199
SCNN1A-35	−	CCUCAACAUCAACCUCAACU	20	574
SCNN1A-6351	−	GUCUAGAAUGCUGCAGCACU	20	10200
SCNN1A-6352	−	AGGGUGCUGAGGUGCUCACU	20	10201
SCNN1A-6353	+	GCCAGCAGUGAGCUCUACCU	20	10202
SCNN1A-6354	+	GGAGCGGGCUAGAACAGGCU	20	10203
SCNN1A-18	−	AAGCGUGAGGAGCAGGGGCU	20	564
SCNN1A-66	+	CUCCUCCGCCGUGGGCUGCU	20	595
SCNN1A-50	+	CGUCUUCAUGCGGUUGUGCU	20	583
SCNN1A-6355	+	AGGAUCAUGCACUAUCCUCU	20	10204
SCNN1A-57	+	AGAAGAACUCGAAGAGCUCU	20	588
SCNN1A-6356	+	AGAAUUGCAAUGCCUGGUCU	20	10205
SCNN1A-29	−	CCGCAUGAAGACGGCCUUCU	20	571
SCNN1A-64	+	AGGGCCUCCUCCUCCGCCGU	20	593
SCNN1A-423	−	CACCCUCAAUCCCUACAGGU	20	4272
SCNN1A-58	+	GAACUCGAAGAGCUCUCGGU	20	524
SCNN1A-6357	−	AGAGCCUCAGACCUGAGGGU	20	10206
SCNN1A-424	+	AGAGGGACUAACCGACCUGU	20	4273
SCNN1A-33	−	GGCAUGAUGUACUGGCAAUU	20	515
SCNN1A-6358	+	GAAAUCUGAGACCUGGACUU	20	10207
SCNN1A-31	−	GUGCUGUGGCUCUGCACCUU	20	513
SCNN1A-6359	−	GUGGCAGGGUCACCACCCUU	20	10208
SCNN1A-6360	−	AAAUUAUGGUGGCUCCCCUU	20	10209
SCNN1A-69	+	CUGCUGGGGCGCCGCAGGUU	20	597
SCNN1A-6361	−	AAUUAUGGUGGCUCCCCUUU	20	10210
SCNN1A-34	−	UGGCAAUUCGGCCUGCUUUU	20	573

Table 47A provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the first tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), have a high level of orthogonality, start with a 5′G, and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 47A
1st Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-6362	+	GAAGGAGCCAGCACCAAA	18	10211
SCNN1A-6363	+	GCCAGCGCUGGAAAGGAA	18	10212
SCNN1A-6364	+	GGCCAGCGCUGGAAAGGAA	19	10213
SCNN1A-6365	+	GUGGCCAGCGCUGGAAAGGAA	21	10214
SCNN1A-6366	+	GAUGUGGCCAGCGCUGGAAAGGAA	24	10215
SCNN1A-6367	+	GCUGAAUCUUGACAAGCA	18	10216
SCNN1A-6368	+	GUAAUCGCCCCUGCUGUGGUCA	22	10217
SCNN1A-6369	+	GUGUAAUCGCCCCUGCUGUGGUCA	24	10218
SCNN1A-6370	+	GUGAAAGCCGGUGUCAAC	18	10219
SCNN1A-1304	+	GCCCUCUCCCAUCACCCCUGGAAC	24	5153
SCNN1A-6371	+	GAUCGGGGCUCAGGUGCAC	19	10220
SCNN1A-6372	+	GGAUCGGGGCUCAGGUGCAC	20	10221
SCNN1A-6373	+	GGGAUCGGGGCUCAGGUGCAC	21	10222
SCNN1A-6374	+	GGGGAUCGGGGCUCAGGUGCAC	22	10223
SCNN1A-6375	+	GGGGGAUCGGGGCUCAGGUGCAC	23	10224
SCNN1A-6376	+	GCCAGGGAUGGAAGCGAC	18	10225
SCNN1A-6377	+	GGCCAGGGAUGGAAGCGAC	19	10226
SCNN1A-6378	+	GCCGGCCAGGGAUGGAAGCGAC	22	10227
SCNN1A-6379	+	GGCCGGCCAGGGAUGGAAGCGAC	23	10228
SCNN1A-6380	+	GAAGAAACUGACCCUUCCC	19	10229
SCNN1A-6381	+	GCCCCACAGGAGGCAGCC	18	10230
SCNN1A-6382	+	GGCCCCACAGGAGGCAGCC	19	10231
SCNN1A-6383	+	GGGCCCCACAGGAGGCAGCC	20	10232
SCNN1A-5221	+	GCUGAGGAGGAGUCAGAGCC	20	9070
SCNN1A-6384	+	GCCCGCCCGCUGGCCGGCC	19	10233
SCNN1A-6385	+	GAGCCCGCCCGCUGGCCGGCC	21	10234
SCNN1A-6386	+	GGAGCCCGCCCGCUGGCCGGCC	22	10235
SCNN1A-6387	+	GGGAGCCCGCCCGCUGGCCGGCC	23	10236
SCNN1A-6388	+	GGGGAGCCCGCCCGCUGGCCGGCC	24	10237
SCNN1A-1305	+	GUCAAGGCUGAGCUCUGGGCC	21	5154
SCNN1A-1306	+	GGUCAAGGCUGAGCUCUGGGCC	22	5155
SCNN1A-1307	+	GGGUCAAGGCUGAGCUCUGGGCC	23	5156
SCNN1A-1308	+	GAGUGGAUUGGGGAGAGC	18	5157
SCNN1A-1309	+	GGAGUGGAUUGGGGAGAGC	19	5158
SCNN1A-1310	+	GCCCCGGAGUGGAUUGGGGAGAGC	24	5159
SCNN1A-1311	+	GCCCUGGAGUGGACUGUGGAGGGC	24	5160
SCNN1A-6389	+	GGAGGCAGCCCAGAGUGC	18	10238
SCNN1A-6390	+	GCUGUGGUCACAGAGUUGC	19	10239
SCNN1A-1312	+	GUAUGGGCUGCAGAGGUC	18	5161
SCNN1A-1313	+	GGUAUGGGCUGCAGAGGUC	19	5162
SCNN1A-1314	+	GACCUGGUAUGGGCUGCAGAGGUC	24	5163
SCNN1A-1315	+	GAUACCUCCCCUUGGAAGGGACAG	24	5164
SCNN1A-6391	+	GGACUGGUUCCUUUCCAG	18	10240
SCNN1A-6392	+	GGGACUGGUUCCUUUCCAG	19	10241
SCNN1A-6393	+	GACUGGGACUGGUUCCUUUCCAG	23	10242
SCNN1A-6394	+	GGACUGGGACUGGUUCCUUUCCAG	24	10243
SCNN1A-6395	+	GCAGCAAAAGGAUAAGGAG	19	10244
SCNN1A-6396	+	GGCAAAGAUCUGAACAAGUAG	21	10245
SCNN1A-6397	+	GGGCAAAGAUCUGAACAAGUAG	22	10246
SCNN1A-6398	+	GGGGCAAAGAUCUGAACAAGUAG	23	10247
SCNN1A-6399	+	GCAGGCACUGAAGGUGCAGG	20	10248
SCNN1A-6400	+	GGGAGCAGCGCACUCAGG	18	10249
SCNN1A-5260	+	GUGGGAGCAGCGCACUCAGG	20	9109
SCNN1A-6401	+	GAUUCGUCUGCUCUCUGGGUG	21	10250
SCNN1A-6402	+	GGAUUCGUCUGCUCUCUGGGUG	22	10251
SCNN1A-6403	+	GUGGAUUCGUCUGCUCUCUGGGUG	24	10252
SCNN1A-6404	+	GCCCGUGGAUUCGUCUGCUCU	21	10253
SCNN1A-6405	+	GAGCCCGUGGAUUCGUCUGCUCU	23	10254
SCNN1A-1322	+	GAUUGGGGAGAGCAAGGGU	19	5171
SCNN1A-1323	+	GGAUUGGGGAGAGCAAGGGU	20	5172
SCNN1A-1324	+	GUGGAUUGGGGAGAGCAAGGGU	22	5173
SCNN1A-1325	+	GAGUGGAUUGGGGAGAGCAAGGGU	24	5174
SCNN1A-6406	+	GCAGAGCUAUAAACAGAAUU	20	10255
SCNN1A-6407	+	GAGCAGAGCUAUAAACAGAAUU	22	10256
SCNN1A-6408	+	GGAGCAGAGCUAUAAACAGAAUU	23	10257
SCNN1A-6409	+	GCUUCCCUGAUAGGGCCACCUU	22	10258
SCNN1A-6410	−	GCCAACAGUGUAAAAAAGAA	20	10259
SCNN1A-6411	−	GCAGCCAACAGUGUAAAAAAGAA	23	10260
SCNN1A-6412	−	GGCAGCCAACAGUGUAAAAAAGAA	24	10261
SCNN1A-6413	−	GAGAAAAUAUAGCCCAUCA	19	10262
SCNN1A-6414	−	GGAGAAAAUAUAGCCCAUCA	20	10263
SCNN1A-6415	−	GCAGUCCUGGGGCAGAGA	18	10264
SCNN1A-6416	−	GGUCUGGACAAGGUUGGA	18	10265
SCNN1A-6417	−	GGGUCUGGACAAGGUUGGA	19	10266
SCNN1A-6418	−	GAGGCAGACGCAUCCCAC	18	10267
SCNN1A-6419	−	GGAGGCAGACGCAUCCCAC	19	10268
SCNN1A-6420	−	GAGGAGGCAGACGCAUCCCAC	21	10269
SCNN1A-6421	−	GGAGGAGGCAGACGCAUCCCAC	22	10270
SCNN1A-1335	−	GGCCAGGGGCAGCCUCAC	18	5184
SCNN1A-6422	−	GACCUGGCUCAAGGGAGAC	19	10271
SCNN1A-5207	−	GGACCUGGCUCAAGGGAGAC	20	9056
SCNN1A-6423	−	GCACCUGAGCCCCGAUCCCCC	21	10272
SCNN1A-6424	−	GUGCACCUGAGCCCCGAUCCCCC	23	10273
SCNN1A-6425	−	GGUGCACCUGAGCCCCGAUCCCCC	24	10274
SCNN1A-6426	−	GACCAGGUUGGACCCUGAGCC	21	10275
SCNN1A-6427	−	GCGUCUAAAGCCCCUGCC	18	10276
SCNN1A-6428	−	GUCUGCGUCUAAAGCCCCUGCC	22	10277
SCNN1A-1336	−	GCAGCCUCACUCGGGUUCC	19	5185
SCNN1A-348	−	GGCAGCCUCACUCGGGUUCC	20	4197
SCNN1A-6429	−	GAACCUUUGAGAUCAAACAGC	21	10278
SCNN1A-6430	−	GCCUUCCCUGCCGCGUGCAGGGC	23	10279
SCNN1A-6431	−	GCUUCACCUGGGCCCCUC	18	10280
SCNN1A-6432	−	GUUGUGUGGGUGGCUCUC	18	10281
SCNN1A-6433	−	GGUUGUGUGGGUGGCUCUC	19	10282
SCNN1A-6434	−	GGGUUGUGUGGGUGGCUCUC	20	10283
SCNN1A-6435	−	GGAGUUUCUAGGGGUCUC	18	10284
SCNN1A-6436	−	GACUGGAGUUUCUAGGGGUCUC	22	10285
SCNN1A-6437	−	GAGACUGGAGUUUCUAGGGGUCUC	24	10286
SCNN1A-6438	−	GAUAACCCAGCACCCAGAGAGCAG	24	10287
SCNN1A-6439	−	GAUAGCCCCAGAGGAGGAG	19	10288
SCNN1A-6440	−	GUAGAUAGCCCCAGAGGAGGAG	22	10289
SCNN1A-6441	−	GAGUGGGAGAAUGUGGGCG	19	10290
SCNN1A-6442	−	GGAGUGGGAGAAUGUGGGCG	20	10291
SCNN1A-6443	−	GACAAGGUUGGAGGGGGUGGCG	22	10292
SCNN1A-6444	−	GGACAAGGUUGGAGGGGGUGGCG	23	10293
SCNN1A-6445	−	GCUGCCUUAAGCUAGUGG	18	10294
SCNN1A-6446	−	GCCAUGCUGCCUUAAGCUAGUGG	23	10295
SCNN1A-6447	−	GUCCCAGUCCAGCCGCAACCU	21	10296
SCNN1A-6448	−	GCCUGAGGGUGAGGCUGACCU	21	10297
SCNN1A-6449	−	GGCCUGAGGGUGAGGCUGACCU	22	10298
SCNN1A-6450	−	GGGCCUGAGGGUGAGGCUGACCU	23	10299
SCNN1A-6451	−	GCCCUCCUAGCUGUGGGCU	19	10300
SCNN1A-6452	−	GCUCAAGGGAGACUGGAGUUUCU	23	10301
SCNN1A-6453	−	GGCUCAAGGGAGACUGGAGUUUCU	24	10302
SCNN1A-6454	−	GAAUCCACGGGCUCUGUGU	19	10303
SCNN1A-6455	−	GACGAAUCCACGGGCUCUGUGU	22	10304
SCNN1A-6456	−	GUGCAGGGCCUGGGUUGU	18	10305
SCNN1A-6457	−	GCGUGCAGGGCCUGGGUUGU	20	10306
SCNN1A-6458	−	GCCGCGUGCAGGGCCUGGGUUGU	23	10307
SCNN1A-437	−	GUAAGCAAGGGAACCUGGUU	20	4286
SCNN1A-1339	−	GGUAAGCAAGGGAACCUGGUU	21	5188
SCNN1A-6459	−	GAGUCUCCUCCAGCCCUUU	19	10308

Table 47B provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the second tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), have a high level of orthogonality and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 47B
2nd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-6460	+	AGAAGGAGCCAGCACCAAA	19	10309
SCNN1A-5515	+	UAGAAGGAGCCAGCACCAAA	20	9364
SCNN1A-6461	+	UAGGAGCAGAGCUAUAAA	18	10310
SCNN1A-6462	+	AUAGGAGCAGAGCUAUAAA	19	10311
SCNN1A-6463	+	AAUAGGAGCAGAGCUAUAAA	20	10312
SCNN1A-6464	+	AAAUAGGAGCAGAGCUAUAAA	21	10313
SCNN1A-6465	+	AAAAUAGGAGCAGAGCUAUAAA	22	10314
SCNN1A-6466	+	CAAAAUAGGAGCAGAGCUAUAAA	23	10315
SCNN1A-6467	+	ACAAAAUAGGAGCAGAGCUAUAAA	24	10316
SCNN1A-6468	+	UUUCCAAACUUAAUGCAGCAA	21	10317
SCNN1A-6469	+	CUUUCCAAACUUAAUGCAGCAA	22	10318
SCNN1A-6470	+	UCUUUCCAAACUUAAUGCAGCAA	23	10319
SCNN1A-6471	+	CUCUUUCCAAACUUAAUGCAGCAA	24	10320
SCNN1A-6472	+	UGGCCAGCGCUGGAAAGGAA	20	10321
SCNN1A-6473	+	UGUGGCCAGCGCUGGAAAGGAA	22	10322
SCNN1A-6474	+	AUGUGGCCAGCGCUGGAAAGGAA	23	10323
SCNN1A-6475	+	UGCUGAAUCUUGACAAGCA	19	10324
SCNN1A-5532	+	CUGCUGAAUCUUGACAAGCA	20	9381
SCNN1A-6476	+	UCUGCUGAAUCUUGACAAGCA	21	10325
SCNN1A-6477	+	CUCUGCUGAAUCUUGACAAGCA	22	10326
SCNN1A-6478	+	UCUCUGCUGAAUCUUGACAAGCA	23	10327
SCNN1A-6479	+	AUCUCUGCUGAAUCUUGACAAGCA	24	10328
SCNN1A-6480	+	AGGGAUGGAGGAGGGGCA	18	10329
SCNN1A-6481	+	UAGGGAUGGAGGAGGGGCA	19	10330
SCNN1A-6482	+	AUAGGGAUGGAGGAGGGGCA	20	10331
SCNN1A-6483	+	UCGCCCCUGCUGUGGUCA	18	10332
SCNN1A-6484	+	AUCGCCCCUGCUGUGGUCA	19	10333
SCNN1A-6485	+	AAUCGCCCCUGCUGUGGUCA	20	10334
SCNN1A-6486	+	UAAUCGCCCCUGCUGUGGUCA	21	10335
SCNN1A-6487	+	UGUAAUCGCCCCUGCUGUGGUCA	23	10336
SCNN1A-6488	+	UAAUGCAGCAAAAGGAUA	18	10337
SCNN1A-6489	+	UUAAUGCAGCAAAAGGAUA	19	10338
SCNN1A-6098	+	CUUAAUGCAGCAAAAGGAUA	20	9947
SCNN1A-6490	+	AGUGAAAGCCGGUGUCAAC	19	10339
SCNN1A-6491	+	AAGUGAAAGCCGGUGUCAAC	20	10340
SCNN1A-6492	+	AAAGUGAAAGCCGGUGUCAAC	21	10341
SCNN1A-6493	+	UAAAGUGAAAGCCGGUGUCAAC	22	10342
SCNN1A-6494	+	UUAAAGUGAAAGCCGGUGUCAAC	23	10343
SCNN1A-6495	+	CUUAAAGUGAAAGCCGGUGUCAAC	24	10344
SCNN1A-1344	+	UCCCAUCACCCCUGGAAC	18	5193
SCNN1A-1345	+	CUCCCAUCACCCCUGGAAC	19	5194
SCNN1A-1346	+	UCUCCCAUCACCCCUGGAAC	20	5195
SCNN1A-1347	+	CUCUCCCAUCACCCCUGGAAC	21	5196
SCNN1A-1348	+	CCUCUCCCAUCACCCCUGGAAC	22	5197
SCNN1A-1349	+	CCCUCUCCCAUCACCCCUGGAAC	23	5198
SCNN1A-6496	+	AUCGGGGCUCAGGUGCAC	18	10345
SCNN1A-6497	+	UGGGGGAUCGGGGCUCAGGUGCAC	24	10346
SCNN1A-5564	+	CGGCCAGGGAUGGAAGCGAC	20	9413
SCNN1A-6498	+	CCGGCCAGGGAUGGAAGCGAC	21	10347
SCNN1A-6499	+	UGGCCGGCCAGGGAUGGAAGCGAC	24	10348
SCNN1A-6500	+	CACUCCCACACAGAGCCC	18	10349
SCNN1A-6501	+	UCACUCCCACACAGAGCCC	19	10350
SCNN1A-6502	+	CUCACUCCCACACAGAGCCC	20	10351
SCNN1A-6503	+	AAGAAACUGACCCUUCCC	18	10352
SCNN1A-6504	+	UGAAGAAACUGACCCUUCCC	20	10353
SCNN1A-6505	+	AUGAAGAAACUGACCCUUCCC	21	10354
SCNN1A-6506	+	AAUGAAGAAACUGACCCUUCCC	22	10355
SCNN1A-6507	+	UAAUGAAGAAACUGACCCUUCCC	23	10356
SCNN1A-6508	+	CUAAUGAAGAAACUGACCCUUCCC	24	10357
SCNN1A-6509	+	CGGGCCCCACAGGAGGCAGCC	21	10358
SCNN1A-6510	+	ACGGGCCCCACAGGAGGCAGCC	22	10359
SCNN1A-6511	+	CACGGGCCCCACAGGAGGCAGCC	23	10360
SCNN1A-6512	+	UCACGGGCCCCACAGGAGGCAGCC	24	10361
SCNN1A-6513	+	UGAGGAGGAGUCAGAGCC	18	10362
SCNN1A-6514	+	CUGAGGAGGAGUCAGAGCC	19	10363
SCNN1A-6515	+	ACUGUUGGCUGCCAGGCC	18	10364
SCNN1A-6516	+	CACUGUUGGCUGCCAGGCC	19	10365
SCNN1A-5583	+	ACACUGUUGGCUGCCAGGCC	20	9432
SCNN1A-6517	+	UACACUGUUGGCUGCCAGGCC	21	10366
SCNN1A-6518	+	UUACACUGUUGGCUGCCAGGCC	22	10367
SCNN1A-6519	+	UUUACACUGUUGGCUGCCAGGCC	23	10368
SCNN1A-6520	+	UUUUACACUGUUGGCUGCCAGGCC	24	10369
SCNN1A-6521	+	CCCGCCCGCUGGCCGGCC	18	10370
SCNN1A-6109	+	AGCCCGCCCGCUGGCCGGCC	20	9958
SCNN1A-1350	+	AAGGCUGAGCUCUGGGCC	18	5199
SCNN1A-1351	+	CAAGGCUGAGCUCUGGGCC	19	5200
SCNN1A-1352	+	UCAAGGCUGAGCUCUGGGCC	20	5201
SCNN1A-1353	+	AGGGUCAAGGCUGAGCUCUGGGCC	24	5202
SCNN1A-1354	+	CGGAGUGGAUUGGGGAGAGC	20	5203
SCNN1A-1355	+	CCGGAGUGGAUUGGGGAGAGC	21	5204
SCNN1A-1356	+	CCCGGAGUGGAUUGGGGAGAGC	22	5205
SCNN1A-1357	+	CCCCGGAGUGGAUUGGGGAGAGC	23	5206
SCNN1A-1358	+	CUGGAGUGGACUGUGGAGGGC	21	5207
SCNN1A-1359	+	CCUGGAGUGGACUGUGGAGGGC	22	5208
SCNN1A-1360	+	CCCUGGAGUGGACUGUGGAGGGC	23	5209
SCNN1A-6522	+	UGGAGCCAGCAGACCUGC	18	10371
SCNN1A-6523	+	CUGGAGCCAGCAGACCUGC	19	10372
SCNN1A-5615	+	CCUGGAGCCAGCAGACCUGC	20	9464
SCNN1A-6524	+	AGGAGGCAGCCCAGAGUGC	19	10373
SCNN1A-6130	+	CAGGAGGCAGCCCAGAGUGC	20	9979
SCNN1A-6525	+	ACAGGAGGCAGCCCAGAGUGC	21	10374
SCNN1A-6526	+	CACAGGAGGCAGCCCAGAGUGC	22	10375
SCNN1A-6527	+	CCACAGGAGGCAGCCCAGAGUGC	23	10376
SCNN1A-6528	+	CCCACAGGAGGCAGCCCAGAGUGC	24	10377
SCNN1A-6529	+	CUGUGGUCACAGAGUUGC	18	10378
SCNN1A-5623	+	UGCUGUGGUCACAGAGUUGC	20	9472
SCNN1A-6530	+	CUGCUGUGGUCACAGAGUUGC	21	10379
SCNN1A-6531	+	CCUGCUGUGGUCACAGAGUUGC	22	10380
SCNN1A-6532	+	CCCUGCUGUGGUCACAGAGUUGC	23	10381
SCNN1A-6533	+	CCCCUGCUGUGGUCACAGAGUUGC	24	10382
SCNN1A-6534	+	CCUUUGGUCUUCUUCCUC	18	10383
SCNN1A-6535	+	UCCUUUGGUCUUCUUCCUC	19	10384
SCNN1A-6536	+	UUCCUUUGGUCUUCUUCCUC	20	10385
SCNN1A-1361	+	UGGUAUGGGCUGCAGAGGUC	20	5210
SCNN1A-1362	+	CUGGUAUGGGCUGCAGAGGUC	21	5211
SCNN1A-1363	+	CCUGGUAUGGGCUGCAGAGGUC	22	5212
SCNN1A-1364	+	ACCUGGUAUGGGCUGCAGAGGUC	23	5213
SCNN1A-1365	+	UCCCCUUGGAAGGGACAG	18	5214
SCNN1A-1366	+	CUCCCCUUGGAAGGGACAG	19	5215
SCNN1A-1367	+	CCUCCCCUUGGAAGGGACAG	20	5216
SCNN1A-1368	+	ACCUCCCCUUGGAAGGGACAG	21	5217
SCNN1A-1369	+	UACCUCCCCUUGGAAGGGACAG	22	5218
SCNN1A-1370	+	AUACCUCCCCUUGGAAGGGACAG	23	5219
SCNN1A-6537	+	UGGGACUGGUUCCUUUCCAG	20	10386
SCNN1A-6538	+	CUGGGACUGGUUCCUUUCCAG	21	10387
SCNN1A-6539	+	ACUGGGACUGGUUCCUUUCCAG	22	10388
SCNN1A-6540	+	CAGCAAAAGGAUAAGGAG	18	10389
SCNN1A-5654	+	UGCAGCAAAAGGAUAAGGAG	20	9503
SCNN1A-6541	+	AUGCAGCAAAAGGAUAAGGAG	21	10390
SCNN1A-6542	+	AAUGCAGCAAAAGGAUAAGGAG	22	10391
SCNN1A-6543	+	UAAUGCAGCAAAAGGAUAAGGAG	23	10392
SCNN1A-6544	+	UUAAUGCAGCAAAAGGAUAAGGAG	24	10393
SCNN1A-6545	+	UAUCAAGGGCUCUGUGAG	18	10394
SCNN1A-6546	+	AUAUCAAGGGCUCUGUGAG	19	10395
SCNN1A-6547	+	CAUAUCAAGGGCUCUGUGAG	20	10396
SCNN1A-6548	+	UCAUAUCAAGGGCUCUGUGAG	21	10397
SCNN1A-6549	+	UUCAUAUCAAGGGCUCUGUGAG	22	10398
SCNN1A-6550	+	UUUCAUAUCAAGGGCUCUGUGAG	23	10399
SCNN1A-6551	+	UUUUCAUAUCAAGGGCUCUGUGAG	24	10400
SCNN1A-6552	+	AGGGGCAAAGAUCUGAACAAGUAG	24	10401
SCNN1A-6553	+	AGGCACUGAAGGUGCAGG	18	10402
SCNN1A-6554	+	CAGGCACUGAAGGUGCAGG	19	10403
SCNN1A-6555	+	UGGGAGCAGCGCACUCAGG	19	10404
SCNN1A-6556	+	AGUGGGAGCAGCGCACUCAGG	21	10405
SCNN1A-6557	+	AAGUGGGAGCAGCGCACUCAGG	22	10406
SCNN1A-6558	+	UAAGUGGGAGCAGCGCACUCAGG	23	10407
SCNN1A-6559	+	CUAAGUGGGAGCAGCGCACUCAGG	24	10408
SCNN1A-6560	+	CAGGAAGGAGAGCAAGGG	18	10409
SCNN1A-6561	+	CCAGGAAGGAGAGCAAGGG	19	10410
SCNN1A-6159	+	UCCAGGAAGGAGAGCAAGGG	20	10008
SCNN1A-6562	+	UCCUGAGACAGACUCAUG	18	10411
SCNN1A-6563	+	UUCCUGAGACAGACUCAUG	19	10412
SCNN1A-5698	+	CUUCCUGAGACAGACUCAUG	20	9547
SCNN1A-6564	+	ACUUCCUGAGACAGACUCAUG	21	10413
SCNN1A-6565	+	UACUUCCUGAGACAGACUCAUG	22	10414
SCNN1A-6566	+	UUACUUCCUGAGACAGACUCAUG	23	10415
SCNN1A-6567	+	UUUACUUCCUGAGACAGACUCAUG	24	10416
SCNN1A-6568	+	UCGUCUGCUCUCUGGGUG	18	10417
SCNN1A-6569	+	UUCGUCUGCUCUCUGGGUG	19	10418
SCNN1A-6570	+	AUUCGUCUGCUCUCUGGGUG	20	10419
SCNN1A-6571	+	UGGAUUCGUCUGCUCUCUGGGUG	23	10420
SCNN1A-6572	+	AGCGAAGGACAGAGAGAU	18	10421
SCNN1A-6573	+	CAGCGAAGGACAGAGAGAU	19	10422
SCNN1A-5722	+	ACAGCGAAGGACAGAGAGAU	20	9571
SCNN1A-6574	+	CCCGAGGGCAGGUGAACU	18	10423
SCNN1A-6575	+	UCCCGAGGGCAGGUGAACU	19	10424
SCNN1A-5726	+	CUCCCGAGGGCAGGUGAACU	20	9575
SCNN1A-6576	+	AAGGCAGUACUCCAGGCU	18	10425
SCNN1A-6577	+	AAAGGCAGUACUCCAGGCU	19	10426
SCNN1A-6578	+	AAAAGGCAGUACUCCAGGCU	20	10427
SCNN1A-6579	+	CGUGGAUUCGUCUGCUCU	18	10428
SCNN1A-6580	+	CCGUGGAUUCGUCUGCUCU	19	10429
SCNN1A-6581	+	CCCGUGGAUUCGUCUGCUCU	20	10430
SCNN1A-6582	+	AGCCCGUGGAUUCGUCUGCUCU	22	10431
SCNN1A-6583	+	AGAGCCCGUGGAUUCGUCUGCUCU	24	10432
SCNN1A-6584	+	UCUGCCUUCUGUUUCUCU	18	10433
SCNN1A-6585	+	AUCUGCCUUCUGUUUCUCU	19	10434
SCNN1A-6586	+	UAUCUGCCUUCUGUUUCUCU	20	10435
SCNN1A-6587	+	CUAUCUGCCUUCUGUUUCUCU	21	10436
SCNN1A-6588	+	UCUAUCUGCCUUCUGUUUCUCU	22	10437
SCNN1A-6589	+	CUCUAUCUGCCUUCUGUUUCUCU	23	10438
SCNN1A-6590	+	UCUCUAUCUGCCUUCUGUUUCUCU	24	10439
SCNN1A-1377	+	AUUGGGGAGAGCAAGGGU	18	5226
SCNN1A-1378	+	UGGAUUGGGGAGAGCAAGGGU	21	5227
SCNN1A-1379	+	AGUGGAUUGGGGAGAGCAAGGGU	23	5228
SCNN1A-6591	+	AGAGCUAUAAACAGAAUU	18	10440
SCNN1A-6592	+	CAGAGCUAUAAACAGAAUU	19	10441
SCNN1A-6593	+	AGCAGAGCUAUAAACAGAAUU	21	10442
SCNN1A-6594	+	AGGAGCAGAGCUAUAAACAGAAUU	24	10443
SCNN1A-6595	+	CUUCCCUGAUAGGGCCACCUU	21	10444
SCNN1A-6596	+	UGCUUCCCUGAUAGGGCCACCUU	23	10445
SCNN1A-6597	+	CUGCUUCCCUGAUAGGGCCACCUU	24	10446
SCNN1A-6598	−	CAACAGUGUAAAAAAGAA	18	10447
SCNN1A-6599	−	CCAACAGUGUAAAAAAGAA	19	10448
SCNN1A-6600	−	AGCCAACAGUGUAAAAAAGAA	21	10449
SCNN1A-6601	−	CAGCCAACAGUGUAAAAAAGAA	22	10450
SCNN1A-6602	−	AGAAAAUAUAGCCCAUCA	18	10451
SCNN1A-6603	−	UGCAGUCCUGGGGCAGAGA	19	10452
SCNN1A-6604	−	CUGCAGUCCUGGGGCAGAGA	20	10453
SCNN1A-5553	−	CGGGUCUGGACAAGGUUGGA	20	9402
SCNN1A-6605	−	CCGGGUCUGGACAAGGUUGGA	21	10454
SCNN1A-6606	−	CCCGGGUCUGGACAAGGUUGGA	22	10455
SCNN1A-6607	−	UCCCGGGUCUGGACAAGGUUGGA	23	10456
SCNN1A-6608	−	CUCCCGGGUCUGGACAAGGUUGGA	24	10457
SCNN1A-6609	−	AGGAGGCAGACGCAUCCCAC	20	10458
SCNN1A-6610	−	AGGAGGAGGCAGACGCAUCCCAC	23	10459
SCNN1A-6611	−	CAGGAGGAGGCAGACGCAUCCCAC	24	10460
SCNN1A-1392	−	UGGCCAGGGGCAGCCUCAC	19	5241
SCNN1A-1393	−	AUGGCCAGGGGCAGCCUCAC	20	5242
SCNN1A-6612	−	ACCUGGCUCAAGGGAGAC	18	10461
SCNN1A-6613	−	CCUGAGCCCCGAUCCCCC	18	10462
SCNN1A-6614	−	ACCUGAGCCCCGAUCCCCC	19	10463
SCNN1A-6615	−	CACCUGAGCCCCGAUCCCCC	20	10464
SCNN1A-6616	−	UGCACCUGAGCCCCGAUCCCCC	22	10465
SCNN1A-6617	−	CAGGUUGGACCCUGAGCC	18	10466
SCNN1A-6618	−	CCAGGUUGGACCCUGAGCC	19	10467
SCNN1A-5581	−	ACCAGGUUGGACCCUGAGCC	20	9430
SCNN1A-6619	−	AGACCAGGUUGGACCCUGAGCC	22	10468
SCNN1A-6620	−	CAGACCAGGUUGGACCCUGAGCC	23	10469
SCNN1A-6621	−	ACAGACCAGGUUGGACCCUGAGCC	24	10470
SCNN1A-6622	−	UGCGUCUAAAGCCCCUGCC	19	10471
SCNN1A-6623	−	CUGCGUCUAAAGCCCCUGCC	20	10472
SCNN1A-6624	−	UCUGCGUCUAAAGCCCCUGCC	21	10473
SCNN1A-6625	−	UGUCUGCGUCUAAAGCCCCUGCC	23	10474
SCNN1A-6626	−	CUGUCUGCGUCUAAAGCCCCUGCC	24	10475
SCNN1A-1394	−	CAGCCUCACUCGGGUUCC	18	5243
SCNN1A-6627	−	CCUUUGAGAUCAAACAGC	18	10476
SCNN1A-6628	−	ACCUUUGAGAUCAAACAGC	19	10477
SCNN1A-6629	−	AACCUUUGAGAUCAAACAGC	20	10478
SCNN1A-6630	−	AGAACCUUUGAGAUCAAACAGC	22	10479
SCNN1A-6631	−	CAGAACCUUUGAGAUCAAACAGC	23	10480
SCNN1A-6632	−	UCAGAACCUUUGAGAUCAAACAGC	24	10481
SCNN1A-6633	−	CCCUGCCGCGUGCAGGGC	18	10482
SCNN1A-6634	−	UCCCUGCCGCGUGCAGGGC	19	10483
SCNN1A-6635	−	UUCCCUGCCGCGUGCAGGGC	20	10484
SCNN1A-6636	−	CUUCCCUGCCGCGUGCAGGGC	21	10485
SCNN1A-6637	−	CCUUCCCUGCCGCGUGCAGGGC	22	10486
SCNN1A-6638	−	AGCCUUCCCUGCCGCGUGCAGGGC	24	10487
SCNN1A-6639	−	AGCUUCACCUGGGCCCCUC	19	10488
SCNN1A-6640	−	CAGCUUCACCUGGGCCCCUC	20	10489
SCNN1A-6641	−	CCAGCUUCACCUGGGCCCCUC	21	10490
SCNN1A-6642	−	CCCAGCUUCACCUGGGCCCCUC	22	10491
SCNN1A-6643	−	CCCCAGCUUCACCUGGGCCCCUC	23	10492
SCNN1A-6644	−	CCCCCAGCUUCACCUGGGCCCCUC	24	10493
SCNN1A-6645	−	UGGAGUUUCUAGGGGUCUC	19	10494
SCNN1A-5635	−	CUGGAGUUUCUAGGGGUCUC	20	9484
SCNN1A-6646	−	ACUGGAGUUUCUAGGGGUCUC	21	10495
SCNN1A-6647	−	AGACUGGAGUUUCUAGGGGUCUC	23	10496
SCNN1A-6648	−	CCAGCACCCAGAGAGCAG	18	10497
SCNN1A-6649	−	CCCAGCACCCAGAGAGCAG	19	10498
SCNN1A-6650	−	ACCCAGCACCCAGAGAGCAG	20	10499
SCNN1A-6651	−	AACCCAGCACCCAGAGAGCAG	21	10500
SCNN1A-6652	−	UAACCCAGCACCCAGAGAGCAG	22	10501
SCNN1A-6653	−	AUAACCCAGCACCCAGAGAGCAG	23	10502
SCNN1A-6654	−	AUAGCCCCAGAGGAGGAG	18	10503
SCNN1A-6655	−	AGAUAGCCCCAGAGGAGGAG	20	10504
SCNN1A-6656	−	UAGAUAGCCCCAGAGGAGGAG	21	10505
SCNN1A-6657	−	AGUAGAUAGCCCCAGAGGAGGAG	23	10506
SCNN1A-6658	−	AAGUAGAUAGCCCCAGAGGAGGAG	24	10507
SCNN1A-6659	−	AGUGGGAGAAUGUGGGCG	18	10508
SCNN1A-6660	−	AGGUUGGAGGGGGUGGCG	18	10509
SCNN1A-6661	−	AAGGUUGGAGGGGGUGGCG	19	10510
SCNN1A-5670	−	CAAGGUUGGAGGGGGUGGCG	20	9519
SCNN1A-6662	−	ACAAGGUUGGAGGGGGUGGCG	21	10511
SCNN1A-6663	−	UGGACAAGGUUGGAGGGGGUGGCG	24	10512
SCNN1A-6664	−	AACUGAUUUAUCCUUGGG	18	10513
SCNN1A-6665	−	AAACUGAUUUAUCCUUGGG	19	10514
SCNN1A-6666	−	AAAACUGAUUUAUCCUUGGG	20	10515
SCNN1A-6667	−	UGCUGCCUUAAGCUAGUGG	19	10516
SCNN1A-6668	−	AUGCUGCCUUAAGCUAGUGG	20	10517
SCNN1A-6669	−	CAUGCUGCCUUAAGCUAGUGG	21	10518
SCNN1A-6670	−	CCAUGCUGCCUUAAGCUAGUGG	22	10519
SCNN1A-6671	−	UGCCAUGCUGCCUUAAGCUAGUGG	24	10520
SCNN1A-6672	−	CCAGUCCAGCCGCAACCU	18	10521
SCNN1A-6673	−	CCCAGUCCAGCCGCAACCU	19	10522
SCNN1A-5731	−	UCCCAGUCCAGCCGCAACCU	20	9580
SCNN1A-6674	−	AGUCCCAGUCCAGCCGCAACCU	22	10523
SCNN1A-6675	−	CAGUCCCAGUCCAGCCGCAACCU	23	10524
SCNN1A-6676	−	CCAGUCCCAGUCCAGCCGCAACCU	24	10525
SCNN1A-6677	−	UGAGGGUGAGGCUGACCU	18	10526
SCNN1A-6678	−	CUGAGGGUGAGGCUGACCU	19	10527
SCNN1A-6679	−	CCUGAGGGUGAGGCUGACCU	20	10528
SCNN1A-6680	−	AGGGCCUGAGGGUGAGGCUGACCU	24	10529
SCNN1A-6681	−	CUCUUCUCUGCAGGGCCU	18	10530
SCNN1A-6682	−	UCUCUUCUCUGCAGGGCCU	19	10531
SCNN1A-6683	−	CUCUCUUCUCUGCAGGGCCU	20	10532
SCNN1A-6684	−	UCUCUCUUCUCUGCAGGGCCU	21	10533
SCNN1A-6685	−	UUCUCUCUUCUCUGCAGGGCCU	22	10534
SCNN1A-6686	−	CUUCUCUCUUCUCUGCAGGGCCU	23	10535
SCNN1A-6687	−	UCUUCUCUCUUCUCUGCAGGGCCU	24	10536
SCNN1A-6688	−	CCUGCCUCUUCCUGGGCU	18	10537
SCNN1A-6689	−	CCCUGCCUCUUCCUGGGCU	19	10538
SCNN1A-6690	−	UCCCUGCCUCUUCCUGGGCU	20	10539
SCNN1A-6691	−	CCCUCCUAGCUGUGGGCU	18	10540
SCNN1A-6692	−	UGCCCUCCUAGCUGUGGGCU	20	10541
SCNN1A-6693	−	AGGGAGACUGGAGUUUCU	18	10542
SCNN1A-6694	−	AAGGGAGACUGGAGUUUCU	19	10543
SCNN1A-5751	−	CAAGGGAGACUGGAGUUUCU	20	9600
SCNN1A-6695	−	UCAAGGGAGACUGGAGUUUCU	21	10544
SCNN1A-6696	−	CUCAAGGGAGACUGGAGUUUCU	22	10545
SCNN1A-6697	−	AAUCCACGGGCUCUGUGU	18	10546
SCNN1A-5766	−	CGAAUCCACGGGCUCUGUGU	20	9615
SCNN1A-6698	−	ACGAAUCCACGGGCUCUGUGU	21	10547
SCNN1A-6699	−	AGACGAAUCCACGGGCUCUGUGU	23	10548
SCNN1A-6700	−	CAGACGAAUCCACGGGCUCUGUGU	24	10549
SCNN1A-6701	−	CGUGCAGGGCCUGGGUUGU	19	10550
SCNN1A-6702	−	CGCGUGCAGGGCCUGGGUUGU	21	10551
SCNN1A-6703	−	CCGCGUGCAGGGCCUGGGUUGU	22	10552
SCNN1A-6704	−	UGCCGCGUGCAGGGCCUGGGUUGU	24	10553
SCNN1A-1405	−	AAGCAAGGGAACCUGGUU	18	5254
SCNN1A-1406	−	UAAGCAAGGGAACCUGGUU	19	5255
SCNN1A-1407	−	AGGUAAGCAAGGGAACCUGGUU	22	5256
SCNN1A-1408	−	AAGGUAAGCAAGGGAACCUGGUU	23	5257
SCNN1A-1409	−	CAAGGUAAGCAAGGGAACCUGGUU	24	5258
SCNN1A-6705	−	AGUCUCCUCCAGCCCUUU	18	10554
SCNN1A-6706	−	CGAGUCUCCUCCAGCCCUUU	20	10555
SCNN1A-6707	−	CCGAGUCUCCUCCAGCCCUUU	21	10556
SCNN1A-6708	−	CCCGAGUCUCCUCCAGCCCUUU	22	10557
SCNN1A-6709	−	UCCCGAGUCUCCUCCAGCCCUUU	23	10558
SCNN1A-6710	−	CUCCCGAGUCUCCUCCAGCCCUUU	24	10559

Table 47C provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the third tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 47C
3rd Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-6711	+	AUAGAAGGAGCCAGCACCAAA	21	10560
SCNN1A-6712	+	AAUAGAAGGAGCCAGCACCAAA	22	10561
SCNN1A-6713	+	AAAUAGAAGGAGCCAGCACCAAA	23	10562
SCNN1A-6714	+	CAAAUAGAAGGAGCCAGCACCAAA	24	10563
SCNN1A-6715	+	CCAAACUUAAUGCAGCAA	18	10564
SCNN1A-6716	+	UCCAAACUUAAUGCAGCAA	19	10565
SCNN1A-6717	+	UUCCAAACUUAAUGCAGCAA	20	10566
SCNN1A-6718	+	GAUAGGGAUGGAGGAGGGGCA	21	10567
SCNN1A-6719	+	AGAUAGGGAUGGAGGAGGGGCA	22	10568
SCNN1A-6720	+	GAGAUAGGGAUGGAGGAGGGGCA	23	10569
SCNN1A-6721	+	AGAGAUAGGGAUGGAGGAGGGGCA	24	10570
SCNN1A-6722	+	GGAGAGAGAGGAGGGUCA	18	10571
SCNN1A-6723	+	AGGAGAGAGAGGAGGGUCA	19	10572
SCNN1A-6724	+	AAGGAGAGAGAGGAGGGUCA	20	10573
SCNN1A-6725	+	CAAGGAGAGAGAGGAGGGUCA	21	10574
SCNN1A-6726	+	GCAAGGAGAGAGAGGAGGGUCA	22	10575
SCNN1A-6727	+	AGCAAGGAGAGAGAGGAGGGUCA	23	10576
SCNN1A-6728	+	GAGCAAGGAGAGAGAGGAGGGUCA	24	10577
SCNN1A-1410	+	CCCUUCAUGAGCCCCGGA	18	5259
SCNN1A-1411	+	CCCCUUCAUGAGCCCCGGA	19	5260
SCNN1A-1412	+	UCCCCUUCAUGAGCCCCGGA	20	5261
SCNN1A-1413	+	UUCCCCUUCAUGAGCCCCGGA	21	5262
SCNN1A-1414	+	GUUCCCCUUCAUGAGCCCCGGA	22	5263
SCNN1A-1415	+	UGUUCCCCUUCAUGAGCCCCGGA	23	5264
SCNN1A-1416	+	UUGUUCCCCUUCAUGAGCCCCGGA	24	5265
SCNN1A-6729	+	GGCAAGGAGGCUGGGGGA	18	10578
SCNN1A-6730	+	AGGCAAGGAGGCUGGGGGA	19	10579
SCNN1A-6731	+	CAGGCAAGGAGGCUGGGGGA	20	10580
SCNN1A-6732	+	ACAGGCAAGGAGGCUGGGGGA	21	10581
SCNN1A-6733	+	GACAGGCAAGGAGGCUGGGGGA	22	10582
SCNN1A-6734	+	AGACAGGCAAGGAGGCUGGGGGA	23	10583
SCNN1A-6735	+	CAGACAGGCAAGGAGGCUGGGGGA	24	10584
SCNN1A-6736	+	AUGGAGGAGGGGCACUGA	18	10585
SCNN1A-6737	+	GAUGGAGGAGGGGCACUGA	19	10586
SCNN1A-6738	+	GGAUGGAGGAGGGGCACUGA	20	10587
SCNN1A-6739	+	GGGAUGGAGGAGGGGCACUGA	21	10588
SCNN1A-6740	+	AGGGAUGGAGGAGGGGCACUGA	22	10589
SCNN1A-6741	+	UAGGGAUGGAGGAGGGGCACUGA	23	10590
SCNN1A-6742	+	AUAGGGAUGGAGGAGGGGCACUGA	24	10591
SCNN1A-6743	+	ACUUAAUGCAGCAAAAGGAUA	21	10592
SCNN1A-6744	+	AACUUAAUGCAGCAAAAGGAUA	22	10593
SCNN1A-6745	+	AAACUUAAUGCAGCAAAAGGAUA	23	10594
SCNN1A-6746	+	CAAACUUAAUGCAGCAAAAGGAUA	24	10595
SCNN1A-6747	+	CCUCACUCCCACACAGAGCCC	21	10596
SCNN1A-6748	+	CCCUCACUCCCACACAGAGCCC	22	10597
SCNN1A-6749	+	UCCCUCACUCCCACACAGAGCCC	23	10598
SCNN1A-6750	+	CUCCCUCACUCCCACACAGAGCCC	24	10599
SCNN1A-1417	+	GUUCCCCUUCAUGAGCCC	18	5266
SCNN1A-1418	+	UGUUCCCCUUCAUGAGCCC	19	5267
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-1419	+	CUUGUUCCCCUUCAUGAGCCC	21	5268
SCNN1A-1420	+	GCUUGUUCCCCUUCAUGAGCCC	22	5269
SCNN1A-1421	+	AGCUUGUUCCCCUUCAUGAGCCC	23	5270
SCNN1A-1422	+	CAGCUUGUUCCCCUUCAUGAGCCC	24	5271
SCNN1A-6751	+	GGCUGAGGAGGAGUCAGAGCC	21	10600
SCNN1A-6752	+	GGGCUGAGGAGGAGUCAGAGCC	22	10601
SCNN1A-6753	+	GGGGCUGAGGAGGAGUCAGAGCC	23	10602
SCNN1A-6754	+	AGGGGCUGAGGAGGAGUCAGAGCC	24	10603
SCNN1A-6755	+	CAGCCAGGCUGAGAGGGC	18	10604
SCNN1A-6756	+	CCAGCCAGGCUGAGAGGGC	19	10605
SCNN1A-6757	+	GCCAGCCAGGCUGAGAGGGC	20	10606
SCNN1A-6758	+	GGCCAGCCAGGCUGAGAGGGC	21	10607
SCNN1A-6759	+	GGGCCAGCCAGGCUGAGAGGGC	22	10608
SCNN1A-6760	+	GGGGCCAGCCAGGCUGAGAGGGC	23	10609
SCNN1A-6761	+	AGGGGCCAGCCAGGCUGAGAGGGC	24	10610
SCNN1A-1431	+	GAGUGGACUGUGGAGGGC	18	5280
SCNN1A-1432	+	GGAGUGGACUGUGGAGGGC	19	5281
SCNN1A-201	+	UGGAGUGGACUGUGGAGGGC	20	830
SCNN1A-6762	+	UCCUGGAGCCAGCAGACCUGC	21	10611
SCNN1A-6763	+	UUCCUGGAGCCAGCAGACCUGC	22	10612
SCNN1A-6764	+	UUUCCUGGAGCCAGCAGACCUGC	23	10613
SCNN1A-6765	+	CUUUCCUGGAGCCAGCAGACCUGC	24	10614
SCNN1A-6766	+	CUUCCUUUGGUCUUCUUCCUC	21	10615
SCNN1A-6767	+	CCUUCCUUUGGUCUUCUUCCUC	22	10616
SCNN1A-6768	+	CCCUUCCUUUGGUCUUCUUCCUC	23	10617
SCNN1A-6769	+	CCCCUUCCUUUGGUCUUCUUCCUC	24	10618
SCNN1A-6770	+	GUGAGCAAGGAGAGAGAG	18	10619
SCNN1A-6771	+	GGUGAGCAAGGAGAGAGAG	19	10620
SCNN1A-6772	+	UGGUGAGCAAGGAGAGAGAG	20	10621
SCNN1A-6773	+	GUGGUGAGCAAGGAGAGAGAG	21	10622
SCNN1A-6774	+	AGUGGUGAGCAAGGAGAGAGAG	22	10623
SCNN1A-6775	+	AAGUGGUGAGCAAGGAGAGAGAG	23	10624
SCNN1A-6776	+	CAAGUGGUGAGCAAGGAGAGAGAG	24	10625
SCNN1A-6777	+	AAAGAUCUGAACAAGUAG	18	10626
SCNN1A-6778	+	CAAAGAUCUGAACAAGUAG	19	10627
SCNN1A-6779	+	GCAAAGAUCUGAACAAGUAG	20	10628
SCNN1A-6780	+	AGCAGGCACUGAAGGUGCAGG	21	10629
SCNN1A-6781	+	AAGCAGGCACUGAAGGUGCAGG	22	10630
SCNN1A-6782	+	AAAGCAGGCACUGAAGGUGCAGG	23	10631
SCNN1A-6783	+	GAAAGCAGGCACUGAAGGUGCAGG	24	10632
SCNN1A-6784	+	CGGGGGGAGGGGCUGAGG	18	10633
SCNN1A-6785	+	GCGGGGGGAGGGGCUGAGG	19	10634
SCNN1A-5907	+	GGCGGGGGGAGGGGCUGAGG	20	9756
SCNN1A-6786	+	GGGCGGGGGGAGGGGCUGAGG	21	10635
SCNN1A-6787	+	AGGGCGGGGGGAGGGGCUGAGG	22	10636
SCNN1A-6788	+	CAGGGCGGGGGGAGGGGCUGAGG	23	10637
SCNN1A-6789	+	GCAGGGCGGGGGGAGGGGCUGAGG	24	10638
SCNN1A-6790	+	CUCCAGGAAGGAGAGCAAGGG	21	10639
SCNN1A-6791	+	UCUCCAGGAAGGAGAGCAAGGG	22	10640
SCNN1A-6792	+	GUCUCCAGGAAGGAGAGCAAGGG	23	10641
SCNN1A-6793	+	UGUCUCCAGGAAGGAGAGCAAGGG	24	10642
SCNN1A-6794	+	GAGAAGGUGUCAUCUCUG	18	10643
SCNN1A-6795	+	AGAGAAGGUGUCAUCUCUG	19	10644
SCNN1A-6796	+	CAGAGAAGGUGUCAUCUCUG	20	10645
SCNN1A-6797	+	CCAGAGAAGGUGUCAUCUCUG	21	10646
SCNN1A-6798	+	CCCAGAGAAGGUGUCAUCUCUG	22	10647
SCNN1A-6799	+	UCCCAGAGAAGGUGUCAUCUCUG	23	10648
SCNN1A-6800	+	UUCCCAGAGAAGGUGUCAUCUCUG	24	10649
SCNN1A-6801	+	GACAGCGAAGGACAGAGAGAU	21	10650
SCNN1A-6802	+	GGACAGCGAAGGACAGAGAGAU	22	10651
SCNN1A-6803	+	GGGACAGCGAAGGACAGAGAGAU	23	10652
SCNN1A-6804	+	AGGGACAGCGAAGGACAGAGAGAU	24	10653
SCNN1A-6805	+	GCUCCCGAGGGCAGGUGAACU	21	10654
SCNN1A-6806	+	GGCUCCCGAGGGCAGGUGAACU	22	10655
SCNN1A-6807	+	GGGCUCCCGAGGGCAGGUGAACU	23	10656
SCNN1A-6808	+	AGGGCUCCCGAGGGCAGGUGAACU	24	10657
SCNN1A-6809	+	GAAAAGGCAGUACUCCAGGCU	21	10658
SCNN1A-6810	+	AGAAAAGGCAGUACUCCAGGCU	22	10659
SCNN1A-6811	+	GAGAAAAGGCAGUACUCCAGGCU	23	10660
SCNN1A-6812	+	AGAGAAAAGGCAGUACUCCAGGCU	24	10661
SCNN1A-6813	+	CCCUGAUAGGGCCACCUU	18	10662
SCNN1A-6814	+	UCCCUGAUAGGGCCACCUU	19	10663
SCNN1A-6815	+	UUCCCUGAUAGGGCCACCUU	20	10664
SCNN1A-6816	−	UGGAGAAAAUAUAGCCCAUCA	21	10665
SCNN1A-6817	−	UUGGAGAAAAUAUAGCCCAUCA	22	10666
SCNN1A-6818	−	UUUGGAGAAAAUAUAGCCCAUCA	23	10667
SCNN1A-6819	−	UUUUGGAGAAAAUAUAGCCCAUCA	24	10668
SCNN1A-6820	−	CCUGCAGUCCUGGGGCAGAGA	21	10669
SCNN1A-6821	−	CCCUGCAGUCCUGGGGCAGAGA	22	10670
SCNN1A-6822	−	GCCCUGCAGUCCUGGGGCAGAGA	23	10671
SCNN1A-6823	−	AGCCCUGCAGUCCUGGGGCAGAGA	24	10672
SCNN1A-6824	−	ACAGAAGGCAGAUAGAGA	18	10673
SCNN1A-6825	−	AACAGAAGGCAGAUAGAGA	19	10674
SCNN1A-6088	−	AAACAGAAGGCAGAUAGAGA	20	9937
SCNN1A-6826	−	GAAACAGAAGGCAGAUAGAGA	21	10675
SCNN1A-6827	−	AGAAACAGAAGGCAGAUAGAGA	22	10676
SCNN1A-6828	−	GAGAAACAGAAGGCAGAUAGAGA	23	10677
SCNN1A-6829	−	AGAGAAACAGAAGGCAGAUAGAGA	24	10678
SCNN1A-1437	−	CAUGGCCAGGGGCAGCCUCAC	21	5286
SCNN1A-1438	−	GCAUGGCCAGGGGCAGCCUCAC	22	5287
SCNN1A-1439	−	GGCAUGGCCAGGGGCAGCCUCAC	23	5288
SCNN1A-1440	−	GGGCAUGGCCAGGGGCAGCCUCAC	24	5289
SCNN1A-6830	−	AGGACCUGGCUCAAGGGAGAC	21	10679
SCNN1A-6831	−	AAGGACCUGGCUCAAGGGAGAC	22	10680
SCNN1A-6832	−	UAAGGACCUGGCUCAAGGGAGAC	23	10681
SCNN1A-6833	−	GUAAGGACCUGGCUCAAGGGAGAC	24	10682
SCNN1A-6834	−	AGGCUGGAGCUGAGGGCC	18	10683
SCNN1A-6835	−	GAGGCUGGAGCUGAGGGCC	19	10684
SCNN1A-6836	−	AGAGGCUGGAGCUGAGGGCC	20	10685
SCNN1A-6837	−	CAGAGGCUGGAGCUGAGGGCC	21	10686
SCNN1A-6838	−	CCAGAGGCUGGAGCUGAGGGCC	22	10687
SCNN1A-6839	−	GCCAGAGGCUGGAGCUGAGGGCC	23	10688
SCNN1A-6840	−	GGCCAGAGGCUGGAGCUGAGGGCC	24	10689
SCNN1A-1441	−	GGGCAGCCUCACUCGGGUUCC	21	5290
SCNN1A-1442	−	GGGGCAGCCUCACUCGGGUUCC	22	5291
SCNN1A-1443	−	AGGGGCAGCCUCACUCGGGUUCC	23	5292
SCNN1A-1444	−	CAGGGGCAGCCUCACUCGGGUUCC	24	5293
SCNN1A-6841	−	UGGGUUGUGUGGGUGGCUCUC	21	10690
SCNN1A-6842	−	CUGGGUUGUGUGGGUGGCUCUC	22	10691
SCNN1A-6843	−	CCUGGGUUGUGUGGGUGGCUCUC	23	10692
SCNN1A-6844	−	GCCUGGGUUGUGUGGGUGGCUCUC	24	10693
SCNN1A-6845	−	CUUCUCUGGGAAGGCUUC	18	10694
SCNN1A-6846	−	CCUUCUCUGGGAAGGCUUC	19	10695
SCNN1A-6847	−	ACCUUCUCUGGGAAGGCUUC	20	10696
SCNN1A-6848	−	CACCUUCUCUGGGAAGGCUUC	21	10697
SCNN1A-6849	−	ACACCUUCUCUGGGAAGGCUUC	22	10698
SCNN1A-6850	−	GACACCUUCUCUGGGAAGGCUUC	23	10699
SCNN1A-6851	−	UGACACCUUCUCUGGGAAGGCUUC	24	10700
SCNN1A-6852	−	AGGAGUGGGAGAAUGUGGGCG	21	10701
SCNN1A-6853	−	GAGGAGUGGGAGAAUGUGGGCG	22	10702
SCNN1A-6854	−	GGAGGAGUGGGAGAAUGUGGGCG	23	10703
SCNN1A-6855	−	GGGAGGAGUGGGAGAAUGUGGGCG	24	10704
SCNN1A-6856	−	GGGGGAGAGGAAGAGAGG	18	10705
SCNN1A-6857	−	GGGGGGAGAGGAAGAGAGG	19	10706
SCNN1A-6858	−	GGGGGGGAGAGGAAGAGAGG	20	10707
SCNN1A-6859	−	AGGGGGGGAGAGGAAGAGAGG	21	10708
SCNN1A-6860	−	AAGGGGGGGAGAGGAAGAGAGG	22	10709
SCNN1A-6861	−	CAAGGGGGGGAGAGGAAGAGAGG	23	10710
SCNN1A-6862	−	GCAAGGGGGGGAGAGGAAGAGAGG	24	10711
SCNN1A-6863	−	AAGGUGGAGGAGGGAGGG	18	10712
SCNN1A-6864	−	AAAGGUGGAGGAGGGAGGG	19	10713
SCNN1A-5911	−	GAAAGGUGGAGGAGGGAGGG	20	9760
SCNN1A-6865	−	GGAAAGGUGGAGGAGGGAGGG	21	10714
SCNN1A-6866	−	AGGAAAGGUGGAGGAGGGAGGG	22	10715
SCNN1A-6867	−	CAGGAAAGGUGGAGGAGGGAGGG	23	10716
SCNN1A-6868	−	CCAGGAAAGGUGGAGGAGGGAGGG	24	10717
SCNN1A-6869	−	GAAAACUGAUUUAUCCUUGGG	21	10718
SCNN1A-6870	−	AGAAAACUGAUUUAUCCUUGGG	22	10719
SCNN1A-6871	−	CAGAAAACUGAUUUAUCCUUGGG	23	10720
SCNN1A-6872	−	UCAGAAAACUGAUUUAUCCUUGGG	24	10721
SCNN1A-6873	−	GGAGGGAGGGAGGAGUGG	18	10722
SCNN1A-6874	−	AGGAGGGAGGGAGGAGUGG	19	10723
SCNN1A-6875	−	GAGGAGGGAGGGAGGAGUGG	20	10724
SCNN1A-6876	−	GGAGGAGGGAGGGAGGAGUGG	21	10725
SCNN1A-6877	−	UGGAGGAGGGAGGGAGGAGUGG	22	10726
SCNN1A-6878	−	GUGGAGGAGGGAGGGAGGAGUGG	23	10727
SCNN1A-6879	−	GGUGGAGGAGGGAGGGAGGAGUGG	24	10728
SCNN1A-6880	−	UUCCCUGCCUCUUCCUGGGCU	21	10729
SCNN1A-6881	−	UUUCCCUGCCUCUUCCUGGGCU	22	10730
SCNN1A-6882	−	CUUUCCCUGCCUCUUCCUGGGCU	23	10731
SCNN1A-6883	−	GCUUUCCCUGCCUCUUCCUGGGCU	24	10732
SCNN1A-6884	−	UUGCCCUCCUAGCUGUGGGCU	21	10733
SCNN1A-6885	−	GUUGCCCUCCUAGCUGUGGGCU	22	10734
SCNN1A-6886	−	UGUUGCCCUCCUAGCUGUGGGCU	23	10735
SCNN1A-6887	−	GUGUUGCCCUCCUAGCUGUGGGCU	24	10736
SCNN1A-6888	−	CAGAGGAGGAGGAGAAUU	18	10737
SCNN1A-6889	−	CCAGAGGAGGAGGAGAAUU	19	10738
SCNN1A-6890	−	CCCAGAGGAGGAGGAGAAUU	20	10739
SCNN1A-6891	−	CCCCAGAGGAGGAGGAGAAUU	21	10740
SCNN1A-6892	−	GCCCCAGAGGAGGAGGAGAAUU	22	10741
SCNN1A-6893	−	AGCCCCAGAGGAGGAGGAGAAUU	23	10742
SCNN1A-6894	−	UAGCCCCAGAGGAGGAGGAGAAUU	24	10743

Table 47D provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the fourth tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 47D
4th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-6895	+	UGAGGUUAGAAAACAAAA	18	10744
SCNN1A-6896	+	CUGAGGUUAGAAAACAAAA	19	10745
SCNN1A-6897	+	UCUGAGGUUAGAAAACAAAA	20	10746
SCNN1A-6898	+	UUCUGAGGUUAGAAAACAAAA	21	10747
SCNN1A-6899	+	UUUCUGAGGUUAGAAAACAAAA	22	10748
SCNN1A-6900	+	UUUUCUGAGGUUAGAAAACAAAA	23	10749
SCNN1A-6901	+	GUUUUCUGAGGUUAGAAAACAAAA	24	10750
SCNN1A-6902	+	CAGAGAAUCAGACCCAAA	18	10751
SCNN1A-6903	+	UCAGAGAAUCAGACCCAAA	19	10752
SCNN1A-6904	+	GUCAGAGAAUCAGACCCAAA	20	10753
SCNN1A-6905	+	GGUCAGAGAAUCAGACCCAAA	21	10754
SCNN1A-6906	+	GGGUCAGAGAAUCAGACCCAAA	22	10755
SCNN1A-6907	+	AGGGUCAGAGAAUCAGACCCAAA	23	10756
SCNN1A-6908	+	GAGGGUCAGAGAAUCAGACCCAAA	24	10757
SCNN1A-6909	+	GGCAGUGGUGGGGGCAAA	18	10758
SCNN1A-6910	+	GGGCAGUGGUGGGGGCAAA	19	10759
SCNN1A-6911	+	GGGGCAGUGGUGGGGGCAAA	20	10760
SCNN1A-6912	+	GGGGGCAGUGGUGGGGGCAAA	21	10761
SCNN1A-6913	+	GGGGGGCAGUGGUGGGGGCAAA	22	10762
SCNN1A-6914	+	UGGGGGGCAGUGGUGGGGGCAAA	23	10763
SCNN1A-6915	+	GUGGGGGGCAGUGGUGGGGGCAAA	24	10764
SCNN1A-6916	+	AGGACAGGAGGGCAGAAA	18	10765
SCNN1A-6917	+	GAGGACAGGAGGGCAGAAA	19	10766
SCNN1A-6918	+	GGAGGACAGGAGGGCAGAAA	20	10767
SCNN1A-6919	+	GGGAGGACAGGAGGGCAGAAA	21	10768
SCNN1A-6920	+	CGGGAGGACAGGAGGGCAGAAA	22	10769
SCNN1A-6921	+	CCGGGAGGACAGGAGGGCAGAAA	23	10770
SCNN1A-6922	+	ACCGGGAGGACAGGAGGGCAGAAA	24	10771
SCNN1A-6923	+	CUCUUGCGACUUCUUAAA	18	10772
SCNN1A-6924	+	UCUCUUGCGACUUCUUAAA	19	10773
SCNN1A-6925	+	GUCUCUUGCGACUUCUUAAA	20	10774
SCNN1A-6926	+	AGUCUCUUGCGACUUCUUAAA	21	10775
SCNN1A-6927	+	CAGUCUCUUGCGACUUCUUAAA	22	10776
SCNN1A-6928	+	GCAGUCUCUUGCGACUUCUUAAA	23	10777
SCNN1A-6929	+	GGCAGUCUCUUGCGACUUCUUAAA	24	10778
SCNN1A-6930	+	UAAAAGAUUGUCUUUAAA	18	10779
SCNN1A-6931	+	UUAAAAGAUUGUCUUUAAA	19	10780
SCNN1A-6932	+	UUUAAAAGAUUGUCUUUAAA	20	10781
SCNN1A-6933	+	CUUUAAAAGAUUGUCUUUAAA	21	10782
SCNN1A-6934	+	ACUUUAAAAGAUUGUCUUUAAA	22	10783
SCNN1A-6935	+	CACUUUAAAAGAUUGUCUUUAAA	23	10784
SCNN1A-6936	+	ACACUUUAAAAGAUUGUCUUUAAA	24	10785
SCNN1A-6937	+	GCAGAAAGAGGGAGACAA	18	10786
SCNN1A-6938	+	GGCAGAAAGAGGGAGACAA	19	10787
SCNN1A-6939	+	GGGCAGAAAGAGGGAGACAA	20	10788
SCNN1A-6940	+	AGGGCAGAAAGAGGGAGACAA	21	10789
SCNN1A-6941	+	GAGGGCAGAAAGAGGGAGACAA	22	10790
SCNN1A-6942	+	GGAGGGCAGAAAGAGGGAGACAA	23	10791
SCNN1A-6943	+	AGGAGGGCAGAAAGAGGGAGACAA	24	10792
SCNN1A-6944	+	AGAAGGAGCCAGCACCAA	18	10793
SCNN1A-6945	+	UAGAAGGAGCCAGCACCAA	19	10794
SCNN1A-5518	+	AUAGAAGGAGCCAGCACCAA	20	9367
SCNN1A-6946	+	AAUAGAAGGAGCCAGCACCAA	21	10795
SCNN1A-6947	+	AAAUAGAAGGAGCCAGCACCAA	22	10796
SCNN1A-6948	+	CAAAUAGAAGGAGCCAGCACCAA	23	10797
SCNN1A-6949	+	GCAAAUAGAAGGAGCCAGCACCAA	24	10798
SCNN1A-6950	+	GAGCUAGAGGCUCAGCAA	18	10799
SCNN1A-6951	+	GGAGCUAGAGGCUCAGCAA	19	10800
SCNN1A-6952	+	AGGAGCUAGAGGCUCAGCAA	20	10801
SCNN1A-6953	+	CAGGAGCUAGAGGCUCAGCAA	21	10802
SCNN1A-6954	+	CCAGGAGCUAGAGGCUCAGCAA	22	10803
SCNN1A-6955	+	UCCAGGAGCUAGAGGCUCAGCAA	23	10804
SCNN1A-6956	+	UUCCAGGAGCUAGAGGCUCAGCAA	24	10805
SCNN1A-6957	+	CUCCAGGAAGGAGAGCAA	18	10806
SCNN1A-6958	+	UCUCCAGGAAGGAGAGCAA	19	10807
SCNN1A-5168	+	GUCUCCAGGAAGGAGAGCAA	20	9017
SCNN1A-6959	+	UGUCUCCAGGAAGGAGAGCAA	21	10808
SCNN1A-6960	+	CUGUCUCCAGGAAGGAGAGCAA	22	10809
SCNN1A-6961	+	UCUGUCUCCAGGAAGGAGAGCAA	23	10810
SCNN1A-6962	+	GUCUGUCUCCAGGAAGGAGAGCAA	24	10811
SCNN1A-6963	+	AGUUUAGCAGGCAAAGAA	18	10812
SCNN1A-6964	+	GAGUUUAGCAGGCAAAGAA	19	10813
SCNN1A-6965	+	GGAGUUUAGCAGGCAAAGAA	20	10814
SCNN1A-6966	+	AGGAGUUUAGCAGGCAAAGAA	21	10815
SCNN1A-6967	+	AAGGAGUUUAGCAGGCAAAGAA	22	10816
SCNN1A-6968	+	CAAGGAGUUUAGCAGGCAAAGAA	23	10817
SCNN1A-6969	+	GCAAGGAGUUUAGCAGGCAAAGAA	24	10818
SCNN1A-6970	+	CUCAGGCCCUGCAGAGAA	18	10819
SCNN1A-6971	+	CCUCAGGCCCUGCAGAGAA	19	10820
SCNN1A-6972	+	CCCUCAGGCCCUGCAGAGAA	20	10821
SCNN1A-6973	+	ACCCUCAGGCCCUGCAGAGAA	21	10822
SCNN1A-6974	+	CACCCUCAGGCCCUGCAGAGAA	22	10823
SCNN1A-6975	+	UCACCCUCAGGCCCUGCAGAGAA	23	10824
SCNN1A-6976	+	CUCACCCUCAGGCCCUGCAGAGAA	24	10825
SCNN1A-6977	+	GAGGGCCUGGGUGGGGAA	18	10826
SCNN1A-6978	+	AGAGGGCCUGGGUGGGGAA	19	10827
SCNN1A-6979	+	GAGAGGGCCUGGGUGGGGAA	20	10828
SCNN1A-6980	+	UGAGAGGGCCUGGGUGGGGAA	21	10829
SCNN1A-6981	+	CUGAGAGGGCCUGGGUGGGGAA	22	10830
SCNN1A-6982	+	GCUGAGAGGGCCUGGGUGGGGAA	23	10831
SCNN1A-6983	+	GGCUGAGAGGGCCUGGGUGGGGAA	24	10832
SCNN1A-6984	+	AUGUGGCCAGCGCUGGAA	18	10833
SCNN1A-6985	+	GAUGUGGCCAGCGCUGGAA	19	10834
SCNN1A-5174	+	GGAUGUGGCCAGCGCUGGAA	20	9023
SCNN1A-6986	+	AGGAUGUGGCCAGCGCUGGAA	21	10835
SCNN1A-6987	+	GAGGAUGUGGCCAGCGCUGGAA	22	10836
SCNN1A-6988	+	GGAGGAUGUGGCCAGCGCUGGAA	23	10837
SCNN1A-6989	+	GGGAGGAUGUGGCCAGCGCUGGAA	24	10838
SCNN1A-6990	+	CUCCCGAGGGCAGGUGAA	18	10839
SCNN1A-6991	+	GCUCCCGAGGGCAGGUGAA	19	10840
SCNN1A-6992	+	GGCUCCCGAGGGCAGGUGAA	20	10841
SCNN1A-6993	+	GGGCUCCCGAGGGCAGGUGAA	21	10842
SCNN1A-6994	+	AGGGCUCCCGAGGGCAGGUGAA	22	10843
SCNN1A-6995	+	GAGGGCUCCCGAGGGCAGGUGAA	23	10844
SCNN1A-6996	+	GGAGGGCUCCCGAGGGCAGGUGAA	24	10845
SCNN1A-6997	+	CUCCUCCCCGCUCACUAA	18	10846
SCNN1A-6998	+	UCUCCUCCCCGCUCACUAA	19	10847
SCNN1A-6999	+	GUCUCCUCCCCGCUCACUAA	20	10848
SCNN1A-7000	+	GGUCUCCUCCCCGCUCACUAA	21	10849
SCNN1A-7001	+	AGGUCUCCUCCCCGCUCACUAA	22	10850
SCNN1A-7002	+	CAGGUCUCCUCCCCGCUCACUAA	23	10851
SCNN1A-7003	+	GCAGGUCUCCUCCCCGCUCACUAA	24	10852
SCNN1A-7004	+	AGCUAGGAGGGCAACACA	18	10853
SCNN1A-7005	+	CAGCUAGGAGGGCAACACA	19	10854
SCNN1A-5527	+	ACAGCUAGGAGGGCAACACA	20	9376
SCNN1A-7006	+	CACAGCUAGGAGGGCAACACA	21	10855
SCNN1A-7007	+	CCACAGCUAGGAGGGCAACACA	22	10856
SCNN1A-7008	+	CCCACAGCUAGGAGGGCAACACA	23	10857
SCNN1A-7009	+	GCCCACAGCUAGGAGGGCAACACA	24	10858
SCNN1A-7010	+	CCUGAGCAUUGAUACACA	18	10859
SCNN1A-7011	+	GCCUGAGCAUUGAUACACA	19	10860
SCNN1A-7012	+	AGCCUGAGCAUUGAUACACA	20	10861
SCNN1A-7013	+	CAGCCUGAGCAUUGAUACACA	21	10862
SCNN1A-7014	+	CCAGCCUGAGCAUUGAUACACA	22	10863
SCNN1A-7015	+	CCCAGCCUGAGCAUUGAUACACA	23	10864
SCNN1A-7016	+	GCCCAGCCUGAGCAUUGAUACACA	24	10865
SCNN1A-7017	+	GCCUCCCUCACUCCCACA	18	10866
SCNN1A-7018	+	GGCCUCCCUCACUCCCACA	19	10867
SCNN1A-7019	+	AGGCCUCCCUCACUCCCACA	20	10868
SCNN1A-7020	+	AAGGCCUCCCUCACUCCCACA	21	10869
SCNN1A-7021	+	GAAGGCCUCCCUCACUCCCACA	22	10870
SCNN1A-7022	+	GGAAGGCCUCCCUCACUCCCACA	23	10871
SCNN1A-7023	+	GGGAAGGCCUCCCUCACUCCCACA	24	10872
SCNN1A-7024	+	GAGGGACAGCGAAGGACA	18	10873
SCNN1A-7025	+	AGAGGGACAGCGAAGGACA	19	10874
SCNN1A-7026	+	GAGAGGGACAGCGAAGGACA	20	10875
SCNN1A-7027	+	AGAGAGGGACAGCGAAGGACA	21	10876
SCNN1A-7028	+	UAGAGAGGGACAGCGAAGGACA	22	10877
SCNN1A-7029	+	AUAGAGAGGGACAGCGAAGGACA	23	10878
SCNN1A-7030	+	AAUAGAGAGGGACAGCGAAGGACA	24	10879
SCNN1A-7031	+	AGACAAUAGAGAGGGACA	18	10880
SCNN1A-7032	+	GAGACAAUAGAGAGGGACA	19	10881
SCNN1A-7033	+	GGAGACAAUAGAGAGGGACA	20	10882
SCNN1A-7034	+	GGGAGACAAUAGAGAGGGACA	21	10883
SCNN1A-7035	+	AGGGAGACAAUAGAGAGGGACA	22	10884
SCNN1A-7036	+	GAGGGAGACAAUAGAGAGGGACA	23	10885
SCNN1A-7037	+	AGAGGGAGACAAUAGAGAGGGACA	24	10886
SCNN1A-7038	+	UUGAGCCAGGUCCUUACA	18	10887
SCNN1A-7039	+	CUUGAGCCAGGUCCUUACA	19	10888
SCNN1A-7040	+	CCUUGAGCCAGGUCCUUACA	20	10889
SCNN1A-7041	+	CCCUUGAGCCAGGUCCUUACA	21	10890
SCNN1A-7042	+	UCCCUUGAGCCAGGUCCUUACA	22	10891
SCNN1A-7043	+	CUCCCUUGAGCCAGGUCCUUACA	23	10892
SCNN1A-7044	+	UCUCCCUUGAGCCAGGUCCUUACA	24	10893
SCNN1A-7045	+	UAGAAGGAGCCAGCACCA	18	10894
SCNN1A-7046	+	AUAGAAGGAGCCAGCACCA	19	10895
SCNN1A-7047	+	AAUAGAAGGAGCCAGCACCA	20	10896
SCNN1A-7048	+	AAAUAGAAGGAGCCAGCACCA	21	10897
SCNN1A-7049	+	CAAAUAGAAGGAGCCAGCACCA	22	10898
SCNN1A-7050	+	GCAAAUAGAAGGAGCCAGCACCA	23	10899
SCNN1A-7051	+	GGCAAAUAGAAGGAGCCAGCACCA	24	10900
SCNN1A-7052	+	GCUUCCUCACGGGCCCCA	18	10901
SCNN1A-7053	+	CGCUUCCUCACGGGCCCCA	19	10902
SCNN1A-7054	+	CCGCUUCCUCACGGGCCCCA	20	10903
SCNN1A-7055	+	GCCGCUUCCUCACGGGCCCCA	21	10904
SCNN1A-7056	+	UGCCGCUUCCUCACGGGCCCCA	22	10905
SCNN1A-7057	+	CUGCCGCUUCCUCACGGGCCCCA	23	10906
SCNN1A-7058	+	GCUGCCGCUUCCUCACGGGCCCCA	24	10907
SCNN1A-7059	+	ACUCAGGAAGCCUUCCCA	18	10908
SCNN1A-7060	+	GACUCAGGAAGCCUUCCCA	19	10909
SCNN1A-7061	+	AGACUCAGGAAGCCUUCCCA	20	10910
SCNN1A-7062	+	GAGACUCAGGAAGCCUUCCCA	21	10911
SCNN1A-7063	+	GGAGACUCAGGAAGCCUUCCCA	22	10912
SCNN1A-7064	+	AGGAGACUCAGGAAGCCUUCCCA	23	10913
SCNN1A-7065	+	CAGGAGACUCAGGAAGCCUUCCCA	24	10914
SCNN1A-7066	+	UCUCCAGGAAGGAGAGCA	18	10915
SCNN1A-7067	+	GUCUCCAGGAAGGAGAGCA	19	10916
SCNN1A-5533	+	UGUCUCCAGGAAGGAGAGCA	20	9382
SCNN1A-7068	+	CUGUCUCCAGGAAGGAGAGCA	21	10917
SCNN1A-7069	+	UCUGUCUCCAGGAAGGAGAGCA	22	10918
SCNN1A-7070	+	GUCUGUCUCCAGGAAGGAGAGCA	23	10919
SCNN1A-7071	+	AGUCUGUCUCCAGGAAGGAGAGCA	24	10920
SCNN1A-7072	+	AGUGCCAAGUGGUGAGCA	18	10921
SCNN1A-7073	+	GAGUGCCAAGUGGUGAGCA	19	10922
SCNN1A-5179	+	GGAGUGCCAAGUGGUGAGCA	20	9028
SCNN1A-7074	+	UGGAGUGCCAAGUGGUGAGCA	21	10923
SCNN1A-7075	+	GUGGAGUGCCAAGUGGUGAGCA	22	10924
SCNN1A-7076	+	AGUGGAGUGCCAAGUGGUGAGCA	23	10925
SCNN1A-7077	+	GAGUGGAGUGCCAAGUGGUGAGCA	24	10926
SCNN1A-7078	+	UUUAGACGCAGACAGGCA	18	10927
SCNN1A-7079	+	CUUUAGACGCAGACAGGCA	19	10928
SCNN1A-5181	+	GCUUUAGACGCAGACAGGCA	20	9030
SCNN1A-7080	+	GGCUUUAGACGCAGACAGGCA	21	10929
SCNN1A-7081	+	GGGCUUUAGACGCAGACAGGCA	22	10930
SCNN1A-7082	+	GGGGCUUUAGACGCAGACAGGCA	23	10931
SCNN1A-7083	+	AGGGGCUUUAGACGCAGACAGGCA	24	10932
SCNN1A-7084	+	AGGCAGGGAAAGCAGGCA	18	10933
SCNN1A-7085	+	GAGGCAGGGAAAGCAGGCA	19	10934
SCNN1A-7086	+	AGAGGCAGGGAAAGCAGGCA	20	10935
SCNN1A-7087	+	AAGAGGCAGGGAAAGCAGGCA	21	10936
SCNN1A-7088	+	GAAGAGGCAGGGAAAGCAGGCA	22	10937
SCNN1A-7089	+	GGAAGAGGCAGGGAAAGCAGGCA	23	10938
SCNN1A-7090	+	AGGAAGAGGCAGGGAAAGCAGGCA	24	10939
SCNN1A-7091	+	CAAGGAGUUUAGCAGGCA	18	10940
SCNN1A-7092	+	GCAAGGAGUUUAGCAGGCA	19	10941
SCNN1A-7093	+	AGCAAGGAGUUUAGCAGGCA	20	10942
SCNN1A-7094	+	AAGCAAGGAGUUUAGCAGGCA	21	10943
SCNN1A-7095	+	CAAGCAAGGAGUUUAGCAGGCA	22	10944
SCNN1A-7096	+	ACAAGCAAGGAGUUUAGCAGGCA	23	10945
SCNN1A-7097	+	GACAAGCAAGGAGUUUAGCAGGCA	24	10946
SCNN1A-7098	+	GGAGCCCAGGAAGAGGCA	18	10947
SCNN1A-7099	+	CGGAGCCCAGGAAGAGGCA	19	10948
SCNN1A-5535	+	CCGGAGCCCAGGAAGAGGCA	20	9384
SCNN1A-7100	+	CCCGGAGCCCAGGAAGAGGCA	21	10949
SCNN1A-7101	+	ACCCGGAGCCCAGGAAGAGGCA	22	10950
SCNN1A-7102	+	GACCCGGAGCCCAGGAAGAGGCA	23	10951
SCNN1A-7103	+	AGACCCGGAGCCCAGGAAGAGGCA	24	10952
SCNN1A-7104	+	CAGGCCCUGCACGCGGCA	18	10953
SCNN1A-7105	+	CCAGGCCCUGCACGCGGCA	19	10954
SCNN1A-5536	+	CCCAGGCCCUGCACGCGGCA	20	9385
SCNN1A-7106	+	ACCCAGGCCCUGCACGCGGCA	21	10955
SCNN1A-7107	+	AACCCAGGCCCUGCACGCGGCA	22	10956
SCNN1A-7108	+	CAACCCAGGCCCUGCACGCGGCA	23	10957
SCNN1A-7109	+	ACAACCCAGGCCCUGCACGCGGCA	24	10958
SCNN1A-7110	+	UCACCCUCAGGCCCUGCA	18	10959
SCNN1A-7111	+	CUCACCCUCAGGCCCUGCA	19	10960
SCNN1A-7112	+	CCUCACCCUCAGGCCCUGCA	20	10961
SCNN1A-7113	+	GCCUCACCCUCAGGCCCUGCA	21	10962
SCNN1A-7114	+	AGCCUCACCCUCAGGCCCUGCA	22	10963
SCNN1A-7115	+	CAGCCUCACCCUCAGGCCCUGCA	23	10964
SCNN1A-7116	+	UCAGCCUCACCCUCAGGCCCUGCA	24	10965
SCNN1A-7117	+	GCAGGCACUGAAGGUGCA	18	10966
SCNN1A-7118	+	AGCAGGCACUGAAGGUGCA	19	10967
SCNN1A-5539	+	AAGCAGGCACUGAAGGUGCA	20	9388
SCNN1A-7119	+	AAAGCAGGCACUGAAGGUGCA	21	10968
SCNN1A-7120	+	GAAAGCAGGCACUGAAGGUGCA	22	10969
SCNN1A-7121	+	GGAAAGCAGGCACUGAAGGUGCA	23	10970
SCNN1A-7122	+	GGGAAAGCAGGCACUGAAGGUGCA	24	10971
SCNN1A-7123	+	CUUCCUGAGACAGACUCA	18	10972
SCNN1A-7124	+	ACUUCCUGAGACAGACUCA	19	10973
SCNN1A-6083	+	UACUUCCUGAGACAGACUCA	20	9932
SCNN1A-7125	+	UUACUUCCUGAGACAGACUCA	21	10974
SCNN1A-7126	+	UUUACUUCCUGAGACAGACUCA	22	10975
SCNN1A-7127	+	AUUUACUUCCUGAGACAGACUCA	23	10976
SCNN1A-7128	+	CAUUUACUUCCUGAGACAGACUCA	24	10977
SCNN1A-7129	+	GACAGGAGGGCAGAAAGA	18	10978
SCNN1A-7130	+	GGACAGGAGGGCAGAAAGA	19	10979
SCNN1A-6085	+	AGGACAGGAGGGCAGAAAGA	20	9934
SCNN1A-7131	+	GAGGACAGGAGGGCAGAAAGA	21	10980
SCNN1A-7132	+	GGAGGACAGGAGGGCAGAAAGA	22	10981
SCNN1A-7133	+	GGGAGGACAGGAGGGCAGAAAGA	23	10982
SCNN1A-7134	+	CGGGAGGACAGGAGGGCAGAAAGA	24	10983
SCNN1A-7135	+	CAGGCCCUGCAGAGAAGA	18	10984
SCNN1A-7136	+	UCAGGCCCUGCAGAGAAGA	19	10985
SCNN1A-7137	+	CUCAGGCCCUGCAGAGAAGA	20	10986
SCNN1A-7138	+	CCUCAGGCCCUGCAGAGAAGA	21	10987
SCNN1A-7139	+	CCCUCAGGCCCUGCAGAGAAGA	22	10988
SCNN1A-7140	+	ACCCUCAGGCCCUGCAGAGAAGA	23	10989
SCNN1A-7141	+	CACCCUCAGGCCCUGCAGAGAAGA	24	10990
SCNN1A-7142	+	GGAGGACAGGAGGGCAGA	18	10991
SCNN1A-7143	+	GGGAGGACAGGAGGGCAGA	19	10992
SCNN1A-7144	+	CGGGAGGACAGGAGGGCAGA	20	10993
SCNN1A-7145	+	CCGGGAGGACAGGAGGGCAGA	21	10994
SCNN1A-7146	+	ACCGGGAGGACAGGAGGGCAGA	22	10995
SCNN1A-7147	+	AACCGGGAGGACAGGAGGGCAGA	23	10996
SCNN1A-7148	+	GAACCGGGAGGACAGGAGGGCAGA	24	10997
SCNN1A-7149	+	CAGCGAAGGACAGAGAGA	18	10998
SCNN1A-7150	+	ACAGCGAAGGACAGAGAGA	19	10999
SCNN1A-7151	+	GACAGCGAAGGACAGAGAGA	20	11000
SCNN1A-7152	+	GGACAGCGAAGGACAGAGAGA	21	11001
SCNN1A-7153	+	GGGACAGCGAAGGACAGAGAGA	22	11002
SCNN1A-7154	+	AGGGACAGCGAAGGACAGAGAGA	23	11003
SCNN1A-7155	+	GAGGGACAGCGAAGGACAGAGAGA	24	11004
SCNN1A-7156	+	GUGGUGAGCAAGGAGAGA	18	11005
SCNN1A-7157	+	AGUGGUGAGCAAGGAGAGA	19	11006
SCNN1A-7158	+	AAGUGGUGAGCAAGGAGAGA	20	11007
SCNN1A-7159	+	CAAGUGGUGAGCAAGGAGAGA	21	11008
SCNN1A-7160	+	CCAAGUGGUGAGCAAGGAGAGA	22	11009
SCNN1A-7161	+	GCCAAGUGGUGAGCAAGGAGAGA	23	11010
SCNN1A-7162	+	UGCCAAGUGGUGAGCAAGGAGAGA	24	11011
SCNN1A-7163	+	GAGGGCAACACAAGGAGA	18	11012
SCNN1A-7164	+	GGAGGGCAACACAAGGAGA	19	11013
SCNN1A-6089	+	AGGAGGGCAACACAAGGAGA	20	9938
SCNN1A-7165	+	UAGGAGGGCAACACAAGGAGA	21	11014
SCNN1A-7166	+	CUAGGAGGGCAACACAAGGAGA	22	11015
SCNN1A-7167	+	GCUAGGAGGGCAACACAAGGAGA	23	11016
SCNN1A-7168	+	AGCUAGGAGGGCAACACAAGGAGA	24	11017
SCNN1A-7169	+	AAGUGGUGAGCAAGGAGA	18	11018
SCNN1A-7170	+	CAAGUGGUGAGCAAGGAGA	19	11019
SCNN1A-7171	+	CCAAGUGGUGAGCAAGGAGA	20	11020
SCNN1A-7172	+	GCCAAGUGGUGAGCAAGGAGA	21	11021
SCNN1A-7173	+	UGCCAAGUGGUGAGCAAGGAGA	22	11022
SCNN1A-7174	+	GUGCCAAGUGGUGAGCAAGGAGA	23	11023
SCNN1A-7175	+	AGUGCCAAGUGGUGAGCAAGGAGA	24	11024
SCNN1A-7176	+	GUGGUGGGGGCAAAUAGA	18	11025
SCNN1A-7177	+	AGUGGUGGGGGCAAAUAGA	19	11026
SCNN1A-6091	+	CAGUGGUGGGGGCAAAUAGA	20	9940
SCNN1A-7178	+	GCAGUGGUGGGGGCAAAUAGA	21	11027
SCNN1A-7179	+	GGCAGUGGUGGGGGCAAAUAGA	22	11028
SCNN1A-7180	+	GGGCAGUGGUGGGGGCAAAUAGA	23	11029
SCNN1A-7181	+	GGGGCAGUGGUGGGGGCAAAUAGA	24	11030
SCNN1A-7182	+	AAAGAGGGAGACAAUAGA	18	11031
SCNN1A-7183	+	GAAAGAGGGAGACAAUAGA	19	11032
SCNN1A-7184	+	AGAAAGAGGGAGACAAUAGA	20	11033
SCNN1A-7185	+	CAGAAAGAGGGAGACAAUAGA	21	11034
SCNN1A-7186	+	GCAGAAAGAGGGAGACAAUAGA	22	11035
SCNN1A-7187	+	GGCAGAAAGAGGGAGACAAUAGA	23	11036
SCNN1A-7188	+	GGGCAGAAAGAGGGAGACAAUAGA	24	11037
SCNN1A-1445	+	AUCACCCCUGGAACCCGA	18	5294
SCNN1A-1446	+	CAUCACCCCUGGAACCCGA	19	5295
SCNN1A-1447	+	CCAUCACCCCUGGAACCCGA	20	5296
SCNN1A-1448	+	CCCAUCACCCCUGGAACCCGA	21	5297
SCNN1A-1449	+	UCCCAUCACCCCUGGAACCCGA	22	5298
SCNN1A-1450	+	CUCCCAUCACCCCUGGAACCCGA	23	5299
SCNN1A-1451	+	UCUCCCAUCACCCCUGGAACCCGA	24	5300
SCNN1A-7189	+	GAGCCGGGAGUUUUCCGA	18	11038
SCNN1A-7190	+	AGAGCCGGGAGUUUUCCGA	19	11039
SCNN1A-5544	+	CAGAGCCGGGAGUUUUCCGA	20	9393
SCNN1A-7191	+	UCAGAGCCGGGAGUUUUCCGA	21	11040
SCNN1A-7192	+	GUCAGAGCCGGGAGUUUUCCGA	22	11041
SCNN1A-7193	+	AGUCAGAGCCGGGAGUUUUCCGA	23	11042
SCNN1A-7194	+	GAGUCAGAGCCGGGAGUUUUCCGA	24	11043
SCNN1A-7195	+	GGCCAGGGAUGGAAGCGA	18	11044
SCNN1A-7196	+	CGGCCAGGGAUGGAAGCGA	19	11045
SCNN1A-7197	+	CCGGCCAGGGAUGGAAGCGA	20	11046
SCNN1A-7198	+	GCCGGCCAGGGAUGGAAGCGA	21	11047
SCNN1A-7199	+	GGCCGGCCAGGGAUGGAAGCGA	22	11048
SCNN1A-7200	+	UGGCCGGCCAGGGAUGGAAGCGA	23	11049
SCNN1A-7201	+	CUGGCCGGCCAGGGAUGGAAGCGA	24	11050
SCNN1A-7202	+	CCAAGUGGUGAGCAAGGA	18	11051
SCNN1A-7203	+	GCCAAGUGGUGAGCAAGGA	19	11052
SCNN1A-7204	+	UGCCAAGUGGUGAGCAAGGA	20	11053
SCNN1A-7205	+	GUGCCAAGUGGUGAGCAAGGA	21	11054
SCNN1A-7206	+	AGUGCCAAGUGGUGAGCAAGGA	22	11055
SCNN1A-7207	+	GAGUGCCAAGUGGUGAGCAAGGA	23	11056
SCNN1A-7208	+	GGAGUGCCAAGUGGUGAGCAAGGA	24	11057
SCNN1A-7209	+	CGGGAGUUUUCCGAAGGA	18	11058
SCNN1A-7210	+	CCGGGAGUUUUCCGAAGGA	19	11059
SCNN1A-5190	+	GCCGGGAGUUUUCCGAAGGA	20	9039
SCNN1A-7211	+	AGCCGGGAGUUUUCCGAAGGA	21	11060
SCNN1A-7212	+	GAGCCGGGAGUUUUCCGAAGGA	22	11061
SCNN1A-7213	+	AGAGCCGGGAGUUUUCCGAAGGA	23	11062
SCNN1A-7214	+	CAGAGCCGGGAGUUUUCCGAAGGA	24	11063
SCNN1A-7215	+	GAGAGGGACAGCGAAGGA	18	11064
SCNN1A-7216	+	AGAGAGGGACAGCGAAGGA	19	11065
SCNN1A-7217	+	UAGAGAGGGACAGCGAAGGA	20	11066
SCNN1A-7218	+	AUAGAGAGGGACAGCGAAGGA	21	11067
SCNN1A-7219	+	AAUAGAGAGGGACAGCGAAGGA	22	11068
SCNN1A-7220	+	CAAUAGAGAGGGACAGCGAAGGA	23	11069
SCNN1A-7221	+	ACAAUAGAGAGGGACAGCGAAGGA	24	11070
SCNN1A-7222	+	GCAGCAAAAGGAUAAGGA	18	11071
SCNN1A-7223	+	UGCAGCAAAAGGAUAAGGA	19	11072
SCNN1A-7224	+	AUGCAGCAAAAGGAUAAGGA	20	11073
SCNN1A-7225	+	AAUGCAGCAAAAGGAUAAGGA	21	11074
SCNN1A-7226	+	UAAUGCAGCAAAAGGAUAAGGA	22	11075
SCNN1A-7227	+	UUAAUGCAGCAAAAGGAUAAGGA	23	11076
SCNN1A-7228	+	CUUAAUGCAGCAAAAGGAUAAGGA	24	11077
SCNN1A-7229	+	GGGAGUCUGUCUCCAGGA	18	11078
SCNN1A-7230	+	AGGGAGUCUGUCUCCAGGA	19	11079
SCNN1A-5546	+	AAGGGAGUCUGUCUCCAGGA	20	9395
SCNN1A-7231	+	AAAGGGAGUCUGUCUCCAGGA	21	11080
SCNN1A-7232	+	CAAAGGGAGUCUGUCUCCAGGA	22	11081
SCNN1A-7233	+	CCAAAGGGAGUCUGUCUCCAGGA	23	11082
SCNN1A-7234	+	ACCAAAGGGAGUCUGUCUCCAGGA	24	11083
SCNN1A-7235	+	GGUGGGGAACCGGGAGGA	18	11084
SCNN1A-7236	+	GGGUGGGGAACCGGGAGGA	19	11085
SCNN1A-7237	+	UGGGUGGGGAACCGGGAGGA	20	11086
SCNN1A-7238	+	CUGGGUGGGGAACCGGGAGGA	21	11087
SCNN1A-7239	+	CCUGGGUGGGGAACCGGGAGGA	22	11088
SCNN1A-7240	+	GCCUGGGUGGGGAACCGGGAGGA	23	11089
SCNN1A-7241	+	GGCCUGGGUGGGGAACCGGGAGGA	24	11090
SCNN1A-7242	+	CCGCUGGCCGGCCAGGGA	18	11091
SCNN1A-7243	+	CCCGCUGGCCGGCCAGGGA	19	11092
SCNN1A-5192	+	GCCCGCUGGCCGGCCAGGGA	20	9041
SCNN1A-7244	+	CGCCCGCUGGCCGGCCAGGGA	21	11093
SCNN1A-7245	+	CCGCCCGCUGGCCGGCCAGGGA	22	11094
SCNN1A-7246	+	CCCGCCCGCUGGCCGGCCAGGGA	23	11095
SCNN1A-7247	+	GCCCGCCCGCUGGCCGGCCAGGGA	24	11096
SCNN1A-7248	+	AGGACAGAGAGAUAGGGA	18	11097
SCNN1A-7249	+	AAGGACAGAGAGAUAGGGA	19	11098
SCNN1A-5878	+	GAAGGACAGAGAGAUAGGGA	20	9727
SCNN1A-7250	+	CGAAGGACAGAGAGAUAGGGA	21	11099
SCNN1A-7251	+	GCGAAGGACAGAGAGAUAGGGA	22	11100
SCNN1A-7252	+	AGCGAAGGACAGAGAGAUAGGGA	23	11101
SCNN1A-7253	+	CAGCGAAGGACAGAGAGAUAGGGA	24	11102
SCNN1A-7254	+	AGACAGACUCAUGGGGGA	18	11103
SCNN1A-7255	+	GAGACAGACUCAUGGGGGA	19	11104
SCNN1A-7256	+	UGAGACAGACUCAUGGGGGA	20	11105
SCNN1A-7257	+	CUGAGACAGACUCAUGGGGGA	21	11106
SCNN1A-7258	+	CCUGAGACAGACUCAUGGGGGA	22	11107
SCNN1A-7259	+	UCCUGAGACAGACUCAUGGGGGA	23	11108
SCNN1A-7260	+	UUCCUGAGACAGACUCAUGGGGGA	24	11109
SCNN1A-7261	+	GAUGUGGCCAGCGCUGGA	18	11110
SCNN1A-7262	+	GGAUGUGGCCAGCGCUGGA	19	11111
SCNN1A-7263	+	AGGAUGUGGCCAGCGCUGGA	20	11112
SCNN1A-7264	+	GAGGAUGUGGCCAGCGCUGGA	21	11113
SCNN1A-7265	+	GGAGGAUGUGGCCAGCGCUGGA	22	11114
SCNN1A-7266	+	GGGAGGAUGUGGCCAGCGCUGGA	23	11115
SCNN1A-7267	+	AGGGAGGAUGUGGCCAGCGCUGGA	24	11116
SCNN1A-7268	+	UCCCAGGUUGCGGCUGGA	18	11117
SCNN1A-7269	+	CUCCCAGGUUGCGGCUGGA	19	11118
SCNN1A-7270	+	ACUCCCAGGUUGCGGCUGGA	20	11119
SCNN1A-7271	+	CACUCCCAGGUUGCGGCUGGA	21	11120
SCNN1A-7272	+	CCACUCCCAGGUUGCGGCUGGA	22	11121
SCNN1A-7273	+	CCCACUCCCAGGUUGCGGCUGGA	23	11122
SCNN1A-7274	+	UCCCACUCCCAGGUUGCGGCUGGA	24	11123
SCNN1A-1465	+	CAUGAGCCCCGGAGUGGA	18	5314
SCNN1A-1466	+	UCAUGAGCCCCGGAGUGGA	19	5315
SCNN1A-1467	+	UUCAUGAGCCCCGGAGUGGA	20	5316
SCNN1A-1468	+	CUUCAUGAGCCCCGGAGUGGA	21	5317
SCNN1A-1469	+	CCUUCAUGAGCCCCGGAGUGGA	22	5318
SCNN1A-1470	+	CCCUUCAUGAGCCCCGGAGUGGA	23	5319
SCNN1A-1471	+	CCCCUUCAUGAGCCCCGGAGUGGA	24	5320
SCNN1A-1472	+	AUGAUACCUCCCCUUGGA	18	5321
SCNN1A-1473	+	CAUGAUACCUCCCCUUGGA	19	5322
SCNN1A-399	+	UCAUGAUACCUCCCCUUGGA	20	4248
SCNN1A-1474	+	CUCAUGAUACCUCCCCUUGGA	21	5323
SCNN1A-1475	+	GCUCAUGAUACCUCCCCUUGGA	22	5324
SCNN1A-1476	+	UGCUCAUGAUACCUCCCCUUGGA	23	5325
SCNN1A-1477	+	CUGCUCAUGAUACCUCCCCUUGGA	24	5326
SCNN1A-7275	+	UCUCCUCUGCUUCCCUGA	18	11124
SCNN1A-7276	+	CUCUCCUCUGCUUCCCUGA	19	11125
SCNN1A-7277	+	CCUCUCCUCUGCUUCCCUGA	20	11126
SCNN1A-7278	+	GCCUCUCCUCUGCUUCCCUGA	21	11127
SCNN1A-7279	+	GGCCUCUCCUCUGCUUCCCUGA	22	11128
SCNN1A-7280	+	CGGCCUCUCCUCUGCUUCCCUGA	23	11129
SCNN1A-7281	+	ACGGCCUCUCCUCUGCUUCCCUGA	24	11130
SCNN1A-7282	+	AGGGGCCAGCCAGGCUGA	18	11131
SCNN1A-7283	+	AAGGGGCCAGCCAGGCUGA	19	11132
SCNN1A-7284	+	GAAGGGGCCAGCCAGGCUGA	20	11133
SCNN1A-7285	+	AGAAGGGGCCAGCCAGGCUGA	21	11134
SCNN1A-7286	+	GAGAAGGGGCCAGCCAGGCUGA	22	11135
SCNN1A-7287	+	GGAGAAGGGGCCAGCCAGGCUGA	23	11136
SCNN1A-7288	+	AGGAGAAGGGGCCAGCCAGGCUGA	24	11137
SCNN1A-7289	+	AGAAAGAGGGAGACAAUA	18	11138
SCNN1A-7290	+	CAGAAAGAGGGAGACAAUA	19	11139
SCNN1A-7291	+	GCAGAAAGAGGGAGACAAUA	20	11140
SCNN1A-7292	+	GGCAGAAAGAGGGAGACAAUA	21	11141
SCNN1A-7293	+	GGGCAGAAAGAGGGAGACAAUA	22	11142
SCNN1A-7294	+	AGGGCAGAAAGAGGGAGACAAUA	23	11143
SCNN1A-7295	+	GAGGGCAGAAAGAGGGAGACAAUA	24	11144
SCNN1A-7296	+	UUUUUCUUCAUUGUCCUA	18	11145
SCNN1A-7297	+	AUUUUUCUUCAUUGUCCUA	19	11146
SCNN1A-7298	+	GAUUUUUCUUCAUUGUCCUA	20	11147
SCNN1A-7299	+	GGAUUUUUCUUCAUUGUCCUA	21	11148
SCNN1A-7300	+	UGGAUUUUUCUUCAUUGUCCUA	22	11149
SCNN1A-7301	+	CUGGAUUUUUCUUCAUUGUCCUA	23	11150
SCNN1A-7302	+	GCUGGAUUUUUCUUCAUUGUCCUA	24	11151
SCNN1A-7303	+	CAUAAGAGCCAAGGGCUA	18	11152
SCNN1A-7304	+	ACAUAAGAGCCAAGGGCUA	19	11153
SCNN1A-5198	+	GACAUAAGAGCCAAGGGCUA	20	9047
SCNN1A-7305	+	AGACAUAAGAGCCAAGGGCUA	21	11154
SCNN1A-7306	+	AAGACAUAAGAGCCAAGGGCUA	22	11155
SCNN1A-7307	+	UAAGACAUAAGAGCCAAGGGCUA	23	11156
SCNN1A-7308	+	AUAAGACAUAAGAGCCAAGGGCUA	24	11157
SCNN1A-7309	+	GCAGGUGAACUGGGAGUA	18	11158
SCNN1A-7310	+	GGCAGGUGAACUGGGAGUA	19	11159
SCNN1A-7311	+	GGGCAGGUGAACUGGGAGUA	20	11160
SCNN1A-7312	+	AGGGCAGGUGAACUGGGAGUA	21	11161
SCNN1A-7313	+	GAGGGCAGGUGAACUGGGAGUA	22	11162
SCNN1A-7314	+	CGAGGGCAGGUGAACUGGGAGUA	23	11163
SCNN1A-7315	+	CCGAGGGCAGGUGAACUGGGAGUA	24	11164
SCNN1A-7316	+	UGCAGGAAUGUGGGCAAC	18	11165
SCNN1A-7317	+	UUGCAGGAAUGUGGGCAAC	19	11166
SCNN1A-7318	+	GUUGCAGGAAUGUGGGCAAC	20	11167
SCNN1A-7319	+	AGUUGCAGGAAUGUGGGCAAC	21	11168
SCNN1A-7320	+	GAGUUGCAGGAAUGUGGGCAAC	22	11169
SCNN1A-7321	+	AGAGUUGCAGGAAUGUGGGCAAC	23	11170
SCNN1A-7322	+	CAGAGUUGCAGGAAUGUGGGCAAC	24	11171
SCNN1A-7323	+	AGGGCCUGGGUGGGGAAC	18	11172
SCNN1A-7324	+	GAGGGCCUGGGUGGGGAAC	19	11173
SCNN1A-6101	+	AGAGGGCCUGGGUGGGGAAC	20	9950
SCNN1A-7325	+	GAGAGGGCCUGGGUGGGGAAC	21	11174
SCNN1A-7326	+	UGAGAGGGCCUGGGUGGGGAAC	22	11175
SCNN1A-7327	+	CUGAGAGGGCCUGGGUGGGGAAC	23	11176
SCNN1A-7328	+	GCUGAGAGGGCCUGGGUGGGGAAC	24	11177
SCNN1A-7329	+	UCCCGAGGGCAGGUGAAC	18	11178
SCNN1A-7330	+	CUCCCGAGGGCAGGUGAAC	19	11179
SCNN1A-5203	+	GCUCCCGAGGGCAGGUGAAC	20	9052
SCNN1A-7331	+	GGCUCCCGAGGGCAGGUGAAC	21	11180
SCNN1A-7332	+	GGGCUCCCGAGGGCAGGUGAAC	22	11181
SCNN1A-7333	+	AGGGCUCCCGAGGGCAGGUGAAC	23	11182
SCNN1A-7334	+	GAGGGCUCCCGAGGGCAGGUGAAC	24	11183
SCNN1A-7335	+	CAGCUAGGAGGGCAACAC	18	11184
SCNN1A-7336	+	ACAGCUAGGAGGGCAACAC	19	11185
SCNN1A-7337	+	CACAGCUAGGAGGGCAACAC	20	11186
SCNN1A-7338	+	CCACAGCUAGGAGGGCAACAC	21	11187
SCNN1A-7339	+	CCCACAGCUAGGAGGGCAACAC	22	11188
SCNN1A-7340	+	GCCCACAGCUAGGAGGGCAACAC	23	11189
SCNN1A-7341	+	AGCCCACAGCUAGGAGGGCAACAC	24	11190
SCNN1A-7342	+	CUGAGCAUUGAUACACAC	18	11191
SCNN1A-7343	+	CCUGAGCAUUGAUACACAC	19	11192
SCNN1A-5204	+	GCCUGAGCAUUGAUACACAC	20	9053
SCNN1A-7344	+	AGCCUGAGCAUUGAUACACAC	21	11193
SCNN1A-7345	+	CAGCCUGAGCAUUGAUACACAC	22	11194
SCNN1A-7346	+	CCAGCCUGAGCAUUGAUACACAC	23	11195
SCNN1A-7347	+	CCCAGCCUGAGCAUUGAUACACAC	24	11196
SCNN1A-7348	+	CUUCCUCACGGGCCCCAC	18	11197
SCNN1A-7349	+	GCUUCCUCACGGGCCCCAC	19	11198
SCNN1A-5561	+	CGCUUCCUCACGGGCCCCAC	20	9410
SCNN1A-7350	+	CCGCUUCCUCACGGGCCCCAC	21	11199
SCNN1A-7351	+	GCCGCUUCCUCACGGGCCCCAC	22	11200
SCNN1A-7352	+	UGCCGCUUCCUCACGGGCCCCAC	23	11201
SCNN1A-7353	+	CUGCCGCUUCCUCACGGGCCCCAC	24	11202
SCNN1A-7354	+	GACACUGUGGACACAGAC	18	11203
SCNN1A-7355	+	GGACACUGUGGACACAGAC	19	11204
SCNN1A-7356	+	AGGACACUGUGGACACAGAC	20	11205
SCNN1A-7357	+	CAGGACACUGUGGACACAGAC	21	11206
SCNN1A-7358	+	GCAGGACACUGUGGACACAGAC	22	11207
SCNN1A-7359	+	CGCAGGACACUGUGGACACAGAC	23	11208
SCNN1A-7360	+	ACGCAGGACACUGUGGACACAGAC	24	11209
SCNN1A-7361	+	CUCCAACCUUGUCCAGAC	18	11210
SCNN1A-7362	+	CCUCCAACCUUGUCCAGAC	19	11211
SCNN1A-7363	+	CCCUCCAACCUUGUCCAGAC	20	11212
SCNN1A-7364	+	CCCCUCCAACCUUGUCCAGAC	21	11213
SCNN1A-7365	+	CCCCCUCCAACCUUGUCCAGAC	22	11214
SCNN1A-7366	+	ACCCCCUCCAACCUUGUCCAGAC	23	11215
SCNN1A-7367	+	CACCCCCUCCAACCUUGUCCAGAC	24	11216
SCNN1A-7368	+	AAAAGGGCUGGAGGAGAC	18	11217
SCNN1A-7369	+	AAAAAGGGCUGGAGGAGAC	19	11218
SCNN1A-7370	+	CAAAAAGGGCUGGAGGAGAC	20	11219
SCNN1A-7371	+	CCAAAAAGGGCUGGAGGAGAC	21	11220
SCNN1A-7372	+	CCCAAAAAGGGCUGGAGGAGAC	22	11221
SCNN1A-7373	+	ACCCAAAAAGGGCUGGAGGAGAC	23	11222
SCNN1A-7374	+	GACCCAAAAAGGGCUGGAGGAGAC	24	11223
SCNN1A-7375	+	GUGGGGAACCGGGAGGAC	18	11224
SCNN1A-7376	+	GGUGGGGAACCGGGAGGAC	19	11225
SCNN1A-5209	+	GGGUGGGGAACCGGGAGGAC	20	9058
SCNN1A-7377	+	UGGGUGGGGAACCGGGAGGAC	21	11226
SCNN1A-7378	+	CUGGGUGGGGAACCGGGAGGAC	22	11227
SCNN1A-7379	+	CCUGGGUGGGGAACCGGGAGGAC	23	11228
SCNN1A-7380	+	GCCUGGGUGGGGAACCGGGAGGAC	24	11229
SCNN1A-7381	+	GAACUGGGAGUACUGGAC	18	11230
SCNN1A-7382	+	UGAACUGGGAGUACUGGAC	19	11231
SCNN1A-7383	+	GUGAACUGGGAGUACUGGAC	20	11232
SCNN1A-7384	+	GGUGAACUGGGAGUACUGGAC	21	11233
SCNN1A-7385	+	AGGUGAACUGGGAGUACUGGAC	22	11234
SCNN1A-7386	+	CAGGUGAACUGGGAGUACUGGAC	23	11235
SCNN1A-7387	+	GCAGGUGAACUGGGAGUACUGGAC	24	11236
SCNN1A-7388	+	CCCAGGUUGCGGCUGGAC	18	11237
SCNN1A-7389	+	UCCCAGGUUGCGGCUGGAC	19	11238
SCNN1A-5565	+	CUCCCAGGUUGCGGCUGGAC	20	9414
SCNN1A-7390	+	ACUCCCAGGUUGCGGCUGGAC	21	11239
SCNN1A-7391	+	CACUCCCAGGUUGCGGCUGGAC	22	11240
SCNN1A-7392	+	CCACUCCCAGGUUGCGGCUGGAC	23	11241
SCNN1A-7393	+	CCCACUCCCAGGUUGCGGCUGGAC	24	11242
SCNN1A-7394	+	GGGCCUGGGUGGGGAACC	18	11243
SCNN1A-7395	+	AGGGCCUGGGUGGGGAACC	19	11244
SCNN1A-5214	+	GAGGGCCUGGGUGGGGAACC	20	9063
SCNN1A-7396	+	AGAGGGCCUGGGUGGGGAACC	21	11245
SCNN1A-7397	+	GAGAGGGCCUGGGUGGGGAACC	22	11246
SCNN1A-7398	+	UGAGAGGGCCUGGGUGGGGAACC	23	11247
SCNN1A-7399	+	CUGAGAGGGCCUGGGUGGGGAACC	24	11248
SCNN1A-7400	+	UGAGCAUUGAUACACACC	18	11249
SCNN1A-7401	+	CUGAGCAUUGAUACACACC	19	11250
SCNN1A-5568	+	CCUGAGCAUUGAUACACACC	20	9417
SCNN1A-7402	+	GCCUGAGCAUUGAUACACACC	21	11251
SCNN1A-7403	+	AGCCUGAGCAUUGAUACACACC	22	11252
SCNN1A-7404	+	CAGCCUGAGCAUUGAUACACACC	23	11253
SCNN1A-7405	+	CCAGCCUGAGCAUUGAUACACACC	24	11254
SCNN1A-7406	+	ACACUGUGGACACAGACC	18	11255
SCNN1A-7407	+	GACACUGUGGACACAGACC	19	11256
SCNN1A-5217	+	GGACACUGUGGACACAGACC	20	9066
SCNN1A-7408	+	AGGACACUGUGGACACAGACC	21	11257
SCNN1A-7409	+	CAGGACACUGUGGACACAGACC	22	11258
SCNN1A-7410	+	GCAGGACACUGUGGACACAGACC	23	11259
SCNN1A-7411	+	CGCAGGACACUGUGGACACAGACC	24	11260
SCNN1A-7412	+	UCCAACCUUGUCCAGACC	18	11261
SCNN1A-7413	+	CUCCAACCUUGUCCAGACC	19	11262
SCNN1A-5569	+	CCUCCAACCUUGUCCAGACC	20	9418
SCNN1A-7414	+	CCCUCCAACCUUGUCCAGACC	21	11263
SCNN1A-7415	+	CCCCUCCAACCUUGUCCAGACC	22	11264
SCNN1A-7416	+	CCCCCUCCAACCUUGUCCAGACC	23	11265
SCNN1A-7417	+	ACCCCCUCCAACCUUGUCCAGACC	24	11266
SCNN1A-7418	+	CAGCCUCUGGCCCUGACC	18	11267
SCNN1A-7419	+	CCAGCCUCUGGCCCUGACC	19	11268
SCNN1A-7420	+	UCCAGCCUCUGGCCCUGACC	20	11269
SCNN1A-7421	+	CUCCAGCCUCUGGCCCUGACC	21	11270
SCNN1A-7422	+	GCUCCAGCCUCUGGCCCUGACC	22	11271
SCNN1A-7423	+	AGCUCCAGCCUCUGGCCCUGACC	23	11272
SCNN1A-7424	+	CAGCUCCAGCCUCUGGCCCUGACC	24	11273
SCNN1A-1484	+	UGCCCUCUCCCAUCACCC	18	5333
SCNN1A-1485	+	GUGCCCUCUCCCAUCACCC	19	5334
SCNN1A-1486	+	AGUGCCCUCUCCCAUCACCC	20	5335
SCNN1A-1487	+	GAGUGCCCUCUCCCAUCACCC	21	5336
SCNN1A-1488	+	UGAGUGCCCUCUCCCAUCACCC	22	5337
SCNN1A-1489	+	CUGAGUGCCCUCUCCCAUCACCC	23	5338
SCNN1A-1490	+	CCUGAGUGCCCUCUCCCAUCACCC	24	5339
SCNN1A-7425	+	CCAACCUUGUCCAGACCC	18	11274
SCNN1A-7426	+	UCCAACCUUGUCCAGACCC	19	11275
SCNN1A-5572	+	CUCCAACCUUGUCCAGACCC	20	9421
SCNN1A-7427	+	CCUCCAACCUUGUCCAGACCC	21	11276
SCNN1A-7428	+	CCCUCCAACCUUGUCCAGACCC	22	11277
SCNN1A-7429	+	CCCCUCCAACCUUGUCCAGACCC	23	11278
SCNN1A-7430	+	CCCCCUCCAACCUUGUCCAGACCC	24	11279
SCNN1A-1491	+	GCCCUCUCCCAUCACCCC	18	5340
SCNN1A-1492	+	UGCCCUCUCCCAUCACCCC	19	5341
SCNN1A-346	+	GUGCCCUCUCCCAUCACCCC	20	4195
SCNN1A-1493	+	AGUGCCCUCUCCCAUCACCCC	21	5342
SCNN1A-1494	+	GAGUGCCCUCUCCCAUCACCCC	22	5343
SCNN1A-1495	+	UGAGUGCCCUCUCCCAUCACCCC	23	5344
SCNN1A-1496	+	CUGAGUGCCCUCUCCCAUCACCCC	24	5345
SCNN1A-7431	+	ACAUAUCCCAGAGACCCC	18	11280
SCNN1A-7432	+	CACAUAUCCCAGAGACCCC	19	11281
SCNN1A-7433	+	CCACAUAUCCCAGAGACCCC	20	11282
SCNN1A-7434	+	CCCACAUAUCCCAGAGACCCC	21	11283
SCNN1A-7435	+	CCCCACAUAUCCCAGAGACCCC	22	11284
SCNN1A-7436	+	GCCCCACAUAUCCCAGAGACCCC	23	11285
SCNN1A-7437	+	UGCCCCACAUAUCCCAGAGACCCC	24	11286
SCNN1A-1497	+	UGCUCAUGAUACCUCCCC	18	5346
SCNN1A-1498	+	CUGCUCAUGAUACCUCCCC	19	5347
SCNN1A-1499	+	ACUGCUCAUGAUACCUCCCC	20	5348
SCNN1A-1500	+	UACUGCUCAUGAUACCUCCCC	21	5349
SCNN1A-1501	+	AUACUGCUCAUGAUACCUCCCC	22	5350
SCNN1A-1502	+	GAUACUGCUCAUGAUACCUCCCC	23	5351
SCNN1A-1503	+	UGAUACUGCUCAUGAUACCUCCCC	24	5352
SCNN1A-7438	+	GACACAGACCCGGAGCCC	18	11287
SCNN1A-7439	+	GGACACAGACCCGGAGCCC	19	11288
SCNN1A-5575	+	UGGACACAGACCCGGAGCCC	20	9424
SCNN1A-7440	+	GUGGACACAGACCCGGAGCCC	21	11289
SCNN1A-7441	+	UGUGGACACAGACCCGGAGCCC	22	11290
SCNN1A-7442	+	CUGUGGACACAGACCCGGAGCCC	23	11291
SCNN1A-7443	+	ACUGUGGACACAGACCCGGAGCCC	24	11292
SCNN1A-7444	+	ACACGCCUAGACAGGCCC	18	11293
SCNN1A-7445	+	CACACGCCUAGACAGGCCC	19	11294
SCNN1A-5219	+	GCACACGCCUAGACAGGCCC	20	9068
SCNN1A-7446	+	GGCACACGCCUAGACAGGCCC	21	11295
SCNN1A-7447	+	UGGCACACGCCUAGACAGGCCC	22	11296
SCNN1A-7448	+	AUGGCACACGCCUAGACAGGCCC	23	11297
SCNN1A-7449	+	CAUGGCACACGCCUAGACAGGCCC	24	11298
SCNN1A-7450	+	GGGGGCUAGGCGGGGCCC	18	11299
SCNN1A-7451	+	UGGGGGCUAGGCGGGGCCC	19	11300
SCNN1A-7452	+	CUGGGGGCUAGGCGGGGCCC	20	11301
SCNN1A-7453	+	GCUGGGGGCUAGGCGGGGCCC	21	11302
SCNN1A-7454	+	AGCUGGGGGCUAGGCGGGGCCC	22	11303
SCNN1A-7455	+	AAGCUGGGGGCUAGGCGGGGCCC	23	11304
SCNN1A-7456	+	GAAGCUGGGGGCUAGGCGGGGCCC	24	11305
SCNN1A-7457	+	CUGAUUCUGUCUCUGCCC	18	11306
SCNN1A-7458	+	CCUGAUUCUGUCUCUGCCC	19	11307
SCNN1A-7459	+	UCCUGAUUCUGUCUCUGCCC	20	11308
SCNN1A-7460	+	GUCCUGAUUCUGUCUCUGCCC	21	11309
SCNN1A-7461	+	UGUCCUGAUUCUGUCUCUGCCC	22	11310
SCNN1A-7462	+	GUGUCCUGAUUCUGUCUCUGCCC	23	11311
SCNN1A-7463	+	UGUGUCCUGAUUCUGUCUCUGCCC	24	11312
SCNN1A-7464	+	GAAGGAAGGAGGGCUCCC	18	11313
SCNN1A-7465	+	CGAAGGAAGGAGGGCUCCC	19	11314
SCNN1A-7466	+	CCGAAGGAAGGAGGGCUCCC	20	11315
SCNN1A-7467	+	UCCGAAGGAAGGAGGGCUCCC	21	11316
SCNN1A-7468	+	UUCCGAAGGAAGGAGGGCUCCC	22	11317
SCNN1A-7469	+	UUUCCGAAGGAAGGAGGGCUCCC	23	11318
SCNN1A-7470	+	UUUUCCGAAGGAAGGAGGGCUCCC	24	11319
SCNN1A-7471	+	UAGAAACUCCAGUCUCCC	18	11320
SCNN1A-7472	+	CUAGAAACUCCAGUCUCCC	19	11321
SCNN1A-7473	+	CCUAGAAACUCCAGUCUCCC	20	11322
SCNN1A-7474	+	CCCUAGAAACUCCAGUCUCCC	21	11323
SCNN1A-7475	+	CCCCUAGAAACUCCAGUCUCCC	22	11324
SCNN1A-7476	+	ACCCCUAGAAACUCCAGUCUCCC	23	11325
SCNN1A-7477	+	GACCCCUAGAAACUCCAGUCUCCC	24	11326
SCNN1A-7478	+	GCCGGAGCUGGGCUUCCC	18	11327
SCNN1A-7479	+	UGCCGGAGCUGGGCUUCCC	19	11328
SCNN1A-7480	+	GUGCCGGAGCUGGGCUUCCC	20	11329
SCNN1A-7481	+	AGUGCCGGAGCUGGGCUUCCC	21	11330
SCNN1A-7482	+	AAGUGCCGGAGCUGGGCUUCCC	22	11331
SCNN1A-7483	+	AAAGUGCCGGAGCUGGGCUUCCC	23	11332
SCNN1A-7484	+	AAAAGUGCCGGAGCUGGGCUUCCC	24	11333
SCNN1A-7485	+	CACCUGGAUGUGAAAGCC	18	11334
SCNN1A-7486	+	GCACCUGGAUGUGAAAGCC	19	11335
SCNN1A-6107	+	UGCACCUGGAUGUGAAAGCC	20	9956
SCNN1A-7487	+	GUGCACCUGGAUGUGAAAGCC	21	11336
SCNN1A-7488	+	GGUGCACCUGGAUGUGAAAGCC	22	11337
SCNN1A-7489	+	AGGUGCACCUGGAUGUGAAAGCC	23	11338
SCNN1A-7490	+	CAGGUGCACCUGGAUGUGAAAGCC	24	11339
SCNN1A-7491	+	AGAUAAGACAUAAGAGCC	18	11340
SCNN1A-7492	+	GAGAUAAGACAUAAGAGCC	19	11341
SCNN1A-7493	+	AGAGAUAAGACAUAAGAGCC	20	11342
SCNN1A-7494	+	CAGAGAUAAGACAUAAGAGCC	21	11343
SCNN1A-7495	+	UCAGAGAUAAGACAUAAGAGCC	22	11344
SCNN1A-7496	+	CUCAGAGAUAAGACAUAAGAGCC	23	11345
SCNN1A-7497	+	UCUCAGAGAUAAGACAUAAGAGCC	24	11346
SCNN1A-7498	+	GGACACAGACCCGGAGCC	18	11347
SCNN1A-7499	+	UGGACACAGACCCGGAGCC	19	11348
SCNN1A-7500	+	GUGGACACAGACCCGGAGCC	20	11349
SCNN1A-7501	+	UGUGGACACAGACCCGGAGCC	21	11350
SCNN1A-7502	+	CUGUGGACACAGACCCGGAGCC	22	11351
SCNN1A-7503	+	ACUGUGGACACAGACCCGGAGCC	23	11352
SCNN1A-7504	+	CACUGUGGACACAGACCCGGAGCC	24	11353
SCNN1A-7505	+	CCAAGGGCUAGGGGAGCC	18	11354
SCNN1A-7506	+	GCCAAGGGCUAGGGGAGCC	19	11355
SCNN1A-7507	+	AGCCAAGGGCUAGGGGAGCC	20	11356
SCNN1A-7508	+	GAGCCAAGGGCUAGGGGAGCC	21	11357
SCNN1A-7509	+	AGAGCCAAGGGCUAGGGGAGCC	22	11358
SCNN1A-7510	+	AAGAGCCAAGGGCUAGGGGAGCC	23	11359
SCNN1A-7511	+	UAAGAGCCAAGGGCUAGGGGAGCC	24	11360
SCNN1A-1504	+	UGUUCCCCUUCAUGAGCC	18	5353
SCNN1A-1505	+	UUGUUCCCCUUCAUGAGCC	19	5354
SCNN1A-207	+	CUUGUUCCCCUUCAUGAGCC	20	834
SCNN1A-1506	+	GCUUGUUCCCCUUCAUGAGCC	21	5355
SCNN1A-1507	+	AGCUUGUUCCCCUUCAUGAGCC	22	5356
SCNN1A-1508	+	CAGCUUGUUCCCCUUCAUGAGCC	23	5357
SCNN1A-1509	+	CCAGCUUGUUCCCCUUCAUGAGCC	24	5358
SCNN1A-7512	+	CACACGCCUAGACAGGCC	18	11361
SCNN1A-7513	+	GCACACGCCUAGACAGGCC	19	11362
SCNN1A-7514	+	GGCACACGCCUAGACAGGCC	20	11363
SCNN1A-7515	+	UGGCACACGCCUAGACAGGCC	21	11364
SCNN1A-7516	+	AUGGCACACGCCUAGACAGGCC	22	11365
SCNN1A-7517	+	CAUGGCACACGCCUAGACAGGCC	23	11366
SCNN1A-7518	+	GCAUGGCACACGCCUAGACAGGCC	24	11367
SCNN1A-7519	+	CCACUGCCCCACAUAUCC	18	11368
SCNN1A-7520	+	CCCACUGCCCCACAUAUCC	19	11369
SCNN1A-7521	+	CCCCACUGCCCCACAUAUCC	20	11370
SCNN1A-7522	+	UCCCCACUGCCCCACAUAUCC	21	11371
SCNN1A-7523	+	GUCCCCACUGCCCCACAUAUCC	22	11372
SCNN1A-7524	+	UGUCCCCACUGCCCCACAUAUCC	23	11373
SCNN1A-7525	+	CUGUCCCCACUGCCCCACAUAUCC	24	11374
SCNN1A-1525	+	UCCAGCUUGUUCCCCUCC	18	5374
SCNN1A-1526	+	CUCCAGCUUGUUCCCCUCC	19	5375
SCNN1A-200	+	CCUCCAGCUUGUUCCCCUCC	20	829
SCNN1A-1527	+	UCCUCCAGCUUGUUCCCCUCC	21	5376
SCNN1A-1528	+	CUCCUCCAGCUUGUUCCCCUCC	22	5377
SCNN1A-1529	+	GCUCCUCCAGCUUGUUCCCCUCC	23	5378
SCNN1A-1530	+	UGCUCCUCCAGCUUGUUCCCCUCC	24	5379
SCNN1A-7526	+	GCAAGUGGGCAGCCCUCC	18	11375
SCNN1A-7527	+	AGCAAGUGGGCAGCCCUCC	19	11376
SCNN1A-7528	+	CAGCAAGUGGGCAGCCCUCC	20	11377
SCNN1A-7529	+	UCAGCAAGUGGGCAGCCCUCC	21	11378
SCNN1A-7530	+	CUCAGCAAGUGGGCAGCCCUCC	22	11379
SCNN1A-7531	+	GCUCAGCAAGUGGGCAGCCCUCC	23	11380
SCNN1A-7532	+	GGCUCAGCAAGUGGGCAGCCCUCC	24	11381
SCNN1A-7533	+	CCAGGACUGCAGGGCUCC	18	11382
SCNN1A-7534	+	CCCAGGACUGCAGGGCUCC	19	11383
SCNN1A-6112	+	CCCCAGGACUGCAGGGCUCC	20	9961
SCNN1A-7535	+	GCCCCAGGACUGCAGGGCUCC	21	11384
SCNN1A-7536	+	UGCCCCAGGACUGCAGGGCUCC	22	11385
SCNN1A-7537	+	CUGCCCCAGGACUGCAGGGCUCC	23	11386
SCNN1A-7538	+	UCUGCCCCAGGACUGCAGGGCUCC	24	11387
SCNN1A-7539	+	CAAAGGGAGUCUGUCUCC	18	11388
SCNN1A-7540	+	CCAAAGGGAGUCUGUCUCC	19	11389
SCNN1A-5596	+	ACCAAAGGGAGUCUGUCUCC	20	9445
SCNN1A-7541	+	CACCAAAGGGAGUCUGUCUCC	21	11390
SCNN1A-7542	+	GCACCAAAGGGAGUCUGUCUCC	22	11391
SCNN1A-7543	+	AGCACCAAAGGGAGUCUGUCUCC	23	11392
SCNN1A-7544	+	CAGCACCAAAGGGAGUCUGUCUCC	24	11393
SCNN1A-7545	+	AGACUCAGGAAGCCUUCC	18	11394
SCNN1A-7546	+	GAGACUCAGGAAGCCUUCC	19	11395
SCNN1A-7547	+	GGAGACUCAGGAAGCCUUCC	20	11396
SCNN1A-7548	+	AGGAGACUCAGGAAGCCUUCC	21	11397
SCNN1A-7549	+	CAGGAGACUCAGGAAGCCUUCC	22	11398
SCNN1A-7550	+	GCAGGAGACUCAGGAAGCCUUCC	23	11399
SCNN1A-7551	+	UGCAGGAGACUCAGGAAGCCUUCC	24	11400
SCNN1A-7552	+	AGUCCCAAGUGUGCUUCC	18	11401
SCNN1A-7553	+	GAGUCCCAAGUGUGCUUCC	19	11402
SCNN1A-5226	+	GGAGUCCCAAGUGUGCUUCC	20	9075
SCNN1A-7554	+	GGGAGUCCCAAGUGUGCUUCC	21	11403
SCNN1A-7555	+	GGGGAGUCCCAAGUGUGCUUCC	22	11404
SCNN1A-7556	+	GGGGGAGUCCCAAGUGUGCUUCC	23	11405
SCNN1A-7557	+	GGGGGGAGUCCCAAGUGUGCUUCC	24	11406
SCNN1A-7558	+	UCCCUCCUCCACCUUUCC	18	11407
SCNN1A-7559	+	CUCCCUCCUCCACCUUUCC	19	11408
SCNN1A-6116	+	CCUCCCUCCUCCACCUUUCC	20	9965
SCNN1A-7560	+	CCCUCCCUCCUCCACCUUUCC	21	11409
SCNN1A-7561	+	UCCCUCCCUCCUCCACCUUUCC	22	11410
SCNN1A-7562	+	CUCCCUCCCUCCUCCACCUUUCC	23	11411
SCNN1A-7563	+	CCUCCCUCCCUCCUCCACCUUUCC	24	11412
SCNN1A-7564	+	GCACCUGGAUGUGAAAGC	18	11413
SCNN1A-7565	+	UGCACCUGGAUGUGAAAGC	19	11414
SCNN1A-5227	+	GUGCACCUGGAUGUGAAAGC	20	9076
SCNN1A-7566	+	GGUGCACCUGGAUGUGAAAGC	21	11415
SCNN1A-7567	+	AGGUGCACCUGGAUGUGAAAGC	22	11416
SCNN1A-7568	+	CAGGUGCACCUGGAUGUGAAAGC	23	11417
SCNN1A-7569	+	UCAGGUGCACCUGGAUGUGAAAGC	24	11418
SCNN1A-7570	+	UGCUGAAUCUUGACAAGC	18	11419
SCNN1A-7571	+	CUGCUGAAUCUUGACAAGC	19	11420
SCNN1A-7572	+	UCUGCUGAAUCUUGACAAGC	20	11421
SCNN1A-7573	+	CUCUGCUGAAUCUUGACAAGC	21	11422
SCNN1A-7574	+	UCUCUGCUGAAUCUUGACAAGC	22	11423
SCNN1A-7575	+	AUCUCUGCUGAAUCUUGACAAGC	23	11424
SCNN1A-7576	+	CAUCUCUGCUGAAUCUUGACAAGC	24	11425
SCNN1A-7577	+	GAGGGGCCCAGGUGAAGC	18	11426
SCNN1A-7578	+	GGAGGGGCCCAGGUGAAGC	19	11427
SCNN1A-5885	+	GGGAGGGGCCCAGGUGAAGC	20	9734
SCNN1A-7579	+	CGGGAGGGGCCCAGGUGAAGC	21	11428
SCNN1A-7580	+	CCGGGAGGGGCCCAGGUGAAGC	22	11429
SCNN1A-7581	+	CCCGGGAGGGGCCCAGGUGAAGC	23	11430
SCNN1A-7582	+	ACCCGGGAGGGGCCCAGGUGAAGC	24	11431
SCNN1A-7583	+	GGAUCCUGAGCCCACAGC	18	11432
SCNN1A-7584	+	AGGAUCCUGAGCCCACAGC	19	11433
SCNN1A-7585	+	AAGGAUCCUGAGCCCACAGC	20	11434
SCNN1A-7586	+	GAAGGAUCCUGAGCCCACAGC	21	11435
SCNN1A-7587	+	AGAAGGAUCCUGAGCCCACAGC	22	11436
SCNN1A-7588	+	UAGAAGGAUCCUGAGCCCACAGC	23	11437
SCNN1A-7589	+	GUAGAAGGAUCCUGAGCCCACAGC	24	11438
SCNN1A-7590	+	AGCAGACAAAGGCCCAGC	18	11439
SCNN1A-7591	+	CAGCAGACAAAGGCCCAGC	19	11440
SCNN1A-7592	+	CCAGCAGACAAAGGCCCAGC	20	11441
SCNN1A-7593	+	GCCAGCAGACAAAGGCCCAGC	21	11442
SCNN1A-7594	+	AGCCAGCAGACAAAGGCCCAGC	22	11443
SCNN1A-7595	+	AAGCCAGCAGACAAAGGCCCAGC	23	11444
SCNN1A-7596	+	CAAGCCAGCAGACAAAGGCCCAGC	24	11445
SCNN1A-7597	+	UGGGCAACCAGAGGCAGC	18	11446
SCNN1A-7598	+	GUGGGCAACCAGAGGCAGC	19	11447
SCNN1A-7599	+	UGUGGGCAACCAGAGGCAGC	20	11448
SCNN1A-7600	+	AUGUGGGCAACCAGAGGCAGC	21	11449
SCNN1A-7601	+	AAUGUGGGCAACCAGAGGCAGC	22	11450
SCNN1A-7602	+	GAAUGUGGGCAACCAGAGGCAGC	23	11451
SCNN1A-7603	+	GGAAUGUGGGCAACCAGAGGCAGC	24	11452
SCNN1A-7604	+	CUGAGGAGGAGUCAGAGC	18	11453
SCNN1A-7605	+	GCUGAGGAGGAGUCAGAGC	19	11454
SCNN1A-5886	+	GGCUGAGGAGGAGUCAGAGC	20	9735
SCNN1A-7606	+	GGGCUGAGGAGGAGUCAGAGC	21	11455
SCNN1A-7607	+	GGGGCUGAGGAGGAGUCAGAGC	22	11456
SCNN1A-7608	+	AGGGGCUGAGGAGGAGUCAGAGC	23	11457
SCNN1A-7609	+	GAGGGGCUGAGGAGGAGUCAGAGC	24	11458
SCNN1A-7610	+	GUCUCCAGGAAGGAGAGC	18	11459
SCNN1A-7611	+	UGUCUCCAGGAAGGAGAGC	19	11460
SCNN1A-7612	+	CUGUCUCCAGGAAGGAGAGC	20	11461
SCNN1A-7613	+	UCUGUCUCCAGGAAGGAGAGC	21	11462
SCNN1A-7614	+	GUCUGUCUCCAGGAAGGAGAGC	22	11463
SCNN1A-7615	+	AGUCUGUCUCCAGGAAGGAGAGC	23	11464
SCNN1A-7616	+	GAGUCUGUCUCCAGGAAGGAGAGC	24	11465
SCNN1A-7617	+	AAGUGUGCUUCCAGGAGC	18	11466
SCNN1A-7618	+	CAAGUGUGCUUCCAGGAGC	19	11467
SCNN1A-7619	+	CCAAGUGUGCUUCCAGGAGC	20	11468
SCNN1A-7620	+	CCCAAGUGUGCUUCCAGGAGC	21	11469
SCNN1A-7621	+	UCCCAAGUGUGCUUCCAGGAGC	22	11470
SCNN1A-7622	+	GUCCCAAGUGUGCUUCCAGGAGC	23	11471
SCNN1A-7623	+	AGUCCCAAGUGUGCUUCCAGGAGC	24	11472
SCNN1A-7624	+	GAGUGCCAAGUGGUGAGC	18	11473
SCNN1A-7625	+	GGAGUGCCAAGUGGUGAGC	19	11474
SCNN1A-7626	+	UGGAGUGCCAAGUGGUGAGC	20	11475
SCNN1A-7627	+	GUGGAGUGCCAAGUGGUGAGC	21	11476
SCNN1A-7628	+	AGUGGAGUGCCAAGUGGUGAGC	22	11477
SCNN1A-7629	+	GAGUGGAGUGCCAAGUGGUGAGC	23	11478
SCNN1A-7630	+	GGAGUGGAGUGCCAAGUGGUGAGC	24	11479
SCNN1A-7631	+	GGAGGAUGUGGCCAGCGC	18	11480
SCNN1A-7632	+	GGGAGGAUGUGGCCAGCGC	19	11481
SCNN1A-6120	+	AGGGAGGAUGUGGCCAGCGC	20	9969
SCNN1A-7633	+	CAGGGAGGAUGUGGCCAGCGC	21	11482
SCNN1A-7634	+	GCAGGGAGGAUGUGGCCAGCGC	22	11483
SCNN1A-7635	+	UGCAGGGAGGAUGUGGCCAGCGC	23	11484
SCNN1A-7636	+	GUGCAGGGAGGAUGUGGCCAGCGC	24	11485
SCNN1A-7637	+	GGCAACCAGAGGCAGCGC	18	11486
SCNN1A-7638	+	GGGCAACCAGAGGCAGCGC	19	11487
SCNN1A-7639	+	UGGGCAACCAGAGGCAGCGC	20	11488
SCNN1A-7640	+	GUGGGCAACCAGAGGCAGCGC	21	11489
SCNN1A-7641	+	UGUGGGCAACCAGAGGCAGCGC	22	11490
SCNN1A-7642	+	AUGUGGGCAACCAGAGGCAGCGC	23	11491
SCNN1A-7643	+	AAUGUGGGCAACCAGAGGCAGCGC	24	11492
SCNN1A-7644	+	CUUUAGACGCAGACAGGC	18	11493
SCNN1A-7645	+	GCUUUAGACGCAGACAGGC	19	11494
SCNN1A-7646	+	GGCUUUAGACGCAGACAGGC	20	11495
SCNN1A-7647	+	GGGCUUUAGACGCAGACAGGC	21	11496
SCNN1A-7648	+	GGGGCUUUAGACGCAGACAGGC	22	11497
SCNN1A-7649	+	AGGGGCUUUAGACGCAGACAGGC	23	11498
SCNN1A-7650	+	CAGGGGCUUUAGACGCAGACAGGC	24	11499
SCNN1A-7651	+	CACUGUUGGCUGCCAGGC	18	11500
SCNN1A-7652	+	ACACUGUUGGCUGCCAGGC	19	11501
SCNN1A-7653	+	UACACUGUUGGCUGCCAGGC	20	11502
SCNN1A-7654	+	UUACACUGUUGGCUGCCAGGC	21	11503
SCNN1A-7655	+	UUUACACUGUUGGCUGCCAGGC	22	11504
SCNN1A-7656	+	UUUUACACUGUUGGCUGCCAGGC	23	11505
SCNN1A-7657	+	UUUUUACACUGUUGGCUGCCAGGC	24	11506
SCNN1A-7658	+	CGGAGCCCAGGAAGAGGC	18	11507
SCNN1A-7659	+	CCGGAGCCCAGGAAGAGGC	19	11508
SCNN1A-6122	+	CCCGGAGCCCAGGAAGAGGC	20	9971
SCNN1A-7660	+	ACCCGGAGCCCAGGAAGAGGC	21	11509
SCNN1A-7661	+	GACCCGGAGCCCAGGAAGAGGC	22	11510
SCNN1A-7662	+	AGACCCGGAGCCCAGGAAGAGGC	23	11511
SCNN1A-7663	+	CAGACCCGGAGCCCAGGAAGAGGC	24	11512
SCNN1A-7664	+	GCAGACAGGCAAGGAGGC	18	11513
SCNN1A-7665	+	CGCAGACAGGCAAGGAGGC	19	11514
SCNN1A-5608	+	ACGCAGACAGGCAAGGAGGC	20	9457
SCNN1A-7666	+	GACGCAGACAGGCAAGGAGGC	21	11515
SCNN1A-7667	+	AGACGCAGACAGGCAAGGAGGC	22	11516
SCNN1A-7668	+	UAGACGCAGACAGGCAAGGAGGC	23	11517
SCNN1A-7669	+	UUAGACGCAGACAGGCAAGGAGGC	24	11518
SCNN1A-7670	+	GCCCGCCCGCUGGCCGGC	18	11519
SCNN1A-7671	+	AGCCCGCCCGCUGGCCGGC	19	11520
SCNN1A-7672	+	GAGCCCGCCCGCUGGCCGGC	20	11521
SCNN1A-7673	+	GGAGCCCGCCCGCUGGCCGGC	21	11522
SCNN1A-7674	+	GGGAGCCCGCCCGCUGGCCGGC	22	11523
SCNN1A-7675	+	GGGGAGCCCGCCCGCUGGCCGGC	23	11524
SCNN1A-7676	+	UGGGGAGCCCGCCCGCUGGCCGGC	24	11525
SCNN1A-7677	+	CCAGGCCCUGCACGCGGC	18	11526
SCNN1A-7678	+	CCCAGGCCCUGCACGCGGC	19	11527
SCNN1A-5609	+	ACCCAGGCCCUGCACGCGGC	20	9458
SCNN1A-7679	+	AACCCAGGCCCUGCACGCGGC	21	11528
SCNN1A-7680	+	CAACCCAGGCCCUGCACGCGGC	22	11529
SCNN1A-7681	+	ACAACCCAGGCCCUGCACGCGGC	23	11530
SCNN1A-7682	+	CACAACCCAGGCCCUGCACGCGGC	24	11531
SCNN1A-7683	+	AUCAGACCCAAAAAGGGC	18	11532
SCNN1A-7684	+	AAUCAGACCCAAAAAGGGC	19	11533
SCNN1A-5232	+	GAAUCAGACCCAAAAAGGGC	20	9081
SCNN1A-7685	+	AGAAUCAGACCCAAAAAGGGC	21	11534
SCNN1A-7686	+	GAGAAUCAGACCCAAAAAGGGC	22	11535
SCNN1A-7687	+	AGAGAAUCAGACCCAAAAAGGGC	23	11536
SCNN1A-7688	+	CAGAGAAUCAGACCCAAAAAGGGC	24	11537
SCNN1A-7689	+	GACAUAAGAGCCAAGGGC	18	11538
SCNN1A-7690	+	AGACAUAAGAGCCAAGGGC	19	11539
SCNN1A-7691	+	AAGACAUAAGAGCCAAGGGC	20	11540
SCNN1A-7692	+	UAAGACAUAAGAGCCAAGGGC	21	11541
SCNN1A-7693	+	AUAAGACAUAAGAGCCAAGGGC	22	11542
SCNN1A-7694	+	GAUAAGACAUAAGAGCCAAGGGC	23	11543
SCNN1A-7695	+	AGAUAAGACAUAAGAGCCAAGGGC	24	11544
SCNN1A-7696	+	AUUAAAGGUGAGCAGGGC	18	11545
SCNN1A-7697	+	AAUUAAAGGUGAGCAGGGC	19	11546
SCNN1A-5611	+	CAAUUAAAGGUGAGCAGGGC	20	9460
SCNN1A-7698	+	UCAAUUAAAGGUGAGCAGGGC	21	11547
SCNN1A-7699	+	CUCAAUUAAAGGUGAGCAGGGC	22	11548
SCNN1A-7700	+	UCUCAAUUAAAGGUGAGCAGGGC	23	11549
SCNN1A-7701	+	AUCUCAAUUAAAGGUGAGCAGGGC	24	11550
SCNN1A-7702	+	AGAAGGCGGACUCUGGGC	18	11551
SCNN1A-7703	+	GAGAAGGCGGACUCUGGGC	19	11552
SCNN1A-5613	+	UGAGAAGGCGGACUCUGGGC	20	9462
SCNN1A-7704	+	CUGAGAAGGCGGACUCUGGGC	21	11553
SCNN1A-7705	+	CCUGAGAAGGCGGACUCUGGGC	22	11554
SCNN1A-7706	+	ACCUGAGAAGGCGGACUCUGGGC	23	11555
SCNN1A-7707	+	GACCUGAGAAGGCGGACUCUGGGC	24	11556
SCNN1A-7708	+	CAGGUGCAGCGGCCUGGC	18	11557
SCNN1A-7709	+	ACAGGUGCAGCGGCCUGGC	19	11558
SCNN1A-5234	+	GACAGGUGCAGCGGCCUGGC	20	9083
SCNN1A-7710	+	UGACAGGUGCAGCGGCCUGGC	21	11559
SCNN1A-7711	+	CUGACAGGUGCAGCGGCCUGGC	22	11560
SCNN1A-7712	+	CCUGACAGGUGCAGCGGCCUGGC	23	11561
SCNN1A-7713	+	ACCUGACAGGUGCAGCGGCCUGGC	24	11562
SCNN1A-7714	+	CUAUUUGCCAGCUCAUGC	18	11563
SCNN1A-7715	+	UCUAUUUGCCAGCUCAUGC	19	11564
SCNN1A-7716	+	UUCUAUUUGCCAGCUCAUGC	20	11565
SCNN1A-7717	+	UUUCUAUUUGCCAGCUCAUGC	21	11566
SCNN1A-7718	+	UUUUCUAUUUGCCAGCUCAUGC	22	11567
SCNN1A-7719	+	CUUUUCUAUUUGCCAGCUCAUGC	23	11568
SCNN1A-7720	+	CCUUUUCUAUUUGCCAGCUCAUGC	24	11569
SCNN1A-7721	+	AGCCUAGGGGCUCACUGC	18	11570
SCNN1A-7722	+	GAGCCUAGGGGCUCACUGC	19	11571
SCNN1A-5235	+	GGAGCCUAGGGGCUCACUGC	20	9084
SCNN1A-7723	+	GGGAGCCUAGGGGCUCACUGC	21	11572
SCNN1A-7724	+	GGGGAGCCUAGGGGCUCACUGC	22	11573
SCNN1A-7725	+	AGGGGAGCCUAGGGGCUCACUGC	23	11574
SCNN1A-7726	+	UAGGGGAGCCUAGGGGCUCACUGC	24	11575
SCNN1A-7727	+	AGUUGGGGCCAAAAGUGC	18	11576
SCNN1A-7728	+	GAGUUGGGGCCAAAAGUGC	19	11577
SCNN1A-5236	+	GGAGUUGGGGCCAAAAGUGC	20	9085
SCNN1A-7729	+	GGGAGUUGGGGCCAAAAGUGC	21	11578
SCNN1A-7730	+	CGGGAGUUGGGGCCAAAAGUGC	22	11579
SCNN1A-7731	+	GCGGGAGUUGGGGCCAAAAGUGC	23	11580
SCNN1A-7732	+	UGCGGGAGUUGGGGCCAAAAGUGC	24	11581
SCNN1A-7733	+	AGCAGGCACUGAAGGUGC	18	11582
SCNN1A-7734	+	AAGCAGGCACUGAAGGUGC	19	11583
SCNN1A-5620	+	AAAGCAGGCACUGAAGGUGC	20	9469
SCNN1A-7735	+	GAAAGCAGGCACUGAAGGUGC	21	11584
SCNN1A-7736	+	GGAAAGCAGGCACUGAAGGUGC	22	11585
SCNN1A-7737	+	GGGAAAGCAGGCACUGAAGGUGC	23	11586
SCNN1A-7738	+	AGGGAAAGCAGGCACUGAAGGUGC	24	11587
SCNN1A-7739	+	UGAACAAGUAGAAGGAUC	18	11588
SCNN1A-7740	+	CUGAACAAGUAGAAGGAUC	19	11589
SCNN1A-7741	+	UCUGAACAAGUAGAAGGAUC	20	11590
SCNN1A-7742	+	AUCUGAACAAGUAGAAGGAUC	21	11591
SCNN1A-7743	+	GAUCUGAACAAGUAGAAGGAUC	22	11592
SCNN1A-7744	+	AGAUCUGAACAAGUAGAAGGAUC	23	11593
SCNN1A-7745	+	AAGAUCUGAACAAGUAGAAGGAUC	24	11594
SCNN1A-7746	+	GCAAAUAGUUUUCAUAUC	18	11595
SCNN1A-7747	+	GGCAAAUAGUUUUCAUAUC	19	11596
SCNN1A-7748	+	UGGCAAAUAGUUUUCAUAUC	20	11597
SCNN1A-7749	+	AUGGCAAAUAGUUUUCAUAUC	21	11598
SCNN1A-7750	+	CAUGGCAAAUAGUUUUCAUAUC	22	11599
SCNN1A-7751	+	GCAUGGCAAAUAGUUUUCAUAUC	23	11600
SCNN1A-7752	+	AGCAUGGCAAAUAGUUUUCAUAUC	24	11601
SCNN1A-7753	+	ACUUCCUGAGACAGACUC	18	11602
SCNN1A-7754	+	UACUUCCUGAGACAGACUC	19	11603
SCNN1A-7755	+	UUACUUCCUGAGACAGACUC	20	11604
SCNN1A-7756	+	UUUACUUCCUGAGACAGACUC	21	11605
SCNN1A-7757	+	AUUUACUUCCUGAGACAGACUC	22	11606
SCNN1A-7758	+	CAUUUACUUCCUGAGACAGACUC	23	11607
SCNN1A-7759	+	CCAUUUACUUCCUGAGACAGACUC	24	11608
SCNN1A-7760	+	GCUCACUGCAGGAGACUC	18	11609
SCNN1A-7761	+	GGCUCACUGCAGGAGACUC	19	11610
SCNN1A-5239	+	GGGCUCACUGCAGGAGACUC	20	9088
SCNN1A-7762	+	GGGGCUCACUGCAGGAGACUC	21	11611
SCNN1A-7763	+	AGGGGCUCACUGCAGGAGACUC	22	11612
SCNN1A-7764	+	UAGGGGCUCACUGCAGGAGACUC	23	11613
SCNN1A-7765	+	CUAGGGGCUCACUGCAGGAGACUC	24	11614
SCNN1A-7766	+	AAGGGCUGGAGGAGACUC	18	11615
SCNN1A-7767	+	AAAGGGCUGGAGGAGACUC	19	11616
SCNN1A-5628	+	AAAAGGGCUGGAGGAGACUC	20	9477
SCNN1A-7768	+	AAAAAGGGCUGGAGGAGACUC	21	11617
SCNN1A-7769	+	CAAAAAGGGCUGGAGGAGACUC	22	11618
SCNN1A-7770	+	CCAAAAAGGGCUGGAGGAGACUC	23	11619
SCNN1A-7771	+	CCCAAAAAGGGCUGGAGGAGACUC	24	11620
SCNN1A-7772	+	AGAAUUCUCCUCCUCCUC	18	11621
SCNN1A-7773	+	CAGAAUUCUCCUCCUCCUC	19	11622
SCNN1A-6134	+	UCAGAAUUCUCCUCCUCCUC	20	9983
SCNN1A-7774	+	UUCAGAAUUCUCCUCCUCCUC	21	11623
SCNN1A-7775	+	AUUCAGAAUUCUCCUCCUCCUC	22	11624
SCNN1A-7776	+	AAUUCAGAAUUCUCCUCCUCCUC	23	11625
SCNN1A-7777	+	GAAUUCAGAAUUCUCCUCCUCCUC	24	11626
SCNN1A-7778	+	GAAGGCUGCCGCUUCCUC	18	11627
SCNN1A-7779	+	GGAAGGCUGCCGCUUCCUC	19	11628
SCNN1A-7780	+	GGGAAGGCUGCCGCUUCCUC	20	11629
SCNN1A-7781	+	AGGGAAGGCUGCCGCUUCCUC	21	11630
SCNN1A-7782	+	CAGGGAAGGCUGCCGCUUCCUC	22	11631
SCNN1A-7783	+	GCAGGGAAGGCUGCCGCUUCCUC	23	11632
SCNN1A-7784	+	GGCAGGGAAGGCUGCCGCUUCCUC	24	11633
SCNN1A-7785	+	CCCAGGACUGCAGGGCUC	18	11634
SCNN1A-7786	+	CCCCAGGACUGCAGGGCUC	19	11635
SCNN1A-7787	+	GCCCCAGGACUGCAGGGCUC	20	11636
SCNN1A-7788	+	UGCCCCAGGACUGCAGGGCUC	21	11637
SCNN1A-7789	+	CUGCCCCAGGACUGCAGGGCUC	22	11638
SCNN1A-7790	+	UCUGCCCCAGGACUGCAGGGCUC	23	11639
SCNN1A-7791	+	CUCUGCCCCAGGACUGCAGGGCUC	24	11640
SCNN1A-7792	+	CCGAAGGAAGGAGGGCUC	18	11641
SCNN1A-7793	+	UCCGAAGGAAGGAGGGCUC	19	11642
SCNN1A-7794	+	UUCCGAAGGAAGGAGGGCUC	20	11643
SCNN1A-7795	+	UUUCCGAAGGAAGGAGGGCUC	21	11644
SCNN1A-7796	+	UUUUCCGAAGGAAGGAGGGCUC	22	11645
SCNN1A-7797	+	GUUUUCCGAAGGAAGGAGGGCUC	23	11646
SCNN1A-7798	+	AGUUUUCCGAAGGAAGGAGGGCUC	24	11647
SCNN1A-7799	+	CCAAAGGGAGUCUGUCUC	18	11648
SCNN1A-7800	+	ACCAAAGGGAGUCUGUCUC	19	11649
SCNN1A-7801	+	CACCAAAGGGAGUCUGUCUC	20	11650
SCNN1A-7802	+	GCACCAAAGGGAGUCUGUCUC	21	11651
SCNN1A-7803	+	AGCACCAAAGGGAGUCUGUCUC	22	11652
SCNN1A-7804	+	CAGCACCAAAGGGAGUCUGUCUC	23	11653
SCNN1A-7805	+	CCAGCACCAAAGGGAGUCUGUCUC	24	11654
SCNN1A-7806	+	GCUUUUGCCAUUUACUUC	18	11655
SCNN1A-7807	+	CGCUUUUGCCAUUUACUUC	19	11656
SCNN1A-7808	+	GCGCUUUUGCCAUUUACUUC	20	11657
SCNN1A-7809	+	AGCGCUUUUGCCAUUUACUUC	21	11658
SCNN1A-7810	+	UAGCGCUUUUGCCAUUUACUUC	22	11659
SCNN1A-7811	+	UUAGCGCUUUUGCCAUUUACUUC	23	11660
SCNN1A-7812	+	CUUAGCGCUUUUGCCAUUUACUUC	24	11661
SCNN1A-1549	+	UCCAGCUUGUUCCCCUUC	18	5398
SCNN1A-1550	+	CUCCAGCUUGUUCCCCUUC	19	5399
SCNN1A-1551	+	CCUCCAGCUUGUUCCCCUUC	20	5400
SCNN1A-1552	+	UCCUCCAGCUUGUUCCCCUUC	21	5401
SCNN1A-1553	+	CUCCUCCAGCUUGUUCCCCUUC	22	5402
SCNN1A-1554	+	GCUCCUCCAGCUUGUUCCCCUUC	23	5403
SCNN1A-1555	+	UGCUCCUCCAGCUUGUUCCCCUUC	24	5404
SCNN1A-7813	+	GAGUCCCAAGUGUGCUUC	18	11662
SCNN1A-7814	+	GGAGUCCCAAGUGUGCUUC	19	11663
SCNN1A-7815	+	GGGAGUCCCAAGUGUGCUUC	20	11664
SCNN1A-7816	+	GGGGAGUCCCAAGUGUGCUUC	21	11665
SCNN1A-7817	+	GGGGGAGUCCCAAGUGUGCUUC	22	11666
SCNN1A-7818	+	GGGGGGAGUCCCAAGUGUGCUUC	23	11667
SCNN1A-7819	+	AGGGGGGAGUCCCAAGUGUGCUUC	24	11668
SCNN1A-7820	+	CUCCCUCCUCCACCUUUC	18	11669
SCNN1A-7821	+	CCUCCCUCCUCCACCUUUC	19	11670
SCNN1A-7822	+	CCCUCCCUCCUCCACCUUUC	20	11671
SCNN1A-7823	+	UCCCUCCCUCCUCCACCUUUC	21	11672
SCNN1A-7824	+	CUCCCUCCCUCCUCCACCUUUC	22	11673
SCNN1A-7825	+	CCUCCCUCCCUCCUCCACCUUUC	23	11674
SCNN1A-7826	+	UCCUCCCUCCCUCCUCCACCUUUC	24	11675
SCNN1A-7827	+	GGAGUUUAGCAGGCAAAG	18	11676
SCNN1A-7828	+	AGGAGUUUAGCAGGCAAAG	19	11677
SCNN1A-7829	+	AAGGAGUUUAGCAGGCAAAG	20	11678
SCNN1A-7830	+	CAAGGAGUUUAGCAGGCAAAG	21	11679
SCNN1A-7831	+	GCAAGGAGUUUAGCAGGCAAAG	22	11680
SCNN1A-7832	+	AGCAAGGAGUUUAGCAGGCAAAG	23	11681
SCNN1A-7833	+	AAGCAAGGAGUUUAGCAGGCAAAG	24	11682
SCNN1A-7834	+	GGACAGGAGGGCAGAAAG	18	11683
SCNN1A-7835	+	AGGACAGGAGGGCAGAAAG	19	11684
SCNN1A-5894	+	GAGGACAGGAGGGCAGAAAG	20	9743
SCNN1A-7836	+	GGAGGACAGGAGGGCAGAAAG	21	11685
SCNN1A-7837	+	GGGAGGACAGGAGGGCAGAAAG	22	11686
SCNN1A-7838	+	CGGGAGGACAGGAGGGCAGAAAG	23	11687
SCNN1A-7839	+	CCGGGAGGACAGGAGGGCAGAAAG	24	11688
SCNN1A-7840	+	UGCACCUGGAUGUGAAAG	18	11689
SCNN1A-7841	+	GUGCACCUGGAUGUGAAAG	19	11690
SCNN1A-7842	+	GGUGCACCUGGAUGUGAAAG	20	11691
SCNN1A-7843	+	AGGUGCACCUGGAUGUGAAAG	21	11692
SCNN1A-7844	+	CAGGUGCACCUGGAUGUGAAAG	22	11693
SCNN1A-7845	+	UCAGGUGCACCUGGAUGUGAAAG	23	11694
SCNN1A-7846	+	CUCAGGUGCACCUGGAUGUGAAAG	24	11695
SCNN1A-7847	+	UUAGCAUCUCAAUUAAAG	18	11696
SCNN1A-7848	+	AUUAGCAUCUCAAUUAAAG	19	11697
SCNN1A-7849	+	CAUUAGCAUCUCAAUUAAAG	20	11698
SCNN1A-7850	+	UCAUUAGCAUCUCAAUUAAAG	21	11699
SCNN1A-7851	+	CUCAUUAGCAUCUCAAUUAAAG	22	11700
SCNN1A-7852	+	UCUCAUUAGCAUCUCAAUUAAAG	23	11701
SCNN1A-7853	+	AUCUCAUUAGCAUCUCAAUUAAAG	24	11702
SCNN1A-7854	+	GGCAAAGAUCUGAACAAG	18	11703
SCNN1A-7855	+	GGGCAAAGAUCUGAACAAG	19	11704
SCNN1A-7856	+	GGGGCAAAGAUCUGAACAAG	20	11705
SCNN1A-7857	+	AGGGGCAAAGAUCUGAACAAG	21	11706
SCNN1A-7858	+	GAGGGGCAAAGAUCUGAACAAG	22	11707
SCNN1A-7859	+	UGAGGGGCAAAGAUCUGAACAAG	23	11708
SCNN1A-7860	+	GUGAGGGGCAAAGAUCUGAACAAG	24	11709
SCNN1A-7861	+	CUAGGAGGGCAACACAAG	18	11710
SCNN1A-7862	+	GCUAGGAGGGCAACACAAG	19	11711
SCNN1A-7863	+	AGCUAGGAGGGCAACACAAG	20	11712
SCNN1A-7864	+	CAGCUAGGAGGGCAACACAAG	21	11713
SCNN1A-7865	+	ACAGCUAGGAGGGCAACACAAG	22	11714
SCNN1A-7866	+	CACAGCUAGGAGGGCAACACAAG	23	11715
SCNN1A-7867	+	CCACAGCUAGGAGGGCAACACAAG	24	11716
SCNN1A-7868	+	UCCAGGAAGGAGAGCAAG	18	11717
SCNN1A-7869	+	CUCCAGGAAGGAGAGCAAG	19	11718
SCNN1A-6140	+	UCUCCAGGAAGGAGAGCAAG	20	9989
SCNN1A-7870	+	GUCUCCAGGAAGGAGAGCAAG	21	11719
SCNN1A-7871	+	UGUCUCCAGGAAGGAGAGCAAG	22	11720
SCNN1A-7872	+	CUGUCUCCAGGAAGGAGAGCAAG	23	11721
SCNN1A-7873	+	UCUGUCUCCAGGAAGGAGAGCAAG	24	11722
SCNN1A-7874	+	UGCCAAGUGGUGAGCAAG	18	11723
SCNN1A-7875	+	GUGCCAAGUGGUGAGCAAG	19	11724
SCNN1A-7876	+	AGUGCCAAGUGGUGAGCAAG	20	11725
SCNN1A-7877	+	GAGUGCCAAGUGGUGAGCAAG	21	11726
SCNN1A-7878	+	GGAGUGCCAAGUGGUGAGCAAG	22	11727
SCNN1A-7879	+	UGGAGUGCCAAGUGGUGAGCAAG	23	11728
SCNN1A-7880	+	GUGGAGUGCCAAGUGGUGAGCAAG	24	11729
SCNN1A-7881	+	AGUACUGGACCUGAGAAG	18	11730
SCNN1A-7882	+	GAGUACUGGACCUGAGAAG	19	11731
SCNN1A-7883	+	GGAGUACUGGACCUGAGAAG	20	11732
SCNN1A-7884	+	GGGAGUACUGGACCUGAGAAG	21	11733
SCNN1A-7885	+	UGGGAGUACUGGACCUGAGAAG	22	11734
SCNN1A-7886	+	CUGGGAGUACUGGACCUGAGAAG	23	11735
SCNN1A-7887	+	ACUGGGAGUACUGGACCUGAGAAG	24	11736
SCNN1A-7888	+	GGAGUUUUCCGAAGGAAG	18	11737
SCNN1A-7889	+	GGGAGUUUUCCGAAGGAAG	19	11738
SCNN1A-7890	+	CGGGAGUUUUCCGAAGGAAG	20	11739
SCNN1A-7891	+	CCGGGAGUUUUCCGAAGGAAG	21	11740
SCNN1A-7892	+	GCCGGGAGUUUUCCGAAGGAAG	22	11741
SCNN1A-7893	+	AGCCGGGAGUUUUCCGAAGGAAG	23	11742
SCNN1A-7894	+	GAGCCGGGAGUUUUCCGAAGGAAG	24	11743
SCNN1A-7895	+	GAGUCUGUCUCCAGGAAG	18	11744
SCNN1A-7896	+	GGAGUCUGUCUCCAGGAAG	19	11745
SCNN1A-7897	+	GGGAGUCUGUCUCCAGGAAG	20	11746
SCNN1A-7898	+	AGGGAGUCUGUCUCCAGGAAG	21	11747
SCNN1A-7899	+	AAGGGAGUCUGUCUCCAGGAAG	22	11748
SCNN1A-7900	+	AAAGGGAGUCUGUCUCCAGGAAG	23	11749
SCNN1A-7901	+	CAAAGGGAGUCUGUCUCCAGGAAG	24	11750
SCNN1A-7902	+	GGAGGGGCCCAGGUGAAG	18	11751
SCNN1A-7903	+	GGGAGGGGCCCAGGUGAAG	19	11752
SCNN1A-7904	+	CGGGAGGGGCCCAGGUGAAG	20	11753
SCNN1A-7905	+	CCGGGAGGGGCCCAGGUGAAG	21	11754
SCNN1A-7906	+	CCCGGGAGGGGCCCAGGUGAAG	22	11755
SCNN1A-7907	+	ACCCGGGAGGGGCCCAGGUGAAG	23	11756
SCNN1A-7908	+	GACCCGGGAGGGGCCCAGGUGAAG	24	11757
SCNN1A-7909	+	UCCUCCCCGCUCACUAAG	18	11758
SCNN1A-7910	+	CUCCUCCCCGCUCACUAAG	19	11759
SCNN1A-5645	+	UCUCCUCCCCGCUCACUAAG	20	9494
SCNN1A-7911	+	GUCUCCUCCCCGCUCACUAAG	21	11760
SCNN1A-7912	+	GGUCUCCUCCCCGCUCACUAAG	22	11761
SCNN1A-7913	+	AGGUCUCCUCCCCGCUCACUAAG	23	11762
SCNN1A-7914	+	CAGGUCUCCUCCCCGCUCACUAAG	24	11763
SCNN1A-7915	+	GGGGAACCGGGAGGACAG	18	11764
SCNN1A-7916	+	UGGGGAACCGGGAGGACAG	19	11765
SCNN1A-7917	+	GUGGGGAACCGGGAGGACAG	20	11766
SCNN1A-7918	+	GGUGGGGAACCGGGAGGACAG	21	11767
SCNN1A-7919	+	GGGUGGGGAACCGGGAGGACAG	22	11768
SCNN1A-7920	+	UGGGUGGGGAACCGGGAGGACAG	23	11769
SCNN1A-7921	+	CUGGGUGGGGAACCGGGAGGACAG	24	11770
SCNN1A-7922	+	GACCCGGGAGGGGCCCAG	18	11771
SCNN1A-7923	+	AGACCCGGGAGGGGCCCAG	19	11772
SCNN1A-7924	+	CAGACCCGGGAGGGGCCCAG	20	11773
SCNN1A-7925	+	CCAGACCCGGGAGGGGCCCAG	21	11774
SCNN1A-7926	+	UCCAGACCCGGGAGGGGCCCAG	22	11775
SCNN1A-7927	+	GUCCAGACCCGGGAGGGGCCCAG	23	11776
SCNN1A-7928	+	UGUCCAGACCCGGGAGGGGCCCAG	24	11777
SCNN1A-7929	+	CUGAGUGAGUAGAGGCAG	18	11778
SCNN1A-7930	+	ACUGAGUGAGUAGAGGCAG	19	11779
SCNN1A-7931	+	CACUGAGUGAGUAGAGGCAG	20	11780
SCNN1A-7932	+	GCACUGAGUGAGUAGAGGCAG	21	11781
SCNN1A-7933	+	GGCACUGAGUGAGUAGAGGCAG	22	11782
SCNN1A-7934	+	GGGCACUGAGUGAGUAGAGGCAG	23	11783
SCNN1A-7935	+	GGGGCACUGAGUGAGUAGAGGCAG	24	11784
SCNN1A-7936	+	GAGGGCUCCCGAGGGCAG	18	11785
SCNN1A-7937	+	GGAGGGCUCCCGAGGGCAG	19	11786
SCNN1A-7938	+	AGGAGGGCUCCCGAGGGCAG	20	11787
SCNN1A-7939	+	AAGGAGGGCUCCCGAGGGCAG	21	11788
SCNN1A-7940	+	GAAGGAGGGCUCCCGAGGGCAG	22	11789
SCNN1A-7941	+	GGAAGGAGGGCUCCCGAGGGCAG	23	11790
SCNN1A-7942	+	AGGAAGGAGGGCUCCCGAGGGCAG	24	11791
SCNN1A-7943	+	UGGGGGACAGGAUGGCAG	18	11792
SCNN1A-7944	+	CUGGGGGACAGGAUGGCAG	19	11793
SCNN1A-7945	+	GCUGGGGGACAGGAUGGCAG	20	11794
SCNN1A-7946	+	GGCUGGGGGACAGGAUGGCAG	21	11795
SCNN1A-7947	+	AGGCUGGGGGACAGGAUGGCAG	22	11796
SCNN1A-7948	+	GAGGCUGGGGGACAGGAUGGCAG	23	11797
SCNN1A-7949	+	GGAGGCUGGGGGACAGGAUGGCAG	24	11798
SCNN1A-7950	+	UGGGAGCAGCGCACUCAG	18	11799
SCNN1A-7951	+	GUGGGAGCAGCGCACUCAG	19	11800
SCNN1A-7952	+	AGUGGGAGCAGCGCACUCAG	20	11801
SCNN1A-7953	+	AAGUGGGAGCAGCGCACUCAG	21	11802
SCNN1A-7954	+	UAAGUGGGAGCAGCGCACUCAG	22	11803
SCNN1A-7955	+	CUAAGUGGGAGCAGCGCACUCAG	23	11804
SCNN1A-7956	+	ACUAAGUGGGAGCAGCGCACUCAG	24	11805
SCNN1A-7957	+	CCCUCAGGCCCUGCAGAG	18	11806
SCNN1A-7958	+	ACCCUCAGGCCCUGCAGAG	19	11807
SCNN1A-7959	+	CACCCUCAGGCCCUGCAGAG	20	11808
SCNN1A-7960	+	UCACCCUCAGGCCCUGCAGAG	21	11809
SCNN1A-7961	+	CUCACCCUCAGGCCCUGCAGAG	22	11810
SCNN1A-7962	+	CCUCACCCUCAGGCCCUGCAGAG	23	11811
SCNN1A-7963	+	GCCUCACCCUCAGGCCCUGCAGAG	24	11812
SCNN1A-7964	+	GCUGAGGAGGAGUCAGAG	18	11813
SCNN1A-7965	+	GGCUGAGGAGGAGUCAGAG	19	11814
SCNN1A-7966	+	GGGCUGAGGAGGAGUCAGAG	20	11815
SCNN1A-7967	+	GGGGCUGAGGAGGAGUCAGAG	21	11816
SCNN1A-7968	+	AGGGGCUGAGGAGGAGUCAGAG	22	11817
SCNN1A-7969	+	GAGGGGCUGAGGAGGAGUCAGAG	23	11818
SCNN1A-7970	+	GGAGGGGCUGAGGAGGAGUCAGAG	24	11819
SCNN1A-7971	+	GCCCUGCAGAGAAGAGAG	18	11820
SCNN1A-7972	+	GGCCCUGCAGAGAAGAGAG	19	11821
SCNN1A-7973	+	AGGCCCUGCAGAGAAGAGAG	20	11822
SCNN1A-7974	+	CAGGCCCUGCAGAGAAGAGAG	21	11823
SCNN1A-7975	+	UCAGGCCCUGCAGAGAAGAGAG	22	11824
SCNN1A-7976	+	CUCAGGCCCUGCAGAGAAGAGAG	23	11825
SCNN1A-7977	+	CCUCAGGCCCUGCAGAGAAGAGAG	24	11826
SCNN1A-7978	+	UGGUGAGCAAGGAGAGAG	18	11827
SCNN1A-7979	+	GUGGUGAGCAAGGAGAGAG	19	11828
SCNN1A-6146	+	AGUGGUGAGCAAGGAGAGAG	20	9995
SCNN1A-7980	+	AAGUGGUGAGCAAGGAGAGAG	21	11829
SCNN1A-7981	+	CAAGUGGUGAGCAAGGAGAGAG	22	11830
SCNN1A-7982	+	CCAAGUGGUGAGCAAGGAGAGAG	23	11831
SCNN1A-7983	+	GCCAAGUGGUGAGCAAGGAGAGAG	24	11832
SCNN1A-7984	+	AAGAGGGAGACAAUAGAG	18	11833
SCNN1A-7985	+	AAAGAGGGAGACAAUAGAG	19	11834
SCNN1A-5896	+	GAAAGAGGGAGACAAUAGAG	20	9745
SCNN1A-7986	+	AGAAAGAGGGAGACAAUAGAG	21	11835
SCNN1A-7987	+	CAGAAAGAGGGAGACAAUAGAG	22	11836
SCNN1A-7988	+	GCAGAAAGAGGGAGACAAUAGAG	23	11837
SCNN1A-7989	+	GGCAGAAAGAGGGAGACAAUAGAG	24	11838
SCNN1A-7990	+	GGAGGGCAACACAAGGAG	18	11839
SCNN1A-7991	+	AGGAGGGCAACACAAGGAG	19	11840
SCNN1A-7992	+	UAGGAGGGCAACACAAGGAG	20	11841
SCNN1A-7993	+	CUAGGAGGGCAACACAAGGAG	21	11842
SCNN1A-7994	+	GCUAGGAGGGCAACACAAGGAG	22	11843
SCNN1A-7995	+	AGCUAGGAGGGCAACACAAGGAG	23	11844
SCNN1A-7996	+	CAGCUAGGAGGGCAACACAAGGAG	24	11845
SCNN1A-7997	+	GACAGGCCCUGGGAGGAG	18	11846
SCNN1A-7998	+	AGACAGGCCCUGGGAGGAG	19	11847
SCNN1A-7999	+	UAGACAGGCCCUGGGAGGAG	20	11848
SCNN1A-8000	+	CUAGACAGGCCCUGGGAGGAG	21	11849
SCNN1A-8001	+	CCUAGACAGGCCCUGGGAGGAG	22	11850
SCNN1A-8002	+	GCCUAGACAGGCCCUGGGAGGAG	23	11851
SCNN1A-8003	+	CGCCUAGACAGGCCCUGGGAGGAG	24	11852
SCNN1A-8004	+	UAGAAAACAAAAUAGGAG	18	11853
SCNN1A-8005	+	UUAGAAAACAAAAUAGGAG	19	11854
SCNN1A-8006	+	GUUAGAAAACAAAAUAGGAG	20	11855
SCNN1A-8007	+	GGUUAGAAAACAAAAUAGGAG	21	11856
SCNN1A-8008	+	AGGUUAGAAAACAAAAUAGGAG	22	11857
SCNN1A-8009	+	GAGGUUAGAAAACAAAAUAGGAG	23	11858
SCNN1A-8010	+	UGAGGUUAGAAAACAAAAUAGGAG	24	11859
SCNN1A-8011	+	GGGCCAAAAGUGCCGGAG	18	11860
SCNN1A-8012	+	GGGGCCAAAAGUGCCGGAG	19	11861
SCNN1A-8013	+	UGGGGCCAAAAGUGCCGGAG	20	11862
SCNN1A-8014	+	UUGGGGCCAAAAGUGCCGGAG	21	11863
SCNN1A-8015	+	GUUGGGGCCAAAAGUGCCGGAG	22	11864
SCNN1A-8016	+	AGUUGGGGCCAAAAGUGCCGGAG	23	11865
SCNN1A-8017	+	GAGUUGGGGCCAAAAGUGCCGGAG	24	11866
SCNN1A-8018	+	CCAGCAGACCUGCGGGAG	18	11867
SCNN1A-8019	+	GCCAGCAGACCUGCGGGAG	19	11868
SCNN1A-8020	+	AGCCAGCAGACCUGCGGGAG	20	11869
SCNN1A-8021	+	GAGCCAGCAGACCUGCGGGAG	21	11870
SCNN1A-8022	+	GGAGCCAGCAGACCUGCGGGAG	22	11871
SCNN1A-8023	+	UGGAGCCAGCAGACCUGCGGGAG	23	11872
SCNN1A-8024	+	CUGGAGCCAGCAGACCUGCGGGAG	24	11873
SCNN1A-8025	+	CUAGACAGGCCCUGGGAG	18	11874
SCNN1A-8026	+	CCUAGACAGGCCCUGGGAG	19	11875
SCNN1A-8027	+	GCCUAGACAGGCCCUGGGAG	20	11876
SCNN1A-8028	+	CGCCUAGACAGGCCCUGGGAG	21	11877
SCNN1A-8029	+	ACGCCUAGACAGGCCCUGGGAG	22	11878
SCNN1A-8030	+	CACGCCUAGACAGGCCCUGGGAG	23	11879
SCNN1A-8031	+	ACACGCCUAGACAGGCCCUGGGAG	24	11880
SCNN1A-8032	+	AGAGAGAUAGGGAUGGAG	18	11881
SCNN1A-8033	+	CAGAGAGAUAGGGAUGGAG	19	11882
SCNN1A-8034	+	ACAGAGAGAUAGGGAUGGAG	20	11883
SCNN1A-8035	+	GACAGAGAGAUAGGGAUGGAG	21	11884
SCNN1A-8036	+	GGACAGAGAGAUAGGGAUGGAG	22	11885
SCNN1A-8037	+	AGGACAGAGAGAUAGGGAUGGAG	23	11886
SCNN1A-8038	+	AAGGACAGAGAGAUAGGGAUGGAG	24	11887
SCNN1A-8039	+	GCGGGGGGAGGGGCUGAG	18	11888
SCNN1A-8040	+	GGCGGGGGGAGGGGCUGAG	19	11889
SCNN1A-8041	+	GGGCGGGGGGAGGGGCUGAG	20	11890
SCNN1A-8042	+	AGGGCGGGGGGAGGGGCUGAG	21	11891
SCNN1A-8043	+	CAGGGCGGGGGGAGGGGCUGAG	22	11892
SCNN1A-8044	+	GCAGGGCGGGGGGAGGGGCUGAG	23	11893
SCNN1A-8045	+	AGCAGGGCGGGGGGAGGGGCUGAG	24	11894
SCNN1A-8046	+	GGAGGGGCACUGAGUGAG	18	11895
SCNN1A-8047	+	AGGAGGGGCACUGAGUGAG	19	11896
SCNN1A-8048	+	GAGGAGGGGCACUGAGUGAG	20	11897
SCNN1A-8049	+	GGAGGAGGGGCACUGAGUGAG	21	11898
SCNN1A-8050	+	UGGAGGAGGGGCACUGAGUGAG	22	11899
SCNN1A-8051	+	AUGGAGGAGGGGCACUGAGUGAG	23	11900
SCNN1A-8052	+	GAUGGAGGAGGGGCACUGAGUGAG	24	11901
SCNN1A-8053	+	AUCUCAAUUAAAGGUGAG	18	11902
SCNN1A-8054	+	CAUCUCAAUUAAAGGUGAG	19	11903
SCNN1A-8055	+	GCAUCUCAAUUAAAGGUGAG	20	11904
SCNN1A-8056	+	AGCAUCUCAAUUAAAGGUGAG	21	11905
SCNN1A-8057	+	UAGCAUCUCAAUUAAAGGUGAG	22	11906
SCNN1A-8058	+	UUAGCAUCUCAAUUAAAGGUGAG	23	11907
SCNN1A-8059	+	AUUAGCAUCUCAAUUAAAGGUGAG	24	11908
SCNN1A-8060	+	AGUGGUGGGGGCAAAUAG	18	11909
SCNN1A-8061	+	CAGUGGUGGGGGCAAAUAG	19	11910
SCNN1A-8062	+	GCAGUGGUGGGGGCAAAUAG	20	11911
SCNN1A-8063	+	GGCAGUGGUGGGGGCAAAUAG	21	11912
SCNN1A-8064	+	GGGCAGUGGUGGGGGCAAAUAG	22	11913
SCNN1A-8065	+	GGGGCAGUGGUGGGGGCAAAUAG	23	11914
SCNN1A-8066	+	GGGGGCAGUGGUGGGGGCAAAUAG	24	11915
SCNN1A-8067	+	UCCUGAGCCCACAGCUAG	18	11916
SCNN1A-8068	+	AUCCUGAGCCCACAGCUAG	19	11917
SCNN1A-8069	+	GAUCCUGAGCCCACAGCUAG	20	11918
SCNN1A-8070	+	GGAUCCUGAGCCCACAGCUAG	21	11919
SCNN1A-8071	+	AGGAUCCUGAGCCCACAGCUAG	22	11920
SCNN1A-8072	+	AAGGAUCCUGAGCCCACAGCUAG	23	11921
SCNN1A-8073	+	GAAGGAUCCUGAGCCCACAGCUAG	24	11922
SCNN1A-8074	+	AUAAGAGCCAAGGGCUAG	18	11923
SCNN1A-8075	+	CAUAAGAGCCAAGGGCUAG	19	11924
SCNN1A-5662	+	ACAUAAGAGCCAAGGGCUAG	20	9511
SCNN1A-8076	+	GACAUAAGAGCCAAGGGCUAG	21	11925
SCNN1A-8077	+	AGACAUAAGAGCCAAGGGCUAG	22	11926
SCNN1A-8078	+	AAGACAUAAGAGCCAAGGGCUAG	23	11927
SCNN1A-8079	+	UAAGACAUAAGAGCCAAGGGCUAG	24	11928
SCNN1A-8080	+	GGUGAAGCUGGGGGCUAG	18	11929
SCNN1A-8081	+	AGGUGAAGCUGGGGGCUAG	19	11930
SCNN1A-8082	+	CAGGUGAAGCUGGGGGCUAG	20	11931
SCNN1A-8083	+	CCAGGUGAAGCUGGGGGCUAG	21	11932
SCNN1A-8084	+	CCCAGGUGAAGCUGGGGGCUAG	22	11933
SCNN1A-8085	+	GCCCAGGUGAAGCUGGGGGCUAG	23	11934
SCNN1A-8086	+	GGCCCAGGUGAAGCUGGGGGCUAG	24	11935
SCNN1A-8087	+	GGCAGCGCGAGGGCCACG	18	11936
SCNN1A-8088	+	AGGCAGCGCGAGGGCCACG	19	11937
SCNN1A-8089	+	GAGGCAGCGCGAGGGCCACG	20	11938
SCNN1A-8090	+	AGAGGCAGCGCGAGGGCCACG	21	11939
SCNN1A-8091	+	CAGAGGCAGCGCGAGGGCCACG	22	11940
SCNN1A-8092	+	CCAGAGGCAGCGCGAGGGCCACG	23	11941
SCNN1A-8093	+	ACCAGAGGCAGCGCGAGGGCCACG	24	11942
SCNN1A-8094	+	GAGCAUUGAUACACACCG	18	11943
SCNN1A-8095	+	UGAGCAUUGAUACACACCG	19	11944
SCNN1A-5665	+	CUGAGCAUUGAUACACACCG	20	9514
SCNN1A-8096	+	CCUGAGCAUUGAUACACACCG	21	11945
SCNN1A-8097	+	GCCUGAGCAUUGAUACACACCG	22	11946
SCNN1A-8098	+	AGCCUGAGCAUUGAUACACACCG	23	11947
SCNN1A-8099	+	CAGCCUGAGCAUUGAUACACACCG	24	11948
SCNN1A-8100	+	AGAGCCGGGAGUUUUCCG	18	11949
SCNN1A-8101	+	CAGAGCCGGGAGUUUUCCG	19	11950
SCNN1A-8102	+	UCAGAGCCGGGAGUUUUCCG	20	11951
SCNN1A-8103	+	GUCAGAGCCGGGAGUUUUCCG	21	11952
SCNN1A-8104	+	AGUCAGAGCCGGGAGUUUUCCG	22	11953
SCNN1A-8105	+	GAGUCAGAGCCGGGAGUUUUCCG	23	11954
SCNN1A-8106	+	GGAGUCAGAGCCGGGAGUUUUCCG	24	11955
SCNN1A-8107	+	CAAUAGAGAGGGACAGCG	18	11956
SCNN1A-8108	+	ACAAUAGAGAGGGACAGCG	19	11957
SCNN1A-8109	+	GACAAUAGAGAGGGACAGCG	20	11958
SCNN1A-8110	+	AGACAAUAGAGAGGGACAGCG	21	11959
SCNN1A-8111	+	GAGACAAUAGAGAGGGACAGCG	22	11960
SCNN1A-8112	+	GGAGACAAUAGAGAGGGACAGCG	23	11961
SCNN1A-8113	+	GGGAGACAAUAGAGAGGGACAGCG	24	11962
SCNN1A-8114	+	GGGAGGAUGUGGCCAGCG	18	11963
SCNN1A-8115	+	AGGGAGGAUGUGGCCAGCG	19	11964
SCNN1A-8116	+	CAGGGAGGAUGUGGCCAGCG	20	11965
SCNN1A-8117	+	GCAGGGAGGAUGUGGCCAGCG	21	11966
SCNN1A-8118	+	UGCAGGGAGGAUGUGGCCAGCG	22	11967
SCNN1A-8119	+	GUGCAGGGAGGAUGUGGCCAGCG	23	11968
SCNN1A-8120	+	GGUGCAGGGAGGAUGUGGCCAGCG	24	11969
SCNN1A-8121	+	UUAAAGGUGAGCAGGGCG	18	11970
SCNN1A-8122	+	AUUAAAGGUGAGCAGGGCG	19	11971
SCNN1A-5669	+	AAUUAAAGGUGAGCAGGGCG	20	9518
SCNN1A-8123	+	CAAUUAAAGGUGAGCAGGGCG	21	11972
SCNN1A-8124	+	UCAAUUAAAGGUGAGCAGGGCG	22	11973
SCNN1A-8125	+	CUCAAUUAAAGGUGAGCAGGGCG	23	11974
SCNN1A-8126	+	UCUCAAUUAAAGGUGAGCAGGGCG	24	11975
SCNN1A-8127	+	UGGCCAGCGCUGGAAAGG	18	11976
SCNN1A-8128	+	GUGGCCAGCGCUGGAAAGG	19	11977
SCNN1A-8129	+	UGUGGCCAGCGCUGGAAAGG	20	11978
SCNN1A-8130	+	AUGUGGCCAGCGCUGGAAAGG	21	11979
SCNN1A-8131	+	GAUGUGGCCAGCGCUGGAAAGG	22	11980
SCNN1A-8132	+	GGAUGUGGCCAGCGCUGGAAAGG	23	11981
SCNN1A-8133	+	AGGAUGUGGCCAGCGCUGGAAAGG	24	11982
SCNN1A-8134	+	CCAGGAAGGAGAGCAAGG	18	11983
SCNN1A-8135	+	UCCAGGAAGGAGAGCAAGG	19	11984
SCNN1A-6151	+	CUCCAGGAAGGAGAGCAAGG	20	10000
SCNN1A-8136	+	UCUCCAGGAAGGAGAGCAAGG	21	11985
SCNN1A-8137	+	GUCUCCAGGAAGGAGAGCAAGG	22	11986
SCNN1A-8138	+	UGUCUCCAGGAAGGAGAGCAAGG	23	11987
SCNN1A-8139	+	CUGUCUCCAGGAAGGAGAGCAAGG	24	11988
SCNN1A-1604	+	CAAGGGUCAGGGUCAAGG	18	5453
SCNN1A-1605	+	GCAAGGGUCAGGGUCAAGG	19	5454
SCNN1A-1606	+	AGCAAGGGUCAGGGUCAAGG	20	5455
SCNN1A-1607	+	GAGCAAGGGUCAGGGUCAAGG	21	5456
SCNN1A-1608	+	AGAGCAAGGGUCAGGGUCAAGG	22	5457
SCNN1A-1609	+	GAGAGCAAGGGUCAGGGUCAAGG	23	5458
SCNN1A-1610	+	GGAGAGCAAGGGUCAGGGUCAAGG	24	5459
SCNN1A-8140	+	CCGGGAGUUUUCCGAAGG	18	11989
SCNN1A-8141	+	GCCGGGAGUUUUCCGAAGG	19	11990
SCNN1A-8142	+	AGCCGGGAGUUUUCCGAAGG	20	11991
SCNN1A-8143	+	GAGCCGGGAGUUUUCCGAAGG	21	11992
SCNN1A-8144	+	AGAGCCGGGAGUUUUCCGAAGG	22	11993
SCNN1A-8145	+	CAGAGCCGGGAGUUUUCCGAAGG	23	11994
SCNN1A-8146	+	UCAGAGCCGGGAGUUUUCCGAAGG	24	11995
SCNN1A-8147	+	ACAGACCCGGAGCCCAGG	18	11996
SCNN1A-8148	+	CACAGACCCGGAGCCCAGG	19	11997
SCNN1A-8149	+	ACACAGACCCGGAGCCCAGG	20	11998
SCNN1A-8150	+	GACACAGACCCGGAGCCCAGG	21	11999
SCNN1A-8151	+	GGACACAGACCCGGAGCCCAGG	22	12000
SCNN1A-8152	+	UGGACACAGACCCGGAGCCCAGG	23	12001
SCNN1A-8153	+	GUGGACACAGACCCGGAGCCCAGG	24	12002
SCNN1A-8154	+	GAGAAGGGGCCAGCCAGG	18	12003
SCNN1A-8155	+	GGAGAAGGGGCCAGCCAGG	19	12004
SCNN1A-8156	+	AGGAGAAGGGGCCAGCCAGG	20	12005
SCNN1A-8157	+	AAGGAGAAGGGGCCAGCCAGG	21	12006
SCNN1A-8158	+	CAAGGAGAAGGGGCCAGCCAGG	22	12007
SCNN1A-8159	+	ACAAGGAGAAGGGGCCAGCCAGG	23	12008
SCNN1A-8160	+	CACAAGGAGAAGGGGCCAGCCAGG	24	12009
SCNN1A-8161	+	AGGGAGUCUGUCUCCAGG	18	12010
SCNN1A-8162	+	AAGGGAGUCUGUCUCCAGG	19	12011
SCNN1A-8163	+	AAAGGGAGUCUGUCUCCAGG	20	12012
SCNN1A-8164	+	CAAAGGGAGUCUGUCUCCAGG	21	12013
SCNN1A-8165	+	CCAAAGGGAGUCUGUCUCCAGG	22	12014
SCNN1A-8166	+	ACCAAAGGGAGUCUGUCUCCAGG	23	12015
SCNN1A-8167	+	CACCAAAGGGAGUCUGUCUCCAGG	24	12016
SCNN1A-8168	+	CAAUUAAAGGUGAGCAGG	18	12017
SCNN1A-8169	+	UCAAUUAAAGGUGAGCAGG	19	12018
SCNN1A-8170	+	CUCAAUUAAAGGUGAGCAGG	20	12019
SCNN1A-8171	+	UCUCAAUUAAAGGUGAGCAGG	21	12020
SCNN1A-8172	+	AUCUCAAUUAAAGGUGAGCAGG	22	12021
SCNN1A-8173	+	CAUCUCAAUUAAAGGUGAGCAGG	23	12022
SCNN1A-8174	+	GCAUCUCAAUUAAAGGUGAGCAGG	24	12023
SCNN1A-8175	+	UGAGUGAGUAGAGGCAGG	18	12024
SCNN1A-8176	+	CUGAGUGAGUAGAGGCAGG	19	12025
SCNN1A-5677	+	ACUGAGUGAGUAGAGGCAGG	20	9526
SCNN1A-8177	+	CACUGAGUGAGUAGAGGCAGG	21	12026
SCNN1A-8178	+	GCACUGAGUGAGUAGAGGCAGG	22	12027
SCNN1A-8179	+	GGCACUGAGUGAGUAGAGGCAGG	23	12028
SCNN1A-8180	+	GGGCACUGAGUGAGUAGAGGCAGG	24	12029
SCNN1A-8181	+	GCGCUGGAAAGGAAGAGG	18	12030
SCNN1A-8182	+	AGCGCUGGAAAGGAAGAGG	19	12031
SCNN1A-8183	+	CAGCGCUGGAAAGGAAGAGG	20	12032
SCNN1A-8184	+	CCAGCGCUGGAAAGGAAGAGG	21	12033
SCNN1A-8185	+	GCCAGCGCUGGAAAGGAAGAGG	22	12034
SCNN1A-8186	+	GGCCAGCGCUGGAAAGGAAGAGG	23	12035
SCNN1A-8187	+	UGGCCAGCGCUGGAAAGGAAGAGG	24	12036
SCNN1A-8188	+	CCGGAGCCCAGGAAGAGG	18	12037
SCNN1A-8189	+	CCCGGAGCCCAGGAAGAGG	19	12038
SCNN1A-8190	+	ACCCGGAGCCCAGGAAGAGG	20	12039
SCNN1A-8191	+	GACCCGGAGCCCAGGAAGAGG	21	12040
SCNN1A-8192	+	AGACCCGGAGCCCAGGAAGAGG	22	12041
SCNN1A-8193	+	CAGACCCGGAGCCCAGGAAGAGG	23	12042
SCNN1A-8194	+	ACAGACCCGGAGCCCAGGAAGAGG	24	12043
SCNN1A-8195	+	CGCAGACAGGCAAGGAGG	18	12044
SCNN1A-8196	+	ACGCAGACAGGCAAGGAGG	19	12045
SCNN1A-8197	+	GACGCAGACAGGCAAGGAGG	20	12046
SCNN1A-8198	+	AGACGCAGACAGGCAAGGAGG	21	12047
SCNN1A-8199	+	UAGACGCAGACAGGCAAGGAGG	22	12048
SCNN1A-8200	+	UUAGACGCAGACAGGCAAGGAGG	23	12049
SCNN1A-8201	+	UUUAGACGCAGACAGGCAAGGAGG	24	12050
SCNN1A-8202	+	UAGACAGGCCCUGGGAGG	18	12051
SCNN1A-8203	+	CUAGACAGGCCCUGGGAGG	19	12052
SCNN1A-6157	+	CCUAGACAGGCCCUGGGAGG	20	10006
SCNN1A-8204	+	GCCUAGACAGGCCCUGGGAGG	21	12053
SCNN1A-8205	+	CGCCUAGACAGGCCCUGGGAGG	22	12054
SCNN1A-8206	+	ACGCCUAGACAGGCCCUGGGAGG	23	12055
SCNN1A-8207	+	CACGCCUAGACAGGCCCUGGGAGG	24	12056
SCNN1A-8208	+	GAGAGAUAGGGAUGGAGG	18	12057
SCNN1A-8209	+	AGAGAGAUAGGGAUGGAGG	19	12058
SCNN1A-6158	+	CAGAGAGAUAGGGAUGGAGG	20	10007
SCNN1A-8210	+	ACAGAGAGAUAGGGAUGGAGG	21	12059
SCNN1A-8211	+	GACAGAGAGAUAGGGAUGGAGG	22	12060
SCNN1A-8212	+	GGACAGAGAGAUAGGGAUGGAGG	23	12061
SCNN1A-8213	+	AGGACAGAGAGAUAGGGAUGGAGG	24	12062
SCNN1A-8214	+	GUGAAGCUGGGGGCUAGG	18	12063
SCNN1A-8215	+	GGUGAAGCUGGGGGCUAGG	19	12064
SCNN1A-5681	+	AGGUGAAGCUGGGGGCUAGG	20	9530
SCNN1A-8216	+	CAGGUGAAGCUGGGGGCUAGG	21	12065
SCNN1A-8217	+	CCAGGUGAAGCUGGGGGCUAGG	22	12066
SCNN1A-8218	+	CCCAGGUGAAGCUGGGGGCUAGG	23	12067
SCNN1A-8219	+	GCCCAGGUGAAGCUGGGGGCUAGG	24	12068
SCNN1A-8220	+	GCCUGGGUGGGGAACCGG	18	12069
SCNN1A-8221	+	GGCCUGGGUGGGGAACCGG	19	12070
SCNN1A-8222	+	GGGCCUGGGUGGGGAACCGG	20	12071
SCNN1A-8223	+	AGGGCCUGGGUGGGGAACCGG	21	12072
SCNN1A-8224	+	GAGGGCCUGGGUGGGGAACCGG	22	12073
SCNN1A-8225	+	AGAGGGCCUGGGUGGGGAACCGG	23	12074
SCNN1A-8226	+	GAGAGGGCCUGGGUGGGGAACCGG	24	12075
SCNN1A-8227	+	AGCAUUGAUACACACCGG	18	12076
SCNN1A-8228	+	GAGCAUUGAUACACACCGG	19	12077
SCNN1A-5682	+	UGAGCAUUGAUACACACCGG	20	9531
SCNN1A-8229	+	CUGAGCAUUGAUACACACCGG	21	12078
SCNN1A-8230	+	CCUGAGCAUUGAUACACACCGG	22	12079
SCNN1A-8231	+	GCCUGAGCAUUGAUACACACCGG	23	12080
SCNN1A-8232	+	AGCCUGAGCAUUGAUACACACCGG	24	12081
SCNN1A-8233	+	AACCUUGUCCAGACCCGG	18	12082
SCNN1A-8234	+	CAACCUUGUCCAGACCCGG	19	12083
SCNN1A-8235	+	CCAACCUUGUCCAGACCCGG	20	12084
SCNN1A-8236	+	UCCAACCUUGUCCAGACCCGG	21	12085
SCNN1A-8237	+	CUCCAACCUUGUCCAGACCCGG	22	12086
SCNN1A-8238	+	CCUCCAACCUUGUCCAGACCCGG	23	12087
SCNN1A-8239	+	CCCUCCAACCUUGUCCAGACCCGG	24	12088
SCNN1A-8240	+	CCCAGGCCCUGCACGCGG	18	12089
SCNN1A-8241	+	ACCCAGGCCCUGCACGCGG	19	12090
SCNN1A-8242	+	AACCCAGGCCCUGCACGCGG	20	12091
SCNN1A-8243	+	CAACCCAGGCCCUGCACGCGG	21	12092
SCNN1A-8244	+	ACAACCCAGGCCCUGCACGCGG	22	12093
SCNN1A-8245	+	CACAACCCAGGCCCUGCACGCGG	23	12094
SCNN1A-8246	+	ACACAACCCAGGCCCUGCACGCGG	24	12095
SCNN1A-8247	+	UAAAGGUGAGCAGGGCGG	18	12096
SCNN1A-8248	+	UUAAAGGUGAGCAGGGCGG	19	12097
SCNN1A-5683	+	AUUAAAGGUGAGCAGGGCGG	20	9532
SCNN1A-8249	+	AAUUAAAGGUGAGCAGGGCGG	21	12098
SCNN1A-8250	+	CAAUUAAAGGUGAGCAGGGCGG	22	12099
SCNN1A-8251	+	UCAAUUAAAGGUGAGCAGGGCGG	23	12100
SCNN1A-8252	+	CUCAAUUAAAGGUGAGCAGGGCGG	24	12101
SCNN1A-8253	+	CCCACUCCCAGGUUGCGG	18	12102
SCNN1A-8254	+	UCCCACUCCCAGGUUGCGG	19	12103
SCNN1A-8255	+	UUCCCACUCCCAGGUUGCGG	20	12104
SCNN1A-8256	+	CUUCCCACUCCCAGGUUGCGG	21	12105
SCNN1A-8257	+	GCUUCCCACUCCCAGGUUGCGG	22	12106
SCNN1A-8258	+	AGCUUCCCACUCCCAGGUUGCGG	23	12107
SCNN1A-8259	+	CAGCUUCCCACUCCCAGGUUGCGG	24	12108
SCNN1A-8260	+	GGGCUGGAGGAGACUCGG	18	12109
SCNN1A-8261	+	AGGGCUGGAGGAGACUCGG	19	12110
SCNN1A-8262	+	AAGGGCUGGAGGAGACUCGG	20	12111
SCNN1A-8263	+	AAAGGGCUGGAGGAGACUCGG	21	12112
SCNN1A-8264	+	AAAAGGGCUGGAGGAGACUCGG	22	12113
SCNN1A-8265	+	AAAAAGGGCUGGAGGAGACUCGG	23	12114
SCNN1A-8266	+	CAAAAAGGGCUGGAGGAGACUCGG	24	12115
SCNN1A-8267	+	AAUCAGACCCAAAAAGGG	18	12116
SCNN1A-8268	+	GAAUCAGACCCAAAAAGGG	19	12117
SCNN1A-8269	+	AGAAUCAGACCCAAAAAGGG	20	12118
SCNN1A-8270	+	GAGAAUCAGACCCAAAAAGGG	21	12119
SCNN1A-8271	+	AGAGAAUCAGACCCAAAAAGGG	22	12120
SCNN1A-8272	+	CAGAGAAUCAGACCCAAAAAGGG	23	12121
SCNN1A-8273	+	UCAGAGAAUCAGACCCAAAAAGGG	24	12122
SCNN1A-8274	+	CCCGCUGGCCGGCCAGGG	18	12123
SCNN1A-8275	+	GCCCGCUGGCCGGCCAGGG	19	12124
SCNN1A-8276	+	CGCCCGCUGGCCGGCCAGGG	20	12125
SCNN1A-8277	+	CCGCCCGCUGGCCGGCCAGGG	21	12126
SCNN1A-8278	+	CCCGCCCGCUGGCCGGCCAGGG	22	12127
SCNN1A-8279	+	GCCCGCCCGCUGGCCGGCCAGGG	23	12128
SCNN1A-8280	+	AGCCCGCCCGCUGGCCGGCCAGGG	24	12129
SCNN1A-8281	+	AAUUAAAGGUGAGCAGGG	18	12130
SCNN1A-8282	+	CAAUUAAAGGUGAGCAGGG	19	12131
SCNN1A-6160	+	UCAAUUAAAGGUGAGCAGGG	20	10009
SCNN1A-8283	+	CUCAAUUAAAGGUGAGCAGGG	21	12132
SCNN1A-8284	+	UCUCAAUUAAAGGUGAGCAGGG	22	12133
SCNN1A-8285	+	AUCUCAAUUAAAGGUGAGCAGGG	23	12134
SCNN1A-8286	+	CAUCUCAAUUAAAGGUGAGCAGGG	24	12135
SCNN1A-8287	+	ACCGGGAGGACAGGAGGG	18	12136
SCNN1A-8288	+	AACCGGGAGGACAGGAGGG	19	12137
SCNN1A-8289	+	GAACCGGGAGGACAGGAGGG	20	12138
SCNN1A-8290	+	GGAACCGGGAGGACAGGAGGG	21	12139
SCNN1A-8291	+	GGGAACCGGGAGGACAGGAGGG	22	12140
SCNN1A-8292	+	GGGGAACCGGGAGGACAGGAGGG	23	12141
SCNN1A-8293	+	UGGGGAACCGGGAGGACAGGAGGG	24	12142
SCNN1A-8294	+	AAGGACAGAGAGAUAGGG	18	12143
SCNN1A-8295	+	GAAGGACAGAGAGAUAGGG	19	12144
SCNN1A-8296	+	CGAAGGACAGAGAGAUAGGG	20	12145
SCNN1A-8297	+	GCGAAGGACAGAGAGAUAGGG	21	12146
SCNN1A-8298	+	AGCGAAGGACAGAGAGAUAGGG	22	12147
SCNN1A-8299	+	CAGCGAAGGACAGAGAGAUAGGG	23	12148
SCNN1A-8300	+	ACAGCGAAGGACAGAGAGAUAGGG	24	12149
SCNN1A-8301	+	ACCUUGUCCAGACCCGGG	18	12150
SCNN1A-8302	+	AACCUUGUCCAGACCCGGG	19	12151
SCNN1A-5686	+	CAACCUUGUCCAGACCCGGG	20	9535
SCNN1A-8303	+	CCAACCUUGUCCAGACCCGGG	21	12152
SCNN1A-8304	+	UCCAACCUUGUCCAGACCCGGG	22	12153
SCNN1A-8305	+	CUCCAACCUUGUCCAGACCCGGG	23	12154
SCNN1A-8306	+	CCUCCAACCUUGUCCAGACCCGGG	24	12155
SCNN1A-8307	+	AAAGGUGAGCAGGGCGGG	18	12156
SCNN1A-8308	+	UAAAGGUGAGCAGGGCGGG	19	12157
SCNN1A-5688	+	UUAAAGGUGAGCAGGGCGGG	20	9537
SCNN1A-8309	+	AUUAAAGGUGAGCAGGGCGGG	21	12158
SCNN1A-8310	+	AAUUAAAGGUGAGCAGGGCGGG	22	12159
SCNN1A-8311	+	CAAUUAAAGGUGAGCAGGGCGGG	23	12160
SCNN1A-8312	+	UCAAUUAAAGGUGAGCAGGGCGGG	24	12161
SCNN1A-8313	+	GCAGGGCGGGGGGAGGGG	18	12162
SCNN1A-8314	+	AGCAGGGCGGGGGGAGGGG	19	12163
SCNN1A-8315	+	GAGCAGGGCGGGGGGAGGGG	20	12164
SCNN1A-8316	+	UGAGCAGGGCGGGGGGAGGGG	21	12165
SCNN1A-8317	+	GUGAGCAGGGCGGGGGGAGGGG	22	12166
SCNN1A-8318	+	GGUGAGCAGGGCGGGGGGAGGGG	23	12167
SCNN1A-8319	+	AGGUGAGCAGGGCGGGGGGAGGGG	24	12168
SCNN1A-8320	+	CAUUGAUACACACCGGGG	18	12169
SCNN1A-8321	+	GCAUUGAUACACACCGGGG	19	12170
SCNN1A-8322	+	AGCAUUGAUACACACCGGGG	20	12171
SCNN1A-8323	+	GAGCAUUGAUACACACCGGGG	21	12172
SCNN1A-8324	+	UGAGCAUUGAUACACACCGGGG	22	12173
SCNN1A-8325	+	CUGAGCAUUGAUACACACCGGGG	23	12174
SCNN1A-8326	+	CCUGAGCAUUGAUACACACCGGGG	24	12175
SCNN1A-8327	+	AUUGAUACACACCGGGGG	18	12176
SCNN1A-8328	+	CAUUGAUACACACCGGGGG	19	12177
SCNN1A-5265	+	GCAUUGAUACACACCGGGGG	20	9114
SCNN1A-8329	+	AGCAUUGAUACACACCGGGGG	21	12178
SCNN1A-8330	+	GAGCAUUGAUACACACCGGGGG	22	12179
SCNN1A-8331	+	UGAGCAUUGAUACACACCGGGGG	23	12180
SCNN1A-8332	+	CUGAGCAUUGAUACACACCGGGGG	24	12181
SCNN1A-8333	+	AGGUGAGCAGGGCGGGGG	18	12182
SCNN1A-8334	+	AAGGUGAGCAGGGCGGGGG	19	12183
SCNN1A-8335	+	AAAGGUGAGCAGGGCGGGGG	20	12184
SCNN1A-8336	+	UAAAGGUGAGCAGGGCGGGGG	21	12185
SCNN1A-8337	+	UUAAAGGUGAGCAGGGCGGGGG	22	12186
SCNN1A-8338	+	AUUAAAGGUGAGCAGGGCGGGGG	23	12187
SCNN1A-8339	+	AAUUAAAGGUGAGCAGGGCGGGGG	24	12188
SCNN1A-8340	+	GGUGAGCAGGGCGGGGGG	18	12189
SCNN1A-8341	+	AGGUGAGCAGGGCGGGGGG	19	12190
SCNN1A-6164	+	AAGGUGAGCAGGGCGGGGGG	20	10013
SCNN1A-8342	+	AAAGGUGAGCAGGGCGGGGGG	21	12191
SCNN1A-8343	+	UAAAGGUGAGCAGGGCGGGGGG	22	12192
SCNN1A-8344	+	UUAAAGGUGAGCAGGGCGGGGGG	23	12193
SCNN1A-8345	+	AUUAAAGGUGAGCAGGGCGGGGGG	24	12194
SCNN1A-8346	+	GCCUAGACAGGCCCUGGG	18	12195
SCNN1A-8347	+	CGCCUAGACAGGCCCUGGG	19	12196
SCNN1A-5691	+	ACGCCUAGACAGGCCCUGGG	20	9540
SCNN1A-8348	+	CACGCCUAGACAGGCCCUGGG	21	12197
SCNN1A-8349	+	ACACGCCUAGACAGGCCCUGGG	22	12198
SCNN1A-8350	+	CACACGCCUAGACAGGCCCUGGG	23	12199
SCNN1A-8351	+	GCACACGCCUAGACAGGCCCUGGG	24	12200
SCNN1A-8352	+	AGGCUGAGAGGGCCUGGG	18	12201
SCNN1A-8353	+	CAGGCUGAGAGGGCCUGGG	19	12202
SCNN1A-6165	+	CCAGGCUGAGAGGGCCUGGG	20	10014
SCNN1A-8354	+	GCCAGGCUGAGAGGGCCUGGG	21	12203
SCNN1A-8355	+	AGCCAGGCUGAGAGGGCCUGGG	22	12204
SCNN1A-8356	+	CAGCCAGGCUGAGAGGGCCUGGG	23	12205
SCNN1A-8357	+	CCAGCCAGGCUGAGAGGGCCUGGG	24	12206
SCNN1A-8358	+	GAGAAGGCGGACUCUGGG	18	12207
SCNN1A-8359	+	UGAGAAGGCGGACUCUGGG	19	12208
SCNN1A-8360	+	CUGAGAAGGCGGACUCUGGG	20	12209
SCNN1A-8361	+	CCUGAGAAGGCGGACUCUGGG	21	12210
SCNN1A-8362	+	ACCUGAGAAGGCGGACUCUGGG	22	12211
SCNN1A-8363	+	GACCUGAGAAGGCGGACUCUGGG	23	12212
SCNN1A-8364	+	GGACCUGAGAAGGCGGACUCUGGG	24	12213
SCNN1A-1623	+	GCCCCGGAGUGGAUUGGG	18	5472
SCNN1A-1624	+	AGCCCCGGAGUGGAUUGGG	19	5473
SCNN1A-1625	+	GAGCCCCGGAGUGGAUUGGG	20	5474
SCNN1A-1626	+	UGAGCCCCGGAGUGGAUUGGG	21	5475
SCNN1A-1627	+	AUGAGCCCCGGAGUGGAUUGGG	22	5476
SCNN1A-1628	+	CAUGAGCCCCGGAGUGGAUUGGG	23	5477
SCNN1A-1629	+	UCAUGAGCCCCGGAGUGGAUUGGG	24	5478
SCNN1A-8365	+	ACAGAGAGAUAGGGAUGG	18	12214
SCNN1A-8366	+	GACAGAGAGAUAGGGAUGG	19	12215
SCNN1A-5915	+	GGACAGAGAGAUAGGGAUGG	20	9764
SCNN1A-8367	+	AGGACAGAGAGAUAGGGAUGG	21	12216
SCNN1A-8368	+	AAGGACAGAGAGAUAGGGAUGG	22	12217
SCNN1A-8369	+	GAAGGACAGAGAGAUAGGGAUGG	23	12218
SCNN1A-8370	+	CGAAGGACAGAGAGAUAGGGAUGG	24	12219
SCNN1A-8371	+	CGCCUAGACAGGCCCUGG	18	12220
SCNN1A-8372	+	ACGCCUAGACAGGCCCUGG	19	12221
SCNN1A-8373	+	CACGCCUAGACAGGCCCUGG	20	12222
SCNN1A-8374	+	ACACGCCUAGACAGGCCCUGG	21	12223
SCNN1A-8375	+	CACACGCCUAGACAGGCCCUGG	22	12224
SCNN1A-8376	+	GCACACGCCUAGACAGGCCCUGG	23	12225
SCNN1A-8377	+	GGCACACGCCUAGACAGGCCCUGG	24	12226
SCNN1A-8378	+	ACAGGUGCAGCGGCCUGG	18	12227
SCNN1A-8379	+	GACAGGUGCAGCGGCCUGG	19	12228
SCNN1A-8380	+	UGACAGGUGCAGCGGCCUGG	20	12229
SCNN1A-8381	+	CUGACAGGUGCAGCGGCCUGG	21	12230
SCNN1A-8382	+	CCUGACAGGUGCAGCGGCCUGG	22	12231
SCNN1A-8383	+	ACCUGACAGGUGCAGCGGCCUGG	23	12232
SCNN1A-8384	+	CACCUGACAGGUGCAGCGGCCUGG	24	12233
SCNN1A-8385	+	CAGGCUGAGAGGGCCUGG	18	12234
SCNN1A-8386	+	CCAGGCUGAGAGGGCCUGG	19	12235
SCNN1A-8387	+	GCCAGGCUGAGAGGGCCUGG	20	12236
SCNN1A-8388	+	AGCCAGGCUGAGAGGGCCUGG	21	12237
SCNN1A-8389	+	CAGCCAGGCUGAGAGGGCCUGG	22	12238
SCNN1A-8390	+	CCAGCCAGGCUGAGAGGGCCUGG	23	12239
SCNN1A-8391	+	GCCAGCCAGGCUGAGAGGGCCUGG	24	12240
SCNN1A-8392	+	AGACCCAAAAAGGGCUGG	18	12241
SCNN1A-8393	+	CAGACCCAAAAAGGGCUGG	19	12242
SCNN1A-5694	+	UCAGACCCAAAAAGGGCUGG	20	9543
SCNN1A-8394	+	AUCAGACCCAAAAAGGGCUGG	21	12243
SCNN1A-8395	+	AAUCAGACCCAAAAAGGGCUGG	22	12244
SCNN1A-8396	+	GAAUCAGACCCAAAAAGGGCUGG	23	12245
SCNN1A-8397	+	AGAAUCAGACCCAAAAAGGGCUGG	24	12246
SCNN1A-8398	+	GCAGGUGGGGGGCAGUGG	18	12247
SCNN1A-8399	+	GGCAGGUGGGGGGCAGUGG	19	12248
SCNN1A-6171	+	AGGCAGGUGGGGGGCAGUGG	20	10020
SCNN1A-8400	+	GAGGCAGGUGGGGGGCAGUGG	21	12249
SCNN1A-8401	+	AGAGGCAGGUGGGGGGCAGUGG	22	12250
SCNN1A-8402	+	UAGAGGCAGGUGGGGGGCAGUGG	23	12251
SCNN1A-8403	+	GUAGAGGCAGGUGGGGGGCAGUGG	24	12252
SCNN1A-1630	+	CAUGAUACCUCCCCUUGG	18	5479
SCNN1A-1631	+	UCAUGAUACCUCCCCUUGG	19	5480
SCNN1A-1632	+	CUCAUGAUACCUCCCCUUGG	20	5481
SCNN1A-1633	+	GCUCAUGAUACCUCCCCUUGG	21	5482
SCNN1A-1634	+	UGCUCAUGAUACCUCCCCUUGG	22	5483
SCNN1A-1635	+	CUGCUCAUGAUACCUCCCCUUGG	23	5484
SCNN1A-1636	+	ACUGCUCAUGAUACCUCCCCUUGG	24	5485
SCNN1A-8404	+	UUCUUCAUUGUCCUAAUG	18	12253
SCNN1A-8405	+	UUUCUUCAUUGUCCUAAUG	19	12254
SCNN1A-8406	+	UUUUCUUCAUUGUCCUAAUG	20	12255
SCNN1A-8407	+	UUUUUCUUCAUUGUCCUAAUG	21	12256
SCNN1A-8408	+	AUUUUUCUUCAUUGUCCUAAUG	22	12257
SCNN1A-8409	+	GAUUUUUCUUCAUUGUCCUAAUG	23	12258
SCNN1A-8410	+	GGAUUUUUCUUCAUUGUCCUAAUG	24	12259
SCNN1A-8411	+	GACAGAGAGAUAGGGAUG	18	12260
SCNN1A-8412	+	GGACAGAGAGAUAGGGAUG	19	12261
SCNN1A-8413	+	AGGACAGAGAGAUAGGGAUG	20	12262
SCNN1A-8414	+	AAGGACAGAGAGAUAGGGAUG	21	12263
SCNN1A-8415	+	GAAGGACAGAGAGAUAGGGAUG	22	12264
SCNN1A-8416	+	CGAAGGACAGAGAGAUAGGGAUG	23	12265
SCNN1A-8417	+	GCGAAGGACAGAGAGAUAGGGAUG	24	12266
SCNN1A-8418	+	GAGCCUAGGGGCUCACUG	18	12267
SCNN1A-8419	+	GGAGCCUAGGGGCUCACUG	19	12268
SCNN1A-8420	+	GGGAGCCUAGGGGCUCACUG	20	12269
SCNN1A-8421	+	GGGGAGCCUAGGGGCUCACUG	21	12270
SCNN1A-8422	+	AGGGGAGCCUAGGGGCUCACUG	22	12271
SCNN1A-8423	+	UAGGGGAGCCUAGGGGCUCACUG	23	12272
SCNN1A-8424	+	CUAGGGGAGCCUAGGGGCUCACUG	24	12273
SCNN1A-8425	+	GUCUCUGCCCCAGGACUG	18	12274
SCNN1A-8426	+	UGUCUCUGCCCCAGGACUG	19	12275
SCNN1A-8427	+	CUGUCUCUGCCCCAGGACUG	20	12276
SCNN1A-8428	+	UCUGUCUCUGCCCCAGGACUG	21	12277
SCNN1A-8429	+	UUCUGUCUCUGCCCCAGGACUG	22	12278
SCNN1A-8430	+	AUUCUGUCUCUGCCCCAGGACUG	23	12279
SCNN1A-8431	+	GAUUCUGUCUCUGCCCCAGGACUG	24	12280
SCNN1A-8432	+	CUGGAGCCAGCAGACCUG	18	12281
SCNN1A-8433	+	CCUGGAGCCAGCAGACCUG	19	12282
SCNN1A-5701	+	UCCUGGAGCCAGCAGACCUG	20	9550
SCNN1A-8434	+	UUCCUGGAGCCAGCAGACCUG	21	12283
SCNN1A-8435	+	UUUCCUGGAGCCAGCAGACCUG	22	12284
SCNN1A-8436	+	CUUUCCUGGAGCCAGCAGACCUG	23	12285
SCNN1A-8437	+	CCUUUCCUGGAGCCAGCAGACCUG	24	12286
SCNN1A-8438	+	CCUCACCCUCAGGCCCUG	18	12287
SCNN1A-8439	+	GCCUCACCCUCAGGCCCUG	19	12288
SCNN1A-8440	+	AGCCUCACCCUCAGGCCCUG	20	12289
SCNN1A-8441	+	CAGCCUCACCCUCAGGCCCUG	21	12290
SCNN1A-8442	+	UCAGCCUCACCCUCAGGCCCUG	22	12291
SCNN1A-8443	+	GUCAGCCUCACCCUCAGGCCCUG	23	12292
SCNN1A-8444	+	GGUCAGCCUCACCCUCAGGCCCUG	24	12293
SCNN1A-8445	+	AGACAGGCAAGGAGGCUG	18	12294
SCNN1A-8446	+	CAGACAGGCAAGGAGGCUG	19	12295
SCNN1A-5919	+	GCAGACAGGCAAGGAGGCUG	20	9768
SCNN1A-8447	+	CGCAGACAGGCAAGGAGGCUG	21	12296
SCNN1A-8448	+	ACGCAGACAGGCAAGGAGGCUG	22	12297
SCNN1A-8449	+	GACGCAGACAGGCAAGGAGGCUG	23	12298
SCNN1A-8450	+	AGACGCAGACAGGCAAGGAGGCUG	24	12299
SCNN1A-8451	+	CAGACCCAAAAAGGGCUG	18	12300
SCNN1A-8452	+	UCAGACCCAAAAAGGGCUG	19	12301
SCNN1A-8453	+	AUCAGACCCAAAAAGGGCUG	20	12302
SCNN1A-8454	+	AAUCAGACCCAAAAAGGGCUG	21	12303
SCNN1A-8455	+	GAAUCAGACCCAAAAAGGGCUG	22	12304
SCNN1A-8456	+	AGAAUCAGACCCAAAAAGGGCUG	23	12305
SCNN1A-8457	+	GAGAAUCAGACCCAAAAAGGGCUG	24	12306
SCNN1A-8458	+	GGGCGGGGGGAGGGGCUG	18	12307
SCNN1A-8459	+	AGGGCGGGGGGAGGGGCUG	19	12308
SCNN1A-6176	+	CAGGGCGGGGGGAGGGGCUG	20	10025
SCNN1A-8460	+	GCAGGGCGGGGGGAGGGGCUG	21	12309
SCNN1A-8461	+	AGCAGGGCGGGGGGAGGGGCUG	22	12310
SCNN1A-8462	+	GAGCAGGGCGGGGGGAGGGGCUG	23	12311
SCNN1A-8463	+	UGAGCAGGGCGGGGGGAGGGGCUG	24	12312
SCNN1A-1668	+	GAGACCUGGUAUGGGCUG	18	5517
SCNN1A-1669	+	UGAGACCUGGUAUGGGCUG	19	5518
SCNN1A-1670	+	AUGAGACCUGGUAUGGGCUG	20	5519
SCNN1A-1671	+	CAUGAGACCUGGUAUGGGCUG	21	5520
SCNN1A-1672	+	CCAUGAGACCUGGUAUGGGCUG	22	5521
SCNN1A-1673	+	UCCAUGAGACCUGGUAUGGGCUG	23	5522
SCNN1A-1674	+	CUCCAUGAGACCUGGUAUGGGCUG	24	5523
SCNN1A-8464	+	GGUGCAGCGGCCUGGCUG	18	12313
SCNN1A-8465	+	AGGUGCAGCGGCCUGGCUG	19	12314
SCNN1A-5705	+	CAGGUGCAGCGGCCUGGCUG	20	9554
SCNN1A-8466	+	ACAGGUGCAGCGGCCUGGCUG	21	12315
SCNN1A-8467	+	GACAGGUGCAGCGGCCUGGCUG	22	12316
SCNN1A-8468	+	UGACAGGUGCAGCGGCCUGGCUG	23	12317
SCNN1A-8469	+	CUGACAGGUGCAGCGGCCUGGCUG	24	12318
SCNN1A-8470	+	GAGUUGGGGCCAAAAGUG	18	12319
SCNN1A-8471	+	GGAGUUGGGGCCAAAAGUG	19	12320
SCNN1A-8472	+	GGGAGUUGGGGCCAAAAGUG	20	12321
SCNN1A-8473	+	CGGGAGUUGGGGCCAAAAGUG	21	12322
SCNN1A-8474	+	GCGGGAGUUGGGGCCAAAAGUG	22	12323
SCNN1A-8475	+	UGCGGGAGUUGGGGCCAAAAGUG	23	12324
SCNN1A-8476	+	CUGCGGGAGUUGGGGCCAAAAGUG	24	12325
SCNN1A-8477	+	GGAGUGGAGUGCCAAGUG	18	12326
SCNN1A-8478	+	AGGAGUGGAGUGCCAAGUG	19	12327
SCNN1A-8479	+	AAGGAGUGGAGUGCCAAGUG	20	12328
SCNN1A-8480	+	UAAGGAGUGGAGUGCCAAGUG	21	12329
SCNN1A-8481	+	AUAAGGAGUGGAGUGCCAAGUG	22	12330
SCNN1A-8482	+	GAUAAGGAGUGGAGUGCCAAGUG	23	12331
SCNN1A-8483	+	GGAUAAGGAGUGGAGUGCCAAGUG	24	12332
SCNN1A-8484	+	GGCAGGUGGGGGGCAGUG	18	12333
SCNN1A-8485	+	AGGCAGGUGGGGGGCAGUG	19	12334
SCNN1A-8486	+	GAGGCAGGUGGGGGGCAGUG	20	12335
SCNN1A-8487	+	AGAGGCAGGUGGGGGGCAGUG	21	12336
SCNN1A-8488	+	UAGAGGCAGGUGGGGGGCAGUG	22	12337
SCNN1A-8489	+	GUAGAGGCAGGUGGGGGGCAGUG	23	12338
SCNN1A-8490	+	AGUAGAGGCAGGUGGGGGGCAGUG	24	12339
SCNN1A-8491	+	AGGAGGCAGCCCAGAGUG	18	12340
SCNN1A-8492	+	CAGGAGGCAGCCCAGAGUG	19	12341
SCNN1A-8493	+	ACAGGAGGCAGCCCAGAGUG	20	12342
SCNN1A-8494	+	CACAGGAGGCAGCCCAGAGUG	21	12343
SCNN1A-8495	+	CCACAGGAGGCAGCCCAGAGUG	22	12344
SCNN1A-8496	+	CCCACAGGAGGCAGCCCAGAGUG	23	12345
SCNN1A-8497	+	CCCCACAGGAGGCAGCCCAGAGUG	24	12346
SCNN1A-8498	+	AAGCAGGCACUGAAGGUG	18	12347
SCNN1A-8499	+	AAAGCAGGCACUGAAGGUG	19	12348
SCNN1A-8500	+	GAAAGCAGGCACUGAAGGUG	20	12349
SCNN1A-8501	+	GGAAAGCAGGCACUGAAGGUG	21	12350
SCNN1A-8502	+	GGGAAAGCAGGCACUGAAGGUG	22	12351
SCNN1A-8503	+	AGGGAAAGCAGGCACUGAAGGUG	23	12352
SCNN1A-8504	+	CAGGGAAAGCAGGCACUGAAGGUG	24	12353
SCNN1A-8505	+	AGUGAGUAGAGGCAGGUG	18	12354
SCNN1A-8506	+	GAGUGAGUAGAGGCAGGUG	19	12355
SCNN1A-5713	+	UGAGUGAGUAGAGGCAGGUG	20	9562
SCNN1A-8507	+	CUGAGUGAGUAGAGGCAGGUG	21	12356
SCNN1A-8508	+	ACUGAGUGAGUAGAGGCAGGUG	22	12357
SCNN1A-8509	+	CACUGAGUGAGUAGAGGCAGGUG	23	12358
SCNN1A-8510	+	GCACUGAGUGAGUAGAGGCAGGUG	24	12359
SCNN1A-8511	+	GGGACAGGAUGGCAGGUG	18	12360
SCNN1A-8512	+	GGGGACAGGAUGGCAGGUG	19	12361
SCNN1A-5920	+	GGGGGACAGGAUGGCAGGUG	20	9769
SCNN1A-8513	+	UGGGGGACAGGAUGGCAGGUG	21	12362
SCNN1A-8514	+	CUGGGGGACAGGAUGGCAGGUG	22	12363
SCNN1A-8515	+	GCUGGGGGACAGGAUGGCAGGUG	23	12364
SCNN1A-8516	+	GGCUGGGGGACAGGAUGGCAGGUG	24	12365
SCNN1A-8517	+	GCUGAGAGGGCCUGGGUG	18	12366
SCNN1A-8518	+	GGCUGAGAGGGCCUGGGUG	19	12367
SCNN1A-6177	+	AGGCUGAGAGGGCCUGGGUG	20	10026
SCNN1A-8519	+	CAGGCUGAGAGGGCCUGGGUG	21	12368
SCNN1A-8520	+	CCAGGCUGAGAGGGCCUGGGUG	22	12369
SCNN1A-8521	+	GCCAGGCUGAGAGGGCCUGGGUG	23	12370
SCNN1A-8522	+	AGCCAGGCUGAGAGGGCCUGGGUG	24	12371
SCNN1A-1699	+	GAGCCCCGGAGUGGAUUG	18	5548
SCNN1A-1700	+	UGAGCCCCGGAGUGGAUUG	19	5549
SCNN1A-419	+	AUGAGCCCCGGAGUGGAUUG	20	4268
SCNN1A-1701	+	CAUGAGCCCCGGAGUGGAUUG	21	5550
SCNN1A-1702	+	UCAUGAGCCCCGGAGUGGAUUG	22	5551
SCNN1A-1703	+	UUCAUGAGCCCCGGAGUGGAUUG	23	5552
SCNN1A-1704	+	CUUCAUGAGCCCCGGAGUGGAUUG	24	5553
SCNN1A-8523	+	GCUGUGGUCACAGAGUUG	18	12372
SCNN1A-8524	+	UGCUGUGGUCACAGAGUUG	19	12373
SCNN1A-8525	+	CUGCUGUGGUCACAGAGUUG	20	12374
SCNN1A-8526	+	CCUGCUGUGGUCACAGAGUUG	21	12375
SCNN1A-8527	+	CCCUGCUGUGGUCACAGAGUUG	22	12376
SCNN1A-8528	+	CCCCUGCUGUGGUCACAGAGUUG	23	12377
SCNN1A-8529	+	GCCCCUGCUGUGGUCACAGAGUUG	24	12378
SCNN1A-8530	+	AGGAGGAGAAAUUCGUUG	18	12379
SCNN1A-8531	+	GAGGAGGAGAAAUUCGUUG	19	12380
SCNN1A-8532	+	GGAGGAGGAGAAAUUCGUUG	20	12381
SCNN1A-8533	+	GGGAGGAGGAGAAAUUCGUUG	21	12382
SCNN1A-8534	+	UGGGAGGAGGAGAAAUUCGUUG	22	12383
SCNN1A-8535	+	CUGGGAGGAGGAGAAAUUCGUUG	23	12384
SCNN1A-8536	+	CCUGGGAGGAGGAGAAAUUCGUUG	24	12385
SCNN1A-8537	+	GAGGUUAGAAAACAAAAU	18	12386
SCNN1A-8538	+	UGAGGUUAGAAAACAAAAU	19	12387
SCNN1A-5720	+	CUGAGGUUAGAAAACAAAAU	20	9569
SCNN1A-8539	+	UCUGAGGUUAGAAAACAAAAU	21	12388
SCNN1A-8540	+	UUCUGAGGUUAGAAAACAAAAU	22	12389
SCNN1A-8541	+	UUUCUGAGGUUAGAAAACAAAAU	23	12390
SCNN1A-8542	+	UUUUCUGAGGUUAGAAAACAAAAU	24	12391
SCNN1A-8543	+	UCACAGAGUUGCAGGAAU	18	12392
SCNN1A-8544	+	GUCACAGAGUUGCAGGAAU	19	12393
SCNN1A-8545	+	GGUCACAGAGUUGCAGGAAU	20	12394
SCNN1A-8546	+	UGGUCACAGAGUUGCAGGAAU	21	12395
SCNN1A-8547	+	GUGGUCACAGAGUUGCAGGAAU	22	12396
SCNN1A-8548	+	UGUGGUCACAGAGUUGCAGGAAU	23	12397
SCNN1A-8549	+	CUGUGGUCACAGAGUUGCAGGAAU	24	12398
SCNN1A-8550	+	UUCUCAGAGAUAAGACAU	18	12399
SCNN1A-8551	+	UUUCUCAGAGAUAAGACAU	19	12400
SCNN1A-8552	+	AUUUCUCAGAGAUAAGACAU	20	12401
SCNN1A-8553	+	GAUUUCUCAGAGAUAAGACAU	21	12402
SCNN1A-8554	+	AGAUUUCUCAGAGAUAAGACAU	22	12403
SCNN1A-8555	+	CAGAUUUCUCAGAGAUAAGACAU	23	12404
SCNN1A-8556	+	UCAGAUUUCUCAGAGAUAAGACAU	24	12405
SCNN1A-8557	+	UUCCUGAGACAGACUCAU	18	12406
SCNN1A-8558	+	CUUCCUGAGACAGACUCAU	19	12407
SCNN1A-6179	+	ACUUCCUGAGACAGACUCAU	20	10028
SCNN1A-8559	+	UACUUCCUGAGACAGACUCAU	21	12408
SCNN1A-8560	+	UUACUUCCUGAGACAGACUCAU	22	12409
SCNN1A-8561	+	UUUACUUCCUGAGACAGACUCAU	23	12410
SCNN1A-8562	+	AUUUACUUCCUGAGACAGACUCAU	24	12411
SCNN1A-8563	+	CAGGUGAGGGGCAAAGAU	18	12412
SCNN1A-8564	+	GCAGGUGAGGGGCAAAGAU	19	12413
SCNN1A-8565	+	GGCAGGUGAGGGGCAAAGAU	20	12414
SCNN1A-8566	+	UGGCAGGUGAGGGGCAAAGAU	21	12415
SCNN1A-8567	+	AUGGCAGGUGAGGGGCAAAGAU	22	12416
SCNN1A-8568	+	GAUGGCAGGUGAGGGGCAAAGAU	23	12417
SCNN1A-8569	+	GGAUGGCAGGUGAGGGGCAAAGAU	24	12418
SCNN1A-8570	+	UUAAUGCAGCAAAAGGAU	18	12419
SCNN1A-8571	+	CUUAAUGCAGCAAAAGGAU	19	12420
SCNN1A-8572	+	ACUUAAUGCAGCAAAAGGAU	20	12421
SCNN1A-8573	+	AACUUAAUGCAGCAAAAGGAU	21	12422
SCNN1A-8574	+	AAACUUAAUGCAGCAAAAGGAU	22	12423
SCNN1A-8575	+	CAAACUUAAUGCAGCAAAAGGAU	23	12424
SCNN1A-8576	+	CCAAACUUAAUGCAGCAAAAGGAU	24	12425
SCNN1A-8577	+	GACAGACUCAUGGGGGAU	18	12426
SCNN1A-8578	+	AGACAGACUCAUGGGGGAU	19	12427
SCNN1A-5272	+	GAGACAGACUCAUGGGGGAU	20	9121
SCNN1A-8579	+	UGAGACAGACUCAUGGGGGAU	21	12428
SCNN1A-8580	+	CUGAGACAGACUCAUGGGGGAU	22	12429
SCNN1A-8581	+	CCUGAGACAGACUCAUGGGGGAU	23	12430
SCNN1A-8582	+	UCCUGAGACAGACUCAUGGGGGAU	24	12431
SCNN1A-8583	+	GCUCAGGUGCACCUGGAU	18	12432
SCNN1A-8584	+	GGCUCAGGUGCACCUGGAU	19	12433
SCNN1A-8585	+	GGGCUCAGGUGCACCUGGAU	20	12434
SCNN1A-8586	+	GGGGCUCAGGUGCACCUGGAU	21	12435
SCNN1A-8587	+	CGGGGCUCAGGUGCACCUGGAU	22	12436
SCNN1A-8588	+	UCGGGGCUCAGGUGCACCUGGAU	23	12437
SCNN1A-8589	+	AUCGGGGCUCAGGUGCACCUGGAU	24	12438
SCNN1A-1717	+	AUGAGCCCCGGAGUGGAU	18	5566
SCNN1A-1718	+	CAUGAGCCCCGGAGUGGAU	19	5567
SCNN1A-420	+	UCAUGAGCCCCGGAGUGGAU	20	4269
SCNN1A-1719	+	UUCAUGAGCCCCGGAGUGGAU	21	5568
SCNN1A-1720	+	CUUCAUGAGCCCCGGAGUGGAU	22	5569
SCNN1A-1721	+	CCUUCAUGAGCCCCGGAGUGGAU	23	5570
SCNN1A-1722	+	CCCUUCAUGAGCCCCGGAGUGGAU	24	5571
SCNN1A-8590	+	AGGGCCACGCAGGACACU	18	12439
SCNN1A-8591	+	GAGGGCCACGCAGGACACU	19	12440
SCNN1A-8592	+	CGAGGGCCACGCAGGACACU	20	12441
SCNN1A-8593	+	GCGAGGGCCACGCAGGACACU	21	12442
SCNN1A-8594	+	CGCGAGGGCCACGCAGGACACU	22	12443
SCNN1A-8595	+	GCGCGAGGGCCACGCAGGACACU	23	12444
SCNN1A-8596	+	AGCGCGAGGGCCACGCAGGACACU	24	12445
SCNN1A-8597	+	GGCUCACUGCAGGAGACU	18	12446
SCNN1A-8598	+	GGGCUCACUGCAGGAGACU	19	12447
SCNN1A-8599	+	GGGGCUCACUGCAGGAGACU	20	12448
SCNN1A-8600	+	AGGGGCUCACUGCAGGAGACU	21	12449
SCNN1A-8601	+	UAGGGGCUCACUGCAGGAGACU	22	12450
SCNN1A-8602	+	CUAGGGGCUCACUGCAGGAGACU	23	12451
SCNN1A-8603	+	CCUAGGGGCUCACUGCAGGAGACU	24	12452
SCNN1A-8604	+	AAAGGGCUGGAGGAGACU	18	12453
SCNN1A-8605	+	AAAAGGGCUGGAGGAGACU	19	12454
SCNN1A-5729	+	AAAAAGGGCUGGAGGAGACU	20	9578
SCNN1A-8606	+	CAAAAAGGGCUGGAGGAGACU	21	12455
SCNN1A-8607	+	CCAAAAAGGGCUGGAGGAGACU	22	12456
SCNN1A-8608	+	CCCAAAAAGGGCUGGAGGAGACU	23	12457
SCNN1A-8609	+	ACCCAAAAAGGGCUGGAGGAGACU	24	12458
SCNN1A-8610	+	GACCUGAGAAGGCGGACU	18	12459
SCNN1A-8611	+	GGACCUGAGAAGGCGGACU	19	12460
SCNN1A-8612	+	UGGACCUGAGAAGGCGGACU	20	12461
SCNN1A-8613	+	CUGGACCUGAGAAGGCGGACU	21	12462
SCNN1A-8614	+	ACUGGACCUGAGAAGGCGGACU	22	12463
SCNN1A-8615	+	UACUGGACCUGAGAAGGCGGACU	23	12464
SCNN1A-8616	+	GUACUGGACCUGAGAAGGCGGACU	24	12465
SCNN1A-8617	+	CCUGGAGCCAGCAGACCU	18	12466
SCNN1A-8618	+	UCCUGGAGCCAGCAGACCU	19	12467
SCNN1A-8619	+	UUCCUGGAGCCAGCAGACCU	20	12468
SCNN1A-8620	+	UUUCCUGGAGCCAGCAGACCU	21	12469
SCNN1A-8621	+	CUUUCCUGGAGCCAGCAGACCU	22	12470
SCNN1A-8622	+	CCUUUCCUGGAGCCAGCAGACCU	23	12471
SCNN1A-8623	+	ACCUUUCCUGGAGCCAGCAGACCU	24	12472
SCNN1A-8624	+	ACUGGGAGUACUGGACCU	18	12473
SCNN1A-8625	+	AACUGGGAGUACUGGACCU	19	12474
SCNN1A-8626	+	GAACUGGGAGUACUGGACCU	20	12475
SCNN1A-8627	+	UGAACUGGGAGUACUGGACCU	21	12476
SCNN1A-8628	+	GUGAACUGGGAGUACUGGACCU	22	12477
SCNN1A-8629	+	GGUGAACUGGGAGUACUGGACCU	23	12478
SCNN1A-8630	+	AGGUGAACUGGGAGUACUGGACCU	24	12479
SCNN1A-1735	+	GCUCAUGAUACCUCCCCU	18	5584
SCNN1A-1736	+	UGCUCAUGAUACCUCCCCU	19	5585
SCNN1A-457	+	CUGCUCAUGAUACCUCCCCU	20	4306
SCNN1A-1737	+	ACUGCUCAUGAUACCUCCCCU	21	5586
SCNN1A-1738	+	UACUGCUCAUGAUACCUCCCCU	22	5587
SCNN1A-1739	+	AUACUGCUCAUGAUACCUCCCCU	23	5588
SCNN1A-1740	+	GAUACUGCUCAUGAUACCUCCCCU	24	5589
SCNN1A-8631	+	CACGCCUAGACAGGCCCU	18	12480
SCNN1A-8632	+	ACACGCCUAGACAGGCCCU	19	12481
SCNN1A-5734	+	CACACGCCUAGACAGGCCCU	20	9583
SCNN1A-8633	+	GCACACGCCUAGACAGGCCCU	21	12482
SCNN1A-8634	+	GGCACACGCCUAGACAGGCCCU	22	12483
SCNN1A-8635	+	UGGCACACGCCUAGACAGGCCCU	23	12484
SCNN1A-8636	+	AUGGCACACGCCUAGACAGGCCCU	24	12485
SCNN1A-8637	+	CAAGGGCUAGGGGAGCCU	18	12486
SCNN1A-8638	+	CCAAGGGCUAGGGGAGCCU	19	12487
SCNN1A-5275	+	GCCAAGGGCUAGGGGAGCCU	20	9124
SCNN1A-8639	+	AGCCAAGGGCUAGGGGAGCCU	21	12488
SCNN1A-8640	+	GAGCCAAGGGCUAGGGGAGCCU	22	12489
SCNN1A-8641	+	AGAGCCAAGGGCUAGGGGAGCCU	23	12490
SCNN1A-8642	+	AAGAGCCAAGGGCUAGGGGAGCCU	24	12491
SCNN1A-8643	+	CAGAAUUCUCCUCCUCCU	18	12492
SCNN1A-8644	+	UCAGAAUUCUCCUCCUCCU	19	12493
SCNN1A-8645	+	UUCAGAAUUCUCCUCCUCCU	20	12494
SCNN1A-8646	+	AUUCAGAAUUCUCCUCCUCCU	21	12495
SCNN1A-8647	+	AAUUCAGAAUUCUCCUCCUCCU	22	12496
SCNN1A-8648	+	GAAUUCAGAAUUCUCCUCCUCCU	23	12497
SCNN1A-8649	+	AGAAUUCAGAAUUCUCCUCCUCCU	24	12498
SCNN1A-8650	+	AGGGGCCCAGGUGAAGCU	18	12499
SCNN1A-8651	+	GAGGGGCCCAGGUGAAGCU	19	12500
SCNN1A-5923	+	GGAGGGGCCCAGGUGAAGCU	20	9772
SCNN1A-8652	+	GGGAGGGGCCCAGGUGAAGCU	21	12501
SCNN1A-8653	+	CGGGAGGGGCCCAGGUGAAGCU	22	12502
SCNN1A-8654	+	CCGGGAGGGGCCCAGGUGAAGCU	23	12503
SCNN1A-8655	+	CCCGGGAGGGGCCCAGGUGAAGCU	24	12504
SCNN1A-8656	+	GAUCCUGAGCCCACAGCU	18	12505
SCNN1A-8657	+	GGAUCCUGAGCCCACAGCU	19	12506
SCNN1A-5740	+	AGGAUCCUGAGCCCACAGCU	20	9589
SCNN1A-8658	+	AAGGAUCCUGAGCCCACAGCU	21	12507
SCNN1A-8659	+	GAAGGAUCCUGAGCCCACAGCU	22	12508
SCNN1A-8660	+	AGAAGGAUCCUGAGCCCACAGCU	23	12509
SCNN1A-8661	+	UAGAAGGAUCCUGAGCCCACAGCU	24	12510
SCNN1A-1741	+	CAGGGUCAAGGCUGAGCU	18	5590
SCNN1A-1742	+	UCAGGGUCAAGGCUGAGCU	19	5591
SCNN1A-1743	+	GUCAGGGUCAAGGCUGAGCU	20	5592
SCNN1A-1744	+	GGUCAGGGUCAAGGCUGAGCU	21	5593
SCNN1A-1745	+	GGGUCAGGGUCAAGGCUGAGCU	22	5594
SCNN1A-1746	+	AGGGUCAGGGUCAAGGCUGAGCU	23	5595
SCNN1A-1747	+	AAGGGUCAGGGUCAAGGCUGAGCU	24	5596
SCNN1A-8662	+	GAAGGGGCCAGCCAGGCU	18	12511
SCNN1A-8663	+	AGAAGGGGCCAGCCAGGCU	19	12512
SCNN1A-8664	+	GAGAAGGGGCCAGCCAGGCU	20	12513
SCNN1A-8665	+	GGAGAAGGGGCCAGCCAGGCU	21	12514
SCNN1A-8666	+	AGGAGAAGGGGCCAGCCAGGCU	22	12515
SCNN1A-8667	+	AAGGAGAAGGGGCCAGCCAGGCU	23	12516
SCNN1A-8668	+	CAAGGAGAAGGGGCCAGCCAGGCU	24	12517
SCNN1A-8669	+	CAGACAGGCAAGGAGGCU	18	12518
SCNN1A-8670	+	GCAGACAGGCAAGGAGGCU	19	12519
SCNN1A-5742	+	CGCAGACAGGCAAGGAGGCU	20	9591
SCNN1A-8671	+	ACGCAGACAGGCAAGGAGGCU	21	12520
SCNN1A-8672	+	GACGCAGACAGGCAAGGAGGCU	22	12521
SCNN1A-8673	+	AGACGCAGACAGGCAAGGAGGCU	23	12522
SCNN1A-8674	+	UAGACGCAGACAGGCAAGGAGGCU	24	12523
SCNN1A-8675	+	ACAUAAGAGCCAAGGGCU	18	12524
SCNN1A-8676	+	GACAUAAGAGCCAAGGGCU	19	12525
SCNN1A-5743	+	AGACAUAAGAGCCAAGGGCU	20	9592
SCNN1A-8677	+	AAGACAUAAGAGCCAAGGGCU	21	12526
SCNN1A-8678	+	UAAGACAUAAGAGCCAAGGGCU	22	12527
SCNN1A-8679	+	AUAAGACAUAAGAGCCAAGGGCU	23	12528
SCNN1A-8680	+	GAUAAGACAUAAGAGCCAAGGGCU	24	12529
SCNN1A-8681	+	AGGGCGGGGGGAGGGGCU	18	12530
SCNN1A-8682	+	CAGGGCGGGGGGAGGGGCU	19	12531
SCNN1A-8683	+	GCAGGGCGGGGGGAGGGGCU	20	12532
SCNN1A-8684	+	AGCAGGGCGGGGGGAGGGGCU	21	12533
SCNN1A-8685	+	GAGCAGGGCGGGGGGAGGGGCU	22	12534
SCNN1A-8686	+	UGAGCAGGGCGGGGGGAGGGGCU	23	12535
SCNN1A-8687	+	GUGAGCAGGGCGGGGGGAGGGGCU	24	12536
SCNN1A-8688	+	AGGUGCAGCGGCCUGGCU	18	12537
SCNN1A-8689	+	CAGGUGCAGCGGCCUGGCU	19	12538
SCNN1A-5744	+	ACAGGUGCAGCGGCCUGGCU	20	9593
SCNN1A-8690	+	GACAGGUGCAGCGGCCUGGCU	21	12539
SCNN1A-8691	+	UGACAGGUGCAGCGGCCUGGCU	22	12540
SCNN1A-8692	+	CUGACAGGUGCAGCGGCCUGGCU	23	12541
SCNN1A-8693	+	CCUGACAGGUGCAGCGGCCUGGCU	24	12542
SCNN1A-8694	+	UUUCAUAUCAAGGGCUCU	18	12543
SCNN1A-8695	+	UUUUCAUAUCAAGGGCUCU	19	12544
SCNN1A-8696	+	GUUUUCAUAUCAAGGGCUCU	20	12545
SCNN1A-8697	+	AGUUUUCAUAUCAAGGGCUCU	21	12546
SCNN1A-8698	+	UAGUUUUCAUAUCAAGGGCUCU	22	12547
SCNN1A-8699	+	AUAGUUUUCAUAUCAAGGGCUCU	23	12548
SCNN1A-8700	+	AAUAGUUUUCAUAUCAAGGGCUCU	24	12549
SCNN1A-8701	+	GGUUAUCUCCUUGGCUCU	18	12550
SCNN1A-8702	+	GGGUUAUCUCCUUGGCUCU	19	12551
SCNN1A-8703	+	UGGGUUAUCUCCUUGGCUCU	20	12552
SCNN1A-8704	+	CUGGGUUAUCUCCUUGGCUCU	21	12553
SCNN1A-8705	+	GCUGGGUUAUCUCCUUGGCUCU	22	12554
SCNN1A-8706	+	UGCUGGGUUAUCUCCUUGGCUCU	23	12555
SCNN1A-8707	+	GUGCUGGGUUAUCUCCUUGGCUCU	24	12556
SCNN1A-8708	+	UGCAGAUCUCAGAUUUCU	18	12557
SCNN1A-8709	+	GUGCAGAUCUCAGAUUUCU	19	12558
SCNN1A-8710	+	AGUGCAGAUCUCAGAUUUCU	20	12559
SCNN1A-8711	+	AAGUGCAGAUCUCAGAUUUCU	21	12560
SCNN1A-8712	+	AAAGUGCAGAUCUCAGAUUUCU	22	12561
SCNN1A-8713	+	AAAAGUGCAGAUCUCAGAUUUCU	23	12562
SCNN1A-8714	+	CAAAAGUGCAGAUCUCAGAUUUCU	24	12563
SCNN1A-8715	+	CCUCCCCGCUCACUAAGU	18	12564
SCNN1A-8716	+	UCCUCCCCGCUCACUAAGU	19	12565
SCNN1A-5752	+	CUCCUCCCCGCUCACUAAGU	20	9601
SCNN1A-8717	+	UCUCCUCCCCGCUCACUAAGU	21	12566
SCNN1A-8718	+	GUCUCCUCCCCGCUCACUAAGU	22	12567
SCNN1A-8719	+	GGUCUCCUCCCCGCUCACUAAGU	23	12568
SCNN1A-8720	+	AGGUCUCCUCCCCGCUCACUAAGU	24	12569
SCNN1A-8721	+	GAGGGGCUGAGGAGGAGU	18	12570
SCNN1A-8722	+	GGAGGGGCUGAGGAGGAGU	19	12571
SCNN1A-8723	+	GGGAGGGGCUGAGGAGGAGU	20	12572
SCNN1A-8724	+	GGGGAGGGGCUGAGGAGGAGU	21	12573
SCNN1A-8725	+	GGGGGAGGGGCUGAGGAGGAGU	22	12574
SCNN1A-8726	+	GGGGGGAGGGGCUGAGGAGGAGU	23	12575
SCNN1A-8727	+	CGGGGGGAGGGGCUGAGGAGGAGU	24	12576
SCNN1A-8728	+	CAGCAGACCUGCGGGAGU	18	12577
SCNN1A-8729	+	CCAGCAGACCUGCGGGAGU	19	12578
SCNN1A-5278	+	GCCAGCAGACCUGCGGGAGU	20	9127
SCNN1A-8730	+	AGCCAGCAGACCUGCGGGAGU	21	12579
SCNN1A-8731	+	GAGCCAGCAGACCUGCGGGAGU	22	12580
SCNN1A-8732	+	GGAGCCAGCAGACCUGCGGGAGU	23	12581
SCNN1A-8733	+	UGGAGCCAGCAGACCUGCGGGAGU	24	12582
SCNN1A-8734	+	GAGUGAGUAGAGGCAGGU	18	12583
SCNN1A-8735	+	UGAGUGAGUAGAGGCAGGU	19	12584
SCNN1A-5756	+	CUGAGUGAGUAGAGGCAGGU	20	9605
SCNN1A-8736	+	ACUGAGUGAGUAGAGGCAGGU	21	12585
SCNN1A-8737	+	CACUGAGUGAGUAGAGGCAGGU	22	12586
SCNN1A-8738	+	GCACUGAGUGAGUAGAGGCAGGU	23	12587
SCNN1A-8739	+	GGCACUGAGUGAGUAGAGGCAGGU	24	12588
SCNN1A-8740	+	GGGGACAGGAUGGCAGGU	18	12589
SCNN1A-8741	+	GGGGGACAGGAUGGCAGGU	19	12590
SCNN1A-8742	+	UGGGGGACAGGAUGGCAGGU	20	12591
SCNN1A-8743	+	CUGGGGGACAGGAUGGCAGGU	21	12592
SCNN1A-8744	+	GCUGGGGGACAGGAUGGCAGGU	22	12593
SCNN1A-8745	+	GGCUGGGGGACAGGAUGGCAGGU	23	12594
SCNN1A-8746	+	AGGCUGGGGGACAGGAUGGCAGGU	24	12595
SCNN1A-8747	+	UGCAGGGCUCCAGGAGGU	18	12596
SCNN1A-8748	+	CUGCAGGGCUCCAGGAGGU	19	12597
SCNN1A-8749	+	ACUGCAGGGCUCCAGGAGGU	20	12598
SCNN1A-8750	+	GACUGCAGGGCUCCAGGAGGU	21	12599
SCNN1A-8751	+	GGACUGCAGGGCUCCAGGAGGU	22	12600
SCNN1A-8752	+	AGGACUGCAGGGCUCCAGGAGGU	23	12601
SCNN1A-8753	+	CAGGACUGCAGGGCUCCAGGAGGU	24	12602
SCNN1A-8754	+	AAAUCAGUUUUCUGAGGU	18	12603
SCNN1A-8755	+	UAAAUCAGUUUUCUGAGGU	19	12604
SCNN1A-8756	+	AUAAAUCAGUUUUCUGAGGU	20	12605
SCNN1A-8757	+	GAUAAAUCAGUUUUCUGAGGU	21	12606
SCNN1A-8758	+	GGAUAAAUCAGUUUUCUGAGGU	22	12607
SCNN1A-8759	+	AGGAUAAAUCAGUUUUCUGAGGU	23	12608
SCNN1A-8760	+	AAGGAUAAAUCAGUUUUCUGAGGU	24	12609
SCNN1A-8761	+	AAGGAGAGAGAGGAGGGU	18	12610
SCNN1A-8762	+	CAAGGAGAGAGAGGAGGGU	19	12611
SCNN1A-8763	+	GCAAGGAGAGAGAGGAGGGU	20	12612
SCNN1A-8764	+	AGCAAGGAGAGAGAGGAGGGU	21	12613
SCNN1A-8765	+	GAGCAAGGAGAGAGAGGAGGGU	22	12614
SCNN1A-8766	+	UGAGCAAGGAGAGAGAGGAGGGU	23	12615
SCNN1A-8767	+	GUGAGCAAGGAGAGAGAGGAGGGU	24	12616
SCNN1A-8768	+	GGCUGAGAGGGCCUGGGU	18	12617
SCNN1A-8769	+	AGGCUGAGAGGGCCUGGGU	19	12618
SCNN1A-6188	+	CAGGCUGAGAGGGCCUGGGU	20	10037
SCNN1A-8770	+	CCAGGCUGAGAGGGCCUGGGU	21	12619
SCNN1A-8771	+	GCCAGGCUGAGAGGGCCUGGGU	22	12620
SCNN1A-8772	+	AGCCAGGCUGAGAGGGCCUGGGU	23	12621
SCNN1A-8773	+	CAGCCAGGCUGAGAGGGCCUGGGU	24	12622
SCNN1A-1772	+	CCCUCCAUGAGACCUGGU	18	5621
SCNN1A-1773	+	CCCCUCCAUGAGACCUGGU	19	5622
SCNN1A-199	+	UCCCCUCCAUGAGACCUGGU	20	828
SCNN1A-1774	+	UUCCCCUCCAUGAGACCUGGU	21	5623
SCNN1A-1775	+	GUUCCCCUCCAUGAGACCUGGU	22	5624
SCNN1A-1776	+	UGUUCCCCUCCAUGAGACCUGGU	23	5625
SCNN1A-1777	+	UUGUUCCCCUCCAUGAGACCUGGU	24	5626
SCNN1A-8774	+	CAGGUGGGGGGCAGUGGU	18	12623
SCNN1A-8775	+	GCAGGUGGGGGGCAGUGGU	19	12624
SCNN1A-5928	+	GGCAGGUGGGGGGCAGUGGU	20	9777
SCNN1A-8776	+	AGGCAGGUGGGGGGCAGUGGU	21	12625
SCNN1A-8777	+	GAGGCAGGUGGGGGGCAGUGGU	22	12626
SCNN1A-8778	+	AGAGGCAGGUGGGGGGCAGUGGU	23	12627
SCNN1A-8779	+	UAGAGGCAGGUGGGGGGCAGUGGU	24	12628
SCNN1A-8780	+	UCAUAUCAAGGGCUCUGU	18	12629
SCNN1A-8781	+	UUCAUAUCAAGGGCUCUGU	19	12630
SCNN1A-8782	+	UUUCAUAUCAAGGGCUCUGU	20	12631
SCNN1A-8783	+	UUUUCAUAUCAAGGGCUCUGU	21	12632
SCNN1A-8784	+	GUUUUCAUAUCAAGGGCUCUGU	22	12633
SCNN1A-8785	+	AGUUUUCAUAUCAAGGGCUCUGU	23	12634
SCNN1A-8786	+	UAGUUUUCAUAUCAAGGGCUCUGU	24	12635
SCNN1A-1778	+	UGAGCCCCGGAGUGGAUU	18	5627
SCNN1A-1779	+	AUGAGCCCCGGAGUGGAUU	19	5628
SCNN1A-425	+	CAUGAGCCCCGGAGUGGAUU	20	4274
SCNN1A-1780	+	UCAUGAGCCCCGGAGUGGAUU	21	5629
SCNN1A-1781	+	UUCAUGAGCCCCGGAGUGGAUU	22	5630
SCNN1A-1782	+	CUUCAUGAGCCCCGGAGUGGAUU	23	5631
SCNN1A-1783	+	CCUUCAUGAGCCCCGGAGUGGAUU	24	5632
SCNN1A-8787	+	UGUUUGAUCUCAAAGGUU	18	12636
SCNN1A-8788	+	CUGUUUGAUCUCAAAGGUU	19	12637
SCNN1A-8789	+	GCUGUUUGAUCUCAAAGGUU	20	12638
SCNN1A-8790	+	GGCUGUUUGAUCUCAAAGGUU	21	12639
SCNN1A-8791	+	UGGCUGUUUGAUCUCAAAGGUU	22	12640
SCNN1A-8792	+	CUGGCUGUUUGAUCUCAAAGGUU	23	12641
SCNN1A-8793	+	CCUGGCUGUUUGAUCUCAAAGGUU	24	12642
SCNN1A-8794	+	CAAGGAUAAAUCAGUUUU	18	12643
SCNN1A-8795	+	CCAAGGAUAAAUCAGUUUU	19	12644
SCNN1A-8796	+	CCCAAGGAUAAAUCAGUUUU	20	12645
SCNN1A-8797	+	UCCCAAGGAUAAAUCAGUUUU	21	12646
SCNN1A-8798	+	UUCCCAAGGAUAAAUCAGUUUU	22	12647
SCNN1A-8799	+	CUUCCCAAGGAUAAAUCAGUUUU	23	12648
SCNN1A-8800	+	CCUUCCCAAGGAUAAAUCAGUUUU	24	12649
SCNN1A-8801	+	GUCAGAGCCGGGAGUUUU	18	12650
SCNN1A-8802	+	AGUCAGAGCCGGGAGUUUU	19	12651
SCNN1A-8803	+	GAGUCAGAGCCGGGAGUUUU	20	12652
SCNN1A-8804	+	GGAGUCAGAGCCGGGAGUUUU	21	12653
SCNN1A-8805	+	AGGAGUCAGAGCCGGGAGUUUU	22	12654
SCNN1A-8806	+	GAGGAGUCAGAGCCGGGAGUUUU	23	12655
SCNN1A-8807	+	GGAGGAGUCAGAGCCGGGAGUUUU	24	12656
SCNN1A-8808	−	GCAGCCAACAGUGUAAAA	18	12657
SCNN1A-8809	−	GGCAGCCAACAGUGUAAAA	19	12658
SCNN1A-8810	−	UGGCAGCCAACAGUGUAAAA	20	12659
SCNN1A-8811	−	CUGGCAGCCAACAGUGUAAAA	21	12660
SCNN1A-8812	−	CCUGGCAGCCAACAGUGUAAAA	22	12661
SCNN1A-8813	−	GCCUGGCAGCCAACAGUGUAAAA	23	12662
SCNN1A-8814	−	GGCCUGGCAGCCAACAGUGUAAAA	24	12663
SCNN1A-8815	−	UCUUUUAAAGUGUACAAA	18	12664
SCNN1A-8816	−	AUCUUUUAAAGUGUACAAA	19	12665
SCNN1A-8817	−	AAUCUUUUAAAGUGUACAAA	20	12666
SCNN1A-8818	−	CAAUCUUUUAAAGUGUACAAA	21	12667
SCNN1A-8819	−	ACAAUCUUUUAAAGUGUACAAA	22	12668
SCNN1A-8820	−	GACAAUCUUUUAAAGUGUACAAA	23	12669
SCNN1A-8821	−	AGACAAUCUUUUAAAGUGUACAAA	24	12670
SCNN1A-8822	−	GAGCAGGAGAGACCCAAA	18	12671
SCNN1A-8823	−	AGAGCAGGAGAGACCCAAA	19	12672
SCNN1A-8824	−	GAGAGCAGGAGAGACCCAAA	20	12673
SCNN1A-8825	−	GGAGAGCAGGAGAGACCCAAA	21	12674
SCNN1A-8826	−	AGGAGAGCAGGAGAGACCCAAA	22	12675
SCNN1A-8827	−	GAGGAGAGCAGGAGAGACCCAAA	23	12676
SCNN1A-8828	−	AGAGGAGAGCAGGAGAGACCCAAA	24	12677
SCNN1A-8829	−	CAGGCAUGAGCUGGCAAA	18	12678
SCNN1A-8830	−	UCAGGCAUGAGCUGGCAAA	19	12679
SCNN1A-8831	−	UUCAGGCAUGAGCUGGCAAA	20	12680
SCNN1A-8832	−	UUUCAGGCAUGAGCUGGCAAA	21	12681
SCNN1A-8833	−	AUUUCAGGCAUGAGCUGGCAAA	22	12682
SCNN1A-8834	−	GAUUUCAGGCAUGAGCUGGCAAA	23	12683
SCNN1A-8835	−	GGAUUUCAGGCAUGAGCUGGCAAA	24	12684
SCNN1A-8836	−	AGGGGGCAGAGACAGAAA	18	12685
SCNN1A-8837	−	AAGGGGGCAGAGACAGAAA	19	12686
SCNN1A-5863	−	GAAGGGGGCAGAGACAGAAA	20	9712
SCNN1A-8838	−	GGAAGGGGGCAGAGACAGAAA	21	12687
SCNN1A-8839	−	AGGAAGGGGGCAGAGACAGAAA	22	12688
SCNN1A-8840	−	AAGGAAGGGGGCAGAGACAGAAA	23	12689
SCNN1A-8841	−	AAAGGAAGGGGGCAGAGACAGAAA	24	12690
SCNN1A-8842	−	GAGGAGGCAGGCCAGAAA	18	12691
SCNN1A-8843	−	AGAGGAGGCAGGCCAGAAA	19	12692
SCNN1A-8844	−	GAGAGGAGGCAGGCCAGAAA	20	12693
SCNN1A-8845	−	AGAGAGGAGGCAGGCCAGAAA	21	12694
SCNN1A-8846	−	GAGAGAGGAGGCAGGCCAGAAA	22	12695
SCNN1A-8847	−	AGAGAGAGGAGGCAGGCCAGAAA	23	12696
SCNN1A-8848	−	UAGAGAGAGGAGGCAGGCCAGAAA	24	12697
SCNN1A-8849	−	GAGAGACCCAAAGAGAAA	18	12698
SCNN1A-8850	−	GGAGAGACCCAAAGAGAAA	19	12699
SCNN1A-8851	−	AGGAGAGACCCAAAGAGAAA	20	12700
SCNN1A-8852	−	CAGGAGAGACCCAAAGAGAAA	21	12701
SCNN1A-8853	−	GCAGGAGAGACCCAAAGAGAAA	22	12702
SCNN1A-8854	−	AGCAGGAGAGACCCAAAGAGAAA	23	12703
SCNN1A-8855	−	GAGCAGGAGAGACCCAAAGAGAAA	24	12704
SCNN1A-8856	−	CGAGGAAUCAGCAGGAAA	18	12705
SCNN1A-8857	−	GCGAGGAAUCAGCAGGAAA	19	12706
SCNN1A-8858	−	GGCGAGGAAUCAGCAGGAAA	20	12707
SCNN1A-8859	−	UGGCGAGGAAUCAGCAGGAAA	21	12708
SCNN1A-8860	−	GUGGCGAGGAAUCAGCAGGAAA	22	12709
SCNN1A-8861	−	GGUGGCGAGGAAUCAGCAGGAAA	23	12710
SCNN1A-8862	−	GGGUGGCGAGGAAUCAGCAGGAAA	24	12711
SCNN1A-8863	−	CUGGAGGAAGAAGACCAA	18	12712
SCNN1A-8864	−	CCUGGAGGAAGAAGACCAA	19	12713
SCNN1A-5519	−	UCCUGGAGGAAGAAGACCAA	20	9368
SCNN1A-8865	−	AUCCUGGAGGAAGAAGACCAA	21	12714
SCNN1A-8866	−	GAUCCUGGAGGAAGAAGACCAA	22	12715
SCNN1A-8867	−	AGAUCCUGGAGGAAGAAGACCAA	23	12716
SCNN1A-8868	−	CAGAUCCUGGAGGAAGAAGACCAA	24	12717
SCNN1A-8869	−	UCCAGCUGUCCCUUCCAA	18	12718
SCNN1A-8870	−	AUCCAGCUGUCCCUUCCAA	19	12719
SCNN1A-5521	−	AAUCCAGCUGUCCCUUCCAA	20	9370
SCNN1A-8871	−	AAAUCCAGCUGUCCCUUCCAA	21	12720
SCNN1A-8872	−	AAAAUCCAGCUGUCCCUUCCAA	22	12721
SCNN1A-8873	−	AAAAAUCCAGCUGUCCCUUCCAA	23	12722
SCNN1A-8874	−	GAAAAAUCCAGCUGUCCCUUCCAA	24	12723
SCNN1A-1790	−	CAGUAUCAAGGUAAGCAA	18	5639
SCNN1A-1791	−	GCAGUAUCAAGGUAAGCAA	19	5640
SCNN1A-393	−	AGCAGUAUCAAGGUAAGCAA	20	4242
SCNN1A-1792	−	GAGCAGUAUCAAGGUAAGCAA	21	5641
SCNN1A-1793	−	UGAGCAGUAUCAAGGUAAGCAA	22	5642
SCNN1A-1794	−	AUGAGCAGUAUCAAGGUAAGCAA	23	5643
SCNN1A-1795	−	CAUGAGCAGUAUCAAGGUAAGCAA	24	5644
SCNN1A-8875	−	CGCAAGAGACUGCCGCAA	18	12724
SCNN1A-8876	−	UCGCAAGAGACUGCCGCAA	19	12725
SCNN1A-8877	−	GUCGCAAGAGACUGCCGCAA	20	12726
SCNN1A-8878	−	AGUCGCAAGAGACUGCCGCAA	21	12727
SCNN1A-8879	−	AAGUCGCAAGAGACUGCCGCAA	22	12728
SCNN1A-8880	−	GAAGUCGCAAGAGACUGCCGCAA	23	12729
SCNN1A-8881	−	AGAAGUCGCAAGAGACUGCCGCAA	24	12730
SCNN1A-8882	−	UGAGAGGGGGCAAGGCAA	18	12731
SCNN1A-8883	−	GUGAGAGGGGGCAAGGCAA	19	12732
SCNN1A-6079	−	AGUGAGAGGGGGCAAGGCAA	20	9928
SCNN1A-8884	−	GAGUGAGAGGGGGCAAGGCAA	21	12733
SCNN1A-8885	−	AGAGUGAGAGGGGGCAAGGCAA	22	12734
SCNN1A-8886	−	UAGAGUGAGAGGGGGCAAGGCAA	23	12735
SCNN1A-8887	−	CUAGAGUGAGAGGGGGCAAGGCAA	24	12736
SCNN1A-8888	−	UGUAAGGACCUGGCUCAA	18	12737
SCNN1A-8889	−	AUGUAAGGACCUGGCUCAA	19	12738
SCNN1A-5522	−	AAUGUAAGGACCUGGCUCAA	20	9371
SCNN1A-8890	−	CAAUGUAAGGACCUGGCUCAA	21	12739
SCNN1A-8891	−	CCAAUGUAAGGACCUGGCUCAA	22	12740
SCNN1A-8892	−	CCCAAUGUAAGGACCUGGCUCAA	23	12741
SCNN1A-8893	−	GCCCAAUGUAAGGACCUGGCUCAA	24	12742
SCNN1A-8894	−	UUUGGCUGCCAGAUUCAA	18	12743
SCNN1A-8895	−	GUUUGGCUGCCAGAUUCAA	19	12744
SCNN1A-8896	−	GGUUUGGCUGCCAGAUUCAA	20	12745
SCNN1A-8897	−	AGGUUUGGCUGCCAGAUUCAA	21	12746
SCNN1A-8898	−	GAGGUUUGGCUGCCAGAUUCAA	22	12747
SCNN1A-8899	−	AGAGGUUUGGCUGCCAGAUUCAA	23	12748
SCNN1A-8900	−	GAGAGGUUUGGCUGCCAGAUUCAA	24	12749
SCNN1A-8901	−	AAGGGGGCAGAGACAGAA	18	12750
SCNN1A-8902	−	GAAGGGGGCAGAGACAGAA	19	12751
SCNN1A-5864	−	GGAAGGGGGCAGAGACAGAA	20	9713
SCNN1A-8903	−	AGGAAGGGGGCAGAGACAGAA	21	12752
SCNN1A-8904	−	AAGGAAGGGGGCAGAGACAGAA	22	12753
SCNN1A-8905	−	AAAGGAAGGGGGCAGAGACAGAA	23	12754
SCNN1A-8906	−	CAAAGGAAGGGGGCAGAGACAGAA	24	12755
SCNN1A-8907	−	GGAAGAAGACCAAAGGAA	18	12756
SCNN1A-8908	−	AGGAAGAAGACCAAAGGAA	19	12757
SCNN1A-5865	−	GAGGAAGAAGACCAAAGGAA	20	9714
SCNN1A-8909	−	GGAGGAAGAAGACCAAAGGAA	21	12758
SCNN1A-8910	−	UGGAGGAAGAAGACCAAAGGAA	22	12759
SCNN1A-8911	−	CUGGAGGAAGAAGACCAAAGGAA	23	12760
SCNN1A-8912	−	CCUGGAGGAAGAAGACCAAAGGAA	24	12761
SCNN1A-8913	−	GCAAGGGGGGGAGAGGAA	18	12762
SCNN1A-8914	−	GGCAAGGGGGGGAGAGGAA	19	12763
SCNN1A-8915	−	AGGCAAGGGGGGGAGAGGAA	20	12764
SCNN1A-8916	−	AAGGCAAGGGGGGGAGAGGAA	21	12765
SCNN1A-8917	−	CAAGGCAAGGGGGGGAGAGGAA	22	12766
SCNN1A-8918	−	GCAAGGCAAGGGGGGGAGAGGAA	23	12767
SCNN1A-8919	−	GGCAAGGCAAGGGGGGGAGAGGAA	24	12768
SCNN1A-8920	−	UGCCAGAUUCAACUGGAA	18	12769
SCNN1A-8921	−	CUGCCAGAUUCAACUGGAA	19	12770
SCNN1A-5173	−	GCUGCCAGAUUCAACUGGAA	20	9022
SCNN1A-8922	−	GGCUGCCAGAUUCAACUGGAA	21	12771
SCNN1A-8923	−	UGGCUGCCAGAUUCAACUGGAA	22	12772
SCNN1A-8924	−	UUGGCUGCCAGAUUCAACUGGAA	23	12773
SCNN1A-8925	−	UUUGGCUGCCAGAUUCAACUGGAA	24	12774
SCNN1A-1802	−	CACUCCGGGGCUCAUGAA	18	5651
SCNN1A-1803	−	CCACUCCGGGGCUCAUGAA	19	5652
SCNN1A-451	−	UCCACUCCGGGGCUCAUGAA	20	4300
SCNN1A-1804	−	AUCCACUCCGGGGCUCAUGAA	21	5653
SCNN1A-1805	−	AAUCCACUCCGGGGCUCAUGAA	22	5654
SCNN1A-1806	−	CAAUCCACUCCGGGGCUCAUGAA	23	5655
SCNN1A-1807	−	CCAAUCCACUCCGGGGCUCAUGAA	24	5656
SCNN1A-8926	−	CGCCCUGCUCACCUUUAA	18	12775
SCNN1A-8927	−	CCGCCCUGCUCACCUUUAA	19	12776
SCNN1A-8928	−	CCCGCCCUGCUCACCUUUAA	20	12777
SCNN1A-8929	−	CCCCGCCCUGCUCACCUUUAA	21	12778
SCNN1A-8930	−	CCCCCGCCCUGCUCACCUUUAA	22	12779
SCNN1A-8931	−	CCCCCCGCCCUGCUCACCUUUAA	23	12780
SCNN1A-8932	−	UCCCCCCGCCCUGCUCACCUUUAA	24	12781
SCNN1A-8933	−	AGUUUCUUCAUUAGGACA	18	12782
SCNN1A-8934	−	CAGUUUCUUCAUUAGGACA	19	12783
SCNN1A-8935	−	UCAGUUUCUUCAUUAGGACA	20	12784
SCNN1A-8936	−	GUCAGUUUCUUCAUUAGGACA	21	12785
SCNN1A-8937	−	GGUCAGUUUCUUCAUUAGGACA	22	12786
SCNN1A-8938	−	GGGUCAGUUUCUUCAUUAGGACA	23	12787
SCNN1A-8939	−	AGGGUCAGUUUCUUCAUUAGGACA	24	12788
SCNN1A-8940	−	CCUGGAGGAAGAAGACCA	18	12789
SCNN1A-8941	−	UCCUGGAGGAAGAAGACCA	19	12790
SCNN1A-8942	−	AUCCUGGAGGAAGAAGACCA	20	12791
SCNN1A-8943	−	GAUCCUGGAGGAAGAAGACCA	21	12792
SCNN1A-8944	−	AGAUCCUGGAGGAAGAAGACCA	22	12793
SCNN1A-8945	−	CAGAUCCUGGAGGAAGAAGACCA	23	12794
SCNN1A-8946	−	ACAGAUCCUGGAGGAAGAAGACCA	24	12795
SCNN1A-8947	−	GAGAUAACCCAGCACCCA	18	12796
SCNN1A-8948	−	GGAGAUAACCCAGCACCCA	19	12797
SCNN1A-8949	−	AGGAGAUAACCCAGCACCCA	20	12798
SCNN1A-8950	−	AAGGAGAUAACCCAGCACCCA	21	12799
SCNN1A-8951	−	CAAGGAGAUAACCCAGCACCCA	22	12800
SCNN1A-8952	−	CCAAGGAGAUAACCCAGCACCCA	23	12801
SCNN1A-8953	−	GCCAAGGAGAUAACCCAGCACCCA	24	12802
SCNN1A-8954	−	GAGAGCAGGAGAGACCCA	18	12803
SCNN1A-8955	−	GGAGAGCAGGAGAGACCCA	19	12804
SCNN1A-8956	−	AGGAGAGCAGGAGAGACCCA	20	12805
SCNN1A-8957	−	GAGGAGAGCAGGAGAGACCCA	21	12806
SCNN1A-8958	−	AGAGGAGAGCAGGAGAGACCCA	22	12807
SCNN1A-8959	−	AAGAGGAGAGCAGGAGAGACCCA	23	12808
SCNN1A-8960	−	AAAGAGGAGAGCAGGAGAGACCCA	24	12809
SCNN1A-8961	−	GCUAAGUAGAUAGCCCCA	18	12810
SCNN1A-8962	−	CGCUAAGUAGAUAGCCCCA	19	12811
SCNN1A-8963	−	GCGCUAAGUAGAUAGCCCCA	20	12812
SCNN1A-8964	−	AGCGCUAAGUAGAUAGCCCCA	21	12813
SCNN1A-8965	−	AAGCGCUAAGUAGAUAGCCCCA	22	12814
SCNN1A-8966	−	AAAGCGCUAAGUAGAUAGCCCCA	23	12815
SCNN1A-8967	−	AAAAGCGCUAAGUAGAUAGCCCCA	24	12816
SCNN1A-8968	−	GACCUUUUCACAGAGCCA	18	12817
SCNN1A-8969	−	AGACCUUUUCACAGAGCCA	19	12818
SCNN1A-5866	−	GAGACCUUUUCACAGAGCCA	20	9715
SCNN1A-8970	−	AGAGACCUUUUCACAGAGCCA	21	12819
SCNN1A-8971	−	CAGAGACCUUUUCACAGAGCCA	22	12820
SCNN1A-8972	−	GCAGAGACCUUUUCACAGAGCCA	23	12821
SCNN1A-8973	−	UGCAGAGACCUUUUCACAGAGCCA	24	12822
SCNN1A-8974	−	UCCAUCCCUGGCCGGCCA	18	12823
SCNN1A-8975	−	UUCCAUCCCUGGCCGGCCA	19	12824
SCNN1A-8976	−	CUUCCAUCCCUGGCCGGCCA	20	12825
SCNN1A-8977	−	GCUUCCAUCCCUGGCCGGCCA	21	12826
SCNN1A-8978	−	CGCUUCCAUCCCUGGCCGGCCA	22	12827
SCNN1A-8979	−	UCGCUUCCAUCCCUGGCCGGCCA	23	12828
SCNN1A-8980	−	GUCGCUUCCAUCCCUGGCCGGCCA	24	12829
SCNN1A-8981	−	AUCCAGCUGUCCCUUCCA	18	12830
SCNN1A-8982	−	AAUCCAGCUGUCCCUUCCA	19	12831
SCNN1A-5531	−	AAAUCCAGCUGUCCCUUCCA	20	9380
SCNN1A-8983	−	AAAAUCCAGCUGUCCCUUCCA	21	12832
SCNN1A-8984	−	AAAAAUCCAGCUGUCCCUUCCA	22	12833
SCNN1A-8985	−	GAAAAAUCCAGCUGUCCCUUCCA	23	12834
SCNN1A-8986	−	AGAAAAAUCCAGCUGUCCCUUCCA	24	12835
SCNN1A-8987	−	GGCCCUAUCAGGGAAGCA	18	12836
SCNN1A-8988	−	UGGCCCUAUCAGGGAAGCA	19	12837
SCNN1A-8989	−	GUGGCCCUAUCAGGGAAGCA	20	12838
SCNN1A-8990	−	GGUGGCCCUAUCAGGGAAGCA	21	12839
SCNN1A-8991	−	AGGUGGCCCUAUCAGGGAAGCA	22	12840
SCNN1A-8992	−	AAGGUGGCCCUAUCAGGGAAGCA	23	12841
SCNN1A-8993	−	AAAGGUGGCCCUAUCAGGGAAGCA	24	12842
SCNN1A-1808	−	GCAGUAUCAAGGUAAGCA	18	5657
SCNN1A-1809	−	AGCAGUAUCAAGGUAAGCA	19	5658
SCNN1A-342	−	GAGCAGUAUCAAGGUAAGCA	20	4191
SCNN1A-1810	−	UGAGCAGUAUCAAGGUAAGCA	21	5659
SCNN1A-1811	−	AUGAGCAGUAUCAAGGUAAGCA	22	5660
SCNN1A-1812	−	CAUGAGCAGUAUCAAGGUAAGCA	23	5661
SCNN1A-1813	−	UCAUGAGCAGUAUCAAGGUAAGCA	24	5662
SCNN1A-8994	−	UGGCAAAUAGAAAAGGCA	18	12843
SCNN1A-8995	−	CUGGCAAAUAGAAAAGGCA	19	12844
SCNN1A-5180	−	GCUGGCAAAUAGAAAAGGCA	20	9029
SCNN1A-8996	−	AGCUGGCAAAUAGAAAAGGCA	21	12845
SCNN1A-8997	−	GAGCUGGCAAAUAGAAAAGGCA	22	12846
SCNN1A-8998	−	UGAGCUGGCAAAUAGAAAAGGCA	23	12847
SCNN1A-8999	−	AUGAGCUGGCAAAUAGAAAAGGCA	24	12848
SCNN1A-9000	−	GUGAGAGGGGGCAAGGCA	18	12849
SCNN1A-9001	−	AGUGAGAGGGGGCAAGGCA	19	12850
SCNN1A-5868	−	GAGUGAGAGGGGGCAAGGCA	20	9717
SCNN1A-9002	−	AGAGUGAGAGGGGGCAAGGCA	21	12851
SCNN1A-9003	−	UAGAGUGAGAGGGGGCAAGGCA	22	12852
SCNN1A-9004	−	CUAGAGUGAGAGGGGGCAAGGCA	23	12853
SCNN1A-9005	−	CCUAGAGUGAGAGGGGGCAAGGCA	24	12854
SCNN1A-9006	−	UCUGGGAUAUGUGGGGCA	18	12855
SCNN1A-9007	−	CUCUGGGAUAUGUGGGGCA	19	12856
SCNN1A-9008	−	UCUCUGGGAUAUGUGGGGCA	20	12857
SCNN1A-9009	−	GUCUCUGGGAUAUGUGGGGCA	21	12858
SCNN1A-9010	−	GGUCUCUGGGAUAUGUGGGGCA	22	12859
SCNN1A-9011	−	GGGUCUCUGGGAUAUGUGGGGCA	23	12860
SCNN1A-9012	−	GGGGUCUCUGGGAUAUGUGGGGCA	24	12861
SCNN1A-9013	−	CUUCCUGAGUCUCCUGCA	18	12862
SCNN1A-9014	−	GCUUCCUGAGUCUCCUGCA	19	12863
SCNN1A-9015	−	GGCUUCCUGAGUCUCCUGCA	20	12864
SCNN1A-9016	−	AGGCUUCCUGAGUCUCCUGCA	21	12865
SCNN1A-9017	−	AAGGCUUCCUGAGUCUCCUGCA	22	12866
SCNN1A-9018	−	GAAGGCUUCCUGAGUCUCCUGCA	23	12867
SCNN1A-9019	−	GGAAGGCUUCCUGAGUCUCCUGCA	24	12868
SCNN1A-9020	−	GCUGAGCACCUUAUUGCA	18	12869
SCNN1A-9021	−	UGCUGAGCACCUUAUUGCA	19	12870
SCNN1A-5184	−	GUGCUGAGCACCUUAUUGCA	20	9033
SCNN1A-9022	−	GGUGCUGAGCACCUUAUUGCA	21	12871
SCNN1A-9023	−	GGGUGCUGAGCACCUUAUUGCA	22	12872
SCNN1A-9024	−	AGGGUGCUGAGCACCUUAUUGCA	23	12873
SCNN1A-9025	−	CAGGGUGCUGAGCACCUUAUUGCA	24	12874
SCNN1A-9026	−	CGAAAGGUGGCCCUAUCA	18	12875
SCNN1A-9027	−	UCGAAAGGUGGCCCUAUCA	19	12876
SCNN1A-5540	−	CUCGAAAGGUGGCCCUAUCA	20	9389
SCNN1A-9028	−	ACUCGAAAGGUGGCCCUAUCA	21	12877
SCNN1A-9029	−	AACUCGAAAGGUGGCCCUAUCA	22	12878
SCNN1A-9030	−	AAACUCGAAAGGUGGCCCUAUCA	23	12879
SCNN1A-9031	−	AAAACUCGAAAGGUGGCCCUAUCA	24	12880
SCNN1A-9032	−	AUGUAAGGACCUGGCUCA	18	12881
SCNN1A-9033	−	AAUGUAAGGACCUGGCUCA	19	12882
SCNN1A-5542	−	CAAUGUAAGGACCUGGCUCA	20	9391
SCNN1A-9034	−	CCAAUGUAAGGACCUGGCUCA	21	12883
SCNN1A-9035	−	CCCAAUGUAAGGACCUGGCUCA	22	12884
SCNN1A-9036	−	GCCCAAUGUAAGGACCUGGCUCA	23	12885
SCNN1A-9037	−	UGCCCAAUGUAAGGACCUGGCUCA	24	12886
SCNN1A-1814	−	AGCCCAUACCAGGUCUCA	18	5663
SCNN1A-1815	−	CAGCCCAUACCAGGUCUCA	19	5664
SCNN1A-1	−	GCAGCCCAUACCAGGUCUCA	20	503
SCNN1A-1816	−	UGCAGCCCAUACCAGGUCUCA	21	5665
SCNN1A-1817	−	CUGCAGCCCAUACCAGGUCUCA	22	5666
SCNN1A-1818	−	UCUGCAGCCCAUACCAGGUCUCA	23	5667
SCNN1A-1819	−	CUCUGCAGCCCAUACCAGGUCUCA	24	5668
SCNN1A-9038	−	GCAUUGCAAUUCUUCUCA	18	12887
SCNN1A-9039	−	GGCAUUGCAAUUCUUCUCA	19	12888
SCNN1A-9040	−	AGGCAUUGCAAUUCUUCUCA	20	12889
SCNN1A-9041	−	CAGGCAUUGCAAUUCUUCUCA	21	12890
SCNN1A-9042	−	CCAGGCAUUGCAAUUCUUCUCA	22	12891
SCNN1A-9043	−	ACCAGGCAUUGCAAUUCUUCUCA	23	12892
SCNN1A-9044	−	GACCAGGCAUUGCAAUUCUUCUCA	24	12893
SCNN1A-9045	−	AGUGCAGAGACCUUUUCA	18	12894
SCNN1A-9046	−	CAGUGCAGAGACCUUUUCA	19	12895
SCNN1A-9047	−	ACAGUGCAGAGACCUUUUCA	20	12896
SCNN1A-9048	−	GACAGUGCAGAGACCUUUUCA	21	12897
SCNN1A-9049	−	GGACAGUGCAGAGACCUUUUCA	22	12898
SCNN1A-9050	−	GGGACAGUGCAGAGACCUUUUCA	23	12899
SCNN1A-9051	−	GGGGACAGUGCAGAGACCUUUUCA	24	12900
SCNN1A-9052	−	CAAGAGACUGCCGCAAGA	18	12901
SCNN1A-9053	−	GCAAGAGACUGCCGCAAGA	19	12902
SCNN1A-9054	−	CGCAAGAGACUGCCGCAAGA	20	12903
SCNN1A-9055	−	UCGCAAGAGACUGCCGCAAGA	21	12904
SCNN1A-9056	−	GUCGCAAGAGACUGCCGCAAGA	22	12905
SCNN1A-9057	−	AGUCGCAAGAGACUGCCGCAAGA	23	12906
SCNN1A-9058	−	AAGUCGCAAGAGACUGCCGCAAGA	24	12907
SCNN1A-9059	−	GAAGGGGGCAGAGACAGA	18	12908
SCNN1A-9060	−	GGAAGGGGGCAGAGACAGA	19	12909
SCNN1A-9061	−	AGGAAGGGGGCAGAGACAGA	20	12910
SCNN1A-9062	−	AAGGAAGGGGGCAGAGACAGA	21	12911
SCNN1A-9063	−	AAAGGAAGGGGGCAGAGACAGA	22	12912
SCNN1A-9064	−	CAAAGGAAGGGGGCAGAGACAGA	23	12913
SCNN1A-9065	−	CCAAAGGAAGGGGGCAGAGACAGA	24	12914
SCNN1A-9066	−	GAGAGGAGGCAGGCCAGA	18	12915
SCNN1A-9067	−	AGAGAGGAGGCAGGCCAGA	19	12916
SCNN1A-9068	−	GAGAGAGGAGGCAGGCCAGA	20	12917
SCNN1A-9069	−	AGAGAGAGGAGGCAGGCCAGA	21	12918
SCNN1A-9070	−	UAGAGAGAGGAGGCAGGCCAGA	22	12919
SCNN1A-9071	−	UUAGAGAGAGGAGGCAGGCCAGA	23	12920
SCNN1A-9072	−	AUUAGAGAGAGGAGGCAGGCCAGA	24	12921
SCNN1A-9073	−	AGAGAAACAGAAGGCAGA	18	12922
SCNN1A-9074	−	AAGAGAAACAGAAGGCAGA	19	12923
SCNN1A-9075	−	AAAGAGAAACAGAAGGCAGA	20	12924
SCNN1A-9076	−	CAAAGAGAAACAGAAGGCAGA	21	12925
SCNN1A-9077	−	CCAAAGAGAAACAGAAGGCAGA	22	12926
SCNN1A-9078	−	CCCAAAGAGAAACAGAAGGCAGA	23	12927
SCNN1A-9079	−	ACCCAAAGAGAAACAGAAGGCAGA	24	12928
SCNN1A-9080	−	AAAGGAAGGGGGCAGAGA	18	12929
SCNN1A-9081	−	CAAAGGAAGGGGGCAGAGA	19	12930
SCNN1A-9082	−	CCAAAGGAAGGGGGCAGAGA	20	12931
SCNN1A-9083	−	ACCAAAGGAAGGGGGCAGAGA	21	12932
SCNN1A-9084	−	GACCAAAGGAAGGGGGCAGAGA	22	12933
SCNN1A-9085	−	AGACCAAAGGAAGGGGGCAGAGA	23	12934
SCNN1A-9086	−	AAGACCAAAGGAAGGGGGCAGAGA	24	12935
SCNN1A-9087	−	GAGAGGCAGGAUUAGAGA	18	12936
SCNN1A-9088	−	AGAGAGGCAGGAUUAGAGA	19	12937
SCNN1A-9089	−	AAGAGAGGCAGGAUUAGAGA	20	12938
SCNN1A-9090	−	GAAGAGAGGCAGGAUUAGAGA	21	12939
SCNN1A-9091	−	GGAAGAGAGGCAGGAUUAGAGA	22	12940
SCNN1A-9092	−	AGGAAGAGAGGCAGGAUUAGAGA	23	12941
SCNN1A-9093	−	GAGGAAGAGAGGCAGGAUUAGAGA	24	12942
SCNN1A-9094	−	GACCUGGCUCAAGGGAGA	18	12943
SCNN1A-9095	−	GGACCUGGCUCAAGGGAGA	19	12944
SCNN1A-9096	−	AGGACCUGGCUCAAGGGAGA	20	12945
SCNN1A-9097	−	AAGGACCUGGCUCAAGGGAGA	21	12946
SCNN1A-9098	−	UAAGGACCUGGCUCAAGGGAGA	22	12947
SCNN1A-9099	−	GUAAGGACCUGGCUCAAGGGAGA	23	12948
SCNN1A-9100	−	UGUAAGGACCUGGCUCAAGGGAGA	24	12949
SCNN1A-9101	−	UGAGGGCCUAGAGUGAGA	18	12950
SCNN1A-9102	−	CUGAGGGCCUAGAGUGAGA	19	12951
SCNN1A-5188	−	GCUGAGGGCCUAGAGUGAGA	20	9037
SCNN1A-9103	−	AGCUGAGGGCCUAGAGUGAGA	21	12952
SCNN1A-9104	−	GAGCUGAGGGCCUAGAGUGAGA	22	12953
SCNN1A-9105	−	GGAGCUGAGGGCCUAGAGUGAGA	23	12954
SCNN1A-9106	−	UGGAGCUGAGGGCCUAGAGUGAGA	24	12955
SCNN1A-9107	−	AAACAGAAGGCAGAUAGA	18	12956
SCNN1A-9108	−	GAAACAGAAGGCAGAUAGA	19	12957
SCNN1A-9109	−	AGAAACAGAAGGCAGAUAGA	20	12958
SCNN1A-9110	−	GAGAAACAGAAGGCAGAUAGA	21	12959
SCNN1A-9111	−	AGAGAAACAGAAGGCAGAUAGA	22	12960
SCNN1A-9112	−	AAGAGAAACAGAAGGCAGAUAGA	23	12961
SCNN1A-9113	−	AAAGAGAAACAGAAGGCAGAUAGA	24	12962
SCNN1A-9114	−	UGGAGCUGAGGGCCUAGA	18	12963
SCNN1A-9115	−	CUGGAGCUGAGGGCCUAGA	19	12964
SCNN1A-9116	−	GCUGGAGCUGAGGGCCUAGA	20	12965
SCNN1A-9117	−	GGCUGGAGCUGAGGGCCUAGA	21	12966
SCNN1A-9118	−	AGGCUGGAGCUGAGGGCCUAGA	22	12967
SCNN1A-9119	−	GAGGCUGGAGCUGAGGGCCUAGA	23	12968
SCNN1A-9120	−	AGAGGCUGGAGCUGAGGGCCUAGA	24	12969
SCNN1A-9121	−	AAGAGAGGCAGGAUUAGA	18	12970
SCNN1A-9122	−	GAAGAGAGGCAGGAUUAGA	19	12971
SCNN1A-9123	−	GGAAGAGAGGCAGGAUUAGA	20	12972
SCNN1A-9124	−	AGGAAGAGAGGCAGGAUUAGA	21	12973
SCNN1A-9125	−	GAGGAAGAGAGGCAGGAUUAGA	22	12974
SCNN1A-9126	−	AGAGGAAGAGAGGCAGGAUUAGA	23	12975
SCNN1A-9127	−	GAGAGGAAGAGAGGCAGGAUUAGA	24	12976
SCNN1A-9128	−	AGGAAGAAGACCAAAGGA	18	12977
SCNN1A-9129	−	GAGGAAGAAGACCAAAGGA	19	12978
SCNN1A-5873	−	GGAGGAAGAAGACCAAAGGA	20	9722
SCNN1A-9130	−	UGGAGGAAGAAGACCAAAGGA	21	12979
SCNN1A-9131	−	CUGGAGGAAGAAGACCAAAGGA	22	12980
SCNN1A-9132	−	CCUGGAGGAAGAAGACCAAAGGA	23	12981
SCNN1A-9133	−	UCCUGGAGGAAGAAGACCAAAGGA	24	12982
SCNN1A-9134	−	GGCGAGGAAUCAGCAGGA	18	12983
SCNN1A-9135	−	UGGCGAGGAAUCAGCAGGA	19	12984
SCNN1A-9136	−	GUGGCGAGGAAUCAGCAGGA	20	12985
SCNN1A-9137	−	GGUGGCGAGGAAUCAGCAGGA	21	12986
SCNN1A-9138	−	GGGUGGCGAGGAAUCAGCAGGA	22	12987
SCNN1A-9139	−	GGGGUGGCGAGGAAUCAGCAGGA	23	12988
SCNN1A-9140	−	GGGGGUGGCGAGGAAUCAGCAGGA	24	12989
SCNN1A-9141	−	UGGAGGAGGGAGGGAGGA	18	12990
SCNN1A-9142	−	GUGGAGGAGGGAGGGAGGA	19	12991
SCNN1A-9143	−	GGUGGAGGAGGGAGGGAGGA	20	12992
SCNN1A-9144	−	AGGUGGAGGAGGGAGGGAGGA	21	12993
SCNN1A-9145	−	AAGGUGGAGGAGGGAGGGAGGA	22	12994
SCNN1A-9146	−	AAAGGUGGAGGAGGGAGGGAGGA	23	12995
SCNN1A-9147	−	GAAAGGUGGAGGAGGGAGGGAGGA	24	12996
SCNN1A-9148	−	UCCAGGAAAGGUGGAGGA	18	12997
SCNN1A-9149	−	CUCCAGGAAAGGUGGAGGA	19	12998
SCNN1A-5877	−	GCUCCAGGAAAGGUGGAGGA	20	9726
SCNN1A-9150	−	GGCUCCAGGAAAGGUGGAGGA	21	12999
SCNN1A-9151	−	UGGCUCCAGGAAAGGUGGAGGA	22	13000
SCNN1A-9152	−	CUGGCUCCAGGAAAGGUGGAGGA	23	13001
SCNN1A-9153	−	GCUGGCUCCAGGAAAGGUGGAGGA	24	13002
SCNN1A-9154	−	AAGGCAGAUAGAGAGGGA	18	13003
SCNN1A-9155	−	GAAGGCAGAUAGAGAGGGA	19	13004
SCNN1A-9156	−	AGAAGGCAGAUAGAGAGGGA	20	13005
SCNN1A-9157	−	CAGAAGGCAGAUAGAGAGGGA	21	13006
SCNN1A-9158	−	ACAGAAGGCAGAUAGAGAGGGA	22	13007
SCNN1A-9159	−	AACAGAAGGCAGAUAGAGAGGGA	23	13008
SCNN1A-9160	−	AAACAGAAGGCAGAUAGAGAGGGA	24	13009
SCNN1A-9161	−	GGAAAGGUGGAGGAGGGA	18	13010
SCNN1A-9162	−	AGGAAAGGUGGAGGAGGGA	19	13011
SCNN1A-6095	−	CAGGAAAGGUGGAGGAGGGA	20	9944
SCNN1A-9163	−	CCAGGAAAGGUGGAGGAGGGA	21	13012
SCNN1A-9164	−	UCCAGGAAAGGUGGAGGAGGGA	22	13013
SCNN1A-9165	−	CUCCAGGAAAGGUGGAGGAGGGA	23	13014
SCNN1A-9166	−	GCUCCAGGAAAGGUGGAGGAGGGA	24	13015
SCNN1A-9167	−	GGCAAGGCAAGGGGGGGA	18	13016
SCNN1A-9168	−	GGGCAAGGCAAGGGGGGGA	19	13017
SCNN1A-9169	−	GGGGCAAGGCAAGGGGGGGA	20	13018
SCNN1A-9170	−	GGGGGCAAGGCAAGGGGGGGA	21	13019
SCNN1A-9171	−	AGGGGGCAAGGCAAGGGGGGGA	22	13020
SCNN1A-9172	−	GAGGGGGCAAGGCAAGGGGGGGA	23	13021
SCNN1A-9173	−	AGAGGGGGCAAGGCAAGGGGGGGA	24	13022
SCNN1A-1820	−	GUUCCAGGGGUGAUGGGA	18	5669
SCNN1A-1821	−	GGUUCCAGGGGUGAUGGGA	19	5670
SCNN1A-1822	−	GGGUUCCAGGGGUGAUGGGA	20	5671
SCNN1A-1823	−	CGGGUUCCAGGGGUGAUGGGA	21	5672
SCNN1A-1824	−	UCGGGUUCCAGGGGUGAUGGGA	22	5673
SCNN1A-1825	−	CUCGGGUUCCAGGGGUGAUGGGA	23	5674
SCNN1A-1826	−	ACUCGGGUUCCAGGGGUGAUGGGA	24	5675
SCNN1A-9174	−	UCCAGCCGCAACCUGGGA	18	13023
SCNN1A-9175	−	GUCCAGCCGCAACCUGGGA	19	13024
SCNN1A-9176	−	AGUCCAGCCGCAACCUGGGA	20	13025
SCNN1A-9177	−	CAGUCCAGCCGCAACCUGGGA	21	13026
SCNN1A-9178	−	CCAGUCCAGCCGCAACCUGGGA	22	13027
SCNN1A-9179	−	CCCAGUCCAGCCGCAACCUGGGA	23	13028
SCNN1A-9180	−	UCCCAGUCCAGCCGCAACCUGGGA	24	13029
SCNN1A-9181	−	CACGGGCUCUGUGUGGGA	18	13030
SCNN1A-9182	−	CCACGGGCUCUGUGUGGGA	19	13031
SCNN1A-9183	−	UCCACGGGCUCUGUGUGGGA	20	13032
SCNN1A-9184	−	AUCCACGGGCUCUGUGUGGGA	21	13033
SCNN1A-9185	−	AAUCCACGGGCUCUGUGUGGGA	22	13034
SCNN1A-9186	−	GAAUCCACGGGCUCUGUGUGGGA	23	13035
SCNN1A-9187	−	CGAAUCCACGGGCUCUGUGUGGGA	24	13036
SCNN1A-1827	−	CAUACCAGGUCUCAUGGA	18	5676
SCNN1A-1828	−	CCAUACCAGGUCUCAUGGA	19	5677
SCNN1A-3	−	CCCAUACCAGGUCUCAUGGA	20	556
SCNN1A-1829	−	GCCCAUACCAGGUCUCAUGGA	21	5678
SCNN1A-1830	−	AGCCCAUACCAGGUCUCAUGGA	22	5679
SCNN1A-1831	−	CAGCCCAUACCAGGUCUCAUGGA	23	5680
SCNN1A-1832	−	GCAGCCCAUACCAGGUCUCAUGGA	24	5681
SCNN1A-9188	−	CUGCCAGAUUCAACUGGA	18	13037
SCNN1A-9189	−	GCUGCCAGAUUCAACUGGA	19	13038
SCNN1A-9190	−	GGCUGCCAGAUUCAACUGGA	20	13039
SCNN1A-9191	−	UGGCUGCCAGAUUCAACUGGA	21	13040
SCNN1A-9192	−	UUGGCUGCCAGAUUCAACUGGA	22	13041
SCNN1A-9193	−	UUUGGCUGCCAGAUUCAACUGGA	23	13042
SCNN1A-9194	−	GUUUGGCUGCCAGAUUCAACUGGA	24	13043
SCNN1A-9195	−	UGUCUGCUGGCUUGUGGA	18	13044
SCNN1A-9196	−	UUGUCUGCUGGCUUGUGGA	19	13045
SCNN1A-5552	−	UUUGUCUGCUGGCUUGUGGA	20	9401
SCNN1A-9197	−	CUUUGUCUGCUGGCUUGUGGA	21	13046
SCNN1A-9198	−	CCUUUGUCUGCUGGCUUGUGGA	22	13047
SCNN1A-9199	−	GCCUUUGUCUGCUGGCUUGUGGA	23	13048
SCNN1A-9200	−	GGCCUUUGUCUGCUGGCUUGUGGA	24	13049
SCNN1A-9201	−	UGCUGCAUUAAGUUUGGA	18	13050
SCNN1A-9202	−	UUGCUGCAUUAAGUUUGGA	19	13051
SCNN1A-9203	−	UUUGCUGCAUUAAGUUUGGA	20	13052
SCNN1A-9204	−	UUUUGCUGCAUUAAGUUUGGA	21	13053
SCNN1A-9205	−	CUUUUGCUGCAUUAAGUUUGGA	22	13054
SCNN1A-9206	−	CCUUUUGCUGCAUUAAGUUUGGA	23	13055
SCNN1A-9207	−	UCCUUUUGCUGCAUUAAGUUUGGA	24	13056
SCNN1A-1839	−	CCACUCCGGGGCUCAUGA	18	5688
SCNN1A-1840	−	UCCACUCCGGGGCUCAUGA	19	5689
SCNN1A-400	−	AUCCACUCCGGGGCUCAUGA	20	4249
SCNN1A-1841	−	AAUCCACUCCGGGGCUCAUGA	21	5690
SCNN1A-1842	−	CAAUCCACUCCGGGGCUCAUGA	22	5691
SCNN1A-1843	−	CCAAUCCACUCCGGGGCUCAUGA	23	5692
SCNN1A-1844	−	CCCAAUCCACUCCGGGGCUCAUGA	24	5693
SCNN1A-9208	−	GCUGAGGGCCUAGAGUGA	18	13057
SCNN1A-9209	−	AGCUGAGGGCCUAGAGUGA	19	13058
SCNN1A-9210	−	GAGCUGAGGGCCUAGAGUGA	20	13059
SCNN1A-9211	−	GGAGCUGAGGGCCUAGAGUGA	21	13060
SCNN1A-9212	−	UGGAGCUGAGGGCCUAGAGUGA	22	13061
SCNN1A-9213	−	CUGGAGCUGAGGGCCUAGAGUGA	23	13062
SCNN1A-9214	−	GCUGGAGCUGAGGGCCUAGAGUGA	24	13063
SCNN1A-9215	−	GGCUCUGUGUGGGAGUGA	18	13064
SCNN1A-9216	−	GGGCUCUGUGUGGGAGUGA	19	13065
SCNN1A-5555	−	CGGGCUCUGUGUGGGAGUGA	20	9404
SCNN1A-9217	−	ACGGGCUCUGUGUGGGAGUGA	21	13066
SCNN1A-9218	−	CACGGGCUCUGUGUGGGAGUGA	22	13067
SCNN1A-9219	−	CCACGGGCUCUGUGUGGGAGUGA	23	13068
SCNN1A-9220	−	UCCACGGGCUCUGUGUGGGAGUGA	24	13069
SCNN1A-9221	−	GCUGCUCCCACUUAGUGA	18	13070
SCNN1A-9222	−	CGCUGCUCCCACUUAGUGA	19	13071
SCNN1A-9223	−	GCGCUGCUCCCACUUAGUGA	20	13072
SCNN1A-9224	−	UGCGCUGCUCCCACUUAGUGA	21	13073
SCNN1A-9225	−	GUGCGCUGCUCCCACUUAGUGA	22	13074
SCNN1A-9226	−	AGUGCGCUGCUCCCACUUAGUGA	23	13075
SCNN1A-9227	−	GAGUGCGCUGCUCCCACUUAGUGA	24	13076
SCNN1A-9228	−	GCUGCACCUGUCAGGUGA	18	13077
SCNN1A-9229	−	CGCUGCACCUGUCAGGUGA	19	13078
SCNN1A-5556	−	CCGCUGCACCUGUCAGGUGA	20	9405
SCNN1A-9230	−	GCCGCUGCACCUGUCAGGUGA	21	13079
SCNN1A-9231	−	GGCCGCUGCACCUGUCAGGUGA	22	13080
SCNN1A-9232	−	AGGCCGCUGCACCUGUCAGGUGA	23	13081
SCNN1A-9233	−	CAGGCCGCUGCACCUGUCAGGUGA	24	13082
SCNN1A-1845	−	CUCGGGUUCCAGGGGUGA	18	5694
SCNN1A-1846	−	ACUCGGGUUCCAGGGGUGA	19	5695
SCNN1A-401	−	CACUCGGGUUCCAGGGGUGA	20	4250
SCNN1A-1847	−	UCACUCGGGUUCCAGGGGUGA	21	5696
SCNN1A-1848	−	CUCACUCGGGUUCCAGGGGUGA	22	5697
SCNN1A-1849	−	CCUCACUCGGGUUCCAGGGGUGA	23	5698
SCNN1A-1850	−	GCCUCACUCGGGUUCCAGGGGUGA	24	5699
SCNN1A-9234	−	AGAAACAGAAGGCAGAUA	18	13083
SCNN1A-9235	−	GAGAAACAGAAGGCAGAUA	19	13084
SCNN1A-9236	−	AGAGAAACAGAAGGCAGAUA	20	13085
SCNN1A-9237	−	AAGAGAAACAGAAGGCAGAUA	21	13086
SCNN1A-9238	−	AAAGAGAAACAGAAGGCAGAUA	22	13087
SCNN1A-9239	−	CAAAGAGAAACAGAAGGCAGAUA	23	13088
SCNN1A-9240	−	CCAAAGAGAAACAGAAGGCAGAUA	24	13089
SCNN1A-9241	−	CCUUUAAUUGAGAUGCUA	18	13090
SCNN1A-9242	−	ACCUUUAAUUGAGAUGCUA	19	13091
SCNN1A-9243	−	CACCUUUAAUUGAGAUGCUA	20	13092
SCNN1A-9244	−	UCACCUUUAAUUGAGAUGCUA	21	13093
SCNN1A-9245	−	CUCACCUUUAAUUGAGAUGCUA	22	13094
SCNN1A-9246	−	GCUCACCUUUAAUUGAGAUGCUA	23	13095
SCNN1A-9247	−	UGCUCACCUUUAAUUGAGAUGCUA	24	13096
SCNN1A-9248	−	AGAGGAGAGGCCGUUCUA	18	13097
SCNN1A-9249	−	CAGAGGAGAGGCCGUUCUA	19	13098
SCNN1A-5199	−	GCAGAGGAGAGGCCGUUCUA	20	9048
SCNN1A-9250	−	AGCAGAGGAGAGGCCGUUCUA	21	13099
SCNN1A-9251	−	AAGCAGAGGAGAGGCCGUUCUA	22	13100
SCNN1A-9252	−	GAAGCAGAGGAGAGGCCGUUCUA	23	13101
SCNN1A-9253	−	GGAAGCAGAGGAGAGGCCGUUCUA	24	13102
SCNN1A-9254	−	GGAAGAGAGGCAGGAUUA	18	13103
SCNN1A-9255	−	AGGAAGAGAGGCAGGAUUA	19	13104
SCNN1A-9256	−	GAGGAAGAGAGGCAGGAUUA	20	13105
SCNN1A-9257	−	AGAGGAAGAGAGGCAGGAUUA	21	13106
SCNN1A-9258	−	GAGAGGAAGAGAGGCAGGAUUA	22	13107
SCNN1A-9259	−	GGAGAGGAAGAGAGGCAGGAUUA	23	13108
SCNN1A-9260	−	GGGAGAGGAAGAGAGGCAGGAUUA	24	13109
SCNN1A-9261	−	GUGCGCUGCUCCCACUUA	18	13110
SCNN1A-9262	−	AGUGCGCUGCUCCCACUUA	19	13111
SCNN1A-9263	−	GAGUGCGCUGCUCCCACUUA	20	13112
SCNN1A-9264	−	UGAGUGCGCUGCUCCCACUUA	21	13113
SCNN1A-9265	−	CUGAGUGCGCUGCUCCCACUUA	22	13114
SCNN1A-9266	−	CCUGAGUGCGCUGCUCCCACUUA	23	13115
SCNN1A-9267	−	ACCUGAGUGCGCUGCUCCCACUUA	24	13116
SCNN1A-9268	−	GAGGUGCUAGGACAAAAC	18	13117
SCNN1A-9269	−	GGAGGUGCUAGGACAAAAC	19	13118
SCNN1A-9270	−	GGGAGGUGCUAGGACAAAAC	20	13119
SCNN1A-9271	−	AGGGAGGUGCUAGGACAAAAC	21	13120
SCNN1A-9272	−	AAGGGAGGUGCUAGGACAAAAC	22	13121
SCNN1A-9273	−	AAAGGGAGGUGCUAGGACAAAAC	23	13122
SCNN1A-9274	−	GAAAGGGAGGUGCUAGGACAAAAC	24	13123
SCNN1A-9275	−	UCCCAGUCCAGCCGCAAC	18	13124
SCNN1A-9276	−	GUCCCAGUCCAGCCGCAAC	19	13125
SCNN1A-9277	−	AGUCCCAGUCCAGCCGCAAC	20	13126
SCNN1A-9278	−	CAGUCCCAGUCCAGCCGCAAC	21	13127
SCNN1A-9279	−	CCAGUCCCAGUCCAGCCGCAAC	22	13128
SCNN1A-9280	−	ACCAGUCCCAGUCCAGCCGCAAC	23	13129
SCNN1A-9281	−	AACCAGUCCCAGUCCAGCCGCAAC	24	13130
SCNN1A-9282	−	UUGGCUGCCAGAUUCAAC	18	13131
SCNN1A-9283	−	UUUGGCUGCCAGAUUCAAC	19	13132
SCNN1A-5202	−	GUUUGGCUGCCAGAUUCAAC	20	9051
SCNN1A-9284	−	GGUUUGGCUGCCAGAUUCAAC	21	13133
SCNN1A-9285	−	AGGUUUGGCUGCCAGAUUCAAC	22	13134
SCNN1A-9286	−	GAGGUUUGGCUGCCAGAUUCAAC	23	13135
SCNN1A-9287	−	AGAGGUUUGGCUGCCAGAUUCAAC	24	13136
SCNN1A-9288	−	UAGCUCCUGGAAGCACAC	18	13137
SCNN1A-9289	−	CUAGCUCCUGGAAGCACAC	19	13138
SCNN1A-9290	−	UCUAGCUCCUGGAAGCACAC	20	13139
SCNN1A-9291	−	CUCUAGCUCCUGGAAGCACAC	21	13140
SCNN1A-9292	−	CCUCUAGCUCCUGGAAGCACAC	22	13141
SCNN1A-9293	−	GCCUCUAGCUCCUGGAAGCACAC	23	13142
SCNN1A-9294	−	AGCCUCUAGCUCCUGGAAGCACAC	24	13143
SCNN1A-9295	−	UUUCACAUCCAGGUGCAC	18	13144
SCNN1A-9296	−	CUUUCACAUCCAGGUGCAC	19	13145
SCNN1A-9297	−	GCUUUCACAUCCAGGUGCAC	20	13146
SCNN1A-9298	−	GGCUUUCACAUCCAGGUGCAC	21	13147
SCNN1A-9299	−	CGGCUUUCACAUCCAGGUGCAC	22	13148
SCNN1A-9300	−	CCGGCUUUCACAUCCAGGUGCAC	23	13149
SCNN1A-9301	−	CCCGGCUUUCACAUCCAGGUGCAC	24	13150
SCNN1A-9302	−	CCUAGCCCCCAGCUUCAC	18	13151
SCNN1A-9303	−	GCCUAGCCCCCAGCUUCAC	19	13152
SCNN1A-9304	−	CGCCUAGCCCCCAGCUUCAC	20	13153
SCNN1A-9305	−	CCGCCUAGCCCCCAGCUUCAC	21	13154
SCNN1A-9306	−	CCCGCCUAGCCCCCAGCUUCAC	22	13155
SCNN1A-9307	−	CCCCGCCUAGCCCCCAGCUUCAC	23	13156
SCNN1A-9308	−	GCCCCGCCUAGCCCCCAGCUUCAC	24	13157
SCNN1A-9309	−	GCAGGAAAGAGGAGGGAC	18	13158
SCNN1A-9310	−	AGCAGGAAAGAGGAGGGAC	19	13159
SCNN1A-9311	−	CAGCAGGAAAGAGGAGGGAC	20	13160
SCNN1A-9312	−	UCAGCAGGAAAGAGGAGGGAC	21	13161
SCNN1A-9313	−	AUCAGCAGGAAAGAGGAGGGAC	22	13162
SCNN1A-9314	−	AAUCAGCAGGAAAGAGGAGGGAC	23	13163
SCNN1A-9315	−	GAAUCAGCAGGAAAGAGGAGGGAC	24	13164
SCNN1A-1863	−	GUGGGCGCAGGGUGGGAC	18	5712
SCNN1A-1864	−	UGUGGGCGCAGGGUGGGAC	19	5713
SCNN1A-1865	−	AUGUGGGCGCAGGGUGGGAC	20	5714
SCNN1A-1866	−	AAUGUGGGCGCAGGGUGGGAC	21	5715
SCNN1A-1867	−	GAAUGUGGGCGCAGGGUGGGAC	22	5716
SCNN1A-1868	−	AGAAUGUGGGCGCAGGGUGGGAC	23	5717
SCNN1A-1869	−	GAGAAUGUGGGCGCAGGGUGGGAC	24	5718
SCNN1A-9316	−	CCCAGUCCAGCCGCAACC	18	13165
SCNN1A-9317	−	UCCCAGUCCAGCCGCAACC	19	13166
SCNN1A-5213	−	GUCCCAGUCCAGCCGCAACC	20	9062
SCNN1A-9318	−	AGUCCCAGUCCAGCCGCAACC	21	13167
SCNN1A-9319	−	CAGUCCCAGUCCAGCCGCAACC	22	13168
SCNN1A-9320	−	CCAGUCCCAGUCCAGCCGCAACC	23	13169
SCNN1A-9321	−	ACCAGUCCCAGUCCAGCCGCAACC	24	13170
SCNN1A-9322	−	AGGAGAUAACCCAGCACC	18	13171
SCNN1A-9323	−	AAGGAGAUAACCCAGCACC	19	13172
SCNN1A-9324	−	CAAGGAGAUAACCCAGCACC	20	13173
SCNN1A-9325	−	CCAAGGAGAUAACCCAGCACC	21	13174
SCNN1A-9326	−	GCCAAGGAGAUAACCCAGCACC	22	13175
SCNN1A-9327	−	AGCCAAGGAGAUAACCCAGCACC	23	13176
SCNN1A-9328	−	GAGCCAAGGAGAUAACCCAGCACC	24	13177
SCNN1A-9329	−	CAGGAAAGAGGAGGGACC	18	13178
SCNN1A-9330	−	GCAGGAAAGAGGAGGGACC	19	13179
SCNN1A-5571	−	AGCAGGAAAGAGGAGGGACC	20	9420
SCNN1A-9331	−	CAGCAGGAAAGAGGAGGGACC	21	13180
SCNN1A-9332	−	UCAGCAGGAAAGAGGAGGGACC	22	13181
SCNN1A-9333	−	AUCAGCAGGAAAGAGGAGGGACC	23	13182
SCNN1A-9334	−	AAUCAGCAGGAAAGAGGAGGGACC	24	13183
SCNN1A-9335	−	CACAGACCAGGUUGGACC	18	13184
SCNN1A-9336	−	CCACAGACCAGGUUGGACC	19	13185
SCNN1A-9337	−	GCCACAGACCAGGUUGGACC	20	13186
SCNN1A-9338	−	AGCCACAGACCAGGUUGGACC	21	13187
SCNN1A-9339	−	AAGCCACAGACCAGGUUGGACC	22	13188
SCNN1A-9340	−	GAAGCCACAGACCAGGUUGGACC	23	13189
SCNN1A-9341	−	GGAAGCCACAGACCAGGUUGGACC	24	13190
SCNN1A-9342	−	GCGCUAAGUAGAUAGCCC	18	13191
SCNN1A-9343	−	AGCGCUAAGUAGAUAGCCC	19	13192
SCNN1A-9344	−	AAGCGCUAAGUAGAUAGCCC	20	13193
SCNN1A-9345	−	AAAGCGCUAAGUAGAUAGCCC	21	13194
SCNN1A-9346	−	AAAAGCGCUAAGUAGAUAGCCC	22	13195
SCNN1A-9347	−	CAAAAGCGCUAAGUAGAUAGCCC	23	13196
SCNN1A-9348	−	GCAAAAGCGCUAAGUAGAUAGCCC	24	13197
SCNN1A-9349	−	CUGCCUCCUGUGGGGCCC	18	13198
SCNN1A-9350	−	GCUGCCUCCUGUGGGGCCC	19	13199
SCNN1A-9351	−	GGCUGCCUCCUGUGGGGCCC	20	13200
SCNN1A-9352	−	GGGCUGCCUCCUGUGGGGCCC	21	13201
SCNN1A-9353	−	UGGGCUGCCUCCUGUGGGGCCC	22	13202
SCNN1A-9354	−	CUGGGCUGCCUCCUGUGGGGCCC	23	13203
SCNN1A-9355	−	UCUGGGCUGCCUCCUGUGGGGCCC	24	13204
SCNN1A-9356	−	CUCCCAGUUCACCUGCCC	18	13205
SCNN1A-9357	−	ACUCCCAGUUCACCUGCCC	19	13206
SCNN1A-9358	−	UACUCCCAGUUCACCUGCCC	20	13207
SCNN1A-9359	−	GUACUCCCAGUUCACCUGCCC	21	13208
SCNN1A-9360	−	AGUACUCCCAGUUCACCUGCCC	22	13209
SCNN1A-9361	−	CAGUACUCCCAGUUCACCUGCCC	23	13210
SCNN1A-9362	−	CCAGUACUCCCAGUUCACCUGCCC	24	13211
SCNN1A-9363	−	GCUGACCUGUGGGUGCCC	18	13212
SCNN1A-9364	−	GGCUGACCUGUGGGUGCCC	19	13213
SCNN1A-9365	−	AGGCUGACCUGUGGGUGCCC	20	13214
SCNN1A-9366	−	GAGGCUGACCUGUGGGUGCCC	21	13215
SCNN1A-9367	−	UGAGGCUGACCUGUGGGUGCCC	22	13216
SCNN1A-9368	−	GUGAGGCUGACCUGUGGGUGCCC	23	13217
SCNN1A-9369	−	GGUGAGGCUGACCUGUGGGUGCCC	24	13218
SCNN1A-9370	−	AGACCUUUUCACAGAGCC	18	13219
SCNN1A-9371	−	GAGACCUUUUCACAGAGCC	19	13220
SCNN1A-9372	−	AGAGACCUUUUCACAGAGCC	20	13221
SCNN1A-9373	−	CAGAGACCUUUUCACAGAGCC	21	13222
SCNN1A-9374	−	GCAGAGACCUUUUCACAGAGCC	22	13223
SCNN1A-9375	−	UGCAGAGACCUUUUCACAGAGCC	23	13224
SCNN1A-9376	−	GUGCAGAGACCUUUUCACAGAGCC	24	13225
SCNN1A-1876	−	GAGAGGGCACUCAGGGCC	18	5725
SCNN1A-1877	−	GGAGAGGGCACUCAGGGCC	19	5726
SCNN1A-1878	−	GGGAGAGGGCACUCAGGGCC	20	5727
SCNN1A-1879	−	UGGGAGAGGGCACUCAGGGCC	21	5728
SCNN1A-1880	−	AUGGGAGAGGGCACUCAGGGCC	22	5729
SCNN1A-1881	−	GAUGGGAGAGGGCACUCAGGGCC	23	5730
SCNN1A-1882	−	UGAUGGGAGAGGGCACUCAGGGCC	24	5731
SCNN1A-1889	−	UGGGACAUGGGCAUGGCC	18	5738
SCNN1A-1890	−	GUGGGACAUGGGCAUGGCC	19	5739
SCNN1A-347	−	GGUGGGACAUGGGCAUGGCC	20	4196
SCNN1A-1891	−	GGGUGGGACAUGGGCAUGGCC	21	5740
SCNN1A-1892	−	AGGGUGGGACAUGGGCAUGGCC	22	5741
SCNN1A-1893	−	CAGGGUGGGACAUGGGCAUGGCC	23	5742
SCNN1A-1894	−	GCAGGGUGGGACAUGGGCAUGGCC	24	5743
SCNN1A-9377	−	CAGAGAGCAGACGAAUCC	18	13226
SCNN1A-9378	−	CCAGAGAGCAGACGAAUCC	19	13227
SCNN1A-9379	−	CCCAGAGAGCAGACGAAUCC	20	13228
SCNN1A-9380	−	ACCCAGAGAGCAGACGAAUCC	21	13229
SCNN1A-9381	−	CACCCAGAGAGCAGACGAAUCC	22	13230
SCNN1A-9382	−	GCACCCAGAGAGCAGACGAAUCC	23	13231
SCNN1A-9383	−	AGCACCCAGAGAGCAGACGAAUCC	24	13232
SCNN1A-9384	−	GAGCUGAGACACAGAUCC	18	13233
SCNN1A-9385	−	GGAGCUGAGACACAGAUCC	19	13234
SCNN1A-5588	−	AGGAGCUGAGACACAGAUCC	20	9437
SCNN1A-9386	−	CAGGAGCUGAGACACAGAUCC	21	13235
SCNN1A-9387	−	GCAGGAGCUGAGACACAGAUCC	22	13236
SCNN1A-9388	−	GGCAGGAGCUGAGACACAGAUCC	23	13237
SCNN1A-9389	−	AGGCAGGAGCUGAGACACAGAUCC	24	13238
SCNN1A-9390	−	CAGAAAACUGAUUUAUCC	18	13239
SCNN1A-9391	−	UCAGAAAACUGAUUUAUCC	19	13240
SCNN1A-9392	−	CUCAGAAAACUGAUUUAUCC	20	13241
SCNN1A-9393	−	CCUCAGAAAACUGAUUUAUCC	21	13242
SCNN1A-9394	−	ACCUCAGAAAACUGAUUUAUCC	22	13243
SCNN1A-9395	−	AACCUCAGAAAACUGAUUUAUCC	23	13244
SCNN1A-9396	−	UAACCUCAGAAAACUGAUUUAUCC	24	13245
SCNN1A-9397	−	GAGGCAGCCCAGACCUCC	18	13246
SCNN1A-9398	−	GGAGGCAGCCCAGACCUCC	19	13247
SCNN1A-5591	−	UGGAGGCAGCCCAGACCUCC	20	9440
SCNN1A-9399	−	CUGGAGGCAGCCCAGACCUCC	21	13248
SCNN1A-9400	−	GCUGGAGGCAGCCCAGACCUCC	22	13249
SCNN1A-9401	−	AGCUGGAGGCAGCCCAGACCUCC	23	13250
SCNN1A-9402	−	AAGCUGGAGGCAGCCCAGACCUCC	24	13251
SCNN1A-9403	−	ACGAAUUUCUCCUCCUCC	18	13252
SCNN1A-9404	−	AACGAAUUUCUCCUCCUCC	19	13253
SCNN1A-9405	−	CAACGAAUUUCUCCUCCUCC	20	13254
SCNN1A-9406	−	UCAACGAAUUUCUCCUCCUCC	21	13255
SCNN1A-9407	−	AUCAACGAAUUUCUCCUCCUCC	22	13256
SCNN1A-9408	−	CAUCAACGAAUUUCUCCUCCUCC	23	13257
SCNN1A-9409	−	CCAUCAACGAAUUUCUCCUCCUCC	24	13258
SCNN1A-9410	−	UGCUGAGCCUCUAGCUCC	18	13259
SCNN1A-9411	−	UUGCUGAGCCUCUAGCUCC	19	13260
SCNN1A-5594	−	CUUGCUGAGCCUCUAGCUCC	20	9443
SCNN1A-9412	−	ACUUGCUGAGCCUCUAGCUCC	21	13261
SCNN1A-9413	−	CACUUGCUGAGCCUCUAGCUCC	22	13262
SCNN1A-9414	−	CCACUUGCUGAGCCUCUAGCUCC	23	13263
SCNN1A-9415	−	CCCACUUGCUGAGCCUCUAGCUCC	24	13264
SCNN1A-9416	−	CGCAGGUCUGCUGGCUCC	18	13265
SCNN1A-9417	−	CCGCAGGUCUGCUGGCUCC	19	13266
SCNN1A-5595	−	CCCGCAGGUCUGCUGGCUCC	20	9444
SCNN1A-9418	−	UCCCGCAGGUCUGCUGGCUCC	21	13267
SCNN1A-9419	−	CUCCCGCAGGUCUGCUGGCUCC	22	13268
SCNN1A-9420	−	ACUCCCGCAGGUCUGCUGGCUCC	23	13269
SCNN1A-9421	−	AACUCCCGCAGGUCUGCUGGCUCC	24	13270
SCNN1A-9422	−	CCUGGAGCCCUGCAGUCC	18	13271
SCNN1A-9423	−	UCCUGGAGCCCUGCAGUCC	19	13272
SCNN1A-6114	−	CUCCUGGAGCCCUGCAGUCC	20	9963
SCNN1A-9424	−	CCUCCUGGAGCCCUGCAGUCC	21	13273
SCNN1A-9425	−	ACCUCCUGGAGCCCUGCAGUCC	22	13274
SCNN1A-9426	−	GACCUCCUGGAGCCCUGCAGUCC	23	13275
SCNN1A-9427	−	AGACCUCCUGGAGCCCUGCAGUCC	24	13276
SCNN1A-9428	−	AAAAAGAACAGAAUGUCC	18	13277
SCNN1A-9429	−	AAAAAAGAACAGAAUGUCC	19	13278
SCNN1A-9430	−	UAAAAAAGAACAGAAUGUCC	20	13279
SCNN1A-9431	−	GUAAAAAAGAACAGAAUGUCC	21	13280
SCNN1A-9432	−	UGUAAAAAAGAACAGAAUGUCC	22	13281
SCNN1A-9433	−	GUGUAAAAAAGAACAGAAUGUCC	23	13282
SCNN1A-9434	−	AGUGUAAAAAAGAACAGAAUGUCC	24	13283
SCNN1A-9435	−	AAUCCAGCUGUCCCUUCC	18	13284
SCNN1A-9436	−	AAAUCCAGCUGUCCCUUCC	19	13285
SCNN1A-9437	−	AAAAUCCAGCUGUCCCUUCC	20	13286
SCNN1A-9438	−	AAAAAUCCAGCUGUCCCUUCC	21	13287
SCNN1A-9439	−	GAAAAAUCCAGCUGUCCCUUCC	22	13288
SCNN1A-9440	−	AGAAAAAUCCAGCUGUCCCUUCC	23	13289
SCNN1A-9441	−	AAGAAAAAUCCAGCUGUCCCUUCC	24	13290
SCNN1A-9442	−	CCCCCUUGCUCUCCUUCC	18	13291
SCNN1A-9443	−	CCCCCCUUGCUCUCCUUCC	19	13292
SCNN1A-5598	−	UCCCCCCUUGCUCUCCUUCC	20	9447
SCNN1A-9444	−	CUCCCCCCUUGCUCUCCUUCC	21	13293
SCNN1A-9445	−	ACUCCCCCCUUGCUCUCCUUCC	22	13294
SCNN1A-9446	−	GACUCCCCCCUUGCUCUCCUUCC	23	13295
SCNN1A-9447	−	GGACUCCCCCCUUGCUCUCCUUCC	24	13296
SCNN1A-1895	−	UCAUGAAGGGGAACAAGC	18	5744
SCNN1A-1896	−	CUCAUGAAGGGGAACAAGC	19	5745
SCNN1A-176	−	GCUCAUGAAGGGGAACAAGC	20	811
SCNN1A-1897	−	GGCUCAUGAAGGGGAACAAGC	21	5746
SCNN1A-1898	−	GGGCUCAUGAAGGGGAACAAGC	22	5747
SCNN1A-1901	−	GGGGCUCAUGAAGGGGAACAAGC	23	5750
SCNN1A-1902	−	CGGGGCUCAUGAAGGGGAACAAGC	24	5751
SCNN1A-1903	−	UCAUGGAGGGGAACAAGC	18	5752
SCNN1A-1904	−	CUCAUGGAGGGGAACAAGC	19	5753
SCNN1A-5	−	UCUCAUGGAGGGGAACAAGC	20	557
SCNN1A-1905	−	GUCUCAUGGAGGGGAACAAGC	21	5754
SCNN1A-1906	−	GGUCUCAUGGAGGGGAACAAGC	22	5755
SCNN1A-1907	−	AGGUCUCAUGGAGGGGAACAAGC	23	5756
SCNN1A-1908	−	CAGGUCUCAUGGAGGGGAACAAGC	24	5757
SCNN1A-9448	−	AACCUGGGAGUGGGAAGC	18	13297
SCNN1A-9449	−	CAACCUGGGAGUGGGAAGC	19	13298
SCNN1A-5228	−	GCAACCUGGGAGUGGGAAGC	20	9077
SCNN1A-9450	−	CGCAACCUGGGAGUGGGAAGC	21	13299
SCNN1A-9451	−	CCGCAACCUGGGAGUGGGAAGC	22	13300
SCNN1A-9452	−	GCCGCAACCUGGGAGUGGGAAGC	23	13301
SCNN1A-9453	−	AGCCGCAACCUGGGAGUGGGAAGC	24	13302
SCNN1A-1909	−	AGCAGUAUCAAGGUAAGC	18	5758
SCNN1A-1910	−	GAGCAGUAUCAAGGUAAGC	19	5759
SCNN1A-1911	−	UGAGCAGUAUCAAGGUAAGC	20	5760
SCNN1A-1912	−	AUGAGCAGUAUCAAGGUAAGC	21	5761
SCNN1A-1913	−	CAUGAGCAGUAUCAAGGUAAGC	22	5762
SCNN1A-1914	−	UCAUGAGCAGUAUCAAGGUAAGC	23	5763
SCNN1A-1915	−	AUCAUGAGCAGUAUCAAGGUAAGC	24	5764
SCNN1A-9454	−	ACAGAAUCAGGACACAGC	18	13303
SCNN1A-9455	−	GACAGAAUCAGGACACAGC	19	13304
SCNN1A-9456	−	AGACAGAAUCAGGACACAGC	20	13305
SCNN1A-9457	−	GAGACAGAAUCAGGACACAGC	21	13306
SCNN1A-9458	−	AGAGACAGAAUCAGGACACAGC	22	13307
SCNN1A-9459	−	CAGAGACAGAAUCAGGACACAGC	23	13308
SCNN1A-9460	−	GCAGAGACAGAAUCAGGACACAGC	24	13309
SCNN1A-9461	−	CAACUCUGUGACCACAGC	18	13310
SCNN1A-9462	−	GCAACUCUGUGACCACAGC	19	13311
SCNN1A-5599	−	UGCAACUCUGUGACCACAGC	20	9448
SCNN1A-9463	−	CUGCAACUCUGUGACCACAGC	21	13312
SCNN1A-9464	−	CCUGCAACUCUGUGACCACAGC	22	13313
SCNN1A-9465	−	UCCUGCAACUCUGUGACCACAGC	23	13314
SCNN1A-9466	−	UUCCUGCAACUCUGUGACCACAGC	24	13315
SCNN1A-9467	−	GGGUGGCGAGGAAUCAGC	18	13316
SCNN1A-9468	−	GGGGUGGCGAGGAAUCAGC	19	13317
SCNN1A-5229	−	GGGGGUGGCGAGGAAUCAGC	20	9078
SCNN1A-9469	−	AGGGGGUGGCGAGGAAUCAGC	21	13318
SCNN1A-9470	−	GAGGGGGUGGCGAGGAAUCAGC	22	13319
SCNN1A-9471	−	GGAGGGGGUGGCGAGGAAUCAGC	23	13320
SCNN1A-9472	−	UGGAGGGGGUGGCGAGGAAUCAGC	24	13321
SCNN1A-9473	−	GGCCAGAAAGAGGAGAGC	18	13322
SCNN1A-9474	−	AGGCCAGAAAGAGGAGAGC	19	13323
SCNN1A-6119	−	CAGGCCAGAAAGAGGAGAGC	20	9968
SCNN1A-9475	−	GCAGGCCAGAAAGAGGAGAGC	21	13324
SCNN1A-9476	−	GGCAGGCCAGAAAGAGGAGAGC	22	13325
SCNN1A-9477	−	AGGCAGGCCAGAAAGAGGAGAGC	23	13326
SCNN1A-9478	−	GAGGCAGGCCAGAAAGAGGAGAGC	24	13327
SCNN1A-9479	−	CCAGGUUGGACCCUGAGC	18	13328
SCNN1A-9480	−	ACCAGGUUGGACCCUGAGC	19	13329
SCNN1A-9481	−	GACCAGGUUGGACCCUGAGC	20	13330
SCNN1A-9482	−	AGACCAGGUUGGACCCUGAGC	21	13331
SCNN1A-9483	−	CAGACCAGGUUGGACCCUGAGC	22	13332
SCNN1A-9484	−	ACAGACCAGGUUGGACCCUGAGC	23	13333
SCNN1A-9485	−	CACAGACCAGGUUGGACCCUGAGC	24	13334
SCNN1A-9486	−	UGCUCCCACUUAGUGAGC	18	13335
SCNN1A-9487	−	CUGCUCCCACUUAGUGAGC	19	13336
SCNN1A-5230	−	GCUGCUCCCACUUAGUGAGC	20	9079
SCNN1A-9488	−	CGCUGCUCCCACUUAGUGAGC	21	13337
SCNN1A-9489	−	GCGCUGCUCCCACUUAGUGAGC	22	13338
SCNN1A-9490	−	UGCGCUGCUCCCACUUAGUGAGC	23	13339
SCNN1A-9491	−	GUGCGCUGCUCCCACUUAGUGAGC	24	13340
SCNN1A-9492	−	GUCGCAAGAGACUGCCGC	18	13341
SCNN1A-9493	−	AGUCGCAAGAGACUGCCGC	19	13342
SCNN1A-9494	−	AAGUCGCAAGAGACUGCCGC	20	13343
SCNN1A-9495	−	GAAGUCGCAAGAGACUGCCGC	21	13344
SCNN1A-9496	−	AGAAGUCGCAAGAGACUGCCGC	22	13345
SCNN1A-9497	−	AAGAAGUCGCAAGAGACUGCCGC	23	13346
SCNN1A-9498	−	UAAGAAGUCGCAAGAGACUGCCGC	24	13347
SCNN1A-9499	−	UUCACUUUAAGAAGUCGC	18	13348
SCNN1A-9500	−	UUUCACUUUAAGAAGUCGC	19	13349
SCNN1A-9501	−	CUUUCACUUUAAGAAGUCGC	20	13350
SCNN1A-9502	−	GCUUUCACUUUAAGAAGUCGC	21	13351
SCNN1A-9503	−	GGCUUUCACUUUAAGAAGUCGC	22	13352
SCNN1A-9504	−	CGGCUUUCACUUUAAGAAGUCGC	23	13353
SCNN1A-9505	−	CCGGCUUUCACUUUAAGAAGUCGC	24	13354
SCNN1A-9506	−	CUGGCAAAUAGAAAAGGC	18	13355
SCNN1A-9507	−	GCUGGCAAAUAGAAAAGGC	19	13356
SCNN1A-6121	−	AGCUGGCAAAUAGAAAAGGC	20	9970
SCNN1A-9508	−	GAGCUGGCAAAUAGAAAAGGC	21	13357
SCNN1A-9509	−	UGAGCUGGCAAAUAGAAAAGGC	22	13358
SCNN1A-9510	−	AUGAGCUGGCAAAUAGAAAAGGC	23	13359
SCNN1A-9511	−	CAUGAGCUGGCAAAUAGAAAAGGC	24	13360
SCNN1A-9512	−	AGUGAGAGGGGGCAAGGC	18	13361
SCNN1A-9513	−	GAGUGAGAGGGGGCAAGGC	19	13362
SCNN1A-9514	−	AGAGUGAGAGGGGGCAAGGC	20	13363
SCNN1A-9515	−	UAGAGUGAGAGGGGGCAAGGC	21	13364
SCNN1A-9516	−	CUAGAGUGAGAGGGGGCAAGGC	22	13365
SCNN1A-9517	−	CCUAGAGUGAGAGGGGGCAAGGC	23	13366
SCNN1A-9518	−	GCCUAGAGUGAGAGGGGGCAAGGC	24	13367
SCNN1A-9519	−	UAGAGAGAGGAGGCAGGC	18	13368
SCNN1A-9520	−	UUAGAGAGAGGAGGCAGGC	19	13369
SCNN1A-9521	−	AUUAGAGAGAGGAGGCAGGC	20	13370
SCNN1A-9522	−	GAUUAGAGAGAGGAGGCAGGC	21	13371
SCNN1A-9523	−	GGAUUAGAGAGAGGAGGCAGGC	22	13372
SCNN1A-9524	−	AGGAUUAGAGAGAGGAGGCAGGC	23	13373
SCNN1A-9525	−	CAGGAUUAGAGAGAGGAGGCAGGC	24	13374
SCNN1A-9526	−	AGUGGUUGGAUUUCAGGC	18	13375
SCNN1A-9527	−	UAGUGGUUGGAUUUCAGGC	19	13376
SCNN1A-9528	−	CUAGUGGUUGGAUUUCAGGC	20	13377
SCNN1A-9529	−	GCUAGUGGUUGGAUUUCAGGC	21	13378
SCNN1A-9530	−	AGCUAGUGGUUGGAUUUCAGGC	22	13379
SCNN1A-9531	−	AAGCUAGUGGUUGGAUUUCAGGC	23	13380
SCNN1A-9532	−	UAAGCUAGUGGUUGGAUUUCAGGC	24	13381
SCNN1A-9533	−	GAGGUCAGGGCCAGAGGC	18	13382
SCNN1A-9534	−	CGAGGUCAGGGCCAGAGGC	19	13383
SCNN1A-5607	−	UCGAGGUCAGGGCCAGAGGC	20	9456
SCNN1A-9535	−	CUCGAGGUCAGGGCCAGAGGC	21	13384
SCNN1A-9536	−	GCUCGAGGUCAGGGCCAGAGGC	22	13385
SCNN1A-9537	−	AGCUCGAGGUCAGGGCCAGAGGC	23	13386
SCNN1A-9538	−	CAGCUCGAGGUCAGGGCCAGAGGC	24	13387
SCNN1A-9539	−	AGAGAGGGAGUGAGAGGC	18	13388
SCNN1A-9540	−	UAGAGAGGGAGUGAGAGGC	19	13389
SCNN1A-6123	−	AUAGAGAGGGAGUGAGAGGC	20	9972
SCNN1A-9541	−	GAUAGAGAGGGAGUGAGAGGC	21	13390
SCNN1A-9542	−	AGAUAGAGAGGGAGUGAGAGGC	22	13391
SCNN1A-9543	−	CAGAUAGAGAGGGAGUGAGAGGC	23	13392
SCNN1A-9544	−	GCAGAUAGAGAGGGAGUGAGAGGC	24	13393
SCNN1A-9545	−	CUCUCUUCUCUGCAGGGC	18	13394
SCNN1A-9546	−	UCUCUCUUCUCUGCAGGGC	19	13395
SCNN1A-9547	−	UUCUCUCUUCUCUGCAGGGC	20	13396
SCNN1A-9548	−	CUUCUCUCUUCUCUGCAGGGC	21	13397
SCNN1A-9549	−	UCUUCUCUCUUCUCUGCAGGGC	22	13398
SCNN1A-9550	−	CUCUUCUCUCUUCUCUGCAGGGC	23	13399
SCNN1A-9551	−	CCUCUUCUCUCUUCUCUGCAGGGC	24	13400
SCNN1A-9552	−	ACAGCUCGAGGUCAGGGC	18	13401
SCNN1A-9553	−	CACAGCUCGAGGUCAGGGC	19	13402
SCNN1A-9554	−	ACACAGCUCGAGGUCAGGGC	20	13403
SCNN1A-9555	−	GACACAGCUCGAGGUCAGGGC	21	13404
SCNN1A-9556	−	GGACACAGCUCGAGGUCAGGGC	22	13405
SCNN1A-9557	−	AGGACACAGCUCGAGGUCAGGGC	23	13406
SCNN1A-9558	−	CAGGACACAGCUCGAGGUCAGGGC	24	13407
SCNN1A-1928	−	GUGGGACAUGGGCAUGGC	18	5777
SCNN1A-1929	−	GGUGGGACAUGGGCAUGGC	19	5778
SCNN1A-1930	−	GGGUGGGACAUGGGCAUGGC	20	5779
SCNN1A-1931	−	AGGGUGGGACAUGGGCAUGGC	21	5780
SCNN1A-1932	−	CAGGGUGGGACAUGGGCAUGGC	22	5781
SCNN1A-1933	−	GCAGGGUGGGACAUGGGCAUGGC	23	5782
SCNN1A-1934	−	CGCAGGGUGGGACAUGGGCAUGGC	24	5783
SCNN1A-9559	−	AAGGUUGGAGGGGGUGGC	18	13408
SCNN1A-9560	−	CAAGGUUGGAGGGGGUGGC	19	13409
SCNN1A-9561	−	ACAAGGUUGGAGGGGGUGGC	20	13410
SCNN1A-9562	−	GACAAGGUUGGAGGGGGUGGC	21	13411
SCNN1A-9563	−	GGACAAGGUUGGAGGGGGUGGC	22	13412
SCNN1A-9564	−	UGGACAAGGUUGGAGGGGGUGGC	23	13413
SCNN1A-9565	−	CUGGACAAGGUUGGAGGGGGUGGC	24	13414
SCNN1A-9566	−	AGACAGAAAGGGAGGUGC	18	13415
SCNN1A-9567	−	GAGACAGAAAGGGAGGUGC	19	13416
SCNN1A-9568	−	AGAGACAGAAAGGGAGGUGC	20	13417
SCNN1A-9569	−	CAGAGACAGAAAGGGAGGUGC	21	13418
SCNN1A-9570	−	GCAGAGACAGAAAGGGAGGUGC	22	13419
SCNN1A-9571	−	GGCAGAGACAGAAAGGGAGGUGC	23	13420
SCNN1A-9572	−	GGGCAGAGACAGAAAGGGAGGUGC	24	13421
SCNN1A-9573	−	UGCUGAGCACCUUAUUGC	18	13422
SCNN1A-9574	−	GUGCUGAGCACCUUAUUGC	19	13423
SCNN1A-5237	−	GGUGCUGAGCACCUUAUUGC	20	9086
SCNN1A-9575	−	GGGUGCUGAGCACCUUAUUGC	21	13424
SCNN1A-9576	−	AGGGUGCUGAGCACCUUAUUGC	22	13425
SCNN1A-9577	−	CAGGGUGCUGAGCACCUUAUUGC	23	13426
SCNN1A-9578	−	CCAGGGUGCUGAGCACCUUAUUGC	24	13427
SCNN1A-9579	−	GGAGCUGAGACACAGAUC	18	13428
SCNN1A-9580	−	AGGAGCUGAGACACAGAUC	19	13429
SCNN1A-9581	−	CAGGAGCUGAGACACAGAUC	20	13430
SCNN1A-9582	−	GCAGGAGCUGAGACACAGAUC	21	13431
SCNN1A-9583	−	GGCAGGAGCUGAGACACAGAUC	22	13432
SCNN1A-9584	−	AGGCAGGAGCUGAGACACAGAUC	23	13433
SCNN1A-9585	−	GAGGCAGGAGCUGAGACACAGAUC	24	13434
SCNN1A-9586	−	UCGAAAGGUGGCCCUAUC	18	13435
SCNN1A-9587	−	CUCGAAAGGUGGCCCUAUC	19	13436
SCNN1A-5626	−	ACUCGAAAGGUGGCCCUAUC	20	9475
SCNN1A-9588	−	AACUCGAAAGGUGGCCCUAUC	21	13437
SCNN1A-9589	−	AAACUCGAAAGGUGGCCCUAUC	22	13438
SCNN1A-9590	−	AAAACUCGAAAGGUGGCCCUAUC	23	13439
SCNN1A-9591	−	CAAAACUCGAAAGGUGGCCCUAUC	24	13440
SCNN1A-1935	−	CUUCCAAGGGGAGGUAUC	18	5784
SCNN1A-1936	−	CCUUCCAAGGGGAGGUAUC	19	5785
SCNN1A-1937	−	CCCUUCCAAGGGGAGGUAUC	20	5786
SCNN1A-1938	−	UCCCUUCCAAGGGGAGGUAUC	21	5787
SCNN1A-1939	−	GUCCCUUCCAAGGGGAGGUAUC	22	5788
SCNN1A-1940	−	UGUCCCUUCCAAGGGGAGGUAUC	23	5789
SCNN1A-1941	−	CUGUCCCUUCCAAGGGGAGGUAUC	24	5790
SCNN1A-1942	−	GCUCUCCCCAAUCCACUC	18	5791
SCNN1A-1943	−	UGCUCUCCCCAAUCCACUC	19	5792
SCNN1A-410	−	UUGCUCUCCCCAAUCCACUC	20	4259
SCNN1A-1944	−	CUUGCUCUCCCCAAUCCACUC	21	5793
SCNN1A-1945	−	CCUUGCUCUCCCCAAUCCACUC	22	5794
SCNN1A-1946	−	CCCUUGCUCUCCCCAAUCCACUC	23	5795
SCNN1A-1947	−	ACCCUUGCUCUCCCCAAUCCACUC	24	5796
SCNN1A-1948	−	GCCCUCCACAGUCCACUC	18	5797
SCNN1A-1949	−	AGCCCUCCACAGUCCACUC	19	5798
SCNN1A-170	−	UAGCCCUCCACAGUCCACUC	20	808
SCNN1A-1950	−	CUAGCCCUCCACAGUCCACUC	21	5799
SCNN1A-1951	−	UCUAGCCCUCCACAGUCCACUC	22	5800
SCNN1A-1952	−	CUCUAGCCCUCCACAGUCCACUC	23	5801
SCNN1A-1953	−	ACUCUAGCCCUCCACAGUCCACUC	24	5802
SCNN1A-9592	−	GGAGGCAGCCCAGACCUC	18	13441
SCNN1A-9593	−	UGGAGGCAGCCCAGACCUC	19	13442
SCNN1A-9594	−	CUGGAGGCAGCCCAGACCUC	20	13443
SCNN1A-9595	−	GCUGGAGGCAGCCCAGACCUC	21	13444
SCNN1A-9596	−	AGCUGGAGGCAGCCCAGACCUC	22	13445
SCNN1A-9597	−	AAGCUGGAGGCAGCCCAGACCUC	23	13446
SCNN1A-9598	−	GAAGCUGGAGGCAGCCCAGACCUC	24	13447
SCNN1A-9599	−	CCCAGUUCACCUGCCCUC	18	13448
SCNN1A-9600	−	UCCCAGUUCACCUGCCCUC	19	13449
SCNN1A-6132	−	CUCCCAGUUCACCUGCCCUC	20	9981
SCNN1A-9601	−	ACUCCCAGUUCACCUGCCCUC	21	13450
SCNN1A-9602	−	UACUCCCAGUUCACCUGCCCUC	22	13451
SCNN1A-9603	−	GUACUCCCAGUUCACCUGCCCUC	23	13452
SCNN1A-9604	−	AGUACUCCCAGUUCACCUGCCCUC	24	13453
SCNN1A-9605	−	UUGCUGAGCCUCUAGCUC	18	13454
SCNN1A-9606	−	CUUGCUGAGCCUCUAGCUC	19	13455
SCNN1A-9607	−	ACUUGCUGAGCCUCUAGCUC	20	13456
SCNN1A-9608	−	CACUUGCUGAGCCUCUAGCUC	21	13457
SCNN1A-9609	−	CCACUUGCUGAGCCUCUAGCUC	22	13458
SCNN1A-9610	−	CCCACUUGCUGAGCCUCUAGCUC	23	13459
SCNN1A-9611	−	GCCCACUUGCUGAGCCUCUAGCUC	24	13460
SCNN1A-1960	−	CAAUCCACUCCGGGGCUC	18	5809
SCNN1A-1961	−	CCAAUCCACUCCGGGGCUC	19	5810
SCNN1A-1962	−	CCCAAUCCACUCCGGGGCUC	20	5811
SCNN1A-1963	−	CCCCAAUCCACUCCGGGGCUC	21	5812
SCNN1A-1964	−	UCCCCAAUCCACUCCGGGGCUC	22	5813
SCNN1A-1965	−	CUCCCCAAUCCACUCCGGGGCUC	23	5814
SCNN1A-1966	−	UCUCCCCAAUCCACUCCGGGGCUC	24	5815
SCNN1A-9612	−	AAUGUAAGGACCUGGCUC	18	13461
SCNN1A-9613	−	CAAUGUAAGGACCUGGCUC	19	13462
SCNN1A-9614	−	CCAAUGUAAGGACCUGGCUC	20	13463
SCNN1A-9615	−	CCCAAUGUAAGGACCUGGCUC	21	13464
SCNN1A-9616	−	GCCCAAUGUAAGGACCUGGCUC	22	13465
SCNN1A-9617	−	UGCCCAAUGUAAGGACCUGGCUC	23	13466
SCNN1A-9618	−	AUGCCCAAUGUAAGGACCUGGCUC	24	13467
SCNN1A-9619	−	CCGCAGGUCUGCUGGCUC	18	13468
SCNN1A-9620	−	CCCGCAGGUCUGCUGGCUC	19	13469
SCNN1A-9621	−	UCCCGCAGGUCUGCUGGCUC	20	13470
SCNN1A-9622	−	CUCCCGCAGGUCUGCUGGCUC	21	13471
SCNN1A-9623	−	ACUCCCGCAGGUCUGCUGGCUC	22	13472
SCNN1A-9624	−	AACUCCCGCAGGUCUGCUGGCUC	23	13473
SCNN1A-9625	−	CAACUCCCGCAGGUCUGCUGGCUC	24	13474
SCNN1A-1967	−	CAGCCCAUACCAGGUCUC	18	5816
SCNN1A-1968	−	GCAGCCCAUACCAGGUCUC	19	5817
SCNN1A-159	−	UGCAGCCCAUACCAGGUCUC	20	803
SCNN1A-1969	−	CUGCAGCCCAUACCAGGUCUC	21	5818
SCNN1A-1970	−	UCUGCAGCCCAUACCAGGUCUC	22	5819
SCNN1A-1971	−	CUCUGCAGCCCAUACCAGGUCUC	23	5820
SCNN1A-1972	−	CCUCUGCAGCCCAUACCAGGUCUC	24	5821
SCNN1A-9626	−	CCCCCAUGAGUCUGUCUC	18	13475
SCNN1A-9627	−	UCCCCCAUGAGUCUGUCUC	19	13476
SCNN1A-5636	−	AUCCCCCAUGAGUCUGUCUC	20	9485
SCNN1A-9628	−	GAUCCCCCAUGAGUCUGUCUC	21	13477
SCNN1A-9629	−	CGAUCCCCCAUGAGUCUGUCUC	22	13478
SCNN1A-9630	−	CCGAUCCCCCAUGAGUCUGUCUC	23	13479
SCNN1A-9631	−	CCCGAUCCCCCAUGAGUCUGUCUC	24	13480
SCNN1A-9632	−	CAGAGAUGACACCUUCUC	18	13481
SCNN1A-9633	−	GCAGAGAUGACACCUUCUC	19	13482
SCNN1A-5637	−	AGCAGAGAUGACACCUUCUC	20	9486
SCNN1A-9634	−	CAGCAGAGAUGACACCUUCUC	21	13483
SCNN1A-9635	−	UCAGCAGAGAUGACACCUUCUC	22	13484
SCNN1A-9636	−	UUCAGCAGAGAUGACACCUUCUC	23	13485
SCNN1A-9637	−	AUUCAGCAGAGAUGACACCUUCUC	24	13486
SCNN1A-9638	−	UCCUGGAGCCCUGCAGUC	18	13487
SCNN1A-9639	−	CUCCUGGAGCCCUGCAGUC	19	13488
SCNN1A-9640	−	CCUCCUGGAGCCCUGCAGUC	20	13489
SCNN1A-9641	−	ACCUCCUGGAGCCCUGCAGUC	21	13490
SCNN1A-9642	−	GACCUCCUGGAGCCCUGCAGUC	22	13491
SCNN1A-9643	−	AGACCUCCUGGAGCCCUGCAGUC	23	13492
SCNN1A-9644	−	CAGACCUCCUGGAGCCCUGCAGUC	24	13493
SCNN1A-9645	−	CCCCCCUUGCUCUCCUUC	18	13494
SCNN1A-9646	−	UCCCCCCUUGCUCUCCUUC	19	13495
SCNN1A-9647	−	CUCCCCCCUUGCUCUCCUUC	20	13496
SCNN1A-9648	−	ACUCCCCCCUUGCUCUCCUUC	21	13497
SCNN1A-9649	−	GACUCCCCCCUUGCUCUCCUUC	22	13498
SCNN1A-9650	−	GGACUCCCCCCUUGCUCUCCUUC	23	13499
SCNN1A-9651	−	GGGACUCCCCCCUUGCUCUCCUUC	24	13500
SCNN1A-9652	−	UGCUUUCCCUGCCUCUUC	18	13501
SCNN1A-9653	−	CUGCUUUCCCUGCCUCUUC	19	13502
SCNN1A-9654	−	CCUGCUUUCCCUGCCUCUUC	20	13503
SCNN1A-9655	−	GCCUGCUUUCCCUGCCUCUUC	21	13504
SCNN1A-9656	−	UGCCUGCUUUCCCUGCCUCUUC	22	13505
SCNN1A-9657	−	GUGCCUGCUUUCCCUGCCUCUUC	23	13506
SCNN1A-9658	−	AGUGCCUGCUUUCCCUGCCUCUUC	24	13507
SCNN1A-9659	−	GCAGAGGAGAGGCCGUUC	18	13508
SCNN1A-9660	−	AGCAGAGGAGAGGCCGUUC	19	13509
SCNN1A-9661	−	AAGCAGAGGAGAGGCCGUUC	20	13510
SCNN1A-9662	−	GAAGCAGAGGAGAGGCCGUUC	21	13511
SCNN1A-9663	−	GGAAGCAGAGGAGAGGCCGUUC	22	13512
SCNN1A-9664	−	GGGAAGCAGAGGAGAGGCCGUUC	23	13513
SCNN1A-9665	−	AGGGAAGCAGAGGAGAGGCCGUUC	24	13514
SCNN1A-1973	−	GCAGCCUCACUCGGGUUC	18	5822
SCNN1A-1974	−	GGCAGCCUCACUCGGGUUC	19	5823
SCNN1A-1975	−	GGGCAGCCUCACUCGGGUUC	20	5824
SCNN1A-1976	−	GGGGCAGCCUCACUCGGGUUC	21	5825
SCNN1A-1977	−	AGGGGCAGCCUCACUCGGGUUC	22	5826
SCNN1A-1978	−	CAGGGGCAGCCUCACUCGGGUUC	23	5827
SCNN1A-1979	−	CCAGGGGCAGCCUCACUCGGGUUC	24	5828
SCNN1A-9666	−	AAGGGAGACUGGAGUUUC	18	13515
SCNN1A-9667	−	CAAGGGAGACUGGAGUUUC	19	13516
SCNN1A-9668	−	UCAAGGGAGACUGGAGUUUC	20	13517
SCNN1A-9669	−	CUCAAGGGAGACUGGAGUUUC	21	13518
SCNN1A-9670	−	GCUCAAGGGAGACUGGAGUUUC	22	13519
SCNN1A-9671	−	GGCUCAAGGGAGACUGGAGUUUC	23	13520
SCNN1A-9672	−	UGGCUCAAGGGAGACUGGAGUUUC	24	13521
SCNN1A-9673	−	AGGAGGCAGGCCAGAAAG	18	13522
SCNN1A-9674	−	GAGGAGGCAGGCCAGAAAG	19	13523
SCNN1A-6139	−	AGAGGAGGCAGGCCAGAAAG	20	9988
SCNN1A-9675	−	GAGAGGAGGCAGGCCAGAAAG	21	13524
SCNN1A-9676	−	AGAGAGGAGGCAGGCCAGAAAG	22	13525
SCNN1A-9677	−	GAGAGAGGAGGCAGGCCAGAAAG	23	13526
SCNN1A-9678	−	AGAGAGAGGAGGCAGGCCAGAAAG	24	13527
SCNN1A-9679	−	CUGCUGGCUCCAGGAAAG	18	13528
SCNN1A-9680	−	UCUGCUGGCUCCAGGAAAG	19	13529
SCNN1A-9681	−	GUCUGCUGGCUCCAGGAAAG	20	13530
SCNN1A-9682	−	GGUCUGCUGGCUCCAGGAAAG	21	13531
SCNN1A-9683	−	AGGUCUGCUGGCUCCAGGAAAG	22	13532
SCNN1A-9684	−	CAGGUCUGCUGGCUCCAGGAAAG	23	13533
SCNN1A-9685	−	GCAGGUCUGCUGGCUCCAGGAAAG	24	13534
SCNN1A-9686	−	GAGGAAUCAGCAGGAAAG	18	13535
SCNN1A-9687	−	CGAGGAAUCAGCAGGAAAG	19	13536
SCNN1A-5244	−	GCGAGGAAUCAGCAGGAAAG	20	9093
SCNN1A-9688	−	GGCGAGGAAUCAGCAGGAAAG	21	13537
SCNN1A-9689	−	UGGCGAGGAAUCAGCAGGAAAG	22	13538
SCNN1A-9690	−	GUGGCGAGGAAUCAGCAGGAAAG	23	13539
SCNN1A-9691	−	GGUGGCGAGGAAUCAGCAGGAAAG	24	13540
SCNN1A-1980	−	CUCAUGAAGGGGAACAAG	18	5829
SCNN1A-1981	−	GCUCAUGAAGGGGAACAAG	19	5830
SCNN1A-1982	−	GGCUCAUGAAGGGGAACAAG	20	5831
SCNN1A-1983	−	GGGCUCAUGAAGGGGAACAAG	21	5832
SCNN1A-1984	−	GGGGCUCAUGAAGGGGAACAAG	22	5833
SCNN1A-1985	−	CGGGGCUCAUGAAGGGGAACAAG	23	5834
SCNN1A-1986	−	CCGGGGCUCAUGAAGGGGAACAAG	24	5835
SCNN1A-1987	−	CUCAUGGAGGGGAACAAG	18	5836
SCNN1A-1988	−	UCUCAUGGAGGGGAACAAG	19	5837
SCNN1A-165	−	GUCUCAUGGAGGGGAACAAG	20	805
SCNN1A-1989	−	GGUCUCAUGGAGGGGAACAAG	21	5838
SCNN1A-1990	−	AGGUCUCAUGGAGGGGAACAAG	22	5839
SCNN1A-1991	−	CAGGUCUCAUGGAGGGGAACAAG	23	5840
SCNN1A-1992	−	CCAGGUCUCAUGGAGGGGAACAAG	24	5841
SCNN1A-1993	−	CCAGCUGUCCCUUCCAAG	18	5842
SCNN1A-1994	−	UCCAGCUGUCCCUUCCAAG	19	5843
SCNN1A-412	−	AUCCAGCUGUCCCUUCCAAG	20	4261
SCNN1A-9692	−	AAUCCAGCUGUCCCUUCCAAG	21	13541
SCNN1A-9693	−	AAAUCCAGCUGUCCCUUCCAAG	22	13542
SCNN1A-9694	−	AAAAUCCAGCUGUCCCUUCCAAG	23	13543
SCNN1A-9695	−	AAAAAUCCAGCUGUCCCUUCCAAG	24	13544
SCNN1A-9696	−	GAGAGGGGGCAAGGCAAG	18	13545
SCNN1A-9697	−	UGAGAGGGGGCAAGGCAAG	19	13546
SCNN1A-5246	−	GUGAGAGGGGGCAAGGCAAG	20	9095
SCNN1A-9698	−	AGUGAGAGGGGGCAAGGCAAG	21	13547
SCNN1A-9699	−	GAGUGAGAGGGGGCAAGGCAAG	22	13548
SCNN1A-9700	−	AGAGUGAGAGGGGGCAAGGCAAG	23	13549
SCNN1A-9701	−	UAGAGUGAGAGGGGGCAAGGCAAG	24	13550
SCNN1A-9702	−	GUGGCCCUAUCAGGGAAG	18	13551
SCNN1A-9703	−	GGUGGCCCUAUCAGGGAAG	19	13552
SCNN1A-9704	−	AGGUGGCCCUAUCAGGGAAG	20	13553
SCNN1A-9705	−	AAGGUGGCCCUAUCAGGGAAG	21	13554
SCNN1A-9706	−	AAAGGUGGCCCUAUCAGGGAAG	22	13555
SCNN1A-9707	−	GAAAGGUGGCCCUAUCAGGGAAG	23	13556
SCNN1A-9708	−	CGAAAGGUGGCCCUAUCAGGGAAG	24	13557
SCNN1A-9709	−	CAACCUGGGAGUGGGAAG	18	13558
SCNN1A-9710	−	GCAACCUGGGAGUGGGAAG	19	13559
SCNN1A-9711	−	CGCAACCUGGGAGUGGGAAG	20	13560
SCNN1A-9712	−	CCGCAACCUGGGAGUGGGAAG	21	13561
SCNN1A-9713	−	GCCGCAACCUGGGAGUGGGAAG	22	13562
SCNN1A-9714	−	AGCCGCAACCUGGGAGUGGGAAG	23	13563
SCNN1A-9715	−	CAGCCGCAACCUGGGAGUGGGAAG	24	13564
SCNN1A-2001	−	ACUCCGGGGCUCAUGAAG	18	5850
SCNN1A-2002	−	CACUCCGGGGCUCAUGAAG	19	5851
SCNN1A-453	−	CCACUCCGGGGCUCAUGAAG	20	4302
SCNN1A-2003	−	UCCACUCCGGGGCUCAUGAAG	21	5852
SCNN1A-2004	−	AUCCACUCCGGGGCUCAUGAAG	22	5853
SCNN1A-2005	−	AAUCCACUCCGGGGCUCAUGAAG	23	5854
SCNN1A-2006	−	CAAUCCACUCCGGGGCUCAUGAAG	24	5855
SCNN1A-9716	−	GCAACUCUGUGACCACAG	18	13565
SCNN1A-9717	−	UGCAACUCUGUGACCACAG	19	13566
SCNN1A-9718	−	CUGCAACUCUGUGACCACAG	20	13567
SCNN1A-9719	−	CCUGCAACUCUGUGACCACAG	21	13568
SCNN1A-9720	−	UCCUGCAACUCUGUGACCACAG	22	13569
SCNN1A-9721	−	UUCCUGCAACUCUGUGACCACAG	23	13570
SCNN1A-9722	−	AUUCCUGCAACUCUGUGACCACAG	24	13571
SCNN1A-9723	−	GGAAAGAGGAGGGACCAG	18	13572
SCNN1A-9724	−	AGGAAAGAGGAGGGACCAG	19	13573
SCNN1A-9725	−	CAGGAAAGAGGAGGGACCAG	20	13574
SCNN1A-9726	−	GCAGGAAAGAGGAGGGACCAG	21	13575
SCNN1A-9727	−	AGCAGGAAAGAGGAGGGACCAG	22	13576
SCNN1A-9728	−	CAGCAGGAAAGAGGAGGGACCAG	23	13577
SCNN1A-9729	−	UCAGCAGGAAAGAGGAGGGACCAG	24	13578
SCNN1A-9730	−	CUAAGUAGAUAGCCCCAG	18	13579
SCNN1A-9731	−	GCUAAGUAGAUAGCCCCAG	19	13580
SCNN1A-5646	−	CGCUAAGUAGAUAGCCCCAG	20	9495
SCNN1A-9732	−	GCGCUAAGUAGAUAGCCCCAG	21	13581
SCNN1A-9733	−	AGCGCUAAGUAGAUAGCCCCAG	22	13582
SCNN1A-9734	−	AAGCGCUAAGUAGAUAGCCCCAG	23	13583
SCNN1A-9735	−	AAAGCGCUAAGUAGAUAGCCCCAG	24	13584
SCNN1A-9736	−	GCCCUAUCAGGGAAGCAG	18	13585
SCNN1A-9737	−	GGCCCUAUCAGGGAAGCAG	19	13586
SCNN1A-5649	−	UGGCCCUAUCAGGGAAGCAG	20	9498
SCNN1A-9738	−	GUGGCCCUAUCAGGGAAGCAG	21	13587
SCNN1A-9739	−	GGUGGCCCUAUCAGGGAAGCAG	22	13588
SCNN1A-9740	−	AGGUGGCCCUAUCAGGGAAGCAG	23	13589
SCNN1A-9741	−	AAGGUGGCCCUAUCAGGGAAGCAG	24	13590
SCNN1A-9742	−	CCAGAAAGAGGAGAGCAG	18	13591
SCNN1A-9743	−	GCCAGAAAGAGGAGAGCAG	19	13592
SCNN1A-9744	−	GGCCAGAAAGAGGAGAGCAG	20	13593
SCNN1A-9745	−	AGGCCAGAAAGAGGAGAGCAG	21	13594
SCNN1A-9746	−	CAGGCCAGAAAGAGGAGAGCAG	22	13595
SCNN1A-9747	−	GCAGGCCAGAAAGAGGAGAGCAG	23	13596
SCNN1A-9748	−	GGCAGGCCAGAAAGAGGAGAGCAG	24	13597
SCNN1A-9749	−	CUGGGAUAUGUGGGGCAG	18	13598
SCNN1A-9750	−	UCUGGGAUAUGUGGGGCAG	19	13599
SCNN1A-5651	−	CUCUGGGAUAUGUGGGGCAG	20	9500
SCNN1A-9751	−	UCUCUGGGAUAUGUGGGGCAG	21	13600
SCNN1A-9752	−	GUCUCUGGGAUAUGUGGGGCAG	22	13601
SCNN1A-9753	−	GGUCUCUGGGAUAUGUGGGGCAG	23	13602
SCNN1A-9754	−	GGGUCUCUGGGAUAUGUGGGGCAG	24	13603
SCNN1A-9755	−	GGGGUGGCGAGGAAUCAG	18	13604
SCNN1A-9756	−	GGGGGUGGCGAGGAAUCAG	19	13605
SCNN1A-9757	−	AGGGGGUGGCGAGGAAUCAG	20	13606
SCNN1A-9758	−	GAGGGGGUGGCGAGGAAUCAG	21	13607
SCNN1A-9759	−	GGAGGGGGUGGCGAGGAAUCAG	22	13608
SCNN1A-9760	−	UGGAGGGGGUGGCGAGGAAUCAG	23	13609
SCNN1A-9761	−	UUGGAGGGGGUGGCGAGGAAUCAG	24	13610
SCNN1A-9762	−	GGCCGCUGCACCUGUCAG	18	13611
SCNN1A-9763	−	AGGCCGCUGCACCUGUCAG	19	13612
SCNN1A-9764	−	CAGGCCGCUGCACCUGUCAG	20	13613
SCNN1A-9765	−	CCAGGCCGCUGCACCUGUCAG	21	13614
SCNN1A-9766	−	GCCAGGCCGCUGCACCUGUCAG	22	13615
SCNN1A-9767	−	AGCCAGGCCGCUGCACCUGUCAG	23	13616
SCNN1A-9768	−	CAGCCAGGCCGCUGCACCUGUCAG	24	13617
SCNN1A-9769	−	UUGCUUGUCAAGAUUCAG	18	13618
SCNN1A-9770	−	CUUGCUUGUCAAGAUUCAG	19	13619
SCNN1A-9771	−	CCUUGCUUGUCAAGAUUCAG	20	13620
SCNN1A-9772	−	UCCUUGCUUGUCAAGAUUCAG	21	13621
SCNN1A-9773	−	CUCCUUGCUUGUCAAGAUUCAG	22	13622
SCNN1A-9774	−	ACUCCUUGCUUGUCAAGAUUCAG	23	13623
SCNN1A-9775	−	AACUCCUUGCUUGUCAAGAUUCAG	24	13624
SCNN1A-9776	−	GAGGCAGGCCAGAAAGAG	18	13625
SCNN1A-9777	−	GGAGGCAGGCCAGAAAGAG	19	13626
SCNN1A-9778	−	AGGAGGCAGGCCAGAAAGAG	20	13627
SCNN1A-9779	−	GAGGAGGCAGGCCAGAAAGAG	21	13628
SCNN1A-9780	−	AGAGGAGGCAGGCCAGAAAGAG	22	13629
SCNN1A-9781	−	GAGAGGAGGCAGGCCAGAAAGAG	23	13630
SCNN1A-9782	−	AGAGAGGAGGCAGGCCAGAAAGAG	24	13631
SCNN1A-9783	−	GGAAUCAGCAGGAAAGAG	18	13632
SCNN1A-9784	−	AGGAAUCAGCAGGAAAGAG	19	13633
SCNN1A-9785	−	GAGGAAUCAGCAGGAAAGAG	20	13634
SCNN1A-9786	−	CGAGGAAUCAGCAGGAAAGAG	21	13635
SCNN1A-9787	−	GCGAGGAAUCAGCAGGAAAGAG	22	13636
SCNN1A-9788	−	GGCGAGGAAUCAGCAGGAAAGAG	23	13637
SCNN1A-9789	−	UGGCGAGGAAUCAGCAGGAAAGAG	24	13638
SCNN1A-9790	−	AAGAGACUGCCGCAAGAG	18	13639
SCNN1A-9791	−	CAAGAGACUGCCGCAAGAG	19	13640
SCNN1A-5249	−	GCAAGAGACUGCCGCAAGAG	20	9098
SCNN1A-9792	−	CGCAAGAGACUGCCGCAAGAG	21	13641
SCNN1A-9793	−	UCGCAAGAGACUGCCGCAAGAG	22	13642
SCNN1A-9794	−	GUCGCAAGAGACUGCCGCAAGAG	23	13643
SCNN1A-9795	−	AGUCGCAAGAGACUGCCGCAAGAG	24	13644
SCNN1A-9796	−	AAGUAGAUAGCCCCAGAG	18	13645
SCNN1A-9797	−	UAAGUAGAUAGCCCCAGAG	19	13646
SCNN1A-9798	−	CUAAGUAGAUAGCCCCAGAG	20	13647
SCNN1A-9799	−	GCUAAGUAGAUAGCCCCAGAG	21	13648
SCNN1A-9800	−	CGCUAAGUAGAUAGCCCCAGAG	22	13649
SCNN1A-9801	−	GCGCUAAGUAGAUAGCCCCAGAG	23	13650
SCNN1A-9802	−	AGCGCUAAGUAGAUAGCCCCAGAG	24	13651
SCNN1A-9803	−	CCUAUCAGGGAAGCAGAG	18	13652
SCNN1A-9804	−	CCCUAUCAGGGAAGCAGAG	19	13653
SCNN1A-9805	−	GCCCUAUCAGGGAAGCAGAG	20	13654
SCNN1A-9806	−	GGCCCUAUCAGGGAAGCAGAG	21	13655
SCNN1A-9807	−	UGGCCCUAUCAGGGAAGCAGAG	22	13656
SCNN1A-9808	−	GUGGCCCUAUCAGGGAAGCAGAG	23	13657
SCNN1A-9809	−	GGUGGCCCUAUCAGGGAAGCAGAG	24	13658
SCNN1A-9810	−	AGAGGCAGGAUUAGAGAG	18	13659
SCNN1A-9811	−	GAGAGGCAGGAUUAGAGAG	19	13660
SCNN1A-6147	−	AGAGAGGCAGGAUUAGAGAG	20	9996
SCNN1A-9812	−	AAGAGAGGCAGGAUUAGAGAG	21	13661
SCNN1A-9813	−	GAAGAGAGGCAGGAUUAGAGAG	22	13662
SCNN1A-9814	−	GGAAGAGAGGCAGGAUUAGAGAG	23	13663
SCNN1A-9815	−	AGGAAGAGAGGCAGGAUUAGAGAG	24	13664
SCNN1A-9816	−	AGGCCAGAAAGAGGAGAG	18	13665
SCNN1A-9817	−	CAGGCCAGAAAGAGGAGAG	19	13666
SCNN1A-9818	−	GCAGGCCAGAAAGAGGAGAG	20	13667
SCNN1A-9819	−	GGCAGGCCAGAAAGAGGAGAG	21	13668
SCNN1A-9820	−	AGGCAGGCCAGAAAGAGGAGAG	22	13669
SCNN1A-9821	−	GAGGCAGGCCAGAAAGAGGAGAG	23	13670
SCNN1A-9822	−	GGAGGCAGGCCAGAAAGAGGAGAG	24	13671
SCNN1A-9823	−	AACAGAAGGCAGAUAGAG	18	13672
SCNN1A-9824	−	AAACAGAAGGCAGAUAGAG	19	13673
SCNN1A-5250	−	GAAACAGAAGGCAGAUAGAG	20	9099
SCNN1A-9825	−	AGAAACAGAAGGCAGAUAGAG	21	13674
SCNN1A-9826	−	GAGAAACAGAAGGCAGAUAGAG	22	13675
SCNN1A-9827	−	AGAGAAACAGAAGGCAGAUAGAG	23	13676
SCNN1A-9828	−	AAGAGAAACAGAAGGCAGAUAGAG	24	13677
SCNN1A-9829	−	GGGAGUGAGAGGCAGGAG	18	13678
SCNN1A-9830	−	AGGGAGUGAGAGGCAGGAG	19	13679
SCNN1A-9831	−	GAGGGAGUGAGAGGCAGGAG	20	13680
SCNN1A-9832	−	AGAGGGAGUGAGAGGCAGGAG	21	13681
SCNN1A-9833	−	GAGAGGGAGUGAGAGGCAGGAG	22	13682
SCNN1A-9834	−	AGAGAGGGAGUGAGAGGCAGGAG	23	13683
SCNN1A-9835	−	UAGAGAGGGAGUGAGAGGCAGGAG	24	13684
SCNN1A-9836	−	UAGAUAGCCCCAGAGGAG	18	13685
SCNN1A-9837	−	GUAGAUAGCCCCAGAGGAG	19	13686
SCNN1A-9838	−	AGUAGAUAGCCCCAGAGGAG	20	13687
SCNN1A-9839	−	AAGUAGAUAGCCCCAGAGGAG	21	13688
SCNN1A-9840	−	UAAGUAGAUAGCCCCAGAGGAG	22	13689
SCNN1A-9841	−	CUAAGUAGAUAGCCCCAGAGGAG	23	13690
SCNN1A-9842	−	GCUAAGUAGAUAGCCCCAGAGGAG	24	13691
SCNN1A-9843	−	GGAGGAGGGAGGGAGGAG	18	13692
SCNN1A-9844	−	UGGAGGAGGGAGGGAGGAG	19	13693
SCNN1A-5897	−	GUGGAGGAGGGAGGGAGGAG	20	9746
SCNN1A-9845	−	GGUGGAGGAGGGAGGGAGGAG	21	13694
SCNN1A-9846	−	AGGUGGAGGAGGGAGGGAGGAG	22	13695
SCNN1A-9847	−	AAGGUGGAGGAGGGAGGGAGGAG	23	13696
SCNN1A-9848	−	AAAGGUGGAGGAGGGAGGGAGGAG	24	13697
SCNN1A-2007	−	GGGAACAAGCUGGAGGAG	18	5856
SCNN1A-2008	−	GGGGAACAAGCUGGAGGAG	19	5857
SCNN1A-169	−	AGGGGAACAAGCUGGAGGAG	20	807
SCNN1A-2009	−	AAGGGGAACAAGCUGGAGGAG	21	5858
SCNN1A-2010	−	GAAGGGGAACAAGCUGGAGGAG	22	5859
SCNN1A-2011	−	UGAAGGGGAACAAGCUGGAGGAG	23	5860
SCNN1A-2012	−	AUGAAGGGGAACAAGCUGGAGGAG	24	5861
SCNN1A-2013	−	GAGGGGAACAAGCUGGAGGAG	21	5862
SCNN1A-2014	−	GGAGGGGAACAAGCUGGAGGAG	22	5863
SCNN1A-2015	−	UGGAGGGGAACAAGCUGGAGGAG	23	5864
SCNN1A-2016	−	AUGGAGGGGAACAAGCUGGAGGAG	24	5865
SCNN1A-9849	−	CUGUCAGGUGAGGGGGAG	18	13698
SCNN1A-9850	−	CCUGUCAGGUGAGGGGGAG	19	13699
SCNN1A-9851	−	ACCUGUCAGGUGAGGGGGAG	20	13700
SCNN1A-9852	−	CACCUGUCAGGUGAGGGGGAG	21	13701
SCNN1A-9853	−	GCACCUGUCAGGUGAGGGGGAG	22	13702
SCNN1A-9854	−	UGCACCUGUCAGGUGAGGGGGAG	23	13703
SCNN1A-9855	−	CUGCACCUGUCAGGUGAGGGGGAG	24	13704
SCNN1A-9856	−	GCAAGGCAAGGGGGGGAG	18	13705
SCNN1A-9857	−	GGCAAGGCAAGGGGGGGAG	19	13706
SCNN1A-5900	−	GGGCAAGGCAAGGGGGGGAG	20	9749
SCNN1A-9858	−	GGGGCAAGGCAAGGGGGGGAG	21	13707
SCNN1A-9859	−	GGGGGCAAGGCAAGGGGGGGAG	22	13708
SCNN1A-9860	−	AGGGGGCAAGGCAAGGGGGGGAG	23	13709
SCNN1A-9861	−	GAGGGGGCAAGGCAAGGGGGGGAG	24	13710
SCNN1A-9862	−	CCAGCCGCAACCUGGGAG	18	13711
SCNN1A-9863	−	UCCAGCCGCAACCUGGGAG	19	13712
SCNN1A-5251	−	GUCCAGCCGCAACCUGGGAG	20	9100
SCNN1A-9864	−	AGUCCAGCCGCAACCUGGGAG	21	13713
SCNN1A-9865	−	CAGUCCAGCCGCAACCUGGGAG	22	13714
SCNN1A-9866	−	CCAGUCCAGCCGCAACCUGGGAG	23	13715
SCNN1A-9867	−	CCCAGUCCAGCCGCAACCUGGGAG	24	13716
SCNN1A-2029	−	AUACCAGGUCUCAUGGAG	18	5878
SCNN1A-2030	−	CAUACCAGGUCUCAUGGAG	19	5879
SCNN1A-4	−	CCAUACCAGGUCUCAUGGAG	20	498
SCNN1A-2031	−	CCCAUACCAGGUCUCAUGGAG	21	5880
SCNN1A-2032	−	GCCCAUACCAGGUCUCAUGGAG	22	5881
SCNN1A-2033	−	AGCCCAUACCAGGUCUCAUGGAG	23	5882
SCNN1A-2034	−	CAGCCCAUACCAGGUCUCAUGGAG	24	5883
SCNN1A-9868	−	CAGGGCCAGAGGCUGGAG	18	13717
SCNN1A-9869	−	UCAGGGCCAGAGGCUGGAG	19	13718
SCNN1A-9870	−	GUCAGGGCCAGAGGCUGGAG	20	13719
SCNN1A-9871	−	GGUCAGGGCCAGAGGCUGGAG	21	13720
SCNN1A-9872	−	AGGUCAGGGCCAGAGGCUGGAG	22	13721
SCNN1A-9873	−	GAGGUCAGGGCCAGAGGCUGGAG	23	13722
SCNN1A-9874	−	CGAGGUCAGGGCCAGAGGCUGGAG	24	13723
SCNN1A-9875	−	GCUCCAGGAAAGGUGGAG	18	13724
SCNN1A-9876	−	GGCUCCAGGAAAGGUGGAG	19	13725
SCNN1A-9877	−	UGGCUCCAGGAAAGGUGGAG	20	13726
SCNN1A-9878	−	CUGGCUCCAGGAAAGGUGGAG	21	13727
SCNN1A-9879	−	GCUGGCUCCAGGAAAGGUGGAG	22	13728
SCNN1A-9880	−	UGCUGGCUCCAGGAAAGGUGGAG	23	13729
SCNN1A-9881	−	CUGCUGGCUCCAGGAAAGGUGGAG	24	13730
SCNN1A-9882	−	CUGAGGGCCUAGAGUGAG	18	13731
SCNN1A-9883	−	GCUGAGGGCCUAGAGUGAG	19	13732
SCNN1A-5657	−	AGCUGAGGGCCUAGAGUGAG	20	9506
SCNN1A-9884	−	GAGCUGAGGGCCUAGAGUGAG	21	13733
SCNN1A-9885	−	GGAGCUGAGGGCCUAGAGUGAG	22	13734
SCNN1A-9886	−	UGGAGCUGAGGGCCUAGAGUGAG	23	13735
SCNN1A-9887	−	CUGGAGCUGAGGGCCUAGAGUGAG	24	13736
SCNN1A-9888	−	CUGCUCCCACUUAGUGAG	18	13737
SCNN1A-9889	−	GCUGCUCCCACUUAGUGAG	19	13738
SCNN1A-5658	−	CGCUGCUCCCACUUAGUGAG	20	9507
SCNN1A-9890	−	GCGCUGCUCCCACUUAGUGAG	21	13739
SCNN1A-9891	−	UGCGCUGCUCCCACUUAGUGAG	22	13740
SCNN1A-9892	−	GUGCGCUGCUCCCACUUAGUGAG	23	13741
SCNN1A-9893	−	AGUGCGCUGCUCCCACUUAGUGAG	24	13742
SCNN1A-9894	−	CUGCACCUGUCAGGUGAG	18	13743
SCNN1A-9895	−	GCUGCACCUGUCAGGUGAG	19	13744
SCNN1A-5659	−	CGCUGCACCUGUCAGGUGAG	20	9508
SCNN1A-9896	−	CCGCUGCACCUGUCAGGUGAG	21	13745
SCNN1A-9897	−	GCCGCUGCACCUGUCAGGUGAG	22	13746
SCNN1A-9898	−	GGCCGCUGCACCUGUCAGGUGAG	23	13747
SCNN1A-9899	−	AGGCCGCUGCACCUGUCAGGUGAG	24	13748
SCNN1A-9900	−	GCUCCCACUUAGUGAGCG	18	13749
SCNN1A-9901	−	UGCUCCCACUUAGUGAGCG	19	13750
SCNN1A-5668	−	CUGCUCCCACUUAGUGAGCG	20	9517
SCNN1A-9902	−	GCUGCUCCCACUUAGUGAGCG	21	13751
SCNN1A-9903	−	CGCUGCUCCCACUUAGUGAGCG	22	13752
SCNN1A-9904	−	GCGCUGCUCCCACUUAGUGAGCG	23	13753
SCNN1A-9905	−	UGCGCUGCUCCCACUUAGUGAGCG	24	13754
SCNN1A-9906	−	GCUGGCAAAUAGAAAAGG	18	13755
SCNN1A-9907	−	AGCUGGCAAAUAGAAAAGG	19	13756
SCNN1A-9908	−	GAGCUGGCAAAUAGAAAAGG	20	13757
SCNN1A-9909	−	UGAGCUGGCAAAUAGAAAAGG	21	13758
SCNN1A-9910	−	AUGAGCUGGCAAAUAGAAAAGG	22	13759
SCNN1A-9911	−	CAUGAGCUGGCAAAUAGAAAAGG	23	13760
SCNN1A-9912	−	GCAUGAGCUGGCAAAUAGAAAAGG	24	13761
SCNN1A-9913	−	GAGGAAGAAGACCAAAGG	18	13762
SCNN1A-9914	−	GGAGGAAGAAGACCAAAGG	19	13763
SCNN1A-9915	−	UGGAGGAAGAAGACCAAAGG	20	13764
SCNN1A-9916	−	CUGGAGGAAGAAGACCAAAGG	21	13765
SCNN1A-9917	−	CCUGGAGGAAGAAGACCAAAGG	22	13766
SCNN1A-9918	−	UCCUGGAGGAAGAAGACCAAAGG	23	13767
SCNN1A-9919	−	AUCCUGGAGGAAGAAGACCAAAGG	24	13768
SCNN1A-9920	−	UGCUGGCUCCAGGAAAGG	18	13769
SCNN1A-9921	−	CUGCUGGCUCCAGGAAAGG	19	13770
SCNN1A-6150	−	UCUGCUGGCUCCAGGAAAGG	20	9999
SCNN1A-9922	−	GUCUGCUGGCUCCAGGAAAGG	21	13771
SCNN1A-9923	−	GGUCUGCUGGCUCCAGGAAAGG	22	13772
SCNN1A-9924	−	AGGUCUGCUGGCUCCAGGAAAGG	23	13773
SCNN1A-9925	−	CAGGUCUGCUGGCUCCAGGAAAGG	24	13774
SCNN1A-9926	−	UCCCGGGUCUGGACAAGG	18	13775
SCNN1A-9927	−	CUCCCGGGUCUGGACAAGG	19	13776
SCNN1A-9928	−	CCUCCCGGGUCUGGACAAGG	20	13777
SCNN1A-9929	−	CCCUCCCGGGUCUGGACAAGG	21	13778
SCNN1A-9930	−	CCCCUCCCGGGUCUGGACAAGG	22	13779
SCNN1A-9931	−	GCCCCUCCCGGGUCUGGACAAGG	23	13780
SCNN1A-9932	−	GGCCCCUCCCGGGUCUGGACAAGG	24	13781
SCNN1A-9933	−	AGAGGGGGCAAGGCAAGG	18	13782
SCNN1A-9934	−	GAGAGGGGGCAAGGCAAGG	19	13783
SCNN1A-6152	−	UGAGAGGGGGCAAGGCAAGG	20	10001
SCNN1A-9935	−	GUGAGAGGGGGCAAGGCAAGG	21	13784
SCNN1A-9936	−	AGUGAGAGGGGGCAAGGCAAGG	22	13785
SCNN1A-9937	−	GAGUGAGAGGGGGCAAGGCAAGG	23	13786
SCNN1A-9938	−	AGAGUGAGAGGGGGCAAGGCAAGG	24	13787
SCNN1A-9939	−	AGGAAGCCACAGACCAGG	18	13788
SCNN1A-9940	−	GAGGAAGCCACAGACCAGG	19	13789
SCNN1A-9941	−	AGAGGAAGCCACAGACCAGG	20	13790
SCNN1A-9942	−	GAGAGGAAGCCACAGACCAGG	21	13791
SCNN1A-9943	−	AGAGAGGAAGCCACAGACCAGG	22	13792
SCNN1A-9944	−	AAGAGAGGAAGCCACAGACCAGG	23	13793
SCNN1A-9945	−	CAAGAGAGGAAGCCACAGACCAGG	24	13794
SCNN1A-9946	−	GAAAGAGGAGGGACCAGG	18	13795
SCNN1A-9947	−	GGAAAGAGGAGGGACCAGG	19	13796
SCNN1A-6153	−	AGGAAAGAGGAGGGACCAGG	20	10002
SCNN1A-9948	−	CAGGAAAGAGGAGGGACCAGG	21	13797
SCNN1A-9949	−	GCAGGAAAGAGGAGGGACCAGG	22	13798
SCNN1A-9950	−	AGCAGGAAAGAGGAGGGACCAGG	23	13799
SCNN1A-9951	−	CAGCAGGAAAGAGGAGGGACCAGG	24	13800
SCNN1A-2047	−	GGAGAAUGUGGGCGCAGG	18	5896
SCNN1A-2048	−	GGGAGAAUGUGGGCGCAGG	19	5897
SCNN1A-2049	−	UGGGAGAAUGUGGGCGCAGG	20	5898
SCNN1A-9952	−	GUGGGAGAAUGUGGGCGCAGG	21	13801
SCNN1A-9953	−	AGUGGGAGAAUGUGGGCGCAGG	22	13802
SCNN1A-9954	−	GAGUGGGAGAAUGUGGGCGCAGG	23	13803
SCNN1A-9955	−	GGAGUGGGAGAAUGUGGGCGCAGG	24	13804
SCNN1A-9956	−	UGAGCACCUUAUUGCAGG	18	13805
SCNN1A-9957	−	CUGAGCACCUUAUUGCAGG	19	13806
SCNN1A-9958	−	GCUGAGCACCUUAUUGCAGG	20	13807
SCNN1A-9959	−	UGCUGAGCACCUUAUUGCAGG	21	13808
SCNN1A-9960	−	GUGCUGAGCACCUUAUUGCAGG	22	13809
SCNN1A-9961	−	GGUGCUGAGCACCUUAUUGCAGG	23	13810
SCNN1A-9962	−	GGGUGCUGAGCACCUUAUUGCAGG	24	13811
SCNN1A-9963	−	UGUGUAUCAAUGCUCAGG	18	13812
SCNN1A-9964	−	GUGUGUAUCAAUGCUCAGG	19	13813
SCNN1A-9965	−	GGUGUGUAUCAAUGCUCAGG	20	13814
SCNN1A-9966	−	CGGUGUGUAUCAAUGCUCAGG	21	13815
SCNN1A-9967	−	CCGGUGUGUAUCAAUGCUCAGG	22	13816
SCNN1A-9968	−	CCCGGUGUGUAUCAAUGCUCAGG	23	13817
SCNN1A-9969	−	CCCCGGUGUGUAUCAAUGCUCAGG	24	13818
SCNN1A-9970	−	GAAUCAGCAGGAAAGAGG	18	13819
SCNN1A-9971	−	GGAAUCAGCAGGAAAGAGG	19	13820
SCNN1A-6155	−	AGGAAUCAGCAGGAAAGAGG	20	10004
SCNN1A-9972	−	GAGGAAUCAGCAGGAAAGAGG	21	13821
SCNN1A-9973	−	CGAGGAAUCAGCAGGAAAGAGG	22	13822
SCNN1A-9974	−	GCGAGGAAUCAGCAGGAAAGAGG	23	13823
SCNN1A-9975	−	GGCGAGGAAUCAGCAGGAAAGAGG	24	13824
SCNN1A-9976	−	AGUAGAUAGCCCCAGAGG	18	13825
SCNN1A-9977	−	AAGUAGAUAGCCCCAGAGG	19	13826
SCNN1A-5678	−	UAAGUAGAUAGCCCCAGAGG	20	9527
SCNN1A-9978	−	CUAAGUAGAUAGCCCCAGAGG	21	13827
SCNN1A-9979	−	GCUAAGUAGAUAGCCCCAGAGG	22	13828
SCNN1A-9980	−	CGCUAAGUAGAUAGCCCCAGAGG	23	13829
SCNN1A-9981	−	GCGCUAAGUAGAUAGCCCCAGAGG	24	13830
SCNN1A-9982	−	CGAGGUCAGGGCCAGAGG	18	13831
SCNN1A-9983	−	UCGAGGUCAGGGCCAGAGG	19	13832
SCNN1A-9984	−	CUCGAGGUCAGGGCCAGAGG	20	13833
SCNN1A-9985	−	GCUCGAGGUCAGGGCCAGAGG	21	13834
SCNN1A-9986	−	AGCUCGAGGUCAGGGCCAGAGG	22	13835
SCNN1A-9987	−	CAGCUCGAGGUCAGGGCCAGAGG	23	13836
SCNN1A-9988	−	ACAGCUCGAGGUCAGGGCCAGAGG	24	13837
SCNN1A-9989	−	AGGCAAGGGGGGGAGAGG	18	13838
SCNN1A-9990	−	AAGGCAAGGGGGGGAGAGG	19	13839
SCNN1A-9991	−	CAAGGCAAGGGGGGGAGAGG	20	13840
SCNN1A-9992	−	GCAAGGCAAGGGGGGGAGAGG	21	13841
SCNN1A-9993	−	GGCAAGGCAAGGGGGGGAGAGG	22	13842
SCNN1A-9994	−	GGGCAAGGCAAGGGGGGGAGAGG	23	13843
SCNN1A-9995	−	GGGGCAAGGCAAGGGGGGGAGAGG	24	13844
SCNN1A-9996	−	UAGAGAGGGAGUGAGAGG	18	13845
SCNN1A-9997	−	AUAGAGAGGGAGUGAGAGG	19	13846
SCNN1A-9998	−	GAUAGAGAGGGAGUGAGAGG	20	13847
SCNN1A-9999	−	AGAUAGAGAGGGAGUGAGAGG	21	13848
SCNN1A-10000	−	CAGAUAGAGAGGGAGUGAGAGG	22	13849
SCNN1A-10001	−	GCAGAUAGAGAGGGAGUGAGAGG	23	13850
SCNN1A-10002	−	GGCAGAUAGAGAGGGAGUGAGAGG	24	13851
SCNN1A-10003	−	AGAUAGCCCCAGAGGAGG	18	13852
SCNN1A-10004	−	UAGAUAGCCCCAGAGGAGG	19	13853
SCNN1A-5261	−	GUAGAUAGCCCCAGAGGAGG	20	9110
SCNN1A-10005	−	AGUAGAUAGCCCCAGAGGAGG	21	13854
SCNN1A-10006	−	AAGUAGAUAGCCCCAGAGGAGG	22	13855
SCNN1A-10007	−	UAAGUAGAUAGCCCCAGAGGAGG	23	13856
SCNN1A-10008	−	CUAAGUAGAUAGCCCCAGAGGAGG	24	13857
SCNN1A-10009	−	CAGGAAAGGUGGAGGAGG	18	13858
SCNN1A-10010	−	CCAGGAAAGGUGGAGGAGG	19	13859
SCNN1A-10011	−	UCCAGGAAAGGUGGAGGAGG	20	13860
SCNN1A-10012	−	CUCCAGGAAAGGUGGAGGAGG	21	13861
SCNN1A-10013	−	GCUCCAGGAAAGGUGGAGGAGG	22	13862
SCNN1A-10014	−	GGCUCCAGGAAAGGUGGAGGAGG	23	13863
SCNN1A-10015	−	UGGCUCCAGGAAAGGUGGAGGAGG	24	13864
SCNN1A-10016	−	AAAGGUGGAGGAGGGAGG	18	13865
SCNN1A-10017	−	GAAAGGUGGAGGAGGGAGG	19	13866
SCNN1A-10018	−	GGAAAGGUGGAGGAGGGAGG	20	13867
SCNN1A-10019	−	AGGAAAGGUGGAGGAGGGAGG	21	13868
SCNN1A-10020	−	CAGGAAAGGUGGAGGAGGGAGG	22	13869
SCNN1A-10021	−	CCAGGAAAGGUGGAGGAGGGAGG	23	13870
SCNN1A-10022	−	UCCAGGAAAGGUGGAGGAGGGAGG	24	13871
SCNN1A-10023	−	CUGGCUUGUGGAGGGAGG	18	13872
SCNN1A-10024	−	GCUGGCUUGUGGAGGGAGG	19	13873
SCNN1A-10025	−	UGCUGGCUUGUGGAGGGAGG	20	13874
SCNN1A-10026	−	CUGCUGGCUUGUGGAGGGAGG	21	13875
SCNN1A-10027	−	UCUGCUGGCUUGUGGAGGGAGG	22	13876
SCNN1A-10028	−	GUCUGCUGGCUUGUGGAGGGAGG	23	13877
SCNN1A-10029	−	UGUCUGCUGGCUUGUGGAGGGAGG	24	13878
SCNN1A-10030	−	AGACACAGAUCCUGGAGG	18	13879
SCNN1A-10031	−	GAGACACAGAUCCUGGAGG	19	13880
SCNN1A-10032	−	UGAGACACAGAUCCUGGAGG	20	13881
SCNN1A-10033	−	CUGAGACACAGAUCCUGGAGG	21	13882
SCNN1A-10034	−	GCUGAGACACAGAUCCUGGAGG	22	13883
SCNN1A-10035	−	AGCUGAGACACAGAUCCUGGAGG	23	13884
SCNN1A-10036	−	GAGCUGAGACACAGAUCCUGGAGG	24	13885
SCNN1A-10037	−	CUCCAGGAAAGGUGGAGG	18	13886
SCNN1A-10038	−	GCUCCAGGAAAGGUGGAGG	19	13887
SCNN1A-5906	−	GGCUCCAGGAAAGGUGGAGG	20	9755
SCNN1A-10039	−	UGGCUCCAGGAAAGGUGGAGG	21	13888
SCNN1A-10040	−	CUGGCUCCAGGAAAGGUGGAGG	22	13889
SCNN1A-10041	−	GCUGGCUCCAGGAAAGGUGGAGG	23	13890
SCNN1A-10042	−	UGCUGGCUCCAGGAAAGGUGGAGG	24	13891
SCNN1A-10043	−	UCUCUGCAGGGCCUGAGG	18	13892
SCNN1A-10044	−	UUCUCUGCAGGGCCUGAGG	19	13893
SCNN1A-10045	−	CUUCUCUGCAGGGCCUGAGG	20	13894
SCNN1A-10046	−	UCUUCUCUGCAGGGCCUGAGG	21	13895
SCNN1A-10047	−	CUCUUCUCUGCAGGGCCUGAGG	22	13896
SCNN1A-10048	−	UCUCUUCUCUGCAGGGCCUGAGG	23	13897
SCNN1A-10049	−	CUCUCUUCUCUGCAGGGCCUGAGG	24	13898
SCNN1A-10050	−	UGCACCUGUCAGGUGAGG	18	13899
SCNN1A-10051	−	CUGCACCUGUCAGGUGAGG	19	13900
SCNN1A-5908	−	GCUGCACCUGUCAGGUGAGG	20	9757
SCNN1A-10052	−	CGCUGCACCUGUCAGGUGAGG	21	13901
SCNN1A-10053	−	CCGCUGCACCUGUCAGGUGAGG	22	13902
SCNN1A-10054	−	GCCGCUGCACCUGUCAGGUGAGG	23	13903
SCNN1A-10055	−	GGCCGCUGCACCUGUCAGGUGAGG	24	13904
SCNN1A-10056	−	UCCCUGGCCGGCCAGCGG	18	13905
SCNN1A-10057	−	AUCCCUGGCCGGCCAGCGG	19	13906
SCNN1A-10058	−	CAUCCCUGGCCGGCCAGCGG	20	13907
SCNN1A-10059	−	CCAUCCCUGGCCGGCCAGCGG	21	13908
SCNN1A-10060	−	UCCAUCCCUGGCCGGCCAGCGG	22	13909
SCNN1A-10061	−	UUCCAUCCCUGGCCGGCCAGCGG	23	13910
SCNN1A-10062	−	CUUCCAUCCCUGGCCGGCCAGCGG	24	13911
SCNN1A-10063	−	GAGGGGGCAAGGCAAGGG	18	13912
SCNN1A-10064	−	AGAGGGGGCAAGGCAAGGG	19	13913
SCNN1A-5910	−	GAGAGGGGGCAAGGCAAGGG	20	9759
SCNN1A-10065	−	UGAGAGGGGGCAAGGCAAGGG	21	13914
SCNN1A-10066	−	GUGAGAGGGGGCAAGGCAAGGG	22	13915
SCNN1A-10067	−	AGUGAGAGGGGGCAAGGCAAGGG	23	13916
SCNN1A-10068	−	GAGUGAGAGGGGGCAAGGCAAGGG	24	13917
SCNN1A-2068	−	GAGAAUGUGGGCGCAGGG	18	5917
SCNN1A-2069	−	GGAGAAUGUGGGCGCAGGG	19	5918
SCNN1A-354	−	GGGAGAAUGUGGGCGCAGGG	20	4203
SCNN1A-2070	−	UGGGAGAAUGUGGGCGCAGGG	21	5919
SCNN1A-2071	−	GUGGGAGAAUGUGGGCGCAGGG	22	5920
SCNN1A-2072	−	AGUGGGAGAAUGUGGGCGCAGGG	23	5921
SCNN1A-2073	−	GAGUGGGAGAAUGUGGGCGCAGGG	24	5922
SCNN1A-10069	−	AGGAAAGGUGGAGGAGGG	18	13918
SCNN1A-10070	−	CAGGAAAGGUGGAGGAGGG	19	13919
SCNN1A-6162	−	CCAGGAAAGGUGGAGGAGGG	20	10011
SCNN1A-10071	−	UCCAGGAAAGGUGGAGGAGGG	21	13920
SCNN1A-10072	−	CUCCAGGAAAGGUGGAGGAGGG	22	13921
SCNN1A-10073	−	GCUCCAGGAAAGGUGGAGGAGGG	23	13922
SCNN1A-10074	−	GGCUCCAGGAAAGGUGGAGGAGGG	24	13923
SCNN1A-10075	−	UCCCACUUAGUGAGCGGG	18	13924
SCNN1A-10076	−	CUCCCACUUAGUGAGCGGG	19	13925
SCNN1A-10077	−	GCUCCCACUUAGUGAGCGGG	20	13926
SCNN1A-10078	−	UGCUCCCACUUAGUGAGCGGG	21	13927
SCNN1A-10079	−	CUGCUCCCACUUAGUGAGCGGG	22	13928
SCNN1A-10080	−	GCUGCUCCCACUUAGUGAGCGGG	23	13929
SCNN1A-10081	−	CGCUGCUCCCACUUAGUGAGCGGG	24	13930
SCNN1A-10082	−	AGGGGGCAAGGCAAGGGG	18	13931
SCNN1A-10083	−	GAGGGGGCAAGGCAAGGGG	19	13932
SCNN1A-6163	−	AGAGGGGGCAAGGCAAGGGG	20	10012
SCNN1A-10084	−	GAGAGGGGGCAAGGCAAGGGG	21	13933
SCNN1A-10085	−	UGAGAGGGGGCAAGGCAAGGGG	22	13934
SCNN1A-10086	−	GUGAGAGGGGGCAAGGCAAGGGG	23	13935
SCNN1A-10087	−	AGUGAGAGGGGGCAAGGCAAGGGG	24	13936
SCNN1A-10088	−	CACCUGUCAGGUGAGGGG	18	13937
SCNN1A-10089	−	GCACCUGUCAGGUGAGGGG	19	13938
SCNN1A-10090	−	UGCACCUGUCAGGUGAGGGG	20	13939
SCNN1A-10091	−	CUGCACCUGUCAGGUGAGGGG	21	13940
SCNN1A-10092	−	GCUGCACCUGUCAGGUGAGGGG	22	13941
SCNN1A-10093	−	CGCUGCACCUGUCAGGUGAGGGG	23	13942
SCNN1A-10094	−	CCGCUGCACCUGUCAGGUGAGGGG	24	13943
SCNN1A-10095	−	CCCACUUAGUGAGCGGGG	18	13944
SCNN1A-10096	−	UCCCACUUAGUGAGCGGGG	19	13945
SCNN1A-5689	−	CUCCCACUUAGUGAGCGGGG	20	9538
SCNN1A-10097	−	GCUCCCACUUAGUGAGCGGGG	21	13946
SCNN1A-10098	−	UGCUCCCACUUAGUGAGCGGGG	22	13947
SCNN1A-10099	−	CUGCUCCCACUUAGUGAGCGGGG	23	13948
SCNN1A-10100	−	GCUGCUCCCACUUAGUGAGCGGGG	24	13949
SCNN1A-10101	−	AAGACCAAAGGAAGGGGG	18	13950
SCNN1A-10102	−	GAAGACCAAAGGAAGGGGG	19	13951
SCNN1A-10103	−	AGAAGACCAAAGGAAGGGGG	20	13952
SCNN1A-10104	−	AAGAAGACCAAAGGAAGGGGG	21	13953
SCNN1A-10105	−	GAAGAAGACCAAAGGAAGGGGG	22	13954
SCNN1A-10106	−	GGAAGAAGACCAAAGGAAGGGGG	23	13955
SCNN1A-10107	−	AGGAAGAAGACCAAAGGAAGGGGG	24	13956
SCNN1A-10108	−	ACCUGUCAGGUGAGGGGG	18	13957
SCNN1A-10109	−	CACCUGUCAGGUGAGGGGG	19	13958
SCNN1A-5914	−	GCACCUGUCAGGUGAGGGGG	20	9763
SCNN1A-10110	−	UGCACCUGUCAGGUGAGGGGG	21	13959
SCNN1A-10111	−	CUGCACCUGUCAGGUGAGGGGG	22	13960
SCNN1A-10112	−	GCUGCACCUGUCAGGUGAGGGGG	23	13961
SCNN1A-10113	−	CGCUGCACCUGUCAGGUGAGGGGG	24	13962
SCNN1A-10114	−	GGGGCAAGGCAAGGGGGG	18	13963
SCNN1A-10115	−	GGGGGCAAGGCAAGGGGGG	19	13964
SCNN1A-10116	−	AGGGGGCAAGGCAAGGGGGG	20	13965
SCNN1A-10117	−	GAGGGGGCAAGGCAAGGGGGG	21	13966
SCNN1A-10118	−	AGAGGGGGCAAGGCAAGGGGGG	22	13967
SCNN1A-10119	−	GAGAGGGGGCAAGGCAAGGGGGG	23	13968
SCNN1A-10120	−	UGAGAGGGGGCAAGGCAAGGGGGG	24	13969
SCNN1A-10121	−	AGCCCUGCAGUCCUGGGG	18	13970
SCNN1A-10122	−	GAGCCCUGCAGUCCUGGGG	19	13971
SCNN1A-10123	−	GGAGCCCUGCAGUCCUGGGG	20	13972
SCNN1A-10124	−	UGGAGCCCUGCAGUCCUGGGG	21	13973
SCNN1A-10125	−	CUGGAGCCCUGCAGUCCUGGGG	22	13974
SCNN1A-10126	−	CCUGGAGCCCUGCAGUCCUGGGG	23	13975
SCNN1A-10127	−	UCCUGGAGCCCUGCAGUCCUGGGG	24	13976
SCNN1A-2080	−	CCAUACCAGGUCUCAUGG	18	5929
SCNN1A-2081	−	CCCAUACCAGGUCUCAUGG	19	5930
SCNN1A-2	−	GCCCAUACCAGGUCUCAUGG	20	497
SCNN1A-2082	−	AGCCCAUACCAGGUCUCAUGG	21	5931
SCNN1A-2083	−	CAGCCCAUACCAGGUCUCAUGG	22	5932
SCNN1A-2084	−	GCAGCCCAUACCAGGUCUCAUGG	23	5933
SCNN1A-2085	−	UGCAGCCCAUACCAGGUCUCAUGG	24	5934
SCNN1A-2086	−	GGGUUCCAGGGGUGAUGG	18	5935
SCNN1A-2087	−	CGGGUUCCAGGGGUGAUGG	19	5936
SCNN1A-2088	−	UCGGGUUCCAGGGGUGAUGG	20	5937
SCNN1A-2089	−	CUCGGGUUCCAGGGGUGAUGG	21	5938
SCNN1A-2090	−	ACUCGGGUUCCAGGGGUGAUGG	22	5939
SCNN1A-2091	−	CACUCGGGUUCCAGGGGUGAUGG	23	5940
SCNN1A-2092	−	UCACUCGGGUUCCAGGGGUGAUGG	24	5941
SCNN1A-10128	−	CUGAGACACAGAUCCUGG	18	13977
SCNN1A-10129	−	GCUGAGACACAGAUCCUGG	19	13978
SCNN1A-5693	−	AGCUGAGACACAGAUCCUGG	20	9542
SCNN1A-10130	−	GAGCUGAGACACAGAUCCUGG	21	13979
SCNN1A-10131	−	GGAGCUGAGACACAGAUCCUGG	22	13980
SCNN1A-10132	−	AGGAGCUGAGACACAGAUCCUGG	23	13981
SCNN1A-10133	−	CAGGAGCUGAGACACAGAUCCUGG	24	13982
SCNN1A-2093	−	UGAAGGGGAACAAGCUGG	18	5942
SCNN1A-2094	−	AUGAAGGGGAACAAGCUGG	19	5943
SCNN1A-455	−	CAUGAAGGGGAACAAGCUGG	20	4304
SCNN1A-2095	−	UCAUGAAGGGGAACAAGCUGG	21	5944
SCNN1A-2096	−	CUCAUGAAGGGGAACAAGCUGG	22	5945
SCNN1A-2097	−	GCUCAUGAAGGGGAACAAGCUGG	23	5946
SCNN1A-2098	−	GGCUCAUGAAGGGGAACAAGCUGG	24	5947
SCNN1A-2099	−	UGGAGGGGAACAAGCUGG	18	5948
SCNN1A-2100	−	AUGGAGGGGAACAAGCUGG	19	5949
SCNN1A-6	−	CAUGGAGGGGAACAAGCUGG	20	558
SCNN1A-2101	−	UCAUGGAGGGGAACAAGCUGG	21	5950
SCNN1A-2102	−	CUCAUGGAGGGGAACAAGCUGG	22	5951
SCNN1A-2103	−	UCUCAUGGAGGGGAACAAGCUGG	23	5952
SCNN1A-2104	−	GUCUCAUGGAGGGGAACAAGCUGG	24	5953
SCNN1A-10134	−	UGGCUCCAGGAAAGGUGG	18	13983
SCNN1A-10135	−	CUGGCUCCAGGAAAGGUGG	19	13984
SCNN1A-5266	−	GCUGGCUCCAGGAAAGGUGG	20	9115
SCNN1A-10136	−	UGCUGGCUCCAGGAAAGGUGG	21	13985
SCNN1A-10137	−	CUGCUGGCUCCAGGAAAGGUGG	22	13986
SCNN1A-10138	−	UCUGCUGGCUCCAGGAAAGGUGG	23	13987
SCNN1A-10139	−	GUCUGCUGGCUCCAGGAAAGGUGG	24	13988
SCNN1A-10140	−	UUGUCUGCUGGCUUGUGG	18	13989
SCNN1A-10141	−	UUUGUCUGCUGGCUUGUGG	19	13990
SCNN1A-5695	−	CUUUGUCUGCUGGCUUGUGG	20	9544
SCNN1A-10142	−	CCUUUGUCUGCUGGCUUGUGG	21	13991
SCNN1A-10143	−	GCCUUUGUCUGCUGGCUUGUGG	22	13992
SCNN1A-10144	−	GGCCUUUGUCUGCUGGCUUGUGG	23	13993
SCNN1A-10145	−	GGGCCUUUGUCUGCUGGCUUGUGG	24	13994
SCNN1A-10146	−	GGGUCUGGACAAGGUUGG	18	13995
SCNN1A-10147	−	CGGGUCUGGACAAGGUUGG	19	13996
SCNN1A-5697	−	CCGGGUCUGGACAAGGUUGG	20	9546
SCNN1A-10148	−	CCCGGGUCUGGACAAGGUUGG	21	13997
SCNN1A-10149	−	UCCCGGGUCUGGACAAGGUUGG	22	13998
SCNN1A-10150	−	CUCCCGGGUCUGGACAAGGUUGG	23	13999
SCNN1A-10151	−	CCUCCCGGGUCUGGACAAGGUUGG	24	14000
SCNN1A-10152	−	UUCUUCAUUAGGACAAUG	18	14001
SCNN1A-10153	−	UUUCUUCAUUAGGACAAUG	19	14002
SCNN1A-10154	−	GUUUCUUCAUUAGGACAAUG	20	14003
SCNN1A-10155	−	AGUUUCUUCAUUAGGACAAUG	21	14004
SCNN1A-10156	−	CAGUUUCUUCAUUAGGACAAUG	22	14005
SCNN1A-10157	−	UCAGUUUCUUCAUUAGGACAAUG	23	14006
SCNN1A-10158	−	GUCAGUUUCUUCAUUAGGACAAUG	24	14007
SCNN1A-2111	−	UCCACUCCGGGGCUCAUG	18	5960
SCNN1A-2112	−	AUCCACUCCGGGGCUCAUG	19	5961
SCNN1A-2113	−	AAUCCACUCCGGGGCUCAUG	20	5962
SCNN1A-2114	−	CAAUCCACUCCGGGGCUCAUG	21	5963
SCNN1A-2115	−	CCAAUCCACUCCGGGGCUCAUG	22	5964
SCNN1A-2116	−	CCCAAUCCACUCCGGGGCUCAUG	23	5965
SCNN1A-2117	−	CCCCAAUCCACUCCGGGGCUCAUG	24	5966
SCNN1A-2118	−	CCCAUACCAGGUCUCAUG	18	5967
SCNN1A-2119	−	GCCCAUACCAGGUCUCAUG	19	5968
SCNN1A-161	−	AGCCCAUACCAGGUCUCAUG	20	804
SCNN1A-2120	−	CAGCCCAUACCAGGUCUCAUG	21	5969
SCNN1A-2121	−	GCAGCCCAUACCAGGUCUCAUG	22	5970
SCNN1A-2122	−	UGCAGCCCAUACCAGGUCUCAUG	23	5971
SCNN1A-2123	−	CUGCAGCCCAUACCAGGUCUCAUG	24	5972
SCNN1A-10159	−	AGGGGUCUCUGGGAUAUG	18	14008
SCNN1A-10160	−	UAGGGGUCUCUGGGAUAUG	19	14009
SCNN1A-5700	−	CUAGGGGUCUCUGGGAUAUG	20	9549
SCNN1A-10161	−	UCUAGGGGUCUCUGGGAUAUG	21	14010
SCNN1A-10162	−	UUCUAGGGGUCUCUGGGAUAUG	22	14011
SCNN1A-10163	−	UUUCUAGGGGUCUCUGGGAUAUG	23	14012
SCNN1A-10164	−	GUUUCUAGGGGUCUCUGGGAUAUG	24	14013
SCNN1A-10165	−	GAGCGGGGAGGAGACCUG	18	14014
SCNN1A-10166	−	UGAGCGGGGAGGAGACCUG	19	14015
SCNN1A-10167	−	GUGAGCGGGGAGGAGACCUG	20	14016
SCNN1A-10168	−	AGUGAGCGGGGAGGAGACCUG	21	14017
SCNN1A-10169	−	UAGUGAGCGGGGAGGAGACCUG	22	14018
SCNN1A-10170	−	UUAGUGAGCGGGGAGGAGACCUG	23	14019
SCNN1A-10171	−	CUUAGUGAGCGGGGAGGAGACCUG	24	14020
SCNN1A-10172	−	GCUGAGACACAGAUCCUG	18	14021
SCNN1A-10173	−	AGCUGAGACACAGAUCCUG	19	14022
SCNN1A-10174	−	GAGCUGAGACACAGAUCCUG	20	14023
SCNN1A-10175	−	GGAGCUGAGACACAGAUCCUG	21	14024
SCNN1A-10176	−	AGGAGCUGAGACACAGAUCCUG	22	14025
SCNN1A-10177	−	CAGGAGCUGAGACACAGAUCCUG	23	14026
SCNN1A-10178	−	GCAGGAGCUGAGACACAGAUCCUG	24	14027
SCNN1A-10179	−	ACUCUGGGCUGCCUCCUG	18	14028
SCNN1A-10180	−	CACUCUGGGCUGCCUCCUG	19	14029
SCNN1A-5269	−	GCACUCUGGGCUGCCUCCUG	20	9118
SCNN1A-10181	−	UGCACUCUGGGCUGCCUCCUG	21	14030
SCNN1A-10182	−	CUGCACUCUGGGCUGCCUCCUG	22	14031
SCNN1A-10183	−	CCUGCACUCUGGGCUGCCUCCUG	23	14032
SCNN1A-10184	−	UCCUGCACUCUGGGCUGCCUCCUG	24	14033
SCNN1A-2124	−	AUGAAGGGGAACAAGCUG	18	5973
SCNN1A-2125	−	CAUGAAGGGGAACAAGCUG	19	5974
SCNN1A-2126	−	UCAUGAAGGGGAACAAGCUG	20	5975
SCNN1A-2127	−	CUCAUGAAGGGGAACAAGCUG	21	5976
SCNN1A-2128	−	GCUCAUGAAGGGGAACAAGCUG	22	5977
SCNN1A-2129	−	GGCUCAUGAAGGGGAACAAGCUG	23	5978
SCNN1A-2130	−	GGGCUCAUGAAGGGGAACAAGCUG	24	5979
SCNN1A-2131	−	AUGGAGGGGAACAAGCUG	18	5980
SCNN1A-2132	−	CAUGGAGGGGAACAAGCUG	19	5981
SCNN1A-167	−	UCAUGGAGGGGAACAAGCUG	20	806
SCNN1A-2133	−	CUCAUGGAGGGGAACAAGCUG	21	5982
SCNN1A-2134	−	UCUCAUGGAGGGGAACAAGCUG	22	5983
SCNN1A-2135	−	GUCUCAUGGAGGGGAACAAGCUG	23	5984
SCNN1A-2136	−	GGUCUCAUGGAGGGGAACAAGCUG	24	5985
SCNN1A-10185	−	CCUCUUCUCUCUUCUCUG	18	14034
SCNN1A-10186	−	ACCUCUUCUCUCUUCUCUG	19	14035
SCNN1A-10187	−	GACCUCUUCUCUCUUCUCUG	20	14036
SCNN1A-10188	−	AGACCUCUUCUCUCUUCUCUG	21	14037
SCNN1A-10189	−	GAGACCUCUUCUCUCUUCUCUG	22	14038
SCNN1A-10190	−	AGAGACCUCUUCUCUCUUCUCUG	23	14039
SCNN1A-10191	−	CAGAGACCUCUUCUCUCUUCUCUG	24	14040
SCNN1A-10192	−	GGGGCAGUGGGGACAGUG	18	14041
SCNN1A-10193	−	UGGGGCAGUGGGGACAGUG	19	14042
SCNN1A-10194	−	GUGGGGCAGUGGGGACAGUG	20	14043
SCNN1A-10195	−	UGUGGGGCAGUGGGGACAGUG	21	14044
SCNN1A-10196	−	AUGUGGGGCAGUGGGGACAGUG	22	14045
SCNN1A-10197	−	UAUGUGGGGCAGUGGGGACAGUG	23	14046
SCNN1A-10198	−	AUAUGUGGGGCAGUGGGGACAGUG	24	14047
SCNN1A-10199	−	GGGCUCUGUGUGGGAGUG	18	14048
SCNN1A-10200	−	CGGGCUCUGUGUGGGAGUG	19	14049
SCNN1A-5711	−	ACGGGCUCUGUGUGGGAGUG	20	9560
SCNN1A-10201	−	CACGGGCUCUGUGUGGGAGUG	21	14050
SCNN1A-10202	−	CCACGGGCUCUGUGUGGGAGUG	22	14051
SCNN1A-10203	−	UCCACGGGCUCUGUGUGGGAGUG	23	14052
SCNN1A-10204	−	AUCCACGGGCUCUGUGUGGGAGUG	24	14053
SCNN1A-10205	−	CCUCCUGUGGGGCCCGUG	18	14054
SCNN1A-10206	−	GCCUCCUGUGGGGCCCGUG	19	14055
SCNN1A-5712	−	UGCCUCCUGUGGGGCCCGUG	20	9561
SCNN1A-10207	−	CUGCCUCCUGUGGGGCCCGUG	21	14056
SCNN1A-10208	−	GCUGCCUCCUGUGGGGCCCGUG	22	14057
SCNN1A-10209	−	GGCUGCCUCCUGUGGGGCCCGUG	23	14058
SCNN1A-10210	−	GGGCUGCCUCCUGUGGGGCCCGUG	24	14059
SCNN1A-10211	−	AGCCUUCCCUGCCGCGUG	18	14060
SCNN1A-10212	−	CAGCCUUCCCUGCCGCGUG	19	14061
SCNN1A-10213	−	GCAGCCUUCCCUGCCGCGUG	20	14062
SCNN1A-10214	−	GGCAGCCUUCCCUGCCGCGUG	21	14063
SCNN1A-10215	−	CGGCAGCCUUCCCUGCCGCGUG	22	14064
SCNN1A-10216	−	GCGGCAGCCUUCCCUGCCGCGUG	23	14065
SCNN1A-10217	−	AGCGGCAGCCUUCCCUGCCGCGUG	24	14066
SCNN1A-10218	−	CUGGCUCCAGGAAAGGUG	18	14067
SCNN1A-10219	−	GCUGGCUCCAGGAAAGGUG	19	14068
SCNN1A-10220	−	UGCUGGCUCCAGGAAAGGUG	20	14069
SCNN1A-10221	−	CUGCUGGCUCCAGGAAAGGUG	21	14070
SCNN1A-10222	−	UCUGCUGGCUCCAGGAAAGGUG	22	14071
SCNN1A-10223	−	GUCUGCUGGCUCCAGGAAAGGUG	23	14072
SCNN1A-10224	−	GGUCUGCUGGCUCCAGGAAAGGUG	24	14073
SCNN1A-10225	−	CGCUGCACCUGUCAGGUG	18	14074
SCNN1A-10226	−	CCGCUGCACCUGUCAGGUG	19	14075
SCNN1A-5270	−	GCCGCUGCACCUGUCAGGUG	20	9119
SCNN1A-10227	−	GGCCGCUGCACCUGUCAGGUG	21	14076
SCNN1A-10228	−	AGGCCGCUGCACCUGUCAGGUG	22	14077
SCNN1A-10229	−	CAGGCCGCUGCACCUGUCAGGUG	23	14078
SCNN1A-10230	−	CCAGGCCGCUGCACCUGUCAGGUG	24	14079
SCNN1A-10231	−	GAUCAAACAGCCAGGGUG	18	14080
SCNN1A-10232	−	AGAUCAAACAGCCAGGGUG	19	14081
SCNN1A-10233	−	GAGAUCAAACAGCCAGGGUG	20	14082
SCNN1A-10234	−	UGAGAUCAAACAGCCAGGGUG	21	14083
SCNN1A-10235	−	UUGAGAUCAAACAGCCAGGGUG	22	14084
SCNN1A-10236	−	UUUGAGAUCAAACAGCCAGGGUG	23	14085
SCNN1A-10237	−	CUUUGAGAUCAAACAGCCAGGGUG	24	14086
SCNN1A-2143	−	ACUCGGGUUCCAGGGGUG	18	5992
SCNN1A-2144	−	CACUCGGGUUCCAGGGGUG	19	5993
SCNN1A-2145	−	UCACUCGGGUUCCAGGGGUG	20	5994
SCNN1A-2146	−	CUCACUCGGGUUCCAGGGGUG	21	5995
SCNN1A-2147	−	CCUCACUCGGGUUCCAGGGGUG	22	5996
SCNN1A-2148	−	GCCUCACUCGGGUUCCAGGGGUG	23	5997
SCNN1A-2149	−	AGCCUCACUCGGGUUCCAGGGGUG	24	5998
SCNN1A-10238	−	ACAAGGUUGGAGGGGGUG	18	14087
SCNN1A-10239	−	GACAAGGUUGGAGGGGGUG	19	14088
SCNN1A-10240	−	GGACAAGGUUGGAGGGGGUG	20	14089
SCNN1A-10241	−	UGGACAAGGUUGGAGGGGGUG	21	14090
SCNN1A-10242	−	CUGGACAAGGUUGGAGGGGGUG	22	14091
SCNN1A-10243	−	UCUGGACAAGGUUGGAGGGGGUG	23	14092
SCNN1A-10244	−	GUCUGGACAAGGUUGGAGGGGGUG	24	14093
SCNN1A-10245	−	GAAUCCACGGGCUCUGUG	18	14094
SCNN1A-10246	−	CGAAUCCACGGGCUCUGUG	19	14095
SCNN1A-5717	−	ACGAAUCCACGGGCUCUGUG	20	9566
SCNN1A-10247	−	GACGAAUCCACGGGCUCUGUG	21	14096
SCNN1A-10248	−	AGACGAAUCCACGGGCUCUGUG	22	14097
SCNN1A-10249	−	CAGACGAAUCCACGGGCUCUGUG	23	14098
SCNN1A-10250	−	GCAGACGAAUCCACGGGCUCUGUG	24	14099
SCNN1A-10251	−	UUUGUCUGCUGGCUUGUG	18	14100
SCNN1A-10252	−	CUUUGUCUGCUGGCUUGUG	19	14101
SCNN1A-10253	−	CCUUUGUCUGCUGGCUUGUG	20	14102
SCNN1A-10254	−	GCCUUUGUCUGCUGGCUUGUG	21	14103
SCNN1A-10255	−	GGCCUUUGUCUGCUGGCUUGUG	22	14104
SCNN1A-10256	−	GGGCCUUUGUCUGCUGGCUUGUG	23	14105
SCNN1A-10257	−	UGGGCCUUUGUCUGCUGGCUUGUG	24	14106
SCNN1A-10258	−	GUGCUGAGCACCUUAUUG	18	14107
SCNN1A-10259	−	GGUGCUGAGCACCUUAUUG	19	14108
SCNN1A-10260	−	GGGUGCUGAGCACCUUAUUG	20	14109
SCNN1A-10261	−	AGGGUGCUGAGCACCUUAUUG	21	14110
SCNN1A-10262	−	CAGGGUGCUGAGCACCUUAUUG	22	14111
SCNN1A-10263	−	CCAGGGUGCUGAGCACCUUAUUG	23	14112
SCNN1A-10264	−	GCCAGGGUGCUGAGCACCUUAUUG	24	14113
SCNN1A-10265	−	UGGAGGGCUGCCCACUUG	18	14114
SCNN1A-10266	−	UUGGAGGGCUGCCCACUUG	19	14115
SCNN1A-10267	−	CUUGGAGGGCUGCCCACUUG	20	14116
SCNN1A-10268	−	CCUUGGAGGGCUGCCCACUUG	21	14117
SCNN1A-10269	−	CCCUUGGAGGGCUGCCCACUUG	22	14118
SCNN1A-10270	−	GCCCUUGGAGGGCUGCCCACUUG	23	14119
SCNN1A-10271	−	UGCCCUUGGAGGGCUGCCCACUUG	24	14120
SCNN1A-10272	−	GACCUGUGGGUGCCCUUG	18	14121
SCNN1A-10273	−	UGACCUGUGGGUGCCCUUG	19	14122
SCNN1A-10274	−	CUGACCUGUGGGUGCCCUUG	20	14123
SCNN1A-10275	−	GCUGACCUGUGGGUGCCCUUG	21	14124
SCNN1A-10276	−	GGCUGACCUGUGGGUGCCCUUG	22	14125
SCNN1A-10277	−	AGGCUGACCUGUGGGUGCCCUUG	23	14126
SCNN1A-10278	−	GAGGCUGACCUGUGGGUGCCCUUG	24	14127
SCNN1A-10279	−	CCUUUGUCUGCUGGCUUG	18	14128
SCNN1A-10280	−	GCCUUUGUCUGCUGGCUUG	19	14129
SCNN1A-5271	−	GGCCUUUGUCUGCUGGCUUG	20	9120
SCNN1A-10281	−	GGGCCUUUGUCUGCUGGCUUG	21	14130
SCNN1A-10282	−	UGGGCCUUUGUCUGCUGGCUUG	22	14131
SCNN1A-10283	−	CUGGGCCUUUGUCUGCUGGCUUG	23	14132
SCNN1A-10284	−	GCUGGGCCUUUGUCUGCUGGCUUG	24	14133
SCNN1A-10285	−	CGGGUCUGGACAAGGUUG	18	14134
SCNN1A-10286	−	CCGGGUCUGGACAAGGUUG	19	14135
SCNN1A-10287	−	CCCGGGUCUGGACAAGGUUG	20	14136
SCNN1A-10288	−	UCCCGGGUCUGGACAAGGUUG	21	14137
SCNN1A-10289	−	CUCCCGGGUCUGGACAAGGUUG	22	14138
SCNN1A-10290	−	CCUCCCGGGUCUGGACAAGGUUG	23	14139
SCNN1A-10291	−	CCCUCCCGGGUCUGGACAAGGUUG	24	14140
SCNN1A-10292	−	GUUUGGAAAGAGAUUUUG	18	14141
SCNN1A-10293	−	AGUUUGGAAAGAGAUUUUG	19	14142
SCNN1A-10294	−	AAGUUUGGAAAGAGAUUUUG	20	14143
SCNN1A-10295	−	UAAGUUUGGAAAGAGAUUUUG	21	14144
SCNN1A-10296	−	UUAAGUUUGGAAAGAGAUUUUG	22	14145
SCNN1A-10297	−	AUUAAGUUUGGAAAGAGAUUUUG	23	14146
SCNN1A-10298	−	CAUUAAGUUUGGAAAGAGAUUUUG	24	14147
SCNN1A-10299	−	GUCUUAUCUCUGAGAAAU	18	14148
SCNN1A-10300	−	UGUCUUAUCUCUGAGAAAU	19	14149
SCNN1A-10301	−	AUGUCUUAUCUCUGAGAAAU	20	14150
SCNN1A-10302	−	UAUGUCUUAUCUCUGAGAAAU	21	14151
SCNN1A-10303	−	UUAUGUCUUAUCUCUGAGAAAU	22	14152
SCNN1A-10304	−	CUUAUGUCUUAUCUCUGAGAAAU	23	14153
SCNN1A-10305	−	UCUUAUGUCUUAUCUCUGAGAAAU	24	14154
SCNN1A-10306	−	CUGGGGCAGAGACAGAAU	18	14155
SCNN1A-10307	−	CCUGGGGCAGAGACAGAAU	19	14156
SCNN1A-10308	−	UCCUGGGGCAGAGACAGAAU	20	14157
SCNN1A-10309	−	GUCCUGGGGCAGAGACAGAAU	21	14158
SCNN1A-10310	−	AGUCCUGGGGCAGAGACAGAAU	22	14159
SCNN1A-10311	−	CAGUCCUGGGGCAGAGACAGAAU	23	14160
SCNN1A-10312	−	GCAGUCCUGGGGCAGAGACAGAAU	24	14161
SCNN1A-10313	−	AGGGAGGAGUGGGAGAAU	18	14162
SCNN1A-10314	−	GAGGGAGGAGUGGGAGAAU	19	14163
SCNN1A-10315	−	GGAGGGAGGAGUGGGAGAAU	20	14164
SCNN1A-10316	−	GGGAGGGAGGAGUGGGAGAAU	21	14165
SCNN1A-10317	−	AGGGAGGGAGGAGUGGGAGAAU	22	14166
SCNN1A-10318	−	GAGGGAGGGAGGAGUGGGAGAAU	23	14167
SCNN1A-10319	−	GGAGGGAGGGAGGAGUGGGAGAAU	24	14168
SCNN1A-10320	−	AAGGGUCAGUUUCUUCAU	18	14169
SCNN1A-10321	−	GAAGGGUCAGUUUCUUCAU	19	14170
SCNN1A-10322	−	GGAAGGGUCAGUUUCUUCAU	20	14171
SCNN1A-10323	−	GGGAAGGGUCAGUUUCUUCAU	21	14172
SCNN1A-10324	−	UGGGAAGGGUCAGUUUCUUCAU	22	14173
SCNN1A-10325	−	UUGGGAAGGGUCAGUUUCUUCAU	23	14174
SCNN1A-10326	−	CUUGGGAAGGGUCAGUUUCUUCAU	24	14175
SCNN1A-10327	−	GAGGAAGAGAGGCAGGAU	18	14176
SCNN1A-10328	−	AGAGGAAGAGAGGCAGGAU	19	14177
SCNN1A-10329	−	GAGAGGAAGAGAGGCAGGAU	20	14178
SCNN1A-10330	−	GGAGAGGAAGAGAGGCAGGAU	21	14179
SCNN1A-10331	−	GGGAGAGGAAGAGAGGCAGGAU	22	14180
SCNN1A-10332	−	GGGGAGAGGAAGAGAGGCAGGAU	23	14181
SCNN1A-10333	−	GGGGGAGAGGAAGAGAGGCAGGAU	24	14182
SCNN1A-2150	−	UCGGGUUCCAGGGGUGAU	18	5999
SCNN1A-2151	−	CUCGGGUUCCAGGGGUGAU	19	6000
SCNN1A-421	−	ACUCGGGUUCCAGGGGUGAU	20	4270
SCNN1A-2152	−	CACUCGGGUUCCAGGGGUGAU	21	6001
SCNN1A-2153	−	UCACUCGGGUUCCAGGGGUGAU	22	6002
SCNN1A-2154	−	CUCACUCGGGUUCCAGGGGUGAU	23	6003
SCNN1A-2155	−	CCUCACUCGGGUUCCAGGGGUGAU	24	6004
SCNN1A-10334	−	UCUCACAGAGCCCUUGAU	18	14183
SCNN1A-10335	−	UUCUCACAGAGCCCUUGAU	19	14184
SCNN1A-10336	−	CUUCUCACAGAGCCCUUGAU	20	14185
SCNN1A-10337	−	UCUUCUCACAGAGCCCUUGAU	21	14186
SCNN1A-10338	−	UUCUUCUCACAGAGCCCUUGAU	22	14187
SCNN1A-10339	−	AUUCUUCUCACAGAGCCCUUGAU	23	14188
SCNN1A-10340	−	AAUUCUUCUCACAGAGCCCUUGAU	24	14189
SCNN1A-10341	−	UAGGGGUCUCUGGGAUAU	18	14190
SCNN1A-10342	−	CUAGGGGUCUCUGGGAUAU	19	14191
SCNN1A-10343	−	UCUAGGGGUCUCUGGGAUAU	20	14192
SCNN1A-10344	−	UUCUAGGGGUCUCUGGGAUAU	21	14193
SCNN1A-10345	−	UUUCUAGGGGUCUCUGGGAUAU	22	14194
SCNN1A-10346	−	GUUUCUAGGGGUCUCUGGGAUAU	23	14195
SCNN1A-10347	−	AGUUUCUAGGGGUCUCUGGGAUAU	24	14196
SCNN1A-10348	−	CUCGAAAGGUGGCCCUAU	18	14197
SCNN1A-10349	−	ACUCGAAAGGUGGCCCUAU	19	14198
SCNN1A-10350	−	AACUCGAAAGGUGGCCCUAU	20	14199
SCNN1A-10351	−	AAACUCGAAAGGUGGCCCUAU	21	14200
SCNN1A-10352	−	AAAACUCGAAAGGUGGCCCUAU	22	14201
SCNN1A-10353	−	CAAAACUCGAAAGGUGGCCCUAU	23	14202
SCNN1A-10354	−	ACAAAACUCGAAAGGUGGCCCUAU	24	14203
SCNN1A-10355	−	AGCUCCUGGAAGCACACU	18	14204
SCNN1A-10356	−	UAGCUCCUGGAAGCACACU	19	14205
SCNN1A-5727	−	CUAGCUCCUGGAAGCACACU	20	9576
SCNN1A-10357	−	UCUAGCUCCUGGAAGCACACU	21	14206
SCNN1A-10358	−	CUCUAGCUCCUGGAAGCACACU	22	14207
SCNN1A-10359	−	CCUCUAGCUCCUGGAAGCACACU	23	14208
SCNN1A-10360	−	GCCUCUAGCUCCUGGAAGCACACU	24	14209
SCNN1A-2156	−	UGCUCUCCCCAAUCCACU	18	6005
SCNN1A-2157	−	UUGCUCUCCCCAAUCCACU	19	6006
SCNN1A-2158	−	CUUGCUCUCCCCAAUCCACU	20	6007
SCNN1A-2159	−	CCUUGCUCUCCCCAAUCCACU	21	6008
SCNN1A-2160	−	CCCUUGCUCUCCCCAAUCCACU	22	6009
SCNN1A-2161	−	ACCCUUGCUCUCCCCAAUCCACU	23	6010
SCNN1A-2162	−	GACCCUUGCUCUCCCCAAUCCACU	24	6011
SCNN1A-2163	−	GUGAUGGGAGAGGGCACU	18	6012
SCNN1A-2164	−	GGUGAUGGGAGAGGGCACU	19	6013
SCNN1A-2165	−	GGGUGAUGGGAGAGGGCACU	20	6014
SCNN1A-2166	−	GGGGUGAUGGGAGAGGGCACU	21	6015
SCNN1A-2167	−	AGGGGUGAUGGGAGAGGGCACU	22	6016
SCNN1A-2168	−	CAGGGGUGAUGGGAGAGGGCACU	23	6017
SCNN1A-2169	−	CCAGGGGUGAUGGGAGAGGGCACU	24	6018
SCNN1A-10361	−	UGACCACAUUCCUGCACU	18	14210
SCNN1A-10362	−	GUGACCACAUUCCUGCACU	19	14211
SCNN1A-10363	−	AGUGACCACAUUCCUGCACU	20	14212
SCNN1A-10364	−	CAGUGACCACAUUCCUGCACU	21	14213
SCNN1A-10365	−	CCAGUGACCACAUUCCUGCACU	22	14214
SCNN1A-10366	−	GCCAGUGACCACAUUCCUGCACU	23	14215
SCNN1A-10367	−	AGCCAGUGACCACAUUCCUGCACU	24	14216
SCNN1A-10368	−	AGGUGCUUUUCAGAACCU	18	14217
SCNN1A-10369	−	GAGGUGCUUUUCAGAACCU	19	14218
SCNN1A-10370	−	GGAGGUGCUUUUCAGAACCU	20	14219
SCNN1A-10371	−	GGGAGGUGCUUUUCAGAACCU	21	14220
SCNN1A-10372	−	AGGGAGGUGCUUUUCAGAACCU	22	14221
SCNN1A-10373	−	CAGGGAGGUGCUUUUCAGAACCU	23	14222
SCNN1A-10374	−	GCAGGGAGGUGCUUUUCAGAACCU	24	14223
SCNN1A-10375	−	UAUUUUGUUUUCUAACCU	18	14224
SCNN1A-10376	−	CUAUUUUGUUUUCUAACCU	19	14225
SCNN1A-10377	−	CCUAUUUUGUUUUCUAACCU	20	14226
SCNN1A-10378	−	UCCUAUUUUGUUUUCUAACCU	21	14227
SCNN1A-10379	−	CUCCUAUUUUGUUUUCUAACCU	22	14228
SCNN1A-10380	−	GCUCCUAUUUUGUUUUCUAACCU	23	14229
SCNN1A-10381	−	UGCUCCUAUUUUGUUUUCUAACCU	24	14230
SCNN1A-10382	−	UCCCAGUUCACCUGCCCU	18	14231
SCNN1A-10383	−	CUCCCAGUUCACCUGCCCU	19	14232
SCNN1A-5736	−	ACUCCCAGUUCACCUGCCCU	20	9585
SCNN1A-10384	−	UACUCCCAGUUCACCUGCCCU	21	14233
SCNN1A-10385	−	GUACUCCCAGUUCACCUGCCCU	22	14234
SCNN1A-10386	−	AGUACUCCCAGUUCACCUGCCCU	23	14235
SCNN1A-10387	−	CAGUACUCCCAGUUCACCUGCCCU	24	14236
SCNN1A-10388	−	CUGACCUGUGGGUGCCCU	18	14237
SCNN1A-10389	−	GCUGACCUGUGGGUGCCCU	19	14238
SCNN1A-5274	−	GGCUGACCUGUGGGUGCCCU	20	9123
SCNN1A-10390	−	AGGCUGACCUGUGGGUGCCCU	21	14239
SCNN1A-10391	−	GAGGCUGACCUGUGGGUGCCCU	22	14240
SCNN1A-10392	−	UGAGGCUGACCUGUGGGUGCCCU	23	14241
SCNN1A-10393	−	GUGAGGCUGACCUGUGGGUGCCCU	24	14242
SCNN1A-10394	−	AGAAAACUGAUUUAUCCU	18	14243
SCNN1A-10395	−	CAGAAAACUGAUUUAUCCU	19	14244
SCNN1A-6181	−	UCAGAAAACUGAUUUAUCCU	20	10030
SCNN1A-10396	−	CUCAGAAAACUGAUUUAUCCU	21	14245
SCNN1A-10397	−	CCUCAGAAAACUGAUUUAUCCU	22	14246
SCNN1A-10398	−	ACCUCAGAAAACUGAUUUAUCCU	23	14247
SCNN1A-10399	−	AACCUCAGAAAACUGAUUUAUCCU	24	14248
SCNN1A-10400	−	CACUCUGGGCUGCCUCCU	18	14249
SCNN1A-10401	−	GCACUCUGGGCUGCCUCCU	19	14250
SCNN1A-10402	−	UGCACUCUGGGCUGCCUCCU	20	14251
SCNN1A-10403	−	CUGCACUCUGGGCUGCCUCCU	21	14252
SCNN1A-10404	−	CCUGCACUCUGGGCUGCCUCCU	22	14253
SCNN1A-10405	−	UCCUGCACUCUGGGCUGCCUCCU	23	14254
SCNN1A-10406	−	UUCCUGCACUCUGGGCUGCCUCCU	24	14255
SCNN1A-10407	−	UCGGGAGCCCUCCUUCCU	18	14256
SCNN1A-10408	−	CUCGGGAGCCCUCCUUCCU	19	14257
SCNN1A-10409	−	CCUCGGGAGCCCUCCUUCCU	20	14258
SCNN1A-10410	−	CCCUCGGGAGCCCUCCUUCCU	21	14259
SCNN1A-10411	−	GCCCUCGGGAGCCCUCCUUCCU	22	14260
SCNN1A-10412	−	UGCCCUCGGGAGCCCUCCUUCCU	23	14261
SCNN1A-10413	−	CUGCCCUCGGGAGCCCUCCUUCCU	24	14262
SCNN1A-10414	−	GGGCCAGAGGCUGGAGCU	18	14263
SCNN1A-10415	−	AGGGCCAGAGGCUGGAGCU	19	14264
SCNN1A-10416	−	CAGGGCCAGAGGCUGGAGCU	20	14265
SCNN1A-10417	−	UCAGGGCCAGAGGCUGGAGCU	21	14266
SCNN1A-10418	−	GUCAGGGCCAGAGGCUGGAGCU	22	14267
SCNN1A-10419	−	GGUCAGGGCCAGAGGCUGGAGCU	23	14268
SCNN1A-10420	−	AGGUCAGGGCCAGAGGCUGGAGCU	24	14269
SCNN1A-10421	−	UGUGUUGCCCUCCUAGCU	18	14270
SCNN1A-10422	−	UUGUGUUGCCCUCCUAGCU	19	14271
SCNN1A-10423	−	CUUGUGUUGCCCUCCUAGCU	20	14272
SCNN1A-10424	−	CCUUGUGUUGCCCUCCUAGCU	21	14273
SCNN1A-10425	−	UCCUUGUGUUGCCCUCCUAGCU	22	14274
SCNN1A-10426	−	CUCCUUGUGUUGCCCUCCUAGCU	23	14275
SCNN1A-10427	−	UCUCCUUGUGUUGCCCUCCUAGCU	24	14276
SCNN1A-10428	−	GGCUCUUAUGUCUUAUCU	18	14277
SCNN1A-10429	−	UGGCUCUUAUGUCUUAUCU	19	14278
SCNN1A-10430	−	UUGGCUCUUAUGUCUUAUCU	20	14279
SCNN1A-10431	−	CUUGGCUCUUAUGUCUUAUCU	21	14280
SCNN1A-10432	−	CCUUGGCUCUUAUGUCUUAUCU	22	14281
SCNN1A-10433	−	CCCUUGGCUCUUAUGUCUUAUCU	23	14282
SCNN1A-10434	−	GCCCUUGGCUCUUAUGUCUUAUCU	24	14283
SCNN1A-10435	−	CUCUUAUGUCUUAUCUCU	18	14284
SCNN1A-10436	−	GCUCUUAUGUCUUAUCUCU	19	14285
SCNN1A-10437	−	GGCUCUUAUGUCUUAUCUCU	20	14286
SCNN1A-10438	−	UGGCUCUUAUGUCUUAUCUCU	21	14287
SCNN1A-10439	−	UUGGCUCUUAUGUCUUAUCUCU	22	14288
SCNN1A-10440	−	CUUGGCUCUUAUGUCUUAUCUCU	23	14289
SCNN1A-10441	−	CCUUGGCUCUUAUGUCUUAUCUCU	24	14290
SCNN1A-10442	−	AGAGAUGACACCUUCUCU	18	14291
SCNN1A-10443	−	CAGAGAUGACACCUUCUCU	19	14292
SCNN1A-5926	−	GCAGAGAUGACACCUUCUCU	20	9775
SCNN1A-10444	−	AGCAGAGAUGACACCUUCUCU	21	14293
SCNN1A-10445	−	CAGCAGAGAUGACACCUUCUCU	22	14294
SCNN1A-10446	−	UCAGCAGAGAUGACACCUUCUCU	23	14295
SCNN1A-10447	−	UUCAGCAGAGAUGACACCUUCUCU	24	14296
SCNN1A-10448	−	UGGAGUUUCUAGGGGUCU	18	14297
SCNN1A-10449	−	CUGGAGUUUCUAGGGGUCU	19	14298
SCNN1A-10450	−	ACUGGAGUUUCUAGGGGUCU	20	14299
SCNN1A-10451	−	GACUGGAGUUUCUAGGGGUCU	21	14300
SCNN1A-10452	−	AGACUGGAGUUUCUAGGGGUCU	22	14301
SCNN1A-10453	−	GAGACUGGAGUUUCUAGGGGUCU	23	14302
SCNN1A-10454	−	GGAGACUGGAGUUUCUAGGGGUCU	24	14303
SCNN1A-10455	−	UCCCCCAUGAGUCUGUCU	18	14304
SCNN1A-10456	−	AUCCCCCAUGAGUCUGUCU	19	14305
SCNN1A-10457	−	GAUCCCCCAUGAGUCUGUCU	20	14306
SCNN1A-10458	−	CGAUCCCCCAUGAGUCUGUCU	21	14307
SCNN1A-10459	−	CCGAUCCCCCAUGAGUCUGUCU	22	14308
SCNN1A-10460	−	CCCGAUCCCCCAUGAGUCUGUCU	23	14309
SCNN1A-10461	−	CCCCGAUCCCCCAUGAGUCUGUCU	24	14310
SCNN1A-10462	−	GCAGAGAUGACACCUUCU	18	14311
SCNN1A-10463	−	AGCAGAGAUGACACCUUCU	19	14312
SCNN1A-10464	−	CAGCAGAGAUGACACCUUCU	20	14313
SCNN1A-10465	−	UCAGCAGAGAUGACACCUUCU	21	14314
SCNN1A-10466	−	UUCAGCAGAGAUGACACCUUCU	22	14315
SCNN1A-10467	−	AUUCAGCAGAGAUGACACCUUCU	23	14316
SCNN1A-10468	−	GAUUCAGCAGAGAUGACACCUUCU	24	14317
SCNN1A-10469	−	CAGAGGAGAGGCCGUUCU	18	14318
SCNN1A-10470	−	GCAGAGGAGAGGCCGUUCU	19	14319
SCNN1A-5750	−	AGCAGAGGAGAGGCCGUUCU	20	9599
SCNN1A-10471	−	AAGCAGAGGAGAGGCCGUUCU	21	14320
SCNN1A-10472	−	GAAGCAGAGGAGAGGCCGUUCU	22	14321
SCNN1A-10473	−	GGAAGCAGAGGAGAGGCCGUUCU	23	14322
SCNN1A-10474	−	GGGAAGCAGAGGAGAGGCCGUUCU	24	14323
SCNN1A-10475	−	CCUUUUGCUGCAUUAAGU	18	14324
SCNN1A-10476	−	UCCUUUUGCUGCAUUAAGU	19	14325
SCNN1A-10477	−	AUCCUUUUGCUGCAUUAAGU	20	14326
SCNN1A-10478	−	UAUCCUUUUGCUGCAUUAAGU	21	14327
SCNN1A-10479	−	UUAUCCUUUUGCUGCAUUAAGU	22	14328
SCNN1A-10480	−	CUUAUCCUUUUGCUGCAUUAAGU	23	14329
SCNN1A-10481	−	CCUUAUCCUUUUGCUGCAUUAAGU	24	14330
SCNN1A-10482	−	UGGGAUAUGUGGGGCAGU	18	14331
SCNN1A-10483	−	CUGGGAUAUGUGGGGCAGU	19	14332
SCNN1A-5753	−	UCUGGGAUAUGUGGGGCAGU	20	9602
SCNN1A-10484	−	CUCUGGGAUAUGUGGGGCAGU	21	14333
SCNN1A-10485	−	UCUCUGGGAUAUGUGGGGCAGU	22	14334
SCNN1A-10486	−	GUCUCUGGGAUAUGUGGGGCAGU	23	14335
SCNN1A-10487	−	GGUCUCUGGGAUAUGUGGGGCAGU	24	14336
SCNN1A-10488	−	GAGCUGAGGGCCUAGAGU	18	14337
SCNN1A-10489	−	GGAGCUGAGGGCCUAGAGU	19	14338
SCNN1A-10490	−	UGGAGCUGAGGGCCUAGAGU	20	14339
SCNN1A-10491	−	CUGGAGCUGAGGGCCUAGAGU	21	14340
SCNN1A-10492	−	GCUGGAGCUGAGGGCCUAGAGU	22	14341
SCNN1A-10493	−	GGCUGGAGCUGAGGGCCUAGAGU	23	14342
SCNN1A-10494	−	AGGCUGGAGCUGAGGGCCUAGAGU	24	14343
SCNN1A-10495	−	GAGGAGGGAGGGAGGAGU	18	14344
SCNN1A-10496	−	GGAGGAGGGAGGGAGGAGU	19	14345
SCNN1A-6187	−	UGGAGGAGGGAGGGAGGAGU	20	10036
SCNN1A-10497	−	GUGGAGGAGGGAGGGAGGAGU	21	14346
SCNN1A-10498	−	GGUGGAGGAGGGAGGGAGGAGU	22	14347
SCNN1A-10499	−	AGGUGGAGGAGGGAGGGAGGAGU	23	14348
SCNN1A-10500	−	AAGGUGGAGGAGGGAGGGAGGAGU	24	14349
SCNN1A-10501	−	GGCAGAUAGAGAGGGAGU	18	14350
SCNN1A-10502	−	AGGCAGAUAGAGAGGGAGU	19	14351
SCNN1A-10503	−	AAGGCAGAUAGAGAGGGAGU	20	14352
SCNN1A-10504	−	GAAGGCAGAUAGAGAGGGAGU	21	14353
SCNN1A-10505	−	AGAAGGCAGAUAGAGAGGGAGU	22	14354
SCNN1A-10506	−	CAGAAGGCAGAUAGAGAGGGAGU	23	14355
SCNN1A-10507	−	ACAGAAGGCAGAUAGAGAGGGAGU	24	14356
SCNN1A-10508	−	CAGCCGCAACCUGGGAGU	18	14357
SCNN1A-10509	−	CCAGCCGCAACCUGGGAGU	19	14358
SCNN1A-5754	−	UCCAGCCGCAACCUGGGAGU	20	9603
SCNN1A-10510	−	GUCCAGCCGCAACCUGGGAGU	21	14359
SCNN1A-10511	−	AGUCCAGCCGCAACCUGGGAGU	22	14360
SCNN1A-10512	−	CAGUCCAGCCGCAACCUGGGAGU	23	14361
SCNN1A-10513	−	CCAGUCCAGCCGCAACCUGGGAGU	24	14362
SCNN1A-10514	−	CGGGCUCUGUGUGGGAGU	18	14363
SCNN1A-10515	−	ACGGGCUCUGUGUGGGAGU	19	14364
SCNN1A-10516	−	CACGGGCUCUGUGUGGGAGU	20	14365
SCNN1A-10517	−	CCACGGGCUCUGUGUGGGAGU	21	14366
SCNN1A-10518	−	UCCACGGGCUCUGUGUGGGAGU	22	14367
SCNN1A-10519	−	AUCCACGGGCUCUGUGUGGGAGU	23	14368
SCNN1A-10520	−	AAUCCACGGGCUCUGUGUGGGAGU	24	14369
SCNN1A-10521	−	GCCUCCUGUGGGGCCCGU	18	14370
SCNN1A-10522	−	UGCCUCCUGUGGGGCCCGU	19	14371
SCNN1A-10523	−	CUGCCUCCUGUGGGGCCCGU	20	14372
SCNN1A-10524	−	GCUGCCUCCUGUGGGGCCCGU	21	14373
SCNN1A-10525	−	GGCUGCCUCCUGUGGGGCCCGU	22	14374
SCNN1A-10526	−	GGGCUGCCUCCUGUGGGGCCCGU	23	14375
SCNN1A-10527	−	UGGGCUGCCUCCUGUGGGGCCCGU	24	14376
SCNN1A-10528	−	CCCGGGUCUGGACAAGGU	18	14377
SCNN1A-10529	−	UCCCGGGUCUGGACAAGGU	19	14378
SCNN1A-5755	−	CUCCCGGGUCUGGACAAGGU	20	9604
SCNN1A-10530	−	CCUCCCGGGUCUGGACAAGGU	21	14379
SCNN1A-10531	−	CCCUCCCGGGUCUGGACAAGGU	22	14380
SCNN1A-10532	−	CCCCUCCCGGGUCUGGACAAGGU	23	14381
SCNN1A-10533	−	GCCCCUCCCGGGUCUGGACAAGGU	24	14382
SCNN1A-10534	−	CCGCUGCACCUGUCAGGU	18	14383
SCNN1A-10535	−	GCCGCUGCACCUGUCAGGU	19	14384
SCNN1A-10536	−	GGCCGCUGCACCUGUCAGGU	20	14385
SCNN1A-10537	−	AGGCCGCUGCACCUGUCAGGU	21	14386
SCNN1A-10538	−	CAGGCCGCUGCACCUGUCAGGU	22	14387
SCNN1A-10539	−	CCAGGCCGCUGCACCUGUCAGGU	23	14388
SCNN1A-10540	−	GCCAGGCCGCUGCACCUGUCAGGU	24	14389
SCNN1A-10541	−	CAGGACACAGCUCGAGGU	18	14390
SCNN1A-10542	−	UCAGGACACAGCUCGAGGU	19	14391
SCNN1A-10543	−	AUCAGGACACAGCUCGAGGU	20	14392
SCNN1A-10544	−	AAUCAGGACACAGCUCGAGGU	21	14393
SCNN1A-10545	−	GAAUCAGGACACAGCUCGAGGU	22	14394
SCNN1A-10546	−	AGAAUCAGGACACAGCUCGAGGU	23	14395
SCNN1A-10547	−	CAGAAUCAGGACACAGCUCGAGGU	24	14396
SCNN1A-10548	−	CCUGGGCCCCUCCCGGGU	18	14397
SCNN1A-10549	−	ACCUGGGCCCCUCCCGGGU	19	14398
SCNN1A-10550	−	CACCUGGGCCCCUCCCGGGU	20	14399
SCNN1A-10551	−	UCACCUGGGCCCCUCCCGGGU	21	14400
SCNN1A-10552	−	UUCACCUGGGCCCCUCCCGGGU	22	14401
SCNN1A-10553	−	CUUCACCUGGGCCCCUCCCGGGU	23	14402
SCNN1A-10554	−	GCUUCACCUGGGCCCCUCCCGGGU	24	14403
SCNN1A-2176	−	UAAGCAAGGGAACCUGGU	18	6025
SCNN1A-2177	−	GUAAGCAAGGGAACCUGGU	19	6026
SCNN1A-2178	−	GGUAAGCAAGGGAACCUGGU	20	6027
SCNN1A-2179	−	AGGUAAGCAAGGGAACCUGGU	21	6028
SCNN1A-2180	−	AAGGUAAGCAAGGGAACCUGGU	22	6029
SCNN1A-2181	−	CAAGGUAAGCAAGGGAACCUGGU	23	6030
SCNN1A-2182	−	UCAAGGUAAGCAAGGGAACCUGGU	24	6031
SCNN1A-10555	−	GAGGACCAUGCCCAAUGU	18	14404
SCNN1A-10556	−	GGAGGACCAUGCCCAAUGU	19	14405
SCNN1A-10557	−	GGGAGGACCAUGCCCAAUGU	20	14406
SCNN1A-10558	−	AGGGAGGACCAUGCCCAAUGU	21	14407
SCNN1A-10559	−	CAGGGAGGACCAUGCCCAAUGU	22	14408
SCNN1A-10560	−	GCAGGGAGGACCAUGCCCAAUGU	23	14409
SCNN1A-10561	−	UGCAGGGAGGACCAUGCCCAAUGU	24	14410
SCNN1A-10562	−	CGAAUCCACGGGCUCUGU	18	14411
SCNN1A-10563	−	ACGAAUCCACGGGCUCUGU	19	14412
SCNN1A-10564	−	GACGAAUCCACGGGCUCUGU	20	14413
SCNN1A-10565	−	AGACGAAUCCACGGGCUCUGU	21	14414
SCNN1A-10566	−	CAGACGAAUCCACGGGCUCUGU	22	14415
SCNN1A-10567	−	GCAGACGAAUCCACGGGCUCUGU	23	14416
SCNN1A-10568	−	AGCAGACGAAUCCACGGGCUCUGU	24	14417
SCNN1A-10569	−	UGAGAUCUGCACUUUUGU	18	14418
SCNN1A-10570	−	CUGAGAUCUGCACUUUUGU	19	14419
SCNN1A-10571	−	UCUGAGAUCUGCACUUUUGU	20	14420
SCNN1A-10572	−	AUCUGAGAUCUGCACUUUUGU	21	14421
SCNN1A-10573	−	AAUCUGAGAUCUGCACUUUUGU	22	14422
SCNN1A-10574	−	AAAUCUGAGAUCUGCACUUUUGU	23	14423
SCNN1A-10575	−	GAAAUCUGAGAUCUGCACUUUUGU	24	14424
SCNN1A-10576	−	UAAGUUUGGAAAGAGAUU	18	14425
SCNN1A-10577	−	UUAAGUUUGGAAAGAGAUU	19	14426
SCNN1A-10578	−	AUUAAGUUUGGAAAGAGAUU	20	14427
SCNN1A-10579	−	CAUUAAGUUUGGAAAGAGAUU	21	14428
SCNN1A-10580	−	GCAUUAAGUUUGGAAAGAGAUU	22	14429
SCNN1A-10581	−	UGCAUUAAGUUUGGAAAGAGAUU	23	14430
SCNN1A-10582	−	CUGCAUUAAGUUUGGAAAGAGAUU	24	14431
SCNN1A-10583	−	GAAAACUGAUUUAUCCUU	18	14432
SCNN1A-10584	−	AGAAAACUGAUUUAUCCUU	19	14433
SCNN1A-6189	−	CAGAAAACUGAUUUAUCCUU	20	10038
SCNN1A-10585	−	UCAGAAAACUGAUUUAUCCUU	21	14434
SCNN1A-10586	−	CUCAGAAAACUGAUUUAUCCUU	22	14435
SCNN1A-10587	−	CCUCAGAAAACUGAUUUAUCCUU	23	14436
SCNN1A-10588	−	ACCUCAGAAAACUGAUUUAUCCUU	24	14437
SCNN1A-10589	−	CGGGAGCCCUCCUUCCUU	18	14438
SCNN1A-10590	−	UCGGGAGCCCUCCUUCCUU	19	14439
SCNN1A-5770	−	CUCGGGAGCCCUCCUUCCUU	20	9619
SCNN1A-10591	−	CCUCGGGAGCCCUCCUUCCUU	21	14440
SCNN1A-10592	−	CCCUCGGGAGCCCUCCUUCCUU	22	14441
SCNN1A-10593	−	GCCCUCGGGAGCCCUCCUUCCUU	23	14442
SCNN1A-10594	−	UGCCCUCGGGAGCCCUCCUUCCUU	24	14443
SCNN1A-10595	−	GCCUUUGUCUGCUGGCUU	18	14444
SCNN1A-10596	−	GGCCUUUGUCUGCUGGCUU	19	14445
SCNN1A-10597	−	GGGCCUUUGUCUGCUGGCUU	20	14446
SCNN1A-10598	−	UGGGCCUUUGUCUGCUGGCUU	21	14447
SCNN1A-10599	−	CUGGGCCUUUGUCUGCUGGCUU	22	14448
SCNN1A-10600	−	GCUGGGCCUUUGUCUGCUGGCUU	23	14449
SCNN1A-10601	−	GGCUGGGCCUUUGUCUGCUGGCUU	24	14450
SCNN1A-10602	−	CUUUUGCUGCAUUAAGUU	18	14451
SCNN1A-10603	−	CCUUUUGCUGCAUUAAGUU	19	14452
SCNN1A-5771	−	UCCUUUUGCUGCAUUAAGUU	20	9620
SCNN1A-10604	−	AUCCUUUUGCUGCAUUAAGUU	21	14453
SCNN1A-10605	−	UAUCCUUUUGCUGCAUUAAGUU	22	14454
SCNN1A-10606	−	UUAUCCUUUUGCUGCAUUAAGUU	23	14455
SCNN1A-10607	−	CUUAUCCUUUUGCUGCAUUAAGUU	24	14456
SCNN1A-10608	−	AAGUUUGGAAAGAGAUUU	18	14457
SCNN1A-10609	−	UAAGUUUGGAAAGAGAUUU	19	14458
SCNN1A-5773	−	UUAAGUUUGGAAAGAGAUUU	20	9622
SCNN1A-10610	−	AUUAAGUUUGGAAAGAGAUUU	21	14459
SCNN1A-10611	−	CAUUAAGUUUGGAAAGAGAUUU	22	14460
SCNN1A-10612	−	GCAUUAAGUUUGGAAAGAGAUUU	23	14461
SCNN1A-10613	−	UGCAUUAAGUUUGGAAAGAGAUUU	24	14462
SCNN1A-10614	−	GACACCGGCUUUCACUUU	18	14463
SCNN1A-10615	−	UGACACCGGCUUUCACUUU	19	14464
SCNN1A-10616	−	UUGACACCGGCUUUCACUUU	20	14465
SCNN1A-10617	−	GUUGACACCGGCUUUCACUUU	21	14466
SCNN1A-10618	−	GGUUGACACCGGCUUUCACUUU	22	14467
SCNN1A-10619	−	UGGUUGACACCGGCUUUCACUUU	23	14468
SCNN1A-10620	−	CUGGUUGACACCGGCUUUCACUUU	24	14469
SCNN1A-10621	−	AGGCAGGGAGGUGCUUUU	18	14470
SCNN1A-10622	−	AAGGCAGGGAGGUGCUUUU	19	14471
SCNN1A-10623	−	AAAGGCAGGGAGGUGCUUUU	20	14472
SCNN1A-10624	−	AAAAGGCAGGGAGGUGCUUUU	21	14473
SCNN1A-10625	−	GAAAAGGCAGGGAGGUGCUUUU	22	14474
SCNN1A-10626	−	AGAAAAGGCAGGGAGGUGCUUUU	23	14475
SCNN1A-10627	−	UAGAAAAGGCAGGGAGGUGCUUUU	24	14476

Table 47E provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the fifth tier parameters. The targeting domains bind within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS, starts with a 5′G and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through co Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene mplementary base pairing. Any of the targeting domains in the Table can be used with a S. aureus Cas9 molecule that generates a double stranded break (Cas9 nuclease) or a single-stranded break (Cas9 nickase).

TABLE 47E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-10628	+	GCCUGGUCUGGGCUGAGCCA	20	14477
SCNN1A-1302	+	GGUUGAUGUUGAGGCUGA	18	5151
SCNN1A-42	+	GAGGUUGAUGUUGAGGCUGA	20	519
SCNN1A-1303	+	GUUGAGGUUGAUGUUGAGGCUGA	23	5152
SCNN1A-10629	+	GUGAGCUCUACCUGGGAC	18	14478
SCNN1A-10630	+	GCAGUGAGCUCUACCUGGGAC	21	14479
SCNN1A-1417	+	GUUCCCCUUCAUGAGCCC	18	5266
SCNN1A-1420	+	GCUUGUUCCCCUUCAUGAGCCC	22	5269
SCNN1A-1427	+	GCACACCAGGCGGAUGGCGCC	21	5276
SCNN1A-1429	+	GAGCACACCAGGCGGAUGGCGCC	23	5278
SCNN1A-1430	+	GGAGCACACCAGGCGGAUGGCGCC	24	5279
SCNN1A-10631	+	GAUCAUGCACUAUCCUCUAGGC	22	14480
SCNN1A-10632	+	GGAUCAUGCACUAUCCUCUAGGC	23	14481
SCNN1A-1316	+	GUGCUGGGAGCACACCAG	18	5165
SCNN1A-1317	+	GUUGUGCUGGGAGCACACCAG	21	5166
SCNN1A-1318	+	GGUUGUGCUGGGAGCACACCAG	22	5167
SCNN1A-1319	+	GCGGUUGUGCUGGGAGCACACCAG	24	5168
SCNN1A-1320	+	GUACUCUCCGAAAAGCAGG	19	5169
SCNN1A-1321	+	GAAGUACUCUCCGAAAAGCAGG	22	5170
SCNN1A-10633	+	GUGACCCUGCCACGUCCUG	19	14482
SCNN1A-10634	+	GGUGACCCUGCCACGUCCUG	20	14483
SCNN1A-10635	+	GUGGUGACCCUGCCACGUCCUG	22	14484
SCNN1A-10636	+	GGUGGUGACCCUGCCACGUCCUG	23	14485
SCNN1A-10637	+	GGGUGGUGACCCUGCCACGUCCUG	24	14486
SCNN1A-10638	+	GCCACGUCCUGCCGGGUAU	19	14487
SCNN1A-1326	+	GAGGGACUAACCGACCUGU	19	5175
SCNN1A-1327	+	GCAGAGGGACUAACCGACCUGU	22	5176
SCNN1A-1328	+	GGCAGAGGGACUAACCGACCUGU	23	5177
SCNN1A-1329	+	GGGCAGAGGGACUAACCGACCUGU	24	5178
SCNN1A-1330	+	GCGGGGAAGACGAGCUUGU	19	5179
SCNN1A-1331	+	GACUAACCGACCUGUAGGGAUU	22	5180
SCNN1A-1332	+	GGACUAACCGACCUGUAGGGAUU	23	5181
SCNN1A-1333	+	GGGACUAACCGACCUGUAGGGAUU	24	5182
SCNN1A-1334	−	GCGGAGGAGGAGGCCCUGA	19	5183
SCNN1A-189	−	GGCGGAGGAGGAGGCCCUGA	20	819
SCNN1A-10639	−	GCUGCUGUACUCCAGCCUA	19	14488
SCNN1A-10640	−	GUUCUAGCCCGCUCCAGGUC	20	14489
SCNN1A-10641	−	GCCUGUUCUAGCCCGCUCCAGGUC	24	14490
SCNN1A-10642	−	GCGCCUGGAAGGGUGGUC	18	14491
SCNN1A-10643	−	GCCUGCGCCUGGAAGGGUGGUC	22	14492
SCNN1A-10644	−	GUGCCUGCGCCUGGAAGGGUGGUC	24	14493
SCNN1A-197	−	GCAAUUCGGCCUGCUUUUCG	20	826
SCNN1A-1337	−	GGCAAUUCGGCCUGCUUUUCG	21	5186
SCNN1A-10645	−	GCAGGCAGAGCCUCAGACCU	20	14494
SCNN1A-10646	−	GGCAGGCAGAGCCUCAGACCU	21	14495
SCNN1A-10647	−	GGGCAGGCAGAGCCUCAGACCU	22	14496
SCNN1A-1338	−	GCUCCUACCGAGAGCUCU	18	5187

Table 47F provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the six tier parameters. The targeting domains bind within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS and PAM is NNGRRT. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 47F
6th Tier
			Target
	DNA		Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-10648	+	CUGGUCUGGGCUGAGCCA	18	14497
SCNN1A-10649	+	CCUGGUCUGGGCUGAGCCA	19	14498
SCNN1A-10650	+	UGCCUGGUCUGGGCUGAGCCA	21	14499
SCNN1A-10651	+	AUGCCUGGUCUGGGCUGAGCCA	22	14500
SCNN1A-10652	+	AAUGCCUGGUCUGGGCUGAGCCA	23	14501
SCNN1A-10653	+	CAAUGCCUGGUCUGGGCUGAGCCA	24	14502
SCNN1A-10654	+	UCUUAUUUAUCUUAGAGA	18	14503
SCNN1A-10655	+	UUCUUAUUUAUCUUAGAGA	19	14504
SCNN1A-10656	+	UUUCUUAUUUAUCUUAGAGA	20	14505
SCNN1A-10657	+	UUUUCUUAUUUAUCUUAGAGA	21	14506
SCNN1A-10658	+	AUUUUCUUAUUUAUCUUAGAGA	22	14507
SCNN1A-10659	+	UAUUUUCUUAUUUAUCUUAGAGA	23	14508
SCNN1A-10660	+	UUAUUUUCUUAUUUAUCUUAGAGA	24	14509
SCNN1A-1340	+	AGGUUGAUGUUGAGGCUGA	19	5189
SCNN1A-1341	+	UGAGGUUGAUGUUGAGGCUGA	21	5190
SCNN1A-1342	+	UUGAGGUUGAUGUUGAGGCUGA	22	5191
SCNN1A-1343	+	AGUUGAGGUUGAUGUUGAGGCUGA	24	5192
SCNN1A-10661	+	AGUGAGCUCUACCUGGGAC	19	14510
SCNN1A-6306	+	CAGUGAGCUCUACCUGGGAC	20	10155
SCNN1A-10662	+	AGCAGUGAGCUCUACCUGGGAC	22	14511
SCNN1A-10663	+	CAGCAGUGAGCUCUACCUGGGAC	23	14512
SCNN1A-10664	+	CCAGCAGUGAGCUCUACCUGGGAC	24	14513
SCNN1A-1418	+	UGUUCCCCUUCAUGAGCCC	19	5267
SCNN1A-72	+	UUGUUCCCCUUCAUGAGCCC	20	599
SCNN1A-1419	+	CUUGUUCCCCUUCAUGAGCCC	21	5268
SCNN1A-1423	+	CGCUUGUUCCCCUUCAUGAGCCC	23	5272
SCNN1A-1424	+	ACGCUUGUUCCCCUUCAUGAGCCC	24	5273
SCNN1A-1425	+	CACCAGGCGGAUGGCGCC	18	5274
SCNN1A-1426	+	ACACCAGGCGGAUGGCGCC	19	5275
SCNN1A-223	+	CACACCAGGCGGAUGGCGCC	20	846
SCNN1A-1428	+	AGCACACCAGGCGGAUGGCGCC	22	5277
SCNN1A-10665	+	AUGCACUAUCCUCUAGGC	18	14514
SCNN1A-10666	+	CAUGCACUAUCCUCUAGGC	19	14515
SCNN1A-6323	+	UCAUGCACUAUCCUCUAGGC	20	10172
SCNN1A-10667	+	AUCAUGCACUAUCCUCUAGGC	21	14516
SCNN1A-10668	+	AGGAUCAUGCACUAUCCUCUAGGC	24	14517
SCNN1A-1371	+	UGUGCUGGGAGCACACCAG	19	5220
SCNN1A-224	+	UUGUGCUGGGAGCACACCAG	20	847
SCNN1A-1372	+	CGGUUGUGCUGGGAGCACACCAG	23	5221
SCNN1A-1373	+	UACUCUCCGAAAAGCAGG	18	5222
SCNN1A-230	+	AGUACUCUCCGAAAAGCAGG	20	851
SCNN1A-1374	+	AAGUACUCUCCGAAAAGCAGG	21	5223
SCNN1A-1375	+	UGAAGUACUCUCCGAAAAGCAGG	23	5224
SCNN1A-1376	+	CUGAAGUACUCUCCGAAAAGCAGG	24	5225
SCNN1A-10669	+	UGACCCUGCCACGUCCUG	18	14518
SCNN1A-10670	+	UGGUGACCCUGCCACGUCCUG	21	14519
SCNN1A-10671	+	CCACGUCCUGCCGGGUAU	18	14520
SCNN1A-6350	+	UGCCACGUCCUGCCGGGUAU	20	10199
SCNN1A-10672	+	CUGCCACGUCCUGCCGGGUAU	21	14521
SCNN1A-10673	+	CCUGCCACGUCCUGCCGGGUAU	22	14522
SCNN1A-10674	+	CCCUGCCACGUCCUGCCGGGUAU	23	14523
SCNN1A-10675	+	ACCCUGCCACGUCCUGCCGGGUAU	24	14524
SCNN1A-1380	+	AGGGACUAACCGACCUGU	18	5229
SCNN1A-424	+	AGAGGGACUAACCGACCUGU	20	4273
SCNN1A-1381	+	CAGAGGGACUAACCGACCUGU	21	5230
SCNN1A-1382	+	CGGGGAAGACGAGCUUGU	18	5231
SCNN1A-237	+	UGCGGGGAAGACGAGCUUGU	20	857
SCNN1A-1383	+	CUGCGGGGAAGACGAGCUUGU	21	5232
SCNN1A-1384	+	ACUGCGGGGAAGACGAGCUUGU	22	5233
SCNN1A-1385	+	CACUGCGGGGAAGACGAGCUUGU	23	5234
SCNN1A-1386	+	UCACUGCGGGGAAGACGAGCUUGU	24	5235
SCNN1A-1387	+	AACCGACCUGUAGGGAUU	18	5236
SCNN1A-1388	+	UAACCGACCUGUAGGGAUU	19	5237
SCNN1A-1389	+	CUAACCGACCUGUAGGGAUU	20	5238
SCNN1A-1390	+	ACUAACCGACCUGUAGGGAUU	21	5239
SCNN1A-1391	−	CGGAGGAGGAGGCCCUGA	18	5240
SCNN1A-1433	−	CGGCGGAGGAGGAGGCCCUGA	21	5282
SCNN1A-1434	−	ACGGCGGAGGAGGAGGCCCUGA	22	5283
SCNN1A-1435	−	CACGGCGGAGGAGGAGGCCCUGA	23	5284
SCNN1A-1436	−	CCACGGCGGAGGAGGAGGCCCUGA	24	5285
SCNN1A-10676	−	CUGCUGUACUCCAGCCUA	18	14525
SCNN1A-10677	−	UGCUGCUGUACUCCAGCCUA	20	14526
SCNN1A-10678	−	AUGCUGCUGUACUCCAGCCUA	21	14527
SCNN1A-10679	−	CAUGCUGCUGUACUCCAGCCUA	22	14528
SCNN1A-10680	−	UCAUGCUGCUGUACUCCAGCCUA	23	14529
SCNN1A-10681	−	AUCAUGCUGCUGUACUCCAGCCUA	24	14530
SCNN1A-10682	−	UCUAGCCCGCUCCAGGUC	18	14531
SCNN1A-10683	−	UUCUAGCCCGCUCCAGGUC	19	14532
SCNN1A-10684	−	UGUUCUAGCCCGCUCCAGGUC	21	14533
SCNN1A-10685	−	CUGUUCUAGCCCGCUCCAGGUC	22	14534
SCNN1A-10686	−	CCUGUUCUAGCCCGCUCCAGGUC	23	14535
SCNN1A-10687	−	UGCGCCUGGAAGGGUGGUC	19	14536
SCNN1A-10688	−	CUGCGCCUGGAAGGGUGGUC	20	14537
SCNN1A-10689	−	CCUGCGCCUGGAAGGGUGGUC	21	14538
SCNN1A-10690	−	UGCCUGCGCCUGGAAGGGUGGUC	23	14539
SCNN1A-1395	−	AAUUCGGCCUGCUUUUCG	18	5244
SCNN1A-1396	−	CAAUUCGGCCUGCUUUUCG	19	5245
SCNN1A-1397	−	UGGCAAUUCGGCCUGCUUUUCG	22	5246
SCNN1A-1398	−	CUGGCAAUUCGGCCUGCUUUUCG	23	5247
SCNN1A-1399	−	ACUGGCAAUUCGGCCUGCUUUUCG	24	5248
SCNN1A-10691	−	CCUGGUGCCUGCGCCUGG	18	14540
SCNN1A-10692	−	CCCUGGUGCCUGCGCCUGG	19	14541
SCNN1A-10693	−	UCCCUGGUGCCUGCGCCUGG	20	14542
SCNN1A-10694	−	UUCCCUGGUGCCUGCGCCUGG	21	14543
SCNN1A-10695	−	CUUCCCUGGUGCCUGCGCCUGG	22	14544
SCNN1A-10696	−	CCUUCCCUGGUGCCUGCGCCUGG	23	14545
SCNN1A-10697	−	CCCUUCCCUGGUGCCUGCGCCUGG	24	14546
SCNN1A-10698	−	AUACCCGGCAGGACGUGG	18	14547
SCNN1A-10699	−	CAUACCCGGCAGGACGUGG	19	14548
SCNN1A-10700	−	CCAUACCCGGCAGGACGUGG	20	14549
SCNN1A-10701	−	CCCAUACCCGGCAGGACGUGG	21	14550
SCNN1A-10702	−	UCCCAUACCCGGCAGGACGUGG	22	14551
SCNN1A-10703	−	CUCCCAUACCCGGCAGGACGUGG	23	14552
SCNN1A-10704	−	ACUCCCAUACCCGGCAGGACGUGG	24	14553
SCNN1A-10705	−	AGGCAGAGCCUCAGACCU	18	14554
SCNN1A-10706	−	CAGGCAGAGCCUCAGACCU	19	14555
SCNN1A-10707	−	UGGGCAGGCAGAGCCUCAGACCU	23	14556
SCNN1A-10708	−	CUGGGCAGGCAGAGCCUCAGACCU	24	14557
SCNN1A-1400	−	CGCUCCUACCGAGAGCUCU	19	5249
SCNN1A-192	−	CCGCUCCUACCGAGAGCUCU	20	822
SCNN1A-1401	−	ACCGCUCCUACCGAGAGCUCU	21	5250
SCNN1A-1402	−	CACCGCUCCUACCGAGAGCUCU	22	5251
SCNN1A-1403	−	CCACCGCUCCUACCGAGAGCUCU	23	5252
SCNN1A-1404	−	UCCACCGCUCCUACCGAGAGCUCU	24	5253

Table 47G provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the seven tier parameters. The targeting domains bind within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS and PAM is NNGRRV. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a S. aureus eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 47G
7th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-10709	+	UUGGUGUUGUGAGGAAAA	18	14558
SCNN1A-10710	+	CUUGGUGUUGUGAGGAAAA	19	14559
SCNN1A-10711	+	GCUUGGUGUUGUGAGGAAAA	20	14560
SCNN1A-10712	+	GGCUUGGUGUUGUGAGGAAAA	21	14561
SCNN1A-10713	+	AGGCUUGGUGUUGUGAGGAAAA	22	14562
SCNN1A-10714	+	CAGGCUUGGUGUUGUGAGGAAAA	23	14563
SCNN1A-10715	+	ACAGGCUUGGUGUUGUGAGGAAAA	24	14564
SCNN1A-10716	+	UUCCUUUCCCUCCCCAAA	18	14565
SCNN1A-10717	+	CUUCCUUUCCCUCCCCAAA	19	14566
SCNN1A-6279	+	CCUUCCUUUCCCUCCCCAAA	20	10128
SCNN1A-10718	+	CCCUUCCUUUCCCUCCCCAAA	21	14567
SCNN1A-10719	+	CCCCUUCCUUUCCCUCCCCAAA	22	14568
SCNN1A-10720	+	UCCCCUUCCUUUCCCUCCCCAAA	23	14569
SCNN1A-10721	+	GUCCCCUUCCUUUCCCUCCCCAAA	24	14570
SCNN1A-10722	+	CUUCCUUUCCCUCCCCAA	18	14571
SCNN1A-10723	+	CCUUCCUUUCCCUCCCCAA	19	14572
SCNN1A-6281	+	CCCUUCCUUUCCCUCCCCAA	20	10130
SCNN1A-10724	+	CCCCUUCCUUUCCCUCCCCAA	21	14573
SCNN1A-10725	+	UCCCCUUCCUUUCCCUCCCCAA	22	14574
SCNN1A-10726	+	GUCCCCUUCCUUUCCCUCCCCAA	23	14575
SCNN1A-10727	+	AGUCCCCUUCCUUUCCCUCCCCAA	24	14576
SCNN1A-10728	+	UUCCAGGCGCAGGCACCA	18	14577
SCNN1A-10729	+	CUUCCAGGCGCAGGCACCA	19	14578
SCNN1A-6290	+	CCUUCCAGGCGCAGGCACCA	20	10139
SCNN1A-10730	+	CCCUUCCAGGCGCAGGCACCA	21	14579
SCNN1A-10731	+	ACCCUUCCAGGCGCAGGCACCA	22	14580
SCNN1A-10732	+	CACCCUUCCAGGCGCAGGCACCA	23	14581
SCNN1A-10733	+	CCACCCUUCCAGGCGCAGGCACCA	24	14582
SCNN1A-10734	+	CCUUCCUUUCCCUCCCCA	18	14583
SCNN1A-10735	+	CCCUUCCUUUCCCUCCCCA	19	14584
SCNN1A-10736	+	CCCCUUCCUUUCCCUCCCCA	20	14585
SCNN1A-10737	+	UCCCCUUCCUUUCCCUCCCCA	21	14586
SCNN1A-10738	+	GUCCCCUUCCUUUCCCUCCCCA	22	14587
SCNN1A-10739	+	AGUCCCCUUCCUUUCCCUCCCCA	23	14588
SCNN1A-10740	+	UAGUCCCCUUCCUUUCCCUCCCCA	24	14589
SCNN1A-10741	+	UGAGGCUCUGCCUGCCCA	18	14590
SCNN1A-10742	+	CUGAGGCUCUGCCUGCCCA	19	14591
SCNN1A-10743	+	UCUGAGGCUCUGCCUGCCCA	20	14592
SCNN1A-10744	+	GUCUGAGGCUCUGCCUGCCCA	21	14593
SCNN1A-10745	+	GGUCUGAGGCUCUGCCUGCCCA	22	14594
SCNN1A-10746	+	AGGUCUGAGGCUCUGCCUGCCCA	23	14595
SCNN1A-10747	+	CAGGUCUGAGGCUCUGCCUGCCCA	24	14596
SCNN1A-10748	+	GGCACCAGGGAAGGGGCA	18	14597
SCNN1A-10749	+	AGGCACCAGGGAAGGGGCA	19	14598
SCNN1A-10750	+	CAGGCACCAGGGAAGGGGCA	20	14599
SCNN1A-10751	+	GCAGGCACCAGGGAAGGGGCA	21	14600
SCNN1A-10752	+	CGCAGGCACCAGGGAAGGGGCA	22	14601
SCNN1A-10753	+	GCGCAGGCACCAGGGAAGGGGCA	23	14602
SCNN1A-10754	+	GGCGCAGGCACCAGGGAAGGGGCA	24	14603
SCNN1A-10755	+	AGGCGCAGGCACCAGGGA	18	14604
SCNN1A-10756	+	CAGGCGCAGGCACCAGGGA	19	14605
SCNN1A-6296	+	CCAGGCGCAGGCACCAGGGA	20	10145
SCNN1A-10757	+	UCCAGGCGCAGGCACCAGGGA	21	14606
SCNN1A-10758	+	UUCCAGGCGCAGGCACCAGGGA	22	14607
SCNN1A-10759	+	CUUCCAGGCGCAGGCACCAGGGA	23	14608
SCNN1A-10760	+	CCUUCCAGGCGCAGGCACCAGGGA	24	14609
SCNN1A-1452	+	CUAACCGACCUGUAGGGA	18	5301
SCNN1A-1453	+	ACUAACCGACCUGUAGGGA	19	5302
SCNN1A-1454	+	GACUAACCGACCUGUAGGGA	20	5303
SCNN1A-1455	+	GGACUAACCGACCUGUAGGGA	21	5304
SCNN1A-1456	+	GGGACUAACCGACCUGUAGGGA	22	5305
SCNN1A-1457	+	AGGGACUAACCGACCUGUAGGGA	23	5306
SCNN1A-1458	+	GAGGGACUAACCGACCUGUAGGGA	24	5307
SCNN1A-10761	+	AGUGAGCUCUACCUGGGA	18	14610
SCNN1A-10762	+	CAGUGAGCUCUACCUGGGA	19	14611
SCNN1A-10763	+	GCAGUGAGCUCUACCUGGGA	20	14612
SCNN1A-10764	+	AGCAGUGAGCUCUACCUGGGA	21	14613
SCNN1A-10765	+	CAGCAGUGAGCUCUACCUGGGA	22	14614
SCNN1A-10766	+	CCAGCAGUGAGCUCUACCUGGGA	23	14615
SCNN1A-10767	+	GCCAGCAGUGAGCUCUACCUGGGA	24	14616
SCNN1A-10768	+	CAGCAUUCUAGACCUGGA	18	14617
SCNN1A-10769	+	GCAGCAUUCUAGACCUGGA	19	14618
SCNN1A-10770	+	UGCAGCAUUCUAGACCUGGA	20	14619
SCNN1A-10771	+	CUGCAGCAUUCUAGACCUGGA	21	14620
SCNN1A-10772	+	GCUGCAGCAUUCUAGACCUGGA	22	14621
SCNN1A-10773	+	UGCUGCAGCAUUCUAGACCUGGA	23	14622
SCNN1A-10774	+	GUGCUGCAGCAUUCUAGACCUGGA	24	14623
SCNN1A-1459	+	CCCUUCAUGAGCCCUGGA	18	5308
SCNN1A-1460	+	CCCCUUCAUGAGCCCUGGA	19	5309
SCNN1A-205	+	UCCCCUUCAUGAGCCCUGGA	20	833
SCNN1A-1461	+	UUCCCCUUCAUGAGCCCUGGA	21	5310
SCNN1A-1462	+	GUUCCCCUUCAUGAGCCCUGGA	22	5311
SCNN1A-1463	+	UGUUCCCCUUCAUGAGCCCUGGA	23	5312
SCNN1A-1464	+	UUGUUCCCCUUCAUGAGCCCUGGA	24	5313
SCNN1A-10775	+	UAUAGUUCUUUUUUAUGA	18	14624
SCNN1A-10776	+	AUAUAGUUCUUUUUUAUGA	19	14625
SCNN1A-10777	+	UAUAUAGUUCUUUUUUAUGA	20	14626
SCNN1A-10778	+	AUAUAUAGUUCUUUUUUAUGA	21	14627
SCNN1A-10779	+	AAUAUAUAGUUCUUUUUUAUGA	22	14628
SCNN1A-10780	+	AAAUAUAUAGUUCUUUUUUAUGA	23	14629
SCNN1A-10781	+	AAAAUAUAUAGUUCUUUUUUAUGA	24	14630
SCNN1A-10782	+	UACAAUUUUUCAGCAAUA	18	14631
SCNN1A-10783	+	GUACAAUUUUUCAGCAAUA	19	14632
SCNN1A-10784	+	AGUACAAUUUUUCAGCAAUA	20	14633
SCNN1A-10785	+	CAGUACAAUUUUUCAGCAAUA	21	14634
SCNN1A-10786	+	ACAGUACAAUUUUUCAGCAAUA	22	14635
SCNN1A-10787	+	CACAGUACAAUUUUUCAGCAAUA	23	14636
SCNN1A-10788	+	UCACAGUACAAUUUUUCAGCAAUA	24	14637
SCNN1A-10789	+	CAGCAAUACAGAAGUAUA	18	14638
SCNN1A-10790	+	UCAGCAAUACAGAAGUAUA	19	14639
SCNN1A-10791	+	UUCAGCAAUACAGAAGUAUA	20	14640
SCNN1A-10792	+	UUUCAGCAAUACAGAAGUAUA	21	14641
SCNN1A-10793	+	UUUUCAGCAAUACAGAAGUAUA	22	14642
SCNN1A-10794	+	UUUUUCAGCAAUACAGAAGUAUA	23	14643
SCNN1A-10795	+	AUUUUUCAGCAAUACAGAAGUAUA	24	14644
SCNN1A-10796	+	GCCACGUCCUGCCGGGUA	18	14645
SCNN1A-10797	+	UGCCACGUCCUGCCGGGUA	19	14646
SCNN1A-6301	+	CUGCCACGUCCUGCCGGGUA	20	10150
SCNN1A-10798	+	CCUGCCACGUCCUGCCGGGUA	21	14647
SCNN1A-10799	+	CCCUGCCACGUCCUGCCGGGUA	22	14648
SCNN1A-10800	+	ACCCUGCCACGUCCUGCCGGGUA	23	14649
SCNN1A-10801	+	GACCCUGCCACGUCCUGCCGGGUA	24	14650
SCNN1A-1478	+	GUGUUGUUGCAGAAGAAC	18	5327
SCNN1A-1479	+	GGUGUUGUUGCAGAAGAAC	19	5328
SCNN1A-220	+	UGGUGUUGUUGCAGAAGAAC	20	843
SCNN1A-1480	+	GUGGUGUUGUUGCAGAAGAAC	21	5329
SCNN1A-1481	+	GGUGGUGUUGUUGCAGAAGAAC	22	5330
SCNN1A-1482	+	UGGUGGUGUUGUUGCAGAAGAAC	23	5331
SCNN1A-1483	+	AUGGUGGUGUUGUUGCAGAAGAAC	24	5332
SCNN1A-10802	+	CCUUCCAGGCGCAGGCAC	18	14651
SCNN1A-10803	+	CCCUUCCAGGCGCAGGCAC	19	14652
SCNN1A-10804	+	ACCCUUCCAGGCGCAGGCAC	20	14653
SCNN1A-10805	+	CACCCUUCCAGGCGCAGGCAC	21	14654
SCNN1A-10806	+	CCACCCUUCCAGGCGCAGGCAC	22	14655
SCNN1A-10807	+	ACCACCCUUCCAGGCGCAGGCAC	23	14656
SCNN1A-10808	+	GACCACCCUUCCAGGCGCAGGCAC	24	14657
SCNN1A-10809	+	AAAAUAGAAAUCUGAGAC	18	14658
SCNN1A-10810	+	GAAAAUAGAAAUCUGAGAC	19	14659
SCNN1A-10811	+	GGAAAAUAGAAAUCUGAGAC	20	14660
SCNN1A-10812	+	AGGAAAAUAGAAAUCUGAGAC	21	14661
SCNN1A-10813	+	GAGGAAAAUAGAAAUCUGAGAC	22	14662
SCNN1A-10814	+	UGAGGAAAAUAGAAAUCUGAGAC	23	14663
SCNN1A-10815	+	GUGAGGAAAAUAGAAAUCUGAGAC	24	14664
SCNN1A-10816	+	UGCUGCAGCAUUCUAGAC	18	14665
SCNN1A-10817	+	GUGCUGCAGCAUUCUAGAC	19	14666
SCNN1A-10818	+	AGUGCUGCAGCAUUCUAGAC	20	14667
SCNN1A-10819	+	UAGUGCUGCAGCAUUCUAGAC	21	14668
SCNN1A-10820	+	CUAGUGCUGCAGCAUUCUAGAC	22	14669
SCNN1A-10821	+	CCUAGUGCUGCAGCAUUCUAGAC	23	14670
SCNN1A-10822	+	GCCUAGUGCUGCAGCAUUCUAGAC	24	14671
SCNN1A-10823	+	AGUGAGCACCUCAGCACC	18	14672
SCNN1A-10824	+	CAGUGAGCACCUCAGCACC	19	14673
SCNN1A-10825	+	CCAGUGAGCACCUCAGCACC	20	14674
SCNN1A-10826	+	CCCAGUGAGCACCUCAGCACC	21	14675
SCNN1A-10827	+	GCCCAGUGAGCACCUCAGCACC	22	14676
SCNN1A-10828	+	UGCCCAGUGAGCACCUCAGCACC	23	14677
SCNN1A-10829	+	CUGCCCAGUGAGCACCUCAGCACC	24	14678
SCNN1A-10830	+	CUUCCAGGCGCAGGCACC	18	14679
SCNN1A-10831	+	CCUUCCAGGCGCAGGCACC	19	14680
SCNN1A-6307	+	CCCUUCCAGGCGCAGGCACC	20	10156
SCNN1A-10832	+	ACCCUUCCAGGCGCAGGCACC	21	14681
SCNN1A-10833	+	CACCCUUCCAGGCGCAGGCACC	22	14682
SCNN1A-10834	+	CCACCCUUCCAGGCGCAGGCACC	23	14683
SCNN1A-10835	+	ACCACCCUUCCAGGCGCAGGCACC	24	14684
SCNN1A-10836	+	GCUGCAGCAUUCUAGACC	18	14685
SCNN1A-10837	+	UGCUGCAGCAUUCUAGACC	19	14686
SCNN1A-6310	+	GUGCUGCAGCAUUCUAGACC	20	10159
SCNN1A-10838	+	AGUGCUGCAGCAUUCUAGACC	21	14687
SCNN1A-10839	+	UAGUGCUGCAGCAUUCUAGACC	22	14688
SCNN1A-10840	+	CUAGUGCUGCAGCAUUCUAGACC	23	14689
SCNN1A-10841	+	CCUAGUGCUGCAGCAUUCUAGACC	24	14690
SCNN1A-10842	+	CCAGCAGUGAGCUCUACC	18	14691
SCNN1A-10843	+	GCCAGCAGUGAGCUCUACC	19	14692
SCNN1A-6312	+	UGCCAGCAGUGAGCUCUACC	20	10161
SCNN1A-1504	+	UGUUCCCCUUCAUGAGCC	18	5353
SCNN1A-1505	+	UUGUUCCCCUUCAUGAGCC	19	5354
SCNN1A-207	+	CUUGUUCCCCUUCAUGAGCC	20	834
SCNN1A-1506	+	GCUUGUUCCCCUUCAUGAGCC	21	5355
SCNN1A-1510	+	CGCUUGUUCCCCUUCAUGAGCC	22	5359
SCNN1A-1511	+	ACGCUUGUUCCCCUUCAUGAGCC	23	5360
SCNN1A-1512	+	CACGCUUGUUCCCCUUCAUGAGCC	24	5361
SCNN1A-1513	+	AGGGCCUCCUCCUCCGCC	18	5362
SCNN1A-1514	+	CAGGGCCUCCUCCUCCGCC	19	5363
SCNN1A-213	+	UCAGGGCCUCCUCCUCCGCC	20	838
SCNN1A-1515	+	AUCAGGGCCUCCUCCUCCGCC	21	5364
SCNN1A-1516	+	GAUCAGGGCCUCCUCCUCCGCC	22	5365
SCNN1A-1517	+	CGAUCAGGGCCUCCUCCUCCGCC	23	5366
SCNN1A-1518	+	UCGAUCAGGGCCUCCUCCUCCGCC	24	5367
SCNN1A-1519	+	CAGAGCCACAGCACUGCC	18	5368
SCNN1A-1520	+	GCAGAGCCACAGCACUGCC	19	5369
SCNN1A-228	+	UGCAGAGCCACAGCACUGCC	20	849
SCNN1A-1521	+	GUGCAGAGCCACAGCACUGCC	21	5370
SCNN1A-1522	+	GGUGCAGAGCCACAGCACUGCC	22	5371
SCNN1A-1523	+	AGGUGCAGAGCCACAGCACUGCC	23	5372
SCNN1A-1524	+	AAGGUGCAGAGCCACAGCACUGCC	24	5373
SCNN1A-1431	+	GAGUGGACUGUGGAGGGC	18	5280
SCNN1A-1432	+	GGAGUGGACUGUGGAGGGC	19	5281
SCNN1A-201	+	UGGAGUGGACUGUGGAGGGC	20	830
SCNN1A-1358	+	CUGGAGUGGACUGUGGAGGGC	21	5207
SCNN1A-1359	+	CCUGGAGUGGACUGUGGAGGGC	22	5208
SCNN1A-1360	+	CCCUGGAGUGGACUGUGGAGGGC	23	5209
SCNN1A-1311	+	GCCCUGGAGUGGACUGUGGAGGGC	24	5160
SCNN1A-10844	+	UCUAGACCUGGAGCGGGC	18	14693
SCNN1A-10845	+	UUCUAGACCUGGAGCGGGC	19	14694
SCNN1A-10846	+	AUUCUAGACCUGGAGCGGGC	20	14695
SCNN1A-10847	+	CAUUCUAGACCUGGAGCGGGC	21	14696
SCNN1A-10848	+	GCAUUCUAGACCUGGAGCGGGC	22	14697
SCNN1A-10849	+	AGCAUUCUAGACCUGGAGCGGGC	23	14698
SCNN1A-10850	+	CAGCAUUCUAGACCUGGAGCGGGC	24	14699
SCNN1A-1531	+	GGUGCAGAUGGUCACUGC	18	5380
SCNN1A-1532	+	GGGUGCAGAUGGUCACUGC	19	5381
SCNN1A-38	+	AGGGUGCAGAUGGUCACUGC	20	575
SCNN1A-1533	+	GAGGGUGCAGAUGGUCACUGC	21	5382
SCNN1A-1534	+	UGAGGGUGCAGAUGGUCACUGC	22	5383
SCNN1A-1535	+	UUGAGGGUGCAGAUGGUCACUGC	23	5384
SCNN1A-1536	+	AUUGAGGGUGCAGAUGGUCACUGC	24	5385
SCNN1A-1537	+	UCCUCCGCCGUGGGCUGC	18	5386
SCNN1A-1538	+	CUCCUCCGCCGUGGGCUGC	19	5387
SCNN1A-65	+	CCUCCUCCGCCGUGGGCUGC	20	594
SCNN1A-1539	+	UCCUCCUCCGCCGUGGGCUGC	21	5388
SCNN1A-1540	+	CUCCUCCUCCGCCGUGGGCUGC	22	5389
SCNN1A-1541	+	CCUCCUCCUCCGCCGUGGGCUGC	23	5390
SCNN1A-1542	+	GCCUCCUCCUCCGCCGUGGGCUGC	24	5391
SCNN1A-1543	+	GUCUUCAUGCGGUUGUGC	18	5392
SCNN1A-1544	+	CGUCUUCAUGCGGUUGUGC	19	5393
SCNN1A-49	+	CCGUCUUCAUGCGGUUGUGC	20	582
SCNN1A-1545	+	GCCGUCUUCAUGCGGUUGUGC	21	5394
SCNN1A-1546	+	GGCCGUCUUCAUGCGGUUGUGC	22	5395
SCNN1A-1547	+	AGGCCGUCUUCAUGCGGUUGUGC	23	5396
SCNN1A-1548	+	AAGGCCGUCUUCAUGCGGUUGUGC	24	5397
SCNN1A-1556	+	UCACGCUUGUUCCCCUUC	18	5405
SCNN1A-1557	+	CUCACGCUUGUUCCCCUUC	19	5406
SCNN1A-208	+	CCUCACGCUUGUUCCCCUUC	20	835
SCNN1A-1558	+	UCCUCACGCUUGUUCCCCUUC	21	5407
SCNN1A-1559	+	CUCCUCACGCUUGUUCCCCUUC	22	5408
SCNN1A-1560	+	GCUCCUCACGCUUGUUCCCCUUC	23	5409
SCNN1A-1561	+	UGCUCCUCACGCUUGUUCCCCUUC	24	5410
SCNN1A-10851	+	UCCUUUCCCUCCCCAAAG	18	14700
SCNN1A-10852	+	UUCCUUUCCCUCCCCAAAG	19	14701
SCNN1A-6330	+	CUUCCUUUCCCUCCCCAAAG	20	10179
SCNN1A-10853	+	CCUUCCUUUCCCUCCCCAAAG	21	14702
SCNN1A-10854	+	CCCUUCCUUUCCCUCCCCAAAG	22	14703
SCNN1A-10855	+	CCCCUUCCUUUCCCUCCCCAAAG	23	14704
SCNN1A-10856	+	UCCCCUUCCUUUCCCUCCCCAAAG	24	14705
SCNN1A-1562	+	AUGGUCACUGCGGGGAAG	18	5411
SCNN1A-1563	+	GAUGGUCACUGCGGGGAAG	19	5412
SCNN1A-238	+	AGAUGGUCACUGCGGGGAAG	20	858
SCNN1A-1564	+	CAGAUGGUCACUGCGGGGAAG	21	5413
SCNN1A-1565	+	GCAGAUGGUCACUGCGGGGAAG	22	5414
SCNN1A-1566	+	UGCAGAUGGUCACUGCGGGGAAG	23	5415
SCNN1A-1567	+	GUGCAGAUGGUCACUGCGGGGAAG	24	5416
SCNN1A-10857	+	GCACCAGGGAAGGGGCAG	18	14706
SCNN1A-10858	+	GGCACCAGGGAAGGGGCAG	19	14707
SCNN1A-6334	+	AGGCACCAGGGAAGGGGCAG	20	10183
SCNN1A-10859	+	CAGGCACCAGGGAAGGGGCAG	21	14708
SCNN1A-10860	+	GCAGGCACCAGGGAAGGGGCAG	22	14709
SCNN1A-10861	+	CGCAGGCACCAGGGAAGGGGCAG	23	14710
SCNN1A-10862	+	GCGCAGGCACCAGGGAAGGGGCAG	24	14711
SCNN1A-1568	+	AUGGUGGUGUUGUUGCAG	18	5417
SCNN1A-1569	+	GAUGGUGGUGUUGUUGCAG	19	5418
SCNN1A-221	+	GGAUGGUGGUGUUGUUGCAG	20	844
SCNN1A-1570	+	UGGAUGGUGGUGUUGUUGCAG	21	5419
SCNN1A-1571	+	GUGGAUGGUGGUGUUGUUGCAG	22	5420
SCNN1A-1572	+	CGUGGAUGGUGGUGUUGUUGCAG	23	5421
SCNN1A-1573	+	CCGUGGAUGGUGGUGUUGUUGCAG	24	5422
SCNN1A-1574	+	AAGACGAGCUUGUCCGAG	18	5423
SCNN1A-1575	+	GAAGACGAGCUUGUCCGAG	19	5424
SCNN1A-236	+	GGAAGACGAGCUUGUCCGAG	20	856
SCNN1A-1576	+	GGGAAGACGAGCUUGUCCGAG	21	5425
SCNN1A-1577	+	GGGGAAGACGAGCUUGUCCGAG	22	5426
SCNN1A-1578	+	CGGGGAAGACGAGCUUGUCCGAG	23	5427
SCNN1A-1579	+	GCGGGGAAGACGAGCUUGUCCGAG	24	5428
SCNN1A-1580	+	UUGAGGCUGACGGGGUAG	18	5429
SCNN1A-1581	+	GUUGAGGCUGACGGGGUAG	19	5430
SCNN1A-232	+	UGUUGAGGCUGACGGGGUAG	20	853
SCNN1A-1582	+	AUGUUGAGGCUGACGGGGUAG	21	5431
SCNN1A-1583	+	GAUGUUGAGGCUGACGGGGUAG	22	5432
SCNN1A-1584	+	UGAUGUUGAGGCUGACGGGGUAG	23	5433
SCNN1A-1585	+	UUGAUGUUGAGGCUGACGGGGUAG	24	5434
SCNN1A-1586	+	GAGCUCUCGGUAGGAGCG	18	5435
SCNN1A-1587	+	AGAGCUCUCGGUAGGAGCG	19	5436
SCNN1A-216	+	AAGAGCUCUCGGUAGGAGCG	20	840
SCNN1A-1588	+	GAAGAGCUCUCGGUAGGAGCG	21	5437
SCNN1A-1589	+	CGAAGAGCUCUCGGUAGGAGCG	22	5438
SCNN1A-1590	+	UCGAAGAGCUCUCGGUAGGAGCG	23	5439
SCNN1A-1591	+	CUCGAAGAGCUCUCGGUAGGAGCG	24	5440
SCNN1A-1592	+	GUGCAGAUGGUCACUGCG	18	5441
SCNN1A-1593	+	GGUGCAGAUGGUCACUGCG	19	5442
SCNN1A-39	+	GGGUGCAGAUGGUCACUGCG	20	518
SCNN1A-1594	+	AGGGUGCAGAUGGUCACUGCG	21	5443
SCNN1A-1595	+	GAGGGUGCAGAUGGUCACUGCG	22	5444
SCNN1A-1596	+	UGAGGGUGCAGAUGGUCACUGCG	23	5445
SCNN1A-1597	+	UUGAGGGUGCAGAUGGUCACUGCG	24	5446
SCNN1A-1598	+	UUGUUGCAGAAGAACUCG	18	5447
SCNN1A-1599	+	GUUGUUGCAGAAGAACUCG	19	5448
SCNN1A-219	+	UGUUGUUGCAGAAGAACUCG	20	842
SCNN1A-1600	+	GUGUUGUUGCAGAAGAACUCG	21	5449
SCNN1A-1601	+	GGUGUUGUUGCAGAAGAACUCG	22	5450
SCNN1A-1602	+	UGGUGUUGUUGCAGAAGAACUCG	23	5451
SCNN1A-1603	+	GUGGUGUUGUUGCAGAAGAACUCG	24	5452
SCNN1A-10863	+	CAUGCACUAUCCUCUAGG	18	14712
SCNN1A-10864	+	UCAUGCACUAUCCUCUAGG	19	14713
SCNN1A-10865	+	AUCAUGCACUAUCCUCUAGG	20	14714
SCNN1A-10866	+	GAUCAUGCACUAUCCUCUAGG	21	14715
SCNN1A-10867	+	GGAUCAUGCACUAUCCUCUAGG	22	14716
SCNN1A-10868	+	AGGAUCAUGCACUAUCCUCUAGG	23	14717
SCNN1A-10869	+	CAGGAUCAUGCACUAUCCUCUAGG	24	14718
SCNN1A-1611	+	AGCUCUCGGUAGGAGCGG	18	5460
SCNN1A-1612	+	GAGCUCUCGGUAGGAGCGG	19	5461
SCNN1A-60	+	AGAGCUCUCGGUAGGAGCGG	20	590
SCNN1A-1613	+	AAGAGCUCUCGGUAGGAGCGG	21	5462
SCNN1A-1614	+	GAAGAGCUCUCGGUAGGAGCGG	22	5463
SCNN1A-1615	+	CGAAGAGCUCUCGGUAGGAGCGG	23	5464
SCNN1A-1616	+	UCGAAGAGCUCUCGGUAGGAGCGG	24	5465
SCNN1A-1617	+	AACUCGAAGAGCUCUCGG	18	5466
SCNN1A-1618	+	GAACUCGAAGAGCUCUCGG	19	5467
SCNN1A-218	+	AGAACUCGAAGAGCUCUCGG	20	841
SCNN1A-1619	+	AAGAACUCGAAGAGCUCUCGG	21	5468
SCNN1A-1620	+	GAAGAACUCGAAGAGCUCUCGG	22	5469
SCNN1A-1621	+	AGAAGAACUCGAAGAGCUCUCGG	23	5470
SCNN1A-1622	+	CAGAAGAACUCGAAGAGCUCUCGG	24	5471
SCNN1A-10870	+	CAGGCGCAGGCACCAGGG	18	14719
SCNN1A-10871	+	CCAGGCGCAGGCACCAGGG	19	14720
SCNN1A-10872	+	UCCAGGCGCAGGCACCAGGG	20	14721
SCNN1A-10873	+	UUCCAGGCGCAGGCACCAGGG	21	14722
SCNN1A-10874	+	CUUCCAGGCGCAGGCACCAGGG	22	14723
SCNN1A-10875	+	CCUUCCAGGCGCAGGCACCAGGG	23	14724
SCNN1A-10876	+	CCCUUCCAGGCGCAGGCACCAGGG	24	14725
SCNN1A-10877	+	CAGGCACCAGGGAAGGGG	18	14726
SCNN1A-10878	+	GCAGGCACCAGGGAAGGGG	19	14727
SCNN1A-10879	+	CGCAGGCACCAGGGAAGGGG	20	14728
SCNN1A-10880	+	GCGCAGGCACCAGGGAAGGGG	21	14729
SCNN1A-10881	+	GGCGCAGGCACCAGGGAAGGGG	22	14730
SCNN1A-10882	+	AGGCGCAGGCACCAGGGAAGGGG	23	14731
SCNN1A-10883	+	CAGGCGCAGGCACCAGGGAAGGGG	24	14732
SCNN1A-10884	+	UGCAAUGCCUGGUCUGGG	18	14733
SCNN1A-10885	+	UUGCAAUGCCUGGUCUGGG	19	14734
SCNN1A-10886	+	AUUGCAAUGCCUGGUCUGGG	20	14735
SCNN1A-10887	+	AAUUGCAAUGCCUGGUCUGGG	21	14736
SCNN1A-10888	+	GAAUUGCAAUGCCUGGUCUGGG	22	14737
SCNN1A-10889	+	AGAAUUGCAAUGCCUGGUCUGGG	23	14738
SCNN1A-10890	+	AAGAAUUGCAAUGCCUGGUCUGGG	24	14739
SCNN1A-1637	+	UCCGAGUUGAGGUUGAUG	18	5486
SCNN1A-1638	+	GUCCGAGUUGAGGUUGAUG	19	5487
SCNN1A-235	+	UGUCCGAGUUGAGGUUGAUG	20	855
SCNN1A-1639	+	UUGUCCGAGUUGAGGUUGAUG	21	5488
SCNN1A-1640	+	CUUGUCCGAGUUGAGGUUGAUG	22	5489
SCNN1A-1641	+	GCUUGUCCGAGUUGAGGUUGAUG	23	5490
SCNN1A-1642	+	AGCUUGUCCGAGUUGAGGUUGAUG	24	5491
SCNN1A-1643	+	GGGUGCAGAUGGUCACUG	18	5492
SCNN1A-1644	+	AGGGUGCAGAUGGUCACUG	19	5493
SCNN1A-37	+	GAGGGUGCAGAUGGUCACUG	20	517
SCNN1A-1645	+	UGAGGGUGCAGAUGGUCACUG	21	5494
SCNN1A-1646	+	UUGAGGGUGCAGAUGGUCACUG	22	5495
SCNN1A-1647	+	AUUGAGGGUGCAGAUGGUCACUG	23	5496
SCNN1A-1648	+	GAUUGAGGGUGCAGAUGGUCACUG	24	5497
SCNN1A-1649	+	GAGCCCUGGAGUGGACUG	18	5498
SCNN1A-1650	+	UGAGCCCUGGAGUGGACUG	19	5499
SCNN1A-74	+	AUGAGCCCUGGAGUGGACUG	20	601
SCNN1A-1651	+	CAUGAGCCCUGGAGUGGACUG	21	5500
SCNN1A-1652	+	UCAUGAGCCCUGGAGUGGACUG	22	5501
SCNN1A-1653	+	UUCAUGAGCCCUGGAGUGGACUG	23	5502
SCNN1A-1654	+	CUUCAUGAGCCCUGGAGUGGACUG	24	5503
SCNN1A-1655	+	GAGGGACUAACCGACCUG	18	5504
SCNN1A-1656	+	AGAGGGACUAACCGACCUG	19	5505
SCNN1A-1657	+	CAGAGGGACUAACCGACCUG	20	5506
SCNN1A-1658	+	GCAGAGGGACUAACCGACCUG	21	5507
SCNN1A-1659	+	GGCAGAGGGACUAACCGACCUG	22	5508
SCNN1A-1660	+	GGGCAGAGGGACUAACCGACCUG	23	5509
SCNN1A-1661	+	GGGGCAGAGGGACUAACCGACCUG	24	5510
SCNN1A-1662	+	AGGUUGAUGUUGAGGCUG	18	5511
SCNN1A-1663	+	GAGGUUGAUGUUGAGGCUG	19	5512
SCNN1A-234	+	UGAGGUUGAUGUUGAGGCUG	20	854
SCNN1A-1664	+	UUGAGGUUGAUGUUGAGGCUG	21	5513
SCNN1A-1665	+	GUUGAGGUUGAUGUUGAGGCUG	22	5514
SCNN1A-1666	+	AGUUGAGGUUGAUGUUGAGGCUG	23	5515
SCNN1A-1667	+	GAGUUGAGGUUGAUGUUGAGGCUG	24	5516
SCNN1A-1675	+	CUCCUCCGCCGUGGGCUG	18	5524
SCNN1A-1676	+	CCUCCUCCGCCGUGGGCUG	19	5525
SCNN1A-212	+	UCCUCCUCCGCCGUGGGCUG	20	837
SCNN1A-1677	+	CUCCUCCUCCGCCGUGGGCUG	21	5526
SCNN1A-1678	+	CCUCCUCCUCCGCCGUGGGCUG	22	5527
SCNN1A-1679	+	GCCUCCUCCUCCGCCGUGGGCUG	23	5528
SCNN1A-1680	+	GGCCUCCUCCUCCGCCGUGGGCUG	24	5529
SCNN1A-1681	+	UACAUCAUGCCAAAGGUG	18	5530
SCNN1A-1682	+	GUACAUCAUGCCAAAGGUG	19	5531
SCNN1A-229	+	AGUACAUCAUGCCAAAGGUG	20	850
SCNN1A-1683	+	CAGUACAUCAUGCCAAAGGUG	21	5532
SCNN1A-1684	+	CCAGUACAUCAUGCCAAAGGUG	22	5533
SCNN1A-1685	+	GCCAGUACAUCAUGCCAAAGGUG	23	5534
SCNN1A-1686	+	UGCCAGUACAUCAUGCCAAAGGUG	24	5535
SCNN1A-1687	+	GCCCUGGAGUGGACUGUG	18	5536
SCNN1A-1688	+	AGCCCUGGAGUGGACUGUG	19	5537
SCNN1A-202	+	GAGCCCUGGAGUGGACUGUG	20	831
SCNN1A-1689	+	UGAGCCCUGGAGUGGACUGUG	21	5538
SCNN1A-1690	+	AUGAGCCCUGGAGUGGACUGUG	22	5539
SCNN1A-1691	+	CAUGAGCCCUGGAGUGGACUGUG	23	5540
SCNN1A-1692	+	UCAUGAGCCCUGGAGUGGACUGUG	24	5541
SCNN1A-1693	+	CGUCUUCAUGCGGUUGUG	18	5542
SCNN1A-1694	+	CCGUCUUCAUGCGGUUGUG	19	5543
SCNN1A-227	+	GCCGUCUUCAUGCGGUUGUG	20	848
SCNN1A-1695	+	GGCCGUCUUCAUGCGGUUGUG	21	5544
SCNN1A-1696	+	AGGCCGUCUUCAUGCGGUUGUG	22	5545
SCNN1A-1697	+	AAGGCCGUCUUCAUGCGGUUGUG	23	5546
SCNN1A-1698	+	GAAGGCCGUCUUCAUGCGGUUGUG	24	5547
SCNN1A-10891	+	AACAGGCUUGGUGUUGUG	18	14740
SCNN1A-10892	+	GAACAGGCUUGGUGUUGUG	19	14741
SCNN1A-6347	+	AGAACAGGCUUGGUGUUGUG	20	10196
SCNN1A-10893	+	UAGAACAGGCUUGGUGUUGUG	21	14742
SCNN1A-10894	+	CUAGAACAGGCUUGGUGUUGUG	22	14743
SCNN1A-10895	+	GCUAGAACAGGCUUGGUGUUGUG	23	14744
SCNN1A-10896	+	GGCUAGAACAGGCUUGGUGUUGUG	24	14745
SCNN1A-1705	+	UGGAUGGUGGUGUUGUUG	18	5554
SCNN1A-1706	+	GUGGAUGGUGGUGUUGUUG	19	5555
SCNN1A-222	+	CGUGGAUGGUGGUGUUGUUG	20	845
SCNN1A-1707	+	CCGUGGAUGGUGGUGUUGUUG	21	5556
SCNN1A-1708	+	GCCGUGGAUGGUGGUGUUGUUG	22	5557
SCNN1A-1709	+	CGCCGUGGAUGGUGGUGUUGUUG	23	5558
SCNN1A-1710	+	GCGCCGUGGAUGGUGGUGUUGUUG	24	5559
SCNN1A-10897	+	UGUGAGGAAAAUAGAAAU	18	14746
SCNN1A-10898	+	UUGUGAGGAAAAUAGAAAU	19	14747
SCNN1A-10899	+	GUUGUGAGGAAAAUAGAAAU	20	14748
SCNN1A-10900	+	UGUUGUGAGGAAAAUAGAAAU	21	14749
SCNN1A-10901	+	GUGUUGUGAGGAAAAUAGAAAU	22	14750
SCNN1A-10902	+	GGUGUUGUGAGGAAAAUAGAAAU	23	14751
SCNN1A-10903	+	UGGUGUUGUGAGGAAAAUAGAAAU	24	14752
SCNN1A-10904	+	GGGUAUGGGAGUGGCAAU	18	14753
SCNN1A-10905	+	CGGGUAUGGGAGUGGCAAU	19	14754
SCNN1A-10906	+	CCGGGUAUGGGAGUGGCAAU	20	14755
SCNN1A-10907	+	GCCGGGUAUGGGAGUGGCAAU	21	14756
SCNN1A-10908	+	UGCCGGGUAUGGGAGUGGCAAU	22	14757
SCNN1A-10909	+	CUGCCGGGUAUGGGAGUGGCAAU	23	14758
SCNN1A-10910	+	CCUGCCGGGUAUGGGAGUGGCAAU	24	14759
SCNN1A-1711	+	GGAGCGGUGGAACUCGAU	18	5560
SCNN1A-1712	+	AGGAGCGGUGGAACUCGAU	19	5561
SCNN1A-214	+	UAGGAGCGGUGGAACUCGAU	20	839
SCNN1A-1713	+	GUAGGAGCGGUGGAACUCGAU	21	5562
SCNN1A-1714	+	GGUAGGAGCGGUGGAACUCGAU	22	5563
SCNN1A-1715	+	CGGUAGGAGCGGUGGAACUCGAU	23	5564
SCNN1A-1716	+	UCGGUAGGAGCGGUGGAACUCGAU	24	5565
SCNN1A-1723	+	AGGGUGCAGAUGGUCACU	18	5572
SCNN1A-1724	+	GAGGGUGCAGAUGGUCACU	19	5573
SCNN1A-242	+	UGAGGGUGCAGAUGGUCACU	20	859
SCNN1A-1725	+	UUGAGGGUGCAGAUGGUCACU	21	5574
SCNN1A-1726	+	AUUGAGGGUGCAGAUGGUCACU	22	5575
SCNN1A-1727	+	GAUUGAGGGUGCAGAUGGUCACU	23	5576
SCNN1A-1728	+	GGAUUGAGGGUGCAGAUGGUCACU	24	5577
SCNN1A-1729	+	UGAGCCCUGGAGUGGACU	18	5578
SCNN1A-1730	+	AUGAGCCCUGGAGUGGACU	19	5579
SCNN1A-204	+	CAUGAGCCCUGGAGUGGACU	20	832
SCNN1A-1731	+	UCAUGAGCCCUGGAGUGGACU	21	5580
SCNN1A-1732	+	UUCAUGAGCCCUGGAGUGGACU	22	5581
SCNN1A-1733	+	CUUCAUGAGCCCUGGAGUGGACU	23	5582
SCNN1A-1734	+	CCUUCAUGAGCCCUGGAGUGGACU	24	5583
SCNN1A-1748	+	UCUUCAUGCGGUUGUGCU	18	5597
SCNN1A-1749	+	GUCUUCAUGCGGUUGUGCU	19	5598
SCNN1A-50	+	CGUCUUCAUGCGGUUGUGCU	20	583
SCNN1A-1750	+	CCGUCUUCAUGCGGUUGUGCU	21	5599
SCNN1A-1751	+	GCCGUCUUCAUGCGGUUGUGCU	22	5600
SCNN1A-1752	+	GGCCGUCUUCAUGCGGUUGUGCU	23	5601
SCNN1A-1753	+	AGGCCGUCUUCAUGCGGUUGUGCU	24	5602
SCNN1A-10911	+	UUAUUUUCUUAUUUAUCU	18	14760
SCNN1A-10912	+	UUUAUUUUCUUAUUUAUCU	19	14761
SCNN1A-10913	+	UUUUAUUUUCUUAUUUAUCU	20	14762
SCNN1A-10914	+	CUUUUAUUUUCUUAUUUAUCU	21	14763
SCNN1A-10915	+	GCUUUUAUUUUCUUAUUUAUCU	22	14764
SCNN1A-10916	+	UGCUUUUAUUUUCUUAUUUAUCU	23	14765
SCNN1A-10917	+	UUGCUUUUAUUUUCUUAUUUAUCU	24	14766
SCNN1A-1754	+	GGGUAGCUGAAGUACUCU	18	5603
SCNN1A-1755	+	GGGGUAGCUGAAGUACUCU	19	5604
SCNN1A-231	+	CGGGGUAGCUGAAGUACUCU	20	852
SCNN1A-1756	+	ACGGGGUAGCUGAAGUACUCU	21	5605
SCNN1A-1757	+	GACGGGGUAGCUGAAGUACUCU	22	5606
SCNN1A-1758	+	UGACGGGGUAGCUGAAGUACUCU	23	5607
SCNN1A-1759	+	CUGACGGGGUAGCUGAAGUACUCU	24	5608
SCNN1A-1760	+	UGCUGGGGCGCCGCAGGU	18	5609
SCNN1A-1761	+	CUGCUGGGGCGCCGCAGGU	19	5610
SCNN1A-210	+	GCUGCUGGGGCGCCGCAGGU	20	836
SCNN1A-1762	+	GGCUGCUGGGGCGCCGCAGGU	21	5611
SCNN1A-1763	+	GGGCUGCUGGGGCGCCGCAGGU	22	5612
SCNN1A-1764	+	UGGGCUGCUGGGGCGCCGCAGGU	23	5613
SCNN1A-1765	+	GUGGGCUGCUGGGGCGCCGCAGGU	24	5614
SCNN1A-10918	+	CAGUUCCCACCCUCAGGU	18	14767
SCNN1A-10919	+	UCAGUUCCCACCCUCAGGU	19	14768
SCNN1A-10920	+	GUCAGUUCCCACCCUCAGGU	20	14769
SCNN1A-10921	+	UGUCAGUUCCCACCCUCAGGU	21	14770
SCNN1A-10922	+	GUGUCAGUUCCCACCCUCAGGU	22	14771
SCNN1A-10923	+	GGUGUCAGUUCCCACCCUCAGGU	23	14772
SCNN1A-10924	+	GGGUGUCAGUUCCCACCCUCAGGU	24	14773
SCNN1A-1766	+	ACUCGAAGAGCUCUCGGU	18	5615
SCNN1A-1767	+	AACUCGAAGAGCUCUCGGU	19	5616
SCNN1A-58	+	GAACUCGAAGAGCUCUCGGU	20	524
SCNN1A-1768	+	AGAACUCGAAGAGCUCUCGGU	21	5617
SCNN1A-1769	+	AAGAACUCGAAGAGCUCUCGGU	22	5618
SCNN1A-1770	+	GAAGAACUCGAAGAGCUCUCGGU	23	5619
SCNN1A-1771	+	AGAAGAACUCGAAGAGCUCUCGGU	24	5620
SCNN1A-10925	+	UGCCACGUCCUGCCGGGU	18	14774
SCNN1A-10926	+	CUGCCACGUCCUGCCGGGU	19	14775
SCNN1A-10927	+	CCUGCCACGUCCUGCCGGGU	20	14776
SCNN1A-10928	+	CCCUGCCACGUCCUGCCGGGU	21	14777
SCNN1A-10929	+	ACCCUGCCACGUCCUGCCGGGU	22	14778
SCNN1A-10930	+	GACCCUGCCACGUCCUGCCGGGU	23	14779
SCNN1A-10931	+	UGACCCUGCCACGUCCUGCCGGGU	24	14780
SCNN1A-10932	+	AGAAUUGCAAUGCCUGGU	18	14781
SCNN1A-10933	+	AAGAAUUGCAAUGCCUGGU	19	14782
SCNN1A-10934	+	GAAGAAUUGCAAUGCCUGGU	20	14783
SCNN1A-10935	+	AGAAGAAUUGCAAUGCCUGGU	21	14784
SCNN1A-10936	+	GAGAAGAAUUGCAAUGCCUGGU	22	14785
SCNN1A-10937	+	UGAGAAGAAUUGCAAUGCCUGGU	23	14786
SCNN1A-10938	+	GUGAGAAGAAUUGCAAUGCCUGGU	24	14787
SCNN1A-10939	+	UGAGACCUGGACUUUGGU	18	14788
SCNN1A-10940	+	CUGAGACCUGGACUUUGGU	19	14789
SCNN1A-10941	+	UCUGAGACCUGGACUUUGGU	20	14790
SCNN1A-10942	+	AUCUGAGACCUGGACUUUGGU	21	14791
SCNN1A-10943	+	AAUCUGAGACCUGGACUUUGGU	22	14792
SCNN1A-10944	+	AAAUCUGAGACCUGGACUUUGGU	23	14793
SCNN1A-10945	+	GAAAUCUGAGACCUGGACUUUGGU	24	14794
SCNN1A-10946	+	GAACAGGCUUGGUGUUGU	18	14795
SCNN1A-10947	+	AGAACAGGCUUGGUGUUGU	19	14796
SCNN1A-10948	+	UAGAACAGGCUUGGUGUUGU	20	14797
SCNN1A-10949	+	CUAGAACAGGCUUGGUGUUGU	21	14798
SCNN1A-10950	+	GCUAGAACAGGCUUGGUGUUGU	22	14799
SCNN1A-10951	+	GGCUAGAACAGGCUUGGUGUUGU	23	14800
SCNN1A-10952	+	GGGCUAGAACAGGCUUGGUGUUGU	24	14801
SCNN1A-1784	+	GCUGGGGCGCCGCAGGUU	18	5633
SCNN1A-1785	+	UGCUGGGGCGCCGCAGGUU	19	5634
SCNN1A-69	+	CUGCUGGGGCGCCGCAGGUU	20	597
SCNN1A-1786	+	GCUGCUGGGGCGCCGCAGGUU	21	5635
SCNN1A-1787	+	GGCUGCUGGGGCGCCGCAGGUU	22	5636
SCNN1A-1788	+	GGGCUGCUGGGGCGCCGCAGGUU	23	5637
SCNN1A-1789	+	UGGGCUGCUGGGGCGCCGCAGGUU	24	5638
SCNN1A-10953	+	UAGAACAGGCUUGGUGUU	18	14802
SCNN1A-10954	+	CUAGAACAGGCUUGGUGUU	19	14803
SCNN1A-10955	+	GCUAGAACAGGCUUGGUGUU	20	14804
SCNN1A-10956	+	GGCUAGAACAGGCUUGGUGUU	21	14805
SCNN1A-10957	+	GGGCUAGAACAGGCUUGGUGUU	22	14806
SCNN1A-10958	+	CGGGCUAGAACAGGCUUGGUGUU	23	14807
SCNN1A-10959	+	GCGGGCUAGAACAGGCUUGGUGUU	24	14808
SCNN1A-10960	−	AGAAAAUAAAAGCAAAAA	18	14809
SCNN1A-10961	−	AAGAAAAUAAAAGCAAAAA	19	14810
SCNN1A-6277	−	UAAGAAAAUAAAAGCAAAAA	20	10126
SCNN1A-10962	−	AUAAGAAAAUAAAAGCAAAAA	21	14811
SCNN1A-10963	−	AAUAAGAAAAUAAAAGCAAAAA	22	14812
SCNN1A-10964	−	AAAUAAGAAAAUAAAAGCAAAAA	23	14813
SCNN1A-10965	−	UAAAUAAGAAAAUAAAAGCAAAAA	24	14814
SCNN1A-10966	−	AAGAAAAUAAAAGCAAAA	18	14815
SCNN1A-10967	−	UAAGAAAAUAAAAGCAAAA	19	14816
SCNN1A-10968	−	AUAAGAAAAUAAAAGCAAAA	20	14817
SCNN1A-10969	−	AAUAAGAAAAUAAAAGCAAAA	21	14818
SCNN1A-10970	−	AAAUAAGAAAAUAAAAGCAAAA	22	14819
SCNN1A-10971	−	UAAAUAAGAAAAUAAAAGCAAAA	23	14820
SCNN1A-10972	−	AUAAAUAAGAAAAUAAAAGCAAAA	24	14821
SCNN1A-10973	−	AUGGUCUCUGUCAUAAAA	18	14822
SCNN1A-10974	−	CAUGGUCUCUGUCAUAAAA	19	14823
SCNN1A-10975	−	GCAUGGUCUCUGUCAUAAAA	20	14824
SCNN1A-10976	−	AGCAUGGUCUCUGUCAUAAAA	21	14825
SCNN1A-10977	−	UAGCAUGGUCUCUGUCAUAAAA	22	14826
SCNN1A-10978	−	AUAGCAUGGUCUCUGUCAUAAAA	23	14827
SCNN1A-10979	−	UAUAGCAUGGUCUCUGUCAUAAAA	24	14828
SCNN1A-10980	−	UAAAAGAUCAUCUUUAAA	18	14829
SCNN1A-10981	−	UUAAAAGAUCAUCUUUAAA	19	14830
SCNN1A-10982	−	UUUAAAAGAUCAUCUUUAAA	20	14831
SCNN1A-10983	−	CUUUAAAAGAUCAUCUUUAAA	21	14832
SCNN1A-10984	−	ACUUUAAAAGAUCAUCUUUAAA	22	14833
SCNN1A-10985	−	CACUUUAAAAGAUCAUCUUUAAA	23	14834
SCNN1A-10986	−	ACACUUUAAAAGAUCAUCUUUAAA	24	14835
SCNN1A-10987	−	UUUGGGGAGGGAAAGGAA	18	14836
SCNN1A-10988	−	CUUUGGGGAGGGAAAGGAA	19	14837
SCNN1A-6283	−	CCUUUGGGGAGGGAAAGGAA	20	10132
SCNN1A-10989	−	CCCUUUGGGGAGGGAAAGGAA	21	14838
SCNN1A-10990	−	CCCCUUUGGGGAGGGAAAGGAA	22	14839
SCNN1A-10991	−	UCCCCUUUGGGGAGGGAAAGGAA	23	14840
SCNN1A-10992	−	CUCCCCUUUGGGGAGGGAAAGGAA	24	14841
SCNN1A-10993	−	UCCCCUUUGGGGAGGGAA	18	14842
SCNN1A-10994	−	CUCCCCUUUGGGGAGGGAA	19	14843
SCNN1A-6285	−	GCUCCCCUUUGGGGAGGGAA	20	10134
SCNN1A-10995	−	GGCUCCCCUUUGGGGAGGGAA	21	14844
SCNN1A-10996	−	UGGCUCCCCUUUGGGGAGGGAA	22	14845
SCNN1A-10997	−	GUGGCUCCCCUUUGGGGAGGGAA	23	14846
SCNN1A-10998	−	GGUGGCUCCCCUUUGGGGAGGGAA	24	14847
SCNN1A-1796	−	CACUCCAGGGCUCAUGAA	18	5645
SCNN1A-1797	−	CCACUCCAGGGCUCAUGAA	19	5646
SCNN1A-11	−	UCCACUCCAGGGCUCAUGAA	20	560
SCNN1A-1798	−	GUCCACUCCAGGGCUCAUGAA	21	5647
SCNN1A-1799	−	AGUCCACUCCAGGGCUCAUGAA	22	5648
SCNN1A-1800	−	CAGUCCACUCCAGGGCUCAUGAA	23	5649
SCNN1A-1801	−	ACAGUCCACUCCAGGGCUCAUGAA	24	5650
SCNN1A-10999	−	GGAAAGGAAGGGGACUAA	18	14848
SCNN1A-11000	−	GGGAAAGGAAGGGGACUAA	19	14849
SCNN1A-6288	−	AGGGAAAGGAAGGGGACUAA	20	10137
SCNN1A-11001	−	GAGGGAAAGGAAGGGGACUAA	21	14850
SCNN1A-11002	−	GGAGGGAAAGGAAGGGGACUAA	22	14851
SCNN1A-11003	−	GGGAGGGAAAGGAAGGGGACUAA	23	14852
SCNN1A-11004	−	GGGGAGGGAAAGGAAGGGGACUAA	24	14853
SCNN1A-11005	−	AGGGUGCUGAGGUGCUCA	18	14854
SCNN1A-11006	−	CAGGGUGCUGAGGUGCUCA	19	14855
SCNN1A-11007	−	CCAGGGUGCUGAGGUGCUCA	20	14856
SCNN1A-11008	−	UCCAGGGUGCUGAGGUGCUCA	21	14857
SCNN1A-11009	−	GUCCAGGGUGCUGAGGUGCUCA	22	14858
SCNN1A-11010	−	GGUCCAGGGUGCUGAGGUGCUCA	23	14859
SCNN1A-11011	−	UGGUCCAGGGUGCUGAGGUGCUCA	24	14860
SCNN1A-11012	−	CUUUGGGGAGGGAAAGGA	18	14861
SCNN1A-11013	−	CCUUUGGGGAGGGAAAGGA	19	14862
SCNN1A-6295	−	CCCUUUGGGGAGGGAAAGGA	20	10144
SCNN1A-11014	−	CCCCUUUGGGGAGGGAAAGGA	21	14863
SCNN1A-11015	−	UCCCCUUUGGGGAGGGAAAGGA	22	14864
SCNN1A-11016	−	CUCCCCUUUGGGGAGGGAAAGGA	23	14865
SCNN1A-11017	−	GCUCCCCUUUGGGGAGGGAAAGGA	24	14866
SCNN1A-11018	−	CUCCCCUUUGGGGAGGGA	18	14867
SCNN1A-11019	−	GCUCCCCUUUGGGGAGGGA	19	14868
SCNN1A-11020	−	GGCUCCCCUUUGGGGAGGGA	20	14869
SCNN1A-11021	−	UGGCUCCCCUUUGGGGAGGGA	21	14870
SCNN1A-11022	−	GUGGCUCCCCUUUGGGGAGGGA	22	14871
SCNN1A-11023	−	GGUGGCUCCCCUUUGGGGAGGGA	23	14872
SCNN1A-11024	−	UGGUGGCUCCCCUUUGGGGAGGGA	24	14873
SCNN1A-11025	−	GUGGCUCCCCUUUGGGGA	18	14874
SCNN1A-11026	−	GGUGGCUCCCCUUUGGGGA	19	14875
SCNN1A-6297	−	UGGUGGCUCCCCUUUGGGGA	20	10146
SCNN1A-11027	−	AUGGUGGCUCCCCUUUGGGGA	21	14876
SCNN1A-11028	−	UAUGGUGGCUCCCCUUUGGGGA	22	14877
SCNN1A-11029	−	UUAUGGUGGCUCCCCUUUGGGGA	23	14878
SCNN1A-11030	−	AUUAUGGUGGCUCCCCUUUGGGGA	24	14879
SCNN1A-1833	−	CCACUCCAGGGCUCAUGA	18	5682
SCNN1A-1834	−	UCCACUCCAGGGCUCAUGA	19	5683
SCNN1A-10	−	GUCCACUCCAGGGCUCAUGA	20	505
SCNN1A-1835	−	AGUCCACUCCAGGGCUCAUGA	21	5684
SCNN1A-1836	−	CAGUCCACUCCAGGGCUCAUGA	22	5685
SCNN1A-1837	−	ACAGUCCACUCCAGGGCUCAUGA	23	5686
SCNN1A-1838	−	CACAGUCCACUCCAGGGCUCAUGA	24	5687
SCNN1A-11031	−	GGGAAAGGAAGGGGACUA	18	14880
SCNN1A-11032	−	AGGGAAAGGAAGGGGACUA	19	14881
SCNN1A-6300	−	GAGGGAAAGGAAGGGGACUA	20	10149
SCNN1A-11033	−	GGAGGGAAAGGAAGGGGACUA	21	14882
SCNN1A-11034	−	GGGAGGGAAAGGAAGGGGACUA	22	14883
SCNN1A-11035	−	GGGGAGGGAAAGGAAGGGGACUA	23	14884
SCNN1A-11036	−	UGGGGAGGGAAAGGAAGGGGACUA	24	14885
SCNN1A-1851	−	CGAGUUCCACCGCUCCUA	18	5700
SCNN1A-1852	−	UCGAGUUCCACCGCUCCUA	19	5701
SCNN1A-190	−	AUCGAGUUCCACCGCUCCUA	20	820
SCNN1A-1853	−	GAUCGAGUUCCACCGCUCCUA	21	5702
SCNN1A-1854	−	UGAUCGAGUUCCACCGCUCCUA	22	5703
SCNN1A-1855	−	CUGAUCGAGUUCCACCGCUCCUA	23	5704
SCNN1A-1856	−	CCUGAUCGAGUUCCACCGCUCCUA	24	5705
SCNN1A-1857	−	CUCAACAUCAACCUCAAC	18	5706
SCNN1A-1858	−	CCUCAACAUCAACCUCAAC	19	5707
SCNN1A-198	−	GCCUCAACAUCAACCUCAAC	20	827
SCNN1A-1859	−	AGCCUCAACAUCAACCUCAAC	21	5708
SCNN1A-1860	−	CAGCCUCAACAUCAACCUCAAC	22	5709
SCNN1A-1861	−	UCAGCCUCAACAUCAACCUCAAC	23	5710
SCNN1A-1862	−	GUCAGCCUCAACAUCAACCUCAAC	24	5711
SCNN1A-11037	−	GCAGGCAGAGCCUCAGAC	18	14886
SCNN1A-11038	−	GGCAGGCAGAGCCUCAGAC	19	14887
SCNN1A-11039	−	GGGCAGGCAGAGCCUCAGAC	20	14888
SCNN1A-11040	−	UGGGCAGGCAGAGCCUCAGAC	21	14889
SCNN1A-11041	−	CUGGGCAGGCAGAGCCUCAGAC	22	14890
SCNN1A-11042	−	ACUGGGCAGGCAGAGCCUCAGAC	23	14891
SCNN1A-11043	−	CACUGGGCAGGCAGAGCCUCAGAC	24	14892
SCNN1A-1870	−	AGUUCCACCGCUCCUACC	18	5719
SCNN1A-1871	−	GAGUUCCACCGCUCCUACC	19	5720
SCNN1A-191	−	CGAGUUCCACCGCUCCUACC	20	821
SCNN1A-1872	−	UCGAGUUCCACCGCUCCUACC	21	5721
SCNN1A-1873	−	AUCGAGUUCCACCGCUCCUACC	22	5722
SCNN1A-1874	−	GAUCGAGUUCCACCGCUCCUACC	23	5723
SCNN1A-1875	−	UGAUCGAGUUCCACCGCUCCUACC	24	5724
SCNN1A-11044	−	UGCUGCUGUACUCCAGCC	18	14893
SCNN1A-11045	−	AUGCUGCUGUACUCCAGCC	19	14894
SCNN1A-11046	−	CAUGCUGCUGUACUCCAGCC	20	14895
SCNN1A-11047	−	UCAUGCUGCUGUACUCCAGCC	21	14896
SCNN1A-11048	−	AUCAUGCUGCUGUACUCCAGCC	22	14897
SCNN1A-11049	−	GAUCAUGCUGCUGUACUCCAGCC	23	14898
SCNN1A-11050	−	UGAUCAUGCUGCUGUACUCCAGCC	24	14899
SCNN1A-11051	−	UUCCCUGGUGCCUGCGCC	18	14900
SCNN1A-11052	−	CUUCCCUGGUGCCUGCGCC	19	14901
SCNN1A-6315	−	CCUUCCCUGGUGCCUGCGCC	20	10164
SCNN1A-11053	−	CCCUUCCCUGGUGCCUGCGCC	21	14902
SCNN1A-11054	−	CCCCUUCCCUGGUGCCUGCGCC	22	14903
SCNN1A-11055	−	GCCCCUUCCCUGGUGCCUGCGCC	23	14904
SCNN1A-11056	−	UGCCCCUUCCCUGGUGCCUGCGCC	24	14905
SCNN1A-1883	−	AGGAGCAGGGGCUGGGCC	18	5732
SCNN1A-1884	−	GAGGAGCAGGGGCUGGGCC	19	5733
SCNN1A-182	−	UGAGGAGCAGGGGCUGGGCC	20	815
SCNN1A-1885	−	GUGAGGAGCAGGGGCUGGGCC	21	5734
SCNN1A-1886	−	CGUGAGGAGCAGGGGCUGGGCC	22	5735
SCNN1A-1887	−	GCGUGAGGAGCAGGGGCUGGGCC	23	5736
SCNN1A-1888	−	AGCGUGAGGAGCAGGGGCUGGGCC	24	5737
SCNN1A-1895	−	UCAUGAAGGGGAACAAGC	18	5744
SCNN1A-1896	−	CUCAUGAAGGGGAACAAGC	19	5745
SCNN1A-176	−	GCUCAUGAAGGGGAACAAGC	20	811
SCNN1A-1897	−	GGCUCAUGAAGGGGAACAAGC	21	5746
SCNN1A-1898	−	GGGCUCAUGAAGGGGAACAAGC	22	5747
SCNN1A-1899	−	AGGGCUCAUGAAGGGGAACAAGC	23	5748
SCNN1A-1900	−	CAGGGCUCAUGAAGGGGAACAAGC	24	5749
SCNN1A-1916	−	GGAACAAGCGUGAGGAGC	18	5765
SCNN1A-1917	−	GGGAACAAGCGUGAGGAGC	19	5766
SCNN1A-14	−	GGGGAACAAGCGUGAGGAGC	20	506
SCNN1A-1918	−	AGGGGAACAAGCGUGAGGAGC	21	5767
SCNN1A-1919	−	AAGGGGAACAAGCGUGAGGAGC	22	5768
SCNN1A-1920	−	GAAGGGGAACAAGCGUGAGGAGC	23	5769
SCNN1A-1921	−	UGAAGGGGAACAAGCGUGAGGAGC	24	5770
SCNN1A-1922	−	UGCUCCCAGCACAACCGC	18	5771
SCNN1A-1923	−	GUGCUCCCAGCACAACCGC	19	5772
SCNN1A-193	−	UGUGCUCCCAGCACAACCGC	20	823
SCNN1A-1924	−	GUGUGCUCCCAGCACAACCGC	21	5773
SCNN1A-1925	−	GGUGUGCUCCCAGCACAACCGC	22	5774
SCNN1A-1926	−	UGGUGUGCUCCCAGCACAACCGC	23	5775
SCNN1A-1927	−	CUGGUGUGCUCCCAGCACAACCGC	24	5776
SCNN1A-11057	−	CUUCCCUGGUGCCUGCGC	18	14906
SCNN1A-11058	−	CCUUCCCUGGUGCCUGCGC	19	14907
SCNN1A-11059	−	CCCUUCCCUGGUGCCUGCGC	20	14908
SCNN1A-11060	−	CCCCUUCCCUGGUGCCUGCGC	21	14909
SCNN1A-11061	−	GCCCCUUCCCUGGUGCCUGCGC	22	14910
SCNN1A-11062	−	UGCCCCUUCCCUGGUGCCUGCGC	23	14911
SCNN1A-11063	−	CUGCCCCUUCCCUGGUGCCUGCGC	24	14912
SCNN1A-1948	−	GCCCUCCACAGUCCACUC	18	5797
SCNN1A-1949	−	AGCCCUCCACAGUCCACUC	19	5798
SCNN1A-170	−	UAGCCCUCCACAGUCCACUC	20	808
SCNN1A-1954	−	CAGUCCACUCCAGGGCUC	18	5803
SCNN1A-1955	−	ACAGUCCACUCCAGGGCUC	19	5804
SCNN1A-171	−	CACAGUCCACUCCAGGGCUC	20	809
SCNN1A-1956	−	CCACAGUCCACUCCAGGGCUC	21	5805
SCNN1A-1957	−	UCCACAGUCCACUCCAGGGCUC	22	5806
SCNN1A-1958	−	CUCCACAGUCCACUCCAGGGCUC	23	5807
SCNN1A-1959	−	CCUCCACAGUCCACUCCAGGGCUC	24	5808
SCNN1A-1995	−	ACUCCAGGGCUCAUGAAG	18	5844
SCNN1A-1996	−	CACUCCAGGGCUCAUGAAG	19	5845
SCNN1A-12	−	CCACUCCAGGGCUCAUGAAG	20	561
SCNN1A-1997	−	UCCACUCCAGGGCUCAUGAAG	21	5846
SCNN1A-1998	−	GUCCACUCCAGGGCUCAUGAAG	22	5847
SCNN1A-1999	−	AGUCCACUCCAGGGCUCAUGAAG	23	5848
SCNN1A-2000	−	CAGUCCACUCCAGGGCUCAUGAAG	24	5849
SCNN1A-2017	−	GGGAACAAGCGUGAGGAG	18	5866
SCNN1A-2018	−	GGGGAACAAGCGUGAGGAG	19	5867
SCNN1A-179	−	AGGGGAACAAGCGUGAGGAG	20	813
SCNN1A-2019	−	AAGGGGAACAAGCGUGAGGAG	21	5868
SCNN1A-2020	−	GAAGGGGAACAAGCGUGAGGAG	22	5869
SCNN1A-2021	−	UGAAGGGGAACAAGCGUGAGGAG	23	5870
SCNN1A-2022	−	AUGAAGGGGAACAAGCGUGAGGAG	24	5871
SCNN1A-2023	−	CAGCAGCCCACGGCGGAG	18	5872
SCNN1A-2024	−	CCAGCAGCCCACGGCGGAG	19	5873
SCNN1A-187	−	CCCAGCAGCCCACGGCGGAG	20	818
SCNN1A-2025	−	CCCCAGCAGCCCACGGCGGAG	21	5874
SCNN1A-2026	−	GCCCCAGCAGCCCACGGCGGAG	22	5875
SCNN1A-2027	−	CGCCCCAGCAGCCCACGGCGGAG	23	5876
SCNN1A-2028	−	GCGCCCCAGCAGCCCACGGCGGAG	24	5877
SCNN1A-2035	−	GCGCCCCAGCAGCCCACG	18	5884
SCNN1A-2036	−	GGCGCCCCAGCAGCCCACG	19	5885
SCNN1A-183	−	CGGCGCCCCAGCAGCCCACG	20	816
SCNN1A-2037	−	GCGGCGCCCCAGCAGCCCACG	21	5886
SCNN1A-2038	−	UGCGGCGCCCCAGCAGCCCACG	22	5887
SCNN1A-2039	−	CUGCGGCGCCCCAGCAGCCCACG	23	5888
SCNN1A-2040	−	CCUGCGGCGCCCCAGCAGCCCACG	24	5889
SCNN1A-2041	−	CCCCAGCAGCCCACGGCG	18	5890
SCNN1A-2042	−	GCCCCAGCAGCCCACGGCG	19	5891
SCNN1A-185	−	CGCCCCAGCAGCCCACGGCG	20	817
SCNN1A-2043	−	GCGCCCCAGCAGCCCACGGCG	21	5892
SCNN1A-2044	−	GGCGCCCCAGCAGCCCACGGCG	22	5893
SCNN1A-2045	−	CGGCGCCCCAGCAGCCCACGGCG	23	5894
SCNN1A-2046	−	GCGGCGCCCCAGCAGCCCACGGCG	24	5895
SCNN1A-11064	−	CCUUUGGGGAGGGAAAGG	18	14913
SCNN1A-11065	−	CCCUUUGGGGAGGGAAAGG	19	14914
SCNN1A-11066	−	CCCCUUUGGGGAGGGAAAGG	20	14915
SCNN1A-11067	−	UCCCCUUUGGGGAGGGAAAGG	21	14916
SCNN1A-11068	−	CUCCCCUUUGGGGAGGGAAAGG	22	14917
SCNN1A-11069	−	GCUCCCCUUUGGGGAGGGAAAGG	23	14918
SCNN1A-11070	−	GGCUCCCCUUUGGGGAGGGAAAGG	24	14919
SCNN1A-11071	−	UGACACCCCUGUCCCAGG	18	14920
SCNN1A-11072	−	CUGACACCCCUGUCCCAGG	19	14921
SCNN1A-11073	−	ACUGACACCCCUGUCCCAGG	20	14922
SCNN1A-11074	−	AACUGACACCCCUGUCCCAGG	21	14923
SCNN1A-11075	−	GAACUGACACCCCUGUCCCAGG	22	14924
SCNN1A-11076	−	GGAACUGACACCCCUGUCCCAGG	23	14925
SCNN1A-11077	−	GGGAACUGACACCCCUGUCCCAGG	24	14926
SCNN1A-11078	−	AGGUGCUCACUGGGCAGG	18	14927
SCNN1A-11079	−	GAGGUGCUCACUGGGCAGG	19	14928
SCNN1A-11080	−	UGAGGUGCUCACUGGGCAGG	20	14929
SCNN1A-11081	−	CUGAGGUGCUCACUGGGCAGG	21	14930
SCNN1A-11082	−	GCUGAGGUGCUCACUGGGCAGG	22	14931
SCNN1A-11083	−	UGCUGAGGUGCUCACUGGGCAGG	23	14932
SCNN1A-11084	−	GUGCUGAGGUGCUCACUGGGCAGG	24	14933
SCNN1A-2050	−	AGCAGCCCACGGCGGAGG	18	5899
SCNN1A-2051	−	CAGCAGCCCACGGCGGAGG	19	5900
SCNN1A-23	−	CCAGCAGCCCACGGCGGAGG	20	566
SCNN1A-2052	−	CCCAGCAGCCCACGGCGGAGG	21	5901
SCNN1A-2053	−	CCCCAGCAGCCCACGGCGGAGG	22	5902
SCNN1A-2054	−	GCCCCAGCAGCCCACGGCGGAGG	23	5903
SCNN1A-2055	−	CGCCCCAGCAGCCCACGGCGGAGG	24	5904
SCNN1A-11085	−	AGAGCCUCAGACCUGAGG	18	14934
SCNN1A-11086	−	CAGAGCCUCAGACCUGAGG	19	14935
SCNN1A-11087	−	GCAGAGCCUCAGACCUGAGG	20	14936
SCNN1A-11088	−	GGCAGAGCCUCAGACCUGAGG	21	14937
SCNN1A-11089	−	AGGCAGAGCCUCAGACCUGAGG	22	14938
SCNN1A-11090	−	CAGGCAGAGCCUCAGACCUGAGG	23	14939
SCNN1A-11091	−	GCAGGCAGAGCCUCAGACCUGAGG	24	14940
SCNN1A-2056	−	CGCCCCAGCAGCCCACGG	18	5905
SCNN1A-2057	−	GCGCCCCAGCAGCCCACGG	19	5906
SCNN1A-21	−	GGCGCCCCAGCAGCCCACGG	20	510
SCNN1A-2058	−	CGGCGCCCCAGCAGCCCACGG	21	5907
SCNN1A-2059	−	GCGGCGCCCCAGCAGCCCACGG	22	5908
SCNN1A-2060	−	UGCGGCGCCCCAGCAGCCCACGG	23	5909
SCNN1A-2061	−	CUGCGGCGCCCCAGCAGCCCACGG	24	5910
SCNN1A-11092	−	UGCCACUCCCAUACCCGG	18	14941
SCNN1A-11093	−	UUGCCACUCCCAUACCCGG	19	14942
SCNN1A-11094	−	AUUGCCACUCCCAUACCCGG	20	14943
SCNN1A-11095	−	CAUUGCCACUCCCAUACCCGG	21	14944
SCNN1A-11096	−	GCAUUGCCACUCCCAUACCCGG	22	14945
SCNN1A-11097	−	CGCAUUGCCACUCCCAUACCCGG	23	14946
SCNN1A-11098	−	UCGCAUUGCCACUCCCAUACCCGG	24	14947
SCNN1A-2062	−	CCCAGCAGCCCACGGCGG	18	5911
SCNN1A-2063	−	CCCCAGCAGCCCACGGCGG	19	5912
SCNN1A-22	−	GCCCCAGCAGCCCACGGCGG	20	511
SCNN1A-2064	−	CGCCCCAGCAGCCCACGGCGG	21	5913
SCNN1A-2065	−	GCGCCCCAGCAGCCCACGGCGG	22	5914
SCNN1A-2066	−	GGCGCCCCAGCAGCCCACGGCGG	23	5915
SCNN1A-2067	−	CGGCGCCCCAGCAGCCCACGGCGG	24	5916
SCNN1A-11099	−	GAGCCUCAGACCUGAGGG	18	14948
SCNN1A-11100	−	AGAGCCUCAGACCUGAGGG	19	14949
SCNN1A-6341	−	CAGAGCCUCAGACCUGAGGG	20	10190
SCNN1A-11101	−	GCAGAGCCUCAGACCUGAGGG	21	14950
SCNN1A-11102	−	GGCAGAGCCUCAGACCUGAGGG	22	14951
SCNN1A-11103	−	AGGCAGAGCCUCAGACCUGAGGG	23	14952
SCNN1A-11104	−	CAGGCAGAGCCUCAGACCUGAGGG	24	14953
SCNN1A-2074	−	AAGCGUGAGGAGCAGGGG	18	5923
SCNN1A-2075	−	CAAGCGUGAGGAGCAGGGG	19	5924
SCNN1A-181	−	ACAAGCGUGAGGAGCAGGGG	20	814
SCNN1A-2076	−	AACAAGCGUGAGGAGCAGGGG	21	5925
SCNN1A-2077	−	GAACAAGCGUGAGGAGCAGGGG	22	5926
SCNN1A-2078	−	GGAACAAGCGUGAGGAGCAGGGG	23	5927
SCNN1A-2079	−	GGGAACAAGCGUGAGGAGCAGGGG	24	5928
SCNN1A-11105	−	GGUGGCUCCCCUUUGGGG	18	14954
SCNN1A-11106	−	UGGUGGCUCCCCUUUGGGG	19	14955
SCNN1A-6342	−	AUGGUGGCUCCCCUUUGGGG	20	10191
SCNN1A-11107	−	UAUGGUGGCUCCCCUUUGGGG	21	14956
SCNN1A-11108	−	UUAUGGUGGCUCCCCUUUGGGG	22	14957
SCNN1A-11109	−	AUUAUGGUGGCUCCCCUUUGGGG	23	14958
SCNN1A-11110	−	AAUUAUGGUGGCUCCCCUUUGGGG	24	14959
SCNN1A-11111	−	UGGUGGCUCCCCUUUGGG	18	14960
SCNN1A-11112	−	AUGGUGGCUCCCCUUUGGG	19	14961
SCNN1A-11113	−	UAUGGUGGCUCCCCUUUGGG	20	14962
SCNN1A-11114	−	UUAUGGUGGCUCCCCUUUGGG	21	14963
SCNN1A-11115	−	AUUAUGGUGGCUCCCCUUUGGG	22	14964
SCNN1A-11116	−	AAUUAUGGUGGCUCCCCUUUGGG	23	14965
SCNN1A-11117	−	AAAUUAUGGUGGCUCCCCUUUGGG	24	14966
SCNN1A-2105	−	UCCACUCCAGGGCUCAUG	18	5954
SCNN1A-2106	−	GUCCACUCCAGGGCUCAUG	19	5955
SCNN1A-172	−	AGUCCACUCCAGGGCUCAUG	20	810
SCNN1A-2107	−	CAGUCCACUCCAGGGCUCAUG	21	5956
SCNN1A-2108	−	ACAGUCCACUCCAGGGCUCAUG	22	5957
SCNN1A-2109	−	CACAGUCCACUCCAGGGCUCAUG	23	5958
SCNN1A-2110	−	CCACAGUCCACUCCAGGGCUCAUG	24	5959
SCNN1A-2137	−	UGAAGGGGAACAAGCGUG	18	5986
SCNN1A-2138	−	AUGAAGGGGAACAAGCGUG	19	5987
SCNN1A-13	−	CAUGAAGGGGAACAAGCGUG	20	562
SCNN1A-2139	−	UCAUGAAGGGGAACAAGCGUG	21	5988
SCNN1A-2140	−	CUCAUGAAGGGGAACAAGCGUG	22	5989
SCNN1A-2141	−	GCUCAUGAAGGGGAACAAGCGUG	23	5990
SCNN1A-2142	−	GGCUCAUGAAGGGGAACAAGCGUG	24	5991
SCNN1A-11118	−	GAAGGGUGGUCCAGGGUG	18	14967
SCNN1A-11119	−	GGAAGGGUGGUCCAGGGUG	19	14968
SCNN1A-11120	−	UGGAAGGGUGGUCCAGGGUG	20	14969
SCNN1A-11121	−	CUGGAAGGGUGGUCCAGGGUG	21	14970
SCNN1A-11122	−	CCUGGAAGGGUGGUCCAGGGUG	22	14971
SCNN1A-11123	−	GCCUGGAAGGGUGGUCCAGGGUG	23	14972
SCNN1A-11124	−	CGCCUGGAAGGGUGGUCCAGGGUG	24	14973
SCNN1A-11125	−	CUAUAUACUUCUGUAUUG	18	14974
SCNN1A-11126	−	UCUAUAUACUUCUGUAUUG	19	14975
SCNN1A-11127	−	CUCUAUAUACUUCUGUAUUG	20	14976
SCNN1A-11128	−	GCUCUAUAUACUUCUGUAUUG	21	14977
SCNN1A-11129	−	AGCUCUAUAUACUUCUGUAUUG	22	14978
SCNN1A-11130	−	AAGCUCUAUAUACUUCUGUAUUG	23	14979
SCNN1A-11131	−	GAAGCUCUAUAUACUUCUGUAUUG	24	14980
SCNN1A-11132	−	AAGCAAAAAUGGAAGUUG	18	14981
SCNN1A-11133	−	AAAGCAAAAAUGGAAGUUG	19	14982
SCNN1A-11134	−	AAAAGCAAAAAUGGAAGUUG	20	14983
SCNN1A-11135	−	UAAAAGCAAAAAUGGAAGUUG	21	14984
SCNN1A-11136	−	AUAAAAGCAAAAAUGGAAGUUG	22	14985
SCNN1A-11137	−	AAUAAAAGCAAAAAUGGAAGUUG	23	14986
SCNN1A-11138	−	AAAUAAAAGCAAAAAUGGAAGUUG	24	14987
SCNN1A-11139	−	UAUGGUGGCUCCCCUUUG	18	14988
SCNN1A-11140	−	UUAUGGUGGCUCCCCUUUG	19	14989
SCNN1A-6348	−	AUUAUGGUGGCUCCCCUUUG	20	10197
SCNN1A-11141	−	AAUUAUGGUGGCUCCCCUUUG	21	14990
SCNN1A-11142	−	AAAUUAUGGUGGCUCCCCUUUG	22	14991
SCNN1A-11143	−	CAAAUUAUGGUGGCUCCCCUUUG	23	14992
SCNN1A-11144	−	ACAAAUUAUGGUGGCUCCCCUUUG	24	14993
SCNN1A-11145	−	CCUGUCUCUAAGAUAAAU	18	14994
SCNN1A-11146	−	UCCUGUCUCUAAGAUAAAU	19	14995
SCNN1A-11147	−	AUCCUGUCUCUAAGAUAAAU	20	14996
SCNN1A-11148	−	GAUCCUGUCUCUAAGAUAAAU	21	14997
SCNN1A-11149	−	UGAUCCUGUCUCUAAGAUAAAU	22	14998
SCNN1A-11150	−	AUGAUCCUGUCUCUAAGAUAAAU	23	14999
SCNN1A-11151	−	CAUGAUCCUGUCUCUAAGAUAAAU	24	15000
SCNN1A-11152	−	AGGGAAAGGAAGGGGACU	18	15001
SCNN1A-11153	−	GAGGGAAAGGAAGGGGACU	19	15002
SCNN1A-11154	−	GGAGGGAAAGGAAGGGGACU	20	15003
SCNN1A-11155	−	GGGAGGGAAAGGAAGGGGACU	21	15004
SCNN1A-11156	−	GGGGAGGGAAAGGAAGGGGACU	22	15005
SCNN1A-11157	−	UGGGGAGGGAAAGGAAGGGGACU	23	15006
SCNN1A-11158	−	UUGGGGAGGGAAAGGAAGGGGACU	24	15007
SCNN1A-11159	−	AAUUAUGGUGGCUCCCCU	18	15008
SCNN1A-11160	−	AAAUUAUGGUGGCUCCCCU	19	15009
SCNN1A-11161	−	CAAAUUAUGGUGGCUCCCCU	20	15010
SCNN1A-11162	−	ACAAAUUAUGGUGGCUCCCCU	21	15011
SCNN1A-11163	−	UACAAAUUAUGGUGGCUCCCCU	22	15012
SCNN1A-11164	−	AUACAAAUUAUGGUGGCUCCCCU	23	15013
SCNN1A-11165	−	UAUACAAAUUAUGGUGGCUCCCCU	24	15014
SCNN1A-2170	−	AUGAAGGGGAACAAGCGU	18	6019
SCNN1A-2171	−	CAUGAAGGGGAACAAGCGU	19	6020
SCNN1A-177	−	UCAUGAAGGGGAACAAGCGU	20	812
SCNN1A-2172	−	CUCAUGAAGGGGAACAAGCGU	21	6021
SCNN1A-2173	−	GCUCAUGAAGGGGAACAAGCGU	22	6022
SCNN1A-2174	−	GGCUCAUGAAGGGGAACAAGCGU	23	6023
SCNN1A-2175	−	GGGCUCAUGAAGGGGAACAAGCGU	24	6024
SCNN1A-11166	−	AGCCUCAGACCUGAGGGU	18	15015
SCNN1A-11167	−	GAGCCUCAGACCUGAGGGU	19	15016
SCNN1A-6357	−	AGAGCCUCAGACCUGAGGGU	20	10206
SCNN1A-11168	−	CAGAGCCUCAGACCUGAGGGU	21	15017
SCNN1A-11169	−	GCAGAGCCUCAGACCUGAGGGU	22	15018
SCNN1A-11170	−	GGCAGAGCCUCAGACCUGAGGGU	23	15019
SCNN1A-11171	−	AGGCAGAGCCUCAGACCUGAGGGU	24	15020
SCNN1A-11172	−	AUUAUGGUGGCUCCCCUU	18	15021
SCNN1A-11173	−	AAUUAUGGUGGCUCCCCUU	19	15022
SCNN1A-6360	−	AAAUUAUGGUGGCUCCCCUU	20	10209
SCNN1A-11174	−	CAAAUUAUGGUGGCUCCCCUU	21	15023
SCNN1A-11175	−	ACAAAUUAUGGUGGCUCCCCUU	22	15024
SCNN1A-11176	−	UACAAAUUAUGGUGGCUCCCCUU	23	15025
SCNN1A-11177	−	AUACAAAUUAUGGUGGCUCCCCUU	24	15026
SCNN1A-2183	−	CCGCAUGAAGACGGCCUU	18	6032
SCNN1A-2184	−	ACCGCAUGAAGACGGCCUU	19	6033
SCNN1A-194	−	AACCGCAUGAAGACGGCCUU	20	824
SCNN1A-2185	−	CAACCGCAUGAAGACGGCCUU	21	6034
SCNN1A-2186	−	ACAACCGCAUGAAGACGGCCUU	22	6035
SCNN1A-2187	−	CACAACCGCAUGAAGACGGCCUU	23	6036
SCNN1A-2188	−	GCACAACCGCAUGAAGACGGCCUU	24	6037
SCNN1A-11178	−	UUAUGGUGGCUCCCCUUU	18	15027
SCNN1A-11179	−	AUUAUGGUGGCUCCCCUUU	19	15028
SCNN1A-6361	−	AAUUAUGGUGGCUCCCCUUU	20	10210
SCNN1A-11180	−	AAAUUAUGGUGGCUCCCCUUU	21	15029
SCNN1A-11181	−	CAAAUUAUGGUGGCUCCCCUUU	22	15030
SCNN1A-11182	−	ACAAAUUAUGGUGGCUCCCCUUU	23	15031
SCNN1A-11183	−	UACAAAUUAUGGUGGCUCCCCUUU	24	15032
SCNN1A-2189	−	GGCAAUUCGGCCUGCUUU	18	6038
SCNN1A-2190	−	UGGCAAUUCGGCCUGCUUU	19	6039
SCNN1A-195	−	CUGGCAAUUCGGCCUGCUUU	20	825
SCNN1A-2191	−	ACUGGCAAUUCGGCCUGCUUU	21	6040
SCNN1A-2192	−	UACUGGCAAUUCGGCCUGCUUU	22	6041
SCNN1A-2193	−	GUACUGGCAAUUCGGCCUGCUUU	23	6042
SCNN1A-2194	−	UGUACUGGCAAUUCGGCCUGCUUU	24	6043
SCNN1A-2195	−	GCAAUUCGGCCUGCUUUU	18	6044
SCNN1A-2196	−	GGCAAUUCGGCCUGCUUUU	19	6045
SCNN1A-34	−	UGGCAAUUCGGCCUGCUUUU	20	573
SCNN1A-2197	−	CUGGCAAUUCGGCCUGCUUUU	21	6046
SCNN1A-2198	−	ACUGGCAAUUCGGCCUGCUUUU	22	6047
SCNN1A-2199	−	UACUGGCAAUUCGGCCUGCUUUU	23	6048
SCNN1A-2200	−	GUACUGGCAAUUCGGCCUGCUUUU	24	6049

Table 48A provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the first tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), have a high level of orthogonality and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. miningtidis eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

Table 48A
1st Tier
			Target
gRNA	DNA		Site
Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-	+	GUGAAAGCCGGUGUCAA	17	15033
11184
SCNN1A-	−	GUUUUCUAACCUCAGAA	17	15034
11185
SCNN1A-	−	GCUGCAUUAAGUUUGGA	17	15035
11186
SCNN1A-5020	+	GGCUAGAGUCCUGCUCC	17	8869
SCNN1A-5021	+	GUCUAGGGUCCUGCUCC	17	8870
SCNN1A-	−	GAUGCUAAUGAGAUUCC	17	15036
11187
SCNN1A-5106	+	GAAGGCGGACUCUGGGC	17	8955
SCNN1A-5022	+	GAUUCCAAACCAGGUUC	17	8871
SCNN1A-	+	GGCCAAAAGUGCCGGAG	17	15037
11188
SCNN1A-	−	GAUGACACCUUCUCUGG	17	15038
11189
SCNN1A-	−	GCUGCCUUAAGCUAGUG	17	15039
11190
SCNN1A-	−	GCUAAACUCCUUGCUUG	17	15040
11191
SCNN1A-	−	GGAGUGAGGGAGGCCUU	17	15041
11192
SCNN1A-	+	GAGCAAGGGGGGAGUCCCAA	20	15042
11193
SCNN1A-	−	GGUUUGGAAUCCUGGUUGAC	20	15043
11194
SCNN1A-	+	GCUCAGGGUCCAACCUGGUC	20	15044
11195
SCNN1A-	+	GGCCCUGACCUCGAGCUGUG	20	15045
11196
SCNN1A-	−	GGGGGAGGAGAGGUUUGGCU	20	15046
11197
SCNN1A-	−	GUGGGAGUGAGGGAGGCCUU	20	15047
11198
SCNN1A-	+	GGUUUCUAUUUGUACACUUU	20	15048
11199

Table 48B provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the second tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and have a high level of orthogonality. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. miningtidis eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 48B
2nd Tier
			Target
gRNA	DNA		Site
Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-	+	CAAGGGGGGAGUCCCAA	17	15049
11200
SCNN1A-	+	UCCCCUUGGAAGGGACA	17	15050
11201
SCNN1A-	−	CUUUAAUUGAGAUGCUA	17	15051
11202
SCNN1A-	−	UUGGAAUCCUGGUUGAC	17	15052
11203
SCNN1A-	+	AUGCCUGAAAUCCAACC	17	15053
11204
SCNN1A-	+	CACUCCCACACAGAGCC	17	15054
11205
SCNN1A-	−	UAGGGCCCCGCCUAGCC	17	15055
11206
SCNN1A-	+	AGGAGGUCUGGGCUGCC	17	15056
11207
SCNN1A-	+	UGGUCCCUCCUCUUUCC	17	15057
11208
SCNN1A-	+	CACGCGGCAGGGAAGGC	17	15058
11209
SCNN1A-	+	CCCUAGAACGGCCUCUC	17	15059
11210
SCNN1A-	+	CAGGGUCCAACCUGGUC	17	15060
11211
SCNN1A-	+	AGUGCAGGAAUGUGGUC	17	15061
11212
SCNN1A-5426	−	CUCUGUGACCACAGCAG	17	9275
SCNN1A-5024	+	CCCUUCAUGAGCCCCGG	17	8873
SCNN1A-6029	−	AAAUAGAAAAGGCAGGG	17	9878
SCNN1A-	−	CCUCCAGCCCUUUUUGG	17	15062
11213
SCNN1A-	+	CCUGACCUCGAGCUGUG	17	15063
11214
SCNN1A-	+	CUAACAAAAGUGCAGAU	17	15064
11215
SCNN1A-	−	UCUUUGCCUGCUAAACU	17	15065
11216
SCNN1A-	+	CUCUGGGGCUAUCUACU	17	15066
11217
SCNN1A-	+	UUCUAUUUGUACACUUU	17	15067
11218
SCNN1A-	+	AAAGUGAAAGCCGGUGUCAA	20	15068
11219
SCNN1A-	−	UUUGUUUUCUAACCUCAGAA	20	15069
11220
SCNN1A-	+	ACCUCCCCUUGGAAGGGACA	20	15070
11221
SCNN1A-9203	−	UUUGCUGCAUUAAGUUUGGA	20	13052
SCNN1A-9243	−	CACCUUUAAUUGAGAUGCUA	20	13092
SCNN1A-	+	CUCAUGCCUGAAAUCCAACC	20	15071
11222
SCNN1A-	+	CCUCACUCCCACACAGAGCC	20	15072
11223
SCNN1A-	−	UCCUAGGGCCCCGCCUAGCC	20	15073
11224
SCNN1A-	+	UCCAGGAGGUCUGGGCUGCC	20	15074
11225
SCNN1A-	−	UGAGAUGCUAAUGAGAUUCC	20	15075
11226
SCNN1A-	+	UCCUGGUCCCUCCUCUUUCC	20	15076
11227
SCNN1A-	+	CUGCACGCGGCAGGGAAGGC	20	15077
11228
SCNN1A-	+	CUUCCCUAGAACGGCCUCUC	20	15078
11229
SCNN1A-	+	CAGAGUGCAGGAAUGUGGUC	20	15079
11230
SCNN1A-5650	−	CAACUCUGUGACCACAGCAG	20	9499
SCNN1A-8013	+	UGGGGCCAAAAGUGCCGGAG	20	11862
SCNN1A-5027	+	UUCCCCUUCAUGAGCCCCGG	20	8876
SCNN1A-	−	UCUCCUCCAGCCCUUUUUGG	20	15080
11231
SCNN1A-	−	CAUGCUGCCUUAAGCUAGUG	20	15081
11232
SCNN1A-	−	CCUGCUAAACUCCUUGCUUG	20	15082
11233
SCNN1A-	+	CUUCUAACAAAAGUGCAGAU	20	15083
11234
SCNN1A-	−	UCUUCUUUGCCUGCUAAACU	20	15084
11235
SCNN1A-	+	CUCCUCUGGGGCUAUCUACU	20	15085
11236
SCNN1A-	−	CUCAGGCUGGGCCUUUGUCU	20	15086
11237
SCNN1A-	−	AUCCUCCCUGCACCUUCAGU	20	15087
11238

Table 48C provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the third tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS) and start with a 5′G. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. miningtidis eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 48C
3rd Tier
			Target
gRNA	DNA		Site
Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-	−	GGGGGAGAGGAAGAGAG	17	15088
11239
SCNN1A-	−	GGAGGAGAGGUUUGGCU	17	15089
11240
SCNN1A-5029	+	GAGGGCUAGAGUCCUGCUCC	20	8878
SCNN1A-5030	+	GAGGUCUAGGGUCCUGCUCC	20	8879
SCNN1A-5263	−	GGCAAAUAGAAAAGGCAGGG	20	9112

Table 48D provides exemplary targeting domains for knocking out the SCNN1A gene selected according to the fourth tier parameters. The targeting domains bind within 500 bp (e.g., upstream or downstream) of a transcription start site (TSS). It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. miningtidis eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

Table 48D
4th Tier
			Target
gRNA	DNA		Site
Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-	−	AGGCUGGGCCUUUGUCU	17	15090
11241
SCNN1A-	−	CUCCCUGCACCUUCAGU	17	15091
11242
SCNN1A-5613	+	UGAGAAGGCGGACUCUGGGC	20	9462
SCNN1A-5032	+	CAGGAUUCCAAACCAGGUUC	20	8881
SCNN1A-	−	AGGGGGGGAGAGGAAGAGAG	20	15092
11243
SCNN1A-	−	AGAGAUGACACCUUCUCUGG	20	15093
11244

Table 48E provides exemplary targeting domains for knocking down the SCNN1A gene selected according to the fifth tier parameters. The targeting domains bind within the additional 500 bp (e.g., upstream or downstream) of a transcription start site (TSS), e.g., extending to 1 kb upstream and downstream of a TSS. It is contemplated herein that in an embodiment the targeting domain hybridizes to the target domain through complementary base pairing. Any of the targeting domains in the table can be used with a N. miningtidis eiCas9 molecule or eiCas9 fusion protein (e.g., an eiCas9 fused to a transcription repressor domain) to alter the SCNN1A gene (e.g., reduce or eliminate SCNN1A gene expression, SCNN1A protein function, or the level of SCNN1A protein). One or more gRNA may be used to target an eiCas9 to the promoter region of the SCNN1A gene.

TABLE 48E
5th Tier
	DNA		Target Site
gRNA Name	Strand	Targeting Domain	Length	Seq ID
SCNN1A-11245	+	ACCUGGAGCGGGCUAGA	17	15094
SCNN1A-11246	+	AGCAAUACAGAAGUAUA	17	15095
SCNN1A-5028	+	GGCCCAGCCCCUGCUCC	17	8877
SCNN1A-322	+	UGGUCACUGCGGGGAAG	17	915
SCNN1A-5023	−	GAUGUACUGGCAAUUCG	17	8872
SCNN1A-5025	+	AGGGACUAACCGACCUG	17	8874
SCNN1A-11247	+	GUUUCUACAACUUCCAU	17	15096
SCNN1A-11248	−	CUGACCAAAGUCCAGGU	17	15097
SCNN1A-11249	+	UAGACCUGGAGCGGGCUAGA	20	15098
SCNN1A-10791	+	UUCAGCAAUACAGAAGUAUA	20	14640
SCNN1A-5031	+	CGGGGCCCAGCCCCUGCUCC	20	8880
SCNN1A-238	+	AGAUGGUCACUGCGGGGAAG	20	858
SCNN1A-5026	−	CAUGAUGUACUGGCAAUUCG	20	8875
SCNN1A-1657	+	CAGAGGGACUAACCGACCUG	20	5506
SCNN1A-11250	+	UAUGUUUCUACAACUUCCAU	20	15099
SCNN1A-11251	−	CUUCUGACCAAAGUCCAGGU	20	15100

III. Cas9 Molecules

Cas9 molecules of a variety of species can be used in the methods and compositions described herein. While the S. pyogenes, S. aureus and S. thermophilus Cas9 molecules are the subject of much of the disclosure herein, Cas9 molecules of, derived from, or based on the Cas9 proteins of other species listed herein can be used as well. In other words, while the much of the description herein uses S. pyogenes and S. thermophilus Cas9 molecules, Cas9 molecules from the other species can replace them, e.g., Staphylococcus aureus and Neisseria meningitidis Cas9 molecules. Additional Cas9 species include: Acidovorax avenae, Actinobacillus pleuropneumoniae, Actinobacillus succinogenes, Actinobacillus suis, Actinomyces sp., Cycliphilus denitrificans, Aminomonas paucivorans, Bacillus cereus, Bacillus smithi, Bacillus thuringiensis, Bacteroides sp., Blastopirellula marina, Bradyrhizobium sp., Brevibacillus laterosporus, Campylobacter coli, Campylobacter jejuni, Campylobacter lari, Candidatus puniceispirillum, Clostridium cellulolyticum, Clostridium perfringens, Corynebacterium accolens, Corynebacterium diphtheria, Corynebacterium matruchotii, Dinoroseobacter shibae, Eubacterium dolichum, Gamma proteobacterium, Gluconacetobacter diazotrophicus, Haemophilus parainfluenzae, Haemophilus sputorum, Helicobacter canadensis, Helicobacter cinaedi, Helicobacter mustelae, Ilyobacter polytropus, Kingella kingae, Lactobacillus crispatus, Listeria ivanovii, Listeria monocytogenes, Listeriaceae bacterium, Methylocystis sp., Methylosinus trichosporium, Mobiluncus mulieris, Neisseria bacilliformis, Neisseria cinerea, Neisseria flavescens, Neisseria lactamica, Neisseria meningitidis, Neisseria sp., Neisseria wadsworthii, Nitrosomonas sp., Parvibaculum lavamentivorans, Pasteurella multocida, Phascolarctobacterium succinatutens, Ralstonia syzygii, Rhodopseudomonas palustris, Rhodovulum sp., Simonsiella muelleri, Sphingomonas sp., Sporolactobacillus vineae, Staphylococcus lugdunensis, Streptococcus sp., Subdoligranulum sp., Tistrella mobilis, Treponema sp., or Verminephrobacter eiseniae.

A Cas9 molecule or Cas9 polypeptide, as that term is used herein, refers to a molecule or polypeptide that can interact with a guide RNA (gRNA) molecule and, in concert with the gRNA molecule, home or localizes to a site which comprises a target domain and PAM sequence. Cas9 molecule and Cas9 polypeptide, as those terms are used herein, refer to naturally occurring Cas9 molecules and to engineered, altered, or modified Cas9 molecules or Cas9 polypeptides that differ, e.g., by at least one amino acid residue, from a reference sequence, e.g., the most similar naturally occurring Cas9 molecule or a sequence of Table 50.

Cas9 Domains

Crystal structures have been determined for two different naturally occurring bacterial Cas9 molecules (Jinek et al., Science, 343(6176):1247997, 2014) and for S. pyogenes Cas9 with a guide RNA (e.g., a synthetic fusion of crRNA and tracrRNA) (Nishimasu et al., Cell, 156:935-949, 2014; and Anders et al., Nature, 2014, doi: 10.1038/nature13579).

A naturally occurring Cas9 molecule comprises two lobes: a recognition (REC) lobe and a nuclease (NUC) lobe; each of which further comprises domains described herein. FIGS. 9A-9B provide a schematic of the organization of important Cas9 domains in the primary structure. The domain nomenclature and the numbering of the amino acid residues encompassed by each domain used throughout this disclosure is as described in Nishimasu et al. The numbering of the amino acid residues is with reference to Cas9 from S. pyogenes.

The REC lobe comprises the arginine-rich bridge helix (BH), the REC1 domain, and the REC2 domain. The REC lobe does not share structural similarity with other known proteins, indicating that it is a Cas9-specific functional domain. The BH domain is a long α helix and arginine rich region and comprises amino acids 60-93 of the sequence of S. pyogenes Cas9. The REC1 domain is important for recognition of the repeat:anti-repeat duplex, e.g., of a gRNA or a tracrRNA, and is therefore critical for Cas9 activity by recognizing the target sequence. The REC1 domain comprises two REC1 motifs at amino acids 94 to 179 and 308 to 717 of the sequence of S. pyogenes Cas9. These two REC1 domains, though separated by the REC2 domain in the linear primary structure, assemble in the tertiary structure to form the REC1 domain. The REC2 domain, or parts thereof, may also play a role in the recognition of the repeat:anti-repeat duplex. The REC2 domain comprises amino acids 180-307 of the sequence of S. pyogenes Cas9.

The NUC lobe comprises the RuvC domain (also referred to herein as RuvC-like domain), the HNH domain (also referred to herein as HNH-like domain), and the PAM-interacting (PI) domain. The RuvC domain shares structural similarity to retroviral integrase superfamily members and cleaves a single strand, e.g., the non-complementary strand of the target nucleic acid molecule. The RuvC domain is assembled from the three split RuvC motifs (RuvC I, RuvCII, and RuvCIII, which are often commonly referred to in the art as RuvCI domain, or N-terminal RuvC domain, RuvCII domain, and RuvCIII domain) at amino acids 1-59, 718-769, and 909-1098, respectively, of the sequence of S. pyogenes Cas9. Similar to the REC1 domain, the three RuvC motifs are linearly separated by other domains in the primary structure, however in the tertiary structure, the three RuvC motifs assemble and form the RuvC domain. The HNH domain shares structural similarity with HNH endonucleases, and cleaves a single strand, e.g., the complementary strand of the target nucleic acid molecule. The HNH domain lies between the RuvC II-III motifs and comprises amino acids 775-908 of the sequence of S. pyogenes Cas9. The PI domain interacts with the PAM of the target nucleic acid molecule, and comprises amino acids 1099-1368 of the sequence of S. pyogenes Cas9.

A RuvC-Like Domain and an HNH-Like Domain

In an embodiment, a Cas9 molecule or Cas9 polypeptide comprises an HNH-like domain and a RuvC-like domain. In an embodiment, cleavage activity is dependent on a RuvC-like domain and an HNH-like domain. A Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, can comprise one or more of the following domains: a RuvC-like domain and an HNH-like domain. In an embodiment, a Cas9 molecule or Cas9 polypeptide is an eaCas9 molecule or eaCas9 polypeptide and the eaCas9 molecule or eaCas9 polypeptide comprises a RuvC-like domain, e.g., a RuvC-like domain described below, and/or an HNH-like domain, e.g., an HNH-like domain described below.

RuvC-Like Domains

In an embodiment, a RuvC-like domain cleaves, a single strand, e.g., the non-complementary strand of the target nucleic acid molecule. The Cas9 molecule or Cas9 polypeptide can include more than one RuvC-like domain (e.g., one, two, three or more RuvC-like domains). In an embodiment, a RuvC-like domain is at least 5, 6, 7, 8 amino acids in length but not more than 20, 19, 18, 17, 16 or 15 amino acids in length. In an embodiment, the Cas9 molecule or Cas9 polypeptide comprises an N-terminal RuvC-like domain of about 10 to 20 amino acids, e.g., about 15 amino acids in length.

N-Terminal RuvC-Like Domains

Some naturally occurring Cas9 molecules comprise more than one RuvC-like domain with cleavage being dependent on the N-terminal RuvC-like domain. Accordingly, Cas9 molecules or Cas9 polypeptide can comprise an N-terminal RuvC-like domain. Exemplary N-terminal RuvC-like domains are described below.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an N-terminal RuvC-like domain comprising an amino acid sequence of formula I:

(SEQ ID NO: 8)
D-X1-G-X2-X3-X4-X5-G-X6-X7-X8-X9,

• • wherein,
  • X1 is selected from I, V, M, L and T (e.g., selected from I, V, and L);
  • X2 is selected from T, I, V, S, N, Y, E and L (e.g., selected from T, V, and I);
  • X3 is selected from N, S, G, A, D, T, R, M and F (e.g., A or N);
  • X4 is selected from S, Y, N and F (e.g., S);
  • X5 is selected from V, I, L, C, T and F (e.g., selected from V, I and L);
  • X6 is selected from W, F, V, Y, S and L (e.g., W);
  • X7 is selected from A, S, C, V and G (e.g., selected from A and S);
  • X8 is selected from V, I, L, A, M and H (e.g., selected from V, I, M and L); and
  • X9 is selected from any amino acid or is absent (e.g., selected from T, V, I, L, Δ, F, S, A, Y, M and R, or, e.g., selected from T, V, I, L and Δ).

In an embodiment, the N-terminal RuvC-like domain differs from a sequence of SEQ ID NO:8, by as many as 1 but no more than 2, 3, 4, or 5 residues.

In embodiment, the N-terminal RuvC-like domain is cleavage competent.

In embodiment, the N-terminal RuvC-like domain is cleavage incompetent.

In an embodiment, a eaCas9 molecule or eaCas9 polypeptide comprises an N-terminal RuvC-like domain comprising an amino acid sequence of formula II:

(SEQ ID NO: 9)
D-X1-G-X2-X3-S-X5-G-X6-X7-X8-X9,,

• • wherein
  • X1 is selected from I, V, M, L and T (e.g., selected from I, V, and L);
  • X2 is selected from T, I, V, S, N, Y, E and L (e.g., selected from T, V, and I);
  • X3 is selected from N, S, G, A, D, T, R, M and F (e.g., A or N);
  • X5 is selected from V, I, L, C, T and F (e.g., selected from V, I and L);
  • X6 is selected from W, F, V, Y, S and L (e.g., W);
  • X7 is selected from A, S, C, V and G (e.g., selected from A and S);
  • X8 is selected from V, I, L, A, M and H (e.g., selected from V, I, M and L); and
  • X9 is selected from any amino acid or is absent (e.g., selected from T, V, I, L, Δ, F, S, A, Y, M and R or selected from e.g., T, V, I, L and Δ).

In an embodiment, the N-terminal RuvC-like domain differs from a sequence of SEQ ID NO:9 by as many as 1 but no more than 2, 3, 4, or 5 residues.

In an embodiment, the N-terminal RuvC-like domain comprises an amino acid sequence of formula III:

(SEQ ID NO: 10)
D-I-G-X2-X3-S-V-G-W-A-X8-X9,

• • wherein
  • X2 is selected from T, I, V, S, N, Y, E and L (e.g., selected from T, V, and I);
  • X3 is selected from N, S, G, A, D, T, R, M and F (e.g., A or N);
  • X8 is selected from V, I, L, A, M and H (e.g., selected from V, I, M and L); and
  • X9 is selected from any amino acid or is absent (e.g., selected from T, V, I, L, Δ, F, S, A, Y, M and R or selected from e.g., T, V, I, L and Δ).

In an embodiment, the N-terminal RuvC-like domain differs from a sequence of SEQ ID NO:10 by as many as 1 but no more than, 2, 3, 4, or 5 residues.

In an embodiment, the N-terminal RuvC-like domain comprises an amino acid sequence of formula III:

(SEQ ID NO: 11)
D-I-G-T-N-S-V-G-W-A-V-X,

• • wherein
  • X is a non-polar alkyl amino acid or a hydroxyl amino acid, e.g., X is selected from V, I, L and T (e.g., the eaCas9 molecule can comprise an N-terminal RuvC-like domain shown in FIGS. 2A-2G (is depicted as Y)).

In an embodiment, the N-terminal RuvC-like domain differs from a sequence of SEQ ID NO:11 by as many as 1 but no more than, 2, 3, 4, or 5 residues.

In an embodiment, the N-terminal RuvC-like domain differs from a sequence of an N-terminal RuvC like domain disclosed herein, e.g., in FIGS. 3A-3B or FIGS. 7A-7B, as many as 1 but no more than 2, 3, 4, or 5 residues. In an embodiment, 1, 2, 3 or all of the highly conserved residues identified in FIGS. 3A-3B or FIGS. 7A-7B are present.

In an embodiment, the N-terminal RuvC-like domain differs from a sequence of an N-terminal RuvC-like domain disclosed herein, e.g., in FIGS. 4A-4B or FIGS. 7A-7B, as many as 1 but no more than 2, 3, 4, or 5 residues. In an embodiment, 1, 2, or all of the highly conserved residues identified in FIGS. 4A-4B or FIGS. 7A-7B are present.

Additional RuvC-Like Domains

In addition to the N-terminal RuvC-like domain, the Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, can comprise one or more additional RuvC-like domains. In an embodiment, the Cas9 molecule or Cas9 polypeptide can comprise two additional RuvC-like domains. Preferably, the additional RuvC-like domain is at least 5 amino acids in length and, e.g., less than 15 amino acids in length, e.g., 5 to 10 amino acids in length, e.g., 8 amino acids in length.

An additional RuvC-like domain can comprise an amino acid sequence:

(SEQ ID NO: 12)
I-X1-X2-E-X3-A-R-E,

wherein

• • X1 is V or H,
  • X2 is I, L or V (e.g., I or V); and
  • X3 is M or T.

In an embodiment, the additional RuvC-like domain comprises the amino acid sequence:

• • I-V-X2-E-M-A-R-E (SEQ ID NO:13), wherein
  • X2 is I, L or V (e.g., I or V) (e.g., the eaCas9 molecule or eaCas9 polypeptide can comprise an additional RuvC-like domain shown in FIG. 2A-2G or FIGS. 7A-7B (depicted as B)).

An additional RuvC-like domain can comprise an amino acid sequence:

(SEQ ID NO: 14)
H-H-A-X1-D-A-X2-X3,

wherein

• • X1 is H or L;
  • X2 is R or V; and
  • X3 is E or V.

In an embodiment, the additional RuvC-like domain comprises the amino acid sequence: H-H-A-H-D-A-Y-L (SEQ ID NO:15).

In an embodiment, the additional RuvC-like domain differs from a sequence of SEQ ID NO: 12, 13, 14 or 15 by as many as 1 but no more than 2, 3, 4, or 5 residues.

In some embodiments, the sequence flanking the N-terminal RuvC-like domain is a sequences of formula V:

(SEQ ID NO: 16)
K-X1′-Y-X2′-X3′-X4′-Z-T-D-X9′-Y,.

• • wherein
  • X1′ is selected from K and P,
  • X2′ is selected from V, L, I, and F (e.g., V, I and L);
  • X3′ is selected from G, A and S (e.g., G),
  • X4′ is selected from L, I, V and F (e.g., L);
  • X9′ is selected from D, E, N and Q; and
  • Z is an N-terminal RuvC-like domain, e.g., as described above.

HNH-Like Domains

In an embodiment, an HNH-like domain cleaves a single stranded complementary domain, e.g., a complementary strand of a double stranded nucleic acid molecule. In an embodiment, an HNH-like domain is at least 15, 20, 25 amino acids in length but not more than 40, 35 or 30 amino acids in length, e.g., 20 to 35 amino acids in length, e.g., 25 to 30 amino acids in length. Exemplary HNH-like domains are described below.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an HNH-like domain having an amino acid sequence of formula VI:

(SEQ ID NO: 17)
X1-X2-X3-H-X4-X5-P-X6-X7-X9-X10-X11-X12-X13-X14-
X15-N-X16-X17-X18-X19-X20-X21-X22-X23-N,

wherein

• • X1 is selected from D, E, Q and N (e.g., D and E);
  • X2 is selected from L, I, R, Q, V, M and K;
  • X3 is selected from D and E;
  • X4 is selected from I, V, T, A and L (e.g., A, I and V);
  • X5 is selected from V, Y, I, L, F and W (e.g., V, I and L);
  • X6 is selected from Q, H, R, K, Y, I, L, F and W;
  • X7 is selected from S, A, D, T and K (e.g., S and A);
  • X8 is selected from F, L, V, K, Y, M, I, R, A, E, D and Q (e.g., F);
  • X9 is selected from L, R, T, I, V, S, C, Y, K, F and G;
  • X10 is selected from K, Q, Y, T, F, L, W, M, A, E, G, and S;
  • X11 is selected from D, S, N, R, L and T (e.g., D);
  • X12 is selected from D, N and S;
  • X13 is selected from S, A, T, G and R (e.g., S);
  • X14 is selected from I, L, F, S, R, Y, Q, W, D, K and H (e.g., I, L and F);
  • X15 is selected from D, S, I, N, E, A, H, F, L, Q, M, G, Y and V;
  • X16 is selected from K, L, R, M, T and F (e.g., L, R and K);
  • X17 is selected from V, L, I, A and T;
  • X18 is selected from L, I, V and A (e.g., L and I);
  • X19 is selected from T, V, C, E, S and A (e.g., T and V);
  • X20 is selected from R, F, T, W, E, L, N, C, K, V, S, Q, I, Y, H and A;
  • X21 is selected from S, P, R, K, N, A, H, Q, G and L;
  • X22 is selected from D, G, T, N, S, K, A, I, E, L, Q, R and Y; and
  • X23 is selected from K, V, A, E, Y, I, C, L, S, T, G, K, M, D and F.

In an embodiment, a HNH-like domain differs from a sequence of SEQ ID NO: 17 by at least one but no more than, 2, 3, 4, or 5 residues.

In an embodiment, the HNH-like domain is cleavage competent.

In an embodiment, the HNH-like domain is cleavage incompetent.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an HNH-like domain comprising an amino acid sequence of formula VII:

(SEQ ID NO: 18)
X1-X2-X3-H-X4-X5-P-X6-S-X8-X9-X10-D-D-S-X14-X15-
N-K-V-L-X19-X20-X21-X22-X23-N,

• • wherein
  • X1 is selected from D and E;
  • X2 is selected from L, I, R, Q, V, M and K;
  • X3 is selected from D and E;
  • X4 is selected from I, V, T, A and L (e.g., A, I and V);
  • X5 is selected from V, Y, I, L, F and W (e.g., V, I and L);
  • X6 is selected from Q, H, R, K, Y, I, L, F and W;
  • X8 is selected from F, L, V, K, Y, M, I, R, A, E, D and Q (e.g., F);
  • X9 is selected from L, R, T, I, V, S, C, Y, K, F and G;
  • X10 is selected from K, Q, Y, T, F, L, W, M, A, E, G, and S;
  • X14 is selected from I, L, F, S, R, Y, Q, W, D, K and H (e.g., I, L and F);
  • X15 is selected from D, S, I, N, E, A, H, F, L, Q, M, G, Y and V;
  • X19 is selected from T, V, C, E, S and A (e.g., T and V);
  • X20 is selected from R, F, T, W, E, L, N, C, K, V, S, Q, I, Y, H and A;
  • X21 is selected from S, P, R, K, N, A, H, Q, G and L;
  • X22 is selected from D, G, T, N, S, K, A, I, E, L, Q, R and Y; and
  • X23 is selected from K, V, A, E, Y, I, C, L, S, T, G, K, M, D and F.

In an embodiment, the HNH-like domain differs from a sequence of SEQ ID NO: 18 by 1, 2, 3, 4, or 5 residues.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an HNH-like domain comprising an amino acid sequence of formula VII:

(SEQ ID NO: 19)
X1-V-X3-H-I-V-P-X6-S-X8-X9-X10-D-D-S-X14-X15-N-K-
V-L-T-X20-X21-X22-X23-N,

• • wherein
  • X1 is selected from D and E;
  • X3 is selected from D and E;
  • X6 is selected from Q, H, R, K, Y, I, L and W;
  • X8 is selected from F, L, V, K, Y, M, I, R, A, E, D and Q (e.g., F);
  • X9 is selected from L, R, T, I, V, S, C, Y, K, F and G;
  • X10 is selected from K, Q, Y, T, F, L, W, M, A, E, G, and S;
  • X14 is selected from I, L, F, S, R, Y, Q, W, D, K and H (e.g., I, L and F);
  • X15 is selected from D, S, I, N, E, A, H, F, L, Q, M, G, Y and V;
  • X20 is selected from R, F, T, W, E, L, N, C, K, V, S, Q, I, Y, H and A;
  • X21 is selected from S, P, R, K, N, A, H, Q, G and L;
  • X22 is selected from D, G, T, N, S, K, A, I, E, L, Q, R and Y; and
  • X23 is selected from K, V, A, E, Y, I, C, L, S, T, G, K, M, D and F.

In an embodiment, the HNH-like domain differs from a sequence of SEQ ID NO: 19 by 1, 2, 3, 4, or 5 residues.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an HNH-like domain having an amino acid sequence of formula VIII:

(SEQ ID NO: 20)
D-X2-D-H-I-X5-P-Q-X7-F-X9-X10-D-X12-S-I-D-N-X16-V-
L-X19-X20-S-X22-X23-N,

• • wherein
  • X2 is selected from I and V;
  • X5 is selected from I and V;
  • X7 is selected from A and S;
  • X9 is selected from I and L;
  • X10 is selected from K and T;
  • X12 is selected from D and N;
  • X16 is selected from R, K and L; X19 is selected from T and V;
  • X20 is selected from S and R;
  • X22 is selected from K, D and A; and
  • X23 is selected from E, K, G and N (e.g., the eaCas9 molecule or eaCas9 polypeptide can comprise an HNH-like domain as described herein).

In an embodiment, the HNH-like domain differs from a sequence of SEQ ID NO: 20 by as many as 1 but no more than 2, 3, 4, or 5 residues.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises the amino acid sequence of formula IX:

(SEQ ID NO: 21)
L-Y-Y-L-Q-N-G-X1′-D-M-Y-X2′-X3′-X4′-X5′-L-D-I-X6′-
X7′-L-S-X8′-Y-Z-N-R-X9′-K-X10′-D-X11′-V-P,

• • wherein
  • X1′ is selected from K and R;
  • X2′ is selected from V and T;
  • X3′ is selected from G and D;
  • X4′ is selected from E, Q and D;
  • X5′ is selected from E and D;
  • X6′ is selected from D, N and H;
  • X7′ is selected from Y, R and N;
  • X8′ is selected from Q, D and N; X9′ is selected from G and E;
  • X10′ is selected from S and G;
  • X11′ is selected from D and N; and
  • Z is an HNH-like domain, e.g., as described above.

In an embodiment, the eaCas9 molecule or eaCas9 polypeptide comprises an amino acid sequence that differs from a sequence of SEQ ID NO:21 by as many as 1 but no more than 2, 3, 4, or 5 residues.

In an embodiment, the HNH-like domain differs from a sequence of an HNH-like domain disclosed herein, e.g., in FIGS. 5A-5C or FIGS. 7A-7B, as many as 1 but no more than 2, 3, 4, or 5 residues. In an embodiment, 1 or both of the highly conserved residues identified in FIGS. 5A-5C or FIGS. 7A-7B are present.

In an embodiment, the HNH-like domain differs from a sequence of an HNH-like domain disclosed herein, e.g., in FIGS. 6A-6B or FIGS. 7A-7B, as many as 1 but no more than 2, 3, 4, or 5 residues. In an embodiment, 1, 2, all 3 of the highly conserved residues identified in FIGS. 6A-6B or FIGS. 7A-7B are present.

Cas9 Activities

Nuclease and Helicase Activities

In an embodiment, the Cas9 molecule or Cas9 polypeptide is capable of cleaving a target nucleic acid molecule. Typically wild type Cas9 molecules cleave both strands of a target nucleic acid molecule. Cas9 molecules and Cas9 polypeptides can be engineered to alter nuclease cleavage (or other properties), e.g., to provide a Cas9 molecule or Cas9 polypeptide which is a nickase, or which lacks the ability to cleave target nucleic acid. A Cas9 molecule or Cas9 polypeptide that is capable of cleaving a target nucleic acid molecule is referred to herein as an eaCas9 (an enzymatically active Cas9) molecule or eaCas9 polypeptide. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide, comprises one or more of the following activities:

• • a nickase activity, i.e., the ability to cleave a single strand, e.g., the non-complementary strand or the complementary strand, of a nucleic acid molecule;
  • a double stranded nuclease activity, i.e., the ability to cleave both strands of a double stranded nucleic acid and create a double stranded break, which in an embodiment is the presence of two nickase activities;
  • an endonuclease activity;
  • an exonuclease activity; and
  • a helicase activity, i.e., the ability to unwind the helical structure of a double stranded nucleic acid.

In an embodiment, an enzymatically active Cas9 or an eaCas9 molecule or an eaCas9 polypeptide cleaves both DNA strands and results in a double stranded break. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide cleaves only one strand, e.g., the strand to which the gRNA hybridizes to, or the strand complementary to the strand the gRNA hybridizes with. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises cleavage activity associated with an HNH-like domain. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises cleavage activity associated with an N-terminal RuvC-like domain. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises cleavage activity associated with an HNH-like domain and cleavage activity associated with an N-terminal RuvC-like domain. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an active, or cleavage competent, HNH-like domain and an inactive, or cleavage incompetent, N-terminal RuvC-like domain. In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an inactive, or cleavage incompetent, HNH-like domain and an active, or cleavage competent, N-terminal RuvC-like domain.

Some Cas9 molecules or Cas9 polypeptides have the ability to interact with a gRNA molecule, and in conjunction with the gRNA molecule localize to a core target domain, but are incapable of cleaving the target nucleic acid, or incapable of cleaving at efficient rates. Cas9 molecules having no, or no substantial, cleavage activity are referred to herein as an eiCas9 molecule or eiCas9 polypeptide. For example, an eiCas9 molecule or eiCas9 polypeptide can lack cleavage activity or have substantially less, e.g., less than 20, 10, 5, 1 or 0.1% of the cleavage activity of a reference Cas9 molecule or eiCas9 polypeptide, as measured by an assay described herein.

Targeting and PAMs

A Cas9 molecule or Cas9 polypeptide, is a polypeptide that can interact with a guide RNA (gRNA) molecule and, in concert with the gRNA molecule, localizes to a site which comprises a target domain and PAM sequence.

In an embodiment, the ability of an eaCas9 molecule or eaCas9 polypeptide to interact with and cleave a target nucleic acid is PAM sequence dependent. A PAM sequence is a sequence in the target nucleic acid. In an embodiment, cleavage of the target nucleic acid occurs upstream from the PAM sequence. EaCas9 molecules from different bacterial species can recognize different sequence motifs (e.g., PAM sequences). In an embodiment, an eaCas9 molecule of S. pyogenes recognizes the sequence motif NGG and directs cleavage of a target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from that sequence. See, e.g., Mali et al., SCIENCE 2013; 339(6121): 823-826. In an embodiment, an eaCas9 molecule of S. thermophilus recognizes the sequence motif NGGNG and NNAGAAW (W=A or T) and directs cleavage of a core target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from these sequences. See, e.g., Horvath et al., SCIENCE 2010; 327(5962):167-170, and Deveau et al., J BACTERIOL 2008; 190(4): 1390-1400. In an embodiment, an eaCas9 molecule of S. mutans recognizes the sequence motif NGG and/or NAAR (R=A or G) and directs cleavage of a core target nucleic acid sequence 1 to 10, e.g., 3 to 5 base pairs, upstream from this sequence. See, e.g., Deveau et al., J BACTERIOL 2008; 190(4): 1390-1400. In an embodiment, an eaCas9 molecule of S. aureus recognizes the sequence motif NNGRR (R=A or G) and directs cleavage of a target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from that sequence. In an embodiment, an eaCas9 molecule of S. aureus recognizes the sequence motif NNGRRN (R=A or G) and directs cleavage of a target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from that sequence. In an embodiment, an eaCas9 molecule of S. aureus recognizes the sequence motif NNGRRT (R=A or G) and directs cleavage of a target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from that sequence. In an embodiment, an eaCas9 molecule of S. aureus recognizes the sequence motif NNGRRV (R=A or G, V=A, G or C) and directs cleavage of a target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from that sequence. In an embodiment, an eaCas9 molecule of Neisseria meningitidis recognizes the sequence motif NNNNGATT or NNNGCTT and directs cleavage of a target nucleic acid sequence 1 to 10, e.g., 3 to 5, base pairs upstream from that sequence. See, e.g., Hou et al., PNAS Early Edition 2013, 1-6. The ability of a Cas9 molecule to recognize a PAM sequence can be determined, e.g., using a transformation assay described in Jinek et al., SCIENCE 2012 337:816. In the aforementioned embodiments, N can be any nucleotide residue, e.g., any of A, G, C or T.

As is discussed herein, Cas9 molecules can be engineered to alter the PAM specificity of the Cas9 molecule.

Exemplary naturally occurring Cas9 molecules are described in Chylinski et al., RNA BIOLOGY 2013 10:5, 727-737. Such Cas9 molecules include Cas9 molecules of a cluster 1 bacterial family, cluster 2 bacterial family, cluster 3 bacterial family, cluster 4 bacterial family, cluster 5 bacterial family, cluster 6 bacterial family, a cluster 7 bacterial family, a cluster 8 bacterial family, a cluster 9 bacterial family, a cluster 10 bacterial family, a cluster 11 bacterial family, a cluster 12 bacterial family, a cluster 13 bacterial family, a cluster 14 bacterial family, a cluster 15 bacterial family, a cluster 16 bacterial family, a cluster 17 bacterial family, a cluster 18 bacterial family, a cluster 19 bacterial family, a cluster 20 bacterial family, a cluster 21 bacterial family, a cluster 22 bacterial family, a cluster 23 bacterial family, a cluster 24 bacterial family, a cluster 25 bacterial family, a cluster 26 bacterial family, a cluster 27 bacterial family, a cluster 28 bacterial family, a cluster 29 bacterial family, a cluster 30 bacterial family, a cluster 31 bacterial family, a cluster 32 bacterial family, a cluster 33 bacterial family, a cluster 34 bacterial family, a cluster 35 bacterial family, a cluster 36 bacterial family, a cluster 37 bacterial family, a cluster 38 bacterial family, a cluster 39 bacterial family, a cluster 40 bacterial family, a cluster 41 bacterial family, a cluster 42 bacterial family, a cluster 43 bacterial family, a cluster 44 bacterial family, a cluster 45 bacterial family, a cluster 46 bacterial family, a cluster 47 bacterial family, a cluster 48 bacterial family, a cluster 49 bacterial family, a cluster 50 bacterial family, a cluster 51 bacterial family, a cluster 52 bacterial family, a cluster 53 bacterial family, a cluster 54 bacterial family, a cluster 55 bacterial family, a cluster 56 bacterial family, a cluster 57 bacterial family, a cluster 58 bacterial family, a cluster 59 bacterial family, a cluster 60 bacterial family, a cluster 61 bacterial family, a cluster 62 bacterial family, a cluster 63 bacterial family, a cluster 64 bacterial family, a cluster 65 bacterial family, a cluster 66 bacterial family, a cluster 67 bacterial family, a cluster 68 bacterial family, a cluster 69 bacterial family, a cluster 70 bacterial family, a cluster 71 bacterial family, a cluster 72 bacterial family, a cluster 73 bacterial family, a cluster 74 bacterial family, a cluster 75 bacterial family, a cluster 76 bacterial family, a cluster 77 bacterial family, or a cluster 78 bacterial family.

Exemplary naturally occurring Cas9 molecules include a Cas9 molecule of a cluster 1 bacterial family. Examples include a Cas9 molecule of: S. pyogenes (e.g., strain SF370, MGAS10270, MGAS10750, MGAS2096, MGAS315, MGAS5005, MGAS6180, MGAS9429, NZ131 and SSI-1), S. thermophilus (e.g., strain LMD-9), S. pseudoporcinus (e.g., strain SPIN 20026), S. mutans (e.g., strain UA159, NN2025), S. macacae (e.g., strain NCTC11558), S. gallolyticus (e.g., strain UCN34, ATCC BAA-2069), S. equines (e.g., strain ATCC 9812, MGCS 124), S. dysdalactiae (e.g., strain GGS 124), S. bovis (e.g., strain ATCC 700338), S. anginosus (e.g., strain F0211), S. agalactiae (e.g., strain NEM316, A909), Listeria monocytogenes (e.g., strain F6854), Listeria innocua (L. innocua, e.g., strain Clip11262), Enterococcus italicus (e.g., strain DSM 15952), or Enterococcus faecium (e.g., strain 1,231,408). Additional exemplary Cas9 molecules are a Cas9 molecule of Neisseria meningitides (Hou et al., PNAS Early Edition 2013, 1-6 and a S. aureus cas9 molecule.

In an embodiment, a Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, comprises an amino acid sequence:

• • having 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% homology with;
  • differs at no more than, 2, 5, 10, 15, 20, 30, or 40% of the amino acid residues when compared with;
  • differs by at least 1, 2, 5, 10 or 20 amino acids, but by no more than 100, 80, 70, 60, 50, 40 or 30 amino acids from; or
  • is identical to any Cas9 molecule sequence described herein, or a naturally occurring Cas9 molecule sequence, e.g., a Cas9 molecule from a species listed herein or described in Chylinski et al., RNA BIOLOGY 2013 10:5, 727-737; Hou et al., PNAS Early Edition 2013, 1-6; SEQ ID NO:1-4. In an embodiment, the Cas9 molecule or Cas9 polypeptide comprises one or more of the following activities: a nickase activity; a double stranded cleavage activity (e.g., an endonuclease and/or exonuclease activity); a helicase activity; or the ability, together with a gRNA molecule, to localize to a target nucleic acid.

In an embodiment, a Cas9 molecule or Cas9 polypeptide comprises any of the amino acid sequence of the consensus sequence of FIGS. 2A-2G, wherein “*” indicates any amino acid found in the corresponding position in the amino acid sequence of a Cas9 molecule or Cas9 polypeptide of S. pyogenes, S. thermophilus, S. mutans and L. innocua, and “−” indicates any amino acid. In an embodiment, a Cas9 molecule differs from the sequence of the consensus sequence of FIGS. 2A-2G by at least 1, but no more than 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acid residues. In an embodiment, a Cas9 molecule or Cas9 polypeptide comprises the amino acid sequence of SEQ ID NO:7 of FIGS. 7A-7B, wherein “*” indicates any amino acid found in the corresponding position in the amino acid sequence of a Cas9 molecule or Cas9 polypeptide of S. pyogenes, or N. meningitides, “−” indicates any amino acid, and “−” indicates any amino acid or absent. In an embodiment, a Cas9 molecule or Cas9 polypeptide differs from the sequence of SEQ ID NO:6 or 7 disclosed in FIGS. 7A-7B by at least 1, but no more than 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acid residues.

A comparison of the sequence of a number of Cas9 molecules indicate that certain regions are conserved. These are identified below as:

• • region 1 (residues 1 to 180, or in the case of region 1′ residues 120 to 180)
  • region 2 (residues 360 to 480);
  • region 3 (residues 660 to 720);
  • region 4 (residues 817 to 900); and
  • region 5 (residues 900 to 960);

In an embodiment, a Cas9 molecule or Cas9 polypeptide comprises regions 1-5, together with sufficient additional Cas9 molecule sequence to provide a biologically active molecule, e.g., a Cas9 molecule having at least one activity described herein. In an embodiment, each of regions 1-5, independently, have 50%, 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% homology with the corresponding residues of a Cas9 molecule or Cas9 polypeptide described herein, e.g., a sequence from FIGS. 2A-2G or from FIGS. 7A-7B.

In an embodiment, a Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, comprises an amino acid sequence referred to as region 1:

• • having 50%, 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% homology with amino acids 1-180 (the numbering is according to the motif sequence in FIGS. 2A-2G; 52% of residues in the four Cas9 sequences in FIGS. 2A-2G are conserved) of the amino acid sequence of Cas9 of S. pyogenes;
  • differs by at least 1, 2, 5, 10 or 20 amino acids but by no more than 90, 80, 70, 60, 50, 40 or 30 amino acids from amino acids 1-180 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or Listeria innocua; or
  • is identical to 1-180 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua.

In an embodiment, a Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, comprises an amino acid sequence referred to as region 1′:

• • having 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% homology with amino acids 120-180 (55% of residues in the four Cas9 sequences in FIGS. 2A-2G are conserved) of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua;
  • differs by at least 1, 2, or 5 amino acids but by no more than 35, 30, 25, 20 or 10 amino acids from amino acids 120-180 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua; or
  • is identical to 120-180 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua.

In an embodiment, a Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, comprises an amino acid sequence referred to as region 2:

• • having 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% homology with amino acids 360-480 (52% of residues in the four Cas9 sequences in FIGS. 2A-2G are conserved) of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua;
  • differs by at least 1, 2, or 5 amino acids but by no more than 35, 30, 25, 20 or 10 amino acids from amino acids 360-480 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua; or
  • is identical to 360-480 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua.

In an embodiment, a Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, comprises an amino acid sequence referred to as region 3:

• • having 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% homology with amino acids 660-720 (56% of residues in the four Cas9 sequences in FIGS. 2A-2G are conserved) of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua;
  • differs by at least 1, 2, or 5 amino acids but by no more than 35, 30, 25, 20 or 10 amino acids from amino acids 660-720 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua; or
  • is identical to 660-720 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua.

In an embodiment, a Cas9 molecule, e.g., an eaCas9 molecule, comprises an amino acid sequence referred to as region 4:

• • having 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% homology with amino acids 817-900 (55% of residues in the four Cas9 sequences in FIGS. 2A-2G are conserved) of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua;
  • differs by at least 1, 2, or 5 amino acids but by no more than 35, 30, 25, 20 or 10 amino acids from amino acids 817-900 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua; or
  • is identical to 817-900 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua.

In an embodiment, a Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, comprises an amino acid sequence referred to as region 5:

• • having 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% homology with amino acids 900-960 (60% of residues in the four Cas9 sequences in FIGS. 2A-2G are conserved) of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua;
  • differs by at least 1, 2, or 5 amino acids but by no more than 35, 30, 25, 20 or 10 amino acids from amino acids 900-960 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua; or
  • is identical to 900-960 of the amino acid sequence of Cas9 of S. pyogenes, S. thermophilus, S. mutans or L. innocua.

Engineered or Altered Cas9 Molecules and Cas9 Polypeptides

Cas9 molecules and Cas9 polypeptides described herein, e.g., naturally occurring Cas9 molecules can possess any of a number of properties, including: nickase activity, nuclease activity (e.g., endonuclease and/or exonuclease activity); helicase activity; the ability to associate functionally with a gRNA molecule; and the ability to target (or localize to) a site on a nucleic acid (e.g., PAM recognition and specificity). In an embodiment, a Cas9 molecule or Cas9 polypeptide can include all or a subset of these properties. In typical embodiments, a Cas9 molecule or Cas9 polypeptide have the ability to interact with a gRNA molecule and, in concert with the gRNA molecule, localize to a site in a nucleic acid. Other activities, e.g., PAM specificity, cleavage activity, or helicase activity can vary more widely in Cas9 molecules and Cas9 polypeptides.

Cas9 molecules include engineered Cas9 molecules and engineered Cas9 polypeptides (engineered, as used in this context, means merely that the Cas9 molecule or Cas9 polypeptide differs from a reference sequences, and implies no process or origin limitation). An engineered Cas9 molecule or Cas9 polypeptide can comprise altered enzymatic properties, e.g., altered nuclease activity, (as compared with a naturally occurring or other reference Cas9 molecule) or altered helicase activity. As discussed herein, an engineered Cas9 molecule or Cas9 polypeptide can have nickase activity (as opposed to double strand nuclease activity). In an embodiment an engineered Cas9 molecule or Cas9 polypeptide can have an alteration that alters its size, e.g., a deletion of amino acid sequence that reduces its size, e.g., without significant effect on one or more, or any Cas9 activity. In an embodiment, an engineered Cas9 molecule or Cas9 polypeptide can comprise an alteration that affects PAM recognition. E.g., an engineered Cas9 molecule can be altered to recognize a PAM sequence other than that recognized by the endogenous wild-type PI domain. In an embodiment, a Cas9 molecule or Cas9 polypeptide can differ in sequence from a naturally occurring Cas9 molecule but not have significant alteration in one or more Cas9 activities.

Cas9 molecules or Cas9 polypeptides with desired properties can be made in a number of ways, e.g., by alteration of a parental, e.g., naturally occurring Cas9 molecules or Cas9 polypeptides to provide an altered Cas9 molecule or Cas9 polypeptide having a desired property. For example, one or more mutations or differences relative to a parental Cas9 molecule, e.g., a naturally occurring or engineered Cas9 molecule, can be introduced. Such mutations and differences comprise: substitutions (e.g., conservative substitutions or substitutions of non-essential amino acids); insertions; or deletions. In an embodiment, a Cas9 molecule or Cas9 polypeptide can comprises one or more mutations or differences, e.g., at least 1, 2, 3, 4, 5, 10, 15, 20, 30, 40 or 50 mutations, but less than 200, 100, or 80 mutations relative to a reference, e.g., a parental, Cas9 molecule.

In an embodiment, a mutation or mutations do not have a substantial effect on a Cas9 activity, e.g. a Cas9 activity described herein. In an embodiment, a mutation or mutations have a substantial effect on a Cas9 activity, e.g. a Cas9 activity described herein.

Non-Cleaving and Modified-Cleavage Cas9 Molecules and Cas9 Polypeptides

In an embodiment, a Cas9 molecule or Cas9 polypeptide comprises a cleavage property that differs from naturally occurring Cas9 molecules, e.g., that differs from the naturally occurring Cas9 molecule having the closest homology. For example, a Cas9 molecule or Cas9 polypeptide can differ from naturally occurring Cas9 molecules, e.g., a Cas9 molecule of S. pyogenes, as follows: its ability to modulate, e.g., decreased or increased, cleavage of a double stranded nucleic acid (endonuclease and/or exonuclease activity), e.g., as compared to a naturally occurring Cas9 molecule (e.g., a Cas9 molecule of S. pyogenes); its ability to modulate, e.g., decreased or increased, cleavage of a single strand of a nucleic acid, e.g., a non-complementary strand of a nucleic acid molecule or a complementary strand of a nucleic acid molecule (nickase activity), e.g., as compared to a naturally occurring Cas9 molecule (e.g., a Cas9 molecule of S. pyogenes); or the ability to cleave a nucleic acid molecule, e.g., a double stranded or single stranded nucleic acid molecule, can be eliminated.

Modified Cleavage eaCas9 Molecules and eaCas9 Polypeptides

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises one or more of the following activities: cleavage activity associated with an N-terminal RuvC-like domain; cleavage activity associated with an HNH-like domain; cleavage activity associated with an HNH-like domain and cleavage activity associated with an N-terminal RuvC-like domain.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an active, or cleavage competent, HNH-like domain (e.g., an HNH-like domain described herein, e.g., SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20 or SEQ ID NO: 21) and an inactive, or cleavage incompetent, N-terminal RuvC-like domain. An exemplary inactive, or cleavage incompetent N-terminal RuvC-like domain can have a mutation of an aspartic acid in an N-terminal RuvC-like domain, e.g., an aspartic acid at position 9 of the consensus sequence disclosed in FIGS. 2A-2G or an aspartic acid at position 10 of SEQ ID NO: 7, e.g., can be substituted with an alanine. In an embodiment, the eaCas9 molecule or eaCas9 polypeptide differs from wild type in the N-terminal RuvC-like domain and does not cleave the target nucleic acid, or cleaves with significantly less efficiency, e.g., less than 20, 10, 5, 1 or 0.1% of the cleavage activity of a reference Cas9 molecule, e.g., as measured by an assay described herein. The reference Cas9 molecule can by a naturally occurring unmodified Cas9 molecule, e.g., a naturally occurring Cas9 molecule such as a Cas9 molecule of S. pyogenes, or S. thermophilus. In an embodiment, the reference Cas9 molecule is the naturally occurring Cas9 molecule having the closest sequence identity or homology.

In an embodiment, an eaCas9 molecule or eaCas9 polypeptide comprises an inactive, or cleavage incompetent, HNH domain and an active, or cleavage competent, N-terminal RuvC-like domain (e.g., a RuvC-like domain described herein, e.g., SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, or SEQ ID NO: 16). Exemplary inactive, or cleavage incompetent HNH-like domains can have a mutation at one or more of: a histidine in an HNH-like domain, e.g., a histidine shown at position 856 of the consensus sequence disclosed in FIGS. 2A-2G, e.g., can be substituted with an alanine; and one or more asparagines in an HNH-like domain, e.g., an asparagine shown at position 870 of the consensus sequence disclosed in FIGS. 2A-2G and/or at position 879 of the consensus sequence disclosed in FIGS. 2A-2G, e.g., can be substituted with an alanine. In an embodiment, the eaCas9 differs from wild type in the HNH-like domain and does not cleave the target nucleic acid, or cleaves with significantly less efficiency, e.g., less than 20, 10, 5, 1 or 0.1% of the cleavage activity of a reference Cas9 molecule, e.g., as measured by an assay described herein. The reference Cas9 molecule can by a naturally occurring unmodified Cas9 molecule, e.g., a naturally occurring Cas9 molecule such as a Cas9 molecule of S. pyogenes, or S. thermophilus. In an embodiment, the reference Cas9 molecule is the naturally occurring Cas9 molecule having the closest sequence identity or homology.

Alterations in the Ability to Cleave One or Both Strands of a Target Nucleic Acid

In an embodiment, exemplary Cas9 activities comprise one or more of PAM specificity, cleavage activity, and helicase activity. A mutation(s) can be present, e.g., in one or more RuvC-like domain, e.g., an N-terminal RuvC-like domain; an HNH-like domain; a region outside the RuvC-like domains and the HNH-like domain. In some embodiments, a mutation(s) is present in a RuvC-like domain, e.g., an N-terminal RuvC-like domain. In some embodiments, a mutation(s) is present in an HNH-like domain. In some embodiments, mutations are present in both a RuvC-like domain, e.g., an N-terminal RuvC-like domain and an HNH-like domain.

Exemplary mutations that may be made in the RuvC domain or HNH domain with reference to the S. pyogenes sequence include: D10A, E762A, H840A, N854A, N863A and/or D986A.

In an embodiment, a Cas9 molecule or Cas9 polypeptide is an eiCas9 molecule or eiCas9 polypeptide comprising one or more differences in a RuvC domain and/or in an HNH domain as compared to a reference Cas9 molecule, and the eiCas9 molecule or eiCas9 polypeptide does not cleave a nucleic acid, or cleaves with significantly less efficiency than does wildype, e.g., when compared with wild type in a cleavage assay, e.g., as described herein, cuts with less than 50, 25, 10, or 1% of a reference Cas9 molecule, as measured by an assay described herein.

Whether or not a particular sequence, e.g., a substitution, may affect one or more activity, such as targeting activity, cleavage activity, etc., can be evaluated or predicted, e.g., by evaluating whether the mutation is conservative or by the method described in Section IV. In an embodiment, a “non-essential” amino acid residue, as used in the context of a Cas9 molecule, is a residue that can be altered from the wild-type sequence of a Cas9 molecule, e.g., a naturally occurring Cas9 molecule, e.g., an eaCas9 molecule, without abolishing or more preferably, without substantially altering a Cas9 activity (e.g., cleavage activity), whereas changing an “essential” amino acid residue results in a substantial loss of activity (e.g., cleavage activity).

In an embodiment, a Cas9 molecule or Cas9 polypeptide comprises a cleavage property that differs from naturally occurring Cas9 molecules, e.g., that differs from the naturally occurring Cas9 molecule having the closest homology. For example, a Cas9 molecule or Cas9 polypeptide can differ from naturally occurring Cas9 molecules, e.g., a Cas9 molecule of S aureus, S. pyogenes, or C. jejuni as follows: its ability to modulate, e.g., decreased or increased, cleavage of a double stranded break (endonuclease and/or exonuclease activity), e.g., as compared to a naturally occurring Cas9 molecule (e.g., a Cas9 molecule of S aureus, S. pyogenes, or C. jejuni); its ability to modulate, e.g., decreased or increased, cleavage of a single strand of a nucleic acid, e.g., a non-complimentary strand of a nucleic acid molecule or a complementary strand of a nucleic acid molecule (nickase activity), e.g., as compared to a naturally occurring Cas9 molecule (e.g., a Cas9 molecule of S aureus, S. pyogenes, or C. jejuni); or the ability to cleave a nucleic acid molecule, e.g., a double stranded or single stranded nucleic acid molecule, can be eliminated.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide is an eaCas9 molecule or eaCas9 polypeptide comprising one or more of the following activities: cleavage activity associated with a RuvC domain; cleavage activity associated with an HNH domain; cleavage activity associated with an HNH domain and cleavage activity associated with a RuvC domain.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide is an eiCas9 molecule or eiCas9 polypeptide which does not cleave a nucleic acid molecule (either double stranded or single stranded nucleic acid molecules) or cleaves a nucleic acid molecule with significantly less efficiency, e.g., less than 20, 10, 5, 1 or 0.1% of the cleavage activity of a reference Cas9 molecule, e.g., as measured by an assay described herein. The reference Cas9 molecule can be a naturally occurring unmodified Cas9 molecule, e.g., a naturally occurring Cas9 molecule such as a Cas9 molecule of S. pyogenes, S. thermophilus, S. aureus, C. jejuni or N. meningitidis. In an embodiment, the reference Cas9 molecule is the naturally occurring Cas9 molecule having the closest sequence identity or homology. In an embodiment, the eiCas9 molecule or eiCas9 polypeptide lacks substantial cleavage activity associated with a RuvC domain and cleavage activity associated with an HNH domain.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide is an eaCas9 molecule or eaCas9 polypeptide comprising the fixed amino acid residues of S. pyogenes shown in the consensus sequence disclosed in FIGS. 2A-2G, and has one or more amino acids that differ from the amino acid sequence of S. pyogenes (e.g., has a substitution) at one or more residue (e.g., 2, 3, 5, 10, 15, 20, 30, 50, 70, 80, 90, 100, 200 amino acid residues) represented by an “−” in the consensus sequence disclosed in FIGS. 2A-2G or SEQ ID NO:7.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide comprises a sequence in which:

• • the sequence corresponding to the fixed sequence of the consensus sequence disclosed in FIGS. 2A-2G differs at no more than 1, 2, 3, 4, 5, 10, 15, or 20% of the fixed residues in the consensus sequence disclosed in FIGS. 2A-2G;
  • the sequence corresponding to the residues identified by “*” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, or 40% of the “*” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an S. pyogenes Cas9 molecule; and,
  • the sequence corresponding to the residues identified by “−” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 5, 10, 15, 20, 25, 30, 35, 40, 45, 55, or 60% of the “−” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an S. pyogenes Cas9 molecule.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide is an eaCas9 molecule or eaCas9 polypeptide comprising the fixed amino acid residues of S. thermophilus shown in the consensus sequence disclosed in FIGS. 2A-2G, and has one or more amino acids that differ from the amino acid sequence of S. thermophilus (e.g., has a substitution) at one or more residue (e.g., 2, 3, 5, 10, 15, 20, 30, 50, 70, 80, 90, 100, 200 amino acid residues) represented by an “−” in the consensus sequence disclosed in FIGS. 2A-2G.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide comprises a sequence in which:

• • the sequence corresponding to the fixed sequence of the consensus sequence disclosed in FIGS. 2A-2G differs at no more than 1, 2, 3, 4, 5, 10, 15, or 20% of the fixed residues in the consensus sequence disclosed in FIGS. 2A-2G;
  • the sequence corresponding to the residues identified by “*” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, or 40% of the “*” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an S. thermophilus Cas9 molecule; and,
  • the sequence corresponding to the residues identified by “−” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 5, 10, 15, 20, 25, 30, 35, 40, 45, 55, or 60% of the “−” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an S. thermophilus Cas9 molecule.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide is an eaCas9 molecule or eaCas9 polypeptide comprising the fixed amino acid residues of S. mutans shown in the consensus sequence disclosed in FIGS. 2A-2G, and has one or more amino acids that differ from the amino acid sequence of S. mutans (e.g., has a substitution) at one or more residue (e.g., 2, 3, 5, 10, 15, 20, 30, 50, 70, 80, 90, 100, 200 amino acid residues) represented by an “−” in the consensus sequence disclosed in FIGS. 2A-2G.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide comprises a sequence in which:

• • the sequence corresponding to the fixed sequence of the consensus sequence disclosed in FIGS. 2A-2G differs at no more than 1, 2, 3, 4, 5, 10, 15, or 20% of the fixed residues in the consensus sequence disclosed in FIGS. 2A-2G;
  • the sequence corresponding to the residues identified by “*” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, or 40% of the “*” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an S. mutans Cas9 molecule; and,
  • the sequence corresponding to the residues identified by “−” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 5, 10, 15, 20, 25, 30, 35, 40, 45, 55, or 60% of the “−” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an S. mutans Cas9 molecule.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide is an eaCas9 molecule or eaCas9 polypeptide comprising the fixed amino acid residues of L. innocula shown in the consensus sequence disclosed in FIGS. 2A-2G, and has one or more amino acids that differ from the amino acid sequence of L. innocula (e.g., has a substitution) at one or more residue (e.g., 2, 3, 5, 10, 15, 20, 30, 50, 70, 80, 90, 100, 200 amino acid residues) represented by an “−” in the consensus sequence disclosed in FIGS. 2A-2G.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide comprises a sequence in which:

• • the sequence corresponding to the fixed sequence of the consensus sequence disclosed in FIGS. 2A-2G differs at no more than 1, 2, 3, 4, 5, 10, 15, or 20% of the fixed residues in the consensus sequence disclosed in FIGS. 2A-2G;
  • the sequence corresponding to the residues identified by “*” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, or 40% of the “*” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an L. innocula Cas9 molecule; and,
  • the sequence corresponding to the residues identified by “−” in the consensus sequence disclosed in FIGS. 2A-2G differ at no more than 5, 10, 15, 20, 25, 30, 35, 40, 45, 55, or 60% of the “−” residues from the corresponding sequence of naturally occurring Cas9 molecule, e.g., an L. innocula Cas9 molecule.

In an embodiment, the altered Cas9 molecule or Cas9 polypeptide, e.g., an eaCas9 molecule or eaCas9 polypeptide, can be a fusion, e.g., of two of more different Cas9 molecules, e.g., of two or more naturally occurring Cas9 molecules of different species. For example, a fragment of a naturally occurring Cas9 molecule of one species can be fused to a fragment of a Cas9 molecule of a second species. As an example, a fragment of a Cas9 molecule of S. pyogenes comprising an N-terminal RuvC-like domain can be fused to a fragment of a Cas9 molecule of a species other than S. pyogenes (e.g., S. thermophilus) comprising an HNH-like domain.

Cas9 Molecules or Cas9 Polypeptides with Altered PAM Recognition or No PAM Recognition

Naturally occurring Cas9 molecules can recognize specific PAM sequences, for example, the PAM recognition sequences described above for S. pyogenes, S. thermophiles, S. mutans, S. aureus and N. meningitidis.

In an embodiment, a Cas9 molecule or Cas9 polypeptide has the same PAM specificities as a naturally occurring Cas9 molecule. In another embodiment, a Cas9 molecule or Cas9 polypeptide has a PAM specificity not associated with a naturally occurring Cas9 molecule, or a PAM specificity not associated with the naturally occurring Cas9 molecule to which it has the closest sequence homology. For example, a naturally occurring Cas9 molecule or Cas9 polypeptide can be altered, e.g., to alter PAM recognition, e.g., to alter the PAM sequence that the Cas9 molecule recognizes to decrease off target sites and/or improve specificity; or eliminate a PAM recognition requirement. In an embodiment, a Cas9 molecule or Cas9 polypeptide can be altered, e.g., to increase length of PAM recognition sequence and/or improve Cas9 specificity to high level of identity (e.g., 98%, 99% or 100% match between gRNA and a PAM sequence), e.g., to decrease off target sites and increase specificity. In an embodiment, the length of the PAM recognition sequence is at least 4, 5, 6, 7, 8, 9, 10 or 15 amino acids in length. In an embodiment, the Cas9 specificity requires at least 90%, 95%, 96%, 97%, 98%, 99% or more homology between the gRNA and the PAM sequence. Cas9 molecules or Cas9 polypeptides that recognize different PAM sequences and/or have reduced off-target activity can be generated using directed evolution. Exemplary methods and systems that can be used for directed evolution of Cas9 molecules are described, e.g., in Esvelt et al. NATURE 2011, 472(7344): 499-503. Candidate Cas9 molecules can be evaluated, e.g., by methods described in Section IV.

Alterations of the PI domain, which mediates PAM recognition, are discussed below.

Synthetic Cas9 Molecules and Cas9 Polypeptides with Altered PI Domains

Current genome-editing methods are limited in the diversity of target sequences that can be targeted by the PAM sequence that is recognized by the Cas9 molecule utilized. A synthetic Cas9 molecule (or Syn-Cas9 molecule), or synthetic Cas9 polypeptide (or Syn-Cas9 polypeptide), as that term is used herein, refers to a Cas9 molecule or Cas9 polypeptide that comprises a Cas9 core domain from one bacterial species and a functional altered PI domain, i.e., a PI domain other than that naturally associated with the Cas9 core domain, e.g., from a different bacterial species.

In an embodiment, the altered PI domain recognizes a PAM sequence that is different from the PAM sequence recognized by the naturally-occurring Cas9 from which the Cas9 core domain is derived. In an embodiment, the altered PI domain recognizes the same PAM sequence recognized by the naturally-occurring Cas9 from which the Cas9 core domain is derived, but with different affinity or specificity. A Syn-Cas9 molecule or Syn-Cas9 polypeptide can be, respectively, a Syn-eaCas9 molecule or Syn-eaCas9 polypeptide or a Syn-eiCas9 molecule Syn-eiCas9 polypeptide.

An exemplary Syn-Cas9 molecule or Syn-Cas9 polypeptide comprises:

• • a) a Cas9 core domain, e.g., a Cas9 core domain from Table 50 or 51, e.g., a S. aureus, S. pyogenes, or C. jejuni Cas9 core domain; and
  • b) an altered PI domain from a species X Cas9 sequence selected from Tables 53 and 54.

In an embodiment, the RKR motif (the PAM binding motif) of said altered PI domain comprises: differences at 1, 2, or 3 amino acid residues; a difference in amino acid sequence at the first, second, or third position; differences in amino acid sequence at the first and second positions, the first and third positions, or the second and third positions; as compared with the sequence of the RKR motif of the native or endogenous PI domain associated with the Cas9 core domain.

In an embodiment, the Cas9 core domain comprises the Cas9 core domain from a species X Cas9 from Table 50 and said altered PI domain comprises a PI domain from a species Y Cas9 from Table 50.

In an embodiment, the RKR motif of the species X Cas9 is other than the RKR motif of the species Y Cas9.

In an embodiment, the RKR motif of the altered PI domain is selected from XXY, XNG, and XNQ.

In an embodiment, the altered PI domain has at least 60, 70, 80, 90, 95, or 100% homology with the amino acid sequence of a naturally occurring PI domain of said species Y from Table 50.

In an embodiment, the altered PI domain differs by no more than 50, 40, 30, 25, 20, 15, 10, 5, 4, 3, 2, or 1 amino acid residue from the amino acid sequence of a naturally occurring PI domain of said second species from Table 50.

In an embodiment, the Cas9 core domain comprises a S. aureus core domain and altered PI domain comprises: an A. denitrificans PI domain; a C. jejuni PI domain; a H. mustelae PI domain; or an altered PI domain of species X PI domain, wherein species X is selected from Table 54.

In an embodiment, the Cas9 core domain comprises a S. pyogenes core domain and the altered PI domain comprises: an A. denitrificans PI domain; a C. jejuni PI domain; a H. mustelae PI domain; or an altered PI domain of species X PI domain, wherein species X is selected from Table 54.

In an embodiment, the Cas9 core domain comprises a C. jejuni core domain and the altered PI domain comprises: an A. denitrificans PI domain; a H. mustelae PI domain; or an altered PI domain of species X PI domain, wherein species X is selected from Table 54.

In an embodiment, the Cas9 molecule or Cas9 polypeptide further comprises a linker disposed between said Cas9 core domain and said altered PI domain.

In an embodiment, the linker comprises: a linker described elsewhere herein disposed between the Cas9 core domain and the heterologous PI domain. Suitable linkers are further described in Section V.

Exemplary altered PI domains for use in Syn-Cas9 molecules are described in Tables 53 and 54. The sequences for the 83 Cas9 orthologs referenced in Tables 53 and 54 are provided in Table 50. Table 52 provides the Cas9 orthologs with known PAM sequences and the corresponding RKR motif.

In an embodiment, a Syn-Cas9 molecule or Syn-Cas9 polypeptide may also be size-optimized, e.g., the Syn-Cas9 molecule or Syn-Cas9 polypeptide comprises one or more deletions, and optionally one or more linkers disposed between the amino acid residues flanking the deletions. In an embodiment, a Syn-Cas9 molecule or Syn-Cas9 polypeptide comprises a REC deletion.

Size-Optimized Cas9 Molecules and Cas9 Polypeptides

Engineered Cas9 molecules and engineered Cas9 polypeptides described herein include a Cas9 molecule or Cas9 polypeptide comprising a deletion that reduces the size of the molecule while still retaining desired Cas9 properties, e.g., essentially native conformation, Cas9 nuclease activity, and/or target nucleic acid molecule recognition. Provided herein are Cas9 molecules or Cas9 polypeptides comprising one or more deletions and optionally one or more linkers, wherein a linker is disposed between the amino acid residues that flank the deletion. Methods for identifying suitable deletions in a reference Cas9 molecule, methods for generating Cas9 molecules with a deletion and a linker, and methods for using such Cas9 molecules will be apparent to one of ordinary skill in the art upon review of this document.

A Cas9 molecule, e.g., a S. aureus, S. pyogenes, or C. jejuni, Cas9 molecule, having a deletion is smaller, e.g., has reduced number of amino acids, than the corresponding naturally-occurring Cas9 molecule. The smaller size of the Cas9 molecules allows increased flexibility for delivery methods, and thereby increases utility for genome-editing. A Cas9 molecule or Cas9 polypeptide can comprise one or more deletions that do not substantially affect or decrease the activity of the resultant Cas9 molecules or Cas9 polypeptides described herein. Activities that are retained in the Cas9 molecules or Cas9 polypeptides comprising a deletion as described herein include one or more of the following:

• • a nickase activity, i.e., the ability to cleave a single strand, e.g., the non-complementary strand or the complementary strand, of a nucleic acid molecule; a double stranded nuclease activity, i.e., the ability to cleave both strands of a double stranded nucleic acid and create a double stranded break, which in an embodiment is the presence of two nickase activities;
  • an endonuclease activity;
  • an exonuclease activity;
  • a helicase activity, i.e., the ability to unwind the helical structure of a double stranded nucleic acid;
  • and recognition activity of a nucleic acid molecule, e.g., a target nucleic acid or a gRNA.

Activity of the Cas9 molecules or Cas9 polypeptides described herein can be assessed using the activity assays described herein or in the art.

Identifying Regions Suitable for Deletion

Suitable regions of Cas9 molecules for deletion can be identified by a variety of methods. Naturally-occurring orthologous Cas9 molecules from various bacterial species, e.g., any one of those listed in Table 50, can be modeled onto the crystal structure of S. pyogenes Cas9 (Nishimasu et al., Cell, 156:935-949, 2014) to examine the level of conservation across the selected Cas9 orthologs with respect to the three-dimensional conformation of the protein. Less conserved or unconserved regions that are spatially located distant from regions involved in Cas9 activity, e.g., interface with the target nucleic acid molecule and/or gRNA, represent regions or domains are candidates for deletion without substantially affecting or decreasing Cas9 activity.

REC-Optimized Cas9 Molecules and Cas9 Polypeptides

A REC-optimized Cas9 molecule, or a REC-optimized Cas9 polypeptide, as that term is used herein, refers to a Cas9 molecule or Cas9 polypeptide that comprises a deletion in one or both of the REC2 domain and the RE1_CT domain (collectively a REC deletion), wherein the deletion comprises at least 10% of the amino acid residues in the cognate domain. A REC-optimized Cas9 molecule or Cas9 polypeptide can be an eaCas9 molecule or eaCas9 polypeptide, or an eiCas9 molecule or eiCas9 polypeptide. An exemplary REC-optimized Cas9 molecule or REC-optimized Cas9 polypeptide comprises:

• • a) a deletion selected from:
    • i) a REC2 deletion;
    • ii) a REC1_CT deletion; or
    • iii) a REC1_SUB deletion.

Optionally, a linker is disposed between the amino acid residues that flank the deletion.

In an embodiment, a Cas9 molecule or Cas9 polypeptide includes only one deletion, or only two deletions. A Cas9 molecule or Cas9 polypeptide can comprise a REC2 deletion and a REC1_CT deletion. A Cas9 molecule or Cas9 polypeptide can comprise a REC2 deletion and a REC1_SUB deletion.

Generally, the deletion will contain at least 10% of the amino acids in the cognate domain, e.g., a REC2 deletion will include at least 10% of the amino acids in the REC2 domain.

A deletion can comprise: at least 10, 20, 30, 40, 50, 60, 70, 80, or 90% of the amino acid residues of its cognate domain; all of the amino acid residues of its cognate domain; an amino acid residue outside its cognate domain; a plurality of amino acid residues outside its cognate domain; the amino acid residue immediately N terminal to its cognate domain; the amino acid residue immediately C terminal to its cognate domain; the amino acid residue immediately N terminal to its cognate and the amino acid residue immediately C terminal to its cognate domain; a plurality of, e.g., up to 5, 10, 15, or 20, amino acid residues N terminal to its cognate domain; a plurality of, e.g., up to 5, 10, 15, or 20, amino acid residues C terminal to its cognate domain; a plurality of, e.g., up to 5, 10, 15, or 20, amino acid residues N terminal to to its cognate domain and a plurality of e.g., up to 5, 10, 15, or 20, amino acid residues C terminal to its cognate domain.

In an embodiment, a deletion does not extend beyond: its cognate domain; the N terminal amino acid residue of its cognate domain; the C terminal amino acid residue of its cognate domain.

A REC-optimized Cas9 molecule or REC-optimized Cas9 polypeptide can include a linker disposed between the amino acid residues that flank the deletion. Any linkers known in the art that maintain the conformation or native fold of the Cas9 molecule (thereby retaining Cas9 activity) can be used between the amino acid resides that flank a REC deletion in a REC-optimized Cas9 molecule or REC-optimized Cas9 polypeptide. Linkers for use in generating recombinant proteins, e.g., multi-domain proteins, are known in the art (Chen et al., Adv Drug Delivery Rev, 65:1357-69, 2013).

In an embodiment, a REC-optimized Cas9 molecule or REC-optimized Cas9 polypeptide comprises an amino acid sequence that, other than any REC deletion and associated linker, has at least 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 99, or 100% homology with the amino acid sequence of a naturally occurring Cas 9, e.g., a Cas9 molecule described in Table 50, e.g., a S. aureus Cas9 molecule, a S. pyogenes Cas9 molecule, or a C. jejuni Cas9 molecule.

In an embodiment, a a REC-optimized Cas9 molecule or REC-optimized Cas9 polypeptide comprises an amino acid sequence that, other than any REC deletion and associated linker, differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, or 25, amino acid residues from the amino acid sequence of a naturally occurring Cas 9, e.g., a Cas9 molecule described in Table 50, e.g., a S. aureus Cas9 molecule, a S. pyogenes Cas9 molecule, or a C. jejuni Cas9 molecule.

In an embodiment, a REC-optimized Cas9 molecule or REC-optimized Cas9 polypeptide comprises an amino acid sequence that, other than any REC deletion and associate linker, differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, or 25% of the, amino acid residues from the amino acid sequence of a naturally occurring Cas 9, e.g., a Cas9 molecule described in Table 50, e.g., a S. aureus Cas9 molecule, a S. pyogenes Cas9 molecule, or a C. jejuni Cas9 molecule.

For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters. Methods of alignment of sequences for comparison are well known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith and Waterman, (1970) Adv. Appl. Math. 2:482c, by the homology alignment algorithm of Needleman and Wunsch, (1970) J. Mol. Biol. 48:443, by the search for similarity method of Pearson and Lipman, (1988) Proc. Nat'l. Acad. Sci. USA 85:2444, by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection (see, e.g., Brent et al., (2003) Current Protocols in Molecular Biology).

Two examples of algorithms that are suitable for determining percent sequence identity and sequence similarity are the BLAST and BLAST 2.0 algorithms, which are described in Altschul et al., (1977) Nuc. Acids Res. 25:3389-3402; and Altschul et al., (1990) J. Mol. Biol. 215:403-410, respectively. Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information.

The percent identity between two amino acid sequences can also be determined using the algorithm of E. Meyers and W. Miller, (1988) Comput. Appl. Biosci. 4:11-17) which has been incorporated into the ALIGN program (version 2.0), using a PAM120 weight residue table, a gap length penalty of 12 and a gap penalty of 4. In addition, the percent identity between two amino acid sequences can be determined using the Needleman and Wunsch (1970) J. Mol. Biol. 48:444-453) algorithm which has been incorporated into the GAP program in the GCG software package (available at www.gcg.com), using either a Blossom 62 matrix or a PAM250 matrix, and a gap weight of 16, 14, 12, 10, 8, 6, or 4 and a length weight of 1, 2, 3, 4, 5, or 6.

Sequence information for exemplary REC deletions are provided for 83 naturally-occurring Cas9 orthologs in Table 50.

The amino acid sequences of exemplary Cas9 molecules from different bacterial species are shown below.

TABLE 50
Amino Acid Sequence of Cas9 Orthologs
		REC2	REC1CT	Recsub
		start	stop	#AA	start	stop	#AA	start	stop	#AA
	Amino acid	(AA	(AA	delete	(AA	(AA	delete	(AA	(AA	delete
Species/Composite ID	sequence	pos)	pos)	d (n)	pos)	pos)	d (n)	pos)	pos)	d (n)
Staphylococcus Aureus	SEQ ID NO:	126	166	41	296	352	57	296	352	57
tr|J7RUA5|J7RUA5_STAAU	304
Streptococcus Pyogenes	SEQ ID NO:	176	314	139	511	592	82	511	592	82
sp|Q99ZW2|CAS9_STRP1	305
Campylobacter jejuni NCTC 11168	SEQ ID NO:	137	181	45	316	360	45	316	360	45
gi|218563121|ref|YP_002344900.1	306
Bacteroides fragilis NCTC 9343	SEQ ID NO:	148	339	192	524	617	84	524	617	84
gi|60683389|ref|YP_213533.1|	307
Bifidobacterium bifidum S17	SEQ ID NO:	173	335	163	516	607	87	516	607	87
gi|310286728|ref|YP_003937986.	308
Veillonella atypica	SEQ ID NO:	185	339	155	574	663	79	574	663	79
ACS-134-V-Col7a	309
gi|303229466|ref|ZP_07316256.1
Lactobacillus rhamnosus GG	SEQ ID NO:	169	320	152	559	645	78	559	645	78
gi|258509199|ref|YP_003171950.1	310
Filifactor alocis ATCC 35896	SEQ ID NO:	166	314	149	508	592	76	508	592	76
gi|374307738|ref|YP_005054169.1	311
Oenococcus kitaharae DSM 17330	SEQ ID NO:	169	317	149	555	639	80	555	639	80
gi|366983953|gb|EHN59352.1|	312
Fructobacillus fructosus	SEQ ID NO:	168	314	147	488	571	76	488	571	76
KCTC 3544	313
gi|339625081|ref|ZP_08660870.1
Catenibacterium mitsuokai	SEQ ID NO:	173	318	146	511	594	78	511	594	78
DSM 15897	314
gi|224543312|ref|ZP_03683851.1
Finegoldia magna ATCC 29328	SEQ ID NO:	168	313	146	452	534	77	452	534	77
gi|169823755|ref|YP_001691366.1	315
Coriobacterium glomeransPW2	SEQ ID NO:	175	318	144	511	592	82	511	592	82
gi|328956315|ref|YP_004373648.1	316
Eubacterium yurii ATCC 43715	SEQ ID NO:	169	310	142	552	633	76	552	633	76
gi|306821691|ref|ZP_07455288.1	317
Peptoniphilus duerdenii ATCC	SEQ ID NO:	171	311	141	535	615	76	535	615	76
BAA-1640	318
gi|304438954|ref|ZP_07398877.1
Acidaminococcus sp. D21	SEQ ID NO:	167	306	140	511	591	75	511	591	75
gi|227824983|ref|ZP_03989815.1	319
Lactobacillus farciminis KCTC 3681	SEQ ID NO:	171	310	140	542	621	85	542	621	85
gi|336394882|ref|ZP_08576281.1	320
Streptococcus sanguinis SK49	SEQ ID NO:	185	324	140	411	490	85	411	490	85
gi|422884106|ref|ZP_16930555.1	321
Coprococcus catus GD-7	SEQ ID NO:	172	310	139	556	634	76	556	634	76
gi|291520705|emb|CBK78998.1|	322
Streptococcus mutans UA159	SEQ ID NO:	176	314	139	392	470	84	392	470	84
gi|24379809|ref|NP_721764.1|	323
Streptococcus pyogenes M1 GAS	SEQ ID NO:	176	314	139	523	600	82	523	600	82
gi|13622193|gb|AAK33936.1|	324
Streptococcus thermophilus LMD-9	SEQ ID NO:	176	314	139	481	558	81	481	558	81
gi|116628213|ref|YP_820832.1|	325
Fusobacterium nucleatum	SEQ ID NO:	171	308	138	537	614	76	537	614	76
ATCC49256	326
gi|34762592|ref|ZP_00143587.1|
Planococcus antarcticus DSM 14505	SEQ ID NO:	162	299	138	538	614	94	538	614	94
gi|389815359|ref|ZP_10206685.1	327
Treponema denticola ATCC 35405	SEQ ID NO:	169	305	137	524	600	81	524	600	81
gi|42525843|ref|NP_970941.1|	328
Solobacterium moorei F0204	SEQ ID NO:	179	314	136	544	619	77	544	619	77
gi|320528778|ref|ZP_08029929.1	329
Staphylococcus pseudintermedius	SEQ ID NO:	164	299	136	531	606	92	531	606	92
ED99	330
gi|323463801|gb|ADX75954.1|
Flavobacterium branchiophilum	SEQ ID NO:	162	286	125	538	613	63	538	613	63
FL-15	331
gi|347536497|ref|YP_004843922.1
Ignavibacterium album JCM 16511	SEQ ID NO:	223	329	107	357	432	90	357	432	90
gi|385811609|ref|YP_005848005.1	332
Bergeyella zoohelcum ATCC 43767	SEQ ID NO:	165	261	97	529	604	56	529	604	56
gi|423317190|ref|ZP_17295095.1	333
Nitrobacter hamburgensis X14	SEQ ID NO:	169	253	85	536	611	48	536	611	48
gi|92109262|ref|YP_571550.1|	334
Odoribacter laneus YIT 12061	SEQ ID NO:	164	242	79	535	610	63	535	610	63
gi|374384763|ref|ZP_09642280.1	335
Legionella pneumophila str. Paris	SEQ ID NO:	164	239	76	402	476	67	402	476	67
gi|54296138|ref|YP_122507.1|	336
Bacteroides sp. 20 3	SEQ ID NO:	198	269	72	530	604	83	530	604	83
gi|301311869|ref|ZP_07217791.1	337
Akkermansia muciniphila	SEQ ID NO:	136	202	67	348	418	62	348	418	62
ATCC BAA-835	338
gi|187736489|ref|YP_001878601.
Prevotella sp. C561	SEQ ID NO:	184	250	67	357	425	78	357	425	78
gi|345885718|ref|ZP_08837074.1	339
Wolinella succinogenes DSM 1740	SEQ ID NO:	157	218	36	401	468	60	401	468	60
gi|34557932|ref|NP_907747.1|	340
Alicyclobacillus hesperidum	SEQ ID NO:	142	196	55	416	482	61	416	482	61
URH17-3-68	341
gi|403744858|ref|ZP_10953934.1
Caenispirillum salinarum AK4	SEQ ID NO:	161	214	54	330	393	68	330	393	68
gi|427429481|ref|ZP_18919511.1	342
Eubacterium rectale ATCC 33656	SEQ ID NO:	133	185	53	322	384	60	322	384	60
gi|238924075|ref|YP_002937591.1	343
Mycoplasma synoviae 53	SEQ ID NO:	187	239	53	319	381	80	319	381	80
gi|71894592|ref|YP278700.1|	344
Porphyromonas sp. oral taxon	SEQ ID NO:	150	202	53	309	371	60	309	371	60
279str. F0450	345
gi|402847315|ref|ZP_10895610.1
Streptococcus thermophilus LMD-9	SEQ ID NO:	127	178	139	424	486	81	424	486	81
gi|116627542|ref|YP_820161.1|	346
Roseburia inulinivorans DSM 16841	SEQ ID NO:	154	204	51	318	380	69	318	380	69
gi|225377804|ref|ZP_03755025.1	347
Methylosinus trichosporium OB3b	SEQ ID NO:	144	193	50	426	488	64	426	488	64
gi|296446027|ref|ZP_06887976.1	348
Ruminococcus albus 8	SEQ ID NO:	139	187	49	351	412	55	351	412	55
gi|325677756|ref|ZP_08157403.1	349
Bifidobacterium longum DJO10A	SEQ ID NO:	183	230	48	370	431	44	370	431	44
gi|189440764|ref|YP_001955845.	350
Enterococcus faecalis TX0012	SEQ ID NO:	123	170	48	327	387	60	327	387	60
gi|315149830|gb|EFT93846.1|	351
Mycoplasma mobile 163K	SEQ ID NO:	179	226	48	314	374	79	314	374	79
gi|47458868|ref|YP_015730.1|	352
Actinomyces coleocanis DSM 15436	SEQ ID NO:	147	193	47	358	418	40	358	418	40
gi|227494853|ref|ZP_03925169.1	353
Dinoroseobacter shibae DFL 12	SEQ ID NO:	138	184	47	338	398	48	338	398	48
gi|159042956|ref|YP_001531750.1	354
Actinomyces sp. oral taxon 180	SEQ ID NO:	183	228	46	349	409	40	349	409	40
str. F0310	355
gi|315605738|ref|ZP_07880770.1
Alcanivorax sp. W11-5	SEQ ID NO:	139	183	45	344	404	61	344	404	61
gi|407803669|ref|ZP_11150502.1	356
Aminomonas paucivorans DSM 12260	SEQ ID NO:	134	178	45	341	401	63	341	401	63
gi|312879015|ref|ZP_07738815.1	357
Mycoplasma canis PG 14	SEQ ID NO:	139	183	45	319	379	76	319	379	76
gi|384393286|gb|EIE39736.1|	358
Lactobacillus coryniformis	SEQ ID NO:	141	184	44	328	387	61	328	387	61
KCTC 3535	359
gi|336393381|ref|ZP_08574780.1
Elusimicrobium minutum Pei191	SEQ ID NO:	177	219	43	322	381	47	322	381	47
gi|187250660|ref|YP_001875142.1	360
Neisseria meningitidis Z2491	SEQ ID NO:	147	189	43	360	419	61	360	419	61
gi|218767588|ref|YP_002342100.1	361
Pasteurella multocida str. Pm70	SEQ ID NO:	139	181	43	319	378	61	319	378	61
gi|15602992|ref|NP_246064.1|	362
Rhodovulum sp. PH10	SEQ ID NO:	141	183	43	319	378	48	319	378	48
gi|402849997|ref|ZP_10898214.1	363
Eubacterium dolichum DSM 3991	SEQ ID NO:	131	172	42	303	361	59	303	361	59
gi|160915782|ref|ZP_02077990.1	364
Nitratifractor salsuginis DSM 16511	SEQ ID NO:	143	184	42	347	404	61	347	404	61
gi|319957206|ref|YP_004168469.1	365
Rhodospirillum rubrum ATCC 11170	SEQ ID NO:	139	180	42	314	371	55	314	371	55
gi|83591793|ref|YP_425545.1|	366
Clostridium cellulolyticum H10	SEQ ID NO:	137	176	40	320	376	61	320	376	61
gi|220930482|ref|YP_002507391.1	367
Helicobacter mustelae 12198	SEQ ID NO:	148	187	40	298	354	48	298	354	48
gi|291276265|ref|YP_003516037.1	368
Ilyobacter polytropus DSM 2926	SEQ ID NO:	134	173	40	462	517	63	462	517	63
gi|310780384|ref|YP_003968716.1	369
Sphaerochaeta globus str. Buddy	SEQ ID NO:	163	202	40	335	389	45	335	389	45
gi|325972003|ref|YP_004248194.1	370
Staphylococcus lugdunensis M23590	SEQ ID NO:	128	167	40	337	391	57	337	391	57
gi|315659848|ref|ZP_07912707.1	371
Treponema sp. JC4	SEQ ID NO:	144	183	40	328	382	63	328	382	63
gi|384109266|ref|ZP_10010146.1	372
uncultured delta	SEQ ID NO:	154	193	40	313	365	55	313	365	55
proteobacterium HF0070 07E19	373
gi|297182908|gb|ADI19058.1|
Alicycliphilus denitrificans K601	SEQ ID NO:	140	178	39	317	366	48	317	366	48
gi|330822845|ref|YP_004386148.1	374
Azospirillum sp. B510	SEQ ID NO:	205	243	39	342	389	46	342	389	46
gi|288957741|ref|YP_003448082.1	375
Bradyrhizobium sp. BTAil	SEQ ID NO:	143	181	39	323	370	48	323	370	48
gi|148255343|ref|YP_001239928.1	376
Parvibaculum lavamentivorans DS-1	SEQ ID NO:	138	176	39	327	374	58	327	374	58
gi|154250555|ref|YP_001411379.1	377
Prevotella timonensis CRIS 5C-B1	SEQ ID NO:	170	208	39	328	375	61	328	375	61
gi|282880052|ref|ZP_06288774.1	378
Bacillus smithii 7 3 47FAA	SEQ ID NO:	134	171	38	401	448	63	401	448	63
gi|365156657|ref|ZP_09352959.1	379
Cand. Puniceispirillum marinum	SEQ ID NO:	135	172	38	344	391	53	344	391	53
IMCC1322	380
gi|294086111|ref|YP_003552871.1
Barnesiella intestinihominis	SEQ ID NO:	140	176	37	371	417	60	371	417	60
YIT 11860	381
gi|404487228|ref|ZP_11022414.1
Ralstonia syzygii R24	SEQ ID NO:	140	176	37	395	440	50	395	440	50
gi|344171927|emb|CCA84553.1|	382
Wolinella succinogenes DSM 1740	SEQ ID NO:	145	180	36	348	392	60	348	392	60
gi|34557790|ref|NP_907605.1|	383
Mycoplasma gallisepticum str. F	SEQ ID NO:	144	177	34	373	416	71	373	416	71
gi|284931710|gb|ADC31648.1|	384
Acidothermus cellulolyticus 11B	SEQ ID NO:	150	182	33	341	380	58	341	380	58
gi|117929158|ref|YP_873709.1|	385
Mycoplasma ovipneumoniae SC01	SEQ ID NO:	156	184	29	381	420	62	381	420	62
gi|363542550|ref|ZP_09312133.1	386

TABLE 51
Amino Acid Sequence of Cas9 Core Domains
		Cas9 Start	Cas9 Stop
	Strain Name	(AA pos)	(AA pos)
		Start and Stop numbers refer to the
		sequence in Table 50
	Staphylococcus Aureus	1	772
	Streptococcus Pyogenes	1	1099
	Campulobacter Jejuni	1	741

TABLE 52
Identified PAM sequences and corresponding
RKR motifs.
	PAM sequence	RKR motif
Strain Name	(NA)	(AA)
Streptococcus pyogenes	NGG	RKR
Streptococcus mutans	NGG	RKR
Streptococcus	NGGNG	RYR
thermophilus A
Treponema denticola	NAAAAN	VAK
Streptococcus	NNAAAAW	IYK
thermophilus B
Campylobacter jejuni	NNNNACA	NLK
Pasteurella multocida	GNNNCNNA	KDG
Neisseria meningitidis	NNNNGATT or	IGK
Staphylococcus aureus	NNGRRV (R = A	NDK
	or G; V = A, G or
	C) NNGRRT (R =
	A or G)

TABLE 53
Altered PI Domains
	PI Start	PI Stop	Length of PI	RKR motif
Strain Name	(AA pos)	(AA pos)	(AA)	(AA)
	Start and Stop numbers
	refer to the sequences in
	Table 50
Alicycliphilus	837	1029	193	--Y
denitrificans K601
Campylobacter	741	984	244	-NG
jejuni NCTC 11168
Helicobacter	771	1024	254	-NQ
mustelae 12198

TABLE 54
Other Altered PI Domains
	PI Start	PI Stop	Length of PI	RKR motif
Strain Name	(AA pos)	(AA pos)	(AA)	(AA)
	Start and
	Stop numbers
	refer to the
	sequences in
	Table 50
Akkermansia	871	1101	231	ALK
muciniphila
ATCC BAA-835
Ralstonia	821	1062	242	APY
syzygii R24
Cand.	815	1035	221	AYK
Puniceispirillum
marinum
IMCC1322
Fructobacillus	1074	1323	250	DGN
fructosus
KCTC 3544
Eubacterium yurii	1107	1391	285	DGY
ATCC 43715
Eubacterium	779	1096	318	DKK
dolichum
DSM 3991
Dinoroseobacter	851	1079	229	DPI
shibae
DFL 12
Clostridium	767	1021	255	EGK
cellulolyticum
H10
Pasteurella multocida	815	1056	242	ENN
str. Pm70
Mycoplasma canis	907	1233	327	EPK
PG 14
Poiphyromonas sp.	935	1197	263	EPT
oral taxon 279
str. F0450
Filifactor alocis	1094	1365	272	EVD
ATCC 35896
Aminomonas	801	1052	252	EVY
paucivorans
DSM 12260
Wolinella	1034	1409	376	EYK
succinogenes
DSM 1740
Oenococcus	1119	1389	271	GAL
kitaharae
DSM 17330
Coriobacterium	1126	1384	259	GDR
glomerans PW2
Peptoniphilus	1091	1364	274	GDS
duerdenii ATCC
BAA-1640
Bifidobacterium	1138	1420	283	GGL
bifidum S17
Alicyclobacillus	876	1146	271	GGR
hesperidum
URH17-3-68
Roseburia	895	1152	258	GGT
inulinivorans
DSM 16841
Actinomyces	843	1105	263	GKK
coleocanis
DSM 15436
Odoribacter laneus	1103	1498	396	GKV
YIT 12061
Coprococcus catus	1063	1338	276	GNQ
GD-7
Enterococcus	829	1150	322	GRK
faecalis
TX0012
Bacillus smithii	809	1088	280	GSK
7 3 47FAA
Legionella	1021	1372	352	GTM
pneumophila
str. Paris
Bacteroides fragilis	1140	1436	297	IPV
NCTC 9343
Mycoplasma	923	1265	343	IRI
ovipneumoniae
SC01
Actinomyces sp.	895	1181	287	KEK
oral taxon 180 str.
F0310
Treponema sp. JC4	832	1062	231	KIS
Fusobacterium	1073	1374	302	KKV
nucleatum
ATCC49256
Lactobacillus	1101	1356	256	KKV
farciminis
KCTC 3681
Nitratifractor	840	1132	293	KMR
salsuginis
DSM 16511
Lactobacillus	850	1119	270	KNK
colyniformis
KCTC 3535
Mycoplasma	916	1236	321	KNY
mobile 163K
Flavobacterium	1182	1473	292	KQK
branchiophilum
FL-15
Prevotella	957	1218	262	KQQ
timonensis
CRIS 5C-B1
Methylosinus	830	1082	253	KRP
trichosporium OB3b
Prevotella sp. C561	1099	1424	326	KRY
Mycoplasma	911	1269	359	KTA
gallisepticum str. F
Lactobacillus	1077	1363	287	KYG
rhamnosus GG
Wolinella	811	1059	249	LPN
succinogenes
DSM 1740
Streptococcus	1099	1388	290	MLA
thermophilus
LMD-9
Treponema	1092	1395	304	NDS
denticola
ATCC 35405
Bergeyella	1098	1415	318	NEK
zoohelcum
ATCC 43767
Veillonella atypica	1107	1398	292	NGF
ACS-134-V-Col7a
Neisseria	835	1082	248	NHN
meningitidis Z2491
Ignavibacterium	1296	1688	393	NKK
album JCM 16511
Ruminococcus	853	1156	304	NNF
albus 8
Streptococcus	811	1121	311	NNK
thermophilus LMD-9
Barnesiella	871	1153	283	NPV
intestinihominis
YIT 11860
Azospirillum sp.	911	1168	258	PFH
B510
Rhodospirillum	863	1173	311	PRG
rubrum
ATCC 11170
Planococcus	1087	1333	247	PYY
antarcticus DSM
14505
Staphylococcus	1073	1334	262	QIV
pseudintermedius
ED99
Alcanivorax sp.	843	1113	271	RIE
W11-5
Bradyrhizobium sp.	811	1064	254	RIY
BTAi1
Streptococcus	1099	1368	270	RKR
pyogenes
M1 GAS
Streptococcus	1078	1345	268	RKR
mutans UA159
Streptococcus	1099	1368	270	RKR
Pyogenes
Bacteroides sp.	1147	1517	371	RNI
20 3
S. aureus	772	1053	282	RNK
Solobacterium	1062	1327	266	RSG
moorei F0204
Finegoldia magna	1081	1348	268	RTE
ATCC 29328
uncultured delta	770	1011	242	SGG
proteobacterium
HF0070 07E19
Acidaminococcus sp.	1064	1358	295	SIG
D21
Eubacterium rectale	824	1114	291	SKK
ATCC 33656
Caenispirillum	1048	1442	395	SLV
salinarum AK4
Acidothermus	830	1138	309	SPS
cellulolyticus 11B
Catenibacterium	1068	1329	262	SPT
mitsuokai
DSM 15897
Parvibaculum	827	1037	211	TGN
lavamentivorans
DS-1
Staphylococcus	772	1054	283	TKK
lugdunensis M23590
Streptococcus	1123	1421	299	TRM
sanguinis SK49
Elusimicrobium	910	1195	286	TTG
minutum Pei191
Nitrobacter	914	1166	253	VAY
hamburgensis X14
Mycoplasma	991	1314	324	VGF
synoviae 53
Sphaerochaeta	877	1179	303	VKG
globus str. Buddy
Ilyobacter	837	1092	256	VNG
polytropus
DSM 2926
Rhodovulum sp.	821	1059	239	VPY
PH10
Bifidobacterium	904	1187	284	VRK
longum DJO10A

Amino Acid Sequences Described in Table 50:

SEQ ID NO: 304
MKRNYILGLDIGITSVGYGIIDYETRDVIDAGVRLFKEANVENNEGRRSKRGARRLKRRRRHRI
QRVKKLLFDYNLLTDHSELSGINPYEARVKGLSQKLSEEEFSAALLHLAKRRGVHNVNEVEEDT
GNELSTKEQISRNSKALEEKYVAELQLERLKKDGEVRGSINRFKTSDYVKEAKQLLKVQKAYHQ
LDQSFIDTYIDLLETRRTYYEGPGEGSPFGWKDIKEWYEMLMGHCTYFPEELRSVKYAYNADLY
NALNDLNNLVITRDENEKLEYYEKFQIIENVFKQKKKPTLKQIAKEILVNEEDIKGYRVTSTGK
PEFTNLKVYHDIKDITARKEIIENAELLDQIAKILTIYQSSEDIQEELTNLNSELTQEEIEQIS
NLKGYTGTHNLSLKAINLILDELWHTNDNQIAIFNRLKLVPKKVDLSQQKEIPTTLVDDFILSP
VVKRSFIQSIKVINAIIKKYGLPNDIIIELAREKNSKDAQKMINEMQKRNRQTNERIEEIIRTT
GKENAKYLIEKIKLHDMQEGKCLYSLEAIPLEDLLNNPFNYEVDHIIPRSVSFDNSFNNKVLVK
QEENSKKGNRTPFQYLSSSDSKISYETFKKHILNLAKGKGRISKTKKEYLLEERDINRFSVQKD
FINRNLVDTRYATRGLMNLLRSYFRVNNLDVKVKSINGGFTSFLRRKWKFKKERNKGYKHHAED
ALIIANADFIFKEWKKLDKAKKVMENQMFEEKQAESMPEIETEQEYKEIFITPHQIKHIKDFKD
YKYSHRVDKKPNRELINDTLYSTRKDDKGNTLIVNNLNGLYDKDNDKLKKLINKSPEKLLMYHH
DPQTYQKLKLIMEQYGDEKNPLYKYYEETGNYLTKYSKKDNGPVIKKIKYYGNKLNAHLDITDD
YPNSRNKVVKLSLKPYRFDVYLDNGVYKFVTVKNLDVIKKENYYEVNSKCYEEAKKLKKISNQA
EFIASFYNNDLIKINGELYRVIGVNNDLLNRIEVNMIDITYREYLENMNDKRPPRIIKTIASKT
QSIKKYSTDILGNLYEVKSKKHPQIIKKG
SEQ ID NO: 305
MDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRL
KRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAY
HEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTY
NQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNF
DLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSAS
MIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMD
GTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRI
PYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHS
LLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFD
SVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYA
HLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTF
KEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQ
TTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINR
LSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRK
FDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKS
KLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAK
SEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLS
MPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKG
KSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLAS
AGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRV
ILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLD
ATLIHQSITGLYETRIDLSQLGGD
SEQ ID NO: 306
MARILAFDIGISSIGWAFSENDELKDCGVRIFTKVENPKTGESLALPRRLARSARKRLARRKAR
LNHLKHLIANEFKLNYEDYQSFDESLAKAYKGSLISPYELRFRALNELLSKQDFARVILHIAKR
RGYDDIKNSDDKEKGAILKAIKQNEEKLANYQSVGEYLYKEYFQKFKENSKEFTNVRNKKESYE
RCIAQSFLKDELKLIFKKQREFGFSFSKKFEEEVLSVAFYKRALKDFSHLVGNCSFFTDEKRAP
KNSPLAFMFVALTRIINLLNNLKNTEGILYTKDDLNALLNEVLKNGTLTYKQTKKLLGLSDDYE
FKGEKGTYFIEFKKYKEFIKALGEHNLSQDDLNEIAKDITLIKDEIKLKKALAKYDLNQNQIDS
LSKLEFKDHLNISFKALKLVTPLMLEGKKYDEACNELNLKVAINEDKKDFLPAFNETYYKDEVT
NPVVLRAIKEYRKVLNALLKKYGKVHKINIELAREVGKNHSQRAKIEKEQNENYKAKKDAELEC
EKLGLKINSKNILKLRLFKEQKEFCAYSGEKIKISDLQDEKMLEIDHIYPYSRSFDDSYMNKVL
VFTKQNQEKLNQTPFEAFGNDSAKWQKIEVLAKNLPTKKQKRILDKNYKDKEQKNFKDRNLNDT
RYIARLVLNYTKDYLDFLPLSDDENTKLNDTQKGSKVHVEAKSGMLTSALRHTWGFSAKDRNNH
LHHAIDAVIIAYANNSIVKAFSDFKKEQESNSAELYAKKISELDYKNKRKFFEPFSGFRQKVLD
KIDEIFVSKPERKKPSGALHEETFRKEEEFYQSYGGKEGVLKALELGKIRKVNGKIVKNGDMFR
VDIFKHKKTNKFYAVPIYTMDFALKVLPNKAVARSKKGEIKDWILMDENYEFCFSLYKDSLILI
QTKDMQEPEFVYYNAFTSSTVSLIVSKHDNKFETLSKNQKILFKNANEKEVIAKSIGIQNLKVF
EKYIVSALGEVTKAEFRQREDFKK
SEQ ID NO: 307
MKRILGLDLGTNSIGWALVNEAENKDERSSIVKLGVRVNPLTVDELTNFEKGKSITTNADRTLK
RGMRRNLQRYKLRRETLTEVLKEHKLITEDTILSENGNRTTFETYRLRAKAVTEEISLEEFARV
LLMINKKRGYKSSRKAKGVEEGTLIDGMDIARELYNNNLTPGELCLQLLDAGKKFLPDFYRSDL
QNELDRIWEKQKEYYPEILTDVLKEELRGKKRDAVWAICAKYFVWKENYTEWNKEKGKTEQQER
EHKLEGIYSKRKRDEAKRENLQWRVNGLKEKLSLEQLVIVFQEMNTQINNSSGYLGAISDRSKE
LYFNKQTVGQYQMEMLDKNPNASLRNMVFYRQDYLDEFNMLWEKQAVYHKELTEELKKEIRDII
IFYQRRLKSQKGLIGFCEFESRQIEVDIDGKKKIKTVGNRVISRSSPLFQEFKIWQILNNIEVT
VVGKKRKRRKLKENYSALFEELNDAEQLELNGSRRLCQEEKELLAQELFIRDKMTKSEVLKLLF
DNPQELDLNFKTIDGNKTGYALFQAYSKMIEMSGHEPVDFKKPVEKVVEYIKAVFDLLNWNTDI
LGFNSNEELDNQPYYKLWHLLYSFEGDNTPTGNGRLIQKMTELYGFEKEYATILANVSFQDDYG
SLSAKAIHKILPHLKEGNRYDVACVYAGYRHSESSLTREEIANKVLKDRLMLLPKNSLHNPVVE
KILNQMVNVINVIIDIYGKPDEIRVELARELKKNAKEREELTKSIAQTTKAHEEYKTLLQTEFG
LTNVSRTDILRYKLYKELESCGYKTLYSNTYISREKLFSKEFDIEHIIPQARLFDDSFSNKTLE
ARSVNIEKGNKTAYDFVKEKFGESGADNSLEHYLNNIEDLFKSGKISKTKYNKLKMAEQDIPDG
FIERDLRNTQYIAKKALSMLNEISHRVVATSGSVTDKLREDWQLIDVMKELNWEKYKALGLVEY
FEDRDGRQIGRIKDWTKRNDHRHHAMDALTVAFTKDVFIQYFNNKNASLDPNANEHAIKNKYFQ
NGRAIAPMPLREFRAEAKKHLENTLISIKAKNKVITGNINKTRKKGGVNKNMQQTPRGQLHLET
IYGSGKQYLTKEEKVNASFDMRKIGTVSKSAYRDALLKRLYENDNDPKKAFAGKNSLDKQPIWL
DKEQMRKVPEKVKIVTLEAIYTIRKEISPDLKVDKVIDVGVRKILIDRLNEYGNDAKKAFSNLD
KNPIWLNKEKGISIKRVTISGISNAQSLHVKKDKDGKPILDENGRNIPVDFVNTGNNHHVAVYY
RPVIDKRGQLVVDEAGNPKYELEEVVVSFFEAVTRANLGLPIIDKDYKTTEGWQFLFSMKQNEY
FVFPNEKTGFNPKEIDLLDVENYGLISPNLFRVQKFSLKNYVFRHHLETTIKDTSSILRGITWI
DFRSSKGLDTIVKVRVNHIGQIVSVGEY
SEQ ID NO: 308
MSRKNYVDDYAISLDIGNASVGWSAFTPNYRLVRAKGHELIGVRLFDPADTAESRRMARTTRRR
YSRRRWRLRLLDALFDQALSEIDPSFLARRKYSWVHPDDENNADCWYGSVLFDSNEQDKRFYEK
YPTIYHLRKALMEDDSQHDIREIYLAIHHMVKYRGNFLVEGTLESSNAFKEDELLKLLGRITRY
EMSEGEQNSDIEQDDENKLVAPANGQLADALCATRGSRSMRVDNALEALSAVNDLSREQRAIVK
AIFAGLEGNKLDLAKIFVSKEFSSENKKILGIYFNKSDYEEKCVQIVDSGLLDDEEREFLDRMQ
GQYNAIALKQLLGRSTSVSDSKCASYDAHRANWNLIKLQLRTKENEKDINENYGILVGWKIDSG
QRKSVRGESAYENMRKKANVFFKKMIETSDLSETDKNRLIHDIEEDKLFPIQRDSDNGVIPHQL
HQNELKQIIKKQGKYYPFLLDAFEKDGKQINKIEGLLTFRVPYFVGPLVVPEDLQKSDNSENHW
MVRKKKGEITPWNFDEMVDKDASGRKFIERLVGTDSYLLGEPTLPKNSLLYQEYEVLNELNNVR
LSVRTGNHWNDKRRMRLGREEKTLLCQRLFMKGQTVTKRTAENLLRKEYGRTYELSGLSDESKF
TSSLSTYGKMCRIFGEKYVNEHRDLMEKIVELQTVFEDKETLLHQLRQLEGISEADCALLVNTH
YTGWGRLSRKLLTTKAGECKISDDFAPRKHSIIEIMRAEDRNLMEIITDKQLGFSDWIEQENLG
AENGSSLMEVVDDLRVSPKVKRGIIQSIRLIDDISKAVGKRPSRIFLELADDIQPSGRTISRKS
RLQDLYRNANLGKEFKGIADELNACSDKDLQDDRLFLYYTQLGKDMYTGEELDLDRLSSAYDID
HIIPQAVTQNDSIDNRVLVARAENARKTDSFTYMPQIADRMRNFWQILLDNGLISRVKFERLTR
QNEFSEREKERFVQRSLVETRQIMKNVATLMRQRYGNSAAVIGLNAELTKEMHRYLGFSHKNRD
INDYHHAQDALCVGIAGQFAANRGFFADGEVSDGAQNSYNQYLRDYLRGYREKLSAEDRKQGRA
FGFIVGSMRSQDEQKRVNPRTGEVVWSEEDKDYLRKVMNYRKMLVTQKVGDDFGALYDETRYAA
TDPKGIKGIPFDGAKQDTSLYGGFSSAKPAYAVLIESKGKTRLVNVTMQEYSLLGDRPSDDELR
KVLAKKKSEYAKANILLRHVPKMQLIRYGGGLMVIKSAGELNNAQQLWLPYEEYCYFDDLSQGK
GSLEKDDLKKLLDSILGSVQCLYPWHRFTEEELADLHVAFDKLPEDEKKNVITGIVSALHADAK
TANLSIVGMTGSWRRMNNKSGYTFSDEDEFIFQSPSGLFEKRVTVGELKRKAKKEVNSKYRTNE
KRLPTLSGASQP
SEQ ID NO: 309
METQTSNQLITSHLKDYPKQDYFVGLDIGTNSVGWAVTNTSYELLKFHSHKMWGSRLFEEGESA
VTRRGFRSMRRRLERRKLRLKLLEELFADAMAQVDSTFFIRLHESKYHYEDKTTGHSSKHILFI
DEDYTDQDYFTEYPTIYHLRKDLMENGTDDIRKLFLAVHHILKYRGNFLYEGATFNSNAFTFED
VLKQALVNITFNCFDTNSAISSISNILMESGKTKSDKAKAIERLVDTYTVFDEVNTPDKPQKEQ
VKEDKKTLKAFANLVLGLSANLIDLFGSVEDIDDDLKKLQIVGDTYDEKRDELAKVWGDEIHII
DDCKSVYDAIILMSIKEPGLTISQSKVKAFDKHKEDLVILKSLLKLDRNVYNEMFKSDKKGLHN
YVHYIKQGRTEETSCSREDFYKYTKKIVEGLADSKDKEYILNEIELQTLLPLQRIKDNGVIPYQ
LHLEELKVILDKCGPKFPFLHTVSDGFSVTEKLIKMLEFRIPYYVGPLNTHHNIDNGGFSWAVR
KQAGRVTPWNFEEKIDREKSAAAFIKNLTNKCTYLFGEDVLPKSSLLYSEFMLLNELNNVRIDG
KALAQGVKQHLIDSIFKQDHKKMTKNRIELFLKDNNYITKKHKPEITGLDGEIKNDLTSYRDMV
RILGNNFDVSMAEDIITDITIFGESKKMLRQTLRNKFGSQLNDETIKKLSKLRYRDWGRLSKKL
LKGIDGCDKAGNGAPKTIIELMRNDSYNLMEILGDKFSFMECIEEENAKLAQGQVVNPHDIIDE
LALSPAVKRAVWQALRIVDEVAHIKKALPSRIFVEVARTNKSEKKKKDSRQKRLSDLYSAIKKD
DVLQSGLQDKEFGALKSGLANYDDAALRSKKLYLYYTQMGRCAYTGNIIDLNQLNTDNYDIDHI
YPRSLTKDDSFDNLVLCERTANAKKSDIYPIDNRIQTKQKPFWAFLKHQGLISERKYERLTRIA
PLTADDLSGFIARQLVETNQSVKATTTLLRRLYPDIDVVFVKAENVSDFRHNNNFIKVRSLNHH
HHAKDAYLNIVVGNVYHEKFTRNFRLFFKKNGANRTYNLAKMFNYDVICTNAQDGKAWDVKTSM
NTVKKMMASNDVRVTRRLLEQSGALADATIYKASVAAKAKDGAYIGMKTKYSVFADVTKYGGMT
KIKNAYSIIVQYTGKKGEEIKEIVPLPIYLINRNATDIELIDYVKSVIPKAKDISIKYRKLCIN
QLVKVNGFYYYLGGKTNDKIYIDNAIELVVPHDIATYIKLLDKYDLLRKENKTLKASSITTSIY
NINTSTVVSLNKVGIDVFDYFMSKLRTPLYMKMKGNKVDELSSTGRSKFIKMTLEEQSIYLLEV
LNLLTNSKTTFDVKPLGITGSRSTIGVKIHNLDEFKIINESITGLYSNEVTIV
SEQ ID NO: 310
MTKLNQPYGIGLDIGSNSIGFAVVDANSHLLRLKGETAIGARLFREGQSAADRRGSRTTRRRLS
RTRWRLSFLRDFFAPHITKIDPDFFLRQKYSEISPKDKDRFKYEKRLFNDRTDAEFYEDYPSMY
HLRLHLMTHTHKADPREIFLAIHHILKSRGHFLTPGAAKDFNTDKVDLEDIFPALTEAYAQVYP
DLELTFDLAKADDFKAKLLDEQATPSDTQKALVNLLLSSDGEKEIVKKRKQVLTEFAKAITGLK
TKFNLALGTEVDEADASNWQFSMGQLDDKWSNIETSMTDQGTEIFEQIQELYRARLLNGIVPAG
MSLSQAKVADYGQHKEDLELFKTYLKKLNDHELAKTIRGLYDRYINGDDAKPFLREDFVKALTK
EVTAHPNEVSEQLLNRMGQANFMLKQRTKANGAIPIQLQQRELDQIIANQSKYYDWLAAPNPVE
AHRWKMPYQLDELLNFHIPYYVGPLITPKQQAESGENVFAWMVRKDPSGNITPYNFDEKVDREA
SANTFIQRMKTTDTYLIGEDVLPKQSLLYQKYEVLNELNNVRINNECLGTDQKQRLIREVFERH
SSVTIKQVADNLVAHGDFARRPEIRGLADEKRFLSSLSTYHQLKEILHEAIDDPTKLLDIENII
TWSTVFEDHTIFETKLAEIEWLDPKKINELSGIRYRGWGQFSRKLLDGLKLGNGHTVIQELMLS
NHNLMQILADETLKETMTELNQDKLKTDDIEDVINDAYTSPSNKKALRQVLRVVEDIKHAANGQ
DPSWLFIETADGTGTAGKRTQSRQKQIQTVYANAAQELIDSAVRGELEDKIADKASFTDRLVLY
FMQGGRDIYTGAPLNIDQLSHYDIDHILPQSLIKDDSLDNRVLVNATINREKNNVFASTLFAGK
MKATWRKWHEAGLISGRKLRNLMLRPDEIDKFAKGFVARQLVETRQIIKLTEQIAAAQYPNTKI
IAVKAGLSHQLREELDFPKNRDVNHYHHAFDAFLAARIGTYLLKRYPKLAPFFTYGEFAKVDVK
KFREFNFIGALTHAKKNIIAKDTGEIVWDKERDIRELDRIYNFKRMLITHEVYFETADLFKQTI
YAAKDSKERGGSKQLIPKKQGYPTQVYGGYTQESGSYNALVRVAEADTTAYQVIKISAQNASKI
ASANLKSREKGKQLLNEIVVKQLAKRRKNWKPSANSFKIVIPRFGMGTLFQNAKYGLFMVNSDT
YYRNYQELWLSRENQKLLKKLFSIKYEKTQMNHDALQVYKAIIDQVEKFFKLYDINQFRAKLSD
AIERFEKLPINTDGNKIGKTETLRQILIGLQANGTRSNVKNLGIKTDLGLLQVGSGIKLDKDTQ
IVYQSPSGLFKRRIPLADL
SEQ ID NO: 311
MTKEYYLGLDVGTNSVGWAVTDSQYNLCKFKKKDMWGIRLFESANTAKDRRLQRGNRRRLERKK
QRIDLLQEIFSPEICKIDPTFFIRLNESRLHLEDKSNDFKYPLFIEKDYSDIEYYKEFPTIFHL
RKHLIESEEKQDIRLIYLALHNIIKTRGHFLIDGDLQSAKQLRPILDTFLLSLQEEQNLSVSLS
ENQKDEYEEILKNRSIAKSEKVKKLKNLFEISDELEKEEKKAQSAVIENFCKFIVGNKGDVCKF
LRVSKEELEIDSFSFSEGKYEDDIVKNLEEKVPEKVYLFEQMKAMYDWNILVDILETEEYISFA
KVKQYEKHKTNLRLLRDIILKYCTKDEYNRMFNDEKEAGSYTAYVGKLKKNNKKYWIEKKRNPE
EFYKSLGKLLDKIEPLKEDLEVLTMMIEECKNHTLLPIQKNKDNGVIPHQVHEVELKKILENAK
KYYSFLTETDKDGYSVVQKIESIFRFRIPYYVGPLSTRHQEKGSNVWMVRKPGREDRIYPWNME
EIIDFEKSNENFITRMTNKCTYLIGEDVLPKHSLLYSKYMVLNELNNVKVRGKKLPTSLKQKVF
EDLFENKSKVTGKNLLEYLQIQDKDIQIDDLSGFDKDFKTSLKSYLDFKKQIFGEEIEKESIQN
MIEDIIKWITIYGNDKEMLKRVIRANYSNQLTEEQMKKITGFQYSGWGNFSKMFLKGISGSDVS
TGETFDIITAMWETDNNLMQILSKKFTFMDNVEDFNSGKVGKIDKITYDSTVKEMFLSPENKRA
VWQTIQVAEEIKKVMGCEPKKIFIEMARGGEKVKKRTKSRKAQLLELYAACEEDCRELIKEIED
RDERDFNSMKLFLYYTQFGKCMYSGDDIDINELIRGNSKWDRDHIYPQSKIKDDSIDNLVLVNK
TYNAKKSNELLSEDIQKKMHSFWLSLLNKKLITKSKYDRLTRKGDFTDEELSGFIARQLVETRQ
STKAIADIFKQIYSSEVVYVKSSLVSDFRKKPLNYLKSRRVNDYHHAKDAYLNIVVGNVYNKKF
TSNPIQWMKKNRDTNYSLNKVFEHDVVINGEVIWEKCTYHEDTNTYDGGTLDRIRKIVERDNIL
YTEYAYCEKGELFNATIQNKNGNSTVSLKKGLDVKKYGGYFSANTSYFSLIEFEDKKGDRARHI
IGVPIYIANMLEHSPSAFLEYCEQKGYQNVRILVEKIKKNSLLIINGYPLRIRGENEVDTSFKR
AIQLKLDQKNYELVRNIEKFLEKYVEKKGNYPIDENRDHITHEKMNQLYEVLLSKMKKFNKKGM
ADPSDRIEKSKPKFIKLEDLIDKINVINKMLNLLRCDNDTKADLSLIELPKNAGSFVVKKNTIG
KSKIILVNQSVTGLYENRREL
SEQ ID NO: 312
MARDYSVGLDIGTSSVGWAAIDNKYHLIRAKSKNLIGVRLFDSAVTAEKRRGYRTTRRRLSRRH
WRLRLLNDIFAGPLTDFGDENFLARLKYSWVHPQDQSNQAHFAAGLLFDSKEQDKDFYRKYPTI
YHLRLALMNDDQKHDLREVYLAIHHLVKYRGHFLIEGDVKADSAFDVHTFADAIQRYAESNNSD
ENLLGKIDEKKLSAALTDKHGSKSQRAETAETAFDILDLQSKKQIQAILKSVVGNQANLMAIFG
LDSSAISKDEQKNYKFSFDDADIDEKIADSEALLSDTEFEFLCDLKAAFDGLTLKMLLGDDKTV
SAAMVRRFNEHQKDWEYIKSHIRNAKNAGNGLYEKSKKFDGINAAYLALQSDNEDDRKKAKKIF
QDEISSADIPDDVKADFLKKIDDDQFLPIQRTKNNGTIPHQLHRNELEQIIEKQGIYYPFLKDT
YQENSHELNKITALINFRVPYYVGPLVEEEQKIADDGKNIPDPTNHWMVRKSNDTITPWNLSQV
VDLDKSGRRFIERLTGTDTYLIGEPTLPKNSLLYQKFDVLQELNNIRVSGRRLDIRAKQDAFEH
LFKVQKTVSATNLKDFLVQAGYISEDTQIEGLADVNGKNFNNALTTYNYLVSVLGREFVENPSN
EELLEEITELQTVFEDKKVLRRQLDQLDGLSDHNREKLSRKHYTGWGRISKKLLTTKIVQNADK
IDNQTFDVPRMNQSIIDTLYNTKMNLMEIINNAEDDFGVRAWIDKQNTTDGDEQDVYSLIDELA
GPKEIKRGIVQSFRILDDITKAVGYAPKRVYLEFARKTQESHLTNSRKNQLSTLLKNAGLSELV
TQVSQYDAAALQNDRLYLYFLQQGKDMYSGEKLNLDNLSNYDIDHIIPQAYTKDNSLDNRVLVS
NITNRRKSDSSNYLPALIDKMRPFWSVLSKQGLLSKHKFANLTRTRDFDDMEKERFIARSLVET
RQIIKNVASLIDSHFGGETKAVAIRSSLTADMRRYVDIPKNRDINDYHHAFDALLFSTVGQYTE
NSGLMKKGQLSDSAGNQYNRYIKEWIHAARLNAQSQRVNPFGFVVGSMRNAAPGKLNPETGEIT
PEENADWSIADLDYLHKVMNFRKITVTRRLKDQKGQLYDESRYPSVLHDAKSKASINFDKHKPV
DLYGGFSSAKPAYAALIKFKNKFRLVNVLRQWTYSDKNSEDYILEQIRGKYPKAEMVLSHIPYG
QLVKKDGALVTISSATELHNFEQLWLPLADYKLINTLLKTKEDNLVDILHNRLDLPEMTIESAF
YKAFDSILSFAFNRYALHQNALVKLQAHRDDFNALNYEDKQQTLERILDALHASPASSDLKKIN
LSSGFGRLFSPSHFTLADTDEFIFQSVTGLFSTQKTVAQLYQETK
SEQ ID NO: 313
MVYDVGLDIGTGSVGWVALDENGKLARAKGKNLVGVRLFDTAQTAADRRGFRTTRRRLSRRKWR
LRLLDELFSAEINEIDSSFFQRLKYSYVHPKDEENKAHYYGGYLFPTEEETKKFHRSYPTIYHL
RQELMAQPNKRFDIREIYLAIHHLVKYRGHFLSSQEKITIGSTYNPEDLANAIEVYADEKGLSW
ELNNPEQLTEIISGEAGYGLNKSMKADEALKLFEFDNNQDKVAIKTLLAGLTGNQIDFAKLFGK
DISDKDEAKLWKLKLDDEALEEKSQTILSQLTDEEIELFHAVVQAYDGFVLIGLLNGADSVSAA
MVQLYDQHREDRKLLKSLAQKAGLKHKRFSEIYEQLALATDEATIKNGISTARELVEESNLSKE
VKEDTLRRLDENEFLPKQRTKANSVIPHQLHLAELQKILQNQGQYYPFLLDTFEKEDGQDNKIE
ELLRFRIPYYVGPLVTKKDVEHAGGDADNHWVERNEGFEKSRVTPWNFDKVFNRDKAARDFIER
LTGNDTYLIGEKTLPQNSLRYQLFTVLNELNNVRVNGKKFDSKTKADLINDLFKARKTVSLSAL
KDYLKAQGKGDVTITGLADESKFNSSLSSYNDLKKTFDAEYLENEDNQETLEKIIEIQTVFEDS
KIASRELSKLPLDDDQVKKLSQTHYTGWGRLSEKLLDSKIIDERGQKVSILDKLKSTSQNFMSI
INNDKYGVQAWITEQNTGSSKLTFDEKVNELTTSPANKRGIKQSFAVLNDIKKAMKEEPRRVYL
EFAREDQTSVRSVPRYNQLKEKYQSKSLSEEAKVLKKTLDGNKNKMSDDRYFLYFQQQGKDMYT
GRPINFERLSQDYDIDHIIPQAFTKDDSLDNRVLVSRPENARKSDSFAYTDEVQKQDGSLWTSL
LKSGFINRKKYERLTKAGKYLDGQKTGFIARQLVETRQIIKNVASLIEGEYENSKAVAIRSEIT
ADMRLLVGIKKHREINSFHHAFDALLITAAGQYMQNRYPDRDSTNVYNEFDRYTNDYLKNLRQL
SSRDEVRRLKSFGFVVGTMRKGNEDWSEENTSYLRKVMMFKNILTTKKTEKDRGPLNKETIFSP
KSGKKLIPLNSKRSDTALYGGYSNVYSAYMTLVRANGKNLLIKIPISIANQIEVGNLKINDYIV
NNPAIKKFEKILISKLPLGQLVNEDGNLIYLASNEYRHNAKQLWLSTTDADKIASISENSSDEE
LLEAYDILTSENVKNRFPFFKKDIDKLSQVRDEFLDSDKRIAVIQTILRGLQIDAAYQAPVKII
SKKVSDWHKLQQSGGIKLSDNSEMIYQSATGIFETRVKISDLL
SEQ ID NO: 314
IVDYCIGLDLGTGSVGWAVVDMNHRLMKRNGKHLWGSRLFSNAETAANRRASRSIRRRYNKRRE
RIRLLRAILQDMVLEKDPTFFIRLEHTSFLDEEDKAKYLGTDYKDNYNLFIDEDFNDYTYYHKY
PTIYHLRKALCESTEKADPRLIYLALHHIVKYRGNFLYEGQKFNMDASNIEDKLSDIFTQFTSF
NNIPYEDDEKKNLEILEILKKPLSKKAKVDEVMTLIAPEKDYKSAFKELVTGIAGNKMNVTKMI
LCEPIKQGDSEIKLKFSDSNYDDQFSEVEKDLGEYVEFVDALHNVYSWVELQTIMGATHTDNAS
ISEAMVSRYNKHHDDLKLLKDCIKNNVPNKYFDMFRNDSEKSKGYYNYINRPSKAPVDEFYKYV
KKCIEKVDTPEAKQILNDIELENFLLKQNSRTNGSVPYQMQLDEMIKIIDNQAEYYPILKEKRE
QLLSILTFRIPYYFGPLNETSEHAWIKRLEGKENQRILPWNYQDIVDVDATAEGFIKRMRSYCT
YFPDEEVLPKNSLIVSKYEVYNELNKIRVDDKLLEVDVKNDIYNELFMKNKTVTEKKLKNWLVN
NQCCSKDAEIKGFQKENQFSTSLTPWIDFTNIFGKIDQSNFDLIENIIYDLTVFEDKKIMKRRL
KKKYALPDDKVKQILKLKYKDWSRLSKKLLDGIVADNRFGSSVTVLDVLEMSRLNLMEIINDKD
LGYAQMIEEATSCPEDGKFTYEEVERLAGSPALKRGIWQSLQIVEEITKVMKCRPKYIYIEFER
SEEAKERTESKIKKLENVYKDLDEQTKKEYKSVLEELKGFDNTKKISSDSLFLYFTQLGKCMYS
GKKLDIDSLDKYQIDHIVPQSLVKDDSFDNRVLVVPSENQRKLDDLVVPFDIRDKMYRFWKLLF
DHELISPKKFYSLIKTEYTERDEERFINRQLVETRQITKNVTQIIEDHYSTTKVAAIRANLSHE
FRVKNHIYKNRDINDYHHAHDAYIVALIGGFMRDRYPNMHDSKAVYSEYMKMFRKNKNDQKRWK
DGFVINSMNYPYEVDGKLIWNPDLINEIKKCFYYKDCYCTTKLDQKSGQLFNLTVLSNDAHADK
GVTKAVVPVNKNRSDVHKYGGFSGLQYTIVAIEGQKKKGKKTELVKKISGVPLHLKAASINEKI
NYIEEKEGLSDVRIIKDNIPVNQMIEMDGGEYLLTSPTEYVNARQLVLNEKQCALIADIYNAIY
KQDYDNLDDILMIQLYIELTNKMKVLYPAYRGIAEKFESMNENYVVISKEEKANIIKQMLIVMH
RGPQNGNIVYDDFKISDRIGRLKTKNHNLNNIVFISQSPTGIYTKKYKL
SEQ ID NO: 315
MKSEKKYYIGLDVGTNSVGWAVTDEFYNILRAKGKDLWGVRLFEKADTAANTRIFRSGRRRNDR
KGMRLQILREIFEDEIKKVDKDFYDRLDESKFWAEDKKVSGKYSLFNDKNFSDKQYFEKFPTIF
HLRKYLMEEHGKVDIRYYFLAINQMMKRRGHFLIDGQISHVTDDKPLKEQLILLINDLLKIELE
EELMDSIFEILADVNEKRTDKKNNLKELIKGQDFNKQEGNILNSIFESIVTGKAKIKNIISDED
ILEKIKEDNKEDFVLTGDSYEENLQYFEEVLQENITLFNTLKSTYDFLILQSILKGKSTLSDAQ
VERYDEHKKDLEILKKVIKKYDEDGKLFKQVFKEDNGNGYVSYIGYYLNKNKKITAKKKISNIE
FTKYVKGILEKQCDCEDEDVKYLLGKIEQENFLLKQISSINSVIPHQIHLFELDKILENLAKNY
PSFNNKKEEFTKIEKIRKTFTFRIPYYVGPLNDYHKNNGGNAWIFRNKGEKIRPWNFEKIVDLH
KSEEEFIKRMLNQCTYLPEETVLPKSSILYSEYMVLNELNNLRINGKPLDTDVKLKLIEELFKK
KTKVTLKSIRDYMVRNNFADKEDFDNSEKNLEIASNMKSYIDFNNILEDKFDVEMVEDLIEKIT
IHTGNKKLLKKYIEETYPDLSSSQIQKIINLKYKDWGRLSRKLLDGIKGTKKETEKTDTVINFL
RNSSDNLMQIIGSQNYSFNEYIDKLRKKYIPQEISYEVVENLYVSPSVKKMIWQVIRVTEEITK
VMGYDPDKIFIEMAKSEEEKKTTISRKNKLLDLYKAIKKDERDSQYEKLLTGLNKLDDSDLRSR
KLYLYYTQMGRDMYTGEKIDLDKLFDSTHYDKDHIIPQSMKKDDSIINNLVLVNKNANQTTKGN
IYPVPSSIRNNPKIYNYWKYLMEKEFISKEKYNRLIRNTPLTNEELGGFINRQLVETRQSTKAI
KELFEKFYQKSKIIPVKASLASDLRKDMNTLKSREVNDLHHAHDAFLNIVAGDVWNREFTSNPI
NYVKENREGDKVKYSLSKDFTRPRKSKGKVIWTPEKGRKLIVDTLNKPSVLISNESHVKKGELF
NATIAGKKDYKKGKIYLPLKKDDRLQDVSKYGGYKAINGAFFFLVEHTKSKKRIRSIELFPLHL
LSKFYEDKNTVLDYAINVLQLQDPKIIIDKINYRTEIIIDNFSYLISTKSNDGSITVKPNEQMY
WRVDEISNLKKIENKYKKDAILTEEDRKIMESYIDKIYQQFKAGKYKNRRTTDTIIEKYEIIDL
DTLDNKQLYQLLVAFISLSYKTSNNAVDFTVIGLGTECGKPRITNLPDNTYLVYKSITGIYEKR
IRIK
SEQ ID NO: 316
MKLRGIEDDYSIGLDMGTSSVGWAVTDERGTLAHFKRKPTWGSRLFREAQTAAVARMPRGQRRR
YVRRRWRLDLLQKLFEQQMEQADPDFFIRLRQSRLLRDDRAEEHADYRWPLFNDCKFTERDYYQ
RFPTIYHVRSWLMETDEQADIRLIYLALHNIVKHRGNFLREGQSLSAKSARPDEALNHLRETLR
VWSSERGFECSIADNGSILAMLTHPDLSPSDRRKKIAPLFDVKSDDAAADKKLGIALAGAVIGL
KTEFKNIFGDFPCEDSSIYLSNDEAVDAVRSACPDDCAELFDRLCEVYSAYVLQGLLSYAPGQT
ISANMVEKYRRYGEDLALLKKLVKIYAPDQYRMFFSGATYPGTGIYDAAQARGYTKYNLGPKKS
EYKPSESMQYDDFRKAVEKLFAKTDARADERYRMMMDRFDKQQFLRRLKTSDNGSIYHQLHLEE
LKAIVENQGRFYPFLKRDADKLVSLVSFRIPYYVGPLSTRNARTDQHGENRFAWSERKPGMQDE
PIFPWNWESIIDRSKSAEKFILRMTGMCTYLQQEPVLPKSSLLYEEFCVLNELNGAHWSIDGDD
EHRFDAADREGIIEELFRRKRTVSYGDVAGWMERERNQIGAHVCGGQGEKGFESKLGSYIFFCK
DVFKVERLEQSDYPMIERIILWNTLFEDRKILSQRLKEEYGSRLSAEQIKTICKKRFTGWGRLS
EKFLTGITVQVDEDSVSIMDVLREGCPVSGKRGRAMVMMEILRDEELGFQKKVDDFNRAFFAEN
AQALGVNELPGSPAVRRSLNQSIRIVDEIASIAGKAPANIFIEVTRDEDPKKKGRRTKRRYNDL
KDALEAFKKEDPELWRELCETAPNDMDERLSLYFMQRGKCLYSGRAIDIHQLSNAGIYEVDHII
PRTYVKDDSLENKALVYREENQRKTDMLLIDPEIRRRMSGYWRMLHEAKLIGDKKFRNLLRSRI
DDKALKGFIARQLVETGQMVKLVRSLLEARYPETNIISVKASISHDLRTAAELVKCREANDFHH
AHDAFLACRVGLFIQKRHPCVYENPIGLSQVVRNYVRQQADIFKRCRTIPGSSGFIVNSFMTSG
FDKETGEIFKDDWDAEAEVEGIRRSLNFRQCFISRMPFEDHGVFWDATIYSPRAKKTAALPLKQ
GLNPSRYGSFSREQFAYFFIYKARNPRKEQTLFEFAQVPVRLSAQIRQDENALERYARELAKDQ
GLEFIRIERSKILKNQLIEIDGDRLCITGKEEVRNACELAFAQDEMRVIRMLVSEKPVSRECVI
SLFNRILLHGDQASRRLSKQLKLALLSEAFSEASDNVQRNVVLGLIAIFNGSTNMVNLSDIGGS
KFAGNVRIKYKKELASPKVNVHLIDQSVTGMFERRTKIGL
SEQ ID NO: 317
MENKQYYIGLDVGTNSVGWAVTDTSYNLLRAKGKDMWGARLFEKANTAAERRTKRTSRRRSERE
KARKAMLKELFADEINRVDPSFFIRLEESKFFLDDRSENNRQRYTLFNDATFTDKDYYEKYKTI
FHLRSALINSDEKFDVRLVFLAILNLFSHRGHFLNASLKGDGDIQGMDVFYNDLVESCEYFEIE
LPRITNIDNFEKILSQKGKSRTKILEELSEELSISKKDKSKYNLIKLISGLEASVVELYNIEDI
QDENKKIKIGFRESDYEESSLKVKEIIGDEYFDLVERAKSVHDMGLLSNIIGNSKYLCEARVEA
YENHHKDLLKIKELLKKYDKKAYNDMFRKMTDKNYSAYVGSVNSNIAKERRSVDKRKIEDLYKY
IEDTALKNIPDDNKDKIEILEKIKLGEFLKKQLTASNGVIPNQLQSRELRAILKKAENYLPFLK
EKGEKNLTVSEMIIQLFEFQIPYYVGPLDKNPKKDNKANSWAKIKQGGRILPWNFEDKVDVKGS
RKEFIEKMVRKCTYISDEHTLPKQSLLYEKFMVLNEINNIKIDGEKISVEAKQKIYNDLFVKGK
KVSQKDIKKELISLNIMDKDSVLSGTDTVCNAYLSSIGKFTGVFKEEINKQSIVDMIEDIIFLK
TVYGDEKRFVKEEIVEKYGDEIDKDKIKRILGFKFSNWGNLSKSFLELEGADVGTGEVRSIIQS
LWETNFNLMELLSSRFTYMDELEKRVKKLEKPLSEWTIEDLDDMYLSSPVKRMIWQSMKIVDEI
QTVIGYAPKRIFVEMTRSEGEKVRTKSRKDRLKELYNGIKEDSKQWVKELDSKDESYFRSKKMY
LYYLQKGRCMYSGEVIELDKLMDDNLYDIDHIYPRSFVKDDSLDNLVLVKKEINNRKQNDPITP
QIQASCQGFWKILHDQGFMSNEKYSRLTRKTQEFSDEEKLSFINRQIVETGQATKCMAQILQKS
MGEDVDVVFSKARLVSEFRHKFELFKSRLINDFHHANDAYLNIVVGNSYFVKFTRNPANFIKDA
RKNPDNPVYKYHMDRFFERDVKSKSEVAWIGQSEGNSGTIVIVKKTMAKNSPLITKKVEEGHGS
ITKETIVGVKEIKFGRNKVEKADKTPKKPNLQAYRPIKTSDERLCNILRYGGRTSISISGYCLV
EYVKKRKTIRSLEAIPVYLGRKDSLSEEKLLNYFRYNLNDGGKDSVSDIRLCLPFISTNSLVKI
DGYLYYLGGKNDDRIQLYNAYQLKMKKEEVEYIRKIEKAVSMSKFDEIDREKNPVLTEEKNIEL
YNKIQDKFENTVFSKRMSLVKYNKKDLSFGDFLKNKKSKFEEIDLEKQCKVLYNIIFNLSNLKE
VDLSDIGGSKSTGKCRCKKNITNYKEFKLIQQSITGLYSCEKDLMTI
SEQ ID NO: 318
MKNLKEYYIGLDIGTASVGWAVTDESYNIPKFNGKKMWGVRLFDDAKTAEERRTQRGSRRRLNR
RKERINLLQDLFATEISKVDPNFFLRLDNSDLYREDKDEKLKSKYTLFNDKDFKDRDYHKKYPT
IHHLIMDLIEDEGKKDIRLLYLACHYLLKNRGHFIFEGQKFDTKNSFDKSINDLKIHLRDEYNI
DLEFNNEDLIEIITDTTLNKTNKKKELKNIVGDTKFLKAISAIMIGSSQKLVDLFEDGEFEETT
VKSVDFSTTAFDDKYSEYEEALGDTISLLNILKSIYDSSILENLLKDADKSKDGNKYISKAFVK
KFNKHGKDLKTLKRIIKKYLPSEYANIFRNKSINDNYVAYTKSNITSNKRTKASKFTKQEDFYK
FIKKHLDTIKETKLNSSENEDLKLIDEMLTDIEFKTFIPKLKSSDNGVIPYQLKLMELKKILDN
QSKYYDFLNESDEYGTVKDKVESIMEFRIPYYVGPLNPDSKYAWIKRENTKITPWNFKDIVDLD
SSREEFIDRLIGRCTYLKEEKVLPKASLIYNEFMVLNELNNLKLNEFLITEEMKKAIFEELFKT
KKKVTLKAVSNLLKKEFNLTGDILLSGTDGDFKQGLNSYIDFKNIIGDKVDRDDYRIKIEEIIK
LIVLYEDDKTYLKKKIKSAYKNDFTDDEIKKIAALNYKDWGRLSKRFLTGIEGVDKTTGEKGSI
IYFMREYNLNLMELMSGHYTFTEEVEKLNPVENRELCYEMVDELYLSPSVKRMLWQSLRVVDEI
KRIIGKDPKKIFIEMARAKEAKNSRKESRKNKLLEFYKFGKKAFINEIGEERYNYLLNEINSEE
ESKFRWDNLYLYYTQLGRCMYSLEPIDLADLKSNNIYDQDHIYPKSKIYDDSLENRVLVKKNLN
HEKGNQYPIPEKVLNKNAYGFWKILFDKGLIGQKKYTRLTRRTPFEERELAEFIERQIVETRQA
TKETANLLKNICQDSEIVYSKAENASRFRQEFDIIKCRTVNDLHHMHDAYLNIVVGNVYNTKFT
KNPLNFIKDKDNVRSYNLENMFKYDVVRGSYTAWIADDSEGNVKAATIKKVKRELEGKNYRFTR
MSYIGTGGLYDQNLMRKGKGQIPQKENTNKSNIEKYGGYNKASSAYFALIESDGKAGRERTLET
IPIMVYNQEKYGNTEAVDKYLKDNLELQDPKILKDKIKINSLIKLDGFLYNIKGKTGDSLSIAG
SVQLIVNKEEQKLIKKMDKFLVKKKDNKDIKVTSFDNIKEEELIKLYKTLSDKLNNGIYSNKRN
NQAKNISEALDKFKEISIEEKIDVLNQIILLFQSYNNGCNLKSIGLSAKTGVVFIPKKLNYKEC
KLINQSITGLFENEVDLLNL
SEQ ID NO: 319
MGKMYYLGLDIGTNSVGYAVTDPSYHLLKFKGEPMWGAHVFAAGNQSAERRSFRTSRRRLDRRQ
QRVKLVQEIFAPVISPIDPRFFIRLHESALWRDDVAETDKHIFFNDPTYTDKEYYSDYPTIHHL
IVDLMESSEKHDPRLVYLAVAWLVAHRGHFLNEVDKDNIGDVLSFDAFYPEFLAFLSDNGVSPW
VCESKALQATLLSRNSVNDKYKALKSLIFGSQKPEDNFDANISEDGLIQLLAGKKVKVNKLFPQ
ESNDASFTLNDKEDAIEEILGTLTPDECEWIAHIRRLFDWAIMKHALKDGRTISESKVKLYEQH
HHDLTQLKYFVKTYLAKEYDDIFRNVDSETTKNYVAYSYHVKEVKGTLPKNKATQEEFCKYVLG
KVKNIECSEADKVDFDEMIQRLTDNSFMPKQVSGENRVIPYQLYYYELKTILNKAASYLPFLTQ
CGKDAISNQDKLLSIMTFRIPYFVGPLRKDNSEHAWLERKAGKIYPWNFNDKVDLDKSEEAFIR
RMTNTCTYYPGEDVLPLDSLIYEKFMILNEINNIRIDGYPISVDVKQQVFGLFEKKRRVTVKDI
QNLLLSLGALDKHGKLTGIDTTIHSNYNTYHHFKSLMERGVLTRDDVERIVERMTYSDDTKRVR
LWLNNNYGTLTADDVKHISRLRKHDFGRLSKMFLTGLKGVHKETGERASILDFMWNTNDNLMQL
LSECYTFSDEITKLQEAYYAKAQLSLNDFLDSMYISNAVKRPIYRTLAVVNDIRKACGTAPKRI
FIEMARDGESKKKRSVTRREQIKNLYRSIRKDFQQEVDFLEKILENKSDGQLQSDALYLYFAQL
GRDMYTGDPIKLEHIKDQSFYNIDHIYPQSMVKDDSLDNKVLVQSEINGEKSSRYPLDAAIRNK
MKPLWDAYYNHGLISLKKYQRLTRSTPFTDDEKWDFINRQLVETRQSTKALAILLKRKFPDTEI
VYSKAGLSSDFRHEFGLVKSRNINDLHHAKDAFLAIVTGNVYHERFNRRWFMVNQPYSVKTKTL
FTHSIKNGNFVAWNGEEDLGRIVKMLKQNKNTIHFTRFSFDRKEGLFDIQPLKASTGLVPRKAG
LDVVKYGGYDKSTAAYYLLVRFTLEDKKTQHKLMMIPVEGLYKARIDHDKEFLTDYAQTTISEI
LQKDKQKVINIMFPMGTRHIKLNSMISIDGFYLSIGGKSSKGKSVLCHAMVPLIVPHKIECYIK
AMESFARKFKENNKLRIVEKFDKITVEDNLNLYELFLQKLQHNPYNKFFSTQFDVLTNGRSTFT
KLSPEEQVQTLLNILSIFKTCRSSGCDLKSINGSAQAARIMISADLTGLSKKYSDIRLVEQSAS
GLFVSKSQNLLEYL
SEQ ID NO: 320
MTKKEQPYNIGLDIGTSSVGWAVTNDNYDLLNIKKKNLWGVRLFEEAQTAKETRLNRSTRRRYR
RRKNRINWLNEIFSEELAKTDPSFLIRLQNSWVSKKDPDRKRDKYNLFIDGPYTDKEYYREFPT
IFHLRKELILNKDKADIRLIYLALHNILKYRGNFTYEHQKFNISNLNNNLSKELIELNQQLIKY
DISFPDDCDWNHISDILIGRGNATQKSSNILKDFTLDKETKKLLKEVINLILGNVAHLNTIFKT
SLTKDEEKLNFSGKDIESKLDDLDSILDDDQFTVLDAANRIYSTITLNEILNGESYFSMAKVNQ
YENHAIDLCKLRDMWHTTKNEEAVEQSRQAYDDYINKPKYGTKELYTSLKKFLKVALPTNLAKE
AEEKISKGTYLVKPRNSENGVVPYQLNKIEMEKIIDNQSQYYPFLKENKEKLLSILSFRIPYYV
GPLQSAEKNPFAWMERKSNGHARPWNFDEIVDREKSSNKFIRRMTVTDSYLVGEPVLPKNSLIY
QRYEVLNELNNIRITENLKTNPIGSRLTVETKQRIYNELFKKYKKVTVKKLTKWLIAQGYYKNP
ILIGLSQKDEFNSTLTTYLDMKKIFGSSFMEDNKNYDQIEELIEWLTIFEDKQILNEKLHSSKY
SYTPDQIKKISNMRYKGWGRLSKKILMDITTETNTPQLLQLSNYSILDLMWATNNNFISIMSND
KYDFKNYIENHNLNKNEDQNISDLVNDIHVSPALKRGITQSIKIVQEIVKFMGHAPKHIFIEVT
RETKKSEITTSREKRIKRLQSKLLNKANDFKPQLREYLVPNKKIQEELKKHKNDLSSERIMLYF
LQNGKSLYSEESLNINKLSDYQVDHILPRTYIPDDSLENKALVLAKENQRKADDLLLNSNVIDR
NLERWTYMLNNNMIGLKKFKNLTRRVITDKDKLGFIHRQLVQTSQMVKGVANILDNMYKNQGTT
CIQARANLSTAFRKALSGQDDTYHFKHPELVKNRNVNDFHHAQDAYLASFLGTYRLRRFPTNEM
LLMNGEYNKFYGQVKELYSKKKKLPDSRKNGFIISPLVNGTTQYDRNTGEIIWNVGFRDKILKI
FNYHQCNVTRKTEIKTGQFYDQTIYSPKNPKYKKLIAQKKDMDPNIYGGFSGDNKSSITIVKID
NNKIKPVAIPIRLINDLKDKKTLQNWLEENVKHKKSIQIIKNNVPIGQIIYSKKVGLLSLNSDR
EVANRQQLILPPEHSALLRLLQIPDEDLDQILAFYDKNILVEILQELITKMKKFYPFYKGEREF
LIANIENFNQATTSEKVNSLEELITLLHANSTSAHLIFNNIEKKAFGRKTHGLTLNNTDFIYQS
VTGLYETRIHIE
SEQ ID NO: 321
MTKFNKNYSIGLDIGVSSVGYAVVTEDYRVPAFKFKVLGNTEKEKIKKNLIGSTTFVSAQPAKG
TRVFRVNRRRIDRRNHRITYLRDIFQKEIEKVDKNFYRRLDESFRVLGDKSEDLQIKQPFFGDK
ELETAYHKKYPTIYHLRKHLADADKNSPVADIREVYMAISHILKYRGHFLTLDKINPNNINMQN
SWIDFIESCQEVFDLEISDESKNIADIFKSSENRQEKVKKILPYFQQELLKKDKSIFKQLLQLL
FGLKTKFKDCFELEEEPDLNFSKENYDENLENFLGSLEEDFSDVFAKLKVLRDTILLSGMLTYT
GATHARFSATMVERYEEHRKDLQRFKFFIKQNLSEQDYLDIFGRKTQNGFDVDKETKGYVGYIT
NKMVLTNPQKQKTIQQNFYDYISGKITGIEGAEYFLNKISDGTFLRKLRTSDNGAIPNQIHAYE
LEKIIERQGKDYPFLLENKDKLLSILTFKIPYYVGPLAKGSNSRFAWIKRATSSDILDDNDEDT
RNGKIRPWNYQKLINMDETRDAFITNLIGNDIILLNEKVLPKRSLIYEEVMLQNELTRVKYKDK
YGKAHFFDSELRQNIINGLFKNNSKRVNAKSLIKYLSDNHKDLNAIEIVSGVEKGKSFNSTLKT
YNDLKTIFSEELLDSEIYQKELEEIIKVITVFDDKKSIKNYLTKFFGHLEILDEEKINQLSKLR
YSGWGRYSAKLLLDIRDEDTGFNLLQFLRNDEENRNLTKLISDNTLSFEPKIKDIQSKSTIEDD
IFDEIKKLAGSPAIKRGILNSIKIVDELVQIIGYPPHNIVIEMARENMTTEEGQKKAKTRKTKL
ESALKNIENSLLENGKVPHSDEQLQSEKLYLYYLQNGKDMYTLDKTGSPAPLYLDQLDQYEVDH
IIPYSFLPIDSIDNKVLTHRENNQQKLNNIPDKETVANMKPFWEKLYNAKLISQTKYQRLTTSE
RTPDGVLTESMKAGFIERQLVETRQIIKHVARILDNRFSDTKIITLKSQLITNFRNTFHIAKIR
ELNDYHHAHDAYLAVVVGQTLLKVYPKLAPELIYGHHAHFNRHEENKATLRKHLYSNIMRFFNN
PDSKVSKDIWDCNRDLPIIKDVIYNSQINFVKRTMIKKGAFYNQNPVGKFNKQLAANNRYPLKT
KALCLDTSIYGGYGPMNSALSIIIIAERFNEKKGKIETVKEFHDIFIIDYEKFNNNPFQFLNDT
SENGFLKKNNINRVLGFYRIPKYSLMQKIDGTRMLFESKSNLHKATQFKLTKTQNELFFHMKRL
LTKSNLMDLKSKSAIKESQNFILKHKEEFDNISNQLSAFSQKMLGNTTSLKNLIKGYNERKIKE
IDIRDETIKYFYDNFIKMFSFVKSGAPKDINDFFDNKCTVARMRPKPDKKLLNATLIHQSITGL
YETRIDLSKLGED
SEQ ID NO: 322
MKQEYFLGLDMGTGSLGWAVTDSTYQVMRKHGKALWGTRLFESASTAEERRMFRTARRRLDRRN
WRIQVLQEIFSEEISKVDPGFFLRMKESKYYPEDKRDAEGNCPELPYALFVDDNYTDKNYHKDY
PTIYHLRKMLMETTEIPDIRLVYLVLHHMMKHRGHFLLSGDISQIKEFKSTFEQLIQNIQDEEL
EWHISLDDAAIQFVEHVLKDRNLTRSTKKSRLIKQLNAKSACEKAILNLLSGGTVKLSDIFNNK
ELDESERPKVSFADSGYDDYIGIVEAELAEQYYIIASAKAVYDWSVLVEILGNSVSISEAKIKV
YQKHQADLKTLKKIVRQYMTKEDYKRVFVDTEEKLNNYSAYIGMTKKNGKKVDLKSKQCTQADF
YDFLKKNVIKVIDHKEITQEIESEIEKENFLPKQVTKDNGVIPYQVHDYELKKILDNLGTRMPF
IKENAEKIQQLFEFRIPYYVGPLNRVDDGKDGKFTWSVRKSDARIYPWNFTEVIDVEASAEKFI
RRMTNKCTYLVGEDVLPKDSLVYSKFMVLNELNNLRLNGEKISVELKQRIYEELFCKYRKVTRK
KLERYLVIEGIAKKGVEITGIDGDFKASLTAYHDFKERLTDVQLSQRAKEAIVLNVVLFGDDKK
LLKQRLSKMYPNLTTGQLKGICSLSYQGWGRLSKTFLEEITVPAPGTGEVWNIMTALWQTNDNL
MQLLSRNYGFTNEVEEFNTLKKETDLSYKTVDELYVSPAVKRQIWQTLKVVKEIQKVMGNAPKR
VFVEMAREKQEGKRSDSRKKQLVELYRACKNEERDWITELNAQSDQQLRSDKLFLYYIQKGRCM
YSGETIQLDELWDNTKYDIDHIYPQSKTMDDSLNNRVLVKKNYNAIKSDTYPLSLDIQKKMMSF
WKMLQQQGFITKEKYVRLVRSDELSADELAGFIERQIVETRQSTKAVATILKEALPDTEIVYVK
AGNVSNFRQTYELLKVREMNDLHHAKDAYLNIVVGNAYFVKFTKNAAWFIRNNPGRSYNLKRMF
EFDIERSGEIAWKAGNKGSIVTVKKVMQKNNILVTRKAYEVKGGLFDQQIMKKGKGQVPIKGND
ERLADIEKYGGYNKAAGTYFMLVKSLDKKGKEIRTIEFVPLYLKNQIEINHESAIQYLAQERGL
NSPEILLSKIKIDTLFKVDGFKMWLSGRTGNQLIFKGANQLILSHQEAAILKGVVKYVNRKNEN
KDAKLSERDGMTEEKLLQLYDTFLDKLSNTVYSIRLSAQIKTLTEKRAKFIGLSNEDQCIVLNE
ILHMFQCQSGSANLKLIGGPGSAGILVMNNNITACKQISVINQSPTGIYEKEIDLIKL
SEQ ID NO: 323
MKKPYSIGLDIGTNSVGWAVVTDDYKVPAKKMKVLGNTDKSHIEKNLLGALLFDSGNTAEDRRL
KRTARRRYTRRRNRILYLQEIFSEEMGKVDDSFFHRLEDSFLVTEDKRGERHPIFGNLEEEVKY
HENFPTIYHLRQYLADNPEKVDLRLVYLALAHIIKFRGHFLIEGKFDTRNNDVQRLFQEFLAVY
DNTFENSSLQEQNVQVEEILTDKISKSAKKDRVLKLFPNEKSNGRFAEFLKLIVGNQADFKKHF
ELEEKAPLQFSKDTYEEELEVLLAQIGDNYAELFLSAKKLYDSILLSGILTVTDVGTKAPLSAS
MIQRYNEHQMDLAQLKQFIRQKLSDKYNEVFSDVSKDGYAGYIDGKTNQEAFYKYLKGLLNKIE
GSGYFLDKIEREDFLRKQRTFDNGSIPHQIHLQEMRAIIRRQAEFYPFLADNQDRIEKLLTFRI
PYYVGPLARGKSDFAWLSRKSADKITPWNFDEIVDKESSAEAFINRMTNYDLYLPNQKVLPKHS
LLYEKFTVYNELTKVKYKTEQGKTAFFDANMKQEIFDGVFKVYRKVTKDKLMDFLEKEFDEFRI
VDLTGLDKENKVFNASYGTYHDLCKILDKDFLDNSKNEKILEDIVLTLTLFEDREMIRKRLENY
SDLLTKEQVKKLERRHYTGWGRLSAELIHGIRNKESRKTILDYLIDDGNSNRNFMQLINDDALS
FKEEIAKAQVIGETDNLNQVVSDIAGSPAIKKGILQSLKIVDELVKIMGHQPENIVVEMARENQ
FTNQGRRNSQQRLKGLTDSIKEFGSQILKEHPVENSQLQNDRLFLYYLQNGRDMYTGEELDIDY
LSQYDIDHIIPQAFIKDNSIDNRVLTSSKENRGKSDDVPSKDVVRKMKSYWSKLLSAKLITQRK
FDNLTKAERGGLTDDDKAGFIKRQLVETRQITKHVARILDERFNTETDENNKKIRQVKIVTLKS
NLVSNFRKEFELYKVREINDYHHAHDAYLNAVIGKALLGVYPQLEPEFVYGDYPHFHGHKENKA
TAKKFFYSNIMNFFKKDDVRTDKNGEIIWKKDEHISNIKKVLSYPQVNIVKKVEEQTGGFSKES
ILPKGNSDKLIPRKTKKFYWDTKKYGGFDSPIVAYSILVIADIEKGKSKKLKTVKALVGVTIME
KMTFERDPVAFLERKGYRNVQEENIIKLPKYSLFKLENGRKRLLASARELQKGNEIVLPNHLGT
LLYHAKNIHKVDEPKHLDYVDKHKDEFKELLDVVSNFSKKYTLAEGNLEKIKELYAQNNGEDLK
ELASSFINLLTFTAIGAPATFKFFDKNIDRKRYTSTTEILNATLIHQSITGLYETRIDLNKLGG
D
SEQ ID NO: 324
MDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRL
KRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAY
HEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTY
NQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSNF
DLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSAS
MIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMD
GTEELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRI
PYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHS
LLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFD
SVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYA
HLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTF
KEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQ
TTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINR
LSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRK
FDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKS
KLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAK
SEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLS
MPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKG
KSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLAS
AGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRV
ILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLD
ATLIHQSITGLYETRIDLSQLGGD
SEQ ID NO: 325
MTKPYSIGLDIGTNSVGWAVTTDNYKVPSKKMKVLGNTSKKYIKKNLLGVLLFDSGITAEGRRL
KRTARRRYTRRRNRILYLQEIFSTEMATLDDAFFQRLDDSFLVPDDKRDSKYPIFGNLVEEKAY
HDEFPTIYHLRKYLADSTKKADLRLVYLALAHMIKYRGHFLIEGEFNSKNNDIQKNFQDFLDTY
NAIFESDLSLENSKQLEEIVKDKISKLEKKDRILKLFPGEKNSGIFSEFLKLIVGNQADFRKCF
NLDEKASLHFSKESYDEDLETLLGYIGDDYSDVFLKAKKLYDAILLSGFLTVTDNETEAPLSSA
MIKRYNEHKEDLALLKEYIRNISLKTYNEVFKDDTKNGYAGYIDGKTNQEDFYVYLKKLLAEFE
GADYFLEKIDREDFLRKQRTFDNGSIPYQIHLQEMRAILDKQAKFYPFLAKNKERIEKILTFRI
PYYVGPLARGNSDFAWSIRKRNEKITPWNFEDVIDKESSAEAFINRMTSFDLYLPEEKVLPKHS
LLYETFNVYNELTKVRFIAESMRDYQFLDSKQKKDIVRLYFKDKRKVTDKDIIEYLHAIYGYDG
IELKGIEKQFNSSLSTYHDLLNIINDKEFLDDSSNEAIIEEIIHTLTIFEDREMIKQRLSKFEN
IFDKSVLKKLSRRHYTGWGKLSAKLINGIRDEKSGNTILDYLIDDGISNRNFMQLIHDDALSFK
KKIQKAQIIGDEDKGNIKEVVKSLPGSPAIKKGILQSIKIVDELVKVMGGRKPESIVVEMAREN
QYTNQGKSNSQQRLKRLEKSLKELGSKILKENIPAKLSKIDNNALQNDRLYLYYLQNGKDMYTG
DDLDIDRLSNYDIDHIIPQAFLKDNSIDNKVLVSSASNRGKSDDVPSLEVVKKRKTFWYQLLKS
KLISQRKFDNLTKAERGGLSPEDKAGFIQRQLVETRQITKHVARLLDEKFNNKKDENNRAVRTV
KIITLKSTLVSQFRKDFELYKVREINDFHHAHDAYLNAVVASALLKKYPKLEPEFVYGDYPKYN
SFRERKSATEKVYFYSNIMNIFKKSISLADGRVIERPLIEVNEETGESVWNKESDLATVRRVLS
YPQVNVVKKVEEQNHGLDRGKPKGLFNANLSSKPKPNSNENLVGAKEYLDPKKYGGYAGISNSF
TVLVKGTIEKGAKKKITNVLEFQGISILDRINYRKDKLNFLLEKGYKDIELIIELPKYSLFELS
DGSRRMLASILSTNNKRGEIHKGNQIFLSQKFVKLLYHAKRISNTINENHRKYVENHKKEFEEL
FYYILEFNENYVGAKKNGKLLNSAFQSWQNHSIDELCSSFIGPTGSERKGLFELTSRGSAADFE
FLGVKIPRYRDYTPSSLLKDATLIHQSVTGLYETRIDLAKLGEG
SEQ ID NO: 326
MKKQKFSDYYLGFDIGTNSVGWCVTDLDYNVLRFNKKDMWGSRLFDEAKTAAERRVQRNSRRRL
KRRKWRLNLLEEIFSDEIMKIDSNFFRRLKESSLWLEDKNSKEKFTLFNDDNYKDYDFYKQYPT
IFHLRDELIKNPEKKDIRLIYLALHSIFKSRGHFLFEGQNLKEIKNFETLYNNLISFLEDNGIN
KSIDKDNIEKLEKIICDSGKGLKDKEKEFKGIFNSDKQLVAIFKLSVGSSVSLNDLFDTDEYKK
EEVEKEKISFREQIYEDDKPIYYSILGEKIELLDIAKSFYDFMVLNNILSDSNYISEAKVKLYE
EHKKDLKNLKYIIRKYNKENYDKLFKDKNENNYPAYIGLNKEKDKKEVVEKSRLKIDDLIKVTK
GYLPKPERIEEKDKTIFNEILNKIELKTILPKQRISDNGTLPYQIHEVELEKILENQSKYYDFL
NYEENGVSTKDKLLKTFKFRIPYYVGPLNSYHKDKGGNSWIVRKEEGKILPWNFEQKVDIEKSA
EEFIKRMTNKCTYLNGEDVIPKDSFLYSEYIILNELNKVQVNDEFLNEENKRKIIDELFKENKK
VSEKKFKEYLLVNQIANRTVELKGIKDSFNSNYVSYIKFKDIFGEKLNLDIYKEISEKSILWKC
LYGDDKKIFEKKIKNEYGDILNKDEIKKINSFKFNTWGRLSEKLLTGIEFINLETGECYSSVME
ALRRTNYNLMELLSSKFTLQESIDNENKEMNEVSYRDLIEESYVSPSLKRAILQTLKIYEEIKK
ITGRVPKKVFIEMARGGDESMKNKKIPARQEQLKKLYDSCGNDIANFSIDIKEMKNSLSSYDNN
SLRQKKLYLYYLQFGKCMYTGREIDLDRLLQNNDTYDIDHIYPRSKVIKDDSFDNLVLVLKNEN
AEKSNEYPVKKEIQEKMKSFWRFLKEKNFISDEKYKRLTGKDDFELRGFMARQLVNVRQTTKEV
GKILQQIEPEIKIVYSKAEIASSFREMFDFIKVRELNDTHHAKDAYLNIVAGNVYNTKFTEKPY
RYLQEIKENYDVKKIYNYDIKNAWDKENSLEIVKKNMEKNTVNITRFIKEEKGELFNLNPIKKG
ETSNEIISIKPKLYDGKDNKLNEKYGYYTSLKAAYFIYVEHEKKNKKVKTFERITRIDSTLIKN
EKNLIKYLVSQKKLLNPKIIKKIYKEQTLIIDSYPYTFTGVDSNKKVELKNKKQLYLEKKYEQI
LKNALKFVEDNQGETEENYKFIYLKKRNNNEKNETIDAVKERYNIEFNEMYDKFLEKLSSKDYK
NYINNKLYTNFLNSKEKFKKLKLWEKSLILREFLKIFNKNTYGKYEIKDSQTKEKLFSFPEDTG
RIRLGQSSLGNNKELLEESVTGLFVKKIKL
SEQ ID NO: 327
MKNYTIGLDIGVASVGWVCIDENYKILNYNNRHAFGVHEFESAESAAGRRLKRGMRRRYNRRKK
RLQLLQSLFDSYITDSGFFSKTDSQHFWKNNNEFENRSLTEVLSSLRISSRKYPTIYHLRSDLI
ESNKKMDLRLVYLALHNLVKYRGHFLQEGNWSEAASAEGMDDQLLELVTRYAELENLSPLDLSE
SQWKAAETLLLNRNLTKTDQSKELTAMFGKEYEPFCKLVAGLGVSLHQLFPSSEQALAYKETKT
KVQLSNENVEEVMELLLEEESALLEAVQPFYQQVVLYELLKGETYVAKAKVSAFKQYQKDMASL
KNLLDKTFGEKVYRSYFISDKNSQREYQKSHKVEVLCKLDQFNKEAKFAETFYKDLKKLLEDKS
KTSIGTTEKDEMLRIIKAIDSNQFLQKQKGIQNAAIPHQNSLYEAEKILRNQQAHYPFITTEWI
EKVKQILAFRIPYYIGPLVKDTTQSPFSWVERKGDAPITPWNFDEQIDKAASAEAFISRMRKTC
TYLKGQEVLPKSSLTYERFEVLNELNGIQLRTTGAESDFRHRLSYEMKCWIIDNVFKQYKTVST
KRLLQELKKSPYADELYDEHTGEIKEVFGTQKENAFATSLSGYISMKSILGAVVDDNPAMTEEL
IYWIAVFEDREILHLKIQEKYPSITDVQRQKLALVKLPGWGRFSRLLIDGLPLDEQGQSVLDHM
EQYSSVFMEVLKNKGFGLEKKIQKMNQHQVDGTKKIRYEDIEELAGSPALKRGIWRSVKIVEEL
VSIFGEPANIVLEVAREDGEKKRTKSRKDQWEELTKTTLKNDPDLKSFIGEIKSQGDQRFNEQR
FWLYVTQQGKCLYTGKALDIQNLSMYEVDHILPQNFVKDDSLDNLALVMPEANQRKNQVGQNKM
PLEIIEANQQYAMRTLWERLHELKLISSGKLGRLKKPSFDEVDKDKFIARQLVETRQIIKHVRD
LLDERFSKSDIHLVKAGIVSKFRRFSEIPKIRDYNNKHHAMDALFAAALIQSILGKYGKNFLAF
DLSKKDRQKQWRSVKGSNKEFFLFKNFGNLRLQSPVTGEEVSGVEYMKHVYFELPWQTTKMTQT
GDGMFYKESIFSPKVKQAKYVSPKTEKFVHDEVKNHSICLVEFTFMKKEKEVQETKFIDLKVIE
HHQFLKEPESQLAKFLAEKETNSPIIHARIIRTIPKYQKIWIEHFPYYFISTRELHNARQFEIS
YELMEKVKQLSERSSVEELKIVFGLLIDQMNDNYPIYTKSSIQDRVQKFVDTQLYDFKSFEIGF
EELKKAVAANAQRSDTFGSRISKKPKPEEVAIGYESITGLKYRKPRSVVGTKR
SEQ ID NO: 328
MKKEIKDYFLGLDVGTGSVGWAVTDTDYKLLKANRKDLWGMRCFETAETAEVRRLHRGARRRIE
RRKKRIKLLQELFSQEIAKTDEGFFQRMKESPFYAEDKTILQENTLFNDKDFADKTYHKAYPTI
NHLIKAWIENKVKPDPRLLYLACHNIIKKRGHFLFEGDFDSENQFDTSIQALFEYLREDMEVDI
DADSQKVKEILKDSSLKNSEKQSRLNKILGLKPSDKQKKAITNLISGNKINFADLYDNPDLKDA
EKNSISFSKDDFDALSDDLASILGDSFELLLKAKAVYNCSVLSKVIGDEQYLSFAKVKIYEKHK
TDLTKLKNVIKKHFPKDYKKVFGYNKNEKNNNNYSGYVGVCKTKSKKLIINNSVNQEDFYKFLK
TILSAKSEIKEVNDILTEIETGTFLPKQISKSNAEIPYQLRKMELEKILSNAEKHFSFLKQKDE
KGLSHSEKIIMLLTFKIPYYIGPINDNHKKFFPDRCWVVKKEKSPSGKTTPWNFFDHIDKEKTA
EAFITSRTNFCTYLVGESVLPKSSLLYSEYTVLNEINNLQIIIDGKNICDIKLKQKIYEDLFKK
YKKITQKQISTFIKHEGICNKTDEVIILGIDKECTSSLKSYIELKNIFGKQVDEISTKNMLEEI
IRWATIYDEGEGKTILKTKIKAEYGKYCSDEQIKKILNLKFSGWGRLSRKFLETVTSEMPGFSE
PVNIITAMRETQNNLMELLSSEFTFTENIKKINSGFEDAEKQFSYDGLVKPLFLSPSVKKMLWQ
TLKLVKEISHITQAPPKKIFIEMAKGAELEPARTKTRLKILQDLYNNCKNDADAFSSEIKDLSG
KIENEDNLRLRSDKLYLYYTQLGKCMYCGKPIEIGHVFDTSNYDIDHIYPQSKIKDDSISNRVL
VCSSCNKNKEDKYPLKSEIQSKQRGFWNFLQRNNFISLEKLNRLTRATPISDDETAKFIARQLV
ETRQATKVAAKVLEKMFPETKIVYSKAETVSMFRNKFDIVKCREINDFHHAHDAYLNIVVGNVY
NTKFTNNPWNFIKEKRDNPKIADTYNYYKVFDYDVKRNNITAWEKGKTIITVKDMLKRNTPIYT
RQAACKKGELFNQTIMKKGLGQHPLKKEGPFSNISKYGGYNKVSAAYYTLIEYEEKGNKIRSLE
TIPLYLVKDIQKDQDVLKSYLTDLLGKKEFKILVPKIKINSLLKINGFPCHITGKTNDSFLLRP
AVQFCCSNNEVLYFKKIIRFSEIRSQREKIGKTISPYEDLSFRSYIKENLWKKTKNDEIGEKEF
YDLLQKKNLEIYDMLLTKHKDTIYKKRPNSATIDILVKGKEKFKSLIIENQFEVILEILKLFSA
TRNVSDLQHIGGSKYSGVAKIGNKISSLDNCILIYQSITGIFEKRIDLLKV
SEQ ID NO: 329
MEGQMKNNGNNLQQGNYYLGLDVGTSSVGWAVTDTDYNVLKFRGKSMWGARLFDEASTAEERRT
HRGNRRRLARRKYRLLLLEQLFEKEIRKIDDNFFVRLHESNLWADDKSKPSKFLLFNDTNFTDK
DYLKKYPTIYHLRSDLIHNSTEHDIRLVFLALHHLIKYRGHFIYDNSANGDVKTLDEAVSDFEE
YLNENDIEFNIENKKEFINVLSDKHLTKKEKKISLKKLYGDITDSENINISVLIEMLSGSSISL
SNLFKDIEFDGKQNLSLDSDIEETLNDVVDILGDNIDLLIHAKEVYDIAVLTSSLGKHKYLCDA
KVELFEKNKKDLMILKKYIKKNHPEDYKKIFSSPTEKKNYAAYSQTNSKNVCSQEEFCLFIKPY
IRDMVKSENEDEVRIAKEVEDKSFLTKLKGTNNSVVPYQIHERELNQILKNIVAYLPFMNDEQE
DISVVDKIKLIFKFKIPYYVGPLNTKSTRSWVYRSDEKIYPWNFSNVIDLDKTAHEFMNRLIGR
CTYTNDPVLPMDSLLYSKYNVLNEINPIKVNGKAIPVEVKQAIYTDLFENSKKKVTRKSIYIYL
LKNGYIEKEDIVSGIDIEIKSKLKSHHDFTQIVQENKCTPEEIERIIKGILVYSDDKSMLRRWL
KNNIKGLSENDVKYLAKLNYKEWGRLSKTLLTDIYTINPEDGEACSILDIMWNTNATLMEILSN
EKYQFKQNIENYKAENYDEKQNLHEELDDMYISPAARRSIWQALRIVDEIVDIKKSAPKKIFIE
MAREKKSAMKKKRTESRKDTLLELYKSCKSQADGFYDEELFEKLSNESNSRLRRDQLYLYYTQM
GRSMYTGKRIDFDKLINDKNTYDIDHIYPRSKIKDDSITNRVLVEKDINGEKTDIYPISEDIRQ
KMQPFWKILKEKGLINEEKYKRLTRNYELTDEELSSFVARQLVETQQSTKALATLLKKEYPSAK
IVYSKAGNVSEFRNRKDKELPKFREINDLHHAKDAYLNIVVGNVYDTKFTEKFFNNIRNENYSL
KRVFDFSVPGAWDAKGSTFNTIKKYMAKNNPIIAFAPYEVKGELFDQQIVPKGKGQFPIKQGKD
IEKYGGYNKLSSAFLFAVEYKGKKARERSLETVYIKDVELYLQDPIKYCESVLGLKEPQIIKPK
ILMGSLFSINNKKLVVTGRSGKQYVCHHIYQLSINDEDSQYLKNIAKYLQEEPDGNIERQNILN
ITSVNNIKLFDVLCTKFNSNTYEIILNSLKNDVNEGREKFSELDILEQCNILLQLLKAFKCNRE
SSNLEKLNNKKQAGVIVIPHLFTKCSVFKVIHQSITGLFEKEMDLLK
SEQ ID NO: 330
MGRKPYILSLDIGTGSVGYACMDKGFNVLKYHDKDALGVYLFDGALTAQERRQFRTSRRRKNRR
IKRLGLLQELLAPLVQNPNFYQFQRQFAWKNDNMDFKNKSLSEVLSFLGYESKKYPTIYHLQEA
LLLKDEKFDPELIYMALYHLVKYRGHFLFDHLKIENLTNNDNMHDFVELIETYENLNNIKLNLD
YEKTKVIYEILKDNEMTKNDRAKRVKNMEKKLEQFSIMLLGLKFNEGKLFNHADNAEELKGANQ
SHTFADNYEENLTPFLTVEQSEFIERANKIYLSLTLQDILKGKKSMAMSKVAAYDKFRNELKQV
KDIVYKADSTRTQFKKIFVSSKKSLKQYDATPNDQTFSSLCLFDQYLIRPKKQYSLLIKELKKI
IPQDSELYFEAENDTLLKVLNTTDNASIPMQINLYEAETILRNQQKYHAEITDEMIEKVLSLIQ
FRIPYYVGPLVNDHTASKFGWMERKSNESIKPWNFDEVVDRSKSATQFIRRMTNKCSYLINEDV
LPKNSLLYQEMEVLNELNATQIRLQTDPKNRKYRMMPQIKLFAVEHIFKKYKTVSHSKFLEIML
NSNHRENFMNHGEKLSIFGTQDDKKFASKLSSYQDMTKIFGDIEGKRAQIEEIIQWITIFEDKK
ILVQKLKECYPELTSKQINQLKKLNYSGWGRLSEKLLTHAYQGHSIIELLRHSDENFMEILTND
VYGFQNFIKEENQVQSNKIQHQDIANLTTSPALKKGIWSTIKLVRELTSIFGEPEKIIMEFATE
DQQKGKKQKSRKQLWDDNIKKNKLKSVDEYKYIIDVANKLNNEQLQQEKLWLYLSQNGKCMYSG
QSIDLDALLSPNATKHYEVDHIFPRSFIKDDSIDNKVLVIKKMNQTKGDQVPLQFIQQPYERIA
YWKSLNKAGLISDSKLHKLMKPEFTAMDKEGFIQRQLVETRQISVHVRDFLKEEYPNTKVIPMK
AKMVSEFRKKFDIPKIRQMNDAHHAIDAYLNGVVYHGAQLAYPNVDLFDFNFKWEKVREKWKAL
GEFNTKQKSRELFFFKKLEKMEVSQGERLISKIKLDMNHFKINYSRKLANIPQQFYNQTAVSPK
TAELKYESNKSNEVVYKGLTPYQTYVVAIKSVNKKGKEKMEYQMIDHYVFDFYKFQNGNEKELA
LYLAQRENKDEVLDAQIVYSLNKGDLLYINNHPCYFVSRKEVINAKQFELTVEQQLSLYNVMNN
KETNVEKLLIEYDFIAEKVINEYHHYLNSKLKEKRVRTFFSESNQTHEDFIKALDELFKVVTAS
ATRSDKIGSRKNSMTHRAFLGKGKDVKIAYTSISGLKTTKPKSLFKLAESRNEL
SEQ ID NO: 331
MAKILGLDLGTNSIGWAVVERENIDFSLIDKGVRIFSEGVKSEKGIESSRAAERTGYRSARKIK
YRRKLRKYETLKVLSLNRMCPLSIEEVEEWKKSGFKDYPLNPEFLKWLSTDEESNVNPYFFRDR
ASKHKVSLFELGRAFYHIAQRRGFLSNRLDQSAEGILEEHCPKIEAIVEDLISIDEISTNITDY
FFETGILDSNEKNGYAKDLDEGDKKLVSLYKSLLAILKKNESDFENCKSEIIERLNKKDVLGKV
KGKIKDISQAMLDGNYKTLGQYFYSLYSKEKIRNQYTSREEHYLSEFITICKVQGIDQINEEEK
INEKKFDGLAKDLYKAIFFQRPLKSQKGLIGKCSFEKSKSRCAISHPDFEEYRMWTYLNTIKIG
TQSDKKLRFLTQDEKLKLVPKFYRKNDFNFDVLAKELIEKGSSFGFYKSSKKNDFFYWFNYKPT
DTVAACQVAASLKNAIGEDWKTKSFKYQTINSNKEQVSRTVDYKDLWHLLTVATSDVYLYEFAI
DKLGLDEKNAKAFSKTKLKKDFASLSLSAINKILPYLKEGLLYSHAVFVANIENIVDENIWKDE
KQRDYIKTQISEIIENYTLEKSRFEIINGLLKEYKSENEDGKRVYYSKEAEQSFENDLKKKLVL
FYKSNEIENKEQQETIFNELLPIFIQQLKDYEFIKIQRLDQKVLIFLKGKNETGQIFCTEEKGT
AEEKEKKIKNRLKKLYHPSDIEKFKKKIIKDEFGNEKIVLGSPLTPSIKNPMAMRALHQLRKVL
NALILEGQIDEKTIIHIEMARELNDANKRKGIQDYQNDNKKFREDAIKEIKKLYFEDCKKEVEP
TEDDILRYQLWMEQNRSEIYEEGKNISICDIIGSNPAYDIEHTIPRSRSQDNSQMNKTLCSQRF
NREVKKQSMPIELNNHLEILPRIAHWKEEADNLTREIEIISRSIKAAATKEIKDKKIRRRHYLT
LKRDYLQGKYDRFIWEEPKVGFKNSQIPDTGIITKYAQAYLKSYFKKVESVKGGMVAEFRKIWG
IQESFIDENGMKHYKVKDRSKHTHHTIDAITIACMTKEKYDVLAHAWTLEDQQNKKEARSIIEA
SKPWKTFKEDLLKIEEEILVSHYTPDNVKKQAKKIVRVRGKKQFVAEVERDVNGKAVPKKAASG
KTIYKLDGEGKKLPRLQQGDTIRGSLHQDSIYGAIKNPLNTDEIKYVIRKDLESIKGSDVESIV
DEVVKEKIKEAIANKVLLLSSNAQQKNKLVGTVWMNEEKRIAINKVRIYANSVKNPLHIKEHSL
LSKSKHVHKQKVYGQNDENYAMAIYELDGKRDFELINIFNLAKLIKQGQGFYPLHKKKEIKGKI
VFVPIEKRNKRDVVLKRGQQVVFYDKEVENPKDISEIVDFKGRIYIIEGLSIQRIVRPSGKVDE
YGVIMLRYFKEARKADDIKQDNFKPDGVFKLGENKPTRKMNHQFTAFVEGIDFKVLPSGKFEKI
SEQ ID NO: 332
MEFKKVLGLDIGTNSIGCALLSLPKSIQDYGKGGRLEWLTSRVIPLDADYMKAFIDGKNGLPQV
ITPAGKRRQKRGSRRLKHRYKLRRSRLIRVFKTLNWLPEDFPLDNPKRIKETISTEGKFSFRIS
DYVPISDESYREFYREFGYPENEIEQVIEEINFRRKTKGKNKNPMIKLLPEDWVVYYLRKKALI
KPTTKEELIRIIYLFNQRRGFKSSRKDLTETAILDYDEFAKRLAEKEKYSAENYETKFVSITKV
KEVVELKTDGRKGKKRFKVILEDSRIEPYEIERKEKPDWEGKEYTFLVTQKLEKGKFKQNKPDL
PKEEDWALCTTALDNRMGSKHPGEFFFDELLKAFKEKRGYKIRQYPVNRWRYKKELEFIWTKQC
QLNPELNNLNINKEILRKLATVLYPSQSKFFGPKIKEFENSDVLHIISEDIIYYQRDLKSQKSL
ISECRYEKRKGIDGEIYGLKCIPKSSPLYQEFRIWQDIHNIKVIRKESEVNGKKKINIDETQLY
INENIKEKLFELFNSKDSLSEKDILELISLNIINSGIKISKKEEETTHRINLFANRKELKGNET
KSRYRKVFKKLGFDGEYILNHPSKLNRLWHSDYSNDYADKEKTEKSILSSLGWKNRNGKWEKSK
NYDVFNLPLEVAKAIANLPPLKKEYGSYSALAIRKMLVVMRDGKYWQHPDQIAKDQENTSLMLF
DKNLIQLTNNQRKVLNKYLLTLAEVQKRSTLIKQKLNEIEHNPYKLELVSDQDLEKQVLKSFLE
KKNESDYLKGLKTYQAGYLIYGKHSEKDVPIVNSPDELGEYIRKKLPNNSLRNPIVEQVIRETI
FIVRDVWKSFGIIDEIHIELGRELKNNSEERKKTSESQEKNFQEKERARKLLKELLNSSNFEHY
DENGNKIFSSFTVNPNPDSPLDIEKFRIWKNQSGLTDEELNKKLKDEKIPTEIEVKKYILWLTQ
KCRSPYTGKIIPLSKLFDSNVYEIEHIIPRSKMKNDSTNNLVICELGVNKAKGDRLAANFISES
NGKCKFGEVEYTLLKYGDYLQYCKDTFKYQKAKYKNLLATEPPEDFIERQINDTRYIGRKLAEL
LTPVVKDSKNIIFTIGSITSELKITWGLNGVWKDILRPRFKRLESIINKKLIFQDEDDPNKYHF
DLSINPQLDKEGLKRLDHRHHALDATIIAATTREHVRYLNSLNAADNDEEKREYFLSLCNHKIR
DFKLPWENFTSEVKSKLLSCVVSYKESKPILSDPFNKYLKWEYKNGKWQKVFAIQIKNDRWKAV
RRSMFKEPIGTVWIKKIKEVSLKEAIKIQAIWEEVKNDPVRKKKEKYIYDDYAQKVIAKIVQEL
GLSSSMRKQDDEKLNKFINEAKVSAGVNKNLNTTNKTIYNLEGRFYEKIKVAEYVLYKAKRMPL
NKKEYIEKLSLQKMFNDLPNFILEKSILDNYPEILKELESDNKYIIEPHKKNNPVNRLLLEHIL
EYHNNPKEAFSTEGLEKLNKKAINKIGKPIKYITRLDGDINEEEIFRGAVFETDKGSNVYFVMY
ENNQTKDREFLKPNPSISVLKAIEHKNKIDFFAPNRLGFSRIILSPGDLVYVPTNDQYVLIKDN
SSNETIINWDDNEFISNRIYQVKKFTGNSCYFLKNDIASLILSYSASNGVGEFGSQNISEYSVD
DPPIRIKDVCIKIRVDRLGNVRPL
SEQ ID NO: 333
MKHILGLDLGTNSIGWALIERNIEEKYGKIIGMGSRIVPMGAELSKFEQGQAQTKNADRRTNRG
ARRLNKRYKQRRNKLIYILQKLDMLPSQIKLKEDFSDPNKIDKITILPISKKQEQLTAFDLVSL
RVKALTEKVGLEDLGKIIYKYNQLRGYAGGSLEPEKEDIFDEEQSKDKKNKSFIAFSKIVFLGE
PQEEIFKNKKLNRRAIIVETEEGNFEGSTFLENIKVGDSLELLINISASKSGDTITIKLPNKTN
WRKKMENIENQLKEKSKEMGREFYISEFLLELLKENRWAKIRNNTILRARYESEFEAIWNEQVK
HYPFLENLDKKTLIEIVSFIFPGEKESQKKYRELGLEKGLKYIIKNQVVFYQRELKDQSHLISD
CRYEPNEKAIAKSHPVFQEYKVWEQINKLIVNTKIEAGTNRKGEKKYKYIDRPIPTALKEWIFE
ELQNKKEITFSAIFKKLKAEFDLREGIDFLNGMSPKDKLKGNETKLQLQKSLGELWDVLGLDSI
NRQIELWNILYNEKGNEYDLTSDRTSKVLEFINKYGNNIVDDNAEETAIRISKIKFARAYSSLS
LKAVERILPLVRAGKYFNNDFSQQLQSKILKLLNENVEDPFAKAAQTYLDNNQSVLSEGGVGNS
IATILVYDKHTAKEYSHDELYKSYKEINLLKQGDLRNPLVEQIINEALVLIRDIWKNYGIKPNE
IRVELARDLKNSAKERATIHKRNKDNQTINNKIKETLVKNKKELSLANIEKVKLWEAQRHLSPY
TGQPIPLSDLFDKEKYDVDHIIPISRYFDDSFTNKVISEKSVNQEKANRTAMEYFEVGSLKYSI
FTKEQFIAHVNEYFSGVKRKNLLATSIPEDPVQRQIKDTQYIAIRVKEELNKIVGNENVKTTTG
SITDYLRNHWGLTDKFKLLLKERYEALLESEKFLEAEYDNYKKDFDSRKKEYEEKEVLFEEQEL
TREEFIKEYKENYIRYKKNKLIIKGWSKRIDHRHHAIDALIVACTEPAHIKRLNDLNKVLQDWL
VEHKSEFMPNFEGSNSELLEEILSLPENERTEIFTQIEKFRAIEMPWKGFPEQVEQKLKEIIIS
HKPKDKLLLQYNKAGDRQIKLRGQLHEGTLYGISQGKEAYRIPLTKFGGSKFATEKNIQKIVSP
FLSGFIANHLKEYNNKKEEAFSAEGIMDLNNKLAQYRNEKGELKPHTPISTVKIYYKDPSKNKK
KKDEEDLSLQKLDREKAFNEKLYVKTGDNYLFAVLEGEIKTKKTSQIKRLYDIISFFDATNFLK
EEFRNAPDKKTFDKDLLFRQYFEERNKAKLLFTLKQGDFVYLPNENEEVILDKESPLYNQYWGD
LKERGKNIYVVQKFSKKQIYFIKHTIADIIKKDVEFGSQNCYETVEGRSIKENCFKLEIDRLGN
IVKVIKR
SEQ ID NO: 334
MHVEIDFPHFSRGDSHLAMNKNEILRGSSVLYRLGLDLGSNSLGWFVTHLEKRGDRHEPVALGP
GGVRIFPDGRDPQSGTSNAVDRRMARGARKRRDRFVERRKELIAALIKYNLLPDDARERRALEV
LDPYALRKTALTDTLPAHHVGRALFHLNQRRGFQSNRKTDSKQSEDGAIKQAASRLATDKGNET
LGVFFADMHLRKSYEDRQTAIRAELVRLGKDHLTGNARKKIWAKVRKRLFGDEVLPRADAPHGV
RARATITGTKASYDYYPTRDMLRDEFNAIWAGQSAHHATITDEARTEIEHIIFYQRPLKPAIVG
KCTLDPATRPFKEDPEGYRAPWSHPLAQRFRILSEARNLEIRDTGKGSRRLTKEQSDLVVAALL
ANREVKFDKLRTLLKLPAEARFNLESDRRAALDGDQTAARLSDKKGFNKAWRGFPPERQIAIVA
RLEETEDENELIAWLEKECALDGAAAARVANTTLPDGHCRLGLRAIKKIVPIMQDGLDEDGVAG
AGYHIAAKRAGYDHAKLPTGEQLGRLPYYGQWLQDAVVGSGDARDQKEKQYGQFPNPTVHIGLG
QLRRVVNDLIDKYGPPTEISIEFTRALKLSEQQKAERQREQRRNQDKNKARAEELAKFGRPANP
RNLLKMRLWEELAHDPLDRKCVYTGEQISIERLLSDEVDIDHILPVAMTLDDSPANKIICMRYA
NRHKRKQTPSEAFGSSPTLQGHRYNWDDIAARATGLPRNKRWRFDANAREEFDKRGGFLARQLN
ETGWLARLAKQYLGAVTDPNQIWVVPGRLTSMLRGKWGLNGLLPSDNYAGVQDKAEEFLASTDD
MEFSGVKNRADHRHHAIDGLVTALTDRSLLWKMANAYDEEHEKFVIEPPWPTMRDDLKAALEKM
VVSHKPDHGIEGKLHEDSAYGFVKPLDATGLKEEEAGNLVYRKAIESLNENEVDRIRDIQLRTI
VRDHVNVEKTKGVALADALRQLQAPSDDYPQFKHGLRHVRILKKEKGDYLVPIANRASGVAYKA
YSAGENFCVEVFETAGGKWDGEAVRRFDANKKNAGPKIAHAPQWRDANEGAKLVMRIHKGDLIR
LDHEGRARIMVVHRLDAAAGRFKLADHNETGNLDKRHATNNDIDPFRWLMASYNTLKKLAAVPV
RVDELGRVWRVMPN
SEQ ID NO: 335
METTLGIDLGTNSIGLALVDQEEHQILYSGVRIFPEGINKDTIGLGEKEESRNATRRAKRQMRR
QYFRKKLRKAKLLELLIAYDMCPLKPEDVRRWKNWDKQQKSTVRQFPDTPAFREWLKQNPYELR
KQAVTEDVTRPELGRILYQMIQRRGFLSSRKGKEEGKIFTGKDRMVGIDETRKNLQKQTLGAYL
YDIAPKNGEKYRFRTERVRARYTLRDMYIREFEIIWQRQAGHLGLAHEQATRKKNIFLEGSATN
VRNSKLITHLQAKYGRGHVLIEDTRITVTFQLPLKEVLGGKIEIEEEQLKFKSNESVLFWQRPL
RSQKSLLSKCVFEGRNFYDPVHQKWIIAGPTPAPLSHPEFEEFRAYQFINNIIYGKNEHLTAIQ
REAVFELMCTESKDFNFEKIPKHLKLFEKFNFDDTTKVPACTTISQLRKLFPHPVWEEKREEIW
HCFYFYDDNTLLFEKLQKDYALQTNDLEKIKKIRLSESYGNVSLKAIRRINPYLKKGYAYSTAV
LLGGIRNSFGKRFEYFKEYEPEIEKAVCRILKEKNAEGEVIRKIKDYLVHNRFGFAKNDRAFQK
LYHHSQAITTQAQKERLPETGNLRNPIVQQGLNELRRTVNKLLATCREKYGPSFKFDHIHVEMG
RELRSSKTEREKQSRQIRENEKKNEAAKVKLAEYGLKAYRDNIQKYLLYKEIEEKGGTVCCPYT
GKTLNISHTLGSDNSVQIEHIIPYSISLDDSLANKTLCDATFNREKGELTPYDFYQKDPSPEKW
GASSWEEIEDRAFRLLPYAKAQRFIRRKPQESNEFISRQLNDTRYISKKAVEYLSAICSDVKAF
PGQLTAELRHLWGLNNILQSAPDITFPLPVSATENHREYYVITNEQNEVIRLFPKQGETPRTEK
GELLLTGEVERKVFRCKGMQEFQTDVSDGKYWRRIKLSSSVTWSPLFAPKPISADGQIVLKGRI
EKGVFVCNQLKQKLKTGLPDGSYWISLPVISQTFKEGESVNNSKLTSQQVQLFGRVREGIFRCH
NYQCPASGADGNFWCTLDTDTAQPAFTPIKNAPPGVGGGQIILTGDVDDKGIFHADDDLHYELP
ASLPKGKYYGIFTVESCDPTLIPIELSAPKTSKGENLIEGNIWVDEHTGEVRFDPKKNREDQRH
HAIDAIVIALSSQSLFQRLSTYNARRENKKRGLDSTEHFPSPWPGFAQDVRQSVVPLLVSYKQN
PKTLCKISKTLYKDGKKIHSCGNAVRGQLHKETVYGQRTAPGATEKSYHIRKDIRELKTSKHIG
KVVDITIRQMLLKHLQENYHIDITQEFNIPSNAFFKEGVYRIFLPNKHGEPVPIKKIRMKEELG
NAERLKDNINQYVNPRNNHHVMIYQDADGNLKEEIVSFWSVIERQNQGQPIYQLPREGRNIVSI
LQINDTFLIGLKEEEPEVYRNDLSTLSKHLYRVQKLSGMYYTFRHHLASTLNNEREEFRIQSLE
AWKRANPVKVQIDEIGRITFLNGPLC
SEQ ID NO: 336
MESSQILSPIGIDLGGKFTGVCLSHLEAFAELPNHANTKYSVILIDHNNFQLSQAQRRATRHRV
RNKKRNQFVKRVALQLFQHILSRDLNAKEETALCHYLNNRGYTYVDTDLDEYIKDETTINLLKE
LLPSESEHNFIDWFLQKMQSSEFRKILVSKVEEKKDDKELKNAVKNIKNFITGFEKNSVEGHRH
RKVYFENIKSDITKDNQLDSIKKKIPSVCLSNLLGHLSNLQWKNLHRYLAKNPKQFDEQTFGNE
FLRMLKNFRHLKGSQESLAVRNLIQQLEQSQDYISILEKTPPEITIPPYEARTNTGMEKDQSLL
LNPEKLNNLYPNWRNLIPGIIDAHPFLEKDLEHTKLRDRKRIISPSKQDEKRDSYILQRYLDLN
KKIDKFKIKKQLSFLGQGKQLPANLIETQKEMETHFNSSLVSVLIQIASAYNKEREDAAQGIWF
DNAFSLCELSNINPPRKQKILPLLVGAILSEDFINNKDKWAKFKIFWNTHKIGRTSLKSKCKEI
EEARKNSGNAFKIDYEEALNHPEHSNNKALIKIIQTIPDIIQAIQSHLGHNDSQALIYHNPFSL
SQLYTILETKRDGFHKNCVAVTCENYWRSQKTEIDPEISYASRLPADSVRPFDGVLARMMQRLA
YEIAMAKWEQIKHIPDNSSLLIPIYLEQNRFEFEESFKKIKGSSSDKTLEQAIEKQNIQWEEKF
QRIINASMNICPYKGASIGGQGEIDHIYPRSLSKKHFGVIFNSEVNLIYCSSQGNREKKEEHYL
LEHLSPLYLKHQFGTDNVSDIKNFISQNVANIKKYISFHLLTPEQQKAARHALFLDYDDEAFKT
ITKFLMSQQKARVNGTQKFLGKQIMEFLSTLADSKQLQLEFSIKQITAEEVHDHRELLSKQEPK
LVKSRQQSFPSHAIDATLTMSIGLKEFPQFSQELDNSWFINHLMPDEVHLNPVRSKEKYNKPNI
SSTPLFKDSLYAERFIPVWVKGETFAIGFSEKDLFEIKPSNKEKLFTLLKTYSTKNPGESLQEL
QAKSKAKWLYFPINKTLALEFLHHYFHKEIVTPDDTTVCHFINSLRYYTKKESITVKILKEPMP
VLSVKFESSKKNVLGSFKHTIALPATKDWERLFNHPNFLALKANPAPNPKEFNEFIRKYFLSDN
NPNSDIPNNGHNIKPQKHKAVRKVFSLPVIPGNAGTMMRIRRKDNKGQPLYQLQTIDDTPSMGI
QINEDRLVKQEVLMDAYKTRNLSTIDGINNSEGQAYATFDNWLTLPVSTFKPEIIKLEMKPHSK
TRRYIRITQSLADFIKTIDEALMIKPSDSIDDPLNMPNEIVCKNKLFGNELKPRDGKMKIVSTG
KIVTYEFESDSTPQWIQTLYVTQLKKQP
SEQ ID NO: 337
MKKIVGLDLGTNSIGWALINAYINKEHLYGIEACGSRIIPMDAAILGNFDKGNSISQTADRTSY
RGIRRLRERHLLRRERLHRILDLLGFLPKHYSDSLNRYGKFLNDIECKLPWVKDETGSYKFIFQ
ESFKEMLANFTEHHPILIANNKKVPYDWTIYYLRKKALTQKISKEELAWILLNFNQKRGYYQLR
GEEEETPNKLVEYYSLKVEKVEDSGERKGKDTWYNVHLENGMIYRRTSNIPLDWEGKTKEFIVT
TDLEADGSPKKDKEGNIKRSFRAPKDDDWTLIKKKTEADIDKIKMTVGAYIYDTLLQKPDQKIR
GKLVRTIERKYYKNELYQILKTQSEFHEELRDKQLYIACLNELYPNNEPRRNSISTRDFCHLFI
EDIIFYQRPLKSKKSLIDNCPYEENRYIDKESGEIKHASIKCIAKSHPLYQEFRLWQFIVNLRI
YRKETDVDVTQELLPTEADYVTLFEWLNEKKEIDQKAFFKYPPFGFKKTTSNYRWNYVEDKPYP
CNETHAQIIARLGKAHIPKAFLSKEKEETLWHILYSIEDKQEIEKALHSFANKNNLSEEFIEQF
KNFPPFKKEYGSYSAKAIKKLLPLMRMGKYWSIENIDNGTRIRINKIIDGEYDENIRERVRQKA
INLTDITHFRALPLWLACYLVYDRHSEVKDIVKWKTPKDIDLYLKSFKQHSLRNPIVEQVITET
LRTVRDIWQQVGHIDEIHIELGREMKNPADKRARMSQQMIKNENTNLRIKALLTEFLNPEFGIE
NVRPYSPSQQDLLRIYEEGVLNSILELPEDIGIILGKFNQTDTLKRPTRSEILRYKLWLEQKYR
SPYTGEMIPLSKLFTPAYEIEHIIPQSRYFDDSLSNKVICESEINKLKDRSLGYEFIKNHHGEK
VELAFDKPVEVLSVEAYEKLVHESYSHNRSKMKKLLMEDIPDQFIERQLNDSRYISKVVKSLLS
NIVREENEQEAISKNVIPCTGGITDRLKKDWGINDVWNKIVLPRFIRLNELTESTRFTSINTNN
TMIPSMPLELQKGFNKKRIDHRHHAMDAIIIACANRNIVNYLNNVSASKNTKITRRDLQTLLCH
KDKTDNNGNYKWVIDKPWETFTQDTLTALQKITVSFKQNLRVINKTTNHYQHYENGKKIVSNQS
KGDSWAIRKSMHKETVHGEVNLRMIKTVSFNEALKKPQAIVEMDLKKKILAMLELGYDTKRIKN
YFEENKDTWQDINPSKIKVYYFTKETKDRYFAVRKPIDTSFDKKKIKESITDTGIQQIMLRHLE
TKDNDPTLAFSPDGIDEMNRNILILNKGKKHQPIYKVRVYEKAEKFTVGQKGNKRTKFVEAAKG
TNLFFAIYETEEIDKDTKKVIRKRSYSTIPLNVVIERQKQGLSSAPEDENGNLPKYILSPNDLV
YVPTQEEINKGEVVMPIDRDRIYKMVDSSGITANFIPASTANLIFALPKATAEIYCNGENCIQN
EYGIGSPQSKNQKAITGEMVKEICFPIKVDRLGNIIQVGSCILTN
SEQ ID NO: 338
MSRSLTFSFDIGYASIGWAVIASASHDDADPSVCGCGTVLFPKDDCQAFKRREYRRLRRNIRSR
RVRIERIGRLLVQAQIITPEMKETSGHPAPFYLASEALKGHRTLAPIELWHVLRWYAHNRGYDN
NASWSNSLSEDGGNGEDTERVKHAQDLMDKHGTATMAETICRELKLEEGKADAPMEVSTPAYKN
LNTAFPRLIVEKEVRRILELSAPLIPGLTAEIIELIAQHHPLTTEQRGVLLQHGIKLARRYRGS
LLFGQLIPRFDNRIISRCPVTWAQVYEAELKKGNSEQSARERAEKLSKVPTANCPEFYEYRMAR
ILCNIRADGEPLSAEIRRELMNQARQEGKLTKASLEKAISSRLGKETETNVSNYFTLHPDSEEA
LYLNPAVEVLQRSGIGQILSPSVYRIAANRLRRGKSVTPNYLLNLLKSRGESGEALEKKIEKES
KKKEADYADTPLKPKYATGRAPYARTVLKKVVEEILDGEDPTRPARGEAHPDGELKAHDGCLYC
LLDTDSSVNQHQKERRLDTMTNNHLVRHRMLILDRLLKDLIQDFADGQKDRISRVCVEVGKELT
TFSAMDSKKIQRELTLRQKSHTDAVNRLKRKLPGKALSANLIRKCRIAMDMNWTCPFTGATYGD
HELENLELEHIVPHSFRQSNALSSLVLTWPGVNRMKGQRTGYDFVEQEQENPVPDKPNLHICSL
NNYRELVEKLDDKKGHEDDRRRKKKRKALLMVRGLSHKHQSQNHEAMKEIGMTEGMMTQSSHLM
KLACKSIKTSLPDAHIDMIPGAVTAEVRKAWDVFGVFKELCPEAADPDSGKILKENLRSLTHLH
HALDACVLGLIPYIIPAHHNGLLRRVLAMRRIPEKLIPQVRPVANQRHYVLNDDGRMMLRDLSA
SLKENIREQLMEQRVIQHVPADMGGALLKETMQRVLSVDGSGEDAMVSLSKKKDGKKEKNQVKA
SKLVGVFPEGPSKLKALKAAIEIDGNYGVALDPKPVVIRHIKVFKRIMALKEQNGGKPVRILKK
GMLIHLTSSKDPKHAGVWRIESIQDSKGGVKLDLQRAHCAVPKNKTHECNWREVDLISLLKKYQ
MKRYPTSYTGTPR
SEQ ID NO: 339
MTQKVLGLDLGTNSIGSAVRNLDLSDDLQWQLEFFSSDIFRSSVNKESNGREYSLAAQRSAHRR
SRGLNEVRRRRLWATLNLLIKHGFCPMSSESLMRWCTYDKRKGLFREYPIDDKDFNAWILLDFN
GDGRPDYSSPYQLRRELVTRQFDFEQPIERYKLGRALYHIAQHRGFKSSKGETLSQQETNSKPS
STDEIPDVAGAMKASEEKLSKGLSTYMKEHNLLTVGAAFAQLEDEGVRVRNNNDYRAIRSQFQH
EIETIFKFQQGLSVESELYERLISEKKNVGTIFYKRPLRSQRGNVGKCTLERSKPRCAIGHPLF
EKFRAWTLINNIKVRMSVDTLDEQLPMKLRLDLYNECFLAFVRTEFKFEDIRKYLEKRLGIHFS
YNDKTINYKDSTSVAGCPITARFRKMLGEEWESFRVEGQKERQAHSKNNISFHRVSYSIEDIWH
FCYDAEEPEAVLAFAQETLRLERKKAEELVRIWSAMPQGYAMLSQKAIRNINKILMLGLKYSDA
VILAKVPELVDVSDEELLSIAKDYYLVEAQVNYDKRINSIVNGLIAKYKSVSEEYRFADHNYEY
LLDESDEKDIIRQIENSLGARRWSLMDANEQTDILQKVRDRYQDFFRSHERKFVESPKLGESFE
NYLTKKFPMVEREQWKKLYHPSQITIYRPVSVGKDRSVLRLGNPDIGAIKNPTVLRVLNTLRRR
VNQLLDDGVISPDETRVVVETARELNDANRKWALDTYNRIRHDENEKIKKILEEFYPKRDGIST
DDIDKARYVIDQREVDYFTGSKTYNKDIKKYKFWLEQGGQCMYTGRTINLSNLFDPNAFDIEHT
IPESLSFDSSDMNLTLCDAHYNRFIKKNHIPTDMPNYDKAITIDGKEYPAITSQLQRWVERVER
LNRNVEYWKGQARRAQNKDRKDQCMREMHLWKMELEYWKKKLERFTVTEVTDGFKNSQLVDTRV
ITRHAVLYLKSIFPHVDVQRGDVTAKFRKILGIQSVDEKKDRSLHSHHAIDATTLTIIPVSAKR
DRMLELFAKIEEINKMLSFSGSEDRTGLIQELEGLKNKLQMEVKVCRIGHNVSEIGTFINDNII
VNHHIKNQALTPVRRRLRKKGYIVGGVDNPRWQTGDALRGEIHKASYYGAITQFAKDDEGKVLM
KEGRPQVNPTIKFVIRRELKYKKSAADSGFASWDDLGKAIVDKELFALMKGQFPAETSFKDACE
QGIYMIKKGKNGMPDIKLHHIRHVRCEAPQSGLKIKEQTYKSEKEYKRYFYAAVGDLYAMCCYT
NGKIREFRIYSLYDVSCHRKSDIEDIPEFITDKKGNRLMLDYKLRTGDMILLYKDNPAELYDLD
NVNLSRRLYKINRFESQSNLVLMTHHLSTSKERGRSLGKTVDYQNLPESIRSSVKSLNFLIMGE
NRDFVIKNGKIIFNHR
SEQ ID NO: 340
MLVSPISVDLGGKNTGFFSFTDSLDNSQSGTVIYDESFVLSQVGRRSKRHSKRNNLRNKLVKRL
FLLILQEHHGLSIDVLPDEIRGLFNKRGYTYAGFELDEKKKDALESDTLKEFLSEKLQSIDRDS
DVEDFLNQIASNAESFKDYKKGFEAVFASATHSPNKKLELKDELKSEYGENAKELLAGLRVTKE
ILDEFDKQENQGNLPRAKYFEELGEYIATNEKVKSFFDSNSLKLTDMTKLIGNISNYQLKELRR
YFNDKEMEKGDIWIPNKLHKITERFVRSWHPKNDADRQRRAELMKDLKSKEIMELLTTTEPVMT
IPPYDDMNNRGAVKCQTLRLNEEYLDKHLPNWRDIAKRLNHGKFNDDLADSTVKGYSEDSTLLH
RLLDTSKEIDIYELRGKKPNELLVKTLGQSDANRLYGFAQNYYELIRQKVRAGIWVPVKNKDDS
LNLEDNSNMLKRCNHNPPHKKNQIHNLVAGILGVKLDEAKFAEFEKELWSAKVGNKKLSAYCKN
IEELRKTHGNTFKIDIEELRKKDPAELSKEEKAKLRLTDDVILNEWSQKIANFFDIDDKHRQRF
NNLFSMAQLHTVIDTPRSGFSSTCKRCTAENRFRSETAFYNDETGEFHKKATATCQRLPADTQR
PFSGKIERYIDKLGYELAKIKAKELEGMEAKEIKVPIILEQNAFEYEESLRKSKTGSNDRVINS
KKDRDGKKLAKAKENAEDRLKDKDKRIKAFSSGICPYCGDTIGDDGEIDHILPRSHTLKIYGTV
FNPEGNLIYVHQKCNQAKADSIYKLSDIKAGVSAQWIEEQVANIKGYKTFSVLSAEQQKAFRYA
LFLQNDNEAYKKVVDWLRTDQSARVNGTQKYLAKKIQEKLTKMLPNKHLSFEFILADATEVSEL
RRQYARQNPLLAKAEKQAPSSHAIDAVMAFVARYQKVFKDGTPPNADEVAKLAMLDSWNPASNE
PLTKGLSTNQKIEKMIKSGDYGQKNMREVFGKSIFGENAIGERYKPIVVQEGGYYIGYPATVKK
GYELKNCKVVTSKNDIAKLEKIIKNQDLISLKENQYIKIFSINKQTISELSNRYFNMNYKNLVE
RDKEIVGLLEFIVENCRYYTKKVDVKFAPKYIHETKYPFYDDWRRFDEAWRYLQENQNKTSSKD
RFVIDKSSLNEYYQPDKNEYKLDVDTQPIWDDFCRWYFLDRYKTANDKKSIRIKARKTFSLLAE
SGVQGKVFRAKRKIPTGYAYQALPMDNNVIAGDYANILLEANSKTLSLVPKSGISIEKQLDKKL
DVIKKTDVRGLAIDNNSFFNADFDTHGIRLIVENTSVKVGNFPISAIDKSAKRMIFRALFEKEK
GKRKKKTTISFKESGPVQDYLKVFLKKIVKIQLRTDGSISNIVVRKNAADFTLSFRSEHIQKLL
K
SEQ ID NO: 341
MAYRLGLDIGITSVGWAVVALEKDESGLKPVRIQDLGVRIFDKAEDSKTGASLALPRREARSAR
RRTRRRRHRLWRVKRLLEQHGILSMEQIEALYAQRTSSPDVYALRVAGLDRCLIAEEIARVLIH
IAHRRGFQSNRKSEIKDSDAGKLLKAVQENENLMQSKGYRTVAEMLVSEATKTDAEGKLVHGKK
HGYVSNVRNKAGEYRHTVSRQAIVDEVRKIFAAQRALGNDVMSEELEDSYLKILCSQRNFDDGP
GGDSPYGHGSVSPDGVRQSIYERMVGSCTFETGEKRAPRSSYSFERFQLLTKVVNLRIYRQQED
GGRYPCELTQTERARVIDCAYEQTKITYGKLRKLLDMKDTESFAGLTYGLNRSRNKTEDTVFVE
MKFYHEVRKALQRAGVFIQDLSIETLDQIGWILSVWKSDDNRRKKLSTLGLSDNVIEELLPLNG
SKFGHLSLKAIRKILPFLEDGYSYDVACELAGYQFQGKTEYVKQRLLPPLGEGEVTNPVVRRAL
SQAIKVVNAVIRKHGSPESIHIELARELSKNLDERRKIEKAQKENQKNNEQIKDEIREILGSAH
VTGRDIVKYKLFKQQQEFCMYSGEKLDVTRLFEPGYAEVDHIIPYGISFDDSYDNKVLVKTEQN
RQKGNRTPLEYLRDKPEQKAKFIALVESIPLSQKKKNHLLMDKRAIDLEQEGFRERNLSDTRYI
TRALMNHIQAWLLFDETASTRSKRVVCVNGAVTAYMRARWGLTKDRDAGDKHHAADAVVVACIG
DSLIQRVTKYDKFKRNALADRNRYVQQVSKSEGITQYVDKETGEVFTWESFDERKFLPNEPLEP
WPFFRDELLARLSDDPSKNIRAIGLLTYSETEQIDPIFVSRMPTRKVTGAAHKETIRSPRIVKV
DDNKGTEIQVVVSKVALTELKLTKDGEIKDYFRPEDDPRLYNTLRERLVQFGGDAKAAFKEPVY
KISKDGSVRTPVRKVKIQEKLTLGVPVHGGRGIAENGGMVRIDVFAKGGKYYFVPIYVADVLKR
ELPNRLATAHKPYSEWRVVDDSYQFKFSLYPNDAVMIKPSREVDITYKDRKEPVGCRIMYFVSA
NIASASISLRTHDNSGELEGLGIQGLEVFEKYVVGPLGDTHPVYKERRMPFRVERKMN
SEQ ID NO: 342
MPVLSPLSPNAAQGRRRWSLALDIGEGSIGWAVAEVDAEGRVLQLTGTGVTLFPSAWSNENGTY
VAHGAADRAVRGQQQRHDSRRRRLAGLARLCAPVLERSPEDLKDLTRTPPKADPRAIFFLRADA
ARRPLDGPELFRVLHHMAAHRGIRLAELQEVDPPPESDADDAAPAATEDEDGTRRAAADERAFR
RLMAEHMHRHGTQPTCGEIMAGRLRETPAGAQPVTRARDGLRVGGGVAVPTRALIEQEFDAIRA
IQAPRHPDLPWDSLRRLVLDQAPIAVPPATPCLFLEELRRRGETFQGRTITREAIDRGLTVDPL
IQALRIRETVGNLRLHERITEPDGRQRYVPRAMPELGLSHGELTAPERDTLVRALMHDPDGLAA
KDGRIPYTRLRKLIGYDNSPVCFAQERDTSGGGITVNPTDPLMARWIDGWVDLPLKARSLYVRD
VVARGADSAALARLLAEGAHGVPPVAAAAVPAATAAILESDIMQPGRYSVCPWAAEAILDAWAN
APTEGFYDVTRGLFGFAPGEIVLEDLRRARGALLAHLPRTMAAARTPNRAAQQRGPLPAYESVI
PSQLITSLRRAHKGRAADWSAADPEERNPFLRTWTGNAATDHILNQVRKTANEVITKYGNRRGW
DPLPSRITVELAREAKHGVIRRNEIAKENRENEGRRKKESAALDTFCQDNTVSWQAGGLPKERA
ALRLRLAQRQEFFCPYCAERPKLRATDLFSPAETEIDHVIERRMGGDGPDNLVLAHKDCNNAKG
KKTPHEHAGDLLDSPALAALWQGWRKENADRLKGKGHKARTPREDKDFMDRVGWRFEEDARAKA
EENQERRGRRMLHDTARATRLARLYLAAAVMPEDPAEIGAPPVETPPSPEDPTGYTAIYRTISR
VQPVNGSVTHMLRQRLLQRDKNRDYQTHHAEDACLLLLAGPAVVQAFNTEAAQHGADAPDDRPV
DLMPTSDAYHQQRRARALGRVPLATVDAALADIVMPESDRQDPETGRVHWRLTRAGRGLKRRID
DLTRNCVILSRPRRPSETGTPGALHNATHYGRREITVDGRTDTVVTQRMNARDLVALLDNAKIV
PAARLDAAAPGDTILKEICTEIADRHDRVVDPEGTHARRWISARLAALVPAHAEAVARDIAELA
DLDALADADRTPEQEARRSALRQSPYLGRAISAKKADGRARAREQEILTRALLDPHWGPRGLRH
LIMREARAPSLVRIRANKTDAFGRPVPDAAVWVKTDGNAVSQLWRLTSVVTDDGRRIPLPKPIE
KRIEISNLEYARLNGLDEGAGVTGNNAPPRPLRQDIDRLTPLWRDHGTAPGGYLGTAVGELEDK
ARSALRGKAMRQTLTDAGITAEAGWRLDSEGAVCDLEVAKGDTVKKDGKTYKVGVITQGIFGMP
VDAAGSAPRTPEDCEKFEEQYGIKPWKAKGIPLA
SEQ ID NO: 343
MNYTEKEKLFMKYILALDIGIASVGWAILDKESETVIEAGSNIFPEASAADNQLRRDMRGAKRN
NRRLKTRINDFIKLWENNNLSIPQFKSTEIVGLKVRAITEEITLDELYLILYSYLKHRGISYLE
DALDDTVSGSSAYANGLKLNAKELETHYPCEIQQERLNTIGKYRGQSQIINENGEVLDLSNVFT
IGAYRKEIQRVFEIQKKYHPELTDEFCDGYMLIFNRKRKYYEGPGNEKSRTDYGRFTTKLDANG
NYITEDNIFEKLIGKCSVYPDELRAAAASYTAQEYNVLNDLNNLTINGRKLEENEKHEIVERIK
SSNTINMRKIISDCMGENIDDFAGARIDKSGKEIFHKFEVYNKMRKALLEIGIDISNYSREELD
EIGYIMTINTDKEAMMEAFQKSWIDLSDDVKQCLINMRKTNGALFNKWQSFSLKIMNELIPEMY
AQPKEQMTLLTEMGVTKGTQEEFAGLKYIPVDVVSEDIFNPVVRRSVRISFKILNAVLKKYKAL
DTIVIEMPRDRNSEEQKKRINDSQKLNEKEMEYIEKKLAVTYGIKLSPSDFSSQKQLSLKLKLW
NEQDGICLYSGKTIDPNDIINNPQLFEIDHIIPRSISFDDARSNKVLVYRSENQKKGNQTPYYY
LTHSHSEWSFEQYKATVMNLSKKKEYAISRKKIQNLLYSEDITKMDVLKGFINRNINDTSYASR
LVLNTIQNFFMANEADTKVKVIKGSYTHQMRCNLKLDKNRDESYSHHAVDAMLIGYSELGYEAY
HKLQGEFIDFETGEILRKDMWDENMSDEVYADYLYGKKWANIRNEVVKAEKNVKYWHYVMRKSN
RGLCNQTIRGTREYDGKQYKINKLDIRTKEGIKVFAKLAFSKKDSDRERLLVYLNDRRTFDDLC
KIYEDYSDAANPFVQYEKETGDIIRKYSKKHNGPRIDKLKYKDGEVGACIDISHKYGFEKGSKK
VILESLVPYRMDVYYKEENHSYYLVGVKQSDIKFEKGRNVIDEEAYARILVNEKMIQPGQSRAD
LENLGFKFKLSFYKNDIIEYEKDGKIYTERLVSRTMPKQRNYIETKPIDKAKFEKQNLVGLGKT
KFIKKYRYDILGNKYSCSEEKFTSFC
SEQ ID NO: 344
MLRLYCANNLVLNNVQNLWKYLLLLIFDKKIIFLFKIKVILIRRYMENNNKEKIVIGFDLGVAS
VGWSIVNAETKEVIDLGVRLFSEPEKADYRRAKRTTRRLLRRKKFKREKFHKLILKNAEIFGLQ
SRNEILNVYKDQSSKYRNILKLKINALKEEIKPSELVWILRDYLQNRGYFYKNEKLTDEFVSNS
FPSKKLHEHYEKYGFFRGSVKLDNKLDNKKDKAKEKDEEEESDAKKESEELIFSNKQWINEIVK
VFENQSYLTESFKEEYLKLFNYVRPFNKGPGSKNSRTAYGVFSTDIDPETNKFKDYSNIWDKTI
GKCSLFEEEIRAPKNLPSALIFNLQNEICTIKNEFTEFKNWWLNAEQKSEILKFVFTELFNWKD
KKYSDKKFNKNLQDKIKKYLLNFALENFNLNEEILKNRDLENDTVLGLKGVKYYEKSNATADAA
LEFSSLKPLYVFIKFLKEKKLDLNYLLGLENTEILYFLDSIYLAISYSSDLKERNEWFKKLLKE
LYPKIKNNNLEIIENVEDIFEITDQEKFESFSKTHSLSREAFNHIIPLLLSNNEGKNYESLKHS
NEELKKRTEKAELKAQQNQKYLKDNFLKEALVPLSVKTSVLQAIKIFNQIIKNFGKKYEISQVV
IEMARELTKPNLEKLLNNATNSNIKILKEKLDQTEKFDDFTKKKFIDKIENSVVFRNKLFLWFE
QDRKDPYTQLDIKINEIEDETEIDHVIPYSKSADDSWFNKLLVKKSTNQLKKNKTVWEYYQNES
DPEAKWNKFVAWAKRIYLVQKSDKESKDNSEKNSIFKNKKPNLKFKNITKKLFDPYKDLGFLAR
NLNDTRYATKVFRDQLNNYSKHHSKDDENKLFKVVCMNGSITSFLRKSMWRKNEEQVYRFNFWK
KDRDQFFHHAVDASIIAIFSLLTKTLYNKLRVYESYDVQRREDGVYLINKETGEVKKADKDYWK
DQHNFLKIRENAIEIKNVLNNVDFQNQVRYSRKANTKLNTQLFNETLYGVKEFENNFYKLEKVN
LFSRKDLRKFILEDLNEESEKNKKNENGSRKRILTEKYIVDEILQILENEEFKDSKSDINALNK
YMDSLPSKFSEFFSQDFINKCKKENSLILTFDAIKHNDPKKVIKIKNLKFFREDATLKNKQAVH
KDSKNQIKSFYESYKCVGFIWLKNKNDLEESIFVPINSRVIHFGDKDKDIFDFDSYNKEKLLNE
INLKRPENKKFNSINEIEFVKFVKPGALLLNFENQQIYYISTLESSSLRAKIKLLNKMDKGKAV
SMKKITNPDEYKIIEHVNPLGINLNWTKKLENNN
SEQ ID NO: 345
MLMSKHVLGLDLGVGSIGWCLIALDAQGDPAEILGMGSRVVPLNNATKAIEAFNAGAAFTASQE
RTARRTMRRGFARYQLRRYRLRRELEKVGMLPDAALIQLPLLELWELRERAATAGRRLTLPELG
RVLCHINQKRGYRHVKSDAAAIVGDEGEKKKDSNSAYLAGIRANDEKLQAEHKTVGQYFAEQLR
QNQSESPTGGISYRIKDQIFSRQCYIDEYDQIMAVQRVHYPDILTDEFIRMLRDEVIFMQRPLK
SCKHLVSLCEFEKQERVMRVQQDDGKGGWQLVERRVKFGPKVAPKSSPLFQLCCIYEAVNNIRL
TRPNGSPCDITPEERAKIVAHLQSSASLSFAALKKLLKEKALIADQLTSKSGLKGNSTRVALAS
ALQPYPQYHHLLDMELETRMMTVQLTDEETGEVTEREVAVVTDSYVRKPLYRLWHILYSIEERE
AMRRALITQLGMKEEDLDGGLLDQLYRLDFVKPGYGNKSAKFICKLLPQLQQGLGYSEACAAVG
YRHSNSPTSEEITERTLLEKIPLLQRNELRQPLVEKILNQMINLVNALKAEYGIDEVRVELARE
LKMSREERERMARNNKDREERNKGVAAKIRECGLYPTKPRIQKYMLWKEAGRQCLYCGRSIEEE
QCLREGGMEVEHIIPKSVLYDDSYGNKTCACRRCNKEKGNRTALEYIRAKGREAEYMKRINDLL
KEKKISYSKHQRLRWLKEDIPSDFLERQLRLTQYISRQAMAILQQGIRRVSASEGGVTARLRSL
WGYGKILHTLNLDRYDSMGETERVSREGEATEELHITNWSKRMDHRHHAIDALVVACTRQSYIQ
RLNRLSSEFGREDKKKEDQEAQEQQATETGRLSNLERWLTQRPHFSVRTVSDKVAEILISYRPG
QRVVTRGRNIYRKKMADGREVSCVQRGVLVPRGELMEASFYGKILSQGRVRIVKRYPLHDLKGE
VVDPHLRELITTYNQELKSREKGAPIPPLCLDKDKKQEVRSVRCYAKTLSLDKAIPMCFDEKGE
PTAFVKSASNHHLALYRTPKGKLVESIVTFWDAVDRARYGIPLVITHPREVMEQVLQRGDIPEQ
VLSLLPPSDWVFVDSLQQDEMVVIGLSDEELQRALEAQNYRKISEHLYRVQKMSSSYYVFRYHL
ETSVADDKNTSGRIPKFHRVQSLKAYEERNIRKVRVDLLGRISLL
SEQ ID NO: 346
MSDLVLGLDIGIGSVGVGILNKVTGEIIHKNSRIFPAAQAENNLVRRTNRQGRRLARRKKHRRV
RLNRLFEESGLITDFTKISINLNPYQLRVKGLTDELSNEELFIALKNMVKHRGISYLDDASDDG
NSSVGDYAQIVKENSKQLETKTPGQIQLERYQTYGQLRGDFTVEKDGKKHRLINVFPTSAYRSE
ALRILQTQQEFNPQITDEFINRYLEILTGKRKYYHGPGNEKSRTDYGRYRTSGETLDNIFGILI
GKCTFYPDEFRAAKASYTAQEFNLLNDLNNLTVPTETKKLSKEQKNQIINYVKNEKAMGPAKLF
KYIAKLLSCDVADIKGYRIDKSGKAEIHTFEAYRKMKTLETLDIEQMDRETLDKLAYVLTLNTE
REGIQEALEHEFADGSFSQKQVDELVQFRKANSSIFGKGWHNFSVKLMMELIPELYETSEEQMT
ILTRLGKQKTTSSSNKTKYIDEKLLTEEIYNPVVAKSVRQAIKIVNAAIKEYGDFDNIVIEMAR
ETNEDDEKKAIQKIQKANKDEKDAAMLKAANQYNGKAELPHSVFHGHKQLATKIRLWHQQGERC
LYTGKTISIHDLINNSNQFEVDHILPLSITFDDSLANKVLVYATANQEKGQRTPYQALDSMDDA
WSFRELKAFVRESKTLSNKKKEYLLTEEDISKFDVRKKFIERNLVDTRYASRVVLNALQEHFRA
HKIDTKVSVVRGQFTSQLRRHWGIEKTRDTYHHHAVDALIIAASSQLNLWKKQKNTLVSYSEDQ
LLDIETGELISDDEYKESVFKAPYQHFVDTLKSKEFEDSILFSYQVDSKFNRKISDATIYATRQ
AKVGKDKADETYVLGKIKDIYTQDGYDAFMKIYKKDKSKFLMYRHDPQTFEKVIEPILENYPNK
QINEKGKEVPCNPFLKYKEEHGYIRKYSKKGNGPEIKSLKYYDSKLGNHIDITPKDSNNKVVLQ
SVSPWRADVYFNKTTGKYEILGLKYADLQFEKGTGTYKISQEKYNDIKKKEGVDSDSEFKFTLY
KNDLLLVKDTETKEQQLFRFLSRTMPKQKHYVELKPYDKQKFEGGEALIKVLGNVANSGQCKKG
LGKSNISIYKVRTDVLGNQHIIKNEGDKPKLDF
SEQ ID NO: 347
MNAEHGKEGLLIMEENFQYRIGLDIGITSVGWAVLQNNSQDEPVRITDLGVRIFDVAENPKNGD
ALAAPRRDARTTRRRLRRRRHRLERIKFLLQENGLIEMDSFMERYYKGNLPDVYQLRYEGLDRK
LKDEELAQVLIHIAKHRGFRSTRKAETKEKEGGAVLKATTENQKIMQEKGYRTVGEMLYLDEAF
HTECLWNEKGYVLTPRNRPDDYKHTILRSMLVEEVHAIFAAQRAHGNQKATEGLEEAYVEIMTS
QRSFDMGPGLQPDGKPSPYAMEGFGDRVGKCTFEKDEYRAPKATYTAELFVALQKINHTKLIDE
FGTGRFFSEEERKTIIGLLLSSKELKYGTIRKKLNIDPSLKFNSLNYSAKKEGETEEERVLDTE
KAKFASMFWTYEYSKCLKDRTEEMPVGEKADLFDRIGEILTAYKNDDSRSSRLKELGLSGEEID
GLLDLSPAKYQRVSLKAMRKMQPYLEDGLIYDKACEAAGYDFRALNDGNKKHLLKGEEINAIVN
DITNPVVKRSVSQTIKVINAIIQKYGSPQAVNIELAREMSKNFQDRTNLEKEMKKRQQENERAK
QQIIELGKQNPTGQDILKYRLWNDQGGYCLYSGKKIPLEELFDGGYDIDHILPYSITFDDSYRN
KVLVTAQENRQKGNRTPYEYFGADEKRWEDYEASVRLLVRDYKKQQKLLKKNFTEEERKEFKER
NLNDTKYITRVVYNMIRQNLELEPFNHPEKKKQVWAVNGAVTSYLRKRWGLMQKDRSTDRHHAM
DAVVIACCTDGMIHKISRYMQGRELAYSRNFKFPDEETGEILNRDNFTREQWDEKFGVKVPLPW
NSFRDELDIRLLNEDPKNFLLTHADVQRELDYPGWMYGEEESPIEEGRYINYIRPLFVSRMPNH
KVTGSAHDATIRSARDYETRGVVITKVPLTDLKLNKDNEIEGYYDKDSDRLLYQALVRQLLLHG
NDGKKAFAEDFHKPKADGTEGPVVRKVKIEKKQTSGVMVRGGTGIAANGEMVRIDVFRENGKYY
FVPVYTADVVRKVLPNRAATHTKPYSEWRVMDDANFVFSLYSRDLIHVKSKKDIKTNLVNGGLL
LQKEIFAYYTGADIATASIAGFANDSNFKFRGLGIQSLEIFEKCQVDILGNISVVRHENRQEFH
SEQ ID NO: 348
MRVLGLDAGIASLGWALIEIEESNRGELSQGTIIGAGTWMFDAPEEKTQAGAKLKSEQRRTFRG
QRRVVRRRRQRMNEVRRILHSHGLLPSSDRDALKQPGLDPWRIRAEALDRLLGPVELAVALGHI
ARHRGFKSNSKGAKTNDPADDTSKMKRAVNETREKLARFGSAAKMLVEDESFVLRQTPTKNGAS
EIVRRFRNREGDYSRSLLRDDLAAEMRALFTAQARFQSAIATADLQTAFTKAAFFQRPLQDSEK
LVGPCPFEVDEKRAPKRGYSFELFRFLSRLNHVTLRDGKQERTLTRDELALAAADFGAAAKVSF
TALRKKLKLPETTVFVGVKADEESKLDVVARSGKAAEGTARLRSVIVDALGELAWGALLCSPEK
LDKIAEVISFRSDIGRISEGLAQAGCNAPLVDALTAAASDGRFDPFTGAGHISSKAARNILSGL
RQGMTYDKACCAADYDHTASRERGAFDVGGHGREALKRILQEERISRELVGSPTARKALIESIK
QVKAIVERYGVPDRIHVELARDVGKSIEEREEITRGIEKRNRQKDKLRGLFEKEVGRPPQDGAR
GKEELLRFELWSEQMGRCLYTDDYISPSQLVATDDAVQVDHILPWSRFADDSYANKTLCMAKAN
QDKKGRTPYEWFKAEKTDTEWDAFIVRVEALADMKGFKKRNYKLRNAEEAAAKFRNRNLNDTRW
ACRLLAEALKQLYPKGEKDKDGKERRRVFSRPGALTDRLRRAWGLQWMKKSTKGDRIPDDRHHA
LDAIVIAATTESLLQRATREVQEIEDKGLHYDLVKNVTPPWPGFREQAVEAVEKVFVARAERRR
ARGKAHDATIRHIAVREGEQRVYERRKVAELKLADLDRVKDAERNARLIEKLRNWIEAGSPKDD
PPLSPKGDPIFKVRLVTKSKVNIALDTGNPKRPGTVDRGEMARVDVFRKASKKGKYEYYLVPIY
PHDIATMKTPPIRAVQAYKPEDEWPEMDSSYEFCWSLVPMTYLQVISSKGEIFEGYYRGMNRSV
GAIQLSAHSNSSDVVQGIGARTLTEFKKFNVDRFGRKHEVERELRTWRGETWRGKAYI
SEQ ID NO: 349
MGNYYLGLDVGIGSIGWAVINIEKKRIEDFNVRIFKSGEIQEKNRNSRASQQCRRSRGLRRLYR
RKSHRKLRLKNYLSIIGLTTSEKIDYYYETADNNVIQLRNKGLSEKLTPEEIAACLIHICNNRG
YKDFYEVNVEDIEDPDERNEYKEEHDSIVLISNLMNEGGYCTPAEMICNCREFDEPNSVYRKFH
NSAASKNHYLITRHMLVKEVDLILENQSKYYGILDDKTIAKIKDIIFAQRDFEIGPGKNERFRR
FTGYLDSIGKCQFFKDQERGSRFTVIADIYAFVNVLSQYTYTNNRGESVFDTSFANDLINSALK
NGSMDKRELKAIAKSYHIDISDKNSDTSLTKCFKYIKVVKPLFEKYGYDWDKLIENYTDTDNNV
LNRIGIVLSQAQTPKRRREKLKALNIGLDDGLINELTKLKLSGTANVSYKYMQGSIEAFCEGDL
YGKYQAKFNKEIPDIDENAKPQKLPPFKNEDDCEFFKNPVVFRSINETRKLINAIIDKYGYPAA
VNIETADELNKTFEDRAIDTKRNNDNQKENDRIVKEIIECIKCDEVHARHLIEKYKLWEAQEGK
CLYSGETITKEDMLRDKDKLFEVDHIVPYSLILDNTINNKALVYAEENQKKGQRTPLMYMNEAQ
AADYRVRVNTMFKSKKCSKKKYQYLMLPDLNDQELLGGWRSRNLNDTRYICKYLVNYLRKNLRF
DRSYESSDEDDLKIRDHYRVFPVKSRFTSMFRRWWLNEKTWGRYDKAELKKLTYLDHAADAIII
ANCRPEYVVLAGEKLKLNKMYHQAGKRITPEYEQSKKACIDNLYKLFRMDRRTAEKLLSGHGRL
TPIIPNLSEEVDKRLWDKNIYEQFWKDDKDKKSCEELYRENVASLYKGDPKFASSLSMPVISLK
PDHKYRGTITGEEAIRVKEIDGKLIKLKRKSISEITAESINSIYTDDKILIDSLKTIFEQADYK
DVGDYLKKTNQHFFTTSSGKRVNKVTVIEKVPSRWLRKEIDDNNFSLLNDSSYYCIELYKDSKG
DNNLQGIAMSDIVHDRKTKKLYLKPDFNYPDDYYTHVMYIFPGDYLRIKSTSKKSGEQLKFEGY
FISVKNVNENSFRFISDNKPCAKDKRVSITKKDIVIKLAVDLMGKVQGENNGKGISCGEPLSLL
KEKN
SEQ ID NO: 350
MLSRQLLGASHLARPVSYSYNVQDNDVHCSYGERCFMRGKRYRIGIDVGLNSVGLAAVEVSDEN
SPVRLLNAQSVIHDGGVDPQKNKEAITRKNMSGVARRTRRMRRRKRERLHKLDMLLGKFGYPVI
EPESLDKPFEEWHVRAELATRYIEDDELRRESISIALRHMARHRGWRNPYRQVDSLISDNPYSK
QYGELKEKAKAYNDDATAAEEESTPAQLVVAMLDAGYAEAPRLRWRTGSKKPDAEGYLPVRLMQ
EDNANELKQIFRVQRVPADEWKPLFRSVFYAVSPKGSAEQRVGQDPLAPEQARALKASLAFQEY
RIANVITNLRIKDASAELRKLTVDEKQSIYDQLVSPSSEDITWSDLCDFLGFKRSQLKGVGSLT
EDGEERISSRPPRLTSVQRIYESDNKIRKPLVAWWKSASDNEHEAMIRLLSNTVDIDKVREDVA
YASAIEFIDGLDDDALTKLDSVDLPSGRAAYSVETLQKLTRQMLTTDDDLHEARKTLFNVTDSW
RPPADPIGEPLGNPSVDRVLKNVNRYLMNCQQRWGNPVSVNIEHVRSSFSSVAFARKDKREYEK
NNEKRSIFRSSLSEQLRADEQMEKVRESDLRRLEAIQRQNGQCLYCGRTITFRTCEMDHIVPRK
GVGSTNTRTNFAAVCAECNRMKSNTPFAIWARSEDAQTRGVSLAEAKKRVTMFTFNPKSYAPRE
VKAFKQAVIARLQQTEDDAAIDNRSIESVAWMADELHRRIDWYFNAKQYVNSASIDDAEAETMK
TTVSVFQGRVTASARRAAGIEGKIHFIGQQSKTRLDRRHHAVDASVIAMMNTAAAQTLMERESL
RESQRLIGLMPGERSWKEYPYEGTSRYESFHLWLDNMDVLLELLNDALDNDRIAVMQSQRYVLG
NSIAHDATIHPLEKVPLGSAMSADLIRRASTPALWCALTRLPDYDEKEGLPEDSHREIRVHDTR
YSADDEMGFFASQAAQIAVQEGSADIGSAIHHARVYRCWKTNAKGVRKYFYGMIRVFQTDLLRA
CHDDLFTVPLPPQSISMRYGEPRVVQALQSGNAQYLGSLVVGDEIEMDFSSLDVDGQIGEYLQF
FSQFSGGNLAWKHWVVDGFFNQTQLRIRPRYLAAEGLAKAFSDDVVPDGVQKIVTKQGWLPPVN
TASKTAVRIVRRNAFGEPRLSSAHHMPCSWQWRHE
SEQ ID NO: 351
MYSIGLDLGISSVGWSVIDERTGNVIDLGVRLFSAKNSEKNLERRTNRGGRRLIRRKTNRLKDA
KKILAAVGFYEDKSLKNSCPYQLRVKGLTEPLSRGEIYKVTLHILKKRGISYLDEVDTEAAKES
QDYKEQVRKNAQLLTKYTPGQIQLQRLKENNRVKTGINAQGNYQLNVFKVSAYANELATILKTQ
QAFYPNELTDDWIALFVQPGIAEEAGLIYRKRPYYHGPGNEANNSPYGRWSDFQKTGEPATNIF
DKLIGKDFQGELRASGLSLSAQQYNLLNDLTNLKIDGEVPLSSEQKEYILTELMTKEFTRFGVN
DVVKLLGVKKERLSGWRLDKKGKPEIHTLKGYRNWRKIFAEAGIDLATLPTETIDCLAKVLTLN
TEREGIENTLAFELPELSESVKLLVLDRYKELSQSISTQSWHRFSLKTLHLLIPELMNATSEQN
TLLEQFQLKSDVRKRYSEYKKLPTKDVLAEIYNPTVNKTVSQAFKVIDALLVKYGKEQIRYITI
EMPRDDNEEDEKKRIKELHAKNSQRKNDSQSYFMQKSGWSQEKFQTTIQKNRRFLAKLLYYYEQ
DGICAYTGLPISPELLVSDSTEIDHIIPISISLDDSINNKVLVLSKANQVKGQQTPYDAWMDGS
FKKINGKFSNWDDYQKWVESRHFSHKKENNLLETRNIFDSEQVEKFLARNLNDTRYASRLVLNT
LQSFFTNQETKVRVVNGSFTHTLRKKWGADLDKTRETHHHHAVDATLCAVTSFVKVSRYHYAVK
EETGEKVMREIDFETGEIVNEMSYWEFKKSKKYERKTYQVKWPNFREQLKPVNLHPRIKFSHQV
DRKANRKLSDATIYSVREKTEVKTLKSGKQKITTDEYTIGKIKDIYTLDGWEAFKKKQDKLLMK
DLDEKTYERLLSIAETTPDFQEVEEKNGKVKRVKRSPFAVYCEENDIPAIQKYAKKNNGPLIRS
LKYYDGKLNKHINITKDSQGRPVEKTKNGRKVTLQSLKPYRYDIYQDLETKAYYTVQLYYSDLR
FVEGKYGITEKEYMKKVAEQTKGQVVRFCFSLQKNDGLEIEWKDSQRYDVRFYNFQSANSINFK
GLEQEMMPAENQFKQKPYNNGAINLNIAKYGKEGKKLRKFNTDILGKKHYLFYEKEPKNIIK
SEQ ID NO: 352
MYFYKNKENKLNKKVVLGLDLGIASVGWCLTDISQKEDNKFPIILHGVRLFETVDDSDDKLLNE
TRRKKRGQRRRNRRLFTRKRDFIKYLIDNNIIELEFDKNPKILVRNFIEKYINPFSKNLELKYK
SVTNLPIGFHNLRKAAINEKYKLDKSELIVLLYFYLSLRGAFFDNPEDTKSKEMNKNEIEIFDK
NESIKNAEFPIDKIIEFYKISGKIRSTINLKFGHQDYLKEIKQVFEKQNIDFMNYEKFAMEEKS
FFSRIRNYSEGPGNEKSFSKYGLYANENGNPELIINEKGQKIYTKIFKTLWESKIGKCSYDKKL
YRAPKNSFSAKVFDITNKLTDWKHKNEYISERLKRKILLSRFLNKDSKSAVEKILKEENIKFEN
LSEIAYNKDDNKINLPIINAYHSLTTIFKKHLINFENYLISNENDLSKLMSFYKQQSEKLFVPN
EKGSYEINQNNNVLHIFDAISNILNKFSTIQDRIRILEGYFEFSNLKKDVKSSEIYSEIAKLRE
FSGTSSLSFGAYYKFIPNLISEGSKNYSTISYEEKALQNQKNNFSHSNLFEKTWVEDLIASPTV
KRSLRQTMNLLKEIFKYSEKNNLEIEKIVVEVTRSSNNKHERKKIEGINKYRKEKYEELKKVYD
LPNENTTLLKKLWLLRQQQGYDAYSLRKIEANDVINKPWNYDIDHIVPRSISFDDSFSNLVIVN
KLDNAKKSNDLSAKQFIEKIYGIEKLKEAKENWGNWYLRNANGKAFNDKGKFIKLYTIDNLDEF
DNSDFINRNLSDTSYITNALVNHLTFSNSKYKYSVVSVNGKQTSNLRNQIAFVGIKNNKETERE
WKRPEGFKSINSNDFLIREEGKNDVKDDVLIKDRSFNGHHAEDAYFITIISQYFRSFKRIERLN
VNYRKETRELDDLEKNNIKFKEKASFDNFLLINALDELNEKLNQMRFSRMVITKKNTQLFNETL
YSGKYDKGKNTIKKVEKLNLLDNRTDKIKKIEEFFDEDKLKENELTKLHIFNHDKNLYETLKII
WNEVKIEIKNKNLNEKNYFKYFVNKKLQEGKISFNEWVPILDNDFKIIRKIRYIKFSSEEKETD
EIIFSQSNFLKIDQRQNFSFHNTLYWVQIWVYKNQKDQYCFISIDARNSKFEKDEIKINYEKLK
TQKEKLQIINEEPILKINKGDLFENEEKELFYIVGRDEKPQKLEIKYILGKKIKDQKQIQKPVK
KYFPNWKKVNLTYMGEIFKK
SEQ ID NO: 353
MDNKNYRIGIDVGLNSIGFCAVEVDQHDTPLGFLNLSVYRHDAGIDPNGKKTNTTRLAMSGVAR
RTRRLFRKRKRRLAALDRFIEAQGWTLPDHADYKDPYTPWLVRAELAQTPIRDENDLHEKLAIA
VRHIARHRGWRSPWVPVRSLHVEQPPSDQYLALKERVEAKTLLQMPEGATPAEMVVALDLSVDV
NLRPKNREKTDTRPENKKPGFLGGKLMQSDNANELRKIAKIQGLDDALLRELIELVFAADSPKG
ASGELVGYDVLPGQHGKRRAEKAHPAFQRYRIASIVSNLRIRHLGSGADERLDVETQKRVFEYL
LNAKPTADITWSDVAEEIGVERNLLMGTATQTADGERASAKPPVDVTNVAFATCKIKPLKEWWL
NADYEARCVMVSALSHAEKLTEGTAAEVEVAEFLQNLSDEDNEKLDSFSLPIGRAAYSVDSLER
LTKRMIENGEDLFEARVNEFGVSEDWRPPAEPIGARVGNPAVDRVLKAVNRYLMAAEAEWGAPL
SVNIEHVREGFISKRQAVEIDRENQKRYQRNQAVRSQIADHINATSGVRGSDVTRYLAIQRQNG
ECLYCGTAITFVNSEMDHIVPRAGLGSTNTRDNLVATCERCNKSKSNKPFAVWAAECGIPGVSV
AEALKRVDFWIADGFASSKEHRELQKGVKDRLKRKVSDPEIDNRSMESVAWMARELAHRVQYYF
DEKHTGTKVRVFRGSLTSAARKASGFESRVNFIGGNGKTRLDRRHHAMDAATVAMLRNSVAKTL
VLRGNIRASERAIGAAETWKSFRGENVADRQIFESWSENMRVLVEKFNLALYNDEVSIFSSLRL
QLGNGKAHDDTITKLQMHKVGDAWSLTEIDRASTPALWCALTRQPDFTWKDGLPANEDRTIIVN
GTHYGPLDKVGIFGKAAASLLVRGGSVDIGSAIHHARIYRIAGKKPTYGMVRVFAPDLLRYRNE
DLFNVELPPQSVSMRYAEPKVREAIREGKAEYLGWLVVGDELLLDLSSETSGQIAELQQDFPGT
THWTVAGFFSPSRLRLRPVYLAQEGLGEDVSEGSKSIIAGQGWRPAVNKVFGSAMPEVIRRDGL
GRKRRFSYSGLPVSWQG
SEQ ID NO: 354
MRLGLDIGTSSIGWWLYETDGAGSDARITGVVDGGVRIFSDGRDPKSGASLAVDRRAARAMRRR
RDRYLRRRATLMKVLAETGLMPADPAEAKALEALDPFALRAAGLDEPLPLPHLGRALFHLNQRR
GFKSNRKTDRGDNESGKIKDATARLDMEMMANGARTYGEFLHKRRQKATDPRHVPSVRTRLSIA
NRGGPDGKEEAGYDFYPDRRHLEEEFHKLWAAQGAHHPELTETLRDLLFEKIFFQRPLKEPEVG
LCLFSGHHGVPPKDPRLPKAHPLTQRRVLYETVNQLRVTADGREARPLTREERDQVIHALDNKK
PTKSLSSMVLKLPALAKVLKLRDGERFTLETGVRDAIACDPLRASPAHPDRFGPRWSILDADAQ
WEVISRIRRVQSDAEHAALVDWLTEAHGLDRAHAEATAHAPLPDGYGRLGLTATTRILYQLTAD
VVTYADAVKACGWHHSDGRTGECFDRLPYYGEVLERHVIPGSYHPDDDDITRFGRITNPTVHIG
LNQLRRLVNRIIETHGKPHQIVVELARDLKKSEEQKRADIKRIRDTTEAAKKRSEKLEELEIED
NGRNRMLLRLWEDLNPDDAMRRFCPYTGTRISAAMIFDGSCDVDHILPYSRTLDDSFPNRTLCL
REANRQKRNQTPWQAWGDTPHWHAIAANLKNLPENKRWRFAPDAMTRFEGENGFLDRALKDTQY
LARISRSYLDTLFTKGGHVWVVPGRFTEMLRRHWGLNSLLSDAGRGAVKAKNRTDHRHHAIDAA
VIAATDPGLLNRISRAAGQGEAAGQSAELIARDTPPPWEGFRDDLRVRLDRIIVSHRADHGRID
HAARKQGRDSTAGQLHQETAYSIVDDIHVASRTDLLSLKPAQLLDEPGRSGQVRDPQLRKALRV
ATGGKTGKDFENALRYFASKPGPYQAIRRVRIIKPLQAQARVPVPAQDPIKAYQGGSNHLFEIW
RLPDGEIEAQVITSFEAHTLEGEKRPHPAAKRLLRVHKGDMVALERDGRRVVGHVQKMDIANGL
FIVPHNEANADTRNNDKSDPFKWIQIGARPAIASGIRRVSVDEIGRLRDGGTRPI
SEQ ID NO: 355
MLHCIAVIRVPPSEEPGFFETHADSCALCHHGCMTYAANDKAIRYRVGIDVGLRSIGFCAVEVD
DEDHPIRILNSVVHVHDAGTGGPGETESLRKRSGVAARARRRGRAEKQRLKKLDVLLEELGWGV
SSNELLDSHAPWHIRKRLVSEYIEDETERRQCLSVAMAHIARHRGWRNSFSKVDTLLLEQAPSD
RMQGLKERVEDRTGLQFSEEVTQGELVATLLEHDGDVTIRGFVRKGGKATKVHGVLEGKYMQSD
LVAELRQICRTQRVSETTFEKLVLSIFHSKEPAPSAARQRERVGLDELQLALDPAAKQPRAERA
HPAFQKFKVVATLANMRIREQSAGERSLTSEELNRVARYLLNHTESESPTWDDVARKLEVPRHR
LRGSSRASLETGGGLTYPPVDDTTVRVMSAEVDWLADWWDCANDESRGHMIDAISNGCGSEPDD
VEDEEVNELISSATAEDMLKLELLAKKLPSGRVAYSLKTLREVTAAILETGDDLSQAITRLYGV
DPGWVPTPAPIEAPVGNPSVDRVLKQVARWLKFASKRWGVPQTVNIEHTREGLKSASLLEEERE
RWERFEARREIRQKEMYKRLGISGPFRRSDQVRYEILDLQDCACLYCGNEINFQTFEVDHIIPR
VDASSDSRRTNLAAVCHSCNSAKGGLAFGQWVKRGDCPSGVSLENAIKRVRSWSKDRLGLTEKA
MGKRKSEVISRLKTEMPYEEFDGRSMESVAWMAIELKKRIEGYFNSDRPEGCAAVQVNAYSGRL
TACARRAAHVDKRVRLIRLKGDDGHHKNRFDRRNHAMDALVIALMTPAIARTIAVREDRREAQQ
LTRAFESWKNFLGSEERMQDRWESWIGDVEYACDRLNELIDADKIPVTENLRLRNSGKLHADQP
ESLKKARRGSKRPRPQRYVLGDALPADVINRVTDPGLWTALVRAPGFDSQLGLPADLNRGLKLR
GKRISADFPIDYFPTDSPALAVQGGYVGLEFHHARLYRIIGPKEKVKYALLRVCAIDLCGIDCD
DLFEVELKPSSISMRTADAKLKEAMGNGSAKQIGWLVLGDEIQIDPTKFPKQSIGKFLKECGPV
SSWRVSALDTPSKITLKPRLLSNEPLLKTSRVGGHESDLVVAECVEKIMKKTGWVVEINALCQS
GLIRVIRRNALGEVRTSPKSGLPISLNLR
SEQ ID NO: 356
MRYRVGLDLGTASVGAAVFSMDEQGNPMELIWHYERLFSEPLVPDMGQLKPKKAARRLARQQRR
QIDRRASRLRRIAIVSRRLGIAPGRNDSGVHGNDVPTLRAMAVNERIELGQLRAVLLRMGKKRG
YGGTFKAVRKVGEAGEVASGASRLEEEMVALASVQNKDSVTVGEYLAARVEHGLPSKLKVAANN
EYYAPEYALFRQYLGLPAIKGRPDCLPNMYALRHQIEHEFERIWATQSQFHDVMKDHGVKEEIR
NAIFFQRPLKSPADKVGRCSLQTNLPRAPRAQIAAQNFRIEKQMADLRWGMGRRAEMLNDHQKA
VIRELLNQQKELSFRKIYKELERAGCPGPEGKGLNMDRAALGGRDDLSGNTTLAAWRKLGLEDR
WQELDEVTQIQVINFLADLGSPEQLDTDDWSCRFMGKNGRPRNFSDEFVAFMNELRMTDGFDRL
SKMGFEGGRSSYSIKALKALTEWMIAPHWRETPETHRVDEEAAIRECYPESLATPAQGGRQSKL
EPPPLTGNEVVDVALRQVRHTINMMIDDLGSVPAQIVVEMAREMKGGVTRRNDIEKQNKRFASE
RKKAAQSIEENGKTPTPARILRYQLWIEQGHQCPYCESNISLEQALSGAYTNFEHILPRTLTQI
GRKRSELVLAHRECNDEKGNRTPYQAFGHDDRRWRIVEQRANALPKKSSRKTRLLLLKDFEGEA
LTDESIDEFADRQLHESSWLAKVTTQWLSSLGSDVYVSRGSLTAELRRRWGLDTVIPQVRFESG
MPVVDEEGAEITPEEFEKFRLQWEGHRVTREMRTDRRPDKRIDHRHHLVDAIVTALTSRSLYQQ
YAKAWKVADEKQRHGRVDVKVELPMPILTIRDIALEAVRSVRISHKPDRYPDGRFFEATAYGIA
QRLDERSGEKVDWLVSRKSLTDLAPEKKSIDVDKVRANISRIVGEAIRLHISNIFEKRVSKGMT
PQQALREPIEFQGNILRKVRCFYSKADDCVRIEHSSRRGHHYKMLLNDGFAYMEVPCKEGILYG
VPNLVRPSEAVGIKRAPESGDFIRFYKGDTVKNIKTGRVYTIKQILGDGGGKLILTPVTETKPA
DLLSAKWGRLKVGGRNIHLLRLCAE
SEQ ID NO: 357
MIGEHVRGGCLFDDHWTPNWGAFRLPNTVRTFTKAENPKDGSSLAEPRRQARGLRRRLRRKTQR
LEDLRRLLAKEGVLSLSDLETLFRETPAKDPYQLRAEGLDRPLSFPEWVRVLYHITKHRGFQSN
RRNPVEDGQERSRQEEEGKLLSGVGENERLLREGGYRTAGEMLARDPKFQDHRRNRAGDYSHTL
SRSLLLEEARRLFQSQRTLGNPHASSNLEEAFLHLVAFQNPFASGEDIRNKAGHCSLEPDQIRA
PRRSASAETFMLLQKTGNLRLIHRRTGEERPLTDKEREQIHLLAWKQEKVTHKTLRRHLEIPEE
WLFTGLPYHRSGDKAEEKLFVHLAGIHEIRKALDKGPDPAVWDTLRSRRDLLDSIADTLTFYKN
EDEILPRLESLGLSPENARALAPLSFSGTAHLSLSALGKLLPHLEEGKSYTQARADAGYAAPPP
DRHPKLPPLEEADWRNPVVFRALTQTRKVVNALVRRYGPPWCIHLETARELSQPAKVRRRIETE
QQANEKKKQQAEREFLDIVGTAPGPGDLLKMRLWREQGGFCPYCEEYLNPTRLAEPGYAEMDHI
LPYSRSLDNGWHNRVLVHGKDNRDKGNRTPFEAFGGDTARWDRLVAWVQASHLSAPKKRNLLRE
DFGEEAERELKDRNLTDTRFITKTAATLLRDRLTFHPEAPKDPVMTLNGRLTAFLRKQWGLHKN
RKNGDLHHALDAAVLAVASRSFVYRLSSHNAAWGELPRGREAENGFSLPYPAFRSEVLARLCPT
REEILLRLDQGGVGYDEAFRNGLRPVFVSRAPSRRLRGKAHMETLRSPKWKDHPEGPRTASRIP
LKDLNLEKLERMVGKDRDRKLYEALRERLAAFGGNGKKAFVAPFRKPCRSGEGPLVRSLRIFDS
GYSGVELRDGGEVYAVADHESMVRVDVYAKKNRFYLVPVYVADVARGIVKNRAIVAHKSEEEWD
LVDGSFDFRFSLFPGDLVEIEKKDGAYLGYYKSCHRGDGRLLLDRHDRMPRESDCGTFYVSTRK
DVLSMSKYQVDPLGEIRLVGSEKPPFVL
SEQ ID NO: 358
MEKKRKVTLGFDLGIASVGWAIVDSETNQVYKLGSRLFDAPDTNLERRTQRGTRRLLRRRKYRN
QKFYNLVKRTEVFGLSSREAIENRFRELSIKYPNIIELKTKALSQEVCPDEIAWILHDYLKNRG
YFYDEKETKEDFDQQTVESMPSYKLNEFYKKYGYFKGALSQPTESEMKDNKDLKEAFFFDFSNK
EWLKEINYFFNVQKNILSETFIEEFKKIFSFTRDISKGPGSDNMPSPYGIFGEFGDNGQGGRYE
HIWDKNIGKCSIFTNEQRAPKYLPSALIFNFLNELANIRLYSTDKKNIQPLWKLSSVDKLNILL
NLFNLPISEKKKKLTSTNINDIVKKESIKSIMISVEDIDMIKDEWAGKEPNVYGVGLSGLNIEE
SAKENKFKFQDLKILNVLINLLDNVGIKFEFKDRNDIIKNLELLDNLYLFLIYQKESNNKDSSI
DLFIAKNESLNIENLKLKLKEFLLGAGNEFENHNSKTHSLSKKAIDEILPKLLDNNEGWNLEAI
KNYDEEIKSQIEDNSSLMAKQDKKYLNDNFLKDAILPPNVKVTFQQAILIFNKIIQKFSKDFEI
DKVVIELAREMTQDQENDALKGIAKAQKSKKSLVEERLEANNIDKSVFNDKYEKLIYKIFLWIS
QDFKDPYTGAQISVNEIVNNKVEIDHIIPYSLCFDDSSANKVLVHKQSNQEKSNSLPYEYIKQG
HSGWNWDEFTKYVKRVFVNNVDSILSKKERLKKSENLLTASYDGYDKLGFLARNLNDTRYATIL
FRDQLNNYAEHHLIDNKKMFKVIAMNGAVTSFIRKNMSYDNKLRLKDRSDFSHHAYDAAIIALF
SNKTKTLYNLIDPSLNGIISKRSEGYWVIEDRYTGEIKELKKEDWTSIKNNVQARKIAKEIEEY
LIDLDDEVFFSRKTKRKTNRQLYNETIYGIATKTDEDGITNYYKKEKFSILDDKDIYLRLLRER
EKFVINQSNPEVIDQIIEIIESYGKENNIPSRDEAINIKYTKNKINYNLYLKQYMRSLTKSLDQ
FSEEFINQMIANKTFVLYNPTKNTTRKIKFLRLVNDVKINDIRKNQVINKFNGKNNEPKAFYEN
INSLGAIVFKNSANNFKTLSINTQIAIFGDKNWDIEDFKTYNMEKIEKYKEIYGIDKTYNFHSF
IFPGTILLDKQNKEFYYISSIQTVRDIIEIKFLNKIEFKDENKNQDTSKTPKRLMFGIKSIMNN
YEQVDISPFGINKKIFE
SEQ ID NO: 359
MGYRIGLDVGITSTGYAVLKTDKNGLPYKILTLDSVIYPRAENPQTGASLAEPRRIKRGLRRRT
RRTKFRKQRTQQLFIHSGLLSKPEIEQILATPQAKYSVYELRVAGLDRRLTNSELFRVLYFFIG
HRGFKSNRKAELNPENEADKKQMGQLLNSIEEIRKAIAEKGYRTVGELYLKDPKYNDHKRNKGY
IDGYLSTPNRQMLVDEIKQILDKQRELGNEKLTDEFYATYLLGDENRAGIFQAQRDFDEGPGAG
PYAGDQIKKMVGKDIFEPTEDRAAKATYTFQYFNLLQKMTSLNYQNTTGDTWHTLNGLDRQAII
DAVFAKAEKPTKTYKPTDFGELRKLLKLPDDARFNLVNYGSLQTQKEIETVEKKTRFVDFKAYH
DLVKVLPEEMWQSRQLLDHIGTALTLYSSDKRRRRYFAEELNLPAELIEKLLPLNFSKFGHLSI
KSMQNIIPYLEMGQVYSEATTNTGYDFRKKQISKDTIREEITNPVVRRAVTKTIKIVEQIIRRY
GKPDGINIELARELGRNFKERGDIQKRQDKNRQTNDKIAAELTELGIPVNGQNIIRYKLHKEQN
GVDPYTGDQIPFERAFSEGYEVDHIIPYSISWDDSYTNKVLTSAKCNREKGNRIPMVYLANNEQ
RLNALTNIADNIIRNSRKRQKLLKQKLSDEELKDWKQRNINDTRFITRVLYNYFRQAIEFNPEL
EKKQRVLPLNGEVTSKIRSRWGFLKVREDGDLHHAIDATVIAAITPKFIQQVTKYSQHQEVKNN
QALWHDAEIKDAEYAAEAQRMDADLFNKIFNGFPLPWPEFLDELLARISDNPVEMMKSRSWNTY
TPIEIAKLKPVFVVRLANHKISGPAHLDTIRSAKLFDEKGIVLSRVSITKLKINKKGQVATGDG
IYDPENSNNGDKVVYSAIRQALEAHNGSGELAFPDGYLEYVDHGTKKLVRKVRVAKKVSLPVRL
KNKAAADNGSMVRIDVFNTGKKFVFVPIYIKDTVEQVLPNKAIARGKSLWYQITESDQFCFSLY
PGDMVHIESKTGIKPKYSNKENNTSVVPIKNFYGYFDGADIATASILVRAHDSSYTARSIGIAG
LLKFEKYQVDYFGRYHKVHEKKRQLFVKRDE
SEQ ID NO: 360
MQKNINTKQNHIYIKQAQKIKEKLGDKPYRIGLDLGVGSIGFAIVSMEENDGNVLLPKEIIMVG
SRIFKASAGAADRKLSRGQRNNHRHTRERMRYLWKVLAEQKLALPVPADLDRKENSSEGETSAK
RFLGDVLQKDIYELRVKSLDERLSLQELGYVLYHIAGHRGSSAIRTFENDSEEAQKENTENKKI
AGNIKRLMAKKNYRTYGEYLYKEFFENKEKHKREKISNAANNHKFSPTRDLVIKEAEAILKKQA
GKDGFHKELTEEYIEKLTKAIGYESEKLIPESGFCPYLKDEKRLPASHKLNEERRLWETLNNAR
YSDPIVDIVTGEITGYYEKQFTKEQKQKLFDYLLTGSELTPAQTKKLLGLKNTNFEDIILQGRD
KKAQKIKGYKLIKLESMPFWARLSEAQQDSFLYDWNSCPDEKLLTEKLSNEYHLTEEEIDNAFN
EIVLSSSYAPLGKSAMLIILEKIKNDLSYTEAVEEALKEGKLTKEKQAIKDRLPYYGAVLQEST
QKIIAKGFSPQFKDKGYKTPHTNKYELEYGRIANPVVHQTLNELRKLVNEIIDILGKKPCEIGL
ETARELKKSAEDRSKLSREQNDNESNRNRIYEIYIRPQQQVIITRRENPRNYILKFELLEEQKS
QCPFCGGQISPNDIINNQADIEHLFPIAESEDNGRNNLVISHSACNADKAKRSPWAAFASAAKD
SKYDYNRILSNVKENIPHKAWRFNQGAFEKFIENKPMAARFKTDNSYISKVAHKYLACLFEKPN
IICVKGSLTAQLRMAWGLQGLMIPFAKQLITEKESESFNKDVNSNKKIRLDNRHHALDAIVIAY
ASRGYGNLLNKMAGKDYKINYSERNWLSKILLPPNNIVWENIDADLESFESSVKTALKNAFISV
KHDHSDNGELVKGTMYKIFYSERGYTLTTYKKLSALKLTDPQKKKTPKDFLETALLKFKGRESE
MKNEKIKSAIENNKRLFDVIQDNLEKAKKLLEEENEKSKAEGKKEKNINDASIYQKAISLSGDK
YVQLSKKEPGKFFAISKPTPTTTGYGYDTGDSLCVDLYYDNKGKLCGEIIRKIDAQQKNPLKYK
EQGFTLFERIYGGDILEVDFDIHSDKNSFRNNTGSAPENRVFIKVGTFTEITNNNIQIWFGNII
KSTGGQDDSFTINSMQQYNPRKLILSSCGFIKYRSPILKNKEG
SEQ ID NO: 361
MAAFKPNPINYILGLDIGIASVGWAMVEIDEDENPICLIDLGVRVFERAEVPKTGDSLAMARRL
ARSVRRLTRRRAHRLLRARRLLKREGVLQAADFDENGLIKSLPNTPWQLRAAALDRKLTPLEWS
AVLLHLIKHRGYLSQRKNEGETADKELGALLKGVADNAHALQTGDFRTPAELALNKFEKESGHI
RNQRGDYSHTFSRKDLQAELILLFEKQKEFGNPHVSGGLKEGIETLLMTQRPALSGDAVQKMLG
HCTFEPAEPKAAKNTYTAERFIWLTKLNNLRILEQGSERPLTDTERATLMDEPYRKSKLTYAQA
RKLLGLEDTAFFKGLRYGKDNAEASTLMEMKAYHAISRALEKEGLKDKKSPLNLSPELQDEIGT
AFSLFKTDEDITGRLKDRIQPEILEALLKHISFDKFVQISLKALRRIVPLMEQGKRYDEACAEI
YGDHYGKKNTEEKIYLPPIPADEIRNPVVLRALSQARKVINGVVRRYGSPARIHIETAREVGKS
FKDRKEIEKRQEENRKDREKAAAKFREYFPNFVGEPKSKDILKLRLYEQQHGKCLYSGKEINLG
RLNEKGYVEIDHALPFSRTWDDSFNNKVLVLGSENQNKGNQTPYEYFNGKDNSREWQEFKARVE
TSRFPRSKKQRILLQKFDEDGFKERNLNDTRYVNRFLCQFVADRMRLTGKGKKRVFASNGQITN
LLRGFWGLRKVRAENDRHHALDAVVVACSTVAMQQKITRFVRYKEMNAFDGKTIDKETGEVLHQ
KTHFPQPWEFFAQEVMIRVFGKPDGKPEFEEADTPEKLRTLLAEKLSSRPEAVHEYVTPLFVSR
APNRKMSGQGHMETVKSAKRLDEGVSVLRVPLTQLKLKDLEKMVNREREPKLYEALKARLEAHK
DDPAKAFAEPFYKYDKAGNRTQQVKAVRVEQVQKTGVWVRNHNGIADNATMVRVDVFEKGDKYY
LVPIYSWQVAKGILPDRAVVQGKDEEDWQLIDDSFNFKFSLHPNDLVEVITKKARMFGYFASCH
RGTGNINIRIHDLDHKIGKNGILEGIGVKTALSFQKYQIDELGKEIRPCRLKKRPPVR
SEQ ID NO: 362
MQTTNLSYILGLDLGIASVGWAVVEINENEDPIGLIDVGVRIFERAEVPKTGESLALSRRLARS
TRRLIRRRAHRLLLAKRFLKREGILSTIDLEKGLPNQAWELRVAGLERRLSAIEWGAVLLHLIK
HRGYLSKRKNESQTNNKELGALLSGVAQNHQLLQSDDYRTPAELALKKFAKEEGHIRNQRGAYT
HTFNRLDLLAELNLLFAQQHQFGNPHCKEHIQQYMTELLMWQKPALSGEAILKMLGKCTHEKNE
FKAAKHTYSAERFVWLTKLNNLRILEDGAERALNEEERQLLINHPYEKSKLTYAQVRKLLGLSE
QAIFKHLRYSKENAESATFMELKAWHAIRKALENQGLKDTWQDLAKKPDLLDEIGTAFSLYKTD
EDIQQYLTNKVPNSVINALLVSLNFDKFIELSLKSLRKILPLMEQGKRYDQACREIYGHHYGEA
NQKTSQLLPAIPAQEIRNPVVLRTLSQARKVINAIIRQYGSPARVHIETGRELGKSFKERREIQ
KQQEDNRTKRESAVQKFKELFSDFSSEPKSKDILKFRLYEQQHGKCLYSGKEINIHRLNEKGYV
EIDHALPFSRTWDDSFNNKVLVLASENQNKGNQTPYEWLQGKINSERWKNFVALVLGSQCSAAK
KQRLLTQVIDDNKFIDRNLNDTRYIARFLSNYIQENLLLVGKNKKNVFTPNGQITALLRSRWGL
IKARENNNRHHALDAIVVACATPSMQQKITRFIRFKEVHPYKIENRYEMVDQESGEIISPHFPE
PWAYFRQEVNIRVFDNHPDTVLKEMLPDRPQANHQFVQPLFVSRAPTRKMSGQGHMETIKSAKR
LAEGISVLRIPLTQLKPNLLENMVNKEREPALYAGLKARLAEFNQDPAKAFATPFYKQGGQQVK
AIRVEQVQKSGVLVRENNGVADNASIVRTDVFIKNNKFFLVPIYTWQVAKGILPNKAIVAHKNE
DEWEEMDEGAKFKFSLFPNDLVELKTKKEYFFGYYIGLDRATGNISLKEHDGEISKGKDGVYRV
GVKLALSFEKYQVDELGKNRQICRPQQRQPVR
SEQ ID NO: 363
MGIRFAFDLGTNSIGWAVWRTGPGVFGEDTAASLDGSGVLIFKDGRNPKDGQSLATMRRVPRQS
RKRRDRFVLRRRDLLAALRKAGLFPVDVEEGRRLAATDPYHLRAKALDESLTPHEMGRVIFHLN
QRRGFRSNRKADRQDREKGKIAEGSKRLAETLAATNCRTLGEFLWSRHRGTPRTRSPTRIRMEG
EGAKALYAFYPTREMVRAEFERLWTAQSRFAPDLLTPERHEEIAGILFRQRDLAPPKIGCCTFE
PSERRLPRALPSVEARGIYERLAHLRITTGPVSDRGLTRPERDVLASALLAGKSLTFKAVRKTL
KILPHALVNFEEAGEKGLDGALTAKLLSKPDHYGAAWHGLSFAEKDTFVGKLLDEADEERLIRR
LVTENRLSEDAARRCASIPLADGYGRLGRTANTEILAALVEETDETGTVVTYAEAVRRAGERTG
RNWHHSDERDGVILDRLPYYGEILQRHVVPGSGEPEEKNEAARWGRLANPTVHIGLNQLRKVVN
RLIAAHGRPDQIVVELARELKLNREQKERLDRENRKNREENERRTAILAEHGQRDTAENKIRLR
LFEEQARANAGIALCPYTGRAIGIAELFTSEVEIDHILPVSLTLDDSLANRVLCRREANREKRR
QTPFQAFGATPAWNDIVARAAKLPPNKRWRFDPAALERFEREGGFLGRQLNETKYLSRLAKIYL
GKICDPDRVYVTPGTLTGLLRARWGLNSILSDSNFKNRSDHRHHAVDAVVIGVLTRGMIQRIAH
DAARAEDQDLDRVFRDVPVPFEDFRDHVRERVSTITVAVKPEHGKGGALHEDTSYGLVPDTDPN
AALGNLVVRKPIRSLTAGEVDRVRDRALRARLGALAAPFRDESGRVRDAKGLAQALEAFGAENG
IRRVRILKPDASVVTIADRRTGVPYRAVAPGENHHVDIVQMRDGSWRGFAASVFEVNRPGWRPE
WEVKKLGGKLVMRLHKGDMVELSDKDGQRRVKVVQQIEISANRVRLSPHNDGGKLQDRHADADD
PFRWDLATIPLLKDRGCVAVRVDPIGVVTLRRSNV
SEQ ID NO: 364
MMEVFMGRLVLGLDIGITSVGFGIIDLDESEIVDYGVRLFKEGTAAENETRRTKRGGRRLKRRR
VTRREDMLHLLKQAGIISTSFHPLNNPYDVRVKGLNERLNGEELATALLHLCKHRGSSVETIED
DEAKAKEAGETKKVLSMNDQLLKSGKYVCEIQKERLRTNGHIRGHENNFKTRAYVDEAFQILSH
QDLSNELKSAIITIISRKRMYYDGPGGPLSPTPYGRYTYFGQKEPIDLIEKMRGKCSLFPNEPR
APKLAYSAELFNLLNDLNNLSIEGEKLTSEQKAMILKIVHEKGKITPKQLAKEVGVSLEQIRGF
RIDTKGSPLLSELTGYKMIREVLEKSNDEHLEDHVFYDEIAEILTKTKDIEGRKKQISELSSDL
NEESVHQLAGLTKFTAYHSLSFKALRLINEEMLKTELNQMQSITLFGLKQNNELSVKGMKNIQA
DDTAILSPVAKRAQRETFKVVNRLREIYGEFDSIVVEMAREKNSEEQRKAIRERQKFFEMRNKQ
VADIIGDDRKINAKLREKLVLYQEQDGKTAYSLEPIDLKLLIDDPNAYEVDHIIPISISLDDSI
TNKVLVTHRENQEKGNLTPISAFVKGRFTKGSLAQYKAYCLKLKEKNIKTNKGYRKKVEQYLLN
ENDIYKYDIQKEFINRNLVDTSYASRVVLNTLTTYFKQNEIPTKVFTVKGSLTNAFRRKINLKK
DRDEDYGHHAIDALIIASMPKMRLLSTIFSRYKIEDIYDESTGEVFSSGDDSMYYDDRYFAFIA
SLKAIKVRKFSHKIDTKPNRSVADETIYSTRVIDGKEKVVKKYKDIYDPKFTALAEDILNNAYQ
EKYLMALHDPQTFDQIVKVVNYYFEEMSKSEKYFTKDKKGRIKISGMNPLSLYRDEHGMLKKYS
KKGDGPAITQMKYFDGVLGNHIDISAHYQVRDKKVVLQQISPYRTDFYYSKENGYKFVTIRYKD
VRWSEKKKKYVIDQQDYAMKKAEKKIDDTYEFQFSMHRDELIGITKAEGEALIYPDETWHNFNF
FFHAGETPEILKFTATNNDKSNKIEVKPIHCYCKMRLMPTISKKIVRIDKYATDVVGNLYKVKK
NTLKFEFD
SEQ ID NO: 365
MKKILGVDLGITSFGYAILQETGKDLYRCLDNSVVMRNNPYDEKSGESSQSIRSTQKSMRRLIE
KRKKRIRCVAQTMERYGILDYSETMKINDPKNNPIKNRWQLRAVDAWKRPLSPQELFAIFAHMA
KHRGYKSIATEDLIYELELELGLNDPEKESEKKADERRQVYNALRHLEELRKKYGGETIAQTIH
RAVEAGDLRSYRNHDDYEKMIRREDIEEEIEKVLLRQAELGALGLPEEQVSELIDELKACITDQ
EMPTIDESLFGKCTFYKDELAAPAYSYLYDLYRLYKKLADLNIDGYEVTQEDREKVIEWVEKKI
AQGKNLKKITHKDLRKILGLAPEQKIFGVEDERIVKGKKEPRTFVPFFFLADIAKFKELFASIQ
KHPDALQIFRELAEILQRSKTPQEALDRLRALMAGKGIDTDDRELLELFKNKRSGTRELSHRYI
LEALPLFLEGYDEKEVQRILGFDDREDYSRYPKSLRHLHLREGNLFEKEENPINNHAVKSLASW
ALGLIADLSWRYGPFDEIILETTRDALPEKIRKEIDKAMREREKALDKIIGKYKKEFPSIDKRL
ARKIQLWERQKGLDLYSGKVINLSQLLDGSADIEHIVPQSLGGLSTDYNTIVTLKSVNAAKGNR
LPGDWLAGNPDYRERIGMLSEKGLIDWKKRKNLLAQSLDEIYTENTHSKGIRATSYLEALVAQV
LKRYYPFPDPELRKNGIGVRMIPGKVTSKTRSLLGIKSKSRETNFHHAEDALILSTLTRGWQNR
LHRMLRDNYGKSEAELKELWKKYMPHIEGLTLADYIDEAFRRFMSKGEESLFYRDMFDTIRSIS
YWVDKKPLSASSHKETVYSSRHEVPTLRKNILEAFDSLNVIKDRHKLTTEEFMKRYDKEIRQKL
WLHRIGNTNDESYRAVEERATQIAQILTRYQLMDAQNDKEIDEKFQQALKELITSPIEVTGKLL
RKMRFVYDKLNAMQIDRGLVETDKNMLGIHISKGPNEKLIFRRMDVNNAHELQKERSGILCYLN
EMLFIFNKKGLIHYGCLRSYLEKGQGSKYIALFNPRFPANPKAQPSKFTSDSKIKQVGIGSATG
IIKAHLDLDGHVRSYEVFGTLPEGSIEWFKEESGYGRVEDDPHH
SEQ ID NO: 366
MRPIEPWILGLDIGTDSLGWAVFSCEEKGPPTAKELLGGGVRLFDSGRDAKDHTSRQAERGAFR
RARRQTRTWPWRRDRLIALFQAAGLTPPAAETRQIALALRREAVSRPLAPDALWAALLHLAHHR
GFRSNRIDKRERAAAKALAKAKPAKATAKATAPAKEADDEAGFWEGAEAALRQRMAASGAPTVG
ALLADDLDRGQPVRMRYNQSDRDGVVAPTRALIAEELAEIVARQSSAYPGLDWPAVTRLVLDQR
PLRSKGAGPCAFLPGEDRALRALPTVQDFIIRQTLANLRLPSTSADEPRPLTDEEHAKALALLS
TARFVEWPALRRALGLKRGVKFTAETERNGAKQAARGTAGNLTEAILAPLIPGWSGWDLDRKDR
VFSDLWAARQDRSALLALIGDPRGPTRVTEDETAEAVADAIQIVLPTGRASLSAKAARAIAQAM
APGIGYDEAVTLALGLHHSHRPRQERLARLPYYAAALPDVGLDGDPVGPPPAEDDGAAAEAYYG
RIGNISVHIALNETRKIVNALLHRHGPILRLVMVETTRELKAGADERKRMIAEQAERERENAEI
DVELRKSDRWMANARERRQRVRLARRQNNLCPYTSTPIGHADLLGDAYDIDHVIPLARGGRDSL
DNMVLCQSDANKTKGDKTPWEAFHDKPGWIAQRDDFLARLDPQTAKALAWRFADDAGERVARKS
AEDEDQGFLPRQLTDTGYIARVALRYLSLVTNEPNAVVATNGRLTGLLRLAWDITPGPAPRDLL
PTPRDALRDDTAARRFLDGLTPPPLAKAVEGAVQARLAALGRSRVADAGLADALGLTLASLGGG
GKNRADHRHHFIDAAMIAVTTRGLINQINQASGAGRILDLRKWPRTNFEPPYPTFRAEVMKQWD
HIHPSIRPAHRDGGSLHAATVFGVRNRPDARVLVQRKPVEKLFLDANAKPLPADKIAEIIDGFA
SPRMAKRFKALLARYQAAHPEVPPALAALAVARDPAFGPRGMTANTVIAGRSDGDGEDAGLITP
FRANPKAAVRTMGNAVYEVWEIQVKGRPRWTHRVLTRFDRTQPAPPPPPENARLVMRLRRGDLV
YWPLESGDRLFLVKKMAVDGRLALWPARLATGKATALYAQLSCPNINLNGDQGYCVQSAEGIRK
EKIRTTSCTALGRLRLSKKAT
SEQ ID NO: 367
MKYTLGLDVGIASVGWAVIDKDNNKIIDLGVRCFDKAEESKTGESLATARRIARGMRRRISRRS
QRLRLVKKLFVQYEIIKDSSEFNRIFDTSRDGWKDPWELRYNALSRILKPYELVQVLTHITKRR
GFKSNRKEDLSTTKEGVVITSIKNNSEMLRTKNYRTIGEMIFMETPENSNKRNKVDEYIHTIAR
EDLLNEIKYIFSIQRKLGSPFVTEKLEHDFLNIWEFQRPFASGDSILSKVGKCTLLKEELRAPT
SCYTSEYFGLLQSINNLVLVEDNNTLTLNNDQRAKIIEYAHFKNEIKYSEIRKLLDIEPEILFK
AHNLTHKNPSGNNESKKFYEMKSYHKLKSTLPTDIWGKLHSNKESLDNLFYCLTVYKNDNEIKD
YLQANNLDYLIEYIAKLPTFNKFKHLSLVAMKRIIPFMEKGYKYSDACNMAELDFTGSSKLEKC
NKLTVEPIIENVTNPVVIRALTQARKVINAIIQKYGLPYMVNIELAREAGMTRQDRDNLKKEHE
NNRKAREKISDLIRQNGRVASGLDILKWRLWEDQGGRCAYSGKPIPVCDLLNDSLTQIDHIYPY
SRSMDDSYMNKVLVLTDENQNKRSYTPYEVWGSTEKWEDFEARIYSMHLPQSKEKRLLNRNFIT
KDLDSFISRNLNDTRYISRFLKNYIESYLQFSNDSPKSCVVCVNGQCTAQLRSRWGLNKNREES
DLHHALDAAVIACADRKIIKEITNYYNERENHNYKVKYPLPWHSFRQDLMETLAGVFISRAPRR
KITGPAHDETIRSPKHFNKGLTSVKIPLTTVTLEKLETMVKNTKGGISDKAVYNVLKNRLIEHN
NKPLKAFAEKIYKPLKNGTNGAIIRSIRVETPSYTGVFRNEGKGISDNSLMVRVDVFKKKDKYY
LVPIYVAHMIKKELPSKAIVPLKPESQWELIDSTHEFLFSLYQNDYLVIKTKKGITEGYYRSCH
RGTGSLSLMPHFANNKNVKIDIGVRTAISIEKYNVDILGNKSIVKGEPRRGMEKYNSFKSN
SEQ ID NO: 368
MIRTLGIDIGIASIGWAVIEGEYTDKGLENKEIVASGVRVFTKAENPKNKESLALPRTLARSAR
RRNARKKGRIQQVKHYLSKALGLDLECFVQGEKLATLFQTSKDFLSPWELRERALYRVLDKEEL
ARVILHIAKRRGYDDITYGVEDNDSGKIKKAIAENSKRIKEEQCKTIGEMMYKLYFQKSLNVRN
KKESYNRCVGRSELREELKTIFQIQQELKSPWVNEELIYKLLGNPDAQSKQEREGLIFYQRPLK
GFGDKIGKCSHIKKGENSPYRACKHAPSAEEFVALTKSINFLKNLTNRHGLCFSQEDMCVYLGK
ILQEAQKNEKGLTYSKLKLLLDLPSDFEFLGLDYSGKNPEKAVFLSLPSTFKLNKITQDRKTQD
KIANILGANKDWEAILKELESLQLSKEQIQTIKDAKLNFSKHINLSLEALYHLLPLMREGKRYD
EGVEILQERGIFSKPQPKNRQLLPPLSELAKEESYFDIPNPVLRRALSEFRKVVNALLEKYGGF
HYFHIELTRDVCKAKSARMQLEKINKKNKSENDAASQLLEVLGLPNTYNNRLKCKLWKQQEEYC
LYSGEKITIDHLKDQRALQIDHAFPLSRSLDDSQSNKVLCLTSSNQEKSNKTPYEWLGSDEKKW
DMYVGRVYSSNFSPSKKRKLTQKNFKERNEEDFLARNLVDTGYIGRVTKEYIKHSLSFLPLPDG
KKEHIRIISGSMTSTMRSFWGVQEKNRDHHLHHAQDAIIIACIEPSMIQKYTTYLKDKETHRLK
SHQKAQILREGDHKLSLRWPMSNFKDKIQESIQNIIPSHHVSHKVTGELHQETVRTKEFYYQAF
GGEEGVKKALKFGKIREINQGIVDNGAMVRVDIFKSKDKGKFYAVPIYTYDFAIGKLPNKAIVQ
GKKNGIIKDWLEMDENYEFCFSLFKNDCIKIQTKEMQEAVLAIYKSTNSAKATIELEHLSKYAL
KNEDEEKMFTDTDKEKNKTMTRESCGIQGLKVFQKVKLSVLGEVLEHKPRNRQNIALKTTPKHV
SEQ ID NO: 369
MKYSIGLDIGIASVGWSVINKDKERIEDMGVRIFQKAENPKDGSSLASSRREKRGSRRRNRRKK
HRLDRIKNILCESGLVKKNEIEKIYKNAYLKSPWELRAKSLEAKISNKEIAQILLHIAKRRGFK
SFRKTDRNADDTGKLLSGIQENKKIMEEKGYLTIGDMVAKDPKFNTHVRNKAGSYLFSFSRKLL
EDEVRKIQAKQKELGNTHFTDDVLEKYIEVFNSQRNFDEGPSKPSPYYSEIGQIAKMIGNCTFE
SSEKRTAKNTWSGERFVFLQKLNNFRIVGLSGKRPLTEEERDIVEKEVYLKKEVRYEKLRKILY
LKEEERFGDLNYSKDEKQDKKTEKTKFISLIGNYTIKKLNLSEKLKSEIEEDKSKLDKIIEILT
FNKSDKTIESNLKKLELSREDIEILLSEEFSGTLNLSLKAIKKILPYLEKGLSYNEACEKADYD
YKNNGIKFKRGELLPVVDKDLIANPVVLRAISQTRKVVNAIIRKYGTPHTIHVEVARDLAKSYD
DRQTIIKENKKRELENEKTKKFISEEFGIKNVKGKLLLKYRLYQEQEGRCAYSRKELSLSEVIL
DESMTDIDHIIPYSRSMDDSYSNKVLVLSGENRKKSNLLPKEYFDRQGRDWDTFVLNVKAMKIH
PRKKSNLLKEKFTREDNKDWKSRALNDTRYISRFVANYLENALEYRDDSPKKRVFMIPGQLTAQ
LRARWRLNKVRENGDLHHALDAAVVAVTDQKAINNISNISRYKELKNCKDVIPSIEYHADEETG
EVYFEEVKDTRFPMPWSGFDLELQKRLESENPREEFYNLLSDKRYLGWFNYEEGFIEKLRPVFV
SRMPNRGVKGQAHQETIRSSKKISNQIAVSKKPLNSIKLKDLEKMQGRDTDRKLYEALKNRLEE
YDDKPEKAFAEPFYKPTNSGKRGPLVRGIKVEEKQNVGVYVNGGQASNGSMVRIDVFRKNGKFY
TVPIYVHQTLLKELPNRAINGKPYKDWDLIDGSFEFLYSFYPNDLIEIEFGKSKSIKNDNKLTK
TEIPEVNLSEVLGYYRGMDTSTGAATIDTQDGKIQMRIGIKTVKNIKKYQVDVLGNVYKVKREK
RQTF
SEQ ID NO: 370
MSKKVSRRYEEQAQEICQRLGSRPYSIGLDLGVGSIGVAVAAYDPIKKQPSDLVFVSSRIFIPS
TGAAERRQKRGQRNSLRHRANRLKFLWKLLAERNLMLSYSEQDVPDPARLRFEDAVVRANPYEL
RLKGLNEQLTLSELGYALYHIANHRGSSSVRTFLDEEKSSDDKKLEEQQAMTEQLAKEKGISTF
IEVLTAFNTNGLIGYRNSESVKSKGVPVPTRDIISNEIDVLLQTQKQFYQEILSDEYCDRIVSA
ILFENEKIVPEAGCCPYFPDEKKLPRCHFLNEERRLWEAINNARIKMPMQEGAAKRYQSASFSD
EQRHILFHIARSGTDITPKLVQKEFPALKTSIIVLQGKEKAIQKIAGFRFRRLEEKSFWKRLSE
EQKDDFFSAWTNTPDDKRLSKYLMKHLLLTENEVVDALKTVSLIGDYGPIGKTATQLLMKHLED
GLTYTEALERGMETGEFQELSVWEQQSLLPYYGQILTGSTQALMGKYWHSAFKEKRDSEGFFKP
NTNSDEEKYGRIANPVVHQTLNELRKLMNELITILGAKPQEITVELARELKVGAEKREDIIKQQ
TKQEKEAVLAYSKYCEPNNLDKRYIERFRLLEDQAFVCPYCLEHISVADIAAGRADVDHIFPRD
DTADNSYGNKVVAHRQCNDIKGKRTPYAAFSNTSAWGPIMHYLDETPGMWRKRRKFETNEEEYA
KYLQSKGFVSRFESDNSYIAKAAKEYLRCLFNPNNVTAVGSLKGMETSILRKAWNLQGIDDLLG
SRHWSKDADTSPTMRKNRDDNRHHGLDAIVALYCSRSLVQMINTMSEQGKRAVEIEAMIPIPGY
ASEPNLSFEAQRELFRKKILEFMDLHAFVSMKTDNDANGALLKDTVYSILGADTQGEDLVFVVK
KKIKDIGVKIGDYEEVASAIRGRITDKQPKWYPMEMKDKIEQLQSKNEAALQKYKESLVQAAAV
LEESNRKLIESGKKPIQLSEKTISKKALELVGGYYYLISNNKRTKTFVVKEPSNEVKGFAFDTG
SNLCLDFYHDAQGKLCGEIIRKIQAMNPSYKPAYMKQGYSLYVRLYQGDVCELRASDLTEAESN
LAKTTHVRLPNAKPGRTFVIIITFTEMGSGYQIYFSNLAKSKKGQDTSFTLTTIKNYDVRKVQL
SSAGLVRYVSPLLVDKIEKDEVALCGE
SEQ ID NO: 371
MNQKFILGLDIGITSVGYGLIDYETKNIIDAGVRLFPEANVENNEGRRSKRGSRRLKRRRIHRL
ERVKKLLEDYNLLDQSQIPQSTNPYAIRVKGLSEALSKDELVIALLHIAKRRGIHKIDVIDSND
DVGNELSTKEQLNKNSKLLKDKFVCQIQLERMNEGQVRGEKNRFKTADIIKEIIQLLNVQKNFH
QLDENFINKYIELVEMRREYFEGPGKGSPYGWEGDPKAWYETLMGHCTYFPDELRSVKYAYSAD
LFNALNDLNNLVIQRDGLSKLEYHEKYHIIENVFKQKKKPTLKQIANEINVNPEDIKGYRITKS
GKPQFTEFKLYHDLKSVLFDQSILENEDVLDQIAEILTIYQDKDSIKSKLTELDILLNEEDKEN
IAQLTGYTGTHRLSLKCIRLVLEEQWYSSRNQMEIFTHLNIKPKKINLTAANKIPKAMIDEFIL
SPVVKRTFGQAINLINKIIEKYGVPEDIIIELARENNSKDKQKFINEMQKKNENTRKRINEIIG
KYGNQNAKRLVEKIRLHDEQEGKCLYSLESIPLEDLLNNPNHYEVDHIIPRSVSFDNSYHNKVL
VKQSENSKKSNLTPYQYFNSGKSKLSYNQFKQHILNLSKSQDRISKKKKEYLLEERDINKFEVQ
KEFINRNLVDTRYATRELTNYLKAYFSANNMNVKVKTINGSFTDYLRKVWKFKKERNHGYKHHA
EDALIIANADFLFKENKKLKAVNSVLEKPEIESKQLDIQVDSEDNYSEMFIIPKQVQDIKDFRN
FKYSHRVDKKPNRQLINDTLYSTRKKDNSTYIVQTIKDIYAKDNTTLKKQFDKSPEKFLMYQHD
PRTFEKLEVIMKQYANEKNPLAKYHEETGEYLTKYSKKNNGPIVKSLKYIGNKLGSHLDVTHQF
KSSTKKLVKLSIKPYRFDVYLTDKGYKFITISYLDVLKKDNYYYIPEQKYDKLKLGKAIDKNAK
FIASFYKNDLIKLDGEIYKIIGVNSDTRNMIELDLPDIRYKEYCELNNIKGEPRIKKTIGKKVN
SIEKLTTDVLGNVFTNTQYTKPQLLFKRGN
SEQ ID NO: 372
MIMKLEKWRLGLDLGTNSIGWSVFSLDKDNSVQDLIDMGVRIFSDGRDPKTKEPLAVARRTARS
QRKLIYRRKLRRKQVFKFLQEQGLFPKTKEECMTLKSLNPYELRIKALDEKLEPYELGRALFNL
AVRRGFKSNRKDGSREEVSEKKSPDEIKTQADMQTHLEKAIKENGCRTITEFLYKNQGENGGIR
FAPGRMTYYPTRKMYEEEFNLIRSKQEKYYPQVDWDDIYKAIFYQRPLKPQQRGYCIYENDKER
TFKAMPCSQKLRILQDIGNLAYYEGGSKKRVELNDNQDKVLYELLNSKDKVTFDQMRKALCLAD
SNSFNLEENRDFLIGNPTAVKMRSKNRFGKLWDEIPLEEQDLIIETIITADEDDAVYEVIKKYD
LTQEQRDFIVKNTILQSGTSMLCKEVSEKLVKRLEEIADLKYHEAVESLGYKFADQTVEKYDLL
PYYGKVLPGSTMEIDLSAPETNPEKHYGKISNPTVHVALNQTRVVVNALIKEYGKPSQIAIELS
RDLKNNVEKKAEIARKQNQRAKENIAINDTISALYHTAFPGKSFYPNRNDRMKYRLWSELGLGN
KCIYCGKGISGAELFTKEIEIEHILPFSRTLLDAESNLTVAHSSCNAFKAERSPFEAFGTNPSG
YSWQEIIQRANQLKNTSKKNKFSPNAMDSFEKDSSFIARQLSDNQYIAKAALRYLKCLVENPSD
VWTTNGSMTKLLRDKWEMDSILCRKFTEKEVALLGLKPEQIGNYKKNRFDHRHHAIDAVVIGLT
DRSMVQKLATKNSHKGNRIEIPEFPILRSDLIEKVKNIVVSFKPDHGAEGKLSKETLLGKIKLH
GKETFVCRENIVSLSEKNLDDIVDEIKSKVKDYVAKHKGQKIEAVLSDFSKENGIKKVRCVNRV
QTPIEITSGKISRYLSPEDYFAAVIWEIPGEKKTFKAQYIRRNEVEKNSKGLNVVKPAVLENGK
PHPAAKQVCLLHKDDYLEFSDKGKMYFCRIAGYAATNNKLDIRPVYAVSYCADWINSTNETMLT
GYWKPTPTQNWVSVNVLFDKQKARLVTVSPIGRVFRK
SEQ ID NO: 373
MSSKAIDSLEQLDLFKPQEYTLGLDLGIKSIGWAILSGERIANAGVYLFETAEELNSTGNKLIS
KAAERGRKRRIRRMLDRKARRGRHIRYLLEREGLPTDELEEVVVHQSNRTLWDVRAEAVERKLT
KQELAAVLFHLVRHRGYFPNTKKLPPDDESDSADEEQGKINRATSRLREELKASDCKTIGQFLA
QNRDRQRNREGDYSNLMARKLVFEEALQILAFQRKQGHELSKDFEKTYLDVLMGQRSGRSPKLG
NCSLIPSELRAPSSAPSTEWFKFLQNLGNLQISNAYREEWSIDAPRRAQIIDACSQRSTSSYWQ
IRRDFQIPDEYRFNLVNYERRDPDVDLQEYLQQQERKTLANFRNWKQLEKIIGTGHPIQTLDEA
ARLITLIKDDEKLSDQLADLLPEASDKAITQLCELDFTTAAKISLEAMYRILPHMNQGMGFFDA
CQQESLPEIGVPPAGDRVPPFDEMYNPVVNRVLSQSRKLINAVIDEYGMPAKIRVELARDLGKG
RELRERIKLDQLDKSKQNDQRAEDFRAEFQQAPRGDQSLRYRLWKEQNCTCPYSGRMIPVNSVL
SEDTQIDHILPISQSFDNSLSNKVLCFTEENAQKSNRTPFEYLDAADFQRLEAISGNWPEAKRN
KLLHKSFGKVAEEWKSRALNDTRYLTSALADHLRHHLPDSKIQTVNGRITGYLRKQWGLEKDRD
KHTHHAVDAIVVACTTPAIVQQVTLYHQDIRRYKKLGEKRPTPWPETFRQDVLDVEEEIFITRQ
PKKVSGGIQTKDTLRKHRSKPDRQRVALTKVKLADLERLVEKDASNRNLYEHLKQCLEESGDQP
TKAFKAPFYMPSGPEAKQRPILSKVTLLREKPEPPKQLTELSGGRRYDSMAQGRLDIYRYKPGG
KRKDEYRVVLQRMIDLMRGEENVHVFQKGVPYDQGPEIEQNYTFLFSLYFDDLVEFQRSADSEV
IRGYYRTFNIANGQLKISTYLEGRQDFDFFGANRLAHFAKVQVNLLGKVIK
SEQ ID NO: 374
MRSLRYRLALDLGSTSLGWALFRLDACNRPTAVIKAGVRIFSDGRNPKDGSSLAVTRRAARAMR
RRRDRLLKRKTRMQAKLVEHGFFPADAGKRKALEQLNPYALRAKGLQEALLPGEFARALFHINQ
RRGFKSNRKTDKKDNDSGVLKKAIGQLRQQMAEQGSRTVGEYLWTRLQQGQGVRARYREKPYTT
EEGKKRIDKSYDLYIDRAMIEQEFDALWAAQAAFNPTLFHEAARADLKDTLLHQRPLRPVKPGR
CTLLPEEERAPLALPSTQRFRIHQEVNHLRLLDENLREVALTLAQRDAVVTALETKAKLSFEQI
RKLLKLSGSVQFNLEDAKRTELKGNATSAALARKELFGAAWSGFDEALQDEIVWQLVTEEGEGA
LIAWLQTHTGVDEARAQAIVDVSLPEGYGNLSRKALARIVPALRAAVITYDKAVQAAGFDHHSQ
LGFEYDASEVEDLVHPETGEIRSVFKQLPYYGKALQRHVAFGSGKPEDPDEKRYGKIANPTVHI
GLNQVRMVVNALIRRYGRPTEVVIELARDLKQSREQKVEAQRRQADNQRRNARIRRSIAEVLGI
GEERVRGSDIQKWICWEELSFDAADRRCPYSGVQISAAMLLSDEVEVEHILPFSKTLDDSLNNR
TVAMRQANRIKRNRTPWDARAEFEAQGWSYEDILQRAERMPLRKRYRFAPDGYERWLGDDKDFL
ARALNDTRYLSRVAAEYLRLVCPGTRVIPGQLTALLRGKFGLNDVLGLDGEKNRNDHRHHAVDA
CVIGVTDQGLMQRFATASAQARGDGLTRLVDGMPMPWPTYRDHVERAVRHIWVSHRPDHGFEGA
MMEETSYGIRKDGSIKQRRKADGSAGREISNLIRIHEATQPLRHGVSADGQPLAYKGYVGGSNY
CIEITVNDKGKWEGEVISTFRAYGVVRAGGMGRLRNPHEGQNGRKLIMRLVIGDSVRLEVDGAE
RTMRIVKISGSNGQIFMAPIHEANVDARNTDKQDAFTYTSKYAGSLQKAKTRRVTISPIGEVRD
PGFKG
SEQ ID NO: 375
MARPAFRAPRREHVNGWTPDPHRISKPFFILVSWHLLSRVVIDSSSGCFPGTSRDHTDKFAEWE
CAVQPYRLSFDLGTNSIGWGLLNLDRQGKPREIRALGSRIFSDGRDPQDKASLAVARRLARQMR
RRRDRYLTRRTRLMGALVRFGLMPADPAARKRLEVAVDPYLARERATRERLEPFEIGRALFHLN
QRRGYKPVRTATKPDEEAGKVKEAVERLEAAIAAAGAPTLGAWFAWRKTRGETLRARLAGKGKE
AAYPFYPARRMLEAEFDTLWAEQARHHPDLLTAEAREILRHRIFHQRPLKPPPVGRCTLYPDDG
RAPRALPSAQRLRLFQELASLRVIHLDLSERPLTPAERDRIVAFVQGRPPKAGRKPGKVQKSVP
FEKLRGLLELPPGTGFSLESDKRPELLGDETGARIAPAFGPGWTALPLEEQDALVELLLTEAEP
ERAIAALTARWALDEATAAKLAGATLPDFHGRYGRRAVAELLPVLERETRGDPDGRVRPIRLDE
AVKLLRGGKDHSDFSREGALLDALPYYGAVLERHVAFGTGNPADPEEKRVGRVANPTVHIALNQ
LRHLVNAILARHGRPEEIVIELARDLKRSAEDRRREDKRQADNQKRNEERKRLILSLGERPTPR
NLLKLRLWEEQGPVENRRCPYSGETISMRMLLSEQVDIDHILPFSVSLDDSAANKVVCLREANR
IKRNRSPWEAFGHDSERWAGILARAEALPKNKRWRFAPDALEKLEGEGGLRARHLNDTRHLSRL
AVEYLRCVCPKVRVSPGRLTALLRRRWGIDAILAEADGPPPEVPAETLDPSPAEKNRADHRHHA
LDAVVIGCIDRSMVQRVQLAAASAEREAAAREDNIRRVLEGFKEEPWDGFRAELERRARTIVVS
HRPEHGIGGALHKETAYGPVDPPEEGFNLVVRKPIDGLSKDEINSVRDPRLRRALIDRLAIRRR
DANDPATALAKAAEDLAAQPASRGIRRVRVLKKESNPIRVEHGGNPSGPRSGGPFHKLLLAGEV
HHVDVALRADGRRWVGHWVTLFEAHGGRGADGAAAPPRLGDGERFLMRLHKGDCLKLEHKGRVR
VMQVVKLEPSSNSVVVVEPHQVKTDRSKHVKISCDQLRARGARRVTVDPLGRVRVHAPGARVGI
GGDAGRTAMEPAEDIS
SEQ ID NO: 376
MKRTSLRAYRLGVDLGANSLGWFVVWLDDHGQPEGLGPGGVRIFPDGRNPQSKQSNAAGRRLAR
SARRRRDRYLQRRGKLMGLLVKHGLMPADEPARKRLECLDPYGLRAKALDEVLPLHHVGRALFH
LNQRRGLFANRAIEQGDKDASAIKAAAGRLQTSMQACGARTLGEFLNRRHQLRATVRARSPVGG
DVQARYEFYPTRAMVDAEFEAIWAAQAPHHPTMTAEAHDTIREAIFSQRAMKRPSIGKCSLDPA
TSQDDVDGFRCAWSHPLAQRFRIWQDVRNLAVVETGPTSSRLGKEDQDKVARALLQTDQLSFDE
IRGLLGLPSDARFNLESDRRDHLKGDATGAILSARRHFGPAWHDRSLDRQIDIVALLESALDEA
AIIASLGTTHSLDEAAAQRALSALLPDGYCRLGLRAIKRVLPLMEAGRTYAEAASAAGYDHALL
PGGKLSPTGYLPYYGQWLQNDVVGSDDERDTNERRWGRLPNPTVHIGIGQLRRVVNELIRWHGP
PAEITVELTRDLKLSPRRLAELEREQAENQRKNDKRTSLLRKLGLPASTHNLLKLRLWDEQGDV
ASECPYTGEAIGLERLVSDDVDIDHLIPFSISWDDSAANKVVCMRYANREKGNRTPFEAFGHRQ
GRPYDWADIAERAARLPRGKRWRFGPGARAQFEELGDFQARLLNETSWLARVAKQYLAAVTHPH
RIHVLPGRLTALLRATWELNDLLPGSDDRAAKSRKDHRHHAIDALVAALTDQALLRRMANAHDD
TRRKIEVLLPWPTFRIDLETRLKAMLVSHKPDHGLQARLHEDTAYGTVEHPETEDGANLVYRKT
FVDISEKEIDRIRDRRLRDLVRAHVAGERQQGKTLKAAVLSFAQRRDIAGHPNGIRHVRLTKSI
KPDYLVPIRDKAGRIYKSYNAGENAFVDILQAESGRWIARATTVFQANQANESHDAPAAQPIMR
VFKGDMLRIDHAGAEKFVKIVRLSPSNNLLYLVEHHQAGVFQTRHDDPEDSFRWLFASFDKLRE
WNAELVRIDTLGQPWRRKRGLETGSEDATRIGWTRPKKWP
SEQ ID NO: 377
MERIFGFDIGTTSIGFSVIDYSSTQSAGNIQRLGVRIFPEARDPDGTPLNQQRRQKRMMRRQLR
RRRIRRKALNETLHEAGFLPAYGSADWPVVMADEPYELRRRGLEEGLSAYEFGRAIYHLAQHRH
FKGRELEESDTPDPDVDDEKEAANERAATLKALKNEQTTLGAWLARRPPSDRKRGIHAHRNVVA
EEFERLWEVQSKFHPALKSEEMRARISDTIFAQRPVFWRKNTLGECRFMPGEPLCPKGSWLSQQ
RRMLEKLNNLAIAGGNARPLDAEERDAILSKLQQQASMSWPGVRSALKALYKQRGEPGAEKSLK
FNLELGGESKLLGNALEAKLADMFGPDWPAHPRKQEIRHAVHERLWAADYGETPDKKRVIILSE
KDRKAHREAAANSFVADFGITGEQAAQLQALKLPTGWEPYSIPALNLFLAELEKGERFGALVNG
PDWEGWRRTNFPHRNQPTGEILDKLPSPASKEERERISQLRNPTVVRTQNELRKVVNNLIGLYG
KPDRIRIEVGRDVGKSKREREEIQSGIRRNEKQRKKATEDLIKNGIANPSRDDVEKWILWKEGQ
ERCPYTGDQIGFNALFREGRYEVEHIWPRSRSFDNSPRNKTLCRKDVNIEKGNRMPFEAFGHDE
DRWSAIQIRLQGMVSAKGGTGMSPGKVKRFLAKTMPEDFAARQLNDTRYAAKQILAQLKRLWPD
MGPEAPVKVEAVTGQVTAQLRKLWTLNNILADDGEKTRADHRHHAIDALTVACTHPGMTNKLSR
YWQLRDDPRAEKPALTPPWDTIRADAEKAVSEIVVSHRVRKKVSGPLHKETTYGDTGTDIKTKS
GTYRQFVTRKKIESLSKGELDEIRDPRIKEIVAAHVAGRGGDPKKAFPPYPCVSPGGPEIRKVR
LTSKQQLNLMAQTGNGYADLGSNHHIAIYRLPDGKADFEIVSLFDASRRLAQRNPIVQRTRADG
ASFVMSLAAGEAIMIPEGSKKGIWIVQGVWASGQVVLERDTDADHSTTTRPMPNPILKDDAKKV
SIDPIGRVRPSND
SEQ ID NO: 378
MNKRILGLDTGTNSLGWAVVDWDEHAQSYELIKYGDVIFQEGVKIEKGIESSKAAERSGYKAIR
KQYFRRRLRKIQVLKVLVKYHLCPYLSDDDLRQWHLQKQYPKSDELMLWQRTSDEEGKNPYYDR
HRCLHEKLDLTVEADRYTLGRALYHLTQRRGFLSNRLDTSADNKEDGVVKSGISQLSTEMEEAG
CEYLGDYFYKLYDAQGNKVRIRQRYTDRNKHYQHEFDAICEKQELSSELIEDLQRAIFFQLPLK
SQRHGVGRCTFERGKPRCADSHPDYEEFRMLCFVNNIQVKGPHDLELRPLTYEEREKIEPLFFR
KSKPNFDFEDIAKALAGKKNYAWIHDKEERAYKFNYRMTQGVPGCPTIAQLKSIFGDDWKTGIA
ETYTLIQKKNGSKSLQEMVDDVWNVLYSFSSVEKLKEFAHHKLQLDEESAEKFAKIKLSHSFAA
LSLKAIRKFLPFLRKGMYYTHASFFANIPTIVGKEIWNKEQNRKYIMENVGELVFNYQPKHREV
QGTIEMLIKDFLANNFELPAGATDKLYHPSMIETYPNAQRNEFGILQLGSPRTNAIRNPMAMRS
LHILRRVVNQLLKESIIDENTEVHVEYARELNDANKRRAIADRQKEQDKQHKKYGDEIRKLYKE
ETGKDIEPTQTDVLKFQLWEEQNHHCLYTGEQIGITDFIGSNPKFDIEHTIPQSVGGDSTQMNL
TLCDNRFNREVKKAKLPTELANHEEILTRIEPWKNKYEQLVKERDKQRTFAGMDKAVKDIRIQK
RHKLQMEIDYWRGKYERFTMTEVPEGFSRRQGTGIGLISRYAGLYLKSLFHQADSRNKSNVYVV
KGVATAEFRKMWGLQSEYEKKCRDNHSHHCMDAITIACIGKREYDLMAEYYRMEETFKQGRGSK
PKFSKPWATFTEDVLNIYKNLLVVHDTPNNMPKHTKKYVQTSIGKVLAQGDTARGSLHLDTYYG
AIERDGEIRYVVRRPLSSFTKPEELENIVDETVKRTIKEAIADKNFKQAIAEPIYMNEEKGILI
KKVRCFAKSVKQPINIRQHRDLSKKEYKQQYHVMNENNYLLAIYEGLVKNKVVREFEIVSYIEA
AKYYKRSQDRNIFSSIVPTHSTKYGLPLKTKLLMGQLVLMFEENPDEIQVDNTKDLVKRLYKVV
GIEKDGRIKFKYHQEARKEGLPIFSTPYKNNDDYAPIFRQSINNINILVDGIDFTIDILGKVTL
KE
SEQ ID NO: 379
MNYKMGLDIGIASVGWAVINLDLKRIEDLGVRIFDKAEHPQNGESLALPRRIARSARRRLRRRK
HRLERIRRLLVSENVLTKEEMNLLFKQKKQIDVWQLRVDALERKLNNDELARVLLHLAKRRGFK
SNRKSERNSKESSEFLKNIEENQSILAQYRSVGEMIVKDSKFAYHKRNKLDSYSNMIARDDLER
EIKLIFEKQREFNNPVCTERLEEKYLNIWSSQRPFASKEDIEKKVGFCTFEPKEKRAPKATYTF
QSFIVWEHINKLRLVSPDETRALTEIERNLLYKQAFSKNKMTYYDIRKLLNLSDDIHFKGLLYD
PKSSLKQIENIRFLELDSYHKIRKCIENVYGKDGIRMFNETDIDTFGYALTIFKDDEDIVAYLQ
NEYITKNGKRVSNLANKVYDKSLIDELLNLSFSKFAHLSMKAIRNILPYMEQGEIYSKACELAG
YNFTGPKKKEKALLLPVIPNIANPVVMRALTQSRKVVNAIIKKYGSPVSIHIELARDLSHSFDE
RKKIQKDQTENRKKNETAIKQLIEYELTKNPTGLDIVKFKLWSEQQGRCMYSLKPIELERLLEP
GYVEVDHILPYSRSLDDSYANKVLVLTKENREKGNHTPVEYLGLGSERWKKFEKFVLANKQFSK
KKKQNLLRLRYEETEEKEFKERNLNDTRYISKFFANFIKEHLKFADGDGGQKVYTINGKITAHL
RSRWDFNKNREESDLHHAVDAVIVACATQGMIKKITEFYKAREQNKESAKKKEPIFPQPWPHFA
DELKARLSKFPQESIEAFALGNYDRKKLESLRPVFVSRMPKRSVTGAAHQETLRRCVGIDEQSG
KIQTAVKTKLSDIKLDKDGHFPMYQKESDPRTYEAIRQRLLEHNNDPKKAFQEPLYKPKKNGEP
GPVIRTVKIIDTKNKVVHLDGSKTVAYNSNIVRTDVFEKDGKYYCVPVYTMDIMKGTLPNKAIE
ANKPYSEWKEMTEEYTFQFSLFPNDLVRIVLPREKTIKTSTNEEIIIKDIFAYYKTIDSATGGL
ELISHDRNFSLRGVGSKTLKRFEKYQVDVLGNIHKVKGEKRVGLAAPTNQKKGKTVDSLQSVSD
SEQ ID NO: 380
MRRLGLDLGTNSIGWCLLDLGDDGEPVSIFRTGARIFSDGRDPKSLGSLKATRREARLTRRRRD
RFIQRQKNLINALVKYGLMPADEIQRQALAYKDPYPIRKKALDEAIDPYEMGRAIFHINQRRGF
KSNRKSADNEAGVVKQSIADLEMKLGEAGARTIGEFLADRQATNDTVRARRLSGTNALYEFYPD
RYMLEQEFDTLWAKQAAFNPSLYIEAARERLKEIVFFQRKLKPQEVGRCIFLSDEDRISKALPS
FQRFRIYQELSNLAWIDHDGVAHRITASLALRDHLFDELEHKKKLTFKAMRAILRKQGVVDYPV
GFNLESDNRDHLIGNLTSCIMRDAKKMIGSAWDRLDEEEQDSFILMLQDDQKGDDEVRSILTQQ
YGLSDDVAEDCLDVRLPDGHGSLSKKAIDRILPVLRDQGLIYYDAVKEAGLGEANLYDPYAALS
DKLDYYGKALAGHVMGASGKFEDSDEKRYGTISNPTVHIALNQVRAVVNELIRLHGKPDEVVIE
IGRDLPMGADGKRELERFQKEGRAKNERARDELKKLGHIDSRESRQKFQLWEQLAKEPVDRCCP
FTGKMMSISDLFSDKVEIEHLLPFSLTLDDSMANKTVCFRQANRDKGNRAPFDAFGNSPAGYDW
QEILGRSQNLPYAKRWRFLPDAMKRFEADGGFLERQLNDTRYISRYTTEYISTIIPKNKIWVVT
GRLTSLLRGFWGLNSILRGHNTDDGTPAKKSRDDHRHHAIDAIVVGMTSRGLLQKVSKAARRSE
DLDLTRLFEGRIDPWDGFRDEVKKHIDAIIVSHRPRKKSQGALHNDTAYGIVEHAENGASTVVH
RVPITSLGKQSDIEKVRDPLIKSALLNETAGLSGKSFENAVQKWCADNSIKSLRIVETVSIIPI
TDKEGVAYKGYKGDGNAYMDIYQDPTSSKWKGEIVSRFDANQKGFIPSWQSQFPTARLIMRLRI
NDLLKLQDGEIEEIYRVQRLSGSKILMAPHTEANVDARDRDKNDTFKLTSKSPGKLQSASARKV
HISPTGLIREG
SEQ ID NO: 381
MKNILGLDLGLSSIGWSVIRENSEEQELVAMGSRVVSLTAAELSSFTQGNGVSINSQRTQKRTQ
RKGYDRYQLRRTLLRNKLDTLGMLPDDSLSYLPKLQLWGLRAKAVTQRIELNELGRVLLHLNQK
RGYKSIKSDFSGDKKITDYVKTVKTRYDELKEMRLTIGELFFRRLTENAFFRCKEQVYPRQAYV
EEFDCIMNCQRKFYPDILTDETIRCIRDEIIYYQRPLKSCKYLVSRCEFEKRFYLNAAGKKTEA
GPKVSPRTSPLFQVCRLWESINNIVVKDRRNEIVFISAEQRAALFDFLNTHEKLKGSDLLKLLG
LSKTYGYRLGEQFKTGIQGNKTRVEIERALGNYPDKKRLLQFNLQEESSSMVNTETGEIIPMIS
LSFEQEPLYRLWHVLYSIDDREQLQSVLRQKFGIDDDEVLERLSAIDLVKAGFGNKSSKAIRRI
LPFLQLGMNYAEACEAAGYNHSNNYTKAENEARALLDRLPAIKKNELRQPVVEKILNQMVNVVN
ALMEKYGRFDEIRVELARELKQSKEERSNTYKSINKNQRENEQIAKRIVEYGVPTRSRIQKYKM
WEESKHCCIYCGQPVDVGDFLRGFDVEVEHIIPKSLYFDDSFANKVCSCRSCNKEKNNRTAYDY
MKSKGEKALSDYVERVNTMYTNNQISKTKWQNLLTPVDKISIDFIDRQLRESQYIARKAKEILT
SICYNVTATSGSVTSFLRHVWGWDTVLHDLNFDRYKKVGLTEVIEVNHRGSVIRREQIKDWSKR
FDHRHHAIDALTIACTKQAYIQRLNNLRAEEGPDFNKMSLERYIQSQPHFSVAQVREAVDRILV
SFRAGKRAVTPGKRYIRKNRKRISVQSVLIPRGALSEESVYGVIHVWEKDEQGHVIQKQRAVMK
YPITSINREMLDKEKVVDKRIHRILSGRLAQYNDNPKEAFAKPVYIDKECRIPIRTVRCFAKPA
INTLVPLKKDDKGNPVAWVNPGNNHHVAIYRDEDGKYKERTVTFWEAVDRCRVGIPAIVTQPDT
IWDNILQRNDISENVLESLPDVKWQFVLSLQQNEMFILGMNEEDYRYAMDQQDYALLNKYLYRV
QKLSKSDYSFRYHTETSVEDKYDGKPNLKLSMQMGKLKRVSIKSLLGLNPHKVHISVLGEIKEI
S
SEQ ID NO: 382
MAEKQHRWGLDIGTNSIGWAVIALIEGRPAGLVATGSRIFSDGRNPKDGSSLAVERRGPRQMRR
RRDRYLRRRDRFMQALINVGLMPGDAAARKALVTENPYVLRQRGLDQALTLPEFGRALFHLNQR
RGFQSNRKTDRATAKESGKVKNAIAAFRAGMGNARTVGEALARRLEDGRPVRARMVGQGKDEHY
ELYIAREWIAQEFDALWASQQRFHAEVLADAARDRLRAILLFQRKLLPVPVGKCFLEPNQPRVA
AALPSAQRFRLMQELNHLRVMTLADKRERPLSFQERNDLLAQLVARPKCGFDMLRKIVFGANKE
AYRFTIESERRKELKGCDTAAKLAKVNALGTRWQALSLDEQDRLVCLLLDGENDAVLADALREH
YGLTDAQIDTLLGLSFEDGHMRLGRSALLRVLDALESGRDEQGLPLSYDKAVVAAGYPAHTADL
ENGERDALPYYGELLWRYTQDAPTAKNDAERKFGKIANPTVHIGLNQLRKLVNALIQRYGKPAQ
IVVELARNLKAGLEEKERIKKQQTANLERNERIRQKLQDAGVPDNRENRLRMRLFEELGQGNGL
GTPCIYSGRQISLQRLFSNDVQVDHILPFSKTLDDSFANKVLAQHDANRYKGNRGPFEAFGANR
DGYAWDDIRARAAVLPRNKRNRFAETAMQDWLHNETDFLARQLTDTAYLSRVARQYLTAICSKD
DVYVSPGRLTAMLRAKWGLNRVLDGVMEEQGRPAVKNRDDHRHHAIDAVVIGATDRAMLQQVAT
LAARAREQDAERLIGDMPTPWPNFLEDVRAAVARCVVSHKPDHGPEGGLHNDTAYGIVAGPFED
GRYRVRHRVSLFDLKPGDLSNVRCDAPLQAELEPIFEQDDARAREVALTALAERYRQRKVWLEE
LMSVLPIRPRGEDGKTLPDSAPYKAYKGDSNYCYELFINERGRWDGELISTFRANQAAYRRFRN
DPARFRRYTAGGRPLLMRLCINDYIAVGTAAERTIFRVVKMSENKITLAEHFEGGTLKQRDADK
DDPFKYLTKSPGALRDLGARRIFVDLIGRVLDPGIKGD
SEQ ID NO: 383
MIERILGVDLGISSLGWAIVEYDKDDEAANRIIDCGVRLFTAAETPKKKESPNKARREARGIRR
VLNRRRVRMNMIKKLFLRAGLIQDVDLDGEGGMFYSKANRADVWELRHDGLYRLLKGDELARVL
IHIAKHRGYKFIGDDEADEESGKVKKAGVVLRQNFEAAGCRTVGEWLWRERGANGKKRNKHGDY
EISIHRDLLVEEVEAIFVAQQEMRSTIATDALKAAYREIAFFVRPMQRIEKMVGHCTYFPEERR
APKSAPTAEKFIAISKFFSTVIIDNEGWEQKIIERKTLEELLDFAVSREKVEFRHLRKFLDLSD
NEIFKGLHYKGKPKTAKKREATLFDPNEPTELEFDKVEAEKKAWISLRGAAKLREALGNEFYGR
FVALGKHADEATKILTYYKDEGQKRRELTKLPLEAEMVERLVKIGFSDFLKLSLKAIRDILPAM
ESGARYDEAVLMLGVPHKEKSAILPPLNKTDIDILNPTVIRAFAQFRKVANALVRKYGAFDRVH
FELAREINTKGEIEDIKESQRKNEKERKEAADWIAETSFQVPLTRKNILKKRLYIQQDGRCAYT
GDVIELERLFDEGYCEIDHILPRSRSADDSFANKVLCLARANQQKTDRTPYEWFGHDAARWNAF
ETRTSAPSNRVRTGKGKIDRLLKKNFDENSEMAFKDRNLNDTRYMARAIKTYCEQYWVFKNSHT
KAPVQVRSGKLTSVLRYQWGLESKDRESHTHHAVDAIIIAFSTQGMVQKLSEYYRFKETHREKE
RPKLAVPLANFRDAVEEATRIENTETVKEGVEVKRLLISRPPRARVTGQAHEQTAKPYPRIKQV
KNKKKWRLAPIDEEKFESFKADRVASANQKNFYETSTIPRVDVYHKKGKFHLVPIYLHEMVLNE
LPNLSLGTNPEAMDENFFKFSIFKDDLISIQTQGTPKKPAKIIMGYFKNMHGANMVLSSINNSP
CEGFTCTPVSMDKKHKDKCKLCPEENRIAGRCLQGFLDYWSQEGLRPPRKEFECDQGVKFALDV
KKYQIDPLGYYYEVKQEKRLGTIPQMRSAKKLVKK
SEQ ID NO: 384
MNNSIKSKPEVTIGLDLGVGSVGWAIVDNETNIIHHLGSRLFSQAKTAEDRRSFRGVRRLIRRR
KYKLKRFVNLIWKYNSYFGFKNKEDILNNYQEQQKLHNTVLNLKSEALNAKIDPKALSWILHDY
LKNRGHFYEDNRDFNVYPTKELAKYFDKYGYYKGIIDSKEDNDNKLEEELTKYKFSNKHWLEEV
KKVLSNQTGLPEKFKEEYESLFSYVRNYSEGPGSINSVSPYGIYHLDEKEGKVVQKYNNIWDKT
IGKCNIFPDEYRAPKNSPIAMIFNEINELSTIRSYSIYLTGWFINQEFKKAYLNKLLDLLIKTN
GEKPIDARQFKKLREETIAESIGKETLKDVENEEKLEKEDHKWKLKGLKLNTNGKIQYNDLSSL
AKFVHKLKQHLKLDFLLEDQYATLDKINFLQSLFVYLGKHLRYSNRVDSANLKEFSDSNKLFER
ILQKQKDGLFKLFEQTDKDDEKILAQTHSLSTKAMLLAITRMTNLDNDEDNQKNNDKGWNFEAI
KNFDQKFIDITKKNNNLSLKQNKRYLDDRFINDAILSPGVKRILREATKVFNAILKQFSEEYDV
TKVVIELARELSEEKELENTKNYKKLIKKNGDKISEGLKALGISEDEIKDILKSPTKSYKFLLW
LQQDHIDPYSLKEIAFDDIFTKTEKFEIDHIIPYSISFDDSSSNKLLVLAESNQAKSNQTPYEF
ISSGNAGIKWEDYEAYCRKFKDGDSSLLDSTQRSKKFAKMMKTDTSSKYDIGFLARNLNDTRYA
TIVFRDALEDYANNHLVEDKPMFKVVCINGSVTSFLRKNFDDSSYAKKDRDKNIHHAVDASIIS
IFSNETKTLFNQLTQFADYKLFKNTDGSWKKIDPKTGVVTEVTDENWKQIRVRNQVSEIAKVIE
KYIQDSNIERKARYSRKIENKTNISLFNDTVYSAKKVGYEDQIKRKNLKTLDIHESAKENKNSK
VKRQFVYRKLVNVSLLNNDKLADLFAEKEDILMYRANPWVINLAEQIFNEYTENKKIKSQNVFE
KYMLDLTKEFPEKFSEFLVKSMLRNKTAIIYDDKKNIVHRIKRLKMLSSELKENKLSNVIIRSK
NQSGTKLSYQDTINSLALMIMRSIDPTAKKQYIRVPLNTLNLHLGDHDFDLHNMDAYLKKPKFV
KYLKANEIGDEYKPWRVLTSGTLLIHKKDKKLMYISSFQNLNDVIEIKNLIETEYKENDDSDSK
KKKKANRFLMTLSTILNDYILLDAKDNFDILGLSKNRIDEILNSKLGLDKIVK
SEQ ID NO: 385
MGGSEVGTVPVTWRLGVDVGERSIGLAAVSYEEDKPKEILAAVSWIHDGGVGDERSGASRLALR
GMARRARRLRRFRRARLRDLDMLLSELGWTPLPDKNVSPVDAWLARKRLAEEYVVDETERRRLL
GYAVSHMARHRGWRNPWTTIKDLKNLPQPSDSWERTRESLEARYSVSLEPGTVGQWAGYLLQRA
PGIRLNPTQQSAGRRAELSNATAFETRLRQEDVLWELRCIADVQGLPEDVVSNVIDAVFCQKRP
SVPAERIGRDPLDPSQLRASRACLEFQEYRIVAAVANLRIRDGSGSRPLSLEERNAVIEALLAQ
TERSLTWSDIALEILKLPNESDLTSVPEEDGPSSLAYSQFAPFDETSARIAEFIAKNRRKIPTF
AQWWQEQDRTSRSDLVAALADNSIAGEEEQELLVHLPDAELEALEGLALPSGRVAYSRLTLSGL
TRVMRDDGVDVHNARKTCFGVDDNWRPPLPALHEATGHPVVDRNLAILRKFLSSATMRWGPPQS
IVVELARGASESRERQAEEEAARRAHRKANDRIRAELRASGLSDPSPADLVRARLLELYDCHCM
YCGAPISWENSELDHIVPRTDGGSNRHENLAITCGACNKEKGRRPFASWAETSNRVQLRDVIDR
VQKLKYSGNMYWTRDEFSRYKKSVVARLKRRTSDPEVIQSIESTGYAAVALRDRLLSYGEKNGV
AQVAVFRGGVTAEARRWLDISIERLFSRVAIFAQSTSTKRLDRRHHAVDAVVLTTLTPGVAKTL
ADARSRRVSAEFWRRPSDVNRHSTEEPQSPAYRQWKESCSGLGDLLISTAARDSIAVAAPLRLR
PTGALHEETLRAFSEHTVGAAWKGAELRRIVEPEVYAAFLALTDPGGRFLKVSPSEDVLPADEN
RHIVLSDRVLGPRDRVKLFPDDRGSIRVRGGAAYIASFHHARVFRWGSSHSPSFALLRVSLADL
AVAGLLRDGVDVFTAELPPWTPAWRYASIALVKAVESGDAKQVGWLVPGDELDFGPEGVTTAAG
DLSMFLKYFPERHWVVTGFEDDKRINLKPAFLSAEQAEVLRTERSDRPDTLTEAGEILAQFFPR
CWRATVAKVLCHPGLTVIRRTALGQPRWRRGHLPYSWRPWSADPWSGGTP
SEQ ID NO: 386
MHNKKNITIGFDLGIASIGWAIIDSTTSKILDWGTRTFEERKTANERRAFRSTRRNIRRKAYRN
QRFINLILKYKDLFELKNISDIQRANKKDTENYEKIISFFTEIYKKCAAKHSNILEVKVKALDS
KIEKLDLIWILHDYLENRGFFYDLEEENVADKYEGIEHPSILLYDFFKKNGFFKSNSSIPKDLG
GYSFSNLQWVNEIKKLFEVQEINPEFSEKFLNLFTSVRDYAKGPGSEHSASEYGIFQKDEKGKV
FKKYDNIWDKTIGKCSFFVEENRSPVNYPSYEIFNLLNQLINLSTDLKTTNKKIWQLSSNDRNE
LLDELLKVKEKAKIISISLKKNEIKKIILKDFGFEKSDIDDQDTIEGRKIIKEEPTTKLEVTKH
LLATIYSHSSDSNWININNILEFLPYLDAICIILDREKSRGQDEVLKKLTEKNIFEVLKIDREK
QLDFVKSIFSNTKFNFKKIGNFSLKAIREFLPKMFEQNKNSEYLKWKDEEIRRKWEEQKSKLGK
TDKKTKYLNPRIFQDEIISPGTKNTFEQAVLVLNQIIKKYSKENIIDAIIIESPREKNDKKTIE
EIKKRNKKGKGKTLEKLFQILNLENKGYKLSDLETKPAKLLDRLRFYHQQDGIDLYTLDKINID
QLINGSQKYEIEHIIPYSMSYDNSQANKILTEKAENLKKGKLIASEYIKRNGDEFYNKYYEKAK
ELFINKYKKNKKLDSYVDLDEDSAKNRFRFLTLQDYDEFQVEFLARNLNDTRYSTKLFYHALVE
HFENNEFFTYIDENSSKHKVKISTIKGHVTKYFRAKPVQKNNGPNENLNNNKPEKIEKNRENNE
HHAVDAAIVAIIGNKNPQIANLLTLADNKTDKKFLLHDENYKENIETGELVKIPKFEVDKLAKV
EDLKKIIQEKYEEAKKHTAIKFSRKTRTILNGGLSDETLYGFKYDEKEDKYFKIIKKKLVTSKN
EELKKYFENPFGKKADGKSEYTVLMAQSHLSEFNKLKEIFEKYNGFSNKTGNAFVEYMNDLALK
EPTLKAEIESAKSVEKLLYYNFKPSDQFTYHDNINNKSFKRFYKNIRIIEYKSIPIKFKILSKH
DGGKSFKDTLFSLYSLVYKVYENGKESYKSIPVTSQMRNFGIDEFDFLDENLYNKEKLDIYKSD
FAKPIPVNCKPVFVLKKGSILKKKSLDIDDFKETKETEEGNYYFISTISKRFNRDTAYGLKPLK
LSVVKPVAEPSTNPIFKEYIPIHLDELGNEYPVKIKEHTDDEKLMCTIK

Nucleic Acids Encoding Cas9 Molecules

Nucleic acids encoding the Cas9 molecules or Cas9 polypeptides, e.g., an eaCas9 molecule or eaCas9 polypeptide are provided herein.

Exemplary nucleic acids encoding Cas9 molecules are described in Cong et al., SCIENCE 2013, 399(6121):819-823; Wang et al., CELL 2013, 153(4):910-918; Mali et al., SCIENCE 2013, 399(6121):823-826; Jinek et al., SCIENCE 2012, 337(6096):816-821. Another exemplary nucleic acid encoding a Cas9 molecule or Cas9 polypeptide is shown in FIG. 8.

In an embodiment, a nucleic acid encoding a Cas9 molecule or Cas9 polypeptide can be a synthetic nucleic acid sequence. For example, the synthetic nucleic acid molecule can be chemically modified, e.g., as described in Section VIII. In an embodiment, the Cas9 mRNA has one or more (e.g., all of the following properties: it is capped, polyadenylated, substituted with 5-methylcytidine and/or pseudouridine.

In addition, or alternatively, the synthetic nucleic acid sequence can be codon optimized, e.g., at least one non-common codon or less-common codon has been replaced by a common codon. For example, the synthetic nucleic acid can direct the synthesis of an optimized messenger mRNA, e.g., optimized for expression in a mammalian expression system, e.g., described herein.

In addition, or alternatively, a nucleic acid encoding a Cas9 molecule or Cas9 polypeptide may comprise a nuclear localization sequence (NLS). Nuclear localization sequences are known in the art.

Provided below is an exemplary codon optimized nucleic acid sequence encoding a Cas9 molecule of S. pyogenes.

(SEQ ID NO: 22)
ATGGATAAAA AGTACAGCAT CGGGCTGGAC ATCGGTACAA
ACTCAGTGGG GTGGGCCGTG ATTACGGACG AGTACAAGGT
ACCCTCCAAA AAATTTAAAG TGCTGGGTAA CACGGACAGA
CACTCTATAA AGAAAAATCT TATTGGAGCC TTGCTGTTCG
ACTCAGGCGA GACAGCCGAA GCCACAAGGT TGAAGCGGAC
CGCCAGGAGG CGGTATACCA GGAGAAAGAA CCGCATATGC
TACCTGCAAG AAATCTTCAG TAACGAGATG GCAAAGGTTG
ACGATAGCTT TTTCCATCGC CTGGAAGAAT CCTTTCTTGT
TGAGGAAGAC AAGAAGCACG AACGGCACCC CATCTTTGGC
AATATTGTCG ACGAAGTGGC ATATCACGAA AAGTACCCGA
CTATCTACCA CCTCAGGAAG AAGCTGGTGG ACTCTACCGA
TAAGGCGGAC CTCAGACTTA TTTATTTGGC ACTCGCCCAC
ATGATTAAAT TTAGAGGACA TTTCTTGATC GAGGGCGACC
TGAACCCGGA CAACAGTGAC GTCGATAAGC TGTTCATCCA
ACTTGTGCAG ACCTACAATC AACTGTTCGA AGAAAACCCT
ATAAATGCTT CAGGAGTCGA CGCTAAAGCA ATCCTGTCCG
CGCGCCTCTC AAAATCTAGA AGACTTGAGA ATCTGATTGC
TCAGTTGCCC GGGGAAAAGA AAAATGGATT GTTTGGCAAC
CTGATCGCCC TCAGTCTCGG ACTGACCCCA AATTTCAAAA
GTAACTTCGA CCTGGCCGAA GACGCTAAGC TCCAGCTGTC
CAAGGACACA TACGATGACG ACCTCGACAA TCTGCTGGCC
CAGATTGGGG ATCAGTACGC CGATCTCTTT TTGGCAGCAA
AGAACCTGTC CGACGCCATC CTGTTGAGCG ATATCTTGAG
AGTGAACACC GAAATTACTA AAGCACCCCT TAGCGCATCT
ATGATCAAGC GGTACGACGA GCATCATCAG GATCTGACCC
TGCTGAAGGC TCTTGTGAGG CAACAGCTCC CCGAAAAATA
CAAGGAAATC TTCTTTGACC AGAGCAAAAA CGGCTACGCT
GGCTATATAG ATGGTGGGGC CAGTCAGGAG GAATTCTATA
AATTCATCAA GCCCATTCTC GAGAAAATGG ACGGCACAGA
GGAGTTGCTG GTCAAACTTA ACAGGGAGGA CCTGCTGCGG
AAGCAGCGGA CCTTTGACAA CGGGTCTATC CCCCACCAGA
TTCATCTGGG CGAACTGCAC GCAATCCTGA GGAGGCAGGA
GGATTTTTAT CCTTTTCTTA AAGATAACCG CGAGAAAATA
GAAAAGATTC TTACATTCAG GATCCCGTAC TACGTGGGAC
CTCTCGCCCG GGGCAATTCA CGGTTTGCCT GGATGACAAG
GAAGTCAGAG GAGACTATTA CACCTTGGAA CTTCGAAGAA
GTGGTGGACA AGGGTGCATC TGCCCAGTCT TTCATCGAGC
GGATGACAAA TTTTGACAAG AACCTCCCTA ATGAGAAGGT
GCTGCCCAAA CATTCTCTGC TCTACGAGTA CTTTACCGTC
TACAATGAAC TGACTAAAGT CAAGTACGTC ACCGAGGGAA
TGAGGAAGCC GGCATTCCTT AGTGGAGAAC AGAAGAAGGC
GATTGTAGAC CTGTTGTTCA AGACCAACAG GAAGGTGACT
GTGAAGCAAC TTAAAGAAGA CTACTTTAAG AAGATCGAAT
GTTTTGACAG TGTGGAAATT TCAGGGGTTG AAGACCGCTT
CAATGCGTCA TTGGGGACTT ACCATGATCT TCTCAAGATC
ATAAAGGACA AAGACTTCCT GGACAACGAA GAAAATGAGG
ATATTCTCGA AGACATCGTC CTCACCCTGA CCCTGTTCGA
AGACAGGGAA ATGATAGAAG AGCGCTTGAA AACCTATGCC
CACCTCTTCG ACGATAAAGT TATGAAGCAG CTGAAGCGCA
GGAGATACAC AGGATGGGGA AGATTGTCAA GGAAGCTGAT
CAATGGAATT AGGGATAAAC AGAGTGGCAA GACCATACTG
GATTTCCTCA AATCTGATGG CTTCGCCAAT AGGAACTTCA
TGCAACTGAT TCACGATGAC TCTCTTACCT TCAAGGAGGA
CATTCAAAAG GCTCAGGTGA GCGGGCAGGG AGACTCCCTT
CATGAACACA TCGCGAATTT GGCAGGTTCC CCCGCTATTA
AAAAGGGCAT CCTTCAAACT GTCAAGGTGG TGGATGAATT
GGTCAAGGTA ATGGGCAGAC ATAAGCCAGA AAATATTGTG
ATCGAGATGG CCCGCGAAAA CCAGACCACA CAGAAGGGCC
AGAAAAATAG TAGAGAGCGG ATGAAGAGGA TCGAGGAGGG
CATCAAAGAG CTGGGATCTC AGATTCTCAA AGAACACCCC
GTAGAAAACA CACAGCTGCA GAACGAAAAA TTGTACTTGT
ACTATCTGCA GAACGGCAGA GACATGTACG TCGACCAAGA
ACTTGATATT AATAGACTGT CCGACTATGA CGTAGACCAT
ATCGTGCCCC AGTCCTTCCT GAAGGACGAC TCCATTGATA
ACAAAGTCTT GACAAGAAGC GACAAGAACA GGGGTAAAAG
TGATAATGTG CCTAGCGAGG AGGTGGTGAA AAAAATGAAG
AACTACTGGC GACAGCTGCT TAATGCAAAG CTCATTACAC
AACGGAAGTT CGATAATCTG ACGAAAGCAG AGAGAGGTGG
CTTGTCTGAG TTGGACAAGG CAGGGTTTAT TAAGCGGCAG
CTGGTGGAAA CTAGGCAGAT CACAAAGCAC GTGGCGCAGA
TTTTGGACAG CCGGATGAAC ACAAAATACG ACGAAAATGA
TAAACTGATA CGAGAGGTCA AAGTTATCAC GCTGAAAAGC
AAGCTGGTGT CCGATTTTCG GAAAGACTTC CAGTTCTACA
AAGTTCGCGA GATTAATAAC TACCATCATG CTCACGATGC
GTACCTGAAC GCTGTTGTCG GGACCGCCTT GATAAAGAAG
TACCCAAAGC TGGAATCCGA GTTCGTATAC GGGGATTACA
AAGTGTACGA TGTGAGGAAA ATGATAGCCA AGTCCGAGCA
GGAGATTGGA AAGGCCACAG CTAAGTACTT CTTTTATTCT
AACATCATGA ATTTTTTTAA GACGGAAATT ACCCTGGCCA
ACGGAGAGAT CAGAAAGCGG CCCCTTATAG AGACAAATGG
TGAAACAGGT GAAATCGTCT GGGATAAGGG CAGGGATTTC
GCTACTGTGA GGAAGGTGCT GAGTATGCCA CAGGTAAATA
TCGTGAAAAA AACCGAAGTA CAGACCGGAG GATTTTCCAA
GGAAAGCATT TTGCCTAAAA GAAACTCAGA CAAGCTCATC
GCCCGCAAGA AAGATTGGGA CCCTAAGAAA TACGGGGGAT
TTGACTCACC CACCGTAGCC TATTCTGTGC TGGTGGTAGC
TAAGGTGGAA AAAGGAAAGT CTAAGAAGCT GAAGTCCGTG
AAGGAACTCT TGGGAATCAC TATCATGGAA AGATCATCCT
TTGAAAAGAA CCCTATCGAT TTCCTGGAGG CTAAGGGTTA
CAAGGAGGTC AAGAAAGACC TCATCATTAA ACTGCCAAAA
TACTCTCTCT TCGAGCTGGA AAATGGCAGG AAGAGAATGT
TGGCCAGCGC CGGAGAGCTG CAAAAGGGAA ACGAGCTTGC
TCTGCCCTCC AAATATGTTA ATTTTCTCTA TCTCGCTTCC
CACTATGAAA AGCTGAAAGG GTCTCCCGAA GATAACGAGC
AGAAGCAGCT GTTCGTCGAA CAGCACAAGC ACTATCTGGA
TGAAATAATC GAACAAATAA GCGAGTTCAG CAAAAGGGTT
ATCCTGGCGG ATGCTAATTT GGACAAAGTA CTGTCTGCTT
ATAACAAGCA CCGGGATAAG CCTATTAGGG AACAAGCCGA
GAATATAATT CACCTCTTTA CACTCACGAA TCTCGGAGCC
CCCGCCGCCT TCAAATACTT TGATACGACT ATCGACCGGA
AACGGTATAC CAGTACCAAA GAGGTCCTCG ATGCCACCCT
CATCCACCAG TCAATTACTG GCCTGTACGA AACACGGATC
GACCTCTCTC AACTGGGCGG CGACTAG

Provided below is the corresponding amino acid sequence of a S. pyogenes Cas9 molecule.

(SEQ ID NO: 23)
MDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIG
ALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFF
HRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTD
KADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLF
EENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALS
LGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAK
NLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQL
PEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVK
LNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQS
FIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAF
LSGEQKKAIVDLLFKTNRKVIVKQLKEDYFKKIECFDSVEISGVEDRFN
ASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLK
TYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSD
GFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKK
GILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRI
EEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRL
SDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNY
WRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHV
AQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINN
YHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEI
GKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGR
DFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWD
PKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEK
NPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNE
LALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQIS
EFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAA
FKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGD*

Provided below is an exemplary codon optimized nucleic acid sequence encoding a Cas9 molecule of N. meningitidis.

(SEQ ID NO: 24)
ATGGCCGCCTTCAAGCCCAACCCCATCAACTACATCCTGGGCCTGGACA
TCGGCATCGCCAGCGTGGGCTGGGCCATGGTGGAGATCGACGAGGACGA
GAACCCCATCTGCCTGATCGACCTGGGTGTGCGCGTGTTCGAGCGCGCT
GAGGTGCCCAAGACTGGTGACAGTCTGGCTATGGCTCGCCGGCTTGCTC
GCTCTGTTCGGCGCCTTACTCGCCGGCGCGCTCACCGCCTTCTGCGCGC
TCGCCGCCTGCTGAAGCGCGAGGGTGTGCTGCAGGCTGCCGACTTCGAC
GAGAACGGCCTGATCAAGAGCCTGCCCAACACTCCTTGGCAGCTGCGCG
CTGCCGCTCTGGACCGCAAGCTGACTCCTCTGGAGTGGAGCGCCGTGCT
GCTGCACCTGATCAAGCACCGCGGCTACCTGAGCCAGCGCAAGAACGAG
GGCGAGACCGCCGACAAGGAGCTGGGTGCTCTGCTGAAGGGCGTGGCCG
ACAACGCCCACGCCCTGCAGACTGGTGACTTCCGCACTCCTGCTGAGCT
GGCCCTGAACAAGTTCGAGAAGGAGAGCGGCCACATCCGCAACCAGCGC
GGCGACTACAGCCACACCTTCAGCCGCAAGGACCTGCAGGCCGAGCTGA
TCCTGCTGTTCGAGAAGCAGAAGGAGTTCGGCAACCCCCACGTGAGCGG
CGGCCTGAAGGAGGGCATCGAGACCCTGCTGATGACCCAGCGCCCCGCC
CTGAGCGGCGACGCCGTGCAGAAGATGCTGGGCCACTGCACCTTCGAGC
CAGCCGAGCCCAAGGCCGCCAAGAACACCTACACCGCCGAGCGCTTCAT
CTGGCTGACCAAGCTGAACAACCTGCGCATCCTGGAGCAGGGCAGCGAG
CGCCCCCTGACCGACACCGAGCGCGCCACCCTGATGGACGAGCCCTACC
GCAAGAGCAAGCTGACCTACGCCCAGGCCCGCAAGCTGCTGGGTCTGGA
GGACACCGCCTTCTTCAAGGGCCTGCGCTACGGCAAGGACAACGCCGAG
GCCAGCACCCTGATGGAGATGAAGGCCTACCACGCCATCAGCCGCGCCC
TGGAGAAGGAGGGCCTGAAGGACAAGAAGAGTCCTCTGAACCTGAGCCC
CGAGCTGCAGGACGAGATCGGCACCGCCTTCAGCCTGTTCAAGACCGAC
GAGGACATCACCGGCCGCCTGAAGGACCGCATCCAGCCCGAGATCCTGG
AGGCCCTGCTGAAGCACATCAGCTTCGACAAGTTCGTGCAGATCAGCCT
GAAGGCCCTGCGCCGCATCGTGCCCCTGATGGAGCAGGGCAAGCGCTAC
GACGAGGCCTGCGCCGAGATCTACGGCGACCACTACGGCAAGAAGAACA
CCGAGGAGAAGATCTACCTGCCTCCTATCCCCGCCGACGAGATCCGCAA
CCCCGTGGTGCTGCGCGCCCTGAGCCAGGCCCGCAAGGTGATCAACGGC
GTGGTGCGCCGCTACGGCAGCCCCGCCCGCATCCACATCGAGACCGCCC
GCGAGGTGGGCAAGAGCTTCAAGGACCGCAAGGAGATCGAGAAGCGCCA
GGAGGAGAACCGCAAGGACCGCGAGAAGGCCGCCGCCAAGTTCCGCGAG
TACTTCCCCAACTTCGTGGGCGAGCCCAAGAGCAAGGACATCCTGAAGC
TGCGCCTGTACGAGCAGCAGCACGGCAAGTGCCTGTACAGCGGCAAGGA
GATCAACCTGGGCCGCCTGAACGAGAAGGGCTACGTGGAGATCGACCAC
GCCCTGCCCTTCAGCCGCACCTGGGACGACAGCTTCAACAACAAGGTGC
TGGTGCTGGGCAGCGAGAACCAGAACAAGGGCAACCAGACCCCCTACGA
GTACTTCAACGGCAAGGACAACAGCCGCGAGTGGCAGGAGTTCAAGGCC
CGCGTGGAGACCAGCCGCTTCCCCCGCAGCAAGAAGCAGCGCATCCTGC
TGCAGAAGTTCGACGAGGACGGCTTCAAGGAGCGCAACCTGAACGACAC
CCGCTACGTGAACCGCTTCCTGTGCCAGTTCGTGGCCGACCGCATGCGC
CTGACCGGCAAGGGCAAGAAGCGCGTGTTCGCCAGCAACGGCCAGATCA
CCAACCTGCTGCGCGGCTTCTGGGGCCTGCGCAAGGTGCGCGCCGAGAA
CGACCGCCACCACGCCCTGGACGCCGTGGTGGTGGCCTGCAGCACCGTG
GCCATGCAGCAGAAGATCACCCGCTTCGTGCGCTACAAGGAGATGAACG
CCTTCGACGGTAAAACCATCGACAAGGAGACCGGCGAGGTGCTGCACCA
GAAGACCCACTTCCCCCAGCCCTGGGAGTTCTTCGCCCAGGAGGTGATG
ATCCGCGTGTTCGGCAAGCCCGACGGCAAGCCCGAGTTCGAGGAGGCCG
ACACCCCCGAGAAGCTGCGCACCCTGCTGGCCGAGAAGCTGAGCAGCCG
CCCTGAGGCCGTGCACGAGTACGTGACTCCTCTGTTCGTGAGCCGCGCC
CCCAACCGCAAGATGAGCGGTCAGGGTCACATGGAGACCGTGAAGAGCG
CCAAGCGCCTGGACGAGGGCGTGAGCGTGCTGCGCGTGCCCCTGACCCA
GCTGAAGCTGAAGGACCTGGAGAAGATGGTGAACCGCGAGCGCGAGCCC
AAGCTGTACGAGGCCCTGAAGGCCCGCCTGGAGGCCCACAAGGACGACC
CCGCCAAGGCCTTCGCCGAGCCCTTCTACAAGTACGACAAGGCCGGCAA
CCGCACCCAGCAGGTGAAGGCCGTGCGCGTGGAGCAGGTGCAGAAGACC
GGCGTGTGGGTGCGCAACCACAACGGCATCGCCGACAACGCCACCATGG
TGCGCGTGGACGTGTTCGAGAAGGGCGACAAGTACTACCTGGTGCCCAT
CTACAGCTGGCAGGTGGCCAAGGGCATCCTGCCCGACCGCGCCGTGGTG
CAGGGCAAGGACGAGGAGGACTGGCAGCTGATCGACGACAGCTTCAACT
TCAAGTTCAGCCTGCACCCCAACGACCTGGTGGAGGTGATCACCAAGAA
GGCCCGCATGTTCGGCTACTTCGCCAGCTGCCACCGCGGCACCGGCAAC
ATCAACATCCGCATCCACGACCTGGACCACAAGATCGGCAAGAACGGCA
TCCTGGAGGGCATCGGCGTGAAGACCGCCCTGAGCTTCCAGAAGTACCA
GATCGACGAGCTGGGCAAGGAGATCCGCCCCTGCCGCCTGAAGAAGCGC
CCTCCTGTGCGCTAA

Provided below is the corresponding amino acid sequence of a N. meningitidis Cas9 molecule.

(SEQ ID NO: 25)
MAAFKPNPINYILGLDIGIASVGWAMVEIDEDENPICLIDLGVRVFERA
EVPKTGDSLAMARRLARSVRRLTRRRAHRLLRARRLLKREGVLQAADFD
ENGLIKSLPNTPWQLRAAALDRKLTPLEWSAVLLHLIKHRGYLSQRKNE
GETADKELGALLKGVADNAHALQTGDFRTPAELALNKFEKESGHIRNQR
GDYSHTFSRKDLQAELILLFEKQKEFGNPHVSGGLKEGIETLLMTQRPA
LSGDAVQKMLGHCTFEPAEPKAAKNTYTAERFIWLTKLNNLRILEQGSE
RPLTDTERATLMDEPYRKSKLTYAQARKLLGLEDTAFFKGLRYGKDNAE
ASTLMEMKAYHAISRALEKEGLKDKKSPLNLSPELQDEIGTAFSLFKTD
EDITGRLKDRIQPEILEALLKHISFDKFVQISLKALRRIVPLMEQGKRY
DEACAEIYGDHYGKKNTEEKIYLPPIPADEIRNPVVLRALSQARKVING
VVRRYGSPARIHIETAREVGKSFKDRKEIEKRQEENRKDREKAAAKFRE
YFPNFVGEPKSKDILKLRLYEQQHGKCLYSGKEINLGRLNEKGYVEIDH
ALPFSRTWDDSFNNKVLVLGSENQNKGNQTPYEYFNGKDNSREWQEFKA
RVETSRFPRSKKQRILLQKFDEDGFKERNLNDTRYVNRFLCQFVADRMR
LTGKGKKRVFASNGQITNLLRGFWGLRKVRAENDRHHALDAVVVACSTV
AMQQKITRFVRYKEMNAFDGKTIDKETGEVLHQKTHFPQPWEFFAQEVM
IRVFGKPDGKPEFEEADTPEKLRTLLAEKLSSRPEAVHEYVTPLFVSRA
PNRKMSGQGHMETVKSAKRLDEGVSVLRVPLTQLKLKDLEKMVNREREP
KLYEALKARLEAHKDDPAKAFAEPFYKYDKAGNRTQQVKAVRVEQVQKT
GVWVRNHNGIADNATMVRVDVFEKGDKYYLVPIYSWQVAKGILPDRAVV
QGKDEEDWQLIDDSFNFKFSLHPNDLVEVITKKARMFGYFASCHRGIGN
INIRIHDLDHKIGKNGILEGIGVKTALSFQKYQIDELGKEIRPCRLKKR
PPVR*

Provided below is an amino acid sequence of a S. aureus Cas9 molecule.

(SEQ ID NO: 26)
MKRNYILGLDIGITSVGYGIIDYETRDVIDAGVRLFKEANVENNEGRRS
KRGARRLKRRRRHRIQRVKKLLFDYNLLTDHSELSGINPYEARVKGLSQ
KLSEEEFSAALLHLAKRRGVHNVNEVEEDTGNELSTKEQISRNSKALEE
KYVAELQLERLKKDGEVRGSINRFKTSDYVKEAKQLLKVQKAYHQLDQS
FIDTYIDLLETRRTYYEGPGEGSPFGWKDIKEWYEMLMGHCTYFFEELR
SVKYAYNADLYNALNDLNNLVITRDENEKLEYYEKFQIIENVFKQKKKP
TLKQIAKEILVNEEDIKGYRVTSTGKPEFTNLKVYHDIKDITARKEIIE
NAELLDQIAKILTIYQSSEDIQEELTNLNSELTQEEIEQISNLKGYTGT
HNLSLKAINLILDELWHTNDNQIAIFNRLKLVPKKVDLSQQKEIPTTLV
DDFILSPVVKRSFIQSIKVINAIIKKYGLPNDIIIELAREKNSKDAQKM
INEMQKRNRQTNERIEEIIRTTGKENAKYLIEKIKLHDMQEGKCLYSLE
AIPLEDLLNNPFNYEVDHIIPRSVSFDNSFNNKVLVKQEENSKKGNRTP
FQYLSSSDSKISYETFKKHILNLAKGKGRISKTKKEYLLEERDINRFSV
QKDFINRNLVDTRYATRGLMNLLRSYFRVNNLDVKVKSINGGFTSFLRR
KWKFKKERNKGYKHHAEDALIIANADFIFKEWKKLDKAKKVMENQMFEE
KQAESMPEIETEQEYKEIFITPHQIKHIKDFKDYKYSHRVDKKPNRELI
NDTLYSTRKDDKGNTLIVNNLNGLYDKDNDKLKKLINKSPEKLLMYHHD
PQTYQKLKLIMEQYGDEKNPLYKYYEETGNYLTKYSKKDNGPVIKKIKY
YGNKLNAHLDITDDYPNSRNKVVKLSLKPYRFDVYLDNGVYKFVTVKNL
DVIKKENYYEVNSKCYEEAKKLKKISNQAEFIASFYNNDLIKINGELYR
VIGVNNDLLNRIEVNMIDITYREYLENMNDKRPPRIIKTIASKTQSIKK
YSTDILGNLYEVKSKKHPQIIKKG*

Provided below is an exemplary codon optimized nucleic acid sequence encoding a Cas9 molecule of S. aureus Cas9.

(SEQ ID NO: 39)
ATGAAAAGGAACTACATTCTGGGGCTGGACATCGGGATTACAAGCGTGG
GGTATGGGATTATTGACTATGAAACAAGGGACGTGATCGACGCAGGCGT
CAGACTGTTCAAGGAGGCCAACGTGGAAAACAATGAGGGACGGAGAAGC
AAGAGGGGAGCCAGGCGCCTGAAACGACGGAGAAGGCACAGAATCCAGA
GGGTGAAGAAACTGCTGTTCGATTACAACCTGCTGACCGACCATTCTGA
GCTGAGTGGAATTAATCCTTATGAAGCCAGGGTGAAAGGCCTGAGTCAG
AAGCTGTCAGAGGAAGAGTTTTCCGCAGCTCTGCTGCACCTGGCTAAGC
GCCGAGGAGTGCATAACGTCAATGAGGTGGAAGAGGACACCGGCAACGA
GCTGTCTACAAAGGAACAGATCTCACGCAATAGCAAAGCTCTGGAAGAG
AAGTATGTCGCAGAGCTGCAGCTGGAACGGCTGAAGAAAGATGGCGAGG
TGAGAGGGTCAATTAATAGGTTCAAGACAAGCGACTACGTCAAAGAAGC
CAAGCAGCTGCTGAAAGTGCAGAAGGCTTACCACCAGCTGGATCAGAGC
TTCATCGATACTTATATCGACCTGCTGGAGACTCGGAGAACCTACTATG
AGGGACCAGGAGAAGGGAGCCCCTTCGGATGGAAAGACATCAAGGAATG
GTACGAGATGCTGATGGGACATTGCACCTATTTTCCAGAAGAGCTGAGA
AGCGTCAAGTACGCTTATAACGCAGATCTGTACAACGCCCTGAATGACC
TGAACAACCTGGTCATCACCAGGGATGAAAACGAGAAACTGGAATACTA
TGAGAAGTTCCAGATCATCGAAAACGTGTTTAAGCAGAAGAAAAAGCCT
ACACTGAAACAGATTGCTAAGGAGATCCTGGTCAACGAAGAGGACATCA
AGGGCTACCGGGTGACAAGCACTGGAAAACCAGAGTTCACCAATCTGAA
AGTGTATCACGATATTAAGGACATCACAGCACGGAAAGAAATCATTGAG
AACGCCGAACTGCTGGATCAGATTGCTAAGATCCTGACTATCTACCAGA
GCTCCGAGGACATCCAGGAAGAGCTGACTAACCTGAACAGCGAGCTGAC
CCAGGAAGAGATCGAACAGATTAGTAATCTGAAGGGGTACACCGGAACA
CACAACCTGTCCCTGAAAGCTATCAATCTGATTCTGGATGAGCTGTGGC
ATACAAACGACAATCAGATTGCAATCTTTAACCGGCTGAAGCTGGTCCC
AAAAAAGGTGGACCTGAGTCAGCAGAAAGAGATCCCAACCACACTGGTG
GACGATTTCATTCTGTCACCCGTGGTCAAGCGGAGCTTCATCCAGAGCA
TCAAAGTGATCAACGCCATCATCAAGAAGTACGGCCTGCCCAATGATAT
CATTATCGAGCTGGCTAGGGAGAAGAACAGCAAGGACGCACAGAAGATG
ATCAATGAGATGCAGAAACGAAACCGGCAGACCAATGAACGCATTGAAG
AGATTATCCGAACTACCGGGAAAGAGAACGCAAAGTACCTGATTGAAAA
AATCAAGCTGCACGATATGCAGGAGGGAAAGTGTCTGTATTCTCTGGAG
GCCATCCCCCTGGAGGACCTGCTGAACAATCCATTCAACTACGAGGTCG
ATCATATTATCCCCAGAAGCGTGTCCTTCGACAATTCCTTTAACAACAA
GGTGCTGGTCAAGCAGGAAGAGAACTCTAAAAAGGGCAATAGGACTCCT
TTCCAGTACCTGTCTAGTTCAGATTCCAAGATCTCTTACGAAACCTTTA
AAAAGCACATTCTGAATCTGGCCAAAGGAAAGGGCCGCATCAGCAAGAC
CAAAAAGGAGTACCTGCTGGAAGAGCGGGACATCAACAGATTCTCCGTC
CAGAAGGATTTTATTAACCGGAATCTGGTGGACACAAGATACGCTACTC
GCGGCCTGATGAATCTGCTGCGATCCTATTTCCGGGTGAACAATCTGGA
TGTGAAAGTCAAGTCCATCAACGGCGGGTTCACATCTTTTCTGAGGCGC
AAATGGAAGTTTAAAAAGGAGCGCAACAAAGGGTACAAGCACCATGCCG
AAGATGCTCTGATTATCGCAAATGCCGACTTCATCTTTAAGGAGTGGAA
AAAGCTGGACAAAGCCAAGAAAGTGATGGAGAACCAGATGTTCGAAGAG
AAGCAGGCCGAATCTATGCCCGAAATCGAGACAGAACAGGAGTACAAGG
AGATTTTCATCACTCCTCACCAGATCAAGCATATCAAGGATTTCAAGGA
CTACAAGTACTCTCACCGGGTGGATAAAAAGCCCAACAGAGAGCTGATC
AATGACACCCTGTATAGTACAAGAAAAGACGATAAGGGGAATACCCTGA
TTGTGAACAATCTGAACGGACTGTACGACAAAGATAATGACAAGCTGAA
AAAGCTGATCAACAAAAGTCCCGAGAAGCTGCTGATGTACCACCATGAT
CCTCAGACATATCAGAAACTGAAGCTGATTATGGAGCAGTACGGCGACG
AGAAGAACCCACTGTATAAGTACTATGAAGAGACTGGGAACTACCTGAC
CAAGTATAGCAAAAAGGATAATGGCCCCGTGATCAAGAAGATCAAGTAC
TATGGGAACAAGCTGAATGCCCATCTGGACATCACAGACGATTACCCTA
ACAGTCGCAACAAGGTGGTCAAGCTGTCACTGAAGCCATACAGATTCGA
TGTCTATCTGGACAACGGCGTGTATAAATTTGTGACTGTCAAGAATCTG
GATGTCATCAAAAAGGAGAACTACTATGAAGTGAATAGCAAGTGCTACG
AAGAGGCTAAAAAGCTGAAAAAGATTAGCAACCAGGCAGAGTTCATCGC
CTCCTTTTACAACAACGACCTGATTAAGATCAATGGCGAACTGTATAGG
GTCATCGGGGTGAACAATGATCTGCTGAACCGCATTGAAGTGAATATGA
TTGACATCACTTACCGAGAGTATCTGGAAAACATGAATGATAAGCGCCC
CCCTCGAATTATCAAAACAATTGCCTCTAAGACTCAGAGTATCAAAAAG
TACTCAACCGACATTCTGGGAAACCTGTATGAGGTGAAGAGCAAAAAGC
ACCCTCAGATTATCAAAAAGGGC

If any of the above Cas9 sequences are fused with a peptide or polypeptide at the C-terminus, it is understood that the stop codon will be removed.

Other Cas Molecules and Cas9 Polypeptides

Various types of Cas molecules or Cas9 polypeptides can be used to practice the inventions disclosed herein. In some embodiments, Cas molecules of Type II Cas systems are used. In other embodiments, Cas molecules of other Cas systems are used. For example, Type I or Type III Cas molecules may be used. Exemplary Cas molecules (and Cas systems) are described, e.g., in Haft et al., PLOS COMPUTATIONAL BIOLOGY 2005, 1(6): e60 and Makarova et al., NATURE REVIEW MICROBIOLOGY 2011, 9:467-477, the contents of both references are incorporated herein by reference in their entirety. Exemplary Cas molecules (and Cas systems) are also shown in Table 55.

TABLE 55
Cas Systems
			Structure	Families
			of	(and
			encoded	super-
	System	Name	protein	family)
	type	from	(PDB	of
Gene	or	Haft	acces-	encoded	Represent-
name‡	subtype	et al.§	sions)¶	protein#**	atives
cas1	Type I	cas1	3GOD,	COG1518	SERP2463,
	Type II		3LFX		SPy1047
	Type III		and		and ygbT
			2YZS
cas2	Type I	cas2	2IVY,	COG1343	SERP2462,
	Type II		218E	and	SPy1048,
	Type III		and	COG3512	SPy1723
			3EXC		(N-terminal
					domain)
					and ygbF
cas3′	Type I‡‡	cas3	NA	COG1203	APE1232
					and ygcB
cas3″	Subtype	NA	NA	COG2254	APE1231
	I-A				and
	Subtype				BH0336
	I-B
cas4	Subtype	cas4	NA	COG1468	APE1239
	I-A	and			and
	Subtype	csa1			BH0340
	I-B
	Subtype
	I-C
	Subtype
	I-D
	Subtype
	II-B
cas5	Subtype	cas5a,	3KG4	COG1688	APE1234,
	I-A	cas5d,		(RAMP)	BH0337,
	Subtype	cas5e,			devS
	I-B	cas5h,			and
	Subtype	cas5p,			ygcI
	I-C	cas5t
	Subtype	and
	I-E	cmx5
cas6	Subtype	cas6	3I4H	COG1583	PF1131
	I-A	and		and	and
	Subtype	cmx6		COG5551	slr7014
	I-B			(RAMP)
	Subtype
	I-D
	Subtype
	III-A
	Subtype
	III-B
cas6e	Subtype	cse3	1WJ9	(RAMP)	ygcH
	I-E
cas6f	Subtype	csy4	2XLJ	(RAMP)	y1727
	I-F
cas7	Subtype	csa2,	NA	COG1857	devR
	I-A	csd2,		and	and ygcJ
	Subtype	cse4,		COG3649
	I-B	csh2,		(RAMP)
	Subtype	csp1
	I-C	and
	Subtype	cst2
	I-E
cas8a1	Subtype	cmx1,	NA	BH0338-like	LA3191§§
	I-A‡‡	cst1,			and
		csx8,			PG2018§§
		csx13
		and
		CXXC-
		CXX
cas8a2	Subtype	csa4	NA	PH0918	AF0070,
	I-A‡‡	and			AF1873,
		csx9			MJ0385,
					PF0637,
					PH0918
					and
					SSO1401
cas8b	Subtype	csh1	NA	BH0338-like	MTH1090
	I-B‡‡	and			and
		TM1802			TM1802
cas8c	Subtype	csd1	NA	BH0338-like	BH0338
	I-C‡‡	and
		csp2
cas9	Type	csn1	NA	COG3513	FTN_0757
	II‡‡	and			and
		csx12			SPy1046
cas10	Type	cmr2,	NA	COG1353	MTH326,
	III‡‡	csm1			Rv2823c§§
		and			and
		csx11			TM1794§§
cas10d	Subtype	csc3	NA	COG1353	slr7011
	I-D‡‡
csy1	Subtype	csy1	NA	y1724-like	y1724
	I-F‡‡
csy2	Subtype	csy2	NA	(RAMP)	y1725
	I-F
csy3	Subtype	csy3	NA	(RAMP)	y1726
	I-F
cse1	Subtype	cse1	NA	YgcL-like	ygcL
	I-E‡‡
cse2	Subtype	cse2	2ZCA	YgcK-like	ygcK
	I-E
csc1	Subtype	csc1	NA	alr1563-like	alr1563
	I-D			(RAMP)
csc2	Subtype	csc1	NA	COG1337	slr7012
	I-D	and		(RAMP)
		csc2
csa5	Subtype	csa5	NA	AF1870	AF1870,
	I-A				MJ0380,
					PF0643
					and
					SS01398
csn2	Subtype	csn2	NA	SPy1049-like	SPy1049
	II-A
csm2	Subtype	csm2	NA	COG1421	MTH1081
	III-A‡‡				and
					SERP2460
csm3	Subtype	csc2	NA	COG1337	MTH1080
	III-A	and		(RAMP)	and
		csm3			SERP2459
csm4	Subtype	csm4	NA	COG1567	MTH1079
	III-A			(RAMP)	and
					SERP2458
csm5	Subtype	csm5	NA	COG1332	MTH1078
	III-A			(RAMP)	and
					SERP2457
csm6	Subtype	APE2256	2WTE	COG1517	APE2256
	III-A	and			and
		csm6			SSO1445
cmr1	Subtype	cmr1	NA	COG1367	PF1130
	III-B			(RAMP)
cmr3	Subtype	cmr3	NA	COG1769	PF1128
	III-B			(RAMP)
cmr4	Subtype	cmr4	NA	COG1336	PF1126
	III-B			(RAMP)
cmr5	Subtype	cmr5	2ZOP	COG3337	MTH324
	III-B‡‡		and		and
			2OEB		PF1125
cmr6	Subtype	cmr6	NA	COG1604	PF1124
	III-B			(RAMP)
csb1	Subtype	GSU0053	NA	(RAMP)	Balac_1306
	I-U				and
					GSU0053
csb2	Subtype	NA	NA	(RAMP)	Balac_1305
	I-U§§				and
					GSU0054
csb3	Subtype	NA	NA	(RAMP)	Balac_1303§§
	I-U
csx17	Subtype	NA	NA	NA	Btus_2683
	I-U
csx14	Subtype	NA	NA	NA	GSU0052
	I-U
csx10	Subtype	csx10	NA	(RAMP)	Caur_2274
	I-U
csx16	Subtype	VVA1548	NA	NA	VVA1548
	III-U
csaX	Subtype	csaX	NA	NA	SSO1438
	III-U
csx3	Subtype	csx3	NA	NA	AF1864
	III-U
csx1	Subtype	csa3,	1XMX	COG1517	MJ1666,
	III-U	csx1,	and	and	NE0113,
		csx2,	2I71	COG4006	PF1127
		DXTHG,			and
		NE0113			TM1812
		and
		TIGR02710
csx15	Un-	NA	NA	TTE2665	TTE2665
	known
csf1	Type U	csf1	NA	NA	AFE_1038
csf2	Type U	csf2	NA	(RAMP)	AFE_1039
csf3	Type U	csf3	NA	(RAMP)	AFE_1040
csf4	Type U	csf4	NA	NA	AFE_1037

IV. Functional Analysis of Candidate Molecules

Candidate Cas9 molecules, candidate gRNA molecules, candidate Cas9 molecule/gRNA molecule complexes, can be evaluated by art-known methods or as described herein. For example, exemplary methods for evaluating the endonuclease activity of Cas9 molecule are described, e.g., in Jinek et al., SCIENCE 2012, 337(6096):816-821.

Binding and Cleavage Assay: Testing the Endonuclease Activity of Cas9 Molecule

The ability of a Cas9 molecule/gRNA molecule complex to bind to and cleave a target nucleic acid can be evaluated in a plasmid cleavage assay. In this assay, synthetic or in vitro-transcribed gRNA molecule is pre-annealed prior to the reaction by heating to 95° C. and slowly cooling down to room temperature. Native or restriction digest-linearized plasmid DNA (300 ng (˜8 nM)) is incubated for 60 min at 37° C. with purified Cas9 protein molecule (50-500 nM) and gRNA (50-500 nM, 1:1) in a Cas9 plasmid cleavage buffer (20 mM HEPES pH 7.5, 150 mM KCl, 0.5 mM DTT, 0.1 mM EDTA) with or without 10 mM MgCl₂. The reactions are stopped with 5×DNA loading buffer (30% glycerol, 1.2% SDS, 250 mM EDTA), resolved by a 0.8 or 1% agarose gel electrophoresis and visualized by ethidium bromide staining. The resulting cleavage products indicate whether the Cas9 molecule cleaves both DNA strands, or only one of the two strands. For example, linear DNA products indicate the cleavage of both DNA strands. Nicked open circular products indicate that only one of the two strands is cleaved.

Alternatively, the ability of a Cas9 molecule/gRNA molecule complex to bind to and cleave a target nucleic acid can be evaluated in an oligonucleotide DNA cleavage assay. In this assay, DNA oligonucleotides (10 pmol) are radiolabeled by incubating with 5 units T4 polynucleotide kinase and ˜3-6 pmol (˜20-40 mCi) [γ-32P]-ATP in 1×T4 polynucleotide kinase reaction buffer at 37° C. for 30 min, in a 50 μL reaction. After heat inactivation (65° C. for 20 min), reactions are purified through a column to remove unincorporated label. Duplex substrates (100 nM) are generated by annealing labeled oligonucleotides with equimolar amounts of unlabeled complementary oligonucleotide at 95° C. for 3 min, followed by slow cooling to room temperature. For cleavage assays, gRNA molecules are annealed by heating to 95° C. for 30 s, followed by slow cooling to room temperature. Cas9 (500 nM final concentration) is pre-incubated with the annealed gRNA molecules (500 nM) in cleavage assay buffer (20 mM HEPES pH 7.5, 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 5% glycerol) in a total volume of 9 μl. Reactions are initiated by the addition of 1 μl target DNA (10 nM) and incubated for 1 h at 37° C. Reactions are quenched by the addition of 20 μl of loading dye (5 mM EDTA, 0.025% SDS, 5% glycerol in formamide) and heated to 95° C. for 5 min. Cleavage products are resolved on 12% denaturing polyacrylamide gels containing 7 M urea and visualized by phosphorimaging. The resulting cleavage products indicate that whether the complementary strand, the non-complementary strand, or both, are cleaved.

One or both of these assays can be used to evaluate the suitability of a candidate gRNA molecule or candidate Cas9 molecule.

Binding Assay: Testing the Binding of Cas9 Molecule to Target DNA

Exemplary methods for evaluating the binding of Cas9 molecule to target DNA are described, e.g., in Jinek et al., SCIENCE 2012; 337(6096):816-821.

For example, in an electrophoretic mobility shift assay, target DNA duplexes are formed by mixing of each strand (10 nmol) in deionized water, heating to 95° C. for 3 min and slow cooling to room temperature. All DNAs are purified on 8% native gels containing 1×TBE. DNA bands are visualized by UV shadowing, excised, and eluted by soaking gel pieces in DEPC-treated H₂O. Eluted DNA is ethanol precipitated and dissolved in DEPC-treated H₂O. DNA samples are 5′ end labeled with [γ-32P]-ATP using T4 polynucleotide kinase for 30 min at 37° C. Polynucleotide kinase is heat denatured at 65° C. for 20 min, and unincorporated radiolabel is removed using a column. Binding assays are performed in buffer containing 20 mM HEPES pH 7.5, 100 mM KCl, 5 mM MgCl₂, 1 mM DTT and 10% glycerol in a total volume of 10 μl. Cas9 protein molecule is programmed with equimolar amounts of pre-annealed gRNA molecule and titrated from 100 pM to 1 μM. Radiolabeled DNA is added to a final concentration of 20 pM. Samples are incubated for 1 h at 37° C. and resolved at 4° C. on an 8% native polyacrylamide gel containing 1×TBE and 5 mM MgCl₂. Gels are dried and DNA visualized by phosphorimaging.

Differential Scanning Flourimetry (DSF)

The thermostability of Cas9-gRNA ribonucleoprotein (RNP) complexes can be measured via DSF. This technique measures the thermostability of a protein, which can increase under favorable conditions such as the addition of a binding RNA molecule, e.g., a gRNA.

The assay is performed using two different protocols, one to test the best stoichiometric ratio of gRNA:Cas9 protein and another to determine the best solution conditions for RNP formation.

To determine the best solution to form RNP complexes, a 2 uM solution of Cas9 in water+10×SYPRO Orange® (Life Techonologies cat #S-6650) and dispensed into a 384 well plate. An equimolar amount of gRNA diluted in solutions with varied pH and salt is then added. After incubating at room temperature for 10′ and brief centrifugation to remove any bubbles, a Bio-Rad CFX384™ Real-Time System C1000 Touch™ Thermal Cycler with the Bio-Rad CFX Manager software is used to run a gradient from 20° C. to 90° C. with a 1° increase in temperature every 10 seconds.

The second assay consists of mixing various concentrations of gRNA with 2 uM Cas9 in optimal buffer from assay 1 above and incubating at RT for 10′ in a 384 well plate. An equal volume of optimal buffer+10×SYPRO Orange® (Life Techonologies cat #S-6650) is added and the plate sealed with Microseal® B adhesive (MSB-1001). Following brief centrifugation to remove any bubbles, a Bio-Rad CFX384™ Real-Time System C1000 Touch™ Thermal Cycler with the Bio-Rad CFX Manager software is used to run a gradient from 20° C. to 90° C. with a 1° increase in temperature every 10 seconds.

V. Genome Editing Approaches

Mutations in the CFTR gene may be corrected using one of the approaches or pathways described herein, e.g., using HDR and/or NHEJ. In an embodiment, a mutation in the CFTR gene is corrected by homology directed repair (HDR) using a template nucleic acid (see Section V.1).

Also described herein are methods for targeted knockout of one or both alleles of the SCNN1A gene using NHEJ (see Section V.2).

V.1 HDR Repair, HDR Mediated Knockin and Template Nucleic Acids

As described herein, nuclease-induced homology directed repair (HDR) can be used to alter a target sequence and correct (e.g., repair or edit) a mutation in the genome. While not wishing to be bound by theory, it is believed that alteration of the target sequence occurs by homology-directed repair (HDR) with a donor template or template nucleic acid. For example, the donor template or the template nucleic acid provides for alteration of the target sequence. It is contemplated that a plasmid donor can be used as a template for homologous recombination. It is further contemplated that a single stranded donor template can be used as a template for alteration of the target sequence by alternate methods of homology directed repair (e.g., single strand annealing) between the target sequence and the donor template. Donor template-effected alteration of a target sequence depends on cleavage by a Cas9 molecule. Cleavage by Cas9 can comprise a double strand break or one, two or more single strand breaks.

Mutations that can be corrected by HDR using a template nucleic acid include point mutations. In an embodiment, a point mutation can be corrected by either a single double-strand break or two single strand breaks. In an embodiment, a point mutation can be corrected by (1) a single double-strand break, (2) two single strand breaks, (3) two double stranded breaks with a break occurring on each side of the target sequence, or (4) four single stranded breaks with a pair of single stranded breaks occurring on each side of the target sequence.

Mutations in the CFTR gene that can be corrected (e.g., altered) by HDR with a template nucleic acid include deletion mutation at F508 (F508del) or point mutation at G551, e.g., G551D.

Double Strand Break Mediated Correction or Knockin

In an embodiment, double strand cleavage is effected by a Cas9 molecule having cleavage activity associated with an HNH-like domain and cleavage activity associated with an RuvC-like domain, e.g., an N-terminal RuvC-like domain, e.g., a wild type Cas9. Such embodiments require only a single gRNA.

Single Strand Break Mediated Correction or Knockin

In other embodiments, two single strand breaks, or nicks, are effected by a Cas9 molecule having nickase activity, e.g., cleavage activity associated with an HNH-like domain or cleavage activity associated with an N-terminal RuvC-like domain. Such embodiments require two gRNAs, one for placement of each single strand break. In an embodiment, the Cas9 molecule having nickase activity cleaves the strand to which the gRNA hybridizes, but not the strand that is complementary to the strand to which the gRNA hybridizes. In an embodiment, the Cas9 molecule having nickase activity does not cleave the strand to which the gRNA hybridizes, but rather cleaves the strand that is complementary to the strand to which the gRNA hybridizes.

In an embodiment, the nickase has HNH activity, e.g., a Cas9 molecule having the RuvC activity inactivated, e.g., a Cas9 molecule having a mutation at D10, e.g., the D10A mutation. D10A inactivates RuvC; therefore, the Cas9 nickase has (only) HNH activity and will cut on the strand to which the gRNA hybridizes (e.g., the complementary strand, which does not have the NGG PAM on it). In other embodiments, a Cas9 molecule having an H840, e.g., an H840A, mutation can be used as a nickase. H840A inactivates HNH; therefore, the Cas9 nickase has (only) RuvC activity and cuts on the non-complementary strand (e.g., the strand that has the NGG PAM and whose sequence is identical to the gRNA). In other embodiments, a Cas9 molecule having an N863, e.g., an N863A mutation can be used as a nickase. N863A inactivates HNH therefore the Cas9 nickase has (only) RuvC activity and cuts on the non-complementary strand (the strand that has the PAM and whose sequence is identical to the gRNA).

In an embodiment, in which a nickase and two gRNAs are used to position two single strand nicks, one nick is on the +strand and one nick is on the −strand of the target nucleic acid. The PAMs are outwardly facing. The gRNAs can be selected such that the gRNAs are separated by, from about 0-50, 0-100, or 0-200 nucleotides. In an embodiment, there is no overlap between the target sequence that is complementary to the targeting domains of the two gRNAs. In an embodiment, the gRNAs do not overlap and are separated by as much as 50, 100, or 200 nucleotides. In an embodiment, the use of two gRNAs can increase specificity, e.g., by decreasing off-target binding (Ran et al., Cell 2013; 154(6):1380-1389).

In an embodiment, a single nick can be used to induce HDR. It is contemplated herein that a single nick can be used to increase the ratio of HR to NHEJ at a given cleavage site.

Placement of Double Strand or Single Strand Breaks Relative to the Target Position

The double strand break or single strand break in one of the strands should be sufficiently close to the target position such that correction occurs. In an embodiment, the distance is not more than 50, 100, 200, 300, 350 or 400 nucleotides. While not wishing to be bound by theory, it is believed that the break should be sufficiently close to the target sequence such that the break is within the region that is subject to exonuclease-mediated removal during end resection. If the distance between the target sequence and a break is too great, the mutation may not be included in the end resection and, therefore, may not be corrected, as donor sequence may only be used to correct sequence within the end resection region.

In an embodiment, in which a gRNA (unimolecular (or chimeric) or modular gRNA) and Cas9 nuclease induce a double strand break for the purpose of inducing HDR-mediated correction, the cleavage site is between 0 to 200 bp (e.g., 0 to 175, 0 to 150, 0 to 125, 0 to 100, 0 to 75, 0 to 50, 0 to 25, 25 to 200, 25 to 175, 25 to 150, 25 to 125, 25 to 100, 25 to 75, 25 to 50, 50 to 200, 50 to 175, 50 to 150, 50 to 125, 50 to 100, 50 to 75, 75 to 200, 75 to 175, 75 to 150, 75 to 125, 75 to 100 bp) away from the target position. In an embodiment, the cleavage site is between 0 to 100 bp (e.g., 0 to 75, 0 to 50, 0 to 25, 25 to 100, 25 to 75, 25 to 50, 50 to 100, 50 to 75 or 75 to 100 bp) away from the target position.

In an embodiment, in which two gRNAs (independently, unimolecular (or chimeric) or modular gRNA) complexing with Cas9 nickases induce two single strand breaks for the purpose of inducing HDR-mediated correction, the closer nick is between 0 to 200 bp (e.g., 0 to 175, 0 to 150, 0 to 125, 0 to 100, 0 to 75, 0 to 50, 0 to 25, 25 to 200, 25 to 175, 25 to 150, 25 to 125, 25 to 100, 25 to 75, 25 to 50, 50 to 200, 50 to 175, 50 to 150, 50 to 125, 50 to 100, 50 to 75, 75 to 200, 75 to 175, 75 to 150, 75 to 125, 75 to 100 bp) away from the target position and the two nicks will ideally be within 25 to 55 bp of each other (e.g., 25 to 50, 25 to 45, 25 to 40, 25 to 35, 25 to 30, 30 to 55, 30 to 50, 30 to 45, 30 to 40, 30 to 35, 35 to 55, 35 to 50, 35 to 45, 35 to 40, 40 to 55, 40 to 50, 40 to 45 bp) and no more than 100 bp away from each other (e.g., no more than 90, 80, 70, 60, 50, 40, 30, 20, 10 or 5 bp away from each other). In an embodiment, the cleavage site is between 0 to 100 bp (e.g., 0 to 75, 0 to 50, 0 to 25, 25 to 100, 25 to 75, 25 to 50, 50 to 100, 50 to 75 or 75 to 100 bp) away from the target position.

In one embodiment, two gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to position a double-strand break on both sides of a target position. In an alternate embodiment, three gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to position a double strand break (i.e., one gRNA complexes with a cas9 nuclease) and two single strand breaks or paired single stranded breaks (i.e., two gRNAs complex with Cas9 nickases) on either side of the target position. In another embodiment, four gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to generate two pairs of single stranded breaks (i.e., two pairs of two gRNAs complex with Cas9 nickases) on either side of the target position. The double strand break(s) or the closer of the two single strand nicks in a pair will ideally be within 0-500 bp of the target position (e.g., no more than 450, 400, 350, 300, 250, 200, 150, 100, 50 or 25 bp from the target position). When nickases are used, the two nicks in a pair are within 25-55 bp of each other (e.g., between 25 to 50, 25 to 45, 25 to 40, 25 to 35, 25 to 30, 50 to 55, 45 to 55, 40 to 55, 35 to 55, 30 to 55, 30 to 50, 35 to 50, 40 to 50, 45 to 50, 35 to 45, or 40 to 45 bp) and no more than 100 bp away from each other (e.g., no more than 90, 80, 70, 60, 50, 40, 30, 20 or 10 bp). In an embodiment, the gRNAs are configured to place a single strand break on either side of the target position. In an embodiment, the gRNAs are configured to place a single strand break on the same side (either 5′ or 3′) of the target position.

Regardless of whether a break is a double strand or a single strand break, the gRNA should be configured to avoid unwanted target chromosome elements, such as repeated elements, e.g., an Alu repeat, in the target domain. In addition, a break, whether a double strand or a single strand break, should be sufficiently distant from any sequence that should not be altered. For example, cleavage sites positioned within introns should be sufficiently distant from any intron/exon border, or naturally occurring splice signal, to avoid alteration of the exonic sequence or unwanted splicing events.

Length of the Homology Arms

The homology arm should extend at least as far as the region in which end resection may occur, e.g., in order to allow the resected single stranded overhang to find a complementary region within the donor template. The overall length could be limited by parameters such as plasmid size or viral packaging limits. In an embodiment, a homology arm does not extend into repeated elements, e.g., Alu repeats, LINE repeats.

Exemplary homology arm lengths include a least 50, 100, 250, 500, 750 or 1000 nucleotides.

Target position, as used herein, refers to a site on a target nucleic acid (e.g., the chromosome) that is modified by a Cas9 molecule-dependent process. For example, the target position can be a modified Cas9 molecule cleavage of the target nucleic acid and template nucleic acid directed modification, e.g., correction, of the target position. In an embodiment, a target position can be a site between two nucleotides, e.g., adjacent nucleotides, on the target nucleic acid into which one or more nucleotides is added. The target position may comprise one or more nucleotides that are altered, e.g., corrected, by a template nucleic acid. In an embodiment, the target position is within a target sequence (e.g., the sequence to which the gRNA binds). In an embodiment, a target position is upstream or downstream of a target sequence (e.g., the sequence to which the gRNA binds).

A template nucleic acid, as that term is used herein, refers to a nucleic acid sequence which can be used in conjunction with a Cas9 molecule and a gRNA molecule to alter the structure of a target position. In an embodiment, the target nucleic acid is modified to have the some or all of the sequence of the template nucleic acid, typically at or near cleavage site(s). In an embodiment, the template nucleic acid is single stranded. In an alternate embodiment, the template nucleic acid is double stranded. In an embodiment, the template nucleic acid is DNA, e.g., double stranded DNA. In an alternate embodiment, the template nucleic acid is single stranded DNA. In an embodiment, the template nucleic acid is encoded on the same vector backbone, e.g. AAV genome, plasmid DNA, as the Cas9 and gRNA. In an embodiment, the template nucleic acid is excised from a vector backbone in vivo, e.g., it is flanked by gRNA recognition sequences.

In an embodiment, the template nucleic acid alters the structure of the target position by participating in a homology directed repair event. In an embodiment, the template nucleic acid alters the sequence of the target position. In an embodiment, the template nucleic acid results in the incorporation of a modified, or non-naturally occurring base into the target nucleic acid.

Typically, the template sequence undergoes a breakage mediated or catalyzed recombination with the target sequence. In an embodiment, the template nucleic acid includes sequence that corresponds to a site on the target sequence that is cleaved by an eaCas9 mediated cleavage event. In an embodiment, the template nucleic acid includes sequence that corresponds to both, a first site on the target sequence that is cleaved in a first Cas9 mediated event, and a second site on the target sequence that is cleaved in a second Cas9 mediated event.

In an embodiment, the template nucleic acid can include sequence which results in an alteration in the coding sequence of a translated sequence, e.g., one which results in the substitution of one amino acid for another in a protein product, e.g., transforming a mutant allele into a wild type allele, transforming a wild type allele into a mutant allele, and/or introducing a stop codon, insertion of an amino acid residue, deletion of an amino acid residue, or a nonsense mutation.

In another embodiment, the template nucleic acid can include sequence which results in an alteration in a non-coding sequence, e.g., an alteration in an exon or in a 5′ or 3′ non-translated or non-transcribed region. Such alterations include an alteration in a control element, e.g., a promoter, enhancer, and an alteration in a cis-acting or trans-acting control element.

A template nucleic acid having homology with a target position in the CFTR gene can be used to alter the structure of a target sequence. The template sequence can be used to alter an unwanted structure, e.g., an unwanted or mutant nucleotide.

A template nucleic acid comprises the following components:

• • [5′ homology arm]-[replacement sequence]-[3′ homology arm].

The homology arms provide for recombination into the chromosome, thus replacing the undesired element, e.g., a mutation or signature, with the replacement sequence. In an embodiment, the homology arms flank the most distal cleavage sites.

In an embodiment, the 3′ end of the 5′ homology arm is the position next to the 5′ end of the replacement sequence. In an embodiment, the 5′ homology arm can extend at least 10, 20, 30, 40, 50, 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, or 2000 nucleotides 5′ from the 5′ end of the replacement sequence.

In an embodiment, the 5′ end of the 3′ homology arm is the position next to the 3′ end of the replacement sequence. In an embodiment, the 3′ homology arm can extend at least 10, 20, 30, 40, 50, 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, or 2000 nucleotides 3′ from the 3′ end of the replacement sequence.

Exemplary Template Nucleic Acids

Exemplary template nucleic acids (also referred to herein as donor constructs) to correct a mutation, e.g., F508del target position in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(5′H arm)
SEQ ID NO: 27266
AAAATACAAAAAATTAGCCAGACGTGATGGCGGGTGCCCGTAGTCCCAGC
TACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCCAGGAGGCAGAACT
TGCAGTGAGCCGAGATCGCGCCACTGCACTCTAGCCTGGGTGACAGAGTG
AGACTCTGTCTCTAAATAAATAAATAAATAAATAAATAAATAAATAAAAT
CAGTGCTTTTTCTTCCTCTGCTACCTCCTTTCCTTCTACTCAGTTTTAGT
CAGTAGTATTATCTTTTTTCAGATTTATCTTTGTATTGTTAAATCTGCTT
ATGCTTCTATTACTTTATTTATTAGCTTTAAATGATACCTTTTGACTTTC
AGCTTTTCTTAATAAAGCAATCAGCAAATTTCCTTTACACTCCACACTTA
TACCCCATTTCCTTTGTTTGTTTATTTGGTTTTTACTTCTAACTTTTCTT
ATTGTCAGGACATATAACATATTTAAACTTTGTTTTTCAACTCGAATTCT
GCCATTAGTTTTAATTTTTGTTCACAGTTATATAAATCTTTGTTCACTGA
TAGTCCTTTTGTACTATCATCTCTTAAATGACTTTATACTCCAAGAAAGG
CTCATGGGAACAATATTACCTGAATATGTCTCTATTACTTAATCTGTACC
TAATAATATGAAGGTAATCTACTTTGTAGGATTTCTGTGAAGATTAAATA
AATTAATATAGTTAAAGCACATAGAACAGCACTCGACACAGAGTGAGCAC
TTGGCAACTGTTAGCTGTTACTAACCTTTCCCATTCTTCCTCCAAACCTA
TTCCAACTATCTGAATCATGTGCCCCTTCTCTGTGAACCTCTATCATAAT
ACTTGTCACACTGTATTGTAATTGTCTCTTTTACTTTCCCTTGTATCTTT
TGTGCATAGCAGAGTACCTGAAACAGGAAGTATTTTAAATATTTTGAATC
AAATGAGTTAATAGAATCTTTACAAATAAGAATATACACTTCTGCTTAGG
ATGATAATTGGAGGCAAGTGAATCCTGAGCGTGATTTGATAATGACCTAA
TAATGATGGGTTTTATTTCCAGACTTCACTTCTAATGGTGATTATGGGAG
AACTGGAGCCTTCAGAGGGTAAAATTAAGCACAGTGGAAGAATTTCATTC
TGTTCTCAGTTTTCCTGGATTATGCCTGGCACCATTAAAGAAAATATCAT

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(3′H arm)
SEQ ID NO: 27267
TGGTGTTTCCTATGATGAATATAGATACAGAAGCGTCATCAAAGCATGCC
AACTAGAAGAGGTAAGAAACTATGTGAAAACTTTTTGATTATGCATATGA
ACCCTTCACACTACCCAAATTATATATTTGGCTCCATATTCAATCGGTTA
GTCTACATATATTTATGTTTCCTCTATGGGTAAGCTACTGTGAATGGATC
AATTAATAAAACACATGACCTATGCTTTAAGAAGCTTGCAAACACATGAA
ATAAATGCAATTTATTTTTTAAATAATGGGTTCATTTGATCACAATAAAT
GCATTTTATGAAATGGTGAGAATTTTGTTCACTCATTAGTGAGACAAACG
TCCTCAATGGTTATTTATATGGCATGCATATAAGTGATATGTGGTATCTT
TTTAAAAGATACCACAAAATATGCATCTTTAAAAATATACTCCAAAAATT
ATTAAGATTATTTTAATAATTTTAATAATACTATAGCCTAATGGAATGAG
CATTGATCTGCCAGCAGAGAATTAGAGGGGTAAAATTGTGAAGATATTGT
ATCCCTGGCTTTGAACAAATACCATATAACTTCTAGTGACTGCAATTCTT
TGATGCAGAGGCAAAATGAAGATGATGTCATTACTCATTTCACAACAATA
TTGGAGAATGAGCTAATTATCTGAAAATTACATGAAGTATTCCAAGAGAA
ACCAGTATATGGATCTTGTGCTGTTCACTATGTAAATTGTGTGATGGTGG
GTTCAGTAGTTATTGCTGTAAATGTTAGGGCAGGGAATATGTTACTATGA
AGTTTATTGACAGTATACTCCAAATAGTGTTTGTGATTCAAAAGCAATAT
CTTTGATAGTTGGCATTTGCAATTCCTTTATATAATCTTTTATGAAAAAA
ATTGCAGAGAAAGTAAAATGTAGCTTAAAATACAGTATCCAAAAAAATGG
AAAAGGGCAAACCGTGGATTAGATAGAAATGGCAATTCTTATAAAAAGGG
TTGCATGCTTACATGAATGGCTTTCCATGTATATACTCAGTCATTCAACA
GTTTTTTTTTTAGAGCCCCATTCTTATTTTTTATACACTTTGAGAGCATA
ATGAAAAGAAAAGCTACCTGCAAAAGTTTTGGACTTACCTCAAAGAGGAT
ATACTTCATTCCTCAAAAGGCCTTCTTCCAGGAATAGTATTTCATAACCT

In an embodiment, the replacement sequence comprises or consists of CTT residues.

In an embodiment, to correct a mutation, e.g., F508del target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted bases to correct the F508del mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 1; SEQ ID NO: 27268)
AAAATACAAAAAATTAGCCAGACGTGATGGCGGGTGCCCGTAGTCCCAGC
TACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCCAGGAGGCAGAACT
TGCAGTGAGCCGAGATCGCGCCACTGCACTCTAGCCTGGGTGACAGAGTG
AGACTCTGTCTCTAAATAAATAAATAAATAAATAAATAAATAAATAAAAT
CAGTGCTTTTTCTTCCTCTGCTACCTCCTTTCCTTCTACTCAGTTTTAGT
CAGTAGTATTATCTTTTTTCAGATTTATCTTTGTATTGTTAAATCTGCTT
ATGCTTCTATTACTTTATTTATTAGCTTTAAATGATACCTTTTGACTTTC
AGCTTTTCTTAATAAAGCAATCAGCAAATTTCCTTTACACTCCACACTTA
TACCCCATTTCCTTTGTTTGTTTATTTGGTTTTTACTTCTAACTTTTCTT
ATTGTCAGGACATATAACATATTTAAACTTTGTTTTTCAACTCGAATTCT
GCCATTAGTTTTAATTTTTGTTCACAGTTATATAAATCTTTGTTCACTGA
TAGTCCTTTTGTACTATCATCTCTTAAATGACTTTATACTCCAAGAAAGG
CTCATGGGAACAATATTACCTGAATATGTCTCTATTACTTAATCTGTACC
TAATAATATGAAGGTAATCTACTTTGTAGGATTTCTGTGAAGATTAAATA
AATTAATATAGTTAAAGCACATAGAACAGCACTCGACACAGAGTGAGCAC
TTGGCAACTGTTAGCTGTTACTAACCTTTCCCATTCTTCCTCCAAACCTA
TTCCAACTATCTGAATCATGTGCCCCTTCTCTGTGAACCTCTATCATAAT
ACTTGTCACACTGTATTGTAATTGTCTCTTTTACTTTCCCTTGTATCTTT
TGTGCATAGCAGAGTACCTGAAACAGGAAGTATTTTAAATATTTTGAATC
AAATGAGTTAATAGAATCTTTACAAATAAGAATATACACTTCTGCTTAGG
ATGATAATTGGAGGCAAGTGAATCCTGAGCGTGATTTGATAATGACCTAA
TAATGATGGGTTTTATTTCCAGACTTCACTTCTAATGGTGATTATGGGAG
AACTGGAGCCTTCAGAGGGTAAAATTAAGCACAGTGGAAGAATTTCATTC
TGTTCTCAGTTTTCCTGGATTATGCCTGGCACCATTAAAGAAAATATCAT
cttTGGTGTTTCCTATGATGAATATAGATACAGAAGCGTCATCAAAGCAT
GCCAACTAGAAGAGGTAAGAAACTATGTGAAAACTTTTTGATTATGCATA
TGAACCCTTCACACTACCCAAATTATATATTTGGCTCCATATTCAATCGG
TTAGTCTACATATATTTATGTTTCCTCTATGGGTAAGCTACTGTGAATGG
ATCAATTAATAAAACACATGACCTATGCTTTAAGAAGCTTGCAAACACAT
GAAATAAATGCAATTTATTTTTTAAATAATGGGTTCATTTGATCACAATA
AATGCATTTTATGAAATGGTGAGAATTTTGTTCACTCATTAGTGAGACAA
ACGTCCTCAATGGTTATTTATATGGCATGCATATAAGTGATATGTGGTAT
CTTTTTAAAAGATACCACAAAATATGCATCTTTAAAAATATACTCCAAAA
ATTATTAAGATTATTTTAATAATTTTAATAATACTATAGCCTAATGGAAT
GAGCATTGATCTGCCAGCAGAGAATTAGAGGGGTAAAATTGTGAAGATAT
TGTATCCCTGGCTTTGAACAAATACCATATAACTTCTAGTGACTGCAATT
CTTTGATGCAGAGGCAAAATGAAGATGATGTCATTACTCATTTCACAACA
ATATTGGAGAATGAGCTAATTATCTGAAAATTACATGAAGTATTCCAAGA
GAAACCAGTATATGGATCTTGTGCTGTTCACTATGTAAATTGTGTGATGG
TGGGTTCAGTAGTTATTGCTGTAAATGTTAGGGCAGGGAATATGTTACTA
TGAAGTTTATTGACAGTATACTCCAAATAGTGTTTGTGATTCAAAAGCAA
TATCTTTGATAGTTGGCATTTGCAATTCCTTTATATAATCTTTTATGAAA
AAAATTGCAGAGAAAGTAAAATGTAGCTTAAAATACAGTATCCAAAAAAA
TGGAAAAGGGCAAACCGTGGATTAGATAGAAATGGCAATTCTTATAAAAA
GGGTTGCATGCTTACATGAATGGCTTTCCATGTATATACTCAGTCATTCA
ACAGTTTTTTTTTTAGAGCCCCATTCTTATTTTTTATACACTTTGAGAGC
ATAATGAAAAGAAAAGCTACCTGCAAAAGTTTTGGACTTACCTCAAAGAG
GATATACTTCATTCCTCAAAAGGCCTTCTTCCAGGAATAGTATTTCATAA
CCT

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct F508del mutation in the CFTR gene, the 5′ homology arm may be shortened less than 500 nucleotides, e.g., approximately 450 nucleotides, e.g., 428 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the F508del mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 2; SEQ ID NO: 27269)
AACCTTTCCCATTCTTCCTCCAAACCTATTCCAACTATCTGAATCATGTG
CCCCTTCTCTGTGAACCTCTATCATAATACTTGTCACACTGTATTGTAAT
TGTCTCTTTTACTTTCCCTTGTATCTTTTGTGCATAGCAGAGTACCTGAA
ACAGGAAGTATTTTAAATATTTTGAATCAAATGAGTTAATAGAATCTTTA
CAAATAAGAATATACACTTCTGCTTAGGATGATAATTGGAGGCAAGTGAA
TCCTGAGCGTGATTTGATAATGACCTAATAATGATGGGTTTTATTTCCAG
ACTTCACTTCTAATGGTGATTATGGGAGAACTGGAGCCTTCAGAGGGTAA
AATTAAGCACAGTGGAAGAATTTCATTCTGTTCTCAGTTTTCCTGGATTA
TGCCTGGCACCATTAAAGAAAATATCATcttTGGTGTTTCCTATGATGAA
TATAGATACAGAAGCGTCATCAAAGCATGCCAACTAGAAGAGGTAAGAAA
CTATGTGAAAACTTTTTGATTATGCATATGAACCCTTCACACTACCCAAA
TTATATATTTGGCTCCATATTCAATCGGTTAGTCTACATATATTTATGTT
TCCTCTATGGGTAAGCTACTGTGAATGGATCAATTAATAAAACACATGAC
CTATGCTTTAAGAAGCTTGCAAACACATGAAATAAATGCAATTTATTTTT
TAAATAATGGGTTCATTTGATCACAATAAATGCATTTTATGAAATGGTGA
GAATTTTGTTCACTCATTAGTGAGACAAACGTCCTCAATGGTTATTTATA
TGGCATGCATATAAGTGATATGTGGTATCTTTTTAAAAGATACCACAAAA
TATGCATCTTTAAAAATATACTCCAAAAATTATTAAGATTATTTTAATAA
TTTTAATAATACTATAGCCTAATGGAATGAGCATTGATCTGCCAGCAGAG
AATTAGAGGGGTAAAATTGTGAAGATATTGTATCCCTGGCTTTGAACAAA
TACCATATAACTTCTAGTGACTGCAATTCTTTGATGCAGAGGCAAAATGA
AGATGATGTCATTACTCATTTCACAACAATATTGGAGAATGAGCTAATTA
TCTGAAAATTACATGAAGTATTCCAAGAGAAACCAGTATATGGATCTTGT
GCTGTTCACTATGTAAATTGTGTGATGGTGGGTTCAGTAGTTATTGCTGT
AAATGTTAGGGCAGGGAATATGTTACTATGAAGTTTATTGACAGTATACT
CCAAATAGTGTTTGTGATTCAAAAGCAATATCTTTGATAGTTGGCATTTG
CAATTCCTTTATATAATCTTTTATGAAAAAAATTGCAGAGAAAGTAAAAT
GTAGCTTAAAATACAGTATCCAAAAAAATGGAAAAGGGCAAACCGTGGAT
TAGATAGAAATGGCAATTCTTATAAAAAGGGTTGCATGCTTACATGAATG
GCTTTCCATGTATATACTCAGTCATTCAACAGTTTTTTTTTTAGAGCCCC
ATTCTTATTTTTTATACACTTTGAGAGCATAATGAAAAGAAAAGCTACCT
GCAAAAGTTTTGGACTTACCTCAAAGAGGATATACTTCATTCCTCAAAAG
GCCTTCTTCCAGGAATAGTATTTCATAACCT

In an embodiment, to correct F508del mutation in the CFTR gene, the 5′ homology arm may be shortened to approximately 500 nucleotides. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the F508del mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 3; SEQ ID NO: 27270)
AATTAATATAGTTAAAGCACATAGAACAGCACTCGACACAGAGTGAGCAC
TTGGCAACTGTTAGCTGTTACTAACCTTTCCCATTCTTCCTCCAAACCTA
TTCCAACTATCTGAATCATGTGCCCCTTCTCTGTGAACCTCTATCATAAT
ACTTGTCACACTGTATTGTAATTGTCTCTTTTACTTTCCCTTGTATCTTT
TGTGCATAGCAGAGTACCTGAAACAGGAAGTATTTTAAATATTTTGAATC
AAATGAGTTAATAGAATCTTTACAAATAAGAATATACACTTCTGCTTAGG
ATGATAATTGGAGGCAAGTGAATCCTGAGCGTGATTTGATAATGACCTAA
TAATGATGGGTTTTATTTCCAGACTTCACTTCTAATGGTGATTATGGGAG
AACTGGAGCCTTCAGAGGGTAAAATTAAGCACAGTGGAAGAATTTCATTC
TGTTCTCAGTTTTCCTGGATTATGCCTGGC
cttTGGTGTTTCCTATGATGAATATAGATACAGAAGCGTCATCAAAGCAT
GCCAACTAGAAGAGGTAAGAAACTATGTGAAAACTTTTTGATTATGCATA
TGAACCCTTCACACTACCCAAATTATATATTTGGCTCCATATTCAATCGG
TTAGTCTACATATATTTATGTTTCCTCTATGGGTAAGCTACTGTGAATGG
ATCAATTAATAAAACACATGACCTATGCTTTAAGAAGCTTGCAAACACAT
GAAATAAATGCAATTTATTTTTTAAATAATGGGTTCATTTGATCACAATA
AATGCATTTTATGAAATGGTGAGAATTTTGTTCACTCATTAGTGAGACAA
ACGTCCTCAATGGTTATTTATATGGCATGCATATAAGTGATATGTGGTAT
CTTTTTAAAAGATACCACAAAATATGCATCTTTAAAAATATACTCCAAAA
ATTATTAAGATTATTTTAATAATTTTAATAATACTATAGCCTAATGGAAT
GAG

It is contemplated herein that, in an embodiment, template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., F508del target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the F508del mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 4; SEQ ID NO: 27271)
TAAGCACAGTGGAAGAATTTCATTCTGTTCTCAGTTTTCCTGGATTATGC
CTGGCACCATTAAAGAAAATATCATcttTGGTGTTTCCTATGATGAATAT
AGATACAGAAGCGTCATCAAAGCATGCCAACTAGAAGAGGTAAGAAACTA
TGT

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., G542X target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(5′H arm)
SEQ ID NO: 27272
TGTCCATATGGTAGATAAATGGAACAAATGAATAACAGAAGTAACCATTT
TGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTGTGAAAGAA
GAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGG
AGGTGGAAACGAATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTT
TTTTTTTTTAAGGCGAGAGTTTACTACCTATCTAACTCTTCGCATTCTTG
AAGTCTCAGACCAAATCCCATCGGTTTGAAAGCCTCTAGGGTATTCTATC
TATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTGAA
CTGTTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTAT
TTAGCTTTCTCCAGGATTATGACTTACCTTCTAAATTAGACATACAATGC
CTAGGAGTCAAGGACTATTTTGCATAAATTCCAGTCTTCTTTTACAATGC
CTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAGGATGA
CAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGG
ATGGACGAGGAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCA
TGGAAAGGAATTGCCTTGGACCCATGGAAGCCCAGTGAAGATACTTAGAT
CCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCTTCTTAGGAGGTTT
GTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAA
AGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATG
GATGATCTACACATATTTATATACCCATAAATATACACATATTTTAATTT
TTGGTATTTTATAATTATTATTTAATGATCATTCATGACATTTTAAAAAT
TACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTGACCAACT
AAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACT
GTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGC
CTTTCAAATTCAGATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATT
TTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTT

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(3′H arm)
SEQ ID NO: 27273
GAGAAGGTGGAATCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTTA
GCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTC
ATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTT
CTGGAATTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCAC
ATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGGTAGAGATTAT
GGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGCC
TCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATAC
TGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCAC
TCCAATGTACACACCAGCTTTAGGCTTCTTGGTATAGATAAACATACATT
TTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAATGAT
GTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCAT
TAACATTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAG
CATTTTAAAGCTGTCAAAGAGATGTAAATATAGATAATGTATGTCAAGGA
GAGAGCTTTGTGGTTAAACTGTAACTTTCAGTTTAAACAATTATTGGTGA
CTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCTCAC
TTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTTT
GGCTCCTTTCCCTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAAC
TAACCCTAACTGAGCACCTGCAATTGCCTGGTAGTATTCTAGTCATGTGT
GTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAAAGTAAGAATTG
TTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGATG
TTAACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACC
AGGTCCTTTTGATTCTTTACATTAAACCATGCTTTGATCTTGGAAATACA
CTGTAAGGCAATAAATCAATAGATACGGATAATTCACAGGCTTCTAAATA
AATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTATTCTAA

In an embodiment, the replacement sequence comprises or consists of a Guanine (G) residue.

In an embodiment, to correct a mutation, e.g., G542X target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the G542X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 5; SEQ ID NO: 27274)
TGTCCATATGGTAGATAAATGGAACAAATGAATAACAGAAGTAACCATTT
TGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTGTGAAAGAA
GAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGG
AGGTGGAAACGAATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTT
TTTTTTTTTAAGGCGAGAGTTTACTACCTATCTAACTCTTCGCATTCTTG
AAGTCTCAGACCAAATCCCATCGGTTTGAAAGCCTCTAGGGTATTCTATC
TATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTGAA
CTGTTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTAT
TTAGCTTTCTCCAGGATTATGACTTACCTTCTAAATTAGACATACAATGC
CTAGGAGTCAAGGACTATTTTGCATAAATTCCAGTCTTCTTTTACAATGC
CTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAGGATGA
CAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGG
ATGGACGAGGAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCA
TGGAAAGGAATTGCCTTGGACCCATGGAAGCCCAGTGAAGATACTTAGAT
CCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCTTCTTAGGAGGTTT
GTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAA
AGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATG
GATGATCTACACATATTTATATACCCATAAATATACACATATTTTAATTT
TTGGTATTTTATAATTATTATTTAATGATCATTCATGACATTTTAAAAAT
TACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTGACCAACT
AAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACT
GTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGC
CTTTCAAATTCAGATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATT
TTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTT
gGAGAAGGTGGAATCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTT
AGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGT
CATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTT
TCTGGAATTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCA
CATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGGTAGAGATTA
TGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGC
CTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATA
CTGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCA
CTCCAATGTACACACCAGCTTTAGGCTTCTTGGTATAGATAAACATACAT
TTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAATGA
TGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCA
TTAACATTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAA
GCATTTTAAAGCTGTCAAAGAGATGTAAATATAGATAATGTATGTCAAGG
AGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTTTAAACAATTATTGGTG
ACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCTCA
CTTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTT
TGGCTCCTTTCCCTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAA
CTAACCCTAACTGAGCACCTGCAATTGCCTGGTAGTATTCTAGTCATGTG
TGTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAAAGTAAGAATT
GTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGAT
GTTAACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAAC
CAGGTCCTTTTGATTCTTTACATTAAACCATGCTTTGATCTTGGAAATAC
ACTGTAAGGCAATAAATCAATAGATACGGATAATTCACAGGCTTCTAAAT
AAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTATTCTA
A

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct G542X mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the G542X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 6; SEQ ID NO: 27275)
CCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCTTCTTAGGAGGTTT
GTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAA
AGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATG
GATGATCTACACATATTTATATACCCATAAATATACACATATTTTAATTT
TTGGTATTTTATAATTATTATTTAATGATCATTCATGACATTTTAAAAAT
TACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTGACCAACT
AAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACT
GTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGC
CTTTCAAATTCAGATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATT
TTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTT
gGAGAAGGTGGAATCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTT
AGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGT
CATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTT
TCTGGAATTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCA
CATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGGTAGAGATTA
TGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGC
CTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATA
CTGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCA
CTCCAATGTACACACCAGCTTTAGGCTTCTTGGTATAGATAAACATACAT
TTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAATGA
T

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., G542X target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the G542X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 7; SEQ ID NO: 27276)
AAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTT
TGCAGAGAAAGACAATATAGTTCTTgGAGAAGGTGGAATCACACTGAGTG
GAGGTCAACGAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGG
T

It is contemplated herein that, in an embodiment, a Cas9 molecule could potentially cleave donor constructs either prior to or following homology directed repair (e.g., homologous recombination), resulting in a possible non-homologous-end-joining event and further DNA sequence mutation at the chromosomal locus of interest. Therefore, to avoid cleavage of the donor sequence before and/or after Cas9-mediated homology directed repair, alternate versions of the donor sequence may be used where silent mutations are introduced. These silent mutations may disrupt Cas9 binding and cleavage, but not disrupt the amino acid sequence of the repaired gene. For example, mutations may include those made to a donor sequence to repair the CFTR gene, the mutant form which can cause CF or CF-like disease. In an embodiment, a silent mutation that disrupts Cas9 binding and cleavage, but does not disrupt the amino acid sequence of the repaired gene, is a sense mutation.

In an embodiment, to correct a mutation, e.g., G542X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the G542X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 8; SEQ ID NO: 27277)
TGTCCATATGGTAGATAAATGGAACAAATGAATAACAGAAGTAACCATTT
TGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTGTGAAAGAA
GAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGG
AGGTGGAAACGAATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTT
TTTTTTTTTAAGGCGAGAGTTTACTACCTATCTAACTCTTCGCATTCTTG
AAGTCTCAGACCAAATCCCATCGGTTTGAAAGCCTCTAGGGTATTCTATC
TATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTGAA
CTGTTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTAT
TTAGCTTTCTCCAGGATTATGACTTACCTTCTAAATTAGACATACAATGC
CTAGGAGTCAAGGACTATTTTGCATAAATTCCAGTCTTCTTTTACAATGC
CTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAGGATGA
CAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGG
ATGGACGAGGAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCA
TGGAAAGGAATTGCCTTGGACCCATGGAAGCCCAGTGAAGATACTTAGAT
CCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCTTCTTAGGAGGTTT
GTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAA
AGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATG
GATGATCTACACATATTTATATACCCATAAATATACACATATTTTAATTT
TTGGTATTTTATAATTATTATTTAATGATCATTCATGACATTTTAAAAAT
TACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTGACCAACT
AAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACT
GTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGC
CTTTCAAATTCAGATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATT
TTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTa
gGtGAAGGTGGAATCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTT
AGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGT
CATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTT
TCTGGAATTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCA
CATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGGTAGAGATTA
TGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGC
CTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATA
CTGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCA
CTCCAATGTACACACCAGCTTTAGGCTTCTTGGTATAGATAAACATACAT
TTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAATGA
TGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCA
TTAACATTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAA
GCATTTTAAAGCTGTCAAAGAGATGTAAATATAGATAATGTATGTCAAGG
AGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTTTAAACAATTATTGGTG
ACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCTCA
CTTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTT
TGGCTCCTTTCCCTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAA
CTAACCCTAACTGAGCACCTGCAATTGCCTGGTAGTATTCTAGTCATGTG
TGTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAAAGTAAGAATT
GTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGAT
GTTAACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAAC
CAGGTCCTTTTGATTCTTTACATTAAACCATGCTTTGATCTTGGAAATAC
ACTGTAAGGCAATAAATCAATAGATACGGATAATTCACAGGCTTCTAAAT
AAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTATTCTA
A

In an embodiment, to correct a mutation, e.g., G542X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the G542X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 9; SEQ ID NO: 27278)
CCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCTTCTTAGGAGGTTT
GTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAA
AGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATG
GATGATCTACACATATTTATATACCCATAAATATACACATATTTTAATTT
TTGGTATTTTATAATTATTATTTAATGATCATTCATGACATTTTAAAAAT
TACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTGACCAACT
AAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACT
GTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGC
CTTTCAAATTCAGATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATT
TTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTa
gGtGAAGGTGGAATCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTT
AGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGT
CATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTT
TCTGGAATTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCA
CATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGGTAGAGATTA
TGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGC
CTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATA
CTGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCA
CTCCAATGTACACACCAGCTTTAGGCTTCTTGGTATAGATAAACATACAT
TTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAATGA
T

In an embodiment, an ssODN may be to correct a mutation, e.g., G542X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the G542X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 10; SEQ ID NO: 27279)
AAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTT
TGCAGAGAAAGACAATATAGTTCTagGtGAAGGTGGAATCACACTGAGTG
GAGGTCAACGAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGG
T

The underlined A has been changed from a T to A at that position and the underlined T has been changed from an A to T at that position so that wild-type CFTR is still transcribed, but the PAM sequence AGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., G551D target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(5′H arm)
SEQ ID NO: 27280
TGAATAACAGAAGTAACCATTTTGATACTTTAGATATAGATAATATTGGA
TTATTTCTGGATTGTGAAAGAAGAAGGAAGAAGCATATGGAAGAGAAGTT
TTAGTAGAGGGGAGGAAGGAGGAGGTGGAAACGAATGTACAAGGATGGGA
GGAGAAAAGGGAGAGAGACTTTTTTTTTTTTAAGGCGAGAGTTTACTACC
TATCTAACTCTTCGCATTCTTGAAGTCTCAGACCAAATCCCATCGGTTTG
AAAGCCTCTAGGGTATTCTATCTATTGTATACTTCTGTTATGTACAAAAT
TAATTTGCCAATTAATTGTGAACTGTTTTATAAACTATCTTAAAATGGTT
AGTTAAATCTTTGGGATAGTATTTAGCTTTCTCCAGGATTATGACTTACC
TTCTAAATTAGACATACAATGCCTAGGAGTCAAGGACTATTTTGCATAAA
TTCCAGTCTTCTTTTACAATGCCTAGAATGATTGTTACCACAGAAATATT
CATTACCTGGGAGAAAGGATGACAGGAGGGGCAGAATGAATGGAGAGAGG
TCGTGAGAATGAGGTGCTGAGGATGGACGAGGAAGAAAGCTGTTTTAGTT
GGGAGGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTGGACCCATGGA
AGCCCAGTGAAGATACTTAGATCCTGCAGGGGTGTGAATAATGTTCTTTT
AGTTTCTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAA
GAGTGAACTTAAATTGGAGAAAAGTACATTTTAGTATGTTGATAACATTT
GAATTTGTAAAATGGACCTATGGATGATCTACACATATTTATATACCCAT
AAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTAATGA
TCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCA
GCAATGTTGTTTTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGA
TGCAATGTTCAAAATTTCAACTGTGGTTAAAGCAATAGTGTGATATATGA
TTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTGAGCATACTAAA
AGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGC
AGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTGGAG

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27281 (3′H arm)
TCAACGAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTG
TAAATGTCATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAA
TTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAAT
GGTATAGTATCCAGATTTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTC
AGTGTATTTGTTTGCCTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAAT
ACTGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACAC
ACCAGCTTTAGGCTTCTTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCA
TAACAAAATAGGAAGGCAAATGATGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGG
ACAAATGCATTAACATTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAGCATT
TTAAAGCTGTCAAAGAGATGTAAATATAGATAATGTATGTCAAGGAGAGAGCTTTGTGGTTAAA
CTGTAACTTTCAGTTTAAACAATTATTGGTGACTCTGATGTCAAATGTTTCTCAAGCTTTATCT
GAACAAAATTCTTCTCACTTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATG
TTTTGGCTCCTTTCCCTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAACTAACCCTAAC
TGAGCACCTGCAATTGCCTGGTAGTATTCTAGTCATGTGTGTACTTTTGTGTGTATGTAATCCC
CTTACAGCTCTGCAAAGTAAGAATTGTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGA
GGCTGTTAGATGTTAACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACCAG
GTCCTTTTGATTCTTTACATTAAACCATGCTTTGATCTTGGAAATACACTGTAAGGCAATAAAT
CAATAGATACGGATAATTCACAGGCTTCTAAATAAATGGAAGTTGATTGTTTTTATCTGTGAGC
CAAAGTAAGACTTATTCTAAGAATTCCACAAATTTAGATAAGATAGAG

In an embodiment, the replacement sequence comprises or consists of a Guanine (G) residue.

In an embodiment, to correct a mutation, e.g., G551D target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, codon 551 is shown as underlined sequence, the inserted base to correct the G551D mutation is shown as non-bold and boxed sequence, and the 3′ homology arm is shown as no emphasis sequence.

(Template Construct 11; SEQ ID NO: 27282)
TGAATAACAGAAGTAACCATTTTGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTG
TGAAAGAAGAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGGAGGTGG
AAACGAATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTTTTTTTTTTTAAGGCGAGAGT
TTACTACCTATCTAACTCTTCGCATTCTTGAAGTCTCAGACCAAATCCCATCGGTTTGAAAGCC
TCTAGGGTATTCTATCTATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTG
AACTGTTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTATTTAGCTTTCTCC
AGGATTATGACTTACCTTCTAAATTAGACATACAATGCCTAGGAGTCAAGGACTATTTTGCATA
AATTCCAGTCTTCTTTTACAATGCCTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGA
GAAAGGATGACAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGGATGG
ACGAGGAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTG
GACCCATGGAAGCCCAGTGAAGATACTTAGATCCTGCAGGGGTGTGAATAATGTTCTTTTAGTT
TCTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGA
GAAAAGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTAC
ACATATTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTA
ATGATCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGT
TTTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGT
GGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATT
GAGCATACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAG
AGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTGGAG  TCAACGAGCAAGAAT
TTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATG
TAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGG
GGTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATCCAGA
TTTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGC
CTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAGAAGA
TGTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAGGCTT
CTIGGTATAGATAAACATACATITICAAAATITTICATCATAATTTTCATAACAAAATAGGAAG
GCAAATGATGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCATTAACA
TTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAGCATTTTAAAGCTGTCAAAG
AGATGTAAATATAGATAATGTATGTCAAGGAGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTT
TAAACAATTATTGGTGACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCT
CACTTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTTTGGCTCCTTTCC
CTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAACTAACCCTAACTGAGCACCTGCAATT
GCCTGGTAGTATTCTAGTCATGTGTGTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAA
AGTAAGAATTGTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGATGTTA
ACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACCAGGTCCTTTTGATTCTT
TACATTAAACCATGCTTTGATCTTGGAAATACACTGTAAGGCAATAAATCAATAGATACGGATA
ATTCACAGGCTTCTAAATAAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTAT
TCTAAGAATTCCACAAATTTAGATAAGATAGAG

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct G551D mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., approximately 750 nucleotides, e.g., 724 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, codon 551 is shown as underlined sequence, the inserted base to correct the G551D mutation is shown as non-bold and boxed sequence, and the 3′ homology arm is shown as no emphasis sequence.

(Template Construct 12; SEQ ID NO: 27283)
AATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAGGATGACAGGAGGGGCAGAATGAA
TGGAGAGAGGTCGTGAGAATGAGGTGCTGAGGATGGACGAGGAAGAAAGCTGTTTTAGTTGGGA
GGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTGGACCCATGGAAGCCCAGTGAAGATACTT
AGATCCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCTTCTTAGGAGGTTTGTTCATTTTG
GGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAAAGTACATTTTAGTATGTTGATAAC
ATTTGAATTTGTAAAATGGACCTATGGATGATCTACACATATTTATATACCCATAAATATACAC
ATATTTTAATTTTTGGTATTTTATAATTATTATTTAATGATCATTCATGACATTTTAAAAATTA
CAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTGACCAACTAAATAAATTGCATTTG
AAATAATGGAGATGCAATGTTCAAAATTTCAACTGTGGTTAAAGCAATAGTGTGATATATGATT
ACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTGAGCATACTAAAAGTGACTCTCTAATTT
TCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTTGGAGAAGG
TGGAATCACACTGAGTGGAG  TCAACGAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTAT
TGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATGTAAAAAAATTACAGACATTTCTCTATTG
CTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCA
CATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGGTAGAGATTATGGTTACTCAGAAT
CTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGCCTCATAGTATAGTTTACTACAAATGGAA
AACTCTAGGATTCTGCATAATACTGGACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGA
CCCTGCCACTCCAATGTACACACCAGCTTTAGGCTTCTTGGTATAGATAAACATACATTTTCAA
AATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAATGATGTCACTTGGCTTAAAATCT
ATAATATTTAAAATAAACAGGACAAATGCATTAACATTGTTGGGGGAGGAGGTCCCTTAGTAGA
AACACICTIGGTCCAAGCATITTAAAGCTGTCAAAGAGATGTAAATATAGATAATGTATGTCAA
GGAGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTTTAAACAATTATTGGTGACTCTGATGTCA
AATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCTCACTTTGTTGCCAAAGTCGTTAACAAGA
AATCACATTGACTCATTGATGTTTTGGCTCCTTTCCCTTACTTTCTGTTGCTTTCCAAAAGCTG
AGACAGGA

In an embodiment, to correct G551D mutation in the CFTR gene, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the G551D mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 13; SEQ ID NO: 27284)
AGTTTCTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAAT
TGGAGAAAAGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGAT
CTACACATATTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTA
TTTAATGATCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATG
TTGTTTTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAA
CTGTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCA
GATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTT
GCAGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTGGAGgTCAACGAGCAA
GAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATT
CATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATC
CTGGGGTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATC
CAGATTTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGT
TTGCCTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAG
AAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAG
GCTTCTTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAG
GAAGGCAAATGATGTCACTTGGCTTAAAATCTATAATATTT

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., G551D target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the G542X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 14; SEQ ID NO: 27285)
GGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAG
TTCTTGGAGAAGGTGGAATCACACTGAGTGGAGgTCAACGAG
CAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTA
GCAAGCATTTGCTGTAAATGTCATT

In an embodiment, to correct a mutation, e.g., G551D target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the G551D mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 15; SEQ ID NO: 27286)
TGAATAACAGAAGTAACCATTTTGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTG
TGAAAGAAGAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGGAGGTGG
AAACGAATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTTTTTTTTTTTAAGGCGAGAGT
TTACTACCTATCTAACTCTTCGCATTCTTGAAGTCTCAGACCAAATCCCATCGGTTTGAAAGCC
TCTAGGGTATTCTATCTATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTG
AACTGTTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTATTTAGCTTTCTCC
AGGATTATGACTTACCTTCTAAATTAGACATACAATGCCTAGGAGTCAAGGACTATTTTGCATA
AATTCCAGTCTTCTTTTACAATGCCTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGA
GAAAGGATGACAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGGATGG
ACGAGGAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTG
GACCCATGGAAGCCCAGTGAAGATACTTAGATCCTGCAGGGGTGTGAATAATGTTCTTTTAGTT
TCTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGA
GAAAAGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTAC
ACATATTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTA
ATGATCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGT
TTTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGT
GGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATT
GAGCATACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAG
AGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGtcTGGAGgTCAACGAGCAAGAAT
TTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATG
TAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGG
GGTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATCCAGA
TTTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGC
CTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAGAAGA
TGTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAGGCTT
CTTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAG
GCAAATGATGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCATTAACA
TTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAGCATTTTAAAGCTGTCAAAG
AGATGTAAATATAGATAATGTATGTCAAGGAGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTT
TAAACAATTATTGGTGACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCT
CACTTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTTTGGCTCCTTTCC
CTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAACTAACCCTAACTGAGCACCTGCAATT
GCCTGGTAGTATTCTAGTCATGTGTGTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAA
AGTAAGAATTGTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGATGTTA
ACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACCAGGTCCTTTTGATTCTT
TACATTAAACCATGCTTTGATCTTGGAAATACACTGTAAGGCAATAAATCAATAGATACGGATA
ATTCACAGGCTTCTAAATAAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTAT
TCTAAGAATTCCACAAATTTAGATAAGATAGAG

In an embodiment, to correct a mutation, e.g., G551D target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the G551D mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 16; SEQ ID NO: 27287)
AGTTTCTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAAT
TGGAGAAAAGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGAT
CTACACATATTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTA
TTTAATGATCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATG
TTGTTTTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAA
CTGTGGTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCA
GATTGAGCATACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTT
GCAGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGtcTGGAGgTCAACGAGCAA
GAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATT
CATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATC
CTGGGGTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATC
CAGATTTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGT
TTGCCTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAG
AAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAG
GCTTCTTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAG
GAAGGCAAATGATGTCACTTGGCTTAAAATCTATAATATTT

In an embodiment, an ssODN may be to correct a mutation, e.g., G551D target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the G551D mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 18; SEQ ID NO: 27288)
GGTAATAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTT
CTTGGAGAAGGTGGAATCACACTGtcTGGAGgTCAACGAGCAAG
AATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGC
ATTTGCTGTAAATGTCATT

The underlined T has been changed from a A to T at that position and the underlined C has been changed from an G to C at that position so that wild-type CFTR is still transcribed, but the PAM sequence TGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., N1303K target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27289 (5′H arm)
GTTTCTGAGACATTTGACAACAACTTTTTCTTTAAGTCATCAGTTATGCCCCGGGGTATGAAAT
TTCTAACATGATCCTCAGTAAACTTGGCTGCCTTGCTGAGGATACTCTCCATCTGCCTGAGAGA
CACAGACACCATTAATTGGGAATTGACTTGACTTGTGTGGTTCCTTGTGGACCAGATGGCCACT
AAATATTCTCATTTCAAGGCAATTGGTAAAAACTACACTTCAAGAAATTTCATTCTTAATTCCC
CTTAGTGGATGTTATTAACCAAAGGCAAAAGAAAAAAAGGGTTAAAAAAATATTCTAAATGTTA
ATATCAAAAATATTATTTTTCATTCACCCCAGGCACAGAGAACTAAGTATTATTATTGCTATTG
CACCGGCATTCCCCAATGAGACAGTGATTTTCTTTTAAGACATTTTTAAATAATATAGGCAGAA
TTAAGTAGACGGTGATCTGGTAAGTAGATGTTTCAGGGTAACAGCTGTGCAATGCTCCATGCAG
GGAATTAGATTGTCATTTTATTCCTTACCAGGAACATACATTCAGTTAAACAATTATTTGACTT
CTGCTCTTCCACTGATTTCTAAGTTGAGGCTCTCTCTTGTGCCTGTCTGATCAGATAAGTAGAG
TTGTGCCTTGGTTTATAGATGAGATAAATGTGTATTTGAATAAGCATAAGTTAAAGAAATTTTA
AAATCCCTTAGGAAGCTAGGCTTATCAGAGAAATCCAAGGAAATACATTAACAAACTAGGAATT
TGTTCTAACAGGTTAATTATAACTCATAAACTTATTGGGTTTTTTTACCTTTTAATTTTATATT
ACATTTGCTTATAATAAGGAATATTGCTAGGAATAAAATTTTTTAATATTCTACAATTAACAAT
TATCTCAATTTCTTTATTCTAAAGACATTGGGATTAGAAAAATGTTCACAAGGGACTCCAAATA
TTGCTGTAGTATTTGTTTCTTAAAAGAATGATACAAAGCAGACATGATAAAATATTAAAATTTG
AGAGAACTTGATGGTAAGTACATGGGTGTTTCTTATTTTAAAATAATTTTTCTACTTGAAATAT
TTTACAATACAATAAGGGAAAAATAAAAAGTTATTTAAGTTATTCATACTTTCTTCTTCTTTTC
TTTTTTGCTATAGAAAGTATTTATTTTTTCTGGAACATTTAGAAAAAA

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence.

SEQ ID NO: 27290 (3′H arm)
TTGGATCCCTATGAACAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAGGCTGC
TAACTGAAATGATTTTGAAAGGGGTAACTCATACCAACACAAATGGCTGATATAGCTGACATCA
TTCTACACACTTTGTGTGCATGTATGTGTGTGCACAACTTTAAAATGGAGTACCCTAACATACC
TGGAGCAACAGGTACTTTTGACTGGACCTACCCCTAACTGAAATGATTTTGAAAGAGGTAACTC
ATACCAACACAAATGGTTGATATGGCTAAGATCATTCTACACACTTTGTGTGCATGTATTTCTG
TGCACAACTTCAAAATGGAGTACCCTAAAATACCTGGCGCGACAAGTACTTTTGACTGAGCCTA
CTTCTCTCCTCACTGGTATGGCTCCAACCATCAGGCCCTATCTTGGTCCATTTAGGCTGCTAAA
ATAAAATACCAAAGACTGAGCTGCTTATAAGCAATCTTTGGAGGCTGAGAAGTCAAAGATCAAG
GTGCCAGCAGGTTTGCTGTCTCGTGAGAGCATACTTCCTGGTTCATTGATGGTGCTTTCTTGCT
GTGTCCTCACATAATGGAAAGGGCAAGACCTCTCTGGTGTCTCTTTTACAATGGCACTAATCCC
ATCATGAGGGCTTTGTTCTCATGACCTAATCACCTCCCACATGTCCTACATTCTAATACTATCA
CCTTGGGGGTTAGGATTTTAACATATGAATTTGAGGAGGTGGCGGGGGGGACACAAATATTTAG
ACCATAGCATTTCACTCCTGACCTCCAAAGTTCATGTCTTCTTCACATGCAAAATACATTCATT
CCATCCCAATAGCCCCCAAAGTCTTAACTTGTTCCAGCATCAACTTACAAGGCTAAAGTCCAAG
GTTTCATCTAAATATCAGCTAAATCAGCACAAACAGCTAAATCAGGTAGAGTGGGACTTAAGGT
GTGATTCCTCTTTAGGCAGATTGCTCTCCAACTATGAAATTGTGAAATCAAACCTATTATGTAC
TTTCAAAATAAAATGGTGAAACAGGCACAGGCTAGACAGTCCCATTTCAAAAAAGAGAAATAGA
AAAGAAAAAAGGAGTGACAGGTCTCTATAAGTCTAAAACTTTAAGGCTTGAGAATAATTTGCTT
TGCTTTGCCTCCAGGCTCACTGGGGTGGTGTCTTACCTCTGGACACAC

In an embodiment, the replacement sequence comprises or consists of a Cytosine (C) residue.

In an embodiment, to correct a mutation, e.g., N1303K target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the G542X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 19; SEQ ID NO: 27291)
GTTTCTGAGACATTTGACAACAACTTTTTCTTTAAGTCATCAGTTATGCCCCGGGGTATGAAAT
TTCTAACATGATCCTCAGTAAACTTGGCTGCCTTGCTGAGGATACTCTCCATCTGCCTGAGAGA
CACAGACACCATTAATTGGGAATTGACTTGACTTGTGTGGTTCCTTGTGGACCAGATGGCCACT
AAATATTCTCATTTCAAGGCAATTGGTAAAAACTACACTTCAAGAAATTTCATTCTTAATTCCC
CTTAGTGGATGTTATTAACCAAAGGCAAAAGAAAAAAAGGGTAAAAAAAATATTCTAAATGTTA
ATATCAAAAATATTATTTTCAATTCACCCCAGGCACAGAGAACTAAGTATTATTATTGCTATTG
CACCGGCATTCCCCAATGAGACAGTGATTTTCTTTTAAGACATTTTTAAATAATATAGGCAGAA
TTAAGTAGACGGTGATCTGGTAAGTAGATGTTTCAGGGTAACAGCTGTGCAATGCTCCATGCAG
GGAATTAGATTGTCATTTTATTCCTTACCAGGAACATACATTCAGTTAAACAATTATTTGACTT
CTGCTCTTCCACTGATTTCTAAGTTGAGGCTCTCTCTTGTGCCTGTCTGATCAGATAAGTAGAG
TTGTGCCTTGGTTTATAGATGAGATAAATGTGTATTTGAATAAGCATAAGTTAAAGAAATTTTA
AAATCCCTTAGGAAGCTAGGCTTATCAGAGAAATCCAAGGAAATACATTAACAAACTAGGAATT
TGTTCTAACAGGTTAATTATAACTCATAAACTTATTGGGTTTTTTTACCTTTTAATTTTATATT
ACATTTGCTTATAATAAGGAATATTGCTAGGAATAAAATTTTTTAATATTCTACAATTAACAAT
TATCTCAATTTCTTTATTCTAAAGACATTGGGATTAGAAAAATGTTCACAAGGGACTCCAAATA
TTGCTGTAGTATTTGTTTCTTAAAAGAATGATACAAAGCAGACATGATAAAATATTAAAATTTG
AGAGAACTTGATGGTAAGTACATGGGTGTTTCTTATTTTAAAATAATTTTTCTACTTGAAATAT
TTTACAATACAATAAGGGAAAAATAAAAAGTTATTTAAGTTATTCATACTTTCTTCTTCTTTTC
TTTTTTGCTATAGAAAGTATTTATTTTTTCTGGAACATTTAGAAAAAAcTTGGATCCCTATGAA
CAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAGGCTGCTAACTGAAATGATTT
TGAAAGGGGTAACTCATACCAACACAAATGGCTGATATAGCTGACATCATTCTACACACTTTGT
GTGCATGTATGTGTGTGCACAACTTTAAAATGGAGTACCCTAACATACCTGGAGCAACAGGTAC
TTTTGACTGGACCTACCCCTAACTGAAATGATTTTGAAAGAGGTAACTCATACCAACACAAATG
GTTGATATGGCTAAGATCATTCTACACACTTTGTGTGCATGTATTTCTGTGCACAACTTCAAAA
TGGAGTACCCTAAAATACCTGGCGCGACAAGTACTTTTGACTGAGCCTACTTCTCTCCTCACTG
GTATGGCTCCAACCATCAGGCCCTATCTTGGTCCATTTAGGCTGCTAAAATAAAATACCAAAGA
CTGAGCTGCTTATAAGCAATCTTTGGAGGCTGAGAAGTCAAAGATCAAGGTGCCAGCAGGTTTG
CTGTCTCGTGAGAGCATACTTCCTGGTTCATTGATGGTGCTTTCTTGCTGTGTCCTCACATAAT
GGAAAGGGCAAGACCTCTCTGGTGTCTCTTTTACAATGGCACTAATCCCATCATGAGGGCTTTG
TTCTCATGACCTAATCACCTCCCACATGTCCTACATTCTAATACTATCACCTTGGGGGTTAGGA
TTTTAACATATGAATTTGAGGAGGTGGCGGGGGGGACACAAATATTTAGACCATAGCATTTCAC
TCCTGACCTCCAAAGTTCATGTCTTCTTCACATGCAAAATACATTCATTCCATCCCAATAGCCC
CCAAAGTCTTAACTTGTTCCAGCATCAACTTACAAGGCTAAAGTCCAAGGTTTCATCTAAATAT
CAGCTAAATCAGCACAAACAGCTAAATCAGGTAGAGTGGGACTTAAGGTGTGATTCCTCTTTAG
GCAGATTGCTCTCCAACTATGAAATTGTGAAATCAAACCTATTATGTACTTTCAAAATAAAATG
GTGAAACAGGCACAGGCTAGACAGTCCCATTTCAAAAAAGAGAAATAGAAAAGAAAAAAGGAGT
GACAGGTCTCTATAAGTCTAAAACTTTAAGGCTTGAGAATAATTTGCTTTGCTTTGCCTCCAGG
CTCACTGGGGTGGTGTCTTACCTCTGGACACAC

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct N1303K mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the N1303K mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 20; SEQ ID NO: 27292)
TTTAAAATCCCTTAGGAAGCTAGGCTTATCAGAGAAATCCAAGGAAATACATTAACAAACTAGG
AATTTGTTCTAACAGGTTAATTATAACTCATAAACTTATTGGGTTTTTTTACCTTTTAATTTTA
TATTACATTTGCTTATAATAAGGAATATTGCTAGGAATAAAATTTTTTAATATTCTACAATTAA
CAATTATCTCAATTTCTTTATTCTAAAGACATTGGGATTAGAAAAATGTTCACAAGGGACTCCA
AATATTGCTGTAGTATTTGTTTCTTAAAAGAATGATACAAAGCAGACATGATAAAATATTAAAA
TTTGAGAGAACTTGATGGTAAGTACATGGGTGTTTCTTATTTTAAAATAATTTTTCTACTTGAA
ATATTTTACAATACAATAAGGGAAAAATAAAAAGTTATTTAAGTTATTCATACTTTCTTCTTCT
TTTCTTTTTTGCTATAGAAAGTATTTATTTTTTCTGGAACATTTAGAAAAAAcTTGGATCCCTA
TGAACAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAGGCTGCTAACTGAAATG
ATTTTGAAAGGGGTAACTCATACCAACACAAATGGCTGATATAGCTGACATCATTCTACACACT
TTGTGTGCATGTATGTGTGTGCACAACTTTAAAATGGAGTACCCTAACATACCTGGAGCAACAG
GTACTTTTGACTGGACCTACCCCTAACTGAAATGATTTTGAAAGAGGTAACTCATACCAACACA
AATGGTTGATATGGCTAAGATCATTCTACACACTTTGTGTGCATGTATTTCTGTGCACAACTTC
AAAATGGAGTACCCTAAAATACCTGGCGCGACAAGTACTTTTGACTGAGCCTACTTCTCTCCTC
ACTGGTATGGCTCCAACCATCAGGCCCTATCTTGGTCCATTTAGGCTGCTAAAATAAAATACCA
AAGACTGAGCTGCTTATAAGCAATCTTTGGAGGCTGAGAAG

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., N1303K target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the N1303K mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 21; SEQ ID NO: 27293)
AGTTATTCATACTTTCTTCTTCTTTTCTTTTTTGCTATAGAAAGTAT
TTATTTTTTCTGGAACATTTAGAAAAAAcTTGGATCCCTATGAACAG
TGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAGGCTGCT
AACTGAAATG

In an embodiment, to correct a mutation, e.g., N1303K target site in the CFTR gene, and concomitantly introduce a silent sense mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the N1303K mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 22; SEQ ID NO: 27294)
GTTTCTGAGACATTTGACAACAACTTTTTCTTTAAGTCATCAGTTATGCCCCGGGGTATGAAAT
TTCTAACATGATCCTCAGTAAACTTGGCTGCCTTGCTGAGGATACTCTCCATCTGCCTGAGAGA
CACAGACACCATTAATTGGGAATTGACTTGACTTGTGTGGTTCCTTGTGGACCAGATGGCCACT
AAATATTCTCATTTCAAGGCAATTGGTAAAAACTACACTTCAAGAAATTTCATTCTTAATTCCC
CTTAGTGGATGTTATTAACCAAAGGCAAAAGAAAAAAAGGGTAAAAAAAATATTCTAAATGTTA
ATATCAAAAATATTATTTTCAATTCACCCCAGGCACAGAGAACTAAGTATTATTATTGCTATTG
CACCGGCATTCCCCAATGAGACAGTGATTTTCTTTTAAGACATTTTTAAATAATATAGGCAGAA
TTAAGTAGACGGTGATCTGGTAAGTAGATGTTTCAGGGTAACAGCTGTGCAATGCTCCATGCAG
GGAATTAGATTGTCATTTTATTCCTTACCAGGAACATACATTCAGTTAAACAATTATTTGACTT
CTGCTCTTCCACTGATTTCTAAGTTGAGGCTCTCTCTTGTGCCTGTCTGATCAGATAAGTAGAG
TTGTGCCTTGGTTTATAGATGAGATAAATGTGTATTTGAATAAGCATAAGTTAAAGAAATTTTA
AAATCCCTTAGGAAGCTAGGCTTATCAGAGAAATCCAAGGAAATACATTAACAAACTAGGAATT
TGTTCTAACAGGTTAATTATAACTCATAAACTTATTGGGTTTTTTTACCTTTTAATTTTATATT
ACATTTGCTTATAATAAGGAATATTGCTAGGAATAAAATTTTTTAATATTCTACAATTAACAAT
TATCTCAATTTCTTTATTCTAAAGACATTGGGATTAGAAAAATGTTCACAAGGGACTCCAAATA
TTGCTGTAGTATTTGTTTCTTAAAAGAATGATACAAAGCAGACATGATAAAATATTAAAATTTG
AGAGAACTTGATGGTAAGTACATGGGTGTTTCTTATTTTAAAATAATTTTTCTACTTGAAATAT
TTTACAATACAATAAGGGAAAAATAAAAAGTTATTTAAGTTATTCATACTTTCTTCTTCTTTTC
TTTTTTGCTATAGAAAGTATTTATTTTTTCTGGAACATTTAGAAAAAAccTcGATCCCTATGAA
CAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAGGCTGCTAACTGAAATGATTT
TGAAAGGGGTAACTCATACCAACACAAATGGCTGATATAGCTGACATCATTCTACACACTTTGT
GTGCATGTATGTGTGTGCACAACTTTAAAATGGAGTACCCTAACATACCTGGAGCAACAGGTAC
TTTTGACTGGACCTACCCCTAACTGAAATGATTTTGAAAGAGGTAACTCATACCAACACAAATG
GTTGATATGGCTAAGATCATTCTACACACTTTGTGTGCATGTATTTCTGTGCACAACTTCAAAA
TGGAGTACCCTAAAATACCTGGCGCGACAAGTACTTTTGACTGAGCCTACTTCTCTCCTCACTG
GTATGGCTCCAACCATCAGGCCCTATCTTGGTCCATTTAGGCTGCTAAAATAAAATACCAAAGA
CTGAGCTGCTTATAAGCAATCTTTGGAGGCTGAGAAGTCAAAGATCAAGGTGCCAGCAGGTTTG
CTGTCTCGTGAGAGCATACTTCCTGGTTCATTGATGGTGCTTTCTTGCTGTGTCCTCACATAAT
GGAAAGGGCAAGACCTCTCTGGTGTCTCTTTTACAATGGCACTAATCCCATCATGAGGGCTTTG
TTCTCATGACCTAATCACCTCCCACATGTCCTACATTCTAATACTATCACCTTGGGGGTTAGGA
TTTTAACATATGAATTTGAGGAGGTGGCGGGGGGGACACAAATATTTAGACCATAGCATTTCAC
TCCTGACCTCCAAAGTTCATGTCTTCTTCACATGCAAAATACATTCATTCCATCCCAATAGCCC
CCAAAGTCTTAACTTGTTCCAGCATCAACTTACAAGGCTAAAGTCCAAGGTTTCATCTAAATAT
CAGCTAAATCAGCACAAACAGCTAAATCAGGTAGAGTGGGACTTAAGGTGTGATTCCTCTTTAG
GCAGATTGCTCTCCAACTATGAAATTGTGAAATCAAACCTATTATGTACTTTCAAAATAAAATG
GTGAAACAGGCACAGGCTAGACAGTCCCATTTCAAAAAAGAGAAATAGAAAAGAAAAAAGGAGT
GACAGGTCTCTATAAGTCTAAAACTTTAAGGCTTGAGAATAATTTGCTTTGCTTTGCCTCCAGG
CTCACTGGGGTGGTGTCTTACCTCTGGACACAC

In an embodiment, to correct a mutation, e.g., N1303K target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the N1303K mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 23; SEQ ID NO: 27295)
TTTAAAATCCCTTAGGAAGCTAGGCTTATCAGAGAAATCCAAGGAAATACATTAACAAACTAGG
AATTTGTTCTAACAGGTTAATTATAACTCATAAACTTATTGGGTTTTTTTACCTTTTAATTTTA
TATTACATTTGCTTATAATAAGGAATATTGCTAGGAATAAAATTTTTTAATATTCTACAATTAA
CAATTATCTCAATTTCTTTATTCTAAAGACATTGGGATTAGAAAAATGTTCACAAGGGACTCCA
AATATTGCTGTAGTATTTGTTTCTTAAAAGAATGATACAAAGCAGACATGATAAAATATTAAAA
TTTGAGAGAACTTGATGGTAAGTACATGGGTGTTTCTTATTTTAAAATAATTTTTCTACTTGAA
ATATTTTACAATACAATAAGGGAAAAATAAAAAGTTATTTAAGTTATTCATACTTTCTTCTTCT
TTTCTTTTTTGCTATAGAAAGTATTTATTTTTTCTGGAACATTTAGAAAAAAccTcGATCCCTA
TGAACAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAGGCTGCTAACTGAAATG
ATTTTGAAAGGGGTAACTCATACCAACACAAATGGCTGATATAGCTGACATCATTCTACACACT
TTGTGTGCATGTATGTGTGTGCACAACTTTAAAATGGAGTACCCTAACATACCTGGAGCAACAG
GTACTTTTGACTGGACCTACCCCTAACTGAAATGATTTTGAAAGAGGTAACTCATACCAACACA
AATGGTTGATATGGCTAAGATCATTCTACACACTTTGTGTGCATGTATTTCTGTGCACAACTTC
AAAATGGAGTACCCTAAAATACCTGGCGCGACAAGTACTTTTGACTGAGCCTACTTCTCTCCTC
ACTGGTATGGCTCCAACCATCAGGCCCTATCTTGGTCCATTTAGGCTGCTAAAATAAAATACCA
AAGACTGAGCTGCTTATAAGCAATCTTTGGAGGCTGAGAAG

In an embodiment, an ssODN may be to correct a mutation, e.g., N1303K target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the N1303K mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 24; SEQ ID NO: 27296)
AGTTATTCATACTTTCTTCTTCTTTTCTTTTTTGCTATAGAAAGT
ATTTATTTTTTCTGGAACATTTAGAAAAAAccTcGATCCCTATGA
ACAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGATGAGGTAAG
GCTGCTAACTGAAATG

The underlined C has been changed from a G to C so that wild-type CFTR is still transcribed, but the PAM sequence TGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., R117H target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27297(5′H arm)
AACCCCTCAAATTAAGGGATGAGGCAGAATAATGCTTGGCAATACCAGGGGTAGGCTGCAGTCT
TTCTTGGAAATATATATTTTAAATGGAACCAATTATCATAGCATCATTTCCTCTCAGGGTTACC
CTCTGATCCCTATTTTACTAAATCGTTATAAAACAAAATGAGGAATTATGTGTCCTTCCCTTTT
GAAGCCAATGTAACAAGATGGGTAAGAATTAGACCTCCTGAGTTCAAAATCCCTGGATTCAGAT
CTATTCCTGTATATTCAGGAGAAGTGGTAATAAATTCGATGGACAATTTGGTTTAGTAGTCGAT
TGAGGACCCTGATGAGGTATATTTGGGAAAACATAACTTCCGCTCTCTCTCATTGACTCACGGG
CCTTTGAGGAGTCCAGGAGTCATTGGAATCTGGCCTGAGGTTGAGGCTGCTGGCAAAACTCCTT
CCCCAAAGTCCATTCCTATTGCTGACTGAGAAGGGACTAGCATTGGAAGTGGCTGATTTTAAAT
ACCGCTAGTGCTGGTGTGCTCCTCCCTCCCATTCCCAGCTCTGCTTTGTGTAGTTGCCTTGAGA
AGCTAAGTTCATTCTGAAAATAATGCCATTGCACAAAACACTTTTGAAAGTTCTAGTTTGAAAT
TACATCAGGTCACTTGGTCTGTGTGGCCTCAGTTTCTTCATCTGCCATGTGAAAATAATAATGC
CTACTCTGTAGCAAAGAAAGTCTCTATAGTAAACAAAAAAAAAGCCTACTCTGATACTGAAAGT
TGTTATGAAAAATAAAAAAGGGAAATGCTTTAGAAACTGTTAAGTGCTATGTAGATGTTACTAA
TTAACAAACCATTTCAGAAACTATACTTTTTATTTTATGGCCACTATTCACTGTTTAACTTAAA
ATACCTCATATGTAAACTTGTCTCCCACTGTTGCTATAACAAATCCCAAGTCTTATTTCAAAGT
ACCAAGATATTGAAAATAGTGCTAAGAGTTTCACATATGGTATGACCCTCTATATAAACTCATT
TTAAGTCTCCTCTAAAGATGAAAAGTCTTGTGTTGAAATTCTCAGGGTATTTTATGAGAAATAA
ATGAAATTTAATTTCTCTGTTTTTCCCCTTTTGTAGGAAGTCACCAAAGCAGTACAGCCTCTCT
TACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAAC

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(3′H arm)
SEQ ID NO: 27298
CTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTGA
GGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAATG
CAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAGGTAATACTTCC
TTGCACAGGCCCCATGGCACATATATTCTGTATCGTACATGTTTTAATGT
CATAAATTAGGTAGTGAGCTGGTACAAGTAAGGGATAAATGCTGAAATTA
ATTTAATATGCCTATTAAATAAATGGCAGGAATAATTAATGCTCTTAATT
ATCCTTGATAATTTAATTGACTTAAACTGATAATTATTGAGTATCTTCTG
TAAACTGCCTCTGTTGTAGTTTTTTTTTTCTCCTAATCATGTTATCATTT
TTTTGGAATCCATGGTTTCCTGTTAAGATGACTCACACAGCCTACATAAA
AGTAATTGACAAAATATCATCTTATAGTAAAATGCCACATATCTTTATGT
TCAGCAAGAAGAGTATAATATATGATTGTTAATGATAACCCAAACAACAA
AAGATTTCACCTTAACTGGTTGTCATAAGTAGTAGTATCCACCGCCTTAT
TTTGAGTTGGATTTTTATCATCCTATGAGCCCTACAAATTTAAAGTTTTT
GGAACAGCACGTGCATTGAACCCATAAGAACCTACTCTGCTTTTCTGCAT
GTATTGTCCAGACAAGAGACCAAATTGCCGAGGCATCATTTAGGTGAATT
CTAATTAACATTTAGCTACCTTACAACCACAATTCAAGGTTGTTTCAAAG
GCATGTGCTTGCATCATCCTGATTCACTACCATGTGTTACTAACTTGGAT
CTGCAAAGTCATTATAAAAAGCTGTTTTGATGGACTTATTTGGATATTGC
TTTACCCTTCTTCTCTCTTTTCTTTTATCAATGTAAAAACATTATATGTT
AAATACTTGGCTTTTAAGAGCATAGATCTGAAATCTGCCTCTAGCAAATA
ACCCATAACACTTCTAAGATATACCTGCAAGGTCAATTGTGTTGTAAAAC
CTTGATAACCATACTTTATTGTTCAAAAAAGCCTTTTATGAAGGCAGAAG
TTAAAAAAAAAAAACAAAAAAAACAGAGTCCACAGTTATCACCTCAGCTA
CAATCTCATCAGTTCACAAGTACCAGCAAAACATGTGATAAGTCAACAAA

In an embodiment, the replacement sequence comprises or consists of a Guanine (G) residue.

In an embodiment, to correct a mutation, e.g., R117H target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the R117H mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 25; SEQ ID NO: 27299)
AACCCCTCAAATTAAGGGATGAGGCAGAATAATGCTTGGCAATACCAGGG
GTAGGCTGCAGTCTTTCTTGGAAATATATATTTTAAATGGAACCAATTAT
CATAGCATCATTTCCTCTCAGGGTTACCCTCTGATCCCTATTTTACTAAA
TCGTTATAAAACAAAATGAGGAATTATGTGTCCTTCCCTTTTGAAGCCAA
TGTAACAAGATGGGTAAGAATTAGACCTCCTGAGTTCAAAATCCCTGGAT
TCAGATCTATTCCTGTATATTCAGGAGAAGTGGTAATAAATTCGATGGAC
AATTTGGTTTAGTAGTCGATTGAGGACCCTGATGAGGTATATTTGGGAAA
ACATAACTTCCGCTCTCTCTCATTGACTCACGGGCCTTTGAGGAGTCCAG
GAGTCATTGGAATCTGGCCTGAGGTTGAGGCTGCTGGCAAAACTCCTTCC
CCAAAGTCCATTCCTATTGCTGACTGAGAAGGGACTAGCATTGGAAGTGG
CTGATTTTAAATACCGCTAGTGCTGGTGTGCTCCTCCCTCCCATTCCCAG
CTCTGCTTTGTGTAGTTGCCTTGAGAAGCTAAGTTCATTCTGAAAATAAT
GCCATTGCACAAAACACTTTTGAAAGTTCTAGTTTGAAATTACATCAGGT
CACTTGGTCTGTGTGGCCTCAGTTTCTTCATCTGCCATGTGAAAATAATA
ATGCCTACTCTGTAGCAAAGAAAGTCTCTATAGTAAACAAAAAAAAAGCC
TACTCTGATACTGAAAGTTGTTATGAAAAATAAAAAAGGGAAATGCTTTA
GAAACTGTTAAGTGCTATGTAGATGTTACTAATTAACAAACCATTTCAGA
AACTATACTTTTTATTTTATGGCCACTATTCACTGTTTAACTTAAAATAC
CTCATATGTAAACTTGTCTCCCACTGTTGCTATAACAAATCCCAAGTCTT
ATTTCAAAGTACCAAGATATTGAAAATAGTGCTAAGAGTTTCACATATGG
TATGACCCTCTATATAAACTCATTTTAAGTCTCCTCTAAAGATGAAAAGT
CTTGTGTTGAAATTCTCAGGGTATTTTATGAGAAATAAATGAAATTTAAT
TTCTCTGTTTTTCCCCTTTTGTAGGAAGTCACCAAAGCAGTACAGCCTCT
CTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAAC
gCTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTG
AGGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAAT
GCAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAGGTAATACTTC
CTTGCACAGGCCCCATGGCACATATATTCTGTATCGTACATGTTTTAATG
TCATAAATTAGGTAGTGAGCTGGTACAAGTAAGGGATAAATGCTGAAATT
AATTTAATATGCCTATTAAATAAATGGCAGGAATAATTAATGCTCTTAAT
TATCCTTGATAATTTAATTGACTTAAACTGATAATTATTGAGTATCTTCT
GTAAACTGCCTCTGTTGTAGTTTTTTTTTTCTCCTAATCATGTTATCATT
TTTTTGGAATCCATGGTTTCCTGTTAAGATGACTCACACAGCCTACATAA
AAGTAATTGACAAAATATCATCTTATAGTAAAATGCCACATATCTTTATG
TTCAGCAAGAAGAGTATAATATATGATTGTTAATGATAACCCAAACAACA
AAAGATTTCACCTTAACTGGTTGTCATAAGTAGTAGTATCCACCGCCTTA
TTTTGAGTTGGATTTTTATCATCCTATGAGCCCTACAAATTTAAAGTTTT
TGGAACAGCACGTGCATTGAACCCATAAGAACCTACTCTGCTTTTCTGCA
TGTATTGTCCAGACAAGAGACCAAATTGCCGAGGCATCATTTAGGTGAAT
TCTAATTAACATTTAGCTACCTTACAACCACAATTCAAGGTTGTTTCAAA
GGCATGTGCTTGCATCATCCTGATTCACTACCATGTGTTACTAACTTGGA
TCTGCAAAGTCATTATAAAAAGCTGTTTTGATGGACTTATTTGGATATTG
CTTTACCCTTCTTCTCTCTTTTCTTTTATCAATGTAAAAACATTATATGT
TAAATACTTGGCTTTTAAGAGCATAGATCTGAAATCTGCCTCTAGCAAAT
AACCCATAACACTTCTAAGATATACCTGCAAGGTCAATTGTGTTGTAAAA
CCTTGATAACCATACTTTATTGTTCAAAAAAGCCTTTTATGAAGGCAGAA
GTTAAAAAAAAAAAACAAAAAAAACAGAGTCCACAGTTATCACCTCAGCT
ACAATCTCATCAGTTCACAAGTACCAGCAAAACATGTGATAAGTCAACAA
A

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct R117H mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the R117H mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 26; SEQ ID NO: 27300)
ATGCCTACTCTGTAGCAAAGAAAGTCTCTATAGTAAACAAAAAAAAAGCC
TACTCTGATACTGAAAGTTGTTATGAAAAATAAAAAAGGGAAATGCTTTA
GAAACTGTTAAGTGCTATGTAGATGTTACTAATTAACAAACCATTTCAGA
AACTATACTTTTTATTTTATGGCCACTATTCACTGTTTAACTTAAAATAC
CTCATATGTAAACTTGTCTCCCACTGTTGCTATAACAAATCCCAAGTCTT
ATTTCAAAGTACCAAGATATTGAAAATAGTGCTAAGAGTTTCACATATGG
TATGACCCTCTATATAAACTCATTTTAAGTCTCCTCTAAAGATGAAAAGT
CTTGTGTTGAAATTCTCAGGGTATTTTATGAGAAATAAATGAAATTTAAT
TTCTCTGTTTTTCCCCTTTTGTAGGAAGTCACCAAAGCAGTACAGCCTCT
CTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAAC
gCTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTG
AGGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAAT
GCAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAGGTAATACTTC
CTTGCACAGGCCCCATGGCACATATATTCTGTATCGTACATGTTTTAATG
TCATAAATTAGGTAGTGAGCTGGTACAAGTAAGGGATAAATGCTGAAATT
AATTTAATATGCCTATTAAATAAATGGCAGGAATAATTAATGCTCTTAAT
TATCCTTGATAATTTAATTGACTTAAACTGATAATTATTGAGTATCTTCT
GTAAACTGCCTCTGTTGTAGTTTTTTTTTTCTCCTAATCATGTTATCATT
TTTTTGGAATCCATGGTTTCCTGTTAAGATGACTCACACAGCCTACATAA
AAGTAATTGACAAAATATCATCTTATAGTAAAATGCCACATATCTTTATG
T

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., R117H target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the R117H mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 27; SEQ ID NO: 27301)
AAGTCACCAAAGCAGTACAGCCTCTCTTACTGGGAAGAATCATAGCTTCC
TATGACCCGGATAACAAGGAGGAACgCTCTATCGCGATTTATCTAGGCAT
AGGCTTATGCCTTCTCTTTATTGTGAGGACACTGCTCCTACACCCAGCCA
T

In an embodiment, to correct a mutation, e.g., R117H target site in the CFTR gene, and concomitantly introduce a silent sense mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the R117H mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 28; SEQ ID NO: 27302)
AACCCCTCAAATTAAGGGATGAGGCAGAATAATGCTTGGCAATACCAGGG
GTAGGCTGCAGTCTTTCTTGGAAATATATATTTTAAATGGAACCAATTAT
CATAGCATCATTTCCTCTCAGGGTTACCCTCTGATCCCTATTTTACTAAA
TCGTTATAAAACAAAATGAGGAATTATGTGTCCTTCCCTTTTGAAGCCAA
TGTAACAAGATGGGTAAGAATTAGACCTCCTGAGTTCAAAATCCCTGGAT
TCAGATCTATTCCTGTATATTCAGGAGAAGTGGTAATAAATTCGATGGAC
AATTTGGTTTAGTAGTCGATTGAGGACCCTGATGAGGTATATTTGGGAAA
ACATAACTTCCGCTCTCTCTCATTGACTCACGGGCCTTTGAGGAGTCCAG
GAGTCATTGGAATCTGGCCTGAGGTTGAGGCTGCTGGCAAAACTCCTTCC
CCAAAGTCCATTCCTATTGCTGACTGAGAAGGGACTAGCATTGGAAGTGG
CTGATTTTAAATACCGCTAGTGCTGGTGTGCTCCTCCCTCCCATTCCCAG
CTCTGCTTTGTGTAGTTGCCTTGAGAAGCTAAGTTCATTCTGAAAATAAT
GCCATTGCACAAAACACTTTTGAAAGTTCTAGTTTGAAATTACATCAGGT
CACTTGGTCTGTGTGGCCTCAGTTTCTTCATCTGCCATGTGAAAATAATA
ATGCCTACTCTGTAGCAAAGAAAGTCTCTATAGTAAACAAAAAAAAAGCC
TACTCTGATACTGAAAGTTGTTATGAAAAATAAAAAAGGGAAATGCTTTA
GAAACTGTTAAGTGCTATGTAGATGTTACTAATTAACAAACCATTTCAGA
AACTATACTTTTTATTTTATGGCCACTATTCACTGTTTAACTTAAAATAC
CTCATATGTAAACTTGTCTCCCACTGTTGCTATAACAAATCCCAAGTCTT
ATTTCAAAGTACCAAGATATTGAAAATAGTGCTAAGAGTTTCACATATGG
TATGACCCTCTATATAAACTCATTTTAAGTCTCCTCTAAAGATGAAAAGT
CTTGTGTTGAAATTCTCAGGGTATTTTATGAGAAATAAATGAAATTTAAT
TTCTCTGTTTTTCCCCTTTTGTAGGAAGTCACCAAAGCAGTACAGCCTCT
CTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAAtAAaGAaGAAC
gCTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTG
AGGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAAT
GCAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAGGTAATACTTC
CTTGCACAGGCCCCATGGCACATATATTCTGTATCGTACATGTTTTAATG
TCATAAATTAGGTAGTGAGCTGGTACAAGTAAGGGATAAATGCTGAAATT
AATTTAATATGCCTATTAAATAAATGGCAGGAATAATTAATGCTCTTAAT
TATCCTTGATAATTTAATTGACTTAAACTGATAATTATTGAGTATCTTCT
GTAAACTGCCTCTGTTGTAGTTTTTTTTTTCTCCTAATCATGTTATCATT
TTTTTGGAATCCATGGTTTCCTGTTAAGATGACTCACACAGCCTACATAA
AAGTAATTGACAAAATATCATCTTATAGTAAAATGCCACATATCTTTATG
TTCAGCAAGAAGAGTATAATATATGATTGTTAATGATAACCCAAACAACA
AAAGATTTCACCTTAACTGGTTGTCATAAGTAGTAGTATCCACCGCCTTA
TTTTGAGTTGGATTTTTATCATCCTATGAGCCCTACAAATTTAAAGTTTT
TGGAACAGCACGTGCATTGAACCCATAAGAACCTACTCTGCTTTTCTGCA
TGTATTGTCCAGACAAGAGACCAAATTGCCGAGGCATCATTTAGGTGAAT
TCTAATTAACATTTAGCTACCTTACAACCACAATTCAAGGTTGTTTCAAA
GGCATGTGCTTGCATCATCCTGATTCACTACCATGTGTTACTAACTTGGA
TCTGCAAAGTCATTATAAAAAGCTGTTTTGATGGACTTATTTGGATATTG
CTTTACCCTTCTTCTCTCTTTTCTTTTATCAATGTAAAAACATTATATGT
TAAATACTTGGCTTTTAAGAGCATAGATCTGAAATCTGCCTCTAGCAAAT
AACCCATAACACTTCTAAGATATACCTGCAAGGTCAATTGTGTTGTAAAA
CCTTGATAACCATACTTTATTGTTCAAAAAAGCCTTTTATGAAGGCAGAA
GTTAAAAAAAAAAAACAAAAAAAACAGAGTCCACAGTTATCACCTCAGCT
ACAATCTCATCAGTTCACAAGTACCAGCAAAACATGTGATAAGTCAACAA
A

In an embodiment, to correct a mutation, e.g., R117H target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the R117H mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 29; SEQ ID NO: 27303)
ATGCCTACTCTGTAGCAAAGAAAGTCTCTATAGTAAACAAAAAAAAAGCC
TACTCTGATACTGAAAGTTGTTATGAAAAATAAAAAAGGGAAATGCTTTA
GAAACTGTTAAGTGCTATGTAGATGTTACTAATTAACAAACCATTTCAGA
AACTATACTTTTTATTTTATGGCCACTATTCACTGTTTAACTTAAAATAC
CTCATATGTAAACTTGTCTCCCACTGTTGCTATAACAAATCCCAAGTCTT
ATTTCAAAGTACCAAGATATTGAAAATAGTGCTAAGAGTTTCACATATGG
TATGACCCTCTATATAAACTCATTTTAAGTCTCCTCTAAAGATGAAAAGT
CTTGTGTTGAAATTCTCAGGGTATTTTATGAGAAATAAATGAAATTTAAT
TTCTCTGTTTTTCCCCTTTTGTAGGAAGTCACCAAAGCAGTACAGCCTCT
CTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAAtAAaGAaGAAC
gCTCTATCGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTG
AGGACACTGCTCCTACACCCAGCCATTTTTGGCCTTCATCACATTGGAAT
GCAGATGAGAATAGCTATGTTTAGTTTGATTTATAAGAAGGTAATACTTC
CTTGCACAGGCCCCATGGCACATATATTCTGTATCGTACATGTTTTAATG
TCATAAATTAGGTAGTGAGCTGGTACAAGTAAGGGATAAATGCTGAAATT
AATTTAATATGCCTATTAAATAAATGGCAGGAATAATTAATGCTCTTAAT
TATCCTTGATAATTTAATTGACTTAAACTGATAATTATTGAGTATCTTCT
GTAAACTGCCTCTGTTGTAGTTTTTTTTTTCTCCTAATCATGTTATCATT
TTTTTGGAATCCATGGTTTCCTGTTAAGATGACTCACACAGCCTACATAA
AAGTAATTGACAAAATATCATCTTATAGTAAAATGCCACATATCTTTATG
T

In an embodiment, an ssODN may be to correct a mutation, e.g., R117H target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the R117H mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 30; SEQ ID NO: 27304)
AAGTCACCAAAGCAGTACAGCCTCTCTTACTGGGAAGAATCATAGCTTCC
TATGACCCGGATAAtAAaGAaGAACgCTCTATCGCGATTTATCTAGGCAT
AGGCTTATGCCTTCTCTTTATTGTGAGGACACTGCTCCTACACCCAGCCA
T

The underlined T has been changed from an A to T at that position and each underlined A has been changed from a T to A at that position so that wild-type CFTR is still transcribed, but the PAM sequence TGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., W1282X target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(5′H arm)
SEQ ID NO: 27305
TTTTTATTATATATTTTTGAAGTATTGATATGTAGTGAATTAGAAATTTA
AAAAGAAAACAAAACTGTCCTTCACTACAGATTGAAAAGCATTATACTAA
AAGACCATTTGCTCAGTTATAGTATATAAAGGCCAAATGACTTAAAAACA
AATTATGTAAGGAGAAGGAAACAACCATTTATTCAGTGCCACTAACTGTC
AGCCAGTTTTTTCAGTGGTCAGTTAATGACTGCAGTAGTGTTCTACCTTG
CTCAAAGCACCCTCCTCAAGTTCTGGCATCTAAGCTGACATCAGAACACA
GAGTTGGGGCTCTCTGTGGGTCACCTCTAGCACTTGATCTCCTCATGCAG
TGCATGGTGCTCTCACGTCTATGCTATGTTCTTATGGTCTTTAGGTAACA
AGAATAATTTTCTTTCTTTTCCTTACTATACATTTTGCTTTCTGAAATTC
CCTTCTCGCCAATCCAGGTGAATGTCAGAATGTGATTTGACAACTGTCCA
AAGTACTCATTCACTGAGGAGTGGTAAGGCCTTCGCCCAACCTGCCTTCT
CTGGGAATATACTGCTGCCTGAACATATCATTGTTTATTGCCAGGCTTGA
ACTTCACCAAATTAATTTATTAGGGTCAACATCTAAATATTAGAACTATT
TCAGATTAATTTTTAAGTCGTATCCACTTTGGGTACTAGATCAAATTGCA
GGTCTCTGCTTCTGGCTTGAGCCTATGTTTAGAGATGATGTGCATGAAGA
CACTCTTTGCTTTTCCTTTATGCAAAATGGGCATTTTCAATCTTTTTGTC
ATTAGTAAAGGTCAGTGATAAAGGAAGTCTGCATCAGGGGTCCAATTCCT
TATGGCCAGTTTCTCTATTCTGTTCCAAGGTTGTTTGTCTCCATATATCA
ACATTGGTCAGGATTGAAAGTGTGCAACAAGGTTTGAATGAATAAGTGAA
AATCTTCCACTGGTGACAGGATAAAATATTCCAATGGTTTTTATTGAAGT
ACAATACTGAATTATGTTTATGGCATGGTACCTATATGTCACAGAAGTGA
TCCCATCACTTTTACCTTATAGGTGGGCCTCTTGGGAAGAACTGGATCAG
GGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGA
GAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAACAGTG

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

(3′H arm)
SEQ ID NO: 27306
AGGAAAGCCTTTGGAGTGATACCACAGGTGAGCAAAAGGACTTAGCCAGA
AAAAAGGCAACTAAATTATATTTTTTACTGCTATTTGATACTTGTACTCA
AGAAATTCATATTACTCTGCAAAATATATTTGTTATGCATTGCTGTCTTT
TTTCTCCAGTGCAGTTTTCTCATAGGCAGAAAAGATGTCTCTAAAAGTTT
GGAATTCTCAAATTCTGGTTATTGAAATGTTCATAGCTTTGATAGTGTTT
TTCAGAAGACCAAATTTACAGTGGGAGCCTTGGGCTTTTGTTTTTTAACA
GCTCTTTTTTGTTCCTGCTTCAGTGGCCTGACCTCCAAGTTAGCAATCGC
CAGGTTGAGAAATGCTTTGCGAGACATAACAGATGCTCCTGAAATAACAA
ACACTTGGAATCATGAGGTAGTGGAATTGAAAATAGAAAGTGTAGTGATT
GTTTTTTGTTATTTGGATGGGATGAACAATGTCAGATTAGTCTGTAACTA
TTTTTTTTTAATGTCACTCTGATTTGGTCACAAAGGATCTCTAGTCTCAT
TGCCTTAGTATCATTCTACGAATTAGAATGTGTTACTGTGTAAGAGCACT
TCTTGTATATGAGAGAAATAGCAACAGTTCCAGTTTAAAGTGATATAAAT
GGAAACCAAGAAATGTCTTTACTGGGACCAAATCTGGACAGCATTTACTG
TATTTTTGCTGGTATTTTCTCTAGTCTTTCCGGGTATATTCACATTTAAT
GATCACTTTTCTCCCTTTGTGCTAATGGACACTGAATCCATTCCACTACC
ATAGTTCTTGCTAATACTACTCTACTTTTTACACAAAATTAAAATGCCAG
GAGCACCTCCAGGTAGACTGACTATAAATCTAGACTGAAAAAAAAGCTTG
TATTTCTTAACAGATTACCTTGTGGAACATTTGCTCCTTTCAACTAATGA
GGCACTAAATATTGTAACTGCTCAACTGGTGCTTTTAATTTATTTGTCTA
GACTTTGTCATGTTGCCAGAAGCTTTATCCTGGTTGGAGTTTTGAAAACA
GTATTGTTTCTTCAGAAAGAAAAAAGGGATTGTCAGATGATCTAAAAATA
AAGAAACACTGGAAATACAAGTATCCCAAGGTGATAGCATTAGGCAAGAT
AAAAATGTTGAAAAGCGAAAAAGAACTGGTTGATAGAGAAGTGTTGTTAT

In an embodiment, the replacement sequence comprises or consists of a Guanine (G) residue.

In an embodiment, to correct a mutation, e.g., W1282X target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the W1282X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 31; SEQ ID NO: 27307)
TTTTTATTATATATTTTTGAAGTATTGATATGTAGTGAATTAGAAATTTA
AAAAGAAAACAAAACTGTCCTTCACTACAGATTGAAAAGCATTATACTAA
AAGACCATTTGCTCAGTTATAGTATATAAAGGCCAAATGACTTAAAAACA
AATTATGTAAGGAGAAGGAAACAACCATTTATTCAGTGCCACTAACTGTC
AGCCAGTTTTTTCAGTGGTCAGTTAATGACTGCAGTAGTGTTCTACCTTG
CTCAAAGCACCCTCCTCAAGTTCTGGCATCTAAGCTGACATCAGAACACA
GAGTTGGGGCTCTCTGTGGGTCACCTCTAGCACTTGATCTCCTCATGCAG
TGCATGGTGCTCTCACGTCTATGCTATGTTCTTATGGTCTTTAGGTAACA
AGAATAATTTTCTTTCTTTTCCTTACTATACATTTTGCTTTCTGAAATTC
CCTTCTCGCCAATCCAGGTGAATGTCAGAATGTGATTTGACAACTGTCCA
AAGTACTCATTCACTGAGGAGTGGTAAGGCCTTCGCCCAACCTGCCTTCT
CTGGGAATATACTGCTGCCTGAACATATCATTGTTTATTGCCAGGCTTGA
ACTTCACCAAATTAATTTATTAGGGTCAACATCTAAATATTAGAACTATT
TCAGATTAATTTTTAAGTCGTATCCACTTTGGGTACTAGATCAAATTGCA
GGTCTCTGCTTCTGGCTTGAGCCTATGTTTAGAGATGATGTGCATGAAGA
CACTCTTTGCTTTTCCTTTATGCAAAATGGGCATTTTCAATCTTTTTGTC
ATTAGTAAAGGTCAGTGATAAAGGAAGTCTGCATCAGGGGTCCAATTCCT
TATGGCCAGTTTCTCTATTCTGTTCCAAGGTTGTTTGTCTCCATATATCA
ACATTGGTCAGGATTGAAAGTGTGCAACAAGGTTTGAATGAATAAGTGAA
AATCTTCCACTGGTGACAGGATAAAATATTCCAATGGTTTTTATTGAAGT
ACAATACTGAATTATGTTTATGGCATGGTACCTATATGTCACAGAAGTGA
TCCCATCACTTTTACCTTATAGGTGGGCCTCTTGGGAAGAACTGGATCAG
GGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGA
GAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAACAGTG
gAGGAAAGCCTTTGGAGTGATACCACAGGTGAGCAAAAGGACTTAGCCAG
AAAAAAGGCAACTAAATTATATTTTTTACTGCTATTTGATACTTGTACTC
AAGAAATTCATATTACTCTGCAAAATATATTTGTTATGCATTGCTGTCTT
TTTTCTCCAGTGCAGTTTTCTCATAGGCAGAAAAGATGTCTCTAAAAGTT
TGGAATTCTCAAATTCTGGTTATTGAAATGTTCATAGCTTTGATAGTGTT
TTTCAGAAGACCAAATTTACAGTGGGAGCCTTGGGCTTTTGTTTTTTAAC
AGCTCTTTTTTGTTCCTGCTTCAGTGGCCTGACCTCCAAGTTAGCAATCG
CCAGGTTGAGAAATGCTTTGCGAGACATAACAGATGCTCCTGAAATAACA
AACACTTGGAATCATGAGGTAGTGGAATTGAAAATAGAAAGTGTAGTGAT
TGTTTTTTGTTATTTGGATGGGATGAACAATGTCAGATTAGTCTGTAACT
ATTTTTTTTTAATGTCACTCTGATTTGGTCACAAAGGATCTCTAGTCTCA
TTGCCTTAGTATCATTCTACGAATTAGAATGTGTTACTGTGTAAGAGCAC
TTCTTGTATATGAGAGAAATAGCAACAGTTCCAGTTTAAAGTGATATAAA
TGGAAACCAAGAAATGTCTTTACTGGGACCAAATCTGGACAGCATTTACT
GTATTTTTGCTGGTATTTTCTCTAGTCTTTCCGGGTATATTCACATTTAA
TGATCACTTTTCTCCCTTTGTGCTAATGGACACTGAATCCATTCCACTAC
CATAGTTCTTGCTAATACTACTCTACTTTTTACACAAAATTAAAATGCCA
GGAGCACCTCCAGGTAGACTGACTATAAATCTAGACTGAAAAAAAAGCTT
GTATTTCTTAACAGATTACCTTGTGGAACATTTGCTCCTTTCAACTAATG
AGGCACTAAATATTGTAACTGCTCAACTGGTGCTTTTAATTTATTTGTCT
AGACTTTGTCATGTTGCCAGAAGCTTTATCCTGGTTGGAGTTTTGAAAAC
AGTATTGTTTCTTCAGAAAGAAAAAAGGGATTGTCAGATGATCTAAAAAT
AAAGAAACACTGGAAATACAAGTATCCCAAGGTGATAGCATTAGGCAAGA
TAAAAATGTTGAAAAGCGAAAAAGAACTGGTTGATAGAGAAGTGTTGTTA
T

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct W1282X mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the W1282X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 32; SEQ ID NO: 27308)
GGTCTCTGCTTCTGGCTTGAGCCTATGTTTAGAGATGATGTGCATGAAGA
CACTCTTTGCTTTTCCTTTATGCAAAATGGGCATTTTCAATCTTTTTGTC
ATTAGTAAAGGTCAGTGATAAAGGAAGTCTGCATCAGGGGTCCAATTCCT
TATGGCCAGTTTCTCTATTCTGTTCCAAGGTTGTTTGTCTCCATATATCA
ACATTGGTCAGGATTGAAAGTGTGCAACAAGGTTTGAATGAATAAGTGAA
AATCTTCCACTGGTGACAGGATAAAATATTCCAATGGTTTTTATTGAAGT
ACAATACTGAATTATGTTTATGGCATGGTACCTATATGTCACAGAAGTGA
TCCCATCACTTTTACCTTATAGGTGGGCCTCTTGGGAAGAACTGGATCAG
GGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGA
GAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAACAGTG
gAGGAAAGCCTTTGGAGTGATACCACAGGTGAGCAAAAGGACTTAGCCAG
AAAAAAGGCAACTAAATTATATTTTTTACTGCTATTTGATACTTGTACTC
AAGAAATTCATATTACTCTGCAAAATATATTTGTTATGCATTGCTGTCTT
TTTTCTCCAGTGCAGTTTTCTCATAGGCAGAAAAGATGTCTCTAAAAGTT
TGGAATTCTCAAATTCTGGTTATTGAAATGTTCATAGCTTTGATAGTGTT
TTTCAGAAGACCAAATTTACAGTGGGAGCCTTGGGCTTTTGTTTTTTAAC
AGCTCTTTTTTGTTCCTGCTTCAGTGGCCTGACCTCCAAGTTAGCAATCG
CCAGGTTGAGAAATGCTTTGCGAGACATAACAGATGCTCCTGAAATAACA
AACACTTGGAATCATGAGGTAGTGGAATTGAAAATAGAAAGTGTAGTGAT
TGTTTTTTGTTATTTGGATGGGATGAACAATGTCAGATTAGTCTGTAACT
A

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., W1282X target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the W1282X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 33; SEQ ID NO: 27309)
TTTGAGACTACTGAACACTGAAGGAGAAATCCAGATCGATGGTGTGTCTT
GGGATTCAATAACTTTGCAACAGTGgAGGAAAGCCTTTGGAGTGATACCA
CAGGTGAGCAAAAGGACTTAGCCAGAAAAAAGGCAACTAAATTATATTTT

In an embodiment, to correct a mutation, e.g., W1282X target site in the CFTR gene, and concomitantly introduce a silent sense mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the W1282X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 34; SEQ ID NO: 27310)
TTTTTATTATATATTTTTGAAGTATTGATATGTAGTGAATTAGAAATTTA
AAAAGAAAACAAAACTGTCCTTCACTACAGATTGAAAAGCATTATACTAA
AAGACCATTTGCTCAGTTATAGTATATAAAGGCCAAATGACTTAAAAACA
AATTATGTAAGGAGAAGGAAACAACCATTTATTCAGTGCCACTAACTGTC
AGCCAGTTTTTTCAGTGGTCAGTTAATGACTGCAGTAGTGTTCTACCTTG
CTCAAAGCACCCTCCTCAAGTTCTGGCATCTAAGCTGACATCAGAACACA
GAGTTGGGGCTCTCTGTGGGTCACCTCTAGCACTTGATCTCCTCATGCAG
TGCATGGTGCTCTCACGTCTATGCTATGTTCTTATGGTCTTTAGGTAACA
AGAATAATTTTCTTTCTTTTCCTTACTATACATTTTGCTTTCTGAAATTC
CCTTCTCGCCAATCCAGGTGAATGTCAGAATGTGATTTGACAACTGTCCA
AAGTACTCATTCACTGAGGAGTGGTAAGGCCTTCGCCCAACCTGCCTTCT
CTGGGAATATACTGCTGCCTGAACATATCATTGTTTATTGCCAGGCTTGA
ACTTCACCAAATTAATTTATTAGGGTCAACATCTAAATATTAGAACTATT
TCAGATTAATTTTTAAGTCGTATCCACTTTGGGTACTAGATCAAATTGCA
GGTCTCTGCTTCTGGCTTGAGCCTATGTTTAGAGATGATGTGCATGAAGA
CACTCTTTGCTTTTCCTTTATGCAAAATGGGCATTTTCAATCTTTTTGTC
ATTAGTAAAGGTCAGTGATAAAGGAAGTCTGCATCAGGGGTCCAATTCCT
TATGGCCAGTTTCTCTATTCTGTTCCAAGGTTGTTTGTCTCCATATATCA
ACATTGGTCAGGATTGAAAGTGTGCAACAAGGTTTGAATGAATAAGTGAA
AATCTTCCACTGGTGACAGGATAAAATATTCCAATGGTTTTTATTGAAGT
ACAATACTGAATTATGTTTATGGCATGGTACCTATATGTCACAGAAGTGA
TCCCATCACTTTTACCTTATAGGTGGGCCTCTTGGGAAGAACTGGATCAG
GGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGA
GAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAACAGTG
gAGaAAAGCCTTTGGAGTGATACCACAGGTGAGCAAAAGGACTTAGCCAG
AAAAAAGGCAACTAAATTATATTTTTTACTGCTATTTGATACTTGTACTC
AAGAAATTCATATTACTCTGCAAAATATATTTGTTATGCATTGCTGTCTT
TTTTCTCCAGTGCAGTTTTCTCATAGGCAGAAAAGATGTCTCTAAAAGTT
TGGAATTCTCAAATTCTGGTTATTGAAATGTTCATAGCTTTGATAGTGTT
TTTCAGAAGACCAAATTTACAGTGGGAGCCTTGGGCTTTTGTTTTTTAAC
AGCTCTTTTTTGTTCCTGCTTCAGTGGCCTGACCTCCAAGTTAGCAATCG
CCAGGTTGAGAAATGCTTTGCGAGACATAACAGATGCTCCTGAAATAACA
AACACTTGGAATCATGAGGTAGTGGAATTGAAAATAGAAAGTGTAGTGAT
TGTTTTTTGTTATTTGGATGGGATGAACAATGTCAGATTAGTCTGTAACT
ATTTTTTTTTAATGTCACTCTGATTTGGTCACAAAGGATCTCTAGTCTCA
TTGCCTTAGTATCATTCTACGAATTAGAATGTGTTACTGTGTAAGAGCAC
TTCTTGTATATGAGAGAAATAGCAACAGTTCCAGTTTAAAGTGATATAAA
TGGAAACCAAGAAATGTCTTTACTGGGACCAAATCTGGACAGCATTTACT
GTATTTTTGCTGGTATTTTCTCTAGTCTTTCCGGGTATATTCACATTTAA
TGATCACTTTTCTCCCTTTGTGCTAATGGACACTGAATCCATTCCACTAC
CATAGTTCTTGCTAATACTACTCTACTTTTTACACAAAATTAAAATGCCA
GGAGCACCTCCAGGTAGACTGACTATAAATCTAGACTGAAAAAAAAGCTT
GTATTTCTTAACAGATTACCTTGTGGAACATTTGCTCCTTTCAACTAATG
AGGCACTAAATATTGTAACTGCTCAACTGGTGCTTTTAATTTATTTGTCT
AGACTTTGTCATGTTGCCAGAAGCTTTATCCTGGTTGGAGTTTTGAAAAC
AGTATTGTTTCTTCAGAAAGAAAAAAGGGATTGTCAGATGATCTAAAAAT
AAAGAAACACTGGAAATACAAGTATCCCAAGGTGATAGCATTAGGCAAGA
TAAAAATGTTGAAAAGCGAAAAAGAACTGGTTGATAGAGAAGTGTTGTTA
T

In an embodiment, to correct a mutation, e.g., W1282X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the W1282X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

GGTCTCTGCTTCTGGCTTGAGCCTATGTTTAGAGATGATGTGCATGAAGA
CACTCTTTGCTTTTCCTTTATGCAAAATGGGCATTTTCAATCTTTTTGTC
ATTAGTAAAGGTCAGTGATAAAGGAAGTCTGCATCAGGGGTCCAATTCCT
TATGGCCAGTTTCTCTATTCTGTTCCAAGGTTGTTTGTCTCCATATATCA
ACATTGGTCAGGATTGAAAGTGTGCAACAAGGTTTGAATGAATAAGTGAA
AATCTTCCACTGGTGACAGGATAAAATATTCCAATGGTTTTTATTGAAGT
ACAATACTGAATTATGTTTATGGCATGGTACCTATATGTCACAGAAGTGA
TCCCATCACTTTTACCTTATAGGTGGGCCTCTTGGGAAGAACTGGATCAG
GGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGA
GAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAACAGTG
gAGaAAAGCCTTTGGAGTGATACCACAGGTGAGCAAAAGGACTTAGCCAG
AAAAAAGGCAACTAAATTATATTTTTTACTGCTATTTGATACTTGTACTC
AAGAAATTCATATTACTCTGCAAAATATATTTGTTATGCATTGCTGTCTT
TTTTCTCCAGTGCAGTTTTCTCATAGGCAGAAAAGATGTCTCTAAAAGTT
TGGAATTCTCAAATTCTGGTTATTGAAATGTTCATAGCTTTGATAGTGTT
TTTCAGAAGACCAAATTTACAGTGGGAGCCTTGGGCTTTTGTTTTTTAAC
AGCTCTTTTTTGTTCCTGCTTCAGTGGCCTGACCTCCAAGTTAGCAATCG
CCAGGTTGAGAAATGCTTTGCGAGACATAACAGATGCTCCTGAAATAACA
AACACTTGGAATCATGAGGTAGTGGAATTGAAAATAGAAAGTGTAGTGAT
TGTTTTTTGTTATTTGGATGGGATGAACAATGTCAGATTAGTCTGTAACT
A

In an embodiment, an ssODN may be to correct a mutation, e.g., W1282X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the W1282X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 35; SEQ ID NO: 27311)
TTTGAGACTACTGAACACTGAAGGAGAAATCCAGATCGATGGTGTGTCTT
GGGATTCAATAACTTTGCAACAGTGgAGaAAAGCCTTTGGAGTGATACCA
CAGGTGAGCAAAAGGACTTAGCCAGAAAAAAGGCAACTAAATTATATTTT

The underlined A has been changed from a T to A at that position so that wild-type CFTR is still transcribed, but the PAM sequence AGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., R553X target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27312 (5'H arm)
AACAGAAGTAACCATTTTGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTGTGAAA
GAAGAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGGAGGTGGAAACG
AATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTTTTTTTTTTTAAGGCGAGAGTTTACT
ACCTATCTAACTCTTCGCATTCTTGAAGTCTCAGACCAAATCCCATCGGTTTGAAAGCCTCTAG
GGTATTCTATCTATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTGAACTG
TTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTATTTAGCTTTCTCCAGGAT
TATGACTTACCTTCTAAATTAGACATACAATGCCTAGGAGTCAAGGACTATTTTGCATAAATTC
CAGTCTTCTTTTACAATGCCTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAG
GATGACAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGGATGGACGAG
GAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTGGACCC
ATGGAAGCCCAGTGAAGATACTTAGATCCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCT
TCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAAA
GTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTACACATA
TTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTAATGAT
CATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTG
ACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGTGGTTA
AAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTGAGCA
TACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAA
GACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTGGAGGTCAA

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27313 (3'H arm)
GAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAAT
GTCATTCATGTAAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAA
AAAATCCTGGGGTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTAT
AGTATCCAGATTTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGT
ATTTGTTTGCCTCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGG
ACAGAGAAGATGTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAG
CTTTAGGCTTCTTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACA
AAATAGGAAGGCAAATGATGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAA
TGCATTAACATTGTTGGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAGCATTTTAAA
GCTGTCAAAGAGATGTAAATATAGATAATGTATGTCAAGGAGAGAGCTTTGTGGTTAAACTGTA
ACTTTCAGTTTAAACAATTATTGGTGACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACA
AAATTCTTCTCACTTTGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTTTG
GCTCCITTCCCTTACTTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAACTAACCCTAACTGAGC
ACCTGCAATTGCCTGGTAGTATTCTAGTCATGTGTGTACTTTTGTGTGTATGTAATCCCCTTAC
AGCTCTGCAAAGTAAGAATTGTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTG
TTAGATGTTAACTTGCCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACCAGGTCCT
TTTGATTCTTTACATTAAACCATGCTTTGATCTTGGAAATACACTGTAAGGCAATAAATCAATA
GATACGGATAATTCACAGGCTTCTAAATAAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAG
TAAGACTTATTCTAAGAATTCCACAAATTTAGATAAGATAGAGTATAT

In an embodiment, the replacement sequence comprises or consists of a Cytosine (C) residue.

In an embodiment, to correct a mutation, e.g., R553X target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the R553X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 36; SEQ ID NO: 27314)
AACAGAAGTAACCATTTTGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTGTGAAA
GAAGAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGGAGGTGGAAACG
AATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTTTTTTTTTTTAAGGCGAGAGTTTACT
ACCTATCTAACTCTTCGCATTCTTGAAGTCTCAGACCAAATCCCATCGGTTTGAAAGCCTCTAG
GGTATTCTATCTATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTGAACTG
TTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTATTTAGCTTTCTCCAGGAT
TATGACTTACCTTCTAAATTAGACATACAATGCCTAGGAGTCAAGGACTATTTTGCATAAATTC
CAGTCTTCTTTTACAATGCCTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAG
GATGACAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGGATGGACGAG
GAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTGGACCC
ATGGAAGCCCAGTGAAGATACTTAGATCCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCT
TCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAAA
GTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTACACATA
TTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTAATGAT
CATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTG
ACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGTGGTTA
AAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTGAGCA
TACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAA
GACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTGGAGGTCAAcGAGCAAGAATTTCTT
TAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATGTAAAA
AAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGGGGTTT
TATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGG
TAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGCCTCAT
AGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAGAAGATGTAA
ATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAGGCTTCTTGG
TATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAA
TGATGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCATTAACATTGTT
GGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAGCATTTTAAAGCTGTCAAAGAGATG
TAAATATAGATAATGTATGTCAAGGAGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTTTAAAC
AATTATTGGTGACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCTCACTT
TGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTTTGGCTCCTTTCCCTTAC
TTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAACTAACCCTAACTGAGCACCTGCAATTGCCTG
GTAGTATTCTAGTCATGTGTGTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAAAGTAA
GAATTGTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGATGTTAACTTG
CCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACCAGGTCCTTTTGATTCTTTACAT
TAAACCATGCTTTGATCTTGGAAATACACTGTAAGGCAATAAATCAATAGATACGGATAATTCA
CAGGCTTCTAAATAAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTATTCTAA
GAATTCCACAAATTTAGATAAGATAGAGTATAT

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct R553X mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the R553X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 37; SEQ ID NO: 27315)
CTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAG
AAAAGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTACA
CATATTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTAA
TGATCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTT
TTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGTG
GTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTG
AGCATACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAGA
GAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTGGAGGTCAAcGAGCAAGAATT
TCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATGT
AAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGGG
GTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATCCAGAT
TTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGCC
TCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAGAAGAT
GTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAGGCTTC
TTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGG
CAAATGATGTCACTTGGCTTAAAATCTATAATATTTAAAAT

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., R553X target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the R553X mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 38; SEQ ID NO: 27316)
TAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGA
GTGGAGGTCAAcGAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCA
TTTGCTGTAAATGTCATTCATGT

In an embodiment, to correct a mutation, e.g., R553X target site in the CFTR gene, and concomitantly introduce a silent sense mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the R553X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 39; SEQ ID NO: 27317)
AACAGAAGTAACCATTTTGATACTTTAGATATAGATAATATTGGATTATTTCTGGATTGTGAAA
GAAGAAGGAAGAAGCATATGGAAGAGAAGTTTTAGTAGAGGGGAGGAAGGAGGAGGTGGAAACG
AATGTACAAGGATGGGAGGAGAAAAGGGAGAGAGACTTTTTTTTTTTTAAGGCGAGAGTTTACT
ACCTATCTAACTCTTCGCATTCTTGAAGTCTCAGACCAAATCCCATCGGTTTGAAAGCCTCTAG
GGTATTCTATCTATTGTATACTTCTGTTATGTACAAAATTAATTTGCCAATTAATTGTGAACTG
TTTTATAAACTATCTTAAAATGGTTAGTTAAATCTTTGGGATAGTATTTAGCTTTCTCCAGGAT
TATGACTTACCTTCTAAATTAGACATACAATGCCTAGGAGTCAAGGACTATTTTGCATAAATTC
CAGTCTTCTTTTACAATGCCTAGAATGATTGTTACCACAGAAATATTCATTACCTGGGAGAAAG
GATGACAGGAGGGGCAGAATGAATGGAGAGAGGTCGTGAGAATGAGGTGCTGAGGATGGACGAG
GAAGAAAGCTGTTTTAGTTGGGAGGATAGGTGACAGAAGCATGGAAAGGAATTGCCTTGGACCC
ATGGAAGCCCAGTGAAGATACTTAGATCCTGCAGGGGTGTGAATAATGTTCTTTTAGTTTCTCT
TCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAGAAAA
GTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTACACATA
TTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTAATGAT
CATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTTTTTG
ACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGTGGTTA
AAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTGAGCA
TACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAGAGAAA
GACAATATAGTTCTTGGAGAAGGTGGAATCACACTGtcaGGAGGTCAAcGAGCAAGAATTTCTT
TAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATGTAAAA
AAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGGGGTTT
TATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATCCAGATTTGG
TAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGCCTCAT
AGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAGAAGATGTAA
ATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAGGCTTCTTGG
TATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGGCAAA
TGATGTCACTTGGCTTAAAATCTATAATATTTAAAATAAACAGGACAAATGCATTAACATTGTT
GGGGGAGGAGGTCCCTTAGTAGAAACACTCTTGGTCCAAGCATTTTAAAGCTGTCAAAGAGATG
TAAATATAGATAATGTATGTCAAGGAGAGAGCTTTGTGGTTAAACTGTAACTTTCAGTTTAAAC
AATTATTGGTGACTCTGATGTCAAATGTTTCTCAAGCTTTATCTGAACAAAATTCTTCTCACTT
TGTTGCCAAAGTCGTTAACAAGAAATCACATTGACTCATTGATGTTTTGGCTCCTTTCCCTTAC
TTTCTGTTGCTTTCCAAAAGCTGAGACAGGAAACTAACCCTAACTGAGCACCTGCAATTGCCTG
GTAGTATTCTAGTCATGTGTGTACTTTTGTGTGTATGTAATCCCCTTACAGCTCTGCAAAGTAA
GAATTGTTCTCCCTGCTTTACAGAAGAGATCATAAGATAATTGAGGCTGTTAGATGTTAACTTG
CCAAAAGCCATACAGGAAAATGGTAGAGTCACAGTTTGAACCAGGTCCTTTTGATTCTTTACAT
TAAACCATGCTTTGATCTTGGAAATACACTGTAAGGCAATAAATCAATAGATACGGATAATTCA
CAGGCTTCTAAATAAATGGAAGTTGATTGTTTTTATCTGTGAGCCAAAGTAAGACTTATTCTAA
GAATTCCACAAATTTAGATAAGATAGAGTATAT

In an embodiment, to correct a mutation, e.g., R553X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the R553X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 40; SEQ ID NO: 27318)
CTCTTCTTAGGAGGTTTGTTCATTTTGGGAGATTTCTTTTGAAAAGAGTGAACTTAAATTGGAG
AAAAGTACATTTTAGTATGTTGATAACATTTGAATTTGTAAAATGGACCTATGGATGATCTACA
CATATTTATATACCCATAAATATACACATATTTTAATTTTTGGTATTTTATAATTATTATTTAA
TGATCATTCATGACATTTTAAAAATTACAGAAAAATTTACATCTAAAATTTCAGCAATGTTGTT
TTTGACCAACTAAATAAATTGCATTTGAAATAATGGAGATGCAATGTTCAAAATTTCAACTGTG
GTTAAAGCAATAGTGTGATATATGATTACATTAGAAGGAAGATGTGCCTTTCAAATTCAGATTG
AGCATACTAAAAGTGACTCTCTAATTTTCTATTTTTGGTAATAGGACATCTCCAAGTTTGCAGA
GAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGtcaGGAGGTCAAcGAGCAAGAATT
TCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCATTTGCTGTAAATGTCATTCATGT
AAAAAAATTACAGACATTTCTCTATTGCTTTATATTCTGTTTCTGGAATTGAAAAAATCCTGGG
GTTTTATGGCTAGTGGGTTAAGAATCACATTTAAGAACTATAAATAATGGTATAGTATCCAGAT
TTGGTAGAGATTATGGTTACTCAGAATCTGTGCCCGTATCTTGGTGTCAGTGTATTTGTTTGCC
TCATAGTATAGTTTACTACAAATGGAAAACTCTAGGATTCTGCATAATACTGGACAGAGAAGAT
GTAAATATCTGTTAGTTCCATCATAGACCCTGCCACTCCAATGTACACACCAGCTTTAGGCTTC
TTGGTATAGATAAACATACATTTTCAAAATTTTTCATCATAATTTTCATAACAAAATAGGAAGG
CAAATGATGTCACTTGGCTTAAAATCTATAATATTTAAAAT

In an embodiment, an ssODN may be to correct a mutation, e.g., R553X target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the R553X mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 41; SEQ ID NO: 27319)
TAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGt
caGGAGGTCAAcGAGCAAGAATTTCTTTAGCAAGGTGAATAACTAATTATTGGTCTAGCAAGCA
TTTGCTGTAAATGTCATTCATGT

The underlined T has been changed from an A to T at that position, the underlined C has been changed from a G to C at that position, and the underlined A has been changed from a T to A at that position, so that wild-type CFTR is still transcribed, but the PAM sequence AGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., an intronic 2789+5bp (G→A) target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27320 (5'H arm)
TTTTTCTGTTTCATTCTGTGGTAAAGGTATCATTTGGCTAATTGTATAATTTCAGTGTCATTTC
TAATATTCCAATTGTGATAGTATCAACACAAGATTAAATTTCTCTACATGGTTTATGAGAATGG
AATGCCAAATTGAAATAGAACAGAGCACAGATGATCTAAATATAAAAAGAACTACAAAAATCAC
AGTTGTTTAAAAAGGTTTTTTGTTTGTTTATATATGGTGCAGAACATTTGTTCCTTAGCCAAAT
GTTTCCACCTTGAGAAAGCTATAGAGATTCTATGTAGTCCTAGTACCAATAATATGTTTTAACC
TGAATGTACCTTATCTTTATTCATAAACTGTGACTTTTTACACTGCTGAAACTTTTTTTTTTAA
GACAATCTCACTCTGTCGTCCAGTCTGGAGTGCAGCAGTGGTGTGATCTTGGCTCACTGCAACC
TCTACCTTCTGTGTTCAAGCAATTCTGGTGCCTCGGCCACCTGAGTAGTTGGGATCACAGGTGT
ACACCACCAGGCCTGGCTAATAGTTTTTGATATTTCTAGTAGAGATGAGTTTTGCCACATTGGC
CAGGCTGGCCTGAAACTCCTGGCCTCAAGTGATCTGCCTGCCTTGGCCTCCCAAAGTGTTGGTA
TTACAAGTGTGAGCCACTGTGCCTGGCCTGAAACTCATAATTCATTTCCATTAATATTAATCTC
ACCTTTTCCAATAATTAATTGATTTCACAAGTATTAGTCCCCTATAATCATTGAATGGCTAATA
AAATTATTTATAGCAAACAGATTAATTATCTGCCAGCAGTCTGAGATTAGTTTCTTTAAAAAAT
GTTTATTATTTAAAACATTCAGCTGTGATCTTGGCTTTCTTGTGAGGTTCAATAGTTTCTATTG
AGTAAAGGAGAGAAATGGCAGAGAATTTACTTCAGTGAAATTTGAATTCCATTAACTTAATGTG
GTCTCATCACAAATAATAGTACTTAGAACACCTAGTACAGCTGCTGGACCCAGGAACACAAAGC
AAAGGAAGATGAAATTGTGTGTACCTTGATATTGGTACACACATCAAATGGTGTGATGTGAATT
TAGATGTGGGCATGGGAGGAATAGGTGAAGATGTTAGAAAAAAAATCAACTGTGTCTTGTTCCA
TTCCAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAAGTGA

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27321 (3'H arm)
TATTCCATGTCCTATTGTGTAGATTGTGTTTTATTTCTGTTGATTAAATATTGTAATCCACTAT
GTTTGTATGTATTGTAATCCACTTTGTTTCATTTCTCCCAAGCATTATGGTAGTGGAAAGATAA
GGTTTTTTGTTTAAATGATGACCATTAGTTGGGTGAGGTGACACATTCCTGTAGTCCTAGCTCC
TCCACAGGCTGACGCAGGAGGATCACTTGAGCCCAGGAGTTCAGGGCTGTAGTGTTGTATCATT
GTGAGTAGCCACCGCACTCCAGCCTGGACAATATAGTGAGATCCTATATCTAAAATAAAATAAA
ATAAAATGAATAAATTGTGAGCATGTGCAGCTCCTGCAGTTTCTAAAGAATATAGTTCTGTTCA
GTTTCTGTGAAACACAATAAAAATATTTGAAATAACATTACATATTTAGGGTTTTCTTCAAATT
TTTTAATTTAATAAAGAACAACTCAATCTCTATCAATAGTGAGAAAACATATCTATTTTCTTGC
AATAATAGTATGATTTTGAGGTTAAGGGTGCATGCTCTTCTAATGCAAAATATTGTATTTATTT
AGACTCAAGTTTAGTTCCATTTACATGTATTGGAAATTCAGTAAGTAACTTTGGCTGCCAAATA
ACGATTTCCTATTTGCTTTACAGCACTCCTCTTCAAGACAAAGGGAATAGTACTCATAGTAGAA
ATAACAGCTATGCAGTGATTATCACCAGCACCAGTTCGTATTATGTGTTTTACATTTACGTGGG
AGTAGCCGACACTTTGCTTGCTATGGGATTCTTCAGAGGTCTACCACTGGTGCATACTCTAATC
ACAGTGTCGAAAATTTTACACCACAAAATGTTACATTCTGTTCTTCAAGCACCTATGTCAACCC
TCAACACGTTGAAAGCAGGTACTTTACTAGGTCTAAGAAATGAAACTGCTGATCCACCATCAAT
AGGGCCTGTGGTTTTGTTGGTTTTCTAATGGCAGTGCTGGCTTTTGCACAGAGGCATGTGCCCT
TTGTTGAACCTCCATTTGACTGGCATGCACATGTCTCAGATATTATAGGTTATCATATATTGTT
GCTCCTAATATTTCTGTGTTAGATAATTAGAGTAGCTTGGTTTGTAAGAATGTGATGTTGGTGG
GACTGTAGCAGAACAAGAAGGCCCTTATGGGTCAGTCATACCTCTCTT

In an embodiment, the replacement sequence comprises or consists of a Guanine (G) residue.

In an embodiment, to correct a mutation, e.g., an intronic 2789+5bp (G→A) target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 2789+5bp (G→A) mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 42; SEQ ID NO: 27322)
TTTTTCTGTTTCATTCTGTGGTAAAGGTATCATTTGGCTAATTGTATAATTTCAGTGTCATTTC
TAATATTCCAATTGTGATAGTATCAACACAAGATTAAATTTCTCTACATGGTTTATGAGAATGG
AATGCCAAATTGAAATAGAACAGAGCACAGATGATCTAAATATAAAAAGAACTACAAAAATCAC
AGTTGTTTAAAAAGGTTTTTTGTTTGTTTATATATGGTGCAGAACATTTGTTCCTTAGCCAAAT
GTTTCCACCTTGAGAAAGCTATAGAGATTCTATGTAGTCCTAGTACCAATAATATGTTTTAACC
TGAATGTACCTTATCTTTATTCATAAACTGTGACTTTTTACACTGCTGAAACTTTTTTTTTTAA
GACAATCTCACTCTGTCGTCCAGTCTGGAGTGCAGCAGTGGTGTGATCTTGGCTCACTGCAACC
TCTACCTTCTGTGTTCAAGCAATTCTGGTGCCTCGGCCACCTGAGTAGTTGGGATCACAGGTGT
ACACCACCAGGCCTGGCTAATAGTTTTTGATATTTCTAGTAGAGATGAGTTTTGCCACATTGGC
CAGGCTGGCCTGAAACTCCTGGCCTCAAGTGATCTGCCTGCCTTGGCCTCCCAAAGTGTTGGTA
TTACAAGTGTGAGCCACTGTGCCTGGCCTGAAACTCATAATTCATTTCCATTAATATTAATCTC
ACCTTTTCCAATAATTAATTGATTTCACAAGTATTAGTCCCCTATAATCATTGAATGGCTAATA
AAATTATTTATAGCAAACAGATTAATTATCTGCCAGCAGTCTGAGATTAGTTTCTTTAAAAAAT
GTTTATTATTTAAAACATTCAGCTGTGATCTTGGCTTTCTTGTGAGGTTCAATAGTTTCTATTG
AGTAAAGGAGAGAAATGGCAGAGAATTTACTTCAGTGAAATTTGAATTCCATTAACTTAATGTG
GTCTCATCACAAATAATAGTACTTAGAACACCTAGTACAGCTGCTGGACCCAGGAACACAAAGC
AAAGGAAGATGAAATTGTGTGTACCTTGATATTGGTACACACATCAAATGGTGTGATGTGAATT
TAGATGTGGGCATGGGAGGAATAGGTGAAGATGTTAGAAAAAAAATCAACTGTGTCTTGTTCCA
TTCCAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAAGTGAgTATTCCATGTCCTAT
TGTGTAGATTGTGTTTTATTTCTGTTGATTAAATATTGTAATCCACTATGITTGTATGTATTGT
AATCCACTTTGTTTCATTTCTCCCAAGCATTATGGTAGTGGAAAGATAAGGTTTTTTGTTTAAA
TGATGACCATTAGTTGGGTGAGGTGACACATTCCTGTAGTCCTAGCTCCTCCACAGGCTGACGC
AGGAGGATCACTTGAGCCCAGGAGTTCAGGGCTGTAGTGTTGTATCATTGTGAGTAGCCACCGC
ACTCCAGCCTGGACAATATAGTGAGATCCTATATCTAAAATAAAATAAAATAAAATGAATAAAT
TGTGAGCATGTGCAGCTCCTGCAGTTTCTAAAGAATATAGTTCTGTTCAGTTTCTGTGAAACAC
AATAAAAATATTTGAAATAACATTACATATTTAGGGTTTTCTTCAAATTTTTTAATTTAATAAA
GAACAACTCAATCTCTATCAATAGTGAGAAAACATATCTATTTTCTTGCAATAATAGTATGATT
TTGAGGTTAAGGGTGCATGCTCTTCTAATGCAAAATATTGTATTTATTTAGACTCAAGTTTAGT
TCCATTTACATGTATTGGAAATTCAGTAAGTAACTTTGGCTGCCAAATAACGATTTCCTATTTG
CTTTACAGCACTCCTCTTCAAGACAAAGGGAATAGTACTCATAGTAGAAATAACAGCTATGCAG
TGATTATCACCAGCACCAGTTCGTATTATGTGTTTTACATTTACGTGGGAGTAGCCGACACTTT
GCTTGCTATGGGATTCTTCAGAGGTCTACCACTGGTGCATACTCTAATCACAGTGTCGAAAATT
TTACACCACAAAATGTTACATTCTGTTCTTCAAGCACCTATGTCAACCCTCAACACGTTGAAAG
CAGGTACTTTACTAGGTCTAAGAAATGAAACTGCTGATCCACCATCAATAGGGCCTGTGGTTTT
GTTGGTTTTCTAATGGCAGTGCTGGCTTTTGCACAGAGGCATGTGCCCTTTGTTGAACCTCCAT
TTGACTGGCATGCACATGTCTCAGATATTATAGGTTATCATATATTGTTGCTCCTAATATTTCT
GTGTTAGATAATTAGAGTAGCTTGGTTTGTAAGAATGTGATGTTGGTGGGACTGTAGCAGAACA
AGAAGGCCCTTATGGGTCAGTCATACCTCTCTT

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct an intronic 2789+5bp (G→A) mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 2789+5bp (G→A) mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 43; SEQ ID NO: 27323)
TCTCACCTTTTCCAATAATTAATTGATTTCACAAGTATTAGTCCCCTATAATCATTGAATGGCT
AATAAAATTATTTATAGCAAACAGATTAATTATCTGCCAGCAGTCTGAGATTAGTTTCTTTAAA
AAATGTTTATTATTTAAAACATTCAGCTGTGATCTTGGCTTTCTTGTGAGGTTCAATAGTTTCT
ATTGAGTAAAGGAGAGAAATGGCAGAGAATTTACTTCAGTGAAATTTGAATTCCATTAACTTAA
TGTGGTCTCATCACAAATAATAGTACTTAGAACACCTAGTACAGCTGCTGGACCCAGGAACACA
AAGCAAAGGAAGATGAAATTGTGTGTACCTTGATATTGGTACACACATCAAATGGTGTGATGTG
AATTTAGATGTGGGCATGGGAGGAATAGGTGAAGATGTTAGAAAAAAAATCAACTGTGTCTTGT
TCCATTCCAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAAGTGAgTATTCCATGTC
CTATTGTGTAGATTGTGTTTTATTTCTGTTGATTAAATATTGTAATCCACTATGTTTGTATGTA
TTGTAATCCACTTTGTTTCATTTCTCCCAAGCATTATGGTAGTGGAAAGATAAGGTTTTTTGTT
TAAATGATGACCATTAGTTGGGTGAGGTGACACATTCCTGTAGTCCTAGCTCCTCCACAGGCTG
ACGCAGGAGGATCACTTGAGCCCAGGAGTTCAGGGCTGTAGTGTTGTATCATTGTGAGTAGCCA
CCGCACTCCAGCCTGGACAATATAGTGAGATCCTATATCTAAAATAAAATAAAATAAAATGAAT
AAATTGTGAGCATGTGCAGCTCCTGCAGTTTCTAAAGAATATAGTTCTGTTCAGTTTCTGTGAA
ACACAATAAAAATATTTGAAATAACATTACATATTTAGGGTTTTCTTCAAATTTTTTAATTTAA
TAAAGAACAACTCAATCTCTATCAATAGTGAGAAAACATAT

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., an intronic 2789+5bp (G→A) target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the intronic 2789+5bp (G→A) mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 44; SEQ ID NO: 27324)
AAAAAAAATCAACTGTGTCTTGTTCCATTCCAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCC
TTGGAAAGTGAgTATTCCATGTCCTATTGTGTAGATTGTGTTTTATTTCTGTTGATTAAATATT
GTAATCCACTATGTTTGTATGTA

In an embodiment, to correct a mutation, e.g., an intronic 2789+5bp (G→A) target site in the CFTR gene, and concomitantly introduce a silent sense mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 2789+5bp (G→A) mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 45; SEQ ID NO: 27325)
TTTTTCTGTTTCATTCTGTGGTAAAGGTATCATTTGGCTAATTGTATAATTTCAGTGTCATTTC
TAATATTCCAATTGTGATAGTATCAACACAAGATTAAATTTCTCTACATGGTTTATGAGAATGG
AATGCCAAATTGAAATAGAACAGAGCACAGATGATCTAAATATAAAAAGAACTACAAAAATCAC
AGTTGTTTAAAAAGGTTTTTTGTTTGTTTATATATGGTGCAGAACATTTGTTCCTTAGCCAAAT
GTTTCCACCTTGAGAAAGCTATAGAGATTCTATGTAGTCCTAGTACCAATAATATGTTTTAACC
TGAATGTACCTTATCTTTATTCATAAACTGTGACTTTTTACACTGCTGAAACTTTTTTTTTTAA
GACAATCTCACTCTGTCGTCCAGTCTGGAGTGCAGCAGTGGTGTGATCTTGGCTCACTGCAACC
TCTACCTTCTGTGTTCAAGCAATTCTGGTGCCTCGGCCACCTGAGTAGTTGGGATCACAGGTGT
ACACCACCAGGCCTGGCTAATAGTTTTTGATATTTCTAGTAGAGATGAGTTTTGCCACATTGGC
CAGGCTGGCCTGAAACTCCTGGCCTCAAGTGATCTGCCTGCCTTGGCCTCCCAAAGTGTTGGTA
TTACAAGTGTGAGCCACTGTGCCTGGCCTGAAACTCATAATTCATTTCCATTAATATTAATCTC
ACCTTTTCCAATAATTAATTGATTTCACAAGTATTAGTCCCCTATAATCATTGAATGGCTAATA
AAATTATTTATAGCAAACAGATTAATTATCTGCCAGCAGTCTGAGATTAGTTTCTTTAAAAAAT
GTTTATTATTTAAAACATTCAGCTGTGATCTTGGCTTTCTTGTGAGGTTCAATAGTTTCTATTG
AGTAAAGGAGAGAAATGGCAGAGAATTTACTTCAGTGAAATTTGAATTCCATTAACTTAATGTG
GTCTCATCACAAATAATAGTACTTAGAACACCTAGTACAGCTGCTGGACCCAGGAACACAAAGC
AAAGGAAGATGAAATTGTGTGTACCTTGATATTGGTACACACATCAAATGGTGTGATGTGAATT
TAGATGTGGGCATGGGAGGAATAGGTGAAGATGTTAGAAAAAAAATCAACTGTGTCTTGTTCCA
TTCCAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAAGTGAgTATTggATGTCCTAT
TGTGTAGATTGTGTTTTATTICTGTTGATTAAATATTGTAATCCACTATGTTTGTATGTATTGT
AATCCACTTTGTTTCATTTCTCCCAAGCATTATGGTAGTGGAAAGATAAGGTTTTTTGTTTAAA
TGATGACCATTAGTTGGGTGAGGTGACACATTCCTGTAGTCCTAGCTCCTCCACAGGCTGACGC
AGGAGGATCACTTGAGCCCAGGAGTTCAGGGCTGTAGTGTTGTATCATTGTGAGTAGCCACCGC
ACTCCAGCCTGGACAATATAGTGAGATCCTATATCTAAAATAAAATAAAATAAAATGAATAAAT
TGTGAGCATGTGCAGCTCCTGCAGTTTCTAAAGAATATAGTTCTGTTCAGTTTCTGTGAAACAC
AATAAAAATATTTGAAATAACATTACATATTTAGGGTTTTCTTCAAATTTTTTAATTTAATAAA
GAACAACTCAATCTCTATCAATAGTGAGAAAACATATCTATTTTCTTGCAATAATAGTATGATT
TTGAGGTTAAGGGTGCATGCTCTTCTAATGCAAAATATTGTATTTATTTAGACTCAAGTTTAGT
TCCATTTACATGTATTGGAAATTCAGTAAGTAACTTTGGCTGCCAAATAACGATTTCCTATTTG
CTTTACAGCACTCCTCTTCAAGACAAAGGGAATAGTACTCATAGTAGAAATAACAGCTATGCAG
TGATTATCACCAGCACCAGTTCGTATTATGTGTTTTACATTTACGTGGGAGTAGCCGACACTTT
GCTTGCTATGGGATTCTTCAGAGGTCTACCACTGGTGCATACTCTAATCACAGTGTCGAAAATT
TTACACCACAAAATGTTACATTCTGTTCTTCAAGCACCTATGTCAACCCTCAACACGTTGAAAG
CAGGTACTTTACTAGGTCTAAGAAATGAAACTGCTGATCCACCATCAATAGGGCCTGTGGTTTT
GTTGGTTTTCTAATGGCAGTGCTGGCTTTTGCACAGAGGCATGTGCCCTTTGTTGAACCTCCAT
TTGACTGGCATGCACATGTCTCAGATATTATAGGTTATCATATATTGTTGCTCCTAATATTTCT
GTGTTAGATAATTAGAGTAGCTTGGTTTGTAAGAATGTGATGTTGGTGGGACTGTAGCAGAACA
AGAAGGCCCTTATGGGTCAGTCATACCTCTCTT

In an embodiment, to correct a mutation, e.g., an intronic 2789+5bp (G→A) target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 2789+5bp (G→A) mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 46; SEQ ID NO: 27326)
TCTCACCTTTTCCAATAATTAATTGATTTCACAAGTATTAGTCCCCTATAATCATTGAATGGCT
AATAAAATTATTTATAGCAAACAGATTAATTATCTGCCAGCAGTCTGAGATTAGTTTCTTTAAA
AAATGTTTATTATTTAAAACATTCAGCTGTGATCTTGGCTTTCTTGTGAGGTTCAATAGTTTCT
ATTGAGTAAAGGAGAGAAATGGCAGAGAATTTACTTCAGTGAAATTTGAATTCCATTAACTTAA
TGTGGTCTCATCACAAATAATAGTACTTAGAACACCTAGTACAGCTGCTGGACCCAGGAACACA
AAGCAAAGGAAGATGAAATTGTGTGTACCTTGATATTGGTACACACATCAAATGGTGTGATGTG
AATTTAGATGTGGGCATGGGAGGAATAGGTGAAGATGTTAGAAAAAAAATCAACTGTGTCTTGT
TCCATTCCAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAAGTGAgTATTggATGTC
CTATTGTGTAGATTGTGTTTTATTTCTGTTGATTAAATATTGTAATCCACTATGTTTGTATGTA
TTGTAATCCACTTTGTTTCATTTCTCCCAAGCATTATGGTAGTGGAAAGATAAGGTTTTTTGTT
TAAATGATGACCATTAGTTGGGTGAGGTGACACATTCCTGTAGTCCTAGCTCCTCCACAGGCTG
ACGCAGGAGGATCACTTGAGCCCAGGAGTTCAGGGCTGTAGTGTTGTATCATTGTGAGTAGCCA
CCGCACTCCAGCCTGGACAATATAGTGAGATCCTATATCTAAAATAAAATAAAATAAAATGAAT
AAATTGTGAGCATGTGCAGCTCCTGCAGTTTCTAAAGAATATAGTTCTGTTCAGTTTCTGTGAA
ACACAATAAAAATATTTGAAATAACATTACATATTTAGGGTTTTCTTCAAATTTTTTAATTTAA
TAAAGAACAACTCATCTCTATCAATAGTGAGAAAACATAT

In an embodiment, an ssODN may be to correct a mutation, e.g., an intronic 2789+5bp (G→A) target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 2789+5bp (G→A) mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 47; SEQ ID NO: 27327)
AAAAAAAATCAACTGTGTCTTGTTCCATTCCAGGTGGCTGCTTCTTTGG
TTGTGCTGTGGCTCCTTGGAAAGTGAgTATTggATTCCTATTGTGTAGA
TTGTGTTTTATTTCTGTTGATTAAATATTGTAATCCACTATGTTTGTAT
GTA

The underlined G has been changed from a C to G at that position, so that wild-type CFTR is still transcribed, but the PAM sequence CCA has been modified to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template nucleic acids (also referred to herein as donor constructs) to correction a mutation, e.g., an intronic 3272-26bp (A→G) target site in the CFTR gene, are provided.

Suitable sequence for the 5′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27328(5′H arm)
GTGCACATGTACCCTAAAACTTAAAGTATAATAAAAAAAATAAAAAAAAGTTTGAGGTGTTTAA
AGTATGCAAAAAAAAAAAAAGAAATAAATCACTGACACACTTTGTCCACTTTGCAATGTGAAAA
TGTTTACTCACCAACATGTTTTCTTTGATCTTACAGTTGTTATTAATTGTGATTGGAGCTATAG
CAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTAT
TATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATG
ACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGT
TAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTAC
ATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAAT
GACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAG
GACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAA
GGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGAC
ACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGG
GAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATA
TTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAA
AAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCA
GTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCC
AAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACC
AGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTT
CAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCA

Suitable sequence for the 3′ homology arm can be selected from (e.g., includes a portion of) or include the following sequence:

SEQ ID NO: 27329(3′H arm)
TGTTTTCTATGGAAATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAA
AAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGC
TCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGA
ATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGTA
CTATGAACTCATTAACTTTAGCTAAGCATTTAAGTAAAAAATTTTCAATGAATAAAATGCTGCA
TTCTATAGGTTATCAATTTTTGATATCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATT
ATTGAACAAGTGATTTCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTTCCTTGAAAT
CGGATATATATATATATATGTATATATATATATATATATATATATATATACATATATATATATA
GTATTATCCCTGTTTTCACAGTTTTAAAAACCGATGCACACAGATTGTCAGATAGCAATTCTGT
GATTGAAGGGGAAATATGTCACCTCTTCATACTCATATTGGTGAAGGGTCCTAGCTTCAAAATT
AATAGATTCCTAAAGAGGGGAAATGAAACATCCGCATTTACACACACACACACACACACACACA
CAGAGTTCCTCTTGTCGGTAAGTTTTGTTTTTTTTAAATCTCTACTAGATAAAATTTGTTATCT
AATTGTGAGTTTTACACAAAGAAAAACTGTCACAGAAAAGAAAGACAGTGTCACATTTTTCAAA
AGAAAAAGAAGAAAAGAAAGTGCCATGTTTTTCAAATACAAATGTTCTGGATTGATTTTAGGAT
CTTTAGTGAAAAACAAAGTATTTCATAATAAGTAAAATAAAAATCTATGTAGGTAAATTTGTTT
CTCTAATTTAAGAATTTGAATTTCTGAGTATTTATGATAAGTGTTGAAATAACTTCTTATATGT
GACAGTGAATACTGGCAGAGCAAATGCCAAATCAATGCCAAATCTGTAGGATCATTTGATTGTA
GGAACAGAATTCTACTCAAACCGAAAGCAGGCATTTGCTGGAGTTACAGAAAGGCCTCATGGAA
CACCGAGAAGGTGGTGCCATTCGACTCTTAAAGAAGCTGCAACAGGCA

In an embodiment, the replacement sequence comprises or consists of an Adenine (A) residue.

In an embodiment, to correct a mutation, e.g., an intronic 3272-26bp (A→G) target site in the CFTR gene, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 3272-26bp (A→G) mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 48; SEQ ID NO: 27330)
GTGCACATGTACCCTAAAACTTAAAGTATAATAAAAAAAATAAAAAAAAGTTTGAGGTGTTTAA
AGTATGCAAAAAAAAAAAAAGAAATAAATCACTGACACACTTTGTCCACTTTGCAATGTGAAAA
TGTTTACTCACCAACATGTTTTCTTTGATCTTACAGTTGTTATTAATTGTGATTGGAGCTATAG
CAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTAT
TATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATG
ACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGT
TAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTAC
ATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAAT
GACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAG
GACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAA
GGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGAC
ACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGG
GAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATA
TTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAA
AAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCA
GTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCC
AAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACC
AGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTT
CAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAaTGTTTTCTATGGAAA
TATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGGACAC
TTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTACATAC
TGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATTTTT
GTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGTACTATGAACTCATTAA
CTTTAGCTAAGCATTTAAGTAAAAAATTTTCAATGAATAAAATGCTGCATTCTATAGGTTATCA
ATTTTTGATATCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATTATTGAACAAGTGATT
TCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTTCCTTGAAATCGGATATATATATAT
ATATGTATATATATATATATATATATATATATATACATATATATATATAGTATTATCCCTGTTT
TCACAGTTTTAAAAACCGATGCACACAGATTGTCAGATAGCAATTCTGTGATTGAAGGGGAAAT
ATGTCACCTCTTCATACTCATATTGGTGAAGGGTCCTAGCTTCAAAATTAATAGATTCCTAAAG
AGGGGAAATGAAACATCCGCATTTACACACACACACACACACACACACACAGAGTTCCTCTTGT
CGGTAAGTTTTGTTTTTTTTAAATCTCTACTAGATAAAATTTGTTATCTAATTGTGAGTTTTAC
ACAAAGAAAAACTGTCACAGAAAAGAAAGACAGTGTCACATTTTTCAAAAGAAAAAGAAGAAAA
GAAAGTGCCATGTTTTTCAAATACAAATGTTCTGGATTGATTTTAGGATCTTTAGTGAAAAACA
AAGTATTTCATAATAAGTAAAATAAAAATCTATGTAGGTAAATTTGTTTCTCTAATTTAAGAAT
TTGAATTTCTGAGTATTTATGATAAGTGTTGAAATAACTTCTTATATGTGACAGTGAATACTGG
CAGAGCAAATGCCAAATCAATGCCAAATCTGTAGGATCATTTGATTGTAGGAACAGAATTCTAC
TCAAACCGAAAGCAGGCATTTGCTGGAGTTACAGAAAGGCCTCATGGAACACCGAGAAGGTGGT
GCCATTCGACTCTTAAAGAAGCTGCAACAGGCA

As described below in Table 49, shorter homology arms, e.g., 5′ and/or 3′ homology arms may be used.

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to correct an intronic 3272-26bp (A→G) mutation in the CFTR gene, the 5′ homology arm may be shortened less than 1000 nucleotides, e.g., e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 3272-26bp (A→G) mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 49; SEQ ID NO: 27331)
AGACACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCA
AACTCTACTTGAGCTGTTAGGGAATCACATTTTGCAGTGACAGCCTT
AGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATATTTCTGCTT
TGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGA
TACTTGAAAAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAA
TTTAGAATTAGCCAGAAAACTCCCAGTGGTAGCCAAGAAAGAGGAAT
AAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCCAAGTA
AAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCA
AAGAATGGCACCAGTGTGAAAAAAAGCTTTTTAACCAATGACATTTG
TGATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATG
AAATTACATTTTGTGTTTATGTTATTTGCAaTGTTTTCTATGGAAAT
ATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTA
AAAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGA
AACTCTGTTCCACAAAGCTCTGAATTTACATACTGCCAACTGGTTCT
TGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATT
TTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAAC
AGGTACTATGAACTCATTAACTTTAGCTAAGCATTTAAGTAAAAAAT
TTTCAATGAATAAAATGCTGCATTCTATAGGTTATCAATTTTTGATA
TCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATTATTGAACA
AGTGATTTCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTT
CCTTGAAATCGGATATATATATATATATGTATATATATATATATATA
TATATATATATACA

It is contemplated herein that template nucleic acids for correcting a mutation may designed for use as a single-stranded oligonucleotide (ssODN). When using a ssODN, 5′ and 3′ homology arms may range up to about 200 base pairs (bp) in length, e.g., at least 25, 50, 75, 100, 125, 150, 175, or 200 bp in length. Longer homology arms are also contemplated for ssODNs as improvements in oligonucleotide synthesis continue to be made.

In an embodiment, an ssODN may be used to correct a mutation, e.g., an intronic 3272-26bp (A→G) target site in the CFTR gene. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted bases to correct the intronic 3272-26bp (A→G) mutation is shown as lower case sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 50; SEQ ID NO: 27332)
ATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATGAA
ATTACATTTTGTGTTTATGTTATTTGCAaTGTTTTCTATGGAAATAT
TTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAA
AGGACTATGG

In an embodiment, to correct a mutation, e.g., an intronic 3272-26bp (A→G) target site in the CFTR gene, and concomitantly introduce a silent sense mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 3272-26bp (A→G) mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 51; SEQ ID NO: 27333)
GTGCACATGTACCCTAAAACTTAAAGTATAATAAAAAAAATAAAAAAAAGTTTGAGGTGTTTAA
AGTATGCAAAAAAAAAAAAAGAAATAAATCACTGACACACTTTGTCCACTTTGCAATGTGAAAA
TGTTTACTCACCAACATGTTTTCTTTGATCTTACAGTTGTTATTAATTGTGATTGGAGCTATAG
CAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTAT
TATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATG
ACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGT
TAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTAC
ATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAAT
GACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAG
GACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAA
GGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGAC
ACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGG
GAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATA
TTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAA
AAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCA
GTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCC
AAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACC
AGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTT
CAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAaTGTTTTCTATccAAA
TATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGGACAC
TTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTACATAC
TGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATTTTT
GTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGTACTATGAACTCATTAA
CTTTAGCTAAGCATTTAAGTAAAAAATTTTCAATGAATAAAATGCTGCATTCTATAGGTTATCA
ATTTTTGATATCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATTATTGAACAAGTGATT
TCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTTCCTTGAAATCGGATATATATATAT
ATATGTATATATATATATATATATATATATATATACATATATATATATAGTATTATCCCTGTTT
TCACAGTTTTAAAAACCGATGCACACAGATTGTCAGATAGCAATTCTGTGATTGAAGGGGAAAT
ATGTCACCTCTTCATACTCATATTGGTGAAGGGTCCTAGCTTCAAAATTAATAGATTCCTAAAG
AGGGGAAATGAAACATCCGCATTTACACACACACACACACACACACACACAGAGTTCCTCTTGT
CGGTAAGTTTTGTTTTTTTTAAATCTCTACTAGATAAAATTTGTTATCTAATTGTGAGTTTTAC
ACAAAGAAAAACTGTCACAGAAAAGAAAGACAGTGTCACATTTTTCAAAAGAAAAAGAAGAAAA
GAAAGTGCCATGTTTTTCAAATACAAATGTTCTGGATTGATTTTAGGATCTTTAGTGAAAAACA
AAGTATTTCATAATAAGTAAAATAAAAATCTATGTAGGTAAATTTGTTTCTCTAATTTAAGAAT
TTGAATTTCTGAGTATTTATGATAAGTGTTGAAATAACTTCTTATATGTGACAGTGAATACTGG
CAGAGCAAATGCCAAATCAATGCCAAATCTGTAGGATCATTTGATTGTAGGAACAGAATTCTAC
TCAAACCGAAAGCAGGCATTTGCTGGAGTTACAGAAAGGCCTCATGGAACACCGAGAAGGTGGT
GCCATTCGACTCTTAAAGAAGCTGCAACAGGCA

In an embodiment, to correct a mutation, e.g., an intronic 3272-26bp (A→G) target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the 5′ homology arm may be shortened less than 750 nucleotides, e.g., 500 nucleotides, to avoid inclusion of a LINE repeat element in the 5′ homology arm. The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 3272-26bp (A→G) mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 52; SEQ ID NO: 27334)
AGACACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGT
TAGGGAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAG
TATATTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACT
TGAAAAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACT
CCCAGTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGT
AGCCAAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGG
CACCAGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCT
TTTTCAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAaTGTTTTCTATc
cAAATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGG
ACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTAC
ATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGAT
TTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGTACTATGAACTCA
TTAACTTTAGCTAAGCATTTAAGTAAAAAATTTTCAATGAATAAAATGCTGCATTCTATAGGTT
ATCAATTTTTGATATCTTTAGAGTTTAGTAATTAACAAATTTGTTGGTTTATTATTGAACAAGT
GATTTCTTTGAATTTCCATTGTTTTATTGTTAAACAAATAATTTCCTTGAAATCGGATATATAT
ATATATATGTATATATATATATATATATATATATATATACA

In an embodiment, an ssODN may be to correct a mutation, e.g., an intronic 3272-26bp (A→G) target site in the CFTR gene, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage. For example, the ssODN may include 5′ and 3′ homology arms as shown below. The 5′ homology arm is shown as bold sequence, the inserted base to correct the intronic 3272-26bp (A→G) mutation is shown as lower case sequence, the silent sense mutation is shown as lower case underlined and italicized sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(Template Construct 53; SEQ ID NO: 27335)
ATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATG
AAATTACATTTTGTGTTTATGTTATTTGCAaTGTTTTCTATccAA
ATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAG
CTTAAAAGGACTATGG

The underlined C has been changed from a G to C at that position, so that wild-type CFTR is still transcribed, but the PAM sequence TGG has been modified to reduce or eliminate Cas9 cleavage at that locus.

Table 49 below provides exemplary template nucleic acids. In an embodiment, the template nucleic acid includes the 5′ homology arm and the 3′ homology arm of a row from Table 49. In other embodiments, a 5′ homology arm from the first column can be combined with a 3′ homology arm from Table 49. In each embodiment, a combination of the 5′ and 3′ homology arms include a replacement sequence, e.g., Cytosine-Thymine-Thymine (CTT) residues or a Guanine (G) residue.

	TABLE 49
	5′ homology arm		3′ homology arm
	(the number of		(the number of
	nucleotides from		nucleotides from
	SEQ ID NO: 5′H,		SEQ ID NO: 3′H,
	beginning at	Replacement	beginning at
	the 3′ end of	Sequence = CT	the 5′ end of
	SEQ ID NO: 5′H)	T or G	SEQ ID NO: 3′H)
	10 or more		10 or more
	20 or more		20 or more
	50 or more		50 or more
	100 or more		100 or more
	150 or more		150 or more
	200 or more		200 or more
	250 or more		250 or more
	300 or more		300 or more
	350 or more		350 or more
	400 or more		400 or more
	450 or more		450 or more
	500 or more		500 or more
	550 or more		550 or more
	600 or more		600 or more
	650 or more		650 or more
	700 or more		700 or more
	750 or more		750 or more
	800 or more		800 or more
	850 or more		850 or more
	900 or more		900 or more
	1000 or more		1000 or more
	1100 or more		1100 or more
	1200 or more		1200 or more
	1300 or more		1300 or more
	1400 or more		1400 or more
	1500 or more		1500 or more
	1600 or more		1600 or more
	1700 or more		1700 or more
	1800 or more		1800 or more
	1900 or more		1900 or more
	1200 or more		1200 or more
	At least 50 but not		At least 50 but not
	long enough to		long enough to
	include a		include a
	repeated element.		repeated element.
	At least 100 but		At least 100 but
	not long enough to		not long enough to
	include a		include a
	repeated element.		repeated element.
	At least 150 but		At least 150 but
	not long enough to		not long enough to
	include a		include a
	repeated element.		repeated element.
	5 to 100 nucleotides		5 to 100 nucleotides
	10 to 150 nucleotides		10 to 150 nucleotides
	20 to 150 nucleotides		20 to 150 nucleotides
	Template Construct No. 1
	Template Construct No. 2
	Template Construct No. 3
	Template Construct No. 4

In an embodiment, a single or dual nickase eaCas9 is used to cleave the target DNA near the site of the mutation, or signature, to be modified, e.g., replaced. While not wishing to be bound by theory, in an embodiment, it is believed that the Cas9 mediated break induces HDR with the template nucleic acid to replace the target DNA sequence with the template sequence.

Targeted Knockin by cDNA Insertion

In an embodiment, homology-directed repair of the CFTR gene is used to target an intronic region between exons X and Y, wherein exons X and Y are any exons between exon 1 and exon 27, given that exon X and exon Y are adjacent and exon X has a lower number than exon Y, and deliver a Cas9 molecule, CRIPSR-gRNAs, and homology-directed repair templates that include homology arms, splice acceptor, contiguous coding sequence of exons (X+1) through exon 27 of CFTR gene and polyadenylation signal.

In an embodiment, one single strand break, two single strand breaks, one double strand break or two double strand breaks are introduced (e.g., positioned by one, two, three, or four gRNA molecule/s) at or in close proximity to a CF target knockin position in the CFTR gene. The CF target knockin position is the intronic region between CFTR exons X and Y. Altering the CF target knockin position refers to homology-directed repair of genomic sequence including the delivery of cDNA template of contiguous exons (X+1) through exon 27 of CFTR gene. Targeted knockin of CFTR cDNA leads to the cessation of production of mutant or truncated CFTR protein and results in the production of wild-type CFTR protein. Targeted knockin of CFTR cDNA prevents the development or progression of lung, gastrointestinal and/or reproductive disease in a subject due to the cessation of production of mutant CFTR protein and restoration of wild-type CFTR protein production. This approach cures and/or prevents the progression of lung, gastrointestinal and/or reproductive disease in any subject with CF or CF-like disease deficiency who has a mutation in exon (X+1) through exon 27 of the CFTR gene, or in any subject who has a mutation in an intronic or exonic region of the CFTR gene that is after intron X.

In an embodiment, homology-directed repair of the CFTR gene in any subject with CF mutations in exons 3 through 27 and introns 2 through 26 by targeting intronic region between exons 2 and 3 and with delivery of a homology-directed repair template including homology arms, splice acceptor, coding sequence of contiguous exons 3-27 of CFTR gene and polyadenylation signal. The CF target position is the intronic region between exons 2 and 3. Altering the CF target position refers to homology-directed repair of genomic sequence including the delivery of cDNA template of exons 3-27 of CFTR gene. This approach cures and/or prevents the progression of lung, gastrointestinal and/or reproductive disease in any subject with CF or CF-like disease deficiency who has a mutation in exons 3-27 of the CFTR gene, or in any subject who has a mutation in an intronic or exonic region of the CFTR gene that is on or after the second intron, including but not limited to the following mutations: e.g., F508del, G551D, G542X, N1303K, R117H, W1282X, R553X, c.3717+12191C>T, 2657+5G>A, or c.3140-26A>G.

In an embodiment, a cDNA insert construct comprises a 5′ homology arm, a splice acceptor, a cDNA insert (e.g., CFTR exons 3 to 27, e.g., CFTR exons 11 to 27), a 3′ homology arm, and a polyadenylation signal. Splice acceptors and polyadenylation signals are well known to one of skill in the art.

It is contemplated herein that, in an embodiment, a Cas9 molecule could potentially cleave cDNA insert constructs either prior to or following homology directed repair (e.g., homologous recombination), resulting in a possible non-homologous-end-joining event and further DNA sequence mutation at the chromosomal locus of interest. Therefore, to avoid cleavage of the cDNA insert sequence before and/or after Cas9-mediated homology directed repair, alternate versions of the homology arms may be used where silent mutations are introduced into a PAM. These silent mutations may disrupt Cas9 binding and cleavage, but not disrupt the amino acid sequence of the cDNA insert.

Exemplary template cDNA (also referred to herein as cDNA inserts) to introduce wild-type sequence, e.g., exons 3 to 27 of the CFTR gene, are provided. In an embodiment, the CRISPR-Cas9 binding site is CTCAAGTGATCTGCCCACCTTGG (SEQ ID NO: 27336) (PAM is underlined TGG).

In an embodiment, to insert CFTR cDNA (e.g., CFTR exons 3 to 27) into intron 2, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the CRISPR-Cas9 binding site is shown as italicized sequence, the PAM site is underlined, the silent sense mutation in the PAM is shown as lower case underlined sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(SEQ ID NO: 27337)
CAATCAAAAGGTTAGGATCCTTTTGATTGCCAGTGACAGAAACCCAATTTACTAGCTTAAGTAA
ATAAAAGGAACGAATTTATTGGCTCATGAAGCCTGAACTATGTGAAGACCTAGGTGGAGAACTG
GCCTTAGGAACTCAATGGGACCAAGGACTCAAATGCCACCTGGTGGCATTTGCCTTATGCTGGT
TTTATTTTCTCAGACCGGACCAGCTTTCTACATAAAGTGGGTCCCTGGTTAGAACTCTTTGCTC
CTATCTTTAAGGACCACGAAAGAAGGAGCCCTTTGTCCTTGGCTAAATGTGAAAAATCCCAGAG
ACTCTTGAGTCATAGTGCTTACCCCTTGGGCCACTCATAGTCTAGAATGAACTAGGCTGAGTCT
CGTGCCAACAGCACAGGCCTGATGCCAGATAAAAGGGTGAGTGAAGGGGGATAAAAAATAAGAC
ATAGCTACTAAATTATTGCACCAAAGTAAAAACATTGAGTTGACTTGCAATTTGTTTCTTTTAA
TTAAATTCATTTCCTTTTTTTGGCATTTTGAAGGCAAAGTAAGATATTAAACTTTATTTTTATT
GATTTTATTCAAAGAATTAAGCTAGTGGGAGTAGCAGATTCACACTTCTAAGATCAAGGGCCAG
CTTCTATTATTGAACACTTGGTGTGTGCAAATGCCATGAGGTAGGGATACTTTGTTTTGTTTTT
TATTTTTTATTGGGTTCGATCTCTTTTGTTTATGATGTATCCCCAAGTGCCTAGAATAGGGCCT
GGCATATGGTATATACTCAATAAATATTTGTTGAATGAATCCATGATGGAATGTGAAATGGCTA
GCATTACATAGAAACCTGTAGCATTGCTGGAGAGATAAAATATATAAACATAATCCATTGCAGG
TATATTGACAAGTTCAAAATAATATAATGGGTATTGAATATCTAAATGTTTGTTGTTGTTGTTG
CTGTTGTTTTTGAGACAGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGTAATGGTGCAATTTTGG
CTCACTGCAAACTTCGTCTCCTGGGTTCAAGTGATTCTCCTGCCTCAGCCTCTCGAGTAGCTGG
GTTTACAGGCACTCGCCACAATGCCTGGCTAATTTTTGTATTTTAGTAGATGTGGAGTTTCGCC
ATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAAGTGATCTGCCCACCTTaaCCTCCCAAAA
TGCTGGGATTATAGGTGTGAGCCACTATGCCCAGCTTTGAATATCTAAGTTTTAATTGGATGCT
GAGGGAATGATTAATCAGAGTAGGGCTGGGTTAATTGAAAAATGTGATACATTTGTATTTATGG
CCAGATAGAGAACATGAATCTGAATTTGCAGAATTATCTGGCTTAACATTTTTTTCTTTCCAGT
TTTCACTGTATCCCCCATGTTGATTCAATTTAAAAAATATACCTATTTTACTTCAATTCAACAA
TGCTATGCCAGTACAAACCCATACGTTCTATTATTTTTGTTTTGTTTTGTTTTTGTATCTCCAC
CCTGTTACTTCTTTTCTTATAAAATTGGTATTTGAAATTTATTGAAATATTTTGGAAGAGTGAC
ATACCATTTTTGGTACTTTGTACCTCTGCACCCTTGGGAAGTGACCCTGGCTTCACATTTCATA
ACTGCCTTGTGACCATGGCCCTCAAGTGGTTGCCAGATGGTTGAAGAACATTAACCTATCTGGC
TCAATTTTGTGACCATGGATTGAATCCTCTACATAACTGCAGTGTGCAAACCACACATCCGTTC
CAAGATTGTAGTCAGGATATGAACTTTTTAAGAATAAAACTTCTTCCCTTCTGATCTGGGCCTG
GTATGTGGTCCTACTAGAACCACATCACCTACTCTTGGTGCTAACAATTTGTGGCACCAAGTTG
TTCAAGTTTCACCCATTAAAGAAATTCCCCGACCTTGCCTTCTCCTCAGGTAACTACCCCATTC
TATTTTTTCTTTCATAGCTAACATTCTCTGCTCTCCTGGTCTCTCTACTTCACTTTCATTTACA
TCTCAGCTCCTGAAGTATGGTTTCCACCATGTTCCTAAAACTACATTGCCCAGGGTCACTAGAG
ACCTCTTATGAAATATAACAACACCTTTCTACATTACTTCCGTGTGGACCACTTTTTCACATTG
AACCCATTTTGTTGGTTTATGTACACACCCCTTCCTTGGCTTTCCCATCTGATCCATTTCTCCT
TTGATGGAGAAGGTGAGTCTGCTCCATATTTAGCTTCTTACTCTGAGTAACCAAATGTTATGGA
TGGGAGGTTAGCTCTGTGTGTGAGAGAAAGGTGGAGAAGCATGTGGGGAGGGAAATAGATGGGA
AAAGGTAATTAGGCTTTATAGAAGGGCTCTCA

The underlined A has been changed from a G to A at that position so that wild-type CFTR is still transcribed, but the PAM sequence TGG has been modified to TAA to reduce or eliminate Cas9 cleavage at that locus.

In an embodiment, suitable sequence for the cDNA insert of CFTR exons 3 to 27, can be selected from (e.g., includes a portion of) or include the following sequence:

(SEQ ID NO: 27338)
AGAATGGGATAGAGAGCTGGCTTCAAAGAAAAATCCTAAACTCATTAATGCCCTTCGGCGATGT
TTTTTCTGGAGATTTATGTTCTATGGAATCTTTTTATATTTAGGGGAAGTCACCAAAGCAGTAC
AGCCTCTCTTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAACGCTCTAT
CGCGATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTGAGGACACTGCTCCTACACCCA
GCCATTTTTGGCCTTCATCACATTGGAATGCAGATGAGAATAGCTATGTTTAGTTTGATTTATA
AGAAGACTTTAAAGCTGTCAAGCCGTGTTCTAGATAAAATAAGTATTGGACAACTTGTTAGTCT
CCTTTCCAACAACCTGAACAAATTTGATGAAGGACTTGCATTGGCACATTTCGTGTGGATCGCT
CCTTTGCAAGTGGCACTCCTCATGGGGCTAATCTGGGAGTTGTTACAGGCGTCTGCCTTCTGTG
GACTTGGTTTCCTGATAGTCCTTGCCCTTTTTCAGGCTGGGCTAGGGAGAATGATGATGAAGTA
CAGAGATCAGAGAGCTGGGAAGATCAGTGAAAGACTTGTGATTACCTCAGAAATGATTGAAAAT
ATCCAATCTGTTAAGGCATACTGCTGGGAAGAAGCAATGGAAAAAATGATTGAAAACTTAAGAC
AAACAGAACTGAAACTGACTCGGAAGGCAGCCTATGTGAGATACTTCAATAGCTCAGCCTTCTT
CTTCTCAGGGTTCTTTGTGGTGTTTTTATCTGTGCTTCCCTATGCACTAATCAAAGGAATCATC
CTCCGGAAAATATTCACCACCATCTCATTCTGCATTGTTCTGCGCATGGCGGTCACTCGGCAAT
TTCCCTGGGCTGTACAAACATGGTATGACTCTCTTGGAGCAATAAACAAAATACAGGATTTCTT
ACAAAAGCAAGAATATAAGACATTGGAATATAACTTAACGACTACAGAAGTAGTGATGGAGAAT
GTAACAGCCTTCTGGGAGGAGGGATTTGGGGAATTATTTGAGAAAGCAAAACAAAACAATAACA
ATAGAAAAACTTCTAATGGTGATGACAGCCTCTTCTTCAGTAATTTCTCACTTCTTGGTACTCC
TGTCCTGAAAGATATTAATTTCAAGATAGAAAGAGGACAGTTGTTGGCGGTTGCTGGATCCACT
GGAGCAGGCAAGACTTCACTTCTAATGGTGATTATGGGAGAACTGGAGCCTTCAGAGGGTAAAA
TTAAGCACAGTGGAAGAATTTCATTCTGTTCTCAGTTTTCCTGGATTATGCCTGGCACCATTAA
AGAAAATATCATCTTTGGTGTTTCCTATGATGAATATAGATACAGAAGCGTCATCAAAGCATGC
CAACTAGAAGAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAA
TCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTTAGCAAGAGCAGTATACAAAGATGCTGA
TTTGTATTTATTAGACTCTCCTTTTGGATACCTAGATGTTTTAACAGAAAAAGAAATATTTGAA
AGCTGTGTCTGTAAACTGATGGCTAACAAAACTAGGATTTTGGTCACTTCTAAAATGGAACATT
TAAAGAAAGCTGACAAAATATTAATTTTGCATGAAGGTAGCAGCTATTTTTATGGGACATTTTC
AGAACTCCAAAATCTACAGCCAGACTTTAGCTCAAAACTCATGGGATGTGATTCTTTCGACCAA
TTTAGTGCAGAAAGAAGAAATTCAATCCTAACTGAGACCTTACACCGTTTCTCATTAGAAGGAG
ATGCTCCTGTCTCCTGGACAGAAACAAAAAAACAATCTTTTAAACAGACTGGAGAGTTTGGGGA
AAAAAGGAAGAATTCTATTCTCAATCCAATCAACTCTATACGAAAATTTTCCATTGTGCAAAAG
ACTCCCTTACAAATGAATGGCATCGAAGAGGATTCTGATGAGCCTTTAGAGAGAAGGCTGTCCT
TAGTACCAGATTCTGAGCAGGGAGAGGCGATACTGCCTCGCATCAGCGTGATCAGCACTGGCCC
CACGCTTCAGGCACGAAGGAGGCAGTCTGTCCTGAACCTGATGACACACTCAGTTAACCAAGGT
CAGAACATTCACCGAAAGACAACAGCATCCACACGAAAAGTGTCACTGGCCCCTCAGGCAAACT
TGACTGAACTGGATATATATTCAAGAAGGTTATCTCAAGAAACTGGCTTGGAAATAAGTGAAGA
AATTAACGAAGAAGACTTAAAGGAGTGCTTTTTTGATGATATGGAGAGCATACCAGCAGTGACT
ACATGGAACACATACCTTCGATATATTACTGTCCACAAGAGCTTAATTTTTGTGCTAATTTGGT
GCTTAGTAATTTTTCTGGCAGAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAACAC
TCCTCTTCAAGACAAAGGGAATAGTACTCATAGTAGAAATAACAGCTATGCAGTGATTATCACC
AGCACCAGTTCGTATTATGTGTTTTACATTTACGTGGGAGTAGCCGACACTTTGCTTGCTATGG
GATTCTTCAGAGGTCTACCACTGGTGCATACTCTAATCACAGTGTCGAAAATTTTACACCACAA
AATGTTACATTCTGTTCTTCAAGCACCTATGTCAACCCTCAACACGTTGAAAGCAGGTGGGATT
CTTAATAGATTCTCCAAAGATATAGCAATTTTGGATGACCTTCTGCCTCTTACCATATTTGACT
TCATCCAGTTGTTATTAATTGTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACAT
CTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACC
TCACAGCAACTCAAACAACTGGAATCTGAAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAA
GCTTAAAAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCA
CAAAGCTCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAA
ATGAGAATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAA
CAGGAGAAGGAGAAGGAAGAGTTGGTATTATCCTGACTTTAGCCATGAATATCATGAGTACATT
GCAGTGGGCTGTAAACTCCAGCATAGATGTGGATAGCTTGATGCGATCTGTGAGCCGAGTCTTT
AAGTTCATTGACATGCCAACAGAAGGTAAACCTACCAAGTCAACCAAACCATACAAGAATGGCC
AACTCTCGAAAGTTATGATTATTGAGAATTCACACGTGAAGAAAGATGACATCTGGCCCTCAGG
GGGCCAAATGACTGTCAAAGATCTCACAGCAAAATACACAGAAGGTGGAAATGCCATATTAGAG
AACATTTCCTTCTCAATAAGTCCTGGCCAGAGGGTGGGCCTCTTGGGAAGAACTGGATCAGGGA
AGAGTACTTTGTTATCAGCTTTTTTGAGACTACTGAACACTGAAGGAGAAATCCAGATCGATGG
TGTGTCTTGGGATTCAATAACTTTGCAACAGTGGAGGAAAGCCTTTGGAGTGATACCACAGAAA
GTATTTATTTTTTCTGGAACATTTAGAAAAAACTTGGATCCCTATGAACAGTGGAGTGATCAAG
AAATATGGAAAGTTGCAGATGAGGTTGGGCTCAGATCTGTGATAGAACAGTTTCCTGGGAAGCT
TGACTTTGTCCTTGTGGATGGGGGCTGTGTCCTAAGCCATGGCCACAAGCAGTTGATGTGCTTG
GCTAGATCTGTTCTCAGTAAGGCGAAGATCTTGCTGCTTGATGAACCCAGTGCTCATTTGGATC
CAGTAACATACCAAATAATTAGAAGAACTCTAAAACAAGCATTTGCTGATTGCACAGTAATTCT
CTGTGAACACAGGATAGAAGCAATGCTGGAATGCCAACAATTTTTGGTCATAGAAGAGAACAAA
GTGCGGCAGTACGATTCCATCCAGAAACTGCTGAACGAGAGGAGCCTCTTCCGGCAAGCCATCA
GCCCCTCCGACAGGGTGAAGCTCTTTCCCCACCGGAACTCAAGCAAGTGCAAGTCTAAGCCCCA
GATTGCTGCTCTGAAAGAGGAGACAGAAGAAGAGGTGCAAGATACAAGGCTTTAG

It is contemplated herein that one or both homology arms may be shortened to avoid including certain sequence repeat elements, e.g., Alu repeats, LINE elements. For example, a 5′ homology arm may be shortened to avoid a sequence repeat element. In other embodiments, a 3′ homology arm may be shortened to avoid a sequence repeat element. In some embodiments, both the 5′ and the 3′ homology arms may be shortened to avoid including certain sequence repeat elements.

In an embodiment, to insert CFTR cDNA (e.g., CFTR exons 3 to 27) into intron 2, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may be shorted to approximately 500 bp. The 5′ homology arm is shown as bold sequence, the CRISPR-Cas9 binding site is shown as italicized sequence, the PAM site is underlined, the silent sense mutation in the PAM is shown as lower case underlined sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(SEQ ID NO: 27339)
TTTTTATTTTTTATTGGGTTCGATCTCTTTTGTTTATGATGTATCCCCAAGTGCCTAGAATAGG
GCCTGGCATATGGTATATACTCAATAAATATTTGTTGAATGAATCCATGATGGAATGTGAAATG
GCTAGCATTACATAGAAACCTGTAGCATTGCTGGAGAGATAAAATATATAAACATAATCCATTG
CAGGTATATTGACAAGTTCAAAATAATATAATGGGTATTGAATATCTAAATGTTTGTTGTTGTT
GTTGCTGTTGTTTTTGAGACAGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGTAATGGTGCAATT
TTGGCTCACTGCAAACTTCGTCTCCTGGGTTCAAGTGATTCTCCTGCCTCAGCCTCTCGAGTAG
CTGGGTTTACAGGCACTCGCCACAATGCCTGGCTAATTTTTGTATTTTAGTAGATGTGGAGTTT
CGCCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAAGTGATCTGCCCACCTTaaCCTCCC
AAAATGCTGGGATTATAGGTGTGAGCCACTATGCCCAGCTTTGAATATCTAAGTTTTAATTGGA
TGCTGAGGGAATGATTAATCAGAGTAGGGCTGGGTTAATTGAAAAATGTGATACATTTGTATTT
ATGGCCAGATAGAGAACATGAATCTGAATTTGCAGAATTATCTGGCTTAACATTTTTTTCTTTC
CAGTTTTCACTGTATCCCCCATGTTGATTCAATTTAAAAAATATACCTATTTTACTTCAATTCA
ACAATGCTATGCCAGTACAAACCCATACGTTCTATTATTTTTGTTTTGTTTTGTTTTTGTATCT
CCACCCTGTTACTTCTTTTCTTATAAAATTGGTATTTGAAATTTATTGAAATATTTTGGAAGAG
TGACATACCATTTTTGGTACTTTGTACCTCTGCACCCTTGGGAAGTGACCCTGGCTTCACATTT
CATAACTGCCTTGTGACCATGGCCCTCAAGTGGTTGCCAG

The underlined A has been changed from a G to A at that position so that wild-type CFTR is still transcribed, but the PAM sequence TGG has been modified to TAA to reduce or eliminate Cas9 cleavage at that locus.

Exemplary template cDNA (also referred to herein as cDNA inserts) to introduce wild-type sequence, e.g., exons 11 to 27 of the CFTR gene, are provided. In an embodiment, the CRISPR-Cas9 binding site is AGTGAATGAATGTGGTATCCCGG (SEQ ID NO: 27340) (PAM is underlined CGG).

In an embodiment, to insert CFTR cDNA (e.g., CFTR exons 11 to 27) into intron 10, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may each comprise about 1000 base pairs (bp) of sequence flanking the most distal gRNAs (e.g., 1200 bp of sequence on either side of the mutation). The 5′ homology arm is shown as bold sequence, the CRISPR-Cas9 binding site is shown as italicized sequence, the PAM site is underlined, the silent sense mutation in the PAM is shown as lower case underlined sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(SEQ ID NO: 27341)
CTAAATAGAGTGCTGATTTCCCCACAGCATTACTAACAGATGATATTATCTAATTTAAAAAGTT
TCTCATCTTATAGGGAAAATAGTATGTCAATGTATTCTTAACTTGCATTTCTTTTATTATAAGT
AGTGTAAAATATCATTTCAACTTATACACAGGAGGAATTTCTCTCTATATAAAGTGATCCTAGA
ATCATAATGAAAAATATCACCAACTCATTAGGAAAATGTACAAAGGATTGAATAGATATCTCAT
CAAAAATAAAAATATAAGTGGCCTTTAAACATTGAAAGGTAACATTTGAACAAAGACTTGCAGG
AGGTGAGGGATTAGGGAATGCAGACTCTGGGAAGAGTCTTCCAAGTAGCAGGTGAAGCAAGTGC
AAAGCTTTCAGATGGGACTGACTATACCTGTCTGGTTTGAAGAACAGTAAGGAGGTCACTGAGG
CTGGCATAGAGTAAGACAGGGAGGGTAGAATACTGTCAGAGAAGTAATCGGCGGTGGAGGTAGG
GGGTAAACCATAAAGTGCTCGTAAAGACTAAGGCTTATTTCTCTGGGTGAGATTAGAGGCCACT
GGAGAGTTTTAAACAGAAGTAACAGGGCCACTTTGGCTAATGTTTTTAGGCTATTCTGTAGGGA
GACAAGGGAGGAAGCAAGGAGATGAGTTAGGAGTCTATTGTGCCAGTTCAGGCAAGTGATGATG
GTGGCTTGATCCAGGTAGTAGTGGAAGTAGTATAGTAGGAAGTGATCAGATTCAGGACATGCTT
TGAAGGAAGATCCAATAGGATTAATGGATAAGTTGAACAATGGCATATGAGAAAAGTCACAGAG
GAGTCAAAGATGATTCCAAGCTTTCTGGACTGAGTAACTGGAAGGATAAATGTGCCGTTTACTA
GAAAGATAATGGGAGAAACAGGTTTTGGATGGAGCTTGGTTTGGGAATATTAAGTTTGAAATGC
CTATTTGACATCCAAATAGAGATGTTAGTTGGATGTACAAGTCTAGTTTCAAGGAAGAGGGGGC
TGGTAGTGTGAAGATGGGGCTGGATAAGATTCTAAAGGAAAGAGGGTTGATAAGAAGAGAAAGG
GGTGTAGGGGTTAGCCTAAGGGCATTCTAAGTATTAGAGGTTAAGGAGGTGGGTGAAGAAAACC
CAATAAAATAAAAGTCTGAGAAGACAAAGCTAGTGAATGAATGTGGTATCCCttAACCCAACTG
ATGTCAAGCAGAAGGGTGTTATCAACTAGGTCAAATGCTCATTCATCAAGTAAGATGAAACTGT
TATAATTAACCGGTGTCTTCTGAAATACGGAGATAACTCGTGACTTAATGAAAGCAATAGTAGA
GAAGGTCAAACTTGACCAGAATGAAATTAGAAAGAATAAGAGGAAAGAAAAGACCAAATACAGA
CAACCATTGATGCCTTATTCTTTTGATATACTCCTGGAGTCCACTTGCTAATACAATTGACCCT
TAAACAATACAGGCTTGAACTGCATGGGTCCACTTATTTGTGAATTTTTTTTCAGTTAATACAT
TGGAAAATTTTTGGGGTTTTTTGACAATTTGAAAAAACTCACAAACTGTCTAGCCTAGAAATAC
CGAGAAAATTAAGAAAAAGTAAGATATGCCATGAATGCATAAAATATATGTAGACACTAGCCTA
TTTTATCATTTGCTACTATAAAATATACACAATCTATTATAAAAAGTTAAAATTTATCAAAACT
TAACACACACTAACACCTACCCTACCTGGCACCATTCACAGTAAAGAGAAATGTAAATAAACAT
AAAAATGTAGTATTAAACCATAATGGCATAAAACTAATTGTAGTACATATGGTACTACTGTAAT
AATTTGGAAGCCACTTCCTGTTGCTATTACGGTAAGCTCAAGCATTGTGGATAGCCATTTAAAA
CACCACGTGATGCTAATCATCTCCGTGTGAGCAGTTCTCTCTCCAGTAAATTGCATATTGCAGT
AAAAAGTGATCTCTAGTGGTTCTCGCATATTTTTCATCATGTTTAGTGCAATGCCATAAACCTT
GAATAACATCAAGCAATCCATACAAAGTGCCACTAGTGATGCACGGAAAAGTTGTAACAGTACA
AGAAAAAAGTTGAGTTGCTTGGTATTTACCATATATTGAGGTCTGCAGCTACAGTTGCCTGCAA
TTTCGAGATAAATGAACCCAGTATAAAGACTGTTGTAACAAAAGAAAAGAAAATGTGAAACCAT
CAGTGCAGCTATGCCAGCAGGTGTGAAGTCTTGCACTTTTTGCAAAATACAAAATATGAAATAT
GTGTTAATTGACTGTTTATGTTATCTGTAAGGTTTCCACTCAACAATAGGCTATTAGTAGTTAA
GTTTTTGTGGAGTCAAAAATTATACGTGGATT

The underlined T has been changed from a G to T at that position so that wild-type CFTR is still transcribed, but the PAM sequence CGG has been modified to CTT to reduce or eliminate Cas9 cleavage at that locus.

In an embodiment, suitable sequence for the cDNA insert of CFTR exons 11 to 27, can be selected from (e.g., includes a portion of) or include the following sequence:

(SEQ ID NO: 27342)
ACTTCACTTCTAATGGTGATTATGGGAGAACTGGAGCCTTCAGAGGGTAAAATTAAGCACAGTG
GAAGAATTTCATTCTGTTCTCAGTTTTCCTGGATTATGCCTGGCACCATTAAAGAAAATATCAT
CTTTGGTGTTTCCTATGATGAATATAGATACAGAAGCGTCATCAAAGCATGCCAACTAGAAGAG
GACATCTCCAAGTTTGCAGAGAAAGACAATATAGTTCTTGGAGAAGGTGGAATCACACTGAGTG
GAGGTCAACGAGCAAGAATTTCTTTAGCAAGAGCAGTATACAAAGATGCTGATTTGTATTTATT
AGACTCTCCTTTTGGATACCTAGATGTTTTAACAGAAAAAGAAATATTTGAAAGCTGTGTCTGT
AAACTGATGGCTAACAAAACTAGGATTTTGGTCACTTCTAAAATGGAACATTTAAAGAAAGCTG
ACAAAATATTAATTTTGCATGAAGGTAGCAGCTATTTTTATGGGACATTTTCAGAACTCCAAAA
TCTACAGCCAGACTTTAGCTCAAAACTCATGGGATGTGATTCTTTCGACCAATTTAGTGCAGAA
AGAAGAAATTCAATCCTAACTGAGACCTTACACCGTTTCTCATTAGAAGGAGATGCTCCTGTCT
CCTGGACAGAAACAAAAAAACAATCTTTTAAACAGACTGGAGAGTTTGGGGAAAAAAGGAAGAA
TTCTATTCTCAATCCAATCAACTCTATACGAAAATTTTCCATTGTGCAAAAGACTCCCTTACAA
ATGAATGGCATCGAAGAGGATTCTGATGAGCCTTTAGAGAGAAGGCTGTCCTTAGTACCAGATT
CTGAGCAGGGAGAGGCGATACTGCCTCGCATCAGCGTGATCAGCACTGGCCCCACGCTTCAGGC
ACGAAGGAGGCAGTCTGTCCTGAACCTGATGACACACTCAGTTAACCAAGGTCAGAACATTCAC
CGAAAGACAACAGCATCCACACGAAAAGTGTCACTGGCCCCTCAGGCAAACTTGACTGAACTGG
ATATATATTCAAGAAGGTTATCTCAAGAAACTGGCTTGGAAATAAGTGAAGAAATTAACGAAGA
AGACTTAAAGGAGTGCTTTTTTGATGATATGGAGAGCATACCAGCAGTGACTACATGGAACACA
TACCTTCGATATATTACTGTCCACAAGAGCTTAATTTTTGTGCTAATTTGGTGCTTAGTAATTT
TTCTGGCAGAGGTGGCTGCTTCTTTGGTTGTGCTGTGGCTCCTTGGAAACACTCCTCTTCAAGA
CAAAGGGAATAGTACTCATAGTAGAAATAACAGCTATGCAGTGATTATCACCAGCACCAGTTCG
TATTATGTGTTTTACATTTACGTGGGAGTAGCCGACACTTTGCTTGCTATGGGATTCTTCAGAG
GTCTACCACTGGTGCATACTCTAATCACAGTGTCGAAAATTTTACACCACAAAATGTTACATTC
TGTTCTTCAAGCACCTATGTCAACCCTCAACACGTTGAAAGCAGGTGGGATTCTTAATAGATTC
TCCAAAGATATAGCAATTTTGGATGACCTTCTGCCTCTTACCATATTTGACTTCATCCAGTTGT
TATTAATTGTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAAC
AGTGCCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTC
AAACAACTGGAATCTGAAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGAC
TATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAA
TTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAA
ATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACAACAGGAGAAGGAG
AAGGAAGAGTTGGTATTATCCTGACTTTAGCCATGAATATCATGAGTACATTGCAGTGGGCTGT
AAACTCCAGCATAGATGTGGATAGCTTGATGCGATCTGTGAGCCGAGTCTTTAAGTTCATTGAC
ATGCCAACAGAAGGTAAACCTACCAAGTCAACCAAACCATACAAGAATGGCCAACTCTCGAAAG
TTATGATTATTGAGAATTCACACGTGAAGAAAGATGACATCTGGCCCTCAGGGGGCCAAATGAC
TGTCAAAGATCTCACAGCAAAATACACAGAAGGTGGAAATGCCATATTAGAGAACATTTCCTTC
TCAATAAGTCCTGGCCAGAGGGTGGGCCTCTTGGGAAGAACTGGATCAGGGAAGAGTACTTTGT
TATCAGCTTTTTTGAGACTACTGAACACTGAAGGAGAAATCCAGATCGATGGTGTGTCTTGGGA
TTCAATAACTTTGCAACAGTGGAGGAAAGCCTTTGGAGTGATACCACAGAAAGTATTTATTTTT
TCTGGAACATTTAGAAAAAACTTGGATCCCTATGAACAGTGGAGTGATCAAGAAATATGGAAAG
TTGCAGATGAGGTTGGGCTCAGATCTGTGATAGAACAGTTTCCTGGGAAGCTTGACTTTGTCCT
TGTGGATGGGGGCTGTGTCCTAAGCCATGGCCACAAGCAGTTGATGTGCTTGGCTAGATCTGTT
CTCAGTAAGGCGAAGATCTTGCTGCTTGATGAACCCAGTGCTCATTTGGATCCAGTAACATACC
AAATAATTAGAAGAACTCTAAAACAAGCATTTGCTGATTGCACAGTAATTCTCTGTGAACACAG
GATAGAAGCAATGCTGGAATGCCAACAATTTTTGGTCATAGAAGAGAACAAAGTGCGGCAGTAC
GATTCCATCCAGAAACTGCTGAACGAGAGGAGCCTCTTCCGGCAAGCCATCAGCCCCTCCGACA
GGGTGAAGCTCTTTCCCCACCGGAACTCAAGCAAGTGCAAGTCTAAGCCCCAGATTGCTGCTCT
GAAAGAGGAGACAGAAGAAGAGGTGCAAGATACAAGGCTTTAG

In an embodiment, to insert CFTR cDNA (e.g., CFTR exons 11 to 27) into intron 10, and concomitantly introduce a silent mutation to disrupt subsequent Cas9 binding and cleavage, the homology arms, e.g., the 5′ and 3′ homology arms, may be shorted to approximately 500 bp. The 5′ homology arm is shown as bold sequence, the CRISPR-Cas9 binding site is shown as italicized sequence, the PAM site is underlined, the silent sense mutation in the PAM is shown as lower case underlined sequence, and the 3′ homology arm is shown as no emphasis capitalized sequence.

(SEQ ID NO: 27343)
GATGGTGGCTTGATCCAGGTAGTAGTGGAAGTAGTATAGTAGGAAGTGATCAGATTCAGGACAT
GCTTTGAAGGAAGATCCAATAGGATTAATGGATAAGTTGAACAATGGCATATGAGAAAAGTCAC
AGAGGAGTCAAAGATGATTCCAAGCTTTCTGGACTGAGTAACTGGAAGGATAAATGTGCCGTTT
ACTAGAAAGATAATGGGAGAAACAGGTTTTGGATGGAGCTTGGTTTGGGAATATTAAGTTTGAA
ATGCCTATTTGACATCCAAATAGAGATGTTAGTTGGATGTACAAGTCTAGTTTCAAGGAAGAGG
GGGCTGGTAGTGTGAAGATGGGGCTGGATAAGATTCTAAAGGAAAGAGGGTTGATAAGAAGAGA
AAGGGGTGTAGGGGTTAGCCTAAGGGCATTCTAAGTATTAGAGGTTAAGGAGGTGGGTGAAGAA
AACCCAATAAAATAAAAGTCTGAGAAGACAAAGCTAGTGAATGAATGTGGTATCCCttAACCCA
ACTGATGTCAAGCAGAAGGGTGTTATCAACTAGGTCAAATGCTCATTCATCAAGTAAGATGAAA
CTGTTATAATTAACCGGTGTCTTCTGAAATACGGAGATAACTCGTGACTTAATGAAAGCAATAG
TAGAGAAGGTCAAACTTGACCAGAATGAAATTAGAAAGAATAAGAGGAAAGAAAAGACCAAATA
CAGACAACCATTGATGCCTTATTCTTTTGATATACTCCTGGAGTCCACTTGCTAATACAATTGA
CCCTTAAACAATACAGGCTTGAACTGCATGGGTCCACTTATTTGTGAATTTTTTTTCAGTTAAT
ACATTGGAAAATTTTTGGGGTTTTTTGACAATTTGAAAAAACTCACAAACTGTCTAGCCTAGAA
ATACCGAGAAAATTAAGAAAAAGTAAGATATGCCATGAATGCATAAAATATATGTAGACACTAG
CCTATTTTATCATTTGCTACTATAAAATATACACAATCTA

The underlined T has been changed from a G to T at that position so that wild-type CFTR is still transcribed, but the PAM sequence CGG has been modified to CTT to reduce or eliminate Cas9 cleavage at that locus.

V.2 NHEJ Approaches for Gene Targeting

As described herein, nuclease-induced non-homologous end-joining (NHEJ) can be used to target gene-specific knockouts. Nuclease-induced NHEJ can also be used to remove (e.g., delete) sequence insertions in a gene of interest.

While not wishing to be bound by theory, it is believed that, in an embodiment, the genomic alterations associated with the methods described herein rely on nuclease-induced NHEJ and the error-prone nature of the NHEJ repair pathway. NHEJ repairs a double-strand break in the DNA by joining together the two ends; however, generally, the original sequence is restored only if two compatible ends, exactly as they were formed by the double-strand break, are perfectly ligated. The DNA ends of the double-strand break are frequently the subject of enzymatic processing, resulting in the addition or removal of nucleotides, at one or both strands, prior to rejoining of the ends. This results in the presence of insertion and/or deletion (indel) mutations in the DNA sequence at the site of the NHEJ repair. Two-thirds of these mutations typically alter the reading frame and, therefore, produce a non-functional protein. Additionally, mutations that maintain the reading frame, but which insert or delete a significant amount of sequence, can destroy functionality of the protein. This is locus dependent as mutations in critical functional domains are likely less tolerable than mutations in non-critical regions of the protein.

The indel mutations generated by NHEJ are unpredictable in nature; however, at a given break site certain indel sequences are favored and are over represented in the population, likely due to small regions of microhomology. The lengths of deletions can vary widely; most commonly in the 1-50 bp range, but they can easily reach greater than 100-200 bp. Insertions tend to be shorter and often include short duplications of the sequence immediately surrounding the break site. However, it is possible to obtain large insertions, and in these cases, the inserted sequence has often been traced to other regions of the genome or to plasmid DNA present in the cells.

Because NHEJ is a mutagenic process, it can also be used to delete small sequence motifs as long as the generation of a specific final sequence is not required. If a double-strand break is targeted near to a short target sequence, the deletion mutations caused by the NHEJ repair often span, and therefore remove, the unwanted nucleotides. For the deletion of larger DNA segments, introducing two double-strand breaks, one on each side of the sequence, can result in NHEJ between the ends with removal of the entire intervening sequence. Both of these approaches can be used to delete specific DNA sequences; however, the error-prone nature of NHEJ may still produce indel mutations at the site of repair.

Both double strand cleaving eaCas9 molecules and single strand, or nickase, eaCas9 molecules can be used in the methods and compositions described herein to generate NHEJ-mediated indels. NHEJ-mediated indels targeted to the gene, e.g., a coding region, e.g., an early coding region of a gene of interest can be used to knockout (i.e., eliminate expression of) a gene of interest. For example, early coding region of a gene of interest includes sequence immediately following a transcription start site, within a first exon of the coding sequence, or within 500 bp of the transcription start site (e.g., less than 500, 450, 400, 350, 300, 250, 200, 150, 100 or 50 bp).

Placement of Double Strand or Single Strand Breaks Relative to the Target Position

In an embodiment, in which a gRNA and Cas9 nuclease generate a double strand break for the purpose of inducing NHEJ-mediated indels, a gRNA, e.g., a unimolecular (or chimeric) or modular gRNA molecule, is configured to position one double-strand break in close proximity to a nucleotide of the target position. In an embodiment, the cleavage site is between 0-30 bp away from the target position (e.g., less than 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 bp from the target position).

In an embodiment, in which two gRNAs complexing with Cas9 nickases induce two single strand breaks for the purpose of inducing NHEJ-mediated indels, two gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to position two single-strand breaks to provide for NHEJ repair a nucleotide of the target position. In an embodiment, the gRNAs are configured to position cuts at the same position, or within a few nucleotides of one another, on different strands, essentially mimicking a double strand break. In an embodiment, the closer nick is between 0-30 bp away from the target position (e.g., less than 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 bp from the target position), and the two nicks are within 25-55 bp of each other (e.g., between 25 to 50, 25 to 45, 25 to 40, 25 to 35, 25 to 30, 50 to 55, 45 to 55, 40 to 55, 35 to 55, 30 to 55, 30 to 50, 35 to 50, 40 to 50, 45 to 50, 35 to 45, or 40 to 45 bp) and no more than 100 bp away from each other (e.g., no more than 90, 80, 70, 60, 50, 40, 30, 20 or 10 bp). In an embodiment, the gRNAs are configured to place a single strand break on either side of a nucleotide of the target position.

Both double strand cleaving eaCas9 molecules and single strand, or nickase, eaCas9 molecules can be used in the methods and compositions described herein to generate breaks both sides of a target position. Double strand or paired single strand breaks may be generated on both sides of a target position to remove the nucleic acid sequence between the two cuts (e.g., the region between the two breaks in deleted). In one embodiment, two gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to position a double-strand break on both sides of a target position. In an alternate embodiment, three gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to position a double strand break (i.e., one gRNA complexes with a cas9 nuclease) and two single strand breaks or paired single stranded breaks (i.e., two gRNAs complex with Cas9 nickases) on either side of the target position. In another embodiment, four gRNAs, e.g., independently, unimolecular (or chimeric) or modular gRNA, are configured to generate two pairs of single stranded breaks (i.e., two pairs of two gRNAs complex with Cas9 nickases) on either side of the target position. The double strand break(s) or the closer of the two single strand nicks in a pair will ideally be within 0-500 bp of the target position (e.g., no more than 450, 400, 350, 300, 250, 200, 150, 100, 50 or 25 bp from the target position). When nickases are used, the two nicks in a pair are within 25-55 bp of each other (e.g., between 25 to 50, 25 to 45, 25 to 40, 25 to 35, 25 to 30, 50 to 55, 45 to 55, 40 to 55, 35 to 55, 30 to 55, 30 to 50, 35 to 50, 40 to 50, 45 to 50, 35 to 45, or 40 to 45 bp) and no more than 100 bp away from each other (e.g., no more than 90, 80, 70, 60, 50, 40, 30, 20 or 10 bp).

V.3 Single-Strand Annealing

Single strand annealing (SSA) is another DNA repair process that repairs a double-strand break between two repeat sequences present in a target nucleic acid. Repeat sequences utilized by the SSA pathway are generally greater than 30 nucleotides in length. Resection at the break ends occurs to reveal repeat sequences on both strands of the target nucleic acid. After resection, single strand overhangs containing the repeat sequences are coated with RPA protein to prevent the repeats sequences from inappropriate annealing, e.g., to themselves. RAD52 binds to and each of the repeat sequences on the overhangs and aligns the sequences to enable the annealing of the complementary repeat sequences. After annealing, the single-strand flaps of the overhangs are cleaved. New DNA synthesis fills in any gaps, and ligation restores the DNA duplex. As a result of the processing, the DNA sequence between the two repeats is deleted. The length of the deletion can depend on many factors including the location of the two repeats utilized, and the pathway or processivity of the resection.

In contrast to HDR pathways, SSA does not require a template nucleic acid to alter or correct a target nucleic acid sequence. Instead, the complementary repeat sequence is utilized.

V.4 Other DNA Repair Pathways

SSBR (Single Strand Break Repair)

Single-stranded breaks (SSB) in the genome are repaired by the SSBR pathway, which is a distinct mechanism from the DSB repair mechanisms discussed above. The SSBR pathway has four major stages: SSB detection, DNA end processing, DNA gap filling, and DNA ligation. A more detailed explanation is given in Caldecott, Nature Reviews Genetics 9, 619-631 (August 2008), and a summary is given here.

In the first stage, when a SSB forms, PARP1 and/or PARP2 recognize the break and recruit repair machinery. The binding and activity of PARP1 at DNA breaks is transient and it seems to accelerate SSBr by promoting the focal accumulation or stability of SSBr protein complexes at the lesion. Arguably the most important of these SSBr proteins is XRCC1, which functions as a molecular scaffold that interacts with, stabilizes, and stimulates multiple enzymatic components of the SSBr process including the protein responsible for cleaning the DNA 3′ and 5′ ends. For instance, XRCC1 interacts with several proteins (DNA polymerase beta, PNK, and three nucleases, APE1, APTX, and APLF) that promote end processing. APE1 has endonuclease activity. APLF exhibits endonuclease and 3′ to 5′ exonuclease activities. APTX has endonuclease and 3′ to 5′ exonuclease activity.

This end processing is an important stage of SSBR since the 3′- and/or 5′-termini of most, if not all, SSBs are ‘damaged’. End processing generally involves restoring a damaged 3′-end to a hydroxylated state and and/or a damaged 5′ end to a phosphate moiety, so that the ends become ligation-competent. Enzymes that can process damaged 3′ termini include PNKP, APE1, and TDP1. Enzymes that can process damaged 5′ termini include PNKP, DNA polymerase beta, and APTX. LIG3 (DNA ligase III) can also participate in end processing. Once the ends are cleaned, gap filling can occur.

At the DNA gap filling stage, the proteins typically present are PARP1, DNA polymerase beta, XRCC1, FEN1 (flap endonuclease 1), DNA polymerase delta/epsilon, PCNA, and LIG1. There are two ways of gap filling, the short patch repair and the long patch repair. Short patch repair involves the insertion of a single nucleotide that is missing. At some SSBs, “gap filling” might continue displacing two or more nucleotides (displacement of up to 12 bases have been reported). FEN1 is an endonuclease that removes the displaced 5′-residues. Multiple DNA polymerases, including Pol β, are involved in the repair of SSBs, with the choice of DNA polymerase influenced by the source and type of SSB.

In the fourth stage, a DNA ligase such as LIG1 (Ligase I) or LIG3 (Ligase III) catalyzes joining of the ends. Short patch repair uses Ligase III and long patch repair uses Ligase I.

Sometimes, SSBR is replication-coupled. This pathway can involve one or more of CtIP, MRN, ERCC1, and FEN1. Additional factors that may promote SSBR include: aPARP, PARP1, PARP2, PARG, XRCC1, DNA polymerase b, DNA polymerase d, DNA polymerase e, PCNA, LIG1, PNK, PNKP, APE1, APTX, APLF, TDP1, LIG3, FEN1, CtIP, MRN, and ERCC1.

MMR (Mismatch Repair)

Cells contain three excision repair pathways: MMR, BER, and NER. The excision repair pathways hace a common feature in that they typically recognize a lesion on one strand of the DNA, then exo/endonucleaseases remove the lesion and leave a 1-30 nucleotide gap that is sub-sequentially filled in by DNA polymerase and finally sealed with ligase. A more complete picture is given in Li, Cell Research (2008) 18:85-98, and a summary is provided here.

Mismatch repair (MMR) operates on mispaired DNA bases.

The MSH2/6 or MSH2/3 complexes both have ATPases activity that plays an important role in mismatch recognition and the initiation of repair. MSH2/6 preferentially recognizes base-base mismatches and identifies mispairs of 1 or 2 nucleotides, while MSH2/3 preferentially recognizes larger ID mispairs.

hMLH1 heterodimerizes with hPMS2 to form hMutL a which possesses an ATPase activity and is important for multiple steps of MMR. It possesses a PCNA/replication factor C (RFC)-dependent endonuclease activity which plays an important role in 3′ nick-directed MMR involving EXO1. (EXO1 is a participant in both HR and MMR.) It regulates termination of mismatch-provoked excision. Ligase I is the relevant ligase for this pathway. Additional factors that may promote MMR include: EXO1, MSH2, MSH3, MSH6, MLH1, PMS2, MLH3, DNA Pol d, RPA, HMGB1, RFC, and DNA ligase I.

Base Excision Repair (BER)

The base excision repair (BER) pathway is active throughout the cell cycle; it is responsible primarily for removing small, non-helix-distorting base lesions from the genome. In contrast, the related Nucleotide Excision Repair pathway (discussed in the next section) repairs bulky helix-distorting lesions. A more detailed explanation is given in Caldecott, Nature Reviews Genetics 9, 619-631 (August 2008), and a summary is given here.

Upon DNA base damage, base excision repair (BER) is initiated and the process can be simplified into five major steps: (a) removal of the damaged DNA base; (b) incision of the subsequent a basic site; (c) clean-up of the DNA ends; (d) insertion of the correct nucleotide into the repair gap; and (e) ligation of the remaining nick in the DNA backbone. These last steps are similar to the SSBR.

In the first step, a damage-specific DNA glycosylase excises the damaged base through cleavage of the N-glycosidic bond linking the base to the sugar phosphate backbone. Then AP endonuclease-1 (APE1) or bifunctional DNA glycosylases with an associated lyase activity incised the phosphodiester backbone to create a DNA single strand break (SSB). The third step of BER involves cleaning-up of the DNA ends. The fourth step in BER is conducted by Pol R that adds a new complementary nucleotide into the repair gap and in the final step XRCC1/Ligase III seals the remaining nick in the DNA backbone. This completes the short-patch BER pathway in which the majority (80%) of damaged DNA bases are repaired. However, if the 5′-ends in step 3 are resistant to end processing activity, following one nucleotide insertion by Pol β there is then a polymerase switch to the replicative DNA polymerases, Pol δ/ε, which then add ˜2-8 more nucleotides into the DNA repair gap. This creates a 5′-flap structure, which is recognized and excised by flap endonuclease-1 (FEN-1) in association with the processivity factor proliferating cell nuclear antigen (PCNA). DNA ligase I then seals the remaining nick in the DNA backbone and completes long-patch BER. Additional factors that may promote the BER pathway include: DNA glycosylase, APE1, Polb, Pold, Pole, XRCC1, Ligase III, FEN-1, PCNA, RECQL4, WRN, MYH, PNKP, and APTX.

Nucleotide Excision Repair (NER)

Nucleotide excision repair (NER) is an important excision mechanism that removes bulky helix-distorting lesions from DNA. Additional details about NER are given in Marteijn et al., Nature Reviews Molecular Cell Biology 15, 465-481 (2014), and a summary is given here. NER a broad pathway encompassing two smaller pathways: global genomic NER (GG-NER) and transcription coupled repair NER (TC-NER). GG-NER and TC-NER use different factors for recognizing DNA damage. However, they utilize the same machinery for lesion incision, repair, and ligation.

Once damage is recognized, the cell removes a short single-stranded DNA segment that contains the lesion. Endonucleases XPF/ERCC1 and XPG (encoded by ERCC5) remove the lesion by cutting the damaged strand on either side of the lesion, resulting in a single-strand gap of 22-30 nucleotides. Next, the cell performs DNA gap filling synthesis and ligation. Involved in this process are: PCNA, RFC, DNA Pol δ, DNA Pol ε or DNA Pol κ, and DNA ligase I or XRCC1/Ligase III. Replicating cells tend to use DNA pol ε and DNA ligase I, while non-replicating cells tend to use DNA Pol δ, DNA Pol κ, and the XRCC1/Ligase III complex to perform the ligation step.

NER can involve the following factors: XPA-G, POLH, XPF, ERCC1, XPA-G, and LIG1. Transcription-coupled NER (TC-NER) can involve the following factors: CSA, CSB, XPB, XPD, XPG, ERCC1, and TTDA. Additional factors that may promote the NER repair pathway include XPA-G, POLH, XPF, ERCC1, XPA-G, LIG1, CSA, CSB, XPA, XPB, XPC, XPD, XPF, XPG, TTDA, UVSSA, USP7, CETN2, RAD23B, UV-DDB, CAK subcomplex, RPA, and PCNA.

Interstrand Crosslink (ICL)

A dedicated pathway called the ICL repair pathway repairs interstrand crosslinks. Interstrand crosslinks, or covalent crosslinks between bases in different DNA strand, can occur during replication or transcription. ICL repair involves the coordination of multiple repair processes, in particular, nucleolytic activity, translesion synthesis (TLS), and HDR. Nucleases are recruited to excise the ICL on either side of the crosslinked bases, while TLS and HDR are coordinated to repair the cut strands. ICL repair can involve the following factors: endonucleases, e.g., XPF and RAD51C, endonucleases such as RAD51, translesion polymerases, e.g., DNA polymerase zeta and Rev1), and the Fanconi anemia (FA) proteins, e.g., FancJ.

Other Pathways

Several other DNA repair pathways exist in mammals.

Translesion synthesis (TLS) is a pathway for repairing a single stranded break left after a defective replication event and involves translesion polymerases, e.g., DNA pol□ and Rev1.

Error-free postreplication repair (PRR) is another pathway for repairing a single stranded break left after a defective replication event.

V.5 Targeted Knockdown

Unlike CRISPR/Cas-mediated gene knockout, which permanently eliminates expression by mutating the gene at the DNA level, CRISPR/Cas knockdown allows for temporary reduction of gene expression through the use of artificial transcription factors. Mutating key residues in both DNA cleavage domains of the Cas9 protein (e.g. the D10A and H840A mutations) results in the generation of a catalytically inactive Cas9 (eiCas9 which is also known as dead Cas9 or dCas9) molecule. A catalytically inactive Cas9 complexes with a gRNA and localizes to the DNA sequence specified by that gRNA's targeting domain, however, it does not cleave the target DNA. Fusion of the dCas9 to an effector domain, e.g., a transcription repression domain, enables recruitment of the effector to any DNA site specified by the gRNA. Although an enzymatically inactive (eiCas9) Cas9 molecule itself can block transcription when recruited to early regions in the coding sequence, more robust repression can be achieved by fusing a transcriptional repression domain (for example KRAB, SID or ERD) to the Cas9 and recruiting it to the target knockdown position, e.g., within 1000 bp of sequence 3′ of the start codon or within 500 bp of a promoter region 5′ of the start codon of a gene. It is likely that targeting DNAseI hypersensitive sites (DHSs) of the promoter may yield more efficient gene repression or activation because these regions are more likely to be accessible to the Cas9 protein and are also more likely to harbor sites for endogenous transcription factors. Especially for gene repression, it is contemplated herein that blocking the binding site of an endogenous transcription factor would aid in downregulating gene expression. In an embodiment, one or more eiCas9 molecules may be used to block binding of one or more endogenous transcription factors. In another embodiment, an eiCas9 molecule can be fused to a chromatin modifying protein. Altering chromatin status can result in decreased expression of the target gene. One or more eiCas9 molecules fused to one or more chromatin modifying proteins may be used to alter chromatin status.

In an embodiment, a gRNA molecule can be targeted to a known transcription response elements (e.g., promoters, enhancers, etc.), a known upstream activating sequences (UAS), and/or sequences of unknown or known function that are suspected of being able to control expression of the target DNA.

CRISPR/Cas-mediated gene knockdown can be used to reduce expression of an unwanted allele or transcript. Contemplated herein are scenarios wherein permanent destruction of the gene is not ideal. In these scenarios, site-specific repression may be used to temporarily reduce or eliminate expression. It is also contemplated herein that the off-target effects of a Cas-repressor may be less severe than those of a Cas-nuclease as a nuclease can cleave any DNA sequence and cause mutations whereas a Cas-repressor may only have an effect if it targets the promoter region of an actively transcribed gene. However, while nuclease-mediated knockout is permanent, repression may only persist as long as the Cas-repressor is present in the cells. Once the repressor is no longer present, it is likely that endogenous transcription factors and gene regulatory elements would restore expression to its natural state.

V.6 Examples of gRNAs in Genome Editing Methods

gRNA molecules as described herein can be used with Cas9 molecules that generate a double strand break or a single strand break to alter the sequence of a target nucleic acid, e.g., a target position or target genetic signature. gRNA molecules useful in these methods are described below.

In an embodiment, the gRNA, e.g., a chimeric gRNA, is configured such that it comprises one or more of the following properties;

• • a) it can position, e.g., when targeting a Cas9 molecule that makes double strand breaks, a double strand break (i) within 50, 100, 150 or 200 nucleotides of a target position, or (ii) sufficiently close that the target position is within the region of end resection;
  • b) it has a targeting domain of at least 17 nucleotides, e.g., a targeting domain of (i) 17, (ii) 18, or (iii) 20 nucleotides; and
  • c)
    • (i) the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides, e.g., at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides from a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail and proximal domain, or a sequence that differs by no more than 1, 2, 3, 4, 5; 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (ii) there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain, e.g., at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides from the corresponding sequence of a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis gRNA, or a sequence that differs by no more than 1, 2, 3, 4, 5; 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (iii) there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain, e.g., at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides from the corresponding sequence of a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis gRNA, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (iv) the tail domain is at least 10, 15, 20, 25, 30, 35 or 40 nucleotides in length, e.g., it comprises at least 10, 15, 20, 25, 30, 35 or 40 nucleotides from a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail domain; or, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom; or
    • (v) the tail domain comprises 15, 20, 25, 30, 35, 40 nucleotides or all of the corresponding portions of a naturally occurring tail domain, e.g., a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail domain.

In an embodiment, the gRNA is configured such that it comprises properties: a and b(i).

In an embodiment, the gRNA is configured such that it comprises properties: a and b(ii).

In an embodiment, the gRNA is configured such that it comprises properties: a and b(iii).

In an embodiment, the gRNA is configured such that it comprises properties: a and c.

In an embodiment, the gRNA is configured such that in comprises properties: a, b, and c.

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(i), and c(i).

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(i), and c(ii).

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(iii), and c(i).

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(iii), and c(ii).

In an embodiment, the gRNA, e.g., a chimeric gRNA, is configured such that it comprises one or more of the following properties;

• • a) it can position, e.g., when targeting a Cas9 molecule that makes single strand breaks, a single strand break (i) within 50, 100, 150 or 200 nucleotides of a target position, or (ii) sufficiently close that the target position is within the region of end resection;
  • b) it has a targeting domain of at least 17 nucleotides, e.g., a targeting domain of (i) 17, (ii) 18, or (iii) 20 nucleotides; and
  • c)
    • (i) the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides, e.g., at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides from a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail and proximal domain, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (ii) there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain, e.g., at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides from the corresponding sequence of a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis gRNA, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (iii) there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain, e.g., at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides from the corresponding sequence of a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis gRNA, or a sequence that differs by no more than 1, 2, 3, 4, 5; 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (iv) the tail domain is at least 10, 15, 20, 25, 30, 35 or 40 nucleotides in length, e.g., it comprises at least 10, 15, 20, 25, 30, 35 or 40 nucleotides from a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail domain; or, a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom; or
    • (v) the tail domain comprises 15, 20, 25, 30, 35, 40 nucleotides or all of the corresponding portions of a naturally occurring tail domain, e.g., a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail domain.

In an embodiment, the gRNA is configured such that it comprises properties: a and b(i).

In an embodiment, the gRNA is configured such that it comprises properties: a and b(ii).

In an embodiment, the gRNA is configured such that it comprises properties: a and b(iii).

In an embodiment, the gRNA is configured such that it comprises properties: a and c.

In an embodiment, the gRNA is configured such that in comprises properties: a, b, and c.

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(i), and c(i).

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(i), and c(ii).

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(iii), and c(i).

In an embodiment, the gRNA is configured such that in comprises properties: a(i), b(iii), and c(ii).

In an embodiment, the gRNA is used with a Cas9 nickase molecule having HNH activity, e.g., a Cas9 molecule having the RuvC activity inactivated, e.g., a Cas9 molecule having a mutation at D10, e.g., the D10A mutation.

In an embodiment, the gRNA is used with a Cas9 nickase molecule having RuvC activity, e.g., a Cas9 molecule having the HNH activity inactivated, e.g., a Cas9 molecule having a mutation at H840, e.g., a H840A.

In an embodiment, the gRNAs are used with a Cas9 nickase molecule having RuvC activity, e.g., a Cas9 molecule having the HNH activity inactivated, e.g., a Cas9 molecule having a mutation at N863, e.g., an N863A mutation.

In an embodiment, a pair of gRNAs, e.g., a pair of chimeric gRNAs, comprising a first and a second gRNA, is configured such that they comprises one or more of the following properties;

• • a) one or both of the gRNAs can position, e.g., when targeting a Cas9 molecule that makes single strand breaks, a single strand break within (i) 50, 100, 150 or 200 nucleotides of a target position, or (ii) sufficiently close that the target position is within the region of end resection;
  • b) one or both have a targeting domain of at least 17 nucleotides, e.g., a targeting domain of (i) 17 or (ii) 18 nucleotides;
  • c) for one or both:
    • (i) the proximal and tail domain, when taken together, comprise at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides, e.g., at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides from a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail and proximal domain, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (ii) there are at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides 3′ to the last nucleotide of the second complementarity domain, e.g., at least 15, 18, 20, 25, 30, 31, 35, 40, 45, 49, 50, or 53 nucleotides from the corresponding sequence of a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis gRNA, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (iii) there are at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides 3′ to the last nucleotide of the second complementarity domain that is complementary to its corresponding nucleotide of the first complementarity domain, e.g., at least 16, 19, 21, 26, 31, 32, 36, 41, 46, 50, 51, or 54 nucleotides from the corresponding sequence of a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis gRNA, or a sequence that differs by no more than 1, 2, 3, 4, 5; 6, 7, 8, 9 or 10 nucleotides therefrom;
    • (iv) the tail domain is at least 10, 15, 20, 25, 30, 35 or 40 nucleotides in length, e.g., it comprises at least 10, 15, 20, 25, 30, 35 or 40 nucleotides from a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail domain; or, or a sequence that differs by no more than 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 nucleotides therefrom; or
    • (v) the tail domain comprises 15, 20, 25, 30, 35, 40 nucleotides or all of the corresponding portions of a naturally occurring tail domain, e.g., a naturally occurring S. pyogenes, S. thermophilus, S. aureus, or N. meningitidis tail domain;
  • d) the gRNAs are configured such that, when hybridized to target nucleic acid, they are separated by 0-50, 0-100, 0-200, at least 10, at least 20, at least 30 or at least 50 nucleotides;
  • e) the breaks made by the first gRNA and second gRNA are on different strands; and
  • f) the PAMs are facing outwards.

In an embodiment, one or both of the gRNAs is configured such that it comprises properties: a and b(i).

In an embodiment, one or both of the gRNAs is configured such that it comprises properties: a and b(ii).

In an embodiment, one or both of the gRNAs is configured such that it comprises properties: a and b(iii).

In an embodiment, one or both of the gRNAs configured such that it comprises properties: a and c.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a, b, and c.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(i), and c(i).

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(i), and c(ii).

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(i), c, and d.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(i), c, and e.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(i), c, d, and e.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(iii), and c(i).

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(iii), and c(ii).

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(iii), c, and d.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(iii), c, and e.

In an embodiment, one or both of the gRNAs is configured such that in comprises properties: a(i), b(iii), c, d, and e.

In an embodiment, the gRNAs are used with a Cas9 nickase molecule having HNH activity, e.g., a Cas9 molecule having the RuvC activity inactivated, e.g., a Cas9 molecule having a mutation at D10, e.g., the D10A mutation.

In an embodiment, the gRNAs are used with a Cas9 nickase molecule having RuvC activity, e.g., a Cas9 molecule having the HNH activity inactivated, e.g., a Cas9 molecule having a mutation at H840, e.g., a H840A.

In an embodiment, the gRNAs are used with a Cas9 nickase molecule having RuvC activity, e.g., a Cas9 molecule having the HNH activity inactivated, e.g., a Cas9 molecule having a mutation at N863, e.g., a N863A mutation.

VI. Target Cells

Cas9 molecules, gRNA molecules (e.g., a Cas9 molecule/gRNA molecule complex), and donor nucleic acids can be used to manipulate a cell, e.g., to edit a target nucleic acid, in a wide variety of cells.

In an embodiment, a cell is manipulated by editing (e.g., correcting or introducing a mutation in) the CFTR and/or SCNN1A target genes, e.g., as described herein. In an embodiment, the expression of the CFTR and/or SCNN1A target genes is modulated, e.g., in vivo.

In another embodiment, the expression of the CFTR and/or SCNN1A target genes is modulated, e.g., ex vivo.

The Cas9 and gRNA molecules described herein can be delivered to a target cell. Methods and compositions discussed herein, provide for treating or delaying the onset or progression of diseases of the lung and airways, including the nose, trachea, bronchus, bronchioles, alveoli, submucosal ducts and submucosal glands. In an embodiment, the target cell is an airway cell, e.g., a nasal epithelial cell, e.g., a tracheal epithelial cell. In an embodiment, the target cell is a lung epithelial cell, e.g., a bronchial epithelial cell, e.g., a proximal bronchial epithelial cell, e.g., a bronchiolar epithelial cell, e.g., an alveolar epithelial cell, e.g., a clara cell, e.g., a ciliated cell, e.g., a goblet cell, e.g., a basal cell, e.g., an acinus cell. Methods and compositions discussed herein, provide for treating or delaying the onset or progression of diseases of the gastrointestinal tract, including pancreas, bile ducts, gallbladder, small intestine, large intestine and salivary glands. In an embodiment, the target cell is a gastrointestinal epithelial cell. In an embodiment, the target cell is a biliary epithelial cell. In an embodiment, the target cell is a pancreatic ductal epithelial cell. In an embodiment, the target cell is a gastrointestinal cell, e.g., an enteroendocrine cell, e.g., a Brunner's gland cell. In an embodiment, the target cell is a hepatobiliary epithelial cell. In an embodiment, the target cell is a gallbladder epithelial cell. In an embodiment, the target cell is a large intestine epithelial cell. In an embodiment, the target cell is a small intestine epithelial cell. In an embodiment, the target cell is a jejunum epithelial cell. In an embodiment, the target cell is an epithelial cell of the iluem. In an embodiment, the target cell is a duodenum epithelial cell. Methods and compositions discussed herein, provide for treating or delaying the onset or progression of diseases of the reproductive tract, including the epididymis. In an embodiment, the target cell is a reproductive epithelial cell, e.g. an epididymal epithelial cell. In an embodiment, the target cell is a pulmonary stem cell. In an embodiment, the target cell is a gastrointestinal stem cell.

In an embodiment, the target cell is manipulated ex vivo by editing (e.g., correcting or introducing a mutation in) the CFTR and/or SCNN1A target genes and/or modulating the expression of the CFTR and/or SCNN1A target genes, and administered to the subject. A suitable cell for such manipulation can include a stem cell such as, by way of example, an embryonic stem cell, an induced pluripotent stem cell, a pulmonary stem cell, a gastrointestinal stem cell and a mesenchymal stem cell. In an embodiment, the cell is an induced pluripotent stem cell (iPS) cell or a cell derived from an iPS cell, e.g., an iPS cell generated from the subject, modified to correct or introduce the mutation and differentiated into a clinically relevant cell such as a pulmonary stem cell, a gastrointestinal stem cell, a pulmonary epithelial cell, a bronchial epithelial cell, a proximal bronchial epithelial cell, a bronchiolar epithelial cell, an alveolar epithelial cell, a clara cell, a ciliated cell, a goblet cell, a basal cell, an acinus cell, a gastrointestinal epithelial cell, a biliary epithelial cell, a pancreatic ductal epithelial cell, a hepatobiliary epithelial cell, an enteroendocrine cell, a Brunner's gland cell, a reproductive epithelial cell, or an epididymal epithelial cell.

VII. Delivery, Formulations and Routes of Administration

The components, e.g., a Cas9 molecule and gRNA molecule (e.g., a Cas9 molecule/gRNA molecule complex), and a donor template nucleic acid can be delivered or formulated in a variety of forms, see, e.g., Tables 56-57. In an embodiment, one Cas9 molecule and two or more (e.g., 2, 3, 4, or more) different gRNA molecules are delivered, e.g., by an AAV vector. In an embodiment, the sequence encoding the Cas9 molecule and the sequence(s) encoding the two or more (e.g., 2, 3, 4, or more) different gRNA molecules are present on the same nucleic acid molecule, e.g., an AAV vector. When a Cas9 or gRNA component is encoded as DNA for delivery, the DNA will typically but not necessarily include a control region, e.g., comprising a promoter, to effect expression. Useful promoters for Cas9 molecule sequences include CMV, EFS, EF-1a, MSCV, PGK, CAG control promoters. In an embodiment, the promoter is a constitutive promoter. In another embodiment, the promoter is a tissue specific promoter. Useful promoters for gRNAs include H1, 7SK, tRNA and U6 promoters. Promoters with similar or dissimilar strengths can be selected to tune the expression of components. Sequences encoding a Cas9 molecule can comprise a nuclear localization signal (NLS), e.g., an SV40 NLS. In an embodiment, the sequence encoding a Cas9 molecule comprises at least two nuclear localization signals. In an embodiment a promoter for a Cas9 molecule or a gRNA molecule can be, independently, inducible, tissue specific, or cell specific.

Table 56 provides examples of how the components can be formulated, delivered, or administered.

TABLE 56
Elements
		Donor
Cas9	gRNA	Template
Molecule(s)	Molecule(s)	Nucleic Acid	Comments
DNA	DNA	DNA	In this embodiment, a
			Cas9 molecule, typically
			an eaCas9 molecule,
			and a gRNA are
			transcribed from DNA.
			In this embodiment,
			they are encoded on
			separate molecules. In this
			embodiment, the donor
			template is provided as
			a separate DNA molecule.
DNA	DNA	In this embodiment, a Cas9
		molecule, typically
		an eaCas9 molecule,
		and a gRNA are
		transcribed from DNA.
		In this embodiment,
		they are encoded on
		separate molecules. In this
		embodiment, the donor
		template is provided on
		the same DNA molecule
		that encodes the gRNA.
DNA	DNA	In this embodiment, a Cas9
		molecule, typically
		an eaCas9 molecule,
		and a gRNA are
		transcribed from DNA,
		here from a single
		molecule. In this
		embodiment, the donor
		template is provided
		as a separate DNA
		molecule.
DNA	DNA	DNA	In this embodiment, a
			Cas9 molecule, typically
			an eaCas9 molecule,
			and a gRNA are
			transcribed from DNA.
			In this embodiment,
			they are encoded on
			separate molecules. In this
			embodiment, the donor
			template is provided on
			the same DNA molecule
			that encodes the Cas9.
DNA	RNA	DNA	In this embodiment,
			a Cas9 molecule, typically
			an eaCas9 molecule, is
			transcribed from DNA,
			and a gRNA is provided
			as in vitro transcribed
			or synthesized RNA.
			In this embodiment, the
			donor template is provided
			as a separate DNA
			molecule.
DNA	RNA	DNA	In this embodiment, a
			Cas9 molecule, typically
			an eaCas9 molecule, is
			transcribed from DNA,
			and a gRNA is provided
			as in vitro transcribed
			or synthesized RNA.
			In this embodiment, the
			donor template is provided
			on the same DNA
			molecule that
			encodes the Cas9.
mRNA	RNA	DNA	In this embodiment, a
			Cas9 molecule, typically
			an eaCas9 molecule,
			is translated from in vitro
			transcribed mRNA, and
			a gRNA is provided as
			in vitro transcribed or
			synthesized RNA. In this
			embodiment, the donor
			template is provided as
			a DNA molecule.
mRNA	DNA	DNA	In this embodiment, a
			Cas9 molecule, typically
			an eaCas9 molecule,
			is translated from in vitro
			transcribed mRNA, and
			a gRNA is transcribed
			from DNA. In this
			embodiment, the donor
			template is provided
			as a separate DNA
			molecule.
mRNA	DNA	In this embodiment, a
		Cas9 molecule, typically
		an eaCas9 molecule,
		is translated from in vitro
		transcribed mRNA, and
		a gRNA is transcribed
		from DNA. In this
		embodiment, the donor
		template is provided
		on the same DNA
		molecule that
		encodes the gRNA.
Protein	DNA	DNA	In this embodiment, a
			Cas9 molecule, typically
			an eaCas9 molecule,
			is provided as a protein,
			and a gRNA is transcribed
			from DNA. In this
			embodiment, the donor
			template is provided as
			a separate DNA molecule.
Protein	DNA	In this embodiment, a
		Cas9 molecule, typically
		an eaCas9 molecule,
		is provided as a protein,
		and a gRNA is transcribed
		from DNA. In this
		embodiment, the donor
		template is provided on
		the same DNA molecule
		that encodes the gRNA.
Protein	RNA	DNA	In this embodiment, an
			eaCas9 molecule is
			provided as a protein,
			and a gRNA is provided
			as transcribed or
			synthesized RNA. In this
			embodiment, the donor
			template is provided as
			a DNA molecule.

Table 57 summarizes various delivery methods for the components of a Cas system, e.g., the Cas9 molecule component and the gRNA molecule component, as described herein.

TABLE 57
	Delivery
	into Non-	Duration		Type of
Delivery	Dividing	of	Genome	Molecule
Vector/Mode	Cells	Expression	Integration	Delivered
Physical (eg,	YES	Transient	NO	Nucleic
electroporation,				Acids
particle gun, Calcium				and
Phosphate transfection,				Proteins
cell compression
or squeezing))
Viral	Retrovirus	NO	Stable	YES	RNA
	Lentivirus	YES	Stable	YES/NO with	RNA
				modifications
	Adenovirus	YES	Transient	NO	DNA
	Adeno-	YES	Stable	NO	DNA
	Associated
	Virus (AAV)
	Vaccinia	YES	Very	NO	DNA
	Virus		Transient
	Herpes	YES	Stable	NO	DNA
	Simplex
	Virus
Non-Viral	Cationic	YES	Transient	Depends on	Nucleic
	Liposomes			what is	Acids
				delivered	and
					Proteins
	Polymeric	YES	Transient	Depends on	Nucleic
	Nanoparticles			what is	Acids
				delivered	and
					Proteins
Biological	Attenuated	YES	Transient	NO	Nucleic
Non-Viral	Bacteria				Acids
Delivery	Engineered	YES	Transient	NO	Nucleic
Vehicles	Bacterio-				Acids
	phages
	Mammalian	YES	Transient	NO	Nucleic
	Virus-like				Acids
	Particles
	Biological	YES	Transient	NO	Nucleic
	liposomes:				Acids
	Erythrocyte
	Ghosts and
	Exosomes

DNA-Based Delivery of a Cas9 Molecule and/or One or More gRNA Molecule

Nucleic acids encoding Cas9 molecules (e.g., eaCas9 molecules), gRNA molecules, a donor template nucleic acid, or a combination thereof, can be administered to subjects or delivered into cells by art-known methods or as described herein. For example, Cas9-encoding and/or gRNA-encoding DNA, as well as donor nucleic acids can be delivered, e.g., by vectors (e.g., viral or non-viral vectors), non-vector based methods (e.g., using naked DNA or DNA complexes), or a combination thereof.

DNA encoding Cas9 molecules (e.g., eaCas9 molecules) and/or gRNA molecules, as well as template nucleic acids, can be conjugated to molecules (e.g., N-acetylgalactosamine), thereby promoting uptake by the target cells (e.g., the target cells described herein).

In some embodiments, the Cas9- and/or gRNA-encoding DNA is delivered by a vector (e.g., viral vector/virus or plasmid). In some embodiments the donor nucleic acid is delivered by a vector (e.g., a viral vector/virus or plasmid).

A vector can comprise a sequence that encodes a Cas9 molecule and/or a gRNA molecule. A vector can comprise a donor nucleic acid. A vector can also comprise a sequence encoding a signal peptide (e.g., for nuclear localization, nucleolar localization, mitochondrial localization), fused, e.g., to a Cas9 molecule sequence. For example, ae vector can comprise a nuclear localization sequence (e.g., from SV40) fused to the sequence encoding the Cas9 molecule.

One or more regulatory/control elements, e.g., a promoter, an enhancer, an intron, a polyadenylation signal, a Kozak consensus sequence, internal ribosome entry sites (IRES), a 2A sequence, and splice acceptor or donor can be included in the vectors. In some embodiments, the promoter is recognized by RNA polymerase II (e.g., a CMV promoter). In other embodiments, the promoter is recognized by RNA polymerase III (e.g., a U6 promoter). In some embodiments, the promoter is a regulated promoter (e.g., inducible promoter). In other embodiments, the promoter is a constitutive promoter. In some embodiments, the promoter is a tissue specific promoter. In some embodiments, the promoter is a viral promoter. In other embodiments, the promoter is a non-viral promoter.

In some embodiments, the vector or delivery vehicle is a viral vector (e.g., for generation of recombinant viruses). In some embodiments, the virus is a DNA virus (e.g., dsDNA or ssDNA virus). In other embodiments, the virus is an RNA virus (e.g., an ssRNA virus). Exemplary viral vectors/viruses include, e.g., retroviruses, lentiviruses, adenovirus, adeno-associated virus (AAV), vaccinia viruses, poxviruses, and herpes simplex viruses.

In some embodiments, the virus infects dividing cells. In other embodiments, the virus infects non-dividing cells. In some embodiments, the virus infects both dividing and non-dividing cells. In some embodiments, the virus can integrate into the host genome. In some embodiments, the virus is engineered to have reduced immunity, e.g., in human. In some embodiments, the virus is replication-competent. In other embodiments, the virus is replication-defective, e.g., having one or more coding regions for the genes necessary for additional rounds of virion replication and/or packaging replaced with other genes or deleted. In some embodiments, the virus causes transient expression of the Cas9 molecule and/or the gRNA molecule. In other embodiments, the virus causes long-lasting, e.g., at least 1 week, 2 weeks, 1 month, 2 months, 3 months, 6 months, 9 months, 1 year, 2 years, or permanent expression, of the Cas9 molecule and/or the gRNA molecule. The packaging capacity of the viruses may vary, e.g., from at least about 4 kb to at least about 30 kb, e.g., at least about 5 kb, 10 kb, 15 kb, 20 kb, 25 kb, 30 kb, 35 kb, 40 kb, 45 kb, or 50 kb.

In an embodiment, the viral vector recognizes a specific cell type or tissue. For example, the viral vector can be pseudotyped with a different/alternative viral envelope glycoprotein; engineered with a cell type-specific receptor (e.g., genetic modification(s) of one or more viral envelope glycoproteins to incorporate a targeting ligand such as a peptide ligand, a single chain antibody, or a growth factor); and/or engineered to have a molecular bridge with dual specificities with one end recognizing a viral glycoprotein and the other end recognizing a moiety of the target cell surface (e.g., a ligand-receptor, monoclonal antibody, avidin-biotin and chemical conjugation).

Exemplary viral vectors/viruses include, e.g., retroviruses, lentiviruses, adenovirus, adeno-associated virus (AAV), vaccinia viruses, poxviruses, and herpes simplex viruses.

In some embodiments, the Cas9- and/or gRNA-encoding sequence is delivered by a recombinant retrovirus. In some embodiments, the donor nucleic acid is delivered by a recombinant retrovirus. In some embodiments, the retrovirus (e.g., Moloney murine leukemia virus) comprises a reverse transcriptase, e.g., that allows integration into the host genome. In some embodiments, the retrovirus is replication-competent. In other embodiments, the retrovirus is replication-defective, e.g., having one of more coding regions for the genes necessary for additional rounds of virion replication and packaging replaced with other genes, or deleted.

In some embodiments, the Cas9- and/or gRNA-encoding sequence is delivered by a recombinant lentivirus. In some embodiments, the donor nucleic acid is delivered by a recombinant lentivirus. For example, the lentivirus is replication-defective, e.g., does not comprise one or more genes required for viral replication.

In some embodiments, the Cas9- and/or gRNA-encoding sequence is delivered by a recombinant adenovirus. In some embodiments, the donor nucleic acid is delivered by a recombinant adenoviru. In some embodiments, the adenovirus is engineered to have reduced immunity in human.

In some embodiments, the Cas9- and/or gRNA-encoding DNA is delivered by a recombinant AAV. In some embodiments, the AAV does not incorporate its genome into that of a host cell, e.g., a target cell as describe herein. In some embodiments, the AAV can incorporate at least part of its genome into that of a host cell, e.g., a target cell as described herein. In some embodiments, the AAV is a self-complementary adeno-associated virus (scAAV), e.g., a scAAV that packages both strands which anneal together to form double stranded DNA. AAV serotypes that may be used in the disclosed methods, include AAV1, AAV2, modified AAV2 (e.g., modifications at Y444F, Y500F, Y730F and/or S662V), AAV3, modified AAV3 (e.g., modifications at Y705F, Y731F and/or T492V), AAV4, AAV5, AAV6, modified AAV6 (e.g., modifications at S663V and/or T492V), AAV8, AAV 8.2, AAV9, AAV rh 10, and pseudotyped AAV, such as AAV2/8, AAV2/5 and AAV2/6 can also be used in the disclosed methods. In an embodiment, an AAV capsid that can be used in the methods described herein is a capsid sequence from serotype AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAV.rh8, AAV.rh10, AAV.rh32/33, AAV.rh43, AAV.rh64R1, or AAV7m8.

In an embodiment, the Cas9- and/or gRNA-encoding DNA is delivered in a re-engineered AAV capsid, e.g., with 50% or greater, e.g., 60% or greater, 70% or greater, 80% or greater, 90% or greater, or 95% or greater, sequence homology with a capsid sequence from serotypes AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAV.rh8, AAV.rh10, AAV.rh32/33, AAV.rh43, or AAV.rh64R1.

In an embodiment, the Cas9- and/or gRNA-encoding DNA is delivered by a chimeric AAV capsid. In an embodiment, the donor nucleic acid is delivered by a chimeric AAV capsid. Exemplary chimeric AAV capsids include, but are not limited to, AAV9i1, AAV2i8, AAV-DJ, AAV2G9, AAV2i8G9, or AAV8G9.

In an embodiment, the AAV is a self-complementary adeno-associated virus (scAAV), e.g., a scAAV that packages both strands which anneal together to form double stranded DNA.

In some embodiments, the Cas9- and/or gRNA-encoding DNA is delivered by a hybrid virus, e.g., a hybrid of one or more of the viruses described herein. In an embodiment, the hybrid virus is hybrid of an AAV (e.g., of any AAV serotype), with a Bocavirus, B19 virus, porcine AAV, goose AAV, feline AAV, canine AAV, or MVM.

A Packaging cell is used to form a virus particle that is capable of infecting a target cell. Such a cell includes a 293 cell, which can package adenovirus, and a W2 cell or a PA317 cell, which can package retrovirus. A viral vector used in gene therapy is usually generated by a producer cell line that packages a nucleic acid vector into a viral particle. The vector typically contains the minimal viral sequences required for packaging and subsequent integration into a host or target cell (if applicable), with other viral sequences being replaced by an expression cassette encoding the protein to be expressed, eg. Cas9. For example, an AAV vector used in gene therapy typically only possesses inverted terminal repeat (ITR) sequences from the AAV genome which are required for packaging and gene expression in the host or target cell. The missing viral functions can be supplied in trans by the packaging cell line and/or plasmid containing E2A, E4, and VA genes from adenovirus, and plasmid encoding Rep and Cap genes from AAV, as described in “Triple Transfection Protocol.” Henceforth, the viral DNA is packaged in a cell line, which contains a helper plasmid encoding the other AAV genes, namely rep and cap, but lacking ITR sequences. In embodiment, the viral DNA is packaged in a producer cell line, which contains E1A and/or E1B genes from adenovirus. The cell line is also infected with adenovirus as a helper. The helper virus (e.g., adenovirus or HSV) or helper plasmid promotes replication of the AAV vector and expression of AAV genes from the helper plasmid with ITRs. The helper plasmid is not packaged in significant amounts due to a lack of ITR sequences. Contamination with adenovirus can be reduced by, e.g., heat treatment to which adenovirus is more sensitive than AAV.

In an embodiment, the viral vector has the ability of cell type and/or tissue type recognition. For example, the viral vector can be pseudotyped with a different/alternative viral envelope glycoprotein; engineered with a cell type-specific receptor (e.g., genetic modification of the viral envelope glycoproteins to incorporate targeting ligands such as a peptide ligand, a single chain antibodie, a growth factor); and/or engineered to have a molecular bridge with dual specificities with one end recognizing a viral glycoprotein and the other end recognizing a moiety of the target cell surface (e.g., ligand-receptor, monoclonal antibody, avidin-biotin and chemical conjugation).

In an embodiment, the viral vector achieves cell type specific expression. For example, a tissue-specific promoter can be constructed to restrict expression of the transgene (Cas 9 and gRNA) in only the target cell. The specificity of the vector can also be mediated by microRNA-dependent control of transgene expression. In an embodiment, the viral vector has increased efficiency of fusion of the viral vector and a target cell membrane. For example, a fusion protein such as fusion-competent hemagglutin (HA) can be incorporated to increase viral uptake into cells. In an embodiment, the viral vector has the ability of nuclear localization. For example, aviruse that requires the breakdown of the nuclear envelope (during cell division) and therefore will not infect a non-diving cell can be altered to incorporate a nuclear localization peptide in the matrix protein of the virus thereby enabling the transduction of non-proliferating cells.

In some embodiments, the Cas9- and/or gRNA-encoding DNA is delivered by a non-vector based method (e.g., using naked DNA or DNA complexes). For example, the DNA can be delivered, e.g., by organically modified silica or silicate (Ormosil), electroporation, transient cell compression or squeezing (e.g., as described in Lee, et al [2012] Nano Lett 12: 6322-27), gene gun, sonoporation, magnetofection, lipid-mediated transfection, dendrimers, inorganic nanoparticles, calcium phosphates, or a combination thereof.

In an embodiment, delivery via electroporation comprises mixing the cells with the Cas9- and/or gRNA-encoding DNA in a cartridge, chamber or cuvette and applying one or more electrical impulses of defined duration and amplitude. In an embodiment, delivery via electroporation is performed using a system in which cells are mixed with the Cas9- and/or gRNA-encoding DNA in a vessel connected to a device (eg, a pump) which feeds the mixture into a cartridge, chamber or cuvette wherein one or more electrical impulses of defined duration and amplitude are applied, after which the cells are delivered to a second vessel.

In some embodiments, the Cas9- and/or gRNA-encoding DNA is delivered by a combination of a vector and a non-vector based method. In some embodiments, the donor nucleic acid is delivered by a combination of a vector and a non-vector based method. For example, a virosome comprises a liposome combined with an inactivated virus (e.g., HIV or influenza virus), which can result in more efficient gene transfer, e.g., in a respiratory epithelial cell than either a viral or a liposomal method alone.

In an embodiment, the delivery vehicle is a non-viral vector. In an embodiment, the non-viral vector is an inorganic nanoparticle. Exemplary inorganic nanoparticles include, e.g., magnetic nanoparticles (e.g., Fe₃MnO₂) or silica. The outer surface of the nanoparticle can be conjugated with a positively charged polymer (e.g., polyethylenimine, polylysine, polyserine) which allows for attachment (e.g., conjugation or entrapment) of payload. In an embodiment, the non-viral vector is an organic nanoparticle. Exemplary organic nanoparticles include, e.g., SNALP liposomes (e.g., SNALP liposomes that contain cationic lipids together with neutral helper lipids and polyethylene glycol (PEG)-conjugated lipids) and protamine-nucleic acid complexes, e.g., protamine-nucleic acid complexes coated with lipid coating.

Exemplary lipids for gene transfer are shown below in Table 58.

TABLE 58
Lipids Used for Gene Transfer
Lipid	Abbreviation	Feature
1,2-Dioleoyl-sn-glycero-3-phosphatidylcholine	DOPC	Helper
1,2-Dioleoyl-sn-glycero-3-phosphatidyl-	DOPE	Helper
ethanolamine Cholesterol		Helper
N-[1-(2,3-Dioleyloxy)proph-	DOTMA	Cationic
yl]N,N,N-trimethylammonium chloride
1,2-Dioleoyloxy-3-trimethyl-	DOTAP	Cationic
ammonium-propane
Dioctadecylamidoglycylspermine	DOGS	Cationic
N-(3-Aminopropyl)-N,N-dimeth-	GAP-DLRIE	Cationic
yl-2,3-bis(dodecyloxy)-1-prop-
anaminium bromide
Cetyltrimethylammonium bromide	CTAB	Cationic
6-Lauroxyhexyl ornithinate	LHON	Cationic
1-(2,3-Dioleoyloxyprop-	2Oc	Cationic
yl)-2,4,6-trimethylpyridinium
2,3-Dioleyloxy-N-[2(sperminecarbox-	DOSPA	Cationic
amido-ethyl]-N,N-dimethyl-1-prop-
anaminium trifluoroacetate
1,2-Dioleyl-3-trimethylammonium-propane	DOPA	Cationic
N-(2-Hydroxyethyl)-N,N-dimeth-	MDRIE	Cationic
yl-2,3-bis(tetradecyloxy)-1-prop-
anaminium bromide
Dimyristooxypropyl dimethyl	DMRI	Cationic
hydroxyethyl ammonium bromide
3β-[N-(N′,N′-Dimethylaminoeth-	DC-Chol	Cationic
ane)-carbamoyl]cholesterol
Bis-guanidium-tren-cholesterol	BGTC	Cationic
1,3-Diodeoxy-2-(6-carboxy-sperm-	DOSPER	Cationic
yl)-propylamide
Dimethyloctadecylammonium bromide	DDAB	Cationic
Dioctadecylamidoglicylspermidin	DSL	Cationic
rac-[(2,3-Dioctadecyloxypropyl)(2-hydroxy-	CLIP-1	Cationic
ethyl)]dimethylammonium chloride
rac-[2(2,3-Dihexadecyloxypropyl-	CLIP-6	Cationic
oxymethyloxy)ethyl]trimethyl-
ammonium bromide
Ethyldimyristoylphosphatidylcholine	EDMPC	Cationic
1,2-Distearyloxy-N,N-dimeth-	DSDMA	Cationic
yl-3-aminopropane
1,2-Dimyristoyl-trimethyl-	DMTAP	Cationic
ammonium propane
O,O′-Dimyristyl-N-lysyl aspartate	DMKE	Cationic
1,2-Distearoyl-sn-glycero-3-ethyl-	DSEPC	Cationic
phosphocholine
N-Palmitoyl D-erythro-sphingosyl	CCS	Cationic
carbamoyl-spermine
N-t-Butyl-N0-tetradecyl-3-tetradecyl-	diC14-amidine	Cationic
aminopropionamidine
Octadecenolyoxy[ethyl-2-heptadecen-	DOTIM	Cationic
yl-3 hydroxyethyl] imidazolinium chloride
N1-Cholesteryloxycarbon-	CDAN	Cationic
yl-3,7-diazanonane-1,9-diamine
2-(3-[Bis(3-amino-propyl)-amino]propyl-	RPR209120	Cationic
amino)-N-ditetradecyl-
carbamoylme-ethyl-acetamide
1,2-dilinoleyloxy-3-dimethylaminopropane	DLinDMA	Cationic
2,2-dilinoleyl-4-dimethylaminoeth-	DLin-KC2-	Cationic
yl-[1,3]-dioxolane	DMA
dilinoleyl-methyl-4-dimethyl-	DLin-MC3-	Cationic
aminobutyrate	DMA

Exemplary polymers for gene transfer are shown below in Table 59.

TABLE 59
Polymers Used for Gene Transfer
Polymer                          Abbreviation
Poly(ethylene)glycol             PEG
Polyethylenimine                 PEI
Dithiobis(succinimidylpropionate) DSP
Dimethyl-3,3′-dithiobispropionimidate DTBP
Poly(ethylene imine) biscarbamate PEIC
Poly(L-lysine)                   PLL
Histidine modified PLL
Poly(N-vinylpyrrolidone)         PVP
Poly(propylenimine)              PPI
Poly(amidoamine)                 PAMAM
Poly(amido ethylenimine)         SS-PAEI
Triethylenetetramine             TETA
Poly(β-aminoester)
Poly(4-hydroxy-L-proline ester)  PHP
Poly(allylamine)
Poly(α[4-aminobutyl]-L-glycolic acid) PAGA
Poly(D,L-lactic-co-glycolic acid) PLGA
Poly(N-ethyl-4-vinylpyridinium bromide)
Poly(phosphazene)s               PPZ
Poly(phosphoester)s              PPE
Poly(phosphoramidate)s           PPA
Poly(N-2-hydroxypropylmethacrylamide) pHPMA
Poly(2-(dimethylamino)ethyl methacrylate) pDMAEMA
Poly(2-aminoethyl propylene phosphate) PPE-EA
Chitosan
Galactosylated chitosan
N-Dodacylated chitosan
Histone
Collagen
Dextran-spermine                 D-SPM

In an embodiment, the vehicle has targeting modifications to increase target cell update of nanoparticles and liposomes, e.g., cell specific antigens, monoclonal antibodies, single chain antibodies, aptamers, polymers, sugars, and cell penetrating peptides. In an embodiment, the vehicle uses fusogenic and endosome-destabilizing peptides/polymers. In an embodiment, the vehicle undergoes acid-triggered conformational changes (e.g., to accelerate endosomal escape of the cargo). In an embodiment, a stimuli-cleavable polymer is used, e.g., for release in a cellular compartment. For example, disulfide-based cationic polymers that are cleaved in the reducing cellular environment can be used.

In an embodiment, the delivery vehicle is a biological non-viral delivery vehicle. In an embodiment, the vehicle is an attenuated bacterium (e.g., naturally or artificially engineered to be invasive but attenuated to prevent pathogenesis and expressing the transgene (e.g., Listeria monocytogenes, certain Salmonella strains, Bifidobacterium longum, and modified Escherichia coli), bacteria having nutritional and tissue-specific tropism to target specific tissues, bacteria having modified surface proteins to alter target tissue specificity). In an embodiment, the vehicle is a genetically modified bacteriophage (e.g., engineered phages having large packaging capacity, less immunogenic, containing mammalian plasmid maintenance sequences and having incorporated targeting ligands). In an embodiment, the vehicle is a mammalian virus-like particle. For example, modified viral particles can be generated (e.g., by purification of the “empty” particles followed by ex vivo assembly of the virus with the desired cargo). The vehicle can also be engineered to incorporate targeting ligands to alter target tissue specificity. In an embodiment, the vehicle is a biological liposome. For example, the biological liposome is a phospholipid-based particle derived from human cells (e.g., erythrocyte ghosts, which are red blood cells broken down into spherical structures derived from the subject (e.g., tissue targeting can be achieved by attachment of various tissue or cell-specific ligands), or secretory exosomes—subject (i.e., patient) derived membrane-bound nanovesicle (30-100 nm) of endocytic origin (e.g., can be produced from various cell types and can therefore be taken up by cells without the need of for targeting ligands).

In an embodiment, the delivery vehicle is a powder comprising, e.g., calcium carbonate, sucrose, mannitol, dextrose, or lactose.

In an embodiment, components are delivered as an aerosol.

In an embodiment, one or more nucleic acid molecules (e.g., DNA molecules) other than the components of a Cas system, e.g., the Cas9 molecule component and/or the gRNA molecule component described herein, are delivered. In an embodiment, the nucleic acid molecule is delivered at the same time as one or more of the components of the Cas system are delivered. In an embodiment, the nucleic acid molecule is delivered before or after (e.g., less than about 30 minutes, 1 hour, 2 hours, 3 hours, 6 hours, 9 hours, 12 hours, 1 day, 2 days, 3 days, 1 week, 2 weeks, or 4 weeks) one or more of the components of the Cas system are delivered. In an embodiment, the nucleic acid molecule is delivered by a different means than one or more of the components of the Cas system, e.g., the Cas9 molecule component and/or the gRNA molecule component, are delivered. The nucleic acid molecule can be delivered by any of the delivery methods described herein. For example, the nucleic acid molecule can be delivered by a viral vector, e.g., an integration-deficient lentivirus, and the Cas9 molecule component and/or the gRNA molecule component can be delivered by electroporation, e.g., such that the toxicity caused by nucleic acids (e.g., DNAs) can be reduced. In an embodiment, the nucleic acid molecule encodes a therapeutic protein, e.g., a protein described herein. In an embodiment, the nucleic acid molecule encodes an RNA molecule, e.g., an RNA molecule described herein.

Delivery of RNA Encoding a Cas9 Molecule

RNA encoding Cas9 molecules (e.g., eaCas9 molecules or eiCas9 molecules) and/or gRNA molecules, can be delivered into cells, e.g., target cells described herein, by art-known methods or as described herein. For example, Cas9-encoding and/or gRNA-encoding RNA can be delivered, e.g., by microinjection, electroporation, transient cell compression or squeezing (e.g., as described in Lee, et al [2012] Nano Lett 12: 6322-27), lipid-mediated transfection, lipid-mediated transfection, peptide-mediated delivery, or a combination thereof. Cas9-encoding and/or gRNA-encoding RNA can be conjugated to molecules promoting uptake by the target cells (e.g., target cells described herein).

In an embodiment, delivery via electroporation comprises mixing the cells with the RNA encoding Cas9 molecules (e.g., eaCas9 molecules, eiCas9 molecules or eiCas9 fusion proteins) and/or gRNA molecules, with or without donor nucleic acid molecules in a cartridge, chamber or cuvette and applying one or more electrical impulses of defined duration and amplitude. In an embodiment, delivery via electroporation is performed using a system in which cells are mixed with the RNA encoding Cas9 molecules (e.g., eaCas9 molecules, eiCas9 molecules or eiCas9 fusion proteins) and/or gRNA molecules, with or without donor nucleic acid molecules in a vessel connected to a device (eg, a pump) which feeds the mixture into a cartridge, chamber or cuvette wherein one or more electrical impulses of defined duration and amplitude are applied, after which the cells are delivered to a second vessel.

Delivery Cas9 Molecule Protein

Cas9 molecules (e.g., eaCas9 molecules or eiCas9 molecules) can be delivered into cells by art-known methods or as described herein. For example, Cas9 protein molecules can be delivered, e.g., by microinjection, electroporation, lipid-mediated transfection, peptide-mediated delivery, or a combination thereof. Delivery can be accompanied by DNA encoding a gRNA or by a gRNA. Cas9 protein can be conjugated to molecules promoting uptake by the target cells (e.g., target cells described herein).

In an embodiment, delivery via electroporation comprises mixing the cells with the Cas9 molecules (e.g., eaCas9 molecules, eiCas9 molecules or eiCas9 fusion proteins) and/or gRNA molecules, with or without donor nucleic acid, in a cartridge, chamber or cuvette and applying one or more electrical impulses of defined duration and amplitude. In an embodiment, delivery via electroporation is performed using a system in which cells are mixed with the Cas9 molecules (e.g., eaCas9 molecules, eiCas9 molecules or eiCas9 fusion proteins) and/or gRNA molecules, with or without donor nucleic acid in a vessel connected to a device (eg, a pump) which feeds the mixture into a cartridge, chamber or cuvette wherein one or more electrical impulses of defined duration and amplitude are applied, after which the cells are delivered to a second vessel.

Route of Administration

Systemic modes of administration include oral and parenteral routes. Parenteral routes include, by way of example, intravenous, intra-arterial, intraosseous, intramuscular, intradermal, subcutaneous and intraperitoneal routes. Components administered systemically may be modified or formulated to target the components to specific cells, e.g., airway epithelial cells, pulmonary epithelial cells, gastrointestinal epithelial cells, biliary epithelial cells, pancreatic ductal epithelial cells, reproductive epithelial cells or pulmonary stem cells.

Local modes of administration include, by way of example, inhalation, intra-nasal instillation, and intraparenchymal injection, e.g., intraparenchymal injection into the lung, bronchial tree, liver, pancreas, pancreatic duct, bile duct, gastrointestinal tract or reproductive tract. In an embodiment, significantly smaller amounts of the components (compared with systemic approaches) may exert an effect when administered locally (for example, by inhalation) compared to when administered systemically (for example, intravenously). Local modes of administration can reduce or eliminate the incidence of potentially toxic side effects that may occur when therapeutically effective amounts of a component are administered systemically.

In an embodiment, components described herein are delivered by inhalation.

In an embodiment, nanoparticle or viral, e.g., AAV vector, delivery is via inhalation.

In an embodiment, subjects are treated with mucus loosening agents and/or chest physical therapy prior to administration of components by inhalation.

Administration may be provided as a periodic bolus or as continuous infusion from an internal reservoir or from an external reservoir (for example, from an intravenous bag). Components may be administered locally, for example, by continuous release from a sustained release drug delivery device.

In addition, components may be formulated to permit release over a prolonged period of time. A release system can include a matrix of a biodegradable material or a material which releases the incorporated components by diffusion. The components can be homogeneously or heterogeneously distributed within the release system. A variety of release systems may be useful, however, the choice of the appropriate system will depend upon rate of release required by a particular application. Both non-degradable and degradable release systems can be used. Suitable release systems include polymers and polymeric matrices, non-polymeric matrices, or inorganic and organic excipients and diluents such as, but not limited to, calcium carbonate and sugar (for example, trehalose). Release systems may be natural or synthetic. However, synthetic release systems are preferred because generally they are more reliable, more reproducible and produce more defined release profiles. The release system material can be selected so that components having different molecular weights are released by diffusion through or degradation of the material.

Representative synthetic, biodegradable polymers include, for example: polyamides such as poly(amino acids) and poly(peptides); polyesters such as poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid), and poly(caprolactone); poly(anhydrides); polyorthoesters; polycarbonates; and chemical derivatives thereof (substitutions, additions of chemical groups, for example, alkyl, alkylene, hydroxylations, oxidations, and other modifications routinely made by those skilled in the art), copolymers and mixtures thereof. Representative synthetic, non-degradable polymers include, for example: polyethers such as poly(ethylene oxide), poly(ethylene glycol), and poly(tetramethylene oxide); vinyl polymers-polyacrylates and polymethacrylates such as methyl, ethyl, other alkyl, hydroxyethyl methacrylate, acrylic and methacrylic acids, and others such as poly(vinyl alcohol), poly(vinyl pyrolidone), and poly(vinyl acetate); poly(urethanes); cellulose and its derivatives such as alkyl, hydroxyalkyl, ethers, esters, nitrocellulose, and various cellulose acetates; polysiloxanes; and any chemical derivatives thereof (substitutions, additions of chemical groups, for example, alkyl, alkylene, hydroxylations, oxidations, and other modifications routinely made by those skilled in the art), copolymers and mixtures thereof.

Poly(lactide-co-glycolide) microsphere can also be used for injection. Typically the microspheres are composed of a polymer of lactic acid and glycolic acid, which are structured to form hollow spheres. The spheres can be approximately 15-30 microns in diameter and can be loaded with components described herein.

Bi-Modal or Differential Delivery of Components

Separate delivery of the components of a Cas system, e.g., the Cas9 molecule component and the gRNA molecule component, and more particularly, delivery of the components by differing modes, can enhance performance, e.g., by improving tissue specificity and safety.

In an embodiment, the Cas9 molecule and the gRNA molecule are delivered by different modes, or as sometimes referred to herein as differential modes. Different or differential modes, as used herein, refer modes of delivery that confer different pharmacodynamic or pharmacokinetic properties on the subject component molecule, e.g., a Cas9 molecule, gRNA molecule, or template nucleic acid. For example, the modes of delivery can result in different tissue distribution, different half-life, or different temporal distribution, e.g., in a selected compartment, tissue, or organ.

Some modes of delivery, e.g., delivery by a nucleic acid vector that persists in a cell, or in progeny of a cell, e.g., by autonomous replication or insertion into cellular nucleic acid, result in more persistent expression of and presence of a component. Examples include viral, e.g., adeno-associated virus or lentivirus, delivery.

By way of example, the components, e.g., a Cas9 molecule and a gRNA molecule, can be delivered by modes that differ in terms of resulting half-life or persistent of the delivered component the body, or in a particular compartment, tissue or organ. In an embodiment, a gRNA molecule can be delivered by such modes. The Cas9 molecule component can be delivered by a mode which results in less persistence or less exposure to the body or a particular compartment or tissue or organ.

More generally, in an embodiment, a first mode of delivery is used to deliver a first component and a second mode of delivery is used to deliver a second component. The first mode of delivery confers a first pharmacodynamic or pharmacokinetic property. The first pharmacodynamic property can be, e.g., distribution, persistence, or exposure, of the component, or of a nucleic acid that encodes the component, in the body, a compartment, tissue or organ. The second mode of delivery confers a second pharmacodynamic or pharmacokinetic property. The second pharmacodynamic property can be, e.g., distribution, persistence, or exposure, of the component, or of a nucleic acid that encodes the component, in the body, a compartment, tissue or organ.

In an embodiment, the first pharmacodynamic or pharmacokinetic property, e.g., distribution, persistence or exposure, is more limited than the second pharmacodynamic or pharmacokinetic property.

In an embodiment, the first mode of delivery is selected to optimize, e.g., minimize, a pharmacodynamic or pharmacokinetic property, e.g., distribution, persistence or exposure.

In an embodiment, the second mode of delivery is selected to optimize, e.g., maximize, a pharmacodynamic or pharmcokinetic property, e.g., distribution, persistence or exposure.

In an embodiment, the first mode of delivery comprises the use of a relatively persistent element, e.g., a nucleic acid, e.g., a plasmid or viral vector, e.g., an AAV or lentivirus. As such vectors are relatively persistent product transcribed from them would be relatively persistent.

In an embodiment, the second mode of delivery comprises a relatively transient element, e.g., an RNA or protein.

In an embodiment, the first component comprises gRNA, and the delivery mode is relatively persistent, e.g., the gRNA is transcribed from a plasmid or viral vector, e.g., an AAV or lentivirus. Transcription of these genes would be of little physiological consequence because the genes do not encode for a protein product, and the gRNAs are incapable of acting in isolation. The second component, a Cas9 molecule, is delivered in a transient manner, for example as mRNA or as protein, ensuring that the full Cas9 molecule/gRNA molecule complex is only present and active for a short period of time.

Furthermore, the components can be delivered in different molecular form or with different delivery vectors that complement one another to enhance safety and tissue specificity.

Use of differential delivery modes can enhance performance, safety and efficacy. E.g., the likelihood of an eventual off-target modification can be reduced. Delivery of immunogenic components, e.g., Cas9 molecules, by less persistent modes can reduce immunogenicity, as peptides from the bacterially-derived Cas enzyme are displayed on the surface of the cell by MHC molecules. A two-part delivery system can alleviate these drawbacks.

Differential delivery modes can be used to deliver components to different, but overlapping target regions. The formation active complex is minimized outside the overlap of the target regions. Thus, in an embodiment, a first component, e.g., a gRNA molecule is delivered by a first delivery mode that results in a first spatial, e.g., tissue, distribution. A second component, e.g., a Cas9 molecule is delivered by a second delivery mode that results in a second spatial, e.g., tissue, distribution. In an embodiment, the first mode comprises a first element selected from a liposome, nanoparticle, e.g., polymeric nanoparticle, and a nucleic acid, e.g., viral vector. The second mode comprises a second element selected from the group. In an embodiment, the first mode of delivery comprises a first targeting element, e.g., a cell specific receptor or an antibody, and the second mode of delivery does not include that element. In embodiment, the second mode of delivery comprises a second targeting element, e.g., a second cell specific receptor or second antibody.

When the Cas9 molecule is delivered in a virus delivery vector, a liposome, or polymeric nanoparticle, there is the potential for delivery to and therapeutic activity in multiple tissues, when it may be desirable to only target a single tissue. A two-part delivery system can resolve this challenge and enhance tissue specificity. If the gRNA molecule and the Cas9 molecule are packaged in separated delivery vehicles with distinct but overlapping tissue tropism, the fully functional complex is only be formed in the tissue that is targeted by both vectors.

Ex Vivo Delivery

In some embodiments, components described in Table 56 are introduced into cells which are then introduced into the subject e.g., cells are removed from a subject, manipulated ex vivo and then introduced into the subject. Methods of introducing the components can include, e.g., any of the delivery methods described herein, e.g., any of the delivery methods described in Table 57.

VIII. Modified Nucleosides, Nucleotides, and Nucleic Acids

Modified nucleosides and modified nucleotides can be present in nucleic acids, e.g., particularly gRNA, but also other forms of RNA, e.g., mRNA, RNAi, or siRNA. As described herein, “nucleoside” is defined as a compound containing a five-carbon sugar molecule (a pentose or ribose) or derivative thereof, and an organic base, purine or pyrimidine, or a derivative thereof. As described herein, “nucleotide” is defined as a nucleoside further comprising a phosphate group.

Modified nucleosides and nucleotides can include one or more of:

• • (i) alteration, e.g., replacement, of one or both of the non-linking phosphate oxygens and/or of one or more of the linking phosphate oxygens in the phosphodiester backbone linkage;
  • (ii) alteration, e.g., replacement, of a constituent of the ribose sugar, e.g., of the 2′ hydroxyl on the ribose sugar;
  • (iii) wholesale replacement of the phosphate moiety with “dephospho” linkers;
  • (iv) modification or replacement of a naturally occurring nucleobase;
  • (v) replacement or modification of the ribose-phosphate backbone;
  • (vi) modification of the 3′ end or 5′ end of the oligonucleotide, e.g., removal, modification or replacement of a terminal phosphate group or conjugation of a moiety; and
  • (vii) modification of the sugar.

The modifications listed above can be combined to provide modified nucleosides and nucleotides that can have two, three, four, or more modifications. For example, a modified nucleoside or nucleotide can have a modified sugar and a modified nucleobase. In an embodiment, every base of a gRNA is modified, e.g., all bases have a modified phosphate group, e.g., all are phosphorothioate groups. In an embodiment, all, or substantially all, of the phosphate groups of a unimolecular or modular gRNA molecule are replaced with phosphorothioate groups.

In an embodiment, modified nucleotides, e.g., nucleotides having modifications as described herein, can be incorporated into a nucleic acid, e.g., a “modified nucleic acid.” In some embodiments, the modified nucleic acids comprise one, two, three or more modified nucleotides. In some embodiments, at least 5% (e.g., at least about 5%, at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50%, at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or about 100%) of the positions in a modified nucleic acid are a modified nucleotides.

Unmodified nucleic acids can be prone to degradation by, e.g., cellular nucleases. For example, nucleases can hydrolyze nucleic acid phosphodiester bonds. Accordingly, in one aspect the modified nucleic acids described herein can contain one or more modified nucleosides or nucleotides, e.g., to introduce stability toward nucleases.

In some embodiments, the modified nucleosides, modified nucleotides, and modified nucleic acids described herein can exhibit a reduced innate immune response when introduced into a population of cells, both in vivo and ex vivo. The term “innate immune response” includes a cellular response to exogenous nucleic acids, including single stranded nucleic acids, generally of viral or bacterial origin, which involves the induction of cytokine expression and release, particularly the interferons, and cell death. In some embodiments, the modified nucleosides, modified nucleotides, and modified nucleic acids described herein can disrupt binding of a major groove interacting partner with the nucleic acid. In some embodiments, the modified nucleosides, modified nucleotides, and modified nucleic acids described herein can exhibit a reduced innate immune response when introduced into a population of cells, both in vivo and ex vivo, and also disrupt binding of a major groove interacting partner with the nucleic acid.

Definitions of Chemical Groups

As used herein, “alkyl” is meant to refer to a saturated hydrocarbon group which is straight-chained or branched. Example alkyl groups include methyl (Me), ethyl (Et), propyl (e.g., n-propyl and isopropyl), butyl (e.g., n-butyl, isobutyl, t-butyl), pentyl (e.g., n-pentyl, isopentyl, neopentyl), and the like. An alkyl group can contain from 1 to about 20, from 2 to about 20, from 1 to about 12, from 1 to about 8, from 1 to about 6, from 1 to about 4, or from 1 to about 3 carbon atoms.

As used herein, “aryl” refers to monocyclic or polycyclic (e.g., having 2, 3 or 4 fused rings) aromatic hydrocarbons such as, for example, phenyl, naphthyl, anthracenyl, phenanthrenyl, indanyl, indenyl, and the like. In some embodiments, aryl groups have from 6 to about 20 carbon atoms.

As used herein, “alkenyl” refers to an aliphatic group containing at least one double bond.

As used herein, “alkynyl” refers to a straight or branched hydrocarbon chain containing 2-12 carbon atoms and characterized in having one or more triple bonds. Examples of alkynyl groups include, but are not limited to, ethynyl, propargyl, and 3-hexynyl.

As used herein, “arylalkyl” or “aralkyl” refers to an alkyl moiety in which an alkyl hydrogen atom is replaced by an aryl group. Aralkyl includes groups in which more than one hydrogen atom has been replaced by an aryl group. Examples of “arylalkyl” or “aralkyl” include benzyl, 2-phenylethyl, 3-phenylpropyl, 9-fluorenyl, benzhydryl, and trityl groups.

As used herein, “cycloalkyl” refers to a cyclic, bicyclic, tricyclic, or polycyclic non-aromatic hydrocarbon groups having 3 to 12 carbons. Examples of cycloalkyl moieties include, but are not limited to, cyclopropyl, cyclopentyl, and cyclohexyl.

As used herein, “heterocyclyl” refers to a monovalent radical of a heterocyclic ring system. Representative heterocyclyls include, without limitation, tetrahydrofuranyl, tetrahydrothienyl, pyrrolidinyl, pyrrolidonyl, piperidinyl, pyrrolinyl, piperazinyl, dioxanyl, dioxolanyl, diazepinyl, oxazepinyl, thiazepinyl, and morpholinyl.

As used herein, “heteroaryl” refers to a monovalent radical of a heteroaromatic ring system. Examples of heteroaryl moieties include, but are not limited to, imidazolyl, oxazolyl, thiazolyl, triazolyl, pyrrolyl, furanyl, indolyl, thiophenyl pyrazolyl, pyridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, indolizinyl, purinyl, naphthyridinyl, quinolyl, and pteridinyl.

Phosphate Backbone Modifications

The Phosphate Group

In some embodiments, the phosphate group of a modified nucleotide can be modified by replacing one or more of the oxygens with a different substituent. Further, the modified nucleotide, e.g., modified nucleotide present in a modified nucleic acid, can include the wholesale replacement of an unmodified phosphate moiety with a modified phosphate as described herein. In some embodiments, the modification of the phosphate backbone can include alterations that result in either an uncharged linker or a charged linker with unsymmetrical charge distribution.

Examples of modified phosphate groups include, phosphorothioate, phosphoroselenates, borano phosphates, borano phosphate esters, hydrogen phosphonates, phosphoroamidates, alkyl or aryl phosphonates and phosphotriesters. In some embodiments, one of the non-bridging phosphate oxygen atoms in the phosphate backbone moiety can be replaced by any of the following groups: sulfur (S), selenium (Se), BR₃ (wherein R can be, e.g., hydrogen, alkyl, or aryl), C (e.g., an alkyl group, an aryl group, and the like), H, NR₂ (wherein R can be, e.g., hydrogen, alkyl, or aryl), or OR (wherein R can be, e.g., alkyl or aryl). The phosphorous atom in an unmodified phosphate group is achiral. However, replacement of one of the non-bridging oxygens with one of the above atoms or groups of atoms can render the phosphorous atom chiral; that is to say that a phosphorous atom in a phosphate group modified in this way is a stereogenic center. The stereogenic phosphorous atom can possess either the “R” configuration (herein Rp) or the “S” configuration (herein Sp).

Phosphorodithioates have both non-bridging oxygens replaced by sulfur. The phosphorus center in the phosphorodithioates is achiral which precludes the formation of oligoribonucleotide diastereomers. In some embodiments, modifications to one or both non-bridging oxygens can also include the replacement of the non-bridging oxygens with a group independently selected from S, Se, B, C, H, N, and OR (R can be, e.g., alkyl or aryl).

The phosphate linker can also be modified by replacement of a bridging oxygen, (i.e., the oxygen that links the phosphate to the nucleoside), with nitrogen (bridged phosphoroamidates), sulfur (bridged phosphorothioates) and carbon (bridged methylenephosphonates). The replacement can occur at either linking oxygen or at both of the linking oxygens.

Replacement of the Phosphate Group

The phosphate group can be replaced by non-phosphorus containing connectors. In some embodiments, the charge phosphate group can be replaced by a neutral moiety.

Examples of moieties which can replace the phosphate group can include, without limitation, e.g., methyl phosphonate, hydroxylamino, siloxane, carbonate, carboxymethyl, carbamate, amide, thioether, ethylene oxide linker, sulfonate, sulfonamide, thioformacetal, formacetal, oxime, methyleneimino, methylenemethylimino, methylenehydrazo, methylenedimethylhydrazo and methyleneoxymethylimino.

Replacement of the Ribophosphate Backbone

Scaffolds that can mimic nucleic acids can also be constructed wherein the phosphate linker and ribose sugar are replaced by nuclease resistant nucleoside or nucleotide surrogates. In some embodiments, the nucleobases can be tethered by a surrogate backbone. Examples can include, without limitation, the morpholino, cyclobutyl, pyrrolidine and peptide nucleic acid (PNA) nucleoside surrogates.

Sugar Modifications

The modified nucleosides and modified nucleotides can include one or more modifications to the sugar group. For example, the 2′ hydroxyl group (OH) can be modified or replaced with a number of different “oxy” or “deoxy” substituents. In some embodiments, modifications to the 2′ hydroxyl group can enhance the stability of the nucleic acid since the hydroxyl can no longer be deprotonated to form a 2′-alkoxide ion. The 2′-alkoxide can catalyze degradation by intramolecular nucleophilic attack on the linker phosphorus atom.

Examples of “oxy”-2′ hydroxyl group modifications can include alkoxy or aryloxy (OR, wherein “R” can be, e.g., alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or a sugar); polyethyleneglycols (PEG), O(CH₂CH₂O)_nCH₂CH₂OR wherein R can be, e.g., H or optionally substituted alkyl, and n can be an integer from 0 to 20 (e.g., from 0 to 4, from 0 to 8, from 0 to 10, from 0 to 16, from 1 to 4, from 1 to 8, from 1 to 10, from 1 to 16, from 1 to 20, from 2 to 4, from 2 to 8, from 2 to 10, from 2 to 16, from 2 to 20, from 4 to 8, from 4 to 10, from 4 to 16, and from 4 to 20). In some embodiments, the “oxy”-2′ hydroxyl group modification can include “locked” nucleic acids (LNA) in which the 2′ hydroxyl can be connected, e.g., by a C_1-6 alkylene or C_1-6 heteroalkylene bridge, to the 4′ carbon of the same ribose sugar, where exemplary bridges can include methylene, propylene, ether, or amino bridges; O-amino (wherein amino can be, e.g., NH₂; alkylamino, dialkylamino, heterocyclyl, arylamino, diarylamino, heteroarylamino, or diheteroarylamino, ethylenediamine, or polyamino) and aminoalkoxy, O(CH₂)_n-amino, (wherein amino can be, e.g., NH₂; alkylamino, dialkylamino, heterocyclyl, arylamino, diarylamino, heteroarylamino, or diheteroarylamino, ethylenediamine, or polyamino). In some embodiments, the “oxy”-2′ hydroxyl group modification can include the methoxyethyl group (MOE), (OCH₂CH₂OCH₃, e.g., a PEG derivative).

“Deoxy” modifications can include hydrogen (i.e. deoxyribose sugars, e.g., at the overhang portions of partially ds RNA); halo (e.g., bromo, chloro, fluoro, or iodo); amino (wherein amino can be, e.g., NH₂; alkylamino, dialkylamino, heterocyclyl, arylamino, diarylamino, heteroarylamino, diheteroarylamino, or amino acid); NH(CH₂CH₂NH)_nCH₂CH₂-amino (wherein amino can be, e.g., as described herein), —NHC(O)R (wherein R can be, e.g., alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or sugar), cyano; mercapto; alkyl-thio-alkyl; thioalkoxy; and alkyl, cycloalkyl, aryl, alkenyl and alkynyl, which may be optionally substituted with e.g., an amino as described herein.

The sugar group can also contain one or more carbons that possess the opposite stereochemical configuration than that of the corresponding carbon in ribose. Thus, a modified nucleic acid can include nucleotides containing e.g., arabinose, as the sugar. The nucleotide “monomer” can have an alpha linkage at the 1′ position on the sugar, e.g., alpha-nucleosides. The modified nucleic acids can also include “abasic” sugars, which lack a nucleobase at C-1′. These abasic sugars can also be further modified at one or more of the constituent sugar atoms. The modified nucleic acids can also include one or more sugars that are in the L form, e.g. L-nucleosides.

Generally, RNA includes the sugar group ribose, which is a 5-membered ring having an oxygen. Exemplary modified nucleosides and modified nucleotides can include, without limitation, replacement of the oxygen in ribose (e.g., with sulfur (S), selenium (Se), or alkylene, such as, e.g., methylene or ethylene); addition of a double bond (e.g., to replace ribose with cyclopentenyl or cyclohexenyl); ring contraction of ribose (e.g., to form a 4-membered ring of cyclobutane or oxetane); ring expansion of ribose (e.g., to form a 6- or 7-membered ring having an additional carbon or heteroatom, such as for example, anhydrohexitol, altritol, mannitol, cyclohexanyl, cyclohexenyl, and morpholino that also has a phosphoramidate backbone). In some embodiments, the modified nucleotides can include multicyclic forms (e.g., tricyclo; and “unlocked” forms, such as glycol nucleic acid (GNA) (e.g., R-GNA or S-GNA, where ribose is replaced by glycol units attached to phosphodiester bonds), threose nucleic acid (TNA, where ribose is replaced with α-L-threofuranosyl-(3′→2′)).

Modifications on the Nucleobase

The modified nucleosides and modified nucleotides described herein, which can be incorporated into a modified nucleic acid, can include a modified nucleobase. Examples of nucleobases include, but are not limited to, adenine (A), guanine (G), cytosine (C), and uracil (U). These nucleobases can be modified or wholly replaced to provide modified nucleosides and modified nucleotides that can be incorporated into modified nucleic acids. The nucleobase of the nucleotide can be independently selected from a purine, a pyrimidine, a purine or pyrimidine analog. In some embodiments, the nucleobase can include, for example, naturally-occurring and synthetic derivatives of a base.

Uracil

In some embodiments, the modified nucleobase is a modified uracil. Exemplary nucleobases and nucleosides having a modified uracil include without limitation pseudouridine (ψ), pyridin-4-one ribonucleoside, 5-aza-uridine, 6-aza-uridine, 2-thio-5-aza-uridine, 2-thio-uridine (s2U), 4-thio-uridine (s4U), 4-thio-pseudouridine, 2-thio-pseudouridine, 5-hydroxy-uridine (ho⁵U), 5-aminoallyl-uridine, 5-halo-uridine (e.g., 5-iodo-uridine or 5-bromo-uridine), 3-methyl-uridine (m³U), 5-methoxy-uridine (mo⁵U), uridine 5-oxyacetic acid (cmo⁵U), uridine 5-oxyacetic acid methyl ester (mcmo⁵U), 5-carboxymethyl-uridine (cm⁵U), 1-carboxymethyl-pseudouridine, 5-carboxyhydroxymethyl-uridine (chm⁵U), 5-carboxyhydroxymethyl-uridine methyl ester (mchm⁵U), 5-methoxycarbonylmethyl-uridine (mcm⁵U), 5-methoxycarbonylmethyl-2-thio-uridine (mcm⁵s2U), 5-aminomethyl-2-thio-uridine (nm⁵s2U), 5-methylaminomethyl-uridine (mnm⁵U), 5-methylaminomethyl-2-thio-uridine (mnm⁵s2U), 5-methylaminomethyl-2-seleno-uridine (mnm⁵se²U), 5-carbamoylmethyl-uridine (ncm⁵U), 5-carboxymethylaminomethyl-uridine (cmnm⁵U), 5-carboxymethylaminomethyl-2-thio-uridine (cmnm⁵s2U), 5-propynyl-uridine, 1-propynyl-pseudouridine, 5-taurinomethyl-uridine (τcm⁵U), 1-taurinomethyl-pseudouridine, 5-taurinomethyl-2-thio-uridine (τm⁵s2U), 1-taurinomethyl-4-thio-pseudouridine, 5-methyl-uridine (m⁵U, i.e., having the nucleobase deoxythymine), 1-methyl-pseudouridine (m¹ψ), 5-methyl-2-thio-uridine (m⁵s2U), 1-methyl-4-thio-pseudouridine (m¹s4ψ), 4-thio-1-methyl-pseudouridine, 3-methyl-pseudouridine (m³ψ), 2-thio-1-methyl-pseudouridine, 1-methyl-1-deaza-pseudouridine, 2-thio-1-methyl-1-deaza-pseudouridine, dihydrouridine (D), dihydropseudouridine, 5,6-dihydrouridine, 5-methyl-dihydrouridine (m⁵D), 2-thio-dihydrouridine, 2-thio-dihydropseudouridine, 2-methoxy-uridine, 2-methoxy-4-thio-uridine, 4-methoxy-pseudouridine, 4-methoxy-2-thio-pseudouridine, N1-methyl-pseudouridine, 3-(3-amino-3-carboxypropyl)uridine (acp³U), 1-methyl-3-(3-amino-3-carboxypropyl)pseudouridine (acp³ψ), 5-(isopentenylaminomethyl)uridine (inm⁵U), 5-(isopentenylaminomethyl)-2-thio-uridine (inm⁵s2U), α-thio-uridine, 2′-O-methyl-uridine (Um), 5,2′-O-dimethyl-uridine (m⁵Um), 2′-O-methyl-pseudouridine (ψm), 2-thio-2′-O-methyl-uridine (s2Um), 5-methoxycarbonylmethyl-2′-O-methyl-uridine (mcm⁵Um), 5-carbamoylmethyl-2′-O-methyl-uridine (ncm⁵Um), 5-carboxymethylaminomethyl-2′-O-methyl-uridine (cmnm⁵Um), 3,2′-O-dimethyl-uridine (m³Um), 5-(isopentenylaminomethyl)-2′-O-methyl-uridine (inm⁵Um), 1-thio-uridine, deoxythymidine, 2′-F-ara-uridine, 2′-F-uridine, 2′-OH-ara-uridine, 5-(2-carbomethoxyvinyl) uridine, 5-[3-(1-E-propenylamino)uridine, pyrazolo[3,4-d]pyrimidines, xanthine, and hypoxanthine.

Cytosine

In some embodiments, the modified nucleobase is a modified cytosine. Exemplary nucleobases and nucleosides having a modified cytosine include without limitation 5-aza-cytidine, 6-aza-cytidine, pseudoisocytidine, 3-methyl-cytidine (m³C), N4-acetyl-cytidine (act), 5-formyl-cytidine (f⁵C), N4-methyl-cytidine (m⁴C), 5-methyl-cytidine (m⁵C), 5-halo-cytidine (e.g., 5-iodo-cytidine), 5-hydroxymethyl-cytidine (hm⁵C), 1-methyl-pseudoisocytidine, pyrrolo-cytidine, pyrrolo-pseudoisocytidine, 2-thio-cytidine (s2C), 2-thio-5-methyl-cytidine, 4-thio-pseudoisocytidine, 4-thio-1-methyl-pseudoisocytidine, 4-thio-1-methyl-1-deaza-pseudoisocytidine, 1-methyl-1-deaza-pseudoisocytidine, zebularine, 5-aza-zebularine, 5-methyl-zebularine, 5-aza-2-thio-zebularine, 2-thio-zebularine, 2-methoxy-cytidine, 2-methoxy-5-methyl-cytidine, 4-methoxy-pseudoisocytidine, 4-methoxy-1-methyl-pseudoisocytidine, lysidine (k²C), α-thio-cytidine, 2′-O-methyl-cytidine (Cm), 5,2′-O-dimethyl-cytidine (m⁵Cm), N4-acetyl-2′-O-methyl-cytidine (ac⁴Cm), N4,2′-O-dimethyl-cytidine (m⁴Cm), 5-formyl-2′-O-methyl-cytidine (f⁵Cm), N4,N4,2′-O-trimethyl-cytidine (m⁴₂Cm), 1-thio-cytidine, 2′-F-ara-cytidine, 2′-F-cytidine, and 2′-OH-ara-cytidine.

Adenine

In some embodiments, the modified nucleobase is a modified adenine. Exemplary nucleobases and nucleosides having a modified adenine include without limitation 2-amino-purine, 2,6-diaminopurine, 2-amino-6-halo-purine (e.g., 2-amino-6-chloro-purine), 6-halo-purine (e.g., 6-chloro-purine), 2-amino-6-methyl-purine, 8-azido-adenosine, 7-deaza-adenosine, 7-deaza-8-aza-adenosine, 7-deaza-2-amino-purine, 7-deaza-8-aza-2-amino-purine, 7-deaza-2,6-diaminopurine, 7-deaza-8-aza-2,6-diaminopurine, 1-methyl-adenosine (m¹A), 2-methyl-adenosine (m²A), N6-methyl-adenosine (m⁶A), 2-methylthio-N6-methyl-adenosine (ms2 m⁶A), N6-isopentenyl-adenosine (i⁶A), 2-methylthio-N6-isopentenyl-adenosine (ms²i⁶A), N6-(cis-hydroxyisopentenyl)adenosine (io⁶A), 2-methylthio-N6-(cis-hydroxyisopentenyl)adenosine (ms2io⁶A), N6-glycinylcarbamoyl-adenosine (g⁶A), N6-threonylcarbamoyl-adenosine (t⁶A), N6-methyl-N6-threonylcarbamoyl-adenosine (m⁶t⁶A), 2-methylthio-N6-threonylcarbamoyl-adenosine (ms²g⁶A), N6,N6-dimethyl-adenosine (m⁶₂A), N6-hydroxynorvalylcarbamoyl-adenosine (hn⁶A), 2-methylthio-N6-hydroxynorvalylcarbamoyl-adenosine (ms2hn⁶A), N6-acetyl-adenosine (ac⁶A), 7-methyl-adenosine, 2-methylthio-adenosine, 2-methoxy-adenosine, α-thio-adenosine, 2′-O-methyl-adenosine (Am), N⁶,2′-O-dimethyl-adenosine (m⁶Am), N⁶-Methyl-2′-deoxyadenosine, N6,N6,2′-O-trimethyl-adenosine (m⁶₂Am), 1,2′-O-dimethyl-adenosine (m¹Am), 2′-O-ribosyladenosine (phosphate) (Ar(p)), 2-amino-N6-methyl-purine, 1-thio-adenosine, 8-azido-adenosine, 2′-F-ara-adenosine, 2′-F-adenosine, 2′-OH-ara-adenosine, and N6-(19-amino-pentaoxanonadecyl)-adenosine.

Guanine

In some embodiments, the modified nucleobase is a modified guanine. Exemplary nucleobases and nucleosides having a modified guanine include without limitation inosine (I), 1-methyl-inosine (m¹I), wyosine (imG), methylwyosine (mimG), 4-demethyl-wyosine (imG-14), isowyosine (imG2), wybutosine (yW), peroxywybutosine (o₂yW), hydroxywybutosine (OHyW), undermodified hydroxywybutosine (OHyW*), 7-deaza-guanosine, queuosine (Q), epoxyqueuosine (oQ), galactosyl-queuosine (galQ), mannosyl-queuosine (manQ), 7-cyano-7-deaza-guanosine (preQo), 7-aminomethyl-7-deaza-guanosine (preQ₁), archaeosine (G⁺), 7-deaza-8-aza-guanosine, 6-thio-guanosine, 6-thio-7-deaza-guanosine, 6-thio-7-deaza-8-aza-guanosine, 7-methyl-guanosine (m⁷G), 6-thio-7-methyl-guanosine, 7-methyl-inosine, 6-methoxy-guanosine, 1-methyl-guanosine (m′G), N2-methyl-guanosine (m²G), N2,N2-dimethyl-guanosine (m²₂G), N2,7-dimethyl-guanosine (m²,7G), N2, N2,7-dimethyl-guanosine (m²,2,7G), 8-oxo-guanosine, 7-methyl-8-oxo-guanosine, 1-methyl-6-thio-guanosine, N2-methyl-6-thio-guanosine, N2,N2-dimethyl-6-thio-guanosine, α-thio-guanosine, 2′-O-methyl-guanosine (Gm), N2-methyl-2′-O-methyl-guanosine (m²Gm), N2,N2-dimethyl-2′-O-methyl-guanosine (m²₂Gm), 1-methyl-2′-O-methyl-guanosine (m′Gm), N2,7-dimethyl-2′-O-methyl-guanosine (m²,7Gm), 2′-O-methyl-inosine (Im), 1,2′-O-dimethyl-inosine (m′Im), O⁶-phenyl-2′-deoxyinosine, 2′-O-ribosylguanosine (phosphate) (Gr(p)), 1-thio-guanosine, O⁶-methyl-guanosine, O⁶-Methyl-2′-deoxyguanosine, 2′-F-ara-guanosine, and 2′-F-guanosine.

Exemplary Modified gRNAs

In some embodiments, the modified nucleic acids can be modified gRNAs. It is to be understood that any of the gRNAs described herein can be modified in accordance with this section, including any gRNA that comprises a targeting domain from Tables 1A-1E, 2A-2E, 3A-3D, 4A-4D, 5A-5E, 6A-6C, 7A-7D, 8A-8E, 9A-9B, 10A-10C, 11A-11E, 12A-12C, 13A-13D, 14A-14E, 15A-15C, or 16A-16D, 17A-17E, 18A-18C, 19A-19D, 20A-20E, 21A-21B, 22A-22D, 23A-23E, 24A-24D, 25A-25D, 26A-26E, 27A-27D, 28A-28D, 29A-29E, 30A-30B, 31A-31D, 32A-32D, 33A-33B, 34A-34D, 35A-35D, 36A-36D, 37A-37D, 38A-38E, 39A-39D, 40A-40D, 41A-41E, 42A-42D, 43A-43E, 44A-44G, 45A-45E, 46A-46E, 47A-47G, or 48A-48E.

Through experimentation (results not shown) we have found that the guide RNA (gRNA) component of the CRISPR/Cas system is more efficient at editing genes in T cells when it has been modified at or near its 5′ end (e.g., when the 5′ end of a gRNA is modified by the inclusion of a eukaryotic mRNA cap structure or cap analog). While not wishing to be bound by theory it is believed that these and other modified gRNAs described herein elicit a reduced innate immune response from certain circulatory cell types (e.g., T cells) and that this might be responsible for the observed improvements. The present invention encompasses the realization that minimizing the innate immune response of circulating cells (e.g., T cells) to gRNAs could be advantageous when using gRNAs to edit circulating cells (whether ex vivo or in vivo) and could also be advantageous when using gRNAs to edit non-circulating cells, e.g., when a gRNA is administered systemically or locally for in vivo gene editing purposes. The present invention also encompasses the realization that the improvements observed with a 5′ capped gRNA can be extended to gRNAs that have been modified in other ways to achieve the same type of structural or functional result (e.g., by the inclusion of modified nucleosides or nucleotides, or when an in vitro transcribed gRNA is modified by treatment with a phosphatase such as calf intestinal alkaline phosphatase to remove the 5′ triphosphate group). While not wishing to be bound by theory, in some embodiments, the modified gRNAs described herein may contain one or more modifications (e.g., modified nucleosides or nucleotides) which introduce stability toward nucleases (e.g., by the inclusion of modified nucleosides or nucleotides and/or a 3′ polyA tract).

Thus, in one aspect, methods and compositions discussed herein provide methods and compositions for gene editing by using gRNAs which have been modified at or near their 5′ end (e.g., within 1-10, 1-5, or 1-2 nucleotides of their 5′ end). In an embodiment, the 5′ end of a gRNA is modified by the inclusion of a eukaryotic mRNA cap structure or cap analog (e.g., a G(5′)ppp(5′)G cap analog, a m7G(5′)ppp(5′)G cap analog, or a 3′-O-Me-m7G(5′)ppp(5′)G anti reverse cap analog (ARCA)). The cap or cap analog can be included during either chemical synthesis or in vitro transcription of the gRNA. In an embodiment, an in vitro transcribed gRNA is modified by treatment with a phosphatase (e.g., calf intestinal alkaline phosphatase) to remove the 5′ triphosphate group.

In another aspect, methods and compositions discussed herein provide methods and compositions for gene editing by using gRNAs which include one or more modified nucleosides or nucleotides that are described herein. In some embodiments, the inclusion of the one or more modified nucleosides or nucleotides causes the gRNA to elicit a reduced innate immune response in certain circulating cell types (e.g., T cells, macrophages, dendritic cells, and/or B cells) as compared to an otherwise unmodified gRNA.

While some of the exemplary modifications discussed in this section may be included at any position within the gRNA sequence, in some embodiments, a gRNA comprises a modification at or near its 5′ end (e.g., within 1-10, 1-5, or 1-2 nucleotides of its 5′ end). In some embodiments, a gRNA comprises a modification at or near its 3′ end (e.g., within 1-10, 1-5, or 1-2 nucleotides of its 3′ end). In some embodiments, a gRNA comprises both a modification at or near its 5′ end and a modification at or near its 3′ end.

In an embodiment, the 3′ end of a gRNA is modified by the addition of one or more (e.g., 25-200) adenine (A) residues. The polyA tract can be contained in the nucleic acid (e.g., plasmid, PCR product, viral genome) encoding the gRNA, or can be added to the gRNA during chemical synthesis, or following in vitro transcription using a polyadenosine polymerase (e.g., E. coli Poly(A)Polymerase).

In an embodiment, in vitro transcribed gRNA contains both a 5′ cap structure or cap analog and a 3′ polyA tract. In an embodiment, an in vitro transcribed gRNA is modified by treatment with a phosphatase (e.g., calf intestinal alkaline phosphatase) to remove the 5′ triphosphate group and comprises a 3′ polyA tract.

In some embodiments, gRNAs can be modified at a 3′ terminal U ribose. For example, the two terminal hydroxyl groups of the U ribose can be oxidized to aldehyde groups and a concomitant opening of the ribose ring to afford a modified nucleoside as shown below:

wherein “U” can be an unmodified or modified uridine.

In another embodiment, the 3′ terminal U can be modified with a 2′3′ cyclic phosphate as shown below:

wherein “U” can be an unmodified or modified uridine.

In some embodiments, the gRNA molecules may contain 3′ nucleotides which can be stabilized against degradation, e.g., by incorporating one or more of the modified nucleotides described herein. In this embodiment, e.g., uridines can be replaced with modified uridines, e.g., 5-(2-amino)propyl uridine, and 5-bromo uridine, or with any of the modified uridines described herein; adenosines, cytidines and guanosines can be replaced with modified adenosines, cytidines and guanosines, e.g., with modifications at the 8-position, e.g., 8-bromo guanosine, or with any of the modified adenosines, cytidines or guanosines described herein.

In some embodiments, sugar-modified ribonucleotides can be incorporated into the gRNA, e.g., wherein the 2′ OH-group is replaced by a group selected from H, —OR, —R (wherein R can be, e.g., alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or sugar), halo, —SH, —SR (wherein R can be, e.g., alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or sugar), amino (wherein amino can be, e.g., NH₂; alkylamino, dialkylamino, heterocyclylamino, arylamino, diarylamino, heteroarylamino, diheteroarylamino, or amino acid); or cyano (—CN). In some embodiments, the phosphate backbone can be modified as described herein, e.g., with a phosphothioate group. In some embodiments, one or more of the nucleotides of the gRNA can each independently be a modified or unmodified nucleotide including, but not limited to 2′-sugar modified, such as, 2′-O-methyl, 2′-O-methoxyethyl, or 2′-Fluoro modified including, e.g., 2′-F or 2′-O-methyl, adenosine (A), 2′-F or 2′-O-methyl, cytidine (C), 2′-F or 2′-O-methyl, uridine (U), 2′-F or 2′-O-methyl, thymidine (T), 2′-F or 2′-O-methyl, guanosine (G), 2′-O-methoxyethyl-5-methyluridine (Teo), 2′-O-methoxyethyladenosine (Aeo), 2′-O-methoxyethyl-5-methylcytidine (m5Ceo), and any combinations thereof.

In some embodiments, a gRNA can include “locked” nucleic acids (LNA) in which the 2′ OH-group can be connected, e.g., by a C1-6 alkylene or C1-6 heteroalkylene bridge, to the 4′ carbon of the same ribose sugar, where exemplary bridges can include methylene, propylene, ether, or amino bridges; O-amino (wherein amino can be, e.g., NH₂; alkylamino, dialkylamino, heterocyclylamino, arylamino, diarylamino, heteroarylamino, or diheteroarylamino, ethylenediamine, or polyamino) and aminoalkoxy or O(CH₂)_n-amino (wherein amino can be, e.g., NH₂; alkylamino, dialkylamino, heterocyclylamino, arylamino, diarylamino, heteroarylamino, or diheteroarylamino, ethylenediamine, or polyamino).

In some embodiments, a gRNA can include a modified nucleotide which is multicyclic (e.g., tricyclo; and “unlocked” forms, such as glycol nucleic acid (GNA) (e.g., R-GNA or S-GNA, where ribose is replaced by glycol units attached to phosphodiester bonds), or threose nucleic acid (TNA, where ribose is replaced with α-L-threofuranosyl-(3′→2′)).

Generally, gRNA molecules include the sugar group ribose, which is a 5-membered ring having an oxygen. Exemplary modified gRNAs can include, without limitation, replacement of the oxygen in ribose (e.g., with sulfur (S), selenium (Se), or alkylene, such as, e.g., methylene or ethylene); addition of a double bond (e.g., to replace ribose with cyclopentenyl or cyclohexenyl); ring contraction of ribose (e.g., to form a 4-membered ring of cyclobutane or oxetane); ring expansion of ribose (e.g., to form a 6- or 7-membered ring having an additional carbon or heteroatom, such as for example, anhydrohexitol, altritol, mannitol, cyclohexanyl, cyclohexenyl, and morpholino that also has a phosphoramidate backbone). Although the majority of sugar analog alterations are localized to the 2′ position, other sites are amenable to modification, including the 4′ position. In an embodiment, a gRNA comprises a 4′-S, 4′-Se or a 4′-C-aminomethyl-2′-O-Me modification.

In some embodiments, deaza nucleotides, e.g., 7-deaza-adenosine, can be incorporated into the gRNA. In some embodiments, O- and N-alkylated nucleotides, e.g., N6-methyl adenosine, can be incorporated into the gRNA. In some embodiments, one or more or all of the nucleotides in a gRNA molecule are deoxynucleotides.

miRNA Binding Sites

microRNAs (or miRNAs) are naturally occurring cellular 19-25 nucleotide long noncoding RNAs. They bind to nucleic acid molecules having an appropriate miRNA binding site, e.g., in the 3′ UTR of an mRNA, and down-regulate gene expression. While not wishing to be bound by theory it is believed that the down regulation is either by reducing nucleic acid molecule stability or by inhibiting translation. An RNA species disclosed herein, e.g., an mRNA encoding Cas9 can comprise an miRNA binding site, e.g., in its 3′UTR. The miRNA binding site can be selected to promote down regulation of expression is a selected cell type. By way of example, the incorporation of a binding site for miR-122, a microRNA abundant in liver, can inhibit the expression of the gene of interest in the liver.

EXAMPLES

The following Examples are merely illustrative and are not intended to limit the scope or content of the invention in any way.

Example 1: Evaluation of Candidate Guide RNAs (gRNAs)

The suitability of candidate gRNAs can be evaluated as described in this example. Although described for a chimeric gRNA, the approach can also be used to evaluate modular gRNAs.

Cloning gRNAs into Vectors

For each gRNA, a pair of overlapping oligonucleotides is designed and obtained. Oligonucleotides are annealed and ligated into a digested vector backbone containing an upstream U6 promoter and the remaining sequence of a long chimeric gRNA. Plasmid is sequence-verified and prepped to generate sufficient amounts of transfection-quality DNA. Alternate promoters maybe used to drive in vivo transcription (e.g. H1 promoter) or for in vitro transcription (e.g., a T7 promoter).

Cloning gRNAs in Linear dsDNA Molecule (STITCHR)

For each gRNA, a single oligonucleotide is designed and obtained. The U6 promoter and the gRNA scaffold (e.g. including everything except the targeting domain, e.g., including sequences derived from the crRNA and tracrRNA, e.g., including a first complementarity domain; a linking domain; a second complementarity domain; a proximal domain; and a tail domain) are separately PCR amplified and purified as dsDNA molecules. The gRNA-specific oligonucleotide is used in a PCR reaction to stitch together the U6 and the gRNA scaffold, linked by the targeting domain specified in the oligonucleotide. Resulting dsDNA molecule (STITCHR product) is purified for transfection. Alternate promoters may be used to drive in vivo transcription (e.g., H1 promoter) or for in vitro transcription (e.g., T7 promoter). Any gRNA scaffold may be used to create gRNAs compatible with Cas9s from any bacterial species.

Initial gRNA Screen

Each gRNA to be tested is transfected, along with a plasmid expressing Cas9 and a small amount of a GFP-expressing plasmid into human cells. In preliminary experiments, these cells can be immortalized human cell lines such as 293T, K562 or U2OS. Alternatively, primary human cells may be used. In this case, cells may be relevant to the eventual therapeutic cell target (for example, an erythroid cell). The use of primary cells similar to the potential therapeutic target cell population may provide important information on gene targeting rates in the context of endogenous chromatin and gene expression.

Transfection may be performed using lipid transfection (such as Lipofectamine or Fugene) or by electroporation (such as Lonza Nucleofection). Following transfection, GFP expression can be determined either by fluorescence microscopy or by flow cytometry to confirm consistent and high levels of transfection. These preliminary transfections can comprise different gRNAs and different targeting approaches (17-mers, 20-mers, nuclease, dual-nickase, etc.) to determine which gRNAs/combinations of gRNAs give the greatest activity.

Efficiency of cleavage with each gRNA may be assessed by measuring NHEJ-induced indel formation at the target locus by a T7E1-type assay or by sequencing. Alternatively, other mismatch-sensitive enzymes, such as Cell/Surveyor nuclease, may also be used.

For the T7E1 assay, PCR amplicons are approximately 500-700 bp with the intended cut site placed asymmetrically in the amplicon. Following amplification, purification and size-verification of PCR products, DNA is denatured and re-hybridized by heating to 95° C. and then slowly cooling. Hybridized PCR products are then digested with T7 Endonuclease I (or other mismatch-sensitive enzyme) which recognizes and cleaves non-perfectly matched DNA. If indels are present in the original template DNA, when the amplicons are denatured and re-annealed, this results in the hybridization of DNA strands harboring different indels and therefore lead to double-stranded DNA that is not perfectly matched. Digestion products may be visualized by gel electrophoresis or by capillary electrophoresis. The fraction of DNA that is cleaved (density of cleavage products divided by the density of cleaved and uncleaved) may be used to estimate a percent NHEJ using the following equation: % NHEJ=(1−(1−fraction cleaved)^1/2). The T7E1 assay is sensitive down to about 2-5% NHEJ.

Sequencing may be used instead of, or in addition to, the T7E1 assay. For Sanger sequencing, purified PCR amplicons are cloned into a plasmid backbone, transformed, miniprepped and sequenced with a single primer. Sanger sequencing may be used for determining the exact nature of indels after determining the NHEJ rate by T7E1.

Sequencing may also be performed using next generation sequencing techniques. When using next generation sequencing, amplicons may be 300-500 bp with the intended cut site placed asymmetrically. Following PCR, next generation sequencing adapters and barcodes (for example Illumina multiplex adapters and indexes) may be added to the ends of the amplicon, e.g., for use in high throughput sequencing (for example on an Illumina MiSeq). This method allows for detection of very low NHEJ rates.

Example 2: Assessment of Gene Targeting by NHEJ

The gRNAs that induce the greatest levels of NHEJ in initial tests can be selected for further evaluation of gene targeting efficiency. In this case, cells are derived from disease subjects and, therefore, harbor the relevant mutation.

Following transfection (usually 2-3 days post-transfection) genomic DNA may be isolated from a bulk population of transfected cells and PCR may be used to amplify the target region. Following PCR, gene targeting efficiency to generate the desired mutations (either knockout of a target gene or removal of a target sequence motif) may be determined by sequencing. For Sanger sequencing, PCR amplicons may be 500-700 bp long. For next generation sequencing, PCR amplicons may be 300-500 bp long. If the goal is to knockout gene function, sequencing may be used to assess what percent of alleles have undergone NHEJ-induced indels that result in a frameshift or large deletion or insertion that would be expected to destroy gene function. If the goal is to remove a specific sequence motif, sequencing may be used to assess what percent of alleles have undergone NHEJ-induced deletions that span this sequence.

Example 3: Assessment of Gene Targeting by HDR

The gRNAs that induce the greatest levels of NHEJ in initial tests can be selected for further evaluation of gene targeting efficiency. In this case, cells are derived from disease subjects and, therefore, harbor the relevant mutation.

Following transfection (usually 2-3 days post-transfection) genomic DNA may be isolated from a bulk population of transfected cells and PCR may be used to amplify the target region. Following PCR, gene targeting efficiency can be determined by several methods.

Determination of gene targeting frequency involves measuring the percentage of alleles that have undergone homologous directed repair (HDR) with the donor template and which therefore have incorporated desired correction. If the desired HDR event creates or destroys a restriction enzyme site, the frequency of gene targeting may be determined by a RFLP assay. If no restriction site is created or destroyed, sequencing may be used to determine gene targeting frequency. If a RFLP assay is used, sequencing may still be used to verify the desired HDR event and ensure that no other mutations are present. At least one of the primers is placed in the endogenous gene sequence outside of the region included in the homology arms, which prevents amplification of donor template still present in the cells. Therefore, the length of the homology arms present in the donor template may affect the length of the PCR amplicon. PCR amplicons can either span the entire donor region (both primers placed outside the homology arms) or they can span only part of the donor region and a single junction between donor and endogenous DNA (one internal and one external primer). If the amplicons span less than entire donor region, two different PCRs should be used to amplify and sequence both the 5′ and the 3′ junction.

If the PCR amplicon is short (less than 600 bp) it is possible to use next generation sequencing. Following PCR, next generation sequencing adapters and barcodes (for example Illumina multiplex adapters and indexes) may be added to the ends of the amplicon, e.g., for use in high throughput sequencing (for example on an Illumina MiSeq). This method allows for detection of very low gene targeting rates.

If the PCR amplicon is too long for next generation sequencing, Sanger sequencing can be performed. For Sanger sequencing, purified PCR amplicons will be cloned into a plasmid backbone (for example, TOPO cloned using the LifeTech Zero Blunt® TOPO® cloning kit), transformed, miniprepped and sequenced.

INCORPORATION BY REFERENCE

All publications, patents, and patent applications mentioned herein are hereby incorporated by reference in their entirety as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference. In case of conflict, the present application, including any definitions herein, will control.

EQUIVALENTS

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

Claims

1. A method of altering a cystic fibrosis transmembrane conductance regulator (CFTR) gene in a cell, comprising administering to said cell:

(i) a CRISPR/Cas system comprising: (a) a gRNA molecule comprising a targeting domain that is complementary with a target sequence of a CFTR gene and (b) a Cas9 molecule; or

(ii) a nucleic acid composition comprising: (a) a first nucleotide sequence encoding a gRNA molecule comprising a targeting domain that is complementary with a target sequence of a CFTR gene and (b) a second nucleotide sequence encoding a Cas9 molecule.

2. The method of claim 1, wherein said alteration comprises correction of one or more mutations in said CFTR gene.

3. The method of claim 1, wherein said alteration of said CFTR gene results in restoration of a mutant CFTR gene to its wild type state thereby providing a functional CFTR protein.

4. The method of claim 1, wherein said cell is from a subject suffering from or at risk for Cystic Fibrosis (CF) and CF-like disease.

5. The method of claim 1, wherein said cell is from a subject having a mutation at a CF target mutant position.

6. The method of claim 1, wherein said cell is selected from the group consisting of an airway cell, an epithelial cell, and a stem cell.

7. The method of claim 6, wherein said epithelial cell is selected from the group consisting of a lung epithelial cell, a gastrointestinal epithelial cell, a biliary epithelial cell, a pancreatic ductal epithelial cell, a gastrointestinal cell, a hepatobiliary epithelial cell, a gallbladder epithelial cell, a large intestine epithelial cell, a small intestine epithelial cell, a jejunum epithelial cell, a epithelial cell of the ileum, a duodenum epithelial cell, and a reproductive epithelial cell; and said stem cell is selected from the group consisting of an embryonic stem cell, an induced pluripotent stem cell, a pulmonary stem cell, a gastrointestinal stem cell, and a mesenchymal stem cell.

8. The method of claim 1, wherein said targeting domain that is complementary with a target sequence of said CFTR gene comprises or consists of a nucleotide sequence that is the same as, or differs by no more than 3 nucleotides from, a nucleotide sequence set forth in SEQ ID NOs: 15101-27265.

9. A method of altering a sodium channel epithelial 1 alpha (SCNN1A) gene in a cell, comprising administering to said cell:

(i) a CRISPR/Cas system comprising: (a) a gRNA molecule comprising a targeting domain that is complementary with a target sequence of a SCNN1A gene and (b) a Cas9 molecule; or

(ii) a nucleic acid composition comprising: (a) a first nucleotide sequence encoding a gRNA molecule comprising a targeting domain that is complementary with a target sequence of a SCNN1A gene and (b) a second nucleotide sequence encoding a Cas9 molecule.

10. The method of claim 9, wherein said alteration comprises correction of one or more mutations in said SCNN1A gene, knockout of said SCNN1A gene, or knockdown of said SCNN1A gene.

11. The method of claim 9, wherein the alteration of said SCNN1A gene results in a reduction or elimination of expression of said SCNN1A gene.

12. The method of claim 9, wherein said cell is from a subject suffering from or at risk for Cystic Fibrosis (CF) and CF-like disease.

13. The method of claim 9, wherein said cell is from a subject having a mutation at a CF target mutant position, or from a subject who would benefit from having a mutation in said SCNN1A gene.

14. The method of claim 9, wherein the cell is selected from the group consisting of an airway cell, an epithelial cell, and a stem cell.

15. The method of claim 14, wherein said epithelial cell is selected from the group consisting of a lung epithelial cell, a gastrointestinal epithelial cell, a biliary epithelial cell, a pancreatic ductal epithelial cell, a gastrointestinal cell, a hepatobiliary epithelial cell, a gallbladder epithelial cell, a large intestine epithelial cell, a small intestine epithelial cell, a jejunum epithelial cell, a epithelial cell of the ileum, a duodenum epithelial cell, and a reproductive epithelial cell; and said stem cell is selected from the group consisting of an embryonic stem cell, an induced pluripotent stem cell, a pulmonary stem cell, a gastrointestinal stem cell, and a mesenchymal stem cell.

16. The method of claim 9, wherein said targeting domain that is complementary to a target sequence of said SCNN1A gene comprises or consists of a nucleotide sequence that is the same as, or differs by no more than 3 nucleotides from, a nucleotide sequence set forth in SEQ ID NOs: 497-654, 803-916, and 4176-15100.